PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Dubey, AK; Barad, S; Luria, N; Kumar, D; Espeso, EA; Prusky, DB				Dubey, Amit K.; Barad, Shiri; Luria, Neta; Kumar, Dilip; Espeso, Eduardo A.; Prusky, Dov B.			Cation-Stress-Responsive Transcription Factors SItA and CrzA Regulate Morphogenetic Processes and Pathogenicity of Colletotrichurn gloeosporioides	PLOS ONE			English	Article							ZINC-FINGER PROTEIN; ASPERGILLUS-NIDULANS; PLASMA-MEMBRANE; GENE-EXPRESSION; SACCHAROMYCES-CEREVISIAE; APPRESSORIUM FORMATION; MAGNAPORTHE-GRISEA; TOLERANCE PATHWAY; HYPHAL GROWTH; DOCKING SITE	Growth of Colletotrichum gloeosporioides in the presence of cation salts NaCI and KCI inhibited fungal growth and anthracnose symptom of colonization. Previous reports indicate that adaptation of Aspergillus nidulans to salt- and osmotic-stress conditions revealed the role of zinc-finger transcription factors SItA and CrzA in cation homeostasis. Homologs of A. nidulans SItA and CrzA were identified in C. gloeosporioides. The C. gloeosporioides CrzA homolog is a 682-amino acid protein, which contains a C2H2 zinc finger DNA-binding domain that is highly conserved among CrzA proteins from yeast and filamentous fungi. The C. gloeosporioides SItA homolog encodes a 775-amino acid protein with strong similarity to A. nidulans SItA and Trichoderma reeseiACE1, and highest conservation in the three zinc finger regions with almost no changes compared to ACE1 sequences. Knockout of C. gloeosporioides crzA (AcrzA) resulted in a phenotype with inhibited growth, sporulation, germination and appressorium formation, indicating the importance of this calciu006D-activated transcription factor in regulating these morphogenetic processes. In contrast, knockout of C. gloeosporioides sltA (AsItA) mainly inhibited appressorium formation. Both mutants had reduced pathogenicity on mango and avocado fruit. Inhibition of the different morphogenetic stages in the AcrzA mutant was accompanied by drastic inhibition of chitin synthase A and B and glucan synthase, which was partially restored with Ca2+ supplementation. Inhibition of appressorium formation in AsItA mutants was accompanied by downregulation of the MAP kinase pmkl and carnitine acetyl transferase (call), genes involved in appressorium formation and colonization, which was restored by Ca2+ supplementation. Furthermore, exposure of C. gloeosporioides AcrzA or AsItA mutants to cations such as Na+, K+ and Li+ at concentrations that the wild type C. gloeosporioides is not affected had further adverse morphogenetic effects on C. gloeosporioides which were partially or fully restored by Ca2+. Overall results suggest that both genes modulating alkali cation homeostasis have significant morphogenetic effects that reduce C. gloeosporioides colonization.	[Dubey, Amit K.; Barad, Shiri; Luria, Neta; Kumar, Dilip; Prusky, Dov B.] Agr Res Org, Volcani Ctr, Dept Postharvest Sci Fresh Produce, Bet Dagan, Israel; [Barad, Shiri] Hebrew Univ Jerusalem, Robert H Smith Fac Agr Food & Environm, Dept Plant Pathol & Microbiol, Rehovot, Israel; [Espeso, Eduardo A.] CIB, Dept Mol & Cellular Biol, Madrid, Spain	VOLCANI INSTITUTE OF AGRICULTURAL RESEARCH; Hebrew University of Jerusalem; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Investigaciones Biologicas (CIB)	Prusky, DB (corresponding author), Agr Res Org, Volcani Ctr, Dept Postharvest Sci Fresh Produce, Bet Dagan, Israel.	dovprusk@volcani.agri.gov.il	Espeso, Eduardo A/AAC-7238-2022; Espeso, Eduardo A/C-5259-2011; Kumar, Dilip/GQB-0364-2022	Espeso, Eduardo A/0000-0002-5873-6059; Espeso, Eduardo A/0000-0002-5873-6059; Kumar, Dilip/0000-0003-3721-4718; Kumar, Dilip/0000-0003-4566-1446	US/Israel Binational Agricultural Research Fund (ISBARD) [IS-4773-14]; Ministerio de Economia y Competitividad; Fondo Europeo de Desarrollo Regional (FEDER) [BFU2012-33142, BFU2015-66806R]	US/Israel Binational Agricultural Research Fund (ISBARD)(US-Israel Binational Science Foundation); Ministerio de Economia y Competitividad(Spanish Government); Fondo Europeo de Desarrollo Regional (FEDER)(European CommissionSpanish Government)	This work was supported by the US/Israel Binational Agricultural Research Fund (ISBARD), grant no. IS-4773-14, the Ministerio de Economia y Competitividad and Fondo Europeo de Desarrollo Regional (FEDER), grant nos. BFU2012-33142 and BFU2015-66806R. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abang MM, 2009, MYCOL RES, V113, P130, DOI 10.1016/j.mycres.2008.09.004; Asrar AWA, 2011, SAUDI J BIOL SCI, V18, P93, DOI 10.1016/j.sjbs.2010.06.007; Barad S, 2014, MOL PLANT MICROBE IN, V27, P66, DOI 10.1094/MPMI-05-13-0138-R; Barhoom S, 2004, FUNGAL GENET BIOL, V41, P317, DOI 10.1016/j.fgb.2003.11.011; Bhambra GK, 2006, MOL MICROBIOL, V61, P46, DOI 10.1111/j.1365-2958.2006.05209.x; Bi FC, 2016, MOL PLANT PATHOL, V17, P1178, DOI 10.1111/mpp.12355; Boustany LM, 2002, GENE DEV, V16, P608, DOI 10.1101/gad.967602; Calcagno-Pizarelli AM, 2011, J CELL SCI, V124, P4064, DOI 10.1242/jcs.088344; Chang PK, 2008, INT J MOL SCI, V9, P2027, DOI 10.3390/ijms9102027; Chen SC, 2010, FUNGAL GENET BIOL, V47, P268, DOI 10.1016/j.fgb.2009.12.008; Chilton IJ, 2008, MYCOL RES, V112, P1435, DOI 10.1016/j.mycres.2008.06.028; Cramer RA, 2008, EUKARYOT CELL, V7, P1085, DOI 10.1128/EC.00086-08; Dinamarco TM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037591; Ferreira T, 2001, J BIOL CHEM, V276, P29613, DOI 10.1074/jbc.R100022200; Findon H, 2010, FUNGAL GENET BIOL, V47, P647, DOI 10.1016/j.fgb.2010.04.002; GABER RF, 1992, INT REV CYTOL, V137A, P299; Garzia A, 2010, MOL MICROBIOL, V75, P1314, DOI 10.1111/j.1365-2958.2010.07063.x; Hagiwara D, 2008, CURR GENET, V54, P325, DOI 10.1007/s00294-008-0220-z; HARO R, 1993, PHYSIOL PLANTARUM, V89, P868, DOI 10.1111/j.1399-3054.1993.tb05298.x; Harrington BJ, 2003, LAB MED, V34, P361, DOI 10.1309/EPH2TDT8335GH0R3; Hernandez-Ortiz P, 2013, MOL MICROBIOL, V89, P532, DOI 10.1111/mmi.12294; Juvvadi PR, 2014, FUNGAL BIOL REV, V28, P56, DOI 10.1016/j.fbr.2014.02.004; Kafer E, 1977, Adv Genet, V19, P33, DOI 10.1016/S0065-2660(08)60245-X; Kim SY, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1086; MAGALHAES BP, 1991, PROTOPLASMA, V160, P77, DOI 10.1007/BF01539959; Matheos DP, 1997, GENE DEV, V11, P3445, DOI 10.1101/gad.11.24.3445; Mellado L, 2016, MOL BIOL CELL, V27, P2598, DOI 10.1091/mbc.E16-01-0049; Mellado L, 2015, FUNGAL GENET BIOL, V82, P116, DOI 10.1016/j.fgb.2015.06.002; Ment D, 2015, MOL PLANT MICROBE IN, V28, P154, DOI 10.1094/MPMI-09-14-0252-R; Miyara I, 2008, MOL PLANT PATHOL, V9, P281, DOI 10.1111/J.1364-3703.2007.00462.X; Miyara I, 2010, MOL PLANT MICROBE IN, V23, P304, DOI 10.1094/MPMI-23-3-0304; Miyazaki T, 2011, FEMS YEAST RES, V11, P449, DOI 10.1111/j.1567-1364.2011.00734.x; O'Neil JD, 2002, MYCOL RES, V106, P491, DOI 10.1017/S0953756202005701; Perrin RM, 2007, PLOS PATHOG, V3, P508, DOI 10.1371/journal.ppat.0030050; PITT D, 1993, J GEN MICROBIOL, V139, P3053, DOI 10.1099/00221287-139-12-3053; Prusky D, 2014, POSTHARVEST PATHOLOG, V7, P43; Prusky D, 2013, ANNU REV PHYTOPATHOL, V51, P155, DOI 10.1146/annurev-phyto-082712-102349; Pusztahelyi T, 2015, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.00573; Ramos-Pamplona M, 2006, MOL MICROBIOL, V61, P61, DOI 10.1111/j.1365-2958.2006.05194.x; Robinson M, 1999, CURR GENET, V36, P98, DOI 10.1007/s002940050478; Rodriguez-Navarro A, 2006, J EXP BOT, V57, P1149, DOI 10.1093/jxb/erj068; Roy J, 2007, MOL CELL, V25, P889, DOI 10.1016/j.molcel.2007.02.014; Ruiz A, 2008, J BIOL CHEM, V283, P13923, DOI 10.1074/jbc.M708683200; Saloheimo A, 2000, J BIOL CHEM, V275, P5817, DOI 10.1074/jbc.275.8.5817; Serrano MA, 2002, PLACENTA, V23, P527, DOI 10.1053/plac.2002.0838; Shafran H, 2008, FUNGAL GENET BIOL, V45, P1147, DOI 10.1016/j.fgb.2008.04.011; Shantappa S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068492; Soanes DM, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002514; Soriani FM, 2008, MOL MICROBIOL, V67, P1274, DOI 10.1111/j.1365-2958.2008.06122.x; Spathas DH, 1978, ASPERGILLUS NEWSL, V46, P28; Spielvogel A, 2008, BIOCHEM J, V414, P419, DOI 10.1042/BJ20080344; Stathopoulos AM, 1997, GENE DEV, V11, P3432, DOI 10.1101/gad.11.24.3432; Stathopoulos-Gerontides A, 1999, GENE DEV, V13, P798, DOI 10.1101/gad.13.7.798; Thewes S, 2014, EUKARYOT CELL, V13, P694, DOI 10.1128/EC.00038-14; Thines E, 2000, PLANT CELL, V12, P1703, DOI 10.1105/tpc.12.9.1703; TOURNAS V, 1994, CRIT REV MICROBIOL, V20, P243, DOI 10.3109/10408419409113558; TU JC, 1985, MICROBIOS, V44, P87; WIELAND J, 1995, EMBO J, V14, P3870, DOI 10.1002/j.1460-2075.1995.tb00059.x; Yakoby N, 2001, MOL PLANT MICROBE IN, V14, P988, DOI 10.1094/MPMI.2001.14.8.988; Yoshimoto H, 2002, J BIOL CHEM, V277, P31079, DOI 10.1074/jbc.M202718200	60	16	17	0	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2016	11	12							e0168561	10.1371/journal.pone.0168561	http://dx.doi.org/10.1371/journal.pone.0168561			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EG7JB	28030573	Green Published, gold, Green Submitted			2022-12-27	WOS:000391222000056
J	Huh, DA; Choi, YH; Moon, KW				Huh, Da-An; Choi, Yun-Hee; Moon, Kyong Whan			The Effects of Earphone Use and Environmental Lead Exposure on Hearing Loss in the Korean Population: Data Analysis of the Korea National Health and Nutrition Examination Survey (KNHANES), 2010-2013	PLOS ONE			English	Article							OCCUPATIONAL NOISE EXPOSURE; LISTENING LEVELS; ADULTS; EPIDEMIOLOGY; IMPAIRMENT; PREVALENCE; SURVEILLANCE; HYPERTENSION; ADOLESCENTS; RISK	Background Although previous studies have reported that frequent earphone use and lead exposure are risk factors for hearing loss, most of these studies were limited to small populations or animal experiments. Several studies that presented the joint effect of combined exposure of noise and heavy metal on hearing loss were also mainly conducted on occupational workers exposed to high concentration. Objectives We investigated both the individual and joint effects of earphone use and environmental lead exposure on hearing loss in the Korean general population. Methods We analyzed data from 7,596 Koreans provided by the Korea National Health and Nutrition Examination Survey (KNHANES) during the period 2010-2013. The pure-tone average (PTA) of hearing thresholds at 2, 3, and 4 kHz frequencies was computed, and hearing loss was defined as a PTA >= 25 dB in one or both ears. Results A dose-response relationship in hearing loss with earphone use time and blood lead level is observed after adjustment for confounding factors. With a 1-hour increase in earphone use time and 1 mu g/dL increase in blood lead concentration, the odds of hearing loss increased by 1.19 and 1.43 times, respectively. For hearing loss, the additive and multiplicative effect of earphone use and blood lead level were not statistically significant. Conclusions Earphone use and environmental lead exposure have an individual effect on hearing loss in the general population. However, the estimated joint effect of earphone use and lead exposure was not statistically significant.	[Huh, Da-An] Korea Univ, Grad Sch, Dept Publ Hlth Sci, Seoul, South Korea; [Choi, Yun-Hee; Moon, Kyong Whan] Korea Univ, Dept Hlth & Environm Sci, Coll Hlth Sci, Seoul, South Korea	Korea University; Korea University	Moon, KW (corresponding author), Korea Univ, Dept Hlth & Environm Sci, Coll Hlth Sci, Seoul, South Korea.	kwmoon@korea.ac.kr	Moon, Kyong_Whan/ABH-5166-2020	Huh, Da-An/0000-0001-7633-0805	Korea University [K1508311]	Korea University	This study was supported by grants from The Korea University (K1508311). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrawal Y, 2009, OTOL NEUROTOL, V30, P139, DOI 10.1097/MAO.0b013e318192483c; Bainbridge KE, 2008, ANN INTERN MED, V149, P1, DOI 10.7326/0003-4819-149-1-200807010-00231; Chang TY, 2011, ENVIRON HEALTH-GLOB, V10, DOI 10.1186/1476-069X-10-35; Choi YH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097538; Choi YH, 2012, ENVIRON HEALTH PERSP, V120, P1544, DOI 10.1289/ehp.1104863; Chuang HY, 2007, SCI TOTAL ENVIRON, V387, P79, DOI 10.1016/j.scitotenv.2007.07.032; Cruickshanks KJ, 2003, ARCH OTOLARYNGOL, V129, P1041, DOI 10.1001/archotol.129.10.1041; Daniel E, 2007, J SCHOOL HEALTH, V77, P225, DOI 10.1111/j.1746-1561.2007.00197.x; Duck SW, 1997, LARYNGOSCOPE, V107, P1596, DOI 10.1097/00005537-199712000-00004; Fuente A, 2009, J OCCUP ENVIRON MED, V51, P1202, DOI 10.1097/JOM.0b013e3181bae17c; Gallagher G, 1989, HEARING J, V42, P7; Girard SA, 2015, INJURY PREV, V21, pE88, DOI 10.1136/injuryprev-2013-040828; HIRATA M, 1993, ENVIRON RES, V63, P60, DOI 10.1006/enrs.1993.1127; Hodgetts W, 2009, INT J AUDIOL, V48, P825, DOI 10.3109/14992020903082104; Hong HN, 2013, J ACOUST SOC KOREA, V32, P56, DOI 10.7776/ASK.2013.32.1.056; Horikawa C, 2013, J CLIN ENDOCR METAB, V98, P51, DOI 10.1210/jc.2012-2119; HOSMER DW, 1992, EPIDEMIOLOGY, V3, P452, DOI 10.1097/00001648-199209000-00012; Johnson A-C, 2008, OCCUPATIONAL EXPOSUR, P1; Jokitulppo Jaana, 2003, Noise Health, V5, P53; Jones LG, 2008, J COMP NEUROL, V506, P1003, DOI 10.1002/cne.21563; Kim MG, 2009, YONSEI MED J, V50, P771, DOI 10.3349/ymj.2009.50.6.771; Knol MJ, 2012, INT J EPIDEMIOL, V41, P514, DOI 10.1093/ije/dyr218; LASKY RE, 1995, NEUROTOXICOL TERATOL, V17, P633, DOI 10.1016/0892-0362(95)02006-3; Levey S, 2011, J SPEECH LANG HEAR R, V54, P263, DOI 10.1044/1092-4388(2010/09-0283); Mazlan R, 2002, Malays J Med Sci, V9, P17; Money A, 2011, OCCUP MED-OXFORD, V61, P226, DOI 10.1093/occmed/kqr047; Muchnik C, 2012, INT J AUDIOL, V51, P287, DOI 10.3109/14992027.2011.631590; Narlawar Uday W, 2006, Indian J Physiol Pharmacol, V50, P60; Nelson DI, 2005, AM J IND MED, V48, P446, DOI 10.1002/ajim.20223; Park SK, 2010, HEARING RES, V269, P48, DOI 10.1016/j.heares.2010.07.004; Park YH, 2016, PLOS ONE, V11, DOI [10.1371/journal.pone.0150783, DOI 10.1371/J0URNAL.P0NE.0150]; Pierre Campo KM, 2009, COMBINED EXPOSURE NO; Pouryaghoub G, 2007, BMC PUBLIC HEALTH, V7, DOI 10.1186/1471-2458-7-137; Railly MJ, 1998, J OCCUP ENVIRON MED, V40, P667, DOI 10.1097/00043764-199808000-00002; Sabolic I, 2006, NEPHRON PHYSIOL, V104, P107, DOI 10.1159/000095539; Sadhra S, 2002, ANN OCCUP HYG, V46, P455, DOI 10.1093/annhyg/mef051; Shargorodsky J, 2011, ARCH OTOLARYNGOL, V137, P1177, DOI 10.1001/archoto.2011.202; Stanbury M, 2008, J OCCUP ENVIRON MED, V50, P72, DOI 10.1097/JOM.0b013e31815b568c; Stevens G, 2013, EUR J PUBLIC HEALTH, V23, P146, DOI 10.1093/eurpub/ckr176; Trong-neng wu C-ys, 2000, ARCH ENV HLTH, V55; VandenLangenberg GM, 1998, AM J EPIDEMIOL, V148, P204, DOI 10.1093/oxfordjournals.aje.a009625; Vogel I, 2009, PEDIATRICS, V123, pE953, DOI 10.1542/peds.2008-3179; Vyskocil A, 2012, TOXICOL IND HEALTH, V28, P796, DOI 10.1177/0748233711425067; Wu TN, 1998, PREV MED, V27, P65, DOI 10.1006/pmed.1997.0238; YAMAMURA K, 1989, FUND APPL TOXICOL, V13, P509, DOI 10.1016/0272-0590(89)90287-X; Yamasoba T, 2013, HEARING RES, V303, P30, DOI 10.1016/j.heares.2013.01.021; Yang HY, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2015-010533; 곽혜원, 2012, [Journal of Korean Public Health Nursing, 한국보건간호학회지], V26, P126	48	8	8	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2016	11	12							e0168718	10.1371/journal.pone.0168718	http://dx.doi.org/10.1371/journal.pone.0168718			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EG7JB	28030613	gold, Green Submitted, Green Published			2022-12-27	WOS:000391222000066
J	Marcondes-Braga, FG; Batista, GL; Gutz, IGR; Saldiva, PHN; Mangini, S; Issa, VS; Ayub-Ferreira, SM; Bocchi, EA; Pereira, AC; Bacal, F				Marcondes-Braga, Fabiana G.; Batista, Guilherme L.; Gutz, Ivano G. R.; Saldiva, Paulo H. N.; Mangini, Sandrigo; Issa, Victor S.; Ayub-Ferreira, Silvia M.; Bocchi, Edimar A.; Pereira, Alexandre Costa; Bacal, Fernando			Impact of Exhaled Breath Acetone in the Prognosis of Patients with Heart Failure with Reduced Ejection Fraction (HFrEF). One Year of Clinical Follow-up	PLOS ONE			English	Article							BRAIN NATRIURETIC PEPTIDE; MORTALITY; ADRENOMEDULLIN; BIOMARKERS; PREDICTOR; OUTCOMES; TRIAL	Background The identification of new biomarkers of heart failure (HF) could help in its treatment. Previously, our group studied 89 patients with HF and showed that exhaled breath acetone (EBA) is a new noninvasive biomarker of HF diagnosis. However, there is no data about the relevance of EBA as a biomarker of prognosis. Objectives To evaluate whether EBA could give prognostic information in patients with heart failure with reduced ejection fraction (HFrEF). Methods After breath collection and analysis by gas chromatography-mass spectrometry and by spectrophotometry, the 89 patients referred before were followed by one year. Study physicians, blind to the results of cardiac biomarker testing, ascertained vital status of each study participant at 12 months. Results The composite endpoint death and heart transplantation (HT) were observed in 35 patients (39.3%): 29 patients (32.6%) died and 6 (6.7%) were submitted to HT within 12 months after study enrollment. High levels of EBA (>= 3.7 mu g/L, 50th percentile) were associated with a progressively worse prognosis in 12-month follow-up (log-rank = 11.06, p = 0.001). Concentrations of EBA above 3.7 mu g/L increased the risk of death or HT in 3.26 times (HR = 3.26, 95% CI = 1.56-6.80, p = 0.002) within 12 months. In a multivariable cox regression model, the independent predictors of all-cause mortality were systolic blood pressure, respiratory rate and EBA levels. Conclusions High EBA levels could be associated to poor prognosis in HFrEF patients.	[Marcondes-Braga, Fabiana G.; Mangini, Sandrigo; Bacal, Fernando] Univ Sao Paulo, Dept Heart Transplant, Hosp Clin, Heart Inst InCor,Fac Med, Ave Dr Eneas de Carvalho Aguiar 44,2 Andar, Sao Paulo, Brazil; [Batista, Guilherme L.; Gutz, Ivano G. R.] Univ Sao Paulo, Inst Chem, Ave Prof Lineu Prestes 748,Bloco 12,Sala 1270, Sao Paulo, Brazil; [Saldiva, Paulo H. N.] Univ Sao Paulo, Dept Pathol, Fac Med, Ave Dr Arnaldo 455,1 Andar, Sao Paulo, Brazil; [Issa, Victor S.; Ayub-Ferreira, Silvia M.; Bocchi, Edimar A.] Univ Sao Paulo, Dept Heart Failure, Heart Inst InCor, Hosp Clin,Fac Med, Sao Paulo, Brazil; [Pereira, Alexandre Costa] Univ Sao Paulo, Lab Genet & Mol Cardiol, Fac Med, Ave Dr Eneas de Carvalho Aguiar 44,10 Andar, Sao Paulo, Brazil	Universidade de Sao Paulo; Universidade de Sao Paulo; Universidade de Sao Paulo; Universidade de Sao Paulo; Universidade de Sao Paulo	Marcondes-Braga, FG (corresponding author), Univ Sao Paulo, Dept Heart Transplant, Hosp Clin, Heart Inst InCor,Fac Med, Ave Dr Eneas de Carvalho Aguiar 44,2 Andar, Sao Paulo, Brazil.	fgmarcondes@yahoo.com.br	Ayub-Ferreira, Silvia/AAK-4196-2020; Marcondes-Braga, Fabiana G/H-7380-2012; Mangini, Sandrigo/S-3083-2016; Pereira, Alexandre/HHN-1038-2022; Saldiva, Paulo HN/D-7385-2012; Gutz, Ivano G. R./H-8748-2012	Ayub-Ferreira, Silvia/0000-0002-9271-8233; Mangini, Sandrigo/0000-0003-0894-1131; Saldiva, Paulo HN/0000-0003-2005-8253; Gutz, Ivano G. R./0000-0001-9759-7920; Lopes Batista, Guilherme/0000-0003-4399-7368; Marcondes-Braga, Fabiana/0000-0002-2533-5638	FAPESP (Fundacao de Amparo a Pesquisa do Estado de Sao Paulo)	FAPESP (Fundacao de Amparo a Pesquisa do Estado de Sao Paulo)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	The study was supported by a grant from FAPESP (Fundacao de Amparo a Pesquisa do Estado de Sao Paulo).	Anand IS, 2003, CIRCULATION, V107, P1278, DOI 10.1161/01.CIR.0000054164.99881.00; Batista GL, 2010, THESIS; Berger R, 2002, CIRCULATION, V105, P2392, DOI 10.1161/01.CIR.0000016642.15031.34; BERNTSSON S, 1956, ANAL CHEM, V28, P1337, DOI 10.1021/ac60116a036; Bocchi EA, 2009, HEART, V95, P181, DOI 10.1136/hrt.2008.151225; Bocchi EA, 2008, CIRC-HEART FAIL, V1, P115, DOI 10.1161/CIRCHEARTFAILURE.107.744870; Cikach FS, 2012, PROG CARDIOVASC DIS, V55, P34, DOI 10.1016/j.pcad.2012.05.005; de Boer RA, 2011, ANN MED, V43, P60, DOI 10.3109/07853890.2010.538080; Fonarow GC, 2007, J AM COLL CARDIOL, V49, P1943, DOI 10.1016/j.jacc.2007.02.037; GOTTLIEB, 1989, J AM COLL CARDIOL, V14, P812; KUPARI M, 1995, AM J CARDIOL, V76, P1076, DOI 10.1016/S0002-9149(99)80304-X; Lam LL, 2010, ANN INTERN MED, V153, P728, DOI 10.7326/0003-4819-153-11-201012070-00006; Lommi J, 1996, J AM COLL CARDIOL, V28, P665, DOI 10.1016/0735-1097(96)00214-8; Marcondes-Braga FG, 2012, CHEST, V142, P457, DOI 10.1378/chest.11-2892; MCKEE PA, 1971, NEW ENGL J MED, V285, P1441, DOI 10.1056/NEJM197112232852601; Nohria A, 2003, J AM COLL CARDIOL, V41, P1797, DOI 10.1016/S0735-1097(03)00309-7; Pabst F, 2007, J CARDIOTHORAC SURG, V2, DOI 10.1186/1749-8090-2-37; Potocki M, 2010, CRIT CARE, V14, DOI 10.1186/cc9336; Rehman SU, 2008, J AM COLL CARDIOL, V52, P1458, DOI 10.1016/j.jacc.2008.07.042; Richards AM, 2001, J AM COLL CARDIOL, V37, P1781, DOI 10.1016/S0735-1097(01)01269-4; Samara MA, 2013, J AM COLL CARDIOL, V61, P1463, DOI 10.1016/j.jacc.2012.12.033; Stanley WC, 2005, PHYSIOL REV, V85, P1093, DOI 10.1152/physrev.00006.2004; von Haehling S, 2010, EUR J HEART FAIL, V12, P484, DOI 10.1093/eurjhf/hfq031; Xue Y, 2011, EUR J HEART FAIL, V13, P37, DOI 10.1093/eurjhf/hfq210; Yu CM, 1999, EUR J HEART FAIL, V1, P59, DOI 10.1016/S1388-9842(98)00010-5	25	21	24	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2016	11	12							e0168790	10.1371/journal.pone.0168790	http://dx.doi.org/10.1371/journal.pone.0168790			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EG7JB	28030609	Green Published, Green Submitted, gold			2022-12-27	WOS:000391222000077
J	Akhoundan, M; Shadman, Z; Jandaghi, P; Aboeerad, M; Larijani, B; Jamshidi, Z; Ardalani, H; Nikoo, MK				Akhoundan, Mahdieh; Shadman, Zhaleh; Jandaghi, Parisa; Aboeerad, Maryam; Larijani, Bagher; Jamshidi, Zahra; Ardalani, Hamidreza; Nikoo, Mohsen Khoshniat			The Association of Bread and Rice with Metabolic Factors in Type 2 Diabetic Patients	PLoS One			English	Article							CORONARY-HEART-DISEASE; WHOLE-GRAIN INTAKE; GLYCEMIC INDEX; RISK-FACTORS; WHITE RICE; CARDIOVASCULAR-DISEASE; INSULIN-RESISTANCE; DIETARY FIBER; LOAD; MELLITUS	Purpose Carbohydrates are shown to have an important role in blood glucose control, type 2 diabetes and cardiovascular diseases risk. This is even more challenging when considering populations consuming refined grains diets. Bread and rice are staple foods which supply main proportion of Iranian calorie intake. This study was designed to investigate the effect of bread and rice intake on blood glucose control, lipid profile and anthropometric measurements in Iranian type 2 diabetic patients. Methods 426 patients with type 2 diabetes were included in this study. Anthropometric measurements were done using standard methods. Dietary information was assessed by a valid and reliable food frequency questionnaire (FFQ). Fasting blood glucose (FBG), glycated hemoglobin (HbA1c), serum triglycride (TG), total cholesterol (TC), low density lipoprotein (LDL) and high density lipoprotein (HDL) cholesterol were examined after 12-hour fasting. Results The results represented that people in the highest tertile compared to the lowest tertile of calorie adjusted total bread intake have higher FBG. FBG in the highest tertile of calorie adjusted total bread-rice intake was also significantly higher than the lowest. The association remained significant after adjusting for potential confounders. Rice intake showed no association with cardio-metabolic risk factors. Conclusion We founded that higher total bread intake and total bread-rice intake were associated with FBG in type 2 diabetic patients whereas rice intake was not associated with glucose and lipid profile. This result should be confirmed in prospective studies, considering varieties, glycemic index (GI), glycemic load (GL) and cooking method of bread and rice.	[Akhoundan, Mahdieh; Shadman, Zhaleh; Jandaghi, Parisa] Univ Tehran Med Sci, Diabet Res Ctr, Endocrinol & Metab Clin Sci Inst, Tehran, Iran; [Akhoundan, Mahdieh; Shadman, Zhaleh; Jandaghi, Parisa; Larijani, Bagher; Jamshidi, Zahra] Univ Tehran Med Sci, Endocrinol & Metab Res Ctr EMRC, Endocrinol & Metab Res Inst, Tehran, Iran; [Aboeerad, Maryam; Nikoo, Mohsen Khoshniat] Univ Tehran Med Sci, Endocrinol & Metab Res Ctr, Endocrinol & Metab Clin Sci Inst, Tehran, Iran; [Ardalani, Hamidreza] Islamic Azad Univ, Dept Hort Sci, Sci & Res Branch, Tehran, Iran	Tehran University of Medical Sciences; Tehran University of Medical Sciences; Tehran University of Medical Sciences; Islamic Azad University	Nikoo, MK (corresponding author), Univ Tehran Med Sci, Endocrinol & Metab Res Ctr, Endocrinol & Metab Clin Sci Inst, Tehran, Iran.	M.khoshniatnikoo@yahoo.com	Ardalani, Hamidreza/AAB-5211-2020; larijani, Bagher/ABE-3315-2020	Ardalani, Hamidreza/0000-0002-3245-7991; larijani, Bagher/0000-0001-5386-7597				Adeghate E, 2006, ANN NY ACAD SCI, V1084, P1, DOI 10.1196/annals.1372.029; ANDERSON JW, 1991, DIABETES CARE, V14, P1126, DOI 10.2337/diacare.14.12.1126; Azizi F, 2003, East Mediterr Health J, V9, P1122; Chen YJ, 2010, WORLD J GASTROENTERO, V16, P1512, DOI 10.3748/wjg.v16.i12.1512; Eshak ES, 2011, J NUTR, V141, P595, DOI 10.3945/jn.110.132167; Esmaillzadeh A, 2005, EUR J CLIN NUTR, V59, P353, DOI 10.1038/sj.ejcn.1602080; Ezenwaka CE, 2005, INDIAN J MED RES, V121, P23; Fasanmade O A, 2008, Afr J Med Med Sci, V37, P99; Foster-Powell K, 2002, AM J CLIN NUTR, V76, P5, DOI 10.1093/ajcn/76.1.5; Frei M, 2003, FOOD CHEM, V83, P395, DOI 10.1016/S0308-8146(03)00101-8; Gadsby R, 2002, ADV DRUG DELIVER REV, V54, P1165, DOI 10.1016/S0169-409X(02)00094-7; Ghaffarpour M, 1999, TEHRAN NASHRE OLUME, V7, P213; Kalantari N., 2005, NATL COMPREHENSIVE S; Kaseb F., 2010, IRAN J DIAB OBES, V2, P33; Kelishadi R, 2001, SHAHREKORD U MED SCI; Kelishadi R, 2012, INT J PREVENTIVE MED, V3, P394; Khosravi-Boroujeni H, 2013, J HEALTH POPUL NUTR, V31, P252; Kimiagar S. M., 1998, Eastern Mediterranean Health Journal, V4, P539; King H, 1998, DIABETES CARE, V21, P1414, DOI 10.2337/diacare.21.9.1414; Liu SM, 2001, CURR OPIN LIPIDOL, V12, P395, DOI 10.1097/00041433-200108000-00005; Liu SM, 2000, AM J PUBLIC HEALTH, V90, P1409, DOI 10.2105/AJPH.90.9.1409; Ludwig DS, 2002, JAMA-J AM MED ASSOC, V287, P2414, DOI 10.1001/jama.287.18.2414; Manson J, 1993, AM J PREV MED, V10, P172; MCGEE DL, 1984, AM J EPIDEMIOL, V119, P667, DOI 10.1093/oxfordjournals.aje.a113788; McKeown NM, 2004, DIABETES CARE, V27, P538, DOI 10.2337/diacare.27.2.538; McKeown NM, 2002, AM J CLIN NUTR, V76, P390, DOI 10.1093/ajcn/76.2.390; Meyer KA, 2000, AM J CLIN NUTR, V71, P921; MILLER JB, 1992, AM J CLIN NUTR, V56, P1034, DOI 10.1093/ajcn/56.6.1034; Mirmiran P, 2010, PUBLIC HEALTH NUTR, V13, P654, DOI 10.1017/S1368980009991698; Mizoue T, 2006, J NUTR, V136, P1352, DOI 10.1093/jn/136.5.1352; Murakami K, 2006, AM J CLIN NUTR, V83, P1161, DOI 10.1093/ajcn/83.5.1161; Paolisso G, 1997, AM J HYPERTENS, V10, P346, DOI 10.1016/S0895-7061(96)00342-1; Radhika G, 2009, METABOLISM, V58, P675, DOI 10.1016/j.metabol.2009.01.008; Ramachandran A, 2010, LANCET, V375, P408, DOI 10.1016/S0140-6736(09)60937-5; Sahyoun NR, 2006, AM J CLIN NUTR, V83, P124; Shadman Z, 2014, J DIABETES METAB DIS, V13, DOI 10.1186/2251-6581-13-71; Slavin J, 2003, P NUTR SOC, V62, P129, DOI 10.1079/PNS2002221; Sugiyama M, 2003, EUR J CLIN NUTR, V57, P743, DOI 10.1038/sj.ejcn.1601606; Sun Q, 2010, ARCH INTERN MED, V170, P961, DOI 10.1001/archinternmed.2010.109; Villegas R, 2007, ARCH INTERN MED, V167, P2310, DOI 10.1001/archinte.167.21.2310; Wild S, 2004, DIABETES CARE, V27, P1047, DOI 10.2337/diacare.27.5.1047; Yu DX, 2013, AM J EPIDEMIOL, V178, P1542, DOI 10.1093/aje/kwt178; Zarrati M, 2008, INT J ENDOCRINOL MET, V6, P200	43	10	10	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2016	11	12							e0167921	10.1371/journal.pone.0167921	http://dx.doi.org/10.1371/journal.pone.0167921			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI9QH	28005914	Green Published, Green Submitted, gold			2022-12-27	WOS:000392843200024
J	Newton, TM; Reid, E				Newton, Timothy M.; Reid, Evan			An Automated Image Analysis System to Quantify Endosomal Tubulation	PLoS One			English	Article							CYTOKINESIS; TRANSPORT	Recycling of cargos from early endosomes requires regulation of endosomal tubule formation and fission. This regulation is disrupted in cells depleted of the microtubule severing enzyme spastin, causing elongation of endosomal tubules and mis-trafficking of recycling endosomal cargos such as the transferrin receptor. Spastin is encoded by SPAST, mutations in which are the most frequent cause of autosomal dominant hereditary spastic paraplegia, a condition characterised by a progressive loss of lower limb function resulting from upper motor neuron axonopathy. Investigation of molecular factors involved in endosomal tubule regulation is hindered by the need for manual counting of endosomal tubules. We report here the development of an open source automated system for the quantification of endosomal tubules, using ImageJ and R. We validate the method in cells depleted of spastin and its binding partner IST1. The additional speed and reproducibility of this system compared with manual counting makes feasible screens of candidates to further understand the mechanisms of endosomal tubule formation and fission.	[Reid, Evan] Univ Cambridge, Dept Med Genet, Cambridge, England; Univ Cambridge, Cambridge Inst Med Res, Cambridge, England	University of Cambridge; University of Cambridge	Reid, E (corresponding author), Univ Cambridge, Dept Med Genet, Cambridge, England.	ealr4@cam.ac.uk	Reid, Evan/F-3250-2010	Reid, Evan/0000-0003-1623-7304; Newton, Timothy/0000-0003-1818-4023	UK Medical Research Council [MR/M00046X/1]; Wellcome Trust Senior Research Fellowship in Clinical Science [082381]; United States Spastic Paraplegia Foundation; Tom Wahlig Stiftung; MRC PhD studentship [G0800117]; Wellcome Trust Strategic Award [100140]; Equipment Grant [093026]; MRC [MR/M00046X/1] Funding Source: UKRI; Medical Research Council [MR/M00046X/1] Funding Source: researchfish	UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust Senior Research Fellowship in Clinical Science(Wellcome Trust); United States Spastic Paraplegia Foundation; Tom Wahlig Stiftung; MRC PhD studentship(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust Strategic Award(Wellcome Trust); Equipment Grant; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by grants to ER: UK Medical Research Council Project Grant [MR/M00046X/1], www.mrc.ac.uk; Wellcome Trust Senior Research Fellowship in Clinical Science [082381], www.wellcome.ac.uk; Project Grant from United States Spastic Paraplegia Foundation, sp-foundation.org, and from the Tom Wahlig Stiftung. TMN was supported by MRC PhD studentship [G0800117]. CIMR is supported by a Wellcome Trust Strategic Award [100140] and Equipment Grant [093026]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agromayor M, 2009, MOL BIOL CELL, V20, P1374, DOI 10.1091/mbc.E08-05-0474; Allison R, 2013, J CELL BIOL, V202, P527, DOI 10.1083/jcb.201211045; Arganda-Carreras I, 2010, MICROSC RES TECHNIQ, V73, P1019, DOI 10.1002/jemt.20829; Carlton J, 2004, CURR BIOL, V14, P1791, DOI 10.1016/j.cub.2004.09.077; Connell JW, 2009, TRAFFIC, V10, P42, DOI 10.1111/j.1600-0854.2008.00847.x; Lumb JH, 2012, BBA-MOL CELL RES, V1823, P192, DOI 10.1016/j.bbamcr.2011.08.010; Maxfield FR, 2004, NAT REV MOL CELL BIO, V5, P121, DOI 10.1038/nrm1315; Reid E, 2005, HUM MOL GENET, V14, P19, DOI 10.1093/hmg/ddi003; Reid E., 2010, ONLINE METABOLIC MOL; Renvoise B, 2010, MOL BIOL CELL, V21, P3293, DOI 10.1091/mbc.E09-10-0879; Seaman MNJ, 2004, J CELL BIOL, V165, P111, DOI 10.1083/jcb.200312034; Traer CJ, 2007, NAT CELL BIOL, V9, P1370, DOI 10.1038/ncb1656; van Weering JRT, 2010, SEMIN CELL DEV BIOL, V21, P371, DOI 10.1016/j.semcdb.2009.11.009	13	3	3	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2016	11	12							e0168294	10.1371/journal.pone.0168294	http://dx.doi.org/10.1371/journal.pone.0168294			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI9QH	28006827	Green Submitted, gold, Green Published			2022-12-27	WOS:000392843200042
J	Park, H; Melamed, D				Park, Hyomin; Melamed, David			The Effects of Stability and Presentation Order of Rewards on Justice Evaluations	PLoS One			English	Article							DISTRIBUTIVE JUSTICE; SOCIAL-EXCHANGE; EQUITY; PSYCHOLOGY; INEQUITY; DECISION; FAIRNESS; CHOICE	Justice research has evolved by elucidating the factors that affect justice evaluations, as well as their consequences. Unfortunately, few researchers have paid attention to the pattern of rewards over time as a predictor of justice evaluations. There are two main objectives of this research. First, it aims to test the effect of reward stability on justice evaluations. Based on justice theory and prospect theory, we assume that an under-reward at one time cannot be fully offset by an equivalent over-reward at another time. Therefore, in unstable reward systems the asymmetry of the effect of unjust rewards with opposite directions will produce a lower level of justice evaluations over time. The second objective of this research is to show the moderating effect of the presentation order (primacy vs. recency) of unstable rewards on justice evaluations. The results from a controlled experiment with five conditions, which presents the instability of rewards in different orders, confirm both the negative effect of unstable rewards and the stronger effect of primacy on justice evaluations.	[Park, Hyomin] Sungkyunkwan Univ, Dept Sociol, Seoul, South Korea; [Melamed, David] Ohio State Univ, Dept Sociol, Columbus, OH 43210 USA	Sungkyunkwan University (SKKU); Ohio State University	Park, H (corresponding author), Sungkyunkwan Univ, Dept Sociol, Seoul, South Korea.	hyominp@gmail.com			Nation Research Foundation of Korea - Korean Government [NRF-2015-S1A3A2-046431]	Nation Research Foundation of Korea - Korean Government	The research was supported by the Nation Research Foundation of Korea Grant funded by the Korean Government (NRF-2015-S1A3A2-046431) for preparing the manuscript and Support to Promote Advancement of Research and Creativity (SPARC) grant from the University of South Carolina for data collection. www.nrf.re.kr; www.sc.edu.	ADAMS JS, 1965, ADV EXP SOC PSYCHOL, V2, P267; [Anonymous], 2011, J SOCIO-ECON, DOI DOI 10.1016/J.SOCEC.2010.10.008; AUSTIN W, 1974, J PERS SOC PSYCHOL, V30, P208, DOI 10.1037/h0036622; Axelrod R., 1984, EVOLUTION COOPERATIO, DOI DOI 10.2307/3323905; Baumeister R.F., 2001, REV GEN PSYCHOL, V5, P323, DOI [10.1037//1089-2680.5.4.323, DOI 10.1037//1089-2680.5.4.323, https://doi.org/10.1037/1089-2680.5.4.323, DOI 10.1037/1089-2680.5.4.323]; Berger J, 2002, SOCIOL THEOR, V20, P157, DOI 10.1111/1467-9558.00157; COSIER RA, 1983, ACAD MANAGE REV, V8, P311, DOI 10.2307/257759; Fehr E, 2002, NATURE, V415, P137, DOI 10.1038/415137a; Forgas JP, 2011, J EXP SOC PSYCHOL, V47, P425, DOI 10.1016/j.jesp.2010.11.005; FURNHAM A, 1986, J GEN PSYCHOL, V113, P351, DOI 10.1080/00221309.1986.9711045; Gao ZK, 2012, NONLINEAR ANAL-REAL, V13, P947, DOI 10.1016/j.nonrwa.2011.08.029; Greenberg J, 1996, RES ORGAN BEHAV, V18, P111; Hegtvedt KA, 2009, AM BEHAV SCI, V53, P376, DOI 10.1177/0002764209338798; Hollensbe EC, 2008, ACAD MANAGE J, V51, P1099, DOI 10.5465/AMJ.2008.35732600; JASSO G, 1978, AM J SOCIOL, V83, P1398, DOI 10.1086/226706; JASSO G, 1980, AM SOCIOL REV, V45, P3, DOI 10.2307/2095239; Jasso G., 2006, HDB SOCIOLOGY EMOTIO, P321; KAHNEMAN D, 1979, ECONOMETRICA, V47, P263, DOI 10.2307/1914185; LIND EA, 1993, ADMIN SCI QUART, V38, P224, DOI 10.2307/2393412; Lind EA, 2001, ORGAN BEHAV HUM DEC, V85, P189, DOI 10.1006/obhd.2000.2937; Lund FH, 1925, J ABNORM SOC PSYCH, V20, P174, DOI 10.1037/h0066996; MARKOVSKY B, 1988, SOC PSYCHOL QUART, V51, P213, DOI 10.2307/2786920; MARKOVSKY B, 1985, AM SOCIOL REV, V50, P822, DOI 10.2307/2095506; McGraw AP, 2010, PSYCHOL SCI, V21, P1438, DOI 10.1177/0956797610381504; Melamed D, 2014, ADV GROUP PROCESSES, P31; Melamed D, 2012, SOC SCI RES, V41, P170, DOI 10.1016/j.ssresearch.2011.09.006; Morrison AB, 2014, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.00006; MURDOCK BB, 1962, J EXP PSYCHOL, V64, P482, DOI 10.1037/h0045106; Paddock EL, 2015, J BEHAV DECIS MAKING, V28, P167, DOI 10.1002/bdm.1834; Panagopoulos C, 2011, POLIT BEHAV, V33, P79, DOI 10.1007/s11109-010-9125-x; Park H, 2015, SOC PSYCHOL QUART, V78, P283, DOI 10.1177/0190272515609272; Rozin P, 2001, PERS SOC PSYCHOL REV, V5, P296, DOI 10.1207/S15327957PSPR0504_2; Singer JD, 1998, J EDUC BEHAV STAT, V23, P323; THALER R, 1980, J ECON BEHAV ORGAN, V1, P39, DOI 10.1016/0167-2681(80)90051-7; Turner J, 2007, SOCIAL JUSTICE RES, V20, P288; TVERSKY A, 1981, SCIENCE, V211, P453, DOI 10.1126/science.7455683; TVERSKY A, 1974, SCIENCE, V185, P1124, DOI 10.1126/science.185.4157.1124; van den Bos K, 2015, SOC JUSTICE RES, V28, P229, DOI 10.1007/s11211-015-0237-7; vandenBos K, 1997, J PERS SOC PSYCHOL, V72, P95, DOI 10.1037/0022-3514.72.1.95; Wayne SJ, 1997, ACAD MANAGE J, V40, P82, DOI 10.2307/257021; Webster M, 2016, SOC PSYCHOL QUART, V79, P5, DOI 10.1177/0190272516628829; Zelditch Jr Morris, 1969, SOCIOLOGICAL READER, P528; ZELDITCH M, 1970, PAC SOCIOL REV, V13, P19	43	0	0	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2016	11	12							e0168956	10.1371/journal.pone.0168956	http://dx.doi.org/10.1371/journal.pone.0168956			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EI9QH	28005957	Green Published, Green Submitted, gold			2022-12-27	WOS:000392843200116
J	Starosolski, R				Starosolski, Roman			Skipping Selected Steps of DWT Computation in Lossless JPEG 2000 for Improved Bitrates	PLoS One			English	Article							IMAGE COMPRESSION; WAVELET TRANSFORMS; LIFTING STEPS	In order to improve bitrates of lossless JPEG 2000, we propose to modify the discrete wavelet transform (DWT) by skipping selected steps of its computation. We employ a heuristic to construct the skipped steps DWT (SS-DWT) in an image-adaptive way and define fixed SS-DWT variants. For a large and diverse set of images, we find that SS-DWT significantly improves bitrates of non-photographic images. From a practical standpoint, the most interesting results are obtained by applying entropy estimation of coding effects for selecting among the fixed SS-DWT variants. This way we get the compression scheme that, as opposed to the general SS-DWT case, is compliant with the JPEG 2000 part 2 standard. It provides average bitrate improvement of roughly 5% for the entire test-set, whereas the overall compression time becomes only 3% greater than that of the unmodified JPEG 2000. Bitrates of photographic and non-photographic images are improved by roughly 0.5% and 14%, respectively. At a significantly increased cost of exploiting a heuristic, selecting the steps to be skipped based on the actual bitrate instead of an estimated one, and by applying reversible denoising and lifting steps to SS-DWT, we have attained greater bitrate improvements of up to about 17.5% for non-photographic images.	[Starosolski, Roman] Silesian Tech Univ, Inst Informat, Fac Automat Control Elect & Comp Sci, Gliwice, Poland	Silesian University of Technology	Starosolski, R (corresponding author), Silesian Tech Univ, Inst Informat, Fac Automat Control Elect & Comp Sci, Gliwice, Poland.	rstarosolski@polsl.pl	Starosolski, Roman/AAF-6974-2019	Starosolski, Roman/0000-0003-1322-3345	Institute of Informatics, Silesian University of Technology [BK-219/RAU2/2016]; Silesian University of Technology [02/020/RGH15/0060]	Institute of Informatics, Silesian University of Technology; Silesian University of Technology	This work was supported by the BK-219/RAU2/2016 grant from the Institute of Informatics, Silesian University of Technology and by the 02/020/RGH15/0060 grant from the Silesian University of Technology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2019, 230082 ISOIEC, P701; [Anonymous], 2004, 154442 ISOIEC; Boulgouris NV, 2001, IEEE T IMAGE PROCESS, V10, P1, DOI 10.1109/83.892438; Bruylants T, 2015, SIGNAL PROCESS-IMAGE, V31, P112, DOI 10.1016/j.image.2014.12.007; Claypoole RL, 2003, IEEE T IMAGE PROCESS, V12, P1449, DOI 10.1109/TIP.2003.817237; Daubechies I, 1998, J FOURIER ANAL APPL, V4, P247, DOI 10.1007/BF02476026; Dufaux F, 2009, IEEE SIGNAL PROC MAG, V26, P195, DOI 10.1109/MSP.2009.934187; International Telecommunications Union, 2012, T832 ITUT; ISO/ IEC, 2004, 154441 ISOIEC; ISO/IEC and ITU-T, 2006, 144951 ISOIEC; ISO/IEC and ITU-T, 2011, 1544410 ISOIEC; MALLAT SG, 1989, IEEE T PATTERN ANAL, V11, P674, DOI 10.1109/34.192463; MARTUCCI SA, 1990, 1990 IEEE INTERNATIONAL SYMP ON CIRCUITS AND SYSTEMS, VOLS 1-4, P1310, DOI 10.1109/ISCAS.1990.112371; Starosolski R, 2016, PREPRINT; Starosolski R, 2016, J ELECTRON IMAGING, V25, DOI 10.1117/1.JEI.25.4.043025; Starosolski R, 2015, SIGNAL PROCESS-IMAGE, V39, P249, DOI 10.1016/j.image.2015.09.013; Strutz T, 2015, IEEE SIGNAL PROC LET, V22, P1269, DOI 10.1109/LSP.2015.2397034; Strutz T, 2013, IEEE T CIRC SYST VID, V23, P1249, DOI 10.1109/TCSVT.2013.2242612; Sullivan GJ, 2012, IEEE T CIRC SYST VID, V22, P1649, DOI 10.1109/TCSVT.2012.2221191; Taubman DS, 2004, JPEG2000 IMAGE COMPR; Weinberger MJ, 2000, IEEE T IMAGE PROCESS, V9, P1309, DOI 10.1109/83.855427	21	9	9	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2016	11	12							e0168704	10.1371/journal.pone.0168704	http://dx.doi.org/10.1371/journal.pone.0168704			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI9QH	28006015	Green Published, Green Submitted, gold			2022-12-27	WOS:000392843200085
J	Takada, H; Shimada, T; Dey, D; Quyyum, MZ; Nakano, M; Ishiguro, A; Yoshida, H; Yamamoto, K; Sen, R; Ishihama, A				Takada, Hiraku; Shimada, Tomohiro; Dey, Debashish; Quyyum, M. Zuhaib; Nakano, Masahiro; Ishiguro, Akira; Yoshida, Hideji; Yamamoto, Kaneyoshi; Sen, Ranjan; Ishihama, Akira			Differential Regulation of rRNA and tRNA Transcription from the rRNA-tRNA Composite Operon in Escherichia coli	PLOS ONE			English	Article							PROKARYOTIC GENOME REGULATION; PROTEIN H-NS; INTERNAL PROMOTER; TRYPTOPHAN OPERON; IN-VIVO; POLYMERASE-BINDING; ILVGMEDA OPERON; E ESSENTIALITY; DNA-SEQUENCES; CELL-DIVISION	Escherichia coli contains seven rRNA operons, each consisting of the genes for three rRNAs (16S, 23S and 5S rRNA in this order) and one or two tRNA genes in the spacer between 16S and 23S rRNA genes and one or two tRNA genes in the 3' proximal region. All of these rRNA and tRNA genes are transcribed from two promoters, P1 and P2, into single large precursors that are afterward processed to individual rRNAs and tRNAs by a set of RNases. In the course of Genomic SELEX screening of promoters recognized by RNA polymerase (RNAP) holoenzyme containing RpoD sigma, a strong binding site was identified within 16S rRNA gene in each of all seven rRNA operons. The binding in vitro of RNAP RpoD holoenzyme to an internal promoter, referred to the promoter of riRNA (an internal RNA of the rRNA operon), within each 16S rRNA gene was confirmed by gel shift assay and AFM observation. Using this riRNA promoter within the rrnD operon as a representative, transcription in vitro was detected with use of the purified RpoD holoenzyme, confirming the presence of a constitutive promoter in this region. LacZ reporter assay indicated that this riRNA promoter is functional in vivo. The location of riRNA promoter in vivo as identified using a set of reporter plasmids agrees well with that identified in vitro. Based on transcription profile in vitro and Northern blot analysis in vivo, the majority of transcript initiated from this riRNA promoter was estimated to terminate near the beginning of 23S rRNA gene, indicating that riRNA leads to produce the spacer -coded tRNA. Under starved conditions, transcription of the rRNA operon is markedly repressed to reduce the intracellular level of ribosomes, but the levels of both riRNA and its processed tRNAGIu stayed unaffected, implying that riRNA plays a role in the continued steady-state synthesis of tRNAs from the spacers of rRNA operons. We then propose that the tRNA genes organized within the spacers of rRNA-tRNA composite operons are expressed independent of rRNA synthesis under specific conditions where further synthesis of ribosomes is not needed.	[Takada, Hiraku; Shimada, Tomohiro; Ishiguro, Akira; Yamamoto, Kaneyoshi; Ishihama, Akira] Hosei Univ, Res Ctr Micronano Technol, Koganei, Tokyo, Japan; [Shimada, Tomohiro] Tokyo Inst Technol, Lab Chem & Life Sci, Yokohama, Kanagawa, Japan; [Dey, Debashish; Quyyum, M. Zuhaib; Sen, Ranjan] Ctr DNA Fingerprinting & Diagnost, Hyderabad, Andhra Pradesh, India; [Nakano, Masahiro] Kyoto Univ, Inst Virus Res, Sakyo Ku, Kyoto, Japan; [Yoshida, Hideji] Osaka Med Coll, Dept Phys, Takatsuki, Osaka, Japan; [Yamamoto, Kaneyoshi; Ishihama, Akira] Hosei Univ, Dept Frontier Biosci, Koganei, Tokyo, Japan; [Takada, Hiraku] Rikkyo Univ, Dept Life Sci, Toshima Ku, Tokyo, Japan	Hosei University; Tokyo Institute of Technology; Department of Biotechnology (DBT) India; Centre for DNA Fingerprinting & Diagnostics (CDFD); Kyoto University; Osaka Medical College; Hosei University; Rikkyo University	Ishihama, A (corresponding author), Hosei Univ, Res Ctr Micronano Technol, Koganei, Tokyo, Japan.; Ishihama, A (corresponding author), Hosei Univ, Dept Frontier Biosci, Koganei, Tokyo, Japan.	aishiham@hosei.ac.jp	Shimada, Tomohiro/E-7660-2014; Qayyum, Mohammad Zuhaib/AAD-8672-2022; Yoshida, Hideji/P-1403-2018	Shimada, Tomohiro/0000-0002-8361-0730; Qayyum, Mohammad Zuhaib/0000-0003-2442-4812; Yoshida, Hideji/0000-0001-7213-4735; Ishihama, Akira/0000-0002-6339-9042; Ishiguro, Akira/0000-0003-1867-3134; Takada, Hiraku/0000-0003-2034-5666	MEXT [21241047, 18310133, 25430173, 24710214, 208-2012 (S0801037)]; Research Fund from IFO (Institute for Fermentation, Osaka); MEXT Cooperative Research Program of Network Joint Research Center for Materials and Devices	MEXT(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Research Fund from IFO (Institute for Fermentation, Osaka); MEXT Cooperative Research Program of Network Joint Research Center for Materials and Devices	MEXT Grants-in-Aid for Scientific Research (A) (21241047), (B) (18310133) and (C) (25430173) to A lshihama, MEXT Grant-in-Aid for Young Scientists (B) (24710214) to TS, Research Fund from IFO (Institute for Fermentation, Osaka) to TS, a support from the MEXT Cooperative Research Program of Network Joint Research Center for Materials and Devices to TS and A lshihama, and the MEXT-Supported Program for the Strategic Research Foundation at Private Universities 208-2012 (S0801037) to Hosei University.	ADAMS CW, 1985, J BIOL CHEM, V260, P8538; Afflerbach H, 1998, MOL MICROBIOL, V28, P641, DOI 10.1046/j.1365-2958.1998.00829.x; AMEMIYA K, 1986, J MOL BIOL, V187, P1, DOI 10.1016/0022-2836(86)90401-8; APIRION D, 1993, BIOESSAYS, V15, P113, DOI 10.1002/bies.950150207; Appleman JA, 1998, J BACTERIOL, V180, P1525, DOI 10.1128/JB.180.6.1525-1532.1998; Asai T, 1999, J BACTERIOL, V181, P3803, DOI 10.1128/JB.181.12.3803-3809.1999; Baba T, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100050; Barker MM, 2001, J BACTERIOL, V183, P6315, DOI 10.1128/JB.183.21.6315-6323.2001; BERG KL, 1987, J BACTERIOL, V169, P1691, DOI 10.1128/jb.169.4.1691-1701.1987; Blattner FR, 1997, SCIENCE, V277, P1453, DOI 10.1126/science.277.5331.1453; BROSIUS J, 1981, J MOL BIOL, V148, P107, DOI 10.1016/0022-2836(81)90508-8; CASADABAN MJ, 1980, J MOL BIOL, V138, P179, DOI 10.1016/0022-2836(80)90283-1; CHANG SC, 1992, BIOCHIM BIOPHYS ACTA, V1129, P219, DOI 10.1016/0167-4781(92)90491-H; CHASHEL M, 1969, NATURE, V221, P838, DOI 10.1038/221838a0; CONDON C, 1995, J BACTERIOL, V177, P4152, DOI 10.1128/jb.177.14.4152-4156.1995; CONDON C, 1993, EMBO J, V12, P4305, DOI 10.1002/j.1460-2075.1993.tb06115.x; Conway T, 2014, MBIO, V5, DOI 10.1128/mBio.01442-14; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; Davies BW, 2010, MOL MICROBIOL, V78, P506, DOI 10.1111/j.1365-2958.2010.07351.x; DEBOER HA, 1979, CELL, V17, P201, DOI 10.1016/0092-8674(79)90308-8; Dennis PP, 2004, MICROBIOL MOL BIOL R, V68, P639, DOI 10.1128/MMBR.68.4.639-668.2004; EMILSSON V, 1990, EMBO J, V9, P4359, DOI 10.1002/j.1460-2075.1990.tb07885.x; EMILSSON V, 1993, J MOL BIOL, V230, P483, DOI 10.1006/jmbi.1993.1165; Fujita N, 1996, METHOD ENZYMOL, V273, P121; Gourse RL, 1996, ANNU REV MICROBIOL, V50, P645, DOI 10.1146/annurev.micro.50.1.645; Gralla JD, 2005, MOL MICROBIOL, V55, P973, DOI 10.1111/j.1365-2958.2004.04455.x; GRANT SGN, 1990, P NATL ACAD SCI USA, V87, P4645, DOI 10.1073/pnas.87.12.4645; Gyorfy Z, 2015, NUCLEIC ACIDS RES, V43, P1783, DOI 10.1093/nar/gkv040; Hara H, 1997, J BACTERIOL, V179, P5802, DOI 10.1128/jb.179.18.5802-5811.1997; Hayashi K, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100049; HILL CW, 1981, P NATL ACAD SCI-BIOL, V78, P7069, DOI 10.1073/pnas.78.11.7069; Hirvonen CA, 2001, J BACTERIOL, V183, P6305, DOI 10.1128/JB.183.21.6305-6314.2001; HOROWITZ H, 1982, J MOL BIOL, V156, P257, DOI 10.1016/0022-2836(82)90327-8; IKEMURA T, 1982, COLD SPRING HARB SYM, V47, P1087, DOI 10.1101/SQB.1983.047.01.123; Ishihama A, 1990, Adv Biophys, V26, P19, DOI 10.1016/0065-227X(90)90005-E; Ishihama A, 1999, GENES CELLS, V4, P135, DOI 10.1046/j.1365-2443.1999.00247.x; Ishihama A, 1981, Adv Biophys, V14, P1; Ishihama A, 2016, NUCLEIC ACIDS RES, V44, P2058, DOI 10.1093/nar/gkw051; Ishihama A, 2012, P JPN ACAD B-PHYS, V88, P485, DOI 10.2183/pjab.88.485; Ishihama A, 2010, FEMS MICROBIOL REV, V34, P628, DOI 10.1111/j.1574-6976.2010.00227.x; JACKSON EN, 1972, J MOL BIOL, V69, P307, DOI 10.1016/0022-2836(72)90232-X; Jishage M, 1997, J BACTERIOL, V179, P959, DOI 10.1128/jb.179.3.959-963.1997; KAJITANI M, 1984, J BIOL CHEM, V259, P1951; KJELDGAARD NO, 1958, J GEN MICROBIOL, V19, P607, DOI 10.1099/00221287-19-3-607; KOLTER R, 1992, ANNU REV MICROBIOL, V46, P141, DOI 10.1146/annurev.mi.46.100192.001041; KURLAND CG, 1993, BIOCHEM SOC T, V21, P841, DOI 10.1042/bst0210841; Li ZW, 1999, RNA, V5, P139, DOI 10.1017/S1355838299981669; Li ZW, 1999, EMBO J, V18, P2878, DOI 10.1093/emboj/18.10.2878; LOPES JM, 1989, GENE, V76, P255, DOI 10.1016/0378-1119(89)90166-2; MAALOE O, 1996, CONTROL MACROMOLECUL; Maeda M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0144697; MANKIN AS, 1987, FEBS LETT, V219, P269, DOI 10.1016/0014-5793(87)80233-8; Millar JH, 1972, EXPT MOL GENETICS; Mishra S, 2015, NUCLEIC ACIDS RES, V43, P5744, DOI 10.1093/nar/gkv479; MISRA TK, 1979, J BIOL CHEM, V254, P1154; MORSE DE, 1968, J MOL BIOL, V38, P447, DOI 10.1016/0022-2836(68)90401-4; Nakano M, 2014, FEMS MICROBIOL LETT, V355, P93, DOI 10.1111/1574-6968.12466; NILSSON L, 1994, J BIOL CHEM, V269, P9460; NOMURA M, 1977, ANNU REV GENET, V11, P297, DOI 10.1146/annurev.ge.11.120177.001501; Ogasawara H, 2007, J BACTERIOL, V189, P4791, DOI 10.1128/JB.00319-07; ORTUNO MJ, 1987, NUCLEIC ACIDS RES, V15, P1521, DOI 10.1093/nar/15.4.1521; Paul BJ, 2004, ANNU REV GENET, V38, P749, DOI 10.1146/annurev.genet.38.072902.091347; ROSS W, 1990, EMBO J, V9, P3733, DOI 10.1002/j.1460-2075.1990.tb07586.x; Schneider DA, 2003, CURR OPIN MICROBIOL, V6, P151, DOI 10.1016/S1369-5274(03)00038-9; Shimada K, 2013, MICROBIOL-SGM, V159, P2501, DOI 10.1099/mic.0.067538-0; Shimada T, 2005, GENES CELLS, V10, P907, DOI 10.1111/j.1365-2443.2005.00888.x; Shimada T, 2007, MOL MICROBIOL, V66, P744, DOI 10.1111/j.1365-2958.2007.05954.x; Shimada T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090447; Shimada T, 2011, MOL MICROBIOL, V82, P378, DOI 10.1111/j.1365-2958.2011.07818.x; SRIVASTAVA AK, 1990, ANNU REV MICROBIOL, V44, P105, DOI 10.1146/annurev.mi.44.100190.000541; STUDIER FW, 1986, J MOL BIOL, V189, P113, DOI 10.1016/0022-2836(86)90385-2; Tamura M, 2013, J BACTERIOL, V195, P1133, DOI 10.1128/JB.01558-12; Tamura M, 2012, J BACTERIOL, V194, P1919, DOI 10.1128/JB.06652-11; TAYLOR WE, 1979, GENE, V6, P331, DOI 10.1016/0378-1119(79)90073-8; Tenson T, 1995, BIOCHEM CELL BIOL, V73, P1061, DOI 10.1139/o95-114; Tenson T, 1996, P NATL ACAD SCI USA, V93, P5641, DOI 10.1073/pnas.93.11.5641; TIPPNER D, 1994, MOL MICROBIOL, V11, P589, DOI 10.1111/j.1365-2958.1994.tb00339.x; Umitsuki G, 2001, GENES CELLS, V6, P403, DOI 10.1046/j.1365-2443.2001.00430.x; Vicente M, 1998, CELL MOL LIFE SCI, V54, P317, DOI 10.1007/s000180050158; Wada A, 1998, GENES CELLS, V3, P203, DOI 10.1046/j.1365-2443.1998.00187.x; WEK RC, 1986, NUCLEIC ACIDS RES, V14, P2763, DOI 10.1093/nar/14.6.2763; YAMAO F, 1991, NUCLEIC ACIDS RES, V19, P6119, DOI 10.1093/nar/19.22.6119; YOUNG RA, 1979, CELL, V17, P225, DOI 10.1016/0092-8674(79)90310-6; ZACHARIAS M, 1989, MOL MICROBIOL, V3, P405, DOI 10.1111/j.1365-2958.1989.tb00185.x	84	4	4	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2016	11	12							e0163057	10.1371/journal.pone.0163057	http://dx.doi.org/10.1371/journal.pone.0163057			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI9QH	28005933	Green Submitted, Green Published, gold			2022-12-27	WOS:000392843200001
J	Burgute, BD; Peche, VS; Muller, R; Matthias, J; Gassen, B; Eichinger, L; Glockner, G; Noegel, AA				Burgute, Bhagyashri D.; Peche, Vivek S.; Mueller, Rolf; Matthias, Jan; Gassen, Berthold; Eichinger, Ludwig; Gloeckner, Gernot; Noegel, Angelika A.			The C-Terminal SynMuv/DdDUF926 Domain Regulates the Function of the N-Terminal Domain of DdNKAP	PLOS ONE			English	Article							DICTYOSTELIUM; PROTEIN; GENE; CHROMATIN; GENOME; DIFFERENTIATION; IDENTIFICATION; COMPLEX; NKAP	NKAP (NF-kappa B activating protein) is a highly conserved SR (serine/arginine-rich) protein involved in transcriptional control and splicing in mammals. We identified DdNKAP, the Dictyostelium discoideum ortholog of mammalian NKAP, as interacting partner of the nuclear envelope protein SUN-1. DdNKAP harbors a number of basic RDR/RDRS repeats in its N-terminal domain and the SynMuv/DUF926 domain at its C-terminus. We describe a novel and direct interaction between DdNKAP and Prp19 (Pre mRNA processing factor 19) which might be relevant for the observed DdNKAP ubiquitination. Genome wide analysis using cross-linking immunoprecipitation-high-throughput sequencing (CLIP-seq) revealed DdNKAP association with intergenic regions, exons, introns and non-coding RNAs. Ectopic expression of DdNKAP and its domains affects several developmental aspects like stream formation, aggregation, and chemotaxis. We conclude that DdNKAP is a multifunctional protein, which might influence Dictyostelium development through its interaction with RNA and RNA binding proteins. Mutants overexpressing full length DdNKAP and the N-terminal domain alone (DdN-NKAP) showed opposite phenotypes in development and opposite expression profiles of several genes and rRNAs. The observed interaction between DdNNKAP and the DdDUF926 domain indicates that the DdDUF926 domain acts as negative regulator of the N-terminus.	[Burgute, Bhagyashri D.; Peche, Vivek S.; Mueller, Rolf; Matthias, Jan; Gassen, Berthold; Eichinger, Ludwig; Gloeckner, Gernot; Noegel, Angelika A.] Univ Cologne, CMMC, Fac Med,Inst Biochem 1, Cologne Excellence Cluster Cellular Stress Respon, Cologne, Germany; [Gloeckner, Gernot] IGB, Leibniz Inst Freshwater Ecol & Inland Fisheries, Berlin, Germany	University of Cologne; Leibniz Institut fur Gewasserokologie und Binnenfischerei (IGB)	Noegel, AA (corresponding author), Univ Cologne, CMMC, Fac Med,Inst Biochem 1, Cologne Excellence Cluster Cellular Stress Respon, Cologne, Germany.	noegel@uni-koeln.de	Peche, Vivek/GWZ-4668-2022; Glöckner, Gernot/A-7800-2010; Eichinger, Ludwig/AAJ-8895-2021	Glöckner, Gernot/0000-0002-9061-1061; Eichinger, Ludwig/0000-0003-1594-6117	International Graduate School in Development, Health and Disease (IGSDHD); Cologne Excellence Cluster on Cellular Stress Responses in Aging-Associated Diseases (CECAD) [C05]; Maria Pesch Foundation	International Graduate School in Development, Health and Disease (IGSDHD); Cologne Excellence Cluster on Cellular Stress Responses in Aging-Associated Diseases (CECAD); Maria Pesch Foundation	B.D.B was supported by the International Graduate School in Development, Health and Disease (IGSDHD). This work was supported by the Cologne Excellence Cluster on Cellular Stress Responses in Aging-Associated Diseases (CECAD), grant C05. The funding through the Maria Pesch Foundation to B.D.B. is acknowledged.	Aguilera V, 2015, PLANT CELL, V1; Anders S, 2015, BIOINFORMATICS, V31, P166, DOI 10.1093/bioinformatics/btu638; Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; Burgute BD, 2013, NUCLEIC ACIDS RES, P1; Catalano A, 2012, HISTOCHEM CELL BIOL, V138, P515, DOI 10.1007/s00418-012-0973-9; Chanarat S, 2013, BBA-MOL CELL RES, V1833, P2126, DOI 10.1016/j.bbamcr.2013.05.023; Chanarat S, 2011, GENE DEV, V25, P1147, DOI 10.1101/gad.623411; Chang W, 2015, J CELL BIOL, V208, P11, DOI 10.1083/jcb.201409047; Chen DY, 2003, BIOCHEM BIOPH RES CO, V310, P720, DOI 10.1016/j.bbrc.2003.09.074; de Almeida SF, 2012, TRENDS BIOCHEM SCI, V37, P248, DOI 10.1016/j.tibs.2012.02.002; DiAntonio A, 2004, ANNU REV NEUROSCI, V27, P223, DOI 10.1146/annurev.neuro.27.070203.144317; Eichinger L, 2005, NATURE, V435, P43, DOI 10.1038/nature03481; Faix J, 2001, EMBO J, V20, P3705, DOI 10.1093/emboj/20.14.3705; Farbrother P, 2006, CELL MICROBIOL, V8, P438, DOI 10.1111/j.1462-5822.2005.00633.x; Fisher PR, 1997, CURR BIOL, V7, P889, DOI 10.1016/S0960-9822(06)00379-4; GERISCH G, 1981, J CELL SCI, V52, P1; Giot L, 2003, SCIENCE, V302, P1727, DOI 10.1126/science.1090289; Hegele A, 2012, MOL CELL, V45, P567, DOI 10.1016/j.molcel.2011.12.034; Hinas A, 2006, EUKARYOT CELL, V5, P924, DOI 10.1128/EC.00065-06; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Ji HT, 2015, PLANT J, V81, P399, DOI 10.1111/tpj.12733; KILMARTIN JV, 1982, J CELL BIOL, V93, P576, DOI 10.1083/jcb.93.3.576; Konig J, 2011, JOVE-J VIS EXP, DOI 10.3791/2638; Kruse J, 2016, RNA BIOL, V13, P1000, DOI 10.1080/15476286.2016.1212153; Kwong PN, 2015, J BIOL CHEM, V290, P30119, DOI 10.1074/jbc.M115.681171; Lamond AI, 2003, NAT REV MOL CELL BIO, V4, P605, DOI 10.1038/nrm1172; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Li P, 2015, NUCLEIC ACIDS RES, V43; Meier D, 2016, PLOS GENET, V12, DOI 10.1371/journal.pgen.1006057; Mi HY, 2013, NAT PROTOC, V8, P1551, DOI 10.1038/nprot.2013.092; Muller-Taubenberger A, 2013, EUR J CELL BIOL, V92, P45, DOI 10.1016/j.ejcb.2012.10.003; MULLERTAUBENBERGER A, 1988, J CELL SCI, V90, P51; Muramoto T, 2008, DEVELOPMENT, V135, P1647, DOI 10.1242/dev.020115; Noegel AA, 2004, MOL BIOL CELL, V15, P934, DOI 10.1091/mbc.E03-05-0269; O'Day DH, 2014, BIOL REV; Pajerowski AG, 2010, BLOOD, V116, P2684, DOI 10.1182/blood-2010-02-268391; Pajerowski AG, 2009, IMMUNITY, V30, P696, DOI 10.1016/j.immuni.2009.02.011; Pandit S, 2008, CURR OPIN CELL BIOL, V20, P260, DOI 10.1016/j.ceb.2008.03.001; Poulin G, 2005, EMBO J, V24, P2613, DOI 10.1038/sj.emboj.7600726; Sasaki K, 2008, DIFFERENTIATION, V76, P1093, DOI 10.1111/j.1432-0436.2008.00298.x; SCHLEICHER M, 1984, EMBO J, V3, P2095, DOI 10.1002/j.1460-2075.1984.tb02096.x; Shepard PJ, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-10-242; Sucgang R, 2003, NUCLEIC ACIDS RES, V31, P2361, DOI 10.1093/nar/gkg348; Sutherland BW, 2001, EMBO REP, V2, P1024, DOI 10.1093/embo-reports/kve222; Taniura H, 2006, J BIOL CHEM, V281, P12336, DOI 10.1074/jbc.M512723200; TARN WY, 1993, P NATL ACAD SCI USA, V90, P10821, DOI 10.1073/pnas.90.22.10821; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Urushihara H, 2004, NUCLEIC ACIDS RES, V32, P1647, DOI 10.1093/nar/gkh262; Westphal M, 1997, CURR BIOL, V7, P176, DOI 10.1016/S0960-9822(97)70088-5; Xiong HJ, 2008, TRAFFIC, V9, P708, DOI 10.1111/j.1600-0854.2008.00721.x; Yu B, 2011, PROTEIN CELL, V2, P395, DOI 10.1007/s13238-011-1052-z	51	3	3	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2016	11	12							e0168617	10.1371/journal.pone.0168617	http://dx.doi.org/10.1371/journal.pone.0168617			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI9QF	27997579	Green Submitted, gold, Green Published			2022-12-27	WOS:000392842900063
J	Sibille, E; Berdeaux, O; Martine, L; Bron, AM; Creuzot-Garcher, CP; He, ZG; Thuret, G; Bretillon, L; Masson, EAY				Sibille, Estelle; Berdeaux, Olivier; Martine, Lucy; Bron, Alain M.; Creuzot-Garcher, Catherine P.; He, Zhiguo; Thuret, Gilles; Bretillon, Lionel; Masson, Elodie A. Y.			Ganglioside Profiling of the Human Retina: Comparison with Other Ocular Structures, Brain and Plasma Reveals Tissue Specificities	PLOS ONE			English	Article							TANDEM MASS-SPECTROMETRY; CERAMIDE COMPOSITION; SIGNAL-TRANSDUCTION; MAJOR GANGLIOSIDES; FUNCTIONAL-ROLE; RAT RETINA; GLYCOSPHINGOLIPIDS; GM1; BOVINE; RAFTS	Gangliosides make a wide family of glycosphingolipids, highly heterogeneous in both the ceramide moiety and the oligosaccharide chain. While ubiquitously expressed in mammalian tissues, they are particularly abundant in the brain and the peripheral nervous system. Gangliosides are known to play a crucial role in the development, maintenance and functional integrity of the nervous system. However, the expression and roles of gangliosides in the retina, although often considered as a window on the brain, has been far less studied. We performed an in-depth analysis of gangliosides of the human retina, especially using powerful LC/MS methods. We compared the pattern of ganglioside classes and ceramide molecular species of this tissue with other ocular structures and with brain and plasma in elderly human individuals. About a hundred of ganglioside molecular species among 15 distinct classes were detected illustrating the huge structural diversity of these compounds. The retina exhibited a very diverse ganglioside profile and shared several common features with the brain (prominence of tetraosylgangliosides, abundance of d20:1 long chain base and 18:0 fatty acid...). However, the retina stood out with the specific expression of GD3, GT3 and AcGT3, which further presented a peculiar molecular species distribution. The unique ganglioside pattern we observed in the human retina suggests that these ganglioside species play a specific role in the structure and function of this tissue. This lipidomic study, by highlighting retina specific ganglioside species, opens up novel research directions for a better understanding of the biological role of gangliosides in the retina.	[Sibille, Estelle; Berdeaux, Olivier; Martine, Lucy; Bron, Alain M.; Creuzot-Garcher, Catherine P.; Bretillon, Lionel; Masson, Elodie A. Y.] Univ Bourgogne Franche Comte, CNRS, Ctr Sci Gout & Alimentat, INRA, Dijon, France; [Bron, Alain M.; Creuzot-Garcher, Catherine P.] Univ Hosp, Dept Ophthalmol, Dijon, France; [He, Zhiguo; Thuret, Gilles] Univ Jean Monnet, Lab Biol Imaging & Engn Corneal Grafts, EA2521, Fac Med, St Etienne, France; [Thuret, Gilles] Inst Univ France, Paris, France	INRAE; Institut Agro; AgroSup Dijon; Centre National de la Recherche Scientifique (CNRS); Universite de Bourgogne; CHU Dijon Bourgogne; Institut Universitaire de France	Masson, EAY (corresponding author), Univ Bourgogne Franche Comte, CNRS, Ctr Sci Gout & Alimentat, INRA, Dijon, France.	elodie.masson@inra.fr	Bron, Alain/AAP-8010-2020	Bron, Alain/0000-0002-7265-931X; MASSON, Elodie/0000-0001-6312-0913; Bretillon, Lionel/0000-0002-6957-100X	Regional Council of Burgundy; French National Institute for Research on Agronomy (INRA); European Regional Development Fund (FEDER)	Regional Council of Burgundy(Region Bourgogne-Franche-Comte); French National Institute for Research on Agronomy (INRA); European Regional Development Fund (FEDER)(European Commission)	This work was supported by the Regional Council of Burgundy, the European Regional Development Fund (FEDER) and the French National Institute for Research on Agronomy (INRA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Choi JS, 2003, INVEST OPHTH VIS SCI, V44, P1747, DOI 10.1167/iovs.01-0886; DANIOTTI JL, 1991, J NEUROCHEM, V57, P2054, DOI 10.1111/j.1471-4159.1991.tb06421.x; DANIOTTI JL, 1994, J NEUROCHEM, V62, P1131; Degroote S, 2004, SEMIN CELL DEV BIOL, V15, P375, DOI 10.1016/j.semcdb.2004.03.007; Denny CA, 2007, J NEUROCHEM, V101, P1294, DOI 10.1111/j.1471-4159.2007.04525.x; Dreyfus H, 1976, Adv Exp Med Biol, V71, P163; Dreyfus H, 1996, INVEST OPHTH VIS SCI, V37, P574; DUBOIS C, 1986, J BIOL CHEM, V261, P3826; Fontaine V, 1998, GLYCOBIOLOGY, V8, P183, DOI 10.1093/glycob/8.2.183; Furukawa K, 2011, NEUROCHEM RES, V36, P1578, DOI 10.1007/s11064-011-0494-2; Garcia AD, 2014, J CHROMATOGR B, V947, P1, DOI 10.1016/j.jchromb.2013.11.025; HAKOMORI S, 1995, J BIOCHEM, V118, P1091, DOI 10.1093/oxfordjournals.jbchem.a124992; HOLM M, 1974, FEBS LETT, V45, P159, DOI 10.1016/0014-5793(74)80835-5; HOLM M, 1974, FEBS LETT, V38, P261, DOI 10.1016/0014-5793(74)80067-0; Ikeda K, 2008, J LIPID RES, V49, P2678, DOI 10.1194/jlr.D800038-JLR200; Ikeda K, 2010, RAPID COMMUN MASS SP, V24, P2957, DOI 10.1002/rcm.4716; KADOWAKI H, 1984, J LIPID RES, V25, P1132; Kolter T, 2006, BBA-BIOMEMBRANES, V1758, P2057, DOI 10.1016/j.bbamem.2006.05.027; LANDA CA, 1985, DEV BRAIN RES, V21, P193, DOI 10.1016/0165-3806(85)90208-1; Lauritzen L, 2001, PROG LIPID RES, V40, P1, DOI 10.1016/S0163-7827(00)00017-5; Li YT, 2002, J LIPID RES, V43, P1019, DOI 10.1194/jlr.M200010-JLR200; Masson EAY, 2015, J LIPID RES, V56, P1821, DOI 10.1194/jlr.D060764; MohandSaid S, 1997, STROKE, V28, P617, DOI 10.1161/01.STR.28.3.617; Ngamukote S, 2007, J NEUROCHEM, V103, P2327, DOI 10.1111/j.1471-4159.2007.04910.x; PALESTINI P, 1993, J NEUROCHEM, V61, P955, DOI 10.1111/j.1471-4159.1993.tb03608.x; PALESTINI P, 1990, J NEUROCHEM, V54, P230, DOI 10.1111/j.1471-4159.1990.tb13305.x; PALESTINI P, 1995, BBA-BIOMEMBRANES, V1235, P221, DOI 10.1016/0005-2736(95)80008-4; Proia RL, 2003, PHILOS T R SOC B, V358, P879, DOI 10.1098/rstb.2003.1268; Sango K, 2005, INVEST OPHTH VIS SCI, V46, P3420, DOI 10.1167/iovs.05-0038; Simons K, 2000, NAT REV MOL CELL BIO, V1, P31, DOI 10.1038/35036052; Simons K, 1997, NATURE, V387, P569, DOI 10.1038/42408; Simons K, 2010, NAT REV MOL CELL BIO, V11, P688, DOI 10.1038/nrm2977; Simpson MA, 2004, NAT GENET, V36, P1225, DOI 10.1038/ng1460; Sonnino S, 2000, BBA-REV BIOMEMBRANES, V1469, P63, DOI 10.1016/S0005-2736(00)00210-8; Sonnino S, 2007, GLYCOBIOLOGY, V17, p1R, DOI 10.1093/glycob/cwl052; Sonnino S, 2006, CHEM REV, V106, P2111, DOI 10.1021/cr0100446; Svennerholm L, 1980, Adv Exp Med Biol, V125, P11; Todeschini AR, 2008, BBA-GEN SUBJECTS, V1780, P421, DOI 10.1016/j.bbagen.2007.10.008; Tsui ZC, 2005, ANAL BIOCHEM, V341, P251, DOI 10.1016/j.ab.2005.03.036; Urban P F, 1980, Adv Exp Med Biol, V125, P149; Vukelic Z, 2007, GLYCOBIOLOGY, V17, P504, DOI 10.1093/glycob/cwm012; Yu R. K., 2007, COMPREHENSIVE GLYCOS, P73, DOI 10.1016/B978-044451967-2/00003-9; YU RK, 1972, J LIPID RES, V13, P680; Yu RK, 2007, J NEUROCHEM, V103, P39, DOI 10.1111/j.1471-4159.2007.04710.x; Yu RK, 2012, NEUROCHEM RES, V37, P1230, DOI 10.1007/s11064-012-0744-y; Zamfir A, 2004, J AM SOC MASS SPECTR, V15, P1649, DOI 10.1016/j.jasms.2004.08.002; Zamfir A, 2002, ELECTROPHORESIS, V23, P2894, DOI 10.1002/1522-2683(200209)23:17<2894::AID-ELPS2894>3.0.CO;2-Q; Zamfir AD, 2013, ANAL BIOANAL CHEM, V405, P7321, DOI 10.1007/s00216-013-7173-x	48	15	15	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2016	11	12							e0168794	10.1371/journal.pone.0168794	http://dx.doi.org/10.1371/journal.pone.0168794			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI9QF	27997589	gold, Green Submitted, Green Published			2022-12-27	WOS:000392842900076
J	Ren, C; Chen, HB; Yang, BT; Liu, F; Ouyang, ZY; Bo, XC; Shu, WJ				Ren, Chao; Chen, Hebing; Yang, Bite; Liu, Feng; Ouyang, Zhangyi; Bo, Xiaochen; Shu, Wenjie			iFORM: Incorporating Find Occurrence of Regulatory Motifs	PLOS ONE			English	Article							TRANSCRIPTION FACTORS; HOT REGIONS; BINDING; DNA; DISCOVERY; DATABASE; TOOLS	Accurately identifying the binding sites of transcription factors (TFs) is crucial to understanding the mechanisms of transcriptional regulation and human disease. We present incorporating Find Occurrence of Regulatory Motifs (iFORM), an easy-to-use and efficient tool for scanning DNA sequences with TF motifs described as position weight matrices (PWMs). Both performance assessment with a receiver operating characteristic (ROC) curve and a correlation-based approach demonstrated that iFORM achieves higher accuracy and sensitivity by integrating five classical motif discovery programs using Fisher's combined probability test. We have used iFORM to provide accurate results on a variety of data in the ENCODE Project and the NIH Roadmap Epigenomics Project, and the tool has demonstrated its utility in further elucidating individual roles of functional elements. Both the source and binary codes for iFORM can be freely accessed at https://github.com/wenjiegroup/iFORM. The identified TF binding sites across human cell and tissue types using iFORM have been deposited in the Gene Expression Omnibus under the accession ID GSE53962.	[Ren, Chao; Chen, Hebing; Yang, Bite; Liu, Feng; Ouyang, Zhangyi; Bo, Xiaochen; Shu, Wenjie] Beijing Inst Radiat Med, Dept Biotechnol, Beijing, Peoples R China; [Liu, Feng] 188th Hosp Chaozhou, Dept Informat, Chaozhou, Peoples R China	Academy of Military Medical Sciences - China	Bo, XC; Shu, WJ (corresponding author), Beijing Inst Radiat Med, Dept Biotechnol, Beijing, Peoples R China.	boxc@bmi.ac.cn; shuwj@bmi.ac.cn		Shu, Wenjie/0000-0001-9044-2352; Chen, Hebing/0000-0003-4102-356X; Bo, Xiao-chen/0000-0003-1911-7922	Major Research plan of the National Natural Science Foundation of China [U1435222]; Program of International ST Cooperation [2014DFB30020]; National High Technology Research and Development Program of China [2015AA020108]	Major Research plan of the National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Program of International ST Cooperation; National High Technology Research and Development Program of China(National High Technology Research and Development Program of China)	This work was supported by grants from the Major Research plan of the National Natural Science Foundation of China (No. U1435222), the Program of International S&T Cooperation (No. 2014DFB30020) and the National High Technology Research and Development Program of China (No. 2015AA020108). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bernstein BE, 2010, NAT BIOTECHNOL, V28, P1045, DOI 10.1038/nbt1010-1045; Bradley RK, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000343; Chen HB, 2015, SCI REP-UK, V5, DOI 10.1038/srep08465; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Grant CE, 2011, BIOINFORMATICS, V27, P1017, DOI 10.1093/bioinformatics/btr064; Gretton A., 2007, ADV NEURAL INF PROCE, V20, P585; Harbison CT, 2004, NATURE, V431, P99, DOI 10.1038/nature02800; Haverty PM, 2004, BIOINFORMATICS, V20, P1815, DOI 10.1093/bioinformatics/bth162; Heinz S, 2010, MOL CELL, V38, P576, DOI 10.1016/j.molcel.2010.05.004; Hertz GZ, 1999, BIOINFORMATICS, V15, P563, DOI 10.1093/bioinformatics/15.7.563; Li H, 2016, BMC GENOMICS, V17, DOI 10.1186/s12864-016-3077-4; Li H, 2015, SCI REP-UK, V5, DOI 10.1038/srep11633; MacArthur S, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-7-r80; MacIsaac KD, 2006, PLOS COMPUT BIOL, V2, P201, DOI 10.1371/journal.pcbi.0020036; Matys V, 2006, NUCLEIC ACIDS RES, V34, pD108, DOI 10.1093/nar/gkj143; Pique-Regi R, 2011, GENOME RES, V21, P447, DOI 10.1101/gr.112623.110; Portales-Casamar E, 2010, NUCLEIC ACIDS RES, V38, pD105, DOI 10.1093/nar/gkp950; Robasky K, 2011, NUCLEIC ACIDS RES, V39, pD124, DOI 10.1093/nar/gkq992; Scholkopf Bernhard, 2016, KERNEL BASED TESTS J, P67; Schones DE, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-19; Speir ML, 2016, NUCLEIC ACIDS RES, V44, pD717, DOI 10.1093/nar/gkv1275; Storey JD, 2003, ANN STAT, V31, P2013, DOI 10.1214/aos/1074290335; Storey JD, 2002, J ROY STAT SOC B, V64, P479, DOI 10.1111/1467-9868.00346; STORMO GD, 1989, P NATL ACAD SCI USA, V86, P1183, DOI 10.1073/pnas.86.4.1183; Thomas-Chollier M, 2011, NUCLEIC ACIDS RES, V39, pW86, DOI 10.1093/nar/gkr377; Tompa M, 2005, NAT BIOTECHNOL, V23, P137, DOI 10.1038/nbt1053	26	1	1	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 19	2016	11	12							e0168607	10.1371/journal.pone.0168607	http://dx.doi.org/10.1371/journal.pone.0168607			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI9QC	27992540	Green Submitted, Green Published, gold			2022-12-27	WOS:000392842600078
J	Hong, JW; Noh, JH; Kim, DJ				Hong, Jae Won; Noh, Jung Hyun; Kim, Dong-Jun			The Association of Resting Heart Rate with the Presence of Diabetes in Korean Adults: The 2010-2013 Korea National Health and Nutrition Examination Survey	PLOS ONE			English	Article							METABOLIC SYNDROME; INSULIN-RESISTANCE; NERVOUS-SYSTEM; BLOOD-PRESSURE; LIFE-STYLE; RISK; POPULATION; OBESITY; DETERMINANTS; HYPERTENSION	Background Previous epidemiologic studies have shown that elevated resting heart rate (HR) is associated with higher cardiovascular disease (CVD) morbidity and mortality. Although the relationship between elevated HR and CVD is well established, the association between resting HR and diabetes has been relatively understudied, particularly in non-Western populations. Objectives We confirmed the association between the presence of type 2 diabetes and resting HR in the Korean adult population using data from the 2010-2013 Korea National Health and Nutrition Examination Survey (KNHANES). Methods Among 25,712 adults (>= 19 years of age) who participated in the 2010-2013 KNHANES, a total of 22,512 subjects completed laboratory examinations and were included in this analysis. The fasting plasma glucose (FPG) level was categorized into the following five groups: normal fasting glucose (NFG) 1 (<90 mg/dL), NFG 2 (90-99 mg/dL), impaired fasting glucose (IFG) 1 (100-110 mg/dL), IFG 2 (111-125 mg/dL), and diabetes (>= 126 mg/dL). Results The unadjusted weighted resting HRs were 69.6, 69.4, 69.8, 70.1, and 72.0 beats per minute (bpm) in the NFG 1, NFG 2, IFG 1, IFG 2, and diabetes groups, respectively (P<0.001). We assessed the adjusted weighted resting HR according to the FPG level after adjusting for age, sex, smoking history, high risk alcohol drinking, daily energy intake, waist circumference, serum total cholesterol level, serum triglyceride (TG) level, serum white blood cell (WBC) count, serum hemoglobin (Hb), and the presence of hypertension. The adjusted weighted resting HR significantly increased across the FPG groups (P<0.001). The weighted prevalence rates of diabetes were 6.8% (6.2-7.5%), 7.6% (6.7-8.5%), 8.0% (7.0-9.1%), and 11.8% (10.8-12.7%) in subjects with HR <= 64, 65-69, 70-75, and >= 76 bpm, respectively (P<0.001), after adjusting for the confounding factors mentioned above. Using resting HR <= 64 bpm as the control, resting HR >= 76 bpm was correlated with the presence of diabetes (adjusted OR 1.83, 95% CI 1.55-2.16, P<0.001). Each 10 bpm increment of HR increased the risk of the presence of diabetes by 35% (P<0.001). This association of high resting HR with the presence of diabetes was not influenced by the status of blood pressure (BP) medication. Conclusion We demonstrated that higher HR was associated with diabetes in a representative sample of Korean adults. These positive associations were independent of age, sex, current smoking, high risk alcohol drinking, daily energy intake, waist circumference, and the presence of hypertension and other potential confounders. This study suggests that individuals with higher resting HR are at risk of diabetes and that HR might provide an easy and simple surrogate marker for the risk of diabetes.	[Hong, Jae Won; Noh, Jung Hyun; Kim, Dong-Jun] Inje Univ, Dept Internal Med, Ilsan Paik Hosp, Coll Med, Koyang, Gyeonggi Do, South Korea	Inje University	Kim, DJ (corresponding author), Inje Univ, Dept Internal Med, Ilsan Paik Hosp, Coll Med, Koyang, Gyeonggi Do, South Korea.	djkim@paik.ac.kr	Noh, Junghyun/AAU-8113-2020					Aune D, 2015, NUTR METAB CARDIOVAS, V25, P526, DOI 10.1016/j.numecd.2015.02.008; Babor T.F., 2001, ALCOHOL USE DISORDER; Balcioglu AS, 2015, WORLD J DIABETES, V6, P80, DOI 10.4239/wjd.v6.i1.80; Bohm M, 2015, AM J MED, V128, P219, DOI 10.1016/j.amjmed.2014.09.016; Carnethon MR, 2008, DIABETES CARE, V31, P335, DOI 10.2337/dc07-0874; Carnethon MR, 2003, CIRCULATION, V107, P2190, DOI 10.1161/01.CIR.0000066324.74807.95; Christou DD, 2008, J APPL PHYSIOL, V105, P24, DOI 10.1152/japplphysiol.90401.2008; CRYER PE, 1976, NEW ENGL J MED, V295, P573, DOI 10.1056/NEJM197609092951101; DYER AR, 1980, AM J EPIDEMIOL, V112, P736, DOI 10.1093/oxfordjournals.aje.a113046; Esser N, 2014, DIABETES RES CLIN PR, V105, P141, DOI 10.1016/j.diabres.2014.04.006; Flanagan DE, 1999, J CLIN ENDOCR METAB, V84, P1263, DOI 10.1210/jc.84.4.1263; GILLUM RF, 1991, AM HEART J, V121, P172, DOI 10.1016/0002-8703(91)90970-S; Grantham NM, 2013, DIABETIC MED, V30, P421, DOI 10.1111/dme.12045; Hartaigh BO, 2013, ACTA DIABETOL, V50, P325, DOI 10.1007/s00592-012-0396-z; Hong JW, 2015, MEDICINE, V94, DOI 10.1097/MD.0000000000000611; JAMERSON KA, 1993, HYPERTENSION, V21, P618, DOI 10.1161/01.HYP.21.5.618; Julius S, 1992, Blood Press, V1, P9, DOI 10.3109/08037059209065119; Julius S, 2000, HYPERTENSION, V35, P807, DOI 10.1161/01.HYP.35.3.807; KANNEL WB, 1987, AM HEART J, V113, P1489, DOI 10.1016/0002-8703(87)90666-1; Li YQ, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-1052; Low PA, 2004, DIABETES CARE, V27, P2942, DOI 10.2337/diacare.27.12.2942; Mancia G, 2007, J HYPERTENS, V25, P909, DOI 10.1097/HJH.0b013e328048d004; Ministry of Health and Welfare, 1998, KOR HLTH IND DEV I D; Nagaya T, 2010, INT J EPIDEMIOL, V39, P215, DOI 10.1093/ije/dyp229; Nilsson PM, 2004, DIABETES CARE, V27, P2464, DOI 10.2337/diacare.27.10.2464; Oda E, 2014, ACTA DIABETOL, V51, P85, DOI 10.1007/s00592-013-0503-9; Pop-Busui R, 2010, DIABETES CARE, V33, P434, DOI 10.2337/dc09-1294; Rogowski O, 2009, CARDIOVASC DIABETOL, V8, DOI 10.1186/1475-2840-8-55; Shibao C, 2007, HYPERTENSION, V49, P27, DOI 10.1161/01.HYP.0000251679.87348.05; Shigetoh Y, 2009, AM J HYPERTENS, V22, P151, DOI 10.1038/ajh.2008.331; Stolarz K, 2003, J HYPERTENS, V21, P525, DOI 10.1097/00004872-200303000-00018; Straznicky NE, 2005, J CLIN ENDOCR METAB, V90, P5998, DOI 10.1210/jc.2005-0961; The Korean Centers for Disease Control and Prevention, KOR HLTH IND DEV I G; Valentini M, 2004, J HYPERTENS, V22, P1999, DOI 10.1097/00004872-200410000-00024; Valentini M, 2009, PROG CARDIOVASC DIS, V52, P11, DOI 10.1016/j.pcad.2009.05.004; Vinik Aaron I, 2012, Front Endocrinol (Lausanne), V3, P71, DOI 10.3389/fendo.2012.00071; Wang L, 2015, INT J EPIDEMIOL, V44, P689, DOI 10.1093/ije/dyv079; Whelton SP, 2014, AM J CARDIOL, V113, P644, DOI 10.1016/j.amjcard.2013.11.009; Yang HI, 2016, CLIN CHIM ACTA, V455, P195, DOI 10.1016/j.cca.2016.01.006; Zhang J, 1999, EUR HEART J, V20, P103, DOI 10.1053/euhj.1999.1230; Zhang XL, 2010, INT J EPIDEMIOL, V39, P900, DOI 10.1093/ije/dyq068	41	6	8	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2016	11	12							e0168527	10.1371/journal.pone.0168527	http://dx.doi.org/10.1371/journal.pone.0168527			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI8LN	27992613	Green Published, Green Submitted, gold			2022-12-27	WOS:000392758000057
J	Colleter, R; Dedouit, F; Duchesne, S; Mokrane, FZ; Gendrot, V; Gerard, P; Dabernat, H; Crubezy, E; Telmon, N				Colleter, Rozenn; Dedouit, Fabrice; Duchesne, Sylvie; Mokrane, Fatima-Zohra; Gendrot, Veronique; Gerard, Patrice; Dabernat, Henri; Crubezy, Eric; Telmon, Norbert			Procedures and Frequencies of Embalming and Heart Extractions in Modern Period in Brittany. Contribution to the Evolution of Ritual Funerary in Europe	PLOS ONE			English	Article							LONG BONES; RADIOGRAPHS; CHILDREN; STATURE	The evolution of funeral practices from the Middle Ages through the Modern era in Europe is generally seen as a process of secularization. The study, through imaging and autopsy, of two mummies, five lead urns containing hearts, and more than six hundred skeletons of nobles and clergymen from a Renaissance convent in Brittany has led us to reject this view. In addition to exceptional embalming, we observed instances in which hearts alone had been extracted, a phenomenon that had never before been described, and brains alone as well, and instances in which each spouse's heart had been placed on the other's coffin. In some identified cases we were able to establish links between the religious attitudes of given individuals and either ancient Medieval practices or more modern ones generated by the Council of Trent. All of these practices, which were a function of social status, were rooted in religion. They offer no evidence of secularization whatsoever.	[Colleter, Rozenn; Duchesne, Sylvie] Natl Inst Prevent Archaeol Res INRAP, Cesson Sevigne, France; [Colleter, Rozenn; Dedouit, Fabrice; Duchesne, Sylvie; Mokrane, Fatima-Zohra; Gerard, Patrice; Dabernat, Henri; Crubezy, Eric; Telmon, Norbert] Univ Toulouse, French Natl Ctr Sci Res, UMR 5288, Toulouse, France; [Dedouit, Fabrice] CURML, Unit Forens & Anthropol Imaging, Lausanne, Switzerland; [Mokrane, Fatima-Zohra] CHU Toulouse Rangueil, Dept Radiol, Toulouse, France; [Gendrot, Veronique] French Reg Archaeol Serv, Rennes, Bretagne, France; [Gendrot, Veronique] French Natl Ctr Sci Res, UMR 6566, Rennes, France; [Telmon, Norbert] CHU Toulouse Rangueil, Medicolegal Dept, Toulouse, France	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Universite de Toulouse; Universite Toulouse III - Paul Sabatier; CHU de Toulouse; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); CHU de Toulouse	Colleter, R (corresponding author), Natl Inst Prevent Archaeol Res INRAP, Cesson Sevigne, France.; Colleter, R; Crubezy, E (corresponding author), Univ Toulouse, French Natl Ctr Sci Res, UMR 5288, Toulouse, France.	rozenn.colleter@inrap.fr; crubezy.eric@free.fr	Duchesne, Sylvie/AAA-7467-2022; DEDOUIT, Fabrice/AAH-7634-2019; Crubézy, Eric/AAB-5165-2022	Duchesne, Sylvie/0000-0003-0138-8409; Crubézy, Eric/0000-0001-9417-9053; Mokrane, Fatima-Zohra/0000-0003-1610-1474; Colleter, Rozenn/0000-0003-2711-115X; Gerard, Patrice/0000-0002-6018-6092				Albert Jean-Pierre, 1990, ODEURS SAINTETE MYTH; Alexandre-Bidon D, 1993, REVEILLER MORTS MORT; Aries P, 1975, W ATTITUDES DEATH MI, V3; Aries Philippe, 2008, HOUR OUR DEATH; Bande A, 2009, CAPETIENS SEPULTURES; BEN-AMOS Avner, 2000, FUNERALS POLITICS ME; Birkner R., 1980, IMAGE RADIOLOGIQUE T; Blanchard P, 2014, REV ARCHEOLOGIQUE CE, P53; Brown E A, 1981, Viator, V12, P221; Bruzek J, 2002, AM J PHYS ANTHROPOL, V117, P157, DOI 10.1002/ajpa.10012; Charlier P, 2015, MED SCI LAW; Charlier Philippe, 2006, Med Secoli, V18, P777; Chroscicki Juliusz A., 2012, FUNERAILLES PRINCIER; Ciranni Rosalba, 2005, Med Secoli, V17, P251; Colleter R, 2011, ACT 3 C INT PATH RES, P449; Croix A, 1981, BRETAGNE 16 SIECLES; croix Alain., 1981, LA CROIX, V1, P299; Crubezy E, 1990, COLLECTION ONE WORLD, V18, P189; Depierre G, 1989, HOMMES MILIEU APPROC, P121; Devriendt W, 2012, ARCHEOLOGIE MEDIEV, V42, P23; Dietz A, 1998, KLEINE KULTURGESCHIC; Dionis P, 1765, COURS OPERATIONS CHI; Dittmar JM, 2015, J ARCHAEOL SCI-REP, V3, P73, DOI 10.1016/j.jasrep.2015.05.019; DUDAY H, 1990, Bulletins et Memoires de la Societe d'Anthropologie de Paris, V2, P29, DOI 10.3406/bmsap.1990.1740; Fornaciari A, 2008, MUMMIES SCI WORLD MU, P521; Fornaciari Gino, 2007, Med Secoli, V19, P521; Gannal J.-N., 1841, HIST EMBAUMEMENTS PR; Gaude-Ferragu M, 2005, CENDRES MORT FUNERAI; Georges P, 2009, ACTES DU 2E COLLOQUE, P233; Giesey RE, 1960, ROYAL FUNERAL CEREMO; Girault P-G, 2014, FUNERAILLES ANNE BRE; Giuffra V, 2011, J ARCHAEOL SCI, V38, P1949, DOI 10.1016/j.jas.2011.04.009; Gryglewski Ryszard W, 2002, Arch Hist Filoz Med, V65, P47; Hadjouis D, 2011, ACT 3 C INT PATH, P31; Isbled B, 1992, MOI CLAUDE BORDEAUX; Kuzminsky SC, 2012, J ARCHAEOL SCI, V39, P2744, DOI 10.1016/j.jas.2012.04.020; Maat G J, 1997, Ned Tijdschr Geneeskd, V141, P2501; Mafart B, 2004, INT J OSTEOARCHAEOL, V14, P67, DOI 10.1002/oa.692; Martin H, 1975, PAUVRETE VOLONTAIRE; Metcalf P., 1995, CELEBRATIONS DEATH A; Mokrane FZ, 2016, FORENSIC SCI INT, V268, P14, DOI 10.1016/j.forsciint.2016.08.035; Molleson T., 1993, SPITALFIELDS PROJECT; MOORREES CF, 1963, AM J PHYS ANTHROPOL, V21, P205, DOI 10.1002/ajpa.1330210212; MOORREES COENRAAD F.A., 1963, JOUR DENT RES, V42, P1490, DOI 10.1177/00220345630420062701; MURAIL P, 2005, B MEM SOC ANTHRO PAR, V17, P167, DOI DOI 10.4000/BMSAP.1157; PALKAMA A, 1962, ANN MED EXP BIOL FEN, V40, P219; Pare Ambroise, 1652, OEVRES AMBROISE PARE, V11th; Regnier C, 2009, MEDICOGRAPHIA, V31, P429; Schmitt Aurore, 2005, Bulletins et Memoires de la Societe d'Anthropologie de Paris, V17, P89; Sorensen MLS., 2010, BODY PARTS BODIES WH; Stone Lawrence Stone, 1967, CRISIS ARISTOCRACY 1; TELKKA A, 1962, ANN MED EXP BIOL FEN, V40, P91; Toller H, 1977, BRIT ARCHAEOLOGICAL; VALENTIN F, 1995, AM J PHYS ANTHROPOL, V98, P375, DOI 10.1002/ajpa.1330980310; VIRTAMA P, 1962, ANN MED EXP BIOL FEN, V40, P283; Vovelle M, 2000, MORT OCCIDENT 1300 N; Westerhof Danielle, 2008, DEATH NOBLE BODY MED	57	11	11	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2016	11	12							e0167988	10.1371/journal.pone.0167988	http://dx.doi.org/10.1371/journal.pone.0167988			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EG7JB	28030554	Green Published, gold, Green Submitted			2022-12-27	WOS:000391222000028
J	Setamou, M; Simpson, CR; Alabi, OJ; Nelson, SD; Telagamsetty, S; Jifon, JL				Setamou, Mamoudou; Simpson, Catherine R.; Alabi, Olufemi J.; Nelson, Shad D.; Telagamsetty, Srilakshmi; Jifon, John L.			Quality Matters: Influences of Citrus Flush Physicochemical Characteristics on Population Dynamics of the Asian Citrus Psyllid (Hemiptera: Liviidae)	PLOS ONE			English	Article							DIAPHORINA-CITRI; AMINO-ACIDS; PHLOEM-SAP; NUTRITIONAL QUALITY; GREENING DISEASE; PLANT-GROWTH; BIOLOGY; PERFORMANCE; TRANSITION; HOMOPTERA	Studies were conducted to relate the influence of the physical characteristics, leaf nutrient content and phloem sap amino acid concentration of citrus flush shoots on the densities of various Diaphorina citri life stages. Adult D. citri preferentially selected young shoots for feeding and numbers of D. citri immatures were positively correlated with flush shoot softness. Young flush shoots had higher concentrations of macro and micro nutrients relative to mature ones and this was associated with higher densities of all D. citri life stages. All D. citri life stages were positively correlated with higher nitrogen-carbon (N:C), nitrogen: sulfur (N: S) and nitrogen: calcium (N:Ca) ratios in leaf tissue, while densities of adults were negatively related to calcium, manganese and boron levels. Concentrations of total and essential amino acids were highest in phloem sap of young expanding flush shoots in both grapefruit and lemon, but dramatically declined as flush shoots matured. The sulfur-containing amino acids cystine, methionine and taurine occurred only in younger flush shoots. In contrast, cystathionine was only present in phloem sap of mature shoots. These results clearly indicate that young citrus flush shoots are a nutritionally richer diet relative to mature shoots, thus explaining their preference by D. citri for feeding and reproduction. Conversely, tissue hardness and the lower nutritional quality of mature flush shoots may limit oviposition and immature development. The data suggest that both physical characteristics and nutritional composition of flush shoots and their phloem sap are important factors regulating host colonization and behavior of D. citri, and this interaction can impact the dynamics and spread of HLB in citrus groves.	[Setamou, Mamoudou; Simpson, Catherine R.; Nelson, Shad D.; Telagamsetty, Srilakshmi] Texas A&M Univ, Kingsville Citrus Ctr, Dept Agr Agribusiness & Environm Sci, Weslaco, TX 78596 USA; [Alabi, Olufemi J.] Texas A&M AgriLife Res & Extens Ctr, Dept Plant Pathol & Microbiol, Weslaco, TX USA; [Jifon, John L.] Texas A&M AgriLife Res & Extens Ctr, Dept Hort, Weslaco, TX USA	Texas A&M University System; Texas A&M University Kingsville; Texas A&M University System; Texas A&M University College Station; Texas A&M AgriLife Research; Texas A&M University System; Texas A&M University College Station; Texas A&M AgriLife Research	Setamou, M (corresponding author), Texas A&M Univ, Kingsville Citrus Ctr, Dept Agr Agribusiness & Environm Sci, Weslaco, TX 78596 USA.	mamoudou.setamou@tamuk.edu	Alabi, Olufemi J./ABD-9930-2020	Alabi, Olufemi J./0000-0002-2471-7052; Setamou, Mamoudou/0000-0002-4777-4826; Jifon, John/0000-0003-0618-6056; Simpson, Catherine/0000-0002-8164-4275	United States Department of Agriculture (USDA-NIFA) Hispanic Serving Institution Award [2011-38422-30803]; multi-institutional collaborative grant 'BGREEN' project; Texas Citrus Producers Board	United States Department of Agriculture (USDA-NIFA) Hispanic Serving Institution Award; multi-institutional collaborative grant 'BGREEN' project; Texas Citrus Producers Board	This research was supported by a student research funding from the United States Department of Agriculture (USDA-NIFA) Hispanic Serving Institution Award #2011-38422-30803, a multi-institutional collaborative grant 'BGREEN' project. This research was also supported by the Texas Citrus Producers Board. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alabi LJ, 2014, PLANT HLTH PROG, P184, DOI DOI 10.1094/PHP-RS-14-0028; Ammar ED, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064938; [Anonymous], 2015, J CITRUS PATHOL; Arredondo IMJ, 2009, ABUNDANCE POPULATION; Baldwin IT, 2001, CURR OPIN PLANT BIOL, V4, P351, DOI 10.1016/S1369-5266(00)00184-9; Bi JL, 2007, J CHEM ECOL, V33, P1692, DOI 10.1007/s10886-007-9346-6; BI JL, 1995, J CHEM ECOL, V21, P1511, DOI 10.1007/BF02035149; Blackmer JL, 1999, ENTOMOL EXP APPL, V93, P29, DOI 10.1023/A:1003886107024; Bove JM, 2006, J PLANT PATHOL, V88, P7; Conway JM, 2003, ORGAN RES METHODS, V6, P147, DOI 10.1177/1094428103251541; Corbesier L, 2001, PLANT CELL ENVIRON, V24, P367, DOI 10.1046/j.1365-3040.2001.00683.x; DAGRACA JV, 1991, ANNU REV PHYTOPATHOL, V29, P109, DOI 10.1146/annurev.py.29.090191.000545; DEYL Z, 1986, J CHROMATOGR, V379, P177, DOI 10.1016/S0378-4347(00)80685-4; DOUGLAS AE, 1993, ECOL ENTOMOL, V18, P31, DOI 10.1111/j.1365-2311.1993.tb01076.x; Douglas AE, 2006, J EXP BOT, V57, P747, DOI 10.1093/jxb/erj067; Fekkes D, 1996, J CHROMATOGR B, V682, P3, DOI 10.1016/0378-4347(96)00057-6; Gottwald T. R., 2007, Plant Health Progress, P1, DOI 10.1094/PHP-2007-0405-01-RS; Grafton-Cardwell EE, 2013, ANNU REV ENTOMOL, V58, P413, DOI 10.1146/annurev-ento-120811-153542; Halbert SE, 2004, FLA ENTOMOL, V87, P330, DOI 10.1653/0015-4040(2004)087[0330:ACPSPA]2.0.CO;2; Hall DG, 2013, ENTOMOL EXP APPL, V146, P207, DOI 10.1111/eea.12025; Hepler PK, 2005, PLANT CELL, V17, P2142, DOI 10.1105/tpc.105.032508; Hodges A, 2012, EC IMPACTS CITRUS GR; Jagoueix S, 1996, MOL CELL PROBE, V10, P43, DOI 10.1006/mcpr.1996.0006; Karley AJ, 2002, J EXP BIOL, V205, P3009; KING RW, 1974, PLANT PHYSIOL, V53, P96, DOI 10.1104/pp.53.1.96; LeBoucher J, 1997, CLIN CHEM, V43, P1421; Littell R. C., 2006, SAS SYSTEMS MIXED MO, V2nd; Liu YH, 2000, ANN APPL BIOL, V137, P201, DOI 10.1111/j.1744-7348.2000.tb00060.x; Marchi S, 2005, J AM SOC HORTIC SCI, V130, P928, DOI 10.21273/JASHS.130.6.928; Marschner H., 2012, MARSCHNERS MINERAL N, V89; Marschner H, 2012, MARSCHNERS MINERAL N, V95; Martini X, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129373; MATTSON WJ, 1980, ANNU REV ECOL SYST, V11, P119, DOI 10.1146/annurev.es.11.110180.001003; SAS Institute, 2008, SAS PROC GUID VERS 9; Setamou M, 2008, J ECON ENTOMOL, V101, P1478, DOI 10.1603/0022-0493(2008)101[1478:DPASPF]2.0.CO;2; Setamou M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0131917; Setamou M, 2012, J INSECT BEHAV, V25, P264, DOI 10.1007/s10905-011-9295-3; Spann T.M., 2010, CITRUS IND, P1, DOI [10.1016/j.porgcoat.2009.09.005, DOI 10.1016/J.PORGCOAT.2009.09.005]; Spiegel-Roy P, 1996, BIOL CITRUS; Stansly P, 2013, CITRUS IND, P1; Tetyuk O, 2013, JOVE-J VIS EXP, DOI 10.3791/51111; Tsagkarakis AE, 2012, J AM SOC HORTIC SCI, V137, P3, DOI 10.21273/JASHS.137.1.3; Underwood W, 2012, FRONT PLANT SCI, V3, DOI 10.3389/fpls.2012.00085; Yasuda K, 2005, JPN J APPL ENTOMOL Z, V49, P146, DOI 10.1303/jjaez.2005.146; Zar J.H., 1999, ZAR KUHR 5 2019, V4th	45	45	45	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2016	11	12							e0168997	10.1371/journal.pone.0168997	http://dx.doi.org/10.1371/journal.pone.0168997			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EG7JB	28030637	Green Submitted, gold, Green Published			2022-12-27	WOS:000391222000098
J	Portman, SL; Krishnankutty, SM; Reddy, GVP				Portman, Scott L.; Krishnankutty, Sindhu M.; Reddy, Gadi V. P.			Entomopathogenic Nematodes Combined with Adjuvants Presents a New Potential Biological Control Method for Managing the Wheat Stem Sawfly, Cephus cinctus (Hymenoptera: Cephidae)	PLOS ONE			English	Article							STEINERNEMA-CARPOCAPSAE; EFFICACY; LARVAE; SPRAY; GEL; DISTRIBUTIONS; LEPIDOPTERA; RHABDITIDA; MANAGEMENT; BORER	The wheat stem sawfly, (Cephus cinctus Norton) Hymenoptera: Cephidae, has been a major pest of winter wheat and barley in the northern Great Plains for more than 100 years. The insect's cryptic nature and lack of safe chemical control options make the wheat stem sawfly (WSS) difficult to manage; thus, biological control offers the best hope for sustainable management of WSS. Entomopathogenic nematodes (EPNs) have been used successfully against other above-ground insect pests, and adding adjuvants to sprays containing EPNs has been shown to improve their effectiveness. We tested the hypothesis that adding chemical adjuvants to sprays containing EPNs will increase the ability of EPNs to enter wheat stems and kill diapausing WSS larvae. This is the first study to test the ability of EPNs to infect the WSS, C. cinctus, and test EPNs combined with adjuvants against C. cinctus in both the laboratory and the field. Infection assays showed that three different species of EPNs caused 60-100% mortality to WSS larvae. Adding Penterra, Silwet L-77, Sunspray 11N, or Syl-Tac to solutions containing EPNs resulted in higher WSS mortality than solutions made with water alone. Field tests showed that sprays containing S. feltiae added to 0.1% Penterra increased WSS mortality up to 29.1%. These results indicate a novel control method for WSS, and represent a significant advancement in the biological control of this persistent insect pest.	[Portman, Scott L.; Reddy, Gadi V. P.] Montana State Univ, Western Triangle Agr Res Ctr, Conrad, MT 59425 USA; [Krishnankutty, Sindhu M.] Xavier Univ, USDA, APHIS PPQ, Buzzards Bay, MA USA; [Portman, Scott L.] ARS, Exot & Invas Weed Res Unit, Western Reg Res Ctr, USDA, Albany, CA 94710 USA	Montana State University System; Montana State University Bozeman; United States Department of Agriculture (USDA); United States Department of Agriculture (USDA)	Portman, SL; Reddy, GVP (corresponding author), Montana State Univ, Western Triangle Agr Res Ctr, Conrad, MT 59425 USA.; Portman, SL (corresponding author), ARS, Exot & Invas Weed Res Unit, Western Reg Res Ctr, USDA, Albany, CA 94710 USA.	slportman37@gmail.com; reddy@montana.edu	Reddy, Gadi V.P./J-5270-2015	Reddy, Gadi V.P./0000-0001-6377-0721	Montana Wheat and Barley Committee	Montana Wheat and Barley Committee	This work was supported by a grant from the Montana Wheat and Barley Committee to Gadi VP Reddy.	Ainslie CN, 1929, US DEP AGR B, V841; Antwi FB, 2016, J ECON ENTOMOL, V109, P1706, DOI 10.1093/jee/tow140; Arthurs S, 2004, B ENTOMOL RES, V94, P297, DOI 10.1079/BER2003309; Bal HK, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129887; Baur ME, 1997, BIOCONTROL SCI TECHN, V7, P513, DOI 10.1080/09583159730587; Beck B, 2013, BIOCONTROL SCI TECHN, V23, P507, DOI 10.1080/09583157.2013.777692; Beres BL, 2011, CAN ENTOMOL, V143, P105, DOI 10.4039/n10-056; Canhilal R, 2006, J AGR URBAN ENTOMOL, V23, P27; Criddle N., 1923, Canadian Entomologist, V55, P1; DAVIS E. G., 1955, Bi-Monthly Bulletin. North Dakota Agricultural Experiment Station, V17, P171; Dito DF, 2016, BIOCONTROL SCI TECHN, V26, P835, DOI 10.1080/09583157.2016.1159659; Farstad C. W., 1946, SCI AGRIC [OTTAWA], V26, P216; Fife JP, 2003, BIOL CONTROL, V27, P65, DOI 10.1016/S1049-9644(02)00183-4; Fulbright J, 2011, WHEAT STEM SAWFLY BI; Grant JA, 2003, ENVIRON ENTOMOL, V32, P80, DOI 10.1603/0046-225X-32.1.80; Grewal PS, 2005, NEMATODES AS BIOCONTROL AGENTS, P1, DOI 10.1079/9780851990170.0000; HOLMES ND, 1982, CAN ENTOMOL, V114, P775, DOI 10.4039/Ent114775-9; Kaspi R, 2010, APPL SOIL ECOL, V45, P243, DOI 10.1016/j.apsoil.2010.04.012; Kega V. M., 2013, Journal of Entomology, V10, P103, DOI 10.3923/je.2013.103.109; Knodel JJ, 2009, J AGR URBAN ENTOMOL, V26, P183, DOI 10.3954/1523-5475-26.4.183; Koppenhofer AM, 2005, NEMATODES AS BIOCONTROL AGENTS, P363, DOI 10.1079/9780851990170.0363; Lerro CC, 2015, OCCUP ENVIRON MED, V72, P736, DOI 10.1136/oemed-2014-102798; Mahajan R, 2006, ENVIRON HEALTH PERSP, V114, P1205, DOI 10.1289/ehp.8911; Mason JM, 1998, CROP PROT, V17, P463, DOI 10.1016/S0261-2194(98)00043-X; McNEAL F. H., 1955, AGRON JOUR, V47, P522; MORRILL WL, 1994, J ECON ENTOMOL, V87, P1373, DOI 10.1093/jee/87.5.1373; Mwaitulo S., 2011, International Journal of Tropical Insect Science, V31, P154, DOI 10.1017/S1742758411000294; Nansen C, 2005, CAN ENTOMOL, V137, P428; Negrisoli AS, 2010, CROP PROT, V29, P677, DOI 10.1016/j.cropro.2010.02.002; Noosidum A, 2016, BIOL CONTROL, V97, P48, DOI 10.1016/j.biocontrol.2016.03.004; Norton E, 1872, T AM ENTOMOL SOC, V4, P77, DOI DOI 10.2307/25076265; Patel SKM, 2015, INDIAN J FISH, V62, P133; Reddy GVP, 2015, ANN REPORT; Santhi VS, 2015, BIOL CONTROL, V83, P75, DOI 10.1016/j.biocontrol.2015.01.003; Schneider-Orelli O., 1947, SCHWEIZ ZEITSCHR FORSTW, V98, P89; Schroer S, 2005, BIOCONTROL SCI TECHN, V15, P601, DOI 10.1080/09583150500088694; Shanower TG, 2004, J AGR URBAN ENTOMOL, V21, P197; Shapiro-Ilan DI, 2016, BIOL CONTROL, V94, P33, DOI 10.1016/j.biocontrol.2015.12.006; Shapiro-Ilan DI, 2010, BIOL CONTROL, V54, P23, DOI 10.1016/j.biocontrol.2009.11.009; Stock D, 2000, WEED TECHNOL, V14, P798, DOI 10.1614/0890-037X(2000)014[0798:PPOAVA]2.0.CO;2; Szczepaniec A, 2015, J ECON ENTOMOL, V108, P2316, DOI 10.1093/jee/tov207; Tangtrakulwanich K., 2014, Journal of Agricultural Science (Toronto), V6, P1; Tannahill B, 2016, ESA PAC BRANCH M HAW; WALLACE LE, 1962, J ECON ENTOMOL, V55, P908, DOI 10.1093/jee/55.6.908; Weaver DK, 2005, BIOL CONTROL, V34, P1, DOI 10.1016/j.biocontrol.2005.04.001; Weiss Michael J., 1992, American Entomologist, V38, P241; WHITE G. F., 1927, SCIENCE, V66, P302, DOI 10.1126/science.66.1709.302-a	47	14	14	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2016	11	12							e0169022	10.1371/journal.pone.0169022	http://dx.doi.org/10.1371/journal.pone.0169022			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI9QH	28006820	Green Published, Green Submitted, gold			2022-12-27	WOS:000392843200126
J	Priyadarsini, S; Sarker-Nag, A; Rowsey, TG; Ma, JX; Karamichos, D				Priyadarsini, Shrestha; Sarker-Nag, Akhee; Rowsey, Tyler G.; Ma, Jian-Xing; Karamichos, Dimitrios			Establishment of a 3D In Vitro Model to Accelerate the Development of Human Therapies against Corneal Diabetes	PLOS ONE			English	Article							EPITHELIAL BARRIER FUNCTION; BASEMENT-MEMBRANE; OXIDATIVE STRESS; SKELETAL-MUSCLE; MATRIX; CELLS; MITOCHONDRIA; METABOLISM; EXPRESSION; THICKNESS	Purpose To establish an in vitro model that would mirror the in vivo corneal stromal environment in diabetes (DM) patients. Methods Human corneal fibroblasts from Healthy (HCFs), Type 1DM (T1DM) and Type 2DM (T2DM) donors were isolated and cultured for 4 weeks with Vitamin C stimulation in order to allow for extracellular matrix (ECM) secretion and assembly. Results Our data indicated altered cellular morphology, increased cellular migration, increased ECM assembly, and severe mitochondrial damage in both T1DM and T2DMs when compared to HCFs. Furthermore, we found significant downregulation of Collagen I and Collagen V expression in both T1DM and T2DMs. Furthermore, a significant up regulation of fibrotic markers was seen, including a-smooth muscle actin in T2DM and Collagen III in both T1DM and T2DMs. Metabolic analysis suggested impaired Glycolysis and Tricarboxylic acid cycle (TCA) pathway. Conclusion DM has significant effects on physiological and clinical aspects of the human cornea. The benefits in developing and fully characterizing our 3D in vitro model are enormous and might provide clues for the development of novel therapeutics.	[Priyadarsini, Shrestha; Sarker-Nag, Akhee; Karamichos, Dimitrios] Univ Oklahoma, Hlth Sci Ctr, Dean McGee Eye Inst, Dept Ophthalmol, Oklahoma City, OK 73104 USA; [Rowsey, Tyler G.] East Cent Univ, Dept Biol & Chem, Ada, OK 74820 USA; [Ma, Jian-Xing] Univ Oklahoma, Hlth Sci Ctr, Harold Hamm Diabet Ctr, Dept Physiol, Oklahoma City, OK 73104 USA	University of Oklahoma System; University of Oklahoma Health Sciences Center; University of Oklahoma System; University of Oklahoma Health Sciences Center	Karamichos, D (corresponding author), Univ Oklahoma, Hlth Sci Ctr, Dean McGee Eye Inst, Dept Ophthalmol, Oklahoma City, OK 73104 USA.	dimitrios-karamichos@ouhsc.edu		karamichos, dimitrios/0000-0002-8761-3824	National Eye Institute [EY020886, P30EY021725]	National Eye Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported by the National Eye Institute, EY020886 (DK), https://nei.nih.gov/; National Eye Institute, P30EY021725 (Dr. Gene Anderson), https://nei.nih.gov/.	Alper M G, 1975, Trans Am Ophthalmol Soc, V73, P323; Amer Diabet Assoc, 2013, DIABETES CARE, V36, pS67, DOI [10.2337/dc13-S067, 10.2337/dc10-S062, 10.2337/dc12-s064, 10.2337/dc11-S062]; Amer Diabet Assoc, 2010, DIABETES CARE, V33, pS62, DOI 10.2337/dc10-s062; ARAKI K, 1994, CURR EYE RES, V13, P203, DOI 10.3109/02713689408995778; BAKER KS, 1993, INVEST OPHTH VIS SCI, V34, P137; Bardsley Joan K, 2004, Crit Care Nurs Q, V27, P106; BIRK DE, 1988, J CELL BIOL, V106, P999, DOI 10.1083/jcb.106.3.999; Bravard A, 2011, AM J PHYSIOL-ENDOC M, V300, pE581, DOI 10.1152/ajpendo.00455.2010; Burkart AM, 2016, SCI REP-UK, V6, DOI 10.1038/srep22788; BUSTED N, 1981, BRIT J OPHTHALMOL, V65, P687, DOI 10.1136/bjo.65.10.687; Crescenzo R, 2015, FRONT PHYSIOL, V5, DOI 10.3389/fphys.2014.00512; Danaei G, 2011, LANCET, V378, P31, DOI 10.1016/S0140-6736(11)60679-X; Fillmore N, 2014, BRIT J PHARMACOL, V171, P2080, DOI 10.1111/bph.12475; Forouhi Nita Gandhi, 2014, Medicine (Abingdon), V42, P698; FOULKS GN, 1979, ARCH OPHTHALMOL-CHIC, V97, P1076; Gallagher EJ, 2011, ANN NY ACAD SCI, V1243, P54, DOI 10.1111/j.1749-6632.2011.06285.x; Garrett Q, 2014, AUSTIN J CLIN OPHTHA, V1; Gekka M, 2004, CORNEA, V23, P35, DOI 10.1097/00003226-200401000-00006; Gibran NS, 2002, J SURG RES, V108, P122, DOI 10.1006/jsre.2002.6525; GOBBELS M, 1989, GRAEF ARCH CLIN EXP, V227, P142, DOI 10.1007/BF02169787; Guo XQ, 2007, INVEST OPHTH VIS SCI, V48, P4050, DOI 10.1167/iovs.06-1216; HERSE PR, 1988, AM J OPTOM PHYS OPT, V65, P224; HOLT IJ, 1988, NATURE, V331, P717, DOI 10.1038/331717a0; Karamichos D, 2014, EXP EYE RES, V124, P31, DOI 10.1016/j.exer.2014.04.020; Karamichos D, 2014, SCI REP-UK, V4, DOI 10.1038/srep04608; Karamichos D, 2011, J TISSUE ENG REGEN M, V5, pE228, DOI 10.1002/term.429; Karamichos D, 2012, J FUNCT BIOMATER, V3, P760, DOI 10.3390/jfb3040760; Karamichos D, 2011, J FUNCT BIOMATER, V2, P213, DOI 10.3390/jfb2030213; Karamichos D, 2007, INVEST OPHTH VIS SCI, V48, P5030, DOI 10.1167/iovs.07-0443; Karamichos D, 2010, INVEST OPHTH VIS SCI, V51, P1382, DOI 10.1167/iovs.09-3860; Karamichos D, 2009, CELL MOTIL CYTOSKEL, V66, P1, DOI 10.1002/cm.20326; Kelley DE, 2002, DIABETES, V51, P2944, DOI 10.2337/diabetes.51.10.2944; King AJF, 2012, BRIT J PHARMACOL, V166, P877, DOI 10.1111/j.1476-5381.2012.01911.x; Koussounadis A, 2015, SCI REP-UK, V5, DOI 10.1038/srep10775; Lambert P., 2002, MEDICINE, V30, P1, DOI [DOI 10.1383/MEDC.30.1.1.28264, 10.1383/medc.30.1.1.28264.edit]; Lee JS, 2006, EYE, V20, P315, DOI 10.1038/sj.eye.6701868; Leppin K, 2014, INVEST OPHTH VIS SCI, V55, P3603, DOI 10.1167/iovs.14-14307; Liang CC, 2007, NAT PROTOC, V2, P329, DOI 10.1038/nprot.2007.30; Liu H, 2015, INT J CLIN EXP PATHO, V8, P7644; Ljubimov AV, 1998, J HISTOCHEM CYTOCHEM, V46, P1033, DOI 10.1177/002215549804600907; Ljubimov AV, 2001, J HISTOCHEM CYTOCHEM, V49, P1341, DOI 10.1177/002215540104901102; McKay TB, 2015, CELL BIOCHEM FUNCT, V33, P341, DOI 10.1002/cbf.3122; Mishima S., 1957, JPN J OPHTHALMOL, V1, P65; NERUP J, 1994, DIABETOLOGIA, V37, pS82, DOI 10.1007/BF00400830; Owen CG, 2005, OPHTHALMOLOGY, V112, P1801, DOI 10.1016/j.ophtha.2005.04.030; Pascal LE, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-246; Patti ME, 2010, ENDOCR REV, V31, P364, DOI 10.1210/er.2009-0027; Priyadarsini S, 2015, MOL VIS, V21, P577; Priyadarsini S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113310; Putti R, 2015, FRONT PHYSIOL, V6, DOI 10.3389/fphys.2015.00109; Rehany U, 2000, CORNEA, V19, P534, DOI 10.1097/00003226-200007000-00026; Ren R, 2008, DEV DYNAM, V237, P2705, DOI 10.1002/dvdy.21606; Rizvi F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018137; Robert L, 2001, PATHOL BIOL, V49, P353, DOI 10.1016/S0369-8114(01)00144-4; Rother KI, 2007, NEW ENGL J MED, V356, P1499, DOI 10.1056/NEJMp078030; SAINI JS, 1995, CAN J OPHTHALMOL, V30, P142; Saini JS, 1996, ARCH OPHTHALMOL-CHIC, V114, P649, DOI 10.1001/archopht.1996.01100130641001; Schultz R O, 1981, Trans Am Ophthalmol Soc, V79, P180; SCHULTZ RO, 1983, AM J OPHTHALMOL, V96, P368, DOI 10.1016/S0002-9394(14)77829-8; SCHWARTZ DE, 1974, ARCH OPHTHALMOL-CHIC, V91, P174; Sherer TB, 2002, NEUROSCIENTIST, V8, P192, DOI 10.1177/1073858402008003004; Skarbez K, 2010, EXPERT REV OPHTHALMO, V5, P557, DOI 10.1586/EOP.10.44; Su DHW, 2008, OPHTHALMOLOGY, V115, P964, DOI 10.1016/j.ophtha.2007.08.021; Torricelli AAM, 2014, EXP EYE RES, V129, P151, DOI 10.1016/j.exer.2014.09.013; Trepat X, 2012, COMPR PHYSIOL, V2, P2369, DOI 10.1002/cphy.c110012; Webhofer C, 2013, J PSYCHIATR RES, V47, P289, DOI 10.1016/j.jpsychires.2012.11.003; Welf ES, 2011, WIRES SYST BIOL MED, V3, P231, DOI 10.1002/wsbm.110; Whiting DR, 2011, DIABETES RES CLIN PR, V94, P311, DOI 10.1016/j.diabres.2011.10.029; Yang Y, 2006, CLIN SCI, V110, P627, DOI 10.1042/CS20050330; Yuan M, 2012, NAT PROTOC, V7, P872, DOI 10.1038/nprot.2012.024; ZIESKE JD, 1994, EXP CELL RES, V214, P621, DOI 10.1006/excr.1994.1300	71	19	19	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2016	11	12							e0168845	10.1371/journal.pone.0168845	http://dx.doi.org/10.1371/journal.pone.0168845			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI9QH	28005998	Green Published, Green Submitted, gold			2022-12-27	WOS:000392843200103
J	Tota, JE; Jiang, MZ; Ramanakumar, AV; Walter, SD; Kaufman, JS; Coutlee, F; Richardson, H; Burchell, AN; Koushik, A; Mayrand, MH; Villa, LL; Franco, EL				Tota, Joseph E.; Jiang, Mengzhu; Ramanakumar, Agnihotram V.; Walter, Stephen D.; Kaufman, Jay S.; Coutlee, Francois; Richardson, Harriet; Burchell, Ann N.; Koushik, Anita; Mayrand, Marie Helene; Villa, Luisa L.; Franco, Eduardo L.			Epidemiologic Evaluation of Human Papillomavirus Type Competition and the Potential for Type Replacement Post-Vaccination	PLOS ONE			English	Article							CERVICAL-CANCER; HPV TYPES; CLUSTERING PATTERNS; PARTICLE VACCINE; INFECTION; WOMEN; RISK; DNA; COINFECTION; ACQUISITION	Background Millions of women have been vaccinated with one of two first-generation human papillomavirus (HPV) vaccines. Both vaccines remain in use and target two oncogenic types (HPVs 16 and 18); however, if these types naturally compete with others that are not targeted, type replacement may occur following reductions in the circulating prevalence of targeted types. To explore the potential for type replacement, we evaluated natural HPV type competition in unvaccinated females. Methods Valid HPV DNA typing information was available from five epidemiological studies conducted in Canada and Brazil (n = 14,685; enrollment across studies took place between1993 and 2010), which used similar consensus-primer PCR assays, capable of detecting up to 40 HPV types. A total of 38,088 cervicovaginal specimens were available for inclusion in our analyses evaluating HPV type-type interactions involving vaccine-targeted types (6, 11, 16, and 18), and infection with each of the other HPV types. Results Across the studies, the average age of participants ranged from 21.0 to 43.7 years. HPV16 was the most common type (prevalence range: 1.0% to 13.8%), and in general HPV types were more likely to be detected as part of a multiple infection than as single infections. In our analyses focusing on each of the vaccine-targeted HPV types separately, many significant positive associations were observed (particularly involving HPV16); however, we did not observe any statistically significant negative associations. Conclusions Our findings suggest that natural HPV type competition does not exist, and that type replacement is unlikely to occur in vaccinated populations.	[Tota, Joseph E.; Jiang, Mengzhu; Ramanakumar, Agnihotram V.; Franco, Eduardo L.] McGill Univ, Dept Oncol, Montreal, PQ, Canada; [Tota, Joseph E.; Kaufman, Jay S.; Franco, Eduardo L.] McGill Univ, Dept Epidemiol Biostat & Occupat Hlth, Montreal, PQ, Canada; [Tota, Joseph E.] NCI, Div Canc Epidemiol & Genet, Infect & Immunoepidemiol Branch, Rockville, MD 20892 USA; [Walter, Stephen D.] McMaster Univ, Dept Clin Epidemiol & Biostat, Hamilton, ON, Canada; [Coutlee, Francois] Univ Montreal, Dept Microbiol & Infectiol, Montreal, PQ, Canada; [Coutlee, Francois; Koushik, Anita; Mayrand, Marie Helene] Univ Montreal, Hosp Res Ctr, Montreal, PQ, Canada; [Richardson, Harriet] Queens Univ, Dept Publ Hlth Sci, Kingston, ON, Canada; [Burchell, Ann N.] St Michaels Hosp, Dept Family & Community Med, Toronto, ON, Canada; [Burchell, Ann N.] Li Ka Shing Knowledge Inst, Ctr Res Inner City Hlth, Toronto, ON, Canada; [Koushik, Anita] Univ Montreal, Dept Med Sociale & Prevent, Montreal, PQ, Canada; [Mayrand, Marie Helene] Univ Montreal, Dept Obstet Gynecol & Med Sociale & Prevent, Montreal, PQ, Canada; [Villa, Luisa L.] Univ Sao Paulo, Sch Med, Dept Radiol & Oncol, Sao Paulo, Brazil	McGill University; McGill University; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); McMaster University; Universite de Montreal; Universite de Montreal; Queens University - Canada; University of Toronto; University Toronto Affiliates; Saint Michaels Hospital Toronto; University of Toronto; Li Ka Shing Knowledge Institute; Universite de Montreal; Universite de Montreal; Universidade de Sao Paulo	Tota, JE (corresponding author), McGill Univ, Dept Oncol, Montreal, PQ, Canada.; Tota, JE (corresponding author), McGill Univ, Dept Epidemiol Biostat & Occupat Hlth, Montreal, PQ, Canada.; Tota, JE (corresponding author), NCI, Div Canc Epidemiol & Genet, Infect & Immunoepidemiol Branch, Rockville, MD 20892 USA.	joseph.tota@nih.gov	VILLA, LUISA/AAH-4761-2019; Walter, Stephen/AAB-5548-2022; Mayrand, Marie-Hélène/ABB-7029-2020; Franco, Eduardo/C-6445-2014	VILLA, LUISA/0000-0003-4074-2335; Walter, Stephen/0000-0003-4157-8928; Franco, Eduardo/0000-0002-4409-8084; Kaufman, Jay/0000-0003-1606-401X	Canadian Institutes of Health Research [MOP-53111, MOP-49396, MOP-68893, MOP-42532, MCT-54063, MOP-67155, CRN-83320]; Canadian Cancer Society [12030]; US National Institutes of Health [CA70269, AI073889]; Society of Gynecologic Oncology of Canada; Roseau FRSQ SIDA maladies infectieuses; CIHR New Investigator awards; Canada Research Chairs program	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Canadian Cancer Society(Canadian Cancer Society (CCS)); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Society of Gynecologic Oncology of Canada; Roseau FRSQ SIDA maladies infectieuses; CIHR New Investigator awards(Canadian Institutes of Health Research (CIHR)); Canada Research Chairs program(Canada Research Chairs)	Funding for this study and for the parent investigations was provided by the Canadian Institutes of Health Research (grants MOP-53111, MOP-49396, MOP-68893, MOP-42532, MCT-54063, MOP-67155, CRN-83320), Canadian Cancer Society (grant 12030), the US National Institutes of Health (grants CA70269, AI073889), the Society of Gynecologic Oncology of Canada, and by the Roseau FRSQ SIDA maladies infectieuses. A.N.B. and A.K. are supported by CIHR New Investigator awards. J.S.K. was supported by the Canada Research Chairs program.	Bernard HU, 2010, VIROLOGY, V401, P70, DOI 10.1016/j.virol.2010.02.002; Brown DR, 2009, J INFECT DIS, V199, P926, DOI 10.1086/597307; Burchell AN, 2010, EPIDEMIOLOGY, V21, P31, DOI 10.1097/EDE.0b013e3181c1e70b; Chaturvedi AK, 2005, CANCER EPIDEM BIOMAR, V14, P2439, DOI 10.1158/1055-9965.EPI-05-0465; Chaturvedi AK, 2011, J INFECT DIS, V203, P910, DOI 10.1093/infdis/jiq139; Cole SR, 2010, INT J EPIDEMIOL, V39, P417, DOI 10.1093/ije/dyp334; Coutlee F, 1997, CLIN DIAGN VIROL, V8, P123, DOI 10.1016/S0928-0197(97)00021-4; Coutlee F, 2002, J CLIN MICROBIOL, V40, P902, DOI 10.1128/JCM.40.3.902-907.2002; Coutlee Francois, 2005, Can J Infect Dis Med Microbiol, V16, P83; de Sanjose S, 2010, LANCET ONCOL, V11, P1048, DOI 10.1016/S1470-2045(10)70230-8; de Villiers EM, 2004, VIROLOGY, V324, P17, DOI 10.1016/j.virol.2004.03.033; Dillner J, 2011, CLIN EXP IMMUNOL, V163, P17, DOI 10.1111/j.1365-2249.2010.04268.x; Franco E, 1999, Rev Panam Salud Publica, V6, P223, DOI 10.1590/S1020-49891999000900001; Gheit T, 2011, METHODS MOL BIOL, V665, P195, DOI 10.1007/978-1-60761-817-1_12; Giovannelli L, 2004, J CLIN MICROBIOL, V42, P3861, DOI 10.1128/JCM.42.8.3861-3864.2004; Gravitt PE, 2000, J CLIN MICROBIOL, V38, P357; Greenland S, 2000, INT J EPIDEMIOL, V29, P158, DOI 10.1093/ije/29.1.158; Harper DM, 2006, LANCET, V367, P1247, DOI 10.1016/S0140-6736(06)68439-0; Hubbard RA, 2003, ARCH PATHOL LAB MED, V127, P940; Joura EA, 2015, NEW ENGL J MED, V372, P711, DOI 10.1056/NEJMoa1405044; Kahn JA, 2012, PEDIATRICS, V130, pE249, DOI 10.1542/peds.2011-3587; Koushik A, 2005, CANCER DETECT PREV, V29, P307, DOI 10.1016/j.cdp.2005.06.007; Li N, 2011, INT J CANCER, V128, P927, DOI 10.1002/ijc.25396; Liaw KL, 2001, J INFECT DIS, V183, P8, DOI 10.1086/317638; Martcheva M, 2008, J R SOC INTERFACE, V5, P3, DOI 10.1098/rsif.2007.0236; Mayrand MH, 2006, INT J CANCER, V119, P615, DOI 10.1002/ijc.21897; Mejlhede N, 2010, APMIS, V118, P346, DOI 10.1111/j.1600-0463.2010.02602.x; Mendez F, 2005, J INFECT DIS, V192, P1158, DOI 10.1086/444391; Mollers M, 2014, AM J EPIDEMIOL; Munoz N, 2004, INT J CANCER, V111, P278, DOI 10.1002/ijc.20244; Plummer M, 2007, J INFECT DIS, V195, P1582, DOI 10.1086/516784; Richardson H, 2003, CANCER EPIDEM BIOMAR, V12, P485; Rositch AF, 2011, J INFECT DIS; Rousseau MC, 2003, SEX TRANSM DIS, V30, P581, DOI 10.1097/00007435-200307000-00010; Rousseau MC, 2001, J INFECT DIS, V184, P1508, DOI 10.1086/324579; Schiffman Mark, 2009, Infect Agent Cancer, V4, P8, DOI 10.1186/1750-9378-4-8; Thomas KK, 2000, J INFECT DIS, V182, P1097, DOI 10.1086/315805; Tota JE, 2016, J INFECT DIS; Tota JE, 2015, CANCER EPIDEM BIOMAR, V24, P286, DOI 10.1158/1055-9965.EPI-14-0566; Tota JE, 2013, AM J EPIDEMIOL, V178, P625, DOI 10.1093/aje/kwt018; Tota JE, 2011, PREV MED, V53, pS12, DOI 10.1016/j.ypmed.2011.08.017; Vaccarella S, 2013, INFECT AGENTS CANCER, V8, DOI 10.1186/1750-9378-8-50; Vaccarella S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071617; Vaccarella S, 2011, J INFECT DIS, V204, P385, DOI 10.1093/infdis/jir286; Vaccarella S, 2010, CANCER EPIDEM BIOMAR, V19, P503, DOI 10.1158/1055-9965.EPI-09-0983; VILLA LL, 1989, J NATL CANCER I, V81, P332, DOI 10.1093/jnci/81.5.332; Walboomers JMM, 1999, J PATHOL, V189, P12, DOI 10.1002/(SICI)1096-9896(199909)189:1&lt;12::AID-PATH431&gt;3.0.CO;2-F; Yang ZH, 2014, AM J EPIDEMIOL, V180, P1066, DOI 10.1093/aje/kwu267	48	15	15	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2016	11	12							e0166329	10.1371/journal.pone.0166329	http://dx.doi.org/10.1371/journal.pone.0166329			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI9QH	28005904	Green Published, Green Submitted, gold			2022-12-27	WOS:000392843200005
J	van der Heide, I; Gehring, U; Koppelman, GH; Wijga, AH				van der Heide, Iris; Gehring, Ulrike; Koppelman, Gerard H.; Wijga, Alet H.			Health-Related Factors Associated with Discrepancies between Children's Potential and Attained Secondary School Level: A Longitudinal Study	PLOS ONE			English	Article							MENTAL-HEALTH; PERFORMANCE; ADOLESCENCE; PATHWAYS; OUTCOMES; COHORT	Objectives This longitudinal study examines children's health-related characteristics in relation to discrepancies between their educational potential assessed by a cognitive test in primary school at age 11 and their attained secondary school level at age 14. Methods Data were used from 1510 participants of the Dutch PIAMA (Prevention and Incidence of Asthma and Mite Allergy) birth cohort. Multiple multinomial logistic regression analyses were used to estimate the associations between indicators of physical health, psychosocial health, lifestyle, sleeping patterns and stressful life events and attending a higher or lower level of secondary education than indicated by the cognitive test. Results We found no evidence that physical health contributes to discrepancies between the potential and attained level of secondary education, but attention disorders and stressful life events (nasty experiences and parents' divorce) were associated with educational attainment below children's potential level. Furthermore, substance use (alcohol, drugs and smoking) were strongly associated with attending a lower level of secondary education than expected (odds ratios from 2.2 (CI: 1.5-3.3) to 5.0 (CI: 2.8-8.7)). Conclusion In this general population study, attention disorders, stressful life events and especially substance use seemed to be more important than physical health for the discrepancy between expected and attained level of secondary education. The longitudinal design of the present study and the broad range of health-related factors that were studied, adds insights to the process of health-selection.	[van der Heide, Iris; Wijga, Alet H.] Natl Inst Publ Hlth & Environm, Ctr Nutr Prevent & Hlth Serv, Bilthoven, Netherlands; [Gehring, Ulrike] Univ Utrecht, Inst Risk Assessment Sci, Div Environm Epidemiol, Utrecht, Netherlands; [Koppelman, Gerard H.] Univ Groningen, Univ Med Ctr Groningen, Beatrix Childrens Hosp, GRIAC Res Inst,Dept Pediat Pulmonol & Pediat Alle, Groningen, Netherlands	Netherlands National Institute for Public Health & the Environment; Utrecht University	van der Heide, I (corresponding author), Natl Inst Publ Hlth & Environm, Ctr Nutr Prevent & Hlth Serv, Bilthoven, Netherlands.	irisvanderheide@gmail.com	Koppelman, Gerard/AAG-9187-2020	Gehring, Ulrike/0000-0003-3612-5780; Koppelman, Gerard/0000-0001-8567-3252	The Netherlands Organisation for Health Research and Development; Netherlands Asthma Foundation; the Netherlands Ministry of Planning, Housing and the Environment; the Netherlands Ministry of Health, Welfare and Sport; Institute for Public Health and the Environment	The Netherlands Organisation for Health Research and Development(Netherlands Organization for Health Research and Development); Netherlands Asthma Foundation; the Netherlands Ministry of Planning, Housing and the Environment; the Netherlands Ministry of Health, Welfare and Sport; Institute for Public Health and the Environment	The Prevention and Incidence of Asthma and Mite Allergy Study was funded by grants from The Netherlands Organisation for Health Research and Development; the Netherlands Asthma Foundation; the Netherlands Ministry of Planning, Housing and the Environment; the Netherlands Ministry of Health, Welfare and Sport; and the Institute for Public Health and the Environment. The study sponsors had no role in the design and conduct of the study; collection, management, analysis, and interpretation of the data; preparation, review, or approval of the manuscript; and decision to submit the manuscript for publication.	Alper J, 2014, EXPLORING OPPORTUNIT; Basch CE, 2011, J SCHOOL HEALTH, V81, P593, DOI 10.1111/j.1746-1561.2011.00632.x; BERWICK DM, 1991, MED CARE, V29, P169, DOI 10.1097/00005650-199102000-00008; Bevans KB, 2010, QUAL LIFE RES, V19, P1195, DOI 10.1007/s11136-010-9687-4; Bosker RJ, 1985, GENERATIE GESELECT 1; Bradley RH, 2002, ANNU REV PSYCHOL, V53, P371, DOI 10.1146/annurev.psych.53.100901.135233; Brunekreef B, 2002, PEDIAT ALLERG IMM-UK, V13, P55, DOI 10.1034/j.1399-3038.13.s.15.1.x; Chevalier A, 2005, DISCUSSION PAPER SER, V1496; Cito, 2014, BET STAND CIT; Forrest CB, 2013, J ADOLESCENT HEALTH, V52, P186, DOI 10.1016/j.jadohealth.2012.06.019; Glew GM, 2005, ARCH PEDIAT ADOL MED, V159, P1026, DOI 10.1001/archpedi.159.11.1026; Glew GM, 2008, J PEDIATR-US, V152, P123, DOI 10.1016/j.jpeds.2007.05.045; Goodman A, 2010, J EPIDEMIOL COMMUN H, V64, pA11, DOI 10.1136/jech.2010.120956.27; Hoeymans N, 2010, HLTH DETERMINANTS SE; Koivusilta L, 2003, SOC SCI MED, V57, P577, DOI 10.1016/S0277-9536(02)00405-7; Koivusilta LK, 2001, HEALTH EDUC RES, V16, P201, DOI 10.1093/her/16.2.201; Onderwijsconsument, 2008, UITSL CIT 2008; Rosenbaum JE, 1999, SOCIOL EDUC, V72, P179, DOI 10.2307/2673228; Ruijsbroek A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134780; Rumpf HJ, 2001, PSYCHIAT RES, V105, P243, DOI 10.1016/S0165-1781(01)00329-8; Sharif I, 2006, PEDIATRICS, V118, pE1061, DOI 10.1542/peds.2005-2854; Stenberga S-A, 2014, BRIT J SOCIOLOGY ED; Stroucken L, 2008, SOCIAALECONOMISCHE T, P7; Suhrcke M, 2011, IMPACT HLTH HLTH BEH; Timmermans A. C., 2013, SCHOOLADVIEZEN ONDER; Traag T, 2008, ROLE STUDENT FAMILY; Uiters E, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-1104; Van de Mheen D., 1999, INEQUALITIES HLTH BE; Wolfson AR, 2003, SLEEP MED REV, V7, P491, DOI 10.1016/S1087-0792(03)90003-7	29	4	4	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2016	11	12							e0168110	10.1371/journal.pone.0168110	http://dx.doi.org/10.1371/journal.pone.0168110			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EI9QH	28005962	Green Published, gold, Green Submitted			2022-12-27	WOS:000392843200029
J	Hinton, JW; Proctor, C; Kelly, MJ; van Manen, FT; Vaughan, MR; Chamberlain, MJ				Hinton, Joseph W.; Proctor, Christine; Kelly, Marcella J.; van Manen, Frank T.; Vaughan, Michael R.; Chamberlain, Michael J.			Space Use and Habitat Selection by Resident and Transient Red Wolves (Canis rufus)	PLOS ONE			English	Article							EASTERN NORTH-CAROLINA; SCENT-MARKING; LARGE CARNIVORE; GRAY WOLVES; BODY-SIZE; WOLF; RANGE; HYBRIDIZATION; DISPERSAL; DYNAMICS	Recovery of large carnivores remains a challenge because complex spatial dynamics that facilitate population persistence are poorly understood. In particular, recovery of the critically endangered red wolf (Canis rufus) has been challenging because of its vulnerability to extinction via human-caused mortality and hybridization with coyotes (Canis latrans). Therefore, understanding red wolf space use and habitat selection is important to assist recovery because key aspects of wolf ecology such as interspecific competition, foraging, and habitat selection are well-known to influence population dynamics and persistence. During 2009-2011, we used global positioning system (GPS) radio-telemetry to quantify space use and 3rd-order habitat selection for resident and transient red wolves on the Albemarle Peninsula of eastern North Carolina. The Albemarle Peninsula was a predominantly agricultural landscape in which red wolves maintained spatially stable home ranges that varied between 25 km(2) and 190 km(2). Conversely, transient red wolves did not maintain home ranges and traversed areas between 122 km(2) and 681 km(2). Space use by transient red wolves was not spatially stable and exhibited shifting patterns until residency was achieved by individual wolves. Habitat selection was similar between resident and transient red wolves in which agricultural habitats were selected over forested habitats. However, transients showed stronger selection for edges and roads than resident red wolves. Behaviors of transient wolves are rarely reported in studies of space use and habitat selection because of technological limitations to observed extensive space use and because they do not contribute reproductively to populations. Transients in our study comprised displaced red wolves and younger dispersers that competed for limited space and mating opportunities. Therefore, our results suggest that transiency is likely an important life-history strategy for red wolves that facilitates metapopulation dynamics through short- and long-distance movements and eventual replacement of breeding residents lost to mortality.	[Hinton, Joseph W.; Chamberlain, Michael J.] Univ Georgia, Warnell Sch Forestry & Nat Resources, Athens, GA 30602 USA; [Proctor, Christine; Kelly, Marcella J.; Vaughan, Michael R.] Virginia Tech, Dept Fish & Wildlife Conservat, Blacksburg, VA USA; [van Manen, Frank T.] US Geol Survey, Northern Rocky Mt Sci Ctr, Interagency Grizzly Bear Study Team, Bozeman, MT USA	University System of Georgia; University of Georgia; Virginia Polytechnic Institute & State University; United States Department of the Interior; United States Geological Survey	Hinton, JW (corresponding author), Univ Georgia, Warnell Sch Forestry & Nat Resources, Athens, GA 30602 USA.	jhinton@uga.edu	Kelly, Marcella/B-4891-2011	Kelly, Marcella/0000-0001-9044-3873; T. van Manen, Frank/0000-0001-5340-8489	North Carolina Department of Transportation VT - NCDOT [09-0776-10]; Warnell of School of Forestry and Natural Resources	North Carolina Department of Transportation VT - NCDOT; Warnell of School of Forestry and Natural Resources	This work was supported by the North Carolina Department of Transportation VT - NCDOT Contract No. 09-0776-10. Publication fees were covered by the Warnell of School of Forestry and Natural Resources.	Abbott KC, 2011, ECOL LETT, V14, P1158, DOI 10.1111/j.1461-0248.2011.01670.x; Adams LG, 2008, WILDLIFE MONOGR, P1, DOI 10.2193/2008-012; BEKOFF M, 1981, OECOLOGIA, V50, P386, DOI 10.1007/BF00344981; Benson JF, 2015, OIKOS; Benson JF, 2014, ECOLOGY, V95, P254, DOI 10.1890/13-0698.1; Benson JF, 2013, METHODS ECOL EVOL, V4, P244, DOI 10.1111/2041-210x.12006; Berger KM, 2007, J ANIM ECOL, V76, P1075, DOI 10.1111/j.1365-2656.2007.01287.x; Bohling JH, 2016, EVOL APPL, V9, P791, DOI 10.1111/eva.12388; Bohling JH, 2015, BIOL CONSERV, V184, P108, DOI 10.1016/j.biocon.2015.01.013; Borg BL, 2015, J ANIM ECOL, V84, P177, DOI 10.1111/1365-2656.12256; Brainerd SM, 2008, J WILDLIFE MANAGE, V72, P89, DOI 10.2193/2006-305; Breitenmoser U, 1991, CARNIVORE CONSERVATI, P241; Brzeski KE, 2014, MOL ECOL, V23, P4241, DOI 10.1111/mec.12871; Byrne ME, 2014, J ANIM ECOL; Cassidy KA, 2015, BEHAV ECOL, V26, P1352, DOI 10.1093/beheco/arv081; Chadwick J, 2010, SOUTHEAST NAT, V9, P303, DOI 10.1656/058.009.0207; Dellinger JA, 2013, BIOL CONSERV, V157, P324, DOI 10.1016/j.biocon.2012.09.004; Dickie M, 2016, J APPL ECOL; Frair JL, 2010, PHILOS T R SOC B, V365, P2187, DOI 10.1098/rstb.2010.0084; FULLER TK, 1989, WILDLIFE MONOGR, P1; Fuller Todd K., 2003, P161; Gannon WL, 2007, J MAMMAL, V88, P809, DOI 10.1644/06-MAMM-F-185R1.1; Gelman A, 2008, STAT MED, V27, P2865, DOI 10.1002/sim.3107; Gese EM, 1997, ANIM BEHAV, V54, P1155, DOI 10.1006/anbe.1997.0561; Gese EM, 2015, BIOL CONSERV, V192, P11, DOI 10.1016/j.biocon.2015.09.003; Gese EM, 2015, CURR ZOOL, V61, P191, DOI 10.1093/czoolo/61.1.191; Gier HT., 1968, KAN STATE COLL AG EX, V939, P1; Gipson PS, 2000, J WILDLIFE MANAGE, V64, P752, DOI 10.2307/3802745; Gittleman J.L., 1989, P183; GITTLEMAN JL, 1982, BEHAV ECOL SOCIOBIOL, V10, P57, DOI 10.1007/BF00296396; GOMPPER ME, 1991, OECOLOGIA, V87, P343, DOI 10.1007/BF00634589; Gurarie E, 2009, ECOL LETT, V12, P395, DOI 10.1111/j.1461-0248.2009.01293.x; Hadfield JD, 2010, J STAT SOFTW, V33, P1, DOI 10.18637/jss.v033.i02; HANSKI I, 1991, BIOL J LINN SOC, V42, P3, DOI 10.1111/j.1095-8312.1991.tb00548.x; Hayward MW, 2007, ORYX, V41, P205, DOI 10.1017/S0030605307001767; Henry V. G., 1998, FED REGISTER, V63, P54152; Hinton J. W., 2014, THESIS; Hinton JW, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132203; Hinton JW, 2014, J MAMMAL, V95, P855, DOI 10.1644/13-MAMM-A-202; Hinton Joseph W., 2013, Animals, V3, P722, DOI 10.3390/ani3030722; Hinton JW, 2012, AM MIDL NAT, V168, P281; Hinton JW, 2010, J WILDLIFE MANAGE, V74, P55, DOI 10.2193/2008-583; Hinton JW, 2015, CANID BIOL CONSERV, V18, P22; Hinton JW, 2017, J WILDLIFE IN PRESS; Hinton JW, 2015, ORYX; Horne JS, 2007, ECOLOGY, V88, P2354, DOI 10.1890/06-0957.1; Kamler JF, 2000, CAN J ZOOL, V78, P2106, DOI 10.1139/cjz-78-12-2106; Karlin M, 2012, J ZOOL, V286, P266, DOI 10.1111/j.1469-7998.2011.00876.x; Karlin M, 2016, MAMM STUDY, V41, P87; Kellert SR, 1996, CONSERV BIOL, V10, P977, DOI 10.1046/j.1523-1739.1996.10040977.x; Kelly B. T., 1999, POP HAB VIAB ASS WOR; Kleiman DG, 2011, BEHAV GENET, V41, P803, DOI 10.1007/s10519-011-9459-0; Kranstauber B, 2012, J ANIM ECOL, V81, P738, DOI 10.1111/j.1365-2656.2012.01955.x; Kyle CJ, 2006, CONSERV GENET, V7, P273, DOI 10.1007/s10592-006-9130-0; Lucash C, 1999, ECOSYSTEM MANAGEMENT, P225; Manly B.F.J., 2002, RESOURCE SELECTION A; Mauney HF, 2005, THESIS; McKerrow AJ, 2006, CAROLINA GAP ANAL PR; MCNAB BK, 1963, AM NAT, V97, P133, DOI 10.1086/282264; Mech L. David, 2003, P1; Miller CR, 2003, MOL ECOL, V12, P3287, DOI 10.1046/j.1365-294X.2003.02003.x; Moveud Collier B., 2013, MOVEUD CREATES DYNAM; Murray DL, 2015, CONSERV LETT, V8, P338, DOI 10.1111/conl.12157; PETERS RP, 1975, AM SCI, V63, P628; R Core Team, 2021, R LANGUAGE ENV STAT; Rabon D.R., 2013, RED WOLF ADAPTIVE MA; Reading Richard P., 1996, P296; Ripple WJ, 2014, SCIENCE, V343, P151, DOI 10.1126/science.1241484; Rutledge LY, 2012, BIOL CONSERV, V155, P186, DOI 10.1016/j.biocon.2012.05.017; Rutledge LY, 2012, ECOL EVOL, V2, P19, DOI 10.1002/ece3.61; Rutledge LY, 2010, BIOL CONSERV, V143, P332, DOI 10.1016/j.biocon.2009.10.017; Sawyer H, 2011, J ANIM ECOL, V80, P1078, DOI 10.1111/j.1365-2656.2011.01845.x; Sillero-Zubiri C, 1998, J ZOOL, V245, P351, DOI 10.1111/j.1469-7998.1998.tb00110.x; Spiegelhalter DJ, 2002, J R STAT SOC B, V64, P583, DOI 10.1111/1467-9868.00353; Stoskopf MK, 2005, WILDLIFE SOC B, V33, P1145, DOI 10.2193/0091-7648(2005)33[1145:FTFIRO]2.0.CO;2; TAYLOR AD, 1990, ECOLOGY, V71, P429, DOI 10.2307/1940297; THURBER JM, 1991, J MAMMAL, V72, P750, DOI 10.2307/1381838; Treves A, 2015, BIOL REV; U.S. Fish and Wildlife Service, 2016, CAUS MORT WILD RED W; U.S. Fish and Wildlife Service, 1989, RED WOLF REC SPEC SU; Whittington J, 2005, ECOL APPL, V15, P543, DOI 10.1890/03-5317; Wyatt TD, 2014, PHEROMONES AND ANIMAL BEHAVIOR: CHEMICAL SIGNALS AND SIGNATURES, 2ND EDITION, P1	82	31	31	6	76	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2016	11	12							e0167603	10.1371/journal.pone.0167603	http://dx.doi.org/10.1371/journal.pone.0167603			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI9TW	28002495	Green Published, gold, Green Submitted			2022-12-27	WOS:000392853100015
J	Montgomery, P; Hennegan, J; Dolan, C; Wu, M; Steinfield, L; Scott, L				Montgomery, Paul; Hennegan, Julie; Dolan, Catherine; Wu, Maryalice; Steinfield, Laurel; Scott, Linda			Menstruation and the Cycle of Poverty: A Cluster Quasi-Randomised Control Trial of Sanitary Pad and Puberty Education Provision in Uganda	PLOS ONE			English	Article							MENTAL-HEALTH; DIFFICULTIES QUESTIONNAIRE; HYGIENE MANAGEMENT; SCHOOL ABSENTEEISM; ADOLESCENT GIRLS; MENARCHE; CHILDREN; STRENGTHS; BEHAVIOR; PERIOD	Background Poor menstrual knowledge and access to sanitary products have been proposed as barriers to menstrual health and school attendance. In response, interventions targeting these needs have seen increasing implementation in public and private sectors. However, there has been limited assessment of their effectiveness. Objectives Assess the impact of providing reusable sanitary pads and puberty education on girls' school attendance and psychosocial wellbeing outcomes. Methods A cluster quasi-randomised controlled trial was conducted across 8 schools, including 1124 girls, in rural Uganda. Schools were allocated to one of four conditions: the provision of puberty education alone; reusable sanitary pads alone; puberty education and reusable sanitary pads; and a control (no intervention). The primary outcome was school attendance. Secondary outcomes reflected psychosocial wellbeing. Results At follow-up, school attendance had worsened for girls across all conditions. Per-protocol analysis revealed that this decline was significantly greater for those in the control condition d= 0.52 (95%Cl 0.26-0.77), with those in control schools having a 17.1% (95%Cl: 8.725.5) greater drop in attendance than those in any intervention school. There were no differences between the intervention conditions. High rates of school drop-out and transfer meant the trial suffered from substantial participant drop-out. Intention-to-treat analyses using two different imputation strategies were consistent with the main results, with mean differences of 5.2% attendance in best-case and 24.5% in worst-case imputations. Results were robust to adjustments for clustering. There was no impact of the interventions on girls' self-reported shame or insecurity during menstruation. Conclusion Results of the trial support the hypothesised positive impact of providing sanitary pads or puberty education for girls' school attendance in a developing country context. Findings must be interpreted with caution in light of poor participant retention, intervention fidelity, and the attendance measures used.	[Montgomery, Paul; Hennegan, Julie] Univ Oxford, Ctr Evidence Based Intervent, Oxford, England; [Dolan, Catherine] Univ London, SOAS, London, England; [Wu, Maryalice] Univ Illinois, Appl Technol Learning Arts & Sci, Urbana, IL 61801 USA; [Steinfield, Laurel] Bentley Univ, Waltham, MA USA; [Scott, Linda] Univ Oxford, Said Business Sch, Oxford, England	University of Oxford; University of London; University of London School Oriental & African Studies (SOAS); University of Illinois System; University of Illinois Urbana-Champaign; Bentley University; University of Oxford	Montgomery, P (corresponding author), Univ Oxford, Ctr Evidence Based Intervent, Oxford, England.	paul.montgomery@spi.ox.ac.uk		Montgomery, Paul/0000-0001-8008-1370; Hennegan, Julie/0000-0003-2011-1595	DFID-ESRC (Economic and Social Research Council) [ES/I034145/1]; Economic and Social Research Council [ES/I034145/2] Funding Source: researchfish; ESRC [ES/I034145/2] Funding Source: UKRI	DFID-ESRC (Economic and Social Research Council); Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); ESRC(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC))	The study was funded by a DFID-ESRC (Economic and Social Research Council) Grant (ref: ES/I034145/1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson SE, 2003, PEDIATRICS, V111, P844, DOI 10.1542/peds.111.4.844; Barro RJ, 2013, J DEV ECON, V104, P184, DOI 10.1016/j.jdeveco.2012.10.001; Cameron AC, 2008, REV ECON STAT, V90, P414, DOI 10.1162/rest.90.3.414; Campbell MK, 2012, BMJ-BRIT MED J, V345, DOI 10.1136/bmj.e5661; Chromy JR, JSM P SURV RES METH, P4323; Clinton Foundation Bill & Melinda Gates Foundation Economist Intelligence Unit and WORLD Policy Analysis Center, 2015, FULL PART REP NO CEI; Cortina MA, 2012, ARCH PEDIAT ADOL MED, V166, P276, DOI 10.1001/archpediatrics.2011.592; Crichton J, 2013, HEALTH CARE WOMEN IN, V34, P891, DOI 10.1080/07399332.2012.740112; Dolan CS, 2014, J INT DEV, V26, P643, DOI 10.1002/jid.2917; Fazel M, 2003, BRIT MED J, V327, P134, DOI 10.1136/bmj.327.7407.134; Freedman DS, 2002, PEDIATRICS, V110, DOI 10.1542/peds.110.4.e43; Gakidou E., 2010, LANCET, V376; Garg R, 2012, MATERN CHILD HLTH J, V16, P767, DOI 10.1007/s10995-011-0798-5; Gelbach J, 2009, CGMREG ADO ROBUST IN; Goodman R, 1998, EUR CHILD ADOLES PSY, V7, P125, DOI 10.1007/s007870050057; Grant M, 2013, COMP EDUC REV, V57, P260, DOI 10.1086/669121; Hennegan J, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0146985; Higgins J, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.ED000049; IBM Corp Released, 2021, IBM SPSS STAT WINDOW; Kashala E, 2005, EUR CHILD ADOLES PSY, V14, P208, DOI 10.1007/s00787-005-0446-y; Kirk J., 2006, MENSTRUATION BODY AW, P1; LeVine RA, 2004, SOC SCI MED, V58, P863, DOI 10.1016/S0277-9536(03)00261-2; Lloyd C. B., 2009, NEW LESSONS POWER ED; Lloyd CB, 2008, POP STUD-J DEMOG, V62, P1, DOI 10.1080/00324720701810840; McCambridge J, 2014, J CLIN EPIDEMIOL, V67, P267, DOI 10.1016/j.jclinepi.2013.08.015; McCambridge J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025223; McMahon SA, 2011, BMC INT HEALTH HUM R, V11, DOI 10.1186/1472-698X-11-7; Mmari K, 2015, AMERICAN JOURNAL OF, pe1; Montenegro CE, 2014, WORLD BANK POLICY RE; Montgomery P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048274; Nakabugo Z., 2013, OBSERVER; OECD, 2012, CLOS GEND GAP ACT NO; Oster E, 2011, AM ECON J-APPL ECON, V3, P91, DOI 10.1257/app.3.1.91; Parkes J., 2013, STOP VIOLENCE GIRLS; Pillitteri SP, 2011, WATERAID; Proctor & Gamble, 2010, KEEP GIRLS SCH SUPP; Republic of Uganda, 2008, KAMULI DISTRICT LOCA; Scott L., 2013, SANITARY PAD ACCEPTA; Sommer M, 2008, WASH SCH NOTES N APR, P4; Sommer M, 2015, COMPARE, V45, P589, DOI 10.1080/03057925.2013.871399; Sommer M, 2015, REPROD HEALTH, V12, DOI 10.1186/s12978-015-0009-8; Sommer M, 2013, AM J PUBLIC HEALTH, V103, P1556, DOI 10.2105/AJPH.2013.301374; StataCorp, 2015, STAT SOFTW REL 14; Sumpter C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062004; Syed EU, 2009, JCPSP-J COLL PHYSICI, V19, P375, DOI 06.2009/JCPSP.375379; Tegegne TK, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-1118; The World Bank, 2015, COUNTR DAT; Uganda Development Services, 2013, PRIM LIT PROJ; UNESCO, 2015, ED ALL GLOBAL MONITO; UNESCO, 2008, ED STAT UNICEF DIV P; UNESCO, 2010, GLOB ED DIG COMP ED; Wilson E, 2014, DEV PRACT, V24, P63, DOI 10.1080/09614524.2014.867305; Winkler I, 2015, CARDOZO J L IN PRESS; Winthrop R., 2015, WHAT WORKS GIRLS ED; World Bank, 2014, COUNTR LEND GROUPS D	55	41	41	0	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2016	11	12							e0166122	10.1371/journal.pone.0166122	http://dx.doi.org/10.1371/journal.pone.0166122			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EI9TW	28002415	gold, Green Accepted, Green Published, Green Submitted			2022-12-27	WOS:000392853100003
J	Hemmatzadeh, F; Boardman, W; Alinejad, A; Hematzade, A; Moghadam, MK				Hemmatzadeh, Farhid; Boardman, Wayne; Alinejad, Arezo; Hematzade, Azar; Moghadam, Majid Kharazian			Molecular and Serological Survey of Selected Viruses in Free-Ranging Wild Ruminants in Iran	PLOS ONE			English	Article							MALIGNANT CATARRHAL FEVER; DES PETITS RUMINANTS; MOUTH-DISEASE VIRUS; POLYMERASE-CHAIN-REACTION; VIRAL DIARRHEA VIRUS; SHEEP OVIS-ORIENTALIS; BLUETONGUE VIRUS; BOVINE HERPESVIRUS-1; INFECTIOUS-DISEASES; ANTIBODIES	A molecular and serological survey of selected viruses in free-ranging wild ruminants was conducted in 13 different districts in Iran. Samples were collected from 64 small wild ruminants belonging to four different species including 25 Mouflon (Ovis orientalis), 22 wild goat (Capra aegagrus), nine Indian gazelle (Gazella bennettii) and eight Goitered gazelle (Gazella subgutturosa) during the national survey for wildlife diseases in Iran. Serum samples were evaluated using serologic antibody tests for Peste de petits ruminants virus (PPRV), Pestiviruses [Border Disease virus (BVD) and Bovine Viral Diarrhoea virus (BVDV)], Bluetongue virus (BTV), Bovine herpesvirus type 1 (BHV-1), and Parainfluenza type 3 (P13). Sera were also ELISA tested for Pestivirus antigen. Tissue samples including spleen, liver, lung, tonsils, mesenteric and mediastinal lymph nodes and white blood cells (WBCs) were tested using polymerase chain reaction (PCR) for PPRV, Foot and Mouth Disease virus (FMDV), Pestivirus, BTV, Ovine herpesvirus type 2 (OvHV-2) and BHV-1. Serologic tests were positive for antibodies against PPRV (17%), Pestiviruses (2%) and BTV (2%). No antibodies were detected for BHV-1 or P13, and no Pestivirus antigen was detected. PCR results were positive for PPRV (7.8%), FMDV (11%), BTV (3%), OvHV-2 (31%) and BHV-1 (1.5%). None of the samples were positive for Pestiviruses.	[Hemmatzadeh, Farhid; Boardman, Wayne] Univ Adelaide, Sch Anim & Vet Sci, Adelaide, SA, Australia; [Boardman, Wayne] Univ South Australia, Sch Pharm & Med Sci, Adelaide, SA, Australia; [Alinejad, Arezo] Univ Tehran, Fac Vet Med, Tehran, Iran; [Hematzade, Azar] Islamic Azad Univ, Shahrekord Branch, Fac Agr, Shahrekord, Iran; [Moghadam, Majid Kharazian] Iran Dept Environm, Tehran, Iran	University of Adelaide; University of South Australia; University of Tehran; Islamic Azad University	Hemmatzadeh, F (corresponding author), Univ Adelaide, Sch Anim & Vet Sci, Adelaide, SA, Australia.	Farhid.hemmatzadeh@adelaide.edu.au	Boardman, Wayne S.J/J-6479-2013; Boardman, Wayne/ABE-7528-2020	Boardman, Wayne/0000-0002-1746-0682; Hemmatzadeh, Farhid/0000-0002-4572-8869	Iran DoE fund [01-1384]	Iran DoE fund	This work was supported by Iran DoE fund (project number 01-1384). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdollahpour G., 2006, Journal of Veterinary Medicine. Series B, V53, P14, DOI 10.1111/j.1439-0450.2006.01013.x; AFSHAR A, 1994, COMP IMMUNOL MICROB, V17, P221, DOI 10.1016/0147-9571(94)90045-0; AFSHAR A, 1974, VET REC, V94, P233, DOI 10.1136/vr.94.11.233; Akens MK, 1997, VET IMMUNOL IMMUNOP, V58, P231, DOI 10.1016/S0165-2427(97)00044-5; AKITA GY, 1992, J VET DIAGN INVEST, V4, P400, DOI 10.1177/104063879200400405; Alexandersen S, 2003, J COMP PATHOL, V129, P1, DOI 10.1016/S0021-9975(03)00041-0; Alexandersen S, 2002, MICROBES INFECT, V4, P1099, DOI 10.1016/S1286-4579(02)01634-9; Alexandrov T, 2013, VET MICROBIOL, V166, P84, DOI 10.1016/j.vetmic.2013.05.016; ANDERSON J, 1994, EPIDEMIOL INFECT, V112, P225, DOI 10.1017/S0950268800057599; [Anonymous], 2006, REFERENCE REV, V20, P40; Banyard AC, 2010, J GEN VIROL, V91, P2885, DOI 10.1099/vir.0.025841-0; Bashari H, 2013, J NAT CONSERV, V21, P319, DOI 10.1016/j.jnc.2013.03.005; Bazargani TT, 2008, IRAN J VET RES, V9, P271; Bazarghani T. T., 2006, Journal of Veterinary Medicine. Series B, V53, P17, DOI 10.1111/j.1439-0450.2006.01014.x; Benetka V, 2009, J WILDLIFE DIS, V45, P508, DOI 10.7589/0090-3558-45.2.508; Bengis RH, 2004, REV SCI TECH OIE, V23, P497; Bolortsetseg S, 2012, J WILDLIFE DIS, V48, P33, DOI 10.7589/0090-3558-48.1.33; Bouwknegt C, 2010, EXP APPL ACAROL, V52, P183, DOI 10.1007/s10493-010-9359-7; Brito BP, 2015, TRANSBOUND EMERG DIS; Casaubon J, 2012, BMC VET RES, V8, DOI 10.1186/1746-6148-8-204; Chauhan HC, 2014, REV SCI TECH OIE, V33, P803, DOI 10.20506/rst.33.3.2319; Coetzee P, 2014, VIRUS RES, V182, P21, DOI 10.1016/j.virusres.2013.12.044; Cunha CW, 2012, VET MICROBIOL, V159, P307, DOI 10.1016/j.vetmic.2012.04.021; Daniels PW, 2007, CURR TOP MICROBIOL, V315, P113; Daszak P, 2000, SCIENCE, V287, P443, DOI 10.1126/science.287.5452.443; Department of Environment Islamic Tepublic of Iran, 2015, INCR MORT DUE SMALL; Drolet BS, 2015, VECTOR-BORNE ZOONOT, V15, P339, DOI 10.1089/vbz.2014.1701; Ellis JA, 2010, VET CLIN N AM-FOOD A, V26, P575, DOI 10.1016/j.cvfa.2010.08.002; ESLAMI A, 1980, VET PARASITOL, V7, P75, DOI 10.1016/0304-4017(80)90012-6; Forsyth MA, 1995, VIRUS RES, V39, P151, DOI 10.1016/0168-1702(95)00076-3; Garcia-Lastra R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034421; GHRAM A, 1989, CAN J VET RES, V53, P62; Griebel P, 2014, ANIM HEALTH RES REV, V15, P161, DOI 10.1017/S1466252314000280; Hoffmann B, 2012, TRANSBOUND EMERG DIS, V59, P173, DOI 10.1111/j.1865-1682.2011.01270.x; Jafarzadeh SR, 2014, PREV VET MED, V115, P101, DOI 10.1016/j.prevetmed.2014.03.018; Kalman D, 2005, J WILDLIFE DIS, V41, P482, DOI 10.7589/0090-3558-41.3.482; Karamii M, 2008, KOMENTOVANY SOUPIS S, V39, P63; Keyvanfar H, 1999, J FACULTY VET MED U, V54, P6; Khezri M, 2013, VET WORLD, V6, P122, DOI [10.5455/vetworld.2013.122-125, 10.14202/vetworld.2013.974-977, 10.14202/vetworld.2013.964-977]; Kim SH, 2014, J WILDLIFE DIS, V50, P478, DOI 10.7589/2013-06-137; Knowles NJ, 2003, VIRUS RES, V91, P65, DOI 10.1016/S0168-1702(02)00260-5; Kojouri G. A., 2011, Comparative Clinical Pathology, V20, P201, DOI 10.1007/s00580-010-0958-9; Kruse H, 2004, EMERG INFECT DIS, V10, P2067, DOI 10.3201/eid1012.040707; Kumar N, 2014, VIRUSES-BASEL, V6, P2287, DOI 10.3390/v6062287; Lemaire M, 2000, J CLIN MICROBIOL, V38, P1885, DOI 10.1128/JCM.38.5.1885-1894.2000; Leylabadlo HE, 2016, PESTE PETITS RUMINAN, V4, P2; Li H, 2014, ANNU REV ANIM BIOSCI, V2, P209, DOI 10.1146/annurev-animal-022513-114156; Mahravani H., 2010, Journal of Veterinary Research, V65, P123; Mallon DP, 2009, J APPL ECOL, V46, P516, DOI 10.1111/j.1365-2664.2009.01654.x; Matzat T, 2015, BERL MUNCH TIERARZTL, V128, P218, DOI 10.2376/0005-9366-128-218; Mkama Mathias, 2014, Onderstepoort J Vet Res, V81, pE1, DOI 10.4102/ojvr.v81i2.718; Momatz H, 2009, RES J BIOL SCI, V4, P558; Morrison W.I, 2010, MERCK VET MANUAL, V10, P33; Mouchantat S, 2014, VET MICROBIOL, V172, P329, DOI 10.1016/j.vetmic.2014.05.021; Mozaffari Ali Asghar, 2014, Asian Pacific Journal of Tropical Biomedicine, V4, pS275, DOI 10.12980/APJTB.4.2014B599; Munir M, 2014, TRANSBOUND EMERG DIS, V61, P411, DOI 10.1111/tbed.12052; Muylkens B, 2007, VET RES, V38, P181, DOI 10.1051/vetres:2006059; NADLER CF, 1971, CYTOGENETICS, V10, P137, DOI 10.1159/000130135; Noaman V, 2013, VET ITAL, V49, P141, DOI 10.12834/VetIt.2013.492.141.144; Palmer MV, 2013, J COMP PATHOL, V149, P162, DOI 10.1016/j.jcpa.2013.01.005; Passler Thomas, 2010, Animal Health Research Reviews, V11, P191, DOI 10.1017/S1466252309990065; Pedersen AB, 2007, CONSERV BIOL, V21, P1269, DOI 10.1111/j.1523-1739.2007.00776.x; RAMYAR H, 1972, VET REC, V91, P630, DOI 10.1136/vr.91.25.630; Raoofi A, 2010, TROP ANIM HEALTH PRO, V42, P411, DOI 10.1007/s11250-009-9435-3; Ridpath JF, 1998, MOL CELL PROBE, V12, P101, DOI 10.1006/mcpr.1998.0158; Roeder P, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2012.0139; Ruiz-Fons F, 2014, VIRUS RES, V182, P50, DOI 10.1016/j.virusres.2013.12.031; Russell GC, 2009, VET J, V179, P324, DOI 10.1016/j.tvjl.2007.11.007; Siembieda J. L., 2011, Animal Health Research Reviews, V12, P95, DOI 10.1017/S1466252311000041; Smith MJ, 2009, P NATL ACAD SCI USA, V106, P7905, DOI 10.1073/pnas.0809145106; Temmam S, 2014, INT J MOL SCI, V15, P10377, DOI 10.3390/ijms150610377; Ullah A, 2016, TRANSBOUND EMERG DIS; VALDEZ R, 1976, J MAMMAL, V57, P762, DOI 10.2307/1379451; Vangrysperre W, 1996, ARCH VIROL, V141, P331, DOI 10.1007/BF01718403; Vilcek S, 2006, VET MICROBIOL, V116, P1, DOI 10.1016/j.vetmic.2006.06.003; VILCEK S, 1993, J VIROL METHODS, V41, P245, DOI 10.1016/0166-0934(93)90132-B; Weaver GV, 2013, J WILDLIFE DIS, V49, P759, DOI 10.7589/2012-11-276; Weinberg A N, 1991, Infect Dis Clin North Am, V5, P1; Zakian A, 2016, TROP ANIM HLTH PROD; Zibaei S., 2010, Journal of Veterinary Research, V65, P199	80	9	9	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2016	11	12							e0168756	10.1371/journal.pone.0168756	http://dx.doi.org/10.1371/journal.pone.0168756			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI9QF	27997620	Green Accepted, Green Submitted, Green Published, gold			2022-12-27	WOS:000392842900073
J	Ismael, FO; Barrett, TJ; Sheipouri, D; Brown, BE; Davies, MJ; Hawkins, CL				Ismael, Fahd O.; Barrett, Tessa J.; Sheipouri, Diba; Brown, Bronwyn E.; Davies, Michael J.; Hawkins, Clare L.			Role of Myeloperoxidase Oxidants in the Modulation of Cellular Lysosomal Enzyme Function: A Contributing Factor to Macrophage Dysfunction in Atherosclerosis?	PLOS ONE			English	Article							LOW-DENSITY-LIPOPROTEIN; HYPOCHLOROUS ACID; OXIDIZED LDL; HYPOTHIOCYANOUS ACID; CHOLESTEROL HOMEOSTASIS; OXIDATIVE MODIFICATIONS; CARDIOVASCULAR-DISEASE; APOLIPOPROTEIN-B; YOUNG-PEOPLE; CATHEPSIN-B	Low-density lipoprotein (LDL) is the major source of lipid within atherosclerotic lesions. Myeloperoxidase (MPO) is present in lesions and forms the reactive oxidants hypochlorous acid (HOCl) and hypothiocyanous acid (HOSCN). These oxidants modify LDL and have been strongly linked with the development of atherosclerosis. In this study, we examined the effect of HOCl, HOSCN and LDL pre-treated with these oxidants on the function of lysosomal enzymes responsible for protein catabolism and lipid hydrolysis in murine macrophage -like J774A.1 cells. In each case, the cells were exposed to HOCI or HOSCN or LDL pre-treated with these oxidants. Lysosomal cathepsin (B, L and D) and acid lipase activities were quantified, with cathepsin and LAMP-1 protein levels determined by Western blotting. Exposure of J774A.1 cells to HOCI or HOSCN resulted in a significant decrease in the activity of the Cys-dependent cathepsins B and L, but not the Asp-dependent cathepsin D. Cathepsins B and L were also inhibited in macrophages exposed to HOSCN-modified, and to a lesser extent, HOCI-modified LDL. No change was seen in cathepsin D activity or the expression of the cathepsin proteins or lysosomal marker protein LAMP-1. The activity of lysosomal acid lipase was also decreased on treatment of macrophages with each modified LDL. Taken together, these results suggest that HOCI, HOSCN and LDL modified by these oxidants could contribute to lysosomal dysfunction and thus perturb the cellular processing of LDL, which could be important during the development of atherosclerosis.	[Ismael, Fahd O.; Barrett, Tessa J.; Sheipouri, Diba; Brown, Bronwyn E.; Davies, Michael J.; Hawkins, Clare L.] Heart Res Inst, Sydney, NSW, Australia; [Ismael, Fahd O.; Barrett, Tessa J.; Brown, Bronwyn E.; Davies, Michael J.; Hawkins, Clare L.] Univ Sydney, Sydney Med Sch, Sydney, NSW, Australia; [Davies, Michael J.] Univ Copenhagen, Panum Inst, Dept Biomed Sci, Copenhagen, Denmark	University of Sydney; Heart Research Institute; University of Sydney; University of Copenhagen	Hawkins, CL (corresponding author), Heart Res Inst, Sydney, NSW, Australia.; Hawkins, CL (corresponding author), Univ Sydney, Sydney Med Sch, Sydney, NSW, Australia.	clare.hawkins@hri.org.au	Davies, Michael J/H-4939-2011; Hawkins, Clare/AAV-7424-2021; Davies, Michael/GWV-2527-2022; Hawkins, Clare L/F-6696-2014; Davies, Michael/AGX-9184-2022	Davies, Michael J/0000-0002-5196-6919; Hawkins, Clare/0000-0003-2738-5089; Hawkins, Clare L/0000-0003-2738-5089; Davies, Michael/0000-0002-5196-6919; Barrett, Tessa/0000-0003-0751-1578	National Health and Medical Research Council (AU) Project Grant [570829]; Australian Research Council (AU) Centre's of Excellence Scheme [CE0561607]; Australian Research Council (AU) Future Fellowship Scheme [FT120100682]; Australian Postgraduate Award, University of Sydney	National Health and Medical Research Council (AU) Project Grant; Australian Research Council (AU) Centre's of Excellence Scheme(Australian Research Council); Australian Research Council (AU) Future Fellowship Scheme(Australian Research Council); Australian Postgraduate Award, University of Sydney	This work was supported National Health and Medical Research Council (AU) Project Grant, Grant #570829; (http://www.nhmrc.gov.au/) to CH, MD; Australian Research Council (AU) Centre's of Excellence Scheme, Grant # CE0561607 (http://www.arc.gov.au/) to MD; Australian Research Council (AU) Future Fellowship Scheme, Grant # FT120100682(http://www.arc.gov.au/) to CH and Australian Postgraduate Award, University of Sydney to TB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERSON RA, 1991, J BIOL CHEM, V266, P22479; Barrett TJ, 2012, FREE RADICAL BIO MED, V52, P1075, DOI 10.1016/j.freeradbiomed.2011.12.024; Bobryshev YV, 2013, J CELL MOL MED, V17, P626, DOI 10.1111/jcmm.12042; Botti TP, 1996, ATHEROSCLEROSIS, V124, P191, DOI 10.1016/0021-9150(96)05825-X; Brown BE, 2005, DIABETOLOGIA, V48, P361, DOI 10.1007/s00125-004-1648-4; BROWN MS, 1986, SCIENCE, V232, P34, DOI 10.1126/science.3513311; Calay D, 2010, ANTIOXID REDOX SIGN, V13, P1491, DOI 10.1089/ars.2009.2971; Carr AC, 2001, REDOX REP, V6, P343, DOI 10.1179/135100001101536526; Carstea ED, 1997, SCIENCE, V277, P228, DOI 10.1126/science.277.5323.228; Chevallier J, 2008, J BIOL CHEM, V283, P27871, DOI 10.1074/jbc.M801463200; Cox BE, 2007, J LIPID RES, V48, P1012, DOI 10.1194/jlr.M600390-JLR200; DAUGHERTY A, 1994, J CLIN INVEST, V94, P437, DOI 10.1172/JCI117342; Davies MJ, 2008, ANTIOXID REDOX SIGN, V10, P1199, DOI 10.1089/ars.2007.1927; Delporte C, 2014, J LIPID RES, V55, P747, DOI 10.1194/jlr.M047449; Dubland JA, 2015, FRONT CELL DEV BIOL, V3, DOI 10.3389/fcell.2015.00003; Emanuel R, 2014, ARTERIOSCL THROM VAS, V34, P1942, DOI 10.1161/ATVBAHA.114.303342; Exner M, 2004, FREE RADICAL BIO MED, V37, P146, DOI 10.1016/j.freeradbiomed.2004.04.039; Eyer P, 2003, ANAL BIOCHEM, V312, P224, DOI 10.1016/S0003-2697(02)00506-7; Hawkins CL, 2009, FREE RADICAL BIO MED, V46, P965, DOI 10.1016/j.freeradbiomed.2009.01.007; Hawkins CL, 2008, BIOCHEM J, V416, P441, DOI 10.1042/BJ20070941; Hazell LJ, 1996, J CLIN INVEST, V97, P1535, DOI 10.1172/JCI118576; Hazen SL, 1997, J CLIN INVEST, V99, P2075, DOI 10.1172/JCI119379; Headlam HA, 2006, FREE RADICAL BIO MED, V40, P1539, DOI 10.1016/j.freeradbiomed.2005.12.036; HOPPE G, 1994, J CLIN INVEST, V94, P1506, DOI 10.1172/JCI117490; Ismael FO, 2015, ARCH BIOCHEM BIOPHYS, V573, P40, DOI 10.1016/j.abb.2015.03.008; Itabe H, 2000, BBA-MOL CELL BIOL L, V1487, P233, DOI 10.1016/S1388-1981(00)00098-6; JESSUP W, 1992, BIOCHIM BIOPHYS ACTA, V1126, P167, DOI 10.1016/0005-2760(92)90287-6; Levitan I, 2010, ANTIOXID REDOX SIGN, V13, P39, DOI 10.1089/ars.2009.2733; Li W, 1998, ARTERIOSCL THROM VAS, V18, P177, DOI 10.1161/01.ATV.18.2.177; Lloyd MM, 2008, BIOCHEM J, V414, P271, DOI 10.1042/BJ20080468; Lougheed M, 1999, ARTERIOSCL THROM VAS, V19, P1881, DOI 10.1161/01.ATV.19.8.1881; Lutgens SPM, 2007, FASEB J, V21, P3029, DOI 10.1096/fj.06-7924com; MAEHIRA F, 1994, BIOCHEM MOL BIOL INT, V32, P221; Malle E, 2006, BBA-MOL CELL BIOL L, V1761, P392, DOI 10.1016/j.bbalip.2006.03.024; Moheimani F, 2012, ATHEROSCLEROSIS, V223, P144, DOI 10.1016/j.atherosclerosis.2012.04.026; Morgan PE, 2015, FREE RADICAL RES, V49, P743, DOI 10.3109/10715762.2015.1019347; ONeil J, 1997, FREE RADICAL BIO MED, V23, P215, DOI 10.1016/S0891-5849(96)00612-0; Pattison DI, 2012, FREE RADICAL RES, V46, P975, DOI 10.3109/10715762.2012.667566; Pattison DI, 2003, CHEM RES TOXICOL, V16, P439, DOI 10.1021/tx025670s; Peskin AV, 2006, FREE RADICAL BIO MED, V40, P45, DOI 10.1016/j.freeradbiomed.2005.08.019; Scanlon CEO, 1996, ATHEROSCLEROSIS, V121, P23, DOI 10.1016/0021-9150(95)05672-6; Schindhelm RK, 2009, CLIN CHEM, V55, P1462, DOI 10.1373/clinchem.2009.126029; Sokolov AV, 2014, CHEM PHYS LIPIDS, V180, P72, DOI 10.1016/j.chemphyslip.2014.02.006; Stadler N, 2004, ARTERIOSCL THROM VAS, V24, P949, DOI 10.1161/01.ATV.0000124892.90999.cb; Stark G R, 1972, Methods Enzymol, V25, P579, DOI 10.1016/S0076-6879(72)25057-1; STEINBERG D, 1989, NEW ENGL J MED, V320, P915; Stocker R, 2004, PHYSIOL REV, V84, P1381, DOI 10.1152/physrev.00047.2003; Summers FA, 2012, BIOCHEM BIOPH RES CO, V425, P157, DOI 10.1016/j.bbrc.2012.07.057; Wang Z, 2007, NAT MED, V13, P1176, DOI 10.1038/nm1637; WEISS SJ, 1989, NEW ENGL J MED, V320, P365; WOLMAN M, 1995, CLIN PEDIATR, V34, P207, DOI 10.1177/000992289503400406; Yan C, 2006, AM J PATHOL, V169, P916, DOI 10.2353/ajpath.2006.051327; Zschenker O, 2006, J BIOCHEM, V140, P23, DOI 10.1093/jb/mvj137	53	11	12	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2016	11	12							e0168844	10.1371/journal.pone.0168844	http://dx.doi.org/10.1371/journal.pone.0168844			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI9QF	27997605	Green Published, gold, Green Submitted			2022-12-27	WOS:000392842900079
J	Sayegh, RSR; Batista, IDC; de Melo, RL; Riske, KA; Daffre, S; Montich, G; da Silva, PI				Rosa Sayegh, Raphael Santa; Correia Batista, Isabel de Fatima; de Melo, Robson Lopes; Riske, Karin A.; Daffre, Sirlei; Montich, Guillermo; da Silva Junior, Pedro Ismael			Longipin: An Amyloid Antimicrobial Peptide from the Harvestman Acutisoma longipes (Arachnida: Opiliones) with Preferential Affinity for Anionic Vesicles	PLOS ONE			English	Article							TICK BOOPHILUS-MICROPLUS; SPIDER ACANTHOSCURRIA-GOMESIANA; HOST-DEFENSE PEPTIDES; CATTLE TICK; INNATE IMMUNITY; MASS-SPECTROMETRY; HORSESHOE-CRAB; THIOFLAVIN-T; BETA-SHEET; HEMOCYTES	In contrast to vertebrate immune systems, invertebrates lack an adaptive response and rely solely on innate immunity in which antimicrobial peptides (AMPs) play an essential role. Most of them are membrane active molecules that are typically unstructured in solution and adopt secondary/tertiary structures upon binding to phospholipid bilayers. This work presents the first characterization of a constitutive AMP from the hemolymph of an Opiliones order animal: the harvestman Acutisoma longipes. This peptide was named longipin. It presents 18 aminoacid residues (SGYLPGKEYVYKYKGKVF) and a positive net charge at neutral pH. No similarity with other AMPs was observed. However, high sequence similarity with heme-lipoproteins from ticks suggested that longipin might be a protein fragment. The synthetic peptide showed enhanced antifungal activity against Candida guilliermondii and C. tropicalis yeasts (MIC: 3.8-7.5 mu M) and did not interfered with VERO cells line viability at all concentrations tested (200-0.1 mu M). This selectivity against microbial cells is related to the highest affinity of longipin for anionic charged vesicles (POPG:POPC) compared to zwitterionic ones (POPC), once microbial plasma membrane are generally more negatively charged compared to mammalian cells membrane. Dye leakage from carboxyfluorescein-loaded POPG:POPC vesicles suggested that longipin is a membrane active antimicrobial peptide and FT-IR spectroscopy showed that the peptide chain is mainly unstructured in solution or in the presence of POPC vesicles. However, upon binding to POPG:POPC vesicles, the FT-IR spectrum showed bands related to beta-sheet and amyloid-like fibril conformations in agreement with thioflavin-T binding assays, indicating that longipin is an amyloid antimicrobial peptide.	[Rosa Sayegh, Raphael Santa; da Silva Junior, Pedro Ismael] Univ Sao Paulo, Inst Ciencias Biomed, Programa Interunidades Biotecnol, Sao Paulo, Brazil; [Rosa Sayegh, Raphael Santa; de Melo, Robson Lopes; da Silva Junior, Pedro Ismael] Inst Butantan, Lab Especial Toxinol Aplicada, Sao Paulo, Brazil; [Correia Batista, Isabel de Fatima] Inst Butantan, Unidade Sequenciamento Prot & Peptideos, Sao Paulo, Brazil; [Correia Batista, Isabel de Fatima] Inst Butantan, Lab Bioquim & Biofis, Sao Paulo, Brazil; [Riske, Karin A.] Univ Fed Sao Paulo, Dept Biofis, Sao Paulo, Brazil; [Daffre, Sirlei] Univ Sao Paulo, Inst Ciencias Biomed, Dept Parasitol, Sao Paulo, Brazil; [Montich, Guillermo] Univ Nacl Cordoba, Fac Ciencias Quim, Dept Quim Biol, Ctr Invest Quim Biol Cordoba CIQUIBIC,CONICET, Cordoba, Argentina	Universidade de Sao Paulo; Instituto Butantan; Instituto Butantan; Instituto Butantan; Universidade Federal de Sao Paulo (UNIFESP); Universidade de Sao Paulo; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); National University of Cordoba	Sayegh, RSR; da Silva, PI (corresponding author), Univ Sao Paulo, Inst Ciencias Biomed, Programa Interunidades Biotecnol, Sao Paulo, Brazil.; Sayegh, RSR; da Silva, PI (corresponding author), Inst Butantan, Lab Especial Toxinol Aplicada, Sao Paulo, Brazil.	raphael.sayegh@usp.br; pedro.junior@butantan.gov.br	Batista, Isabel FC/B-9535-2015; Instituto Butantan, Center of Toxins Immune Response and Cell Signaling CeTICS/J-5731-2015; Riske, Karin A/F-2314-2014; Daffre, Sirlei/M-4233-2013	Batista, Isabel FC/0000-0001-7398-4184; Daffre, Sirlei/0000-0002-9966-0433; da Silva Junior, Pedro Ismael/0000-0001-6619-6489	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP, State of Sao Paulo Foundation) [2013/07467-1]; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) [472744/2012-7]; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES); Red de Universidades de America Latina y el Caribe	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP, State of Sao Paulo Foundation)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Red de Universidades de America Latina y el Caribe	This work was support by grants from Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP, State of Sao Paulo Foundation, grant 2013/07467-1, CeTICS-CEPID) and Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq, grant 472744/2012-7). RSRS acknowledges the scholarship from Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES) and from Red de Universidades de America Latina y el Caribe. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was support by grants from Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP, State of Sao Paulo Foundation, grant 2013/07467-1, CeTICS-CEPID) and Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq, grant 472744/2012-7). RSRS acknowledges the scholarship from Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES) and from Red de Universidades de America Latina y el Caribe. The authors also would like to thank Daniel M. Lorenzini (in memoriam) for his support with the mass spectrometry analysis, Prof. Antonio de Miranda for his suggestions on ThT assays, Mauricio P. M. Pavani for collection of animals and Dr. Ronaldo Zucatelli Mendonca and Juliana Cuoco Badari for their help with the MTT assay.	Amblard M, 2006, MOL BIOTECHNOL, V33, P239, DOI 10.1385/MB:33:3:239; Arrondo JLR, 1999, PROG BIOPHYS MOL BIO, V72, P367, DOI 10.1016/S0079-6107(99)00007-3; Baumann T, 2010, CELL MOL LIFE SCI, V67, P2643, DOI 10.1007/s00018-010-0354-2; Biancalana M, 2010, BBA-PROTEINS PROTEOM, V1804, P1405, DOI 10.1016/j.bbapap.2010.04.001; Braz GRC, 1999, CURR BIOL, V9, P703, DOI 10.1016/S0960-9822(99)80312-1; Brogden KA, 2005, NAT REV MICROBIOL, V3, P238, DOI 10.1038/nrmicro1098; Bulet P, 2004, IMMUNOL REV, V198, P169, DOI 10.1111/j.0105-2896.2004.0124.x; Bulet P, 2005, PROTEIN PEPTIDE LETT, V12, P3, DOI 10.2174/0929866053406011; BULET P, 1993, J BIOL CHEM, V268, P14893; BYLER DM, 1986, BIOPOLYMERS, V25, P469, DOI 10.1002/bip.360250307; Caillon L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075528; Charlet M, 1996, J BIOL CHEM, V271, P21808, DOI 10.1074/jbc.271.36.21808; Chiti F, 1999, P NATL ACAD SCI USA, V96, P3590, DOI 10.1073/pnas.96.7.3590; Costa JP, 2015, APPL MICROBIOL BIOT, V99, P2023, DOI [10.1007/s00253-015-6375-x, DOI 10.1007/S00253-015-6375-X]; DaSilva MB, 2009, INVERTEBR SYST, V23, P530, DOI 10.1071/IS09022; Destoumieux-Garzon D, 2001, J BIOL CHEM, V276, P47070, DOI 10.1074/jbc.M103817200; EhretSabatier L, 1996, J BIOL CHEM, V271, P29537, DOI 10.1074/jbc.271.47.29537; FALICK AM, 1993, J AM SOC MASS SPECTR, V4, P882, DOI 10.1016/1044-0305(93)87006-X; Fogaca AC, 2006, PEPTIDES, V27, P667, DOI 10.1016/j.peptides.2005.07.013; Fogaca AC, 1999, J BIOL CHEM, V274, P25330, DOI 10.1074/jbc.274.36.25330; Fogaca AC, 2004, DEV COMP IMMUNOL, V28, P191, DOI 10.1016/j.dci.2003.08.001; Garvey M, 2013, BBA-PROTEINS PROTEOM, V1834, P1615, DOI 10.1016/j.bbapap.2013.04.030; Hancock REW, 2006, IMMUNOBIOLOGY, V211, P315, DOI 10.1016/j.imbio.2005.10.017; Hancock REW, 2006, NAT BIOTECHNOL, V24, P1551, DOI 10.1038/nbt1267; HOPE MJ, 1985, BIOCHIM BIOPHYS ACTA, V812, P55, DOI 10.1016/0005-2736(85)90521-8; IWANAGA S, 1993, CURR OPIN IMMUNOL, V5, P74, DOI 10.1016/0952-7915(93)90084-6; Iwanaga S, 2005, J BIOCHEM MOL BIOL, V38, P128; Iwanaga S, 2002, CURR OPIN IMMUNOL, V14, P87, DOI 10.1016/S0952-7915(01)00302-8; Jang H, 2011, BIOPHYS J, V100, P1775, DOI 10.1016/j.bpj.2011.01.072; Jenssen H, 2006, CLIN MICROBIOL REV, V19, P491, DOI 10.1128/CMR.00056-05; Kagan BL, 2012, MOL PHARMACEUT, V9, P708, DOI 10.1021/mp200419b; KAISER E, 1970, ANAL BIOCHEM, V34, P595, DOI 10.1016/0003-2697(70)90146-6; Lee MT, 2008, P NATL ACAD SCI USA, V105, P5087, DOI 10.1073/pnas.0710625105; Lorenzini DM, 2003, INSECT BIOCHEM MOLEC, V33, P1011, DOI 10.1016/S0965-1748(03)00115-2; Lorenzini DM, 2003, DEV COMP IMMUNOL, V27, P781, DOI 10.1016/S0145-305X(03)00058-2; Luders T, 2005, ANTIMICROB AGENTS CH, V49, P2399, DOI 10.1128/AAC.49.6.2399-2406.2005; Marr AK, 2006, CURR OPIN PHARMACOL, V6, P468, DOI 10.1016/j.coph.2006.04.006; Matsuzaki K, 2009, BBA-BIOMEMBRANES, V1788, P1687, DOI 10.1016/j.bbamem.2008.09.013; Maya-Monteiro CM, 2000, J BIOL CHEM, V275, P36584, DOI 10.1074/jbc.M007344200; Mouls L, 2007, J PROTEOME RES, V6, P1378, DOI 10.1021/pr060574o; Nolan V, 2003, BBA-BIOMEMBRANES, V1611, P98, DOI 10.1016/S0005-2736(03)00030-0; Petersen B, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015079; Riciluca K C T, 2012, Results Immunol, V2, P66, DOI 10.1016/j.rinim.2012.03.001; ROEPSTORFF P, 1984, BIOMED MASS SPECTROM, V11, P601, DOI 10.1002/bms.1200111109; Rossi LM, 2008, J PHARM SCI-US, V97, P1060, DOI 10.1002/jps.21053; Samgina TY, 2010, J AM SOC MASS SPECTR, V21, P104, DOI 10.1016/j.jasms.2009.09.008; Shai Y, 2002, BIOPOLYMERS, V66, P236, DOI 10.1002/bip.10260; Silva PI, 2000, J BIOL CHEM, V275, P33464, DOI 10.1074/jbc.M001491200; Strohalm M, 2010, ANAL CHEM, V82, P4648, DOI 10.1021/ac100818g; Tzeng YL, 2015, BBA BIOMEMBRANES; Vaisar T, 1996, J MASS SPECTROM, V31, P1185, DOI 10.1002/(SICI)1096-9888(199610)31:10<1185::AID-JMS396>3.0.CO;2-Q; Wu C, 2009, J MOL BIOL, V394, P627, DOI 10.1016/j.jmb.2009.09.056; Zandomeneghi G, 2004, PROTEIN SCI, V13, P3314, DOI 10.1110/ps.041024904; Zasloff M, 2002, NATURE, V415, P389, DOI 10.1038/415389a; Zhang KL, 2004, PROTEOMICS, V4, P1, DOI 10.1002/pmic.200300503; Zhang ZQ, 1998, J AM SOC MASS SPECTR, V9, P225, DOI 10.1016/S1044-0305(97)00284-5; Zhao H, 2006, BBA-BIOMEMBRANES, V1758, P1461, DOI 10.1016/j.bbamem.2006.03.037; BIOPOLYMERS	58	13	13	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2016	11	12							e0167953	10.1371/journal.pone.0167953	http://dx.doi.org/10.1371/journal.pone.0167953			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI9QF	27997568	Green Published, Green Submitted, gold			2022-12-27	WOS:000392842900020
J	Ziegler, I; Fagerstrom, A; Stralin, K; Molling, P				Ziegler, Ingrid; Fagerstrom, Anna; Stralin, Kristoffer; Molling, Paula			Evaluation of a Commercial Multiplex PCR Assay for Detection of Pathogen DNA in Blood from Patients with Suspected Sepsis	PLOS ONE			English	Article							REAL-TIME PCR; COMMUNITY-ACQUIRED PNEUMONIA; STREAM INFECTIONS; CRITICALLY-ILL; UNITED-STATES; DIAGNOSIS; IDENTIFICATION; CULTURES; BACTEREMIA; EPIDEMIOLOGY	The Magicplex Sepsis Real-time Test (MST) is a commercial multiplex PCR that can detect more than 90 different pathogens in blood, with an analysis time of six hours. The aim of the present study was to evaluate this method for the detection of bloodstream infection (BSI). An EDTA whole blood sample for MST was collected together with blood cultures (BC) from patients with suspected sepsis at the Emergency Department of a university hospital. Among 696 study patients, 322 (46%) patients were positive with at least one method; 128 (18%) were BC positive and 268 (38%) were MST positive. Considering BC to be the gold standard, MST had an overall sensitivity of 47%, specificity of 66%, positive predictive value (PPV) of 23%, and a negative predictive value of 87%. Among the MST positive samples with a negative BC, coagulase-negative staphylococci (CONS) and species that rarely cause community-acquired BSI were frequently noted. However, the quantification cycle (Cq) values of the MST+/BC-results were often high. We thus hypothesized that the performance of the MST test could be improved if the Cq cut-off level was adjusted downwards. With a lower Cq cut-off value, i.e. 6.0 for Staphylococcus species and 9.0 for all other species, the number of MST positive cases decreased to 83 (12%) and the overall sensitivity decreased to 38%. However, the PPV increased to 59% and the specificity increased to 96%, as many MST positive results for CoNS and bacteria that rarely cause community-acquired BSI turned MST negative. In conclusion, our study shows that with a lower Cq cut-off value, the MST will detect less contaminants and findings with unclear relevance, but to the cost of a lower sensitivity. Consequently, we consider that a positive MST results with a Cq value above the adjusted cut-off should be interpreted with caution, as the result might be clinically irrelevant. In a correspondent way, quantitative results could probably be useful in the interpretation of positive results from other molecular assays for the detection of BSI.	[Ziegler, Ingrid] Univ Orebro, Dept Infect Dis, Orebro, Sweden; [Ziegler, Ingrid; Fagerstrom, Anna; Stralin, Kristoffer; Molling, Paula] Univ Orebro, Sch Hlth & Med Sci, Orebro, Sweden; [Fagerstrom, Anna; Molling, Paula] Orebro Univ Hosp, Dept Lab Med, Orebro, Sweden; [Stralin, Kristoffer] Karolinska Univ Hosp, Dept Infect Dis, Stockholm, Sweden; [Stralin, Kristoffer] Karolinska Inst, Dept Med Huddinge, Stockholm, Sweden	Orebro University; Orebro University; Orebro University; Karolinska Institutet; Karolinska University Hospital; Karolinska Institutet	Ziegler, I (corresponding author), Univ Orebro, Dept Infect Dis, Orebro, Sweden.; Ziegler, I (corresponding author), Univ Orebro, Sch Hlth & Med Sci, Orebro, Sweden.	ingrid.ziegler@regionorebrolan.se			resaerch committee of Region Orebro Lan	resaerch committee of Region Orebro Lan	The study was supported by grants from the resaerch committee of Region Orebro Lan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angus D C, 2001, Crit Care Med, V29, P1303, DOI 10.1097/00003246-200107000-00002; Bahrani-Mougeot FK, 2008, ORAL SURG ORAL MED O, V105, P720, DOI 10.1016/j.tripleo.2008.02.009; Benitez-Paez A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057782; Berglund C, 2005, CLIN MICROBIOL INFEC, V11, P447, DOI 10.1111/j.1469-0691.2005.01150.x; Bloos F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046003; Bloos F, 2010, INTENS CARE MED, V36, P241, DOI 10.1007/s00134-009-1705-z; Bochud PY, 2001, INTENS CARE MED, V27, pS33, DOI 10.1007/PL00003796; Campbell SG, 2003, CHEST, V123, P1142, DOI 10.1378/chest.123.4.1142; Carrara L, 2013, J MED MICROBIOL, V62, P1673, DOI 10.1099/jmm.0.064758-0; Dark P, 2015, INTENS CARE MED, V41, P21, DOI 10.1007/s00134-014-3553-8; Dellinger RP, 2008, CRIT CARE MED, V36, P296, DOI 10.1097/01.CCM.0000298158.12101.41; Glerant JC, 1999, RESP MED, V93, P208, DOI 10.1016/S0954-6111(99)90010-0; Hedberg ST, 2009, APMIS, V117, P856, DOI 10.1111/j.1600-0463.2009.02539.x; Ibrahim EH, 2000, CHEST, V118, P146, DOI 10.1378/chest.118.1.146; Jordana-Lluch E, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0140865; Josefson P, 2011, EUR J CLIN MICROBIOL, V30, P1127, DOI 10.1007/s10096-011-1201-6; Kumar A, 2006, CRIT CARE MED, V34, P1589, DOI 10.1097/01.CCM.0000217961.75225.E9; Lehmann LE, 2008, MED MICROBIOL IMMUN, V197, P313, DOI 10.1007/s00430-007-0063-0; Lehmann LE, 2010, INTENS CARE MED, V36, P49, DOI 10.1007/s00134-009-1608-z; Leitner E, 2013, J MICROBIOL METH, V92, P253, DOI 10.1016/j.mimet.2012.12.012; Ljungstrom L, 2015, BMC INFECT DIS, V15, DOI 10.1186/s12879-015-0938-4; Loonen AJM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087315; Lucas VS, 2008, J DENT, V36, P481, DOI 10.1016/j.jdent.2008.03.005; Martin GS, 2003, NEW ENGL J MED, V348, P1546, DOI 10.1056/NEJMoa022139; MCKENZIE R, 1987, DIAGN MICR INFEC DIS, V8, P165, DOI 10.1016/0732-8893(87)90167-2; Olsen I, 2008, TRANSFUS APHER SCI, V39, P173, DOI 10.1016/j.transci.2008.06.008; Patel R, 2013, CLIN INFECT DIS, V57, P564, DOI 10.1093/cid/cit247; Peters RPH, 2004, LANCET INFECT DIS, V4, P751, DOI 10.1016/S1473-3099(04)01205-8; RANGELFRAUSTO MS, 1995, JAMA-J AM MED ASSOC, V273, P117, DOI 10.1001/jama.273.2.117; Schreiber J, 2013, MED KLIN-INTENSIVMED, V108, P311, DOI 10.1007/s00063-013-0227-1; Vincent JL, 2015, CRIT CARE MED, V43, P2283, DOI 10.1097/CCM.0000000000001249; Vlek ALM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032589; Wellinghausen N, 2009, J CLIN MICROBIOL, V47, P2759, DOI 10.1128/JCM.00567-09; Westh H, 2009, CLIN MICROBIOL INFEC, V15, P544, DOI 10.1111/j.1469-0691.2009.02736.x; Yoshitomi KJ, 2003, MOL CELL PROBE, V17, P275, DOI 10.1016/j.mcp.2003.07.001; Ziegler I, 2014, BMC INFECT DIS, V14, DOI 10.1186/1471-2334-14-155	36	27	28	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2016	11	12							e0167883	10.1371/journal.pone.0167883	http://dx.doi.org/10.1371/journal.pone.0167883			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI9QF	27997618	gold, Green Submitted, Green Published			2022-12-27	WOS:000392842900017
J	Qin, H; Wang, YY; Wang, J; Liu, H; Zhao, H; Deng, ZA; Zhang, ZL; Huang, RF; Zhang, ZJ				Qin, Hua; Wang, Yayun; Wang, Juan; Liu, Hai; Zhao, Hui; Deng, Zaian; Zhang, Zhili; Huang, Rongfeng; Zhang, Zhijin			Knocking Down the Expression of GMPase Gene OsVTC1-1 Decreases Salt Tolerance of Rice at Seedling and Reproductive Stages	PLoS One			English	Article							GDP-MANNOSE PYROPHOSPHORYLASE; DEFICIENT ARABIDOPSIS MUTANT; ASCORBIC-ACID SYNTHESIS; ROOT-GROWTH INHIBITION; VITAMIN-C; L-GALACTONO-1,4-LACTONE DEHYDROGENASE; DISEASE RESISTANCE; SALICYLIC-ACID; HIGHER-PLANTS; FLORAL DIP	Salinity is a severe environmental stress that greatly impairs production of crops worldwide. Previous studies have shown that GMPase plays an important role in tolerance of plants to salt stress at vegetative stage. However, the function of GMPase in plant responses to salt stress at reproductive stage remains unclear. Studies have shown that heterologous expression of rice GMPase OsVTC1-1 enhanced salt tolerance of tobacco seedlings, but the native role of OsVTC1-1 in salt stress tolerance of rice is unknown. To illustrate the native function of GMPase in response of rice to salt stress, OsVTC1-1 expression was suppressed using RNAi-mediated gene silencing. Suppressing OsVTC1-1 expression obviously decreased salt tolerance of rice varieties at vegetative stage. Intriguingly, grain yield of OsVTC1-1 RNAi rice was also significantly reduced under salt stress, indicating that OsVTC1-1 plays an important role in salt tolerance of rice at both seedling and reproductive stages. OsVTC1-1 RNAi rice accumulated more ROS under salt stress, and supplying exogenous ascorbic acid restored salt tolerance of OsVTC1-1 RNAi lines, suggesting that OsVTC1-1 is involved in salt tolerance of rice through the biosynthesis regulation of ascorbic acid. Altogether, results of present study showed that rice GMPase gene OsVTC1-1 plays a critical role in salt tolerance of rice at both vegetative and reproductive stages through AsA scavenging of excess ROS.	[Qin, Hua; Wang, Yayun; Wang, Juan; Zhao, Hui; Deng, Zaian; Huang, Rongfeng; Zhang, Zhijin] Chinese Acad Agr Sci, Biotechnol Res Inst, Beijing, Peoples R China; [Wang, Juan; Huang, Rongfeng; Zhang, Zhijin] Natl Key Facil Crop Gene Resources & Genet Improv, Beijing, Peoples R China; [Liu, Hai] Univ Virginia, Dept Biol, Charlottesville, VA USA; [Deng, Zaian; Zhang, Zhili] Hainan Acad Agr Sci, Haikou, Peoples R China	Chinese Academy of Agricultural Sciences; Biotechnology Research Institute, CAAS; University of Virginia	Huang, RF; Zhang, ZJ (corresponding author), Chinese Acad Agr Sci, Biotechnol Res Inst, Beijing, Peoples R China.; Huang, RF; Zhang, ZJ (corresponding author), Natl Key Facil Crop Gene Resources & Genet Improv, Beijing, Peoples R China.	rfhuang@caas.cn; zhangzhijin@caas.cn	Zhao, Hui/GXH-9348-2022; Liu, Hai/AAE-6577-2020	Liu, Hai/0000-0002-1846-9718	National Basic Research Program of China [2013CB127003]; National Science Foundation of China [31070270]; National Transgenic Major Program [2015ZX08001-002, 2014ZX08009-15B]	National Basic Research Program of China(National Basic Research Program of China); National Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Transgenic Major Program	This work was supported by the National Basic Research Program of China (Grant No: 2013CB127003), the National Science Foundation of China (Grant No: 31070270) and National Transgenic Major Program (Grant No: 2015ZX08001-002 and Grant No: 2014ZX08009-15B).	Agius F, 2003, NAT BIOTECHNOL, V21, P177, DOI 10.1038/nbt777; Alhagdow M, 2007, PLANT PHYSIOL, V145, P1408, DOI 10.1104/pp.107.106500; AONO M, 1993, PLANT CELL PHYSIOL, V34, P129; Apel K, 2004, ANNU REV PLANT BIOL, V55, P373, DOI 10.1146/annurev.arplant.55.031903.141701; Barth C, 2004, PLANT PHYSIOL, V134, P1784, DOI 10.1104/pp.103.032185; Barth C, 2010, J EXP BOT, V61, P379, DOI 10.1093/jxb/erp310; Bent A, 2006, METH MOL B, V343, P87; Bose J, 2014, J EXP BOT, V65, P1241, DOI 10.1093/jxb/ert430; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; Conklin PL, 2006, J BIOL CHEM, V281, P15662, DOI 10.1074/jbc.M601409200; Conklin PL, 2004, PLANT CELL ENVIRON, V27, P959, DOI 10.1111/j.1365-3040.2004.01203.x; Conklin PL, 1996, P NATL ACAD SCI USA, V93, P9970, DOI 10.1073/pnas.93.18.9970; Conklin PL, 1997, PLANT PHYSIOL, V115, P1277, DOI 10.1104/pp.115.3.1277; Conklin PL, 1999, P NATL ACAD SCI USA, V96, P4198, DOI 10.1073/pnas.96.7.4198; Dowdle J, 2007, PLANT J, V52, P673, DOI 10.1111/j.1365-313X.2007.03266.x; Flowers TJ, 2015, ANN BOT-LONDON, V115, P419, DOI 10.1093/aob/mcu217; Frei M, 2012, PLANT PHYSIOL BIOCH, V59, P63, DOI 10.1016/j.plaphy.2012.02.015; Freshour G, 2003, PLANT PHYSIOL, V131, P1602, DOI 10.1104/pp.102.016444; Gatzek S, 2002, PLANT J, V30, P541, DOI 10.1046/j.1365-313X.2002.01315.x; Hu TX, 2016, PLANT J, V85, P16, DOI 10.1111/tpj.13085; Huang CH, 2005, J EXP BOT, V56, P3041, DOI 10.1093/jxb/eri301; Keller R, 1999, PLANT J, V19, P131, DOI 10.1046/j.1365-313X.1999.00507.x; Kotchoni SO, 2009, PLANT PHYSIOL, V149, P803, DOI 10.1104/pp.108.132324; Kumar R, 2012, PLANT MOL BIOL, V79, P555, DOI 10.1007/s11103-012-9928-8; Lamb C, 1997, ANNU REV PLANT PHYS, V48, P251, DOI 10.1146/annurev.arplant.48.1.251; Lee MH, 2013, PLANT PHYSIOL BIOCH, V70, P325, DOI 10.1016/j.plaphy.2013.05.047; Li Q, 2010, PLANT CELL ENVIRON, V33, P1529, DOI 10.1111/j.1365-3040.2010.02162.x; Linster CL, 2008, TRENDS PLANT SCI, V13, P567, DOI 10.1016/j.tplants.2008.08.005; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lorence A, 2004, PLANT PHYSIOL, V134, P1200, DOI 10.1104/pp.103.033936; Lukowitz W, 2001, P NATL ACAD SCI USA, V98, P2262, DOI 10.1073/pnas.051625798; Lutts S, 1995, J EXP BOT, V46, P1843, DOI 10.1093/jxb/46.12.1843; Maeda Y, 2008, BBA-GEN SUBJECTS, V1780, P861, DOI 10.1016/j.bbagen.2008.03.005; Miller G, 2010, PLANT CELL ENVIRON, V33, P453, DOI 10.1111/j.1365-3040.2009.02041.x; Moradi F, 2007, ANN BOT-LONDON, V99, P1161, DOI 10.1093/aob/mcm052; Mortimer JC, 2013, PLANT CELL, V25, P1881, DOI 10.1105/tpc.113.111500; Mukherjee M, 2010, MOL PLANT MICROBE IN, V23, P340, DOI 10.1094/MPMI-23-3-0340; Nickle TC, 1998, PLANT J, V15, P321, DOI 10.1046/j.1365-313X.1998.00212.x; Noctor G, 1998, ANNU REV PLANT PHYS, V49, P249, DOI 10.1146/annurev.arplant.49.1.249; Pastori GM, 2003, PLANT CELL, V15, P939, DOI 10.1105/tpc.010538; Pavet V, 2005, PLANT PHYSIOL, V139, P1291, DOI 10.1104/pp.105.067686; Pospisil P, 2009, BBA-BIOENERGETICS, V1787, P1151, DOI 10.1016/j.bbabio.2009.05.005; Qin C, 2008, P NATL ACAD SCI USA, V105, P18308, DOI 10.1073/pnas.0806168105; Qin H, 2016, PLANT MOL BIOL, V90, P317, DOI 10.1007/s11103-015-0420-0; Rao PS, 2008, PLANT BREEDING, V127, P256, DOI 10.1111/j.1439-0523.2007.01455.x; Shalata A, 2001, J EXP BOT, V52, P2207, DOI 10.1093/jexbot/52.364.2207; Smirnoff N, 2000, CRIT REV BIOCHEM MOL, V35, P291, DOI 10.1080/10409230008984166; SMOOT JW, 1985, EUR J BIOCHEM, V148, P83, DOI 10.1111/j.1432-1033.1985.tb08810.x; Tabata K, 2001, PLANT J, V27, P139, DOI 10.1046/j.1365-313x.2001.01074.x; Tajdoost S, 2007, Pak J Biol Sci, V10, P2086, DOI 10.3923/pjbs.2007.2086.2090; Tuteja N, 2007, METHOD ENZYMOL, V428, P419, DOI 10.1016/S0076-6879(07)28024-3; Uchendu EE, 2010, PLANT CELL REP, V29, P25, DOI 10.1007/s00299-009-0795-y; Veljovic-Jovanovic SD, 2001, PLANT PHYSIOL, V127, P426, DOI 10.1104/pp.010141; Walia H, 2007, PLANT MOL BIOL, V63, P609, DOI 10.1007/s11103-006-9112-0; Wang HS, 2012, MOL BIOL REP, V39, P10413, DOI 10.1007/s11033-012-1920-5; Wang HS, 2011, PLANT CELL REP, V30, P1029, DOI 10.1007/s00299-011-1009-y; Wang J, 2013, PLANT CELL, V25, P625, DOI 10.1105/tpc.112.106880; Wheeler GL, 1998, NATURE, V393, P365, DOI 10.1038/30728; Wolucka BA, 2003, J BIOL CHEM, V278, P47483, DOI 10.1074/jbc.M309135200; Yadav S, 2011, J ENVIRON BIOL, V32, P667; Zeng LH, 2000, CROP SCI, V40, P996, DOI 10.2135/cropsci2000.404996x; Zhang CJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061987; Zhang CJ, 2011, PLANT CELL REP, V30, P389, DOI 10.1007/s00299-010-0939-0; Zhang GY, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125870; Zhang ZJ, 2012, PLANT J, V71, P273, DOI 10.1111/j.1365-313X.2012.04996.x	65	21	21	4	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 19	2016	11	12							e0168650	10.1371/journal.pone.0168650	http://dx.doi.org/10.1371/journal.pone.0168650			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI9QC	27992560	gold, Green Published, Green Submitted			2022-12-27	WOS:000392842600086
J	Ducarme, G; Hamel, JF; Brun, S; Madar, H; Merlot, B; Sentilhes, L				Ducarme, Guillaume; Hamel, Jean-Francois; Brun, Stephanie; Madar, Hugo; Merlot, Benjamin; Sentilhes, Loic			Pelvic Floor Disorders 6 Months after Attempted Operative Vaginal Delivery According to the Fetal Head Station: A Prospective Cohort Study	PLOS ONE			English	Article							STRESS URINARY-INCONTINENCE; TRACT SYMPTOMS QUESTIONNAIRE; ANAL INCONTINENCE; FECAL INCONTINENCE; INSTRUMENTAL DELIVERY; NEONATAL MORBIDITY; CESAREAN DELIVERY; 1ST DELIVERY; MODE; POSTPARTUM	Objective To evaluate the effect of the fetal head station at attempted operative vaginal delivery (aOVD), and specifically midpelvic or low aOVD, on urinary incontinence (UI), anal incontinence (AI), and perineal pain at 6 months. Design Prospective cohort study. Setting 1941 women with singleton term fetuses in vertex presentation with midpelvic or low aOVD between 2008 and 2013 in a tertiary care university hospital. Methods Symptoms of urinary incontinence (UI) using the Bristol Female Lower Urinary Tract Symptoms questionnaire, and symptoms of anal incontinence (AI) severity using Fecal Incontinence Severity Index (FISI) were assessed 6 months after aOVD. We measured the association between midpelvic or low aOVD and symptoms of UI, AI, and perineal pain at 6 months using multiple regression and adjusting for demographics, and risk factors of UI and AI, with adjusted odds ratios (aORs) and 95% confidence intervals (95% CI). Results The study included 907 women (46.7%) who responded to the questionnaire; 18.4% (167/ 907) had midpelvic aOVD, and 81.6% (740/907) low; and none of women with symptoms of UI (26.6%, and 22.4%, respectively; p = 0.31), AI (15.9%, and 21.8%; p = 0.09), the FISI score, and perineal pain (17.2%, and 12.7%; p = 0.14) differed significantly between groups. The same was true for stress, urge, and mixed-type UI, severe UI and difficulty voiding. Compared with low pelvic aOVD, the aORs for symptoms of UI in midpelvic aOVD were 0.70 (0.46-1.05) and AI 1.42 (0.85-2.39). Third-and fourth-degree tears were a major risk factor of symptoms of UI (aOR 3.08, 95% CI 1.35-7.00) and AI (aOR 3.47, 95% CI 1.43-8.39). Conclusion Neither symptoms of urinary nor anal incontinence differed at 6 months among women who had midpelvic and low pelvic aOVD. These findings are reassuring and need further studies at long-term to confirm these short-term data.	[Ducarme, Guillaume] Ctr Hosp Dept, Dept Obstet & Gynecol, La Roche Sur Yon, France; [Hamel, Jean-Francois] Angers Univ Hosp, Clin Res Ctr, Angers, France; [Brun, Stephanie; Madar, Hugo; Merlot, Benjamin; Sentilhes, Loic] Bordeaux Univ Hosp, Dept Obstet & Gynecol, Bordeaux, France	CHD Vendee; Universite d'Angers; Centre Hospitalier Universitaire d'Angers; CHU Bordeaux	Ducarme, G (corresponding author), Ctr Hosp Dept, Dept Obstet & Gynecol, La Roche Sur Yon, France.	g.ducarme@gmail.com	, DUCARME/I-1248-2019	, DUCARME/0000-0002-2549-353X	Angers University Hospital	Angers University Hospital	The Angers University Hospital provided the funding for the study. The funding source had no role in the design or conduct of the study, collection, analysis, or interpretation of the date, or writing the article or decision to submit for publication.	[Anonymous], 2013, J GYNECOL OBST BIO R, V42, P1018, DOI 10.1016/j.jgyn.2013.09.023; Bahl R, 2005, AM J OBSTET GYNECOL, V192, P789, DOI 10.1016/j.ajog.2004.10.601; Borello-France D, 2006, OBSTET GYNECOL, V108, P863, DOI 10.1097/01.AOG.0000232504.32589.3b; BOZDOGAN H, 1987, PSYCHOMETRIKA, V52, P345, DOI 10.1007/BF02294361; Brookes ST, 2004, AM J OBSTET GYNECOL, V191, P73, DOI 10.1016/j.ajog.2003.12.027; Brown S, 1998, BRIT J OBSTET GYNAEC, V105, P156, DOI 10.1111/j.1471-0528.1998.tb10045.x; Buhling KJ, 2006, EUR J OBSTET GYN R B, V124, P42, DOI 10.1016/j.ejogrb.2005.04.008; Burgio KL, 2003, OBSTET GYNECOL, V102, P1291, DOI 10.1016/j.obstetgynecol.2003.09.013; Burnham K. P., 2002, MODEL SELECTION MULT, V2nd; Ducarme G, 2015, OBSTET GYNECOL, V126, P521, DOI 10.1097/AOG.0000000000001000; Eason E, 2002, CAN MED ASSOC J, V166, P326; Farrell SA, 2001, OBSTET GYNECOL, V97, P350, DOI 10.1016/S0029-7844(00)01164-9; Fritel X, 2008, BJOG-INT J OBSTET GY, V115, P247, DOI 10.1111/j.1471-0528.2007.01540.x; Fritel X, 2005, BJOG-INT J OBSTET GY, V112, P1646, DOI 10.1111/j.1471-0528.2005.00763.x; Fritel X, 2004, ACTA OBSTET GYN SCAN, V83, P941, DOI 10.1111/j.0001-6349.2004.00457.x; HADLOCK FP, 1985, AM J OBSTET GYNECOL, V151, P333, DOI 10.1016/0002-9378(85)90298-4; Handa VL, 2015, NEUROUROL URODYNAM, V34, P356, DOI 10.1002/nau.22583; Handa VL, 2012, OBSTET GYNECOL, V119, P233, DOI 10.1097/AOG.0b013e318240df4f; Hannah ME, 2004, AM J OBSTET GYNECOL, V191, P917, DOI 10.1016/j.ajog.2004.08.004; Herbruck LF, 2008, UROL NURS, V28, P185; Herbruck Lianne F, 2008, Urol Nurs, V28, P173; Hijaz A, 2012, INT UROGYNECOL J, V23, P395, DOI 10.1007/s00192-011-1562-5; Huebner M, 2013, INT J GYNECOL OBSTET, V121, P74, DOI 10.1016/j.ijgo.2012.10.023; Jackson S, 1996, BRIT J UROL, V77, P805, DOI 10.1046/j.1464-410X.1996.00186.x; Johannessen HH, 2014, BJOG-INT J OBSTET GY, V121, P269, DOI 10.1111/1471-0528.12438; Johannessen HH, 2015, ACTA OBSTET GYN SCAN, V94, P1005, DOI 10.1111/aogs.12689; Johanson RB, 1999, BRIT J OBSTET GYNAEC, V106, P544, DOI 10.1111/j.1471-0528.1999.tb08322.x; Lal M, 2003, OBSTET GYNECOL, V101, P305, DOI 10.1016/S0029-7844(02)02716-3; Liebling RE, 2004, AM J OBSTET GYNECOL, V191, P4, DOI 10.1016/j.ajog.2004.01.013; MacArthur C, 2005, BJOG-INT J OBSTET GY, V112, P1075, DOI 10.1111/j.1471-0528.2005.00721.x; MacArthur C, 2001, BRIT J OBSTET GYNAEC, V108, P678, DOI 10.1111/j.1471-0528.2001.00183.x; Murphy DJ, 2001, LANCET, V358, P1203, DOI 10.1016/S0140-6736(01)06341-3; Peaceman AM, 2015, OBSTET GYNECOL, V126, pE56, DOI 10.1097/AOG.0000000000001147; Pretlove SJ, 2008, BJOG-INT J OBSTET GY, V115, P421, DOI 10.1111/j.1471-0528.2007.01553.x; Quiboeuf E, 2016, BJOG-INT J OBSTET GY, V123, P1222, DOI 10.1111/1471-0528.13545; Rockwood TH, 2004, GASTROENTEROLOGY, V126, pS106, DOI 10.1053/j.gastro.2003.10.057; Rockwood TH, 1999, DIS COLON RECTUM, V42, P1525, DOI 10.1007/BF02236199; Rortveit G, 2003, AM J OBSTET GYNECOL, V189, P1268, DOI 10.1067/S0002-9378(03)00588-X; Rortveit G, 2003, NEW ENGL J MED, V348, P900, DOI 10.1056/NEJMoa021788; Solans-Domenech M, 2010, OBSTET GYNECOL, V115, P618, DOI 10.1097/AOG.0b013e3181d04dff; SULTAN AH, 1994, BRIT MED J, V308, P887, DOI 10.1136/bmj.308.6933.887; Tahtinen RM, 2016, EUR UROL, V70, P148, DOI 10.1016/j.eururo.2016.01.037; Zetterstrom JP, 1999, BRIT J OBSTET GYNAEC, V106, P324, DOI 10.1111/j.1471-0528.1999.tb08269.x	43	4	4	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2016	11	12							e0168591	10.1371/journal.pone.0168591	http://dx.doi.org/10.1371/journal.pone.0168591			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI8LN	27992558	gold, Green Submitted, Green Published			2022-12-27	WOS:000392758000063
J	Wang, HZ; Zheng, YS; Lai, JZ; Luo, QP; Ke, HC; Chen, Q				Wang, Hanze; Zheng, Yansong; Lai, Junzhong; Luo, Qianping; Ke, Huican; Chen, Qi			Methylation-Sensitive Melt Curve Analysis of the Reprimo Gene Methylation in Gastric Cancer	PLOS ONE			English	Article							CIRCULATING TUMOR DNA; NUCLEIC-ACIDS	Reprimo (RPRM) is a p53-induced tumor suppressor gene. Its aberrant DNA methylation is correlated with carcinogenesis and may be used as a surrogate marker for the early detection of gastric cancer. However, the detail information regarding its DNA methylation has not been revealed. Here, we investigated the RPRM gene methylation in gastric cancer tumor and plasma samples by methylation-sensitive melt curve analysis (MS-MCA) and bisulfite sequencing in depth. We developed a semi-quantitative method based on MS-MCA for detecting DNA methylation and unraveled the RPRM gene methylation pattern in gastric cancer. This study provides a solid foundation for the future application of detecting RPRM gene methylation in human plasma or serum samples to help diagnose gastric cancer or for prognosis evaluation.	[Wang, Hanze; Lai, Junzhong; Luo, Qianping; Ke, Huican; Chen, Qi] Fujian Normal Univ, Coll Life Sci, Biomed Res Ctr South China, Fujian Key Lab Innate Immune Biol, Qishan Campus, Fuzhou, Fujian, Peoples R China; [Zheng, Yansong] Fujian Med Univ, Affiliated Hosp 1, Fuzhou, Fujian, Peoples R China	Fujian Normal University; Fujian Medical University	Chen, Q (corresponding author), Fujian Normal Univ, Coll Life Sci, Biomed Res Ctr South China, Fujian Key Lab Innate Immune Biol, Qishan Campus, Fuzhou, Fujian, Peoples R China.	nfsw@fjnu.edu.cn	yang, zheng/HGC-7753-2022		Fujian Provincial Health and Education Alliance Funds [WKJ-FJ-28]; Fujian Key Laboratories Funds; Fujian Provincial Lingjun Scholarship	Fujian Provincial Health and Education Alliance Funds; Fujian Key Laboratories Funds; Fujian Provincial Lingjun Scholarship	This work was supported by Fujian Provincial Health and Education Alliance Funds (WKJ-FJ-28), Fujian Key Laboratories Funds, and a Fujian Provincial Lingjun Scholarship to QC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anker P, 1999, CANCER METAST REV, V18, P65, DOI 10.1023/A:1006260319913; Baylin SB, 2011, NAT REV CANCER, V11, P726, DOI 10.1038/nrc3130; Bernal C, 2008, CLIN CANCER RES, V14, P6264, DOI 10.1158/1078-0432.CCR-07-4522; Diaz LA, 2014, J CLIN ONCOL, V32, P579, DOI 10.1200/JCO.2012.45.2011; Diehl F, 2008, NAT MED, V14, P985, DOI 10.1038/nm.1789; Gilbert N, 2007, J CELL BIOL, V177, P401, DOI 10.1083/jcb.200607133; Hall T.A., 1999, NUCL ACIDS S SER, V41, P95; KLEIN E, 1976, ANN NY ACAD SCI, V276, P207, DOI 10.1111/j.1749-6632.1976.tb41647.x; Li LC, 2002, BIOINFORMATICS, V18, P1427, DOI 10.1093/bioinformatics/18.11.1427; Ohki R, 2000, J BIOL CHEM, V275, P22627, DOI 10.1074/jbc.C000235200; Ooki A, 2013, MOL CANCER RES, V11, P1362, DOI 10.1158/1541-7786.MCR-13-0091; Otsuka T, 1996, GENE CHROMOSOME CANC, V16, P113, DOI 10.1002/(SICI)1098-2264(199606)16:2<113::AID-GCC5>3.0.CO;2-2; Parkin DM, 2004, ONCOGENE, V23, P6329, DOI 10.1038/sj.onc.1207726; Schwarzenbach H, 2011, NAT REV CANCER, V11, P426, DOI 10.1038/nrc3066; Takahashi T, 2005, INT J CANCER, V115, P503, DOI 10.1002/ijc.20910; Taylor WR, 2001, ONCOGENE, V20, P1803, DOI 10.1038/sj.onc.1204252; Tong YK, 2006, CLIN CHIM ACTA, V363, P187, DOI 10.1016/j.cccn.2005.05.048; Wong TS, 2005, INT J CANCER, V117, P697, DOI 10.1002/ijc.21208; You JS, 2012, CANCER CELL, V22, P9, DOI 10.1016/j.ccr.2012.06.008; ZWEIG MH, 1993, CLIN CHEM, V39, P561	20	8	8	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2016	11	12							e0168635	10.1371/journal.pone.0168635	http://dx.doi.org/10.1371/journal.pone.0168635			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI8LN	27992600	Green Published, Green Submitted, gold			2022-12-27	WOS:000392758000069
J	Li, N; Hennelly, SP; Stubben, CJ; Micheva-Viteva, S; Hu, B; Shou, YL; Vuyisich, M; Tung, CS; Chain, PS; Sanbonmatsu, KY; Hong-Geller, E				Li, Nan; Hennelly, Scott P.; Stubben, Chris J.; Micheva-Viteva, Sofiya; Hu, Bin; Shou, Yulin; Vuyisich, Momchilo; Tung, Chang-Shung; Chain, Patrick S.; Sanbonmatsu, Karissa Y.; Hong-Geller, Elizabeth			Functional and Structural Analysis of a Highly-Expressed Yersinia pestis Small RNA following Infection of Cultured Macrophages	PLOS ONE			English	Article							III SECRETION; AMINOGLYCOSIDE ANTIBIOTICS; TERTIARY STRUCTURE; HFQ; ACCURATE; REGULATOR; DISCOVERY; BINDING	Non-coding small RNAs (sRNAs) are found in practically all bacterial genomes and play important roles in regulating gene expression to impact bacterial metabolism, growth, and virulence. We performed transcriptomics analysis to identify sRNAs that are differentially expressed in Yersinia pestis that invaded the human macrophage cell line THP-1, compared to pathogens that remained extracellular in the presence of host. Using ultra high-throughput sequencing, we identified 37 novel and 143 previously known sRNAs in Y. pestis. In particular, the sRNA Ysr170 was highly expressed in intracellular Yersinia and exhibited a log2 fold change similar to 3.6 higher levels compared to extracellular bacteria. We found that knock-down of Ysr170 expression attenuated infection efficiency in cell culture and growth rate in response to different stressors. In addition, we applied selective 2'-hydroxyl acylation analyzed by primer extension (SHAPE) analysis to determine the secondary structure of Ysr170 and observed structural changes resulting from interactions with the aminoglycoside antibiotic gentamycin and the RNA chaperone Hfq. Interestingly, gentamicin stabilized helix 4 of Ysr170, which structurally resembles the native gentamicin 16S ribosomal binding site. Finally, we modeled the tertiary structure of Ysr170 binding to gentamycin using RNA motif modeling. Integration of these experimental and structural methods can provide further insight into the design of small molecules that can inhibit function of sRNAs required for pathogen virulence.	[Li, Nan; Stubben, Chris J.; Micheva-Viteva, Sofiya; Hu, Bin; Shou, Yulin; Vuyisich, Momchilo; Chain, Patrick S.; Hong-Geller, Elizabeth] Los Alamos Natl Lab, Biosci Div, Los Alamos, NM 87544 USA; [Hennelly, Scott P.; Tung, Chang-Shung; Sanbonmatsu, Karissa Y.] Los Alamos Natl Lab, Div Theoret, Los Alamos, NM USA; [Li, Nan] Sichuan Univ, Chengdu, Peoples R China; [Stubben, Chris J.] Univ Utah, Salt Lake City, UT USA; [Hu, Bin] SRA Int, Atlanta, GA USA; [Vuyisich, Momchilo] Viome Inc, Los Alamos, NM USA	United States Department of Energy (DOE); Los Alamos National Laboratory; United States Department of Energy (DOE); Los Alamos National Laboratory; Sichuan University; Utah System of Higher Education; University of Utah; SRA International	Hong-Geller, E (corresponding author), Los Alamos Natl Lab, Biosci Div, Los Alamos, NM 87544 USA.	ehong@lanl.gov	Chain, Patrick/O-4140-2019	Chain, Patrick/0000-0003-3949-3634; Hu, Bin/0000-0002-0278-8466; Stubben, Chris/0000-0002-3390-4888	Laboratory Directed Research and Development Directed Research (LDRD-DR) [20110051]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM110310] Funding Source: NIH RePORTER	Laboratory Directed Research and Development Directed Research (LDRD-DR); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was funded by Laboratory Directed Research and Development Directed Research (LDRD-DR) #20110051. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achtman M, 1999, P NATL ACAD SCI USA, V96, P14043, DOI 10.1073/pnas.96.24.14043; Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; Argaman L, 2001, CURR BIOL, V11, P941, DOI 10.1016/S0960-9822(01)00270-6; Beauregard A, 2013, RNA BIOL, V10, P397, DOI 10.4161/rna.23590; BISWAS DK, 1972, P NATL ACAD SCI USA, V69, P2141, DOI 10.1073/pnas.69.8.2141; Chao YJ, 2010, CURR OPIN MICROBIOL, V13, P24, DOI 10.1016/j.mib.2010.01.001; CLOUETDORVAL B, 1995, BIOCHEMISTRY-US, V34, P11186, DOI 10.1021/bi00035a025; Cornelis GR, 2002, J CELL BIOL, V158, P401, DOI 10.1083/jcb.200205077; De Gregorio E, 2006, J BACTERIOL, V188, P7876, DOI 10.1128/JB.00942-06; Faner MA, 2013, METHODS, V63, P144, DOI 10.1016/j.ymeth.2013.04.023; Fang N, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00685; Gardner PP, 2011, NUCLEIC ACIDS RES, V39, pD141, DOI 10.1093/nar/gkq1129; Geng J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006213; Henderson CA, 2013, RNA, V19, P1089, DOI 10.1261/rna.034595.112; Hennelly SP, 2013, NUCLEIC ACIDS RES, V41, P1922, DOI 10.1093/nar/gks978; Karabiber F, 2013, RNA, V19, P63, DOI 10.1261/rna.036327.112; Kawamoto H, 2006, MOL MICROBIOL, V61, P1013, DOI 10.1111/j.1365-2958.2006.05288.x; Kim H, 2012, MOL BIOSYST, V8, P2857, DOI 10.1039/c2mb25333j; Kingsford CL, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-2-r22; Koo JT, 2011, P NATL ACAD SCI USA, V108, pE709, DOI 10.1073/pnas.1101655108; Kwuan L, 2013, INFECT IMMUN, V81, P905, DOI 10.1128/IAI.01014-12; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Livny J, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003197; McClure R, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gkt444; Mei HY, 1998, BIOCHEMISTRY-US, V37, P14204, DOI 10.1021/bi981308u; Micheva-Viteva SN, 2013, BMC MICROBIOL, V13, DOI 10.1186/1471-2180-13-249; MOAZED D, 1987, NATURE, V327, P389, DOI 10.1038/327389a0; Mortimer SA, 2007, J AM CHEM SOC, V129, P4144, DOI 10.1021/ja0704028; Noah JW, 1999, J BIOL CHEM, V274, P16576, DOI 10.1074/jbc.274.23.16576; Novikova IV, 2013, J MOL BIOL, V425, P3731, DOI 10.1016/j.jmb.2013.02.030; Ribeiro ED, 2012, NUCLEIC ACIDS RES, V40, P8072, DOI 10.1093/nar/gks510; Romby P, 2006, CURR OPIN MICROBIOL, V9, P229, DOI 10.1016/j.mib.2006.02.005; Schiano CA, 2014, J BACTERIOL, V196, P1659, DOI 10.1128/JB.01456-13; Shepherd DP, 2013, ANAL CHEM; Stubben CJ, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-385; Tok JBH, 1999, BIOCHEMISTRY-US, V38, P199, DOI 10.1021/bi9819428; Toledo-Arana A, 2007, CURR OPIN MICROBIOL, V10, P182, DOI 10.1016/j.mib.2007.03.004; Tung CS, 2002, NAT STRUCT BIOL, V9, P750, DOI 10.1038/nsb841; Viboud GI, 2005, ANNU REV MICROBIOL, V59, P69, DOI 10.1146/annurev.micro.59.030804.121320; Vincent HA, 2012, NUCLEIC ACIDS RES, V40, P8698, DOI 10.1093/nar/gks582; Waters LS, 2009, CELL, V136, P615, DOI 10.1016/j.cell.2009.01.043; Yan YF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074495; ZAPP ML, 1993, CELL, V74, P969, DOI 10.1016/0092-8674(93)90720-B	43	7	8	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2016	11	12							e0168915	10.1371/journal.pone.0168915	http://dx.doi.org/10.1371/journal.pone.0168915			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EG7JB	28030576	gold, Green Published, Green Submitted			2022-12-27	WOS:000391222000084
J	Muric, G; Jorswieck, E; Scheunert, C				Muric, Goran; Jorswieck, Eduard; Scheunert, Christian			Using LTI Dynamics to Identify the Influential Nodes in a Network	PLOS ONE			English	Article							COMPLEX; IDENTIFICATION; SPREADERS	Networks are used for modeling numerous technical, social or biological systems. In order to better understand the system dynamics, it is a matter of great interest to identify the most important nodes within the network. For a large set of problems, whether it is the optimal use of available resources, spreading information efficiently or even protection from malicious attacks, the most important node is the most influential spreader, the one that is capable of propagating information in the shortest time to a large portion of the network. Here we propose the Node Imposed Response (NiR), a measure which accurately evaluates node spreading power. It outperforms betweenness, degree, k-shell and h-index centrality in many cases and shows the similar accuracy to dynamics-sensitive centrality. We utilize the system-theoretic approach considering the network as a Linear Time-Invariant system. By observing the system response we can quantify the importance of each node. In addition, our study provides a robust tool set for various protective strategies.	[Muric, Goran; Jorswieck, Eduard; Scheunert, Christian] Tech Univ Dresden, Commun Lab, Commun Theory, Saxony, Germany; [Muric, Goran] Leibniz Inst Ecol Urban & Reg Dev, Dresden Leibniz Grad Sch, Dresden, Saxony, Germany	Technische Universitat Dresden; Leibniz Institut fur okologische Raumentwicklung	Muric, G (corresponding author), Tech Univ Dresden, Commun Lab, Commun Theory, Saxony, Germany.; Muric, G (corresponding author), Leibniz Inst Ecol Urban & Reg Dev, Dresden Leibniz Grad Sch, Dresden, Saxony, Germany.	g.muric@dlgs.ioer.de	Jorswieck, Eduard Axel/A-2516-2009; Muric, Goran/ABD-2839-2020; Jorswieck, Eduard/O-8092-2019	Jorswieck, Eduard Axel/0000-0001-7893-8435; Muric, Goran/0000-0002-3700-2347; Jorswieck, Eduard/0000-0001-7893-8435	Dresden Leibniz Graduate School; German Research Foundation (DFG) within the Cluster of Excellence "Center for Advancing Electronics Dresden (cfaed)" - Deutsche Forschungsgemeinschaft (DE) [EXC 1056]	Dresden Leibniz Graduate School; German Research Foundation (DFG) within the Cluster of Excellence "Center for Advancing Electronics Dresden (cfaed)" - Deutsche Forschungsgemeinschaft (DE)(German Research Foundation (DFG))	The work of Goran Muric is supported by Dresden Leibniz Graduate School (http://www.dlgs-dresden.de/). The work of Eduard Jorswieck is partly supported by the German Research Foundation (DFG) within the Cluster of Excellence "Center for Advancing Electronics Dresden (cfaed)" - Deutsche Forschungsgemeinschaft (DE) grant no. EXC 1056 (http://www.dfg.de/en/research_funding/programmes/list/projectdetails/index.jsp?id=194636624).	Alvarez-Hamelin J. I., 2005, ADV NEURAL INFORM PR, P41; [Anonymous], 2010, SOCIAL EC NETWORKS; Barabasi AL, 1999, SCIENCE, V286, P509, DOI 10.1126/science.286.5439.509; Barrat A., 2008, DYNAMICAL PROCESSES, DOI 10.1017/cbo9780511791383; Batagelj V, 2005, PHYS REV E, V71, DOI 10.1103/PhysRevE.71.036113; Bauer F, 2012, EPL-EUROPHYS LETT, V99, DOI 10.1209/0295-5075/99/68007; Benzi M, 2015, SIAM J MATRIX ANAL A, V36, P686, DOI 10.1137/130950550; BONACICH P, 1987, AM J SOCIOL, V92, P1170, DOI 10.1086/228631; Borgatti SP, 2006, SOC NETWORKS, V28, P466, DOI 10.1016/j.socnet.2005.11.005; Carmi S, 2007, P NATL ACAD SCI USA, V104, P11150, DOI 10.1073/pnas.0701175104; Diestel R., 2006, GRAPH THEORY, Vthird; Estrada E, 2005, PHYS REV E, V71, DOI 10.1103/PhysRevE.71.056103; Estrada E, 2010, J THEOR BIOL, V263, P556, DOI 10.1016/j.jtbi.2010.01.014; FREEMAN LC, 1979, SOC NETWORKS, V1, P215, DOI 10.1016/0378-8733(78)90021-7; Hagmann P, 2008, PLOS BIOL, V6, P1479, DOI 10.1371/journal.pbio.0060159; HAKIMI SL, 1962, J SOC IND APPL MATH, V10, P496, DOI 10.1137/0110037; Hoffmann H., 2015, VIOLIN M SIMPLE VIOL; Kendall MG, 1938, BIOMETRIKA, V30, P81, DOI 10.2307/2332226; Kitsak M, 2010, NAT PHYS, V6, P888, DOI [10.1038/nphys1746, 10.1038/NPHYS1746]; Klemm K, 2012, SCI REPORTS, V2, P8; Knight S, 2011, IEEE J SEL AREA COMM, V29, P1765, DOI 10.1109/JSAC.2011.111002; Lawyer G, 2015, SCI REP-UK, V5, DOI 10.1038/srep08665; Leskovec J., 2014, SNAP DATASETS STANFO; Liu JG, 2016, SCI REP-UK, V6, DOI 10.1038/srep21380; Liu YY, 2011, NATURE, V473, P167, DOI 10.1038/nature10011; Lu LY, 2016, PHYS REP, V650, P1, DOI 10.1016/j.physrep.2016.06.007; Lu L, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10168; Malliaros FD, 2016, SCI REP-UK, V6, DOI 10.1038/srep19307; Milena M, 2002, ARACNE 2002; Muric G, 2015, IEEE CONF WIREL MOB, P138, DOI 10.1109/WiMOB.2015.7347953; Pei S, 2013, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2013/12/P12002; Piraveenan M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053095; Proakis J. G., 2007, DIGITAL SIGNAL PROCE; Sikic M, 2013, EUR PHYS J B, V86, DOI 10.1140/epjb/e2013-31025-5; Taylor A, 2009, ACM T MATH SOFTWARE, V35, DOI 10.1145/1462173.1462175; Viana MP, 2012, PHYS REV E, V85, DOI 10.1103/PhysRevE.85.036105; Watts DJ, 1998, NATURE, V393, P440, DOI 10.1038/30918; Zhang B, INTERNET TOPOLOGY PR	38	3	3	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2016	11	12							e0168514	10.1371/journal.pone.0168514	http://dx.doi.org/10.1371/journal.pone.0168514			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EG7JB	28030548	Green Submitted, Green Published, gold			2022-12-27	WOS:000391222000052
J	Sofin, Y; Danker-Hopfe, H; Neu, P				Sofin, Yvonne; Danker-Hopfe, Heidi; Neu, Peter			The Effect of Significant International Sports Events on Qualified Detoxification Treatment Outcome - Do Drop-Out Rates Change during UEFA European Championship?	PLOS ONE			English	Article								No previous studies have evaluated the influence of significant international sports events on qualified detoxification treatment outcome. This prospective study examines the impact of the 2012 UEFA European Football Championship on inpatient treatment outcome of alcohol dependent patients. Hospital admission and premature drop-out rates of consecutively admitted alcohol dependent patients were determined before, during and immediately after the UEFA Championship in the year 2012. The admission rate of male patients increased significantly after the European Football Championship had ended whereas for female patients, no change in admission rate was found. Daily average discharge rate was calculated. No statistically relevant differences between the treatment days before, during and after the UEFA Championship was found for the discharges. During the tournament, exclusively male patients dropped out. Our results are consistent with an interpretation of an association between European Football Championship and detoxification treatment outcome. Further research to replicate and extend our findings is necessary.	[Sofin, Yvonne; Neu, Peter] Jewish Hosp Berlin, Clin Psychiat & Psychotherapy, Berlin, Germany; [Danker-Hopfe, Heidi] Charite Sch Med, Competence Ctr Sleep Med, Campus Benjamin Franklin, Berlin, Germany; [Neu, Peter] Charite Sch Med, Campus Benjamin Franklin, Berlin, Germany	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Neu, P (corresponding author), Jewish Hosp Berlin, Clin Psychiat & Psychotherapy, Berlin, Germany.; Neu, P (corresponding author), Charite Sch Med, Campus Benjamin Franklin, Berlin, Germany.	peter.neu@jkb-online.de		Danker-Hopfe, Heidi/0000-0001-7001-1715				Adams J, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-473; Bedendo A, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-247; Braune NJ, 2008, FORTSCHR NEUROL PSYC, V76, P217, DOI 10.1055/s-2008-1038116; Martinez-Raga J, 2002, ALCOHOL ALCOHOLISM, V37, P277, DOI 10.1093/alcalc/37.3.277; Moore Simon C, 2007, Crim Behav Ment Health, V17, P118, DOI 10.1002/cbm.647; SULLIVAN JT, 1989, BRIT J ADDICT, V84, P1353	6	1	1	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2016	11	12							e0167446	10.1371/journal.pone.0167446	http://dx.doi.org/10.1371/journal.pone.0167446			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EG7JB	28030560	Green Published, gold, Green Submitted			2022-12-27	WOS:000391222000008
J	Sundstrom, A; Bar-Sagi, D; Mishra, B				Sundstrom, Andrew; Bar-Sagi, Dafna; Mishra, Bud			Simulating Heterogeneous Tumor Cell Populations	PLOS ONE			English	Article							METABOLIC HETEROGENEITY; CANCER; MODEL; HYPOXIA; MYC; GLUCOSE; FIBROBLASTS; HALLMARKS; CARCINOMA; IMPACT	Certain tumor phenomena, like metabolic heterogeneity and local stable regions of chronic hypoxia, signify a tumor's resistance to therapy. Although recent research has shed light on the intracellular mechanisms of cancer metabolic reprogramming, little is known about how tumors become metabolically heterogeneous or chronically hypoxic, namely the initial conditions and spatiotemporal dynamics that drive these cell population conditions. To study these aspects, we developed a minimal, spatially-resolved simulation framework for modeling tissue-scale mixed populations of cells based on diffusible particles the cells consume and release, the concentrations of which determine their behavior in arbitrarily complex ways, and on stochastic reproduction. We simulate cell populations that self-sort to facilitate metabolic symbiosis, that grow according to tumor-stroma signaling patterns, and that give rise to stable local regions of chronic hypoxia near blood vessels. We raise two novel questions in the context of these results: (1) How will two metabolically symbiotic cell subpopulations self-sort in the presence of glucose, oxygen, and lactate gradients? We observe a robust pattern of alternating striations. (2) What is the proper time scale to observe stable local regions of chronic hypoxia? We observe the stability is a function of the balance of three factors related to O-2-diffusion rate, local vessel release rate, and viable and hypoxic tumor cell consumption rate. We anticipate our simulation framework will help researchers design better experiments and generate novel hypotheses to better understand dynamic, emergent whole-tumor behavior.	[Sundstrom, Andrew] Icahn Sch Med Mt Sinai, Dept Pharmacol & Syst Therapeut, New York, NY 10029 USA; [Bar-Sagi, Dafna] NYU, Sch Med, Dept Biochem & Mol Pharmacol, New York, NY USA; [Sundstrom, Andrew; Mishra, Bud] Courant Inst Math Sci, Dept Comp Sci, New York, NY 10012 USA	Icahn School of Medicine at Mount Sinai; New York University	Sundstrom, A (corresponding author), Icahn Sch Med Mt Sinai, Dept Pharmacol & Syst Therapeut, New York, NY 10029 USA.; Sundstrom, A (corresponding author), Courant Inst Math Sci, Dept Comp Sci, New York, NY 10012 USA.	andrew.sundstrom@mssm.edu	Sundstrom, Andrew/AAI-3621-2021	Sundstrom, Andrew/0000-0002-3378-4513; Bar-Sagi, Dafna/0000-0003-2597-8948	National Science Foundation [DGE-0333389, CNS-0926166]	National Science Foundation(National Science Foundation (NSF))	AS was supported by National Science Foundation - DGE-0333389 - IGERT: Program in Computation - http://www.nsf.gov/. BM was supported by National Science Foundation - CNS-0926166 - Collaborative Research: Next Generation Model Checking and Abstract Interpretation with a Focus on Embedded Control and Systems Biology - http://www.nsf.gov/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andasari V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033726; [Anonymous], 2013, CELL; Bauer AL, 2007, BIOPHYS J, V92, P3105, DOI 10.1529/biophysj.106.101501; Bock M, 2010, B MATH BIOL, V72, P1696, DOI 10.1007/s11538-009-9498-3; Cantor JR, 2012, CANCER DISCOV, pOF1; Chen N, 2007, COMPUT PHYS COMMUN, V176, P670, DOI 10.1016/j.cpc.2007.03.007; Cirri P, 2011, AM J CANCER RES, V1, P482; Cleveland C, 2012, AIP ADV, V2, P1; Dang CV, 2010, CANCER RES, V70, P859, DOI 10.1158/0008-5472.CAN-09-3556; Dang CV, 2009, CELL CYCLE, V8, P3243, DOI 10.4161/cc.8.20.9522; Emily M, 2007, THEOR BIOL MED MODEL, V4, DOI 10.1186/1742-4682-4-37; Gaglio D, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.56; Gatenby RA, 2008, NAT REV CANCER, V8, P56, DOI 10.1038/nrc2255; Giaccia AJ, 2010, CURR TOP MICROBIOL, V345, P31, DOI 10.1007/82_2010_73; Glazier JA, 2007, SINGLE CELL BASED MO, P79, DOI [10.1007/978-3-7643-8123-3_4, DOI 10.1007/978-3-7643-8123-3_4]; GRANER F, 1992, PHYS REV LETT, V69, P2013, DOI 10.1103/PhysRevLett.69.2013; Green DR, 2011, MEANS END APOPTOSIS; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Hatzikirou H, 2008, CURR TOP DEV BIOL, V81, P401, DOI 10.1016/S0070-2153(07)81014-3; Hockel M, 1996, CANCER RES, V56, P4509; Hoppensteadt FC, 2011, COURANT LECT NOTES A, V22; Hu J, 2013, NAT BIOTECHNOL, P1; Jain M, 2012, SCIENCE, V336, P1040, DOI 10.1126/science.1218595; Jamali Y, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012097; Jeon J, 2010, BIOPHYS J, V98, P37, DOI 10.1016/j.bpj.2009.10.002; Jha SK, 2009, LECT N BIOINFORMAT, V5688, P218, DOI 10.1007/978-3-642-03845-7_15; Jones RG, 2009, GENE DEV, V23, P537, DOI 10.1101/gad.1756509; Jose C, 2011, BBA-BIOENERGETICS, V1807, P552, DOI 10.1016/j.bbabio.2010.10.012; LAND AH, 1960, ECONOMETRICA, V28, P497, DOI 10.2307/1910129; Lea A, 2014, P NATL ACAD SCI USA, V111, P12486, DOI 10.1073/pnas.1402012111; Locasale JW, 2012, TRENDS ENDOCRIN MET, V23, P545, DOI 10.1016/j.tem.2012.07.005; Locasale JW, 2010, BMC BIOL, V8, DOI 10.1186/1741-7007-8-88; Lyssiotis CA, 2012, CELL, V151, P1155, DOI 10.1016/j.cell.2012.11.020; Maree AFM, 2007, SINGLE CELL BASED MO, P79; METROPOLIS N, 1949, J AM STAT ASSOC, V44, P335, DOI 10.2307/2280232; Michalewicz Z., 2004, SOLVE IT MODERN HEUR, DOI [DOI 10.1007/978-3-662-07807-5, 10.1007/978-3-662-07807-5]; Miller DM, 2012, CLIN CANCER RES, V18, P5546, DOI 10.1158/1078-0432.CCR-12-0977; Nakajima EC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102452; Navin N, 2010, GENOME RES, V20, P68, DOI 10.1101/gr.099622.109; Osinsky S, 2011, CLIN TRANSL ONCOL, V13, P133, DOI 10.1007/s12094-011-0630-0; Plank MJ, 2012, J R SOC INTERFACE, V9, P2983, DOI 10.1098/rsif.2012.0319; Scianna M, 2016, COMPUT BIOL MED, V76, P94, DOI 10.1016/j.compbiomed.2016.06.027; Sebastian C, 2012, CELL, V151, P1185, DOI 10.1016/j.cell.2012.10.047; SEGEBARTH CM, 1990, MAGN RESON MED, V13, P62, DOI 10.1002/mrm.1910130108; Semenza GL, 2008, J CLIN INVEST, V118, P3835, DOI 10.1172/JCI37373; Simon MC, 2010, DIVERSE EFFECTS HYPO, V345, DOI [10.1007/978-3-642-13329-9, DOI 10.1007/978-3-642-13329-9]; Son SH, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-585; Sonveaux P, 2008, J CLIN INVEST, V118, P3930, DOI 10.1172/JCI36843; SULSKY D, 1984, J THEOR BIOL, V106, P275, DOI 10.1016/0022-5193(84)90031-6; Szabo A, 2013, FRONT ONCOL, V3, DOI 10.3389/fonc.2013.00087; THOMLINSON RH, 1955, BRIT J CANCER, V9, P539, DOI 10.1038/bjc.1955.55; TURING AM, 1952, PHILOS T ROY SOC B, V237, P37, DOI 10.1098/rstb.1952.0012; Umeda T, 2004, J THEOR BIOL, V226, P215, DOI 10.1016/j.jtbi.2003.08.016; Vander Heiden MG, 2013, J CLIN INVEST, V123, P3648, DOI 10.1172/JCI72391; Vaupel P, 2007, CANCER METAST REV, V26, P225, DOI 10.1007/s10555-007-9055-1; Vazquez A, 2010, BMC SYST BIOL, V4, DOI 10.1186/1752-0509-4-58; von Neumann J, 1966, THEORY SELF PRODUCIN; Voss-Bohme A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042852; WARBURG O, 1956, SCIENCE, V123, P309, DOI 10.1126/science.123.3191.309; Warburg O, 1924, BIOCHEM Z, V152, P319; Wise DR, 2010, TRENDS BIOCHEM SCI, V35, P427, DOI 10.1016/j.tibs.2010.05.003; Wise DR, 2008, P NATL ACAD SCI USA, V105, P18782, DOI 10.1073/pnas.0810199105; Xu HN, 2013, SPRINGERPLUS, V2, DOI 10.1186/2193-1801-2-73; Ying HQ, 2012, CELL, V149, P656, DOI 10.1016/j.cell.2012.01.058	65	1	1	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2016	11	12							e0168984	10.1371/journal.pone.0168984	http://dx.doi.org/10.1371/journal.pone.0168984			42	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EG7JB	28030620	gold, Green Submitted, Green Published			2022-12-27	WOS:000391222000095
J	Alford, L; Androdias, A; Franco, T; Pierre, JS; Burel, F; van Baaren, J				Alford, Lucy; Androdias, Annabelle; Franco, Thomas; Pierre, Jean-Sebastien; Burel, Francoise; van Baaren, Joan			Potential Host Manipulation by the Aphid Parasitoid Aphidius avenae to Enhance Cold Tolerance	PLoS One			English	Article							RUSSIAN WHEAT APHID; BEHAVIORAL THERMOREGULATION; THERMAL TOLERANCE; ALARM PHEROMONE; MYZUS-PERSICAE; PEA APHIDS; HYMENOPTERA; STRATEGIES; TEMPERATURES; HARDINESS	During parasitoid development, the immature parasitoid is confined to the host species. As a result, any potential to modify the physiology or behaviour of the host could play an important role in parasitoid fitness. The potential for host manipulation by the aphid parasitoid Aphidius avenae to increase cold thermotolerance was investigated using the aphid host species Metopolophium dirhodum and Sitobion avenae. Aphids were parasitized at L3/L4 instar stage (5 d old) and allowed to develop into pre-reproductive adults (10 d old) containing a 5 d old parasitoid larva. A control group was created of non-parasitized pre-reproductive adults (10 d old). The inherent physiological thermotolerance (LT50) and potential behavioural thermoregulation (behaviour in a declining temperature regime) of parasitized and non-parasitized aphids were investigated. Results revealed no effect of parasitism on the physiological thermotolerance of S. avenae and M. dirhodum. Significant differences in the behaviour of parasitized and non-parasitized aphids were observed, in addition to differences between host species, and such behaviours are discussed in view of the potential for host manipulation.	[Alford, Lucy; Androdias, Annabelle; Franco, Thomas; Pierre, Jean-Sebastien; Burel, Francoise; van Baaren, Joan] Univ Rennes 1, UMR 6553, ECOBIO, Ave Gen Leclerc, Rennes, France; [Alford, Lucy] Univ Glasgow, Coll Med Vet & Life Sci, Inst Mol Cell & Syst Biol, Davidson Bldg, Glasgow, Lanark, Scotland	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); Universite de Rennes; University of Glasgow	Alford, L (corresponding author), Univ Rennes 1, UMR 6553, ECOBIO, Ave Gen Leclerc, Rennes, France.; Alford, L (corresponding author), Univ Glasgow, Coll Med Vet & Life Sci, Inst Mol Cell & Syst Biol, Davidson Bldg, Glasgow, Lanark, Scotland.	l.alford.02@cantab.net		Alford, Lucy/0000-0002-2967-4274; van baaren, joan/0000-0002-8552-9645	Marie Curie Intra-European Fellowship [FP7-PEOPLE-2012-IEF-326943]	Marie Curie Intra-European Fellowship(European Commission)	This work was funded by a Marie Curie Intra-European Fellowship for the project 'Climland' (FP7-PEOPLE-2012-IEF-326943) awarded to L Alford, F Burel and J van Baaren.	Alford L, 2012, J APPL ENTOMOL, V135, P332, DOI 10.1111/j.1439-0418.2011.01658.x; Alford L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114982; Alford L, 2012, AGR FOREST ENTOMOL, V14, P69, DOI 10.1111/j.1461-9563.2011.00553.x; Alleyne M, 1997, J INSECT PHYSIOL, V43, P407, DOI 10.1016/S0022-1910(96)00086-8; Andrade TO, 2013, ENTOMOL EXP APPL, V147, P167, DOI 10.1111/eea.12055; Bale JS, 2002, PHILOS T R SOC B, V357, P849, DOI 10.1098/rstb.2002.1074; Barton M, 2014, J THERM BIOL, V41, P65, DOI 10.1016/j.jtherbio.2014.02.004; Beckage NE, 2004, ANNU REV ENTOMOL, V49, P299, DOI 10.1146/annurev.ento.49.061802.123324; BRODEUR J, 1992, ECOL ENTOMOL, V17, P97, DOI 10.1111/j.1365-2311.1992.tb01164.x; BRODEUR J, 1989, SCIENCE, V244, P226, DOI 10.1126/science.244.4901.226; BRODEUR J, 1994, ANIM BEHAV, V48, P187, DOI 10.1006/anbe.1994.1225; BUTTS RA, 1992, J ECON ENTOMOL, V85, P1140, DOI 10.1093/jee/85.4.1140; CLEGG JM, 1982, CAN J ZOOL, V60, P2245, DOI 10.1139/z82-289; Colinet H, 2005, ECOL ENTOMOL, V30, P473, DOI 10.1111/j.0307-6946.2005.00716.x; Digilio MC, 2000, J INSECT PHYSIOL, V46, P1041, DOI 10.1016/S0022-1910(99)00216-4; Dixon AFG, 1998, APHID ECOLOGY OPTIMI; EGGLETON P, 1992, PHILOS T R SOC B, V337, P1, DOI 10.1098/rstb.1992.0079; Eoche-Bosy D, 2016, ENTOMOL EXP IN PRESS; Feder ME, 1999, ANNU REV PHYSIOL, V61, P243, DOI 10.1146/annurev.physiol.61.1.243; Godfray H. C. J., 1994, PARASITOIDS BEHAV EV, DOI 10.1515/9780691207025; HANCE T, 1993, CAN J ZOOL, V71, P759, DOI 10.1139/z93-100; HARRINGTON R, 1990, J ANIM ECOL, V59, P1177, DOI 10.2307/5039; HART BL, 1990, NEUROSCI BIOBEHAV R, V14, P273, DOI 10.1016/S0149-7634(05)80038-7; Hazell SP, 2010, J INSECT PHYSIOL, V56, P115, DOI 10.1016/j.jinsphys.2009.08.020; Hazell SP, 2008, PHYSIOL ENTOMOL, V33, P389, DOI 10.1111/j.1365-3032.2008.00637.x; He XZ, 2011, J INSECT BEHAV, V24, P447, DOI 10.1007/s10905-011-9271-y; Hughes GE, 2010, PHYSIOL ENTOMOL, V35, P373, DOI 10.1111/j.1365-3032.2010.00754.x; Hughes GE, 2009, BIOCONTROL, V54, P785, DOI 10.1007/s10526-009-9230-0; Josso C, 2011, NATURWISSENSCHAFTEN, V98, P705, DOI 10.1007/s00114-011-0813-0; KINDLMANN P, 1989, FUNCT ECOL, V3, P531, DOI 10.2307/2389567; Lagos NA, 2001, J THERM BIOL, V26, P133, DOI 10.1016/S0306-4565(00)00033-4; LARSEN KJ, 1994, J INSECT PHYSIOL, V40, P859, DOI 10.1016/0022-1910(94)90019-1; Le Lann C, 2011, PHYSIOL ENTOMOL, V36, P21, DOI 10.1111/j.1365-3032.2010.00758.x; Libersat F, 2009, ANNU REV ENTOMOL, V54, P189, DOI 10.1146/annurev.ento.54.110807.090556; Losey JE, 1998, ECOL ENTOMOL, V23, P53, DOI 10.1046/j.1365-2311.1998.00102.x; Ma G, 2012, J INSECT PHYSIOL, V58, P1456, DOI 10.1016/j.jinsphys.2012.08.012; MCALLISTER MK, 1987, NATURE, V328, P797, DOI 10.1038/328797b0; MONTGOMERY ME, 1977, ENTOMOL EXP APPL, V22, P236, DOI 10.1007/BF00302860; Nowierski RM, 2002, BIOCONTROL, V47, P279, DOI 10.1023/A:1014824725240; Poulin R, 1995, INT J PARASITOL, V25, P1371, DOI 10.1016/0020-7519(95)00100-X; Poulin R, 2010, ADV STUD BEHAV, V41, P151, DOI 10.1016/S0065-3454(10)41005-0; Powell SJ, 2008, ECOL ENTOMOL, V33, P95, DOI 10.1111/j.1365-2311.2007.00947.x; Powell SJ, 2005, J EXP BIOL, V208, P2615, DOI 10.1242/jeb.01685; Powell SJ, 2004, J INSECT PHYSIOL, V50, P277, DOI 10.1016/j.jinsphys.2004.01.003; REITZ SR, 1994, ENTOMOL EXP APPL, V71, P33, DOI 10.1007/BF02380567; Rivers DB, 2000, J INSECT PHYSIOL, V46, P99, DOI 10.1016/S0022-1910(99)00106-7; Seyahooei MA, 2009, OIKOS, V118, P1148, DOI 10.1111/j.1600-0706.2009.17508.x; SHIROTA Y, 1983, ENTOMOL EXP APPL, V34, P27, DOI 10.1007/BF00300896; Sinclair BJ, 2006, PHYSIOL ENTOMOL, V31, P98, DOI 10.1111/j.1365-3032.2005.00481.x; Sinclair BJ, 2015, J THERM BIOL, V53, P180, DOI 10.1016/j.jtherbio.2015.11.003; Sunday JM, 2014, P NATL ACAD SCI USA, V111, P5610, DOI 10.1073/pnas.1316145111; Terblanche JS, 2008, J INSECT PHYSIOL, V54, P114, DOI 10.1016/j.jinsphys.2007.08.007; van Baaren J, 2004, ETHOL ECOL EVOL, V16, P231; Ward D, 1996, ANN ENTOMOL SOC AM, V89, P442, DOI 10.1093/aesa/89.3.442; Worland MR, 2010, J THERM BIOL, V35, P255, DOI 10.1016/j.jtherbio.2010.05.008	55	5	7	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2016	11	12							e0168693	10.1371/journal.pone.0168693	http://dx.doi.org/10.1371/journal.pone.0168693			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI9QH	28006018	Green Accepted, Green Published, gold, Green Submitted			2022-12-27	WOS:000392843200083
J	Baldi, G; Texeira, M; Murray, F; Jobbagy, EG				Baldi, Germaan; Texeira, Marcos; Murray, Francisco; Jobbagy, Esteban G.			Vegetation Productivity in Natural vs. Cultivated Systems along Water Availability Gradients in the Dry Subtropics	PLOS ONE			English	Article							NET PRIMARY PRODUCTION; DECIDUOUS BROADLEAF FOREST; RADIATION-USE EFFICIENCY; GROSS PRIMARY PRODUCTION; LIGHT-USE-EFFICIENCY; RAIN-USE EFFICIENCY; QUANTILE REGRESSION; SEASONAL-VARIATION; LAND-USE; MODIS	The dry subtropics are subject to a rapid expansion of crops and pastures over vast areas of natural woodlands and savannas. In this paper, we explored the effect of this transformation on vegetation productivity (magnitude, and seasonal and long-term variability) along aridity gradients which span from semiarid to subhumid conditions, considering exclusively those areas with summer rains (>66%). Vegetation productivity was characterized with the proxy metric "Enhanced Vegetation Index" (EVI) (2000 to 2012 period), on 6186 natural and cultivated sampling points on five continents, and combined with a global climatology database by means of additive models for quantile regressions. Globally and regionally, cultivation amplified the seasonal and inter-annual variability of EVI without affecting its magnitude. Natural and cultivated systems maintained a similar and continuous increase of EVI with increasing water availability, yet achieved through contrasting ways. In natural systems, the productivity peak and the growing season length displayed concurrent steady increases with water availability, while in cultivated systems the productivity peak increased from semiarid to dry-subhumid conditions, and stabilized thereafter giving place to an increase in the growing season length towards wetter conditions. Our results help to understand and predict the ecological impacts of deforestation on vegetation productivity, a key ecosystem process linked to a broad range of services.	[Baldi, Germaan; Murray, Francisco; Jobbagy, Esteban G.] Univ Nacl San Luis, IMASL, Grp Estudios Ambientales, San Luis, Argentina; [Baldi, Germaan; Murray, Francisco; Jobbagy, Esteban G.] Consejo Nacl Invest Cient & Tecn, San Luis, Argentina; [Texeira, Marcos] Univ Buenos Aires, IFEVA, Lab Anal Reg & Teledetecc, Buenos Aires, DF, Argentina; [Texeira, Marcos] Consejo Nacl Invest Cient & Tecn, Buenos Aires, DF, Argentina; [Texeira, Marcos] Univ Buenos Aires, Fac Agron, Dept Metodos Cuantitat & Sistemas Informac, Buenos Aires, DF, Argentina; [Murray, Francisco] Inst Nacl Tecnol Agr, AER San Luis, San Luis, Argentina	Universidad Nacional de San Luis; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); University of Buenos Aires; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); University of Buenos Aires; Instituto Nacional de Tecnologia Agropecuaria (INTA)	Baldi, G (corresponding author), Univ Nacl San Luis, IMASL, Grp Estudios Ambientales, San Luis, Argentina.; Baldi, G (corresponding author), Consejo Nacl Invest Cient & Tecn, San Luis, Argentina.	baldi@unsl.edu.ar	Jobbágy, Esteban Gabriel/A-6293-2010	Jobbágy, Esteban Gabriel/0000-0002-4214-6011; Texeira, Marcos/0000-0002-6355-5113	Inter-American Institute for Global Change Research [CRN 3095]; US National Science Foundation [GEO-1128040)]; Agencia Nacional de Promocion Cientifica y Tecnologica [PICT-2013-2973]; Directorate For Geosciences [1459322] Funding Source: National Science Foundation; ICER [1128040] Funding Source: National Science Foundation	Inter-American Institute for Global Change Research; US National Science Foundation(National Science Foundation (NSF)); Agencia Nacional de Promocion Cientifica y Tecnologica(ANPCyT); Directorate For Geosciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO)); ICER(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO))	This work was funded by grants from the Inter-American Institute for Global Change Research (http://www.iai.int, IAI) CRN 3095, supported by the US National Science Foundation (Grant GEO-1128040) [GB EGJ], and the Agencia Nacional de Promocion Cientifica y Tecnologica (http://www.agencia.mincyt.gob.ar) PICT-2013-2973 [GB]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen R.G., 2004, CROP EVAPOTRANSPIRAT; [Anonymous], 2006, CROPPING PATTERN AGR; Bai YF, 2008, ECOLOGY, V89, P2140, DOI 10.1890/07-0992.1; Baldi G, 2012, J ARID ENVIRON, V76, P115, DOI 10.1016/j.jaridenv.2011.08.016; Baldi G, 2015, J ARID ENVIRON, V123, P47, DOI 10.1016/j.jaridenv.2014.05.027; Boling A, 2004, FIELD CROP RES, V90, P351, DOI 10.1016/j.fcr.2004.04.005; Cade BS, 2003, FRONT ECOL ENVIRON, V1, P412, DOI 10.1890/1540-9295(2003)001[0412:AGITQR]2.0.CO;2; Canadell J, 1996, OECOLOGIA, V108, P583, DOI 10.1007/BF00329030; Chidumayo EN, 2002, J BIOGEOGR, V29, P1619, DOI 10.1046/j.1365-2699.2002.00794.x; Christian B, 2015, AGR FOREST METEOROL, V214, P91, DOI 10.1016/j.agrformet.2015.08.246; CROWLEY PH, 1992, ANNU REV ECOL SYST, V23, P405, DOI 10.1146/annurev.es.23.110192.002201; De La Maza M, 2009, GLOBAL CHANGE BIOL, V15, P1116, DOI 10.1111/j.1365-2486.2008.01796.x; Del Grosso S, 2008, ECOLOGY, V89, P2117, DOI 10.1890/07-0850.1; Eklundh L., 2011, TIMESAT 3 1 SOFTWARE; FAO, 1997, 1990 RES NAT CENS AG; FIELD CB, 1995, REMOTE SENS ENVIRON, V51, P74, DOI 10.1016/0034-4257(94)00066-V; Gadgil Madhav, 2013, THIS FISSURED LAND E; GAMON JA, 1992, REMOTE SENS ENVIRON, V41, P35, DOI 10.1016/0034-4257(92)90059-S; Gao X, 2000, REMOTE SENS ENVIRON, V74, P609, DOI 10.1016/S0034-4257(00)00150-4; Garbulsky MF, 2008, GLOBAL CHANGE BIOL, V14, P2860, DOI 10.1111/j.1365-2486.2008.01684.x; Garbulsky MF, 2011, REMOTE SENS ENVIRON, V115, P281, DOI 10.1016/j.rse.2010.08.023; Garbulsky MF, 2010, GLOBAL ECOL BIOGEOGR, V19, P253, DOI 10.1111/j.1466-8238.2009.00504.x; Gilmanov TG, 2010, RANGELAND ECOL MANAG, V63, P16, DOI 10.2111/REM-D-09-00072.1; Guerschman JP, 2003, ECOL APPL, V13, P616, DOI 10.1890/1051-0761(2003)013[0616:LUIOTN]2.0.CO;2; Hotelling H, 1939, AM J MATH, V61, P440, DOI 10.2307/2371512; Houspanossian J, 2016, J LAND USE SCI; Huete A, 2002, REMOTE SENS ENVIRON, V83, P195, DOI 10.1016/S0034-4257(02)00096-2; Huete A, 2011, REMOTE SENS DIGIT IM, V11, P579, DOI 10.1007/978-1-4419-6749-7_26; Huete AR, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2005GL025583; Huston MA, 2012, ECOL MONOGR, V82, P277, DOI 10.1890/11-1927.1; Huxman TE, 2004, NATURE, V429, P651, DOI 10.1038/nature02561; Gasparri NI, 2016, CONSERV LETT, V9, P21, DOI 10.1111/conl.12173; Ise T, 2010, J GEOPHYS RES-BIOGEO, V115, DOI 10.1029/2010JG001326; Jobbagy EG, 2002, ECOLOGY, V83, P307, DOI 10.1890/0012-9658(2002)083[0307:PACOPP]2.0.CO;2; Jonsson P, 2004, COMPUT GEOSCI-UK, V30, P833, DOI 10.1016/j.cageo.2004.05.006; Knapp AK, 2001, SCIENCE, V291, P481, DOI 10.1126/science.291.5503.481; Koenker R, 2011, BRAZ J PROBAB STAT, V25, P239, DOI 10.1214/10-BJPS131; Lambers H., 2008, PLANT PHYSL ECOLOGY, DOI DOI 10.1007/978-0-387-78341-3_9; Lobell DB, 2010, FIELD CROP RES, V118, P13, DOI 10.1016/j.fcr.2010.03.013; Ma XL, 2014, REMOTE SENS ENVIRON, V154, P253, DOI 10.1016/j.rse.2014.08.025; MDA Federal, 2004, LANDS GEOCOVER 2000; Millennium Ecosystem Assessment, 2005, CURR STAT TRENDS ASS; Monger C, 2015, FRONT ECOL ENVIRON, V13, P13, DOI 10.1890/140269; MONTEITH JL, 1977, PHILOS T ROY SOC B, V281, P277, DOI 10.1098/rstb.1977.0140; MONTEITH JL, 1972, J APPL ECOL, V9, P747, DOI 10.2307/2401901; Murray F, 2016, AGR SYST, V149, P20, DOI 10.1016/j.agsy.2016.08.004; New M, 2002, CLIMATE RES, V21, P1, DOI 10.3354/cr021001; NICHOLSON SE, 1994, REMOTE SENS ENVIRON, V50, P107, DOI 10.1016/0034-4257(94)90038-8; Ospina S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035555; Paruelo JM, 2001, ECOSYSTEMS, V4, P683, DOI 10.1007/s10021-001-0037-9; Paruelo JM, 1998, J BIOGEOGR, V25, P721, DOI 10.1046/j.1365-2699.1998.2540721.x; Pettorelli N, 2011, CLIM RES, V46, P15, DOI 10.3354/cr00936; Pineiro G, 2006, ECOSYSTEMS, V9, P357, DOI 10.1007/s10021-005-0013-x; Rahman AF, 2004, GEOPHYS RES LETT, V31, DOI 10.1029/2004GL019778; Redo D, 2011, LAND USE POLICY, V28, P227, DOI 10.1016/j.landusepol.2010.06.004; Running SW, 2004, BIOSCIENCE, V54, P547, DOI 10.1641/0006-3568(2004)054[0547:ACSMOG]2.0.CO;2; Ruppert JC, 2012, J VEG SCI, V23, P1035, DOI 10.1111/j.1654-1103.2012.01420.x; SALA OE, 1988, ECOLOGY, V69, P40, DOI 10.2307/1943158; Scanlon BR, 2006, HYDROL PROCESS, V20, P3335, DOI 10.1002/hyp.6335; Schenk HJ, 2002, ECOL MONOGR, V72, P311, DOI 10.1890/0012-9615(2002)072[0311:TGBOR]2.0.CO;2; Seabrook L, 2006, LANDSCAPE URBAN PLAN, V78, P373, DOI 10.1016/j.landurbplan.2005.11.007; Shi H, 2014, ENVIRON RES LETT, V9, DOI 10.1088/1748-9326/9/10/104002; Sims DA, 2006, J GEOPHYS RES-BIOGEO, V111, DOI 10.1029/2006JG000162; Snyman HA, 1998, J ARID ENVIRON, V39, P645, DOI 10.1006/jare.1998.0387; Thomas GA, 2007, AUST J EXP AGR, V47, P887, DOI 10.1071/EA06204; Tsubo M, 2005, THEOR APPL CLIMATOL, V80, P17, DOI 10.1007/s00704-004-0080-5; Turner DP, 2003, GLOBAL CHANGE BIOL, V9, P383, DOI 10.1046/j.1365-2486.2003.00573.x; Vallejos M, 2015, J ARID ENVIRON, V123, P3, DOI 10.1016/j.jaridenv.2014.11.009; Veron SR, 2002, ECOSYSTEMS, V5, P625, DOI 10.1007/s10021-002-0145-1; Volante JN, 2012, AGR ECOSYST ENVIRON, V154, P12, DOI 10.1016/j.agee.2011.08.012; WEBB W, 1978, ECOLOGY, V59, P1239, DOI 10.2307/1938237; Wichelns D, 2004, J SUSTAIN AGR, V23, P67, DOI 10.1300/J064v23n03_07; Wood S, 2017, GEN ADDITIVE MODELS, DOI 10.1201/9781315370279; Xiao XM, 2004, REMOTE SENS ENVIRON, V91, P256, DOI 10.1016/j.rse.2004.03.010; Xiao XM, 2004, REMOTE SENS ENVIRON, V89, P519, DOI 10.1016/j.rse.2003.11.008; Zhang QY, 2006, REMOTE SENS ENVIRON, V105, P189, DOI 10.1016/j.rse.2006.06.013; Zhang QY, 2015, AGR FOREST METEOROL, V200, P1, DOI 10.1016/j.agrformet.2014.09.003; Zhao MS, 2005, REMOTE SENS ENVIRON, V95, P164, DOI 10.1016/j.rse.2004.12.011	78	4	4	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2016	11	12							e0168168	10.1371/journal.pone.0168168	http://dx.doi.org/10.1371/journal.pone.0168168			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI9QH	28005955	Green Submitted, Green Published, gold			2022-12-27	WOS:000392843200033
J	Short, SM; Morse, TM; McTavish, TS; Shepherd, GM; Verhagen, JV				Short, Shaina M.; Morse, Thomas M.; McTavish, Thomas S.; Shepherd, Gordon M.; Verhagen, Justus V.			Respiration Gates Sensory Input Responses in the Mitral Cell Layer of the Olfactory Bulb	PLOS ONE			English	Article							EXTERNAL TUFTED CELLS; RECEPTOR NEURON INPUT; DEPENDENT MODULATION; ODOR DISCRIMINATION; EVOKED ACTIVITY; INHIBITION; INFORMATION; AWAKE; SNIFF; ORGANIZATION	Respiration plays an essential role in odor processing. Even in the absence of odors, oscillating excitatory and inhibitory activity in the olfactory bulb synchronizes with respiration, commonly resulting in a burst of action potentials in mammalian mitral/tufted cells (MTCs) during the transition from inhalation to exhalation. This excitation is followed by inhibition that quiets MTC activity in both the glomerular and granule cell layers. Odor processing is hypothesized to be modulated by and may even rely on respiration-mediated activity, yet exactly how respiration influences sensory processing by MTCs is still not well understood. By using optogenetics to stimulate discrete sensory inputs in vivo, it was possible to temporally vary the stimulus to occur at unique phases of each respiration. Single unit recordings obtained from the mitral cell layer were used to map spatiotemporal patterns of glomerular evoked responses that were unique to stimulations occurring during periods of inhalation or exhalation. Sensory evoked activity in MTCs was gated to periods outside phasic respiratory mediated firing, causing net shifts in MTC activity across the cycle. In contrast, odor evoked inhibitory responses appear to be permitted throughout the respiratory cycle. Computational models were used to further explore mechanisms of inhibition that can be activated by respiratory activity and influence MTC responses. In silico results indicate that both periglomerular and granule cell inhibition can be activated by respiration to internally gate sensory responses in the olfactory bulb. Both the respiration rate and strength of lateral connectivity influenced inhibitory mechanisms that gate sensory evoked responses.	[Short, Shaina M.; Morse, Thomas M.; McTavish, Thomas S.; Shepherd, Gordon M.; Verhagen, Justus V.] Yale Sch Med, Dept Neurosci, New Haven, CT 06510 USA; [Short, Shaina M.; Verhagen, Justus V.] John B Pierce Lab, New Haven, CT 06519 USA; [Short, Shaina M.] Univ Utah, Dept Neurobiol & Anat, Salt Lake City, UT 84112 USA	Yale University; Yale University; The John B Pierce Laboratory, Inc; Utah System of Higher Education; University of Utah	Short, SM (corresponding author), Yale Sch Med, Dept Neurosci, New Haven, CT 06510 USA.; Short, SM (corresponding author), John B Pierce Lab, New Haven, CT 06519 USA.; Short, SM (corresponding author), Univ Utah, Dept Neurobiol & Anat, Salt Lake City, UT 84112 USA.	shainashort@gmail.com			NIH [R01DC011286, R01DC009994, R01DC014723, R01DC009977, T15LM007056, T32NS007224, RR19895, RR029676-01]; Yale's HPC facilities; National Science Foundation; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC014723, R01DC009977] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Yale's HPC facilities; National Science Foundation(National Science Foundation (NSF)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This work was funded by NIH grants: R01DC011286, R01DC009994 and R01DC014723 to Dr. Justus V. Verhagen, R01DC009977 to Dr. Gordon M. Shepherd, and departmental training awards T15LM007056 to Dr. Thomas S. McTavish and T32NS007224 to Dr. Shaina M. Short. This work was also supported by Yale's HPC facilities operated by the Yale Center for Research Computing and Yale's W.M. Keck Biotechnology Laboratory, funded by NIH grants: RR19895 and RR029676-01. We are grateful for the Neuroscience Gateway (NSG) Portal supported by the National Science Foundation.	Abraham NM, 2010, NEURON, V65, P399, DOI 10.1016/j.neuron.2010.01.009; ADRIAN ED, 1950, ELECTROEN CLIN NEURO, V2, P377, DOI 10.1016/0013-4694(50)90075-7; Balu R, 2004, J NEUROPHYSIOL, V92, P743, DOI 10.1152/jn.00016.2004; Banerjee A, 2015, NEURON, V87, P193, DOI 10.1016/j.neuron.2015.06.019; Bazhenov M, 2001, NEURON, V30, P569, DOI 10.1016/S0896-6273(01)00286-0; Bhalla US, 1997, J COMPUT NEUROSCI, V4, P221, DOI 10.1023/A:1008819818970; Briffaud V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043964; Brunert D, 2016, J NEUROSCI, V36, P6820, DOI 10.1523/JNEUROSCI.3667-15.2016; Burton SD, 2014, J PHYSIOL-LONDON, V592, P2097, DOI 10.1113/jphysiol.2013.269886; Carey RM, 2009, J NEUROPHYSIOL, V101, P1073, DOI 10.1152/jn.90902.2008; Cazakoff BN, 2014, NAT NEUROSCI, V17, P569, DOI 10.1038/nn.3669; CHAPUT MA, 1986, PHYSIOL BEHAV, V36, P319, DOI 10.1016/0031-9384(86)90023-5; Connelly T, 2013, J NEUROPHYSIOL, V110, P55, DOI 10.1152/jn.00910.2012; Cury KM, 2010, NEURON, V68, P570, DOI 10.1016/j.neuron.2010.09.040; David F, 2008, J COMPUT NEUROSCI, V25, P25, DOI 10.1007/s10827-007-0063-5; Dhawale AK, 2010, NAT NEUROSCI, V13, P1404, DOI 10.1038/nn.2673; Fukunaga I, 2014, NAT NEUROSCI, V17, P1208, DOI 10.1038/nn.3760; Fukunaga I, 2012, NEURON, V75, P320, DOI 10.1016/j.neuron.2012.05.017; GETCHELL TV, 1975, J PHYSIOL-LONDON, V251, P523, DOI 10.1113/jphysiol.1975.sp011106; Gire DH, 2012, J NEUROSCI, V32, P2964, DOI 10.1523/JNEUROSCI.5580-11.2012; Grosmaitre X, 2007, NAT NEUROSCI, V10, P348, DOI 10.1038/nn1856; Haddad R, 2013, NAT NEUROSCI, V16, P949, DOI 10.1038/nn.3407; Hayar A, 2004, J NEUROSCI, V24, P6676, DOI 10.1523/JNEUROSCI.1367-04.2004; Hayar A, 2004, J NEUROSCI, V24, P1190, DOI 10.1523/JNEUROSCI.4714-03.2004; Hines ML, 2004, J COMPUT NEUROSCI, V17, P7, DOI 10.1023/B:JCNS.0000023869.22017.2e; Hines ML, 2001, NEUROSCIENTIST, V7, P123, DOI 10.1177/107385840100700207; Homma R, 2013, FRONT NEURAL CIRCUIT, V7, DOI 10.3389/fncir.2013.00023; Igarashi KM, 2012, J NEUROSCI, V32, P7970, DOI 10.1523/JNEUROSCI.0154-12.2012; Kato HK, 2013, NEURON, V80, P1218, DOI 10.1016/j.neuron.2013.08.036; Kato HK, 2012, NEURON, V76, P962, DOI 10.1016/j.neuron.2012.09.037; Kay LM, 2006, SEMIN CELL DEV BIOL, V17, P433, DOI 10.1016/j.semcdb.2006.04.012; Kay LM, 2009, TRENDS NEUROSCI, V32, P207, DOI 10.1016/j.tins.2008.11.008; Kay LM, 1999, NAT NEUROSCI, V2, P1003, DOI 10.1038/14801; Kepecs A, 2006, CHEM SENSES, V31, P167, DOI 10.1093/chemsce/bjj016; Kosaka T, 2016, ANAT SCI INT, V91, P115, DOI 10.1007/s12565-015-0309-7; Labarrera C, 2013, J PHYSIOL-LONDON, V591, P1841, DOI 10.1113/jphysiol.2012.241851; Lehmann A, 2016, FRONT NEURAL CIRCUIT, V10, DOI 10.3389/fncir.2016.00015; Li A, 2014, J NEUROSCI, V34, P16058, DOI 10.1523/JNEUROSCI.3382-14.2014; Li GS, 2013, J NEUROSCI, V33, P3037, DOI 10.1523/JNEUROSCI.2831-12.2013; Liu SL, 2016, J NEUROSCI, V36, P9604, DOI 10.1523/JNEUROSCI.1763-16.2016; Liu SL, 2012, J NEUROPHYSIOL, V107, P473, DOI 10.1152/jn.00741.2011; MacLeod K, 1996, SCIENCE, V274, P976, DOI 10.1126/science.274.5289.976; McTavish TS, 2012, FRONT COMPUT NEUROSC, V6, DOI 10.3389/fncom.2012.00003; Nagayama S, 2004, J NEUROPHYSIOL, V91, P2532, DOI 10.1152/jn.01266.2003; ONODA N, 1980, J NEUROPHYSIOL, V44, P29, DOI 10.1152/jn.1980.44.1.29; PAGER J, 1985, BEHAV BRAIN RES, V16, P81, DOI 10.1016/0166-4328(85)90084-1; Phillips ME, 2012, J NEUROSCI, V32, P85, DOI 10.1523/JNEUROSCI.4278-11.2012; PINCHING AJ, 1971, J CELL SCI, V9, P347; Rebello MR, 2014, PLOS BIOL, V12, DOI 10.1371/journal.pbio.1002021; ROSPARS JP, 1994, BRAIN RES, V662, P31, DOI 10.1016/0006-8993(94)90793-5; Schaefer AT, 2006, PLOS BIOL, V4, P1010, DOI 10.1371/journal.pbio.0040163; Schoppa NE, 2006, J NEUROSCI, V26, P12996, DOI 10.1523/JNEUROSCI.3503-06.2006; Shepherd G.M., 2004, SYNAPTIC ORG BRAIN, DOI [DOI 10.1093/ACPROF:OSO/9780195159561.001.1, 10.1093/acprof:oso/9780195159561.001.1]; SHEPHERD GM, 1972, PHYSIOL REV, V52, P864, DOI 10.1152/physrev.1972.52.4.864; Shusterman R, 2011, NAT NEUROSCI, V14, P1039, DOI 10.1038/nn.2877; Sivagnanam S, 2013, CEUR WORKSHOP P, V993; Smear M, 2011, NATURE, V479, P397, DOI 10.1038/nature10521; Spors H, 2006, J NEUROSCI, V26, P1247, DOI 10.1523/JNEUROSCI.3100-05.2006; Stopfer M, 1997, NATURE, V390, P70, DOI 10.1038/36335; Verhagen JV, 2007, NAT NEUROSCI, V10, P631, DOI 10.1038/nn1892; Wachowiak M, 2006, SEMIN CELL DEV BIOL, V17, P411, DOI 10.1016/j.semcdb.2006.04.007; Wachowiak M, 2011, NEURON, V71, P962, DOI 10.1016/j.neuron.2011.08.030; Wesson DW, 2008, PLOS BIOL, V6, P717, DOI 10.1371/journal.pbio.0060082; Wienisch M, 2016, SCI REPORTS, P6; Willhite DC, 2006, P NATL ACAD SCI USA, V103, P12592, DOI 10.1073/pnas.0602032103; Wilson RI, 2005, J NEUROSCI, V25, P9069, DOI 10.1523/JNEUROSCI.2070-05.2005; Young TA, 1999, NEUROSCI LETT, V276, P65, DOI 10.1016/S0304-3940(99)00781-8; Youngstrom IA, 2015, J NEUROSCI, V35, P8758, DOI 10.1523/JNEUROSCI.0311-15.2015; Yu YG, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003014	69	8	9	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2016	11	12							e0168356	10.1371/journal.pone.0168356	http://dx.doi.org/10.1371/journal.pone.0168356			29	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI9QH	28005923	Green Published, Green Submitted, gold			2022-12-27	WOS:000392843200045
J	Alam, MF; Laskar, AA; Maryam, L; Younus, H				Alam, Md. Fazle; Laskar, Amaj Ahmed; Maryam, Lubna; Younus, Hina			Activation of Human Salivary Aldehyde Dehydrogenase by Sulforaphane: Mechanism and Significance	PLOS ONE			English	Article							SERUM-ALBUMIN; GENETIC POLYMORPHISMS; HEALTH-BENEFITS; CANCER-RISK; ALCOHOL; DRINKING; ETHANOL; BINDING; ENZYME; LOMEFLOXACIN	Cruciferous vegetables contain the bio-active compound sulforaphane (SF) which has been reported to protect individuals against various diseases by a number of mechanisms, including activation of the phase Ildetoxification enzymes. In this study, we show that the extracts of five cruciferous vegetables that we commonly consume and SF activate human salivary aldehyde dehydrogenase (hsALDH), which is a very important detoxifying enzyme in the mouth. Maximum activation was observed at 1 lag/m1 of cabbage extract with 2.6 fold increase in the activity. There was a-1.9 fold increase in the activity of hsALDH at SF concentration of > 100 nM. The concentration of SF at half the maximum response (EC50 value) was determined to be 52 2 nM. There was an increase in the Vmaxand a decrease in the Km of the enzyme in the presence of SF. Hence, SF interacts with the enzyme and increases its affinity for the substrate. UV absorbance, fluorescence and CD studies revealed that SF binds to hsALDH and does not disrupt its native structure. SF binds with the enzyme with a binding constant of 1.23 x 107M(-1). There is one binding site on hsALDH for SF, and the thermodynamic parameters indicate the formation of a spontaneous strong complex between the two. Molecular docking analysis depicted that SF fits into the active site of ALDH3A1, and facilitates the catalytic mechanism of the enzyme. SF being an antioxidant, is very likely to protect the catalytic Cys 243 residue from oxidation, which leads to the increase in the catalytic efficiency and hence the activation of the enzyme. Further, hsALDH which is virtually inactive towards acetaldehyde exhibited significant activity towards it in the presence of SF. It is therefore very likely that consumption of large quantities of cruciferous vegetables or SF supplements, through their activating effect on hsALDH can protect individuals who are alcohol intolerant against acetaldehyde toxicity and also lower the risk of oral cancer development.	[Alam, Md. Fazle; Laskar, Amaj Ahmed; Maryam, Lubna; Younus, Hina] Aligarh Muslim Univ, Enzymol Lab, Interdisciplinary Biotechnol Unit, Aligarh, Uttar Pradesh, India	Aligarh Muslim University	Younus, H (corresponding author), Aligarh Muslim Univ, Enzymol Lab, Interdisciplinary Biotechnol Unit, Aligarh, Uttar Pradesh, India.	hyounus.cb@amu.ac.in	Younus, Hina/AAF-3337-2019; Alam, Mohammad Fazle/N-9959-2019	ALAM, MOHAMMAD/0000-0002-3684-2475; Younus, Hina/0000-0003-3066-1312; Laskar, Amaj/0000-0002-5730-7906				Ajmal M, 2015, J HYDRO-ENVIRON RES, V9, P592, DOI 10.1016/j.jher.2014.11.003; Alam MF, 2016, CELL BIOCHEM BIOPHYS, V74, P307, DOI 10.1007/s12013-016-0742-9; Anwar S, 2014, INT J BIOL MACROMOL, V69, P476, DOI 10.1016/j.ijbiomac.2014.06.003; Baan R, 2007, LANCET ONCOL, V8, P292, DOI 10.1016/S1470-2045(07)70099-2; Baig U, 2016, INT J POLYM MAT POLY; Baig U, 2016, J PHOTOCH PHOTOBIO B, V164, P244, DOI 10.1016/j.jphotobiol.2016.09.034; Balbo S, 2012, MUTAGENESIS, V27, P485, DOI 10.1093/mutage/ges008; Boddupalli Sekhar, 2012, Frontiers in Genetics, V3, P7, DOI 10.3389/fgene.2012.00007; Brooks PJ, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000050; Chamani J, 2010, J LUMIN, V130, P1160, DOI 10.1016/j.jlumin.2010.02.014; Chamani J, 2011, J PHARMACEUT BIOMED, V55, P114, DOI 10.1016/j.jpba.2010.12.029; Chaturvedi SK, 2015, MOL BIOSYST, V11, P307, DOI 10.1039/c4mb00548a; Chen CH, 2015, P NATL ACAD SCI USA, V112, P3074, DOI 10.1073/pnas.1414657112; Chen CH, 2014, PHYSIOL REV, V94, P1, DOI 10.1152/physrev.00017.2013; Crabb DW, 2004, P NUTR SOC, V63, P49, DOI 10.1079/PNS2003327; Druesne-Pecollo N, 2009, LANCET ONCOL, V10, P173, DOI 10.1016/S1470-2045(09)70019-1; Elbarbry F, 2011, J MED PLANTS RES, V5, P473; Eng MY, 2007, ALCOHOL RES HEALTH, V30, P22; Fahey JW, 2012, CANCER PREV RES, V5, P179, DOI 10.1158/1940-6207.CAPR-11-0572; Giebultowicz J, 2009, MOLECULES, V14, P2363, DOI 10.3390/molecules14072363; Giebuttowicz J, 2010, ACTA BIOCHIM POL, V57, P361; Greenfield NJ, 2006, NAT PROTOC, V1, P2876, DOI 10.1038/nprot.2006.202; Helminen A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074418; Hempel J, 2001, EUR J BIOCHEM, V268, P722, DOI 10.1046/j.1432-1327.2001.01926.x; Herr I, 2013, WIEN MED WOCHENSCHR, V163, P80, DOI 10.1007/s10354-012-0163-3; IMPRAIM C, 1982, AM J HUM GENET, V34, P837; Kabiri M, 2012, MOLECULES, V17, P3114, DOI 10.3390/molecules17033114; LAKOWICZ JR, 1973, BIOCHEMISTRY-US, V12, P4171, DOI 10.1021/bi00745a021; Laskar AA, 2016, BIOCHIMIE, V127, P205, DOI 10.1016/j.biochi.2016.05.020; Li DW, 2012, HUM GENET, V131, P725, DOI 10.1007/s00439-011-1116-4; Manchali S, 2012, J FUNCT FOODS, V4, P94, DOI 10.1016/j.jff.2011.08.004; Moazzez R, 2011, EUR J ORAL SCI, V119, P441, DOI 10.1111/j.1600-0722.2011.00886.x; Moosavi-Movahedi AA, 2003, J PROTEIN CHEM, V22, P23, DOI 10.1023/A:1023011609931; Moosavi-Movahedi AA, 2003, BIOORGAN MED CHEM, V11, P4303, DOI 10.1016/S0968-0896(03)00524-8; Nienhaus Karin, 2005, V305, P215; Oze I, 2011, JPN J CLIN ONCOL, V41, P677, DOI 10.1093/jjco/hyr026; Pelucchi C, 2008, EUR J CANCER PREV, V17, P340, DOI 10.1097/CEJ.0b013e3282f75e91; Perez-Miller S, 2010, NAT STRUCT MOL BIOL, V17, P159, DOI 10.1038/nsmb.1737; Riedl MA, 2009, CLIN IMMUNOL, V130, P244, DOI 10.1016/j.clim.2008.10.007; Sasaki K, 2012, J CHROMATOGR B, V903, P171, DOI 10.1016/j.jchromb.2012.07.017; Shakir M, 2016, J PHOTOCH PHOTOBIO B, V165, P96, DOI 10.1016/j.jphotobiol.2016.10.006; Sladek NE, 2003, J BIOCHEM MOL TOXIC, V17, P7, DOI 10.1002/jbt.10057; Sreerama L, 1995, CLIN CANCER RES, V1, P1153; Talalay P, 1995, TOXICOL LETT, V82-3, P173, DOI 10.1016/0378-4274(95)03553-2; Tang B, 2016, FOOD CHEM, V212, P434, DOI 10.1016/j.foodchem.2016.06.007; Ushida Y, 2013, ALCOHOL ALCOHOLISM, V48, P526, DOI 10.1093/alcalc/agt063; Vahedian-Movahed H, 2011, J BIOMOL STRUCT DYN, V28, P483, DOI 10.1080/07391102.2011.10508590; Vasiliou V, 2000, PHARMACOLOGY, V61, P192, DOI 10.1159/000028400; Whitmore L, 2008, BIOPOLYMERS, V89, P392, DOI 10.1002/bip.20853; Wierzchowski J, 1997, ANAL BIOCHEM, V245, P69, DOI 10.1006/abio.1996.9921; Yokoyama A, 1998, CARCINOGENESIS, V19, P1383, DOI 10.1093/carcin/19.8.1383; Yokoyama A, 2002, CARCINOGENESIS, V23, P1851, DOI 10.1093/carcin/23.11.1851; Yoshida A, 1998, EUR J BIOCHEM, V251, P549, DOI 10.1046/j.1432-1327.1998.2510549.x; ZHANG YS, 1992, P NATL ACAD SCI USA, V89, P2399, DOI 10.1073/pnas.89.6.2399; Ziyarat FP, 2014, J BIOMOL STRUCT DYN, V32, P613, DOI 10.1080/07391102.2013.785919	55	20	20	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2016	11	12							e0168463	10.1371/journal.pone.0168463	http://dx.doi.org/10.1371/journal.pone.0168463			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI9QF	27997560	Green Submitted, gold, Green Published			2022-12-27	WOS:000392842900048
J	Antonissen, G; Haesendonck, R; Devreese, M; Broekaert, N; Verbrugghe, E; De Saeger, S; Audenaert, K; Haesebrouck, F; Pasmans, F; Ducatelle, R; Croubels, S; Martel, A				Antonissen, Gunther; Haesendonck, Roel; Devreese, Mathias; Broekaert, Nathan; Verbrugghe, Elin; De Saeger, Sarah; Audenaert, Kris; Haesebrouck, Freddy; Pasmans, Frank; Ducatelle, Richard; Croubels, Siska; Martel, An			The Impact of Deoxynivalenol on Pigeon Health: Occurrence in Feed, Toxicokinetics and Interaction with Salmonellosis	PLOS ONE			English	Article							T-2 TOXIN; ORAL BIOAVAILABILITY; MYCOTOXINS; TYPHIMURIUM; TOXICITY; FOOD; FUMONISINS; RESISTANCE; TOXICOLOGY; INFECTION	Seed-based pigeon diets could be expected to result in exposure of pigeons to mycotoxins such as deoxynivalenol (DON). Ingestion of low to moderate contamination levels of DON may impair intestinal health, immune function and/or pathogen fitness, resulting in altered host-pathogen interactions and thus different outcome of infections. Here we demonstrate that DON was one of the most frequently detected mycotoxins in seed-based racing pigeons feed, contaminating 5 out of 10 samples (range 177-1,466 mu g/kg). Subsequently, a toxicokinetic analysis revealed a low absolute oral bioavailability (F) of DON in pigeons (30.4%), which is comparable to other avian species. Furthermore, semi-quantitative analysis using high-resolution mass spectrometry revealed that DON-3 alpha-sulphate is the major metabolite of DON in pigeons after intravenous as well as oral administration. Following ingestion of DON contaminated feed, the intestinal epithelial cells are exposed to significant DON concentrations which eventually may affect intestinal translocation and colonization of bacteria. Feeding pigeons a DON contaminated diet resulted in an increased percentage of pigeons shedding Salmonella compared to birds fed control diet, 87 +/- 17% versus 74 +/- 13%, respectively. However, no impact of DON was observed on the Salmonella induced disease signs, organ lesions, faecal and organ Salmonella counts. The presented risk assessment indicates that pigeons are frequently exposed to mycotoxins such as DON, which can affect the outcome of a Salmonella infection. The increasing number of pigeons shedding Salmonella suggests that DON can promote the spread of the bacterium within pigeon populations.	[Antonissen, Gunther; Devreese, Mathias; Broekaert, Nathan; Croubels, Siska] Univ Ghent, Fac Vet Med, Dept Pharmacol Toxicol & Biochem, Merelbeke, Belgium; [Antonissen, Gunther; Haesendonck, Roel; Verbrugghe, Elin; Haesebrouck, Freddy; Pasmans, Frank; Ducatelle, Richard; Martel, An] Univ Ghent, Fac Vet Med, Dept Pathol Bacteriol & Avian Dis, Merelbeke, Belgium; [De Saeger, Sarah] Univ Ghent, Fac Pharmaceut Sci, Dept Bioanal, Ghent, Belgium; [Audenaert, Kris] Univ Ghent, Fac Biosci Engn, Dept Appl Biosci, Ghent, Belgium	Ghent University; Ghent University; Ghent University; Ghent University	Antonissen, G (corresponding author), Univ Ghent, Fac Vet Med, Dept Pharmacol Toxicol & Biochem, Merelbeke, Belgium.; Antonissen, G (corresponding author), Univ Ghent, Fac Vet Med, Dept Pathol Bacteriol & Avian Dis, Merelbeke, Belgium.	Gunther.Antonissen@UGent.be	Haesebrouck, Freddy/M-3857-2014; Pasmans, Frank/D-3667-2014	Haesebrouck, Freddy/0000-0002-1709-933X; Croubels, Siska/0000-0001-6357-3517; Antonissen, Gunther/0000-0001-8832-1498	Biomin GmbH (Herzogenburg, Austria); Special Research Fund of Ghent University, Belgium (BOF) [01D20312]	Biomin GmbH (Herzogenburg, Austria); Special Research Fund of Ghent University, Belgium (BOF)	G. Antonissen is supported by a postdoctoral fellowship from Biomin GmbH (Herzogenburg, Austria). R. Haesendonck is supported by the Special Research Fund of Ghent University, Belgium (BOF Grant 01D20312). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alassane-Kpembi I, 2013, TOXICOL APPL PHARM, V272, P191, DOI 10.1016/j.taap.2013.05.023; Alexander J, 2011, EFSA J, V9, DOI 10.2903/j.efsa.2011.2407; Antonissen G, 2015, J AGR FOOD CHEM, V63, P10846, DOI 10.1021/acs.jafc.5b04119; Antonissen G, 2015, VET RES, V46, DOI 10.1186/s13567-015-0234-8; Antonissen G, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108775; Antonissen G, 2014, TOXINS, V6, P430, DOI 10.3390/toxins6020430; Bottalico A., 1998, Journal of Plant Pathology, V80, P85; Bouhet S, 2005, VET IMMUNOL IMMUNOP, V108, P199, DOI 10.1016/j.vetimm.2005.08.010; Broekaert N, 2014, J CHROMATOGR B, V971, P43, DOI 10.1016/j.jchromb.2014.09.012; Broekaert N, 2015, J AGR FOOD CHEM, V63, P8734, DOI 10.1021/acs.jafc.5b03270; Burel C, 2013, TOXINS, V5, P841, DOI 10.3390/toxins5040841; Clarke R, 2014, TOXICON, V90, P70, DOI 10.1016/j.toxicon.2014.07.019; CUNDLIFFE E, 1974, P NATL ACAD SCI USA, V71, P30, DOI 10.1073/pnas.71.1.30; Devreese M, 2015, WORLD MYCOTOXIN J, V8, P533, DOI 10.3920/WMJ2014.1843; FADDOUL GP, 1965, AVIAN DIS, V9, P377, DOI 10.2307/1588367; Maresca M, 2013, TOXINS, V5, P784, DOI 10.3390/toxins5040784; Monbaliu S, 2010, J AGR FOOD CHEM, V58, P66, DOI 10.1021/jf903859z; Osselaere A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069014; Osselaere A, 2013, FOOD CHEM TOXICOL, V51, P350, DOI 10.1016/j.fct.2012.10.006; Ostry V, 2008, WORLD MYCOTOXIN J, V1, P175, DOI 10.3920/WMJ2008.x013; Oswald IP, 2005, FOOD ADDIT CONTAM A, V22, P354, DOI 10.1080/02652030500058320; Pasmans F, 2003, INFECT IMMUN, V71, P6068, DOI 10.1128/IAI.71.10.6068-6074.2003; Pasmans F, 2008, ANTIMICROB AGENTS CH, V52, P954, DOI 10.1128/AAC.00575-07; Pestka JJ, 2007, ANIM FEED SCI TECH, V137, P283, DOI 10.1016/j.anifeedsci.2007.06.006; Pestka JJ, 2005, J TOXICOL ENV HEAL B, V8, P39, DOI 10.1080/10937400590889458; Rotter BA, 1996, J TOXICOL ENV HEALTH, V48, P1, DOI 10.1080/009841096161447; Schatzmayr G, 2013, WORLD MYCOTOXIN J, V6, P213, DOI 10.3920/WMJ2013.1572; Streit E, 2013, J SCI FOOD AGR, V93, P2892, DOI 10.1002/jsfa.6225; Streit E, 2012, TOXINS, V4, P788, DOI 10.3390/toxins4100788; TAI JH, 1990, MYCOPATHOLOGIA, V109, P149, DOI 10.1007/BF00436803; TAI JH, 1988, FOOD CHEM TOXICOL, V26, P691, DOI 10.1016/0278-6915(88)90068-3; THOMPSON WL, 1986, TOXICON, V24, P985, DOI 10.1016/0041-0101(86)90004-8; Vandenbroucke V, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023871; Vandenbroucke V, 2009, VET RES, V40, DOI 10.1051/vetres/2009045; Verbrugghe E, 2012, VET RES, V43, P1; VIDAL D, 1989, INFECT IMMUN, V57, P2260, DOI 10.1128/IAI.57.7.2260-2264.1989; Wan D, 2014, J AGR FOOD CHEM, V62, P288, DOI 10.1021/jf4047946; Widestrand J, 2001, FOOD ADDIT CONTAM, V18, P987, DOI 10.1080/02652030110050168; Wu F, 2014, ANNU REV FOOD SCI T, V5, P351, DOI 10.1146/annurev-food-030713-092431; ZIPRIN RL, 1990, AM J VET RES, V51, P1869	40	7	7	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2016	11	12							e0168205	10.1371/journal.pone.0168205	http://dx.doi.org/10.1371/journal.pone.0168205			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI9QF	27997572	Green Published, Green Submitted, gold			2022-12-27	WOS:000392842900026
J	Aydos, A; Gurel, A; Islakoglu, YO; Noyan, S; Gokce, B; Ecemis, T; Kaya, C; Aksu, AT; Dedeoglu, BG				Aydos, Alp; Gurel, Aykut; Islakoglu, Yasemin Oztemur; Noyan, Senem; Gokce, Bagdagul; Ecemis, Tolga; Kaya, Cemil; Aksu, Arif Tarik; Dedeoglu, Bala Gur			Identification of Polycystic Ovary Syndrome (PCOS) Specific Genes in Cumulus and Mural Granulosa Cells	PLOS ONE			English	Article							INSULIN-RESISTANCE; ENRICHMENT ANALYSIS; MEIOTIC RESUMPTION; EXPRESSION; UPDATE; POLYMORPHISM; ACTIVATION; MECHANISMS; COMPONENTS; PATHWAY	Polycystic ovary syndrome (PCOS) is a metabolic and endocrine disorder which affects women of reproductive age with prevalence of 8-18%. The oocyte within the follicle is surrounded by cumulus cells (CCs), which connect with mural granulosa cells (MGCs) that are responsible for secreting steroid hormones. The main aim of this study is comparing gene expression profiles of MGCs and CCs in PCOS and control samples to identify PCOS-specific differentially expressed genes (DEGs). In this study, two microarray databases were searched for mRNA expression microarray studies performed with CCs and MGCs obtained from PCOS patients and control samples. Three independent studies were selected to be integrated with naive meta-analysis since raw meta-data from these studies were found to be highly correlated. DEGs in these somatic cells were identified for PCOS and control groups. This study enabled us to reveal dysregulation in MAPK (mitogen activated protein kinase), insulin and Wnt signaling pathways between CCs and MGCs in PCOS. The meta analysis results together with qRT-PCR validations provide evidence that molecular signaling is dysregulated through MGCs and CCs in PCOS, which is important for follicle and oocyte maturation and may contribute to the pathogenesis of the syndrome.	[Aydos, Alp; Islakoglu, Yasemin Oztemur; Noyan, Senem; Dedeoglu, Bala Gur] Ankara Univ, Inst Biotechnol, Ankara, Turkey; [Gurel, Aykut] HRS Women Hosp, Test Tube Babies Unit, Ankara, Turkey; [Gokce, Bagdagul] Medicana Int Ankara Hosp, Test Tube Babies Unit, Ankara, Turkey; [Ecemis, Tolga] Liv Hosp, Dept Gynecol & Obstet, Ankara, Turkey; [Kaya, Cemil] TOBB ETU Hosp, Dept Gynecol & Obstet, Ankara, Turkey; [Aksu, Arif Tarik] HRS Women Hosp, Dept Gynecol & Obstet, Ankara, Turkey	Ankara University; HRS Kadin Hospital; Medicana Hospital; Ankara Liv Hospital; TOBB Ekonomi ve Teknoloji University; HRS Kadin Hospital	Dedeoglu, BG (corresponding author), Ankara Univ, Inst Biotechnol, Ankara, Turkey.	gurbala@yahoo.com	Dedeoglu, Bala Gur/ABC-2436-2020; Aydos, Alp/AAH-5316-2020; Dedeoglu, Bala Gur/O-1604-2014; ıslakoglu, yasemin oztemur/AAY-7401-2020; Noyan, Senem/AAA-8541-2020	Dedeoglu, Bala Gur/0000-0002-4320-5685; Aydos, Alp/0000-0002-8670-3393; Dedeoglu, Bala Gur/0000-0002-4320-5685; ıslakoglu, yasemin oztemur/0000-0001-7792-7777; Noyan, Senem/0000-0001-6455-3702	Medicana International Hospital; HRS Women Hospital; Liv Hospital; TOBB ETU Hospital	Medicana International Hospital; HRS Women Hospital; Liv Hospital; TOBB ETU Hospital(TOBB Ekonomi ve Teknoloji University)	The Medicana International Hospital provided support in the form of salaries for the author [BG], HRS Women Hospital provided support in the form of salaries for the authors [AG], [ATA], Liv Hospital provided support in the form of salaries for the author [TE], TOBB ETU Hospital provided support in the form of salaries for the author [CK] but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Campain A, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-408; Carmona-Saez P, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-1-r3; Corbould A, 2005, AM J PHYSIOL-ENDOC M, V288, pE1047, DOI 10.1152/ajpendo.00361.2004; Diamanti-Kandarakis E, 2012, ENDOCR REV, V33, P981, DOI 10.1210/er.2011-1034; Dumesic DA, 2008, OBSTET GYNECOL SURV, V63, P39, DOI 10.1097/OGX.0b013e31815e85fc; Dunaif A, 1997, ENDOCR REV, V18, P774, DOI 10.1210/er.18.6.774; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Eijssen LMT, 2013, NUCLEIC ACIDS RES, V41, pW71, DOI 10.1093/nar/gkt293; Feng C, 2015, INT J MOL SCI, V16, P2403, DOI 10.3390/ijms16022403; Fragouli E, 2014, HUM REPROD UPDATE, V20, P1, DOI 10.1093/humupd/dmt044; FRANKS S, 1995, NEW ENGL J MED, V333, P853, DOI 10.1056/NEJM199509283331307; Gambineri A, 2002, INT J OBESITY, V26, P883, DOI 10.1038/sj.ijo.0801994; Gangopadhyay S, 2016, BIOCHEM GENET, V54, P158, DOI 10.1007/s10528-015-9708-7; Grondahl ML, 2012, MOL HUM REPROD, V18, P572, DOI 10.1093/molehr/gas035; Hsieh M, 2002, ENDOCRINOLOGY, V143, P898, DOI 10.1210/en.143.3.898; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Kaur S, 2012, J CLIN ENDOCR METAB, V97, pE2016, DOI 10.1210/jc.2011-3441; Kawamura K, 2011, HUM REPROD, V26, P3094, DOI 10.1093/humrep/der282; Kenigsberg S, 2009, MOL HUM REPROD, V15, P89, DOI 10.1093/molehr/gan082; Lesoine B, 2016, INT J ENDOCRINOL, V2016, DOI 10.1155/2016/4378507; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; MacDonald BT, 2009, DEV CELL, V17, P9, DOI 10.1016/j.devcel.2009.06.016; Muasher SJ, 2006, FERTIL STERIL, V86, P267, DOI 10.1016/j.fertnstert.2005.09.067; Nelson-Degrave VL, 2005, MOL ENDOCRINOL, V19, P379, DOI 10.1210/me.2004-0178; Nogales-Cadenas R, 2009, NUCLEIC ACIDS RES, V37, pW317, DOI 10.1093/nar/gkp416; Oliveros J.C., 2007, VENNY INTERACTIVE TO; Purcell SH, 2012, ENDOCRINOLOGY, V153, P2444, DOI 10.1210/en.2011-1974; Raja-Khan N, 2014, REPROD SCI, V21, P20, DOI 10.1177/1933719113485294; Ricken A, 2002, ENDOCRINOLOGY, V143, P2741, DOI 10.1210/en.143.7.2741; Rustici G, 2013, NUCLEIC ACIDS RES, V41, pD987, DOI 10.1093/nar/gks1174; Sharma SC, 2000, J BIOL CHEM, V275, P33718, DOI 10.1074/jbc.M003555200; Simon R, 2007, CANCER INFORM, V3, P11; Su YQ, 2003, DEV BIOL, V263, P126, DOI 10.1016/S0012-1606(03)00437-8; Tabas-Madrid D, 2012, NUCLEIC ACIDS RES, V40, pW478, DOI 10.1093/nar/gks402; Wang HX, 2009, MOL HUM REPROD, V15, P11, DOI 10.1093/molehr/gan070; Wang J, 2013, NUCLEIC ACIDS RES, V41, pW77, DOI 10.1093/nar/gkt439; Wood JR, 2004, J REPROD IMMUNOL, V63, P51, DOI 10.1016/j.jri.2004.01.010; Wright GW, 2003, BIOINFORMATICS, V19, P2448, DOI 10.1093/bioinformatics/btg345; Yamashita Y, 2009, J OVARIAN RES, V2, DOI 10.1186/1757-2215-2-20; Yang ZZ, 2014, BMC MED GENET, V15, DOI 10.1186/1471-2350-15-80; Zhang MJ, 2009, MOL HUM REPROD, V15, P399, DOI 10.1093/molehr/gap031	41	21	24	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2016	11	12							e0168875	10.1371/journal.pone.0168875	http://dx.doi.org/10.1371/journal.pone.0168875			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI9QF	27997581	Green Published, Green Submitted, gold			2022-12-27	WOS:000392842900080
J	Boer, S; Unal, S; van Wouwe, JP; van Dommelen, P				Boer, Suzanne; Unal, Sevim; van Wouwe, Jacobus P.; van Dommelen, Paula			Evidence Based Weighing Policy during the First Week to Prevent Neonatal Hypernatremic Dehydration while Breastfeeding	PLOS ONE			English	Article							FED INFANTS	Background Neonatal hypernatremic dehydration is prevented by daily neonatal weight monitoring. We aim to provide evidence-based support of this universally promoted weighing policy and to establish the most crucial days of weighing. Methods Weight measurements of 2,359 healthy newborns and of 271 newborns with clinical hypernatremic dehydration were used within the first seven days of life to simulate various weighting policies to prevent hypernatremic dehydration; its sensitivity, specificity and positive predictive value (PPV) of these policies were calculated. Various referral criteria were also evaluated. Results A policy of daily weighing with a cut-off value of -2.5 Standard Deviation Score (SDS) on the growth chart for weight loss, had a 97.6% sensitivity, 97.6% specificity and a PPV of 2.80%. Weighing at birth and only at days two, four and seven with the same -2.5 SDS cut-off, resulted in 97.3% sensitivity, 98.5% specificity and a PPV of 4.43%. Conclusion A weighing policy with measurements restricted to birth and day two, four and seven applying the -2.5 SDS cut-off seems an optimal policy to detect hypernatremic dehydration. Therefore we recommend to preferably weigh newborns at least on day two (i.e. -48h), four and seven, and refer them to clinical pediatric care if their weight loss increases below -2.5 SDS. We also suggest lactation support for the mother, full clinical assessment of the infant and weighing again the following day in all newborns reaching a weight loss below -2.0 SDS.	[Boer, Suzanne; van Dommelen, Paula] Netherlands Org Appl Sci Res TNO, Dept Life Style, Leiden, Netherlands; [Unal, Sevim] Ankara Childrens Hematol & Oncol Res Hosp, Neonatal Intens Care Unit, Ankara, Turkey; [van Wouwe, Jacobus P.] Netherlands Org Appl Sci Res TNO, Dept Child Hlth, Leiden, Netherlands	Netherlands Organization Applied Science Research; Ankara Children's Hematology Oncology Training & Research Hospital; Netherlands Organization Applied Science Research	van Wouwe, JP (corresponding author), Netherlands Org Appl Sci Res TNO, Dept Child Hlth, Leiden, Netherlands.	ko.vanwouwe@tno.nl	unal, sevim/G-4468-2014; Van Wouwe, Jacobus P/D-5549-2018	unal, sevim/0000-0002-7863-1924; Van Wouwe, Jacobus P/0000-0001-9273-6258				[Anonymous], 2016, LANCET, V387, P404, DOI DOI 10.1016/50140-6736(16)00210-5; Boskabadi H, 2010, ASIA PAC J CLIN NUTR, V19, P301; Breuning-Boers J M, 2006, Ned Tijdschr Geneeskd, V150, P904; Britton C, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001141.pub3; Chantry CJ, 2011, PEDIATRICS, V127, pE171, DOI 10.1542/peds.2009-2663; Cole TJ, 1998, STAT MED, V17, P2697, DOI 10.1002/(SICI)1097-0258(19981215)17:23<2697::AID-SIM36>3.3.CO;2-F; Iyer NP, 2008, ARCH DIS CHILD, V93, P297, DOI 10.1136/adc.2006.108415; Konetzny G, 2009, EUR J PEDIATR, V168, P815, DOI 10.1007/s00431-008-0841-8; Livingstone V, 1995, World Rev Nutr Diet, V78, P28; Livingstone VH, 2000, CAN MED ASSOC J, V162, P647; Manganaro R, 2001, J PEDIATR-US, V139, P673, DOI 10.1067/mpd.2001.118880; Oddie S, 2001, ARCH DIS CHILD, V85, P318, DOI 10.1136/adc.85.4.318; Pelleboer RAA, 2009, ACTA PAEDIATR, V98, P807, DOI 10.1111/j.1651-2227.2009.01230.x; Rollins NC, 2016, LANCET, V387, P491, DOI 10.1016/S0140-6736(15)01044-2; Unal S, 2008, PEDIATR INT, V50, P29, DOI 10.1111/j.1442-200X.2007.02507.x; van Dommelen P, 2014, STAT METHODS MED RES, V23, P369, DOI 10.1177/0962280212473301; van Dommelen P, 2014, BIRTH-ISS PERINAT C, V41, P153, DOI 10.1111/birt.12105; Victora CG, 2016, LANCET, V387, P475, DOI 10.1016/S0140-6736(15)01024-7	18	6	7	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2016	11	12							e0167313	10.1371/journal.pone.0167313	http://dx.doi.org/10.1371/journal.pone.0167313			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI9QF	27997557	Green Published, Green Submitted, gold			2022-12-27	WOS:000392842900006
J	Sachindra, DA; Perera, BJC				Sachindra, D. A.; Perera, B. J. C.			Statistical Downscaling of General Circulation Model Outputs to Precipitation Accounting for Non-Stationarities in Predictor-Predictand Relationships	PLOS ONE			English	Article							CLIMATE-CHANGE; SUPPORT VECTOR; NONSTATIONARY; TEMPERATURE; EVAPORATION; REGRESSION; SCENARIOS; IMPACT	This paper presents a novel approach to incorporate the non-stationarities characterised in the GCM outputs, into the Predictor-Predictand Relationships (PPRs) in statistical down scaling models. In this approach, a series of 42 PPRs based on multi-linear regression (MLR) technique were determined for each calendar month using a 20-year moving window moved at a 1-year time step on the predictor data obtained from the NCEP/NCAR reanalysis data archive and observations of precipitation at 3 stations located in Victoria, Australia, for the period 1950-2010. Then the relationships between the constants and coefficients in the PPRs and the statistics of reanalysis data of predictors were determined for the period 1950-2010, for each calendar month. Thereafter, using these relationships with the statistics of the past data of HadCM3 GCM pertaining to the predictors, new PPRs were derived for the periods 1950-69,1970-89 and 1990-99 for each station. This process yielded a non-stationary downscaling model consisting of a PPR per calendar month for each of the above three periods for each station. The non-stationarities in the climate are characterised by the long-term changes in the statistics of the climate variables and above process enabled relating the non-stationarities in the climate to the PPRs. These new PPRs were then used with the past data of HadCM3, to reproduce the observed precipitation. It was found that the non-stationary MLR based downscaling model was able to produce more accurate simulations of observed precipitation more often than conventional stationary downscaling models developed with MLR and Genetic Programming (GP).	[Sachindra, D. A.; Perera, B. J. C.] Victoria Univ, Coll Engn & Sci, Inst Sustainabil & Innovat, Melbourne, Vic, Australia	Victoria University	Sachindra, DA (corresponding author), Victoria Univ, Coll Engn & Sci, Inst Sustainabil & Innovat, Melbourne, Vic, Australia.	sachindra.dhanapalaarachchige@vu.edu.au	Arachchige, Sachindra Dhanapala/AAB-1926-2019; Perera, Chris/J-7130-2019	Dhanapala Arachchige, Sachindra/0000-0002-4022-0636	Victoria University, Australia	Victoria University, Australia	The authors wish to acknowledge the financial assistance provided by the Victoria University, Australia (https://www.vu.edu.au/) for this project.	Anandhi A, 2008, INT J CLIMATOL, V28, P401, DOI 10.1002/joc.1529; Benestad RE, 2008, EMPIRICAL STAT DOWNS, DOI 10.1142/6908; Beuchat X, 2012, J GEOPHYS RES-ATMOS, V117, DOI 10.1029/2011JD016449; Duan J., 2012, BRIT HYDR SOC 11 NAT; Fowler HJ, 2007, INT J CLIMATOL, V27, P1547, DOI 10.1002/joc.1556; Hertig E, 2013, J GEOPHYS RES-ATMOS, V118, P520, DOI 10.1002/jgrd.50112; Iizumi T, 2011, J GEOPHYS RES-ATMOS, V116, DOI 10.1029/2010JD014513; Jeffrey SJ, 2001, ENVIRON MODELL SOFTW, V16, P309, DOI 10.1016/S1364-8152(01)00008-1; Johnson F, 2012, WATER RESOUR RES, V48, DOI 10.1029/2011WR010464; Koza JR, 1992, GENETIC PROGRAMMING; Maurer EP, 2008, HYDROL EARTH SYST SC, V12, P551; Prudhomme C, 2010, J HYDROL, V390, P198, DOI 10.1016/j.jhydrol.2010.06.043; Raje D, 2010, WATER RESOUR RES, V46, DOI 10.1029/2009WR008425; Rashid MM, 2016, THEOR APPL CLIMATOL, V124, P919, DOI 10.1007/s00704-015-1465-3; Rummukainen M, 2010, WIRES CLIM CHANGE, V1, P82, DOI 10.1002/wcc.8; Russo R., 2003, STAT BEHAV SCI INTRO; Sachindra DA, 2015, J WATER CLIM CHANGE, V6, P241, DOI 10.2166/wcc.2014.145; Sachindra DA, 2014, J WATER CLIM CHANGE, V5, P496, DOI 10.2166/wcc.2014.056; Sachindra DA, 2014, INT J CLIMATOL, V34, P3264, DOI 10.1002/joc.3914; Sachindra DA, 2014, INT J CLIMATOL, V34, P3282, DOI 10.1002/joc.3915; Sachindra DA, 2014, Q J ROY METEOR SOC, V140, P1161, DOI 10.1002/qj.2205; Sachindra DA, 2013, INT J CLIMATOL, V33, P1087, DOI 10.1002/joc.3493; Schmith T, 2008, J CLIMATE, V21, P4529, DOI 10.1175/2008JCLI1910.1; Smith I, 2010, CLIMATIC CHANGE, V102, P377, DOI 10.1007/s10584-009-9757-1; Tisseuil C, 2010, J HYDROL, V385, P279, DOI 10.1016/j.jhydrol.2010.02.030; Tofiq FA, 2014, J HYDROL, V517, P1145, DOI 10.1016/j.jhydrol.2014.06.028; Vrac M, 2007, GEOPHYS RES LETT, V34, DOI 10.1029/2007GL030295; Wilby RL, 1997, INT J CLIMATOL, V17, P439, DOI 10.1002/(SICI)1097-0088(19970330)17:4<439::AID-JOC145>3.0.CO;2-U; Yang T, 2012, HYDROL PROCESS, V26, P3510, DOI 10.1002/hyp.8427; Zhang XC, 2013, INT J CLIMATOL, V33, P326, DOI 10.1002/joc.3425	30	19	19	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2016	11	12							e0168701	10.1371/journal.pone.0168701	http://dx.doi.org/10.1371/journal.pone.0168701			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI9QF	27997609	Green Submitted, Green Published, Green Accepted, gold			2022-12-27	WOS:000392842900070
J	Shi, ZJ; Zhou, HX; Pan, B; Lu, L; Liu, J; Kang, Y; Yao, X; Feng, SQ				Shi, Zhongju; Zhou, Hengxing; Pan, Bin; Lu, Lu; Liu, Jun; Kang, Yi; Yao, Xue; Feng, Shiqing			Effectiveness of Teriparatide on Fracture Healing: A Systematic Review and Meta Analysis	PLOS ONE			English	Review							RECOMBINANT PARATHYROID-HORMONE; POSTMENOPAUSAL WOMEN; OSTEOPOROTIC WOMEN; THERAPY; RISK; PTH; DENSITY; TRIAL; RATS	Purpose Nowadays, the efficacy of teriparatide in treating osteoporosis was widely accepted, but the discussion about using teriparatide to enhance fracture healing hasn't come to an agreement. This meta-analysis was conducted to evaluate the effectiveness of teriparatide for fracture healing. Methods We searched PubMed, the Cochrane Library, and Embase in August 2016 for randomized controlled trials (RCTs) which concerned the treatment of teriparatide for fracture healing. Results Finally, a total of 380 patients were randomly assigned in the 5 trials included in this meta analysis. There was a significant effectiveness with regards to function improvement in patients following fracture, however, there was no significant effectiveness with regards to time of radiographic fracture healing, fracture healing rate and reduction in pain. Conclusions This analysis showed that administration of teriparatide following fracture lacked the effectiveness for fracture healing. Moreover, teriparatide administration had no apparent adverse effects. These results should be interpreted with caution because of some clear limitations. If we want to confirm whether teriparatide improves fracture healing, more high-quality randomized controlled trials are needed.	[Shi, Zhongju; Zhou, Hengxing; Pan, Bin; Lu, Lu; Liu, Jun; Kang, Yi; Yao, Xue; Feng, Shiqing] Tianjin Med Univ, Dept Orthopaed, Gen Hosp, Tianjin, Peoples R China	Tianjin Medical University	Feng, SQ (corresponding author), Tianjin Med Univ, Dept Orthopaed, Gen Hosp, Tianjin, Peoples R China.	sqfeng@tmu.edu.cn			State Key Program of National Natural Science Foundation of China [81330042]; Special Program for Sino-Russian Joint Research - Ministry of Science and Technology, China [2014DFR31210]; Key Program - Tianjin Science and Technology Committee, China [13RCGFSY19000, 14ZCZDSY00044]	State Key Program of National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Special Program for Sino-Russian Joint Research - Ministry of Science and Technology, China; Key Program - Tianjin Science and Technology Committee, China	This work was supported by State Key Program of National Natural Science Foundation of China (81330042), Special Program for Sino-Russian Joint Research Sponsored by the Ministry of Science and Technology, China (2014DFR31210) and Key Program Sponsored by the Tianjin Science and Technology Committee, China (13RCGFSY19000, 14ZCZDSY00044).	Alkhawashki HMI, 2015, INJURY, V46, P2248, DOI 10.1016/j.injury.2015.06.035; Alkhiary YM, 2005, J BONE JOINT SURG AM, V87A, P731, DOI 10.2106/JBJS.D.02115; Almirol EA, 2016, J CLIN TRANSL ENDOCR, V5, P7, DOI 10.1016/j.jcte.2016.05.004; Aspenberg P, 2010, J BONE MINER RES, V25, P404, DOI 10.1359/jbmr.090731; Bhandari M, 2016, CLIN ORTHOP RELAT R, V474, P1234, DOI 10.1007/s11999-015-4669-z; Bishop GB, 2007, INT ORTHOP, V31, P721, DOI 10.1007/s00264-007-0424-8; Campbell EJ, 2015, EXPERT OPIN BIOL TH, V15, P119, DOI 10.1517/14712598.2015.977249; Chen JX, 2016, INT ORTHOP, V40, P1253, DOI 10.1007/s00264-016-3180-9; Compston J, 2005, CALCIFIED TISSUE INT, V77, P65, DOI 10.1007/s00223-005-0012-0; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Einhorn TA, 2015, NAT REV RHEUMATOL, V11, P45, DOI 10.1038/nrrheum.2014.164; Gerstenfeld LC, 2003, J CELL BIOCHEM, V88, P873, DOI 10.1002/jcb.10435; Hankenson KD, 2015, ADV DRUG DELIVER REV, V94, P3, DOI 10.1016/j.addr.2015.09.008; Harvey NC, 2015, OSTEOPOROSIS INT, V26, P2677, DOI 10.1007/s00198-015-3173-3; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Hodsman AB, 2005, ENDOCR REV, V26, P688, DOI 10.1210/er.2004-0006; Huang TW, 2016, BMC MUSCULOSKEL DIS, V17, DOI 10.1186/s12891-016-1149-x; Johansson T, 2016, ACTA ORTHOP, V87, P79, DOI 10.3109/17453674.2015.1073050; Knecht Thomas P, 2004, Endocr Pract, V10, P293; Komrakova M, 2010, BONE, V47, P480, DOI 10.1016/j.bone.2010.05.013; Kramer I, 2010, TRENDS ENDOCRIN MET, V21, P237, DOI 10.1016/j.tem.2009.12.002; Lane NE, 1998, J CLIN INVEST, V102, P1627, DOI 10.1172/JCI3914; Lindsay R, 1997, LANCET, V350, P550, DOI 10.1016/S0140-6736(97)02342-8; Lou SH, 2016, BIOMED RES INT, V2016, DOI 10.1155/2016/6040379; Moreau PG, 1994, ANN SAUDI MED, V14, P75; Namazi H, 2016, ORTHOP TRAUMATOL-SUR, V102, P47, DOI 10.1016/j.otsr.2015.11.002; Neer RM, 2001, NEW ENGL J MED, V344, P1434, DOI 10.1056/NEJM200105103441904; Orwoll E, 2003, J BONE MINER RES, V18, P9, DOI 10.1359/jbmr.2003.18.1.9; Peichl P, 2011, J BONE JOINT SURG AM, V93A, P1583, DOI 10.2106/JBJS.J.01379; Phillips AM, 2005, INJURY, V36, P5, DOI 10.1016/j.injury.2005.07.027; Prince R, 2005, J BONE MINER RES, V20, P1507, DOI 10.1359/JBMR.050501; Resmini Giuseppina, 2007, Aging Clin Exp Res, V19, P30; Rowshan HH, 2010, J ORAL MAXIL SURG, V68, P260, DOI 10.1016/j.joms.2009.09.045; Rubery PT, 2010, J SPINAL DISORD TECH, V23, P151, DOI 10.1097/BSD.0b013e31819a8b7a; Rubin MR, 2005, DRUGS, V65, P2481, DOI 10.2165/00003495-200565170-00005; Sone T, 2014, BONE, V64, P75, DOI 10.1016/j.bone.2014.04.004; Wang CJ, 2012, J ORTHOP SURG RES, V7, DOI 10.1186/1749-799X-7-11; Zhang DF, 2014, J ORTHOP TRAUMA, V28, P57, DOI 10.1097/BOT.0b013e31828e13fe	38	47	48	2	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2016	11	12							e0168691	10.1371/journal.pone.0168691	http://dx.doi.org/10.1371/journal.pone.0168691			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI9QF	27997614	Green Published, gold, Green Submitted			2022-12-27	WOS:000392842900069
J	Wu, X; Li, YX; Fu, JJ; Li, X; Li, CH; Zhang, DF; Shi, YS; Song, YC; Li, Y; Wang, TY				Wu, Xun; Li, Yongxiang; Fu, Junjie; Li, Xin; Li, Chunhui; Zhang, Dengfeng; Shi, Yunsu; Song, Yanchun; Li, Yu; Wang, Tianyu			Exploring Identity-By-Descent Segments and Putative Functions Using Different Foundation Parents in Maize	PLOS ONE			English	Article							QUANTITATIVE TRAIT LOCUS; POPULATION-STRUCTURE; INBRED LINES; GENETIC-CHARACTERIZATION; LINKAGE DISEQUILIBRIUM; ASSOCIATION; DIVERSITY; ADAPTATION; POLYMORPHISMS; ENVIRONMENT	Maize foundation parents (FPs) play no-alternative roles in hybrid breeding because they were widely used in the development of new lines and hybrids. The combination of different identity-by-descent (IBD) segments and genes could account for the formation patterns of different FPs, and knowledge of these IBD regions would provide an extensive foundation for the development of new candidate FP lines in future maize breeding. In this paper, a panel of 304 elite lines derived from FPs, i.e., B73, 207, Mo17, and Huangzaosi (HZS), was collected and analyzed using 43,252 single nucleotide polymorphism (SNP) markers. Most IBD segments specific to particular FP groups were identified, including 116 IBD segments in B73, 105 in Mo17, 111 in 207, and 190 in HZS. In these regions, 423 quantitative trait nucleotides (QTNs) associated with 15 agronomic traits and 804 candidate genes were identified. Some known adaptation-related genes, e.g., dwarf8 and vgtl in HZS, zcn8 and epc in Mo17, and ZmCCT in 207, were validated as being tightly linked to particular IBD segments. In addition, numerous new candidate genes were also identified. For example, GRMZM2G154278 in HZS, which belongs to the cell cycle control family, was closely linked to a QTN of the ear height/plant height (EH/PH) trait; GRMZM2G051943 in 207, which encodes an endochitinase precursor (EP) chitinase, was closely linked to a QTN for kernel density; and GRMZM2G170586 in Mo17 was closely linked to a QTN for ear diameter. Complex correlations among these genes were also found. Many IBD segments and genes were included in the formation of FP lines, and complex regulatory networks exist among them. These results provide new insights on the genetic basis of complex traits and provide new candidate IBD regions or genes for the improvement of special traits in maize production.	[Wu, Xun; Li, Yongxiang; Fu, Junjie; Li, Xin; Li, Chunhui; Zhang, Dengfeng; Shi, Yunsu; Song, Yanchun; Li, Yu; Wang, Tianyu] Chinese Acad Agr Sci, Inst Crop Sci, Beijing, Peoples R China; [Wu, Xun] Guizhou Inst Upland Food Crops, Guiyang, Guizhou, Peoples R China	Chinese Academy of Agricultural Sciences; Institute of Crop Sciences, CAAS	Li, Y; Wang, TY (corresponding author), Chinese Acad Agr Sci, Inst Crop Sci, Beijing, Peoples R China.	yuli@mail.caas.net.cn; wangtianyu@caas.cn	li, yong/HDN-3885-2022; li, yongxiang/GPW-6930-2022	Fu, Junjie/0000-0002-4702-2392	Ministry of Science and Technology of China [2016YFD0100303, 2016YFD0100103, 2014CB138200, 2013BAD01B02]; National Natural Science Foundation [91335206]; CAAS Innovation Program; China Postdoctoral Sciences Foundation [2014M550901]	Ministry of Science and Technology of China(Ministry of Science and Technology, China); National Natural Science Foundation(National Natural Science Foundation of China (NSFC)); CAAS Innovation Program; China Postdoctoral Sciences Foundation(China Postdoctoral Science Foundation)	This research was supported by the Ministry of Science and Technology of China (2016YFD0100303, 2016YFD0100103, 2014CB138200, 2013BAD01B02), the National Natural Science Foundation (91335206), the CAAS Innovation Program, and the China Postdoctoral Sciences Foundation (2014M550901).	Beyene Y, 2015, CROP SCI, V55, P154, DOI 10.2135/cropsci2014.07.0460; Bouchet S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071377; Bradbury PJ, 2007, BIOINFORMATICS, V23, P2633, DOI 10.1093/bioinformatics/btm308; Brown PJ, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002383; Browning SR, 2012, GENETICS, V190, P1521, DOI 10.1534/genetics.111.136937; Browning SR, 2010, AM J HUM GENET, V86, P526, DOI 10.1016/j.ajhg.2010.02.021; Ducrocq S, 2008, GENETICS, V178, P2433, DOI 10.1534/genetics.107.084830; Flint-Garcia SA, 2005, PLANT J, V44, P1054, DOI 10.1111/j.1365-313X.2005.02591.x; Hufford MB, 2012, NAT GENET, V44, P808, DOI 10.1038/ng.2309; Hung HY, 2012, P NATL ACAD SCI USA, V109, pE1913, DOI 10.1073/pnas.1203189109; Jiao YP, 2012, NAT GENET, V44, P812, DOI 10.1038/ng.2312; Kim EJ, 2012, GENES GENOM, V34, P529, DOI 10.1007/s13258-012-0074-0; Lai JS, 2010, NAT GENET, V42, P1027, DOI 10.1038/ng.684; Legesse BW, 2007, HEREDITAS, V144, P10, DOI 10.1111/j.2006.0018-0661.01921.x; Li H, 2013, NAT GENET, V45, P43, DOI 10.1038/ng.2484; [黎裕 Li Yu], 2010, [玉米科学, Maize Science], V18, P1; Lipka AE, 2012, BIOINFORMATICS, V28, P2397, DOI 10.1093/bioinformatics/bts444; Liu CL, 2015, MOL BREEDING, V35, DOI 10.1007/s11032-015-0344-z; Liu HJ, 2015, MOL PLANT, V8, P871, DOI 10.1016/j.molp.2015.01.016; Liu KJ, 2005, BIOINFORMATICS, V21, P2128, DOI 10.1093/bioinformatics/bti282; Lu YL, 2009, THEOR APPL GENET, V120, P93, DOI 10.1007/s00122-009-1162-7; Mikel MA, 2006, CROP SCI, V46, P1193, DOI 10.2135/cropsci2005.10-0371; Passarinho PA, 2001, PLANTA, V212, P556, DOI 10.1007/s004250000464; Patterson N, 2006, PLOS GENET, V2, P2074, DOI 10.1371/journal.pgen.0020190; Peng B, 2011, THEOR APPL GENET, V122, P1305, DOI 10.1007/s00122-011-1532-9; Pritchard JK, 2000, GENETICS, V155, P945; SAGHAIMAROOF MA, 1984, P NATL ACAD SCI-BIOL, V81, P8014, DOI 10.1073/pnas.81.24.8014; Schaefer CM, 2013, CROP SCI, V53, P1529, DOI 10.2135/cropsci2012.11.0632; Schnable JC, 2012, GENOME BIOL EVOL, V4, P265, DOI 10.1093/gbe/evs009; Schnable PS, 2009, SCIENCE, V326, P1112, DOI 10.1126/science.1178534; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Smith JSC, 2004, CROP SCI, V44, P1935, DOI 10.2135/cropsci2004.1935; Smith S, 2007, CROP SCI, V47, P1914, DOI 10.2135/cropsci2006.12.0763; Stevens EL, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002287; Teng F, 2013, PLANT J, V73, P405, DOI 10.1111/tpj.12038; Thornsberry JM, 2001, NAT GENET, V28, P286, DOI 10.1038/90135; Troyer AF, 2007, CROP SCI, V47, P905, DOI 10.2135/cropsci2006.10.0651; van Heerwaarden J, 2012, P NATL ACAD SCI USA, V109, P12420, DOI 10.1073/pnas.1209275109; Vega SH, 2002, PLANT CELL, V14, P133, DOI 10.1105/tpc.010406; Wang RH, 2008, THEOR APPL GENET, V117, P1141, DOI 10.1007/s00122-008-0852-x; Wang TY, 2011, CROP SCI, V51, P512, DOI 10.2135/cropsci2010.06.0383; Westerlind H, 2015, EUR J HUM GENET, V23, P688, DOI 10.1038/ejhg.2014.155; Wu X, 2015, BMC PLANT BIOL, V15, DOI 10.1186/s12870-015-0646-7; Wu X, 2014, THEOR APPL GENET, V127, P621, DOI 10.1007/s00122-013-2246-y; Yan JB, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008451; Yang N, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004573; Yang XH, 2011, MOL BREEDING, V28, P511, DOI 10.1007/s11032-010-9500-7; Yu JM, 2006, NAT GENET, V38, P203, DOI 10.1038/ng1702; Yu YT, 2014, GENET MOL RES, V13, P3069, DOI 10.4238/2014.April.17.3; Zambrano JL, 2014, MOL BREEDING, V34, P989, DOI 10.1007/s11032-014-0091-6	50	10	11	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2016	11	12							e0168374	10.1371/journal.pone.0168374	http://dx.doi.org/10.1371/journal.pone.0168374			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI9QF	27997600	Green Published, Green Submitted, gold			2022-12-27	WOS:000392842900038
J	Chatterjee, A; Manohar, M; Ramadurai, G				Chatterjee, Atanu; Manohar, Manju; Ramadurai, Gitakrishnan			Statistical Analysis of Bus Networks in India	PLOS ONE			English	Article							POWER-LAW; TRANSPORT NETWORKS; COMPLEX; DISTRIBUTIONS; CENTRALITY	In this paper, we model the bus networks of six major Indian cities as graphs in L-space, and evaluate their various statistical properties. While airline and railway networks have been extensively studied, a comprehensive study on the structure and growth of bus networks is lacking. In India, where bus transport plays an important role in day-to-day commutation, it is of significant interest to analyze its topological structure and answer basic questions on its evolution, growth, robustness and resiliency. Although the common feature of small-world property is observed, our analysis reveals a wide spectrum of network topologies arising due to significant variation in the degree-distribution patterns in the networks. We also observe that these networks although, robust and resilient to random attacks are particularly degree-sensitive. Unlike real-world networks, such as Internet, WWW and airline, that are virtual, bus networks are physically constrained. Our findings therefore, throw light on the evolution of such geographically and constrained networks that will help us in designing more efficient bus networks in the future.	[Chatterjee, Atanu; Manohar, Manju; Ramadurai, Gitakrishnan] Indian Inst Technol Madras, Dept Civil Engn, Chennai 600036, Tamil Nadu, India; [Chatterjee, Atanu] Worcester Polytech Inst, Dept Phys, 100 Inst Rd, Worcester, MA 01609 USA	Indian Institute of Technology System (IIT System); Indian Institute of Technology (IIT) - Madras; Worcester Polytechnic Institute	Ramadurai, G (corresponding author), Indian Inst Technol Madras, Dept Civil Engn, Chennai 600036, Tamil Nadu, India.	gitakrishnan@iitm.ac.in	Ramadurai, Gitakrishnan/B-7150-2017; Chatterjee, Atanu/AAY-7895-2021	Ramadurai, Gitakrishnan/0000-0002-1787-9838; Manohar Manjalavil, Manju/0000-0003-4827-5452	Center of Excellence in Urban Transport at the Indian Institute of Technology, Madras - Ministry of Urban Development, Government of India; Information Technology Research Academy, a Division of Media Labs Asia, a non-profit organization of the Department of Electronics and Information Technology - Ministry of Communications and Information Technology, Government of India	Center of Excellence in Urban Transport at the Indian Institute of Technology, Madras - Ministry of Urban Development, Government of India; Information Technology Research Academy, a Division of Media Labs Asia, a non-profit organization of the Department of Electronics and Information Technology - Ministry of Communications and Information Technology, Government of India	The authors acknowledge the support from Center of Excellence in Urban Transport at the Indian Institute of Technology, Madras, sponsored by the Ministry of Urban Development, Government of India and the Information Technology Research Academy, a Division of Media Labs Asia, a non-profit organization of the Department of Electronics and Information Technology, funded by the Ministry of Communications and Information Technology, Government of India. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors acknowledge the support from Center of Excellence in Urban Transport at the Indian Institute of Technology, Madras, sponsored by the Ministry of Urban Development, Government of India and the Information Technology Research Academy, a Division of Media Labs Asia, a non-profit organization of the Department of Electronics and Information Technology, funded by the Ministry of Communications and Information Technology, Government of India. The authors also acknowledge the reviewers for their constructive criticisms and suggestions.	Ahuja R.K., 1988, NETWORK FLOWS; Albert R, 2004, PHYS REV E, V69, DOI 10.1103/PhysRevE.69.025103; Albert R, 2002, REV MOD PHYS, V74, P47, DOI 10.1103/RevModPhys.74.47; Albert R, 1999, NATURE, V401, P130, DOI 10.1038/43601; Angeloudis P, 2006, PHYSICA A, V367, P553, DOI 10.1016/j.physa.2005.11.007; [Anonymous], ARXIV151205909; Bagler G, 2008, PHYSICA A, V387, P2972, DOI 10.1016/j.physa.2008.01.077; Barabasi AL, 1999, SCIENCE, V286, P509, DOI 10.1126/science.286.5439.509; Barrat A, 2004, P NATL ACAD SCI USA, V101, P3747, DOI 10.1073/pnas.0400087101; Bertsimas D, 2003, MATH PROGRAM, V98, P49, DOI 10.1007/s10107-003-0396-4; Bork P, 2004, CURR OPIN STRUC BIOL, V14, P292, DOI 10.1016/j.sbi.2004.05.003; Cancho RFI, 2003, P NATL ACAD SCI USA, V100, P788, DOI 10.1073/pnas.0335980100; Chatterjee A, 2014, 4 INT C COMPL SYST A, P137; Chatterjee A., 2016, COMPLEXITY; Chen YZ, 2007, PHYSICA A, V376, P747, DOI 10.1016/j.physa.2006.10.071; Clauset A, 2009, SIAM REV, V51, P661, DOI 10.1137/070710111; Derrible S, 2009, TRANSPORT RES REC, P17, DOI 10.3141/2112-03; Dorogovtsev SN, 2002, PHYS REV E, V65, DOI 10.1103/PhysRevE.65.066122; Easley D, 2010, NETWORKS CROWDS MARK; ERDOS P, 1960, B INT STATIST INST, V38, P343; Guimera R, 2005, P NATL ACAD SCI USA, V102, P7794, DOI 10.1073/pnas.0407994102; Jeong H, 2001, NATURE, V411, P41, DOI 10.1038/35075138; Jiang J, 2010, ARXIV10020151; Ma K, 2011, CHINESE SCI BULL, V56, P3731, DOI 10.1007/s11434-011-4769-4; Newman MEJ, 2003, SIAM REV, V45, P167, DOI 10.1137/S003614450342480; Newman MEJ, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.208701; Niwa HS, 2003, J THEOR BIOL, V224, P451, DOI 10.1016/S0022-5193(03)00192-9; Porta S, 2006, PHYSICA A, V369, P853, DOI 10.1016/j.physa.2005.12.063; Ravasz E, 2003, PHYS REV E, V67, DOI 10.1103/PhysRevE.67.026112; Sen P, 2003, PHYS REV E, V67, DOI 10.1103/PhysRevE.67.036106; Sienkiewicz J, 2005, PHYS REV E, V72, DOI 10.1103/PhysRevE.72.046127; Soh H, 2010, PHYSICA A, V389, P5852, DOI 10.1016/j.physa.2010.08.015; Strogatz SH, 2001, NATURE, V410, P268, DOI 10.1038/35065725; von Ferber C, 2009, EUR PHYS J B, V68, P261, DOI 10.1140/epjb/e2009-00090-x; Watts DJ, 1998, NATURE, V393, P440, DOI 10.1038/30918; Woolley-Meza O, 2011, EUR PHYS J B, V84, P589, DOI 10.1140/epjb/e2011-20208-9; Xu XP, 2007, PHYSICA A, V374, P441, DOI 10.1016/j.physa.2006.06.021; Yang XH, 2014, TRANSPORT RES A-POL, V69, P1, DOI 10.1016/j.tra.2014.08.004; Zhang YZ, 2014, IEEE W CONTR MODEL, DOI 10.1109/COMPEL.2014.6877120	39	26	26	2	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 19	2016	11	12							e0168478	10.1371/journal.pone.0168478	http://dx.doi.org/10.1371/journal.pone.0168478			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI9QC	27992590	Green Published, gold, Green Submitted			2022-12-27	WOS:000392842600066
J	Fargier, R; Laganaro, M				Fargier, Raphael; Laganaro, Marina			Neurophysiological Modulations of Non Verbal and Verbal Dual-Tasks Interference during Word Planning	PLOS ONE			English	Article							TIME-COURSE; CHRONOMETRIC EVIDENCE; VISUAL COMPLEXITY; IMAGE VARIABILITY; NAMING OBJECTS; LEXICAL ACCESS; NAME AGREEMENT; FRENCH; FAMILIARITY; ACTIVATION	Running a concurrent task while speaking clearly interferes with speech planning, but whether verbal vs. non-verbal tasks interfere with the same processes is virtually unknown. We investigated the neural dynamics of dual-task interference on word production using event-related potentials (ERPs) with either tones or syllables as concurrent stimuli. Participants produced words from pictures in three conditions: without distractors, while passively listening to distractors and during a distractor detection task. Production latencies increased for tasks with higher attentional demand and were longer for syllables relative to tones. ERP analyses revealed common modulations by dual-task for verbal and non-verbal stimuli around 240 ms, likely corresponding to lexical selection. Modulations starting around 350 ms prior to vocal onset were only observed when verbal stimuli were involved. These later modulations, likely reflecting interference with phonological-phonetic encoding, were observed only when overlap between tasks was maximal and the same underlying neural circuits were engaged (cross-talk).	[Fargier, Raphael; Laganaro, Marina] Univ Geneva, Fac Psychol & Educ Sci, Geneva, Switzerland	University of Geneva	Fargier, R (corresponding author), Univ Geneva, Fac Psychol & Educ Sci, Geneva, Switzerland.	raphael.fargier@unige.ch	Fargier, Raphaël/P-7125-2019	Fargier, Raphaël/0000-0002-0165-0238; Laganaro, Marina/0000-0002-4054-0939	Swiss National Science Foundation [105319_146113]	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	This work was supported by Swiss National Science Foundation grant no 105319_146113. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alario FX, 1999, BEHAV RES METH INS C, V31, P531, DOI 10.3758/BF03200732; Aristei S, 2011, J COGNITIVE NEUROSCI, V23, P1567, DOI 10.1162/jocn.2010.21474; Baayen RH, 2008, J MEM LANG, V59, P390, DOI 10.1016/j.jml.2007.12.005; Barr DJ, 2013, J MEM LANG, V68, P255, DOI 10.1016/j.jml.2012.11.001; Bates Douglas, 2014, LME4 LINEAR MIXED EF; Bergen B, 2013, J EXP PSYCHOL GEN, V142, P119, DOI 10.1037/a0028428; Bonin P, 2003, BEHAV RES METH INS C, V35, P158, DOI 10.3758/BF03195507; Brunet D, 2011, COMPUT INTEL NEUROSC, V2011, DOI 10.1155/2011/813870; Burki A, 2015, BRAIN LANG, V150, P90, DOI 10.1016/j.bandl.2015.08.006; Christoffels IK, 2007, BRAIN RES, V1147, P192, DOI 10.1016/j.brainres.2007.01.137; Cook AE, 2008, J EXP PSYCHOL LEARN, V34, P886, DOI 10.1037/0278-7393.34.4.886; Costa A, 2009, P NATL ACAD SCI USA, V106, P21442, DOI 10.1073/pnas.0908921106; Daliri A, 2015, BRAIN LANG, V143, P59, DOI 10.1016/j.bandl.2015.03.002; DELL GS, 1986, PSYCHOL REV, V93, P283, DOI 10.1037/0033-295X.93.3.283; Fargier R, 2015, BRAIN LANG, V150, P129, DOI 10.1016/j.bandl.2015.09.004; Ferreira VS, 2002, J EXP PSYCHOL LEARN, V28, P1187, DOI 10.1037//0278-7393.28.6.1187; Garrod S, 2006, AUTOMATICITY LANGUAG, P1; GOLDSTEIN H, 1987, BIOMETRIKA, V74, P430, DOI 10.1093/biomet/74.2.430; Goldstein H, 1995, MULTILEVEL STAT MODE, DOI 10.1002/9780470973394; Hazeltine E, 2006, COGNITIVE PSYCHOL, V52, P291, DOI 10.1016/j.cogpsych.2005.11.001; Hommel B, 1998, J EXP PSYCHOL HUMAN, V24, P1368, DOI 10.1037/0096-1523.24.5.1368; Indefrey P, 2004, COGNITION, V92, P101, DOI 10.1016/j.cognition.2002.06.001; Indefrey P, 2011, FRONT PSYCHOL, V2, DOI 10.3389/fpsyg.2011.00255; Johnston JC, 1995, PSYCHOL SCI, V6, P365, DOI 10.1111/j.1467-9280.1995.tb00527.x; Jongman SR, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0137557; Joos K, 2014, NEUROSCI BIOBEHAV R, V42, P148, DOI 10.1016/j.neubiorev.2014.02.009; Kahneman D., 1973, ATTENTION EFFORT; Kinsbourne M., 1978, ATTENTION PERFORM, VVII, P345; Kleinman D, 2013, J EXP PSYCHOL LEARN, V39, P1860, DOI 10.1037/a0033095; Koenig T, 2014, BRAIN TOPOGR, V27, P72, DOI 10.1007/s10548-013-0310-1; Koenig T, 2011, COMPUT INTEL NEUROSC, V2011, DOI 10.1155/2011/938925; Korvorst M, 2007, EXP PSYCHOL, V54, P187, DOI 10.1027/1618-3169.54.3.187; Kuznetsova A, 2013, LEMERTEST TESTS RAND, P2; Laganaro M, 2015, NEUROIMAGE, V111, P204, DOI 10.1016/j.neuroimage.2015.02.027; Laganaro M, 2014, FRONT PSYCHOL, V5, DOI 10.3389/fpsyg.2014.00493; Laganaro M, 2012, NEUROIMAGE, V59, P3881, DOI 10.1016/j.neuroimage.2011.10.082; Laganaro M, 2011, BRAIN TOPOGR, V24, P19, DOI 10.1007/s10548-010-0162-x; LEHMANN D, 1980, ELECTROEN CLIN NEURO, V48, P609, DOI 10.1016/0013-4694(80)90419-8; Levelt W., 1989, SPEAKING INTENTION A; Levelt WJM, 1999, BEHAV BRAIN SCI, V22, P1; Lien MC, 2002, PSYCHON B REV, V9, P212, DOI 10.3758/BF03196277; Lin SH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098260; Marti S, 2015, NEURON, V88, P1297, DOI 10.1016/j.neuron.2015.10.040; Max L, 2008, P 8 INT SEM SPEECH P, P41; Meyer AS, 2000, PSYCHON B REV, V7, P314, DOI 10.3758/BF03212987; Meyer AS, 1998, COGNITION, V66, pB25, DOI 10.1016/S0010-0277(98)00009-2; Meyer AS, 2003, J MEM LANG, V48, P131, DOI 10.1016/S0749-596X(02)00509-0; Michel C.M., 2009, ELECT NEUROIMAGING; Michel CM, 2001, BRAIN RES REV, V36, P108, DOI 10.1016/S0165-0173(01)00086-8; Michel CM, 2004, CLIN NEUROPHYSIOL, V115, P2195, DOI 10.1016/j.clinph.2004.06.001; Navon D, 2002, COGNITIVE PSYCHOL, V44, P193, DOI 10.1006/cogp.2001.0767; New B, 2004, BEHAV RES METH INS C, V36, P516, DOI 10.3758/BF03195598; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; PASHLER H, 1994, PSYCHOL BULL, V116, P220, DOI 10.1037/0033-2909.116.2.220; PASHLER H, 1989, Q J EXP PSYCHOL-A, V41, P19, DOI 10.1080/14640748908402351; Perret C, 2014, BRAIN LANG, V135, P20, DOI 10.1016/j.bandl.2014.04.006; Protopapas A, 2007, BEHAV RES METHODS, V39, P859, DOI 10.3758/BF03192979; Roelofs A, 2004, MEM COGNITION, V32, P212, DOI 10.3758/BF03196853; Roelofs A, 2011, FRONT PSYCHOL, V2, DOI 10.3389/fpsyg.2011.00307; Roelofs A, 2008, J EXP PSYCHOL HUMAN, V34, P1580, DOI 10.1037/a0012476; Schubert T, 2008, J EXP PSYCHOL HUMAN, V34, P376, DOI 10.1037/0096-1523.34.2.376; Strijkers K, 2010, CEREB CORTEX, V20, P912, DOI 10.1093/cercor/bhp153; Tombu M, 2003, J EXP PSYCHOL HUMAN, V29, P3, DOI 10.1037/0096-1523.29.1.3; Valente A, 2014, FRONT NEUROSCI-SWITZ, V8, DOI 10.3389/fnins.2014.00390; WELFORD AT, 1952, AM J PSYCHOL, V65, P91, DOI 10.2307/1418834	65	18	18	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 19	2016	11	12							e0168358	10.1371/journal.pone.0168358	http://dx.doi.org/10.1371/journal.pone.0168358			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EI9QC	27992586	gold, Green Submitted, Green Published			2022-12-27	WOS:000392842600051
J	Kobayashi, N; Shinagawa, S; Nagata, T; Shimada, K; Shibata, N; Ohnuma, T; Kasanuki, K; Arai, H; Yamada, H; Nakayama, K; Kondo, K				Kobayashi, Nobuyuki; Shinagawa, Shunichiro; Nagata, Tomoyuki; Shimada, Kazuya; Shibata, Nobuto; Ohnuma, Tohru; Kasanuki, Koji; Arai, Heii; Yamada, Hisashi; Nakayama, Kazuhiko; Kondo, Kazuhiro			Usefulness of DNA Methylation Levels in COASY and SPINT1 Gene Promoter Regions as Biomarkers in Diagnosis of Alzheimer's Disease and Amnestic Mild Cognitive Impairment	PLoS One			English	Article							FACTOR ACTIVATOR INHIBITOR; ASSOCIATION WORKGROUPS; NATIONAL INSTITUTE; RISK; RECOMMENDATIONS; GUIDELINES; DEMENTIA; TYPE-1; ANK1; BIN1	In order to conduct early therapeutic interventions for Alzheimer's disease (AD), convenient, early diagnosis markers are required. We previously reported that changes in DNA methylation levels were associated with amnestic mild cognitive impairment (aMCI) and AD. As the results suggested changes in DNA methylation levels in the COASYand SPINT1 gene promoter regions, in the present study we examined DNA methylation in these regions in normal controls (NCs, n = 30), aMCI subjects (n = 28) and AD subjects (n = 30) using methylation-sensitive high resolution melting (MS-HRM) analysis. The results indicated that DNA methylation in the two regions was significantly increased in AD and aMCI as compared to NCs (P< 0.0001, P< 0.0001, ANOVA). Further analysis suggested that DNA methylation in the COASY gene promoter region in particular could be a high sensitivity, high specificity diagnosis biomarker (COASY: sensitivity 96.6%, specificity 96.7%; SPINT1: sensitivity 63.8%, specificity 83.3%). DNA methylation in the COASYpromoter region was associated with CDR Scale Sum of Boxes (CDR-SB), an indicator of dementia severity. In the SPINT1 promoter region, DNA methylation was negatively associated with age in NCs and elevated in aMCI and AD subjects positive for antibodies to Herpes simplex virus type 1 (HSV-1). These findings suggested that changes in DNA methylation in the COASY and SPINT1 promoter regions are influenced by various factors. In conclusion, DNA methylation levels in the COASYand SPINT1 promoter regions were considered to potentially be a convenient and useful biomarker for diagnosis of AD and aMCI.	[Kobayashi, Nobuyuki; Shimada, Kazuya; Kondo, Kazuhiro] Jikei Univ, Sch Med, Dept Virol, Tokyo, Japan; [Shinagawa, Shunichiro; Nagata, Tomoyuki; Nakayama, Kazuhiko] Jikei Univ, Sch Med, Dept Psychiat, Tokyo, Japan; [Nagata, Tomoyuki; Yamada, Hisashi] Jikei Univ, Sch Med, Div Mol Genet, Tokyo, Japan; [Shibata, Nobuto; Ohnuma, Tohru; Kasanuki, Koji; Arai, Heii] Juntendo Univ, Sch Med, Dept Psychiat, Tokyo, Japan	Jikei University; Jikei University; Jikei University; Juntendo University	Kobayashi, N (corresponding author), Jikei Univ, Sch Med, Dept Virol, Tokyo, Japan.	kobayashi-n@jikei.ac.jp	Shibata, Nobuto/AAB-9366-2020; Kobayashi, Nobuyuki/AAS-9795-2021; Ohnuma, Tohru/AAN-2363-2020	Kobayashi, Nobuyuki/0000-0001-8627-515X; Ohnuma, Tohru/0000-0003-1522-3832; dao tian, he ye/0000-0003-1471-8067	Japan Society for the Promotion of Science (JSPS) KAKENHI [25893251, 26860946]; Jikei University Research Fund; Ministry of Education, Culture, Sports, Science and Technology (MEXT) [S1201032]; Uehara Memorial Foundation	Japan Society for the Promotion of Science (JSPS) KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Jikei University Research Fund(Jikei University); Ministry of Education, Culture, Sports, Science and Technology (MEXT)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Uehara Memorial Foundation(Uehara Memorial Foundation)	The present work was supported by Japan Society for the Promotion of Science (JSPS) KAKENHI (grant numbers 25893251 [TN] and 26860946 [NK]; http://www.jsps.go.jp/j.grantsinaid/), The Jikei University Research Fund (SS, http://www.jikei.ac.jp), The Ministry of Education, Culture, Sports, Science and Technology (MEXT)-Supported Program for the Strategic Research Foundation at Private Universities (grant number S1201032 [KKo]; http://www.mextgo.jp/a_menu/koutou/shinkou/07021403/002/002/1218299.htm) and The Uehara Memorial Foundation (NK, http://www.ueharazaidan.or.jp). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adalsteinsson BT, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046705; BARTUS RT, 1982, SCIENCE, V217, P408, DOI 10.1126/science.7046051; Bennett DA, 2015, TRANSL RES, V165, P200, DOI 10.1016/j.trsl.2014.05.006; CORDER EH, 1993, SCIENCE, V261, P921, DOI 10.1126/science.8346443; De Jager PL, 2014, NAT NEUROSCI, V17, P1156, DOI 10.1038/nn.3786; Dubois B, 2000, NEUROLOGY, V55, P1621, DOI 10.1212/WNL.55.11.1621; Dusi S, 2014, AM J HUM GENET, V94, P11, DOI 10.1016/j.ajhg.2013.11.008; Eckhardt F, 2006, NAT GENET, V38, P1378, DOI 10.1038/ng1909; Fjell AM, 2010, CEREB CORTEX, V20, P2069, DOI 10.1093/cercor/bhp279; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Fuchikami M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023881; Houseman EA, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-86; HUGHES CP, 1982, BRIT J PSYCHIAT, V140, P566, DOI 10.1192/bjp.140.6.566; Itzhaki RF, 2016, J ALZHEIMERS DIS; Jones PA, 2012, NAT REV GENET, V13, P484, DOI 10.1038/nrg3230; Katan M, 2013, NEUROLOGY, V80, P1209, DOI 10.1212/WNL.0b013e3182896e79; Kataoka H, 2000, J BIOL CHEM, V275, P40453, DOI 10.1074/jbc.M006412200; Kawai E, 2015, NEUROMOLECULAR MED; Kim JM, 2013, J AFFECT DISORDERS, V149, P93, DOI 10.1016/j.jad.2013.01.008; Kobayashi N, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0146449; Kobayashi N, 2013, BIOCHEM BIOPH RES CO, V430, P907, DOI 10.1016/j.bbrc.2012.12.054; Lee JH, 2012, CURR GERONTOL GERIAT, V2012, DOI [10.1155/2012/3612183310186, DOI 10.1155/2012/361218]; Lehmann-Werman R, 2016, P NATL ACAD SCI USA, V113, pE1826, DOI 10.1073/pnas.1519286113; Li G, 2007, NEUROLOGY, V69, P631, DOI 10.1212/01.wnl.0000267428.62582.aa; Lovheim H, 2015, ALZHEIMERS DEMENT, V11, P587, DOI 10.1016/j.jalz.2014.07.157; Lunnon K, 2014, NAT NEUROSCI, V17, P1164, DOI 10.1038/nn.3782; MCKHANN G, 1984, NEUROLOGY, V34, P939, DOI 10.1212/WNL.34.7.939; McKhann GM, 2011, ALZHEIMERS DEMENT, V7, P263, DOI 10.1016/j.jalz.2011.03.005; Migheli F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0052501; Nagata T, 2012, DEMENT GERIATR COGN, V33, P266, DOI 10.1159/000339358; Petersen RC, 2001, ARCH NEUROL-CHICAGO, V58, P1985, DOI 10.1001/archneur.58.12.1985; REISBERG B, 1987, J CLIN PSYCHIAT, V48, P9; Rowe CC, 2010, NEUROBIOL AGING, V31, P1275, DOI 10.1016/j.neurobiolaging.2010.04.007; Sanchez-Mut JV, 2016, TRANSL PSYCHIAT, V6, DOI 10.1038/tp.2015.214; Sperling RA, 2011, ALZHEIMERS DEMENT, V7, P280, DOI 10.1016/j.jalz.2011.03.003; Sun LQ, 2004, GENE DEV, V18, P1035, DOI 10.1101/gad.1176104; Uno K, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0157959; Ushijima T, 2005, CANCER SCI, V96, P206, DOI 10.1111/j.1349-7006.2005.00035.x; Wojdacz TK, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm013; Yamada T, 1998, EXP NEUROL, V153, P60, DOI 10.1006/exnr.1998.6874; Yu L, 2015, JAMA NEUROL, V72, P15, DOI 10.1001/jamaneurol.2014.3049	41	19	19	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 19	2016	11	12							e0168816	10.1371/journal.pone.0168816	http://dx.doi.org/10.1371/journal.pone.0168816			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI9QC	27992572	Green Published, Green Submitted, gold			2022-12-27	WOS:000392842600101
J	Ji, P; Xu, F; Huang, BY; Li, YX; Li, L; Zhang, GF				Ji, Peng; Xu, Fei; Huang, Baoyu; Li, Yingxiang; Li, Li; Zhang, Guofan			Molecular Characterization and Functional Analysis of a Putative Octopamine/Tyramine Receptor during the Developmental Stages of the Pacific Oyster, Crassostrea gigas	PLOS ONE			English	Article							PROTEIN-COUPLED RECEPTORS; GATED CHLORIDE CHANNEL; LARVAL NERVOUS-SYSTEM; TYRAMINE-RECEPTOR; PHARMACOLOGICAL CHARACTERIZATION; DROSOPHILA-MELANOGASTER; SIGNAL-TRANSDUCTION; ILYANASSA-OBSOLETA; CHLAMYS-FARRERI; GENE-EXPRESSION	Octopamine (OA) and its precursor, tyramine (TA), participate in invertebrate development such as growth, maturation, and reproduction by activating their corresponding G protein-coupled receptors (GPCRs). Although OA was first discovered in mollusks (octopus), subsequent studies on OA, TA and related receptors have primarily been conducted in Ecdysozoa, especially in insects. Accordingly, only limited reports on OA/TA receptors in mollusks are available and their physiological roles remain unclear. Here, a full-length cDNA encoding a putative 524 amino acid OA/TA receptor (CgGPR1) was isolated from the Pacific oyster Crassostrea gigas. CgGPR1 was most closely related to the Lymnaea stagnalis OA receptor OAR2 in sequence. Phylogenetic analysis showed that CgGPR1 belongs to a poorly studied subfamily of invertebrate OA/TA receptors. The spatio-temporal expression of CgGPR1 in C. gigas larvae was examined by quantitative real-time PCR and Western blot analysis. CgGPR1 was expressed during all developmental stages of C. gigas with higher levels at mid-developmental stages, indicating its potential role in embryogenesis and tissue differentiation. Immunoreactive fluorescence of CgGPR1 was mainly observed in the velum, foot, gill and mantle of C. gigas larvae. CgGPR1 transcripts were detected in all the tested organs of adult C. gigas, with highest level in the mantle. Pharmacological analysis showed that cAMP and Ca2+ concentrations remained unchanged in HEK293 cells expressing CgGPR1 upon addition of OA, TA or related amines, suggesting that CgGPR1 modulates other unknown molecules rather than cAMP and Ca2+. Our study sheds light on CgGPR1 function in oysters.	[Ji, Peng; Xu, Fei; Huang, Baoyu; Li, Yingxiang; Li, Li; Zhang, Guofan] Chinese Acad Sci, Key Lab Expt Marine Biol, Inst Oceanol, Qingdao, Shandong, Peoples R China; [Ji, Peng] Univ Chinese Acad Sci, Beijing, Peoples R China; [Ji, Peng; Xu, Fei; Huang, Baoyu; Li, Yingxiang; Li, Li; Zhang, Guofan] Chinese Acad Sci, Natl & Local Joint Engn Lab Ecol Mariculture, Inst Oceanol, Qingdao, Shandong, Peoples R China; [Xu, Fei; Zhang, Guofan] Qingdao Natl Lab Marine Sci & Technol, Lab Marine Biol & Biotechnol, Qingdao, Shandong, Peoples R China; [Li, Li] Qingdao Natl Lab Marine Sci & Technol, Lab Marine Fisheries & Aquaculture, Qingdao, Shandong, Peoples R China	Chinese Academy of Sciences; Institute of Oceanology, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Chinese Academy of Sciences; Institute of Oceanology, CAS; Qingdao National Laboratory for Marine Science & Technology; Qingdao National Laboratory for Marine Science & Technology	Xu, F; Zhang, GF (corresponding author), Chinese Acad Sci, Key Lab Expt Marine Biol, Inst Oceanol, Qingdao, Shandong, Peoples R China.; Xu, F; Zhang, GF (corresponding author), Chinese Acad Sci, Natl & Local Joint Engn Lab Ecol Mariculture, Inst Oceanol, Qingdao, Shandong, Peoples R China.; Xu, F; Zhang, GF (corresponding author), Qingdao Natl Lab Marine Sci & Technol, Lab Marine Biol & Biotechnol, Qingdao, Shandong, Peoples R China.	xufei@qdio.ac.cn; gfzhang@qdio.ac.cn	li, li/GPX-3938-2022; Xu, Fei/A-1736-2012; Li, Li/AEM-3636-2022; li, li/HII-4157-2022; LI, LI/GVS-5344-2022	Xu, Fei/0000-0002-0981-8429; Li, Yingxiang/0000-0001-6671-2965	National Natural Science Foundation of China [31402285, 31530079]; National Basic Research Program of China (973 Program) [2010CB126401]; Earmarked Fund for Modern Agro-industry Technology Research System [CARS-48]; Scientific and Technological Innovation Project - Qingdao National Laboratory for Marine Science and Technology [2015ASKJ02-03]; Taishan Scholars Climbing Program of Shandong	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research Program of China (973 Program)(National Basic Research Program of China); Earmarked Fund for Modern Agro-industry Technology Research System; Scientific and Technological Innovation Project - Qingdao National Laboratory for Marine Science and Technology; Taishan Scholars Climbing Program of Shandong	This research was supported by the National Natural Science Foundation of China (31402285, 31530079), the National Basic Research Program of China (973 Program, 2010CB126401), the Earmarked Fund for Modern Agro-industry Technology Research System (CARS-48), the Scientific and Technological Innovation Project Financially Supported by Qingdao National Laboratory for Marine Science and Technology (2015ASKJ02-03), and Taishan Scholars Climbing Program of Shandong. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alkema MJ, 2005, NEURON, V46, P247, DOI 10.1016/j.neuron.2005.02.024; Amador-Cano G, 2006, BIOL BULL-US, V210, P121, DOI 10.2307/4134601; BARAK LS, 1994, J BIOL CHEM, V269, P2790; Bayne BL, 1971, SOME MORPHOLOGICAL C; Blais V, 2010, GEN COMP ENDOCR, V167, P215, DOI 10.1016/j.ygcen.2010.03.008; Bockaert J, 1999, EMBO J, V18, P1723, DOI 10.1093/emboj/18.7.1723; Braubach OR, 2006, J EXP BIOL, V209, P4676, DOI 10.1242/jeb.02556; Chambon JP, 2007, DEVELOPMENT, V134, P1203, DOI 10.1242/dev.002220; CLARE AS, 1995, J EXP BIOL, V198, P655; Crocker A, 2008, J NEUROSCI, V28, P9377, DOI 10.1523/JNEUROSCI.3072-08a.2008; Croll RP, 2004, INVERTEBR REPROD DEV, V46, P173, DOI 10.1080/07924259.2004.9652620; Dickinson AJG, 2003, J COMP NEUROL, V466, P197, DOI 10.1002/cne.10863; Du YS, 2013, FISH SHELLFISH IMMUN, V34, P939, DOI 10.1016/j.fsi.2012.12.007; Duportets L, 2010, INSECT MOL BIOL, V19, P489, DOI 10.1111/j.1365-2583.2010.01009.x; Evans Peter D., 2005, Invertebrate Neuroscience, V5, P111, DOI 10.1007/s10158-005-0001-z; FRETTER VERA, 1967, PROC MALACOL SOC LONDON, V37, P357; Gerhardt CC, 1997, J BIOL CHEM, V272, P6201, DOI 10.1074/jbc.272.10.6201; Gerhardt CC, 1997, MOL PHARMACOL, V51, P293, DOI 10.1124/mol.51.2.293; Gerhart J, 1999, TERATOLOGY, V60, P226; Grohmann L, 2003, J NEUROCHEM, V86, P725, DOI 10.1046/j.1471-4159.2003.01876.x; Harper EM, 1997, PALAEONTOLOGY, V40, P71; Haszprunar G, 2012, CURR BIOL, V22, pR510, DOI 10.1016/j.cub.2012.05.039; Holm ER, 1998, BIOL BULL, V195, P21, DOI 10.2307/1542772; Hoyer SC, 2008, CURR BIOL, V18, P159, DOI 10.1016/j.cub.2007.12.052; Huang W, 2015, GENE, V567, P164, DOI 10.1016/j.gene.2015.04.082; Kurten RC, 2003, ADV DRUG DELIVER REV, V55, P1405, DOI 10.1016/j.addr.2003.07.003; Kutsukake M, 2000, GENE, V245, P31, DOI 10.1016/S0378-1119(99)00569-7; LANE DJW, 1975, J MAR BIOL ASSOC UK, V55, P477, DOI 10.1017/S0025315400016076; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; MACKIE GO, 1976, BIOL BULL-US, V151, P182, DOI 10.2307/1540713; Monastirioti M, 2003, DEV BIOL, V264, P38, DOI 10.1016/j.ydbio.2003.07.019; Mustard JA, 2005, J COMP NEUROL, V483, P66, DOI 10.1002/cne.20420; Ohhara Y, 2015, P NATL ACAD SCI USA, V112, P1452, DOI 10.1073/pnas.1414966112; PAWLIK JR, 1990, B MAR SCI, V46, P512; Pirri JK, 2009, NEURON, V62, P526, DOI 10.1016/j.neuron.2009.04.013; Pryce Kerri, 2015, In Vivo (Brooklyn), V37, P16; Rao VTS, 2010, MOL BIOCHEM PARASIT, V173, P64, DOI 10.1016/j.molbiopara.2010.05.005; Rex E, 2005, J NEUROCHEM, V94, P181, DOI 10.1111/j.1471-4159.2005.03180.x; Selcho M, 2012, J COMP NEUROL, V520, P3764, DOI 10.1002/cne.23152; Smith KA, 2007, MOL BIOCHEM PARASIT, V154, P52, DOI 10.1016/j.molbiopara.2007.04.004; STRADER CD, 1995, FASEB J, V9, P745, DOI 10.1096/fasebj.9.9.7601339; STRADER CD, 1994, ANNU REV BIOCHEM, V63, P101, DOI 10.1146/annurev.bi.63.070194.000533; VonNickischRosenegk E, 1996, INSECT BIOCHEM MOLEC, V26, P817, DOI 10.1016/S0965-1748(96)00031-8; Wu SF, 2013, PEST MANAG SCI, V69, P126, DOI 10.1002/ps.3378; Wu TT, 2012, FISH SHELLFISH IMMUN, V33, P286, DOI 10.1016/j.fsi.2012.05.011; YAMAMOTO H, 1995, ZOOL SCI, V12, P391, DOI 10.2108/zsj.12.391; Yang BY, 2015, MOL BIOL REP, V42, P963, DOI 10.1007/s11033-014-3833-y; Yang BY, 2013, COMP BIOCHEM PHYS B, V164, P168, DOI 10.1016/j.cbpb.2012.12.006; Yang BY, 2012, AQUACULTURE, V366, P54, DOI 10.1016/j.aquaculture.2012.08.040; Yue F, 2013, FISH SHELLFISH IMMUN, V34, P855, DOI 10.1016/j.fsi.2012.12.023; Zhang GF, 2012, NATURE, V490, P49, DOI 10.1038/nature11413	51	4	4	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2016	11	12							e0168574	10.1371/journal.pone.0168574	http://dx.doi.org/10.1371/journal.pone.0168574			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI8LN	27992549	Green Published, gold, Green Submitted			2022-12-27	WOS:000392758000059
J	Gu, CM; Liu, Y; Mohamed, I; Zhang, RH; Wang, X; Nie, XX; Jiang, M; Brooks, M; Chen, F; Li, ZG				Gu, Chiming; Liu, Yi; Mohamed, Ibrahim; Zhang, Runhua; Wang, Xiao; Nie, Xinxin; Jiang, Min; Brooks, Margot; Chen, Fang; Li, Zhiguo			Dynamic Changes of Soil Surface Organic Carbon under Different Mulching Practices in Citrus Orchards on Sloping Land	PLOS ONE			English	Article							MATTER; FRACTIONS; PARTICULATE; NITROGEN; TILLAGE; SEQUESTRATION; MANAGEMENT; RUNOFF; POOLS; ASSOCIATIONS	Mulching management has been used in many places all over the world to improve agricultural sustainability. However, the cycling of carbon in the soil under applications of mulch on sloping arable land is not yet fully understood. A four-year field experiment was carried out in Xiaofuling watershed of Danjiangkou reservoir in China. The object was to evaluate the effects of the application of straw mulch (ST) and grass mulch (GT) on dynamic changes in soil organic carbon and its fractions. Results showed that mulch applied on the soil surface increased the contents of SOC and its active fractions in the soil. Compared to the control without cover (CK), ST and GT treatments increased the contents of SOC, LOC, DOC, POC and EOC by 14.73%, 16.5%, 22.5%, 41.5% and 21%, respectively, in the 0-40 cm soil layer, and by 17%, 14%, 19%, and 30%, respectively, in the 0-100 cm soil layer. The contents of organic carbon and its active fractions decreased with increasing soil depth in all of the treatments. SOC was accumulated in the period of December to the following March. The contents of soil DOC and LOC were high in January to March, while the contents of soil POC and EOC were high in June to September. The relative contents of soil organic carbon fractions were POC > EOC > LOC > DOC over the four years. Straw mulching had no significant effect on the changes in soil organic carbon active fractions during the different periods. Based on this long-term field experiment in Danjiangkou reservoir, we found that straw mulching had a significant effect on soil, increasing SOC content and stock in slopping arable land, and that live grass mulching was more effective than rice straw mulching. We discuss possible optimal periods for the implementation of mulching practices on sloping land.	[Gu, Chiming; Liu, Yi; Mohamed, Ibrahim; Wang, Xiao; Nie, Xinxin; Jiang, Min; Chen, Fang; Li, Zhiguo] Chinese Acad Sci China, Wuhan Bot Garden, Lab Aquat Bot & Watershed Ecol, Wuhan, Peoples R China; [Gu, Chiming] Univ Chinese Acad Sci, Grad Sch, Beijing, Peoples R China; [Gu, Chiming] Chinese Acad Agr Sci, Oil Crops Res Inst, Key Lab Biol & Genet Improvement Oil Crops, Minist Agr, Wuhan, Peoples R China; [Zhang, Runhua] Wuhan Acad Agr Sci & Technol, Inst Vegetable, Wuhan, Peoples R China; [Brooks, Margot] Rhodes Univ, Dept Biochem & Microbiol, Grahamstown, South Africa; [Chen, Fang] China Program Int Plant Nutr Inst, Wuhan, Peoples R China	Chinese Academy of Sciences; Wuhan Botanical Garden, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Chinese Academy of Agricultural Sciences; Oil Crops Research Institute, CAAS; Ministry of Agriculture & Rural Affairs; Rhodes University	Chen, F; Li, ZG (corresponding author), Chinese Acad Sci China, Wuhan Bot Garden, Lab Aquat Bot & Watershed Ecol, Wuhan, Peoples R China.; Chen, F (corresponding author), China Program Int Plant Nutr Inst, Wuhan, Peoples R China.	fchen@ipni.ac.cn; lzg250@126.com	Gu, Chiming/K-5381-2019; Li, Xibing/ABD-5781-2021		Knowledge Innovative Program of the Chinese Academy of Sciences [Y455434102]; National Natural Science Foundation of China [41501313, 41471242, 31201618]; National Key Research and Development Plan [2016YFD0200108-4]	Knowledge Innovative Program of the Chinese Academy of Sciences(Knowledge Innovation Program of the Chinese Academy of Sciences); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Key Research and Development Plan	This study was financially supported by the projects of the Knowledge Innovative Program of the Chinese Academy of Sciences (Y455434102), the National Natural Science Foundation of China (41501313; 41471242; 31201618), and the National Key Research and Development Plan (2016YFD0200108-4).; This study was financially supported by the projects of the Knowledge Innovative Program of the Chinese Academy of Sciences (Y455434102), the National Natural Science Foundation of China (41501313; 41471242; 31201618), and the National Key Research and Development Plan (2016YFD0200108-4). We gratefully acknowledge the comments of the subject editor and anonymous reviewers.	Adekalu KO, 2007, BIORESOURCE TECHNOL, V98, P912, DOI 10.1016/j.biortech.2006.02.044; Alvarez CR, 1998, SOIL BIOL BIOCHEM, V30, P767, DOI 10.1016/S0038-0717(97)00168-5; Alvarez R, 2000, SOIL SCI SOC AM J, V64, P184, DOI 10.2136/sssaj2000.641184x; Arneth A, 2015, NATURE, V524, P44, DOI 10.1038/524044a; Bai SH, 2014, BIOL FERT SOILS, V50, P37, DOI 10.1007/s00374-013-0829-z; Bao S.D, 2000, SOIL AGR CHEM ANAL; Bastian F, 2009, SOIL BIOL BIOCHEM, V41, P262, DOI 10.1016/j.soilbio.2008.10.024; BEARE MH, 1993, SOIL SCI SOC AM J, V57, P392, DOI 10.2136/sssaj1993.03615995005700020018x; Bernacchi CJ, 2005, GLOBAL CHANGE BIOL, V11, P1867, DOI 10.1111/j.1365-2486.01050.x; BIEDERBECK VO, 1994, SOIL BIOL BIOCHEM, V26, P1647, DOI 10.1016/0038-0717(94)90317-4; BLAIR GJ, 1995, AUST J AGR RES, V46, P1459, DOI 10.1071/AR9951459; CAMBARDELLA CA, 1992, SOIL SCI SOC AM J, V56, P777, DOI 10.2136/sssaj1992.03615995005600030017x; Chen FS, 2010, APPL SOIL ECOL, V44, P42, DOI 10.1016/j.apsoil.2009.09.003; Chen GS, 2004, PEDOSPHERE, V14, P297; Chen HQ, 2009, SOIL TILL RES, V106, P85, DOI 10.1016/j.still.2009.09.009; Chinese Academy of Sciences, 1978, SOIL PHYS PROP DET M; Conteh A., 1999, HUM SUBST ENV J, V1, P3; Diacono M, 2010, AGRON SUSTAIN DEV, V30, P401, DOI 10.1051/agro/2009040; Duiker SW, 1999, SOIL TILL RES, V52, P73, DOI 10.1016/S0167-1987(99)00059-8; Fallahzade J, 2012, LAND DEGRAD DEV, V23, P53, DOI 10.1002/ldr.1049; Franzluebbers AJ, 2003, SOIL SCI SOC AM J, V67, P132, DOI 10.2136/sssaj2003.0132; Gale WJ, 2000, SOIL SCI SOC AM J, V64, P201, DOI 10.2136/sssaj2000.641201x; GREGORICH EG, 1994, CAN J SOIL SCI, V74, P367, DOI 10.4141/cjss94-051; Gu CM, 2013, AGR RES ARID AREAS, V05, P48; Gu CM, 2013, AGR RES ARID AREAS, V05, P73; Jaillard B., 2003, Handbook of soil acidity, P231; JANZEN HH, 1992, SOIL SCI SOC AM J, V56, P1799, DOI 10.2136/sssaj1992.03615995005600060025x; JARDINE PM, 1989, SOIL SCI SOC AM J, V53, P1378, DOI 10.2136/sssaj1989.03615995005300050013x; Jastrow JD, 1996, SOIL BIOL BIOCHEM, V28, P665, DOI 10.1016/0038-0717(95)00159-X; Jiang PK, 2006, FOREST ECOL MANAG, V236, P30, DOI 10.1016/j.foreco.2006.06.010; Kuhn NJ, 2009, EARTH SURF PROC LAND, V34, P1033, DOI 10.1002/esp.1796; Lal R, 2004, SCIENCE, V304, P1623, DOI 10.1126/science.1097396; LARSON WE, 1972, AGRON J, V64, P204, DOI 10.2134/agronj1972.00021962006400020023x; Lei AL, 2013, CHINA SCI TECHNOLOGY, V12, P22; Lei AL, 2013, CHINA SCI TECHNOLOGY, V12, P20; Li CF, 2012, SOIL TILL RES, V119, P31, DOI 10.1016/j.still.2011.12.005; Liang Q, 2012, NUTR CYCL AGROECOSYS, V92, P21, DOI 10.1007/s10705-011-9469-6; Liu Y, 2012, AGR WATER MANAGE, V110, P34, DOI 10.1016/j.agwat.2012.03.011; Lou Y, 2011, SOIL USE MANAGE, V27, P163, DOI 10.1111/j.1475-2743.2010.00325.x; Luo SS, 2015, EUR J SOIL BIOL, V67, P35, DOI 10.1016/j.ejsobi.2015.01.004; Malhi SS, 2003, NUTR CYCL AGROECOSYS, V66, P33, DOI 10.1023/A:1023376905096; Mendham DS, 2004, SOIL BIOL BIOCHEM, V36, P1067, DOI 10.1016/j.soilbio.2004.02.018; Mi N, 2008, GLOBAL CHANGE BIOL, V14, P2380, DOI 10.1111/j.1365-2486.2008.01642.x; Mulumba LN, 2008, SOIL TILL RES, V98, P106, DOI 10.1016/j.still.2007.10.011; National Soil Survey Office, 1992, SOIL SURV TECHN CHIN, P42; Obalum SE, 2010, SOIL TILL RES, V108, P30, DOI 10.1016/j.still.2010.03.009; Polyakov VO, 2004, SOIL SCI, V169, P590, DOI 10.1097/01.ss.0000138414.84427.40; Post WM, 2000, GLOBAL CHANGE BIOL, V6, P317, DOI 10.1046/j.1365-2486.2000.00308.x; Powlson DS, 2012, AGR ECOSYST ENVIRON, V146, P23, DOI 10.1016/j.agee.2011.10.004; Qiu Y, 2015, J ARID LAND, V7, P46, DOI 10.1007/s40333-014-0076-7; Quinton JN, 2001, J ENVIRON QUAL, V30, P538, DOI 10.2134/jeq2001.302538x; Saito M, 2009, GLOBAL CHANGE BIOL, V15, P221, DOI 10.1111/j.1365-2486.2008.01713.x; Six J, 2002, AGRONOMIE, V22, P755, DOI 10.1051/agro:2002043; [苏永中 Su Yongzhong], 2002, [中国沙漠, Journal of Desert Research], V22, P220; TURCHENEK LW, 1979, GEODERMA, V21, P311, DOI 10.1016/0016-7061(79)90005-3; Unger PW, 1998, SOIL TILL RES, V45, P39, DOI 10.1016/S0167-1987(97)00068-8; Wan ZM, 2011, 2011 5 INT C BIOINF; Wander MM, 2000, SOIL BIOL BIOCHEM, V32, P1151, DOI 10.1016/S0038-0717(00)00031-6; Wang Hu, 2014, Yingyong Shengtai Xuebao, V25, P3491; [王晶 Wang Jing], 2003, [生态学杂志, Chinese Journal of Ecology], V22, P109; Worrall F, 2008, J HYDROL, V358, P84, DOI 10.1016/j.jhydrol.2008.05.037; Yang Y, 2009, CHINA FRUIT IND INFO, V26, P36; YEOMANS JC, 1988, COMMUN SOIL SCI PLAN, V19, P1467, DOI 10.1080/00103628809368027; Zheng LC, 2006, J LIAONING TECHNOLOG, V6, P330; Zhong MF, 2006, P ANN M WAT SOIL CON; Zhu HongXun, 1997, Acta Pedologica Sinica, V34, P138; Zou XM, 2005, SOIL BIOL BIOCHEM, V37, P1923, DOI 10.1016/j.soilbio.2005.02.028	67	33	39	11	76	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2016	11	12							e0168384	10.1371/journal.pone.0168384	http://dx.doi.org/10.1371/journal.pone.0168384			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EG7JB	28030551	gold, Green Published, Green Submitted			2022-12-27	WOS:000391222000046
J	Lede, V; Franke, C; Meusel, A; Teupser, D; Ricken, A; Thiery, J; Schiller, J; Huster, D; Schoneberg, T; Schulz, A				Lede, Vera; Franke, Christin; Meusel, Andrej; Teupser, Daniel; Ricken, Albert; Thiery, Joachim; Schiller, Juergen; Huster, Daniel; Schoeneberg, Torsten; Schulz, Angela			Severe Atherosclerosis and Hypercholesterolemia in Mice Lacking Both the Melanocortin Type 4 Receptor and Low Density Lipoprotein Receptor	PLOS ONE			English	Article							E-DEFICIENT MICE; NONALCOHOLIC STEATOHEPATITIS; BRACHIOCEPHALIC ARTERY; FRAMESHIFT MUTATION; KNOCKOUT MICE; HUMAN OBESITY; MOUSE MODELS; AORTIC ROOT; LEPTIN; LIVER	Dysfunction of the melanocortin system can result in severe obesity accompanied with dyslipidemia and symptoms of the metabolic syndrome but the effect on vascular atherogenesis is not known. To study the impact of obesity and dyslipidemia on the cardiovascular system, we generated mice double-deficient for the melanocortin type 4 receptor (Mc4r(mut) mice) and the LDL receptor (Ldlr(-/-) mice). Mc4r(mut) mice develop obesity due to hyperphagia. Double-mutant mice (Mc4r(mut); Ldlr(-/-)) exhibited massive increases in body weight, plasma cholesterol and triacylglycerol levels and developed atherosclerosis. Atherosclerotic lesion size was affected throughout the aortic root and brachiocephalic artery not only under semisynthetic, cholesterol-containing diet but also under cholesterol-free standard chow. The Mc4r(mut) mice developed a hepatic steatosis which contributes to increased plasma cholesterol levels even under cholesterol-free standard chow. Transcripts of cholesterol biosynthesis components and liver cholesterol levels did not significantly differ between wild-type and all mutant mouse strains but RNA sequencing data and biochemical measurements point to an altered bile acid elimination in Mc4r(mut); Ldlr(-/-). Therefore, the unchanged endogenous cholesterol biosynthesis together with a reduced hepatic VLDL and LDL-cholesterol clearance most likely led to increased plasma lipid levels and consequently to atherosclerosis in this animal model. Our data indicate that dysfunction of the melanocortin-regulated food intake and the resulting obesity significantly add to the proatherogenic lipoprotein profile caused by LDL receptor deficiency and, therefore, can be regarded as relevant risk factor for atherosclerosis.	[Lede, Vera; Franke, Christin; Meusel, Andrej; Schoeneberg, Torsten; Schulz, Angela] Univ Leipzig, Rudolf Schonheimer Inst Biochem, Fac Med, Mol Biochem, Leipzig, Germany; [Meusel, Andrej; Schiller, Juergen; Huster, Daniel] Univ Leipzig, Inst Med Phys & Biophys, Fac Med, Leipzig, Germany; [Teupser, Daniel; Thiery, Joachim] Univ Leipzig, Inst Lab Med Clin Chem & Mol Diagnost, Fac Med, Leipzig, Germany; [Teupser, Daniel] Ludwig Maximilians Univ Munchen, Inst Lab Med, Munich, Germany; [Ricken, Albert] Univ Leipzig, Inst Anat, Fac Med, Leipzig, Germany	Leipzig University; Leipzig University; Leipzig University; University of Munich; Leipzig University	Schoneberg, T; Schulz, A (corresponding author), Univ Leipzig, Rudolf Schonheimer Inst Biochem, Fac Med, Mol Biochem, Leipzig, Germany.	schoberg@medizin.uni-leipzig.de; angela.schulz@medizin.uni-leipzig.de	Lede, Vera/C-7258-2014	Lede, Vera/0000-0001-6045-2605	Deutsche Forschungsgemeinschaft [Sfb 1052]; Medical Faculty, University of Leipzig	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Medical Faculty, University of Leipzig	This work was supported by the Deutsche Forschungsgemeinschaft (Sfb 1052, B6 and B7) and a student fellowship of the Medical Faculty, University of Leipzig, to C.M. http://www.sfb1052.de/index.php/en/.	Albarado DC, 2004, ENDOCRINOLOGY, V145, P243, DOI 10.1210/en.2003-0452; Alberti KGMM, 2009, CIRCULATION, V120, P1640, DOI 10.1161/CIRCULATIONAHA.109.192644; Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; Atkinson RD, 2008, AM J PHYSIOL-ENDOC M, V294, pE284, DOI 10.1152/ajpendo.00601.2007; Bamba V, 2007, GASTROENTEROLOGY, V132, P2181, DOI 10.1053/j.gastro.2007.03.056; Chiba T, 2008, ATHEROSCLEROSIS, V196, P68, DOI 10.1016/j.atherosclerosis.2007.01.040; Crowley VEF, 2008, ANN CLIN BIOCHEM, V45, P245, DOI 10.1258/acb.2007.007193; Fan T, 2000, ENDOCRINOLOGY, V141, P3072; Farooqi IS, 2006, ENDOCR REV, V27, P710, DOI 10.1210/er.2006-0040; Farooqi IS, 2003, NEW ENGL J MED, V348, P1085, DOI 10.1056/NEJMoa022050; Flicek P, 2012, NUCLEIC ACIDS RES, V40, pD84, DOI 10.1093/nar/gkr991; FOLCH J, 1957, J BIOL CHEM, V226, P497; Fu SN, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002902; Gavrilova O, 2003, J BIOL CHEM, V278, P34268, DOI 10.1074/jbc.M300043200; Grosse J, 2006, PHYSIOL GENOMICS, V26, P209, DOI 10.1152/physiolgenomics.00289.2005; Haskell-Luevano C, 2009, FASEB J, V23, P642, DOI 10.1096/fj.08-109686; Hasty AH, 2001, J BIOL CHEM, V276, P37402, DOI 10.1074/jbc.M010176200; Huszar D, 1997, CELL, V88, P131, DOI 10.1016/S0092-8674(00)81865-6; ISHIBASHI S, 1993, J CLIN INVEST, V92, P883, DOI 10.1172/JCI116663; ISHIBASHI S, 1994, J CLIN INVEST, V93, P1885, DOI 10.1172/JCI117179; Itoh M, 2011, AM J PATHOL, V179, P2454, DOI 10.1016/j.ajpath.2011.07.014; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Li SZ, 2009, CIRC RES, V105, P1072, DOI 10.1161/CIRCRESAHA.109.199570; Matsusue K, 2003, J CLIN INVEST, V111, P737, DOI 10.1172/JCI200317223; Meyer M, 2012, SCIENCE, V338, P222, DOI 10.1126/science.1224344; Mueller MA, 2008, ATHEROSCLEROSIS, V198, P39, DOI 10.1016/j.atherosclerosis.2007.09.019; Nogueiras R, 2007, J CLIN INVEST, V117, P3475, DOI 10.1172/JCI31743; Nojima K, 2013, ENDOCR J, V60, P261, DOI 10.1507/endocrj.EJ12-0258; Perfield JW, 2013, J OBES, V2013, DOI 10.1155/2013/296537; Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033; Shimizu H, 2007, J ENDOCRINOL, V193, P1, DOI 10.1677/JOE-06-0144; Shimomura I, 2000, MOL CELL, V6, P77, DOI 10.1016/S1097-2765(00)00009-5; Staubert C, 2007, ENDOCRINOLOGY, V148, P4642, DOI 10.1210/en.2007-0138; Ste Marie L, 2000, P NATL ACAD SCI USA, V97, P12339, DOI 10.1073/pnas.220409497; Sutton GM, 2006, ENDOCRINOLOGY, V147, P2183, DOI 10.1210/en.2005-1209; Taleb S, 2007, ARTERIOSCL THROM VAS, V27, P2691, DOI 10.1161/ATVBAHA.107.149567; Tallam LS, 2005, HYPERTENSION, V46, P326, DOI 10.1161/01.HYP.0000175474.99326.bf; TANGIRALA RK, 1995, J LIPID RES, V36, P2320; Tao YX, 2010, ENDOCR REV, V31, P506, DOI 10.1210/er.2009-0037; Teupser D, 2004, P NATL ACAD SCI USA, V101, P17795, DOI 10.1073/pnas.0408096101; Teupser D, 2003, ARTERIOSCL THROM VAS, V23, P1907, DOI 10.1161/01.ATV.0000090126.34881.B1; Vaisse C, 1998, NAT GENET, V20, P113, DOI 10.1038/2407; VANREE JH, 1994, ATHEROSCLEROSIS, V111, P25, DOI 10.1016/0021-9150(94)90188-0; Wouters K, 2008, HEPATOLOGY, V48, P474, DOI 10.1002/hep.22363; Wu KK, 2005, ATHEROSCLEROSIS, V181, P251, DOI 10.1016/j.atherosclerosis.2005.01.029; Yeo GSH, 1998, NAT GENET, V20, P111, DOI 10.1038/2404	46	4	4	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2016	11	12							e0167888	10.1371/journal.pone.0167888	http://dx.doi.org/10.1371/journal.pone.0167888			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EG7JB	28030540	Green Published, gold, Green Submitted			2022-12-27	WOS:000391222000025
J	Nguyen, LDN; Deschaght, P; Merlin, S; Loywick, A; Audebert, C; Van Daele, S; Viscogliosi, E; Vaneechoutte, M; Delhaes, L				Linh Do Ngoc Nguyen; Deschaght, Pieter; Merlin, Sophie; Loywick, Alexandre; Audebert, Christophe; Van Daele, Sabine; Viscogliosi, Eric; Vaneechoutte, Mario; Delhaes, Laurence			Effects of Propidium Monoazide (PMA) Treatment on Mycobiome and Bacteriome Analysis of Cystic Fibrosis Airways during Exacerbation	PLOS ONE			English	Article							PSEUDOMONAS-AERUGINOSA; CANDIDA-ALBICANS; SAMPLES; MICROBIOME; CELLS; RARE; QUANTIFICATION; ASPERGILLOSIS; COMMUNITIES; DIVERSITY	Introduction and Purpose Propidium monoazide (PMA)-pretreatment has increasingly been applied to remove the bias from dead or damaged cell artefacts, which could impact the microbiota analysis by high-throughput sequencing. Our study aimed to determine whether a PMA-pretreatment coupled with high-throughput sequencing analysis provides a different picture of the airway mycobiome and bacteriome. Results and Discussion We compared deep-sequencing data of mycobiota and microbiota of 15 sputum samples from 5 cystic fibrosis (CF) patients with and without prior PMA-treatment of the DNA-extracts. PMA-pretreatment had no significant effect on the entire and abundant bacterial community (genera expressed as operational taxonomic units (OTUs) with a relative abundance greater than or equal to 1%), but caused a significant difference in the intermediate community (less than 1%) when analyzing the alpha biodiversity Simpson index (p = 0.03). Regarding PMA impact on the airway mycobiota evaluated for the first time here; no significant differences in alpha diversity indexes between PMA-treated and untreated samples were observed. Regarding beta diversity analysis, the intermediate communities also differed more dramatically than the total and abundant ones when studying both mycobiome and bacteriome. Our results showed that only the intermediate (or low abundance) population diversity is impacted by PMA-treatment, and therefore that abundant taxa are mostly viable during acute exacerbation in CF. Given such a cumbersome protocol (PMA-pretreatment coupled with high-throughput sequencing), we discuss its potential interest within the follow-up of CF patients. Further studies using PMA-pretreatment are warranted to improve our "omic" knowledge of the CF airways.	[Linh Do Ngoc Nguyen; Viscogliosi, Eric; Delhaes, Laurence] Univ Lille, Inst Pasteur Lille, Ctr Infect & Immun Lille, INSERM U1019,CNRS UMR 8204, Lille, France; [Deschaght, Pieter; Vaneechoutte, Mario] Univ Ghent, Lab Bacteriol Res, Fac Med & Hlth Sci, Ghent, Belgium; [Merlin, Sophie; Loywick, Alexandre; Audebert, Christophe] GenesDiffusion, Douai, France; [Merlin, Sophie; Loywick, Alexandre; Audebert, Christophe] Inst Pasteur, PEGASE, Biosci, Lille, France; [Van Daele, Sabine] Univ Ghent, Dept Pediat & Genet, Fac Med & Hlth Sci, Ghent, Belgium; [Delhaes, Laurence] Fac Med, Reg Hosp Ctr, Parasitol Med Mycol Dept, Lille, France; [Delhaes, Laurence] Reg Hosp Ctr, INSERM U1045, Parasitol Med Mycol Dept, Bordeaux, France; [Delhaes, Laurence] Fac Med Bordeaux, Bordeaux, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); Le Reseau International des Instituts Pasteur (RIIP); Universite de Lille - ISITE; Institut Pasteur Lille; Universite de Lille; Ghent University; Le Reseau International des Instituts Pasteur (RIIP); Universite de Lille - ISITE; Institut Pasteur Lille; Ghent University; Universite de Lille - ISITE; CHU Lille; Universite de Lille; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite de Bordeaux	Delhaes, L (corresponding author), Univ Lille, Inst Pasteur Lille, Ctr Infect & Immun Lille, INSERM U1019,CNRS UMR 8204, Lille, France.; Delhaes, L (corresponding author), Fac Med, Reg Hosp Ctr, Parasitol Med Mycol Dept, Lille, France.; Delhaes, L (corresponding author), Reg Hosp Ctr, INSERM U1045, Parasitol Med Mycol Dept, Bordeaux, France.; Delhaes, L (corresponding author), Fac Med Bordeaux, Bordeaux, France.	laurence.delhaes@chu-bordeaux.fr	Vaneechoutte, Mario/A-6189-2009; Delhaes, Laurence/AAD-6930-2020	Vaneechoutte, Mario/0000-0002-4586-203X; Delhaes, Laurence/0000-0001-7489-9205; Van daele, Sabine/0000-0002-6632-1240	French Ministry of Health and Research (PHRC) [2006/1902]; Lille Hospital; Lille 2 University [R7000]; Pasteur Institute of Lille	French Ministry of Health and Research (PHRC); Lille Hospital; Lille 2 University; Pasteur Institute of Lille	Laurence Delhaes has received research grants from the French Ministry of Health and Research (PHRC no. 2006/1902), Lille Hospital, Lille 2 University (Lille and Ghent Universities partnership: R7000), and Pasteur Institute of Lille. These funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. GenesDiffusion's company provided support in the form of salaries for authors (SM, AL, AC) of GenesDiffusion's company, but did not have any additional role in the study design, data collection and analysis, or decision to publish. The specific roles of these authors are articulated in the 'author contributions' section.	Agusti G, 2013, APPL MICROBIOL BIOT, V97, P341, DOI 10.1007/s00253-012-4524-z; Baxter CG, 2013, J ALLERGY CLIN IMMUN, V132, P560, DOI 10.1016/j.jaci.2013.04.007; Cai YP, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkr349; Charlson ES, 2012, AM J RESP CRIT CARE, V186, P536, DOI 10.1164/rccm.201204-0693OC; Chiao TH, 2014, ENVIRON SCI TECHNOL, V48, P4038, DOI 10.1021/es4055725; Delhaes L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036313; Deschaght P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079010; Deschaght P, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-245; Dickson RP, 2015, ANN AM THORAC SOC, V12, P821, DOI 10.1513/AnnalsATS.201501-029OC; Exterkate RAM, 2015, CLIN ORAL INVEST, V19, P813, DOI 10.1007/s00784-014-1297-z; Filkins LM, 2012, J BACTERIOL, V194, P4709, DOI 10.1128/JB.00566-12; Fittipaldi M, 2012, J MICROBIOL METH, V91, P276, DOI 10.1016/j.mimet.2012.08.007; Frealle E, 2009, EUR J CLIN MICROBIOL, V28, P223, DOI 10.1007/s10096-008-0616-1; Galand PE, 2009, P NATL ACAD SCI USA, V106, P22427, DOI 10.1073/pnas.0908284106; Goddard AF, 2012, P NATL ACAD SCI USA, V109, P13769, DOI 10.1073/pnas.1107435109; Goecks J, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-8-r86; Hammer Oyvind, 2001, Palaeontologia Electronica, V4, pUnpaginated; Hoiby N, 2010, FUTURE MICROBIOL, V5, P1663, DOI [10.2217/fmb.10.125, 10.2217/FMB.10.125]; Kurtzman CP, 2003, FEMS YEAST RES, V4, P233, DOI 10.1016/S1567-1356(03)00175-2; Logares R, 2014, CURR BIOL, V24, P813, DOI 10.1016/j.cub.2014.02.050; Manavathu EK, 2014, BMC MICROBIOL, V14, DOI 10.1186/1471-2180-14-53; Mangot JF, 2013, ENVIRON MICROBIOL, V15, P1745, DOI 10.1111/1462-2920.12065; Marsland BJ, 2014, NAT REV IMMUNOL, V14, P827, DOI 10.1038/nri3769; McDonald D, 2012, GIGASCIENCE, V1, DOI 10.1186/2047-217X-1-7; Mear JB, 2013, MED MALADIES INFECT, V43, P146, DOI 10.1016/j.medmal.2013.02.005; Nguyen LDN, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00089; Nocker A, 2010, INT MICROBIOL, V13, P59, DOI 10.2436/20.1501.01.111; Peleg AY, 2010, NAT REV MICROBIOL, V8, P340, DOI 10.1038/nrmicro2313; Pruesse E, 2007, NUCLEIC ACIDS RES, V35, P7188, DOI 10.1093/nar/gkm864; Quero GM, 2014, MAR GENOM, V17, P9, DOI 10.1016/j.margen.2014.04.002; Quinn RA, 2015, ISME J, V9, P1024, DOI 10.1038/ismej.2014.234; Ratjen F, 2012, AM J RESP CRIT CARE, V185, P933, DOI 10.1164/rccm.201202-0306UP; Rogers GB, 2013, ISME J, V7, P697, DOI 10.1038/ismej.2012.145; Roges GB, 2008, DIAGN MICR INFEC DIS, V62, P133, DOI 10.1016/j.diagmicrobio.2008.06.011; Roux D, 2009, CRIT CARE MED, V37, P1062, DOI 10.1097/CCM.0b013e31819629d2; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Stenbit AE, 2011, CURR OPIN PULM MED, V17, P442, DOI 10.1097/MCP.0b013e32834b8c04; Surette Michael G, 2014, Ann Am Thorac Soc, V11 Suppl 1, pS61, DOI 10.1513/AnnalsATS.201306-159MG; Tavernier S, 2015, PEERJ, V3, DOI 10.7717/peerj.787; Taylor Michael J, 2014, Microbiol Insights, V7, P15, DOI 10.4137/MBI.S17723; Toju H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040863; Touati K, 2014, CURR FUNGAL INFECT R, V8, P302, DOI 10.1007/s12281-014-0197-7; Vaishampayan P, 2013, ISME J, V7, P312, DOI 10.1038/ismej.2012.114; van Woerden HC, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-69; Venkataraman A, 2015, MBIO, V6, DOI 10.1128/mBio.02284-14; Venkateswaran K, 2014, APPL MICROBIOL BIOT, V98, P6453, DOI 10.1007/s00253-014-5650-6; Vesper S, 2008, J MICROBIOL METH, V72, P180, DOI 10.1016/j.mimet.2007.11.017; Waters VJ, 2015, J CYST FIBROS, V14, P755, DOI 10.1016/j.jcf.2015.01.007; Whiley RA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0115513; Whiteson KL, 2014, ISME J, V8, P1247, DOI 10.1038/ismej.2013.229; Willger SD, 2014, MICROBIOME, V2, DOI 10.1186/2049-2618-2-40; Xu H, 2014, CELL MICROBIOL, V16, P214, DOI 10.1111/cmi.12216; Zhao JC, 2012, P NATL ACAD SCI USA, V109, P5809, DOI 10.1073/pnas.1120577109	53	18	19	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2016	11	12							e0168860	10.1371/journal.pone.0168860	http://dx.doi.org/10.1371/journal.pone.0168860			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EG7JB	28030619	Green Published, gold, Green Submitted			2022-12-27	WOS:000391222000081
J	Mier-Aguilar, CA; Cashman, KS; Raman, C; Soldevila, G				Mier-Aguilar, Carlos A.; Cashman, Kevin S.; Raman, Chander; Soldevila, Gloria			CD5-CK2 Signaling Modulates Erk Activation and Thymocyte Survival	PLOS ONE			English	Article							T-CELL DEVELOPMENT; CASEIN KINASE 2; NEGATIVE SELECTION; REGULATED KINASE; IN-VIVO; TRANSGENIC MICE; CD5; RECEPTOR; CK2; EXPRESSION	CD5 is well recognized for its importance in thymic selection. Although this property of CD5 has been attributed to its ITIM-domain dependent regulation of TCR-signal strength, the mechanism has not been established. A second major signaling domain within the cytoplasmic tail of CD5 is a CK2 binding/activation domain (CD5-CK2BD). Using a gene-targeted mouse in which the CD5-CK2BD is selectively ablated (CD5-ACK2BD), we determined that loss of function of CD5-CK2 signaling in a MHC-II selecting TCR transgenic (OT-11) mouse resulted in decrease in double positive (DP) thymocytes, which correlated with enhanced apoptosis. Remarkably, DP cells expressing high levels of CD5 and CD69 and single positive (CD4+SP) thymocytes were increased in CD5-ACK2BD mice indicating that CD5-CK2 signaling regulates positive selection and promotes survival. Consistent with this possibility, we determined that the activation and nuclear localization of ERK as well as apoptosis was greater in thymic populations from OTI1 CD5-ACK2BD mice than OTII CD5-WT mice following injection of OVA(323-339)-peptide. The mobilization of Ca2+, an early event of TCR activation, was not altered by the loss of CD5-CK2 signaling. Collectively, these data demonstrate that the CD5-CK2 signaling axis regulates positive selection by modulating activation of ERK and promoting survival independent of proximal TCR signals.	[Mier-Aguilar, Carlos A.; Soldevila, Gloria] Univ Nacl Autonoma Mexico, Dept Inmunol, Inst Invest Biomed, Mexico City, DF, Mexico; [Cashman, Kevin S.; Raman, Chander] Univ Alabama Birmingham, Dept Microbiol, Div Clin Immunol & Rheumatol, Birmingham, AL 35294 USA; [Raman, Chander] Univ Alabama Birmingham, Dept Med, Div Clin Immunol & Rheumatol, Birmingham, AL 35294 USA; [Mier-Aguilar, Carlos A.] Inst Nacl Enfermedades Resp Ismael Cosio Villegas, Dept Invest Enfermedades Infecciosas, Mexico City, DF, Mexico; [Cashman, Kevin S.] Emory Univ, Div Rheumatol, Lowance Ctr Human Immunol, 255 Whitehead Biomed Res Bldg, Atlanta, GA 30322 USA	Universidad Nacional Autonoma de Mexico; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; Emory University	Soldevila, G (corresponding author), Univ Nacl Autonoma Mexico, Dept Inmunol, Inst Invest Biomed, Mexico City, DF, Mexico.; Raman, C (corresponding author), Univ Alabama Birmingham, Dept Microbiol, Div Clin Immunol & Rheumatol, Birmingham, AL 35294 USA.; Raman, C (corresponding author), Univ Alabama Birmingham, Dept Med, Div Clin Immunol & Rheumatol, Birmingham, AL 35294 USA.	craman@uab.edu; soldevi@unam.mx		Soldevila, Gloria/0000-0003-1539-2548	Consejo Nacional de Ciencia y Tecnologia (CONACYT), Mexico [166024]; National Institutes of Health [AI 1076562]; Consejo Nacional de Ciencia y Tecnologia (CONACYT) [245318/303389]; NATIONAL CANCER INSTITUTE [P30CA013148] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [G20RR022807, G20RR025858] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI027767] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [P30AR048311] Funding Source: NIH RePORTER	Consejo Nacional de Ciencia y Tecnologia (CONACYT), Mexico(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Consejo Nacional de Ciencia y Tecnologia (CONACYT)(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	Work was supported by Grants from Consejo Nacional de Ciencia y Tecnologia (CONACYT #166024) (GS), Mexico (www.conacyt.gob.mx), and from National Institutes of Health AI 1076562 (CR) (https://www.nih.gov). CMA was supported by a doctoral fellowship from Consejo Nacional de Ciencia y Tecnologia (CONACYT#245318/303389).	Au-Yeung BB, 2014, NAT IMMUNOL, V15, P687, DOI 10.1038/ni.2918; Axtell RC, 2006, J IMMUNOL, V177, P8542, DOI 10.4049/jimmunol.177.12.8542; Azzam HS, 1998, J EXP MED, V188, P2301, DOI 10.1084/jem.188.12.2301; Azzam HS, 2001, J IMMUNOL, V166, P5464, DOI 10.4049/jimmunol.166.9.5464; Barnden MJ, 1998, IMMUNOL CELL BIOL, V76, P34, DOI 10.1046/j.1440-1711.1998.00709.x; Brewer JA, 2002, J IMMUNOL, V169, P1837, DOI 10.4049/jimmunol.169.4.1837; Castellanos MD, 1997, J IMMUNOL, V159, P5463; Chan S, 1999, EUR J IMMUNOL, V29, P2916, DOI 10.1002/(SICI)1521-4141(199909)29:09<2916::AID-IMMU2916>3.0.CO;2-I; Di Maira G, 2005, CELL DEATH DIFFER, V12, P668, DOI 10.1038/sj.cdd.4401604; Fink PJ, 2013, ANNU REV IMMUNOL, V31, P31, DOI 10.1146/annurev-immunol-032712-100010; Fischer AM, 2005, IMMUNITY, V23, P431, DOI 10.1016/j.immuni.2005.08.013; Fu GP, 2010, J EXP MED, V207, P309, DOI 10.1084/jem.20090880; Haxhinasto S, 2008, J EXP MED, V205, P565, DOI 10.1084/jem.20071477; Heriche JK, 1997, SCIENCE, V276, P952, DOI 10.1126/science.276.5314.952; Hogquist KA, 2014, NAT IMMUNOL, V15, P815, DOI 10.1038/ni.2938; Hsieh CS, 2012, NAT REV IMMUNOL, V12, P157, DOI 10.1038/nri3155; Kishimoto H, 1997, J EXP MED, V185, P263, DOI 10.1084/jem.185.2.263; Kishimoto H, 1998, J EXP MED, V187, P1427, DOI 10.1084/jem.187.9.1427; Klein L, 2014, NAT REV IMMUNOL, V14, P377, DOI 10.1038/nri3667; Koonpaew S, 2006, J EXP MED, V203, P119, DOI 10.1084/jem.20050903; Love PE, 2011, NAT REV IMMUNOL, V11, P469, DOI 10.1038/nri2989; Ludviksson BR, 1999, J IMMUNOL, V163, P4349; McGargill MA, 2000, NAT IMMUNOL, V1, P336, DOI 10.1038/79790; McGuire DJ, 2014, EUR J IMMUNOL, V44, P1137, DOI 10.1002/eji.201343998; McNeil LK, 2005, P NATL ACAD SCI USA, V102, P13574, DOI 10.1073/pnas.0505110102; Meggio F, 2003, FASEB J, V17, P349, DOI 10.1096/fj.02-0473rev; Mier-Aguilar CA, 2015, BIOCHEM BIOPH RES CO, V466, P381, DOI 10.1016/j.bbrc.2015.09.033; Miyata Y, 2004, MOL CELL BIOL, V24, P4065, DOI 10.1128/MCB.24.9.4065-4074.2004; Ordonez-Rueda D, 2009, EUR J IMMUNOL, V39, P2233, DOI 10.1002/eji.200839053; Plotnikov A, 2011, MOL CELL BIOL, V31, P3515, DOI 10.1128/MCB.05424-11; Raman C, 1998, J BIOL CHEM, V273, P19183, DOI 10.1074/jbc.273.30.19183; Roa NS, 2013, BIOCHEM BIOPH RES CO, V432, P52, DOI 10.1016/j.bbrc.2013.01.086; Sauer S, 2008, P NATL ACAD SCI USA, V105, P7797, DOI 10.1073/pnas.0800928105; Sestero CM, 2012, J IMMUNOL, V189, P2918, DOI 10.4049/jimmunol.1200065; Sinclair C, 2013, P NATL ACAD SCI USA, V110, pE2905, DOI 10.1073/pnas.1304859110; Singer A, 2008, NAT REV IMMUNOL, V8, P788, DOI 10.1038/nri2416; SINGER GG, 1994, IMMUNITY, V1, P365, DOI 10.1016/1074-7613(94)90067-1; Soldevila G, 2011, CURR OPIN IMMUNOL, V23, P310, DOI 10.1016/j.coi.2011.03.003; Starr TK, 2003, ANNU REV IMMUNOL, V21, P139, DOI 10.1146/annurev.immunol.21.120601.141107; Stritesky GL, 2013, P NATL ACAD SCI USA, V110, P4679, DOI 10.1073/pnas.1217532110; TARAKHOVSKY A, 1995, SCIENCE, V269, P535, DOI 10.1126/science.7542801; Thornton TM, 2008, SCIENCE, V320, P667, DOI 10.1126/science.1156037; Ulges A, 2015, NAT IMMUNOL, V16, P267, DOI 10.1038/ni.3083; Whitmarsh AJ, 2011, MOL CELL BIOL, V31, P3512, DOI 10.1128/MCB.05916-11; Yoon S, 2006, GROWTH FACTORS, V24, P21, DOI 10.1080/02699050500284218; Zhou XY, 2000, J IMMUNOL, V164, P1260, DOI 10.4049/jimmunol.164.3.1260; Zhuang SG, 2006, J PHARMACOL EXP THER, V319, P991, DOI 10.1124/jpet.106.107367	47	10	11	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2016	11	12							e0168155	10.1371/journal.pone.0168155	http://dx.doi.org/10.1371/journal.pone.0168155			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EG7JB	28030587	Green Published, gold, Green Submitted			2022-12-27	WOS:000391222000038
J	Sarrazin, C; Manns, M; Calleja, JL; Garcia-Samaniego, J; Forns, X; Kaste, R; Bai, XF; Wu, J; Stern, JO				Sarrazin, Christoph; Manns, Michael; Luis Calleja, Jose; Garcia-Samaniego, Javier; Forns, Xavier; Kaste, Renee; Bai, Xiaofei; Wu, Jing; Stern, Jerry O.			HCVerso3: An Open-Label, Phase IIb Study of Faldaprevir and Deleobuvir with Ribavirin in Hepatitis C Virus Genotype-1b-Infected Patients with Cirrhosis and Moderate Hepatic Impairment	PLOS ONE			English	Article							BI 207127; INFECTION; INHIBITOR	This study evaluated the interferon-free, oral combination of deleobuvir (non-nucleoside HCV NS5-RNA-polymerase inhibitor) and faldaprevir (HCV NS3/4A-protease inhibitor) with ribavirin in patients with HCV genotype-1b and moderate (Child-Pugh B [CPB], n = 17) or mild hepatic impairment (Child-Pugh A [CPA], n = 18). Patients received faldaprevir 120 mg and deleobuvir (600 mg [CPA], 400 mg [CPB]) twice-daily with weight-based ribavirin for 24 weeks. Baseline characteristics were similar between groups. Among CPA patients, 13/18 completed treatment; discontinuations were for adverse events (AEs, n = 1), lack of efficacy (n = 3) and withdrawal (n = 1). Among CPB patients, 8/17 completed treatment; discontinuations were for AEs (n = 6), withdrawal (n =1) and 'other' (n = 2). Sustained virologic response at post-treatment Week 12 (SVR12) was achieved by 11 (61%) CPA patients (95% confidence interval: 38.6%-83.6%) and 9 (53%) CPB patients (95% confidence interval: 29.2%-76.7%), including most CPA (11/16) patients with Week 4 HCV RNA <25 IU.mL(-1) (target detected or not detected) and most CPB (8/9) patients with Week 4 HCV RNA <25 IU.mL(-1) (target not detected); 0/4 CPB patients with Week 4 HCV RNA <25 IU.mL(-1) (target detected) achieved SVR12. The most common AEs in both groups were nausea, diarrhoea and vomiting. Serious AEs were observed in 9 (53%) CPB patients and 1 (6%) CPA patient. Plasma trough concentrations of deleobuvir and faldaprevir were not substantially different between the CPA and CPB groups. In conclusion, in this small study the safety and efficacy profiles for 24 weeks of treatment with faldaprevir+deleobuvir+ribavirin in patients with mild or moderate hepatic impairment were consistent with the safety and efficacy profile of this regimen in non-cirrhotic patients. Faldaprevir+deleobuvir+ribavirin resulted in SVR12 in 53-61% of patients: proportions achieving SVR4 but not SVR12 were higher than in non-cirrhotic patients and overall response rates were lower than rates reported with other all oral regimens in patients with cirrhosis.	[Sarrazin, Christoph] JW Goethe Univ Hosp, Frankfurt, Germany; [Manns, Michael] Hannover Med Sch, Hannover, Germany; [Luis Calleja, Jose] Univ Auton Madrid, CIBERehd, Hosp Univ Puerta Hierro, Madrid, Spain; [Garcia-Samaniego, Javier] Hosp Univ La Paz Carlos III, CIBERehd, IdiPAZ, Madrid, Spain; [Forns, Xavier] Hosp Clin Barcelona, CIBERehd, IDIBAPS, Barcelona, Spain; [Kaste, Renee; Bai, Xiaofei; Wu, Jing; Stern, Jerry O.] Boehringer Ingelheim Pharmaceut Inc, 90 E Ridge POB 368, Ridgefield, CT 06877 USA	Goethe University Frankfurt; Goethe University Frankfurt Hospital; Hannover Medical School; CIBER - Centro de Investigacion Biomedica en Red; CIBEREHD; Hospital Puerta de Hierro-Majadahonda; CIBER - Centro de Investigacion Biomedica en Red; CIBEREHD; Hospital Carlos III; Hospital Universitario La Paz; CIBER - Centro de Investigacion Biomedica en Red; CIBEREHD; University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; Boehringer Ingelheim	Sarrazin, C (corresponding author), JW Goethe Univ Hosp, Frankfurt, Germany.	sarrazin@em.uni-frankfurt.de	Panero, Jose Luis Calleja/A-5351-2010	Panero, Jose Luis Calleja/0000-0002-2265-6591; Garcia-Samaniego, Javier/0000-0002-9974-0855; Forns, Xavier/0000-0002-8188-1764	Boehringer Ingelheim Pharma GmbH Co. KG; Boehringer Ingelheim; Esther Race of Choice Healthcare Solutions	Boehringer Ingelheim Pharma GmbH Co. KG(Boehringer Ingelheim); Boehringer Ingelheim(Boehringer Ingelheim); Esther Race of Choice Healthcare Solutions	This study was wholly funded and supported by Boehringer Ingelheim Pharma GmbH & Co. KG. The funder was involved in study design, data collection and analysis, decision to publish, and preparation of the manuscript. Medical writing assistance, supported financially by Boehringer Ingelheim, was provided by Esther Race of Choice Healthcare Solutions, during the preparation of this manuscript.	[Anonymous], 2014, EASL REC TREAT HEP C; Bourliere M, 2015, LANCET INFECT DIS; El-Kamary SS, 2011, CLIN INFECT DIS, V53, P150, DOI 10.1093/cid/cir306; Gilead Sciences I, 2013, SOVALDITM SOF PRESCR; Gower E, 2014, J HEPATOL, V61, pS45, DOI 10.1016/j.jhep.2014.07.027; LaPlante SR, 2014, J MED CHEM, V57, P1845, DOI 10.1021/jm4011862; Larrey D, 2013, ANTIMICROB AGENTS CH, V57, P4727, DOI 10.1128/AAC.00565-13; Manns MP, 2011, J HEPATOL, V54, P1114, DOI 10.1016/j.jhep.2010.08.040; Mohd Hanafiah K, 2013, HEPATOLOGY, V57, P1333, DOI DOI 10.1002/HEP.26141; Negro F, 2011, LIVER INT, V31, P1, DOI 10.1111/j.1478-3231.2011.02537.x; Pawlotsky JM, 2014, GASTROENTEROLOGY, V146, P1176, DOI 10.1053/j.gastro.2014.03.003; Poordad F, 2014, NEW ENGL J MED, V370, P1973, DOI 10.1056/NEJMoa1402869; Sarrazin C, 2016, CLIN EXP GA IN PRESS; Velosa J., 2016, ANTIVIR THER; White PW, 2010, ANTIMICROB AGENTS CH, V54, P4611, DOI 10.1128/AAC.00787-10; Zeuzem S, 2015, LIVER INT, V35, P417, DOI 10.1111/liv.12693; Zeuzem S, 2013, ANTIVIR THER, V18, P1015, DOI 10.3851/IMP2567; Zeuzem S, 2013, NEW ENGL J MED, V369, P630, DOI 10.1056/NEJMoa1213557	18	0	0	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2016	11	12							e0168544	10.1371/journal.pone.0168544	http://dx.doi.org/10.1371/journal.pone.0168544			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EG7JB	28030579	Green Submitted, Green Published, gold			2022-12-27	WOS:000391222000055
J	Zhang, N; Yang, XL; Zhang, M; Sun, Y				Zhang, Nan; Yang, Xiaolong; Zhang, Min; Sun, Yan			Crowd-Funding: A New Resource Cooperation Mode for Mobile Cloud Computing	PLOS ONE			English	Article								Mobile cloud computing, which integrates the cloud computing techniques into the mobile environment, is regarded as one of the enabler technologies for 5G mobile wireless networks. There are many sporadic spare resources distributed within various devices in the networks, which can be used to support mobile cloud applications. However, these devices, with only a few spare resources, cannot support some resource-intensive mobile applications alone. If some of them cooperate with each other and share their resources, then they can support many applications. In this paper, we propose a resource cooperative provision mode referred to as "Crowd-funding", which is designed to aggregate the distributed devices together as the resource provider of mobile applications. Moreover, to facilitate high-efficiency resource management via dynamic resource allocation, different resource providers should be selected to form a stable resource coalition for different requirements. Thus, considering different requirements, we propose two different resource aggregation models for coalition formation. Finally, we may allocate the revenues based on their attributions according to the concept of the "Shapley value" to enable a more impartial revenue share among the cooperators. It is shown that a dynamic and flexible resource-management method can be developed based on the proposed Crowd-funding model, relying on the spare resources in the network.	[Zhang, Nan; Yang, Xiaolong; Zhang, Min; Sun, Yan] Univ Sci & Technol Beijing, Sch Comp & Commun Engn, Beijing, Peoples R China	University of Science & Technology Beijing	Yang, XL (corresponding author), Univ Sci & Technol Beijing, Sch Comp & Commun Engn, Beijing, Peoples R China.	yangxl@ustb.edu.cn			National Science Foundation of China [61671057, 61303250]; National High-tech RD Program [2013AA01A209]	National Science Foundation of China(National Natural Science Foundation of China (NSFC)); National High-tech RD Program(National High Technology Research and Development Program of China)	This research was supported by National Science Foundation of China (Grant No. 61671057, 61303250), and National High-tech R&D Program (Grant No. 2013AA01A209). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This research was supported by National Science Foundation of China (Grant No. 61671057, 61303250), and National High-tech R&D Program (Grant No. 2013AA01A209). In addition, we thank American Journal Experts (AJE) for its linguistic assistance during the preparation of this manuscript.	Abolfazli S, 2014, IEEE COMMUN SURV TUT, V16, P337, DOI 10.1109/SURV.2013.070813.00285; Ahmed SH, CODIE CONTROLLED DAT; Butun I, 2016, IEEE COMMUN MAG, V54, P47, DOI 10.1109/MCOM.2016.7452265; Buyya R, 2009, FUTURE GENER COMP SY, V25, P599, DOI 10.1016/j.future.2008.12.001; Cordeschi N, 2015, VEH COMMUN, V2, P1, DOI 10.1016/j.vehcom.2014.08.004; Dharmale P N, 2013, INT J SCI REIJSR; Dinh HT, 2013, WIREL COMMUN MOB COM, V13, P1587, DOI 10.1002/wcm.1203; Hoang DT, 2012, IEEE WCNC, P3145, DOI 10.1109/WCNC.2012.6214347; Fernando N, 2013, FUTURE GENER COMP SY, V29, P84, DOI 10.1016/j.future.2012.05.023; Guan L., 2011, 10 IEEE ACIS INT C C, P387, DOI DOI 10.1109/ICIS.2011.67; Hongbin Liang, 2011, IEEE INFOCOM 2011 - IEEE Conference on Computer Communications. Workshops, P191, DOI 10.1109/INFCOMW.2011.5928806; Kaewpuang R, 2013, IEEE J SEL AREA COMM, V31, P2685, DOI 10.1109/JSAC.2013.131209; Khan AUR, 2014, IEEE COMMUN SURV TUT, V16, P393, DOI 10.1109/SURV.2013.062613.00160; Kumar K, 2010, COMPUTER, V43, P51, DOI 10.1109/MC.2010.98; Li W, 2016, FUTURE GENERATION CO; Li Z., 2001, P 2001 INT C COMP AR, P238, DOI DOI 10.1145/502217.502257; Liu FM, 2013, IEEE WIREL COMMUN, V20, P14; Marinelli E.E., 2009, THESIS CARNEGIE MELL; Mehta V., 2016, COMM NCC 2016 22 NAT, P1; Misra V, 2010, PERF E R SI, V38, P215, DOI 10.1145/1811099.1811064; Peleg B., 2007, INTRO THEORY COOPERA; Peng D., 2015, ACM, P177, DOI DOI 10.1145/2746285.2746306; Pouryazdan M, 2016, IEEE ACCESS, V4, P529, DOI 10.1109/ACCESS.2016.2519820; Satyanarayanan M., 1996, Proceedings of the Fifteenth Annual ACM Symposium on Principles of Distributed Computing, P1, DOI 10.1145/248052.248053; Shojafar M., 2016, ENERGY EFFICIENT ADA; Shojafar M., 2015, 2015 IEEE GLOB WORKS, P1, DOI [DOI 10.1109/GLOCOMW.2015.7413988, 10.1109/GLOCOMW.2015.7413988]; Song C, 2015, PROCEEDINGS 2015 IEEE FIFTH INTERNATIONAL CONFERENCE ON BIG DATA AND CLOUD COMPUTING BDCLOUD 2015, P293, DOI 10.1109/BDCloud.2015.68; Tawalbeh LA, 2016, 2016 IEEE FIRST INTERNATIONAL CONFERENCE ON CONNECTED HEALTH: APPLICATIONS, SYSTEMS AND ENGINEERING TECHNOLOGIES (CHASE), P73, DOI 10.1109/CHASE.2016.40; Wang C, 2004, ACM SIGPLAN NOTICES, V39, P119, DOI 10.1145/996893.996857; Xin Jin, 2010, Proceedings 2010 IEEE 16th International Conference on Parallel and Distributed Systems (ICPADS 2010), P800, DOI 10.1109/ICPADS.2010.78; Yang Dejun, 2015, INCENTIVE MECH CROWD; Yang J., 2016, FUTURE GENERATION CO; Zhang L., 2010, EURASIP J ADV SIG PR, V2010, P1, DOI DOI 10.1109/EC0C.2010.5622099	33	6	6	1	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2016	11	12							e0167657	10.1371/journal.pone.0167657	http://dx.doi.org/10.1371/journal.pone.0167657			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EG7JB	28030553	Green Published, gold, Green Submitted			2022-12-27	WOS:000391222000016
J	Hinojosa, R; Hinojosa, MS				Hinojosa, Ramon; Hinojosa, Melanie Sberna			Activity-Limiting Musculoskeletal Conditions in US Veterans Compared to Non-Veterans: Results from the 2013 National Health Interview Survey	PLOS ONE			English	Article							PERSIAN-GULF-WAR; LOW-BACK-PAIN; MILITARY SERVICE; UNITED-STATES; MORTALITY; AFGHANISTAN; BURDEN; PREVALENCE; TRANSITION; DEPLOYMENT	Past military service is associated with health outcomes, both positive and negative. In this study we use the 2013 National Health Interview Survey to examine the constellation of conditions referred to as musculoskeletal disorders (MSDs) for Veterans and non-veterans with health conditions that limit their daily activities. Multivariate logistic regression analysis reveal that Veterans are more likely to report MSDs like neck and back problems, fracture bone and joint problems as an activity limiting problem compared to non-veterans. The relationship between age and reports of activity limiting MSDs is moderated by Veteran status. Veterans in this sample report more activity limiting MSDs at younger ages compared to non-veterans and fewer MSDs at older ages. This research contributes to our understanding of potentially limiting health conditions at earlier ages for Veterans.	[Hinojosa, Ramon; Hinojosa, Melanie Sberna] Univ Cent Florida, Dept Sociol, 4297 Andromeda Loop North,Howard Phillips Hall 40, Orlando, FL 32816 USA	State University System of Florida; University of Central Florida	Hinojosa, MS (corresponding author), Univ Cent Florida, Dept Sociol, 4297 Andromeda Loop North,Howard Phillips Hall 40, Orlando, FL 32816 USA.	melanie.hinojosa@ucf.edu	Hinojosa, Melanie Sberna/AAA-9467-2019	Hinojosa, Melanie/0000-0001-5188-3315				Agha Z, 2000, ARCH INTERN MED, V160, P3252, DOI 10.1001/archinte.160.21.3252; [Anonymous], 1958, VETERANS BENEFITS; Barber J, 2011, MIL MED, V176, P151, DOI 10.7205/MILMED-D-09-00275; Bollinger MJ, 2015, POPUL HEALTH METR, V13, DOI 10.1186/s12963-015-0040-6; Cameron KL, 2011, ARTHRITIS RHEUM-US, V63, P2974, DOI 10.1002/art.30498; Center D.M.D., 2015, PROF CURR DEPL PERS; Clever M, 2013, FUTURE CHILD, V23, P13, DOI 10.1353/foc.2013.0018; Department of Veterans Affairs, 1976, SCHED RAT DIS 4; Department of Veterans Affairs, 2010, NAT SURV VET ACT DUT; DOD, 2016, DODIG2016088; DOD U. S. D. o. D., 2015, PROF MIL COMM; Dominick KL, 2006, J RHEUMATOL, V33, P348; Fasoli DR, 2010, MED CARE, V48, P288, DOI 10.1097/MLR.0b013e3181cafbe3; Fejer R, 2012, CHIROPR MAN THER, V20, DOI 10.1186/2045-709X-20-31; GAO, 2015, GAO15266; Haskell SG, 2011, WOMEN HEALTH ISS, V21, P92, DOI 10.1016/j.whi.2010.08.001; Hinojosa R., 2010, J MENS STUDIES, V18, P179, DOI DOI 10.3149/JMS.1802.179; Hoerster KD, 2012, AM J PREV MED, V43, P483, DOI 10.1016/j.amepre.2012.07.029; Kaaria S, 2006, PAIN, V120, P131, DOI 10.1016/j.pain.2005.10.020; Kang HK, 1996, NEW ENGL J MED, V335, P1498, DOI 10.1056/NEJM199611143352006; Kang HK, 2002, OCCUP ENVIRON MED, V59, P794, DOI 10.1136/oem.59.12.794; Kelty R, 2010, FUTURE CHILD, V20, P181; Kessler RC, 2001, J OCCUP ENVIRON MED, V43, P218, DOI 10.1097/00043764-200103000-00009; Knox J, 2011, SPINE, V36, P1492, DOI 10.1097/BRS.0b013e3181f40ddd; LP S., 2014, STATA DAT AN STAT SO; McLaughlin R, 2008, ANN EPIDEMIOL, V18, P928, DOI 10.1016/j.annepidem.2008.09.002; Murphy LB, 2014, MMWR-MORBID MORTAL W, V63, P999; National Center for Health Statistics. National Health Interview Survey, 2013, PUBL US DAT FIL DOC; NCVAS National Center for Veterans Analysis and Statistics, 2014, PROF VET FY 2012 DAT; NCVAS National Center for Veterans Analysis and Statistics, 2014, UN VET US REP FY 201; Nelson KM, 2006, J GEN INTERN MED, V21, P915, DOI 10.1007/BF02743137; Pizarro J, 2006, ARCH GEN PSYCHIAT, V63, P193, DOI 10.1001/archpsyc.63.2.193; Roy TC, 2013, SPINE, V38, P1310, DOI 10.1097/BRS.0b013e31829265c4; Roy TC, 2012, AVIAT SPACE ENVIR MD, V83, P1060, DOI 10.3357/ASEM.3341.2012; Roy TC, 2012, MIL MED, V177, P716, DOI 10.7205/MILMED-D-11-00402; SELTZER CC, 1974, AM J EPIDEMIOL, V100, P367, DOI 10.1093/oxfordjournals.aje.a112047; Thompson JM, 2015, DISABIL REHABIL, V37, P884, DOI 10.3109/09638288.2014.947441; VanDenKerkhof E. G., 2014, JBI DATABASE SYSTEMA, V12; VanDenKerkhof EG, 2015, PAIN RES MANAG, V20, P89, DOI 10.1155/2015/763768; Waller M, 2011, POPUL HEALTH METR, V9, DOI 10.1186/1478-7954-9-7; Watch H. R., 2016, BOOTED LACK RECOURSE; Wilmoth J. M., 2011, HDB SOCIOLOGY AGING; Woolf AD, 2003, B WORLD HEALTH ORGAN, V81, P646	43	16	16	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2016	11	12							e0167143	10.1371/journal.pone.0167143	http://dx.doi.org/10.1371/journal.pone.0167143			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EI9QH	28005905	Green Published, gold, Green Submitted			2022-12-27	WOS:000392843200009
J	Huhndorf, M; Moussavi, A; Kramann, N; Will, O; Hattermann, K; Stadelmann, C; Jansen, O; Boretius, S				Huhndorf, Monika; Moussavi, Amir; Kramann, Nadine; Will, Olga; Hattermann, Kirsten; Stadelmann, Christine; Jansen, Olav; Boretius, Susann			Alterations of the Blood-Brain Barrier and Regional Perfusion in Tumor Development: MRI Insights from a Rat C6 Glioma Model	PLoS One			English	Article							CONTRAST-ENHANCED MRI; SIGNAL INTENSITY RECOVERY; HIGH-GRADE GLIOMAS; GLIOBLASTOMA-MULTIFORME; GAMMA-VARIATE; DIFFERENTIATION; PERCENTAGE; SYSTEM; GROWTH; VOLUME	Objectives Angiogenesis and anti-angiogenetic medications play an important role in progression and therapy of glioblastoma. In this context, in vivo characterization of the blood-brain-barrier and tumor vascularization may be important for individual prognosis and therapy optimization. Methods We analyzed perfusion and capillary permeability of C6-gliomas in rats at different stages of tumor-growth by contrast enhanced MRI and dynamic susceptibility contrast (DSC) MRI at 7 Tesla. The analyses included maps of relative cerebral blood volume (CBV) and signal recovery derived from DSC data over a time period of up to 35 days after tumor cell injections. Results In all rats tumor progression was accompanied by temporal and spatial changes in CBV and capillary permeability. A leakage of the blood-brain barrier (slow contrast enhancement) was observed as soon as the tumor became detectable on T2-weighted images. Interestingly, areas of strong capillary permeability (fast signal enhancement) were predominantly localized in the center of the tumor. In contrast, the tumor rim was dominated by an increased CBV and showed the highest vessel density compared to the tumor center and the contralateral hemisphere as confirmed by histology. Conclusion Substantial regional differences in the tumor highlight the importance of parameter maps in contrast or in addition to region-of-interest analyses. The data vividly illustrate how MRI including contrast-enhanced and DSC-MRI may contribute to a better understanding of tumor development.	[Huhndorf, Monika; Moussavi, Amir; Will, Olga; Jansen, Olav; Boretius, Susann] Univ Kiel, Univ Med Ctr, Clin Radiol & Neuroradiol, Schleswig Holstein, Kiel, Germany; [Moussavi, Amir; Will, Olga; Boretius, Susann] Univ Kiel, Mol Imaging North Competence Ctr, Kiel, Germany; [Moussavi, Amir; Boretius, Susann] Leibniz Inst Primate Res, German Primate Ctr, Gottingen, Germany; [Kramann, Nadine; Stadelmann, Christine] Univ Med Ctr Gottingen, Inst Neuropathol, Gottingen, Germany; [Hattermann, Kirsten] Univ Kiel, Inst Anat, Kiel, Germany; [Boretius, Susann] Univ Gottingen, Fac Biol & Psychol, Gottingen, Germany	University of Kiel; Schleswig Holstein University Hospital; University of Kiel; Deutsches Primatenzentrum (DPZ); University of Gottingen; University of Kiel; University of Gottingen	Boretius, S (corresponding author), Univ Kiel, Univ Med Ctr, Clin Radiol & Neuroradiol, Schleswig Holstein, Kiel, Germany.; Boretius, S (corresponding author), Univ Kiel, Mol Imaging North Competence Ctr, Kiel, Germany.; Boretius, S (corresponding author), Leibniz Inst Primate Res, German Primate Ctr, Gottingen, Germany.; Boretius, S (corresponding author), Univ Gottingen, Fac Biol & Psychol, Gottingen, Germany.	sboretius@dpz.eu	Hattermann, Kirsten/E-8043-2010; Boretius, Susann/ABF-4993-2021; Jansen, Olav/CAF-4179-2022	Boretius, Susann/0000-0003-2792-7423; Stadelmann, Christine/0000-0003-1766-5458	European Regional Development Fund (ERDF) [CCI: 2007DE052P0011]	European Regional Development Fund (ERDF)(European Commission)	This study has received funding by the European Regional Development Fund (ERDF), CCI: 2007DE052P0011 (http://ec.europa.eu/regional_policy/en/funding/erdf/).	Aprile I, 2015, RADIOL MED, V120, P967, DOI 10.1007/s11547-015-0511-7; Artzi M, 2015, J NEURO-ONCOL, V121, P349, DOI 10.1007/s11060-014-1639-3; Barth RF, 2009, J NEURO-ONCOL, V94, P299, DOI 10.1007/s11060-009-9875-7; BELLIVEAU JW, 1990, MAGNET RESON MED, V14, P538, DOI 10.1002/mrm.1910140311; Benner T, 1997, MAGN RESON IMAGING, V15, P307, DOI 10.1016/S0730-725X(96)00392-X; Blasel S, 2013, J NEURO-ONCOL, V114, P127, DOI 10.1007/s11060-013-1161-z; Boretius S, 2012, NEUROIMAGE, V59, P2678, DOI 10.1016/j.neuroimage.2011.08.051; Boxerman JL, 2006, AM J NEURORADIOL, V27, P859; Cha S, 2007, AM J NEURORADIOL, V28, P1078, DOI 10.3174/ajnr.A0484; Cha S, 2003, MAGNET RESON MED, V49, P848, DOI 10.1002/mrm.10446; Chakravorty A, 2015, NEURORADIOL J, V28, P574, DOI 10.1177/1971400915611916; Chinot OL, 2011, ADV THER, V28, P334, DOI 10.1007/s12325-011-0007-3; da Silva AC, 2012, EINSTEIN-SAO PAULO, V10, P11, DOI 10.1590/S1679-45082012000100004; EDELMAN RR, 1990, RADIOLOGY, V176, P211, DOI 10.1148/radiology.176.1.2353094; Fan GG, 2005, ACAD RADIOL, V12, P640, DOI 10.1016/j.acra.2005.01.024; Garcia-Palmero I, 2013, NMR BIOMED, V26, P1059, DOI 10.1002/nbm.2918; Grobben B, 2002, CELL TISSUE RES, V310, P257, DOI 10.1007/s00441-002-0651-7; Hartmann M, 2003, NEUROSCI LETT, V338, P119, DOI 10.1016/S0304-3940(02)01367-8; Heye AK, 2014, NEUROIMAGE-CLIN, V6, P262, DOI 10.1016/j.nicl.2014.09.002; Jensen-Kondering U, 2012, NEUROL RES, V34, P984, DOI 10.1179/1743132812Y.0000000105; Kim WY, 2009, FEBS J, V276, P4653, DOI 10.1111/j.1742-4658.2009.07177.x; Law M, 2003, AM J NEURORADIOL, V24, P1989; Law M, 2002, RADIOLOGY, V222, P715, DOI 10.1148/radiol.2223010558; Liao WH, 2009, ACTA RADIOL, V50, P217, DOI 10.1080/02841850802616752; Louis DN, 2006, ANNU REV PATHOL-MECH, V1, P97, DOI 10.1146/annurev.pathol.1.110304.100043; Mangla R, 2011, AM J NEURORADIOL, V32, P1004, DOI 10.3174/ajnr.A2441; Ostrom QT, 2013, NEURO-ONCOLOGY, V15, P1, DOI 10.1093/neuonc/not151; ROSEN BR, 1990, MAGNET RESON MED, V14, P249, DOI 10.1002/mrm.1910140211; Server A, 2011, NEURORADIOLOGY, V53, P435, DOI 10.1007/s00234-010-0770-x; Shin JH, 2002, AM J ROENTGENOL, V179, DOI 10.2214/ajr.179.3.1790783; SHWEIKI D, 1992, NATURE, V359, P843, DOI 10.1038/359843a0; Sourbron SP, 2013, NMR BIOMED, V26, P1004, DOI 10.1002/nbm.2940; Stupp R, 2005, NEW ENGL J MED, V352, P987, DOI 10.1056/NEJMoa043330; Thomas AA, 2014, CURR TREAT OPTION ON, V15, P551, DOI 10.1007/s11864-014-0308-2; THOMPSON HK, 1964, CIRC RES, V14, P502, DOI 10.1161/01.RES.14.6.502; Wen PY, 2010, J CLIN ONCOL, V28, P1963, DOI 10.1200/JCO.2009.26.3541; Young RJ, 2013, CLIN IMAG, V37, P41, DOI 10.1016/j.clinimag.2012.02.016	37	8	9	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2016	11	12							e0168174	10.1371/journal.pone.0168174	http://dx.doi.org/10.1371/journal.pone.0168174			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI9QH	28005983	Green Published, gold			2022-12-27	WOS:000392843200034
J	Iannotti, L; Dulience, SJL; Joseph, S; Cooley, C; Tufte, T; Cox, K; Eaton, J; Delnatus, JR; Wolff, PB				Iannotti, Lora; Dulience, Sherlie Jean-Louis; Joseph, Saminetha; Cooley, Charmayne; Tufte, Teresa; Cox, Katherine; Eaton, Jacob; Delnatus, Jacques Raymond; Wolff, Patricia B.			Fortified Snack Reduced Anemia in Rural School-Aged Children of Haiti: A Cluster-Randomized, Controlled Trial	PLOS ONE			English	Article							VITAMIN-A; HEMOGLOBIN CONCENTRATIONS; DEVELOPING-COUNTRIES; MICRONUTRIENT STATUS; DOUBLE-BLIND; SCHOOLCHILDREN; IRON; FOOD; COGNITION; BEVERAGE	Background Nutrition in the school-aged child matters for brain development and public policy investments globally. Our group previously conducted a trial in urban schools of Haiti to examine the effects of a fortified peanut butter snack, Vita Mamba, with limited findings for anemia. Objective We aimed to test the hypothesis that Vita Mamba, with systematic deworming in both study arms, would significantly reduce anemia among rural, school-aged children. Methods A cluster, randomized longitudinal study was conducted in two rural communities of the North-East Department of Haiti, 2014-2015. Healthy children ages 3-16 years were enrolled (n = 321) and assigned by school to intervention (Vita Mamba and deworming) and control (deworming). Vita Mamba contains 260 kcal and meets >75% of the Recommended Dietary Allowance for critical micronutrients. Multivariate regression analyses including propensity score matching techniques to correct for potential group imbalance (Kernel-based Matching and Propensity Score Weighting) were applied to examine difference-in-difference intervention effects. Results At baseline, 51% of the children were anemic with no significant differences between study groups. Vita Mamba supplementation showed a consistent, positive effect across regression models on increasing Hb concentration and reducing the odds of anemia compared to the control group after adjusting for child age, vitamin A supplementation, milk consumption, and height-for-age z score. The average treatment effect for the treated in the Propensity Score Weighting models was 0.62 +/- 0.27 grams per 100 milliliters (g/dL) for Hb concentration (F = 4.64, P = 0.001), and the odds of anemia were reduced by 88% (Wald chi = 9.77, P = 0.02). No differences in change in anthropometric markers were evident. Conclusions School feeding programs that integrate fortified foods with deworming could reduce anemia burden with important implications for learning, health, and well-being. The rural-urban differences in anemia require further study.	[Iannotti, Lora; Dulience, Sherlie Jean-Louis; Joseph, Saminetha; Cooley, Charmayne; Tufte, Teresa; Cox, Katherine; Eaton, Jacob] Washington Univ, Brown Sch, Inst Publ Hlth, St Louis, MO 63130 USA; [Delnatus, Jacques Raymond; Wolff, Patricia B.] Meds & Food Kids, St Louis, MO USA	Washington University (WUSTL)	Iannotti, L (corresponding author), Washington Univ, Brown Sch, Inst Publ Hlth, St Louis, MO 63130 USA.	liannotti@wustl.edu			United States Department of Agriculture (USDA) Foreign Agricultural Service Micronutrient Fortified Food Aid Products program [FFE-521-2012/034-00]	United States Department of Agriculture (USDA) Foreign Agricultural Service Micronutrient Fortified Food Aid Products program	This work was supported by the United States Department of Agriculture (USDA) Foreign Agricultural Service Micronutrient Fortified Food Aid Products program FFE-521-2012/034-00, http://www.fas.usda.gov. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aaron GJ, 2015, NUTRIENTS, V7, P3847, DOI 10.3390/nu7053847; Abizari AR, 2014, BRIT J NUTR, V112, P1019, DOI 10.1017/S0007114514001585; [Anonymous], 2001, WHO TECHN REP SER; Best C, 2011, NUTR REV, V69, P186, DOI 10.1111/j.1753-4887.2011.00378.x; Cabalda AB, 2009, J AM COLL NUTR, V28, P591, DOI 10.1080/07315724.2009.10719791; CHANDLER AMK, 1995, J NUTR, V125, P894; Cogill B, 2003, ANTHROPOMETRIC INDIC; Egbi G, 2015, FOOD NUTR BULL, V36, P264, DOI 10.1177/0379572115596253; ElMenchawy I, 2015, J NUTR METAB, V2015, DOI 10.1155/2015/690954; Gonzales Elena, 2015, Rev. perú. med. exp. salud publica, V32, P431; Grantham-McGregor S, 2007, LANCET, V369, P60, DOI 10.1016/S0140-6736(07)60032-4; Groff J.L., 2000, ADV NUTR HUMAN METAB; Guo S, 2015, PROPENSITY SCORE ANA; Heckman JJ, 2005, SOCIOL METHODOL, V35, P1, DOI 10.1111/j.0081-1750.2006.00164.x; Heckman JJ, 1998, REV ECON STUD, V65, P261, DOI 10.1111/1467-937X.00044; Heckman JJ, 1997, REV ECON STUD, V64, P605, DOI 10.2307/2971733; Herrador Z, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112858; Hoffbrand AV., 2006, ESSENTIAL HAEMATOLOG, V5th ed; Iannotti LL, 2015, AM J TROP MED HYG, V93, P1092, DOI 10.4269/ajtmh.15-0073; Iannotti LL, 2015, J NUTR, V145, P813, DOI 10.3945/jn.114.203182; Imbens GW, 2009, J ECON LIT, V47, P5, DOI 10.1257/jel.47.1.5; Jomaa LH, 2011, NUTR REV, V69, P83, DOI 10.1111/j.1753-4887.2010.00369.x; Kuriyan R, 2016, CLIN NUTR, V35, P190, DOI 10.1016/j.clnu.2015.02.001; Kyu HH, 2016, JAMA PEDIATR, V170, P267, DOI 10.1001/jamapediatrics.2015.4276; Lentz EC, 2013, WORLD DEV, V49, P9, DOI 10.1016/j.worlddev.2013.01.017; Ministry of Public Health and Population (le Ministere de la Sante A Publique and de la Population MSPP) Haitian Childhood Institute (l'Institut Haitien de l'Enfance IHE) ICF International, 2013, ICF INT 2012 HAIT MO; Perignon M, 2016, NUTRIENTS, V8, DOI 10.3390/nu8010029; Perignon M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112605; Pita GM, 2014, MEDICC REV, V16, P16, DOI 10.37757/MR2014.V16.N1.5; Rahman AS, 2015, MATERN CHILD NUTR, V11, P120, DOI 10.1111/mcn.12065; Simeon DT, 1998, AM J CLIN NUTR, V67, p790S, DOI 10.1093/ajcn/67.4.790S; Sumbele IU, 2015, PLOS ONE, V10, P1; Swindale A., 2006, FHI 360FANTA; Taljaard C, 2013, BRIT J NUTR, V110, P2271, DOI 10.1017/S000711451300189X; Tran TN, 2009, J NUTR, V139, P1013, DOI 10.3945/jn.108.099754; Van de Poel E, 2007, SOC SCI MED, V65, P1986, DOI 10.1016/j.socscimed.2007.06.032; WHO, 2006, WHO CHILD GROWTH STA; Wittes J, 2002, EPIDEMIOL REV, V24, P39, DOI 10.1093/epirev/24.1.39; World Health Organization (WHO), 2007, GROWTH REF 5 19 YEAR; Yeka A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118901; Zimmermann MB, 2006, AM J CLIN NUTR, V84, P580, DOI 10.1093/ajcn/84.3.580	41	8	8	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2016	11	12							e0168121	10.1371/journal.pone.0168121	http://dx.doi.org/10.1371/journal.pone.0168121			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI9QH	28005920	Green Published, Green Submitted, gold			2022-12-27	WOS:000392843200030
J	Josefson, AB				Josefson, Alf B.			Species Sorting of Benthic Invertebrates in a Salinity Gradient - Importance of Dispersal Limitation	PLOS ONE			English	Article							METACOMMUNITY STRUCTURE; BETA-DIVERSITY; DEVELOPMENTAL MODE; DISTANCE DECAY; BALTIC SEA; RICHNESS; COLONIZATION; NESTEDNESS; TURNOVER; PATTERNS	The relative importance of environment and dispersal related processes for community assembly has attracted great interest over recent decades, but few empirical studies from the marine/estuarine realm have examined the possible effects of these two types of factors in the same system. Importance of these processes was investigated in a hypothetical metacommunity of benthic invertebrates in 16 micro-tidal estuaries connected to the same open sea area. The estuaries differed in size and connectivity to the open sea and represented a salinity gradient across the estuaries. The Elements of Metacommunity Structure (EMS) approach on estuary scale was complemented with a mechanistic variance partitioning approach on sample scale to disentangle effects of factors affecting assembly of three trait groups of species with different dispersivity. A quasi-Clementsian pattern was observed for all three traits, a likely response to some latent gradient. The primary axis in the pattern was most strongly related to gradients in estuary salinity and estuary entrance width and correlation with richness indicated nestedness only in the matrix of the most dispersive trait group. In the variance partitioning approach measures of turnover and nestedness between paired samples each from different estuaries were related to environmental distance in different gradients. Distance between estuaries was unimportant suggesting importance of factors characterizing the estuaries. While the high dispersive species mainly were sorted in the salinity gradient, apparently according to their tolerance ranges towards salinity, the two less dispersive traits were additionally affected by estuary entrance width and possibly also area. The results exemplify a mechanism of community assembly in the marine realm where the niche factor salinity in conjunction with differential dispersal structure invertebrates in a metacommunity of connected estuaries, and support the idea that dispersive species are more controlled by the environment than less dispersive species.	[Josefson, Alf B.] Aarhus Univ, Dept Biosci, Roskilde, Denmark	Aarhus University	Josefson, AB (corresponding author), Aarhus Univ, Dept Biosci, Roskilde, Denmark.	aj@bios.au.dk	Josefson, Alf B/J-8174-2013		Danish Nature Agency; DEVOTES project in the European Union's Seventh Program for research, technological development and demonstration [308392]; Cocoa project under the EU-Bonus programme The Danish Nature Agency; EU [S12657705, MARE/2012/10 - Lot 5]	Danish Nature Agency; DEVOTES project in the European Union's Seventh Program for research, technological development and demonstration; Cocoa project under the EU-Bonus programme The Danish Nature Agency; EU(European Commission)	The author received funding for this work from The Danish Nature Agency, The DEVOTES project in the European Union's Seventh Program for research, technological development and demonstration under grant agreement No "308392", The Cocoa project under the EU-Bonus programme The Danish Nature Agency collected the primary data. This work was also supported by EU EMODnet contr. No. S12657705 under contract no. MARE/2012/10 - Lot 5 Biology.	Algarte VM, 2014, HYDROBIOLOGIA, V722, P279, DOI 10.1007/s10750-013-1711-6; Anderson M.J., 2008, PERMANOVA PRIMER GUI; Astorga A, 2012, GLOBAL ECOL BIOGEOGR, V21, P365, DOI 10.1111/j.1466-8238.2011.00681.x; Baselga A, 2015, METHODS ECOL EVOL; Baselga A, 2007, ECOGRAPHY, V30, P838, DOI 10.1111/j.2007.0906-7590.05191.x; Baselga A, 2010, GLOBAL ECOL BIOGEOGR, V19, P134, DOI 10.1111/j.1466-8238.2009.00490.x; Beauchamp VB, 2011, ECOL APPL, V21, P465, DOI 10.1890/09-1638.1; Bleich S, 2011, MAR ECOL PROG SER, V436, P101, DOI 10.3354/meps09219; Bloch CP, 2007, OIKOS, V116, P395, DOI 10.1111/j.0030-1299.2007.15391.x; Bonsdorff E, 1999, AUST J ECOL, V24, P312, DOI 10.1046/j.1442-9993.1999.00986.x; Brault S, 2013, GLOBAL ECOL BIOGEOGR, V22, P433, DOI 10.1111/geb.12005; BUHLJENSEN L, 1986, SARSIA, V71, P193, DOI 10.1080/00364827.1986.10419690; BUHLMORTENSEN L, 1993, MAR ECOL PROG SER, V97, P209, DOI 10.3354/meps097209; Cadotte MW, 2006, ECOLOGY, V87, P1008, DOI 10.1890/0012-9658(2006)87[1008:MIOCRA]2.0.CO;2; Carvalho JC, 2012, GLOBAL ECOL BIOGEOGR, V21, P760, DOI 10.1111/j.1466-8238.2011.00694.x; Chase J.M., 2009, ECOLOGICAL NICHES; Chase JM, 2007, P NATL ACAD SCI USA, V104, P17430, DOI 10.1073/pnas.0704350104; Chase JM, 2011, PHILOS T R SOC B, V366, P2351, DOI 10.1098/rstb.2011.0063; Chesson P, 2000, THEOR POPUL BIOL, V58, P211, DOI 10.1006/tpbi.2000.1486; Conley DJ, 2000, ESTUARIES, V23, P820, DOI 10.2307/1353000; COOK RR, 1995, OECOLOGIA, V102, P413, DOI 10.1007/BF00341353; Cottenie K, 2005, ECOL LETT, V8, P1175, DOI 10.1111/j.1461-0248.2005.00820.x; Dahl E., 1956, Oikos, V7, P1, DOI 10.2307/3564981; Dallas T, 2014, ECOGRAPHY, V37, P402, DOI 10.1111/j.1600-0587.2013.00695.x; De Bie T, 2012, ECOL LETT, V15, P740, DOI 10.1111/j.1461-0248.2012.01794.x; Foggo A, 2007, J ANIM ECOL, V76, P695, DOI 10.1111/j.1365-2656.2007.01245.x; Gotelli NJ, 2000, ECOLOGY, V81, P2606, DOI 10.1890/0012-9658(2000)081[2606:NMAOSC]2.0.CO;2; Gronroos M, 2013, ECOL EVOL, V3, P4473, DOI 10.1002/ece3.834; GUNTER G, 1961, LIMNOL OCEANOGR, V6, P182, DOI 10.4319/lo.1961.6.2.0182; Heino J, 2015, FRESHWATER BIOL, V60, P845, DOI 10.1111/fwb.12533; Heino J, 2013, OECOLOGIA, V171, P971, DOI 10.1007/s00442-012-2451-4; HELCOM, 1988, BALTIC SEA ENV P, V27D, P1; Hendrickx F, 2009, GLOBAL ECOL BIOGEOGR, V18, P607, DOI 10.1111/j.1466-8238.2009.00473.x; Josefson AB, 2004, GLOBAL ECOL BIOGEOGR, V13, P273, DOI 10.1111/j.1466-822X.2004.00091.x; Josefson AB, 2013, J BIOGEOGR, V40, P1000, DOI 10.1111/jbi.12047; Josefson AB, 2009, MAR ECOL PROG SER, V396, P283, DOI 10.3354/meps08375; Leibold MA, 2004, ECOL LETT, V7, P601, DOI 10.1111/j.1461-0248.2004.00608.x; Leibold MA, 2002, OIKOS, V97, P237, DOI 10.1034/j.1600-0706.2002.970210.x; Lindo Z, 2008, OIKOS, V117, P1856, DOI 10.1111/j.1600-0706.2008.16920.x; Loo SE, 2002, OECOLOGIA, V132, P118, DOI 10.1007/s00442-002-0933-5; May F, 2012, OIKOS, V121, P942, DOI 10.1111/j.1600-0706.2011.20078.x; Mercier A, 2013, GLOBAL ECOL BIOGEOGR, V22, P517, DOI 10.1111/geb.12018; Meynard CN, 2013, J BIOGEOGR, V40, P1560, DOI 10.1111/jbi.12116; Moritz C, 2013, OIKOS, V122, P1401, DOI 10.1111/j.1600-0706.2013.00377.x; Mouquet N, 2003, AM NAT, V162, P544, DOI 10.1086/378857; PATTERSON BD., 2000, BONN ZOOL MONOGR, V46, P9; Pilditch CA, 2015, BIOL LETTERS, V11, DOI 10.1098/rsbl.2014.0795; Presley SJ, 2010, OIKOS, V119, P908, DOI 10.1111/j.1600-0706.2010.18544.x; Presley SJ, 2010, GLOBAL ECOL BIOGEOGR, V19, P185, DOI 10.1111/j.1466-8238.2009.00505.x; Pulliam HR, 2000, ECOL LETT, V3, P349, DOI 10.1046/j.1461-0248.2000.00143.x; Qian H, 2009, GLOBAL ECOL BIOGEOGR, V18, P327, DOI 10.1111/j.1466-8238.2009.00450.x; Rasmussen B, 2002, ESTUAR COAST SHELF S, V54, P65, DOI 10.1006/ecss.2001.0836; Remane A., 1934, ZOOL ANZ, V7, P34; Soininen J, 2007, ECOGRAPHY, V30, P3, DOI 10.1111/j.2006.0906-7590.04817.x; Sommer B, 2014, ECOLOGY, V95, P1000, DOI 10.1890/13-1445.1; Thompson R, 2006, J ANIM ECOL, V75, P476, DOI 10.1111/j.1365-2656.2006.01068.x; THORSON G, 1946, REPROD LARVAL DEV DA; TILMAN D, 1982, ANNU REV ECOL SYST, V13, P349, DOI 10.1146/annurev.es.13.110182.002025; Ulrich W, 2009, OIKOS, V118, P3, DOI 10.1111/j.1600-0706.2008.17053.x; Valanko S, 2015, ECOL EVOL, V5, P5203, DOI 10.1002/ece3.1767; Wlodarska-Kowalczuk M, 2012, MAR ECOL PROG SER, V463, P73, DOI 10.3354/meps09858	61	18	19	1	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2016	11	12							e0168908	10.1371/journal.pone.0168908	http://dx.doi.org/10.1371/journal.pone.0168908			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI9QH	28006014	gold, Green Submitted, Green Published			2022-12-27	WOS:000392843200109
J	La, J; Reed, E; Chan, L; Smolyaninova, LV; Akomova, OA; Mutlu, GM; Orlov, SN; Dulin, NO				La, Jennifer; Reed, Eleanor; Chan, Lan; Smolyaninova, Larisa V.; Akomova, Olga A.; Mutlu, Gokhan M.; Orlov, Sergei N.; Dulin, Nickolai O.			Downregulation of TGF-beta Receptor-2 Expression and Signaling through Inhibition of Na/K-ATPase	PLoS One			English	Article							GROWTH-FACTOR-BETA; PULMONARY MYOFIBROBLAST DIFFERENTIATION; EPITHELIAL-CELL PROLIFERATION; SMOOTH-MUSCLE-CELLS; CARDIAC-GLYCOSIDES; NA+/K+-ATPASE; BREAST-CANCER; FIBROBLASTS; FIBROSIS; DIGITALIS	Transforming growth factor-beta (TGF-beta) is a multi-functional cytokine implicated in the control of cell growth and differentiation. TGF-beta signals through a complex of TGF-beta receptors 1 and 2 (TGF beta R1 and TGF beta R2) that phosphorylate and activate Smad2/3 transcription factors driving transcription of the Smad-target genes. The Na+/K+-ATPase is an integral plasma membrane protein critical for maintaining the electro-chemical gradient of Na+ and K+ in the cell. We found that inhibition of the Na+/K+ ATPase by ouabain results in a dramatic decrease in the expression of TGF beta R2 in human lung fibrobalsts (HLF) at the mRNA and protein levels. This was accompanied by inhibition of TGF-beta-induced Smad phosphorylation and the expression of TGF-beta target genes, such as fibronectin and smooth muscle alpha-actin. Inhibition of Na+/K+ ATPase by an alternative approach (removal of extracellular potassium) had a similar effect in HLF. Finally, treatment of lung alveolar epithelial cells (A549) with ouabain also resulted in the downregulation of TGF beta R2, the inhibition of TGF-beta-induced Smad phosphorylation and of the expression of mesenchymal markers, vimentin and fibronectin. Together, these data demonstrate a critical role of Na+/K+-ATPase in the control of TGF beta R2 expression, TGF-beta signaling and cell responses to TGF-beta.	[La, Jennifer; Reed, Eleanor; Chan, Lan; Mutlu, Gokhan M.; Dulin, Nickolai O.] Univ Chicago, Dept Med, Sect Pulm & Crit Care Med, 5841 S Maryland Ave, Chicago, IL 60637 USA; [Smolyaninova, Larisa V.; Akomova, Olga A.; Orlov, Sergei N.] Lomonosov Moscow State Univ, Fac Biol, Dept Biophys, Lab Biomembranes, Moscow, Russia; [Orlov, Sergei N.; Dulin, Nickolai O.] Siberian Med State Univ, Tomsk, Russia	University of Chicago; Lomonosov Moscow State University; Siberian State Medical University	Dulin, NO (corresponding author), Univ Chicago, Dept Med, Sect Pulm & Crit Care Med, 5841 S Maryland Ave, Chicago, IL 60637 USA.; Orlov, SN (corresponding author), Lomonosov Moscow State Univ, Fac Biol, Dept Biophys, Lab Biomembranes, Moscow, Russia.; Orlov, SN; Dulin, NO (corresponding author), Siberian Med State Univ, Tomsk, Russia.	sergeinorlov@ya.ru; ndulin@medicine.bsd.uchicago.edu	Smolyaninova, Larisa/H-4093-2014; Orlov, Sergey N./T-3729-2018; Mutlu, Gokhan/HIR-2545-2022		National Institutes of Health Award [1R56HL127395]; National Center For Advancing Translational Sciences of the National Institutes of Health [UL1TR000430]; American Heart Association Predoctoral Fellowship [14PRE18360017]; Russian Foundation for Fundamental Research [14-04-31705, 15-04-385 00101]; Russian Scientific Foundation [14-15-0006]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000430] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R56HL127395] Funding Source: NIH RePORTER	National Institutes of Health Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Center For Advancing Translational Sciences of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); American Heart Association Predoctoral Fellowship(American Heart Association); Russian Foundation for Fundamental Research(Russian Foundation for Basic Research (RFBR)); Russian Scientific Foundation(Russian Science Foundation (RSF)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	Research reported in this publication was supported by the National Institutes of Health Award 1R56HL127395 (N.O.D.) and National Center For Advancing Translational Sciences of the National Institutes of Health under Award UL1TR000430 (N.O.D.). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. This study was also supported by American Heart Association Predoctoral Fellowship Award 14PRE18360017 (J.L.), the Russian Foundation for Fundamental Research (14-04-31705 and 15-04-385 00101) and the Russian Scientific Foundation #14-15-0006. (O.A.A., S.N.O.).	Abramowitz J, 2003, CIRCULATION, V108, P3048, DOI 10.1161/01.CIR.0000101919.00548.86; ACKERMANN U, 1990, FEBS LETT, V269, P105, DOI 10.1016/0014-5793(90)81130-G; Bai Y, 2016, PHYSL GENOMICS; BARNARD JA, 1989, P NATL ACAD SCI USA, V86, P1578, DOI 10.1073/pnas.86.5.1578; Biernacka A, 2011, GROWTH FACTORS, V29, P196, DOI 10.3109/08977194.2011.595714; Blaustein MP, 1999, PHYSIOL REV, V79, P763, DOI 10.1152/physrev.1999.79.3.763; BOYD FT, 1989, J BIOL CHEM, V264, P2272; Bridoux F, 1997, J EXP MED, V185, P1769, DOI 10.1084/jem.185.10.1769; Brown RD, 2005, ANNU REV PHARMACOL, V45, P657, DOI 10.1146/annurev.pharmtox.45.120403.095802; Chen YG, 2009, CELL RES, V19, P58, DOI 10.1038/cr.2008.315; Cucoranu I, 2005, CIRC RES, V97, P900, DOI 10.1161/01.RES.0000187457.24338.3D; DESMOULIERE A, 1993, J CELL BIOL, V122, P103, DOI 10.1083/jcb.122.1.103; Di Guglielmo GM, 2003, NAT CELL BIOL, V5, P410, DOI 10.1038/ncb975; Fan D, 2012, FIBROGENESIS TISSUE, V5, DOI 10.1186/1755-1536-5-15; Feng XH, 2005, ANNU REV CELL DEV BI, V21, P659, DOI 10.1146/annurev.cellbio.21.022404.142018; Frese S, 2006, CANCER RES, V66, P5867, DOI 10.1158/0008-5472.CAN-05-3544; Geering K, 2001, J BIOENERG BIOMEMBR, V33, P425, DOI 10.1023/A:1010623724749; GEERING K, 1989, AM J PHYSIOL, V257, pC851, DOI 10.1152/ajpcell.1989.257.5.C851; Geering K, 1996, J CELL BIOL, V133, P1193, DOI 10.1083/jcb.133.6.1193; Hinz B, 2007, AM J PATHOL, V170, P1807, DOI 10.2353/ajpath.2007.070112; Iwano M, 2002, J CLIN INVEST, V110, P341, DOI 10.1172/JCI200215518; Jakowlew SB, 2006, CANCER METAST REV, V25, P435, DOI 10.1007/s10555-006-9006-2; Kach J, 2014, J BIOL CHEM, V289, P7505, DOI 10.1074/jbc.M113.546812; Kach J, 2013, AM J PHYSIOL-LUNG C, V304, pL757, DOI 10.1152/ajplung.00262.2012; Kasai H, 2005, RESP RES, V6, DOI 10.1186/1465-9921-6-56; Kometiani P, 2005, MOL PHARMACOL, V67, P929, DOI 10.1124/mol.104.007302; Lee SJ, 2014, WORLD J HEPATOL, V6, P207, DOI 10.4254/wjh.v6.i4.207; Li MO, 2008, CELL, V134, P392, DOI 10.1016/j.cell.2008.07.025; Li ZC, 2009, J BIOL CHEM, V284, P21066, DOI 10.1074/jbc.M109.013821; Liang M, 2007, J BIOL CHEM, V282, P10585, DOI 10.1074/jbc.M609181200; Lin SY, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0123305; Lingrel JB, 2010, ANNU REV PHYSIOL, V72, P395, DOI 10.1146/annurev-physiol-021909-135725; Liu LJ, 2007, AM J PHYSIOL-CELL PH, V293, pC1489, DOI 10.1152/ajpcell.00158.2007; Liu LJ, 2004, AM J PHYSIOL-HEART C, V287, pH2173, DOI 10.1152/ajpheart.00352.2004; Liu LJ, 2003, AM J PHYSIOL-CELL PH, V284, pC1550, DOI 10.1152/ajpcell.00555.2002; Mack CP, 2011, ARTERIOSCL THROM VAS, V31, P1495, DOI 10.1161/ATVBAHA.110.221135; Menger L, 2013, ONCOIMMUNOLOGY, V2, DOI 10.4161/onci.23082; Meran S, 2011, INT J EXP PATHOL, V92, P158, DOI 10.1111/j.1365-2613.2011.00764.x; MONTESANO R, 1988, P NATL ACAD SCI USA, V85, P4894, DOI 10.1073/pnas.85.13.4894; MOSES HL, 1992, MOL REPROD DEV, V32, P179, DOI 10.1002/mrd.1080320215; MUSTOE TA, 1987, SCIENCE, V237, P1333, DOI 10.1126/science.2442813; OROSZ F, 1986, ANAL BIOCHEM, V156, P171, DOI 10.1016/0003-2697(86)90169-7; Padua D, 2009, CELL RES, V19, P89, DOI 10.1038/cr.2008.316; Penheiter SG, 2002, MOL CELL BIOL, V22, P4750, DOI 10.1128/MCB.22.13.4750-4759.2002; Phan SH, 2002, CHEST, V122, p286S, DOI 10.1378/chest.122.6_suppl.286S; Pickup M, 2013, NAT REV CANCER, V13, P788, DOI 10.1038/nrc3603; Pohlers D, 2009, BBA-MOL BASIS DIS, V1792, P746, DOI 10.1016/j.bbadis.2009.06.004; Quintas LEM, 2010, J MOL CELL CARDIOL, V49, P525, DOI 10.1016/j.yjmcc.2010.04.015; Rahimtoola SH, 1996, CURR PROB CARDIOLOGY, V21, P787; Sandbo N, 2011, AM J PHYSIOL-LUNG C, V301, pL656, DOI 10.1152/ajplung.00166.2011; Sandbo N, 2009, AM J RESP CELL MOL, V41, P332, DOI 10.1165/rcmb.2008-0288OC; Schoner W, 2007, AM J PHYSIOL-CELL PH, V293, pC509, DOI 10.1152/ajpcell.00098.2007; Schuppan D, 2008, LANCET, V371, P838, DOI 10.1016/S0140-6736(08)60383-9; Slingerland M, 2013, INVEST NEW DRUG, V31, P1087, DOI 10.1007/s10637-013-9984-1; SOLOMON AK, 1956, J GEN PHYSIOL, V40, P327, DOI 10.1085/jgp.40.2.327; Stenkvist B, 1999, ONCOL REP, V6, P493; STENKVIST B, 1979, LANCET, V1, P563; STENKVIST B, 1982, NEW ENGL J MED, V306, P484; Strutz F, 2006, J AM SOC NEPHROL, V17, P2992, DOI 10.1681/ASN.2006050420; Tian J, 2006, MOL BIOL CELL, V17, P317, DOI 10.1091/mbc.E05-08-0735; Varga J, 2007, J CLIN INVEST, V117, P557, DOI 10.1172/JCI31139; Wu J, 2013, BIOCHEMISTRY-US, V52, P9059, DOI 10.1021/bi4011804; Wynn TA, 2007, J CLIN INVEST, V117, P524, DOI 10.1172/JCI31487; Xu J, 2009, CELL RES, V19, P156, DOI 10.1038/cr.2009.5; Ye QQ, 2011, J BIOL CHEM, V286, P6225, DOI 10.1074/jbc.M110.202051	65	18	18	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2016	11	12							e0168363	10.1371/journal.pone.0168363	http://dx.doi.org/10.1371/journal.pone.0168363			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI9QH	28006004	Green Submitted, Green Published, gold			2022-12-27	WOS:000392843200046
J	Liao, YL; Wang, LF; Li, YM; Li, Y; Jiang, QQ				Liao, Yulei; Wang, Leifeng; Li, Yiming; Li, Ye; Jiang, Quanquan			The Intelligent Control System and Experiments for an Unmanned Wave Glider (Publication with Expression of Concern. See vol. 17, 2022)	PLOS ONE			English	Article; Publication with Expression of Concern								The control system designing of Unmanned Wave Glider (UWG) is challenging since the control system is weak maneuvering, large time-lag and large disturbance, which is difficult to establish accurate mathematical model. Meanwhile, to complete marine environment monitoring in long time scale and large spatial scale autonomously, UWG asks high requirements of intelligence and reliability. This paper focuses on the "Ocean Rambler" UWG. First, the intelligent control system architecture is designed based on the cerebrum basic function combination zone theory and hierarchic control method. The hardware and software designing of the embedded motion control system are mainly discussed. A motion control system based on rational behavior model of four layers is proposed. Then, combining with the line-of sight method(LOS), a self-adapting PID guidance law is proposed to compensate the steady state error in path following of UWG caused by marine environment disturbance especially current. Based on S-surface control method, an improved S-surface heading controller is proposed to solve the heading control problem of the weak maneuvering carrier under large disturbance. Finally, the simulation experiments were carried out and the UWG completed autonomous path following and marine environment monitoring in sea trials. The simulation experiments and sea trial results prove that the proposed intelligent control system, guidance law, controller have favorable control performance, and the feasibility and reliability of the designed intelligent control system of UWG are verified.	[Liao, Yulei; Wang, Leifeng; Li, Yiming; Li, Ye; Jiang, Quanquan] Harbin Engn Univ, Sci & Technol Underwater Vehicle Lab, Harbin, Heilongjiang, Peoples R China	Harbin Engineering University	Liao, YL (corresponding author), Harbin Engn Univ, Sci & Technol Underwater Vehicle Lab, Harbin, Heilongjiang, Peoples R China.	liaoyulei@hrbeu.edu.cn	li, ye/GWN-2672-2022		National Natural Science Foundation of China [51409061, 51409054, 51579053, 51579022]; Natural Science Foundation of Heilongjiang Province of China [QC2016062]; China Postdoctoral Science Foundation [2013M540271]; Heilongjiang Postdoctoral Financial Assistance [LBH-Z13055]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Heilongjiang Province of China(Natural Science Foundation of Heilongjiang Province); China Postdoctoral Science Foundation(China Postdoctoral Science Foundation); Heilongjiang Postdoctoral Financial Assistance	This work is supported by the National Natural Science Foundation of China (Grant: 51409061 to Y. Liao), the Natural Science Foundation of Heilongjiang Province of China (Grant: QC2016062 to Y. Liao), the China Postdoctoral Science Foundation (Grant: 2013M540271 to Y. Liao), the Heilongjiang Postdoctoral Financial Assistance (Grant: LBH-Z13055 to Y. Liao), and the National Natural Science Foundation of China (Grants: 51409054, 51579053, and 51579022 to Y. Liao). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed SH, 2016, IEEE T VEH TECHNOL, V65, P3954, DOI 10.1109/TVT.2016.2558650; Bertaska IR, 2015, OCEAN ENG, V106, P496, DOI 10.1016/j.oceaneng.2015.07.002; Bibuli M, 2008, 2008 IEEE/RSJ INTERNATIONAL CONFERENCE ON ROBOTS AND INTELLIGENT SYSTEMS, VOLS 1-3, CONFERENCE PROCEEDINGS, P3641, DOI 10.1109/IROS.2008.4650890; Breivik M, 2008, UNDERWATER VEHICLES, P51; Cordeschi N, 2015, VEH COMMUN, V2, P1, DOI 10.1016/j.vehcom.2014.08.004; Crimmins DA, 2006, OCEANS-IEEE, P1690; Du QH, 2016, J MED SYST, V40, DOI 10.1007/s10916-016-0506-5; Fossen TI, 2002, MARINE CONTROL SYSTE, P1; Galgani Francois, 2013, Rapport du Congress de la CIESM, V40, P306; [甘永 Gan Yong], 2004, [机器人, Robot], V26, P246; Goebel NL, 2014, METHODS OCEANOGRAPHY, V10, P90; Hermsdorfer K, 2015, 19 C AIR SEA INT; Kraus ND, 2012, WAVE GLIDER DYNAMIC, P27; Kraus ND, 2011, OCEANS, P1; [廖煜雷 Liao Yulei], 2012, [高技术通讯, Chinese High Technology Letters], V22, P416; Liao YL, 2010, 2ND IEEE INTERNATIONAL CONFERENCE ON ADVANCED COMPUTER CONTROL (ICACC 2010), VOL. 4, P70, DOI 10.1109/ICACC.2010.5486937; Liu HB, 2005, NEUROPSYCHOLOGICAL M, P18; Liu X.M., 2001, OCEAN ENG, V19, P81; Lu X., 2015, RES GEN TECHNOLOGY W, P23; Manley J, 2011, IEEE INSTRUMENTATION, V13, P8; Manley JE., 2008, P OC 2008 MTS IEEE Q; Meyer-Gutbrod E, 2012, IEEE MTS OCEANS 2012, V11, P1; Moreira L, 2007, OCEAN ENG, V34, P2074, DOI 10.1016/j.oceaneng.2007.02.005; Ngo P, 2013, P AUSTR C ROB AUT AU, P1; Ngo P, 2014, IEEE INT C INT ROBOT, P2250, DOI 10.1109/IROS.2014.6942866; O'Reilly TC, 2015, COMMICATIONS RELAY A; Oh SR, 2009, OCEAN ENG, V36, P1; [史健 Shi Jian], 2014, [传感器与微系统, Transducer and Microsystem Technology], V33, P23; Shojafar Mohammad, 2013, Journal of Computing Science and Engineering, V7, P44, DOI 10.5626/JCSE.2013.7.1.44; Smith RN, 2011, OCEANS 11 MTS IEEE K, P1; Van LV, 2015, PLOS ONE, V10, P1; Wang XM, 2012, RENEW SUST ENERG REV, V16, P1958, DOI 10.1016/j.rser.2011.12.016; Xu C. Y., 2014, J OCEAN TECHNOL, V33, P111; [张顺 Zhang Shun], 2014, [振动与冲击, Journal of Vibration and Shock], V33, P119; 王迅, 2008, [海洋科学, Marine Sciences], V32, P84	35	19	23	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2016	11	12							e0168792	10.1371/journal.pone.0168792	http://dx.doi.org/10.1371/journal.pone.0168792			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI9QH	28005956	Green Submitted, Green Published, gold			2022-12-27	WOS:000392843200094
J	Ma, LN; Wang, LY; Chu, YF; Li, XR; Cui, YJ; Chen, SL; Zhou, JH; Li, CL; Lu, ZX; Liu, JX; Liu, YS				Ma, Lina; Wang, Liyan; Chu, Yuefeng; Li, Xuerui; Cui, Yujun; Chen, Shengli; Zhou, Jianhua; Li, Chunling; Lu, Zhongxin; Liu, Jixing; Liu, Yongsheng			Characterization of Chinese Haemophilus parasuis Isolates by Traditional Serotyping and Molecular Serotyping Methods	PLoS One			English	Article							SEROLOGICAL CHARACTERIZATION; INDIRECT HEMAGGLUTINATION; RESPIRATORY-TRACT; PIGS; PREVALENCE; SEROVARS; STRAINS; SWINE; PCR; PASTEURELLACEAE	Haemophilus parasuis is classified mainly through serotyping, but traditional serotyping always yields non-typable (NT) strains and unreliable results via cross-reactions. Here, we surveyed the serotype prevalence of Chinese H. parasuis isolates using traditional serotyping (gel immuno-diffusion test, GID) and molecular serotyping (multiplex PCR, mPCR). We also investigated why discrepant results between these methods were obtained, and investigated mPCR failure through whole-genome sequencing. Of the 100 isolate tested, 73 (73%) and 93 (93%) were serotyped by the GID test and mPCR, respectively, with a concordance rate of 66% (66/100). Additionally, mPCR reduced the number of NT isolates from 27 (27%) for the GID testing, to seven (7%). Eleven isolates were sequenced, including nine serotype-discrepant isolates from mPCR and GID typing (excluding strains that were NT by GID only) and two NT isolates from both methods, and their in silico serotypes were obtained from genome sequencing based on their capsule loci. The mPCR results were supported by the in silico serotyping of the seven serotype-discrepant isolates. The discrepant results and NT isolates determined by mPCR were attributed to deletions and unknown sequences in the serotype-specific region of each capsule locus. Compared with previous investigations, this study found a similar predominant serotype profile, but a different prevalence frequency for H. parasuis, and the five most prevalent serotypes or strain groups were serotypes 5, 4, NT, 7 and 13 for mPCR, and serotypes 5, NT, 4, 7 and 13/10/14 for GID. Additionally, serotype 7 was recognized as a principal serotype in this work.	[Ma, Lina; Wang, Liyan; Chu, Yuefeng; Li, Xuerui; Chen, Shengli; Zhou, Jianhua; Lu, Zhongxin; Liu, Jixing; Liu, Yongsheng] Chinese Acad Agr Sci, Lanzhou Vet Res Inst, State Key Lab Vet Etiol Biol, Lanzhou, Gansu, Peoples R China; [Cui, Yujun] Beijing Inst Microbiol & Epidemiol, State Key Lab Pathogen & Biosecur, Beijing, Peoples R China; [Li, Chunling] Guangdong Acad Agr Sci, Inst Anim Hlth, Guangzhou, Guangdong, Peoples R China	Chinese Academy of Agricultural Sciences; Lanzhou Veterinary Research Institute, CAAS; Beijing Institute of Microbiology & Epidemiology; Guangdong Academy of Agricultural Sciences	Liu, YS (corresponding author), Chinese Acad Agr Sci, Lanzhou Vet Res Inst, State Key Lab Vet Etiol Biol, Lanzhou, Gansu, Peoples R China.	liuyongsheng@caas.cn	Chu, Yuefeng/K-9892-2019		National Nature Science Foundation of China [31172335]; Special Fund for Agro-scientific Research in the Public Interest [201303034-2]; State Key Laboratory of Veterinary Etiological Biology, Lanzhou Veterinary Research Institute, CAAS [SKLVEB2012KFKT010]	National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC)); Special Fund for Agro-scientific Research in the Public Interest; State Key Laboratory of Veterinary Etiological Biology, Lanzhou Veterinary Research Institute, CAAS	This work was supported by National Nature Science Foundation of China (No.31172335) for YL, the Special Fund for Agro-scientific Research in the Public Interest (Grant No. 201303034-2) for ZI and State Key Laboratory of Veterinary Etiological Biology, Lanzhou Veterinary Research Institute, CAAS (No. SKLVEB2012KFKT010) for YC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angen O, 2004, VET MICROBIOL, V103, P255, DOI 10.1016/j.vetmic.2004.07.013; Angen O, 2007, VET MICROBIOL, V119, P266, DOI 10.1016/j.vetmic.2006.10.008; Aragon V, 2010, VET MICROBIOL, V142, P387, DOI 10.1016/j.vetmic.2009.10.025; BIBERSTEIN EL, 1969, J MED MICROBIOL, V2, P75, DOI 10.1099/00222615-2-1-75; Blackall PJ, 1996, AUST VET J, V73, P93, DOI 10.1111/j.1751-0813.1996.tb09984.x; Brockmeier SL, 2002, POLYMICROBIAL DISEASES, P231; Cai XW, 2005, VET MICROBIOL, V111, P231, DOI 10.1016/j.vetmic.2005.07.007; Castilla KS, 2012, RES VET SCI, V92, P366, DOI 10.1016/j.rvsc.2011.04.006; Del Rio ML, 2003, J CLIN MICROBIOL, V41, P880, DOI 10.1128/JCM.41.2.880-882.2003; Dijkman R, 2012, RES VET SCI, V93, P589, DOI 10.1016/j.rvsc.2011.10.013; Gentle A, 2016, J CLIN MICROBIOL, V54, P1456, DOI 10.1128/JCM.03386-15; Howell KJ, 2015, J CLIN MICROBIOL, V53, P3812, DOI 10.1128/JCM.01991-15; Howell KJ, 2013, J BACTERIOL, V195, P4264, DOI 10.1128/JB.00471-13; KIELSTEIN P, 1992, J CLIN MICROBIOL, V30, P862, DOI 10.1128/JCM.30.4.862-865.1992; KIELSTEIN P, 1991, J VET MED B, V38, P315, DOI 10.1111/j.1439-0450.1991.tb00877.x; Kim J, 2002, J VET MED SCI, V64, P57, DOI 10.1292/jvms.64.57; Maskell D.J, 2014, BMC GENOMICS, V15, P1179, DOI 10.1186/1471-2164-15-1179; MOLLER K, 1993, VET MICROBIOL, V36, P261, DOI 10.1016/0378-1135(93)90093-M; MOLLER K, 1990, J CLIN MICROBIOL, V28, P2711; MOROZUMI T, 1986, J CLIN MICROBIOL, V23, P1022, DOI 10.1128/JCM.23.6.1022-1025.1986; MOROZUMI T, 1986, J CLIN MICROBIOL, V23, P138, DOI 10.1128/JCM.23.1.138-142.1986; Oliveira S, 2004, VET MICROBIOL, V99, P1, DOI 10.1016/j.vetmic.2003.12.001; Oliveira S, 2003, AM J VET RES, V64, P435, DOI 10.2460/ajvr.2003.64.435; Palzer A, 2015, CAN VET J, V56, P285; Rafiee M, 2000, AUST VET J, V78, P172, DOI 10.1111/j.1751-0813.2000.tb10586.x; RAPPGABRIELSON VJ, 1992, AM J VET RES, V53, P659; Rubies X, 1999, VET MICROBIOL, V66, P245, DOI 10.1016/S0378-1135(99)00007-3; SMART NL, 1989, CAN VET J, V30, P339; Tadjine A, 2004, J CLIN MICROBIOL, V42, P839, DOI 10.1128/JCM.42.2.839-840.2004; Turni C, 2005, VET MICROBIOL, V106, P145, DOI 10.1016/j.vetmic.2004.12.019; Turni C, 2010, AUST VET J, V88, P255, DOI 10.1111/j.1751-0813.2010.00592.x; Yu J, 2012, VET MICROBIOL, V158, P316, DOI 10.1016/j.vetmic.2012.03.001; Yue M, 2009, J BACTERIOL, V191, P1359, DOI 10.1128/JB.01682-08; Zhang J, 2011, LETT APPL MICROBIOL, V52, P589, DOI 10.1111/j.1472-765X.2011.03048.x	34	25	32	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2016	11	12							e0168903	10.1371/journal.pone.0168903	http://dx.doi.org/10.1371/journal.pone.0168903			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI9QH	28005999	Green Published, Green Submitted, gold			2022-12-27	WOS:000392843200108
J	Persson, N; Jansson, B; Stuhr-Hansen, N; Kovacs, A; Welinder, C; Danielsson, L; Blixt, O				Persson, Nina; Jansson, Bo; Stuhr-Hansen, Nicolai; Kovacs, Andras; Welinder, Charlotte; Danielsson, Lena; Blixt, Ola			A Combinatory Antibody-Antigen Microarray Assay for High-Content Screening of Single-Chain Fragment Variable Clones from Recombinant Libraries	PLOS ONE			English	Article							MONOCLONAL-ANTIBODY; TN-ANTIGEN; CONSTRUCTION; EXPRESSION; GENERATION	We have developed a combinatory antibody-antigen microarray for direct screening of multiple single-chain fragment variable (scFv) clones with no need for pre-purification or enrichment before screening. The straightforward workflow allows for early selection of binders to predefined peptide and glycopeptide targets. A capture antibody is contact printed on microarray slides, side by side with the antigens of interest. A large number of scFv clones, in supernatants, are printed on top of the capture antibody and the antigen in a "spot-on-spot" print. The printed scFv clones, which bind to the capture antibody, are detected using biotinylated antigen, while the binding of scFv clones to the printed antigen is detected through a mouse anti-tag antibody. Two different analyses are thus performed on the same slide, generating two kinds of information: one on the ability of an individual scFv clone to bind to the soluble form of the antigen, which may favour selection for higher affinity rather than avidity, while the other allows the identification of large numbers of clones, simultaneously, due to the binding of scFv clones to densely presented antigens, thus providing an overall increased hit rate. The functionality of the new screening approach was illustrated through the generation of antibodies against peptides from the chaperone complex Ku70/Ku80 and the GalNAc alpha-serine/threonine epitope on the IgA1 alpha chain hinge region. In total, 659 scFv clones were screened with a hit rate of approximately 20%. This approach allowed the identification of functional antibodies in both cases, illustrating the usefulness and capacity of this combinatory microarray screening technique for efficient analysis and validation of antibodies at an early stage of antibody generation.	[Persson, Nina; Stuhr-Hansen, Nicolai; Kovacs, Andras; Blixt, Ola] Univ Copenhagen, Dept Chem, Chem Glycobiol Lab, Copenhagen, Denmark; [Jansson, Bo; Welinder, Charlotte] Lund Univ, Div Oncol & Pathol, Dept Clin Sci Lund, Lund, Sweden; [Kovacs, Andras; Danielsson, Lena] Lund Univ, Div Clin Chem & Pharmacol, Dept Lab Med, Lund, Sweden; [Welinder, Charlotte] Lund Univ, Ctr Excellence Biol & Med Mass Spectrometry CEBMM, Biomed Ctr D13, Lund, Sweden	University of Copenhagen; Lund University; Lund University; Lund University	Blixt, O (corresponding author), Univ Copenhagen, Dept Chem, Chem Glycobiol Lab, Copenhagen, Denmark.	olablixt@chem.ku.dk	Welinder, Charlotte/G-1144-2014	Welinder, Charlotte/0000-0001-9626-0576; Stuhr-Hansen, Nicolai/0000-0001-7497-8915; Blixt, Ola/0000-0003-4143-6276	European Union, Seventh Framework Programme, GastricGlycoExplorer (GGE) initial training network [316929]; Danish Research Council [DFF-4005-00285]; Innovationsfonden; Mrs. Berta Kamprad's Foundation	European Union, Seventh Framework Programme, GastricGlycoExplorer (GGE) initial training network; Danish Research Council(Det Frie Forskningsrad (DFF)); Innovationsfonden; Mrs. Berta Kamprad's Foundation	This work was supported by European Union, Seventh Framework Programme, GastricGlycoExplorer (GGE) initial training network: grant number 316929, OB; The Danish Research Council: DFF-4005-00285, OB, BJ, LD, CW; Innovationsfonden in the framework of the EU-ERASynBio project SynGlycTis, OB; and Mrs. Berta Kamprad's Foundation, CW and BJ.	Abdiche YN, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092451; Ando H, 2008, BIOL PHARM BULL, V31, P1739, DOI 10.1248/bpb.31.1739; Angenendt P, 2004, ANAL CHEM, V76, P2916, DOI 10.1021/ac035357a; Ayriss J, 2007, J PROTEOME RES, V6, P1072, DOI 10.1021/pr0604108; Babel I, 2011, BMC BIOTECHNOL, V11, DOI 10.1186/1472-6750-11-61; Blixt O, 2013, METHODS MOL BIOL, V1047, P201, DOI 10.1007/978-1-62703-544-6_14; Blixt O, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr2841; Blixt O, 2010, J PROTEOME RES, V9, P5250, DOI 10.1021/pr1005229; Cai H, 2015, CHEMBIOCHEM, V16, P959, DOI 10.1002/cbic.201402689; Ecker DM, 2015, MABS-AUSTIN, V7, P9, DOI 10.4161/19420862.2015.989042; Hoogenboom HR, 2005, NAT BIOTECHNOL, V23, P1105, DOI 10.1038/nbt1126; Ju TZ, 2014, CANCER BIOMARK, V14, P63, DOI 10.3233/CBM-130375; Kibat J, NEW BIOTECHNOLOGY; Kibat J, 2016, NEW BIOTECHNOL, V33, P574, DOI 10.1016/j.nbt.2015.12.003; Krebber A, 1997, J IMMUNOL METHODS, V201, P35, DOI 10.1016/S0022-1759(96)00208-6; Li J, 2010, ACTA PHARMACOL SIN, V31, P1198, DOI 10.1038/aps.2010.120; Lindner Peter, 2001, P637; Loureiro LR, 2015, BIOMOLECULES, V5, P1783, DOI 10.3390/biom5031783; Muller C, 2005, CELL CYCLE, V4, P438, DOI 10.4161/cc.4.3.1565; NAKADA H, 1991, BIOCHEM BIOPH RES CO, V179, P762, DOI 10.1016/0006-291X(91)91882-D; Schaefer JV, 2010, ANTIBODY ENGINEERING, VOL 1, SECOND EDITION, P21, DOI 10.1007/978-3-642-01144-3_3; Schwenk JM, 2007, MOL CELL PROTEOMICS, V6, P125, DOI 10.1074/mcp.T600035-MCP200; Seurynck-Servoss SL, 2008, PROTEOMICS, V8, P2199, DOI 10.1002/pmic.200701036; Shahsavarian MA, 2014, J IMMUNOL METHODS, V407, P26, DOI 10.1016/j.jim.2014.03.015; Turunen L, 2009, J BIOMOL SCREEN, V14, P282, DOI 10.1177/1087057108330113; Welinder C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061749; Welinder C, 2011, GLYCOBIOLOGY, V21, P1097, DOI 10.1093/glycob/cwr048; Yuasa N, 2012, J BIOCHEM, V151, P371, DOI 10.1093/jb/mvs007; ZEGERS N, 1990, J IMMUNOL METHODS, V130, P195, DOI 10.1016/0022-1759(90)90048-Z	29	6	6	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2016	11	12							e0168761	10.1371/journal.pone.0168761	http://dx.doi.org/10.1371/journal.pone.0168761			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI9TW	28002485	Green Published, gold, Green Submitted			2022-12-27	WOS:000392853100065
J	Xue, B; Lipps, D; Devineni, S				Xue, Bin; Lipps, David; Devineni, Sree			Integrated Strategy Improves the Prediction Accuracy of miRNA in Large Dataset	PLOS ONE			English	Article							SINGLE NUCLEOTIDE POLYMORPHISMS; MICRORNA PRECURSORS; HUMAN GENOME; CONSENSUS PREDICTION; IDENTIFICATION; SEQUENCE; REAL; CLASSIFICATION; MAP	MiRNAs are short non-coding RNAs of about 22 nucleotides, which play critical roles in gene expression regulation. The biogenesis of miRNAs is largely determined by the sequence and structural features of their parental RNA molecules. Based on these features, multiple computational tools have been developed to predict if RNA transcripts contain miRNAs or not. Although being very successful, these predictors started to face multiple challenges in recent years. Many predictors were optimized using datasets of hundreds of miRNA samples. The sizes of these datasets are much smaller than the number of known miRNAs. Consequently, the prediction accuracy of these predictors in large dataset becomes unknown and needs to be re-tested. In addition, many predictors were optimized for either high sensitivity or high specificity. These optimization strategies may bring in serious limitations in applications. Moreover, to meet continuously raised expectations on these computational tools, improving the prediction accuracy becomes extremely important. In this study, a meta-predictor mirMeta was developed by integrating a set of non-linear transformations with meta-strategy. More specifically, the outputs of five individual predictors were first preprocessed using non-linear transformations, and then fed into an artificial neural network to make the meta-prediction. The prediction accuracy of meta-predictor was validated using both multi-fold cross-validation and independent dataset. The final accuracy of meta-predictor in newly-designed large dataset is improved by 7% to 93%. The meta-predictor is also proved to be less dependent on datasets, as well as has refined balance between sensitivity and specificity. This study has two folds of importance: First, it shows that the combination of non-linear transformations and artificial neural networks improves the prediction accuracy of individual predictors. Second, a new miRNA predictor with significantly improved prediction accuracy is developed for the community for identifying novel miRNAs and the complete set of miRNAs.	[Xue, Bin; Lipps, David; Devineni, Sree] Univ S Florida, Coll Arts & Sci, Dept Cell Biol Microbiol & Mol Biol, Sch Nat Sci & Math, Tampa, FL 33620 USA	State University System of Florida; University of South Florida	Xue, B (corresponding author), Univ S Florida, Coll Arts & Sci, Dept Cell Biol Microbiol & Mol Biol, Sch Nat Sci & Math, Tampa, FL 33620 USA.	binxue@usf.edu	D, Sree Phani Kishore/U-5335-2018	D, Sree Phani Kishore/0000-0001-7287-5162	Department of Cell Biology, Microbiology and Molecular Biology and College of Arts and Sciences at the University of South Florida	Department of Cell Biology, Microbiology and Molecular Biology and College of Arts and Sciences at the University of South Florida	This work was supported by startup funding from the Department of Cell Biology, Microbiology and Molecular Biology and College of Arts and Sciences at the University of South Florida to BX. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altshuler D, 2000, NATURE, V407, P513, DOI 10.1038/35035083; Bentwich I, 2005, NAT GENET, V37, P766, DOI 10.1038/ng1590; Bernstein E, 2001, NATURE, V409, P363, DOI 10.1038/35053110; Brameier M, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-478; Chatterjee P, 2011, J MOL MODEL, V17, P2191, DOI 10.1007/s00894-011-1102-8; Chorley BN, 2008, MUTAT RES-REV MUTAT, V659, P147, DOI 10.1016/j.mrrev.2008.05.001; Czech B, 2011, NAT REV GENET, V12, P19, DOI 10.1038/nrg2916; den Dunnen JT, 2000, HUM MUTAT, V15, P7; DENMAN RB, 1993, BIOTECHNIQUES, V15, P1090; Dezulian T, 2006, BIOINFORMATICS, V22, P359, DOI 10.1093/bioinformatics/bti802; Dole NS, 2016, BONE, V84, P57, DOI 10.1016/j.bone.2015.12.016; Ennis S, 2001, Brief Bioinform, V2, P375, DOI 10.1093/bib/2.4.375; Eyers CE, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M110.003384; Fischer D, 2003, PROTEINS, V51, P434, DOI 10.1002/prot.10357; Friedman RC, 2009, GENOME RES, V19, P92, DOI 10.1101/gr.082701.108; Gan YL, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-49; Gaspari Z, 2012, BBA-PROTEINS PROTEOM, V1824, P637, DOI 10.1016/j.bbapap.2012.01.012; Hammond SM, 2000, NATURE, V404, P293, DOI 10.1038/35005107; Haraksingh RR, 2013, J MOL BIOL, V425, P3970, DOI 10.1016/j.jmb.2013.07.015; Hertel J, 2006, BIOINFORMATICS, V22, pE197, DOI 10.1093/bioinformatics/btl257; Hooper CM, 2014, BIOINFORMATICS, V30, P3356, DOI 10.1093/bioinformatics/btu550; Huang QY, 2015, J GENET GENOMICS, V42, P87, DOI 10.1016/j.jgg.2015.02.001; Huang TH, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-341; IONOV Y, 1993, NATURE, V363, P558, DOI 10.1038/363558a0; Jiang P, 2007, NUCLEIC ACIDS RES, V35, pW339, DOI 10.1093/nar/gkm368; Kozomara A, 2014, NUCLEIC ACIDS RES, V42, pD68, DOI 10.1093/nar/gkt1181; Lai EC, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-7-r42; LeCun Y, 2015, NATURE, V521, P436, DOI 10.1038/nature14539; Lee Y, 2003, NATURE, V425, P415, DOI 10.1038/nature01957; Legendre M, 2005, BIOINFORMATICS, V21, P841, DOI 10.1093/bioinformatics/bti073; Lim LP, 2003, GENE DEV, V17, P991, DOI 10.1101/gad.1074403; Liu J, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm562; Mathelier A, 2010, BIOINFORMATICS, V26, P2226, DOI 10.1093/bioinformatics/btq329; Mishra PJ, 2008, CELL CYCLE, V7, P853, DOI 10.4161/cc.7.7.5666; Morozova N, 2012, RNA, V18, P1635, DOI 10.1261/rna.032284.112; Nam JW, 2006, NUCLEIC ACIDS RES, V34, pW455, DOI 10.1093/nar/gkl321; Nawrocki EP, 2015, NUCLEIC ACIDS RES, V43, pD130, DOI 10.1093/nar/gku1063; Ohue Masahito, 2013, BMC Proc, V7, pS6, DOI 10.1186/1753-6561-7-S7-S6; Riley J H, 2000, Pharmacogenomics, V1, P39, DOI 10.1517/14622416.1.1.39; Ritchie W, 2008, BIOINFORMATICS, V24, P1394, DOI 10.1093/bioinformatics/btn137; Sachidanandam R, 2001, NATURE, V409, P928, DOI 10.1038/35057149; Schlessinger A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004433; Schmidhuber J, 2015, NEURAL NETWORKS, V61, P85, DOI 10.1016/j.neunet.2014.09.003; Sewer A, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-267; Singh H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105667; Stefl S, 2013, J MOL BIOL, V425, P3919, DOI 10.1016/j.jmb.2013.07.014; Wan J, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkm848; Wang JW, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-374; Wang Xuting, 2005, Toxicol Appl Pharmacol, V207, P84, DOI 10.1016/j.taap.2004.09.024; Wang XW, 2005, BIOINFORMATICS, V21, P3610, DOI 10.1093/bioinformatics/bti562; Wu YG, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-107; Xia JF, 2010, AMINO ACIDS, V39, P1595, DOI 10.1007/s00726-010-0588-1; Xue B, 2008, PROTEINS, V72, P427, DOI 10.1002/prot.21940; Xue B, 2010, BBA-PROTEINS PROTEOM, V1804, P996, DOI 10.1016/j.bbapap.2010.01.011; Xue B, 2009, FEBS LETT, V583, P1469, DOI 10.1016/j.febslet.2009.03.070; Xue CH, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-310; Yates CM, 2013, J MOL BIOL, V425, P3949, DOI 10.1016/j.jmb.2013.07.012; Yousef M, 2006, BIOINFORMATICS, V22, P1325, DOI 10.1093/bioinformatics/btl094	58	9	9	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2016	11	12							e0168392	10.1371/journal.pone.0168392	http://dx.doi.org/10.1371/journal.pone.0168392			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI9TW	28002428	Green Submitted, gold, Green Published			2022-12-27	WOS:000392853100042
J	Chang, L; He, SY; Mao, DQ; Liu, YH; Xiong, ZJ; Fu, DK; Li, B; Wei, SG; Xu, X; Li, SB; Yuan, H				Chang, Liao; He, Shiyang; Mao, Danqing; Liu, Yuanhong; Xiong, Zijun; Fu, Dongke; Li, Bo; Wei, Shuguang; Xu, Xun; Li, Shengbin; Yuan, Hui			Signatures of Crested Ibis MHC Revealed by Recombination Screening and Short-Reads Assembly Strategy	PLOS ONE			English	Article							C-TYPE LECTIN; CHICKEN MHC; GENES; COMPLEX; CONSTRUCTION; COEVOLUTION; DIVERSITY; EVOLUTION; SEQUENCE; CHOICE	Whole-genome shotgun (WGS) sequencing has become a routine method in genome research over the past decade. However, the assembly of highly polymorphic regions in WGS projects remains a challenge, especially for large genomes. Employing BAC library constructing, PCR screening and Sanger sequencing, traditional strategy is laborious and expensive, which hampers research on polymorphic genomic regions. As one of the most highly polymorphic regions, the major histocompatibility complex (MHC) plays a central role in the adaptive immunity of all jawed vertebrates. In this study, we introduced an efficient procedure based on recombination screening and short-reads assembly. With this procedure, we constructed a high quality 488-kb region of crested ibis MHC that consists of 3 superscaffolds and contains 50 genes. Our sequence showed comparable quality (97.29% identity) to traditional Sanger assembly, while the workload was reduced almost 7 times. Comparative study revealed distinctive features of crested ibis by exhibiting the COL11A2-BLA-BLB-BRD2 cluster and presenting both ADPRH and odorant receptor (OR) gene in the MHC region. Furthermore, the conservation of the BF-TAP1-TAP2 structure in crested ibis and other vertebrate lineages is interesting in light of the hypothesis that coevolution of functionally related genes in the primordial MHC is responsible for the appearance of the antigen presentation pathways at the birth of the adaptive immune system.	[Chang, Liao; Xiong, Zijun; Fu, Dongke; Wei, Shuguang; Li, Shengbin] Xi An Jiao Tong Univ, Coll Med & Forens, Xian, Shaanxi, Peoples R China; [Chang, Liao; He, Shiyang; Mao, Danqing; Liu, Yuanhong; Xiong, Zijun; Li, Bo; Xu, Xun; Li, Shengbin; Yuan, Hui] BGI Shenzhen, Shenzhen, Guangdong, Peoples R China; [Yuan, Hui] Northeast Agr Univ, Coll Anim Sci & Technol, Harbin, Heilongjiang, Peoples R China	Xi'an Jiaotong University; Beijing Genomics Institute (BGI); Northeast Agricultural University - China	Li, SB (corresponding author), Xi An Jiao Tong Univ, Coll Med & Forens, Xian, Shaanxi, Peoples R China.; Li, SB; Yuan, H (corresponding author), BGI Shenzhen, Shenzhen, Guangdong, Peoples R China.; Yuan, H (corresponding author), Northeast Agr Univ, Coll Anim Sci & Technol, Harbin, Heilongjiang, Peoples R China.	shbinlee@mail.xjtu.edu.cn; huiyuanChina@163.com	He, Shiyang/CAH-6600-2022; Xu, Xun/AAI-6763-2020; Chang, Liao/AAG-1643-2020	He, Shiyang/0000-0002-1849-2635; Xu, Xun/0000-0002-5338-5173; Xiong, Zijun/0000-0003-3923-0703; Yuan, Hui/0000-0001-9739-3645				Alexeyenko A, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-439; Asakawa S, 1997, GENE, V191, P69, DOI 10.1016/S0378-1119(97)00044-9; Bairoch A, 2000, NUCLEIC ACIDS RES, V28, P45, DOI 10.1093/nar/28.1.45; Balakrishnan CN, 2010, BMC BIOL, V8, DOI 10.1186/1741-7007-8-29; Beck S, 1999, NATURE, V401, P921, DOI 10.1038/44853; Birney E, 2004, GENOME RES, V14, P988, DOI 10.1101/gr.1865504; Chaves LD, 2009, J IMMUNOL, V183, P6530, DOI 10.4049/jimmunol.0901310; Chen LC, 2015, SCI REP-UK, V5, DOI 10.1038/srep07963; Dirscherl H, 2014, DEV COMP IMMUNOL, V46, P11, DOI 10.1016/j.dci.2014.02.018; Ekblom R, 2011, IMMUNOGENETICS, V63, P523, DOI [10.1007/s00251-011-0525-9, 10.1007/s00251-011-0528-6]; Farrar K, 2007, NAT PROTOC, V2, P1661, DOI 10.1038/nprot.2007.204; Fernando MMA, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000024; Hedrick PW, 2000, EVOLUTION, V54, P2145; Huddleston J, 2014, GENOME RES, V24, P688, DOI 10.1101/gr.168450.113; Hughes CR, 2008, IMMUNOGENETICS, V60, P219, DOI 10.1007/s00251-008-0287-1; Hughes JF, 2012, NATURE, V483, P82, DOI 10.1038/nature10843; Hurt P, 2004, GENOME RES, V14, P631, DOI 10.1101/gr.1987704; Jaratlerdsiri W, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114631; Kaufman J, 1999, NATURE, V401, P923, DOI 10.1038/44856; Laloi D, 2011, BEHAV PROCESS, V88, P149, DOI 10.1016/j.beproc.2011.08.011; Li SB, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0557-1; LI SX, 2014, J INEQUAL APPL 1119, P6312, DOI DOI 10.1186/S13059-014-0557-1; LIN YZ, 1981, ACTA ZOOL SINICA, V27, P273; Luo RB, 2012, GIGASCIENCE, V1, DOI 10.1186/2047-217X-1-18; Magor KE, 2013, DEV COMP IMMUNOL, V41, P377, DOI 10.1016/j.dci.2013.04.010; McPeek MA, 2006, EVOLUTION, V60, P1967, DOI 10.1111/j.0014-3820.2006.tb01835.x; Miller MM, 2014, J HERED, V105, P203, DOI 10.1093/jhered/est091; Miller MM, 2004, IMMUNOGENETICS, V56, P261, DOI 10.1007/s00251-004-0682-1; Nedelkova M, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkr668; Ohta Y, 2015, IMMUNOL REV, V267, P6, DOI 10.1111/imr.12324; Ren LM, 2011, IMMUNOGENETICS, V63, P667, DOI 10.1007/s00251-011-0545-5; Richardson DS, 2003, MOL ECOL, V12, P3523, DOI 10.1046/j.1365-294X.2003.02005.x; Roberts A, 2011, BIOINFORMATICS, V27, P2325, DOI 10.1093/bioinformatics/btr355; Roberts SC, 2003, NAT GENET, V35, P103, DOI 10.1038/ng1231; Rogers SL, 2005, J IMMUNOL, V174, P3475, DOI 10.4049/jimmunol.174.6.3475; Ruby T, 2005, IMMUNOGENETICS, V57, P116, DOI 10.1007/s00251-005-0770-x; Salomonsen J, 2003, IMMUNOGENETICS, V55, P605, DOI 10.1007/s00251-003-0620-7; Schwartz S, 2000, GENOME RES, V10, P577, DOI 10.1101/gr.10.4.577; She R, 2009, GENOME RES, V19, P143, DOI 10.1101/gr.082081.108; Shiina T, 2006, ANIM SCI J, V77, P151, DOI 10.1111/j.1740-0929.2006.00333.x; Shiina T, 2004, J IMMUNOL, V172, P6751, DOI 10.4049/jimmunol.172.11.6751; Shiina T, 2007, J IMMUNOL, V178, P7162, DOI 10.4049/jimmunol.178.11.7162; Solinhac R, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-616; Stanke M, 2003, BIOINFORMATICS, V19, pII215, DOI 10.1093/bioinformatics/btg1080; Sudmant PH, 2010, SCIENCE, V330, P641, DOI 10.1126/science.1197005; Taniguchi Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108506; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Walker BA, 2011, P NATL ACAD SCI USA, V108, P8396, DOI 10.1073/pnas.1019496108; Walter L, 2000, IMMUNOGENETICS, V51, P829, DOI 10.1007/s002510000219; Wang B, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-553; Wilming LG, 2013, DATABASE-OXFORD, DOI 10.1093/database/bat011; Ye Q, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032154; Zhang GF, 2012, NATURE, V490, P49, DOI 10.1038/nature11413	53	2	2	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2016	11	12							e0168744	10.1371/journal.pone.0168744	http://dx.doi.org/10.1371/journal.pone.0168744			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI9QF	27997612	Green Published, Green Submitted, gold			2022-12-27	WOS:000392842900072
J	Chung, JW; Kim, BH; Lee, CS; Kim, GH; Sohn, HR; Min, BY; Song, JC; Park, HK; Jang, ES; Yoon, H; Kim, J; Shin, CM; Park, YS; Hwang, JH; Jeong, SH; Kim, N; Lee, DH; Lee, J; Ahn, S; Kim, JW				Chung, Jung Wha; Kim, Beom Hee; Lee, Chung Seop; Kim, Gi Hyun; Sohn, Hyung Rae; Min, Bo Young; Song, Joon Chang; Park, Hyun Kyung; Jang, Eun Sun; Yoon, Hyuk; Kim, Jaihwan; Shin, Cheol Min; Park, Young Soo; Hwang, Jin-Hyeok; Jeong, Sook-Hyang; Kim, Nayoung; Lee, Dong Ho; Lee, Jaebong; Ahn, Soyeon; Kim, Jin-Wook			Optimizing Surveillance Performance of Alpha-Fetoprotein by Selection of Proper Target Population in Chronic Hepatitis B	PLOS ONE			English	Article							RANDOMIZED CONTROLLED-TRIAL; HEPATOCELLULAR-CARCINOMA; MANAGEMENT; ENTECAVIR; DIAGNOSIS; EPIDEMIOLOGY; CIRRHOSIS	Although alpha-fetoprotein (AFP) is the most widely used biomarker in hepatocellular carcinoma (HCC) surveillance, disease activity may also increase AFP levels in chronic hepatitis B (CHB). Since nucleos(t)ide analog (NA) therapy may reduce not only HBV viral loads and transaminase levels but also the falsely elevated AFP levels in CHB, we tried to determine whether exposure to NA therapy influences AFP performance and whether selective application can optimize the performance of AFP testing in CHB during HCC surveillance. A retrospective cohort of 6,453 CHB patients who received HCC surveillance was constructed from the electronic clinical data warehouse. Covariates of AFP elevation were determined from 53,137 AFP measurements, and covariate-specific receiver operating characteristics regression analysis revealed that albumin levels and exposure to NA therapy were independent determinants of AFP performance. C statistics were largest in patients with albumin levels > 3.7 g/dL who were followed without NA therapy during study period, whereas AFP performance was poorest when tested in patients with NA therapy during study and albumin levels were < 3.7 g/dL (difference in C statics = 0.35, p < 0.0001). Contrary to expectation, CHB patients with current or recent exposure to NA therapy showed poorer performance of AFP during HCC surveillance. Combination of concomitant albumin levels and status of NA therapy can identify subgroup of CHB patients who will show optimized AFP performance.	[Chung, Jung Wha; Kim, Beom Hee; Lee, Chung Seop; Kim, Gi Hyun; Sohn, Hyung Rae; Min, Bo Young; Song, Joon Chang; Park, Hyun Kyung; Jang, Eun Sun; Yoon, Hyuk; Kim, Jaihwan; Shin, Cheol Min; Park, Young Soo; Hwang, Jin-Hyeok; Jeong, Sook-Hyang; Kim, Nayoung; Lee, Dong Ho; Kim, Jin-Wook] Seoul Natl Univ, Bundang Hosp, Dept Med, Seongnam, South Korea; [Park, Young Soo; Hwang, Jin-Hyeok; Jeong, Sook-Hyang; Kim, Nayoung; Lee, Dong Ho; Kim, Jin-Wook] Seoul Natl Univ, Coll Med, Dept Internal Med, Seoul, South Korea; [Lee, Jaebong; Ahn, Soyeon] Seoul Natl Univ, Bundang Hosp, Med Res Collaborating Ctr, Div Stat, Seongnam, South Korea	Seoul National University (SNU); Seoul National University (SNU); Seoul National University (SNU)	Kim, JW (corresponding author), Seoul Natl Univ, Bundang Hosp, Dept Med, Seongnam, South Korea.; Kim, JW (corresponding author), Seoul Natl Univ, Coll Med, Dept Internal Med, Seoul, South Korea.	kimjw@snubh.org	Yoon, Hyuk/AAT-4978-2020	Yoon, Hyuk/0000-0002-2657-0349; Kim, Nayoung/0000-0002-9397-0406; Kim, Jin-Wook/0000-0003-0934-3344	National Research Foundation of Korea (NRF) - Korean Government [2013R1A1A2061509]	National Research Foundation of Korea (NRF) - Korean Government(National Research Foundation of Korea)	This work was supported by a National Research Foundation of Korea (NRF) grant to J-W Kim, funded by the Korean Government (2013R1A1A2061509). As such, the sponsor played no active role in the study.	Bayati N, 1998, AM J GASTROENTEROL, V93, P2452, DOI 10.1111/j.1572-0241.1998.00703.x; Bruix J, 2005, HEPATOLOGY, V42, P1208, DOI 10.1002/hep.20933; Bruix J, 2001, J HEPATOL, V35, P421, DOI 10.1016/S0168-8278(01)00130-1; Bruix J S M., 2010, MANAGEMENT OF HEPATO; Chen JG, 2003, J MED SCREEN, V10, P204, DOI 10.1258/096914103771773320; Chen TM, 2007, J GASTROEN HEPATOL, V22, P669, DOI 10.1111/j.1440-1746.2007.04898.x; Davila JA, 2010, HEPATOLOGY, V52, P132, DOI 10.1002/hep.23615; Di Bisceglie AM, 2005, J HEPATOL, V43, P434, DOI 10.1016/j.jhep.2005.03.019; DIBISCEGLIE AM, 1989, CANCER, V64, P2117, DOI 10.1002/1097-0142(19891115)64:10<2117::AID-CNCR2820641024>3.0.CO;2-7; European Assoc Study Liver, 2012, EUR J CANCER, V48, P599, DOI 10.1016/j.ejca.2011.12.021; Forner A, 2010, SEMIN LIVER DIS, V30, P61, DOI 10.1055/s-0030-1247133; Gopal P, 2014, CLIN GASTROENTEROL H, V12, P870, DOI 10.1016/j.cgh.2013.09.053; Hu KQ, 2004, AM J GASTROENTEROL, V99, P860, DOI 10.1111/j.1572-0241.2004.04152.x; IMAEDA T, 1992, J GASTROEN HEPATOL, V7, P132, DOI 10.1111/j.1440-1746.1992.tb00949.x; Janes H, 2009, STATA J, V9, P17, DOI 10.1177/1536867X0900900102; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Kim GA, 2015, LIVER INT, V35, P232, DOI 10.1111/liv.12516; Kim SS, 2014, AM J GASTROENTEROL, V109, P1223, DOI 10.1038/ajg.2014.145; Liaw YF, 2008, HEPATOL INT, V2, P263, DOI 10.1007/s12072-008-9080-3; Lok AS, 2010, GASTROENTEROLOGY, V138, P493, DOI 10.1053/j.gastro.2009.10.031; LOK ASF, 1989, HEPATOLOGY, V9, P110, DOI 10.1002/hep.1840090119; Luo K, 2010, J VIRAL HEPATITIS, V17, P511, DOI 10.1111/j.1365-2893.2009.01208.x; Marrero JA, 2009, GASTROENTEROLOGY, V137, P110, DOI 10.1053/j.gastro.2009.04.005; Nguyen MH, 2002, HEPATOLOGY, V36, P410, DOI 10.1053/jhep.2002.34744; Omata M, 2010, HEPATOL INT, V4, P439, DOI 10.1007/s12072-010-9165-7; Pepe MS, 2009, STATA J, V9, P1; Richardson P, 2012, CLIN GASTROENTEROL H, V10, P428, DOI 10.1016/j.cgh.2011.11.025; Shen QJ, 2012, LANCET ONCOL, V13, P817, DOI 10.1016/S1470-2045(12)70233-4; Sherman M, 2010, SEMIN LIVER DIS, V30, P3, DOI 10.1055/s-0030-1247128; Shim JJ, 2014, J GASTROEN HEPATOL, V29, P1699, DOI 10.1111/jgh.12612; Trevisani F, 2001, J HEPATOL, V34, P570, DOI 10.1016/S0168-8278(00)00053-2; Venook AP, 2010, ONCOLOGIST, V15, P5, DOI 10.1634/theoncologist.2010-S4-05; Wong GLH, 2014, HEPATOLOGY, V59, P986, DOI 10.1002/hep.26739; Yang SW, 2015, J GASTROEN HEPATOL, V30, P1175, DOI 10.1111/jgh.12921; Yoo S, 2012, HEALTHC INFORM RES, V18, P145, DOI 10.4258/hir.2012.18.2.145; Zhang BH, 2004, J CANCER RES CLIN, V130, P417, DOI 10.1007/s00432-004-0552-0	36	6	6	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2016	11	12							e0168189	10.1371/journal.pone.0168189	http://dx.doi.org/10.1371/journal.pone.0168189			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI9QF	27997559	gold, Green Published, Green Submitted			2022-12-27	WOS:000392842900025
J	Zuo, ZB; Liang, S; Sun, XG; Bussell, S; Yan, J; Kan, W; Leng, XB; Liao, LJ; Ruan, YH; Shao, YM; Xing, H				Zuo, Zhongbao; Liang, Shu; Sun, Xianguang; Bussell, Scottie; Yan, Jing; Kan, Wei; Leng, Xuebing; Liao, Lingjie; Ruan, Yuhua; Shao, Yiming; Xing, Hui			Drug Resistance and Virological Failure among HIV-Infected Patients after a Decade of Antiretroviral Treatment Expansion in Eight Provinces of China	PLOS ONE			English	Article							RANDOMIZED CONTROLLED-TRIAL; REVERSE-TRANSCRIPTASE; MEDICATION ADHERENCE; TREATMENT PROGRAM; TREATMENT COHORT; SOUTH-AFRICA; THERAPY; MORTALITY; SURVEILLANCE; REGIMENS	Background China's National Free Antiretroviral Treatment Program (NFATP) has substantially increased the survival rate since 2002. However, the emergence of HIV drug resistance (HIVDR) limits the durability and effectiveness of antiretroviral treatment (ART) in at risk patients. Method A cross-sectional survey was conducted among patients having received a median of 13.9 months of ART in eight provinces in China. Demographic and clinical information was collected, and venous blood was sampled for CD4 cell counts, measurement of the HIV viral load (VL), and HIV drug resistance (HIVDR) genotyping. Possible risk factors for HIVDR were analyzed by the logistic regression model. Results The study included 765 patients. Among them, 65 patients (8.5%) had virological failure (VLF) defined as >= 1,000 copies/ml. Among the individuals with VLF, 64 were successful genotyped, and of these, 33 had one or more HIVDR mutations. The prevalence of HIVDR mutations among patients receiving first-line ART was 4.3% (33/765). All of the patients with HIVDR mutations were resistant to non-nucleoside transcriptase inhibitors, 81.8% were resistant to nucleoside reverse transcriptase inhibitors, and only 3% had mutations that caused resistance to protease inhibitors. Having lower ratios of drug intake in the past month and dwelling in two southwestern provinces were factors independently associated with the emergence of HIVDR. Conclusion Most patients receiving first-line ART treatment achieved sound virological and immunological outcomes. However, poor adherence is still a key problem, which has led to the high rate of HIVDR. It was notable that the proportion of drug resistance widely varied among the provinces. More studies are needed to focus on adherence.	[Zuo, Zhongbao; Yan, Jing; Kan, Wei; Leng, Xuebing; Liao, Lingjie; Ruan, Yuhua; Shao, Yiming; Xing, Hui] Chinese Ctr Dis Control & Prevent, Collaborat Innovat Ctr Diag & Treatment Infect Di, Natl Ctr AIDS STD Control & Prevent, State Key Lab Infect Dis Prevent & Control, Beijing, Peoples R China; [Liang, Shu] Sichuan Ctr Dis Control Prevent, Chengdu, Peoples R China; [Sun, Xianguang] Guizhou Ctr Dis Control & Prevent, Guiyang, Peoples R China; [Bussell, Scottie] Vanderbilt Inst Global Hlth, Nashville, TN USA	Chinese Center for Disease Control & Prevention; National Center for AIDS/STD Control & Prevention, Chinese Center for Disease Control & Prevention; Collaborative Innovation Center for Diagnosis & Treatment of Infectious Diseases; Vanderbilt University	Xing, H (corresponding author), Chinese Ctr Dis Control & Prevent, Collaborat Innovat Ctr Diag & Treatment Infect Di, Natl Ctr AIDS STD Control & Prevent, State Key Lab Infect Dis Prevent & Control, Beijing, Peoples R China.	xingh@chinaaids.cn		Leng, Xuebing/0000-0001-6884-4910	Ministry of Science and Technology of China [2012ZX10001-002]; Chinese State Key Laboratory of Infectious Disease Develop Grant; International Development Research Center of Canada [104519-010]; National Institutes of Health (NIH) Research Training Grant - Fogarty International Center [R25 TW009337]; NIH Office of the Director; National institute of Mental Health	Ministry of Science and Technology of China(Ministry of Science and Technology, China); Chinese State Key Laboratory of Infectious Disease Develop Grant; International Development Research Center of Canada; National Institutes of Health (NIH) Research Training Grant - Fogarty International Center; NIH Office of the Director(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This study was supported by grants from the Ministry of Science and Technology of China (2012ZX10001-002), the Chinese State Key Laboratory of Infectious Disease Develop Grant, and the International Development Research Center of Canada (grant #104519-010). The fund providers had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Scottie Bussell contributed to this work during his fellowship, which was supported by National Institutes of Health (NIH) Research Training Grant R25 TW009337, funded by Fogarty International Center, the NIH Office of the Director, and the National institute of Mental Health.	Andrade ASA, 2005, CLIN INFECT DIS, V41, P875, DOI 10.1086/432877; Billong SC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072680; Casado JL, 2000, AIDS, V14, pF1, DOI 10.1097/00002030-200001280-00001; Cornell M, 2010, AIDS, V24, P2263, DOI 10.1097/QAD.0b013e32833d45c5; Etiebet MAA, 2013, AIDS, V27, P553, DOI 10.1097/QAD.0b013e32835b0f59; Goggin K, 2007, PUBLIC HEALTH REP, V122, P472, DOI 10.1177/003335490712200408; Hemkens LG, 2015, HIV CLIN TRIALS, V16, P178, DOI 10.1179/1945577115Y.0000000004; Hong SY, 2015, JAIDS-J ACQ IMM DEF, V68, P463, DOI 10.1097/QAI.0000000000000509; Keiser O, 2008, TROP MED INT HEALTH, V13, P870, DOI 10.1111/j.1365-3156.2008.02078.x; Leng XB, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2014-005886; Lessells RJ, 2014, JAIDS-J ACQ IMM DEF, V65, pE17, DOI 10.1097/QAI.0b013e31829ceb14; Lewden C, 2014, J INT AIDS SOC, V17, DOI 10.7448/IAS.17.1.18797; Liang SJ, 2015, FRONT PUBLIC HEALTH, V3, DOI 10.3389/fpubh.2015.00244; Liao LJ, 2013, AIDS, V27, P1815, DOI 10.1097/QAD.0b013e3283611931; Liao LJ, 2010, JAIDS-J ACQ IMM DEF, V53, pS10, DOI 10.1097/QAI.0b013e3181c7d363; Liu HX, 2014, CLIN INFECT DIS, V59, P1495, DOI 10.1093/cid/ciu590; Liu TF, 2006, CLIN INFECT DIS, V42, P1608, DOI 10.1086/503914; Ma Y, 2010, INT J EPIDEMIOL, V39, P973, DOI 10.1093/ije/dyp233; May MT, 2006, LANCET, V368, P451, DOI 10.1016/S0140-6736(06)69152-6; NCAIDS N and China CDC, 2015, CHIN J AIDS STD, V21, P87, DOI 10.13419/j.cnki.aids.2015.02.01; Scarsi KK, 2015, CLIN INFECT DIS OFFI; Shafer RW, 2007, AIDS, V21, P215, DOI 10.1097/QAD.0b013e328011e691; Simoni JM, 2007, HEALTH PSYCHOL, V26, P488, DOI 10.1037/0278-6133.26.4.488; Simoni Jane M, 2008, Curr Infect Dis Rep, V10, P515, DOI 10.1007/s11908-008-0083-y; Sorensen JL, 2007, DRUG ALCOHOL DEPEN, V88, P54, DOI 10.1016/j.drugalcdep.2006.09.019; TISDALE M, 1993, P NATL ACAD SCI USA, V90, P5653, DOI 10.1073/pnas.90.12.5653; Velen K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064459; Wadonda-Kabondo N, 2012, CLIN INFECT DIS, V54, pS355, DOI 10.1093/cid/cis004; Wagner GJ, 2006, AIDS, V20, P1295, DOI 10.1097/01.aids.0000232238.28415.d2; Wang J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088305; Wang X, 2011, CURR HIV RES, V9, P103, DOI 10.2174/157016211795569122; Xing H, 2015, J ANTIMICROB CHEMOTH, V70, P2097, DOI 10.1093/jac/dkv078; Xing H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062408; Xing H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054917; Zhang FJ, 2008, CLIN INFECT DIS, V47, P825, DOI 10.1086/590945; Zhang FJ, 2011, LANCET INFECT DIS, V11, P516, DOI 10.1016/S1473-3099(11)70097-4; Zhang FJ, 2009, ANN INTERN MED, V151, P241, DOI 10.7326/0003-4819-151-4-200908180-00006; Zhang Y, 2012, JAIDS-J ACQ IMM DEF, V60, P59, DOI 10.1097/QAI.0b013e31824c3d9f; Zhao DC, 2012, CHINESE MED J-PEKING, V125, P3514, DOI 10.3760/cma.j.issn.0366-6999.2012.19.028; Zhu H, 2013, JAIDS-J ACQ IMM DEF, V63, pE150, DOI 10.1097/QAI.0b013e3182948d82	40	29	31	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2016	11	12							e0166661	10.1371/journal.pone.0166661	http://dx.doi.org/10.1371/journal.pone.0166661			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI9QF	27997554	gold, Green Submitted, Green Published			2022-12-27	WOS:000392842900003
J	Wen, J; Tan, YH; Jiang, L				Wen, Juan; Tan, Yanghong; Jiang, Lin			A Reconfiguration Strategy of Distribution Networks Considering Node Importance	PLOS ONE			English	Article							SWARM OPTIMIZATION; ALGORITHM; FLOW	Node importance degree is a vital index in distribution network reconfiguration because it reflects the robustness of the network structure by evaluating node importance. Since the traditional reconfiguration ignores this index, the reconstructed network structure may be vulnerable which would reduce the security and stability of the distribution systems. This paper presents a novel reconfiguration strategy considering the node importance. The optimization objectives are the improvement of the node importance degree and the reduction of power loss. To balance the objectives, the reconfiguration mathematical model is formulated as a compound objective function with weight coefficients. Then the quantum particle swarm algorithm is employed to address this compound objective optimization problem. The strategy can model different scenarios network reconfiguration by adjusting the weight vector based on the tendencies of the utility decision maker. Illustrative examples verify the effectiveness of the proposed strategy.	[Wen, Juan; Tan, Yanghong] Hunan Univ, Coll Elect & Informat Engn, Changsha 410082, Hunan, Peoples R China; [Wen, Juan; Jiang, Lin] Univ South China, Coll Elect & Informat Engn, Hengyang, Hunan, Peoples R China	Hunan University; University of South China	Wen, J (corresponding author), Hunan Univ, Coll Elect & Informat Engn, Changsha 410082, Hunan, Peoples R China.; Wen, J (corresponding author), Univ South China, Coll Elect & Informat Engn, Hengyang, Hunan, Peoples R China.	55wenjuan@163.com		tan, yanghong/0000-0002-6713-5618	National Natural Science Foundation of China [61102039]; National Hi-Tech Research and Development Plan [2014AA052600]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Hi-Tech Research and Development Plan(National High Technology Research and Development Program of China)	This work was supported by National Natural Science Foundation of China (61102039) and National Hi-Tech Research and Development Plan (2014AA052600). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alonso FR, 2015, IEEE T POWER SYST, V30, P840, DOI 10.1109/TPWRS.2014.2330628; Andervazh MR, 2013, IET GENER TRANSM DIS, V7, P1367, DOI 10.1049/iet-gtd.2012.0712; Arianos S, 2009, CHAOS, V19, DOI 10.1063/1.3077229; Bernardon DP, 2010, IEEE T POWER DELIVER, V25, P2684, DOI 10.1109/TPWRD.2010.2041013; Bhuyan MH, 2016, INFORM SCIENCES, V348, P243, DOI 10.1016/j.ins.2016.02.023; Callaway DS, 2000, PHYS REV LETT, V85, P5468, DOI 10.1103/PhysRevLett.85.5468; Chen WN, 2013, IEEE T EVOLUT COMPUT, V17, P241, DOI 10.1109/TEVC.2011.2173577; Crucitti P, 2004, PHYS REV E, V69, DOI 10.1103/PhysRevE.69.045104; DENG Chao, 2009, 2009 INT WORKSH INT, P1, DOI [DOI 10.1109/IWISA.2009.5073027, 10.1109/IWISA.2009.5073027]; Dong D, 2013, IEEE T POWER ELECTR, V28, P1655, DOI 10.1109/TPEL.2012.2212462; Ghosh S, 1999, IEE P-GENER TRANSM D, V146, P641, DOI 10.1049/ip-gtd:19990464; Gomes FV, 2006, IEEE T POWER SYST, V21, P1616, DOI 10.1109/TPWRS.2006.879290; Gupta N, 2014, INT J ELEC POWER, V54, P664, DOI 10.1016/j.ijepes.2013.08.016; Huang Jin-Kai, 2012, POW EN ENG C APPEEC, P1, DOI DOI 10.1109/APPEEC.2012.6307449; Huang YC, 2002, IEE P-GENER TRANSM D, V149, P615, DOI 10.1049/ip-gtd:20020512; Imran AM, 2014, INT J ELEC POWER, V62, P312, DOI 10.1016/j.ijepes.2014.04.034; Khan SU, 2016, IEEE T MAGN, V52, DOI 10.1109/TMAG.2015.2487678; Li CB, 2014, IET GENER TRANSM DIS, V8, P1843, DOI 10.1049/iet-gtd.2014.0051; Liu Y, 2007, IEEE T POWER SYST, V22, P1267, DOI 10.1109/TPWRS.2007.901486; Liu YS, 2017, IEEE ACM T COMPUT BI, V14, P905, DOI 10.1109/TCBB.2016.2550432; Ma J, 2014, INT J ELEC POWER, V63, P1030, DOI 10.1016/j.ijepes.2014.07.017; Maghsudi S, 2016, IEEE T VEH TECHNOL, V65, P2481, DOI 10.1109/TVT.2015.2423691; Mendoza JE, 2009, IET GENER TRANSM DIS, V3, P825, DOI 10.1049/iet-gtd.2009.0009; Neshvad S, 2016, IET GENER TRANSM DIS, V10, P1710, DOI 10.1049/iet-gtd.2015.1163; Rao RS, 2011, IEEE T POWER SYST, V26, P1080, DOI 10.1109/TPWRS.2010.2076839; Tian Z, 2016, IET GENER TRANSM DIS, V10, P1938, DOI 10.1049/iet-gtd.2015.1228; Vukovic O, 2012, IEEE J SEL AREA COMM, V30, P1108, DOI 10.1109/JSAC.2012.120709; Wang SP, 2016, BBA-GEN SUBJECTS, V1860, P2716, DOI 10.1016/j.bbagen.2016.04.010; Watts DJ, 1998, NATURE, V393, P440, DOI 10.1038/30918; Werho T., 2016, POWER SYSTEM CONNECT, P1; Xu Y, 2013, IEEE T POWER SYST, V28, P4072, DOI 10.1109/TPWRS.2013.2273502; Zeng XX, 2016, BRIEF BIOINFORM, V17, P193, DOI 10.1093/bib/bbv033; Zhang C, 2014, IET GENER TRANSM DIS, V8, P91, DOI 10.1049/iet-gtd.2013.0065; Zin AAM, 2012, IEEE T POWER SYST, V27, P968, DOI 10.1109/TPWRS.2011.2174258; Zou Q, 2016, BRIEF FUNCT GENOMICS, V15, P55, DOI 10.1093/bfgp/elv024; Zou Q, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/810514; Zou Q, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/416323	37	1	1	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 19	2016	11	12							e0168350	10.1371/journal.pone.0168350	http://dx.doi.org/10.1371/journal.pone.0168350			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI9QC	27992589	gold, Green Published, Green Submitted			2022-12-27	WOS:000392842600050
J	Sakamoto, S; Ikeda, H; Tsuyuguchi, N; Uda, T; Okumura, E; Asakawa, T; Haruta, Y; Nishiyama, H; Okada, T; Kamada, H; Ohata, K; Miki, Y				Sakamoto, Shinichi; Ikeda, Hidetoshi; Tsuyuguchi, Naohiro; Uda, Takehiro; Okumura, Eiichi; Asakawa, Takashi; Haruta, Yasuhiro; Nishiyama, Hideki; Okada, Toyoji; Kamada, Hajime; Ohata, Kenji; Miki, Yukio			MEG Frequency Analysis Depicts the Impaired Neurophysiological Condition of Ischemic Brain	PLOS ONE			English	Article							POSITRON-EMISSION-TOMOGRAPHY; CEREBRAL-ARTERY OCCLUSION; ACUTE HEMISPHERIC STROKE; BLOOD-FLOW; COMPUTED-TOMOGRAPHY; SOURCE LOCALIZATION; OXYGEN-METABOLISM; QUANTITATIVE EEG; MISERY-PERFUSION; MAGNETIC-FIELD	Purpose Quantitative imaging of neuromagnetic fields based on automated region of interest (ROI) setting was analyzed to determine the characteristics of cerebral neural activity in ischemic areas. Methods Magnetoencephalography (MEG) was used to evaluate spontaneous neuromagnetic fields in the ischemic areas of 37 patients with unilateral internal carotid artery (ICA) occlusive disease. Voxel-based time-averaged intensity of slow waves was obtained in two frequency bands (0.3-4 Hz and 4-8 Hz) using standardized low-resolution brain electromagnetic tomography (sLORETA) modified for a quantifiable method (sLORETA-qm). ROIs were automatically applied to the anterior cerebral artery (ACA), anterior middle cerebral artery (MCAa), posterior middle cerebral artery (MCAp), and posterior cerebral artery (PCA) using statistical parametric mapping (SPM). Positron emission tomography with O-15-gas inhalation (O-15-PET) was also performed to evaluate cerebral blood flow (CBF) and oxygen extraction fraction (OEF). Statistical analyses were performed using laterality index of MEG and O-15-PET in each ROI with respect to distribution and intensity. Results MEG revealed statistically significant laterality in affected MCA regions, including 4-8 Hz waves in MCAa, and 0.3-4 Hz and 4-8 Hz waves in MCAp (95% confidence interval: 0.020-0.190, 0.030-0.207, and 0.034-0.213), respectively. We found that 0.3-4 Hz waves in MCAp were highly correlated with CBF in MCAa and MCAp (r = 0.74, r = 0.68, respectively), whereas 4-8 Hz waves were moderately correlated with CBF in both the MCAa and MCAp (r = 0.60, r = 0.63, respectively). We also found that 4-8 Hz waves in MCAp were statistically significant for misery perfusion identified on 15 O-PET (p<0.05). Conclusions Quantitatively imaged spontaneous neuromagnetic fields using the automated ROI setting enabled clear depiction of cerebral ischemic areas. Frequency analysis may reveal unique neural activity that is distributed in the impaired vascular metabolic territory, in which the cerebral infarction has not yet been completed.	[Sakamoto, Shinichi; Miki, Yukio] Osaka City Univ, Grad Sch Med, Dept Diagnost & Intervent Radiol, Osaka, Japan; [Ikeda, Hidetoshi; Tsuyuguchi, Naohiro; Uda, Takehiro; Ohata, Kenji] Osaka City Univ, Grad Sch Med, Dept Neurosurg, Osaka, Japan; [Okumura, Eiichi; Asakawa, Takashi] Ricoh Co Ltd, Med Imaging Business Dept, Kanazawa, Ishikawa, Japan; [Haruta, Yasuhiro] Kanazawa Inst Technol, Appl Elect Lab, Kanazawa, Ishikawa, Japan; [Nishiyama, Hideki] Nihon Medi Phys Corp, Tokyo, Japan; [Okada, Toyoji] Hokuto Hosp, Dept Clin Lab, Obihiro, Hokkaido, Japan; [Kamada, Hajime] Hokuto Hosp, Dept Neurosurg, Obihiro, Hokkaido, Japan	Osaka Metropolitan University; Osaka Metropolitan University; Ricoh Company, Ltd.; Kanazawa Institute of Technology	Sakamoto, S (corresponding author), Osaka City Univ, Grad Sch Med, Dept Diagnost & Intervent Radiol, Osaka, Japan.	s-sakamoto@med.osaka-cu.ac.jp	Uda, Takehiro/ABD-7340-2021; Miki, Yukio/AAY-2146-2020	Miki, Yukio/0000-0003-0621-0044; Uda, Takehiro/0000-0001-6422-4140	JSPS (Japan Society for the Promotion of Science) KAKENHI [22591349]	JSPS (Japan Society for the Promotion of Science) KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by JSPS (Japan Society for the Promotion of Science) KAKENHI Grant Number 22591349, Grant-in-Aid for Scientific Research (C) (URLs:http://www.jsps.go.jp/index.html) This funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Two authors, EO and TA, are employed by commercial company: "Ricoh Company, Ltd "and one author, HN, is employed by commercial company:" Nihon Medi-Physics Corporation". These funders provided support in the form of salaries for authors, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	ASTRUP J, 1981, STROKE, V12, P723, DOI 10.1161/01.STR.12.6.723; BARON JC, 1981, STROKE, V12, P454, DOI 10.1161/01.STR.12.4.454; Bundo M, 2002, STROKE, V33, P61, DOI 10.1161/hs0102.101816; Burghaus L, 2007, CLIN NEUROL NEUROSUR, V109, P45, DOI 10.1016/j.clineuro.2006.06.003; Butz M, 2004, NEUROSCI LETT, V355, P93, DOI 10.1016/j.neulet.2003.10.065; Didelot A, 2010, J NUCL MED, V51, P1732, DOI 10.2967/jnumed.109.070938; EFRON B, 1987, J AM STAT ASSOC, V82, P171, DOI 10.2307/2289144; FAUGHT E, 1993, STROKE, V24, P609, DOI 10.1161/01.STR.24.4.609; FAUGHT E, 1988, Neurological Research, V10, P184; Fernandez-Bouzas A, 2000, CLIN ELECTROENCEPHAL, V31, P165, DOI 10.1177/155005940003100403; Finnigan S, 2013, CLIN NEUROPHYSIOL, V124, P10, DOI 10.1016/j.clinph.2012.07.003; FRACKOWIAK RSJ, 1980, J COMPUT ASSIST TOMO, V4, P727, DOI 10.1097/00004728-198012000-00001; Furlan M, 1996, ANN NEUROL, V40, P216, DOI 10.1002/ana.410400213; Goto T, 2002, J NEUROSURG, V96, P62, DOI 10.3171/spi.2002.96.1.0062; Grubb RL, 1998, JAMA-J AM MED ASSOC, V280, P1055, DOI 10.1001/jama.280.12.1055; Heiss WD, 2000, J CEREBR BLOOD F MET, V20, P1276, DOI 10.1097/00004647-200009000-00002; Higuchi M, 1997, APPL SUPERCOND, V5, P441, DOI 10.1016/S0964-1807(98)00071-4; Huang MX, 1999, PHYS MED BIOL, V44, P423, DOI 10.1088/0031-9155/44/2/010; Ito H, 2004, EUR J NUCL MED MOL I, V31, P635, DOI 10.1007/s00259-003-1430-8; Jovin TG, 2003, STROKE, V34, P2426, DOI 10.1161/01.STR.0000091232.81947.C9; Kamada K, 1997, ANN NEUROL, V42, P554, DOI 10.1002/ana.410420405; KAPPELLE LJ, 1990, J NEUROL NEUROSUR PS, V53, P63, DOI 10.1136/jnnp.53.1.63; KURODA S, 1993, NEUROSURGERY, V32, P912, DOI 10.1227/00006123-199306000-00005; LAMMERTSMA AA, 1983, J CEREBR BLOOD F MET, V3, P416, DOI 10.1038/jcbfm.1983.67; LEBLANC R, 1989, CAN J NEUROL SCI, V16, P51, DOI 10.1017/S031716710002850X; MACDONELL RAL, 1988, ARCH NEUROL-CHICAGO, V45, P520, DOI 10.1001/archneur.1988.00520290048013; Machado C, 2004, CLIN EEG NEUROSCI, V35, P116, DOI 10.1177/155005940403500303; MARTIN WRW, 1987, J CEREBR BLOOD F MET, V7, P421, DOI 10.1038/jcbfm.1987.85; Muller C, 2002, EUR NEUROL, V48, P164, DOI 10.1159/000065509; Murphy BD, 2006, STROKE, V37, P1771, DOI 10.1161/01.STR.0000227243.96808.53; NAGATA K, 1989, Brain Topography, V2, P119, DOI 10.1007/BF01128849; NAGATA K, 1989, ELECTROEN CLIN NEURO, V72, P16, DOI 10.1016/0013-4694(89)90027-8; NUWER MR, 1987, NEUROLOGY, V37, P1153, DOI 10.1212/WNL.37.7.1153; Ogasawara K, 2002, STROKE, V33, P1857, DOI 10.1161/01.STR.0000019511.81583.A8; Ogura T, 2009, ANN NUCL MED, V23, P33, DOI 10.1007/s12149-008-0203-7; Ohtomo S, 2009, CLIN NEUROPHYSIOL, V120, P1227, DOI 10.1016/j.clinph.2009.05.015; Oppenheim C, 2000, STROKE, V31, P2175, DOI 10.1161/01.STR.31.9.2175; OTOMO E, 1966, ELECTROEN CLIN NEURO, V20, P77, DOI 10.1016/0013-4694(66)90143-X; Pascual-Marqui RD, 2002, METHOD FIND EXP CLIN, V24, P5; Phan TG, 2012, CEREBROVASC DIS, V33, P405, DOI 10.1159/000336332; POWERS WJ, 1987, ANN INTERN MED, V106, P27, DOI 10.7326/0003-4819-106-1-27; Prosser J, 2005, STROKE, V36, P1700, DOI 10.1161/01.STR.0000173407.40773.17; Rohl L, 2001, STROKE, V32, P1140, DOI 10.1161/01.STR.32.5.1140; Sakamoto S, 2003, EPILEPSIA, V44, P1196, DOI 10.1046/j.1528-1157.2003.08603.x; Sakamoto S, 2010, NEUROIMAGE, V49, P488, DOI 10.1016/j.neuroimage.2009.07.039; Sakamoto S, 2008, ACTA NEUROCHIR, V150, P1285, DOI 10.1007/s00701-008-0156-6; Seki S, 2005, NEUROIMAGE, V25, P502, DOI 10.1016/j.neuroimage.2004.11.025; SILVERMAN AJ, 1955, ELECTROEN CLIN NEURO, V7, P67, DOI 10.1016/0013-4694(55)90060-2; Srinivasan A, 2006, RADIOGRAPHICS, V26, pS75, DOI 10.1148/rg.26si065501; Stippich C, 2000, NEUROREPORT, V11, P3309, DOI 10.1097/00001756-200010200-00010; TAYLOR DW, 1991, NEW ENGL J MED, V325, P445; Tecchio F, 2005, NEUROIMAGE, V28, P72, DOI 10.1016/j.neuroimage.2005.05.051; Terakawa Y, 2008, CLIN NEUROPHYSIOL, V119, P1917, DOI 10.1016/j.clinph.2008.04.008; TOLONEN U, 1981, ELECTROEN CLIN NEURO, V51, P177, DOI 10.1016/0013-4694(81)90007-9; TORRES F, 1983, ELECTROEN CLIN NEURO, V56, P391, DOI 10.1016/0013-4694(83)90220-1; Tsutada T, 1999, CLIN NEUROPHYSIOL, V110, P2127, DOI 10.1016/S1388-2457(99)00188-1; VANSWIETEN JC, 1988, STROKE, V19, P604, DOI 10.1161/01.STR.19.5.604; Vieth J B, 1990, Adv Neurol, V54, P261; Wintermark M, 2006, STROKE, V37, P979, DOI 10.1161/01.STR.0000209238.61459.39; Yamauchi H, 1996, J NEUROL NEUROSUR PS, V61, P18, DOI 10.1136/jnnp.61.1.18; YAMAUCHI H, 1990, STROKE, V21, P1400, DOI 10.1161/01.STR.21.10.1400; Zumsteg D, 2006, CLIN NEUROPHYSIOL, V117, P2257, DOI 10.1016/j.clinph.2006.07.137	62	2	2	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2016	11	12							e0168588	10.1371/journal.pone.0168588	http://dx.doi.org/10.1371/journal.pone.0168588			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI8LN	27992543	Green Submitted, Green Published, gold			2022-12-27	WOS:000392758000062
J	De Luca, A; Frasquet-Darrieux, M; Gaud, MA; Christin, P; Boquien, CY; Millet, C; Herviou, M; Darmaun, D; Robins, RJ; Ingrand, P; Hankard, R				De Luca, Arnaud; Frasquet-Darrieux, Marine; Gaud, Marie-Agnes; Christin, Patricia; Boquien, Clair-Yves; Millet, Christine; Herviou, Manon; Darmaun, Dominique; Robins, Richard J.; Ingrand, Pierre; Hankard, Regis			Higher Leptin but Not Human Milk Macronutrient Concentration Distinguishes Normal-Weight from Obese Mothers at 1-Month Postpartum	PLOS ONE			English	Article							BODY-MASS INDEX; MATERNAL OBESITY; BREAST-MILK; FULL; PREDICTORS; LACTATION; WHITE; WOMEN; RATS	Introduction Exclusively breastfed infants born to obese mothers have previously been shown to gain less weight by 1-month postpartum than infants of normal-weight mothers. Our hypothesis is that human milk composition and volume may differ between obese and normal-weight mothers. Objective To compare human milk leptin, macronutrient concentration, and volume in obese and normal-weight mothers. Mother and infant characteristics were studied as secondary aims. Materials and Methods This cross-sectional observational study compared 50 obese mothers matched for age, parity, ethnic origin, and educational level with 50 normal-weight mothers. Leptin, macronutrient human milk concentration, and milk volume were determined at 1 month in exclusively breastfed infants. Mother characteristics and infant growth were recorded. Results Human milk leptin concentration was higher in obese mothers than normal-weight mothers (4.8 +/- 2.7 vs. 2.5 +/- 1.5 ng.mL(-1), p<0.001). No difference was observed between obese and normal-weight mothers in protein, lipid, carbohydrate content, and volume, nor in infant weight gain. Conclusion Leptin concentration was higher in the milk of obese mothers than that of normal-weight mothers, but macronutrient concentration was not. It remains to be established whether the higher leptin content impacts on infant growth beyond the 1-month of the study period.	[De Luca, Arnaud; Hankard, Regis] INSERM, U 1069, Tours, France; [De Luca, Arnaud] Univ Hosp Tours, Tours, France; [Frasquet-Darrieux, Marine; Gaud, Marie-Agnes; Herviou, Manon; Ingrand, Pierre] INSERM, CIC 1402, Poitiers, France; [Frasquet-Darrieux, Marine; Gaud, Marie-Agnes; Herviou, Manon; Ingrand, Pierre] Univ Poitiers, Poitiers, France; [Gaud, Marie-Agnes; Christin, Patricia] Univ Hosp Poitiers, Pediat Child Nutr, Poitiers, France; [Christin, Patricia] Gen Hosp Chatellerault, Matern, Chatellerault, France; [Boquien, Clair-Yves; Darmaun, Dominique] Univ Hosp Nantes, Inst Malad Appareil Digestif, INRA, UMR 1280, Nantes, France; [Boquien, Clair-Yves; Darmaun, Dominique] Ctr Rech Nutr Humaine Ouest, Nantes, France; [Millet, Christine] Univ Hosp Poitiers, Nucl Med Lab, Poitiers, France; [Robins, Richard J.] Univ Nantes, CNRS, UMR 6230, Elucidat Biosynth Isotop Spectrometry Grp,CEISAM, Nantes, France; [Hankard, Regis] Univ F Rabelais, Tours, France	Institut National de la Sante et de la Recherche Medicale (Inserm); CHU Tours; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Poitiers; Universite de Poitiers; CHU Poitiers; Universite de Poitiers; Universite de Poitiers; INRAE; Nantes Universite; CHU de Nantes; CHU Poitiers; Universite de Poitiers; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC); Nantes Universite	De Luca, A (corresponding author), INSERM, U 1069, Tours, France.; De Luca, A (corresponding author), Univ Hosp Tours, Tours, France.	a.deluca@chu-tours.fr	de Luca, Arnaud/AAC-2039-2022; Darmaun, Dominique/X-8453-2018; Boquien, Clair-Yves/AAP-5275-2020	de Luca, Arnaud/0000-0003-1704-8599; Darmaun, Dominique/0000-0002-0366-3227; Boquien, Clair-Yves/0000-0001-6944-5372; Robins, Richard/0000-0002-5325-8983; HANKARD, Regis/0000-0001-8450-5839	regional hospital program for clinical research of Western France (PHRC interregional Grand-Ouest) [B91049-20]	regional hospital program for clinical research of Western France (PHRC interregional Grand-Ouest)	This work was supported by the regional hospital program for clinical research of Western France (PHRC interregional Grand-Ouest; B91049-20). The funder had no role in the design, analysis or writing of this article.	American College of Obstetricians and Gynecologists, 2013, Obstet Gynecol, V121, P213, DOI http://10.1097/01.AOG.0000425667.10377.60; Andreas NJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0115043; Baker JL, 2007, AM J CLIN NUTR, V86, P404, DOI 10.1093/ajcn/86.2.404; Billard H., 2015, J HUM LACT; Charles MA, 2008, OBESITY, V16, P2180, DOI [10.1038/oby.2008.285, 10.1038/oby.2008.286]; DiGirolamo A, 2005, HEALTH EDUC BEHAV, V32, P208, DOI 10.1177/1090198104271971; Helland IB, 1998, PEDIATRICS, V101, DOI 10.1542/peds.101.3.e12; Hilson JA, 1997, AM J CLIN NUTR, V66, P1371, DOI 10.1093/ajcn/66.6.1371; Hilson JA, 2004, J HUM LACT, V20, P18, DOI 10.1177/0890334403261345; Hochner H, 2012, CIRCULATION, V125, P1381, DOI 10.1161/CIRCULATIONAHA.111.070060; Li RW, 2003, AM J CLIN NUTR, V77, P931, DOI 10.1093/ajcn/77.4.931; Mamelle N., 1996, Journal de Gynecologie Obstetrique et Biologie de la Reproduction, V25, P71; Miralles O, 2006, OBESITY, V14, P1371, DOI 10.1038/oby.2006.155; Mok E, 2008, PEDIATRICS, V121, pE1319, DOI 10.1542/peds.2007-2747; Pico C, 2007, INT J OBESITY, V31, P1199, DOI 10.1038/sj.ijo.0803585; Rasmussen KM, 2004, PEDIATRICS, V113, pE465, DOI 10.1542/peds.113.5.e465; Regnault N, 2010, AM J CLIN NUTR, V92, P594, DOI 10.3945/ajcn.2010.29292; Salanave B., 2012, B EPIDEMIOL HEBD, V34, P383; Sanchez J, 2005, ENDOCRINOLOGY, V146, P2575, DOI 10.1210/en.2005-0112; Schueler J, 2013, OBESITY, V21, P1451, DOI 10.1002/oby.20345; Scott JA, 2006, PEDIATRICS, V117, pE646, DOI 10.1542/peds.2005-1991	21	25	25	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2016	11	12							e0168568	10.1371/journal.pone.0168568	http://dx.doi.org/10.1371/journal.pone.0168568			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI9QH	28005966	Green Published, Green Submitted, gold			2022-12-27	WOS:000392843200065
J	Flitcroft, RL; Lewis, SL; Arismendi, I; LovellFord, R; Santelmann, MV; Safeeq, M; Grant, G				Flitcroft, Rebecca L.; Lewis, Sarah L.; Arismendi, Ivan; LovellFord, Rachel; Santelmann, Mary V.; Safeeq, Mohammad; Grant, Gordon			Linking Hydroclimate to Fish Phenology and Habitat Use with Ichthyographs	PLoS One			English	Article							PACIFIC-NORTHWEST; BRITISH-COLUMBIA; SOCKEYE-SALMON; LIFE-HISTORIES; CHINOOK SALMON; MIGRATION; PATTERN; KISUTCH; COHO	Streamflow and water temperature (hydroclimate) influence the life histories of aquatic biota. The relationship between streamflow and temperature varies with climate, hydrogeomorphic setting, and season. Life histories of native fishes reflect, in part, their adaptation to regional hydroclimate (flow and water temperature), local habitats, and natural disturbance regimes, all of which may be affected by water management. Alterations to natural hydroclimates, such as those caused by river regulation or climate change, can modify the suitability and variety of in-stream habitat for fishes throughout the year. Here, we present the ichthyograph, a new empirically-based graphical tool to help visualize relationships between hydroclimate and fish phenology. Generally, this graphical tool can be used to display a variety of phenotypic traits. We used long-term data sets of daily fish passage to examine linkages between hydroclimate and the expression of life-history phenology by native fishes. The ichthyograph may be used to characterize the environmental phenology for fishes across multiple spatio-temporal domains. We illustrate the ichthyograph in two applications to visualize: 1) river use for the community of fishes at a specific location; and 2) stream conditions at multiple locations within the river network for one species at different life-history stages. The novel, yet simple, ichthyograph offers a flexible framework to enable transformations in thinking regarding relationships between hydroclimate and aquatic species across space and time. The potential broad application of this innovative tool promotes synergism between assessments of physical characteristics and the biological needs of aquatic species.	[Flitcroft, Rebecca L.; Grant, Gordon] USDA Forest Serv, Pacific Northwest Res Stn, Corvallis, OR 97331 USA; [Lewis, Sarah L.; Santelmann, Mary V.] Oregon State Univ, Coll Earth Ocean & Atmospher Sci, Corvallis, OR USA; [Arismendi, Ivan] Oregon State Univ, Dept Fisheries & Wildlife, Corvallis, OR 97331 USA; [LovellFord, Rachel] Water Resources Dept State Oregon, Salem, OR USA; [Safeeq, Mohammad] Univ Calif Merced, Geosci Dept, Merced, CA USA	United States Department of Agriculture (USDA); United States Forest Service; Oregon State University; Oregon State University; University of California System; University of California Merced	Flitcroft, RL (corresponding author), USDA Forest Serv, Pacific Northwest Res Stn, Corvallis, OR 97331 USA.	rflitcroft@fs.fed.us	Arismendi, Ivan/B-3144-2010	Arismendi, Ivan/0000-0002-8774-9350; Lewis, Sarah/0000-0002-1824-8739; Santelmann, Mary/0000-0002-1074-8237	USDA Forest Service; PNW Research Lab	USDA Forest Service(United States Department of Agriculture (USDA)United States Forest Service); PNW Research Lab	Research funds to support data analysis and writing were provided by the USDA Forest Service, PNW Research Lab, through joint venture agreements at Oregon State University.	Arismendi I, 2013, HYDROBIOLOGIA, V712, P61, DOI 10.1007/s10750-012-1327-2; Brandon R.N., 1990, ADAPTATION ENV; Cooke SJ, 2004, FISHERIES, V29, P22, DOI 10.1577/1548-8446(2004)29[22:AMTAHE]2.0.CO;2; Crozier LG, 2008, EVOL APPL, V1, P252, DOI 10.1111/j.1752-4571.2008.00033.x; Groot C., 1991, PACIFIC SALMON LIFE; Healey MC, 2009, ECOL SOC, V14; Hinch SG, 2000, T AM FISH SOC, V129, P598, DOI 10.1577/1548-8659(2000)129<0598:EOSSAA>2.0.CO;2; Jones KK, 2014, J FISH BIOL, V85, P52, DOI 10.1111/jfb.12380; Lee CG, 2003, J EXP BIOL, V206, P3239, DOI 10.1242/jeb.00547; LovellFord R. M., 2013, THESIS; NMFS (National Marine Fisheries Service), 1998, FED REGISTER, V63, P42587; Poff NL, 1997, BIOSCIENCE, V47, P769, DOI 10.2307/1313099; POFF NL, 1990, ENVIRON MANAGE, V14, P629, DOI 10.1007/BF02394714; Quinn TP, 2002, T AM FISH SOC, V131, P591, DOI 10.1577/1548-8659(2002)131&lt;0591:ASAECC&gt;2.0.CO;2; QUINN TP, 1993, CAN J FISH AQUAT SCI, V50, P1414, DOI 10.1139/f93-162; Reeves GH, 1995, AM FISH S S, V17, P334; Reimers P.E., 1971, THESIS; Safeeq M, 2014, HYDROL EARTH SYST SC, V18, P1; Safeeq M, 2015, HYDROL PROCESS, V29, P5337, DOI 10.1002/hyp.10553; Taylor G.H., 1999, CLIMATE OREGON RAIN; USGS (United States Geological Survey), 2016, NAT WAT INF SYST WEB; Waples RS, 2008, EVOL APPL, V1, P189, DOI 10.1111/j.1752-4571.2008.00023.x; Ward EJ, 2015, GLOBAL CHANGE BIOL, V21, P2500, DOI 10.1111/gcb.12847	23	24	25	2	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2016	11	12							e0168831	10.1371/journal.pone.0168831	http://dx.doi.org/10.1371/journal.pone.0168831			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI9QH	28006825	Green Published, Green Submitted, gold			2022-12-27	WOS:000392843200100
J	Fujimoto, D; Kato, R; Morimoto, T; Shimizu, R; Sato, Y; Kogo, M; Ito, J; Teraoka, S; Nagata, K; Nakagawa, A; Otsuka, K; Tomii, K				Fujimoto, Daichi; Kato, Ryoji; Morimoto, Takeshi; Shimizu, Ryoko; Sato, Yuki; Kogo, Mariko; Ito, Jiro; Teraoka, Shunsuke; Nagata, Kazuma; Nakagawa, Atsushi; Otsuka, Kojiro; Tomii, Keisuke			Characteristics and Prognostic Impact of Pneumonitis during Systemic Anti-Cancer Therapy in Patients with Advanced Non-Small Cell Lung Cancer	PLOS ONE			English	Article							PULMONARY-FIBROSIS; INTENSIVE-CARE; RADIATION PNEUMONITIS; PERFORMANCE STATUS; JAPANESE PATIENTS; DECISION-MAKING; SINGLE-AGENT; RISK-FACTORS; CHEMOTHERAPY; DISEASE	Background Data on characteristics, outcomes, and prognosis of advanced non-small-cell lung cancer (NSCLC) patients who develop pneumonitis during systemic anti-cancer therapy (pneumonitis) are currently lacking. Methods We conducted a retrospective cohort study of 910 consecutive patients diagnosed with advanced NSCLC between January 2004 and January 2014. Of these, 140 patients were excluded because they did not receive systemic anti-cancer therapy at this hospital. Results A total of 770 patients were included in the study, of whom 44 (6%) were diagnosed with pneumonitis. The mortality rate of pneumonitis was 36%. The incidence of pneumonitis was independently associated with pre-existing ILD (adjusted odds ratio, 2.99, P = 0.008), and survivors were significantly associated with younger age (P = 0.003) and radiographic non-acute interstitial pneumonia pattern (P = 0.004). In all patients, pneumonitis was identified as an independent predictor of overall survival (OS) (adjusted hazard ratio 1.53, 95% Cl, 1.09-2.09, P = 0.015). Performance status was poor in 82% of survivors of pneumonitis; in 62% of survivors, the PS worsened after the pneumonitis improved. Additionally, 54% of survivors received no further systemic anti-cancer therapy after pneumonitis. The median survival time of survivors after pneumonitis was 3.5 months (95% Cl, 2.3-7.2 months). Conclusions Our study indicated that 6% of patients with advanced NSCLC developed pneumonitis during systemic anti-cancer therapy. The early mortality rate of pneumonitis is high, and the survival and PS after pneumonitis is extremely poor. Additionally, pneumonitis has an adverse impact on the survival of patients with advanced NSCLC. These data should be considered for the management of pneumonitis, and we recommend that future work focuses on pneumonitis particularly to improve the survival of patients with advanced NSCLC.	[Fujimoto, Daichi; Kato, Ryoji; Shimizu, Ryoko; Sato, Yuki; Kogo, Mariko; Ito, Jiro; Teraoka, Shunsuke; Nagata, Kazuma; Nakagawa, Atsushi; Otsuka, Kojiro; Tomii, Keisuke] Kobe City Med Ctr Gen Hosp, Dept Resp Med, Kobe, Hyogo, Japan; [Morimoto, Takeshi] Kobe City Med Ctr Gen Hosp, Clin Res Ctr, Kobe, Hyogo, Japan; [Morimoto, Takeshi] Hyogo Coll Med, Dept Clin Epidemiol, Nishinomiya, Hyogo, Japan	Kobe City Medical Center General Hospital; Kobe City Medical Center General Hospital; Hyogo College of Medicine	Fujimoto, D (corresponding author), Kobe City Med Ctr Gen Hosp, Dept Resp Med, Kobe, Hyogo, Japan.	daichianzen@yahoo.co.jp	Ito, Jiro/M-1811-2019	Ito, Jiro/0000-0003-4836-9379; Fujimoto, Daichi/0000-0003-0615-3000	Ethics Committee of Kobe City Medical Center General Hospital	Ethics Committee of Kobe City Medical Center General Hospital	This study was supported by internal funding and the Ethics Committee of Kobe City Medical Center General Hospital. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2015, N Engl J Med, V373, P782, DOI 10.1056/NEJMx150012; Aubry MC, 2002, MAYO CLIN PROC, V77, P763, DOI 10.4065/77.8.763; Azzoli CG, 2009, J CLIN ONCOL, V27, P6251, DOI 10.1200/JCO.2009.23.5622; Bonomi MR, 2012, LUNG CANCER, V77, P600, DOI 10.1016/j.lungcan.2012.05.103; Camus P, 2001, EUR RESPIR J, V18, p93S; Collard HR, 2007, AM J RESP CRIT CARE, V176, P636, DOI 10.1164/rccm.200703-463PP; Cushley MJ, 1999, THORAX, V54, pS1; Dhokarh R, 2012, CHEST, V142, P845, DOI 10.1378/chest.11-2103; Enomoto Y, 2016, LUNG CANCER, V96, P63, DOI 10.1016/j.lungcan.2016.03.017; Fujimoto D, 2015, EUR RESPIR J, V45, P1098, DOI 10.1183/09031936.00068114; Goldstraw P, 2007, J THORAC ONCOL, V2, P706, DOI 10.1097/JTO.0b013e31812f3c1a; Isobe K, 2010, RESPIROLOGY, V15, P88, DOI 10.1111/j.1440-1843.2009.01666.x; Kane HL, 2014, CA-CANCER J CLIN, V64, P377, DOI 10.3322/caac.21245; Katz SJ, 2013, JAMA-J AM MED ASSOC, V310, P1559, DOI 10.1001/jama.2013.278944; Kenmotsu H, 2015, CANCER CHEMOTH PHARM, V75, P521, DOI 10.1007/s00280-014-2670-y; Kenmotsu H, 2011, J THORAC ONCOL, V6, P1242, DOI 10.1097/JTO.0b013e318216ee6b; Kim JY, 2009, RADIAT ONCOL, V4, DOI 10.1186/1748-717X-4-59; Kinoshita T, 2012, ONCOL LETT, V4, P477, DOI 10.3892/ol.2012.753; Kubo K, 2013, RESPIR INVESTIG, V51, P260, DOI 10.1016/j.resinv.2013.09.001; Kudoh S, 2008, AM J RESP CRIT CARE, V177, P1348, DOI 10.1164/rccm.200710-1501OC; Lilenbaum RC, 2004, ONCOLOGY-NY, V18, P1321; Minami-Shimmyo Y, 2012, J THORAC ONCOL, V7, P177, DOI 10.1097/JTO.0b013e31823c4c07; Minegishi Y, 2014, LUNG CANCER, V85, P258, DOI 10.1016/j.lungcan.2014.05.016; Morth C, 2014, LUNG CANCER, V84, P209, DOI 10.1016/j.lungcan.2014.03.015; Nagai Y, 2005, CANCER RES, V65, P7276, DOI 10.1158/0008-5472.CAN-05-0331; Nishino M, 2016, CLIN CANC RES OFFICI; Nishino M, 2015, EUR J RADIOL, V84, P1259, DOI 10.1016/j.ejrad.2015.03.017; Niu XM, 2012, J THORAC ONCOL, V7, P1668, DOI 10.1097/JTO.0b013e318267cf5b; Ozawa Y, 2016, CANCER CHEMOTH PHARM, V77, P1031, DOI 10.1007/s00280-016-3025-7; Raghu G, 2011, AM J RESP CRIT CARE, V183, P788, DOI 10.1164/rccm.2009-040GL; Ramalingam SS, 2011, CA-CANCER J CLIN, V61, P91, DOI 10.3322/caac.20102; Rodrigues G, 2004, RADIOTHER ONCOL, V71, P127, DOI 10.1016/j.radonc.2004.02.015; Sakurada T, 2015, ANN PHARMACOTHER, V49, P398, DOI 10.1177/1060028014566446; Siegel R, 2014, CA-CANCER J CLIN, V64, P9, DOI 10.3322/caac.21208; Slatore CG, 2012, J CLIN ONCOL, V30, P1686, DOI 10.1200/JCO.2011.40.0846; Soares M, 2014, ANN ONCOL, V25, P1829, DOI 10.1093/annonc/mdu234; Soares M, 2007, CHEST, V131, P840, DOI 10.1378/chest.06-2244; Takeda M, 2015, LUNG CANCER, V88, P74, DOI 10.1016/j.lungcan.2015.01.026; Togashi Y, 2012, CLIN LUNG CANCER, V13, P304, DOI 10.1016/j.cllc.2011.11.001; Tomassetti S, 2015, CHEST, V147, P157, DOI 10.1378/chest.14-0359; Usui K, 2011, RESPIROLOGY, V16, P326, DOI 10.1111/j.1440-1843.2010.01907.x; Vahid B, 2008, CHEST, V133, P528, DOI 10.1378/chest.07-0851; Yagihashi K, 2016, EUR RESPIR J, V47, P1189, DOI 10.1183/13993003.01680-2015; Zukin M, 2013, J CLIN ONCOL, V31, P2849, DOI 10.1200/JCO.2012.48.1911	44	32	35	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2016	11	12							e0168465	10.1371/journal.pone.0168465	http://dx.doi.org/10.1371/journal.pone.0168465			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI9QH	28006019	Green Published, gold, Green Submitted			2022-12-27	WOS:000392843200056
J	Han, RT; Back, SK; Lee, H; Lee, J; Kim, HY; Kim, HJ; Na, HS				Han, Rafael Taeho; Back, Seung Keun; Lee, Hyunkyoung; Lee, JaeHee; Kim, Hye Young; Kim, Hee Jin; Na, Heung Sik			Formaldehyde-Induced Aggravation of Pruritus and Dermatitis Is Associated with the Elevated Expression of Thl Cytokines in a Rat Model of Atopic Dermatitis	PLoS One			English	Article							HUMAN SERUM-ALBUMIN; MATERNAL SEPARATION; MEDICAL-STUDENTS; LESIONAL SKIN; PATCH TEST; EXPOSURE; MICE; INFLAMMATION; DISEASE; ECZEMA	Atopic dermatitis is a complex disease of heterogeneous pathogenesis, in particular, genetic predisposition, environmental triggers, and their interactions. Indoor air pollution, increasing with urbanization, plays a role as environmental risk factor in the development of AD. However, we still lack a detailed picture of the role of air pollution in the development of the disease. Here, we examined the effect of formaldehyde (FA) exposure on the manifestation of atopic dermatitis and the underlying molecular mechanism in naive rats and in a rat model of atopic dermatitis (AD) produced by neonatal capsaicin treatment. The AD and naive rats were exposed to 0.8 ppm FA, 1.2 ppm FA, or fresh air (Air) for 6 weeks (2 hours/day and 5 days/week). So, six groups, namely the 1.2 FA-AD, 0.8 FA-AD, Air-AD, 1.2 FA-naive, 0.8 FA-naive and Air-naive groups, were established. Pruritus and dermatitis, two major symptoms of atopic dermatitis, were evaluated every week for 6 weeks. After that, samples of the blood, the skin and the thymus were collected from the 1.2 FA-AD, the Air-AD, the 1.2 FA naive and the Air-naive groups. Serum IgE levels were quantified with ELISA, and mRNA expression levels of inflammatory cytokines from extracts of the skin and the thymus were calculated with qRT-PCR. The dermatitis and pruritus significantly worsened in 1.2 FA-AD group, but not in 0.8 FA-AD, compared to the Air-AD animals, whereas FA didn't induce any symptoms in naive rats. Consistently, the levels of serum IgE were significantly higher in 1.2 FA-AD than in air-AD, however, there was no significant difference following FA exposure in naive animals. In the skin, mRNA expression levels of Th1 cytokines such as INF-a and IL 113 were significantly higher in the 1.2 FA-AD rats compared to the air-AD rats, whereas mRNA expression levels of Th2 cytokines (IL-4, IL-5, IL-13), IL-17A and TSLP were significantly higher in 1.2 FA-naive group than in the Air-naive group. These results suggested that 1.2 ppm of FA penetrated the injured skin barrier, and exacerbated Th1 responses and serum IgE level in the AD rats so that dermatitis and pruritus were aggravated, while the elevated expression of Th2 cytokines by 1.2 ppm of FA in naive rats was probably insufficient for clinical manifestation. In conclusion, in a rat model of atopic dermatitis, exposure to 1.2 ppm of FA aggravated pruritus and skin inflammation, which was associated with the elevated expression of Th1 cytokines.	[Han, Rafael Taeho; Lee, Hyunkyoung; Lee, JaeHee; Kim, Hye Young; Na, Heung Sik] Korea Univ, Coll Med, Neurosci Res Inst, Seoul, South Korea; [Han, Rafael Taeho; Lee, Hyunkyoung; Lee, JaeHee; Kim, Hye Young; Na, Heung Sik] Korea Univ, Coll Med, Dept Physiol, Seoul, South Korea; [Back, Seung Keun] Konyang Univ, Coll Med Engn, Dept Pharmaceut & Biotechnol, Chungnam, South Korea; [Kim, Hee Jin] Yonsei Univ, Coll Sci & Technol, Div Biol Sci & Technol, Wonju Campus, Wonju, South Korea	Korea University; Korea University Medicine (KU Medicine); Korea University; Korea University Medicine (KU Medicine); Konyang University; Yonsei University	Na, HS (corresponding author), Korea Univ, Coll Med, Neurosci Res Inst, Seoul, South Korea.; Na, HS (corresponding author), Korea Univ, Coll Med, Dept Physiol, Seoul, South Korea.	hsna@korea.ac.kr	Kim, Heejin/HII-8568-2022	Han, Rafael/0000-0002-0123-877X; Han, Rafael Taeho/0000-0002-0127-2396	National Research Foundation of Korea [NRF-2015M3C8A5060108]; Chung Yang, Cha Young Sun, M.D. and Jang Hi Joo Yeu Sa Memorial Fund	National Research Foundation of Korea(National Research Foundation of Korea); Chung Yang, Cha Young Sun, M.D. and Jang Hi Joo Yeu Sa Memorial Fund	This work was supported by National Research Foundation of Korea, Recipient: Heung Sik Na, www.nrf.re.kr, NRF-2015M3C8A5060108; and The Chung Yang, Cha Young Sun, M.D. and Jang Hi Joo Yeu Sa Memorial Fund, Recipient: Heung Sik Na, No URL, No grant numbers.	Adgate JL, 2014, ENVIRON SCI TECHNOL, V48, P8307, DOI 10.1021/es404621d; Ahmed Ijaz, 2007, J Pak Med Assoc, V57, P431; Ahn K, 2014, J ALLERGY CLIN IMMUN, V134, P993, DOI 10.1016/j.jaci.2014.09.023; Back SK, 2012, J DERMATOL SCI, V67, P111, DOI 10.1016/j.jdermsci.2012.05.006; Barnes KC, 2010, J ALLERGY CLIN IMMUN, V125, P16, DOI 10.1016/j.jaci.2009.11.008; Bieber T, 2008, NEW ENGL J MED, V358, P1483, DOI 10.1056/NEJMra074081; Brandt E.B., 2011, J CLIN CELLULAR IMMU, V2; Darsow U, 2004, ALLERGY, V59, P1318, DOI 10.1111/j.1398-9995.2004.00556.x; DaVeiga SP, 2012, ALLERGY ASTHMA PROC, V33, P227, DOI 10.2500/aap.2012.33.3569; Dearman RJ, 1999, CLIN EXP ALLERGY, V29, P124; DYKEWICZ MS, 1991, J ALLERGY CLIN IMMUN, V87, P48, DOI 10.1016/0091-6749(91)90212-7; Eichenfield LF, 2014, J AM ACAD DERMATOL, V70, P338, DOI 10.1016/j.jaad.2013.10.010; Eyerich K, 2013, ALLERGY, V68, P974, DOI 10.1111/all.12184; Eyerich K, 2008, INT ARCH ALLERGY IMM, V145, P213, DOI 10.1159/000109290; Fujimaki H, 2004, TOXICOLOGY, V197, P1, DOI 10.1016/j.tox.2003.11.015; GREWE M, 1995, J INVEST DERMATOL, V105, P407, DOI 10.1111/1523-1747.ep12321078; Hisamitsu Minako, 2011, Allergology International, V60, P373, DOI 10.2332/allergolint.10-OA-0210; Jeong CW, 2003, CLIN EXP ALLERGY, V33, P1717, DOI 10.1111/j.1365-2222.2003.01782.x; Jeong KY, 2015, ALLERGY ASTHMA IMMUN, V7, P69, DOI 10.4168/aair.2015.7.1.69; Jung WW, 2007, ENVIRON TOXICOL PHAR, V24, P174, DOI 10.1016/j.etap.2007.05.001; Kim H, 1999, ARCH ENVIRON HEALTH, V54, P115, DOI 10.1080/00039899909602245; Kim J, 2013, J ALLERGY CLIN IMMUN, V132, P495, DOI 10.1016/j.jaci.2013.04.019; Koga C, 2008, J INVEST DERMATOL, V128, P2625, DOI 10.1038/jid.2008.111; Kozera B, 2013, J APPL GENET, V54, P391, DOI 10.1007/s13353-013-0173-x; Laske N, 2004, PEDIAT ALLERG IMM-UK, V15, P86, DOI 10.1046/j.0905-6157.2003.00106.x; Leung DYM, 2004, J CLIN INVEST, V113, P651, DOI 10.1172/JCI200421060; Lippmann M, 2007, EUR J NEUROSCI, V25, P3091, DOI 10.1111/j.1460-9568.2007.05522.x; Liu YJ, 2006, J EXP MED, V203, P269, DOI 10.1084/jem.20051745; McAleer MA, 2013, J ALLERGY CLIN IMMUN, V131, P280, DOI 10.1016/j.jaci.2012.12.668; Mihara K, 2004, BRIT J DERMATOL, V151, P335, DOI 10.1111/j.1365-2133.2004.06036.x; OSOBA D, 1966, CAN MED ASSOC J, V94, P488; Aguggia JP, 2013, BEHAV BRAIN RES, V248, P25, DOI 10.1016/j.bbr.2013.03.040; Saito A, 2011, ENVIRON TOXICOL, V26, P224, DOI 10.1002/tox.20547; Salthammer T, 2010, CHEM REV, V110, P2536, DOI 10.1021/cr800399g; Song S, 2011, ENVIRON RES, V111, P394, DOI 10.1016/j.envres.2010.10.010; TARKOWSKI M, 1995, INT ARCH ALLERGY IMM, V106, P422, DOI 10.1159/000236876; Tazawa T, 2004, ARCH DERMATOL RES, V295, P459, DOI 10.1007/s00403-004-0455-6; Thellin O, 1999, J BIOTECHNOL, V75, P291, DOI 10.1016/S0168-1656(99)00163-7; Tupker RA, 1996, J ALLERGY CLIN IMMUN, V97, P1064, DOI 10.1016/S0091-6749(96)70259-2; Xu BH, 2002, IMMUNOL LETT, V84, P49, DOI 10.1016/S0165-2478(02)00126-8	40	17	18	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2016	11	12							e0168466	10.1371/journal.pone.0168466	http://dx.doi.org/10.1371/journal.pone.0168466			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI9QH	28005965	Green Published, gold, Green Submitted			2022-12-27	WOS:000392843200057
J	Li, XY; Yu, CX; Huang, X; Sun, SJ				Li, Xiuyun; Yu, Cuixiang; Huang, Xin; Sun, Shujuan			Synergistic Effects and Mechanisms of Budesonide in Combination with Fluconazole against Resistant Candida albicans	PLOS ONE			English	Article							IATROGENIC CUSHING SYNDROME; IN-VITRO; GALLERIA-MELLONELLA; DRUG-RESISTANCE; INFECTION MODEL; VIRULENCE; APOPTOSIS; BIOFILM; EFFLUX; EPIDEMIOLOGY	Candida albicans is an important opportunistic pathogen, causing both superficial mucosal infections and life-threatening systemic diseases in the clinic. The emergence of drug resistance in Candida albicans has become a noteworthy phenomenon due to the extensive use of antifungal agents and the development of biofilms. This study showed that budesonide potentiates the antifungal effect of fluconazole against fluconazole-resistant Candida albicans strains both in vitro and in vivo. In addition, our results demonstrated, for the first time, that the combination of fluconazole and budesonide can reverse the resistance of Candida albicans by inhibiting the function of drug transporters, reducing the formation of biofilms, promoting apoptosis and inhibiting the activity of extracellular phospholipases. This is the first study implicating the effects and mechanisms of budesonide against Candida albicans alone or in combination with fluconazole, which may ultimately lead to the identification of new potential antifungal targets.	[Li, Xiuyun] Shandong Univ, Sch Pharmaceut Sci, Jinan, Shandong, Peoples R China; [Yu, Cuixiang] Shandong Univ, Qianfoshan Hosp, Respirat Med, Jinan, Shandong, Peoples R China; [Huang, Xin; Sun, Shujuan] Shandong Univ, Qianfoshan Hosp, Dept Pharmaceut, Jinan, Shandong, Peoples R China	Shandong University; Shandong First Medical University & Shandong Academy of Medical Sciences; Shandong University; Shandong First Medical University & Shandong Academy of Medical Sciences; Shandong University	Sun, SJ (corresponding author), Shandong Univ, Qianfoshan Hosp, Dept Pharmaceut, Jinan, Shandong, Peoples R China.	sunshujuan888@163.com			Finance Department of Shandong Province of China [2015GSF118022, 2016GSF201187]	Finance Department of Shandong Province of China	This work was supported by 2015GSF118022 from Finance Department of Shandong Province of China (http://www.sdcz.gov.cn/) and 2016GSF201187 from Finance Department of Shandong Province of China (http://www.sdcz.gov.cn/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akbari F, 2015, PATHOGENS, V4, P457, DOI 10.3390/pathogens4030457; Albertson GD, 1996, ANTIMICROB AGENTS CH, V40, P2835, DOI 10.1128/AAC.40.12.2835; Angiolella L, 2008, ANTIMICROB AGENTS CH, V52, P927, DOI 10.1128/AAC.01223-07; [Anonymous], 2012, INT J MICROBIOL, DOI DOI 10.1155/2012/528521; Bink A, 2012, J MED MICROBIOL, V61, P813, DOI 10.1099/jmm.0.041020-0; Blondin MC, 2013, ENDOCR PRACT, V19, pE138, DOI 10.4158/EP13122.CR; Brown GD, 2012, SCIENCE, V336, P647, DOI 10.1126/science.1222236; Calabrese D, 2000, MICROBIOL-UK, V146, P2743, DOI 10.1099/00221287-146-11-2743; Cannon RD, 2007, MICROBIOL-SGM, V153, P3211, DOI 10.1099/mic.0.2007/010405-0; Mesa-Arango AC, 2013, MED MYCOL, V51, P461, DOI 10.3109/13693786.2012.737031; Clark TA, 2002, CURR OPIN INFECT DIS, V15, P569, DOI 10.1097/00001432-200212000-00003; Cowen LE, 2005, SCIENCE, V309, P2185, DOI 10.1126/science.1118370; Cowen LE, 2006, EUKARYOT CELL, V5, P2184, DOI 10.1128/EC.00274-06; Dai BD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045109; Dominic R M, 2007, Kathmandu Univ Med J (KUMJ), V5, P431; Epp E, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000753; Fiori A, 2012, ANTIMICROB AGENTS CH, V56, P3785, DOI 10.1128/AAC.06017-11; Fukushima C, 2003, ANN ALLERG ASTHMA IM, V90, P646, DOI 10.1016/S1081-1206(10)61870-4; Ghannoum MA, 2000, CLIN MICROBIOL REV, V13, P122, DOI 10.1128/CMR.13.1.122-143.2000; Golabek K, 2015, ACTA BIOCHIM POL, V62, P247, DOI 10.18388/abp.2014_940; Gourlay CW, 2006, MOL MICROBIOL, V62, P1515, DOI 10.1111/j.1365-2958.2006.05486.x; Gu W, 2016, ANTIMICROB AGENTS CH, V8; Guo QiongJie, 2015, China Tropical Medicine, V15, P920; Han S, 2013, ANTIMICROB AGENTS CH, V57, P1006, DOI 10.1128/AAC.01372-12; IBRAHIM AS, 1995, INFECT IMMUN, V63, P1993, DOI 10.1128/IAI.63.5.1993-1998.1995; Jones W, 2014, PHARMACOTHERAPY, V34, pE116, DOI 10.1002/phar.1432; Khan MAS, 2005, P NATL ACAD SCI USA, V102, P17326, DOI 10.1073/pnas.0508120102; Lee J, 2015, CURR MICROBIOL, V70, P383, DOI 10.1007/s00284-014-0734-1; Lewis K, 2007, NAT REV MICROBIOL, V5, P48, DOI 10.1038/nrmicro1557; Li DD, 2013, BIOL PHARM BULL, V36, P1482, DOI 10.1248/bpb.b13-00270; Li H, 2015, J MED MICROBIOL, V64, P44, DOI 10.1099/jmm.0.081760-0; Li R, 2013, ANTIMICROB AGENTS CH, V57, P1832, DOI 10.1128/AAC.02295-12; Li XS, 2015, APPL ENVIRON MICROB, V81, P5048, DOI 10.1128/AEM.01313-15; Liu RH, 2015, J AM CHEM SOC, V137, P2183, DOI 10.1021/ja512567y; Liu SY, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0150859; Madeo F, 2004, CURR OPIN MICROBIOL, V7, P655, DOI 10.1016/j.mib.2004.10.012; Mathe L, 2013, CURR GENET, V59, P251, DOI 10.1007/s00294-013-0400-3; Sardi JDO, 2014, REV IBEROAM MICOL, V31, P22, DOI 10.1016/j.riam.2013.09.014; Orsi CF, 2014, MICROB PATHOGENESIS, V69-70, P20, DOI 10.1016/j.micpath.2014.03.003; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Phillips AJ, 2006, P NATL ACAD SCI USA, V103, P726, DOI 10.1073/pnas.0506405103; Phillips AJ, 2003, P NATL ACAD SCI USA, V100, P14327, DOI 10.1073/pnas.2332326100; POLAK A, 1992, MYCOSES, V35, P9; PRICE MF, 1982, SABOURAUDIA, V20, P7; Ramage G, 2005, METH MOLEC MED, V118, P71; Ramage G, 2002, FEMS MICROBIOL LETT, V214, P95, DOI 10.1111/j.1574-6968.2002.tb11330.x; Sanglard D, 2003, MOL MICROBIOL, V48, P959, DOI 10.1046/j.1365-2958.2003.03495.x; Sariguzel FM, 2015, J INFECT DEV COUNTR, V9, P857, DOI 10.3855/jidc.5359; Sarkar S, 2014, ANTIMICROB AGENTS CH, V58, P1183, DOI 10.1128/AAC.01745-13; Sprynski N, 2014, METHODS MOL BIOL, V1197, P3, DOI 10.1007/978-1-4939-1261-2_1; Sun S, 2008, ANTIMICROB AGENTS CH, V52, P409, DOI 10.1128/AAC.01070-07; Tortorano AM, 2006, INT J ANTIMICROB AG, V27, P359, DOI 10.1016/j.ijantimicag.2006.01.002; Wang TM, 2015, MICROB PATHOGENESIS, V87, P21, DOI 10.1016/j.micpath.2015.07.006; Youngsaye W, 2013, BEILSTEIN J ORG CHEM, V9, P1501, DOI 10.3762/bjoc.9.171; Yu LH, 2012, ANTIMICROB AGENTS CH, V56, P770, DOI 10.1128/AAC.05290-11; Zhang L, 2013, INT J NANOMED, V8, P4453, DOI 10.2147/IJN.S50312	56	16	16	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2016	11	12							e0168936	10.1371/journal.pone.0168936	http://dx.doi.org/10.1371/journal.pone.0168936			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI9QH	28006028	Green Published, gold, Green Submitted			2022-12-27	WOS:000392843200111
J	Othman, EM; Naseem, M; Awad, E; Dandekar, T; Stopper, H				Othman, Eman M.; Naseem, Muhammed; Awad, Eman; Dandekar, Thomas; Stopper, Helga			The Plant Hormone Cytokinin Confers Protection against Oxidative Stress in Mammalian Cells	PLoS One			English	Article							ANTIOXIDANT ACTIVITY; FAMILIAL DYSAUTONOMIA; KINETIN-RIBOSIDE; FREE-RADICALS; HUMAN-DISEASE; D-GALACTOSE; FIBROBLASTS; PATIENT; CANCER; OXYGEN	Modulating key dynamics of plant growth and development, the effects of the plant hormone cytokinin on animal cells gained much attention recently. Most previous studies on cytokinin effects on mammalian cells have been conducted with elevated cytokinin concentration (in the mu M range). However, to examine physiologically relevant dose effects of cytokinins on animal cells, we systematically analyzed the impact of kinetin in cultured cells at low and high concentrations (1nM-10 mu M) and examined cytotoxic and genotoxic conditions. We furthermore measured the intrinsic antioxidant activity of kinetin in a cell-free system using the Ferric Reducing Antioxidant Power assay and in cells using the dihydroethidium staining method. Monitoring viability, we looked at kinetin effects in mammalian cells such as HL60 cells, HaCaT human keratinocyte cells, NRK rat epithelial kidney cells and human peripheral lymphocytes. Kinetin manifests no antioxidant activity in the cell free system and high doses of kinetin (500 nM and higher) reduce cell viability and mediate DNA damage in vitro. In contrast, low doses (concentrations up to 100 nM) of kinetin confer protection in cells against oxidative stress. Moreover, our results show that pretreatment of the cells with kinetin significantly reduces 4-nitroquinoline 1-oxide mediated reactive oxygen species production. Also, pretreatment with kinetin retains cellular GSH levels when they are also treated with the GSH-depleting agent patulin. Our results explicitly show that low kinetin doses reduce apoptosis and protect cells from oxidative stress mediated cell death. Future studies on the interaction between cytokinins and human cellular pathway targets will be intriguing.	[Othman, Eman M.; Awad, Eman; Stopper, Helga] Univ Wurzburg, Inst Pharmacol & Toxicol, Wurzburg, Germany; [Othman, Eman M.] Univ El Minia, Fac Pharm, Dept Analyt Chem, Al Minya, Egypt; [Naseem, Muhammed; Dandekar, Thomas] Univ Wurzburg, Bioctr, Dept Bioinformat, Wurzburg, Germany; [Naseem, Muhammed] Bogazici Univ, Dept Mol Biol & Genet, Kuzey Pk, Istanbul, Turkey	University of Wurzburg; Egyptian Knowledge Bank (EKB); Minia University; University of Wurzburg; Bogazici University	Othman, EM (corresponding author), Univ Wurzburg, Inst Pharmacol & Toxicol, Wurzburg, Germany.; Othman, EM (corresponding author), Univ El Minia, Fac Pharm, Dept Analyt Chem, Al Minya, Egypt.; Dandekar, T (corresponding author), Univ Wurzburg, Bioctr, Dept Bioinformat, Wurzburg, Germany.	eman@toxi.uni-wuerzburg.de; dandekar@biozentrum.uni-wuerzburg.de	; Dandekar, Thomas/A-4431-2017	Naseem, Muhammad/0000-0001-8712-8936; Dandekar, Thomas/0000-0003-1886-7625	Deutsche Forschungsgemeinschaft [TR124/B1]; University of Wurzburg	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); University of Wurzburg	We thank Deutsche Forschungsgemeinschaft (TR124/B1) for support. This publication was supported by the open access publication fund of the University of Wurzburg. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdelmohsen UR, 2012, MAR DRUGS, V10, P2208, DOI 10.3390/md10102208; Alfardan J, 2010, MOL GENET METAB, V100, P333, DOI 10.1016/j.ymgme.2010.04.014; Axelrod FB, 2011, PEDIATR RES, V70, P480, DOI 10.1203/PDR.0b013e31822e1825; Bartsch I, 2004, IN VITRO CELL DEV-AN, V40, P278; Benzie IFF, 1999, METHOD ENZYMOL, V299, P15; Boone N, 2012, HUM MUTAT, V33, P530, DOI 10.1002/humu.22010; BOUKAMP P, 1988, J CELL BIOL, V106, P761, DOI 10.1083/jcb.106.3.761; Cabello CM, 2009, BIOCHEM PHARMACOL, V77, P1125, DOI 10.1016/j.bcp.2008.12.002; Chiu Pin-Chi, 2007, J Cosmet Dermatol, V6, P243; Cronin H, 2010, J COSMET DERMATOL-US, V9, P218, DOI 10.1111/j.1473-2165.2010.00516.x; CROSS CE, 1987, ANN INTERN MED, V107, P526, DOI 10.7326/0003-4819-107-4-526; GALLAGHER R, 1979, BLOOD, V54, P713; Griffaut B, 2004, INT J BIOL MACROMOL, V34, P271, DOI 10.1016/j.ijbiomac.2004.06.004; HALLIWELL B, 1992, J LAB CLIN MED, V119, P598; Hims MM, 2007, J MOL MED, V85, P149, DOI 10.1007/s00109-006-0137-2; Huda-Faujan N, 2009, AFR J BIOTECHNOL, V8, P484; Hwang I, 2012, ANNU REV PLANT BIOL, V63, P353, DOI 10.1146/annurev-arplant-042811-105503; Jablonska-Trypuc A, 2016, MOL CELL BIOCHEM, V413, P97, DOI 10.1007/s11010-015-2642-5; KEHRER JP, 1993, CRIT REV TOXICOL, V23, P21, DOI 10.3109/10408449309104073; Lappas CM, 2015, CELL MOL IMMUNOL, V12, DOI 10.1038/cmi.2014.33; Lee YC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038865; Li MY, 2014, J VET SCI, V15, P353, DOI 10.4142/jvs.2014.15.3.353; Mehrzad J, 2011, AFR J BIOTECHNOL, V10, P6304; Moyer RA, 2002, J AGR FOOD CHEM, V50, P519, DOI 10.1021/jf011062r; Naseem M, 2015, TRENDS PLANT SCI, V20, P781, DOI 10.1016/j.tplants.2015.10.017; Naseem M, 2014, TRENDS PLANT SCI, V19, P481, DOI 10.1016/j.tplants.2014.04.001; Olsen A, 1999, BIOCHEM BIOPH RES CO, V265, P499, DOI 10.1006/bbrc.1999.1669; RATTAN SIS, 1994, BIOCHEM BIOPH RES CO, V201, P665, DOI 10.1006/bbrc.1994.1752; Robischon M, 2015, BIOESSAYS, V37, P356, DOI 10.1002/bies.201400099; Samanovic MI, 2015, MOL CELL, V57, P984, DOI 10.1016/j.molcel.2015.01.024; Saurav K, 2012, SAUDI J BIOL SCI, V19, P81, DOI 10.1016/j.sjbs.2011.07.003; Schmitt E, 2002, TOXICOL LETT, V136, P133, DOI 10.1016/S0378-4274(02)00290-4; Sun Jiang-Hong, 2013, Shengli Xuebao, V65, P389; Verbeke P, 2000, BIOCHEM BIOPH RES CO, V276, P1265, DOI 10.1006/bbrc.2000.3616; Villanueva C, 2012, INT J MOL SCI, V13, P2091, DOI 10.3390/ijms13022091; Wiseman H, 1996, BIOCHEM J, V313, P17, DOI 10.1042/bj3130017; Wu JJ, 2007, CLIN EXP DERMATOL, V32, P693, DOI 10.1111/j.1365-2230.2007.02513.x	37	28	30	2	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2016	11	12							e0168386	10.1371/journal.pone.0168386	http://dx.doi.org/10.1371/journal.pone.0168386			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI9QH	28005918	Green Published, Green Submitted, gold			2022-12-27	WOS:000392843200048
J	Hanel, PHP; Vione, KC				Hanel, Paul H. P.; Vione, Katia C.			Do Student Samples Provide an Accurate Estimate of the General Public?	PLOS ONE			English	Article							COLLEGE-STUDENTS; PERSONALITY	Most psychological studies rely on student samples. Students are usually considered as more homogenous than representative samples both within and across countries. However, little is known about the nature of the differences between student and representative samples. This is an important gap, also because knowledge about the degree of difference between student and representative samples may allow to infer from the former to the latter group. Across 59 countries and 12 personality (Big-5) and attitudinal variables we found that differences between students and general public were partly substantial, incoherent, and contradicted previous findings. Two often used cultural variables, embeddedness and intellectual autonomy, failed to explain the differences between both groups across countries. We further found that students vary as much as the general population both between and within countries. In summary, our results indicate that generalizing from students to the general public can be problematic when personal and attitudinal variables are used, as students vary mostly randomly from the general public. Findings are also discussed in terms of the replication crisis within psychology.	[Hanel, Paul H. P.; Vione, Katia C.] Cardiff Univ, Sch Psychol, Cardiff, S Glam, Wales	Cardiff University	Hanel, PHP (corresponding author), Cardiff Univ, Sch Psychol, Cardiff, S Glam, Wales.	hanelph@cardiff.ac.uk	Hanel, Paul/AAB-3287-2020	Hanel, Paul/0000-0002-3225-1395; C. Vione, Katia/0000-0001-6633-8520	School of Psychology, Cardiff University; Economic and Social Research Council (ESRC) [ES/J500197/1]; CAPES Foundation (Brazil); Economic and Social Research Council [1358978] Funding Source: researchfish	School of Psychology, Cardiff University; Economic and Social Research Council (ESRC)(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); CAPES Foundation (Brazil)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC))	The authors acknowledge financial support by the School of Psychology, Cardiff University (psych.cf.ac.uk), the Economic and Social Research Council (ESRC; www.esrc.ac.uk) to the first author (ES/J500197/1), and the CAPES Foundation (Brazil, http://www.capes.gov.br/) to the second author. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aarts AA, 2015, SCIENCE, V349, DOI 10.1126/science.aac4716; Arnett JJ, 2008, AM PSYCHOL, V63, P602, DOI 10.1037/0003-066X.63.7.602; Bardi A, 2014, J PERS SOC PSYCHOL, V106, P131, DOI 10.1037/a0034818; Bavel JJV, 2016, P NATL ACAD SCI USA; Bender R, 2001, J CLIN EPIDEMIOL, V54, P343, DOI 10.1016/S0895-4356(00)00314-0; Button KS, 2013, NAT REV NEUROSCI, V14, P365, DOI 10.1038/nrn3475; DIENER E, 1995, J PERS SOC PSYCHOL, V69, P851, DOI 10.1037/0022-3514.69.5.851; Dienes Z, 2014, FRONT PSYCHOL, V5, DOI 10.3389/fpsyg.2014.00781; Druckman J.N., 2009, STUDENTS EXPT PARTIC, DOI [DOI 10.1017/CBO9780511921452.004, 10.2139/ssrn.1498843, DOI 10.2139/SSRN.1498843]; Economist Intelligence Unit, 2012, DEM IND 2012 DEM STA; Fischer R, 2011, J CROSS CULT PSYCHOL, V42, P1127, DOI 10.1177/0022022110381429; Gelfand MJ, 2011, SCIENCE, V332, P1100, DOI 10.1126/science.1197754; Gelman A, 2015, J MANAGE, V41, P632, DOI 10.1177/0149206314525208; Gosling SD, 2003, J RES PERS, V37, P504, DOI 10.1016/S0092-6566(03)00046-1; Gosling SD, NOTE ALPHA RELIABILI; Greenfield PM, 2014, J CROSS CULT PSYCHOL, V45, P37, DOI 10.1177/0022022113513402; Harding S., 1986, CONTRASTING VALUES W; Henrich J, 2010, BEHAV BRAIN SCI, V33, P111, DOI 10.1017/S0140525X10000725; Kerr N L, 1998, Pers Soc Psychol Rev, V2, P196, DOI 10.1207/s15327957pspr0203_4; Klein RA, 2014, SOC PSYCHOL-GERMANY, V45, P142, DOI 10.1027/1864-9335/a000178; Morey RD, 2016, BAYESFACTOR COMPUTAT; Peterson RA, 2001, J CONSUM RES, V28, P450, DOI 10.1086/323732; Peterson RA, 2014, J BUS RES, V67, P1035, DOI 10.1016/j.jbusres.2013.08.010; Saucier G, 2015, J CROSS CULT PSYCHOL, V46, P53, DOI 10.1177/0022022114551791; Schwartz S.H., 2008, 7 SCHWARTZ CULTURAL, DOI DOI 10.13140/RG.2.1.3313.3040; SCHWARTZ SH, 1992, ADV EXP SOC PSYCHOL, V25, P1, DOI 10.1016/s0065-2601(08)60281-6; Schwartz SH, 2006, COMP SOCIOL, V5, P137, DOI 10.1163/156913306778667357; SEARS DO, 1986, J PERS SOC PSYCHOL, V51, P515, DOI 10.1037/0022-3514.51.3.515; Simmons JP, 2011, PSYCHOL SCI, V22, P1359, DOI 10.1177/0956797611417632; Srivastava S, 2003, J PERS SOC PSYCHOL, V84, P1041, DOI 10.1037/0022-3514.84.5.1041; United Nations Developmental Programme, 2014, HUM DEV REP HUM DEV; Vauclair CM, 2011, EUR J SOC PSYCHOL, V41, P645, DOI 10.1002/ejsp.794	32	197	200	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2016	11	12							e0168354	10.1371/journal.pone.0168354	http://dx.doi.org/10.1371/journal.pone.0168354			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EI9TW	28002494	gold, Green Published, Green Submitted, Green Accepted			2022-12-27	WOS:000392853100041
J	Lim, K; Jackson, KL; Burke, SL; Head, GA				Lim, Kyungjoon; Jackson, Kristy L.; Burke, Sandra L.; Head, Geoffrey A.			The Effects of Rilmenidine and Perindopril on Arousal Blood Pressure during 24 Hour Recordings in SHR	PLoS One			English	Article							SPONTANEOUSLY HYPERTENSIVE-RATS; SYMPATHETIC-NERVOUS-SYSTEM; MORNING SURGE; CARDIOVASCULAR ACTIONS; CARDIAC BAROREFLEX; CONSCIOUS RABBITS; STROKE; CLONIDINE; RHYTHMICITY; VARIABILITY	The surge in arterial pressure during arousal in the waking period is thought to be largely due to activation of the sympathetic nervous system. In this study we compared in SHR the effects of chronic administration of the centrally acting sympatholytic agent rilmenidine with an angiotensin converting enzyme inhibitor perindopril on the rate of rise and power of the surge in mean arterial pressure (MAP) that occurs with arousal associated with the onset of night. Recordings were made using radiotelemetry in 17 adult SHR before and after treatment with rilmenidine (2mg/kg/day), perindopril (1 mg/kg/day) or vehicle in the drinking water for 2 weeks. Rilmenidine reduced MAP by 7.2 +/- 1.7mmHg while perindopril reduced MAP by 19 +/- 3mmHg. Double logistic curve fit analysis showed that the rate and power of increase in systolic pressure during the transition from light to dark was reduced by 50% and 65%, respectively, but had no effect on diastolic pressure. Rilmenidine also reduced blood pressure variability in the autonomic frequency in the active period as assessed by spectral analysis which is consistent with reduction in sympathetic nervous system activity. Perindopril had no effect on the rate or power of the arousal surge in either systolic or diastolic pressure. These results suggest that the arousal induced surge in blood pressure can largely be reduced by an antihypertensive agent that inhibits the sympathetic nervous system and that angiotensin converting enzyme inhibition, while effective in reducing blood pressure, does not alter the rate or power of the surge associated with arousal.	[Lim, Kyungjoon; Jackson, Kristy L.; Burke, Sandra L.; Head, Geoffrey A.] Baker IDI Heart & Diabet Inst, Neuropharmacol Lab, Melbourne, Vic, Australia; [Head, Geoffrey A.] Monash Univ, Dept Pharmacol, Clayton, Vic, Australia	Baker Heart and Diabetes Institute; Monash University	Lim, K (corresponding author), Baker IDI Heart & Diabet Inst, Neuropharmacol Lab, Melbourne, Vic, Australia.	joon.lim@bakeridi.edu.au	Head, Geoffrey A./B-2177-2010; Lim, Joon/AAX-7788-2020	Head, Geoffrey A./0000-0002-7623-137X; Jackson, Kristy/0000-0002-4707-4096				Adams DJ, 2006, J BIOL CHEM, V281, P31753, DOI 10.1074/jbc.M605720200; BROCKWAY BP, 1991, CLIN EXP HYPERTENS A, V13, P885, DOI 10.3109/10641969109042094; Burke SL, 2016, AM J PHYSIOL-HEART C, V310, pH1222, DOI 10.1152/ajpheart.00866.2015; Burke SL, 1998, J AUTONOM NERV SYST, V72, P177, DOI 10.1016/S0165-1838(98)00103-9; Chan CKS, 1996, J PHARMACOL EXP THER, V276, P411; Davern PJ, 2009, HYPERTENSION, V54, P852, DOI 10.1161/HYPERTENSIONAHA.109.136069; Elliott WJ, 1998, STROKE, V29, P992, DOI 10.1161/01.STR.29.5.992; Fennessy PA, 1996, PHARMACOL RES, V34, P135, DOI 10.1006/phrs.1996.0078; Finta E, 2006, J HYPERTENS, V24, P1619, DOI 10.1097/01.hjh.0000239298.63377.db; Gallerani M, 1996, STROKE, V27, P1793, DOI 10.1161/01.STR.27.10.1793; Gaudet E, 1996, AM J PHYSIOL-REG I, V270, pR1265, DOI 10.1152/ajpregu.1996.270.6.R1265; Hashimoto J, 2003, J HYPERTENS, V21, P805, DOI 10.1097/00004872-200304000-00025; Head G A, 1995, Ann N Y Acad Sci, V763, P531, DOI 10.1111/j.1749-6632.1995.tb32447.x; Head GA, 1998, J HYPERTENS, V16, pS7; Head GA, 2004, J HYPERTENS, V22, P2075, DOI 10.1097/00004872-200411000-00008; Head GA, 2001, IEEE ENG MED BIOL, V20, P43, DOI 10.1109/51.917723; Head GA, 2006, AM J HYPERTENS, V19, P1010, DOI 10.1016/j.amjhyper.2006.03.014; Head GA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093186; Head GA, 2010, AM J HYPERTENS, V23, P1074, DOI 10.1038/ajh.2010.126; Hermida RC, 2008, AM J HYPERTENS, V21, P948, DOI 10.1038/ajh.2008.216; Hermida RC, 2004, CHRONOBIOL INT, V21, P277, DOI 10.1081/CBI-120037772; Jackson KL, 2014, J HYPERTENS, V32, P575, DOI 10.1097/HJH.0000000000000036; JANSSEN BJA, 1993, CHRONOBIOL INT, V10, P420, DOI 10.3109/07420529309059718; Janssen BJA, 2002, AM J PHYSIOL-RENAL, V282, pF113, DOI 10.1152/ajprenal.0153.2001; JULIEN C, 1990, AM J PHYSIOL, V259, pH1337, DOI 10.1152/ajpheart.1990.259.5.H1337; Kario K, 2005, HYPERTENSION, V45, P485, DOI 10.1161/01.HYP.0000158313.57142.3f; Kario K, 2003, CIRCULATION, V107, P1401, DOI 10.1161/01.CIR.0000056521.67546.AA; Kario K, 2006, HYPERTENS RES, V29, P581, DOI 10.1291/hypres.29.581; Lambert EA, 2014, AM J HYPERTENS, V27, P783, DOI 10.1093/ajh/hpt273; Lim K, 2015, EXP PHYSIOL, V100, P1132, DOI 10.1113/EP085312; Luo Y, 2013, CHINESE MED J-PEKING, V126, P510, DOI 10.3760/cma.j.issn.0366-6999.20122110; MARQUARDT DW, 1963, J SOC IND APPL MATH, V11, P431, DOI 10.1137/0111030; Martin CA, 2013, J HUM HYPERTENS, V27, P315, DOI 10.1038/jhh.2012.44; Mayorov DN, 2001, J CARDIOVASC PHARM, V37, P252, DOI 10.1097/00005344-200103000-00003; MIDDLEKAUFF HR, 1995, CIRCULATION, V91, P2549, DOI 10.1161/01.CIR.91.10.2549; MINAMI N, 1993, J HYPERTENS, V11, P523, DOI 10.1097/00004872-199305000-00008; MINAMI N, 1992, COLLOQ INSE, V218, P69; Monassier L, 2004, J CARDIOVASC PHARM, V43, P394, DOI 10.1097/00005344-200403000-00010; Navakatikyan MA, 2002, IEEE T BIO-MED ENG, V49, P662, DOI 10.1109/TBME.2002.1010849; Nowak L, 2005, AM J HYPERTENS, V18, P1470, DOI 10.1016/j.amjhyper.2005.05.026; Ricketts JH, 1999, AM J PHYSIOL-REG I, V277, pR441, DOI 10.1152/ajpregu.1999.277.2.R441; SANNAJUST F, 1989, CLIN EXP PHARMACOL P, V16, P837, DOI 10.1111/j.1440-1681.1989.tb01523.x; SASSARD J, 1989, B ACAD NAT MED PARIS, V173, P1219; WILLICH SN, 1989, CIRCULATION, V80, P853, DOI 10.1161/01.CIR.80.4.853	44	1	1	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2016	11	12							e0168425	10.1371/journal.pone.0168425	http://dx.doi.org/10.1371/journal.pone.0168425			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI9TW	28002478	Green Submitted, Green Published, gold			2022-12-27	WOS:000392853100045
J	Mogollon, CM; van Pul, FJA; Imai, T; Ramesar, J; Chevalley-Maurel, S; de Roo, GM; Veld, SAJ; Kroeze, H; Franke-Fayard, BMD; Janse, CJ; Khan, SM				Mogollon, Catherin Marin; van Pul, Fiona J. A.; Imai, Takashi; Ramesar, Jai; Chevalley-Maurel, Severine; de Roo, Guido M.; Veld, Sabrina A. J.; Kroeze, Hans; Franke-Fayard, Blandine M. D.; Janse, Chris J.; Khan, Shahid M.			Rapid Generation of Marker-Free P. falciparum Fluorescent Reporter Lines Using Modified CRISPR/Cas9 Constructs and Selection Protocol	PLOS ONE			English	Article							TARGETED GENE DELETION; PLASMODIUM-FALCIPARUM; MALARIA PARASITE; NEGATIVE SELECTION; EXPRESSES GFP; BLOOD STAGES; LIVER-STAGE; LUCIFERASE; TRANSFECTION; GAMETOCYTES	The CRISPR/Cas9 system is a powerful genome editing technique employed in a wide variety of organisms including recently the human malaria parasite, P. falciparum. Here we report on further improvements to the CRISPR/Cas9 transfection constructs and selection protocol to more rapidly modify the P. falciparum genome and to introduce transgenes into the parasite genome without the inclusion of drug-selectable marker genes. This method was used to stably integrate the gene encoding GFP into the P. falciparum genome under the control of promoters of three different Plasmodium genes (calmodulin, gapdh and hsp70). These genes were selected as they are highly transcribed in blood stages. We show that the three reporter parasite lines generated in this study (GFP@ cam, GFP@gapdh and GFP@ hsp70) have in vitro blood stage growth kinetics and drug-sensitivity profiles comparable to the parental P. falciparum (NF54) wild-type line. Both asexual and sexual blood stages of the three reporter lines expressed GFP-fluorescence with GFP@ hsp70 having the highest fluorescent intensity in schizont stages as shown by flow cytometry analysis of GFP-fluorescence intensity. The improved CRISPR/Cas9 constructs/protocol will aid in the rapid generation of transgenic and modified P. falciparum parasites, including those expressing different reporters proteins under different (stage specific) promoters.	[Mogollon, Catherin Marin; van Pul, Fiona J. A.; Imai, Takashi; Ramesar, Jai; Chevalley-Maurel, Severine; Kroeze, Hans; Franke-Fayard, Blandine M. D.; Janse, Chris J.; Khan, Shahid M.] Leiden Univ, Med Ctr, Dept Parasitol, Leiden Malaria Res Grp, Leiden, Netherlands; [de Roo, Guido M.; Veld, Sabrina A. J.] Leiden Univ, Med Ctr, Dept Hematol, Leiden, Netherlands	Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC	Khan, SM (corresponding author), Leiden Univ, Med Ctr, Dept Parasitol, Leiden Malaria Res Grp, Leiden, Netherlands.	S.M.Khan@lumc.nl		Imai, Takashi/0000-0001-9049-8102; , Blandine/0000-0001-6041-4182; Khan, Shahid/0000-0002-0533-4670; Janse, Chris J/0000-0002-6410-6205	Colciencias Ph.D. fellowship; Uehara Memorial Foundation	Colciencias Ph.D. fellowship; Uehara Memorial Foundation(Uehara Memorial Foundation)	C. M. Mogollon was supported by Colciencias Ph.D. fellowship (Call 568 from 2012 Resolution 01218 Bogota, Colombia). Takashi Imai was, in part, supported by Uehara Memorial Foundation grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adjalley SH, 2010, METHODS MOL BIOL, V634, P87, DOI 10.1007/978-1-60761-652-8_6; Amino R, 2005, CURR OPIN MICROBIOL, V8, P407, DOI 10.1016/j.mib.2005.06.019; Annoura T, 2012, VACCINE, V30, P2662, DOI 10.1016/j.vaccine.2012.02.010; Braks JAM, 2006, NUCLEIC ACIDS RES, V34, DOI 10.1093/nar/gnj033; Coombes JL, 2010, NAT REV IMMUNOL, V10, P353, DOI 10.1038/nri2746; Cui L, 2008, EXP PARASITOL, V120, P80, DOI 10.1016/j.exppara.2008.05.003; de Koning-Ward TF, 2015, NAT REV MICROBIOL, V13, P373, DOI 10.1038/nrmicro3450; Dube A, 2009, TRENDS PARASITOL, V25, P432, DOI 10.1016/j.pt.2009.06.006; Duraisingh MT, 2002, INT J PARASITOL, V32, P81, DOI 10.1016/S0020-7519(01)00345-9; Erbs P, 2000, CANCER RES, V60, P3813; Franke-Fayard B, 2008, INT J PARASITOL, V38, P1651, DOI 10.1016/j.ijpara.2008.05.012; Franke-Fayard B, 2004, MOL BIOCHEM PARASIT, V137, P23, DOI 10.1016/j.molbiopara.2004.04.007; Ghorbal M, 2014, NAT BIOTECHNOL, V32, P819, DOI 10.1038/nbt.2925; Heussler V, 2006, TRENDS PARASITOL, V22, P192, DOI 10.1016/j.pt.2006.03.001; Hill DA, 2007, P NATL ACAD SCI USA, V104, P1063, DOI 10.1073/pnas.0610353104; Janse CJ, 2006, NAT PROTOC, V1, P346, DOI 10.1038/nprot.2006.53; Janse CJ, 2011, TRENDS PARASITOL, V27, P31, DOI 10.1016/j.pt.2010.06.016; JANSE CJ, 1994, METHOD CELL BIOL, V42, P295; Khan SM, 2012, CURRENT OPINION BIOT; LaMonte G, 2016, MBIO, V7, DOI 10.1128/mBio.00696-16; Lee MCS, 2014, GENOME MED, V6, DOI 10.1186/s13073-014-0063-9; Lin Jing-Wen, 2013, Methods Mol Biol, V923, P507; Lin JW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029289; Longley RJ, 2015, SCI REP-UK, V5, DOI 10.1038/srep11820; Lu JN, 2016, PARASITE VECTOR, V9, DOI 10.1186/s13071-016-1487-4; Maier AG, 2006, MOL BIOCHEM PARASIT, V150, P118, DOI 10.1016/j.molbiopara.2006.06.014; Maier Alexander G, 2013, Methods Mol Biol, V923, P3; Manzoni G, 2014, SCI REP-UK, V4, DOI 10.1038/srep04760; Meister S, 2011, SCIENCE, V334, P1372, DOI 10.1126/science.1211936; Militello KT, 2003, PARASITOL RES, V89, P154, DOI 10.1007/s00436-002-0721-5; Mojica FJ, 2016, TRENDS MICROBIOL; Ng CL, 2016, MOL MICROBIOL, V101, P381, DOI 10.1111/mmi.13397; O'Neill MT, 2011, INT J PARASITOL, V41, P117, DOI 10.1016/j.ijpara.2010.08.001; Ploemen IHJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007881; PONNUDURAI T, 1981, TROP GEOGR MED, V33, P50; PONNUDURAI T, 1986, PARASITOLOGY, V93, P263, DOI 10.1017/S003118200005143X; Rankin KE, 2010, CELL MICROBIOL, V12, P569, DOI 10.1111/j.1462-5822.2010.01454.x; Rijpma SR, 2016, CELL MICROBIOL, V18, P369, DOI 10.1111/cmi.12517; Rug M, 2013, METHOD MOL BIOL, V923, P75, DOI [DOI 10.1007/978-1-62703-026-7_6, 10.1007/978-1-62703-026-7_6]; Silvie O, 2008, CURR OPIN MICROBIOL, V11, P352, DOI 10.1016/j.mib.2008.06.005; Talman AM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009156; van Dijk MR, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000853; van Niekerk DD, 2016, FEBS J, V283, P634, DOI 10.1111/febs.13615; van Schaijk BCL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015121; Vaughan AM, 2012, MOL BIOCHEM PARASIT, V186, P143, DOI 10.1016/j.molbiopara.2012.10.004; Wagner JC, 2014, NAT METHODS, V11, P915, DOI [10.1038/NMETH.3063, 10.1038/nmeth.3063]; Wright AV, 2016, CELL, V164, P29, DOI 10.1016/j.cell.2015.12.035	47	28	28	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2016	11	12							e0168362	10.1371/journal.pone.0168362	http://dx.doi.org/10.1371/journal.pone.0168362			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI9QF	27997583	Green Published, Green Submitted, gold			2022-12-27	WOS:000392842900037
J	Mukherjee, A; Nayak, MK; Dutta, S; Panda, S; Satpathi, BR; Chawla-Sarkar, M				Mukherjee, Anupam; Nayak, Mukti Kant; Dutta, Shanta; Panda, Samiran; Satpathi, Biswa Ranjan; Chawla-Sarkar, Mamta			Genetic Characterization of Circulating 2015 A(H1N1)pdm09 Influenza Viruses from Eastern India	PLOS ONE			English	Article							A H1N1 VIRUS; NEURAMINIDASE INHIBITORS; EVOLUTIONARY DYNAMICS; HEMAGGLUTININ; H1N1PDM09; HUMANS	In 2015, the swine derived A(H1N1)pdm09 pandemic strain outbreak became widespread throughout the different states of India. The reported cases and deaths in 2015 surpassed the previous years with more than 39000 laboratory confirmed cases and a death toll of more than 2500 people. There are relatively limited complete genetic sequences available for this virus from Asian countries. In this study, we describe the full genome analysis of influenza 2015 A(H1N1)pdm09 viruses isolated from West Bengal between January through December 2015. The phylogenetic analysis of the haemagglutinin sequence revealed clustering with globally circulating strains of genogroup 6B. This was further confirmed by the constructed concatenated tree using all eight complete gene segments of Kolkata A(H1N1)pdm09 isolates with the other strains from different timeline and lineages. A study from Massachusetts Institute of Technology (MIT) in 2015 reported novel mutations T200A and D225N in haemagglutinin gene of a 2014 Indian strain (A/India/6427/2014). However, in all the pandemic strains of 2014-2015 reported from India, so far including A(H1N1)pdm09 strains from Kolkata, D225N mutation was not observed, though the T200A mutation was found to be conserved. Neuraminidase gene of the analyzed strains did not show any oseltamivir resistant mutation H275Y suggesting continuation of Tamiflu as drug of choice. The amino acid sequences of the all gene segments from 2015 A(H1N1)pdm09 isolates identified several new mutations compared to the 2009 A(H1N1)pdm09 strains, which may have contributed towards enhanced virulence, compared to 2009 A(H1N1)pdm09 strains.	[Mukherjee, Anupam; Nayak, Mukti Kant; Chawla-Sarkar, Mamta] Natl Inst Cholera & Enter Dis, Div Mol Virol, Kolkata, India; [Dutta, Shanta] Natl Inst Cholera & Enter Dis, Div Bacteriol, Kolkata, India; [Panda, Samiran] Natl Inst Cholera & Enter Dis, Div Epidemiol, Kolkata, India; [Satpathi, Biswa Ranjan] Govt West Bengal, Dept Hlth & Family Welf, Kolkata, India	Indian Council of Medical Research (ICMR); ICMR - National Institute of Cholera & Enteric Diseases (NICED); Indian Council of Medical Research (ICMR); ICMR - National Institute of Cholera & Enteric Diseases (NICED); Indian Council of Medical Research (ICMR); ICMR - National Institute of Cholera & Enteric Diseases (NICED)	Chawla-Sarkar, M (corresponding author), Natl Inst Cholera & Enter Dis, Div Mol Virol, Kolkata, India.	chawlam70@gmail.com	Mukherjee, Anupam/ABB-9438-2020	Mukherjee, Anupam/0000-0002-0612-2258	Department of Health and Family Welfare, Government of West Bengal [10-2/2015-SD]	Department of Health and Family Welfare, Government of West Bengal	Genetic characterization of 2015 H1N1pdm09 strains was financially supported by the Department of Health and Family Welfare, Government of West Bengal funded research grant - D.O.No.10-2/2015-SD. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anupam Mukherjee, 2010, Journal of Public Health and Epidemiology, V2, P171; Baillie GJ, 2012, J VIROL, V86, P11, DOI 10.1128/JVI.05347-11; Baranovich T, 2015, ANTIVIR RES, V117, P10, DOI 10.1016/j.antiviral.2015.02.004; Barrero PR, 2011, J VIROL, V85, P1058, DOI 10.1128/JVI.00936-10; Battegay M, 2020, SWISS MED WKLY, V150, DOI [10.4414/smw.w20203, 10.4414/smw.2020.20203]; Broor S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029129; COUSINS S, 2015, BMJ-BRIT MED J, V351, DOI DOI 10.1136/BMJ.H4966; DuBois RM, 2011, J VIROL, V85, P865, DOI 10.1128/JVI.01412-10; European Centre for Disease Prevention and Control (ECDC), 2013, INFL VIR CHAR SUMM E; Garten RJ, 2009, SCIENCE, V325, P197, DOI 10.1126/science.1176225; Gatherer D, 2009, J CLIN VIROL, V45, P174, DOI 10.1016/j.jcv.2009.06.004; Goka EA, 2014, ARCH VIROL, V159, P3167, DOI 10.1007/s00705-014-2179-z; Gubareva LV, 2010, ANTIVIR THER, V15, P1151, DOI 10.3851/IMP1678; Hanson RM, 2013, ISR J CHEM, V53, P207, DOI 10.1002/ijch.201300024; Horm SV, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110713; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Igarashi M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008553; Ilyushina NA, 2010, MBIO, V1, DOI 10.1128/mBio.00249-10; Jimenez-Jorge S, 2014, EUROSURVEILLANCE, V19, P19, DOI DOI 10.2807/1560-7917.ES2014.19.9.20727; Laskowski RA, 1996, J BIOMOL NMR, V8, P477, DOI 10.1007/BF00228148; LeGoff J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037095; Li XY, 2013, VIRUS GENES, V47, P199, DOI 10.1007/s11262-013-0931-1; LUTHY R, 1992, NATURE, V356, P83, DOI 10.1038/356083a0; McKimm-Breschkin JL, 2013, INFLUENZA OTHER RESP, V7, P25, DOI 10.1111/irv.12047; Mir MA, 2012, J MED VIROL, V84, P386, DOI 10.1002/jmv.23205; Mishra AC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010540; Morens DM, 2010, MBIO, V1, DOI 10.1128/mBio.00211-10; Mullick J, 2011, INFECT GENET EVOL, V11, P997, DOI 10.1016/j.meegid.2011.03.015; Nelson Martha, 2009, PLoS Curr, V1, pRRN1126; Nelson MI, 2011, J VIROL, V85, P828, DOI 10.1128/JVI.01762-10; Parida M, 2016, EUROSURVEILLANCE, V21, P6, DOI 10.2807/1560-7917.ES.2016.21.5.30124; Rogers MB, 2015, MBIO, V6, DOI 10.1128/mBio.02464-14; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Tate MD, 2014, VIRUSES-BASEL, V6, P1294, DOI 10.3390/v6031294; Taubenberger JK, 2010, PUBLIC HEALTH REP, V125, P16, DOI 10.1177/00333549101250S305; Tharakaraman K, 2015, CELL HOST MICROBE, V17, P279, DOI 10.1016/j.chom.2015.02.019; Treanor J, 2004, NEW ENGL J MED, V350, P218, DOI 10.1056/NEJMp038238; Vaidya G, 2011, CLADISTICS, V27, P171, DOI 10.1111/j.1096-0031.2010.00329.x; Viboud C, 2005, J INFECT DIS, V192, P233, DOI 10.1086/431150; Wang B, 2010, ANTIVIR RES, V87, P16, DOI 10.1016/j.antiviral.2010.04.002; Webb Benjamin, 2016, Curr Protoc Protein Sci, V86, DOI [10.1002/cpbi.3, 10.1002/0471250953.bi0506s15, 10.1002/0471140864.ps0209s50, 10.1002/cpps.20]; WHO, 2009, SEQ PRIM PROT; World Health Organization, 2009, CDC PROT REAL TIM RT	43	5	5	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2016	11	12							e0168464	10.1371/journal.pone.0168464	http://dx.doi.org/10.1371/journal.pone.0168464			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI9QF	27997573	Green Published, Green Submitted, gold			2022-12-27	WOS:000392842900049
J	Terama, E; Smallman, M; Lock, SJ; Johnson, C; Austwick, MZ				Terama, Emma; Smallman, Melanie; Lock, Simon J.; Johnson, Charlotte; Austwick, Martin Zaltz			Beyond Academia - Interrogating Research Impact in the Research Excellence Framework	PLOS ONE			English	Article							POLICY; PROPOSALS	Big changes to the way in which research funding is allocated to UK universities were brought about in the Research Excellence Framework (REF), overseen by the Higher Education Funding Council, England. Replacing the earlier Research Assessment Exercise, the purpose of the REF was to assess the quality and reach of research in UK universities and allocate funding accordingly. For the first time, this included an assessment of research `impact', accounting for 20% of the funding allocation. In this article we use a text mining technique to investigate the interpretations of impact put forward via impact case studies in the REF process. We find that institutions have developed a diverse interpretation of impact, ranging from commercial applications to public and cultural engagement activities. These interpretations of impact vary from discipline to discipline and between institutions, with more broad-based institutions depicting a greater variety of impacts. Comparing the interpretations with the score given by REF, we found no evidence of one particular interpretation being more highly rewarded than another. Importantly, we also found a positive correlation between impact score and [overall research] quality score, suggesting that impact is not being achieved at the expense of research excellence.	[Terama, Emma; Johnson, Charlotte] UCL, UCL Inst Sustainable Resources, London, England; [Smallman, Melanie; Lock, Simon J.] UCL, Dept Sci & Technol Studies, London, England; [Austwick, Martin Zaltz] UCL, Ctr Adv Spatial Anal, London, England	University of London; University College London; University of London; University College London; University of London; University College London	Austwick, MZ (corresponding author), UCL, Ctr Adv Spatial Anal, London, England.	m.austwick@ucl.ac.uk		Terama, Emma/0000-0003-1790-2126; Johnson, Charlotte/0000-0002-7340-1601	Kone Foundation; Direct For Social, Behav & Economic Scie [1257246] Funding Source: National Science Foundation	Kone Foundation; Direct For Social, Behav & Economic Scie(National Science Foundation (NSF)NSF - Directorate for Social, Behavioral & Economic Sciences (SBE))	ET respectfully acknowledges support from the Kone Foundation, http://www.koneensaatiofi/. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2014, REF2014 RES; [Anonymous], 2014, 012012 REF; Assembly Research, 2020, REP HUAW MACR IMP DE; Bara J, 2007, SWISS POLIT SCI REV, V13, P577, DOI 10.1002/j.1662-6370.2007.tb00090.x; Bell S, 2011, RES EVALUAT, V20, P227, DOI 10.3152/095820211X13118583635792; Bholat David, 2015, TEXT MINING CENTRAL, P1; Chartier J. F., 2011, PAPERS SOCIAL REPRES, V20, P1; Derrick GE, 2016, MINERVA, V54, P75, DOI 10.1007/s11024-016-9290-0; Engines of growth, 2015, ENG GROWTH 3; Firth J, 1986, BRIT J PSYCHOTHERAPY, V2, P169; Francis B., 2011, SCOTTISH ED REV, V43, P4; Huutoniemi K, 2012, SOC STUD SCI, V42, P897, DOI 10.1177/0306312712458478; King's College London and Digital Science, 2015, 201501 HEFCE KINGS C; Klautzer L, 2011, RES EVALUAT, V20, P201, DOI 10.3152/095820211X13118583635675; Kronberger N., 2000, QUALITATIVE RES TEXT, P299; LOMAS J, 1990, J HEALTH POLIT POLIC, V15, P525, DOI 10.1215/03616878-15-3-525; Luukkonen T, 2012, RES EVALUAT, V21, P48, DOI 10.1093/reseval/rvs001; Manville C., 2015, PREPARING IMPACT SUB; Martin BR, 2011, RES EVALUAT, V20, P247, DOI 10.3152/095820211X13118583635693; Mutombo E, 2013, 1 INT C PUBL POL; NIEMANN HJ, 1986, ENG STRUCT, V8, P74, DOI 10.1016/0141-0296(86)90023-4; Oancea A., 2013, EUROPEAN ED RES J, V12; Oancea A., 2013, RES TRENDS, P6; Pain R, 2011, AREA, V43, P183, DOI 10.1111/j.1475-4762.2010.00978.x; Parker J., 2012, PRACTICE SOCIAL WORK, V24, P41, DOI DOI 10.1080/09503153.2011.647682; Penfield T, 2013, RES EVALUAT; Pettigrew AM, 2011, BRIT J MANAGE, V22, P347, DOI 10.1111/j.1467-8551.2011.00769.x; Phillips R, 2010, T I BRIT GEOGR, V35, P447, DOI 10.1111/j.1475-5661.2010.00393.x; RAND, RR1032HEFCE; Ratinaud P., 2009, IRAMUTEQ INTERFACE R; REF, 2012, PAN CRIT WORK METH; REF, 2014, DEC ASS RES IMP RES; REF, 2014, ASS FRAM GUID SUBM; REF Research Impact Pilot Exercise Lessons-Learned Project, 2010, REF RES IMP PIL EX L; Sa CM, 2013, RES EVALUAT, V22, P105, DOI 10.1093/reseval/rvs041; Sahlgren M., 2006, THESIS; SHERMAN LW, 1989, LAW SOC REV, V23, P117, DOI 10.2307/3053883; Slater T, 2012, AREA, V44, P117, DOI 10.1111/j.1475-4762.2011.01067.x; Smith S, 2011, RES POLICY, V40, P1369, DOI 10.1016/j.respol.2011.05.026; Stoneman P, 2013, PUBLIC UNDERST SCI, V22, P850, DOI 10.1177/0963662512441569; Suppes P., 1978, IMPACT RES ED SOME C; VIELLE JP, 1981, PROSPECTS, V11, P313, DOI 10.1007/BF02254384; Watermeyer R, 2016, STUD HIGH EDUC, V41, P199, DOI 10.1080/03075079.2014.915303; Watermeyer R, 2012, TERT EDUC MANAG, V18, P115, DOI 10.1080/13583883.2011.641578; Wilsdon J., 2015, METRIC TIDE LIT REV; Wooding S, 2015, PLOSONE	46	29	29	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2016	11	12							e0168533	10.1371/journal.pone.0168533	http://dx.doi.org/10.1371/journal.pone.0168533			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EI9QF	27997599	gold, Green Published, Green Submitted			2022-12-27	WOS:000392842900055
J	Jois, T; Howard, V; Youngs, K; Cowley, MA; Sleeman, MW				Jois, Tara; Howard, Victor; Youngs, Kristina; Cowley, Michael A.; Sleeman, Mark W.			Dietary Macronutrient Composition Directs ChREBP Isoform Expression and Glucose Metabolism in Mice	PLOS ONE			English	Article							ELEMENT-BINDING PROTEIN; DE-NOVO LIPOGENESIS; HEPATIC INSULIN-RESISTANCE; URBAN-RURAL EPIDEMIOLOGY; CORONARY-ARTERY-DISEASE; ADIPOSE-TISSUE; TRANSCRIPTION FACTOR; GENE-EXPRESSION; GLYCEMIC LOAD; OB/OB MICE	Carbohydrate response element binding protein (ChREBP) is a lipogenic transcription factor that is thought to be involved in the development of hepatic steatosis and insulin resistance. Increased ChREBP expression in liver results in increased hepatic steatosis, and the isoform ChREBP6 in adipose tissue can predict insulin sensitivity in obese humans. As ChREBP is activated by glucose, it was postulated that the composition of diet would regulate ChREBP isoform expression in metabolically relevant tissues. We compared the effects of diets with high complex carbohydrate, high fat, or a normal chow on ChREBP expression and metabolic parameters in C57BL/6 mice. We found that diets high in fat decrease ChREBP expression in adipose tissue, but isocaloric diets high in carbohydrate have no effect. Interestingly, this decrease in adipose ChREBP was associated with increased inflammatory markers. In the same animals a high carbohydrate diet induced a robust increase in hepatic ChREBP6 expression (approximate to 2-fold; p = 0.0002), but little detectable change in the more abundant ChREBP alpha transcript. This change was accompanied by increased expression of target genes liver pyruvate kinase (p<0.0001), acetyl-CoA carboxylase (p = 0.0191) and stearoyl-CoA desaturase-1 (p = 0.0045). This increase in ChREBP expression was associated with increased hepatic steatosis, despite no changes in body weight or body fat when compared to chow-fed mice. Unexpectedly, mice fed a high carbohydrate diet displayed enhanced sensitivity to exogenous insulin, despite having mild glucose intolerance and increased liver steatosis. In summary, we have shown the composition of diet can selectively regulate ChREBP isoform expression in a tissue specific manner. Furthermore, we have shown a high complex carbohydrate diet selectively increases hepatic ChREBP6 expression, which associates with hepatic steatosis but not insulin resistance. In contrast, a high fat diet reduces adipose ChREBP, which associates with inflammation and insulin resistance.	[Jois, Tara; Howard, Victor; Youngs, Kristina; Cowley, Michael A.; Sleeman, Mark W.] Monash Univ, Dept Physiol, Clayton, Vic, Australia; [Cowley, Michael A.; Sleeman, Mark W.] Monash Univ, Biomed Discovery Inst, Clayton, Vic, Australia; [Sleeman, Mark W.] Monash Univ, Dept Biochem & Mol Biol, Clayton, Vic, Australia	Monash University; Monash University; Monash University	Sleeman, MW (corresponding author), Monash Univ, Dept Physiol, Clayton, Vic, Australia.; Sleeman, MW (corresponding author), Monash Univ, Biomed Discovery Inst, Clayton, Vic, Australia.; Sleeman, MW (corresponding author), Monash Univ, Dept Biochem & Mol Biol, Clayton, Vic, Australia.	mark.sleeman@monash.edu	Cowley, Michael A/B-9428-2008	Cowley, Michael A/0000-0001-7811-134X				Agius L, 2013, BIOCHEM PHARMACOL, V85, P306, DOI 10.1016/j.bcp.2012.09.019; Arden C, 2012, BIOCHEM J, V443, P111, DOI 10.1042/BJ20111280; Barclay AW, 2008, AM J CLIN NUTR, V87, P627, DOI 10.1093/ajcn/87.3.627; Benhamed F, 2012, J CLIN INVEST, V122, P2176, DOI 10.1172/JCI41636; Bricambert J, 2010, J CLIN INVEST, V120, P4316, DOI 10.1172/JCI41624; Buettner R, 2004, AM J PHYSIOL-ENDOC M, V286, pE828, DOI 10.1152/ajpendo.00453.2003; Cairo S, 2001, HUM MOL GENET, V10, P617, DOI 10.1093/hmg/10.6.617; Cao HM, 2008, CELL, V134, P933, DOI 10.1016/j.cell.2008.07.048; Dentin R, 2005, J CLIN INVEST, V115, P2843, DOI 10.1172/JCI25256; Dentin R, 2006, DIABETES, V55, P2159, DOI 10.2337/db06-0200; Diaz-Moralli S, 2012, AM J PHYSIOL-ENDOC M, V303, pE234, DOI 10.1152/ajpendo.00675.2011; Eissing L, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2537; FOLCH J, 1957, J BIOL CHEM, V226, P497; Galgani J, 2006, NUTR J, V5, DOI 10.1186/1475-2891-5-22; Guo SR, 2011, CLIN CHIM ACTA, V412, P1854, DOI 10.1016/j.cca.2011.06.024; Herman MA, 2012, NATURE, V484, P333, DOI 10.1038/nature10986; del Pozo CH, 2011, BBA-MOL CELL BIOL L, V1811, P1194, DOI 10.1016/j.bbalip.2011.07.016; Iizuka K, 2004, P NATL ACAD SCI USA, V101, P7281, DOI 10.1073/pnas.0401516101; Iizuka K, 2006, AM J PHYSIOL-ENDOC M, V291, pE358, DOI 10.1152/ajpendo.00027.2006; Iizuka K, 2013, ENDOCR J, V60, P473; Janevski M, 2012, FOOD FUNCT, V3, P141, DOI 10.1039/c1fo10111k; Jeong YS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022544; Kabashima T, 2003, P NATL ACAD SCI USA, V100, P5107, DOI 10.1073/pnas.0730817100; Kooner JS, 2008, NAT GENET, V40, P149, DOI 10.1038/ng.2007.61; Kursawe R, 2013, DIABETES, V62, P837, DOI 10.2337/db12-0889; Letexier D, 2005, DIABETES METAB, V31, P558, DOI 10.1016/S1262-3636(07)70231-8; Li MV, 2010, BIOCHEM BIOPH RES CO, V395, P395, DOI 10.1016/j.bbrc.2010.04.028; Liu J, 2013, J DIABETES RES, V2013, DOI 10.1155/2013/585897; Ma L, 2006, J BIOL CHEM, V281, P28721, DOI 10.1074/jbc.M601576200; Mohan V, 2009, BRIT J NUTR, V102, P1498, DOI 10.1017/S0007114509990468; Nakagawa T, 2013, J BIOL CHEM, V288, P28358, DOI 10.1074/jbc.M113.498550; Nuotio-Antar AM, 2015, ENDOCRINOLOGY, V156, P4020, DOI 10.1210/en.2015-1210; Oliveira MC, 2013, OBESITY, V21, pE396, DOI [10.1002/oby.20230, 10.1038/oby.20230]; Oslowski CM, 2012, CELL METAB, V16, P265, DOI 10.1016/j.cmet.2012.07.005; Park MJ, 2014, J BIOL CHEM, V289, P13519, DOI 10.1074/jbc.M113.530139; Perry RJ, 2015, CELL, V160, P745, DOI 10.1016/j.cell.2015.01.012; Radhika G, 2009, EUR J CLIN NUTR, V63, P413, DOI 10.1038/sj.ejcn.1602951; Radhika G, 2011, PUBLIC HEALTH NUTR, V14, P591, DOI 10.1017/S136898001000203X; Radhika G, 2009, METABOLISM, V58, P675, DOI 10.1016/j.metabol.2009.01.008; RASTOGI GK, 1970, DIABETOLOGIA, V6, P445, DOI 10.1007/BF01212080; Sarrazy V, 2015, CELL REP, V13, P132, DOI 10.1016/j.celrep.2015.08.068; Schwarz JM, 1995, J CLIN INVEST, V96, P2735, DOI 10.1172/JCI118342; Shao JH, 2005, DIABETES, V54, P976, DOI 10.2337/diabetes.54.4.976; Shaw JE, 2010, DIABETES RES CLIN PR, V87, P4, DOI 10.1016/j.diabres.2009.10.007; Tang YF, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11365; Wang HY, 2002, J BIOL CHEM, V277, P32746, DOI 10.1074/jbc.M201635200; Willer CJ, 2008, NAT GENET, V40, P161, DOI 10.1038/ng.76; Wutthisathapornchai A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102730; Yamashita H, 2001, P NATL ACAD SCI USA, V98, P9116, DOI 10.1073/pnas.161284298; Yore MM, 2014, CELL, V159, P318, DOI 10.1016/j.cell.2014.09.035	50	8	8	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 19	2016	11	12							e0168797	10.1371/journal.pone.0168797	http://dx.doi.org/10.1371/journal.pone.0168797			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI9QC	27992582	Green Submitted, gold, Green Published			2022-12-27	WOS:000392842600099
J	Hundie, GB; Woldemeskel, D; Gessesse, A				Hundie, Gadissa Bedada; Woldemeskel, Dawit; Gessesse, Amare			Evaluation of Direct Colorimetric MTT Assay for Rapid Detection of Rifampicin and Isoniazid Resistance in Mycobacterium tuberculosis	PLOS ONE			English	Article							LOW-INCOME COUNTRIES; LINE PROBE ASSAY; MULTIDRUG-RESISTANT; XPERT(R) MTB/RIF; SUSCEPTIBILITY; DIAGNOSIS; GROWTH; SPECIMENS; PROGRAMS	With the spread of multidrug-resistant tuberculosis (MDR-TB) strains there is an increasing need for new accurate and cost-effective methods for a rapid diagnostic and drug susceptibility testing (DST), particularly in low-income countries where tuberculosis is hyperendemic. A colorimetric assay using 3-(4, 5-dimethylthiazol-2-yl)-2, 5-diphenyltetrazolium bromide (MTT) has been suggested as a promising method for DST, especially to rifampicin. In this study, we standardized and evaluated the MTT assay for a rapid direct detection of rifampicin and isoniazid resistant Mycobacterium tuberculosis strains from sputum specimens using Lowenstein-Jensen (LJ) culture medium as a gold standard. The MTT assay sensitivity, specificity, positive and negative predictive values for rifampicin were 100%, 86%, 100%, 99%, respectively. For isoniazid, the MTT assay had a 100% sensitivity, specificity, positive and negative predictive values. Interestingly, the MTT assay gave interpretable results within two weeks for 94% of the samples compared to 7-14 weeks for LJ media. Overall, an excellent agreement was observed between MTT assay and LJ proportion method (Kappa, 0.91 for rifampicin and 1.00 for isoniazid). In conclusion, the direct colorimetric MTT assay simultaneously detects susceptible and resistant strains of M. tuberculosis within three weeks. It significantly shortens the time required to obtain a DST result and could be a reliable alternative method for rapid detection of drug-resistant TB strains in high-TB-burden resource-limited settings.	[Hundie, Gadissa Bedada] Univ Addis Ababa, Coll Nat Sci, Dept Microbial Cellular & Mol Biol, Addis Ababa, Ethiopia; [Woldemeskel, Dawit; Gessesse, Amare] Univ Addis Ababa, Inst Biotechnol, Coll Nat Sci, Addis Ababa, Ethiopia; [Hundie, Gadissa Bedada] Erasmus MC, Dept Virosci, Rotterdam, Netherlands	Addis Ababa University; Addis Ababa University; Erasmus University Rotterdam; Erasmus MC	Hundie, GB (corresponding author), Univ Addis Ababa, Coll Nat Sci, Dept Microbial Cellular & Mol Biol, Addis Ababa, Ethiopia.; Hundie, GB (corresponding author), Erasmus MC, Dept Virosci, Rotterdam, Netherlands.	g.hundie@erasmusmc.nl	Hundie, Gadissa/GPF-9108-2022	Hundie, Gadissa/0000-0002-5627-9675				Abate G, 2004, J CLIN MICROBIOL, V42, P871, DOI 10.1128/JCM.42.2.871-873.2004; Abate G, 1998, INT J TUBERC LUNG D, V2, P1011; Ahmed MM, 2016, INT J MYCOBACT, V5, P249, DOI 10.1016/j.ijmyco.2016.08.008; [Anonymous], 2010, MULTIDRUG EXTENSIVEL; [Anonymous], 2008, 4 WHO; Arentz M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076533; Bhatter P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033507; CANETTI G, 1969, B WORLD HEALTH ORGAN, V41, P21; Coban AY, 2014, J CLIN MICROBIOL, V52, P15, DOI 10.1128/JCM.01990-13; Evans CA, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001064; Foongladda S, 2002, INT J TUBERC LUNG D, V6, P1118; Goloubeva V, 2001, J CLIN MICROBIOL, V39, P1501, DOI 10.1128/JCM.39.4.1501-1505.2001; Johansen IS, 2003, J CLIN MICROBIOL, V41, P4454, DOI 10.1128/JCM.41.9.4454-4456.2003; Jureen P, 2004, TUBERCULOSIS, V84, P311, DOI 10.1016/j.tube.2003.12.001; Lawn SD, 2011, FUTURE MICROBIOL, V6, P1067, DOI [10.2217/FMB.11.84, 10.2217/fmb.11.84]; Leung E, 2012, INT J TUBERC LUNG D, V16, P16, DOI 10.5588/ijtld.10.0065; Martin A, 2005, INT J TUBERC LUNG D, V9, P901; Montoro E, 2005, J ANTIMICROB CHEMOTH, V55, P500, DOI 10.1093/jac/dki023; Morcillo N, 2004, INT J TUBERC LUNG D, V8, P253; MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4; Mshana RN, J CLIN MICROBIOL; Palomino JC, 2005, EUR RESPIR J, V26, P339, DOI 10.1183/09031936.05.00050305; Parsons LM, 2002, J CLIN MICROBIOL, V40, P2339, DOI 10.1128/JCM.40.7.2339-2345.2002; Piatek AS, 2013, GLOB HEALTH-SCI PRAC, V1, P18, DOI 10.9745/GHSP-D-12-00004; Riello FN, 2016, BMC INFECT DIS, V16, DOI 10.1186/s12879-016-1474-6; Singh JA, 2011, INT J TUBERC LUNG D, V15, P1563, DOI 10.5588/ijtld.11.0728; Skenders G, 2005, EMERG INFECT DIS, V11, P1461, DOI 10.3201/eid1109.041236; Trebucq A, 2011, INT J TUBERC LUNG D, V15, P1567, DOI 10.5588/ijtld.11.0392; WHO, 2011, AUT REAL TIM NUCL AC; WHO, 2016, GLOB TUB REP	30	18	18	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2016	11	12							e0169188	10.1371/journal.pone.0169188	http://dx.doi.org/10.1371/journal.pone.0169188			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EG7JB	28030634	Green Published, Green Submitted, gold			2022-12-27	WOS:000391222000109
J	Sand, H; Eklund, A; Zimmermann, B; Wikenros, C; Wabakken, P				Sand, Hakan; Eklund, Ann; Zimmermann, Barbara; Wikenros, Camilla; Wabakken, Petter			Prey Selection of Scandinavian Wolves: Single Large or Several Small?	PLOS ONE			English	Article							BIALOWIEZA PRIMEVAL FOREST; GLACIER NATIONAL-PARK; WHITE-TAILED DEER; CANIS-LUPUS; KILL RATES; FUNCTIONAL-RESPONSE; WOLF PREDATION; SNOW DEPTH; ROE DEER; GROUP-SIZE	Research on large predator-prey interactions are often limited to the predators' primary prey, with the potential for prey switching in systems with multiple ungulate species rarely investigated. We evaluated wolf (Canis lupus) prey selection at two different spatial scales, i.e., inter- and intra-territorial, using data from 409 ungulate wolf-kills in an expanding wolf population in Scandinavia. This expansion includes a change from a one-prey into a two prey system with variable densities of one large-sized ungulate; moose (Aloes aloes) and one small-sized ungulate; roe deer (Capreolus capreolus). Among wolf territories, the proportion of roe deer in wolf kills was related to both pack size and roe deer density, but not to moose density. Pairs of wolves killed a higher proportion of roe deer than did packs, and wolves switched to kill more roe deer as their density increased above a 1:1 ratio in relation to the availability of the two species. At the intra-territorial level, wolves again responded to changes in roe deer density in their prey selection whereas we found no effect of snow depth, time during winter, or other predator-related factors on the wolves' choice to kill moose or roe deer. Moose population density was only weakly related to intra-territorial prey selection. Our results show that the functional response of wolves on moose, the species hitherto considered as the main prey, was strongly dependent on the density of a smaller, alternative, ungulate prey. The impact of wolf predation on the prey species community is therefore likely to change with the composition of the multi-prey species community along with the geographical expansion of the wolf population.	[Sand, Hakan; Eklund, Ann; Wikenros, Camilla] Swedish Univ Agr Sci, Dept Ecol, Grimso Wildlife Res Stn, Riddarhyttan, Sweden; [Zimmermann, Barbara; Wabakken, Petter] Hedmark Univ Appl Sci, Fac Appl Ecol & Agr Sci, Evenstad, Koppang, Norway	Swedish University of Agricultural Sciences	Sand, H (corresponding author), Swedish Univ Agr Sci, Dept Ecol, Grimso Wildlife Res Stn, Riddarhyttan, Sweden.	hakan.sand@slu.se	Zimmermann, Barbara/AAA-2631-2019	Zimmermann, Barbara/0000-0001-5133-9379; Sand, Hakan/0000-0002-2646-022X	Swedish Environmental Protection Agency; Norwegian Environment Agency; Norwegian Research Council; Norwegian Institute for Nature Research; Hedmark University of Applied Sciences; Office of Environmental Affairs in Hedmark County; Swedish Association for Hunting and Wildlife Management; Worldwide Fund for Nature (Sweden); Swedish University of Agricultural Sciences; Carl Tryggers Foundation; Marie-Claires Cronstedts Foundation; Swedish Carnivore Association	Swedish Environmental Protection Agency; Norwegian Environment Agency; Norwegian Research Council(Research Council of NorwayEuropean Commission); Norwegian Institute for Nature Research(Bioforsk); Hedmark University of Applied Sciences; Office of Environmental Affairs in Hedmark County; Swedish Association for Hunting and Wildlife Management; Worldwide Fund for Nature (Sweden); Swedish University of Agricultural Sciences; Carl Tryggers Foundation; Marie-Claires Cronstedts Foundation; Swedish Carnivore Association	The Scandinavian wolf projects (SKANDULV) have been primarily funded by the Swedish Environmental Protection Agency the Norwegian Environment Agency, the Norwegian Research Council, the Norwegian Institute for Nature Research, Hedmark University of Applied Sciences, the Office of Environmental Affairs in Hedmark County, the Swedish Association for Hunting and Wildlife Management, the Worldwide Fund for Nature (Sweden), and the Swedish University of Agricultural Sciences, Carl Tryggers Foundation, Marie-Claires Cronstedts Foundation, and the Swedish Carnivore Association.	Arnemo J. M., 2012, BIOMEDICAL PROTOCOLS; Aronson A, 2001, WOLF SCANDINAVIA STA; Becker MS, ECOLOGY MAMMALS CENT, P305; Bergman EJ, 2006, ECOL APPL, V16, P273, DOI 10.1890/04-1532; Burnham KP, 2004, SOCIOL METHOD RES, V33, P261, DOI 10.1177/0049124104268644; Cederlund G, 1998, EUROPEAN ROE DEER: THE BIOLOGY OF SUCCESS, P337; CEDERLUND GN, 1991, J WILDLIFE MANAGE, V55, P675, DOI 10.2307/3809517; Creel S., 2002, AFRICAN WILD DOG BEH; Cromhout M., 2006, THESIS; Dale B. W., 1995, ECOLOGY CONSERVATION, P223; DALE BW, 1994, J ANIM ECOL, V63, P644, DOI 10.2307/5230; ESRI (Environmental Systems Resource Institute), 2009, ARCMAP 9 3 1; FRYXELL JM, 1993, EVOL ECOL, V7, P379, DOI 10.1007/BF01237869; FULLER TK, 1991, CAN J ZOOL, V69, P283, DOI 10.1139/z91-044; Fuller Todd K., 2003, P161; Garrott RA, 2007, ECOL APPL, V17, P1588, DOI 10.1890/06-1439.1; Gervasi V, 2013, ECOL APPL, V23, P1722, DOI 10.1890/12-1615.1; Gervasi V, 2012, J ANIM ECOL, V81, P443, DOI 10.1111/j.1365-2656.2011.01928.x; Giraldeau L.-A., 2008, BEHAV ECOLOGY; Hegel TM, 2010, OIKOS, V119, P1453, DOI 10.1111/j.1600-0706.2010.18358.x; Holand O, 1998, EUROPEAN ROE DEER: THE BIOLOGY OF SUCCESS, P117; HOLLING C. S., 1959, CANADIAN ENT, V91, P293; HUGGARD DJ, 1993, CAN J ZOOL, V71, P140, DOI 10.1139/z93-020; HUGGARD DJ, 1993, CAN J ZOOL, V71, P130, DOI 10.1139/z93-019; JACOBS J, 1974, OECOLOGIA, V14, P413, DOI 10.1007/BF00384581; JEDRZEJEWSKI W, 1992, OECOLOGIA, V90, P27, DOI 10.1007/BF00317805; Jedrzejewski W, 2002, ECOLOGY, V83, P1341, DOI 10.2307/3071948; Jedrzejewski W, 2000, J MAMMAL, V81, P197, DOI 10.1644/1545-1542(2000)081&lt;0197:PSAPBW&gt;2.0.CO;2; Keech MA, 2011, J WILDLIFE MANAGE, V75, P1361, DOI 10.1002/jwmg.188; Kjellander P, 2004, OECOLOGIA, V139, P478, DOI 10.1007/s00442-004-1529-z; Koper Nicola, 2012, Rangifer, V32, P195; Krebs JR, 1978, BEHAV ECOLOGY EVOLUT; Kunkel K, 2001, J WILDLIFE MANAGE, V65, P520, DOI 10.2307/3803105; Kunkel KE, 2004, J WILDLIFE MANAGE, V68, P167, DOI 10.2193/0022-541X(2004)068[0167:FCWFBO]2.0.CO;2; Latham ADM, 2013, ECOGRAPHY, V36, P1276, DOI 10.1111/j.1600-0587.2013.00035.x; Liberg O, 2012, HYSTRIX, V23, P29, DOI 10.4404/hystrix-23.1-4670; Lone K, 2014, OIKOS, V123, P641, DOI 10.1111/j.1600-0706.2013.00938.x; MacNulty DR, 2012, BEHAV ECOL, V23, P75, DOI 10.1093/beheco/arr159; MacNulty DR, 2009, ECOL LETT, V12, P1347, DOI 10.1111/j.1461-0248.2009.01385.x; Mansson J, 2011, EUR J WILDLIFE RES, V57, P1017, DOI 10.1007/s10344-011-0512-3; Mattioli L, 2011, EUR J WILDLIFE RES, V57, P909, DOI 10.1007/s10344-011-0503-4; Mattisson J, 2013, OECOLOGIA, V173, P813, DOI 10.1007/s00442-013-2668-x; MESSIER F, 1994, ECOLOGY, V75, P478, DOI 10.2307/1939551; Messier Francois, 1995, Canadian Circumpolar Institute Occasional Publication, V35, P187; Metz MC, 2012, J ANIM ECOL, V81, P553, DOI 10.1111/j.1365-2656.2011.01945.x; Milanesi P, 2012, ETHOL ECOL EVOL, V24, P81, DOI 10.1080/03949370.2011.592220; MURDOCH WW, 1975, ECOLOGY, V56, P1094, DOI 10.2307/1936149; MURDOCH WW, 1969, ECOL MONOGR, V39, P335, DOI 10.2307/1942352; NEFF DJ, 1968, J WILDLIFE MANAGE, V32, P597, DOI 10.2307/3798941; NELSON ME, 1986, J WILDLIFE MANAGE, V50, P471, DOI 10.2307/3801108; Nicholson KL, 2008, CAN FIELD NAT, V122, P253, DOI 10.22621/cfn.v122i3.608; Nowak S, 2005, ACTA THERIOL, V50, P263, DOI 10.1007/BF03194489; Nowak S, 2011, MAMM BIOL, V76, P709, DOI 10.1016/j.mambio.2011.06.007; OATEN A, 1975, AM NAT, V109, P299, DOI 10.1086/282999; Ordiz A, 2015, ECOSPHERE, V6, DOI 10.1890/ES15-00243.1; Peterson Rolf O., 2003, P104; Renecker Lyle A., 1998, P403; Ronnegard L, 2008, WILDLIFE BIOL, V14, P358, DOI 10.2981/0909-6396(2008)14[358:EOFMUT]2.0.CO;2; Sand H, 2005, WILDLIFE SOC B, V33, P914, DOI 10.2193/0091-7648(2005)33[914:UGTAGC]2.0.CO;2; Sand H, 2012, CAN J ZOOL, V90, P403, DOI 10.1139/Z2012-007; Sand H, 2008, OECOLOGIA, V156, P53, DOI 10.1007/s00442-008-0969-2; Sand H, 2006, ANIM BEHAV, V72, P781, DOI 10.1016/j.anbehav.2005.11.030; Sand H, 2012, OIKOS, V121, P1454, DOI 10.1111/j.1600-0706.2012.20082.x; Schwartz Charles C., 1998, P441; Shultz S, 2010, BEHAV ECOL, V21, P1073, DOI 10.1093/beheco/arq108; Smith DW, 2004, J WILDLIFE MANAGE, V68, P153, DOI 10.2193/0022-541X(2004)068[0153:WPSAEO]2.0.CO;2; Stephens D.W., 1986, pi; Svensson L, WOLF SCANDINAVIA FIN; Taylor R.J., 1984, PREDATION; Vedin H., 1995, KLIMAT SJOAR VATTEND, P44; VINCENT JP, 1995, J ZOOL, V236, P371, DOI 10.1111/j.1469-7998.1995.tb02719.x; Vucetich JA, 2004, ANIM BEHAV, V67, P1117, DOI 10.1016/j.anbehav.2003.06.018; Vucetich JA, 2002, ECOLOGY, V83, P3003; Wabakken P, 2001, CAN J ZOOL, V79, P710, DOI 10.1139/cjz-79-4-710; Wagner C, 2012, MAMM BIOL, V77, P196, DOI 10.1016/j.mambio.2011.12.004; Wikenros C, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119957; Wikenros C, 2009, ACTA THERIOL, V54, P207, DOI 10.4098/j.at.0001-7051.082.2008; Zimmermann B, 2014, THESIS; Zimmermann B, 2007, J WILDLIFE MANAGE, V71, P1177, DOI 10.2193/2006-306; Zimmermann B, 2015, J ANIM ECOL, V84, P102, DOI 10.1111/1365-2656.12280	80	26	27	3	73	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2016	11	12							e0168062	10.1371/journal.pone.0168062	http://dx.doi.org/10.1371/journal.pone.0168062			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EG7JB	28030549	Green Submitted, Green Published, gold			2022-12-27	WOS:000391222000032
J	Cabral, L; Afreixo, V; Almeida, L; Paiva, JA				Cabral, Luis; Afreixo, Vera; Almeida, Luis; Paiva, Jose Artur			The Use of Procalcitonin (PCT) for Diagnosis of Sepsis in Burn Patients: A Meta-Analysis	PLOS ONE			English	Article							ANTIBIOTIC-THERAPY; SERUM PROCALCITONIN; ANTIMICROBIAL THERAPY; GUIDED ALGORITHMS; INFECTIONS; BACTEREMIA; INITIATION; INDICATOR; MARKERS; INJURY	The continuous development of resuscitation techniques and intensive care reduced the mortality rate induced by the initial shock in burn patients and, currently, infections (especially sepsis) are the main causes of mortality of these patients. The misuse of antimicrobial agents is strongly related to antimicrobial and adverse patient outcomes, development of microbial resistance and increased healthcare-related costs. To overcome these risks, antimicrobial stewardship is mandatory and biomarkers are useful to avoid unnecessary medical prescription, to monitor antimicrobial therapy and to support the decision of its stop. Among a large array of laboratory tests, procalcitonin (PCT) emerged as the leading biomarker to accurately and time-effectively indicate the presence of systemic infection. In the presence of systemic infection, PCT blood levels undergo a sudden and dramatic increase, following the course of the infection, and quickly subside after the control of the septic process. This work is a meta-analysis on PCT performance as a biomarker for sepsis. This meta analysis showed that overall pooled area under the curve (AUC) is 0.83 (95% Cl = 0.76 to 0.90); the estimated cut-off is 1.47 ng/m L. The overall sepsis effect in PCT levels is significant and strong (Cohen's d is 2.1 and 95% Cl = 1.1 to 3.2). This meta analysis showed PCT may be considered as a biomarker with a strong diagnostic ability to discriminate between the septic from the non-septic burn patients. Thus, this work encourages the determination of PCT levels in clinical practice for the management of these patients, in order to timely identify the susceptibility to sepsis and to initiate the antimicrobial therapy, improving the patients' outcomes.	[Cabral, Luis] CHUC, Dept Plast Surg, Coimbra, Portugal; [Cabral, Luis] CHUC, Burns Unit, Coimbra, Portugal; [Cabral, Luis] Univ Aveiro, SACS, Autonomous Sect Hlth Sci, Aveiro, Portugal; [Afreixo, Vera] Univ Aveiro, Ctr Res & Dev Math & Applicat, CIDMA, Aveiro, Portugal; [Afreixo, Vera] Univ Aveiro, Inst Biomed, iBiMED, Aveiro, Portugal; [Almeida, Luis; Paiva, Jose Artur] Univ Porto, Fac Med, Dept Pharmacol & Therapeut, Oporto, Portugal; [Paiva, Jose Artur] Ctr Hosp Sao Joao, Dept Emergency & Intens Care Med, Oporto, Portugal	Universidade de Coimbra; Universidade de Coimbra; Universidade de Aveiro; Universidade de Aveiro; Universidade de Aveiro; Universidade do Porto; Sao Joao Hospital	Cabral, L (corresponding author), CHUC, Dept Plast Surg, Coimbra, Portugal.; Cabral, L (corresponding author), CHUC, Burns Unit, Coimbra, Portugal.; Cabral, L (corresponding author), Univ Aveiro, SACS, Autonomous Sect Hlth Sci, Aveiro, Portugal.	jlacabral@gmail.com	Paiva, Jose-Artur/AAO-9730-2021; Cabral, Luis/A-8302-2017; Afreixo, Vera/H-8877-2012	Cabral, Luis/0000-0002-6820-5251; Almeida, Luis/0000-0002-4861-8649; Afreixo, Vera/0000-0003-1051-8084; Paiva, Jose-Artur/0000-0003-4323-0220				Abdel-Hafez N M, 2007, Ann Burns Fire Disasters, V20, P89; Angeletti Silvia, 2015, Dis Markers, V2015, P951532, DOI 10.1155/2015/951532; Angeletti S, 2015, APMIS, V123, P740, DOI 10.1111/apm.12406; Angeletti S, 2013, CLIN CHEM LAB MED, V51, P1059, DOI 10.1515/cclm-2012-0595; Appelgren P, 2002, BURNS, V28, P39, DOI 10.1016/S0305-4179(01)00070-5; ASSICOT M, 1993, LANCET, V341, P515, DOI 10.1016/0140-6736(93)90277-N; Barati M, 2008, BURNS, V34, P770, DOI 10.1016/j.burns.2008.01.014; Barques L, 2007, BURNS, V33, P860, DOI 10.1016/j.burns.2006.10.401; BATES DW, 1995, ARCH INTERN MED, V155, P593, DOI 10.1001/archinte.155.6.593; Bochud Pierre-Yves, 2004, Crit Care Med, V32, pS495, DOI 10.1097/01.CCM.0000143118.41100.14; Bognar Z, 2010, BURNS, V36, P1263, DOI 10.1016/j.burns.2010.04.006; BONE RC, 1992, CHEST, V101, P1644, DOI 10.1378/chest.101.6.1644; Bouadma L, 2010, LANCET, V375, P463, DOI 10.1016/S0140-6736(09)61879-1; Carsin H, 1997, BURNS, V23, P218, DOI 10.1016/S0305-4179(96)00124-6; Chipp E, 2010, ANN PLAS SURG, V65, P228, DOI 10.1097/SAP.0b013e3181c9c35c; Englert NC, 2015, CRIT CARE NURS Q, V38, P175, DOI 10.1097/CNQ.0000000000000059; Greenhalgh DG, 2007, J BURN CARE RES, V28, P776, DOI 10.1097/BCR.0b013e3181599bc9; HANLEY JA, 1982, RADIOLOGY, V143, P29, DOI 10.1148/radiology.143.1.7063747; Jensen JU, 2011, CRIT CARE MED, V39, P2048, DOI 10.1097/CCM.0b013e31821e8791; Kim HS, 2012, ANN CLIN LAB SCI, V42, P57; Kollef MH, 2001, ANN INTERN MED, V134, P298, DOI 10.7326/0003-4819-134-4-200102200-00014; Kopterides P, 2010, CRIT CARE MED, V38, P2229, DOI 10.1097/CCM.0b013e3181f17bf9; Kramer G.C., 2012, TOTAL BURN CARE, V4th ed., P103, DOI DOI 10.1016/B978-1-4377-2786-9.00008-4; Krishnan P, 2013, BURNS, V39, P583, DOI 10.1016/j.burns.2012.09.017; Kumar A, 2006, CRIT CARE MED, V34, P1589, DOI 10.1097/01.CCM.0000217961.75225.E9; Lavrentieva A, 2012, BURNS, V38, P356, DOI 10.1016/j.burns.2011.08.021; Lavrentieva A, 2007, BURNS, V33, P189, DOI 10.1016/j.burns.2006.07.001; Lee HL, 2014, INFECT CHEMOTHER, V46, P199, DOI [10.3947/ic.2014.46.3.199, 10.3947/ic.2014.46.1.1]; Levy MM, 2003, CRIT CARE MED, V31, P1250, DOI 10.1097/01.CCM.0000050454.01978.3B; Madenci OC, 2014, BURNS, V40, P664, DOI 10.1016/j.burns.2013.08.024; Mann EA, 2011, BURNS, V37, P549, DOI 10.1016/j.burns.2010.04.013; Matthaiou DK, 2012, INTENS CARE MED, V38, P940, DOI 10.1007/s00134-012-2563-7; Mehanic Snjezana, 2013, Mater Sociomed, V25, P277, DOI 10.5455/msm.2013.25.277-281; Neely AN, 2004, J BURN CARE REHABIL, V25, P76, DOI 10.1097/01.BCR.0000105095.94766.89; oueslati H., 2015, PROCALCITONIN DIAGNO, VXXVIII, P116; Paratz JD, 2014, CRIT CARE MED, V42, P2029, DOI 10.1097/CCM.0000000000000400; Pereira CT, 2016, J AM COLL SURGEONS, V202, P536; Quenot JP, 2013, ANN INTENSIVE CARE, V3, DOI 10.1186/2110-5820-3-21; Ren HT, 2015, BURNS, V41, P502, DOI 10.1016/j.burns.2014.08.019; Riedel S, 2011, AM J CLIN PATHOL, V135, P182, DOI 10.1309/AJCP1MFYINQLECV2; Sachse C, 1999, J BURN CARE REHABIL, V20, P354, DOI 10.1097/00004630-199909000-00004; Schuetz P, 2013, CURR OPIN CRIT CARE, V19, P453, DOI 10.1097/MCC.0b013e328363bd38; Schuetz Philipp, 2013, Evid Based Child Health, V8, P1297, DOI 10.1002/ebch.1927; Schuetz P, 2011, ARCH INTERN MED, V171, P1322, DOI 10.1001/archinternmed.2011.318; Schuetz P, 2009, JAMA-J AM MED ASSOC, V302, P1059, DOI 10.1001/jama.2009.1297; Seoane L, 2014, BURNS, V40, P223, DOI 10.1016/j.burns.2013.11.018; SHELBY J, 1987, J TRAUMA, V27, P213; Simon L, 2004, CLIN INFECT DIS, V39, P206, DOI 10.1086/421997; Uzzan B, 2006, CRIT CARE MED, V34, P1996, DOI 10.1097/01.CCM.0000226413.54364.36; von Heimburg D, 1998, BURNS, V24, P745, DOI 10.1016/S0305-4179(98)00109-0; Zamora Javier, 2006, BMC Med Res Methodol, V6, P31, DOI 10.1186/1471-2288-6-31	51	43	49	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2016	11	12							e0168475	10.1371/journal.pone.0168475	http://dx.doi.org/10.1371/journal.pone.0168475			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI9QH	28005932	Green Submitted, gold, Green Published			2022-12-27	WOS:000392843200058
J	Yamada, S; Hashizume, A; Hijikata, Y; Inagaki, T; Suzuki, K; Kondo, N; Kawai, K; Noda, S; Nakanishi, H; Banno, H; Hirakawa, A; Koike, H; Halievski, K; Jordan, CL; Katsuno, M; Sobue, G				Yamada, Shinichiro; Hashizume, Atsushi; Hijikata, Yasuhiro; Inagaki, Tomonori; Suzuki, Keisuke; Kondo, Naohide; Kawai, Kaori; Noda, Seiya; Nakanishi, Hirotaka; Banno, Haruhiko; Hirakawa, Akihiro; Koike, Haruki; Halievski, Katherine; Jordan, Cynthia L.; Katsuno, Masahisa; Sobue, Gen			Decreased Peak Expiratory Flow Associated with Muscle Fiber-Type Switching in Spinal and Bulbar Muscular Atrophy	PLoS One			English	Article							AMYOTROPHIC-LATERAL-SCLEROSIS; ACTIVATED PROTEIN-KINASE; ANDROGEN RECEPTOR GENE; SKELETAL-MUSCLE; CAG REPEAT; IIB FIBERS; FEATURES; SBMA; LARYNGOSPASM; CONTRACTILE	The aim of this study was to characterize the respiratory function profile of subjects with spinal and bulbar muscular atrophy (SBMA), and to explore the underlying pathological mechanism by comparing the clinical and biochemical indices of this disease with those of amyotrophic lateral sclerosis (ALS). We enrolled male subjects with SBMA (n = 40) and ALS (n = 25) along with 15 healthy control subjects, and assessed their respiratory function, motor function, and muscle strength. Predicted values of peak expiratory flow (%PEF) and forced vital capacity were decreased in subjects with SBMA compared with controls. In SBMA, both values were strongly correlated with the trunk subscores of the motor function tests and showed deterioration relative to disease duration. Compared with activities of daily living (ADL)-matched ALS subjects, %PEF, tongue pressure, and grip power were substantially decreased in subjects with SBMA. Both immunofluorescence and RT-PCR demonstrated a selective decrease in the expression levels of the genes encoding the myosin heavy chains specific to fast-twitch fibers in SBMA subjects. The mRNA levels of peroxisome proliferator-activated receptor gamma coactivator 1-alpha and peroxisome proliferator-activated receptor delta were up-regulated in SBMA compared with ALS and controls. In conclusion, %PEF is a disease-specific respiratory marker for the severity and progression of SBMA. Explosive muscle strength, including %PEF, was selectively affected in subjects with SBMA and was associated with activation of the mitochondrial biogenesis-related molecular pathway in skeletal muscles.	[Yamada, Shinichiro; Hashizume, Atsushi; Hijikata, Yasuhiro; Inagaki, Tomonori; Kondo, Naohide; Kawai, Kaori; Noda, Seiya; Nakanishi, Hirotaka; Banno, Haruhiko; Koike, Haruki; Katsuno, Masahisa; Sobue, Gen] Nagoya Univ, Grad Sch Med, Dept Neurol, Nagoya, Aichi, Japan; [Suzuki, Keisuke] Natl Ctr Geriatr & Gerontol, Innovat Ctr Clin Res, Obu, Japan; [Banno, Haruhiko] Nagoya Univ, Inst Adv Res, Nagoya, Aichi, Japan; [Hirakawa, Akihiro] Nagoya Univ, Grad Sch Med, Ctr Adv Med & Clin Res, Biostat Sect, Nagoya, Aichi, Japan; [Halievski, Katherine; Jordan, Cynthia L.] Michigan State Univ, Neurosci Program, E Lansing, MI 48824 USA; [Sobue, Gen] Nagoya Univ, Grad Sch Med, Res Div Dementia & Neurodegenerat Dis, Nagoya, Aichi, Japan	Nagoya University; National Center for Geriatrics & Gerontology; Nagoya University; Nagoya University; Michigan State University; Nagoya University	Katsuno, M; Sobue, G (corresponding author), Nagoya Univ, Grad Sch Med, Dept Neurol, Nagoya, Aichi, Japan.; Sobue, G (corresponding author), Nagoya Univ, Grad Sch Med, Res Div Dementia & Neurodegenerat Dis, Nagoya, Aichi, Japan.	ka2no@med.nagoya-u.ac.jp; sobueg@med.nagoya-u.ac.jp	Hirakawa, Akihiro/AAE-5936-2019; Banno, Haruhiko/AAN-4305-2021; Banno, Haruhiko/Q-1029-2015; Halievski, Katherine/AAA-1563-2022	Banno, Haruhiko/0000-0002-0404-3839; Banno, Haruhiko/0000-0002-0404-3839; Halievski, Katherine/0000-0003-0365-5953	KAKENHI grants from Japan Society for the Promotion of Science [26293206, 26670440, 15K15337, 16K15480]; Japan Agency for Medical Research and Development [15ek0109025, 15ek0109048]; KAKENHI grant from Japan Society for the Promotion of Science [26293206]; Japan Science and Technology Agency; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS045195] Funding Source: NIH RePORTER	KAKENHI grants from Japan Society for the Promotion of Science; Japan Agency for Medical Research and Development(Japan Agency for Medical Research and Development (AMED)); KAKENHI grant from Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Japan Science and Technology Agency(Japan Science & Technology Agency (JST)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	Dr. Katsuno received KAKENHI grants from Japan Society for the Promotion of Science (https://www.jsps.go.jp/) (Nos. 26293206, 26670440, 15K15337, and 16K15480) and grants from the Japan Agency for Medical Research and Development (http://www.amed.go.jp/) (Nos. 15ek0109025, 15ek0109048). Dr. Sobue received a KAKENHI grant from Japan Society for the Promotion of Science (https://www.jsps.go.jp/) (No. 26293206), grants from the Japan Agency for Medical Research and Development (http://www.amed.go.jp/) (Nos. 15ek0109025, 15ek0109048), and grants from the Japan Science and Technology Agency (https://www.jst.go.jp/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atsuta N, 2006, BRAIN, V129, P1446, DOI 10.1093/brain/awl096; BALDWIN ED, 1948, MEDICINE, V27, P243; BERGLUND E, 1963, ACTA MED SCAND, V173, P185; Bloemberg D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035273; Brooks BR, 2000, AMYOTROPH LATERAL SC, V1, P293, DOI 10.1080/146608200300079536; Dejager S, 2002, J CLIN ENDOCR METAB, V87, P3893, DOI 10.1210/jc.87.8.3893; DOYU M, 1992, ANN NEUROL, V32, P707, DOI 10.1002/ana.410320517; Fernandez-Rhodes LE, 2011, LANCET NEUROL, V10, P140, DOI 10.1016/S1474-4422(10)70321-5; Fratta P, 2014, NEUROLOGY, V82, P2077, DOI 10.1212/WNL.0000000000000507; Hashizume A, 2015, NEUROMUSCULAR DISORD, V25, P554, DOI 10.1016/j.nmd.2015.03.008; Hashizume A, 2012, BRAIN, V135, P2838, DOI 10.1093/brain/aws170; Katsuno M, 2012, PROG NEUROBIOL, V99, P246, DOI 10.1016/j.pneurobio.2012.05.007; Katsuno M, 2010, LANCET NEUROL, V9, P875, DOI 10.1016/S1474-4422(10)70182-4; KENNEDY WR, 1968, NEUROLOGY, V18, P671, DOI 10.1212/WNL.18.7.671; LASPADA AR, 1991, NATURE, V352, P77, DOI 10.1038/352077a0; Lin J, 2002, NATURE, V418, P797, DOI 10.1038/nature00904; Lo Coco D, 2006, NEUROLOGY, V67, P761, DOI 10.1212/01.wnl.0000227785.73714.64; Maeshima S, 2015, J NEUROL, V262, P1035, DOI 10.1007/s00415-015-7680-0; Mantilla CB, 2013, J APPL PHYSIOL, V114, P380, DOI 10.1152/japplphysiol.01122.2012; Mayer OH, 2015, PEDIATR PULM, V50, P487, DOI 10.1002/ppul.23172; Miller RG, 2009, NEUROLOGY, V73, P1218, DOI 10.1212/WNL.0b013e3181bc0141; Oki K, 2015, J APPL PHYSIOL, V118, P941, DOI 10.1152/japplphysiol.00886.2014; Oki K, 2013, MUSCLE NERVE, V47, P823, DOI 10.1002/mus.23813; Pedersen O F, 1997, Eur Respir J Suppl, V24, p9S; Ranganathan S, 2009, HUM MOL GENET, V18, P27, DOI 10.1093/hmg/ddn310; Rocchi A, 2016, ACTA NEUROPATHOL, V132, P127, DOI 10.1007/s00401-016-1550-4; Rockl KSC, 2007, DIABETES, V56, P2062, DOI 10.2337/db07-0255; Schiaffino S, 2011, PHYSIOL REV, V91, P1447, DOI 10.1152/physrev.00031.2010; Shen M, 2014, J CELL PHYSIOL, V229, P688, DOI 10.1002/jcp.24494; Sieck GC, 2013, COMPR PHYSIOL, V3, P1533, DOI 10.1002/cphy.c130003; SMERDU V, 1994, AM J PHYSIOL-CELL PH, V267, pC1723, DOI 10.1152/ajpcell.1994.267.6.C1723; Smith M, 2013, INT J EPIDEMIOL, V42, P803, DOI 10.1093/ije/dyt079; Soraru G, 2008, J NEUROL SCI, V264, P100, DOI 10.1016/j.jns.2007.08.012; Sperfeld AD, 2005, NEUROLOGY, V64, P753, DOI 10.1212/01.WNL.0000151978.74467.E7; Stevens L, 2008, NEUROPATH APPL NEURO, V34, P659, DOI 10.1111/j.1365-2990.2008.00950.x; Tanaka S, 2014, J NEUROL SCI, V337, P193, DOI 10.1016/j.jns.2013.12.010; Tzani P, 2014, EUR J PHYS REHAB MED, V50, P427; Wang AY, 1997, SPINAL CORD, V35, P299, DOI 10.1038/sj.sc.3100370; Wang YX, 2004, PLOS BIOL, V2, P1532, DOI 10.1371/journal.pbio.0020294	39	20	21	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2016	11	12							e0168846	10.1371/journal.pone.0168846	http://dx.doi.org/10.1371/journal.pone.0168846			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI9QH	28005993	Green Submitted, gold, Green Published			2022-12-27	WOS:000392843200104
J	Dovel, K; Yeatman, S; van Oosterhout, JJ; Chan, A; Mantengeni, A; Landes, M; Bedell, R; Kawalazira, G; Sodhi, S				Dovel, Kathryn; Yeatman, Sara; van Oosterhout, Joep J.; Chan, Adrienne; Mantengeni, Alfred; Landes, Megan; Bedell, Richard; Kawalazira, Gift; Sodhi, Sumeet			Trends in ART Initiation among Men and Non-Pregnant/Non-Breastfeeding Women before and after Option B plus in Southern Malawi	PLOS ONE			English	Article							TO-CHILD TRANSMISSION; ANTIRETROVIRAL THERAPY; HIV; CARE; PREVENTION; RETENTION; COMMUNITY; DISTRICT; AFRICA; RISK	Background Option B+ is promoted as a key component to eliminating vertical transmission of HIV; however, little is known about the policy's impact on non-targeted populations, such as men and non-pregnant/non-breastfeeding women. We compare ART uptake among non-targeted populations during pre/post Option B+ periods in Zomba District, Malawi. Methods Individual-level ART registry data from 27 health facilities were digitized and new-ART initiates were disaggregated by sex and type of initiate (Option B+ or not). Data were analyzed over the pre-(January 2009-June 2011) and post-(July 2011-December 2013) Option B+ periods. Results After the implementation of Option B+, the total number of new female initiates increased significantly (quarterly median: 547 vs. 816; P = 0.001) and their median age decreased from 34 to 31 years (P = <0.001). Both changes were the result of the rapid and sustained uptake of ART among Option B+ clients. Post-policy, Option B+ clients represented 48% of all new female initiates while the number of females who initiated through CD4 or WHO staging criteria significantly decreased (quarterly median: 547 vs. 419; P = 0.005). The number and age of male initiates remained stable; however, the proportion of men among new initiates decreased (36% vs. 31%; P = <0.001). Conclusions Option B+ shifted the profile of first-time initiates towards younger and fertile women. Declines among non-Option B+ women most likely reflect earlier initiation during pregnancies before deteriorations in health. The decreased proportion of men among first-time initiates represents a growing gender disparity in HIV services that deserves immediate attention.	[Dovel, Kathryn] Univ Calif Los Angeles, David Geffen Sch Med, Ctr World Hlth, Div Infect Dis, Los Angeles, CA 90095 USA; [Yeatman, Sara] Univ Colorado, Dept Hlth & Behav Sci, Denver, CO 80202 USA; [van Oosterhout, Joep J.] Univ Malawi, Dept Med, Coll Med, Blantyre, Malawi; [van Oosterhout, Joep J.; Chan, Adrienne; Mantengeni, Alfred; Landes, Megan; Bedell, Richard; Sodhi, Sumeet] Dignitas Int, Zomba, Malawi; [Chan, Adrienne; Landes, Megan; Sodhi, Sumeet] Univ Toronto, Dept Family & Community Med, Toronto, ON, Canada; [Chan, Adrienne] Univ Toronto, Div Infect Dis, Dept Med, Sunnybrook Hlth Sci Ctr, Toronto, ON, Canada; [Kawalazira, Gift] Minist Hlth, Dist Hlth Off, Zomba, Malawi; [Sodhi, Sumeet] Toronto Western Hosp, Univ Hlth Network, Dept Family & Community Med, Toronto, ON, Canada	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of Colorado System; University of Colorado Denver; University of Malawi; University of Toronto; University of Toronto; Sunnybrook Research Institute; University Toronto Affiliates; Sunnybrook Health Science Center; University of Toronto; University Toronto Affiliates; University Health Network Toronto	Dovel, K (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Ctr World Hlth, Div Infect Dis, Los Angeles, CA 90095 USA.	kdovel@mednet.ucla.edu	Bedell, Richard/AAC-2595-2020	Bedell, Richard/0000-0002-5687-8053; Yeatman, Sara/0000-0002-5991-6473	Canadian Institutes for Health Research under Grant HIV/AIDS Operating Grant; United States Agency for International Development [674-A-00-010-00034-00]; National Institute of Child Health and Human Development [R01-HD077873]; National Institute of Mental Health [F31-MH103078]	Canadian Institutes for Health Research under Grant HIV/AIDS Operating Grant(Canadian Institutes of Health Research (CIHR)); United States Agency for International Development(United States Agency for International Development (USAID)); National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This study was partially funded by the Canadian Institutes for Health Research under Grant HIV/AIDS Operating Grant 2010 and 2012, and the United States Agency for International Development under Grant 674-A-00-010-00034-00. Authors' time was supported by the National Institute of Child Health and Human Development under Grant R01-HD077873, and the National Institute of Mental Health under Grant F31-MH103078. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal M, 2013, PUBLIC HEALTH ACTION, V3, P175, DOI 10.5588/pha.12.0096; Bemelmans M, 2014, TROP MED INT HEALTH, V19, P968, DOI 10.1111/tmi.12332; Bor J, 2016, COMMUNICATION; Bor J, 2015, PLOS MED, V12, DOI 10.1371/journal.pmed.1001905; Bor J, 2013, SCIENCE, V339, P961, DOI 10.1126/science.1230413; CDC, 2011, MMWR-MORBID MORTAL W, V62, P148; Chan AK, 2010, TROP MED INT HEALTH, V15, P90, DOI 10.1111/j.1365-3156.2010.02503.x; Cohen MS, 2016, NEW ENGL J MED, V375, P830, DOI [10.1056/NEJMoa1600693, 10.1056/NEJMoa1105243]; Cornell M, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001304; Coutsoudis A, 2013, LANCET, V381, P269, DOI 10.1016/S0140-6736(12)61807-8; Dieffenbach CW, 2009, JAMA-J AM MED ASSOC, V301, P2380, DOI 10.1001/jama.2009.828; Doherty M, 2016, UPTAKE IMPLEMENTATIO; Dovel K, 2015, AIDS, V29, P1123, DOI 10.1097/QAD.0000000000000655; Estem KS, 2016, CURR HIV-AIDS REP, V13, P107, DOI 10.1007/s11904-016-0307-y; Granich RM, 2009, LANCET, V373, P48, DOI 10.1016/S0140-6736(08)61697-9; Haas AD, 2016, LANCET HIV, V3, pE175, DOI 10.1016/S2352-3018(16)00008-4; Hawkins C, 2011, AIDS, V25, P1189, DOI 10.1097/QAD.0b013e3283471deb; Hensen B, 2014, AIDS, V28, P2133, DOI 10.1097/QAD.0000000000000395; Kennedy CE, 2013, AIDS BEHAV, V17, P1571, DOI 10.1007/s10461-012-0241-y; Khanna AS, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134271; Kim MH, 2015, JAIDS-J ACQ IMM DEF, V70, P99, DOI 10.1097/QAI.0000000000000692; Lahuerta M, 2014, CLIN INFECT DIS, V58, P432, DOI 10.1093/cid/cit724; Lowrance D, 2007, TROP MED INT HEALTH, V12, P377, DOI 10.1111/j.1365-3156.2006.01800.x; Matheson R, 2015, J INT AIDS SOC, V18, P50, DOI 10.7448/IAS.18.6.20286; Ministry of Health Government of Malawi, 2008, TREATM AIDS GUID US; Ministry of Health Government of Malawi, 2011, CLIN MAN HIV CHILDR; Ministry of Health [Malawi], 2014, INT HIV PROGR REP JA; Ministry of Health [Malawi], 2011, INT HIV PROGR REP AP; Ministry of Health [Malawi], 2012, 2012 GLOB AIDS RESP; NSO & ORC Macro, 2011, MAL DEM HLTH SURV 20; Schouten EJ, 2011, LANCET, V378, P282, DOI 10.1016/S0140-6736(10)62303-3; Shaffer N, 2014, AIDS, V28, P599, DOI 10.1097/QAD.0000000000000144; Sharma M, 2015, NATURE, V528, pS77, DOI 10.1038/nature16044; Siedner MJ, 2015, CLIN INFECT DIS, V60, P1120, DOI 10.1093/cid/ciu1137; Staveteig S, 2013, DHS COMP REPORTS; Tanser F, 2013, SCIENCE, V339, P966, DOI 10.1126/science.1228160; Tenthani L, 2014, AIDS, V28, P589, DOI 10.1097/QAD.0000000000000143; The Interagency Task Team on the Prevention and Treatment of HIV Infection in Pregnant Women Mothers and Children (IATT), 2015, OPT B COUNTR PMTCT R; Van de Perre P, 2012, BMJ-BRIT MED J, V346, pf3767; van Lettow M, 2014, J INT AIDS SOC, V17, DOI 10.7448/IAS.17.1.18994; Venkatesh KK, 2011, JAIDS-J ACQ IMM DEF, V56, P151, DOI 10.1097/QAI.0b013e318202c82c; World Health Organization, 2015, GUID START ANT THER; Zachariah R, 2011, TROP MED INT HEALTH, V16, P37, DOI 10.1111/j.1365-3156.2010.02669.x	43	5	5	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2016	11	12							e0165025	10.1371/journal.pone.0165025	http://dx.doi.org/10.1371/journal.pone.0165025			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI9TW	28002413	Green Submitted, gold, Green Published			2022-12-27	WOS:000392853100002
J	Tan, XM; Xu, XP; Gao, Y; Yang, QM; Zhu, YS; Wang, JQ; Wan, FH; Zhou, HX				Tan, Xiumei; Xu, Xiuping; Gao, Yong; Yang, Qinmin; Zhu, Yunsheng; Wang, Jiqing; Wan, Fanghao; Zhou, Hongxu			Levels of Salivary Enzymes of Apolygus Lucorum (Hemiptera: Miridae), From 1st Instar Nymph to Adult, and Their Potential Relation to Bug Feeding	PLOS ONE			English	Article							INDUCED PLANT-RESPONSES; DIGESTIVE ENZYMES; STYLET MORPHOLOGY; LYGUS-HESPERUS; ALPHA-AMYLASE; BT COTTON; SUNN PEST; ADAPTATIONS; PROTEINS; APHIDS	In recent years, Apolygus lucorum has caused increasing damage to cotton and fruit trees in China. The salivary enzymes secreted by A. lucorum when sucking on host plants induce a series of biochemical reactions in plants, and the pre-oral digestion benefits the bug feeding. In this study, the food intake of A. lucorum from 1 st instar nymphs to adults was measured, and the corresponding salivary activity of pectinase, amylase, cellulase, protease, polyphenol oxidase and peroxidase was determined. Daily food intake varied with developmental stage, peaking in 3rd and 4 th instar nymphs. Pectinase, amylase, cellulase and protease were detected in both nymphal and adult saliva of A. lucorum, while neither polyphenol oxidase nor peroxidase was detected. Protease activity varied with food intake peaking at the 3rd-4th instar, and then slightly decreasing at the 5th instar. Levels of pectinase, amylase and cellulase increased significantly with the daily feeding level until the 3 rd instar, corresponding with increasing damage to host plants. The activity of both cellulase and protease had a significant linear relationship with the average daily food intake. The increasing activity of enzymes in saliva explain stage-specific impacts of A. lucorum on the host plants, and suggest that optimal management of A. lucorum would be confined to its control threshold prior to the peak of daily feeding in the 3rd instar.	[Tan, Xiumei; Xu, Xiuping; Gao, Yong; Zhu, Yunsheng; Wan, Fanghao; Zhou, Hongxu] Qingdao Agr Univ, Coll Agron & Plant Protect, Key Lab Integrated Crop Pest Management Shandong, Qingdao, Peoples R China; [Yang, Qinmin] Gen Stn Plant Protect Shandong Prov, Jinan, Peoples R China; [Wang, Jiqing] Qingdao Acad Agr Sci, Inst Plant Protect, Qingdao, Peoples R China; [Wan, Fanghao] Chinese Acad Agr Sci, Inst Plant Protect, State Key Lab Biol Plant Dis & Insect Pests, Beijing, Peoples R China	Qingdao Agricultural University; Chinese Academy of Agricultural Sciences; Institute of Plant Protection, CAAS	Zhou, HX (corresponding author), Qingdao Agr Univ, Coll Agron & Plant Protect, Key Lab Integrated Crop Pest Management Shandong, Qingdao, Peoples R China.	hxzhou@qau.edu.cn			National Key Research and Development Plan [2016YFC1201200]; Special Fund for Agro-scientific Research in the Public Interest [201103012]; Natural Science Foundation of Shandong Province [ZR2012CM018]; Taishan Mountain Scholar Constructive Engineering Foundation of Shandong Province	National Key Research and Development Plan; Special Fund for Agro-scientific Research in the Public Interest; Natural Science Foundation of Shandong Province(Natural Science Foundation of Shandong Province); Taishan Mountain Scholar Constructive Engineering Foundation of Shandong Province	This research was supported by the National Key Research and Development Plan (2016YFC1201200), the Special Fund for Agro-scientific Research in the Public Interest (201103012), the Natural Science Foundation of Shandong Province (ZR2012CM018) and the Taishan Mountain Scholar Constructive Engineering Foundation of Shandong Province. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAMS JB, 1963, CAN J ZOOLOG, V41, P1263, DOI 10.1139/z63-108; Adams JB, 1963, CAN J ZOOL, V41, P489; Agrawal AA, 2005, ENTOMOL EXP APPL, V115, P97, DOI 10.1111/j.1570-7458.2005.00294.x; Agusti N, 2000, J ENTOMOL SCI, V35, P176, DOI 10.18474/0749-8004-35.2.176; Bai LiXin, 2004, Jiangsu Journal of Agricultural Sciences, V20, P233; Boyd DW, 2003, ANN ENTOMOL SOC AM, V96, P667, DOI 10.1603/0013-8746(2003)096[0667:DEASMO]2.0.CO;2; Boyd DW, 2002, ANN ENTOMOL SOC AM, V95, P395, DOI 10.1603/0013-8746(2002)095[0395:DEASMO]2.0.CO;2; Chen Julian, 2000, Scientia Agricultura Sinica, V33, P54; Chen MS, 2004, INSECT MOL BIOL, V13, P101, DOI 10.1111/j.1365-2583.2004.00465.x; Chen Y.-n., 1988, Entomological Knowledge, V25, P235; Chen Z.-h., 1987, Entomological Knowledge, V24, P299; Cipollini D, 2003, BASIC APPL ECOL, V4, P79, DOI 10.1078/1439-1791-00134; Cohen AC, 1998, AM ENTOMOLOGIST  SUM, P103; Cohen Allen C., 1996, P1; Dicke M, 1999, HERBIVORES: BETWEEN PLANTS AND PREDATORS, P483; Fan GuangHua, 2009, Zhongguo Shengtai Nongye Xuebao / Chinese Journal of Eco-Agriculture, V17, P728; Geng Hui-Hui, 2012, Chinese Journal of Applied Entomology, V49, P601; Jiang X, 2010, SCI TECHNOLOGY FOOD, V5, P65; JIANG Y, 1993, PHYTOCHEMISTRY, V33, P29; Karban R, 1997, INDUCED RESPONSE HER; Kazzazi M., 2005, Communications in Agricultural and Applied Biological Sciences, V70, P863; Kazzazi M, 2005, ENTOMOL SCI, V8, P371, DOI 10.1111/j.1479-8298.2005.00137.x; Lian Mei-Xia, 2011, Chinese Journal of Applied Entomology, V48, P982; Lu YH, 2008, CROP PROT, V27, P465, DOI 10.1016/j.cropro.2007.07.017; Lu YH, 2010, SCIENCE, V328, P1151, DOI 10.1126/science.1187881; Lu Yanhui, 2008, Acta Phytophylacica Sinica, V35, P215; [罗礼智 Luo Lizhi], 2008, [植物保护, Plant Protection], V34, P32; Madhusudhan VV, 1994, THESIS, P81; Madhusudhan VV, 2008, ENTOMOL EXPERIMEN AP, V86, P25; MCALLAN JW, 1961, CAN J ZOOLOG, V39, P305, DOI 10.1139/z61-034; Mehrabadi M, 2014, CR BIOL, V337, P373, DOI 10.1016/j.crvi.2014.04.003; MILES P. W., 1965, J INSECT PHYSIOL, V11, P1261, DOI 10.1016/0022-1910(65)90119-8; Miles P.W., 1987, World Crop Pests, V2A, P321; MILES PW, 1991, ENTOMOL EXP APPL, V59, P123, DOI 10.1007/BF00351957; Peng Lu, 2010, Chinese Bulletin of Entomology, V47, P1017; Powell G, 2006, ANNU REV ENTOMOL, V51, P309, DOI 10.1146/annurev.ento.51.110104.151107; Rodriguez-Saona C, 2002, J CHEM ECOL, V28, P1733, DOI 10.1023/A:1020552932566; Shackel KA, 2005, ARCH INSECT BIOCHEM, V58, P69, DOI 10.1002/arch.20033; STRONG FE, 1968, J INSECT PHYSIOL, V14, P1113, DOI 10.1016/0022-1910(68)90050-4; TJALLINGII WF, 1993, PHYSIOL ENTOMOL, V18, P317, DOI 10.1111/j.1365-3032.1993.tb00604.x; Urbanska A, 1998, ENTOMOL EXP APPL, V86, P197, DOI 10.1023/A:1003119900578; Wang TL, 2008, FOOD MACHINERY, V3; Wang XM, 2007, SCI TECHNOLOGY FOOD, V5, P227; Yang YP, 2006, FOOD RES DEV, V3, P116; Yin Hai-Di, 2006, Acta Entomologica Sinica, V49, P843; Zangerl AR, 2003, BASIC APPL ECOL, V4, P91, DOI 10.1078/1439-1791-00135; Zeng F, 2000, COMP BIOCHEM PHYS A, V126, P101, DOI 10.1016/S1095-6433(00)00193-8; [张飞 Zhang Fei], 2004, [西北农业学报, Acat Agriculturae Boreali-Occidentalis Sinica], V13, P134; Zhang Guifen, 2008, Shengwu Duoyangxing, V16, P313, DOI 10.3724/SP.J.1003.2008.08050	49	7	7	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2016	11	12							e0168848	10.1371/journal.pone.0168848	http://dx.doi.org/10.1371/journal.pone.0168848			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI9TW	28002486	Green Submitted, Green Published, gold			2022-12-27	WOS:000392853100070
J	de Oliveira, RG; Guedes, DP				de Oliveira, Raphael Goncalves; Guedes, Dartagnan Pinto			Physical Activity, Sedentary Behavior, Cardiorespiratory Fitness and Metabolic Syndrome in Adolescents: Systematic Review and Meta-Analysis of Observational Evidence	PLOS ONE			English	Review							3RD NATIONAL-HEALTH; RISK-FACTORS; INSULIN-RESISTANCE; PREVALENCE; CHILDREN; ASSOCIATION; CRITERIA; TIME; DEFINITION	Background Metabolic syndrome (MetS) has been diagnosed in adolescents and among the associated factors are low levels of physical activity, sedentary behavior over long periods and low cardiorespiratory fitness. However, specifically in adolescents, studies present conflicting results. The aim of the present study was to conduct a systematic review and meta-analysis of observational studies, in order to map the association between physical activity, sedentary behavior, cardiorespiratory fitness and MetS in adolescents. Methods A search was performed in the databases PubMed, SPORTDiscus, LILACS and the Cochrane Library. For the meta-analysis, the odds ratio (OR) was calculated together with the respective confidence intervals (95% CI), in which the measures of effect were analyzed by dichotomous data (exposure variables) with MetS used as events. Results Eighteen studies were included in the meta-analysis. Primary analysis demonstrated that low levels of physical activity (OR = 1.35 [1.03 to 1.79]; p = 0.03) and low cardiorespiratory fitness (OR = 4.05 [2.09 to 7.87]; p < 0.01) were significantly associated with the development of MetS, while for sedentary behavior, represented by screen time > 2 hours/day, a significant association was not identified (OR = 1.20 [0.91 to 1.59]; p = 0.20). Subgroup analyses demonstrated that the association between low physical activity and MetS was dependent on the use of the accelerometry technique (OR = 2.93 [1.56 to 5.47]; p < 0.01). Screen time > 2 hours/day was significantly associated with MetS only on weekends (OR = 2.05 [1.13 to 3.73]; p = 0.02). With respect to cardiorespiratory fitness, a significant association with MetS was found independent of the maximal oxygen uptake (VO(2)max) measurement method. Conclusions Low levels of physical activity, low indices of cardiorespiratory fitness and sedentary behavior, represented by screen time > 2 hours/day on weekends, were significantly associated with the development of MetS in adolescence.	[de Oliveira, Raphael Goncalves; Guedes, Dartagnan Pinto] Univ Norte Parana UNOPAR, Ctr Pesquisa Ciencias Saude, Londrina, Parana, Brazil; [de Oliveira, Raphael Goncalves] UENP, Ctr Ciencias Saude, Jacarezinho, Parana, Brazil	University Norte Parana; Universidade Estadual do Norte do Parana (UENP)	de Oliveira, RG (corresponding author), Univ Norte Parana UNOPAR, Ctr Pesquisa Ciencias Saude, Londrina, Parana, Brazil.; de Oliveira, RG (corresponding author), UENP, Ctr Ciencias Saude, Jacarezinho, Parana, Brazil.	rgoliveira@uenp.edu.br	Guedes, Dartagnan Pinto/Q-2982-2019	Guedes, Dartagnan Pinto/0000-0002-7367-2276; Goncalves de Oliveira, Raphael/0000-0003-0904-9305	Fundacao Araucaria (FA); Secretaria de Estado da Ciencia, Tecnologia e Ensino Superior do Parana (SETI); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES), Brazil	Fundacao Araucaria (FA)(Fundacao Araucaria de Apoio ao Desenvolvimento Cientifico e Tecnologico do Estado do Parana FA); Secretaria de Estado da Ciencia, Tecnologia e Ensino Superior do Parana (SETI); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES), Brazil(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	A doctoral scholarship was granted to the author RGO by the Fundacao Araucaria (FA) for Support of Scientific and Technological Development of Parana, and the Secretaria de Estado da Ciencia, Tecnologia e Ensino Superior do Parana (SETI), in partnership with the Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES), Brazil.	Agudelo GM, 2014, METAB SYNDR RELAT D, V12, P202, DOI 10.1089/met.2013.0127; Bermudez-Cardona J, 2016, NUTRIENTS, V8, DOI 10.3390/nu8020054; Bland JM, 2000, BRIT MED J, V320, P1468, DOI 10.1136/bmj.320.7247.1468; Budak N, 2010, EUR J NUTR, V49, P219, DOI 10.1007/s00394-009-0066-2; CASPERSEN CJ, 1985, PUBLIC HEALTH REP, V100, P126; Cleeman JI, 2001, JAMA-J AM MED ASSOC, V285, P2486, DOI 10.1001/jama.285.19.2486; Cook S, 2003, ARCH PEDIAT ADOL MED, V157, P821, DOI 10.1001/archpedi.157.8.821; de Ferranti SD, 2004, CIRCULATION, V110, P2494, DOI 10.1161/01.CIR.0000145117.40114.C7; Downs SH, 1998, J EPIDEMIOL COMMUN H, V52, P377, DOI 10.1136/jech.52.6.377; Edwardson CL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034916; Ekelund U, 2009, AM J CLIN NUTR, V89, P90, DOI 10.3945/ajcn.2008.26649; Munera NE, 2012, BIOMEDICA, V32, P77, DOI 10.1590/S0120-41572012000100010; Ella NAA, 2010, J CLIN LIPIDOL, V4, P185, DOI 10.1016/j.jacl.2010.03.007; Fadzlina AA, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-S3-S7; Fam B, 2013, INT J PREVENTIVE MED, V4, P1011; Ford ES, 2007, CIRCULATION, V115, P2526, DOI 10.1161/CIRCULATIONAHA.106.657627; Guinhouya BC, 2011, INT J PEDIATR OBES, V6, P361, DOI 10.3109/17477166.2011.605896; He D, 2014, ENDOCRINE, V46, P231, DOI 10.1007/s12020-013-0110-0; Higgins JPT, COCHRANES HDB SYSTEM; Janssen I, 2007, DIABETES CARE, V30, P2143, DOI 10.2337/dc07-0734; Jolliffe CJ, 2007, J AM COLL CARDIOL, V49, P891, DOI 10.1016/j.jacc.2006.08.065; Kang HT, 2010, DIABETES RES CLIN PR, V89, P72, DOI 10.1016/j.diabres.2010.02.016; Katsiki N, 2014, CURR VASC PHARMACOL, V12, P627, DOI 10.2174/15701611113119990131; Kaur J, 2014, CARDIOL RES PRACT, V2014, DOI 10.1155/2014/943162; Kirk MA, 2011, AM J PREV MED, V40, P476, DOI 10.1016/j.amepre.2010.12.015; Laurson KR, 2015, RES Q EXERCISE SPORT, V86, pS13, DOI 10.1080/02701367.2015.1042800; Mark AE, 2008, J PUBLIC HEALTH-UK, V30, P153, DOI 10.1093/pubmed/fdn022; Mayorga-Vega D, 2015, J SPORT SCI MED, V14, P536; McMurray Robert G, 2008, Dyn Med, V7, P5, DOI 10.1186/1476-5918-7-5; Mehairi AE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056159; Mikolajczak Jolanta, 2011, Rocz Panstw Zakl Hig, V62, P83; Moher D., 2015, STATEMENT SYSTEMATIC, V4, DOI [10.1186/2046-4053-4-1, DOI 10.1186/2046-4053-4-12-S2.0-84920780781, DOI 10.14306/RENHYD.20.2.223]; Moher David, 2009, Ann Intern Med, V151, P264, DOI [10.1136/bmj.b2535, 10.1016/j.ijsu.2010.02.007]; Moreira C, 2010, METAB SYNDR RELAT D, V8, P443, DOI 10.1089/met.2010.0022; Nasuti G, 2013, ANN BEHAV MED, V45, P357, DOI 10.1007/s12160-012-9462-6; Nguyen THHD, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-141; Pan Y, 2008, J AM DIET ASSOC, V108, P276, DOI 10.1016/j.jada.2007.10.049; Pate RR, 2008, EXERC SPORT SCI REV, V36, P173, DOI 10.1097/JES.0b013e3181877d1a; Poyrazoglu S, 2014, CURR OPIN ENDOCRINOL, V21, P56, DOI 10.1097/01.med.0000436414.90240.2c; Rafraf M, 2014, PUBLIC HEALTH NUTR, V17, P803, DOI 10.1017/S1368980013003340; Rhodes RE, 2009, ANN BEHAV MED, V38, P180, DOI 10.1007/s12160-009-9147-y; Sirard JR, 2001, SPORTS MED, V31, P439, DOI 10.2165/00007256-200131060-00004; Sokka T, 2008, CLIN EXP RHEUMATOL, V26, pS35, DOI 10.1161/CIRCULATIONAHA.109.192644; Neto AS, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-674; Steele RM, 2008, J APPL PHYSIOL, V105, P342, DOI 10.1152/japplphysiol.00072.2008; Tavares LF, 2012, PUBLIC HEALTH NUTR, V15, P82, DOI 10.1017/S1368980011001571; Tremblay MS, 2011, INT J BEHAV NUTR PHY, V8, DOI 10.1186/1479-5868-8-98; Tremblay MS, 2011, APPL PHYSIOL NUTR ME, V36, P65, DOI 10.1139/H11-013; Troiano RP, 2008, MED SCI SPORT EXER, V40, P181, DOI 10.1249/mss.0b013e31815a51b3; Wilson PWF, 2005, CIRCULATION, V112, P3066, DOI 10.1161/CIRCULATIONAHA.105.539528; Yao CA, 2015, INT J BEHAV NUTR PHY, V12, DOI 10.1186/s12966-015-0163-y; You MA, 2012, ASIA-PAC J PUBLIC HE, V24, P464, DOI 10.1177/1010539511406105; Zimmet P, 2007, PEDIATR DIABETES, V8, P299, DOI 10.1111/j.1399-5448.2007.00271.x	53	71	72	1	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2016	11	12							e0168503	10.1371/journal.pone.0168503	http://dx.doi.org/10.1371/journal.pone.0168503			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EI9QF	27997601	Green Published, Green Submitted, gold			2022-12-27	WOS:000392842900052
J	Volgenant, CMC; Hoogenkamp, MA; Krom, BP; Janus, MM; ten Cate, JM; de Soet, JJ; Crielaard, W; van der Veen, MH				Volgenant, Catherine M. C.; Hoogenkamp, Michel A.; Krom, Bastiaan P.; Janus, Marleen M.; ten Cate, Jacob M.; de Soet, Johannes J.; Crielaard, Wim; van der Veen, Monique H.			Red and Green Fluorescence from Oral Biofilms	PLOS ONE			English	Article							LIGHT-INDUCED FLUORESCENCE; DENTAL MICROCOSM BIOFILM; STREPTOCOCCUS-MUTANS; CHAIN-LENGTH; AUTOFLUORESCENCE; GROWTH; QLF; LESIONS; PLAQUE	Red and green autofluorescence have been observed from dental plaque after excitation by blue light. It has been suggested that this red fluorescence is related to caries and the cariogenic potential of dental plaque. Recently, it was suggested that red fluorescence may be related to gingivitis. Little is known about green fluorescence from biofilms. Therefore, we assessed the dynamics of red and green fluorescence in real-time during biofilm formation. In addition, the fluorescence patterns of biofilm formed from saliva of eight different donors are described under simulated gingivitis and caries conditions. Biofilm formation was analysed for 12 hours under flow conditions in a microfluidic BioFlux flow system with high performance microscopy using a camera to allow live cell imaging. For fluorescence images dedicated excitation and emission filters were used. Both green and red fluorescence were linearly related with the total biomass of the biofilms. All biofilms displayed to some extent green and red fluorescence, with higher red and green fluorescence intensities from biofilms grown in the presence of serum (gingivitis simulation) as compared to the sucrose grown biofilms (cariogenic simulation). Remarkably, cocci with long chain lengths, presumably streptococci, were observed in the biofilms. Green and red fluorescence were not found homogeneously distributed within the biofilms: highly fluorescent spots (both green and red) were visible throughout the biomass. An increase in red fluorescence from the in vitro biofilms appeared to be related to the clinical inflammatory response of the respective saliva donors, which was previously assessed during an in vivo period of performing no-oral hygiene. The BioFlux model proved to be a reliable model to assess biofilm fluorescence. With this model, a prediction can be made whether a patient will be prone to the development of gingivitis or caries.	[Volgenant, Catherine M. C.; Hoogenkamp, Michel A.; Krom, Bastiaan P.; Janus, Marleen M.; ten Cate, Jacob M.; de Soet, Johannes J.; Crielaard, Wim; van der Veen, Monique H.] Univ Amsterdam, Acad Ctr Dent Amsterdam ACTA, Dept Prevent Dent, Amsterdam, Netherlands; [Volgenant, Catherine M. C.; Hoogenkamp, Michel A.; Krom, Bastiaan P.; Janus, Marleen M.; ten Cate, Jacob M.; de Soet, Johannes J.; Crielaard, Wim; van der Veen, Monique H.] Vrije Univ Amsterdam, Amsterdam, Netherlands; [Krom, Bastiaan P.; Janus, Marleen M.; Crielaard, Wim] Top Inst Food & Nutr, Wageningen, Netherlands	Academic Center for Dentistry Amsterdam; University of Amsterdam; Vrije Universiteit Amsterdam; Vrije Universiteit Amsterdam; Top Institute Food & Nutrition	Volgenant, CMC (corresponding author), Univ Amsterdam, Acad Ctr Dent Amsterdam ACTA, Dept Prevent Dent, Amsterdam, Netherlands.; Volgenant, CMC (corresponding author), Vrije Univ Amsterdam, Amsterdam, Netherlands.	c.volgenant@acta.nl	Volgenant, Catherine/AAT-7868-2020; van der Veen, Monique H/B-3719-2014; Krom, Bastiaan/ABC-7026-2020	Volgenant, Catherine/0000-0002-4049-2914; Krom, Bastiaan/0000-0002-1497-1161	Dutch Technology Foundation STW [10948]; Inspektor Research Systems BV, the Netherlands; Top Institute Food and Nutrition (TIFN); NWO Earth and Life Sciences (ALW) [834.13.006]	Dutch Technology Foundation STW(Technologiestichting STW); Inspektor Research Systems BV, the Netherlands(Netherlands Government); Top Institute Food and Nutrition (TIFN); NWO Earth and Life Sciences (ALW)	This research was supported by the Dutch Technology Foundation STW (http://www.stw.nl/en/, project number 10948) and Inspektor Research Systems BV, the Netherlands (http://www.inspektor.nl/). The used saliva samples were obtained as part of a clinical trial [16], which was supported by the Top Institute Food and Nutrition (TIFN; http://www.tifn.nl/). TIFN is a public-private partnership on precompetitive research in food and nutrition. Purchase of the BioFlux Z1000 setup was (partially) funded by NWO Earth and Life Sciences (ALW; http://www.nwo.nl/en), project 834.13.006. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Khateeb S, 1998, AM J ORTHOD DENTOFAC, V113, P595; Ammann TW, 2012, BMC MICROBIOL, V12, P1; Belda-Ferre P, 2012, ISME J, V6, P46, DOI 10.1038/ismej.2011.85; Benedict H C, 1928, Science, V67, P442, DOI 10.1126/science.67.1739.442; Benoit MR, 2010, APPL ENVIRON MICROB, V76, P4136, DOI 10.1128/AEM.03065-09; Billinton N, 2001, ANAL BIOCHEM, V291, P175, DOI 10.1006/abio.2000.5006; Bittar DG, 2014, J BIOMED OPT, V19, DOI 10.1117/1.JBO.19.6.065004; Buchalla W, 2004, J PERIODONTAL RES, V39, P327, DOI 10.1111/j.1600-0765.2004.00747.x; DaCosta RS, 2003, PHOTOCHEM PHOTOBIOL, V78, P384, DOI 10.1562/0031-8655(2003)078<0384:MFEMRT>2.0.CO;2; de Veld DCG, 2003, LASER SURG MED, V32, P367, DOI 10.1002/lsm.10185; Deng DM, 2004, CARIES RES, V38, P54, DOI 10.1159/000073921; EKSTEDT RD, 1960, J EXP MED, V112, P671, DOI 10.1084/jem.112.4.671; Exterkate RAM, 2010, CARIES RES, V44, P372, DOI 10.1159/000316541; FELLNER MJ, 1976, ARCH DERMATOL, V112, P667, DOI 10.1001/archderm.112.5.667; Hajishengallis G, 2014, TRENDS IMMUNOL, V35, P3, DOI 10.1016/j.it.2013.09.001; Heinrich-Weltzien R, 2003, QUINTESSENCE INT, V34, P181; IACONO VJ, 1985, J DENT RES, V64, P48, DOI 10.1177/00220345850640010901; Janus MM, 2015, BIOFOULING, V31, P503, DOI 10.1080/08927014.2015.1067887; Kim YS, 2014, J DENT, V42, P691, DOI 10.1016/j.jdent.2014.03.006; Koenig K., 1994, P SOC PHOTO-OPT INS, V2135, P129; Koenig K., 1993, PROC SPIE, V2080, P170; Lee ES, 2013, J DENT, V41, P1264, DOI 10.1016/j.jdent.2013.08.021; Lennon AM, 2006, CARIES RES, V40, P2, DOI 10.1159/000088898; LOE H, 1965, J PERIODONTOL, V36, P177, DOI 10.1902/jop.1965.36.3.177; Marsh P D, 1994, Adv Dent Res, V8, P263; Mukherjee S, 1985, J Periodontol, V56, P22, DOI 10.1902/jop.1985.56.11s.22; MURCHISON H, 1982, INFECT IMMUN, V38, P282, DOI 10.1128/IAI.38.1.282-291.1982; Peterson SN, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058487; Schneckenburger H., 1994, PROC SPIE, V2128, P403; Shigetani Y, 2008, ODONTOLOGY, V96, P21, DOI 10.1007/s10266-007-0077-5; SHIZUKUISHI S, 1995, FEMS MICROBIOL LETT, V131, P313; Simon-Soro A, 2015, TRENDS MICROBIOL, V23, P76, DOI 10.1016/j.tim.2014.10.010; Stubel, 1911, FLUORESZENZ TIERISCH, P1; Van der Veen MH, 2006, CARIES RES, V40, P542, DOI 10.1159/000095655; van der Veen MH, 2000, MONOGR ORAL SCI, V17, P144; van der Veen MH, 2016, J DENT, V48, P71, DOI 10.1016/j.jdent.2016.02.010; VANDERWEIJDEN GA, 1994, J CLIN PERIODONTOL, V21, P589; vanRaamsdonk M, 1997, CARIES RES, V31, P35, DOI 10.1159/000262371; Volgenant CMC, 2016, J ORAL MICROBIOL, V8, DOI 10.3402/jom.v8.30346; Volgenant CMC, 2013, EUR J ORAL SCI, V121, P156, DOI 10.1111/eos.12045; Volgenant CMC, 2016, CLIN ORAL INVEST, P1, DOI [10.1007/s00784-015-1547-8, DOI 10.1007/S00784-015-1547-8]; WIBAWAN IWT, 1993, J VET MED B, V40, P430, DOI 10.1111/j.1439-0450.1993.tb00160.x	42	12	13	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2016	11	12							e0168428	10.1371/journal.pone.0168428	http://dx.doi.org/10.1371/journal.pone.0168428			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI9QF	27997567	Green Submitted, Green Published, gold			2022-12-27	WOS:000392842900043
J	Alsnes, IV; Janszky, I; Asvold, BO; Okland, I; Forman, MR; Vatten, LJ				Alsnes, Ingvild V.; Janszky, Imre; Asvold, Bjorn O.; Okland, Inger; Forman, Michele R.; Vatten, Lars J.			Maternal Preeclampsia and Androgens in the Offspring around Puberty: A Follow-Up Study	PLOS ONE			English	Article							12-YEAR-OLD CHILDREN BORN; BREAST-CANCER; RISK-FACTORS; GESTATIONAL HYPERTENSION; PREMATURE ADRENARCHE; BLOOD-PRESSURE; HORMONE-LEVELS; BODY-SIZE; PREGNANCY; WOMEN	Background Children born after preeclampsia may have a dominant androgen profile in puberty compared with other children. Circulating androgen concentrations at 11-12 years of age were compared between offspring born after preeclampsia, and children whose mothers did not have preeclampsia. Methods A total of 611 mother-offspring pairs were followed up 11 (daughters) or 12 (sons) years after birth:218 pairs in the preeclampsia group, and 383 pairs without preeclampsia. Circulating total testosterone, androstenedione, dehydroepiandrosterone sulfate (DHEAS), and insulin-like growth factor I (IGF-I) were measured in the children. In boys, testicular volume was also measured. Results Among girls born after preeclampsia, DHEAS concentrations were higher than in unexposed girls (p<0.001), however, girls born after preeclampsia with severe features had the lowest DHEAS levels. In contrast, testosterone concentrations were highest in girls born after preeclampsia with severe features, both compared to other girls in the preeclampsia group, and compared to unexposed girls (p<0.001). For boys, testosterone concentrations were higher in the preeclampsia group compared with unexposed boys (p< 0.001), and boys born after preeclampsia with severe features had the lowest concentrations of DHEAS. Compared with unexposed boys, testicular volume (p = 0.015) and IGF-I (p = 0.004) were higher for boys in the preeclampsia group, except for boys in the clinically severe preeclampsia group. Conclusions In utero exposure to preeclampsia is associated with androgen hormonal patterns in early puberty that depend on clinical severity of preeclampsia and sex of the offspring. The hormonal differences may reflect different timing of pubertal development, and may have consequences for future health of the offspring.	[Alsnes, Ingvild V.; Okland, Inger] Stavanger Univ Hosp, Dept Obstet & Gynecol, Stavanger, Norway; [Alsnes, Ingvild V.; Janszky, Imre; Asvold, Bjorn O.; Vatten, Lars J.] NTNU Norwegian Univ Sci & Technol, Fac Med, Dept Publ Hlth, Trondheim, Norway; [Asvold, Bjorn O.] Univ Trondheim Hosp, St Olavs Hosp, Dept Endocrinol, Trondheim, Norway; [Forman, Michele R.] Univ Texas Austin, Dept Nutr Sci, Austin, TX 78712 USA	Stavanger University Hospital; Norwegian University of Science & Technology (NTNU); Norwegian University of Science & Technology (NTNU); University of Texas System; University of Texas Austin	Alsnes, IV (corresponding author), Stavanger Univ Hosp, Dept Obstet & Gynecol, Stavanger, Norway.; Alsnes, IV (corresponding author), NTNU Norwegian Univ Sci & Technol, Fac Med, Dept Publ Hlth, Trondheim, Norway.	ingvild.vatten@gmail.com	Vatten, Lars/AAF-9380-2022; Vatten, Lars/AFK-2073-2022	Alsnes, Ingvild Vatten/0000-0002-2136-6664	Stavanger University Hospital; Norwegian University of Science and Technology; Norwegian Research Council	Stavanger University Hospital; Norwegian University of Science and Technology; Norwegian Research Council(Research Council of NorwayEuropean Commission)	This study was supported by grants from Stavanger University Hospital, the Norwegian University of Science and Technology, and the Norwegian Research Council (IVA). These institutions had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alsnes IV, 2014, AM J OBSTET GYNECOL, V211, DOI 10.1016/j.ajog.2014.06.026; Ananth CV, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f6564; Auchus RJ, 2004, CLIN ENDOCRINOL, V60, P288, DOI 10.1046/j.1365-2265.2003.01858.x; Bellamy L, 2007, BMJ-BRIT MED J, V335, P974, DOI 10.1136/bmj.39335.385301.BE; BEROYZ G, 1994, LANCET, V343, P619; Biro FM, 2003, J PEDIATR-US, V142, P643, DOI 10.1067/mpd.2003.244; Davis EF, 2012, PEDIATRICS, V129, pE1552, DOI 10.1542/peds.2011-3093; Ferreira I, 2009, J HYPERTENS, V27, P1955, DOI 10.1097/HJH.0b013e328331b8c6; Forman MR, 2005, CANCER INVEST, V23, P609, DOI 10.1080/07357900500283093; Giles GG, 2003, INT J CANCER, V103, P241, DOI 10.1002/ijc.10810; Goede J, 2011, HORM RES PAEDIAT, V76, P56, DOI 10.1159/000326057; Holl K, 2009, INT J CANCER, V124, P2923, DOI 10.1002/ijc.24312; Ibanez L, 2000, ENDOCR REV, V21, P671, DOI 10.1210/er.21.6.671; Idkowiak J, 2011, EUR J ENDOCRINOL, V165, P189, DOI 10.1530/EJE-11-0223; Juul A, 2011, ARCH DIS CHILD, V96, P703, DOI 10.1136/adc.2010.202028; Kajantie E, 2008, HORM-INT J ENDOCRINO, V7, P101, DOI 10.1007/BF03401501; Kim JS, 2013, ACTA ONCOL, V52, P1643, DOI 10.3109/0284186X.2012.750033; Laivuori H, 1998, J CLIN ENDOCR METAB, V83, P344, DOI 10.1210/jc.83.2.344; Lisonkova S, 2013, AM J OBSTET GYNECOL, V209, DOI 10.1016/j.ajog.2013.08.019; MARSHALL WA, 1969, ARCH DIS CHILD, V44, P291, DOI 10.1136/adc.44.235.291; MARSHALL WA, 1970, ARCH DIS CHILD, V45, P13, DOI 10.1136/adc.45.239.13; Mouritsen A, 2015, CLIN CHIM ACTA, V450, P370, DOI 10.1016/j.cca.2015.09.020; Mouritsen A, 2013, EUR J ENDOCRINOL, V168, P129, DOI 10.1530/EJE-12-0191; Nechuta S, 2010, CANCER CAUSE CONTROL, V21, P967, DOI 10.1007/s10552-010-9524-7; Odegard RA, 2000, OBSTET GYNECOL, V96, P950, DOI 10.1016/S0029-7844(00)01040-1; Odegard RA, 2000, BRIT J OBSTET GYNAEC, V107, P1410, DOI 10.1111/j.1471-0528.2000.tb11657.x; Ogland B, 2009, ARCH DIS CHILD, V94, P855, DOI 10.1136/adc.2008.150870; Ogland B, 2011, ARCH DIS CHILD, V96, P740, DOI 10.1136/adc.2009.178434; Ogland B, 2010, HORM RES PAEDIAT, V74, P92, DOI 10.1159/000313376; Opdahl S, 2008, BRIT J CANCER, V99, P201, DOI 10.1038/sj.bjc.6604449; Opdahl S, 2012, BRIT J CANCER, V107, P176, DOI 10.1038/bjc.2012.195; Pettersson A, 2008, CANCER RES, V68, P8832, DOI 10.1158/0008-5472.CAN-08-2309; Rich-Edwards JW, 2014, EPIDEMIOL REV, V36, P57, DOI 10.1093/epirev/mxt006; Roberts CL, 2011, BMJ OPEN, V1, DOI 10.1136/bmjopen-2011-000101; Ruder EH, 2010, CANCER CAUSE CONTROL, V21, P1379, DOI 10.1007/s10552-010-9565-y; Sharifzadeh F, 2012, GYNECOL ENDOCRINOL, V28, P834, DOI 10.3109/09513590.2012.683061; Tenhola S, 2003, J CLIN ENDOCR METAB, V88, P1217, DOI 10.1210/jc.2002-020903; Tenhola S, 2002, J PEDIATR-US, V141, P477, DOI 10.1067/mpd.2002.126923; Troisi R, 2003, INT J EPIDEMIOL, V32, P455, DOI 10.1093/ije/dyg094; Troisi R, 2007, CANCER EPIDEM BIOMAR, V16, P1700, DOI 10.1158/1055-9965.EPI-07-0073; Valensise H, 2008, HYPERTENSION, V52, P873, DOI 10.1161/HYPERTENSIONAHA.108.117358; van der Merwe JL, 2010, HYPERTENS PREGNANCY, V29, P457, DOI 10.3109/10641950903572282; Villar J, 2006, AM J OBSTET GYNECOL, V194, P921, DOI 10.1016/j.ajog.2005.10.813; Xue F, 2007, LANCET ONCOL, V8, P1088, DOI 10.1016/S1470-2045(07)70377-7	44	10	10	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 19	2016	11	12							e0167714	10.1371/journal.pone.0167714	http://dx.doi.org/10.1371/journal.pone.0167714			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI9QC	27992610	Green Published, Green Submitted, gold			2022-12-27	WOS:000392842600020
J	Hansen, S; Schafer, J; Fechner, K; Czerny, CP; Abd El Wahed, A				Hansen, Soeren; Schaefer, Jenny; Fechner, Kim; Czerny, Claus-Peter; Abd El Wahed, Ahmed			Development of a Recombinase Polymerase Amplification Assay for Rapid Detection of the Mycobacterium avium subsp paratuberculosis	PLoS One			English	Article							CROHNS-DISEASE; DNA; PREVALENCE; SAMPLES; IS900; SHEEP	Background The detection of Mycobacterium avium subsp. paratuberculosis (MAP) infections in ruminants is crucial to control spread among animals and to humans. Cultivation of MAP is seen as the gold standard for detection, although it is very time consuming and labour intensive. In addition, several PCR assays have been developed to detect MAP in around 90 minutes, but these assays required highly sophisticated equipment as well as lengthy and complicated procedure. Methodology/Principal Findings In this study, we have developed a rapid assay for the detection of MAP based on the recombinase polymerase amplification (RPA) assay targeting a MAP specific region, the IS900 gene. The detection limit was 16 DNA molecules in 15 minutes as determined by the probit analysis on eight runs of the plasmid standard. Cross reactivity with other mycobacterial and environmentally associated bacterial strains was not observed. The clinical performance of the MAP RPA assay was tested using 48 MAP-positive and 20 MAP-negative blood, sperm, faecal and tissue samples. All results were compared with reads of a highly sensitive real-time PCR assay. The specificity of the MAP RPA assay was 100%, while the sensitivity was 89.5%. Conclusions/Significance The RPA assay is quicker and much easier to handle than real-time PCR. All RPA reagents were cold-chain independent. Moreover, combining RPA assay with a simple extraction protocol will maximize its use at point of need for rapid detection of MAP.	[Hansen, Soeren; Schaefer, Jenny; Fechner, Kim; Czerny, Claus-Peter; Abd El Wahed, Ahmed] Georg August Univ, Div Microbiol & Anim Hyg, Inst Vet Med, Dept Anim Sci,Fac Agr Sci, Gottingen, Germany	University of Gottingen	Abd El Wahed, A (corresponding author), Georg August Univ, Div Microbiol & Anim Hyg, Inst Vet Med, Dept Anim Sci,Fac Agr Sci, Gottingen, Germany.	abdelwahed@gwdg.de						Angelidou E, 2016, PREV VET MED, V124, P102, DOI 10.1016/j.prevetmed.2015.12.011; Benedictus A, 2008, PREV VET MED, V83, P215, DOI 10.1016/j.prevetmed.2007.07.008; Boyle DS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103091; Cheng J, 2005, WORLD J MICROB BIOT, V21, P1175, DOI 10.1007/s11274-005-0809-z; Chi J, 2002, PREV VET MED, V55, P137, DOI 10.1016/S0167-5877(02)00094-6; Daher R., 2015, RECOMBINASE POLYMERA; Daher RK, 2014, CLIN CHEM, V60, P660, DOI 10.1373/clinchem.2013.213504; Dalziel TK., 1913, BRIT MED J, V2; Enosawa M, 2003, J CLIN MICROBIOL, V41, P4359, DOI 10.1128/JCM.41.9.4359-4365.2003; Fechner K, 2015, TRANSBOUNDARY EMERGI; Knosel T, 2009, PATHOL RES PRACT, V205, P223, DOI 10.1016/j.prp.2008.04.018; Lutz S, 2010, LAB CHIP, V10, P887, DOI 10.1039/b921140c; Manning EJB, 2001, REV SCI TECH OIE, V20, P133, DOI 10.20506/rst.20.1.1275; Mendoza JL, 2010, WORLD J GASTROENTERO, V16, P4558, DOI 10.3748/wjg.v16.i36.4558; Mobius P, 2008, VET MICROBIOL, V126, P324, DOI 10.1016/j.vetmic.2007.07.016; Munster P, 2011, VET MICROBIOL, V154, P197, DOI 10.1016/j.vetmic.2011.06.033; Patil KN, 2011, BIOCHEMISTRY-US, V50, P300, DOI 10.1021/bi1018013; Piepenburg O, 2006, PLOS BIOL, V4, P1115, DOI 10.1371/journal.pbio.0040204; Plain KM, 2014, J CLIN MICROBIOL, V52, P745, DOI 10.1128/JCM.03233-13; Ren H, 2016, MOL CELL PROBE, V30, P122, DOI 10.1016/j.mcp.2016.02.007; Rohrman B, 2015, ANAL CHEM, V87, P1963, DOI 10.1021/ac504365v; Vansnick E, 2004, VET MICROBIOL, V100, P197, DOI 10.1016/j.vetmic.2004.02.006; WEISBURG WG, 1991, J BACTERIOL, V173, P697, DOI 10.1128/JB.173.2.697-703.1991; Zhong CY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016025	24	19	20	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 19	2016	11	12							e0168733	10.1371/journal.pone.0168733	http://dx.doi.org/10.1371/journal.pone.0168733			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI9QC	27992571	gold, Green Submitted, Green Published			2022-12-27	WOS:000392842600095
J	Kotov, AA; Karabanov, DP; Bekker, EI; Neretina, TV; Taylor, DJ				Kotov, Alexey A.; Karabanov, Dmitry P.; Bekker, Eugeniya I.; Neretina, Tatiana V.; Taylor, Derek J.			Phylogeography of the Chydorus sphaericus Group (Cladocera: Chydoridae) in the Northern Palearctic	PLOS ONE			English	Article							POPULATION-GROWTH; SPECIES CLADOCERA; DAPHNIA-MAGNA; N-SP; CRUSTACEA; ANOMOPODA; BRANCHIOPODA; ORIGIN; GENUS; DIVERSIFICATION	The biodiversity and the biogeography are still poorly understood for freshwater invertebrates. The crustacean Chydorus sphaericus-brevilabris complex (Cladocera: Chydoridae) is composed of species that are important components of Holarctic freshwater food webs. Recent morphological and genetic study of the complex has indicated a substantial species diversity in the northern hemisphere. However, we know little of the geographic boundaries of these novel lineages. Moreover, a large section of the Palearctic remains unexamined at the genetic level. Here we attempt to address the biodiversity knowledge gap for the Chydorus sphaericus group in the central Palearctic and assess its diversity and biogeographic boundaries. We sequenced nuclear (ITS-2) and mitochondrial (COI) gene regions of Chydorus specimens across the Palearctic and compared them with already available Holarctic sequences. We detected six main clades in the C. sphaericus group in the Palearctic, of which two of the groups are novel. Three of the more divergent clades are geographically widespread. The central portion of Eurasia (the Yenisey River basin) appears to be a narrow zone of secondary contact for phylogroups that expanded from European and Beringian refugia. As such, the previously unsampled central Palearctic represents an important region for understanding the evolutionary consequences of Pleistocene climatic oscillations on the Chydorus sphaericus group.	[Kotov, Alexey A.; Karabanov, Dmitry P.; Bekker, Eugeniya I.] Russian Acad Sci, Lab Aquat Ecol & Invas, AN Severtsov Inst Ecol & Evolut, Moscow, Russia; [Karabanov, Dmitry P.] Russian Acad Sci, Yaroslavl Area, Lab Fish Ecol, ID Papanin Inst Biol Inland Waters, Borok, Russia; [Neretina, Tatiana V.] Moscow MV Lomonosov State Univ, Fac Biol, White Sea Biol Stn, Moscow, Russia; [Taylor, Derek J.] SUNY Buffalo, Dept Biol Sci, Buffalo, NY USA	Russian Academy of Sciences; Saratov Scientific Center of the Russian Academy of Sciences; Severtsov Institute of Ecology & Evolution; Papanin Institute for Biology of Inland Waters; Russian Academy of Sciences; Lomonosov Moscow State University; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo	Kotov, AA (corresponding author), Russian Acad Sci, Lab Aquat Ecol & Invas, AN Severtsov Inst Ecol & Evolut, Moscow, Russia.	alexey-a-kotov@yandex.ru	Kotov, Alexey A./B-1549-2010; Karabanov, Dmitry/F-3779-2011; Bekker, Eugeniya/M-6955-2016; Neretina, Tatiana Vladimirovna/O-3724-2016	Kotov, Alexey A./0000-0002-8863-6438; Karabanov, Dmitry/0000-0001-6008-7441; Bekker, Eugeniya/0000-0001-6425-7727; 	Russian Science Foundation [14-14-0078]; Directorate For Geosciences [1023334] Funding Source: National Science Foundation	Russian Science Foundation(Russian Science Foundation (RSF)); Directorate For Geosciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO))	The work of AAK, DPK and EIB was supported by the Russian Science Foundation grant 14-14-0078. TVN and DJT received no specific funding for their work.	Adamowicz SJ, 2009, MOL PHYLOGENET EVOL, V50, P423, DOI 10.1016/j.ympev.2008.11.026; ALONSO M, 1990, J CRUSTACEAN BIOL, V10, P148, DOI 10.2307/1548678; Alonso M., 1996, CRUSTACEA BRANCHIOPO, V7; Andreicheva LN, 2007, STRATIGR GEO CORREL+, V15, P421, DOI 10.1134/S0869593807040065; Astakhov V.I., 2006, BOREAS, V35, P607, DOI DOI 10.1111/J.1502-3885.2006.TB01167.X; Astakhov VI, 2013, BOREAS, V42, P1, DOI 10.1111/j.1502-3885.2012.00269.x; Avise J. C., 2000, PHYLOGEOGRAPHY HIST; Bandelt HJ, 1999, MOL BIOL EVOL, V16, P37, DOI 10.1093/oxfordjournals.molbev.a026036; Bekker EI, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0161737; Bekker EI, 2012, ZOOTAXA, P1; Bekker EI, 2014, ZOOTAXA, V3895, P297, DOI 10.11646/zootaxa.3895.2.11; Belyaeva M, 2009, MOL PHYLOGENET EVOL, V50, P534, DOI 10.1016/j.ympev.2008.11.007; BENZIE JAH, 1987, HYDROBIOLOGIA, V145, P51, DOI 10.1007/BF02530265; Birge E. A., 1893, T WISC ACAD SCI, V9, P275; Bolotov IN, 2016, HYDROBIOLOGIA; Chen Shouzhong, 1984, Acta Hydrobiologica Sinica, V8, P341; CHENGALATH R, 1981, T AM MICROSC SOC, V100, P229, DOI 10.2307/3225548; Costa FO, 2007, CAN J FISH AQUAT SCI, V64, P272, DOI 10.1139/F07-008; Crease TJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046620; Daday E, 1898, TERMTUD FUZ, V21, P1, DOI DOI 10.5962/BHL.TITLE.114901; Daday EV., 1905, ZOOLOGICA STUTTGART, V44, P1; Darriba D, 2012, NAT METHODS, V9, P772, DOI 10.1038/nmeth.2109; Delport W, 2010, BIOINFORMATICS, V26, P2455, DOI 10.1093/bioinformatics/btq429; deWaard JR, 2006, MOL PHYLOGENET EVOL, V39, P491, DOI 10.1016/j.ympev.2005.11.003; Dlouha S, 2010, HYDROBIOLOGIA, V643, P107, DOI 10.1007/s10750-010-0128-8; Ehlers J, 2008, EPISODES, V31, P211, DOI 10.18814/epiiugs/2008/v31i2/004; Elias-Gutierrez M, 2008, ZOOTAXA, P1; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; Flossner D., 1972, Tierwelt Deutschlands, V60, P1; Flossner D, 2000, HAPLOPODA CLADOCERA; Forro L, 2008, HYDROBIOLOGIA, V595, P177, DOI 10.1007/s10750-007-9013-5; Frey D.G., 1986, Crustacean Issues, V4, P237; FREY DG, 1980, HYDROBIOLOGIA, V69, P83, DOI 10.1007/BF00016540; FREY DG, 1982, HYDROBIOLOGIA, V93, P255, DOI 10.1007/BF00012335; FREY DG, 1982, ECOLOGY, V63, P223; FREY DG, 1987, HYDROBIOLOGIA, V145, P5, DOI 10.1007/BF02530260; FREY DG, 1982, ARCH HYDROBIOL, V93, P484; FREY DG, 1982, CAN J ZOOL, V60, P1892, DOI 10.1139/z82-246; FREY DG, 1985, INT REV GES HYDROBIO, V70, P3; FREY DG, 1987, PHILOS T ROY SOC B, V315, P353, DOI 10.1098/rstb.1987.0012; FREY DG, 1982, HYDROBIOLOGIA, V86, P231, DOI 10.1007/BF00006141; FRYER G, 1972, ZOOL J LINN SOC-LOND, V51, P79, DOI 10.1111/j.1096-3642.1972.tb00774.x; FRYER G, 1995, HYDROBIOLOGIA, V307, P57, DOI 10.1007/BF00031997; Fu YX, 1997, GENETICS, V147, P915; Galimov Y, 2011, J EVOLUTION BIOL, V24, P1572, DOI 10.1111/j.1420-9101.2011.02288.x; Hebert PDN, 2007, LIMNOL OCEANOGR, V52, P2507, DOI 10.4319/lo.2007.52.6.2507; Henry M, 1919, J P ROYAL SOC NEW S, V52, P463; Hewitt GM, 2004, PHILOS T R SOC B, V359, P183, DOI 10.1098/rstb.2003.1388; Hewitt Godfrey M., 2004, Frontiers in Zoology, V1, P1, DOI 10.1186/1742-9994-1-4; Ho SYW, 2015, BIOL LETTERS, V11, DOI 10.1098/rsbl.2015.0194; Ho SYW, 2005, MOL BIOL EVOL, V22, P1561, DOI 10.1093/molbev/msi145; Hudec I., 2010, FAUNA SLOVENSKA, V3; Incagnone G, 2015, HYDROBIOLOGIA, V750, P103, DOI 10.1007/s10750-014-2110-3; Ishida S, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-52; Ishida S, 2007, MOL ECOL, V16, P569, DOI 10.1111/j.1365-294X.2006.03160.x; Ishida S, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-209; Jeffery Nicholas W., 2011, PLoS ONE, V6, P1; KIMURA M, 1980, J MOL EVOL, V16, P111, DOI 10.1007/BF01731581; King R.L., 1853, P ROYAL SOC VAN DIEM, V2, P253; Klimovsky AI, 2015, ZOOL ZH, V94, P1367, DOI 10.7868/S0044513415120077; Klimovsky AI, 2015, ZOOL ZH, V94, P1257, DOI 10.7868/S0044513415110057; Korosi JB, 2012, J PALEOLIMNOL, V48, P587, DOI 10.1007/s10933-012-9636-z; Korovchinsky, 2004, CLADOCERANS ORDER CT; Korovchinsky NM, 2006, ZOOL J LINN SOC-LOND, V147, P109, DOI 10.1111/j.1096-3642.2006.00217.x; Pond SLK, 2006, MOL BIOL EVOL, V23, P1891, DOI 10.1093/molbev/msl051; Kotov AA, 2016, ZOOL ZH, V95, P748, DOI 10.7868/S0044513416070059; Kotov AA, 2007, J NAT HIST, V41, P13, DOI 10.1080/00222930601164445; Kotov AA, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-129; Kotov AA, 2009, ZOOL J LINN SOC-LOND, V156, P1, DOI 10.1111/j.1096-3642.2008.00475.x; Kumar S, 2016, MOL BIOL EVOL, V33, P1870, DOI [10.1093/molbev/msw054, 10.1093/molbev/msv279]; Leach WE, 1816, ENCY BRITANNICA 2, P401; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Litvinchuk LF, 2016, ARCH BIOL SCI, V68, P67, DOI 10.2298/ABS150505010L; Mangerud J, 2001, J QUATERNARY SCI, V16, P773, DOI 10.1002/jqs.661; Millette KL, 2011, LIMNOL OCEANOGR, V56, P1725, DOI 10.4319/lo.2011.56.5.1725; Molak M, 2015, PEERJ, V3, DOI 10.7717/peerj.821; Muller O.F., 1776, ZOOLOGIE DANICAE PRO; Novichkova AA, 2016, J NAT HIST, V50, P1357, DOI 10.1080/00222933.2015.1113319; Okonechnikov K, 2012, BIOINFORMATICS, V28, P1166, DOI 10.1093/bioinformatics/bts091; Omilian AR, 2001, MOL BIOL EVOL, V18, P2201, DOI 10.1093/oxfordjournals.molbev.a003767; Ortells R, 2014, HYDROBIOLOGIA, V723, P167, DOI 10.1007/s10750-013-1593-7; PAGGI J C, 1972, Physis (Buenos Aires), V31, P223; Petrusek A, 2004, HYDROBIOLOGIA, V526, P73, DOI 10.1023/B:HYDR.0000041612.08425.f0; Petrusek A, 2012, LIMNOL OCEANOGR, V57, P1838, DOI 10.4319/lo.2012.57.6.1838; Poggenpol M, 1874, IZVESTIYA IMPERATORS, V10, P69; Posada D, 2004, SYST BIOL, V53, P793, DOI 10.1080/10635150490522304; Prosser S, 2013, MOL ECOL RESOUR, V13, P1151, DOI 10.1111/1755-0998.12132; RAJAPAKSA R, 1986, CAN J ZOOL, V64, P818, DOI 10.1139/z86-123; REMINGTON C L, 1968, Evolutionary Biology (New York), P321; ROEN U, 1987, HYDROBIOLOGIA, V145, P125, DOI 10.1007/BF02530272; ROGERS AR, 1992, MOL BIOL EVOL, V9, P552; Ronquist F, 2012, SYST BIOL, V61, P539, DOI 10.1093/sysbio/sys029; Sacherova V, 2003, BIOL J LINN SOC, V79, P629, DOI 10.1046/j.1095-8312.2003.00216.x; Sars G.O., 1890, FORHANDLINGER VIDENS, V1, P1; Sars G.O., 1901, ARCH MATH NATURVIDEN, VXXIII, P1; Schodler J.E., 1862, JAHRESBERICHT DOROTH, V1862, P1; SCHWENK K, 1993, MOL BIOL EVOL, V10, P1289; Sharma P, 2015, J LIMNOL, V74, P225, DOI 10.4081/jlimnol.2014.1037; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; Smirnov NN, 2010, ZOOL ZH, V89, P635; Smirnov N.N., 1971, FAUNA SSSR R, V1, P1; Stewart JR, 2010, P ROY SOC B-BIOL SCI, V277, P661, DOI 10.1098/rspb.2009.1272; Stewart JR, 2001, TRENDS ECOL EVOL, V16, P608, DOI 10.1016/S0169-5347(01)02338-2; Stingelin T, 1905, ZOOL JB SYST OKOL GE, V21, P327; Svendsen JI, 2004, QUATERNARY SCI REV, V23, P1229, DOI 10.1016/j.quascirev.2003.12.008; Swofford D., 2003, PHYLOGENETIC ANAL US; Szeroczynska K., 2007, ATLAS SUBFOSSIL CLAD; TAJIMA F, 1989, GENETICS, V123, P585; TAMURA K, 1992, MOL BIOL EVOL, V9, P678; Taylor DJ, 2002, LIMNOL OCEANOGR, V47, P1486, DOI 10.4319/lo.2002.47.5.1486; Tsvetkov A.A., 1990, INT GEOL REV, V32, P1202; Van Damme K, 2010, BRAZ J BIOL, V70, P755, DOI 10.1590/S1519-69842010000400008; Wooller MJ, 2015, QUATERNARY SCI REV, V120, P118, DOI 10.1016/j.quascirev.2015.04.027; Xu S, 2009, MOL ECOL, V18, P5161, DOI 10.1111/j.1365-294X.2009.04422.x; Xu S, 2013, MOL ECOL, V22, P4549, DOI 10.1111/mec.12407; Zuykova EI, 2016, RUSS J GENET+, V52, P585, DOI 10.1134/S102279541604013X; Zuykova EI, 2013, HYDROBIOLOGIA, V715, P135, DOI 10.1007/s10750-012-1423-3; [No title captured]	119	55	61	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 19	2016	11	12							e0168711	10.1371/journal.pone.0168711	http://dx.doi.org/10.1371/journal.pone.0168711			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI9QC	27992559	Green Published, Green Submitted, gold			2022-12-27	WOS:000392842600092
J	Zakiyah, N; van Asselt, ADI; Roijmans, F; Postma, MJ				Zakiyah, Neily; van Asselt, Antoinette D. I.; Roijmans, Frank; Postma, Maarten J.			Economic Evaluation of Family Planning Interventions in Low and Middle Income Countries; A Systematic Review	PLOS ONE			English	Review							COST-EFFECTIVENESS; HEALTH-CARE; UNMET NEED; WOMEN; CONTRACEPTION; STRATEGIES; EFFICIENCY; MORTALITY; BENEFITS; NEWBORN	Background A significant number of women in low and middle income countries (L-MICs) who need any family planning, experience a lack in access to modern effective methods. This study was conducted to review potential cost effectiveness of scaling up family planning interventions in these regions from the published literatures and assess their implication for policy and future research. Study design A systematic review was performed in several electronic databases i.e Medline (Pubmed), Embase, Popline, The National Bureau of Economic Research (NBER), EBSCOHost, and The Cochrane Library. Articles reporting full economic evaluations of strategies to improve family planning interventions in one or more L-MICs, published between 1995 until 2015 were eligible for inclusion. Data was synthesized and analyzed using a narrative approach and the reporting quality of the included studies was assessed using the Consolidated Health Economic Evaluation Reporting Standards (CHEERS) statement. Results From 920 references screened, 9 studies were eligible for inclusion. Six references assessed cost effectiveness of improving family planning interventions in one or more LMICs, while the rest assessed costs and consequences of integrating family planning and HIV services, concerning sub-Saharan Africa. Assembled evidence suggested that improving family planning interventions is cost effective in a variety of L-MICs as measured against accepted international cost effectiveness benchmarks. In areas with high HIV prevalence, integrating family planning and HIV services can be efficient and cost effective; however the evidence is only supported by a very limited number of studies. The major drivers of cost effectiveness were cost of increasing coverage, effectiveness of the interventions and country-specific factors. Conclusion Improving family planning interventions in low and middle income countries appears to be cost-effective. Additional economic evaluation studies with improved reporting quality are necessary to generate further evidence on costs, cost-effectiveness, and affordability, and to support increased funding and investments in family planning programs.	[Zakiyah, Neily; van Asselt, Antoinette D. I.; Postma, Maarten J.] Univ Groningen, Dept Pharm, Unit PharmacoTherapy Epidemiol & Econ PTEE, Groningen, Netherlands; [van Asselt, Antoinette D. I.; Postma, Maarten J.] Univ Groningen, Univ Med Ctr Groningen, Dept Epidemiol, Unit Patient Centered Hlth Technol Assessment, Groningen, Netherlands; [Roijmans, Frank] i Solutions, Unit Training Consultancy & Projects, Woerden, Netherlands; [Postma, Maarten J.] Univ Groningen, Univ Med Ctr Groningen, Inst Sci Hlth Aging & HealthcaRE SHARE, Groningen, Netherlands	University of Groningen; University of Groningen; University of Groningen	Zakiyah, N (corresponding author), Univ Groningen, Dept Pharm, Unit PharmacoTherapy Epidemiol & Econ PTEE, Groningen, Netherlands.	n.zakiyah@rug.nl	Zakiyah, Neily/AAC-2210-2021	Zakiyah, Neily/0000-0002-9630-5567; van Asselt, Antoinette/0000-0001-7705-9906; Postma, Maarten/0000-0002-6306-3653	i+Solutions	i+Solutions	i+Solutions provided support in the form of salaries for NZ and FR but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Adam T., 2003, MAKING CHOICES HLTH; Alkema L, 2013, LANCET, V381, P1642, DOI 10.1016/S0140-6736(12)62204-1; Babigumira JB, 2012, POTENTIAL COST EFFEC, V7, DOI [10.1371/journal.pone.0030735, DOI 10.1371/JOURNAL.PONE.0030735]; Bhutta ZA, 2008, LANCET, V372, P972, DOI 10.1016/S0140-6736(08)61407-5; Briggs A, 2006, DECISION MODELLING H; Canning D, 2012, LANCET, V380, P165, DOI 10.1016/S0140-6736(12)60827-7; Carr B, 2012, LANCET, V380, P80, DOI 10.1016/S0140-6736(12)60905-2; Carvalho N, 2013, HEALTH POLICY PLANN, V28, P62, DOI 10.1093/heapol/czs026; Cleland J, 2006, LANCET, V368, P1810, DOI 10.1016/S0140-6736(06)69480-4; Cleland J, 2012, LANCET, V380, P149, DOI 10.1016/S0140-6736(12)60609-6; Drake T, 2014, HEALTH ECON, V23, P248, DOI 10.1002/hec.2925; Drummond MF, 2015, METHODS EC EVALUATIO; Erim DO, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-786; Goldie SJ, 2010, ALTERNATIVE STRATEGI, V7, DOI [10.1371/journal.pmed.1000264, DOI 10.1371/JOURNAL.PMED.1000264]; Halperin DT, 2009, AIDS, V23, pS123, DOI 10.1097/01.aids.0000363785.73450.5a; Horton R, 2012, LANCET, V380, P77, DOI 10.1016/S0140-6736(12)61026-5; Hu D, 2007, COSTS BENEFITS COST, V2, pe750, DOI [10.1371/journal.pone.0000750, DOI 10.1371/JOURNAL.PONE.0000750]; Husereau D, 2013, VALUE HEALTH, V16, pE1, DOI 10.1016/j.jval.2013.02.010; Kennedy EC, 2013, REPROD HEALTH, V10, DOI 10.1186/1742-4755-10-30; Mangham-Jefferies L, 2014, BMC PREGNANCY CHILDB, V14, DOI 10.1186/1471-2393-14-243; Marseille E, 2015, B WORLD HEALTH ORGAN, V93, P118, DOI 10.2471/BLT.14.138206; Maru S, 2014, SYSTEMATIC REV TRIAL; Moher D, 2009, PLOS MED, V6, DOI [10.1136/bmj.b4037, 10.1371/journal.pmed.1000097]; Mulligan Jo-Ann, 2006, Cost Eff Resour Alloc, V4, P7, DOI 10.1186/1478-7547-4-7; Murray SF, 2014, BMC PREGNANCY CHILDB, V14, DOI 10.1186/1471-2393-14-30; Mwaikambo L, 2011, STUD FAMILY PLANN, V42, P67, DOI 10.1111/j.1728-4465.2011.00267.x; Nattabi B, 2009, AIDS BEHAV, V13, P949, DOI 10.1007/s10461-009-9537-y; Partnership for Maternal Newborn and Child Health, 2011, GLOB REV KEY INT REL; Peterson HB, 2013, LANCET, V381, P1696, DOI 10.1016/S0140-6736(13)60999-X; Prata N, 2009, HEALTH POLICY, V89, P131, DOI 10.1016/j.healthpol.2008.05.007; Reynolds HW, 2006, SEX TRANSM DIS, V33, P350, DOI 10.1097/01.olq.0000194602.01058.e1; Shade SB, 2013, AIDS, V27, pS87, DOI 10.1097/QAD.0000000000000038; Shillcutt SD, 2009, PHARMACOECONOMICS, V27, P903, DOI 10.2165/10899580-000000000-00000; Singh S., 2014, ADD COSTS BEN INV SE; Stenberg K, 2014, LANCET, V383, P1333, DOI 10.1016/S0140-6736(13)62231-X; Sweeney S, 2012, SEX TRANSM INFECT, V88, P85, DOI 10.1136/sextrans-2011-050199; Tsui AO, 2010, EPIDEMIOL REV, V32, P152, DOI 10.1093/epirev/mxq012; United Nations, 2011, MILL DEV GOALS REP 2; Walker N., 2016, REPROD MATERNAL NEWB, V2; Wilcher R, 2009, B WORLD HEALTH ORGAN, V87, P833, DOI 10.2471/BLT.08.059360; World Bank, 2015, DATA; World Health Organization, 2007, GUID GLOB SCAL UP PR; World Health Organization, 2015, HIV AIDS; World Health Organization. WHO, 2015, WHO UNM NEED FAM PLA; World Health Organization. WHO, 2015, WHO COST EFF THRESH; Yamey G, 2012, BRIT MED J, V344, DOI 10.1136/bmj.e4160	46	13	13	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 19	2016	11	12							e0168447	10.1371/journal.pone.0168447	http://dx.doi.org/10.1371/journal.pone.0168447			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EI9QC	27992552	gold, Green Submitted, Green Published			2022-12-27	WOS:000392842600059
J	Liu, QF; Wang, R; Li, RJ; Hu, YX; Guo, SL				Liu, Qingfang; Wang, Rui; Li, Rujian; Hu, Yaxian; Guo, Shengli			Temperature Sensitivity of Soil Respiration to Nitrogen Fertilization: Varying Effects between Growing and Non-Growing Seasons	PLOS ONE			English	Article							LOESS PLATEAU; MICROBIAL ACTIVITY; WATER-CONTENT; RESPONSES; COMMUNITY; QUALITY; BIOMASS; MAIZE	Nitrogen (N) fertilization has a considerable effect on food production and carbon cycling in agro-ecosystems. However, the impacts of N fertilization rates on the temperature sensitivity of soil respiration (Q(10)) were controversial. Five N rates (N0, N45, N90, N135, and N180) were applied to a continuous winter wheat (Triticum aestivum L.) cropon the semi-arid Loess Plateau, and the in situ soil respiration was monitored during five consecutive years from 2008 to 2013. During the growing season, the mean soil respiration rates increased with increasing N fertilization rates, peaking at 1.53 mu mol m(-2) s(-1) in the N135 treatment. A similar dynamic pattern was observed during the non-growing season, yet on average with 7.3% greater soil respiration rates than the growing season. In general for all the N fertilization treatments, the mean Q(10) value during the non-growing season was significantly greater than that during the growing season. As N fertilization rates increased, the Q(10) values did not change significantly in the growing season but significantly decreased in the non-growing season. Overall, N fertilization markedly influenced soil respirations and Q(10) values, in particular posing distinct effects on the Q(10) values between the growing and non-growing seasons.	[Liu, Qingfang; Wang, Rui; Guo, Shengli] Northwest A&F Univ, Coll Resources & Environm, Yangling, Peoples R China; [Li, Rujian; Hu, Yaxian; Guo, Shengli] Northwest A&F Univ, Inst Soil & Water Conservat, State Key Lab Soil Eros & Dryland Farming Loess P, Yangling, Shaanxi, Peoples R China; [Hu, Yaxian; Guo, Shengli] Chinese Acad Sci, Inst Soil & Water Conservat, Yangling, Peoples R China; [Hu, Yaxian; Guo, Shengli] Minist Water Resource, Yangling, Peoples R China	Northwest A&F University - China; Chinese Academy of Sciences; Institute of Soil & Water Conservation (ISWC), CAS; Northwest A&F University - China; Chinese Academy of Sciences; Institute of Soil & Water Conservation (ISWC), CAS	Guo, SL (corresponding author), Northwest A&F Univ, Coll Resources & Environm, Yangling, Peoples R China.; Guo, SL (corresponding author), Northwest A&F Univ, Inst Soil & Water Conservat, State Key Lab Soil Eros & Dryland Farming Loess P, Yangling, Shaanxi, Peoples R China.; Guo, SL (corresponding author), Chinese Acad Sci, Inst Soil & Water Conservat, Yangling, Peoples R China.; Guo, SL (corresponding author), Minist Water Resource, Yangling, Peoples R China.	slguo@ms.iswc.ac.cn			Natural Science Foundation of China [41371279]; "Strategic Priority Research Program-Climate Change: Carbon Budget and Related Issues" of the Chinese Academy of Sciences [XDA05050504]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); "Strategic Priority Research Program-Climate Change: Carbon Budget and Related Issues" of the Chinese Academy of Sciences(Chinese Academy of Sciences)	This work was supported by the Natural Science Foundation of China (No. 41371279) and the "Strategic Priority Research Program-Climate Change: Carbon Budget and Related Issues" of the Chinese Academy of Sciences (Grant No. XDA05050504). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agren GI, 2007, SOIL BIOL BIOCHEM, V39, P1794, DOI 10.1016/j.soilbio.2007.02.007; Allison SD, 2008, GLOBAL CHANGE BIOL, V14, P1156, DOI 10.1111/j.1365-2486.2008.01549.x; [Anonymous], 2011, PEOPLES REPUBLIC CHI; Ball BA, 2014, POLAR BIOL, V37, P573, DOI 10.1007/s00300-014-1459-0; Blagodatskaya E, 2010, GLOBAL CHANGE BIOL, V16, P836, DOI 10.1111/j.1365-2486.2009.02006.x; Bosatta E, 1999, SOIL BIOL BIOCHEM, V31, P1889, DOI 10.1016/S0038-0717(99)00105-4; Bowden RD, 2004, FOREST ECOL MANAG, V196, P43, DOI 10.1016/j.foreco.2004.03.011; Chen ST, 2010, AGR FOREST METEOROL, V150, P590, DOI 10.1016/j.agrformet.2010.02.004; Cox PM, 2000, NATURE, V408, P184, DOI 10.1038/35041539; Davidson EA, 2006, GLOBAL CHANGE BIOL, V12, P154, DOI 10.1111/j.1365-2486.2005.01065.x; Dietzel R, 2015, CROP SCI, V55, P910, DOI 10.2135/cropsci2014.08.0572; Drenovsky RE, 2004, MICROB ECOL, V48, P424, DOI 10.1007/s00248-003-1063-2; Fan J, 2000, SOIL ENV SCI, V9, P23; Gao HY, 2009, CARBON SEQUESTRATION; Guo SL, 2012, PLANT SOIL, V353, P321, DOI 10.1007/s11104-011-1034-1; Guo ShengLi, 2009, Plant Nutrition and Fertilizer Science, V15, P808; Huang MB, 2003, SOIL TILL RES, V72, P95, DOI 10.1016/S0167-1987(03)00065-5; Huang MB, 2003, AGR WATER MANAGE, V58, P267, DOI 10.1016/S0378-3774(02)00086-0; Huntingford C, 2000, ECOL MODEL, V134, P41, DOI 10.1016/S0304-3800(00)00330-6; Jia XX, 2013, PLANT SOIL, V373, P125, DOI 10.1007/s11104-013-1771-4; Kuzyakov Y, 2010, GLOBAL CHANGE BIOL, V16, P3386, DOI 10.1111/j.1365-2486.2010.02179.x; Li Z, 2010, SCI CHINA EARTH SCI, V53, P710, DOI 10.1007/s11430-009-0186-9; LLOYD J, 1994, FUNCT ECOL, V8, P315, DOI 10.2307/2389824; Lu SJ, 1998, SOIL BIOL BIOCHEM, V30, P331, DOI 10.1016/S0038-0717(97)00134-X; McCulley RL, 2007, SOIL SCI SOC AM J, V71, P820, DOI 10.2136/sssaj2006.0303; Morell FJ, 2010, AGR ECOSYST ENVIRON, V139, P167, DOI 10.1016/j.agee.2010.07.015; Ni K, 2012, J SOIL SEDIMENT, V12, P1007, DOI 10.1007/s11368-012-0529-6; Madelene OA, 2006, LAND USE POLICY, V23, P361, DOI 10.1016/j.landusepol.2005.04.004; Ruan J, 2010, PLANT BIOLOGY, V12, P724, DOI 10.1111/j.1438-8677.2009.00288.x; Tian W, 2015, AGR ECOSYST ENVIRON, V213, P219, DOI 10.1016/j.agee.2015.08.009; van Grinsven HJM, 2015, ENVIRON RES LETT, V10, DOI 10.1088/1748-9326/10/2/025002; Wan L, 2014, HYDROL PROCESS, V28, P4971, DOI 10.1002/hyp.9951; Wang XK, 2015, AGR WATER MANAGE, V161, P53, DOI 10.1016/j.agwat.2015.07.019; Xu M, 2001, GLOBAL BIOGEOCHEM CY, V15, P687, DOI 10.1029/2000GB001365; Xu X, 2012, SOIL BIOL BIOCHEM, V50, P142, DOI 10.1016/j.soilbio.2012.03.007; Zhou LY, 2014, GLOBAL CHANGE BIOL, V20, P2332, DOI 10.1111/gcb.12490; Zhou XH, 2009, ECOSYSTEMS, V12, P1369, DOI 10.1007/s10021-009-9296-7	37	8	8	10	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2016	11	12							e0168599	10.1371/journal.pone.0168599	http://dx.doi.org/10.1371/journal.pone.0168599			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI8LN	27992576	Green Submitted, Green Published, gold			2022-12-27	WOS:000392758000064
J	Tatah, L; Delbiso, TD; Rodriguez-Llanes, JM; Cuesta, JG; Guha-Sapir, D				Tatah, Lambed; Delbiso, Tefera Darge; Rodriguez-Llanes, Jose Manuel; Cuesta, Julita Gil; Guha-Sapir, Debarati			Impact of Refugees on Local Health Systems: A Difference-in-Differences Analysis in Cameroon	PLOS ONE			English	Article							DETERMINANTS; POPULATIONS; DELIVERY; CARE	Hosting refugees may represent a drain on local resources, particularly since external aid is frequently insufficient. Between 2004 and 2011, over 100,000 refugees settled in the eastern border of Cameroon. With little known on how refugee influx affects health services of the hosting community, we investigated the impact of refugees on mother and child health (MCH) services in the host community in Cameroon. We used Cameroon's 2004 and 2011 Demographic and Health Surveys to evaluate changes in MCH indicators in the refugee hosting community. Our outcome variables were antenatal care (ANC) coverage, caesarean delivery rate, place of delivery and child vaccination coverage; whereas the exposure variable was residence in the refugee hosting community. We used a difference-in-differences analysis to compare indicators of the refugee hosting community to a control group selected through propensity score matching from the rest of the country. A total of 10,656 women were included in our 2004 analysis and 7.6% (n = 826) of them resided in the refugee hosting community. For 2011, 15,426 women were included and 5.8% (n = 902) of them resided in the hosting community. Between 2004 and 2011, both the proportion of women delivering outside health facilities and children not completing DPT3 vaccination in the refugee hosting community decreased by 9.0% (95% Confidence Interval (CI): 3.9-14.1%) and 9.6% (95% CI: 7.9-11.3%) respectively. However, ANC attendance and caesarean delivery did not show any significant change. Our findings demonstrate that none of the evaluated MCH service indicators deteriorated (in fact, two of them improved: delivery in health facilities and completing DPT3 vaccine) with the presence of refugees. This suggests evidence disproving the common belief that refugees always have a negative impact on their hosting community.	[Tatah, Lambed; Delbiso, Tefera Darge; Rodriguez-Llanes, Jose Manuel; Cuesta, Julita Gil; Guha-Sapir, Debarati] Catholic Univ Louvain, Inst Hlth & Soc, Ctr Res Epidemiol Disasters, Brussels, Belgium; [Tatah, Lambed] Hlth & Human Dev 2HD Res Grp, Douala, Cameroon	Universite Catholique Louvain	Tatah, L (corresponding author), Catholic Univ Louvain, Inst Hlth & Soc, Ctr Res Epidemiol Disasters, Brussels, Belgium.; Tatah, L (corresponding author), Hlth & Human Dev 2HD Res Grp, Douala, Cameroon.	tatahlambed@gmail.com	Gil-Cuesta, Julita/AFV-5338-2022; Rodriguez-Llanes, Jose Manuel/L-4537-2019	Gil-Cuesta, Julita/0000-0002-8291-9701; Rodriguez-Llanes, Jose Manuel/0000-0003-3736-736X; Delbiso, Tefera Darge/0000-0002-7681-1649	European Commission through Erasmus Mundus Masters of Public Health in Disaster (EMMPHID) Programme	European Commission through Erasmus Mundus Masters of Public Health in Disaster (EMMPHID) Programme	LT was supported by European Commission through the Erasmus Mundus Masters of Public Health in Disaster (EMMPHID) Programme. We are thankful to the entire staff of the Center for Research in the Epidemiology of Disasters (CRED) for their guidance and support during this study and especially to Alizee Vanderveken who helped assign clusters of the DHS to the refugee zone on QGIS; and Eleanor Hegarty for language editing.	Arevshatian L, 2007, B WORLD HEALTH ORGAN, V85, P449, DOI 10.2471/BLT.06.031526; Becker S, 1993, Health Transit Rev, V3, P77; Briggs DJ, 2008, ENVIRON HEALTH-GLOB, V7, DOI 10.1186/1476-069X-7-61; Burnett A, 2001, BRIT MED J, V322, P544, DOI 10.1136/bmj.322.7285.544; Celik Y, 2000, SOC SCI MED, V50, P1797, DOI 10.1016/S0277-9536(99)00418-9; Delbiso TD, 2016, GLOBAL HEALTH ACTION, V9, DOI 10.3402/gha.v9.30204; Glynn RJ, 2006, BASIC CLIN PHARMACOL, V98, P253, DOI 10.1111/j.1742-7843.2006.pto_293.x; Hogan MC, 2010, LANCET, V375, P1609, DOI 10.1016/S0140-6736(10)60518-1; Jacobsen K, 2002, J MOD AFR STUD, V40, P577, DOI 10.1017/S0022278X02004081; Kuhn M, 2014, APPL PREDICTIVE MODE; Lee PH, 2014, SCI REP-UK, V4, DOI 10.1038/srep06085; Malqvist M, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-641; Mansourian BP, 2009, GLOBAL PERSPECTIVES, VII; Maystadt JF, 2014, ECON DEV CULT CHANGE, V62, P769, DOI 10.1086/676458; Orach CG, 2004, LANCET, V364, P611, DOI 10.1016/S0140-6736(04)16854-2; PAATERO P, 1994, ENVIRONMETRICS, V5, P111, DOI 10.1002/env.3170050203; Rassen JA, 2012, PHARMACOEPIDEM DR S, V21, P69, DOI 10.1002/pds.3263; Reshef DN, 2011, SCIENCE, V334, P1518, DOI 10.1126/science.1205438; Salehyan I, 2006, INT ORGAN, V60, P335, DOI 10.1017/S0020818306060103; Sekhon JS, 2011, J STAT SOFTW, V42, P1; Srinivas SK, 2010, OBSTET GYNECOL, V115, P1007, DOI 10.1097/AOG.0b013e3181d9f4b6; Steel Z, 2009, JAMA-J AM MED ASSOC, V302, P537, DOI 10.1001/jama.2009.1132; Tebeu P-M, 2015, PAN AFR MED J, V21; Van Damme W, 1998, LANCET, V351, P1609, DOI 10.1016/S0140-6736(97)10348-8; von Elm E, 2008, GAC SANIT, V22, P144, DOI 10.1157/13119325; Wilunda C, 2015, REPROD HEALTH, V12, DOI 10.1186/s12978-015-0067-y	26	15	15	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2016	11	12							e0168820	10.1371/journal.pone.0168820	http://dx.doi.org/10.1371/journal.pone.0168820			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EI8LN	27992563	gold, Green Published, Green Submitted			2022-12-27	WOS:000392758000080
J	Shen, L; Wang, Z; Su, ZZ; Qiu, S; Xu, J; Zhou, Y; Yan, A; Yin, R; Lu, B; Nie, XH; Zhao, SF; Yan, RF				Shen, Liang; Wang, Zhuo; Su, Zhongzhou; Qiu, Sheng; Xu, Jie; Zhou, Yue; Yan, Ai; Yin, Rui; Lu, Bin; Nie, Xiaohu; Zhao, Shufa; Yan, Renfu			Effects of Intracranial Pressure Monitoring on Mortality in Patients with Severe Traumatic Brain Injury: A Meta-Analysis	PLOS ONE			English	Article							CEREBRAL PERFUSION-PRESSURE; INTENSIVE-CARE; MANAGEMENT; CHILDREN; REACTIVITY; MODERATE; IMPACT; TRIAL	Background The Brain Trauma Foundation (BTF) guidelines published in 2007 suggest some indications for intracranial pressure (ICP) monitoring in severe traumatic brain injury (TBI). However, some studies had not shown clinical benefit in patients with severe TBI; several studies had even reported that ICP monitoring was associated with an increased mortality rate. The effect of ICP monitoring has remained controversial, regardless of the ICP monitoring guidelines. Here we performed a meta-analysis of published studies to assess the effects of ICP monitoring in patients with severe TBI. Methods We searched three comprehensive databases, the Cochrane Library, PUBMED, and EMBASE, for studies without limitations published up to September 2015. Mortality, ICU LOS, and hospital LOS were analyzed with Review Manager software according to data from the included studies. Results Eighteen eligible studies involving 25229 patients with severe TBI were included in our meta-analysis. The results indicated no significant reduction in the ICP monitored group in mortality (hospitalized before 2007), hospital mortality (hospitalized before 2007), mortality in randomized controlled trials. However, overall mortality, mortality (hospitalized after 2007), hospital mortality (hospitalized after 2007), mortality in observational studies (hospitalized after 2007), 2-week mortality, 6-month mortality, were reduced in ICP monitored group. Patients with an increased ICP were more likely to require ICP monitoring. Conclusion Superior survival was observed in severe TBI patients with ICP monitoring since the third edition of "Guidelines for the Management of Severe Traumatic Brain Injury," which included "Indications for intracranial pressure monitoring," was published in 2007.	[Shen, Liang; Su, Zhongzhou; Qiu, Sheng; Xu, Jie; Zhou, Yue; Yan, Ai; Yin, Rui; Lu, Bin; Nie, Xiaohu; Zhao, Shufa; Yan, Renfu] Huzhou Cent Hosp, Dept Neurosurg, Huzhou, Zhejiang, Peoples R China; [Wang, Zhuo] Huzhou Univ, Coll Nursing, Dept Med Coll, Huzhou, Zhejiang, Peoples R China	Huzhou University; Huzhou University	Yan, RF (corresponding author), Huzhou Cent Hosp, Dept Neurosurg, Huzhou, Zhejiang, Peoples R China.	20125232086@suda.edu.cn						Adelson PD, 2005, NEUROSURGERY, V56, P740, DOI 10.1227/01.NEU.0000156471.50726.26; Agrawal D, 2015, J NEUROTRAUMA; Alali AS, 2015, J NEUROSURG-PEDIATR, V16, P523, DOI 10.3171/2015.3.PEDS14507; Alali AS, 2013, J NEUROTRAUM, V30, P1737, DOI 10.1089/neu.2012.2802; Alkhoury F, 2014, JAMA SURG, V149, P544, DOI 10.1001/jamasurg.2013.4329; Biersteker HAR, 2012, CRIT CARE MED, V40, P1914, DOI 10.1097/CCM.0b013e3182474bde; Brain Trauma Foundation, 2007, J Neurotrauma, V24 Suppl 1, pS37; Bratton SI, GUIDELINES MANAGEMEN, VVIII; Carney N, 2016, NEUROSURGERY; Chesnut RM, 2012, NEW ENGL J MED, V367, P2471, DOI 10.1056/NEJMoa1207363; Cremer OL, 2005, CRIT CARE MED, V33, P2207, DOI 10.1097/01.CCM.0000181300.99078.B5; Dawes AJ, 2015, J TRAUMA ACUTE CARE, V78, P492, DOI 10.1097/TA.0000000000000559; Dings J, 1996, ZBL NEUROCHIR, V57, P177; Farahvar A, 2012, J NEUROSURG, V117, P729, DOI 10.3171/2012.7.JNS111816; Gao L, 2013, WORLD NEUROSURG, V80, P879, DOI 10.1016/j.wneu.2013.01.020; Griesdale DEG, 2010, CAN J NEUROL SCI, V37, P43, DOI 10.1017/S031716710000963X; Grinkeviciute DE, 2008, MEDICINA-LITHUANIA, V44, P119, DOI 10.3390/medicina44020015; Haddad S, 2011, ANAESTH INTENS CARE, V39, P1043, DOI 10.1177/0310057X1103900610; HIGGINS JPT, 2011, COCHRANE HDB SYSTEMA, V0001; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Howells T, 2005, J NEUROSURG, V102, P311, DOI 10.3171/jns.2005.102.2.0311; Jagannathan J, 2007, J NEUROSURG, V106, P268, DOI 10.3171/ped.2007.106.4.268; Kim DR, 2014, J KOREAN NEUROSURG S, V55, P26, DOI 10.3340/jkns.2014.55.1.26; Korley FK, 2015, J HEAD TRAUMA REHABI; Koskinen LOD, 2014, NEUROSCIENCE, V283, P245, DOI 10.1016/j.neuroscience.2014.06.039; Kostic Aleksandar, 2011, Med Pregl, V64, P461; Kukreti V, 2014, J PEDIATR NEUROSCI, V9, P207, DOI 10.4103/1817-1745.147572; Lang EW, 2016, ACTA NEUROCHIR SUPPL, V122, P221, DOI 10.1007/978-3-319-22533-3_44; Maas AIR, 2008, LANCET NEUROL, V7, P728, DOI 10.1016/S1474-4422(08)70164-9; MARMAROU A, 1991, J NEUROSURG, V75, pS59, DOI 10.3171/sup.1991.75.1s.0s59; Mauritz W, 2008, INTENS CARE MED, V34, P1208, DOI 10.1007/s00134-008-1079-7; Mauritz W, 2007, WIEN KLIN WOCHENSCHR, V119, P46, DOI 10.1007/s00508-006-0763-2; MICHAUD LJ, 1992, NEUROSURGERY, V31, P254, DOI 10.1227/00006123-199208000-00010; NARAYAN RK, 1982, J NEUROSURG, V56, P650, DOI 10.3171/jns.1982.56.5.0650; Pfenninger J, 2002, SWISS MED WKLY, V132, P116; Rosso A, 2007, WIEN KLIN WOCHENSCHR, V119, P29, DOI 10.1007/s00508-006-0761-4; Rutland-Brown W, 2006, J HEAD TRAUMA REHAB, V21, P544, DOI 10.1097/00001199-200611000-00009; Shafi S, 2008, J TRAUMA, V64, P335, DOI 10.1097/TA.0b013e31815dd017; Soeken KL, 2003, NURS RES, V52, P57, DOI 10.1097/00006199-200301000-00009; Su SH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087432; Talving P, 2013, J NEUROSURG, V119, P1248, DOI 10.3171/2013.7.JNS122255; Tang A, 2015, J SURG RES, V194, P565, DOI 10.1016/j.jss.2014.11.017; vanSantbrink H, 1996, NEUROSURGERY, V38, P21, DOI 10.1097/00006123-199601000-00007; Wells G.A., NEWCASTLE OTTAWA SCA; Yuan Q, 2015, CRIT CARE MED, V43, P1405, DOI 10.1097/CCM.0000000000000965; Yuan Q, 2015, J NEUROSURG, V122, P574, DOI 10.3171/2014.10.JNS1460; Zhou ZR, 2013, J CANCER RES CLIN, V139, P783, DOI 10.1007/s00432-013-1383-7; Zintzaras E, 2005, GENET EPIDEMIOL, V28, P123, DOI 10.1002/gepi.20048	48	36	38	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2016	11	12							e0168901	10.1371/journal.pone.0168901	http://dx.doi.org/10.1371/journal.pone.0168901			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EG7JB	28030638	Green Submitted, gold, Green Published			2022-12-27	WOS:000391222000083
J	Sun, X; Lu, L; Yang, R; Li, YB; Shan, L; Wang, Y				Sun, Xin; Lu, Li; Yang, Rong; Li, Yanbin; Shan, Ling; Wang, Yang			Increased Incidence of Thyroid Disease in Patients with Celiac Disease: A Systematic Review and Meta-Analysis	PLOS ONE			English	Review							AUTOIMMUNE DISORDERS; GLUTEN; AUTOANTIBODIES; PREVALENCE; RISK; HLA	The prevalence of thyroid disease is likely increased among individuals with celiac disease (CD). In addition, exposure to gluten-free treatment may be associated with a risk of thyroid disease, but this association remains controversial. A systematic review was performed to evaluate the association between thyroid disease and CD. The articles were obtained from the PubMed, Web of Science, Embase, and Chinese WanFang bibliographical databases for the period up to May 2016. The results were analysed in a meta-analysis with odds ratios (ORs) and corresponding 95% confidence intervals (95% CIs). There were 13 articles in this meta-analysis, including 15629 CD cases and 79342 controls. Overall, the prevalence of thyroid disease in patients with CD was significantly increased compared with that in the control groups (OR 3.08, 95% CI 2.67-3.56, P<0.001). Moreover, there was no significant difference in the OR between the gluten-treated and untreated groups (OR 1.08, 95% CI 0.61-1.92, P = 0.786). The results of our meta-analysis support the hypothesis that the prevalence of thyroid disease in patients with CD is increased compared with that in controls, which suggests that CD patients should be screened for thyroid disease. The effect of gluten-free treatment on thyroid disease needs further investigation.	[Sun, Xin; Lu, Li; Yang, Rong; Li, Yanbin; Shan, Ling; Wang, Yang] China Med Univ, Dept Endocrinol & Metab, Peoples Hosp, Shenyang, Peoples R China; [Sun, Xin; Lu, Li; Yang, Rong; Li, Yanbin; Shan, Ling; Wang, Yang] China Med Univ, Dept Endocrinol & Metab, Peoples Hosp, Peoples Hosp Liaoning Prov, 33 Wenyi Rd, Shenyang 110013, Liaoning Provin, Peoples R China	China Medical University; China Medical University	Sun, X (corresponding author), China Med Univ, Dept Endocrinol & Metab, Peoples Hosp, Shenyang, Peoples R China.; Sun, X (corresponding author), China Med Univ, Dept Endocrinol & Metab, Peoples Hosp, Peoples Hosp Liaoning Prov, 33 Wenyi Rd, Shenyang 110013, Liaoning Provin, Peoples R China.	sunxin77@126.com	lu, lu/HII-7530-2022; Sun, Xin/AAF-4356-2020					Ansaldi N, 2003, J PEDIATR GASTR NUTR, V37, P63, DOI 10.1097/00005176-200307000-00010; Badenhoop K, 2001, AM J GASTROENTEROL, V96, P1648; Barker Jennifer M, 2008, Adv Pediatr, V55, P349, DOI 10.1016/j.yapd.2008.07.001; Chistiakov DA, 2003, J MOL ENDOCRINOL, V31, P21, DOI 10.1677/jme.0.0310021; COLLIN P, 1994, GUT, V35, P1215, DOI 10.1136/gut.35.9.1215; Collin P, 2002, ENDOCR REV, V23, P464, DOI 10.1210/er.2001-0035; COOPER BT, 1978, BRIT MED J, V1, P537, DOI 10.1136/bmj.1.6112.537; DALTON TA, 1992, AM J MED, V92, P183, DOI 10.1016/0002-9343(92)90110-W; Dube C, 2005, GASTROENTEROLOGY, V128, pS57, DOI 10.1053/j.gastro.2005.02.014; Elfstrom P, 2008, J CLIN ENDOCR METAB, V93, P3915, DOI 10.1210/jc.2008-0798; Elfstrom P, 2014, ALIMENT PHARM THER, V40, P1123, DOI 10.1111/apt.12973; Fasano A, 2005, GASTROENTEROLOGY, V128, pS68, DOI 10.1053/j.gastro.2005.02.015; Green J R, 1983, Stat Med, V2, P79, DOI 10.1002/sim.4780020109; Green PHR, 2007, NEW ENGL J MED, V357, P1731, DOI 10.1056/NEJMra071600; Guariso G, 2007, ALIMENT PHARM THER, V26, P1409, DOI 10.1111/j.1365-2036.2007.03526.x; Guidetti CS, 2001, GUT, V49, P502, DOI 10.1136/gut.49.4.502; Horwitz A, 2015, SCAND J GASTROENTERO, V50, P824, DOI 10.3109/00365521.2015.1010571; Hunt KA, 2005, EUR J HUM GENET, V13, P440, DOI 10.1038/sj.ejhg.5201357; Kaukinen K, 1999, DIGEST DIS SCI, V44, P1428, DOI 10.1023/A:1026612121041; King AL, 2003, EUR J IMMUNOGENET, V30, P427, DOI 10.1111/j.1365-2370.2003.00430.x; Kowalska E, 2000, Med Sci Monit, V6, P719; Lionetti E, 2011, INT REV IMMUNOL, V30, P219, DOI 10.3109/08830185.2011.602443; LORINI R, 1986, EUR J PEDIATR, V145, P241, DOI 10.1007/BF00446080; Macdonald Geraldine, 2012, Cochrane Database Syst Rev, pCD001930, DOI 10.1002/14651858.CD001930.pub3; Mainardi E, 2002, J CLIN GASTROENTEROL, V35, P245, DOI 10.1097/00004836-200209000-00009; Meloni A, 2009, J PEDIATR-US, V155, P51, DOI 10.1016/j.jpeds.2009.01.013; MIDHAGEN G, 1988, SCAND J GASTROENTERO, V23, P1000, DOI 10.3109/00365528809090160; Mustalahti K, 2010, ANN MED, V42, P587, DOI 10.3109/07853890.2010.505931; Saleem A, 2012, IRISH J MED SCI, V181, P225, DOI 10.1007/s11845-011-0788-z; Sategna-Guidetti C, 2001, AM J GASTROENTEROL, V96, P751, DOI 10.1111/j.1572-0241.2001.03617.x; Sategna-Guidetti C, 1998, EUR J GASTROEN HEPAT, V10, P927, DOI 10.1097/00042737-199811000-00005; SNOOK JA, 1989, Q J MED, V72, P835; Toscano V, 2000, AM J GASTROENTEROL, V95, P1742, DOI 10.1111/j.1572-0241.2000.02187.x; Toumi D, 2008, CLIN CHEM LAB MED, V46, P350, DOI 10.1515/CCLM.2008.075; Valentino R, 2002, EUR J ENDOCRINOL, V146, P479, DOI 10.1530/eje.0.1460479; van der Pals M, 2014, AUTOIMMUN DIS, V2014, DOI 10.1155/2014/417356; Velluzzi F, 1998, AM J GASTROENTEROL, V93, P976; Ventura A, 1999, GASTROENTEROLOGY, V117, P297, DOI 10.1053/gast.1999.0029900297; Ventura A, 2000, J PEDIATR-US, V137, P263, DOI 10.1067/mpd.2000.107160; Viljamaa M, 2005, SCAND J GASTROENTERO, V40, P437, DOI 10.1080/00365520510012181; WEETMAN AP, 1994, ENDOCR REV, V15, P788, DOI 10.1210/er.15.6.788; Wells G.A., NEWCASTLE OTTAWA SCA; YANAGAWA T, 1993, J CLIN ENDOCR METAB, V76, P1569, DOI 10.1210/jcem.76.6.8501164	43	21	22	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2016	11	12							e0168708	10.1371/journal.pone.0168708	http://dx.doi.org/10.1371/journal.pone.0168708			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EG7JB	28030626	gold, Green Published, Green Submitted			2022-12-27	WOS:000391222000065
J	Dong, JP; Teng, GG; Wei, TT; Gao, W; Wang, HH				Dong, Jinpei; Teng, Guigen; Wei, Tiantong; Gao, Wen; Wang, Huahong			Methodological Quality Assessment of Meta-Analyses and Systematic Reviews of Probiotics in Inflammatory Bowel Disease and Pouchitis	PLOS ONE			English	Article							ULCERATIVE-COLITIS; CROHNS-DISEASE; REMISSION; MAINTENANCE; MANAGEMENT; PREVENTION; THERAPY; EFFICACY; RELAPSE; BENEFIT	Background Probiotics are widely used for the induction and maintenance of remission in inflammatory bowel disease (IBD) and pouchitis. There are a large number of meta-analyses (MAs)/systematic reviews (SRs) on this subject, the methodological quality of which has not been evaluated. Objectives This study aimed to evaluate the methodological quality of and summarize the evidence obtained from MAs/SRs of probiotic treatments for IBD and pouchitis patients. Methods The PubMed, EMBASE, Cochrane Library and China National Knowledge Infrastructure (CNKI) databases were searched to identify Chinese and English language MAs/SRs of the use of probiotics for IBD and pouchitis. The Assessment of Multiple Systematic Reviews (AMSTAR) scale was used to assess the methodological quality of the studies. Results A total of 36 MAs/SRs were evaluated. The AMSTAR scores of the included studies ranged from 1 to 10, and the average score was 5.81. According to the Canadian Agency for Drugs and Technologies in Health, 4 articles were classified as high quality, 24 articles were classified as moderate quality, and 8 articles were classified as low quality. Most of the MAs/SRs suggested that probiotics had potential benefits for patients with ulcerative colitis (UC), but failed to show effectiveness in the induction and maintenance of remission in Crohn's disease (CD). The probiotic preparation VSL#3 may play a beneficial role in pouchitis. Conclusion The overall methodological quality of the current MAs/SRs in the field of probiotics for IBD and pouchitis was found to be low to moderate. More MAs/SRs of high quality are required to support using probiotics to treat IBD and pouchitis.	[Dong, Jinpei; Teng, Guigen; Wei, Tiantong; Gao, Wen; Wang, Huahong] Peking Univ, Hosp 1, Dept Gastroenterol, Beijing, Peoples R China	Peking University	Wang, HH (corresponding author), Peking Univ, Hosp 1, Dept Gastroenterol, Beijing, Peoples R China.	wwwanghuahong@163.com						Abdollahi M, 2010, VALUE HEALTH, V13, pA368; Ashraf I, 2014, AM J GASTROENTEROL, V109, pS677, DOI 10.14309/00000434-201410002-02330; Basso PJ, 2014, BRAZ J MED BIOL RES, V47, P727, DOI 10.1590/1414-431X20143932; Butterworth AD, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006634.pub2; Canadian Agency for Drugs and Technologies in Health (CADTH), 2011, INT DIR CONS; Chen RH, 2012, CHIN J GASTROENTEROL, V17, P221; Cornell JE, 2008, ANN INTERN MED, V148, P786, DOI 10.7326/0003-4819-148-10-200805200-00012; Dai ZJ, 2014, CHIN J CLIN ELECT ED, P1303; Del Carmen S, 2015, CURRENT REV GENETICA, V2015; Ding J, 2012, CHIN J GASTROENTEROL, P521; Doherty GA, 2010, ALIMENT PHARM THER, V31, P802, DOI 10.1111/j.1365-2036.2010.04231.x; Doherty GA, 2009, GASTROENTEROLOGY, V136, pA772; Elahi B, 2008, DIGEST DIS SCI, V53, P1278, DOI 10.1007/s10620-007-0006-z; Fujiya M, 2014, CLIN J GASTROENTEROL, V7, P1, DOI 10.1007/s12328-013-0440-8; Ghouri YA, 2014, CLIN EXP GASTROENTER, V7, P473, DOI 10.2147/CEG.S27530; Gordon M, 2016, INFLAMM BOWEL DIS, V22, pS26, DOI 10.1097/01.MIB.0000480157.91552.e9; Hu Z., 2013, CHINA PHARM, V22, P3; Jin DC, 2016, CHIN J CLIN ELECT ED, P401; Jonkers D, 2012, DRUGS, V72, P803, DOI 10.2165/11632710-000000000-00000; Saez-Lara MJ, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/505878; Jun S, 2008, CHIN J GASTROENTEROL, P114; Li XM, 2014, MORDEN PREVENT MED, P4439; Liao Z. L., 2010, THESIS; Losurdo G, 2015, J GASTROINTEST LIVER, V24, P499, DOI 10.15403/jgld.2014.1121.244.ecn; Lu J, 2009, J CLIN INTERN MED, V26, P32; Ma JC, 2008, SHI JIE HUA REN XIAO, V16, P4123; Ma X., 2013, THESIS; Mallon P, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005573.pub2; Mardini HE, 2014, INFLAMM BOWEL DIS, V20, P1562, DOI 10.1097/MIB.0000000000000084; Naidoo K, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007443.pub2; Nikfar S, 2010, INT J PHARMACOL, V6, P826, DOI 10.3923/ijp.2010.826.835; Niu XiaoPing, 2010, Zhongguo Weishengtaxixue Zazhi / Chinese Journal of Microecology, V22, P261; Rahimi R, 2008, DIGEST DIS SCI, V53, P2524, DOI 10.1007/s10620-007-0171-0; Rahimi R, 2008, ARCH MED SCI, V4, P185; Rolfe VE, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004826; Sang LX, 2010, WORLD J GASTROENTERO, V16, P1908, DOI 10.3748/wjg.v16.i15.1908; Sharif Mohammad O, 2013, Oral Health Dent Manag, V12, P9; Shea BJ, 2007, BMC MED RES METHODOL, V7, DOI 10.1186/1471-2288-7-10; Shen J, 2009, INTERN MED J, V39, P103, DOI 10.1111/j.1445-5994.2008.01791.x; Shen J, 2014, INFLAMM BOWEL DIS, V20, P21, DOI 10.1097/01.MIB.0000437495.30052.be; Szajewska H, 2007, PEDIAT WSPOLCZ GASTR, V9, P266; [汤绍辉 TANG Shao-hui], 2010, [解放军医学杂志, Medical Journal of Chinese People's Liberation Army], V35, P521; The Medical Research Library of Brooklyn, 2004, EV PYR; Wang XT, 2015, CHIN J GASTROENTEROL, V20, P29; [伍秋蓉 WU Qiurong], 2008, [中国循证医学杂志, Chinese Journal of Evidence-Based Medicine], V8, P315; Ye K, 2014, J CHINA JAPAN FRIEND, V28, P288; Zhang QN, 2016, CONT MED, P4; Zigra PI, 2007, NETH J MED, V65, P411	48	21	22	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2016	11	12							e0168785	10.1371/journal.pone.0168785	http://dx.doi.org/10.1371/journal.pone.0168785			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI9QH	28005973	gold, Green Published, Green Submitted			2022-12-27	WOS:000392843200093
J	Kajzer-Bonk, J; Skorka, P; Nowicki, P; Bonk, M; Krol, W; Szpilyk, D; Woyciechowski, M				Kajzer-Bonk, Joanna; Skorka, Piotr; Nowicki, Piotr; Bonk, Maciej; Krol, Wieslaw; Szpilyk, Damian; Woyciechowski, Michal			Relative Contribution of Matrix Structure, Patch Resources and Management to the Local Densities of Two Large Blue Butterfly Species	PLOS ONE			English	Article							DIFFERENT SPATIAL SCALES; MACULINEA BUTTERFLIES; FRAGMENTED LANDSCAPES; AGRICULTURAL LANDSCAPES; HABITAT FRAGMENTATION; POPULATION-SIZE; LEPIDOPTERA LYCAENIDAE; METAPOPULATION THEORY; TELEIUS LEPIDOPTERA; ROAD VERGES	The type of matrix, the landscape surrounding habitat patches, may determine the distribution and function of local populations. However, the matrix is often heterogeneous, and its various components may differentially contribute to metapopulation processes at different spatial scales, a phenomenon that has rarely been investigated. The aim of this study was to estimate the relative importance of matrix composition and spatial scale, habitat quality, and management intensity on the occurrence and density of local populations of two endangered large blue butterflies: Phengaris teleius and P. nausithous. Presence and abundance data were assessed over two years, 2011-12, in 100 local patches within two heterogeneous regions (near Krakow and Tarnow, southern Poland). The matrix composition was analyzed at eight spatial scales. We observed high occupancy rates in both species, regions and years. With the exception of area and isolation, almost all of the matrix components contributed to Phengaris sp. densities. The different matrix components acted at different spatial scales (grassland cover within 4 and 3 km, field cover within 0.4 and 0.3 km and water cover within 4 km radii for P. teleius and P. nausithous, respectively) and provided the highest independent contribution to the butterfly densities. Additionally, the effects of a 0.4 km radius of forest cover and a food plant cover on P. teleius, and a 1 km radius of settlement cover and management intensity on P. nausithous densities were observed. Contrary to former studies we conclude that the matrix heterogeneity and spatial scale rather than general matrix type are of relevance for densities of butterflies. Conservation strategies for these umbrella species should concentrate on maintaining habitat quality and managing matrix composition at the most appropriate spatial scales.	[Kajzer-Bonk, Joanna; Nowicki, Piotr; Szpilyk, Damian; Woyciechowski, Michal] Jagiellonian Univ, Inst Environm Sci, Krakow, Poland; [Skorka, Piotr; Bonk, Maciej; Krol, Wieslaw] Polish Acad Sci, Inst Nat Conservat, Krakow, Poland; [Bonk, Maciej] Jagiellonian Univ, Inst Zool, Krakow, Poland	Jagiellonian University; Polish Academy of Sciences; Jagiellonian University	Kajzer-Bonk, J (corresponding author), Jagiellonian Univ, Inst Environm Sci, Krakow, Poland.	joanna.kajzer.bonk@gmail.com	Skórka, Piotr/B-7218-2009; Kajzer-Bonk, Joanna/ABE-1587-2020; Nowicki, Piotr/AFP-2530-2022	Skórka, Piotr/0000-0002-3221-296X; Kajzer-Bonk, Joanna/0000-0003-4063-2785; Skorka, Piotr/0000-0002-7486-2928; Krol, Wieslaw/0000-0002-1217-1654; Nowicki, Piotr/0000-0002-9797-886X	EU FP7 SCALES 410 program [22685]; Polish National Science Centre [N N304 064139, DEC-2013/11/B/NZ8/00912]; Matopolska Foundation; Jagiellonian University [DS/WBiNoZ/INoS/761/10-12]	EU FP7 SCALES 410 program; Polish National Science Centre; Matopolska Foundation; Jagiellonian University	The study was funded by the EU FP7 SCALES 410 program ("Securing the Conservation of biodiversity across Administrative Levels and spatial, temporal and Ecological Scales"; project #22685), the Polish National Science Centre through grants N N304 064139 and DEC-2013/11/B/NZ8/00912, the Matopolska Foundation for PhD Students "Doctus" and the Jagiellonian University through grant DS/WBiNoZ/INoS/761/10-12. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2014, R LANG ENV STAT COMP; Anton C, 2007, MOL ECOL, V16, P3828, DOI 10.1111/j.1365-294X.2007.03441.x; Baguette M, 2004, BASIC APPL ECOL, V5, P213, DOI 10.1016/j.baae.2004.03.001; Banski J, 2010, LANDSCAPE URBAN PLAN, V94, P116, DOI 10.1016/j.landurbplan.2009.08.005; Barton K., MUMIN MULTIMODEL INF; Batary P, 2007, EUR J ENTOMOL, V104, P731, DOI 10.14411/eje.2007.093; Bates Douglas, 2014, LME4 LINEAR MIXED EF; Bender DJ, 2005, ECOLOGY, V86, P1023, DOI 10.1890/03-0769; Bergman KO, 2004, ECOGRAPHY, V27, P619, DOI 10.1111/j.0906-7590.2004.03906.x; Bignal EM, 1996, J APPL ECOL, V33, P413, DOI 10.2307/2404973; Billeter R, 2008, J APPL ECOL, V45, P141, DOI 10.1111/j.1365-2664.2007.01393.x; Bommarco R, 2014, DIVERS DISTRIB, V20, P1; Bonelli S, 2013, POPUL ECOL, V55, P469, DOI 10.1007/s10144-013-0377-2; Botham MS, 2015, J INSECT CONSERV, V19, P403, DOI 10.1007/s10841-015-9760-y; Burnham K. P., 2002, MODEL SELECTION MULT, V2nd; Cattin MF, 2003, BIOL CONSERV, V113, P179, DOI 10.1016/S0006-3207(02)00297-5; Clough Y, 2014, ECOL LETT, V17, P1168, DOI 10.1111/ele.12325; Collins S, 2010, VS2010037 BUTT CONS; Cooch E, 2012, PROGRAM MARK GENTLE; Cozzi G, 2008, LANDSCAPE ECOL, V23, P269, DOI 10.1007/s10980-007-9178-3; Cremene C, 2005, CONSERV BIOL, V19, P1606, DOI 10.1111/j.1523-1739.2005.00084.x; Davis JD, 2007, LANDSCAPE ECOL, V22, P1341, DOI 10.1007/s10980-007-9111-9; Dennis R.L.H., 2010, BUTTERFLIES BRIT LAN; Dennis RLH, 2003, OIKOS, V102, P417, DOI 10.1034/j.1600-0706.2003.12387.x; Didham RK, 2012, OIKOS, V121, P161, DOI 10.1111/j.1600-0706.2011.20273.x; Dierks A, 2009, BIODIVERS CONSERV, V18, P3663, DOI 10.1007/s10531-009-9670-y; Driscoll DA, 2013, TRENDS ECOL EVOL, V28, P605, DOI 10.1016/j.tree.2013.06.010; Ekroos J, 2010, J APPL ECOL, V47, P459, DOI 10.1111/j.1365-2664.2009.01767.x; Elmes GW, 1998, J INSECT CONSERV, V2, P67, DOI 10.1023/A:1009696823965; ELMES GW, 1992, BIODIVERS CONSERV, V1, P155, DOI 10.1007/BF00695913; Eycott AE, 2012, LANDSCAPE ECOL, V27, P1263, DOI 10.1007/s10980-012-9781-9; Fahrig L, 2001, BIOL CONSERV, V100, P65, DOI 10.1016/S0006-3207(00)00208-1; Franklin JF, 2009, P NATL ACAD SCI USA, V106, P349, DOI 10.1073/pnas.0812016105; Gagne SA, 2011, ECOL APPL, V21, P2297, DOI 10.1890/09-1905.1; Grill A, 2008, J INSECT CONSERV, V12, P617, DOI 10.1007/s10841-007-9098-1; Habel JC, 2013, BIODIVERS CONSERV, V22, P2131, DOI 10.1007/s10531-013-0537-x; Hamback PA, 2005, ECOL LETT, V8, P1057, DOI 10.1111/j.1461-0248.2005.00811.x; HANSKI I, 1994, ECOLOGY, V75, P747, DOI 10.2307/1941732; Hanski I, 1996, AM NAT, V147, P527, DOI 10.1086/285864; HANSKI I, 1997, METAPOPULATION BIOL; Hanski Ilkka, 1997, P69, DOI 10.1016/B978-012323445-2/50007-9; Harper KA, 2005, CONSERV BIOL, V19, P768, DOI 10.1111/j.1523-1739.2005.00045.x; Hovestadt T, 2011, J ANIM ECOL, V80, P1070, DOI 10.1111/j.1365-2656.2011.01848.x; Humbert JY, 2012, ENVIRON EVID, V1, DOI 10.1186/2047-2382-1-9; Humbert JY, 2012, BIOL CONSERV, V152, P96, DOI 10.1016/j.biocon.2012.03.015; Johst K, 2006, J APPL ECOL, V43, P333, DOI 10.1111/j.1365-2664.2006.01125.x; Joyce CB, 2014, ECOL ENG, V66, P91, DOI 10.1016/j.ecoleng.2013.05.008; Kacki Z., 2009, OCHRONA ZAGROZONYCH, p[12, 29]; Kajzer-Bonk J, 2016, J INSECT CONSERV, V20, P99, DOI 10.1007/s10841-016-9843-4; Kajzer-Bonk J, 2013, J INSECT CONSERV, V17, P1105, DOI 10.1007/s10841-013-9591-7; Kalarus K, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0138557; Kleijn D, 2006, BASIC APPL ECOL, V7, P201, DOI 10.1016/j.baae.2005.07.011; Kormann U, 2015, DIVERS DISTRIB, V21, P1204, DOI 10.1111/ddi.12324; Korosi A, 2014, AGR ECOSYST ENVIRON, V196, P24, DOI 10.1016/j.agee.2014.06.019; Krauss J, 2003, J BIOGEOGR, V30, P889, DOI 10.1046/j.1365-2699.2003.00878.x; Kumar S, 2009, BIODIVERS CONSERV, V18, P739, DOI 10.1007/s10531-008-9536-8; Kunes P, 2015, QUATERNARY SCI REV, V116, P15, DOI 10.1016/j.quascirev.2015.03.014; Leidner AK, 2010, CONSERV GENET, V11, P2311, DOI 10.1007/s10592-010-0117-5; Lenda M, 2012, BIOL CONSERV, V148, P180, DOI 10.1016/j.biocon.2012.01.014; Levins R., 1970, SOME MATH PROBLEMS B, P75; Lindenmayer D, 2008, ECOL LETT, V11, P78, DOI 10.1111/j.1461-0248.2007.01114.x; LORITZ H, 2005, STUDIES ECOLOGY CONS, V2, P221; MAC ARTHUR ROBERT H., 1967; Mac Nally R, 2002, BIODIVERS CONSERV, V11, P1397, DOI 10.1023/A:1016250716679; Magura T, 2007, AGR ECOSYST ENVIRON, V119, P396, DOI 10.1016/j.agee.2006.08.014; Marini L, 2014, ECOGRAPHY, V37, P544, DOI 10.1111/j.1600-0587.2013.00369.x; Marini L, 2009, INSECT CONSERV DIVER, V2, P213, DOI 10.1111/j.1752-4598.2009.00053.x; MARTIN J., 1999, NATURE ENV, V97; Martins IS, 2014, ACTA OECOL, V61, P41, DOI 10.1016/j.actao.2014.10.005; Marzluff John M., 2001, P19; Mendenhall CD, 2014, NATURE, V509, P213, DOI 10.1038/nature13139; Nakagawa S, 2013, METHODS ECOL EVOL, V4, P133, DOI 10.1111/j.2041-210x.2012.00261.x; Nowicki P, 2005, POPUL ECOL, V47, P203, DOI 10.1007/s10144-005-0223-2; Nowicki P, 2007, BIOL CONSERV, V140, P119, DOI 10.1016/j.biocon.2007.08.001; Nowicki P, 2014, LANDSCAPE ECOL, V29, P401, DOI 10.1007/s10980-013-9971-0; Nowicki P, 2011, OECOLOGIA, V167, P657, DOI 10.1007/s00442-011-2025-x; Nowicki Piotr, 2005, P144; Nowicki P, 2009, OECOLOGIA, V161, P227, DOI 10.1007/s00442-009-1373-2; Ockinger E, 2012, ECOGRAPHY, V35, P259, DOI [10.1111/ j. 1600- 0587.2011.06870, DOI 10.1111/J.1600-0587.2011.06870]; Ovaskainen O, 2002, J THEOR BIOL, V215, P95, DOI 10.1006/jtbi.2001.2502; Pereira HM, 2006, ECOLOGY, V87, P1877, DOI 10.1890/0012-9658(2006)87[1877:MBDICL]2.0.CO;2; Poyry J, 2009, OECOLOGIA, V160, P577, DOI 10.1007/s00442-009-1328-7; Prevedello JA, 2010, BIODIVERS CONSERV, V19, P1205, DOI 10.1007/s10531-009-9750-z; Prugh LR, 2008, P NATL ACAD SCI USA, V105, P20770, DOI 10.1073/pnas.0806080105; Pykala J, 2000, CONSERV BIOL, V14, P705, DOI 10.1046/j.1523-1739.2000.99119.x; Ricketts TH, 2001, AM NAT, V158, P87, DOI 10.1086/320863; Ries L, 2001, J ANIM ECOL, V70, P840, DOI 10.1046/j.0021-8790.2001.00546.x; Pedro ARS, 2015, LANDSCAPE ECOL, V30, P1561, DOI 10.1007/s10980-015-0213-5; Roland J, 2000, ECOLOGY, V81, P1642, DOI 10.1890/0012-9658(2000)081[1642:APBDEO]2.0.CO;2; Rosin ZM, 2011, EUR J ENTOMOL, V108, P99, DOI 10.14411/eje.2011.013; Saunders SC, 2005, ECOL COMPLEX, V2, P87, DOI 10.1016/j.ecocom.2004.11.002; Schippers P, 2002, AGR ECOSYST ENVIRON, V93, P351, DOI 10.1016/S0167-8809(01)00339-5; Skorka P, 2007, AGR ECOSYST ENVIRON, V121, P319, DOI 10.1016/j.agee.2006.11.001; Skorka P, 2016, LANDSCAPE ECOL, V31, P2063, DOI 10.1007/s10980-016-0382-x; Skorka P, 2013, LANDSCAPE ECOL, V28, P533, DOI 10.1007/s10980-013-9855-3; Steffan-Dewenter I, 2002, ECOLOGY, V83, P1421, DOI 10.1890/0012-9658(2002)083[1421:SDEOLC]2.0.CO;2; Sweaney N, 2014, J INSECT CONSERV, V18, P283, DOI 10.1007/s10841-014-9641-9; Thomas J, 1980, ORYX, V15, P243; Thomas J. A., 2005, STUDIES ECOLOGY CONS, V2, P28; Thomas JA, 2004, NATURE, V432, P283, DOI 10.1038/432283a; THOMAS JA, 1989, OECOLOGIA, V79, P452, DOI 10.1007/BF00378660; Thomas JA, 1998, INSECT POPULATIONS IN THEORY AND IN PRACTICE, P261; Trzcinski MK, 1999, ECOL APPL, V9, P586, DOI 10.1890/1051-0761(1999)009[0586:IEOFCA]2.0.CO;2; Tyler GA, 1998, BIRD STUDY, V45, P35, DOI 10.1080/00063659809461076; Valtonen A., 2006, Animal Biodiversity and Conservation, V29, P133; Van Dyck H, 2005, BASIC APPL ECOL, V6, P535, DOI 10.1016/j.baae.2005.03.005; Villemey A, 2015, BIOL CONSERV, V191, P206, DOI 10.1016/j.biocon.2015.06.030; Walasz K., 2015, OCHRONA KRAJOBRAZU Z; WallisDeVries MF, 2004, CONSERV BIOL, V18, P489; Walsh C., 2005, HIER PART PACKAGE VE; Weibull AC, 2000, ECOGRAPHY, V23, P743, DOI 10.1034/j.1600-0587.2000.230611.x; Westphal MI, 2003, LANDSCAPE ECOL, V18, P413, DOI 10.1023/A:1026115807529; Wettstein W, 1999, J APPL ECOL, V36, P363, DOI 10.1046/j.1365-2664.1999.00404.x; WIKUM DA, 1978, ENVIRON MANAGE, V2, P323, DOI 10.1007/BF01866672; Winter M, 2006, J WILDLIFE MANAGE, V70, P158, DOI 10.2193/0022-541X(2006)70[158:PSALEO]2.0.CO;2; Witek M, 2006, OECOLOGIA, V148, P729, DOI 10.1007/s00442-006-0404-5; Wu JG, 2004, LANDSCAPE ECOL, V19, P125, DOI 10.1023/B:LAND.0000021711.40074.ae; Wynhoff I, 2011, J INSECT CONSERV, V15, P189, DOI 10.1007/s10841-010-9337-8; Wysocki C., 2002, FITOSOCJOLOGIA STOSO; Yan H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102124; [No title captured]	121	7	7	0	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2016	11	12							e0168679	10.1371/journal.pone.0168679	http://dx.doi.org/10.1371/journal.pone.0168679			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI9QH	28005942	Green Published, gold			2022-12-27	WOS:000392843200079
J	Laker, RC; Taddeo, EP; Akhtar, YN; Zhang, M; Hoehn, KL; Yan, Z				Laker, Rhianna C.; Taddeo, Evan P.; Akhtar, Yasir N.; Zhang, Mei; Hoehn, Kyle L.; Yan, Zhen			The Mitochondrial Permeability Transition Pore Regulator Cyclophilin D Exhibits Tissue-Specific Control of Metabolic Homeostasis	PLOS ONE			English	Article							MEMBRANE; TRANSLOCATOR; TARGET	The mitochondrial permeability transition pore (mPTP) is a key regulator of mitochondrial function that has been implicated in the pathogenesis of metabolic disease. Cyclophilin D (CypD) is a critical regulator that directly binds to mPTP constituents to facilitate the pore opening. We previously found that global CypD knockout mice (KO) are protected from diet-induced glucose intolerance; however, the tissue-specific function of CypD and mPTP, particularly in the control of glucose homeostasis, has not been ascertained. To this end, we performed calcium retention capacity (CRC) assay to compare the importance of CypD in the liver versus skeletal muscle. We found that liver mitochondria are more dependent on CypD for mPTP opening than skeletal muscle mitochondria. To ascertain the tissue-specific role of CypD in metabolic homeostasis, we generated liver-specific and muscle-specific CypD knockout mice (LKO and MKO, respectively) and fed them either a chow diet or 45% high-fat diet (HFD) for 14 weeks. MKO mice displayed similar body weight gain and glucose intolerance compared with wild type littermates (WT), whereas LKO mice developed greater visceral obesity, glucose intolerance and pyruvate intolerance compared with WT mice. These findings demonstrate that loss of muscle CypD is not sufficient to alter whole body glucose metabolism, while the loss of liver CypD exacerbates obesity and whole-body metabolic dysfunction in mice fed HFD.	[Laker, Rhianna C.; Akhtar, Yasir N.; Zhang, Mei; Yan, Zhen] Univ Virginia, Sch Med, Dept Med, Charlottesville, VA 22908 USA; [Laker, Rhianna C.; Akhtar, Yasir N.; Zhang, Mei; Hoehn, Kyle L.; Yan, Zhen] Univ Virginia, Sch Med, Ctr Skeletal Muscle Res Robert M Berne Cardiovasc, Charlottesville, VA 22908 USA; [Taddeo, Evan P.; Hoehn, Kyle L.; Yan, Zhen] Univ Virginia, Sch Med, Dept Pharmacol, Charlottesville, VA 22908 USA; [Yan, Zhen] Univ Virginia, Sch Med, Dept Mol Physiol & Biol Phys, Charlottesville, VA 22908 USA	University of Virginia; University of Virginia; University of Virginia; University of Virginia	Yan, Z (corresponding author), Univ Virginia, Sch Med, Dept Med, Charlottesville, VA 22908 USA.; Yan, Z (corresponding author), Univ Virginia, Sch Med, Ctr Skeletal Muscle Res Robert M Berne Cardiovasc, Charlottesville, VA 22908 USA.; Yan, Z (corresponding author), Univ Virginia, Sch Med, Dept Pharmacol, Charlottesville, VA 22908 USA.; Yan, Z (corresponding author), Univ Virginia, Sch Med, Dept Mol Physiol & Biol Phys, Charlottesville, VA 22908 USA.	zhen.yan@virginia.edu		Yan, Zhen/0000-0002-4826-9813; Hoehn, Kyle/0000-0002-0214-3238	American Heart Association Postdoctoral Fellowship [14POST20450061]; American Diabetes Association Junior Faculty Award [1-11-JF-17]; American Diabetes Association Basic Research Award [1-11-BS-181]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR050429] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK101803] Funding Source: NIH RePORTER	American Heart Association Postdoctoral Fellowship(American Heart Association); American Diabetes Association Junior Faculty Award(American Diabetes Association); American Diabetes Association Basic Research Award; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by the American Heart Association Postdoctoral Fellowship to RCL (14POST20450061), American Diabetes Association Junior Faculty Award to KLH (1-11-JF-17) and an American Diabetes Association Basic Research Award to ZY (1-11-BS-181). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAMS V, 1989, BIOCHIM BIOPHYS ACTA, V981, P213, DOI 10.1016/0005-2736(89)90031-X; Akimoto T, 2004, AM J PHYSIOL-CELL PH, V287, pC1311, DOI 10.1152/ajpcell.00248.2004; Baines CP, 2007, NAT CELL BIOL, V9, P550, DOI 10.1038/ncb1575; Baines CP, 2005, NATURE, V434, P658, DOI 10.1038/nature03434; BUCHELER K, 1991, BIOCHIM BIOPHYS ACTA, V1056, P233, DOI 10.1016/S0005-2728(05)80054-4; Csukly K, 2006, J PHYSIOL-LONDON, V574, P319, DOI 10.1113/jphysiol.2006.109702; Deutsch MJ, 2014, ANAL BIOCHEM, V445, P87, DOI 10.1016/j.ab.2013.10.001; Devalaraja-Narashimha K, 2011, FEBS LETT, V585, P677, DOI 10.1016/j.febslet.2011.01.031; Elmore SP, 2001, FASEB J, V15, P2286, DOI 10.1096/fj.01-0206fje; Elrod JW, 2013, CIRC J, V77, P1111, DOI 10.1253/circj.CJ-13-0321; Endlicher Rene, 2009, Acta Medica (Hradec Kralove), V52, P69; Fontaine E, 1998, J BIOL CHEM, V273, P12662, DOI 10.1074/jbc.273.20.12662; Giorgi C, 2012, MITOCHONDRION, V12, P77, DOI 10.1016/j.mito.2011.07.004; Giorgio V, 2013, P NATL ACAD SCI USA, V110, P5887, DOI 10.1073/pnas.1217823110; Giorgio V, 2009, J BIOL CHEM, V284, P33982, DOI 10.1074/jbc.M109.020115; Halestrap AP, 1997, J BIOL CHEM, V272, P3346, DOI 10.1074/jbc.272.6.3346; Halestrap AP, 1998, BBA-BIOENERGETICS, V1366, P79, DOI 10.1016/S0005-2728(98)00122-4; Hansson MJ, 2011, J NEUROTRAUM, V28, P143, DOI 10.1089/neu.2010.1613; Hausenloy DJ, 2010, CARDIOVASC RES, V88, P67, DOI 10.1093/cvr/cvq113; He LH, 2002, FEBS LETT, V512, P1, DOI 10.1016/S0014-5793(01)03314-2; Huser J, 1999, BIOCHEM J, V343, P311, DOI 10.1042/0264-6021:3430311; Javadov S, 2009, J PHARMACOL EXP THER, V330, P670, DOI 10.1124/jpet.109.153213; Kokoszka JE, 2004, NATURE, V427, P461, DOI 10.1038/nature02229; Krauskopf A, 2006, BBA-BIOENERGETICS, V1757, P590, DOI 10.1016/j.bbabio.2006.02.007; Luvisetto S, 2008, NEUROSCIENCE, V155, P585, DOI 10.1016/j.neuroscience.2008.06.030; Nguyen TT, 2011, J BIOL CHEM, V286, P40184, DOI 10.1074/jbc.M111.243469; Petronilli V, 1999, BIOPHYS J, V76, P725, DOI 10.1016/S0006-3495(99)77239-5; Rodriguez-Enriquez S, 2004, INT J BIOCHEM CELL B, V36, P2463, DOI 10.1016/j.biocel.2004.04.009; Rodriguez-Enriquez S, 2009, AUTOPHAGY, V5, P1099, DOI 10.4161/auto.5.8.9825; Shang W, 2016, J MOL CELL CARDIOL, V91, P63, DOI 10.1016/j.yjmcc.2015.10.036; Taddeo EP, 2014, MOL METAB, V3, P124, DOI 10.1016/j.molmet.2013.11.003; Tavecchio M, 2015, SCI REP-UK, V5, DOI 10.1038/srep15981; Tubbs E, 2014, DIABETES, V63, P3279, DOI 10.2337/db13-1751; Vyssokikh MY, 2001, BIOCHEM J, V358, P349, DOI 10.1042/0264-6021:3580349; Zorov DB, 2009, CARDIOVASC RES, V83, P213, DOI 10.1093/cvr/cvp151	35	30	31	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2016	11	12							e0167910	10.1371/journal.pone.0167910	http://dx.doi.org/10.1371/journal.pone.0167910			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI9QH	28005946	Green Published, Green Submitted, gold			2022-12-27	WOS:000392843200023
J	Lambkin-Williams, R; Gelder, C; Broughton, R; Mallett, CP; Gilbert, AS; Mann, A; He, D; Oxford, JS; Burt, D				Lambkin-Williams, Rob; Gelder, Colin; Broughton, Richard; Mallett, Corey P.; Gilbert, Anthony S.; Mann, Alex; He, David; Oxford, John S.; Burt, David			An Intranasal Proteosome-Adjuvanted Trivalent Influenza Vaccine Is Safe, Immunogenic & Efficacious in the Human Viral Influenza Challenge Model. Serum IgG & Mucosal IgA Are Important Correlates of Protection against Illness Associated with Infection	PLOS ONE			English	Article							DOUBLE-BLIND; IMMUNIZATION; PREVENTION; IMMUNITY; DISEASE	Introduction A Proteosome-adjuvanted trivalent inactivated influenza vaccine (P-TIV) administered intranasally was shown to be safe, well tolerated and immunogenic in both systemic and mucosal compartments, and effective at preventing illness associated with evidence of influenza infection. Methods In two separate studies using the human viral challenge model, subjects were selected to be immunologically naive to A/Panama/2007/1999 (H3N2) virus and then dosed via nasal spray with one of three regimens of P-TIV or placebo. One or two doses, 15 pg or 30 pg, were given either once only or twice 14 days apart (1 x 30 pg, 2 x 30 pg, 2 x 15 pg) and subjects were challenged with A/Panama/2007/1999 (H3N2) virus. Immune responses to the vaccine antigens were measured by haemagglutination inhibition assay (HAI) and nasal wash secretory IgA (sIgA) antibodies. Results Vaccine reactogenicity was mild, predictable and generally consistent with earlier Phase I studies with this vaccine. Seroconversion to A/Panama/2007/1999 (H3N2), following vaccination but prior to challenge, occurred in 57% to 77% of subjects in active dosing groups and 2% of placebo subjects. The greatest relative rise in sIgA, following vaccination but prior to challenge, was observed in groups that received 2 doses. Conclusion Intranasal vaccination significantly protected against influenza (as defined by influenza symptoms combined with A/Panama seroconversion) following challenge with A/Panama/ 2007/1999 (H3N2). When data were pooled from both studies, efficacy ranged from 58% to 82% in active dosing groups for any influenza symptoms with seroconversion, 67% to 85% for systemic or lower respiratory illness and seroconversion, and 65% to 100% for febrile illness and seroconversion. The two dose regimen was found to be superior to the single dose regimen. In this study, protection against illness associated with evidence of influenza infection (evidence determined by seroconversion) following challenge with virus, significantly correlated with pre-challenge HAI titres (p = 0.0003) and mucosal sIgA (p<0.0001) individually, and HAI (p = 0.028) and sIgA (p = 0.0014) together. HAI and sIgA levels were inversely related to rates of illness.	[Lambkin-Williams, Rob; Gilbert, Anthony S.; Mann, Alex] Queen Mary BioEnterprises Innovat Ctr, HVIVO Grp PLC, London, England; [Gelder, Colin] Univ Hosp Coventry & Warwickshire NHS Trust, Clifford Bridge Rd, Coventry, W Midlands, England; [Broughton, Richard; Mallett, Corey P.; Burt, David] ID Biomed Corp Quebec, 7150 Frederick Banting, St Laurent, PQ, Canada; [He, David] Analyt Solut Grp Inc, 14730 Soft Wind Dr, North Potomac, MD USA; [Oxford, John S.] Barts & London Queen Marys Sch Med & Dent, London, England	University of Warwick; University of London; Queen Mary University London	Lambkin-Williams, R (corresponding author), Queen Mary BioEnterprises Innovat Ctr, HVIVO Grp PLC, London, England.	rlw@hvivo.com	Lambkin-Williams, Rob/L-2397-2019	Lambkin-Williams, Rob/0000-0003-2107-0174; Mann, Alexander/0000-0002-3744-4604; Gilbert, Anthony Saul/0000-0002-6582-3820	hVIVO Group PLC.; University Hospitals Coventry & Warwickshire NHS Trust; ID Biomedical Corporation of Quebec; Analytical Solutions Group, Inc.; Queen Mary's School of Medicine and Dentistry; ID Biomedical Corporation of Maryland	hVIVO Group PLC.; University Hospitals Coventry & Warwickshire NHS Trust; ID Biomedical Corporation of Quebec; Analytical Solutions Group, Inc.; Queen Mary's School of Medicine and Dentistry; ID Biomedical Corporation of Maryland	This study was funded by the authors' affiliations, i.e. hVIVO Group PLC., University Hospitals Coventry & Warwickshire NHS Trust, ID Biomedical Corporation of Quebec, Analytical Solutions Group, Inc. Queen Mary's School of Medicine and Dentistry and ID Biomedical Corporation of Maryland. hVIVO Group PLC., Analytical Solutions Group, Inc., ID Biomedical Corporation of Quebec and ID Biomedical Corporation of Maryland provided support in the form of salaries for authors RLW, ASG, AM, RB, CPM, DB, and DH, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Borroso L, 2005, ANTIVIR THER, V10, P901; Boyce TG, 1999, VACCINE, V18, P82, DOI 10.1016/S0264-410X(99)00183-8; Burt D, 2011, EXPERT REV VACCINES, V10, P365, DOI [10.1586/ERV.10.172, 10.1586/erv.10.172]; Calfee DP, 1998, DRUGS, V56, P537, DOI 10.2165/00003495-199856040-00003; Calfee DP, 1999, ANTIVIR THER, V4, P143; DeVincenzo J, 2010, P NATL ACAD SCI USA, V107, P8800, DOI 10.1073/pnas.0912186107; DeVincenzo JP, 2014, NEW ENGL J MED, V371, P711, DOI 10.1056/NEJMoa1401184; DeVincenzo JP, 2010, AM J RESP CRIT CARE, V182, P1305, DOI 10.1164/rccm.201002-0221OC; Fries LF, 2001, INFECT IMMUN, V69, P4545, DOI 10.1128/IAI.69.7.4545-4553.2001; Grohskopf LA, 2016, MMWR RECOMM REP, V65, P1, DOI 10.15585/mmwr.rr6505a1; HAYDEN FG, 1994, ANTIMICROB AGENTS CH, V38, P1178, DOI 10.1128/AAC.38.5.1178; Hayden FG, 1996, JAMA-J AM MED ASSOC, V275, P295, DOI 10.1001/jama.275.4.295; Hayden FG, 1999, JAMA-J AM MED ASSOC, V282, P1240, DOI 10.1001/jama.282.13.1240; Jones S, 2009, VACCINE, V27, P2506, DOI 10.1016/j.vaccine.2009.02.061; Jones T, 2003, VACCINE, V21, P3706, DOI 10.1016/S0264-410X(03)00387-6; Lambkin R, 2004, VACCINE, V22, P4390, DOI 10.1016/j.vaccine.2003.10.054; Langley JM, 2011, VACCINE, V29, P1921, DOI 10.1016/j.vaccine.2010.12.100; Langley JM, 2006, VACCINE, V24, P1601, DOI 10.1016/j.vaccine.2005.09.056; LEVI R, 1995, VACCINE, V13, P1353, DOI 10.1016/0264-410X(94)00083-Y; Lillie PJ, 2012, CLIN INFECT DIS, V55, P19, DOI 10.1093/cid/cis327; Liu H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052135; McCullers JA, 2012, HUM VACC IMMUNOTHER, V8, P34, DOI 10.4161/hv.8.1.18214; Mett V, 2008, INFLUENZA OTHER RESP, V2, P33, DOI 10.1111/j.1750-2659.2008.00037.x; Mutsch M, 2004, NEW ENGL J MED, V350, P896, DOI 10.1056/NEJMoa030595; Ohmit SE, 2011, J INFECT DIS, V204, P1879, DOI 10.1093/infdis/jir661; Plante M, 2001, VACCINE, V20, P218, DOI 10.1016/S0264-410X(01)00268-7; Romanova J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005984; Rose MA, 2012, EXPERT REV VACCINES, V11, P595, DOI [10.1586/erv.12.31, 10.1586/ERV.12.31]; Treanor J, 2006, VACCINE, V24, P254, DOI 10.1016/j.vaccine.2005.07.088; Treanor J, 2003, Dev Biol (Basel), V115, P97; van Riet E, 2012, VACCINE, V30, P5893, DOI 10.1016/j.vaccine.2012.04.109; Wilkinson TM, 2012, NAT MED, V18, P274, DOI 10.1038/nm.2612; YOUNGNER JS, 1994, J CLIN MICROBIOL, V32, P750, DOI 10.1128/JCM.32.3.750-754.1994	33	20	23	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2016	11	12							e0163089	10.1371/journal.pone.0163089	http://dx.doi.org/10.1371/journal.pone.0163089			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI9QH	28005959	Green Submitted, Green Published, gold			2022-12-27	WOS:000392843200002
J	Langkilde, A; Olsen, LC; Saetrom, P; Drablos, F; Besenbacher, S; Raaby, L; Johansen, C; Iversen, L				Langkilde, Ane; Olsen, Lene C.; Saetrom, Pal; Drablos, Finn; Besenbacher, Soren; Raaby, Line; Johansen, Claus; Iversen, Lars			Pathway Analysis of Skin from Psoriasis Patients after Adalimumab Treatment Reveals New Early Events in the Anti-Inflammatory Mechanism of Anti-TNF-alpha	PLOS ONE			English	Article							MESSENGER-RNA EXPRESSION; NECROSIS-FACTOR-ALPHA; LARGE GENE LISTS; RHEUMATOID-ARTHRITIS; CLINICAL-TRIAL; THERAPY; INHIBITION; CELLS; INFLIXIMAB; AXIS	Psoriasis is a chronic cutaneous inflammatory disease. The immunopathogenesis is a complex interplay between T cells, dendritic cells and the epidermis in which T cells and dendritic cells maintain skin inflammation. Anti-tumour necrosis factor (anti-INF)-a agents have been approved for therapeutic use across a range of inflammatory disorders including psoriasis, but the anti-inflammatory mechanisms of anti-INF-a in lesional psoriatic skin are not fully understood. We investigated early events in skin from psoriasis patients after treatment with anti-INF-a antibodies by use of bioinformatics tools. We used the Human Gene 1.0 ST Array to analyse gene expression in punch biopsies taken from psoriatic patients before and also 4 and 14 days after initiation of treatment with the anti-INF-a agent adalimumab. The gene expression was analysed by gene set enrichment analysis using the Functional Annotation Tool from DAVID Bioinformatics Resources. The most enriched pathway was visualised by the Pathview Package on Kyoto Encyclopedia of Genes and Genomes (KEGG) graphs. The analysis revealed new very early events in psoriasis after adalimumab treatment. Some of these events have been described after longer periods of anti-INF-a treatment when clinical and histological changes appear, suggesting that effects of anti-INF-a treatment on gene expression appear very early before clinical and histological changes. Combining microarray data on biopsies from psoriasis patients with pathway analysis allowed us to integrate in vitro findings into the identification of mechanisms that may be important in vivo. Furthermore, these results may reflect primary effect of anti-INF-a treatment in contrast to studies of gene expression changes following clinical and histological changes, which may reflect secondary changes correlated to the healing of the skin.	[Langkilde, Ane; Raaby, Line; Johansen, Claus; Iversen, Lars] Aarhus Univ Hosp, Dept Dermatol, Aarhus C, Denmark; [Olsen, Lene C.; Saetrom, Pal; Drablos, Finn] Norwegian Univ Sci & Technol NTNU, Dept Canc Res & Mol Med, Fac Med, Trondheim, Norway; [Saetrom, Pal] Norwegian Univ Sci & Technol NTNU, Fac Informat Technol Math & Elect Engn, Dept Comp & Informat Sci, Trondheim, Norway; [Besenbacher, Soren] Aarhus Univ, Bioinformat Res Ctr, Aarhus C, Denmark	Aarhus University; Norwegian University of Science & Technology (NTNU); Norwegian University of Science & Technology (NTNU); Aarhus University	Iversen, L (corresponding author), Aarhus Univ Hosp, Dept Dermatol, Aarhus C, Denmark.	lars.iversen@clin.au.dk	Sætrom, Pål/AAH-1216-2019; Drablos, Finn/L-4970-2019	Sætrom, Pål/0000-0001-8142-7441; Drablos, Finn/0000-0001-5794-828X; Johansen, Claus/0000-0002-5665-5212; Johansen, Claus/0000-0003-0240-5127; Olsen, Lene Christin/0000-0002-5869-4952; Iversen, Lars/0000-0003-1816-4508; Besenbacher, Soren/0000-0003-1455-1738; Raaby, Line/0000-0002-3327-9613	Aase og Einar Danielsens Fond; A.P. Moller og Hustru Chastine Mc-Kinney Mollers Fond til almene Formaal-Fonden til Laegevidenskabens Fremme; Kongelig Hofbuntmager Aage Bangs Fond	Aase og Einar Danielsens Fond; A.P. Moller og Hustru Chastine Mc-Kinney Mollers Fond til almene Formaal-Fonden til Laegevidenskabens Fremme; Kongelig Hofbuntmager Aage Bangs Fond	This work was supported by Aase og Einar Danielsens Fond, http://www.danielsensfond.dk/Default.aspx (AL); A.P. Moller og Hustru Chastine Mc-Kinney Mollers Fond til almene Formaal-Fonden til Laegevidenskabens Fremme, http://www.apmollerfonde.dk/ansoegning/laegefonden.aspx (AL) and Kongelig Hofbuntmager Aage Bangs Fond (AL). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Banno T, 2004, J BIOL CHEM, V279, P32633, DOI 10.1074/jbc.M400642200; Bose F, 2013, AM J PATHOL, V183, P413, DOI 10.1016/j.ajpath.2013.04.021; Bose F, 2011, CLIN IMMUNOL, V139, P164, DOI 10.1016/j.clim.2011.01.015; Cai YH, 2011, IMMUNITY, V35, P596, DOI 10.1016/j.immuni.2011.08.001; Campanati A, 2014, ARCH DERMATOL RES, V306, P915, DOI 10.1007/s00403-014-1493-3; Chen L, 2013, J INVEST DERMATOL, V133, P418, DOI 10.1038/jid.2012.333; Di Cesare A, 2009, J INVEST DERMATOL, V129, P1339, DOI 10.1038/jid.2009.59; Dominical VM, 2011, J IMMUNOL, V73, P309, DOI [10.1111/j.1365-3083.2011.02503.x, DOI 10.1111/J.1365-3083.2011.02503.X]; El Malki K, 2013, J INVEST DERMATOL, V133, P441, DOI 10.1038/jid.2012.318; Feldmann M, 2001, ANNU REV IMMUNOL, V19, P163, DOI 10.1146/annurev.immunol.19.1.163; Fitch Erin, 2007, Curr Rheumatol Rep, V9, P461, DOI 10.1007/s11926-007-0075-1; Gautier L, 2004, BIOINFORMATICS, V20, P307, DOI 10.1093/bioinformatics/btg405; Goldminz AM, 2015, JAMA DERMATOL, V151, P837, DOI 10.1001/jamadermatol.2015.0452; Gottlieb AB, 2005, J IMMUNOL, V175, P2721, DOI 10.4049/jimmunol.175.4.2721; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Jani M, 2014, RHEUMATOLOGY, V53, P213, DOI 10.1093/rheumatology/ket260; Johansen C, 2010, BRIT J DERMATOL, V163, P1194, DOI 10.1111/j.1365-2133.2010.10036.x; Kalden JR, 2008, CLIN EXP RHEUMATOL, V26, P834; Katou F, 2003, J PATHOL, V199, P98, DOI 10.1002/path.1255; Keermann M, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1508-2; Kemp DM, 2007, BIOINFORMATICS, V23, P1356, DOI 10.1093/bioinformatics/btm116; Klimiuk PA, 2006, CLIN EXP RHEUMATOL, V24, P529; Kyle S, 2005, RHEUMATOLOGY, V44, P390, DOI 10.1093/rheumatology/keh514; LARSEN CG, 1989, SCIENCE, V243, P1464, DOI 10.1126/science.2648569; Lowes MA, 2007, NATURE, V445, P866, DOI 10.1038/nature05663; Lun SWM, 2007, INT IMMUNOPHARMACOL, V7, P1668, DOI 10.1016/j.intimp.2007.08.021; Luo WJ, 2013, BIOINFORMATICS, V29, P1830, DOI 10.1093/bioinformatics/btt285; Marina Mihaela Elena, 2015, Clujul Med, V88, P247, DOI 10.15386/cjmed-494; Miele E, 2004, J PEDIATR GASTR NUTR, V38, P502, DOI 10.1097/00005176-200405000-00008; Nestle FO, 2009, NEW ENGL J MED, V361, P496, DOI 10.1056/NEJMra0804595; Otkjaer K, 2005, BRIT J DERMATOL, V153, P911, DOI 10.1111/j.1365-2133.2005.06800.x; Paleolog EM, 1998, ARTHRITIS RHEUM, V41, P1258, DOI 10.1002/1529-0131(199807)41:7<1258::AID-ART17>3.0.CO;2-1; Piaserico S, 2014, DRUG DEVELOP RES, V75, pS73, DOI 10.1002/ddr.21202; Pickens SR, 2011, ARTHRITIS RHEUM-US, V63, P914, DOI 10.1002/art.30232; Plasencia C, 2012, ANN RHEUM DIS, V71, P1955, DOI 10.1136/annrheumdis-2011-200828; Raychaudhuri SP, 2001, J EUR ACAD DERMATOL, V15, P16, DOI 10.1046/j.1468-3083.2001.00192.x; Reich K, 2015, EXP DERMATOL, V24, P529, DOI 10.1111/exd.12710; Ritchie M.E., 2018, LIMMA POWERS DIFFERE, V43, DOI [10.1093/nar/gkv007, DOI 10.1093/NAR/GKV007]; Saxena V, 2006, NUCLEIC ACIDS RES, V34, DOI 10.1093/nar/gkl766; SLOMINSKI A, 2013, J STEROID BIOCHEM, V137, P107, DOI [10.1016/.jsbmb.2013.02.006, DOI 10.1016/J.JSBMB.2013.02.006]; Slominski AT, 2013, ENDOCR REV, V34, P827, DOI 10.1210/er.2012-1092; Slominski Andrzej T, 2012, Adv Anat Embryol Cell Biol, V212, P1; Soegaard-Madsen L, 2010, BRIT J DERMATOL, V162, P1216, DOI 10.1111/j.1365-2133.2010.09706.x; Takekoshi T, 2013, J INVEST DERMATOL, V133, P2530, DOI 10.1038/jid.2013.151; Witte E, 2015, J MOL MED BERL; Wolfle U, 2015, MEDIAT INFLAMM, V2015, DOI 10.1155/2015/630128; Wongpiyabovorn J, 2003, J DERMATOL SCI, V33, P31, DOI 10.1016/S0923-1811(03)00148-8; Yarilina A, 2008, NAT IMMUNOL, V9, P378, DOI 10.1038/ni1576; Zaba LC, 2007, J EXP MED, V204, P3183, DOI 10.1084/jem.20071094; Zaba LC, 2009, J ALLERGY CLIN IMMUN, V124, P1022, DOI 10.1016/j.jaci.2009.08.046; Zhou A, 2003, ONCOGENE, V22, P2054, DOI 10.1038/sj.onc.1206262; Zhou XH, 2003, PHYSIOL GENOMICS, V13, P69, DOI 10.1152/physiolgenomics.00157.2002	53	11	12	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2016	11	12							e0167437	10.1371/journal.pone.0167437	http://dx.doi.org/10.1371/journal.pone.0167437			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI9QH	28005985	Green Published, gold			2022-12-27	WOS:000392843200018
J	Park, MS; Kim, YD; Kim, BM; Kim, YJ; Kim, JK; Rhee, JS				Park, Mi Seon; Kim, Young Dae; Kim, Bo-Mi; Kim, Youn-Jung; Kim, Jang Kyun; Rhee, Jae-Sung			Effects of Antifouling Biocides on Molecular and Biochemical Defense System in the Gill of the Pacific Oyster Crassostrea gigas	PLOS ONE			English	Article							HEAT-SHOCK PROTEINS; COPEPOD TIGRIOPUS-JAPONICUS; ROTIFER BRACHIONUS-KOREANUS; OXIDATIVE STRESS; MONOGONONT ROTIFER; PESTICIDE EXPOSURE; ACETYLCHOLINESTERASE ACTIVITY; ANTIOXIDANT ENZYMES; ORGANOTIN COMPOUNDS; MARINE-ENVIRONMENT	Antifouling biocides such as organotin compounds and their alternatives are potent toxicants in marine ecosystems. In this study, we employed several molecular and biochemical response systems of the Pacific oyster Crassostrea gigas to understand a potential mode of action of antifouling biocides (i.e. tributyltin (TBT), diuron and irgarol) after exposure to different concentrations (0.01, 0.1, and 1 mu g L-1) for 96 h. As a result, all the three antifouling biocides strongly induced the antioxidant defense system. TBT reduced both enzymatic activity and mRNA expression of Na+/K+-ATPase and acetylcholinesterase (AChE). Lower levels of both Na+/K+-ATPase activity and AChE mRNA expression were observed in the diuron-exposed oysters compared to the control, while the irgarol treatment reduced only the transcriptional expression of AChE gene. We also analyzed transcript profile of heat shock protein (Hsp) superfamily in same experimental conditions. All antifouling biocides tested in this study significantly modulated mRNA expression of Hsp superfamily with strong induction of Hsp70 family. Taken together, overall results indicate that representative organotin TBT and alternatives have potential hazardous effects on the gill of C. gigas within relatively short time period. Our results also suggest that analyzing a series of molecular and biochemical parameters can be a way of understanding and uncovering the mode of action of emerging antifouling biocides. In particular, it was revealed that Pacific oysters have different sensitivities depend on the antifouling biocides.	[Park, Mi Seon; Kim, Young Dae] Natl Inst Fisheries Sci, Southeast Sea Fisheries Res Inst, Tongyeong, South Korea; [Kim, Bo-Mi] Korea Polar Res Inst, Unit Polar Genom, Incheon, South Korea; [Kim, Youn-Jung; Kim, Jang Kyun; Rhee, Jae-Sung] Incheon Natl Univ, Dept Marine Sci, Coll Nat Sci, Incheon, South Korea; [Kim, Jang Kyun; Rhee, Jae-Sung] Incheon Natl Univ, Res Inst Basic Sci, Incheon, South Korea; [Rhee, Jae-Sung] Inst Green Environm Res Ctr, 169 Gaetbeol Ro, Incheon, South Korea	National Institute of Fisheries Science; Korea Polar Research Institute (KOPRI); Incheon National University; Incheon National University	Kim, JK; Rhee, JS (corresponding author), Incheon Natl Univ, Dept Marine Sci, Coll Nat Sci, Incheon, South Korea.; Kim, JK; Rhee, JS (corresponding author), Incheon Natl Univ, Res Inst Basic Sci, Incheon, South Korea.; Rhee, JS (corresponding author), Inst Green Environm Res Ctr, 169 Gaetbeol Ro, Incheon, South Korea.	jang.kim@inu.ac.kr; jsrhee@inu.ac.kr		Rhee, Jae-Sung/0000-0003-3313-8850	National Institute of Fisheries Science, Republic of Korea [R2016015]	National Institute of Fisheries Science, Republic of Korea	This work was supported by a grant from the National Institute of Fisheries Science (R2016015), http://www.nifs.go.kr/en/, Republic of Korea. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akcha F, 2016, ENVIRON SCI POLLUT R, V23, P8008, DOI 10.1007/s11356-015-5969-2; Akcha F, 2012, AQUAT TOXICOL, V106, P104, DOI 10.1016/j.aquatox.2011.10.018; ALDRIDGE WN, 1977, BIOCHEM PHARMACOL, V26, P1997, DOI 10.1016/0006-2952(77)90008-9; ALZIEU C, 1986, MAR POLLUT BULL, V17, P494, DOI 10.1016/0025-326X(86)90636-3; Andersen JK, 2004, NAT MED, V10, pS18, DOI 10.1038/nrn1434; Antizar-Ladislao B, 2008, ENVIRON INT, V34, P292, DOI 10.1016/j.envint.2007.09.005; Guardiola FA, 2012, INT J MOL SCI, V13, P1541, DOI 10.3390/ijms13021541; Baek Inseon, 2015, Toxicology and Environmental Health Sciences, V7, P303, DOI 10.1007/s13530-015-0253-x; Barranger A, 2016, COMP BIOCHEM PHYS C, V180, P23, DOI 10.1016/j.cbpc.2015.11.002; Beguel JP, 2013, COMP BIOCHEM PHYS C, V157, P63, DOI 10.1016/j.cbpc.2012.10.004; Bianchini A, 2003, ENVIRON TOXICOL CHEM, V22, P1361, DOI [10.1002/etc.5620220624, 10.1897/1551-5028(2003)022&lt;1361:MOASTI&gt;2.0.CO;2]; Bouilly K, 2007, ARCH ENVIRON CON TOX, V52, P58, DOI 10.1007/s00244-005-0256-8; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797; Callow ME, 1995, BIOFOULING, V9, P153, DOI 10.1080/08927019509378299; Clayton ME, 2000, AQUAT TOXICOL, V47, P213, DOI 10.1016/S0166-445X(99)00022-3; Collin H, 2010, J EXP BIOL, V213, P4010, DOI 10.1242/jeb.048033; Cruz-Rodriguez LA, 2002, AQUAT TOXICOL, V60, P157, DOI 10.1016/S0166-445X(02)00008-5; Dafforn KA, 2011, MAR POLLUT BULL, V62, P453, DOI 10.1016/j.marpolbul.2011.01.012; Downs C, 2007, ARCH ENVIRON CON TOX, V52, P47, DOI 10.1007/s00244-005-0213-6; ELLMAN GL, 1961, BIOCHEM PHARMACOL, V7, P88, DOI 10.1016/0006-2952(61)90145-9; Elsabbagh HS, 2002, PHARMACOL RES, V45, P201, DOI 10.1006/phrs.2001.0909; Fabbri E, 2008, INVERTEBRATE SURVIV, V5, pe161; Farcy E, 2009, CELL STRESS CHAPERON, V14, P371, DOI 10.1007/s12192-008-0091-8; Feder ME, 1999, ANNU REV PHYSIOL, V61, P243, DOI 10.1146/annurev.physiol.61.1.243; FISH RH, 1977, TETRAHEDRON LETT, P3515; Gagnaire B, 2007, AQUAT TOXICOL, V84, P92, DOI 10.1016/j.aquatox.2007.06.002; Geret F, 2002, AQUAT LIVING RESOUR, V15, P61, DOI 10.1016/S0990-7440(01)01147-0; Giacomin M, 2013, AQUAT TOXICOL, V144, P105, DOI 10.1016/j.aquatox.2013.09.028; Guo SH, 2007, CELL STRESS CHAPERON, V12, P245, DOI 10.1379/CSC-265.1; Hamdoun AM, 2003, BIOL BULL-US, V205, P160, DOI 10.2307/1543236; Hartl MGJ, 2001, AQUAT TOXICOL, V55, P125, DOI 10.1016/S0166-445X(01)00184-9; Horiguchi T, 1997, APPL ORGANOMET CHEM, V11, P451, DOI 10.1002/(SICI)1099-0739(199705)11:5<451::AID-AOC598>3.0.CO;2-#; Horiguchi Toshihiro, 2006, Environmental Sciences, V13, P77; Jo PG, 2008, COMP BIOCHEM PHYS C, V147, P460, DOI 10.1016/j.cbpc.2008.02.001; Kalmar B, 2009, ADV DRUG DELIVER REV, V61, P310, DOI 10.1016/j.addr.2009.02.003; Kim BM, 2011, CHEMOSPHERE, V84, P1467, DOI 10.1016/j.chemosphere.2011.04.043; Kim RO, 2016, ENVIRON TOXICOL CHEM, V35, P1449, DOI 10.1002/etc.3288; Kim RO, 2013, ENVIRON SCI TECHNOL, V47, P13804, DOI 10.1021/es403269v; Konstantinou IK, 2004, ENVIRON INT, V30, P235, DOI 10.1016/S0160-4120(03)00176-4; Kotake Y, 2012, BIOL PHARM BULL, V35, P1876, DOI 10.1248/bpb.b212017; La Terza A, 2004, ANTARCT SCI, V16, P23, DOI 10.1017/S0954102004001774; Lee JW, 2015, COMP BIOCHEM PHYS C, V167, P147, DOI 10.1016/j.cbpc.2014.10.005; Lesser MP, 2006, ANNU REV PHYSIOL, V68, P253, DOI 10.1146/annurev.physiol.68.040104.110001; Lewis JA, 1998, MARINE BIOFOULING IT; Li ZH, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0123091; LINDQUIST S, 1988, ANNU REV GENET, V22, P631, DOI 10.1146/annurev.ge.22.120188.003215; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lozano P, 2014, ECOTOX ENVIRON SAFE, V104, P294, DOI 10.1016/j.ecoenv.2014.03.021; Lucu C, 1999, AM J PHYSIOL-REG I, V276, pR490, DOI 10.1152/ajpregu.1999.276.2.R490; Mai H, 2013, MAR ENVIRON RES, V89, P1, DOI [10.1016/j.marenvres.2013.04.003, 10.1016/j.envres.2013.02.006]; Matthiessen P, 1998, ENVIRON TOXICOL CHEM, V17, P37, DOI 10.1002/etc.5620170106; MCCORMICK SD, 1993, CAN J FISH AQUAT SCI, V50, P656, DOI 10.1139/f93-075; Metzger DC, 2012, J SHELLFISH RES, V31, P627, DOI 10.2983/035.031.0305; Morcillo Y, 1997, ARCH ENVIRON CON TOX, V32, P198, DOI 10.1007/s002449900175; Nakatsu Y, 2007, TOXICOL SCI, V97, P438, DOI 10.1093/toxsci/kfm039; Nguyen T, 2009, J BIOL CHEM, V284, P13291, DOI 10.1074/jbc.R900010200; Niyogi S, 2001, SCI TOTAL ENVIRON, V281, P237, DOI 10.1016/S0048-9697(01)00850-6; Oberdorster E, 1998, AQUAT TOXICOL, V41, P83, DOI 10.1016/S0166-445X(97)00067-2; Rainbow PS, 1995, MAR POLLUT BULL, V31, P183, DOI 10.1016/0025-326X(95)00116-5; Rhee JS, 2007, AQUAT TOXICOL, V83, P104, DOI 10.1016/j.aquatox.2007.03.015; Rhee JS, 2013, COMP BIOCHEM PHYS C, V158, P216, DOI 10.1016/j.cbpc.2013.08.005; Rondon R, 2016, AQUAT TOXICOL, V175, P47, DOI 10.1016/j.aquatox.2016.03.007; ROSENBERG DW, 1983, BIOCHEM PHARMACOL, V32, P3823, DOI 10.1016/0006-2952(83)90155-7; Samuel PM, 1998, J APPL TOXICOL, V18, P383, DOI 10.1002/(SICI)1099-1263(1998090)18:5<383::AID-JAT523>3.3.CO;2-S; Serrano MAS, 2015, ENVIRON SCI POLLUT R, V22, P17375, DOI 10.1007/s11356-014-4023-0; Slaninova A, 2009, NEUROENDOCRINOL LETT, V30, P2; Sole M, 2000, B ENVIRON CONTAM TOX, V64, P852; Soreq H, 2001, NAT REV NEUROSCI, V2, P294, DOI 10.1038/35067589; STEGEMAN JJ, 1973, MAR BIOL, V22, P37, DOI 10.1007/BF00388908; STEINERT SA, 1993, MAR ENVIRON RES, V35, P89, DOI 10.1016/0141-1136(93)90019-V; Tanguy A, 2005, FEBS J, V272, P390, DOI 10.1111/j.1742-4658.2004.04479.x; Thomas KV, 2010, BIOFOULING, V26, P73, DOI 10.1080/08927010903216564; Townsend DM, 2003, BIOMED PHARMACOTHER, V57, P145, DOI 10.1016/S0753-3322(03)00043-X; Wang L, 2013, TOXICOL IN VITRO, V27, P1771, DOI 10.1016/j.tiv.2013.05.006; Wang Y, 2012, B ENVIRON CONTAM TOX, V89, P704, DOI 10.1007/s00128-012-0760-2; Wu YQ, 2007, J ENVIRON SCI-CHINA, V19, P1129, DOI 10.1016/S1001-0742(07)60184-3; Zhang GF, 2016, ANNU REV ANIM BIOSCI, V4, P357, DOI 10.1146/annurev-animal-022114-110903; Zhang GF, 2012, NATURE, V490, P49, DOI 10.1038/nature11413; Zhang JL, 2008, CHEMOSPHERE, V73, P337, DOI 10.1016/j.chemosphere.2008.05.072; Zhu QH, 2016, MAR BIOTECHNOL, V18, P176, DOI 10.1007/s10126-015-9678-0	81	24	25	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2016	11	12							e0168978	10.1371/journal.pone.0168978	http://dx.doi.org/10.1371/journal.pone.0168978			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI9QH	28006823	Green Submitted, gold, Green Published			2022-12-27	WOS:000392843200120
J	Sbiera, S; Tryfonidou, MA; Weigand, I; Grinwis, GCM; Broeckx, B; Herterich, S; Allolio, B; Deutschbein, T; Fassnacht, M; Meij, BP				Sbiera, Silviu; Tryfonidou, Marianna A.; Weigand, Isabel; Grinwis, Guy C. M.; Broeckx, Bart; Herterich, Sabine; Allolio, Bruno; Deutschbein, Timo; Fassnacht, Martin; Meij, Bjorn P.			Lack of Ubiquitin Specific Protease 8 (USP8) Mutations in Canine Corticotroph Pituitary Adenomas	PLoS One			English	Article							CUSHINGS-DISEASE; DEPENDENT HYPERADRENOCORTICISM; TRANSSPHENOIDAL HYPOPHYSECTOMY; MEDICAL-MANAGEMENT; DOGS; TUMORS; CELLS	Purpose Cushing's disease (CD), also known as pituitary-dependent hyperadrenocorticism, is caused by adrenocorticotropic hormone (ACTH)-secreting pituitary tumours. Affected humans and dogs have similar clinical manifestations, however, the incidence of the canine disease is thousand-fold higher. This makes the dog an obvious model for studying the pathogenesis of pituitary-dependent hyperadrenocorticism. Despite certain similarities identified at the molecular level, the question still remains whether the two species have a shared oncogenetic background. Recently, hotspot recurrent mutations in the gene encoding for ubiquitin specific protease 8 (USP8) have been identified as the main driver behind the formation of ACTH-secreting pituitary adenomas in humans. In this study, we aimed to verify whether USP8 mutations also play a role in the development of such tumours in dogs. Methods Presence of USP8 mutations was analysed by Sanger and PCR-cloning sequencing in 38 canine ACTH-secreting adenomas. Furthermore, the role of USP8 and EGFR protein expression was assessed by immunohistochemistry in a subset of 25 adenomas. Results None of the analysed canine ACTH-secreting adenomas presented mutations in the USP8 gene. In a subset of these adenomas, however, we observed an increased nuclear expression of USP8, a phenotype characteristic for the USP8 mutated human tumours, that correlated with smaller tumour size but elevated ACTH production in those tumours. Conclusions Canine ACTH-secreting pituitary adenomas lack mutations in the USP8 gene suggesting a different genetic background of pituitary tumourigenesis in dogs. However, elevated nuclear USP8 protein expression in a subset of tumours was associated with a similar phenotype as in their human counterparts, indicating a possible end-point convergence of the different genetic backgrounds in the two species. In order to establish the dog as a useful animal model for the study of CD, further comprehensive studies are needed.	[Sbiera, Silviu; Weigand, Isabel; Allolio, Bruno; Fassnacht, Martin] Univ Wurzburg, Univ Hosp Wurzburg, Div Endocrinol & Diabet, Dept Internal Med 1, Wurzburg, Germany; [Tryfonidou, Marianna A.; Meij, Bjorn P.] Univ Utrecht, Dept Clin Sci Compan Anim, Fac Vet Med, Utrecht, Netherlands; [Grinwis, Guy C. M.] Univ Utrecht, Dept Pathobiol, Vet Pathol Diagnost Ctr, Fac Vet Med, Utrecht, Netherlands; [Broeckx, Bart; Fassnacht, Martin] Univ Ghent, Fac Pharmaceut Sci, Lab Pharmaceut Biotechnol, Ghent, Belgium; [Herterich, Sabine; Deutschbein, Timo] Univ Wurzburg, Univ Hosp Wurzburg, Clin Chem & Lab Med, Wurzburg, Germany; [Fassnacht, Martin] Univ Wurzburg, Comprehens Canc Ctr Mainfranken, Wurzburg, Germany	University of Wurzburg; Utrecht University; Utrecht University; Ghent University; University of Wurzburg; University of Wurzburg	Sbiera, S (corresponding author), Univ Wurzburg, Univ Hosp Wurzburg, Div Endocrinol & Diabet, Dept Internal Med 1, Wurzburg, Germany.	Sbiera_S@ukw.de	Broeckx, Bart/AAH-3940-2021; Sbiera, Silviu/E-8128-2019; Deutschbein, Timo/AAI-4662-2020; Fassnacht, Martin/N-9614-2019; Tryfonidou, Marianna/O-3114-2017	Broeckx, Bart/0000-0001-6742-3911; Sbiera, Silviu/0000-0002-6271-5533; Fassnacht, Martin/0000-0001-6170-6398; Grinwis, Guy/0000-0002-1583-9648; Tryfonidou, Marianna/0000-0002-2333-7162	Deutsche Forschungsgemeinschaft [SB 52/1-1, FA 466/5-1, DE 2657/1-1]; IZKF Wurzburg [Z-2/57, B-281]; ERA-NET "E-Rare" [01GM1407B]; Novartis-Stiftung fur theraputische Forschung; Deutsche Forschungsgemeinschaft (DFG); University of Wuerzburg	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); IZKF Wurzburg; ERA-NET "E-Rare"; Novartis-Stiftung fur theraputische Forschung; Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); University of Wuerzburg	This study was funded by Deutsche Forschungsgemeinschaft (http://www.dfg.de/en/) (grant SB 52/1-1 to SS, grant FA 466/5-1 to ME and grant DE 2657/1-1 to TD), IZKF Wurzburg (http://www.izkf.ukw.de/) (grant Z-2/57 to TD and grant B-281 to ME), the ERA-NET "E-Rare" (http://www.erare.eu/) (grant 01GM1407B to ME) and a fellowship from the Novartis-Stiftung fur theraputische Forschung to SS. In addition, publication costs are covered partially by the Deutsche Forschungsgemeinschaft (DFG) and the University of Wuerzburg through the funding programme Open Access Publishing. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Assie G, 2014, NAT GENET, V46, P607, DOI 10.1038/ng.2953; Biller BMK, 2008, J CLIN ENDOCR METAB, V93, P2454, DOI 10.1210/jc.2007-2734; Broeckx BJG, 2015, SCI REP-UK, V5, DOI 10.1038/srep12810; de Bruin C, 2009, HORM RES, V71, P140, DOI 10.1159/000178058; Dorton A M, 2000, Neonatal Netw, V19, P9; ETXABE J, 1994, CLIN ENDOCRINOL, V40, P479, DOI 10.1111/j.1365-2265.1994.tb02486.x; Feelders RA, 2013, J CLIN ENDOCR METAB, V98, P425, DOI 10.1210/jc.2012-3126; Fukuoka H, 2011, J CLIN INVEST, V121, P4712, DOI 10.1172/JCI60417; Galac S, 1997, VET QUART, V19, P17, DOI 10.1080/01652176.1997.9694731; HALMI NS, 1981, SCIENCE, V211, P72, DOI 10.1126/science.6255564; Hamrahian AH, 2014, ENDOCR PRACT, V20, P746, DOI 10.4158/EP14147.RA; Hanson JM, 2007, J NEUROSURG, V107, P830, DOI 10.3171/JNS-07/10/0830; Hanson JM, 2005, J VET INTERN MED, V19, P687, DOI 10.1892/0891-6640(2005)19[687:EOTHIT]2.0.CO;2; Hayashi K, 2016, EUR J ENDOCRINOL, V174, P213, DOI 10.1530/EJE-15-0689; KEMPPAINEN RJ, 1989, ENDOCRINOLOGY, V124, P2208, DOI 10.1210/endo-124-5-2208; Kooistra HS, 1997, J ENDOCRINOL, V152, P387, DOI 10.1677/joe.0.1520387; Lindholm J, 2001, J CLIN ENDOCR METAB, V86, P117, DOI 10.1210/jc.86.1.117; Ma ZY, 2015, CELL RES, V25, P306, DOI 10.1038/cr.2015.20; Mayer MN, 2007, CAN VET J, V48, P316; Meij BP, 1998, VET SURG, V27, P246, DOI 10.1111/j.1532-950X.1998.tb00123.x; Meij BP, 1997, VET SURG, V26, P295, DOI 10.1111/j.1532-950X.1997.tb01502.x; Meij BP, 2001, VET CLIN N AM-SMALL, V31, P1015, DOI 10.1016/S0195-5616(01)50011-X; MILLER SA, 1988, NUCLEIC ACIDS RES, V16, P1215, DOI 10.1093/nar/16.3.1215; Perez-Rivas LG, 2015, J CLIN ENDOCR METAB, V100, pE997, DOI 10.1210/jc.2015-1453; Reincke M, 2015, NAT GENET, V47, P31, DOI 10.1038/ng.3166; Reine NJ, 2007, CLIN TECH SMALL AN P, V22, P18, DOI 10.1053/j.ctsap.2007.02.003; Rowell JL, 2011, TRENDS MOL MED, V17, P380, DOI 10.1016/j.molmed.2011.02.004; Sbiera S, 2013, HORM METAB RES, V45, P137, DOI 10.1055/s-0032-1327750; Sbiera S, 2015, TRENDS ENDOCRIN MET, V26, P573, DOI 10.1016/j.tem.2015.08.003; Thuroczy J, 1998, ACTA VET HUNG, V46, P157; van Rijn SJ, 2010, DOMEST ANIM ENDOCRIN, V38, P244, DOI 10.1016/j.domaniend.2009.11.003	31	4	4	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2016	11	12							e0169009	10.1371/journal.pone.0169009	http://dx.doi.org/10.1371/journal.pone.0169009			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI9QH	28005997	Green Submitted, Green Published, gold			2022-12-27	WOS:000392843200122
J	Zhang, GW; Wang, Z; Ling, X; Zou, P; Yang, H; Chen, Q; Zhou, NY; Sun, L; Gao, JF; Zhou, ZY; Cao, J; Ao, L				Zhang, Guowei; Wang, Zhi; Ling, Xi; Zou, Peng; Yang, Huan; Chen, Qing; Zhou, Niya; Sun, Lei; Gao, Jianfang; Zhou, Ziyuan; Cao, Jia; Ao, Lin			Mitochondrial Biomarkers Reflect Semen Quality: Results from the MARCHS Study in Chongqing, China	PLOS ONE			English	Article							URINARY PHTHALATE METABOLITES; MALE REPRODUCTIVE HEALTH; SPERM DNA FRAGMENTATION; MALE-INFERTILITY; HUMAN SPERMATOZOA; CIGARETTE-SMOKING; MEN; FUNCTIONALITY; PARAMETERS; DAMAGE	Unexplained infertility requires that more sensitive and mechanism-based biomarkers should be developed and used independently of or in addition to conventional semen parameters for an infertility diagnosis. In the present study, semen samples were collected from young men participating in the Male Reproductive Health in Chongqing College students (MARCHS) cohort study in the follow-up stage in 2014. Conventional semen parameters were measured in all 656 participants, whereas sperm mitochondrial membrane potential (MMP), mitochondrial DNA copy number (mtDNAcn), mtDNA integrity and apoptotic parameters were measured among 627, 386, 362, and 628 participants, respectively. We found that sperm MMP was significantly positively correlated with all of conventional semen parameters including semen volume (r = 0.090, p = 0.025), sperm concentration (r = 0.301, p<0.01), total sperm count (r = 0.324, p<0.01), and progressive motility (r = 0.399, p<0.01); sperm MMP was also negatively correlated with Annexin V+ sperm (r = -0.553, p<0.01); mtDNAcn was significantly negatively correlated with sperm concentration (r = -0.214, p<0.01), total sperm count (r = -0.232, p<0.01), and progressive motility (r = -0.164, p = 0.01); mtDNA integrity was also significantly positively correlated with sperm concentration (r = 0.195, p<0.01), total sperm count (r = 0.185, p<0.01), and progressive motility (r = 0.106, p = 0.043). After adjusting for potential confounders, these relationships remained significant. Furthermore, we explored the potential effects of lifestyles on such mitochondrial biomarkers and found that the current drinkers displayed a higher level of sperm MMP; additionally, mt DNAcn was increased with age. The results indicated that certain mitochondrial biomarkers could serve as predictors of semen quality in a general population, and the study provides a baseline for the effects of population characteristics and lifestyles on such mitochondrial markers.	[Zhang, Guowei; Zhou, Ziyuan] Third Mil Med Univ, Dept Environm Hlth, Coll Prevent Med, Chongqing, Peoples R China; [Wang, Zhi; Ling, Xi; Zou, Peng; Yang, Huan; Chen, Qing; Zhou, Niya; Sun, Lei; Gao, Jianfang; Cao, Jia; Ao, Lin] Third Mil Med Univ, Inst Toxicol, Coll Prevent Med, Chongqing, Peoples R China	Army Medical University; Army Medical University	Cao, J; Ao, L (corresponding author), Third Mil Med Univ, Inst Toxicol, Coll Prevent Med, Chongqing, Peoples R China.	tmmuwsdlcaojia@126.com; tmmuwsdlaolin@126.com	陈, 卿/Q-5601-2019	陈, 卿/0000-0003-4108-7977	National Natural Science Foundation of China [81130051]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	The study is funded by the National Natural Science Foundation of China (grant number 81130051), http://www.nsfc.gov.cn/, to JC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal A, 2005, FERTIL STERIL, V84, P850, DOI 10.1016/j.fertnstert.2005.03.080; Aitken RJ, 2013, INT J DEV BIOL, V57, P265, DOI 10.1387/ijdb.130146ja; Amaral A, 2013, REPRODUCTION, V146, pR163, DOI 10.1530/REP-13-0178; Anifandis G, 2014, ARCH GYNECOL OBSTET, V290, P777, DOI 10.1007/s00404-014-3281-x; Barazani Y, 2014, UROL CLIN N AM, V41, P55, DOI 10.1016/j.ucl.2013.08.017; Chandra Anjani, 2014, Natl Health Stat Report, P1; Cummins JM, 1998, INT J ANDROL, V21, P47; de Jong AME, 2014, ANDROLOGIA, V46, P112, DOI 10.1111/and.12054; Diez-Sanchez C, 2003, BIOL REPROD, V68, P180, DOI 10.1095/biolreprod.102.005140; Dodaran HV, 2015, CRYOBIOLOGY, V71, P12, DOI 10.1016/j.cryobiol.2015.06.008; Eskenazi B, 2003, HUM REPROD, V18, P447, DOI 10.1093/humrep/deg107; Espinoza JA, 2009, HUM REPROD, V24, P2079, DOI 10.1093/humrep/dep120; Gallon F, 2006, FERTIL STERIL, V86, P1526, DOI 10.1016/j.fertnstert.2006.03.055; Grobner S, 2015, J BIOL REG HOMEOS AG, V29, P317; Han X, 2014, INT J HYG ENVIR HEAL, V217, P271, DOI 10.1016/j.ijheh.2013.06.006; Han X, 2011, ENVIRON HEALTH PERSP, V119, P652, DOI 10.1289/ehp.1002340; Huang HFS, 2004, J SPINAL CORD MED, V27, P55, DOI 10.1080/10790268.2004.11753731; Ieremiadou Fotini, 2009, BMC Res Notes, V2, P18, DOI 10.1186/1756-0500-2-18; Jensen TK, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2014-005462; Jensen TK, 2014, HUM REPROD, V29, P1801, DOI 10.1093/humrep/deu118; Jurewicz J, 2013, REPROD TOXICOL, V42, P232, DOI 10.1016/j.reprotox.2013.10.001; KAO SH, 1995, BIOL REPROD, V52, P729, DOI 10.1095/biolreprod52.4.729; Kidd SA, 2001, FERTIL STERIL, V75, P237, DOI 10.1016/S0015-0282(00)01679-4; Ko EY, 2014, FERTIL STERIL, V102, P1518, DOI 10.1016/j.fertnstert.2014.10.020; Lee HC, 1998, FEBS LETT, V441, P292, DOI 10.1016/S0014-5793(98)01564-6; Lee HC, 2000, J BIOMED SCI, V7, P2, DOI 10.1007/BF02255913; Marchetti P, 2012, ANDROLOGIA, V44, P136, DOI 10.1111/j.1439-0272.2010.01117.x; May-Panloup P, 2003, HUM REPROD, V18, P550, DOI 10.1093/humrep/deg096; Pant N, 2008, TOXICOL APPL PHARM, V231, P112, DOI 10.1016/j.taap.2008.04.001; Paoli D, 2011, FERTIL STERIL, V95, P2315, DOI 10.1016/j.fertnstert.2011.03.059; Passos JF, 2007, NUCLEIC ACIDS RES, V35, P7505, DOI 10.1093/nar/gkm893; Pesce V, 2001, FREE RADICAL BIO MED, V30, P1223, DOI 10.1016/S0891-5849(01)00517-2; Rajender S, 2010, MITOCHONDRION, V10, P419, DOI 10.1016/j.mito.2010.05.015; Ramalho-Santos J, 2009, HUM REPROD UPDATE, V15, P553, DOI 10.1093/humupd/dmp016; Rashki Ghaleno L, 2015, GYNECOL OBSTET INVES; Salvioli S, 1997, FEBS LETT, V411, P77, DOI 10.1016/S0014-5793(97)00669-8; Sawyer DE, 2003, MUTAT RES-FUND MOL M, V529, P21, DOI 10.1016/S0027-5107(03)00101-5; Shafik A, 2006, ARCH ANDROLOGY, V52, P197, DOI 10.1080/01485010500503561; Sharlip ID, 2002, FERTIL STERIL, V77, P873, DOI 10.1016/S0015-0282(02)03105-9; Smith RP, 2014, UROL CLIN N AM, V41, P19, DOI 10.1016/j.ucl.2013.08.002; Song GJ, 2008, FERTIL STERIL, V90, P2238, DOI 10.1016/j.fertnstert.2007.10.059; St John JC, 2001, MOL HUM REPROD, V7, P103, DOI 10.1093/molehr/7.1.103; Stepanov I, 2009, CHEM RES TOXICOL, V22, P406, DOI 10.1021/tx800398x; THONNEAU P, 1991, HUM REPROD, V6, P811, DOI 10.1093/oxfordjournals.humrep.a137433; Troiano L, 1998, EXP CELL RES, V241, P384, DOI 10.1006/excr.1998.4064; Wang MJ, 2012, ANTIOXID REDOX SIGN, V17, P513, DOI 10.1089/ars.2012.4514; Yang H, 2015, MEDICINE, V94, DOI 10.1097/MD.0000000000001166; Zorn B, 2012, J ASSIST REPROD GEN, V29, P357, DOI 10.1007/s10815-012-9718-x	49	35	38	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2016	11	12							e0168823	10.1371/journal.pone.0168823	http://dx.doi.org/10.1371/journal.pone.0168823			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI9QH	28006017	Green Submitted, Green Published, gold			2022-12-27	WOS:000392843200099
J	Dale, R; Quervel-Chaumette, M; Huber, L; Range, F; Marshall-Pescini, S				Dale, Rachel; Quervel-Chaumette, Mylene; Huber, Ludwig; Range, Friederike; Marshall-Pescini, Sarah			Task Differences and Prosociality; Investigating Pet Dogs' Prosocial Preferences in a Token Choice Paradigm	PLOS ONE			English	Article							OTHER-REGARDING PREFERENCES; CAPUCHIN MONKEYS; CHIMPANZEES; BEHAVIOR; RECIPROCITY; PRIMATE; FOOD	Prosociality has received increasing interest by non-human animal researchers since the initial discoveries that suggested it is not a uniquely human trait. However, thus far studies, even within the same species, have not garnered conclusive results. A prominent suggestion for this disparity is the effect methodology can have on prosocial responses in animals. We recently found evidence of prosociality in domestic dogs towards familiar conspecifics using a bar-pulling paradigm, in which a subject could pull a rope to deliver food to its partner. Therefore, the current study aimed to assess whether dogs would show a similar response in a different paradigm, based on the token exchange task paradigm frequently used with primates. In this task, dogs had the option to touch a token with their nose that delivered a reward to an adjacent receiver enclosure, which contained a familiar conspecific, a stranger or no dog at all. Crucially, we also included a social facilitation control condition, whereby the partner (stranger/familiar) was present but unable to access the food. We found that the familiarity effect remained consistent across tasks, with dogs of both the bar-pulling and token choice experiments providing more food to familiar partners than in a non-social control and providing less food to stranger partners than this same control. However, in contrast to our previous bar-pulling experiment, we could not exclude social facilitation as an underlying motive in the current task. We propose this difference in results between tasks may be related to increased task complexity in the token choice paradigm, making it harder for dogs to discriminate between the test and social facilitation conditions. Overall our findings suggest that subtle methodological changes can have an impact on prosocial behaviours in dogs and highlights the importance of controlling for social facilitation effects in such experiments.	[Dale, Rachel; Quervel-Chaumette, Mylene; Huber, Ludwig; Range, Friederike; Marshall-Pescini, Sarah] Univ Vienna, Univ Vet Med, Messerli Res Inst, Comparat Cognit, 1 Vet Pl, Vienna, Austria; [Dale, Rachel; Range, Friederike; Marshall-Pescini, Sarah] Wolf Sci Ctr, Ernstbrunn, Austria	University of Veterinary Medicine Vienna; University of Vienna	Dale, R; Quervel-Chaumette, M (corresponding author), Univ Vienna, Univ Vet Med, Messerli Res Inst, Comparat Cognit, 1 Vet Pl, Vienna, Austria.; Dale, R (corresponding author), Wolf Sci Ctr, Ernstbrunn, Austria.	rachel.dale@vetmeduni.ac.at; mylene.chaumette@gmail.com		Marshall-Pescini, Sarah/0000-0002-5944-4701; Range, Friederike/0000-0003-3127-5536; Dale, Rachel/0000-0003-0526-8834; Dale, Rachel/0000-0001-7930-1030	European Research Council under the European Union's Seventh Framework Programme (FP) / ERC [311870]; Austrian Science Fund (FWF) [P24840]; Austrian Science Fund (FWF) [P 24840] Funding Source: researchfish	European Research Council under the European Union's Seventh Framework Programme (FP) / ERC(European Research Council (ERC)); Austrian Science Fund (FWF)(Austrian Science Fund (FWF)); Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	Funding was from the European Research Council under the European Union's Seventh Framework Programme (FP/2007-2013) / ERC Grant Agreement n. [311870]. Mylene Quervel-Chaumette was funded by the Austrian Science Fund (FWF) project (P24840). The funders were not involved in any aspect of the study design, data collection or manuscript preparation.	Bartal IBA, 2011, SCIENCE, V334, P1427, DOI 10.1126/science.1210789; Brosnan SF, 2010, EVOL HUM BEHAV, V31, P279, DOI 10.1016/j.evolhumbehav.2010.02.003; Brosnan SF, 2009, ANIM COGN, V12, P587, DOI 10.1007/s10071-009-0218-z; Burkart JM, 2007, P NATL ACAD SCI USA, V104, P19762, DOI 10.1073/pnas.0710310104; Claidiere N, 2015, SCI REP-UK, V5, DOI 10.1038/srep07631; Cronin KA, 2009, J COMP PSYCHOL, V123, P231, DOI 10.1037/a0015094; de Waal FBM, 2008, P NATL ACAD SCI USA, V105, P13685, DOI 10.1073/pnas.0807060105; Dindo M, 2009, AM J PRIMATOL, V71, P419, DOI 10.1002/ajp.20669; Drayton LA, 2014, BEHAV SCI-BASEL, V4, P87, DOI 10.3390/bs4020087; Horner V, 2011, P NATL ACAD SCI USA, V108, P13847, DOI 10.1073/pnas.1111088108; House BR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103422; Jensen K, 2006, P ROY SOC B-BIOL SCI, V273, P1013, DOI 10.1098/rspb.2005.3417; Jensen K, 2014, FRONT PSYCHOL, V5, DOI 10.3389/fpsyg.2014.00822; Lakshminarayanan VR, 2008, CURR BIOL, V18, pR999, DOI 10.1016/j.cub.2008.08.057; Marshall-Pescini S, 2016, ANIM COGN, V19, P679, DOI 10.1007/s10071-016-0973-6; Massen JJM, 2011, PRIMATES, V52, P237, DOI 10.1007/s10329-011-0244-8; Massen JJM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009734; Nunnally JC, 1994, PSYCHOMETRIC THEORY, V3rd, DOI DOI 10.1037/018882; Peron F, 2013, ANIM COGN, V16, P197, DOI 10.1007/s10071-012-0564-0; Quervel-Chaumette M, 2015, SCI REP-UK, V5, DOI 10.1038/srep18102; Range F, 2013, FRONT PSYCHOL, V4, DOI 10.3389/fpsyg.2013.00868; Rutte C, 2008, BEHAV ECOL SOCIOBIOL, V62, P499, DOI 10.1007/s00265-007-0474-3; Rutte C, 2007, PLOS BIOL, V5, P1421, DOI 10.1371/journal.pbio.0050196; Schneeberger K, 2012, BMC EVOL BIOL, V12, DOI 10.1186/1471-2148-12-41; Silberberg A, 2014, ANIM COGN, V17, P609, DOI [10.1007/s10071-013-0623-1, 10.1007/s10071-013-0692-1]; Silk JB, 2005, NATURE, V437, P1357, DOI 10.1038/nature04243; Skerry AE, 2011, ANIM COGN, V14, P647, DOI 10.1007/s10071-011-0399-0; Stevens JR, 2010, ANIM COGN, V13, P663, DOI 10.1007/s10071-010-0309-x; Suchak Malini, 2012, Proc Natl Acad Sci U S A, V109, P15191; Szetei V, 2003, APPL ANIM BEHAV SCI, V83, P141, DOI 10.1016/S0168-1591(03)00114-X; Vonk J, 2008, ANIM BEHAV, V75, P1757, DOI 10.1016/j.anbehav.2007.09.036; Yamamoto S, 2010, ANIM BEHAV, V79, P595, DOI 10.1016/j.anbehav.2009.11.034	32	17	17	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2016	11	12							e0167750	10.1371/journal.pone.0167750	http://dx.doi.org/10.1371/journal.pone.0167750			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI9TW	28002432	Green Submitted, gold, Green Published			2022-12-27	WOS:000392853100019
J	Poulet, B; Liu, K; Plumb, D; Vo, P; Shah, M; Staines, K; Sampson, A; Nakamura, H; Nagase, H; Carriero, A; Shefelbine, S; Pitsillides, AA; Bou-Gharios, G				Poulet, Blandine; Liu, Ke; Plumb, Darren; Vo, Phoung; Shah, Mittal; Staines, Katherine; Sampson, Alexandra; Nakamura, Hiroyuki; Nagase, Hideaki; Carriero, Alessandra; Shefelbine, Sandra; Pitsillides, Andrew A.; Bou-Gharios, George			Overexpression of TIMP-3 in Chondrocytes Produces Transient Reduction in Growth Plate Length but Permanently Reduces Adult Bone Quality and Quantity	PLoS One			English	Article							TISSUE INHIBITOR; MATRIX METALLOPROTEINASES; GENE-EXPRESSION; TRANSGENIC MICE; OSTEOBLASTS; DIFFERENTIATION; COLLAGEN; CARTILAGE; CELLS; OSTEOCYTES	Bone development and length relies on the growth plate formation, which is dependent on degradative enzymes such as MMPs. Indeed, deletion of specific members of this enzyme family in mice results in important joint and bone abnormalities, suggesting a role in skeletal development. As such, the control of MMP activity is vital in the complex process of bone formation and growth. We generated a transgenic mouse line to overexpress TIMP3 in mouse chondrocytes using the Col2a1-chondrocyte promoter. This overexpression in cartilage resulted in a transient shortening of growth plate in homozygote mice but bone length was restored at eight weeks of age. However, tibial bone structure and mechanical properties remained compromised. Despite no transgene expression in adult osteoblasts from transgenic mice in vitro, their differentiation capacity was decreased. Neonates, however, did show transgene expression in a subset of bone cells. Our data demonstrate for the first time that transgene function persists in the chondro-osseous lineage continuum and exert influence upon bone quantity and quality.	[Poulet, Blandine; Liu, Ke; Plumb, Darren; Bou-Gharios, George] Univ Liverpool, Inst Ageing & Chron Dis, Dept Musculoskeletal Biol, Apex Bldg, Liverpool, Merseyside, England; [Vo, Phoung; Nakamura, Hiroyuki; Nagase, Hideaki] Kennedy Inst Rheumatol, Oxford, England; [Shah, Mittal; Staines, Katherine; Sampson, Alexandra; Pitsillides, Andrew A.] Royal Vet Coll, Comparat Biomed Sci, London, England; [Carriero, Alessandra] Florida Inst Technol, Dept Biomed Engn, Melbourne, FL 32901 USA; [Shefelbine, Sandra] Northeastern Univ, Coll Engn, Boston, MA 02115 USA	University of Liverpool; University of Oxford; University of London; University of London Royal Veterinary College; Florida Institute of Technology; Northeastern University	Bou-Gharios, G (corresponding author), Univ Liverpool, Inst Ageing & Chron Dis, Dept Musculoskeletal Biol, Apex Bldg, Liverpool, Merseyside, England.	ggharios@liverpool.ac.uk	Staines, Katherine/AAF-6823-2020; nakamura, hiroyuki/A-2953-2013; Carriero, Alessandra/D-7893-2013	nakamura, hiroyuki/0000-0002-2524-3063; Nagase, Hideaki/0000-0002-8563-2263; Poulet, Blandine/0000-0002-9224-5253; Staines, Katherine/0000-0002-8492-9778; Bou-Gharios, George/0000-0002-9563-9418; Carriero, Alessandra/0000-0001-8103-4795	Arthritis Research UK [20039, 18768]; BBSRC [BB/1014608/1]; Orthopaedic Research UK [471]; BBSRC [BB/I014608/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/I014608/1] Funding Source: researchfish; Versus Arthritis [20581, 20859, 20039] Funding Source: researchfish	Arthritis Research UK(Versus Arthritis); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Orthopaedic Research UK; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Versus Arthritis(Versus Arthritis)	This study was funded by Arthritis Research UK (20039, 18768), BBSRC (grant BB/1014608/1) and Orthopaedic Research UK (project 471). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	APTE SS, 1994, DEV DYNAM, V200, P177, DOI 10.1002/aja.1002000302; Barthelemi S, 2012, J CELL BIOCHEM, V113, P760, DOI 10.1002/jcb.23401; Basu R, 2013, CARDIOVASC RES, V98, P360, DOI 10.1093/cvr/cvt067; Carriero A, 2014, J BIOMECH, V47, P2490, DOI 10.1016/j.jbiomech.2014.03.035; Carriero A, 2014, J BONE MINER RES, V29, P1392, DOI 10.1002/jbmr.2172; de la Pena S, 2014, DIS MARKERS, V2014, DOI 10.1155/2014/285906; Fan D, 2014, CARDIOVASC RES, V103, P268, DOI 10.1093/cvr/cvu072; Gendron C, 2003, FEBS LETT, V555, P431, DOI 10.1016/S0014-5793(03)01295-X; Govoni KE, 2007, PHYSIOL GENOMICS, V30, P354, DOI 10.1152/physiolgenomics.00022.2007; Guevremont M, 2003, J BONE MINER RES, V18, P1073, DOI 10.1359/jbmr.2003.18.6.1073; Haeusler G, 2005, CALCIFIED TISSUE INT, V76, P326, DOI 10.1007/s00223-004-0161-6; Hatori K, 2004, ANAT REC PART A, V277A, P262, DOI 10.1002/ar.a.20007; Hayami T, 2008, MATRIX BIOL, V27, P682, DOI 10.1016/j.matbio.2008.07.005; Holmbeck K, 1999, CELL, V99, P81, DOI 10.1016/S0092-8674(00)80064-1; Inada M, 2004, P NATL ACAD SCI USA, V101, P17192, DOI 10.1073/pnas.0407788101; Jiang J, 2005, BIOCHEM BIOPH RES CO, V338, P762, DOI 10.1016/j.bbrc.2005.10.025; Karsdal MA, 2004, DNA CELL BIOL, V23, P155, DOI 10.1089/104454904322964751; Kulkarni RN, 2012, BIOCHEM BIOPH RES CO, V417, P824, DOI 10.1016/j.bbrc.2011.12.045; Leco KJ, 2001, J CLIN INVEST, V108, P817, DOI 10.1172/JCI12067; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Maeda Y, 2007, P NATL ACAD SCI USA, V104, P6382, DOI 10.1073/pnas.0608449104; Maes C, 2010, DEV CELL, V19, P329, DOI 10.1016/j.devcel.2010.07.010; Manduca P, 2009, BONE, V44, P251, DOI 10.1016/j.bone.2008.10.046; Murphy G, 2008, NAT CLIN PRACT RHEUM, V4, P128, DOI 10.1038/ncprheum0727; Nieminen J, 2008, CALCIFIED TISSUE INT, V82, P229, DOI 10.1007/s00223-008-9110-0; Ono N, 2014, NAT CELL BIOL, V16, P1157, DOI 10.1038/ncb3067; Prideaux M, 2015, GENE EXPR PATTERNS, V18, P29, DOI 10.1016/j.gep.2015.04.004; Rosewell KL, 2013, BIOL REPROD, V89, DOI 10.1095/biolreprod.112.106989; Sahebjam S, 2007, ARTHRITIS RHEUM, V56, P905, DOI 10.1002/art.22427; Saxon LK, 2011, BONE, V49, P184, DOI 10.1016/j.bone.2011.03.683; Shah M, 2010, BONE, V47, P309, DOI 10.1016/j.bone.2010.04.596; Shen Y, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013086; Shi J, 2008, DEV BIOL, V313, P196, DOI 10.1016/j.ydbio.2007.10.017; Stickens D, 2004, DEVELOPMENT, V131, P5883, DOI 10.1242/dev.01461; Tang SY, 2012, J BONE MINER RES, V27, P1936, DOI 10.1002/jbmr.1646; Tesson L, 2002, TRANSGENIC RES, V11, P43, DOI 10.1023/A:1013928600442; Wang WG, 2012, DEVELOPMENT, V139, P601, DOI 10.1242/dev.069575; Zaman G, 1997, J BONE MINER RES, V12, P769, DOI 10.1359/jbmr.1997.12.5.769; ZHOU G, 1995, J CELL SCI, V108, P3677; Zhou X, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004820; Zhou ZJ, 2000, P NATL ACAD SCI USA, V97, P4052, DOI 10.1073/pnas.060037197	41	14	14	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2016	11	12							e0167971	10.1371/journal.pone.0167971	http://dx.doi.org/10.1371/journal.pone.0167971			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI9TW	28002442	Green Published, Green Submitted, gold, Green Accepted			2022-12-27	WOS:000392853100029
J	Sanchez-Romero, L; Benito-Calvo, A; Perez-Gonzalez, A; Santonja, M				Sanchez-Romero, Laura; Benito-Calvo, Alfonso; Perez-Gonzalez, Alfredo; Santonja, Manuel			Assessment of Accumulation Processes at the Middle Pleistocene Site of Ambrona (Soria, Spain). Density and Orientation Patterns in Spatial Datasets Derived from Excavations Conducted from the 1960s to the Present	PLOS ONE			English	Article							OLDUVAI BED I; PALAEOLOXODON; ASSEMBLAGES; ELEPHANT	The Middle Pleistocene site of Ambrona (Soria, Spain) is a major reference for European Acheulean studies. The origin of the lithic and fauna accumulations at this site was first thought to be anthropogenic, but later studies showed that it was mainly natural. The first person to conduct excavations at the Ambrona site was the Marquis of Cerralbo, in 1914; other research groups followed in more recent times (the Howell & Freeman team and the Santonja & Perez-Gonzalez team). The digs yielded a great amount of information, but until now it had never been unified. In this paper, we compile all the available published and unpublished excavation documentation from the 1960s to the present. We use these maps and sections to present our spatial study of the LSM (Lower Stratigraphic Member) at the Ambrona site, combining stratigraphic criteria with GIS density and orientation analysis. This study enabled us to define the main concentrations of the LSM, providing an initial contribution to an assessment of their accumulation processes. Most of the concentrations preserved in the ancient shore area of the site display marked orientation patterns which coincide with the direction of the main water flows into the Ambrona wetland. However, random orientation patterns were observed in the central part of the site (Alpha concentration); they may be mostly preserved without undergoing transport processes, as previous taphonomic studies also confirm.	[Sanchez-Romero, Laura; Benito-Calvo, Alfonso; Perez-Gonzalez, Alfredo; Santonja, Manuel] Ctr Nacl Invest Evoluc Humana CENIEH, Paseo Sierra de Atapuerca 3, Burgos, Spain; [Sanchez-Romero, Laura] Univ Burgos, Escuela Interuniv Posgrad Evoluc Humana, Juan de Austria 1, Burgos, Spain	Centro Nacional de Investigacion de La Evolucion Humana (CENIEH); Universidad de Burgos	Sanchez-Romero, L (corresponding author), Ctr Nacl Invest Evoluc Humana CENIEH, Paseo Sierra de Atapuerca 3, Burgos, Spain.; Sanchez-Romero, L (corresponding author), Univ Burgos, Escuela Interuniv Posgrad Evoluc Humana, Juan de Austria 1, Burgos, Spain.	laura.sanchez@cenieh.es	Manuel, Santonja/F-1698-2018; Benito-Calvo, Alfonso/G-3897-2015	Benito-Calvo, Alfonso/0000-0002-6363-1753; Santonja, Manuel/0000-0001-5848-9011; Sanchez-Romero, Laura/0000-0003-2027-9996	Junta de Castilla y Leon, Consejeria de Educacion, Direccion General de Universidades e Investigacion [CEN186A12]; European Social Funds; Junta de Castilla y Leon [EDU/1083/2013]	Junta de Castilla y Leon, Consejeria de Educacion, Direccion General de Universidades e Investigacion(Junta de Castilla y Leon); European Social Funds(European Social Fund (ESF)); Junta de Castilla y Leon(Junta de Castilla y Leon)	Current research at Ambrona is funded by the Junta de Castilla y Leon, Consejeria de Educacion, Direccion General de Universidades e Investigacion (CEN186A12) and Laura Sanchez-Romero has a predoctoral grant from European Social Funds and Junta de Castilla y Leon (EDU/1083/2013).	Ambrona Aguirre E., 1989, DIEZ ANOS ARQUEOLOGI, P33; Anzidel AP, 2012, QUATERN INT, V255, P171, DOI 10.1016/j.quaint.2011.06.005; Baltanas A, 2005, ZONA ARQUEOLOGICA, V5, P223; Baxter MJ, 1997, J ARCHAEOL SCI, V24, P347, DOI 10.1006/jasc.1996.0119; BEHRENSMEYER AK, 1988, PALAEOGEOGR PALAEOCL, V63, P183, DOI 10.1016/0031-0182(88)90096-X; Benito-Calvo A, 2009, J ARCHAEOL SCI, V36, P2566, DOI 10.1016/j.jas.2009.07.012; Benito-Calvoa A, 2011, J HUM EVOL, V61, P50, DOI 10.1016/j.jhevol.2011.02.011; BERTRAN P, 1995, J ARCHAEOL SCI, V22, P521, DOI 10.1006/jasc.1995.0050; Bertran P., 2002, PALEO, V14, P13, DOI [10.4000/paleo.1383, DOI 10.4000/PALEO.1383]; Boschian G, 2015, QUATERN INT, V361, P288, DOI 10.1016/j.quaint.2014.04.030; Boschian G, 2010, QUATERN INT, V214, P3, DOI 10.1016/j.quaint.2009.10.016; Buss I. O., 1990, ELEPHANT LIFE 15 YEA; Butzer Karl, 1971, ENV ARCHAEOLOGY ECOL; BUTZER KW, 1965, SCIENCE, V150, P1718, DOI 10.1126/science.150.3704.1718; Conard NJ, 2015, J HUM EVOL, V89, P1, DOI 10.1016/j.jhevol.2015.10.003; De la Torre I, 2013, J ARCHAEOL SCI, V40, P1; Dominguez-Rodrigo M, 2012, J ARCHAEOL SCI, V39, P2116, DOI 10.1016/j.jas.2012.02.027; Dorado M., 2005, ZONA ARQUEOLAGICA, V5, P214; Douglas-Hamilton I.O., 1975, ELEPHANTS, V113, P72; Falgueres C, 2006, J ARCHAEOL SCI, V33, P149, DOI 10.1016/j.jas.2005.07.006; Fisher K., 2010, LANDESMUSEUM VORGESC, V62, P361; Fisher N., 1995, STAT ANAL CIRCULAR D; Freeman L. G., 1991, RAW MAT EC PREHISTOR, P73; Garcia-Moreno A, 2016, J ARCHAEOL SCI-REP, V6, P82, DOI 10.1016/j.jasrep.2016.01.023; Gaudzinski S, 1996, QUATERNARY RES, V46, P319, DOI 10.1006/qres.1996.0070; Goldberg P, 1993, MONOGRAPHS WORLD ARC, P17; Hawkes Jacquetta, 1982, MORTIMER WHEELER ADV; HAYNES CV, 1991, QUATERNARY RES, V35, P438, DOI 10.1016/0033-5894(91)90056-B; Haynes G., 2005, ZONA ARQUEOLOGICA, V5, P154; Haynes G., 1998, J ARCHAEOL SCI, V15, p131 ; Haynes G, 2012, GEOMORPHOLOGY, V157, P99, DOI 10.1016/j.geomorph.2011.04.045; Howell F.C., 1963, NOTICIARIO ARQUEOLOG, VVII, P7; Howell F. Clark, 1965, EARLY MAN; Howell FC, 1995, JB ROMISCH GERMANISC, P38; Lenoble A, 2004, J ARCHAEOL SCI, V31, P457, DOI 10.1016/j.jas.2003.09.013; Mania D., 1990, LANDESMUSEUM VORGESC, V43, P9; Mania D., 2004, KATALOGE DAUERAUSSTE, V1, p122 ; McPherron S, 2005, GEOARCHAEOLOGY, V20, P3; Oron M, 2014, QUATERN INT, V331, P186, DOI 10.1016/j.quaint.2013.04.013; Palombo MR, 2012, QUATERN INT, V276, P77, DOI 10.1016/j.quaint.2012.03.052; Palombo MR, 2010, QUATERNAIRE, V3, P43; Parcerisas Civit J., 2006, SOC PREHISTORICAS RE, P73; Perez-Gonzalez A., 2005, ZONA ARQUEOLOGICA, V5, P176; Perez-Gonzalez A., 1980, OCUPACIONES ACHELENS, V1, P15; PETRAGLIA MD, 1994, J ANTHROPOL ARCHAEOL, V13, P228, DOI 10.1006/jaar.1994.1014; Pinilla A, 2005, ZONA ARQUEOLOGICA, V5, P201; Radmilli AM., 1996, SCAVI CASTEL GUIDO P; Sacca D., 2012, RIV SCI PREISTORICHE, VLXII, P13; Sacca D, 2012, QUATERN INT, V276, P27, DOI 10.1016/j.quaint.2012.03.055; Santonja M, 2005, ZONA ARQUEOLOGICA, V5, p105 ; Santonja M, QUATERNARY IN PRESS; Santonja M., 2014, PLEISTOCENE HOLOCENE, P517; Santonja M, 2006, ZEPHYRUS, V59, P7; Santonja M, 2014, PLEISTOCENE HOLOCENE, P555; Santonja M., 1980, OCUPACIONES ACHELENS, P321; Santucci E, 2016, QUATERN INT, V406, P169, DOI 10.1016/j.quaint.2015.08.042; Schiffer M.B., 1987, FORMATION PROCESSES; Sese C, 2005, ZONA ARQUEOLOGICA, V5, P258; SHICK KD, 1987, J HUM EVOL, V16, P789, DOI 10.1016/0047-2484(87)90024-8; Texier J.-P., 2000, PALEO, V12, P379, DOI DOI 10.3406/PAL.2000.1610; Torralba Villa P., 1990, J HUM EVOL, V19, P299; Vaquero M, 2012, QUATERN INT, V247, P162, DOI 10.1016/j.quaint.2010.12.015; Villa P, 2005, QUATERN INT, V126, P223, DOI 10.1016/j.quaint.2004.03.001; Walter MJ, 2013, J HUM EVOL, V64, P569, DOI 10.1016/j.jhevol.2013.02.011	64	29	29	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2016	11	12							e0167595	10.1371/journal.pone.0167595	http://dx.doi.org/10.1371/journal.pone.0167595			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EI9TW	28002424	gold, Green Published, Green Submitted			2022-12-27	WOS:000392853100014
J	Timmers, I; Roebroeck, A; Bastiani, M; Jansma, B; Rubio-Gozalbo, E; Zhang, H				Timmers, Inge; Roebroeck, Alard; Bastiani, Matteo; Jansma, Bernadette; Rubio-Gozalbo, Estela; Zhang, Hui			Assessing Microstructural Substrates of White Matter Abnormalities: A Comparative Study Using DTI and NODDI	PLOS ONE			English	Article							NEURITE ORIENTATION DISPERSION; MULTISHELL DIFFUSION MRI; HUMAN BRAIN; CLASSIC GALACTOSEMIA; MULTIPLE-SCLEROSIS; ALZHEIMERS-DISEASE; DENSITY; CHILDREN; REGISTRATION; DISORDERS	Neurite orientation dispersion and density imaging (NODDI) enables more specific characterization of tissue microstructure by estimating neurite density (NDI) and orientation dispersion (ODI), two key contributors to fractional anisotropy (FA). The present work compared NODDI- with diffusion tensor imaging (DTI)-derived indices for investigating white matter abnormalities in a clinical sample. We assessed the added value of NODDI parameters over FA, by contrasting group differences identified by both models. Diffusion-weighted images with multiple shells were acquired in a group of 8 healthy controls and 8 patients with an inherited metabolic disease. Both standard DTI and NODDI analyses were performed. Tract based spatial statistics (TBSS) was used for group inferences, after which overlap and unique contributions across different parameters were evaluated. Results showed that group differences in NDI and ODI were complementary, and together could explain much of the FA results. Further, compared to FA analysis, NDI and ODI gave a pattern of results that was more regionally specific and were able to capture additional discriminative voxels that FA failed to identify. Finally, ODI from single-shell NODDI analysis, but not NDI, was found to reproduce the group differences from the multi-shell analysis. To conclude, by using a clinically feasible acquisition and analysis protocol, we demonstrated that NODDI is of added value to standard DTI, by revealing specific microstructural substrates to white matter changes detected with FA. As the (simpler) DTI model was more sensitive in identifying group differences, NODDI is recommended to be used complementary to DTI, thereby adding greater specificity regarding microstructural underpinnings of the differences. The finding that ODI abnormalities can be identified reliably using single-shell data may allow the retrospective analysis of standard DTI with NODDI.	[Timmers, Inge; Roebroeck, Alard; Jansma, Bernadette] Maastricht Univ, Dept Cognit Neurosci, Maastricht, Netherlands; [Timmers, Inge] Maastricht Univ, Dept Rehabil Med, Maastricht, Netherlands; [Roebroeck, Alard; Jansma, Bernadette] M BIC, Maastricht, Netherlands; [Bastiani, Matteo] Univ Oxford, Oxford Ctr Funct MRI, Brain FMRIB Ctr, Oxford, England; [Rubio-Gozalbo, Estela] Maastricht Univ, Med Ctr, Dept Pediat & Lab Genet Metab Dis, Maastricht, Netherlands; [Zhang, Hui] UCL, Dept Comp Sci, London, England; [Zhang, Hui] UCL, Ctr Med Image Comp, London, England	Maastricht University; Maastricht University; Maastricht University; University of Oxford; Maastricht University; University of London; University College London; University of London; University College London	Timmers, I (corresponding author), Maastricht Univ, Dept Cognit Neurosci, Maastricht, Netherlands.; Timmers, I (corresponding author), Maastricht Univ, Dept Rehabil Med, Maastricht, Netherlands.	inge.timmers@maastrichtuniversity.nl	Bastiani, Matteo/ABD-2472-2020; Rubio-Gozalbo, M Estela/H-1833-2011	Bastiani, Matteo/0000-0002-8436-2919; Rubio-Gozalbo, M. Estela/0000-0001-7182-4056; Timmers, Inge/0000-0001-7162-6623; Zhang, Hui/0000-0002-5426-2140; Jansma, Bernadette M./0000-0002-2925-0244	Galactosemia Research Fund (GOF) from the Dutch Patient Organisation (GVN); School for Oncology and Development Biology (GROW); Maastricht University Incentive ("Women in higher positions in science"); UK EPSRC [EP/L022680/1]	Galactosemia Research Fund (GOF) from the Dutch Patient Organisation (GVN); School for Oncology and Development Biology (GROW); Maastricht University Incentive ("Women in higher positions in science"); UK EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	The current study was funded by a Galactosemia Research Fund (GOF) from the Dutch Patient Organisation (GVN), the School for Oncology and Development Biology (GROW), and Maastricht University Incentive ("Women in higher positions in science"). HZ would like to thank the generous support from UK EPSRC (EP/L022680/1). The Open Access team from UCL is covering the publication fees and can be contacted via openaccess@ucl.ac.uk. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adluru G, 2014, IEEE ENG MED BIO, P742, DOI 10.1109/EMBC.2014.6943697; Alexander AL, 2001, MAGN RESON MED, V45, P770, DOI 10.1002/mrm.1105; Andersson JLR, 2016, NEUROIMAGE, V125, P1063, DOI 10.1016/j.neuroimage.2015.10.019; Andersson JLR, 2003, NEUROIMAGE, V20, P870, DOI 10.1016/S1053-8119(03)00336-7; Assaf Y, 2005, NEUROIMAGE, V27, P48, DOI 10.1016/j.neuroimage.2005.03.042; BASSER PJ, 1994, BIOPHYS J, V66, P259, DOI 10.1016/S0006-3495(94)80775-1; Billiet T, 2014, NEUROIMAGE-CLIN, V4, P649, DOI 10.1016/j.nicl.2014.04.005; Caverzasi E, 2016, J NEUROIMAGING, V26, P494, DOI 10.1111/jon.12359; Chang YS, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0123656; Chapman MC, 2013, J MAGNETIC RESONANCE; Chung AW, 2016, HUM BRAIN MAPP; Colgan N, 2016, NEUROIMAGE, V125, P739, DOI 10.1016/j.neuroimage.2015.10.043; Deboy CA, 2007, BRAIN, V130, P2199, DOI 10.1093/brain/awm122; DICE LR, 1945, ECOLOGY, V26, P297, DOI 10.2307/1932409; Doyle CM, 2010, J INHERIT METAB DIS, V33, P603, DOI 10.1007/s10545-010-9154-y; Evangelou N, 2000, ANN NEUROL, V47, P391, DOI 10.1002/1531-8249(200003)47:3<391::AID-ANA20>3.0.CO;2-J; Filippi M, 2010, DIFFUSION MRI THEORY; Graham MS, 2016, NEUROIMAGE, V125, P1079, DOI 10.1016/j.neuroimage.2015.11.006; Guerrero J.M., 2016, INVESTIGATING EFFECT; HABERLAN.C, 1971, J NEUROPATH EXP NEUR, V30, P431, DOI 10.1097/00005072-197107000-00009; Jespersen SN, 2010, NEUROIMAGE, V49, P205, DOI 10.1016/j.neuroimage.2009.08.053; Jespersen SN, 2012, IEEE T MED IMAGING, V31, P16, DOI 10.1109/TMI.2011.2162099; Keihaninejad S, 2013, NEUROIMAGE, V72, P153, DOI 10.1016/j.neuroimage.2013.01.044; Kelly CE, 2016, HUM BRAIN MAPP, V37, P3080, DOI 10.1002/hbm.23227; Kunz N, 2014, NEUROIMAGE, V96, P288, DOI 10.1016/j.neuroimage.2014.03.057; NELSON MD, 1992, RADIOLOGY, V184, P255, DOI 10.1148/radiology.184.1.1319076; Owen JP, 2014, J NEUROSCI, V34, P6214, DOI 10.1523/JNEUROSCI.4495-13.2014; Pierpaoli C, 1996, RADIOLOGY, V201, P637, DOI 10.1148/radiology.201.3.8939209; Potter NL, 2008, J INHERIT METAB DIS, V31, P524, DOI 10.1007/s10545-008-0877-y; Potter NL, 2013, JIMD REP, V11, P31, DOI 10.1007/8904_2013_219; Roosendaal SD, 2009, NEUROIMAGE, V44, P1397, DOI 10.1016/j.neuroimage.2008.10.026; Smith SM, 2004, NEUROIMAGE, V23, pS208, DOI 10.1016/j.neuroimage.2004.07.051; Smith SM, 2006, NEUROIMAGE, V31, P1487, DOI 10.1016/j.neuroimage.2006.02.024; Smith SM, 2009, NEUROIMAGE, V44, P83, DOI 10.1016/j.neuroimage.2008.03.061; Song SK, 2002, NEUROIMAGE, V17, P1429, DOI 10.1006/nimg.2002.1267; Sullivan E. V., 2010, DIFFUSION MRI THEORY; Tariq M, 2016, NEUROIMAGE, V133, P207, DOI 10.1016/j.neuroimage.2016.01.046; Timmers I, 2015, J INHERIT METAB DIS, V38, P295, DOI 10.1007/s10545-014-9780-x; Waisbren SE, 2012, J INHERIT METAB DIS, V35, P279, DOI 10.1007/s10545-011-9372-y; Wang Y, 2011, NEUROIMAGE, V55, P1577, DOI 10.1016/j.neuroimage.2011.01.038; Westlye LT, 2010, CEREB CORTEX, V20, P2055, DOI 10.1093/cercor/bhp280; Wheeler-Kingshott CAM, 2009, MAGN RESON MED, V61, P1255, DOI 10.1002/mrm.21965; Winston GP, 2013, EPILEPSY RES; Zhang H, 2006, MED IMAGE ANAL, V10, P764, DOI 10.1016/j.media.2006.06.004; Zhang H, 2012, NEUROIMAGE, V61, P1000, DOI 10.1016/j.neuroimage.2012.03.072	45	36	37	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2016	11	12							e0167884	10.1371/journal.pone.0167884	http://dx.doi.org/10.1371/journal.pone.0167884			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI9TW	28002426	Green Submitted, Green Published, gold			2022-12-27	WOS:000392853100025
J	Vera, RH; Schwan, E; Fatsis-Kavalopoulos, N; Kreuger, J				Vera, Rodrigo Hernandez; Schwan, Emil; Fatsis-Kavalopoulos, Nikos; Kreuger, Johan			A Modular and Affordable Time-Lapse Imaging and Incubation System Based on 3D Printed Parts, a Smartphone, and Off-The-Shelf Electronics	PLoS One			English	Article							CELL-MIGRATION; BIOTECHNOLOGY	Time-lapse imaging is a powerful tool for studying cellular dynamics and cell behavior over long periods of time to acquire detailed functional information. However, commercially available time-lapse imaging systems are expensive and this has limited a broader implementation of this technique in low-resource environments. Further, the availability of time-lapse imaging systems often present workflow bottlenecks in well-funded institutions. To address these limitations we have designed a modular and affordable time-lapse imaging and incubation system (ATLIS). The ATLIS enables the transformation of simple inverted microscopes into live cell imaging systems using custom-designed 3D-printed parts, a smartphone, and off-the-shelf electronic components. We demonstrate that the ATLIS provides stable environmental conditions to support normal cell behavior during live imaging experiments in both traditional and evaporation-sensitive microfluidic cell culture systems. Thus, the system presented here has the potential to increase the accessibility of time-lapse microscopy of living cells for the wider research community.	[Vera, Rodrigo Hernandez; Schwan, Emil; Fatsis-Kavalopoulos, Nikos; Kreuger, Johan] Uppsala Univ, Dept Med Cell Biol, Uppsala, Sweden; [Fatsis-Kavalopoulos, Nikos] Gradientech AB, Uppsala Sci Pk, Uppsala, Sweden	Uppsala University	Vera, RH; Kreuger, J (corresponding author), Uppsala Univ, Dept Med Cell Biol, Uppsala, Sweden.	rodrigo.hernandez@mcb.uu.se; johan.kreuger@mcb.uu.se	Kreuger, Johan/HDM-1503-2022	Hernandez Vera, Rodrigo/0000-0002-4241-2113	Swedish Cancer Society [CAN 2014/820]; Astrid Karlsson Foundation; European Union [642866]; Gradientech AB	Swedish Cancer Society(Swedish Cancer Society); Astrid Karlsson Foundation; European Union(European Commission); Gradientech AB	The present project was funded by grants to JK from the Swedish Cancer Society (CAN 2014/820; https://www.cancerfonden.se/), to RHV from the Astrid Karlsson Foundation, and to NFK from the European Union's Horizon 2020 research and innovation program under the Marie Sklodowska-Curie grant agreement No 642866 (https://ec.europa.eu/programmes/horizon2020/). Gradientech AB provided support in the form of salaries for the author NFK, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of this author are articulated in the 'author contributions' section.	Baden T, 2015, PLOS BIOL, V13, DOI 10.1371/journal.pbio.1002086; Baker M, 2010, NATURE, V466, P1137, DOI 10.1038/4661137a; Entschladen F, 2005, EXP CELL RES, V307, P418, DOI 10.1016/j.yexcr.2005.03.029; Friedl P, 2009, NAT REV MOL CELL BIO, V10, P445, DOI 10.1038/nrm2720; Frigault MM, 2009, J CELL SCI, V122, P753, DOI 10.1242/jcs.033837; Gross BC, 2014, ANAL CHEM, V86, P3240, DOI 10.1021/ac403397r; Wijnen B, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107216; Wohlers Associates, 2016, WOHL REP 2016 3D PRI; Wolfe DB, 2010, METHODS MOL BIOL, V583, P81, DOI 10.1007/978-1-60327-106-6_3; Zhang YS, 2015, LAB CHIP, V15, P3661, DOI 10.1039/c5lc00666j	10	17	17	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2016	11	12							e0167583	10.1371/journal.pone.0167583	http://dx.doi.org/10.1371/journal.pone.0167583			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI9TW	28002463	Green Published, Green Submitted, gold			2022-12-27	WOS:000392853100013
J	Eom, YS; Gwon, AR; Kwak, KM; Kim, JY; Yu, SH; Lee, S; Kim, YS; Park, IB; Kim, KW; Lee, K; Kim, BJ				Eom, Young Sil; Gwon, A-Ryeong; Kwak, Kyung Min; Kim, Ju-Young; Yu, Seung Hee; Lee, Sihoon; Kim, Yeun Sun; Park, Ie Byung; Kim, Kwang-Won; Lee, Kiyoung; Kim, Byung-Joon			Protective Effects of Vildagliptin against Pioglitazone-Induced Bone Loss in Type 2 Diabetic Rats	PLOS ONE			English	Article							GLUCAGON-LIKE PEPTIDE-1; BETA-CELL FUNCTION; MINERAL DENSITY; POSTMENOPAUSAL WOMEN; COMBINATION THERAPY; INSULIN-RESISTANCE; GLUCOSE-TOLERANCE; FRACTURE RISK; THIAZOLIDINEDIONES; SCLEROSTIN	Long-term use of thiazolidinediones (TZDs) is associated with bone loss and an increased risk of fracture in patients with type 2 diabetes (T2DM). Incretin-based drugs (glucagon-like peptide-1 (GLP-1) agonists and dipeptidylpeptidase-4 (DPP-4) inhibitors) have several benefits in many systems in addition to glycemic control. In a previous study, we reported that exendin-4 might increase bone mineral density (BMD) by decreasing the expression of SOST/sclerostin in osteocytes in a T2DM animal model. In this study, we investigated the effects of a DPP-4 inhibitor on TZD-induced bone loss in a T2DM animal model. We randomly divided 12-week-old male Zucker Diabetic Fatty (ZDF) rats into four groups; control, vildagliptin, pioglitazone, and vildagliptin and pioglitazone combination. Animals in each group received the respective treatments for 5 weeks. We performed an intraperitoneal glucose tolerance test (IPGTT) before and after treatment. BMD and the trabecular micro-architecture were measured by DEXA and micro CT, respectively, at the end of the treatment. The circulating levels of active GLP-1, bone turnover markers, and sclerostin were assayed. Vildagliptin treatment significantly increased BMD and trabecular bone volume. The combination therapy restored BMD, trabecular bone volume, and trabecular bone thickness that were decreased by pioglitazone. The levels of the bone formation marker, osteocalcin, decreased and that of the bone resorption marker, tartrate-resistant acid phosphatase (TRAP) 5b increased in the pioglitazone group. These biomarkers were ameliorated and the pioglitazone-induced increase in sclerostin level was lowered to control values by the addition of vildagliptin. In conclusion, our results indicate that orally administered vildagliptin demonstrated a protective effect on pioglitazone-induced bone loss in a type 2 diabetic rat model.	[Eom, Young Sil; Lee, Sihoon; Park, Ie Byung; Kim, Byung-Joon] Gachon Univ, Sch Med, Dept Internal Med, Incheon, South Korea; [Gwon, A-Ryeong; Kwak, Kyung Min; Yu, Seung Hee; Kim, Yeun Sun; Kim, Kwang-Won; Lee, Kiyoung] Gachon Univ, Gil Med Ctr, Dept Internal Med, Incheon, South Korea; [Kim, Ju-Young] Wonkang Univ, Imaging Sci Based Lung & Bone Dis Res Ctr, Iksan, Jeonbuk, South Korea	Gachon University; Gachon University; Wonkwang University	Kim, BJ (corresponding author), Gachon Univ, Sch Med, Dept Internal Med, Incheon, South Korea.; Lee, K (corresponding author), Gachon Univ, Gil Med Ctr, Dept Internal Med, Incheon, South Korea.	kylee@gilhospital.com; kbjoon4u@naver.com		EOM, YOUNG SIL/0000-0002-9281-7290	National Research Foundation of Korea(NRF) - Korea government (Ministry of Education) [2013R1A1A2011278]; Korea Health Technology R&D Project through the Korea Health Industry Development Institute - Korea government (Ministry of Health Fare) [HI13C-1602-010015]; Handok pharmaceutical company, Republic of Korea	National Research Foundation of Korea(NRF) - Korea government (Ministry of Education); Korea Health Technology R&D Project through the Korea Health Industry Development Institute - Korea government (Ministry of Health Fare); Handok pharmaceutical company, Republic of Korea	This study was supported by the National Research Foundation of Korea(NRF) grant, funded by the Korea government (Ministry of Education) (No. 2013R1A1A2011278), the Grant of the Korea Health Technology R&D Project through the Korea Health Industry Development Institute, funded by Korea government (Ministry of Health & Fare) (No. HI13C-1602-010015) and the Grant of Handok pharmaceutical company, Republic of Korea. The funders had no role in study design, data collecion and analysis, decision to publish, or preparation of the manuscript.	Ali AA, 2005, ENDOCRINOLOGY, V146, P1226, DOI 10.1210/en.2004-0735; Bilezikian JP, 2013, J CLIN ENDOCR METAB, V98, P1519, DOI 10.1210/jc.2012-4018; Bone HG, 2013, J CLIN ENDOCR METAB, V98, P4691, DOI 10.1210/jc.2012-4096; Compton JT, 2014, J BONE JOINT SURG AM, V96A, P1659, DOI 10.2106/JBJS.M.01096; Gaudin-Audrain C, 2013, BONE, V53, P221, DOI 10.1016/j.bone.2012.11.039; Glorie L, 2014, AM J PHYSIOL-ENDOC M, V307, pE447, DOI 10.1152/ajpendo.00217.2014; GOODMAN WG, 1984, DIABETES, V33, P825, DOI 10.2337/diabetes.33.9.825; Gruntmanis U, 2010, CALCIFIED TISSUE INT, V86, P343, DOI 10.1007/s00223-010-9352-5; Higashijima Y, 2015, AM J PHYSIOL-RENAL, V308, pF878, DOI 10.1152/ajprenal.00590.2014; Janghorbani M, 2007, AM J EPIDEMIOL, V166, P495, DOI 10.1093/aje/kwm106; Kahn SE, 2008, DIABETES CARE, V31, P845, DOI 10.2337/dc07-2270; Kim JY, 2013, LIFE SCI, V92, P533, DOI 10.1016/j.lfs.2013.01.001; Sbaraglini ML, 2014, EUR J PHARMACOL, V727, P8, DOI 10.1016/j.ejphar.2014.01.028; Lazarenko OP, 2007, ENDOCRINOLOGY, V148, P2669, DOI 10.1210/en.2006-1587; Loke YK, 2009, CAN MED ASSOC J, V180, P32, DOI 10.1503/cmaj.080486; Mabilleau G, 2010, DIABETIC MED, V27, P925, DOI 10.1111/j.1464-5491.2010.03048.x; McDonough AK, 2008, NAT CLIN PRACT ENDOC, V4, P507, DOI 10.1038/ncpendmet0920; Mieczkowska A, 2013, BONE, V56, P337, DOI 10.1016/j.bone.2013.07.003; Moraes RM, 2015, J PERIODONTOL, V86, P1287, DOI 10.1902/jop.2015.150278; Nishida H, 2014, J BONE MINER RES, V29, P2439, DOI 10.1002/jbmr.2277; NOLAN JJ, 1994, NEW ENGL J MED, V331, P1188, DOI 10.1056/NEJM199411033311803; Nuche-Berenguer B, 2010, REGUL PEPTIDES, V159, P61, DOI 10.1016/j.regpep.2009.06.010; Palermo A, 2015, OSTEOPOROSIS INT, V26, P2073, DOI 10.1007/s00198-015-3123-0; Rathmann W, 2004, DIABETES CARE, V27, P2568, DOI 10.2337/diacare.27.10.2568; Rosenstock J, 2007, DIABETES OBES METAB, V9, P175, DOI 10.1111/j.1463-1326.2006.00698.x; Russell-Jones D, 2012, CLIN ENDOCRINOL, V77, P489, DOI 10.1111/j.1365-2265.2012.04483.x; Saltiel AR, 1996, DIABETES, V45, P1661, DOI 10.2337/diabetes.45.12.1661; Sanz C, 2010, AM J PHYSIOL-ENDOC M, V298, pE634, DOI 10.1152/ajpendo.00460.2009; Sapir-Koren R, 2014, OSTEOPOROSIS INT, V25, P2685, DOI 10.1007/s00198-014-2808-0; Schwartz AV, 2015, J CLIN ENDOCR METAB, V100, P4059, DOI 10.1210/jc.2015-1215; Shaw JE, 2010, DIABETES RES CLIN PR, V87, P4, DOI 10.1016/j.diabres.2009.10.007; van Raalte DH, 2014, EUR J ENDOCRINOL, V170, P565, DOI 10.1530/EJE-13-0639; Vestergaard P, 2007, OSTEOPOROSIS INT, V18, P427, DOI 10.1007/s00198-006-0253-4; Yamada C, 2008, ENDOCRINOLOGY, V149, P574, DOI 10.1210/en.2007-1292; Zander M, 2002, LANCET, V359, P824, DOI 10.1016/S0140-6736(02)07952-7	35	14	15	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2016	11	12							e0168569	10.1371/journal.pone.0168569	http://dx.doi.org/10.1371/journal.pone.0168569			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI9QF	27997588	Green Submitted, Green Published, gold			2022-12-27	WOS:000392842900060
J	Girouard, MP; Pool, M; Alchini, R; Rambaldi, I; Fournier, AE				Girouard, Marie-Pier; Pool, Madeline; Alchini, Ricardo; Rambaldi, Isabel; Fournier, Alyson E.			RhoA Proteolysis Regulates the Actin Cytoskeleton in Response to Oxidative Stress	PLoS One			English	Article							HYDROGEN-PEROXIDE; INDUCED APOPTOSIS; ROD FORMATION; IN-VIVO; PROTEIN; GTPASES; CELLS; DEGRADATION; PHOSPHORYLATION; REORGANIZATION	The small GTPase RhoA regulates the actin cytoskeleton to affect multiple cellular processes including endocytosis, migration and adhesion. RhoA activity is tightly regulated through several mechanisms including GDP/GTP cycling, phosphorylation, glycosylation and prenylation. Previous reports have also reported that cleavage of the carboxy-terminus inactivates RhoA. Here, we describe a novel mechanism of RhoA proteolysis that generates a stable amino-terminal RhoA fragment (RhoA-NTF). RhoA-NTF is detectable in healthy cells and tissues and is upregulated following cell stress. Overexpression of either Rho-ANTF or the carboxy-terminal RhoA cleavage fragment (RhoA-CTF) induces the formation of disorganized actin stress fibres. RhoA-CTF also promotes the formation of disorganized actin stress fibres and nuclear actin rods. Both fragments disrupt the organization of actin stress fibres formed by endogenous RhoA. Together, our findings describe a novel RhoA regulatory mechanism.	[Girouard, Marie-Pier; Pool, Madeline; Alchini, Ricardo; Rambaldi, Isabel; Fournier, Alyson E.] Rue Univ, Montreal Neurol Inst, Dept Neurol & Neurosurg, Montreal, PQ, Canada	McGill University	Fournier, AE (corresponding author), Rue Univ, Montreal Neurol Inst, Dept Neurol & Neurosurg, Montreal, PQ, Canada.	alyson.fournier@mcgill.ca		Fournier, Alyson/0000-0002-1859-7015	Canadian Institute of Health Research [CIHR] [MOP 136794]; Canadian Institutes of Health Research CIHR; McGill Training Program in Neuroengineering; Vanier Canada Graduate Scholarship	Canadian Institute of Health Research [CIHR](Canadian Institutes of Health Research (CIHR)); Canadian Institutes of Health Research CIHR(Canadian Institutes of Health Research (CIHR)); McGill Training Program in Neuroengineering; Vanier Canada Graduate Scholarship	This work was supported by grants from the Canadian Institute of Health Research [CIHR MOP 136794 (AEF); Canadian Institutes of Health Research CIHR; http://www.cihr-irsc.gc.ca/e.193.html] and the McGill Training Program in Neuroengineering. RA was supported by a Vanier Canada Graduate Scholarship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAMSON P, 1992, J CELL BIOL, V119, P617, DOI 10.1083/jcb.119.3.617; Aghajanian A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008045; Belaid A, 2013, CANCER RES, V73, P4311, DOI 10.1158/0008-5472.CAN-12-4142; Bernards A, 2004, TRENDS CELL BIOL, V14, P377, DOI 10.1016/j.tcb.2004.05.003; Chen YZ, 2009, MOL CELL, V35, P841, DOI 10.1016/j.molcel.2009.09.004; DerMardirossian C, 2005, TRENDS CELL BIOL, V15, P356, DOI 10.1016/j.tcb.2005.05.001; Domazetovska A, 2007, BRAIN, V130, P3275, DOI 10.1093/brain/awm247; Ellerbroek SM, 2003, J BIOL CHEM, V278, P19023, DOI 10.1074/jbc.M213066200; Forget MA, 2002, BIOCHEM J, V361, P243, DOI 10.1042/0264-6021:3610243; Fujisawa K, 1998, J BIOL CHEM, V273, P18943, DOI 10.1074/jbc.273.30.18943; Gray CW, 2000, EUR J BIOCHEM, V267, P5699, DOI 10.1046/j.1432-1327.2000.01589.x; Greenberg DL, 2003, BIOCHEMISTRY-US, V42, P702, DOI 10.1021/bi027100x; Grigoriev I, 2006, CELL MOTIL CYTOSKEL, V63, P29, DOI 10.1002/cm.20107; Gunther MI, 2015, J NEUROSCI METH, V251, P143, DOI 10.1016/j.jneumeth.2015.05.021; Hall A, 1998, SCIENCE, V279, P509, DOI 10.1126/science.279.5350.509; HORI Y, 1991, ONCOGENE, V6, P515; Huot J, 1997, CIRC RES, V80, P383, DOI 10.1161/01.RES.80.3.383; Hutchinson DO, 2006, NEUROMUSCULAR DISORD, V16, P113, DOI 10.1016/j.nmd.2005.11.004; Ihara K, 1998, J BIOL CHEM, V273, P9656, DOI 10.1074/jbc.273.16.9656; Jank T, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8807; Kulkarni S, 2002, J BIOL CHEM, V277, P24435, DOI 10.1074/jbc.M203457200; Lang P, 1996, EMBO J, V15, P510, DOI 10.1002/j.1460-2075.1996.tb00383.x; Li G, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2013.519; Miller AL, 2009, NAT CELL BIOL, V11, P71, DOI 10.1038/ncb1814; Munsie L, 2011, HUM MOL GENET, V20, P1937, DOI 10.1093/hmg/ddr075; Munsie LN, 2012, J CELL SCI, V125, P3977, DOI 10.1242/jcs.097667; ONO S, 1993, J MUSCLE RES CELL M, V14, P195, DOI 10.1007/BF00115454; Palazzo AF, 2001, NAT CELL BIOL, V3, P723, DOI 10.1038/35087035; Pampalakis G, 2014, ONCOTARGET, V5, P2390, DOI 10.18632/oncotarget.1235; Pertz O, 2006, NATURE, V440, P1069, DOI 10.1038/nature04665; RIDLEY AJ, 1992, CELL, V70, P389, DOI 10.1016/0092-8674(92)90163-7; Roberts PJ, 2008, J BIOL CHEM, V283, P25150, DOI 10.1074/jbc.M800882200; Saito Y, 2006, FREE RADICAL RES, V40, P619, DOI 10.1080/10715760600632552; Sawada N, 2001, BIOCHEM BIOPH RES CO, V280, P798, DOI 10.1006/bbrc.2000.4194; Schmidt A, 2002, GENE DEV, V16, P1587, DOI 10.1101/gad.1003302; Schoenwaelder SM, 1999, J BIOL CHEM, V274, P14359, DOI 10.1074/jbc.274.20.14359; Shao F, 2003, P NATL ACAD SCI USA, V100, P904, DOI 10.1073/pnas.252770599; Solski PA, 2002, CELL GROWTH DIFFER, V13, P363; Sorg I, 2001, INFECT IMMUN, V69, P7535, DOI 10.1128/IAI.69.12.7535-7543.2001; Stultiens Audrey, 2012, Commun Integr Biol, V5, P99; Subauste MC, 2000, J BIOL CHEM, V275, P9725, DOI 10.1074/jbc.275.13.9725; Teramoto S, 1999, JPN J PHARMACOL, V79, P33, DOI 10.1254/jjp.79.33; Tu S, 2001, J BIOL CHEM, V276, P19656, DOI 10.1074/jbc.M009838200; Vega FM, 2011, J CELL BIOL, V193, P655, DOI 10.1083/jcb.201011038; Wang HR, 2003, SCIENCE, V302, P1775, DOI 10.1126/science.1090772; Watanabe N, 1999, NAT CELL BIOL, V1, P136, DOI 10.1038/11056; Wei JX, 2013, BBA-MOL CELL RES, V1833, P2757, DOI 10.1016/j.bbamcr.2013.07.005; Zhu Y, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.103	48	15	15	4	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 19	2016	11	12							e0168641	10.1371/journal.pone.0168641	http://dx.doi.org/10.1371/journal.pone.0168641			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI9QC	27992599	Green Submitted, gold, Green Published			2022-12-27	WOS:000392842600085
J	Studnicki, M; Wozniak, G; Stepkowski, D				Studnicki, Marcin; Wozniak, Grazyna; Stepkowski, Dariusz			The Calculator of Anti-Alzheimer's Diet. Macronutrients	PLOS ONE			English	Article							CALORIC-INTAKE; MEDITERRANEAN DIET; RISK; DISEASE; BRAIN; ALCOHOL; HEALTH; WINE; MULTICENTER; IMPACTS	The opinions about optimal proportions of macronutrients in a healthy diet have changed significantly over the last century. At the same time nutritional sciences failed to provide strong evidence backing up any of the variety of views on macronutrient proportions. Herein we present an idea how these proportions can be calculated to find an optimal balance of macronutrients with respect to prevention of Alzheimer's Disease (AD) and dementia. These calculations are based on our published observation that per capita personal income (PCPI) in the USA correlates with age-adjusted death rates for AD (AADR). We have previously reported that PCPI through the period 1925-2005 correlated with AADR in 2005 in a remarkable, statistically significant oscillatory manner, as shown by changes in the correlation coefficient R (R-original) A question thus arises what caused the oscillatory behavior of R-original? What historical events in the life of 2005 AD victims had shaped their future with AD? Looking for the answers we found that, considering changes in the per capita availability of macronutrients in the USA in the period 1929-2005, we can mathematically explain the variability of R-original for each quarter of a human life. On the basis of multiple regression of R-original with regard to the availability of three macronutrients: carbohydrates, total fat, and protein, with or without alcohol, we propose seven equations (referred to as "the calculator" throughout the text) which allow calculating optimal changes in the proportions of macronutrients to reduce the risk of AD for each age group: youth, early middle age, late middle age and late age. The results obtained with the use of "the calculator" are grouped in a table (Table 4) of macronutrient proportions optimal for reducing the risk of AD in each age group through minimizing Rpredicted-i.e., minimizing the strength of correlation between PCPI and future AADR.	[Studnicki, Marcin] Warsaw Univ Life Sci SGGW, Dept Expt Design & Bioinformat, Warsaw, Poland; [Wozniak, Grazyna; Stepkowski, Dariusz] Nencki Inst Expt Biol, Lab Mol Basis Cell Motil, Warsaw, Poland	Warsaw University of Life Sciences; Polish Academy of Sciences; Nencki Institute of Experimental Biology of the Polish Academy of Sciences	Stepkowski, D (corresponding author), Nencki Inst Expt Biol, Lab Mol Basis Cell Motil, Warsaw, Poland.	d.stepkowski@nencki.gov.pl	Stępkowski, Dariusz/R-4134-2016; Studnicki, Marcin/J-4927-2019	Stępkowski, Dariusz/0000-0002-9926-3542; Studnicki, Marcin/0000-0001-9773-7313				Basu S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057873; Cunnane SC, 2016, ANN NY ACAD SCI, V1367, P12, DOI 10.1111/nyas.12999; Dietary Guidelines Advisory Committee, 2015, SCI REP 2015 DIET GU; FARQUHARSON J, 1995, ARCH DIS CHILD, V72, P198, DOI 10.1136/adc.72.3.198; Feart C, 2015, CURR OPIN CLIN NUTR, V18, P51, DOI 10.1097/MCO.0000000000000131; Granger C. W. J., 1969, INVESTIGATING CAUSAL, V37, P424; Gu YA, 2010, ARCH NEUROL-CHICAGO, V67, P699, DOI 10.1001/archneurol.2010.84; Henderson ST, 2009, NUTR METAB, V6, DOI 10.1186/1743-7075-6-31; Holmes O, 2012, BIOCHEMISTRY-US, V51, P3565, DOI 10.1021/bi300303g; Janssen CIF, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0155307; Kadish I., 2016, EXP GERONTOL; Kerr WC, 2005, ALCOHOL CLIN EXP RES, V29, P2015, DOI 10.1097/01.alc.0000187596.92804.bd; Kromhout D, 2015, BMJ-BRIT MED J, V351, DOI 10.1136/bmj.h4034; Laitinen MH, 2006, DEMENT GERIATR COGN, V22, P99, DOI 10.1159/000093478; Leonard WR, 2010, EVOLUTIONARY PERSPEC; Luchsinger JA, 2002, ARCH NEUROL-CHICAGO, V59, P1258, DOI 10.1001/archneur.59.8.1258; Mosconi Lisa, 2005, Eur J Nucl Med Mol Imaging, V32, P486, DOI 10.1007/s00259-005-1762-7; OBRIEN JS, 1965, J LIPID RES, V6, P537; Orlov M.L., 1996, MULTIPLE LINEAR REGR; Panza F, 2012, INT J GERIATR PSYCH, V27, P1218, DOI 10.1002/gps.3772; Raider K, 2016, NEUROCHEM INT, V97, P172, DOI 10.1016/j.neuint.2016.04.008; RENAUD S, 1992, LANCET, V339, P1523, DOI 10.1016/0140-6736(92)91277-F; Rimm EB, 1996, BRIT MED J, V312, P731, DOI 10.1136/bmj.312.7033.731; Roberts RO, 2012, J ALZHEIMERS DIS, V32, P329, DOI 10.3233/JAD-2012-120862; Robin A, 2011, 92 PHS NIH US DEP HL; Scarmeas N, 2006, ANN NEUROL, V59, P912, DOI 10.1002/ana.20854; Shakersain B, 2016, ALZHEIMERS DEMENT, V12, P100, DOI 10.1016/j.jalz.2015.08.002; Simpson SJ, 2015, CELL, V161, P18, DOI 10.1016/j.cell.2015.02.033; Solfrizzi V, 2006, NEUROBIOL AGING, V27, P1694, DOI 10.1016/j.neurobiolaging.2005.09.026; Solfrizzi V, 2010, AGEING RES REV, V9, P184, DOI 10.1016/j.arr.2009.07.005; Solon-Biet SM, 2015, J ENDOCRINOL, V226, pR17, DOI 10.1530/JOE-15-0173; Solon-Biet SM, 2015, P NATL ACAD SCI USA, V112, P3481, DOI 10.1073/pnas.1422041112; Solon-Biet SM, 2014, CELL METAB, V19, P418, DOI 10.1016/j.cmet.2014.02.009; Stafstrom CE, 2012, FRONT PHARMACOL, V3, DOI 10.3389/fphar.2012.00059; Stepkowski D, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126139; Vining EPG, 1998, ARCH NEUROL-CHICAGO, V55, P1433, DOI 10.1001/archneur.55.11.1433; Walker JM, 2015, NUTRIENTS, V7, P7332, DOI 10.3390/nu7095341; Wang DD, 2016, JAMA INTERN MED, V176, P1134, DOI 10.1001/jamainternmed.2016.2417	38	4	4	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 19	2016	11	12							e0168385	10.1371/journal.pone.0168385	http://dx.doi.org/10.1371/journal.pone.0168385			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI9QC	27992612	gold, Green Submitted, Green Published			2022-12-27	WOS:000392842600053
J	Wein, A; Bauhus, J; Bilodeau-Gauthier, S; Scherer-Lorenzen, M; Nock, C; Staab, M				Wein, Annika; Bauhus, Juergen; Bilodeau-Gauthier, Simon; Scherer-Lorenzen, Michael; Nock, Charles; Staab, Michael			Tree Species Richness Promotes Invertebrate Herbivory on Congeneric Native and Exotic Tree Saplings in a Young Diversity Experiment	PLOS ONE			English	Article							ENEMY RELEASE HYPOTHESIS; ACER-PLATANOIDES L.; INSECT HERBIVORY; ASSOCIATIONAL RESISTANCE; FOREST DIVERSITY; NATURAL ENEMIES; BIODIVERSITY; PLANTS; GROWTH; COMPLEMENTARITY	Tree diversity in forests is an important driver of ecological processes including herbivory. Empirical evidence suggests both negative and positive effects of tree diversity on herbivory, which can be, respectively, attributed to associational resistance or associational susceptibility. Tree diversity experiments allow testing for associational effects, but evidence regarding which pattern predominates is mixed. Furthermore, it is unknown if herbivory on tree species of native vs. exotic origin is influenced by changing tree diversity in a similar way, or if exotic tree species escape natural enemies, resulting in lower damage that is unrelated to tree diversity. To address these questions, we established a young tree diversity experiment in temperate southwestern Germany that uses high planting density (49 trees per plot; plot size 13 m(2)). The species pool consists of six congeneric species pairs of European and North American origin (12 species in total) planted in monocultures and mixtures (1, 2, 4, 6 species). We assessed leaf damage by leaf-chewing insects on more than 5,000 saplings of six broadleaved tree species. Plot-level tree species richness increased leaf damage, which more than doubled from monocultures to six-species mixtures, strongly supporting associational susceptibility. However, leaf damage among congeneric native and exotic species pairs was similar. There were marked differences in patterns of leaf damage across tree genera, and only the genera likely having a predominately generalist herbivore community showed associational susceptibility, irrespective of the geographical origin of a tree species. In conclusion, an increase in tree species richness in young temperate forests may result in associational susceptibility to feeding by generalist herbivores.	[Wein, Annika; Staab, Michael] Univ Freiburg, Fac Environm & Nat Resources, Dept Nat Conservat & Landscape Ecol, Freiburg, Germany; [Bauhus, Juergen; Nock, Charles] Univ Freiburg, Fac Environm & Nat Resources, Dept Silviculture, Freiburg, Germany; [Bilodeau-Gauthier, Simon] Univ Quebec Montreal, Ctr Forest Res, Centre Ville Stn, Montreal, PQ H3C 3P8, Canada; [Scherer-Lorenzen, Michael; Nock, Charles] Univ Freiburg, Fac Biol, Dept Geobot, Freiburg, Germany	University of Freiburg; University of Freiburg; University of Quebec; University of Quebec Montreal; University of Freiburg	Staab, M (corresponding author), Univ Freiburg, Fac Environm & Nat Resources, Dept Nat Conservat & Landscape Ecol, Freiburg, Germany.	michael.staab@nature.uni-freiburg.de	Bauhus, Jürgen/G-4449-2013; Scherer-Lorenzen, Michael/AGB-4140-2022; Staab, Michael/I-6544-2019	Bauhus, Jürgen/0000-0002-9673-4986; Scherer-Lorenzen, Michael/0000-0001-9566-590X; Staab, Michael/0000-0003-0894-7576	Albert-Ludwigs-University Freiburg; Innovationsfonds Forschung; German Research Foundation (DFG)	Albert-Ludwigs-University Freiburg; Innovationsfonds Forschung; German Research Foundation (DFG)(German Research Foundation (DFG))	The Freiburg field site of IDENT is administratively and financially supported by the Albert-Ludwigs-University Freiburg (www.unifreiburg.de), including a grant to MSL from the "Innovationsfonds Forschung" for the project "Mechanisms of tree diversity effects on ecosystem functioning". The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The article processing charge was funded by the German Research Foundation (DFG; www.dfg.de) and the Albert-Ludwigs-University Freiburg in the funding program Open Access Publishing.	Abdala-Roberts L, 2015, OIKOS, V124, P1527, DOI 10.1111/oik.02033; Adams JM, 2009, BIOL INVASIONS, V11, P1005, DOI 10.1007/s10530-008-9312-4; Agrawal AA, 2003, ECOL LETT, V6, P712, DOI 10.1046/j.1461-0248.2003.00498.x; Agrawal AA, 2006, Q REV BIOL, V81, P349, DOI 10.1086/511529; Alalouni U, 2014, BASIC APPL ECOL, V15, P685, DOI 10.1016/j.baae.2014.08.013; Barbehenn R, 2005, J CHEM ECOL, V31, P969, DOI 10.1007/s10886-005-4242-4; Barbosa P, 2009, ANNU REV ECOL EVOL S, V40, P1, DOI 10.1146/annurev.ecolsys.110308.120242; Barton K, 2015, MUMIN MULTIMODEL INT, V1, P4, DOI DOI 10.1111/J.2041-210X.2012.00261.X; Bates D, 2015, J STAT SOFTW, V67, P1, DOI 10.18637/jss.v067.i01; BERNAYS EA, 1994, ECOLOGY, V75, P1997, DOI 10.2307/1941604; Branco M, 2015, J APPL ECOL, V52, P69, DOI 10.1111/1365-2664.12362; BROWN BJ, 1987, ECOLOGY, V68, P108, DOI 10.2307/1938810; Bruelheide H, 2014, METHODS ECOL EVOL, V5, P74, DOI 10.1111/2041-210X.12126; Cardinale BJ, 2011, AM J BOT, V98, P572, DOI 10.3732/ajb.1000364; Castagneyrol B, 2014, J APPL ECOL, V51, P134, DOI 10.1111/1365-2664.12175; Castagneyrol B, 2013, J ECOL, V101, P418, DOI 10.1111/1365-2745.12055; Chapman SK, 2003, ECOLOGY, V84, P2867, DOI 10.1890/02-0046; Cincotta CL, 2009, BIOL INVASIONS, V11, P379, DOI 10.1007/s10530-008-9255-9; Colautti RI, 2004, ECOL LETT, V7, P721, DOI 10.1111/j.1461-0248.2004.00616.x; COLEY PD, 1988, OECOLOGIA, V74, P531, DOI 10.1007/BF00380050; Comita LS, 2009, ECOLOGY, V90, P328, DOI 10.1890/08-0451.1; FAO, 2020, GLOBAL FOREST RESOUR; Forister ML, 2015, P NATL ACAD SCI USA, V112, P442, DOI 10.1073/pnas.1423042112; Gossner MM, 2009, AM NAT, V173, P599, DOI 10.1086/597603; Haase J, 2015, OIKOS, V124, P1674, DOI 10.1111/oik.02090; Hagele BF, 1999, OECOLOGIA, V119, P521, DOI 10.1007/s004420050815; Hajek P, 2013, FRONT PLANT SCI, V4, DOI 10.3389/fpls.2013.00415; Halekoh U, 2014, J STAT SOFTW, V59, P1; Hamback PA, 2014, ECOLOGY, V95, P1370, DOI 10.1890/13-0793.1; Hooper DU, 2012, NATURE, V486, P105, DOI 10.1038/nature11118; Hothorn T, 2008, BIOMETRICAL J, V50, P346, DOI 10.1002/bimj.200810425; HURLBERT SH, 1984, ECOL MONOGR, V54, P187, DOI 10.2307/1942661; Hynynen J, 2010, FORESTRY, V83, P103, DOI 10.1093/forestry/cpp035; Isbell F, 2011, NATURE, V477, P199, DOI 10.1038/nature10282; Jactel H, 2007, ECOL LETT, V10, P835, DOI 10.1111/j.1461-0248.2007.01073.x; Keane RM, 2002, TRENDS ECOL EVOL, V17, P164, DOI 10.1016/S0169-5347(02)02499-0; Kenward MG, 1997, BIOMETRICS, V53, P983, DOI 10.2307/2533558; Kirichenko N, 2013, BIOL INVASIONS, V15, P2105, DOI 10.1007/s10530-013-0436-9; KLIMETZEK D, 1993, MITT DGAAE, V8, P505; Langellotto GA, 2004, OECOLOGIA, V139, P1, DOI 10.1007/s00442-004-1497-3; Liu H, 2006, BIOL INVASIONS, V8, P1535, DOI 10.1007/s10530-005-5845-y; Loreau M, 2001, NATURE, V412, P72, DOI 10.1038/35083573; Metcalfe DB, 2014, ECOL LETT, V17, P324, DOI 10.1111/ele.12233; Nadrowski K, 2010, CURR OPIN ENV SUST, V2, P75, DOI 10.1016/j.cosust.2010.02.003; Nagel R.-V., 2015, POTENZIALE RISIKEN E, P219; Nakagawa S, 2013, METHODS ECOL EVOL, V4, P133, DOI 10.1111/j.2041-210x.2012.00261.x; Ness JH, 2011, OIKOS, V120, P1327, DOI 10.1111/j.1600-0706.2011.19119.x; Plath M, 2012, OECOLOGIA, V169, P477, DOI 10.1007/s00442-011-2215-6; ROOT RB, 1973, ECOL MONOGR, V43, P95, DOI 10.2307/1942161; Roscher C, 2004, BASIC APPL ECOL, V5, P107, DOI 10.1078/1439-1791-00216; Scherer-Lorenzen M., 2014, FORESTS GLOBAL CHANG, P195, DOI DOI 10.1017/CBO9781107323506.011; Scherer-Lorenzen M, 2007, PERSPECT PLANT ECOL, V9, P53, DOI 10.1016/j.ppees.2007.08.002; Schuldt A, 2015, J ECOL, V103, P563, DOI 10.1111/1365-2745.12396; Schuldt A, 2012, ECOL LETT, V15, P732, DOI 10.1111/j.1461-0248.2012.01792.x; Schuldt A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022905; Schuldt A, 2010, J ECOL, V98, P917, DOI 10.1111/j.1365-2745.2010.01659.x; Schultheis EH, 2015, ECOLOGY, V96, P2446, DOI 10.1890/14-2158.1; SCHULTZ JC, 1982, AM J BOT, V69, P753, DOI 10.2307/2442965; Shaw DC, 2006, WEST N AM NATURALIST, V66, P473, DOI 10.3398/1527-0904(2006)66[473:SHIAOC]2.0.CO;2; Singer MS, 2002, ANIM BEHAV, V64, P629, DOI 10.1006/anbe.2002.3082; Sobek S, 2009, OECOLOGIA, V160, P279, DOI 10.1007/s00442-009-1304-2; Sprick Peter, 2008, P261; Staab M, 2015, OIKOS, V124, P827, DOI 10.1111/oik.01723; Staab M, 2014, ECOL ENTOMOL, V39, P637, DOI 10.1111/een.12143; TAHVANAINEN JO, 1972, OECOLOGIA, V10, P321, DOI 10.1007/BF00345736; Tilman D, 1996, NATURE, V379, P718, DOI 10.1038/379718a0; Tobner CM, 2014, OECOLOGIA, V174, P609, DOI 10.1007/s00442-013-2815-4; Unsicker SB, 2008, OECOLOGIA, V156, P313, DOI 10.1007/s00442-008-0973-6; van Wilgen NJ, 2011, DIVERS DISTRIB, V17, P172, DOI 10.1111/j.1472-4642.2010.00717.x; Vehvilainen H, 2007, OECOLOGIA, V152, P287, DOI 10.1007/s00442-007-0673-7; Verheyen K, 2016, AMBIO, V45, P29, DOI 10.1007/s13280-015-0685-1; Woziwoda B, 2014, ACTA SOC BOT POL, V83, P39, DOI 10.5586/asbp.2013.035; Zuur Alain F., 2009, P1; Zvereva EL, 2012, OIKOS, V121, P2036, DOI 10.1111/j.1600-0706.2012.20688.x	74	12	12	6	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2016	11	12							e0168751	10.1371/journal.pone.0168751	http://dx.doi.org/10.1371/journal.pone.0168751			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI8LN	27992554	Green Published, Green Submitted, gold			2022-12-27	WOS:000392758000076
J	Cokcetin, NN; Pappalardo, M; Campbell, LT; Brooks, P; Carter, DA; Blair, SE; Harry, EJ				Cokcetin, Nural N.; Pappalardo, Matthew; Campbell, Leona T.; Brooks, Peter; Carter, Dee A.; Blair, Shona E.; Harry, Elizabeth J.			The Antibacterial Activity of Australian Leptospermum Honey Correlates with Methylglyoxal Levels	PLOS ONE			English	Article							APIS-MELLIFERA COLONIES; MANUKA HONEY; DIHYDROXYACETONE; EXPRESSION	Most commercially available therapeutic honey is derived from flowering Leptospermum scoparium (manuka) plants from New Zealand. Australia has more than 80 Leptospermum species, and limited research to date has found at least some produce honey with high non-peroxide antibacterial activity (NPA) similar to New Zealand manuka, suggesting Australia may have a ready supply of medical-grade honey. The activity of manuka honey is largely due to the presence of methylglyoxal (MGO), which is produced non-enzymatically from dihydroxyacetone (DHA) present in manuka nectar. The aims of the current study were to chemically quantify the compounds contributing to antibacterial activity in a collection of Australian Leptospermum honeys, to assess the relationship between MGO and NPA in these samples, and to determine whether NPA changes during honey storage. Eighty different Leptospermum honey samples were analysed, and therapeutically useful NPA was seen in samples derived from species including L. liversidgei and L. polygalifolium. Exceptionally high levels of up to 1100 mg/kg MGO were present in L. polygalifolium honey samples sourced from the Northern Rivers region in NSW and Byfield, QLD, with considerable diversity among samples. There was a strong positive relationship between NPA and MGO concentration, and DHA was present in all of the active honey samples, indicating a potential for ongoing conversion to MGO. NPA was stable, with most samples showing little change following seven years of storage in the dark at 4 degrees C. This study demonstrates the potential for Australian Leptospermum honey as a wound care product, and argues for an extension of this analysis to other Leptospermum species.	[Cokcetin, Nural N.; Pappalardo, Matthew; Blair, Shona E.; Harry, Elizabeth J.] Univ Technol Sydney, Ithree Inst, Sydney, NSW, Australia; [Pappalardo, Matthew; Brooks, Peter] Univ Sunshine Coast, Maroochydore, Qld, Australia; [Campbell, Leona T.; Carter, Dee A.] Univ Sydney, Sydney, NSW, Australia	University of Technology Sydney; University of the Sunshine Coast; University of Sydney	Harry, EJ (corresponding author), Univ Technol Sydney, Ithree Inst, Sydney, NSW, Australia.	liz.harry@uts.edu.au	Carter, Dee/C-1331-2010; Harry, Elizabeth/G-8123-2017; Harry, Liz/AAT-9396-2020; Cokcetin, Nural/AAV-6974-2021; Cokcetin, Nural N/Q-2068-2016	Carter, Dee/0000-0002-4638-0059; Cokcetin, Nural/0000-0002-3874-2873; Cokcetin, Nural N/0000-0002-3874-2873; Harry, Elizabeth/0000-0003-0858-9473; Brooks, Peter/0000-0003-4915-4986	Rural Industries Research and Development Corporation, Australia; Comvita NZ Ltd.; Capilano Honey Pty Ltd. Australia; Rural Industries Research & Development Corporation; Capilano Honey Pty Ltd	Rural Industries Research and Development Corporation, Australia; Comvita NZ Ltd.; Capilano Honey Pty Ltd. Australia; Rural Industries Research & Development Corporation; Capilano Honey Pty Ltd	This work was supported by the Rural Industries Research and Development Corporation, Australia http://www.rirdc.gov.au/, and partially funded by Comvita NZ Ltd. http://www.comvita.co.nz/ and Capilano Honey Pty Ltd. Australia http://capilano.com.au/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank the many beekeepers who supplied honey samples for the survey, Comvita New Zealand for the supply of Medihoney (TM) and active 18+ manuka honey, and Ralf Schlothauer for his manuka honey expertise. This research was supported in part by a Rural Industries Research & Development Corporation grant, as well as Comvita NZ Ltd. and Capilano Honey Pty Ltd.	Adams CJ, 2008, CARBOHYD RES, V343, P651, DOI 10.1016/j.carres.2007.12.011; Adams CJ, 2009, CARBOHYD RES, V344, P1050, DOI 10.1016/j.carres.2009.03.020; Allen K.L., 1991, APIACTA, V26, P114, DOI [10.1080/ 0005772X.1992.11099118, DOI 10.1080/0005772X.1992.11099118]; ALLEN KL, 1991, J PHARM PHARMACOL, V43, P817, DOI 10.1111/j.2042-7158.1991.tb03186.x; Atrott J, 2009, CZECH J FOOD SCI, V27, pS163, DOI 10.17221/911-CJFS; Atrott J, 2012, CARBOHYD RES, V361, P7, DOI 10.1016/j.carres.2012.07.025; Blair SE, 2009, EUR J CLIN MICROBIOL, V28, P1199, DOI 10.1007/s10096-009-0763-z; Brady N, 2004, J APICULT RES, V43, P47, DOI 10.1080/00218839.2004.11101109; Cabrera L, 2006, REV CIENT-FAC CIEN V, V16, P556; Carter DA, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.00569; Cooper RA, 2010, EUR J CLIN MICROBIOL, V29, P1237, DOI 10.1007/s10096-010-0992-1; Cooper RA, 2009, HONEY MODERN WOUND M; Cooper R, 2012, EXPERT REV ANTI-INFE, V10, P623, DOI [10.1586/ERI.12.46, 10.1586/eri.12.46]; Forst J, 2013, LEPTOSPERMUM; Grainger MNC, 2014, FOOD CHEM, V153, P134, DOI 10.1016/j.foodchem.2013.12.017; Henriques A, 2005, J APICULT RES, V44, P119, DOI 10.1080/00218839.2005.11101161; Irish J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018229; Janmaat AF, 2000, BEHAV ECOL SOCIOBIOL, V47, P171, DOI 10.1007/s002650050008; Khalil MI, 2010, FOOD CHEM TOXICOL, V48, P2388, DOI 10.1016/j.fct.2010.05.076; Kwakman PHS, 2011, EUR J CLIN MICROBIOL, V30, P251, DOI 10.1007/s10096-010-1077-x; Lu J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055898; Maddocks SE, 2012, MICROBIOL-SGM, V158, P781, DOI 10.1099/mic.0.053959-0; Mattila HR, 2006, ENVIRON ENTOMOL, V35, P708, DOI 10.1603/0046-225X-35.3.708; Mavric E, 2008, MOL NUTR FOOD RES, V52, P483, DOI 10.1002/mnfr.200700282; Ministry for Primary Industries, 2012, FARM MON REP 2012, P9; MOAR NT, 1985, NEW ZEAL J AGR RES, V28, P39, DOI 10.1080/00288233.1985.10426997; MOLAN PC, 1988, J APICULT RES, V27, P62, DOI 10.1080/00218839.1988.11100783; Molan PC, 1996, J PHARM PHARMACOL, V48, P1206, DOI 10.1111/j.2042-7158.1996.tb03922.x; MOLAN PC, 1992, BEE WORLD, V73, P5, DOI 10.1080/0005772X.1992.11099109; Mundo MA, 2004, INT J FOOD MICROBIOL, V97, P1, DOI 10.1016/j.ijfoodmicro.2004.03.025; Norton AM, 2015, J AGR FOOD CHEM, V63, P6513, DOI 10.1021/acs.jafc.5b01930; Ohashi K, 1999, EUR J BIOCHEM, V265, P127, DOI 10.1046/j.1432-1327.1999.00696.x; Price JN, 2006, ECOGRAPHY, V29, P623, DOI 10.1111/j.0906-7590.2006.04645.x; Shaban, 2013, NATL SURVEILLANCE RE; Staveley JP, 2014, HUM ECOL RISK ASSESS, V20, P566, DOI 10.1080/10807039.2013.831263; Stephens JM, 2010, FOOD CHEM, V120, P78, DOI 10.1016/j.foodchem.2009.09.074; Todd JH, 2007, APIDOLOGIE, V38, P354, DOI 10.1051/apido:2007021; Truchado P, 2009, FOOD CHEM, V115, P1337, DOI 10.1016/j.foodchem.2009.01.065; Windsor S, 2012, J PHARMACOGNOSY PHYT, V4; Windsor S., 2013, J PHARMACOGN PHYTOTH, V5, P21; Wrigley J, 1996, AUSTR NATIVE PLANTS; Yao LH, 2003, FOOD CHEM, V81, P159, DOI 10.1016/S0308-8146(02)00388-6	42	43	44	1	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2016	11	12							e0167780	10.1371/journal.pone.0167780	http://dx.doi.org/10.1371/journal.pone.0167780			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EG7JB	28030589	Green Published, Green Submitted, gold			2022-12-27	WOS:000391222000021
J	Kim, JH; Lee, HS; Choi, HK; Kim, JA; Chu, IS; Leem, SH; Oh, IH				Kim, Jung-Ho; Lee, Ho-Sun; Choi, Hyun-Kyung; Kim, Jin-A; Chu, In-Sun; Leem, Sun-Hee; Oh, Il-Hoan			Heterogeneous Niche Activity of Ex-Vivo Expanded MSCs as Factor for Variable Outcomes in Hematopoietic Recovery	PLOS ONE			English	Article							MESENCHYMAL STEM-CELLS; UMBILICAL-CORD BLOOD; STROMAL CELLS; BONE-MARROW; SELF-RENEWAL; REGENERATIVE MEDICINE; PROMOTE ENGRAFTMENT; UNRELATED DONORS; GRAFT FAILURE; FREE MEDIA	Ex-vivo expanded mesenchymal stromal cells (MSCs) are increasingly used for paracrine support of hematopoietic stem cell (HSC) regeneration, but inconsistent outcomes have hindered ongoing clinical trials. Here, we show that significant heterogeneity in the niche activity of MSCs is created during their culture in various serum-supplemented media. The MSCs cultured under stimulatory or non-stimulatory culture conditions exhibited differences in colony forming unit-fibroblast contents, expression levels of cross-talk molecules (Jagged-1 and CXCL-12) and their support for HSC self-renewal. Accordingly, the enhancing effects of MSCs on hematopoietic engraftment were only visible when HSCs were co-transplanted with MSCs under stimulatory conditions. Of note, these differences in MSCs and their effects on HSCs were readily reversed by switching the cultures, indicating that the difference in niche activity can be caused by distinct functional state, rather than by clonal heterogeneity. Supporting the findings, transcriptomic analysis showed distinct upstream signaling pathways such as inhibition of P53 and activation of ER-stress response gene ATF4 for MSCs under stimulatory conditions. Taken together, our study shows that the niche activity of MSCs can vary rapidly by the extrinsic cues during culture causing variable outcomes in hematopoietic recoveries, and point to the possibility that MSCs can be prescreened for more predictable efficacy in various cell therapy trials.	[Kim, Jung-Ho; Lee, Ho-Sun; Choi, Hyun-Kyung; Kim, Jin-A; Oh, Il-Hoan] Catholic Univ Korea, Catholic High Performance Cell Therapy Ctr, Seoul, South Korea; [Kim, Jung-Ho; Lee, Ho-Sun; Choi, Hyun-Kyung; Kim, Jin-A; Oh, Il-Hoan] Catholic Univ Korea, Dept Med Life Sci, Seoul, South Korea; [Chu, In-Sun] Korea Res Inst Biosci & Biotechnol, Korean Bioinformat Ctr, Daejeon, South Korea; [Leem, Sun-Hee] Dong A Univ, Dept Biol Sci, Busan, South Korea	Catholic University of Korea; Catholic University of Korea; Korea Research Institute of Bioscience & Biotechnology (KRIBB); Dong A University	Oh, IH (corresponding author), Catholic Univ Korea, Catholic High Performance Cell Therapy Ctr, Seoul, South Korea.; Oh, IH (corresponding author), Catholic Univ Korea, Dept Med Life Sci, Seoul, South Korea.	iho@catholic.ac.kr			Ministry of Science, ICT, & Future Planning [2011-0019352]; NRF [2012R1A5A2047939]; Ministry of Food and Drug Safety [14172MFDS974]	Ministry of Science, ICT, & Future Planning; NRF; Ministry of Food and Drug Safety(Ministry of Food & Drug Safety (MFDS), Republic of Korea)	This study was funded by the Ministry of Science, ICT, & Future Planning (No. 2011-0019352), a grant from NRF (2012R1A5A2047939) and a grant from Ministry of Food and Drug Safety (14172MFDS974).	Arai F, 2007, ANN NY ACAD SCI, V1106, P41, DOI 10.1196/annals.1392.005; Balboni AL, 2015, MOL CANCER RES, V13, P732, DOI 10.1158/1541-7786.MCR-14-0152-T; Ball LM, 2007, BLOOD, V110, P2764, DOI 10.1182/blood-2007-04-087056; Bernardo ME, 2012, BONE MARROW TRANSPL, V47, P323, DOI 10.1038/bmt.2011.102; Bernardo ME, 2011, BONE MARROW TRANSPL, V46, P200, DOI 10.1038/bmt.2010.87; Calvi LM, 2003, NATURE, V425, P841, DOI 10.1038/nature02040; Caplan AI, 2011, CELL STEM CELL, V9, P11, DOI 10.1016/j.stem.2011.06.008; Chan CKF, 2009, NATURE, V457, P490, DOI 10.1038/nature07547; Chung YJ, 2006, BLOOD, V108, P1208, DOI 10.1182/blood-2006-01-010199; Colter DC, 2001, P NATL ACAD SCI USA, V98, P7841, DOI 10.1073/pnas.141221698; Ding L, 2012, NATURE, V481, P457, DOI 10.1038/nature10783; Drake LE, 2014, J PATHOL, V232, P283, DOI 10.1002/path.4298; Frenette PS, 2013, ANNU REV IMMUNOL, V31, P285, DOI 10.1146/annurev-immunol-032712-095919; Galipeau J, 2013, CYTOTHERAPY, V15, P2, DOI 10.1016/j.jcyt.2012.10.002; Gonzalo-Daganzo R, 2009, CYTOTHERAPY, V11, P278, DOI 10.1080/14653240902807018; Greenbaum A, 2013, NATURE, V495, P227, DOI 10.1038/nature11926; Hagen J, 2014, CANCER RES, V74, P6661, DOI 10.1158/0008-5472.CAN-13-3742; Ho AD, 2008, CYTOTHERAPY, V10, P320, DOI 10.1080/14653240802217011; Horwitz ME, 2015, CURRENT HEMATOLOGIC; Huang GP, 2007, CELL TRANSPLANT, V16, P579, DOI 10.3727/000000007783465073; Jeong Hyunsuk, 2014, International Journal of Stem Cells, V7, P63, DOI 10.15283/ijsc.2014.7.2.63; Jeong H, 2013, STEM CELL RES THER, V4, DOI 10.1186/scrt233; KANG YJ, 2007, STEM CELLS; Keating A, 2006, CURR OPIN HEMATOL, V13, P419, DOI 10.1097/01.moh.0000245697.54887.6f; Kim DW, 2004, BLOOD, V103, P1941, DOI 10.1182/blood-2003-05-1601; Kim JA, 2015, CANCER RES, V75, P2222, DOI 10.1158/0008-5472.CAN-14-3379; Kim JA, 2015, STEM CELL RES, V14, P356, DOI 10.1016/j.scr.2015.02.007; Kim JA, 2009, STEM CELLS, V27, P1318, DOI 10.1002/stem.52; Koc ON, 2000, J CLIN ONCOL, V18, P307, DOI 10.1200/JCO.2000.18.2.307; Kristt D, 2010, BONE MARROW TRANSPL, V45, P137, DOI 10.1038/bmt.2009.120; Kwon KR, 2010, STEM CELLS, V28, P268, DOI 10.1002/stem.285; Laughlin MJ, 2004, NEW ENGL J MED, V351, P2265, DOI 10.1056/NEJMoa041276; Lazarus HM, 2005, BIOL BLOOD MARROW TR, V11, P389, DOI 10.1016/j.bbmt.2005.02.001; Liu Min, 2013, Methods Mol Biol, V946, P241, DOI 10.1007/978-1-62703-128-8_15; Lui K, 2013, J CELL SCI, V126, P2436, DOI 10.1242/jcs.118117; MacMillan ML, 2009, BONE MARROW TRANSPL, V43, P447, DOI 10.1038/bmt.2008.348; Mendez-Ferrer S, 2010, NATURE, V466, P829, DOI 10.1038/nature09262; Mishima S, 2010, EUR J HAEMATOL, V84, P538, DOI 10.1111/j.1600-0609.2010.01419.x; Mitchell JB, 2006, STEM CELLS, V24, P376, DOI 10.1634/stemcells.2005-0234; Montalbano J, 2009, J BIOL CHEM, V284, P18129, DOI 10.1074/jbc.M109.009597; Murphy MB, 2013, EXP MOL MED, V45, DOI 10.1038/emm.2013.94; NISHIZAWA M, 1992, FEBS LETT, V299, P36, DOI 10.1016/0014-5793(92)80094-W; Noort WA, 2002, EXP HEMATOL, V30, P870, DOI 10.1016/S0301-472X(02)00820-2; Oh Il-Hoan, 2012, Korean J Hematol, V47, P87, DOI 10.5045/kjh.2012.47.2.87; Oh IH, 2010, STEM CELLS, V28, P1243, DOI 10.1002/stem.453; Oikonomopoulos A, 2015, SCI REP-UK, V5, DOI 10.1038/srep16570; Park IH, 2013, EXP MOL MED, V45, DOI 10.1038/emm.2013.87; Park JY, 2004, BIOCHEM BIOPH RES CO, V325, P1346, DOI 10.1016/j.bbrc.2004.10.151; PEAULT B, 1993, NOUV REV FR HEMATOL, V35, P91; Pereira ER, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012521; Pinho S, 2013, J EXP MED, V210, P1351, DOI 10.1084/jem.20122252; Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143; Riordan NH, 2015, J TRANSL MED, V13, DOI 10.1186/s12967-015-0561-6; Rocha V, 2004, NEW ENGL J MED, V351, P2276, DOI 10.1056/NEJMoa041469; Rodgers JT, 2014, NATURE, V510, P393, DOI 10.1038/nature13255; Sacchetti B, 2007, CELL, V131, P324, DOI 10.1016/j.cell.2007.08.025; Smith JR, 2004, STEM CELLS, V22, P823, DOI 10.1634/stemcells.22-5-823; Stier S, 2005, J EXP MED, V201, P1781, DOI 10.1084/jem.20041992; Sugiyama T, 2006, IMMUNITY, V25, P977, DOI 10.1016/j.immuni.2006.10.016; Wermann K, 1996, J Hematother, V5, P379, DOI 10.1089/scd.1.1996.5.379; Wilson A, 2008, CELL, V135, P1118, DOI 10.1016/j.cell.2008.10.048; Ye JB, 2009, CURR MOL MED, V9, P411, DOI 10.2174/156652409788167096; Yu SB, 2013, INT J BIOL SCI, V9, P256, DOI 10.7150/ijbs.5898; Zhang DY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021397; Zhang JW, 2003, NATURE, V425, P836, DOI 10.1038/nature02041; Zhao YZ, 2015, BLOOD, V126, P2383, DOI 10.1182/blood-2015-03-633354	66	11	12	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2016	11	12							e0168036	10.1371/journal.pone.0168036	http://dx.doi.org/10.1371/journal.pone.0168036			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EG7JB	28030562	gold, Green Published, Green Submitted			2022-12-27	WOS:000391222000031
J	Krauel, JJ; LeBuhn, G				Krauel, Jennifer J.; LeBuhn, Gretchen			Patterns of Bat Distribution and Foraging Activity in a Highly Urbanized Temperate Environment	PLOS ONE			English	Article							HABITAT USE; COMMUNITY STRUCTURE; INSECTIVOROUS BATS; EUCALYPTUS PLANTATIONS; FOREST FRAGMENTS; BIRD DIVERSITY; PREY SELECTION; ECOLOGY; ABUNDANCE; INSECTS	Understanding how to manage biodiversity in urban areas will become increasingly important as density of humans residing in urban centers increases and urban areas expand. While considerable research has documented the shifts in biodiversity along urbanization gradients, much less work has focused on how characteristics of dense urban centers, effectively novel environments, influence behavior and biodiversity. Urban bats in San Francisco provide an opportunity to document changes in behavior and biodiversity to very high-density development. We studied (1) the distribution and abundance of bat foraging activity in natural areas; and (2) characteristics of natural areas that influence the observed patterns of distribution and foraging activity. We conducted acoustic surveys of twenty-two parks during 2008-2009. We confirmed the presence of four species of bats (Tadarida brasiliensis, Myotis yumanensis, Lasiurus blossevillii, and M. lucifugus). T. brasiliensis were found in all parks, while M. yumanensis occurred in 36% of parks. Results indicate that proximity to water, park size, and amount of forest edge best explained overall foraging activity. Proximity to water best explained species richness. M. yumanensis activity was best explained by reduced proportion of native vegetation as well as proximity to water. Activity was year round but diminished in December. We show that although bats are present even in very densely populated urban centers, there is a large reduction in species richness compared to that of outlying areas, and that most habitat factors explaining their community composition and activity patterns are similar to those documented in less urbanized environments.	[Krauel, Jennifer J.; LeBuhn, Gretchen] San Francisco State Univ, Dept Biol, San Francisco, CA 94132 USA; [Krauel, Jennifer J.] Univ Tennessee, Dept Ecol & Evolutionary Biol, Knoxville, TN 37996 USA	California State University System; San Francisco State University; University of Tennessee System; University of Tennessee Knoxville	Krauel, JJ (corresponding author), San Francisco State Univ, Dept Biol, San Francisco, CA 94132 USA.; Krauel, JJ (corresponding author), Univ Tennessee, Dept Ecol & Evolutionary Biol, Knoxville, TN 37996 USA.	jkrauel@vols.utk.edu	Krauel, Jennifer/AAD-1949-2019	Krauel, Jennifer/0000-0003-2207-8952; lebuhn, gretchen/0000-0001-5030-3366	San Francisco Natural Areas program; Bat Conservation International; Presidio Trust; Wildlife Society; San Francisco State University	San Francisco Natural Areas program; Bat Conservation International; Presidio Trust; Wildlife Society; San Francisco State University	Funding for this study was provided by the San Francisco Natural Areas program, http://sfrecpark.org/parks-open-spaces/natural-areas-program/, Bat Conservation International, http://www.batcon.org/, the Presidio Trust, http://www.presidio.gov/, the Wildlife Society, http://tws-west.org/, and San Francisco State University, http://www.sfsu.edu. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahlen I, 2009, J MAMMAL, V90, P1318, DOI 10.1644/09-MAMM-S-223R.1; [Anonymous], 2016, ESTIMATES STAT ESTIM; [Anonymous], 2010, POPULATION HOUSING U; [Anonymous], 2021, LANG ENV STAT COMP; Avila-Flores R, 2005, J MAMMAL, V86, P1193, DOI 10.1644/04-MAMM-A-085R1.1; Banks PB, 2007, BIOLOGY LETT, V3, P611, DOI 10.1098/rsbl.2007.0374; Barbosa A.M., 2016, MODEVA MODEL EVALUAT; BARCLAY RMR, 1991, J ANIM ECOL, V60, P165, DOI 10.2307/5452; Barton K., 2016, MUMIN MULTIMODEL INF; BELL GP, 1980, CAN J ZOOL, V58, P1876, DOI 10.1139/z80-256; Beninde J, 2015, ECOL LETT, V18, P581, DOI 10.1111/ele.12427; Bennett VJ, 2013, J WILDLIFE MANAGE, V77, P93, DOI 10.1002/jwmg.467; Berthinussen A, 2011, J APPL ECOL; Beyer HL., HAWTHS ANAL TOOLS AR; Bolger DT, 2000, ECOL APPL, V10, P1230, DOI 10.1890/1051-0761(2000)010[1230:AIUHFI]2.0.CO;2; BRIGHAM RM, 1992, J MAMMAL, V73, P640, DOI 10.2307/1382036; Burnham KP, 2002, MODEL SELECTION MULT, VXXVI; Chamberlain DE, 2009, IBIS, V151, P1, DOI 10.1111/j.1474-919X.2008.00899.x; Christensen R.H.B., 2012, ORDINAL REGRESSION M; Ciechanowski M, 2007, CAN J ZOOL, V85, P1249, DOI 10.1139/Z07-090; Clarke Kevin M., 2008, Urban Ecosystems, V11, P317, DOI 10.1007/s11252-008-0065-8; Clergeau P, 2001, J APPL ECOL, V38, P1122, DOI 10.1046/j.1365-2664.2001.00666.x; Clergeau P, 1998, CONDOR, V100, P413, DOI 10.2307/1369707; Cleveland CJ, 2006, FRONT ECOL ENVIRON, V4, P238, DOI 10.1890/1540-9295(2006)004[0238:EVOTPC]2.0.CO;2; Coleman JL, 2013, J MAMMAL, V94, P1111, DOI 10.1644/12-MAMM-A-217.1; Coleman JL, 2012, URBAN ECOSYST, V15, P87, DOI 10.1007/s11252-011-0181-8; Coleman JL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020483; Connor EF, 2002, J INSECT CONSERV, V6, P247, DOI 10.1023/A:1024426727504; Cryan PM, 2007, BIOL CONSERV, V139, P1, DOI 10.1016/j.biocon.2007.05.019; Dallimer M, 2011, BIOL LETTERS, V7, P763, DOI 10.1098/rsbl.2011.0025; Derkzen ML, 2015, J APPL ECOL, V52, P1020, DOI 10.1111/1365-2664.12469; Dixon MD, 2012, URBAN ECOSYST, V15, P683, DOI 10.1007/s11252-011-0219-y; Duchamp JE, 2004, CAN J ZOOL, V82, P1157, DOI [10.1139/z04-095, 10.1139/Z04-095]; Duchamp JE, 2008, LANDSCAPE ECOL, V23, P849, DOI 10.1007/s10980-008-9241-8; EIP Associates, 2005, SIGN NAT RES AR MAN; Evans KL, 2011, GLOBAL CHANGE BIOL, V17, P32, DOI 10.1111/j.1365-2486.2010.02247.x; Evelyn MJ, 2004, BIOL CONSERV, V115, P463, DOI 10.1016/S0006-3207(03)00163-0; Everette AL, 2001, WILDLIFE SOC B, V29, P967; Fabianek F, 2011, ECOSCIENCE, V18, P9, DOI 10.2980/18-1-3373; FAETH SH, 1978, OECOLOGIA, V32, P127, DOI 10.1007/BF00344697; Fellers GM, 2005, ACOUSTIC INVENTORY M; FENTON MB, 1970, CAN J ZOOLOG, V48, P847, DOI 10.1139/z70-148; FENTON MB, 1990, CAN J ZOOL, V68, P411, DOI 10.1139/z90-061; Forman RTT, 1995, LAND MOSAICS ECOLOGY, Vxx; Frank KD, 2006, EFFECTS ARTIFICIAL N; FRANKIE GW, 1978, ANNU REV ENTOMOL, V23, P367, DOI 10.1146/annurev.en.23.010178.002055; Fried JH, 2005, OECOLOGIA, V143, P645, DOI 10.1007/s00442-005-0023-6; Fukui D, 2006, J ANIM ECOL, V75, P1252, DOI 10.1111/j.1365-2656.2006.01146.x; FURLONGER CL, 1987, CAN J ZOOL, V65, P284, DOI 10.1139/z87-044; Gaisler J, 1998, J ZOOL, V244, P439, DOI 10.1111/j.1469-7998.1998.tb00048.x; GAVARESKI CA, 1976, CONDOR, V78, P375, DOI 10.2307/1367699; Gehrt SD, 2003, ECOL APPL, V13, P939, DOI 10.1890/02-5188; Gehrt SD, 2004, ECOL APPL, V14, P625, DOI 10.1890/03-5013; Grimm NB, 2008, SCIENCE, V319, P756, DOI 10.1126/science.1150195; Guisan A, 2000, ECOL MODEL, V135, P147, DOI 10.1016/S0304-3800(00)00354-9; Haase D, 2014, AMBIO, V43, P407, DOI 10.1007/s13280-014-0503-1; Hale JD, 2015, GLOBAL CHANGE BIOL, V21, P2467, DOI 10.1111/gcb.12884; Hale JD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033300; Heady PA, 2000, BAT INVENTORY SURVEY; Hilbe J.M., 2014, MODELING COUNT DATA; Hothorn T, 2008, BIOMETRICAL J, V50, P346, DOI 10.1002/bimj.200810425; Hourigan C. L., 2006, Urban Ecosystems, V9, P67, DOI 10.1007/s11252-006-7902-4; Hourigan CL, 2010, AUSTRAL ECOL, V35, P849, DOI 10.1111/j.1442-9993.2009.02086.x; Jameson JW, 2014, ANIM BEHAV, V97, P145, DOI 10.1016/j.anbehav.2014.09.003; Johnson JS, 2007, J MAMMAL, V88, P1261, DOI 10.1644/06-MAMM-A-254R1.1; Johnson Joshua B., 2008, Urban Ecosystems, V11, P227, DOI 10.1007/s11252-008-0055-x; Jones Gareth, 2009, Endangered Species Research, V8, P93, DOI 10.3354/esr00182; JONES RC, 1987, WATER RESOUR BULL, V23, P1047; Jung Kirsten, 2016, P13; Jung K, 2011, DIVERS DISTRIB, V17, P262, DOI 10.1111/j.1472-4642.2010.00738.x; Kalcounis-Rueppell MC, 2007, BIOL CONSERV, V138, P120, DOI 10.1016/j.biocon.2007.04.009; Kervyn T, 2008, BELG J ZOOL, V138, P41; Krauel Jennifer J., 2013, P293; KRUTZSCH PHILIP H., 1955, JOUR MAMMAL, V36, P236, DOI 10.2307/1375882; KURTA A, 1992, ECOGRAPHY, V15, P257, DOI 10.1111/j.1600-0587.1992.tb00032.x; Lane DJW, 2006, BIOL CONSERV, V131, P584, DOI 10.1016/j.biocon.2006.03.005; Lesinski G, 2000, Z SAUGETIERKD, V65, P129; Lesnoff, 2012, AOD ANAL OVERDISPERS; LEWIS T, 1969, J APPL ECOL, V6, P443, DOI 10.2307/2401510; Li H, 2014, URBAN ECOSYST, V17, P1013, DOI 10.1007/s11252-014-0369-9; Lidicker WZ, 1999, LANDSCAPE ECOL, V14, P333, DOI 10.1023/A:1008056817939; Lintott PR, 2016, ECOL EVOL; Loeb Susan C., 2009, Urban Ecosystems, V12, P197, DOI 10.1007/s11252-008-0075-6; Lookingbill TR, 2010, BIOL CONSERV, V143, P974, DOI 10.1016/j.biocon.2010.01.011; Marsden SJ, 2001, BIODIVERS CONSERV, V10, P737, DOI 10.1023/A:1016669118956; McFrederick QS, 2006, BIOL CONSERV, V129, P372, DOI 10.1016/j.biocon.2005.11.004; McIntyre NE, 2000, ANN ENTOMOL SOC AM, V93, P825, DOI 10.1603/0013-8746(2000)093[0825:EOUAAR]2.0.CO;2; McKinney ML, 2006, BIOL CONSERV, V127, P247, DOI 10.1016/j.biocon.2005.09.005; Mendes ES, 2014, EUR J WILDLIFE RES, V60, P651, DOI 10.1007/s10344-014-0832-1; Morris AD, 2010, J WILDLIFE MANAGE, V74, P26, DOI 10.2193/2008-471; Mudd T, 2007, ASSESSMENT STATUS BA; NUCKOLS MS, 1995, ECOL ENTOMOL, V20, P253, DOI 10.1111/j.1365-2311.1995.tb00455.x; Null J, 1999, CLIMATOLOGY SAN FRAN; Nupp TE, 2000, J MAMMAL, V81, P512, DOI 10.1644/1545-1542(2000)081&lt;0512:LLCOSM&gt;2.0.CO;2; O'Farrell MJ, 1999, J MAMMAL, V80, P11, DOI 10.2307/1383203; O'Shea TJ, 2011, URBAN ECOSYST, V14, P665, DOI 10.1007/s11252-011-0182-7; Ober HK, 2008, J MAMMAL, V89, P1191, DOI 10.1644/08-MAMM-A-025.1; Perre P, 2011, URBAN ECOSYST, V14, P711, DOI 10.1007/s11252-011-0179-2; Pickett STA, 2011, J ENVIRON MANAGE, V92, P331, DOI 10.1016/j.jenvman.2010.08.022; Pierson ED, 2004, DISTRIBUTION STATUS; Pierson ED, 1995, BAT SURVEYS PRESIDIO; PYE JD, 1971, NATURE, V229, P572, DOI 10.1038/229572b0; Rainey WE, 2006, TEMPORAL SPATIAL VAR; Rainho A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019227; Ritter M. E., 2006, PHYS ENV INTRO PHYS; Russo D, 2003, ECOGRAPHY, V26, P197, DOI 10.1034/j.1600-0587.2003.03422.x; Russo D, 2015, MAMM BIOL, V80, P205, DOI 10.1016/j.mambio.2014.10.003; Russo D, 2015, MAMM BIOL, V80, P157, DOI 10.1016/j.mambio.2015.03.005; RYDELL J, 1989, OECOLOGIA, V80, P562, DOI 10.1007/BF00380082; Schaub A, 2008, J EXP BIOL, V211, P3174, DOI 10.1242/jeb.022863; Sherwin RE, 2000, ACTA CHIROPTEROL, V2, P145; Skalak S.L., 2012, METHODS ECOL EVOL; SOULE M E, 1988, Conservation Biology, V2, P75, DOI 10.1111/j.1523-1739.1988.tb00337.x; Sparks DW, 2005, J MAMMAL, V86, P713, DOI 10.1644/1545-1542(2005)086[0713:FHOTIB]2.0.CO;2; Stahlschmidt P, 2012, METHODS ECOL EVOL, V3, P503, DOI 10.1111/j.2041-210X.2012.00188.x; Stanley MC, 2015, FRONT ECOL ENVIRON, V13, P553, DOI 10.1890/150229; Stone EL, 2015, MAMM BIOL, V80, P213, DOI 10.1016/j.mambio.2015.02.004; Sumasgutner P, 2014, FRONT ZOOL, V11, P13, DOI [10.1186/1742-9994-11-13, DOI 10.1186/1742-9994-11-13]; Szewczak JM, 2004, BAT ECHOLOCATION RES; Szewczak JM, 2006, ECHOLOCATION CALL CH; Threlfall C, 2013, BIOL LETTERS, V9, DOI 10.1098/rsbl.2012.1144; Threlfall C, 2011, ECOGRAPHY, V34, P814, DOI 10.1111/j.1600-0587.2010.06939.x; Threlfall CG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038800; Tratalos J, 2007, LANDSCAPE URBAN PLAN, V83, P308, DOI 10.1016/j.landurbplan.2007.05.003; Vaughan N, 1997, J APPL ECOL, V34, P716, DOI 10.2307/2404918; Vindigni MA, 2009, FOREST ECOL MANAG, V258, P2056, DOI 10.1016/j.foreco.2009.07.058; Walsh AL, 1996, J APPL ECOL, V33, P508, DOI 10.2307/2404980; Weller TJ, 2001, J WILDLIFE MANAGE, V65, P489, DOI 10.2307/3803102; Whitaker John O. Jr, 2003, Proceedings of the Indiana Academy of Science, V112, P55; WILKINS K T, 1989, Mammalian Species, P1, DOI 10.2307/3504148; WILLIAMS TC, 1973, J MAMMAL, V54, P807, DOI 10.2307/1379076; Zahn A, 2009, APPL ECOL ENV RES, V7, P297, DOI 10.15666/aeer/0704_297301	132	22	25	2	101	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2016	11	12							e0168927	10.1371/journal.pone.0168927	http://dx.doi.org/10.1371/journal.pone.0168927			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EG7JB	28030640	Green Submitted, Green Published, gold			2022-12-27	WOS:000391222000085
J	Kriegisch, N; Reeves, S; Johnson, CR; Ling, SD				Kriegisch, Nina; Reeves, Simon; Johnson, Craig R.; Ling, Scott D.			Phase-Shift Dynamics of Sea Urchin Overgrazing on Nutrified Reefs	PLOS ONE			English	Article							SHALLOW SUBTIDAL REEFS; CENTROSTEPHANUS-RODGERSII; NUTRIENT ENRICHMENT; REGIME SHIFTS; STABLE STATES; TOP-DOWN; KELP; COMMUNITY; DENSITY; FOREST	Shifts from productive kelp beds to impoverished sea urchin barrens occur globally and represent a wholesale change to the ecology of sub-tidal temperate reefs. Although the theory of shifts between alternative stable states is well advanced, there are few field studies detailing the dynamics of these kinds of transitions. In this study, sea urchin herbivory (a 'top-down' driver of ecosystems) was manipulated over 12 months to estimate (1) the sea urchin density at which kelp beds collapse to sea urchin barrens, and (2) the minimum sea urchin density required to maintain urchin barrens on experimental reefs in the urbanised Port Phillip Bay, Australia. In parallel, the role of one of the 'bottom-up' drivers of ecosystem structure was examined by (3) manipulating local nutrient levels and thus attempting to alter primary production on the experimental reefs. It was found that densities of 8 or more urchins m(-2) (>= 427 g m(-2) biomass) lead to complete overgrazing of kelp beds while kelp bed recovery occurred when densities were reduced to <= 4 urchins m(-2) (<= 213 g m(-2) biomass). This experiment provided further insight into the dynamics of transition between urchin barrens and kelp beds by exploring possible tipping-points which in this system can be found between 4 and 8 urchins m(-2) (213 and 427 g m(-2) respectively). Local enhancement of nutrient loading did not change the urchin density required for overgrazing or kelp bed recovery, as algal growth was not affected by nutrient enhancement.	[Kriegisch, Nina; Reeves, Simon; Johnson, Craig R.; Ling, Scott D.] Univ Tasmania, Inst Marine & Antarctic Studies, Battery Point, Tas, Australia	University of Tasmania	Kriegisch, N (corresponding author), Univ Tasmania, Inst Marine & Antarctic Studies, Battery Point, Tas, Australia.	nina.kriegisch@utas.edu.au	Johnson, Craig R/E-1788-2013; Reeves, Simon E/AAJ-3379-2021; Ling, Scott/J-7161-2014	Johnson, Craig R/0000-0002-9511-905X; Reeves, Simon/0000-0001-6715-466X; Ling, Scott/0000-0002-5544-8174	Victorian Department of Environment, Land, Water and Planning	Victorian Department of Environment, Land, Water and Planning	Funding was provided by the Victorian Department of Environment, Land, Water and Planning. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDREW NL, 1993, ECOLOGY, V74, P292, DOI 10.2307/1939293; ANDREW NL, 1993, MAR ECOL PROG SER, V99, P89, DOI 10.3354/meps099089; Beaugrand G, 2015, PHILOS T R SOC B, V370, DOI 10.1098/rstb.2013.0272; Beisner BE, 2003, FRONT ECOL ENVIRON, V1, P376, DOI 10.2307/3868190; Benedetti-Cecchi L, 1998, MAR ECOL PROG SER, V163, P203, DOI 10.3354/meps163203; Blamey LK, 2012, J EXP MAR BIOL ECOL, V420, P33, DOI 10.1016/j.jembe.2012.03.022; Bonaviri C, 2011, MAR BIOL, V158, P2505, DOI 10.1007/s00227-011-1751-2; Brandt M, 2012, ECOLOGY, V93, P868, DOI 10.1890/10-1785.1; Bulleri F, 2013, MAR BIOL, V160, P2493, DOI 10.1007/s00227-013-2244-2; Burkepile DE, 2006, ECOLOGY, V87, P3128, DOI 10.1890/0012-9658(2006)87[3128:HVNCOM]2.0.CO;2; Carnell PE, 2014, OECOLOGIA, V175, P409, DOI 10.1007/s00442-014-2907-9; CHAPMAN ARO, 1981, MAR BIOL, V62, P307, DOI 10.1007/BF00397697; CHAPMAN ARO, 1990, HYDROBIOLOGIA, V192, P77, DOI 10.1007/BF00006228; CHAPMAN ARO, 1977, MAR BIOL, V40, P197, DOI 10.1007/BF00390875; Collie JS, 2004, PROG OCEANOGR, V60, P281, DOI 10.1016/j.pocean.2004.02.013; Connell SD, 2008, MAR ECOL PROG SER, V360, P63, DOI 10.3354/meps07526; Constable AJ, 1846, INVESTIGATION RESOUR; DAYTON PK, 1984, SCIENCE, V224, P283, DOI 10.1126/science.224.4646.283; Dong Q, 2002, THEOR POPUL BIOL, V61, P1, DOI 10.1006/tpbi.2001.1554; Fauchald P, 2010, ECOLOGY, V91, P2191, DOI 10.1890/09-1500.1; Feehan C, 2012, MAR ECOL PROG SER, V444, P69, DOI 10.3354/meps09441; Filbee-Dexter K, 2014, MAR ECOL PROG SER, V495, P1, DOI 10.3354/meps10573; Flukes EB, 2014, MAR ECOL PROG SER, V514, P57, DOI 10.3354/meps10964; Fung T, 2011, ECOLOGY, V92, P967, DOI 10.1890/10-0378.1; Gagnon P, 2004, MAR BIOL, V144, P1191, DOI 10.1007/s00227-003-1270-x; Guarnieri G, 2014, OECOLOGIA, V175, P959, DOI 10.1007/s00442-014-2944-4; Harris G., 1996, PORT PHILLIP BAY ENV; HARROLD C, 1985, ECOLOGY, V66, P1160, DOI 10.2307/1939168; Heggie DT, 1999, MAR FRESHWATER RES, V50, P589, DOI 10.1071/MF98054; Hill NA, 2003, MAR FRESHWATER RES, V54, P691, DOI 10.1071/MF03052; Hirota M, 2011, SCIENCE, V334, P232, DOI 10.1126/science.1210657; JOHNSON CR, 1988, ECOL MONOGR, V58, P129, DOI 10.2307/1942464; Jung CA, 2011, OCEAN COAST MANAGE, V54, P93, DOI 10.1016/j.ocecoaman.2010.10.035; KENNELLY SJ, 1987, MAR ECOL PROG SER, V40, P145, DOI 10.3354/meps040145; KENNELLY SJ, 1989, MAR ECOL PROG SER, V50, P215, DOI 10.3354/meps050215; Korpinen S, 2007, ECOLOGY, V88, P839, DOI 10.1890/05-0144; Korpinen S, 2008, ESTUAR COAST SHELF S, V78, P437, DOI 10.1016/j.ecss.2008.01.005; Kraufvelin P, 2010, MAR BIOL, V157, P29, DOI 10.1007/s00227-009-1293-z; Lawrence J.M., 1975, Oceanography mar Biol, V13, P213; Lindenmayer DB, 2011, P NATL ACAD SCI USA, V108, P15887, DOI 10.1073/pnas.1110245108; Ling SD, 2008, OECOLOGIA, V156, P883, DOI 10.1007/s00442-008-1043-9; Ling SD, 2015, PHILOS T R SOC B, V370, DOI 10.1098/rstb.2013.0269; Ling SD, 2010, J EXP MAR BIOL ECOL, V395, P135, DOI 10.1016/j.jembe.2010.08.027; Ling SD, 2009, P NATL ACAD SCI USA, V106, P22341, DOI 10.1073/pnas.0907529106; MAY RM, 1977, NATURE, V269, P471, DOI 10.1038/269471a0; MENGE BA, 1976, AM NAT, V110, P351, DOI 10.1086/283073; North W, 1984, INFLUENCES MACRONUTR, P419; Ortega-Borges L, 2009, J SHELLFISH RES, V28, P947, DOI 10.2983/035.028.0426; Osman RW, 2010, MAR ECOL PROG SER, V413, P185, DOI 10.3354/meps08765; Pfister CA, 2003, J PHYCOL, V39, P285, DOI 10.1046/j.1529-8817.2003.01229.x; Poore AGB, 2012, ECOL LETT, V15, P912, DOI 10.1111/j.1461-0248.2012.01804.x; Posey MH, 2002, ESTUARIES, V25, P999, DOI 10.1007/BF02691347; Russell BD, 2007, MAR FRESHWATER RES, V58, P657, DOI 10.1071/MF06194; Russell BD, 2005, MAR BIOL, V147, P551, DOI 10.1007/s00227-005-1571-3; Russell BD, 2005, MAR ECOL PROG SER, V289, P5, DOI 10.3354/meps289005; Scheffer M, 2001, NATURE, V413, P591, DOI 10.1038/35098000; SCHEFFER M, 1993, TRENDS ECOL EVOL, V8, P275, DOI 10.1016/0169-5347(93)90254-M; Shears NT, 2002, OECOLOGIA, V132, P131, DOI 10.1007/s00442-002-0920-x; Sternberg LDL, 2001, GLOBAL ECOL BIOGEOGR, V10, P369, DOI 10.1046/j.1466-822X.2001.00243.x; Valentine JP, 2003, J EXP MAR BIOL ECOL, V295, P63, DOI 10.1016/S0022-0981(03)00272-7; Worm B, 2000, INT REV HYDROBIOL, V85, P359; Wright JT, 2005, MAR ECOL PROG SER, V298, P143, DOI 10.3354/meps298143	62	24	24	2	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2016	11	12							e0168333	10.1371/journal.pone.0168333	http://dx.doi.org/10.1371/journal.pone.0168333			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EG7JB	28030596	Green Published, Green Submitted, gold			2022-12-27	WOS:000391222000044
J	Marzluff, JM; DeLap, JH; Oleyar, MD; Whittaker, KA; Gardner, B				Marzluff, John M.; DeLap, Jack H.; Oleyar, M. David; Whittaker, Kara A.; Gardner, Beth			Breeding Dispersal by Birds in a Dynamic Urban Ecosystem	PLOS ONE			English	Article							BIASED DISPERSAL; TROPHIC DYNAMICS; LAND-USE; MATE; URBANIZATION; SURVIVAL; CONSEQUENCES; BIODIVERSITY; RESPONSES; PATTERNS	Changes in land cover during urbanization profoundly affect the diversity of bird communities, but the demographic mechanisms affecting diversity are poorly known. We advance such understanding by documenting how urbanization influences breeding dispersal-the annual movement of territorial adults-of six songbird species in the Seattle, WA, USA metropolitan area. We color-banded adults and mapped the centers of their annual breeding activities from 2000-2010 to obtain 504 consecutive movements by 337 adults. By comparing movements, annual reproduction, and mate fidelity among 10 developed, 5 reserved, and 11 changing (areas cleared and developed during our study) landscapes, we determined that adaptive breeding dispersal of sensitive forest species (Swainson's Thrush and Pacific wren), which involves shifting territory and mate after reproductive failure, was constrained by development. In changing lands, sensitive forest specialists dispersed from active development to nearby forested areas, but in so doing suffered low annual reproduction. Species tolerant of suburban lands (song sparrow, spotted towhee, dark-eyed junco, and Bewick's wren) dispersed adaptively in changing landscapes. Site fidelity ranged from 0% (Pacific wren in changing landscape) to 83% (Bewick's wren in forest reserve). Mate fidelity ranged from 25% (dark-eyed junco) to 100% (Bewick's wren). Variation in fidelity to mate and territory was consistent with theories positing an influence of territory quality, asynchronous return from migration, prior productivity, and reproductive benefits of retaining a familiar territory. Costly breeding dispersal, as well as reduced reproductive success and lowered survival cause some birds to decline in the face of urbanization. In contrast, the ability of species that utilize edges and early successional habitats to breed successfully, disperse to improve reproductive success after failure, and survive throughout the urban ecosystem enables them to maintain or increase population size.	[Marzluff, John M.; DeLap, Jack H.; Oleyar, M. David; Whittaker, Kara A.; Gardner, Beth] Univ Washington, Sch Environm & Forest Sci, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle	Marzluff, JM (corresponding author), Univ Washington, Sch Environm & Forest Sci, Seattle, WA 98195 USA.	corvid@uw.edu		Marzluff, John/0000-0002-6266-4975	U.S. National Science Foundation [DEB-9875041, IGERT-0114351, BCS 0120024, BCS 0508002]; University of Washington	U.S. National Science Foundation(National Science Foundation (NSF)); University of Washington(University of Washington)	Funding was provided by the U.S. National Science Foundation (DEB-9875041, IGERT-0114351, BCS 0120024, and BCS 0508002) and the University of Washington (Rachel Wood's Endowed Graduate Program, James W. Ridgeway Professorship). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alberti M, 2003, BIOSCIENCE, V53, P1169, DOI 10.1641/0006-3568(2003)053[1169:IHIEOA]2.0.CO;2; ALDRICH J W, 1980, American Birds, V34, P3; Angel S, 2011, PROG PLANN, V75, P53, DOI 10.1016/j.progress.2011.04.001; [Anonymous], 2021, LANG ENV STAT COMP; Arcese P., 2020, BIRDS OF THE WORLD, DOI [10.2173/bow.sonspa.01, DOI 10.2173/BOW.SONSPA.01]; Armstrong RA, 2014, OPHTHAL PHYSL OPT, V34, P502, DOI 10.1111/opo.12131; Bartos Smith S, 2015, BIRDS N AM ONLINE; Blair RB, 1996, ECOL APPL, V6, P506, DOI 10.2307/2269387; Blewett CM, 2005, CONDOR, V107, P678, DOI 10.1650/0010-5422(2005)107[0678:EOUSOS]2.0.CO;2; Boggie MA, 2015, J RAPTOR RES, V49, P458, DOI 10.3356/rapt-49-04-458-470.1; Breton AR, 2014, IBIS, V156, P534, DOI 10.1111/ibi.12161; Camara G, 1996, COMPUT GRAPH, V20, P395, DOI 10.1016/0097-8493(96)00008-8; Chamberlain DE, 2009, IBIS, V151, P1, DOI 10.1111/j.1474-919X.2008.00899.x; Christoferson LL, 2001, WILDLIFE SOC B, V29, P688; Cline MH, 2013, AUK, V130, P742, DOI 10.1525/auk.2013.12244; Clucas B, 2012, AUK, V129, P8, DOI 10.1525/auk.2011.11121; Cramp S., 1980, Acta Congressus Internationalis Ornithologici, V2, P1316; DAVIES NB, 1989, ANIM BEHAV, V38, P226, DOI 10.1016/S0003-3472(89)80085-5; Dhondt AA, 2002, TRENDS ECOL EVOL, V17, P55, DOI 10.1016/S0169-5347(01)02407-7; DHONDT AA, 1994, J ANIM ECOL, V63, P979, DOI 10.2307/5274; Donnelly R, 2004, CONSERV BIOL, V18, P733, DOI 10.1111/j.1523-1739.2004.00032.x; Donnelly Roarke, 2006, Urban Ecosystems, V9, P99, DOI 10.1007/s11252-006-7904-2; Dubois F, 2002, BEHAV ECOL SOCIOBIOL, V52, P357, DOI 10.1007/s00265-002-0521-z; Ens Bruno J., 1996, Oxford Ornithology Series, V6, P344; ESRI, 2011, ARCGIS DESKT REL 10; Evans BS, 2015, ECOLOGY, V96, P1631, DOI 10.1890/14-0171.1; Faeth SH, 2005, BIOSCIENCE, V55, P399, DOI 10.1641/0006-3568(2005)055[0399:TDIUC]2.0.CO;2; Farwell LS, 2013, BIOL CONSERV, V161, P128, DOI 10.1016/j.biocon.2013.03.017; Fischer JD, 2012, BIOSCIENCE, V62, P809, DOI 10.1525/bio.2012.62.9.6; Fisher RA, 1925, P CAMB PHILOS SOC, V22, P700, DOI 10.1017/S0305004100009580; Foody GM, 2002, REMOTE SENS ENVIRON, V80, P185, DOI 10.1016/S0034-4257(01)00295-4; Friedrich MJ, 2015, AUK, V132, P265, DOI 10.1642/AUK-14-100.1; Fuller RA, 2012, STUD AVIAN BIOL, V45, P249; Gehlbach Frederick R., 2005, Bulletin of the Texas Ornithological Society, V38, P35; GREENWOOD PJ, 1982, ANNU REV ECOL SYST, V13, P1, DOI 10.1146/annurev.es.13.110182.000245; Grimm NB, 2000, BIOSCIENCE, V50, P571, DOI 10.1641/0006-3568(2000)050[0571:IATLTO]2.0.CO;2; Gutierrez RJ, 2011, IBIS, V153, P592, DOI 10.1111/j.1474-919X.2011.01140.x; Halabisky M, 2011, J APPL REMOTE SENS, V5, DOI 10.1117/1.3563569; Handel CM, 2000, ANIM BEHAV, V60, P471, DOI 10.1006/anbe.2000.1505; Hansen AJ, 2005, ECOL APPL, V15, P1893, DOI 10.1890/05-5221; Hepinstall JA, 2008, LANDSCAPE ECOL, V23, P1257, DOI 10.1007/s10980-008-9296-6; IBM Corporation, 2010, IBM SPSS STAT, V19; Kath J, 2009, LANDSCAPE URBAN PLAN, V92, P72, DOI 10.1016/j.landurbplan.2009.02.007; Kaye JP, 2006, TRENDS ECOL EVOL, V21, P192, DOI 10.1016/j.tree.2005.12.006; Kennedy ED, 2013, BIRDS N AM ONLINE; Kight CR, 2007, BIOL CONSERV, V138, P189, DOI 10.1016/j.biocon.2007.04.014; Liebgold EB, 2013, MOL ECOL, V22, P5548, DOI 10.1111/mec.12508; Longcore T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034025; Loss SR, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2380; Loss SR, 2014, CONDOR, V116, P8, DOI 10.1650/CONDOR-13-090.1; Mack D. E, 2000, BIRDS N AM ONLINE; Magle SB, 2012, BIOL CONSERV, V155, P23, DOI 10.1016/j.biocon.2012.06.018; Marzluff J.M., 2005, URBAN ECOSYST, V8, P155; MARZLUFF JM, 1989, ECOLOGY, V70, P316, DOI 10.2307/1937536; Marzluff JM, 2015, URBAN ECOSYSTEMS; Marzluff JM, 2012, STUD AVIAN BIOL, V45, P287; Natuhara Y, 2009, ECOLOGY OF CITIES AND TOWNS: A COMPARATIVE APPROACH, P197, DOI 10.1017/CBO9780511609763.013; Newton I., 1996, Oxford Ornithology Series, V6, P249; Nichols J., 2001, DISPERSAL; Nolan V., 2002, BIRDS N AM; Pickett STA, 2001, ANNU REV ECOL SYST, V32, P127, DOI 10.1146/annurev.ecolsys.32.081501.114012; Pyle P, 1997, IDENTIFICATION GUIDE; Ralph C.J., 1993, PSWGTR144WWW USDA; RECHER HF, 1991, CONSERV BIOL, V5, P90, DOI 10.1111/j.1523-1739.1991.tb00391.x; Robb GN, 2008, FRONT ECOL ENVIRON, V6, P476, DOI 10.1890/060152; Robinson DH, 2002, J WILDLIFE MANAGE, V66, P263, DOI 10.2307/3803158; Robinson L, 2005, LANDSCAPE URBAN PLAN, V71, P51, DOI 10.1016/j.landurbplan.2004.02.005; Rodewald AD, 2014, URBAN WILDLIFE CONSE, p117 147, DOI DOI 10.1007/978-1-4899-7500-3_8; Rodewald AD, 2008, J ANIM ECOL, V77, P83, DOI 10.1111/j.1365-2656.2007.01313.x; Rodewald AD, 2011, ECOL APPL, V21, P936, DOI 10.1890/10-0863.1; Rodewald AD, 2010, BIOL INVASIONS, V12, P33, DOI 10.1007/s10530-009-9426-3; Ryder TB, 2010, ECOL APPL, V20, P419, DOI 10.1890/09-0040.1; Sattler T, 2010, ECOLOGY, V91, P3343, DOI 10.1890/09-1810.1; Shochat E, 2006, TRENDS ECOL EVOL, V21, P186, DOI 10.1016/j.tree.2005.11.019; Shochat E, 2010, BIOSCIENCE, V60, P199, DOI 10.1525/bio.2010.60.3.6; Sol D, 2013, ANIM BEHAV, V85, P1101, DOI 10.1016/j.anbehav.2013.01.023; Stamps Judy A., 2001, P230; Svensson S., 1970, Audubon Fld Notes, V24, P722; Terraube J, 2015, OIKOS, V124, P762, DOI 10.1111/oik.01974; Toews D. P. L., 2012, BIRDS N AM ONLINE; Van Coillie FMB, 2014, INT J REMOTE SENS, V35, P754, DOI 10.1080/01431161.2013.873152; VICKERY PD, 1992, AUK, V109, P697, DOI 10.2307/4088145; Whittaker K, 2012, STUD AVIAN BIOL, V45, P183; Whittaker KA, 2009, AUK, V126, P288, DOI 10.1525/auk.2009.07136; Wlodarczyk R, 2013, ACTA ORNITHOL, V48, P237, DOI 10.3161/000164513X678874	85	14	15	1	68	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2016	11	12							e0167829	10.1371/journal.pone.0167829	http://dx.doi.org/10.1371/journal.pone.0167829			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EG7JB	28030559	Green Published, gold, Green Submitted			2022-12-27	WOS:000391222000022
J	Bigaud, M; Dincer, Z; Bollbuck, B; Dawson, J; Beckmann, N; Beerli, C; Fishli-Cavelti, G; Nahler, M; Angst, D; Janser, P; Otto, H; Rosner, E; Hersperger, R; Bruns, C; Quancard, J				Bigaud, Marc; Dincer, Zuhal; Bollbuck, Birgit; Dawson, Janet; Beckmann, Nicolau; Beerli, Christian; Fishli-Cavelti, Gina; Nahler, Michaela; Angst, Daniela; Janser, Philipp; Otto, Heike; Rosner, Elisabeth; Hersperger, Rene; Bruns, Christian; Quancard, Jean			Pathophysiological Consequences of a Break in S1P1-Dependent Homeostasis of Vascular Permeability Revealed by S1P1 Competitive Antagonism	PLoS One			English	Article							SPHINGOSINE 1-PHOSPHATE RECEPTORS; SELECTIVE S1P(1) ANTAGONIST; IN-VIVO; MECHANISTIC INSIGHTS; LYMPHOCYTE EGRESS; FTY720; LUNG; RATS; SPHINGOSINE-1-PHOSPHATE; IMMUNOSUPPRESSANT	Rational Homeostasis of vascular barriers depends upon sphingosine 1-phosphate (S1P) signaling via the S1P1 receptor. Accordingly, S1P1 competitive antagonism is known to reduce vascular barrier integrity with still unclear pathophysiological consequences. This was explored in the present study using NIBR-0213, a potent and selective S1P1 competitive antagonist. Results NIBR-0213 was tolerated at the efficacious oral dose of 30 mg/kg BID in the rat adjuvant-induced arthritis (AiA) model, with no sign of labored breathing. However, it induced dose-dependent acute vascular pulmonary leakage and pleural effusion that fully resolved within 3-4 days, as evidenced by MRI monitoring. At the supra-maximal oral dose of 300 mg/kg QD, NIBR-0213 impaired lung function (with increased breathing rate and reduced tidal volume) within the first 24 hrs. Two weeks of NIBR-0213 oral dosing at 30, 100 and 300 mg/kg QD induced moderate pulmonary changes, characterized by alveolar wall thickening, macrophage accumulation, fibrosis, micro-hemorrhage, edema and necrosis. In addition to this picture of chronic inflammation, perivascular edema and myofiber degeneration observed in the heart were also indicative of vascular leakage and its consequences. Conclusions Overall, these observations suggest that, in the rat, the lung is the main target organ for the S1P1 competitive antagonism-induced acute vascular leakage, which appears first as transient and asymptomatic but could lead, upon chronic dosing, to lung remodeling with functional impairments. Hence, this not only raises the question of organ specificity in the homeostasis of vascular barriers, but also provides insight into the pre-clinical evaluation of a potential safety window for S1P1 competitive antagonists as drug candidates.	[Bigaud, Marc; Dincer, Zuhal; Bollbuck, Birgit; Dawson, Janet; Beckmann, Nicolau; Beerli, Christian; Fishli-Cavelti, Gina; Nahler, Michaela; Angst, Daniela; Janser, Philipp; Otto, Heike; Rosner, Elisabeth; Hersperger, Rene; Bruns, Christian; Quancard, Jean] Novartis Inst Biomed Res Autoimmun Transplantat &, Basel, Switzerland	Novartis	Bigaud, M (corresponding author), Novartis Inst Biomed Res Autoimmun Transplantat &, Basel, Switzerland.	marc.bigaud@novartis.com	Beckmann, Nicolau/H-7616-2019	Dawson, Janet/0000-0003-4615-4091	NIBR	NIBR	NIBR provided support in the form of salaries to all authors (MB, ZD, BB, JD, NB, CB, GFC, MN, DA, PJ, HO, ER, RH, CB, JQ) but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Allende ML, 2002, BIOCHIM BIOPHYS ACTA, V582, P222; Angst D, 2012, J MED CHEM, V55, P9722, DOI 10.1021/jm3009508; Beckmann N, 2002, AM J PHYSIOL-LUNG C, V283, pL22, DOI 10.1152/ajplung.00373.2001; Beckmann N, 2001, MAGNET RESON MED, V45, P88, DOI 10.1002/1522-2594(200101)45:1<88::AID-MRM1013>3.0.CO;2-N; Berst F, 2007, WO Patent, Patent No. 2008028937; Bigaud M, 2014, BBA-MOL CELL BIOL L, V1841, P745, DOI 10.1016/j.bbalip.2013.11.001; Brinkmann V, 2007, PHARMACOL THERAPEUT, V115, P84, DOI 10.1016/j.pharmthera.2007.04.006; Brinkmann V, 2010, NAT REV DRUG DISCOV, V9, P883, DOI 10.1038/nrd3248; Camm J, 2014, AM HEART J, V168, P632, DOI 10.1016/j.ahj.2014.06.028; Curry FRE, 2013, ACTA PHYSIOL, V207, P628, DOI 10.1111/apha.12076; Cyster JG, 2005, ANNU REV IMMUNOL, V23, P127, DOI 10.1146/annurev.immunol.23.021704.115628; Fujii Y, 2012, BBA-MOL CELL BIOL L, V1821, P600, DOI 10.1016/j.bbalip.2011.12.006; Fujii Y, 2012, J IMMUNOL, V188, P206, DOI 10.4049/jimmunol.1101537; Graler MH, 2004, FASEB J, V18, P551, DOI 10.1096/fj.03-0910fje; Hla T, 2011, NEUROLOGY, V76, pS3, DOI 10.1212/WNL.0b013e31820d5ec1; Hoymann Heinz Gerd, 2007, Journal of Pharmacological and Toxicological Methods, V55, P16, DOI 10.1016/j.vascn.2006.04.006; Huggins JT, 2004, CLIN CHEST MED, V25, P141, DOI 10.1016/S0272-5231(03)00125-4; Janes K, 2014, J BIOL CHEM, V289, P21082, DOI 10.1074/jbc.M114.569574; Koyrakh L, 2005, AM J TRANSPLANT, V5, P529, DOI 10.1111/j.1600-6143.2005.00754.x; Lee JF, 2009, AM J PHYSIOL-HEART C, V296, pH33, DOI 10.1152/ajpheart.00097.2008; Light RW, 2011, MED CLIN N AM, V95, P1055, DOI 10.1016/j.mcna.2011.08.005; Markov AG, 2014, FRONT PHYSIOL, V5, DOI 10.3389/fphys.2014.00221; Marsolais D, 2009, NAT REV DRUG DISCOV, V8, P297, DOI 10.1038/nrd2356; Matloubian M, 2004, NATURE, V427, P355, DOI 10.1038/nature02284; Matsuura M, 2000, INFLAMM RES, V49, P404, DOI 10.1007/s000110050608; McVerry BJ, 2005, CELL SIGNAL, V17, P131, DOI 10.1016/j.cellsig.2004.08.006; Miserocchi G, 2009, EUR RESPIR REV, V18, P244, DOI 10.1183/09059180.00002709; Oo ML, 2011, J CLIN INVEST, V121, P2290, DOI 10.1172/JCI45403; PEARSON CM, 1956, P SOC EXP BIOL MED, V91, P95, DOI 10.3181/00379727-91-22179; Quancard J, 2012, CHEM BIOL, V19, P1142, DOI 10.1016/j.chembiol.2012.07.016; Sanchez T, 2003, J BIOL CHEM, V278, P47281, DOI 10.1074/jbc.M306896200; Sanna MG, 2006, NAT CHEM BIOL, V2, P434, DOI 10.1038/nchembio804; Scotton CJ, 2009, J CLIN INVEST, V119, P2550, DOI 10.1172/JCI33288; Shea BS, 2010, AM J RESP CELL MOL, V43, P662, DOI 10.1165/rcmb.2009-0345OC; Singleton PA, 2006, J BIOL CHEM, V281, P34381, DOI 10.1074/jbc.M603680200; Tigani B, 2002, BIOCHEM BIOPH RES CO, V292, P216, DOI 10.1006/bbrc.2002.6633; Wilkerson BA, 2012, J BIOL CHEM, V287, P44645, DOI 10.1074/jbc.M112.423426	37	13	14	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2016	11	12							e0168252	10.1371/journal.pone.0168252	http://dx.doi.org/10.1371/journal.pone.0168252			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI9QH	28005953	gold, Green Published, Green Submitted			2022-12-27	WOS:000392843200040
J	Carestia, A; Frechtel, G; Cerrone, G; Linari, MA; Gonzalez, CD; Casais, P; Schattner, M				Carestia, Agostina; Frechtel, Gustavo; Cerrone, Gloria; Linari, Maria A.; Gonzalez, Claudio D.; Casais, Patricia; Schattner, Mirta			NETosis before and after Hyperglycemic Control in Type 2 Diabetes Mellitus Patients	PLOS ONE			English	Article							NEUTROPHIL EXTRACELLULAR TRAPS; CYTOKINE PRODUCTION; HIGH GLUCOSE; PLATELET; ASSOCIATION; MECHANISMS; MICE	Introduction and Objective Diabetes is characterized by chronic inflammation, endothelial dysfunction, increased risk of infections and early cardiovascular disease. By releasing neutrophil extracellular traps (NETs), neutrophils kill bacteria and exert pro-inflammatory and pro-thrombotic activities. Increased NETosis has been found in cross-sectional studies including treated type 2 diabetes mellitus (T2DM) patients. In this study, we determined whether the ability of neutrophils to form NETs differs in diabetic patients pre- and post-hyperglycemic control versus healthy donors (HD), and the relationship between NETosis with pro-thrombotic, pro-inflammatory biomarkers and thrombotic clinical events. Methods Diabetic patients recently diagnosed and after 6 and 12 months of treatment (N = 25) and HD (N = 25) were included. NET formation was studied by microscopy and fluorometry. Nucleosomes, HNE-DNA complexes, von Willebrand factor (vWF), IL6 and TNF alpha plasma levels were measured by ELISA and P-selectin on the platelet surface was assessed by cytometry. Results Basal levels of NETs in recently diagnosed T2DM patients were higher compared to HD. While TNF alpha stimulation of control neutrophils resulted in DNA release, patient neutrophils were not responsive. Although glycemia decreased after 6 months of metformin treatment, basal and TNF-alpha and PMA-stimulated NETs reached normal values after 12 months. Compared to controls, nucleosomes, HNE-DNA complexes, IL-6 and TNF alpha levels were increased in recently diagnosed patients and decreased after 12 months of treatment. P-selectin and vWF levels were similar in both populations. Conclusion Our data suggest that NETs could represent a biomarker for T2DM. Increased NETosis in T2DM patients does not appear to be the consequence of impaired glycemic control but rather due to pro-inflammatory cytokines and is not related to thrombotic events.	[Carestia, Agostina; Casais, Patricia; Schattner, Mirta] Consejo Nacl Invest Cient & Tecn, Natl Acad Med, Inst Expt Med, Lab Expt Thrombosis, Buenos Aires, DF, Argentina; [Frechtel, Gustavo; Cerrone, Gloria] Univ Buenos Aires, Sch Pharm & Biochem, Dept Microbiol Immunol & Biotechnol, Genet & Mol Biol, Buenos Aires, DF, Argentina; [Linari, Maria A.] UOM, NORMED, Nutr & Endocrinol Sect, Buenos Aires, DF, Argentina; [Gonzalez, Claudio D.] Univ Buenos Aires, Sch Med, Dept Pharmacol, Buenos Aires, DF, Argentina	Buenos Aires National Academy of Medicine; IMEX - Instituto de Medicina Experimental; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); University of Buenos Aires; University of Buenos Aires	Casais, P; Schattner, M (corresponding author), Consejo Nacl Invest Cient & Tecn, Natl Acad Med, Inst Expt Med, Lab Expt Thrombosis, Buenos Aires, DF, Argentina.	casais@epidemiologia.anm.edu.ar; mschattner@hematologia.anm.edu.ar	Casais, Patricia/AAZ-5915-2021	Casais, Patricia/0000-0002-0121-150X; Gonzalez, Claudio/0000-0002-3772-8850; , Mirta/0000-0001-9439-2161	National Agency for Scientific and Technological Promotion (Argentina) [PICT 0733/11, PICT 0352/14, PICTO 0070 GSK/CONICET]	National Agency for Scientific and Technological Promotion (Argentina)(ANPCyT)	This study was financially supported by grants from the National Agency for Scientific and Technological Promotion (Argentina) (PICT 0733/11, PICT 0352/14 and PICTO 0070 GSK/CONICET).	Amer Diabet Assoc, 2014, DIABETES CARE, V37, pS14, DOI 10.2337/dc14-S014; Amulic B, 2012, ANNU REV IMMUNOL, V30, P459, DOI 10.1146/annurev-immunol-020711-074942; Baruch D, 2006, THERAPIE, V61, P371, DOI 10.2515/therapie:2006068; Brinkmann V, 2004, SCIENCE, V303, P1532, DOI 10.1126/science.1092385; Carestia A, 2016, J LEUKOCYTE BIOL, V99, P153, DOI 10.1189/jlb.3A0415-161R; Carestia A, 2013, THROMB HAEMOSTASIS, V110, P1035, DOI 10.1160/TH13-02-0174; Carmona-Rivera C, 2015, ANN RHEUM DIS, V74, P1417, DOI 10.1136/annrheumdis-2013-204837; Caudrillier A, 2012, J CLIN INVEST, V122, P2661, DOI 10.1172/JCI61303; Clark SR, 2007, NAT MED, V13, P463, DOI 10.1038/nm1565; Czaikoski PG, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0148142; Duerschmied D, 2014, THROMB HAEMOSTASIS, V112, P678, DOI 10.1160/TH14-02-0146; Fadini GP, 2016, DIABETES, V65, P1061, DOI 10.2337/db15-0863; Fernandez-Real JM, 2012, DIABETOLOGIA, V55, P273, DOI 10.1007/s00125-011-2387-y; Fuchs TA, 2007, J CELL BIOL, V176, P231, DOI 10.1083/jcb.200606027; Fuchs TA, 2010, P NATL ACAD SCI USA, V107, P15880, DOI 10.1073/pnas.1005743107; GALLACHER SJ, 1995, DIABETIC MED, V12, P916, DOI 10.1111/j.1464-5491.1995.tb00396.x; Lapponi MJ, 2013, J PHARMACOL EXP THER, V345, P430, DOI 10.1124/jpet.112.202879; Joshi MB, 2013, FEBS LETT, V587, P2241, DOI 10.1016/j.febslet.2013.05.053; Kaplan MJ, 2012, J IMMUNOL, V189, P2689, DOI 10.4049/jimmunol.1201719; Maugeri N, 2014, J THROMB HAEMOST, V12, P2074, DOI 10.1111/jth.12710; Menegazzo L, 2015, ACTA DIABETOL, V52, P497, DOI 10.1007/s00592-014-0676-x; Miyoshi A, 2016, PATHOBIOLOGY, V83, P243, DOI 10.1159/000444881; Negrotto S, 2006, J PHARMACOL EXP THER, V319, P972, DOI 10.1124/jpet.106.109389; Peleg AY, 2007, DIABETES-METAB RES, V23, P3, DOI 10.1002/dmrr.682; Pickup JC, 2000, LIFE SCI, V67, P291, DOI 10.1016/S0024-3205(00)00622-6; Qin J, 2016, CLIN EXP IMMUNOL, V184, P318, DOI 10.1111/cei.12783; von Bruhl ML, 2012, J EXP MED, V209, P819, DOI 10.1084/jem.20112322; Wang G, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105698; Wang HT, 2015, ARTHRITIS RHEUMATOL, V67, P3190, DOI 10.1002/art.39296; Warnatsch A, 2015, SCIENCE, V349, P316, DOI 10.1126/science.aaa8064; Wellen KE, 2005, J CLIN INVEST, V115, P1111, DOI 10.1172/JCI200525102; Wong SL, 2015, NAT MED, V21, P815, DOI 10.1038/nm.3887	32	49	49	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2016	11	12							e0168647	10.1371/journal.pone.0168647	http://dx.doi.org/10.1371/journal.pone.0168647			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI9QH	28005949	gold, Green Published, Green Submitted			2022-12-27	WOS:000392843200074
J	Cattani, AM; Siqueira, FM; Guedes, RLM; Schrank, IS				Cattani, Amanda Malvessi; Siqueira, Franciele Maboni; Muniz Guedes, Rafael Lucas; Schrank, Irene Silveira			Repetitive Elements in Mycoplasma hyopneumoniae Transcriptional Regulation	PLOS ONE			English	Article							TANDEM REPEATS; ANTIGENIC VARIATION; PHASE VARIATION; PROKARYOTIC GENOMES; BACTERIAL GENOMES; GENE-EXPRESSION; MOLECULAR-BASIS; DNA-SEQUENCES; FREQUENCY; EVOLUTION	Transcriptional regulation, a multiple-step process, is still poorly understood in the important pig pathogen Mycoplasma hyopneumoniae. Basic motifs like promoters and terminators have already been described, but no other cis-regulatory elements have been found. DNA repeat sequences have been shown to be an interesting potential source of cis-regulatory elements. In this work, a genome-wide search for tandem and palindromic repetitive elements was performed in the intergenic regions of all coding sequences from M. hyopneumoniae strain 7448. Computational analysis demonstrated the presence of 144 tandem repeats and 1,171 palindromic elements. The DNA repeat sequences were distributed within the 5' upstream regions of 86% of transcriptional units of M. hyopneumoniae strain 7448. Comparative analysis between distinct repetitive sequences found in related mycoplasma genomes demonstrated different percentages of conservation among pathogenic and nonpathogenic strains. qPCR assays revealed differential expression among genes showing variable numbers of repetitive elements. In addition, repeats found in 206 genes already described to be differentially regulated under different culture conditions of M. hyopneumoniae strain 232 showed almost 80% conservation in relation to M. hyopneumoniae strain 7448 repeats. Altogether, these findings suggest a potential regulatory role of tandem and palindromic DNA repeats in the M. hyopneumoniae transcriptional profile.	[Cattani, Amanda Malvessi; Siqueira, Franciele Maboni; Schrank, Irene Silveira] Univ Fed Rio Grande do Sul, Programa Posgrad Biol Celular & Mol, Ctr Biotecnol, Porto Alegre, RS, Brazil; [Muniz Guedes, Rafael Lucas] Lab Nacl Comp Cient, Lab Bioinformat, Petropolis, RJ, Brazil; [Schrank, Irene Silveira] Univ Fed Rio Grande do Sul, Inst Biociencias, Dept Biol Mol & Biotecnol, Ctr Biotecnol, Porto Alegre, RS, Brazil	Universidade Federal do Rio Grande do Sul; Laboratorio Nacional de Computacao Cientifica (LNCC); Universidade Federal do Rio Grande do Sul	Schrank, IS (corresponding author), Univ Fed Rio Grande do Sul, Programa Posgrad Biol Celular & Mol, Ctr Biotecnol, Porto Alegre, RS, Brazil.; Schrank, IS (corresponding author), Univ Fed Rio Grande do Sul, Inst Biociencias, Dept Biol Mol & Biotecnol, Ctr Biotecnol, Porto Alegre, RS, Brazil.	irene@cbiot.ufrgs.br	Siqueira, Franciele M/K-4043-2014; Guedes, Rafael Lucas/P-3029-2015	Siqueira, Franciele M/0000-0001-7282-6117; Muniz Guedes, Rafael Lucas/0000-0002-9163-6674	Coordenacao de Apoio de Pessoal de Nivel Superior - CAPES	Coordenacao de Apoio de Pessoal de Nivel Superior - CAPES(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	This work was funded by Coordenacao de Apoio de Pessoal de Nivel Superior - CAPES. CAPES-Biologia Computacional (Process number: 23038.010043/2013-02) and MCTI/CNPq/Universal (Process number: 445228/2014-8). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achaz G, 2002, NUCLEIC ACIDS RES, V30, P2987, DOI 10.1093/nar/gkf391; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Arraes FBM, 2007, GENET MOL BIOL, V30, P182, DOI 10.1590/S1415-47572007000200004; Bailey TL, 2009, NUCLEIC ACIDS RES, V37, pW202, DOI 10.1093/nar/gkp335; Bayliss CD, 2012, ANN NY ACAD SCI, V1267, P39, DOI 10.1111/j.1749-6632.2012.06584.x; Benson G, 1999, NUCLEIC ACIDS RES, V27, P573, DOI 10.1093/nar/27.2.573; Borges CL, 2007, GENET MOL BIOL, V30, P212, DOI 10.1590/S1415-47572007000200007; Brazda V, 2011, BMC MOL BIOL, V12, DOI 10.1186/1471-2199-12-33; Chang LJ, 2008, BIOCHEM BIOPH RES CO, V367, P213, DOI 10.1016/j.bbrc.2007.12.124; Chen CL, 2009, NUCLEIC ACIDS RES, V37, P3756, DOI 10.1093/nar/gkp230; Citti C, 2010, FUTURE MICROBIOL, V5, P1073, DOI 10.2217/FMB.10.71; da Maia Luciano Carlos, 2008, Int J Plant Genomics, V2008, P412696, DOI 10.1155/2008/412696; Ferreira HB, 2007, GENET MOL BIOL, V30, P245, DOI 10.1590/S1415-47572007000200012; Freund T, 2013, FINDING APPROXIMATE; Fritsch TE, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1468-6; Gemayel R, 2012, GENES-BASEL, V3, P461, DOI 10.3390/genes3030461; Gosney F, 2011, VET MICROBIOL, V147, P220, DOI 10.1016/j.vetmic.2010.06.009; Huang YJ, 2014, DNA RES, V21, P285, DOI 10.1093/dnares/dst057; Kuhnert P, 2014, VET MICROBIOL, V174, P261, DOI 10.1016/j.vetmic.2014.08.022; Liu L, 2002, J BACTERIOL, V184, P1335, DOI 10.1128/JB.184.5.1335-1339.2002; Liu L, 2000, INFECT IMMUN, V68, P871, DOI 10.1128/IAI.68.2.871-876.2000; Liu W, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-80; Liu W, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035698; Liu W, 2011, J BACTERIOL, V193, P1016, DOI 10.1128/JB.01305-10; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lysnyansky I, 1996, J BACTERIOL, V178, P5395, DOI 10.1128/jb.178.18.5395-5401.1996; Ma L, 2012, J MED MICROBIOL, V61, P191, DOI 10.1099/jmm.0.030858-0; Ma LA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015660; Madsen ML, 2008, INFECT IMMUN, V76, P658, DOI 10.1128/IAI.01291-07; Madsen ML, 2006, MICROBIOL-SGM, V152, P937, DOI 10.1099/mic.0.28674-0; Madsen ML, 2006, INFECT IMMUN, V74, P160, DOI 10.1128/IAI.74.1.160-166.2006; Minion FC, 2004, J BACTERIOL, V186, P7123, DOI 10.1128/JB.186.21.7123-7133.2004; Moitinho-Silva L, 2012, VET MICROBIOL, V154, P282, DOI 10.1016/j.vetmic.2011.07.009; Mrazek J, 2006, MOL BIOL EVOL, V23, P1370, DOI 10.1093/molbev/msk023; Mrazek J, 2006, BIOINFORMATICS, V22, P3099, DOI 10.1093/bioinformatics/btl551; Musatovova O, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047625; Noormohammadi AH, 1997, INFECT IMMUN, V65, P2542, DOI 10.1128/IAI.65.7.2542-2547.1997; Oneal MJ, 2008, MICROBIOL-SGM, V154, P2581, DOI 10.1099/mic.0.2008/020230-0; Peak IRA, 1996, FEMS MICROBIOL LETT, V137, P109, DOI 10.1111/j.1574-6968.1996.tb08091.x; Rice P, 2000, TRENDS GENET, V16, P276, DOI 10.1016/S0168-9525(00)02024-2; Rocha EPC, 1999, MOL BIOL EVOL, V16, P1219, DOI 10.1093/oxfordjournals.molbev.a026212; Rocha EPC, 2002, NUCLEIC ACIDS RES, V30, P2031, DOI 10.1093/nar/30.9.2031; Schafer ER, 2007, MICROBIOL-SGM, V153, P3785, DOI 10.1099/mic.0.2007/011387-0; Simmons WL, 2004, INFECT IMMUN, V72, P6846, DOI 10.1128/IAI.72.12.6846-6851.2004; Siqueira FM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110327; Siqueira FM, 2014, MOL BIOL REP, V41, P5395, DOI 10.1007/s11033-014-3411-3; Siqueira FM, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-175; Siqueira FM, 2011, DNA RES, V18, P413, DOI 10.1093/dnares/dsr028; Temnykh S, 2001, GENOME RES, V11, P1441, DOI 10.1101/gr.184001; Thacker Eileen L., 2004, Animal Health Research Reviews, V5, P317, DOI 10.1079/AHR200491; Theiss P, 1997, J BACTERIOL, V179, P4013, DOI 10.1128/jb.179.12.4013-4022.1997; Treangen TJ, 2009, FEMS MICROBIOL REV, V33, P539, DOI 10.1111/j.1574-6976.2009.00169.x; van Belkum A, 1998, MICROBIOL MOL BIOL R, V62, P275, DOI 10.1128/MMBR.62.2.275-293.1998; Vasconcelos ATR, 2005, J BACTERIOL, V187, P5568, DOI 10.1128/JB.187.16.5568-5577.2005; Weber SD, 2012, DNA RES, V19, P103, DOI 10.1093/dnares/dsr045; YOGEV D, 1991, EMBO J, V10, P4069, DOI 10.1002/j.1460-2075.1991.tb04983.x; Zhang QJ, 1996, INFECT IMMUN, V64, P2737, DOI 10.1128/IAI.64.7.2737-2744.1996; Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595	58	5	5	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2016	11	12							e0168626	10.1371/journal.pone.0168626	http://dx.doi.org/10.1371/journal.pone.0168626			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI9QH	28005945	Green Submitted, gold, Green Published			2022-12-27	WOS:000392843200071
J	Guo, S; Zeng, C; Yan, MJ; Han, YC; Xia, DD; Sun, GX; Li, LJ; Yang, MJ; Tan, J				Guo, Song; Zeng, Cheng; Yan, Meijun; Han, Yingchao; Xia, Dongdong; Sun, Guixin; Li, Lijun; Yang, Mingjie; Tan, Jun			A Biomechanical Stability Study of Extraforaminal Lumbar Interbody Fusion on the Cadaveric Lumbar Spine Specimens	PLOS ONE			English	Article							PEDICLE SCREW FIXATION; DEGENERATIVE DISC DISEASE; BACK MUSCLE INJURY; POSTEROLATERAL FUSION; TRANSLAMINAR SCREW; SURGERY; SPONDYLOLISTHESIS; DECOMPRESSION; OUTCOMES	Background Transforaminal lumbar interbody fusion (TLIF) is an effective surgery for lumbar degenerative disease. However, this fusion technique requires resection of inferior facet joint to provide access for superior facet joint resection, which results in reduced lumbar spinal stability and unnecessary trauma. We have previously developed extraforaminal lumbar interbody fusion (ELIF) that can avoid back muscle injury with direct nerve root decompression. This study aims to show that ELIF enhances lumbar spinal stability in comparison to TLIF by comparing lumbar spinal stability of L4-L5 range of motion (ROM) on 12 cadaveric spine specimens after performing TLIF or ELIF. Methods 12 cadaveric spine specimens were randomly divided and treated in accordance with the different internal fixations, including ELIF with a unilateral pedicle screw (ELIF+UPS), TLIF with a unilateral pedicle screw (TLIF+UPS), TLIF with a bilateral pedicle screw (TLIF+BPS), ELIF with a unilateral pedicle screw and translaminar facet screw (ELIF+UPS+TLFS) and ELIF with a bilateral pedicle screw (ELIF+BPS). The treatment groups were exposed to a 400-N load and 6 N.m movement force to calculate the angular displacement of L4-L5 during anterior flexion, posterior extension, lateral flexion and rotation operation conditions. Results The ROM in ELIF+UPS group was smaller than that of TLIF+UPS group under all operating conditions, with the significant differences in left lateral flexion and right rotation by 36.15% and 25.97% respectively. The ROM in ELIF+UPS group was higher than that in TLIF+BPS group. The ROM in the ELIF+UPS+TLFS group was much smaller than that in the ELIF +UPS group, but was not significantly different than that in the TLIF+BPS group. Conclusions Despite that TLIF+BPS has great stability, which can be comparable by that of ELIF+UPS. Additionally, ELIF stability can be further improved by using translaminar facet screws without causing more tissue damage to patient.	[Guo, Song; Zeng, Cheng; Yan, Meijun; Han, Yingchao; Xia, Dongdong; Li, Lijun; Yang, Mingjie; Tan, Jun] Tongji Univ, Sch Med, Shanghai East Hosp, Dept Spine, Shanghai, Peoples R China; [Sun, Guixin] Tongji Univ, Sch Med, Shanghai East Hosp, Dept Traumatol, Shanghai, Peoples R China	Tongji University; Tongji University	Yang, MJ; Tan, J (corresponding author), Tongji Univ, Sch Med, Shanghai East Hosp, Dept Spine, Shanghai, Peoples R China.	yangmingjietj2015@163.com; tanjuntj2012@gmail.com	Yan, Meijun/AAE-6966-2019	Yan, Meijun/0000-0002-9517-2854	Programs for Academic Leaders in Shanghai Pudong New Area [PWRd-2011-02, PWRI2012-03]; Projects of Shanghai Municipal Commission of Health and Family Planning [201440049, 2013025]; Projects of Key Faculties Construction of Pudong Public Health Bureau of Shanghai [PWXZ2014-02]	Programs for Academic Leaders in Shanghai Pudong New Area; Projects of Shanghai Municipal Commission of Health and Family Planning; Projects of Key Faculties Construction of Pudong Public Health Bureau of Shanghai	This work was supported by: Jun Tan, Programs for Academic Leaders in Shanghai Pudong New Area (PWRd-2011-02, PWRI2012-03), http://weisheng.pudong.gov.cn/portal/index/index.htm, this funder is used to study design; Lijun Li, Projects of Shanghai Municipal Commission of Health and Family Planning (201440049, 2013025), http://www.wsjsw.gov.cn/wsj/, this funder is used to data collection and analysis; and Mingjie Yang, Projects of Key Faculties Construction of Pudong Public Health Bureau of Shanghai (PWXZ2014-02), http:// weisheng.pudong.gov.cn/portal/index/index.htm, this funder is used to preparation of the manuscript.	Branch CL, 2000, CLIN NEUROSURG, V47, P252; Chin KR, 2015, SPINE J, V15, P1077, DOI 10.1016/j.spinee.2013.06.103; Choi YS, 2009, ASIAN SPINE J, V3, P39, DOI 10.4184/asj.2009.3.1.39; Grob D, 2009, J BONE JOINT SURG BR, V91B, P1347, DOI 10.1302/0301-620X.91B10.22195; HARMS J, 1982, Z ORTHOP GRENZGEB, V120, P343, DOI 10.1055/s-2008-1051624; Harms JG, 1998, ORTHOP TRAUMATOL, V6, P88; KAWAGUCHI Y, 1994, SPINE, V19, P2590, DOI 10.1097/00007632-199411001-00017; Kawaguchi Y, 1996, SPINE, V21, P941, DOI 10.1097/00007632-199604150-00007; Kim JW, 2010, J CRIT SPINE CASES, V3, P144; KING D, 1948, J BONE JOINT SURG AM, V30-A, P560, DOI 10.2106/00004623-194830030-00003; [李立钧 Li Lijun], 2013, [中华创伤骨科杂志, Chinese Journal of Orthopaedic Trauma], V15, P50; Liu ZD, J ORTHOP SURG RES, V15; Malham GM, 2015, EUR SPINE J, V24, pS339, DOI 10.1007/s00586-015-3807-3; Nakashima H, 2015, SPINE, V40, pE831, DOI 10.1097/BRS.0000000000000917; Ntoukas V, 2010, MINIM INVAS NEUROSUR, V53, P21, DOI 10.1055/s-0030-1247560; PANJABI MM, 1988, SPINE, V13, P1129, DOI 10.1097/00007632-198810000-00013; Phillips FM, 2013, SPINE, V38, pE409, DOI 10.1097/BRS.0b013e3182877f11; Quint U, 2008, EUR SPINE J, V17, P1705, DOI 10.1007/s00586-008-0787-6; Rao PJ, 2015, NEUROSURGERY, V76, P7, DOI 10.1227/NEU.0000000000000561; Ruetten S, 2013, OPER ORTHOP TRAUMATO, V25, P31, DOI 10.1007/s00064-012-0195-2; Sakaura H, 2013, J NEUROSURG-SPINE, V19, P90, DOI 10.3171/2013.4.SPINE12651; Schleicher P, 2008, J NEUROSURG-SPINE, V9, P363, DOI 10.3171/SPI.2008.9.10.363; Sethi A, 2009, EUR SPINE J, V18, P430, DOI 10.1007/s00586-008-0825-4; Slucky Andrew V, 2006, Spine J, V6, P78, DOI 10.1016/j.spinee.2005.08.003; Suk SI, 1997, SPINE, V22, P210, DOI 10.1097/00007632-199701150-00016; Tai CL, 2008, BMC MUSCULOSKELET DI, V9; Talia AJ, 2015, J CLIN NEUROSCI, V22, P243, DOI 10.1016/j.jocn.2014.08.008; Tang SJ, 2012, TURK NEUROSURG, V22, P156, DOI 10.5137/1019-5149.JTN.4214-11.1; Tuli SK, 2005, ORTHOPEDICS, V28, P773; Weiler C, 2011, BMC RES NOTES, V16, P1; Wittayapairoj K, 2014, J ORTHOP SURG RES, V9, DOI 10.1186/1749-799X-9-33; Yang Ming-jie, 2012, Zhonghua Wai Ke Za Zhi, V50, P62; Yang MJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105646	33	6	6	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2016	11	12							e0168498	10.1371/journal.pone.0168498	http://dx.doi.org/10.1371/journal.pone.0168498			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI9QH	28005935	Green Published, Green Submitted, gold			2022-12-27	WOS:000392843200061
J	Hamy, AS; Bonsang-Kitzis, H; Lae, M; Moarii, M; Sadacca, B; Pinheiro, A; Galliot, M; Abecassis, J; Laurent, C; Reyal, F				Hamy, Anne-Sophie; Bonsang-Kitzis, Helene; Lae, Marick; Moarii, Matahi; Sadacca, Benjamin; Pinheiro, Alice; Galliot, Marion; Abecassis, Judith; Laurent, Cecile; Reyal, Fabien			A Stromal Immune Module Correlated with the Response to Neoadjuvant Chemotherapy, Prognosis and Lymphocyte Infiltration in HER2-Positive Breast Carcinoma Is Inversely Correlated with Hormonal Pathways	PLOS ONE			English	Article							PATHOLOGICAL COMPLETE RESPONSE; GENE-EXPRESSION; SEX-DIFFERENCES; CANCER; IDENTIFICATION; TRASTUZUMAB; SIGNATURE; CELLS; 17-BETA-ESTRADIOL; SYNERGIZES	Introduction HER2-positive breast cancer (BC) is a heterogeneous group of aggressive breast cancers, the prognosis of which has greatly improved since the introduction of treatments targeting HER2. However, these tumors may display intrinsic or acquired resistance to treatment, and classifiers of HER2-positive tumors are required to improve the prediction of prognosis and to develop novel therapeutic interventions. Methods We analyzed 2893 primary human breast cancer samples from 21 publicly available data sets and developed a six-metagene signature on a training set of 448 HER2-positive BC. We then used external public datasets to assess the ability of these metagenes to predict the response to chemotherapy (Ignatiadis dataset), and prognosis (METABRIC dataset). Results We identified a six-metagene signature (138 genes) containing metagenes enriched in different gene ontologies. The gene clusters were named as follows: Immunity, Tumor suppressors/proliferation, Interferon, Signal transduction, Hormone/survival and Matrix clusters. In all datasets, the Immunity metagene was less strongly expressed in ER-positive than in ER-negative tumors, and was inversely correlated with the Hormonal/survival meta gene. Within the signature, multivariate analyses showed that strong expression of the "Immunity" metagene was associated with higher pCR rates after NAC (OR = 3.71[1.28-11.91], p=0.019) than weak expression, and with a better prognosis in HER2-positive/ER-negative breast cancers (HR = 0.58 [0.36-0.94], p = 0.026). Immunity metagene expression was associated with the presence of tumor-infiltrating lymphocytes (TILs). Conclusion The identification of a predictive and prognostic immune module in HER2-positive BC confirms the need for clinical testing for immune checkpoint modulators and vaccines for this specific subtype. The inverse correlation between Immunity and hormone pathways opens research perspectives and deserves further investigation.	[Hamy, Anne-Sophie; Bonsang-Kitzis, Helene; Sadacca, Benjamin; Pinheiro, Alice; Galliot, Marion; Abecassis, Judith; Laurent, Cecile; Reyal, Fabien] PSL Res Univ, Inst Curie, Translat Res Dept,Immun & Canc U932, Residual Tumor & Response Treatment Lab,LabRT2,IN, Paris, France; [Bonsang-Kitzis, Helene; Reyal, Fabien] Inst Curie, Dept Surg, Paris, France; [Lae, Marick] Inst Curie, Dept Tumor Biol, Paris, France; [Moarii, Matahi; Abecassis, Judith] PSL Res Univ, CBIO Ctr Computat Biol, Mines ParisTech, Mines Paristech, Fontainebleau, France; [Moarii, Matahi; Abecassis, Judith] INSERM, Inst Curie, U900, Paris, France; [Sadacca, Benjamin] Univ Evry Val Essonne, Lab Math & Modelisat Evry, Evry, France	UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Universite Paris Cite; UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; UDICE-French Research Universities; PSL Research University Paris; MINES ParisTech; UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay	Reyal, F (corresponding author), PSL Res Univ, Inst Curie, Translat Res Dept,Immun & Canc U932, Residual Tumor & Response Treatment Lab,LabRT2,IN, Paris, France.; Reyal, F (corresponding author), Inst Curie, Dept Surg, Paris, France.	fabien.reyal@curie.fr		Laurent, Cecile/0000-0002-3022-2283; HAMY, Anne-Sophie/0000-0003-4430-3022; MOARII, Matahi/0000-0001-6011-9212	ITMO-INSERM-AVIESAN cancer translational research grant; Site de Recherche Integree en Cancerologie/INstitut National du Cancer [InCa-DGOS-4654]	ITMO-INSERM-AVIESAN cancer translational research grant; Site de Recherche Integree en Cancerologie/INstitut National du Cancer	A-S Hamy-Petit was supported by an ITMO-INSERM-AVIESAN cancer translational research grant. Funding was also obtained from the Site de Recherche Integree en Cancerologie/INstitut National du Cancer (InCa-DGOS-4654). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexe G, 2007, CANCER RES, V67, P10669, DOI 10.1158/0008-5472.CAN-07-0539; Arruvito L, 2007, J IMMUNOL, V178, P2572, DOI 10.4049/jimmunol.178.4.2572; Barretina J, 2012, NATURE, V483, P603, DOI 10.1038/nature11003; Bonsang-Kitzis H, 2015, ONCOIMMUNOL; Brahmer J, 2015, NEW ENGL J MED, V373, P123, DOI 10.1056/NEJMoa1504627; Burstein MD, 2014, CLIN CANC RES OFF J; Cook IF, 2008, VACCINE, V26, P3551, DOI 10.1016/j.vaccine.2008.04.054; Cun YP, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-69; Curtis C, 2012, NATURE, V486, P346, DOI 10.1038/nature10983; de Cremoux P, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-215; Denkert C, 2015, J CLIN ONCOL, V33, P983, DOI 10.1200/JCO.2014.58.1967; Desmedt C, 2008, CLIN CANCER RES, V14, P5158, DOI 10.1158/1078-0432.CCR-07-4756; Doane AS, 2006, ONCOGENE, V25, P3994, DOI 10.1038/sj.onc.1209415; Farmer P, 2005, ONCOGENE, V24, P4660, DOI 10.1038/sj.onc.1208561; Finak G, 2008, NAT MED, V14, P518, DOI 10.1038/nm1764; Fish EN, 2008, NAT REV IMMUNOL, V8, P737, DOI 10.1038/nri2394; Frohlich H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025364; Garnett MJ, 2012, NATURE, V483, P570, DOI 10.1038/nature11005; Gatza ML, 2010, P NATL ACAD SCI USA, V107, P6994, DOI 10.1073/pnas.0912708107; Giefing-Kroll C, 2015, AGING CELL, V14, P309, DOI 10.1111/acel.12326; Giuliano M, 2013, BREAST CARE, V8, P256, DOI 10.1159/000354253; Gong Y, 2007, LANCET ONCOL, V8, P203, DOI 10.1016/S1470-2045(07)70042-6; Gu-Trantien C, 2013, J CLIN INVEST, V123, P2873, DOI 10.1172/JCI67428; Hao S, 2007, INT IMMUNOPHARMACOL, V7, P1765, DOI 10.1016/j.intimp.2007.09.017; Ignatiadis M, 2012, J CLIN ONCOL, V30, P1996, DOI 10.1200/JCO.2011.39.5624; Isella C, 2015, NAT GENET, P1; Jensen LJ, 2009, NUCLEIC ACIDS RES, V37, pD412, DOI 10.1093/nar/gkn760; Karn T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028403; Klein SL, 2000, NEUROSCI BIOBEHAV R, V24, P627, DOI 10.1016/S0149-7634(00)00027-0; Lehmann BD, 2011, J CLIN INVEST, V121, P2750, DOI 10.1172/JCI45014; Lehmann-Che J, 2013, BREAST CANCER RES, V15, DOI 10.1186/bcr3421; Lockshin MD, 2006, LUPUS, V15, P753, DOI 10.1177/0961203306069353; Loi S, 2014, ANN ONCOL, V25, P1544, DOI 10.1093/annonc/mdu112; Mahmoud SMA, 2011, J CLIN ONCOL, V29, P1949, DOI 10.1200/JCO.2010.30.5037; Mo R, 2005, J IMMUNOL, V174, P6023, DOI 10.4049/jimmunol.174.10.6023; Palmer C, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-115; Perez E, 2014, STROMAL TUMOR INFILT; Perez EA, 2015, J CLIN ONCOL OFF J A; R Core Team, 2020, R LANG ENV STAT COMP; Robert C, 2011, NEW ENGL J MED, V364, P2517, DOI 10.1056/NEJMoa1104621; Rody A, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr3035; Rody A, 2009, BREAST CANCER RES, V11, DOI 10.1186/bcr2234; Sabatier R, 2015, ONCOTARGET, V6, P5449, DOI 10.18632/oncotarget.3216; Sabatier R, 2011, MOL CANCER, V10, DOI 10.1186/1476-4598-10-86; Sakiani S, 2013, NAT REV ENDOCRINOL, V9, P56, DOI 10.1038/nrendo.2012.206; Salgado R, 2015, ANN ONCOL, V26, P259, DOI 10.1093/annonc/mdu450; Salgado R, 2015, JAMA ONCOL, V1, P448, DOI 10.1001/jamaoncol.2015.0830; Servant Nicolas, 2010, BMC Res Notes, V3, P277, DOI 10.1186/1756-0500-3-277; Siracusa MC, 2008, J IMMUNOL, V180, P1423, DOI 10.4049/jimmunol.180.3.1423; Sota Y, 2014, ANN ONCOL, V25, P100, DOI 10.1093/annonc/mdt427; Staaf J, 2010, J CLIN ONCOL, V28, P1813, DOI 10.1200/JCO.2009.22.8775; Stagg J, 2011, P NATL ACAD SCI USA, V108, P7142, DOI 10.1073/pnas.1016569108; Stoll G, 2014, ONCOIMMUNOLOGY, V3, DOI 10.4161/onci.27884; Teschendorff AE, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-8-r157; Wang QF, 2012, CANCER RES, V72, P4417, DOI 10.1158/0008-5472.CAN-12-1339-T; West NR, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr3072	56	7	7	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2016	11	12							e0167397	10.1371/journal.pone.0167397	http://dx.doi.org/10.1371/journal.pone.0167397			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI9QH	28005906	gold, Green Submitted, Green Published			2022-12-27	WOS:000392843200015
J	Johnson, HR; Trinidad, DD; Guzman, S; Khan, Z; Parziale, JV; DeBruyn, JM; Lents, NH				Johnson, Hunter R.; Trinidad, Donovan D.; Guzman, Stephania; Khan, Zenab; Parziale, James V.; DeBruyn, Jennifer M.; Lents, Nathan H.			A Machine Learning Approach for Using the Postmortem Skin Microbiome to Estimate the Postmortem Interval	PLOS ONE			English	Article								Research on the human microbiome, the microbiota that live in, on, and around the human person, has revolutionized our understanding of the complex interactions between microbial life and human health and disease. The microbiome may also provide a valuable tool in forensic death investigations by helping to reveal the postmortem interval (PMI) of a decedent that is discovered after an unknown amount of time since death. Current methods of estimating PMI for cadavers discovered in uncontrolled, unstudied environments have substantial limitations, some of which may be overcome through the use of microbial indicators. In this project, we sampled the microbiomes of decomposing human cadavers, focusing on the skin microbiota found in the nasal and ear canals. We then developed several models of statistical regression to establish an algorithm for predicting the PMI of microbial samples. We found that the complete data set, rather than a curated list of indicator species, was preferred for training the regressor. We further found that genus and family, rather than species, are the most informative taxonomic levels. Finally, we developed a k-nearest- neighbor regressor, tuned with the entire data set from all nasal and ear samples, that predicts the PMI of unknown samples with an average error of 55 accumulated degree days (ADD). This study outlines a machine learning approach for the use of necrobiome data in the prediction of the PMI and thereby provides a successful proof-of- concept that skin microbiota is a promising tool in forensic death investigations.	[Johnson, Hunter R.; Khan, Zenab] CUNY, John Jay Coll, Dept Math & Comp Sci, New York, NY 10019 USA; [Trinidad, Donovan D.; Guzman, Stephania; Khan, Zenab; Parziale, James V.; Lents, Nathan H.] CUNY, John Jay Coll, Dept Sci, New York, NY 10019 USA; [DeBruyn, Jennifer M.] Univ Tennessee, Dept Biosyst Engn & Soil Sci, Knoxville, TN 37996 USA	City University of New York (CUNY) System; City University of New York (CUNY) System; University of Tennessee System; University of Tennessee Knoxville; UT Institute of Agriculture	Lents, NH (corresponding author), CUNY, John Jay Coll, Dept Sci, New York, NY 10019 USA.	NLENTS@jjay.cuny.edu	DeBruyn, Jennifer M./A-8813-2010	DeBruyn, Jennifer M./0000-0002-2993-4144; Trinidad, Donovan/0000-0002-1439-9927; Parziale, James/0000-0002-4633-0078	PSC-CUNY Research Award Program [67672-00-45]; John Jay College Office for the Advancement of Research; PRISM program at John Jay College - Title V and HSI-STEM programs of the US Department of Education; New York state CSTEP Program	PSC-CUNY Research Award Program; John Jay College Office for the Advancement of Research; PRISM program at John Jay College - Title V and HSI-STEM programs of the US Department of Education; New York state CSTEP Program	Reagents, supplies, and sequencing was made by possible by a grant to NHL from the PSC-CUNY Research Award Program (67672-00-45) and the Seed Funding Program from the John Jay College Office for the Advancement of Research. Student stipends to DT, SG, ZK, and JP were provided by the PRISM program at John Jay College, funded by the Title V and HSI-STEM programs of the US Department of Education and the New York state CSTEP Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Basak D., 2007, NEURAL INF PROCESS L, V11, P203; Bashan A, 2016, NATURE, V534, P259, DOI 10.1038/nature18301; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Carter DO, 2015, FORENSIC SCI MED PAT, V11, P202, DOI 10.1007/s12024-015-9667-7; Christopher M., 2006, PATTERN RECOGNITION; Cobaugh KL, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130201; Ethem Alpaydin, 2009, INTRO MACHINE LEARNI; Finley SJ, 2016, MICROB ECOL, V71, P524, DOI 10.1007/s00248-015-0725-1; Guyon I., 2003, J MACH LEARN RES, V3, P1157, DOI DOI 10.1162/153244303322753616; Hauther KA, 2015, J FORENSIC SCI, V60, P1234, DOI 10.1111/1556-4029.12828; HILL MO, 1973, ECOLOGY, V54, P427, DOI 10.2307/1934352; HOERL AE, 1970, TECHNOMETRICS, V12, P55, DOI 10.1080/00401706.1970.10488634; Human Microbiome Project Consortium, 2012, Nature, V486, P207, DOI 10.1038/nature11234; Hyde ER, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077733; Jorth P, 2014, MBIO, V5, DOI 10.1128/mBio.01012-14; Metcalf JL, 2016, SCIENCE, V351, P158, DOI 10.1126/science.aad2646; Metcalf JL, 2013, ELIFE, V2, DOI 10.7554/eLife.01104; Michaud JP, 2011, J FORENSIC SCI, V56, P229, DOI 10.1111/j.1556-4029.2010.01559.x; Oh J, 2016, CELL, V165, P854, DOI 10.1016/j.cell.2016.04.008; Pechal JL, 2014, INT J LEGAL MED, V128, P193, DOI 10.1007/s00414-013-0872-1; Pechal JL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079035; Pedregosa F, 2011, J MACH LEARN RES, V12, P2825; Peterson J, 2009, GENOME RES, V19, P2317, DOI 10.1101/gr.096651.109; Saeys Y, 2007, BIOINFORMATICS, V23, P2507, DOI 10.1093/bioinformatics/btm344	24	56	63	4	49	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2016	11	12							e0167370	10.1371/journal.pone.0167370	http://dx.doi.org/10.1371/journal.pone.0167370			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI9QH	28005908	gold, Green Published			2022-12-27	WOS:000392843200014
J	Rovozzo, R; Korza, G; Baker, MW; Li, M; Bhattacharyya, A; Barbarese, E; Carson, JH				Rovozzo, Rene; Korza, George; Baker, Mei W.; Li, Meng; Bhattacharyya, Anita; Barbarese, Elisa; Carson, John H.			CGG Repeats in the 5 ' UTR of FMR1 RNA Regulate Translation of Other RNAs Localized in the Same RNA Granules	PLoS One			English	Article							TREMOR ATAXIA SYNDROME; FRAGILE-X PREMUTATION; FLUORESCENCE CORRELATION SPECTROSCOPY; ATG RAN TRANSLATION; MESSENGER-RNA; SURVEILLANCE PATHWAY; DROSOPHILA MODEL; PROTEIN-KINASE; GENE; NEURODEGENERATION	CGG repeats in the 5'UTR of Fragile X Mental Retardation 1 (FMR1) RNA mediate RNA localization and translation in granules. Large expansions of CGG repeats (>200 repeats) in FMR1, referred to as full mutations, are associated with fragile X syndrome (FXS). Smaller expansions (55-200 repeats), referred to as premutations, are associated with fragile X tremor ataxia syndrome (FXTAS) and fragile X premature ovarian insufficiency (FXPOI). TMPyP4 is a porphyrin ring compound that destabilizes CGG repeat RNA secondary structure. Here we show that exogenous CGG repeat RNA by itself, lacking the FMRP ORF, microinjected into hippocampal neurons is localized in RNA granules and inhibits translation of ARC RNA, which is localized in the same granules. TMPyP4 rescues translation of ARC RNA in granules. We also show that in human premutation fibroblasts with endogenous CGG repeat expansions in the FMR1 gene, translation of ARC RNA is inhibited and calcium homeostasis is disrupted and both phenotypes are rescued by TMPyP4. Inhibition of granule translation by expanded CGG repeats and rescue of granule translation by TMPy4, represent potential pathogenic mechanism and therapeutic strategy, respectively, for FXTAS and FXPOI.	[Rovozzo, Rene; Carson, John H.] UConn Hlth, Ctr Cell Anal & Modeling, Farmington, CT 06030 USA; [Korza, George] UConn Hlth, Dept Mol Biol & Biophys, Farmington, CT USA; [Baker, Mei W.] Univ Wisconsin, Dept Pediat, Sch Med & Publ Hlth, Wisconsin State Lab Hyg,Newborn Screening Lab, Madison, WI USA; [Li, Meng; Bhattacharyya, Anita] Univ Wisconsin, Waisman Ctr, Madison, WI 53705 USA; [Barbarese, Elisa] UConn Hlth, Dept Neurosci, Farmington, CT USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Carson, JH (corresponding author), UConn Hlth, Ctr Cell Anal & Modeling, Farmington, CT 06030 USA.	jcarson@nso2.uchc.edu	Resource Center, NINDS Human Genetics/AGF-2474-2022; Sander-Effron, Samuel/AAX-2231-2020	Li, Meng/0000-0002-0145-5440; Bhattacharyya, Anita/0000-0002-0360-7145	National Institutes of Health [RR13186, NS19943, UL1TR000427]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by National Institutes of Health, RR13186 (JHC), National Institutes of Health, NS19943 (EB), and National Institutes of Health, UL1TR000427 (AB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABRAMSON JJ, 1993, ARCH BIOCHEM BIOPHYS, V301, P396, DOI 10.1006/abbi.1993.1162; Andrew EJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066242; BARBER GN, 1993, P NATL ACAD SCI USA, V90, P4621, DOI 10.1073/pnas.90.10.4621; Bassell GJ, 2008, NEURON, V60, P201, DOI 10.1016/j.neuron.2008.10.004; Battle A, 2015, SCIENCE, V347, P664, DOI 10.1126/science.1260793; Cao ZY, 2013, J BIOL CHEM, V288, P13831, DOI 10.1074/jbc.M112.441055; Cenik C, 2015, GENOME RES, V25, P1610, DOI 10.1101/gr.193342.115; Chang YF, 2007, ANNU REV BIOCHEM, V76, P51, DOI 10.1146/annurev.biochem.76.050106.093909; Cleary JD, 2013, HUM MOL GENET, V22, pR45, DOI 10.1093/hmg/ddt371; Cleary JD, 2014, CURR OPIN GENET DEV, V26, P6, DOI 10.1016/j.gde.2014.03.002; DEVYS D, 1993, NAT GENET, V4, P335, DOI 10.1038/ng0893-335; Elkon R, 2015, EMBO REP, V16, P1723, DOI 10.15252/embr.201540717; Filipovic-Sadic S, 2010, CLIN CHEM, V56, P399, DOI 10.1373/clinchem.2009.136101; Galloway JN, 2014, HUM MOL GENET, V23, P5906, DOI 10.1093/hmg/ddu314; Gao YZ, 2008, MOL BIOL CELL, V19, P2311, DOI 10.1091/mbc.E07-09-0914; Garcia-Arocena D, 2010, HUM MOL GENET, V19, pR83, DOI 10.1093/hmg/ddq166; Harigaya Y, 2010, WIRES RNA, V1, P132, DOI 10.1002/wrna.17; Ingolia NT, 2009, SCIENCE, V324, P218, DOI 10.1126/science.1168978; Iwasaki S, 2016, NATURE, V534, P558, DOI 10.1038/nature17978; Jang C, 2015, GENOME RES, V25, P1836, DOI 10.1101/gr.191296.115; Jin P, 2007, NEURON, V55, P556, DOI 10.1016/j.neuron.2007.07.020; Kearse MG, 2016, MOL CELL, V62, P314, DOI 10.1016/j.molcel.2016.02.034; Kenneson A, 2001, HUM MOL GENET, V10, P1449, DOI 10.1093/hmg/10.14.1449; Kiliszek A, 2011, NUCLEIC ACIDS RES, V39, P7308, DOI 10.1093/nar/gkr368; Korb E, 2013, NAT NEUROSCI, V16, P874, DOI 10.1038/nn.3429; Kozlowski P, 2010, NUCLEIC ACIDS RES, V38, P4027, DOI 10.1093/nar/gkq127; Kwon S, 1999, J CELL BIOL, V147, P247, DOI 10.1083/jcb.147.2.247; Levin MK, 2004, DIFFERENTIATION, V72, P1, DOI 10.1111/j.1432-0436.2004.07201002.x; Liu J, 2012, HUM MOL GENET, V21, P3795, DOI 10.1093/hmg/dds207; Loomis EW, 2013, GENOME RES, V23, P121, DOI 10.1101/gr.141705.112; McMurray CT, 2010, NAT REV GENET, V11, P786, DOI 10.1038/nrg2828; Miramon H, 2010, ANAL CHEM, V82, P394, DOI 10.1021/ac902211f; Morris MJ, 2012, NUCLEIC ACIDS RES, V40, P4137, DOI 10.1093/nar/gkr1308; Muslimov IA, 2011, J CELL BIOL, V194, P441, DOI 10.1083/jcb.201010027; Ofer N, 2009, NUCLEIC ACIDS RES, V37, P2712, DOI 10.1093/nar/gkp130; Paradise A, 2007, J MOL BIOL, V365, P50, DOI 10.1016/j.jmb.2006.09.089; POOT M, 1985, GERONTOLOGY, V31, P158, DOI 10.1159/000212697; Reid DW, 2015, RNA BASED METHODS VI, V91, P69; Seltzer MM, 2012, AM J MED GENET B, V159B, P589, DOI 10.1002/ajmg.b.32065; Sidrauski C, 2015, ELIFE, V4, DOI 10.7554/eLife.05033; Sofola OA, 2007, NEURON, V55, P565, DOI 10.1016/j.neuron.2007.07.021; Sullivan SD, 2011, SEMIN REPROD MED, V29, P299, DOI 10.1055/s-0031-1280915; Tanenbaum ME, 2015, ELIFE, V4, DOI 10.7554/eLife.07957; Tassone F, 2000, AM J MED GENET, V91, P144, DOI 10.1002/(SICI)1096-8628(20000313)91:2<144::AID-AJMG14>3.0.CO;2-V; Tassone Flora, 2004, RNA Biol, V1, P103, DOI 10.4161/rna.1.2.1035; Tatavarty V, 2012, MOL BIOL CELL, V23, P918, DOI 10.1091/mbc.E11-07-0622; Tirosh O, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1005288; Todd PK, 2013, NEURON, V78, P440, DOI 10.1016/j.neuron.2013.03.026; Vasudevan S, 2002, BIOESSAYS, V24, P785, DOI 10.1002/bies.10153; Werner A, 2015, NATURE, V525, P523, DOI 10.1038/nature14978; Wiita AP, 2013, ELIFE, V2, DOI 10.7554/eLife.01236; Zu T, 2011, P NATL ACAD SCI USA, V108, P260, DOI 10.1073/pnas.1013343108	52	13	15	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2016	11	12							e0168204	10.1371/journal.pone.0168204	http://dx.doi.org/10.1371/journal.pone.0168204			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI9QH	28005950	Green Published, gold, Green Submitted			2022-12-27	WOS:000392843200036
J	Vavilala, MS; Lujan, SB; Qiu, Q; Petroni, GJ; Ballarini, NM; Guadagnoli, N; Depetris, MA; Faguaga, GA; Baggio, GM; Busso, LO; Garcia, ME; Carrillo, OR; Medici, PL; Saenz, SS; Vanella, EE; Fabio, A; Bell, MJ				Vavilala, Monica S.; Lujan, Silvia B.; Qiu, Qian; Petroni, Gustavo J.; Ballarini, Nicolas M.; Guadagnoli, Nahuel; Alejandra Depetris, Maria; Faguaga, Gabriela A.; Baggio, Gloria M.; Busso, Leonardo O.; Garcia, Mirta E.; Gonzalez Carrillo, Osvaldo R.; Medici, Paula L.; Saenz, Silvia S.; Vanella, Elida E.; Fabio, Anthony; Bell, Michael J.			Benchmarking Prehospital and Emergency Department Care for Argentine Children with Traumatic Brain Injury: For the South American Guideline Adherence Group	PLOS ONE			English	Article							SYSTEM-DEVELOPMENT; OUTCOMES; PERFORMANCE; MORTALITY	Objective There is little information on the type of early care provided to children with traumatic brain injury (TBI) in low middle income countries. We benchmarked early prehospital [PH] and emergency department [ED] pediatric TBI care in Argentina. Methods We conducted a secondary analysis of data from patients previously enrolled in a prospective seven center study of children with TBI. Eligible participants were patients 0-18 years, and had diagnosis of TBI (admission Glasgow Coma scale score [GCS] < 13 or with GCS 14-15 and abnormal head CT scan within 48 hours of admission, and head AIS > 0). Outcomes were transport type, transport time, PH and ED adherence to best practice, and discharge Pediatric Cerebral Performance Category Scale (PCPC) and Pediatric Overall Performance category Scale (POPC). Results Of the 366 children, mean age was 8.7 (5.0) years, 58% were male, 90% had isolated TBI and 45.4% were transported by private vehicle. 50 (34.7%) of the 144 children with severe TBI (39.3% of all TBI patients) were transported by private vehicle. Most (267; 73%) patients received initial TBI care at an index hospital prior to study center admission, including children with severe (81.9%) TBI. Transport times were shorter for those patients who were directly transported by ambulance to study center than for the whole cohort (1.4 vs.5.5 hours). Ambulance blood pressure data were recorded in 30.9%. ED guideline adherence rate was higher than PH guideline adherence rate (84.8% vs. 26.4%). For patients directly transferred from scene to study trauma centers, longer transport time was associated with worse discharge outcome (PCPC aOR 1.10 [1.04, 1.18] and (POPC aOR 1.10 [1.04, 1.18]). There was no relationship between PH or ED TBI guideline adherence rate and discharge POPC and PCPC. Conclusion This study benchmarks early pediatric TBI care in Argentina and shows that many critically injured children with TBI do not receive timely or best practice PH care, that PH guideline adherence rate is low and that longer transport time was associated with poor discharge outcomes for patients with direct transfer status. There is an urgent need to improve the early care of children with TBI in Argentina, especially timely transportation to a hospital.	[Vavilala, Monica S.; Qiu, Qian] Univ Washington, Harborview Injury Prevent & Res Ctr, Anesthesiol & Pain Med, Seattle, WA 98195 USA; [Lujan, Silvia B.; Petroni, Gustavo J.; Ballarini, Nicolas M.; Guadagnoli, Nahuel; Alejandra Depetris, Maria] Ctr Informat Invest Clin, Rosario, Santa Fe, Argentina; [Lujan, Silvia B.; Petroni, Gustavo J.] Hosp Emergencias Dr Clemente Alvarez, Rosario, Santa Fe, Argentina; [Faguaga, Gabriela A.; Baggio, Gloria M.] Hosp Ninos Victor J Vilela, Rosario, Santa Fe, Argentina; [Busso, Leonardo O.] Hosp El Cruce Ezpeleta Oeste, Buenos Aires, DF, Argentina; [Garcia, Mirta E.] Hosp Ninos Sor Maria Ludov, La Plata, Buenos Aires, Argentina; [Gonzalez Carrillo, Osvaldo R.] Hosp Ninos Dr Orlando Alassia, Santa Fe, Santa Fe, Argentina; [Medici, Paula L.] Hosp Interzonal Especializado Materno Infantil Dr, Mar Del Plata, Buenos Aires, Argentina; [Saenz, Silvia S.] Hosp Ninos Santisima Trinidad Cordoba, Cordoba, Argentina; [Vanella, Elida E.] Hosp Pediatr Dr Humberto Notti, Mendoza, Argentina; [Fabio, Anthony] Univ Pittsburgh, Epidemiol Data Coordinating Ctr, Grad Sch Publ Hlth, Pittsburgh, PA 15260 USA; [Bell, Michael J.] Univ Pittsburgh, Neurol Surg & Pediat Crit Care Med, Pittsburgh, PA 15260 USA	University of Washington; University of Washington Seattle; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Vavilala, MS (corresponding author), Univ Washington, Harborview Injury Prevent & Res Ctr, Anesthesiol & Pain Med, Seattle, WA 98195 USA.	vavilala@uw.edu		Fabio, Anthony/0000-0002-6808-4939; Ballarini, Nicolas/0000-0002-3432-8931	National Institute of Neurological Disorders and Stroke (NINDS) [R01 NS072308-06, NS081041]	National Institute of Neurological Disorders and Stroke (NINDS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	National Institute of Neurological Disorders and Stroke (NINDS) R01 NS072308-06 (Vavilala) and NS081041 (Bell, Vavilala, Fabio). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2009, GUID TRAUM QUAL IMPR; [Anonymous], 2011, CATEGORIZACION CTR A; Burton A., 2016, LANCET NEUROL; Callese TE, 2015, J SURG RES, V193, P300, DOI 10.1016/j.jss.2014.09.040; Carney NA, 2016, PEDIAT CRIT CARE MED; Cole TB, 2004, JAMA-J AM MED ASSOC, V291, P2531, DOI 10.1001/jama.291.21.2531; DiRusso S, 2001, J TRAUMA, V51, P294, DOI 10.1097/00005373-200108000-00011; Emmanuel G, 1998, QUAL HEALTH CARE, V7, P12; Freeman C, 2002, QUAL SAF HEALTH CARE, V11, P239, DOI 10.1136/qhc.11.3.239; Gupta D, 2016, WORLD NEUROSURG, V89, P169, DOI 10.1016/j.wneu.2015.12.097; Hyder AA, 2007, NEUROREHABILITATION, V22, P341; Kannan N, TIMELY HEMODYNAMIC R; Kochanek PM, 2012, PEDIATR CRIT CARE ME, V13, pS1, DOI 10.1097/PCC.0b013e31823f435c; McNutt LA, 2003, AM J EPIDEMIOL, V157, P940, DOI 10.1093/aje/kwg074; Mock C, 2005, J TRAUMA, V59, P1243, DOI 10.1097/01.ta.0000197290.02807.de; Mock CN, 1998, J TRAUMA, V44, P804, DOI 10.1097/00005373-199805000-00011; Naghavi M, 2015, LANCET, V385, P117, DOI 10.1016/S0140-6736(14)61682-2; Petroni G, 2010, J TRAUMA, V68, P564, DOI 10.1097/TA.0b013e3181ce1eed; Pollack MM, 2014, JAMA PEDIATR, V168, P671, DOI 10.1001/jamapediatrics.2013.5316; Rondina C, 2005, J HEAD TRAUMA REHAB, V20, P368, DOI 10.1097/00001199-200507000-00008; Shrestha GS, 2016, CURR OPIN CRIT CARE, V22, P100, DOI 10.1097/MCC.0000000000000285; Stewart BT, 2016, J VASC SURG; Tansley G, 2016, PREHOSP EMERG CARE, V13, P1; Vavilala MS, 2014, CRIT CARE MED, V42, P2258, DOI 10.1097/CCM.0000000000000507; World Health Organization, 2015, VIOL INJ PREV INJ VI	25	10	10	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2016	11	12							e0166478	10.1371/journal.pone.0166478	http://dx.doi.org/10.1371/journal.pone.0166478			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI9QH	28005912	gold, Green Published, Green Submitted			2022-12-27	WOS:000392843200007
J	Kahan, D; Poremski, D; Wise-Harris, D; Pauly, D; Leszcz, M; Wasylenki, D; Stergiopoulos, V				Kahan, Deborah; Poremski, Daniel; Wise-Harris, Deborah; Pauly, Daniel; Leszcz, Molyn; Wasylenki, Donald; Stergiopoulos, Vicky			Perceived Case Management Needs and Service Preferences of Frequent Emergency Department Users: Lessons Learned in a Large Urban Centre	PLOS ONE			English	Article							HEALTH-CARE UTILIZATION; MENTAL-ILLNESS; SUPPORT; DISCRIMINATION; PRINCIPLES; ALLIANCE; EXPLICIT; VISITS; PEOPLE; TRAUMA	Objectives This study aimed to explore the service needs and preferences of frequent emergency department users with mental health and addictions concerns who participated in a brief intensive case management intervention. Methods We conducted semi-structured individual interviews with 20 frequent emergency department users with mental health and addictions challenges, 13 service providers involved in the delivery of a brief case management intervention, and a focus group with intervention case managers. Thematic analysis was used to explore perceived service user profiles, service needs and preferences of care. Results Service users experienced complex health and social needs and social isolation, while exhibiting resilience and the desire to contribute. They described multiple instances of stigmatization in interactions with healthcare professionals. Components of the brief intensive case management intervention perceived to be helpful included system navigation, advocacy, intermediation, and practical needs assistance. Frequent service users valued relational responsiveness, a non-judgmental stance, and a recovery orientation in case managers. Conclusion Interventions for frequent service users in mental health may be enhanced by focusing on the engagement of formal and informal social supports, practical needs assistance, system navigation, advocacy and intermediation, and attention to the recovery goals of service users.	[Kahan, Deborah; Leszcz, Molyn; Wasylenki, Donald; Stergiopoulos, Vicky] Univ Toronto, Dept Psychiat, Toronto, ON, Canada; [Poremski, Daniel; Wise-Harris, Deborah; Pauly, Daniel; Stergiopoulos, Vicky] St Michaels Hosp, Ctr Urban Hlth Solut, Toronto, ON, Canada; [Poremski, Daniel] Inst Mental Hlth, Singapore, Singapore; [Stergiopoulos, Vicky] Ctr Addict & Mental Hlth, Toronto, ON, Canada	University of Toronto; University of Toronto; University Toronto Affiliates; Saint Michaels Hospital Toronto; University of Toronto; University Toronto Affiliates; Centre for Addiction & Mental Health - Canada	Stergiopoulos, V (corresponding author), Univ Toronto, Dept Psychiat, Toronto, ON, Canada.; Stergiopoulos, V (corresponding author), St Michaels Hosp, Ctr Urban Hlth Solut, Toronto, ON, Canada.; Stergiopoulos, V (corresponding author), Ctr Addict & Mental Hlth, Toronto, ON, Canada.	vicky.stergiopoulos@camh.ca	Pauly, Daniel Marc/AAY-2316-2021; Leszcz, Molyn/N-9043-2016		Ontario Ministry of Health and Long-Term Care	Ontario Ministry of Health and Long-Term Care(Ministry of Health and Long-Term Care, Ontario)	The study was funded by Ontario Ministry of Health and Long-Term Care. VS was the grant recipient.	Althaus F, 2013, EUR J EMERG MED, V20, P413, DOI 10.1097/MEJ.0b013e32835e078e; Althaus F, 2011, ANN EMERG MED, V58, P41, DOI 10.1016/j.annemergmed.2011.03.007; Anderson J Ellen, 2009, Ment Health Fam Med, V6, P15; Bodenmann P, 2014, BMC HEALTH SERV RES, V14, DOI 10.1186/1472-6963-14-264; Braun V., 2006, QUAL RES PSYCHOL, V3, P77, DOI [DOI 10.1191/1478088706QP063OA, 10.1191/1478088706qp063oa]; Buck PW, 2006, ADM POLICY MENT HLTH, V33, P470, DOI 10.1007/s10488-005-0021-3; Byrne M, 2003, ANN EMERG MED, V41, P309, DOI 10.1067/mem.2003.68; Charatan F, 2000, BRIT MED J, V320, P7, DOI 10.1136/bmj.320.7226.7; Chen FP, 2012, QUAL HEALTH RES, V22, P373, DOI 10.1177/1049732311421180; Choo EK, 2015, ACAD EMERG MED, V22, P1096, DOI 10.1111/acem.12736; Clarke DE, 2007, INT J MENT HEALTH NU, V16, P126, DOI 10.1111/j.1447-0349.2007.00455.x; Dabby L, 2015, CAN J PSYCHIAT, V60, P451, DOI 10.1177/070674371506001006; Davidson L, 2009, PURPOSES GOALS HDB S; Di Somma S, 2015, INTERN EMERG MED, V10, P171, DOI 10.1007/s11739-014-1154-8; Elhai J. D., 2005, PSYCHOL SERV, V2, P3, DOI [10.1037/1541-1559.2.1.3, DOI 10.1037/1541-1559.2.1.3]; Goldman HH, 2006, SCHIZOPHRENIA BULL, V32, P424, DOI 10.1093/schbul/sbj042; Government of Ontario, 2011, OP MINDS HLTH MINDS; Hastings SN, 2008, AM J EMERG MED, V26, P454, DOI 10.1016/j.ajem.2007.07.005; Heinonen E, 2014, CLIN PSYCHOL PSYCHOT, V21, P475, DOI 10.1002/cpp.1852; Hunt KA, 2006, ANN EMERG MED, V48, P1, DOI 10.1016/j.annemergmed.2005.12.030; Jacob KS, 2015, INDIAN J PSYCHOL MED, V37, P117, DOI 10.4103/0253-7176.155605; Kartha A, 2008, MED CARE, V46, P388, DOI 10.1097/MLR.0b013e31815dc5d2; Kopera M, 2015, COMMUNITY MENT HLT J, V51, P628, DOI 10.1007/s10597-014-9796-6; Kumar GS, 2013, J EMERG MED, V44, P717, DOI 10.1016/j.jemermed.2012.08.035; LaCalle E, 2010, ANN EMERG MED, V56, P42, DOI 10.1016/j.annemergmed.2010.01.032; Mautner DB, 2013, POPUL HEALTH MANAG, V16, pS26, DOI 10.1089/pop.2013.0033; Miyamoto Yuki, 2012, Clin Pract Epidemiol Ment Health, V8, P22, DOI 10.2174/1745017901208010022; Ochocka J, 2006, J COMMUNITY PSYCHOL, V34, P273, DOI 10.1002/jcop.20099; Olsson M, 2001, EMERG MED J, V18, P430, DOI 10.1136/emj.18.6.430; Pines JM, 2011, ACAD EMERG MED, V18, P655, DOI 10.1111/j.1553-2712.2011.01085.x; Poremski D, 2016, GEN HOSP PSYCHIAT, V40, P55, DOI 10.1016/j.genhosppsych.2016.01.004; Rabenschlag F, 2014, PSYCHIAT QUART, V85, P225, DOI 10.1007/s11126-013-9285-z; Rapp CA, 2004, PSYCHIATR REHABIL J, V27, P319, DOI 10.2975/27.2004.319.333; Raven MC, 2009, J URBAN HEALTH, V86, P230, DOI 10.1007/s11524-008-9336-1; Reinius P, 2013, EUR J EMERG MED, V20, P327, DOI 10.1097/MEJ.0b013e328358bf5a; Repper J, 2011, J MENT HEALTH, V20, P392, DOI 10.3109/09638237.2011.583947; Rocque R, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0139577; Shumway M, 2008, AM J EMERG MED, V26, P155, DOI 10.1016/j.ajem.2007.04.021; Skosireva A, 2014, BMC HEALTH SERV RES, V14, DOI 10.1186/1472-6963-14-376; Slade M, 2012, PSYCHIAT SERV, V63, P702, DOI 10.1176/appi.ps.201100521; Solomon SD, 1997, J CLIN PSYCHIAT, V58, P5; Soril LJJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0123660; Spillane LL, 1997, ACAD EMERG MED, V4, P574, DOI 10.1111/j.1553-2712.1997.tb03581.x; Stuart Heather, 2014, Can J Psychiatry, V59, pS13; Tai-Seale M, 2007, HEALTH SERV RES, V42, P1871, DOI 10.1111/j.1475-6773.2006.00689.x; The Standing Senate Committee on Social Affairs, 2004, MENT HLTH MENT ILLN, P25; Thompson SJ, 2007, CONTEMP FAM THER, V29, P39, DOI 10.1007/s10591-007-9030-6; Wise Harris D, 2016, ADM POLICY MENT HLTH; Young AT, 2008, PSYCHIAT SERV, V59, P1430, DOI 10.1176/appi.ps.59.12.1430; Zerger S, 2014, BMC PSYCHIATRY, V14, DOI 10.1186/s12888-014-0353-1	50	13	13	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2016	11	12							e0168782	10.1371/journal.pone.0168782	http://dx.doi.org/10.1371/journal.pone.0168782			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EI9TW	28002491	Green Published, gold, Green Submitted			2022-12-27	WOS:000392853100068
J	Song, FB; Wang, LM; Zhu, WB; Fu, JJ; Dong, JJ; Dong, ZJ				Song, Feibiao; Wang, Lanmei; Zhu, Wenbin; Fu, Jianjun; Dong, Juanjuan; Dong, Zaijie			A Novel igf3 Gene in Common Carp (Cyprinus carpio): Evidence for Its Role in Regulating Gonadal Development	PLOS ONE			English	Article							17-ALPHA-ETHINYLESTRADIOL EE2; OOCYTE MATURATION; GROWTH; ZEBRAFISH; EXPRESSION; HORMONE; DIFFERENTIATION; DUPLICATION; PROTEINS; CLONING	Since the insulin-like growth factor 3 (igf3) gene was recently discovered in fish ovary, its function in the gonads has received much attention. In this study, we isolated two igf3 sub-types from common carp (Cyprinus carpio), which comprised full-length cDNA of 707 and 1153 nucleotides encoding 205 and 198 amino acids (aa), respectively. The Igf3 aa sequence had the highest gene homology of 72% with the corresponding sequence in zebrafish (Danio rerio). Phylogenetic tree construction revealed that the C. carpio igf3 gene was first clustered with D. rerio and then with other teleost species. Igf3 mRNA was widely expressed, with expression being highest in the gonads and blood. In the gonad development stage, igf3a mRNA expression was highest in the maturity and recession stage of the ovary, and decline phase of the testis, while igf3b was highest in the recession and fully mature periods of the ovaries and testes, respectively. Western blotting of testis protein samples showed two bands of approximately 21 kDa and 34 kDa corresponding to the calculated molecular mass of the two Igf3 subtypes; no signal was detected in the ovary. The Igf3 protein was localized in the ovary granulosa cells and testis spermatogonium and spermatids. 17 beta-Ethinylestradiol treatment increased both ovary and testis igf3 mRNA expression. These findings suggest that Igf3 may play an important role in C. carpio gonadal development.	[Song, Feibiao; Dong, Juanjuan; Dong, Zaijie] Nanjing Agr Univ, Wuxi Fisheries Coll, Wuxi, Jiangsu, Peoples R China; [Wang, Lanmei; Zhu, Wenbin; Fu, Jianjun; Dong, Zaijie] Chinese Acad Fishery Sci, Freshwater Fisheries Res Ctr, Key Lab Freshwater Fisheries & Germplasm Resource, Minist Agr, Wuxi, Jiangsu, Peoples R China	Nanjing Agricultural University; Chinese Academy of Fishery Sciences; Freshwater Fisheries Research Center, CAFS; Ministry of Agriculture & Rural Affairs	Dong, ZJ (corresponding author), Nanjing Agr Univ, Wuxi Fisheries Coll, Wuxi, Jiangsu, Peoples R China.; Dong, ZJ (corresponding author), Chinese Acad Fishery Sci, Freshwater Fisheries Res Ctr, Key Lab Freshwater Fisheries & Germplasm Resource, Minist Agr, Wuxi, Jiangsu, Peoples R China.	dongzj@ffrc.cn	DONG, Zaijie/V-2380-2019; Dong, Zaijie/AAW-9998-2020	DONG, Zaijie/0000-0001-5428-1053; 	National Nonprofit Institute Research Grant of CATAS-TCGRI [2015JBFR01]; Chinese Earmarked Fund for Modern Agro-Industry Technology Research System [CARS-46]; National Science & Technology Pillar Program during the Twelfth Five-year Plan Period [2012BAD26B02]	National Nonprofit Institute Research Grant of CATAS-TCGRI; Chinese Earmarked Fund for Modern Agro-Industry Technology Research System; National Science & Technology Pillar Program during the Twelfth Five-year Plan Period	The National Nonprofit Institute Research Grant of CATAS-TCGRI (2015JBFR01) supported the study design and preparation of the manuscript; the Chinese Earmarked Fund for Modern Agro-Industry Technology Research System (CARS-46) supported the research and data analysis; the National Science & Technology Pillar Program during the Twelfth Five-year Plan Period (2012BAD26B02) supported the materials.	Amaral IPG, 2011, J EXP BIOL, V214, P2125, DOI 10.1242/jeb.053298; Berishvili G, 2010, GEN COMP ENDOCR, V167, P128, DOI 10.1016/j.ygcen.2010.01.023; Carnevali O, 2005, MOL REPROD DEV, V71, P12, DOI 10.1002/mrd.20122; CARR JM, 1995, J ENDOCRINOL, V145, P545, DOI 10.1677/joe.0.1450545; COCHRAN RC, 1992, J EXP ZOOL, V261, P143, DOI 10.1002/jez.1402610205; Dong ZJ, 2015, BMC GENET, V16, DOI 10.1186/s12863-015-0256-2; Filby AL, 2006, J MOL ENDOCRINOL, V37, P121, DOI 10.1677/jme.1.01997; Jaillon O, 2004, NATURE, V431, P946, DOI 10.1038/nature03025; Kwok HF, 2005, BIOL REPROD, V72, P1370, DOI 10.1095/biolreprod.104.038190; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Li JZ, 2015, MOL ENDOCRINOL, V29, P373, DOI 10.1210/me.2014-1218; Li JZ, 2011, BIOL REPROD, V84, P476, DOI 10.1095/biolreprod.110.086363; Li MH, 2012, BIOL REPROD, V86, DOI 10.1095/biolreprod.111.096248; Lin H.R., 2007, FISH PHYSL; LIN YWP, 1987, GEN COMP ENDOCR, V67, P126, DOI 10.1016/0016-6480(87)90212-7; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Macqueen DJ, 2013, MOL BIOL EVOL, V30, P1060, DOI 10.1093/molbev/mst017; Mei J, 2015, SCI CHINA LIFE SCI, V58, P124, DOI 10.1007/s11427-014-4797-9; Nelson SN, 2010, GEN COMP ENDOCR, V168, P111, DOI 10.1016/j.ygcen.2010.04.020; Nobrega RH, 2015, ENDOCRINOLOGY, V156, P3804, DOI 10.1210/en.2015-1157; Reinecke M, 2010, J FISH BIOL, V76, P1233, DOI 10.1111/j.1095-8649.2010.02605.x; Reinecke M, 2010, BIOL REPROD, V82, P656, DOI 10.1095/biolreprod.109.080093; Riley LG, 2004, COMP BIOCHEM PHYS C, V138, P177, DOI 10.1016/j.cca.2004.07.009; Shved N, 2008, TOXICOL SCI, V106, P93, DOI 10.1093/toxsci/kfn150; Shved N, 2007, J ENDOCRINOL, V195, P513, DOI 10.1677/JOE-07-0295; Shved N, 2009, FISH SHELLFISH IMMUN, V26, P524, DOI 10.1016/j.fsi.2009.02.003; Wang DS, 2008, BIOCHEM BIOPH RES CO, V367, P336, DOI 10.1016/j.bbrc.2007.12.136; Wang W., 2000, CULTURE ENHANCEMENT; Yang HR, 2015, COMP BIOCHEM PHYS B, V186, P68, DOI 10.1016/j.cbpb.2015.04.005; Yu SMY, 2007, BIOL REPROD, P81; [周立斌 ZHOU Libin], 2007, [中山大学学报. 自然科学版, Acta Scientiarum Naturalium Universitatis Sunyatseni], V46, P69; Zou SM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007026	32	24	29	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2016	11	12							e0168874	10.1371/journal.pone.0168874	http://dx.doi.org/10.1371/journal.pone.0168874			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI9TW	28002497	Green Published, gold, Green Submitted			2022-12-27	WOS:000392853100073
J	Xue, YS; Zhang, HY; Sun, XF; Zhu, MJ				Xue, Yansong; Zhang, Hanying; Sun, Xiaofei; Zhu, Mei-Jun			Metformin Improves Ileal Epithelial Barrier Function in Interleukin-10 Deficient Mice	PLOS ONE			English	Article							PROTEIN-KINASE PROMOTES; FACTOR-KAPPA-B; SIGNALING PATHWAYS; TIGHT JUNCTIONS; MUCUS LAYERS; BETA-CATENIN; PANETH CELLS; DIFFERENTIATION; INFLAMMATION; COLITIS	Background and aims The impairment of intestinal epithelial barrier is the main etiologic factor of inflammatory bowel disease. The proper intestinal epithelial proliferation and differentiation is crucial for maintaining intestinal integrity. Metformin is a common anti-diabetic drug. The objective is to evaluate the protective effects of metformin on ileal epithelial barrier integrity using interleukin-10 deficient (IL10KO) mice. Methods Wild-type and IL10KO mice were fed with/without metformin for 6 weeks and then ileum was collected for analyses. The mediatory role of AMP-activated protein kinase (AMPK) was further examined by gain and loss of function study in vitro. Results Compared to wild-type mice, IL10KO mice had increased proliferation, reduced goblet cell and Paneth cell lineage differentiation in the ileum tissue, which was accompanied with increased crypt expansion. Metformin supplementation mitigated intestinal cell proliferation, restored villus/crypt ratio, increased goblet cell and Paneth cell differentiation and improved barrier function. In addition, metformin supplementation in IL10KO mice suppressed macrophage pro-inflammatory activity as indicated by reduced M1 macrophage abundance and decreased pro-inflammatory cytokine IL-1 beta, TNF-alpha and IFN-gamma expressions. As a target of metformin, AMPK phosphorylation was enhanced in mice treated with metformin, regardless of mouse genotypes. In correlation, the mRNA level of differentiation regulator including bmp4, bmpr2 and math1 were also increased in IL10KO mice supplemented with metformin, which likely explains the enhanced epithelial differentiation in IL10KO mice with metformin. Consistently, in Caco-2 cells, metformin promoted claudin-3 and E-cadherin assembly and mitigated TNF-alpha-induced fragmentation of tight junction proteins. Gain and loss of function assay also demonstrated AMPK was correlated with epithelial differentiation and proliferation. Conclusions Metformin supplementation promotes secretory cell lineage differentiation, suppresses inflammation and improves epithelial barrier function in IL10KO mice likely through activation of AMPK, showing its beneficial effects on gut epithelial.	[Xue, Yansong; Zhang, Hanying; Sun, Xiaofei; Zhu, Mei-Jun] Washington State Univ, Sch Food Sci, Pullman, WA 99164 USA; [Xue, Yansong; Sun, Xiaofei; Zhu, Mei-Jun] Univ Idaho, Sch Food Sci, Moscow, ID 83843 USA	Washington State University; Idaho; University of Idaho	Zhu, MJ (corresponding author), Washington State Univ, Sch Food Sci, Pullman, WA 99164 USA.; Zhu, MJ (corresponding author), Univ Idaho, Sch Food Sci, Moscow, ID 83843 USA.	meijun.zhu@wsu.edu	Sun, Xiaofei/S-9786-2018	Sun, Xiaofei/0000-0002-4835-9309	National Institutes of Health [R15HD073864]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R15HD073864] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This work was supported by National Institutes of Health (http://www.nih.gov/) Grants R15HD073864. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Auclair BA, 2007, GASTROENTEROLOGY, V133, P887, DOI 10.1053/j.gastro.2007.06.066; Bastide P, 2007, J CELL BIOL, V178, P635, DOI 10.1083/jcb.200704152; Batlle E, 2002, CELL, V111, P251, DOI 10.1016/S0092-8674(02)01015-2; Bevins CL, 2011, NAT REV MICROBIOL, V9, P356, DOI 10.1038/nrmicro2546; Biswas A, 2010, P NATL ACAD SCI USA, V107, P14739, DOI 10.1073/pnas.1003363107; Cario E, 2004, GASTROENTEROLOGY, V127, P224, DOI 10.1053/j.gastro.2004.04.015; Chung YC, 2003, J SURG ONCOL, V83, P222, DOI 10.1002/jso.10269; Correa I, 2009, J LEUKOCYTE BIOL, V85, P896, DOI 10.1189/jlb.1108698; Crosnier C, 2006, NAT REV GENET, V7, P349, DOI 10.1038/nrg1840; Edelblum KL, 2009, CURR OPIN PHARMACOL, V9, P715, DOI 10.1016/j.coph.2009.06.022; Fanning AS, 1998, J BIOL CHEM, V273, P29745, DOI 10.1074/jbc.273.45.29745; Fellermann K, 2006, AM J HUM GENET, V79, P439, DOI 10.1086/505915; Forouzandeh F, 2014, J AM HEART ASSOC, V3, DOI 10.1161/JAHA.114.001202; Fu X, 2013, MOL CELL BIOL, V33, P4517, DOI 10.1128/MCB.01078-13; Geier MS, 2009, DIGEST DIS SCI, V54, P1222, DOI 10.1007/s10620-008-0495-4; Gordon S, 2003, NAT REV IMMUNOL, V3, P23, DOI 10.1038/nri978; Groschwitz KR, 2009, J ALLERGY CLIN IMMUN, V124, P3, DOI 10.1016/j.jaci.2009.05.038; Haramis APG, 2004, SCIENCE, V303, P1684, DOI 10.1126/science.1093587; Hattori Y, 2006, HYPERTENSION, V47, P1183, DOI 10.1161/01.HYP.0000221429.94591.72; He L, 2009, CELL, V137, P635, DOI 10.1016/j.cell.2009.03.016; He XC, 2004, NAT GENET, V36, P1117, DOI 10.1038/ng1430; Heath JK, 2010, CURR TOP DEV BIOL, V90, P159, DOI 10.1016/S0070-2153(10)90004-5; Heldin CH, 1997, NATURE, V390, P465, DOI 10.1038/37284; Isoda K, 2006, ARTERIOSCL THROM VAS, V26, P611, DOI 10.1161/01.ATV.0000201938.78044.75; Jang WG, 2011, BIOCHEM BIOPH RES CO, V404, P1004, DOI 10.1016/j.bbrc.2010.12.099; JARRIAULT S, 1995, NATURE, V377, P355, DOI 10.1038/377355a0; Johansson MEV, 2011, P NATL ACAD SCI USA, V108, P4659, DOI 10.1073/pnas.1006451107; Johansson MEV, 2008, P NATL ACAD SCI USA, V105, P15064, DOI 10.1073/pnas.0803124105; Kanazawa I, 2008, BIOCHEM BIOPH RES CO, V375, P414, DOI 10.1016/j.bbrc.2008.08.034; Keubler LM, 2015, INFLAMM BOWEL DIS, V21, P1967, DOI 10.1097/MIB.0000000000000468; Kim Young S, 2010, Curr Gastroenterol Rep, V12, P319, DOI 10.1007/s11894-010-0131-2; Koh SJ, 2014, J GASTROEN HEPATOL, V29, P502, DOI 10.1111/jgh.12435; Lee S, 2015, INT J NANOMED, V10, P3, DOI 10.2147/IJN.S91389; Li XX, 2008, ARTERIOSCL THROM VAS, V28, P1789, DOI 10.1161/ATVBAHA.108.172452; MACDONALD TT, 1994, CURR BIOL, V4, P261, DOI 10.1016/S0960-9822(00)00060-9; Madison BB, 2005, DEVELOPMENT, V132, P279, DOI 10.1242/dev.01576; Maloum F, 2011, AM J PHYSIOL-GASTR L, V300, pG1065, DOI 10.1152/ajpgi.00176.2010; Maloy KJ, 2011, NATURE, V474, P298, DOI 10.1038/nature10208; McDole JR, 2012, NATURE, V483, P345, DOI 10.1038/nature10863; Mehta S, 2015, CELL TISSUE RES, V360, P749, DOI 10.1007/s00441-014-1994-6; Mei M, 2015, CELL SIGNAL, V27, P1915, DOI 10.1016/j.cellsig.2015.07.002; Mithieux G, 2006, BIOCHEM PHARMACOL, V72, P198, DOI 10.1016/j.bcp.2006.04.020; Neurath MF, 2014, NAT REV IMMUNOL, V14, P329, DOI 10.1038/nri3661; Patel RM, 2012, AM J PATHOL, V180, P626, DOI 10.1016/j.ajpath.2011.10.025; Peterson LW, 2014, NAT REV IMMUNOL, V14, P141, DOI 10.1038/nri3608; Rigby RJ, 2007, ONCOGENE, V26, P4833, DOI 10.1038/sj.onc.1210286; Sag D, 2008, J IMMUNOL, V181, P8633, DOI 10.4049/jimmunol.181.12.8633; Sancho E, 2003, CURR OPIN CELL BIOL, V15, P763, DOI 10.1016/j.ceb.2003.10.012; Scheinin T, 2003, CLIN EXP IMMUNOL, V133, P38, DOI 10.1046/j.1365-2249.2003.02193.x; Seth A, 2007, J BIOL CHEM, V282, P11487, DOI 10.1074/jbc.M610597200; Soderholm JD, 2002, GUT, V50, P307, DOI 10.1136/gut.50.3.307; Steinberg GR, 2006, CELL METAB, V4, P465, DOI 10.1016/j.cmet.2006.11.005; Stoll G, 2004, J NEUROIMMUNOL, V149, P142, DOI 10.1016/j.jneuroim.2003.12.024; Strugala V, 2008, INT J CLIN PRACT, V62, P762, DOI 10.1111/j.1742-1241.2007.01665.x; Sun X, 2016, FASEB J S, V30; Tagore A, 1999, TISSUE ANTIGENS, V54, P386, DOI 10.1034/j.1399-0039.1999.540408.x; Vaishnava S, 2008, P NATL ACAD SCI USA, V105, P20858, DOI 10.1073/pnas.0808723105; Van der Sluis M, 2006, GASTROENTEROLOGY, V131, P117, DOI 10.1053/j.gastro.2006.04.020; Vazquez-Martin A, 2012, CELL CYCLE, V11, P974, DOI 10.4161/cc.11.5.19450; Wang FJ, 2005, AM J PATHOL, V166, P409, DOI 10.1016/S0002-9440(10)62264-X; Wehkamp J, 2005, P NATL ACAD SCI USA, V102, P18129, DOI 10.1073/pnas.0505256102; Wehkamp J, 2007, J IMMUNOL, V179, P3109, DOI 10.4049/jimmunol.179.5.3109; WILCOCK C, 1994, XENOBIOTICA, V24, P49, DOI 10.3109/00498259409043220; Xue Y, 2014, J NUTR BIOCHEM, V25, P758, DOI 10.1016/j.jnutbio.2014.03.009; Yang G, 2015, BRIT J NUTR, V114, P15, DOI 10.1017/S0007114515001415; Zeissig S, 2007, GUT, V56, P61, DOI 10.1136/gut.2006.094375; Zhu HM, 2016, FOOD CONTROL, V66, P291, DOI 10.1016/j.foodcont.2016.02.013; Zhu MJ, 2007, PLACENTA, V28, P1192, DOI 10.1016/j.placenta.2007.05.004	68	34	34	2	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2016	11	12							e0168670	10.1371/journal.pone.0168670	http://dx.doi.org/10.1371/journal.pone.0168670			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI9TW	28002460	Green Published, gold			2022-12-27	WOS:000392853100062
J	Mbunda, T; Tarimo, EAM; Chalamilla, G; Bakari, M; Sandstrom, E; Kulane, A				Mbunda, Theodora; Tarimo, Edith A. M.; Chalamilla, Guerino; Bakari, Muhammad; Sandstrom, Eric; Kulane, Asli			The Influence of Community Members on Participation by Youth in an HIV Vaccine Trial in Tanzania	PLOS ONE			English	Article							ACCEPTABILITY; PREVENTION; STIGMA; MYTHS; RISK	In sub-Saharan Africa, the burden of HIV is high among young people and it is of the utmost importance that they be recruited into vaccination trials. Since community members influence the willingness of young people to participate in the vaccination trials, ascertaining their opinions is essential to overcoming barriers to such participation. Here, in seven focus group discussions we explored the views of 44 community members identified as someone they felt close by youth in Tanzania. The transcripts of these discussions were examined using content analysis. Our participants expressed that community members would be directly involved in the decisions of young people about whether or not to participate in an HIV vaccine trial. In general, they felt that community members would provide social support for youth during the trial and perceived that youth might have misconceptions concerning the vaccine and trial process. The participants pointed out structural factors such as substance use, poverty, stigma and unemployment that are barriers to participation. In conclusion, involvement of community members could be an integral part of the recruitment and retention of young people in HIV vaccine trials in Tanzania.	[Mbunda, Theodora; Bakari, Muhammad] Muhimbili Univ Hlth & Allied Sci, Sch Med, Dept Internal Med, Dar Es Salaam, Tanzania; [Mbunda, Theodora; Kulane, Asli] Karolinska Inst, Dept Publ Hlth Sci, Equ & Hlth Policy Res Grp, Stockholm, Sweden; [Mbunda, Theodora; Chalamilla, Guerino] Management & Dev Hlth, Dar Es Salaam, Tanzania; [Tarimo, Edith A. M.] Muhimbili Univ Hlth & Allied Sci, Sch Nursing, Dept Nursing Management, Dar Es Salaam, Tanzania; [Chalamilla, Guerino] Dar Es Salaam City Council, Dept Hlth, Dar Es Salaam, Tanzania; [Sandstrom, Eric] Karolinska Inst, Dept Clin Sci & Educ, Sodersjukhuset, Stockholm, Sweden	Muhimbili University of Health & Allied Sciences; Karolinska Institutet; Muhimbili University of Health & Allied Sciences; Karolinska Institutet; Sodersjukhuset Hospital	Mbunda, T (corresponding author), Muhimbili Univ Hlth & Allied Sci, Sch Med, Dept Internal Med, Dar Es Salaam, Tanzania.; Mbunda, T (corresponding author), Karolinska Inst, Dept Publ Hlth Sci, Equ & Hlth Policy Res Grp, Stockholm, Sweden.; Mbunda, T (corresponding author), Management & Dev Hlth, Dar Es Salaam, Tanzania.	theodora.daniel80@gmail.com		Kulane, Asli/0000-0002-5823-7559	Swedish International Development Cooperation Agency [Sida]; European and Developing Countries Clinical Trials Partnership [EDCTP]	Swedish International Development Cooperation Agency [Sida]; European and Developing Countries Clinical Trials Partnership [EDCTP]	The Swedish International Development Cooperation Agency [Sida] funded this project as part of PhD training for Theodora Mbunda. The European and Developing Countries Clinical Trials Partnership [EDCTP] partly funded this sub study as a part of an HIV vaccine trial, TaMoVac 2.	[Anonymous], NAT HIV AIDS RESP RE; [Anonymous], TANZ HIV MAL IND SUR; Asiki G, 2013, VACCINE, V31, P5055, DOI 10.1016/j.vaccine.2013.08.080; Barrington C, 2007, AIDS CARE, V19, P871, DOI 10.1080/09540120701203295; Campbell C, 2005, AM J PUBLIC HEALTH, V95, P808, DOI 10.2105/AJPH.2003.037499; Conner M, 2005, PREDICTING HLTH BEHA; DiClemente RJ, 2010, JAIDS-J ACQ IMM DEF, V54, pS12, DOI 10.1097/QAI.0b013e3181e1e2c0; Frew PM, 2011, VACCINE, V29, P6136, DOI 10.1016/j.vaccine.2011.06.082; Frew PM, 2010, PREV SCI, V11, P207, DOI 10.1007/s11121-009-0162-9; Graneheim UH, 2004, NURS EDUC TODAY, V24, P105, DOI 10.1016/j.nedt.2003.10.001; Harmon TM, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0146387; International AIDS Vaccines Initiative (IAVI), 2009, AIDS VACC LIT COR CO; Kakinami L, 2008, AIDS CARE, V20, P542, DOI 10.1080/09540120701867180; McCurdy SA, 2005, AIDS CARE, V17, pS65, DOI 10.1080/09540120500120930; MORGAN DL, 1998, FOCUS GROUP KIT, V2; Munseri PJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119629; Osamor PE, 2012, DEV WORLD BIOETH, V12, P87, DOI 10.1111/j.1471-8847.2012.00326.x; Patton MQ., 2002, QUALITATIVE RES EVAL, V3rd; Pawson R., 1997, REALISTIC EVALUATION; Rabiee F, 2004, P NUTR SOC, V63, P655, DOI 10.1079/PNS2004399; Ramanaik S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0141822; Remes P, 2012, VACCINE, V30, P5363, DOI 10.1016/j.vaccine.2012.06.025; Slevin KW, 2008, COMMUNITY ENGAGEMENT, P14; Suhadev M, 2009, AIDS RES HUMAN RETRO, V25; Tarimo EAM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014619; Tosh PK, 2008, MAYO CLIN PROC, V83, P77, DOI 10.4065/83.1.77; UNAIDS, 2010, COMB HIV PREV TAIL C; UNAIDS, GLOBAL REPORT UNAIDS; UNODC, WORLD DRUG REP 2012; Voronin Y, 2015, VACCINE, V33, P1243, DOI 10.1016/j.vaccine.2014.10.040; Westercamp N, 2007, AIDS BEHAV, V11, P341, DOI 10.1007/s10461-006-9169-4; Zimet GD, 2013, PREV MED, V57, P414, DOI 10.1016/j.ypmed.2013.05.013	32	3	3	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2016	11	12							e0168660	10.1371/journal.pone.0168660	http://dx.doi.org/10.1371/journal.pone.0168660			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EI9QF	27997617	Green Published, gold, Green Submitted			2022-12-27	WOS:000392842900065
J	Van Iterson, EH; Wheatley, CM; Baker, SE; Olson, TP; Morgan, WJ; Snyder, EM				Van Iterson, Erik H.; Wheatley, Courtney M.; Baker, Sarah E.; Olson, Thomas P.; Morgan, Wayne J.; Snyder, Eric M.			The Coupling of Peripheral Blood Pressure and Ventilatory Responses during Exercise in Young Adults with Cystic Fibrosis	PLOS ONE			English	Article							PEAK OXYGEN-UPTAKE; PULMONARY-FUNCTION; MUSCLE WEAKNESS; HEART-FAILURE; LUNG; CHILDREN; ADOLESCENTS; MORTALITY; PERFORMANCE; CAPACITY	Purpose Cystic fibrosis (CF) is commonly recognized as a pulmonary disease associated with reduced airway function. Another primary symptom of CF is low exercise capacity where ventilation and gas-exchange are exacerbated. However, an independent link between pathophysiology of the pulmonary system and abnormal ventilatory and gas-exchange responses during cardiopulmonary exercise testing (CPET) has not been established in CF. Complicating this understanding, accumulating evidence suggests CF demonstrate abnormal peripheral vascular function; although, the clinical implications are unclear. We hypothesized that compared to controls, relative to total work performed (Work(TOT)), CF would demonstrate increased ventilation accompanied by augmented systolic blood pressure (SBP) during CPET. Methods 16 CF and 23 controls (age: 23 4 vs. 27 4 years, P = 0.11; FEV1%predicted: 73 14 vs. 96 5, P<0.01) participated in CPET. Breath-by-breath oxygen uptake (VO2), ventilation (VE), and carbon dioxide output (VCO2) were measured continuously during incremental 3-min stage step-wise cycle ergometry CPET. SBP was measured via manual sphygmomanometry. Linear regression was used to calculate V-E/VCO2 slope from rest to peak-exercise. Results Compared to controls, CF performed less WorkTOT during CPET (90 19 vs. 43 14 kJ, respectively, P<0.01). With Work(TOT) as a covariate, peak VE (62 8 vs. 90 4 L/min, P = 0.76), VCO2 (1.8 +/- 0.3 vs. 2.7 +/- 0.1 L/min, P = 0.40), and SBP (144 +/- 13 vs. 152 +/- 6 mmHg, P = 0.88) were similar between CF and controls, respectively; whereas CF demonstrated increased VE/VCO2 slope (38 4 vs. 28 2, P=0.02) but lower peak VO2 versus controls (22 +/- 5 vs. 33 +/- 4 mUkg/min, P<0.01). There were modest-to-moderate correlations between peak SBP with VO2 (r=0.30), V-E (r= 0.70), and VCO2 (r=0.62) in CF. Conclusions These data suggest that relative to Work(TOT), young adults with mild-to-moderate severity CF demonstrate augmented V-E/VCO2 slope accompanied by increased SBP during CPET. Although the underlying mechanisms remain unclear, the coupling of ventilatory inefficiency with increased blood pressure suggest important contributions from peripheral pathophysiology to low exercise capacity in CF.	[Van Iterson, Erik H.; Wheatley, Courtney M.; Olson, Thomas P.] Mayo Clin, Dept Cardiovasc Dis, Rochester, MN 55905 USA; [Wheatley, Courtney M.; Baker, Sarah E.; Snyder, Eric M.] Univ Arizona, Coll Pharm, 1295 N Martin Ave, Tucson, AZ 85721 USA; [Baker, Sarah E.] Mayo Clin, Dept Anesthesiol, Rochester, MN USA; [Morgan, Wayne J.] Univ Arizona, Dept Pediat, 1501 N Campbell Ave,Room 3301, Tucson, AZ 85721 USA; [Snyder, Eric M.] Univ Minnesota, Dept Kinesiol, Cooke Hall,1900 Univ Ave SE, Minneapolis, MN USA	Mayo Clinic; University of Arizona; Mayo Clinic; University of Arizona; University of Minnesota System; University of Minnesota Twin Cities	Van Iterson, EH (corresponding author), Mayo Clin, Dept Cardiovasc Dis, Rochester, MN 55905 USA.	vaniterson.erik@mayo.edu		Baker, Sarah/0000-0001-9647-7660; Van Iterson, Erik Hoon/0000-0003-0576-3229	National Institutes of Health (NHLBI) [HL108962]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL108962] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [T32DK007352] Funding Source: NIH RePORTER	National Institutes of Health (NHLBI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This research was supported by the National Institutes of Health (NHLBI) (http://www.nhlbi.nih.gov/) (HL108962). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andreacci JL, 2002, J SPORT SCI, V20, P345, DOI 10.1080/026404102753576125; Arena R, 2004, AM HEART J, V147, P354, DOI 10.1016/j.ahj.2003.07.014; Arena R, 2007, J CARD FAIL, V13, P462, DOI 10.1016/j.cardfail.2007.03.004; ATS, 2003, AM J RESP CRIT CARE, V167, P211, DOI 10.1164/rccm.167.2.211; Balady GJ, 2010, CIRCULATION, V122, P191, DOI 10.1161/CIR.0b013e3181e52e69; BEAVER WL, 1986, J APPL PHYSIOL, V60, P2020, DOI 10.1152/jappl.1986.60.6.2020; BENSON LN, 1984, AM REV RESPIR DIS, V130, P987; Bongers BC, 2014, SPRINGERPLUS, V3, DOI 10.1186/2193-1801-3-696; Bongers BC, 2012, PEDIATR EXERC SCI, V24, P129, DOI 10.1123/pes.24.1.129; Borg G A, 1974, Exerc Sport Sci Rev, V2, P131; Carnethon MR, 2005, JAMA-J AM MED ASSOC, V294, P2981, DOI 10.1001/jama.294.23.2981; CHENG SH, 1990, CELL, V63, P827, DOI 10.1016/0092-8674(90)90148-8; COHEN J, 1992, PSYCHOL BULL, V112, P155, DOI 10.1037/0033-2909.112.1.155; Corey M, 1997, J PEDIATR-US, V131, P809, DOI 10.1016/S0022-3476(97)70025-8; Courtney JM, 2007, PEDIATR PULM, V42, P525, DOI 10.1002/ppul.20619; CRAPO RO, 1982, B EUR PHYSIOPATH RES, V18, P419; de Meer K, 1999, AM J RESP CRIT CARE, V159, P748, DOI 10.1164/ajrccm.159.3.9802112; Erickson ML, 2015, EXP PHYSIOL, V100, P545, DOI 10.1113/EP085037; Farrell PM, 2008, J PEDIATR-US, V153, pS4, DOI 10.1016/j.jpeds.2008.05.005; Forman DE, 2012, CIRC-HEART FAIL, V5, P621, DOI 10.1161/CIRCHEARTFAILURE.112.968529; GARDNER MJ, 1986, BMJ-BRIT MED J, V292, P746, DOI 10.1136/bmj.292.6522.746; Gilljam M, 2004, CHEST, V126, P1215, DOI 10.1378/chest.126.4.1215; Hankinson JL, 1999, AM J RESP CRIT CARE, V159, P179, DOI 10.1164/ajrccm.159.1.9712108; Hansen JE, 2007, CHEST, V132, P977, DOI 10.1378/chest.07-0619; HANSEN JE, 1984, AM REV RESPIR DIS, V129, pS49, DOI 10.1164/arrd.1984.129.2P2.S49; Hull JH, 2009, EUR RESPIR J, V34, P1322, DOI 10.1183/09031936.00044009; Hull JH, 2011, J CYST FIBROS, V10, P121, DOI 10.1016/j.jcf.2010.12.001; Hulzebos EHJ, 2014, MED SCI SPORT EXER, V46, P2047, DOI 10.1249/MSS.0000000000000344; Hulzebos HJ, 2012, J CYST FIBROS, V11, P550, DOI 10.1016/j.jcf.2012.05.004; KEREM E, 1990, NEW ENGL J MED, V323, P1517, DOI 10.1056/NEJM199011293232203; KEREM E, 1992, NEW ENGL J MED, V326, P1187, DOI 10.1056/NEJM199204303261804; Kerem E, 2014, EUR RESPIR J, V43, P125, DOI 10.1183/09031936.00166412; Koelling TM, 2003, CHEST, V123, P1488, DOI 10.1378/chest.123.5.1488; Kurl S, 2005, STROKE, V36, P820, DOI 10.1161/01.STR.0000157592.82198.28; LANDS LC, 1992, CLIN SCI, V83, P391, DOI 10.1042/cs0830391; Liou TG, 2001, AM J EPIDEMIOL, V153, P345, DOI 10.1093/aje/153.4.345; Medicine ACoS, 2013, ACSMS GUIDELINES EXE, V9th ed.; Miller MR, 2005, EUR RESPIR J, V26, P319, DOI 10.1183/09031936.05.00034805; Moorcroft AJ, 1997, THORAX, V52, P291, DOI 10.1136/thx.52.3.291; NIXON PA, 1992, NEW ENGL J MED, V327, P1785, DOI 10.1056/NEJM199212173272504; Pastre J, 2014, BMC PULM MED, V14, DOI 10.1186/1471-2466-14-74; Pellegrino R, 2005, EUR RESPIR J, V26, P948, DOI 10.1183/09031936.05.00035205; Pi-Sunyer FX, 1998, OBES RES, V6, p51S; Pianosi P, 2005, THORAX, V60, P50, DOI 10.1136/thx.2003.008102; Poore S, 2013, CHEST, V143, P939, DOI 10.1378/chest.12-1934; Rodriguez-Miguelez P, 2016, AM J PHYSL HEART CIR; Rosenthal M, 2009, PEDIATR PULM, V44, P222, DOI 10.1002/ppul.20899; ROWLAND TW, 1992, CHEST, V101, P485, DOI 10.1378/chest.101.2.485; Saynor ZL, 2014, IMPAIRED AEROBIC FUN; Saynor ZL, 2013, J SCI MED SPORT, V16, P539, DOI 10.1016/j.jsams.2013.01.010; Schluchter MD, 2002, STAT MED, V21, P1271, DOI 10.1002/sim.1104; Schrage WG, 2005, J APPL PHYSIOL, V99, P1866, DOI 10.1152/japplphysiol.00616.2005; Sellers ZM, 2015, J CYST FIBROS, V14, P654, DOI 10.1016/j.jcf.2015.03.010; Snell GI, 1998, J HEART LUNG TRANSPL, V17, P1097; Tanaka H, 2001, J AM COLL CARDIOL, V37, P153, DOI 10.1016/S0735-1097(00)01054-8; Teopompi E, 2014, RESP CARE, V59, P1034, DOI 10.4187/respcare.02629; Troosters T, 2009, EUR RESPIR J, V33, P99, DOI 10.1183/09031936.00091607; Van Iterson EH, 2015, RESP RES, V16, DOI 10.1186/s12931-015-0270-y; WAGNER PD, 1995, MED SCI SPORT EXER, V27, P47; WAGNER PD, 1992, MED SCI SPORT EXER, V24, P54; Wanger J, 2005, EUR RESPIR J, V26, P511, DOI 10.1183/09031936.05.00035005; WARD SA, 1989, J PHYSIOL-LONDON, V411, P27, DOI 10.1113/jphysiol.1989.sp017557; Werkman MS, 2011, PEDIATR PHYS THER, V23, P15, DOI 10.1097/PEP.0b013e318208ca9e; Zhang F, 1998, NAT STRUCT BIOL, V5, P180, DOI 10.1038/nsb0398-180	64	4	4	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2016	11	12							e0168490	10.1371/journal.pone.0168490	http://dx.doi.org/10.1371/journal.pone.0168490			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI9QF	27997623	Green Published, Green Submitted, gold			2022-12-27	WOS:000392842900051
J	Villani, R; Facciorusso, A; Bellanti, F; Tamborra, R; Piscazzi, A; Landriscina, M; Vendemiale, G; Serviddio, G				Villani, Rosanna; Facciorusso, Antonio; Bellanti, Francesco; Tamborra, Rosanna; Piscazzi, Annamaria; Landriscina, Matteo; Vendemiale, Gianluigi; Serviddio, Gaetano			DAAs Rapidly Reduce Inflammation but Increase Serum VEGF Level: A Rationale for Tumor Risk during Anti-HCV Treatment	PLOS ONE			English	Article							C VIRUS-INFECTION; ENDOTHELIAL GROWTH-FACTOR; HEPATITIS-C; GENE-EXPRESSION; SOFOSBUVIR; RIBAVIRIN; ANGIOGENESIS; LEDIPASVIR; CIRRHOSIS; EFFICACY	Background Novel direct-acting antivirals (DAAs) have completely changed the panorama of hepatitis C due to their high efficacy and optimal safety profile. Unfortunately, an unexpectedly high rate of early recurrence of hepatocellular carcinoma has been reported within weeks of starting treatment, but the mechanism is not known. Methods We monitored the serum level of vascular endothelial growth factor (VEGF) and changes in the pattern of circulating interleukins in 103 chronic hepatitis C patients during antiviral treatment with DAA-regimens. VEGF, epidermal growth factor (EGF), and several interleukins were assessed at baseline, during treatment, and after treatment. The biological effect of DAA-treated patient serum on human umbilical vein endothelial cell (HUVEC) proliferation was also confirmed. Results After 4 weeks of therapy, VEGF increased approximately 4-fold compared to baseline, remained elevated up to the end of treatment, and returned to the pre-treatment level after the end of therapy. In contrast, interleukin-10 and tumor necrosis factor-alpha significantly decreased during therapy, which was coincident with HCV clearance. The levels of both remained low after treatment. The addition of serum from patients collected during therapy induced HUVEC proliferation; however, this disappeared after the end of therapy. Conclusions DAA administration induces an early increase in serum VEGF and a change in the inflammatory pattern, coinciding with HCV clearance. This may alter the balance between inflammatory and anti-inflammatory processes and modify the antitumor surveillance of the host. Fortunately, such modifications return reverse to normal after the end of treatment.	[Villani, Rosanna; Facciorusso, Antonio; Bellanti, Francesco; Tamborra, Rosanna; Vendemiale, Gianluigi; Serviddio, Gaetano] Univ Foggia, Dept Med & Surg Sci, Inst Internal Med, CURE Ctr Ric & Cura Epatopatie, Foggia, Italy; [Piscazzi, Annamaria; Landriscina, Matteo] Univ Foggia, Dept Med & Surg Sci, Med Oncol Unit, Foggia, Italy; [Landriscina, Matteo] Referral Canc Ctr Basilicata, IRCCS, Lab Preclin & Translat Res, Rionero In Vulture, Italy	University of Foggia; University of Foggia; IRCCS CROB	Serviddio, G (corresponding author), Univ Foggia, Dept Med & Surg Sci, Inst Internal Med, CURE Ctr Ric & Cura Epatopatie, Foggia, Italy.	gaetano.serviddio@unifg.it	Landriscina, Matteo/K-1092-2016; villani, rosanna/K-5753-2018; Facciorusso, Antonio/AAA-5966-2019; serviddio, gaetano/C-7629-2011	villani, rosanna/0000-0001-9875-019X; serviddio, gaetano/0000-0002-6424-7841; Landriscina, Matteo/0000-0003-0591-9799; BELLANTI, Francesco/0000-0002-8196-7373				Agency EM, 2016, DIR ACT ANT IND TREA; Blackburn SD, 2007, TRENDS MICROBIOL, V15, P143, DOI 10.1016/j.tim.2007.02.006; Brooks DG, 2006, NAT MED, V12, P1301, DOI 10.1038/nm1492; Charlton M, 2015, GASTROENTEROLOGY, V149, P649, DOI 10.1053/j.gastro.2015.05.010; Conti F, 2016, J HEPATOL; Ejrnaes M, 2006, J EXP MED, V203, P2461, DOI 10.1084/jem.20061462; Kozbial K, 2016, J HEPATOL; Lawitz E, 2015, GASTROENTEROLOGY, V149, P971, DOI 10.1053/j.gastro.2015.07.001; Lichtenberger BM, 2010, CELL, V140, P268, DOI 10.1016/j.cell.2009.12.046; Meissner EG, 2016, J VIRAL HEPATITIS, V23, P496, DOI 10.1111/jvh.12510; Meissner EG, 2014, J CLIN INVEST, V124, P3352, DOI 10.1172/JCI75938; Mise M, 1996, HEPATOLOGY, V23, P455; Nault JC, 2016, J HEPATOL; Nelson DR, 2003, HEPATOLOGY, V38, P859, DOI 10.1053/jhep.2003.50427; Park YN, 2000, ARCH PATHOL LAB MED, V124, P1061; Pawlotsky JM, 2015, J HEPATOL, V63, P199, DOI 10.1016/j.jhep.2015.03.025; Pol S, 2016, J HEPATOL; Poordad F, 2016, HEPATOLOGY, V63, P1493, DOI 10.1002/hep.28446; Poordad F, 2014, NEW ENGL J MED, V370, P1973, DOI 10.1056/NEJMoa1402869; Reddy KR, 2015, HEPATOLOGY, V62, P79, DOI 10.1002/hep.27826; Reig M, 2016, J HEPATOL; Sato T, 2011, IMMUNOL RES, V51, P170, DOI 10.1007/s12026-011-8262-6; Schmitt M, 2004, J HEPATOL, V41, P274, DOI 10.1016/j.jhep.2004.04.035; Serti E, 2016, GUT; Serti E, 2015, GASTROENTEROLOGY, V149, P190, DOI 10.1053/j.gastro.2015.03.004; Shepard CW, 2005, LANCET INFECT DIS, V5, P558, DOI 10.1016/S1473-3099(05)70216-4; Zhu AX, 2011, NAT REV CLIN ONCOL, V8, P292, DOI 10.1038/nrclinonc.2011.30	27	83	84	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2016	11	12							e0167934	10.1371/journal.pone.0167934	http://dx.doi.org/10.1371/journal.pone.0167934			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI9QF	27997563	gold, Green Published, Green Submitted			2022-12-27	WOS:000392842900019
J	Wallot, S; Mitkidis, P; McGraw, JJ; Roepstorff, A				Wallot, Sebastian; Mitkidis, Panagiotis; McGraw, John J.; Roepstorff, Andreas			Beyond Synchrony: Joint Action in a Complex Production Task Reveals Beneficial Effects of Decreased Interpersonal Synchrony	PLOS ONE			English	Article							NONVERBAL SYNCHRONY; DYNAMICS; COORDINATION; CONVERSATION; AROUSAL	A variety of joint action studies show that people tend to fall into synchronous behavior with others participating in the same task, and that such synchronization is beneficial, leading to greater rapport, satisfaction, and performance. It has been noted that many of these task environments require simple interactions that involve little planning of action coordination toward a shared goal. The present study utilized a complex joint construction task in which dyads were instructed to build model cars while their hand movements and heart rates were measured. Participants built these models under varying conditions, delimiting how freely they could divide labor during a build session. While hand movement synchrony was sensitive to the different tasks and outcomes, the heart rate measure did not show any effects of interpersonal synchrony. Results for hand movements show that the more participants were constrained by a particular building strategy, the greater their behavioral synchrony. Within the different conditions, the degree of synchrony was predictive of subjective satisfaction and objective product outcomes. However, in contrast to many previous findings, synchrony was negatively associated with superior products, and, depending on the constraints on the interaction, positively or negatively correlated with higher subjective satisfaction. These results show that the task context critically shapes the role of synchronization during joint action, and that in more complex tasks, not synchronization of behavior, but rather complementary types of behavior may be associated with superior task outcomes.	[Wallot, Sebastian] Max Planck Inst Empir Aesthet, Frankfurt, Germany; [Wallot, Sebastian; Mitkidis, Panagiotis; Roepstorff, Andreas] Aarhus Univ, Interacting Minds Ctr, Aarhus C, Denmark; [Mitkidis, Panagiotis] Aarhus Univ, Interdisciplinary Ctr Org Architecture, Aarhus C, Denmark; [Mitkidis, Panagiotis] Duke Univ, Ctr Adv Hindsight, Durham, NC USA; [McGraw, John J.] Calif State Univ Northridge, Dept Religious Studies, Northridge, CA 91330 USA; [McGraw, John J.] Calif State Univ Northridge, Dept Cent Amer Studies, Northridge, CA 91330 USA	Aarhus University; Aarhus University; Duke University; California State University System; California State University Northridge; California State University System; California State University Northridge	Wallot, S (corresponding author), Max Planck Inst Empir Aesthet, Frankfurt, Germany.; Wallot, S (corresponding author), Aarhus Univ, Interacting Minds Ctr, Aarhus C, Denmark.	sebastian.wallot@aesthetics.mpg.de		Wallot, Sebastian/0000-0002-3626-3940	Marie Curie Initial Training Network, "TESIS: Towards an Embodied Science of InterSubjectivity" (FP7-PEOPLE-ITN) [264828]	Marie Curie Initial Training Network, "TESIS: Towards an Embodied Science of InterSubjectivity" (FP7-PEOPLE-ITN)	This work was supported by the Marie Curie Initial Training Network, "TESIS: Towards an Embodied Science of InterSubjectivity" (FP7-PEOPLE-2010-ITN, 264828). http://ec.europa.eu/research/mariecurieactions/.; We thank C. Frith and U. Frith for discussion and comments of earlier versions of this manuscript, and L. Seitzberg and C. Larsen for assistance with carrying out the experiments. Our study would not have been possible without B. Thomsen and T. Sorensen of the LEGO Foundation. This work was supported by the Marie-Curie Initial Training Network, "TESIS: Towards an Embodied Science of InterSubjectivity" (FP7-PEOPLE-2010-ITN, 264828).	Abney DH, 2015, COGN PROCESS, V16, P325, DOI 10.1007/s10339-015-0648-2; Actigraph, 2014, GT3X WGT3X DEV MAN; [Anonymous], 2005, TUTORIALS CONT NONLI; Baumeister RF, 2015, BEHAV BRAIN SCI, P1; Clark HH, 2005, DISCOURSE STUD, V7, P507, DOI 10.1177/1461445605054404; Dale R, 2013, P COG SCI SOC, V35, P79; Dumas G, 2010, PLOS ONE, V5; Enders CK, 2007, PSYCHOL METHODS, V12, P121, DOI 10.1037/1082-989X.12.2.121; Fusaroli R, 2015, ARXIV150405750; Fusaroli R, COGN SCI; Fusaroli R, 2014, SPRINGER P MATH STAT, V103, P137, DOI 10.1007/978-3-319-09531-8_9; Grammer K, 1998, J NONVERBAL BEHAV, V22, P3, DOI 10.1023/A:1022986608835; Hove MJ, 2009, SOC COGNITION, V27, P949, DOI 10.1521/soco.2009.27.6.949; Knoblich G, 2011, PSYCHOL LEARN MOTIV, V54, P59, DOI 10.1016/B978-0-12-385527-5.00003-6; Konvalinka I, 2011, P NATL ACAD SCI USA, V108, P8514, DOI 10.1073/pnas.1016955108; Konvalinka I, 2010, Q J EXP PSYCHOL, V63, P2220, DOI 10.1080/17470218.2010.497843; LAFRANCE M, 1979, US SOC PSYCHOL, V42, P66, DOI 10.2307/3033875; Louwerse MM, 2012, COGNITIVE SCI, V36, P1404, DOI 10.1111/j.1551-6709.2012.01269.x; Marwan N, 2002, PHYS REV E, V66, DOI 10.1103/PhysRevE.66.026702; McGraw JJ, 2014, FRONT PSYCHOL, V5, DOI 10.3389/fpsyg.2014.01017; Miles LK, 2010, EUR J SOC PSYCHOL, V40, P52, DOI 10.1002/ejsp.721; Mitkidis P, 2013, PLOS ONE, P8; Mitkidis P, 2015, PHYSIOL BEHAV, V149, P101, DOI 10.1016/j.physbeh.2015.05.033; Monster D, 2016, PHYSIOL BEHAV, V156, P24, DOI 10.1016/j.physbeh.2016.01.004; Neda Z, 2000, NATURE, V403, P849, DOI 10.1038/35002660; Obhi SS, 2011, EXP BRAIN RES, V211, P329, DOI 10.1007/s00221-011-2721-0; Paxton Alexandra, 2014, P 36 ANN M COGN SCI, P2735; Polar, 2014, POL TEAM2 HEART RAT; Ramseyer F, 2011, J CONSULT CLIN PSYCH, V79, P284, DOI 10.1037/a0023419; Reddish P, 2013, PLOS ONE, P8; Richardson DC, 2007, PSYCHOL SCI, V18, P407, DOI 10.1111/j.1467-9280.2007.01914.x; Richardson MJ, 2007, HUM MOVEMENT SCI, V26, P867, DOI 10.1016/j.humov.2007.07.002; Richardson MJ, 2015, J EXP PSYCHOL HUMAN, V41, P665, DOI 10.1037/xhp0000041; Riley MA, 2011, FRONT PSYCHOL, P2; Schmidt RC, 1997, ECOL PSYCHOL, V9, P189, DOI 10.1207/s15326969eco0903_2; Shockley K, 2003, J EXP PSYCHOL HUMAN, V29, P326, DOI 10.1037/0096-1523.29.2.326; Shockley K, 2002, PHYS LETT A, V305, P59, DOI 10.1016/S0375-9601(02)01411-1; Smith A., 1976, INQUIRY NATURE CAUSE; Sy T, 2005, J APPL PSYCHOL, V90, P295, DOI 10.1037/0021-9010.90.2.295; Takens F, 1981, DYNAMICAL SYSTEMS TU, P366, DOI [10.1007/BFb0091924, DOI 10.1007/BFB0091924]; Thomasson N., 2002, International Journal of Computers and Their Applications, V9, P9; Valdesolo P, 2010, J EXP SOC PSYCHOL, V46, P693, DOI 10.1016/j.jesp.2010.03.004; Vickhoff B, 2013, FRONT PSYCHOL, P4; Wallot S, FRONT PSYCH IN PRESS; Wallot S, 2013, FRONT PHYSIOL, P4; Wiltermuth SS, 2009, PSYCHOL SCI, V20, P1, DOI 10.1111/j.1467-9280.2008.02253.x	46	53	53	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2016	11	12							e0168306	10.1371/journal.pone.0168306	http://dx.doi.org/10.1371/journal.pone.0168306			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EI9QF	27997558	Green Published, gold			2022-12-27	WOS:000392842900031
J	Dales, RE; Cakmak, S				Dales, Robert E.; Cakmak, Sabit			Does Mental Health Status Influence Susceptibility to the Physiologic Effects of Air Pollution? A Population Based Study of Canadian Children	PLOS ONE			English	Article							DIFFICULTIES QUESTIONNAIRE; DEPRESSION; RISK; STRENGTHS; DISORDER; DISEASE; ANXIETY; SDQ	Background Both air pollution exposure and the presence of mental illness are associated with an increased risk of physical illness. Objective To determine whether or not children with less favourable mental health are more susceptible to pulmonary and cardiovascular effects of ambient air pollution, compared to those who are mentally healthy. Methods We carried out a cross-sectional study of 1,883 children between the ages of 6 and 17 years of age who participated in the Canadian Health Measures population survey between 2007 and 2009. Subjects were assigned the air pollution values obtained from the National Air Pollution monitor closest to their neighborhood. Lung function, heart rate and blood pressure were stratified by indicators of mental health. The latter were ascertained by questions about feelings of happiness, a diagnosed mood disorder, and the emotional symptom sub-scale of the Strengths and Difficulties Questionnaire. Results Among those who reported a mood disorder, an interquartile increase in ozone was associated with increases in systolic and diastolic pressures of 3.8 mmHg (95% CI 1.6, 5.9) and 3.0mmHg (95% CI 0.9, 5.2) respectively, and a decreases in FVC of 7.6% (95% CI 2.9, 12.3). No significant changes in these variables were observed in those who did not report a mood disorder. Among those with unfavourable emotional symptoms, ozone was associated with a 6.4% (95% CI 1.7, 11.3) increase in heart rate, a 4.1% (95% CI 1.2, 7.1) increase in systolic blood pressure, and a 6.0% (95% CI 1.4, 10.6) decrease in FEVl. No significant effect was seen in these variables among those with no emotional symptoms. Conclusions In the Canadian population, children who report mood disorders or unfavourable emotional symptoms appear to be more vulnerable to the adverse physiologic effects of air pollution.	[Dales, Robert E.; Cakmak, Sabit] Hlth Canada, Populat Studies Div, Ottawa, ON, Canada; [Dales, Robert E.] Univ Ottawa, Sch Med, Ottawa, ON, Canada	Health Canada; University of Ottawa	Cakmak, S (corresponding author), Hlth Canada, Populat Studies Div, Ottawa, ON, Canada.	sabit.cakmak@canada.ca			Government of Canada, Clean Air Regulatory Agenda	Government of Canada, Clean Air Regulatory Agenda	The work was supported by Government of Canada, Clean Air Regulatory Agenda.	Cakmak S, 2016, INT J SUS DEV PLANN, V11, P537; Cakmak S, 2011, ENVIRON RES, V111, P1309, DOI 10.1016/j.envres.2011.09.016; Campbell NRC, 2005, CAN J PUBLIC HEALTH, V96, P217, DOI 10.1007/BF03403694; Committee on Research Priorities for Airborne Particulate Matter National Research Council, 1998, RES PRIOR AIRB PART; Copeland WE, 2012, BIOL PSYCHIAT, V71, P15, DOI 10.1016/j.biopsych.2011.09.023; DALES RE, 1989, AM REV RESPIR DIS, V139, P1459, DOI 10.1164/ajrccm/139.6.1459; DiMatteo MR, 2000, ARCH INTERN MED, V160, P2101, DOI 10.1001/archinte.160.14.2101; Goodman A, 2011, J CHILD PSYCHOL PSYC, V52, P100, DOI 10.1111/j.1469-7610.2010.02278.x; Goodman R, 1997, J CHILD PSYCHOL PSYC, V38, P581, DOI 10.1111/j.1469-7610.1997.tb01545.x; Hankinson JL, 1999, AM J RESP CRIT CARE, V159, P179, DOI 10.1164/ajrccm.159.1.9712108; Hicken MT, 2013, ENVIRON HEALTH PERSP, V121, P205, DOI 10.1289/ehp.1104517; Kawakami N, 1999, DIABETES CARE, V22, P1071, DOI 10.2337/diacare.22.7.1071; Kessler RC, 2009, EPIDEMIOL PSICHIAT S, V18, P23, DOI 10.1017/S1121189X00001421; Kiecolt-Glaser JK, 2002, J PSYCHOSOM RES, V53, P873, DOI 10.1016/S0022-3999(02)00309-4; Lasalvia A, 2013, LANCET, V381, P55, DOI 10.1016/S0140-6736(12)61379-8; Lawrence D, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f2539; Levy JL, 2002, ENVIRON HEALTH PERSP, V110, P1253, DOI 10.1289/ehp.021101253; Miller MR, 2005, EUR RESPIR J, V26, P319, DOI 10.1183/09031936.05.00034805; National Institute of Mental Health, 2019, MENT ILLN; Penninx BWJH, 2003, BIOL PSYCHIAT, V54, P566, DOI 10.1016/S0006-3223(02)01811-5; Rao J. N. K., 1992, SURV METHODOL, V18, P209; Richter J, 2011, J CHILD PSYCHOL PSYC, V52, P1002, DOI 10.1111/j.1469-7610.2011.02372.x; Rugulies R, 2002, AM J PREV MED, V23, P51, DOI 10.1016/S0749-3797(02)00439-7; Sacks JD, 2011, ENVIRON HEALTH PERSP, V119, P446, DOI 10.1289/ehp.1002255; Shanahan L, 2013, J PEDIATR-US, V163, P1443, DOI 10.1016/j.jpeds.2013.06.046; Stieb DM, 2008, J AIR WASTE MANAGE, V58, P435, DOI 10.3155/1047-3289.58.3.435; US EPA, NAT AMB AIR QUAL STA; Xu WN, 2008, AM J RESP CRIT CARE, V178, P913, DOI 10.1164/rccm.200804-619OC; Zanobetti A, 2000, Biostatistics, V1, P279, DOI 10.1093/biostatistics/1.3.279	29	13	13	2	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2016	11	12							e0168931	10.1371/journal.pone.0168931	http://dx.doi.org/10.1371/journal.pone.0168931			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EG7JB	28030615	Green Published, gold, Green Submitted			2022-12-27	WOS:000391222000086
J	Son, GY; Bak, EJ; Kim, JH; Lee, DE; Kang, SM; Lee, SY; Choi, L; Sun, JS; Kim, SK; Park, W; Kim, BI; Yoo, YJ; Chang, I; Shin, DM				Son, Ga-Yeon; Bak, Eun-Jung; Kim, Ji-Hye; Lee, Dong Eun; Kang, Si-Mook; Lee, So Yun; Choi, Lin; Sun, Ji Su; Kim, Seul Ki; Park, Wonse; Kim, Baek Il; Yoo, Yun-Jung; Chang, Inik; Shin, Dong Min			Endothelin Regulates Porphyromonas gingivalis-Induced Production of Inflammatory Cytokines	PLOS ONE			English	Article							EPITHELIAL-CELLS; ADULT PERIODONTITIS; BONE LOSS; RECEPTOR ANTAGONIST; CONVERTING ENZYME; EXPRESSION; DISEASE; GENE; SYSTEM; MACROPHAGES	Periodontitis is a very common oral inflammatory disease that results in the destruction of supporting connective and osseous tissues of the teeth. Although the exact etiology is still unclear, Gram-negative bacteria, especially Porphyromonas gingivalis in subgingival pockets are thought to be one of the major etiologic agents of periodontitis. Endothelin (ET) is a family of three 21-amino acid peptides, ET-1, -2, and -3, that activate G protein-coupled receptors, ETA and ETB. Endothelin is involved in the occurrence and progression of various inflammatory diseases. Previous reports have shown that ET-1 and its receptors, ETA and ETB are expressed in the periodontal tissues and, that ET-1 levels in gingival crevicular fluid are increased in periodontitis patients. Moreover, P. gingivalis infection has been shown to induce the production of ET-1 along with other inflammatory cytokines. Despite these studies, however, the functional significance of endothelin in periodontitis is still largely unknown. In this study, we explored the cellular and molecular mechanisms of ET-1 action in periodontitis using human gingival epithelial cells (HGECs). ET-1 and ETA, but not ETB, were abundantly expressed in HGECs. Stimulation of HGECs with P. gingivalis or P. gingivalis lipopolysaccharide increased the expression of ET-1 and ETA suggesting the activation of the endothelin signaling pathway. Production of inflammatory cytokines, IL-1 beta, TNF alpha, and IL-6, was significantly enhanced by exogenous ET-1 treatment, and this effect depended on the mitogen-activated protein kinases via intracellular Ca2+ increase, which resulted from the activation of the phospholipase C/inositol 1,4,5-trisphosphate pathway. The inhibition of the endothelin receptor-mediated signaling pathway with the dual receptor inhibitor, bosentan, partially ameliorated alveolar bone loss and immune cell infiltration. These results suggest that endothelin plays an important role in P. gingivalis-mediated periodontitis. Thus, endothelin antagonism may be a potential therapeutic approach for periodontitis treatment.	[Son, Ga-Yeon; Bak, Eun-Jung; Lee, Dong Eun; Lee, So Yun; Choi, Lin; Sun, Ji Su; Kim, Seul Ki; Yoo, Yun-Jung; Chang, Inik; Shin, Dong Min] Yonsei Univ, Coll Dent, Dept Oral Biol, Seoul, South Korea; [Son, Ga-Yeon; Lee, Dong Eun; Kang, Si-Mook; Lee, So Yun; Sun, Ji Su; Kim, Seul Ki; Kim, Baek Il; Shin, Dong Min] Yonsei Univ, Coll Dent, PLUS Project BK21, Seoul, South Korea; [Kim, Ji-Hye] Jeonju Kijeon Coll, Dept Dent Hyg, Jeonju, South Korea; [Kang, Si-Mook; Kim, Baek Il] Yonsei Univ, Coll Dent, Dept Prevent Dent & Publ Oral Hlth, Seoul, South Korea; [Park, Wonse] Yonsei Univ, Coll Dent, Dept Adv Gen Dent, Seoul, South Korea; [Son, Ga-Yeon] NIDCR, Secretory Physiol Sect, Mol Physiol & Therapeut Branch, Bethesda, MD USA; [Son, Ga-Yeon] NIH, Secretory Physiol Sect, Mol Physiol & Therapeut Branch, Bldg 10, Bethesda, MD 20892 USA	Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System; National Institutes of Health (NIH) - USA; NIH National Institute of Dental & Craniofacial Research (NIDCR); National Institutes of Health (NIH) - USA	Chang, I; Shin, DM (corresponding author), Yonsei Univ, Coll Dent, Dept Oral Biol, Seoul, South Korea.; Shin, DM (corresponding author), Yonsei Univ, Coll Dent, PLUS Project BK21, Seoul, South Korea.	ichang@yuhs.ac; dmshin@yuhs.ac	Yoo, Yun-Jung/HDN-0946-2022	Park, Wonse/0000-0002-2081-1156; Kang, Si-Mook/0000-0003-2341-3636; Shin, Dong Min/0000-0001-6042-0435; Kim, Baek Il/0000-0001-8234-2327; Kim, Seul Ki/0000-0002-2926-5972; Yoo, Yun-Jung/0000-0002-0045-9597	Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Education [2013R1A1A2061305]; Ministry of Science, ICT and future Planning [2015R1A2A1A15054157, 2016R1A5A2008630]	Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Education(National Research Foundation of KoreaMinistry of Education (MOE), Republic of KoreaNational Research Council for Economics, Humanities & Social Sciences, Republic of Korea); Ministry of Science, ICT and future Planning(Ministry of Science, ICT & Future Planning, Republic of Korea)	This work was supported by Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education (2013R1A1A2061305 for Inik Chang) and the Ministry of Science, ICT and future Planning (2015R1A2A1A15054157 for Dong Min Shin and 2016R1A5A2008630 for Inik Chang and Dong Min Shin). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agell N, 2002, CELL SIGNAL, V14, P649, DOI 10.1016/S0898-6568(02)00007-4; Ansai T, 2003, ORAL MICROBIOL IMMUN, V18, P398, DOI 10.1046/j.0902-0055.2003.00080.x; Ansai T, 2002, CLIN SCI, V103, p327S, DOI 10.1042/CS103S327S; Anthoni C, 2006, INT J COLORECTAL DIS, V21, P409, DOI 10.1007/s00384-005-0015-3; Awano S, 1999, FEBS LETT, V460, P139, DOI 10.1016/S0014-5793(99)01326-5; Bohm F, 2007, CARDIOVASC RES, V76, P8, DOI 10.1016/j.cardiores.2007.06.004; Chen SZ, 2000, CHINESE MED J-PEKING, V113, P844; Cochran DL, 2008, J PERIODONTOL, V79, P1569, DOI 10.1902/jop.2008.080233; Darveau RP, 2010, NAT REV MICROBIOL, V8, P481, DOI 10.1038/nrmicro2337; Donate PB, 2012, INFLAMM RES, V61, P337, DOI 10.1007/s00011-011-0415-5; Finsnes F, 1997, AM J RESP CRIT CARE, V155, P1404, DOI 10.1164/ajrccm.155.4.9105086; Fujioka D, 2003, J PERIODONTAL RES, V38, P269, DOI 10.1034/j.1600-0765.2003.00653.x; Graves DT, 2011, J DENT RES, V90, P143, DOI 10.1177/0022034510385236; Hirschfeld M, 2001, INFECT IMMUN, V69, P1477, DOI 10.1128/IAI.69.3.1477-1482.2001; Holla LI, 2001, J PERIODONTOL, V72, P85, DOI 10.1902/jop.2001.72.1.85; Kedzierski RM, 2001, ANNU REV PHARMACOL, V41, P851, DOI 10.1146/annurev.pharmtox.41.1.851; Kim JH, 2014, J PERIODONTAL RES, V49, P792, DOI 10.1111/jre.12165; Kirikae T, 1999, INFECT IMMUN, V67, P1736; Lacroix M, 2008, INT J CANCER, V122, P1, DOI 10.1002/ijc.23233; LAMONT RJ, 1995, INFECT IMMUN, V63, P3878, DOI 10.1128/IAI.63.10.3878-3885.1995; Liang L, 2014, J PERIODONTOL, V85, P618, DOI 10.1902/jop.2013.130195; Masters JR, 2002, NAT REV CANCER, V2, P315, DOI 10.1038/nrc775; NAKANO J, 1994, CLIN EXP ALLERGY, V24, P330, DOI 10.1111/j.1365-2222.1994.tb00243.x; Ogawa T, 2007, FRONT BIOSCI-LANDMRK, V12, P3795, DOI 10.2741/2353; Poltorak A, 1998, SCIENCE, V282, P2085, DOI 10.1126/science.282.5396.2085; Prabhu A, 1996, J PERIODONTOL, V67, P515, DOI 10.1902/jop.1996.67.5.515; Rikimaru T, 2009, BIOMED RES-TOKYO, V30, P349, DOI 10.2220/biomedres.30.349; RUBANYI GM, 1994, PHARMACOL REV, V46, P325; Souza PPC, 2013, IMMUNOL INVEST, V42, P555, DOI 10.3109/08820139.2013.822766; Sprogar S, 2008, BONE, V43, P740, DOI 10.1016/j.bone.2008.06.012; Yamamoto E, 2003, J PERIODONTAL RES, V38, P417, DOI 10.1034/j.1600-0765.2003.00668.x; Yamazaki K, 1997, ORAL MICROBIOL IMMUN, V12, P281, DOI 10.1111/j.1399-302X.1997.tb00392.x; Zhang H, 2016, FRONT CELL INFECT MI, V6, DOI 10.3389/fcimb.2016.00023	33	4	4	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2016	11	12							e0167713	10.1371/journal.pone.0167713	http://dx.doi.org/10.1371/journal.pone.0167713			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EG7JB	28030574	gold, Green Published, Green Submitted			2022-12-27	WOS:000391222000018
J	Zheng, XH; Kuang, YY; Lv, WH; Cao, DC; Sun, ZP; Sun, XW				Zheng, Xianhu; Kuang, Youyi; Lv, Weihua; Cao, Dingchen; Sun, Zhipeng; Sun, Xiaowen			Genome-Wide Association Study for Muscle Fat Content and Abdominal Fat Traits in Common Carp (Cyprinus carpio)	PLOS ONE			English	Article							GENETIC-PARAMETERS; BODY-COMPOSITION; QUALITY TRAITS; LIPID-CONTENT; LINKAGE MAP; METABOLISM; SELECTION; SEQUENCE; CHOLINE; WEIGHT	Muscle fat content is an important phenotypic trait in fish, as it affects the nutritional, technical and sensory qualities of flesh. To identify loci and candidate genes associated with muscle fat content and abdominal fat traits, we performed a genome-wide association study (GWAS) using the common carp 250 K SNP assay in a common carp F2 resource population. A total of 18 loci surpassing the genome-wide suggestive significance level were detected for 4 traits: fat content in dorsal muscle (MFdo), fat content in abdominal muscle (MFab), abdominal fat weight (AbFW), and AbFW as a percentage of eviscerated weight (AbFP). Among them, one SNP (carp089419) affecting both AbFW and AbFP reached the genome-wide significance level. Ten of those loci were harbored in or near known genes. Furthermore, relative expressions of 5 genes related to MFdo were compared using dorsal muscle samples with high and low phenotypic values. The results showed that 4 genes were differentially expressed between the high and low phenotypic groups. These genes are, therefore, prospective candidate genes for muscle fat content: ankyrin repeat domain 10a (ankrd10a), tetratricopeptide repeat, ankyrin repeat and coiled-coil containing 2 (tanc2), and four jointed box 1 (fjx1) and choline kinase alpha (chka). These results offer valuable insights into the complex genetic basis of fat metabolism and deposition.	[Zheng, Xianhu; Kuang, Youyi; Lv, Weihua; Cao, Dingchen; Sun, Zhipeng; Sun, Xiaowen] Chinese Acad Fishery Sci, Heilongjiang River Fisheries Res Inst, Natl & Local United Engn Lab Freshwater Fish Bree, Harbin, Heilongjiang, Peoples R China; [Lv, Weihua] Northeast Agr Univ, Coll Life Sci, Harbin, Heilongjiang, Peoples R China	Chinese Academy of Fishery Sciences; Heilongjiang River Fisheries Research Institute, CAFS; Northeast Agricultural University - China	Sun, XW (corresponding author), Chinese Acad Fishery Sci, Heilongjiang River Fisheries Res Inst, Natl & Local United Engn Lab Freshwater Fish Bree, Harbin, Heilongjiang, Peoples R China.	sunxw2002@163.com	Kuang, Youyi/AFO-8327-2022	Kuang, Youyi/0000-0003-4053-9353	National Natural Science Foundation of China [31302174]; Central-Level Non-profit Scientific Research Institutes Special Funds [HSY201303]; China Ministry of Agriculture "948" Program [2016-X15]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Central-Level Non-profit Scientific Research Institutes Special Funds; China Ministry of Agriculture "948" Program	This research was supported in part by the National Natural Science Foundation of China (31302174), the Central-Level Non-profit Scientific Research Institutes Special Funds (HSY201303) and the China Ministry of Agriculture 948 Program (2016-X15).	Ankra-Badu GA, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-107; Baranski M, 2010, GENET SEL EVOL, V42, DOI 10.1186/1297-9686-42-17; Browning SR, 2007, AM J HUM GENET, V81, P1084, DOI 10.1086/521987; Chang CC, 2015, GIGASCIENCE, V4, DOI 10.1186/s13742-015-0047-8; Corbin KD, 2013, FASEB J, V27, P1674, DOI 10.1096/fj.12-219097; Derayat A, 2007, AQUACULTURE, V272, pS250, DOI 10.1016/j.aquaculture.2007.07.046; Dolley G, 2011, MOL GENET METAB, V102, P448, DOI 10.1016/j.ymgme.2010.12.011; FOLCH J, 1957, J BIOL CHEM, V226, P497; Gallego-Ortega D, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007819; Gao XY, 2008, GENET EPIDEMIOL, V32, P361, DOI 10.1002/gepi.20310; Gjedrem T, 2009, REV-METHODS TECHNOL, V10, P1, DOI 10.1007/978-90-481-2773-3_1; Grant RW, 2013, ANIM GENET, V44, P560, DOI 10.1111/age.12035; Haghighi F, 2002, AM J HUM GENET, V70, P142, DOI 10.1086/324709; Hirschhorn JN, 2005, NAT REV GENET, V6, P95, DOI 10.1038/nrg1521; Ionita-Laza I, 2013, EUR J HUM GENET, V21, P1158, DOI 10.1038/ejhg.2012.308; Ishii A, 2013, ANIM SCI J, V84, P675, DOI 10.1111/asj.12063; Jeff JM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086931; Johansson L, 2000, FOOD QUAL PREFER, V11, P247, DOI 10.1016/S0950-3293(99)00073-7; Kocour M, 2007, AQUACULTURE, V270, P43, DOI 10.1016/j.aquaculture.2007.03.001; Kuang YY, 2015, AQUACULTURE, V435, P100, DOI 10.1016/j.aquaculture.2014.09.020; Lee J, 2015, MOL GENET GENOMICS, V290, P1673, DOI 10.1007/s00438-015-1025-7; Li Y, 2011, MAR BIOTECHNOL, V13, P706, DOI 10.1007/s10126-010-9332-9; Liu JS, 2009, J AGR FOOD CHEM, V57, P3808, DOI 10.1021/jf8033144; Liu ZJ, 2007, AQUACULTURE GENOME T; May P, 2007, ANN MED, V39, P219, DOI 10.1080/07853890701214881; Peng WZ, 2016, SCI REP-UK, V6, DOI 10.1038/srep26693; Powell J, 2008, AQUACULTURE, V274, P225, DOI 10.1016/j.aquaculture.2007.11.036; Quillet E, 2005, AQUACULTURE, V245, P49, DOI 10.1016/j.aquaculture.2004.12.014; Quinton CD, 2005, AQUACULTURE, V247, P211, DOI 10.1016/j.aquaculture.2005.02.030; Rye M., 1996, Aquaculture Research, V27, P121; Santana MHA, 2015, GENET MOL RES, V14, P5229, DOI 10.4238/2015.May.18.14; Sharma A, 2015, ASIAN AUSTRAL J ANIM, V28, P1371, DOI 10.5713/ajas.14.0715; Sodeland M, AQUACULTURE; Sun XW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058700; Tobin D, 2006, AQUACULTURE, V261, P510, DOI 10.1016/j.aquaculture.2006.07.023; Ulrich V, 2014, P NATL ACAD SCI USA, V111, P13493, DOI 10.1073/pnas.1402106111; Vicira VLA, 2007, AQUACULTURE, V272, pS100, DOI 10.1016/j.aquaculture.2007.08.028; Visscher PM, 2012, AM J HUM GENET, V90, P7, DOI 10.1016/j.ajhg.2011.11.029; Wang L, 2006, AM J HUM GENET, V78, P770, DOI 10.1086/503712; Wijsman EM, 2016, BMC GENET, V17, DOI 10.1186/s12863-015-0318-5; [吴景 Wu Jing], 2015, [中国水产科学, Journal of Fishery Sciences of China], V22, P9; Xia JH, 2014, MAR BIOTECHNOL, V16, P1, DOI 10.1007/s10126-013-9524-1; Xu J, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-307; Xu P, 2014, NAT GENET, V46, P1212, DOI 10.1038/ng.3098; Xu P, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-537; Xu P, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-188; Yang B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065554; Yao JF, 2010, POULTRY SCI, V89, P883, DOI 10.3382/ps.2009-00613; Zhang H, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002718; Zhang XF, 2013, MAR BIOTECHNOL, V15, P275, DOI 10.1007/s10126-012-9485-9; Zhang Y, 2011, MAR BIOTECHNOL, V13, P376, DOI 10.1007/s10126-010-9307-x; Zheng XH, 2011, MOL GENET GENOMICS, V286, P261, DOI 10.1007/s00438-011-0644-x; Zhou X, 2012, NAT GENET, V44, P821, DOI 10.1038/ng.2310	53	19	26	2	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2016	11	12							e0169127	10.1371/journal.pone.0169127	http://dx.doi.org/10.1371/journal.pone.0169127			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EG7JB	28030623	Green Published, gold, Green Submitted			2022-12-27	WOS:000391222000105
J	McSorley, E; McCloy, R; Williams, L				McSorley, Eugene; McCloy, Rachel; Williams, Louis			The Concurrent Programming of Saccades	PLoS One			English	Article							VISUAL-SEARCH TASK; EYE-MOVEMENTS; REFLEXIVE SACCADES; TARGET SELECTION; SUPERIOR COLLICULUS; SEQUENCES; ATTENTION; VOLUNTARY; GENERATION; OBJECT	Sequences of saccades have been shown to be prepared concurrently however it remains unclear exactly what aspects of those saccades are programmed in parallel. To examine this participants were asked to make one or two target-driven saccades: a reflexive saccade; a voluntary saccade; a reflexive then a voluntary saccade; or vice versa. During the first response the position of a second target was manipulated. The new location of the second saccade target was found to impact on second saccade latencies and second saccade accuracy showing that some aspects of the second saccade program are prepared in parallel with the first. However, differences were found in the specific pattern of effects for each sequence type. These differences fit well within a general framework for saccade control in which a common priority map for saccade control is computed and the influence of saccade programs on one another depends not so much on the types of saccade being produced but rather on the rate at which their programs develop.	[McSorley, Eugene; McCloy, Rachel; Williams, Louis] Univ Reading, Sch Psychol & Clin Language Sci, Reading, Berks, England	University of Reading	McSorley, E (corresponding author), Univ Reading, Sch Psychol & Clin Language Sci, Reading, Berks, England.	e.mcsorley@reading.ac.uk	Williams, Louis/W-3373-2019		British Academy [SG SG142865]	British Academy	This work was supported by the British Academy, Grant No. SG SG142865. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amador N, 1998, J NEUROPHYSIOL, V80, P1775, DOI 10.1152/jn.1998.80.4.1775; Awh E, 2012, TRENDS COGN SCI, V16, P1; Baldauf D, 2008, EXP BRAIN RES, V184, P411, DOI 10.1007/s00221-007-1114-x; Beauvillain C, 2005, EXP BRAIN RES, V165, P315, DOI 10.1007/s00221-005-2308-8; BECKER W, 1979, VISION RES, V19, P967, DOI 10.1016/0042-6989(79)90222-0; Bhutani N, 2013, J NEUROSCI, V33, P9985, DOI 10.1523/JNEUROSCI.4934-12.2013; Bhutani N, 2012, J NEUROPHYSIOL, V108, P3161, DOI 10.1152/jn.00344.2012; BURR DC, 1982, J PHYSIOL-LONDON, V333, P1; De Vries JP, 2014, PSYCHOL SCI, V25, P215, DOI 10.1177/0956797613497020; Engbert R, 2005, PSYCHOL REV, V112, P777, DOI 10.1037/0033-295X.112.4.777; Fecteau JH, 2006, TRENDS COGN SCI, V10, P382, DOI 10.1016/j.tics.2006.06.011; Findlay JM, 2001, VISION RES, V41, P87, DOI 10.1016/S0042-6989(00)00236-4; Findlay JM, 1999, BEHAV BRAIN SCI, V22, P661, DOI 10.1017/S0140525X99002150; Gersch TM, 2009, VISION RES, V49, P1256, DOI 10.1016/j.visres.2007.10.030; Gersch TM, 2004, VISION RES, V44, P1469, DOI 10.1016/j.visres.2003.12.014; Godijn R, 2003, J EXP PSYCHOL HUMAN, V29, P882, DOI 10.1037/0096-1523.29.5.882; Godijn R, 2002, PSYCHOL RES-PSYCH FO, V66, P234, DOI 10.1007/s00426-002-0098-1; HALLETT PE, 1978, VISION RES, V18, P1279, DOI 10.1016/0042-6989(78)90218-3; Hayhoe M, 2005, TRENDS COGN SCI, V9, P188, DOI 10.1016/j.tics.2005.02.009; Hayhoe MM, 1998, VISION RES, V38, P125, DOI 10.1016/S0042-6989(97)00116-8; Hooge LTC, 1996, PERCEPT PSYCHOPHYS, V58, P969, DOI 10.3758/BF03206825; Itti L, 2000, VISION RES, V40, P1489, DOI 10.1016/S0042-6989(99)00163-7; LAND MF, 1998, VISION ACTION, P163; Land MF, 2006, PROG RETIN EYE RES, V25, P296, DOI 10.1016/j.preteyeres.2006.01.002; Lavergne L, 2012, J VISION, V12, DOI [10.1167/12.6.6, 10.1167/12.6/6]; Lavergne L, 2008, BRAIN RES, V1245, P82, DOI 10.1016/j.brainres.2008.09.065; McPeek RM, 2000, VISION RES, V40, P2499, DOI 10.1016/S0042-6989(00)00102-4; McPeek RM, 2001, VISION RES, V41, P785, DOI 10.1016/S0042-6989(00)00287-X; McPeek RM, 2002, J NEUROPHYSIOL, V87, P1805, DOI 10.1152/jn.00501.2001; Mokler A, 1999, EXP BRAIN RES, V125, P511, DOI 10.1007/s002210050709; Mort DJ, 2003, NEUROIMAGE, V18, P231, DOI 10.1016/S1053-8119(02)00028-9; Rayner K, 2009, Q J EXP PSYCHOL, V62, P1457, DOI 10.1080/17470210902816461; Reich ED, 2012, PSYCHOL REV, V119, P155, DOI 10.1037/a0026473; Ross J, 2001, TRENDS NEUROSCI, V24, P113, DOI 10.1016/S0166-2236(00)01685-4; Theeuwes J, 1998, PSYCHOL SCI, V9, P379, DOI 10.1111/1467-9280.00071; Trappenberg TP, 2001, J COGNITIVE NEUROSCI, V13, P256, DOI 10.1162/089892901564306; Trukenbrod HA, 2012, J VISION, V12, DOI 10.1167/12.1.5; Vergilino D, 2000, VISION RES, V40, P3527, DOI 10.1016/S0042-6989(00)00192-9; Vergilino D, 2001, VISION RES, V41, P3547, DOI 10.1016/S0042-6989(01)00225-5; Vergilino-Perez D, 2004, COGNITIVE BRAIN RES, V20, P525, DOI 10.1016/j.cogbrainres.2004.03.022; Vergilino-Perez D, 2004, PSYCHON B REV, V11, P332, DOI 10.3758/BF03196579; Vergilino-Perez D, 2003, EXP BRAIN RES, V150, P255, DOI 10.1007/s00221-003-1418-4; Vergilino-Perez D, 2006, VISION RES, V46, P2204, DOI 10.1016/j.visres.2005.11.034; VIVIANI P, 1982, J EXP PSYCHOL HUMAN, V8, P113, DOI 10.1037/0096-1523.8.1.113; Walker R, 2000, EXP BRAIN RES, V130, P540, DOI 10.1007/s002219900285; Walker R, 2006, VISION RES, V46, P2082, DOI 10.1016/j.visres.2005.12.009; Weber H, 1998, EXP BRAIN RES, V120, P417, DOI 10.1007/s002210050415; Zimmermann E, 2015, FRONT SYST NEUROSCI, V9, DOI 10.3389/fnsys.2015.00132; Zimmermann E, 2015, EXP BRAIN RES, V233, P577, DOI 10.1007/s00221-014-4138-z	50	5	5	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2016	11	12							e0168724	10.1371/journal.pone.0168724	http://dx.doi.org/10.1371/journal.pone.0168724			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EI9QH	28005964	Green Published, Green Accepted, Green Submitted, gold			2022-12-27	WOS:000392843200088
J	Zhang, M; Schmitt-Ulms, G; Sato, C; Xi, ZR; Zhang, YL; Zhou, Y; St George-Hyslop, P; Rogaeva, E				Zhang, Ming; Schmitt-Ulms, Gerold; Sato, Christine; Xi, Zhengrui; Zhang, Yalun; Zhou, Ye; St George-Hyslop, Peter; Rogaeva, Ekaterina			Drug Repositioning for Alzheimer's Disease Based on Systematic 'omics' Data Mining	PLOS ONE			English	Article							MIGRATION INHIBITORY FACTOR; EPIGENETIC AGE; GENE-EXPRESSION; MOUSE MODELS; RISK-FACTOR; CD33; INFORMATION; DISCOVERY; VARIANTS; NETWORKS	Traditional drug development for Alzheimer's disease (AD) is costly, time consuming and burdened by a very low success rate. An alternative strategy is drug repositioning, redirecting existing drugs for another disease. The large amount of biological data accumulated to date warrants a comprehensive investigation to better understand AD pathogenesis and facilitate the process of anti-AD drug repositioning. Hence, we generated a list of anti-AD protein targets by analyzing the most recent publically available 'omics' data, including genomics, epigenomics, proteomics and metabolomics data. The information related to AD pathogenesis was obtained from the OMIM and PubMed databases. Drug-target data was extracted from the DrugBank and Therapeutic Target Database. We generated a list of 524 AD-related proteins, 18 of which are targets for 75 existing drugs-novel candidates for repurposing as anti-AD treatments. We developed a ranking algorithm to prioritize the anti-AD targets, which revealed CD33 and MIF as the strongest candidates with seven existing drugs. We also found 7 drugs inhibiting a known anti-AD target (acetylcholinesterase) that may be repurposed for treating the cognitive symptoms of AD. The CAD protein and 8 proteins implicated by two 'omics' approaches (ABCA7, APOE, BIN1, PICALM, CELF1, INPP5D, SPON1, and SOD3) might also be promising targets for anti-AD drug development. Our systematic 'omics' mining suggested drugs with novel anti-AD indications, including drugs modulating the immune system or reducing neuroinflammation that are particularly promising for AD intervention. Furthermore, the list of 524 AD-related proteins could be useful not only as potential anti-AD targets but also considered for AD biomarker development.	[Zhang, Ming; Schmitt-Ulms, Gerold; Sato, Christine; Xi, Zhengrui; Zhang, Yalun; Zhou, Ye; St George-Hyslop, Peter; Rogaeva, Ekaterina] Univ Toronto, Tanz Ctr Res Neurodegenerat Dis, Toronto, ON, Canada; [St George-Hyslop, Peter; Rogaeva, Ekaterina] Univ Toronto, Div Neurol, Dept Med, Toronto, ON, Canada; [St George-Hyslop, Peter] Univ Cambridge, Cambridge Inst Med Res, Cambridge, England; [St George-Hyslop, Peter] Univ Cambridge, Dept Clin Neurosci, Cambridge, England	University of Toronto; University of Toronto; University of Cambridge; University of Cambridge	Zhang, M (corresponding author), Univ Toronto, Tanz Ctr Res Neurodegenerat Dis, Toronto, ON, Canada.	mingr.zhang@utoronto.ca		St George-Hyslop, Peter/0000-0003-0796-7209	Wellcome Trust; Medical Research Council; Ontario Research Fund; Canadian Institute of Health Research; National Institute of Health Research Cambridge Biomedical Research Unit in Dementia; National Institutes of Health; Alzheimer Society of Ontario	Wellcome Trust(Wellcome Trust); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Ontario Research Fund; Canadian Institute of Health Research(Canadian Institutes of Health Research (CIHR)); National Institute of Health Research Cambridge Biomedical Research Unit in Dementia; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Alzheimer Society of Ontario	This work was supported by Wellcome Trust, Medical Research Council, Ontario Research Fund, Canadian Institute of Health Research, National Institute of Health Research Cambridge Biomedical Research Unit in Dementia, National Institutes of Health, and Alzheimer Society of Ontario. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andreasen N, 1999, ARCH NEUROL-CHICAGO, V56, P673, DOI 10.1001/archneur.56.6.673; Andronis C, 2011, BRIEF BIOINFORM, V12, P357, DOI 10.1093/bib/bbr005; Bacher M, 2010, MOL MED, V16, P116, DOI 10.2119/molmed.2009.00123; Baruch K, 2016, NAT MED, V22, P135, DOI 10.1038/nm.4022; Bradshaw EM, 2013, NAT NEUROSCI, V16, P848, DOI 10.1038/nn.3435; Bryan KJ, 2008, MOL NEURODEGENER, V3, DOI 10.1186/1750-1326-3-13; Burns A, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.b158; Butterfield DA, 2003, CNS DRUGS, V17, P641, DOI 10.2165/00023210-200317090-00004; Chen J, 2009, NUCLEIC ACIDS RES, V37, pW305, DOI 10.1093/nar/gkp427; Chindelevitch L, 2012, BIOINFORMATICS, V28, P1114, DOI 10.1093/bioinformatics/bts090; Corbett Anne, 2015, Front Biosci (Schol Ed), V7, P184; CORDER EH, 1993, SCIENCE, V261, P921, DOI 10.1126/science.8346443; Cowan AJ, 2013, FRONT BIOSCI-LANDMRK, V18, P1312, DOI 10.2741/4181; Cox GM, 2013, J IMMUNOL, V191, P1043, DOI 10.4049/jimmunol.1200485; Craig-Schapiro R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018850; Cummings JL, 2014, ALZHEIMERS RES THER, V6, DOI 10.1186/alzrt269; Doens D, 2014, J NEUROINFLAMM, V11, DOI 10.1186/1742-2094-11-48; Garnache-Ottou F, 2005, BLOOD, V105, P1256, DOI 10.1182/blood-2004-06-2416; Ghani M., 2014, NEURODEGENER DIS, P27; GOATE A, 1991, NATURE, V349, P704, DOI 10.1038/349704a0; Guerreiro R, 2013, NEW ENGL J MED, V368, P117, DOI 10.1056/NEJMoa1211851; Hay M, 2014, NAT BIOTECHNOL, V32, P40, DOI 10.1038/nbt.2786; Holscher C, 2011, BIOCHEM SOC T, V39, P891, DOI 10.1042/BST0390891; Horvath S, 2015, AGING-US, V7, P1130, DOI 10.18632/aging.100859; Horvath S, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-10-r115; Huang H, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-S6-S17; Jo S, 2014, NAT MED, V20, P886, DOI 10.1038/nm.3639; Jonsson T, 2013, NEW ENGL J MED, V368, P107, DOI 10.1056/NEJMoa1211103; Kim WS, 2006, NEUROREPORT, V17, P891, DOI 10.1097/01.wnr.0000221833.41340.cd; Lajaunias F, 2005, EUR J IMMUNOL, V35, P243, DOI 10.1002/eji.200425273; Lamb J, 2006, SCIENCE, V313, P1929, DOI 10.1126/science.1132939; Levine ME, 2015, AGING-US, V7, P1198, DOI 10.18632/aging.100864; Lindsay J, 2002, AM J EPIDEMIOL, V156, P445, DOI 10.1093/aje/kwf074; Liu RL, 2014, BMC BIOINFORMATICS, V15, DOI 10.1186/1471-2105-15-286; Lu AT, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10561; Luo H, 2011, NUCLEIC ACIDS RES, V39, pW492, DOI 10.1093/nar/gkr299; Malik M, 2015, HUM MOL GENET, V24, P3557, DOI 10.1093/hmg/ddv092; MORTIMER JA, 1991, INT J EPIDEMIOL, V20, pS28, DOI 10.1093/ije/20.Supplement_2.S28; Sanseau P, 2012, NAT BIOTECHNOL, V30, P317, DOI 10.1038/nbt.2151; Selkoe DJ, 2007, CELL, V131, P215, DOI 10.1016/j.cell.2007.10.012; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Triantaphyllou E., 2000, MULTICRITERIA DECISI, VVolume 44; Wang WH, 2014, BIOINFORMATICS, V30, P2923, DOI 10.1093/bioinformatics/btu403; Wang ZY, 2013, NAT BIOTECHNOL, V31, P1080, DOI 10.1038/nbt.2758; Wishart DS, 2006, NUCLEIC ACIDS RES, V34, pD668, DOI 10.1093/nar/gkj067; Xi ZR, 2014, NEUROLOGY, V83, P1476, DOI 10.1212/WNL.0000000000000886; Yang L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028025; Yang L, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002016; Zhang M, 2016, J NEUROLOGY NEUROSUR; Zhang M, 2015, BRAIN, V138, DOI 10.1093/brain/awv082; Zhang M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126082; Zhu F, 2012, NUCLEIC ACIDS RES, V40, pD1128, DOI 10.1093/nar/gkr797	52	47	47	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2016	11	12							e0168812	10.1371/journal.pone.0168812	http://dx.doi.org/10.1371/journal.pone.0168812			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI9QH	28005991	Green Submitted, gold, Green Published			2022-12-27	WOS:000392843200098
J	Bent, ZW; Poorey, K; LaBauve, AE; Hamblin, R; Williams, KP; Meagher, RJ				Bent, Zachary W.; Poorey, Kunal; LaBauve, Annette E.; Hamblin, Rachelle; Williams, Kelly P.; Meagher, Robert J.			A Rapid Spin Column-Based Method to Enrich Pathogen Transcripts from Eukaryotic Host Cells Prior to Sequencing	PLOS ONE			English	Article							CARBAPENEM-RESISTANT ENTEROBACTERIACEAE; DUAL RNA-SEQ; KLEBSIELLA-PNEUMONIAE; GENE-EXPRESSION; SELECTIVE CAPTURE; VIRULENCE FACTOR; MACROPHAGES; INFECTION; EPIDEMIOLOGY	When analyzing pathogen transcriptomes during the infection of host cells, the signal-to-background (pathogen-to-host) ratio of nucleic acids (NA) in infected samples is very small. Despite the advancements in next-generation sequencing, the minute amount of pathogen NA makes standard RNA-seq library preps inadequate for effective gene-level analysis of the pathogen in cases with low bacterial loads. In order to provide a more complete picture of the pathogen transcriptome during an infection, we developed a novel pathogen enrichment technique, which can enrich for transcripts from any cultivable bacteria or virus, using common, readily available laboratory equipment and reagents. To evenly enrich for pathogen transcripts, we generate biotinylated pathogen-targeted capture probes in an enzymatic process using the entire genome of the pathogen as a template. The capture probes are hybridized to a strand-specific cDNA library generated from an RNA sample. The biotinylated probes are captured on a monomeric avidin resin in a miniature spin column, and enriched pathogen-specific cDNA is eluted following a series of washes. To test this method, we performed an in vitro time-course infection using Klebsiella pneumoniae to infect murine macrophage cells. K. pneumoniae transcript enrichment efficiency was evaluated using RNA-seq. Bacterial transcripts were enriched up to similar to 400-fold, and allowed the recovery of transcripts from similar to 2000-3600 genes not observed in untreated control samples. These additional transcripts revealed interesting aspects of K. pneumoniae biology including the expression of putative virulence factors and the expression of several genes responsible for antibiotic resistance even in the absence of drugs.	[Bent, Zachary W.; Poorey, Kunal; Hamblin, Rachelle; Williams, Kelly P.] Sandia Natl Labs, Dept Syst Biol, Livermore, CA 94551 USA; [LaBauve, Annette E.; Meagher, Robert J.] Sandia Natl Labs, Biotechnol & Bioengn Dept, Livermore, CA 94551 USA; [Bent, Zachary W.] 10X Genom, Pleasanton, CA 94566 USA	United States Department of Energy (DOE); Sandia National Laboratories; United States Department of Energy (DOE); Sandia National Laboratories	Bent, ZW (corresponding author), Sandia Natl Labs, Dept Syst Biol, Livermore, CA 94551 USA.; Meagher, RJ (corresponding author), Sandia Natl Labs, Biotechnol & Bioengn Dept, Livermore, CA 94551 USA.; Bent, ZW (corresponding author), 10X Genom, Pleasanton, CA 94566 USA.	zachwbent@gmail.com; rmeaghe@sandia.gov		Meagher, Robert/0000-0002-6262-2126	Sandia National Laboratories Laboratory Directed Research and Development (LDRD) [173021]; U.S. Department of Energy's National Nuclear Security Administration [DE-AC04-94AL85000]	Sandia National Laboratories Laboratory Directed Research and Development (LDRD); U.S. Department of Energy's National Nuclear Security Administration(National Nuclear Security Administration)	This work was funded by Sandia National Laboratories Laboratory Directed Research and Development (LDRD) Project 173021 (RJM). Sandia National Laboratories is a multi-program laboratory managed and operated by Sandia Corporation, a wholly owned subsidiary of Lockheed Martin Corporation, for the U.S. Department of Energy's National Nuclear Security Administration under Contract DE-AC04-94AL85000. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anonymous, 2010, Morbidity and Mortality Weekly Report, V59, P750; Avican K, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004600; Baddal B, 2015, MBIO, V6, DOI 10.1128/mBio.01765-15; Bent ZW, 2015, INFECT IMMUN, V83, P2672, DOI 10.1128/IAI.02922-14; Bent ZW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077834; Bent ZW, 2013, ANAL BIOCHEM, V438, P90, DOI 10.1016/j.ab.2013.03.008; Brady RA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124877; Cano V, 2015, CELL MICROBIOL, V17, P1537, DOI 10.1111/cmi.12466; Canton R, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00110; Cortes G, 2002, INFECT IMMUN, V70, P2583, DOI 10.1128/IAI.70.5.2583-2590.2002; Courcelle J, 2001, GENETICS, V158, P41; Date SV, 2014, J INFECT DIS, V209, P1542, DOI 10.1093/infdis/jit668; Eriksson S, 2003, MOL MICROBIOL, V47, P103, DOI 10.1046/j.1365-2958.2003.03313.x; Faucher SP, 2006, P NATL ACAD SCI USA, V103, P1906, DOI 10.1073/pnas.0509183103; Frost LS, 2005, NAT REV MICROBIOL, V3, P722, DOI 10.1038/nrmicro1235; Graham JE, 1999, P NATL ACAD SCI USA, V96, P11554, DOI 10.1073/pnas.96.20.11554; Gu W, 2016, GENOME BIOL, V17, DOI 10.1186/s13059-016-0904-5; Guh AY, 2014, EXPERT REV ANTI-INFE, V12, P565, DOI 10.1586/14787210.2014.902306; Gupta N, 2011, CLIN INFECT DIS, V53, P60, DOI 10.1093/cid/cir202; GYLES CL, 1977, SCIENCE, V198, P198, DOI 10.1126/science.333581; He SM, 2010, NAT METHODS, V7, P807, DOI [10.1038/nmeth.1507, 10.1038/NMETH.1507]; Hudson CM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099209; Istivan TS, 2006, MICROBIOL-SGM, V152, P1263, DOI 10.1099/mic.0.28609-0; Jacob JT, 2013, MMWR-MORBID MORTAL W, V62, P165; Kawahara Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049423; Kim D, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-4-r36; Langevin SA, 2013, RNA BIOL, V10, P502, DOI 10.4161/rna.24284; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Lawlor MS, 2007, INFECT IMMUN, V75, P1463, DOI 10.1128/IAI.00372-06; Lery LMS, 2014, BMC BIOL, V12, DOI 10.1186/1741-7007-12-41; Li J, 2014, SCI REP-UK, V4, DOI 10.1038/srep06216; Mandlik A, 2011, CELL HOST MICROBE, V10, P165, DOI 10.1016/j.chom.2011.07.007; Minato Y, 2013, INFECT IMMUN, V81, P3163, DOI 10.1128/IAI.00071-13; NASSIF X, 1989, MOL MICROBIOL, V3, P1349, DOI 10.1111/j.1365-2958.1989.tb00116.x; Ordas A, 2011, FISH SHELLFISH IMMUN, V31, P716, DOI 10.1016/j.fsi.2010.08.022; Roberts A, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-3-r22; Sandkvist M, 2001, INFECT IMMUN, V69, P3523, DOI 10.1128/IAI.69.6.3523-3535.2001; Shon AS, 2013, VIRULENCE, V4, P107, DOI 10.4161/viru.22718; Srikumar S, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1005262; Stahl J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0138360; Tangden T, 2015, J INTERN MED, V277, P501, DOI 10.1111/joim.12342; Tiemey L, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00085; Tomas A, 2015, J BIOL CHEM, V290, P16678, DOI 10.1074/jbc.M114.621292; van Dijk EL, 2014, TRENDS GENET, V30, P418, DOI 10.1016/j.tig.2014.07.001; VanderNoot VA, 2012, BIOTECHNIQUES, V53, P373, DOI 10.2144/000113937; Waddell SJ, 2007, CURR OPIN MICROBIOL, V10, P297, DOI 10.1016/j.mib.2007.05.013; Wang Z, 2009, NAT REV GENET, V10, P57, DOI 10.1038/nrg2484; Westermann AJ, 2016, NATURE, V529, P496, DOI 10.1038/nature16547; Westermann AJ, 2012, NAT REV MICROBIOL, V10, P618, DOI 10.1038/nrmicro2852; Wilk E, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1867-8; YANCEY RJ, 1979, INFECT IMMUN, V24, P174, DOI 10.1128/IAI.24.1.174-180.1979	51	3	4	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2016	11	12							e0168788	10.1371/journal.pone.0168788	http://dx.doi.org/10.1371/journal.pone.0168788			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI9TW	28002481	Green Published, Green Submitted, gold			2022-12-27	WOS:000392853100069
J	Efferson, C; Lalive, R; Cacault, MP; Kistler, D				Efferson, Charles; Lalive, Rafael; Cacault, Maria Paula; Kistler, Deborah			The Evolution of Facultative Conformity Based on Similarity	PLOS ONE			English	Article							SOCIAL-LEARNING STRATEGIES; CULTURAL TRANSMISSION; ENVIRONMENTS; COEVOLUTION; OTHERS	Conformist social learning can have a pronounced impact on the cultural evolution of human societies, and it can shape both the genetic and cultural evolution of human social behavior more broadly. Conformist social learning is beneficial when the social learner and the demonstrators from whom she learns are similar in the sense that the same behavior is optimal for both. Otherwise, the social learner's optimum is likely to be rare among demonstrators, and conformity is costly. The trade-off between these two situations has figured prominently in the longstanding debate about the evolution of conformity, but the importance of the trade-off can depend critically on the flexibility of one's social learning strategy. We developed a gene-culture coevolutionary model that allows cognition to encode and process information about the similarity between naive learners and experienced demonstrators. Facultative social learning strategies that condition on perceived similarity evolve under certain circumstances. When this happens, facultative adjustments are often asymmetric. Asymmetric adjustments mean that the tendency to follow the majority when learners perceive demonstrators as similar is stronger than the tendency to follow the minority when learners perceive demonstrators as different. In an associated incentivized experiment, we found that social learners adjusted how they used social information based on perceived similarity, but adjustments were symmetric. The symmetry of adjustments completely eliminated the commonly assumed trade-off between cases in which learners and demonstrators share an optimum versus cases in which they do not. In a second experiment that maximized the potential for social learners to follow their preferred strategies, a few social learners exhibited an inclination to follow the majority. Most, however, did not respond systematically to social information. Additionally, in the complete absence of information about their similarity to demonstrators, social learners were unwilling to make assumptions about whether they shared an optimum with demonstrators. Instead, social learners simply ignored social information even though this was the only information available. Our results suggest that social cognition equips people to use conformity in a discriminating fashion that moderates the evolutionary trade-offs that would occur if conformist social learning was rigidly applied.	[Efferson, Charles] Univ Zurich, Dept Econ, Zurich, Switzerland; [Lalive, Rafael; Cacault, Maria Paula; Kistler, Deborah] Univ Lausanne, Dept Econ, Lausanne, Switzerland	University of Zurich; University of Lausanne	Efferson, C (corresponding author), Univ Zurich, Dept Econ, Zurich, Switzerland.	charles.efferson@econ.uzh.ch		Cacault, Maria Paula/0000-0001-9241-2368; Lalive, Rafael/0000-0003-1938-692X; Efferson, Charles/0000-0001-8244-4497	Swiss National Science Foundation [100014-130127/1]; Swiss National Science Foundation	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	CE would like to acknowledge the generous support of the Swiss National Science Foundation (Grant No. 100014-130127/1, "The Social Dynamics of Normative Behavior"). RL thanks LIVES, a Swiss National Center of Competence in Research under the auspices of the Swiss National Science Foundation. The funding agencies played no role in the design or implementation of the study, the analysis or interpretation of the data, or the writing of the paper.	Aoki K, 2014, THEOR POPUL BIOL, V91, P3, DOI 10.1016/j.tpb.2013.10.004; Aoki K, 2008, THEOR POPUL BIOL, V74, P356, DOI 10.1016/j.tpb.2008.09.006; ASCH SE, 1956, PSYCHOL MONOGR, V70, P1, DOI 10.1037/h0093718; Baillargeon R, 2016, ANNU REV PSYCHOL, V67, P159, DOI 10.1146/annurev-psych-010213-115033; Bell AV, 2009, P NATL ACAD SCI USA, V106, P17671, DOI 10.1073/pnas.0903232106; Bowles S, 2011, COOPERATIVE SPECIES: HUMAN RECIPROCITY AND ITS EVOLUTION, P1; BOYD R, 1995, ETHOL SOCIOBIOL, V16, P125, DOI 10.1016/0162-3095(94)00073-G; BOYD R, 1982, HUM ECOL, V10, P325, DOI 10.1007/BF01531189; Boyd R., 1985, CULTURE EVOLUTIONARY; Boyd R, 2005, ORIGIN EVOLUTION CUL; Boyd R., 1987, CULT ANTHROPOL, V2, P65, DOI [10.1525/can.1987.2.1.02a00070, DOI 10.1525/CAN.1987.2.1.02A00070]; Boyd R, 2011, BEHAV ECOL SOCIOBIOL, V65, P431, DOI 10.1007/s00265-010-1100-3; Cameron C., 2005, MICROECONOMETRICS US, P1056; Cialdini RB, 2004, ANNU REV PSYCHOL, V55, P591, DOI 10.1146/annurev.psych.55.090902.142015; Efferson C, 2008, EVOL HUM BEHAV, V29, P56, DOI 10.1016/j.evolhumbehav.2007.08.003; Eriksson K., 2007, J EVOL PSYCHOL, V5, P67, DOI [10.1556/JEP.2007.1009, DOI 10.1556/JEP.2007.1009]; Eugster B, 2014, DO WORK ATTITUDES MA; Eugster B, 2011, ECON J, V121, pF413, DOI 10.1111/j.1468-0297.2011.02479.x; Fehr E, 2004, TRENDS COGN SCI, V8, P185, DOI 10.1016/j.tics.2004.02.007; Fischbacher U, 2007, EXP ECON, V10, P171, DOI 10.1007/s10683-006-9159-4; Gergely G, 2002, NATURE, V415, P755, DOI 10.1038/415755a; Goeree JK, 2007, REV ECON STUD, V74, P733, DOI 10.1111/j.1467-937X.2007.00438.x; Goeree JK, 2015, J ECON SCI ASSOC-JES, V1, P15, DOI 10.1007/s40881-015-0001-7; Guzman RA, 2007, EVOL HUM BEHAV, V28, P112, DOI 10.1016/j.evolhumbehav.2006.08.002; Henrich J, 2003, EVOL ANTHROPOL, V12, P123, DOI 10.1002/evan.10110; Henrich J, 1998, EVOL HUM BEHAV, V19, P215, DOI 10.1016/S1090-5138(98)00018-X; Henrich J, 2001, AM ANTHROPOL, V103, P992, DOI 10.1525/aa.2001.103.4.992; Henrich J, 2008, CURR ANTHROPOL, V49, P715, DOI 10.1086/587889; Izuma K, 2013, NEURON, V78, P563, DOI 10.1016/j.neuron.2013.03.023; JACOBS RC, 1961, J ABNORM SOC PSYCH, V62, P649, DOI 10.1037/h0044182; Jara-Ettinger J, 2016, TRENDS COGN SCI, V20, P589, DOI 10.1016/j.tics.2016.05.011; Jenness A, 1932, J ABNORM SOC PSYCH, V27, P279, DOI 10.1037/h0074620; Lehmann L, 2008, AM NAT, V172, P12, DOI 10.1086/587851; Lehmann L, 2008, THEOR POPUL BIOL, V73, P506, DOI 10.1016/j.tpb.2008.02.004; MANSKI CF, 1993, REV ECON STUD, V60, P531, DOI 10.2307/2298123; Manski CF, 2000, J ECON PERSPECT, V14, P115, DOI 10.1257/jep.14.3.115; MELTZOFF AN, 1995, DEV PSYCHOL, V31, P838, DOI 10.1037/0012-1649.31.5.838; Meltzoff AN, 2007, ACTA PSYCHOL, V124, P26, DOI 10.1016/j.actpsy.2006.09.005; Mesoudi A., 2011, CULTURAL EVOLUTION D; Mesoudi A, 2016, TRENDS ECOL EVOL, V31, P215, DOI 10.1016/j.tree.2015.12.012; Molleman L, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4570; Molleman L, 2013, EVOL HUM BEHAV, V34, P342, DOI 10.1016/j.evolhumbehav.2013.06.001; Molleman L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068153; Morgan TJH, 2012, FRONT NEUROSCI-SWITZ, V6, DOI 10.3389/fnins.2012.00087; Morgan TJH, 2012, P ROY SOC B-BIOL SCI, V279, P653, DOI 10.1098/rspb.2011.1172; Muthukrishna M, 2016, EVOL HUM BEHAV, V37, P10, DOI 10.1016/j.evolhumbehav.2015.05.004; Nakahashi W, 2007, THEOR POPUL BIOL, V72, P52, DOI 10.1016/j.tpb.2007.03.003; Nakahashi W, 2012, HUM NATURE-INT BIOS, V23, P386, DOI 10.1007/s12110-012-9151-y; Perreault C, 2012, EVOL HUM BEHAV, V33, P449, DOI 10.1016/j.evolhumbehav.2011.12.007; Rendell L, 2010, SCIENCE, V328, P208, DOI 10.1126/science.1184719; Rendell L, 2011, TRENDS COGN SCI, V15, P68, DOI 10.1016/j.tics.2010.12.002; Richerson PJ., 2005, NOT GENES ALONE CULT; Richerson PJ, 2015, BEHAV BRAIN SCI; Sherif M., 1936, PSYCHOL SOCIAL NORMS; Skerry A. E., 2013, NAVIGATING SOCIAL WO, P11, DOI DOI 10.1093/ACPROF:OSO/9780199890712.003.0003; Toelch U, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2013.2864; Toelch U, 2010, EVOL HUM BEHAV, V31, P326, DOI 10.1016/j.evolhumbehav.2010.03.002; Verbeek M., 2008, GUIDE MODERN ECONOME, V3rd ed.; Wakano JY, 2007, THEOR POPUL BIOL, V72, P504, DOI 10.1016/j.tpb.2007.04.003; Whitehead H, 2009, EVOL HUM BEHAV, V30, P261, DOI 10.1016/j.evolhumbehav.2009.02.003	60	8	9	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2016	11	12							e0168551	10.1371/journal.pone.0168551	http://dx.doi.org/10.1371/journal.pone.0168551			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EI9TW	28002461	Green Submitted, Green Published, gold, Green Accepted			2022-12-27	WOS:000392853100053
J	Galgani, JE; Gomez, C; Mizgier, ML; Gutierrez, J; Santos, JL; Olmos, P; Mari, A				Galgani, Jose E.; Gomez, Carmen; Mizgier, Maria L.; Gutierrez, Juan; Santos, Jose L.; Olmos, Pablo; Mari, Andrea			Assessment of the Role of Metabolic Determinants on the Relationship between Insulin Sensitivity and Secretion	PLoS One			English	Article							PANCREATIC BETA-CELLS; SKELETAL-MUSCLE; GLUCOSE-HOMEOSTASIS; DIABETIC-PATIENTS; HEALTHY-SUBJECTS; K+ CHANNELS; HUMANS; INTERLEUKIN-6; RESISTANCE; TOLERANCE	Background Insulin secretion correlates inversely with insulin sensitivity, which may suggest the existence of a crosstalk between peripheral organs and pancreas. Such interaction might be mediated through glucose oxidation that may drive the release of circulating factors with action on insulin secretion. Aim To evaluate the association between whole-body carbohydrate oxidation and circulating factors with insulin secretion to consecutive oral glucose loading in non-diabetic individuals. Methods Carbohydrate oxidation was measured after an overnight fast and for 6 hours after two 3-h apart 75-g oral glucose tolerance tests (OGTT) in 53 participants (24/29 males/females; 34 +/-9 y; 274kg/m(2)). Insulin secretion was estimated by deconvolution of serum C-peptide concentration, beta cell function by mathematical modelling and insulin sensitivity from an OGTT. Circulating lactate, free-fatty acids (FFA) and candidate chemokines were assessed before and after OGTT. The effect of recombinant RANTES (regulated on activation, normal T cell expressed and secreted) and IL8 (interleukin 8) on insulin secretion from isolated mice islets was also measured. Results Carbohydrate oxidation assessed over the 6-h period did not relate with insulin secretion (r = -0.11; p = 0.45) or p cell function indexes. Circulating lactate and FFA showed no association with 6-h insulin secretion. Circulating chemokines concentration increased upon oral glucose stimulation. Insulin secretion associated with plasma IL6 (r = 0.35; p<0.05), RANTES (r = 0.30; p<0.05) and IL8 (r = 0.41; p<0.05) determined at 60 min OGTT. IL8 was independently associated with in vivo insulin secretion; however, it did not affect in vitro insulin secretion. Conclusion Whole-body carbohydrate oxidation appears to have no influence on insulin secretion or putative circulating mediators. IL8 may be a potential factor influencing insulin secretion.	[Galgani, Jose E.; Gomez, Carmen; Mizgier, Maria L.; Gutierrez, Juan; Santos, Jose L.; Olmos, Pablo] Pontificia Univ Catolica Chile, Escuela Med, Dept Nutr Diabet & Metab, Santiago, Chile; [Galgani, Jose E.] Pontificia Univ Catolica Chile, Escuela Med, UDA Ciencias Salud Carrera Nutr & Dietet, Santiago, Chile; [Mari, Andrea] CNR, Ist Neurosci, Padua, Italy	Pontificia Universidad Catolica de Chile; Pontificia Universidad Catolica de Chile; Consiglio Nazionale delle Ricerche (CNR)	Galgani, JE (corresponding author), Pontificia Univ Catolica Chile, Escuela Med, Dept Nutr Diabet & Metab, Santiago, Chile.; Galgani, JE (corresponding author), Pontificia Univ Catolica Chile, Escuela Med, UDA Ciencias Salud Carrera Nutr & Dietet, Santiago, Chile.	jgalgani@uc.cl	Mizgier, Maria/AAU-7804-2021; Santos, Jose Luis/D-1818-2017	Mizgier, Maria Luisa/0000-0002-6396-8823; Santos, Jose Luis/0000-0003-2895-0369	Fondo Nacional de Desarrollo Cientifico y Tecnologico [1130217]; Vicerrectoria Academica Pontificia Universidad de Chile	Fondo Nacional de Desarrollo Cientifico y Tecnologico(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT); Vicerrectoria Academica Pontificia Universidad de Chile	The work was supported by the following: Fondo Nacional de Desarrollo Cientifico y Tecnologico 1130217, http://www.conicyt.cl/fondecyt/ (JEG); Vicerrectoria Academica Pontificia Universidad de Chile, http://investigacion.uc.cl/ (JEG).	Akiyoshi H, 1999, HORM METAB RES, V31, P257, DOI 10.1055/s-2007-978728; Andreozzi F, 2006, DIABETES, V55, P2021, DOI 10.2337/db06-0063; Araujo EP, 2004, J ENDOCRINOL, V181, P25, DOI 10.1677/joe.0.1810025; Aspinwall CA, 1999, J BIOL CHEM, V274, P6360, DOI 10.1074/jbc.274.10.6360; BARON AD, 1988, AM J PHYSIOL, V255, pE769, DOI 10.1152/ajpendo.1988.255.6.E769; Bonuccelli S, 2009, AM J PHYSIOL-ENDOC M, V297, pE532, DOI 10.1152/ajpendo.00127.2009; Bouche C, 2010, P NATL ACAD SCI USA, V107, P4770, DOI 10.1073/pnas.1000002107; Bouzakri K, 2011, DIABETES, V60, P1111, DOI 10.2337/db10-1178; Choi HJ, 2013, DIABETES RES CLIN PR, V99, pE27, DOI 10.1016/j.diabres.2012.01.005; CONSOLI A, 1992, METABOLISM, V41, P176, DOI 10.1016/0026-0495(92)90148-4; Corpeleijn E, 2005, J CLIN ENDOCR METAB, V90, P5819, DOI 10.1210/jc.2005-0668; Eckardt K, 2014, DIABETOLOGIA, V57, P1087, DOI 10.1007/s00125-014-3224-x; El Ouaamari A, 2013, CELL REP, V3, P401, DOI 10.1016/j.celrep.2013.01.007; Ellingsgaard H, 2011, NAT MED, V17, P1481, DOI 10.1038/nm.2513; FERRANNINI E, 1985, DIABETES, V34, P580, DOI 10.2337/diabetes.34.6.580; Franckhauser S, 2008, DIABETOLOGIA, V51, P1306, DOI 10.1007/s00125-008-0998-8; Galgani JE, 2014, METABOLISM, V63, P1426, DOI 10.1016/j.metabol.2014.08.002; Galgani JE, 2013, J CLIN ENDOCR METAB, V98, pE646, DOI 10.1210/jc.2012-3111; Gallucci S, 1998, INT IMMUNOL, V10, P267, DOI 10.1093/intimm/10.3.267; Halperin F, 2012, DIABETES, V61, P301, DOI 10.2337/db11-1067; Handschin C, 2007, J CLIN INVEST, V117, P3463, DOI 10.1172/JCI31785; Hartwig S, 2014, BBA-PROTEINS PROTEOM, V1844, P1011, DOI 10.1016/j.bbapap.2013.08.004; Hirner S, 2008, J MOL BIOL, V379, P666, DOI 10.1016/j.jmb.2008.03.049; IVERSEN J, 1971, DIABETES, V20, P1; JEQUIER E, 1987, ANNU REV NUTR, V7, P187, DOI 10.1146/annurev.nu.07.070187.001155; Khan FA, 2001, DIABETES, V50, P2192, DOI 10.2337/diabetes.50.10.2192; Kim J, 2002, AM J CLIN NUTR, V76, P378, DOI 10.1093/ajcn/76.2.378; Kutlu B, 2009, BMC MED GENOMICS, V2, DOI 10.1186/1755-8794-2-3; Lee YS, 2013, CELL, V153, P413, DOI 10.1016/j.cell.2013.03.001; Liu B, 2013, DIABETOLOGIA, V56, P2467, DOI 10.1007/s00125-013-3022-x; Lopez X, 2011, J CLIN ENDOCR METAB, V96, P3811, DOI 10.1210/jc.2011-0627; LOVEJOY J, 1992, METABOLISM, V41, P22, DOI 10.1016/0026-0495(92)90185-D; Mari A, 2006, HORM METAB RES, V38, P838, DOI 10.1055/s-2006-956505; Mari A, 2002, DIABETES, V51, pS221, DOI 10.2337/diabetes.51.2007.S221; MEATS JE, 1989, J MOL ENDOCRINOL, V3, P121, DOI 10.1677/jme.0.0030121; Mizgier ML, 2014, OBES REV, V15, P587, DOI 10.1111/obr.12166; Modi WS, 1999, MOL BIOL EVOL, V16, P180, DOI 10.1093/oxfordjournals.molbev.a026101; Nappo F, 2002, J AM COLL CARDIOL, V39, P1145, DOI 10.1016/S0735-1097(02)01741-2; Pedersen BK, 2013, COMPR PHYSIOL, V3, P1337, DOI 10.1002/cphy.c120033; Persaud SJ, 2002, FEBS LETT, V510, P225, DOI 10.1016/S0014-5793(01)03268-9; Schadewaldt P, 2013, AM J CLIN NUTR, V97, P763, DOI 10.3945/ajcn.112.035014; Tsigos C, 1997, J CLIN ENDOCR METAB, V82, P4167, DOI 10.1210/jc.82.12.4167; Weyer C, 1999, J CLIN INVEST, V104, P787, DOI 10.1172/JCI7231; Yi P, 2013, CELL, V153, P747, DOI 10.1016/j.cell.2013.04.008	44	9	9	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2016	11	12							e0168352	10.1371/journal.pone.0168352	http://dx.doi.org/10.1371/journal.pone.0168352			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI9TW	28002466	gold, Green Published, Green Submitted			2022-12-27	WOS:000392853100040
J	Jonsson, KI; Hygum, TL; Andersen, KN; Clausen, LKB; Mobjerg, N				Jonsson, K. Ingemar; Hygum, Thomas L.; Andersen, Kasper N.; Clausen, Lykke K. B.; Mobjerg, Nadja			Tolerance to Gamma Radiation in the Marine Heterotardigrade, Echiniscoides sigismundi	PLOS ONE			English	Article							DESICCATION TOLERANCE; IONIZING-RADIATION; TARDIGRADES; CRYPTOBIOSIS; RESISTANCE	Tardigrades belong to the most radiation tolerant animals on Earth, as documented by a number of studies using both low-LET and high-LET ionizing radiation. Previous studies have focused on semi-terrestrial species, which are also very tolerant to desiccation. The predominant view on the reason for the high radiation tolerance among these semi-terrestrial species is that it relies on molecular mechanisms that evolved as adaptations for surviving dehydration. In this study we report the first study on radiation tolerance in a marine tardigrade, Echiniscoides sigismundi. Adult specimens in the hydrated active state were exposed to doses of gamma radiation from 100 to 5000 Gy. The results showed little effect of radiation at 100 and 500 Gy but a clear decline in activity at 1000 Gy and higher. The highest dose survived was 4000 Gy, at which ca. 8% of the tardigrades were active 7 days after irradiation. LD50 in the first 7 days after irradiation was in the range of 1100-1600 Gy. Compared to previous studies on radiation tolerance in semi-terrestrial and limnic tardigrades, Echiniscoides sigismundiseems to have a lower tolerance. However, the species still fits into the category of tardigrades that have high tolerance to both desiccation and radiation, supporting the hypothesis that radiation tolerance is a by-product of adaptive mechanisms to survive desiccation. More studies on radiation tolerance in tardigrade species adapted to permanently wet conditions, both marine and freshwater, are needed to obtain a more comprehensive picture of the patterns of radiation tolerance.	[Jonsson, K. Ingemar] Kristianstad Univ, Sch Educ & Environm, Kristianstad, Sweden; [Hygum, Thomas L.; Andersen, Kasper N.; Clausen, Lykke K. B.; Mobjerg, Nadja] Univ Copenhagen, Dept Biol, Copenhagen, Denmark	Kristianstad University; University of Copenhagen	Jonsson, KI (corresponding author), Kristianstad Univ, Sch Educ & Environm, Kristianstad, Sweden.; Mobjerg, N (corresponding author), Univ Copenhagen, Dept Biol, Copenhagen, Denmark.	ingemar.jonsson@hkr.se; nmobjerg@bio.ku.dk	Møbjerg, Nadja/M-2646-2014; Møbjerg, Nadja/AAT-4788-2021; /D-7669-2015	Møbjerg, Nadja/0000-0002-5845-9047; Møbjerg, Nadja/0000-0002-5845-9047; Keldsted Bogsted Hvidepil, Lykke/0000-0002-6954-3914; Jonsson, K. Ingemar/0000-0002-1732-0372; /0000-0002-3393-0621	Danish Council for Independent Research [DFF - 4090-00145]	Danish Council for Independent Research(Det Frie Forskningsrad (DFF))	The current study was supported by The Danish Council for Independent Research (http.//ufm.dk/en/research-and-innovation/councils-and-commissions/the-danish-council-for-independent-research; grant-ID: DFF - 4090-00145 to NM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altiero T, 2011, J ZOOL SYST EVOL RES, V49, P104, DOI 10.1111/j.1439-0469.2010.00607.x; [Anonymous], 109 NCRP; Baumann H., 1922, Zoologische Jahrbuecher Jena Abteilungen f Systematik, V45, P501; Beltran-Pardo E, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0133658; Beltran-Pardo E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072098; Bolus N E, 2001, J Nucl Med Technol, V29, P67; Clausen LKB, 2014, HELGOLAND MAR RES, V68, P531, DOI 10.1007/s10152-014-0409-0; Clegg JS, 2005, INTEGR COMP BIOL, V45, P715, DOI 10.1093/icb/45.5.715; CROWE JH, 1967, T AM MICROSC SOC, V86, P286, DOI 10.2307/3224595; Dallas LJ, 2012, RADIAT RES, V177, P693, DOI 10.1667/RR2687.1; Gladyshev E, 2008, P NATL ACAD SCI USA, V105, P5139, DOI 10.1073/pnas.0800966105; Hashimoto T, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12808; Heidemann NWT, 2016, ZOOL J LINN SOC-LOND, V178, P912, DOI 10.1111/zoj.12502; Horikawa DD, 2006, INT J RADIAT BIOL, V82, P843, DOI 10.1080/09553000600972956; Horikawa DD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064793; Horikawa DD, 2012, ASTROBIOLOGY, V12, P283, DOI 10.1089/ast.2011.0669; Hygum TL, 2016, ZOOL J LINN SOC-LOND, V178, P907, DOI 10.1111/zoj.12444; IWASAKI T, 1964, J Radiat Res, V5, P69, DOI 10.1269/jrr.5.69; Jonsson I, 2013, J LIMNOL, V72, P73, DOI 10.4081/jlimnol.2013.s1.e9; Jonsson KI, 2008, CURR BIOL, V18, pR729, DOI 10.1016/j.cub.2008.06.048; Jonsson KI, 2005, INT J RADIAT BIOL, V81, P649, DOI 10.1080/09553000500368453; Jonsson KI, 2003, PHYSIOL BIOCHEM ZOOL, V76, P429; Mattimore V, 1996, J BACTERIOL, V178, P633, DOI 10.1128/jb.178.3.633-637.1996; May RM, 1964, B BIOL FR BELG, V98, P18; Mobjerg N, 2011, ACTA PHYSIOL, V202, P409, DOI 10.1111/j.1748-1716.2011.02252.x; Nilsson EJC, 2010, INT J RADIAT BIOL, V86, P420, DOI 10.3109/09553000903568001; Watanabe M, 2006, INT J RADIAT BIOL, V82, P835, DOI 10.1080/09553000600979100; Wright JC, 2001, ZOOL ANZ, V240, P563, DOI 10.1078/0044-5231-00068; WRIGHT JC, 1989, J EXP BIOL, V142, P267; WRIGHT JC, 1992, BIOL REV, V67, P1, DOI 10.1111/j.1469-185X.1992.tb01657.x	30	12	12	1	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2016	11	12							e0168884	10.1371/journal.pone.0168884	http://dx.doi.org/10.1371/journal.pone.0168884			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI9QF	27997621	Green Published, gold, Green Submitted			2022-12-27	WOS:000392842900082
J	Nikulkov, A; Barrett, CB; Mude, AG; Wein, LM				Nikulkov, Alex; Barrett, Christopher B.; Mude, Andrew G.; Wein, Lawrence M.			Assessing the Impact of US Food Assistance Delivery Policies on Child Mortality in Northern Kenya	PLOS ONE			English	Article							UPDATED SYSTEMATIC ANALYSIS; NUTRITIONAL-STATUS; AID	The U.S. is the main country in the world that delivers its food assistance primarily via transoceanic shipments of commodity-based in-kind food. This approach is costlier and less timely than cash-based assistance, which includes cash transfers, food vouchers, and local and regional procurement, where food is bought in or nearby the recipient country. The U.S.'s approach is exacerbated by a requirement that half of its transoceanic food shipments need to be sent on U.S.-flag vessels. We estimate the effect of these U.S. food assistance distribution policies on child mortality in northern Kenya by formulating and optimizing a supply chain model. In our model, monthly orders of transoceanic shipments and cash-based interventions are chosen to minimize child mortality subject to an annual budget constraint and to policy constraints on the allowable proportions of cash-based interventions and non-US-flag shipments. By varying the restrictiveness of these policy constraints, we assess the impact of possible changes in U.S. food aid policies on child mortality. The model includes an existing regression model that uses household survey data and geospatial data to forecast the mean mid-upper-arm circumference Z scores among children in a community, and allows food assistance to increase Z scores, and Z scores to influence mortality rates. We find that cash-based interventions are a much more powerful policy lever than the U.S.-flag vessel requirement: switching to cash-based interventions reduces child mortality from 4.4% to 3.7% (a 16.2% relative reduction) in our model, whereas eliminating the U.S.-flag vessel restriction without increasing the use of cash-based interventions generates a relative reduction in child mortality of only 1.1%. The great majority of the gains achieved by cash-based interventions are due to their reduced cost, not their reduced delivery lead times; i.e., the reduction of shipping expenses allows for more food to be delivered, which reduces child mortality.	[Nikulkov, Alex; Wein, Lawrence M.] Stanford Univ, Grad Sch Business, Stanford, CA 94305 USA; [Barrett, Christopher B.] Cornell Univ, Charles H Dyson Sch Appl Econ & Management, Ithaca, NY USA; [Mude, Andrew G.] Int Livestock Res Inst, Nairobi, Kenya	Stanford University; Cornell University; CGIAR; International Livestock Research Institute (ILRI)	Wein, LM (corresponding author), Stanford Univ, Grad Sch Business, Stanford, CA 94305 USA.	lwein@stanford.edu	Barrett, Christopher B./A-9750-2009	Barrett, Christopher B./0000-0001-9139-2721				Abdulai A, 2005, WORLD DEV, V33, P1689, DOI 10.1016/j.worlddev.2005.04.014; [Anonymous], 2013, STATE FOOD INSECURIT; [Anonymous], CASH BASED RESPONSES; Bageant ER, 2010, APPL ECON PERSPECT P, V32, P624, DOI 10.1093/aepp/ppq024; Barrett CB, 2005, FOOD AID 50 YEARS RE; Bertsekas D. P., 1976, DYNAMIC PROGRAMMING; de Onis M, 2007, J NUTR, V137, P144, DOI 10.1093/jn/137.1.144; FAO & WFP, 2014, STAT FOOD INS WORLD; FISHMAN S, 2004, COMP QUANTIFICATION, V1, pCH2; Garenne M, 2006, J NUTR, V136, P2893, DOI 10.1093/jn/136.11.2893; Isanaka S, 2009, JAMA-J AM MED ASSOC, V301, P277, DOI 10.1001/jama.2008.1018; Lentz EC, 2014, CHOICES, V29, P1; Lentz EC, 2008, WORLD DEV, V36, P1152, DOI 10.1016/j.worlddev.2007.06.018; Lentz EC, 2013, WORLD DEV, V49, P9, DOI 10.1016/j.worlddev.2013.01.017; Liu L, 2012, LANCET, V379, P2151, DOI 10.1016/S0140-6736(12)60560-1; Lozano R, 2011, LANCET, V378, P1139, DOI 10.1016/S0140-6736(11)61337-8; Michelson H, 2012, FOOD SECUR, V4, P455, DOI 10.1007/s12571-012-0177-0; Mude AG, 2009, FOOD POLICY, V34, P329, DOI 10.1016/j.foodpol.2009.05.003; Nunn N, 2014, AM ECON REV, V104, P1630, DOI 10.1257/aer.104.6.1630; Requejo JH, 2015, LANCET, V385, P466, DOI 10.1016/S0140-6736(14)60925-9; Schnepf R, 2014, INT FOOD AID PROGRAM; Schnepf R, 2015, R41072 C RES SERV; Smith G., 2011, NEW TECHNOLOGIES CAS; Srivastava RN, 2011, PEDIAT CONCISE TEXT; Tadesse G, 2009, AM J AGR ECON, V91, P942, DOI 10.1111/j.1467-8276.2009.01324.x; U. S. Government Accountability Office, 2012, GAO12790; U. S. Government Accountability Office, 2014, GAO14277; U. S. Government Accountability Office, 2009, GAO09570; U. S. Government Accountability Office, 2015, GAO15328; U. S. Government Accountability Office, 2007, GAO07560; United States Agency for International Development, 2011, DEL IMPR REC CHANG U; United States Department of Agriculture and United States Agency for International Development, 2014, INT FOOD ASS REP FIS; Upton J, 2012, UNITING FOOD ASSISTA, P75; Violette WJ, 2013, WORLD DEV, V49, P30, DOI 10.1016/j.worlddev.2013.01.019; World Food Programme, 2016, FOOD AID INF SYST; Yang Y, 2013, P NATL ACAD SCI USA, V110, P4545, DOI 10.1073/pnas.1216075110	37	7	7	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2016	11	12							e0168432	10.1371/journal.pone.0168432	http://dx.doi.org/10.1371/journal.pone.0168432			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EI9QF	27997571	Green Published, gold, Green Submitted			2022-12-27	WOS:000392842900044
J	Restivo, V; Costantino, C; Mammina, C; Vitale, F				Restivo, Vincenzo; Costantino, Claudio; Mammina, Caterina; Vitale, Francesco			Influenza like Illness among Medical Residents Anticipates Influenza Diffusion in General Population: Data from a National Survey among Italian Medical Residents	PLOS ONE			English	Article							HEALTH-CARE WORKERS; VACCINATION COVERAGE; NOSOCOMIAL OUTBREAK; TRANSMISSION; ATTITUDES; SEASON; RISK	The aim of this multicentre study was to assess incidence of influenza like illness (ILI) among Italian medical residents (MRs) during 2011-2012 influenza season, to detect variables associated with ILI and to compare estimated ILI incidence among MRs and general population. A cross-sectional survey was carried out throughout an anonymous questionnaire administered to all MRs attending the post-graduate medical schools of 18 Italian Universities. At the same time an analysis of the ILI incidence in the Italian general population was conducted through the Italian Influenza Surveillance Network. Of a total of 2,506 MRs, 1,191 (47.5%) reported at least one ILI episode. A higher proportion of ILls was reported by MRs of Central (25.0% with ILI vs 20.2% without ILI) and Southern Italy (40.2% with ILI vs. 36.4 without ILI) compared to Northern Italy (34.8% with ILI vs. 43.4% without ILI) (p<0.001). Italian MRs had a higher cumulative incidence of ILls (546.7 episodes per 1,000 vs. 75.9 episodes per 1,000) and an earlier peak (January 2012 vs. February 2012), compared to general population due to higher number of contacts in hospital setting. MRs reported a high rate of ILI infection probably in association with their working activities. These data suggest the need to offer an earlier influenza vaccination to HCWs than general population with the aim to both prevent ILI and its transmission to patients.	[Restivo, Vincenzo; Costantino, Claudio; Mammina, Caterina; Vitale, Francesco] Univ Palermo, Dept Sci Hlth Promot & Mother Child Care G DAless, Palermo, Italy	University of Palermo	Restivo, V (corresponding author), Univ Palermo, Dept Sci Hlth Promot & Mother Child Care G DAless, Palermo, Italy.	vincenzo.restivo@unipa.it	Costantino, Claudio/F-4742-2018; Vitale, Francesco/AAC-6013-2022	Costantino, Claudio/0000-0002-3397-7331; Vitale, Francesco/0000-0002-6354-8060				Amodio E, 2014, J HOSP INFECT, V86, P182, DOI 10.1016/j.jhin.2014.01.005; Amodio E, 2014, MED PRIN PRACT, V23, P568, DOI 10.1159/000364780; Amodio E, 2011, VACCINE, V29, P8113, DOI 10.1016/j.vaccine.2011.08.033; [Anonymous], 2012, EUROMEDITERRANEAN BI; Bella A, 2013, INFLUNET SISTEMA SOR; Bishburg E, 2008, INFECT CONT HOSP EP, V29, P89, DOI 10.1086/524322; Bridges CB, 2003, CLIN INFECT DIS, V37, P1094, DOI 10.1086/378292; Centers for Disease Control and Prevention (CDC), 2001, 2009 H1N1 EARLY OUTB; Cooley P, 2010, INFLUENZA OTHER RESP, V4, P61, DOI 10.1111/j.1750-2659.2009.00122.x; Costantino C, 2014, HUM VACC IMMUNOTHER, V10, P1204, DOI 10.4161/hv.28081; Edeghere O, 2015, J HEALTH SERV RES PO, V20, P26, DOI 10.1177/1355819614554243; Elder AG, 1996, BRIT MED J, V313, P1241, DOI 10.1136/bmj.313.7067.1241; European Centre for Disease Prevention and Control, 2010, INFL SURV EUR 2008 0; Fedson DS, 1996, INFECT CONT HOSP EP, V17, P431; Gasparini R, 2013, HUM VACC IMMUNOTHER, V9, P561, DOI 10.4161/hv.23235; Horcajada JP, 2003, EUR RESPIR J, V21, P303, DOI 10.1183/09031936.03.00040503; Kuster SP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026239; Luckhaupt SE, 2014, MMWR-MORBID MORTAL W, V63, P217; Malavaud S, 2001, TRANSPLANTATION, V72, P535, DOI 10.1097/00007890-200108150-00032; Mayoral JM, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-118; May L, 2010, INFLUENZA OTHER RESP, V4, P267, DOI 10.1111/j.1750-2659.2010.00151.x; Mitchell R, 2012, AM J INFECT CONTROL, V40, P611, DOI 10.1016/j.ajic.2012.01.011; Pryluka D, 2013, J INFECT DEV COUNTR, V7, P36, DOI 10.3855/jidc.2368; Vanhems P, 2011, ARCH INTERN MED, V171, P151, DOI 10.1001/archinternmed.2010.500; Viboud C, 2004, BRIT J GEN PRACT, V54, P684; Williams CJ, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-8	26	16	16	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2016	11	12							e0168546	10.1371/journal.pone.0168546	http://dx.doi.org/10.1371/journal.pone.0168546			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI9QF	27997602	Green Submitted, Green Published, gold			2022-12-27	WOS:000392842900057
J	Myburgh, E; Ritchie, R; Goundry, A; O'Neill, K; Marchesi, F; Devaney, E				Myburgh, Elmarie; Ritchie, Ryan; Goundry, Amy; O'Neill, Kerry; Marchesi, Francesco; Devaney, Eileen			Attempts to Image the Early Inflammatory Response during Infection with the Lymphatic Filarial Nematode Brugia pahangi in a Mouse Model	PLOS ONE			English	Article							IN-VIVO; 3RD-STAGE LARVA; RESISTANCE; MALAYI; L3; EOSINOPHILS; MODULATION; MECHANISMS; PARASITES; PROTEINS	Helminth parasites remain a major constraint upon human health and well-being in many parts of the world. Treatment of these infections relies upon a very small number of therapeutics, most of which were originally developed for use in animal health. A lack of high throughput screening systems, together with limitations of available animal models, has restricted the development of novel chemotherapeutics. This is particularly so for filarial nematodes, which are long-lived parasites with a complex cycle of development. In this paper, we describe attempts to visualise the immune response elicited by filarial parasites in infected mice using a non-invasive bioluminescence imaging reagent, luminol, our aim being to determine whether such a model could be developed to discriminate between live and dead worms for in vivo compound screening. We show that while imaging can detect the immune response elicited by early stages of infection with L3, it was unable to detect the presence of adult worms or, indeed, later stages of infection with L3, despite the presence of worms within the lymphatic system of infected animals. In the future, more specific reagents that detect secreted products of adult worms may be required for developing screens based upon live imaging of infected animals.	[Myburgh, Elmarie; Ritchie, Ryan; Goundry, Amy] Univ Glasgow, Coll Med Vet & Life Sci, Wellcome Trust Ctr Mol Parasitol, Inst Infect Immun & Inflammat, Glasgow, Lanark, Scotland; [O'Neill, Kerry; Devaney, Eileen] Univ Glasgow, Inst Biodivers Anim Hlth & Comparat Med, Garscube Estate, Glasgow, Lanark, Scotland; [Marchesi, Francesco] Univ Glasgow, Sch Vet Med, Garscube Estate, Glasgow, Lanark, Scotland; [Myburgh, Elmarie; Goundry, Amy] Univ York, Ctr Immunol & Infect, Dept Biol, Heslington, Yorks, England	University of Glasgow; University of Glasgow; University of Glasgow; University of York - UK	Myburgh, E (corresponding author), Univ Glasgow, Coll Med Vet & Life Sci, Wellcome Trust Ctr Mol Parasitol, Inst Infect Immun & Inflammat, Glasgow, Lanark, Scotland.; Devaney, E (corresponding author), Univ Glasgow, Inst Biodivers Anim Hlth & Comparat Med, Garscube Estate, Glasgow, Lanark, Scotland.; Marchesi, F (corresponding author), Univ Glasgow, Sch Vet Med, Garscube Estate, Glasgow, Lanark, Scotland.	Elmarie.myburgh@york.ac.uk; Francesco.marchesi@glasgow.ac.uk; eileen.devaney@glasgow.ac.uk	Marchesi, Francesco/ABF-9255-2021	Marchesi, Francesco/0000-0003-1179-5788; Myburgh, Elmarie/0000-0002-2007-5902; Goundry, Amy/0000-0003-3406-4689	Bill and Melinda Gates Foundation [OPP1098441]; MRC [MW K019384]; Wellcome Trust [104111]; MRC [MR/K019384/2, MR/K019384/1] Funding Source: UKRI; Medical Research Council [MR/K019384/1, MR/K019384/2] Funding Source: researchfish; Bill & Melinda Gates Foundation � Grand Challenges Explorations Initiative [OPP1098441] Funding Source: researchfish	Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome TrustEuropean Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); Bill & Melinda Gates Foundation � Grand Challenges Explorations Initiative	This study was supported by a grant to EM and ED from the Bill and Melinda Gates Foundation (ref: OPP1098441). EM and AG were supported by a grant from the MRC (ref: MW K019384) and core funding from the Wellcome Trust (104111). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bennuru S, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000410; Blum G, 2007, NAT CHEM BIOL, V3, P668, DOI 10.1038/nchembio.2007.26; Boyd A, 2013, INFECT IMMUN, V81, P1420, DOI 10.1128/IAI.01301-12; Chirgwin SR, 2006, J PARASITOL, V92, P46, DOI 10.1645/GE-599R.1; Davies SJ, 2005, INT J PARASITOL, V35, P851, DOI 10.1016/j.ijpara.2005.02.017; Devaney E, 2000, MICROBES INFECT, V2, P1363, DOI 10.1016/S1286-4579(00)01290-9; Devaney E, 2002, PARASITE IMMUNOL, V24, P29, DOI 10.1046/j.0141-9838.2001.00433.x; Geary TG, 2010, INT J PARASITOL, V40, P1, DOI 10.1016/j.ijpara.2009.11.001; Gillan V, 2004, PARASITE IMMUNOL, V26, P359, DOI 10.1111/j.0141-9838.2004.00714.x; Gross S, 2009, NAT MED, V15, P455, DOI 10.1038/nm.1886; Haller J, 2008, J APPL PHYSIOL, V104, P795, DOI 10.1152/japplphysiol.00959.2007; Hansen RDE, 2011, P ROY SOC B-BIOL SCI, V278, P2293, DOI 10.1098/rspb.2010.2367; Hewitson JR, 2008, MOL BIOCHEM PARASIT, V160, P8, DOI 10.1016/j.molbiopara.2008.02.007; Higazi Tarig B, 2013, Methods Mol Biol, V940, P103, DOI 10.1007/978-1-62703-110-3_9; Horn D, 2014, PARASITOLOGY, V141, P77, DOI 10.1017/S0031182013000243; Hotez PJ, 2008, J CLIN INVEST, V118, P1311, DOI 10.1172/JCI34261; HOWELLS RE, 1983, ACTA TROP, V40, P341; JECOCK RM, 1992, MOL BIOCHEM PARASIT, V56, P219, DOI 10.1016/0166-6851(92)90171-F; Lewis MD, 2015, J BIOMOL SCREEN, V20, P36, DOI 10.1177/1087057114552623; Linares M, 2015, MALARIA J, V14, DOI 10.1186/s12936-015-0962-2; MacDonald AS, 1998, J IMMUNOL, V160, P4124; Mann VH, 2014, TRANSGENIC RES, V23, P539, DOI 10.1007/s11248-013-9779-3; Mann VH, 2010, PARASITOLOGY, V137, P451, DOI 10.1017/S0031182009991211; Marcellino C, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001494; Martin C, 2000, INFECT IMMUN, V68, P3651, DOI 10.1128/IAI.68.6.3651-3656.2000; McSorley HJ, 2013, INT J PARASITOL, V43, P301, DOI 10.1016/j.ijpara.2012.11.011; Meyerholz DK, 2009, TOXICOL PATHOL, V37, P249, DOI 10.1177/0192623308329342; Myburgh E, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002384; Oliveira SHP, 2002, J LEUKOCYTE BIOL, V71, P1019; Osborne J, 1998, INT IMMUNOL, V10, P1583, DOI 10.1093/intimm/10.10.1583; Osborne J, 1996, INFECT IMMUN, V64, P3461, DOI 10.1128/IAI.64.9.3461-3466.1996; Porthouse KH, 2006, INFECT IMMUN, V74, P2366, DOI 10.1128/IAI.74.4.2366-2372.2006; Prichard RK, 2007, PARASITOLOGY, V134, P1123, DOI 10.1017/S0031182007000091; Prichard RK, 2007, PARASITOLOGY, V134, P1073, DOI 10.1017/S0031182007000078; Scales HE, 2016, RHEUMATOLOGY, V55, P564, DOI 10.1093/rheumatology/kev361; Shao HG, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002871; Simons JE, 2005, EUR J IMMUNOL, V35, P189, DOI 10.1002/eji.200425541; Specht S, 2011, J IMMUNOL, V186, P4845, DOI 10.4049/jimmunol.1000612; Storey B, 2014, INT J PARASITOL-DRUG, V4, P233, DOI 10.1016/j.ijpddr.2014.08.003; Tseng JC, 2012, CHEM BIOL, V19, P1199, DOI 10.1016/j.chembiol.2012.08.007	40	3	3	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2016	11	12							e0168602	10.1371/journal.pone.0168602	http://dx.doi.org/10.1371/journal.pone.0168602			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI8LN	27992545	Green Accepted, gold, Green Published			2022-12-27	WOS:000392758000065
J	Domert, J; Sackmann, C; Severinsson, E; Agholme, L; Bergstrom, J; Ingelsson, M; Hallbeck, M				Domert, Jakob; Sackmann, Christopher; Severinsson, Emelie; Agholme, Lotta; Bergstrom, Joakim; Ingelsson, Martin; Hallbeck, Martin			Aggregated Alpha-Synuclein Transfer Efficiently between Cultured Human Neuron-Like Cells and Localize to Lysosomes	PLOS ONE			English	Article							AMYLOID-BETA PEPTIDE; PARKINSONS-DISEASE; CEREBROSPINAL-FLUID; IN-VIVO; PATHOLOGY; OLIGOMERS; MITOCHONDRIA; TRANSMISSION; AUTOPHAGY; PATHWAY	Parkinson's disease and other alpha-synucleinopathies are progressive neurodegenerative diseases characterized by aggregates of misfolded alpha-synuclein spreading throughout the brain. Recent evidence suggests that the pathological progression is likely due to neuron-to-neuron transfer of these aggregates between neuroanatomically connected areas of the brain. As the impact of this pathological spreading mechanism is currently debated, we aimed to investigate the transfer and subcellular location of alpha-synuclein species in a novel 3D co-culture human cell model based on highly differentiated SH-SY5Y cells. Fluorescently-labeled monomeric, oligomeric and fibrillar species of alpha-synuclein were introduced into a donor cell population and co-cultured with an EGFP-expressing acceptor-cell population of differentiated neuron-like cells. Subsequent transfer and colocalization of the different species were determined with confocal microscopy. We could confirm cell-to-cell transfer of all three alpha-synuclein species investigated. Interestingly the level of transferred oligomers and fibrils and oligomers were significantly higher than monomers, which could affect the probability of seeding and pathology in the recipient cells. Most alpha-synuclein colocalized with the lysosomal/endosomal system, both pre- and postsynaptically, suggesting its importance in the processing and spreading of alpha-synuclein.	[Domert, Jakob; Sackmann, Christopher; Severinsson, Emelie; Agholme, Lotta; Hallbeck, Martin] Linkoping Univ, Dept Clin Pathol, Linkoping, Sweden; [Domert, Jakob; Sackmann, Christopher; Severinsson, Emelie; Agholme, Lotta; Hallbeck, Martin] Linkoping Univ, Dept Clin & Expt Med, Linkoping, Sweden; [Bergstrom, Joakim; Ingelsson, Martin] Uppsala Univ, Rudbeck Lab, Dept Publ Hlth Geriatr, Uppsala, Sweden; [Agholme, Lotta] Univ Gothenburg, Sahlgrenska Acad, Inst Neurosci & Physiol, Gothenburg, Sweden	Linkoping University; Linkoping University; Uppsala University; University of Gothenburg	Hallbeck, M (corresponding author), Linkoping Univ, Dept Clin Pathol, Linkoping, Sweden.; Hallbeck, M (corresponding author), Linkoping Univ, Dept Clin & Expt Med, Linkoping, Sweden.	Martin.Hallbeck@liu.se		Agholme, Lotta/0000-0003-3816-7474; Hallbeck, Martin/0000-0001-6716-0314; Sackmann, Christopher/0000-0002-1273-6731	Swedish Research Council [MH: 523-2013-2735]; Swedish Brain Power Program; Research Foundation of the Swedish Parkinson's Disease Association; Ostergotland Research Foundation for Parkinson's Disease; Parkinson Research Foundation; Hans-Gabriel and Alice Trolle-Wachtmeister Foundation for Medical Research; Gustav V and Queen Victoria's Foundation; Swedish Dementia Foundation; Linkoping University Neurobiology Centre; County Council of Ostergotland; Marianne and Marcus Wallenberg Foundation	Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Brain Power Program; Research Foundation of the Swedish Parkinson's Disease Association; Ostergotland Research Foundation for Parkinson's Disease; Parkinson Research Foundation; Hans-Gabriel and Alice Trolle-Wachtmeister Foundation for Medical Research; Gustav V and Queen Victoria's Foundation; Swedish Dementia Foundation; Linkoping University Neurobiology Centre; County Council of Ostergotland; Marianne and Marcus Wallenberg Foundation	This research was made possible by funding from the Swedish Research Council (MH: 523-2013-2735), The Swedish Brain Power Program, The Research Foundation of the Swedish Parkinson's Disease Association, Ostergotland Research Foundation for Parkinson's Disease, Parkinson Research Foundation, the Hans-Gabriel and Alice Trolle-Wachtmeister Foundation for Medical Research, Gustav V and Queen Victoria's Foundation, Swedish Dementia Foundation, the Linkoping University Neurobiology Centre and the County Council of Ostergotland, Marianne and Marcus Wallenberg Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agholme L, 2014, MOL CELL NEUROSCI, V58, P29, DOI 10.1016/j.mcn.2013.11.001; Agholme L, 2012, J ALZHEIMERS DIS, V31, P343, DOI 10.3233/JAD-2012-120001; Agholme L, 2010, J ALZHEIMERS DIS, V20, P1069, DOI 10.3233/JAD-2010-091363; Alafuzoff I, 2009, ACTA NEUROPATHOL, V117, P635, DOI 10.1007/s00401-009-0523-2; Blanz J., 2016, J NEUROCHEM; Boassa D, 2013, J NEUROSCI, V33, P2605, DOI 10.1523/JNEUROSCI.2898-12.2013; Braak H, 1995, J NEURAL TRANSM-SUPP, P15; Braak H, 2003, NEUROBIOL AGING, V24, P197, DOI 10.1016/S0197-4580(02)00065-9; Chiasserini D, 2014, J PROTEOMICS, V106, P191, DOI 10.1016/j.jprot.2014.04.028; Choi BK, 2013, P NATL ACAD SCI USA, V110, P4087, DOI 10.1073/pnas.1218424110; Colla E, 2012, J NEUROSCI, V32, P3301, DOI 10.1523/JNEUROSCI.5368-11.2012; Danzer KM, 2007, J NEUROSCI, V27, P9220, DOI 10.1523/JNEUROSCI.2617-07.2007; Danzer KM, 2012, MOL NEURODEGENER, V7, DOI 10.1186/1750-1326-7-42; Danzer KM, 2009, J NEUROCHEM, V111, P192, DOI 10.1111/j.1471-4159.2009.06324.x; DeWitt DC, 2013, BIOCHEMISTRY-US, V52, P2385, DOI 10.1021/bi4002369; Dhungel N, 2015, NEURON, V85, P76, DOI 10.1016/j.neuron.2014.11.027; Dimant Hemi, 2013, Acta Neuropathol Commun, V1, P6, DOI 10.1186/2051-5960-1-6; Domert J, 2014, NEUROBIOL DIS; Gan-Or Z, 2015, AUTOPHAGY, V11, P1443, DOI 10.1080/15548627.2015.1067364; Guardia-Laguarta C, 2014, J NEUROSCI, V34, P249, DOI 10.1523/JNEUROSCI.2507-13.2014; Holmqvist S, 2014, ACTA NEUROPATHOL, V128, P805, DOI 10.1007/s00401-014-1343-6; Hu XY, 2009, P NATL ACAD SCI USA, V106, P20324, DOI 10.1073/pnas.0911281106; Kahle PJ, 2000, J NEUROSCI, V20, P6365, DOI 10.1523/JNEUROSCI.20-17-06365.2000; Kordower JH, 2008, NAT MED, V14, P504, DOI 10.1038/nm1747; Lebouvier T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012728; Lee HJ, 2013, EXP MOL MED, V45, DOI 10.1038/emm.2013.45; Lee HJ, 2004, J NEUROSCI, V24, P1888, DOI 10.1523/JNEUROSCI.3809-03.2004; Li JY, 2008, NAT MED, V14, P501, DOI 10.1038/nm1746; Li WW, 2007, NEUROREPORT, V18, P1543, DOI 10.1097/WNR.0b013e3282f03db4; Lindersson E, 2004, J BIOL CHEM, V279, P12924, DOI 10.1074/jbc.M306390200; Lindstrom V, 2014, IMMUNOTHERAPY-UK, V6, P141, DOI [10.2217/imt.13.162, 10.2217/IMT.13.162]; Luk KC, 2012, SCIENCE, V338, P949, DOI 10.1126/science.1227157; Luk KC, 2009, P NATL ACAD SCI USA, V106, P20051, DOI 10.1073/pnas.0908005106; Luth ES, 2014, J BIOL CHEM, V289, P21490, DOI 10.1074/jbc.M113.545749; Miake H, 2002, J BIOL CHEM, V277, P19213, DOI 10.1074/jbc.M110551200; Miners JS, 2014, ACTA NEUROPATHOL COM, V2, DOI 10.1186/s40478-014-0164-0; Mougenot AL, 2012, NEUROBIOL AGING, V33, P2225, DOI 10.1016/j.neurobiolaging.2011.06.022; Nasstrom T, 2011, FREE RADICAL BIO MED, V50, P428, DOI 10.1016/j.freeradbiomed.2010.11.027; Nath S, 2012, J NEUROSCI, V32, P8767, DOI 10.1523/JNEUROSCI.0615-12.2012; Perrett RM, 2015, MOL CELL NEUROSCI, V66, P21, DOI 10.1016/j.mcn.2015.02.009; Poehler AM, 2014, AUTOPHAGY, V10, P2171, DOI 10.4161/auto.36436; Raiss CC, 2016, SCI REP-UK, V6, DOI 10.1038/srep23116; Ravi M, 2015, J CELL PHYSIOL, V230, P16, DOI 10.1002/jcp.24683; Saido T, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a006379; Saman S, 2012, J BIOL CHEM, V287, P3842, DOI 10.1074/jbc.M111.277061; Small SA, 2015, NAT REV NEUROSCI, V16, P126, DOI 10.1038/nrn3896; Tanaka Y, 2001, HUM MOL GENET, V10, P919, DOI 10.1093/hmg/10.9.919; Tanik SA, 2013, J BIOL CHEM, V288, P15194, DOI 10.1074/jbc.M113.457408; Volpicelli-Daley LA, 2011, NEURON, V72, P57, DOI 10.1016/j.neuron.2011.08.033; Winner B, 2011, P NATL ACAD SCI USA, V108, P4194, DOI 10.1073/pnas.1100976108; Zheng L, 2013, J ALZHEIMERS DIS, V37, P713, DOI 10.3233/JAD-122455	51	38	38	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2016	11	12							e0168700	10.1371/journal.pone.0168700	http://dx.doi.org/10.1371/journal.pone.0168700			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EG7JB	28030591	Green Published, gold, Green Submitted			2022-12-27	WOS:000391222000063
J	Bustamante, AE; Jaime-Perez, JC; Cordero-Perez, P; Galindo-Rodriguez, G; Munoz-Espinosa, LE; Villarreal-Villarreal, CD; Mercado-Longoria, R				Ester Bustamante, Adriana; Carlos Jaime-Perez, Jose; Cordero-Perez, Paula; Galindo-Rodriguez, Gabriela; Elsa Munoz-Espinosa, Linda; Daniel Villarreal-Villarreal, Cesar; Mercado-Longoria, Roberto			A High Level of Soluble CD40L Is Associated with P. aeruginosa Infection in Patients with Cystic Fibrosis	PLOS ONE			English	Article							MUCOID PSEUDOMONAS-AERUGINOSA; LUNG-DISEASE; SCORING SYSTEM; LIGAND LEVELS; CHILDREN; ACIDIFICATION; INFLAMMATION; MACROPHAGES; PROGRESSION; DIAGNOSIS	Objective The aim of this study was to evaluate whether the concentration of sCD40L, a product of platelet activation, correlates with the presence of Pseudomonas aeruginosa in the airway of patients with cystic fibrosis (CF) and to determine its possible clinical association. Methods Sixty patients with CF, ranging in age from 2 months to 36 years, were studied. The demographics, cystic fibrosis transmembrane conductance regulator (CFTR) genotype, spirometry measurements, radiographic and tomographic scans, platelet count in peripheral blood, sCD40L, IL-6, TNF-alpha and ICAM1 data were collected. Infection-colonization of the airway was evaluated using sputum and throat swab cultures; the levels of anti-Pseudomonas aeruginosa antibodies (Anti-PaAb) were evaluated. Results Patients with CF and chronic colonization had anti-PaAb values of 11.6 +/- 2.1 ELISA units (EU) and sCD40L in plasma of 1530.9 +/- 1162.3 pg/mL; those with intermittent infection had 5.7 +/- 2.7 EU and 2243.6 +/- 1475.9 pg/mL; and those who were never infected had 3.46 +/- 1.8 EU (p <= 0.001) and 1008.1 +/- 746.8 pg/ mL (p <= 0.01), respectively. The cutoff value of sCD40L of 1255 pg/ mL was associated with an area under the ROC (receiver operating characteristic curve) of 0.84 (95% CI, 0.71 to 0.97), reflecting P. aeruginosa infection with a sensitivity of 73% and a specificity of 89%. Lung damage was determined using the Brasfield Score, the Bhalla Score, and spirometry (FVC%, FEV1%) and found to be significantly different among the groups (p <= 0.001). Conclusion Circulating sCD40L levels are increased in patients with cystic fibrosis and P. aeruginosa infection. Soluble CD40L appears to reflect infection and provides a tool for monitoring the evolution of lung deterioration.	[Ester Bustamante, Adriana; Mercado-Longoria, Roberto] Univ Autonoma Nuevo Leon, Clin Fibrosis Quist, Hosp Univ Dr Jose E Gonzalez, Serv Neumol,Fac Med, Monterrey Nuevo Leon, Mexico; [Carlos Jaime-Perez, Jose; Daniel Villarreal-Villarreal, Cesar] Univ Autonoma Nuevo Leon, Dept Hematol, Hosp Univ Dr Jose E Gonzalez, Fac Med, Monterrey Nuevo Leon, Mexico; [Cordero-Perez, Paula; Elsa Munoz-Espinosa, Linda] Univ Autonoma Nuevo Leon, Unidad Higado, Hosp Univ Dr Jose E Gonzalez, Fac Med, Monterrey Nuevo Leon, Mexico; [Galindo-Rodriguez, Gabriela] Univ Autonoma Nuevo Leon, Serv Alergia & Inmunol, Hosp Univ Dr Jose E Gonzalez, Fac Med, Monterrey Nuevo Leon, Mexico	Universidad Autonoma de Nuevo Leon; University Hospital Autonomous University of Nuevo Leon; Universidad Autonoma de Nuevo Leon; University Hospital Autonomous University of Nuevo Leon; Universidad Autonoma de Nuevo Leon; University Hospital Autonomous University of Nuevo Leon; Universidad Autonoma de Nuevo Leon; University Hospital Autonomous University of Nuevo Leon	Bustamante, AE (corresponding author), Univ Autonoma Nuevo Leon, Clin Fibrosis Quist, Hosp Univ Dr Jose E Gonzalez, Serv Neumol,Fac Med, Monterrey Nuevo Leon, Mexico.	abustamante@ceprep.edu.mx	Cordero, Paula/AAF-6961-2020; Bustamante, Adriana Ester/AAR-2816-2021	Bustamante, Adriana Ester/0000-0002-8245-6671; Munoz, Linda/0000-0002-0455-9325; Villarreal-Villarreal, Cesar D/0000-0003-2432-2517; Cordero-Perez, Paula/0000-0001-7747-8895				BHALLA M, 1991, RADIOLOGY, V179, P783, DOI 10.1148/radiology.179.3.2027992; Blumberg N, 2009, IMMUNOL RES, V45, P251, DOI 10.1007/s12026-009-8106-9; Boucher RC, 2007, ANNU REV MED, V58, P157, DOI 10.1146/annurev.med.58.071905.105316; BRASFIELD D, 1979, PEDIATRICS, V63, P24; Brodlie M, 2012, AM J RESP CRIT CARE, V185, P108, DOI 10.1164/ajrccm.185.1.108a; Brodlie M, 2011, AM J RESP CRIT CARE, V183, P133, DOI 10.1164/ajrccm.183.1.133; Brodlie M, 2010, AM J RESP CRIT CARE, V182, P369, DOI 10.1164/rccm.200905-0799OC; Cohen-Cymberknoh M, 2013, THORAX, V68, P1157, DOI 10.1136/thoraxjnl-2013-203204; COUTINHO IR, 1988, THROMB RES, V51, P495, DOI 10.1016/0049-3848(88)90115-6; Cystic Fibrosis Foundation, 2013, CYST FIBR FDN REG AN; Cystic Fibrosis Foundation, 2016, CLIN FUNCT TRASL CFT; da Silva LVF, 2007, PEDIATR PULM, V42, P938, DOI 10.1002/ppul.20686; Di A, 2006, NAT CELL BIOL, V8, P933, DOI 10.1038/ncb1456; Douglas TA, 2009, EUR RESPIR J, V33, P305, DOI 10.1183/09031936.00043108; Falco A, 2004, J THROMB HAEMOST, V2, P557, DOI 10.1111/j.1538-7836.2004.00683.x; Farrell PM, 2009, RADIOLOGY, V252, P534, DOI 10.1148/radiol.2522081882; Freedman SD, 2004, NEW ENGL J MED, V350, P560, DOI 10.1056/NEJMoa021218; Gibson RL, 2003, AM J RESP CRIT CARE, V168, P918, DOI 10.1164/rccm.200304-505SO; Goldman MJ, 1997, CELL, V88, P553, DOI 10.1016/S0092-8674(00)81895-4; Heijerman Harry, 2005, J Cyst Fibros, V4 Suppl 2, P3, DOI 10.1016/j.jcf.2005.05.005; HENRY RL, 1992, PEDIATR PULM, V12, P158, DOI 10.1002/ppul.1950120306; Hur YG, 2015, J INFECTION, V70, P346, DOI 10.1016/j.jinf.2014.10.019; Husson MO, 2005, J ANTIMICROB CHEMOTH, V56, P247, DOI 10.1093/jac/dki179; Koch C, 2002, PEDIATR PULM, V34, P232, DOI 10.1002/ppul.10135; KONIG B, 1994, INT ARCH ALLERGY IMM, V104, P33, DOI 10.1159/000236706; Kushwah R, 2013, RESP RES, V14, DOI 10.1186/1465-9921-14-138; Lai ED, 2007, PHYSIOLOGY, V22, P193, DOI 10.1152/physiol.00050.2006; Lamothe J, 2008, MICROBIOL-SGM, V154, P3825, DOI 10.1099/mic.0.2008/023200-0; Lee Tim W R, 2003, J Cyst Fibros, V2, P29, DOI 10.1016/S1569-1993(02)00141-8; Li ZH, 2005, JAMA-J AM MED ASSOC, V293, P581, DOI 10.1001/jama.293.5.581; Lorente L, 2011, CRIT CARE, V15, DOI 10.1186/cc10104; Mauch RM, 2014, J CYST FIBROS, V13, P499, DOI 10.1016/j.jcf.2014.01.005; Metwalley Kotb Abbass, 2013, Indian J Endocrinol Metab, V17, P1024, DOI 10.4103/2230-8210.122617; Miller MR, 2005, EUR RESPIR J, V26, P319, DOI 10.1183/09031936.05.00034805; O'Sullivan BP, 2005, BLOOD, V105, P4635, DOI 10.1182/blood-2004-06-2098; Pezzulo AA, 2012, NATURE, V487, P109, DOI 10.1038/nature11130; Pittman JE, 2011, PEDIATR PULM, V46, P497, DOI 10.1002/ppul.21397; Regamey N, 2012, THORAX, V67, P170, DOI 10.1136/thoraxjnl-2011-200585; ROUM JH, 1993, J APPL PHYSIOL, V75, P2419, DOI 10.1152/jappl.1993.75.6.2419; Segal E, 2004, BUENOS AIRES EDICION, P5; Subauste CS, 2009, SEMIN IMMUNOL, V21, P273, DOI 10.1016/j.smim.2009.06.003; The Hospital for Sick Children, 2011, CYSTIC FIBROSIS MUTA; Tirouvanziam R, 2002, AM J PHYSIOL-LUNG C, V283, pL445, DOI 10.1152/ajplung.00419.2001	43	3	3	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2016	11	12							e0168819	10.1371/journal.pone.0168819	http://dx.doi.org/10.1371/journal.pone.0168819			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EG7JB	28030642	Green Submitted, Green Published, gold			2022-12-27	WOS:000391222000079
J	Feng, XB; Pan, WY; Liu, L; Wu, M; Ding, FW; Hu, HX; Ding, X; Wei, H; Zou, YH; Qian, X; Wang, MM; Wu, J; Tao, J; Tan, J; Da, ZY; Zhang, MJ; Li, J; Sun, LY				Feng, Xuebing; Pan, Wenyou; Liu, Lin; Wu, Min; Ding, Fuwan; Hu, Huaixia; Ding, Xiang; Wei, Hua; Zou, Yaohong; Qian, Xian; Wang, Meimei; Wu, Jian; Tao, Juan; Tan, Jun; Da, Zhanyun; Zhang, Miaojia; Li, Jing; Sun, Lingyun		Jiangsu Lupus Collaborative Grp	Prognosis for Hospitalized Patients with Systemic Lupus Erythematosus in China: 5-Year Update of the Jiangsu Cohort	PLOS ONE			English	Article							REVISED CRITERIA; DISEASE-ACTIVITY; MORTALITY; NEPHRITIS; CLASSIFICATION; PREDICTORS; SURVIVAL; FEATURES; DAMAGE; INDEX	Objective To identify early signs associated with poor prognosis in Chinese patients with systemic lupus erythematosus (SLE) through a large population-based follow-up study. Methods Medical records of > 2,500 SLE patients that first hospitalized between 1999-2009 were collected from 26 centers across Jiangsu province, China, and entered into a database. These patients were followed-up for 5 to 15 years, and those remained contact and had known survival status in 2015 were assessed for the association of factors presented at the initial hospitalization with mortality at two time points (<= 1year and >1year). The independency of mortality factors was evaluated using multivariate Cox regression analysis. Results Among 1,372 patients we assessed, 92.3% were women and 17.2% were deceased in 2015. The main causes of death were infection (30.1%), neuropsychiatric impairment (14.8%), renal failure (14.4%) and cardiopulmonary involvement (8.5%). Hazard ratios (HR) of independent predictors for mortality (<= 1year and >1year, respectively) included hospital presentation of neuropsychiatric involvement (2.03 and 1.91), cardiopulmonary involvement (1.94 and 1.61) and increased serum creatinine (2.52 and 2.58). Patients older than 45 years and with disease durations more than 2 years at admission had unfavorable short-term outcome (HR 1.76 and 1.79), while the presence of anti-dsDNA and anti-Sm antibodies indicated diverse prognosis after 1 year (HR 1.60 and 0.45). Treatment with cyclophosphamide was beneficial for patient's first-year outcome (HR 0.50), and anti-malarial drugs significantly reduced the risk of mortality over different time points (HR 0.48 and 0.54). SLEDAI score, proteinuria or hypocomplementemia was not independently associated with the outcome in this cohort. Conclusion SLE patients presented with vital organ damages rather than active disease at initial hospitalization are likely to have a poor outcome, especially for those with neuropsychiatric, cardiopulmonary involvements and renal insufficiency. Early and effective intervention with the use of anti-malarial drugs may decrease mortality.	[Feng, Xuebing; Sun, Lingyun] Nanjing Univ Med Sch, Dept Rheumatol & Immunol, Affiliated Drum Tower Hosp, Nanjing, Jiangsu, Peoples R China; [Pan, Wenyou] Huaian First Peoples Hosp, Dept Rheumatol, Huaian, Peoples R China; [Liu, Lin] Xuzhou Cent Hosp, Dept Rheumatol, Xuzhou, Peoples R China; [Wu, Min] Soochow Univ, Dept Rheumatol, Affiliated Hosp 3, Changzhou, Peoples R China; [Ding, Fuwan] Yancheng Third Peoples Hosp, Dept Endocrinol, Yancheng, Peoples R China; [Hu, Huaixia] Lianyungang Second Peoples Hosp, Dept Rheumatol, Lianyungang, Peoples R China; [Ding, Xiang] Lianyungang First Peoples Hosp, Dept Rheumatol, Lianyungang, Peoples R China; [Wei, Hua] Northern Jiangsu Peoples Hosp, Dept Rheumatol, Yangzhou, Jiangsu, Peoples R China; [Zou, Yaohong] Wuxi Peoples Hosp, Dept Rheumatol, Wuxi, Peoples R China; [Qian, Xian] TCM, Dept Rheumatol, Jiangsu Prov Hosp, Nanjing, Jiangsu, Peoples R China; [Wang, Meimei] Southeast Univ, Zhongda Hosp, Dept Rheumatol, Nanjing, Jiangsu, Peoples R China; [Wu, Jian] Soochow Univ, Dept Rheumatol, Affiliated Hosp 1, Suzhou, Peoples R China; [Tao, Juan] Wuxi TCM Hosp, Dept Rheumatol, Wuxi, Peoples R China; [Tan, Jun] Zhenjiang First Peoples Hosp, Dept Rheumatol, Zhenjiang, Peoples R China; [Da, Zhanyun] Nantong Univ, Dept Rheumatol, Affiliated Hosp, Nantong, Peoples R China; [Zhang, Miaojia] Jiangsu Prov Hosp, Dept Rheumatol, Nanjing, Jiangsu, Peoples R China; [Li, Jing] Jiangsu Univ, Dept Rheumatol, Affiliated Hosp, Zhenjiang, Jiangsu, Peoples R China	Nanjing University; Soochow University - China; Jiangnan University; Nanjing Medical University; Southeast University - China; Soochow University - China; Nantong University; Nanjing Medical University; Jiangsu University	Feng, XB; Sun, LY (corresponding author), Nanjing Univ Med Sch, Dept Rheumatol & Immunol, Affiliated Drum Tower Hosp, Nanjing, Jiangsu, Peoples R China.	fengxuebing@hotmail.com; lingyunsun@nju.edu.cn		Feng, Xuebing/0000-0002-9837-9690	National Natural Science Foundation of China [81373198]; Jiangsu Provincial Special Program of Medical Science [13E2015602]; Cinkate Corp	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Jiangsu Provincial Special Program of Medical Science; Cinkate Corp	This study was supported by National Natural Science Foundation of China (grant number 81373198 to XF), Jiangsu Provincial Special Program of Medical Science (13E2015602 to LS), and from Cinkate Corp (LS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alarcon GS, 2007, ANN RHEUM DIS, V66, P1168, DOI 10.1136/ard.2006.068676; Ayodele OE, 2010, NEPHROLOGY, V15, P482, DOI 10.1111/j.1440-1797.2010.01290.x; BOMBARDIER C, 1992, ARTHRITIS RHEUM, V35, P630, DOI 10.1002/art.1780350606; Borchers AT, 2004, AUTOIMMUN REV, V3, P423, DOI 10.1016/j.autrev.2004.04.002; Cartella S, 2013, AUTOIMMUNITY, V46, P363, DOI 10.3109/08916934.2013.794793; Elfving P, 2014, LUPUS, V23, P1430, DOI 10.1177/0961203314543919; Feng XB, 2011, J RHEUMATOL, V38, P1289, DOI 10.3899/jrheum.101088; Gladman D, 1996, ARTHRITIS RHEUM, V39, P363, DOI 10.1002/art.1780390303; Hochberg MC, 1997, ARTHRITIS RHEUM, V40, P1725, DOI 10.1002/art.1780400928; Hoi A, 2015, INT J RHEUM DIS, V18, P113, DOI 10.1111/1756-185X.12497; Jakes RW, 2012, ARTHRIT CARE RES, V64, P159, DOI 10.1002/acr.20683; Lerang K, 2014, LUPUS, V23, P1546, DOI 10.1177/0961203314551083; Moroni G, 2013, LUPUS, V22, P810, DOI 10.1177/0961203313492576; Nieves CEF, 2016, CURR RHEUMATOL REP, V18, DOI 10.1007/s11926-016-0571-2; Petri M, 2012, ARTHRITIS RHEUM-US, V64, P4021, DOI 10.1002/art.34672; Rees F, 2016, RHEUMATOLOGY, V55, P854, DOI 10.1093/rheumatology/kev424; TAN EM, 1982, ARTHRITIS RHEUM, V25, P1271, DOI 10.1002/art.1780251101; Tektonidou MG, 2016, ARTHRITIS RHEUMATOL, V68, P1432, DOI 10.1002/art.39594; Thomas G, 2014, ARTHRITIS RHEUMATOL, V66, P2503, DOI 10.1002/art.38731; Yee CS, 2015, RHEUMATOLOGY, V54, P836, DOI 10.1093/rheumatology/keu412	20	14	18	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2016	11	12							e0168619	10.1371/journal.pone.0168619	http://dx.doi.org/10.1371/journal.pone.0168619			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EG7JB	28030595	Green Published, Green Submitted, gold			2022-12-27	WOS:000391222000062
J	Jha, MK; Minhajuddin, A; Greer, TL; Carmody, T; Rush, AJ; Trivedi, MH				Jha, Manish K.; Minhajuddin, Abu; Greer, Tracy L.; Carmody, Thomas; Rush, Augustus John; Trivedi, Madhukar H.			Early Improvement in Psychosocial Function Predicts Longer-Term Symptomatic Remission in Depressed Patients	PLOS ONE			English	Article							QUALITY-OF-LIFE; MEASUREMENT-BASED CARE; STAR-ASTERISK-D; SEQUENCED TREATMENT ALTERNATIVES; SOCIAL-ADJUSTMENT SCALE; REPORT QIDS-SR; COGNITIVE THERAPY; QUICK INVENTORY; MAJOR DEPRESSION; SAS PROCEDURE	The goal of this study was to evaluate the relationship between early change in psychosocial function independent of depression severity and longer-term symptomatic remission. Participants of Combining Medications to Enhance Depression Outcomes trial were randomly selected for model selection (n = 334) and validation (n = 331). Changes in psychosocial function (Work and Social Adjustment Scale, WSAS) from baseline to week 6 were assessed and two data-driven sub-groups of WSAS change were identified in the randomly selected model selection half. Results of analyses to predict symptomatic remission at 3 and 7 months were validated for these sub-groups in the second half (validation sample). From baseline to week 6, psychosocial function improved significantly even after adjusting for depression severity at each visit and select baseline variables (age, gender, race, ethnicity, education, income, employment, depression onset before age 18, anxious features, and suicidal ideation), treatment-arm, and WSAS score. The WSAS change patterns identified two (early improvement and gradual change) subgroups. After adjusting for baseline variables and remission status at week 6, participants with early improvement in the second half (validation sample) had greater remission rates than those with gradual change at both 3 (3.3 times) and 7 months (2.3 times) following acute treatment initiation. In conclusion, early improvement in psychosocial function provides a clinically meaningful prediction of longer-term symptomatic remission, independent of depression symptom severity.	[Jha, Manish K.; Greer, Tracy L.; Carmody, Thomas; Trivedi, Madhukar H.] UT Southwestern Med Ctr, Dept Psychiat, Dallas, TX 75390 USA; [Minhajuddin, Abu] UT Southwestern Med Ctr, Dept Clin Sci, Dallas, TX USA; [Rush, Augustus John] Duke Natl Univ Singapore, Dept Psychiat & Behav Sci, Singapore, Singapore	University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; National University of Singapore	Trivedi, MH (corresponding author), UT Southwestern Med Ctr, Dept Psychiat, Dallas, TX 75390 USA.	madhukar.trivedi@utsouthwestern.edu	Jha, Manish Kumar/ABI-3594-2020; Trivedi, Madhukar/A-9029-2013	Jha, Manish Kumar/0000-0002-2764-2391; Trivedi, Madhukar/0000-0002-2983-1110	National Institute of Mental Health [N01 MH-90003]; Center for Depression Research and Clinical Care; Hersh Foundation	National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Center for Depression Research and Clinical Care; Hersh Foundation	This work was funded by the National Institute of Mental Health under contract N01 MH-90003 to the University of Texas Southwestern Medical Center at Dallas (MHT and AJR). Forest Pharmaceuticals, GlaxoSmithKline, Organon, and Wyeth Pharmaceuticals provided medications for this trial at no cost. This work was also supported in part through the Center for Depression Research and Clinical Care (MHT) and the Hersh Foundation (MHT). The content of this publication does not necessarily reflect the views or policies of the U.S. Department of Health and Human Services, nor does mention of trade names, commercial products, or organizations imply endorsement by the U.S. government. National Institute of Mental Health had no role in the drafting or review of the manuscript or in the collection or analysis of the data.	Aarts AA, 2015, SCIENCE, V349, DOI 10.1126/science.aac4716; Arrandale VH, 2009, INT ARCH OCC ENV HEA, V82, P1097, DOI 10.1007/s00420-009-0412-y; BLAND JM, 1994, BRIT MED J, V308, P896, DOI 10.1136/bmj.308.6933.896; Cabello M, 2012, J AFFECT DISORDERS, V141, P22, DOI 10.1016/j.jad.2011.12.009; Carter MA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047065; Cohen RM, 2013, JAMA PSYCHIAT, V70, P343, DOI 10.1001/jamapsychiatry.2013.286; Daly EJ, 2010, ANN CLIN PSYCHIATRY, V22, P43; Denninger JW, 2011, J NERV MENT DIS, V199, P807, DOI 10.1097/NMD.0b013e31822fcbe2; Dunn TW, 2012, PSYCHOL MED, V42, P317, DOI 10.1017/S0033291711001279; Gilmour H, 2013, HEALTH REP, V24, P14; Greenberg T, 2015, AM J PSYCHIAT, V172, P881, DOI 10.1176/appi.ajp.2015.14050594; Greer TL, 2016, DEPRESS ANXIETY, V33, P870, DOI 10.1002/da.22521; Greer TL, 2010, CNS DRUGS, V24, P267, DOI 10.2165/11530230-000000000-00000; Guo T, 2015, AM J PSYCHIAT, V172, P1004, DOI 10.1176/appi.ajp.2015.14050652; HAMILTON M, 1960, J NEUROL NEUROSUR PS, V23, P56, DOI 10.1136/jnnp.23.1.56; Hamlett A, P STAT DAT AN SAS US; Hirschfeld RMA, 2002, BIOL PSYCHIAT, V51, P123, DOI 10.1016/S0006-3223(01)01291-4; Ioannidis JPA, 2005, PLOS MED, V2, P696, DOI 10.1371/journal.pmed.0020124; Jha M, 2016, AM J PSYCHIAT; Jones BL, 2001, SOCIOL METHOD RES, V29, P374, DOI 10.1177/0049124101029003005; Jones BL, 2007, SOCIOL METHOD RES, V35, P542, DOI 10.1177/0049124106292364; Liang J, 2011, PSYCHOL AGING, V26, P761, DOI 10.1037/a0023945; Lin CH, 2015, J AFFECT DISORDERS, V182, P115, DOI 10.1016/j.jad.2015.04.022; McKnight PE, 2009, CLIN PSYCHOL REV, V29, P243, DOI 10.1016/j.cpr.2009.01.005; Melchior M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114526; Miller IW, 1998, J CLIN PSYCHIAT, V59, P608, DOI 10.4088/JCP.v59n1108; Mundt JC, 2002, BRIT J PSYCHIAT, V180, P461, DOI 10.1192/bjp.180.5.461; Ram N, 2009, INT J BEHAV DEV, V33, P565, DOI 10.1177/0165025409343765; Rush AJ, 2015, J CLIN PSYCHIAT, V76, pE832, DOI 10.4088/JCP.15com09859; Rush AJ, 2011, AM J PSYCHIAT, V168, P689, DOI 10.1176/appi.ajp.2011.10111645; Rush AJ, 2003, BIOL PSYCHIAT, V54, P573, DOI 10.1016/S0006-3223(02)01866-8; Rush AJ, 1996, PSYCHOL MED, V26, P477, DOI 10.1017/S0033291700035558; Rush AJ, 2006, BIOL PSYCHIAT, V59, P493, DOI 10.1016/j.biopsych.2005.08.022; Sheehan D.V., 1998, J CLIN PSYCHIAT; Shelton RC, 2006, J CLIN PSYCHIAT, V67, P1674, DOI 10.4088/JCP.v67n1102; Solomon DA, 2004, COMPR PSYCHIAT, V45, P423, DOI 10.1016/j.comppsych.2004.07.002; Trivedi MH, 2007, DRUG ALCOHOL DEPEN, V88, pS61, DOI 10.1016/j.drugalcdep.2007.01.007; Trivedi MH, 2010, J AFFECT DISORDERS, V126, P420, DOI 10.1016/j.jad.2010.04.011; Trivedi MH, 2009, J CLIN PSYCHIAT, V70, P26, DOI 10.4088/JCP.8133su1c.04; Trivedi MH, 2009, INT CLIN PSYCHOPHARM, V24, P133, DOI 10.1097/YIC.0b013e3283277614; Trivedi MH, 2006, J CLIN PSYCHIAT, V67, P185, DOI 10.4088/JCP.v67n0203; Trivedi MH, 2004, J CLIN PSYCHIAT, V65, P1356, DOI 10.4088/JCP.v65n1010; Trivedi MH, 2004, PSYCHOL MED, V34, P73, DOI 10.1017/S0033291703001107; Trivedi MH, 2006, AM J PSYCHIAT, V163, P28, DOI 10.1176/appi.ajp.163.1.28; Uher R, 2010, PSYCHOL MED, V40, P1367, DOI 10.1017/S0033291709991528; Uher R, 2011, J CLIN PSYCHIAT, V72, P1478, DOI 10.4088/JCP.10m06419; Vittengl JR, 2007, J CONSULT CLIN PSYCH, V75, P475, DOI 10.1037/0022-006X.75.3.475; Vittengl JR, 2009, J AFFECT DISORDERS, V112, P135, DOI 10.1016/j.jad.2008.04.004; Vittengl JR, 2004, PSYCHOL MED, V34, P643, DOI 10.1017/S0033291703001478; Wardenaar KJ, 2014, DEPRESS ANXIETY, V31, P778, DOI 10.1002/da.22228; Wisniewski Stephen R, 2006, J Psychiatr Pract, V12, P71, DOI 10.1097/00131746-200603000-00002; Zahra D, 2014, INT J PSYCHIAT CLIN, V18, P131, DOI 10.3109/13651501.2014.894072; Zimmerman M, 2006, AM J PSYCHIAT, V163, P148, DOI 10.1176/appi.ajp.163.1.148	53	15	16	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2016	11	12							e0167901	10.1371/journal.pone.0167901	http://dx.doi.org/10.1371/journal.pone.0167901			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EG7JB	28030546	Green Published, Green Submitted, gold			2022-12-27	WOS:000391222000026
J	Liu, L; Kalter, HD; Chu, Y; Kazmi, N; Koffi, AK; Amouzou, A; Joos, O; Munos, M; Black, RE				Liu, Li; Kalter, Henry D.; Chu, Yue; Kazmi, Narjis; Koffi, Alain K.; Amouzou, Agbessi; Joos, Olga; Munos, Melinda; Black, Robert E.			Understanding Misclassification between Neonatal Deaths and Stillbirths: Empirical Evidence from Malawi	PLOS ONE			English	Article							VERBAL AUTOPSY; PRETERM BIRTH; PREGNANCY; COUNTRIES; VALIDITY; AFRICA	Improving the counting of stillbirths and neonatal deaths is important to tracking Sustainable Development Goal 3.2 and improving vital statistics in low-and middle-income countries (LMICs). However, the validity of self-reported stillbirths and neonatal deaths in surveys is often threatened by misclassification errors between the two birth outcomes. We assessed the extent and correlates of stillbirths being misclassified as neonatal deaths by comparing two recent and linked population surveys conducted in Malawi, one being a full birth history (FBH) survey, and the other a follow-up verbal/social autopsy (VASA) survey. We found that one-fifth of 365 neonatal deaths identified in the FBH survey were classified as stillbirths in the VASA survey. Neonatal deaths with signs of movements in the last few days before delivery reported were less likely to be misclassified stillbirths (OR = 0.08, p<0.05). Having signs of birth injury was found to be associated with higher odds of misclassification (OR = 6.17, p<0.05). We recommend replicating our study with larger sample size in other settings. Additionally, we recommend conducting validation studies to confirm accuracy and completeness of live births and neonatal deaths reported in household surveys with events reported in a full birth history and the extent of underestimation of neonatal mortality resulting from misclassifications. Questions on fetal movement, signs of life at delivery and improved probing among older mother may be useful to improve accuracy of reported events.	[Liu, Li] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Populat Family & Reprod Hlth, Baltimore, MD 21205 USA; [Liu, Li; Chu, Yue; Kazmi, Narjis; Koffi, Alain K.; Amouzou, Agbessi; Joos, Olga; Munos, Melinda; Black, Robert E.] Johns Hopkins Bloomberg Sch Publ Hlth, Inst Int Programs, Dept Int Hlth, Baltimore, MD 21205 USA; [Kalter, Henry D.] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Int Hlth, Hlth Syst Program, Baltimore, MD USA	Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health	Liu, L (corresponding author), Johns Hopkins Bloomberg Sch Publ Hlth, Dept Populat Family & Reprod Hlth, Baltimore, MD 21205 USA.; Liu, L (corresponding author), Johns Hopkins Bloomberg Sch Publ Hlth, Inst Int Programs, Dept Int Hlth, Baltimore, MD 21205 USA.	lliu26@jhu.edu	liu, li/HGC-0900-2022	Munos, Melinda/0000-0002-1349-8026; Kalter, Henry/0000-0002-4165-2393; Amouzou, Agbessi/0000-0002-6262-3866; Joos, Olga/0000-0003-0335-4982; Koffi, Alain/0000-0003-3499-0949	Foreign Affairs, Trade and Development Canada [7056791]	Foreign Affairs, Trade and Development Canada	The project was funded by Foreign Affairs, Trade and Development Canada (http://www.international.gc.ca/international/index.aspx?lang=eng) through the Real-Time Results Tracking grant (#7056791) under the Catalytic Initiative to Save a Million Lives. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aggarwal AK, 2011, B WORLD HEALTH ORGAN, V89, P31, DOI 10.2471/BLT.10.076828; Amouzou A, 2013, TROP MED INT HEALTH, V18, P1231, DOI 10.1111/tmi.12167; Barrett Anna M, 2003, Cogn Behav Neurol, V16, P160, DOI 10.1097/00146965-200309000-00003; Blencowe H, 2016, LANCET GLOBAL HLTH; Bradford S, 2015, BMC PSYCHIATRY, V15, DOI 10.1186/s12888-015-0694-4; Bryce Jennifer, 2016, PLoS Med, V13, pe1001912, DOI 10.1371/journal.pmed.1001912; Engmann C, 2009, INT J GYNECOL OBSTET, V105, P112, DOI 10.1016/j.ijgo.2008.12.012; Haws RA, 2010, SOC SCI MED, V71, P1764, DOI 10.1016/j.socscimed.2010.03.051; Helleringer S, 2015, TROP MED INT HEALTH, V20, P1415, DOI 10.1111/tmi.12583; Kalter HD, 2015, J GLOB HEALTH, V5, P196, DOI 10.7189/jogh.05.010415; Koffi AK, 2015, J GLOBAL HLTH, V5; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; Lawn J, 2005, B WORLD HEALTH ORGAN, V83, P409; Lawn JE, 2011, LANCET, V377, P1448, DOI 10.1016/S0140-6736(10)62187-3; Lawn JE, 2010, BMC PREGNANCY CHILDB, V10, DOI 10.1186/1471-2393-10-S1-S1; Lawn JE, 2009, INT J GYNECOL OBSTET, V107, pS5, DOI 10.1016/j.ijgo.2009.07.016; Leisher SH, 2016, BMC PREGNANCY CHILDB, V16, DOI 10.1186/s12884-016-1071-0; Liu L, 2016, LANCET; McTavish S, 2010, SOC SCI MED, V71, P1958, DOI 10.1016/j.socscimed.2010.09.007; National Population Commission (NPC) [Nigeria] and ICF International, 2014, NIG DEM HLTH SURV 20; Pullum T. W., 2006, ASSESSMENT AGE DATE; RMM working group, 2014, RMM IN MAL; Rutstein S.O., 2014, MAKING DEMOGRAPHIC H; Setel PW, 2006, TROP MED INT HEALTH, V11, P681, DOI 10.1111/j.1365-3156.2006.01603.x; Stacey T, 2011, BIRTH-ISS PERINAT C, V38, P311, DOI 10.1111/j.1523-536X.2011.00490.x; Stanton C, 2006, LANCET, V367, P1487, DOI 10.1016/S0140-6736(06)68586-3; The World Bank, 2014, GLOB CIV REG VIT STA; Tolhurst R, 2008, MIDWIFERY, V24, P83, DOI 10.1016/j.midw.2006.09.003; Tveit JVH, 2009, ACTA OBSTET GYN SCAN, V88, P1345, DOI 10.3109/00016340903348375; United Nations, 2015, 2030 AG SUST DEV	30	38	38	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2016	11	12							e0168743	10.1371/journal.pone.0168743	http://dx.doi.org/10.1371/journal.pone.0168743			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EG7JB	28030594	Green Submitted, Green Published, gold			2022-12-27	WOS:000391222000073
J	Moerman, R; Roger, N; De Jonghe, R; Michez, D; Vanderplanck, M				Moerman, Romain; Roger, Nathalie; De Jonghe, Roland; Michez, Denis; Vanderplanck, Maryse			Interspecific Variation in Bumblebee Performance on Pollen Diet: New Insights for Mitigation Strategies	PLOS ONE			English	Article							BOMBUS-TERRESTRIS; COLONY DEVELOPMENT; PROTEIN-CONTENT; NUTRITIVE-VALUE; HYMENOPTERA; BEES; DECLINE; RARITY; PLANTS; MIXES	Bumblebees (i.e. Bombus genus) are major pollinators of flowering wild plants and crops. Although many species are currently in decline, a number of them remain stable or are even expanding. One factor potentially driving changes in bumblebee distribution is the suitability of plant communities. Actually, bees probably have specific nutritional requirements that could shape their floral choices and constraint them in the current context of global change. However, most studies primarily focus on one bumblebee species at a time, making comparative studies scarce. Herein we performed comparative bioassays on three bumblebee species (i.e. Bombus hypnorum, B. pratorum and B. terrestris) fed on three different pollen diets with distinct nutritive content (Cistus, Erica and Sa/ixpollen diets). Micro-colony performance was compared through different developmental and resource collection parameters for understanding the impact of change in pollen diet on different bumblebee species. The evidence suggests that B. terrestris is by far the most competitive species because of its performance compared to the other species, regardless of pollen diet. Our results also highlight a Bombus species effect as pollen diet impacts the micro-colonies in different ways according to the actual bumblebee species. Such interspecific variation in Bombus performance in response to a dietetic change underlines the importance of considering different bumblebee species in mitigation strategies. Such comparative studies are good advice for developing appropriate suites of plant species that can benefit threatened species while supporting stable or expanding ones.	[Moerman, Romain] Univ Libre Bruxelles, Evolut Biol & Ecol, 50 Ave FD Roosevelt, Brussels, Belgium; [Moerman, Romain; Roger, Nathalie; De Jonghe, Roland; Michez, Denis; Vanderplanck, Maryse] Univ Mons, Res Inst Biosci, Zool Lab, 20 Pl Parc, Mons, Belgium	Universite Libre de Bruxelles; University of Mons	Moerman, R (corresponding author), Univ Libre Bruxelles, Evolut Biol & Ecol, 50 Ave FD Roosevelt, Brussels, Belgium.; Moerman, R (corresponding author), Univ Mons, Res Inst Biosci, Zool Lab, 20 Pl Parc, Mons, Belgium.	romain.moerman@umons.ac.be	Michez, Denis/L-1370-2019; Vanderplanck, Maryse/K-1072-2019	Michez, Denis/0000-0001-8880-1838; Vanderplanck, Maryse/0000-0002-0110-8019	FRS-FNRS (Fonds de la Recherche Scientifique) FRFC [2.4.613.12.]; FRIA (Fonds pour la formation a la Recherche dans l'Industrie et dans l'Agriculture)	FRS-FNRS (Fonds de la Recherche Scientifique) FRFC(Fonds de la Recherche Scientifique - FNRS); FRIA (Fonds pour la formation a la Recherche dans l'Industrie et dans l'Agriculture)(Fonds de la Recherche Scientifique - FNRS)	This study was partially funded by FRS-FNRS (Fonds de la Recherche Scientifique) FRFC project 2.4.613.12. and FRIA (Fonds pour la formation a la Recherche dans l'Industrie et dans l'Agriculture). MV is a postdoctoral researcher at the F.R.S.-FNRS and NR is a PhD student at the FRIA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2014, EUROPEAN RED LIST BE, DOI DOI 10.2779/77003; Baloglu GH, 2015, J APIC SCI, V59, P83, DOI 10.1515/JAS-2015-0009; Bees Wasps and Ants Recording Society, 2014, BOMB HYPN; Behmer ST, 2008, P NATL ACAD SCI USA, V105, P1977, DOI 10.1073/pnas.0711870105; Cameron SA, 2011, P NATL ACAD SCI USA, V108, P662, DOI 10.1073/pnas.1014743108; Carvalheiro LG, 2013, ECOL LETT, V16, P870, DOI 10.1111/ele.12121; CNAANI J, 1994, INSECT SOC, V41, P301, DOI 10.1007/BF01242301; CORBET SA, 1991, BEE WORLD, V72, P47, DOI 10.1080/0005772X.1991.11099079; Crowther LP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107568; Ellers J, 1996, NETH J ZOOL, V46, P227, DOI 10.1163/156854295X00186; Garibaldi LA, 2016, SCIENCE, V351, P388, DOI 10.1126/science.aac7287; Genissel A, 2002, ENTOMOL EXP APPL, V104, P329, DOI 10.1023/A:1021279220995; Goulson D, 2005, BIOL CONSERV, V122, P1, DOI 10.1016/j.biocon.2004.06.017; Goulson D, 2008, BIODIVERS CONSERV, V17, P3269, DOI 10.1007/s10531-008-9428-y; Goulson Dave, 2001, British Journal of Entomology and Natural History, V14, P129; Goulson D, 2015, SCIENCE, V347, DOI 10.1126/science.1255957; Harmon-Threatt AN, 2015, ECOL ENTOMOL, V40, P471, DOI 10.1111/een.12211; Hetru Charles, 1998, P40; Inari N, 2005, POPUL ECOL, V47, P77, DOI 10.1007/s10144-004-0205-9; Kerr JT, 2015, SCIENCE, V349, P177, DOI 10.1126/science.aaa7031; Kleijn D, 2008, ECOLOGY, V89, P1811, DOI 10.1890/07-1275.1; Korner P, 2005, ENTOMOL SCI, V8, P151, DOI 10.1111/j.1479-8298.2005.00113.x; Kriesell L, 2017, APIDOLOGIE, V48, P102, DOI 10.1007/s13592-016-0454-6; Lecocq T, 2016, CONSERVATION LETT; Mayer C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050353; MICHENER C D, 1974, P404; Moerman R, 2016, J ECON ENTOMOL, V109, P25, DOI 10.1093/jee/tov279; Oksanen J., 2020, VEGAN COMMUNITY ECOL; Ollerton J, 2011, OIKOS, V120, P321, DOI 10.1111/j.1600-0706.2010.18644.x; Pelletier L, 2003, OIKOS, V103, P688, DOI 10.1034/j.1600-0706.2003.12592.x; Plowright C.M.S., 1999, P21; Ponchau O, 2006, ANN SOC ENTOMOL FR, V42, P207, DOI 10.1080/00379271.2006.10700624; R Core Team, 2021, R LANGUAGE ENV STAT; RASMONT P, 1988, ANN SOC ROY ZOOL BEL, V118, P141; Rasmont P, 2008, ANN SOC ENTOMOL FR, V44, P243, DOI 10.1080/00379271.2008.10697559; Rasmont Pierre, 2015, BioRisk, V10, P3; REGALI A, 1995, APIDOLOGIE, V26, P273, DOI 10.1051/apido:19950401; Roger N, 2016, GLOBAL CHANGE BIOL; Roulston TH, 2000, PLANT SYST EVOL, V222, P187, DOI 10.1007/BF00984102; Roulston TH, 2000, ECOL MONOGR, V70, P617, DOI 10.1890/0012-9615(2000)070[0617:WGPCOP]2.0.CO;2; Scheper J, 2014, P NATL ACAD SCI USA, V111, P17552, DOI 10.1073/pnas.1412973111; Somme L, 2015, APIDOLOGIE, V46, P92, DOI 10.1007/s13592-014-0307-0; Stabler D, 2015, J EXP BIOL, V218, P793, DOI 10.1242/jeb.114249; SUTCLIFFE GH, 1990, CAN J ZOOL, V68, P1120, DOI 10.1139/z90-166; SUTCLIFFE GH, 1988, CAN ENTOMOL, V120, P1051, DOI 10.4039/Ent1201051-12; Tasei JN, 2008, APIDOLOGIE, V39, P397, DOI 10.1051/apido:2008017; Tasei JN, 2008, J ECON ENTOMOL, V101, P1737, DOI 10.1603/0022-0493-101.6.1737; Torreta JP, 2016, T AM ENTOMOLOGICAL S; Vanderplanck M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086209; Vaudo AD, 2016, P NATL ACAD SCI US; Vaudo AD, 2015, CURR OPIN INSECT SCI, V10, P133, DOI 10.1016/j.cois.2015.05.008; Vesterlund SR, 2014, INSECT SOC, V61, P265, DOI 10.1007/s00040-014-0351-9; Williams PH, 2008, APIDOLOGIE, V39, P46, DOI 10.1051/apido:2007052; Williams PH, 2009, APIDOLOGIE, V40, P367, DOI 10.1051/apido/2009025; Winfree R, 2007, ECOL LETT, V10, P1105, DOI 10.1111/j.1461-0248.2007.01110.x; Woodcock BA, 2016, NATURE COMMUNICATION; Yoon HyungJoo, 2005, International Journal of Industrial Entomology, V11, P99	57	16	16	1	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2016	11	12							e0168462	10.1371/journal.pone.0168462	http://dx.doi.org/10.1371/journal.pone.0168462			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI9QH	28005943	gold, Green Published, Green Submitted			2022-12-27	WOS:000392843200055
J	Nisser, A; Weidmann, NB				Nisser, Annerose; Weidmann, Nils B.			Measuring Ethnic Preferences in Bosnia and Herzegovina with Mobile Advertising	PLOS ONE			English	Article							PUBLIC-GOODS	We present a field experiment that uses geo-referenced smartphone advertisements to measure ethnic preferences at a highly disaggregated level. Different types of banners advertising a vote matching tool are randomly displayed to mobile Internet users in Bosnia and Herzegovina, while recording their spatial coordinates. Differences in the response (click) rate to different ethnic cues on these banners are used to measure temporal and spatial variation in ethnic preferences among the population of Bosnia and Herzegovina. Our study lays out the theoretical and practical underpinnings of this technology and discusses its potential for future applications, but also highlights limitations of this approach.	[Nisser, Annerose; Weidmann, Nils B.] Univ Konstanz, Dept Polit & Publ Adm, Constance, Germany; [Nisser, Annerose] Univ Konstanz, Grad Sch Decis Sci, Constance, Germany	University of Konstanz; University of Konstanz	Nisser, A (corresponding author), Univ Konstanz, Dept Polit & Publ Adm, Constance, Germany.; Nisser, A (corresponding author), Univ Konstanz, Grad Sch Decis Sci, Constance, Germany.	annerose.nisser@uni-konstanz.de	Weidmann, Nils B/P-8172-2016	Weidmann, Nils B/0000-0002-4791-4913; Nisser, Annerose/0000-0001-8460-620X	Alexander von Humboldt Foundation (Sofja Kovalevskaja Award)	Alexander von Humboldt Foundation (Sofja Kovalevskaja Award)(Alexander von Humboldt Foundation)	The authors received funding from the Alexander von Humboldt Foundation (Sofja Kovalevskaja Award, www.humboldt-foundation.de). The funding organization had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank Jasmina Islamovic and Lukas Kawerau for research assistance, and the Alexander von Humboldt Foundation for financial support (Sofja Kovalevskaja Award to Nils B. Weidmann).	Agency of Statistics of Bosnia and Herzegovina, 2016, RES 2013 CENS POP HO; Alesina A, 1999, Q J ECON, V114, P1243, DOI 10.1162/003355399556269; Association of National Advertisers, 2014, BOT BAS FRAUD DIG AD; Bartneck C, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121595; Bjorvatn Kjetil, 2015, 21715 NBER; Cederman LE, 2007, AM POLIT SCI REV, V101, P173, DOI 10.1017/S0003055407070086; Communications Regulatory Agency, 2014, ANN REP COMM REG AG; Crump MJC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057410; Dhar S, 2011, COMMUN ACM, V54, P121, DOI 10.1145/1941487.1941515; Dunning T, 2010, AM POLIT SCI REV, V104, P21, DOI 10.1017/S0003055409990311; Easterly W, 1997, Q J ECON, V112, P1203, DOI 10.1162/003355300555466; Eifert B, 2010, AM J POLIT SCI, V54, P494, DOI 10.1111/j.1540-5907.2010.00443.x; Epstein L, 2000, AM J POLIT SCI, V44, P66, DOI 10.2307/2669293; Ginsberg J, 2009, NATURE, V457, P1012, DOI 10.1038/nature07634; Habyarimana J, 2007, AM POLIT SCI REV, V101, P709, DOI 10.1017/S0003055407070499; Hijmans R. J., 2015, GLOBAL ADM AREAS DAT; Munzert S., 2015, WORKING PAPER; Podobnik V, 2013, CASES ON WEB 2.0 IN DEVELOPING COUNTRIES: STUDIES ON IMPLEMENTATION, APPLICATION, AND USE, P342, DOI 10.4018/978-1-4666-2515-0.ch013; Snyder J., 2000, VOTING VIOLENCE DEMO; Solve Media, 2013, BLOG POST; Street A, 2015, POLIT ANAL, V23, P225, DOI 10.1093/pan/mpv002; Vigdor JL, 2002, ECON LETT, V75, P271, DOI 10.1016/S0165-1765(01)00614-0; Wlezien C, 2005, ELECT STUD, V24, P555, DOI 10.1016/j.electstud.2005.01.009; Yuan S., 2013, P 7 INT WORKSH DAT M, P1, DOI DOI 10.1145/2501040.2501980	24	2	2	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2016	11	12							e0167779	10.1371/journal.pone.0167779	http://dx.doi.org/10.1371/journal.pone.0167779			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EI9QH	28005924	Green Published, Green Submitted, gold			2022-12-27	WOS:000392843200021
J	Hirayama, J; Hyvarinen, A; Kiviniemi, V; Kawanabe, M; Yamashita, O				Hirayama, Jun-ichiro; Hyvarinen, Aapo; Kiviniemi, Vesa; Kawanabe, Motoaki; Yamashita, Okito			Characterizing Variability of Modular Brain Connectivity with Constrained Principal Component Analysis	PLOS ONE			English	Article							FUNCTIONAL CONNECTIVITY; NETWORKS	Characterizing the variability of resting-state functional brain connectivity across subjects and/or over time has recently attracted much attention. Principal component analysis (PCA) serves as a fundamental statistical technique for such analyses. However, performing PCA on high-dimensional connectivity matrices yields complicated "eigenconnectivity" patterns, for which systematic interpretation is a challenging issue. Here, we overcome this issue with a novel constrained PCA method for connectivity matrices by extending the idea of the previously proposed orthogonal connectivity factorization method. Our new method, modular connectivity factorization (MCF), explicitly introduces the modularity of brain networks as a parametric constraint on eigenconnectivity matrices. In particular, MCF analyzes the variability in both intra-and inter-module connectivities, simultaneously finding network modules in a principled, data-driven manner. The parametric constraint provides a compact module based visualization scheme with which the result can be intuitively interpreted. We develop an optimization algorithm to solve the constrained PCA problem and validate our method in simulation studies and with a resting-state functional connectivity MRI dataset of 986 subjects. The results show that the proposed MCF method successfully reveals the underlying modular eigenconnectivity patterns in more general situations and is a promising alternative to existing methods.	[Hirayama, Jun-ichiro; Kawanabe, Motoaki; Yamashita, Okito] Adv Telecommun Res Inst Int ATR, Brain Informat Commun Res Lab Grp, Kyoto, Japan; [Hyvarinen, Aapo] Univ Helsinki, Dept Comp Sci HIIT, Helsinki, Finland; [Hyvarinen, Aapo] UCL, Gatsby Computat Neurosci Unit, London, England; [Kiviniemi, Vesa] Oulu Univ Hosp, Dept Diagnost Radiol, Oulu, Finland; [Hirayama, Jun-ichiro; Kawanabe, Motoaki; Yamashita, Okito] RIKEN Ctr Adv Integrated Intelligence Res, Wako, Saitama, Japan	Advanced Telecommunications Research Institute International; University of Helsinki; University of London; University College London; University of Oulu; RIKEN	Hirayama, J (corresponding author), Adv Telecommun Res Inst Int ATR, Brain Informat Commun Res Lab Grp, Kyoto, Japan.; Hirayama, J (corresponding author), RIKEN Ctr Adv Integrated Intelligence Res, Wako, Saitama, Japan.	hirayama@atr.jp	Yamashita, Okito/ABW-9839-2022; Hirayama, Jun-ichiro/AAR-6223-2020	Hyvarinen, Aapo/0000-0002-5806-4432; Yamashita, Okito/0000-0002-6039-3657	National Institute of Information and Communications Technology; Japan Science and Technology Agency (JST); KAKENHI from Japan Society for the Promotion of Science (JSPS) [25730155, 15H02759]; Academy of Finland Centre-of-Excellence in Inverse Problems	National Institute of Information and Communications Technology; Japan Science and Technology Agency (JST)(Japan Science & Technology Agency (JST)); KAKENHI from Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Academy of Finland Centre-of-Excellence in Inverse Problems	This work was partially supported by a contract with the National Institute of Information and Communications Technology entitled, "Development of network dynamics modeling methods for human brain data simulation systems," Strategic International Collaborative Research Program (SICORP) from Japan Science and Technology Agency (JST), and KAKENHI 25730155, 15H02759 from Japan Society for the Promotion of Science (JSPS). AH was funded by the Academy of Finland Centre-of-Excellence in Inverse Problems. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander-Bloch AF, 2010, FRONT SYST NEUROSCI, V4, DOI 10.3389/fnsys.2010.00147; Allen EA, 2014, CEREB CORTEX, V24, P663, DOI 10.1093/cercor/bhs352; Andrews-Hanna JR, 2010, NEURON, V65, P550, DOI 10.1016/j.neuron.2010.02.005; Bertsekas D., 1999, NONLINEAR PROGRAMMIN; Brown J, 2012, FRONT NEUROINFORM, V6, DOI 10.3389/fninf.2012.00028; Carvalho CM, 2007, BAYESIAN ANAL, V2, P69, DOI 10.1214/07-BA204; Cichocki A., 2009, NONNEGATIVE MATRIX T, DOI DOI 10.1002/9780470747278; Craddock RC, 2012, HUM BRAIN MAPP, V33, P1914, DOI 10.1002/hbm.21333; Damoiseaux JS, 2006, P NATL ACAD SCI USA, V103, P13848, DOI 10.1073/pnas.0601417103; Edelman A, 1998, SIAM J MATRIX ANAL A, V20, P303, DOI 10.1137/S0895479895290954; Fox MD, 2005, P NATL ACAD SCI USA, V102, P9673, DOI 10.1073/pnas.0504136102; Fox MD, 2007, NAT REV NEUROSCI, V8, P700, DOI 10.1038/nrn2201; Friston Karl J., 1994, Human Brain Mapping, V2, P56, DOI 10.1002/hbm.460020107; Gonzalez-Castillo J, 2015, P NATL ACAD SCI USA, V112, P8762, DOI 10.1073/pnas.1501242112; Hirayama J, 2016, MACHINE LEARNING; HOLLAND PW, 1983, SOC NETWORKS, V5, P109, DOI 10.1016/0378-8733(83)90021-7; Horev I., 2015, P 4 AS C MACH LEARN, P1; Hutchison RM, 2013, NEUROIMAGE, V80, P360, DOI 10.1016/j.neuroimage.2013.05.079; Hyvarinen A, 2016, NEURAL COMPUT, V28, P445, DOI 10.1162/NECO_a_00810; JACKSON DA, 1993, ECOLOGY, V74, P2204, DOI 10.2307/1939574; Journee M, 2010, J MACH LEARN RES, V11, P517; Kiviniemi V, 2011, BRAIN CONNECT, V1, P339, DOI 10.1089/brain.2011.0036; Kolar M, 2010, ANN APPL STAT, V4, P94, DOI 10.1214/09-AOAS308; Leonardi N, 2013, NEUROIMAGE, V83, P937, DOI 10.1016/j.neuroimage.2013.07.019; Liu XM, 2013, BIOSCI TRENDS, V7, P101, DOI 10.5582/bst.2013.v7.2.101; Menon V, 2010, BRAIN STRUCT FUNCT, V214, P655, DOI 10.1007/s00429-010-0262-0; Monti RP, 2014, NEUROIMAGE, V103, P427, DOI 10.1016/j.neuroimage.2014.07.033; Nocedal J, 2006, SPRINGER SER OPER RE, P1, DOI 10.1007/978-0-387-40065-5; Ponce-Alvarez A, 2015, PLOS COMPUT BIOL, V11, DOI 10.1371/journal.pcbi.1004100; Robinson LF, 2012, DETECTING TIME DEPEN; Robinson LF, 2015, NEUROIMAGE, V108, P274, DOI 10.1016/j.neuroimage.2014.12.034; Sanz-Arigita EJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013788; van den Heuvel MP, 2009, J NEUROSCI, V29, P7619, DOI 10.1523/JNEUROSCI.1443-09.2009; Xing EP, 2010, ANN APPL STAT, V4, P535, DOI 10.1214/09-AOAS311; Xuan X., 2007, P 24 INT C MACH LEAR, P1055, DOI DOI 10.1145/1273496.1273629; Yaesoubi M, 2015, NEUROIMAGE, V107, P85, DOI 10.1016/j.neuroimage.2014.11.054; Yang J, 2004, IEEE T PATTERN ANAL, V26, P131, DOI 10.1109/TPAMI.2004.1261097; Yang TB, 2011, MACH LEARN, V82, P157, DOI 10.1007/s10994-010-5214-7; Yu SX, 2003, NINTH IEEE INTERNATIONAL CONFERENCE ON COMPUTER VISION, VOLS I AND II, PROCEEDINGS, P313, DOI 10.1109/iccv.2003.1238361; Zhou SH, 2010, MACH LEARN, V80, P295, DOI 10.1007/s10994-010-5180-0; Zou H, 2006, J COMPUT GRAPH STAT, V15, P265, DOI 10.1198/106186006X113430	41	4	4	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2016	11	12							e0168180	10.1371/journal.pone.0168180	http://dx.doi.org/10.1371/journal.pone.0168180			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI9TW	28002474	Green Published, Green Submitted, gold			2022-12-27	WOS:000392853100033
J	Jounger, SL; Christidis, N; Hedenberg-Magnusson, B; List, T; Svensson, P; Schalling, M; Ernberg, M				Jounger, Sofia Louca; Christidis, Nikolaos; Hedenberg-Magnusson, Britt; List, Thomas; Svensson, Peter; Schalling, Martin; Ernberg, Malin			Influence of Polymorphisms in the HTR3A and HTR3B Genes on Experimental Pain and the Effect of the 5-HT3 Antagonist Granisetron	PLoS One			English	Article							IRRITABLE-BOWEL-SYNDROME; HUMAN MASSETER MUSCLE; RECEPTOR GENE; INTRAMUSCULAR INJECTION; TEMPOROMANDIBULAR DISORDERS; ANTIEMETIC TREATMENT; MAJOR DEPRESSION; TRAPEZIUS MUSCLE; SKELETAL-MUSCLE; SEX-DIFFERENCES	The aim of this study was to investigate experimentally if 5-HT3 single nucleotide polymorphisms (SNP) contribute to pain perception and efficacy of the 5-HT3-antagonist granisetron and sex differences. Sixty healthy participants were genotyped regarding HTR3A (rs1062613) and HTR3B (rs1176744). First, pain was induced by bilateral hypertonic saline injections (HS, 5.5%, 0.2 mL) into the masseter muscles. Thirty min later the masseter muscle on one side was pretreated with 0.5 mL granisetron (1 mg/mL) and on the other side with 0.5 mL placebo (isotonic saline) followed by another HS injection (0.2 mL). Pain intensity, pain duration, pain area and pressure pain thresholds (PPTs) were assessed after each injection. HS evoked moderate pain, with higher intensity in the women (P = 0.023), but had no effect on PPTs. None of the SNPs influenced any pain variable in general, but compared to men, the pain area was larger in women carrying the C/C (HTR3A) (P = 0.015) and pain intensity higher in women with the A/C alleles (HTR3B) (P = 0.019). Pre-treatment with granisetron reduced pain intensity, duration and area to a lesser degree in women (P < 0.05), but the SNPs did not in general influence the efficacy of granisetron. Women carrying the C/T & T/T (HTR3A) genotype had less reduction of pain intensity (P = 0.041) and area (P = 0.005), and women with the C/C genotype (HTR3B) had less reduction of pain intensity (P = 0.030), duration (P = 0.030) and area compared to men (P = 0.017). In conclusion, SNPs did not influence experimental muscle pain or the effect of granisetron on pain variables in general, but there were some sex differences in pain variables that seem to be influenced by genotypes. However, due to the small sample size further research is needed before any firm conclusions can be drawn.	[Jounger, Sofia Louca; Christidis, Nikolaos; Hedenberg-Magnusson, Britt; Svensson, Peter; Ernberg, Malin] Karolinska Inst, Dept Dent Med, Sect Orofacial Pain & Jaw Funct, Huddinge, Sweden; [Jounger, Sofia Louca; Christidis, Nikolaos; Hedenberg-Magnusson, Britt; Svensson, Peter; Ernberg, Malin] SCON, Huddinge, Sweden; [Hedenberg-Magnusson, Britt] Eastman Inst, Dept Clin Oral Physiol, Publ Dent Hlth, Stockholm, Sweden; [List, Thomas] Malmo Univ, Fac Odontol, Dept Orofacial Pain & Jaw Funct, Malmo, Sweden; [List, Thomas] SCON, Malmo, Sweden; [Svensson, Peter] Univ Aarhus, Sch Dent, Sect Orofacial Pain & Jaw Funct, Aarhus C, Denmark; [Svensson, Peter] SCON, Aarhus C, Denmark; [Schalling, Martin] Karolinska Inst, Ctr Mol Med, Stockholm, Sweden	Karolinska Institutet; Malmo University; Aarhus University; Karolinska Institutet	Jounger, SL (corresponding author), Karolinska Inst, Dept Dent Med, Sect Orofacial Pain & Jaw Funct, Huddinge, Sweden.; Jounger, SL (corresponding author), SCON, Huddinge, Sweden.	sofia.louca@ki.se	Ernberg, Malin/AAR-5588-2020; Christidis, Nikolaos/AAB-7471-2020	Christidis, Nikolaos/0000-0002-8199-7863	Swedish Research Council; Stockholm County Council (ALF project); KI/SLL (SOF-project); Swedish Rheumatism Association; Swedish Dental Society; Department of Dental Medicine at Karolinska Institutet; American Dental Society of Sweden	Swedish Research Council(Swedish Research CouncilEuropean Commission); Stockholm County Council (ALF project)(Stockholm County Council); KI/SLL (SOF-project); Swedish Rheumatism Association; Swedish Dental Society; Department of Dental Medicine at Karolinska Institutet; American Dental Society of Sweden	This study was supported by the Swedish Research Council, the Stockholm County Council (ALF project), KI/SLL (SOF-project), the Swedish Rheumatism Association, the Swedish Dental Society, the Department of Dental Medicine at Karolinska Institutet and the American Dental Society of Sweden.	BATES MS, 1993, PAIN, V52, P101, DOI 10.1016/0304-3959(93)90120-E; Castrillon EE, 2008, ARCH ORAL BIOL, V53, P666, DOI 10.1016/j.archoralbio.2008.01.008; Christidis N, 2005, PAIN, V113, P265, DOI 10.1016/j.pain.2004.10.016; Christidis N, 2008, J PAIN, V9, P892, DOI 10.1016/j.jpain.2008.05.002; Christidis N, 2007, CLIN J PAIN, V23, P467, DOI 10.1097/AJP.0b013e318058abb1; Christidis N, 2015, J HEADACHE PAIN, V16, DOI 10.1186/s10194-015-0588-3; Dao TTT, 2000, J OROFAC PAIN, V14, P169; Dawson A, 2015, CLIN J PAIN, V31, P740, DOI 10.1097/AJP.0000000000000154; Delgado PL, 2004, J CLIN PSYCHIAT, V65, P16; Dworkin Samuel F., 1992, Journal of Craniomandibular Disorders, V6, P301; Ernberg M, 1999, LIFE SCI, V65, P313, DOI 10.1016/S0024-3205(99)00250-7; Ernberg M, 2003, PAIN, V101, P275, DOI 10.1016/S0304-3959(02)00334-2; Ernberg M, 2000, PAIN, V84, P339, DOI 10.1016/S0304-3959(99)00221-3; Faerber L, 2007, EUR J PHARMACOL, V560, P1, DOI 10.1016/j.ejphar.2007.01.028; Farber L, 2001, INT J CLIN PHARM RES, V21, P1; Fillingim RB, 2004, EUR J PAIN, V8, P413, DOI 10.1016/j.ejpain.2004.01.007; Frank B, 2004, CLIN RHEUMATOL, V23, P338, DOI 10.1007/s10067-004-0927-2; Ge HY, 2004, PAIN, V110, P72, DOI 10.1016/j.pain.2004.03.005; Gear RW, 1996, NAT MED, V2, P1248, DOI 10.1038/nm1196-1248; Gerdle B, 2008, EUR J PAIN, V12, P82, DOI 10.1016/j.ejpain.2007.03.009; Ghafouri B, 2010, SCAND J CLIN LAB INV, V70, P478, DOI 10.3109/00365513.2010.511257; Giordano James, 2004, Pain Physician, V7, P141; Graven-Nielsen T, 2001, CLIN J PAIN, V17, P2, DOI 10.1097/00002508-200103000-00002; Hammer C, 2012, TRANSL PSYCHIAT, V2, DOI 10.1038/tp.2012.30; Hammer C, 2009, PHARMACOGENET GENOM, V19, P790, DOI 10.1097/FPC.0b013e32833132b3; Haus U, 2004, SCAND J RHEUMATOL S, P12; Horjales-Araujo E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078889; Isong U, 2008, J OROFAC PAIN, V22, P317; Johansson AGM, 2012, EUR NEUROPSYCHOPHARM, V22, P632, DOI 10.1016/j.euroneuro.2012.01.007; Kaiser R, 2004, PHARMACOGENETICS, V14, P271, DOI 10.1097/00008571-200405000-00001; Kapeller J, 2008, HUM MOL GENET, V17, P2967, DOI 10.1093/hmg/ddn195; Kato M, 2006, NEUROPSYCHOBIOLOGY, V53, P186, DOI 10.1159/000094727; Kelley SP, 2003, NATURE, V424, P321, DOI 10.1038/nature01788; Kilpatrick LA, 2011, GASTROENTEROLOGY, V140, P1943, DOI 10.1053/j.gastro.2011.03.011; Kim MS, 2015, YONSEI MED J, V56, P1415, DOI 10.3349/ymj.2015.56.5.1415; Krzywkowski K, 2008, P NATL ACAD SCI USA, V105, P722, DOI 10.1073/pnas.0708454105; LeResche L, 1997, CRIT REV ORAL BIOL M, V8, P291, DOI 10.1177/10454411970080030401; Louca S, 2013, J ORAL REHABIL, V40, P403, DOI 10.1111/joor.12046; Lund JP, 2001, OROFACIAL PAIN BASIC; MENSE S, 1993, PAIN, V54, P241, DOI 10.1016/0304-3959(93)90027-M; Merskey H., 1994, CLASSIFICATION CHRON, V2nd ed; Niesler B, 2001, PHARMACOGENETICS, V11, P471, DOI 10.1097/00008571-200108000-00002; Niesler B, 2008, PHARMACOGENOMICS, V9, P501, DOI 10.2217/14622416.9.5.501; Niesters M, 2010, PAIN, V151, P61, DOI 10.1016/j.pain.2010.06.012; Nikamo P, 2015, J INVEST DERMATOL, V135, P1969, DOI 10.1038/jid.2015.103; Nikamo P, 2014, J INVEST DERMATOL, V134, P1535, DOI 10.1038/jid.2014.5; Papadopoulos IA, 2000, CLIN RHEUMATOL, V19, P6, DOI 10.1007/s100670050002; Rosendal L, 2004, PAIN, V112, P324, DOI 10.1016/j.pain.2004.09.017; Sessle BJ, 1999, J OROFAC PAIN, V13, P238; Shah JP, 2005, J APPL PHYSIOL, V99, P1977, DOI 10.1152/japplphysiol.00419.2005; Slade GD, 2013, PAIN, V154, P2335, DOI 10.1016/j.pain.2013.07.009; Svensson P, 2003, PAIN, V101, P221, DOI 10.1016/S0304-3959(02)00079-9; Svensson P, 2001, PAIN, V92, P399, DOI 10.1016/S0304-3959(01)00284-6; Tremblay PB, 2003, J CLIN ONCOL, V21, P2147, DOI 10.1200/JCO.2003.05.164; VONKORFF MR, 1988, MED CARE, V26, P307, DOI 10.1097/00005650-198803000-00007; Yamada K, 2006, BIOL PSYCHIAT, V60, P192, DOI 10.1016/j.biopsych.2005.11.008	56	10	10	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2016	11	12							e0168703	10.1371/journal.pone.0168703	http://dx.doi.org/10.1371/journal.pone.0168703			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI9TW	28002447	Green Submitted, Green Published, gold			2022-12-27	WOS:000392853100063
J	Catalogna, M; Doenyas-Barak, K; Sagi, R; Abu-Hamad, R; Nevo, U; Ben-Jacob, E; Efrati, S				Catalogna, Merav; Doenyas-Barak, Keren; Sagi, Roi; Abu-Hamad, Ramzia; Nevo, Uri; Ben-Jacob, Eshel; Efrati, Shai			Effect of Peripheral Electrical Stimulation (PES) on Nocturnal Blood Glucose in Type 2 Diabetes: A Randomized Crossover Pilot Study	PLOS ONE			English	Article							LOW-FREQUENCY ELECTROACUPUNCTURE; GLYCEMIC VARIABILITY; HORMONAL-REGULATION; SAMPLE-SIZE; INSULIN; HYPERGLYCEMIA; EXERCISE; GLUCONEOGENESIS	Background Regulation of hepatic glucose production has been a target for antidiabetic drug development, due to its major contribution to glucose homeostasis. Previous pre-clinical study demonstrated that peripheral electrical stimulation (PES) may stimulate glucose utilization and improve hepatic insulin sensitivity. The aim of the present study was to evaluate safety, tolerability, and the glucose-lowering effect of this approach in patients with type 2 diabetes (T2DM). Methods Twelve patients with T2DM were recruited for an open label, interventional, randomized trial. Eleven patients underwent, in a crossover design, an active, and a no-intervention control periods, separated with a two-week washout phase. During the active period, the patients received a daily lower extremity PES treatment (1.33Hz/16Hz burst mode), for 14 days. Study endpoints included changes in glucose levels, number of hypoglycemic episodes, and other potential side effects. Endpoints were analyzed based on continuous glucose meter readings, and laboratory evaluation. Results We found that during the active period, the most significant effect was on nocturnal glucose control (P < 0.0004), as well as on pre-meal mean glucose levels (P < 0.02). The mean daily glucose levels were also decreased although it did not reach clinical significance (P = 0.07). A reduction in serum cortisol (P < 0.01) but not in insulin was also detected after 2 weeks of treatment. No adverse events were recorded. Conclusions These results indicate that repeated PES treatment, even for a very short duration, can improve blood glucose control, possibly by suppressing hepatic glucose production. This effect may be mediated via hypothalamic-pituitary-adrenal axis modulation.	[Catalogna, Merav; Nevo, Uri] Tel Aviv Univ, Dept Biomed Engn, Fac Engn, Tel Aviv, Israel; [Doenyas-Barak, Keren; Sagi, Roi; Abu-Hamad, Ramzia; Efrati, Shai] Assaf Harofeh Med Ctr, Res & Dev Unit, Zerifin, Israel; [Doenyas-Barak, Keren; Sagi, Roi; Abu-Hamad, Ramzia; Efrati, Shai] Tel Aviv Univ, Sackler Fac Med, Tel Aviv, Israel; [Ben-Jacob, Eshel] Tel Aviv Univ, Sch Phys & Astron, Raymond & Beverly Sackler Fac Exact Sci, Tel Aviv, Israel; [Ben-Jacob, Eshel] Rice Univ, Ctr Theoret Biol Phys, Houston, TX USA	Tel Aviv University; Shamir Medical Center (Assaf Harofeh); Tel Aviv University; Tel Aviv University; Sackler Faculty of Medicine; Tel Aviv University; Rice University	Efrati, S (corresponding author), Assaf Harofeh Med Ctr, Res & Dev Unit, Zerifin, Israel.; Efrati, S (corresponding author), Tel Aviv Univ, Sackler Fac Med, Tel Aviv, Israel.	efratishai@013.net			research fund of Assaf-Harofeh medical center; Maguy-Glass Chair in Physics of Complex Systems at Tel Aviv University; Tauber Family Foundation; Direct For Mathematical & Physical Scien [1427654] Funding Source: National Science Foundation	research fund of Assaf-Harofeh medical center; Maguy-Glass Chair in Physics of Complex Systems at Tel Aviv University; Tauber Family Foundation; Direct For Mathematical & Physical Scien(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS))	The study was supported by the research fund of Assaf-Harofeh medical center, by the Tauber Family Foundation and the Maguy-Glass Chair in Physics of Complex Systems at Tel Aviv University.	Amer Diabet Assoc, 2014, DIABETES CARE, V37, pS81, DOI 10.2337/dc14-S081; Belivani M, 2014, ACUPUNCTURE MED; Cabioglu MT, 2006, AM J CHINESE MED, V34, P367, DOI 10.1142/S0192415X06003904; Catalogna M, 2016, METABOLISM, V65, P863, DOI 10.1016/j.metabol.2016.03.004; Cersosimo E, 2000, ENDOTEXT; Chiodini I, 2007, DIABETES CARE, V30, P83, DOI 10.2337/dc06-1267; Clarke W, 2009, DIABETES TECHNOL THE, V11, pS45, DOI 10.1089/dia.2008.0138; Di Dalmazi G, 2012, J NUTR METAB, V2012, DOI 10.1155/2012/525093; Dowswell T, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007214.pub2; Goodyear LJ, 1998, ANNU REV MED, V49, P235, DOI 10.1146/annurev.med.49.1.235; Hamada T, 2004, J APPL PHYSIOL, V96, P911, DOI 10.1152/japplphysiol.00664.2003; Hamada T, 2003, J APPL PHYSIOL, V94, P2107, DOI 10.1152/japplphysiol.00486.2002; Harno E, 2010, TRENDS ENDOCRIN MET, V21, P619, DOI 10.1016/j.tem.2010.06.004; Hausdorff JM, 2008, AM J PHYS MED REHAB, V87, P4, DOI 10.1097/PHM.0b013e31815e6680; Hertzog MA, 2008, RES NURS HEALTH, V31, P180, DOI 10.1002/nur.20247; Higashimura Y, 2009, AUTON NEUROSCI-BASIC, V150, P100, DOI 10.1016/j.autneu.2009.06.003; Ishizaki N, 2009, METABOLISM, V58, P1372, DOI 10.1016/j.metabol.2009.05.001; JENG CY, 1994, DIABETES, V43, P1440, DOI 10.2337/diabetes.43.12.1440; Jitrapakdee S, 2012, INT J BIOCHEM CELL B, V44, P33, DOI 10.1016/j.biocel.2011.10.001; Johansson J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054357; Johansson J, 2010, AM J PHYSIOL-ENDOC M, V299, pE551, DOI 10.1152/ajpendo.00323.2010; Jones B., 1989, DESIGN ANAL CROSS OV, VVolume 5; Julious SA, 2005, PHARM STAT, V4, P287, DOI 10.1002/pst.185; Kovatchev B, 2008, DIABETES CARE, V31, P1160, DOI 10.2337/dc07-2401; KRAUSFRIEDMANN N, 1984, PHYSIOL REV, V64, P170, DOI 10.1152/physrev.1984.64.1.170; Kuo T, 2013, MOL CELL ENDOCRINOL, V380, P79, DOI 10.1016/j.mce.2013.03.003; Liang F, 2011, EVIDENCE BASED COMPL, V2011; Lin RT, 2009, BMC COMPLEM ALTERN M, V9, DOI 10.1186/1472-6882-9-26; Lin RT, 2013, EVID-BASED COMPL ALT, V2013, P9; MAGNUSSON I, 1992, J CLIN INVEST, V90, P1323, DOI 10.1172/JCI115997; Man KM, 2011, EUR J ANAESTH, V28, P420, DOI 10.1097/EJA.0b013e32833fad52; Miyamoto T, 2012, DIABETES RES CLIN PR, V96, P306, DOI 10.1016/j.diabres.2012.01.006; Monnier L, 2003, DIABETES CARE, V26, P881, DOI 10.2337/diacare.26.3.881; Monnier L, 2013, DIABETES CARE, V36, P4057, DOI 10.2337/dc12-2127; Monnier L, 2009, DIABETES CARE, V32, pS199, DOI 10.2337/dc09-S310; Obici S, 2002, NAT MED, V8, P1376, DOI 10.1038/nm798; Osundiji MA, 2013, ENDOCRIN METAB CLIN, V42, P1, DOI 10.1016/j.ecl.2012.11.006; Pai HC, 2009, J ACUPUNCT MERIDIAN, V2, P147, DOI 10.1016/S2005-2901(09)60047-9; Peplow PV, 2014, J ACUPUNCT MERIDIAN, V7, P1, DOI 10.1016/j.jams.2013.04.014; Rodbard D, 2011, DIABETES TECHNOL THE, V13, P1077, DOI 10.1089/dia.2011.0104; Rodbard D, 2009, DIABETES TECHNOL THE, V11, pS55, DOI 10.1089/dia.2008.0132; Rose AJ, 2005, PHYSIOLOGY, V20, P260, DOI 10.1152/physiol.00012.2005; SHIMAZU T, 1965, SCIENCE, V150, P1607, DOI 10.1126/science.150.3703.1607; SHIMAZU T, 1975, AM J PHYSIOL, V228, P1787, DOI 10.1152/ajplegacy.1975.228.6.1787; Siegelaar SE, 2010, ENDOCR REV, V31, P171, DOI 10.1210/er.2009-0021; Stener-Victorin E, 2016, OBESITY SCI PRACTICE; Stener-Victorin E, 2009, AM J PHYSIOL-REG I, V297, pR387, DOI 10.1152/ajpregu.00197.2009; Tominaga A, 2011, ACUPUNCT MED, V29, P276, DOI 10.1136/acupmed-2011-010006; Torres-Rosas R, 2014, NAT MED, V20, P291, DOI 10.1038/nm.3479; Tsigos C, 2002, J PSYCHOSOM RES, V53, P865, DOI 10.1016/S0022-3999(02)00429-4; Walsh DM, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006142.pub2	51	4	4	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2016	11	12							e0168805	10.1371/journal.pone.0168805	http://dx.doi.org/10.1371/journal.pone.0168805			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI9QF	27997608	gold, Green Published, Green Submitted			2022-12-27	WOS:000392842900077
J	Cobiac, LJ; Scarborough, P; Kaur, A; Rayner, M				Cobiac, Linda J.; Scarborough, Peter; Kaur, Asha; Rayner, Mike			The Eatwell Guide: Modelling the Health Implications of Incorporating New Sugar and Fibre Guidelines	PLOS ONE			English	Article							GREENHOUSE-GAS EMISSIONS; VEGETABLE CONSUMPTION; VASCULAR MORTALITY; COST-EFFECTIVENESS; BLOOD CHOLESTEROL; INDIVIDUAL DATA; CANCER RISK; METAANALYSIS; PRESSURE; DISEASE	Objective To model population health impacts of dietary changes associated with the redevelopment of the UK food-based dietary guidelines (the 'Eatwell Guide'). Method Using multi-state lifetable methods, we modelled the impact of dietary changes on cardiovascular disease, diabetes and cancers over the lifetime of the current UK population. From this model, we determined change in life expectancy and disability-adjusted life years (DALYs) that could be averted. Results Changing the average diet to that recommended in the new Eatwell Guide, without increasing total energy intake, could increase average life expectancy by 5.4 months (95% uncertainty interval: 4.7 to 6.2) for men and 4.0 months (3.4 to 4.6) for women; and avert 17.9 million (17.6 to 18.2) DALYs over the lifetime of the current population. A large proportion of the health benefits are from prevention of type 2 diabetes, with 440,000 (400,000 to 480,000) new cases prevented in men and 340,000 (310,000 to 370,000) new cases prevented in women, over the next ten years. Prevention of cardiovascular diseases and colorectal cancer is also large. However, if the diet recommended in the new Eatwell Guide is achieved with an accompanying increase in energy intake (and thus an increase in body mass index), around half the potential improvements in population health will not be realised. Conclusions The dietary changes required to meet recommendations in the Eatwell Guide, which include eating more fruits and vegetables and less red and processed meats and dairy products, are large. However, the potential population health benefits are substantial.	[Cobiac, Linda J.] Univ Melbourne, Sch Populat & Global Hlth, Ctr Hlth Policy, Melbourne, Vic, Australia; [Cobiac, Linda J.; Scarborough, Peter; Kaur, Asha; Rayner, Mike] Univ Oxford, Nuffield Dept Populat Hlth, British Heart Fdn, Ctr Populat Approaches Noncommunicable Dis Preven, Oxford, England	University of Melbourne; University of Oxford	Cobiac, LJ (corresponding author), Univ Melbourne, Sch Populat & Global Hlth, Ctr Hlth Policy, Melbourne, Vic, Australia.; Cobiac, LJ (corresponding author), Univ Oxford, Nuffield Dept Populat Hlth, British Heart Fdn, Ctr Populat Approaches Noncommunicable Dis Preven, Oxford, England.	linda.cobiac@unimelb.edu.au	Scarborough, Peter/ABD-6111-2021	Scarborough, Peter/0000-0002-2378-2944; Kaur, Asha/0000-0003-0617-2287	SUSDIET Research Project: Towards Sustainable Diets in Europe; British Heart Foundation [FS/15/34/31656] Funding Source: researchfish	SUSDIET Research Project: Towards Sustainable Diets in Europe; British Heart Foundation(British Heart Foundation)	The dietary scenarios that we evaluated in this health modelling study, were based on work that was commissioned by Public Health England. Public Health England provided data and were involved in discussions around the methods and analyses of that work, which has been separately submitted for publication. Public Health England did not fund the development of the health model or modelling of health outcomes in this study. They had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The population health model was developed with support from the SUSDIET Research Project: Towards Sustainable Diets in Europe (https://www6.inra.fr/sustainablediets).; The authors would like to acknowledge Public Health England for their input in developing the dietary scenarios that we have evaluated in this study. The population health model was developed with support from the SUSDIET Research Project: Towards Sustainable Diets in Europe (https://www6.inra.fr/sustainablediets).	Audsley E., 2010, LOW CAN WE GO ASSESS; Aune D, 2009, DIABETOLOGIA, V52, P2277, DOI 10.1007/s00125-009-1481-x; Aune D, 2012, ANN ONCOL; Aune D, 2013, CANCER CAUSE CONTROL, V24, P611, DOI 10.1007/s10552-012-0139-z; Aune D, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d6617; Christiansen E, 2002, EUR J CLIN INVEST, V32, P826, DOI 10.1046/j.1365-2362.2002.01036.x; Clarke R, 1997, BRIT MED J, V314, P112, DOI 10.1136/bmj.314.7074.112; Cobiac LJ, 2013, ANNU REV NUTR, V33, P373, DOI 10.1146/annurev-nutr-071812-161133; Cobiac LJ, 2010, HEART, V96, P1920, DOI 10.1136/hrt.2010.199240; Cogswell ME, 2016, N ENGL J MED; Committee on Climate Change, 2008, BUILD LOW CARB EC UK; Danaei G, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000058; Dauchet L, 2005, NEUROLOGY, V65, P1193, DOI 10.1212/01.wnl.0000180600.09719.53; Dauchet L, 2006, J NUTR, V136, P2588, DOI 10.1093/jn/136.10.2588; Diabetes UK, 2014, COST DIAB REP; FAO, 2016, VAL AGR PROD; Forouzanfar MH, 2015, LANCET, V386, P2287, DOI 10.1016/S0140-6736(15)00128-2; Gonzalez AD, 2011, FOOD POLICY, V36, P562, DOI 10.1016/j.foodpol.2011.07.003; He FJ, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f1325; Lewington S, 2002, LANCET, V360, P1903, DOI 10.1016/S0140-6736(02)11911-8; Lewington S, 2007, LANCET, V370, P1829, DOI 10.1016/S0140-6736(07)61778-4; Lim SS, 2012, LANCET, V380, P2224, DOI 10.1016/S0140-6736(12)61766-8; Macdiarmid JI, 2012, AM J CLIN NUTR, V96, P632, DOI 10.3945/ajcn.112.038729; Mann J, 2014, AM J CLIN NUTR; Mente A, 2016, LANCET; NatCen Social Research Medical Research Council Human Nutrition Research & University College London Medical School, 2015, NAT DIET NUTR SURV Y; Newton JN, 2015, LANCET, V386, P2257, DOI 10.1016/S0140-6736(15)00195-6; Norat T, 2011, WCRF AICR SYSTEMATIC; Perignon M, 2016, PUBLIC HEALTH NUTR, V19, P2662, DOI 10.1017/S1368980016000653; Public Health England in association with the Welsh Government FSSatFSAiNI, 2016, THE EATW GTUID; Scarborough P, EATWELLL GUIDE MODEL; Scarborough P, 2014, CLIMATIC CHANGE, V125, P179, DOI 10.1007/s10584-014-1169-1; Scientific Advisory Committee on Nutrition, 2015, CARB HLTH; Song P, 2014, J CANCER RES CLIN, V140, P979, DOI 10.1007/s00432-014-1637-z; Threapleton DE, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f6879; Vieira AR, 2016, ANN ONCOL, V27, P81, DOI 10.1093/annonc/mdv381; Whitlock G, 2009, LANCET, V373, P1083, DOI 10.1016/S0140-6736(09)60318-4; Wilson N, 2016, NUTR J, V15, DOI 10.1186/s12937-016-0161-1; Wilson N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059648; World Bank, 2016, AGR VAL ADD GDP; World Health Organization, 2015, GUID SUG INT AD CHIL; Zhang ZZ, 2013, GASTROENTEROLOGY, V145, P113, DOI 10.1053/j.gastro.2013.04.001; Zhou B, 2016, LANCET, V387, P1513, DOI 10.1016/S0140-6736(16)00618-8	43	25	25	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2016	11	12							e0167859	10.1371/journal.pone.0167859	http://dx.doi.org/10.1371/journal.pone.0167859			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI9QF	27997546	Green Published, gold			2022-12-27	WOS:000392842900015
J	Salama, A; Hegazy, R; Hassan, A				Salama, Abeer; Hegazy, Rehab; Hassan, Azza			Intranasal Chromium Induces Acute Brain and Lung Injuries in Rats: Assessment of Different Potential Hazardous Effects of Environmental and Occupational Exposure to Chromium and Introduction of a Novel Pharmacological and Toxicological Animal Model	PLOS ONE			English	Article							HEXAVALENT CHROMIUM; ACCUMULATION; MECHANISMS; TOXICITY; PHOSPHORYLATION; CARCINOGENICITY; INSTILLATION; PARTICLES; AKT	Chromium (Cr) is used in many industries and it is widely distributed in the environment. Exposure to Cr dust has been reported among workers at these industries. Beside its hazardous effects on the lungs, brain injury could be induced, as the absorption of substances through the nasal membrane has been found to provide them a direct delivery to the brain. We investigated the distribution and the effects of Cr in both brain and lung following the intranasal instillation of potassium dichromate (inPDC) in rats. Simultaneously, we used the common intraperitoneal (ipPDC) rat model of acute Cr-toxicity for comparison. Thirty male Wistar rats were randomly allocated into five groups (n = 6); each received a single dose of saline, ipPDC (15 mg/kg), or inPDC in three dose levels: 0.5, 1, or 2 mg/kg. Locomotor activity was assessed before and 24 h after PDC administration, then, the lungs and brain were collected for biochemical, histopathological, and immunohistochemical investigations. Treatment of rats with ipPDC resulted in a recognition of 36% and 31% of the injected dose of Cr in the brain and lung tissues, respectively. In inPDC-treated rats, targeting the brain by Cr was increased in a dose-dependent manner to reach 46% of the instilled dose in the group treated with the highest dose. Moreover, only this high dose of inPDC resulted in a delivery of a significant concentration of Cr, which represented 42% of the instilled dose, to the lungs. The uppermost alteration in the rats locomotor activity as well as in the brain and lung histopathological features and contents of oxidative stress biomarkers, interleukin-1p (IL-1(3), phosphorylated protein kinase B (PKB), and cyclooxygenase 2 (COX-2) were observed in the rats treated with inPDC (2 mg/kg). The findings revealed that these toxic manifestations were directly proportional to the delivered concentration of Cr to the tissue. In conclusion, the study showed that a comparably higher concentrations of Cr and more elevated levels of oxidative stress and inflammatory markers were observed in brain and lung tissues of rats subjected to inPDC in a dose that is just 0.13 that of ipPDC dose commonly used in Cr-induced toxicity studies. Therefore, the study suggests a high risk of brain-targeting injury among individuals environmentally or occupationally exposed to Cr dust, even in low doses, and an additional risk of lung injury with higher Cr concentrations. Moreover, the study introduces inPDC (2 mg/kg)-instillation as a new experimental animal model suitable to study the acute brain and lung toxicities induced by intranasal exposure to Cr compounds.	[Salama, Abeer; Hegazy, Rehab] Natl Res Ctr, Dept Pharmacol, Div Med, Giza, Egypt; [Hassan, Azza] Cairo Univ, Dept Pathol, Fac Vet Med, Giza, Egypt	Egyptian Knowledge Bank (EKB); National Research Centre (NRC); Egyptian Knowledge Bank (EKB); Cairo University	Hegazy, R (corresponding author), Natl Res Ctr, Dept Pharmacol, Div Med, Giza, Egypt.	rehab_hegazy@hotmail.com		Hegazy, Rehab/0000-0002-2586-2104; Salama, Abeer/0000-0001-9870-5583				Alsarra IA, 2011, ARCH PHARM RES, V34, P573, DOI 10.1007/s12272-011-0407-6; Barceloux DG, 1999, J TOXICOL-CLIN TOXIC, V37, P173, DOI 10.1081/CLT-100102418; Block ML, 2009, TRENDS NEUROSCI, V32, P506, DOI 10.1016/j.tins.2009.05.009; Broom Oliver Jay, 2009, Ugeskr Laeger, V171, P243; Calderon-Garciduenas L, 2008, TOXICOL PATHOL, V36, P289, DOI 10.1177/0192623307313011; Calderon-Garciduenas L, 2013, EXP TOXICOL PATHOL, V65, P503, DOI 10.1016/j.etp.2012.02.006; Choi JI, 2010, PAIN, V149, P243, DOI 10.1016/j.pain.2010.02.008; Dayan AD, 2001, HUM EXP TOXICOL, V20, P439, DOI 10.1191/096032701682693062; DIAZMAYANS J, 1986, COMP BIOCHEM PHYS C, V83, P191, DOI 10.1016/0742-8413(86)90035-6; Drury R.A.B., 1967, CARLETONS HISTOLOGIC, P432; Fatima S, 2007, CLIN CHIM ACTA, V386, P94, DOI 10.1016/j.cca.2007.08.006; French C, 1997, DRUG CHEM TOXICOL, V20, P375, DOI 10.3109/01480549709003894; Gianutsos G, 1997, FUND APPL TOXICOL, V37, P102, DOI 10.1006/faat.1997.2306; Hao SY, 2016, MOLECULES, V21, DOI 10.3390/molecules21030325; Hegazy R, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0151486; Horie M, 2016, ANTIOXIDANTS-BASEL, V5, DOI 10.3390/antiox5010004; Huang LH, 2014, AEROSOL AIR QUAL RES, V14, P1939, DOI 10.4209/aaqr.2013.10.0312; ISHIKAWA Y, 1994, CANCER RES, V54, P2342; Jomova K, 2011, TOXICOLOGY, V283, P65, DOI 10.1016/j.tox.2011.03.001; KAUPPILA T, 1991, EUR J PHARMACOL, V205, P177, DOI 10.1016/0014-2999(91)90817-A; Kaur P, 2016, ARTIF CELL NANOMED B, V44, P1167, DOI 10.3109/21691401.2015.1012260; Keane M, 2015, J OCCUPATIONAL ENV H; Kelly MA, 1998, J NEUROSCI, V18, P3470; Kleinman MT, 2008, TOXICOL LETT, V178, P127, DOI 10.1016/j.toxlet.2008.03.001; Kowalska S, 1983, Med Pr, V34, P171; Malik AS, 2003, J NEUROTRAUM, V20, P463, DOI 10.1089/089771503765355531; Manning BD, 2007, CELL, V129, P1261, DOI 10.1016/j.cell.2007.06.009; Mustafa G, 2016, DRUG DELIV, V23, P933, DOI 10.3109/10717544.2014.923064; Osaki M, 2004, APOPTOSIS, V9, P667, DOI 10.1023/B:APPT.0000045801.15585.dd; Pesch B, 2015, INT J HYG ENVIR HEAL, V218, P500, DOI 10.1016/j.ijheh.2015.04.004; Rajaram MVS, 2006, J IMMUNOL, V177, P6317, DOI 10.4049/jimmunol.177.9.6317; Salama A. A. A., 2014, Journal of Chemical and Pharmaceutical Research, V6, P168; Schneider BC, 2012, TOXICOL APPL PHARM, V259, P38, DOI 10.1016/j.taap.2011.12.001; STOHS SJ, 1995, FREE RADICAL BIO MED, V18, P321, DOI 10.1016/0891-5849(94)00159-H; Suliburska J, 2014, BIOL TRACE ELEM RES, V157, P60, DOI 10.1007/s12011-013-9864-8; Sunderman FW, 2001, ANN CLIN LAB SCI, V31, P3; Tatem KS, 2014, JOVE-J VIS EXP, DOI 10.3791/51785; Toya T, 1999, IND HEALTH, V37, P36, DOI 10.2486/indhealth.37.36; Urbano AM, 2012, CURR DRUG METAB, V13, P284; Vichai V, 2005, INFLAMM RES, V54, P163, DOI 10.1007/s00011-004-1338-1; Wang Tianjing, 2015, Zhonghua Lao Dong Wei Sheng Zhi Ye Bing Za Zhi, V33, P414; Wen RX, 2016, J APPL TOXICOL, V36, P445, DOI 10.1002/jat.3260; Werner ML, 2007, ENVIRON SCI TECHNOL, V41, P4919, DOI 10.1021/es070430q; Xing ZH, 2016, SCI REP-UK, V6, DOI 10.1038/srep20040; Yoon JY, 2015, PHARMACOGN MAG, V11, P477, DOI [10.4103/0973-1296.60454, 10.4103/0973-1296.160454]	45	41	42	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2016	11	12							e0168688	10.1371/journal.pone.0168688	http://dx.doi.org/10.1371/journal.pone.0168688			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI9QF	27997619	gold, Green Submitted, Green Published			2022-12-27	WOS:000392842900068
J	van den Noort, JC; van Beek, N; van der Kraan, T; Veeger, DHEJ; Stegeman, DF; Veltink, PH; Maas, H				van den Noort, Josien C.; van Beek, Nathalie; van der Kraan, Thomas; Veeger, DirkJan H. E. J.; Stegeman, Dick F.; Veltink, Peter H.; Maas, Huub			Variable and Asymmetric Range of Enslaving: Fingers Can Act Independently over Small Range of Flexion	PLOS ONE			English	Article							MYOFASCIAL FORCE TRANSMISSION; HAND KINEMATICS; MOTOR CONTROL; MUSCLE; CONSTRAINTS; MOVEMENTS; DYSTONIA; ANATOMY; NEURONS; STROKE	The variability in the numerous tasks in which we use our hands is very large. However, independent movement control of individual fingers is limited. To assess the extent of finger independency during full-range finger flexion including all finger joints, we studied enslaving (movement in non-instructed fingers) and range of independent finger movement through the whole finger flexion trajectory in single and multi-finger movement tasks. Thirteen young healthy subjects performed single- and multi-finger movement tasks under two conditions: active flexion through the full range of movement with all fingers free to move and active flexion while the non-instructed finger(s) were restrained. Finger kinematics were measured using inertial sensors (PowerGlove), to assess enslaving and range of independent finger movement. Although all fingers showed enslaving movement to some extent, highest enslaving was found in adjacent fingers. Enslaving effects in ring and little finger were increased with movement of additional, non-adjacent fingers. The middle finger was the only finger affected by restriction in movement of non-instructed fingers. Each finger showed a range of independent movement before the non-instructed fingers started to move, which was largest for the index finger. The start of enslaving was asymmetrical for adjacent fingers. Little finger enslaving movement was affected by multi-finger movement. We conclude that no finger can move independently through the full range of finger flexion, although some degree of full independence is present for smaller movements. This range of independent movement is asymmetric and variable between fingers and between subjects. The presented results provide insight into the role of finger independency for different types of tasks and populations.	[van den Noort, Josien C.; Veltink, Peter H.] Univ Twente, MIRA Inst, Biomed Signals & Syst, Enschede, Netherlands; [van den Noort, Josien C.] Vrije Univ Amsterdam, Med Ctr, MOVE Res Inst, Dept Rehabil Med, Amsterdam, Netherlands; [van Beek, Nathalie; Veeger, DirkJan H. E. J.; Stegeman, Dick F.; Maas, Huub] Vrije Univ Amsterdam, Dept Human Movement Sci, Fac Behav & Movement Sci, MOVE Res Inst Amsterdam, Amsterdam, Netherlands; [van der Kraan, Thomas; Stegeman, Dick F.] Radboud Univ Nijmegen, Med Ctr, Donders Inst, Dept Neurol & Clin Neurophysiol, Nijmegen, Netherlands	University of Twente; Vrije Universiteit Amsterdam; Vrije Universiteit Amsterdam; Radboud University Nijmegen	van den Noort, JC (corresponding author), Univ Twente, MIRA Inst, Biomed Signals & Syst, Enschede, Netherlands.; van den Noort, JC (corresponding author), Vrije Univ Amsterdam, Med Ctr, MOVE Res Inst, Dept Rehabil Med, Amsterdam, Netherlands.	j.vandennoort@vumc.nl	Stegeman, Dick/AAN-5134-2021; van den Noort, Josien/ABG-7503-2021	van den Noort, Josien/0000-0002-2305-498X; veeger, dirkjan/0000-0003-0292-6520; van den Noort, Josien/0000-0001-5753-4183; Maas, Huub/0000-0002-2304-2735	European Commission through MOVE-AGE, an Erasmus Mundus Joint Doctorate program [2011-0015]; Dutch Technology Foundation STW, Netherlands Organization for Scientific Research (NWO); Division for Earth and Life Sciences of the Netherlands Organization for Scientific Research [864-10-011]	European Commission through MOVE-AGE, an Erasmus Mundus Joint Doctorate program; Dutch Technology Foundation STW, Netherlands Organization for Scientific Research (NWO)(Technologiestichting STWNetherlands Organization for Scientific Research (NWO)); Division for Earth and Life Sciences of the Netherlands Organization for Scientific Research	This research is funded by the European Commission through MOVE-AGE, an Erasmus Mundus Joint Doctorate program (2011-0015) to DS, NvB and DV; by the Dutch Technology Foundation STW (PowerSensor), part of the Netherlands Organization for Scientific Research (NWO) to PV and JCvdN; and by the Division for Earth and Life Sciences of the Netherlands Organization for Scientific Research (grant 864-10-011) to HM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AN KN, 1983, J BIOMECH, V16, P419, DOI 10.1016/0021-9290(83)90074-X; CLARK FJ, 1985, J NEUROPHYSIOL, V54, P1529, DOI 10.1152/jn.1985.54.6.1529; Danion F, 2003, CLIN NEUROPHYSIOL, V114, P1445, DOI 10.1016/S1388-2457(03)00105-6; Ejaz N, 2015, NAT NEUROSCI, V18, P1034, DOI 10.1038/nn.4038; Furuya S, 2014, NEUROSCIENCE, V275, P444, DOI 10.1016/j.neuroscience.2014.06.031; Furuya S, 2016, NEUROSCI RES, V104, P112, DOI 10.1016/j.neures.2015.12.001; Furuya S, 2011, J NEUROPHYSIOL, V106, P2849, DOI 10.1152/jn.00378.2011; Hager-Ross C, 2000, J NEUROSCI, V20, P8542, DOI 10.1523/JNEUROSCI.20-22-08542.2000; Keen DA, 2004, J NEUROPHYSIOL, V91, P57, DOI 10.1152/jn.00650.2003; Keen DA, 2003, MUSCLE NERVE, V28, P614, DOI 10.1002/mus.10481; Kim SW, 2008, HUM MOVEMENT SCI, V27, P408, DOI 10.1016/j.humov.2007.08.005; Kortier HG, 2014, J NEUROENG REHABIL, V11, DOI 10.1186/1743-0003-11-70; Kragstrup TW, 2011, SCAND J MED SCI SPOR, V21, P749, DOI 10.1111/j.1600-0838.2011.01377.x; Lang CE, 2004, J NEUROPHYSIOL, V92, P2802, DOI 10.1152/jn.00480.2004; Latash ML, 2006, MOTOR CONTROL AND LEARNING, P141, DOI 10.1007/0-387-28287-4_13; Leijnse JNAL, 2008, J NEUROPHYSIOL, V100, P3225, DOI 10.1152/jn.90570.2008; Leijnse JNAL, 1997, J BIOMECH, V30, P873, DOI 10.1016/S0021-9290(97)00045-6; Li ZM, 2004, MOTOR CONTROL, V8, P1; Li ZM, 2000, CLIN BIOMECH, V15, P203, DOI 10.1016/S0268-0033(99)00058-3; Maas H, 2005, EUR J APPL PHYSIOL, V94, P584, DOI 10.1007/s00421-005-1367-7; Maas H, 2003, J APPL PHYSIOL, V95, P2004, DOI 10.1152/japplphysiol.00220.2003; Maas H, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/575672; Marieb EN, 2001, MUSCULAR SYSTEM HUMA, P357; MERZENICH MM, 1984, J COMP NEUROL, V224, P591, DOI 10.1002/cne.902240408; Napier J. R., 1993, HANDS; Raghavan P, 2010, J NEUROPHYSIOL, V103, P3034, DOI 10.1152/jn.00936.2009; Rosenkranz K, 2009, J NEUROSCI, V29, P14627, DOI 10.1523/JNEUROSCI.2094-09.2009; Sanei K, 2013, HUM MOVEMENT SCI, V32, P457, DOI 10.1016/j.humov.2013.01.004; Schieber MH, 2009, ADV EXP MED BIOL, V629, P559, DOI 10.1007/978-0-387-77064-2_30; Schieber MH, 2004, J APPL PHYSIOL, V96, P2293, DOI 10.1152/japplphysiol.01063.2003; Schieber MH, 2002, ADV EXP MED BIOL, V508, P411; SCHIEBER MH, 1993, SCIENCE, V261, P489, DOI 10.1126/science.8332915; SHINODA Y, 1981, NEUROSCI LETT, V23, P7, DOI 10.1016/0304-3940(81)90182-8; Sohn YH, 2004, EXP BRAIN RES, V158, P397, DOI 10.1007/s00221-004-1909-y; van Beek N, 2016, P 21 C INT SOC EL KI; van den Noort JC, 2016, PLOS ONE, V11, P16; van Duinen H, 2011, J PHYSIOL-LONDON, V589, P5583, DOI 10.1113/jphysiol.2011.217810; VONSCHROEDER HP, 1995, J HAND SURG-AM, V20A, P27, DOI 10.1016/S0363-5023(05)80053-X; Wycherley AS, 2005, RHEUMATOLOGY, V44, P638, DOI 10.1093/rheumatology/keh568; Zatsiorsky VM, 1998, BIOL CYBERN, V79, P139, DOI 10.1007/s004220050466; Zatsiorsky VM, 2000, EXP BRAIN RES, V131, P187, DOI 10.1007/s002219900261	41	8	8	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 19	2016	11	12							e0168636	10.1371/journal.pone.0168636	http://dx.doi.org/10.1371/journal.pone.0168636			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI9QC	27992598	gold, Green Published			2022-12-27	WOS:000392842600083
J	Zimbudzi, E; Lo, C; Ranasinha, S; Gallagher, M; Fulcher, G; Kerr, PG; Russell, G; Teede, H; Usherwood, T; Walker, R; Zoungas, S				Zimbudzi, Edward; Lo, Clement; Ranasinha, Sanjeeva; Gallagher, Martin; Fulcher, Gregory; Kerr, Peter G.; Russell, Grant; Teede, Helena; Usherwood, Tim; Walker, Rowan; Zoungas, Sophia			Predictors of Health-Related Quality of Life in Patients with Co-Morbid Diabetes and Chronic Kidney Disease	PLOS ONE			English	Article							ALL-CAUSE MORTALITY; HEMODIALYSIS-PATIENTS; DIALYSIS OUTCOMES; CKD; GENDER; TRIAL	Background People living with diabetes and chronic kidney disease (CKD) experience compromised quality of life. Consequently, it is critical to identify and understand factors influencing their health-related quality of life (HRQoL). This study examined factors associated with HRQoL among patients with diabetes and CKD. Methods A cross sectional study among adults with comorbid diabetes and CKD (eGFR < 60 mL/min/1.73m(2)) recruited from renal and diabetes clinics of four large tertiary referral hospitals in Australia was performed. Each participant completed the Kidney Disease Quality of Life (KDQoL (TM)-36) questionnaire, which is comprised of two composite measures of physical and mental health and 3 kidney disease specific subscales with possible scores ranging from 0 to 100 with higher values indicating better HRQoL. Demographic and clinical data were also collected. Regression analyses were performed to determine the relationship between HRQoL and potential predictor factors. Results A total of 308 patients were studied with a mean age of 66.9 (SD = 11.0) years and 70% were males. Mean scores for the physical composite summary, mental composite summary, symptom/problem list, effects of kidney disease and burden of kidney disease scales were 35.2, 47.0, 73.8, 72.5 and 59.8 respectively. Younger age was associated with lower scores in all subscales except for the physical composite summary. Female gender, obese or normal weight rather than overweight, and smoking were all associated with lower scores in one or more subscales. Scores were progressively lower with more advanced stage of CKD (p<0.05) in all subscales except for the mental composite summary. Conclusion In patients with diabetes and CKD, younger age was associated with lower scores in all HRQoL subscales except the physical composite summary and female gender, obese or normal weight and more advanced stages of CKD were associated with lower scores in one or more subscales. Identifying these factors will inform the timely implementation of interventions to improve the quality of life of these patients.	[Zimbudzi, Edward; Kerr, Peter G.] Monash Hlth, Dept Nephrol, Melbourne, Vic, Australia; [Zimbudzi, Edward; Lo, Clement; Ranasinha, Sanjeeva; Teede, Helena; Zoungas, Sophia] Monash Univ, MCHRI, Sch Publ Hlth & Prevent Med, Melbourne, Vic, Australia; [Lo, Clement; Teede, Helena; Zoungas, Sophia] Monash Hlth, Diabet & Vasc Med Unit, Melbourne, Vic, Australia; [Gallagher, Martin] Univ Sydney, Concord Clin Sch, Sydney, NSW, Australia; [Gallagher, Martin] George Inst Global Hlth, Sydney, NSW, Australia; [Fulcher, Gregory] Royal North Shore Hosp, Dept Diabet Endocrinol & Metab, Sydney, NSW, Australia; [Fulcher, Gregory] Univ Sydney, Royal North Shore Hosp, Northern Clin Sch, Sydney, NSW, Australia; [Russell, Grant] Monash Univ, Sch Primary Hlth Care, Southern Acad Primary Care Res Unit, Melbourne, Vic, Australia; [Usherwood, Tim; Zoungas, Sophia] Univ Sydney, George Inst Global Hlth, Sydney, NSW, Australia; [Usherwood, Tim] Sydney Med Sch Westmead, Dept Gen Practice, Sydney, NSW, Australia; [Walker, Rowan] Alfred Hosp, Dept Renal Med, Melbourne, Australia	Monash University; University of Sydney; George Institute for Global Health; University of Sydney; Royal North Shore Hospital; Royal North Shore Hospital; University of Sydney; Monash University; George Institute for Global Health; University of Sydney; University of Sydney; Florey Institute of Neuroscience & Mental Health	Zoungas, S (corresponding author), Monash Univ, MCHRI, Sch Publ Hlth & Prevent Med, Melbourne, Vic, Australia.; Zoungas, S (corresponding author), Monash Hlth, Diabet & Vasc Med Unit, Melbourne, Vic, Australia.; Zoungas, S (corresponding author), Univ Sydney, George Inst Global Hlth, Sydney, NSW, Australia.	sophia.zoungas@monash.edu	Kerr, Peter G/I-1461-2013; Russell, Grant/I-1874-2014	Russell, Grant/0000-0003-3773-2355; Teede, Helena/0000-0001-7609-577X; Zoungas, Sophia/0000-0003-2672-0949; Gallagher, Martin/0000-0001-9187-6187	National Health and Medical Research Council, Australia (NHMRC) [ID 1055175]; Australian Postgraduate Award Scholarship; NHMRC, Australia Fellowship; National Heart Foundation of Australia Fellowship	National Health and Medical Research Council, Australia (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); Australian Postgraduate Award Scholarship; NHMRC, Australia Fellowship(National Health and Medical Research Council (NHMRC) of Australia); National Heart Foundation of Australia Fellowship(National Heart Foundation of Australia)	This study was supported by a National Health and Medical Research Council, Australia (NHMRC) Partnership Grant (ID 1055175) between the following health services, research institutes and national consumer stakeholder groups Alfred Health; Concord Hospital; Royal North Shore Hospital; Monash Health; Monash Centre for Health Research and Implementation, Monash University; The George Institute for Global Health, University of Sydney; Diabetes Australia; and Kidney Health Australia. CL was supported by an Australian Postgraduate Award Scholarship. HT was supported by a NHMRC, Australia Fellowship. SZ was supported by a National Heart Foundation of Australia Fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Australian Bureau of Statistics, 2013, 2033055001 SEIFA AUS; Ayoub AM, 2013, J FAM COMMUNITY MED, V20, P106, DOI 10.4103/2230-8229.114772; Barotfi S, 2006, J PSYCHOSOM RES, V60, P495, DOI 10.1016/j.jpsychores.2005.09.009; Cruz MC, 2011, CLINICS, V66, P991, DOI 10.1590/S1807-59322011000600012; Griva K, 2015, BMJ OPEN, V5, DOI 10.1136/bmjopen-2014-007253; Guariguata L, 2014, DIABETES RES CLIN PR, V103, P137, DOI 10.1016/j.diabres.2013.11.002; Hallan SI, 2010, NEPHROL DIAL TRANSPL, V25, P2832, DOI 10.1093/ndt/gfq370; Hayashino Y, 2009, DIABETIC MED, V26, P921, DOI 10.1111/j.1464-5491.2009.02800.x; Imran MK, 2010, SINGAP MED J, V51, P157; Kalantar-Zadeh K, 2003, KIDNEY INT, V63, P793, DOI 10.1046/j.1523-1755.2003.00803.x; Karner-Hutuleac A, 2012, PROCD SOC BEHV, V33, P85, DOI 10.1016/j.sbspro.2012.01.088; KIMMEL PL, 1995, J AM SOC NEPHROL, V6, P1418; Lessan Pezeshki M, 2009, INT J NEPHROL UROL, V1, P129; Liu X, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079675; Lu JL, 2014, J AM SOC NEPHROL, V25, P2088, DOI 10.1681/ASN.2013070754; Lung TWC, 2011, QUAL LIFE RES, V20, P1669, DOI 10.1007/s11136-011-9902-y; Madhan K, 2010, NEPHROLOGY, V15, pS32, DOI 10.1111/j.1440-1797.2010.01229.x; Mapes DL, 2003, KIDNEY INT, V64, P339, DOI 10.1046/j.1523-1755.2003.00072.x; Mapes DL, 2004, AM J KIDNEY DIS, V44, pS54, DOI 10.1053/j.ajkd.2004.08.012; Merkus MP, 2000, AM J KIDNEY DIS, V35, P69, DOI 10.1016/S0272-6386(00)70304-0; Moura A, 2015, QUAL LIFE RES, V24, P1327, DOI 10.1007/s11136-014-0854-x; Mujais SK, 2009, CLIN J AM SOC NEPHRO, V4, P1293, DOI 10.2215/CJN.05541008; Niewada M, 2005, NEUROEPIDEMIOLOGY, V24, P123, DOI 10.1159/000082999; Norris CM, 2008, CIRC-CARDIOVASC QUAL, V1, P123, DOI 10.1161/CIRCOUTCOMES.108.793448; Ortega F, 2002, J NEPHROL, V15, P220; Osthus TBH, 2012, BMC NEPHROL, V13, DOI 10.1186/1471-2369-13-78; Pagels AA, 2012, HEALTH QUAL LIFE OUT, V10, DOI 10.1186/1477-7525-10-71; Paniagua R, 2005, KIDNEY INT, V67, P1093, DOI 10.1111/j.1523-1755.2005.00175.x; Porter AC, 2016, CLIN J AM SOC NEPHRO, V11, P1154, DOI 10.2215/CJN.09990915; Rajapurkar MM, 2012, BMC NEPHROL, V13, DOI 10.1186/1471-2369-13-10; Schulz R, 2008, AM J NURS, V108, P23, DOI 10.1097/01.NAJ.0000336406.45248.4c; Seica A, 2009, NEPHROL DIAL TRANSPL, V24, P626, DOI 10.1093/ndt/gfn506; Shaw LJ, 2009, J AM COLL CARDIOL, V54, P1561, DOI 10.1016/j.jacc.2009.04.098; Soni RK, 2010, CURR OPIN NEPHROL HY, V19, P153, DOI 10.1097/MNH.0b013e328335f939; Vos T, 2015, LANCET, V386, P743, DOI 10.1016/S0140-6736(15)60692-4; World Health Organization, 2006, GLOB DAT BOD MASS IN; World Health Organization, 2006, DEF DIAGN DIAB MELL	37	31	31	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 19	2016	11	12							e0168491	10.1371/journal.pone.0168491	http://dx.doi.org/10.1371/journal.pone.0168491			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EI9QC	27992595	gold, Green Published			2022-12-27	WOS:000392842600068
J	Tavares, DC; de Moura, JF; Siciliano, S				Tavares, Davi Castro; de Moura, Jailson Fulgencio; Siciliano, Salvatore			Environmental Predictors of Seabird Wrecks in a Tropical Coastal Area	PLOS ONE			English	Article							BEACHED BIRD SURVEYS; BOOBY SULA-LEUCOGASTER; MARINE OIL POLLUTION; CLIMATE-CHANGE; BODY-SIZE; WATER CLARITY; SEA; INGESTION; MORTALITY; PRODUCTIVITY	Beached bird surveys have been widely used to monitor the impact of oil pollution in the oceans. However, separating the combined effects of oil pollution, environmental variables and methodological aspects of beach monitoring on seabird stranding patterns is a challenging task. The effects of a comprehensive set of oceanographic and climatic variables and oil pollution on seabird strandings in a tropical area of Brazil were investigated herein, using two robust and innovative methods: Generalized Linear Mixed Models and Structural Equation Modeling. We assessed strandings of four resident seabird species along 480 km of beaches divided into 11 sampling areas, between November 2010 and September 2013. We found that increasing the distance from the nearest breeding island reduce the seabird stranding events. Storm activity and biological productivity were the most important factors affecting the stranding events of brown boobies Sula leucogaster, Cabot's terns Thalasseus acuflavidus and kelp gulls Larus dominicanus. These species are also indirectly affected by warm tropical waters, which reduce chlorophyll-a concentrations. Beach surveys are, thus, useful to investigate the mortality rates of resident species near breeding sites, where individuals are more abundant and exposed to local factors associated with at-sea mortality. In contrast, conservation actions and monitoring programs for far-ranging seabird species are needed in more distant foraging areas. Furthermore, beach monitoring programs investigating the impact of oil pollution on seabirds need to account for the effects of environmental factors on stranding patterns. The present study also demonstrated that seabirds inhabiting tropical coastal waters are sensitive to climate conditions such as adverse weather, which are expected to increase in frequency and intensity in next decades.	[Tavares, Davi Castro] Univ Estadual Norte Fluminense, Lab Ciencias Ambientais, Campos Dos Goytacazes, RJ, Brazil; [de Moura, Jailson Fulgencio] Leibniz Ctr Trop Marine Ecol, Syst Ecol Grp, Bremen, Germany; [Siciliano, Salvatore] Fiocruz MS, Inst Oswaldo Cruz, Rio De Janeiro, RJ, Brazil	Universidade Estadual do Norte Fluminense; Leibniz Zentrum fur Marine Tropenforschung (ZMT); Fundacao Oswaldo Cruz	Tavares, DC (corresponding author), Univ Estadual Norte Fluminense, Lab Ciencias Ambientais, Campos Dos Goytacazes, RJ, Brazil.	wetlandbirdsbrazil@gmail.com	Siciliano, Salvatore/ABD-3352-2020; Siciliano, Salvatore/H-7670-2015; Moura, Jailson F./O-4315-2019; Tavares, Davi Castro/H-7960-2015	Siciliano, Salvatore/0000-0002-0124-8070; Moura, Jailson F./0000-0003-3601-3957; Tavares, Davi Castro/0000-0002-6811-9572	CAPES; Alexander von Humboldt Foundation [BEX 0128/ 14-7]; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior-CAPES	CAPES(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Alexander von Humboldt Foundation(Alexander von Humboldt Foundation); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior-CAPES(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	JF Moura gratefully acknowledges CAPES and the Alexander von Humboldt Foundation for financial support (Proc. BEX 0128/ 14-7). DC Tavares is supported by Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior-CAPES.	Adams J, 2010, MAR BIOL, V157, P915, DOI 10.1007/s00227-009-1367-y; Ainley D. G., 1977, ADAPTATIONS ANTARCTI, P669; Alves VS, 2004, AVES MARINHAS INSULA, P83; Ancona S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072665; Anderson Orea R. J., 2011, Endangered Species Research, V14, P91, DOI 10.3354/esr00347; ASCHOFF J, 1981, COMP BIOCHEM PHYS A, V69, P611, DOI 10.1016/0300-9629(81)90145-6; BAKUN A, 1990, SCIENCE, V247, P198, DOI 10.1126/science.247.4939.198; Bakun A., 1973, COASTAL UPWELLING IN, P103; Bandalos DL, 2014, STRUCT EQU MODELING, V21, P102, DOI 10.1080/10705511.2014.859510; Baptist MJ, 2010, IBIS, V152, P815, DOI 10.1111/j.1474-919X.2010.01054.x; BLUEWEISS L, 1978, OECOLOGIA, V37, P257, DOI 10.1007/BF00344996; BOERSMA PD, 1986, SCIENCE, V231, P373, DOI 10.1126/science.231.4736.373; Bolker BM, 2009, TRENDS ECOL EVOL, V24, P127, DOI 10.1016/j.tree.2008.10.008; Briggs KT, 1997, ICES J MAR SCI, V54, P718, DOI 10.1006/jmsc.1997.0254; Bugoni L, 2007, WILSON J ORNITHOL, V119, P725, DOI 10.1676/06-141.1; Burnham K.P., 2002, PRACTICAL INFORM THE, V2nd ed., DOI [DOI 10.1007/B97636, 10.1007/b97636]; Camphysen CJ, 2001, ENVIRON POLLUT, V112, P443, DOI 10.1016/S0269-7491(00)00138-X; Cardoso Maria Duarte, 2014, Aquatic Biosystems, V10, P6, DOI 10.1186/2046-9063-10-6; Castege I, 2007, ARDEOLA, V54, P289; Chambers LE, 2011, EMU, V111, P235, DOI 10.1071/MU10033; Chapin FS, 2016, ECOLOGY; Coelho EP, 2004, AVES MARINHAS INSULA, P233; Croxall JP, 2012, BIRD CONSERV INT, V22, P1, DOI 10.1017/S0959270912000020; Davies RG, 2010, GLOBAL ECOL BIOGEOGR, V19, P98, DOI 10.1111/j.1466-8238.2009.00498.x; Dawson W. L., 1911, Condor Hollywood, V13, DOI 10.2307/1361963; de Moura JF, 2015, MAR POLLUT BULL, V95, P402, DOI 10.1016/j.marpolbul.2015.03.038; de Moura Jailson Fulgencio, 2009, Marine Biodiversity Records, V2, pe66, DOI 10.1017/S1755267209000803; Edenhofer O., 2014, CONTRIBUTION WORKING; Efe MA, 2011, REV BRAS ORNITOL, V19, P358; Epskamp S, 2015, STRUCT EQU MODELING, V22, P474, DOI 10.1080/10705511.2014.937847; Fiedler PC, 2013, MAR ECOL PROG SER, V484, P1, DOI 10.3354/meps10378; Finney SK, 1999, J AVIAN BIOL, V30, P23, DOI 10.2307/3677239; Fonderflick J, 2015, BIOL CONSERV, V192, P120, DOI 10.1016/j.biocon.2015.09.012; Ford R. Glenn, 2009, Marine Ornithology, V37, P205; Ford R. Glenn, 2006, Marine Ornithology, V34, P91; Fort J, 2015, SCI TOTAL ENVIRON, V527, P448, DOI 10.1016/j.scitotenv.2015.05.018; Fulmer EB, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134734; Garcia-Borboroglu P, 2006, MAR POLLUT BULL, V52, P193, DOI 10.1016/j.marpolbul.2005.11.004; Garcia-Borboroglu P, 2010, MAR POLLUT BULL, V60, P1652, DOI 10.1016/j.marpolbul.2010.07.006; Garthe S, 2009, MAR ECOL PROG SER, V391, P243, DOI 10.3354/meps08170; Geraci J. R., 2005, MARINE MAMMALS ASHOR; Godoy JM, 2014, J ENVIRON RADIOACTIV, V135, P108, DOI 10.1016/j.jenvrad.2014.04.008; Gomez-Gesteira M, 2006, J GEOPHYS RES-OCEANS, V111, DOI 10.1029/2005JC003331; Grace J.B., 2006, STRUCT EQ MOD NAT; Grace JB, 2016, NATURE, V529, P390, DOI 10.1038/nature16524; Grace JB, 2012, ECOSPHERE, V3, DOI 10.1890/ES12-00048.1; Grueber CE, 2011, J EVOLUTION BIOL, V24, P699, DOI 10.1111/j.1420-9101.2010.02210.x; Hampton Steve, 2006, Marine Ornithology, V34, P109; Haney JC, 2014, MAR ECOL PROG SER, V513, P239, DOI 10.3354/meps10839; HANEY JC, 1988, MAR ECOL PROG SER, V49, P1, DOI 10.3354/meps049001; Hansen JE, 2001, FISH OCEANOGR, V10, P193, DOI 10.1046/j.1365-2419.2001.00166.x; Hart KM, 2006, BIOL CONSERV, V129, P283, DOI 10.1016/j.biocon.2005.10.047; Hass T, 2012, MAR ECOL PROG SER, V454, P251, DOI 10.3354/meps09723; Henkel LA, 2006, J FIELD ORNITHOL, V77, P151, DOI 10.1111/j.1557-9263.2006.00035.x; Henkel LA, 2014, MAR POLLUT BULL, V79, P155, DOI 10.1016/j.marpolbul.2013.12.023; Hu LT, 1999, STRUCT EQU MODELING, V6, P1, DOI 10.1080/10705519909540118; Hyrenbach KD, 2007, DEEP-SEA RES PT I, V54, P1129, DOI 10.1016/j.dsr.2007.05.002; IPCC, 2007, SYNTH REP 4 ASS REP; Knutson TR, 2010, NAT GEOSCI, V3, P157, DOI 10.1038/NGEO779; Krueger Lucas, 2011, Oecologia Australis, V15, P51; LANGHAM NP, 1986, EMU, V86, P23, DOI 10.1071/MU9860023; Lavers JL, 2014, ENVIRON POLLUT, V187, P124, DOI 10.1016/j.envpol.2013.12.020; Long DG., 1994, DISPLAY COMPUTATION; Madsen V, 2007, AM NAT, V169, pS93, DOI 10.1086/510096; Mateus M, 2014, FORENSIC SCI INT, V238, pE15, DOI 10.1016/j.forsciint.2014.02.026; MATSUURA Y, 1975, Boletim do Instituto Oceanografico, V24, P31; Maurel N, 2016, GLOBAL ECOL BIOGEOGR; Mohriak WU, 2012, GEOL SOC SPEC PUBL, V363, P131, DOI 10.1144/SP363.7; Morrison KW, 2011, AUK, V128, P707, DOI 10.1525/auk.2011.10198; Moura JF, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0146108; Moura JF, 2012, BIODIVERS CONSERV, P263; Munilla I, 2011, ECOSPHERE, V2, DOI 10.1890/ES11-00020.1; Newman Scott H., 2006, Marine Ornithology, V34, P87; Newton I, 2006, J ORNITHOL, V147, P146, DOI 10.1007/s10336-006-0058-4; Newton I, 2008, MIGRATION ECOLOGY OF BIRDS, P1; Newton KM, 2009, MAR ECOL PROG SER, V392, P295, DOI 10.3354/meps08152; Nummi P, 2013, IBIS, V155, P68, DOI 10.1111/ibi.12013; O'Hara P. D., 2006, Marine Ornithology, V34, P133; Page G.W., 1990, Studies in Avian Biology, P164; Paleczny M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129342; Parrish JK, 2007, MAR ECOL PROG SER, V352, P275, DOI 10.3354/meps07077; Phillips RA, 2010, BIOL CONSERV, V143, P501, DOI 10.1016/j.biocon.2009.11.020; Prado JHF, 2013, ECOL INDIC, V32, P35, DOI 10.1016/j.ecolind.2013.03.005; Rosseel Y, 2013, LAVAAN LATENT VARIAB; Schreiber Elizabeth, 2002, BIOL MARINE BIRDS, DOI 10.1201/9781420036305; Schreiber JB, 2006, J EDUC RES, V99, P323, DOI 10.3200/JOER.99.6.323-338; Schwing FB, 1996, NOAA TECH MEMO NMFS; Seys J, 2002, MAR POLLUT BULL, V44, P322, DOI 10.1016/S0025-326X(01)00262-4; Shealer D., 1999, BIRDS N AM, P566; Soanes LM, 2016, MAR POLICY, V70, P85, DOI 10.1016/j.marpol.2016.04.019; Speakman JR, 2005, J EXP BIOL, V208, P1717, DOI 10.1242/jeb.01556; Sydeman WJ, 2015, SCIENCE, V350, P772, DOI 10.1126/science.aac9874; Tavares DC, 2016, ECOL INDIC, V70, P10, DOI 10.1016/j.ecolind.2016.06.005; Tavares DC, 2015, BIOL CONSERV, V186, P12, DOI 10.1016/j.biocon.2015.02.027; Tavares Davi Castro, 2013, Check List, V9, P806; Tavares Davi Castro, 2013, Journal of Threatened Taxa, V5, P4586; Valentin JL, 2001, ECOL STU AN, V144, P97; Verlis KM, 2014, MAR POLLUT BULL, V87, P180, DOI 10.1016/j.marpolbul.2014.07.060; Verwey J., 1915, LEVENDE NAT, V20; Votier SC, 2008, J ANIM ECOL, V77, P974, DOI 10.1111/j.1365-2656.2008.01421.x; Votier SC, 2005, ECOL LETT, V8, P1157, DOI 10.1111/j.1461-0248.2005.00818.x; Weimerskirch H, 2008, MAR ECOL PROG SER, V362, P291, DOI 10.3354/meps07424; Weimerskirch H, 2012, SCIENCE, V335, P211, DOI 10.1126/science.1210270; Weimerskirch H, 2009, MAR ECOL PROG SER, V391, P267, DOI 10.3354/meps07981; Wiese FK, 2003, MAR POLLUT BULL, V46, P1090, DOI 10.1016/S0025-326X(03)00250-9; Wiese Francis K., 2006, Marine Ornithology, V34, P157; Wilhelm SI, 2009, MAR POLLUT BULL, V58, P249, DOI 10.1016/j.marpolbul.2008.09.018; Wolf SG, 2010, GLOBAL CHANGE BIOL, V16, P1923, DOI 10.1111/j.1365-2486.2010.02194.x; Wolfaardt Anton C., 2012, Marine Ornithology, V40, P129; Woodruff JD, 2013, NATURE, V504, P44, DOI 10.1038/nature12855; Zuur Alain F., 2009, P1; Zydelis R, 2009, BIOL CONSERV, V142, P1269, DOI 10.1016/j.biocon.2009.02.025	112	21	21	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2016	11	12							e0168717	10.1371/journal.pone.0168717	http://dx.doi.org/10.1371/journal.pone.0168717			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI8LN	27992578	Green Published, Green Submitted, gold			2022-12-27	WOS:000392758000075
J	Jenny, FH; Basler, K				Jenny, Fabian H.; Basler, Konrad			Drosophila DDX3/Belle Exerts Its Function Outside of the Wnt/Wingless Signaling Pathway	PLOS ONE			English	Article							RNA HELICASE; OVERGROWN PROMOTES; WINGLESS; CATENIN; DDX3; EXPRESSION; FAMILY; CELLS	The helicases human DDX3 and Drosophila Belle (Bel) are part of a well-defined subfamily of the DEAD-box helicases. Individual subfamily-members perform a myriad of functions in nuclear and cytosolic RNA metabolism. It has also been reported that DDX3X is involved in cell signaling, including IFN-alpha and IFN-beta inducing pathways upon viral infection as well as in Wnt signaling. Here we used a collection of EMS-induced bel alleles recovered from a Wingless (Wg) suppressor screen to analyze the role of the Drosophila homolog of DDX3 in Wg/Wnt signaling. These EMS alleles, as well as a P-element induced null allele and RNAimediated knock down of bel, all suppressed the phenotype of ectopic Wg signaling in the eye. However, they did not affect the expression of known Wg target genes like senseless, Distalless or wingful/Notum. Ectopic Wg signaling in eye imaginal discs induces apoptosis by increasing grim expression. Mutations in bel revert grim expression to wild-type levels. Together, these results indicate that Bel does not function as a core component in the Drosophila Wg pathway, and that mutations affecting its helicase function suppress the effects of ectopic Wg signaling downstream of the canonical pathway.	[Jenny, Fabian H.; Basler, Konrad] Univ Zurich, Inst Mol Life Sci, Zurich, Switzerland	University of Zurich	Basler, K (corresponding author), Univ Zurich, Inst Mol Life Sci, Zurich, Switzerland.	konrad.basler@imls.uzh.ch		Basler, Konrad/0000-0003-3534-1529	Swiss National Science Foundation; University of Zurich	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); University of Zurich	This work was financially supported by the Swiss National Science Foundation and the University of Zurich.	Anders S, 2015, BIOINFORMATICS, V31, P166, DOI 10.1093/bioinformatics/btu638; Andrews S, 2011, BABRAHAM BIOINFORMAT; Banziger C, 2006, CELL, V125, P509, DOI 10.1016/j.cell.2006.02.049; Brunner E, 1997, NATURE, V385, P829, DOI 10.1038/385829a0; Brunner E, 1999, DEV BIOL, V206, P178, DOI 10.1006/dbio.1998.9136; Cong F, 2004, MOL CELL BIOL, V24, P2000, DOI 10.1128/MCB.24.5.2000-2011.2004; Cruciat CM, 2013, SCIENCE, V339, P1436, DOI 10.1126/science.1231499; DasGupta R, 2005, SCIENCE, V308, P826, DOI 10.1126/science.1109374; DeVorkin Lindsay, 2014, Cold Spring Harb Protoc, V2014, P951, DOI 10.1101/pdb.prot080325; Fairman-Williams ME, 2010, CURR OPIN STRUC BIOL, V20, P313, DOI 10.1016/j.sbi.2010.03.011; Fogel JL, 2012, JOVE-J VIS EXP, V68, P1; Franca R, 2007, PROTEINS, V67, P1128, DOI 10.1002/prot.21433; Garbelli A, 2011, CURR MED CHEM, V18, P3015, DOI 10.2174/092986711796391688; Guan J, 2007, DEV BIOL, V303, P16, DOI 10.1016/j.ydbio.2006.10.028; Havugimana PC, 2012, CELL, V150, P1068, DOI 10.1016/j.cell.2012.08.011; Klein TJ, 2006, CURR BIOL, V16, P1337, DOI 10.1016/j.cub.2006.06.030; Kramps T, 2002, CELL, V109, P47, DOI 10.1016/S0092-8674(02)00679-7; Linder P, 2011, NAT REV MOL CELL BIO, V12, P505, DOI 10.1038/nrm3154; Poulton JS, 2011, DEVELOPMENT, V138, P1737, DOI 10.1242/dev.059352; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Sharma D, 2014, CRIT REV BIOCHEM MOL, V49, P343, DOI 10.3109/10409238.2014.931339; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120	22	1	1	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2016	11	12							e0166862	10.1371/journal.pone.0166862	http://dx.doi.org/10.1371/journal.pone.0166862			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EG7JB	28030561	Green Published, gold, Green Submitted, Green Accepted			2022-12-27	WOS:000391222000004
J	Matsubara, T; Matsuo, K; Harada, K; Nakano, M; Nakashima, M; Watanuki, T; Egashira, K; Furukawa, M; Matsunaga, N; Watanabe, Y				Matsubara, Toshio; Matsuo, Koji; Harada, Kenichiro; Nakano, Masayuki; Nakashima, Mami; Watanuki, Toshio; Egashira, Kazuteru; Furukawa, Matakazu; Matsunaga, Naofumi; Watanabe, Yoshifumi			Distinct and Shared Endophenotypes of Neural Substrates in Bipolar and Major Depressive Disorders	PLOS ONE			English	Article							SUBGENUAL CINGULATE VOLUMES; VOXEL-BASED MORPHOMETRY; GREY-MATTER; COGNITIVE INHIBITION; 1ST-DEGREE RELATIVES; EXECUTIVE FUNCTION; JAPANESE VERSION; META-REGRESSION; INSULAR CORTEX; WORKING-MEMORY	Little is known about disorder-specific biomarkers of bipolar disorder (BD) and major depressive disorder (MDD). Our aim was to determine a neural substrate that could be used to distinguish BD from MDD. Our study included a BD group (10 patients with BD, 10 first degree relatives (FDRs) of individuals with BD), MDD group (17 patients with MDD, 17 FDRs of individuals with MDD), and 27 healthy individuals. Structural and functional brain abnormalities were evaluated by voxel-based morphometry and a trail making test (TMT), respectively. The BD group showed a significant main effect of diagnosis in the gray matter (GM) volume of the anterior cingulate cortex (ACC; p = 0.01) and left insula (p < 0.01). FDRs of individuals with BD showed significantly smaller left ACC GM volume than healthy subjects (p < 0.01), and patients with BD showed significantly smaller ACC (p < 0.01) and left insular GM volume (p < 0.01) than healthy subjects. The MDD group showed a tendency toward a main effect of diagnosis in the right and left insular GM volume. The BD group showed a significantly inverse correlation between the left insular GM volume and TMT-A scores (p < 0.05). Our results suggest that the ACC volume could be a distinct endophenotype of BD, while the insular volume could be a shared BD and MDD endophenotype. Moreover, the insula could be associated with cognitive decline and poor outcome in BD.	[Matsubara, Toshio; Matsuo, Koji; Harada, Kenichiro; Nakano, Masayuki; Nakashima, Mami; Watanuki, Toshio; Egashira, Kazuteru; Watanabe, Yoshifumi] Yamaguchi Univ, Grad Sch Med, Dept Neurosci, Div Neuropsychiat, Ube, Yamaguchi, Japan; [Matsubara, Toshio] Yamaguchi Univ Org Univ Educ, Hlth Serv Ctr, Yamaguchi, Yamaguchi, Japan; [Nakano, Masayuki] Katakura Hosp, Ube, Yamaguchi, Japan; [Nakashima, Mami] Nagato Ichinomiya Hosp, Shimonoseki, Yamaguchi, Japan; [Egashira, Kazuteru] Egashira Clin, Fukuoka, Japan; [Furukawa, Matakazu; Matsunaga, Naofumi] Yamaguchi Univ, Grad Sch Med, Dept Radiol, Ube, Yamaguchi, Japan	Yamaguchi University; Yamaguchi University	Matsuo, K (corresponding author), Yamaguchi Univ, Grad Sch Med, Dept Neurosci, Div Neuropsychiat, Ube, Yamaguchi, Japan.	kmatsuo@yamaguchi-u.ac.jp			JSPS KAKENHI [24591716, 15K09832, 25861011, 25861012]; Ministry of Education, Science, Sports and Culture of Japan	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Ministry of Education, Science, Sports and Culture of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by JSPS KAKENHI (https://www.jsps.go.jp/j-grantsinaid/) with grant numbers 24591716, 15K09832, 25861011, 25861012, and a Grant-in-Aid for Scientific Research on Innovative Areas (Comprehensive Brain Science Network) from the Ministry of Education, Science, Sports and Culture of Japan. A part of this study contained results of "Integrated Research on Neuropsychiatric Disorders" carried out under the Strategic Research Program for Brain Sciences by the Ministry of Education, Culture, Sports, Science and Technology of Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amico F, 2011, J PSYCHIATR NEUROSCI, V36, P15, DOI 10.1503/jpn.090186; Arnone D, 2013, MOL PSYCHIATR, V18, P1265, DOI 10.1038/mp.2012.150; Arnone D, 2012, EUR NEUROPSYCHOPHARM, V22, P1, DOI 10.1016/j.euroneuro.2011.05.003; Arnone D, 2009, BRIT J PSYCHIAT, V195, P194, DOI 10.1192/bjp.bp.108.059717; Baare WFC, 2010, J PSYCHIATR RES, V44, P655, DOI 10.1016/j.jpsychires.2009.12.009; Bearden CE, 2007, BIOL PSYCHIAT, V62, P7, DOI 10.1016/j.biopsych.2006.10.027; Benedetti F, 2011, J AFFECT DISORDERS, V135, P139, DOI 10.1016/j.jad.2011.07.006; Bertelsen A, 1997, BRIT J PSYCHIAT, V130, P330; Bora E, 2012, PSYCHOL MED, V42, P295, DOI 10.1017/S0033291711001450; Bora E, 2012, J AFFECT DISORDERS, V138, P9, DOI 10.1016/j.jad.2011.03.049; Bora E, 2010, BIOL PSYCHIAT, V67, P1097, DOI 10.1016/j.biopsych.2010.01.020; Bora E, 2009, J AFFECT DISORDERS, V113, P1, DOI 10.1016/j.jad.2008.06.009; Bora E, 2008, PSYCHIAT RES, V161, P318, DOI 10.1016/j.psychres.2007.09.002; Bourne C, 2013, ACTA PSYCHIAT SCAND, V128, P149, DOI 10.1111/acps.12133; Cai Y, 2015, NEUROSCI BULL, V31, P4, DOI 10.1007/s12264-014-1485-5; Cao B, 2016, J PSYCHIATR RES, V81, P48, DOI 10.1016/j.jpsychires.2016.06.006; de Almeida JRC, 2013, BIOL PSYCHIAT, V73, P111, DOI 10.1016/j.biopsych.2012.06.010; Du MY, 2014, J PSYCHIATR NEUROSCI, V39, P397, DOI 10.1503/jpn.130275; Ellison-Wright I, 2010, SCHIZOPHR RES, V117, P1, DOI 10.1016/j.schres.2009.12.022; Gasquoine PG, 2013, NEUROSCI BIOBEHAV R, V37, P340, DOI 10.1016/j.neubiorev.2013.01.002; Giakoumatos CI, 2013, J PSYCHIATR RES, V47, P1389, DOI 10.1016/j.jpsychires.2013.06.011; Glahn DC, 2004, BIPOLAR DISORD, V6, P171, DOI 10.1111/j.1399-5618.2004.00113.x; Gohier B, 2009, J AFFECT DISORDERS, V116, P100, DOI 10.1016/j.jad.2008.10.028; Goodwin FK, 2007, MANIC DEPRESSIVE ILL; Hajek T, 2005, BIPOLAR DISORD, V7, P393, DOI 10.1111/j.1399-5618.2005.00238.x; Hajek T, 2008, J AFFECT DISORDERS, V108, P263, DOI 10.1016/j.jad.2007.10.024; Hajek T, 2008, J PSYCHIATR NEUROSCI, V33, P91; Hajek T, 2013, BIOL PSYCHIAT, V73, P144, DOI 10.1016/j.biopsych.2012.06.015; HAMILTON M, 1960, J NEUROL NEUROSUR PS, V23, P56, DOI 10.1136/jnnp.23.1.56; He H, 2016, J AFFECT DISORDERS, V190, P483, DOI 10.1016/j.jad.2015.10.042; Hirschfeld RMA, 2003, J CLIN PSYCHIAT, V64, P161, DOI 10.4088/JCP.v64n0209; Jacobson SC, 2011, BRAIN COGNITION, V77, P60, DOI 10.1016/j.bandc.2011.06.001; Jie NF, 2015, IEEE T AUTON MENT DE, V7, P320, DOI 10.1109/TAMD.2015.2440298; Keefe RSE, 2014, J CLIN PSYCHIAT, V75, P864, DOI 10.4088/JCP.13r08609; Kempton MJ, 2008, ARCH GEN PSYCHIAT, V65, P1017, DOI 10.1001/archpsyc.65.9.1017; Kempton MJ, 2011, ARCH GEN PSYCHIAT, V68, P675, DOI 10.1001/archgenpsychiatry.2011.60; Kempton MJ, 2009, J NEUROSCI, V29, P10863, DOI 10.1523/JNEUROSCI.2204-09.2009; Klein DN, 2001, ARCH GEN PSYCHIAT, V58, P13, DOI 10.1001/archpsyc.58.1.13; Koutsouleris N, 2010, SCHIZOPHR RES, V123, P160, DOI 10.1016/j.schres.2010.08.026; Lai CH, 2013, PSYCHIAT RES-NEUROIM, V211, P37, DOI 10.1016/j.pscychresns.2012.06.006; Leboyer M, 1998, TRENDS NEUROSCI, V21, P102, DOI 10.1016/S0166-2236(97)01187-9; Liu CH, 2014, NEUROSCIENCE, V262, P190, DOI 10.1016/j.neuroscience.2013.12.058; Matsuo K, 2012, MOL PSYCHIATR, V17, P412, DOI 10.1038/mp.2011.3; Matsuoka K, 2006, PSYCHIAT CLIN NEUROS, V60, P332, DOI 10.1111/j.1440-1819.2006.01510.x; McDonald C, 2004, ARCH GEN PSYCHIAT, V61, P974, DOI 10.1001/archpsyc.61.10.974; McDonald C, 2004, BIOL PSYCHIAT, V56, P411, DOI 10.1016/j.biopsych.2004.06.021; Menon V, 2010, BRAIN STRUCT FUNCT, V214, P655, DOI 10.1007/s00429-010-0262-0; Mortensen PB, 2003, ARCH GEN PSYCHIAT, V60, P1209, DOI 10.1001/archpsyc.60.12.1209; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Otsubo T, 2005, PSYCHIAT CLIN NEUROS, V59, P517, DOI 10.1111/j.1440-1819.2005.01408.x; Phillips ML, 2008, AM J PSYCHIAT, V165, P313, DOI 10.1176/appi.ajp.2007.07071066; Preiss M, 2009, PSYCHIAT RES, V169, P235, DOI 10.1016/j.psychres.2008.06.042; Redlich R, 2014, JAMA PSYCHIAT, V71, P1222, DOI 10.1001/jamapsychiatry.2014.1100; Richard-Devantoy S, 2012, J AFFECT DISORDERS, V140, P193, DOI 10.1016/j.jad.2012.03.006; Robinson LJ, 2006, BIPOLAR DISORD, V8, P103, DOI 10.1111/j.1399-5618.2006.00277.x; Romanczuk-Seiferth N, 2014, NEUROIMAGE-CLIN, V5, P62, DOI 10.1016/j.nicl.2014.05.015; Ryan KA, 2012, BIPOLAR DISORD, V14, P527, DOI 10.1111/j.1399-5618.2012.01032.x; Sacher J, 2012, J AFFECT DISORDERS, V140, P142, DOI 10.1016/j.jad.2011.08.001; Savitz JB, 2011, BIOL PSYCHIAT, V69, P336, DOI 10.1016/j.biopsych.2010.09.027; Schermuly I, 2011, J AFFECT DISORDERS, V135, P405, DOI 10.1016/j.jad.2011.07.017; Schmitz N, 2006, BIOL PSYCHIAT, V59, P7, DOI 10.1016/j.biopsych.2005.06.007; Schulze KK, 2011, BIPOLAR DISORD, V13, P208, DOI 10.1111/j.1399-5618.2011.00901.x; Selvaraj S, 2012, BIPOLAR DISORD, V14, P135, DOI 10.1111/j.1399-5618.2012.01000.x; Singer T, 2006, NEUROSCI BIOBEHAV R, V30, P855, DOI 10.1016/j.neubiorev.2006.06.011; Singer T, 2009, TRENDS COGN SCI, V13, P334, DOI 10.1016/j.tics.2009.05.001; Smith R, 2013, J AFFECT DISORDERS, V146, P414, DOI 10.1016/j.jad.2012.07.029; Takahashi T, 2010, J AFFECT DISORDERS, V121, P231, DOI 10.1016/j.jad.2009.06.003; van Erp TGM, 2012, HUM BRAIN MAPP, V33, P501, DOI 10.1002/hbm.21239; Vinberg M, 2013, J CLIN PSYCHIAT, V74, pE747, DOI 10.4088/JCP.12m08258; Wagner S, 2012, ACTA PSYCHIAT SCAND, V125, P281, DOI 10.1111/j.1600-0447.2011.01762.x; YOUNG RC, 1978, BRIT J PSYCHIAT, V133, P429, DOI 10.1192/bjp.133.5.429; Yuan P, 2014, NEUROSCI BIOBEHAV R, V42, P180, DOI 10.1016/j.neubiorev.2014.02.005; Zakzanis KK, 2005, NEUROPSYCHOLOGIA, V43, P1878, DOI 10.1016/j.neuropsychologia.2005.03.013; Zimmerman ME, 2006, BIPOLAR DISORD, V8, P281, DOI 10.1111/j.1399-5618.2006.00298.x	74	17	17	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2016	11	12							e0168493	10.1371/journal.pone.0168493	http://dx.doi.org/10.1371/journal.pone.0168493			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EG7JB	28030612	Green Published, gold, Green Submitted			2022-12-27	WOS:000391222000051
J	Morato, RG; Stabach, JA; Fleming, CH; Calabrese, JM; De Paula, RC; Ferraz, KMPM; Kantek, DLZ; Miyazaki, SS; Pereira, TDC; Araujo, GR; Paviolo, A; De Angelo, C; Di Bitetti, MS; Cruz, P; Lima, F; Cullen, L; Sana, DA; Ramalho, EE; Carvalho, MM; Soares, FHS; Zimbres, B; Silva, MX; Moraes, MDF; Vogliotti, A; May, JA; Haberfeld, M; Rampim, L; Sartorello, L; Ribeiro, MC; Leimgruber, P				Morato, Ronaldo G.; Stabach, Jared A.; Fleming, Chris H.; Calabrese, Justin M.; De Paula, Rogerio C.; Ferraz, Katia M. P. M.; Kantek, Daniel L. Z.; Miyazaki, Selma S.; Pereira, Thadeu D. C.; Araujo, Gediendson R.; Paviolo, Agustin; De Angelo, Carlos; Di Bitetti, Mario S.; Cruz, Paula; Lima, Fernando; Cullen, Laury; Sana, Denis A.; Ramalho, Emiliano E.; Carvalho, Marina M.; Soares, Fabio H. S.; Zimbres, Barbara; Silva, Marina X.; Moraes, Marcela D. F.; Vogliotti, Alexandre; May, Joares A., Jr.; Haberfeld, Mario; Rampim, Lilian; Sartorello, Leonardo; Ribeiro, Milton C.; Leimgruber, Peter			Space Use and Movement of a Neotropical Top Predator: The Endangered Jaguar	PLOS ONE			English	Article							PANTHERA-ONCA; HABITAT; ECOLOGY; STRATEGIES; CARNIVORES; LANDSCAPE; MODEL; RISK	Accurately estimating home range and understanding movement behavior can provide important information on ecological processes. Advances in data collection and analysis have improved our ability to estimate home range and movement parameters, both of which have the potential to impact species conservation. Fitting continuous-time movement model to data and incorporating the autocorrelated kernel density estimator (AKDE), we investigated range residency of forty-four jaguars fit with GPS collars across five biomes in Brazil and Argentina. We assessed home range and movement parameters of range resident animals and compared AKDE estimates with kernel density estimates (KDE). We accounted for differential space use and movement among individuals, sex, region, and habitat quality. Thirty-three (80%) of collared jaguars were range resident. Home range estimates using AKDE were 1.02 to 4.80 times larger than KDE estimates that did not consider autocorrelation. Males exhibited larger home ranges, more directional movement paths, and a trend towards larger distances traveled per day. Jaguars with the largest home ranges occupied the Atlantic Forest, a biome with high levels of deforestation and high human population density. Our results fill a gap in the knowledge of the species' ecology with an aim towards better conservation of this endangered/critically endangered carnivore the top predator in the Neotropics.	[Morato, Ronaldo G.; De Paula, Rogerio C.] Inst Chico Mendes Conservacao Biodiversidade, Ctr Nacl Pesquisa & Conservacao Mamiferos Carnivo, Sao Paulo, Brazil; [Morato, Ronaldo G.; Stabach, Jared A.; Fleming, Chris H.; Calabrese, Justin M.; Leimgruber, Peter] Smithsonian Conservat Biol Inst, Conservat Ecol Ctr, Natl Zool Pk, Front Royal, VA 22630 USA; [Morato, Ronaldo G.; De Paula, Rogerio C.; Ferraz, Katia M. P. M.; Sana, Denis A.; Ramalho, Emiliano E.] Inst Procarnivoros, Sao Paulo, Brazil; [Ferraz, Katia M. P. M.] Univ Sao Paulo, Escola Super Agr Luiz de Queiroz, Piracicaba, Brazil; [Kantek, Daniel L. Z.; Miyazaki, Selma S.; Pereira, Thadeu D. C.] Inst Chico Mendes Conservacao Biodiversidade, Estacao Ecol Taiama, Caceres, Mato Grosso, Brazil; [Araujo, Gediendson R.] Univ Fed Vicosa, Dept Med Vet, Vicosa, MG, Brazil; [Paviolo, Agustin; De Angelo, Carlos; Di Bitetti, Mario S.; Cruz, Paula] Univ Nacl Misiones, Inst Biol Subtrop, Puerto Iguazu, Argentina; [Paviolo, Agustin; De Angelo, Carlos; Di Bitetti, Mario S.; Cruz, Paula] Consejo Nacl Invest Cient & Tecn, Puerto Iguazu, Argentina; [Lima, Fernando; Cullen, Laury] IPE, Sao Paulo, Brazil; [Lima, Fernando; Ribeiro, Milton C.] Univ Estadual Sao Paulo, Inst Biociencias, Lab Ecol Espacial & Conservacao, Sao Paulo, Brazil; [Sana, Denis A.] Univ Fed Rio Grande do Sul, Programa Posgrad Ecol, Porto Alegre, RS, Brazil; [Ramalho, Emiliano E.] Inst Desenvolvimento Sustentavel Mamiraua, Tefe, Amazonas, Brazil; [Carvalho, Marina M.; Soares, Fabio H. S.] Inst Def & Preservacao Felideos Brasileiros, Corumba De Goias, Go, Brazil; [Zimbres, Barbara] Univ Brasilia, Inst Ciencias Biol, Programa Posgrad Zool, Brasilia, DF, Brazil; [Silva, Marina X.; Moraes, Marcela D. F.] Inst Chico Mendes Conservacao Biodiversidade, Projeto Carnivoros Iguacu, Parque Nacl Iguacu, Foz Do Iguacu, Parana, Brazil; [Vogliotti, Alexandre] Univ Fed Integracao Latino Amer, Foz Do Iguacu, Parana, Brazil; [May, Joares A., Jr.; Haberfeld, Mario; Rampim, Lilian; Sartorello, Leonardo] Projeto Oncafari Miranda, Miranda, MS, Brazil	Smithsonian Institution; Smithsonian National Zoological Park & Conservation Biology Institute; Universidade de Sao Paulo; Universidade Federal de Vicosa; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); Universidade de Sao Paulo; Universidade Estadual Paulista; Universidade Federal do Rio Grande do Sul; Universidade de Brasilia; Universidade Federal da Integracao Latino-Americana	Morato, RG (corresponding author), Inst Chico Mendes Conservacao Biodiversidade, Ctr Nacl Pesquisa & Conservacao Mamiferos Carnivo, Sao Paulo, Brazil.; Morato, RG (corresponding author), Smithsonian Conservat Biol Inst, Conservat Ecol Ctr, Natl Zool Pk, Front Royal, VA 22630 USA.; Morato, RG (corresponding author), Inst Procarnivoros, Sao Paulo, Brazil.	ronaldo.morato@icmbio.gov.br; paviolo4@gmail.com; pardalismitis@gmail.com; eeramalho@gmail.com; mmaribio@gmail.com; haberfeldm@gmail.com	Stabach, Jared/AEX-9187-2022; Kantek, Daniel/AAJ-4781-2021; Ferraz, Katia Maria P. M. B./D-7244-2012; Lima, Fernando/E-8023-2016; May-Junior, Joares Adenilson/AAC-3220-2019; Leimgruber, Peter/O-1304-2015; Sana, Denis/AAE-1570-2019; Calabrese, Justin/B-9131-2012; DE PAULA, ROGERIO/S-2182-2017	Stabach, Jared/0000-0002-7896-1237; Ferraz, Katia Maria P. M. B./0000-0002-7870-8696; Lima, Fernando/0000-0002-8644-9647; May-Junior, Joares Adenilson/0000-0002-0007-9690; Leimgruber, Peter/0000-0002-3682-0153; Calabrese, Justin/0000-0003-0575-6408; Di Bitetti, Mario/0000-0001-9704-8649; DE PAULA, ROGERIO/0000-0003-1943-8320; Morato, Ronaldo/0000-0002-8304-9779	FAPESP [2013-10029-6, 2014-24921-0]; Cat Heaven Endangered Species-Project Survival; Dallas World Aquarium; Orient Express Hotels do Brasil; WWF Switzerland-Fundacion Vida Silvestre Argentina; Panthera Foundation; Rufford Small Grant Foundation; CNPq [312045/2013-1]; National Science Foundation [ABI 1458748]; National Foundation Grant	FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Cat Heaven Endangered Species-Project Survival; Dallas World Aquarium; Orient Express Hotels do Brasil; WWF Switzerland-Fundacion Vida Silvestre Argentina; Panthera Foundation; Rufford Small Grant Foundation; CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); National Science Foundation(National Science Foundation (NSF)); National Foundation Grant	This work was supported by FAPESP (2013-10029-6) to RGM, Cat Heaven Endangered Species-Project Survival to RGM, Dallas World Aquarium to RGM, Orient Express Hotels do Brasil to MSX, WWF Switzerland-Fundacion Vida Silvestre Argentina to AP, Panthera Foundation to EER, Rufford Small Grant Foundation to EER, FAPESP (2014-24921-0) to RGM, CNPq (312045/2013-1) to MCR, National Science Foundation Grant (ABI 1458748) to JMC, and National Foundation Grant to CHF. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; [Anonymous], [No title captured]; [Anonymous], 2012, LIBRO ROJO MAMIFEROS; ASTETE S., 2007, CAT NEWS, V4, P9; Balme GA, 2009, BIOL CONSERV, V142, P2681, DOI 10.1016/j.biocon.2009.06.020; Blackwell PG, 2016, METHODS ECOL EVOL, V7, P184, DOI 10.1111/2041-210X.12460; Boone RB, 2006, ECOLOGY, V87, P1987, DOI 10.1890/0012-9658(2006)87[1987:SWMPMF]2.0.CO;2; Bright EA, 2012, LANDSCAN 2011 DIGIT; Calabrese JM, 2016, METHODS ECOL EVOL; Cardillo M, 2004, PLOS BIOL; Carvalho EAR, 2015, BASIC APPL ECOL, V16, P413, DOI 10.1016/j.baae.2015.03.005; de Azevedo FCC, 2007, BIOL CONSERV, V137, P391, DOI 10.1016/j.biocon.2007.02.022; Caso A., 2008, IUCN RED LIST THREAT; Cavalcanti SMC, 2009, J MAMMAL, V90, P935, DOI 10.1644/08-MAMM-A-188.1; Chapman BB, 2014, ANIMAL MOVEMENT ACROSS SCALES, P11; Chetkiewicz CLB, 2009, J APPL ECOL, V46, P1036, DOI 10.1111/j.1365-2664.2009.01686.x; Colchero F, 2011, ANIM CONSERV, V14, P158, DOI 10.1111/j.1469-1795.2010.00406.x; Conde DA, 2010, BIOL CONSERV, V143, P1980, DOI 10.1016/j.biocon.2010.04.049; Crawshaw, 1995, COMP ECOLOGY OCELOT; CRAWSHAW PG, 1991, J ZOOL, V223, P357, DOI 10.1111/j.1469-7998.1991.tb04770.x; Crooks KR, 2002, CONSERV BIOL, V16, P488, DOI 10.1046/j.1523-1739.2002.00386.x; Cullen Junior L., 2005, Natureza & Conservacao, V3, P43; De Angelo C, 2013, BIOL CONSERV, V159, P422, DOI 10.1016/j.biocon.2012.12.021; De Angelo C, 2011, DIVERS DISTRIB, V17, P422, DOI 10.1111/j.1472-4642.2011.00746.x; Fahrig L, 2007, FUNCT ECOL, V21, P1003, DOI 10.1111/j.1365-2435.2007.01326.x; Fleming CH, 2015, ECOLOGY, V96, P1182, DOI 10.1890/14-2010.1; Fleming C.H., 2015, CTMM CONTINUOUS TIME; Fleming CH, 2015, PHYS REV E, V91, DOI 10.1103/PhysRevE.91.032107; Fleming CH, 2014, AM NAT, V183, pE154, DOI 10.1086/675504; Fleming CH, 2014, METHODS ECOL EVOL, V5, P462, DOI 10.1111/2041-210X.12176; Gelman A., 2006, DATA ANAL USING REGR, DOI DOI 10.2277/0521867061; Gelman A., 1992, STAT SCI, V7, P457, DOI [10.1214/ss/1177011136, DOI 10.1214/SS/1177011136]; Horne JS, 2006, ECOLOGY, V87, P1146, DOI 10.1890/0012-9658(2006)87[1146:STBHRM]2.0.CO;2; Kanda Z, 2015, ECOLOGIA MOVIMENTO D; Kery M., 2010, INTRO WINBUGS ECOLOG; Kittle AM, 2015, J ANIM ECOL, V84, P1177, DOI 10.1111/1365-2656.12366; Leal I.R., 2005, MEGADIVERSIDADE, V1, P139; Liu JG, 1999, CONSERV BIOL, V13, P1360, DOI 10.1046/j.1523-1739.1999.98418.x; MACDONALD DW, 1983, NATURE, V301, P379, DOI 10.1038/301379a0; Mauritzen M, 2001, CAN J ZOOL, V79, P1704, DOI 10.1139/z01-126; May R, 2010, ECOL MODEL, V221, P936, DOI 10.1016/j.ecolmodel.2009.12.024; McCarthy MA, 2007, BAYESIAN METHODS FOR ECOLOGY, P1, DOI 10.1017/CBO9780511802454; McCarthy MA, 2007, BAYESIAN METHODS FOR ECOLOGY, P1; Morato RG, 2001, REPRODUCTION, V122, P745, DOI 10.1530/reprod/122.5.745; Morato Ronaldo Goncalves, 2013, Biodiversidade Brasileira, V3, P122; Nathan R, 2008, P NATL ACAD SCI USA, V105, P19050, DOI 10.1073/pnas.0808918105; Nowell K, 1996, WILD CATS STATUS SUR, P110; Plummer M., 2015, PACKAGE CODA; Powell RA, 2012, J MAMMAL, V93, P948, DOI 10.1644/11-MAMM-S-177.1; R Core Team, 2016, R FDN STAT COMP; RABINOWITZ AR, 1986, J ZOOL, V210, P149, DOI 10.1111/j.1469-7998.1986.tb03627.x; Ribeiro MC, 2009, BIOL CONSERV, V142, P1141, DOI 10.1016/j.biocon.2009.02.021; Robinson TP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096084; Rodriguez-Soto C, 2011, DIVERS DISTRIB, V17, P350, DOI 10.1111/j.1472-4642.2010.00740.x; ROYSTON JP, 1982, J R STAT SOC C-APPL, V31, P176; Sandell M., 1989, P164; Sanderson EW, 2002, CONSERV BIOL, V16, P58, DOI 10.1046/j.1523-1739.2002.00352.x; Schaller G, 1976, SERENGETI LION STUDY; SCHALLER GB, 1980, BIOTROPICA, V12, P161, DOI 10.2307/2387967; Sikes RS, 2011, J MAMMAL, V92, P235, DOI 10.1644/10-MAMM-F-355.1; Silveira L, 2004, ECOLOGIA COMP CONSER; Singh NJ, 2012, ECOL APPL, V22, P2007, DOI 10.1890/12-0245.1; Sollmann R, 2011, BIOL CONSERV, V144, P1017, DOI 10.1016/j.biocon.2010.12.011; Stabach JA, 2016, ECOSPHERE, V7, DOI 10.1002/ecs2.1428	64	63	68	2	68	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2016	11	12							e0168176	10.1371/journal.pone.0168176	http://dx.doi.org/10.1371/journal.pone.0168176			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EG7JB	28030568	Green Published, Green Submitted, gold			2022-12-27	WOS:000391222000039
J	Mei, XY; Zhang, XF; Kassam, SS; Rudstam, LG				Mei, Xueying; Zhang, Xiufeng; Kassam, Sinan-Saleh; Rudstam, Lars G.			Will the Displacement of Zebra Mussels by Quagga Mussels Increase Water Clarity in Shallow Lakes during Summer? Results from a Mesocosm Experiment	PLoS One			English	Article							DREISSENA-ROSTRIFORMIS-BUGENSIS; AMPHIPOD DIPOREIA SPP.; NORTH-AMERICA; BENTHIC ALGAE; ONEIDA LAKE; NEW-YORK; POLYMORPHA; IMPACTS; ECOSYSTEM; SPREAD	Zebra mussels (Dreissena polymorpha) are known to increase water clarity and affect ecosystem processes in invaded lakes. During the last decade, the conspecific quagga mussels (D. rostriformis bugensis) have displaced zebra mussels in many ecosystems including shallow lakes such as Oneida Lake, New York. In this study, an eight-week mesocosm experiment was conducted to test the hypothesis that the displacement of zebra mussels by quagga mussels leads to further decreases in phytoplankton and increases in water clarity resulting in increases in benthic algae. We found that the presence of zebra mussels alone (ZM), quagga mussels alone (QM), or an equal number of both species (ZQ) reduced total phosphorus (TP) and phytoplankton Chl a. Total suspended solids (TSS) was reduced in ZM and ZQ treatments. Light intensity at the sediment surface was higher in all three mussel treatments than in the no-mussel controls but there was no difference among the mussel treatments. There was no increase in benthic algae biomass in the mussel treatments compared with the no-mussel controls. Importantly, there was no significant difference in nutrient (TP, soluble reactive phosphorus and NO3-) levels, TSS, phytoplankton Chl a, benthic algal Chl a, or light intensity on the sediment surface between ZM, QM and ZQ treatments. These results confirm the strong effect of both mussel species on water clarity and indicate that the displacement of zebra mussel by an equivalent biomass of quagga mussel is not likely to lead to further increases in water clarity, at least for the limnological conditions, including summer temperature, tested in this experiment.	[Mei, Xueying] Anhui Agr Univ, Coll Resources & Environm, Hefei, Peoples R China; [Mei, Xueying; Zhang, Xiufeng; Kassam, Sinan-Saleh; Rudstam, Lars G.] Cornell Univ, Dept Nat Resources, Cornell Biol Field Stn, Fernow Hall, Bridgeport, NY 14853 USA; [Zhang, Xiufeng] Jinan Univ, Dept Ecol, Guangzhou, Guangdong, Peoples R China; [Zhang, Xiufeng] Jinan Univ, Inst Hydrobiol, Guangzhou, Guangdong, Peoples R China	Anhui Agricultural University; Cornell University; Jinan University; Chinese Academy of Sciences; Jinan University	Rudstam, LG (corresponding author), Cornell Univ, Dept Nat Resources, Cornell Biol Field Stn, Fernow Hall, Bridgeport, NY 14853 USA.	lgr1@cornell.edu			Provincial Natural Science Foundation of Anhui and Guangdong [1608085MD85, 2016A030313103]; National Natural Science Foundation of China [31570456]; National Institute of Food and Agriculture (NIFA) United States Department of Agriculture (USDA) [NYC 147453]; Cornell University Agricultural Experiment Station	Provincial Natural Science Foundation of Anhui and Guangdong; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Institute of Food and Agriculture (NIFA) United States Department of Agriculture (USDA); Cornell University Agricultural Experiment Station	This research was supported by the Provincial Natural Science Foundation of Anhui and Guangdong (No.1608085MD85; 2016A030313103) and the National Natural Science Foundation of China (No.31570456) with additional support from the Cornell University Agricultural Experiment Station federal formula funds, Project No NYC 147453 received from the National Institute of Food and Agriculture (NIFA) United States Department of Agriculture (USDA). Any opinions, findings, conclusions, or recommendations expressed in the publication are those of the author(s) and do not necessarily reflect the view of the NIFA or USDA.	Ackerman JD, 1999, CAN J FISH AQUAT SCI, V56, P1551, DOI 10.1139/cjfas-56-9-1551; [Anonymous], 1975, STANDARD METHODS EXA, P393; Baldwin BS, 2002, CAN J FISH AQUAT SCI, V59, P680, DOI 10.1139/F02-043; Barbour M. T., 1999, RAPID BIOASSESSMENT, V2; Benson A.J., 2013, QUAGGA ZEBRA MUSSELS, P9, DOI DOI 10.1201/B15437-6; Bruesewitz DA, 2008, THESIS; Burlakova LE, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114926; Carlton JT, 2008, J GREAT LAKES RES, V34, P770, DOI 10.3394/0380-1330-34.4.770; Cecala RK, 2008, J INTEGR PLANT BIOL, V50, P1452, DOI 10.1111/j.1744-7909.2008.00755.x; Diggins TP, 2001, J GREAT LAKES RES, V27, P457, DOI 10.1016/S0380-1330(01)70660-0; Geisler ME, 2016, BIOL INVASIONS, P1; Hetherington AL, 2016, THESIS; Higgins SN, 2010, ECOL MONOGR, V80, P179, DOI 10.1890/09-1249.1; Idrisi N, 2001, CAN J FISH AQUAT SCI, V58, P1430, DOI 10.1139/cjfas-58-7-1430; JONASSON PM, 1972, OIKOS, P1; Karatayev AY, 2007, J SHELLFISH RES, V26, P205, DOI 10.2983/0730-8000(2007)26[205:TIBDPA]2.0.CO;2; Karatayev AY, 2015, HYDROBIOLOGIA, V746, P97, DOI 10.1007/s10750-014-1901-x; Karatayev AY, 2011, J SHELLFISH RES, V30, P923, DOI 10.2983/035.030.0334; Karatayev AV, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0101388, DOI 10.1371/JOURNAL.PONE.0101388]; Karatayev AY, 2014, QUAGGA ZEBRA MUSSELS, P695; Lowe RL, 1995, J GREAT LAKES RES, V21, P558, DOI 10.1016/S0380-1330(95)71066-8; Mayer CM, 2016, ONEIDA LAKE: LONG-TERM DYNAMICS OF A MANAGED ECOSYSTEM AND ITS FISHERY, P161; Mayer CM., 2014, QUAGGA ZEBRA MUSSELS, V2, P575; MENZEL DAVID W., 1965, LIMNOL OCEANOGR, V10, P280; Mills EL, 2016, ONEIDA LAKE: LONG-TERM DYNAMICS OF A MANAGED ECOSYSTEM AND ITS FISHERY, P87; MILLS EL, 1993, CAN J FISH AQUAT SCI, V50, P2305, DOI 10.1139/f93-255; Mills EL, 1996, AM ZOOL, V36, P271; Naddafi R, 2014, FRESHW SCI, V33, P895, DOI 10.1086/676658; Naddafi R, 2013, ANIM BEHAV, V86, P1275, DOI 10.1016/j.anbehav.2013.09.032; NALEPA T.F., 2014, QUAGGA ZEBRA MUSSELS; Nalepa TF, 2010, J GREAT LAKES RES, V36, P5, DOI 10.1016/j.jglr.2010.03.013; Nalepa TF, 2009, FRESHWATER BIOL, V54, P466, DOI 10.1111/j.1365-2427.2008.02123.x; Ozersky T, 2015, FRESHWATER BIOL, V60, P827, DOI 10.1111/fwb.12537; Patterson MWR, 2005, J GREAT LAKES RES, V31, P223, DOI 10.1016/S0380-1330(05)70316-6; Peyer SM, 2011, J EXP BIOL, V214, P2226, DOI 10.1242/jeb.053348; Ricciardi A, 2004, J N AM BENTHOL SOC, V23, P507, DOI 10.1899/0887-3593(2004)023<0507:ESRSDO>2.0.CO;2; Rudstam LG, 2016, ONEIDA LAKE: LONG-TERM DYNAMICS OF A MANAGED ECOSYSTEM AND ITS FISHERY, P3; Spidle AP, 1995, CAN J FISH AQUAT SCI, V52, P2108, DOI 10.1139/f95-804; Stewart TW, 1998, J N AM BENTHOL SOC, V17, P81, DOI 10.2307/1468053; Toomey MB, 2002, J N AM BENTHOL SOC, V21, P468, DOI 10.2307/1468483; Vadeboncoeur Y, 2008, ECOLOGY, V89, P2542, DOI 10.1890/07-1058.1; van der Velde G., 2010, ZEBRA MUSSEL EUROPE, P199; Vanderploeg HA, 2010, J GREAT LAKES RES, V36, P50, DOI 10.1016/j.jglr.2010.04.005; Waajen GWAM, 2016, ECOL ENG, V90, P141, DOI 10.1016/j.ecoleng.2016.01.036; Walter Jr W, 2007, ONEIDA LAKE WATERSHE; Watkins JM, 2012, J GREAT LAKES RES, V38, P226, DOI 10.1016/j.jglr.2012.02.001; Zhang XF, 2015, ENVIRON SCI POLLUT R, V22, P4418, DOI 10.1007/s11356-014-3680-3; Zhang XF, 2014, WATER RES, V50, P135, DOI 10.1016/j.watres.2013.12.003; Zhang XF, 2013, HYDROBIOLOGIA, V710, P109, DOI 10.1007/s10750-012-1134-9; Zhu B, 2006, ECOSYSTEMS, V9, P1017, DOI 10.1007/s10021-005-0049-y	50	7	9	2	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2016	11	12							e0168494	10.1371/journal.pone.0168494	http://dx.doi.org/10.1371/journal.pone.0168494			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI9QH	28005940	Green Published, gold, Green Submitted			2022-12-27	WOS:000392843200060
J	Gradl, R; Zanette, I; Ruiz-Yaniz, M; Dierolf, M; Rack, A; Zaslansky, P; Pfeiffer, F				Gradl, Regine; Zanette, Irene; Ruiz-Yaniz, Maite; Dierolf, Martin; Rack, Alexander; Zaslansky, Paul; Pfeiffer, Franz			Mass Density Measurement of Mineralized Tissue with Grating-Based X-Ray Phase Tomography	PLOS ONE			English	Article							QUANTITATIVE PHASE; ELECTRON-DENSITY; DENTAL ENAMEL; MICROTOMOGRAPHY; SOUND; BONE	Establishing the mineral content distribution in highly mineralized tissues, such as bones and teeth, is fundamental in understanding a variety of structural questions ranging from studies of the mechanical properties to improved pathological investigations. However, non-destructive, volumetric and quantitative density measurements of mineralized samples, some of which may extend several mm in size, remain challenging. Here, we demonstrate the potential of grating-based x-ray phase tomography to gain insight into the three-dimensional mass density distribution of tooth tissues in a non-destructive way and with a sensitivity of 85 mg/cm(3). Density gradients of 13 - 19% over 1 - 2 mm within typical samples are detected, and local variations in density of 0.4 g/cm(3) on a length scale of 0.1 mm are revealed. This method proves to be an excellent quantitative tool for investigations of subtle differences in mineral content of mineralized tissues that can change following treatment or during ageing and healing.	[Gradl, Regine; Zanette, Irene; Ruiz-Yaniz, Maite; Dierolf, Martin; Pfeiffer, Franz] Tech Univ Munich, Dept Phys, D-85748 Garching, Germany; [Gradl, Regine; Zanette, Irene; Ruiz-Yaniz, Maite; Dierolf, Martin; Pfeiffer, Franz] Tech Univ Munich, Inst Med Engn, D-85748 Garching, Germany; [Zanette, Irene] Diamond Light Source, Harwell Sci & Innovat Campus, Didcot OX11 0DE, Oxon, England; [Ruiz-Yaniz, Maite; Rack, Alexander] European Synchrotron, CS40220, F-38043 Grenoble 9, France; [Zaslansky, Paul] Charite Univ Med Berlin, Julius Wolff Inst, D-13353 Berlin, Germany; [Zaslansky, Paul] Charite Univ Med Berlin, Ctr Musculoskeletal Surg, D-13353 Berlin, Germany; [Pfeiffer, Franz] Tech Univ Munich, Klinikum Rechts Isar, Inst Diagnost & Intervent Radiol, D-81675 Munich, Germany	Technical University of Munich; Technical University of Munich; Diamond Light Source; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Technical University of Munich	Gradl, R (corresponding author), Tech Univ Munich, Dept Phys, D-85748 Garching, Germany.; Gradl, R (corresponding author), Tech Univ Munich, Inst Med Engn, D-85748 Garching, Germany.	regine.gradl@tum.de	Dierolf, Martin J/B-9816-2008; zaslansky, paul/AAB-7322-2021; Alexander, Rack/C-9397-2012	Dierolf, Martin J/0000-0001-5150-2949; zaslansky, paul/0000-0002-8714-4992; Alexander, Rack/0000-0001-9486-3621; Zanette, Irene/0000-0001-6096-6059	DFG Cluster of Excellence Munich-Centre for Advanced Photonics (MAP); DFG Gottfried Wilhelm Leibniz program; DFG [SPP1420]; Diamond Light Source	DFG Cluster of Excellence Munich-Centre for Advanced Photonics (MAP)(German Research Foundation (DFG)); DFG Gottfried Wilhelm Leibniz program(German Research Foundation (DFG)); DFG(German Research Foundation (DFG)); Diamond Light Source	FP was funded by DFG Cluster of Excellence Munich-Centre for Advanced Photonics (MAP), the DFG Gottfried Wilhelm Leibniz program, and PZ was funded by the DFG funding through SPP1420. The funder (Diamond Light Source) provided support in the form of salaries for authors [IZ], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. This does not alter our adherence to PLOS ONE policies on sharing data and materials.	Angker L, 2004, ARCH ORAL BIOL, V49, P99, DOI 10.1016/j.archoralbio.2003.08.006; ANGMAR B, 1963, J ULTRA MOL STRUCT R, V8, P12, DOI 10.1016/S0022-5320(63)80017-9; Arola DD, 2006, BIOMATERIALS, V27, P2131, DOI 10.1016/j.biomaterials.2005.10.005; Bartlett John D, 2013, ISRN Dent, V2013, P684607, DOI 10.1155/2013/684607; Bauerlein E., 2007, HDB BIOMINERALIZATIO; Bech M, 2010, PHYS MED BIOL, V55, P5529, DOI 10.1088/0031-9155/55/18/017; Boyes ED, 2000, MICROSC MICROANAL, V6, P307; Cloetens P, 1999, APPL PHYS LETT, V75, P2912, DOI 10.1063/1.125225; Cuy JL, 2002, ARCH ORAL BIOL, V47, P281, DOI 10.1016/S0003-9969(02)00006-7; Davis GR, 2013, J DENT, V41, P475, DOI 10.1016/j.jdent.2013.01.010; Deyhle Hans, 2015, Dent J (Basel), V3, P111, DOI 10.3390/dj3040111; Dowker SEP, 2004, CARIES RES, V38, P514, DOI 10.1159/000080580; Dowker SEP, 2006, EUR J ORAL SCI, V114, P353, DOI 10.1111/j.1600-0722.2006.00315.x; Elliott JC, 1998, CONNECT TISSUE RES, V38, P61, DOI 10.3109/03008209809017022; GARBEROGLIO R, 1976, ARCH ORAL BIOL, V21, P355, DOI 10.1016/S0003-9969(76)80003-9; Herzen J, 2009, OPT EXPRESS, V17, P10010, DOI 10.1364/OE.17.010010; Jensen TH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054047; Kinney JH, 2005, BIOMATERIALS, V26, P3363, DOI 10.1016/j.biomaterials.2004.09.004; Langer M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035691; Marten A, 2010, BIOMATERIALS, V31, P5479, DOI 10.1016/j.biomaterials.2010.03.030; Manly RS, 1939, DENSITY DENT HARD TI, P203, DOI 10.1177/00220345390180030301; Momose A, 2003, JPN J APPL PHYS 2, V42, pL866, DOI 10.1143/JJAP.42.L866; PASHLEY DH, 1989, SCANNING MICROSCOPY, V3, P161; Pfeiffer F, 2008, NAT MATER, V7, P134, DOI 10.1038/nmat2096; Pfeiffer F, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.108105; Qi ZH, 2010, PHYS MED BIOL, V55, P2669, DOI 10.1088/0031-9155/55/9/016; Reznikova E, 2008, MICROSYST TECHNOL, V14, P1683, DOI 10.1007/s00542-007-0507-x; Roschger P, 2008, BONE, V42, P456, DOI 10.1016/j.bone.2007.10.021; Sarapata A, 2014, REV SCI INSTRUM, V85, DOI 10.1063/1.4898052; Sarapata A, 2015, OPT EXPRESS, V23, P523, DOI 10.1364/OE.23.000523; Schmitz JE, 2014, J DENT RES, V93, P256, DOI 10.1177/0022034513520548; Schwass DR, 2009, CARIES RES, V43, P314, DOI 10.1159/000226230; SHRIMPTON PC, 1981, PHYS MED BIOL, V26, P907, DOI 10.1088/0031-9155/26/5/010; Tapfer A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058439; Velroyen A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109562; WEIDMANN SM, 1967, ARCH ORAL BIOL, V12, P85, DOI 10.1016/0003-9969(67)90145-8; Weiner S, 1998, ANNU REV MATER SCI, V28, P271, DOI 10.1146/annurev.matsci.28.1.271; Weitkamp T, 2005, OPT EXPRESS, V13, P6296, DOI 10.1364/OPEX.13.006296; Weitkamp T, 2010, AIP CONF PROC, V1221, P33, DOI 10.1063/1.3399253; Willner M, 2013, OPT EXPRESS, V21, P4155, DOI 10.1364/OE.21.004155; Zanette I, 2015, SCI REP-UK, V5, DOI 10.1038/srep09210; Zanette I, 2011, PHYS STATUS SOLIDI A, V208, P2526, DOI 10.1002/pssa.201184276	42	14	14	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2016	11	12							e0167797	10.1371/journal.pone.0167797	http://dx.doi.org/10.1371/journal.pone.0167797			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI9TW	28002416	Green Published, gold, Green Submitted			2022-12-27	WOS:000392853100023
J	Lai, XL; Friedman, A				Lai, Xiulan; Friedman, Avner			Exosomal miRs in Lung Cancer: A Mathematical Model	PLOS ONE			English	Article							TYROSINE KINASE INHIBITORS; FACTOR RECEPTOR MUTATIONS; BINDING PROTEIN HUR; CROSS-TALK; GROWTH; EXPRESSION; EGFR; RAS; INVASION; PATHWAYS	Lung cancer, primarily non-small-cell lung cancer (NSCLC), is the leading cause of cancer deaths in the United States and worldwide. While early detection significantly improves five-year survival, there are no reliable diagnostic tools for early detection. Several exosomal microRNAs (miRs) are overexpressed in NSCLC, and have been suggested as potential biomarkers for early detection. The present paper develops a mathematical model for early stage of NSCLC with emphasis on the role of the three highest overexpressed miRs, namely miR-21, miR-205 and miR-155. Simulations of the model provide quantitative relationships between the tumor volume and the total mass of each of the above miRs in the tumor. Because of the positive correlation between these miRs in the tumor tissue and in the blood, the results of the paper may be viewed as a first step toward establishing a combination of miRs 21, 205, 155 and possibly other miRs as serum biomarkers for early detection of NSCLC.	[Lai, Xiulan] Renmin Univ China, Inst Math Sci, Beijing, Peoples R China; [Friedman, Avner] Ohio State Univ, Math Biosci Inst, Columbus, OH 43210 USA; [Friedman, Avner] Ohio State Univ, Dept Math, 231 W 18th Ave, Columbus, OH 43210 USA	Renmin University of China; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University	Lai, XL (corresponding author), Renmin Univ China, Inst Math Sci, Beijing, Peoples R China.	xiulanlai@ruc.edu.cn	Lai, Xiula/GMX-1854-2022		Mathematical Biosciences Institute; National Science Foundation [DMS 0931642]; National Natural Science Foundation of China [11501568]; Fundamental Research Funds for the Central Universities; Research Funds of Renmin University of China	Mathematical Biosciences Institute; National Science Foundation(National Science Foundation (NSF)); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); Research Funds of Renmin University of China	AF is supported by the Mathematical Biosciences Institute and the National Science Foundation (Grant DMS 0931642). XL is supported by the National Natural Science Foundation of China (Grant No. 11501568), the Fundamental Research Funds for the Central Universities and the Research Funds of Renmin University of China, and the Mathematical Biosciences Institute and the National Science Foundation (Grant DMS 0931642).	Akinleye A, 2013, J HEMATOL ONCOL, V6, DOI 10.1186/1756-8722-6-27; Ali A, 2013, CURR ONCOL, V20, pE300, DOI 10.3747/co.20.1481; An TX, 2015, J EXTRACELL VESICLES, V4, DOI 10.3402/jev.v4.27522; [Anonymous], QUEST DIAGN; Bader AG, 2011, GENE THER, V18, P1121, DOI 10.1038/gt.2011.79; Basso AD, 2002, J BIOL CHEM, V277, P39858, DOI 10.1074/jbc.M206322200; Bratton SB, 2010, J CELL SCI, V123, P3209, DOI 10.1242/jcs.073643; CALLANS LS, 1995, ANN SURG ONCOL, V2, P38, DOI 10.1007/BF02303700; Cantrell DA, 2001, J CELL SCI, V114, P1439; Dearden S, 2013, ANN ONCOL, V24, P2371, DOI 10.1093/annonc/mdt205; Dhillon AS, 2007, ONCOGENE, V26, P3279, DOI 10.1038/sj.onc.1210421; Faratian D, 2009, CANCER RES, V69, P6713, DOI 10.1158/0008-5472.CAN-09-0777; Ferlay J, 2015, INT J CANCER, V136, pE359, DOI 10.1002/ijc.29210; Florea Ana-Maria, 2011, Cancers (Basel), V3, P1351, DOI 10.3390/cancers3011351; Frydrychowicz M, 2015, SCAND J IMMUNOL, V81, P2, DOI 10.1111/sji.12247; Fujioka A, 2006, J BIOL CHEM, V281, P8917, DOI 10.1074/jbc.M509344200; Fumarola C, 2014, BIOCHEM PHARMACOL, V90, P197, DOI 10.1016/j.bcp.2014.05.011; Gao CF, 2005, P NATL ACAD SCI USA, V102, P10528, DOI 10.1073/pnas.0504367102; Gil-Henn H, 2013, ONCOGENE, V32, P2622, DOI 10.1038/onc.2012.284; Hao WR, 2014, P NATL ACAD SCI USA, V111, P16065, DOI 10.1073/pnas.1417789111; Hao WR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090497; Hatley ME, 2010, CANCER CELL, V18, P282, DOI 10.1016/j.ccr.2010.08.013; Henschke CI, 1999, LANCET, V354, P99, DOI 10.1016/S0140-6736(99)06093-6; Jain HV, 2011, P NATL ACAD SCI USA, V108, P19701, DOI 10.1073/pnas.1115750108; Jo U, 2014, ONCOTARGET, V5, P1265, DOI 10.18632/oncotarget.1711; Kam Y, 2012, J CELL PHYSIOL, V227, P431, DOI 10.1002/jcp.22766; Kang HW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053663; Kaur H, 2006, BIOCHEM J, V393, P235, DOI 10.1042/BJ20051022; Kim Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028293; Komatsu S, 2011, BRIT J CANCER, V105, P104, DOI 10.1038/bjc.2011.198; Komatsu S, 2013, ANTICANCER RES, V33, P271; Leander R, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002757; Lee JH, 2008, INT J MOL MED, V21, P91; Legewie S, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb.2008.29; Lei L, 2013, ONCOL REP, V30, P2897, DOI 10.3892/or.2013.2755; Li B, 2014, LUNG CANCER, V83, P146, DOI 10.1016/j.lungcan.2013.11.003; Liao KL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091844; Liu R, 2012, J TOXICOL ENV HEAL A, V75, P1154, DOI 10.1080/15287394.2012.699856; Marino S, 2008, J THEOR BIOL, V254, P178, DOI 10.1016/j.jtbi.2008.04.011; Marinov M, 2007, CRIT REV ONCOL HEMAT, V63, P172, DOI 10.1016/j.critrevonc.2007.04.002; Matus DQ, 2015, DEV CELL, V35, P162, DOI 10.1016/j.devcel.2015.10.002; McDonald D., 2010, UNDERSTANDING MIRNA; McIlwain DR, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a008656; Mendoza MC, 2011, TRENDS BIOCHEM SCI, V36, P320, DOI 10.1016/j.tibs.2011.03.006; Meyer R, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00451; Normanno N, 2006, GENE, V366, P2, DOI 10.1016/j.gene.2005.10.018; Papadimitrakopoulou V, 2006, J THORAC ONCOL, V1, P749, DOI 10.1016/S1556-0864(15)30399-3; Peters S, 2014, CANCER TREAT REV, V40, P917, DOI 10.1016/j.ctrv.2014.06.010; Properzi F, 2013, BIOMARK MED, V7, P769, DOI 10.2217/bmm.13.63; Quaranta V, 2008, SEMIN CANCER BIOL, V18, P338, DOI 10.1016/j.semcancer.2008.03.018; Rabinowits G, 2009, CLIN LUNG CANCER, V10, P42, DOI 10.3816/CLC.2009.n.006; Reubold TF, 2009, J BIOL CHEM, V284, P32717, DOI 10.1074/jbc.M109.014027; Riches A, 2014, EUR J CANCER, V50, P1025, DOI 10.1016/j.ejca.2013.12.019; Roberts PJ, 2007, ONCOGENE, V26, P3291, DOI 10.1038/sj.onc.1210422; Roskoski R, 2012, PHARMACOL RES, V66, P105, DOI 10.1016/j.phrs.2012.04.005; Salamon RS, 2013, BIOESSAYS, V35, P602, DOI 10.1002/bies.201200176; Satoh M, 2002, STROKE, V33, P775, DOI 10.1161/hs0302.103734; Schumacher C, 1998, MOL PHARMACOL, V53, P97, DOI 10.1124/mol.53.1.97; Sgambato A, 2012, CURR MED CHEM, V19, P3337, DOI 10.2174/092986712801215973; Sharma SV, 2007, NAT REV CANCER, V7, P169, DOI 10.1038/nrc2088; Shaw RJ, 2006, NATURE, V441, P424, DOI 10.1038/nature04869; Shen H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103305; Shui YB, 2003, INVEST OPHTH VIS SCI, V44, P3911, DOI 10.1167/iovs.02-1226; Shukla S, 2014, NEOPLASIA, V16, P115, DOI 10.1593/neo.14184; Siegel RL, 2015, CA-CANCER J CLIN, V65, P5, DOI 10.3322/caac.21254; Siegelin MD, 2014, LAB INVEST, V94, P129, DOI 10.1038/labinvest.2013.147; Soengas MS, 1999, SCIENCE, V284, P156, DOI 10.1126/science.284.5411.156; Sorkin A, 2010, CURR PROTOC CELL BIO, DOI [10. 1002/0471143030. cb1514s46, DOI 10.1002/0471143030.CB1514S46]; Szomolay B, 2012, J THEOR BIOL, V303, P141, DOI 10.1016/j.jtbi.2012.03.024; Tamura K, 2005, EXPERT OPIN PHARMACO, V6, P985, DOI 10.1517/14656566.6.6.985; Vazquez F, 2000, MOL CELL BIOL, V20, P5010, DOI 10.1128/MCB.20.14.5010-5018.2000; von Roretz C, 2013, CELL DEATH DIFFER, V20, P154, DOI 10.1038/cdd.2012.111; Vreeland AC, 2014, MOL CELL BIOL, V34, P2135, DOI 10.1128/MCB.00281-14; Wang PY, 2010, BIOCHEM J, V426, P293, DOI 10.1042/BJ20091459; Weaver BA, 2014, MOL BIOL CELL, V25, P2677, DOI 10.1091/mbc.E14-04-0916; Yang Y, 2015, CANCER GENE THER, V22, P23, DOI 10.1038/cgt.2014.66; Yip PY, 2015, TRANSL LUNG CANCER R, V4, P165, DOI 10.3978/j.issn.2218-6751.2015.01.04; YOUNG ME, 1980, BIOTECHNOL BIOENG, V22, P947, DOI 10.1002/bit.260220504; Yung BC, 2016, MOL PHARMACEUT, V13, P653, DOI 10.1021/acs.molpharmaceut.5b00878; Zang YS, 2012, CANCER GENE THER, V19, P773, DOI 10.1038/cgt.2012.60; Zhang GY, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-440; Zhang JG, 2010, CLIN CHIM ACTA, V411, P846, DOI 10.1016/j.cca.2010.02.074; Zhao W, 2015, INT J CLIN EXP MED, V8, P14759	83	13	14	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2016	11	12							e0167706	10.1371/journal.pone.0167706	http://dx.doi.org/10.1371/journal.pone.0167706			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI9TW	28002496	Green Published, gold, Green Submitted			2022-12-27	WOS:000392853100017
J	Pecora, N; Kaltwasser, PR; Spelta, A				Pecora, Nicolo; Kaltwasser, Pablo Rovira; Spelta, Alessandro			Discovering SIFIs in Interbank Communities	PLOS ONE			English	Article							TRADING STRATEGIES; COMPLEX NETWORKS; MARKET; PARTS	This paper proposes a new methodology based on non-negative matrix factorization to detect communities and to identify central nodes in a network as well as within communities. The method is specifically designed for directed weighted networks and, consequently, it has been applied to the interbank network derived from the e-MID interbank market. In an interbank network indeed links are directed, representing flows of funds between lenders and borrowers. Besides distinguishing between Systemically Important Borrowers and Lenders, the technique complements the detection of systemically important banks, revealing the community structure of the network, that proxies the most plausible areas of contagion of institutions' distress.	[Pecora, Nicolo] Catholic Univ, Dept Econ & Social Sci, Piacenza, Italy; [Kaltwasser, Pablo Rovira] Natl Bank Belgium, Brussels, Belgium; [Spelta, Alessandro] Univ Pavia, Dept Econ & Business Sci, Pavia, Italy	Catholic University of the Sacred Heart; European Central Bank; National Bank of Belgium; University of Pavia	Spelta, A (corresponding author), Univ Pavia, Dept Econ & Business Sci, Pavia, Italy.	alessandro.spelta@unicatt.it			Research Foundations Flanders (FWO) [1510413N]; European Commission [320278]	Research Foundations Flanders (FWO)(FWO); European Commission(European CommissionEuropean Commission Joint Research Centre)	We are indebted to the Research Foundations Flanders (FWO) and the European Commission for their financial support through the research grant 1510413N and the FP7-SSH research grant 320278 respectively. All errors are ours.	Arregui M.N., 2013, ADDRESSING INTERCONN, V13, P199; Basel Committee on Banking Supervision, 2013, TECHNICAL REPORT; Battiston S, 2015, IFC B, V39; Battiston S., 2013, J FINANCIAL MANAGEME, V2, P129, DOI DOI 10.12831/75568; Battiston S, 2012, J ECON DYN CONTROL, V36, P1121, DOI 10.1016/j.jedc.2012.04.001; Battiston S, 2012, SCI REP-UK, V2, DOI 10.1038/srep00541; Bezdek J.C., 1981, PATTERN RECOGN, DOI 10.1007/978-1-4757-0450-1; Blondel VD, 2008, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2008/10/P10008; Borgatti SP, 1999, SOC NETWORKS, V21, P375; Boss M, 2004, QUANT FINANC, V4, P677, DOI 10.1080/14697680400020325; Boss M., 2004, FINANCIAL STABILITY, V7, P77; Brunetti C., 2015, INTERCONNECTEDNESS I; Cao XC, 2013, SCI REP-UK, V3, DOI 10.1038/srep02993; Cocco JF, 2009, J FINANC INTERMED, V18, P24, DOI 10.1016/j.jfi.2008.06.003; Cooper M, 2002, PROCEEDINGS OF THE 2002 IEEE WORKSHOP ON MULTIMEDIA SIGNAL PROCESSING, P25; Craig B, 2014, J FINANC INTERMED, V23, P322, DOI 10.1016/j.jfi.2014.02.003; De Masi G, 2006, PHYS REV E, V74, DOI 10.1103/PhysRevE.74.066112; Della Rossa F, 2013, SCI REP-UK, V3, DOI 10.1038/srep01467; Dunn J. C., 1973, Journal of Cybernetics, V3, P32, DOI 10.1080/01969727308546046; Fricke D, 2015, EMPIR ECON, V49, P1463, DOI 10.1007/s00181-015-0919-x; Fricke D, 2015, COMPUT ECON, V45, P359, DOI 10.1007/s10614-014-9427-x; Fricke D, 2012, PHYSICA A, V391, P6528, DOI 10.1016/j.physa.2012.07.045; Girvan M, 2002, P NATL ACAD SCI USA, V99, P7821, DOI 10.1073/pnas.122653799; Holme P, 2005, PHYS REV E, V72, DOI 10.1103/PhysRevE.72.046111; Huang WT, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0023049, 10.1371/journal.pone.0023829]; Iori G, 2008, J ECON DYN CONTROL, V32, P259, DOI 10.1016/j.jedc.2007.01.032; Iori G, 2007, PHYSICA A, V376, P467, DOI 10.1016/j.physa.2006.10.053; Iori G, 2015, J ECON DYN CONTROL, V50, P98, DOI 10.1016/j.jedc.2014.08.016; Kleinberg JM, 1999, J ACM, V46, P604, DOI 10.1145/324133.324140; Lancichinetti A, 2009, NEW J PHYS, V11, DOI 10.1088/1367-2630/11/3/033015; Lee DD, 1999, NATURE, V401, P788, DOI 10.1038/44565; Levy-Carciente S, 2015, J BANK FINANC, V59, P164, DOI 10.1016/j.jbankfin.2015.05.008; Li D, 2008, PHYS REV LETT, V101, DOI 10.1103/PhysRevLett.101.168701; Li SZ, 2001, PROC CVPR IEEE, P207; MacQueen J., 1967, P 5 BERKELEY S MATH, VVolume 1, P281, DOI DOI 10.1007/S11665-016-2173-6; Mankad S, 2013, PHYS REV E, V88, DOI 10.1103/PhysRevE.88.042812; Nefedov N, 2011, MULTIPLE MEMBERSHIP; Newman MEJ, 2004, PHYS REV E, V70, DOI [10.1103/PhysRevE.70.056131, 10.1103/PhysRevE.69.026113]; Palla G, 2005, NATURE, V435, P814, DOI 10.1038/nature03607; Pauca VP, 2004, SIAM PROC S, P452; Psorakis I, 2011, PHYS REV E, V83, DOI 10.1103/PhysRevE.83.066114; Sha F., 2002, ADV NEURAL INFORM PR, V15, P1041; Shai S, 2015, PHYS REV E, V92, DOI 10.1103/PhysRevE.92.062805; Wang D., 2008, P 31 ANN INT ACM SIG, P307, DOI DOI 10.1145/1390334.1390387; Wang F., 2008, P SIAM INT C DAT MIN, P1, DOI DOI 10.1137/1.9781611972788.1; Zarei M, 2009, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2009/11/P11013; Zhang ZY, 2013, PHYS REV E, V87, DOI 10.1103/PhysRevE.87.062803	47	5	5	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2016	11	12							e0167781	10.1371/journal.pone.0167781	http://dx.doi.org/10.1371/journal.pone.0167781			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EI9TW	28002445	gold, Green Submitted, Green Published			2022-12-27	WOS:000392853100022
J	Awoke, T; Worku, A; Kebede, Y; Kasim, A; Birlie, B; Braekers, R; Zuma, K; Shkedy, Z				Awoke, Tadesse; Worku, Alemayehu; Kebede, Yigzaw; Kasim, Adetayo; Birlie, Belay; Braekers, Roel; Zuma, Khangelani; Shkedy, Ziv			Modeling Outcomes of First-Line Antiretroviral Therapy and Rate of CD4 Counts Change among a Cohort of HIV/AIDS Patients in Ethiopia: A Retrospective Cohort Study	PLOS ONE			English	Article							VIROLOGICAL FAILURE; NEVIRAPINE; EFAVIRENZ; REGIMENS; EFFICACY; EVENTS; SAFETY	Background Antiretroviral therapy has shown to be effective in reducing morbidity and mortality in patients infected with HIV for the past couples of decades. However, there remains a need to better understand the characteristics of long-term treatment outcomes in resource poor settings. The main aim of this study was to determine and compare the long-term response of patients on nevirapine and efavirenz based first line antiretroviral therapy regimen in Ethiopia. Methods Hospital based retrospective cohort study was conducted from January 2009 to December 2013 at University hospital located in Northwest Ethiopia. Human subject research approval for this study was received from University of Gondar Research Ethics Committee and the medical director of the hospital. Cox-proportional hazards model was used to assess the effect of baseline covariates on composite outcome and a semi-parametric mixed effect model was used to investigate CD4 counts response to treatments. Results A total of 2386 HIV/AIDS naive patients were included in this study. Nearly one-in-four patients experienced the events, of which death, lost to follow up, treatment substitution and discontinuation of Non-Nucleoside Reverse Transcriptase Inhibitors(NNRTI) accounted: 99 (26.8%), 122 (33.0%), 137 (37.0%) and 12 (3.2%), respectively. The hazard of composite outcome on nevirapine compared with efavirenz was 1.02(95%Cl: 0.52-1.99) with p-value = 0.96. Similarly, the hazard of composite outcome on tenofovir and stavudine compared with zidovudine were 1.87 (95 degrees%Cl: 1.52-2.32), p-value < 0.0001 and 1.72(95% CI: 1.22-2.32), p-value = 0.002, respectively. The rate of CD4 increase in response to treatment was high during the first 10 months and stabilized later. Conclusions This study revealed that treatment responses were comparable whether nevirapine or efavirenz was chosen to initiate antiretroviral therapy for HIV/AIDS patients in Ethiopia. There was significant difference on risk of composite outcome between patients who were initiated with Tenofovir containing ART regimen compared with zidovudine after controlling for NNRTI drug combinations.	[Awoke, Tadesse; Kebede, Yigzaw] Univ Gondar, Epidemiol & Biostat, Gondar, Ethiopia; [Worku, Alemayehu] Univ Addis Ababa, Sch Publ Hlth, Addis Ababa, Ethiopia; [Kasim, Adetayo] Univ Durham, Wolfson Res Inst, Durham, England; [Birlie, Belay] Jimma Univ, Biostat, Jimma, Ethiopia; [Braekers, Roel; Shkedy, Ziv] Hasselt Univ, I BioStat, Diepenbeek, Belgium; [Zuma, Khangelani] Hlth Sci Res Council, Pretoria, South Africa	University of Gondar; Addis Ababa University; Durham University; Jimma University; Hasselt University	Awoke, T (corresponding author), Univ Gondar, Epidemiol & Biostat, Gondar, Ethiopia.	tawoke7@gmail.com	Shkedy, Ziv/AAQ-3096-2020; BRAEKERS, Roel/AFC-8846-2022	Shkedy, Ziv/0000-0002-6306-0823; BRAEKERS, Roel/0000-0003-1417-5170; Zuma, Khangelani/0000-0003-4492-5083; Kasim, Adetayo Safiriyu/0000-0002-0411-3059; Yimer, Belay Birlie/0000-0001-8621-6539	University of Gondar	University of Gondar	The authors would like to thank University of Gondar for funding this research and TA received the funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alave J, 2013, REV CHIL INFECTOL, V30, P42, DOI 10.4067/S0716-10182013000100006; [Anonymous], 2014, GLOB UPD HLTH SECT R; [Anonymous], 2017, 2013 UNAIDS REP GLOB; [Anonymous], 2014, GUIDELINES USE ANTIR, P1; Barry O, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-476; Bongiovanni M, 2014, CURRENT MED CHEM, V23, P2789; Brennan AT, 2013, J INT AIDS SOC, V16, DOI 10.7448/IAS.16.1.18794; Brinkhof MWG, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005790; Cain LE, 2013, AIDS, V27, P2169, DOI 10.1097/01.aids.0000432446.15061.27; Chi BH, 2011, JAIDS-J ACQ IMM DEF, V58, P475, DOI 10.1097/QAI.0b013e31823058a3; Collaboration HC, 2012, AIDS, V26; Eholie SP, 2012, J INT AIDS SOC, V15, DOI 10.7448/IAS.15.2.17334; EMA, 2011, OUTC REN PROC QUEST; Ethiopia Food Medicine and Healthcare Administration and Control Authority, 2010, LIST ESS MED ETH; Hosmer DW, 2008, APPL SURVIVAL ANAL R, V2nd; Kwobah CM., 2012, WORLD J AIDS, V2, P271, DOI [10.4236/wja.2012.24036, DOI 10.4236/WJA.2012.24036]; Laurent C, 2008, AIDS RES HUM RETROV, V24, P393, DOI 10.1089/aid.2007.0219; Lowenthal ED, 2013, JAMA-J AM MED ASSOC, V309, P1803, DOI 10.1001/jama.2013.3710; Luz PM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093039; Manosuthi W, 2010, AIDS RES THER, V7, DOI 10.1186/1742-6405-7-37; McManus H, 2015, ANTIVIR THER, V20, P131, DOI 10.3851/IMP2774; McManus H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048839; Mugavero MJ, 2008, AIDS, V22, P2481, DOI 10.1097/QAD.0b013e328318f130; Mutasa-Apollo T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086305; Nash D, 2008, AIDS, V22, P2291, DOI 10.1097/QAD.0b013e3283121ca9; Pillay P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068995; Rey D, 2009, J ANTIMICROB CHEMOTH, V63, P380, DOI 10.1093/jac/dkn471; Rizopoulos D, 2012, CH CRC BIOSTAT SER, P1; Sarfo FS, 2014, J ANTIMICROB CHEMOTH, V69, P254, DOI 10.1093/jac/dkt336; Scarsi K, 2010, TDF 3TC NVP IS INFER; Shipton LK, 2009, INT J TUBERC LUNG D, V13, P360; Shubber Z, 2013, AIDS, V27, P1403, DOI 10.1097/QAD.0b013e32835f1db0; Swaminathan S, 2011, CLIN INFECT DIS, V53, P716, DOI 10.1093/cid/cir447; Takuva S, 2013, PAN AFR MED J, V15, DOI 10.11604/pamj.2013.15.5.1889; van Dijk JH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055111; Velen K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064459; Verbeke G., 2000, SPRINGER SERIES STAT; Wainberg M.A., 2007, FUT HIV THER, V1, P291, DOI DOI 10.2217/17469600.1.3.291; WHO, 2010, ANT THER HIV INF AD; WHO, ANT THER HIV INF AD; WHO, 2013, GLOB UND HIB TREATM; Wood S, 2017, GEN ADDITIVE MODELS, DOI 10.1201/9781315370279; World Health Organization, 2004, SCAL ANT THER RES LT; Wright ST, 2013, HIV MED, V14, P208, DOI 10.1111/j.1468-1293.2012.01053.x; Zemedu Mehamed Tirfe, 2013, Health, V5, P1502, DOI 10.4236/health.2013.59204	45	6	7	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2016	11	12							e0168323	10.1371/journal.pone.0168323	http://dx.doi.org/10.1371/journal.pone.0168323			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI9QF	27997931	Green Submitted, gold, Green Accepted, Green Published			2022-12-27	WOS:000392842900034
J	Holczer, M; Banhegyi, G; Kapuy, O				Holczer, Marianna; Banhegyi, Gabor; Kapuy, Orsolya			GADD34 Keeps the mTOR Pathway Inactivated in Endoplasmic Reticulum Stress Related Autophagy	PLOS ONE			English	Article							UNFOLDED PROTEIN RESPONSE; TUBEROUS SCLEROSIS COMPLEX; INDUCED GENE-EXPRESSION; MAMMALIAN TARGET; CELL-SURVIVAL; ALPHA-SUBUNIT; ER STRESS; RESVERATROL; APOPTOSIS; TRANSLATION	The balance of protein synthesis and proteolysis (i.e. proteostasis) is maintained by a complex regulatory network in which mTOR (mechanistic target of rapamycin serine/threonine kinase) pathway and unfolded protein response are prominent positive and negative actors. The interplay between the two systems has been revealed; however the mechanistic details of this crosstalk are largely unknown. The aim of the present study was to investigate the elements of crosstalk during endoplasmic reticulum stress and to verify the key role of GADD34 in the connection with the mTOR pathway. Here, we demonstrate that a transient activation of autophagy is present in endoplasmic reticulum stress provoked by thapsigargin or tunicamycin, which is turned into apoptotic cell death. The transient phase can be characterized by the elevation of the autophagic marker LC3II/I, by mTOR inactivation, AMP-activated protein kinase activation and increased GADD34 level. The switch from autophagy to apoptosis is accompanied with the appearance of apoptotic markers, mTOR reactivation, AMP-activated protein kinase inactivation and a decrease in GADD34. Inhibition of autophagy by 3-methyladenine shortens the transient phase, while inhibition of mTOR by rapamycin or resveratrol prolongs it. Inhibition of GADD34 by guanabenz or transfection of the cells with siGADD34 results in down-regulation of autophagy-dependent survival and a quick activation of mTOR, followed by apoptotic cell death. The negative effect of GADD34 inhibition is diminished when guanabenz or siGADD34 treatment is combined with rapamycin or resveratrol addition. These data confirm that GADD34 constitutes a mechanistic link between endoplasmic reticulum stress and mTOR inactivation, therefore promotes cell survival during endoplasmic reticulum stress.	[Holczer, Marianna; Banhegyi, Gabor; Kapuy, Orsolya] Semmelweis Univ, Dept Med Chem Mol Biol & Pathobiochem, Budapest, Hungary	Semmelweis University	Kapuy, O (corresponding author), Semmelweis Univ, Dept Med Chem Mol Biol & Pathobiochem, Budapest, Hungary.	kapuy.orsolya@med.semmelweis-univ.hu			Hungarian Academy of Sciences; Hungarian Scientific Research Fund [OTKA-PD 104110, OTKA 112696]; COST (European Cooperation in Science and Technology) [PROTEOSTASIS BM1307]	Hungarian Academy of Sciences(Hungarian Academy of Sciences); Hungarian Scientific Research Fund(Orszagos Tudomanyos Kutatasi Alapprogramok (OTKA)); COST (European Cooperation in Science and Technology)(European Cooperation in Science and Technology (COST))	Support was provided by Janos Bolyai Research Scholarship of the Hungarian Academy of Sciences (to OK); Hungarian Scientific Research Fund (OTKA-PD 104110 and OTKA 112696); and MedInProt grant of the Hungarian Academy of Sciences.; The authors are thankful to M. Marton and A. Kurucz (Semmelweis University, Budapest, Hungary) for their technical assistance. O.K. is grateful to Janos Bolyai Research Scholarship of the Hungarian Academy of Sciences. This study was supported by the Hungarian Scientific Research Fund (OTKA-PD 104110 and OTKA 112696) and by a MedInProt grant of the Hungarian Academy of Sciences. This article is based upon work from COST Action (PROTEOSTASIS BM1307), supported by COST (European Cooperation in Science and Technology).	Adler HT, 1999, MOL CELL BIOL, V19, P7050; Alayev A, 2015, ANN NY ACAD SCI, V1348, P116, DOI 10.1111/nyas.12829; Alberts B., 2002, MOL BIOL CELL, V4th; Alers S, 2012, MOL CELL BIOL, V32, P2, DOI 10.1128/MCB.06159-11; Appenzeller-Herzog C, 2012, TRENDS CELL BIOL, V22, P274, DOI 10.1016/j.tcb.2012.02.006; Baur JA, 2006, NAT REV DRUG DISCOV, V5, P493, DOI 10.1038/nrd2060; Brush MH, 2003, MOL CELL BIOL, V23, P1292, DOI 10.1128/MCB.23.4.1292-1303.2003; Chomczynski P, 2006, NAT PROTOC, V1, P581, DOI 10.1038/nprot.2006.83; Garcia-Huerta P, 2016, BRAIN RES, V1649, P173, DOI 10.1016/j.brainres.2016.02.052; Ghosh HS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009199; Gorlach A, 2006, ANTIOXID REDOX SIGN, V8, P1391, DOI 10.1089/ars.2006.8.1391; Harding HP, 2000, MOL CELL, V6, P1099, DOI 10.1016/S1097-2765(00)00108-8; Hay N, 2004, GENE DEV, V18, P1926, DOI 10.1101/gad.1212704; Hetz C, 2012, NAT REV MOL CELL BIO, V13, P89, DOI 10.1038/nrm3270; Holczer M, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/319589; Hyrskyluoto A, 2012, EXP CELL RES, V318, P33, DOI 10.1016/j.yexcr.2011.08.020; Ito S, 2015, SCI REP-UK, V5, DOI 10.1038/srep08327; Jiang HY, 2005, J BIOL CHEM, V280, P14189, DOI 10.1074/jbc.M413660200; Jung CH, 2011, AUTOPHAGY, V7, P1212, DOI 10.4161/auto.7.10.16660; Kapuy O, 2014, FEBS OPEN BIO, V4, P704, DOI 10.1016/j.fob.2014.07.006; Kapuy O, 2013, MOL BIOSYST, V9, P296, DOI 10.1039/c2mb25261a; Kato H, 2012, CELL DEATH DIFFER, V19, P310, DOI 10.1038/cdd.2011.98; Kojima E, 2003, FASEB J, V17, P1573, DOI 10.1096/fj.02-1184fje; Li Y, 2011, MATH PROBL ENG, V2011, DOI 10.1155/2011/575036; Lu PD, 2004, J CELL BIOL, V167, P27, DOI 10.1083/jcb.200408003; Ma YJ, 2003, J BIOL CHEM, V278, P34864, DOI 10.1074/jbc.M301107200; Maiuri MC, 2007, NAT REV MOL CELL BIO, V8, P741, DOI 10.1038/nrm2239; Malhi H, 2011, J HEPATOL, V54, P795, DOI 10.1016/j.jhep.2010.11.005; Marciniak SJ, 2004, GENE DEV, V18, P3066, DOI 10.1101/gad.1250704; Mukai R, 2014, ONCOGENE, V33, P2317, DOI 10.1038/onc.2013.181; Novoa I, 2003, EMBO J, V22, P1180, DOI 10.1093/emboj/cdg112; Ogata M, 2006, MOL CELL BIOL, V26, P9220, DOI 10.1128/MCB.01453-06; Oyadomari S, 2004, CELL DEATH DIFFER, V11, P381, DOI 10.1038/sj.cdd.4401373; Ozean U, 2008, MOL CELL, V29, P541, DOI [10.1016/j.moicel.2007.12.023, 10.1016/j.molcel.2007.12.023]; Park D, 2016, SCI REPORTS, V6; Parker JA, 2005, NAT GENET, V37, P349, DOI 10.1038/ng1534; Pasinetti GM, 2011, EXP NEUROL, V232, P1, DOI 10.1016/j.expneurol.2011.08.014; Ravikumar B, 2006, HUM MOL GENET, V15, P1209, DOI 10.1093/hmg/ddl036; Salminen A, 2012, AGEING RES REV, V11, P230, DOI 10.1016/j.arr.2011.12.005; Tabas I, 2011, NAT CELL BIOL, V13, P184, DOI 10.1038/ncb0311-184; Tambe Y, 2012, CANCER LETT, V314, P82, DOI 10.1016/j.canlet.2011.09.015; Tsaytler P, 2011, SCIENCE, V332, P91, DOI 10.1126/science.1201396; Uddin MN, 2011, BIOCHEM BIOPH RES CO, V407, P692, DOI 10.1016/j.bbrc.2011.03.077; Vingtdeux V, 2010, J BIOL CHEM, V285, P9100, DOI 10.1074/jbc.M109.060061; Walter P, 2011, SCIENCE, V334, P1081, DOI 10.1126/science.1209038; Watanabe R, 2007, INT J MOL MED, V19, P475; Watanabe R, 2011, J NUCL MED, V52, P497, DOI 10.2967/jnumed.111.089623; Yamamoto A, 1998, CELL STRUCT FUNCT, V23, P33, DOI 10.1247/csf.23.33; Zhang HH, 2006, MOL CELL, V24, P185, DOI 10.1016/j.molcel.2006.09.019; Zoncu R, 2011, NAT REV MOL CELL BIO, V12, P21, DOI 10.1038/nrm3025	50	12	12	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2016	11	12							e0168359	10.1371/journal.pone.0168359	http://dx.doi.org/10.1371/journal.pone.0168359			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI8LN	27992581	Green Published, gold			2022-12-27	WOS:000392758000039
J	Abera, SF; Adane, K				Abera, Semaw Ferede; Adane, Kelemework			Burden and Determinants of Smoking among Prisoners with Respiratory Tract Infection: A Cross-Sectional Study of Nine Major Prison Setups in Northern Ethiopia	PLOS ONE			English	Article							CIGARETTE-SMOKING; SUBSTANCE USE; YOUNG-ADULTS; RISK-FACTOR; TOBACCO USE; MORTALITY; INCARCERATION; POPULATION; PREVALENCE; CESSATION	Background Morbidity, mortality and a wide range of associated risk factors are disproportionately clustered among prisoners compared to the general population. Smoking is one of the risk factors for the increased burden of unfavorable health outcomes particularly among prisoners. However, little is known about the level and determinants of smoking among the incarcerated population in Ethiopia. Methods We collected data from 738 prisoners in nine major prison setups in Tigray region by nurses and clinical officers. Data were entered in to Epi Data 3.1 and exported to stata 13.0 for cleaning and further analysis. Multivariable logistic regression model was fitted to identify determinants of smoking at p value of less than 5%. Result The prevalence of smoking was 21 per cent (95% CI = 18.2%, 24.1). Urban residence (AOR = 2.15; 95% CI = 1.20, 3.84), previous history of incarceration (AOR = 1.91; 95% CI = 1.08, 3.40) and alcohol use before incarcerated (AOR = 4.20; 95% CI = 2.57, 6.87) were significantly associated with risk of smoking. In contrast, risk of smoking was significantly lower for farmers (AOR = 0.20; 95% CI = 0.08, 0.49), prisoners with family support (AOR = 0.52; 95% CI = 0.32, 0.87) and for those who were jailed in Shire prison site (AOR = 0.43; 95% CI = 0.20, 0.95). Conclusion Our work clearly indicates that the observed smoking prevalence calls for the need of comprehensive and interdisciplinary interventions targeting prisoners.	[Abera, Semaw Ferede] Mekelle Univ, Sch Publ Hlth, Coll Hlth Sci, Mekelle, Ethiopia; [Abera, Semaw Ferede] Kilte Awlaelo Hlth & Demog Surveillance Site, Mekelle, Ethiopia; [Adane, Kelemework] Mekelle Univ, Dept Med Microbiol & Immunol, Coll Hlth Sci, Mekelle, Ethiopia	Mekelle University; Mekelle University	Abera, SF (corresponding author), Mekelle Univ, Sch Publ Hlth, Coll Hlth Sci, Mekelle, Ethiopia.; Abera, SF (corresponding author), Kilte Awlaelo Hlth & Demog Surveillance Site, Mekelle, Ethiopia.	semawfer@yahoo.com			Mekelle University	Mekelle University	We are grateful to Mekelle University for funding the research project and we are also thankful to Commander Tsegay Uqubay, Head of the Regional Prison Health Office, for facilitating the research process in all the nine prison sites. Last but not least, we are extremely grateful to our research participants, all staffs of the prison sites, staffs of the nearby health centers and clinical officers for all their tremendous support and time.	Alcaide J, 1996, TUBERCLE LUNG DIS, V77, P112, DOI 10.1016/S0962-8479(96)90024-6; Awofeso N, 2001, TOB CONTROL, V10, P84; Bailey ZD, 2015, AM J PUBLIC HEALTH, V105, P2275, DOI 10.2105/AJPH.2015.302772; BARRERA M, 1992, J ABNORM CHILD PSYCH, V20, P1, DOI 10.1007/BF00927113; Bates MN, 2007, ARCH INTERN MED, V167, P335, DOI 10.1001/archinte.167.4.335; Binswanger IA, 2014, BMJ-BRIT MED J, V349, DOI 10.1136/bmj.g4542; Dearden KA, 2007, REV PANAM SALUD PUBL, V22, P160, DOI 10.1590/S1020-49892007000800002; den Velde WO, 2011, PSYCHOL REP, V108, P437, DOI 10.2466/02.10.16.PR0.108.2.437-448; Deressa W, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-660; Dickert J, 2015, PSYCHIAT SERV, V66, P975, DOI 10.1176/appi.ps.201400429; DIFRANZA JR, 1990, J STUD ALCOHOL, V51, P130, DOI 10.15288/jsa.1990.51.130; Donahue J, 2014, J CORRECT HEALTH CAR, V20, P302, DOI 10.1177/1078345814541534; Graham L, 2015, EUR J PUBLIC HEALTH, V25, P879, DOI 10.1093/eurpub/cku252; Howell BA, 2015, ADDICT BEHAV, V50, P157, DOI 10.1016/j.addbeh.2015.06.017; Jama-Alol KA, 2015, INT J PRISON HEALTH, V11, P108, DOI 10.1108/IJPH-10-2013-0046; Kauffman RM, 2011, NICOTINE TOB RES, V13, P449, DOI 10.1093/ntr/ntr024; Mdodo R, 2015, ANN INTERN MED, V162, P335, DOI 10.7326/M14-0954; Olsen MH, 2015, INT J CANCER, V136, P2476, DOI 10.1002/ijc.29288; Papadodima SA, 2010, EUR J PUBLIC HEALTH, V20, P470, DOI 10.1093/eurpub/ckp209; Ramaswamy M, 2013, SUBST ABUSE TREAT PR, V8, DOI 10.1186/1747-597X-8-37; Sieminska A, 2006, BMC PUBLIC HEALTH, V6, DOI 10.1186/1471-2458-6-181; Tiwari RV, 2014, ASIAN PAC J CANCER P, V15, P413, DOI 10.7314/APJCP.2014.15.1.413; Turan O, 2015, J ADDICT MED, V9, P118, DOI 10.1097/ADM.0000000000000103; Wang EA, 2009, ARCH INTERN MED, V169, P687, DOI 10.1001/archinternmed.2009.26; WILLS TA, 1992, AM J COMMUN PSYCHOL, V20, P349, DOI 10.1007/BF00937914; Zlodre Jakov, 2012, Am J Public Health, V102, pe67, DOI 10.2105/AJPH.2012.300764	26	1	2	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2016	11	12							e0168941	10.1371/journal.pone.0168941	http://dx.doi.org/10.1371/journal.pone.0168941			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EG7JB	28030604	gold, Green Published, Green Submitted			2022-12-27	WOS:000391222000087
J	Ahrazem, O; Argandona, J; Castillo, R; Rubio-Moraga, A; Gomez-Gomez, L				Ahrazem, Oussama; Argandona, Javier; Castillo, Raquel; Rubio-Moraga, Angela; Gomez-Gomez, Lourdes			Identification and Cloning of Differentially Expressed SOUL and ELIP Genes in Saffron Stigmas Using a Subtractive Hybridization Approach	PLOS ONE			English	Article							LIGHT-INDUCED-PROTEIN; CHLAMYDOMONAS-REINHARDTII; CROCUS-SATIVUS; CHROMOPLAST DIFFERENTIATION; CAROTENOID BIOSYNTHESIS; INDUCIBLE PROTEINS; PROTEOMIC ANALYSIS; ARABIDOPSIS; BINDING; STRESS	Using a subtractive hybridization approach, differentially expressed genes involved in the light response in saffron stigmas were identified. Twenty-two differentially expressed transcript-derived fragments were cloned and sequenced. Two of them were highly induced by light and had sequence similarity to early inducible proteins (ELIP) and SOUL heme-binding proteins. Using these sequences, we searched for other family members expressed in saffron stigma. ELIP and SOUL are represented by small gene families in saffron, with four and five members, respectively. The expression of these genes was analyzed during the development of the stigma and in light and dark conditions. ELIP transcripts were detected in all the developmental stages showing much higher expression levels in the developed stigmas of saffron and all were up-regulated by light but at different levels. By contrast, only one SOUL gene was up-regulated by light and was highly expressed in the stigma at anthesis. Both the ELIP and SOUL genes induced by light in saffron stigmas might be associated with the structural changes affecting the chromoplast of the stigma, as a result of light exposure, which promotes the development and increases the number of plastoglobules, specialized in the recruitment of specific proteins, which enables them to act in metabolite synthesis and disposal under changing environmental conditions and developmental stages.	[Ahrazem, Oussama; Argandona, Javier; Rubio-Moraga, Angela; Gomez-Gomez, Lourdes] Univ Castilla La Mancha, Dept Ciencia & Tecnol Agroforestal & Genet, Inst Bot, Fac Farm, Albacete, Spain; [Ahrazem, Oussama] Univ Castilla La Mancha, Fac Ciencias Ambientales & Bioquim, Toledo, Spain; [Castillo, Raquel] VITAB Labs, La Gineta, Albacete, Spain	Universidad de Castilla-La Mancha; Universidad de Castilla-La Mancha	Gomez-Gomez, L (corresponding author), Univ Castilla La Mancha, Dept Ciencia & Tecnol Agroforestal & Genet, Inst Bot, Fac Farm, Albacete, Spain.	Marialourdes.gomez@uclm.es	Ahrazem, oussama/AAV-1392-2021; Ahrazem, Oussama/E-5602-2016; Gomez-Gomez, Lourdes/AAF-2371-2020	Ahrazem, oussama/0000-0001-9183-9319; Ahrazem, Oussama/0000-0001-9183-9319; Gomez-Gomez, Lourdes/0000-0003-2586-4457; Rubio-Moraga, Angela/0000-0002-2162-2314	Spanish Ministerio de Economia y Competitividad [BIO2013-44239-R]	Spanish Ministerio de Economia y Competitividad(Spanish Government)	This work was supported by the Spanish Ministerio de Economia y Competitividad (BIO2013-44239-R).	ADAMSKA I, 1993, J BIOL CHEM, V268, P5438; Adamska I, 2001, J BIOL CHEM, V276, P8582, DOI 10.1074/jbc.M010447200; Adamska I, 1999, EUR J BIOCHEM, V260, P453, DOI 10.1046/j.1432-1327.1999.00178.x; Ahrazem O, 2016, PLANT MOL BIOL; Ahrazem O, 2015, J AGR FOOD CHEM, V63, P8751, DOI 10.1021/acs.jafc.5b03194; Ahrazem O, 2012, J EXP BOT, V63, P681, DOI 10.1093/jxb/err293; Ahrazem O, 2010, J EXP BOT, V61, P105, DOI 10.1093/jxb/erp283; Alos E, 2008, PLANT PHYSIOL, V147, P1300, DOI 10.1104/pp.108.119917; Ambrosi E, 2011, BIOCHEM J, V438, P291, DOI 10.1042/BJ20110257; Beltran J, 2015, NAT CHEM BIOL, V11, P598, DOI [10.1038/NCHEMBIO.1840, 10.1038/nchembio.1840]; Berti M, 2012, CHIL J AGR RES, V72, P371, DOI 10.4067/S0718-58392012000300011; Binyamin L, 2001, PLANTA, V212, P591, DOI 10.1007/s004250000423; Boyd Joseph S, 2011, Bioarchitecture, V1, P196; Brehelin C, 2007, TRENDS PLANT SCI, V12, P260, DOI 10.1016/j.tplants.2007.04.003; Bruno AK, 2004, J EXP BOT, V55, P2541, DOI 10.1093/jxb/erh273; Caiola MG, 2004, PLANT BIOSYST, V138, P43, DOI 10.1080/11263500410001684116; Castillo R, 2005, PLANT PHYSIOL, V139, P674, DOI 10.1104/pp.105.067827; Champagne A, 2010, J FOOD COMPOS ANAL, V23, P8; CHEUNG AY, 1993, PLANT PHYSIOL, V101, P1223, DOI 10.1104/pp.101.4.1223; Cluis CP, 2004, PLANT J, V38, P332, DOI 10.1111/j.1365-313X.2004.02052.x; Davidi L, 2015, PLANT PHYSIOL, V167, P60, DOI 10.1104/pp.114.248450; Diatchenko L, 1996, P NATL ACAD SCI USA, V93, P6025, DOI 10.1073/pnas.93.12.6025; Doczi R, 2007, PLANT CELL, V19, P3266, DOI 10.1105/tpc.106.050039; Eitzinger N, 2015, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.01085; Ferreira CF, 2008, CROP BREED APPL BIOT, V8, P23, DOI 10.12702/1984-7033.v08n01a04; Fortunato AE, 2016, J MOL EVOL, V82, P279, DOI 10.1007/s00239-016-9745-9; GREEN BR, 1995, PHOTOSYNTH RES, V44, P139, DOI 10.1007/BF00018304; GRIMM B, 1987, EUR J BIOCHEM, V167, P493, DOI 10.1111/j.1432-1033.1987.tb13364.x; Harari-Steinberg O, 2001, PLANT PHYSIOL, V127, P986, DOI 10.1104/pp.010270; Hardtke CS, 2000, EMBO J, V19, P4997, DOI 10.1093/emboj/19.18.4997; Hayami N, 2015, PLANT PHYSIOL, V169, P840, DOI 10.1104/pp.15.00398; Heddad M, 2006, PLANT PHYSIOL, V142, P75, DOI 10.1104/pp.106.081489; Holm M, 2002, GENE DEV, V16, P1247, DOI 10.1101/gad.969702; KATZ A, 1995, PLANT PHYSIOL, V108, P1657, DOI 10.1104/pp.108.4.1657; Khanna R, 2006, PLANT CELL, V18, P2157, DOI 10.1105/tpc.106.042200; Kreimer G, 2009, CURR GENET, V55, P19, DOI 10.1007/s00294-008-0224-8; KUHLBRANDT W, 1994, NATURE, V367, P614, DOI 10.1038/367614a0; Lado J, 2015, PHYSIOL PLANTARUM, V154, P469, DOI 10.1111/ppl.12332; Lee HJ, 2012, J EXP BOT, V63, P5967, DOI 10.1093/jxb/ers242; Lee JH, 2014, J NANOMATER, V2014, DOI 10.1155/2014/567827; Lee J, 2007, PLANT CELL, V19, P731, DOI 10.1105/tpc.106.047688; LERS A, 1991, J BIOL CHEM, V266, P13698; Liu LH, 2015, MOL PLANT, V8, P28, DOI 10.1016/j.molp.2014.11.006; Llorente B, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.00263; Llorente B, 2016, PLANT J, V85, P107, DOI 10.1111/tpj.13094; Lundquist PK, 2012, PLANT PHYSIOL, V158, P1172, DOI 10.1104/pp.111.193144; McCollum JP, 1954, J FOOD SCI, V19, P7; Noordally ZB, 2013, SCIENCE, V339, P1316, DOI 10.1126/science.1230397; Noren H, 2003, PLANT CELL ENVIRON, V26, P245, DOI 10.1046/j.1365-3040.2003.00954.x; Page D, 2008, POSTHARVEST BIOL TEC, V50, P117, DOI 10.1016/j.postharvbio.2008.05.017; Peng YH, 2008, PHYSIOL PLANTARUM, V132, P44, DOI 10.1111/j.1399-3054.2007.00988.x; Pera EM, 2005, INT J DEV BIOL, V49, P781, DOI 10.1387/ijdb.052003ep; Rensing SA, 2008, SCIENCE, V319, P64, DOI 10.1126/science.1150646; Rodriguez-Concepcion M, 2013, ARCH BIOCHEM BIOPHYS, V539, P110, DOI 10.1016/j.abb.2013.07.009; Rubio A, 2008, J BIOL CHEM, V283, P24816, DOI 10.1074/jbc.M804000200; Moraga AR, 2009, PHYTOCHEMISTRY, V70, P1009, DOI 10.1016/j.phytochem.2009.04.022; Rubio-Moraga A, 2010, PHYTOCHEMISTRY, V71, P1506, DOI 10.1016/j.phytochem.2010.05.026; Ruiz-Sola M Aguila, 2012, Arabidopsis Book, V10, pe0158, DOI 10.1199/tab.0158; Schmidt M, 2006, PLANT CELL, V18, P1908, DOI 10.1105/tpc.106.041749; Schulze T, 2013, MOL PLANT, V6, P931, DOI 10.1093/mp/sss137; Singh DK, 2011, TRENDS PLANT SCI, V16, P432, DOI 10.1016/j.tplants.2011.03.014; Takahashi S, 2008, PHOTOCH PHOTOBIO SCI, V7, P1216, DOI 10.1039/b802588f; Tian L, 2004, ARCH BIOCHEM BIOPHYS, V430, P22, DOI 10.1016/j.abb.2004.02.003; Vanhee C, 2011, PLANT SIGNAL BEHAV, V6, P1383, DOI 10.4161/psb.6.9.16477; Wagner V, 2008, PLANT PHYSIOL, V146, P772, DOI 10.1104/pp.107.109645; Wang H, 2015, ACTA PHYSL PLANTARUM, V37; Waters MT, 2009, PLANT CELL, V21, P1109, DOI 10.1105/tpc.108.065250; Xiao LH, 2015, P NATL ACAD SCI USA, V112, P5833, DOI 10.1073/pnas.1505811112; Xu X, 2011, NATURE, V475, P189, DOI 10.1038/nature10158; Ytterberg AJ, 2006, PLANT PHYSIOL, V140, P984, DOI 10.1104/pp.105.076083; Zeng Qin, 2002, Journal of Experimental Botany, V53, P1197, DOI 10.1093/jexbot/53.371.1197; Zylka MJ, 1999, MOL BRAIN RES, V74, P175, DOI 10.1016/S0169-328X(99)00277-6	72	2	3	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2016	11	12							e0168736	10.1371/journal.pone.0168736	http://dx.doi.org/10.1371/journal.pone.0168736			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EG7JB	28030614	Green Published, gold, Green Submitted			2022-12-27	WOS:000391222000070
J	Griffiths, C; Bremner, S; Islam, K; Sohanpal, R; Vidal, DL; Dawson, C; Foster, G; Ramsay, J; Feder, G; Taylor, S; Barnes, N; Choudhury, A; Packe, G; Bayliss, E; Trathen, D; Moss, P; Cook, V; Livingstone, AE; Eldridge, S				Griffiths, Chris; Bremner, Stephen; Islam, Kamrul; Sohanpal, Ratna; Vidal, Debi-Lee; Dawson, Carolyn; Foster, Gillian; Ramsay, Jean; Feder, Gene; Taylor, Stephanie; Barnes, Neil; Choudhury, Aklak; Packe, Geoff; Bayliss, Elizabeth; Trathen, Duncan; Moss, Philip; Cook, Viv; Livingstone, Anna Eleri; Eldridge, Sandra			Effect of an Education Programme for South Asians with Asthma and Their Clinicians: A Cluster Randomised Controlled Trial (OEDIPUS)	PLOS ONE			English	Article							SELF-MANAGEMENT PROGRAM; SOCIOECONOMICALLY DEPRIVED AREAS; SUBCONTINENT ETHNIC-GROUPS; CHRONIC DISEASE; HOSPITAL ADMISSION; PATIENT OUTCOMES; HEALTH-STATUS; PEDIATRIC ASTHMA; CARE EDUCATION; EAST LONDON	Background People with asthma from ethnic minority groups experience significant morbidity. Culturally-specific interventions to reduce asthma morbidity are rare. We tested the hypothesis that a culturally-specific education programme, adapted from promising theory-based interventions developed in the USA, would reduce unscheduled care for South Asians with asthma in the UK. Methods A cluster randomised controlled trial, set in two east London boroughs. 105 of 107 eligible general practices were randomised to usual care or the education programme. Participants were south Asians with asthma aged 3 years and older with recent unscheduled care. The programme had two components: the Physician Asthma Care Education (PACE) programme and the Chronic Disease Self Management Programme (CDSMP), targeted at clinicians and patients with asthma respectively. Both were culturally adapted for south Asians with asthma. Specialist nurses, and primary care teams from intervention practices were trained using the PACE programme. South Asian participants attended an outpatient appointment; those registered with intervention practices received self-management training from PACE-trained specialist nurses, a follow-up appointment with PACE-trained primary care practices, and an invitation to attend the CDSMP. Patients from control practices received usual care. Primary outcome was unscheduled care. Findings 375 south Asians with asthma from 84 general practices took part, 183 registered with intervention practices and 192 with control practices. Primary outcome data were available for 358/ 375 (95.5%) of participants. The intervention had no effect on time to first unscheduled attendance for asthma (Adjusted Hazard Ratio AHR = 1.19 95% CI 0.92 to 1.53). Time to first review in primary care was reduced (AHR = 2.22, (1.67 to 2.95). Asthma-related quality of life and self-efficacy were improved at 3 months (adjusted mean difference -2.56, (-3.89 to -1.24); 0.44, (0.05 to 0.82) respectively. Conclusions A multi-component education programme adapted for south Asians with asthma did not reduce unscheduled care but did improve follow-up in primary care, self-efficacy and quality of life. More effective interventions are needed for south Asians with asthma.	[Griffiths, Chris; Bremner, Stephen; Islam, Kamrul; Sohanpal, Ratna; Vidal, Debi-Lee; Dawson, Carolyn; Foster, Gillian; Ramsay, Jean; Taylor, Stephanie; Barnes, Neil; Choudhury, Aklak; Cook, Viv; Livingstone, Anna Eleri; Eldridge, Sandra] Queen Mary Univ London, Asthma UK Ctr Appl Res, Ctr Primary Care & Publ Hlth, Barts & London Sch Med & Dent, London, England; [Feder, Gene] Univ Bristol, Ctr Acad Primary Care, Sch Social & Community Med, Canynge Hall, Bristol, Avon, England; [Barnes, Neil] Queen Mary Univ London, William Harvey Res Inst, Barts & London Sch Med & Dent, London, England; [Packe, Geoff] Barts & London NHS Trust, Newham Univ Hosp, London, England; [Bayliss, Elizabeth] Brady Ctr, Social Action Hlth, London, England; [Trathen, Duncan] Newham Transit Practice, London, England; [Moss, Philip] St Georges Univ Hosp NHS Fdn Trust, London, England	University of London; Queen Mary University London; University of Bristol; University of London; Queen Mary University London; Barts Health NHS Trust	Griffiths, C (corresponding author), Queen Mary Univ London, Asthma UK Ctr Appl Res, Ctr Primary Care & Publ Hlth, Barts & London Sch Med & Dent, London, England.	c.j.griffiths@qmul.ac.uk	TAYLOR, STEPHANIE/GYV-4768-2022; Bremner, Stephen/R-4038-2016	Bremner, Stephen/0000-0003-0790-7070; Choudhury, Aklak/0000-0002-7435-0164; Feder, Gene/0000-0002-7890-3926; Eldridge, Sandra/0000-0001-5638-2317; Taylor, Stephanie/0000-0001-7454-6354	Asthma UK [04;060]; Asthma UK [AUK-AC-2012-01] Funding Source: researchfish	Asthma UK; Asthma UK	Asthma UK funded the work; ref 04;060. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bailey EJ, 2009, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD006580.pub4, 10.1002/14651858.CD006580.pub3]; Barley EA, 1998, RESP MED, V92, P1207, DOI 10.1016/S0954-6111(98)90423-1; Blixen CE, 2001, J ASTHMA, V38, P23, DOI 10.1081/JAS-10000000264; Bruzzese JM, 2011, AM J RESP CRIT CARE, V183, P998, DOI 10.1164/rccm.201003-0429OC; Cabana MD, 2006, PEDIATRICS, V117, P2149, DOI 10.1542/peds.2005-1055; Cabana MD, 2014, HEALTH EDUC BEHAV, V41, P509, DOI 10.1177/1090198114547510; Canino G, 2008, J ALLERGY CLIN IMMUN, V121, P665, DOI 10.1016/j.jaci.2007.10.022; Castro M, 2003, AM J RESP CRIT CARE, V168, P1095, DOI 10.1164/rccm.200208-877OC; Clark NM, 2000, EUR RESPIR J, V16, P15, DOI 10.1034/j.1399-3003.2000.16a04.x; Clark NM, 1998, PEDIATRICS, V101, P831, DOI 10.1542/peds.101.5.831; Elaro A, 2014, INT J CLIN PHARM-NET, V36, P976, DOI 10.1007/s11096-014-9984-z; Eldridge SM, 2006, INT J EPIDEMIOL, V35, P1292, DOI 10.1093/ije/dyl129; Eldridge SM, 2009, INT STAT REV, V77, P378, DOI 10.1111/j.1751-5823.2009.00092.x; Erickson SE, 2007, ARCH INTERN MED, V167, P1846, DOI 10.1001/archinte.167.17.1846; Foster G, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005108.pub2; Galbreath AD, 2008, ANN ALLERG ASTHMA IM, V101, P599, DOI 10.1016/S1081-1206(10)60222-0; George MR, 1999, ARCH INTERN MED, V159, P1710, DOI 10.1001/archinte.159.15.1710; Griffiths C, 2005, BRIT J GEN PRACT, V55, P831; Griffiths C, 2004, BMJ-BRIT MED J, V328, P144, DOI 10.1136/bmj.37950.784444.EE; Griffiths C, 2001, BRIT MED J, V323, P962, DOI 10.1136/bmj.323.7319.962; Griffiths C, 2007, BMJ-BRIT MED J, V334, P1254, DOI 10.1136/bmj.39227.698785.47; Gupta A, 2012, PAEDIATR RESPIR REV, V13, P236, DOI 10.1016/j.prrv.2011.07.003; Hull S, 2007, BRIT J GEN PRACT, V57, P836; Hull SA, 2016, NPJ PRIM CARE RESP M, V26, DOI 10.1038/npjpcrm.2016.49; Kennedy A, 2007, J EPIDEMIOL COMMUN H, V61, P254, DOI 10.1136/jech.2006.053538; La Roche MJ, 2006, ANN ALLERG ASTHMA IM, V96, P80, DOI 10.1016/S1081-1206(10)61044-7; Lorig KR, 1999, MED CARE, V37, P5, DOI 10.1097/00005650-199901000-00003; Lorig KR, 2001, MED CARE, V39, P1217, DOI 10.1097/00005650-200111000-00008; MAIMAN LA, 1979, JAMA-J AM MED ASSOC, V241, P1919; Martin MA, 2009, J ALLERGY CLIN IMMUN, V123, P153, DOI 10.1016/j.jaci.2008.10.057; Martineau AR, 2016, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD011511.pub2; Moudgil H, 1998, THORAX, V53, P490, DOI 10.1136/thx.53.6.490; Moudgil H, 2000, THORAX, V55, P177, DOI 10.1136/thorax.55.3.177; Netuveli G, 2005, LANCET, V365, P312, DOI 10.1016/S0140-6736(05)17785-X; Patel MR, 2014, BMC MED EDUC, V14, DOI 10.1186/1472-6920-14-118; Press VG, 2012, J GEN INTERN MED, V27, P1001, DOI 10.1007/s11606-012-2058-9; Reeves D, 2008, BRIT J GEN PRACT, V58, P198, DOI 10.3399/bjgp08X277320; Shah S, 2011, MED J AUSTRALIA, V195, P405, DOI 10.5694/mja10.11422; Sheikh A, 2016, BMC MED, V14, DOI 10.1186/s12916-015-0546-6; Smeeton NC, 2007, ARCH DIS CHILD, V92, P1082, DOI 10.1136/adc.2006.112037; StataCorp L, 2007, STAT DAT AN STAT SOF; STEEN N, 1994, BRIT MED J, V309, P1065, DOI 10.1136/bmj.309.6961.1065; WILLIAMS A, 1990, HEALTH POLICY, V16, P199	43	13	13	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2016	11	12							e0158783	10.1371/journal.pone.0158783	http://dx.doi.org/10.1371/journal.pone.0158783			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EG7JB	28030569	Green Published, Green Submitted, Green Accepted, gold			2022-12-27	WOS:000391222000001
J	Savage, A; Thomas, L; Feilen, KL; Kidney, D; Soto, LH; Pearson, M; Medina, FS; Emeris, G; Guillen, RR				Savage, Anne; Thomas, Len; Feilen, Katie L.; Kidney, Darren; Soto, Luis H.; Pearson, Mackenzie; Medina, Felix S.; Emeris, German; Guillen, Rosamira R.			An Assessment of the Population of Cotton-Top Tamarins (Saguinus oedipus) and Their Habitat in Colombia	PLOS ONE			English	Article							CONSERVATION; BIODIVERSITY; DEFORESTATION	Numerous animals have declining populations due to habitat loss, illegal wildlife trade, and climate change. The cotton-top tamarin (Saguinus oedipus) is a Critically Endangered primate species, endemic to northwest Colombia, threatened by deforestation and illegal trade. In order to assess the current state of this species, we analyzed changes in the population of cotton-top tamarins and its habitat from 2005 to 2012. We used a tailor-made "lure strip transect" method to survey 43 accessible forest parcels that represent 30% of the species' range. Estimated population size in the surveyed region was approximately 2,050 in 2005 and 1,900 in 2012, with a coefficient of variation of approximately 10%. The estimated population change between surveys was -7% (a decline of approximately 1.3% per year) suggesting a relatively stable population. If densities of inaccessible forest parcels are similar to those of surveyed samples, the estimated population of cotton-top tamarins in the wild in 2012 was 6,946 individuals. We also recorded little change in the amount of suitable habitat for cotton-top tamarins between sample periods: in 2005, 18% of surveyed forest was preferred habitat for cotton-top tamarins, while in 2012, 17% percent was preferred. We attribute the relatively stable population of this Critically Endangered species to increased conservation efforts of Proyecto Titi, conservation NGOs, and the Colombian government. Due to continued threats to cotton-top tamarins and their habitat such as agriculture and urban expansion, ongoing conservation efforts are needed to ensure the long-term survival of cotton-top tamarins in Colombia.	[Savage, Anne; Feilen, Katie L.; Pearson, Mackenzie] Disneys Anim Sci & Environm, Conservat Dept, Lake Buena Vista, FL USA; [Thomas, Len; Kidney, Darren] Univ St Andrews, Ctr Res Ecol & Environm Modelling, St Andrews, Scotland; [Thomas, Len; Kidney, Darren] Univ St Andrews, Sch Math & Stat, St Andrews, Scotland; [Soto, Luis H.; Medina, Felix S.; Emeris, German; Guillen, Rosamira R.] Fdn Proyecto Titi, Barranquilla, Colombia	University of St Andrews; University of St Andrews	Savage, A (corresponding author), Disneys Anim Sci & Environm, Conservat Dept, Lake Buena Vista, FL USA.	Anne.Savage@disney.com		Thomas, Len/0000-0002-7436-067X	Disney's Animal, Science and Environment; SeaWorld & Busch Gardens Conservation Fund; Mohammed bin Zayed Species Conservation Fund; Wildlife Conservation Network; Phoenix Zoo	Disney's Animal, Science and Environment; SeaWorld & Busch Gardens Conservation Fund; Mohammed bin Zayed Species Conservation Fund; Wildlife Conservation Network; Phoenix Zoo	Disney's Animal, Science and Environment provided support in the form of salaries for authors AS, KLF, and MP. They also covered a proportion of research expenses (field equipment, transportation to survey areas) for these studies. These authors participated in the study design, data collection and analysis, decision to publish, and preparation of the manuscript, but the funder, itself, did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section. The study was also funded by The SeaWorld & Busch Gardens Conservation Fund, Mohammed bin Zayed Species Conservation Fund, Wildlife Conservation Network, and Phoenix Zoo.	Brawn JD, 1996, ECOLOGY, V77, P3, DOI 10.2307/2265649; Burnham K. P., 2002, MODEL SELECTION MULT, V2nd; Butchart SHM, 2010, SCIENCE, V328, P1164, DOI 10.1126/science.1187512; Calix M., 2018, EUROPEAN RED LIST SA; CDB, 2002, CONTRIBUTION 6 NATL; Davalos LM, 2011, ENVIRON SCI TECHNOL, V45, P1219, DOI 10.1021/es102373d; DUNBAR RIM, 1987, INT J PRIMATOL, V8, P299, DOI 10.1007/BF02737386; Etter A, 2006, AGR ECOSYST ENVIRON, V114, P369, DOI 10.1016/j.agee.2005.11.013; Fearnside PM, 2001, ENVIRON MANAGE, V27, P377, DOI 10.1007/s002670010156; Fewster RM, 2009, BIOMETRICS, V65, P225, DOI 10.1111/j.1541-0420.2008.01018.x; Fitzherbert EB, 2008, TRENDS ECOL EVOL, V23, P538, DOI 10.1016/j.tree.2008.06.012; Hernandez-Camacho J., 1976, P35; Hoffmann M, 2010, SCIENCE, V330, P1503, DOI 10.1126/science.1194442; Kierulff M. C. M., 2012, International Zoo Yearbook, V46, P36, DOI 10.1111/j.1748-1090.2012.00170.x; Kleiman D.G., 1986, P959; McNeilage A, 2006, ORYX, V40, P419, DOI 10.1017/S0030605306001311; Miller L, 2004, AM J PRIMATOL, V64, P451, DOI 10.1002/ajp.20091; Perez-Barrios, 2013, MEDIO CUAL SE DECLAR; ProAves, 2015, PROAVES RES 2015; R Development Core Team, 2016, R LANG ENV STAT COMP; Rico L, 2010, AEROPUERTO BICENTENA; Sanchez-Cuervo AM, 2013, ECOSPHERE, V4, DOI 10.1890/ES13-00207.1; Sanchez-Cuervo AM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043943; Savage A., 2012, International Zoo Yearbook, V46, P56, DOI 10.1111/j.1748-1090.2011.00159.x; Savage A, 2010, AM J PRIMATOL, V72, P379, DOI 10.1002/ajp.20770; Savage A, 1996, AM J PRIMATOL, V38, P85, DOI 10.1002/(SICI)1098-2345(1996)38:1<85::AID-AJP7>3.0.CO;2-P; Savage A, 2009, AM J PRIMATOL, V71, P707, DOI 10.1002/ajp.20696; Savage A, 1997, AM J PRIMATOL, V43, P329, DOI 10.1002/(SICI)1098-2345(1997)43:4<329::AID-AJP4>3.0.CO;2-Z; Savage A, 2009, PRIMATES PERIL WORLD, P1; Savage A, 2014, IUCN RED LIST THREAT; Savage A., 1990, THESIS; Savage A, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1030; Swenson JJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018875; Thompson S.K., 2012, SAMPLING, V3rd; Trust WL, 2014, COLOMBIAS COTTON TOP; UNEP-WCMC (Comps.), 2015, CHECKL CITES SPEC WE; UNEP-WCMC IUCN, 2021, PROT PLAN INS NAM CO; United Nations Development Program, 2012, POW LOC ACT COMM FRO; United Nations Development Programme, 2013, EQ IN CAS STUD SER; Verano de la Rosa E, 2011, 00015 CORP AUT REG A; World Bank Global Poverty Working Group, 2016, POV HEADC RAT NAT PO	41	7	7	1	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2016	11	12							e0168324	10.1371/journal.pone.0168324	http://dx.doi.org/10.1371/journal.pone.0168324			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EG7JB	28030570	gold, Green Published			2022-12-27	WOS:000391222000043
J	Turgeon, N; Michel, K; Ha, TL; Robine, E; Moineau, S; Duchaine, C				Turgeon, Nathalie; Michel, Kevin; Ha, Thi-Lan; Robine, Enric; Moineau, Sylvain; Duchaine, Caroline			Resistance of Aerosolized Bacterial Viruses to Four Germicidal Products	PLOS ONE			English	Article							AIRBORNE INFLUENZA-VIRUS; RELATIVE-HUMIDITY; INACTIVATION; SURVIVAL; QUANTIFICATION; SUSCEPTIBILITY; FILTERS; AIR	Viral diseases can spread through a variety of routes including aerosols. Yet, limited data are available on the efficacy of aerosolized chemicals to reduce viral loads in the air. Bacteriophages (phages) are often used as surrogates for hazardous viruses in aerosol studies because they are inexpensive, easy to handle, and safe for laboratory workers. Moreover, several of these bacterial viruses display physical characteristics similar to pathogenic human and animal viruses, like morphological size, type of nucleic acids, capsid morphology, and the presence of an envelope. In this study, the efficacy of four chemicals was evaluated on four airborne phages at two different relative humidity levels. Non-tailed bacteriophages MS2 (single-stranded RNA), phi 6 (double-stranded RNA, enveloped), PR772 (double-stranded DNA), and phi X174 (single-stranded DNA) were first aerosolized in a 55L rotative environmental chamber at 19 degrees C with 25% and 50% relative humidity. Then, hydrogen peroxide, Eugenol (phenylpropene used in commercial perfumes and flavorings), Mist (R) (automobile disinfectant containing Triethylene glycol), and Pledge (R) (multisurface disinfectant containing Isopropanol, n-Alkyl Dimethyl Benzyl Amonium Chlorides, and n-Alkyl Dimethyl Ethylbenzyl Ammonium Chloride) were nebulized with the phages using a separate nebulizer. Aerosols were maintained in suspension during 10 minutes, 1 hour, and 2 hours. Viral aerosols were sampled using an SKC BioSampler and samples were analyzed using qPCR and plaque assays. The resistance levels of the four phages varied depending on the relative humidity (RH) and germicidal products tested. Phage MS2 was the most stable airborne virus under the environmental conditions tested while phage PR772 was the least stable. Pledge (R) and Eugenol reduced the infectivity of all airborne phages tested. At 25% RH, Pledge (R) and Eugenol were more effective at reducing infectivity of RNA phages phi 6 and MS2. At 50% RH, Pledge (R) was the most effective agent against phage MS2. These findings illustrate that various airborne viruses should be tested to demonstrate the effectiveness of germicidal treatments. This research also provides a set of parameters for testing germicidal products in large-scale settings to reduce the risk of virus transmission.	[Turgeon, Nathalie; Michel, Kevin; Duchaine, Caroline] Univ Laval, Ctr Rech, Inst Univ Cardiol & Pneumol Quebec, Quebec City, PQ, Canada; [Turgeon, Nathalie; Michel, Kevin; Moineau, Sylvain; Duchaine, Caroline] Univ Laval, Dept Biochim Microbiol & Bioinformat, Fac Sci & Genie, Quebec City, PQ, Canada; [Ha, Thi-Lan; Robine, Enric] Ctr Sci & Tech Batiment, Champs Sur Marne, Marne La Vallee, France; [Moineau, Sylvain] Univ Laval, Felix Herelle Reference Ctr Bacterial Viruses, Fac Med Dent, Quebec City, PQ, Canada; [Moineau, Sylvain] Univ Laval, GREB, Fac Med Dent, Quebec City, PQ, Canada	Laval University; Laval University; Laval University; Laval University	Duchaine, C (corresponding author), Univ Laval, Ctr Rech, Inst Univ Cardiol & Pneumol Quebec, Quebec City, PQ, Canada.; Duchaine, C (corresponding author), Univ Laval, Dept Biochim Microbiol & Bioinformat, Fac Sci & Genie, Quebec City, PQ, Canada.	Caroline.Duchaine@bcm.ulaval.ca	Moineau, Sylvain/I-7231-2019	Moineau, Sylvain/0000-0002-2832-5101	Ministere du developpement durable et de l'energie-France	Ministere du developpement durable et de l'energie-France	This work was funded by the Ministere du developpement durable et de l'energie-France and was conducted within the framework of the French research program PRIMEQUAL. Convention no12-MRES-Primequal-5-CVS-37. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bibby K, 2013, ENVIRON SCI-PROC IMP, V15, P336, DOI 10.1039/c2em30831b; Bibby K, 2013, ENVIRON SCI TECHNOL, V47, P1945, DOI 10.1021/es305181x; Bischoff WE, 2013, J INFECT DIS, V207, P1037, DOI 10.1093/infdis/jis773; Blachere FM, 2009, CLIN INFECT DIS, V48, P438, DOI 10.1086/596478; Bonifait L, 2015, CLIN INFECT DIS, V61, P299, DOI 10.1093/cid/civ321; Cutler TD, 2012, VET MICROBIOL, V159, P47, DOI 10.1016/j.vetmic.2012.03.044; Dee S, 2005, CAN J VET RES, V69, P64; ELAZHARY MASY, 1979, CAN J COMP MED, V43, P305; Gendron L, 2010, AEROSOL SCI TECH, V44, P893, DOI 10.1080/02786826.2010.501351; Gregersen JP, 2012, BIOLOGICALS, V40, P282, DOI 10.1016/j.biologicals.2012.02.004; Grinshpun SA, 2007, ENVIRON SCI TECHNOL, V41, P606, DOI 10.1021/es061373o; Hsu CS, 2014, ENVIRON MONIT ASSESS, V186, P2941, DOI 10.1007/s10661-013-3591-7; Hsu CS, 2013, J AIR WASTE MANAGE, V63, P796, DOI 10.1080/10962247.2012.735212; IJAZ MK, 1985, J GEN VIROL, V66, P2743, DOI 10.1099/0022-1317-66-12-2743; KARIM YG, 1985, CAN J MICROBIOL, V31, P1058, DOI 10.1139/m85-199; La Rosa G, 2013, ANN I SUPER SANITA, V49, P124, DOI 10.4415/ANN_13_02_03; Longest PW, 2012, J AEROSOL SCI, V51, P66, DOI 10.1016/j.jaerosci.2012.04.002; LORENZ D, 1980, LAB ANIM SCI, V30, P661; Lowen AC, 2007, PLOS PATHOG, V3, P1470, DOI 10.1371/journal.ppat.0030151; Lute S, 2004, APPL ENVIRON MICROB, V70, P4864, DOI 10.1128/AEM.70.8.4864-4871.2004; McDevitt JJ, 2012, APPL ENVIRON MICROB, V78, P1666, DOI 10.1128/AEM.06960-11; Milton DK, 2012, FRONT CELL INFECT MI, V2, DOI 10.3389/fcimb.2012.00150; Moss OR, 2011, AEROSOL MEASUREMENT, P785; Panec M, 2010, PLAQUE ASSAY PROTOCO; Phillpotts RJ, 2010, AEROBIOLOGIA, V26, P301, DOI 10.1007/s10453-010-9166-y; SCHAFFER FL, 1976, ARCH VIROL, V51, P263, DOI 10.1007/BF01317930; Steel J, 2011, J VIROL, V85, P1400, DOI 10.1128/JVI.02186-10; Tang JW, 2009, J R SOC INTERFACE, V6, pS737, DOI 10.1098/rsif.2009.0227.focus; Tseng CC, 2005, AEROSOL SCI TECH, V39, P1136, DOI 10.1080/02786820500428575; Tseng CC, 2006, AEROSOL SCI TECH, V40, P683, DOI 10.1080/02786820600796590; Turgeon N, 2016, CAN J MICROBIOL; Turgeon N, 2014, APPL ENVIRON MICROB, V80, P4242, DOI 10.1128/AEM.00767-14; Verreault D, 2008, MICROBIOL MOL BIOL R, V72, P413, DOI 10.1128/MMBR.00002-08; Verreault D, 2015, APPL ENVIRON MICROB, V81, P7305, DOI 10.1128/AEM.02484-15; Verreault D, 2014, INHAL TOXICOL, V26, P554, DOI 10.3109/08958378.2014.928763; Verreault D, 2010, AEROSOL SCI TECH, V44, P197, DOI 10.1080/02786820903518899; Walker CM, 2007, ENVIRON SCI TECHNOL, V41, P5460, DOI 10.1021/es070056u; Yu L, 2010, AEROBIOLOGIA, V26, P75, DOI 10.1007/s10453-009-9144-4	38	16	16	3	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2016	11	12							e0168815	10.1371/journal.pone.0168815	http://dx.doi.org/10.1371/journal.pone.0168815			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EG7JB	28030577	Green Published, Green Submitted, gold			2022-12-27	WOS:000391222000078
J	Avelino, AFT; Baylis, K; Honey-Roses, J				Avelino, Andre Fernandes Tomon; Baylis, Kathy; Honey-Roses, Jordi			Goldilocks and the Raster Grid: Selecting Scale when Evaluating Conservation Programs	PLOS ONE			English	Article							AREAL UNIT PROBLEM; PROTECTED AREAS; FOREST CONSERVATION; ECOSYSTEM SERVICES; LAND-USE; DEFORESTATION; PAYMENTS; MAUP	Access to high quality spatial data raises fundamental questions about how to select the appropriate scale and unit of analysis. Studies that evaluate the impact of conservation programs have used multiple scales and areal units: from 5x5 km grids; to 30m pixels; to irregular units based on land uses or political boundaries. These choices affect the estimate of program impact. The bias associated with scale and unit selection is a part of a well-known dilemma called the modifiable areal unit problem (MAUP). We introduce this dilemma to the literature on impact evaluation and then explore the tradeoffs made when choosing different areal units. To illustrate the consequences of the MAUP, we begin by examining the effect of scale selection when evaluating a protected area in Mexico using real data. We then develop a Monte Carlo experiment that simulates a conservation intervention. We find that estimates of treatment effects and variable coefficients are only accurate under restrictive circumstances. Under more realistic conditions, we find biased estimates associated with scale choices that are both too large or too small relative to the data generating process or decision unit. In our context, the MAUP may reflect an errors in variables problem, where imprecise measures of the independent variables will bias the coefficient estimates toward zero. This problem may be pronounced at small scales of analysis. Aggregation may reduce this bias for continuous variables, but aggregation exacerbates bias when using a discrete measure of treatment. While we do not find a solution to these issues, even though treatment effects are generally underestimated. We conclude with suggestions on how researchers might navigate their choice of scale and aerial unit when evaluating conservation policies.	[Avelino, Andre Fernandes Tomon; Baylis, Kathy] Univ Illinois, Dept Agr & Consumer Econ, Urbana, IL USA; [Honey-Roses, Jordi] Univ British Columbia, Sch Community & Reg Planning, Vancouver, BC, Canada	University of Illinois System; University of Illinois Urbana-Champaign; University of British Columbia	Honey-Roses, J (corresponding author), Univ British Columbia, Sch Community & Reg Planning, Vancouver, BC, Canada.	jhoney@mail.ubc.ca	Avelino, Andre Fernandes Tomon/ABD-8293-2020; Honey-Rosés, Jordi/H-3364-2019	Avelino, Andre Fernandes Tomon/0000-0002-7941-2766; Honey-Rosés, Jordi/0000-0003-0097-1811	University of Illinois Urbana Champaign (UlUC)-Universidad Nacional Autonoma de Mexico (UNAM) Joint Research Program; University of Illinois Urbana-Champaign (UIUC); National Autonomous University of Mexico (UNAM), UIUC-UNAM Joint Research Program	University of Illinois Urbana Champaign (UlUC)-Universidad Nacional Autonoma de Mexico (UNAM) Joint Research Program; University of Illinois Urbana-Champaign (UIUC); National Autonomous University of Mexico (UNAM), UIUC-UNAM Joint Research Program	This work was supported by University of Illinois Urbana Champaign (UlUC)-Universidad Nacional Autonoma de Mexico (UNAM) Joint Research Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This paper was funded in part by the University of Illinois Urbana-Champaign (UIUC) and the National Autonomous University of Mexico (UNAM), UIUC-UNAM Joint Research Program. The authors would like to thank M. Isabel Ramirez for providing the land cover data used in the motivating example for the paper. The authors also thank Laura Grant, Sumeet Gulati, Sarah Jacobson, Cory Lang, Lucija Muehlenbachs, Mike McCall, Jaime Paneque-Galvez, Kate Sims, and Alejandro Velazquez for their suggestions and comments on earlier drafts. We are particularly grateful to the reviewers, Juan Robalino, Michael Drielsma, Alex Pfaff and a fourth anonymous reviewer for providing substantial feedback and suggestions. Any remaining errors are our own.	Alix-Garcia J, 2007, J ENVIRON ECON MANAG, V53, P141, DOI 10.1016/j.jeem.2006.09.004; Alix-Garcia JM, 2012, LAND ECON, V88, P613, DOI 10.3368/le.88.4.613; Andam KS, 2008, P NATL ACAD SCI USA, V105, P16089, DOI 10.1073/pnas.0800437105; Arbia G., 1989, SPATIAL DATA CONFIGU; Arbia G, 2011, LETT SPAT RESOUR SCI, V4, P173, DOI 10.1007/s12076-011-0065-9; Baylis K, 2015, CONSERVING FORESTS M; Baylis K, 2016, CONSERV LETT, V9, P58, DOI 10.1111/conl.12180; Blackman A, 2015, ECOL ECON, V112, P14, DOI 10.1016/j.ecolecon.2015.01.009; Blackman A, 2013, FOREST POLICY ECON, V34, P1, DOI 10.1016/j.forpol.2013.04.006; Borner J, 2015, PLOS ONE, V10, DOI [10.1371/journal.pone.0121544, 10.1371/journal.pone.0116846]; Brower Lincoln P., 1995, Journal of the Lepidopterists' Society, V49, P304; Bruggeman D, 2015, LAND USE POLICY, V42, P151, DOI 10.1016/j.landusepol.2014.07.012; Busch J, 2013, ENVIRON RES LETT, V8, DOI 10.1088/1748-9326/8/3/034028; Clements T, 2015, CONSERV BIOL, V29, P78, DOI 10.1111/cobi.12423; Costedoat S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119881; Dark SJ, 2007, PROG PHYS GEOG, V31, P471, DOI 10.1177/0309133307083294; Ferraro PJ, 2014, P NATL ACAD SCI USA, V111, P4332, DOI 10.1073/pnas.1307712111; Figueroa F, 2008, BIODIVERS CONSERV, V17, P3223, DOI 10.1007/s10531-008-9423-3; FOTHERINGHAM AS, 1991, ENVIRON PLANN A, V23, P1025, DOI 10.1068/a231025; Gaveau DLA, 2009, J BIOGEOGR, V36, P2165, DOI 10.1111/j.1365-2699.2009.02147.x; Gehlke CE, 1934, J AM STAT ASSOC, V29, P169, DOI 10.2307/2277827; Gotway CA, 2002, J AM STAT ASSOC, V97, P632, DOI 10.1198/016214502760047140; Haruna A, 2014, ENVIRON RES LETT, V9, DOI 10.1088/1748-9326/9/3/035007; Honey-Roses J, 2011, CONSERV BIOL, V25, P1032, DOI 10.1111/j.1523-1739.2011.01729.x; Honey-Roses J, 2009, ENVIRON CONSERV, V36, P120, DOI 10.1017/S0376892909990063; Jelinski DE, 1996, LANDSCAPE ECOL, V11, P129, DOI 10.1007/BF02447512; Nelson A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022722; Openshaw S, 1970, MODIFIABLE AEREAL UN; Openshaw S., 1979, STAT APPL SPATIAL SC, V21, P127; Pfaff A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129460; Pfaff A, 2014, WORLD DEV, V55, P7, DOI 10.1016/j.worlddev.2013.01.011; Pfaff ASP, 1999, J ENVIRON ECON MANAG, V37, P26, DOI 10.1006/jeem.1998.1056; Qi Y, 1996, LANDSCAPE ECOL, V11, P39, DOI 10.1007/BF02087112; Ramirez MI, 2003, FOREST CHRON, V79, P242, DOI 10.5558/tfc79242-2; Reynolds H.D, 1998, MODIFIABLE AREA UNIT; Robalino JA, 2012, J DEV ECON, V97, P427, DOI 10.1016/j.jdeveco.2011.06.003; Sanchez-Azofeifa GA, 2007, CONSERV BIOL, V21, P1165, DOI 10.1111/j.1523-1739.2007.00751.x; Shah P, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124872; Sills EO, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132590; Sims KRE, 2010, J ENVIRON ECON MANAG, V60, P94, DOI 10.1016/j.jeem.2010.05.003; Sims KRE, 2015, ITS COMPLICATED DIRE	41	17	17	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2016	11	12							e0167945	10.1371/journal.pone.0167945	http://dx.doi.org/10.1371/journal.pone.0167945			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EI9QH	28005915	gold, Green Published, Green Submitted			2022-12-27	WOS:000392843200025
J	Hart, SA; Ganley, CM; Purpura, DJ				Hart, Sara A.; Ganley, Colleen M.; Purpura, David J.			Understanding the Home Math Environment and Its Role in Predicting Parent Report of Children's Math Skills	PLoS One			English	Article							EARLY NUMERACY SKILLS; CHINESE-AMERICAN; NUMBER SENSE; EUROPEAN-AMERICAN; WRITTEN LANGUAGE; PRIMARY-SCHOOL; LITERACY; MATHEMATICS; ACHIEVEMENT; PERFORMANCE	There is a growing literature concerning the role of the home math environment in children's math development. In this study, we examined the relation between these constructs by specifically addressing three goals. The first goal was to identify the measurement structure of the home math environment through a series of confirmatory factor analyses. The second goal was to examine the role of the home math environment in predicting parent report of children's math skills. The third goal was to test a series of potential alternative explanations for the relation between the home math environment and parent report of children's skills, specifically the direct and indirect role of household income, parent math anxiety, and parent math ability as measured by their approximate number system performance. A final sample of 339 parents of children aged 3 through 8 drawn from Mechanical Turk answered a questionnaire online. The best fitting model of the home math environment was a bifactor model with a general factor representing the general home math environment, and three specific factors representing the direct numeracy environment, the indirect numeracy environment, and the spatial environment. When examining the association of the home math environment factors to parent report of child skills, the general home math environment factor and the spatial environment were the only significant predictors. Parents who reported doing more general math activities in the home reported having children with higher math skills, whereas parents who reported doing more spatial activities reported having children with lower math skills.	[Hart, Sara A.; Ganley, Colleen M.] Florida State Univ, Dept Psychol, Tallahassee, FL 32306 USA; [Hart, Sara A.] Florida State Univ, Florida Ctr Reading Res, Tallahassee, FL 32306 USA; [Ganley, Colleen M.] Florida State Univ, Florida Ctr Res Sci Technol Engn & Math, Learning Syst Inst, Tallahassee, FL 32306 USA; [Purpura, David J.] Purdue Univ, Human Dev & Family Studies, W Lafayette, IN 47907 USA	State University System of Florida; Florida State University; State University System of Florida; Florida State University; State University System of Florida; Florida State University; Purdue University System; Purdue University; Purdue University West Lafayette Campus	Hart, SA (corresponding author), Florida State Univ, Dept Psychol, Tallahassee, FL 32306 USA.; Hart, SA (corresponding author), Florida State Univ, Florida Ctr Reading Res, Tallahassee, FL 32306 USA.	hart@psy.fsu.edu		Ganley, Colleen/0000-0002-8902-9189; Hart, Sara/0000-0001-9793-0420				Anders Y, 2012, EARLY CHILD RES Q, V27, P231, DOI 10.1016/j.ecresq.2011.08.003; Benavides-Varela S, 2016, FRONT PSYCHOL, V7, DOI 10.3389/fpsyg.2016.00094; Berkowitz T, 2015, SCIENCE, V350, P196, DOI 10.1126/science.aac7427; Blevins-Knabe B., 2000, EARLY CHILD DEV CARE, V165, P41, DOI 10.1080/0300443001650104; BlevinsKnabe B, 1996, EARLY DEV PARENTING, V5, P35, DOI 10.1002/(SICI)1099-0917(199603)5:1<35::AID-EDP113>3.0.CO;2-0; Bradley RH, 2001, CHILD DEV, V72, P1844, DOI 10.1111/1467-8624.t01-1-00382; Burgess SR, 2002, READ RES QUART, V37, P408, DOI 10.1598/RRQ.37.4.4; Casad BJ, 2015, FRONT PSYCHOL, V6, DOI 10.3389/fpsyg.2015.01597; Casey BM, 2014, EARLY CHILD RES Q, V29, P636, DOI 10.1016/j.ecresq.2014.07.005; Dearing E, 2012, EARLY CHILD RES Q, V27, P458, DOI 10.1016/j.ecresq.2012.01.002; Frijters JC, 2000, J EDUC PSYCHOL, V92, P466, DOI 10.1037/0022-0663.92.3.466; Geary DC, 2004, J LEARN DISABIL-US, V37, P4, DOI 10.1177/00222194040370010201; Gulick ME, 2012, THESIS; Gunderson EA, 2011, DEVELOPMENTAL SCI, V14, P1021, DOI 10.1111/j.1467-7687.2011.01050.x; Halberda J, 2008, DEV PSYCHOL, V44, P1457, DOI 10.1037/a0012682; Halberda J, 2012, P NATL ACAD SCI USA, V109, P11116, DOI 10.1073/pnas.1200196109; Halberda J, 2008, LANG LEARN DEV, V4, P99, DOI 10.1080/15475440801922099; Hart B., 1995, MEANINGFUL DIFFERENC; Hart SA, 2009, J EDUC PSYCHOL, V101, P388, DOI 10.1037/a0015115; Hu LT, 1999, STRUCT EQU MODELING, V6, P1, DOI 10.1080/10705519909540118; Huntsinger CS, 1997, INT J BEHAV DEV, V21, P371, DOI 10.1080/016502597384929; Huntsinger CS, 1998, DEV PSYCHOL, V34, P747, DOI 10.1037/0012-1649.34.4.747; Huntsinger CS, 2000, J EDUC PSYCHOL, V92, P745, DOI 10.1037//0022-0663.92.4.745; Inglis M, 2011, PSYCHON B REV, V18, P1222, DOI 10.3758/s13423-011-0154-1; Kirby J., 2008, EXCEPTIONALITY ED CH, V18, P112; Kleemans T, 2012, EARLY CHILD RES Q, V27, P471, DOI 10.1016/j.ecresq.2011.12.004; LeFevre J, 2002, EARLY CHILD DEV CARE, V172, P293; LeFevre JA, 2010, INT J EARLY YEARS ED, V18, P55, DOI 10.1080/09669761003693926; LeFevre JA, 2010, CHILD DEV, V81, P1753, DOI 10.1111/j.1467-8624.2010.01508.x; LeFevre JA, 2009, CAN J BEHAV SCI, V41, P55, DOI 10.1037/a0014532; Levine SC, 2012, DEV PSYCHOL, V48, P530, DOI 10.1037/a0025913; Levine SC, 2010, DEV PSYCHOL, V46, P1309, DOI 10.1037/a0019671; Libertus ME, 2009, CURR DIR PSYCHOL SCI, V18, P346, DOI 10.1111/j.1467-8721.2009.01665.x; Maloney EA, 2015, PSYCHOL SCI, V26, P1480, DOI 10.1177/0956797615592630; Manolitsis G, 2013, EARLY CHILD RES Q, V28, P692, DOI 10.1016/j.ecresq.2013.05.004; Melhuish EC, 2008, J SOC ISSUES, V64, P95, DOI 10.1111/j.1540-4560.2008.00550.x; Missall K, 2015, EARLY EDUC DEV, V26, P356, DOI 10.1080/10409289.2015.968243; Morrison FJ, 2009, MERRILL PALMER QUART, V55, P361; Muthen B., 2010, MPLUS USERS GUIDE; Niklas F, 2014, EUR J PSYCHOL EDUC, V29, P327, DOI 10.1007/s10212-013-0201-6; PLOMIN R, 1977, PSYCHOL BULL, V84, P309, DOI 10.1037/0033-2909.84.2.309; Pomerantz EM, 2007, REV EDUC RES, V77, P373, DOI 10.3102/003465430305567; Pruden SM, 2011, DEVELOPMENTAL SCI, V14, P1417, DOI 10.1111/j.1467-7687.2011.01088.x; Reise SP, 2010, J PERS ASSESS, V92, P544, DOI 10.1080/00223891.2010.496477; RESNICK LB, 1989, AM PSYCHOL, V44, P162, DOI 10.1037/0003-066X.44.2.162; SCARBOROUGH HS, 1991, J LEARN DISABIL, V24, P508, DOI 10.1177/002221949102400811; SCARR S, 1983, CHILD DEV, V54, P424, DOI 10.2307/1129703; Senechal M, 2002, CHILD DEV, V73, P445, DOI 10.1111/1467-8624.00417; Senechal M, 1998, READ RES QUART, V33, P96, DOI 10.1598/RRQ.33.1.5; Sirin SR, 2005, REV EDUC RES, V75, P417, DOI 10.3102/00346543075003417; Skwarchuk SL, 2014, J EXP CHILD PSYCHOL, V121, P63, DOI 10.1016/j.jecp.2013.11.006; Skwarchuk SL, 2009, EARLY CHILD EDUC J, V37, P189, DOI 10.1007/s10643-009-0340-1; Soni A., 2015, INT J APPL SOCIOLOGY, V5, P159; Willcutt EG, 2011, PSYCHOL ASSESSMENT, V23, P778, DOI 10.1037/a0023290; Zippert EL, 2016, INFANT CHILD DEV	55	50	51	0	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2016	11	12							e0168227	10.1371/journal.pone.0168227	http://dx.doi.org/10.1371/journal.pone.0168227			30	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EI9QH	28005925	Green Published, Green Submitted, gold			2022-12-27	WOS:000392843200038
J	Shin, B; Koh, WJ; Shin, SW; Jeong, BH; Park, HY; Suh, GY; Jeon, K				Shin, Beomsu; Koh, Won-Jung; Shin, Sung Wook; Jeong, Byeong-Ho; Park, Hye Yun; Suh, Gee Young; Jeon, Kyeongman			Outcomes of Bronchial Artery Embolization for Life-Threatening Hemoptysis in Patients with Chronic Pulmonary Aspergillosis	PLoS One			English	Article							INFECTIOUS-DISEASES SOCIETY; CLINICAL CHARACTERISTICS; PRACTICE GUIDELINES; CHRONIC CAVITARY; MANAGEMENT; DIAGNOSIS; TUBERCULOSIS; VORICONAZOLE; PROGNOSIS; SPECTRUM	Background Bronchial artery embolization (BAE) is an important treatment option for short-term control of hemoptysis in patients with simple aspergilloma (SA). However, there are no data on the outcomes of BAE in patients with chronic pulmonary aspergillosis (CPA). In this study, the clinical characteristics and outcomes of BAE were investigated and compared in patients with CPA and SA. Methods We retrospectively analyzed the clinical data of 64 patients (55 [86%] with CPA and 9 [14%] with SA) who underwent BAE for life-threatening hemoptysis. The clinical characteristics and outcomes of BAE in CPA patients were compared to those of patients with SA. Results The most common angiographic abnormality was hypervascularity (n = 60, 94%), followed by contrast extravasation (n = 50, 78%) and systemic-pulmonary shunt (n = 48, 75%), with similar incidence rates in both groups. Immediate success was achieved in 41 (64%) BAE procedures, but it was incomplete in 23 (36%) cases due to difficulty with the approach and/or overuse of contrast medium. Clinical failure of BAE was observed in only one (2%) patient. Complications following BAE were observed in four (6%) patients. Recurrence of hemoptysis was seen in a total of 33 patients (52%) within a median of 2.0 (0.3-10.0) months, and repeat BAE was performed in 25 (76%) of these cases. In comparing the outcomes of patients with CPA and SA, there were no differences in the rates of success of initial BAE, incomplete embolization, or clinical failure in the two groups. However, recurrence of hemoptysis tended to be higher in patients with CPA (55%) than in those with SA (33%). In addition, antifungal medications following BAE were more commonly prescribed in the CPA group (56%) compared to the SA group (0%). Conclusions BAE was a safe and effective procedure for the management of life-threatening hemoptysis in patients with CPA. However, recurrence of hemoptysis was common, especially in patients with CPA. Therefore, definitive treatment for CPA following successful BAE should be considered to ensure the long-term success of the embolization in these patients.	[Shin, Beomsu; Koh, Won-Jung; Jeong, Byeong-Ho; Park, Hye Yun; Suh, Gee Young; Jeon, Kyeongman] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Div Pulm & Crit Care Med,Dept Med, Seoul, South Korea; [Shin, Sung Wook] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Radiol, Seoul, South Korea; [Suh, Gee Young; Jeon, Kyeongman] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Crit Care Med, Seoul, South Korea	Sungkyunkwan University (SKKU); Samsung Medical Center; Sungkyunkwan University (SKKU); Samsung Medical Center; Sungkyunkwan University (SKKU); Samsung Medical Center	Jeon, K (corresponding author), Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Div Pulm & Crit Care Med,Dept Med, Seoul, South Korea.; Jeon, K (corresponding author), Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Crit Care Med, Seoul, South Korea.	kjeon@skku.edu	shin, sw/O-6248-2014; Koh, Won-Jung/D-9586-2018; Jeon, Kyeongman/F-5963-2019; park, hy/O-5934-2014; Koh, Won Jung/C-9595-2011; Suh, Gee Young/O-3676-2019; Shin, Beomsu/AAP-3328-2020	Koh, Won-Jung/0000-0002-4756-3527; Jeon, Kyeongman/0000-0002-4822-1772; Suh, Gee Young/0000-0001-5473-1712; Jeong, Byeong-Ho/0000-0002-3124-1718				Abdulmalak C, 2015, EUR RESPIR J, V46, P503, DOI 10.1183/09031936.00218214; Agarwal R, 2013, MYCOSES, V56, P559, DOI 10.1111/myc.12075; Brinson GM, 1998, AM J RESP CRIT CARE, V157, P1951, DOI 10.1164/ajrccm.157.6.9708067; Cadranel J, 2012, EUR J CLIN MICROBIOL, V31, P3231, DOI 10.1007/s10096-012-1690-y; Camuset J, 2007, CHEST, V131, P1435, DOI 10.1378/chest.06-2441; Chan VL, 2009, INT J TUBERC LUNG D, V13, P1167; Chun JY, 2010, CARDIOVASC INTER RAD, V33, P240, DOI 10.1007/s00270-009-9788-z; Chun JY, 2010, EUR RADIOL, V20, P558, DOI 10.1007/s00330-009-1591-3; Corr P, 2006, CARDIOVASC INTER RAD, V29, P807, DOI 10.1007/s00270-005-0329-0; Denning DW, 2016, EUR RESPIR J, V47, P45, DOI 10.1183/13993003.00583-2015; Denning DW, 2003, CLIN INFECT DIS, V37, pS265, DOI 10.1086/376526; Izumikawa K, 2016, RESPIR INVESTIG, V54, P85, DOI 10.1016/j.resinv.2015.10.003; Jhun BW, 2013, MED MYCOL, V51, P811, DOI 10.3109/13693786.2013.806826; Kim SW, 2015, LUNG, V193, P575, DOI 10.1007/s00408-015-9728-4; Kosmidis C, 2015, THORAX, V70, P270, DOI 10.1136/thoraxjnl-2014-206291; Lee JH, 2007, INT J TUBERC LUNG D, V11, P781; McDonald DM, 2001, AM J RESP CRIT CARE, V164, pS39, DOI 10.1164/ajrccm.164.supplement_2.2106065; Nam HS, 2010, INT J INFECT DIS, V14, pE479, DOI 10.1016/j.ijid.2009.07.011; Ohba H, 2012, RESP MED, V106, P724, DOI 10.1016/j.rmed.2012.01.014; Otani Y, 1997, SURG TODAY, V27, P812, DOI 10.1007/BF02385271; Patterson KC, 2014, CHEST, V146, P1358, DOI 10.1378/chest.14-0917; Patterson TF, 2016, CLIN INFECT DIS, V63, pE1, DOI 10.1093/cid/ciw326; Pei RG, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0115956; Shin BS, 2011, INT J TUBERC LUNG D, V15, P1093, DOI 10.5588/ijtld.10.0659; Shin B, 2014, J INFECTION, V68, P494, DOI 10.1016/j.jinf.2014.01.005; Sopko David R, 2011, Semin Intervent Radiol, V28, P48, DOI 10.1055/s-0031-1273940; Soubani AO, 2002, CHEST, V121, P1988, DOI 10.1378/chest.121.6.1988; UFLACKER R, 1985, RADIOLOGY, V157, P637, DOI 10.1148/radiology.157.3.4059552; van den Heuvel MM, 2007, INT J TUBERC LUNG D, V11, P909; Walsh TJ, 2008, CLIN INFECT DIS, V46, P327, DOI 10.1086/525258	30	20	23	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2016	11	12							e0168373	10.1371/journal.pone.0168373	http://dx.doi.org/10.1371/journal.pone.0168373			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI9QH	28006828	Green Published, Green Submitted, gold			2022-12-27	WOS:000392843200047
J	Lecours, V; Brown, CJ; Devillers, R; Lucieer, VL; Edinger, EN				Lecours, Vincent; Brown, Craig J.; Devillers, Rodolphe; Lucieer, Vanessa L.; Edinger, Evan N.			Comparing Selections of Environmental Variables for Ecological Studies: A Focus on Terrain Attributes	PLOS ONE			English	Article							FRACTAL DIMENSION; ACCURACY; MODELS; CHALLENGES; MARINE; SCALE; TOOL; AUC	Selecting appropriate environmental variables is a key step in ecology. Terrain attributes (e.g. slope, rugosity) are routinely used as abiotic surrogates of species distribution and to produce habitat maps that can be used in decision-making for conservation or management. Selecting appropriate terrain attributes for ecological studies may be a challenging process that can lead users to select a subjective, potentially sub-optimal combination of attributes for their applications. The objective of this paper is to assess the impacts of subjectively selecting terrain attributes for ecological applications by comparing the performance of different combinations of terrain attributes in the production of habitat maps and species distribution models. Seven different selections of terrain attributes, alone or in combination with other environmental variables, were used to map benthic habitats of German Bank (off Nova Scotia, Canada). 29 maps of potential habitats based on unsupervised classifications of biophysical characteristics of German Bank were produced, and 29 species distribution models of sea scallops were generated using MaxEnt. The performances of the 58 maps were quantified and compared to evaluate the effectiveness of the various combinations of environmental variables. One of the combinations of terrain attributes recommended in a related study and that includes a measure of relative position, slope, two measures of orientation, topographic mean and a measure of rugosity yielded better results than the other selections for both methodologies, confirming that they together best describe terrain properties. Important differences in performance (up to 47% in accuracy measurement) and spatial outputs (up to 58% in spatial distribution of habitats) highlighted the importance of carefully selecting variables for ecological applications. This paper demonstrates that making a subjective choice of variables may reduce map accuracy and produce maps that do not adequately represent habitats and species distributions, thus having important implications when these maps are used for decision-making.	[Lecours, Vincent; Devillers, Rodolphe; Edinger, Evan N.] Mem Univ Newfoundland, Dept Geog, 232 Elizabeth Ave, St John, NF, Canada; [Brown, Craig J.] Nova Scotia Community Coll, Appl Res, 80 Mawiomi Pl, Dartmouth, NS, Canada; [Lucieer, Vanessa L.] Univ Tasmania, Inst Marine & Antarctic Studies, 20 Castray Esplanade, Battery Point, Tas, Australia; [Edinger, Evan N.] Mem Univ Newfoundland, Dept Biol, 232 Elizabeth Ave, St John, NF, Canada	Memorial University Newfoundland; University of Tasmania; Memorial University Newfoundland	Lecours, V (corresponding author), Mem Univ Newfoundland, Dept Geog, 232 Elizabeth Ave, St John, NF, Canada.	vlecours@mun.ca	Lecours, Vincent/J-5514-2019; lucieer, vanessa/D-1697-2009; Devillers, Rodolphe/AAR-3509-2021; Devillers, Rodolphe/R-3700-2019	Lecours, Vincent/0000-0002-4777-3348; lucieer, vanessa/0000-0001-7531-5750; Devillers, Rodolphe/0000-0003-0784-847X; Devillers, Rodolphe/0000-0003-0784-847X; Brown, Craig/0000-0002-5125-978X	Natural Sciences and Engineering Research Council of Canada	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR)	VL received funding from the Natural Sciences and Engineering Research Council of Canada. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bouchet PJ, 2015, BIOL REV, V90, P699, DOI 10.1111/brv.12130; Boyce MS, 2002, ECOL MODEL, V157, P281, DOI 10.1016/S0304-3800(02)00200-4; Brown CJ, 2012, J SEA RES, V72, P1, DOI 10.1016/j.seares.2012.04.009; Chipperfield JD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017040; CONGALTON RG, 1991, REMOTE SENS ENVIRON, V37, P35, DOI 10.1016/0034-4257(91)90048-B; Diesing M, 2016, ICES J MAR SCI, V73, P2425, DOI 10.1093/icesjms/fsw118; Dolan MFJ, 2014, MAR GEOD, V37, P187, DOI 10.1080/01490419.2014.902888; Elith J, 2011, DIVERS DISTRIB, V17, P43, DOI 10.1111/j.1472-4642.2010.00725.x; Evans I.S., 1995, Z GEOMORPHOL S, V101, P127; FELIX NA, 1989, PHOTOGRAMM ENG REM S, V55, P475; Fielding AH, 1997, ENVIRON CONSERV, V24, P38, DOI 10.1017/S0376892997000088; Fitzpatrick MC, 2013, ECOSPHERE, V4, DOI 10.1890/ES13-00066.1; Halley JM, 2004, ECOL LETT, V7, P254, DOI 10.1111/j.1461-0248.2004.00568.x; Herzfeld UC, 1999, COMPUT GEOSCI-UK, V25, P979, DOI 10.1016/S0098-3004(99)00062-X; JAYNES ET, 1957, PHYS REV, V106, P620, DOI 10.1103/PhysRev.106.620; Jensen J. R., 2005, INTRO DIGITAL IMAGE; Jimenez-Valverde A, 2012, GLOBAL ECOL BIOGEOGR, V21, P498, DOI 10.1111/j.1466-8238.2011.00683.x; Jones K. H., 1998, GeoInformatica, V2, P235, DOI 10.1023/A:1026472421094; Keitt TH, 2000, LANDSCAPE ECOL, V15, P479, DOI 10.1023/A:1008193015770; Khatchikian C, 2011, MED VET ENTOMOL, V25, P268, DOI 10.1111/j.1365-2915.2010.00935.x; Lecours V., 2015, TERRAIN ATTRIBUTE SE, DOI [10.13140/RG.2.2.15014.52800, DOI 10.13140/RG.2.2.15014.52800]; Lecours V, FRAMEWORK T IN PRESS; Lecours V, 2016, HYDROL EARTH SYST SC; Lecours V, 2015, MAR ECOL PROG SER, V535, P259, DOI 10.3354/meps11378; Lobo JM, 2008, GLOBAL ECOL BIOGEOGR, V17, P145, DOI 10.1111/j.1466-8238.2007.00358.x; McPherson JM, 2004, J APPL ECOL, V41, P811, DOI 10.1111/j.0021-8901.2004.00943.x; Merow C, 2013, ECOGRAPHY, V36, P1058, DOI 10.1111/j.1600-0587.2013.07872.x; MILNE BT, 1992, AM NAT, V139, P32, DOI 10.1086/285312; Monk J, 2010, MAR ECOL PROG SER, V420, P157, DOI 10.3354/meps08858; Palialexis A, 2011, HYDROBIOLOGIA, V670, P241, DOI 10.1007/s10750-011-0673-9; Peitgen H.-O., 1988, SCI FRACTAL IMAGES; Peterson AT, 2008, ECOL MODEL, V213, P63, DOI 10.1016/j.ecolmodel.2007.11.008; PFEIFER P, 1984, APPL SURF SCI, V18, P146, DOI 10.1016/0378-5963(84)90042-4; Phillips S.J, 2004, P 21 INT C MACH LEAR, P83, DOI [10.1145/1015330.1015412, DOI 10.1145/1015330.1015412]; Phillips SJ, 2006, ECOL MODEL, V190, P231, DOI 10.1016/j.ecolmodel.2005.03.026; Sameoto JA, 2015, DFO CAN SCI ADVIS SE, V2015; Sameoto JA, 2014, DFO CAN SCI ADVIS SE, V2014; Sharaya LS, 2011, RUSS J ECOL+, V42, P1, DOI 10.1134/S1067413610061025; Smith SJ, 2016, CAN J FISH AQUAT SCI; Smith SJ, 2014, ICES J MAR SCI, V71, P320, DOI 10.1093/icesjms/fst115; Tate NJ, 1998, COMPUT GEOSCI-UK, V24, P325, DOI 10.1016/S0098-3004(97)00119-2; Vaughan IP, 2005, J APPL ECOL, V42, P720, DOI 10.1111/j.1365-2664.2005.01052.x; Warren DL, 2011, ECOL APPL, V21, P335, DOI 10.1890/10-1171.1; With KA, 1997, OIKOS, V79, P219, DOI 10.2307/3546007; Zajac RN, 2008, LANDSCAPE ECOL, V23, P7, DOI 10.1007/s10980-007-9140-4; ZWEIG MH, 1993, CLIN CHEM, V39, P561	46	37	37	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2016	11	12							e0167128	10.1371/journal.pone.0167128	http://dx.doi.org/10.1371/journal.pone.0167128			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI9TW	28002453	Green Published, gold			2022-12-27	WOS:000392853100007
J	Mallet, KH; Shamloul, RM; Corbett, D; Finestone, HM; Hatcher, S; Lumsden, J; Momoli, F; Shamy, MCF; Stotts, G; Swartz, RH; Yang, C; Dowlatshahi, D				Mallet, Karen H.; Shamloul, Rany M.; Corbett, Dale; Finestone, Hillel M.; Hatcher, Simon; Lumsden, Jim; Momoli, Franco; Shamy, Michel C. F.; Stotts, Grant; Swartz, Richard H.; Yang, Christine; Dowlatshahi, Dar			RecoverNow: Feasibility of a Mobile Tablet Based Rehabilitation Intervention to Treat Post-Stroke Communication Deficits in the Acute Care Setting	PLOS ONE			English	Article							STROKE REHABILITATION; APHASIA THERAPY; IPAD; PROGRAM; TECHNOLOGY	Background Approximately 40% of patients diagnosed with stroke experience some degree of aphasia. With limited health care resources, patients' access to speech and language therapies is often delayed. We propose using mobile-platform technology to initiate early speech-language therapy in the acute care setting. For this pilot, our objective was to assess the feasibility of a tablet-based speech-language therapy for patients with communication deficits following acute stroke. Methods We enrolled consecutive patients admitted with a stroke and communication deficits with NIHSS score >= 1 on the best language and/or dysarthria parameters. We excluded patients with severe comprehension deficits where communication was not possible. Following baseline assessment by a speech-language pathologist (SLP), patients were provided with a mobile tablet programmed with individualized therapy applications based on the assessment, and instructed to use it for at least one hour per day. Our objective was to establish feasibility by measuring recruitment rate, adherence rate, retention rate, protocol deviations and acceptability. Results Over 6 months, 143 patients were admitted with a new diagnosis of stroke: 73 had communication deficits, 44 met inclusion criteria, and 30 were enrolled into RecoverNow (median age 62, 26.6% female) for a recruitment rate of 68% of eligible participants. Participants received mobile tablets at a mean 6.8 days from admission [SEM 1.6], and used them for a mean 149.8 minutes/day [SEM 19.1]. In-hospital retention rate was 97%, and 96% of patients scored the mobile tablet-based communication therapy as at least moderately convenient 3/5 or better with 5/5 being most "convenient". Conclusions Individualized speech-language therapy delivered by mobile tablet technology is feasible in acute care.	[Mallet, Karen H.; Lumsden, Jim] Champlain Reg Stroke Network, Ottawa, ON, Canada; [Mallet, Karen H.; Lumsden, Jim; Shamy, Michel C. F.; Stotts, Grant; Dowlatshahi, Dar] Ottawa Hosp, Ottawa, ON, Canada; [Mallet, Karen H.; Shamloul, Rany M.; Momoli, Franco; Shamy, Michel C. F.; Stotts, Grant; Dowlatshahi, Dar] Ottawa Hosp, Res Inst, Ottawa, ON, Canada; [Corbett, Dale; Finestone, Hillel M.; Hatcher, Simon; Momoli, Franco; Shamy, Michel C. F.; Stotts, Grant; Yang, Christine; Dowlatshahi, Dar] Univ Ottawa, Brain & Mind Res Inst, Ottawa, ON, Canada; [Corbett, Dale; Finestone, Hillel M.; Dowlatshahi, Dar] Canadian Partnership Stroke Recovery, Ottawa, ON, Canada; [Finestone, Hillel M.; Yang, Christine] Elisabeth Bruyere Hosp, Ottawa, ON, Canada; [Momoli, Franco] Childrens Hosp, Eastern Ontario Res Inst, Ottawa, ON, Canada; [Swartz, Richard H.] Univ Toronto, Toronto, ON, Canada; [Mallet, Karen H.] Ottawa Hosp, Champlain Reg Stroke Network, 1053 Carling Ave, Ottawa, ON, Canada	University of Ottawa; Ottawa Hospital Research Institute; University of Ottawa; Ottawa Hospital Research Institute; University of Ottawa; University of Ottawa; University of Ottawa; Children's Hospital of Eastern Ontario; University of Toronto; University of Ottawa; Ottawa Hospital Research Institute	Mallet, KH (corresponding author), Champlain Reg Stroke Network, Ottawa, ON, Canada.; Mallet, KH (corresponding author), Ottawa Hosp, Ottawa, ON, Canada.; Mallet, KH (corresponding author), Ottawa Hosp, Res Inst, Ottawa, ON, Canada.; Mallet, KH (corresponding author), Ottawa Hosp, Champlain Reg Stroke Network, 1053 Carling Ave, Ottawa, ON, Canada.	kmallet@toh.on.ca	Corbett, Dale/D-6625-2011	Corbett, Dale/0000-0003-0217-4576; Dowlatshahi, Dar/0000-0003-1379-3612; Swartz, Rick/0000-0001-6571-5531; Yang, Christine/0000-0002-9059-5452	University of Ottawa Brain and Mind Research Institute	University of Ottawa Brain and Mind Research Institute	Support was provided by the University of Ottawa Brain and Mind Research Institute [http://www.uottawa.ca/brain/] to DD. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bakheit AMO, 2007, CLIN REHABIL, V21, P941, DOI 10.1177/0269215507078452; Bernhardt J, 2004, STROKE, V35, P1005, DOI 10.1161/01.STR.0000120727.40792.40; Bhogal SK, 2003, STROKE, V34, P987, DOI 10.1161/01.STR.0000062343.64383.D0; Brady MC, 2012, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD000425.pub4, 10.1002/14651858.CD000425.pub3]; BROTT T, 1989, STROKE, V20, P864, DOI 10.1161/01.STR.20.7.864; Casaubon LK, 2016, INT J STROKE, V11, P239, DOI 10.1177/1747493015622461; Choi YH, 2016, TELEMED E-HEALTH, V22, P434, DOI 10.1089/tmj.2015.0138; Cook DJ, 2014, TELEMED E-HEALTH, V20, P312, DOI 10.1089/tmj.2013.0219; Dawson AS, 2013, CANADIAN BEST PRACTI; Des Roches CA, 2015, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.01015; Dickey L, 2010, ARCH PHYS MED REHAB, V91, P196, DOI 10.1016/j.apmr.2009.09.020; FEIGENSON JS, 1977, NEW YORK STATE J MED, V77, P1426; Godecke E, 2012, INT J STROKE, V7, P635, DOI 10.1111/j.1747-4949.2011.00631.x; Godecke E, 2014, INT J LANG COMM DIS, V49, P149, DOI 10.1111/1460-6984.12074; Godecke E, 2013, SEMIN SPEECH LANG, V34, P129, DOI 10.1055/s-0033-1358369; Goodglass H, 2001, ASSESSMENT APHASIA R, V3rd; HAYES SH, 1986, ARCH PHYS MED REHAB, V67, P319; Heart and Stroke Foundation, 2014, TOG RIS TID ADV STRO; Hoover EL, 2014, SEMIN SPEECH LANG, V35, P25, DOI 10.1055/s-0033-1362990; Kaplan E, 2001, BOSTON NAMING TEST; Kertesz A., 2007, W APHASIA BATTERY; Kertesz A, 2007, W APHASIA BATTERY BE; Kiran S, 2014, SEMIN SPEECH LANG, V35, P38, DOI 10.1055/s-0033-1362995; Kurland J, 2014, SEMIN SPEECH LANG, V35, P51, DOI 10.1055/s-0033-1362991; O'Leary KJ, 2016, J AM MED INFORM ASSN, V23, P159, DOI 10.1093/jamia/ocv058; OTTENBACHER KJ, 1993, ARCH NEUROL-CHICAGO, V50, P37, DOI 10.1001/archneur.1993.00540010033014; Paolucci S, 2000, ARCH PHYS MED REHAB, V81, P695, DOI 10.1053/apmr.2000.5583; Rand D, 2015, TRIALS, V16, DOI 10.1186/s13063-015-0796-9; Ross- Swain D., 1986, ROSS INFORM PROCESSI; Routhier S, 2014, APHASIOLOGY, P1, DOI DOI 10.1177/1545968313517753; Salter K, EVIDENCE BASED REV S; Saposnik G, 2014, INT J STROKE, V9, P956, DOI 10.1111/ijs.12328; Stark BC, 2018, NEUROPSYCHOL REHABIL, V28, P818, DOI 10.1080/09602011.2016.1146150; Swigert N, 1997, SOURCE DYSARTHRIA; van der Meulen I, 2014, NEUROREHAB NEURAL RE, V28, P536, DOI 10.1177/1545968313517753; White JH, 2015, DISABIL REHABIL, V37, P593, DOI 10.3109/09638288.2014.935876	36	26	26	2	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2016	11	12							e0167950	10.1371/journal.pone.0167950	http://dx.doi.org/10.1371/journal.pone.0167950			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI9TW	28002479	Green Published, gold, Green Submitted			2022-12-27	WOS:000392853100028
J	Saravanakumar, K; Yu, CJ; Dou, K; Wang, M; Li, YQ; Chen, J				Saravanakumar, Kandasamy; Yu, Chuanjin; Dou, Kai; Wang, Meng; Li, Yaqian; Chen, Jie			Biodiversity of Trichoderma Community in the Tidal Flats and Wetland of Southeastern China	PLoS One			English	Article							DIVERSITY; IDENTIFICATION; SPONGE; KONINGII; WHEAT	To investigate the biodiversity of Trichoderma (Hypocreaceae) and their relation to sediment physical and chemical properties, we collected a total of 491 sediment samples from coastal wetlands (tidal flat and wetland) in Southeast China. Further, we applied two types of molecular approaches such as culture dependent and independent methods for identification of Trichoderma spp. A total of 254 isolates were obtained and identified to 13 species such as T. aureoviride, T. asperellum, T. harzianum, T. atroviride, T. koningiopsis, T. longibrachiatum, T. koningii. T. tawa, T. viridescens, T. virens, T. hamatum, T. viride, and T. velutinum by the culture-dependent (CD) method of these, T. tawa was newly described in China. Subsequently, the culture indepented method of 454 pyrosequencing analysis revealed a total of six species such as T. citrinoviride, T. virens, T. polysporum, T. harzianumlHypocrea fixiiand two unknown species. Notably, T. citrinoviride and T. polysporum were not found by the CD method. Therefore, this work revealed that the combination of these two methods could show the higher biodiversity of Trichoderma spp., than either of this method alone. Among the sampling sites, Hangzhou, Zhejiang Province, exhibited rich biodiversity and low in Fengxian. Correlation and Redundancy discriminant analysis (RDA) revealed that sediment properties of temperature, redox potential (Eh) and pH significantly influenced the biodiversity of Trichoderma spp.	[Saravanakumar, Kandasamy; Yu, Chuanjin; Dou, Kai; Wang, Meng; Li, Yaqian; Chen, Jie] Shanghai Jiao Tong Univ, Sch Agr & Biol, Shanghai, Peoples R China; [Saravanakumar, Kandasamy; Yu, Chuanjin; Dou, Kai; Wang, Meng; Li, Yaqian; Chen, Jie] Shanghai Jiao Tong Univ, State Key Lab Microbial Metab, Shanghai, Peoples R China; [Saravanakumar, Kandasamy; Yu, Chuanjin; Dou, Kai; Wang, Meng; Li, Yaqian; Chen, Jie] Minist Agr, Key Lab Urban Agr South, Shanghai, Peoples R China	Shanghai Jiao Tong University; Shanghai Jiao Tong University; Ministry of Agriculture & Rural Affairs	Li, YQ (corresponding author), Shanghai Jiao Tong Univ, Sch Agr & Biol, Shanghai, Peoples R China.; Li, YQ (corresponding author), Shanghai Jiao Tong Univ, State Key Lab Microbial Metab, Shanghai, Peoples R China.; Li, YQ (corresponding author), Minist Agr, Key Lab Urban Agr South, Shanghai, Peoples R China.	lauren@sjtu.edu.cn	Saravanakumar, Kandasamy/P-6745-2018	Saravanakumar, Kandasamy/0000-0002-4465-4378; Dou, Kai/0000-0003-2665-0231	special project of basic work for science and technology [2014FY120900]; key project of the basic research of Shanghai Municipal Science and Technology Commission [12JC1404600]; special fund of modern agricultural industry technology system [CARS-02]	special project of basic work for science and technology; key project of the basic research of Shanghai Municipal Science and Technology Commission; special fund of modern agricultural industry technology system	We thank the financial support from the special project of basic work for science and technology (2014FY120900), the key project of the basic research of Shanghai Municipal Science and Technology Commission (12JC1404600), and the special fund of modern agricultural industry technology system (CARS-02).	Amagata T, 1998, J ANTIBIOT, V51, P33, DOI 10.7164/antibiotics.51.33; Bahram M, 2012, NEW PHYTOL, V193, P465, DOI 10.1111/j.1469-8137.2011.03927.x; Blaszczyk L, 2011, J APPL GENET, V52, P233, DOI 10.1007/s13353-011-0039-z; BOUYOUCOS GJ, 1962, AGRON J, V54, P464, DOI 10.2134/agronj1962.00021962005400050028x; Brewer D., 1993, Proceedings of the Nova Scotian Institute of Science, V40, P29; Burtseva Y, 2006, J APPL PHYCOL, V18, P375, DOI 10.1007/s10811-006-9043-9; Carbone I, 1999, MYCOLOGIA, V91, P553, DOI 10.2307/3761358; Carvajal LH, 2011, THESIS; Chaverri P, 2015, MYCOLOGIA, V107, P558, DOI 10.3852/14-147; Chelkowski J, 2003, J APPL GENET, V44, P323; Christensen M., 1981, FUNGAL COMMUNITY ITS, P201; Cummings NJ, 2016, MYCOL PROG, V15, DOI 10.1007/s11557-016-1192-x; Daghino S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044233; De Respinis S, 2010, MYCOL PROG, V9, P79, DOI 10.1007/s11557-009-0621-5; Doohan FM, 1998, PLANT PATHOL, V47, P197, DOI 10.1046/j.1365-3059.1998.00218.x; DRUZHININA I, 2004, TRICHOBLAST VERSION; Druzhinina Irina, 2005, J Zhejiang Univ Sci B, V6, P100, DOI 10.1631/jzus.2005.B0100; Druzhinina IS, 2005, FUNGAL GENET BIOL, V42, P813, DOI 10.1016/j.fgb.2005.06.007; Eck R.V., 1966, ATLAS PROTEIN SEQUEN; El Wakeel SK., 1957, J CONS PERM INT EXPL, V22, P180, DOI [10.1093/icesjms/22.2.180, DOI 10.1093/ICESJMS/22.2.180]; Gams W, 1998, TRICHODERMA GLIOCLAD, V1, P3, DOI DOI 10.4324/9780203483558; Gil SV, 2009, MICROBIOL RES, V164, P196, DOI 10.1016/j.micres.2006.11.022; He ZiDian, 2010, Acta Phytophylacica Sinica, V37, P459; Hjeljord L, 1998, TRICHODERMA GLIOCLAD, V2, P131; Jaklitsch WM, 2014, STUD MYCOL, V80, P1, DOI DOI 10.1016/J.SIMYC0.2014.11.001; KOBAYASHI M, 1993, TETRAHEDRON LETT, V34, P7925, DOI 10.1016/S0040-4039(00)61513-7; Kubicek CP, 2008, J ZHEJIANG UNIV-SC B, V9, P753, DOI 10.1631/jzus.B0860015; Kubicek CP, 2003, FUNGAL GENET BIOL, V38, P310, DOI 10.1016/S1087-1845(02)00583-2; Kullnig-Gradinger CM, 2002, MYCOL RES, V106, P757, DOI 10.1017/S0953756202006172; Landreau A, 2002, J MICROBIOL METH, V48, P181, DOI 10.1016/S0167-7012(01)00322-0; [李广记 Li Guangji], 2010, [微生物学通报, Microbiology], V37, P1663; Nei M., 2000, MOL EVOLUTION PHYLOG; Pan Z, 2010, J ZHEJIANG U AGR LIF, V6, P405; Paz Z, 2010, FUNGAL DIVERS, V42, P17, DOI 10.1007/s13225-010-0020-x; Samuels G, 2002, MYCOLOGIA, V94, P146, DOI 10.2307/3761854; Samuels GJ, 2006, STUD MYCOL, P67, DOI 10.3114/sim.2006.56.03; Samuels GJ, 2010, MYCOLOGIA, V102, P944, DOI 10.3852/09-243; Samuels GJ, 2009, TRICHODERMA ONLINE S; Sivasithamparam K., 1998, TRICHODERMA GLIOCLAD, V1, P139; Studholme DJ, 2013, FRONT PLANT SCI, V4, DOI 10.3389/fpls.2013.00258; Sun RY, 2012, J APPL GENET, V53, P343, DOI 10.1007/s13353-012-0093-1; Sun S., 2009, ASIAN J TRADIT MED, V4, P123; Sun Z, 2014, SCI REP-UK, V4, DOI 10.1038/srep06966; Syed SS, 2003, PHYTOPATHOL MEDITERR, V42, P135; Tamura K, 2013, MOL BIOL EVOL, V5, P1; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Vinale F, 2008, SOIL BIOL BIOCHEM, V40, P1, DOI 10.1016/j.soilbio.2007.07.002; Wang GY, 2008, ANTON LEEUW INT J G, V93, P163, DOI 10.1007/s10482-007-9190-2; Wardle DA, 2004, SCIENCE, V304, P1629, DOI 10.1126/science.1094875; Wen C, 1992, ACTA PHYTOPATHOLOGIC, V4, P306; Wen C. J., 1993, Acta Mycologica Sinica, V12, P118; White TJ., 1990, PCR PROTOCOLS GUIDE, P315; WIDDEN P, 1988, MYCOLOGIA, V80, P795, DOI 10.2307/3807557; Wiese J, 2011, MAR DRUGS, V9, P561, DOI 10.3390/md9040561; [吴小平 WU Xiaoping], 2008, [农业生物技术学报, Journol of Agricultural Biotechnology], V16, P1048; Wuczkowski M, 2003, MICROBIOL RES, V158, P125, DOI 10.1078/0944-5013-00193; Xia C, 2009, BIODIVERSITY RES GEN; Yu HaoLong, 2010, Guangxi Agricultural Sciences, V41, P703; [Yuan Zhilin 袁志林], 2008, [菌物学报, Mygosystema], V27, P608; Zelazowska M, 2009, ENVIRON MICROBIOL, V11, P35, DOI [10.1111/j.1462-2920.2008.01736.x, DOI 10.1111/J.1462-2920.2008.01736.X]; Zelazowska M, 2010, BMC EVOL BIOL, V10, P94, DOI [10.1186/1471-2148-10-94, DOI 10.1186/1471-2148-10-94]; Zelazowska M, 2010, APPL ENVIRON MICROB, V76, P7259, DOI [10.1128/AEM.01184-10, DOI 10.1128/AEM.01184-10]; Zhang CL, 2005, FEMS MICROBIOL LETT, V251, P251, DOI 10.1016/j.femsle.2005.08.034; Zhu ZX, 2014, MYCOSYSTEMA, V6, P1136	64	18	19	1	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2016	11	12							e0168020	10.1371/journal.pone.0168020	http://dx.doi.org/10.1371/journal.pone.0168020			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI9TW	28002436	gold, Green Published, Green Submitted			2022-12-27	WOS:000392853100031
J	Slawinska, A; Plowiec, A; Siwek, M; Jaroszewski, M; Bednarczyk, M				Slawinska, Anna; Plowiec, Arkadiusz; Siwek, Maria; Jaroszewski, Marcin; Bednarczyk, Marek			Long-Term Transcriptomic Effects of Prebiotics and Synbiotics Delivered In Ovo in Broiler Chickens	PLOS ONE			English	Article							HUMAN COLONIC MICROBIOTA; GENE-EXPRESSION; BIFIDOBACTERIUM-BIFIDUM; DIETARY MODULATION; ENZYMATIC-ACTIVITY; LYMPHOID-TISSUES; GUT; PROBIOTICS; BIOINFORMATICS; MIXTURE	In ovo delivery of prebiotics and synbiotics in chickens allows for the development of intestinal microflora prior to hatching, which boosts their robustness. The goal of this study was to determine the transcriptomic profile of the spleen (S), cecal tonsils (CT), and large intestine (LI) of adult chickens injected with prebiotics and synbiotics in ovo. On day 12 of embryo development, incubating eggs were injected with prebiotics: inulin alone (P1) or in combination with Lactococcus lactis subsp. lactis IBB2955 (S1), galactooligosaccharides (GOS) alone (P2) or in combination with Lactococcus lactis subsp. cremoris IBB477 (S2); control group (C) was mock injected with physiological saline. Gene expression analysis was conducted using an Affymetrix Chicken Gene 1.1 ST Array Strip. Most of the differentially expressed genes (DEG) were detected in the cecal tonsils of P2 (378 DEG), and were assigned to gene ontology categories: lymphocyte proliferation, activation and differentiation, and cytokine production. Ingenuity pathway analysis of the DEG (CT of P2) indicated the inhibition of humoral and cellular immune responses, e.g., role of NFAT in regulation of immune responses, phagocytosis, production of nitric oxide, NF-kappa B, IL-8, and CXCR4 signaling. The DEG with the highest up-regulation from S1 and P2 were involved in gene expression (PAPOLA, RPL27A, RPLP1, and RPS29) from P1 and P2 in transport (BEST4, SLC9A3, and SLC13A2), metabolism (OGT, ALPP, CA4, and CA7), signaling (FGG, G3BP2, UBB, G3BP2, CACNA1G, and ATP6V0A4), and immune responses (MSMB, LGALS3, CABIN1, CXCR5, PAX5, and TNFRSF14). Two DEG influencing the complement system (SERPING1 and MIR1674) were down-regulated in P2 and S1. In conclusion, GOS injected in ovo provided the most potent stimulation of the host transcriptome. This is likely due to its strong bifidogenic effect, which triggers proliferation of indigenous embryonic microflora in ovo, and indirectly influences gene expression regulation in host tissues, especially cecal tonsils.	[Slawinska, Anna; Plowiec, Arkadiusz; Siwek, Maria; Bednarczyk, Marek] UTP Univ Sci & Technol, Dept Anim Biochem & Biotechnol, Mazowiecka 28, Bydgoszcz, Poland; [Jaroszewski, Marcin] Adam Mickiewicz Univ, Dept Human Mol Genet, Umultowska 89, Poznan, Poland	Bydgoszcz University of Science & Technology; Adam Mickiewicz University	Bednarczyk, M (corresponding author), UTP Univ Sci & Technol, Dept Anim Biochem & Biotechnol, Mazowiecka 28, Bydgoszcz, Poland.	marbed13@op.pl	Siwek, Maria/AAG-8929-2019; Slawinska, Anna/B-3781-2016	Siwek, Maria/0000-0003-4148-5174; Slawinska, Anna/0000-0002-5706-6145	National Science Centre in Cracow, Poland [UMO-2011/01/B/NZ9/00642, UMO-2013/11/B/NZ9/00783]	National Science Centre in Cracow, Poland	The study was conducted with support of National Science Centre in Cracow, Poland (https://www.ncn.gov.pl) grants numbers: UMO-2011/01/B/NZ9/00642 and UMO-2013/11/B/NZ9/00783. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ballou AL, 2016, FRONT VET SCI, V3, DOI 10.3389/fvets.2016.00002; Bansal T, 2010, P NATL ACAD SCI USA, V107, P228, DOI 10.1073/pnas.0906112107; Bar-Shira E, 2006, DEV COMP IMMUNOL, V30, P930, DOI 10.1016/j.dci.2005.12.002; Bednarczyk M, 2016, ANIMAL, P1; Bednarczyk M, 2011, B VET I PULAWY, V55, P465; Carbajal-Franco E, 2015, J IMMUNOL RES, V2015, DOI 10.1155/2015/837859; Cardeal PC, 2015, WORLD POULTRY SCI J, V71, P655, DOI 10.1017/S0043933915002445; Carvalho B, 2007, BIOSTATISTICS, V8, P485, DOI 10.1093/biostatistics/kxl042; Cesta MF, 2006, TOXICOL PATHOL, V34, P599, DOI 10.1080/01926230600865531; Chichlowski M, 2007, INT J POULTRY SCI, V6, P10; Chistiakov DA, 2015, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00781; Clark LC, 2014, CELL MICROBIOL, V16, P27, DOI 10.1111/cmi.12234; Clarke TB, 2010, NAT MED, V16, P228, DOI 10.1038/nm.2087; Cryan JF, 2011, NEUROGASTROENT MOTIL, V23, P187, DOI 10.1111/j.1365-2982.2010.01664.x; Friedman A, 2003, WORLD POULTRY SCI J, V59, P209, DOI 10.1079/WPS20030013; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Gibson GR, 2004, NUTR RES REV, V17, P259, DOI 10.1079/NRR200479; GIBSON GR, 1995, J NUTR, V125, P1401, DOI 10.1093/jn/125.6.1401; Hardy H, 2013, NUTRIENTS, V5, P1869, DOI 10.3390/nu5061869; Hu ZL, 2008, ONLINE J BIOINFORMAT, V9, P108, DOI DOI 10.1186/1471-2105-13-134; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Jeurissen SHM, 1999, POULTRY SCI, V78, P965, DOI 10.1093/ps/78.7.965; Julia A, 2014, HUM MOL GENET, V23, P6927, DOI 10.1093/hmg/ddu398; Lan Y, 2005, WORLD POULTRY SCI J, V61, P95, DOI 10.1079/WPS200445; LANDSVERK T, 1987, IMMUNOL CELL BIOL, V65, P425, DOI 10.1038/icb.1987.49; Lillehoj HS, 1996, CLIN MICROBIOL REV, V9, P349, DOI 10.1128/CMR.9.3.349; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Madej JP, 2016, POULTRY SCI, V95, P19, DOI 10.3382/ps/pev291; Madej JP, 2015, POULTRY SCI, V94, P1209, DOI 10.3382/ps/pev076; Maiorano G, 2012, POULTRY SCI, V91, P2963, DOI 10.3382/ps.2012-02208; Moran ET, 2007, POULTRY SCI, V86, P1043, DOI 10.1093/ps/86.5.1043; NURMI E, 1973, NATURE, V241, P210, DOI 10.1038/241210a0; Ohta Y, 2001, POULTRY SCI, V80, P1425, DOI 10.1093/ps/80.10.1425; Oliveros, 2007, VENNY INTERACTIVE TO; Pan D, 2014, GUT MICROBES, V5, P108, DOI 10.4161/gmic.26945; Park AM, 2016, INFECT IMMUN; Pilarski R, 2005, FOLIA BIOL-KRAKOW, V53, P13, DOI 10.3409/1734916054663474; Plowiec A, 2015, AM J VET RES, V76, P975, DOI 10.2460/ajvr.76.11.975; Pruszynska-Oszmalek E, 2015, POULTRY SCI, V94, P1909, DOI 10.3382/ps/pev162; Rashidi H, 2009, BIOESSAYS, V31, P459, DOI 10.1002/bies.200800168; Rawls JF, 2006, CELL, V127, P423, DOI 10.1016/j.cell.2006.08.043; Ritchie ME, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv007; Schippa S, 2014, NUTRIENTS, V6, P5786, DOI 10.3390/nu6125786; Schrezenmeir J, 2001, AM J CLIN NUTR, V73, p361S, DOI 10.1093/ajcn/73.2.361s; Searle LEJ, 2010, J MED MICROBIOL, V59, P1428, DOI 10.1099/jmm.0.022780-0; Searle LEJ, 2009, J MED MICROBIOL, V58, P37, DOI 10.1099/jmm.0.004390-0; SHARMA JM, 1987, AVIAN DIS, V31, P570, DOI 10.2307/1590742; Shreiner AB, 2015, CURR OPIN GASTROEN, V31, P69, DOI 10.1097/MOG.0000000000000139; Slawinska A, 2016, ANIM SCI PAP REP, P34; Slawinska A, 2014, FOLIA BIOL-KRAKOW, V62, P277, DOI 10.3409/fb62_3.277; Smirnov A, 2006, POULTRY SCI, V85, P669, DOI 10.1093/ps/85.4.669; Smith A.L., 2014, AVIAN IMMUNOLOGY EDI, VSecond Edition, P227, DOI [10.1016/b978-0-12-396965-1.00013-3, DOI 10.1016/B978-0-12-396965-1.00013-3]; Tako E, 2004, POULTRY SCI, V83, P2023, DOI 10.1093/ps/83.12.2023; Turnbaugh PJ, 2009, SCI TRANSL MED, V1, DOI 10.1126/scitranslmed.3000322; Tzortzis G, 2005, J NUTR, V135, P1726, DOI 10.1093/jn/135.7.1726; Tzortzis G, 2009, AGRO FOOD IND HI TEC, V20, P43; Uni Z, 2005, POULTRY SCI, V84, P764, DOI 10.1093/ps/84.5.764; Villaluenga CM, 2004, FOLIA BIOL-KRAKOW, V52, P135, DOI 10.3409/1734916044527502; Walker WA, 1998, J NUTR BIOCHEM, V9, P668, DOI 10.1016/S0955-2863(98)00058-8; Yair R, 2015, POULTRY SCI, V94, P2695, DOI 10.3382/ps/pev252; Yair R, 2011, POULTRY SCI, V90, P1523, DOI 10.3382/ps.2010-01283; Ye J, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-134; Yegani M, 2008, POULTRY SCI, V87, P2052, DOI 10.3382/ps.2008-00091	64	34	35	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2016	11	12							e0168899	10.1371/journal.pone.0168899	http://dx.doi.org/10.1371/journal.pone.0168899			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI9TW	28002487	Green Submitted, gold, Green Published			2022-12-27	WOS:000392853100075
J	Densmore-McCulloch, JA; Thompson, DL; Fraser, LH				Densmore-McCulloch, Justine A.; Thompson, Donald L.; Fraser, Lauchlan H.			Short-Term Effects of Changing Precipitation Patterns on Shrub-Steppe Grasslands: Seasonal Watering Is More Important than Frequency of Watering Events	PLOS ONE			English	Article							PLANT-SPECIES DIVERSITY; CLIMATE-CHANGE; PRODUCTIVITY RESPONSES; RAINFALL VARIABILITY; PULSE DYNAMICS; ECOSYSTEMS; VEGETATION; COMMUNITY; RICHNESS; GRADIENT	Climate change is expected to alter precipitation patterns. Droughts may become longer and more frequent, and the timing and intensity of precipitation may change. We tested how shifting precipitation patterns, both seasonally and by frequency of events, affects soil nitrogen availability, plant biomass and diversity in a shrub-steppe temperate grassland along a natural productivity gradient in Lac du Bois Grasslands Protected Area near Kamloops, British Columbia, Canada. We manipulated seasonal watering patterns by either exclusively watering in the spring or the fall. To simulate spring precipitation we restricted precipitation inputs in the fall, then added 50% more water than the long term average in the spring, and vice-versa for the fall precipitation treatment. Overall, the amount of precipitation remained roughly the same. We manipulated the frequency of rainfall events by either applying water weekly (frequent) or monthly (intensive). After 2 years, changes in the seasonality of watering had greater effects on plant biomass and diversity than changes in the frequency of watering. Fall watering reduced biomass and increased species diversity, while spring watering had little effect. The reduction in biomass in fall watered treatments was due to a decline in grasses, but not forbs. Plant available N, measured by Plant Root Simulator (PRS)-probes, increased from spring to summer to fall, and was higher in fall watered treatments compared to spring watered treatments when measured in the fall. The only effect observed due to frequency of watering events was greater extractable soil N in monthly applied treatments compared to weekly watering treatments. Understanding the effects of changing precipitation patterns on grasslands will allow improved grassland conservation and management in the face of global climatic change, and here we show that if precipitation is more abundant in the fall, compared to the spring, grassland primary productivity will likely be negatively affected.	[Densmore-McCulloch, Justine A.; Fraser, Lauchlan H.] Thompson Rivers Univ, Dept Nat Resource Sci, Kamloops, BC, Canada; [Thompson, Donald L.] Agr & Agri Food Canada, Lethbridge, AB, Canada	Agriculture & Agri Food Canada	Fraser, LH (corresponding author), Thompson Rivers Univ, Dept Nat Resource Sci, Kamloops, BC, Canada.	lfraser@tru.ca			Future Forest Ecosystem Scientific Council (FFESC) grant [007_Fraser]; Natural Sciences and Engineering Research Council (NSERC) [312155-2011]; NSERC Industrial Postgraduate Scholarship; Grasslands Conservation Council of BC	Future Forest Ecosystem Scientific Council (FFESC) grant; Natural Sciences and Engineering Research Council (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); NSERC Industrial Postgraduate Scholarship(Natural Sciences and Engineering Research Council of Canada (NSERC)); Grasslands Conservation Council of BC	This research was supported by: 1. A Future Forest Ecosystem Scientific Council (FFESC) grant to LHF (#007_Fraser). 2. A Natural Sciences and Engineering Research Council (NSERC) Discovery Grant to LHF (#312155-2011). 3. An NSERC Industrial Postgraduate Scholarship in partnership with the Grasslands Conservation Council of BC to JAD.r We thank Cameron Carlyle, Tessa Jongbloets, Anna Sapozhnikova, Amanda Schmidt and Laurenz Teuber for assistance in the field. This research was supported by a Future Forest Ecosystem Scientific Council (FFESC) grant and a Natural Sciences and Engineering Research Council (NSERC) Discovery Grant to L. Fraser, as well as an NSERC Industrial Postgraduate Scholarship in partnership with the Grasslands Conservation Council of BC to J. Densmore-McCulloch. This study was conducted under permit # 102724 from BC Ministry of Environment, Parks and Protected Areas Division.	Adler PB, 2007, OIKOS, V116, P221, DOI [10.1111/j.2006.0030-1299.15327.x, 10.1111/j.0030-1299.2007.15327.x]; Asner GP, 2004, ANNU REV ENV RESOUR, V29, P261, DOI 10.1146/annurev.energy.29.062403.102142; Austin AT, 2004, OECOLOGIA, V141, P221, DOI 10.1007/s00442-004-1519-1; Bates JD, 2006, J ARID ENVIRON, V64, P670, DOI 10.1016/j.jaridenv.2005.06.026; Bloor JMG, 2012, PERSPECT PLANT ECOL, V14, P193, DOI 10.1016/j.ppees.2011.12.001; Bond WJ, 2010, BIOL CONSERV, V143, P2395, DOI 10.1016/j.biocon.2009.12.012; Carlyle C, 2014, OECOLOGIA, V174, P1065, DOI 10.1007/s00442-013-2833-2; Carlyle CN, 2011, ECOSYSTEMS, V14, P489, DOI 10.1007/s10021-011-9425-y; Collins SL, 2008, J ECOL, V96, P413, DOI 10.1111/j.1365-2745.2008.01362.x; Dijkstra FA, 2012, OECOLOGIA, V170, P799, DOI 10.1007/s00442-012-2336-6; Dunne JA, 2004, ECOLOGY, V85, P904, DOI 10.1890/03-8003; Fay PA, 2003, OECOLOGIA, V137, P245, DOI 10.1007/s00442-003-1331-3; Fraser LH, 2015, SCIENCE, V349, P302, DOI 10.1126/science.aab3916; Fry EL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057027; GENTRY AH, 1982, ANN MO BOT GARD, V69, P557, DOI 10.2307/2399084; Goedhart CM, 2010, PLANT SOIL, V327, P213, DOI 10.1007/s11104-009-0048-4; Goldberg D, 1997, J ECOL, V85, P409, DOI 10.2307/2960565; Grime JP, 2000, SCIENCE, V289, P762, DOI 10.1126/science.289.5480.762; GUREVITCH J, 2006, ECOLOGY PLANTS; Heisler-White JL, 2008, OECOLOGIA, V158, P129, DOI 10.1007/s00442-008-1116-9; Heisler-White JL, 2009, GLOBAL CHANGE BIOL, V15, P2894, DOI 10.1111/j.1365-2486.2009.01961.x; Intergovernmental Panel on Climate Change, 2014, WORKING GROUP 1 CONT; Iovieno P, 2008, FEMS MICROBIOL ECOL, V65, P400, DOI 10.1111/j.1574-6941.2008.00524.x; Knapp AK, 2002, SCIENCE, V298, P2202, DOI 10.1126/science.1076347; Knapp AK, 2017, GLOBAL CHANGE BIOL, V23, P1774, DOI 10.1111/gcb.13504; Knapp AK, 2012, BIOSCIENCE, V62, P377, DOI 10.1525/bio.2012.62.4.9; Kochy M, 2004, PLANT ECOL, V174, P197, DOI 10.1023/B:VEGE.0000049098.74147.57; Lee RN, 2014, BOTANY, V92, P837, DOI 10.1139/cjb-2014-0107; Maestre FT, 2012, PHILOS T R SOC B, V367, P3062, DOI 10.1098/rstb.2011.0323; Maestre FT, 2012, SCIENCE, V335, P214, DOI 10.1126/science.1215442; Murray S., 2000, PILOT ANAL GLOBAL EC; Nippert JB, 2006, PLANT ECOL, V184, P65, DOI 10.1007/s11258-005-9052-9; Novoplansky A, 2001, J VEG SCI, V12, P199, DOI 10.2307/3236604; Prevey JS, 2014, J ECOL, V102, P1549, DOI 10.1111/1365-2745.12320; SALA OE, 1988, ECOLOGY, V69, P40, DOI 10.2307/1943158; Schwinning S, 2004, OECOLOGIA, V141, P191, DOI 10.1007/s00442-004-1683-3; Spence LA, 2016, J VEG SCI, V27, P249, DOI 10.1111/jvs.12349; Suttle KB, 2007, SCIENCE, V315, P640, DOI 10.1126/science.1136401; VANRYSWYK AL, 1966, CAN J PLANT SCI, V46, P35, DOI 10.4141/cjps66-005; von Wehrden H, 2012, ECOL APPL, V22, P393, DOI 10.1890/11-0802.1; WELKER JM, 1991, THEOR APPL CLIMATOL, V44, P229, DOI 10.1007/BF00868178; Weltzin JF, 2003, BIOSCIENCE, V53, P941, DOI 10.1641/0006-3568(2003)053[0941:ATROTE]2.0.CO;2; Western Ag Innovations Inc, 2010, PLANT ROOT SIM PRS T; White SR, 2012, BIOL LETTERS, V8, P484, DOI 10.1098/rsbl.2011.0956; Yahdjian L, 2002, OECOLOGIA, V133, P95, DOI 10.1007/s00442-002-1024-3	45	11	11	5	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2016	11	12							e0168663	10.1371/journal.pone.0168663	http://dx.doi.org/10.1371/journal.pone.0168663			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI9QF	27997611	Green Published, gold, Green Submitted			2022-12-27	WOS:000392842900067
J	Kollgaard, T; Kornblit, B; Petersen, J; Klausen, TW; Mortensen, BK; Braendstrup, P; Sengelov, H; Hogdall, E; Muller, K; Vindelov, L; Andersen, MH; Straten, PT				Kollgaard, Tania; Kornblit, Brian; Petersen, Jesper; Klausen, Tobias Wirenfeldt; Mortensen, Bo Kok; Braendstrup, Peter; Sengelov, Henrik; Hogdall, Estrid; Muller, Klaus; Vindelov, Lars; Andersen, Mads Hald; Straten, Per Thor			(GT)(n) Repeat Polymorphism in Heme Oxygenase-1 (HO-1) Correlates with Clinical Outcome after Myeloablative or Nonmyeloablative Allogeneic Hematopoietic Cell Transplantation	PLOS ONE			English	Article							GENE PROMOTER; MICROSATELLITE POLYMORPHISM; RISK; DISEASE	Allogeneic hematopoietic cell transplantation (HCT) is a treatment for various hematologic diseases where efficacy of treatment is in part based on the graft versus tumour (GVT) activity of cells in the transplant. The cytoprotective enzyme heme oxygenase-1 (HO-1) is a rate limiting enzyme in heme degradation and it has been shown to exert anti-inflammatory functions. In humans a (GT)(n) repeat polymorphism regulates the expression of HO-1. We conducted fragment length analyses of the (GT)(n) repeat in the promotor region of the gene for HO-1 in DNA from donors and recipients receiving allogeneic myeloablative- (MA) (n = 110) or nonmyeloablative- (NMA-) (n = 250) HCT. Subsequently, we compared the length of the (GT)(n) repeat with clinical outcome after HCT. We demonstrated that transplants from a HO-1(high) donor after MA-conditioning (n = 13) is associated with higher relapse incidence at 3 years (p = 0.01, n = 110). In the NMA-conditioning setting transplantation of HO-1(low) donor cells into HO-1(low) recipients correlated significantly with decreased relapse related mortality (RRM) and longer progression free survival (PFS) (p = 0.03 and p = 0.008, respectively). Overall, our findings suggest that HO-1 may play a role for the induction of GVT effect after allogeneic HCT.	[Kollgaard, Tania; Petersen, Jesper; Klausen, Tobias Wirenfeldt; Andersen, Mads Hald; Straten, Per Thor] Copenhagen Univ Hosp, Dept Hematol, CCIT, 54P4, Herlev, Denmark; [Kornblit, Brian; Mortensen, Bo Kok; Braendstrup, Peter; Vindelov, Lars] Rigshosp, Dept Hematol, Allogene Hematopoiet Cell Transplantat Lab, Copenhagen, Denmark; [Sengelov, Henrik] Rigshosp, Dept Hematol, Bone Marrow Transplantat Unit, Copenhagen, Denmark; [Hogdall, Estrid] Copenhagen Univ Hosp, Mol Unit, Dept Pathol, Herlev, Denmark; [Hogdall, Estrid] Copenhagen Univ Hosp, Mol Unit, Dept Pathol, Herlev, Denmark; [Muller, Klaus] Rigshosp, Dept Pediat & Adolescent Med, Copenhagen, Denmark; [Muller, Klaus] Rigshosp, Inst Inflammat Res, Copenhagen, Denmark	University of Copenhagen; Rigshospitalet; University of Copenhagen; Rigshospitalet; University of Copenhagen; University of Copenhagen; University of Copenhagen; Rigshospitalet; University of Copenhagen; Rigshospitalet; University of Copenhagen	Kollgaard, T (corresponding author), Copenhagen Univ Hosp, Dept Hematol, CCIT, 54P4, Herlev, Denmark.	taniak177@hotmail.com	Müller, Klaus G/B-7241-2015	Müller, Klaus G/0000-0002-5278-1983; Hogdall, Estrid/0000-0003-4689-5658; Andersen, Mads Hald/0000-0002-2914-9605; Petersen, Jesper/0000-0001-6116-5114; thor Straten, Per/0000-0002-4731-4969; Sengelov, Henrik/0000-0002-5991-2958; Braendstrup, Peter/0000-0003-3360-7725	Danish Cancer Society; Danish Medical Research Counsil; Toyota Fonden; The Danish Cancer Society [R72-A4460] Funding Source: researchfish	Danish Cancer Society(Danish Cancer Society); Danish Medical Research Counsil; Toyota Fonden; The Danish Cancer Society(Danish Cancer Society)	This work was funded by the Danish Cancer Society (TK), www.cancer.dk, The Danish Medical Research Counsil (PTS), http.flufm.dkien/research-and-innovationicouncwils-andcornmissionsithe-danish-council-for-independent-research, and Toyota Fonden (PTS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allin KH, 2010, JNCI-J NATL CANCER I, V102, P202, DOI 10.1093/jnci/djp459; Bach FH, 2006, HUM IMMUNOL, V67, P430, DOI 10.1016/j.humimm.2006.03.006; Cruz CR, 2015, HAEMATOLOGICA, V100, P709, DOI 10.3324/haematol.2014.113860; George JF, 2008, AM J PATHOL, V173, P154, DOI 10.2353/ajpath.2008.070963; Gerbitz A, 2008, BIOL BLOOD MARROW TR, V14, P1180, DOI 10.1016/j.bbmt.2008.08.002; Gratwohl A, 2012, BONE MARROW TRANSPL, V47, P749, DOI 10.1038/bmt.2011.110; GRAY RJ, 1988, ANN STAT, V16, P1141, DOI 10.1214/aos/1176350951; Hirai H, 2003, BLOOD, V102, P1619, DOI 10.1182/blood-2002-12-3733; Kahl C, 2007, BLOOD, V110, P2744, DOI 10.1182/blood-2007-03-078592; Kimpara T, 1997, HUM GENET, V100, P145, DOI 10.1007/s004390050480; Kornblit B, 2008, BONE MARROW TRANSPL, V41, P851, DOI 10.1038/bmt.2008.10; MAINES MD, 1988, FASEB J, V2, P2557, DOI 10.1096/fasebj.2.10.3290025; Morup AM, 2011, BIOL BLOOD MARROW TR, V17, P1299, DOI 10.1016/j.bbmt.2011.01.008; PRZEPIORKA D, 1995, BONE MARROW TRANSPL, V15, P825; Walther M, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002579; Wu MM, 2010, J BIOMED SCI, V17, DOI 10.1186/1423-0127-17-70	16	4	4	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2016	11	12							e0168210	10.1371/journal.pone.0168210	http://dx.doi.org/10.1371/journal.pone.0168210			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI9QF	27997582	gold, Green Published, Green Submitted			2022-12-27	WOS:000392842900028
J	Tlelo-Cuautle, E; Quintas-Valles, AD; de la Fraga, LG; Rangel-Magdaleno, JD				Tlelo-Cuautle, Esteban; de Jesus Quintas-Valles, Antonio; Gerardo de la Fraga, Luis; de Jesus Rangel-Magdaleno, Jose			VHDL Descriptions for the FPGA Implementation of PWL-Function-Based Multi-Scroll Chaotic Oscillators	PLOS ONE			English	Article							CHUA CIRCUIT; DESIGN; ATTRACTORS; REALIZATION; GENERATOR	Nowadays, chaos generators are an attractive field for research and the challenge is their realization for the development of engineering applications. From more than three decades ago, chaotic oscillators have been designed using discrete electronic devices, very few with integrated circuit technology, and in this work we propose the use of field-programmable gate arrays (FPGAs) for fast prototyping. FPGA-based applications require that one be expert on programming with very-high-speed integrated circuits hardware description language (VHDL). In this manner, we detail the VHDL descriptions of chaos generators for fast prototyping from high-level programming using Python. The cases of study are three kinds of chaos generators based on piecewise-linear (PWL) functions that can be systematically augmented to generate even and odd number of scrolls. We introduce new algorithms for the VHDL description of PWL functions like saturated functions series, negative slopes and sawtooth. The generated VHDL-code is portable, reusable and open source to be synthesized in an FPGA. Finally, we show experimental results for observing 2, 10 and 30-scroll attractors.	[Tlelo-Cuautle, Esteban; de Jesus Quintas-Valles, Antonio; de Jesus Rangel-Magdaleno, Jose] INAOE, Dept Elect, Puebla, Mexico; [Tlelo-Cuautle, Esteban; Gerardo de la Fraga, Luis] CINVESTAV, Dept Comp Sci, Mexico City, DF, Mexico	Instituto Nacional de Astrofisica, Optica y Electronica; CINVESTAV - Centro de Investigacion y de Estudios Avanzados del Instituto Politecnico Nacional	Tlelo-Cuautle, E (corresponding author), INAOE, Dept Elect, Puebla, Mexico.; Tlelo-Cuautle, E (corresponding author), CINVESTAV, Dept Comp Sci, Mexico City, DF, Mexico.	etlelo@inaoep.mx	de la Fraga, Luis Gerardo/B-1631-2017; Rangel-Magdaleno, Jose J/A-6285-2010; Rangel-Magdaleno, Jose/AAA-2297-2019; Tlelo-Cuautle, Esteban/H-3141-2014	de la Fraga, Luis Gerardo/0000-0002-9373-9837; Rangel-Magdaleno, Jose J/0000-0003-2785-5060; Rangel-Magdaleno, Jose/0000-0003-2785-5060; Tlelo-Cuautle, Esteban/0000-0001-7187-4686	CONACyT-Mexico [237991]; UC-MEXUS-CONACyT [CN-61-161]	CONACyT-Mexico(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); UC-MEXUS-CONACyT(Consejo Nacional de Ciencia y Tecnologia (CONACyT))	This work is supported by CONACyT-Mexico under grant 237991 and by UC-MEXUS-CONACyT under grant CN-61-161.	Akgul A, 2016, NONLINEAR DYNAM, V84, P481, DOI 10.1007/s11071-015-2501-7; CHUA LO, 1994, INT J CIRC THEOR APP, V22, P279, DOI 10.1002/cta.4490220404; Cong L, 2001, IEEE T CIRCUITS-I, V48, P521, DOI 10.1109/81.922455; da Silva ACR, 2011, IEEE LAT AM T, V9, P663, DOI 10.1109/TLA.2011.6030974; Dieci L., 2002, J DYN DIFFER EQ, V14, P697, DOI DOI 10.1023/A:1016395301189; Emary E, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0158738; Hossain FS, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0138457; Li F, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0154282; Logaras E, 2016, IEEE INT SYMP CIRC S, P1214, DOI 10.1109/ISCAS.2016.7527465; Lu JH, 2006, IEEE T CIRCUITS-I, V53, P149, DOI 10.1109/TCSI.2005.854412; Lu JH, 2004, IEEE T CIRCUITS-I, V51, P2476, DOI 10.1109/TCSI.2004.838151; MATSUMOTO T, 1984, IEEE T CIRCUITS SYST, V31, P1055, DOI 10.1109/TCS.1984.1085459; Rashtchi V, 2015, CIRC SYST SIGNAL PR, V34, P3101, DOI 10.1007/s00034-014-9948-5; Rezgui A, 2014, IEEE T MAGN, V50, DOI 10.1109/TMAG.2013.2281495; Selvamuthukumaran R, 2014, IET POWER ELECTRON, V7, P2269, DOI 10.1049/iet-pel.2013.0736; Si-Min ZWJY, 2009, ACTA PHYS SINICA, V1; Sinha R, 2012, IEEE T COMPUT AID D, V31, P1508, DOI 10.1109/TCAD.2012.2198474; SUYKENS JAK, 1993, IEEE T CIRCUITS-I, V40, P861, DOI 10.1109/81.251829; Tlelo-Cuautle E, 2015, NONLINEAR DYNAM, V82, P1879, DOI 10.1007/s11071-015-2284-x; Tlelo-Cuautle E, 2015, COMMUN NONLINEAR SCI, V27, P66, DOI 10.1016/j.cnsns.2015.03.003; Tlelo-Cuautle E., 2016, ENG APPL FPGAS CHAOT; Trejo-Guerra R, 2013, APPL MATH COMPUT, V219, P5113, DOI 10.1016/j.amc.2012.11.021; Urban R, 2015, DES DIAGN EL CIRC SY, P17; Wang QX, 2016, IEEE T CIRCUITS-I, V63, P401, DOI 10.1109/TCSI.2016.2515398; Xiong L, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0158348; Yen JC, 2000, IEE P-VIS IMAGE SIGN, V147, P167, DOI 10.1049/ip-vis:20000208; Yu SM, 2007, IEEE T CIRCUITS-I, V54, P2087, DOI 10.1109/TCSI.2007.904651; ZHONG GQ, 1985, INT J CIRC THEOR APP, V13, P93, DOI 10.1002/cta.4490130109	28	23	23	2	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2016	11	12							e0168300	10.1371/journal.pone.0168300	http://dx.doi.org/10.1371/journal.pone.0168300			32	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI9QF	27997930	Green Published, gold, Green Submitted			2022-12-27	WOS:000392842900030
J	Diessner, J; Wischnewsky, M; Blettner, M; Hausler, S; Janni, W; Kreienberg, R; Stein, R; Stuber, T; Schwentner, L; Bartmann, C; Wockel, A				Diessner, Joachim; Wischnewsky, Manfred; Blettner, Maria; Haeusler, Sebastian; Janni, Wolfgang; Kreienberg, Rolf; Stein, Roland; Stueber, Tanja; Schwentner, Lukas; Bartmann, Catharina; Woeckel, Achim			Do Patients with Luminal A Breast Cancer Profit from Adjuvant Systemic Therapy? A Retrospective Multicenter Study	PLOS ONE			English	Article							ESTROGEN-RECEPTOR; HIGH-RISK; CHEMOTHERAPY; EXPRESSION; TAMOXIFEN; SUBTYPES; SURVIVAL; WOMEN; TRIAL; STAGE	Background Luminal A breast cancers respond well to anti-hormonal therapy (HT), are associated with a generally favorable prognosis and constitute the majority of breast cancer subtypes. HT is the mainstay of treatment of these patients, accompanied by an acceptable profile of side effects, whereas the added benefit of chemotherapy (CHT), including anthracycline and taxane-based programs, is less clear-cut and has undergone a process of critical revision. Methods In the framework of the BRENDA collective, we analyzed the benefits of CHT compared to HT in 4570 luminal A patients (pts) with primary diagnosis between 2001 and 2008. The results were adjusted by nodal status, age, tumor size and grading. Results There has been a progressive reduction in the use of CHT in luminal A patients during the last decade. Neither univariate nor multivariate analyses showed any statistically significant differences in relapse free survival (RFS) with the addition of CHT to adjuvant HT, independent of the nodal status, age, tumor size or grading. Even for patients with more than 3 affected lymph nodes, there was no significant difference (univariate: p = 0.865; HR 0.94; 95% CI: 0.46-1.93; multivariate: p = 0.812; HR 0.92; 95% CI: 0.45-1.88). Conclusions The addition of CHT to HT provides minimal or no clinical benefit at all to patients with luminal A breast cancer, independent of the RFS-risk. Consequently, risk estimation cannot be the initial step in the decisional process. These findings that are in line with several publications-should encourage the critical evaluation of applying adjuvant CHT to patients with luminal A breast cancer.	[Diessner, Joachim; Haeusler, Sebastian; Stein, Roland; Stueber, Tanja; Bartmann, Catharina; Woeckel, Achim] Univ Wurzburg, Sch Med, Dept Obstet & Gynecol, Wurzburg, Germany; [Wischnewsky, Manfred] Univ Bremen, Fac Math & Comp Sci, Bremen, Germany; [Blettner, Maria] Johannes Gutenberg Univ Mainz, IMBEI, Mainz, Germany; [Janni, Wolfgang; Kreienberg, Rolf; Schwentner, Lukas] Univ Ulm, Sch Med, Dept Obstet & Gynecol, Ulm, Germany	University of Wurzburg; University of Bremen; Johannes Gutenberg University of Mainz; Ulm University	Diessner, J (corresponding author), Univ Wurzburg, Sch Med, Dept Obstet & Gynecol, Wurzburg, Germany.	Diessner-bw@t-online.de			German Federal Ministry of Education and Research (BMBF) [01ZP0505]	German Federal Ministry of Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF))	This work was supported by the German Federal Ministry of Education and Research (BMBF-Grant-01ZP0505).	Abe O, 2005, LANCET, V365, P1687, DOI 10.1016/s0140-6736(05)66544-0; Aebi S, 2011, ANN ONCOL, V22, P1981, DOI 10.1093/annonc/mdq754; Albain KS, 2009, LANCET, V374, P2055, DOI 10.1016/S0140-6736(09)61523-3; Berry DA, 2006, JAMA-J AM MED ASSOC, V295, P1658, DOI 10.1001/jama.295.14.1658; Coates AS, 2012, J CLIN ONCOL, V30, P1260, DOI 10.1200/JCO.2011.37.7879; de Oliveira HR, 2015, REV BRAS GINECOL OBS, V37, P308, DOI [10.1590/S0100-720320150005343, 10.1590/SO100-720320150005343]; Diessner J, 2015, ARCH GYNECOL OBSTET, V292, P655, DOI 10.1007/s00404-015-3691-4; Diessner J, 2016, BMC CANCER, V16, DOI 10.1186/s12885-016-2345-7; Ejlertsen B, 2010, CANCER-AM CANCER SOC, V116, P2081, DOI 10.1002/cncr.24969; Gao D, 2015, PATHOLOGY LAB MED, pS1; Geyer FC, 2009, PATHOLOGY, V41, P77, DOI 10.1080/00313020802563536; Goldhirsch A, 2011, ANN ONCOL, V22, P1736, DOI 10.1093/annonc/mdr304; Goldhirsch A, 2002, JNCI-J NATL CANCER I, V94, P1054; Han Y, 2015, GENET MOL RES, V14, P8563, DOI 10.4238/2015.July.31.4; Howell A, 2005, LANCET, V365, P60, DOI 10.1016/s0140-6736(04)17666-6; Hugh J, 2009, J CLIN ONCOL, V27, P1168, DOI 10.1200/JCO.2008.18.1024; Karlsson P, 2011, ANN ONCOL, V22, P2216, DOI 10.1093/annonc/mdq735; Kuijer A, 2016, INT J CANCER, V139, P769, DOI 10.1002/ijc.30132; Kwak HY, 2015, J CHEMOTHERAPY, V27, P290, DOI 10.1179/1973947815Y.0000000015; Liedtke C, 2008, J CLIN ONCOL, V26, P1275, DOI 10.1200/JCO.2007.14.4147; Lim E, 2011, BREAST, V20, pS128, DOI 10.1016/S0960-9776(11)70309-5; Lips EH, 2013, BREAST CANCER RES TR, V140, P63, DOI 10.1007/s10549-013-2620-0; Mayer EL, 2015, BREAST, V24, pS126, DOI 10.1016/j.breast.2015.07.028; Mayer EL, 2015, LANCET, V386, P1317, DOI 10.1016/S0140-6736(15)61206-5; Millikan RC, 2008, BREAST CANCER RES TR, V109, P123, DOI 10.1007/s10549-007-9632-6; Mobus V, 2016, BREAST CARE, V11, P8, DOI 10.1159/000444004; Nguyen PL, 2008, J CLIN ONCOL, V26, P2373, DOI 10.1200/JCO.2007.14.4287; Nielsen TO, 2010, CLIN CANCER RES, V16, P5222, DOI 10.1158/1078-0432.CCR-10-1282; PANEL N. I. O. H. C. D, 2001, J NATL CANCER INST M, P5; Parise CA, 2014, J CANCER EPIDEMIOL, V2014, DOI 10.1155/2014/469251; Perou CM, 2000, NATURE, V406, P747, DOI 10.1038/35021093; Phipps AI, 2011, CANCER CAUSE CONTROL, V22, P399, DOI 10.1007/s10552-010-9709-0; Prat A, 2010, MOL ONCOLOGY; Sorlie T, 2003, P NATL ACAD SCI USA, V100, P8418, DOI 10.1073/pnas.0932692100; Sorlie T, 2001, P NATL ACAD SCI USA, V98, P10869, DOI 10.1073/pnas.191367098; Thomssen C, 2016, BREAST CARE, V11, P61, DOI 10.1159/000443515; Uchida N, 2013, YONAGO ACTA MED, V56, P51; Viale G, 2008, J CLIN ONCOL, V26, P1404, DOI 10.1200/JCO.2007.10.6393; von Minckwitz G, 2012, J CLIN ONCOL, V30, P1796, DOI 10.1200/JCO.2011.38.8595; Wo JY, 2010, INT J RADIAT ONCOL, V77, P188, DOI 10.1016/j.ijrobp.2009.04.059	40	10	10	2	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 19	2016	11	12							e0168730	10.1371/journal.pone.0168730	http://dx.doi.org/10.1371/journal.pone.0168730			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI9QC	27992550	gold, Green Submitted, Green Published			2022-12-27	WOS:000392842600093
J	Agniswamy, J; Louis, JM; Roche, J; Harrison, RW; Weber, IT				Agniswamy, Johnson; Louis, John M.; Roche, Julien; Harrison, Robert W.; Weber, Irene T.			Structural Studies of a Rationally Selected Multi-Drug Resistant HIV-1 Protease Reveal Synergistic Effect of Distal Mutations on Flap Dynamics	PLOS ONE			English	Article							VIRUS TYPE-1 PROTEASE; MOLECULAR-DYNAMICS; CRYSTAL-STRUCTURES; CLINICAL INHIBITORS; BINDING; MUTANTS; COMPLEXES; DARUNAVIR; V82A; CONFORMATION	We report structural analysis of HIV protease variant PRS17 which was rationally selected by machine learning to represent wide classes of highly drug-resistant variants. Crystal structures were solved of PRS17 in the inhibitor-free form and in complex with antiviral inhibitor, darunavir. Despite its 17 mutations, PRS17 has only one mutation (V82S) in the inhibitor/substrate binding cavity, yet exhibits high resistance to all clinical inhibitors. PRS17 has none of the major mutations (I47V, I50V, I54ML, L76V and I84V) associated with darunavir resistance, but has 10,000-fold weaker binding affinity relative to the wild type PR. Comparable binding affinity of 8000-fold weaker than PR is seen for drug resistant mutant PR20, which bears 3 mutations associated with major resistance to darunavir (I47V, I54L and I84V). Inhibitor-free PRS17 shows an open flap conformation with a curled tip correlating with G48V flap mutation. NMR studies on inactive PRD25NS17 unambiguously confirm that the flaps adopt mainly an open conformation in solution very similar to that in the inhibitor-free crystal structure. In PRS17 , the hinge loop cluster of mutations, E35D, M36I and S37D, contributes to the altered flap dynamics by a mechanism similar to that of PR20. An additional K20R mutation anchors an altered conformation of the hinge loop. Flap mutations M46L and G48V in PRS17 /DRV complex alter the Phe53 conformation by steric hindrance between the side chains. Unlike the L10F mutation in PR20, L10I in PRS17 does not break the inter-subunit ion pair or diminish the dimer stability, consistent with a very low dimer dissociation constant comparable to that of wild type PR. Distal mutations A71V, L90M and I93L propagate alterations to the catalytic site of PRS17 . PRS17 exhibits a molecular mechanism whereby mutations act synergistically to alter the flap dynamics resulting in significantly weaker binding yet maintaining active site contacts with darunavir.	[Agniswamy, Johnson; Harrison, Robert W.; Weber, Irene T.] Georgia State Univ, Dept Biol, Atlanta, GA 30302 USA; [Louis, John M.; Roche, Julien] NIDDK, Chem Phys Lab, NIH, DHHS, Bethesda, MD 20892 USA; [Roche, Julien] Iowa State Univ, Roy J Carver Dept Biochem Biophys & Mol Biol, Ames, IA USA; [Harrison, Robert W.] Georgia State Univ, Dept Comp Sci, Atlanta, GA 30303 USA; [Weber, Irene T.] Georgia State Univ, Dept Chem, Atlanta, GA 30303 USA	University System of Georgia; Georgia State University; National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); Iowa State University; University System of Georgia; Georgia State University; University System of Georgia; Georgia State University	Weber, IT (corresponding author), Georgia State Univ, Dept Biol, Atlanta, GA 30302 USA.; Weber, IT (corresponding author), Georgia State Univ, Dept Chem, Atlanta, GA 30303 USA.	iweber@gsu.edu		Harrison, Robert/0000-0003-2449-1214; Agniswamy, Johnson/0000-0002-3053-5677; Louis, John M/0000-0002-0052-1899	National Institutes of Health [GM062920]; Intramural Research Program of the NIDDK, National Institutes of Health (NIH); Intramural AIDS-Targeted Antiviral Program of the Office of the Director, NIH; U.S. Department of Energy, Office of Science, Office of Basic Energy Sciences [W-31-109-Eng-38]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U01GM062920] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Intramural Research Program of the NIDDK, National Institutes of Health (NIH); Intramural AIDS-Targeted Antiviral Program of the Office of the Director, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); U.S. Department of Energy, Office of Science, Office of Basic Energy Sciences(United States Department of Energy (DOE)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The research was supported in part by the National Institutes of Health grant GM062920 (ITW, RWH) and by the Intramural Research Program of the NIDDK, National Institutes of Health (NIH), Intramural AIDS-Targeted Antiviral Program of the Office of the Director, NIH (JML). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank Jane M. Sayer for discussions and critical reading of the manuscript, and Annie Aniana for technical assistance. We thank the staff at the Southeast Regional-Collaborative Access Team (SER-CAT) at the Advanced Photon Source, Argonne National Laboratory, for assistance during X-ray data collection. Supporting institutions may be found at http://www.ser-cat.org/members.html. Use of the Advanced Photon Source was supported by the U.S. Department of Energy, Office of Science, Office of Basic Energy Sciences, under Contract No. W-31-109-Eng-38.	Agniswamy J, 2013, J MED CHEM, V56, P4017, DOI 10.1021/jm400231v; Agniswamy J, 2012, BIOCHEMISTRY-US, V51, P2819, DOI 10.1021/bi2018317; Bax A, 2005, CURR OPIN STRUC BIOL, V15, P563, DOI 10.1016/j.sbi.2005.08.006; Chetty S, 2016, J BIOMOL STRUCT DYN, V34, P135, DOI 10.1080/07391102.2015.1018326; De Clercq E, 2009, INT J ANTIMICROB AG, V33, P307, DOI 10.1016/j.ijantimicag.2008.10.010; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Dierynck I, 2007, J VIROL, V81, P13845, DOI 10.1128/JVI.01184-07; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Flor-Parra F, 2011, AIDS RES HUM RETROV, V27, P65, DOI 10.1089/aid.2010.0072; Freedberg DI, 2002, PROTEIN SCI, V11, P221, DOI 10.1110/ps.33202; Ganser-Pornillos BK, 2008, CURR OPIN STRUC BIOL, V18, P203, DOI 10.1016/j.sbi.2008.02.001; Goddard TD, 2010, SPARKY 3; Heaslet H, 2007, ACTA CRYSTALLOGR D, V63, P866, DOI 10.1107/S0907444907029125; Huang LQ, 2009, J VIROL, V83, P7789, DOI 10.1128/JVI.00473-09; Ishima R, 2007, J BIOL CHEM, V282, P17190, DOI 10.1074/jbc.M701304200; Koh Y, 2003, ANTIMICROB AGENTS CH, V47, P3123, DOI 10.1128/AAC.47.10.3123-3129.2003; Kovalevsky AY, 2006, J MOL BIOL, V363, P161, DOI 10.1016/j.jmb.2006.08.007; Kovalevsky AY, 2006, J MED CHEM, V49, P1379, DOI 10.1021/jm050943c; Lakomek NA, 2012, J BIOMOL NMR, V53, P209, DOI 10.1007/s10858-012-9626-5; Liu FL, 2008, J MOL BIOL, V381, P102, DOI 10.1016/j.jmb.2008.05.062; Liu FL, 2006, J MOL BIOL, V358, P1191, DOI 10.1016/j.jmb.2006.02.076; Louis JM, 2016, J MOL BIOL, V428, P2780, DOI 10.1016/j.jmb.2016.05.005; Louis JM, 2015, BIOCHEMISTRY-US, V54, P5414, DOI 10.1021/acs.biochem.5b00759; Louis JM, 2011, P NATL ACAD SCI USA, V108, P9072, DOI 10.1073/pnas.1102278108; Louis JM, 2009, PROTEIN SCI, V18, P2442, DOI 10.1002/pro.261; Mahalingam B, 1999, EUR J BIOCHEM, V263, P238, DOI 10.1046/j.1432-1327.1999.00514.x; Mahalingam B, 2004, EUR J BIOCHEM, V271, P1516, DOI 10.1111/j.1432-1033.2004.04060.x; Maltsev AS, 2014, J AM CHEM SOC, V136, P3752, DOI 10.1021/ja4132642; MANCHESTER M, 1994, J BIOL CHEM, V269, P7689; May M, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d6016; May MT, 2014, AIDS, V28, P1193, DOI 10.1097/QAD.0000000000000243; McCoy AJ, 2005, ACTA CRYSTALLOGR D, V61, P458, DOI 10.1107/S0907444905001617; Meher BR, 2012, J PHYS CHEM B, V116, P1884, DOI 10.1021/jp2074804; Meiselbach H, 2007, J MOL MODEL, V13, P297, DOI 10.1007/s00894-006-0121-3; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nakashima M, 2016, FRONT MICROBIOL, V7, DOI [10.3389/fmicb.2016,00061, 10.3389/fmicb.2016.00061]; Ode H, 2007, J MOL BIOL, V370, P598, DOI 10.1016/j.jmb.2007.04.081; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Park JH, 2016, BIOCHEMISTRY-US, V55, P2390, DOI 10.1021/acs.biochem.6b00012; Roche J, 2015, CHEMBIOCHEM, V16, P214, DOI 10.1002/cbic.201402585; Sayer JM, 2010, PROTEIN SCI, V19, P2055, DOI 10.1002/pro.486; Shen CH, 2015, J MOL GRAPH MODEL, V62, P87, DOI 10.1016/j.jmgm.2015.09.006; Shen CH, 2010, FEBS J, V277, P3699, DOI 10.1111/j.1742-4658.2010.07771.x; Skalova T, 2006, J MED CHEM, V49, P5777, DOI 10.1021/jm0605583; Storoni LC, 2004, ACTA CRYSTALLOGR D, V60, P432, DOI 10.1107/S0907444903028956; Tie YF, 2007, PROTEINS, V67, P232, DOI 10.1002/prot.21304; Tzoupis H, 2013, J CHEM THEORY COMPUT, V9, P1754, DOI 10.1021/ct301063k; Weber IT, 2015, FUTURE MED CHEM, V7, P1023, DOI [10.4155/FMC.15.44, 10.4155/fmc.15.44]; Weber IT, 2009, VIRUSES-BASEL, V1, P1110, DOI 10.3390/v1031110; Wensing Annemarie M, 2015, Top Antivir Med, V23, P132; Yu X. C., 2014, SCI CHINA EARTH SCI, V1, P1, DOI DOI 10.1371/J0URNAL.P0NE.0083080; Yu X, 2015, STEM CELLS INT, V2015, DOI 10.1155/2015/619290; Yu Xiaxia, 2013, Proc SIAM Int Conf Data Min, V2013, P342	53	30	30	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2016	11	12							e0168616	10.1371/journal.pone.0168616	http://dx.doi.org/10.1371/journal.pone.0168616			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI8LN	27992544	gold, Green Submitted, Green Published			2022-12-27	WOS:000392758000067
J	Christensen, S; Groftehauge, MK; Byriel, K; Huston, WM; Furlong, E; Heras, B; Martin, JL; McMahon, RM				Christensen, Signe; Groftehauge, Morten K.; Byriel, Karl; Huston, Wilhelmina M.; Furlong, Emily; Heras, Begona; Martin, Jennifer L.; McMahon, Roisin M.			Structural and Biochemical Characterization of Chlamydia trachomatis DsbA Reveals a Cysteine-Rich and Weakly Oxidising Oxidoreductase	PLOS ONE			English	Article							PROTEIN DISULFIDE-ISOMERASE; CRYSTAL-STRUCTURE; BOND FORMATION; FUNCTIONAL-CHARACTERIZATION; DESTABILIZING DISULFIDE; REDOX PROPERTIES; CXXC-MOTIF; THIOREDOXIN; IONIZATION; DEPENDENCE	The Gram negative bacteria Chlamydia trachomatis is an obligate intracellular human pathogen that can cause pelvic inflammatory disease, infertility and blinding trachoma. C. trachomatis encodes a homolog of the dithiol oxidoreductase DsbA. Bacterial DsbA proteins introduce disulfide bonds to folding proteins providing structural bracing for secreted virulence factors, consequently these proteins are potential targets for antimicrobial drugs. Despite sharing functional and structural characteristics, the DsbA enzymes studied to date vary widely in their redox character. In this study we show that the truncated soluble form of the predicted membrane anchored protein C. trachomatis DsbA (CtDsbA) has oxidase activity and redox properties broadly similar to other characterized DsbA proteins. However CtDsbA is distinguished from other DsbAs by having six cysteines, including a second disulfide bond, and an unusual dipeptide sequence in its catalytic motif (Cys-Ser-Ala-Cys). We report the 2.7 A crystal structure of CtDsbA revealing a typical DsbA fold,which is most similar to that of DsbA-II type proteins. Consistent with this, the catalytic surface of CtDsbA is negatively charged and lacks the hydrophobic groove found in EcDsbA and DsbAs from other enterobacteriaceae. Biochemical characterization of CtDsbA reveals it to be weakly oxidizing compared to other DsbAs and with only a mildly destabilizing active site disulfide bond. Analysis of the crystal structure suggests that this redox character is consistent with a lack of contributing factors to stabilize the active site nucleophilic thiolate relative to more oxidizing DsbA proteins.	[Christensen, Signe; Groftehauge, Morten K.; Byriel, Karl; Furlong, Emily; Heras, Begona; Martin, Jennifer L.; McMahon, Roisin M.] Univ Queensland, Inst Mol Biosci, Div Chem & Struct Biol, St Lucia, Qld, Australia; [Huston, Wilhelmina M.] Univ Technol Sydney, Sch Life Sci, Broadway, NSW, Australia; [Groftehauge, Morten K.] Univ Durham, Sch Biol & Biomed Sci, Durham, England; [Heras, Begona] La Trobe Univ, La Trobe Inst Mol Sci, Bundoora, Vic, Australia; [Martin, Jennifer L.] Griffith Univ, Eskitis Inst Drug Discovery, Nathan, Qld, Australia	University of Queensland; University of Technology Sydney; Durham University; La Trobe University; Griffith University	Martin, JL; McMahon, RM (corresponding author), Univ Queensland, Inst Mol Biosci, Div Chem & Struct Biol, St Lucia, Qld, Australia.; Martin, JL (corresponding author), Griffith Univ, Eskitis Inst Drug Discovery, Nathan, Qld, Australia.	jlm@griffith.edu.au; r.mcmahon@imb.uq.edu.au	Furlong, Emily J/S-5044-2016; McMahon, Roisin/A-9823-2014; Christensen, Signe/C-7989-2017; Heras, Begona/H-8686-2014; Christensen, Signe/AAF-3443-2019; Christensen, Signe/GQP-7049-2022; Huston, Wilhelmina/S-7269-2019; Byriel, Karl/Y-4155-2019; Huston, Wilhelmina/B-9984-2008	Furlong, Emily J/0000-0002-9086-2979; McMahon, Roisin/0000-0001-5437-0355; Christensen, Signe/0000-0001-9556-1545; Heras, Begona/0000-0003-3469-7988; Christensen, Signe/0000-0001-9556-1545; Byriel, Karl/0000-0003-1615-1551; Huston, Wilhelmina/0000-0002-0879-1287; Groftehauge, Morten/0000-0002-1823-3713	Australian Research Council [FL0992138]; NHMRC [1061241]; Australian Postgraduate Award; Institute for Molecular Bioscience Research Advancement Award	Australian Research Council(Australian Research Council); NHMRC(National Health and Medical Research Council (NHMRC) of Australia); Australian Postgraduate Award(Australian Government); Institute for Molecular Bioscience Research Advancement Award	This work was supported by an Australian Research Council (www.arc.gov.au) Australian Laureate Fellowship (FL0992138) to JLM; RMM, MKG, BH and SC were also supported by this award. RMM is also supported by an NHMRC (www.nhmrc.gov.au) Project Grant (1061241) awarded to JLM. SC holds a UQI Tuition Fee Award (www.scholarships.uq.edu.au/). EF is supported by an Australian Postgraduate Award and an Institute for Molecular Bioscience Research Advancement Award. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AbdelRahman YM, 2005, FEMS MICROBIOL REV, V29, P949, DOI 10.1016/j.femsre.2005.03.002; Adams LA, 2015, ANGEW CHEM INT EDIT, V54, P2179, DOI 10.1002/anie.201410341; Afonine PV, 2012, ACTA CRYSTALLOGR D, V68, P352, DOI 10.1107/S0907444912001308; Arts IS, 2013, MBIO, V4, DOI 10.1128/mBio.00912-13; BARDWELL JCA, 1991, CELL, V67, P581, DOI 10.1016/0092-8674(91)90532-4; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Chivers PT, 1997, BIOCHEMISTRY-US, V36, P4061, DOI 10.1021/bi9628580; Cho SH, 2012, MBIO, V3, DOI 10.1128/mBio.00291-11; Crow A, 2009, J BIOL CHEM, V284, P23719, DOI 10.1074/jbc.M109.005785; DAILEY FE, 1993, P NATL ACAD SCI USA, V90, P1043, DOI 10.1073/pnas.90.3.1043; Duprez W, 2015, J MED CHEM, V58, P577, DOI 10.1021/jm500955s; Emsley P, 2004, ACTA CRYSTALLOGRAP D; EVANS JC, 1959, BIOCHIM BIOPHYS ACTA, V33, P574, DOI 10.1016/0006-3002(59)90157-X; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; Guddat LW, 1997, PROTEIN SCI, V6, P1893, DOI 10.1002/pro.5560060910; Guddat LW, 1998, STRUCT FOLD DES, V6, P757, DOI 10.1016/S0969-2126(98)00077-X; GUZMAN LM, 1995, J BACTERIOL, V177, P4121, DOI 10.1128/jb.177.14.4121-4130.1995; Haggerty CL, 2010, J INFECT DIS, V201, pS134, DOI 10.1086/652395; Heras B, 2008, J BIOL CHEM, V283, P4261, DOI 10.1074/jbc.M707838200; Heras B, 2009, NAT REV MICROBIOL, V7, P215, DOI 10.1038/nrmicro2087; Holm L, 2010, NUCLEIC ACIDS RES, V38, pW545, DOI 10.1093/nar/gkq366; HOLMGREN A, 1979, J BIOL CHEM, V254, P9627; Huber-Wunderlich M, 1998, FOLD DES, V3, P161, DOI 10.1016/S1359-0278(98)00024-8; Inaba K, 2006, CELL, V127, P789, DOI 10.1016/j.cell.2006.10.034; Ireland PM, 2014, ANTIOXID REDOX SIGN, V20, P606, DOI 10.1089/ars.2013.5375; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; KORTEMME T, 1995, J MOL BIOL, V253, P799, DOI 10.1006/jmbi.1995.0592; KRAUSE G, 1991, J BIOL CHEM, V266, P9494; Kurth F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080210; Kurz M, 2009, ANTIOXID REDOX SIGN, V11, P1485, DOI [10.1089/ars.2008.2420, 10.1089/ARS.2008.2420]; Lafaye C, 2009, J MOL BIOL, V392, P952, DOI 10.1016/j.jmb.2009.07.056; Lee K, 2004, J AM CHEM SOC, V126, P13616, DOI 10.1021/ja047300r; LIN TY, 1989, BIOCHEMISTRY-US, V28, P5282, DOI 10.1021/bi00438a054; Mac TT, 2008, J BIOL CHEM, V283, P824, DOI 10.1074/jbc.M707863200; MARTIN JL, 1993, NATURE, V365, P464, DOI 10.1038/365464a0; McMahon RM, 2014, BBA-PROTEINS PROTEOM, V1844, P1391, DOI 10.1016/j.bbapap.2014.01.013; Newman L, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0143304; Nugent T, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-159; Premkumar L, 2013, ACTA CRYSTALLOGR D, V69, P1981, DOI 10.1107/S0907444913017800; Quan S, 2007, J BIOL CHEM, V282, P28823, DOI 10.1074/jbc.M705291200; Robert X, 2014, NUCLEIC ACIDS RES, V42, pW320, DOI 10.1093/nar/gku316; Ruddock LW, 1996, BIOCHEM J, V315, P1001, DOI 10.1042/bj3151001; Shouldice SR, 2011, ANTIOXID REDOX SIGN, V14, P1729, DOI 10.1089/ars.2010.3344; Studier FW, 2005, PROTEIN EXPRES PURIF, V41, P207, DOI 10.1016/j.pep.2005.01.016; Tusnady GE, 2001, BIOINFORMATICS, V17, P849, DOI 10.1093/bioinformatics/17.9.849; Tusnady GE, 1998, J MOL BIOL, V283, P489, DOI 10.1006/jmbi.1998.2107; Vivian JP, 2009, J MOL BIOL, V394, P931, DOI 10.1016/j.jmb.2009.09.065; Vonrhein C, 2011, ACTA CRYSTALLOGR D, V67, P293, DOI 10.1107/S0907444911007773; Walden PM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081440; Walden PM, 2012, ACTA CRYSTALLOGR D, V68, P1290, DOI 10.1107/S0907444912026388; WUNDERLICH M, 1993, J BIOL CHEM, V268, P24547; WUNDERLICH M, 1993, J MOL BIOL, V233, P559, DOI 10.1006/jmbi.1993.1535; ZAPUN A, 1993, BIOCHEMISTRY-US, V32, P5083, DOI 10.1021/bi00070a016	53	8	8	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2016	11	12							e0168485	10.1371/journal.pone.0168485	http://dx.doi.org/10.1371/journal.pone.0168485			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EG7JB	28030602	gold, Green Published, Green Submitted			2022-12-27	WOS:000391222000050
J	Lorenz, K; Beck, S; Keilani, MM; Wasielica-Poslednik, J; Pfeiffer, N; Grus, FH				Lorenz, Katrin; Beck, Sabine; Keilani, Munir M.; Wasielica-Poslednik, Joanna; Pfeiffer, Norbert; Grus, Franz H.			Longitudinal Analysis of Serum Autoantibody-Reactivities in Patients with Primary Open Angle Glaucoma and Optic Disc Hemorrhage	PLOS ONE			English	Article							RETINAL GANGLION-CELLS; OCULAR HYPERTENSION; OXIDATIVE STRESS; PROGRESSION; COMPLEX; NEUROPROTECTION; PROTEIN; TRIAL; PATHOGENESIS; DEGRADATION	Background The aim of our current investigation was to analyze the autoantibody-reactivities of primary open angle glaucoma patients with optic disc hemorrhage as possibly correlated to disease progression by means of a protein microarray approach. Methods Sera of patients with primary open angle glaucoma and optic disc hemorrhage (n = 16) were collected directly after study inclusion (0 weeks) and after 2 weeks, 4 weeks and 12 weeks. As a control group patients with primary open angle glaucoma (n = 18) were used (0 weeks and 12 weeks). Microarrays were incubated and occurring antibody-antigen-reactions were visualized with fluorescence labeled anti-human-IgG secondary antibodies. To detect changes in autoantibodies spot intensities were digitized and compared. Results With respect to the immunoreactivity at 0 weeks level increment of anti-adaptor protein 1 complex subunit mu-1 antibodies and anti-SPRY domain-containing SOCS box protein 3 antibodies in sera of primary open angle patients with optic disc hemorrhage was detected. Linear trend analysis revealed a positive correlation with r >= 0.8 between antibody-level and time course. Control group show no relevant changes in the same period. Significant changes were found in time point 4 comparison between patient groups in anti-adaptor protein 1 complex subunit mu-1-level (p = 0.01). No significant changes in visual acuity were found. Conclusion With this approach we were able to detect autoimmune reactivities in sera of patients with primary open angle glaucoma and optic disc hemorrhage compared to patients without optic disc hemorrhage. These antibodies could give further insights into the pathogenesis and the autoimmune component of glaucomatous optic neuropathy.	[Lorenz, Katrin; Beck, Sabine; Keilani, Munir M.; Wasielica-Poslednik, Joanna; Pfeiffer, Norbert; Grus, Franz H.] Johannes Gutenberg Univ Mainz, Dept Expt Ophthalmol, Univ Med Ctr, Mainz, Germany; [Beck, Sabine] Johannes Gutenberg Univ Mainz, Dept Biochem & Pharm, Mainz, Germany; [Keilani, Munir M.] Vis 100 Augenarzte, Gemeinschaftspraxis Monchengladbach, Monchengladbach, Germany	Johannes Gutenberg University of Mainz; Johannes Gutenberg University of Mainz	Grus, FH (corresponding author), Johannes Gutenberg Univ Mainz, Dept Expt Ophthalmol, Univ Med Ctr, Mainz, Germany.	grus@eye-research.org	Pfeiffer, Norbert/AAO-7586-2020					Aghagolzadeh P, 2016, WORLD J GASTROENTERO, V22, P5678, DOI 10.3748/wjg.v22.i25.5678; Armstrong RA, 2014, OPHTHAL PHYSL OPT, V34, P502, DOI 10.1111/opo.12131; Bateman A, 2015, NUCLEIC ACIDS RES, V43, pD204, DOI 10.1093/nar/gku989; Bell K, 2013, PROG RETIN EYE RES, V36, P199, DOI 10.1016/j.preteyeres.2013.02.003; Bengtsson B, 2008, OPHTHALMOLOGY, V115, P2044, DOI 10.1016/j.ophtha.2008.05.031; Boehm N, 2010, ANAL IMMUNOLOGISCHER; Boehm N, 2012, BRAIN BEHAV IMMUN, V26, P96, DOI 10.1016/j.bbi.2011.07.241; Bonifacino JS, 2014, J CELL BIOL, V204, P7, DOI 10.1083/jcb.201310021; Budenz DL, 2006, OPHTHALMOLOGY, V113, P2137, DOI 10.1016/j.ophtha.2006.06.022; Canagarajah BJ, 2013, PROTEIN SCI, V22, P517, DOI 10.1002/pro.2235; Casson RJ, 2012, CLIN EXP OPHTHALMOL, V40, P341, DOI 10.1111/j.1442-9071.2012.02773.x; Cavet ME, 2014, INVEST OPHTH VIS SCI, V55, P5005, DOI 10.1167/iovs.14-14515; Chang EE, 2012, OPHTHALMOLOGY, V119, P979, DOI 10.1016/j.ophtha.2011.11.003; Chrysostomou V, 2013, CURR OPIN PHARMACOL, V13, P12, DOI 10.1016/j.coph.2012.09.008; Chung E, 2015, BRIT J OPHTHALMOL, V99, P21, DOI 10.1136/bjophthalmol-2014-305349; Cretich M, 2014, ANALYST, V139, P528, DOI 10.1039/c3an01619f; De Moraes CG, 2013, ACTA OPHTHALMOL, V91, pe86, DOI 10.1111/j.1755-3768.2012.02577.x; Diekmann H, 2013, CELL TISSUE RES, V353, P327, DOI 10.1007/s00441-013-1596-8; Farias GG, 2012, NEURON, V75, P810, DOI 10.1016/j.neuron.2012.07.007; Gramlich OW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057557; Grus FH, 2004, MOL VIS, V10, P132; Guo L, 2008, PROG BRAIN RES, V173, P437, DOI 10.1016/S0079-6123(08)01130-8; Hecker M, 2012, AUTOIMMUN REV, V11, P180, DOI 10.1016/j.autrev.2011.05.010; Hoyne GF, 2011, CLIN DEV IMMUNOL, DOI 10.1155/2011/294968; Huang Y, 2007, EXP EYE RES, V85, P684, DOI 10.1016/j.exer.2007.08.003; Hwang YH, 2014, J GLAUCOMA, V23, P547, DOI 10.1097/IJG.0000000000000083; Icking A, 2007, TRAFFIC, V8, P285, DOI 10.1111/j.1600-0854.2006.00526.x; Jeong Daun, 2015, Korean J Ophthalmol, V29, P40, DOI 10.3341/kjo.2015.29.1.40; Jindal V, 2013, MOL NEUROBIOL, V48, P186, DOI 10.1007/s12035-013-8416-8; Joachim SC, 2008, GRAEF ARCH CLIN EXP, V246, P573, DOI 10.1007/s00417-007-0737-8; Joachim SC, 2014, J MOL NEUROSCI, V52, P216, DOI 10.1007/s12031-013-0125-2; Joachim SC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040616; Keller KE, 2013, MOL VIS, V19, P1639; Kim JM, 2014, BRIT J OPHTHALMOL, V98, P1555, DOI 10.1136/bjophthalmol-2013-304584; Landers JA, 2002, CLIN EXP OPHTHALMOL, V30, P338, DOI 10.1046/j.1442-9071.2002.00552.x; Laspas P, 2011, INVEST OPHTH VIS SCI, V52, P8835, DOI 10.1167/iovs.10-6889; Leske MC, 2007, OPHTHALMOLOGY, V114, P1965, DOI 10.1016/j.ophtha.2007.03.016; Leske MC, 2003, ARCH OPHTHALMOL-CHIC, V121, P48; Linossi EM, 2012, IUBMB LIFE, V64, P316, DOI 10.1002/iub.1011; Maruyama I, 2000, INVEST OPHTH VIS SCI, V41, P1657; Medeiros FA, 2009, ARCH OPHTHALMOL-CHIC, V127, P1250, DOI 10.1001/archophthalmol.2009.276; Moore D, 2008, CLIN OPHTHALMOL, V2, P849; Nakagawa S, 2004, BEHAV ECOL, V15, P1044, DOI 10.1093/beheco/arh107; Nakatsu F, 2014, MEMBRANES, V4, P747, DOI 10.3390/membranes4040747; Nishiya T, 2011, J BIOL CHEM, V286, P9009, DOI 10.1074/jbc.M110.190678; Ohno H, 1999, FEBS LETT, V449, P215, DOI 10.1016/S0014-5793(99)00432-9; Park SY, 2014, BIOSCIENCE REPORTS, V34; Pepe MS, 2001, J NATL CANCER I, V93, P1054, DOI 10.1093/jnci/93.14.1054; Perfetto L, 2013, TRENDS BIOCHEM SCI, V38, P38, DOI 10.1016/j.tibs.2012.10.001; Perneger TV, 1998, BRIT MED J, V316, P1236, DOI 10.1136/bmj.316.7139.1236; Piessevaux J, 2008, CYTOKINE GROWTH F R, V19, P371, DOI 10.1016/j.cytogfr.2008.08.006; Ren XF, 2013, CELL, V152, P755, DOI 10.1016/j.cell.2012.12.042; Resnikoff S, 2002, B WORLD HEALTH ORGAN, V82, P844; Schulzer M, 1998, AM J OPHTHALMOL, V126, P487; Sharts-Hopko NC, 2009, AM J NURS, V109, P40, DOI 10.1097/01.NAJ.0000345434.37734.ee; Suh MH, 2014, SURV OPHTHALMOL, V59, P19, DOI 10.1016/j.survophthal.2013.03.005; Tamm ER, 2013, CELL TISSUE RES, V353, P201, DOI 10.1007/s00441-013-1672-0; Tezel G, 2006, PROG RETIN EYE RES, V25, P490, DOI 10.1016/j.preteyeres.2006.07.003; Tham YC, 2014, OPHTHALMOLOGY; Van Veldhuisen PC, 2000, AM J OPHTHALMOL, V130, P429; Weinreb RN, 2014, JAMA-J AM MED ASSOC, V311, P1901, DOI 10.1001/jama.2014.3192; Wilding C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090737; Yang JJ, 2001, INVEST OPHTH VIS SCI, V42, P1273	63	12	12	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2016	11	12							e0166813	10.1371/journal.pone.0166813	http://dx.doi.org/10.1371/journal.pone.0166813			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EG7JB	28030545	Green Published, gold, Green Submitted			2022-12-27	WOS:000391222000002
J	Maceda-Veiga, A; Green, AJ; Poulin, R; Lagrue, C				Maceda-Veiga, Alberto; Green, Andy J.; Poulin, Robert; Lagrue, Clement			Body Condition Peaks at Intermediate Parasite Loads in the Common Bully Gobiomorphus cotidianus	PLOS ONE			English	Article							BARBUS-HAASI; FISH; INFECTION; GROWTH; WINTER; TEMPERATURE; PERFORMANCE; BIOMARKERS; RESIDUALS; ABUNDANCE	Most ecologists and conservationists perceive parasitic infections as deleterious for the hosts. Their effects, however, depend on many factors including host body condition, parasite load and the life cycle of the parasite. More research into how multiple parasite taxa affect host body condition is required and will help us to better understand host-parasite coevolution. We used body condition indices, based on mass-length relationships, to test the effects that abundances and biomasses of six parasite taxa (five trematodes, Apatemon sp., Tylodelphys sp., Stegodexamene anguillae, Telogaster opisthorchis, Coitocaecum parvum, and the nematode Eustrongylides sp.) with different modes of transmission have on the body condition of their intermediate or final fish host, the common bully Gobiomorphus cotidianus in New Zealand. We used two alternative body condition methods, the Scaled Mass Index (SMI) and Fulton's condition factor. General linear and hierarchical partitioning models consistently showed that fish body condition varied strongly across three lakes and seasons, and that most parasites did not have an effect on the two body condition indices. However, fish body condition showed a highly significant humpbacked relationship with the total abundance of all six parasite taxa, mostly driven by Apatemon sp. and S. anguillae, indicating that the effects of these parasites can range from positive to negative as abundance increases. Such a response was also evident in models including total parasite biomass. Our methodological comparison supports the SMI as the most robust mass-length method to examine the effects of parasitic infections on fish body condition, and suggests that linear, negative relationships between host condition and parasite load should not be assumed.	[Maceda-Veiga, Alberto] CSIC, Dept Integrat Ecol, Estn Biol Donana, Seville, Spain; [Maceda-Veiga, Alberto] Univ Barcelona, Fac Biol, Inst Res Biodivers IRBio, Barcelona, Spain; [Green, Andy J.] CSIC, Dept Wetland Ecol, Estn Biol Donana, Seville, Spain; [Poulin, Robert; Lagrue, Clement] Univ Otago, Dept Zool, Dunedin, New Zealand	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Estacion Biologica de Donana (EBD); University of Barcelona; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Estacion Biologica de Donana (EBD); University of Otago	Maceda-Veiga, A (corresponding author), CSIC, Dept Integrat Ecol, Estn Biol Donana, Seville, Spain.; Maceda-Veiga, A (corresponding author), Univ Barcelona, Fac Biol, Inst Res Biodivers IRBio, Barcelona, Spain.	albertomaceda@gmail.com	Poulin, Robert/C-3117-2008; Poulin, Robert/GQO-8936-2022; Green, Andy J/A-5189-2008; Maceda-Veiga, Alberto/F-1185-2010	Poulin, Robert/0000-0003-1390-1206; Poulin, Robert/0000-0003-1390-1206; Green, Andy J/0000-0002-1268-4951; Lagrue, Clement/0000-0003-3347-6497; Maceda-Veiga, Alberto/0000-0002-1736-4631	Marsden Fund (Royal Society of New Zealand); Severo Ochoa Program for Centres of Excellence in R+D+I [SEV-2012-0262]; Ajuda de la Fundacio Barcelona Zoo i l'Ajuntament de Barcelona'	Marsden Fund (Royal Society of New Zealand)(Royal Society of New ZealandMarsden Fund (NZ)); Severo Ochoa Program for Centres of Excellence in R+D+I; Ajuda de la Fundacio Barcelona Zoo i l'Ajuntament de Barcelona'	The project was funded by a grant from the Marsden Fund (Royal Society of New Zealand) to RP. AMV was funded by the Severo Ochoa Program for Centres of Excellence in R+D+I (Ref: SEV-2012-0262) and the grant Ajuda de la Fundacio Barcelona Zoo i l'Ajuntament de Barcelona'. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], IMODEL2 MODEL 2 REGR; Bakke TA, 2007, ADV PARASIT, V64, P161, DOI 10.1016/S0065-308X(06)64003-7; Bearhop S, 2004, P ROY SOC B-BIOL SCI, V271, pS215, DOI 10.1098/rsbl.2003.0129; Bentley KT, 2013, T AM FISH SOC, V142, P747, DOI 10.1080/00028487.2013.769899; BRETT JR, 1969, J FISH RES BOARD CAN, V26, P2363, DOI 10.1139/f69-230; Capela R, 2016, SCI TOTAL ENVIRON, V539, P85, DOI 10.1016/j.scitotenv.2015.08.113; Colin N, 2016, SCI TOTAL ENVIRON, V540, P307, DOI 10.1016/j.scitotenv.2015.06.099; Cornet S, 2010, P ROY SOC B-BIOL SCI, V277, P1929, DOI 10.1098/rspb.2010.0138; Cressler CE, 2014, ECOL LETT, V17, P284, DOI 10.1111/ele.12229; Faltynkova A, 2011, PARASITE VECTOR, V4, DOI 10.1186/1756-3305-4-85; Figuerola B, 2012, HYDROBIOLOGIA, V694, P75, DOI 10.1007/s10750-012-1132-y; Fox J., R COMPANION APPL REG, V3; Freckleton RP, 2011, BEHAV ECOL SOCIOBIOL, V65, P91, DOI 10.1007/s00265-010-1045-6; Garcia-Berthou E, 2001, J ANIM ECOL, V70, P708, DOI 10.1046/j.1365-2656.2001.00524.x; Gislason H, 2010, FISH FISH, V11, P149, DOI 10.1111/j.1467-2979.2009.00350.x; Green AJ, 2001, ECOLOGY, V82, P1473, DOI 10.2307/2680003; Guillemain M, 2013, J ORNITHOL, V154, P1007, DOI 10.1007/s10336-013-0968-x; Jakob EM, 1996, OIKOS, V77, P61, DOI 10.2307/3545585; Karvonen A, 2004, PARASITOLOGY, V129, P473, DOI 10.1017/S0031182004006006; Kelly CD, 2014, ECOL EVOL, V4, P4476, DOI 10.1002/ece3.1257; Kelly DW, 2010, J ANIM ECOL, V79, P445, DOI 10.1111/j.1365-2656.2009.01636.x; Koops MA, 2004, FISH FISH, V5, P120, DOI 10.1111/j.1467-2979.2004.00149.x; Labocha MK, 2014, OIKOS, V123, P111, DOI 10.1111/j.1600-0706.2013.00755.x; Lagrue C, 2015, J FISH BIOL, V87, P836, DOI 10.1111/jfb.12749; Lagrue C, 2015, PARASITOL RES, V114, P3637, DOI 10.1007/s00436-015-4590-0; Lagrue C, 2011, J FISH BIOL, V79, P466, DOI 10.1111/j.1095-8649.2011.03041.x; Lambertucci J. R., 1993, Human schistosomiasis., P195; LECREN ED, 1951, J ANIM ECOL, V20, P201, DOI 10.2307/1540; LEMLY AD, 1984, J PARASITOL, V70, P475, DOI 10.2307/3281395; Lom J., 1992, DEV AQUACULTURE FISH; Lyndon AR, 2001, BULL EUR ASSN FISH P, V21, P263; Mac Nally R, 2004, BIODIVERS CONSERV, V13, P659; MacCracken JG, 2012, J HERPETOL, V46, P346, DOI 10.1670/10-292; Maceda-Veiga A, 2013, B EUR ASSOC FISH PAT, V33, P187; Maceda-Veiga A, 2009, J AQUAT ANIM HEALTH, V21, P189, DOI 10.1577/H08-054.1; Maceda-Veiga A, 2015, SCI TOTAL ENVIRON, V514, P322, DOI 10.1016/j.scitotenv.2015.02.004; Maceda-Veiga A, 2014, FRESHWATER BIOL, V59, P1145, DOI 10.1111/fwb.12336; Marcogliese DJ, 2011, TRENDS PARASITOL, V27, P123, DOI 10.1016/j.pt.2010.11.002; Marshall CT, 1998, CAN J FISH AQUAT SCI, V55, P1766, DOI 10.1139/cjfas-55-7-1766; MCDOWALL RM, 1990, NZ FRESHWATER FISHES; Olstad K., NOBANIS INVASIVE ALI; Omar WA, 2015, J TOXICOL-US, V2015, DOI 10.1155/2015/167319; Peig J, 2010, FUNCT ECOL, V24, P1323, DOI 10.1111/j.1365-2435.2010.01751.x; Peig J, 2009, OIKOS, V118, P1883, DOI 10.1111/j.1600-0706.2009.17643.x; Poulin R, 1999, ECOGRAPHY, V22, P246, DOI 10.1111/j.1600-0587.1999.tb00499.x; Poulin R, 2013, J EXP BIOL, V216, P18, DOI 10.1242/jeb.073353; R Core Team, 2013, R LANG ENV STAT COMP; Redon S, 2015, PEERJ, V3, DOI 10.7717/peerj.1073; Rowe DK, 1998, NEW ZEAL J MAR FRESH, V32, P21, DOI 10.1080/00288330.1998.9516803; Roznik EA, 2015, P ROY SOC B-BIOL SCI, V282, DOI 10.1098/rspb.2015.0694; Sanchez MI, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0161478; Sanchez MI, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005459; Santoro M, 2013, DIS AQUAT ORGAN, V105, P139, DOI 10.3354/dao02626; Seppanen E, 2009, J FISH BIOL, V74, P553, DOI 10.1111/j.1095-8649.2008.02144.x; Solomon NU, 2015, ANN RES REV BIOL, P5; Stevenson RD, 2006, INTEGR COMP BIOL, V46, P1169, DOI 10.1093/icb/icl052; TAYLOR EB, 1991, AQUACULTURE, V98, P185, DOI 10.1016/0044-8486(91)90383-I; Vinyoles D, 2010, J FISH BIOL, V77, P20, DOI 10.1111/j.1095-8649.2010.02653.x; Walsh C, PACKAGE HIER PART; Walsh ML, 2015, J WORLD AQUACULT SOC, V46, P61, DOI 10.1111/jwas.12171; Zamora L, 2009, CONCEPTOS TECNICAS E, P271	61	15	15	1	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2016	11	12							e0168992	10.1371/journal.pone.0168992	http://dx.doi.org/10.1371/journal.pone.0168992			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EG7JB	28030606	Green Published, Green Submitted, gold			2022-12-27	WOS:000391222000096
J	Urman, NM; Mirza, A; Atwood, SX; Whitson, RJ; Sarin, KY; Tang, JY; Oro, AE				Urman, Nicole M.; Mirza, Amar; Atwood, Scott X.; Whitson, Ramon J.; Sarin, Kavita Y.; Tang, Jean Y.; Oro, Anthony E.			Tumor-Derived Suppressor of Fused Mutations Reveal Hedgehog Pathway Interactions	PLOS ONE			English	Article							BASAL-CELL CARCINOMA	The Hedgehog pathway is a potent regulator of cellular growth and plays a central role in the development of many cancers including basal cell carcinoma (BCC). The majority of BCCs arise from mutations in the Patched receptor resulting in constitutive activation of the Hedgehog pathway. Secondary driver mutations promote BCC oncogenesis and occur frequently due to the high mutational burden resulting from sun exposure of the skin. Here, we uncover novel secondary mutations in Suppressor of Fused (SUFU), the major negative regulator of the Hedgehog pathway. SUFU normally binds to a Hedgehog transcriptional activator, GLI1, in order to prevent it from initiating transcription of Hedgehog target genes. We sequenced tumor-normal pairs from patients with early sporadic BCCs. This resulted in the discovery of nine mutations in SUFU, which were functionally investigated to determine whether they help drive BCC formation. Our results show that four of the SUFU mutations inappropriately activate the Hedgehog pathway, suggesting they may act as driver mutations for BCC development. Indeed, all four of the loss of function SUFU variants were found to disrupt its binding to GLI, leading to constitutive pathway activation. Our results from functional characterization of these mutations shed light on SUFU's role in Hedgehog signaling, tumor progression, and highlight a way in which BCCs can arise.	[Urman, Nicole M.; Mirza, Amar; Atwood, Scott X.; Whitson, Ramon J.; Sarin, Kavita Y.; Tang, Jean Y.; Oro, Anthony E.] Stanford Univ, Sch Med, Program Epithelial Biol, Stanford, CA 94305 USA; [Urman, Nicole M.; Mirza, Amar; Atwood, Scott X.; Whitson, Ramon J.; Sarin, Kavita Y.; Tang, Jean Y.; Oro, Anthony E.] Stanford Univ, Sch Med, Dept Dermatol, Stanford, CA 94305 USA; [Atwood, Scott X.] Univ Calif Irvine, Dept Dev & Cell Biol, Chao Family Comprehens Canc Ctr, Irvine, CA 92717 USA	Stanford University; Stanford University; University of California System; University of California Irvine	Oro, AE (corresponding author), Stanford Univ, Sch Med, Program Epithelial Biol, Stanford, CA 94305 USA.; Oro, AE (corresponding author), Stanford Univ, Sch Med, Dept Dermatol, Stanford, CA 94305 USA.	oro@stanford.edu		Tang, Jean/0000-0002-5510-6502; Atwood, Scott/0000-0001-7407-9792; Oro, Anthony/0000-0002-6261-138X; Sarin, Kavita/0000-0001-5363-3053	Stanford University Undergraduate Advising and Research Major Grant; Stanford Bio-X Undergraduate Summer Research Grant award; V Foundation Translational Award; NIAMS [5AR054780, 2AR046786, 5ARO54780]; NIH [5R00CA176847]; Damon Runyon Clinical Investigator Award; Stanford Cancer Institute Grant; Dermatology Foundation Career Development Award; NATIONAL CANCER INSTITUTE [R00CA176847] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR054780, R01AR046786] Funding Source: NIH RePORTER	Stanford University Undergraduate Advising and Research Major Grant; Stanford Bio-X Undergraduate Summer Research Grant award; V Foundation Translational Award; NIAMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Damon Runyon Clinical Investigator Award; Stanford Cancer Institute Grant; Dermatology Foundation Career Development Award; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was funded by the Stanford University Undergraduate Advising and Research Major Grant (Nicole Urman), the Stanford Bio-X Undergraduate Summer Research Grant award (Nicole Urman), the V Foundation Translational Award and the NIAMS 5AR054780, 2AR046786 (Anthony Oro), the NIH Pathway to Independence Award 5R00CA176847 (Scott Atwood), the Damon Runyon Clinical Investigator Award (Jean Tang), the Stanford Cancer Institute Grant, and by the Dermatology Foundation Career Development Award (Kavita Sarin). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.r The authors would like to thank all the members of the A.E.O. lab and the Stanford Dermatology Department for their guidance. This work was funded by the Stanford University Undergraduate Advising and Research Major Grant (Nicole Urman), the Stanford Bio-X Undergraduate Summer Research Grant award (Nicole Urman), the V Foundation Translational Award and the NIAMS 5ARO54780, 2AR046786 (Anthony Oro), the NIH Pathway to Independence Award 5R00CA176847 (Scott Atwood), the Damon Runyon Clinical Investigator Award (Jean Tang), the Stanford Cancer Institute Grant, and by the Dermatology Foundation Career Development Award (Kavita Sarin).	Aavikko M, 2012, AM J HUM GENET, V91, P520, DOI 10.1016/j.ajhg.2012.07.015; Atwood SX, 2015, J INVEST DERMATOL, V135, P2138, DOI 10.1038/jid.2015.115; Atwood SX, 2015, CANCER CELL, V27, P342, DOI 10.1016/j.ccell.2015.02.002; Bonilla X, 2016, NAT GENET, V48, P398, DOI 10.1038/ng.3525; Cheng SY, 2002, P NATL ACAD SCI USA, V99, P5442, DOI 10.1073/pnas.082096999; Cherry AL, 2013, ACTA CRYSTALLOGR D, V69, P2563, DOI 10.1107/S0907444913028473; Dunaeva M, 2003, J BIOL CHEM, V278, P5116, DOI 10.1074/jbc.M209492200; Forbes SA, 2015, NUCLEIC ACIDS RES, V43, pD805, DOI 10.1093/nar/gku1075; Kogerman P, 1999, NAT CELL BIOL, V1, P312, DOI 10.1038/13031; Merchant M, 2004, MOL CELL BIOL, V24, P8627, DOI 10.1128/MCB.24.19.8627-8641.2004; Ng JMY, 2011, NAT REV CANCER, V11, P493, DOI 10.1038/nrc3079; So PL, 2006, EXP DERMATOL, V15, P742, DOI 10.1111/j.1600-0625.2006.00465.x; Svard J, 2006, DEV CELL, V10, P187, DOI 10.1016/j.devcel.2005.12.013; Zhang Y, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3608	14	10	11	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2016	11	12							0168031	10.1371/journal.pone.0168031	http://dx.doi.org/10.1371/journal.pone.0168031			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EG7JB	28030567	Green Published, gold			2022-12-27	WOS:000391222000030
J	Zirbel, SA; Tolman, KA; Trease, BP; Howell, LL				Zirbel, Shannon A.; Tolman, Kyler A.; Trease, Brian P.; Howell, Larry L.			Bistable Mechanisms for Space Applications	PLOS ONE			English	Article							BULK METALLIC-GLASS; COMPLIANT MECHANISMS; DESIGN; COMPOSITES; MICROMECHANISMS; OPTIMIZATION; BISTABILITY; FREEDOM	Compliant bistable mechanisms are monolithic devices with two stable equilibrium positions separated by an unstable equilibrium position. They show promise in space applications as nonexplosive release mechanisms in deployment systems, thereby eliminating friction and improving the reliability and precision of those mechanical devices. This paper presents both analytical and numerical models that are used to predict bistable behavior and can be used to create bistable mechanisms in materials not previously feasible for compliant mechanisms. Materials compatible with space applications are evaluated for use as bistable mechanisms and prototypes are fabricated in three different materials. Pin -puller and cutter release mechanisms are proposed as potential space applications.	[Zirbel, Shannon A.] Aerosp Corp, Vehicle Syst Div, El Segundo, CA 90245 USA; [Trease, Brian P.] Univ Toledo, Dept Mech Ind & Mfg Engn, 2801 W Bancroft St, Toledo, OH 43606 USA; [Tolman, Kyler A.; Howell, Larry L.] Brigham Young Univ, Dept Mech Engn, Provo, UT 84602 USA	Aerospace Corporation - USA; University System of Ohio; University of Toledo; Brigham Young University	Howell, LL (corresponding author), Brigham Young Univ, Dept Mech Engn, Provo, UT 84602 USA.	lhowell@byu.edu	Howell, Larry L/A-6828-2008	Howell, Larry L/0000-0001-8132-8822	NASA Office of the Chief Technologist's Space Technology Research Fellowship	NASA Office of the Chief Technologist's Space Technology Research Fellowship	This work was supported by a NASA Office of the Chief Technologist's Space Technology Research Fellowship. A portion of this work was carried out at the NASA Jet Propulsion Laboratory in Pasadena, California.	Betts DN, 2012, AIAA J, V50, P2211, DOI 10.2514/1.J051535; Chen GM, 2015, J MECH DESIGN, V137, DOI 10.1115/1.4029024; Chen GM, 2011, J MECH DESIGN, V133, DOI 10.1115/1.4004543; Chen GM, 2010, J MECH ROBOT, V2, DOI 10.1115/1.4000529; Conley P, 1998, SPACE VEHICLE MECH E; Daynes S, 2010, J AIRCRAFT, V47, P334, DOI 10.2514/1.45389; Demetriou MD, 2011, NAT MATER, V10, P123, DOI [10.1038/nmat2930, 10.1038/NMAT2930]; Demetriou MD, 2010, JOM-US, V62, P83, DOI 10.1007/s11837-010-0038-2; Emam SA, 2015, APPL MECH REV, V67, DOI 10.1115/1.4032037; Follador M, 2014, APPL PHYS LETT, V105, DOI 10.1063/1.4898142; Follador M, 2015, MECCANICA, V50, P2741, DOI 10.1007/s11012-015-0212-2; Fowler RM, 2011, MECH SCI, V2, P205, DOI 10.5194/ms-2-205-2011; Fowler RM, 2014, MECH MACH THEORY, V82, P203, DOI 10.1016/j.mechmachtheory.2014.08.008; Hofmann DC, 2008, NATURE, V451, P1085, DOI 10.1038/nature06598; Hofmann DC, 2010, SCIENCE, V329, P1294, DOI 10.1126/science.1193522; Homer ER, 2014, ADV ENG MATER, V16, P850, DOI 10.1002/adem.201300566; Howell LL, 2001, 21 CENTURY KINEMATIC; Huang HW, 2013, J MICROELECTROMECH S, V22, P7, DOI 10.1109/JMEMS.2012.2228165; Jensen BD, 1999, J MECH DESIGN, V121, P416, DOI 10.1115/1.2829477; Kim HA, 2010, AIAA J, V48, P1265, DOI 10.2514/1.J050100; Kim SW, 2014, BIOINSPIR BIOMIM, V9, DOI 10.1088/1748-3182/9/3/036004; Launey ME, 2009, P NATL ACAD SCI USA, V106, P4986, DOI 10.1073/pnas.0900740106; Lewis S, 2006, P 38 AER MECH S; Lewis SD, 2009, P 13 EUR SPAC MECH T; Lichter MD, 2001, LECT NOTES CONTR INF, V271, P219; Lusk CP, 2008, J MECH DESIGN, V130, DOI 10.1115/1.2885079; Mallikarachchi H, 2014, J SPACECRAFT ROCKETS, P1; Ohsaki M, 2013, ENG STRUCT, V56, P910, DOI 10.1016/j.engstruct.2013.06.019; Pirrera A, 2012, INT J SOLIDS STRUCT, V49, P685, DOI 10.1016/j.ijsolstr.2011.11.011; Pollard LW, 1987, P 6 INT C APPL LAS E, V563, P109; Purdy WE, 1994, P 28 AER MECH S; Qiu J, 2004, J MICROELECTROMECH S, V13, P137, DOI 10.1109/JMEMS.2004.825308; Robinson A, 1995, P 29 AER MECH S; Safsten C, 2016, J APPL MECH-T ASME, V83, DOI 10.1115/1.4032572; Santer M, 2008, INT J SOLIDS STRUCT, V45, P6190, DOI 10.1016/j.ijsolstr.2008.07.014; Schioler T, 2007, AIAA J, V45, P1740, DOI 10.2514/1.16825; Silverberg JL, 2015, NAT MATER, V14, P389, DOI [10.1038/NMAT4232, 10.1038/nmat4232]; Tibbitts S., 1988, P 22 AER MECH S; Wilcox DL, 2005, J MICROELECTROMECH S, V14, P1223, DOI 10.1109/JMEMS.2005.859089; Wingert A, 2006, IEEE-ASME T MECH, V11, P448, DOI 10.1109/TMECH.2006.878542; Zhang Z, 2016, COMPOS STRUCT, V135, P17, DOI 10.1016/j.compstruct.2015.09.015; Zhou ML, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097086; Zirbel SA, 2013, J MECH DESIGN, V135, DOI 10.1115/1.4025372	43	47	52	5	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2016	11	12							e0168218	10.1371/journal.pone.0168218	http://dx.doi.org/10.1371/journal.pone.0168218			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EG7JB	28030588	Green Submitted, Green Published, gold			2022-12-27	WOS:000391222000040
J	Ameh, CA; Kerr, R; Madaj, B; Mdegela, M; Kana, T; Jones, S; Lambert, J; Dickinson, F; White, S; van den Broek, N				Ameh, Charles A.; Kerr, Robert; Madaj, Barbara; Mdegela, Mselenge; Kana, Terry; Jones, Susan; Lambert, Jaki; Dickinson, Fiona; White, Sarah; van den Broek, Nynke			Knowledge and Skills of Healthcare Providers in Sub-Saharan Africa and Asia before and after Competency -Based Training in Emergency Obstetric and Early Newborn Care	PLoS One			English	Article							COUNTRIES; BIRTH; QUALITY	Background Healthcare provider training in Emergency Obstetric and Newborn Care (EmOC&NC) is a component of 65% of intervention programs aimed at reducing maternal and newborn mortality and morbidity. It is important to evaluate the effectiveness of this. Methods We evaluated knowledge and skills among 5,939 healthcare providers before and after 3-5 days 'skills and drills' training in emergency obstetric and newborn care (EmOC&NC) conducted in 7 sub-Saharan Africa countries (Ghana, Kenya, Malawi, Nigeria, Sierra Leone, Tanzania, Zimbabwe) and 2 Asian countries (Bangladesh, Pakistan). Standardised assessments using multiple choice questions and objective structured clinical examination (OSCE) were used to measure change in knowledge and skills and the Improvement Ratio (IR) by cadre and by country. Linear regression was performed to identify variables associated with pre-training score and IR. Results 99.7% of healthcare providers improved their overall score with a median (IQR) increase of 10.0% (5.0%- 15.0%) for knowledge and 28.8% (23.1%-35.1%) for skill. There were significant improvements in knowledge and skills for each cadre of healthcare provider and for each country (p<0.05). The mean IR was 56% for doctors, 50% for mid-level staff and nurse-midwives and 38% for nursing-aides. A teaching job, previous in-service training, and higher percentage of work-time spent providing maternity care were each associated with a higher pre-training score. Those with more than 11 years of experience in obstetrics had the lowest scores prior to training, with mean IRs 1.4% lower than for those with no more than 2 years of experience. The largest IR was for recognition and management of obstetric haemorrhage (49-70%) and the smallest for recognition and management of obstructed labour and use of the partograph (6-15%). Conclusions Short in-service EmOC&NC training was associated with improved knowledge and skills for all cadres of healthcare providers working in maternity wards in both sub-Saharan Africa and Asia. Additional support and training is needed for use of the partograph as a tool to monitor progress in labour. Further research is needed to assess if this is translated into improved service delivery.	[Ameh, Charles A.; Kerr, Robert; Madaj, Barbara; Mdegela, Mselenge; Kana, Terry; Jones, Susan; Lambert, Jaki; Dickinson, Fiona; White, Sarah; van den Broek, Nynke] Univ Liverpool Liverpool Sch Trop Med, Ctr Maternal & Newborn Hlth, Liverpool, Merseyside, England	Liverpool School of Tropical Medicine	Madaj, B (corresponding author), Univ Liverpool Liverpool Sch Trop Med, Ctr Maternal & Newborn Hlth, Liverpool, Merseyside, England.	Barbara.Madaj@lstmed.ac.uk	Ameh, Charles Anawo/I-9872-2019; Kerr, Robbie/A-4009-2016	Ameh, Charles Anawo/0000-0002-2341-7605; Dickinson, Fiona/0000-0002-5298-9127; White, Sarah/0000-0001-5535-8075; Kerr, Robbie/0000-0003-2932-0895	'Making it Happen' (MiH) program - a DFID multi-country program [202945-101]; UNICEF grant [43144788]; National Institute for Health Research [ACF-2015-07-005] Funding Source: researchfish	'Making it Happen' (MiH) program - a DFID multi-country program; UNICEF grant; National Institute for Health Research(National Institute for Health Research (NIHR))	This research was conducted under the 'Making it Happen' (MiH) program - a DFID multi-country program (Contract number 202945-101) which aims to improve the availability and quality of emergency obstetric and newborn care at health facility level and a UNICEF grant for Sierra Leone (43144788).	Adegoke A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040220; Ameh C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049938; Childhealth Advocacy International (CAI), 2007, EV ESS EMCH TRAIN PA; Childhealth Advocacy International (CAI), 2010, EV ESS SURG SKILLS E; Ersdal HL, 2013, RESUSCITATION, V84, P1422, DOI 10.1016/j.resuscitation.2013.04.005; Evans CL, 2014, INT J GYNECOL OBSTET, V126, P286, DOI 10.1016/j.ijgo.2014.02.021; Fauveau V, 2006, INT J GYNECOL OBSTET, V94, P179, DOI 10.1016/j.ijgo.2006.05.020; Frank K, 2009, SAJOG-S AFR J OBSTET, V15, P94; Grady K, 2011, J OBSTET GYNAECOL, V31, P18, DOI 10.3109/01443615.2010.533218; Homaifar N, 2013, INT J GYNECOL OBSTET, V120, P195, DOI 10.1016/j.ijgo.2012.07.031; Khan KS, 2006, LANCET, V367, P1066, DOI 10.1016/S0140-6736(06)68397-9; Kirkpatrick D, 1996, TRAINING DEV, V50, P54; Kongnyuy EJ, 2009, BJOG-INT J OBSTET GY, V116, P41, DOI 10.1111/j.1471-0528.2009.02332.x; Kongnyuy EJ, 2009, MATERN CHILD HLTH J, V13, P687, DOI 10.1007/s10995-008-0380-y; Nelissen E, 2014, ACTA OBSTET GYN SCAN, V93, P287, DOI 10.1111/aogs.12321; Nyamtema AS, 2011, BMC PREGNANCY CHILDB, V11, DOI 10.1186/1471-2393-11-94; Pattinson RC, 2015, S AFR MED J, V105, P5; Penny S, 2000, HEALTH POLICY PLANN, V15, P386, DOI 10.1093/heapol/15.4.386; Utz B, 2013, ACTA OBSTET GYN SCAN, V92, P1063, DOI 10.1111/aogs.12166; van den Broek N., 2006, LIFE SAVING SKILLS M; van Lonkhuijzen L, 2010, BJOG-INT J OBSTET GY, V117, P777, DOI 10.1111/j.1471-0528.2010.02561.x; Vogel I, 2012, REV USE THEORY CHANG; WHO (World Health Organization), 2015, TRENDS MATERNAL MORT; World Health Organization (WHO), 2004, MAK PREGN SAF CRIT R; World Health Organization (WHO); UNFPA; UNICEF; Columbia University. Mailman School of Public Health, 2009, MON EM OBST CAR HDB	25	48	48	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2016	11	12							e0167270	10.1371/journal.pone.0167270	http://dx.doi.org/10.1371/journal.pone.0167270			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EI9QH	28005984	Green Submitted, Green Published, Green Accepted, gold			2022-12-27	WOS:000392843200011
J	Tran, BX; Hwang, JN; Nguyen, LH; Nguyen, AT; Latkin, NRK; Tran, NK; Thuc, VTM; Nguyen, HLT; Phan, HTT; Le, HT; Tran, TD; Latkin, CA				Bach Xuan Tran; Hwang, Jongnam; Long Hoang Nguyen; Anh Tuan Nguyen; Latkin, Noah Reed Knowlton; Ngoc Kim Tran; Vu Thi Minh Thuc; Huong Lan Thi Nguyen; Huong Thu Thi Phan; Huong Thi Le; Tho Dinh Tran; Latkin, Carl A.			Impact of Socioeconomic Inequality on Access, Adherence, and Outcomes of Antiretroviral Treatment Services for People Living with HIV/AIDS in Vietnam	PLOS ONE			English	Article							HEALTH-CARE; HIV; THERAPY; MORTALITY; DETERMINANTS; POPULATION; INITIATION; ADULTS; VIRUS	Background Ensuring an equal benefit across different patient groups is necessary while scaling up free-of-charge antiretroviral treatment (ART) services. This study aimed to measure the disparity in access, adherence, and outcomes of ART in Vietnam and the effects of socioeconomic status (SES) characteristics on the levels of inequality. Methods A cross-sectional study was conducted in 1133 PLWH in Vietnam. ART access, adherence, and treatment outcomes were self-reported using a structured questionnaire. Wealth-related inequality was calculated using a concentration index, and a decomposition analysis was used to determine the contribution of each SES variable to inequality in access, adherence, and outcomes of ART. Results Based on SES, minor inequality was found in ART access and adherence while there was considerable inequality in ART outcomes. Poor people were more likely to start treatment early, while rich people had better adherence and overall treatment outcomes. Decomposition revealed that occupation and education played important roles in inequality in ART access, adherence, and treatment outcomes Conclusion The findings suggested that health services should be integrated into the ART regimen. Furthermore, occupational orientation and training courses should be provided to reduce inequality in ART access, adherence, and treatment outcomes.	[Bach Xuan Tran; Huong Thi Le] Hanoi Med Univ, Inst Prevent Med & Publ Hlth, Hanoi, Vietnam; [Bach Xuan Tran; Latkin, Noah Reed Knowlton; Latkin, Carl A.] Johns Hopkins Bloomberg Sch Publ Hlth, Baltimore, MD 21205 USA; [Hwang, Jongnam] Daegu Univ, Dept Hlth Promot, Gyongsan, South Korea; [Long Hoang Nguyen] Vietnam Natl Univ, Sch Med & Pharm, Hanoi, Vietnam; [Anh Tuan Nguyen; Huong Lan Thi Nguyen] Duy Tan Univ, Inst Global Hlth Innovat, Da Nang, Vietnam; [Ngoc Kim Tran] Woolcock Med Res Inst, Hanoi, Vietnam; [Vu Thi Minh Thuc] Natl Otolaryngol Hosp, Dept Immunol & Allergy, Hanoi, Vietnam; [Huong Thu Thi Phan] Minist Hlth, Author HIV AIDS Control, Hanoi, Vietnam; [Tho Dinh Tran] Vietnam Germany Hosp, Dept Hepatobiliary Surg, Hanoi, Vietnam	Hanoi Medical University; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Daegu University; Vietnam National University Hanoi; Duy Tan University	Tran, BX (corresponding author), Hanoi Med Univ, Inst Prevent Med & Publ Hlth, Hanoi, Vietnam.; Tran, BX (corresponding author), Johns Hopkins Bloomberg Sch Publ Hlth, Baltimore, MD 21205 USA.	bach@hmu.edu.vn	Nguyen, Huy/GWQ-6433-2022; Nguyen, Huy/AAF-9560-2019; Hwang, Jongnam/GLQ-6437-2022	Nguyen, Huy/0000-0002-5896-9661; Hwang, Jongnam/0000-0001-7078-9244; Tran Kim, Ngoc/0000-0001-7521-5813				Alaba O, 2014, INT J ENV RES PUB HE, V11, P3387, DOI 10.3390/ijerph110303387; Duong AT, 2014, JAIDS-J ACQ IMM DEF, V65, pE1, DOI 10.1097/QAI.0b013e3182a17d15; Tran BX, 2015, BMC HEALTH SERV RES, V15, DOI 10.1186/s12913-014-0640-z; Tran BX, 2013, GLOBAL HEALTH ACTION, V6, DOI 10.3402/gha.v6i0.20690; Tran BX, 2013, GLOBAL HEALTH ACTION, V6, P1, DOI [10.3402/gha.v6i0.19570, 10.3402/gha.v6i0.18619]; Tran BX, 2012, HEALTH QUAL LIFE OUT, V10, DOI 10.1186/1477-7525-10-132; Tran BX, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041062; Tran BX, 2011, AIDS CARE, V23, P1236, DOI 10.1080/09540121.2011.555749; Beral V, 2004, AIDS, V18, P51, DOI [10.1097/00002030-200401020-00006, 10.1097/01.aids.0000096908.73209.5d]; Braveman PA, 2010, AM J PUBLIC HEALTH, V100, pS186, DOI 10.2105/AJPH.2009.166082; Castelnuovo B, 2009, CLIN INFECT DIS, V49, P965, DOI 10.1086/605500; Control VAoHA, 2016, ANN REV HIV AIDS CON; Tran DA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051289; Dray-Spira R, 2003, AIDS, V17, P283, DOI 10.1097/00002030-200302140-00001; Duc Duong Bui, 2011, ADAPTING TREATMENT 2; Egger M, 2002, LANCET, V360, P119, DOI 10.1016/S0140-6736(02)09411-4; Entezarmahdi R, 2014, INT J PREVENTIVE MED, V5, P414; equity PfH, 2011, HLTH EQ VIETN TARG E; Giordano TP, 2004, HIV CLIN TRIALS, V5, P74, DOI 10.1310/JFXH-G3X2-EYM6-D6UG; Girardi E, 2004, JAIDS-J ACQ IMM DEF, V36, P951, DOI 10.1097/00126334-200408010-00009; Go Vietnam, 2012, VIETN AIDS RESP PROG; Group E, 2011, EQ 5D 5L USER GUIDE; Health VMo Group HP, 2013, JOINT ANN HLTH REV 2; IDF (International Diabetes Federation), 2021, CONSOLIDATED GUIDELI, V10th ed.; Jain MK, 2009, CLIN INFECT DIS, V48, P1772, DOI 10.1086/599111; Joint United Nations Programme on HIV/ AIDS (UNAIDS), 2016, GLOB AIDS UPD 2016; Kobin AB, 2011, ANN PHARMACOTHER, V45, P372, DOI 10.1345/aph.1P587; Lim T, 2013, J INT AIDS SOC, V16, DOI 10.7448/IAS.16.3.18637; Lim TW, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090723; Lodi S, 2014, AIDS, V28, P2297, DOI 10.1097/QAD.0000000000000410; May M, 2011, IMPACT LATE DIAGNOSI; Mitchell CG, 2004, SOC WORK, V49, P469, DOI 10.1093/sw/49.3.469; Montarroyos UR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084276; National Committee for AIDS DaPPaC, 2012, NAT STRAT HIV AIDS P; Olaleye A, 2013, AJAR-AFR J AIDS RES, V12, P85, DOI 10.2989/16085906.2013.851718; Posse M, 2008, TROP MED INT HEALTH, V13, P904, DOI 10.1111/j.1365-3156.2008.02091.x; Rougemont Mathieu, 2009, AIDS Res Ther, V6, P21, DOI 10.1186/1742-6405-6-21; Saez-Cirion A, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003211; Schmitt JK, 2004, SOUTH MED J, V97, P329, DOI 10.1097/01.SMJ.0000118132.01508.F0; Scott VE, 2005, SAMJ S AFR MED J, V95, P109; Sobrino-Vegas P, 2012, ANTIVIR THER, V17, P1, DOI 10.3851/IMP1939; Sozmen K, 2014, IRAN J PUBLIC HEALTH, V43, P736; Suthar AB, 2014, AIDS, V28, pS175, DOI 10.1097/QAD.0000000000000259; Tran BX, 2013, TROP MED INT HEALTH, V18, P212, DOI 10.1111/tmi.12032; Turner BJ, 2002, J INFECT DIS, V185, pS143, DOI 10.1086/340197; VAAC VAoHAC, 2014, REP CURR SIT HIV INF; Vu VT, 2011, AIDS CARE, V23, P139, DOI 10.1080/09540121.2010.507741; WAGSTAFF A, 1991, SOC SCI MED, V33, P545, DOI 10.1016/0277-9536(91)90212-U; World Health Organization, 2015, GUID START ANT THER; World Health Organization, 2011, TREATM 2 0 CAT NEXT; Zwahlen M, 2009, INT J EPIDEMIOL, V38, P1624, DOI 10.1093/ije/dyp306	51	22	22	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2016	11	12							e0168687	10.1371/journal.pone.0168687	http://dx.doi.org/10.1371/journal.pone.0168687			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EI9QH	28005937	Green Submitted, gold, Green Published			2022-12-27	WOS:000392843200081
J	Chen, DY; Chen, YM; Chien, HJ; Lin, CC; Hsieh, CW; Chen, HH; Hung, WT; Lai, CC				Chen, Der-Yuan; Chen, Yi-Ming; Chien, Han-Ju; Lin, Chi-Chen; Hsieh, Chia-Wei; Chen, Hsin-Hua; Hung, Wei-Ting; Lai, Chien-Chen			Metabolic Disturbances in Adult-Onset Still's Disease Evaluated Using Liquid Chromatography/Mass Spectrometry-Based Metabolomic Analysis	PLOS ONE			English	Article							RHEUMATIC-DISEASES; CYTOKINE PROFILES; PERIPHERAL-BLOOD; ASSOCIATION; MS; MANIFESTATIONS; INTERLEUKIN-18; INFLAMMATION; METHODOLOGY; ACTIVATION	Objective Liquid chromatography/mass spectrometry (LC/MS)-based comprehensive analysis of metabolic profiles with metabolomics approach has potential diagnostic and predictive implications. However, no metabolomics data have been reported in adult-onset Still's disease (AOSD). This study investigated the metabolomic profiles in AOSD patients and examined their association with clinical characteristics and disease outcome. Methods Serum metabolite profiles were determined on 32 AOSD patients and 30 healthy controls (HC) using ultra-performance liquid chromatography (UPLC)/MS analysis, and the differentially expressed metabolites were quantified using multiple reactions monitoring (MRM)/MS analysis in 44 patients and 42 HC. Pure standards were utilized to confirm the presence of the differentially expressed metabolites. Results Eighteen differentially expressed metabolites were identified in AOSD patents using LC/MS-based analysis, of which 13 metabolites were validated by MRM/MS analysis. Among them, serum levels of lysoPC(18: 2), urocanic acid and indole were significantly lower, and L-phenylalanine levels were significantly higher in AOSD patients compared with HC. Moreover, serum levels of lysoPC(18: 2), PhePhe, uridine, taurine, L-threonine, and (R)-3-Hydroxy-hexadecanoic acid were significantly correlated with disease activity scores (all p<0.05) in AOSD patients. A different clustering of metabolites was associated with a different disease outcome, with significantly lower levels of isovalerylsarcosine observed in patients with chronic articular pattern (median, 77.0AU/ml) compared with monocyclic (341.5AU/ml, p<0.01) or polycyclic systemic pattern (168.0AU/ml, p<0.05). Conclusion Thirteen differentially expressed metabolites identified and validated in AOSD patients were shown to be involved in five metabolic pathways. Significant associations of metabolic profiles with disease activity and outcome of AOSD suggest their involvement in AOSD pathogenesis.	[Chen, Der-Yuan; Chen, Yi-Ming; Chen, Hsin-Hua; Hung, Wei-Ting] Natl Yang Ming Univ, Fac Med, Taipei, Taiwan; [Chen, Der-Yuan; Chen, Yi-Ming; Hsieh, Chia-Wei; Chen, Hsin-Hua; Hung, Wei-Ting] Taichung Vet Gen Hosp, Div Allergy Immunol & Rheumatol, Taichung, Taiwan; [Chen, Der-Yuan; Chen, Yi-Ming; Lin, Chi-Chen; Hsieh, Chia-Wei; Chen, Hsin-Hua; Lai, Chien-Chen] Natl Chung Hsing Univ, PhD Program Translat Med, Taichung, Taiwan; [Chen, Der-Yuan; Chen, Yi-Ming; Lin, Chi-Chen; Hsieh, Chia-Wei; Chen, Hsin-Hua; Lai, Chien-Chen] Natl Chung Hsing Univ, Rong Hsing Res Ctr Translat Med, Taichung, Taiwan; [Chen, Der-Yuan] Chung Shan Med Univ, Inst Biochem Microbiol & Immunol, Taichung, Taiwan; [Chien, Han-Ju; Lai, Chien-Chen] Natl Chung Hsing Univ, Inst Mol Biol, Taichung, Taiwan	National Yang Ming Chiao Tung University; Taichung Veterans General Hospital; National Chung Hsing University; National Chung Hsing University; Chung Shan Medical University; National Chung Hsing University	Lai, CC (corresponding author), Natl Chung Hsing Univ, PhD Program Translat Med, Taichung, Taiwan.; Lai, CC (corresponding author), Natl Chung Hsing Univ, Rong Hsing Res Ctr Translat Med, Taichung, Taiwan.; Lai, CC (corresponding author), Natl Chung Hsing Univ, Inst Mol Biol, Taichung, Taiwan.	lailai@dragon.nchu.edu.tw	/AGZ-4617-2022; Chen, Yi-Ming/AAV-3806-2021	/0000-0002-7133-8266; Chen, Yi-Ming/0000-0001-7593-3065; Lin, Chi-Chien/0000-0002-1464-0231	Taichung Veterans General Hospital and National Chung Hsing University [TCVGH-NCHU1037601, TCVGH-NCHU1057601]	Taichung Veterans General Hospital and National Chung Hsing University	This work was supported by a grant from Taichung Veterans General Hospital and National Chung Hsing University (TCVGH-NCHU1037601 and TCVGH-NCHU1057601). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by a grant from Taichung Veterans General Hospital and National Chung Hsing University (TCVGH-NCHU1037601 and TCVGH-NCHU1057601). The authors thank the Biostatistics Task Force of Taichung Veterans General Hospital, Taichung, Taiwan.	Blanchet L, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-254; Chen DY, 2007, ARTHRIT RHEUM-ARTHR, V57, P1530, DOI 10.1002/art.23088; Chen DY, 2012, BMC MED, V10, DOI 10.1186/1741-7015-10-84; Chen DY, 2009, J RHEUMATOL, V36, P2284, DOI 10.3899/jrheum.090316; Chen DY, 2004, ANN RHEUM DIS, V63, P1300, DOI 10.1136/ard.2003.013680; Choi JH, 2003, J RHEUMATOL, V30, P2422; CUSH JJ, 1987, ARTHRITIS RHEUM, V30, P186, DOI 10.1002/art.1780300209; Fujii T, 2001, RHEUMATOLOGY, V40, P1398, DOI 10.1093/rheumatology/40.12.1398; Gao P, 2008, ANALYST, V133, P1214, DOI 10.1039/b807369d; Garcia-Simon M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0140993; Gerfaud-Valentin M, 2014, MEDICINE, V93, P91, DOI 10.1097/MD.0000000000000021; Jiang M, 2013, J PROTEOME RES, V12, P3769, DOI 10.1021/pr400415a; Kadavath S, 2015, ANN MED, V47, P6, DOI 10.3109/07853890.2014.971052; Kammeyer Arthur, 2012, ISRN Inflamm, V2012, P898153, DOI 10.5402/2012/898153; Kapoor SR, 2013, ARTHRITIS RHEUM-US, V65, P1448, DOI 10.1002/art.37921; Madsen RK, 2011, ARTHRITIS RES THER, V13, DOI 10.1186/ar3243; Manzi S, 2000, ANN RHEUM DIS, V59, P321, DOI 10.1136/ard.59.5.321; Mavragani Clio P, 2012, Int J Inflam, V2012, P879020, DOI 10.1155/2012/879020; Neurauter G, 2008, CURR DRUG METAB, V9, P622, DOI 10.2174/138920008785821738; Nordstrom A, 2006, ANAL CHEM, V78, P3289, DOI 10.1021/ac060245f; Nossent HC, 2006, SCAND J RHEUMATOL, V35, P48, DOI 10.1080/03009740510026616; Pearson H, 2007, NATURE, V446, P8, DOI 10.1038/446008a; Poulopoulou C, 2008, ARTHRITIS RHEUM, V58, P1445, DOI 10.1002/art.23446; Priori R, 2013, AUTOIMMUN REV, V12, P1022, DOI 10.1016/j.autrev.2013.04.002; Qi Y, 2014, MOL BIOSYST, V10, P2617, DOI 10.1039/c4mb00131a; Rau M, 2010, J RHEUMATOL, V37, P2369, DOI 10.3899/jrheum.100247; Rojo D, 2015, SCI REP-UK, V5, DOI 10.1038/srep08310; Romick-Rosendale LE, 2011, ARTHRITIS RES THER, V13, DOI 10.1186/ar3530; Rosario C, 2013, BMC MED, V11, DOI 10.1186/1741-7015-11-185; Scrivo R, 2014, CURR ALLERGY ASTHM R, V14, DOI 10.1007/s11882-014-0445-5; Semerano L, 2015, ANN RHEUM DIS, V74, P1325, DOI 10.1136/annrheumdis-2014-206618; Shimizu K, 1981, Nihon Seikeigeka Gakkai Zasshi, V55, P755; Sugiura T, 2002, GENES IMMUN, V3, P394, DOI 10.1038/sj.gene.6363922; Sun JC, 2012, J CHROMATOGR B, V893, P107, DOI 10.1016/j.jchromb.2012.02.042; Theodoridis G, 2008, TRAC-TREND ANAL CHEM, V27, P251, DOI 10.1016/j.trac.2008.01.008; Vance JE, 2008, J LIPID RES, V49, P1377, DOI 10.1194/jlr.R700020-JLR200; Watanabe H, 2013, KIDNEY INT, V83, P582, DOI 10.1038/ki.2012.448; WOUTERS JMGW, 1988, ANN RHEUM DIS, V47, P764, DOI 10.1136/ard.47.9.764; Wu TF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037210; YAMAGUCHI M, 1992, J RHEUMATOL, V19, P424; Young SP, 2013, ARTHRITIS RHEUM-US, V65, P2015, DOI 10.1002/art.38021	41	8	9	2	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2016	11	12							e0168147	10.1371/journal.pone.0168147	http://dx.doi.org/10.1371/journal.pone.0168147			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI9QH	28005947	Green Published, gold, Green Submitted			2022-12-27	WOS:000392843200031
J	Dammers, C; Yolcu, D; Kukuk, L; Willbold, D; Pickhardt, M; Mandelkow, E; Horn, AHC; Sticht, H; Malhis, MN; Will, N; Schuster, J; Funke, SA				Dammers, Christina; Yolcu, Deniz; Kukuk, Laura; Willbold, Dieter; Pickhardt, Marcus; Mandelkow, Eckhard; Horn, Anselm H. C.; Sticht, Heinrich; Malhis, Marwa Nidal; Will, Nadja; Schuster, Judith; Funke, Susanne Aileen			Selection and Characterization of Tau Binding D-Enantiomeric Peptides with Potential for Therapy of Alzheimer Disease	PLOS ONE			English	Article							PAIRED HELICAL FILAMENTS; IMAGE PHAGE DISPLAY; IN-VITRO; TRANSGENIC MICE; BETA-STRUCTURE; AGGREGATION INHIBITORS; FIBRIL FORMATION; AMYLOID PEPTIDE; PROTEIN-TAU; SEQUENCE	A variety of neurodegenerative disorders, including Alzheimer disease (AD), are associated with neurofibrillary tangles composed of the tau protein, as well as toxic tau oligomers. Inhibitors of pathological tau aggregation, interrupting tau self-assembly, might be useful for the development of therapeutics. Employing mirror image phage display with a large peptide library (over 109 different peptides), we have identified tau fibril binding peptides consisting of D-enantiomeric amino acids. D-enantiomeric peptides are extremely protease stable and not or less immunogenic than L-peptides, and the suitability of D-peptides for in vivo applications have already been demonstrated. Phage display selections were performed using fibrils of the D-enantiomeric hexapeptide VQIVYK, representing residues 306 to 311 of the tau protein, as a target. VQIVYK has been demonstrated to be important for fibril formation of the full lengths protein and forms fibrils by itself. Here, we report on D-enantiomeric peptides, which bind to VQIVYK, tau isoforms like tau3RD (K19) as well as to full lengths tau fibrils, and modulate the aggregation of the respective tau form. The peptides are able to penetrate cells and might be interesting for therapeutic and diagnostic applications in AD research.	[Dammers, Christina; Yolcu, Deniz; Kukuk, Laura; Willbold, Dieter] Forschungszentrum Julich, ICS 6, Julich, Germany; [Willbold, Dieter] Heinrich Heine Univ, Inst Phys Biol, Dusseldorf, Germany; [Pickhardt, Marcus; Mandelkow, Eckhard] DZNE, Bonn, Germany; [Pickhardt, Marcus; Mandelkow, Eckhard] CAESAR Res Ctr, Bonn, Germany; [Mandelkow, Eckhard] Max Planck Inst Metab Res, Cologne, Germany; [Horn, Anselm H. C.; Sticht, Heinrich] Friedrich Alexander Univ Erlangen Nurnberg, Inst Biochem, Erlangen, Germany; [Malhis, Marwa Nidal; Will, Nadja; Schuster, Judith; Funke, Susanne Aileen] Hsch Angew Wissensch, Bioanalyt, Coburg, Germany	Helmholtz Association; Research Center Julich; Heinrich Heine University Dusseldorf; Helmholtz Association; German Center for Neurodegenerative Diseases (DZNE); Center of Advanced European Studies & Research (CAESAR); University of Erlangen Nuremberg	Funke, SA (corresponding author), Hsch Angew Wissensch, Bioanalyt, Coburg, Germany.	aileen.funke@hs-coburg.de	Willbold, Dieter/A-6280-2013	Willbold, Dieter/0000-0002-0065-7366; Sticht, Heinrich/0000-0001-5644-045X; Horn, Anselm/0000-0003-3539-8103	DZNE; MPG; Welcome Trust; Emerging Fields Initiative from the Friedrich-Alexander-Universitat Erlangen-Nurnberg (FAU); grant of Deutsche Hirnliga e.V.; TechnologieAllianzOberfranken - TAO; TAO; grant of "Landeskonferenz der Frauenbeauftragten an bayrischen HAW"	DZNE(Helmholtz Association); MPG(Max Planck Society); Welcome Trust(Wellcome Trust); Emerging Fields Initiative from the Friedrich-Alexander-Universitat Erlangen-Nurnberg (FAU); grant of Deutsche Hirnliga e.V.; TechnologieAllianzOberfranken - TAO; TAO; grant of "Landeskonferenz der Frauenbeauftragten an bayrischen HAW"	MP and EM were supported in part by DZNE, MPG, and Welcome Trust. AHCH and HS acknowledge support by the Emerging Fields Initiative from the Friedrich-Alexander-Universitat Erlangen-Nurnberg (FAU). SAF was supported by a grant of Deutsche Hirnliga e.V. and by TechnologieAllianzOberfranken - TAO. JS was fully supported by TAO. MNM was supported by a grant of "Landeskonferenz der Frauenbeauftragten an bayrischen HAW", and TAO.	Adessi C, 2002, CURR MED CHEM, V9, P963, DOI 10.2174/0929867024606731; Alzheimer A, 1995, Clin Anat, V8, P429; Ballatore C, 2007, NAT REV NEUROSCI, V8, P663, DOI 10.1038/nrn2194; Barghorn S, 2004, BIOCHEMISTRY-US, V43, P1694, DOI 10.1021/bi0357006; Bartnik D, 2010, REJUV RES, V13, P202, DOI 10.1089/rej.2009.0924; Blennow K, 2006, LANCET, V368, P387, DOI 10.1016/S0140-6736(06)69113-7; BRAAK H, 1991, ACTA NEUROPATHOL, V82, P239, DOI 10.1007/BF00308809; Bulic B, 2013, J MED CHEM, V56, P4135, DOI 10.1021/jm3017317; Caplan MR, 2002, BIOMATERIALS, V23, P219, DOI 10.1016/S0142-9612(01)00099-0; Chalifour RJ, 2003, J BIOL CHEM, V278, P34874, DOI 10.1074/jbc.M212694200; Danho W, 2009, ADV EXP MED BIOL, V611, P467, DOI 10.1007/978-0-387-73657-0_201; de la Paz ML, 2002, P NATL ACAD SCI USA, V99, P16052, DOI 10.1073/pnas.252340199; DEROSSI D, 1994, J BIOL CHEM, V269, P10444; Fauchere J.L., 1992, ADV DRUG RES, V23, P127; Frederix PWJM, 2015, NAT CHEM, V7, P30, DOI [10.1038/NCHEM.2122, 10.1038/nchem.2122]; Frenkel-Pinter M, 2016, J ALZHEIMERS DIS, V51, P165, DOI 10.3233/JAD-150927; Friedhoff P, 1998, P NATL ACAD SCI USA, V95, P15712, DOI 10.1073/pnas.95.26.15712; Friedhoff P, 1998, BIOCHEMISTRY-US, V37, P10223, DOI 10.1021/bi980537d; Funke SA, 2012, CURR PHARM DESIGN, V18, P755; Funke SA, 2010, ACS CHEM NEUROSCI, V1, P639, DOI 10.1021/cn100057j; Futaki S, 2005, ADV DRUG DELIVER REV, V57, P547, DOI 10.1016/j.addr.2004.10.009; Godyn J, 2016, PHARMACOL REP, V68, P127, DOI 10.1016/j.pharep.2015.07.006; GOEDERT M, 1989, NEURON, V3, P519, DOI 10.1016/0896-6273(89)90210-9; Gotz J, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00072; Goux WJ, 2004, J BIOL CHEM, V279, P26868, DOI 10.1074/jbc.M402379200; Gump JM, 2007, TRENDS MOL MED, V13, P443, DOI 10.1016/j.molmed.2007.08.002; Guo JL, 2011, J BIOL CHEM, V286, P15317, DOI 10.1074/jbc.M110.209296; Haas C, 2012, J ALZHEIMERS DIS, V28, P241, DOI 10.3233/JAD-2011-110986; Holmes BB, 2014, J BIOL CHEM, V289, P19855, DOI 10.1074/jbc.R114.549295; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Khlistunova I, 2006, J BIOL CHEM, V281, P1205, DOI 10.1074/jbc.M507753200; Khurana R, 2005, J STRUCT BIOL, V151, P229, DOI 10.1016/j.jsb.2005.06.006; Lien S, 2003, TRENDS BIOTECHNOL, V21, P556, DOI 10.1016/j.tibtech.2003.10.005; Margittai M, 2004, P NATL ACAD SCI USA, V101, P10278, DOI 10.1073/pnas.0401911101; Matsuoka Y, 2008, J PHARMACOL EXP THER, V325, P146, DOI 10.1124/jpet.107.130526; Mohamed T, 2013, ACS CHEM NEUROSCI, V4, P1559, DOI 10.1021/cn400151a; Morimoto BH, 2013, DEMENT GERIATR COGN, V35, P325, DOI 10.1159/000348347; Nisbet RM, 2015, ACTA NEUROPATHOL, V129, P207, DOI 10.1007/s00401-014-1371-2; Pappenheimer JR, 1997, J PHARMACOL EXP THER, V280, P292; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Pickhardt M, 2005, J BIOL CHEM, V280, P3628, DOI 10.1074/jbc.M410984200; Roberson ED, 2006, SCIENCE, V314, P781, DOI 10.1126/science.1132813; Rudolph S, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0147470; Sadowski M, 2004, AM J PATHOL, V165, P937, DOI 10.1016/S0002-9440(10)63355-X; Sawaya MR, 2007, NATURE, V447, P453, DOI 10.1038/nature05695; Schumacher TNM, 1996, SCIENCE, V271, P1854, DOI 10.1126/science.271.5257.1854; Shiryaev N, 2009, NEUROBIOL DIS, V34, P381, DOI 10.1016/j.nbd.2009.02.011; Sievers SA, 2011, NATURE, V475, P96, DOI 10.1038/nature10154; Soto C, 1998, NAT MED, V4, P822, DOI 10.1038/nm0798-822; Streets AM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054541; van Groen T, 2013, J ALZHEIMERS DIS, V34, P609, DOI 10.3233/JAD-121792; van Groen T, 2008, CHEMMEDCHEM, V3, P1848, DOI 10.1002/cmdc.200800273; van Groen T, 2009, CHEMMEDCHEM, V4, P276, DOI 10.1002/cmdc.200800289; von Bergen M, 2001, J BIOL CHEM, V276, P48165, DOI 10.1074/jbc.M105196200; von Bergen M, 2000, P NATL ACAD SCI USA, V97, P5129, DOI 10.1073/pnas.97.10.5129; Wadia JS, 2005, ADV DRUG DELIVER REV, V57, P579, DOI 10.1016/j.addr.2004.10.005; Wang YP, 2016, NAT REV NEUROSCI, V17, P5, DOI 10.1038/nrn.2015.1; Wegmann S, 2013, P NATL ACAD SCI USA, V110, pE313, DOI 10.1073/pnas.1212100110; Wiesehan K, 2003, CHEMBIOCHEM, V4, P748, DOI 10.1002/cbic.200300631; Wilson DM, 1997, AM J PATHOL, V150, P2181; Zheng J, 2011, J AM CHEM SOC, V133, P3144, DOI 10.1021/ja110545h	61	27	28	1	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2016	11	12							e0167432	10.1371/journal.pone.0167432	http://dx.doi.org/10.1371/journal.pone.0167432			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI9QH	28006031	Green Published, gold			2022-12-27	WOS:000392843200017
J	Wong, C; Jiang, MH; You, JHS				Wong, Carlos; Jiang, Minghuan; You, Joyce H. S.			Potential Cost-Effectiveness of an Influenza Vaccination Program Offering Microneedle Patch for Vaccine Delivery in Children	PLoS One			English	Article							SEASONAL INFLUENZA; ATTACK RATE; HONG-KONG; INFECTION; IMMUNOGENICITY; COMPLICATIONS; EPIDEMIOLOGY; SAFETY; ADULTS; IMPACT	Objective The influenza vaccine coverage rate of children is low in Hong Kong. Microneedle patches (MNPs) is a technology under development for painless delivery of vaccines. This study aimed to examine the potential clinical outcomes and direct medical costs of an influenza program offering MNP vaccine to children who have declined intramuscular (IM) vaccine in Hong Kong. Methods A decision model was designed to compare potential outcomes between IM vaccine program and a program offering MNP vaccine to those declined IM vaccine (IM/MNP program) in a hypothetical cohort of children over one-year time horizon. The model outcomes included direct medical cost, influenza infection rate, mortality rate, and quality-adjusted life-years (QALYs) loss. Model inputs were retrieved from published literature. Sensitivity analyses were performed to examine the robustness of model results. Results In base-case analysis, IM/MNP program was more costly per child (USD19.13 versus USD13.69; USD1 = HKD7.8) with lower influenza infection rate (98.9 versus 124.8 per 1,000 children), hospitalization rate (0.83 versus 1.05 per 1,000 children) and influenzarelated mortality rate (0.00042 versus 0.00052 per 1,000 children) when compared to IM program. The incremental cost per QALY saved (ICER) of IM/MNP program versus IM program was 27,200 USD/QALY. Using gross domestic product (GDP) per capita of Hong Kong (USD40,594) as threshold of willingness-to-pay (WTP) per QALY, one-way sensitivity analysis found ICER of IM/MNP to exceed WTP when duration of illness in outpatient setting was <5.7 days or cost per MNP vaccine was >1.39-time of IM vaccine cost. In 10,000 Monte Carlo simulations, IM/MNP program was the preferred option in 57.28% and 91.68% of the time, using 1x and 3x GDP per capita as WTP threshold, respectively. Conclusion Acceptance of IM/MNP program as the preferred program was subject to the WTP threshold, duration of illness in outpatient settings, and cost of MNP vaccine.	[Wong, Carlos; Jiang, Minghuan; You, Joyce H. S.] Chinese Univ Hong Kong, Sch Pharm, Fac Med, Shatin, Hong Kong, Peoples R China	Chinese University of Hong Kong	You, JHS (corresponding author), Chinese Univ Hong Kong, Sch Pharm, Fac Med, Shatin, Hong Kong, Peoples R China.	joyceyou@cuhk.edu.hk	You, Joyce H. S./C-2984-2008	You, Joyce H. S./0000-0002-5763-7403				Ampofo K, 2006, PEDIATRICS, V118, P2409, DOI 10.1542/peds.2006-1475; [Anonymous], 2016, FLU EXPR; Census and Statistics Department the Government of Hong Kong, 2016, POPULATION PROJECTIO; Chan D, 2013, COMMUNICABLE DIS WAT, V10, P74; Garnacho-Montero J, 2013, J AM GERIATR SOC, V61, P350, DOI 10.1111/jgs.12152; Gold MR, 1998, MED CARE, V36, P778, DOI 10.1097/00005650-199806000-00002; Greenberg DP, 2014, PEDIATR INFECT DIS J, V33, P630, DOI 10.1097/INF.0000000000000254; Hon KL, 2016, NPJ PRIM CARE RESP M, V26, DOI 10.1038/npjpcrm.2016.11; Jayasundara K, 2014, BMC INFECT DIS, V14, DOI 10.1186/s12879-014-0670-5; Kenney RT, 2004, NEW ENGL J MED, V351, P2295, DOI 10.1056/NEJMoa043540; Kim YC, 2012, ADV DRUG DELIVER REV, V64, P1547, DOI 10.1016/j.addr.2012.04.005; Kwong JC, 2015, VACCINE, V33, P535, DOI 10.1016/j.vaccine.2014.11.044; Lee BY, 2015, VACCINE, V33, P4727, DOI 10.1016/j.vaccine.2015.02.076; Lee BY, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011284; Lee BY, 2010, AM J MANAG CARE, V16, pE75; Leung MK, COST EFFECTIVENESS I; Loughlin J, 2003, PHARMACOECONOMICS, V21, P273, DOI 10.2165/00019053-200321040-00005; Molinari NAM, 2007, VACCINE, V25, P5086, DOI 10.1016/j.vaccine.2007.03.046; Norman JJ, 2014, VACCINE, V32, P1856, DOI 10.1016/j.vaccine.2014.01.076; Petrie JG, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075339; Pileggi C, 2015, BMC INFECT DIS, V15, DOI 10.1186/s12879-015-1161-z; Tsolia MN, 2006, VACCINE, V24, P5970, DOI 10.1016/j.vaccine.2006.05.006; Vellozzi C, 2014, CLIN INFECT DIS, V58, P1149, DOI 10.1093/cid/ciu005; Viboud C, 2004, BRIT J GEN PRACT, V54, P684; World Health Organization (WHO), 2013, WORLD HLTH REPORT 20; Wu JT, 2010, CLIN INFECT DIS, V51, P1184, DOI 10.1086/656740; You JHS, 2015, HUM VACC IMMUNOTHER, V11, P564, DOI 10.1080/21645515.2015.1011016	27	9	10	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2016	11	12							e0169030	10.1371/journal.pone.0169030	http://dx.doi.org/10.1371/journal.pone.0169030			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI9QH	28006012	gold, Green Published, Green Submitted			2022-12-27	WOS:000392843200127
J	Allport, SA; Kikah, N; Abu Saif, N; Ekokobe, F; Atem, FD				Allport, Shannon Anjelica; Kikah, Ngum; Abu Saif, Nessim; Ekokobe, Fonkem; Atem, Folefac D.			Parental Age of Onset of Cardiovascular Disease as a Predictor for Offspring Age of Onset of Cardiovascular Disease	PLOS ONE			English	Article							CORONARY-HEART-DISEASE; JOINT TASK-FORCE; MYOCARDIAL-INFARCTION; FAMILY-HISTORY; REGRESSION CALIBRATION; LOGISTIC-REGRESSION; RISK-FACTOR; CLINICAL-PRACTICE; ARTERY DISEASE; TRANSMISSION	Objective The risk for cardiovascular disease (CVD) is higher for individuals with a first-degree relative who developed premature CVD (with a threshold at age 55 years for a male or 65 years for a female). However, little is known about the effect that each unit increase or decrease of maternal or paternal age of onset of CVD has on offspring age of onset of CVD. We hypothesized that there is an association between maternal and paternal age of onset of CVD and offspring age of onset of CVD. Methods We used the Framingham Heart Study database and performed conditional imputation for CVD-censored parental age (i.e. parents that didn't experience onset of CVD) and Cox proportional regression analysis, with offspring's age of onset of CVD as the dependent variable and parental age of onset of CVD as the primary predictor. Modifiable risk factors in offspring, such as cigarette smoking, body mass index (BMI), diabetes mellitus, systolic blood pressure (SBP), high-density lipoprotein (HDL) level, and low-density lipoprotein (LDL) level, were controlled for. Separate analyses were performed for the association between maternal age of onset of CVD and offspring age of onset of CVD and the association between paternal age of onset of CVD and offspring age of onset of CVD. Results Parental age of onset of CVD was predictive of offspring age of onset of CVD for maternal age of onset of CVD (P < .0001; N = 1401) and for paternal age of onset of CVD (P = 0.0134; N = 1221). A negative estimate of the coefficient of interest signifies that late onset of cardiovascular events in parents is protective of onset of CVD in offspring. Cigarette smoking and HDL level were important associated confounders. Conclusions Offspring age of onset of cardiovascular disease is significantly associated with both maternal and paternal age of onset CVD. The incorporation of the parameters, maternal or paternal age of onset of CVD, into risk estimate calculators may improve accuracy of identification of high-risk patients in clinical settings.	[Allport, Shannon Anjelica] Univ Penn, Perelman Sch Med, Philadelphia, PA 19104 USA; [Allport, Shannon Anjelica; Kikah, Ngum; Abu Saif, Nessim; Atem, Folefac D.] Univ Texas Hlth Sci Ctr, Sch Publ Hlth, Dallas, TX USA; [Abu Saif, Nessim] Trinity Sch Med, Kingstown, St Vincent; [Ekokobe, Fonkem] Texas A&M Hlth Sci Ctr, Sch Med, Dallas, TX USA	University of Pennsylvania; Pennsylvania Medicine; Texas A&M University System; Texas A&M University College Station; Texas A&M Health Science Center	Allport, SA (corresponding author), Univ Penn, Perelman Sch Med, Philadelphia, PA 19104 USA.; Allport, SA (corresponding author), Univ Texas Hlth Sci Ctr, Sch Publ Hlth, Dallas, TX USA.	sallport@mail.med.upenn.edu		Markus, Shannon/0000-0003-1428-1133				[Anonymous], 2009, TAB NAT HOSP D UNPUB; [Anonymous], 2012, MATT YOUR HEART; Austin PC, 2004, STAT MED, V23, P411, DOI 10.1002/sim.1601; Brindle PM, 2005, BRIT J GEN PRACT, V55, P838; Chow CK, 2011, J AM COLL CARDIOL, V57, P619, DOI 10.1016/j.jacc.2010.07.054; Cipriani V, 2010, EUR J INTERN MED, V21, P511, DOI 10.1016/j.ejim.2010.07.017; Clayton DG, 1992, MODELS ANAL COHORT C, P301; Conroy RM, 2003, EUR HEART J, V24, P987, DOI 10.1016/S0195-668X(03)00114-3; COX DR, 1972, J R STAT SOC B, V34, P187; Crouch MA, 2005, PRIMARY CARE, V32, P995, DOI 10.1016/j.pop.2005.09.008; De Backer G, 2003, EUR J CARDIOV PREV R, V10, pS1, DOI 10.1097/01.hjr.0000087913.96265.e2; DONAHUE RP, 1987, LANCET, V1, P821; Dupuy JF, 2009, J STAT PLAN INFER, V139, P317, DOI 10.1016/j.jspi.2008.04.024; Durrington P, 1998, JOINT BRIT RECOMMEND; Grundy SM, 2002, CIRCULATION, V106, P3143, DOI 10.1161/circ.106.25.3143; Huang SYH, 2005, STAT SINICA, V15, P685; KANNEL W B, 1965, R I Med J, V48, P243; Keil U, 2000, BASIC RES CARDIOL, V95, P52; KEYS A, 1970, CIRCULATION, V41, pI1; Kinra S, 2003, HEART, V89, P834, DOI 10.1136/heart.89.8.834; Leander K, 2001, EPIDEMIOLOGY, V12, P215, DOI 10.1097/00001648-200103000-00014; MANSON JAE, 1990, NEW ENGL J MED, V322, P882, DOI 10.1056/NEJM199003293221303; Michos ED, 2006, ATHEROSCLEROSIS, V184, P201, DOI 10.1016/j.atherosclerosis.2005.04.004; MYERS RH, 1990, AM HEART J, V120, P963, DOI 10.1016/0002-8703(90)90216-K; Nasir K, 2004, CIRCULATION, V110, P2150, DOI 10.1161/01.CIR.0000144464.11080.14; NEATON JD, 1992, ARCH INTERN MED, V152, P56, DOI 10.1001/archinte.152.1.56; Nielsen M, 2013, EUR HEART J, V34, P1198, DOI 10.1093/eurheartj/ehs475; Prabhakaran D, 2012, MT SINAI J MED, V79, P721, DOI 10.1002/msj.21348; PRENTICE RL, 1982, BIOMETRIKA, V69, P331, DOI 10.1093/biomet/69.2.331; Rigobon R, 2009, J BUS ECON STAT, V27, P340, DOI 10.1198/jbes.2009.06119; RIMM EB, 1992, LANCET, V338, P464; ROSNER B, 1990, AM J EPIDEMIOL, V132, P734, DOI 10.1093/oxfordjournals.aje.a115715; Scheuner MT, 2003, GENET MED, V5, P269, DOI 10.1097/01.GIM.0000079364.98247.26; SCHILDKRAUT JM, 1989, AM J CARDIOL, V64, P555, DOI 10.1016/0002-9149(89)90477-3; Seshadri S, 2010, CIRCULATION, V121, P1304, DOI 10.1161/CIRCULATIONAHA.109.854240; Sesso HD, 2001, CIRCULATION, V104, P393, DOI 10.1161/hc2901.093115; Spiegelman D, 2001, STAT MED, V20, P139, DOI 10.1002/1097-0258(20010115)20:1<139::AID-SIM644>3.0.CO;2-K; Stocks NP, 2015, BMC FAM PRACT, V16, DOI 10.1186/s12875-015-0328-4; Sundquist K, 2006, AM J PREV MED, V30, P480, DOI 10.1016/j.amepre.2006.01.010; Topol EJ, 2006, HUM MOL GENET, V15, pR117, DOI 10.1093/hmg/ddl183; TSIATIS AA, 1995, J AM STAT ASSOC, V90, P27, DOI 10.2307/2291126; Weijmans M, 2015, INT J CARDIOL, V179, P409, DOI 10.1016/j.ijcard.2014.11.017; Weller EA, 2007, J STAT PLAN INFER, V137, P449, DOI 10.1016/j.jspi.2006.01.009; Williams RR, 2001, AM J CARDIOL, V87, P129, DOI 10.1016/S0002-9149(00)01303-5; Wilson PWF, 1998, CIRCULATION, V97, P1837, DOI 10.1161/01.CIR.97.18.1837; Wood D, 1998, ATHEROSCLEROSIS, V140, P199, DOI 10.1016/S0021-9150(98)90209-X	46	6	6	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2016	11	12							e0163334	10.1371/journal.pone.0163334	http://dx.doi.org/10.1371/journal.pone.0163334			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI9TW	28002456	Green Published, gold, Green Submitted			2022-12-27	WOS:000392853100001
J	DeBeer, BB; Kittel, JA; Cook, A; Davidson, D; Kimbrel, NA; Meyer, EC; Gulliver, SB; Morissette, SB				DeBeer, Bryann B.; Kittel, Julie A.; Cook, Andrew; Davidson, Dena; Kimbrel, Nathan A.; Meyer, Eric C.; Gulliver, Suzy B.; Morissette, Sandra B.			Predicting Suicide Risk in Trauma Exposed Veterans: The Role of Health Promoting Behaviors	PLOS ONE			English	Article							POSTTRAUMATIC-STRESS-DISORDER; MOOD DISORDERS; FOLLOW-UP; IDEATION; PTSD; COMORBIDITY; SYMPTOMS; SLEEP; INDIVIDUALS; AFGHANISTAN	Introduction Returning veterans of the wars in Iraq and Afghanistan experience high rates of post-traumatic stress disorder (PTSD) and suicidal behavior. Suicidal ideation is among the strongest risk factors for completed suicide. Some research suggests an association between PTSD and suicidal ideation, and that health-promoting behaviors behaviors that sustain or increase well-being play a role in this association. The current study examined whether health-promoting behaviors moderate the association between PTSD severity and suicidal ideation. Methods Veterans of Operation Enduring Freedom/Operation Iraqi Freedom (OEF/OIF; N = 108) completed measures of PTSD symptoms, trauma exposure, suicidal ideation, and health promoting behaviors. Results Moderated regression was used to test the hypothesis. Results indicated that health promoting behaviors, beta = -.06, p = .001, and PTSD symptoms, beta = .36, p < .001, were significantly related to suicidal ideation. Consistent with our main hypothesis, the health promoting behaviors x PTSD interaction term was significantly associated with suicidal ideation, beta = -.09, p = .001. The overall model accounted for 13% of the variance in suicidal ideation. Among individuals with high PTSD symptom severity, those who engaged in more health promoting behaviors reported less suicidal ideation than those who engaged in fewer health promoting behaviors. Conclusions Health-promoting behaviors could be important for reducing suicidal ideation among veterans with high levels of PTSD symptoms. It is recommended that future research examine health promotion interventions as a means of reducing suicidal ideation.	[DeBeer, Bryann B.; Kittel, Julie A.; Davidson, Dena; Meyer, Eric C.; Morissette, Sandra B.] Dept Vet Affairs, VISN Ctr Excellence Res Returning War Vet 17, Waco, TX 76706 USA; [DeBeer, Bryann B.; Cook, Andrew; Davidson, Dena; Meyer, Eric C.; Gulliver, Suzy B.; Morissette, Sandra B.] Texas A&M Hlth Sci Ctr, Temple, TX 76504 USA; [Cook, Andrew] Cent Texas Vet Hlth Care Syst, Temple, TX USA; [Kimbrel, Nathan A.] Durham Vet Affairs Med Ctr, Durham, NC USA; [Kimbrel, Nathan A.] VA Midatlantic Mental Illness Res Educ & Clin Ctr, Durham, NC USA; [Kimbrel, Nathan A.] Duke Univ, Sch Med, Durham, NC USA; [Gulliver, Suzy B.] Baylor Scott & White Healthcare Syst, Warriors Res Inst, Waco, TX USA	Texas A&M University System; Texas A&M University College Station; Texas A&M Health Science Center; US Department of Veterans Affairs; Veterans Health Administration (VHA); Durham VA Medical Center; Duke University	DeBeer, BB (corresponding author), Dept Vet Affairs, VISN Ctr Excellence Res Returning War Vet 17, Waco, TX 76706 USA.; DeBeer, BB (corresponding author), Texas A&M Hlth Sci Ctr, Temple, TX 76504 USA.	bryann.debeer@va.gov	Meyer, Eric C/GYV-3448-2022; Gulliver, Suzy/X-9776-2019; Kittel, Julie/U-7880-2019	Gulliver, Suzy Bird/0000-0002-6476-9447	VISN 17 New Investigator Award; Center of Excellence Pilot Funds award; Department of Veterans Affairs (VA) Rehabilitation Research and Development (RR&D) Service of the VA Office of Research and Development (ORD) [I01RX000304]; Clinical Science Research and Development Service of the Department of Veterans Affairs (VA) Office of Research and Development [IK2CX000525, CX000795]; Veterans Affairs [I01RX000304] Funding Source: NIH RePORTER	VISN 17 New Investigator Award; Center of Excellence Pilot Funds award; Department of Veterans Affairs (VA) Rehabilitation Research and Development (RR&D) Service of the VA Office of Research and Development (ORD)(US Department of Veterans Affairs); Clinical Science Research and Development Service of the Department of Veterans Affairs (VA) Office of Research and Development(US Department of Veterans Affairs); Veterans Affairs(US Department of Veterans Affairs)	Dr. DeBeer is supported by a VISN 17 New Investigator Award and Center of Excellence Pilot Funds award. This work was supported in part by a Merit Award (I01RX000304) to Sandra B. Morissette, Ph.D. from the Department of Veterans Affairs (VA) Rehabilitation Research and Development (RR&D) Service of the VA Office of Research and Development (ORD). Dr. Kim brel was supported by a Career Development Award (IK2CX000525) from the Clinical Science Research and Development Service of the Department of Veterans Affairs (VA) Office of Research and Development. Dr. Davidson is supported a Merit award from from the Clinical Science Research and Development Service of the Department of Veterans Affairs (VA) Office of Research and Development CX000795. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American Psychiatric, 2000, DIAGN STAT MAN MENT; Angst F, 2002, J AFFECT DISORDERS, V68, P167, DOI 10.1016/S0165-0327(01)00377-9; [Anonymous], 2013, SUICIDE DATA REPORT; Babiss LA, 2009, J DEV BEHAV PEDIATR, V30, P376, DOI 10.1097/DBP.0b013e3181b33659; BLAKE DD, 1995, J TRAUMA STRESS, V8, P75, DOI 10.1007/BF02105408; Brown TA, 2001, J ABNORM PSYCHOL, V110, P585, DOI 10.1037//0021-843X.110.4.585; Bryan CJ, 2011, PSYCHOL SERV, V8, P94, DOI 10.1037/a0023451; DeBeer BB, 2014, PSYCHIAT RES, V216, P357, DOI 10.1016/j.psychres.2014.02.010; Ferrada-Noli M, 1998, J TRAUMA STRESS, V11, P103, DOI 10.1023/A:1024461216994; Fontana A, 2004, J NERV MENT DIS, V192, P579, DOI 10.1097/01.nmd.0000138224.17375.55; Green B.L., 1996, MEASUREMENT STRESS T, P366; Heisel MJ, 2004, J PSYCHOPATHOL BEHAV, V26, P127, DOI 10.1023/B:JOBA.0000013660.22413.e0; Hemmingsson T, 2003, INT J EPIDEMIOL, V32, P1000, DOI 10.1093/ije/dyg203; Hoge CW, 2004, NEW ENGL J MED, V351, P13, DOI 10.1056/NEJMoa040603; Jakupcak M, 2009, J TRAUMA STRESS, V22, P303, DOI 10.1002/jts.20423; Kessler RC, 1999, ARCH GEN PSYCHIAT, V56, P617, DOI 10.1001/archpsyc.56.7.617; Krakow BJ, 2002, J CLIN PSYCHIAT, V63, P673, DOI 10.4088/JCP.v63n0804; KRAMER TL, 1994, SUICIDE LIFE-THREAT, V24, P58; Landberg J, 2009, SUICIDE LIFE-THREAT, V39, P452, DOI 10.1521/suli.2009.39.4.452; Leistikow BN, 1999, PREV MED, V28, P255, DOI 10.1006/pmed.1998.0412; Li YF, 2009, PSYCHIAT RES, V165, P111, DOI 10.1016/j.psychres.2007.09.004; Maker MJ, 2006, CNS DRUGS, V20, P567; Manger Theresa A, 2005, Int J Emerg Ment Health, V7, P49; Maris RW, 1981, PATHWAYS SUICIDE, P100; Morissette SB, 2007, PSYCHOL BULL, V133, P245, DOI 10.1037/0033-2909.133.2.245; Munthen BO, 2006, MPLUS USERS GUIDE; Pender N.J., 1982, HLTH PROMOTION NURSI; Posner K, 2011, AM J PSYCHIAT, V168, P1266, DOI 10.1176/appi.ajp.2011.10111704; Preuss UW, 2002, ALCOHOL CLIN EXP RES, V26, P471, DOI 10.1111/j.1530-0277.2002.tb02563.x; Prochaska JO, 1997, AM J HEALTH PROMOT, V12, P38, DOI 10.4278/0890-1171-12.1.38; ROY A, 1986, SUICIDE LIFE-THREAT, V16, P244; Scarpa A, 2006, J INTERPERS VIOLENCE, V21, P446, DOI 10.1177/0886260505285726; Schneider B, 2001, EUR PSYCHIAT, V16, P283, DOI 10.1016/S0924-9338(01)00579-X; Sheehan DV, 1998, J CLIN PSYCHIAT, V59, P34, DOI 10.4088/JCP.09m05305whi; Simon TR, 2004, AM J PREV MED, V27, P310, DOI 10.1016/j.amepre.2004.07.003; Spoormaker VI, 2008, SLEEP MED REV, V12, P169, DOI 10.1016/j.smrv.2007.08.008; Stewart SH, 1996, PSYCHOL BULL, V120, P83, DOI 10.1037/0033-2909.120.1.83; Tarrier N, 2004, SOC PSYCH PSYCH EPID, V39, P927, DOI 10.1007/s00127-004-0828-3; Van Orden KA, 2010, PSYCHOL REV, V117, P575, DOI 10.1037/a0018697; WALKER SN, 1987, NURS RES, V36, P76; Wong MM, 2011, J PSYCHIATR RES, V45, P505, DOI 10.1016/j.jpsychires.2010.09.005; Zhang H, 2005, NUTRITION, V21, P711, DOI 10.1016/j.nut.2004.11.009; Zoroya G., 2013, US TODAY        0730	43	8	8	2	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2016	11	12							e0167464	10.1371/journal.pone.0167464	http://dx.doi.org/10.1371/journal.pone.0167464			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EI9TW	28002490	Green Submitted, Green Published, gold			2022-12-27	WOS:000392853100009
J	Gomes-Pepe, ES; Sierra, EGM; Pereira, MR; Castellane, TCL; Lemos, EGD				Gomes-Pepe, Elisangela Soares; Machado Sierra, Elwi Guillermo; Pereira, Mariana Rangel; Luque Castellane, Tereza Cristina; de Macedo Lemos, Eliana Gertrudes			Bg10: A Novel Metagenomics Alcohol-Tolerant and Glucose-Stimulated GH1 SS-Glucosidase Suitable for Lactose-Free Milk Preparation	PLOS ONE			English	Article							EXTRACELLULAR BETA-GLUCOSIDASE; BIOCHEMICAL-CHARACTERIZATION; SUBSTRATE-SPECIFICITY; NUCLEOTIDE-SEQUENCE; STREPTOMYCES SP; PURIFICATION; EXPRESSION; GENE; CLONING; CELLULOSE	New SS-glucosidases with product (glucose) or ethanol tolerances are greatly desired to make industrial processes more marketable and efficient. Therefore, this report describes the in silico/vitro characterization of Bg10, a metagenomically derived homodimeric SS-glucosidase that exhibited a V-max of 10.81 +/- 0.43 mu M min(-1), K-cat of 175.1 +/- 6.91 min(-1), and K-m of 0.49 +/- 0.12 mM at a neutral pH and 37 degrees C when pNP-SS-D-glucopyranoside was used as the substrate, and the enzyme retained greater than 80% activity within the respective pH and temperature ranges of 6.5 to 8.0 and 35 to 40 degrees C. The enzyme was stimulated by its product, glucose; consequently, the Bg10 activity against 50 and 100 mM of glucose were increased by 36.8% and 22%, respectively, while half of the activity was retained at 350 mM. Moreover, the Bg10 was able to hydrolyse 55% (milk sample) and 100% (purified sugar) of the lactose at low (6 degrees C) and optimum (37 degrees C) temperatures, respectively, suggesting the possibility of further optimization of the reaction for lactose-free dairy production. In addition, the enzyme was able to fully hydrolyse 40 mM of cellobiose at one hour and was tolerant to ethanol up to concentrations of 500 mM (86% of activity), while a 1 M concentration still resulted in 41% residual activity, which could be interesting for biofuel production.	[Gomes-Pepe, Elisangela Soares; Machado Sierra, Elwi Guillermo; Pereira, Mariana Rangel; Luque Castellane, Tereza Cristina; de Macedo Lemos, Eliana Gertrudes] Sao Paulo State Univ Unesp, Dept Technol, Sch Agr & Vet Sci, Via Acesso Prof Paulo Donato Castellane S-N,Km 5, Jaboticabal, SP, Brazil; [Gomes-Pepe, Elisangela Soares; Machado Sierra, Elwi Guillermo; Pereira, Mariana Rangel; Luque Castellane, Tereza Cristina; de Macedo Lemos, Eliana Gertrudes] UNESP Jaboticabal, Mol Biol Lab, Inst Res Bioenergy IPBEN, Jaboticabal, SP, Brazil; [Gomes-Pepe, Elisangela Soares] UNESP, Agr Microbiol Postgrad Program, Jaboticabal, SP, Brazil	Universidade Estadual Paulista; Universidade Estadual Paulista; Universidade Estadual Paulista	Lemos, EGD (corresponding author), Sao Paulo State Univ Unesp, Dept Technol, Sch Agr & Vet Sci, Via Acesso Prof Paulo Donato Castellane S-N,Km 5, Jaboticabal, SP, Brazil.; Lemos, EGD (corresponding author), UNESP Jaboticabal, Mol Biol Lab, Inst Res Bioenergy IPBEN, Jaboticabal, SP, Brazil.	egerle@fcav.unesp.br	Gomes-Pepe, Elisângela/C-4003-2013; LEMOS, ELIANA GM/A-3604-2008; Pereira, Mariana/GSE-3546-2022; de Macedo Lemos, Eliana Gertrudes/AAA-4225-2020; machado, elwi G/G-5228-2017	Gomes-Pepe, Elisângela/0000-0003-4401-3869; LEMOS, ELIANA GM/0000-0002-1119-7748; de Macedo Lemos, Eliana Gertrudes/0000-0002-1119-7748; Luque Castellane, Tereza Cristina/0000-0002-7290-5314; Machado Sierra, Elwi Guillermo/0000-0003-3639-1990	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo, FAPESP [ESGP 2011/10981-3]	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo, FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	This work was supported by Fundacao de Amparo a Pesquisa do Estado de Sao Paulo, ESGP 2011/10981-3, FAPESP (http://www.fapesp.br/). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acquaro VR, 2013, SCI CHROMATOGR, V5, P137, DOI DOI 10.4322/SC.2013.010; Ahn DH, 1997, BIOTECHNOL LETT, V19, P483, DOI 10.1023/A:1018360530691; Amorim HV, 2011, APPL MICROBIOL BIOT, V91, P1267, DOI 10.1007/s00253-011-3437-6; Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; Baffi MA, 2013, APPL BIOCHEM BIOTECH, V169, P493, DOI 10.1007/s12010-012-9991-2; Baffi MA, 2013, APPL BIOCHEM BIOTECH, V171, P1681, DOI 10.1007/s12010-013-0471-0; Bhiri F, 2008, APPL BIOCHEM BIOTECH, V149, P169, DOI 10.1007/s12010-008-8146-y; Brulc JM, 2009, P NATL ACAD SCI USA, V106, P1948, DOI 10.1073/pnas.0806191105; da Silveira EL, 2006, PESQUI AGROPECU BRAS, V41, P1507, DOI 10.1590/S0100-204X2006001000008; Daroit DJ, 2008, J MICROBIOL BIOTECHN, V18, P933; Dashtban M, 2010, CRIT REV BIOTECHNOL, V30, P302, DOI 10.3109/07388551.2010.490938; de Giuseppe PO, 2014, ACTA CRYSTALLOGR D, V70, P1631, DOI 10.1107/S1399004714006920; During MJ, 1998, NAT MED, V4, P1131, DOI 10.1038/2625; Gao J, 2014, J BACTERIOL, V196, P4103, DOI 10.1128/JB.02194-14; Gomes Elisângela Soares, 2013, Braz. J. Microbiol., V44, P1007, DOI 10.1590/S1517-83822013000400002; Gonzalez-Pombo P, 2014, FOOD CHEM, V143, P185, DOI 10.1016/j.foodchem.2013.07.107; Gordon D, 1998, GENOME RES, V8, P195, DOI 10.1101/gr.8.3.195; Gu MZ, 2013, APPL BIOCHEM BIOTECH, V170, P1713, DOI 10.1007/s12010-013-0301-4; Guasch A, 1999, ACTA CRYSTALLOGR D, V55, P679, DOI 10.1107/S0907444998013833; Howarth RW, 2009, SCI ANAL IMPLICATION, P9; Jiang CJ, 2009, J MICROBIOL, V47, P542, DOI 10.1007/s12275-009-0024-y; Karnaouri A, 2013, PEERJ, V1, DOI 10.7717/peerj.46; Karnchanatat A, 2007, FEMS MICROBIOL LETT, V270, P162, DOI 10.1111/j.1574-6968.2007.00662.x; KIM HK, 1989, ENZYME MICROB TECH, V11, P313, DOI 10.1016/0141-0229(89)90048-3; Klein-Marcuschamer D, 2012, BIOTECHNOL BIOENG, V109, P1083, DOI 10.1002/bit.24370; Kren V, 2008, FEMS MICROBIOL REV, V32, P858, DOI 10.1111/j.1574-6976.2008.00124.x; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Li A, 2013, BIOTECHNOL BIOFUELS, V6, DOI 10.1186/1754-6834-6-3; Li B, 2013, BMC BIOTECHNOL, V13, DOI 10.1186/1472-6750-13-73; Lorenz P, 2005, NAT REV MICROBIOL, V3, P510, DOI 10.1038/nrmicro1161; Lynd LR, 2002, MICROBIOL MOL BIOL R, V66, P506, DOI 10.1128/MMBR.66.3.506-577.2002; MacLean D, 2009, NAT REV MICROBIOL, V7, P287, DOI [10.1038/nrmicro2088, 10.1038/nrmicro2122]; Marana SR, 2006, IUBMB LIFE, V58, P63, DOI 10.1080/15216540600617156; Mason OU, 2012, ISME J, V6, P1715, DOI 10.1038/ismej.2012.59; Mateus N., 2009, REV REAL ACAD GALEGA, VXXVIII; Miller CS, 2008, BIOINFORMATICS, V24, P1575, DOI 10.1093/bioinformatics/btn248; Nigam PS, 2011, PROG ENERG COMBUST, V37, P52, DOI 10.1016/j.pecs.2010.01.003; Nunoura N, 1997, J FERMENT BIOENG, V83, P309, DOI 10.1016/S0922-338X(97)80134-1; Nunoura N, 1996, BIOSCI BIOTECH BIOCH, V60, P2011, DOI 10.1271/bbb.60.2011; PEREZPONS JA, 1994, EUR J BIOCHEM, V223, P557, DOI 10.1111/j.1432-1033.1994.tb19025.x; Pokusaeva K, 2011, APPL ENVIRON MICROB, V77, P1681, DOI 10.1128/AEM.01786-10; R Core Team, 2021, R LANGUAGE ENV STAT; Riou C, 1998, APPL ENVIRON MICROB, V64, P3607; Ronquist F, 2012, SYST BIOL, V61, P539, DOI 10.1093/sysbio/sys029; Simon C, 2011, APPL ENVIRON MICROB, V77, P1153, DOI 10.1128/AEM.02345-10; Singh D, 2006, GENE, V376, P13, DOI 10.1016/j.gene.2005.12.035; Singh G, 2015, 3 BIOTECH, V6, DOI 10.1007/s13205-015-0328-z; Singhania RR, 2013, BIORESOURCE TECHNOL, V127, P500, DOI 10.1016/j.biortech.2012.09.012; Sleator RD, 2010, ARCH MICROBIOL, V192, P151, DOI 10.1007/s00203-010-0549-9; Smith HE, 2011, BIOTECHNIQUES, V50, P96, DOI 10.2144/000113600; Sonia KG, 2008, WORLD J MICROB BIOT, V24, P599, DOI 10.1007/s11274-007-9512-6; Uchiyama T, 2013, J BIOL CHEM, V288, P18325, DOI 10.1074/jbc.M113.471342; Vallmitjana M, 2001, BIOCHEMISTRY-US, V40, P5975, DOI 10.1021/bi002947j; Wilkins MR, 1999, METH MOL B, V112, P531; Xia Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053779; Yang SQ, 2008, J AGR FOOD CHEM, V56, P602, DOI 10.1021/jf072279+; Yang Y, 2015, MULTIMED TOOLS APPL, P1; Yoon JJ, 2008, J MICROBIOL, V46, P51, DOI 10.1007/s12275-007-0230-4; Zanoelo FF, 2004, FEMS MICROBIOL LETT, V240, P137, DOI 10.1016/j.femsle.2004.09.021; Zhang L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082437	60	13	15	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2016	11	12							e0167932	10.1371/journal.pone.0167932	http://dx.doi.org/10.1371/journal.pone.0167932			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI9TW	28002476	Green Submitted, Green Published, gold			2022-12-27	WOS:000392853100026
J	Marti, HP; Jeffs, A; Scherer, A; Leader, J; Leader, C; Bedford, J; Walker, R				Marti, Hans-Peter; Jeffs, Aaron; Scherer, Andreas; Leader, John; Leader, Catherine; Bedford, Jennifer; Walker, Robert			Renal Fibrosis mRNA Classifier: Validation in Experimental Lithium-Induced Interstitial Fibrosis in the Rat Kidney	PLoS One			English	Article							GROWTH-FACTOR-BETA; ALTERED EXPRESSION; MATRIX METALLOPROTEINASES; THERAPEUTIC TARGETS; INDUCED NDI; CD44; NEPHROPATHY; GENES; CELLS; METZINCINS	Accurate diagnosis of fibrosis is of paramount clinical importance. A human fibrosis classifier based on metzincins and related genes (MARGS) was described previously. In this investigation, expression changes of MARGS genes were explored and evaluated to examine whether the MARGS-based algorithm has any diagnostic value in a rat model of lithium nephropathy. Male Wistar rats (n = 12) were divided into 2 groups (n = 6). One group was given a diet containing lithium (40 mmol/kg food for 7 days, followed by 60mmol/kg food for the rest of the experimental period), while a control group (n = 6) was fed a normal diet. After six months, animals were sacrificed and the renal cortex and medulla of both kidneys removed for analysis. Gene expression changes were analysed using 24 GeneChip Affymetrix Rat Exon 1.0 ST arrays. Statistically relevant genes (p-value<0.05, fold change>1.5, t-test) were further examined. Matrix metalloproteinase-2 (MMP2), CD44, and nephroblastoma overexpressed gene (NOV) were overexpressed in the medulla and cortex of lithium fed rats compared to the control group. TGF beta 2 was overrepresented in the cortex of lithium fed animals 1.5-fold, and 1.3-fold in the medulla of the same animals. In Gene Set Enrichment Analysis (GSEA), both the medulla and cortex of lithium-fed animals showed an enrichment of the MARGS, TGF beta network, and extracellular matrix (ECM) gene sets, while the cortex expression signature was enriched in additional fibrosis-related-genes and the medulla was also enriched in immune response pathways. Importantly, the MARGS-based fibrosis classifier was able to classify all samples correctly. Immunohistochemistry and qPCR confirmed the up-regulation of NOV, CD44, and TGF beta 2. The MARGS classifier represents a cross-organ and cross-species classifier of fibrotic conditions and may help to design a test to diagnose and to monitor fibrosis. The results also provide evidence for a common pathway in the pathogenesis of fibrosis.	[Marti, Hans-Peter] Univ Bergen, Dept Clin Med, Bergen, Norway; [Marti, Hans-Peter] Haukeland Hosp, Bergen, Norway; [Jeffs, Aaron] Univ Otago, Dept Biochem, Dunedin, New Zealand; [Scherer, Andreas] Spheromics Inc, Kontiolahti, Finland; [Leader, John; Leader, Catherine; Bedford, Jennifer; Walker, Robert] Univ Otago, Dept Med, Dunedin, New Zealand	University of Bergen; University of Otago; University of Otago	Walker, R (corresponding author), Univ Otago, Dept Med, Dunedin, New Zealand.	rob.walker@otago.ac.nz	Walker, Robert J/B-1498-2010; Scherer, Andreas/ABD-8660-2020	Walker, Robert J/0000-0003-3366-0956; Scherer, Andreas/0000-0002-4254-7122	Maurice and Phyllis Paykel Trust; Otago Medical Resarch Foundation; Novartis Foundation for Medical-Biological Research	Maurice and Phyllis Paykel Trust; Otago Medical Resarch Foundation; Novartis Foundation for Medical-Biological Research	This study was funded in part from the Maurice and Phyllis Paykel Trust, the Otago Medical Resarch Foundation and Novartis Foundation for Medical-Biological Research. The funders had no role in the study design, data collection and analysis, decision to publish or preparation of the manuscript.	Benigni A, 2006, NEPHRON EXP NEPHROL, V104, pE158, DOI 10.1159/000094967; Benini S, 2005, ONCOGENE, V24, P4349, DOI 10.1038/sj.onc.1208620; Berthier CC, 2006, KIDNEY INT, V69, P358, DOI 10.1038/sj.ki.5000049; Boor P, 2010, NAT REV NEPHROL, V6, P643, DOI 10.1038/nrneph.2010.120; Bourguignon LYW, 2002, J BIOL CHEM, V277, P39703, DOI 10.1074/jbc.M204320200; Chevalier G, 1998, AM J PATHOL, V152, P1563; Christensen BM, 2006, AM J PHYSIOL-RENAL, V291, pF39, DOI 10.1152/ajprenal.00383.2005; El Chaar M, 2007, AM J PHYSIOL-RENAL, V292, pF1291, DOI 10.1152/ajprenal.00327.2005; Finne K, 2016, NEPHRON, V132, P70, DOI 10.1159/000442825; Florquin S, 2002, AM J KIDNEY DIS, V39, P407, DOI 10.1053/ajkd.2002.30563; Guan QN, 2013, AM J PHYSIOL-RENAL, V305, pF199, DOI 10.1152/ajprenal.00665.2012; Kers J, 2010, TRANSPLANTATION, V90, P502, DOI 10.1097/TP.0b013e3181e86b42; Kirimca F, 2001, SCAND J UROL NEPHROL, V35, P509; Kotnik P, 2005, AM J PHYSIOL-RENAL, V288, pF1053, DOI 10.1152/ajprenal.00114.2004; Kwiatkowska E, 2016, KIDNEY BLOOD PRESS R, V41, P288, DOI 10.1159/000443431; Kwon TH, 2000, AM J PHYSIOL-RENAL, V279, pF552, DOI 10.1152/ajprenal.2000.279.3.F552; Laurent M, 2003, FASEB J, V17, P1919, DOI 10.1096/fj.02-1023fje; Lin CG, 2005, J BIOL CHEM, V280, P8229, DOI 10.1074/jbc.M404903200; Liu YH, 2011, NAT REV NEPHROL, V7, P684, DOI 10.1038/nrneph.2011.149; Marti HP, 2014, NEPHROL DIAL TRANSPL, V29, P1177, DOI 10.1093/ndt/gfu027; MARTI HP, 1994, AM J PATHOL, V144, P82; Nagase H, 1999, J BIOL CHEM, V274, P21491, DOI 10.1074/jbc.274.31.21491; Negi LM, 2012, J DRUG TARGET, V20, P561, DOI 10.3109/1061186X.2012.702767; Rodrigo E, 2000, NEPHROL DIAL TRANSPL, V15, P2041, DOI 10.1093/ndt/15.12.2041; Rodder S, 2009, AM J TRANSPLANT, V9, P517, DOI 10.1111/j.1600-6143.2008.02512.x; Rodder S, 2011, VIRCHOWS ARCH, V458, P487, DOI 10.1007/s00428-011-1052-7; Rojek A, 2005, AM J PHYSIOL-RENAL, V288, pF1276, DOI 10.1152/ajprenal.00305.2004; Rouschop KMA, 2004, J AM SOC NEPHROL, V15, P674, DOI 10.1097/01.ASN.0000115703.30835.96; RoyChaudhury P, 1996, KIDNEY INT, V50, P272, DOI 10.1038/ki.1996.312; Schnaper HW, 2003, AM J PHYSIOL-RENAL, V284, pF243, DOI 10.1152/ajprenal.00300.2002; Shi LM, 2006, NAT BIOTECHNOL, V24, P1151, DOI 10.1038/nbt1239; Tzeng HE, 2011, J CELL PHYSIOL, V226, P3181, DOI 10.1002/jcp.22672; Wagrowska-Danilewicz Malgorzata, 2002, Polish Journal of Pathology, V53, P155; Walker RJ, 2013, AM J PHYSIOL-RENAL, V304, pF300, DOI 10.1152/ajprenal.00182.2012; Wanga S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0136276; Yanagita M, 2012, NEPHROL DIAL TRANSPL, V27, P3686, DOI 10.1093/ndt/gfs381; Yang JW, 2001, AM J PATHOL, V159, P1465, DOI 10.1016/S0002-9440(10)62533-3; Yeger H, 2007, J CELL COMMUN SIGNAL, V1, P159, DOI 10.1007/s12079-008-0022-6; Yokoi H, 2001, AM J KIDNEY DIS, V38, pS134, DOI 10.1053/ajkd.2001.27422; Yu L, 2003, KIDNEY INT, V64, P844, DOI 10.1046/j.1523-1755.2003.00162.x; Yu Q, 1999, GENE DEV, V13, P35, DOI 10.1101/gad.13.1.35; Zeisberg M, 2001, AM J PATHOL, V159, P1313, DOI 10.1016/S0002-9440(10)62518-7	42	5	5	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2016	11	12							e0168240	10.1371/journal.pone.0168240	http://dx.doi.org/10.1371/journal.pone.0168240			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI9TW	28002484	gold, Green Published, Green Submitted			2022-12-27	WOS:000392853100036
J	Chen, ST; Yang, JT; Yeh, MY; Weng, HH; Chen, CF; Tsai, YH				Chen, Shu-Tian; Yang, Jen-Tsung; Yeh, Mei-Yu; Weng, Hsu-Huei; Chen, Chih-Feng; Tsai, Yuan-Hsiung			Using Diffusion Tensor Imaging to Evaluate Microstructural Changes and Outcomes after Radiofrequency Rhizotomy of Trigeminal Nerves in Patients with Trigeminal Neuralgia	PLOS ONE			English	Article							NEUROVASCULAR COMPRESSION; ABNORMALITIES; ROOT	Trigeminal neuralgia is characterized by facial pain that may be sudden, intense, and recurrent. Our aim was to investigate microstructural tissue changes of the trigeminal nerve in patients with trigeminal neuralgia resulting from neurovascular compression by diffusion tensor imaging, and to test the predictive value of diffusion tensor imaging for determining outcomes after radiofrequency rhizotomy. Forty-three patients with trigeminal neuralgia were recruited, and diffusion tensor imaging was performed before radiofrequency rhizotomy. By selecting the cisternal segment of the trigeminal nerve manually, we measured the volume of trigeminal nerve, fractional anisotropy, apparent diffusion coefficient, axial diffusivity, and radial diffusivity. The apparent diffusion coefficient and mean value of fractional anisotropy, axial diffusivity, and radial diffusivity were compared between the affected and normal side in the same patient, and were correlated with pre-rhizotomy and post-rhizotomy visual analogue scale pain scores. The results showed the affected side had significantly decreased fractional anisotropy, increased apparent diffusion coefficient and radial diffusivity, and no significant change of axial diffusivity. The volume of the trigeminal nerve on affected side was also significantly smaller. There was a trend of fractional anisotropy reduction and visual analogue scale pain score reduction (P = 0.072). The results suggest that demyelination without axonal injury, and decreased size of the trigeminal nerve, are the microstructural abnormalities of the trigeminal nerve in patients with trigeminal neuralgia caused by neurovascular compression. The application of diffusion tensor imaging in understanding the pathophysiology of trigeminal neuralgia, and predicting the treatment effect has potential and warrants further study.	[Chen, Shu-Tian; Yeh, Mei-Yu; Weng, Hsu-Huei; Tsai, Yuan-Hsiung] Chang Gung Mem Hosp Chiayi, Dept Diagnost Radiol, Chiayi, Taiwan; [Yang, Jen-Tsung] Chang Gung Mem Hosp Chiayi, Dept Neurosurg, Chiayi, Taiwan; [Chen, Chih-Feng] Asia Univ Hosp, Dept Diagnost Radiol, Taichung, Taiwan	Chang Gung Memorial Hospital; Chang Gung Memorial Hospital	Tsai, YH (corresponding author), Chang Gung Mem Hosp Chiayi, Dept Diagnost Radiol, Chiayi, Taiwan.	russel.tsai@gmail.com	; Weng, Hsu-Huei/N-8329-2014	Tsai, Yuan-Hsiung/0000-0003-4906-0365; Weng, Hsu-Huei/0000-0002-2020-8912	Chang Gung Memorial Hospital grants [CMRPG6C0282, CORPG6D0122]	Chang Gung Memorial Hospital grants(Chang Gung Memorial Hospital)	This study was supported by Chang Gung Memorial Hospital grants CMRPG6C0282 and CORPG6D0122. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bes A, 2013, CEPHALALGIA, V33, P629, DOI 10.1177/0333102413485658; Bogner W, 2012, RADIOLOGY, V263, P64, DOI 10.1148/radiol.12111494; DeSouza DD, 2014, PAIN, V155, P37, DOI 10.1016/j.pain.2013.08.029; Devor M, 2002, J NEUROSURG, V96, P532, DOI 10.3171/jns.2002.96.3.0532; Erbay SH, 2006, RADIOLOGY, V238, P689, DOI 10.1148/radiol.2382042214; FRIGYESI TL, 1975, EXP NEUROL, V49, P11, DOI 10.1016/0014-4886(75)90192-2; Fujiwara S, 2011, J NEUROIMAGING, V21, pe102, DOI 10.1111/j.1552-6569.2010.00508.x; Haller S, 2016, AJNR AM J NEURORADIO; Herweh C, 2007, NEUROLOGY, V68, P776, DOI 10.1212/01.wnl.0000256340.16766.1d; HILTON DA, 1994, NEUROSURGERY, V35, P299, DOI 10.1227/00006123-199408000-00017; Holdsworth SJ, 2011, AM J NEURORADIOL, V32, P1274, DOI 10.3174/ajnr.A2481; Iima M, 2012, AM J NEURORADIOL, V33, P1321, DOI 10.3174/ajnr.A2969; JENSEN MP, 1986, PAIN, V27, P117, DOI 10.1016/0304-3959(86)90228-9; Kanpolat Y, 1980, Acta Neurochir Suppl (Wien), V30, P363; Leal PRL, 2011, PAIN, V152, P2357, DOI 10.1016/j.pain.2011.06.029; Lee JS, 2003, ACAD EMERG MED, V10, P1128, DOI 10.1197/S1069-6563(03)00372-5; Liu Y, 2013, EUR J RADIOL, V82, P783, DOI 10.1016/j.ejrad.2012.11.027; Love S, 2001, BRAIN, V124, P2347, DOI 10.1093/brain/124.12.2347; Love S, 2001, NEUROPATH APPL NEURO, V27, P238, DOI 10.1046/j.0305-1846.2001.00318.x; Lutz J, 2011, RADIOLOGY, V258, P524, DOI 10.1148/radiol.10100477; Obermann Mark, 2010, Ther Adv Neurol Disord, V3, P107, DOI 10.1177/1756285609359317; Porter DA, 2009, MAGN RESON MED, V62, P468, DOI 10.1002/mrm.22024; RAMON F, 1978, AM J PHYSIOL, V234, pC162, DOI 10.1152/ajpcell.1978.234.5.C162; RASMINSKY M, 1978, ANN NEUROL, V3, P351, DOI 10.1002/ana.410030413; Skare S, 2007, MAGN RESON MED, V57, P881, DOI 10.1002/mrm.21176; SMITH HP, 1981, J NEUROSURG, V55, P246, DOI 10.3171/jns.1981.55.2.0246; SMITH KJ, 1980, NATURE, V286, P154, DOI 10.1038/286154a0; Yang Jen-Tsung, 2010, Chang Gung Med J, V33, P679; Yoshino N, 2003, RADIOLOGY, V228, P539, DOI 10.1148/radiol.2282020439	29	11	12	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2016	11	12							e0167584	10.1371/journal.pone.0167584	http://dx.doi.org/10.1371/journal.pone.0167584			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI9QF	27997548	gold, Green Published, Green Submitted			2022-12-27	WOS:000392842900011
J	Gorin, S; Kowialiewski, B; Majerus, S				Gorin, Simon; Kowialiewski, Benjamin; Majerus, Steve			Domain-Generality of Timing-Based Serial Order Processes in Short-Term Memory: New Insights from Musical and Verbal Domains	PLoS One			English	Article							WORKING-MEMORY; IRRELEVANT SPEECH; PHONOLOGICAL SIMILARITY; INDIVIDUAL-DIFFERENCES; SEQUENCE PRODUCTION; TONAL SEQUENCES; PITCH STRUCTURE; NETWORK MODEL; INFORMATION; RECALL	Several models in the verbal domain of short-term memory (STM) consider a dissociation between item and order processing. This view is supported by data demonstrating that different types of time-based interference have a greater effect on memory for the order of to be-remembered items than on memory for the items themselves. The present study investigated the domain-generality of the item versus serial order dissociation by comparing the differential effects of time-based interfering tasks, such as rhythmic interference and articulatory suppression, on item and order processing in verbal and musical STM domains. In Experiment 1, participants had to maintain sequences of verbal or musical information in STM, followed by a probe sequence, this under different conditions of interference (no-interference, rhythmic interference, articulatory suppression). They were required to decide whether all items of the probe list matched those of the memory list (item condition) or whether the order of the items in the probe sequence matched the order in the memory list (order condition). In Experiment 2, participants performed a serial order probe recognition task for verbal and musical sequences ensuring sequential maintenance processes, under no-interference or rhythmic interference conditions. For Experiment 1, serial order recognition was not significantly more impacted by interfering tasks than was item recognition, this for both verbal and musical domains. For Experiment 2, we observed selective interference of the rhythmic interference condition on both musical and verbal order STM tasks. Overall, the results suggest a similar and selective sensitivity to time-based interference for serial order STM in verbal and musical domains, but only when the STM tasks ensure sequential maintenance processes.	[Gorin, Simon; Kowialiewski, Benjamin; Majerus, Steve] Univ Liege, Fac Psychol Speech Therapy & Educ Sci, Psychol & Neurosci Cognit Res Unit PsyNCog, Liege, Belgium; [Gorin, Simon; Kowialiewski, Benjamin; Majerus, Steve] Fund Sci Res FNRS, Brussels, Belgium	University of Liege	Gorin, S (corresponding author), Univ Liege, Fac Psychol Speech Therapy & Educ Sci, Psychol & Neurosci Cognit Res Unit PsyNCog, Liege, Belgium.; Gorin, S (corresponding author), Fund Sci Res FNRS, Brussels, Belgium.	simon.gorin@ulg.ac.be	Kowialiewski, Benjamin/GLS-7853-2022; Gorin, Simon/ABD-9481-2020	Kowialiewski, Benjamin/0000-0002-7743-761X; Gorin, Simon/0000-0001-7462-0446; Majerus, Steve/0000-0002-8206-8097	Fund for Scientific Research-FNRS under a FRESH; Belgian Science Policy Office (BELSPO) [PAI-IUAPP7/11]; University of Liege [ARC12/17/01REST]	Fund for Scientific Research-FNRS under a FRESH(Fonds de la Recherche Scientifique - FNRS); Belgian Science Policy Office (BELSPO)(Belgian Federal Science Policy Office); University of Liege(University of Liege)	This research was supported by the Fund for Scientific Research-FNRS under a FRESH grant to SG (www.frs-fnrs.be); the Belgian Science Policy Office (BELSPO) under a PAI-IUAPP7/11 grant to SM (www.belspo.be); and the University of Liege under a ARC12/17/01REST grant to SM (www.ulg.ac.be). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrahamse E, 2014, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.00932; [Anonymous], 2014, R LANG ENV STAT COMP; Attout L, 2012, APHASIOLOGY, V26, P355, DOI 10.1080/02687038.2011.604303; Banbury SP, 2001, HUM FACTORS, V43, P12, DOI 10.1518/001872001775992462; Beaman CP, 1997, J EXP PSYCHOL LEARN, V23, P459, DOI 10.1037/0278-7393.23.2.459; Beaman CP, 1998, Q J EXP PSYCHOL-A, V51, P615, DOI 10.1080/713755774; Besson M, 2011, FRONT PSYCHOL, V2, DOI 10.3389/fpsyg.2011.00094; Blalock LD, 2015, ATTEN PERCEPT PSYCHO, V77, P1143, DOI 10.3758/s13414-014-0823-z; Botvinick M, 2007, J NEUROSCI, V27, P8636, DOI 10.1523/JNEUROSCI.2110-07.2007; Botvinick MM, 2006, PSYCHOL REV, V113, P201, DOI 10.1037/0033-295X.113.2.201; Brown GDA, 2000, PSYCHOL REV, V107, P127, DOI 10.1037/0033-295X.107.1.127; Burgess N, 1999, PSYCHOL REV, V106, P551, DOI 10.1037/0033-295X.106.3.551; Burgess N, 2006, J MEM LANG, V55, P627, DOI 10.1016/j.jml.2006.08.005; Camos V, MEMORY IN PRESS; Campoy G, 2015, Q J EXP PSYCHOL, V68, P759, DOI 10.1080/17470218.2014.966248; Cason N, 2015, NEUROPSYCHOLOGY, V29, P102, DOI 10.1037/neu0000115; Davies J., 1977, PSYCHOL MUSIC, V5, P3, DOI DOI 10.1177/030573567752001; DAVIES JB, 1977, J ACOUST SOC AM, V61, P534, DOI 10.1121/1.381295; DEUTSCH D, 1970, SCIENCE, V168, P1604, DOI 10.1126/science.168.3939.1604; DEUTSCH D, 1980, PERCEPT PSYCHOPHYS, V28, P381, DOI 10.3758/BF03204881; DEWAR KM, 1977, J EXP PSYCHOL-HUM L, V3, P60, DOI 10.1037/0278-7393.3.1.60; Dienes Z, 2014, FRONT PSYCHOL, V5, DOI 10.3389/fpsyg.2014.00781; Dienes Z, 2011, PERSPECT PSYCHOL SCI, V6, P274, DOI 10.1177/1745691611406920; Farrell S, 2004, J MEM LANG, V51, P115, DOI 10.1016/S0749-596X(04)00029-4; Farrell S, 2002, PSYCHON B REV, V9, P59, DOI 10.3758/BF03196257; Flaugnacco E, 2014, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.00392; Gordon RL, 2015, DEVELOPMENTAL SCI, V18, P635, DOI 10.1111/desc.12230; Goswami U, 2011, TRENDS COGN SCI, V15, P3, DOI 10.1016/j.tics.2010.10.001; Hartley T, 2016, COGNITIVE PSYCHOL, V87, P135, DOI 10.1016/j.cogpsych.2016.05.001; Hausen M, 2013, FRONT PSYCHOL, V4, DOI 10.3389/fpsyg.2013.00566; Henson R, 2003, Q J EXP PSYCHOL-A, V56, P1307, DOI 10.1080/02724980244000747; Henson R.N., 1996, THESIS; Henson RNA, 1998, COGNITIVE PSYCHOL, V36, P73, DOI 10.1006/cogp.1998.0685; Henson RNA, 1999, INT J PSYCHOL, V34, P403, DOI 10.1080/002075999399756; Henson RNA, 2000, NEUROPSYCHOLOGIA, V38, P426, DOI 10.1016/S0028-3932(99)00098-6; Hurlstone MJ, 2014, PSYCHOL BULL, V140, P339, DOI 10.1037/a0034221; Huss M, 2011, CORTEX, V47, P674, DOI 10.1016/j.cortex.2010.07.010; Johnson VE, 2013, P NATL ACAD SCI USA, V110, P19313, DOI 10.1073/pnas.1313476110; JONES DM, 1993, J EXP PSYCHOL LEARN, V19, P369, DOI 10.1037/0278-7393.19.2.369; Kraus N, 2015, TRENDS COGN SCI, V19, P642, DOI 10.1016/j.tics.2015.08.017; Krumhansl C.L., 1990, COGNITIVE FDN MUSICA, P77; Larsen JD, 2003, Q J EXP PSYCHOL-A, V56, P1249, DOI 10.1080/02724980244000765; LEE CL, 1981, J EXP PSYCHOL-HUM L, V7, P149, DOI 10.1037/0278-7393.7.3.149; Macken B, 2014, J EXP PSYCHOL LEARN, V40, P1257, DOI 10.1037/a0036845; MACKEN WJ, 1995, J EXP PSYCHOL LEARN, V21, P436, DOI 10.1037/0278-7393.21.2.436; Majerus S, 2006, NEUROIMAGE, V32, P880, DOI 10.1016/j.neuroimage.2006.03.048; Majerus S, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00357; Majerus S, 2009, INTERACTIONS BETWEEN SHORT-TERM AND LONG-TERM MEMORY IN THE VERBAL DOMAIN, P244; Majerus S, 2010, J COGNITIVE NEUROSCI, V22, P2570, DOI 10.1162/jocn.2009.21378; Martin N, 2004, COGN NEUROPSYCHOL, V21, P213, DOI 10.1080/02643290342000447; Mathias B, 2015, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.01040; Mathot S, 2012, BEHAV RES METHODS, V44, P314, DOI 10.3758/s13428-011-0168-7; Morey RD, 2015, PACKAGE BAYESFACTOR; Mullensiefen D., 2011, MUSIC MIND ESSAYS HO, P161; Nairne JS, 2004, J MEM LANG, V50, P113, DOI 10.1016/j.jml.2003.09.005; Ng HLH, 2002, Q J EXP PSYCHOL-A, V55, P391, DOI 10.1080/02724980143000343; Oberauer K, 2012, PSYCHON B REV, V19, P779, DOI 10.3758/s13423-012-0272-4; Page MPA, 1998, PSYCHOL REV, V105, P761, DOI 10.1037/0033-295X.105.4.761-781; Palmer C, 2003, PSYCHOL REV, V110, P683, DOI 10.1037/0033-295X.110.4.683; Patel A. D., 2008, MUSIC LANGUAGE BRAIN; Patel AD, 2014, HEARING RES, V308, P98, DOI 10.1016/j.heares.2013.08.011; Peretz I, 2003, NAT NEUROSCI, V6, P688, DOI 10.1038/nn1083; Peretz I, 2015, PHILOS T R SOC B, V370, P68, DOI 10.1098/rstb.2014.0090; Pfordresher PQ, 2007, COGNITIVE SCI, V31, P63, DOI 10.1080/03640210709336985; POIRIER M, 1995, Q J EXP PSYCHOL-A, V48, P384, DOI 10.1080/14640749508401396; Poirier M, 1996, CAN J EXP PSYCHOL, V50, P408, DOI 10.1037/1196-1961.50.4.408; Prince JB, 2014, J EXP PSYCHOL HUMAN, V40, P2319, DOI 10.1037/a0038010; Prince JB, 2014, J EXP PSYCHOL HUMAN, V40, P2073, DOI 10.1037/a0037730; Prince JB, 2009, MEM COGNITION, V37, P368, DOI 10.3758/MC.37.3.368; Rouder JN, 2009, PSYCHON B REV, V16, P225, DOI 10.3758/PBR.16.2.225; Rudner M, 2009, SCAND J PSYCHOL, V50, P495, DOI 10.1111/j.1467-9450.2009.00744.x; RYAN J, 1969, Q J EXP PSYCHOL, V21, P137, DOI 10.1080/14640746908400206; Saint-Aubin J, 1999, Q J EXP PSYCHOL-A, V52, P367, DOI 10.1080/027249899391115; Saito S, 2001, MEMORY, V9, P313, DOI 10.1080/09658210143000164; Saito S, 1998, JPN PSYCHOL RES, V40, P10, DOI 10.1111/1468-5884.00070; SAITO S, 1994, MEM COGNITION, V22, P181; Schendel ZA, 2007, MEM COGNITION, V35, P640, DOI 10.3758/BF03193302; Schulze K, 2013, MEMORY, V21, P377, DOI 10.1080/09658211.2012.731070; Schulze K, 2011, HUM BRAIN MAPP, V32, P771, DOI 10.1002/hbm.21060; Siedenburg K, 2016, MEMORY, P1; Strait D, 2011, MUSIC PERCEPT, V29, P133, DOI 10.1525/MP.2011.29.2.133; Surprenant AM, 2008, CAN J EXP PSYCHOL, V62, P141, DOI 10.1037/1196-1961.62.3.141; Tillmann B, 2016, BRAIN RES, V1640, P251, DOI 10.1016/j.brainres.2015.10.035; Tse CS, 2009, MEMORY, V17, P874, DOI 10.1080/09658210903376250; Vousden JI, 2000, COGNITIVE PSYCHOL, V41, P101, DOI 10.1006/cogp.2000.0739; Wagenmakers E.J, 2014, BAYESIAN COGNITIVE M, DOI DOI 10.1017/CBO9781139087759; Wagenmakers E.-J, 2008, BAYESIAN EVALUATION, P181, DOI [10.1007/978-0-387-09612-4_9, DOI 10.1007/978-0-387-09612-4_9, 10.1007/978-0-387-09612-4, DOI 10.1007/978-0-387-09612-4]; Wagenmakers EJ, 2007, PSYCHON B REV, V14, P779, DOI 10.3758/BF03194105; Williamson VJ, 2010, PSYCHOL MUSIC, V38, P331, DOI 10.1177/0305735609351918; Williamson VJ, 2010, MEM COGNITION, V38, P163, DOI 10.3758/MC.38.2.163; Zatorre RJ, 2008, PHILOS T R SOC B, V363, P1087, DOI 10.1098/rstb.2007.2161	91	16	16	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 19	2016	11	12							e0168699	10.1371/journal.pone.0168699	http://dx.doi.org/10.1371/journal.pone.0168699			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EI9QC	27992565	Green Published, Green Submitted, gold			2022-12-27	WOS:000392842600090
J	Pang, YL; Ali, J; Wang, XQ; Franje, NJ; Revilleza, JE; Xu, JL; Li, ZK				Pang, Yunlong; Ali, Jauhar; Wang, Xiaoqian; Franje, Neil Johann; Revilleza, Jastin Edrian; Xu, Jianlong; Li, Zhikang			Relationship of Rice Grain Amylose, Gelatinization Temperature and Pasting Properties for Breeding Better Eating and Cooking Quality of Rice Varieties	PLOS ONE			English	Article							STARCH PHYSICOCHEMICAL PROPERTIES; NONWAXY RICE; VISCOSITY; TRAITS	A total of 787 non-waxy rice lines-116 hybrids and 671 inbreds-were used to study the apparent amylose content (AAC), gelatinization temperature (GT), and rapid visco analyzer (RVA) pasting viscosity properties of rice starch to understand their importance in breeding better rice varieties. The investigated traits showed a wide range of diversity for both hybrid (HG) and inbred (IG) groups. The combinations of the different categories of AAC and GT were random in HG but were non-random in IG. For inbred lines, the high level of AAC tended to combine with the low level of GT, the intermediate level of AAC tended to have high or intermediate GT, and the low level of AAC tended to have high or low GT. Some stable correlations of the AAC, GT, and RVA properties may be the results derived from the physicochemical relationships among these traits, which rice breeders could utilize for selection in advanced breeding generations. Through cluster analysis, IG and HG were divided into 52 and 31 sub-clusters, respectively. Identifying the cultivars having AAC, GT, and RVA properties similar to that of popular high-quality rice varieties seems to be an interesting strategy and could be directly used for adaptation trials to breed high-quality rice varieties in targeted areas in a more customized manner.	[Pang, Yunlong; Wang, Xiaoqian; Xu, Jianlong; Li, Zhikang] Chinese Acad Agr Sci, Inst Crop Sci, Natl Key Facil Crop Gene Resources & Genet Improv, Beijing, Peoples R China; [Pang, Yunlong; Ali, Jauhar; Wang, Xiaoqian; Franje, Neil Johann; Revilleza, Jastin Edrian] Int Rice Res Inst, Manila, Philippines	Chinese Academy of Agricultural Sciences; Institute of Crop Sciences, CAAS; CGIAR; International Rice Research Institute (IRRI)	Ali, J (corresponding author), Int Rice Res Inst, Manila, Philippines.	j.ali@irri.org	Xu, Jianlong/AAI-8310-2020; Ali, Jauhar Ali or A. Jauhar/E-4432-2012	Ali, Jauhar Ali or A. Jauhar/0000-0002-3177-2607	Bill & Melinda Gates Foundation [OPP1130530-1]	Bill & Melinda Gates Foundation(Bill & Melinda Gates Foundation)	This research was supported by grant to ZL on "Green Super Rice project for resource poor rice farmers in Africa and Asia" from Bill & Melinda Gates Foundation (OPP1130530-1). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AACC International, 1997, APPR METH AN; Allahgholipour M, 2006, PLANT BREEDING, V125, P357, DOI 10.1111/j.1439-0523.2006.01252.x; Bao JS, 2012, CEREAL FOOD WORLD, V57, P148, DOI 10.1094/CFW-57-4-0148; Bao JS, 2006, STARCH-STARKE, V58, P259, DOI 10.1002/star.200500469; Calingacion M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085106; Charrad M, 2014, J STAT SOFTW, V61, P1; Chen MH, 2008, J CEREAL SCI, V48, P781, DOI 10.1016/j.jcs.2008.05.004; Han XZ, 2001, J CEREAL SCI, V34, P279, DOI 10.1006/jcrs.2001.0374; Hossain MS, 2009, SCIENCEASIA, V35, P320, DOI 10.2306/scienceasia1513-1874.2009.35.320; Hsu YC, 2014, MOL BREEDING, V34, P655, DOI 10.1007/s11032-014-0065-8; IRRI, 2013, STANDARD EVALUATION, P46; Jiranuntakul W, 2011, J FOOD ENG, V104, P246, DOI 10.1016/j.jfoodeng.2010.12.016; Jr FEH, 2015, HMISC HARRELL MISCEL; Juliano B.O., 1993, GRAIN QUALITY EVALUA; Juliano BO, 1985, CRITERIA TEST RICE G, P443; Juliano BO, 1972, PHYSICOCHEMICAL PROP, P389; Kong XL, 2015, FOOD CHEM, V172, P433, DOI 10.1016/j.foodchem.2014.09.085; Lestari P, 2009, J AGR FOOD CHEM, V57, P2754, DOI 10.1021/jf803804k; LITTLE RR, 1958, CEREAL CHEM, V35, P111; R Core Team, 2013, R LANG ENV STAT COMP; Sun MM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018385; Tan YF, 1999, THEOR APPL GENET, V99, P642, DOI 10.1007/s001220051279; Tian ZX, 2009, P NATL ACAD SCI USA, V106, P21760, DOI 10.1073/pnas.0912396106; Wang LQ, 2007, THEOR APPL GENET, V115, P463, DOI 10.1007/s00122-007-0580-7; Wu DX, 2011, ACTA AGRONOMICA SINI, V27, P165; Xu FF, 2015, MOL BREEDING, V35, DOI 10.1007/s11032-015-0296-3; Xu FF, 2013, J AGR FOOD CHEM, V61, P10110, DOI 10.1021/jf4029688; Yan ChangJie, 2005, Rice Science, V12, P39; Yang F, 2014, MOL BREEDING, V34, P1747, DOI 10.1007/s11032-014-0135-y; Zhou ZK, 2002, INT J FOOD SCI TECH, V37, P849, DOI 10.1046/j.1365-2621.2002.00625.x	30	43	45	2	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 19	2016	11	12							e0168483	10.1371/journal.pone.0168483	http://dx.doi.org/10.1371/journal.pone.0168483			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI9QC	27992591	gold, Green Published, Green Submitted			2022-12-27	WOS:000392842600067
J	Xiao, YM; Zhang, XF; Fan, SH; Cui, GH; Shen, ZY				Xiao, Yimin; Zhang, Xiaofei; Fan, Shihao; Cui, Guanghao; Shen, Zhenya			MicroRNA-497 Inhibits Cardiac Hypertrophy by Targeting Sirt4	PLOS ONE			English	Article							HEART-FAILURE; APOPTOSIS; PATHWAY	Cardiac hypertrophy is an adaptive enlargement of the myocardium in response to overload pressure of heart. From abundant studies, a conclusion is drawn that many microRNAs (miRNAs) are associated with cardiac hypertrophy and heart failure. To investigate the role of microRNA-497 (miR-497) in myocardial hypertrophy, two models were established in this study from cell level to integral level. Cardiac hypertrophy was induced by using angiotensin II (Ang II) in vitro and was created by transverse abdominal aortic constriction (TAC) in vivo. There was a significant decrease expression of miR-497 in cardiac hypertrophy models. Moreover, overexpression of miR-497 inhibited myocardial hypertrophy both in vitro and in vivo without heart function variation. In addition, luciferase reporter assays demonstrated that Sirt4 was a direct target gene of miR-497. Taking together, our study indicates that miR-497 modulates cardiac hypertrophy by targeting Sirt4 and may serve as a potential therapeutic substance in the course.	[Xiao, Yimin; Zhang, Xiaofei; Fan, Shihao; Cui, Guanghao; Shen, Zhenya] Soochow Univ, Affiliated Hosp 1, Dept Cardiovasc Surg, Suzhou, Peoples R China; [Xiao, Yimin; Zhang, Xiaofei; Fan, Shihao; Cui, Guanghao; Shen, Zhenya] Soochow Univ, Inst Cardiovasc Sci, Suzhou, Peoples R China; [Xiao, Yimin; Zhang, Xiaofei; Fan, Shihao] Shanghai Yodak Cardiothrac Hosp, Dept Cardiovasc Surg, Shanghai, Peoples R China	Soochow University - China; Soochow University - China	Shen, ZY (corresponding author), Soochow Univ, Affiliated Hosp 1, Dept Cardiovasc Surg, Suzhou, Peoples R China.; Shen, ZY (corresponding author), Soochow Univ, Inst Cardiovasc Sci, Suzhou, Peoples R China.	uuzyshen@aliyun.com						Communal C, 1998, CIRCULATION, V98, P1329, DOI 10.1161/01.CIR.98.13.1329; Ge L, 2016, ONCOL LETT, V11, P2207, DOI 10.3892/ol.2016.4162; Greco CM, 2015, NAT REV CARDIOL, V12, P488, DOI 10.1038/nrcardio.2015.71; Kamo T, 2015, CIRC RES, V117, P89, DOI 10.1161/CIRCRESAHA.117.305349; Li XX, 2015, ONCOTARGET, V6, P18829, DOI 10.18632/oncotarget.4774; Liu J, 2016, DNA CELL BIOL; Liu Q, 2016, MOL MED REP, V14, P439, DOI 10.3892/mmr.2016.5256; Luo YX, 2016, EUROPEAN HEART J; Lv DC, 2015, MINI-REV MED CHEM, V15, P475, DOI 10.2174/1389557515666150324124751; Mukku RB, 2016, J CARD FAIL, V22, P439, DOI 10.1016/j.cardfail.2016.04.009; Ono K, 2015, ADV EXP MED BIOL, V888, P197, DOI 10.1007/978-3-319-22671-2_10; POTTER GD, 1989, J PEDIATR GASTR NUTR, V8, P516, DOI 10.1097/00005176-198905000-00016; Raut SK, 2016, MOL CELL BIOCHEM, V417, P191, DOI 10.1007/s11010-016-2729-7; Shimizu I, 2016, J MOL CELLULAR CARDI; Sun XM, 2015, INT J CLIN EXP PATHO, V8, P14500; Tarantino G, 2014, OXID MED CELL LONGEV, V2014, DOI 10.1155/2014/920676; Tijsen AJ, 2014, CARDIOVASC RES, V104, P61, DOI 10.1093/cvr/cvu184; Vegter EL, 2016, EUR J HEART FAIL, V18, P457, DOI 10.1002/ejhf.495; Verdin E, 2010, TRENDS BIOCHEM SCI, V35, P669, DOI 10.1016/j.tibs.2010.07.003; Yang L, 2016, J BIOL CHEM; Zhu YM, 2014, CANCER METAB, V2, DOI 10.1186/2049-3002-2-15	21	35	39	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2016	11	12							e0168078	10.1371/journal.pone.0168078	http://dx.doi.org/10.1371/journal.pone.0168078			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI8LN	27992564	Green Submitted, Green Published, gold			2022-12-27	WOS:000392758000025
J	Treese, C; Sanchez, P; Grabowski, P; Berg, E; Blaker, H; Kruschewski, M; Haase, O; Hummel, M; Daum, S				Treese, Christoph; Sanchez, Pedro; Grabowski, Patricia; Berg, Erika; Blaeker, Hendrik; Kruschewski, Martin; Haase, Oliver; Hummel, Michael; Daum, Severin			Poorly Differentiated Medullary Phenotype Predicts Poor Survival in Early Lymph Node-Negative Gastro-Esophageal Adenocarcinomas	PLOS ONE			English	Article							EARLY GASTRIC-CANCER; PROGNOSTIC-FACTORS; REGRESSION-ANALYSIS; CURATIVE RESECTION; SEROSAL INVASION; EXPRESSION; CARCINOMA; P53; MARKER; RECURRENCE	Background 5-year survival rate in patients with early adenocarcinoma of the gastro-esophageal junction or stomach (AGE/S) in Caucasian patients is reported to be 60-80%. We aimed to identify prognostic markers for patients with UICC-I without lymph-node involvement (N0). Methods Clinical data and tissue specimen from patients with AGE/S stage UICC-I-N0, treated by surgery only, were collected retrospectively. Tumor size, lymphatic vessel or vein invasion, grading, classification systems (WHO, Lauren, Ming), expression of BAX, BCL-2, CDX2, Cyclin E, E-cadherin, Ki-67, TP53, TP21, SHH, Survivin, HIF1A, TROP2 and mismatch repair deficiency were analyzed using tissue microarrays and correlated with overall and tumor related survival. Results 129 patients (48 female) with a mean follow-up of 129.1 months were identified. 5-year overall survival was 83.9%, 5-year tumor related survival was 95.1%. Poorly differentiated medullary cancer subtypes (p<0.001) and positive vein invasion (p<0.001) were identified as risk factors for decreased overall-and tumor related survival. Ki-67 (p = 0.012) and TP53 mutation (p = 0.044) were the only immunohistochemical markers associated with worse overall survival but did not reach significance for decreased tumor related survival. Conclusion In the presented study patients with AGE/S in stage UICC-I-N0 had a better prognosis as previously reported for Caucasian patients. Poorly differentiated medullary subtype was associated with reduced survival and should be considered when studying prognosis in these patients.	[Treese, Christoph; Sanchez, Pedro; Grabowski, Patricia; Daum, Severin] Charite Univ Med Berlin, Dept Gastroenterol Infect Dis & Rheumatol, Campus Benjamin Franklin, Berlin, Germany; [Treese, Christoph] Berlin Inst Hlth, Berlin, Germany; [Grabowski, Patricia] Zent Klin Bad Berka GmbH, Dept Gastroenterol & Endocrinol, Bad Berka, Germany; [Berg, Erika; Blaeker, Hendrik; Hummel, Michael] Charite Univ Med Berlin, Inst Pathol, Campus Benjamin Franklin, Berlin, Germany; [Kruschewski, Martin] Stadt Klinikum Solingen GmbH, Dept Gen Visceral & Thorac Surg, Solingen, Germany; [Haase, Oliver] Charite Univ Med Berlin, Dept Gen Visceral Vasc & Thorac Surg, Campus Mitte, Berlin, Germany	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Berlin Institute of Health; Zentralklinik Bad Berka; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Treese, C (corresponding author), Charite Univ Med Berlin, Dept Gastroenterol Infect Dis & Rheumatol, Campus Benjamin Franklin, Berlin, Germany.; Treese, C (corresponding author), Berlin Inst Hlth, Berlin, Germany.	christoph.treese@charite.de	Haase, Oliver/W-9231-2019	Haase, Oliver/0000-0002-3220-6236; Hummel, Michael/0000-0001-6717-605X; Treese, Christoph/0000-0001-9120-6773; Daum, Severin/0000-0003-0060-6013	Berliner Krebsgesellschaft [DAFF201101]; Charite-University Medicine Berlin; Berlin Institute of Health	Berliner Krebsgesellschaft; Charite-University Medicine Berlin; Berlin Institute of Health	This study has been supported by a grant from Berliner Krebsgesellschaft (DAFF201101) (http://www.berliner-krebsgesellschaft.de). C. Treese is a participant in the Charite Clinical Scientist Program funded by the Charite-University Medicine Berlin and the Berlin Institute of Health (http://www.stiftung-charite.de/en/funding/private-excellence-initiative-johanna-quandt/bih-clinical-scientists.html).	ADACHI Y, 1992, CANCER, V70, P1462, DOI 10.1002/1097-0142(19920915)70:6<1462::AID-CNCR2820700603>3.0.CO;2-E; BABA H, 1989, ARCH SURG-CHICAGO, V124, P1061; Bai Z, 2007, APMIS, V115, P1383, DOI 10.1111/j.1600-0463.2007.00654.x; Bass AJ, 2014, NATURE, V513, P202, DOI 10.1038/nature13480; Berlth F, 2014, WORLD J GASTROENTERO, V20, P5679, DOI 10.3748/wjg.v20.i19.5679; Borie F, 2004, WORLD J SURG, V28, P686, DOI 10.1007/s00268-004-7127-8; Busuttil RA, 2014, ONCOTARGET, V5, P12016, DOI 10.18632/oncotarget.2434; Cristescu R, 2015, NAT MED, P21; D'Angelica M, 2004, ANN SURG, V240, P808, DOI 10.1097/01.sla.0000143245.28656.15; Fassan M, 2014, GASTRIC CANCER, V17, P442, DOI 10.1007/s10120-013-0315-1; Fenoglio-Preiser CM, 2003, HUM MUTAT, V21, P258, DOI 10.1002/humu.10180; Ferlay J, 2013, GLOBOCAN 2012 V1 0 C; Ferlay J, 2014, INT J CANC; Gamboa-Dominguez A, 2007, J CLIN PATHOL, V60, P756, DOI 10.1136/jcp.2006.038976; Gemmill EH, 2015, ANN ROY COLL SURG, V97, P173, DOI 10.1308/003588414X14055925061630; Grabowski P, 2003, BRIT J CANCER, V88, P115, DOI 10.1038/sj.bjc.6600696; Hamilton SR., 2000, WORLD HLTH ORG CLASS; Holscher AH, 2009, ANN SURG, V250, P791, DOI 10.1097/SLA.0b013e3181bdd3e4; Huang BJ, 2011, EXP THER MED, V2, P1059, DOI 10.3892/etm.2011.323; Isozaki H, 1999, HEPATO-GASTROENTEROL, V46, P2669; Jiaqing Li, 1998, Gastric Cancer, V1, P160, DOI 10.1007/s101200050011; KAIBARA N, 1985, J SURG ONCOL, V28, P195, DOI 10.1002/jso.2930280310; Kim JH, 2008, J SURG ONCOL, V97, P125, DOI 10.1002/jso.20937; Kouraklis G, 2009, DIGEST DIS SCI, V54, P1015, DOI 10.1007/s10620-008-0464-y; Krieg A, 2013, MOL BIOL REP, V40, P5501, DOI 10.1007/s11033-013-2650-z; Lee KB, 2013, APMIS, V121, P926, DOI 10.1111/apm.12119; Li N, 2014, MED ONCOL, P32; Liarmakopoulos E, 2013, MOL MED REP, V7, P887, DOI 10.3892/mmr.2012.1247; Lin SC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056675; Marrelli D, 2012, ANN SURG, V255, P486, DOI 10.1097/SLA.0b013e3182389b1a; McShane LM, 2006, BREAST CANCER RES TR, V100, P229, DOI 10.1007/s10549-006-9242-8; Mrozek A, 2003, CELL DEATH DIFFER, V10, P461, DOI 10.1038/sj.cdd.4401193; Muhlmann G, 2009, J CLIN PATHOL, V62, P152, DOI 10.1136/jcp.2008.060590; Okuyama T, 2002, ONCOLOGY-BASEL, V63, P353, DOI 10.1159/000066223; Peduzzi P, 1995, J CLIN EPIDEMIOL, V48, P1503, DOI 10.1016/0895-4356(95)00048-8; Ren G, 2013, WORLD J GASTROENTERO, V19, P3096, DOI 10.3748/wjg.v19.i20.3096; Saragoni L, 2013, GASTRIC CANCER, V16, P549, DOI 10.1007/s10120-013-0233-2; Siewert JR, 1998, ANN SURG, V228, P449, DOI 10.1097/00000658-199810000-00002; Songun I, 2010, LANCET ONCOL, V11, P439, DOI 10.1016/S1470-2045(10)70070-X; Sumiyoshi Y, 2006, CLIN CANCER RES, V12, P5112, DOI 10.1158/1078-0432.CCR-05-2382; Vallbohmer D, 2008, PHARMACOGENOMICS, V9, P681, DOI 10.2217/14622416.9.6.681; Warneke VS, 2013, DIAGN MOL PATHOL, V22, P127, DOI 10.1097/PDM.0b013e318284188e; Wu JH, 2014, WORLD J SURG ONCOL, V12, DOI 10.1186/1477-7819-12-40; Xiao LJ, 2013, ONCOL LETT, V6, P1277, DOI 10.3892/ol.2013.1532; Yasui Wataru, 2005, Gastric Cancer, V8, P86, DOI 10.1007/s10120-005-0320-0; Yemelyanova A, 2011, MODERN PATHOL, V24, P1248, DOI 10.1038/modpathol.2011.85; Yildirim Mustafa, 2015, Asian Pac J Cancer Prev, V16, P327; Yoon HJ, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/576306; Youn HG, 2010, ANN SURG ONCOL, V17, P448, DOI 10.1245/s10434-009-0772-2; Zhu L, 2015, MOL CLIN ONCOL, V3, P699, DOI 10.3892/mco.2015.506	50	1	1	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2016	11	12							e0168237	10.1371/journal.pone.0168237	http://dx.doi.org/10.1371/journal.pone.0168237			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EG7JB	28030564	gold, Green Published			2022-12-27	WOS:000391222000041
J	Baldry, M; Nielsen, A; Bojer, MS; Zhao, Y; Friberg, C; Ifrah, D; Heede, NG; Larsen, TO; Frokiaer, H; Frees, D; Zhang, LX; Dai, HQ; Ingmer, H				Baldry, Mara; Nielsen, Anita; Bojer, Martin S.; Zhao, Yu; Friberg, Cathrine; Ifrah, Dan; Heede, Nina Glasser; Larsen, Thomas O.; Frokiaer, Hanne; Frees, Dorte; Zhang, Lixin; Dai, Huanqin; Ingmer, Hanne			Norlichexanthone Reduces Virulence Gene Expression and Biofilm Formation in Staphylococcus aureus	PLOS ONE			English	Article							DNA-BINDING; DETERMINANT EXPRESSION; GENOME SEQUENCE; IDENTIFICATION; TRANSCRIPTION; INHIBITION; MECHANISMS; RESISTANCE; EVOLUTION; INFECTION	Staphylococcus aureus is a serious human pathogen and antibiotic resistant, community-associated strains, such as the methicillin resistant S. aureus (MRSA) strain USA300, continue to spread. To avoid resistance, anti-virulence therapy has been proposed where toxicity is targeted rather than viability. Previously we have shown that norlichexanthone, a small non-reduced tricyclic polyketide produced by fungi and lichens, reduces expression of hla encoding a-hemolysin as well as the regulatory RNAIII of the agr quorum sensing system in S. aureus 8325-4. The aim of the present study was to further characterise the mode of action of norlichexanthone and its effect on biofilm formation. We find that norlichexanthone reduces expression of both hla and RNAIII also in strain USA300. Structurally, norlichexanthone resembles.-hydroxyemodin that recently was shown to bind the agr two component response regulator, AgrA, which controls expression of RNAIII and the phenol soluble modulins responsible for human neutrophil killing. We show that norlichexanthone reduces S. aureus toxicity towards human neutrophils and interferes directly with AgrA binding to its DNA target. In contrast to.-hydroxyemodin however, norlichexanthone reduces staphylococcal biofilm formation. Transcriptomic analysis revealed that genes regulated by the SaeRS two-component system are repressed by norlichexanthone when compared to untreated cells, an effect that was mitigated in strain Newman carrying a partially constitutive SaeRS system. Our data show that norlichexanthone treatment reduces expression of key virulence factors in CA-MRSA strain USA300 via AgrA binding and represses biofilm formation.	[Baldry, Mara; Nielsen, Anita; Bojer, Martin S.; Friberg, Cathrine; Ifrah, Dan; Heede, Nina Glasser; Frokiaer, Hanne; Frees, Dorte; Ingmer, Hanne] Univ Copenhagen, Fac Hlth & Med Sci, Dept Vet Dis Biol, Frederiksberg C, Denmark; [Zhao, Yu; Zhang, Lixin; Dai, Huanqin] Chinese Acad Sci, Key Lab Pathogen Microbiol & Immunol, Inst Microbiol, Beijing, Peoples R China; [Larsen, Thomas O.] Tech Univ Denmark, Dept Syst Biol, Ctr Microbial Biotechnol, Lyngby, Denmark; [Friberg, Cathrine] Novo Nordisk, Gentofte, Denmark; [Ifrah, Dan] Agilent Technol, Glostrup, Denmark; [Heede, Nina Glasser] Gentofte Univ Hosp, Hellerup, Denmark	University of Copenhagen; Chinese Academy of Sciences; Institute of Microbiology, CAS; Technical University of Denmark; Agilent Technologies; University of Copenhagen; Herlev & Gentofte Hospital	Ingmer, H (corresponding author), Univ Copenhagen, Fac Hlth & Med Sci, Dept Vet Dis Biol, Frederiksberg C, Denmark.; Dai, HQ (corresponding author), Chinese Acad Sci, Key Lab Pathogen Microbiol & Immunol, Inst Microbiol, Beijing, Peoples R China.	daihuanqin@139.com; hi@sund.ku.dk		Baldry, Mara/0000-0001-6005-1078; Frokiaer, Hanne/0000-0003-1472-9698; Bojer, Martin Saxtorph/0000-0002-8488-9593; Ingmer, Hanne/0000-0002-8350-5631; Frees, Dorte/0000-0003-4946-2890; Zhang, Lixin/0000-0003-0894-9520; Larsen, Thomas Ostenfeld/0000-0002-3362-5707	Seventh framework programme; Danmarks Grundforskningsfond [DNRF 120]; Danish Council for Independent Research [1337-00129, 1335-00772, 12-127417]	Seventh framework programme(European Commission); Danmarks Grundforskningsfond(Danmarks Grundforskningsfond); Danish Council for Independent Research(Det Frie Forskningsrad (DFF))	Seventh framework programme supported Mara Baldry, Danmarks Grundforskningsfond supported Hanne Ingmer, DNRF 120, Danish Council for Independent Research 1337-00129 and 1335-00772 supported Martin Bojer, and Danish Council for Independent Research 12-127417 supported Hanne Ingmer.	Baba T, 2008, J BACTERIOL, V190, P300, DOI 10.1128/JB.01000-07; Boles BR, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000052; Chan PF, 1998, MICROBIOL-SGM, V144, P2469, DOI 10.1099/00221287-144-9-2469; Clatworthy AE, 2007, NAT CHEM BIOL, V3, P541, DOI 10.1038/nchembio.2007.24; Daly SM, 2015, ANTIMICROB AGENTS CH, V59, P2223, DOI 10.1128/AAC.04564-14; del Pozo JL, 2007, CLIN PHARMACOL THER, V82, P204, DOI 10.1038/sj.clpt.6100247; Diep BA, 2006, LANCET, V367, P731, DOI 10.1016/S0140-6736(06)68231-7; FISCHETTI VA, 2000, GRAM POSITIVE PATHOG; Frees D, 2004, MOL MICROBIOL, V54, P1445, DOI 10.1111/j.1365-2958.2004.04368.x; Geiger T, 2008, J BACTERIOL, V190, P3419, DOI 10.1128/JB.01927-07; Geisinger E, 2009, P NATL ACAD SCI USA, V106, P1216, DOI 10.1073/pnas.0807760106; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; George EA, 2007, CHEMBIOCHEM, V8, P847, DOI 10.1002/cbic.200700023; Gordon CP, 2013, J MED CHEM, V56, P1389, DOI 10.1021/jm3014635; Graves SF, 2010, J MOL MED, V88, P109, DOI 10.1007/s00109-009-0573-x; Haaber J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041075; Horsburgh MJ, 2002, J BACTERIOL, V184, P5457, DOI 10.1128/JB.184.19.5457-5467.2002; Jelsbak L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012752; Kennedy AD, 2008, P NATL ACAD SCI USA, V105, P1327, DOI 10.1073/pnas.0710217105; Kobayashi SD, 2011, J INFECT DIS, V204, P937, DOI 10.1093/infdis/jir441; Leonard PG, 2012, BIOCHEMISTRY-US, V51, P10035, DOI 10.1021/bi3011785; Lowy FD, 1998, NEW ENGL J MED, V339, P13; Mainiero M, 2010, J BACTERIOL, V192, P613, DOI 10.1128/JB.01242-09; Mansson M, 2011, MAR DRUGS, V9, P2537, DOI 10.3390/md9122537; McCarthy DJ, 2009, BIOINFORMATICS, V25, P765, DOI 10.1093/bioinformatics/btp053; Moran GJ, 2006, NEW ENGL J MED, V355, P666, DOI 10.1056/NEJMoa055356; Mrak LN, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038453; Neumann Y, 2015, ARCH MICROBIOL, V197, P245, DOI 10.1007/s00203-014-1048-1; Nicod SS, 2014, NUCLEIC ACIDS RES, V42, P12523, DOI 10.1093/nar/gku1015; Nielsen A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084992; Nielsen A, 2010, ANTIMICROB AGENTS CH, V54, P509, DOI 10.1128/AAC.00940-09; Nielsen Lene N, 2012, BMC Res Notes, V5, P457, DOI 10.1186/1756-0500-5-457; Novick RP, 2003, MICROBIOL-SGM, V149, P2709, DOI 10.1099/mic.0.26575-0; NOVICK RP, 1967, J EXP MED, V125, P45, DOI 10.1084/jem.125.1.45; Peres V, 2000, PHYTOCHEMISTRY, V55, P683, DOI 10.1016/S0031-9422(00)00303-4; Periasamy S, 2012, P NATL ACAD SCI USA, V109, P1281, DOI 10.1073/pnas.1115006109; Pohl K, 2009, J BACTERIOL, V191, P2953, DOI 10.1128/JB.01492-08; Queck SY, 2008, MOL CELL, V32, P150, DOI 10.1016/j.molcel.2008.08.005; Rasko DA, 2010, NAT REV DRUG DISCOV, V9, P117, DOI 10.1038/nrd3013; Smyth GK, 2005, BIOINFORMATICS, V21, P2067, DOI 10.1093/bioinformatics/bti270; Strommenger B, 2013, J ANTIMICROBIAL CHEM; Sully EK, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004174; Sun F, 2010, J BACTERIOL, V192, P2111, DOI 10.1128/JB.01524-09; Vanassche T, 2012, THROMB HAEMOSTASIS, V107, P1107, DOI 10.1160/TH11-12-0891; Voyich JA, 2005, J IMMUNOL, V175, P3907, DOI 10.4049/jimmunol.175.6.3907; Vuong C, 2000, J INFECT DIS, V182, P1688, DOI 10.1086/317606; Wang R, 2007, NAT MED, V13, P1510, DOI 10.1038/nm1656	47	36	36	1	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2016	11	12							e0168305	10.1371/journal.pone.0168305	http://dx.doi.org/10.1371/journal.pone.0168305			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI9QH	28005941	gold, Green Published, Green Submitted			2022-12-27	WOS:000392843200043
J	Hicks, DJ				Hicks, Daniel J.			Bibliometrics for Social Validation	PLoS One			English	Article								This paper introduces a bibliometric, citation network-based method for assessing the social validation of novel research, and applies this method to the development of high-throughput toxicology research at the US Environmental Protection Agency. Social validation refers to the acceptance of novel research methods by a relevant scientific community; it is formally independent of the technical validation of methods, and is frequently studied in history, philosophy, and social studies of science using qualitative methods. The quantitative methods introduced here find that high-throughput toxicology methods are spread throughout a large and well-connected research community, which suggests high social validation. Further assessment of social validation involving mixed qualitative and quantitative methods are discussed in the conclusion.	[Hicks, Daniel J.] Univ Western Ontario, Rotman Inst Philosophy, London, ON, Canada; [Hicks, Daniel J.] US EPA, Amer Assoc Adv Sci, Off Res & Dev, Washington, DC 20460 USA	Western University (University of Western Ontario); United States Environmental Protection Agency	Hicks, DJ (corresponding author), Univ Western Ontario, Rotman Inst Philosophy, London, ON, Canada.; Hicks, DJ (corresponding author), US EPA, Amer Assoc Adv Sci, Off Res & Dev, Washington, DC 20460 USA.	hicks.daniel.j@gmail.com	Hicks, Daniel J./H-3657-2019	Hicks, Daniel J./0000-0001-7945-4416				Blei DM, 2003, J MACH LEARN RES, V3, P993, DOI 10.1162/jmlr.2003.3.4-5.993; Browne P, 2015, ENVIRON SCI TECHNOL, V49, P8804, DOI 10.1021/acs.est.5b02641; Catalini C, 2015, P NATL ACAD SCI USA, V112, P13823, DOI 10.1073/pnas.1502280112; CHUBIN DE, 1979, SCIENTOMETRICS, V1, P171, DOI 10.1007/BF02016969; Collins H., 1985, CHANGING ORDER; Dietz L., 2007, P 24 INT C MACHINE L, P233, DOI DOI 10.1145/1273496.1273526; Fleck Ludwik, 1979, GENESIS DEV SCI FACT; Fortunato S, 2010, PHYS REP, V486, P75, DOI 10.1016/j.physrep.2009.11.002; Gigerenzer G., 2004, J SOCIO-ECON, V33, P587, DOI DOI 10.1016/J.SOCEC.2004.09.033; Good BH, 2010, PHYS REV E, V81, DOI 10.1103/PhysRevE.81.046106; Greenberg SA, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b2680; Hicks D., 2016, BIBLIOMETRICS SOCIAL; Hicks D., 2016, SOURC COD BIBL SOC V; HUMMON NP, 1989, SOC NETWORKS, V11, P39, DOI 10.1016/0378-8733(89)90017-8; Hutchins BI, 2016, PLOS BIOL, V14, DOI 10.1371/journal.pbio.1002541; Ioannidis JPA, 2015, PLOS BIOL, V13, DOI 10.1371/journal.pbio.1002264; Janesick AS, 2016, ENVIRON HEALTH PERSP, V124, P1214, DOI 10.1289/ehp.1510352; Kuhn T. S., 1996, STRUCTURE SCI REVOLU; Longino H. E., 1990, SCI SOCIAL KNOWLEDGE, DOI [10.1515/9780691209753, DOI 10.2307/J.CTVX5WBFZ]; Ma N, 2008, INFORM PROCESS MANAG, V44, P800, DOI 10.1016/j.ipm.2007.06.006; MARSHAKOVA IV, 1981, SCIENTOMETRICS, V3, P13, DOI 10.1007/BF02021861; Mayo DG, 2006, BRIT J PHILOS SCI, V57, P323, DOI 10.1093/bjps/axl003; Mingers J, 2015, EUR J OPER RES, V246, P1, DOI 10.1016/j.ejor.2015.04.002; Newman MEJ, 2006, P NATL ACAD SCI USA, V103, P8577, DOI 10.1073/pnas.0601602103; Peixoto TP, 2014, PHYS REV E, V89, DOI 10.1103/PhysRevE.89.012804; Peixoto TP., 2015, GRAPH TOOL 2 12; Peixoto TP., 2016, INFERRING NETWORK ST; Reichardt J, 2006, PHYS REV E, V74, DOI 10.1103/PhysRevE.74.016110; Silva M, 2015, BIRTH DEFECTS RES B, V104, P71, DOI 10.1002/bdrb.21140; US EPA, 2015, CHEM SAF SUST STRAT	30	3	3	2	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2016	11	12							e0168597	10.1371/journal.pone.0168597	http://dx.doi.org/10.1371/journal.pone.0168597			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EI9QH	28005974	Green Published, Green Submitted, gold			2022-12-27	WOS:000392843200069
J	Hinton, AO; Yang, YJ; Quick, AP; Xu, PW; Reddy, CL; Yan, XF; Reynolds, CL; Tong, QC; Zhu, LR; Xu, JM; Wehrens, XHT; Xu, Y; Reddy, AK				Hinton, Antentor Othrell, Jr.; Yang, Yongjie; Quick, Ann P.; Xu, Pingwen; Reddy, Chitra L.; Yan, Xiaofeng; Reynolds, Corey L.; Tong, Qingchun; Zhu, Liangru; Xu, Jianming; Wehrens, Xander H. T.; Xu, Yong; Reddy, Anilkumar K.			SRC-1 Regulates Blood Pressure and Aortic Stiffness in Female Mice	PLoS One			English	Article							ESTROGEN-RECEPTOR-ALPHA; DEOXYCORTICOSTERONE-SALT HYPERTENSION; POSTMENOPAUSAL WOMEN; PARAVENTRICULAR NUCLEUS; SYSTOLIC HYPERTENSION; BETA; HORMONE; RATS; AGE; PREVALENCE	Framingham Heart Study suggests that dysfunction of steroid receptor coactivator-1 may be involved in the development of hypertension. However, there is no functional evidence linking steroid receptor coactivator-1 to the regulation of blood pressure. We used immunohistochemistry to map the expression of steroid receptor coactivator-1 protein in mouse brain, especially in regions implicated in the regulation of blood pressure. Steroid receptor coactivator-1 protein was found in central amygdala, medial amygdala, supraoptic nucleus, arcuate nucleus, ventromedial, dorsomedial, paraventricular hypothalamus, and nucleus of the solitary tract. To determine the effects of steroid receptor coactivator-1 protein on cardiovascular system we measured blood pressures, blood flow velocities, echocardiographic parameters, and aortic input impedance in female steroid receptor coactivator-1 knockout mice and their wild type littermates. Steroid receptor coactivator-1 knockout mice had higher blood pressures and increased aortic stiffness when compared to female wild type littermates. Additionally, the hearts of steroid receptor coactivator-1 knockout mice seem to consume higher energy as evidenced by increased impedance and higher heart rate pressure product when compared to female wild type littermates. Our results demonstrate that steroid receptor coactivator-1 may be functionally involved in the regulation of blood pressure and aortic stiffness through the regulation of sympathetic activation in various neuronal populations.	[Hinton, Antentor Othrell, Jr.; Yang, Yongjie; Xu, Pingwen; Yan, Xiaofeng; Xu, Yong] Baylor Coll Med, Childrens Nutr Res Ctr, Pediat, Houston, TX 77030 USA; [Quick, Ann P.; Reynolds, Corey L.; Wehrens, Xander H. T.] Baylor Coll Med, Dept Mol Physiol & Biophys, Houston, TX 77030 USA; [Quick, Ann P.; Reynolds, Corey L.; Wehrens, Xander H. T.; Reddy, Anilkumar K.] Baylor Coll Med, Cardiovasc Res Inst, Houston, TX 77030 USA; [Reddy, Chitra L.] Debakey High Sch Hlth Profess, Houston, TX USA; [Reynolds, Corey L.] Baylor Coll Med, Adv Technol Core Lab, Houston, TX 77030 USA; [Tong, Qingchun] Univ Texas Hlth Sci Ctr Houston, Brown Fdn Inst Mol Med, Houston, TX 77030 USA; [Zhu, Liangru] Union Hosp, Tongji Med Coll, Dept Gastroenterol, Wuhan, Peoples R China; [Zhu, Liangru] Huazhong Univ Sci & Technol, Wuhan, Peoples R China; [Xu, Jianming; Xu, Yong] Baylor Coll Med, Dept Mol & Cellular Biol, Houston, TX 77030 USA; [Reddy, Anilkumar K.] Baylor Coll Med, Dept Med, Sect Cardiovasc Res, Houston, TX 77030 USA; [Reddy, Anilkumar K.] Baylor Coll Med, DeBakey Heart Ctr, Houston, TX 77030 USA; [Reddy, Anilkumar K.] Ind Instruments, Webster, TX 77598 USA; [Hinton, Antentor Othrell, Jr.] Univ Iowa, Dept Internal Med, Div Endocrinol, Carver Coll Med, Iowa City, IA 52242 USA	Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; University of Texas System; University of Texas Health Science Center Houston; Huazhong University of Science & Technology; Huazhong University of Science & Technology; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; The Methodist Hospital System; The Methodist Hospital - Houston; Methodist DeBakey Heart & Vascular Center; University of Iowa	Xu, Y (corresponding author), Baylor Coll Med, Childrens Nutr Res Ctr, Pediat, Houston, TX 77030 USA.; Reddy, AK (corresponding author), Baylor Coll Med, Cardiovasc Res Inst, Houston, TX 77030 USA.; Xu, Y (corresponding author), Baylor Coll Med, Dept Mol & Cellular Biol, Houston, TX 77030 USA.; Reddy, AK (corresponding author), Baylor Coll Med, Dept Med, Sect Cardiovasc Res, Houston, TX 77030 USA.; Reddy, AK (corresponding author), Baylor Coll Med, DeBakey Heart Ctr, Houston, TX 77030 USA.; Reddy, AK (corresponding author), Ind Instruments, Webster, TX 77598 USA.	yongx@bcm.edu; areddy@bcm.edu	Xu, Pingwen/GRR-9137-2022; Reddy, Anilkumar/GLS-1391-2022; Wehrens, Xander/AAQ-9574-2020	Wehrens, Xander/0000-0001-5044-672X; Quick, Ann P./0000-0003-4223-6217; Xu, Yong/0000-0002-4908-1572; Hinton, Jr., Antentor/0000-0002-7730-952X; Tong, Qingchun/0000-0002-4561-2540	Baylor College of Medicine Cardiovascular Research Institute; NIH [R01 DK93587, R01 DK101379, T32 HL07676, F31 HL128054, T32 GM008231-26, IMSD R25 GM56929, R01 CM 12403, R01 CA193455, P01 DK059820, R01 HL089598, R01 HL117641, R01 HL091947, R41 HL129570, U54 HG006348, 5R01 DK092605]; American Heart Association [13POST 13800000, 15POST 22670017, 14PRE 20490083, 13EIA 14560061]; NATIONAL CANCER INSTITUTE [R01CA193455, R01CA112403] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R41HL129570, F31HL128054, R01HL089598, R01HL117641, R01HL091947, T32HL007676] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P01DK059820, R01DK093587, R01DK101379] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R25GM056929, T32GM008231] Funding Source: NIH RePORTER	Baylor College of Medicine Cardiovascular Research Institute; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This study was funded by a Baylor College of Medicine Cardiovascular Research Institute grant to Dr. Xu and Dr. Reddy. It was also funded in part by NIH grants: R01 DK93587 and R01 DK101379 (to YX), T32 HL07676 (to APQ), F31 HL128054, T32 GM008231-26, and IMSD R25 GM56929 (to AOH Jr), R01 CM 12403, R01 CA193455, P01 DK059820 (to JX), R01 HL089598, R01 HL117641, R01 HL091947, R41 HL129570 (to XHTW), U54 HG006348 and 5R01 DK092605 (to QT), and American Heart Association awards 13POST 13800000 and 15POST 22670017 (to PX), 14PRE 20490083 (to APQ) and 13EIA 14560061 (to XHTW). Echocardiography measurements were performed in the Mouse Phenotyping Core at Baylor College of Medicine. Dr. Reddy (AKR) is employed part-time at Baylor College of Medicine and part-time at Indus Instruments. Dr. Reddy participated in this study exclusively during his part-time effort at Baylor College of Medicine. The commercial company, Indus Instruments, did not fund the study, did not pay the salary of Dr. Reddy to participate in this study, and did not have any role in the study design, data collection and analysis, decision to publish, and preparation of the manuscript. Please note that the DFVS system used for Doppler measurements in this study was a product of the collaboration between Baylor College of Medicine and Indus Instruments about 20 years ago where Dr. Reddy played a key role in the development of this product.	[Anonymous], 2011, WHO REPORT; Arias-Loza PA, 2008, GENDER MED, V5, pS34, DOI 10.1016/j.genm.2008.03.005; BURT VL, 1995, HYPERTENSION, V25, P305, DOI 10.1161/01.HYP.25.3.305; Cacciatore B, 2001, AM J OBSTET GYNECOL, V184, P904, DOI 10.1067/mob.2001.111246; CHAIGNON MM, 1993, J HYPERTENS, V11, pS27, DOI 10.1097/00004872-199303001-00005; Chappell MC, 2006, AM J PHYSIOL-REG I, V291, pR1557, DOI 10.1152/ajpregu.00051.2006; Chen X, 2015, INT J BIOL SCI, V11, P1056, DOI 10.7150/ijbs.12408; COLDITZ GA, 1995, NEW ENGL J MED, V332, P1589, DOI 10.1056/NEJM199506153322401; Coutinho T, 2014, CAN J CARDIOL, V30, P756, DOI 10.1016/j.cjca.2014.03.020; Crofton JT, 1997, HYPERTENSION, V29, P494, DOI 10.1161/01.HYP.29.1.494; Davern PJ, 2010, NEUROSCIENCE, V170, P551, DOI 10.1016/j.neuroscience.2010.07.040; Davern PJ, 2011, CLIN EXP PHARMACOL P, V38, P136, DOI 10.1111/j.1440-1681.2010.05413.x; Gianaros PJ, 2008, J NEUROSCI, V28, P990, DOI 10.1523/JNEUROSCI.3606-07.2008; Gingerich S, 2006, HYPERTENSION, V48, P1130, DOI 10.1161/01.HYP.0000248754.67128.ff; Hajjar I, 2006, ANNU REV PUBL HEALTH, V27, P465, DOI 10.1146/annurev.publhealth.27.021405.102132; Haywood JR, 1997, HYPERTENSION, V30, P667, DOI 10.1161/01.HYP.30.3.667; He Y, 2016, HYPERTENSIO IN PRESS; Hermeling E, 2010, HYPERTENSION, V55, P124, DOI 10.1161/HYPERTENSIONAHA.109.143867; Hinojosa-Laborde C, 2004, HYPERTENSION, V44, P405, DOI 10.1161/01.HYP.0000142893.08655.96; Hinojosa-Laborde C, 2000, HYPERTENSION, V35, P484, DOI 10.1161/01.HYP.35.1.484; Manhem K, 1998, J HUM HYPERTENS, V12, P323, DOI 10.1038/sj.jhh.1000563; Martensson UEA, 2009, ENDOCRINOLOGY, V150, P687, DOI 10.1210/en.2008-0623; Meijer OC, 2000, ENDOCRINOLOGY, V141, P2192, DOI 10.1210/en.141.6.2192; Merchenthaler I, 2004, J COMP NEUROL, V473, P270, DOI 10.1002/cne.20128; Mitchell GF, 2008, HYPERTENSION, V51, P105, DOI 10.1161/HYPERTENSIONAHA.107.099721; Mitchell GF, 2003, CIRCULATION, V108, P1592, DOI 10.1161/01.CIR.0000093435.04334.1F; Nagpal Sangeeta, 2007, Indian J Physiol Pharmacol, V51, P279; Nichols WW, 2011, MCDONALD'S BLOOD FLOW IN ARTERIES: THEORETICAL, EXPERIMENTAL AND CLINICAL PRINCIPLES, 6TH EDITION, P1; OROURKE MF, 1987, VENTRICULAR VASCULAR, P1; OUCHI Y, 1987, HYPERTENSION, V9, P172, DOI 10.1161/01.HYP.9.2.172; Peter I, 2005, J HYPERTENS, V23, P2193, DOI 10.1097/01.hjh.0000188728.66183.92; Purkayastha S, 2011, NAT MED, V17, P883, DOI 10.1038/nm.2372; Reckelhoff JF, 2004, HYPERTENSION, V43, P918, DOI 10.1161/01.HYP.0000124670.03674.15; Reddy AK, 2005, IEEE T BIO-MED ENG, V52, P1771, DOI 10.1109/TBME.2005.855709; Reddy AK, 2003, AM J PHYSIOL-HEART C, V285, pH1464, DOI 10.1152/ajpheart.00004.2003; Reddy AK, 2014, J GERONTOL A-BIOL, V69, P152, DOI 10.1093/gerona/glt055; Reddy AK, 2009, IEEE ENG MED BIO, P1104, DOI 10.1109/IEMBS.2009.5334387; Seely EW, 1999, HYPERTENSION, V33, P1190, DOI 10.1161/01.HYP.33.5.1190; Sookram C, 2015, CARDIOVASC DIAGN THE, V5, P186, DOI 10.3978/j.issn.2223-3652.2015.04.04; Tamura M, 2008, HYPERTENS RES, V31, P221, DOI 10.1291/hypres.31.221; Waddell TK, 2001, J HYPERTENS, V19, P2205, DOI 10.1097/00004872-200112000-00014; Weiss RE, 1999, EMBO J, V18, P1900, DOI 10.1093/emboj/18.7.1900; Westerhof N., 1979, QUANTITATIVE CARDIOV; WIINBERG N, 1995, AM J HYPERTENS, V8, P978, DOI 10.1016/0895-7061(95)00216-2; Xu JM, 1998, SCIENCE, V279, P1922, DOI 10.1126/science.279.5358.1922; Xu Y, 2011, CELL METAB, V14, P453, DOI 10.1016/j.cmet.2011.08.009; Xue BJ, 2007, AM J PHYSIOL-HEART C, V292, pH1770, DOI 10.1152/ajpheart.01011.2005; Xue BJ, 2013, HYPERTENSION, V61, P1255, DOI 10.1161/HYPERTENSIONAHA.111.00903; Zhu LR, 2013, ENDOCRINOLOGY, V154, P150, DOI 10.1210/en.2012-2007; Zhu Y, 2002, SCIENCE, V295, P505, DOI 10.1126/science.1065250	50	6	6	2	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2016	11	12							e0168644	10.1371/journal.pone.0168644	http://dx.doi.org/10.1371/journal.pone.0168644			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI9QH	28006821	gold, Green Published, Green Submitted			2022-12-27	WOS:000392843200073
J	Kang, JH; Kim, SH; Kim, YH; Rha, SE; Hur, BY; Han, JK				Kang, Ji Hee; Kim, Se Hyung; Kim, Young Hoon; Rha, Sung Eun; Hur, Bo Yun; Han, Joon Koo			CT Features of Colorectal Schwannomas: Differentiation from Gastrointestinal Stromal Tumors	PLoS One			English	Article							PATHOLOGICAL CORRELATION; IMAGING FEATURES; LEIOMYOSARCOMAS; RECTUM; TRACT; COLON	Purpose To find differential CT features of colorectal schwannomas from gastrointestinal stromal tumors (GISTs). Materials and Methods CT features of 13 pathologically proven colorectal schwannomas and 21 GISTs were retrospectively reviewed. The following CT items were analyzed: size, longitudinal and transverse location, shape, margin, homogeneity, necrosis, surface ulceration, calcification, degree of attenuation, the presence of enlarged lymph node (LN), and metastasis. Among the features, significant variables were evaluated using univariate statistical tests. The optimal cut-off point of tumor size was obtained by ROC analysis. Binary logistic regression analysis was used to find the most independent CT variables. Results Small size, nonrectum location, smooth margin, homogeneous high attenuation without necrosis, and the presence of enlarged LNs were found to be significant variables to differentiate schwannomas from GISTs (P<0.05). The optimized cut-off point for tumor size in distinguishing GISTs from schwannomas was 3.9 cm (AUC = 0.808, sensitivity = 66.7%, specificity = 92.3%, P<0.0001). Binary regression analysis revealed that only nonrectum location remained independent predictor for schwannomas differentiated from GISTs (odds ratio = 31.667, P = 0.001). Conclusion Colorectal schwannomas usually located in non -rectum and appear as small subepithelial nodules showing homogeneous high attenuation and smooth margin. Schwannomas exclusively accompany with enlarged LNs.	[Kang, Ji Hee; Kim, Se Hyung; Han, Joon Koo] Seoul Natl Univ Hosp, Dept Radiol, Seoul, South Korea; [Kim, Se Hyung; Han, Joon Koo] Seoul Natl Univ, Coll Med, Dept Radiol, Seoul, South Korea; [Kim, Young Hoon] Seoul Natl Univ, Bundang Hosp, Dept Radiol, Seongnam, South Korea; [Rha, Sung Eun] Catholic Univ Korea, Dept Radiol, Seoul, South Korea; [Hur, Bo Yun] Natl Canc Ctr, Dept Radiol, Goyang, South Korea; [Han, Joon Koo] Seoul Natl Univ, Med Res Ctr, Inst Radiat Med, Seoul, South Korea	Seoul National University (SNU); Seoul National University Hospital; Seoul National University (SNU); Seoul National University (SNU); Catholic University of Korea; National Cancer Center - Korea (NCC); Seoul National University (SNU)	Kim, SH (corresponding author), Seoul Natl Univ Hosp, Dept Radiol, Seoul, South Korea.; Kim, SH (corresponding author), Seoul Natl Univ, Coll Med, Dept Radiol, Seoul, South Korea.	shkim7071@gmail.com			Basic Science Research Program through the National Research Foundation of Korea [NRF] - Ministry of Science, ICT & Future Planning [2013R1A1A3005937]	Basic Science Research Program through the National Research Foundation of Korea [NRF] - Ministry of Science, ICT & Future Planning	This research was supported by the Basic Science Research Program through the National Research Foundation of Korea [NRF] funded by the Ministry of Science, ICT & Future Planning [2013R1A1A3005937]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Choi JW, 2012, KOREAN J RADIOL, V13, P425, DOI 10.3348/kjr.2012.13.4.425; Choi YR, 2014, EUR J RADIOL, V83, P250, DOI 10.1016/j.ejrad.2013.10.028; DAIMARU Y, 1988, HUM PATHOL, V19, P257, DOI 10.1016/S0046-8177(88)80518-5; Edge SB, 2010, AM JOINT COMMITTEE C, P175; Hou YY, 2006, HISTOPATHOLOGY, V48, P536, DOI 10.1111/j.1365-2559.2006.02370.x; Jiang ZX, 2013, WORLD J GASTROENTERO, V19, P3108, DOI 10.3748/wjg.v19.i20.3108; Koch MR, 2013, CANCER IMAGING, V12, P557, DOI 10.1102/1470-7330.2012.0048; Miettinen M, 2000, AM J SURG PATHOL, V24, P1339, DOI 10.1097/00000478-200010000-00003; Miettinen M, 2001, VIRCHOWS ARCH, V438, P1, DOI 10.1007/s004280000338; Miettinen M, 2001, AM J SURG PATHOL, V25, P1121, DOI 10.1097/00000478-200109000-00002; Miettinen M, 2001, AM J SURG PATHOL, V25, P846, DOI 10.1097/00000478-200107000-00002; Miettinen M, 2006, SEMIN DIAGN PATHOL, V23, P70, DOI 10.1053/j.semdp.2006.09.001; Miettinen MS, 2000, WHO CLASSIFICATION T, P62	13	1	1	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2016	11	12							e0166377	10.1371/journal.pone.0166377	http://dx.doi.org/10.1371/journal.pone.0166377			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI9QH	28005903	Green Submitted, gold, Green Published			2022-12-27	WOS:000392843200006
J	Li, YP; Hou, MZ; Lu, GY; Ciccone, N; Wang, XD; Zhang, HZ				Li, Yuping; Hou, Mengzhuo; Lu, Guangyu; Ciccone, Natalia; Wang, Xingdong; Zhang, Hengzhu			The Prognosis of Anti-Angiogenesis Treatments Combined with Standard Therapy for Newly Diagnosed Glioblastoma: A Meta-Analysis of Randomized Controlled Trials	PLOS ONE			English	Article							PHASE-II TRIAL; BEVACIZUMAB PLUS IRINOTECAN; ANTIANGIOGENIC THERAPY; RADIATION-THERAPY; SINGLE-AGENT; BRAIN-TUMORS; TEMOZOLOMIDE; RECURRENT; PROGRESSION; SURVIVAL	Background and Purpose Although bevacizumab (BV) has been approved as second-line therapy for recurrent glioblastoma (GB), the efficacy and safety of BV for patients with newly diagnosed GB remain unclear. Methodology/Principal Findings We systematically searched electronic databases (PubMed, EMBASE, OVID, etc.) to identify related studies published from January 1966 and August 2016. Eight randomized controlled trials including a total of 2,185 patients with GB were included. We found that the median progression-free survival (PFS) was higher in the BV group than in the standard therapy (ST) group (pooled hazard ratio, 0.73; 95% CI, 0.62-0.86; P = 0.0001). Compared with ST, BV improved the PFS rate at 6 months (OR 3.33, 95% CI 2.73-4.06, p<0.00001) and 12 months (OR 2.10, 95% CI 1.74-2.54, p< 0.00001). There were no significant differences in median overall survival between the BV and ST groups (OR, 1.01; 95% CI, 0.83-1.23; P = 0.95). The BV group had higher survival rates at 6 months (OR, 1.41; 95% CI, 1.09-1.84; P = 0.01) and 12 months (OR, 1.23; 95% CI, 1.02-1.48; P = 0.03), but a low survival rate at the 36-month follow-up (OR, 0.57; 95% CI, 0.32-0.98; P = 0.04). For the incidence of adverse events, three adverse outcomes were found to be significantly different between BV and ST groups, including hypertension (8.37% vs. 1.62%, p<0.000001), proteinuria (7.65% vs. 0%, p<0.001), and fatigue (14.54% vs. 9.01%, p = 0.05). Conclusions/Significance Our study indicates that combination of BV with ST for newly diagnosed GB did not improve the median overall survival but result in longer median PFS, maintaining the quality of life and functional status. However, the long-term use of BV is associated with a higher incidence of adverse events and mortality.	[Li, Yuping; Wang, Xingdong; Zhang, Hengzhu] Yangzhou Univ, Clin Med Coll, Dept Neurosurg, Yangzhou, Jiangsu, Peoples R China; [Li, Yuping; Hou, Mengzhuo; Ciccone, Natalia] Ludwig Maximilians Univ Munchen, Dept Neurosurg, Neurosurg Res, Munich, Germany; [Lu, Guangyu] Yangzhou Univ, Coll Med, Dept Prevent Med, Yangzhou 225009, Jiangsu, Peoples R China; [Lu, Guangyu] Ruprecht Karls Univ Heidelberg, Sch Med, Inst Publ Hlth, Heidelberg, Germany	Yangzhou University; University of Munich; Yangzhou University; Ruprecht Karls University Heidelberg	Zhang, HZ (corresponding author), Yangzhou Univ, Clin Med Coll, Dept Neurosurg, Yangzhou, Jiangsu, Peoples R China.	zhanghengzhu@sina.com	li, yu/HGL-9518-2022; Li, yu/HHZ-5236-2022; Li, Yuping/C-4122-2014	Li, Yuping/0000-0002-4527-2582	Northern Jiangsu People's Hospital [YZUCMS201602]	Northern Jiangsu People's Hospital	This work was supported in part by Northern Jiangsu Peoples Hospital (YZUCMS201602).	Ballman KV, 2007, NEURO-ONCOLOGY, V9, P29, DOI 10.1215/15228517-2006-025; Beal K, 2011, RADIAT ONCOL, V6, DOI 10.1186/1748-717X-6-2; Bergers G, 2008, NAT REV CANCER, V8, P592, DOI 10.1038/nrc2442; Carlson JA, 2015, J NEURO-ONCOL, V123, P251, DOI 10.1007/s11060-015-1791-4; Carmeliet P, 2005, NATURE, V438, P932, DOI 10.1038/nature04478; Chauffert B, 2014, ANN ONCOL, V25, P1442, DOI 10.1093/annonc/mdu148; Chen CJ, 2015, ANTITUMOR PHARM, V5, P126; Chinot OL, 2014, NEW ENGL J MED, V370, P709, DOI 10.1056/NEJMoa1308345; Chowdhary SA, 2015, J NEURO-ONCOL, V122, P367, DOI 10.1007/s11060-015-1724-2; de Groot JF, 2010, NEURO-ONCOLOGY, V12, P233, DOI 10.1093/neuonc/nop027; Duda DG, 2007, TRENDS MOL MED, V13, P223, DOI 10.1016/j.molmed.2007.04.001; Dumpich M, 2015, NEURAL REGEN RES, V10, P1725, DOI 10.4103/1673-5374.170287; Fernando NT, 2008, CLIN CANCER RES, V14, P1529, DOI 10.1158/1078-0432.CCR-07-4126; Fischer C, 2007, CELL, V131, P463, DOI 10.1016/j.cell.2007.08.038; Fischer I, 2005, BRAIN PATHOL, V15, P297; Friedman HS, 2009, J CLIN ONCOL, V27, P4733, DOI 10.1200/JCO.2008.19.8721; Gila MJ, 2012, ANTI-CANCER DRUG, V23, P659, DOI 10.1097/CAD.0b013e3283534d3e; Gilbert MR, 2014, NEW ENGL J MED, V370, P699, DOI 10.1056/NEJMoa1308573; Hasselbalch B, 2010, NEURO-ONCOLOGY, V12, P508, DOI 10.1093/neuonc/nop063; Hegi ME, 2005, NEW ENGL J MED, V352, P997, DOI 10.1056/NEJMoa043331; Herrlinger U, 2016, J CLIN ONCOL, V34, P1611, DOI 10.1200/JCO.2015.63.4691; Hormigo A, 2011, P NATL ACAD SCI USA, V108, P4271, DOI 10.1073/pnas.1019656108; Hu F, 2014, INT J CANCER, V135, P2569, DOI 10.1002/ijc.28908; Jain RK, 2007, NAT REV NEUROSCI, V8, P610, DOI 10.1038/nrn2175; Jakobsen JN, 2011, EXPERT OPIN PHARMACO, V12, P825, DOI 10.1517/14656566.2011.566558; Kargiotis O, 2006, J NEURO-ONCOL, V78, P281, DOI 10.1007/s11060-005-9097-6; Keunen O, 2011, P NATL ACAD SCI USA, V108, P3749, DOI 10.1073/pnas.1014480108; Kreisl TN, 2009, J CLIN ONCOL, V27, P740, DOI 10.1200/JCO.2008.16.3055; Lai A, 2011, J CLIN ONCOL, V29, P142, DOI 10.1200/JCO.2010.30.2729; Li Xiaoqing, 2011, SCI REP, V5, P14698; Liberati A, 2009, PLOS MED, V6, DOI [10.1371/journal.pmed.1000100, 10.1136/bmj.b2700, 10.7326/0003-4819-151-4-200908180-00136]; Lueio-Eterovie AK, 2009, CLIN CANCER RES, V15, P4589, DOI [10.1158/1078-0432.CCR-09-0575, DOI 10.1158/1078-0432.CCR-09-0575]; Macdonald Geraldine, 2012, Cochrane Database Syst Rev, pCD001930, DOI 10.1002/14651858.CD001930.pub3; Mizukami Y, 2005, NAT MED, V11, P992, DOI 10.1038/nm1294; Moller S, 2012, ACTA ONCOL, V51, P797, DOI 10.3109/0284186X.2012.681063; Narayana A, 2009, J NEUROSURG, V110, P173, DOI 10.3171/2008.4.17492; Norden AD, 2008, NEUROLOGY, V70, P779, DOI 10.1212/01.wnl.0000304121.57857.38; Norden AD, 2008, LANCET NEUROL, V7, P1152, DOI 10.1016/S1474-4422(08)70260-6; Paez-Ribes M, 2009, CANCER CELL, V15, P220, DOI 10.1016/j.ccr.2009.01.027; Paldino MJ, 2012, BRIT J RADIOL, V85, P382, DOI 10.1259/bjr/24774491; Reardon DA, 2012, J NEURO-ONCOL, V107, P155, DOI 10.1007/s11060-011-0722-2; Sathornsumetee S, 2010, NEURO-ONCOLOGY, V12, P1300, DOI 10.1093/neuonc/noq099; Stupp R, 2005, ANN ONCOL, V16, P64, DOI 10.1093/annonc/mdi834; Stupp Roger, 2005, Curr Neurol Neurosci Rep, V5, P198, DOI 10.1007/s11910-005-0047-7; Stupp R, 2009, LANCET ONCOL, V10, P459, DOI 10.1016/S1470-2045(09)70025-7; Trevisan E, 2014, NEUROL SCI, V35, P507, DOI 10.1007/s10072-014-1627-6; Verhoeff JJC, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-444; Vredenburgh JJ, 2007, CLIN CANCER RES, V13, P1253, DOI 10.1158/1078-0432.CCR-06-2309; Wang JQ, 2013, ANTITUMOR PHARM, V3, P274; Yung WKA, 2000, BRIT J CANCER, V83, P588, DOI 10.1054/bjoc.2000.1316; Zhang GB, 2012, J CLIN NEUROSCI, V19, P1636, DOI 10.1016/j.jocn.2011.12.028	51	6	6	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2016	11	12							e0168264	10.1371/journal.pone.0168264	http://dx.doi.org/10.1371/journal.pone.0168264			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI9QH	28005980	gold, Green Published, Green Submitted			2022-12-27	WOS:000392843200041
J	Burritt, NL; Foss, NJ; Neeno-Eckwall, EC; Church, JO; Hilger, AM; Hildebrand, JA; Warshauer, DM; Perna, NT; Burritt, JB				Burritt, Nancy L.; Foss, Nicole J.; Neeno-Eckwall, Eric C.; Church, James O.; Hilger, Anna M.; Hildebrand, Jacob A.; Warshauer, David M.; Perna, Nicole T.; Burritt, James B.			Sepsis and Hemocyte Loss in Honey Bees (Apis mellifera) Infected with Serratia marcescens Strain Sicaria	PLOS ONE			English	Article							POLYPHASIC TAXONOMY; VARROA-DESTRUCTOR; COLONIES; EXPRESSION; PATHOGENS; MICROBES; DYNAMICS; GENOMICS; COLLAPSE; PROTEASE	Global loss of honey bee colonies is threatening the human food supply. Diverse pathogens reduce honey bee hardiness needed to sustain colonies, especially in winter. We isolated a free-living Gram negative bacillus from hemolymph of worker honey bees (Apis mellifera) found separated from winter clusters. In some hives, greater than 90% of the dying bees detached from the winter cluster were found to contain this bacterium in their hemolymph. Throughout the year, the same organism was rarely found in bees engaged in normal hive activities, but was detected in about half of Varroa destructor mites obtained from colonies that housed the septic bees. Flow cytometry of hemolymph from septic bees showed a significant reduction of plasmatocytes and other types of hemocytes. Interpretation of the l6S rRNA sequence of the bacterium indicated that it belongs to the Serratia genus of Gramnegative Gammaproteobacteria, which has not previously been implicated as a pathogen of adult honey bees. Complete genome sequence analysis of the bacterium supported its classification as a novel strain of Serratia marcescens, which was designated as S. marcescens strain sicaria (Ss1). When compared with other strains of S. marcescens, Ss1 demonstrated several phenotypic and genetic differences, including 65 genes not previously found in other Serratia genomes. Some of the unique genes we identified in Ss1 were related to those from bacterial insect pathogens and commensals. Recovery of this organism extends a complex pathosphere of agents which may contribute to failure of honey bee colonies.	[Burritt, Nancy L.; Foss, Nicole J.; Hilger, Anna M.; Hildebrand, Jacob A.; Burritt, James B.] Univ Wisconsin Stout, Dept Biol, Menomonie, WI 54751 USA; [Neeno-Eckwall, Eric C.] Univ Wisconsin, Ctr Biotechnol, Madison, WI 53705 USA; [Church, James O.] La Salle Univ, Dept Biol, Philadelphia, PA 19141 USA; [Warshauer, David M.] Univ Wisconsin, Wisconsin State Lab Hyg, Madison, WI 53706 USA; [Perna, Nicole T.] Univ Wisconsin, Genome Ctr Wisconsin, Madison, WI USA	University of Wisconsin System; University of Wisconsin Stout; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Burritt, JB (corresponding author), Univ Wisconsin Stout, Dept Biol, Menomonie, WI 54751 USA.	burrittj@uwstout.edu		Perna, Nicole/0000-0001-8208-0929	Honey Bee Health Task Force of the North American Pollinator Protection Campaign; State of Wisconsin; Direct For Biological Sciences [0936214] Funding Source: National Science Foundation	Honey Bee Health Task Force of the North American Pollinator Protection Campaign; State of Wisconsin; Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	The authors wish to acknowledge funding from the Honey Bee Health Task Force of the North American Pollinator Protection Campaign to JBB and the State of Wisconsin for funding biotechnology applications in the classroom. The opinions expressed are those of the authors and do not necessarily reflect the views of the funders. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abebe E, 2011, VIRULENCE, V2, P158, DOI 10.4161/viru.2.2.15337; Abebe-Akele F, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1697-8; Altincicek B, 2008, J IMMUNOL, V181, P2705, DOI 10.4049/jimmunol.181.4.2705; Babendreier D, 2007, FEMS MICROBIOL ECOL, V59, P600, DOI 10.1111/j.1574-6941.2006.00249.x; Betti MI, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110237; Boncristiani H, 2012, J INSECT PHYSIOL, V58, P613, DOI 10.1016/j.jinsphys.2011.12.011; Breeze TD, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0082996; Brutscher LM, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005757; Budge GE, 2014, ISME J, V8, P1588, DOI 10.1038/ismej.2014.20; Cavigli I, 2016, APIDOLOGIE, V47, P251, DOI 10.1007/s13592-015-0395-5; Clermont A, 2015, SCI TOTAL ENVIRON, V532, P1, DOI 10.1016/j.scitotenv.2015.05.128; COLWELL RR, 1970, J BACTERIOL, V104, P410, DOI 10.1128/JB.104.1.410-433.1970; Cox-Foster DL, 2007, SCIENCE, V318, P283, DOI 10.1126/science.1146498; de Miranda JR, 2010, J INVERTEBR PATHOL, V103, pS48, DOI 10.1016/j.jip.2009.06.012; Dennis B, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0150055; Di Prisco G, 2016, P NATL ACAD SCI USA, V113, P3203, DOI 10.1073/pnas.1523515113; Edwards PR, 1986, IDENTIFICATION ENTER; ELSANOUSI SM, 1987, J GEN MICROBIOL, V133, P215; Evans JD, 2011, TRENDS MICROBIOL, V19, P614, DOI 10.1016/j.tim.2011.09.003; Evans JD, 2010, J INVERTEBR PATHOL, V103, pS62, DOI 10.1016/j.jip.2009.06.019; Fischer Steve, 2011, Curr Protoc Bioinformatics, VChapter 6, DOI 10.1002/0471250953.bi0612s35; Forfert N, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0140337; Frey E, 2014, J ECON ENTOMOL, V107, P508, DOI 10.1603/EC13381; Gaetschenberger H, 2012, J EXP BIOL, V215, P1313, DOI 10.1242/jeb.065276; Genersch E, 2010, VET RES, V41, DOI 10.1051/vetres/2010027; GENG CX, 1989, DEV COMP IMMUNOL, V13, P17, DOI 10.1016/0145-305X(89)90012-8; GLINSKI ZF, 1990, J APICULT RES, V29, P107; Guidugli KR, 2005, FEBS LETT, V579, P4961, DOI 10.1016/j.febslet.2005.07.085; Han MV, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-356; Hawthorne DJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026796; Human H, 2013, J APICULT RES, V52, DOI 10.3896/IBRA.1.52.4.10; Ishii K, 2014, J BIOL CHEM, V289, P5876, DOI 10.1074/jbc.M113.544536; Ishii K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089917; Jeyaprakash A, 2003, J INVERTEBR PATHOL, V84, P96, DOI 10.1016/j.jip.2003.08.007; Kwong WK, 2016, NAT REV MICROBIOL, V14, P374, DOI 10.1038/nrmicro.2016.43; Lundin O, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0136928; Marringa WJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108486; Martin SJ, 2001, J APPL ECOL, V38, P1082, DOI 10.1046/j.1365-2664.2001.00662.x; Meier-Kolthoff JP, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-60; Moran NA, 2015, CURR OPIN INSECT SCI, V10, P22, DOI 10.1016/j.cois.2015.04.003; Mordecai GJ, 2016, SCI REP-UK, V6, DOI 10.1038/srep34983; Munch D, 2015, EXP GERONTOL; Petersen LM, 2014, J BACTERIOL, V196, P3923, DOI 10.1128/JB.01908-14; Petersen LM, 2012, APPL ENVIRON MICROB, V78, P8840, DOI 10.1128/AEM.02580-12; Pineda-Castellanos ML, 2015, PATHOGENS, V4, P210, DOI 10.3390/pathogens4020210; Porrini C, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0155411; Roberts KE, 2014, J INVERTEBR PATHOL, V121, P1, DOI 10.1016/j.jip.2014.06.004; Rodriguez-R, 2016, PEERJ, V4; Runckel C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095057; Salmela H, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1005015; Sanchez-Bayo F, 2016, ENVIRON INT, V89-90, P7, DOI 10.1016/j.envint.2016.01.009; Schonrich G, 2016, FRONT IMMUNOL, V7, DOI 10.3389/fimmu.2016.00366; Schwarz RS, 2014, MICROBIOLOGYOPEN, V3, P341, DOI 10.1002/mbo3.172; Sentausa E, 2013, CLIN MICROBIOL INFEC, V19, P790, DOI 10.1111/1469-0691.12181; Shanks RMQ, 2015, INFECT IMMUN, V83, P2907, DOI 10.1128/IAI.03096-14; Smith KM, 2013, ECOHEALTH, V10, P434, DOI 10.1007/s10393-013-0870-2; Stabentheiner A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008967; Sumpter DJT, 2000, J THEOR BIOL, V204, P1, DOI 10.1006/jtbi.1999.1063; Thompson CC, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-913; Tu S, 2010, J INVERTEBR PATHOL, V104, P75, DOI 10.1016/j.jip.2010.02.002; Vandamme P, 1996, MICROBIOL REV, V60, P407, DOI 10.1128/MMBR.60.2.407-438.1996; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07; WAYNE LG, 1987, INT J SYST BACTERIOL, V37, P463, DOI 10.1099/00207713-37-4-463; YAGUPSKY P, 1990, CLIN MICROBIOL REV, V3, P269, DOI 10.1128/CMR.3.3.269-279.1990; Youngsteadt E, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0142031	65	40	42	1	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2016	11	12							e0167752	10.1371/journal.pone.0167752	http://dx.doi.org/10.1371/journal.pone.0167752			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI9TW	28002470	gold, Green Published, Green Submitted			2022-12-27	WOS:000392853100020
J	Hartmann, M; Khosla, R; Krishnan, S; George, A; Gruskin, S; Amin, A				Hartmann, Miriam; Khosla, Rajat; Krishnan, Suneeta; George, Asha; Gruskin, Sofia; Amin, Avni			How Are Gender Equality and Human Rights Interventions Included in Sexual and Reproductive Health Programmes and Policies: A Systematic Review of Existing Research Foci and Gaps	PLOS ONE			English	Review							PREVENTION; WORKERS; HIV; ADOLESCENTS	The importance of promoting gender equality and human rights in sexual and reproductive health (SRH) programmes and policies has been affirmed in numerous international and regional agreements, most recently the 2030 Agenda for Sustainable Development. Given the critical role of research to determine what works, we aimed to identify research gaps as part of a broader priority setting exercise on integrating gender equality and human rights approaches in SRH programmes and policies. A systematic literature review of reviews was conducted to examine the question: what do we know about how research in the context of SRH programmes and policies has addressed gender equality and human rights and what are the current gaps in research. We searched three data-bases for reviews that addressed the research question, were published between 19942014, and met methodological standards for systematic reviews, qualitative meta-syntheses and other reviews of relevance to the research question. Additional grey literature was identified based on expert input. Articles were appraised by the primary author and examined by an expert panel. An abstraction and thematic analysis process was used to synthesize findings. Of the 3,073 abstracts identified, 56 articles were reviewed in full and 23 were included along with 10 from the grey literature. The majority focused on interventions addressing gender inequalities; very few reviews explicitly included human rights based interventions. Across both topics, weak study designs and use of intermediate outcome measures limited evidence quality. Further, there was limited evidence on interventions that addressed marginalized groups. Better quality studies, longer-term indicators, and measurement of unintended consequences are needed to better understand the impact of these types of interventions on SRH outcomes. Further efforts are needed to cover research on gender equality and human rights issues as they pertain to a broader set of SRH topics and populations.	[Hartmann, Miriam; Krishnan, Suneeta] RTI Int, Womens Global Hlth Imperat, San Francisco, CA 94104 USA; [Khosla, Rajat; Amin, Avni] WHO, Geneva, Switzerland; [Krishnan, Suneeta] Res Triangle Inst Global India Private Ltd, New Delhi, India; [George, Asha] Univ Western Cape, Sch Publ Hlth, Cape Town, South Africa; [Gruskin, Sofia] Univ Southern Calif, Program Global Hlth & Human Rights, Los Angeles, CA USA	Research Triangle Institute; World Health Organization; Research Triangle Institute; University of the Western Cape; University of Southern California	Hartmann, M (corresponding author), RTI Int, Womens Global Hlth Imperat, San Francisco, CA 94104 USA.	mhartmann@rti.org		Hartmann, Miriam/0000-0001-8109-9679; George, Asha/0000-0002-5968-1424	Human Reproduction Programme, World Health Organization; South African Research Chair's Initiative of the Department of Science and Technology; National Research Foundation of South Africa [82769]	Human Reproduction Programme, World Health Organization; South African Research Chair's Initiative of the Department of Science and Technology; National Research Foundation of South Africa(National Research Foundation - South Africa)	This review was supported by the Human Reproduction Programme, World Health Organization. The content is solely the responsibility of the authors and does not necessarily represent the official views of the authors' employers or funders. Asha George is supported by the South African Research Chair's Initiative of the Department of Science and Technology and National Research Foundation of South Africa (Grant No 82769). Any opinion, finding and conclusion or recommendation expressed in this material is that of the author and the NRF does not accept any liability in this regard.	Amin A, 2015, J INT AIDS SOC S5, V18; [Anonymous], 2009, INT MULT GEND STRAT; [Anonymous], M RES PRIOR SEX REPR; Aprajita Mukherjee, 2011, Eastern Journal of Medicine, V16, P153; Arango DJ, 2014, INTERVENTIONS PREVEN; Barker G., 2007, ENGAGING MEN BOYS CH; Barker G., 2005, YOUNG MEN CONSTRUCTI; Boender C., 2004, SO WHAT REPORT LOOK; Bustreo F, 2013, WOMENS CHILDRENS HLT; Cottingham J, ENGENDERING INT HLTH, P4; Cui RR, 2013, AIDS BEHAV, V17, P2864, DOI 10.1007/s10461-013-0582-1; Emara N., 2014, REV MIDDLE E EC FINA, V10, P263; Gerrits T, 2010, FACTS VIEWS VIS OBGY, V2, P194; Gill R, 2011, WOMEN HEALTH ISS, V21, P12, DOI 10.1016/j.whi.2010.10.003; Guedes A., 2004, ADDRESSING GENDER BA; Hanefeld Johanna, 2008, Promot Educ, V15, P19, DOI 10.1177/1025382307088094; Hartmann M, 2016, PUTTING WOMEN 1 ETHI; Jahan R, 2003, REPROD HEALTH MATTER, V11, P183, DOI 10.1016/S0968-8080(03)02173-6; Jennings L, 2013, INT J EQUITY HEALTH, V12, DOI 10.1186/1475-9276-12-85; Kennedy CE, 2014, AIDS CARE, V26, P659, DOI 10.1080/09540121.2013.845287; Kerrigan D, 2015, LANCET, V385, P172, DOI 10.1016/S0140-6736(14)60973-9; Kraft JM, 2014, J HEALTH COMMUN, V19, P122, DOI 10.1080/10810730.2014.918216; Kumar S, 2015, J INT AIDS SOC, V18, P17, DOI 10.7448/IAS.18.6.20290; Lee YM, 2014, PUBLIC HEALTH NURS, V31, P414, DOI 10.1111/phn.12128; Lee YM, 2013, PUBLIC HEALTH NURS, V30, P390, DOI 10.1111/phn.12039; MacCarthy Sarah, 2012, Reprod Health Matters, V20, P119, DOI 10.1016/S0968-8080(12)39641-9; Overs C, 2011, BMC INT HEALTH HUM R, V11, DOI 10.1186/1472-698X-11-S3-S6; Ravindran T K S, 2008, Glob Public Health, V3 Suppl 1, P121, DOI 10.1080/17441690801900761; Remme M, 2014, J INT AIDS SOC, V17, DOI 10.7448/IAS.17.1.19228; Rodriguez M., 2013, VOLUNTARY FAMILY PLA; Rottach E., 2009, GENDER PERSPECTIVES; Shahmanesh M, 2008, TROP MED INT HEALTH, V13, P659, DOI 10.1111/j.1365-3156.2008.02040.x; Skevington SM, 2013, AIDS BEHAV, V17, P1025, DOI 10.1007/s10461-012-0327-6; Sternberg P, 2004, HEALTH PROMOT INT, V19, P389, DOI 10.1093/heapro/dah312; United Nations, 2015, 2030 AG SUST DEV; United Nations Fund for Population Activities (UNFPA), 2014, FRAM ACT FOLL UP PRO; World Health Organization, 2004, REPR HLTH STRAT ACC	37	20	20	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2016	11	12							e0167542	10.1371/journal.pone.0167542	http://dx.doi.org/10.1371/journal.pone.0167542			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EI9TW	28002440	Green Published, gold			2022-12-27	WOS:000392853100012
J	Chen, YX; Liu, B; Glass, K; Du, W; Banks, E; Kirk, M				Chen, Yingxi; Liu, Bette; Glass, Kathryn; Du, Wei; Banks, Emily; Kirk, Martyn			Use of Proton Pump Inhibitors and the Risk of Hospitalization for Infectious Gastroenteritis	PLOS ONE			English	Article							ACID-SUPPRESSING DRUGS; THERAPY; COHORT	Introduction To quantify the association between PPI use, type and dose and infectious gastroenteritis hospitalization in a population-based cohort of middle-aged and older adults. Methods Prospective study of 38,019 concession card holders followed up over 6 years in the Sax Institute's 45 and Up Study. Data from the baseline questionnaire were linked to prescription medication, hospitalization, notifiable disease, cancer registry and death datasets from 2006-2012. Associations between PPI use and gastroenteritis hospitalization were examined using Cox regressions with age as the underlying time variable. Results Among 38,019 participants, the median age was 69.7 years, and 57.3% were women. Compared to non-users, current PPI users were more likely to be older, and have a higher BMI. During follow-up there were 1,982 incident gastroenteritis hospitalizations (crude rate: 12.9 per 1000 person-years, 95% CI: 12.3-13.5). PPI use was significantly associated with infectious gastroenteritis hospitalization (aHR 1.4, 95% CI: 1.2-1.5). Among current users, a dose-response relationship was observed between the average daily dose (DDD) dispensed per day and infectious gastroenteritis hospitalization (P trend<0.001). We also observed higher rates of infectious gastroenteritis hospitalization and greater PPI use among participants with a history of chronic bowel problems (aHR 2.2, 95% CI: 1.9-2.5). There was no difference in risk by type of PPI. Recent use of H2 receptors was not associated with gastroenteritis hospitalization. Conclusion PPI use is associated with an increased risk of infectious gastroenteritis hospitalization. Clinicians should be aware of this risk when considering PPI therapy.	[Chen, Yingxi; Glass, Kathryn; Du, Wei; Banks, Emily; Kirk, Martyn] Australian Natl Univ, Canberra, ACT, Australia; [Liu, Bette] Univ New South Wales, Sydney, NSW, Australia; [Banks, Emily] Sax Inst, Sydney, NSW, Australia	Australian National University; University of New South Wales Sydney; University of Sydney	Kirk, M (corresponding author), Australian Natl Univ, Canberra, ACT, Australia.	martyn.kirk@anu.edu.au	Du, Wei/H-5376-2012; Chen, Yingxi/ABF-2593-2020	Du, Wei/0000-0003-3622-2265; Chen, Yingxi/0000-0002-3565-1052; Glass, Kathryn/0000-0001-5905-1310; Kirk, Martyn/0000-0001-5432-5984; Banks, Emily/0000-0002-4617-1302	Australian Government Department of Education and Training [3929_2014]; Australian National Health & Medical Research Council Career Development Fellowship	Australian Government Department of Education and Training(Australian GovernmentDepartment of Industry, Innovation and Science); Australian National Health & Medical Research Council Career Development Fellowship	YC received the 2014 Prime Minister's Australia Asia Postgraduate Scholarship from the Australian Government Department of Education and Training (3929_2014). BL is funded by an Australian National Health & Medical Research Council Career Development Fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2013, ATC DDD IND; [Anonymous], 2015, PROTON PUMP INHIBITO; Atkinson JAM, 2015, PUBLIC HEALTH RES PR, V25, DOI 10.17061/phrp2531531; Banks E, 2008, INT J EPIDEMIOL, V37, P941, DOI 10.1093/ije/dym184; Chen Y, FOODBORNE P IN PRESS; Compare D, 2011, EUR J CLIN INVEST, V41, P380, DOI 10.1111/j.1365-2362.2010.02419.x; Cunningham R, 2003, J HOSP INFECT, V54, P243, DOI 10.1016/S0195-6701(03)00088-4; Dial MS, 2009, AM J GASTROENTEROL, V104, pS10, DOI 10.1038/ajg.2009.46; Duckett SJ, 2004, HEALTH CARE FINANC R, V25, P55; Filion KB, 2014, GUT, V63, P552, DOI 10.1136/gutjnl-2013-304738; Forgacs I, 2008, BMJ-BRIT MED J, V336, P2, DOI 10.1136/bmj.39406.449456.BE; Rodriguez LAG, 2007, CLIN GASTROENTEROL H, V5, P1418, DOI 10.1016/j.cgh.2007.09.010; Garnett WR, 1998, AM J HEALTH-SYST PH, V55, P2268, DOI 10.1093/ajhp/55.21.2268; Hassing RJ, 2016, EUR J EPIDEMIOL, V31, P1057, DOI 10.1007/s10654-016-0136-8; Hollingworth S, 2010, PHARMACOEPIDEM DR S, V19, P1019, DOI 10.1002/pds.1969; HOWDEN CW, 1987, GUT, V28, P96, DOI 10.1136/gut.28.1.96; Howell MD, 2010, ARCH INTERN MED, V170, P784, DOI 10.1001/archinternmed.2010.89; Hungin APS, 2012, CLIN GASTROENTEROL H, V10, P109, DOI 10.1016/j.cgh.2011.07.008; Jackson MA, GUT; Jacobson BC, 2003, AM J GASTROENTEROL, V98, P51, DOI 10.1111/j.1572-0241.2003.07186.x; Kwok CS, 2012, AM J GASTROENTEROL, V107, P1011, DOI 10.1038/ajg.2012.108; Lazarus B, 2016, JAMA INTERN MED, V176, P238, DOI 10.1001/jamainternmed.2015.7193; Lombardo L, 2010, CLIN GASTROENTEROL H, V8, P504, DOI 10.1016/j.cgh.2009.12.022; Martinsen TC, 2005, BASIC CLIN PHARMACOL, V96, P94, DOI 10.1111/j.1742-7843.2005.pto960202.x; Mealing NM, 2010, BMC MED RES METHODOL, V10, DOI 10.1186/1471-2288-10-26; National Centre for Classification in Health, 2006, INT STAT CLASS DIS H; [Organization WH. World Health Organization Collaborating Centre for Drug Statistics Methodology], 2005, ATC IND DDDS; Renom-Guiteras A, 2015, EUR J CLIN PHARMACOL, P1; RYDER SD, 1994, BRIT MED J, V308, P827, DOI 10.1136/bmj.308.6932.827; Schoenfeld AJ, 2016, JAMA INTERN MED, V176, P172, DOI 10.1001/jamainternmed.2015.7927; SHARMA BK, 1984, GUT, V25, P957, DOI 10.1136/gut.25.9.957; Shin JM, 2013, J NEUROGASTROENTEROL, V19, P25, DOI 10.5056/jnm.2013.19.1.25; Simren M, 2013, GUT, V62, P159, DOI 10.1136/gutjnl-2012-302167; Vesper BJ, 2009, CURR DRUG METAB, V10, P84, DOI 10.2174/138920009787048392; Williams C, 2006, ALIMENT PHARM THER, V23, P3, DOI 10.1111/j.1365-2036.2006.02707.x; Wolfe MM, 2000, GASTROENTEROLOGY, V118, pS9, DOI 10.1016/S0016-5085(00)70004-7; Yang YX, 2006, JAMA-J AM MED ASSOC, V296, P2947, DOI 10.1001/jama.296.24.2947	37	10	10	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2016	11	12							e0168618	10.1371/journal.pone.0168618	http://dx.doi.org/10.1371/journal.pone.0168618			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI9QF	27997598	gold, Green Published, Green Submitted			2022-12-27	WOS:000392842900064
J	Breen, ME; Gaynor, SC; Monson, ET; de Klerk, K; Parsons, MG; Braun, TA; DeLuca, AP; Zandi, PP; Potash, JB; Willour, VL				Breen, Marie E.; Gaynor, Sophia C.; Monson, Eric T.; de Klerk, Kelly; Parsons, Meredith G.; Braun, Terry A.; DeLuca, Adam P.; Zandi, Peter P.; Potash, James B.; Willour, Virginia L.			Targeted Sequencing of FKBP5 in Suicide Attempters with Bipolar Disorder	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; DEXAMETHASONE SUPPRESSION TEST; HPA AXIS GENES; ANTIDEPRESSANT TREATMENT; CHILDHOOD TRAUMA; IDEATION; POLYMORPHISMS; COMORBIDITY; PREVALENCE; ANNOTATION	FKBP5 is a critical component of the Hypothalamic-Pituitary-Adrenal (HPA) axis, a system which regulates our response to stress. It forms part of a complex of chaperones, which inhibits binding of cortisol and glucocorticoid receptor translocation to the nucleus. Variations in both the HPA axis and FKBP5 have been associated with suicidal behavior. We developed a systematic, targeted sequencing approach to investigate coding and regulatory regions in or near FKBP5 in 476 bipolar disorder suicide attempters and 473 bipolar disorder non-attempters. Following stringent quality control checks, we performed single-variant, gene-level and haplotype tests on the resulting 481 variants. Secondary analyses investigated whether sex-specific variations in FKBP5 increased the risk of attempted suicide. One variant, rs141713011, showed an excess of minor alleles in suicide attempters that was statistically significant following correction for multiple testing (Odds Ratio = 6.65, P-value = 7.5 x 10(-4), Permuted P-value = 0.038). However, this result could not be replicated in an independent cohort (Odds Ratio = 0.90, P-value = 0.78). Three female-specific and four male-specific variants of nominal significance were also identified (P-value < 0.05). The gene-level and haplotype association tests did not produce any significant results. This comprehensive study of common and rare variants in FKBP5 focused on both regulatory and coding regions in relation to attempted suicide. One rare variant remained significant following correction for multiple testing but could not be replicated. Further investigation is required in larger sample sets to fully elucidate the association of this variant with suicidal behavior.	[Breen, Marie E.; Gaynor, Sophia C.; Monson, Eric T.; de Klerk, Kelly; Parsons, Meredith G.; Potash, James B.; Willour, Virginia L.] Univ Iowa, Carver Coll Med, Dept Psychiat, Iowa City, IA 52242 USA; [Braun, Terry A.; DeLuca, Adam P.] Univ Iowa, Carver Coll Med, Dept Ophthalmol & Visual Sci, Iowa City, IA USA; [Braun, Terry A.] Univ Iowa, Coll Engn, Dept Biomed Engn, Iowa City, IA 52242 USA; [Zandi, Peter P.] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Mental Hlth, Baltimore, MD USA	University of Iowa; University of Iowa; University of Iowa; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health	Willour, VL (corresponding author), Univ Iowa, Carver Coll Med, Dept Psychiat, Iowa City, IA 52242 USA.	virginia-willour@uiowa.edu	DeLuca, Adam/AAO-6291-2021	DeLuca, Adam/0000-0001-7798-1538; Willour, Virginia/0000-0002-6639-487X	NIMH [R01 MH079240]; American Foundation for Suicide Prevention [PDF-0-067-12]; University of Iowa Medical Scientist Training Program (MSTP) [5 T32 GM007337]; University of Iowa Interdisciplinary Graduate Program in Genetics; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007337] Funding Source: NIH RePORTER	NIMH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); American Foundation for Suicide Prevention; University of Iowa Medical Scientist Training Program (MSTP); University of Iowa Interdisciplinary Graduate Program in Genetics; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This project was supported by the NIMH Grant R01 MH079240 awarded to Virginia Willour, the Postdoctoral Fellowship Grant PDF-0-067-12 awarded to Marie Breen from the American Foundation for Suicide Prevention, the University of Iowa Medical Scientist Training Program (MSTP) training grant 5 T32 GM007337 awarded to Eric Monson and support from the University of Iowa Interdisciplinary Graduate Program in Genetics (Sophia Gaynor, Eric Monson, Dr. Willour and Dr. Potash). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; Arsenault-Lapierre G, 2004, BMC PSYCHIATRY, V4, DOI 10.1186/1471-244X-4-37; Auton A., 2015, NATURE, V7571, P68, DOI 10.1038/nature15393; Baca-Garcia E, 2010, MOL PSYCHIATR, V15, P250, DOI 10.1038/mp.2008.98; Bani-Fatemi A, 2016, NEUROSCI LETT, V622, P102, DOI 10.1016/j.neulet.2016.04.043; Barnett DW, 2011, BIOINFORMATICS, V27, P1691, DOI 10.1093/bioinformatics/btr174; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Beautrais AL, 1996, AM J PSYCHIAT, V153, P1009; Binder EB, 2009, PSYCHONEUROENDOCRINO, V34, P99, DOI 10.1016/j.psyneuen.2009.05.021; Boyle AP, 2012, GENOME RES, V22, P1790, DOI 10.1101/gr.137323.112; Breen ME, 2015, PSYCHIAT GENET, V25, P106, DOI 10.1097/YPG.0000000000000082; Brent D, 2010, AM J PSYCHIAT, V167, P190, DOI 10.1176/appi.ajp.2009.09040576; Carter H, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-S3-S3; Chun S, 2009, GENOME RES, V19, P1553, DOI 10.1101/gr.092619.109; Coryell W, 2001, AM J PSYCHIAT, V158, P748, DOI 10.1176/appi.ajp.158.5.748; CORYELL W, 1981, AM J PSYCHIAT, V138, P1120; Cunningham F, 2015, NUCLEIC ACIDS RES, V43, pD662, DOI 10.1093/nar/gku1010; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Fudalej S, 2015, NEUROPSYCHOBIOLOGY, V72, P126, DOI 10.1159/000441659; Gabriel SB, 2002, SCIENCE, V296, P2225, DOI 10.1126/science.1069424; Galfalvy H, 2015, AM J MED GENET B, V168, P557, DOI 10.1002/ajmg.b.32330; Gaynor SC, 2016, AM J MED GENET B, V171, P1080, DOI 10.1002/ajmg.b.32479; Gross JA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0128369; Harrow J, 2012, GENOME RES, V22, P1760, DOI 10.1101/gr.135350.111; Heinze G, 2010, STAT MED, V29, P770, DOI 10.1002/sim.3794; Jokinen J, 2009, J AFFECT DISORDERS, V116, P117, DOI 10.1016/j.jad.2008.10.015; Kent WJ, 2002, GENOME RES, V12, P996, DOI 10.1101/gr.229102; Klengel T, 2015, NEUROPSYCHOPHARMACOL, V40, P244, DOI 10.1038/npp.2014.208; Klengel T, 2013, NAT NEUROSCI, V16, P33, DOI 10.1038/nn.3275; Laje G, 2009, PHARMACOGENET GENOM, V19, P666, DOI 10.1097/FPC.0b013e32832e4bcd; Leszczynska-Rodziewicz A, 2014, NEUROPSYCH DIS TREAT, V10, P243, DOI 10.2147/NDT.S54538; Li BS, 2008, AM J HUM GENET, V83, P311, DOI 10.1016/j.ajhg.2008.06.024; Li H, 2009, BIOINFORMATICS, V25, P1094, DOI [10.1093/bioinformatics/btp100, 10.1093/bioinformatics/btp324]; Mann JJ, 1999, AM J PSYCHIAT, V156, P181; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; Menke A, 2012, NEUROPSYCHOPHARMACOL, V37, P797, DOI 10.1038/npp.2011.257; Mullins N, 2014, AM J MED GENET B, V165, P428, DOI 10.1002/ajmg.b.32247; Ng PC, 2003, NUCLEIC ACIDS RES, V31, P3812, DOI 10.1093/nar/gkg509; Nock MK, 2013, JAMA PSYCHIAT, V70, P300, DOI 10.1001/2013.jamapsychiatry.55; NURNBERGER JI, 1994, ARCH GEN PSYCHIAT, V51, P849, DOI 10.1001/archpsyc.1994.03950110009002; Perez-Ortiz J. M., 2012, PSYCHONEUROENDOCRINO; Perlis RH, 2010, AM J PSYCHIAT, V167, P1499, DOI 10.1176/appi.ajp.2010.10040541; Perroud N, 2012, PHARMACOGENOMICS J, V12, P68, DOI 10.1038/tpj.2010.70; Perroud N, 2011, PHARMACOGENOMICS, V12, P365, DOI [10.2217/pgs.10.189, 10.2217/PGS.10.189]; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Pruitt KD, 2014, NUCLEIC ACIDS RES, V42, pD756, DOI 10.1093/nar/gkt1114; Roy A, 2012, J PSYCHIATR RES, V46, P72, DOI 10.1016/j.jpsychires.2011.09.009; Roy A, 2010, NEUROPSYCHOPHARMACOL, V35, P1674, DOI 10.1038/npp.2009.236; Schosser A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020690; Schwarz JM, 2010, NAT METHODS, V7, P575, DOI 10.1038/nmeth0810-575; Sherry ST, 2001, NUCLEIC ACIDS RES, V29, P308, DOI 10.1093/nar/29.1.308; Sokolowski M., 2015, MOL PSYCHIAT; Supriyanto I, 2011, PROG NEURO-PSYCHOPH, V35, P252, DOI 10.1016/j.pnpbp.2010.11.019; Wang K, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq603; Willour VL, 2012, MOL PSYCHIATR, V17, P433, DOI 10.1038/mp.2011.4; Willour VL, 2009, MOL PSYCHIATR, V14, P261, DOI 10.1038/sj.mp.4002141; World Health Organization, 2014, PREV SUIC PREV SUIC; Wu MC, 2011, AM J HUM GENET, V89, P82, DOI 10.1016/j.ajhg.2011.05.029; Yin H, 2016, DEPRESS ANXIETY; Zai CC, 2015, J PSYCHIATR RES, V65, P23, DOI 10.1016/j.jpsychires.2014.11.002; 1997, AM J MED GENETICS, V74, P227	61	6	6	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2016	11	12							e0169158	10.1371/journal.pone.0169158	http://dx.doi.org/10.1371/journal.pone.0169158			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EG7JB	28030643	Green Published, Green Submitted, gold			2022-12-27	WOS:000391222000108
J	Cobey, S; Baskerville, EB				Cobey, Sarah; Baskerville, Edward B.			Limits to Causal Inference with State-Space Reconstruction for Infectious Disease	PLOS ONE			English	Article							EMBEDDING DIMENSION; SEASONALITY; STOCHASTICITY; VACCINATION; DYNAMICS; DRIVERS; MEASLES	Infectious diseases are notorious for their complex dynamics, which make it difficult to fit models to test hypotheses. Methods based on state-space reconstruction have been proposed to infer causal interactions in noisy, nonlinear dynamical systems. These "model-free" methods are collectively known as convergent cross-mapping (CCM). Although CCM has theoretical support, natural systems routinely violate its assumptions. To identify the practical limits of causal inference under CCM, we simulated the dynamics of two pathogen strains with varying interaction strengths. The original method of CCM is extremely sensitive to periodic fluctuations, inferring interactions between independent strains that oscillate with similar frequencies. This sensitivity vanishes with alternative criteria for inferring causality. However, CCM remains sensitive to high levels of process noise and changes to the deterministic attractor. This sensitivity is problematic because it remains challenging to gauge noise and dynamical changes in natural systems, including the quality of reconstructed attractors that underlie cross-mapping. We illustrate these challenges by analyzing time series of reportable childhood infections in New York City and Chicago during the pre-vaccine era. We comment on the statistical and conceptual challenges that currently limit the use of state-space reconstruction in causal inference.	[Cobey, Sarah; Baskerville, Edward B.] Univ Chicago, Ecol & Evolut, Chicago, IL 60637 USA	University of Chicago	Cobey, S (corresponding author), Univ Chicago, Ecol & Evolut, Chicago, IL 60637 USA.	cobey@uchicago.edu			University of Chicago's Big Ideas Generator	University of Chicago's Big Ideas Generator	This work was funded by a seed grant from the University of Chicagos Big Ideas Generator. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alonso D, 2007, J R SOC INTERFACE, V4, P575, DOI 10.1098/rsif.2006.0192; Altizer S, 2006, ECOL LETT, V9, P467, DOI 10.1111/j.1461-0248.2005.00879.x; Anderson R.H, 1991, INFECT DIS HUMANS; ANDERSON RM, 1985, NATURE, V318, P323, DOI 10.1038/318323a0; Boland RP, 2009, PHYS REV E, V79, DOI 10.1103/PhysRevE.79.051131; Burnham K P, 2003, MODEL SELECT MULTIMO; Cao LY, 1997, PHYSICA D, V110, P43, DOI 10.1016/S0167-2789(97)00118-8; CASDAGLI M, 1991, PHYSICA D, V51, P52, DOI 10.1016/0167-2789(91)90222-U; Clark AT, 2015, ECOLOGY, V96, P1174, DOI 10.1890/14-1479.1; Cobey S, 2014, ANN NY ACAD SCI, V1320, P1, DOI 10.1111/nyas.12493; Dalziel BD, 2016, PLOS COMPUT BIOL, V12, DOI 10.1371/journal.pcbi.1004655; de Celles MD, 2016, P ROY SOC B-BIOL SCI, V283, DOI 10.1098/rspb.2015.2309; Deyle ER, 2016, P NATL ACAD SCI USA, V113, P13081, DOI 10.1073/pnas.1607747113; Deyle ER, 2016, P ROY SOC B-BIOL SCI, V283, DOI 10.1098/rspb.2015.2258; DURRETT R, 1994, THEOR POPUL BIOL, V46, P363, DOI 10.1006/tpbi.1994.1032; Earn DJD, 2000, SCIENCE, V287, P667, DOI 10.1126/science.287.5453.667; ELLNER S, 1995, AM NAT, V145, P343, DOI 10.1086/285744; FINE PEM, 1982, INT J EPIDEMIOL, V11, P5, DOI 10.1093/ije/11.1.5; Finkenstadt BF, 2000, J R STAT SOC C-APPL, V49, P187, DOI 10.1111/1467-9876.00187; Gog JR, 2002, J MATH BIOL, V44, P169, DOI 10.1007/s002850100120; Grad YH, 2012, EPIDEMIOLOGY, V23, P523, DOI 10.1097/EDE.0b013e3182572581; GRANGER CWJ, 1969, ECONOMETRICA, V37, P424, DOI 10.2307/1912791; GURNEY WSC, 1978, AM NAT, V112, P1075, DOI 10.1086/283347; Hastings A, 2004, TRENDS ECOL EVOL, V19, P39, DOI 10.1016/j.tree.2003.09.007; He DH, 2010, J R SOC INTERFACE, V7, P271, DOI 10.1098/rsif.2009.0151; Hilborn Ray, 1997, V28; HURLBERT SH, 1984, ECOL MONOGR, V54, P187, DOI 10.2307/1942661; Keeling M.J., 2011, MODELING INFECT DIS, DOI 10.1111/j.1541-0420.2008.01082-_}7.x; KENNEL MB, 1992, PHYS REV A, V45, P3403, DOI 10.1103/PhysRevA.45.3403; Kermack WO, 1927, P R SOC LOND A-CONTA, V115, P700, DOI 10.1098/rspa.1927.0118; Kocarev L, 1996, PHYS REV LETT, V76, P1816, DOI 10.1103/PhysRevLett.76.1816; Laneri K, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000898; Lavine JS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072086; McKane AJ, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.218102; Metcalf CJE, 2009, P ROY SOC B-BIOL SCI, V276, P4111, DOI 10.1098/rspb.2009.1058; Mina MJ, 2015, SCIENCE, V348, P694, DOI 10.1126/science.aaa3662; Mooij JM, 2016, J MACH LEARN RES, V17; Nguyen HTH, 2008, J R SOC INTERFACE, V5, P403, DOI 10.1098/rsif.2007.1168; Nichkawde C, 2013, PHYS REV E, V87, DOI 10.1103/PhysRevE.87.022905; Pecora LM, 2007, CHAOS, V17, DOI 10.1063/1.2430294; Plowright RK, 2008, FRONT ECOL ENVIRON, V6, P420, DOI 10.1890/070086; RAND DA, 1991, P ROY SOC B-BIOL SCI, V246, P179, DOI 10.1098/rspb.1991.0142; Rohani P, 2002, AM NAT, V159, P469, DOI 10.1086/339467; Rohani P, 2003, NATURE, V422, P885, DOI 10.1038/nature01542; Ross R., 1910, PREVENTION MALARIA; Schumacher J, 2015, NEURAL COMPUT, V27, P1555, DOI 10.1162/NECO_a_00756; Shaman J, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000316; SIMBERLOFF DS, 1969, ECOLOGY, V50, P278, DOI 10.2307/1934856; Small M, 2004, PHYSICA D, V194, P283, DOI 10.1016/j.physd.2004.03.006; Stegle O., 2010, ADV NEURAL INF PROCE, V23, P1687; SUGIHARA G, 1990, NATURE, V344, P734, DOI 10.1038/344734a0; SUGIHARA G, 1994, PHILOS T R SOC A, V348, P477, DOI 10.1098/rsta.1994.0106; Sugihara G, 2012, SCIENCE, V338, P496, DOI 10.1126/science.1227079; Tajima S, 2015, PLOS COMPUT BIOL, V11, DOI 10.1371/journal.pcbi.1004537; Takens F, 1981, DYNAMICAL SYSTEMS TU, P366, DOI [10.1007/BFb0091924, DOI 10.1007/BFB0091924]; TILMAN D, 1989, P136; Tsonis AA, 2015, P NATL ACAD SCI USA, V112, P3253, DOI 10.1073/pnas.1420291112; Turchin P., 2003, MONOGRAPHS POPULATIO; Uzal LC, 2011, PHYS REV E, V84, DOI 10.1103/PhysRevE.84.016223; van Panhuis WG, 2013, NEW ENGL J MED, V369, P2152, DOI 10.1056/NEJMms1215400; Wood SN, 1999, P ROY SOC B-BIOL SCI, V266, P565, DOI 10.1098/rspb.1999.0673; Ye H, 2015, SCI REP-UK, V5, DOI 10.1038/srep14750; Ye H, 2015, P NATL ACAD SCI USA, V112, pE1569, DOI 10.1073/pnas.1417063112; YODZIS P, 1988, ECOLOGY, V69, P508, DOI 10.2307/1940449	64	26	26	2	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2016	11	12							e0169050	10.1371/journal.pone.0169050	http://dx.doi.org/10.1371/journal.pone.0169050			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EG7JB	28030639	gold, Green Submitted, Green Published			2022-12-27	WOS:000391222000102
J	Kawase, T; Yahata, I; Kanno, A; Sakamoto, S; Takanashi, Y; Takata, S; Nakasato, N; Kawashima, R; Katori, Y				Kawase, Tetsuaki; Yahata, Izumi; Kanno, Akitake; Sakamoto, Shuichi; Takanashi, Yoshitaka; Takata, Shiho; Nakasato, Nobukazu; Kawashima, Ryuta; Katori, Yukio			Impact of Audio-Visual Asynchrony on Lip-Reading Effects -Neuromagnetic and Psychophysical Study-	PLOS ONE			English	Article							VISUAL SPEECH-PERCEPTION; EVOKED MAGNETIC-FIELDS; HUMAN AUDITORY-CORTEX; HUMAN-BRAIN; MULTISENSORY INTEGRATION; SEEING VOICES; SOUNDS; MEG; LOCALIZATION; MISMATCH	The effects of asynchrony between audio and visual (A/V) stimuli on the N100m responses of magnetoencephalography in the left hemisphere were compared with those on the psychophysical responses in 11 participants. The latency and amplitude of N100m were significantly shortened and reduced in the left hemisphere by the presentation of visual speech as long as the temporal asynchrony between A/V stimuli was within 100 ms, but were not significantly affected with audio lags of -500 and +500 ms. However, some small effects were still preserved on average with audio lags of 500 ms, suggesting similar asymmetry of the temporal window to that observed in psychophysical measurements, which tended to be more robust (wider) for audio lags; i.e., the pattern of visual-speech effects as a function of A/V lag observed in the N100m in the left hemisphere grossly resembled that in psychophysical measurements on average, although the individual responses were somewhat varied. The present results suggest that the basic configuration of the temporal window of visual effects on auditory-speech perception could be observed from the early auditory processing stage.	[Kawase, Tetsuaki; Yahata, Izumi; Takanashi, Yoshitaka; Takata, Shiho; Katori, Yukio] Tohoku Univ, Grad Sch Med, Dept Otolaryngol Head & Neck Surg, Sendai, Miyagi, Japan; [Kawase, Tetsuaki] Tohoku Univ, Grad Sch Biomed Engn, Lab Rehabil Auditory Sci, Sendai, Miyagi, Japan; [Kawase, Tetsuaki] Tohoku Univ, Grad Sch Med, Dept Audiol, Sendai, Miyagi, Japan; [Kanno, Akitake; Kawashima, Ryuta] Tohoku Univ, Inst Dev Aging & Canc, Dept Funct Brain Imaging, Sendai, Miyagi, Japan; [Sakamoto, Shuichi] Tohoku Univ, Elect Commun Res Inst, Sendai, Miyagi, Japan; [Nakasato, Nobukazu] Tohoku Univ, Grad Sch Med, Dept Epileptol, Sendai, Miyagi, Japan	Tohoku University; Tohoku University; Tohoku University; Tohoku University; Tohoku University; Tohoku University	Kawase, T (corresponding author), Tohoku Univ, Grad Sch Med, Dept Otolaryngol Head & Neck Surg, Sendai, Miyagi, Japan.; Kawase, T (corresponding author), Tohoku Univ, Grad Sch Biomed Engn, Lab Rehabil Auditory Sci, Sendai, Miyagi, Japan.; Kawase, T (corresponding author), Tohoku Univ, Grad Sch Med, Dept Audiol, Sendai, Miyagi, Japan.	kawase@orl.med.tohoku.ac.jp	Nakasato, Nobukazu/AAC-3650-2019		Ministry of Education, Culture, Sports, Science and Technology-Japan [24390386, H1605478]; Grants-in-Aid for Scientific Research [16H05435] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science and Technology-Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by grants from the Ministry of Education, Culture, Sports, Science and Technology-Japan (Grant-in-Aid for Scientific Research (B), 24390386, H1605478). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnal LH, 2009, J NEUROSCI, V29, P13445, DOI 10.1523/JNEUROSCI.3194-09.2009; Baum SH, 2012, NEUROIMAGE, V62, P1825, DOI 10.1016/j.neuroimage.2012.05.034; Besle J, 2004, EUR J NEUROSCI, V20, P2225, DOI 10.1111/j.1460-9568.2004.03670.x; Calvert GA, 2000, CURR BIOL, V10, P649, DOI 10.1016/S0960-9822(00)00513-3; Calvert GA, 2003, J COGNITIVE NEUROSCI, V15, P57, DOI 10.1162/089892903321107828; Calvert GA, 2001, NEUROIMAGE, V14, P427, DOI 10.1006/nimg.2001.0812; Calvert GA, 2001, CEREB CORTEX, V11, P1110, DOI 10.1093/cercor/11.12.1110; Cappe C, 2005, EUR J NEUROSCI, V22, P2886, DOI 10.1111/j.1460-9568.2005.04462.x; Davis C, 2008, BRAIN RES, V1242, P151, DOI 10.1016/j.brainres.2008.04.077; ERBER NP, 1971, J SPEECH HEAR RES, V14, P496, DOI 10.1044/jshr.1403.496; Falchier A, 2002, J NEUROSCI, V22, P5749; Giard MH, 1999, J COGNITIVE NEUROSCI, V11, P473, DOI 10.1162/089892999563544; GREEN KP, 1991, PERCEPT PSYCHOPHYS, V50, P524, DOI 10.3758/BF03207536; HARI R, 1980, EXP BRAIN RES, V40, P237, DOI 10.1007/BF00237543; Helenius P, 2002, J NEUROSCI, V22, P2936, DOI 10.1523/JNEUROSCI.22-07-02936.2002; Kanno A, 2000, NEUROSCI LETT, V293, P187, DOI 10.1016/S0304-3940(00)01525-1; Kanno A, 1996, EEG CL N SU, P129; Kawase T, 2012, NEUROIMAGE, V59, P1037, DOI 10.1016/j.neuroimage.2011.08.108; Klucharev V, 2003, COGNITIVE BRAIN RES, V18, P65, DOI 10.1016/j.cogbrainres.2003.09.004; Kujala A, 2004, COGNITIVE BRAIN RES, V21, P106, DOI 10.1016/j.cogbrainres.2004.05.011; KURIKI S, 1989, EXP BRAIN RES, V77, P127; Marinkovic K, 2003, NEURON, V38, P487, DOI 10.1016/S0896-6273(03)00197-1; MCGURK H, 1976, NATURE, V264, P746, DOI 10.1038/264746a0; Munhall KG, 1996, PERCEPT PSYCHOPHYS, V58, P351, DOI 10.3758/BF03206811; Naatanen R, 1997, NATURE, V385, P432, DOI 10.1038/385432a0; NAATANEN R, 1987, PSYCHOPHYSIOLOGY, V24, P375, DOI 10.1111/j.1469-8986.1987.tb00311.x; Nakamura I, 2015, NEUROPSYCHOBIOLOGY, V71, P187, DOI 10.1159/000377680; Nakasato N, 1997, J NEUROSURG, V86, P610, DOI 10.3171/jns.1997.86.4.0610; NAKASATO N, 1995, ELECTROEN CLIN NEURO, V94, P183, DOI 10.1016/0013-4694(94)00280-X; Obleser J, 2004, BMC NEUROSCI, V5, DOI 10.1186/1471-2202-5-24; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; PANTEV C, 1986, AUDIOLOGY, V25, P54; Parviainen T, 2005, CEREB CORTEX, V15, P1054, DOI 10.1093/cercor/bhh206; Phillips C, 2000, J COGNITIVE NEUROSCI, V12, P1038, DOI 10.1162/08989290051137567; Poeppel D, 1996, COGNITIVE BRAIN RES, V4, P231, DOI 10.1016/S0926-6410(96)00643-X; Reale RA, 2007, NEUROSCIENCE, V145, P162, DOI 10.1016/j.neuroscience.2006.11.036; REITE M, 1994, COGNITIVE BRAIN RES, V2, P13, DOI 10.1016/0926-6410(94)90016-7; Rockland KS, 2003, INT J PSYCHOPHYSIOL, V50, P19, DOI 10.1016/S0167-8760(03)00121-1; Saint-Amour D, 2007, NEUROPSYCHOLOGIA, V45, P587, DOI 10.1016/j.neuropsychologia.2006.03.036; Salmelin R, 2007, CLIN NEUROPHYSIOL, V118, P237, DOI 10.1016/j.clinph.2006.07.316; Sasaki T, 2005, NEUROIMAGE, V25, P684, DOI 10.1016/j.neuroimage.2004.11.030; Sekiyama K, 2003, NEUROSCI RES, V47, P277, DOI 10.1016/S0168-0102(03)00214-1; Soto-Faraco S, 2009, J EXP PSYCHOL HUMAN, V35, P580, DOI 10.1037/a0013483; Stekelenburg JJ, 2007, J COGNITIVE NEUROSCI, V19, P1964, DOI 10.1162/jocn.2007.19.12.1964; Stevenson RA, 2012, J EXP PSYCHOL HUMAN, V38, P1517, DOI 10.1037/a0027339; SUMBY WH, 1954, J ACOUST SOC AM, V26, P212, DOI 10.1121/1.1907309; Usubuchi H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099457; van Wassenhove V, 2005, P NATL ACAD SCI USA, V102, P1181, DOI 10.1073/pnas.0408949102; van Wassenhove V, 2007, NEUROPSYCHOLOGIA, V45, P598, DOI 10.1016/j.neuropsychologia.2006.01.001; Vihla M, 2000, P NATL ACAD SCI USA, V97, P10590, DOI 10.1073/pnas.180317297; Wright TM, 2003, CEREB CORTEX, V13, P1034, DOI 10.1093/cercor/13.10.1034	51	2	2	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2016	11	12							e0168740	10.1371/journal.pone.0168740	http://dx.doi.org/10.1371/journal.pone.0168740			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EG7JB	28030631	gold, Green Submitted, Green Published			2022-12-27	WOS:000391222000072
J	Sokolowski, M; Wasserman, J; Wasserman, D				Sokolowski, Marcus; Wasserman, Jerzy; Wasserman, Danuta			Rare CNVs in Suicide Attempt include Schizophrenia-Associated Loci and Neurodevelopmental Genes: A Pilot GenomeWide and Family-Based Study	PLOS ONE			English	Article							COPY NUMBER VARIATION; WIDE ASSOCIATION; ENVIRONMENT INTERACTIONS; DISORDERS; BEHAVIORS; POLYMORPHISMS; VARIANTS; GUIDANCE; RISK	Suicidal behavior (SB) has a complex etiology involving genes and environment. One of the genetic components in SB could be copy number variations (CNVs), as CNVs are implicated in neurodevelopmental disorders. However, a recently published genome-wide and case control study did not observe any significant role of CNVs in SB. Here we complemented these initial observations by instead using a family-based trio-sample that is robust to control biases, having severe suicide attempt (SA) in offspring as main outcome (n = 660 trios). We first tested for CNV associations on the genome-wide Illumina 1M SNP-array by using FBAT-CNV methodology, which allows for evaluating CNVs without reliance on CNV calling algorithms, analogous to a common SNP-based GWAS. We observed association of certain T-cell receptor markers, but this likely reflected inter-individual variation in somatic rearrangements rather than association with SA outcome. Next, we used the PennCNV software to call 385 putative rare (<1%) and large (>100 kb) CNVs, observed in n = 225 SA offspring. Nine SA offspring had rare CNV calls in a set of previously schizophrenia-associated loci, indicating the importance of such CNVs in certain SA subjects. Several additional, very large (>1MB) sized CNV calls in 15 other SA offspring also spanned pathogenic regions or other neural genes of interest. Overall, 45 SA had CNVs enriched for 65 medically relevant genes previously shown to be affected by CNVs, which were characterized by a neurodevelopmental biology. A neurodevelopmental implication was partly congruent with our previous SNP-based GWAS, but follow-up analysis here indicated that carriers of rare CNVs had a decreased burden of common SNP risk-alleles compared to non-carriers. In conclusion, while CNVs did not show genome-wide association by the FBAT-CNV methodology, our preliminary observations indicate rare pathogenic CNVs affecting neurodevelopmental functions in a subset of SA, who were distinct from SA having increased SNP risk allele burden. These observations may open up new avenues in the genetic etiology of SB.	[Sokolowski, Marcus; Wasserman, Jerzy; Wasserman, Danuta] Karolinska Inst, Natl Ctr Suicide Res & Prevent Mental Hlth NASP 3, Stockholm, Sweden; [Wasserman, Danuta] KI, NASP, WHO Collaborating Ctr Res Methods Dev & Training, Stockholm, Sweden	Karolinska Institutet; Karolinska Institutet	Sokolowski, M (corresponding author), Karolinska Inst, Natl Ctr Suicide Res & Prevent Mental Hlth NASP 3, Stockholm, Sweden.	marcus.sokolowski@ki.se	farjad, farshad/AGC-9105-2022	Sokolowski, Marcus/0000-0003-3931-1810	Knut and Alice Wallenberg Foundation	Knut and Alice Wallenberg Foundation(Knut & Alice Wallenberg Foundation)	This GISS study was funded by the Knut and Alice Wallenberg Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramson Joseph H, 2011, Epidemiol Perspect Innov, V8, P1, DOI 10.1186/1742-5573-8-1; BECK AT, 1975, AM J PSYCHIAT, V132, P285; Ben-Efraim YJ, 2011, GENES BRAIN BEHAV, V10, P663, DOI 10.1111/j.1601-183X.2011.00703.x; Ben-Efraim YJ, 2013, NEUROPSYCHOPHARMACOL, V38, P1504, DOI 10.1038/npp.2013.49; Ben-Efraim Y, 2013, MOL PSYCHIATR, V18, P758, DOI 10.1038/mp.2012.86; Brent DA, 2008, PSYCHIAT CLIN N AM, V31, P157, DOI 10.1016/j.psc.2008.02.001; Chapman J, 2013, HUM MOL GENET, V22, P816, DOI 10.1093/hmg/dds476; Chen J, 2009, NUCLEIC ACIDS RES, V37, pW305, DOI 10.1093/nar/gkp427; COX DR, 1970, BIOMETRIKA, V57, P217, DOI 10.1093/biomet/57.1.217; Galfalvy H, 2011, WORLD J BIOL PSYCHIA, DOI http://dx.doi.org/10.3109/15622975.2011.597875; Galfalvy H, 2013, WORLD J BIOL PSYCHIA, V14, P574, DOI 10.3109/15622975.2011.597875; Gauderman WJ, 2002, STAT MED, V21, P35, DOI 10.1002/sim.973; GEIJER T, 1994, EUR ARCH PSY CLIN N, V244, P26, DOI 10.1007/BF02279808; Georgieva L, 2014, HUM MOL GENET, V23, P6677, DOI 10.1093/hmg/ddu379; Grayton HM, 2012, PROG NEUROBIOL, V99, P81, DOI 10.1016/j.pneurobio.2012.07.005; Gross JA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0128369; GROTE SS, 1974, J NEUROCHEM, V23, P791, DOI 10.1111/j.1471-4159.1974.tb04405.x; Grozeva D, 2012, SCHIZOPHR RES, V135, P1, DOI 10.1016/j.schres.2011.11.004; Hoertel N, 2015, MOL PSYCHIATR, V20, P718, DOI 10.1038/mp.2015.19; Ionita-Laza I, 2008, GENET EPIDEMIOL, V32, P273, DOI 10.1002/gepi.20302; Itsara A, 2010, GENOME RES, V20, P1469, DOI 10.1101/gr.107680.110; Jonas RK, 2014, BIOL PSYCHIAT, V75, P351, DOI 10.1016/j.biopsych.2013.07.019; Lenz B, 2016, J NEURAL TRANSM VIEN; Li MX, 2012, HUM GENET, V131, P747, DOI 10.1007/s00439-011-1118-2; Little J, 2009, PLOS MED, V6, P151, DOI 10.1371/journal.pmed.1000022; Mann JJ, 2009, BIOL PSYCHIAT, V65, P556, DOI 10.1016/j.biopsych.2008.11.021; Mittendorfer-Rutz E, 2004, LANCET, V364, P1135, DOI 10.1016/S0140-6736(04)17099-2; Mullins N, 2014, AM J MED GENET B, V165, P428, DOI 10.1002/ajmg.b.32247; Oquendo MA, 2014, AM J PSYCHIAT, V171, P1259, DOI 10.1176/appi.ajp.2014.14020194; Perlis RH, 2010, AM J PSYCHIAT, V167, P1499, DOI 10.1176/appi.ajp.2010.10040541; Quinlan Aaron R, 2014, Curr Protoc Bioinformatics, V47, DOI 10.1002/0471250953.bi1112s47; Rees E, 2014, BRIT J PSYCHIAT, V204, P108, DOI 10.1192/bjp.bp.113.131052; Schild AHE, 2013, PROG NEURO-PSYCHOPH, V46, P36, DOI 10.1016/j.pnpbp.2013.06.014; Schosser A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020690; Schwienbacher C, 2010, IMMUNOGENETICS, V62, P561, DOI 10.1007/s00251-010-0459-7; Sokolowski M, 2016, MOL PSYCHIATR, V21, P1381, DOI 10.1038/mp.2015.187; Sokolowski M, 2015, MOL PSYCHIATR, V20, P56, DOI 10.1038/mp.2014.101; Sokolowski M, 2013, MOL PSYCHIATR, V18, P985, DOI 10.1038/mp.2012.112; Sokolowski M, 2010, MOL PSYCHIATR, V15, P10, DOI 10.1038/mp.2009.70; Sokolowski M, 2014, EUR NEUROPSYCHOPHARM, V24, P1567, DOI 10.1016/j.euroneuro.2014.08.006; Szatkiewicz JP, 2014, MOL PSYCHIATR, V19, P762, DOI 10.1038/mp.2014.40; Szklarczyk D, 2015, NUCLEIC ACIDS RES, V43, pD447, DOI 10.1093/nar/gku1003; Tansey KE, 2015, MOL PSYCHIAT; Turecki G, 2012, TRENDS NEUROSCI, V35, P14, DOI 10.1016/j.tins.2011.11.008; Voracek M, 2007, WIEN KLIN WOCHENSCHR, V119, P463, DOI 10.1007/s00508-007-0823-2; Walsh KM, 2010, MUTAT RES-FUND MOL M, V690, P89, DOI 10.1016/j.mrfmmm.2010.05.005; Wang K, 2007, GENOME RES, V17, P1665, DOI 10.1101/gr.6861907; Wasserman D, 2008, GENES BRAIN BEHAV, V7, P14, DOI 10.1111/j.1601-183X.2007.00310.x; Wasserman D, 2007, GENES BRAIN BEHAV, V6, P321, DOI 10.1111/j.1601-183X.2006.00259.x; Wasserman D, 2005, AM J MED GENET B, V133B, P116, DOI 10.1002/ajmg.b.30128; Wasserman D, 2012, EUR PSYCHIAT, V27, P129, DOI 10.1016/j.eurpsy.2011.06.003; Wasserman Danuta, 2006, Behav Brain Funct, V2, P14, DOI 10.1186/1744-9081-2-14; Wasserman D, 2007, EUR NEUROPSYCHOPHARM, V17, P230, DOI 10.1016/j.euroneuro.2006.08.006; Willour VL, 2012, MOL PSYCHIATR, V17, P433, DOI 10.1038/mp.2011.4; Zanda M, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004367; Zanda M, 2012, GENET EPIDEMIOL, V36, P895, DOI 10.1002/gepi.21674; Zarrei M, 2015, NAT REV GENET, V16, P172, DOI 10.1038/nrg3871	57	11	12	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2016	11	12							e0168531	10.1371/journal.pone.0168531	http://dx.doi.org/10.1371/journal.pone.0168531			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EG7JB	28030616	Green Published, gold, Green Submitted			2022-12-27	WOS:000391222000053
J	Pickering, RT; Lee, MJ; Karastergiou, K; Gower, A; Fried, SK				Pickering, R. Taylor; Lee, Mi-Jeong; Karastergiou, Kalypso; Gower, Adam; Fried, Susan K.			Depot Dependent Effects of Dexamethasone on Gene Expression in Human Omental and Abdominal Subcutaneous Adipose Tissues from Obese Women	PLOS ONE			English	Article							GLUCOCORTICOID-RECEPTOR; BODY-FAT; EXTRACELLULAR-MATRIX; INSULIN-RESISTANCE; VISCERAL OBESITY; INFLAMMATION; PHOSPHORYLATION; ADIPOGENESIS; MODULATION; BINDING	Glucocorticoids promote fat accumulation in visceral compared to subcutaneous depots, but the molecular mechanisms involved remain poorly understood. To identify long-term changes in gene expression that are differentially sensitive or responsive to glucocorticoids in these depots, paired samples of human omental (Om) and abdominal subcutaneous (Abdsc) adipose tissues obtained from obese women during elective surgery were cultured with the glucocorticoid receptor agonist dexamethasone (Dex, 0, 1, 10, 25 and 1000 nM) for 7 days. Dex regulated 32% of the 19,741 genes on the array, while 53% differed by Depot and 2.5% exhibited a Depot*Dex concentration interaction. Gene set enrichment analysis showed Dex regulation of the expected metabolic and inflammatory pathways in both depots. Cluster analysis of the 460 transcripts that exhibited an interaction of Depot and Dex concentration revealed sets of mRNAs for which the responses to Dex differed in magnitude, sensitivity or direction between the two depots as well as mRNAs that responded to Dex only in one depot. These transcripts were also clearly depot different in fresh adipose tissue and are implicated in processes that could affect adipose tissue distribution or functions (e.g. adipogenesis, triacylglycerol synthesis and storage, insulin action). Elucidation of the mechanisms underlying the depot differences in the effect of Dex on the expression of specific genes and pathways that regulate adipose function may offer novel insights into understanding the biology of visceral adipose tissues and their links to metabolic health.	[Pickering, R. Taylor; Lee, Mi-Jeong; Karastergiou, Kalypso; Fried, Susan K.] Boston Univ, Sch Med, Dept Med, Obes Ctr, Boston, MA 02118 USA; [Gower, Adam] Boston Univ, Clin Translat Sci Inst, Boston, MA 02215 USA	Boston University; Boston University	Fried, SK (corresponding author), Boston Univ, Sch Med, Dept Med, Obes Ctr, Boston, MA 02118 USA.	susan.fried@mssm.edu	Lee, Mi-Jeong/ABE-1084-2020; Lee, Mi-Jeong/GXV-9843-2022	Lee, Mi-Jeong/0000-0002-8171-7913; Lee, Mi-Jeong/0000-0002-8171-7913; Pickering, Richard/0000-0002-5243-4068; Gower, Adam/0000-0002-6122-7511; Karastergiou, Kalypso/0000-0002-1790-065X; Karastergiou, Aris/0000-0002-1434-9786	National Institutes of Health [RO1 DK08084, T32 DK007201, P30DK46200, U54 TR001012]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [T32DK007201, R01DK080448] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	Funding was provided by the National Institutes of Health (https://www.nih.gov/), RO1 DK08084, T32 DK007201, P30DK46200 and U54 TR001012.	Aluwihare P, 2009, J CELL SCI, V122, P227, DOI 10.1242/jcs.035246; Arase T, 2009, J IMMUNOL, V182, P7074, DOI 10.4049/jimmunol.0900001; Arner P, 2013, J CLIN ENDOCR METAB, V98, pE897, DOI 10.1210/jc.2012-4106; Berendsen AD, 2011, P NATL ACAD SCI USA, V108, P17022, DOI 10.1073/pnas.1110629108; Catalan V, 2012, J CLIN ENDOCR METAB, V97, pE1880, DOI 10.1210/jc.2012-1670; Chau YY, 2014, NAT CELL BIOL, V16, P367, DOI 10.1038/ncb2922; Chen WW, 2008, MOL ENDOCRINOL, V22, P1754, DOI 10.1210/me.2007-0219; Chodankar R, 2014, P NATL ACAD SCI USA, V111, P4007, DOI 10.1073/pnas.1400522111; Corradetti MN, 2005, J BIOL CHEM, V280, P9769, DOI 10.1074/jbc.C400557200; Darimont C, 2008, INT J OBESITY, V32, P112, DOI 10.1038/sj.ijo.0803688; Drews F, 2008, BBA-MOL CELL RES, V1783, P34, DOI 10.1016/j.bbamcr.2007.08.004; Drolet R, 2008, INT J OBESITY, V32, P283, DOI 10.1038/sj.ijo.0803708; Du BW, 2013, J BIOL CHEM, V288, P3036, DOI 10.1074/jbc.M112.440370; Fried SK, 2000, METH MOL B, V155, P197; Fried SK, 1998, J CLIN ENDOCR METAB, V83, P847, DOI 10.1210/jc.83.3.847; FRIED SK, 1993, J CLIN INVEST, V92, P2191, DOI 10.1172/JCI116821; GARNER JA, 1988, BRAIN RES, V458, P309, DOI 10.1016/0006-8993(88)90473-8; Geer EB, 2012, J CLIN ENDOCR METAB, V97, P1702, DOI 10.1210/jc.2011-3123; Geer EB, 2010, CLIN ENDOCRINOL, V73, P469, DOI 10.1111/j.1365-2265.2010.03829.x; Gesta S, 2006, P NATL ACAD SCI USA, V103, P6676, DOI 10.1073/pnas.0601752103; Grandl G, 2016, MOL METAB, V5, P937, DOI 10.1016/j.molmet.2016.07.008; Hara T, 2016, J CELL BIOCH; Hardy OT, 2011, SURG OBES RELAT DIS, V7, P60, DOI 10.1016/j.soard.2010.05.013; Hashimoto I, 2006, OBESITY, V14, P799, DOI 10.1038/oby.2006.93; Hsu MH, 2007, DRUG METAB REV, V39, P515, DOI 10.1080/03602530701468573; Huang DW, 2007, NUCLEIC ACIDS RES, V35, pW169, DOI 10.1093/nar/gkm415; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Jeimy SB, 2008, THROMB HAEMOSTASIS, V100, P1058, DOI 10.1160/TH08-05-0307; Kong P, 2013, AM J PHYSIOL-ENDOC M, V305, pE439, DOI 10.1152/ajpendo.00006.2013; Le Jan S, 2006, FEBS LETT, V580, P3395, DOI 10.1016/j.febslet.2006.05.011; Lee MJ, 2014, INT J OBESITY, V38, P1228, DOI 10.1038/ijo.2014.6; Lee MJ, 2007, AM J PHYSIOL-ENDOC M, V292, pE858, DOI 10.1152/ajpendo.00439.2006; Lee MJ, 2013, MOL ASPECTS MED, V34, P1, DOI 10.1016/j.mam.2012.10.001; Lee MJ, 2011, AM J PHYSIOL-ENDOC M, V300, pE571, DOI 10.1152/ajpendo.00231.2010; Lessard J, 2014, ADIPOCYTE, V3, P197, DOI 10.4161/adip.29385; Magnusson B, 2010, BIOCHEM BIOPH RES CO, V395, P373, DOI 10.1016/j.bbrc.2010.04.022; Moreno-Navarrete JM, 2011, J CLIN ENDOCR METAB, V96, pE1816, DOI 10.1210/jc.2011-0310; Masuzaki H, 2001, SCIENCE, V294, P2166, DOI 10.1126/science.1066285; Matsuo Y, 2015, METABOLISM, V64, P1490, DOI 10.1016/j.metabol.2015.07.016; Mootha VK, 2003, NAT GENET, V34, P267, DOI 10.1038/ng1180; Nie T, 2012, FEBS LETT, V586, P3618, DOI 10.1016/j.febslet.2012.08.006; Nishimura S, 2014, DIABETES, V63, P4154, DOI 10.2337/db13-1694; Nishizuka M, 2008, FEBS LETT, V582, P3201, DOI 10.1016/j.febslet.2008.08.011; Nye CK, 2008, J BIOL CHEM, V283, P27565, DOI 10.1074/jbc.M804393200; Patel R, 2014, MOL ENDOCRINOL, V28, P999, DOI 10.1210/me.2014-1062; Regazzetti C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052154; Robciuc MR, 2016, CELL METAB, V23, P712, DOI 10.1016/j.cmet.2016.03.004; Roqueta-Rivera M, 2016, CELL METAB, V24, P474, DOI 10.1016/j.cmet.2016.07.025; Rump A, 2004, J BIOL CHEM, V279, P9190, DOI 10.1074/jbc.M312372200; Shan DD, 2010, J LIPID RES, V51, P1971, DOI 10.1194/jlr.M006304; Shitaye HS, 2010, MATRIX BIOL, V29, P549, DOI 10.1016/j.matbio.2010.05.006; Singh P, 2015, OBESITY, V23, P2286, DOI 10.1002/oby.21251; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Tang T, 2013, CONNECT TISSUE RES, V54, P5, DOI 10.3109/03008207.2012.715700; Tchernof A, 2006, DIABETES, V55, P1353, DOI 10.2337/db05-1439; Tchernof A, 2013, PHYSIOL REV, V93, P359, DOI 10.1152/physrev.00033.2011; Tews D, 2014, MOL CELL ENDOCRINOL, V395, P41, DOI 10.1016/j.mce.2014.07.011; Umemoto E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083681; Vandevyver S, 2014, ENDOCR REV, V35, P671, DOI 10.1210/er.2014-1010; Vockley CM, 2016, CELL, V166, P1269, DOI 10.1016/j.cell.2016.07.049; WAJCHENBERG BL, 1995, J CLIN ENDOCR METAB, V80, P2791, DOI 10.1210/jc.80.9.2791; Ward MG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050554; Wellen KE, 2007, CELL, V129, P537, DOI 10.1016/j.cell.2007.02.049; Wu Q, 2015, MOL MED REP, V12, P5891, DOI 10.3892/mmr.2015.4117; Xu JF, 2012, J IMMUNOL, V189, P1992, DOI 10.4049/jimmunol.1103207; Yamamoto Y, 2010, OBESITY, V18, P872, DOI 10.1038/oby.2009.512; Yang RZ, 2006, AM J PHYSIOL-ENDOC M, V290, pE1253, DOI 10.1152/ajpendo.00572.2004; Yasmeen R, 2012, BBA-MOL CELL BIOL L, V1821, P190, DOI 10.1016/j.bbalip.2011.06.004; Yoo HJ, 2013, J CLIN ENDOCR METAB, V98, P2897, DOI 10.1210/jc.2012-4297; Yu CY, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015188; Zaragosi LE, 2010, DIABETES, V59, P2513, DOI 10.2337/db10-0013; Zhou S, 2014, CURR MED CHEM, V21, P1212, DOI 10.2174/0929867321666131218093327	72	13	13	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2016	11	12							e0167337	10.1371/journal.pone.0167337	http://dx.doi.org/10.1371/journal.pone.0167337			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI9QH	28005982	Green Submitted, gold, Green Published			2022-12-27	WOS:000392843200013
J	Bui, VN; Nguyen, TTH; Mai, CT; Bettarel, Y; Hoang, TY; Trinh, TTL; Truong, NH; Chu, HH; Nguyen, VTT; Nguyen, HD; Wolfl, S				Van Ngoc Bui; Thi Thu Huyen Nguyen; Chi Thanh Mai; Bettarel, Yvan; Thi Yen Hoang; Thi Thuy Linh Trinh; Nam Hai Truong; Hoang Ha Chu; Vu Thanh Thanh Nguyen; Huu Duc Nguyen; Woelfl, Stefan			Procarcinogens - Determination and Evaluation by Yeast-Based Biosensor Transformed with Plasmids Incorporating RAD54 Reporter Construct and Cytochrome P450 Genes	PLOS ONE			English	Article							POLYCYCLIC AROMATIC-HYDROCARBONS; HUMAN LIVER-MICROSOMES; METABOLIC-ACTIVATION; HETEROCYCLIC AMINES; GENOTOXICITY ASSAY; AFLATOXIN B-1; HUMAN CYP3A4; CELL-LINES; EXPRESSION; BINDING	In Vietnam, a great number of toxic substances, including carcinogens and procarcinogens, from industrial and agricultural activities, food production, and healthcare services are daily released into the environment. In the present study, we report the development of novel yeast-based biosensor systems to determine both genotoxic carcinogens and procarcinogens by cotransformation with two plasmids. One plasmid is carrying human CPR and CYP (CYP3A4, CYP2B6, or CYP2D6) genes, while the other contains the RAD54-GFP reporter construct. The three resulting coexpression systems bearing both CPR-CYP and RAD54-GFP expression cassettes were designated as CYP3A4/CYP2B6/CYP2D6 + RAD54 systems, respectively and used to detect and evaluate the genotoxic potential of carcinogens and procarcinogens by selective activation and induction of both CPR-CYP and RAD54-GFP expression cassettes in response to DNA damage. Procarcinogens were shown to be predominantly, moderately or not bioactivated by one of the CYP enzymes and thus selectively detected by the specific coexpression system. Aflatoxin B-1 and benzo(a) pyrene were predominantly detected by the CYP3A4 + RAD54 system, while N-nitrosodimethylamine only moderately activated the CYP2B6 + RAD54 reporter system and none of them was identified by the CYP2D6 + RAD54 system. In contrast, the genotoxic carcinogen, methyl methanesulfonate, was detected by all systems. Our yeast-reporter system can be performed in 384-well microplates to provide efficient genotoxicity testing to identify various carcinogenic compounds and reduce chemical consumption to about 53% as compared with existing 96-well genotoxicity bioassays. In association with a liquid handling robot, this platform enables rapid, cost-effective, and high-throughput screening of numerous analytes in a fully automated and continuous manner without the need for user interaction.	[Van Ngoc Bui; Chi Thanh Mai; Thi Yen Hoang; Thi Thuy Linh Trinh; Nam Hai Truong; Hoang Ha Chu] VAST, Inst Biotechnol IBT, Natl Key Lab Gene Technol, Hanoi, Vietnam; [Van Ngoc Bui; Woelfl, Stefan] Heidelberg Univ, IPMB, Heidelberg, Germany; [Thi Thu Huyen Nguyen; Vu Thanh Thanh Nguyen] Thai Nguyen Univ, Thai Nguyen Univ Sci, Thai Nguyen, Vietnam; [Bettarel, Yvan] IRD, UMR MARBEC, Montpellier, France; [Huu Duc Nguyen] Vietnam Natl Univ Agr, Hanoi, Vietnam	Vietnam Academy of Science & Technology (VAST); Ruprecht Karls University Heidelberg; Thai Nguyen University; Ifremer; Institut de Recherche pour le Developpement (IRD); Vietnam National University of Agriculture (VNUA)	Wolfl, S (corresponding author), Heidelberg Univ, IPMB, Heidelberg, Germany.	wolfl@uni-hd.de	Bettarel, Yvan/L-2691-2017	Bettarel, Yvan/0000-0001-7155-3364; Bui, Van Ngoc/0000-0002-4659-7338; CHU, HOANG HA/0000-0002-1103-5845	Vietnam National Foundation for Science and Technology Development (NAFOSTED) [106.16-2012.09]	Vietnam National Foundation for Science and Technology Development (NAFOSTED)(National Foundation for Science & Technology Development (NAFOSTED))	This research was funded by the Vietnam National Foundation for Science and Technology Development (NAFOSTED) under the grant number 106.16-2012.09 for Van Ngoc Bui (VNB) http://www.nafosted.gov.vn/en/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdel-Rahman SZ, 2000, PHARMACOGENETICS, V10, P239, DOI 10.1097/00008571-200004000-00005; Afanassiev V, 2000, MUTAT RES-GEN TOX EN, V464, P297, DOI 10.1016/S1383-5718(99)00209-0; AOYAMA Y, 1984, J BIOL CHEM, V259, P1661; BERANEK DT, 1990, MUTAT RES, V231, P11, DOI 10.1016/0027-5107(90)90173-2; Bonowski F, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010727; Bren U, 2014, CHEM RES TOXICOL, V27, P2136, DOI 10.1021/tx5004062; Cahill PA, 2004, MUTAGENESIS, V19, P105, DOI 10.1093/mutage/geh015; Chen XJ, 2012, WATER RES, V46, P2247, DOI 10.1016/j.watres.2012.01.039; Code EL, 1997, DRUG METAB DISPOS, V25, P985; CRESPI CL, 1991, CARCINOGENESIS, V12, P1197, DOI 10.1093/carcin/12.7.1197; Danielson PB, 2002, CURR DRUG METAB, V3, P561, DOI 10.2174/1389200023337054; Dicke KE, 2005, DRUG METAB DISPOS, V33, P1760, DOI 10.1124/dmd.105.006718; Dietrich M, 2005, CHEMBIOCHEM, V6, P2014, DOI 10.1002/cbic.200500200; Donato MT, 2004, DRUG METAB DISPOS, V32, P699, DOI 10.1124/dmd.32.7.699; Dragan CA, 2011, APPL BIOCHEM BIOTECH, V163, P965, DOI 10.1007/s12010-010-9100-3; Favreau LV, 1999, DRUG METAB DISPOS, V27, P436; Foury F, 1997, GENE, V195, P1, DOI 10.1016/S0378-1119(97)00140-6; Gietz RD, 2007, NAT PROTOC, V2, P31, DOI 10.1038/nprot.2007.13; Guengerich FP, 2008, CHEM RES TOXICOL, V21, P70, DOI 10.1021/tx700079z; Guengerich FP, 2009, NAT PROTOC, V4, P1245, DOI 10.1038/nprot.2009.121; GUENGERICH FP, 1992, PHARMACOL THERAPEUT, V54, P17; Guo Y, 2013, ENVIRON SCI TECHNOL, V47, P2932, DOI 10.1021/es3052262; Hayes AW, 2008, PRINCIPLES METHODS T, Vxxiii; Hodgson E., 2010, TXB MODERN TOXICOLOG, Vxxiv; Ioannides C, 2004, CURR TOP MED CHEM, V4, P1767, DOI 10.2174/1568026043387188; Irigaray P, 2010, CARCINOGENESIS, V31, P135, DOI 10.1093/carcin/bgp252; Johnson WW, 1997, P NATL ACAD SCI USA, V94, P6121, DOI 10.1073/pnas.94.12.6121; Kawanami Shoko, 2014, Journal of UOEH, V36, P1; Kelly SL, 1995, FEBS LETT, V377, P217, DOI 10.1016/0014-5793(95)01342-3; Lewis CW, 1999, MYCOPATHOLOGIA, V148, P97, DOI 10.1023/A:1007130923558; Lipinski CA, 2001, ADV DRUG DELIVER REV, V46, P3, DOI 10.1016/S0169-409X(00)00129-0; Luckert C, 2013, TOXICOL LETT, V222, P180, DOI 10.1016/j.toxlet.2013.06.243; Lundin C, 2005, NUCLEIC ACIDS RES, V33, P3799, DOI 10.1093/nar/gki681; Mace K, 1997, CARCINOGENESIS, V18, P1291, DOI 10.1093/carcin/18.7.1291; Marcussen H, 2012, J ENVIRON SCI HEAL A, V47, P2246, DOI 10.1080/10934529.2012.707546; Moserova Michaela, 2009, Interdiscip Toxicol, V2, P239, DOI 10.2478/v10102-009-0024-0; Minh ND, 2012, SCI TOTAL ENVIRON, V416, P164, DOI 10.1016/j.scitotenv.2011.11.068; Oda Y, 2001, MUTAT RES-GEN TOX EN, V492, P81, DOI 10.1016/S1383-5718(01)00154-1; OMURA T, 1964, J BIOL CHEM, V239, P2370; Parsons Ainslie B, 2003, Prog Cell Cycle Res, V5, P159; Hoai PM, 2011, ENVIRON POLLUT, V159, P3344, DOI 10.1016/j.envpol.2011.08.044; PHILLIPS AH, 1962, J BIOL CHEM, V237, P2652; Schutze D, 1996, CHEM RES TOXICOL, V9, P1103, DOI 10.1021/tx950194+; Shimada T, 2006, CHEM RES TOXICOL, V19, P288, DOI 10.1021/tx050291v; Shimada T, 2013, CHEM RES TOXICOL, V26, P529, DOI 10.1021/tx3004906; Stresser DM, 2002, DRUG METAB DISPOS, V30, P845, DOI 10.1124/dmd.30.7.845; Sulc M, 2010, GEN PHYSIOL BIOPHYS, V29, P175, DOI 10.4149/gpb_2010_02_175; Thieu NQ, 2008, TROP ANIM HEALTH PRO, V40, P77, DOI 10.1007/s11250-007-9056-7; Tran-Dinh N, 2009, MYCOPATHOLOGIA, V168, P257, DOI 10.1007/s11046-009-9221-9; Tuyen LH, 2014, SCI TOTAL ENVIRON, V491, P246, DOI 10.1016/j.scitotenv.2014.01.086; van Delft JHM, 2004, CARCINOGENESIS, V25, P1265, DOI 10.1093/carcin/bgh108; Bui VN, 2015, INT J TOXICOL, V34, P31, DOI 10.1177/1091581814566870; Walsh L, 2005, MUTAGENESIS, V20, P317, DOI 10.1093/mutage/gei044; Watanabe T, 2012, MUTAT RES-GEN TOX EN, V747, P164, DOI 10.1016/j.mrgentox.2012.04.011; Wild CP, 2002, MUTAGENESIS, V17, P471, DOI 10.1093/mutage/17.6.471; YAMAZAKI H, 1995, CARCINOGENESIS, V16, P2167, DOI 10.1093/carcin/16.9.2167; YUN CH, 1992, CANCER RES, V52, P1868; Zeng RS, 2006, J CHEM ECOL, V32, P1459, DOI 10.1007/s10886-006-9062-7	59	5	6	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2016	11	12							e0168721	10.1371/journal.pone.0168721	http://dx.doi.org/10.1371/journal.pone.0168721			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI9QH	28006013	Green Published, gold			2022-12-27	WOS:000392843200087
J	Meduri, F; Beretta-Piccoli, M; Calanni, L; Segreto, V; Giovanetti, G; Barbero, M; Cescon, C; D'Antona, G				Meduri, Federico; Beretta-Piccoli, Matteo; Calanni, Luca; Segreto, Valentina; Giovanetti, Giuseppe; Barbero, Marco; Cescon, Corrado; D'Antona, Giuseppe			Inter-Gender sEMG Evaluation of Central and Peripheral Fatigue in Biceps Brachii of Young Healthy Subjects	PLoS One			English	Article							FIBER CONDUCTION-VELOCITY; HUMAN VASTUS LATERALIS; MAXIMAL VOLUNTARY CONTRACTIONS; MOTOR-UNIT SYNCHRONIZATION; SURFACE EMG VARIABLES; MUSCLE FATIGUE; ISOMETRIC CONTRACTIONS; SEX-DIFFERENCES; SUBMAXIMAL CONTRACTIONS; PERCEIVED EXERTION	Purpose The purpose of the present study was to evaluate inter-arm and inter-gender differences in fractal dimension (FD) and conduction velocity (CV) obtained from multichannel surface electromyographic (sEMG) recordings during sustained fatiguing contractions of the biceps brachii. Methods A total of 20 recreationally active males (24 +/- 6 years) and 18 recreationally active females (22 +/- 9 years) performed two isometric contractions at 120 degrees elbow joint angle: (1) at 20% maximal voluntary contraction (MVC) for 90 s, and (2) at 60% MVC until exhaustion the time to perform the task has been measured. Signals from sEMG were detected from the biceps brachii using bidimensional arrays of 64 electrodes and initial values and rate of change of CV and FD of the sEMG signal were calculated. Results No difference between left and right sides and no statistically significant interaction effect of sides with gender were found for all parameters measured. A significant inter-gender difference was found for MVC (p<0.0001). Initial values of CV were higher in females than in males at both force levels (20% MCV: p<0.0001; 60% MCV: p<0.05) whereas a lower initial estimate of FD was observed in females compared to males (20% MCV: p<0.05; 60% MCV: p<0.0001). No difference in CV and FD slopes was found at 20% MVC between genders. At 60% MVC significantly lower CV and FD slopes (CV and FD: p<0.05) and a more protracted time to exhaustion were found in females than in males (p<0.0001). When considering time to exhaustion at both levels of contraction no difference in percentage change (Delta%) of CV and FD slopes was found between genders (p>0.05). During the sustained 60% MVC no statistical correlation was found between MVC and CV or FD initial estimates nor between MVC and CV or FD slopes both in males and females whereas. A significant positive correlation between CV and FD slopes was found in both genders (males: r = 0,61; females: r = 0,55). Conclusions Fatigue determines changes in FD and CV values in biceps brachii during sustained contractions at 60% MVC. In particular males show greater increase in the rate of change of CV and FD than females whereas no difference in percentage change of these sEMG descriptors of fatigue was found. A significant correlation between FD and CV slopes found in both genders highlights that central and peripheral myoelectric components of fatigue may interact during submaximal isometric contractions.	[Meduri, Federico; Calanni, Luca; Segreto, Valentina; Giovanetti, Giuseppe; D'Antona, Giuseppe] Univ Pavia, Dept Publ Hlth Mol & Forens Med, Pavia, Italy; [Meduri, Federico; Calanni, Luca; Segreto, Valentina; Giovanetti, Giuseppe; D'Antona, Giuseppe] Univ Pavia, Sport Med Ctr Voghera, Pavia, Italy; [Beretta-Piccoli, Matteo; Barbero, Marco; Cescon, Corrado] Univ Appl Sci & Arts Southern Switzerland, Dept Business Econ Hlth & Social Care, 2rLab, Manno, Switzerland	University of Pavia; University of Pavia	D'Antona, G (corresponding author), Univ Pavia, Dept Publ Hlth Mol & Forens Med, Pavia, Italy.; D'Antona, G (corresponding author), Univ Pavia, Sport Med Ctr Voghera, Pavia, Italy.	gdantona@unipv.it	Barbero, Marco/G-3667-2010; Barbero, Marco/AAF-9467-2020	Barbero, Marco/0000-0001-8579-0686; Barbero, Marco/0000-0001-8579-0686; D'Antona, Giuseppe/0000-0002-0683-5565; Cescon, Corrado/0000-0002-1632-6684; Beretta-Piccoli, Matteo/0000-0003-4794-2540; Calanni Pileri, Luca/0000-0003-1695-8398	Association Frangaise Myopathies, Paris, France [17191]	Association Frangaise Myopathies, Paris, France	This study was supported by Association Frangaise Myopathies (http://www.afm-telethon.com), Paris, France (grant 17191 to GD). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adam A, 2003, J NEUROPHYSIOL, V90, P2919, DOI 10.1152/jn.00179.2003; ALLEN GM, 1995, MUSCLE NERVE, V18, P593, DOI 10.1002/mus.880180605; Andreassen S, 1987, Electroencephalogr Clin Neurophysiol Suppl, V39, P13; Arjunan SP, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/197960; BARNES WS, 1980, ERGONOMICS, V23, P351, DOI 10.1080/00140138008924748; Barry BK, 2007, INTEGR COMP BIOL, V47, P465, DOI 10.1093/icb/icm047; Bazzucchi I, 2004, MUSCLE NERVE, V30, P626, DOI 10.1002/mus.20151; Beretta-Piccoli M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0123921; Bernardi M, 1997, Electromyogr Clin Neurophysiol, V37, P3; BIGLANDRITCHIE B, 1978, CLIN SCI MOL MED, V54, P609, DOI 10.1042/cs0540609; BIGLANDRITCHIE B, 1983, J NEUROPHYSIOL, V50, P313, DOI 10.1152/jn.1983.50.1.313; Bilodeau M, 1994, Electromyogr Clin Neurophysiol, V34, P149; Blijham PJ, 2006, J APPL PHYSIOL, V100, P1837, DOI 10.1152/japplphysiol.01009.2005; Boccia G, 2016, PHYSIOL MEAS, V37, P162, DOI 10.1088/0967-3334/37/1/162; BORG G, 1982, INT J SPORTS MED, V3, P153, DOI 10.1055/s-2008-1026080; BOUISSOU P, 1989, J APPL PHYSIOL, V67, P1245, DOI 10.1152/jappl.1989.67.3.1245; BRODY LR, 1991, J APPL PHYSIOL, V71, P1878, DOI 10.1152/jappl.1991.71.5.1878; Clark BC, 2003, J APPL PHYSIOL, V94, P2263, DOI 10.1152/japplphysiol.00926.2002; Contessa P, 2009, J APPL PHYSIOL, V107, P235, DOI 10.1152/japplphysiol.00035.2009; DATTA AK, 1991, J PHYSIOL-LONDON, V432, P401, DOI 10.1113/jphysiol.1991.sp018391; DE LUCA CJ, 1984, CRIT REV BIOMED ENG, V11, P251; Dedering A, 2000, J ELECTROMYOGR KINES, V10, P151, DOI 10.1016/S1050-6411(00)00009-2; Enoka RM, 2008, J PHYSIOL-LONDON, V586, P11, DOI 10.1113/jphysiol.2007.139477; FALLENTIN N, 1993, EUR J APPL PHYSIOL O, V67, P335, DOI 10.1007/BF00357632; Farina D, 2004, J APPL PHYSIOL, V97, P2035, DOI 10.1152/japplphysiol.00606.2004; Farina D, 2004, MED BIOL ENG COMPUT, V42, P432, DOI 10.1007/BF02350984; Farina D, 2003, IEEE T BIO-MED ENG, V50, P1340, DOI 10.1109/TBME.2003.819847; Gandevia SC, 1996, J PHYSIOL-LONDON, V490, P529, DOI 10.1113/jphysiol.1996.sp021164; GITTER JA, 1995, J NEUROSCI METH, V58, P103, DOI 10.1016/0165-0270(94)00164-C; Gonzalez-Izal M, 2012, J ELECTROMYOGR KINES, V22, P501, DOI 10.1016/j.jelekin.2012.02.019; Holtermann A, 2009, J ELECTROMYOGR KINES, V19, P232, DOI 10.1016/j.jelekin.2007.08.008; Hunter SK, 2014, ACTA PHYSIOL, V210, P768, DOI 10.1111/apha.12234; Hunter SK, 2006, J APPL PHYSIOL, V101, P140, DOI 10.1152/japplphysiol.01567.2005; Hunter SK, 2009, EXERC SPORT SCI REV, V37, P113, DOI 10.1097/JES.0b013e3181aa63e2; Hunter SK, 2004, J APPL PHYSIOL, V96, P2125, DOI 10.1152/japplphysiol.01342.2003; Hunter SK, 2001, J APPL PHYSIOL, V91, P2686, DOI 10.1152/jappl.2001.91.6.2686; Inglis JG, 2013, J ELECTROMYOGR KINES, V23, P1289, DOI 10.1016/j.jelekin.2013.09.005; Keller ML, 2011, MED SCI SPORT EXER, V43, P1873, DOI 10.1249/MSS.0b013e318216ebd4; Kent-Braun JA, 1999, EUR J APPL PHYSIOL O, V80, P57, DOI 10.1007/s004210050558; KentBraun JA, 1996, MUSCLE NERVE, V19, P861, DOI 10.1002/(SICI)1097-4598(199607)19:7<861::AID-MUS8>3.0.CO;2-7; Kleine BU, 2001, J APPL PHYSIOL, V91, P1588, DOI 10.1152/jappl.2001.91.4.1588; Kollmitzer J, 1999, CLIN NEUROPHYSIOL, V110, P725, DOI 10.1016/S1388-2457(98)00050-9; KOMI PV, 1979, EUR J APPL PHYSIOL, V42, P41, DOI 10.1007/BF00421103; Kumar DK, 2011, IEEE T NEUR SYS REH, V19, P578, DOI 10.1109/TNSRE.2011.2163527; KUPA EJ, 1995, J APPL PHYSIOL, V79, P23, DOI 10.1152/jappl.1995.79.1.23; LINSSEN WHJP, 1993, MUSCLE NERVE, V16, P849, DOI 10.1002/mus.880160808; Mannion AF, 1998, SPINE, V23, P576, DOI 10.1097/00007632-199803010-00010; Martin PG, 2007, PFLUG ARCH EUR J PHY, V454, P957, DOI 10.1007/s00424-007-0243-1; Merletti R, 2004, DIGESTION, V69, P112, DOI 10.1159/000077877; Merletti R, 1998, MUSCLE NERVE, V21, P184; Merletti R, 1996, J ORTHOP SPORT PHYS, V24, P342, DOI 10.2519/jospt.1996.24.6.342; Merletti R, 2016, BIOPHYSICS GENERATIO, P30; Mesin L, 2009, J ELECTROMYOGR KINES, V19, P851, DOI 10.1016/j.jelekin.2008.08.003; MILLER AEJ, 1993, EUR J APPL PHYSIOL O, V66, P254, DOI 10.1007/BF00235103; Ng JKF, 1996, ARCH PHYS MED REHAB, V77, P259, DOI 10.1016/S0003-9993(96)90108-2; Nybo L, 2004, PROG NEUROBIOL, V72, P223, DOI 10.1016/j.pneurobio.2004.03.005; Rainoldi A, 1999, J ELECTROMYOGR KINES, V9, P105, DOI 10.1016/S1050-6411(98)00042-X; Rainoldi A, 2001, J ELECTROMYOGR KINES, V11, P425, DOI 10.1016/S1050-6411(01)00022-0; Roepstorff C, 2006, J PHYSIOL-LONDON, V574, P125, DOI 10.1113/jphysiol.2006.108720; Russ DW, 2003, J APPL PHYSIOL, V94, P2414, DOI 10.1152/japplphysiol.01145.2002; SADAMOTO T, 1983, EUR J APPL PHYSIOL O, V51, P395, DOI 10.1007/BF00429076; SADOYAMA T, 1988, EUR J APPL PHYSIOL O, V57, P767, DOI 10.1007/BF01076001; Salomoni S, 2008, IEEE ENG MED BIO, P2598, DOI 10.1109/IEMBS.2008.4649732; Schillings ML, 2003, EUR J APPL PHYSIOL, V90, P562, DOI 10.1007/s00421-003-0913-4; Semmler JG, 2000, J NEUROPHYSIOL, V84, P358, DOI 10.1152/jn.2000.84.1.358; Semmler JG, 2002, EXERC SPORT SCI REV, V30, P8, DOI 10.1097/00003677-200201000-00003; SIMONEAU JA, 1989, AM J PHYSIOL, V257, pE567, DOI 10.1152/ajpendo.1989.257.4.E567; Talebinejad M, 2010, J ELECTROMYOGR KINES, V20, P433, DOI 10.1016/j.jelekin.2009.06.002; Troiano A, 2008, GAIT POSTURE, V28, P179, DOI 10.1016/j.gaitpost.2008.04.002; Vila-Cha C, 2010, J APPL PHYSIOL, V109, P1455, DOI 10.1152/japplphysiol.01213.2009; Yoon T, 2007, MUSCLE NERVE, V36, P515, DOI 10.1002/mus.20844	71	5	5	2	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2016	11	12							e0168443	10.1371/journal.pone.0168443	http://dx.doi.org/10.1371/journal.pone.0168443			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI9TW	28002429	gold, Green Published, Green Submitted			2022-12-27	WOS:000392853100046
J	Robertson, JE; Lisonkova, S; Lee, T; De Silva, DA; von Dadelszen, P; Synnes, AR; Joseph, KS; Liston, RM; Magee, LA				Robertson, Julie E.; Lisonkova, Sarka; Lee, Tang; De Silva, Dane A.; von Dadelszen, Peter; Synnes, Anne R.; Joseph, K. S.; Liston, Robert M.; Magee, Laura A.		Canadian Perinatal Network Grp; Canadian Neonatal Network	Fetal, Infant and Maternal Outcomes among Women with Prolapsed Membranes Admitted before 29 Weeks Gestation	PLoS One			English	Article							EMERGENCY CERCLAGE; PRETERM BIRTH; SHORT CERVIX; BED REST; CONTROLLED-TRIAL; PREGNANCY; 2ND-TRIMESTER; PROGESTERONE; DELIVERY; LENGTH	Background Few studies have examined fetal, infant and maternal mortality and morbidity among pregnant women at very early gestation with an open cervix and prolapsed membranes. We carried out a study describing the outcomes of women hospitalized with prolapsed membranes at 22-28 weeks' gestation. Methods We prospectively recruited women with singleton pregnancies admitted at 22-28 weeks' gestation to tertiary hospitals of the Canadian Perinatal Network between 2005 and 2009. Time-to-delivery, perinatal death, neonatal intensive care unit (NICU) admission, severe neonatal morbidity and severe maternal morbidity were compared between women admitted at 22-25 vs. 26-28 weeks gestation. Logistic regression was used to estimate adjusted odds ratios (AOR) and 95% confidence intervals. Results 129 women at 22-25 weeks gestation and 65 women at 26-28 weeks gestation were admitted to hospital and the median time-to-delivery was 4 days in both groups. Stillbirth rates were 12.4% vs 4.6% among women admitted at earlier vs later gestation (AOR 2.8, 95% CI 0.5-14.8), while perinatal death rates were 38.0% vs 6.1% (AOR 14.1, 95% CI 3.5-59.0), respectively. There were no significant differences in NICU admission and severe morbidity among live-born infants; 89.4% and 82.3% died or were admitted to NICU, (P value 0.18), and 53.9% vs 44.0% of NICU infants had severe neonatal morbidity (P value 0.28). Antibiotics, tocolysis and cerclage did not have a significant effect on perinatal death. Maternal death or severe maternal morbidity occurred in 8.5% and 6.2% of women admitted at 22-25 vs 26-28 weeks (AOR 1.2, 95% CI 0.4-4.2). Conclusion Perinatal mortality among women with prolapsed membranes at very early gestation is high, although significantly lower among those admitted at a relatively later gestational age. Rates of adverse maternal outcomes are also high. This information can be used to counsel women with prolapsed membranes at 22 to 28 weeks gestation.	[Robertson, Julie E.; Lisonkova, Sarka; Lee, Tang; von Dadelszen, Peter; Joseph, K. S.; Liston, Robert M.; Magee, Laura A.] Univ British Columbia, Dept Obstet & Gynaecol, Vancouver, BC, Canada; [Robertson, Julie E.; Lisonkova, Sarka; Lee, Tang; von Dadelszen, Peter; Synnes, Anne R.; Joseph, K. S.; Liston, Robert M.; Magee, Laura A.] British Columbias Childrens & Womens Hosp & Hlth, Vancouver, BC, Canada; [De Silva, Dane A.; Joseph, K. S.] Univ British Columbia, Sch Populat & Publ Hlth, Vancouver, BC, Canada; [Synnes, Anne R.] Univ British Columbia, Dept Pediat, Vancouver, BC, Canada	University of British Columbia; University of British Columbia; University of British Columbia	Robertson, JE (corresponding author), Univ British Columbia, Dept Obstet & Gynaecol, Vancouver, BC, Canada.; Robertson, JE (corresponding author), British Columbias Childrens & Womens Hosp & Hlth, Vancouver, BC, Canada.	jrobertson3@cw.bc.ca	Lee, Shoo K/P-3016-2015; De Silva, Dane/AAC-9050-2022; von Dadelszen, Peter/AAP-7480-2021	De Silva, Dane/0000-0001-6558-2716; Lisonkova, Sarka/0000-0002-1220-310X; von Dadelszen, Peter/0000-0003-4136-3070; Joseph, K.S./0000-0003-2317-5607	Canadian Institutes of Health Research [MOP115445, APR-126338]; Ontario Ministry of Health and Long-term Care; Child and Family Research Institute	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Ontario Ministry of Health and Long-term Care(Ministry of Health and Long-Term Care, Ontario); Child and Family Research Institute	This study was funded by the Canadian Institutes of Health Research (MOP115445) and the Ontario Ministry of Health and Long-term Care. KSJ is supported by the Child and Family Research Institute and by a Chair award in maternal, fetal and infant health services research from the Canadian Institutes of Health Research (APR-126338). Open access costs for this publication were provided by the Canadian Institutes of Health Research (APR-126338). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aarts J M, 1995, Obstet Gynecol Surv, V50, P459, DOI 10.1097/00006254-199506000-00022; Althuisius SM, 2003, AM J OBSTET GYNECOL, V189, P907, DOI 10.1067/S0002-9378(03)00718-X; Andrews WW, 2000, OBSTET GYNECOL, V95, P222, DOI 10.1016/S0029-7844(99)00483-4; Bujold E, 2008, J OBSTET GYNAECOL CA, V30, P882, DOI 10.1016/S1701-2163(16)32967-X; Costeloe K, 2000, PEDIATRICS, V106, P659, DOI 10.1542/peds.106.4.659; Daskalakis G, 2006, OBSTET GYNECOL, V107, P221, DOI 10.1097/01.AOG.0000187896.04535.e6; Fonseca EB, 2007, NEW ENGL J MED, V357, P462, DOI 10.1056/NEJMoa067815; Goya M, 2012, LANCET, V379, P1800, DOI 10.1016/S0140-6736(12)60030-0; Hassan SS, 2011, ULTRASOUND OBST GYN, V38, P18, DOI 10.1002/uog.9017; Heath VCF, 1998, ULTRASOUND OBST GYN, V12, P312, DOI 10.1046/j.1469-0705.1998.12050312.x; IAMS JD, 1995, AM J OBSTET GYNECOL, V172, P1097, DOI 10.1016/0002-9378(95)91469-2; Joseph KS., 2014, CURR EPIDEMIOL REP, V1, P1, DOI [10.1007/s40471-013-0004-y, DOI 10.1007/S40471-013-0004-Y]; Lee SE, 2008, AM J OBSTET GYNECOL, V198, DOI 10.1016/j.ajog.2007.11.047; Novy MJ, 2001, AM J OBSTET GYNECOL, V184, P1447, DOI 10.1067/mob.2001.114854; OLATUNBOSUN OA, 1995, INT SURG, V80, P170; Stupin JH, 2008, EUR J OBSTET GYN R B, V139, P32, DOI 10.1016/j.ejogrb.2007.11.009; Ventolini G, 2009, J PERINATOL, V29, P276, DOI 10.1038/jp.2008.221; Wood NS, 2000, NEW ENGL J MED, V343, P378, DOI 10.1056/NEJM200008103430601	18	3	3	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2016	11	12							e0168285	10.1371/journal.pone.0168285	http://dx.doi.org/10.1371/journal.pone.0168285			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI9TW	28002467	Green Published, gold, Green Submitted			2022-12-27	WOS:000392853100037
J	Bocharov, G; Meyerhans, A; Bessonov, N; Trofimchuk, S; Volpert, V				Bocharov, Gennady; Meyerhans, Andreas; Bessonov, Nickolai; Trofimchuk, Sergei; Volpert, Vitaly			Spatiotemporal Dynamics of Virus Infection Spreading in Tissues	PLOS ONE			English	Article							COMBINED ANTIRETROVIRAL THERAPY; T-CELL EXHAUSTION; TRAVELING-WAVES; IMMUNE-RESPONSE; DIFFUSION-EQUATIONS; ASYMPTOTIC-BEHAVIOR; ADAPTIVE IMMUNITY; PATTERN-FORMATION; HIV-INFECTION; TIME-DELAY	Virus spreading in tissues is determined by virus transport, virus multiplication in host cells and the virus-induced immune response. Cytotoxic T cells remove infected cells with a rate determined by the infection level. The intensity of the immune response has a bell-shaped dependence on the concentration of virus, i.e., it increases at low and decays at high infection levels. A combination of these effects and a time delay in the immune response determine the development of virus infection in tissues like spleen or lymph nodes. The mathematical model described in this work consists of reaction-diffusion equations with a delay. It shows that the different regimes of infection spreading like the establishment of a low level infection, a high level infection or a transition between both are determined by the initial virus load and by the intensity of the immune response. The dynamics of the model solutions include simple and composed waves, and periodic and aperiodic oscillations. The results of analytical and numerical studies of the model provide a systematic basis for a quantitative understanding and interpretation of the determinants of the infection process in target organs and tissues from the image-derived data as well as of the spatiotemporal mechanisms of viral disease pathogenesis, and have direct implications for a biopsy-based medical testing of the chronic infection processes caused by viruses, e.g. HIV, HCV and HBV.	[Bocharov, Gennady; Meyerhans, Andreas; Volpert, Vitaly] Russian Acad Sci, Inst Numer Math, Moscow, Russia; [Meyerhans, Andreas] Univ Pompeu Fabra, Dept Expt & Hlth Sci, Infect Biol Lab, Barcelona, Spain; [Meyerhans, Andreas] ICREA, Pg Lluis Co 23, Barcelona, Spain; [Bessonov, Nickolai] Russian Acad Sci, Inst Problems Mech Engn, St Petersburg, Russia; [Trofimchuk, Sergei] Univ Talca, Inst Matemat & Fis, Talca, Chile; [Volpert, Vitaly] Univ Lyon 1, UMR CNRS 5208, Inst Camille Jordan, Villeurbanne, France; [Volpert, Vitaly] INRIA Lyon La Doua, INRIA Team Dracula, Villeurbanne, France; [Volpert, Vitaly] UMI 2615 CNRS, Lab Poncelet, Moscow, Russia; [Bocharov, Gennady] Gamaleya Ctr Epidemiol & Microbiol, Moscow, Russia; [Bocharov, Gennady] RUDN Univ, Moscow, Russia	Russian Academy of Sciences; Pompeu Fabra University; ICREA; Russian Academy of Sciences; Universidad de Talca; UDICE-French Research Universities; Universite Claude Bernard Lyon 1; Centre National de la Recherche Scientifique (CNRS); Ecole Centrale de Lyon; Institut National des Sciences Appliquees de Lyon - INSA Lyon; Universite Jean Monnet; Russian Academy of Medical Sciences; Gamaleya National Research Center for Epidemiology & Microbiology, RAMS; Peoples Friendship University of Russia	Bocharov, G (corresponding author), Russian Acad Sci, Inst Numer Math, Moscow, Russia.; Bocharov, G (corresponding author), Gamaleya Ctr Epidemiol & Microbiol, Moscow, Russia.; Bocharov, G (corresponding author), RUDN Univ, Moscow, Russia.	bocharov@m.inm.ras.ru	Bocharov, Gennady/H-1832-2016; Bocharov, Gennady/AAN-7508-2020; Bocharov, Gennady/AGA-7312-2022; Volpert, Vitaly/E-2969-2019; Bocharov, Gennady/GSN-1705-2022; Trofimchuk, Sergei/A-1111-2008; Bocharov, Gennady/T-1322-2017	Bocharov, Gennady/0000-0002-5049-0656; Bocharov, Gennady/0000-0002-5049-0656; Bocharov, Gennady/0000-0002-5049-0656; Bocharov, Gennady/0000-0002-5049-0656; Trofimchuk, Sergei/0000-0003-1605-222X	Russian Science Foundation [15-11-00029]; Spanish Ministry of Economy and Competitiveness; FEDER [SAF2013-46077-R]; FONDECYT (Chile) project [1150480]; ICREA Funding Source: Custom	Russian Science Foundation(Russian Science Foundation (RSF)); Spanish Ministry of Economy and Competitiveness(Spanish Government); FEDER(European Commission); FONDECYT (Chile) project(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT); ICREA(ICREA)	The research was funded by the Russian Science Foundation (Grant no. 15-11-00029) to G. B., A.M., V.V. A.M. was also partially supported by a grant from the Spanish Ministry of Economy and Competitiveness and FEDER (Grant no. SAF2013-46077-R). S.T. and V.V. were also partially supported by FONDECYT (Chile) project 1150480. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.r The research was funded by the Russian Science Foundation (Grant no. 15-11-00029) to G. B., A.M., V.V. A.M. was also partially supported by a grant from the Spanish Ministry of Economy and Competitiveness and FEDER (Grant no. SAF2013-46077-R). S.T. and V.V. were also partially supported by FONDECYT (Chile) project 1150480.	Baldazzi V, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-387; Beauchemin C, 2006, J THEOR BIOL, V242, P464, DOI 10.1016/j.jtbi.2006.03.014; Berestycki H, 2009, NONLINEARITY, V22, P2813, DOI 10.1088/0951-7715/22/12/002; Bertoletti A, 2016, J HEPATOL, V64, pS71, DOI 10.1016/j.jhep.2016.01.026; Blancou P, 2001, P NATL ACAD SCI USA, V98, P13237, DOI 10.1073/pnas.231348598; Bocharov G, 2005, TRANSFUS MED HEMOTH, V32, P304, DOI 10.1159/000089117; Bocharov G, 2004, J VIROL, V78, P2247, DOI 10.1128/JVI.78.5.2247-2254.2004; Boulle M, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005964; Canini L, 2014, J PHARMACOKINET PHAR, V41, P431, DOI 10.1007/s10928-014-9363-3; Culshaw RV, 2003, J MATH BIOL, V46, P425, DOI 10.1007/s00285-002-0191-5; Ducrot A, 2014, J DIFFER EQUATIONS, V256, P3115, DOI 10.1016/j.jde.2014.01.033; Duehring D, 2007, J DYN DIFFER EQU, V19, P457, DOI 10.1007/s10884-006-9048-8; Dunia R, 2013, J MATH BIOL, V67, P1425, DOI 10.1007/s00285-012-0593-y; Fang J, 2015, J EUR MATH SOC, V17, P2243, DOI 10.4171/JEMS/556; FENNER F, 1948, LANCET, V252, P915, DOI 10.1016/S0140-6736(48)91599-2; Funk GA, 2005, J THEOR BIOL, V233, P221, DOI 10.1016/j.jtbi.2004.10.004; Germain RN, 2011, NAT IMMUNOL, V12, P369, DOI 10.1038/ni0511-369; Gomez A, 2014, J LOND MATH SOC, V89, P47, DOI 10.1112/jlms/jdt050; Gourley S. A., 2004, J MATH SCI-U TOKYO, V124, P5119, DOI [10.1023/B:JOTH.0000047249.39572.6d, DOI 10.1023/B:JOTH.0000047249.39572.6D]; Graw F, 2015, J VIROL, V89, P6551, DOI 10.1128/JVI.00016-15; Grossman Z, 2006, NAT MED, V12, P289, DOI 10.1038/nm1380; Grossman Z, 1999, NAT MED, V5, P1099, DOI 10.1038/13410; Grossman Z, 2015, ANNU REV IMMUNOL, V33, P677, DOI 10.1146/annurev-immunol-032712-100027; Haseltine EL, 2008, B MATH BIOL, V70, P1730, DOI 10.1007/s11538-008-9316-3; Hasik K, 2014, DISCRETE CONT DYN-A, V34, P3511, DOI 10.3934/dcds.2014.34.3511; Jankovic M, 2016, THEOR POPUL BIOL, V110, P51, DOI 10.1016/j.tpb.2016.04.004; Kumberger P, 2016, FEBS LETT, V590, P1972, DOI 10.1002/1873-3468.12095; Lamers SL, 2016, J VIROL, V90, P8968, DOI 10.1128/JVI.00674-16; Levin D, 2016, J THEOR BIOL, V398, P52, DOI 10.1016/j.jtbi.2016.02.022; Li L, 2015, APPL MATH COMPUT, V258, P342, DOI 10.1016/j.amc.2015.02.006; Li QS, 2009, SCIENCE, V323, P1726, DOI 10.1126/science.1168676; Likhoshvai VA, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-S12-S1; Mandl JN, 2014, CURR OPIN IMMUNOL, V29, P8, DOI 10.1016/j.coi.2014.03.002; MARTIN RH, 1990, T AM MATH SOC, V321, P1, DOI 10.2307/2001590; Medyukhina A, 2015, CYTOM PART A, V87A, P462, DOI 10.1002/cyto.a.22638; Morozov AY, 2016, J THEOR BIOL, V396, P116, DOI 10.1016/j.jtbi.2016.02.016; MOSKOPHIDIS D, 1993, NATURE, V362, P758, DOI 10.1038/362758a0; Nakaoka S, 2016, J MATH BIOL, V72, P909, DOI 10.1007/s00285-015-0940-x; Nowak MA., 2000, VIRUS DYNAMICS MATH; Paul WE, 2013, COLD SH Q B, V78, P265, DOI 10.1101/sqb.2013.78.020198; Perelson AS, 1999, SIAM REV, V41, P3, DOI 10.1137/S0036144598335107; Pienaar E, 2015, J THEOR BIOL, V367, P166, DOI 10.1016/j.jtbi.2014.11.021; Prokopiou SA, 2014, COMPUTATION, V2, P159, DOI 10.3390/computation2040159; Pulverer JE, 2010, J VIROL, V84, P8626, DOI 10.1128/JVI.00303-10; Qi H, 2014, ANNU REV CELL DEV BI, V30, P141, DOI 10.1146/annurev-cellbio-100913-013254; Richter K, 2012, EUR J IMMUNOL, V42, P2290, DOI 10.1002/eji.201142275; Rose R, 2016, J VIROL, V90, P8984, DOI 10.1128/JVI.00684-16; Rothenberger MK, 2015, P NATL ACAD SCI USA, V112, pE1126, DOI 10.1073/pnas.1414926112; SCHAAF KW, 1987, T AM MATH SOC, V302, P587; Scully EP, 2016, JCI INSIGHT, V1, DOI 10.1172/jci.insight.85433; Shiwang MA, 2007, J DYN DIFFER EQU, V19, P391, DOI 10.1007/s10884-006-9065-7; Smith H, 2011, INTRO DELAY DIFFEREN; Smith HL, 2000, SIAM J MATH ANAL, V31, P514, DOI 10.1137/S0036141098346785; Stancevic O, 2013, B MATH BIOL, V75, P774, DOI 10.1007/s11538-013-9834-5; Strain MC, 2002, J THEOR BIOL, V218, P85, DOI 10.1006/jtbi.2002.3055; Su B, 2009, COMPUT MATH METHOD M, V10, P9, DOI 10.1080/17486700801982713; Sun GQ, 2012, NONLINEAR DYNAM, V69, P1097, DOI 10.1007/s11071-012-0330-5; Sun GQ, 2016, NONLINEAR DYNAM, V85, P1, DOI 10.1007/s11071-016-2671-y; Sun GQ, 2016, NONLINEAR DYNAM, V83, P811, DOI 10.1007/s11071-015-2369-6; Sun GQ, 2015, SCI REP-UK, V5, DOI 10.1038/srep11246; Sun GQ, 2012, APPL MATH COMPUT, V218, P11151, DOI 10.1016/j.amc.2012.04.071; Sun Gui-Quan, PHYS LIFE REV; Tan A, 2015, CSH PERSPECT MED, V5, DOI 10.1101/cshperspect.a021428; Tang JY, 2013, EUR J IMMUNOL, V43, P1407, DOI 10.1002/eji.201243119; Trofimchuk E, 2008, J DIFFER EQUATIONS, V245, P2307, DOI 10.1016/j.jde.2008.06.023; Trofimchuk E, 2013, J DIFFER EQUATIONS, V254, P3690, DOI 10.1016/j.jde.2013.02.005; Turchin Peter, 2003, Monographs in Population Biology, V35, pi; Volpert A. I., 1994, TRANSLATIONS MATH MO, V140; Volpert V, 2009, PHYS LIFE REV, V6, P267, DOI 10.1016/j.plrev.2009.10.002; Volpert V., 2014, ELLIPTIC PARTIAL DIF, V2; Wang ZC, 2007, J DIFFER EQUATIONS, V238, P153, DOI 10.1016/j.jde.2007.03.025; Watanabe T, 2010, J VIRAL HEPATITIS, V17, P453, DOI 10.1111/j.1365-2893.2010.01313.x; Wherry EJ, 2015, NAT REV IMMUNOL, V15, P486, DOI 10.1038/nri3862; Wu J., 1996, APPL MATH SCI, V119, DOI [10.1007/978-1-4612-4050-1, DOI 10.1007/978-1-4612-4050-1]; Zhang CW, 2015, PLOS COMPUT BIOL, V11, DOI 10.1371/journal.pcbi.1004179; Zinkernagel RM, 2004, SCAND J IMMUNOL, V60, P9, DOI 10.1111/j.0300-9475.2004.01460.x; ZINKERNAGEL RM, 1985, BRIT MED BULL, V41, P92, DOI 10.1093/oxfordjournals.bmb.a072033; Zinkernagel RM, 2001, SCIENCE, V293, P251, DOI 10.1126/science.1063005; Zuniga EI, 2015, ANNU REV VIROL, V2, P573, DOI 10.1146/annurev-virology-100114-055226	79	24	25	3	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2016	11	12							e0168576	10.1371/journal.pone.0168576	http://dx.doi.org/10.1371/journal.pone.0168576			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI9QF	27997613	Green Published, gold, Green Submitted			2022-12-27	WOS:000392842900061
J	Jones, T; Moore, T; Choo, J				Jones, Ted; Moore, Todd; Choo, James			The Impact of Virtual Reality on Chronic Pain	PLOS ONE			English	Article							BURN WOUND DEBRIDEMENT; PHYSICAL-THERAPY; DISTRACTION; OPIOIDS	The treatment of chronic pain could benefit from additional non-opioid interventions. Virtual reality (VR) has been shown to be effective in decreasing pain for procedural or acute pain but to date there have been few studies on its use in chronic pain. The present study was an investigation of the impact of a virtual reality application for chronic pain. Thirty (30) participants with various chronic pain conditions were offered a five-minute session using a virtual reality application called Cool! Participants were asked about their pain using a 0-10 visual analog scale rating before the VR session, during the session and immediately after the session. They were also asked about immersion into the VR world and about possible side effects. Pain was reduced from pre-session to post-session by 33%. Pain was reduced from pre-session during the VR session by 60%. These changes were both statistically significant at the p < .001 level. Three participants (10%) reported no change between pre and post pain ratings. Ten participants (33%) reported complete pain relief while doing the virtual reality session. All participants (100%) reported a decrease in pain to some degree between pre-session pain and during-session pain. The virtual reality experience was found here to provide a significant amount of pain relief. A head mounted display (HMD) was used with all subjects and no discomfort was experienced. Only one participant noted any side effects. VR seems to have promise as a non-opioid treatment for chronic pain and further investigation is warranted.	[Jones, Ted; Choo, James] Pain Consultants East Tennessee, Knoxville, TN 37909 USA; [Moore, Todd] Univ Tennessee, Dept Psychol, Knoxville, TN 37996 USA	University of Tennessee System; University of Tennessee Knoxville	Jones, T (corresponding author), Pain Consultants East Tennessee, Knoxville, TN 37909 USA.	tjones@painconsultants.com						Chan EA, 2007, J CLIN NURS, V16, P786, DOI 10.1111/j.1365-2702.2006.01719.x; Dowell D, 2016, MMWR RECOMM REP, V65, P1, DOI [10.15585/mmwr.rr6501e1, 10.1001/jama.2016.1464, 10.15585/mmwr.rr7103a1]; Federation of State Medical Boards (FSMB), 2013, MOD POL US OP AN TRE; Furlan AD, 2006, CAN MED ASSOC J, V174, P1589, DOI 10.1503/cmaj.051528; Gershon J, 2004, J AM ACAD CHILD PSY, V43, P1243, DOI 10.1097/01.chi.0000135621.23145.05; Gold JI, 2007, CYBERPSYCHOL BEHAV, V10, P536, DOI 10.1089/cpb.2007.9993; GRICHNIK KP, 1991, MT SINAI J MED, V58, P217; Hjermstad MJ, 2011, J PAIN SYMPTOM MANAG, V41, P1073, DOI 10.1016/j.jpainsymman.2010.08.016; Hoffman HG, 2000, CLIN J PAIN, V16, P244, DOI 10.1097/00002508-200009000-00010; Hoffman HG, 2001, CLIN J PAIN, V17, P229, DOI 10.1097/00002508-200109000-00007; Hoffman HG, 2008, CLIN J PAIN, V24, P299, DOI 10.1097/AJP.0b013e318164d2cc; Keefe FJ, 2012, PAIN, V153, P2163, DOI 10.1016/j.pain.2012.05.030; Kenny MP, 2016, PSYCHOL CONSCIOUSNES; Leibovici V, 2009, PAIN RES MANAG, V14, P283, DOI 10.1155/2009/178751; Li A, 2011, PAIN MANAG, V1, P147, DOI 10.2217/PMT.10.15; Maani C., 2008, J CYBERTHERAPY REHAB, V1, P193; Maani CV, 2011, J TRAUMA, V71, pS125, DOI 10.1097/TA.0b013e31822192e2; MELZACK R, 1965, SCIENCE, V150, P971, DOI 10.1126/science.150.3699.971; Mosso J.L., 2012, CYBERTHERAPY MED EXP; Noble M, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006605.pub2; ONDCP, 2011, EP RESP AM PRESCR DR; Patterson DR, 2006, J ABNORM PSYCHOL, V115, P834, DOI 10.1037/0021-843X.115.4.834; Pickrell JE, 2014, TAKING HELMET UNPUB; Rosenblum A, 2008, EXP CLIN PSYCHOPHARM, V16, P405, DOI 10.1037/a0013628; Sharar SR, 2007, ARCH PHYS MED REHAB, V88, pS43, DOI 10.1016/j.apmr.2007.09.004; van Twillert B, 2007, J BURN CARE RES, V28, P694, DOI 10.1097/BCR.0B013E318148C96F; Wiederhold BK, 2014, CYBERPSYCH BEH SOC N, V17, P346, DOI 10.1089/cyber.2014.0207	27	83	85	5	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2016	11	12							e0167523	10.1371/journal.pone.0167523	http://dx.doi.org/10.1371/journal.pone.0167523			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EI9QF	27997539	Green Submitted, gold, Green Published			2022-12-27	WOS:000392842900009
J	Kim, J; Kim, JK				Kim, Joongheon; Kim, Jong-Kook			Achievable Rate Estimation of IEEE 802.11ad Visual Big-Data Uplink Access in Cloud-Enabled Surveillance Applications	PLOS ONE			English	Article							ANTENNAS; QUALITY	This paper addresses the computation procedures for estimating the impact of interference in 60 GHz IEEE 802.11ad uplink access in order to construct visual big-data database from randomly deployed surveillance camera sensing devices. The acquired large-scale massive visual information from surveillance camera devices will be used for organizing big-data database, i.e., this estimation is essential for constructing centralized cloud-enabled surveillance database. This performance estimation study captures interference impacts on the target cloud access points from multiple interference components generated by the 60 GHz wireless transmissions from nearby surveillance camera devices to their associated cloud access points. With this uplink interference scenario, the interference impacts on the main wireless transmission from a target surveillance camera device to its associated target cloud access point with a number of settings are measured and estimated under the consideration of 60 GHz radiation characteristics and antenna radiation pattern models.	[Kim, Joongheon] Chung Ang Univ, Sch Comp Sci & Engn, Seoul 06974, South Korea; [Kim, Jong-Kook] Korea Univ, Sch Elect Engn, Seoul 136713, South Korea	Chung Ang University; Korea University	Kim, JK (corresponding author), Korea Univ, Sch Elect Engn, Seoul 136713, South Korea.	jongkook@korea.ac.kr	Kim, Jong-Kook/W-6679-2018		National Research Foundation of Korea (NRF) [2016R1C1B1015406]; Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Education [2014R1A1A2059527]; Korea University Research Grant	National Research Foundation of Korea (NRF)(National Research Foundation of Korea); Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Education; Korea University Research Grant	This work was supported by National Research Foundation of Korea (NRF) under Grant 2016R1C1B1015406, by Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education (grant no. 2014R1A1A2059527), and also by Korea University Research Grant.	[Anonymous], [No title captured]; [Anonymous], 2012, 80211AD IEEE, P1; Azar Y, 2013, IEEE ICC, P5143, DOI 10.1109/ICC.2013.6655399; Butun I, 2016, IEEE COMMUN MAG, V54, P47, DOI 10.1109/MCOM.2016.7452265; Cordeschi N, 2015, J SUPERCOMPUT, V71, P448, DOI 10.1007/s11227-014-1305-8; Houbing Song CB., 2016, CYBER PHYS SYSTEMS F; ITU, 2012, F13363 ITUR; Kim J, 2015, IEEE T SYST MAN CY-S, V45, P1471, DOI 10.1109/TSMC.2015.2415463; Kim JH, 2013, IEEE ICC, P5148, DOI 10.1109/ICC.2013.6655400; Kim J, 2014, J COMMUN NETW-S KOR, V16, P512, DOI 10.1109/JCN.2014.000090; Kim J, 2014, ELECTRON LETT, V50, P1526, DOI 10.1049/el.2014.2239; Kim J, 2014, INT J DISTRIB SENS N, DOI 10.1155/2014/634191; Kim J, 2013, IEEE T BROADCAST, V59, P500, DOI 10.1109/TBC.2013.2273598; Li W, 2017, FUTURE GENER COMP SY, V70, P104, DOI 10.1016/j.future.2016.06.019; Lin C, 2016, J MED SYST, V40, DOI 10.1007/s10916-016-0446-0; Lin Y, TRANSP RES BOARD 86; MacCartney GR, 2013, IEEE GLOB COMM CONF, P3948, DOI 10.1109/GLOCOM.2013.6831690; Maltsev A, 2016, IEEE VEH TECHNOL MAG, V11, P32, DOI 10.1109/MVT.2015.2508318; Molisch A.F., 2011, WIRELESS COMMUNICATI, V2nd ed.; Rappaport TS, 2013, IEEE T ANTENN PROPAG, V61, P1850, DOI 10.1109/TAP.2012.2235056; Rappaport TS, 2011, P IEEE, V99, P1390, DOI 10.1109/JPROC.2011.2143650; Roh W, 2014, IEEE COMMUN MAG, V52, P106, DOI 10.1109/MCOM.2014.6736750; Shojafar M, 2016, IEEE T CLOUD COMPUT, DOI [10.1109/TCC.2016, DOI 10.1109/TCC.2016]; Singh S, 2011, IEEE ACM T NETWORK, V19, P1513, DOI 10.1109/TNET.2011.2122343; Sun YC, 2016, IEEE ACCESS, V4, P766, DOI 10.1109/ACCESS.2016.2529723; Tawalbeh LA, 2016, 2016 IEEE FIRST INTERNATIONAL CONFERENCE ON CONNECTED HEALTH: APPLICATIONS, SYSTEMS AND ENGINEERING TECHNOLOGIES (CHASE), P73, DOI 10.1109/CHASE.2016.40; Wei W, 2018, IEEE T SERV COMPUT, V11, P78, DOI 10.1109/TSC.2016.2528246; Weiler RJ, 2016, EURASIP J WIREL COMM, DOI 10.1186/s13638-016-0568-6; Zhang YY, 2015, 2015 INTERNATIONAL CONFERENCE ON IDENTIFICATION, INFORMATION, AND KNOWLEDGE IN THE INTERNET OF THINGS (IIKI), P197, DOI 10.1109/IIKI.2015.49; Zhao H, 2013, IEEE ICC, P5163, DOI 10.1109/ICC.2013.6655403	30	4	4	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2016	11	12							e0167447	10.1371/journal.pone.0167447	http://dx.doi.org/10.1371/journal.pone.0167447			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI9QF	27997929	gold, Green Published, Green Submitted			2022-12-27	WOS:000392842900008
J	Lahey, T; Laddy, D; Hill, K; Schaeffer, J; Hogg, A; Keeble, J; Dagg, B; Ho, MM; Arbeit, RD; von Reyn, CF				Lahey, Timothy; Laddy, Dominick; Hill, Krystal; Schaeffer, Jacqueline; Hogg, Alison; Keeble, James; Dagg, Belinda; Ho, Mei Mei; Arbeit, Robert D.; von Reyn, C. Fordham			Immunogenicity and Protective Efficacy of the DAR-901 Booster Vaccine in a Murine Model of Tuberculosis	PLOS ONE			English	Article							HIV-ASSOCIATED TUBERCULOSIS; MYCOBACTERIUM-TUBERCULOSIS; ANIMAL-MODELS; BCG; VACCAE; PREVENTION; INFECTION; ANTIGENS; TRIAL	Background The development of a novel tuberculosis vaccine is a leading global health priority. SRL172, an inactivated, whole-cell mycobacterial vaccine, was safe, immunogenic and reduced the incidence of culture-confirmed tuberculosis in a phase III trial in HIV-infected and BCG immunized adults in Tanzania. Here we describe the immunogenicity and protective efficacy of DAR-901, a booster vaccine against tuberculosis manufactured from the same seed strain using a new scalable method. Methods We evaluated IFN-gamma responses by ELISpot and antibody responses by enzyme linked immunosorbent assay in C57BL/6 and BALB/c mice after three doses of DAR-901. In an aerosol challenge model, we evaluated the protective efficacy of the DAR-901 booster in C57BL/6 mice primed with BCG and boosted with two doses of DAR-901 at 4 dosage levels in comparison with homologous BCG boost. Results DAR-901 vaccination elicited IFN-gamma responses to mycobacterial antigen preparations derived from both DAR-901 and Mycobacterium tuberculosis. DAR-901 immunization enhanced antibody responses to DAR-901 but not Mycobacterium tuberculosis lysate or purified protein derivative. Among animals primed with BCG, boosting with DAR-901 at 1 mg provided greater protection against aerosol challenge than a homologous BCG boost (lungs P = 0.036, spleen P = 0.028). Conclusions DAR-901 induces cellular and humoral immunity and boosts protection from M. tuberculosis compared to a homologous BCG boost.	[Lahey, Timothy; von Reyn, C. Fordham] Dartmouths Geisel Sch Med, 1 Med Ctr Dr, Lebanon, NH 03766 USA; [Laddy, Dominick; Hill, Krystal; Schaeffer, Jacqueline; Hogg, Alison] Aeras, 1405 Res Blvd, Rockville, MD USA; [Keeble, James; Dagg, Belinda; Ho, Mei Mei] MHRA NIBSC, Bacteriol Div, Potters Bar, Herts, England; [Arbeit, Robert D.] Tufts Univ, Sch Med, Boston, MA 02111 USA; [Hill, Krystal] IDT Biol, 1405 Res Blvd, Rockville, MD USA; [Hogg, Alison] Emergent Biosolut, 400 Profess Dr 100, Gaithersburg, MD USA	National Institute for Biological Standards & Control; Tufts University	Lahey, T (corresponding author), Dartmouths Geisel Sch Med, 1 Med Ctr Dr, Lebanon, NH 03766 USA.	Timothy.Lahey@Dartmouth.edu			Aeras; Dartmouth College	Aeras; Dartmouth College	This work was funded by grants from Aeras (aeras.org) and Dartmouth College (dartmouth.edu) to CFvR. Neither grant had a specific number assigned to it.	AbouZeid C, 1997, INFECT IMMUN, V65, P1856, DOI 10.1128/IAI.65.5.1856-1862.1997; Achkar JM, 2013, CELL HOST MICROBE, V13, P250, DOI 10.1016/j.chom.2013.02.009; Dharmadhikari AS, 2008, AM J RESP CELL MOL, V39, P503, DOI 10.1165/rcmb.2008-0154TR; Goonetilleke NP, 2003, J IMMUNOL, V171, P1602, DOI 10.4049/jimmunol.171.3.1602; Jouanguy E, 1996, NEW ENGL J MED, V335, P1956, DOI 10.1056/NEJM199612263352604; Kagina BMN, 2010, AM J RESP CRIT CARE, V182, P1073, DOI 10.1164/rccm.201003-0334OC; Kaufmann SHE, 2014, LANCET RESP MED, V2, P301, DOI 10.1016/S2213-2600(14)70033-5; Kaufmann SHE, 2010, LANCET, V375, P2110, DOI 10.1016/S0140-6736(10)60393-5; Khera AK, 2015, J IMMUNOLOGY; Knight GM, 2014, P NATL ACAD SCI USA, V111, P15520, DOI 10.1073/pnas.1404386111; Laddy DJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002517; Lahey T, 2016, MICROBIOL SPECTR, V4, DOI 10.1128/microbiolspec.TNMI7-0003-2016; Lahey T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022074; Lahey T, 2010, VACCINE, V28, P7652, DOI 10.1016/j.vaccine.2010.09.041; Lahey T, 2010, J INFECT DIS, V202, P1265, DOI 10.1086/656332; Lalvani A, 2013, THORAX, V68, P1092, DOI 10.1136/thoraxjnl-2013-203456; Lu LL, 2016, CELL, V167, P433, DOI 10.1016/j.cell.2016.08.072; Lu LL, 2016, CELL; McShane H, 2014, TUBERCULOSIS, V94, P105, DOI 10.1016/j.tube.2013.11.003; Newport MJ, 1996, NEW ENGL J MED, V335, P1941, DOI 10.1056/NEJM199612263352602; PONNIGHAUS JM, 1992, LANCET, V339, P636, DOI 10.1016/0140-6736(92)90794-4; Rodrigues LC, 2005, LANCET, V366, P1290, DOI 10.1016/S0140-6736(05)67145-0; Skinner MA, 1997, INFECT IMMUN, V65, P4525, DOI 10.1128/IAI.65.11.4525-4530.1997; STANFORD JL, 1991, APMIS, V99, P103, DOI 10.1111/j.1699-0463.1991.tb05127.x; Tameris MD, 2013, LANCET, V381, P1021, DOI 10.1016/S0140-6736(13)60177-4; Verreck FAW, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005264; von Reyn CF, 2010, AIDS, V24, P675, DOI 10.1097/QAD.0b013e3283350f1b; Vordermeier HM, 2009, INFECT IMMUN, V77, P3364, DOI 10.1128/IAI.00287-09; Vuola JM, 2003, AIDS, V17, P2351, DOI 10.1097/00002030-200311070-00010; Waddell RD, 2000, CLIN INFECT DIS, V30, pS309, DOI 10.1086/313880; WHO, 2014, GLOB TUB REP 2014; Young DL, 2009, EUR J IMMUNOL, V39, P2011, DOI 10.1002/eji.200939542; Zumla A, 2013, NEW ENGL J MED, V368, P745, DOI 10.1056/NEJMra1200894	33	22	25	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2016	11	12							e0168521	10.1371/journal.pone.0168521	http://dx.doi.org/10.1371/journal.pone.0168521			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI9QF	27997597	Green Published, Green Submitted, gold			2022-12-27	WOS:000392842900054
J	Li, SY; Zhao, LM; Xu, WY; Jiang, ZH; Kang, J; Wang, FZ; Xin, FJ				Li, Shuying; Zhao, Leiming; Xu, Wenyi; Jiang, Zhonghao; Kang, Jun; Wang, Fengzhong; Xin, Fengjiao			Identification and Characterisation of a Novel Protein FIP-sch3 from Stachybotrys chartarum	PLOS ONE			English	Article							FUNGAL IMMUNOMODULATORY PROTEIN; LUNG-CANCER CELLS; FUNCTIONAL-CHARACTERIZATION; RECOMBINANT EXPRESSION; FLAMMULINA-VELUTIPES; GANODERMA-TSUGAE; BREAST-CANCER; GENE CLONING; TUMOR-GROWTH; FIP-FVE	In this study, a novel FIP named FIP-sch3 has been identified and characterised. FIP-sch3 was identified in the ascomycete Stachybotrys chartarum, making it the second FIP to be identified outside the order of Basidiomycota. Recombinant FIP-sch3 (rFIP-shc3) was produced in Escherichia co/iand purified using GST-affinity magnetic beads. The bioactive characteristics of FIP-sch3 were compared to those of well-known FIPs LZ-8 from Ganoderma lucidum and FIP-fve from Flammulina velutipes, which were produced and purified using the same method. The purified rFIP-sch3 exhibited a broad spectrum of anti-tumour activity in several types of tumour cells but had no cytotoxicity in normal human embryonic kidney 293 cells. Assays that were implemented to study these properties indicated that rFIP-sch3 significantly suppressed cell proliferation, induced apoptosis and inhibited cell migration in human lung adenocarcinoma A549 cells. The anti-tumour effects of rFIP-sch3 in A549 cells were comparable to those of rLZ-8, but they were significantly greater than those of rFIP-fve. Molecular assays that were built on real-time PCR further revealed potential mechanisms related to apoptosis and migration and that underlie phenotypic effects. These results indicate that FIP-shc3 has a unique anti-tumour bioactive profile, as do other FIPs, which provide a foundation for further studies on anti-tumour mechanisms. Importantly, this study also had convenient access to FIP-sch3 with potential human therapeutic applications.	[Li, Shuying; Zhao, Leiming; Xu, Wenyi; Jiang, Zhonghao; Wang, Fengzhong; Xin, Fengjiao] Chinese Acad Agr Sci, Inst Food Sci & Technol, Beijing, Peoples R China; [Kang, Jun] Tianjin Univ, Sch Life Sci, Tianjin, Peoples R China	Chinese Academy of Agricultural Sciences; Institute of Food Science & Technology, CAAS; Tianjin University	Wang, FZ; Xin, FJ (corresponding author), Chinese Acad Agr Sci, Inst Food Sci & Technol, Beijing, Peoples R China.	wangfengzhong@sina.com; 2002hongzhi30@163.com	zhao, leiming/HFZ-7937-2022; li, shuying/GLR-8636-2022					Aramini JM, 2008, PROTEINS, V72, P526, DOI 10.1002/prot.22064; Asada M, 2008, INT J CANCER, V123, P511, DOI 10.1002/ijc.23562; Bastiaan-Net S, 2013, INT IMMUNOPHARMACOL, V15, P167, DOI 10.1016/j.intimp.2012.11.003; BASU S, 1995, J NEUROIMMUNOL, V60, P1, DOI 10.1016/0165-5728(95)00044-3; Bizzozero L, 2014, CELL DEATH DIFFER, V21, P507, DOI 10.1038/cdd.2013.173; Borcherding DC, 2016, ONCOGENE, V35, P3103, DOI 10.1038/onc.2015.369; Carpinteiro A, 2008, CANCER LETT, V264, P1, DOI 10.1016/j.canlet.2008.02.020; Chang HH, 2009, J AGR FOOD CHEM, V57, P6129, DOI 10.1021/jf9011399; Chang YC, 2013, J AGR FOOD CHEM, V61, P12044, DOI 10.1021/jf4030272; Chiu LY, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125774; Cong WR, 2014, APPL MICROBIOL BIOT, V98, P5967, DOI 10.1007/s00253-014-5539-4; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; Hsin IL, 2011, AUTOPHAGY, V7, P873, DOI 10.4161/auto.7.8.15698; Hsu HC, 1997, BIOCHEM J, V323, P557, DOI 10.1042/bj3230557; Ivanova H, 2014, BBA-MOL CELL RES, V1843, P2164, DOI 10.1016/j.bbamcr.2014.03.007; Jarvis BB, 2003, PHYTOCHEMISTRY, V64, P53, DOI 10.1016/S0031-9422(03)00275-9; JONES DT, 1992, COMPUT APPL BIOSCI, V8, P275, DOI 10.1093/bioinformatics/8.3.275; Kim YH, 2006, ONCOGENE, V25, P130, DOI 10.1038/sj.onc.1208997; KINO K, 1989, J BIOL CHEM, V264, P472; KO JL, 1995, EUR J BIOCHEM, V228, P244, DOI 10.1111/j.1432-1033.1995.tb20256.x; Kolesnick RN, 1998, ANNU REV PHYSIOL, V60, P643, DOI 10.1146/annurev.physiol.60.1.643; Li F, 2012, PROTEIN EXPRES PURIF, V82, P339, DOI 10.1016/j.pep.2012.01.015; Li QZ, 2011, CRIT REV BIOTECHNOL, V31, P365, DOI 10.3109/07388551.2010.543967; Li SY, 2015, FOOD CHEM TOXICOL, V78, P64, DOI 10.1016/j.fct.2015.01.013; Li SY, 2014, INT J MOL SCI, V15, P17751, DOI 10.3390/ijms151017751; Liao CH, 2008, FOOD CHEM TOXICOL, V46, P1851, DOI 10.1016/j.fct.2008.01.044; Lin CH, 2010, PROCESS BIOCHEM, V45, P1537, DOI 10.1016/j.procbio.2010.06.006; Lin JW, 2016, J CHEM TECHNOL BIOT, V91, P2761, DOI 10.1002/jctb.4881; Lin WH, 1997, J BIOL CHEM, V272, P20044, DOI 10.1074/jbc.272.32.20044; Lin YC, 2015, CLIN CANCER RES, V21, P428, DOI 10.1158/1078-0432.CCR-14-1150; Maraver A, 2012, CANCER CELL, V22, P222, DOI 10.1016/j.ccr.2012.06.014; OBEID LM, 1995, J CELL BIOCHEM, V58, P191, DOI 10.1002/jcb.240580208; Owens DM, 2007, ONCOGENE, V26, P3203, DOI 10.1038/sj.onc.1210412; Paaventhan P, 2003, J MOL BIOL, V332, P461, DOI 10.1016/S0022-2836(03)00923-9; Renton A, 2003, CARCINOGENESIS, V24, P1177, DOI 10.1093/carcin/bgg044; Robles AI, 2014, CANCER PREV RES, V7, P1210, DOI 10.1158/1940-6207.CAPR-14-0158; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Semeiks J, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-590; Sheu F, 2004, FOOD CHEM, V87, P593, DOI 10.1016/j.foodchem.2004.01.015; Soans E, 2014, ANTICANCER RES, V34, P3271; Sung HY, 2010, INT J RADIAT BIOL, V86, P780, DOI 10.3109/09553002.2010.484481; Tai CJ, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-95; Wang XQ, 2015, CELL BIOCHEM BIOPHYS, V73, P527, DOI 10.1007/s12013-015-0696-3; Wang XF, 2012, CURR TOP NUTRACEUT R, V10, P1; Wu CT, 2011, CARCINOGENESIS, V32, P1890, DOI 10.1093/carcin/bgr221; Xu H, 2016, J AGR FOOD CHEM, V64, P2690, DOI 10.1021/acs.jafc.6b00539; Zhou XW, 2009, INT J MED MUSHROOMS, V11, P77, DOI 10.1615/IntJMedMushr.v11.i1.90	47	7	8	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2016	11	12							e0168436	10.1371/journal.pone.0168436	http://dx.doi.org/10.1371/journal.pone.0168436			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI9QF	27997578	gold, Green Published, Green Submitted			2022-12-27	WOS:000392842900045
J	Yang, YL; Yao, BL; Lei, M; Dan, D; Li, RZ; Van Horn, M; Chen, X; Li, Y; Ye, T				Yang, Yanlong; Yao, Baoli; Lei, Ming; Dan, Dan; Li, Runze; Van Horn, Mark; Chen, Xun; Li, Yang; Ye, Tong			Two-Photon Laser Scanning Stereomicroscopy for Fast Volumetric Imaging	PLOS ONE			English	Article							MICROSCOPY; SOFTWARE; DEEP	Bessel beams have been successfully used in two-photon laser scanning fluorescence microscopy to extend the depth of field (EDF), which makes it possible to observe fast events volumetrically. However, the depth information is lost due to integration of fluorescence signals along the propagation direction. We describe the design and implementation of two-photon lasers scanning stereomicroscopy, which allows viewing dynamic processes in three-dimensional (3D) space stereoscopically in real-time with shutter glasses at the speed of 1.4 volumes per second. The depth information can be appreciated by human visual system or be recovered with correspondence algorithms for some cases.	[Yang, Yanlong; Yao, Baoli; Lei, Ming; Dan, Dan; Li, Runze] Chinese Acad Sci, Xian Inst Opt & Precis Mech, State Key Lab Transient Opt & Photon, Xian, Peoples R China; [Van Horn, Mark] Med Univ South Carolina, Dept Radiol, Charleston, SC USA; [Chen, Xun; Li, Yang; Ye, Tong] Clemson Univ, Dept Bioengn, Clemson, SC 29634 USA; [Chen, Xun; Li, Yang; Ye, Tong] Clemson Univ, COMSET, Clemson, SC 29634 USA; [Ye, Tong] Med Univ South Carolina, Dept Regenerat Med & Cell Biol, Charleston, SC 29425 USA	Chinese Academy of Sciences; Xi'an Institute of Optics & Precision Mechanics, CAS; State Key Laboratory of Transient Optics & Photonics; Medical University of South Carolina; Clemson University; Clemson University; Medical University of South Carolina	Yao, BL (corresponding author), Chinese Acad Sci, Xian Inst Opt & Precis Mech, State Key Lab Transient Opt & Photon, Xian, Peoples R China.; Ye, T (corresponding author), Clemson Univ, Dept Bioengn, Clemson, SC 29634 USA.; Ye, T (corresponding author), Clemson Univ, COMSET, Clemson, SC 29634 USA.; Ye, T (corresponding author), Med Univ South Carolina, Dept Regenerat Med & Cell Biol, Charleston, SC 29425 USA.	yaobl@opt.ac.cn; ye7@clemson.edu	Li, Runze/ABF-1320-2020; Ye, Tong/ABG-8560-2021; Ye, Tong/A-8251-2010; Yao, Baoli/AAB-4606-2021	Li, Runze/0000-0002-0154-2202; Ye, Tong/0000-0003-1017-6969; Ye, Tong/0000-0003-1017-6969; 	National Institute of General Medical Sciences [R21GM104683, P20GM103499]; National Science Foundation [1539034]; National Natural Science Foundation of China (NSFC) [81427802, 61275191, 61522511]; Office of Integrative Activities [1539034] Funding Source: National Science Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R21GM104683, P20GM103499] Funding Source: NIH RePORTER	National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Science Foundation(National Science Foundation (NSF)); National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); Office of Integrative Activities(National Science Foundation (NSF)NSF - Office of the Director (OD)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Funded by R21GM104683, National Institute of General Medical Sciences https://taggs.hhs.gov/Detail/AwardDetail?arg_AwardNum=R21GM104683&arg_ProgOfficeCode=127, P20GM103499, National Institute of General Medical Sciences, 1539034, National Science Foundation; http://www.nsf.gov/awardsearch/showAward?AWD_ID=1539034&HistoricalAwards=false, and National Natural Science Foundation of China (NSFC) (81427802, 61275191 and 61522511) https://isisn.nsfc.gov.cn/egrantindex/funcindex/prjsearch-list#.	Bewersdorf J, 1998, OPT LETT, V23, P655, DOI 10.1364/OL.23.000655; Bingen P, 2011, OPT EXPRESS, V19, P23716, DOI 10.1364/OE.19.023716; Botcherby EJ, 2006, OPT COMMUN, V268, P253, DOI 10.1016/j.optcom.2006.07.026; Brzobohaty O, 2008, OPT EXPRESS, V16, P12688, DOI 10.1364/OE.16.012688; Cha JW, 2015, AIP ADV, V5, DOI 10.1063/1.4916040; Cizmar T, 2009, OPT EXPRESS, V17, P15558, DOI 10.1364/OE.17.015558; Curran A, 2014, OPTICA, V1, P223, DOI 10.1364/OPTICA.1.000223; Davies E., 2005, MACHINE VISION THEOR, V3rd; DENK W, 1990, SCIENCE, V248, P73, DOI 10.1126/science.2321027; Deschout H, 2014, NAT METHODS, V11, P253, DOI 10.1038/nmeth.2843; Huisken J, 2004, SCIENCE, V305, P1007, DOI 10.1126/science.1100035; Ji N, 2016, NAT NEUROSCI, V19, P1154, DOI 10.1038/nn.4358; Ji N, 2008, CURR OPIN NEUROBIOL, V18, P605, DOI 10.1016/j.conb.2009.03.009; Kai Wicker, 2010, NANOSCOPY MULTIDIMEN; Kak A. C., 2001, PRINCIPLES COMPUTERI; Katona G, 2012, NAT METHODS, V9, P201, DOI [10.1038/NMETH.1851, 10.1038/nmeth.1851]; Kong LJ, 2015, NAT METHODS, V12, P759, DOI [10.1038/nmeth.3476, 10.1038/NMETH.3476]; Mahou P, 2014, NAT METHODS, V11, P600, DOI 10.1038/nmeth.2963; Pawley J.B., 2006, HDB BIOL CONFOCAL MI, DOI [10.1007/978-0-387-45524-2_23, 10.1007/978-0-387-45524-2, DOI 10.1007/978-0-387-45524-2]; Pelli DG, 1997, SPATIAL VISION, V10, P437, DOI 10.1163/156856897X00366; Pologruto TA, 2003, BIOMED ENG ONLINE, V2, DOI 10.1186/1475-925X-2-13; Saleh B., 2011, INTRO SUBSURFACE IMA; Scharstein D, 2002, INT J COMPUT VISION, V47, P7, DOI 10.1023/A:1014573219977; SHEPPARD CJR, 1978, IEE PROC-H, V2, P105, DOI 10.1049/ij-moa.1978.0023; Shimozawa T, 2013, P NATL ACAD SCI USA, V110, P3399, DOI 10.1073/pnas.1216696110; Solomon C, 2011, FUNDAMENTALS DIGITAL, V1st, DOI 10.1002/9780470689776; Theriault G, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00139; Tinevez J-Y, METHODS; Truong TV, 2011, NAT METHODS, V8, P757, DOI 10.1038/nmeth.1652; Wolf S, 2015, NAT METHODS, V12, P379, DOI 10.1038/nmeth.3371; Yang YL, 2013, PROC SPIE, V8588, DOI 10.1117/12.2002850; Zipfel WR, 2003, NAT BIOTECHNOL, V21, P1368, DOI 10.1038/nbt899	32	10	11	3	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2016	11	12							e0168885	10.1371/journal.pone.0168885	http://dx.doi.org/10.1371/journal.pone.0168885			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI9QF	27997624	Green Published, Green Submitted, gold			2022-12-27	WOS:000392842900083
J	Matsuoka, A; Maeda, O; Mizutani, T; Nakano, Y; Tsunoda, N; Kikumori, T; Goto, H; Ando, Y				Matsuoka, Ayumu; Maeda, Osamu; Mizutani, Takefumi; Nakano, Yasuyuki; Tsunoda, Nobuyuki; Kikumori, Toyone; Goto, Hidemi; Ando, Yuichi			Bevacizumab Exacerbates Paclitaxel-Induced Neuropathy: A Retrospective Cohort Study	PLoS One			English	Article							ENDOTHELIAL GROWTH-FACTOR; METASTATIC BREAST-CANCER; SENSORY NEUROPATHY; CHEMOTHERAPY; TRIAL	Background Bevacizumab (BEV), a humanized anti-vascular endothelial growth factor (VEGF) monoclonal antibody, enhances the antitumor effectiveness of paclitaxel (PTX)-based chemotherapy in many metastatic cancers. A recent study in mice showed that VEGF receptor inhibitors can interfere with the neuroprotective effects of endogenous VEGF, potentially triggering the exacerbation of PTX-induced neuropathy. In clinical trials, exacerbation of neuropathy in patients who received PTX combined with BEV (PTX+BEV) has generally been explained by increased exposure to PTX owing to the extended duration of chemotherapy. We investigated whether the concurrent use of BEV is associated with the exacerbation of PTX-induced neuropathy. Methods Female patients with breast cancer who had received weekly PTX or PTX+BEV from September 2011 through May 2016 were studied retrospectively. PTX-induced neuropathy was evaluated at the same time points (at the 6th and 12th courses of chemotherapy) in both cohorts. A multivariate Cox proportional-hazards model was used to assess the independent effect of BEV on the time to the onset of neuropathy. Results A total of 107 patients (median age, 55 years; range, 32-83) were studied. Sixty-one patients received PTX as adjuvant chemotherapy, 23 received PTX for metastatic disease, and 23 received PTX+BEV for metastatic disease. Peripheral sensory neuropathy was worse in patients who received PTX+BEV than in those who received PTX alone: at the 6th course, Grade 0/1/2/3 = 4/13/4/0 vs. 25/42/6/0 (P = 0.095); at the 12th course, 2/3/11/3 vs. 7/30/23/2 (P= 0.016). At the 12th course, the incidence of Grade 2 or higher neuropathy was significantly higher in patients treated with PTX+BEV than in those treated with PTX alone (74% vs. 40%; P = 0.017). In multivariate analysis, BEV was significantly associated with an increased risk of neuropathy (HR 2.32, 95% CI 1.21-4.44, P = 0.012). Conclusions The concurrent use of BEV could worsen PTX-induced neuropathy in patients with breast cancer.	[Matsuoka, Ayumu; Maeda, Osamu; Mizutani, Takefumi; Ando, Yuichi] Nagoya Univ Hosp, Dept Clin Oncol & Chemotherapy, Nagoya, Aichi, Japan; [Matsuoka, Ayumu; Goto, Hidemi] Nagoya Univ, Grad Sch Med, Dept Gastroenterol & Hepatol, Nagoya, Aichi, Japan; [Nakano, Yasuyuki] Japanese Red Cross Nagoya Daiichi Hosp, Dept Clin Oncol, Nagoya, Aichi, Japan; [Tsunoda, Nobuyuki] Nagoya Univ, Grad Sch Med, Div Surg Oncol, Dept Surg, Nagoya, Aichi, Japan; [Kikumori, Toyone] Nagoya Univ Hosp, Dept Breast & Endocrine Surg, Nagoya, Aichi, Japan	Nagoya University; Nagoya University; Red Cross Nagoya Daiichi Hospital; Nagoya University; Nagoya University	Matsuoka, A (corresponding author), Nagoya Univ Hosp, Dept Clin Oncol & Chemotherapy, Nagoya, Aichi, Japan.; Matsuoka, A (corresponding author), Nagoya Univ, Grad Sch Med, Dept Gastroenterol & Hepatol, Nagoya, Aichi, Japan.	ayumu0611@med.nagoya-u.ac.jp	Maeda, Osamu/Q-1016-2015	Maeda, Osamu/0000-0003-4700-6541; Ando, Yukio/0000-0001-7115-9105				Allegra CJ, 2009, J CLIN ONCOL, V27, P3385, DOI 10.1200/JCO.2009.21.9220; Aogi K, 2011, BREAST CANCER RES TR, V129, P829, DOI 10.1007/s10549-011-1685-x; Argyriou AA, 2014, CANCER MANAG RES, V6, P135, DOI 10.2147/CMAR.S44261; Beazley-Long N, 2013, AM J PATHOL, V183, P918, DOI 10.1016/j.ajpath.2013.05.031; Cavaletti G, 2010, NAT REV NEUROL, V6, P657, DOI 10.1038/nrneurol.2010.160; Giantonio BJ, 2007, J CLIN ONCOL, V25, P1539, DOI 10.1200/JCO.2006.09.6305; Hamilton EP, 2011, ONCOLOGY-BASEL, V80, P314, DOI 10.1159/000328757; Keating GM, 2014, DRUGS, V74, P1891, DOI 10.1007/s40265-014-0302-9; Miller K, 2007, NEW ENGL J MED, V357, P2666, DOI 10.1056/NEJMoa072113; Perez EA, 2001, J CLIN ONCOL, V19, P4216, DOI 10.1200/JCO.2001.19.22.4216; Pujade-Lauraine E, 2014, J CLIN ONCOL, V32, P1302, DOI 10.1200/JCO.2013.51.4489; Vencappa S, 2015, AM J TRANSL RES, V7, P1032; Verheyen A, 2012, BRAIN, V135, P2629, DOI 10.1093/brain/aws145; Wilke H, 2014, LANCET ONCOL, V15, P1224, DOI 10.1016/S1470-2045(14)70420-6	14	15	15	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 19	2016	11	12							e0168707	10.1371/journal.pone.0168707	http://dx.doi.org/10.1371/journal.pone.0168707			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI9QC	27992556	gold, Green Published, Green Submitted			2022-12-27	WOS:000392842600091
J	Voogd, C; Brian, LA; Varkonyi-Gasic, E				Voogd, Charlotte; Brian, Lara A.; Varkonyi-Gasic, Erika			Two Subclasses of Differentially Expressed TPS1 Genes and Biochemically Active TPS1 Proteins May Contribute to Sugar Signalling in Kiwifruit Actinidia chinensis	PLOS ONE			English	Article							TUBBY-LIKE PROTEINS; TREHALOSE METABOLISM; TREHALOSE-6-PHOSPHATE PHOSPHATASE; ARABIDOPSIS-THALIANA; SMALL AUXIN; ENVIRONMENTAL SIGNALS; VEGETATIVE GROWTH; CELL EXPANSION; FLORAL DIP; FAMILY	Trehalose metabolism and its intermediate trehalose-6-phosphate (T6P) are implicated in sensing and signalling sucrose availability. Four class I TREHALOSE-6-PHOSPHATE SYNTHASE (TPS1) genes were identified in kiwifruit, three of which have both the TPS and trehalose-6-phosphate phosphatase (TPP) domain, while the fourth gene gives rise to a truncated transcript. The transcript with highest sequence homology to Arabidopsis TPS1, designated TPS1.1a was the most highly abundant TPS1 transcript in all examined kiwifruit tissues. An additional exon giving rise to a small N-terminal extension was found for two of the TPS1 transcripts, designated TPS1.2a and TPS1.2b. Homology in sequence and gene structure with TPS1 genes from Solanaceae suggests they belong to a separate, asterid-specific class I TPS subclade. Expression of full-length and potential splice variants of these two kiwifruit TPS1.2 transcripts was sufficient to substitute for the lack of functional TPS1 in the yeast tps1. tps2. mutant, but only weak complementation was detected in the yeast tps1. mutant, and no or very weak complementation was obtained with the TPS1.1a construct. Transgenic Arabidopsis lines expressing kiwifruit TPS1.2 under the control of 35S promoter exhibited growth and morphological defects. We investigated the responses of plants to elevated kiwifruit TPS1 activity at the transcriptional level, using transient expression of TPS1.2a in Nicotiana benthamiana leaves, followed by RNA-seq. Differentially expressed genes were identified as candidates for future functional analyses.	[Voogd, Charlotte; Brian, Lara A.; Varkonyi-Gasic, Erika] New Zealand Inst Plant & Food Res Ltd Plant & Foo, Auckland Mail Ctr, Auckland, New Zealand	New Zealand Institute for Plant & Food Research Ltd	Varkonyi-Gasic, E (corresponding author), New Zealand Inst Plant & Food Res Ltd Plant & Foo, Auckland Mail Ctr, Auckland, New Zealand.	erika.varkonyi-gasic@plantandfood.co.nz	Varkonyi-Gasic, Erika/R-9920-2017	Varkonyi-Gasic, Erika/0000-0002-1068-4085; Voogd, Charlotte/0000-0003-1520-6469	Plant & Food Research Discovery Science grant [1469]	Plant & Food Research Discovery Science grant	Support was provided by Plant & Food Research Discovery Science grant 1469.; The yeast strains were kindly provided by J.M. Thevelein from the Katholieke Universiteit Leuven, Belgium. We thank Cyril Brendolise for the pURA3 construct, Peggy Kashuba for plant material, Ben Warren, Amali Thrimawithana and Cecilia Deng for bioinformatics advice, Monica Dragulescu and the glasshouse staff for plant maintenance, Andrew Allen for helpful discussions and Anne Gunson for critical reading of the manuscript. This work was funded by the Plant & Food Research Discovery Science grant 1469.	Ahveninen J, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3585; Almeida AM, 2007, IN VITRO CELL DEV-PL, V43, P167, DOI 10.1007/s11627-006-9024-3; Avonce N, 2006, BMC EVOL BIOL, V6, DOI 10.1186/1471-2148-6-109; Bao Y, 2014, PLANT MOL BIOL, V86, P471, DOI 10.1007/s11103-014-0241-6; Chae K, 2012, PLANT J, V71, P684, DOI 10.1111/j.1365-313X.2012.05024.x; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; Crowhurst RN, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-351; Delatte TL, 2011, PLANT PHYSIOL, V157, P160, DOI 10.1104/pp.111.180422; Eastmond PJ, 2002, PLANT J, V29, P225, DOI 10.1046/j.1365-313x.2002.01220.x; Egea-Cortines M, 1999, EMBO J, V18, P5370, DOI 10.1093/emboj/18.19.5370; Farrar K, 2003, PLANT J, V33, P61, DOI 10.1046/j.1365-313X.2003.01608.x; Gangappa SN, 2014, TRENDS PLANT SCI, V19, P460, DOI 10.1016/j.tplants.2014.01.010; Glinski M, 2005, MOL CELL PROTEOMICS, V4, P1614, DOI 10.1074/mcp.M500134-MCP200; Goddijn OJM, 1999, TRENDS PLANT SCI, V4, P315, DOI 10.1016/S1360-1385(99)01446-6; Gomez LD, 2006, PLANT J, V46, P69, DOI 10.1111/j.1365-313X.2006.02662.x; Gomez LD, 2010, PLANT J, V64, P1, DOI 10.1111/j.1365-313X.2010.04312.x; Gonzalez-Fontes A, 2013, PLANT SIGNAL BEHAV, V8, DOI 10.4161/psb.26114; Hellens RP, 2005, PLANT METHODS, V1, DOI 10.1186/1746-4811-1-13; Henry C, 2014, J EXP BOT, V65, P5959, DOI 10.1093/jxb/eru335; HOHMANN S, 1993, CURR GENET, V23, P281, DOI 10.1007/BF00310888; HORSCH RB, 1985, SCIENCE, V227, P1229, DOI 10.1126/science.227.4691.1229; Iturriaga G, 2009, INT J MOL SCI, V10, P3793, DOI 10.3390/ijms10093793; Kant S, 2009, PLANT SIGNAL BEHAV, V4, P1174, DOI 10.4161/psb.4.12.10043; Kant S, 2009, PLANT PHYSIOL, V151, P691, DOI 10.1104/pp.109.143875; Kearse M, 2012, BIOINFORMATICS, V28, P1647, DOI 10.1093/bioinformatics/bts199; Kolbe A, 2005, P NATL ACAD SCI USA, V102, P11118, DOI 10.1073/pnas.0503410102; Kondrak M, 2012, BMC PLANT BIOL, V12, DOI 10.1186/1471-2229-12-74; Kondrak M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023466; Kong YY, 2013, PLANT CELL PHYSIOL, V54, P609, DOI 10.1093/pcp/pct028; Kretzschmar T, 2015, NAT PLANTS, V1, DOI [10.1038/NPLANTS.2015.124, 10.1038/nplants.2015.124]; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Li P, 2008, PHYSIOL PLANTARUM, V133, P544, DOI 10.1111/j.1399-3054.2008.01101.x; Licausi F, 2013, NEW PHYTOL, V199, P639, DOI 10.1111/nph.12291; Lisso J, 2013, FRONT PLANT SCI, V4, DOI 10.3389/fpls.2013.00219; Liu DS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046451; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Lunn JE, 2007, FUNCT PLANT BIOL, V34, P550, DOI 10.1071/FP06315; Lunn JE, 2014, PLANT J, V79, P544, DOI 10.1111/tpj.12509; Ma JK, 2011, NEW PHYTOL, V191, P733, DOI 10.1111/j.1469-8137.2011.03735.x; Markakis MN, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082596; Martinez-Trujillo M, 2004, PLANT MOL BIOL REP, V22, P63, DOI 10.1007/BF02773350; Martins MCM, 2013, PLANT PHYSIOL, V163, P1142, DOI 10.1104/pp.113.226787; Mi H, 2015, NUCL ACIDS RES; NEVES MJ, 1995, CURR GENET, V27, P110, DOI 10.1007/BF00313424; Nuccio ML, 2015, NAT BIOTECHNOL, V33, P862, DOI 10.1038/nbt.3277; O'Hara LE, 2013, MOL PLANT, V6, P261, DOI 10.1093/mp/sss120; Paul MJ, 2008, ANNU REV PLANT BIOL, V59, P417, DOI 10.1146/annurev.arplant.59.032607.092945; Pellny TK, 2004, PLANT BIOTECHNOL J, V2, P71, DOI 10.1111/j.1467-7652.2004.00053.x; Petitjean M, 2015, J BIOL CHEM, V290, P16177, DOI 10.1074/jbc.M115.653899; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Ponnu J, 2011, FRONT PLANT SCI, V2, DOI 10.3389/fpls.2011.00070; Ramon M, 2009, PLANT CELL ENVIRON, V32, P1015, DOI 10.1111/j.1365-3040.2009.01985.x; Rangan L, 2008, MOL BIOTECHNOL, V39, P207, DOI 10.1007/s12033-008-9036-9; Reitz MU, 2013, PLANT SIGNAL BEHAV, V8, DOI 10.4161/psb.25198; Reitz MU, 2012, PLANT PHYSIOL, V160, P349, DOI 10.1104/pp.112.201319; Ren H, 2015, MOL PLANT, V8, P1153, DOI 10.1016/j.molp.2015.05.003; Ruijter JM, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp045; Ruijter JM, 2014, MICROCHIM ACTA, V181, P1689, DOI 10.1007/s00604-013-1155-8; Satoh-Nagasawa N, 2006, NATURE, V441, P227, DOI 10.1038/nature04725; Schluepmann H, 2003, P NATL ACAD SCI USA, V100, P6849, DOI 10.1073/pnas.1132018100; Schroder F, 2011, PLANT PHYSIOL, V156, P1620, DOI 10.1104/pp.111.177204; Schroder F, 2009, BMC PLANT BIOL, V9, DOI 10.1186/1471-2229-9-20; Shen HS, 2007, BIOCHEM BIOPH RES CO, V362, P425, DOI 10.1016/j.bbrc.2007.08.026; Spartz AK, 2014, PLANT CELL, V26, P2129, DOI 10.1105/tpc.114.126037; Spartz AK, 2012, PLANT J, V70, P978, DOI 10.1111/j.1365-313X.2012.04946.x; Stefanowicz K, 2012, FEBS OPEN BIO, V2, P151, DOI 10.1016/j.fob.2012.06.002; THOMAS BJ, 1989, CELL, V56, P619, DOI 10.1016/0092-8674(89)90584-9; Tuomi JM, 2010, METHODS, V50, P313, DOI 10.1016/j.ymeth.2010.02.003; Van Dijck P, 2015, TREHALOSE 6 PHOSPHAT, P283; van Dijken AJH, 2004, PLANT PHYSIOL, V135, P969, DOI 10.1104/pp.104.039743; Van Houtte H, 2013, PLANT SIGNAL BEHAV, V8, DOI 10.4161/psb.23209; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Vandesteene L, 2012, PLANT PHYSIOL, V160, P884, DOI 10.1104/pp.112.201400; Vandesteene L, 2010, MOL PLANT, V3, P406, DOI 10.1093/mp/ssp114; Varkonyi-Gasic E, 2013, NEW PHYTOL, V198, P732, DOI 10.1111/nph.12162; Wahl V, 2013, SCIENCE, V339, P704, DOI 10.1126/science.1230406; Winter D, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000718; Xie DW, 2015, J GENET, V94, P55, DOI 10.1007/s12041-015-0495-z; Yadav UP, 2014, J EXP BOT, V65, P1051, DOI 10.1093/jxb/ert457; Yang HL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042438; Zang BS, 2011, PLANT MOL BIOL, V76, P507, DOI 10.1007/s11103-011-9781-1	81	4	4	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 19	2016	11	12							e0168075	10.1371/journal.pone.0168075	http://dx.doi.org/10.1371/journal.pone.0168075			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI9QC	27992562	gold, Green Published, Green Submitted			2022-12-27	WOS:000392842600033
J	Neubeck, A; Sjoberg, S; Price, A; Callac, N; Schnurer, A				Neubeck, Anna; Sjoberg, Susanne; Price, Alex; Callac, Nolwenn; Schnurer, Anna			Effect of Nickel Levels on Hydrogen Partial Pressure and Methane Production in Methanogens	PLOS ONE			English	Article							ANAEROBIC-DIGESTION PROCESS; CARBON-MONOXIDE; COBALT; BIOAVAILABILITY; MOLYBDENUM; SPECIATION; OXIDATION; EMISSION; DEHYDROGENASE; AVAILABILITY	Hydrogen (H-2) consumption and methane (CH4) production in pure cultures of three different methanogens were investigated during cultivation with 0, 0.2 and 4.21 mu M added nickel (Ni). The results showed that the level of dissolved Ni in the anaerobic growth medium did not notably affect CH4 production in the cytochrome-free methanogenic species Methanobacterium bryantii and Methanoculleus bourgensis MAB1, but affected CH4 formation rate in the cytochrome-containing Methanosarcina barkeri grown on H-2 and CO2. Methanosarcina barkeri also had the highest amounts of Ni in its cells, indicating that more Ni is needed by cytochrome-containing than by cytochrome-free methanogenic species. The concentration of Ni affected threshold values of H-2 partial pressure (pH(2)) for all three methanogen species studied, with M. bourgensis MAB1 reaching pH(2) values as low as 0.1 Pa when Ni was available in amounts used in normal anaerobic growth medium. To our knowledge, this is the lowest pH(2) threshold recorded to date in pure methanogen culture, which suggests that M. bourgensis MAB1 have a competitive advantage over other species through its ability to grow at low H-2 concentrations. Our study has implications for research on the H-2-driven deep subsurface biosphere and biogas reactor performance.	[Neubeck, Anna; Sjoberg, Susanne; Callac, Nolwenn] Stockholm Univ, Dept Geol Sci, Stockholm, Sweden; [Price, Alex] Open Univ, Dept Phys Sci, Milton Keynes, Bucks, England; [Schnurer, Anna] Swedish Univ Agr Sci, Dept Microbiol, Bioctr, Uppsala, Sweden	Stockholm University; Open University - UK; Swedish University of Agricultural Sciences	Neubeck, A (corresponding author), Stockholm Univ, Dept Geol Sci, Stockholm, Sweden.	anna.neubeck@geo.su.se	; Callac, Nolwenn/O-3579-2016	Schnurer, Anna/0000-0003-0038-553X; Neubeck, Anna/0000-0002-1291-5529; Callac, Nolwenn/0000-0002-7578-3455	Swedish National Space Board [DNR-100/13]; Royal Swedish Academy of Sciences; Formas [2012-807]	Swedish National Space Board; Royal Swedish Academy of Sciences; Formas(Swedish Research Council Formas)	This work was supported by the Swedish National Space Board (Project number DNR-100/13) (http://www.rymdstyrelsen.se/), the Royal Swedish Academy of Sciences (http://www.kva.se/), and Formas (2012-807) (http://www.formas.se/).	Afting C, 2000, ARCH MICROBIOL, V174, P225, DOI 10.1007/s002030000197; BHATTACHARYA SK, 1989, ENVIRON TECHNOL LETT, V10, P725, DOI 10.1080/09593338909384791; Chen Y, 2008, BIORESOURCE TECHNOL, V99, P4044, DOI 10.1016/j.biortech.2007.01.057; Choong YY, 2016, BIORESOURCE TECHNOL, V209, P369, DOI 10.1016/j.biortech.2016.03.028; CONRAD R, 1990, ARCH MICROBIOL, V155, P94, DOI 10.1007/BF00291281; Costa KC, 2014, CURR OPIN BIOTECH, V29, P70, DOI 10.1016/j.copbio.2014.02.012; DIEKERT G, 1981, J BACTERIOL, V148, P459, DOI 10.1128/JB.148.2.459-464.1981; Dwyer FP, 1964, FRONT MATTER CHELATI; FERRY JG, 1992, J BACTERIOL, V174, P5489, DOI 10.1128/JB.174.17.5489-5495.1992; FLORENCIO L, 1993, J FERMENT BIOENG, V75, P368, DOI 10.1016/0922-338X(93)90136-V; FLORENCIO L, 1994, APPL ENVIRON MICROB, V60, P227, DOI 10.1128/AEM.60.1.227-234.1994; Fournier GP, 2008, J BACTERIOL, V190, P1124, DOI 10.1128/JB.01382-07; Gonzalez-Gil G, 1999, APPL ENVIRON MICROB, V65, P1789; Gonzalez-Gil G, 2003, BIOTECHNOL BIOENG, V82, P134, DOI 10.1002/bit.10551; Haarstad K, 2006, J AIR WASTE MANAGE, V56, P575, DOI 10.1080/10473289.2006.10464470; Hellebrand HJ, 2001, NUTR CYCL AGROECOSYS, V60, P79, DOI 10.1023/A:1012666929651; Karadagli F, 2006, THERMODYNAMIC KINETI, V18, P439, DOI [10.1007/s10532-006-9073-7, DOI 10.1007/S10532-006-9073-7]; Karadagli F, 2007, BIODEGRADATION, V18, P453, DOI 10.1007/s10532-006-9078-2; Konhauser KO, 2015, ASTROBIOLOGY, V15, P804, DOI 10.1089/ast.2015.1301; Konhauser KO, 2009, NATURE, V458, P750, DOI 10.1038/nature07858; Kral TA, 1998, ORIGINS LIFE EVOL B, V28, P311, DOI 10.1023/A:1006552412928; KRZYCKI J, 1980, CURR MICROBIOL, V3, P243, DOI 10.1007/BF02602456; Kung Y, 2011, CURR OPIN CHEM BIOL, V15, P276, DOI 10.1016/j.cbpa.2010.11.005; Laskin AI, 1983, ADV APPL MICROBIOLOG; Lee MJ, 1988, WATER RESOUR RES, V54, P6; Li M, 2011, MATH PROBL ENG, V2011, DOI 10.1155/2011/657839; Liu YC, 2012, TRENDS MICROBIOL, V20, P251, DOI 10.1016/j.tim.2012.02.002; LOVLEY DR, 1982, APPL ENVIRON MICROB, V43, P1373, DOI 10.1128/AEM.43.6.1373-1379.1982; LOVLEY DR, 1985, APPL ENVIRON MICROB, V49, P1530, DOI 10.1128/AEM.49.6.1530-1531.1985; Morris BE, 2013, FEMS MICROBIOL REV, V37, P384, DOI 10.1111/1574-6976.12019; Muller B, 2016, BIOTECHNOL BIOFUELS, V9, P1363; Muller B, 2015, BIOTECHNOL BIOFUELS, V8, P1; MURRAY WD, 1981, APPL ENVIRON MICROB, V42, P502, DOI 10.1128/AEM.42.3.502-505.1981; Narihiro T, 2011, MICROB BIOTECHNOL, V4, P585, DOI 10.1111/j.1751-7915.2010.00239.x; Pramanik P, 2013, CHEMOSPHERE, V90, P873, DOI 10.1016/j.chemosphere.2012.07.008; Scheller S, 2010, NATURE, V465, P606, DOI 10.1038/nature09015; SCHERER P, 1983, BIOL TRACE ELEM RES, V5, P149, DOI 10.1007/BF02916619; Schink B, 1997, MICROBIOL MOL BIOL R, V61, P262, DOI 10.1128/.61.2.262-280.1997; Schnurer A, 1999, FEMS MICROBIOL ECOL, V29, P249; SCHONHEIT P, 1979, ARCH MICROBIOL, V123, P105, DOI 10.1007/BF00403508; Shagufta J., 2007, ENV BIOTECHNOLOGY; SPEECE RE, 1983, WATER RES, V17, P677, DOI 10.1016/0043-1354(83)90237-3; Sprenger WW, 2007, FEMS MICROBIOL ECOL, V60, P266, DOI 10.1111/j.1574-6941.2007.00287.x; Thauer RK, 1996, CHEM REV, V96, P3031, DOI 10.1021/cr9500601; THAUER RK, 1977, BACTERIOL REV, V41, P100, DOI 10.1128/MMBR.41.1.100-180.1977; Thauer RK, 2008, NAT REV MICROBIOL, V6, P579, DOI 10.1038/nrmicro1931; Thauer RK, 2010, ANNU REV BIOCHEM, V79, P507, DOI 10.1146/annurev.biochem.030508.152103; Vandergheynst JS, 1998, ENVIRON SCI TECHNOL, V32, P3713, DOI 10.1021/es980156n; Weng LP, 2003, ENVIRON TOXICOL CHEM, V22, P2180, DOI 10.1897/02-116; Westerholm M., 2012, THESIS; Westerholm M, 2016, BIORESOURCE TECHNOL, V218, P761, DOI 10.1016/j.biortech.2016.07.029; Westerholm M, 2010, FEMS MICROBIOL LETT, V309, P100, DOI 10.1111/j.1574-6968.2010.02023.x; Wichard T, 2009, NAT GEOSCI, V2, P625, DOI 10.1038/NGEO589; Yekta SS, 2014, APPL GEOCHEM, V47, P61, DOI 10.1016/j.apgeochem.2014.05.001; ZEHNDER AJB, 1980, ARCH MICROBIOL, V124, P1, DOI 10.1007/BF00407022; ZIRNGIBL C, 1990, FEBS LETT, V261, P112, DOI 10.1016/0014-5793(90)80649-4	56	15	16	2	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2016	11	12							e0168357	10.1371/journal.pone.0168357	http://dx.doi.org/10.1371/journal.pone.0168357			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI8LN	27992585	gold, Green Published, Green Submitted			2022-12-27	WOS:000392758000038
J	Nishijima, T; Teruya, K; Shibata, S; Yanagawa, Y; Kobayashi, T; Mizushima, D; Aoki, T; Kinai, E; Yazaki, H; Tsukada, K; Genka, I; Kikuchi, Y; Oka, S; Gatanaga, H				Nishijima, Takeshi; Teruya, Katsuji; Shibata, Satoshi; Yanagawa, Yasuaki; Kobayashi, Taiichiro; Mizushima, Daisuke; Aoki, Takahiro; Kinai, Ei; Yazaki, Hirohisa; Tsukada, Kunihisa; Genka, Ikumi; Kikuchi, Yoshimi; Oka, Shinichi; Gatanaga, Hiroyuki			Incidence and Risk Factors for Incident Syphilis among HIV-1-Infected Men Who Have Sex with Men in a Large Urban HIV Clinic in Tokyo, 2008-2015	PLOS ONE			English	Article							DIAGNOSIS; COHORT; VIRUS	Background The epidemiology of incident syphilis infection among HIV-1-infected men who have sex with men (MSM) largely remains unknown. Methods The incidence and risk factors for incident syphilis (positive TPHA and RPR>=1: 8) among HIV-1-infected MSM who visited a large HIV clinic in Tokyo for the first time between 2008 and 2013 were determined, using clinical data and stored blood samples taken every three months for screening and determination of the date of incident syphilis. Poisson regression compared the incidence of syphilis at different observation periods. Results Of 885 HIV-1-infected MSM with baseline data, 34% either presented with active syphilis at baseline (21%) or became infected with syphilis during follow-up (13%). After excluding 214 patients (MSM with syphilis at baseline (n = 190) and no follow-up syphilis test (n = 24)), of 671 men, 112 (17%) developed incident syphilis with an incidence of 43.7/1,000 person-years [95% CI, 36.5-52.3]. The incidence decreased slightly during observation period although the trend was not significant (2008-2009: 48.2/1,000 person-years, 2010-2011: 51.1/1,000 person-years, 2012-2013: 42.6/1,000 person-years, 2014 to 2015: 37.9/1,000 person-years, p = 0.315). Multivariable analysis identified young age (< 33 years versus > 40, HR 4.0, 95% CI 2.22-7.18, p<0.001), history of syphilis at baseline (HR 3.0, 95% CI 2.03-4.47, p<0.001), positive anti-amoeba antibody (HR 1.8, 95% CI 1.17-2.68, p = 0.006), and high baseline CD4 count (CD4 >= 350 /mu L versus CD4 < 200, HR 1.6, 95% CI 1.00-2.53, p = 0.050) as risk factors for incident syphilis. Incidence of syphilis was particularly high among young patients (age < 33 years: 60.1/1,000 person-years). Interestingly, 37% of patients with incident syphilis were asymptomatic. Conclusions Although incidence of syphilis did not increase during the observation period, it was high among HIV-1-infected MSM, especially among young HIV-1-infected MSM and those with history of syphilis, in Tokyo. Regular screening for syphilis needs to be strictly applied to this population.	[Nishijima, Takeshi; Teruya, Katsuji; Shibata, Satoshi; Yanagawa, Yasuaki; Kobayashi, Taiichiro; Mizushima, Daisuke; Aoki, Takahiro; Kinai, Ei; Yazaki, Hirohisa; Tsukada, Kunihisa; Genka, Ikumi; Kikuchi, Yoshimi; Oka, Shinichi; Gatanaga, Hiroyuki] Natl Ctr Global Hlth & Med, AIDS Clin Ctr, Tokyo, Japan	National Center for Global Health & Medicine - Japan	Nishijima, T (corresponding author), Natl Ctr Global Hlth & Med, AIDS Clin Ctr, Tokyo, Japan.	tnishiji@acc.ncgm.go.jp		KOBAYASHI, TAIICHIRO/0000-0002-1239-0275; yanagawa, yasuaki/0000-0002-3723-2425	Grant for National Center for Global Health and Medicine [28-1102]	Grant for National Center for Global Health and Medicine	This work was supported by a Grant for National Center for Global Health and Medicine (28-1102), which was received by HG. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], INF DIS WEEKL REP JA; [Anonymous], INF DIS WEEKL REP JA; [Anonymous], 2015, REP SEX TRANSM INF C; [Anonymous], EURO SURVEILL; Van der Meer JTM, 2009, SEX TRANSM DIS, V36, P84, DOI 10.1097/OLQ.0b013e318186debb; Burchell AN, 2015, BMC INFECT DIS, V15, DOI 10.1186/s12879-015-1098-2; Hu QH, 2014, BMC INFECT DIS, V14, DOI 10.1186/s12879-014-0658-1; Janier M, 2014, J EUR ACAD DERMATOL, V28, P1581, DOI 10.1111/jdv.12734; Jansen K, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0142515; Kenyon C, 2014, EUROSURVEILLANCE, V19, P22, DOI 10.2807/1560-7917.ES2014.19.45.20958; Komatsu H, 2014, WORLD J GASTROENTERO, V20, P8998, DOI 10.3748/wjg.v20.i27.8998; Magnani R, 2005, AIDS, V19, pS67, DOI 10.1097/01.aids.0000172879.20628.e1; Nishijima T, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0143874; Nishijima T, 2014, JAIDS-J ACQ IMM DEF, V65, P213, DOI 10.1097/QAI.0000000000000044; Nishijima T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081960; Patton ME, 2014, MMWR-MORBID MORTAL W, V63, P402; Rani S, 2022, SPAT INF RES, V30, P417, DOI 10.1007/s41324-022-00442-9; Thurnheer MC, 2010, AIDS, V24, P1907, DOI 10.1097/QAD.0b013e32833bfe21; Yanagawa Y, 2016, AM J TROP MED HYG, V95, P604, DOI 10.4269/ajtmh.16-0134; Yang BR, 2013, SEX TRANSM DIS, V40, P957, DOI 10.1097/OLQ.0000000000000056	20	16	17	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2016	11	12							e0168642	10.1371/journal.pone.0168642	http://dx.doi.org/10.1371/journal.pone.0168642			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI8LN	27992604	Green Published, gold			2022-12-27	WOS:000392758000070
J	Benzing, V; Heinks, T; Eggenberger, N; Schmidt, M				Benzing, Valentin; Heinks, Theda; Eggenberger, Noemi; Schmidt, Mirko			Acute Cognitively Engaging Exergame-Based Physical Activity Enhances Executive Functions in Adolescents	PLOS ONE			English	Article							EXERCISE CHARACTERISTICS; COORDINATIVE EXERCISE; ACADEMIC-ACHIEVEMENT; AEROBIC EXERCISE; EARLY ADULTHOOD; HEART-RATE; PERFORMANCE; CHILDREN; INTELLIGENCE; FITNESS	The study aimed to elucidate the influence of cognitive engagement comprised in an acute bout of exergame-based physical activity on executive functions (inhibition, cognitive flexibility) in adolescents. Therefore, the level of cognitive engagement and the intensity of physical activity were systematically varied across three experimental conditions. Sixty-five healthy male adolescents (13-16 years) were randomly assigned to one of three conditions: (a) physical activity with high levels of cognitive engagement during active video gaming, (b) physical activity with low levels of cognitive engagement during active video gaming, (c) sedentary with low levels of cognitive engagement during passive video watching. Manipulation checks, including subjective and objective operationalizations of cognitive engagement, were applied. Executive functions were assessed before and after each condition using the D-KEFS design fluency test. Results showed that cognitive engagement, operationalized by subjects' ratings and heart rate variability, differed between conditions. The physical activity condition with a high level of cognitive engagement resulted in significantly better performance in cognitive flexibility compared to conditions with low levels of cognitive engagement. Regarding benefits for executive functions in male adolescents, the results indicate that acute physical activity with high cognitive engagement could be more efficient than physical activity of the same intensity with low cognitive engagement. Even though further evidence is needed, these results extend previous research and suggest a methodological approach for measuring cognitive engagement.	[Benzing, Valentin; Schmidt, Mirko] Univ Bern, Inst Sport Sci, Bern, Switzerland; [Heinks, Theda; Eggenberger, Noemi] Univ Childrens Hosp, Dept Pediat Neurol Dev & Rehabil, Bern, Switzerland	University of Bern; University of Bern; University Hospital of Bern	Benzing, V (corresponding author), Univ Bern, Inst Sport Sci, Bern, Switzerland.	valentin.benzing@ispw.unibe.ch	Schmidt, Mirko/I-4762-2013; Benzing, Valentin/I-4748-2019	Schmidt, Mirko/0000-0003-4859-6547; Benzing, Valentin/0000-0002-9940-5635	Fondation Gaydoul; Swiss Cancer Research foundation	Fondation Gaydoul; Swiss Cancer Research foundation	This work was supported by the Fondation Gaydoul and the Swiss Cancer Research foundation.	Baggetta P, 2016, MIND BRAIN EDUC, V10, P10, DOI 10.1111/mbe.12100; Barenberg J, 2011, EDUC RES REV-NETH, V6, P208, DOI 10.1016/j.edurev.2011.04.002; Barkley J.E., J EXERC PHYSL ONLINE, V12; Berse T, 2015, FRONT BEHAV NEUROSCI, V9, DOI 10.3389/fnbeh.2015.00196; Best JR, 2013, Z PSYCHOL, V221, P72, DOI 10.1027/2151-2604/a000137; Best JR, 2012, DEV PSYCHOL, V48, P1501, DOI 10.1037/a0026648; Best JR, 2010, DEV REV, V30, P331, DOI 10.1016/j.dr.2010.08.001; BORG GAV, 1982, MED SCI SPORT EXER, V14, P377, DOI 10.1249/00005768-198205000-00012; Boudreau B, 2009, SOC INDIC RES, V94, P29, DOI 10.1007/s11205-008-9334-4; BRADLEY MM, 1994, J BEHAV THER EXP PSY, V25, P49, DOI 10.1016/0005-7916(94)90063-9; Budde H, 2008, NEUROSCI LETT, V441, P219, DOI 10.1016/j.neulet.2008.06.024; Budde H, 2010, NEUROSCI LETT, V483, P16, DOI 10.1016/j.neulet.2010.07.036; Budde H, 2010, NEUROSCI LETT, V474, P131, DOI 10.1016/j.neulet.2010.03.015; Camm AJ, 1996, EUR HEART J, V17, P354; Chang YK, 2012, BRAIN RES, V1453, P87, DOI 10.1016/j.brainres.2012.02.068; Chang YK, 2015, MED SCI SPORT EXER, V47, P159, DOI 10.1249/MSS.0000000000000383; Delis D.C., 2001, DELIS KAPLAN EXECUTI, DOI DOI 10.1037/T15082-000; Diamond A, 2013, ANNU REV PSYCHOL, V64, P135, DOI 10.1146/annurev-psych-113011-143750; Donnelly JE, 2016, MED SCI SPORT EXER, V48, P1197, DOI 10.1249/MSS.0000000000000901; Esteban-Cornejo I, 2015, J SCI MED SPORT, V18, P534, DOI 10.1016/j.jsams.2014.07.007; Esteban-Cornejo I, 2014, J SPORT SCI, V32, P1596, DOI 10.1080/02640414.2014.910607; Faul F, 2007, BEHAV RES METHODS, V39, P175, DOI 10.3758/BF03193146; Faulkner MS, 2003, HEART LUNG, V32, P10, DOI 10.1067/mhl.2003.6; Flynn Rachel M, 2014, J Educ Develop Psychol, V4, P209; Fuchs R, 2015, Z GESUNDHEITSPSYCHOL, V23, P60, DOI 10.1026/0943-8149/a000137; Gale CR, 2010, EPIDEMIOLOGY, V21, P70, DOI 10.1097/EDE.0b013e3181c17da8; Gallotta MC, 2015, SCAND J MED SCI SPOR, V25, pe331, DOI 10.1111/sms.12310; Gallotta MC, 2012, MED SCI SPORT EXER, V44, P550, DOI 10.1249/MSS.0b013e3182305552; Garber CE, 2011, MED SCI SPORT EXER, V43, P1334, DOI 10.1249/MSS.0b013e318213fefb; Hillman CH, 2009, NEUROSCIENCE, V159, P1044, DOI 10.1016/j.neuroscience.2009.01.057; Hillman CH, 2011, PREV MED, V52, pS21, DOI 10.1016/j.ypmed.2011.01.024; Hogan M, 2013, EXP BRAIN RES, V229, P85, DOI 10.1007/s00221-013-3595-0; Homack S, 2005, J CLIN EXP NEUROPSYC, V27, P599, DOI 10.1080/13803390490918444; Jackson DB, 2015, INT J ENV RES PUB HE, V12, P385, DOI 10.3390/ijerph120100385; Jager K, 2015, MENT HEALTH PHYS ACT, V9, P1, DOI 10.1016/j.mhpa.2015.05.002; Jager K, 2014, FRONT PSYCHOL, V5, DOI 10.3389/fpsyg.2014.01473; KAHNEMAN D, 1969, J EXP PSYCHOL, V79, P164, DOI 10.1037/h0026952; Kimhy D, 2013, J PSYCHIATR RES, V47, P628, DOI 10.1016/j.jpsychires.2013.01.018; Kubesch S, 2009, MIND BRAIN EDUC, V3, P235, DOI 10.1111/j.1751-228X.2009.01076.x; Luft CD, 2009, BIOL PSYCHOL, V82, P196, DOI 10.1016/j.biopsycho.2009.07.007; Moodithaya Shailaja, 2012, J Aging Res, V2012, P679345, DOI 10.1155/2012/679345; Mukherjee S, 2011, CLIN NEUROPHYSIOL, V122, P2059, DOI 10.1016/j.clinph.2011.02.032; O'Loughlin EK, 2012, PEDIATRICS, V130, P806, DOI 10.1542/peds.2012-0391; Pendleton DM, 2016, INT J PSYCHOPHYSIOL, V109, P124, DOI 10.1016/j.ijpsycho.2016.08.012; Penko AL, 2010, ANN BEHAV MED, V39, P162, DOI 10.1007/s12160-010-9164-x; Pesce C., 2009, MENT HEALTH PHYS ACT, V2, P16, DOI [10.1016/j.mhpa.2009.02.001, DOI 10.1016/J.MHPA.2009.02.001]; Pesce C, 2013, MENT HEALTH PHYS ACT, V6, P172, DOI 10.1016/j.mhpa.2013.07.001; Pesce C, 2012, J SPORT EXERCISE PSY, V34, P766, DOI 10.1123/jsep.34.6.766; Schmidt M, 2016, FRONT PSYCHOL, V7, DOI 10.3389/fpsyg.2016.01474; Schmidt M, 2015, J SPORT EXERCISE PSY, V37, P575, DOI 10.1123/jsep.2015-0069; Schmidt M, 2015, PERCEPT MOTOR SKILL, V121, P431, DOI 10.2466/22.06.PMS.121c22x1; Staiano AE, 2012, DEV PSYCHOL, V48, P337, DOI 10.1037/a0026938; Suchy Y, 2010, J INT NEUROPSYCH SOC, V16, P26, DOI 10.1017/S1355617709990804; Tarvainen MP, 2014, COMPUT METH PROG BIO, V113, P210, DOI 10.1016/j.cmpb.2013.07.024; Tomporowski PD, 2008, EDUC PSYCHOL REV, V20, P111, DOI 10.1007/s10648-007-9057-0; Tomporowski PD, 2015, J SPORT HEALTH SCI, V4, P47, DOI 10.1016/j.jshs.2014.09.003; Van Breukelen GJP, 2006, J CLIN EPIDEMIOL, V59, P920, DOI 10.1016/j.jclinepi.2006.02.007; Verburgh L, 2014, BRIT J SPORT MED, V48, P973, DOI 10.1136/bjsports-2012-091441; Vickers AJ, 2001, BMJ-BRIT MED J, V323, P1123, DOI 10.1136/bmj.323.7321.1123; Watzlawik M, 2009, DIAGNOSTICA, V55, P55, DOI 10.1026/0012-1924.55.1.55; Wegner M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092953; Yeniad N, 2013, LEARN INDIVID DIFFER, V23, P1, DOI 10.1016/j.lindif.2012.10.004	62	64	64	8	58	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2016	11	12							e0167501	10.1371/journal.pone.0167501	http://dx.doi.org/10.1371/journal.pone.0167501			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EG7JB	28030542	gold, Green Published, Green Submitted			2022-12-27	WOS:000391222000009
J	Meikle, WG; Adamczyk, JJ; Weiss, M; Gregorc, A; Johnson, DR; Stewart, SD; Zawislak, J; Carroll, MJ; Lorenz, GM				Meikle, William G.; Adamczyk, John J.; Weiss, Milagra; Gregorc, Ales; Johnson, Don R.; Stewart, Scott D.; Zawislak, Jon; Carroll, Mark J.; Lorenz, Gus M.			Sublethal Effects of Imidacloprid on Honey Bee Colony Growth and Activity at Three Sites in the U.S.	PLOS ONE			English	Article							NEONICOTINOID INSECTICIDES; PESTICIDE EXPOSURE	Imidacloprid is a neonicotinoid pesticide heavily used by the agricultural industry and shown to have negative impacts on honey bees above certain concentrations. We evaluated the effects of different imidacloprid concentrations in sugar syrup using cage and field studies, and across different environments. Honey bee colonies fed sublethal concentrations of imidicloprid (0, 5, 20 and 100 ppb) over 6 weeks in field trials at a desert site (Arizona), a site near intensive agriculture (Arkansas) and a site with little nearby agriculture but abundant natural forage (Mississippi) were monitored with respect to colony metrics, such as adult bee and brood population sizes, as well as pesticide residues. Hive weight and internal hive temperature were monitored continuously over two trials in Arizona. Colonies fed 100 ppb imidacloprid in Arizona had significantly lower adult bee populations, brood surface areas and average frame weights, and reduced temperature control, compared to colonies in one or more of the other treatment groups, and consumption rates of those colonies were lower compared to other colonies in Arizona and Arkansas, although no differences in capped brood or average frame weight were observed among treatments in Arkansas. At the Mississippi site, also rich in alternative forage, colonies fed 5 ppb imidacloprid had less capped brood than control colonies, but contamination of control colonies was detected. In contrast, significantly higher daily hive weight variability among colonies fed 5 ppb imidacloprid in Arizona suggested greater foraging activity during a nectar flow post treatment, than any other treatment group. Imidacloprid concentrations in stored honey corresponded well with the respective syrup concentrations fed to the colonies and remained stable within the hive for at least 7 months after the end of treatment.	[Meikle, William G.; Weiss, Milagra; Carroll, Mark J.] USDA ARS, Carl Hayden Bee Res Ctr, Tucson, AZ 85719 USA; [Adamczyk, John J.] USDA ARS, Southern Hort Lab, Poplarville, MS USA; [Gregorc, Ales] Mississippi State Univ, South MS Branch Expt Stn, Poplarville, MS USA; [Johnson, Don R.; Lorenz, Gus M.] Univ Arkansas, Div Agr Cooperat Extens Serv, Lonoke Res & Ext Ctr, Lonoke, AR USA; [Stewart, Scott D.] Univ Tennessee, West Tennessee Res & Educ Ctr, 605 Airways Blvd, Jackson, TN USA; [Zawislak, Jon] Univ Arkansas, Div Agr Cooperat Extens Serv, 2301 South Univ, Little Rock, AR 72204 USA	United States Department of Agriculture (USDA); United States Department of Agriculture (USDA); Mississippi State University; University of Arkansas System; University of Arkansas Fayetteville; University of Tennessee System; University of Tennessee Knoxville; UT Institute of Agriculture; University of Arkansas System; University of Arkansas Fayetteville; University of Arkansas Little Rock	Meikle, WG (corresponding author), USDA ARS, Carl Hayden Bee Res Ctr, Tucson, AZ 85719 USA.	william.meikle@ars.usda.gov	Gregorc, Aleš/AAH-2476-2019; Serrano, Jose/A-2854-2009; Meikle, William/AAC-2481-2022	Serrano, Jose/0000-0002-1565-5216; Adamczyk, John/0000-0002-6536-7255; Meikle, William/0000-0002-1759-6950	ARS [ARS-0426270] Funding Source: Federal RePORTER	ARS(United States Department of Agriculture (USDA)USDA Agricultural Research Service)		Alaux C, 2010, ENVIRON MICROBIOL, V12, P774, DOI 10.1111/j.1462-2920.2009.02123.x; Basile R, 2008, ZOOLOGY, V111, P433, DOI 10.1016/j.zool.2007.11.002; Berry JA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076536; Blacquiere T, 2012, ECOTOXICOLOGY, V21, P973, DOI 10.1007/s10646-012-0863-x; Collison E, 2015, BIOL REV; Cresswell JE, 2011, ECOTOXICOLOGY, V20, P149, DOI 10.1007/s10646-010-0566-0; Delaplane KS, 2013, J APICULT RES, V52, DOI [10.3896/IBRA.1.52.1.03, 10.3896/IBRA.1.52.4.12]; Dively GP, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118748; Easton AH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054819; El Hassani AK, 2008, ARCH ENVIRON CON TOX, V54, P653, DOI 10.1007/s00244-007-9071-8; Gill RJ, 2012, NATURE, V491, P105, DOI 10.1038/nature11585; Girolami V, 2009, J ECON ENTOMOL, V102, P1808, DOI 10.1603/029.102.0511; Henry M, 2012, SCIENCE, V336, P348, DOI 10.1126/science.1215039; Johnson RM, 2015, ANNU REV ENTOMOL, V60, P415, DOI 10.1146/annurev-ento-011613-162005; Kessler SC, 2015, NATURE, V521, P74, DOI 10.1038/nature14414; Kohler A, 2012, J INSECT PHYSIOL, V58, P286, DOI 10.1016/j.jinsphys.2011.12.002; Krupke CH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029268; Meikle WG, 2016, APIDOLOGIE, V47, P1, DOI 10.1007/s13592-015-0370-1; Meikle WG, 2008, APIDOLOGIE, V39, P694, DOI 10.1051/apido:2008055; Mullin CA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009754; Owens CD, 1971, USDA TECHNICAL B, V1429; Pettis JS, 2012, NATURWISSENSCHAFTEN, V99, P153, DOI 10.1007/s00114-011-0881-1; Pettis JS, 2004, APIDOLOGIE, V35, P605, DOI 10.1051/apido:2004056; Pochi D, 2012, B ENVIRON CONTAM TOX, V89, P354, DOI 10.1007/s00128-012-0664-1; Reetz JE, 2011, APIDOLOGIE, V42, P596, DOI 10.1007/s13592-011-0049-1; Rortais A, 2005, APIDOLOGIE, V36, P71, DOI 10.1051/apido:2004071; Sandrock C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103592; Singaravelan N, 2006, J CHEM ECOL, V32, P49, DOI 10.1007/s10886-006-9350-2; Stewart SD, 2014, ENVIRON SCI TECHNOL, V48, P9762, DOI 10.1021/es501657w; Stoner KA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039114; Tomizawa M, 2005, ANNU REV PHARMACOL, V45, P247, DOI 10.1146/annurev.pharmtox.45.120403.095930; Toth AL, 2005, ANIM BEHAV, V69, P427, DOI 10.1016/j.anbehav.2004.03.017; Toth PL, 2009, THESIS; Yang EC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049472; Zhu YC, 2015, J ECON ENTOMOL, P1	35	45	47	0	67	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2016	11	12							e0168603	10.1371/journal.pone.0168603	http://dx.doi.org/10.1371/journal.pone.0168603			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EG7JB	28030617	Green Published, Green Submitted, gold			2022-12-27	WOS:000391222000061
J	Stroe-Kunold, E; Buckert, M; Friederich, HC; Wesche, D; Kopf, S; Herzog, W; Wild, B				Stroe-Kunold, Esther; Buckert, Magdalena; Friederich, Hans-Christoph; Wesche, Daniela; Kopf, Stefan; Herzog, Wolfgang; Wild, Beate			Time Course of Leptin in Patients with Anorexia Nervosa during Inpatient Treatment: Longitudinal Relationships to BMI and Psychological Factors	PLOS ONE			English	Article							SERUM LEPTIN; WEIGHT-GAIN; TEMPORAL RELATIONSHIPS; DEPRESSIVE SYMPTOMS; EATING-DISORDERS; FOOD-INTAKE; DYSREGULATION; CORTISOL; ADIPONECTIN; LINK	Background Leptin, a hormone secreted by adipose tissue, appears to play a major role in the homeostasis of body weight and psychobiological processes associated with anorexia nervosa (AN). However, there is scarce data on its exact influence on this disorder, in particular data over time. Objective The present study addresses whether leptin changes during inpatient treatment play a role for treatment outcome and psychological factors in underweight AN patients. Methods In order to understand whether leptin's role differs in relation to AN severity, data were assessed from 11 patients with a very low BMI and a higher chronicity (high severity group; HSS; mean BMI at the beginning of the study = 13.6; mean duration of illness = 5.1 years) vs. nine with less severe symptoms (LSS; mean BMI = 16.2; mean duration of illness = 3.7 years). During the course of treatment, serum leptin concentrations were assessed weekly while weight (BMI) was assessed twice per week. Concomitantly, psychological variables were obtained by means of electronic diaries. Unconditional linear growth models were calculated to evaluate the temporal course of leptin in relation to BMI. For HSS patients, two phases of treatment (BMI < 16 and BMI >= 16 kg/m(2)) were investigated. Results Leptin increased significantly with BMI in both groups of patients. For HSS patients, the increase of leptin in the first treatment phase did not predict later increases in BMI. Furthermore, the relationship of leptin and psychological factors was modulated by symptom severity. In HSS patients, higher leptin levels were associated with greater feelings of depression, anxiety, and stress whereas in LSS patients a higher leptin level showed the trend to be associated with lower psychological symptom burden. Conclusions Our results suggest that leptin changes are differently associated with weight gain and psychological symptoms depending on the severity of starvation.	[Stroe-Kunold, Esther; Buckert, Magdalena; Wesche, Daniela; Herzog, Wolfgang; Wild, Beate] Med Univ Hosp, Dept Gen Internal Med & Psychosomat, Heidelberg, Germany; [Friederich, Hans-Christoph] Univ Dusseldorf, LVR Clin, Dept Psychosomat Med & Psychotherapy, Dusseldorf, Germany; [Kopf, Stefan] Med Univ Hosp, Dept Endocrinol & Clin Chem, Heidelberg, Germany	Ruprecht Karls University Heidelberg; University of Hamburg; University Medical Center Hamburg-Eppendorf; Heinrich Heine University Dusseldorf; Ruprecht Karls University Heidelberg; University of Hamburg; University Medical Center Hamburg-Eppendorf	Wild, B (corresponding author), Med Univ Hosp, Dept Gen Internal Med & Psychosomat, Heidelberg, Germany.	beate.wild@med.uni-heidelberg.de			Medical Faculty of the University of Heidelberg [F.206808]; Deutsche Forschungsgemeinschaft; Ruprecht-Karls-Universitat Heidelberg	Medical Faculty of the University of Heidelberg; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Ruprecht-Karls-Universitat Heidelberg	This study was supported by the Medical Faculty of the University of Heidelberg (Olympia Morata Programme, F.206808; Postdoctoral Fellowship Programme). This study also received funding from the Deutsche Forschungsgemeinschaft and Ruprecht-Karls-Universitat Heidelberg, within the funding programme for Open Access Publishing. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adolphs R, 2002, CURR OPIN NEUROBIOL, V12, P169, DOI 10.1016/S0959-4388(02)00301-X; Ballauff A, 1999, MOL PSYCHIATR, V4, P71, DOI 10.1038/sj.mp.4000478; Bosy-Westphal A, 2005, EUR J NUTR, V44, P355, DOI 10.1007/s00394-005-0533-3; Brockmeyer T, 2012, COMPR PSYCHIAT, V53, P496, DOI 10.1016/j.comppsych.2011.09.003; Burguera B, 2000, NEUROENDOCRINOLOGY, V71, P187, DOI 10.1159/000054536; FAIRBURN CG, 1994, INT J EAT DISORDER, V16, P363; Fantuzzi G, 2000, J LEUKOCYTE BIOL, V68, P437; Haas V, 2005, AM J CLIN NUTR, V81, P889, DOI 10.1093/ajcn/81.4.889; Hatch A, 2010, EUR EAT DISORD REV, V18, P165, DOI 10.1002/erv.974; Haynos AF, 2011, CLIN PSYCHOL-SCI PR, V18, P183, DOI 10.1111/j.1468-2850.2011.01250.x; Hebebrand J, 2007, MOL PSYCHIATR, V12, P23, DOI 10.1038/sj.mp.4001909; Hebebrand J, 1997, MOL PSYCHIATR, V2, P330, DOI 10.1038/sj.mp.4000282; Hebebrand J, 2012, EUR CHILD ADOLES PSY, V21, P63, DOI 10.1007/s00787-012-0243-3; Herpertz S, 2000, EUR J ENDOCRINOL, V142, P373, DOI 10.1530/eje.0.1420373; Hilbert A, 2007, DIAGNOSTICA, V53, P144, DOI 10.1026/0012-1924.53.3.144; Holtkamp K, 2004, PSYCHONEUROENDOCRINO, V29, P791, DOI 10.1016/S0306-4530(03)00143-4; Holtkamp K, 2003, J CLIN ENDOCR METAB, V88, P5169, DOI 10.1210/jc.2003-030569; Holtkamp K, 2003, J NEURAL TRANSM, V110, P427, DOI 10.1007/s00702-002-0800-x; Janas-Kozik M, 2011, REGUL PEPTIDES, V168, P5, DOI 10.1016/j.regpep.2011.02.005; La Cava A, 2004, NAT REV IMMUNOL, V4, P371, DOI 10.1038/nri1350; Lawson EA, 2012, CLIN ENDOCRINOL, V76, P520, DOI 10.1111/j.1365-2265.2011.04182.x; Liu J, 2015, INT J NEUROPSYCHOPHA; Lob S, 2003, EXP CLIN ENDOCR DIAB, V111, P278, DOI 10.1055/s-2003-41286; Lowe B, 2010, J AFFECT DISORDERS, V122, P86, DOI 10.1016/j.jad.2009.06.019; Lu XY, 2007, CURR OPIN PHARMACOL, V7, P648, DOI 10.1016/j.coph.2007.10.010; Lu XY, 2006, P NATL ACAD SCI USA, V103, P1593, DOI 10.1073/pnas.0508901103; Miller KK, 2011, J CLIN ENDOCR METAB, V96, P2939, DOI 10.1210/jc.2011-1222; Modan-Moses D, 2007, J CLIN ENDOCR METAB, V92, P1843, DOI 10.1210/jc.2006-1683; Monteleone P, 2008, REGUL PEPTIDES, V149, P39, DOI 10.1016/j.regpep.2007.10.007; Monteleone P, 2013, PSYCHONEUROENDOCRINO, V38, P312, DOI 10.1016/j.psyneuen.2012.10.021; Morrison CD, 2009, BBA-MOL BASIS DIS, V1792, P401, DOI 10.1016/j.bbadis.2008.12.004; Morton GJ, 2006, NATURE, V443, P289, DOI 10.1038/nature05026; Naylor C, 2016, TRENDS MOL MED, V22, P88, DOI 10.1016/j.molmed.2015.12.001; Oldershaw A, 2011, NEUROSCI BIOBEHAV R, V35, P970, DOI 10.1016/j.neubiorev.2010.11.001; Paz G, 2010, INT J CLIN PRACT, V64, P1808, DOI 10.1111/j.1742-1241.2010.02536.x; Procaccini C, 2016, DEV COMP IMMUNOL, DOI [10.1038/nri1350, DOI 10.1038/NRI1350]; Procaccini C, 2015, METABOLISM, V64, P92, DOI 10.1016/j.metabol.2014.10.014; Ruscica M, 2015, ENDOCRINE, P1; Rybakowski F, 2014, NEUROENDOCRINOL LETT, V35, P64; Seitz J, 2016, EUR CHILD ADOLES PSY, V25, P1019, DOI 10.1007/s00787-016-0819-4; Serpell L, 2004, INT J EAT DISORDER, V36, P416, DOI 10.1002/eat.20040; Singer JD, 1998, J EDUC BEHAV STAT, V23, P323; Sodersten P, 2008, FRONT NEUROENDOCRIN, V29, P445, DOI 10.1016/j.yfrne.2008.06.001; Stieg MR, 2015, PSYCHONEUROENDOCRINO, V51, P47, DOI 10.1016/j.psyneuen.2014.09.004; Stroe-Kunold E, 2012, INT J PSYCHIAT MED, V44, P53, DOI 10.2190/PM.44.1.d; Tortorella A, 2014, EUR EAT DISORD REV, V22, P307, DOI 10.1002/erv.2303; Treasure J, 2012, EUR EAT DISORD REV, V20, P431, DOI 10.1002/erv.2181; Wild B, 2016, INT J PSYCHOPHYSIOL, V102, P25, DOI 10.1016/j.ijpsycho.2016.03.002; Wild B, 2014, INT J PSYCHOPHYSIOL, V94, P272, DOI 10.1016/j.ijpsycho.2014.09.010	49	13	13	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2016	11	12							e0166843	10.1371/journal.pone.0166843	http://dx.doi.org/10.1371/journal.pone.0166843			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EG7JB	28030575	Green Published, gold			2022-12-27	WOS:000391222000003
J	Jiang, F; Zhang, TT; Bai, SX; Wang, ZY; He, KL				Jiang, Fan; Zhang, Tiantao; Bai, Shuxiong; Wang, Zhenying; He, Kanglai			Evaluation of Bt Corn with Pyramided Genes on Efficacy and Insect Resistance Management for the Asian Corn Borer in China	PLoS One			English	Article							OSTRINIA-FURNACALIS GUENEE; BASE-LINE SUSCEPTIBILITY; BACILLUS-THURINGIENSIS; HELICOVERPA-ARMIGERA; CROSS-RESISTANCE; SYNERGISTIC ACTIVITY; TRANSGENIC PLANTS; FIELD-RESISTANCE; AEDES-AEGYPTI; CRY TOXINS	A Bt corn hybrid (Acle) with two Bt genes (cryl le and cryl Ac) was derived by breeding stack from line expressing Cryl le and a line expressing Cryl Ac. Efficacy of this pyramided Bt corn hybrid against the Asian corn borer (ACB), Ostrinia furnacalis, was evaluated. We conducted laboratory bioassays using susceptible and resistant ACB strains fed on artificial diet or fresh plant tissues. We also conducted field trials with artificial infestations of ACB neonates at the V6 and silk stages. The toxin -diet bioassay data indicated that mixtures of Cryl Ac and Cryl le proteins had synergistic insecticidal efficacy. The plant tissue bioassay data indicated that Bt corn hybrids expressing either a single toxin (Cryl Ac or Cryl le) or two toxins had high efficacy against susceptible ACB. Damage ratings in the field trials indicated that the Bt corn hybrids could effectively protect against 1st and the 2' generation ACB in China. The hybrid line with two Bt genes showed a higher efficacy against ACB larvae resistant to Cryl Ac or Cryle than the hybrid containing one Bt gene, and the two gene hybrid would have increased potential for managing or delaying the evolution of ACB resistance to Bt corn plants.	[Jiang, Fan; Zhang, Tiantao; Bai, Shuxiong; Wang, Zhenying; He, Kanglai] Chinese Acad Agr Sci, Inst Plant Protect, State Key Lab Biol Plant Dis & Insect Pests, Beijing, Peoples R China	Chinese Academy of Agricultural Sciences; Institute of Plant Protection, CAAS	He, KL (corresponding author), Chinese Acad Agr Sci, Inst Plant Protect, State Key Lab Biol Plant Dis & Insect Pests, Beijing, Peoples R China.	klhe@ippcaas.cn		Zhang, Tiantao/0000-0002-7746-7931	National ST Project [2014ZX080110B4-003, 2012ZX08011003-005]	National ST Project	This research was supported in part by National S&T Project 2014ZX080110B4-003 and 2012ZX08011003-005.	Avilla C, 2005, J INVERTEBR PATHOL, V90, P51, DOI 10.1016/j.jip.2005.04.003; Bates SL, 2005, NAT BIOTECHNOL, V23, P57, DOI 10.1038/nbt1056; Bergamasco VB, 2013, J INVERTEBR PATHOL, V112, P152, DOI 10.1016/j.jip.2012.11.011; Bolin PC, 1999, J ECON ENTOMOL, V92, P1021, DOI 10.1093/jee/92.5.1021; Chang X, 2013, J ECON ENTOMOL, V106, P2548, DOI 10.1603/EC13100; Chaufaux J, 2001, J ECON ENTOMOL, V94, P1564, DOI 10.1603/0022-0493-94.6.1564; Fang SL, 2009, APPL ENVIRON MICROB, V75, P5237, DOI 10.1128/AEM.00532-09; Farinos GP, 2004, ENTOMOL EXP APPL, V110, P23, DOI 10.1111/j.0013-8703.2004.00116.x; Ferre J, 2002, ANNU REV ENTOMOL, V47, P501, DOI 10.1146/annurev.ento.47.091201.145234; Frutos R, 1999, CRIT REV BIOTECHNOL, V19, P227, DOI 10.1080/0738-859991229251; Gomez Kwanchai A, 1984, STAT PROCEDURES AGR; Han HaiLiang, 2009, Acta Phytophylacica Sinica, V36, P329; He K, 2005, J APPL ENTOMOL, V129, P407, DOI 10.1111/j.1439-0418.2005.00989.x; He KL, 2000, J SHENYANG AGR U, V31; Huang FN, 1997, J ECON ENTOMOL, V90, P1137, DOI 10.1093/jee/90.5.1137; Janmaat AF, 2003, P ROY SOC B-BIOL SCI, V270, P2263, DOI 10.1098/rspb.2003.2497; Jin TT, 2014, TOXINS, V6, P2676, DOI 10.3390/toxins6092676; Lemes ARN, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107196; Peng DH, 2011, MICROB BIOTECHNOL, V4, P794, DOI 10.1111/j.1751-7915.2011.00295.x; Pereira EJG, 2008, ENTOMOL EXP APPL, V126, P115, DOI 10.1111/j.1570-7458.2007.00642.x; Perez C, 2005, P NATL ACAD SCI USA, V102, P18303, DOI 10.1073/pnas.0505494102; Roush RT, 1998, PHILOS T R SOC B, V353, P1777, DOI 10.1098/rstb.1998.0330; Sampson MN, 1998, MICROBIOL-SGM, V144, P2189, DOI 10.1099/00221287-144-8-2189; Shelton AM, 2002, ANNU REV ENTOMOL, V47, P845, DOI 10.1146/annurev.ento.47.091201.145309; Siqueira HAA, 2006, APPL ENVIRON MICROB, V72, P5318, DOI 10.1128/AEM.00219-06; Song FP, 2003, APPL ENVIRON MICROB, V69, P5207, DOI 10.1128/AEM.69.9.5207-5211.2003; Storer NP, 2010, J ECON ENTOMOL, V103, P1031, DOI 10.1603/EC10040; TABASHNIK BE, 1994, ANNU REV ENTOMOL, V39, P47, DOI 10.1146/annurev.en.39.010194.000403; TABASHNIK BE, 1992, J ECON ENTOMOL, V85, P1046, DOI 10.1093/jee/85.4.1046; Tabashnik BE, 2008, NAT BIOTECHNOL, V26, P199, DOI 10.1038/nbt1382; van Rensburg J. B. J., 2007, South African Journal of Plant and Soil, V24, P147; Wirth MC, 2001, APPL ENVIRON MICROB, V67, P3280, DOI 10.1128/AEM.67.7.3280-3284.2001; Wirth MC, 2000, APPL ENVIRON MICROB, V66, P1093, DOI 10.1128/AEM.66.3.1093-1097.2000; Wu C-S, 2016, PLOS ONE, V11; Wu KM, 2008, SCIENCE, V321, P1676, DOI 10.1126/science.1160550; Xu L, 2010, J APPL ENTOMOL, V134, P429, DOI 10.1111/j.1439-0418.2010.01517.x; Xue JL, 2005, LETT APPL MICROBIOL, V40, P460, DOI 10.1111/j.1472-765X.2005.01712.x; Xue J, 2008, FEMS MICROBIOL LETT, V280, P95, DOI 10.1111/j.1574-6968.2007.01053.x; Zhang TT, 2014, TOXINS, V6, P2694, DOI 10.3390/toxins6092694; Zhang YW, 2013, PLANT CELL TISS ORG, V115, P151, DOI 10.1007/s11240-013-0348-5; Zhao JZ, 2005, P NATL ACAD SCI USA, V102, P8426, DOI 10.1073/pnas.0409324102; Zhou DR, 1995, ASIAN CORN BORER ITS; Zhou ZS, 2015, J INTEGR AGR, V14, P1598, DOI 10.1016/S2095-3119(14)60950-3	43	13	16	2	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2016	11	12							e0168442	10.1371/journal.pone.0168442	http://dx.doi.org/10.1371/journal.pone.0168442			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI9QH	28006032	gold, Green Published, Green Submitted			2022-12-27	WOS:000392843200051
J	Sadeghi, M; Ranjbar, B; Ganjalikhany, MR; Khan, FM; Schmitz, U; Wolkenhauer, O; Gupta, SK				Sadeghi, Mehdi; Ranjbar, Bijan; Ganjalikhany, Mohamad Reza; Khan, Faiz M.; Schmitz, Ulf; Wolkenhauer, Olaf; Gupta, Shailendra K.			MicroRNA and Transcription Factor Gene Regulatory Network Analysis Reveals Key Regulatory Elements Associated with Prostate Cancer Progression	PLOS ONE			English	Article							PROGESTERONE-RECEPTOR EXPRESSION; TUMOR-SUPPRESSOR; BREAST-CANCER; TARGET GENES; STAT3; CELLS; AP-1; OVEREXPRESSION; APOPTOSIS; BCL-2	Technological and methodological advances in multi-omics data generation and integration approaches help elucidate genetic features of complex biological traits and diseases such as prostate cancer. Due to its heterogeneity, the identification of key functional components involved in the regulation and progression of prostate cancer is a methodological challenge. In this study, we identified key regulatory interactions responsible for primary to metastasis transitions in prostate cancer using network inference approaches by integrating patient derived transcriptomic and miRomics data into gene/miRNA/transcription factor regulatory networks. One such network was derived for each of the clinical states of prostate cancer based on differentially expressed and significantly correlated gene, miRNA and TF pairs from the patient data. We identified key elements of each network using a network analysis approach and validated our results using patient survival analysis. We observed that HOXD10, BCL2 and PGR are the most important factors affected in primary prostate samples, whereas, in the metastatic state, STAT3, JUN and JUNB are playing a central role. Benefiting integrative networks our analysis suggests that some of these molecules were targeted by several overexpressed miRNAs which may have a major effect on the dysregulation of these molecules. For example, in the metastatic tumors five miRNAs (miR-671-5p, miR-665, miR-663, miR-512-3p and miR-371-5p) are mainly responsible for the dysregulation of STAT3 and hence can provide an opportunity for early detection of metastasis and development of alternative therapeutic approaches. Our findings deliver new details on key functional components in prostate cancer progression and provide opportunities for the development of alternative therapeutic approaches.	[Sadeghi, Mehdi; Ranjbar, Bijan] Tarbiat Modares Univ, Fac Biol Sci, Dept Biophys, Tehran, Iran; [Ganjalikhany, Mohamad Reza] Univ Isfahan, Dept Biol, Fac Sci, Esfahan, Iran; [Khan, Faiz M.; Wolkenhauer, Olaf; Gupta, Shailendra K.] Univ Rostock, Dept Syst Biol & Bioinformat, Rostock, Germany; [Schmitz, Ulf] Univ Sydney, Centenary Inst, Gene & Stem Cell Therapy Program, Camperdown, NSW, Australia; [Schmitz, Ulf] Univ Sydney, Sydney Med Sch, Camperdown, NSW, Australia; [Wolkenhauer, Olaf] Univ Stellenbosch, Wallenberg Res Ctr, Stellenbosch Inst Adv Study STIAS, Stellenbosch, South Africa; [Gupta, Shailendra K.] CSIR, Indian Inst Toxicol Res, Dept Bioinformat, Lucknow, Uttar Pradesh, India	Tarbiat Modares University; University of Isfahan; University of Rostock; University of Sydney; Centenary Institute; University of Sydney; Stellenbosch University; Council of Scientific & Industrial Research (CSIR) - India; CSIR - Indian Institute of Toxicology Research (IITR)	Ranjbar, B (corresponding author), Tarbiat Modares Univ, Fac Biol Sci, Dept Biophys, Tehran, Iran.	ranjbarb@modares.ac.ir	Schmitz, Ulf/B-5400-2010; sadeghi, mehdi/M-8507-2017; Ganjalikhany, Mohamad Reza/AAB-7845-2021; Sadeghi, Mehdi/AAY-7517-2021	Schmitz, Ulf/0000-0001-5806-4662; sadeghi, mehdi/0000-0001-6704-4591; Ganjalikhany, Mohamad Reza/0000-0002-6865-0814; Sadeghi, Mehdi/0000-0001-6704-4591; Gupta, Shailendra/0000-0002-3470-3260	German Federal Ministry of Education and Research (BMBF) [eBio: SysMet [0316171], eBio:MelEVIR [031L0073A]]; Council of Scientific and Industrial Research (CSIR) [BSC0121, BSC0111]	German Federal Ministry of Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF)); Council of Scientific and Industrial Research (CSIR)(Council of Scientific & Industrial Research (CSIR) - India)	We acknowledge Vice Chancellor for Research and Technology of the Tarbiat Modares University. OW, FMK and SKG acknowledge the German Federal Ministry of Education and Research (BMBF) as part of the projects eBio: SysMet [0316171] and eBio:MelEVIR [031L0073A]. SKG acknowledges the Council of Scientific and Industrial Research (CSIR) network projects GENESIS [BSC0121] and INDEPTH [BSC0111].	Abell K, 2005, CELL CYCLE, V4, P897, DOI 10.4161/cc.4.7.1837; Agarwal V, 2015, ELIFE, V4, DOI 10.7554/eLife.05005; Assenov Y, 2008, BIOINFORMATICS, V24, P282, DOI 10.1093/bioinformatics/btm554; Avalle Lidia, 2012, JAKSTAT, V1, P65, DOI 10.4161/jkst.20045; Baek D, 2008, NATURE, V455, P64, DOI 10.1038/nature07242; Bakkar A, 2016, MOL BIOL REP, V43, P229, DOI 10.1007/s11033-016-3948-4; Banerjee K, 2016, INT J CANCER, V138, P2570, DOI 10.1002/ijc.29923; Barabasi AL, 2004, NAT REV GENET, V5, P101, DOI 10.1038/nrg1272; Barabasi AL, 2011, NAT REV GENET, V12, P56, DOI 10.1038/nrg2918; Barton BE, 2004, MOL CANCER THER, V3, P11; Betel D, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-8-r90; Birner P, 2015, CELL DEATH DIFFER, V22, P522, DOI 10.1038/cdd.2014.232; Blando JM, 2011, NEOPLASIA, V13, P254, DOI 10.1593/neo.101388; Bonkhoff H, 2001, PROSTATE, V48, P285, DOI 10.1002/pros.1108; Cai Yimei, 2009, Genomics Proteomics & Bioinformatics, V7, P147, DOI 10.1016/S1672-0229(08)60044-3; Carpenter RL, 2014, CANCERS, V6, P897, DOI 10.3390/cancers6020897; Cha YJ, 2016, PROSTATE, V76, P937, DOI 10.1002/pros.23183; Chou C-H, 2015, NUCL ACIDS RES; Culig Z., 2016, EUROPEAN UROLOGY; Dasgupta Subhamoy, 2012, J Carcinog, V11, P4, DOI 10.4103/1477-3163.93001; Ding ZH, 2011, NATURE, V470, P269, DOI 10.1038/nature09677; Don-Doncow N, 2016, EUR UROL; Esber N, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0140795; Esposito S, 2015, ONCOTARGET, V6; Gitenay D, 2009, FUTURE ONCOL, V5, P993, DOI 10.2217/FON.09.67; Glinsky GV, 2004, J CLIN INVEST, V113, P913, DOI 10.1172/JCI200420032; Gurel B, 2008, MODERN PATHOL, V21, P1156, DOI 10.1038/modpathol.2008.111; Hawksworth D, 2010, PROSTATE CANCER P D, V13, P311, DOI 10.1038/pcan.2010.31; Ho HH, 2006, J BIOL CHEM, V281, P14111, DOI 10.1074/jbc.M511797200; Horvath CM, 2000, TRENDS BIOCHEM SCI, V25, P496, DOI 10.1016/S0968-0004(00)01624-8; Iorio MV, 2012, EMBO MOL MED, V4, P143, DOI 10.1002/emmm.201100209; Jarnicki A, 2010, CELL DIV, V5, DOI 10.1186/1747-1028-5-14; Jiao L, 2014, J CELL PHYSIOL, V229, P834, DOI 10.1002/jcp.24510; Jin Y, 2015, INT J ONCOL, V47, P1594, DOI 10.3892/ijo.2015.3114; Jochum W, 2001, ONCOGENE, V20, P2401, DOI 10.1038/sj.onc.1204389; Karantanos T, 2013, ONCOGENE, V32, P5501, DOI 10.1038/onc.2013.206; Karin M, 1997, CURR OPIN CELL BIOL, V9, P240, DOI 10.1016/S0955-0674(97)80068-3; Kavlashvili T, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0148912; Kawamura N, 2015, ONCOTARGET, V6, P22361, DOI 10.18632/oncotarget.4293; Kim YR, 2016, ONCOL REP, V35, P2011, DOI 10.3892/or.2016.4563; Knox SS, 2010, CANCER CELL INT, V10, DOI 10.1186/1475-2867-10-11; Konishi N, 2008, CLIN CANCER RES, V14, P4408, DOI 10.1158/1078-0432.CCR-07-4120; Lai X, 2012, NUCLEIC ACIDS RES, V40, P8818, DOI 10.1093/nar/gks657; Li ML, 2016, ONCOL LETT, V11, P817, DOI 10.3892/ol.2015.3924; Lin YT, 2007, CELL RES, V17, P531, DOI 10.1038/cr.2007.12; Ling XY, 2005, CANCER RES, V65, P2532, DOI 10.1158/0008-5472.CAN-04-2425; Liu F, 1997, GENE DEV, V11, P3157, DOI 10.1101/gad.11.23.3157; Lonergan Peter E, 2011, J Carcinog, V10, P20, DOI 10.4103/1477-3163.83937; Maere S, 2005, BIOINFORMATICS, V21, P3448, DOI 10.1093/bioinformatics/bti551; Martinez NJ, 2008, GENE DEV, V22, P2535, DOI 10.1101/gad.1678608; Matys V, 2003, NUCLEIC ACIDS RES, V31, P374, DOI 10.1093/nar/gkg108; Mehta HH, 2011, CANCER RES, V71, P5154, DOI 10.1158/0008-5472.CAN-10-4513; Nair S, 2010, ACTA PHARMACOL SIN, V31, P1223, DOI 10.1038/aps.2010.147; Nesbit CE, 1999, ONCOGENE, V18, P3004, DOI 10.1038/sj.onc.1202746; Nowak DG, 2015, CANCER DISCOV, V5, P636, DOI 10.1158/2159-8290.CD-14-1113; Nunez YO, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-725; Ouyang X, 2008, CANCER RES, V68, P2132, DOI 10.1158/0008-5472.CAN-07-6055; Palladinetti P, 2008, ATLAS GENET CYTOGENE, P367; Pencik J, 2015, STAT3 REGULATED ARF, V6; RAFFO AJ, 1995, CANCER RES, V55, P4438; Ramachandran S, 2005, ONCOGENE, V24, P188, DOI 10.1038/sj.onc.1207906; Ravani P, 2010, CLIN J AM SOC NEPHRO, V5, P1243, DOI 10.2215/CJN.06190809; Ritchie MD, 2015, NAT REV GENET, V16, P85, DOI 10.1038/nrg3868; Ritchie ME, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv007; Roca H, 2014, BMC SYST BIOL, V8, DOI 10.1186/1752-0509-8-29; Schmelz M, 2002, NEOPLASIA, V4, P243, DOI 10.1038/sj.neo.7900223; Schuringa JJ, 2001, CYTOKINE, V14, P78, DOI 10.1006/cyto.2001.0856; Senapati S, 2009, ATLAS GENET CYTOGENE, P204; Shalgi R, 2007, PLOS COMPUT BIOL, V3, P1291, DOI 10.1371/journal.pcbi.0030131; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Siegel RL, 2015, CA-CANCER J CLIN, V65, P5, DOI 10.3322/caac.21254; Taylor BS, 2011, INTEGRATIVE GENOMIC, V18, P11; Thomsen MK, 2015, CELL DEATH DIFFER, V22, P574, DOI 10.1038/cdd.2014.213; Toualbi K, 2007, ONCOGENE, V26, P3492, DOI 10.1038/sj.onc.1210133; Tsang J, 2015, MOL CELL ELSEVIER, V26, P753; Tu WH, 2003, NEOPLASIA, V5, P267, DOI 10.1016/S1476-5586(03)80058-1; Vanhara P, 2012, PROSTATE CANCER P D, V15, P320, DOI 10.1038/pcan.2012.6; Varambally S, 2002, NATURE, V419, P624, DOI 10.1038/nature01075; Vera J, 2013, CANCER RES, V73, P3511, DOI 10.1158/0008-5472.CAN-12-4095; Virolle T, 2003, J BIOL CHEM, V278, P11802, DOI 10.1074/jbc.M210279200; Wang LJ, 2012, MOL MED, V18, P389, DOI 10.2119/molmed.2011.00172; Xiong AL, 2014, CANCERS, V6, P926, DOI 10.3390/cancers6020926; Yin P, 2007, J CLIN ENDOCR METAB, V92, P4459, DOI 10.1210/jc.2007-0725; Yu Y, 2015, PROSTATE, V75, P1043, DOI 10.1002/pros.22988; Yu Y, 2013, J CLIN ENDOCR METAB, V98, P2887, DOI 10.1210/jc.2012-4000; Zhang DT, 2014, TUMOR BIOL, V35, P3333, DOI 10.1007/s13277-013-1439-y	86	33	33	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2016	11	12							e0168760	10.1371/journal.pone.0168760	http://dx.doi.org/10.1371/journal.pone.0168760			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI9QH	28005952	Green Published, Green Submitted, gold, Green Accepted			2022-12-27	WOS:000392843200091
J	Zhang, W; Wang, AN; Yao, SY; Luo, YH; Li, ZH; Huang, FF; Li, H; Yin, YZ; Zhang, JP				Zhang, Wen; Wang, An-ni; Yao, Shu-yu; Luo, Yuan-hui; Li, Zhi-hua; Huang, Fei-fei; Li, Hui; Yin, Yi-zhen; Zhang, Jing-ping			Latent Profiles of Posttraumatic Growth and Their Relation to Differences in Resilience among Only-Child-Lost People in China	PLoS One			English	Article							SCALE CD-RISC; BEREAVEMENT SUPPORT; PREMATURE BABY; BREAST-CANCER; MIXTURE; GRIEF; ADVERSITY; PARENTS; TRAUMA; NUMBER	Aims Since the early 1980s, the one-child policy has been implemented nationwide in China. A special group called the "only-child-lost family" (OCL family) has emerged and has become a social phenomenon that cannot be ignored. We report latent profiles of posttraumatic growth and their relation to differences in resilience among OCL people in China. Methods A total of 222 OCL people were investigated using the Posttraumatic Growth Inventory and the Connor-Davidson Resilience Scale. Latent profile analysis was applied to explore PIG latent profiles. Multinomial logistic regression was used to analyze the socio-demographic variables in each latent profile and the association between profile membership and resilience. Results Three latent profiles were identified and labeled the "high appreciation-power group" (30.6%), the "general moderate growth group" (47.7%) and the "low growth and extreme possibility group" (21.7%). Compared to those in the high appreciation-power group, individuals with monthly income >2000 ($312) were less likely to be in the general moderate growth group (OR = 0.13, P<0.01), whereas individuals with a spouse were less likely to be in the low growth and extreme possibility group (OR = 0.43, P<0.01). Individuals in the "general moderate growth group"(OR = 0.92, P<0.01, 95%CI:0.89-0.94) and the "low growth and extreme possibility" groups (OR = 0.83, P<0.01, 95`)/X1:0.79-0.87) demonstrated significantly lower levels of resilience compared to the high appreciation-power group. Conclusion The PTG patterns in only-child-lost parents were varied. Promoting resilience may be a way to foster these parents' PTG. Targeted intervention should be developed based on the characteristics of each latent class, and timely attention must be paid to the mental health of OCL parents who are without a spouse and have low income.	[Zhang, Wen; Wang, An-ni; Yao, Shu-yu; Luo, Yuan-hui; Li, Hui; Yin, Yi-zhen; Zhang, Jing-ping] Cent S Univ, Xiangya Nursing Sch, Nursing Psychol Res Ctr, Changsha, Hunan, Peoples R China; [Li, Zhi-hua] Hunan Agr Univ, Inst Educ, Changsha, Hunan, Peoples R China; [Huang, Fei-fei] Fujian Med Univ, Sch Nursing, Fuzhou, Peoples R China	Central South University; Hunan Agricultural University; Fujian Medical University	Zhang, JP (corresponding author), Cent S Univ, Xiangya Nursing Sch, Nursing Psychol Res Ctr, Changsha, Hunan, Peoples R China.	jpzhang1965@163.com	Li, ZhiHua/GYU-9914-2022; Zhang, Jingping/ABA-4179-2020; zhang, wen/O-4852-2018; li, zh/HII-5698-2022; Anni, Wang/AAH-5183-2019	Zhang, Jingping/0000-0002-7800-9617; zhang, wen/0000-0002-8166-2879; Anni, Wang/0000-0003-3109-7514	National Social Sciences Fund of China [2014BSH137]	National Social Sciences Fund of China	This study was funded by the National Social Sciences Fund of China (2014BSH137).	Agaibi CE, 2005, TRAUMA VIOLENCE ABUS, V6, P195, DOI 10.1177/1524838005277438; Arnold J, 2008, DEATH STUD, V32, P658, DOI 10.1080/07481180802215718; Barlow CA, 2010, DEATH STUD, V34, P915, DOI 10.1080/07481181003761435; Berlin KS, 2014, J PEDIATR PSYCHOL, V39, P174, DOI 10.1093/jpepsy/jst084; Birkeland MS, 2015, ANXIETY STRESS COPIN, V28, P272, DOI 10.1080/10615806.2014.956097; Bogensperger J, 2014, EUR J PSYCHOTRAUMATO, V5, DOI 10.3402/ejpt.v5.22910; Bonanno GA, 2004, PSYCHOL AGING, V19, P260, DOI 10.1037/0882-7974.19.2.260; Bonanno GA, 2013, J CHILD PSYCHOL PSYC, V54, P378, DOI 10.1111/jcpp.12021; Buchi S, 2007, PSYCHOTHER PSYCHOSOM, V76, P106, DOI 10.1159/000097969; Buchi S, 2009, PSYCHOSOMATICS, V50, P123, DOI 10.1176/appi.psy.50.2.123; Butterfoss FD, 2006, HEALTH PROMOT PRACT, V7, pS23, DOI 10.1177/1524839906287062; Celeux G, 1996, J CLASSIF, V13, P195, DOI 10.1007/BF01246098; Connor KM, 2003, DEPRESS ANXIETY, V18, P76, DOI 10.1002/da.10113; Currier JM, 2013, PSYCHOL RELIG SPIRIT, V5, P69, DOI 10.1037/a0027708; Diequan H, 2013, CHINA 3 GORGES TRIBU, V1, P21; Dong Y, 2014, CHINA NONPROFIT REV, V01, P135; Dopp AR, 2012, DEATH STUD, V36, P41, DOI 10.1080/07481187.2011.573175; Duan WJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125707; Engelkemeyer SM, 2008, J TRAUMA STRESS, V21, P344, DOI 10.1002/jts.20338; Fazio RJ, 2005, J LOSS TRAUMA, V10, P221, DOI 10.1080/15325020590928207; Fazio RJ, 2009, J CLIN PSYCHOL, V65, P532, DOI 10.1002/jclp.20590; Friedrichs JB, 2014, MCN-AM J MATERN-CHIL, V39, P198, DOI 10.1097/NMC.0000000000000026; Glad KA, 2013, CHILD ABUSE NEGLECT, V37, P331, DOI 10.1016/j.chiabu.2013.02.007; Hagenaars J., 2002, APPL LATENT CLASS AN, DOI DOI 10.1017/CBO9780511499531; Heazell AEP, 2013, ACTA OBSTET GYN SCAN, V92, P352, DOI 10.1111/aogs.12042; Hildon Z, 2010, GERONTOLOGIST, V50, P36, DOI 10.1093/geront/gnp067; Hu D, 2013, CHINA 3 GORGES TRIBU, V01, P75; Jacob S R, 1994, Nurse Pract, V19, P60, DOI 10.1097/00006205-199407000-00011; Lepore SJ., 2006, HDB POSTTRAUMATIC GR, P24; Levine SZ, 2009, J TRAUMA STRESS, V22, P282, DOI 10.1002/jts.20409; Lo YT, 2001, BIOMETRIKA, V88, P767, DOI 10.1093/biomet/88.3.767; Magidson J., 2002, CAN J MARKET RES, V20, P37, DOI DOI 10.1017/CBO9780511499531.004; Milam JE, 2004, J APPL SOC PSYCHOL, V34, P2353, DOI 10.1111/j.1559-1816.2004.tb01981.x; Murphy PJ, 2013, AIDS BEHAV, V17, P1809, DOI 10.1007/s10461-013-0482-4; Muthen L.K., 2010, MPLUS USERS GUIDE; Mystakidou K, 2008, BREAST, V17, P382, DOI 10.1016/j.breast.2008.01.006; Nylund KL, 2007, STRUCT EQU MODELING, V14, P535, DOI 10.1080/10705510701575396; Ong AD, 2006, J PERS SOC PSYCHOL, V91, P730, DOI 10.1037/0022-3514.91.4.730; Polatinsky S, 2000, J TRAUMA STRESS, V13, P709, DOI 10.1023/A:1007870419116; Possick C, 2008, AM J ORTHOPSYCHIAT, V78, P93, DOI 10.1037/0002-9432.78.1.93; RANDO T A, 1983, Journal of Pediatric Psychology, V8, P3, DOI 10.1093/jpepsy/8.1.3; Rudd Rebecca A, 2013, Int J Emerg Ment Health, V15, P51; Shevlin M, 2014, EUR J PSYCHOTRAUMATO, V5; Spahni S, 2015, GERONTOLOGY, V61, P456, DOI 10.1159/000371444; Stevens GJ, 2013, MED J AUSTRALIA, V198, P273, DOI 10.5694/mja12.11480; Taku K, 2008, DEATH STUD, V32, P428, DOI 10.1080/07481180801974745; Tang CSK, 2006, J PSYCHOSOM RES, V61, P699, DOI 10.1016/j.jpsychores.2006.07.014; Tedeschi RG, 2004, PSYCHOL INQ, V15, P1, DOI 10.1207/s15327965pli1501_01; Tedeschi RG, 1996, J TRAUMA STRESS, V9, P455, DOI 10.1007/BF02103658; Walsh F, 2007, FAM PROCESS, V46, P207, DOI 10.1111/j.1545-5300.2007.00205.x; Wang G, 2008, CHIN J POPUL SCI, V1, P6; [王健怡 WANG Jian yi], 2011, [实用儿科临床杂志, Journal of Applied Clinical Pediatrics], V26, P26; Wang ML, 2014, EUR J ONCOL NURS, V18, P478, DOI 10.1016/j.ejon.2014.04.012; Wu KJ, 2015, FRONT PSYCHOL, V6, DOI 10.3389/fpsyg.2015.01043; Xu W, 2015, PSYCHIAT RES, V230, P108, DOI 10.1016/j.psychres.2015.08.035; Yu XN, 2010, J AFFECT DISORDERS, V123, P327, DOI 10.1016/j.jad.2009.09.019; Yu XN, 2007, SOC BEHAV PERSONAL, V35, P19, DOI 10.2224/sbp.2007.35.1.19; Yu YJ, 2014, PSYCHIAT RES, V215, P401, DOI 10.1016/j.psychres.2013.10.032; [张洁婷 Zhang Jieting], 2010, [心理科学进展, Advances in Psychological Science], V18, P1991	59	11	11	0	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2016	11	12							e0167398	10.1371/journal.pone.0167398	http://dx.doi.org/10.1371/journal.pone.0167398			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EI9QH	28005990	gold, Green Published, Green Submitted			2022-12-27	WOS:000392843200016
J	Farah, CA; Rourke, B; Shin, U; Ferguson, L; Luna, MJ; Sossin, WS				Farah, Carole A.; Rourke, Bryan; Shin, Unkyung; Ferguson, Larissa; Luna, Maria Jose; Sossin, Wayne S.			Investigating the Potential Signaling Pathways That Regulate Activation of the Novel PKC Downstream of Serotonin in Aplysia	PLOS ONE			English	Article							PROTEIN-KINASE-C; LONG-TERM FACILITATION; GROWTH-FACTOR RECEPTOR; APL-II; PRESYNAPTIC FACILITATION; NONDEPRESSED SYNAPSES; SYNAPTIC FACILITATION; ISOFORM SPECIFICITY; TRANSLOCATION; DISHABITUATION	Activation of the novel PKC Apl ll in sensory neurons by serotonin (5HT) underlies the ability of 5HT to reverse synaptic depression, but the pathway from 5HT to PKC Apl ll activation remains unclear. Here we find no evidence for the Ap/ysia-specific B receptors, or for adenylate cyclase activation, to translocate fluorescently-tagged PKC Apl II. Using an anti-PKC Apl ll antibody, we monitor translocation of endogenous PKC Apl ll and determine the dose response for PKC Apl I I translocation, both in isolated sensory neurons and sensory neurons coupled with motor neurons. Using this assay, we confirm an important role for tyrosine kinase activation in 5HT mediated PKC Apl II translocation, but rule out roles for intracellular tyrosine kinases, epidermal growth factor (EGF) receptors and Trk kinases in this response. A partial inhibition of translocation by a fibroblast growth factor (FGF)-receptor inhibitor led us to clone the Aplysia FGF receptor. Since a number of related receptors have been recently characterized, we use bioinformatics to define the relationship between these receptors and find a single FGF receptor orthologue in Aplysia. However, expression of the FGF receptor did not affect translocation or allow it in motor neurons where 5HT does not normally cause PKC Apl II translocation. These results suggest that additional receptor tyrosine kinases (RTKs) or other molecules must also be involved in translocation of PKC Apl II.	[Farah, Carole A.; Rourke, Bryan; Shin, Unkyung; Ferguson, Larissa; Luna, Maria Jose; Sossin, Wayne S.] McGill Univ, Montreal Neurol Inst, Dept Neurol & Neurosurg, Montreal, PQ, Canada	McGill University	Sossin, WS (corresponding author), McGill Univ, Montreal Neurol Inst, Dept Neurol & Neurosurg, Montreal, PQ, Canada.	wayne.sossin@mcgill.ca		Sossin, Wayne/0000-0003-1927-9315; Ferguson, Larissa/0000-0003-4274-8634	Canadian Institute of Health Research Grant [MOP 12046]	Canadian Institute of Health Research Grant(Canadian Institutes of Health Research (CIHR))	This work was supported by Canadian Institute of Health Research Grant MOP 12046 to WSS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bailey CH, 2008, PROG BRAIN RES, V169, P179, DOI 10.1016/S0079-6123(07)00010-6; Bougie JK, 2009, J NEUROCHEM, V109, P1129, DOI 10.1111/j.1471-4159.2009.06045.x; BRAHA O, 1990, P NATL ACAD SCI USA, V87, P2040, DOI 10.1073/pnas.87.5.2040; Bryksin AV, 2010, BIOTECHNIQUES, V48, P463, DOI 10.2144/000113418; CASTELLUCCI V, 1970, SCIENCE, V167, P1745, DOI 10.1126/science.167.3926.1745; Cesare P, 1999, NEURON, V23, P617, DOI 10.1016/S0896-6273(00)80813-2; Dunn TW, 2013, J NEUROPHYSIOL, V110, P2071, DOI 10.1152/jn.00217.2013; Dunn TW, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0136907; Emptage NJ, 1996, J NEUROPHYSIOL, V75, P843, DOI 10.1152/jn.1996.75.2.843; Evellin Sandrine, 2004, Methods Mol Biol, V284, P259; Farah CA, 2008, MOL CELL BIOL, V28, P4719, DOI 10.1128/MCB.00178-08; Farah CA, 2015, EUR J NEUROSCI, V41, P328, DOI 10.1111/ejn.12794; Farah CA, 2011, JOVE-J VIS EXP, DOI 10.3791/2516; Farah CA, 2012, J NEUROCHEM, V123, P360, DOI 10.1111/j.1471-4159.2012.07930.x; FUKAZAWA H, 1994, FEBS LETT, V340, P155, DOI 10.1016/0014-5793(94)80127-4; GHIRARDI M, 1995, NEURON, V14, P413, DOI 10.1016/0896-6273(95)90297-X; GHIRARDI M, 1992, NEURON, V9, P479, DOI 10.1016/0896-6273(92)90185-G; GOLDBERG DJ, 1995, J NEUROBIOL, V27, P553, DOI 10.1002/neu.480270409; GOLDSMITH BA, 1991, P NATL ACAD SCI USA, V88, P9021, DOI 10.1073/pnas.88.20.9021; Hanke JH, 1996, J BIOL CHEM, V271, P695, DOI 10.1074/jbc.271.2.695; Hislop J, 2004, J NEUROBIOL, V60, P127, DOI 10.1002/neu.20004; HOCHNER B, 1986, P NATL ACAD SCI USA, V83, P8794, DOI 10.1073/pnas.83.22.8794; Hucho TB, 2005, J NEUROSCI, V25, P6119, DOI 10.1523/JNEUROSCI.0285-05.2005; Hunter T, 2014, CSH PERSPECT BIOL, V6, DOI 10.1101/cshperspect.a020644; Kandel ER, 2001, SCIENCE, V294, P1030, DOI 10.1126/science.1067020; Kassabov SR, 2013, CELL REP, V3, P1213, DOI 10.1016/j.celrep.2013.03.008; KIM BY, 1995, BIOCHEM BIOPH RES CO, V212, P1061, DOI 10.1006/bbrc.1995.2077; KRUGER KE, 1991, J NEUROSCI, V11, P2303; Lee YS, 2009, P NATL ACAD SCI USA, V106, P14634, DOI 10.1073/pnas.0907502106; Li CK, 2011, BMC BIOTECHNOL, V11, DOI 10.1186/1472-6750-11-92; LI XC, 1995, J NEUROSCI, V15, P7585; Manseau F, 2001, J NEUROSCI, V21, P1247; Marinesco S, 2002, J NEUROSCI, V22, P2299, DOI 10.1523/JNEUROSCI.22-06-02299.2002; MIZUNO K, 1993, FEBS LETT, V330, P114, DOI 10.1016/0014-5793(93)80254-R; Mohammadi M, 1997, SCIENCE, V276, P955, DOI 10.1126/science.276.5314.955; Nagakura I, 2010, J NEUROCHEM, V115, P994, DOI 10.1111/j.1471-4159.2010.06986.x; Naqib F, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002324; Okochi Y, 2005, EMBO J, V24, P2127, DOI 10.1038/sj.emboj.7600697; Ormond J, 2004, NEURON, V44, P715, DOI 10.1016/j.neuron.2004.11.001; Pollak DD, 2014, AMINO ACIDS, V46, P2477, DOI 10.1007/s00726-014-1803-2; Sossin WS, 2007, LEARN MEMORY, V14, P236, DOI 10.1101/lm.469707; Tamvacakis AN, 2015, LEARN MEMORY, V22, P617, DOI 10.1101/lm.038158.115; Wan Q, 2012, NAT NEUROSCI, V15, P1144, DOI 10.1038/nn.3158; WHALEN MM, 1993, IMMUNOLOGY, V79, P542; Xia ZP, 2001, BIOPHYS J, V81, P2395, DOI 10.1016/S0006-3495(01)75886-9; Zhao YL, 2006, J NEUROSCI, V26, P8847, DOI 10.1523/JNEUROSCI.1919-06.2006	46	1	1	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2016	11	12							e0168411	10.1371/journal.pone.0168411	http://dx.doi.org/10.1371/journal.pone.0168411			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI9TW	28002451	Green Published, Green Submitted, gold			2022-12-27	WOS:000392853100044
J	Galante, R; Rediguieri, CF; Kikuchi, IS; Vasquez, PAS; Colaco, R; Serro, AP; Pinto, TJA				Galante, Raquel; Rediguieri, Carolina F.; Kikuchi, Irene Satiko; Vasquez, Pablo A. S.; Colaco, Rogerio; Serro, Ana Paula; Pinto, Terezinha J. A.			About the Sterilization of Chitosan Hydrogel Nanoparticles	PLOS ONE			English	Article							TRIPOLYPHOSPHATE CS/TPP NANOPARTICLES; DRUG-DELIVERY; BIOMEDICAL APPLICATIONS; GLUCOSE COMPLEX; OZONE; CHALLENGES; EFFICIENCY; NANOGELS	In the last years, nanostructured biomaterials have raised a great interest as platforms for delivery of drugs, genes, imaging agents and for tissue engineering applications. In particular, hydrogel nanoparticles (HNP) associate the distinctive features of hydrogels (high water uptake capacity, biocompatibility) with the advantages of being possible to tailor its physicochemical properties at nano-scale to increase solubility, immunocompatibility and cellular uptake. In order to be safe, HNP for biomedical applications, such as injectable or ophthalmic formulations, must be sterile. Literature is very scarce with respect to sterilization effects on nanostructured systems, and even more in what concerns HNP. This work aims to evaluate the effect and effectiveness of different sterilization methods on chitosan (CS) hydrogel nanoparticles. In addition to conventional methods (steam autoclave and gamma irradiation), a recent ozone-based method of sterilization was also tested. A model chitosan-tripolyphosphate (TPP) hydrogel nanoparticles (CS-HNP), with a broad spectrum of possible applications was produced and sterilized in the absence and in the presence of protective sugars (glucose and mannitol). Properties like size, zeta potential, absorbance, morphology, chemical structure and cytotoxicity were evaluated. It was found that the CS-HNP degrade by autoclaving and that sugars have no protective effect. Concerning gamma irradiation, the formation of agglomerates was observed, compromising the suspension stability. However, the nanoparticles resistance increases considerably in the presence of the sugars. Ozone sterilization did not lead to significant physical adverse effects, however, slight toxicity signs were observed, contrarily to gamma irradiation where no detectable changes on cells were found. Ozonation in the presence of sugars avoided cytotoxicity. Nevertheless, some chemical alterations were observed in the nanoparticles.	[Galante, Raquel; Rediguieri, Carolina F.; Kikuchi, Irene Satiko; Pinto, Terezinha J. A.] Univ Sao Paulo, Fac Ciencias Farmaceut, Dept Farm, Butanta, SP, Brazil; [Galante, Raquel; Colaco, Rogerio; Serro, Ana Paula] Univ Lisbon, Inst Super Tecn, Ctr Quim Estrutural, Lisbon, Portugal; [Rediguieri, Carolina F.] Agencia Nacl Vigilaancia Sanit, Brasilia, DF, Brazil; [Vasquez, Pablo A. S.] Ctr Tecnol Radiacoes, Inst Pesquisas Energet & Nucl, Butanta, SP, Brazil; [Colaco, Rogerio] Univ Lisbon, Inst Super Tecn, Dept Engn Mecan, Lisbon, Portugal; [Colaco, Rogerio] Univ Lisbon, Inst Super Tecn, IDMEC, Lisbon, Portugal; [Serro, Ana Paula] Ctr Invest Interdisciplinar Egas Moniz, Inst Super Ciencias Saude Egas Moniz, Monte De Caparica, Caparica, Portugal	Universidade de Sao Paulo; Universidade de Lisboa; Instituto Superior Tecnico; Comissao Nacional de Energia Nuclear (CNEN); Instituto de Pesquisas Energeticas e Nucleares (IPEN); Universidade de Lisboa; Instituto Superior Tecnico; Universidade de Lisboa; Instituto Superior Tecnico; Instituto Superior de Ciencias da Saude Egas Moniz	Serro, AP (corresponding author), Univ Lisbon, Inst Super Tecn, Ctr Quim Estrutural, Lisbon, Portugal.; Serro, AP (corresponding author), Ctr Invest Interdisciplinar Egas Moniz, Inst Super Ciencias Saude Egas Moniz, Monte De Caparica, Caparica, Portugal.	anapaula.serro@tecnico.ulisboa.pt	Kikuchi, Irene S./A-4863-2013; de Jesus Andreoli Pinto, Terezinha/AAR-2389-2020; GALANTE, RAQUEL S.C./K-2512-2014; Vasquez, Pablo/C-3862-2016; Pinto, Terezinha JA/C-4777-2012; Serro, Ana/H-7797-2012; Colaco, Rogerio/B-5432-2013	Kikuchi, Irene S./0000-0002-5223-1308; de Jesus Andreoli Pinto, Terezinha/0000-0002-0238-8227; GALANTE, RAQUEL S.C./0000-0001-8616-4775; Vasquez, Pablo/0000-0003-4168-1626; Colaco, Rogerio/0000-0002-5529-1621; Serro, Ana/0000-0002-6179-9296; Colaco, Rogerio/0000-0001-7374-6741	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico [140863/2014, 400455/2014-5]; projects M-ERA; Fundacao para a Ciencia e Tecnologia [NET/0005/2012, PTDC/CTM-BIO/3640/2014]	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); projects M-ERA; Fundacao para a Ciencia e Tecnologia(Portuguese Foundation for Science and TechnologyEuropean Commission)	This study was supported by PhD grant 140863/2014 and project 400455/2014-5, Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (http://cnpq.br/) and projects M-ERA. NET/0005/2012 and PTDC/CTM-BIO/3640/2014, Fundacao para a Ciencia e Tecnologia (http://www.fct.pt/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdel-Hafez SM, 2014, INT J BIOL MACROMOL, V64, P334, DOI 10.1016/j.ijbiomac.2013.11.041; Audenaert WTM, 2010, CHEM ENG J, V157, P551, DOI 10.1016/j.cej.2009.12.051; Azadi A, 2015, INT J BIOL MACROMOL, V79, P326, DOI 10.1016/j.ijbiomac.2015.05.001; Brink B, 1991, OZONE WATER TREATMEN; Calvo P, 1997, J APPL POLYM SCI, V63, P125, DOI 10.1002/(SICI)1097-4628(19970103)63:1<125::AID-APP13>3.0.CO;2-4; Cataldo F, 2007, INT J BIOL MACROMOL, V41, P210, DOI 10.1016/j.ijbiomac.2007.02.008; De Campos AM, 2001, INT J PHARMACEUT, V224, P54, DOI 10.1016/j.msec.2012.12.066; Dick HB, 2000, ASEPTIC PRODUCTION V, P97; Dufresne S., 2004, AM J INFECT CONTROL, V32, pE26, DOI [10.1016/j.ajic.2004.04.038, DOI 10.1016/J.AJIC.2004.04.038]; Dufresne S, 2008, AM J INFECT CONTROL, V36, P291, DOI 10.1016/j.ajic.2007.06.006; Franca A, 2010, SMALL, V6, P89, DOI 10.1002/smll.200901006; Gao PS, 2013, CARBOHYD POLYM, V95, P371, DOI 10.1016/j.carbpol.2013.03.029; Hamidi M, 2008, ADV DRUG DELIVER REV, V60, P1638, DOI 10.1016/j.addr.2008.08.002; Hassani S, 2015, COLLOID SURFACE A, V482, P34, DOI 10.1016/j.colsurfa.2015.04.006; HEUSINGER H, 1987, Z LEBENSM UNTERS FOR, V185, P106, DOI 10.1007/BF01850087; HOIGNE J, 1985, WATER RES, V19, P993, DOI 10.1016/0043-1354(85)90368-9; Honary S, 2013, TROP J PHARM RES, V12, P265, DOI 10.4314/tjpr.v12i2.20; Jarry C, 2002, CHEM PHARM B TOKYO, V50; Jayakumar R, 2010, CARBOHYD POLYM, V82, P227, DOI 10.1016/j.carbpol.2010.04.074; Jiang YJ, 2014, BIOMATERIALS, V35, P4969, DOI 10.1016/j.biomaterials.2014.03.001; Jing ZW, 2016, BIOMATERIALS, V84, P276, DOI 10.1016/j.biomaterials.2016.01.045; Kanatt SR, 2008, FOOD CHEM, V106, P521, DOI 10.1016/j.foodchem.2007.06.036; Karajanagi SS, 2011, BIOTECHNOL BIOENG, V108, P1716, DOI 10.1002/bit.23105; Kean T, 2010, ADV DRUG DELIVER REV, V62, P3, DOI 10.1016/j.addr.2009.09.004; Killeen S., 2012, SURGERY OXFORD, V30, P687; Kitazaki S, 2014, VACUUM, V110, P217, DOI 10.1016/j.vacuum.2014.06.014; Laverty G, 2012, CHARACTERISTICS TREA, V51, P79; Lerouge S, 2012, WOODH PUBL SER BIOM, V46, P1; Li J, 2012, CARBOHYD POLYM, V87, P1670, DOI 10.1016/j.carbpol.2011.09.074; Loncar B, 2009, ARCH MED RES, V40, P136, DOI 10.1016/j.arcmed.2008.11.002; Mata-Alvarez J., BIOMETHANIZATION ORG, V4, DOI [10.2166/9781780402994, DOI 10.2166/9781780402994]; Morris GA, 2011, CARBOHYD POLYM, V84, P1430, DOI 10.1016/j.carbpol.2011.01.044; O'Donnell C, 2012, STATUS TRENDS OZONE, P1; Pharmacopeia US, 2016, USP39NF34, P167; Pharmacopeia US, 2016, USP39NF34, P136; Pharmacopeia US, 2016, USP 39 NF 34, P589; PHILLIPS GO, 1963, J CHEM SOC, P297, DOI 10.1039/jr9630000297; Rediguieri C., 2016, TISSUE ENG C; Rogers WJ, 2012, WOODH PUBL SER BIOM, V46, P151; Rogers W.J., 2012, STERILISATION BIOMAT, P352; Rutala WA, 2008, GUIDELINE DISINFECTI, P69; Sarkar SD, 2013, MAT SCI ENG C-MATER, V33, P1446, DOI 10.1016/j.msec.2012.12.066; Serro AP, 2003, BIOMATERIALS, V24, P4749, DOI 10.1016/S0142-9612(03)00372-7; Silva CLM, ETHYLENE OXIDE EO ST; Sipoli CC, 2015, BIOCHEM ENG J, V94, P65, DOI 10.1016/j.bej.2014.11.008; Talbot P, 2012, WATER RES, V46, P5893, DOI 10.1016/j.watres.2012.07.052; U. S. Environmental Protection Agency (US EPA), 1999, GUID MAN ALT DIS OX, P1; Uzun H, 2012, FOOD CHEM, V134, P647, DOI 10.1016/j.foodchem.2012.02.146; Vetten MA, 2014, NANOMED-NANOTECHNOL, V10, P1391, DOI 10.1016/j.nano.2014.03.017; Vimal S, 2014, AQUACULTURE, V420, P240, DOI 10.1016/j.aquaculture.2013.11.017; Vimal S, 2013, ACTA TROP, V128, P486, DOI 10.1016/j.actatropica.2013.07.013; Xu YM, 2003, INT J PHARMACEUT, V250, P215, DOI 10.1016/S0378-5173(02)00548-3	52	25	26	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2016	11	12							e0168862	10.1371/journal.pone.0168862	http://dx.doi.org/10.1371/journal.pone.0168862			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI9TW	28002493	Green Published, Green Submitted, gold			2022-12-27	WOS:000392853100072
J	Huang, WC; Chen, HL; Chen, HY; Peng, KP; Lee, Y; Huang, LM; Chang, LY; Liu, FT				Huang, Wen-Chan; Chen, Hung-Lin; Chen, Huan-Yuan; Peng, Kuan-Po; Lee, Yungling; Huang, Li-Min; Chang, Luan-Yin; Liu, Fu-Tong			Galectin-3 and Its Genetic Variation rs4644 Modulate Enterovirus 71 Infection	PLOS ONE			English	Article							CLINICAL-FEATURES; ADIPOSE-TISSUE; MOUTH-DISEASE; ASSOCIATION; CHILDREN; SUSCEPTIBILITY; POLYMORPHISM; EXPRESSION; THERAPY; TAIWAN	Galectin-3, a chimeric type P-galactoside-binding protein, is known to modulate viral infection; however, its role in enterovirus 71 (EV71) infection has not been investigated. We generated galectin-3 null rhabdomyosarcoma (RD) cells and evaluated whether EV71 infection would be affected. In galectin-3 null cells, the released and intracellular EV71 viral loads were suppressed after 24 h of infection, and cell death rates were significantly lower, while cell proliferation remained unaltered. In addition, RD cells expressing a nonsynonymous genetic variant of galectin-3, rs4644 (LGALS3 +191C/A, P64H), produced lower virus titers than those with wild-type galectin-3 (C allele). To clarify whether the in vitro viral load reduction correlates with clinical severity, we enrolled children with laboratory-confirmed EV71 infection. Since hyperglycemia is an indicator of severe EV71 infection in children, 152 of 401 enrolled children had glucose examinations at admission, and 59 subjects had serum glucose levels >= 150 mg/dL. In comparison to the rs4644 AA genotype (2.2 +/- 0.06 log(10) mg/dL), serum glucose levels during EV71 infection were higher in patients with CC (2.4 +/- 0.17 log(10) mg/dL, p = 0.03) and CA (2.4 +/- 0.15 log(10) mg/dL, p = 0.02) genotypes, respectively. These findings suggest that the rs4644 AA genotype of galectin-3 might exert a protective effect. In summary, galectin-3 affects EV71 replication in our cellular model and its variant, rs4644, is associated with hyperglycemia in the clinical setting. The underlying mechanism and its potential therapeutic application warrant further investigation.	[Huang, Wen-Chan; Chen, Hung-Lin; Chen, Huan-Yuan; Lee, Yungling; Liu, Fu-Tong] Acad Sinica, Inst Biomed Sci, Taipei, Taiwan; [Huang, Wen-Chan; Huang, Li-Min; Chang, Luan-Yin] Natl Taiwan Univ, Dept Pediat, Natl Taiwan Univ Hosp, Taipei, Taiwan; [Huang, Wen-Chan; Huang, Li-Min; Chang, Luan-Yin] Natl Taiwan Univ, Coll Med, Taipei, Taiwan; [Huang, Wen-Chan] Natl Taiwan Univ, PhD Program Translat Med, Taipei, Taiwan; [Huang, Wen-Chan] Acad Sinica, Taipei, Taiwan; [Peng, Kuan-Po] Natl Yang Ming Univ, Sch Med, Taipei, Taiwan; [Lee, Yungling] Natl Taiwan Univ, Inst Epidemiol & Prevent Med, Taipei, Taiwan; [Liu, Fu-Tong] Univ Calif Davis, Dept Dermatol, Sacramento, CA 95817 USA	Academia Sinica - Taiwan; National Taiwan University; National Taiwan University Hospital; National Taiwan University; National Taiwan University; Academia Sinica - Taiwan; National Yang Ming Chiao Tung University; National Taiwan University; University of California System; University of California Davis	Liu, FT (corresponding author), Acad Sinica, Inst Biomed Sci, Taipei, Taiwan.; Chang, LY (corresponding author), Natl Taiwan Univ, Dept Pediat, Natl Taiwan Univ Hosp, Taipei, Taiwan.; Chang, LY (corresponding author), Natl Taiwan Univ, Coll Med, Taipei, Taiwan.; Liu, FT (corresponding author), Univ Calif Davis, Dept Dermatol, Sacramento, CA 95817 USA.	lychang@ntu.edu.tw; ftliu@ibms.sinica.edu.tw	Liu, FU-TONG/A-5749-2019; Lee, Yungling/S-7011-2018; Peng, Kuan-Po/V-3773-2018	Liu, FU-TONG/0000-0002-3354-1001; Lee, Yungling/0000-0002-2234-9479; Peng, Kuan-Po/0000-0002-2718-3738; HUANG, LI-MIN/0000-0002-9291-260X; CHANG, LUAN-YIN/0000-0003-2632-1956	National Science Council of Taiwan [NSC 101-2321-B-002-004]	National Science Council of Taiwan(Ministry of Science and Technology, Taiwan)	This study was supported in part by grants from National Science Council of Taiwan (NSC 101-2321-B-002-004). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. There was no additional external funding received for this study.	Altshuler D, 2005, NATURE, V437, P1299, DOI 10.1038/nature04226; Baek JH, 2015, ENDOCRINOLOGY, V156, P147, DOI 10.1210/en.2014-1374; Balan V, 2008, CANCER RES, V68, P10045, DOI 10.1158/0008-5472.CAN-08-3224; Bieche I, 2005, VIROLOGY, V332, P130, DOI 10.1016/j.virol.2004.11.009; Branco RG, 2007, PEDIATR CRIT CARE ME, V8, P546, DOI 10.1097/01.PCC.0000288712.67749.45; Chang LY, 2008, PEDIATRICS, V122, P1271, DOI 10.1542/peds.2007-3735; Chang LY, 2004, JAMA-J AM MED ASSOC, V291, P222, DOI 10.1001/jama.291.2.222; Chang LY, 1999, LANCET, V354, P1682, DOI 10.1016/S0140-6736(99)04434-7; Chen HY, 2014, CURR OPIN MICROBIOL, V17, P75, DOI 10.1016/j.mib.2013.11.006; Cheng HY, 2014, BMC INFECT DIS, V14, DOI 10.1186/1471-2334-14-417; Cheng ML, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113234; Cong H, 2016, J VIROL; De La Vega FA, 2005, MUTAT RES-FUND MOL M, V573, P111, DOI 10.1016/j.mrfmmm.2005.01.008; Doyle EL, 2012, NUCLEIC ACIDS RES, V40, pW117, DOI 10.1093/nar/gks608; Fukumori T, 2006, CANCER RES, V66, P3114, DOI 10.1158/0008-5472.CAN-05-3750; Ho HY, 2008, J GEN VIROL, V89, P2080, DOI 10.1099/vir.0.2008/001404-0; Hsia SH, 2005, PEDIATR INFECT DIS J, V24, P331, DOI 10.1097/01.inf.0000157219.19674.98; Hsu DK, 1999, INT J CANCER, V81, P519, DOI 10.1002/(SICI)1097-0215(19990517)81:4<519::AID-IJC3>3.3.CO;2-S; Hsu DK, 2002, GLYCOCONJUGATE J, V19, P507, DOI 10.1023/B:GLYC.0000014080.95829.52; Huang WC, 2014, J MICROBIOL IMMUNOL; Huang WC, 2013, VIROL J, V10, DOI 10.1186/1743-422X-10-209; Huang WC, 2012, J MICROBIOL IMMUNOL, V45, P96, DOI 10.1016/j.jmii.2011.09.025; Iacobini C, 2011, J HEPATOL, V54, P975, DOI 10.1016/j.jhep.2010.09.020; Kassab S, 2013, EMERG INFECT DIS, V19, P1345, DOI [10.3201/eid1907.130202, 10.3201/eid1908.130202]; Kiwaki K, 2007, OBESITY, V15, P32, DOI 10.1038/oby.2007.526; Lin TY, 2002, CLIN INFECT DIS, V34, pS52, DOI 10.1086/338819; Lu J, 2011, WORLD J GASTROENTERO, V17, P4135, DOI 10.3748/wjg.v17.i36.4135; Lv TG, 2013, INFLAMMATION, V36, P977, DOI 10.1007/s10753-013-9629-8; Manolio TA, 2009, ANNU REV MED, V60, P443, DOI 10.1146/annurev.med.60.061907.093117; Shen GQ, 2009, METHODS MOL BIOL, V578, P293, DOI 10.1007/978-1-60327-411-1_19; Soepandi PZ, 2010, CHEST, V138, P665, DOI 10.1378/chest.09-2644; Trompet S, 2012, NEUROBIOL AGING, V33, DOI 10.1016/j.neurobiolaging.2012.05.001; Wang SF, 2014, GLYCOBIOLOGY, V24, P1022, DOI 10.1093/glycob/cwu064; Willson DF, 2003, J PEDIATR-US, V143, pS142, DOI 10.1067/S0022-3476(03)00514-6; Yang J, 2012, SCAND J INFECT DIS, V44, P465, DOI 10.3109/00365548.2011.649490; Yang RY, 1996, P NATL ACAD SCI USA, V93, P6737, DOI 10.1073/pnas.93.13.6737; Yu F, 2002, J BIOL CHEM, V277, P15819, DOI 10.1074/jbc.M200154200; Zou RR, 2015, SCI REP-UK, V5, DOI 10.1038/srep18541	38	7	7	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2016	11	12							e0168627	10.1371/journal.pone.0168627	http://dx.doi.org/10.1371/journal.pone.0168627			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI9TW	28002441	Green Published, gold, Green Submitted			2022-12-27	WOS:000392853100059
J	Komnik, I; Peters, M; Funken, J; David, S; Weiss, S; Potthast, W				Komnik, Igor; Peters, Markus; Funken, Johannes; David, Sina; Weiss, Stefan; Potthast, Wolfgang			Non-Sagittal Knee Joint Kinematics and Kinetics during Gait on Level and Sloped Grounds with Unicompartmental and Total Knee Arthroplasty Patients	PLOS ONE			English	Article							ANTERIOR CRUCIATE LIGAMENT; FIXED BEARING; REPLACEMENT; WALKING; BIOMECHANICS; ROTATION; DIFFERENCE; DYNAMICS; OUTCOMES; PATTERN	After knee arthroplasty (KA) surgery, patients experience abnormal kinematics and kinetics during numerous activities of daily living. Biomechanical investigations have focused primarily on level walking, whereas walking on sloped surfaces, which is stated to affect knee kinematics and kinetics considerably, has been neglected to this day. This study aimed to analyze over-ground walking on level and sloped surfaces with a special focus on transverse and frontal plane knee kinematics and kinetics in patients with KA. A three-dimensional (3D) motion analysis was performed by means of optoelectronic stereophogrammetry 1.8 +/- 0.4 years following total knee arthroplasty (TKA) and unicompartmental arthroplasty surgery (UKA). AnyBody (TM) Modeling System was used to conduct inverse dynamics. The TKA group negotiated the decline walking task with reduced peak knee internal rotation angles compared with a healthy control group (CG). First-peak knee adduction moments were diminished by 27% (TKA group) and 22% (UKA group) compared with the CG during decline walking. No significant differences were detected between the TKA and UKA groups, regardless of the locomotion task. Decline walking exposed apparently more abnormal knee frontal and transverse plane adjustments in KA patients than level walking compared with the CG. Hence, walking on sloped surfaces should be included in further motion analysis studies investigating KA patients in order to detect potential deficits that might be not obvious during level walking.	[Komnik, Igor; Peters, Markus; Funken, Johannes; David, Sina; Potthast, Wolfgang] German Sport Univ Cologne, Inst Biomech & Orthopaed, Cologne, Nordrhein Westf, Germany; [Weiss, Stefan] ARCUS Clin Pforzheim, Pforzheim, Baden Wurttembe, Germany	German Sport University Cologne	Komnik, I (corresponding author), German Sport Univ Cologne, Inst Biomech & Orthopaed, Cologne, Nordrhein Westf, Germany.	i.komnik@dshs-koeln.de	Funken, Johannes/AAR-8238-2020	Funken, Johannes/0000-0002-0093-8686; David, Sina/0000-0002-9741-7202	ARCUS Clinics Pforzheim; graduate college of the German Sport University; "Verein fur Wissenschaft and Weiterbildung in der Orthopadie e.V." (English: "Science and Advanced Training Society in the field of orthopedics")	ARCUS Clinics Pforzheim; graduate college of the German Sport University; "Verein fur Wissenschaft and Weiterbildung in der Orthopadie e.V." (English: "Science and Advanced Training Society in the field of orthopedics")	The study was supported by ARCUS Clinics Pforzheim. All knee arthroplasty subjects, who participated in the current study, were operated in the mentioned institution. ARCUS Clinics Pforzheim provided support in the form of salary for the author SW, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of SW are articulated in the "author contributions" section. The graduate college of the German Sport University funded the PhD studies for the corresponding author IK in the form of salary (http://www.dshskoeln.de/visitenkarte/einrichtung/graduiertenkolleg-mechanobiologie/). The funder did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. "Verein fur Wissenschaft and Weiterbildung in der Orthopadie e.V." (English: "Science and Advanced Training Society in the field of orthopedics") funded the knee arthroplasty subject's accommodation and travel costs to Cologne (http://www.sportklinik.de/wissepschaft_publikation/). The funder did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALBREKTSSON BEJ, 1990, J BONE JOINT SURG BR, V72, P252, DOI 10.1302/0301-620X.72B2.2312565; Amin S, 2004, ARTHRIT RHEUM-ARTHR, V51, P371, DOI 10.1002/art.20396; ANDRIACCHI TP, 1982, J BONE JOINT SURG AM, V64, P1328, DOI 10.2106/00004623-198264090-00008; Argenson JNA, 2002, J ARTHROPLASTY, V17, P1049, DOI 10.1054/arth.2002.34527; Astephen JL, 2008, J BIOMECH, V41, P868, DOI 10.1016/j.jbiomech.2007.10.016; Astephen JL, 2005, CLIN BIOMECH, V20, P209, DOI 10.1016/j.clinbiomech.2004.09.007; Benedetti MG, 2003, CLIN BIOMECH, V18, P871, DOI 10.1016/S0268-0033(03)00146-3; Capella M, 2016, ANN TRANSL MED, V4, DOI 10.21037/atm.2015.12.64; CLIFT SE, 1989, BIOMATERIALS, V10, P329, DOI 10.1016/0142-9612(89)90074-4; Cohen J.E., 1988, STAT POWER ANAL BEHA; Collier MB, 2007, J BONE JOINT SURG AM, V89A, P1306, DOI 10.2106/JBJS.F.00667; Della Croce U, 2005, GAIT POSTURE, V21, P226, DOI 10.1016/j.gaitpost.2004.05.003; Fisher N, 2006, KNEE, V13, P296, DOI 10.1016/j.knee.2006.03.004; Franz JR, 2014, GAIT POSTURE, V39, P135, DOI 10.1016/j.gaitpost.2013.06.012; Fraser JF, 2015, J KNEE SURG, V28, P139, DOI 10.1055/s-0034-1398375; Fritz CO, 2012, J EXP PSYCHOL GEN, V141, P2, DOI 10.1037/a0024338; Hassaballa MA, 2007, MED SCI MONITOR, V13, pCR77; Huang Chun-Hsiung, 2007, J Orthop Surg Res, V2, P1, DOI 10.1186/1749-799X-2-1; Hunt NC, 2015, BONE JOINT J, V97B, P642, DOI 10.1302/0301-620X.97B5.34999; Hurst JM, 2014, CLIN SPORT MED, V33, P105, DOI 10.1016/j.csm.2013.06.004; Jiang C, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0147865; Jones GG, 2016, BONE JOINT J, V98B, P16, DOI 10.1302/0301-620X.98B10.BJJ.2016.0473.R1; Jung MC, 2014, KNEE SURG SPORT TR A, V22, P1879, DOI 10.1007/s00167-014-3064-8; Kellis E, 1998, SPORTS MED, V25, P37, DOI 10.2165/00007256-199825010-00004; Komnik I, 2015, GAIT POSTURE, V41, P370, DOI 10.1016/j.gaitpost.2015.01.019; KRAEMER WJ, 1995, J ARTHROPLASTY, V10, P227, DOI 10.1016/S0883-5403(05)80132-9; KUSTER M, 1995, CLIN BIOMECH, V10, P79, DOI 10.1016/0268-0033(95)92043-L; Lay AN, 2006, J BIOMECH, V39, P1621, DOI 10.1016/j.jbiomech.2005.05.005; Leffler J, 2012, GAIT POSTURE, V36, P454, DOI 10.1016/j.gaitpost.2012.04.008; Li MG, 2006, KNEE, V13, P365, DOI 10.1016/j.knee.2006.05.003; Lombardi AV, 2014, BONE JOINT J, V96B, P101, DOI 10.1302/0301-620X.96B11.34350; Lund M.E., 2015, INT BIOMECH, V2, P1, DOI [10.1080/23335432.2014.993706, DOI 10.1080/23335432.2014.993706]; MacWilliams BA, 1999, J ORTHOPAED RES, V17, P817, DOI 10.1002/jor.1100170605; McClelland JA, 2007, KNEE, V14, P253, DOI 10.1016/j.knee.2007.04.003; McClelland JA, 2011, KNEE, V18, P151, DOI 10.1016/j.knee.2010.04.005; McIntosh AS, 2006, J BIOMECH, V39, P2491, DOI 10.1016/j.jbiomech.2005.07.025; Milner CE, 2009, J ORTHOP SCI, V14, P114, DOI 10.1007/s00776-008-1285-8; Miyazaki T, 2002, ANN RHEUM DIS, V61, P617, DOI 10.1136/ard.61.7.617; Pandit H, 2008, KNEE, V15, P101, DOI 10.1016/j.knee.2007.11.008; Papagiannis GI, 2016, J ARTHROPLASTY; Patil S, 2005, J BONE JOINT SURG AM, V87A, P332, DOI 10.2106/JBJS.C.01467; PENNOCK GR, 1990, J BIOMECH, V23, P1209, DOI 10.1016/0021-9290(90)90378-G; Redfern MS, 2001, ERGONOMICS, V44, P1138, DOI 10.1080/00140130110085547; Riddle DL, 2008, J ARTHROPLASTY, V23, P408, DOI 10.1016/j.arth.2007.04.012; Schroder C, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/185142; Schroer WC, 2013, J ARTHROPLASTY, V28, P116, DOI 10.1016/j.arth.2013.04.056; Shabani B, 2015, KNEE SURG SPORT TR A, V23, P3259, DOI 10.1007/s00167-014-3169-0; Shakespeare D, 2003, KNEE, V10, P357, DOI 10.1016/S0968-0160(03)00046-2; Standifird TW, 2014, J ARTHROPLASTY, V29, P1857, DOI 10.1016/j.arth.2014.03.040; Takeda K, 2014, J BIOMECH, V47, P2526, DOI 10.1016/j.jbiomech.2014.03.027; Urwin SG, 2014, KNEE, V21, P391, DOI 10.1016/j.knee.2013.10.007; Verra WC, 2015, ACTA ORTHOP, V86, P195, DOI 10.3109/17453674.2014.973329; WASIELEWSKI RC, 1994, CLIN ORTHOP RELAT R, P31; Watanabe T, 2014, J ORTHOP SCI, V19, P552, DOI 10.1007/s00776-014-0578-3; Willis-Owen CA, 2009, KNEE, V16, P473, DOI 10.1016/j.knee.2009.04.006; Winter DA, 2009, BIOMECHANICS MOTOR C, Vxiv, P370; Worsley P, 2013, CLIN BIOMECH, V28, P892, DOI 10.1016/j.clinbiomech.2013.07.014; Wu JL, 2010, AM J SPORT MED, V38, P1475, DOI 10.1177/0363546510364240; Wunschel M, 2011, BMC MUSCULOSKEL DIS, V12, DOI 10.1186/1471-2474-12-29; Zurcher AW, 2014, KNEE, V21, P960, DOI 10.1016/j.knee.2014.05.007	60	13	14	2	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2016	11	12							e0168566	10.1371/journal.pone.0168566	http://dx.doi.org/10.1371/journal.pone.0168566			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI9TW	28002437	Green Published, gold, Green Submitted			2022-12-27	WOS:000392853100055
J	Shin, HJ; Kim, MJ; Kim, HY; Roh, YH; Lee, MJ				Shin, Hyun Joo; Kim, Myung-Joon; Kim, Ha Yan; Roh, Yun Ho; Lee, Mi-Jung			Optimal Acquisition Number for Hepatic Shear Wave Velocity Measurements in Children	PLOS ONE			English	Article							RADIATION FORCE IMPULSE; LIVER FIBROSIS; ULTRASOUND ELASTOGRAPHY; TRANSIENT ELASTOGRAPHY; SPLEEN STIFFNESS; REPRODUCIBILITY; REPEATABILITY; ELASTICITY; ACCURACY; TIMES	Objective To investigate the minimum optimal acquisition number of hepatic shear wave velocities (SWVs) on ultrasound elastography in children. Materials and Methods We prospectively performed hepatic supersonic shear wave elastography in children of four groups (group A-C, healthy children, group A with 0-5 years old; group B with 6-10 years old; group C with 11-18 years old; and group D, children with previous Kasai operation) with free breathing (FB) and breath holding (BH) status, if possible. SWVs were measured fifteen times for each child at a 4 cm depth for the right lobe using a 1-6 MHz convex transducer. Mean SWVs from three, five, and seven acquisitions were compared to the mean SWV from fifteen measurements, using an intraclass correlation coefficient (ICC) analyzed with the 1,000 times bootstrap method. Results Total eighty-eight children were included (25 children in group A, 30 children in group B, 21 children in group C, and 12 children in group D). The mean SWVs from fifteen measurements in FB status were 5.5-1.3 kPa for groups A-C together and 8.0 +/- 2.2 kPa for group D. For all groups together, mean SWVs from the three (ICC 0.944 and 0.937), five (ICC 0.958 and 0.938) and seven (ICC 0.969 and 0.941) acquisitions demonstrated almost perfect agreement with the reference of fifteen acquisitions in both FB and BH status, respectively. A subgroup analysis showed three measurements were in almost perfect agreement during FB for groups B-D and strong agreement (ICC 0.675) for group A. Conclusion Three acquisitions can be enough for hepatic SWVs in children more than 6 years old regardless of breathing status or hepatic pathology. More acquisitions are recommended for children under the age of 5 years during FB.	[Shin, Hyun Joo; Kim, Myung-Joon; Lee, Mi-Jung] Severance Childrens Hosp, Dept Radiol, Seoul, South Korea; [Shin, Hyun Joo; Kim, Myung-Joon; Lee, Mi-Jung] Severance Childrens Hosp, Res Inst Radiol Sci, Seoul, South Korea; [Kim, Ha Yan; Roh, Yun Ho] Yonsei Univ, Coll Med, Biostat Collaborat Unit, Seoul, South Korea	Yonsei University; Yonsei University Health System	Lee, MJ (corresponding author), Severance Childrens Hosp, Dept Radiol, Seoul, South Korea.; Lee, MJ (corresponding author), Severance Childrens Hosp, Res Inst Radiol Sci, Seoul, South Korea.	mjl1213@yuhs.ac	Shin, Hyun Joo/AAG-2016-2019	Shin, Hyun Joo/0000-0002-7462-2609; Kim, Myung-Joon/0000-0002-4608-0275; Lee, Mi-Jung/0000-0003-3244-9171				Barr RG, 2015, RADIOLOGY, V276, P845, DOI 10.1148/radiol.2015150619; Cha SW, 2014, J ULTRAS MED, V33, P53, DOI 10.7863/ultra.33.1.53; Choi SH, 2016, ULTRASONICS, V72, P158, DOI 10.1016/j.ultras.2016.08.005; Dillman JR, 2015, PEDIATR RADIOL, V45, P376, DOI 10.1007/s00247-014-3150-6; Ferraioli G, 2015, ULTRASOUND MED BIOL, V41, P1161, DOI 10.1016/j.ultrasmedbio.2015.03.007; Ferraioli G, 2014, EUR RADIOL, V24, P1283, DOI 10.1007/s00330-014-3140-y; Ferraioli G, 2012, HEPATOLOGY, V56, P2125, DOI 10.1002/hep.25936; Ferraioli G, 2012, EUR J RADIOL, V81, P3102, DOI 10.1016/j.ejrad.2012.05.030; Fontanilla T, 2014, ULTRASOUND MED BIOL, V40, P470, DOI 10.1016/j.ultrasmedbio.2013.10.024; Friedrich-Rust M, 2009, RADIOLOGY, V252, P595, DOI 10.1148/radiol.2523081928; Gennisson J-L, 2013, Diagn Interv Imaging, V94, P487, DOI 10.1016/j.diii.2013.01.022; Huang ZP, 2014, WORLD J GASTROENTERO, V20, P9578, DOI 10.3748/wjg.v20.i28.9578; Lee MJ, 2013, EUR J RADIOL, V82, pE290, DOI 10.1016/j.ejrad.2013.01.018; Park MK, 2014, ULTRASONOGRAPHY, V33, P26, DOI 10.14366/usg.13017; PICCININO F, 1986, J HEPATOL, V2, P165, DOI 10.1016/S0168-8278(86)80075-7; Pinto RB, 2015, WORLD J HEPATOL, V7, P392, DOI 10.4254/wjh.v7.i3.392; Rizzo L, 2011, AM J GASTROENTEROL, V106, P2112, DOI 10.1038/ajg.2011.341; Sohn B, 2014, ULTRASONOGRAPHY, V33, P116, DOI 10.14366/usg.14002; Sporea I, 2013, MED ULTRASON, V15, P268; Zaleska-Dorobisz U, 2014, ADV CLIN EXP MED, V23, P645, DOI 10.17219/acem/26301; Zeng J, 2014, EUR RADIOL, V24, P2572, DOI 10.1007/s00330-014-3292-9	21	21	22	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2016	11	12							e0168758	10.1371/journal.pone.0168758	http://dx.doi.org/10.1371/journal.pone.0168758			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI9TW	28002480	Green Submitted, gold, Green Published			2022-12-27	WOS:000392853100064
J	Krajicek, J; Havlikova, M; Bursova, M; Ston, M; Cabala, R; Exnerova, A; Stys, P; Bosakova, Z				Krajicek, Jan; Havlikova, Martina; Bursova, Miroslava; Ston, Martin; Cabala, Radomir; Exnerova, Alice; Stys, Pavel; Bosakova, Zuzana			Comparative Analysis of Volatile Defensive Secretions of Three Species of Pyrrhocoridae (Insecta: Heteroptera) by Gas Chromatography-Mass Spectrometric Method	PLOS ONE			English	Article							DORSAL ABDOMINAL GLANDS; ALARM PHEROMONE SYSTEM; STINK BUG; SEX-PHEROMONE; SCENT-GLANDS; CHEMISTRY; HEMIPTERA; NYMPHS; ADULTS; APTERUS	The true bugs (Hemiptera: Heteroptera) have evolved a system of well-developed scent glands that produce diverse and frequently strongly odorous compounds that act mainly as chemical protection against predators. A new method of non-lethal sampling with subsequent separation using gas chromatography with mass spectrometric detection was proposed for analysis of these volatile defensive secretions. Separation was performed on Rtx-200 column containing fluorinated polysiloxane stationary phase. Various mechanical irritation methods (ultrasonics, shaking, pressing bugs with plunger of syringe) were tested for secretion sampling with a special focus on non-lethal irritation. The preconcentration step was performed by sorption on solid phase microextraction (SPME) fibers with different polarity. For optimization of sampling procedure, Pyrrhocoris apterus was selected. The entire multi-parameter optimization procedure of secretion sampling was performed using response surface methodology. The irritation of bugs by pressing them with a plunger of syringe was shown to be the most suitable. The developed method was applied to analysis of secretions produced by adult males and females of Pyrrhocoris apterus, Pyrrhocoris tibialis and Scantius aegyptius (all Heteroptera: Pyrrhocoridae). The chemical composition of secretion, particularly that of alcohols, aldehydes and esters, is species-specific in all three pyrrhocorid species studied. The sexual dimorphism in occurrence of particular compounds is largely limited to alcohols and suggests their epigamic intraspecific function. The phenetic overall similarities in composition of secretion do not reflect either relationship of species or similarities in antipredatory color pattern. The similarities of secretions may be linked with antipredatory strategies. The proposed method requires only a few individuals which remain alive after the procedure. Thus secretions of a number of species including even the rare ones can be analyzed and broadly conceived comparative studies can be carried out.	[Krajicek, Jan; Havlikova, Martina; Bursova, Miroslava; Ston, Martin; Cabala, Radomir; Bosakova, Zuzana] Charles Univ Prague, Dept Analyt Chem, Fac Sci, Prague, Czech Republic; [Bursova, Miroslava; Cabala, Radomir] Gen Univ Hosp Prague, Inst Forens Med & Toxicol, Dept Toxicol, Prague, Czech Republic; [Exnerova, Alice; Stys, Pavel] Charles Univ Prague, Dept Zool, Fac Sci, Prague, Czech Republic	Charles University Prague; General University Hospital Prague; Charles University Prague	Bosakova, Z (corresponding author), Charles Univ Prague, Dept Analyt Chem, Fac Sci, Prague, Czech Republic.; Stys, P (corresponding author), Charles Univ Prague, Dept Zool, Fac Sci, Prague, Czech Republic.	pavelstys@gmail.com; bosakova@natur.cuni.cz	Bosáková, Zuzana/M-4364-2017; Čabala, Radomír/G-6105-2016; Havlíková, Martina/S-8532-2017; Bursová, Miroslava/V-3248-2017	Bosáková, Zuzana/0000-0002-8483-5739; Čabala, Radomír/0000-0001-7022-1317; Havlíková, Martina/0000-0002-3551-957X; Bursová, Miroslava/0000-0001-8822-898X	Czech Science Foundation [P505/11/1459]; Grant Agency of Charles University in Prague [760216]	Czech Science Foundation(Grant Agency of the Czech Republic); Grant Agency of Charles University in Prague	This work was supported by: Czech Science Foundation - P505/11/1459, awarded to AE (http//www.gacr.cz/en/); Grant Agency of Charles University in Prague 760216, awarded to MH; Grant Agency of Charles University in Prague SW, awarded to MH.	Aldrich Jeffrey R., 1997, Anais da Sociedade Entomologica do Brasil, V26, P1, DOI 10.1590/S0301-80591997000100001; ALDRICH JR, 1993, Z NATURFORSCH C, V48, P73; ALDRICH JR, 1979, J CHEM ECOL, V5, P53, DOI 10.1007/BF00987687; ALDRICH JR, 1988, ANNU REV ENTOMOL, V33, P211, DOI 10.1146/annurev.en.33.010188.001235; [Anonymous], 1981, CHEM DEFENSES ARTHRO; Balogh ACV, 2008, ANIM BEHAV, V76, P1591, DOI 10.1016/j.anbehav.2008.07.017; Blatt SE, 1998, J CHEM ECOL, V24, P1013, DOI 10.1023/A:1022350402535; Blum M.S., 1985, P193; Byers JA, 2006, J CHEM ECOL, V32, P2205, DOI 10.1007/s10886-006-9140-x; Cheng L, 1998, MAR ECOL PROG SER, V170, P283, DOI 10.3354/meps170283; Djozan D, 2005, ANAL CHIM ACTA, V554, P197, DOI 10.1016/j.aca.2005.08.049; Drijfhout FP, 2000, J CHEM ECOL, V26, P1383, DOI 10.1023/A:1005427507048; Durak D, 2009, CR BIOL, V332, P34, DOI 10.1016/j.crvi.2008.10.004; Eliyahu D, 2012, J CHEM ECOL, V38, P1358, DOI 10.1007/s10886-012-0200-0; Evans CE, 1990, ANAL GLAND SECRETION; FARINE JP, 1992, J CHEM ECOL, V18, P65, DOI 10.1007/BF00997165; FARINE JP, 1992, J CHEM ECOL, V18, P1673, DOI 10.1007/BF02751094; Favaro CF, 2012, J CHEM ECOL, V38, P1124, DOI 10.1007/s10886-012-0172-0; Fountain M, 2014, J CHEM ECOL, V40, P71, DOI 10.1007/s10886-013-0375-z; GOUGH AJE, 1985, J CHEM ECOL, V11, P343, DOI 10.1007/BF01411421; Griepink FC, 2000, J CHEM ECOL, V26, P1013, DOI 10.1023/A:1005468415186; Gunawardena Neelakanthi E., 1994, Journal of the National Science Council of Sri Lanka, V22, P239; Gunawardena Neelakanthi E., 1992, Journal of the National Science Council of Sri Lanka, V20, P209; Henry TJ, 2007, INSECT BIODIVERSITY, P223; Hibbert DB, 2012, J CHROMATOGR B, V910, P2, DOI 10.1016/j.jchromb.2012.01.020; Ho HY, 2003, J CHEM ECOL, V29, P2101, DOI 10.1023/A:1025638502980; Ho HY, 2001, ZOOL STUD, V40, P193; JACOBS DH, 1989, COMP BIOCHEM PHYS B, V93, P459, DOI 10.1016/0305-0491(89)90107-7; Kalinova B, 2006, TALANTA, V69, P542, DOI 10.1016/j.talanta.2005.10.045; Kerzhner IM., 2001, FAMILY PYRRHOCORIDAE, P248; Kochansky J. P., 1988, LYGUS BUG PHEROMONES, P213; Kozlik P, 2013, J CHROMATOGR B, V930, P82, DOI 10.1016/j.jchromb.2013.05.004; Krajicek J, 2014, J CHROMATOGR A, V1336, P94, DOI 10.1016/j.chroma.2014.02.019; Krall BS, 1997, J CHEM ECOL, V23, P1951, DOI 10.1023/B:JOEC.0000006482.12576.90; Krall BS, 1999, J CHEM ECOL, V25, P2477, DOI 10.1023/A:1020822107806; Miklas N, 2003, J CHEM ECOL, V29, P561, DOI 10.1023/A:1022898620429; Moraes MCB, 2008, NEOTROP ENTOMOL, V37, P489, DOI 10.1590/S1519-566X2008000500001; Myers RH., 2016, RESPONSE SURFACE MET; NAGNAN P, 1994, INT J INSECT MORPHOL, V23, P355, DOI 10.1016/0020-7322(94)90031-0; Pareja M, 2007, J INSECT PHYSIOL, V53, P639, DOI 10.1016/j.jinsphys.2007.04.004; PAVIS C, 1994, J CHEM ECOL, V20, P2213, DOI 10.1007/BF02033198; Prudic KL, 2008, J CHEM ECOL, V34, P734, DOI 10.1007/s10886-008-9480-9; REMOLD H, 1962, Z VERGL PHYSIOL, V45, P636, DOI 10.1007/BF00298174; REMOLD H, 1963, NATURE, V198, P764, DOI 10.1038/198764a0; Roper TJ, 1997, ANIM BEHAV, V53, P1241, DOI 10.1006/anbe.1996.0384; Rowe C, 2013, BEHAV ECOL SOCIOBIOL, V67, P1425, DOI 10.1007/s00265-013-1515-8; Ruxton GD, 2004, AVOIDING ATTACK EVOL; Ryan TP, 2006, MODERN EXPT DESIGN; Sanda M, 2012, J CHROMATOGR B, V881-82, P69, DOI 10.1016/j.jchromb.2011.11.043; Schuh RT, 1995, TRUE BUGS WORLD HEMI; Schwarz JJ, 2010, CAN ENTOMOL, V142, P489, DOI 10.4039/n10-027; SCUDDER GGE, 1972, CAN J ZOOLOG, V50, P35, DOI 10.1139/z72-007; Skelhorn J, 2010, P ROY SOC B-BIOL SCI, V277, P1729, DOI 10.1098/rspb.2009.2092; SOCHA R, 1993, EUR J ENTOMOL, V90, P241; Speed MP, 2000, ANIM BEHAV, V60, P269, DOI 10.1006/anbe.2000.1430; STADDON JER, 1979, J EXP PSYCHOL GEN, V108, P48, DOI 10.1037/0096-3445.108.1.48; Stransky K, 1998, HRC-J HIGH RES CHROM, V21, P475, DOI 10.1002/(SICI)1521-4168(19980801)21:8&lt;475::AID-JHRC475&gt;3.0.CO;2-S; Svadova KH, 2014, BEHAVIOUR, V151, P1617, DOI 10.1163/1568539X-00003208; Svadova KH, 2013, ETHOLOGY, V119, P814, DOI 10.1111/eth.12121; Takita M, 2008, APPL ENTOMOL ZOOL, V43, P11, DOI 10.1303/aez.2008.11; Vet LEM, 1999, J CHEM ECOL, V25, P31, DOI 10.1023/A:1020833015559; Williams L, 2001, J CHEM ECOL, V27, P203, DOI 10.1023/A:1005692502595; Yang CY, 2014, J CHEM ECOL, V40, P244, DOI 10.1007/s10886-014-0407-3; Zarbin PHG, 2000, J BRAZIL CHEM SOC, V11, P424, DOI 10.1590/S0103-50532000000400017; Zhang QH, 2003, NATURWISSENSCHAFTEN, V90, P505, DOI 10.1007/s00114-003-0466-8; Zhang QH, 2003, J CHEM ECOL, V29, P1835, DOI 10.1023/A:1024850211619	66	14	16	1	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2016	11	12							e0168827	10.1371/journal.pone.0168827	http://dx.doi.org/10.1371/journal.pone.0168827			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI9QF	27997627	Green Published, gold, Green Submitted			2022-12-27	WOS:000392842900078
J	Luiz, LB; Brito, CLD; Debon, LM; Brandalise, LN; de Azevedo, JT; Monbach, KD; Heberle, LS; Mottin, CC				Luiz, Luciano Billodre; de Souza Brito, Cesar Luis; Debon, Leticia Manoel; Brandalise, Livia Nora; de Azevedo, Juliana Tainski; Monbach, Karin Daniele; Heberle, Luisa Schmidt; Mottin, Claudio Cora			Variation of Binge Eating One Year after Rouxen-Y Gastric Bypass and Its Relationship with Excess Weight Loss	PLOS ONE			English	Article							BARIATRIC SURGERY CANDIDATES; PSYCHIATRIC-DISORDERS; FOLLOW-UP; OUTCOMES; RESPONSIVITY; BEHAVIOR; INCREASES; OBESITY; SCALE; FOODS	Background Bariatric surgery is the most effective treatment for obesity classes II and III. However, some patients do not get the desired results or initially lose and then regain the lost weight. Identifying these individuals early on and treating them adequately remains a challenge. As binge eating directly affects food intake, the study of this symptom and its relation to bariatric surgery and its results is increasing, because it appears to have an influence on the results of surgery. Objectives This study aimed to see how binge eating changes, measured with the Binge Eating Scale, interferes in the % excess weight loss one year after Roux-en-Y gastric bypass. Methods We conducted a cross-sectional study with 149 patients older than 18 years who were evaluated one year after undergoing Roux-en-Y gastric bypass. The variation in the intensity of binge eating was measured with the pre- and postoperative Binge Eating Scale scores. Results The variation of one unit in the Binge Eating Scale implied an inverse variation of 0.41% of % excess weight loss (p<0.05). The correlation coefficient between the variation of binge eating and the % excess weight loss was -0.186 (p = 0.033). The correlation coefficient between the binge eating symptoms one year after surgery and the % excess weight loss was -0.353 (p<0.001). Conclusions There was a correlation between the variation of binge eating one year after gastric bypass and the % excess weight loss. The correlation between binge eating and the % excess weight loss was greater after the surgery than it was at the preoperative stage. This study provides new, valuable information on the intensity and variation of binge eating symptoms one year after gastric bypass, which, to the best of our knowledge, have not been studied in depth earlier.	[Luiz, Luciano Billodre; de Souza Brito, Cesar Luis; Debon, Leticia Manoel; Brandalise, Livia Nora; de Azevedo, Juliana Tainski; Monbach, Karin Daniele; Heberle, Luisa Schmidt; Mottin, Claudio Cora] Pontificial Catholic Univ Rio Grande Sul, Sao Lucas Hosp, Ctr Obes & Metab Syndrome, Porto Alegre, RS, Brazil; [de Souza Brito, Cesar Luis; Mottin, Claudio Cora] Pontificial Catholic Univ Rio Grande Sul, Fac Med, Porto Alegre, RS, Brazil	Pontificia Universidade Catolica Do Rio Grande Do Sul; Pontificia Universidade Catolica Do Rio Grande Do Sul	Luiz, LB (corresponding author), Pontificial Catholic Univ Rio Grande Sul, Sao Lucas Hosp, Ctr Obes & Metab Syndrome, Porto Alegre, RS, Brazil.	lbluiz@icloud.com	de Souza Brito, Cesar Luis/AAG-9984-2019	de Souza Brito, Cesar Luis/0000-0002-2509-7270				Beck NN, 2012, EAT BEHAV, V13, P394, DOI 10.1016/j.eatbeh.2012.06.001; Berridge KC, 2010, BRAIN RES, V1350, P43, DOI 10.1016/j.brainres.2010.04.003; Bocchieri-Ricciardi LE, 2006, OBES SURG, V16, P1198, DOI 10.1381/096089206778392194; Bruce AS, 2014, OBESITY, V22, P337, DOI 10.1002/oby.20630; Buchwald H, 2004, JAMA-J AM MED ASSOC, V292, P1724, DOI 10.1001/jama.292.14.1724; Frank S, 2014, INT J OBESITY, V38, P341, DOI 10.1038/ijo.2013.60; Freitas Silvia, 2001, Revista Brasileira de Psiquiatria, V23, P215; GORMALLY J, 1982, ADDICT BEHAV, V7, P47, DOI 10.1016/0306-4603(82)90024-7; Grupski AE, 2013, OBES SURG, V23, P1, DOI 10.1007/s11695-011-0537-4; Hood MM, 2013, SURG OBES RELAT DIS, V9, P942, DOI 10.1016/j.soard.2012.06.013; Karmali S, 2013, OBES SURG, V23, P1922, DOI 10.1007/s11695-013-1070-4; Larsen JK, 2004, OBES SURG, V14, P1111, DOI 10.1381/0960892041975587; Livhits M, 2012, OBES SURG, V22, P70, DOI 10.1007/s11695-011-0472-4; Meany G, 2014, EUR EAT DISORD REV, V22, P87, DOI 10.1002/erv.2273; Ochner CN, 2012, NEUROSCIENCE, V209, P128, DOI 10.1016/j.neuroscience.2012.02.030; Petry NM, 2008, PSYCHOSOM MED, V70, P288, DOI 10.1097/PSY.0b013e3181651651; Sallet PC, 2007, OBES SURG, V17, P445, DOI 10.1007/s11695-007-9077-3; Scholtz S, 2007, OBES SURG, V17, P1220, DOI 10.1007/BF02802094; Simon GE, 2006, ARCH GEN PSYCHIAT, V63, P824, DOI 10.1001/archpsyc.63.7.824; Stice E, 2013, NEUROIMAGE, V67, P322, DOI 10.1016/j.neuroimage.2012.11.028; Stice E, 2010, NEUROIMAGE, V50, P1618, DOI 10.1016/j.neuroimage.2010.01.081; Wadden TA, 2011, OBESITY, V19, P1220, DOI 10.1038/oby.2010.336; White MA, 2010, J CLIN PSYCHIAT, V71, P175, DOI 10.4088/JCP.08m04328blu; Williams LJ, 2009, J AFFECT DISORDERS, V118, P173, DOI 10.1016/j.jad.2009.02.001; Wood KV, 2012, APPETITE, V59, P177, DOI 10.1016/j.appet.2012.04.019	25	10	10	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 19	2016	11	12							e0167577	10.1371/journal.pone.0167577	http://dx.doi.org/10.1371/journal.pone.0167577			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI9QC	27992541	gold, Green Published, Green Submitted			2022-12-27	WOS:000392842600015
J	Reineri, S; Agati, S; Miano, V; Sani, M; Berchialla, P; Ricci, L; Iannello, A; Tarrero, LC; Cutrupi, S; De Bortoli, M				Reineri, Stefania; Agati, Silvia; Miano, Valentina; Sani, Monica; Berchialla, Paola; Ricci, Laura; Iannello, Andrea; Tarrero, Lucia Coscujuela; Cutrupi, Santina; De Bortoli, Michele			A Novel Functional Domain of Tab2 Involved in the Interaction with Estrogen Receptor Alpha in Breast Cancer Cells	PLoS One			English	Article							NF-KAPPA-B; ADAPTER PROTEIN; PATHWAY; TAK1; IL-1; PHOSPHORYLATION; ACTIVATION; RESISTANCE; KINASE; ROLES	Tab2, originally described as a component of the inflammatory pathway, has been implicated in phenomena of gene de-repression in several contexts, due to its ability to interact with the NCoR corepressor. Tab2 interacts also with steroid receptors and dismisses NCoR from antagonist-bound Estrogen and Androgen Receptors on gene regulatory regions, thus modifying their transcriptional activity and leading to pharmacological resistance in breast and prostate cancer cells. We demonstrated previously that either Tab2 knock-down, or a peptide mimicking the Estrogen Receptor alpha domain interacting with Tab2, restore the antiproliferative response to Tamoxifen in Tamoxifen-resistant breast cancer cells. In this work, we map the domain of Tab2 responsible of Estrogen Receptor alpha interaction. First, using both co-immunoprecipitation and pull-down with recombinant proteins, we found that the central part of Tab2 is primarily responsible for this interaction, and that this region also interacts with Androgen Receptor. Then, we narrowed down the essential interaction region by means of competition assays using recombinant protein pull-down. The interaction motif was finally identified as a small region adjacent to, but not overlapping, the Tab2 MEKK1 phosphorylation sites. A synthetic peptide mimicking this motif efficiently displaced Tab2 from interacting with recombinant Estrogen Receptor alpha in vitro, prompting us to test its efficacy using derivatives of the MCF7 breast carcinoma cell lines that are spontaneously resistant to Tamoxifen. Indeed, we observed that this mimic peptide, made cell-permeable by addition of the TAT minimal carrier domain, reduced the growth of Tamoxifen-resistant MCF7 cells in the presence of Tamoxifen. These data indicate a novel functional domain of the Tab2 protein with potential application in drug design.	[Reineri, Stefania; Miano, Valentina; Berchialla, Paola; Ricci, Laura; Iannello, Andrea; Tarrero, Lucia Coscujuela; Cutrupi, Santina; De Bortoli, Michele] Univ Turin, Dept Clin & Biol Sci, Turin, Italy; [Agati, Silvia; Ricci, Laura] Bioind Pk Silvano Fumero, Turin, Italy; [Miano, Valentina; Cutrupi, Santina; De Bortoli, Michele] Univ Turin, Ctr Mol Syst Biol, Turin, Italy; [Sani, Monica] CNR, Icrm Inst Chem Mol Recognit, Milan, Italy	University of Turin; University of Turin; Consiglio Nazionale delle Ricerche (CNR); Istituto di Chimica del Riconoscimento Molecolare (ICRM-CNR)	De Bortoli, M (corresponding author), Univ Turin, Dept Clin & Biol Sci, Turin, Italy.; De Bortoli, M (corresponding author), Univ Turin, Ctr Mol Syst Biol, Turin, Italy.	michele.debortoli@unito.it	MIANO, VALENTINA/AGB-5923-2022; cutrupi, santina/AAC-4479-2022; Berchialla, Paola/A-3208-2009; Miano, Valentina/K-3716-2018	MIANO, VALENTINA/0000-0002-0260-5885; Berchialla, Paola/0000-0001-5835-5638; Miano, Valentina/0000-0002-0260-5885; Iannello, Andrea/0000-0001-8940-1406; CUTRUPI, SANTINA/0000-0002-2358-5852; De Bortoli, Michele/0000-0002-6666-9052	AIRC (Associazione Italiana per la Ricerca sul Cancro) [IG 15600]; Fondazione CRT [2014.1854]; Universita degli Studi di Torino, Ricerca Locale	AIRC (Associazione Italiana per la Ricerca sul Cancro)(Fondazione AIRC per la ricerca sul cancro); Fondazione CRT(Fondazione CRT); Universita degli Studi di Torino, Ricerca Locale	Support was provided by AIRC (Associazione Italiana per la Ricerca sul Cancro, www.airc.it) grant IG 15600, to MDB, project concerning molecules determining subtypes of breast cancer; Fondazione CRT (www.fondazionecrt.it) grant 2014.1854, to MDB, project on IncRNAs expression to characterize breast cancer subtypes; and Universita degli Studi di Torino, Ricerca Locale 2014, to MDB, project on Molecular Determinants of Human Disease.	Baek SH, 2002, CELL, V110, P55, DOI 10.1016/S0092-8674(02)00809-7; Bian YY, 2014, J PROTEOMICS, V96, P253, DOI 10.1016/j.jprot.2013.11.014; Broglie P, 2010, J BIOL CHEM, V285, P2333, DOI 10.1074/jbc.M109.090522; Brosens JJ, 2006, CELL, V124, P466, DOI 10.1016/j.cell.2006.01.023; Cutrupi S, 2012, ONCOGENE, V31, P4353, DOI 10.1038/onc.2011.627; Ellis MJ, 2012, NATURE, V486, P353, DOI 10.1038/nature11143; Ishitani T, 2003, EMBO J, V22, P6277, DOI 10.1093/emboj/cdg605; Jiang ZF, 2002, MOL CELL BIOL, V22, P7158, DOI 10.1128/MCB.22.20.7158-7167.2002; Kanayama A, 2004, MOL CELL, V15, P535, DOI 10.1016/j.molcel.2004.08.008; Mendoza H, 2008, BIOCHEM J, V409, P711, DOI 10.1042/BJ20071149; Perissi V, 2005, NAT REV MOL CELL BIO, V6, P542, DOI 10.1038/nrm1680; Perissi V, 2010, NAT REV GENET, V11, P109, DOI 10.1038/nrg2736; Rush J, 2005, NAT BIOTECHNOL, V23, P94, DOI 10.1038/nbt1046; Sardi SP, 2006, CELL, V127, P185, DOI 10.1016/j.cell.2006.07.037; Shin MS, 2009, BBA-MOL CELL RES, V1793, P1156, DOI 10.1016/j.bbamcr.2009.04.005; Takaesu G, 2000, MOL CELL, V5, P649, DOI 10.1016/S1097-2765(00)80244-0; Thrane S, 2013, BREAST CANCER RES TR, V139, P71, DOI 10.1007/s10549-013-2485-2; TORA L, 1989, CELL, V59, P477, DOI 10.1016/0092-8674(89)90031-7; Wang B, 2003, J BIOL CHEM, V278, P20225, DOI 10.1074/jbc.M300459200; Zhu P, 2006, CELL, V124, P615, DOI 10.1016/j.cell.2005.12.032	20	4	5	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 19	2016	11	12							e0168639	10.1371/journal.pone.0168639	http://dx.doi.org/10.1371/journal.pone.0168639			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI9QC	27992601	Green Submitted, Green Published, gold			2022-12-27	WOS:000392842600084
J	Marchetti, I; Loeys, T; Alloy, LB; Koster, EHW				Marchetti, Igor; Loeys, Tom; Alloy, Lauren B.; Koster, Ernst H. W.			Unveiling the Structure of Cognitive Vulnerability for Depression: Specificity and Overlap	PLOS ONE			English	Article							HOPELESSNESS DEPRESSION; COMMONALITY ANALYSIS; THERAPY; RUMINATION; FUTURE; INDIVIDUALS; COMORBIDITY; CONTINUITY; SEVERITY; ANXIETY	There is extensive literature establishing the influence of rumination, hopelessness, and dysfunctional attitudes on depressive symptoms. However, it is unclear whether these vulnerability factors are distinctly related to depressive symptoms or show substantial overlap. In two large samples of undergraduates (Study #1, n = 304; Study #2, n = 491) and two samples of clinically depressed individuals (Study #3, n = 141; Study #4, n = 109, from published studies), questionnaire data were used to examine the relationship between cognitive vulnerability factors and depressive symptoms, along with additional measures of anxiety and stress symptoms. To decompose model fit into its specific and common partitions, we relied on commonality analysis (CA). CA showed that there is substantial overlap in cognitive risk factors for depression. Moreover, we found strong evidence that hopelessness provides a unique statistical contribution to depression. This pattern of findings was stable in healthy as well as clinical samples. Symptom-levels analysis revealed that a specific subset of depressive symptoms are associated with hopelessness. In closing, we showed that CA provides a powerful tool to map unique and overlapping variance between multiple risk factors. Moreover, hopelessness emerged to be an important focus of clinical attention.	[Marchetti, Igor; Loeys, Tom; Koster, Ernst H. W.] Univ Ghent, Ghent, Belgium; [Alloy, Lauren B.] Temple Univ, Philadelphia, PA 19122 USA	Ghent University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University	Marchetti, I (corresponding author), Univ Ghent, Ghent, Belgium.	Igor.Marchetti@UGent.be	Koster, Ernst H.W./AFS-7487-2022; Marchetti, Igor/H-2791-2019	Koster, Ernst H.W./0000-0003-0792-476X; Marchetti, Igor/0000-0002-4709-7941; Loeys, Tom/0000-0003-4551-5502	National Institute of Mental Health [MH101168]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH101168] Funding Source: NIH RePORTER	National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	IM is a postdoctoral research fellow of the Research Foundation Flanders (FWO; FWO14/ PDO/115). LBA is supported by the National Institute of Mental Health (Grant MH101168).	Abela JRZ, 2002, J ABNORM CHILD PSYCH, V30, P515, DOI 10.1023/A:1019873015594; Abela JRZ, 2003, J PERS DISORD, V17, P319, DOI 10.1521/pedi.17.4.319.23968; ABRAMSON LY, 1989, PSYCHOL REV, V96, P358, DOI 10.1037/0033-295X.96.2.358; ALFORD BA, 1995, J CLIN PSYCHOL, V51, P331, DOI 10.1002/1097-4679(199505)51:3<331::AID-JCLP2270510303>3.0.CO;2-T; Alloy LB, 2006, J ABNORM PSYCHOL, V115, P145, DOI 10.1037/0021-843X.115.1.145; Alloy LB., 1985, THEORETICAL ISSUES B, P379; Andersen SM, 2001, COGNITIVE THER RES, V25, P311, DOI 10.1023/A:1026447600924; Andersson G, 2013, J AFFECT DISORDERS, V151, P986, DOI 10.1016/j.jad.2013.08.022; Beck A.T., 1967, DEPRESSION CLIN EXPT; Beck AT, 2008, AM J PSYCHIAT, V165, P969, DOI 10.1176/appi.ajp.2008.08050721; Beck AT, 2014, ANNU REV CLIN PSYCHO, V10, P1, DOI 10.1146/annurev-clinpsy-032813-153734; BECK AT, 1961, ARCH GEN PSYCHIAT, V4, P561, DOI 10.1001/archpsyc.1961.01710120031004; BECK AT, 1974, J CONSULT CLIN PSYCH, V42, P861, DOI 10.1037/h0037562; Beck AT., 1996, MANUAL BECK DEPRESSI; Borsboom D, 2013, ANNU REV CLIN PSYCHO, V9, P91, DOI 10.1146/annurev-clinpsy-050212-185608; Brown G., 1978, SOCIAL ORIGINS DEPRE; Cheavens JS, 2006, SOC INDIC RES, V77, P61, DOI 10.1007/s11205-005-5553-0; Clark D.A., 1999, SCI FDN COGNITIVE TH; Cohen J.E., 1988, STAT POWER ANAL BEHA; Cramer AOJ, 2010, BEHAV BRAIN SCI, V33, P137, DOI 10.1017/S0140525X09991567; Disner SG, 2011, NAT REV NEUROSCI, V12, P467, DOI 10.1038/nrn3027; Enns MW, 2001, J AFFECT DISORDERS, V66, P175, DOI 10.1016/S0165-0327(00)00305-0; FERRARI A, 2013, PLOS ONE, V8; Ferrari AJ, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001547; Flett GL, 1997, PSYCHOL BULL, V121, P395, DOI 10.1037/0033-2909.121.3.395; Fried EI, 2014, PSYCHOL MED, V44, P2067, DOI 10.1017/S0033291713002900; Fried EI, 2015, BMC MED, V13, DOI 10.1186/s12916-015-0325-4; Fried EI, 2015, J AFFECT DISORDERS, V172, P96, DOI 10.1016/j.jad.2014.10.010; Gotlib IH, 2000, STRESS, COPING, AND DEPRESSION, P117; Hamilton KE, 2002, CLIN PSYCHOL REV, V22, P875, DOI 10.1016/S0272-7358(02)00106-X; HAMILTON M, 1960, J NEUROL NEUROSUR PS, V23, P56, DOI 10.1136/jnnp.23.1.56; Henry JD, 2005, BRIT J CLIN PSYCHOL, V44, P227, DOI 10.1348/014466505X29657; Hong RY, 2015, CLIN PSYCHOL SCI, V3, P892, DOI 10.1177/2167702614553789; Kraha A, 2012, FRONT PSYCHOL, V3, DOI 10.3389/fpsyg.2012.00044; KWON SM, 1994, CLIN PSYCHOL REV, V14, P331, DOI 10.1016/0272-7358(94)90032-9; Lam D, 2003, PSYCHOL MED, V33, P469, DOI 10.1017/S0033291702007304; MacLeod AK, 2008, J HAPPINESS STUD, V9, P185, DOI 10.1007/s10902-007-9057-2; Metalsky GI, 1997, COGNITIVE THER RES, V21, P359, DOI 10.1023/A:1021882717784; Mineka S, 1998, ANNU REV PSYCHOL, V49, P377, DOI 10.1146/annurev.psych.49.1.377; MOOD AM, 1969, OPER RES, V17, P770, DOI 10.1287/opre.17.5.770; Nickerson RS, 2000, PSYCHOL METHODS, V5, P241, DOI 10.1037//1082-989X.5.2.241; Nimon K, 2012, PACKAGE YHAT INTERP; Nimon K, 2015, ADV DEV HUM RESOUR, V17, P26, DOI 10.1177/1523422314559805; Nimon Kim., 2011, HUM RESOUR DEV REV, V10, P329, DOI [10.1177/1534484311411077, DOI 10.1177/1534484311411077]; Nolen-Hoeksema S, 2008, PERSPECT PSYCHOL SCI, V3, P400, DOI 10.1111/j.1745-6924.2008.00088.x; NOLENHOEKSEMA S, 1991, J ABNORM PSYCHOL, V100, P569, DOI 10.1037/0021-843X.100.4.569; Podsakoff PM, 2003, J APPL PSYCHOL, V88, P879, DOI 10.1037/0021-9010.88.5.879; Possel P, 2011, COGNITIVE THER RES, V35, P342, DOI 10.1007/s10608-010-9325-z; Prunier JG, 2015, MOL ECOL, V24, P263, DOI 10.1111/mec.13029; Ray-Mukherjee J, 2014, METHODS ECOL EVOL, V5, P320, DOI 10.1111/2041-210X.12166; RHOLES WS, 1985, SOC COGNITION, V3, P36, DOI 10.1521/soco.1985.3.1.36; Roepke AM, 2016, BRIT J CLIN PSYCHOL, V55, P23, DOI 10.1111/bjc.12087; Smith JM, 2006, SUICIDE LIFE-THREAT, V36, P443, DOI 10.1521/suli.2006.36.4.443; Treynor W, 2003, COGNITIVE THER RES, V27, P247, DOI 10.1023/A:1023910315561; Vilhauer JS, 2012, CNS NEUROSCI THER, V18, P102, DOI 10.1111/j.1755-5949.2011.00235.x; Watkins ER, 2008, PSYCHOL BULL, V134, P163, DOI 10.1037/0033-2909.134.2.163; Weissman AN., 1978, 86 ANN CONV AM PSYCH, P27; Zientek LR, 2006, J EARLY INTERVENTION, V28, P299; Zientek LR, 2009, EDUC RESEARCHER, V38, P343, DOI 10.3102/0013189X09339056	59	21	23	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2016	11	12							e0168612	10.1371/journal.pone.0168612	http://dx.doi.org/10.1371/journal.pone.0168612			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EI8LN	27992548	Green Published, gold, Green Submitted			2022-12-27	WOS:000392758000066
J	Aperce, CC; Amachawadi, R; Van Bibber-Krueger, CL; Nagaraja, TG; Scott, HM; Vinasco-Torre, J; Drouillard, JS				Aperce, C. C.; Amachawadi, R.; Van Bibber-Krueger, C. L.; Nagaraja, T. G.; Scott, H. M.; Vinasco-Torre, J.; Drouillard, J. S.			Effects of Menthol Supplementation in Feedlot Cattle Diets on the Fecal Prevalence of Antimicrobial-Resistant Escherichia coli	PLOS ONE			English	Article							TETRACYCLINE RESISTANCE; GENES; ANTIBIOTICS; PERFORMANCE; EPIDEMIOLOGY; FERMENTATION; MICROFLORA; ANIMALS; STRAINS; STEERS	The pool of antimicrobial resistance determinants in the environment and in the gut flora of cattle is a serious public health concern. In addition to being a source of human exposure, these bacteria can transfer antibiotic resistance determinants to pathogenic bacteria and endanger the future of antimicrobial therapy. The occurrence of antimicrobial resistance genes on mobile genetic elements, such as plasmids, facilitates spread of resistance. Recent work has shown in vitro anti-plasmid activity of menthol, a plant-based compound with the potential to be used as a feed additive to beneficially alter ruminal fermentation. The present study aimed to determine if menthol supplementation in diets of feedlot cattle decreases the prevalence of multidrug-resistant bacteria in feces. Menthol was included in diets of steers at 0.3% of diet dry matter. Fecal samples were collected weekly for 4 weeks and analyzed for total coliforms counts, antimicrobial susceptibilities, and the prevalence of tet genes in E. coli isolates. Results revealed no effect of menthol supplementation on total coliforms counts or prevalence of E. coli resistant to amoxicillin, ampicillin, azithromycin, cefoxitin, ceftiofur, ceftriaxone, chloramphenicol, ciprofloxacin, gentamicin, kanamycin, nalidixic acid, streptomycin, sulfisoxazole, and sulfamethoxazole; however, 30 days of menthol addition to steer diets increased the prevalence of tetracycline-resistant E. coli (P < 0.02). Although the mechanism by which menthol exerts its effects remains unclear, results of our study suggest that menthol may have an impact on antimicrobial resistance in gut bacteria.	[Aperce, C. C.; Van Bibber-Krueger, C. L.; Drouillard, J. S.] Kansas State Univ, Dept Anim Sci, Manhattan, KS 66506 USA; [Aperce, C. C.; Van Bibber-Krueger, C. L.; Drouillard, J. S.] Kansas State Univ, Dept Ind, Manhattan, KS 66506 USA; [Amachawadi, R.; Nagaraja, T. G.; Scott, H. M.; Vinasco-Torre, J.] Kansas State Univ, Diagnost Med & Pathobiol, Manhattan, KS 66506 USA	Kansas State University; Kansas State University; Kansas State University	Drouillard, JS (corresponding author), Kansas State Univ, Dept Anim Sci, Manhattan, KS 66506 USA.; Drouillard, JS (corresponding author), Kansas State Univ, Dept Ind, Manhattan, KS 66506 USA.	jdrouill@ksu.edu	Scott, Harvey/ABC-9935-2020; Amachawadi, Raghavendra/AIA-9957-2022	Scott, Harvey/0000-0002-0538-5961; Amachawadi, Raghavendra/0000-0001-9689-1124				Agarwal N, 2009, ANIM FEED SCI TECH, V148, P321, DOI 10.1016/j.anifeedsci.2008.04.004; Alexander TW, 2009, APPL ENVIRON MICROB, V75, P7125, DOI 10.1128/AEM.00944-09; Ando S, 2003, LIVEST PROD SCI, V82, P245, DOI 10.1016/S0301-6226(03)00012-5; Benchaar C, 2008, ANIM FEED SCI TECH, V145, P209, DOI 10.1016/j.anifeedsci.2007.04.014; Blake DP, 2003, J APPL MICROBIOL, V94, P1087, DOI 10.1046/j.1365-2672.2003.01937.x; Branham LA, 2007, THESIS; Bryan A, 2004, APPL ENVIRON MICROB, V70, P2503, DOI 10.1128/AEM.70.4.2503-2507.2004; Chopra I, 2002, DRUG RESIST UPDATE, V5, P119, DOI 10.1016/S1368-7646(02)00051-1; Chopra I, 2001, MICROBIOL MOL BIOL R, V65, P232, DOI 10.1128/MMBR.65.2.232-260.2001; Clinical and Laboratory Standards Institute, 2011, M100S21 CLSI; El-Mansi M, 2000, RES MICROBIOL, V151, P201, DOI 10.1016/S0923-2508(00)00140-6; Gaggia F, 2010, INT J FOOD MICROBIOL, V141, pS15, DOI 10.1016/j.ijfoodmicro.2010.02.031; GILMORE A, 1986, CAN MED ASSOC J, V134, P423; Gow SP, 2008, APPL ENVIRON MICROB, V74, P3658, DOI 10.1128/AEM.02505-07; Harvey R, 2009, AM J VET RES, V70, P198, DOI 10.2460/ajvr.70.2.198; Hosoda K, 2005, J ANIM SCI, V18, P1721; JONES CS, 1992, MOL CELL PROBE, V6, P313, DOI 10.1016/0890-8508(92)90007-K; Landau E, 2012, APPL ENVIRON MICROB, V78, P5361, DOI 10.1128/AEM.00894-12; Levy SB, 2001, CLIN INFECT DIS, V33, pS124, DOI 10.1086/321837; Martinez JL, 2009, FEMS MICROBIOL REV, V33, P44, DOI 10.1111/j.1574-6976.2008.00142.x; Ma YP, 2006, J DAIRY SCI, V89, P4573, DOI 10.3168/jds.S0022-0302(06)72507-3; Marshall BM, 2011, CLIN MICROBIOL REV, V24, P718, DOI 10.1128/CMR.00002-11; Medeiros AA, 1997, CLIN INFECT DIS, V24, pS19, DOI 10.1093/clinids/24.Supplement_1.S19; Medina A, 2011, J VET DIAGN INVEST, V23, P91, DOI 10.1177/104063871102300114; Minutolo C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015899; Mirzaagha P, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-78; NURU S, 1972, CORNELL VET, V62, P242; Ocak N, 2008, CZECH J ANIM SCI, V53, P169, DOI 10.17221/373-CJAS; Ochman H, 2000, NATURE, V405, P299, DOI 10.1038/35012500; Patel T, 2007, J AM ACAD DERMATOL, V57, P873, DOI 10.1016/j.jaad.2007.04.008; Sawant AA, 2007, APPL ENVIRON MICROB, V73, P156, DOI 10.1128/AEM.01551-06; Schelz Z, 2006, FITOTERAPIA, V77, P279, DOI 10.1016/j.fitote.2006.03.013; Sharifi SD, 2013, VET ARHIV, V83, P69; Thaker M, 2010, CELL MOL LIFE SCI, V67, P419, DOI 10.1007/s00018-009-0172-6; Toghyani M, 2010, LIVEST SCI, V129, P173, DOI 10.1016/j.livsci.2010.01.021; Trombetta D, 2005, ANTIMICROB AGENTS CH, V49, P2474, DOI 10.1128/AAC.49.6.2474-2478.2005; Van Bibber-Krueger CL, 2016, J ANIM SCI, V94, P1170, DOI 10.2527/jas.2015-8779; van den Bogaard AE, 2000, INT J ANTIMICROB AG, V14, P327, DOI 10.1016/S0924-8579(00)00145-X; White DG, 2000, J CLIN MICROBIOL, V38, P4593, DOI 10.1128/JCM.38.12.4593-4598.2000; WHO, 2001, WHO GLOB STRAT CONT; YAMAGUCHI A, 1990, J BIOL CHEM, V265, P15525	41	11	12	2	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2016	11	12							e0168983	10.1371/journal.pone.0168983	http://dx.doi.org/10.1371/journal.pone.0168983			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EG7JB	28030622	Green Published, gold, Green Submitted			2022-12-27	WOS:000391222000094
J	Roberts, D; Hillstrom, H; Kim, JH				Roberts, Dustyn; Hillstrom, Howard; Kim, Joo H.			Instantaneous Metabolic Cost of Walking: Joint-Space Dynamic Model with Subject Specific Heat Rate	PLOS ONE			English	Article							TO-STEP TRANSITIONS; ENERGY-EXPENDITURE; MECHANICAL WORK; MUSCLE ACTIVATION; ISB RECOMMENDATION; SWING PHASE; OPTIMIZATION; ENERGETICS; MOTION; GAIT	A subject-specific model of instantaneous cost of transport (ICOT) is introduced from the joint-space formulation of metabolic energy expenditure using the laws of thermodynamics and the principles of multibody system dynamics. Work and heat are formulated in generalized coordinates as functions of joint kinematic and dynamic variables. Generalized heat rates mapped from muscle energetics are estimated from experimental walking metabolic data for the whole body, including upper-body and bilateral data synchronization. Identified subject-specific energetic parameters mass, height, (estimated) maximum oxygen uptake, and (estimated) maximum joint torques are incorporated into the heat rate, as opposed to the traditional in vitro and subject-invariant muscle parameters. The total model metabolic energy expenditure values are within 5.7 4.6% error of the measured values with strong (R-2> 0.90) inter- and intra-subject correlations. The model reliably predicts the characteristic convexity and magnitudes (0.326-0.348) of the experimental total COT (0.311-0.358) across different subjects and speeds. The ICOT as a function of time provides insights into gait energetic causes and effects (e.g., normalized comparison and sensitivity with respect to walking speed) and phase-specific COT, which are unavailable from conventional metabolic measurements or muscle models. Using the joint-space variables from commonly measured or simulated data, the models enable real-time and phase-specific evaluations of transient or non-periodic general tasks that use a range of (aerobic) energy pathway similar to that of steady-state walking.	[Roberts, Dustyn; Kim, Joo H.] NYU, Dept Mech & Aerosp Engn, Brooklyn, NY 11201 USA; [Hillstrom, Howard] Hosp Special Surg, Leon Root MD Mot Anal Lab, 535 E 70th St, New York, NY 10021 USA	New York University; New York University Tandon School of Engineering	Kim, JH (corresponding author), NYU, Dept Mech & Aerosp Engn, Brooklyn, NY 11201 USA.	joo.h.kim@nyu.edu	Kim, Joo/I-9517-2012; Roberts, Dustyn/E-9493-2010	Roberts, Dustyn/0000-0002-5898-8555	U.S. National Science Foundation [CMMI-1436636, IIS-1427193, DGE-1104522]; International Society of Biomechanics (ISB) Student Matching Dissertation Grant	U.S. National Science Foundation(National Science Foundation (NSF)); International Society of Biomechanics (ISB) Student Matching Dissertation Grant	Funded by U.S. National Science Foundation grant numbers CMMI-1436636 and IIS-1427193 to JHK. U.S. National Science Foundation grant number DGE-1104522 to DR. and International Society of Biomechanics (ISB) Student Matching Dissertation Grant to DR. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ackermann M, 2010, J BIOMECH, V43, P1055, DOI 10.1016/j.jbiomech.2009.12.012; Anderson DE, 2007, J BIOMECH, V40, P3105, DOI 10.1016/j.jbiomech.2007.03.022; Anderson FC, 2001, J BIOMECH ENG-T ASME, V123, P381, DOI 10.1115/1.1392310; Anderson FC, 2001, J BIOMECH, V34, P153, DOI 10.1016/S0021-9290(00)00155-X; Ashby BM, 2006, J BIOMECH, V39, P1726, DOI 10.1016/j.jbiomech.2005.04.017; Au SK, 2009, IEEE T ROBOT, V25, P51, DOI 10.1109/TRO.2008.2008747; Bhargava LJ, 2004, J BIOMECH, V37, P81, DOI 10.1016/S0021-9290(03)00239-2; Bhounsule PA, 2014, INT J ROBOT RES, V33, P1305, DOI 10.1177/0278364914527485; Black W.Z., 1991, THERMODYNAMICS, V2nd ed.; BROCKWAY JM, 1987, HUM NUTR-CLIN NUTR, V41C, P463; Brown AM, 2014, GAIT POSTURE, V39, P915, DOI 10.1016/j.gaitpost.2013.12.007; Brychta R, 2010, IEEE ENG MED BIOL, V29, P42, DOI 10.1109/MEMB.2009.935463; Carr C., 2005, THESIS; Chappell MA, 2009, J EXP BIOL, V212, P610, DOI 10.1242/jeb.025775; DAVY DT, 1987, J BIOMECH, V20, P187, DOI 10.1016/0021-9290(87)90310-1; DEMPSTER WT, 1967, AM J ANAT, V120, P33, DOI 10.1002/aja.1001200104; Dlugosz EM, 2009, J EXP BIOL, V212, P2612, DOI 10.1242/jeb.029058; Doke J, 2007, J EXP BIOL, V210, P2390, DOI 10.1242/jeb.02782; Donelan JM, 2008, SCIENCE, V319, P807, DOI 10.1126/science.1149860; Donelan JM, 2002, J EXP BIOL, V205, P3717; ELIA M, 1992, ENERGY METABOLISM, P61; England SA, 2007, GAIT POSTURE, V25, P172, DOI 10.1016/j.gaitpost.2006.03.003; Farris DJ, 2012, J R SOC INTERFACE, V9, P110, DOI 10.1098/rsif.2011.0182; Frey-Law LA, 2012, J APPL BIOMECH, V28, P726, DOI 10.1123/jab.28.6.726; GARG A, 1978, AM IND HYG ASSOC J, V39, P661, DOI 10.1080/0002889778507831; Glass SC, 2006, ACSMS METABOLIC CALC; Gonzalez-Alonso J, 2000, J PHYSIOL-LONDON, V524, P603, DOI 10.1111/j.1469-7793.2000.00603.x; Gordon KE, 2009, ARCH PHYS MED REHAB, V90, P136, DOI 10.1016/j.apmr.2008.07.014; Hall C, 2004, MED SCI SPORT EXER, V36, P2128, DOI 10.1249/01.MSS.0000147584.87788.0E; HANAVAN E P Jr, 1964, AMRL TR, P1; Hawkins D, 1997, ANN BIOMED ENG, V25, P822, DOI 10.1007/BF02684166; Hill AV, 1938, PROC R SOC SER B-BIO, V126, P136, DOI 10.1098/rspb.1938.0050; Holzbaur KRS, 2007, J BIOMECH, V40, P2442, DOI 10.1016/j.jbiomech.2006.11.013; Hortobagyi T, 2011, J GERONTOL A-BIOL, V66, P541, DOI 10.1093/gerona/glr008; Joshi V, 2015, P ROY SOC A-MATH PHY, V471, DOI 10.1098/rspa.2014.0662; Kim JA, 2015, COMMUN ALGEBRA, V43, P1983, DOI 10.1080/00927872.2014.881835; Kim JH, 2014, MULTIBODY SYST DYN, V31, P257, DOI 10.1007/s11044-013-9376-5; Kim JH, 2010, MULTIBODY SYST DYN, V24, P1, DOI 10.1007/s11044-010-9193-z; Kramer PA, 2008, GAIT POSTURE, V27, P209, DOI 10.1016/j.gaitpost.2007.03.009; Kuo AD, 2007, IEEE ROBOT AUTOM MAG, V14, P18, DOI 10.1109/MRA.2007.380653; Kuo AD, 2005, EXERC SPORT SCI REV, V33, P88, DOI 10.1097/00003677-200504000-00006; Langhaar H.L., 1989, ENERGY METHODS APPL, V2nd; Long LL, 2013, J R SOC INTERFACE, V10, DOI 10.1098/rsif.2012.0980; Margaria R, 1968, Int Z Angew Physiol, V25, P339; Mian OS, 2006, ACTA PHYSIOL, V186, P127, DOI 10.1111/j.1748-1716.2006.01522.x; Millard M, 2013, J BIOMECH ENG-T ASME, V135, DOI 10.1115/1.4023390; Miller RH, 2013, P AM SOC BIOM C OM N; Miller RH, 2014, J BIOMECH, V47, P1373, DOI 10.1016/j.jbiomech.2014.01.049; Morton RH, 2006, EUR J APPL PHYSIOL, V96, P339, DOI 10.1007/s00421-005-0088-2; Mummolo C, 2016, COMPUT METHOD BIOMEC, V19, P1127, DOI 10.1080/10255842.2015.1110146; Mummolo C, 2013, J BIOMECH ENG-T ASME, V135, DOI 10.1115/1.4024755; Orendurff MS, 2008, J REHABIL RES DEV, V45, P1077, DOI 10.1682/JRRD.2007.11.0197; Pontzer H, 2016, BIOL LETTERS, V12, DOI 10.1098/rsbl.2015.0935; Prilutsky BI, 1997, J APPL BIOMECH, V13, P466, DOI 10.1123/jab.13.4.466; Rab G, 2002, GAIT POSTURE, V15, P113, DOI 10.1016/S0966-6362(01)00155-2; Radhakrishnan V, 1998, P NATL ACAD SCI USA, V95, P5448, DOI 10.1073/pnas.95.10.5448; Riley PO, 2007, GAIT POSTURE, V26, P17, DOI 10.1016/j.gaitpost.2006.07.003; Sasaki K, 2009, J EXP BIOL, V212, P738, DOI 10.1242/jeb.023267; Schwartz MH, 2008, J BIOMECH, V41, P1639, DOI 10.1016/j.jbiomech.2008.03.015; SEALE JL, 1990, AM J CLIN NUTR, V52, P66, DOI 10.1093/ajcn/52.1.66; Selinger JC, 2014, J APPL PHYSIOL, V117, P1406, DOI 10.1152/japplphysiol.00445.2014; Sherman MA, 2014, PROCEEDINGS OF THE ASME INTERNATIONAL DESIGN ENGINEERING TECHNICAL CONFERENCES AND COMPUTERS AND INFORMATION IN ENGINEERING CONFERENCE, 2013, VOL 7B; Silder A, 2007, J BIOMECH, V40, P2628, DOI 10.1016/j.jbiomech.2006.12.017; Slider A, 2012, J BIOMECH, V45, P1842, DOI 10.1016/j.jbiomech.2012.03.032; Sockol MD, 2007, P NATL ACAD SCI USA, V104, P12265, DOI 10.1073/pnas.0703267104; Sohn MH, 2013, J BIOMECH, V46, P1363, DOI 10.1016/j.jbiomech.2013.01.020; Soo CH, 2010, J EXP BIOL, V213, P4265, DOI 10.1242/jeb.044214; Srinivasan M, 2011, J R SOC INTERFACE, V8, P74, DOI 10.1098/rsif.2009.0544; Tanaka H, 2001, J AM COLL CARDIOL, V37, P153, DOI 10.1016/S0735-1097(00)01054-8; Thompson W. R., 2009, ACSMS GUIDELINES EXE; Umberger BR, 2007, J EXP BIOL, V210, P3255, DOI 10.1242/jeb.000950; Umberger Brian R., 2003, Computer Methods in Biomechanics and Biomedical Engineering, V6, P99, DOI 10.1080/1025584031000091678; Umberger BR, 2011, EXERC SPORT SCI REV, V39, P59, DOI 10.1097/JES.0b013e31820d7bc5; Umberger BR, 2010, J R SOC INTERFACE, V7, P1329, DOI 10.1098/rsif.2010.0084; Uth N, 2004, EUR J APPL PHYSIOL, V91, P111, DOI 10.1007/s00421-003-0988-y; van Bolhuis BM, 1999, BIOL CYBERN, V81, P249, DOI 10.1007/s004220050560; Vologodskii A, 2006, PHYS LIFE REV, V3, P119, DOI 10.1016/j.plrev.2006.02.002; Walcott S, 2013, CELL MOL BIOENG, V6, P13, DOI 10.1007/s12195-012-0259-2; WARDSMITH AJ, 1985, J BIOMECH, V18, P337, DOI 10.1016/0021-9290(85)90289-1; Waters RL, 1999, GAIT POSTURE, V9, P207, DOI 10.1016/S0966-6362(99)00009-0; WEIR JBD, 1949, J PHYSIOL-LONDON, V109, P1, DOI 10.1113/jphysiol.1949.sp004363; Weyand PG, 2010, J EXP BIOL, V213, P3972, DOI 10.1242/jeb.048199; Whittington B, 2008, GAIT POSTURE, V27, P628, DOI 10.1016/j.gaitpost.2007.08.005; Willis WT, 2005, METABOLISM, V54, P793, DOI 10.1016/j.metabol.2005.01.024; Winter D., 2009, BIOMECHANICS MOTOR C, V4th; WINTER DA, 1979, J APPL PHYSIOL, V46, P79, DOI 10.1152/jappl.1979.46.1.79; Wu G, 2005, J BIOMECH, V38, P981, DOI 10.1016/j.jbiomech.2004.05.042; Wu G, 2002, J BIOMECH, V35, P543, DOI 10.1016/S0021-9290(01)00222-6; Xiang YJ, 2010, STRUCT MULTIDISCIP O, V41, P465, DOI 10.1007/s00158-009-0423-z; Yang JZ, 2009, J BIOMECH, V42, P1762, DOI 10.1016/j.jbiomech.2009.04.048; ZAJAC FE, 1989, CRIT REV BIOMED ENG, V17, P359; Zelik KE, 2010, J EXP BIOL, V213, P4257, DOI 10.1242/jeb.044297; Zhang LQ, 2001, J BIOMECH, V34, P1107, DOI 10.1016/S0021-9290(01)00080-X	93	5	5	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2016	11	12							e0168070	10.1371/journal.pone.0168070	http://dx.doi.org/10.1371/journal.pone.0168070			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EG7JB	28030598	Green Published, gold, Green Submitted			2022-12-27	WOS:000391222000033
J	Shi, R; Zhang, SL; Zhang, QW; Fu, SP; Wang, ZH				Shi, Rui; Zhang, Shilei; Zhang, Qianwen; Fu, Shaoping; Wang, Zhenhong			Experiential Avoidance Mediates the Association between Emotion Regulation Abilities and Loneliness	PLOS ONE			English	Article							ACTION-STATE ORIENTATION; REVISED MEASURE; ANXIETY; SENSITIVITY; RISK; TRAJECTORIES; ACCEPTANCE; PSYCHOLOGY; CONSTRUCT; SYMPTOMS	Experiential avoidance (EA) involves the unwillingness to remain in contact with aversive experiences such as painful feelings, thoughts, and emotions. EA is often associated with the development and maintenance of emotional problems. Since loneliness is characterized by negative emotions such as sadness and pessimism, which is often linked to emotional problems, this study aims to test the mediating effects of EA on the relationship between emotion regulation abilities (ERA) and loneliness in a sample of Chinese adults. Five hundred undergraduates completed questionnaires measuring EA (Acceptance and Action Questionnaire; AAQ-II), ERA (Failure-relate action orientation; Action Control Scale, ACS 90) and loneliness (UCLA Loneliness Scale). Structural equation modeling showed that EA fully-mediated the relationship between ERA and loneliness. The findings suggest EA is a key mechanism in explaining why people with high ERA are prone to feeling lower levels of loneliness. In particular, these findings have important implications for designing effective psychological interventions for loneliness.	[Shi, Rui; Fu, Shaoping] Northwest A&F Univ, Coll Humanities, Yangling, Peoples R China; [Zhang, Shilei; Zhang, Qianwen] Changan Univ, Psychol Counseling Ctr, Xian, Peoples R China; [Zhang, Shilei; Wang, Zhenhong] Shaanxi Normal Univ, Sch Psychol, Xian, Peoples R China	Northwest A&F University - China; Chang'an University; Shaanxi Normal University	Zhang, SL (corresponding author), Changan Univ, Psychol Counseling Ctr, Xian, Peoples R China.; Zhang, SL (corresponding author), Shaanxi Normal Univ, Sch Psychol, Xian, Peoples R China.	johndiamond@163.com			Projects of the Scientific Startup Funds for Doctors of NWAFU [Z109021614]; Projects of the Shaanxi Province Social Science [2015N014]; Fundamental Research Funds for the Central Universities [310850160666]	Projects of the Scientific Startup Funds for Doctors of NWAFU; Projects of the Shaanxi Province Social Science; Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	This research was supported by the Projects of the Scientific Startup Funds for Doctors of NWAFU(Z109021614), which was awarded to Rui Shi. And by the Projects of the Shaanxi Province Social Science(2015N014), Fundamental Research Funds for the Central Universities (310850160666), which were awarded to Shilei Zhang.	Aldao A, 2010, CLIN PSYCHOL REV, V30, P217, DOI 10.1016/j.cpr.2009.11.004; ANDERSON JC, 1988, PSYCHOL BULL, V103, P411, DOI 10.1037/0033-2909.103.3.411; BELL RA, 1985, COMMUN MONOGR, V52, P218, DOI 10.1080/03637758509376107; Binswanger L, 1963, BEING IN THE WORLD S; Bond FW, 2011, BEHAV THER, V42, P676, DOI 10.1016/j.beth.2011.03.007; Browne M. W., 1993, TESTING STRUCTURAL E, P136, DOI DOI 10.1177/0049124192021002005; Cacioppo, 2008, LIB J, V19, P71; Cacioppo JT, 2015, PERSPECT PSYCHOL SCI, V10, P202, DOI 10.1177/1745691614564876; Cacioppo JT, 2009, TRENDS COGN SCI, V13, P447, DOI 10.1016/j.tics.2009.06.005; Cacioppo JT, 2006, PSYCHOL AGING, V21, P140, DOI 10.1037/0882-7974.21.1.140; Cacioppo S, 2015, PERSPECT PSYCHOL SCI, V10, P238, DOI 10.1177/1745691615570616; [曹静 Cao Jing], 2013, [中国心理卫生杂志, Chinese Mental Health Journal], V27, P873; Caspi A, 2006, ARCH PEDIAT ADOL MED, V160, P805, DOI 10.1001/archpedi.160.8.805; Chatterjee MB, 2013, PERS SOC PSYCHOL B, V39, P432, DOI 10.1177/0146167213476895; Clark DMT, 2015, PERS INDIV DIFFER, V72, P101, DOI 10.1016/j.paid.2014.08.016; Costa J, 2011, CLIN PSYCHOL PSYCHOT, V18, P34, DOI 10.1002/cpp.699; Cribb G, 2006, BEHAV CHANGE, V23, P165, DOI 10.1375/bech.23.3.165; Diefendorff JM, 2000, J APPL PSYCHOL, V85, P250, DOI 10.1037/0021-9010.85.2.250; Fledderus M, 2010, BEHAV MODIF, V34, P503, DOI 10.1177/0145445510378379; Golden J, 2009, INT J GERIATR PSYCH, V24, P694, DOI 10.1002/gps.2181; Gross JJ., 1998, REV GEN PSYCHOL, V2, P271, DOI 10.1037/1089-2680.2.3.271; Hayes S, 2003, PSYCHOL RECORD; Hayes S. C, 2011, ACCEPTANCE COMMITMEN; Hayes SC, 2006, BEHAV RES THER, V44, P1, DOI 10.1016/j.brat.2005.06.006; Hayes SC, 1996, J CONSULT CLIN PSYCH, V64, P1152, DOI 10.1037/0022-006X.64.6.1152; Hayes SC, 2000, ENCY PSYCHOTHERAPY, V32, P1; Heinrich LA, 2006, CLIN PSYCHOL REV, V26, P695, DOI 10.1016/j.cpr.2006.04.002; Holt-Lunstad J, 2015, PERSPECT PSYCHOL SCI, V10, P227, DOI 10.1177/1745691614568352; Hu LT, 1998, PSYCHOL METHODS, V3, P424, DOI 10.1037/1082-989X.3.4.424; Iacobucci D, 2010, J CONSUM PSYCHOL, V20, P90, DOI 10.1016/j.jcps.2009.09.003; Jobe-Shields L, 2011, MERRILL PALMER QUART, V57, P25; John OP, 2004, J PERS, V72, P1301, DOI 10.1111/j.1467-6494.2004.00298.x; JONES WH, 1982, J PERS SOC PSYCHOL, V42, P682, DOI 10.1037/0022-3514.42.4.682; Karekla M, 2011, J BEHAV THER EXP PSY, V42, P163, DOI 10.1016/j.jbtep.2010.10.002; Kashdan TB, 2006, BEHAV RES THER, V44, P1301, DOI 10.1016/j.brat.2005.10.003; Kelly GA, 1955, CLIN DIAGNOSIS PSYC; Klein K, 2001, J EXP PSYCHOL GEN, V130, P520, DOI 10.1037//0096-3445.130.3.520; Kline R.B., 2005, PRINCIPLES PRACTICE, V2, DOI DOI 10.1038/156278A0; Kong F, 2013, SOC INDIC RES, V110, P271, DOI 10.1007/s11205-011-9930-6; Koole S, 2009, COGNITION EMOTION, V23, P4, DOI 10.1080/02699930802619031; Koole SL, 2004, J PERS SOC PSYCHOL, V87, P974, DOI 10.1037/0022-3514.87.6.974; Kudielka BM, 2009, PSYCHONEUROENDOCRINO, V34, P2, DOI 10.1016/j.psyneuen.2008.10.004; Kuhl J., 1994, VOLITION PERSONALITY, P47; Kuhl J., 1994, VOLITION PERSONALITY; Kurina LM, 2011, SLEEP, V34, P1519, DOI 10.5665/sleep.1390; LEARY MR, 1983, J PERS ASSESS, V47, P66, DOI 10.1207/s15327752jpa4701_8; Lee DJ, 2015, J PSYCHOPATHOL BEHAV, V37, P1; Lin-Li LI, 2013, CHINESE J AESTHETIC; Little TD, 2002, STRUCT EQU MODELING, V9, P151, DOI 10.1207/S15328007SEM0902_1; MIJUSKOVIC B, 1986, CHILD STUDY J, V16, P227; Mikolajczak M, 2008, MAKING MOST OU UNPUB, P192; Mikolajczak M, 2009, BRIT J CLIN PSYCHOL, V48, P181, DOI 10.1348/014466508X386027; Nightingale SM, 2013, LEARN INDIVID DIFFER, V27, P174, DOI 10.1016/j.lindif.2013.08.004; Perlman D, 1981, RGILMOUR SDUCK PERSO; Pinquart M, 2001, BASIC APPL SOC PSYCH, V23, P245, DOI 10.1207/S15324834BASP2304_2; Qualter P, 2013, J ADOLESCENCE, V36, P1283, DOI 10.1016/j.adolescence.2013.01.005; Quirin M, 2011, PSYCHONEUROENDOCRINO, V36, P898, DOI 10.1016/j.psyneuen.2010.12.005; Rucker DD, 2011, SOC PERSONAL PSYCHOL, V5, P359, DOI 10.1111/j.1751-9004.2011.00355.x; Russell D, 1988, DEV EVOLUTION UNPUB; SCHLENKER BR, 1982, PSYCHOL BULL, V92, P641, DOI 10.1037/0033-2909.92.3.641; Sivo SA, 2006, J EXP EDUC, V74, P267, DOI 10.3200/JEXE.74.3.267-288; Song ZL, 2006, J VOCAT BEHAV, V68, P490, DOI 10.1016/j.jvb.2005.11.001; Stewart SH, 2002, BEHAV MODIF, V26, P274, DOI 10.1177/0145445502026002007; Stravynski A, 2001, SUICIDE LIFE-THREAT, V31, P32, DOI 10.1521/suli.31.1.32.21312; Tull MT, 2007, BEHAV THER, V38, P378, DOI 10.1016/j.beth.2006.10.006; Tull MT, 2004, J NERV MENT DIS, V192, P754, DOI 10.1097/01.nmd.0000144694.30121.89; Wells A., 2000, EMOTIONAL DISORDERS, DOI DOI 10.1002/9780470713662; Wols A, 2015, J ADOLESCENCE, V39, P40, DOI 10.1016/j.adolescence.2014.12.007; Zawadzki MJ, 2015, PSYCHOL HLTH; Zysberg L, 2012, J PSYCHOL, V146, P37, DOI 10.1080/00223980.2011.574746	70	12	12	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2016	11	12							e0168536	10.1371/journal.pone.0168536	http://dx.doi.org/10.1371/journal.pone.0168536			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EG7JB	28030586	Green Published, Green Submitted, gold			2022-12-27	WOS:000391222000054
J	Brooks, HL; Pontefract, SK; Vallance, HK; Hirsch, CA; Hughes, E; Ferner, RE; Marriott, JF; Coleman, JJ				Brooks, Hannah L.; Pontefract, Sarah K.; Vallance, Hannah K.; Hirsch, Christine A.; Hughes, Elizabeth; Ferner, Robin E.; Marriott, John F.; Coleman, Jamie J.			Perceptions and Impact of Mandatory eLearning for Foundation Trainee Doctors: A Qualitative Evaluation	PLOS ONE			English	Article							TECHNOLOGY ACCEPTANCE MODEL; VIEWS	Background Junior doctors in the UK must complete various educational components during their two year Foundation training programme. It is important that mandatory learning is informative and engaging. The aim of this study was to evaluate trainee doctors' perceptions of a Technology Enhanced Learning (TEL) programme developed to improve prescribing competency. Method Focus groups and interviews were conducted at three hospital sites in the West Midlands. Codes, sub-themes and themes were determined using deductive and inductive thematic analysis. Results Data were collected from 38 Foundation trainee doctors. Results revealed major themes relating to prescribing education, the user experience and user engagement. Key findings included the positive impact of preparedness following undergraduate education on the user experience of the TEL programme at the postgraduate level; the impact of content, structure, and individual learning needs and styles on the user experience; and the impact of motivation and time on engagement. Most trainees engaged with the programme owing to its mandatory nature; however, some trainees also used the programme voluntarily, for example, to acquire knowledge prior to starting a new placement. Conclusions It is important to ensure that learners are willing to engage with mandatory TEL, and that they have the time and motivation to do so. It is also important to ensure that learners have a positive user experience and that in designing TEL individual differences in learning styles and needs are taken into account. These findings have implications for educators and system developers in the construction and design of mandatory eLearning programmes.	[Brooks, Hannah L.; Pontefract, Sarah K.; Vallance, Hannah K.; Hirsch, Christine A.; Ferner, Robin E.; Marriott, John F.; Coleman, Jamie J.] Univ Birmingham, Coll Med & Dent Sci, Birmingham, W Midlands, England; [Pontefract, Sarah K.; Coleman, Jamie J.] Univ Hosp Birmingham NHS Fdn Trust, Birmingham, W Midlands, England; [Hughes, Elizabeth] Hlth Educ England, Birmingham, W Midlands, England; [Ferner, Robin E.] Sandwell & West Birmingham NHS Trust, West Midlands Ctr Adverse Drug React, Birmingham, W Midlands, England	University of Birmingham; University of Birmingham	Pontefract, SK (corresponding author), Univ Birmingham, Coll Med & Dent Sci, Birmingham, W Midlands, England.; Pontefract, SK (corresponding author), Univ Hosp Birmingham NHS Fdn Trust, Birmingham, W Midlands, England.	s.k.pontefract@bham.ac.uk		Ferner, Robin/0000-0003-3769-1346; Pontefract, Sarah Katie/0000-0002-0344-4075; Coleman, Jamie/0000-0002-7512-5153	Health Education England's West Midland Team	Health Education England's West Midland Team	This study was funded by Health Education England's West Midland Team. This article presents independent research. The views expressed are those of the author(s) and not necessarily those of Health Education England or NHS England. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bonnes S, 2016, ACAD MED; Brooks HL, 2016, BMC MED EDUC, V16, DOI 10.1186/s12909-016-0651-z; Davis F.D., 1986, TECHNOLOGY ACCEPTANC; Goldacre MJ, 2014, POSTGRAD MED J, V90, P63, DOI 10.1136/postgradmedj-2012-131321; Han WH, 2006, SCOT MED J, V51, P27; Hortsch M, 2015, MED TEACH, V37, P507, DOI 10.3109/0142159X.2014.1001341; Jenner LE, 2014, MED TEACH, P1; KEOGH MJ, 2010, BJMP, V3, P306; Kirkpatrick DL, 2009, EVALUATING TRAINING; Patton MQ, 1999, HEALTH SERV RES, V34, P1189; Patton MQ, 2005, QUALITATIVE RES EVAL; Rothwell C, 2012, BRIT J CLIN PHARMACO, V73, P194, DOI 10.1111/j.1365-2125.2011.04061.x; Ruiz JG, 2006, ACAD MED, V81, P207, DOI 10.1097/00001888-200603000-00002; T Dornan, 2009, DEPTH INVESTIGATION; Venkatesh V, 2000, MANAGE SCI, V46, P186, DOI 10.1287/mnsc.46.2.186.11926; Venkatesh V, 2008, DECISION SCI, V39, P273, DOI 10.1111/j.1540-5915.2008.00192.x; Walsh K, 2014, PAN AFR MED J, V19, DOI 10.11604/pamj.2014.19.333.5555; Watmough S, 2009, BMC MED EDUC, V9, DOI 10.1186/1472-6920-9-64; Zehry K, 2011, PROCD SOC BEHV, V15, P3163, DOI 10.1016/j.sbspro.2011.04.265; Zhang MWB, 2014, TECHNOL HEALTH CARE, V22, P847, DOI 10.3233/THC-140861	20	9	9	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2016	11	12							e0168558	10.1371/journal.pone.0168558	http://dx.doi.org/10.1371/journal.pone.0168558			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI9QH	28005938	gold, Green Published, Green Submitted			2022-12-27	WOS:000392843200064
J	Buijink, MR; Almog, A; Wit, CB; Roethler, O; Engberink, AHOO; Meijer, JH; Garlaschelli, D; Rohling, JHT; Michel, S				Buijink, M. Renate; Almog, Assaf; Wit, Charlotte B.; Roethler, Ori; Engberink, Anneke H. O. Olde; Meijer, Johanna H.; Garlaschelli, Diego; Rohling, Jos H. T.; Michel, Stephan			Evidence for Weakened Intercellular Coupling in the Mammalian Circadian Clock under Long Photoperiod	PLOS ONE			English	Article							SUPRACHIASMATIC NUCLEUS; GENE-EXPRESSION; MOUSE; MECHANISMS; RHYTHMS; NEURONS; PHASE; PRECISION; ALTERS; ONSET	For animals living in temperate latitudes, seasonal changes in day length are an important cue for adaptations of their physiology and behavior to the altered environmental conditions. The suprachiasmatic nucleus (SCN) is known as the central circadian clock in mammals, but may also play an important role in adaptations to different photoperiods. The SCN receives direct light input from the retina and is able to encode day-length by approximating the waveform of the electrical activity rhythm to the duration of daylight. Changing the overall waveform requires a reorganization of the neuronal network within the SCN with a change in the degree of synchrony between the neurons; however, the underlying mechanisms are yet unknown. In the present study we used PER2::LUC bioluminescence imaging in cultured SCN slices to characterize network dynamics on the single-cell level and we aimed to provide evidence for a role of modulations in coupling strength in the photoperiodic-induced phase dispersal. Exposure to long photoperiod (LP) induced a larger distribution of peak times of the single-cell PER2::LUC rhythms in the anterior SCN, compared to short photoperiod. Interestingly, the cycle-to-cycle variability in single-cell period of PER2::LUC rhythms is also higher in the anterior SCN in LP, and is positively correlated with peak time dispersal. Applying a new, impartial community detection method on the time series data of the PER2::LUC rhythm revealed two clusters of cells with a specific spatial distribution, which we define as dorsolateral and ventromedial SCN. Post hoc analysis of rhythm characteristics of these clusters showed larger cycle-to-cycle single-cell period variability in the dorsolateral compared to the ventromedial cluster in the anterior SCN. We conclude that a change in coupling strength within the SCN network is a plausible explanation to the observed changes in single-cell period variability, which can contribute to the photoperiod-induced phase distribution.	[Buijink, M. Renate; Wit, Charlotte B.; Roethler, Ori; Engberink, Anneke H. O. Olde; Meijer, Johanna H.; Rohling, Jos H. T.; Michel, Stephan] Leiden Univ, Med Ctr, Neurophysiol Lab, Dept Mol Cell Biol, Leiden, Netherlands; [Almog, Assaf; Garlaschelli, Diego] Leiden Univ, Lorentz Inst Theoret Phys, Leiden, Netherlands	Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University - Excl LUMC	Michel, S (corresponding author), Leiden Univ, Med Ctr, Neurophysiol Lab, Dept Mol Cell Biol, Leiden, Netherlands.	s.michel@lumc.nl	Michel, Stephan/ABC-4211-2021; Garlaschelli, Diego/P-2795-2019; Rohling, Jos/AAC-3516-2022; Garlaschelli, Diego/O-4862-2014	Garlaschelli, Diego/0000-0001-6035-1783; Olde Engberink, Anneke/0000-0002-0100-4770; Rohling, Jos H T/0000-0001-5721-2715; Buijink, Renate/0000-0002-0904-139X	Netherlands Foundation of Technology [STW] [ONTIME 12191]	Netherlands Foundation of Technology [STW]	This work was supported by funding from the Netherlands Foundation of Technology [STW, ONTIME 12191] to SM.	Abel JH, 2016, P NATL ACAD SCI USA, V113, P4512, DOI 10.1073/pnas.1521178113; Abrahamson EE, 2001, BRAIN RES, V916, P172, DOI 10.1016/S0006-8993(01)02890-6; Almog A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0133679; CHEE CA, 1988, NEUROBIOL AGING, V9, P307, DOI 10.1016/S0197-4580(88)80070-8; Coomans CP, 2015, FRONT NEUROENDOCRIN, V37, P29, DOI 10.1016/j.yfrne.2014.11.002; Daan S, 2003, CHRONOBIOL INT, V20, P209, DOI 10.1081/CBI-120019309; de la Iglesia HO, 2000, SCIENCE, V290, P799, DOI 10.1126/science.290.5492.799; DeWoskin D, 2015, P NATL ACAD SCI USA, V112, pE3911, DOI 10.1073/pnas.1420753112; Eilers PHC, 2003, ANAL CHEM, V75, P3631, DOI 10.1021/ac034173t; Evans JA, 2016, NEUROSCIENCE, V320, P259, DOI 10.1016/j.neuroscience.2016.01.072; Evans JA, 2013, NEURON, V80, P973, DOI 10.1016/j.neuron.2013.08.022; Evans JA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015869; Farajnia S, 2014, P NATL ACAD SCI USA, V111, P9627, DOI 10.1073/pnas.1319820111; Farajnia S, 2012, J NEUROSCI, V32, P5891, DOI 10.1523/JNEUROSCI.0469-12.2012; Foley NC, 2011, EUR J NEUROSCI, V33, P1851, DOI 10.1111/j.1460-9568.2011.07682.x; Forger DB, 2005, P NATL ACAD SCI USA, V102, P321, DOI 10.1073/pnas.0408465102; Gonze D, 2006, CHAOS, V16, DOI 10.1063/1.2211767; Gonze D, 2002, P NATL ACAD SCI USA, V99, P673, DOI 10.1073/pnas.022628299; Hazlerigg DG, 2005, CURR BIOL, V15, pR449, DOI 10.1016/j.cub.2005.06.010; Herzog ED, 2004, J BIOL RHYTHM, V19, P35, DOI 10.1177/0748730403260776; Honma S, 2004, NEUROSCI LETT, V358, P173, DOI 10.1016/j.neulet.2004.01.022; Inagaki N, 2007, P NATL ACAD SCI USA, V104, P7664, DOI 10.1073/pnas.0607713104; Krajnak K, 1998, J NEUROSCI, V18, P4767; Laloux L, 1999, PHYS REV LETT, V83, P1467, DOI 10.1103/PhysRevLett.83.1467; MacMahon M, 2015, PHYS REV X, V5, DOI 10.1103/PhysRevX.5.021006; Mickman CT, 2008, AM J PHYSIOL-REG I, V295, pR1688, DOI 10.1152/ajpregu.90510.2008; Myung J, 2015, P NATL ACAD SCI USA, V112, pE3920, DOI 10.1073/pnas.1421200112; Myung J, 2012, J NEUROSCI, V32, P8900, DOI 10.1523/JNEUROSCI.5586-11.2012; Naito E, 2008, J BIOL RHYTHM, V23, P140, DOI 10.1177/0748730408314572; Nygard M, 2005, BRAIN RES BULL, V65, P149, DOI 10.1016/j.brainresbull.2004.12.006; Pauls S, 2014, EUR J NEUROSCI, V40, P2528, DOI 10.1111/ejn.12631; PITTENDRIGH CS, 1976, J COMP PHYSIOL, V106, P223, DOI 10.1007/BF01417856; Savelyev SA, 2011, JOVE-J VIS EXP, DOI 10.3791/2439; Schaap J, 2003, P NATL ACAD SCI USA, V100, P15994, DOI 10.1073/pnas.2436298100; Schroder S, 2012, J BIOL RHYTHM, V27, P79, DOI 10.1177/0748730411429659; Sosniyenko S, 2010, AM J PHYSIOL-REG I, V298, pR959, DOI 10.1152/ajpregu.00561.2009; VanderLeest HT, 2007, CURR BIOL, V17, P468, DOI 10.1016/j.cub.2007.01.048; vanderLeest HT, 2009, CHRONOBIOL INT, V26, P1075, DOI 10.1080/07420520903227746; Yan L, 2007, COLD SH Q B, V72, P527, DOI 10.1101/sqb.2007.72.037; Yoo SH, 2004, P NATL ACAD SCI USA, V101, P5339, DOI 10.1073/pnas.0308709101; Yoshikawa T, 2005, J BIOL RHYTHM, V20, P500, DOI 10.1177/0748730405280775	41	30	30	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2016	11	12							e0168954	10.1371/journal.pone.0168954	http://dx.doi.org/10.1371/journal.pone.0168954			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI9QH	28006027	Green Submitted, Green Published, gold			2022-12-27	WOS:000392843200115
J	Dreano, D; Raitsos, DE; Gittings, J; Krokos, G; Hoteit, I				Dreano, Denis; Raitsos, Dionysios E.; Gittings, John; Krokos, George; Hoteit, Ibrahim			The Gulf of Aden Intermediate Water Intrusion Regulates the Southern Red Sea Summer Phytoplankton Blooms	PLOS ONE			English	Article							SEASONAL OVERTURNING CIRCULATION; STABLE-ISOTOPE RATIOS; ENVIRONMENTAL GRADIENTS; CHLOROPHYLL; MODIS; VARIABILITY; PHENOLOGY; ECOLOGY; IMPACT; CARBON	Knowledge on large-scale biological processes in the southern Red Sea is relatively limited, primarily due to the scarce in situ, and satellite-derived chlorophyll-a (Chl-a) datasets. During summer, adverse atmospheric conditions in the southern Red Sea (haze and clouds) have long severely limited the retrieval of satellite ocean colour observations. Recently, a new merged ocean colour product developed by the European Space Agency (ESA)-the Ocean Color Climate Change Initiative (OC-CCI)-has substantially improved the southern Red Sea coverage of Chl-a, allowing the discovery of unexpected intense summer blooms. Here we provide the first detailed description of their spatiotemporal distribution and report the mechanisms regulating them. During summer, the monsoon-driven wind reversal modifies the circulation dynamics at the Bab-el-Mandeb strait, leading to a subsurface influx of colder, fresher, nutrient-rich water from the Indian Ocean. Using satellite observations, model simulation outputs, and in situ datasets, we track the pathway of this intrusion into the extensive shallow areas and coral reef complexes along the basin's shores. We also provide statistical evidence that the subsurface intrusion plays a key role in the development of the southern Red Sea phytoplankton blooms.	[Dreano, Denis; Hoteit, Ibrahim] King Abdullah Univ Sci & Technol, Comp Elect & Math Sci & Engn Div, Thuwal, Saudi Arabia; [Raitsos, Dionysios E.] Plymouth Marine Lab, Remote Sensing Grp, Plymouth, Devon, England; [Raitsos, Dionysios E.] Plymouth Marine Lab, Natl Ctr Earth Observat, Plymouth, Devon, England; [Gittings, John] King Abdullah Univ Sci & Technol, Biol & Environm Sci & Engn Div, Thuwal, Saudi Arabia; [Krokos, George; Hoteit, Ibrahim] King Abdullah Univ Sci & Technol, Phys Sci & Engn Div, Thuwal, Saudi Arabia	King Abdullah University of Science & Technology; Plymouth Marine Laboratory; Plymouth Marine Laboratory; UK Research & Innovation (UKRI); Natural Environment Research Council (NERC); NERC National Centre for Earth Observation; King Abdullah University of Science & Technology; King Abdullah University of Science & Technology	Hoteit, I (corresponding author), King Abdullah Univ Sci & Technol, Comp Elect & Math Sci & Engn Div, Thuwal, Saudi Arabia.; Hoteit, I (corresponding author), King Abdullah Univ Sci & Technol, Phys Sci & Engn Div, Thuwal, Saudi Arabia.	ibrahim.hoteit@kaust.edu.sa	Krokos, George/AAK-5612-2020; Raitsos, Dionysios/AAA-3031-2021	Krokos, George/0000-0001-7428-0066; Raitsos, Dionysios/0000-0002-6714-2180; Dreano, Denis/0000-0001-7956-5538; Hoteit, Ibrahim/0000-0002-3751-4393; Gittings, John/0000-0003-4183-3482	King Abdullah University of Science and Technology (KAUST), Thuwal, Saudi Arabia; NERC's UK National Centre for Earth Observation; NERC [pml010007, pml010009, nceo020006] Funding Source: UKRI; Natural Environment Research Council [nceo020006, pml010009, pml010007] Funding Source: researchfish	King Abdullah University of Science and Technology (KAUST), Thuwal, Saudi Arabia(King Abdullah University of Science & Technology); NERC's UK National Centre for Earth Observation; NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	This research was funded by King Abdullah University of Science and Technology (KAUST), Thuwal, Saudi Arabia. D.R.E. is funded through the NERCs UK National Centre for Earth Observation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abualnaja Y, 2015, J CLIMATE; Acker J, 2008, J MARINE SYST, V69, P191, DOI 10.1016/j.jmarsys.2005.12.006; Saafani MA, 2007, J OCEANOGR, V63, P1, DOI 10.1007/s10872-007-0001-1; Barbini R, 2004, INT J REMOTE SENS, V25, P2095, DOI 10.1080/01431160310001618086; Belkin IM, 2009, PROG OCEANOGR, V81, P207, DOI 10.1016/j.pocean.2009.04.011; Berumen ML, 2013, CORAL REEFS, V32, P737, DOI 10.1007/s00338-013-1055-8; BOYER TP, 2002, WORLD OCEAN ATLAS 20, V2; Brewin RJW, 2015, REMOTE SENS ENVIRON, V165, P64, DOI 10.1016/j.rse.2015.04.024; Brewin RJW, 2013, REMOTE SENS ENVIRON, V136, P218, DOI 10.1016/j.rse.2013.04.018; Churchill JH, 2014, J MAR RES, V72, P165, DOI 10.1357/002224014814901994; DiBattista J.D., 2015, J BIOGEOGR; Edwards M, 2004, NATURE, V430, P881, DOI 10.1038/nature02808; Gitting J, REMOTE SENS IN PRESS; IOCCG S, 2000, REPORTS INT OCEAN CO, V3; James G., 2014, INTRO STAT LEARNING; Kalnay E, 1996, B AM METEOROL SOC, V77, P437, DOI 10.1175/1520-0477(1996)077<0437:TNYRP>2.0.CO;2; Kohl A, 2008, J PHYS OCEANOGR, V38, P1913, DOI 10.1175/2008JPO3775.1; Kurten B, 2016, PROG OCEANOGR, V140, P69, DOI 10.1016/j.pocean.2015.11.003; Kuerten B, 2014, J SEA RES, V85, P379, DOI 10.1016/j.seares.2013.07.008; Langodan S, 2016, OCEAN ENG, V116, P200, DOI 10.1016/j.oceaneng.2016.02.020; Langodan S, 2014, J PHYS OCEANOGR, V44, P3139, DOI 10.1175/JPO-D-13-0242.1; Lo JCF, 2008, J GEOPHYS RES-ATMOS, V113, DOI 10.1029/2007JD009216; Lo-Yat A, 2011, GLOBAL CHANGE BIOL, V17, P1695, DOI 10.1111/j.1365-2486.2010.02355.x; Longhurst A.R, 2007, EC GEOGR SEA 2 ED; Nanninga GB, 2014, MOL ECOL, V23, P591, DOI 10.1111/mec.12623; National Climatic Data Center, GHRSST LEV 4 AVHRR O; Papadopoulos VP, 2013, J CLIMATE, V26, P1685, DOI 10.1175/JCLI-D-12-00267.1; Papadopoulos VP, J GEOPHYS RES OCEANS; PATZERT WC, 1974, DEEP-SEA RES, V21, P109, DOI 10.1016/0011-7471(74)90068-0; Platt T, 2003, NATURE, V423, P398, DOI 10.1038/423398b; Racault MF, 2015, REMOTE SENS ENVIRON, V160, P222, DOI 10.1016/j.rse.2015.01.019; Raitsos DE, 2015, GEOPHYS RES LETT, V42, P855, DOI 10.1002/2014GL062882; Raitsos DE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064909; Reynolds RW, 2007, J CLIMATE, V20, P5473, DOI 10.1175/2007JCLI1824.1; SHAIKH EA, 1986, MAR BIOL, V92, P405, DOI 10.1007/BF00392681; Shen CY, 2014, INT J REMOTE SENS, V35, P4127, DOI 10.1080/01431161.2014.916056; Skamarock W., 2005, DESCRIPTION ADV RES; Sofianos SS, 2007, J GEOPHYS RES-OCEANS, V112, DOI 10.1029/2006JC003886; Sofianos SS, 2002, J GEOPHYS RES-OCEANS, V107, DOI 10.1029/2001JC001184; SOUVERMEZOGLOU E, 1989, J MAR RES, V47, P441, DOI 10.1357/002224089785076244; Spalding M. D., 2001, WORLD ATLAS CORAL RE; STEPHENS C, 2002, WORLD OCEAN ATLAS 20, V1; Triantafyllou G, 2014, J GEOPHYS RES-OCEANS, V119, P1791, DOI 10.1002/2013JC009641; Viswanadhapalli Y, 2016, INT J CLIMATOL, V37, P1; Wang B, 2001, J CLIMATE, V14, P4073, DOI 10.1175/1520-0442(2001)014<4073:IVOTAS>2.0.CO;2; Yao F, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0138213; Yao FC, 2014, J GEOPHYS RES-OCEANS, V119, P2238, DOI 10.1002/2013JC009004; Yao FC, 2014, J GEOPHYS RES-OCEANS, V119, P2263, DOI 10.1002/2013JC009331; Zhan P, 2015, ENVIRON SCI ENG, P501, DOI 10.1007/978-3-319-13203-7_21; Zhan P, 2014, J GEOPHYS RES-OCEANS, V119, P3909, DOI 10.1002/2013JC009563	50	44	44	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2016	11	12							e0168440	10.1371/journal.pone.0168440	http://dx.doi.org/10.1371/journal.pone.0168440			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI9QH	28006006	Green Published, gold, Green Submitted, Green Accepted			2022-12-27	WOS:000392843200050
J	Jiao, L; Su, M; Chen, L; Wang, YG; Zhu, HL; Dai, HQ				Jiao, Li; Su, Ming; Chen, Liao; Wang, Yuangang; Zhu, Hongli; Dai, Hongqi			Natural Cellulose Nanofibers As Sustainable Enhancers in Construction Cement	PLOS ONE			English	Article							FIBER-REINFORCED CEMENT; MECHANICAL-PROPERTIES; GLASS-FIBER; MICROCRYSTALLINE CELLULOSE; CARBON NANOTUBE; HYDRATION; COMPOSITES; MICROSTRUCTURE; FRACTURE; POLYSACCHARIDES	Cement is one of the mostly used construction materials due to its high durability and low cost, but it suffers from brittle fracture and facile crack initiation. This article describes the use of naturally-derived renewable cellulose nanofibers (CNFs) to reinforce cement. The effects of CNFs on the mechanical properties, degree of hydration (DOH), and microstructure of cement pastes have been studied. It is found that an addition of 0.15% by weight of CNFs leads to a 15% and 20% increase in the flexural and compressive strengths of cement paste. The enhancement in mechanical strength is attributed to high DOH and dense microstructure of cement pastes after adding CNFs.	[Jiao, Li; Dai, Hongqi] Nanjing Forestry Univ, Dept Pulp & Paper Engn, Nanjing, Jiangsu, Peoples R China; [Jiao, Li; Su, Ming] Northeastern Univ, Dept Chem Engn, Boston, MA 02115 USA; [Chen, Liao; Zhu, Hongli] Northeastern Univ, Dept Mech & Ind Engn, Boston, MA 02115 USA; [Wang, Yuangang] Nanjing Forestry Univ, Dept Civil Engn, Nanjing, Jiangsu, Peoples R China	Nanjing Forestry University; Northeastern University; Northeastern University; Nanjing Forestry University	Dai, HQ (corresponding author), Nanjing Forestry Univ, Dept Pulp & Paper Engn, Nanjing, Jiangsu, Peoples R China.	hgdhq@njfu.edu.cn	Wang, Yuan/HHC-1520-2022; Lv, Yuanjie/AER-0767-2022		Introduction of Advanced International Project of Forestry Science and Technology [2015454]; National Natural Science Foundation of China [31470599]; Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD); Nanjing Forestry University Innovation fund program for the Doctorate Fellowship Foundation and Innovation program of Jiangsu province [KYZZ15-0254]	Introduction of Advanced International Project of Forestry Science and Technology; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD); Nanjing Forestry University Innovation fund program for the Doctorate Fellowship Foundation and Innovation program of Jiangsu province	This work was supported by the Introduction of Advanced International Project of Forestry Science and Technology (Grant number: 2015454), the National Natural Science Foundation of China (Grant Number: 31470599) and the Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD). We thank the Nanjing Forestry University Innovation fund program for the Doctorate Fellowship Foundation and Innovation program KYZZ15-0254 of Jiangsu province for their financial support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Azeredo HMC, 2010, J FOOD SCI, V75, pN1, DOI 10.1111/j.1750-3841.2009.01386.x; Balbosh A, 2006, J PROSTHET DENT, V95, P218, DOI 10.1016/j.prosdent.2006.01.006; Batalin BS, 2014, GLASS CERAM+, V71, P294, DOI 10.1007/s10717-014-9672-4; Bentz Dale P., 2009, J MATER CIVIL ENG, V21, P521; Bentz DP, 2006, CEMENT CONCRETE RES, V36, P238, DOI 10.1016/j.cemconres.2005.04.014; Bondeson D, 2006, CELLULOSE, V13, P171, DOI 10.1007/s10570-006-9061-4; Cao Y, 2015, CEMENT CONCRETE COMP, V56, P73, DOI 10.1016/j.cemconcomp.2014.11.008; Chakraborty S, 2013, IND ENG CHEM RES, V52, P1252, DOI 10.1021/ie300607r; Chen LH, 2015, CELLULOSE, V22, P1753, DOI 10.1007/s10570-015-0615-1; Chung DDL, 2001, COMPOS INTERFACE, V8, P67, DOI 10.1163/15685540052543665; Chung DDL, 2001, COMPOSITES B, V31, P511; Das S, 2015, CONSTR BUILD MATER, V93, P360, DOI 10.1016/j.conbuildmat.2015.06.011; Escalante-Garcia JI, 2001, CEMENT CONCRETE RES, V31, P695, DOI 10.1016/S0008-8846(01)00471-9; Farzanian K, 2016, CONSTR BUILD MATER, V109, P156, DOI 10.1016/j.conbuildmat.2015.12.082; Fujisawa S, 2011, CARBOHYD POLYM, V84, P579, DOI 10.1016/j.carbpol.2010.12.029; Hoyos CG, 2013, MATER DESIGN, V51, P810, DOI 10.1016/j.matdes.2013.04.060; Habibi Y, 2006, CELLULOSE, V13, P679, DOI 10.1007/s10570-006-9075-y; Isogai A, 2011, NANOSCALE, V3, P71, DOI 10.1039/c0nr00583e; Iwamoto S, 2009, BIOMACROMOLECULES, V10, P2571, DOI 10.1021/bm900520n; Jacobsen J, 2013, SCI REP-UK, V3, DOI 10.1038/srep02667; Jo BW, 2015, SCI REP-UK, V5, DOI 10.1038/srep07837; Jonoobi M, 2010, COMPOS SCI TECHNOL, V70, P1742, DOI 10.1016/j.compscitech.2010.07.005; Klemm D, 2011, ANGEW CHEM INT EDIT, V50, P5438, DOI 10.1002/anie.201001273; Kordkheili HY, 2015, J FORESTRY RES, V26, P247, DOI 10.1007/s11676-014-0003-y; Lam L, 2000, CEMENT CONCRETE RES, V30, P747, DOI 10.1016/S0008-8846(00)00213-1; Lootens D, 2016, CEMENT CONCRETE COMP, V68, P9, DOI 10.1016/j.cemconcomp.2016.02.010; MacVicar R, 1999, CEMENT CONCRETE COMP, V21, P189, DOI 10.1016/S0958-9465(98)00050-X; Merta I, 2013, CONSTR BUILD MATER, V40, P991, DOI 10.1016/j.conbuildmat.2012.11.060; Mohammadkazemi F, 2015, CONSTR BUILD MATER, V101, P958, DOI 10.1016/j.conbuildmat.2015.10.093; Mohammed MS, 2014, PIGM RESIN TECHNOL, V43, P104, DOI 10.1108/PRT-05-2013-0038; Olivito RS, 2014, MATER DESIGN, V57, P258, DOI 10.1016/j.matdes.2013.11.023; Onuaguluchi O, 2016, CEMENT CONCRETE COMP, V68, P96, DOI 10.1016/j.cemconcomp.2016.02.014; Pane I, 2005, CEMENT CONCRETE RES, V35, P1155, DOI 10.1016/j.cemconres.2004.10.027; Peschard A, 2006, J EUR CERAM SOC, V26, P1439, DOI 10.1016/j.jeurceramsoc.2005.02.005; Peschard A, 2004, CEMENT CONCRETE RES, V34, P2153, DOI 10.1016/j.cemconres.2004.04.001; Poinot T, 2015, CEMENT CONCRETE RES, V70, P50, DOI 10.1016/j.cemconres.2015.01.004; Pourjavadi A, 2013, CEMENT CONCRETE COMP, V37, P196, DOI 10.1016/j.cemconcomp.2012.10.005; Reis JML, 2006, CONSTR BUILD MATER, V20, P673, DOI 10.1016/j.conbuildmat.2005.02.008; Rybin VA, 2016, CORROS SCI, V102, P503, DOI 10.1016/j.corsci.2015.11.004; Saito T, 2007, BIOMACROMOLECULES, V8, P2485, DOI 10.1021/bm0703970; Saito T, 2006, BIOMACROMOLECULES, V7, P1687, DOI 10.1021/bm060154s; Savastano H, 2005, CEMENT CONCRETE COMP, V27, P583, DOI 10.1016/j.cemconcomp.2004.09.009; Sedan D, 2008, J EUR CERAM SOC, V28, P183, DOI 10.1016/j.jeurceramsoc.2007.05.019; da Fonseca BS, 2015, J MATER CIVIL ENG, V27, DOI 10.1061/(ASCE)MT.1943-5533.0001039; Toledo RD, 2000, CEMENT CONCRETE COMP, V22, P127, DOI 10.1016/S0958-9465(99)00039-6; Wang SQ, 2009, J APPL POLYM SCI, V113, P1270, DOI 10.1002/app.30072; Wei JQ, 2016, CORROS SCI, V106, P1, DOI 10.1016/j.corsci.2016.01.020; Wei JQ, 2016, CEMENT CONCRETE RES, V81, P94, DOI 10.1016/j.cemconres.2015.12.001; Xie XL, 2015, COMPOS PART B-ENG, V78, P153, DOI 10.1016/j.compositesb.2015.03.086; Xu SL, 2015, CONSTR BUILD MATER, V76, P16, DOI 10.1016/j.conbuildmat.2014.11.049; Yi XW, 2015, GEOTEXT GEOMEMBRANES, V43, P207, DOI 10.1016/j.geotexmem.2015.03.003; Yu R, 2014, CEMENT CONCRETE RES, V56, P29, DOI 10.1016/j.cemconres.2013.11.002; Zimmermann T, 2010, CARBOHYD POLYM, V79, P1086, DOI 10.1016/j.carbpol.2009.10.045	53	49	51	6	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2016	11	12							e0168422	10.1371/journal.pone.0168422	http://dx.doi.org/10.1371/journal.pone.0168422			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI9QH	28005917	Green Published, Green Submitted, gold			2022-12-27	WOS:000392843200049
J	Li, S; Lin, RK; Bian, CH; Ma, QDY; Ivanov, PC				Li, Shan; Lin, Ruokuang; Bian, Chunhua; Ma, Qianli D. Y.; Ivanov, Plamen Ch.			Model of the Dynamic Construction Process of Texts and Scaling Laws of Words Organization in Language Systems	PLOS ONE			English	Article							LONG-RANGE CORRELATIONS; POWER LAWS; DNA; ZIPFS	Scaling laws characterize diverse complex systems in a broad range of fields, including physics, biology, finance, and social science. The human language is another example of a complex system of words organization. Studies on written texts have shown that scaling laws characterize the occurrence frequency of words, words rank, and the growth of distinct words with increasing text length. However, these studies have mainly concentrated on the western linguistic systems, and the laws that govern the lexical organization, structure and dynamics of the Chinese language remain not well understood. Here we study a database of Chinese and English language books. We report that three distinct scaling laws characterize words organization in the Chinese language. We find that these scaling laws have different exponents and crossover behaviors compared to English texts, indicating different words organization and dynamics of words in the process of text growth. We propose a stochastic feedback model of words organization and text growth, which successfully accounts for the empirically observed scaling laws with their corresponding scaling exponents and characteristic crossover regimes. Further, by varying key model parameters, we reproduce differences in the organization and scaling laws of words between the Chinese and English language. We also identify functional relationships between model parameters and the empirically observed scaling exponents, thus providing new insights into the words organization and growth dynamics in the Chinese and English language.	[Li, Shan; Lin, Ruokuang; Bian, Chunhua] Nanjing Univ, Inst Biomed Elect Engn, Sch Elect Sci & Engn, Minist Educ,Key Lab Modern Acoust, Nanjing 210093, Jiangsu, Peoples R China; [Bian, Chunhua; Ma, Qianli D. Y.; Ivanov, Plamen Ch.] Boston Univ, Dept Phys, Keck Lab Network Physiol, 590 Commonwealth Ave, Boston, MA 02215 USA; [Bian, Chunhua] Harvard Med Sch, Dept Neurol, Beth Israel Deaconess Med Ctr, Boston, MA 02215 USA; [Bian, Chunhua] Harvard Med Sch, Program Neurosci, Beth Israel Deaconess Med Ctr, Boston, MA 02215 USA; [Ma, Qianli D. Y.] Nanjing Univ Posts & Telecommun, Coll Geog & Biol Informat, Nanjing 210003, Peoples R China; [Ma, Qianli D. Y.; Ivanov, Plamen Ch.] Harvard Med Sch, Boston, MA 02115 USA; [Ma, Qianli D. Y.; Ivanov, Plamen Ch.] Brigham & Womens Hosp, Div Sleep Med, 75 Francis St, Boston, MA 02115 USA; [Ivanov, Plamen Ch.] Bulgarian Acad Sci, Inst Solid State Phys, Blvd Lenin 72, BU-1784 Sofia, Bulgaria	Nanjing University; Boston University; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Nanjing University of Posts & Telecommunications; Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Bulgarian Academy of Sciences	Bian, CH (corresponding author), Nanjing Univ, Inst Biomed Elect Engn, Sch Elect Sci & Engn, Minist Educ,Key Lab Modern Acoust, Nanjing 210093, Jiangsu, Peoples R China.; Bian, CH; Ivanov, PC (corresponding author), Boston Univ, Dept Phys, Keck Lab Network Physiol, 590 Commonwealth Ave, Boston, MA 02215 USA.; Bian, CH (corresponding author), Harvard Med Sch, Dept Neurol, Beth Israel Deaconess Med Ctr, Boston, MA 02215 USA.; Bian, CH (corresponding author), Harvard Med Sch, Program Neurosci, Beth Israel Deaconess Med Ctr, Boston, MA 02215 USA.; Ivanov, PC (corresponding author), Harvard Med Sch, Boston, MA 02115 USA.; Ivanov, PC (corresponding author), Brigham & Womens Hosp, Div Sleep Med, 75 Francis St, Boston, MA 02115 USA.; Ivanov, PC (corresponding author), Bulgarian Acad Sci, Inst Solid State Phys, Blvd Lenin 72, BU-1784 Sofia, Bulgaria.	bch@nju.edu.cn; plamen@buphy.bu.edu	Ivanov, Plamen Ch./E-8004-2012	Ivanov, Plamen Ch./0000-0001-7629-762X	National Natural Science Foundation of China [61271082, 61201029]; Fundamental Research Funds for the Central Universities of China; Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD); Nanjing University Scholar Exchange Project; National Institutes of Health (NIH) [1R01-HL098437]; US-Israel Binational Science Foundation (BSF) [2008137]; W.M. Keck Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL098437] Funding Source: NIH RePORTER	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fundamental Research Funds for the Central Universities of China(Fundamental Research Funds for the Central Universities); Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD); Nanjing University Scholar Exchange Project; National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); US-Israel Binational Science Foundation (BSF)(US-Israel Binational Science Foundation); W.M. Keck Foundation(W.M. Keck Foundation); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work is supported by the National Natural Science Foundation of China (61271082, 61201029, recipient, Q.D.Y.M); Fundamental Research Funds for the Central Universities of China, Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD, recipient, C.B.); Nanjing University Scholar Exchange Project (recipient, C.B.); National Institutes of Health (NIH Grant 1R01-HL098437, recipient, P.Ch. I.); the US-Israel Binational Science Foundation (BSF Grant 2008137, recipient P.Ch. I.); and the W.M. Keck Foundation (recipient, P.Ch. I.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1989, OXFORD ENGLISH DICT; ARNEODO A, 1995, PHYS REV LETT, V74, P3293, DOI 10.1103/PhysRevLett.74.3293; Berryman MJ, 2003, FLUCT NOISE LETT, V3, pL1, DOI 10.1142/S021947750300104X; Bian CH, 2016, EPL-EUROPHYS LETT, V113, DOI 10.1209/0295-5075/113/18002; Blank A, 2000, PHYSICA A, V287, P279, DOI 10.1016/S0378-4371(00)00464-7; Carpena P, 2009, PHYS REV E, V79, DOI 10.1103/PhysRevE.79.035102; EBELING W, 1995, PHYSICA A, V215, P233, DOI 10.1016/0378-4371(95)00025-3; Font-Clos F, 2013, NEW J PHYS, V15, DOI 10.1088/1367-2630/15/9/093033; Golosovsky M, 2012, PHYS REV LETT, V109, DOI 10.1103/PhysRevLett.109.098701; Hackenberg M, 2012, J THEOR BIOL, V297, P127, DOI 10.1016/j.jtbi.2011.12.024; Hatzigeorgiu N., 2001, J QUANT LINGUIST, V8, P175, DOI [10.1076/jqul.8.3.175.4096, DOI 10.1076/JQUL.8.3.175.4096]; Heaps Harold Stanley, 1978, INFORM RETRIEVAL COM; Ivanov PC, 1998, EUROPHYS LETT, V43, P363, DOI 10.1209/epl/i1998-00366-3; Ivanov PC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092885; Levy M, 1997, PHYSICA A, V242, P90, DOI 10.1016/S0378-4371(97)00217-3; Lu LY, 2013, SCI REP-UK, V3, DOI 10.1038/srep01082; Lu L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014139; Makse HA, 1996, PHYS REV E, V54, P3129, DOI 10.1103/PhysRevE.54.3129; Makse HA, 1995, NATURE, V377, P779; Newman MEJ, 2005, CONTEMP PHYS, V46, P323, DOI 10.1080/00107510500052444; Ortuno M, 2002, EUROPHYS LETT, V57, P759, DOI 10.1209/epl/i2002-00528-3; Perc M, 2013, J R SOC INTERFACE, V10, DOI 10.1098/rsif.2012.0997; Petersen AM, 2012, SCI REP-UK, V2, DOI 10.1038/srep00313; Putnins TJ, 2006, PROC SPIE, V6039, DOI 10.1117/12.639281; Romero NE, 2010, EPL-EUROPHYS LETT, V90, DOI 10.1209/0295-5075/90/18004; SHTRIKMAN S, 1994, J INFORM SCI, V20, P142, DOI 10.1177/016555159402000208; Solomon S, 1996, INT J MOD PHYS C, V7, P745, DOI 10.1142/S0129183196000624; Solomon S, 2001, LECT NOTES EC MATH S, V503, P141, DOI [10.1007/978-3-642-56472-7_10, DOI 10.1007/978-3-642-56472-7_10]; van Leijenhorst DC, 2005, INFORM SCIENCES, V170, P263, DOI 10.1016/j.ins.2004.03.006; Zipf G. K., 1949, HUMAN BEHAV PRINCIPL	30	5	5	2	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2016	11	12							e0168971	10.1371/journal.pone.0168971	http://dx.doi.org/10.1371/journal.pone.0168971			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI9QH	28006026	Green Submitted, Green Published, gold			2022-12-27	WOS:000392843200118
J	Yeh, JJ; Wang, YC; Lin, CC; Lin, CL; Hsu, WH				Yeh, Jun-Jun; Wang, Yu-Chiao; Lin, Che-Chen; Lin, Cheng-Li; Hsu, Wu-Huei			Association of Respiratory Tuberculosis with Incident Bone Fracture: Bridging the Tuberculosis Airway Infection and the Osteoporotic Bone	PLOS ONE			English	Article							MINERAL DENSITY; HIGH-RISK; PREVENTION; CORTICOSTEROIDS; LIGAND; GAMMA	Objective The relationship between respiratory tuberculosis (RT) and incident fragility fracture and osteoporosis/fragility fracture in the general population is not well determined; therefore, we conducted a nationwide cohort study to investigate this relationship. Methods We used the National Health Insurance Research Database of Taiwan to identify 6612 newly diagnosed patients with RT (RT cohort) and 13220 patients without RT (non-RT cohort) from 1999 to 2005. The mean durations of follow-up were (6.73 +/- 4.00 years, 8.11 +/- 3.24 years) in the (RT cohort, non-RT cohort); respectively. The occurrence of incident fragility fracture and osteoporosis/fragility fracture were followed up until the end of 2011. The adjusted hazard ratios (aHRs) and 95% confidence intervals (CIs) and 98% CIs of incident fragility fracture and osteoporosis/fragility fracture were estimated using the multivariable Cox proportional hazard model after adjusting for age, sex, occupation, drug use, and comorbidities. Results A Cox proportional hazards regression analysis was performed and showed the aHRs of [incident fragility fracture; osteoporosis/fragility fracture] were [1.69 (95% CI = 1.26 +/- 2.28, 98% CI = 1.18 +/- 2.44); 1.42 (95% CI = 1.25 +/- 1.61, 98% CI = 1.21 +/- 1.65)] between the RT and non-RT cohorts. Regarding the sex, the aHRs of the [incident fragility fracture; osteoporosis /fragility fracture] were [1.57 (98% CI = 1.10 +/- 2.23, 98% CI = 1.02 +/- 2.41); 1.15 (95% CI = 0.97 +/- 1.36, 98% CI = 0.94 +/- 1.41)] in the men. The aHRs of the RT cohort without oral steroid use in the [incident fragility fracture; osteoporosis /fragility fracture] were [1.87 (95% CI = 1.20-2.90, 98% CI = 1.09-3.19); 1.41 (95% CI = 1.19-1.67, 98% CI = 1.14-1.74)]. Conclusion The RT associated with the incident fragility fracture, either in men or absence of oral steroid use.	[Yeh, Jun-Jun] Ditmanson Med Fdn, Chia Yi Christian Hosp, Chiayi, Taiwan; [Yeh, Jun-Jun] Chia Nan Univ Pharm & Sci, Tainan, Taiwan; [Yeh, Jun-Jun] Meiho Univ, Pingtung, Taiwan; [Wang, Yu-Chiao; Lin, Che-Chen; Lin, Cheng-Li] China Med Univ Hosp, Management Off Hlth Data, Taichung, Taiwan; [Wang, Yu-Chiao; Lin, Che-Chen; Lin, Cheng-Li] China Med Univ, Coll Med, Taichung, Taiwan; [Hsu, Wu-Huei] China Med Univ, Coll Med, Grad Inst Clin Med Sci, Taichung, Taiwan; [Hsu, Wu-Huei] China Med Univ, Coll Med, Sch Med, Taichung, Taiwan; [Hsu, Wu-Huei] China Med Univ Hosp, Dept Internal Med, Div Pulm & Crit Care Med, Taichung, Taiwan	Chia Nan University of Pharmacy & Science; China Medical University Taiwan; China Medical University Hospital - Taiwan; China Medical University Taiwan; China Medical University Taiwan; China Medical University Taiwan; China Medical University Taiwan; China Medical University Hospital - Taiwan	Hsu, WH (corresponding author), China Med Univ, Coll Med, Grad Inst Clin Med Sci, Taichung, Taiwan.; Hsu, WH (corresponding author), China Med Univ, Coll Med, Sch Med, Taichung, Taiwan.; Hsu, WH (corresponding author), China Med Univ Hosp, Dept Internal Med, Div Pulm & Crit Care Med, Taichung, Taiwan.	pccm.hsu@gmail.com			Taiwan Ministry of Health and Welfare Clinical Trial and Research Center of Excellence [MOHW105-TDU-B-212-133019]; China Medical University Hospital, Academia Sinica Taiwan Biobank Stroke Biosignature Project [BM10501010037]; NRPB Stroke Clinical Trial Consortium [MOST 104-2325-B-039-005]; Tseng-Lien Lin Foundation, Taichung, Taiwan; Taiwan Brain Disease Foundation, Taipei, Taiwan; Katsuzo and Kiyo Aoshima Memorial Funds, Japan; CMU under the Aim for Top University Plan of the Ministry of Education, Taiwan	Taiwan Ministry of Health and Welfare Clinical Trial and Research Center of Excellence; China Medical University Hospital, Academia Sinica Taiwan Biobank Stroke Biosignature Project; NRPB Stroke Clinical Trial Consortium; Tseng-Lien Lin Foundation, Taichung, Taiwan; Taiwan Brain Disease Foundation, Taipei, Taiwan; Katsuzo and Kiyo Aoshima Memorial Funds, Japan; CMU under the Aim for Top University Plan of the Ministry of Education, Taiwan	This study is supported in part by Taiwan Ministry of Health and Welfare Clinical Trial and Research Center of Excellence (MOHW105-TDU-B-212-133019), China Medical University Hospital, Academia Sinica Taiwan Biobank Stroke Biosignature Project (BM10501010037), NRPB Stroke Clinical Trial Consortium (MOST 104-2325-B-039-005), Tseng-Lien Lin Foundation, Taichung, Taiwan, Taiwan Brain Disease Foundation, Taipei, Taiwan, and Katsuzo and Kiyo Aoshima Memorial Funds, Japan; and CMU under the Aim for Top University Plan of the Ministry of Education, Taiwan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.	Apalset EM, 2014, OSTEOPOROSIS INT, V25, P2067, DOI 10.1007/s00198-014-2720-7; Armstrong RA, 2014, OPHTHAL PHYSL OPT, V34, P502, DOI 10.1111/opo.12131; Burge R, 2007, J BONE MINER RES, V22, P465, DOI [10.1359/jbmr.061113, 10.1359/JBMR.061113]; Chen HW, 2014, CELL BIOCHEM BIOPHYS, V70, P1759, DOI 10.1007/s12013-014-0125-z; Curtis JR, 2009, OSTEOPOROSIS INT, V20, P1969, DOI 10.1007/s00198-009-0840-2; del Rey A, 2007, BRAIN BEHAV IMMUN, V21, P171, DOI 10.1016/j.bbi.2006.06.005; Dong HV, 2014, AIDS, V28, P2119, DOI 10.1097/QAD.0000000000000363; Dooley DP, 1997, CLIN INFECT DIS, V25, P872, DOI 10.1086/515543; Evans DJ, 2008, RESP MED, V102, P793, DOI 10.1016/j.rmed.2008.01.018; Forli L, 2004, J INTERN MED, V256, P56, DOI 10.1111/j.1365-2796.2004.01337.x; Ho-Pham LT, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-306; Hodgson Stephen F, 2003, Endocr Pract, V9, P544; Holloway KL, 2011, HOMO, V62, P402, DOI 10.1016/j.jchb.2011.10.001; Holloway KL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062798; Hwang JS, 2014, J BONE MINER METAB, V32, P10, DOI 10.1007/s00774-013-0495-0; Kanis JA, 2013, OSTEOPOROSIS INT, V24, P23, DOI 10.1007/s00198-012-2074-y; Kim M, 1998, TUBERC RESP DIS, V45, P1167; Lai SW, 2013, J EPIDEMIOL, V23, P109, DOI 10.2188/jea.JE20120071; Li XJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074274; Liu H, 2008, ANN INTERN MED, V148, P685, DOI 10.7326/0003-4819-148-9-200805060-00009; Liu SF, 2016, INT J CHRONIC OBSTR, V11, P1607, DOI 10.2147/COPD.S106054; Liu S, 2015, CLIN REHABIL, V29, P285, DOI 10.1177/0269215514542358; McGowan B, 2012, IRISH J MED SCI, V181, P511, DOI 10.1007/s11845-012-0806-9; Nanjundaiah SM, 2013, EVID-BASED COMPL ALT, V2013, DOI 10.1155/2013/518094; Osteoporosis, 2009, AM FAM PHYSICIAN, V79, P201; Pattamapaspong N, 2011, SEMIN MUSCULOSKEL R, V15, P459, DOI 10.1055/s-0031-1293492; Perneger TV, 1998, BRIT MED J, V316, P1236, DOI 10.1136/bmj.316.7139.1236; Pietri M, 2007, CLIN CASES MINER BON, V4, P108; Romas E, 2009, INTERN MED J, V39, P110, DOI 10.1111/j.1445-5994.2008.01732.x; Sale JEM, 2014, CLIN GERIATR MED, V30, P317, DOI 10.1016/j.cger.2014.01.009; Sambrook P, 2006, LANCET, V367, P2010, DOI 10.1016/S0140-6736(06)68891-0; Savula M M, 2004, Probl Tuberk Bolezn Legk, P45; Shriraam Vanishree, 2014, Indian J Endocrinol Metab, V18, P7, DOI 10.4103/2230-8210.126521; Spiegel DA, 2005, TECH ORTHOP, V20, P167, DOI 10.1097/01.bto.0000167745.24646.dc; Trouvin AP, 2010, CLIN INTERV AGING, V5, P345, DOI 10.2147/CIA.S10153; Vanderspank D, 2014, BIOL RES NURS, V16, P7, DOI 10.1177/1099800412463120; Wang NB, 2005, CHINESE J CLIN REHAB, V9, P176; Wang YD, 2006, CELL MOL IMMUNOL, V3, P41; Yang TS, 2004, OSTEOPOROSIS INT, V15, P345, DOI 10.1007/s00198-003-1509-x; Yang YC, 2015, CLINICOECONOMIC OUTC, V7, P205, DOI 10.2147/CEOR.S77175; Yanik B, 2009, CLINICS, V64, P313, DOI 10.1590/S1807-59322009000400008; Yeh CC, 2013, MAYO CLIN PROC, V88, P1091, DOI 10.1016/j.mayocp.2013.06.024; Yeh MC, 2015, J CLIN ENDOCR METAB, V100, P2413, DOI 10.1210/jc.2014-4316; Yen YF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079644	44	3	5	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2016	11	12							e0168673	10.1371/journal.pone.0168673	http://dx.doi.org/10.1371/journal.pone.0168673			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI9QH	28005963	Green Submitted, Green Published, gold			2022-12-27	WOS:000392843200077
J	Yu, XJ; Wang, CY; Hu, HJ; Liu, HF				Yu, Xingjian; Wang, Chenye; Hu, Hongjie; Liu, Huafeng			Low Dose PET Image Reconstruction with Total Variation Using Alternating Direction Method	PLOS ONE			English	Article							TOTAL VARIATION MINIMIZATION; AUGMENTED LAGRANGIAN METHOD; BAYESIAN RECONSTRUCTION; ALGORITHM; SHRINKAGE	In this paper, a total variation (TV) minimization strategy is proposed to overcome the problem of sparse spatial resolution and large amounts of noise in low dose positron emission tomography (PET) imaging reconstruction. Two types of objective function were established based on two statistical models of measured PET data, least-square (LS) TV for the Gaussian distribution and Poisson-TV for the Poisson distribution. To efficiently obtain high quality reconstructed images, the alternating direction method (ADM) is used to solve these objective functions. As compared with the iterative shrinkage/thresholding (1ST) based algorithms, the proposed ADM can make full use of the TV constraint and its convergence rate is faster. The performance of the proposed approach is validated through comparisons with the expectation-maximization (EM) method using synthetic and experimental biological data. In the comparisons, the results of both LS-TV and Poisson-TV are taken into consideration to find which models are more suitable for PET imaging, in particular low-dose PET. To evaluate the results quantitatively, we computed bias, variance, and the contrast recovery coefficient (CRC) and drew profiles of the reconstructed images produced by the different methods. The results show that both Poisson-TV and LS-TV can provide a high visual quality at a low dose level. The bias and variance of the proposed LS-TV and Poisson-TV methods are 20% to 74% less at all counting levels than those of the EM method. Poisson TV gives the best performance in terms of high-accuracy reconstruction with the lowest bias and variance as compared to the ground truth (14.3% less bias and 21.9% less variance). In contrast, LS-TV gives the best performance in terms of the high contrast of the reconstruction with the highest CRC.	[Yu, Xingjian; Wang, Chenye; Liu, Huafeng] Zhejiang Univ, Dept Opt Engn, State Key Lab Modern Opt Instrumentat, Hangzhou, Zhejiang, Peoples R China; [Hu, Hongjie] Zhejiang Univ, Sir Run Run Shaw Hosp, Hangzhou, Zhejiang, Peoples R China	Zhejiang University; Zhejiang University	Liu, HF (corresponding author), Zhejiang Univ, Dept Opt Engn, State Key Lab Modern Opt Instrumentat, Hangzhou, Zhejiang, Peoples R China.	liuhf@zju.edu.cn			National Natural Science Foundation of China [61427807, 61271083, 61525106]; National Key Technology Research and Development Program of the Ministry of Science and Technology of China [2016YFC1300302]; Shenzhen Innovation Funding [SGLH20131010110119871]; Zhejiang Province Science and Technology Projects [2015C33061]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Key Technology Research and Development Program of the Ministry of Science and Technology of China(National Key Technology R&D Program); Shenzhen Innovation Funding; Zhejiang Province Science and Technology Projects	This work is supported in part by the National Natural Science Foundation of China (No: 61427807, 61271083,61525106), by National Key Technology Research and Development Program of the Ministry of Science and Technology of China (No: 2016YFC1300302), by the Shenzhen Innovation Funding (SGLH20131010110119871), by Zhejiang Province Science and Technology Projects (No: 2015C33061). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alizadeh F, 2003, MATH PROGRAM, V95, P3, DOI 10.1007/s10107-002-0339-5; BAILEY DL, 1994, PHYS MED BIOL, V39, P411, DOI 10.1088/0031-9155/39/3/009; BARZILAI J, 1988, IMA J NUMER ANAL, V8, P141, DOI 10.1093/imanum/8.1.141; Beck A, 2009, SIAM J IMAGING SCI, V2, P183, DOI 10.1137/080716542; Bioucas-Dias JM, 2007, IEEE T IMAGE PROCESS, V16, P2992, DOI 10.1109/TIP.2007.909319; Burger M, 2014, INVERSE PROBL, V30, DOI 10.1088/0266-5611/30/10/105003; Chambolle A, 1997, NUMER MATH, V76, P167, DOI 10.1007/s002110050258; Chambolle A, 2004, J MATH IMAGING VIS, V20, P89; Chan T, 2006, HANDBOOK OF MATHEMATICAL MODELS IN COMPUTER VISION, P17, DOI 10.1007/0-387-28831-7_2; Chan TF, 2006, SIAM J APPL MATH, V66, P1632, DOI 10.1137/040615286; Chen CH, 2012, IMA J NUMER ANAL, V32, P227, DOI 10.1093/imanum/drq039; Cheng JC, 2012, MED PHYS, V39, P1029, DOI 10.1118/1.3678489; Cheng-Liao JX, 2011, PHYS MED BIOL, V56, P6899, DOI 10.1088/0031-9155/56/21/009; Christe SA, 2012, ARXIV12012542; Elad M, 2006, IEEE T INFORM THEORY, V52, P5559, DOI 10.1109/TIT.2006.885522; Fessler J. A., 2012, IMAGE RECONSTRUCTION; FESSLER JA, 1994, IEEE T MED IMAGING, V13, P290, DOI 10.1109/42.293921; Figueiredo Mario A. T., 2011, P 28 INT C MACH LEAR, P169; Gaitanis A, 2010, COMPUT MED IMAG GRAP, V34, P131, DOI 10.1016/j.compmedimag.2009.07.006; Gill PE, 2012, COMPUT OPTIM APPL, V51, P1, DOI 10.1007/s10589-010-9339-1; Goldfarb D, 2005, SIAM J SCI COMPUT, V27, P622, DOI 10.1137/040608982; GREEN PJ, 1990, IEEE T MED IMAGING, V9, P84, DOI 10.1109/42.52985; HEBERT T, 1989, IEEE T MED IMAGING, V8, P194, DOI 10.1109/42.24868; Henry T, 2012, MED IMAGING PRINCIPL; Hestenes M. R., 1969, Journal of Optimization Theory and Applications, V4, P303, DOI 10.1007/BF00927673; HUDSON HM, 1994, IEEE T MED IMAGING, V13, P601, DOI 10.1109/42.363108; Jan S, 2004, PHYS MED BIOL, V49, P4543, DOI 10.1088/0031-9155/49/19/007; Meza JC, 2010, WIRES COMPUT STAT, V2, P719, DOI 10.1002/wics.117; MUMCUOGLU EU, 1994, IEEE T MED IMAGING, V13, P687, DOI 10.1109/42.363099; Mumcuoglu EU, 1996, PHYS MED BIOL, V41, P1777, DOI 10.1088/0031-9155/41/9/015; Osher S, 2005, MULTISCALE MODEL SIM, V4, P460, DOI 10.1137/040605412; Powell M.J., 1967, METHOD NONLINEAR CON; Sawatzky A, 2009, LECT NOTES COMPUT SC, V5702, P533, DOI 10.1007/978-3-642-03767-2_65; Shepp L A, 1982, IEEE Trans Med Imaging, V1, P113, DOI 10.1109/TMI.1982.4307558; Stutzer K, 2013, PHYS MED BIOL, V58, DOI 10.1088/0031-9155/58/15/5085; Tomioka R, 2011, J MACH LEARN RES, V12, P1537; Vese LA, 2003, J SCI COMPUT, V19, P553, DOI 10.1023/A:1025384832106; Wang YL, 2008, SIAM J IMAGING SCI, V1, P248, DOI 10.1137/080724265; Wu CL, 2011, INVERSE PROBL IMAG, V5, P237, DOI 10.3934/ipi.2011.5.237; Wu CL, 2010, SIAM J IMAGING SCI, V3, P300, DOI 10.1137/090767558; Yang JF, 2010, IEEE J-STSP, V4, P288, DOI 10.1109/JSTSP.2010.2042333; Ye XJ, 2011, IEEE T MED IMAGING, V30, P1055, DOI 10.1109/TMI.2010.2073717; Yuan YX., 2008, AMSIP STUD ADV MATH, V42, P785; Zhou J, 2008, COMPUT MED IMAG GRAP, V32, P710, DOI 10.1016/j.compmedimag.2008.08.008	44	4	5	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2016	11	12							e0166871	10.1371/journal.pone.0166871	http://dx.doi.org/10.1371/journal.pone.0166871			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI9QH	28005929	Green Published, Green Submitted, gold			2022-12-27	WOS:000392843200008
J	Kavitha, MS; Park, SY; Heo, MS; Chien, SI				Kavitha, Muthu Subash; Park, Soon-Yong; Heo, Min-Suk; Chien, Sung-Il			Distributional Variations in the Quantitative Cortical and Trabecular Bone Radiographic Measurements of Mandible, between Male and Female Populations of Korea, and its Utilization	PLOS ONE			English	Article							MINERAL DENSITY; FRACTAL DIMENSION; RADIOMORPHOMETRIC INDEXES; PANORAMIC RADIOGRAPHS; OSTEOPOROSIS; WOMEN; RISK; FRACTURES; DIAGNOSIS; MEN	It is important to investigate the irregularities in aging-associated changes in bone, between men and women for bone strength and osteoporosis. The purpose of this study was to characterize the changes and associations of mandibular cortical and trabecular bone measures of men and women based on age and to the evaluation of cortical shape categories, in a large Korean population. Panoramic radiographs of 1047 subjects (603 women and 444 men) aged between 15 to 90 years were used. Mandibular cortical width (MCW), mandibular cortical index (MCI), and fractal dimensions (FD) of the molar, premolar, and anterior regions of the mandibular trabecular bone were measured. Study subjects were grouped into six 10-years age groups. A local linear regression smoothing with bootstrap resampling for robust fitting of data was used to estimate the relationship between radiographic mandibular variables and age groups as well as genders. The mean age of women (49.56 +/- 19.5 years) was significantly higher than that of men (45.57 +/- 19.6 years). The MCW of men and women (3.17mm and 2.91mm, respectively, p < 0.0001) was strongly associated with age and MCI. Indeed, trabecular measures also correlated with age in men (r>-0.140, p = 0.003), though not as strongly as in women (r>-0.210, p < 0.0001). In men aged over 55 years, only MCW was significantly associated (r=-0.412, p < 0.0001). Furthermore, by comparison of mandibular variables from different age groups and MCI categories, the results suggest that MCW was detected to be strongly associated in both men and women for the detection of bone strength and osteoporosis. The FD measures revealed relatively higher association with age among women than men, but not as strong as MCW.	[Kavitha, Muthu Subash; Chien, Sung-Il] Kyungpook Natl Univ, Dept Comp Vis & Image Proc, Sch Elect Engn, Daegu, South Korea; [Park, Soon-Yong] Kyungpook Natl Univ, Dept Comp & Robot Vis, Sch Comp Sci & Engn, Daegu, South Korea; [Heo, Min-Suk] Seoul Natl Univ, Sch Dent, Dept Oral & Maxillofacial Radiol, Seoul, South Korea	Kyungpook National University; Kyungpook National University; Seoul National University (SNU)	Chien, SI (corresponding author), Kyungpook Natl Univ, Dept Comp Vis & Image Proc, Sch Elect Engn, Daegu, South Korea.; Heo, MS (corresponding author), Seoul Natl Univ, Sch Dent, Dept Oral & Maxillofacial Radiol, Seoul, South Korea.	hmslsh@snu.ac.kr; sichien@ee.knu.ac.kr	Kavitha, M.S./AAI-6438-2020; Park, Soon-Yong/HGV-2374-2022	Kavitha, Muthu Subash/0000-0002-1676-561X; Heo, Min-Suk/0000-0003-3406-0645	BK21 Plus project - Ministry of Education, Korea [21A20131600011]	BK21 Plus project - Ministry of Education, Korea	This study was supported by the BK21 Plus project funded by the Ministry of Education, Korea (21A20131600011).	Alman AC, 2012, OSTEOPOROSIS INT, V23, P1631, DOI 10.1007/s00198-011-1678-y; Amer ME, 2012, IMAGNG SCI DENT, V42, P5, DOI 10.5624/isd.2012.42.1.5; Apolinario AC, 2016, DENTOMAXILLOFAC RAD, V45, DOI 10.1259/dmfr.20150400; Bollen AM, 2000, ORAL SURG ORAL MED O, V90, P518, DOI 10.1067/moe.2000.107802; Demirbas AK, 2008, ORAL SURG ORAL MED O, V106, pE41, DOI 10.1016/j.tripleo.2008.03.007; Drozdzowska B, 2002, DENTOMAXILLOFAC RAD, V31, P361, DOI 10.1038/sj.dmfr.4600729; Gulsahi A, 2008, DENTOMAXILLOFAC RAD, V37, P288, DOI 10.1259/dmfr/19491030; Gulsahi A, 2010, DENTOMAXILLOFAC RAD, V39, P284, DOI 10.1259/dmfr/20522657; Kanis JA, 2002, LANCET, V359, P1929, DOI 10.1016/S0140-6736(02)08761-5; Kavitha MS, 2016, DENTOMAXILLOFAC RAD, V45, DOI 10.1259/dmfr.20160076; Kavitha MS, 2015, OR SURG OR MED OR PA, V119, P346, DOI 10.1016/j.oooo.2014.11.009; Kazakia GJ, 2013, BONE, V52, P623, DOI 10.1016/j.bone.2012.10.031; Kim J, 2016, EC BURDEN OSTEOPOROT, V9C, P36; KLEMETTI E, 1994, SCAND J DENT RES, V102, P68; Koh KJ, 2012, IMAGNG SCI DENT, V42, P231, DOI 10.5624/isd.2012.42.4.231; Nguyen TV, 2004, MED J AUSTRALIA, V180, pS18; Okabe S, 2008, ORAL SURG ORAL MED O, V106, P433, DOI 10.1016/j.tripleo.2007.09.013; Oliveira ML, 2013, CLIN ORAL INVEST, V17, P1847, DOI 10.1007/s00784-012-0882-2; Park C, 2011, J BONE MINER METAB, V29, P744, DOI 10.1007/s00774-011-0279-3; Poole KES, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016190; Roberts M, 2011, OSTEOPOROSIS INT, V22, P1915, DOI 10.1007/s00198-010-1410-3; Roberts MG, 2013, IEEE T BIO-MED ENG, V60, P2384, DOI 10.1109/TBME.2013.2256908; Rushton VE, 1996, J DENT, V24, P185, DOI 10.1016/0300-5712(95)00055-0; Sapthagirivasan V, 2013, COMPUT BIOL MED, V43, P1910, DOI 10.1016/j.compbiomed.2013.09.002; Scheiner S, 2015, COMPUT MED IMAG GRAP, V45, P36, DOI 10.1016/j.compmedimag.2015.06.005; Sharma G, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0144180; Sindeaux R, 2014, MATURITAS, V77, P142, DOI 10.1016/j.maturitas.2013.10.011; TAGUCHI A, 1995, ORAL SURG ORAL MED O, V79, P127, DOI 10.1016/S1079-2104(05)80088-5; Walsh J, 2011, INT J BIOL MED SCI, V1, P33; Watanabe Plauto Christopher Aranha, 2007, Int. J. Morphol., V25, P875, DOI 10.4067/S0717-95022007000400031; White SC, 2000, DENTOMAXILLOFAC RAD, V29, P119, DOI 10.1038/sj.dmfr.4600516; Yamada S, 2015, ORAL DIS, V21, P335, DOI 10.1111/odi.12282; Yasar F, 2006, DENTOMAXILLOFAC RAD, V35, P1, DOI 10.1259/dmfr/97652136	33	8	8	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2016	11	12							e0167992	10.1371/journal.pone.0167992	http://dx.doi.org/10.1371/journal.pone.0167992			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI9TW	28002443	Green Submitted, gold, Green Published			2022-12-27	WOS:000392853100030
J	Marcenaro, D; Valkonen, JPT				Marcenaro, Delfia; Valkonen, Jari P. T.			Seedborne Pathogenic Fungi in Common Bean (Phaseolus vulgaris cv. INTA Rojo) in Nicaragua	PLOS ONE			English	Article							F-SP PHASEOLI; LASIODIPLODIA-THEOBROMAE; RHIZOCTONIA-BATATICOLA; FUSARIUM-INCARNATUM; 1ST REPORT; ROOT-ROT; DIVERSITY; DISEASE; FRUIT; BOTRYOSPHAERIACEAE	Common bean (Phaseolus vulgaris L.) is an important legume with high nutritional value. In Nicaragua, certified healthy seeds of local bean varieties are not available, and seedborne fungi have gained little attention. Here, were surveyed seedborne pathogenic fungi in an important local bean cultivar, `INTA Rojo'. Beans grown in the four main production areas in Nicaragua (Boaco, Carazo, Estelf, Matagalpa) for future use as seed stock were sampled from four seed storehouses and six seed lots. A total of 133 fungal strains were isolated from surface-sterilized beans and inoculated to healthy lima beans (Phaseolus lunatus) under controlled conditions. Eighty-seven isolates caused symptoms of varying severity in the seedlings, including discoloration, necrotic lesions, cankers, rot, and lethal necrosis. Pathogenic isolates were divided into eight phenotypically distinguishable groups based on morphology and growth characteristics on artificial growth medium, and further identified by analysis of the internal transcribed spacer sequences (ITS1 and ITS2) of the ribosomal RNA genes. The pathogenic isolates belonged to eight genera. Fusarium spp. (F. chlamydosporum, F. equiseti, F. incarnatum), Lasiodiplodia theobromae, Macrophomina phaseolina, and Penicillium citrinum were the most damaging and common fungi found in the seed lots. Furthermore, Corynespora cassiicola, Colletotrichum capsisi, Colletotrichum gloeosporioides, Aspergillus flavus, and Diaporthe sp. (Phomopsis) were seedborne in cultivar `INTA Rojo' and found to be pathogenic to bean seedlings. This study reveals, for the first time, many seedborne pathogenic fungi in beans in Nicaragua; furthermore, prior to this study, little information was available concerning F. equiseti, F. incarnatum, L. theobromae, C. cassiicola, and Diaporthespp. as seedborne pathogens of common bean. Our results lay the basis for developing diagnostic tools for seed health inspection and for further study of the epidemiology, ecology, and control of the pathogenic fungi of common beans in the field.	[Marcenaro, Delfia] Nicaraguan Inst Agr Technol CNIAB INTA, Managua, Nicaragua; [Marcenaro, Delfia; Valkonen, Jari P. T.] Univ Helsinki, Dept Agr Sci, Latokartanonkaari 7, Helsinki, Finland	University of Helsinki	Valkonen, JPT (corresponding author), Univ Helsinki, Dept Agr Sci, Latokartanonkaari 7, Helsinki, Finland.	jari.valkonen@helsinki.fi		Valkonen, Jari/0000-0002-3704-9911	Ministry for Foreign Affairs of Finland [36419901, 36421515]; Nicaraguan Institute of Agricultural Technology (INTA)	Ministry for Foreign Affairs of Finland; Nicaraguan Institute of Agricultural Technology (INTA)	This work was supported financially by Ministry for Foreign Affairs of Finland (grants 36419901 and 36421515 to JPTV) having no role in data collection and analysis, decision to publish, or preparation of the manuscript, and Nicaraguan Institute of Agricultural Technology (INTA) supported financially collection of research material but had no role in decision to publish, or preparation of the manuscript.	Agrios GN, 2005, PLANT PATHOLOGY; Anderson IC, 2007, J MICROBIOL METH, V68, P248, DOI 10.1016/j.mimet.2006.08.005; [Anonymous], 1990, AVRDC PUBL, V90-328; [Anonymous], 2006, MANUAL DIFFUSION TEC, P84; Aoki T, 2014, J GEN PLANT PATHOL, V80, P189, DOI 10.1007/s10327-014-0509-3; Arauz LF, 1986, DIAGNOSTICO INCIDENC, V10, P89; Ausubel FM, 1995, SHORT PROTOCOLS MOL, V3rd; Booth C., 1978, FUSARIUM EQUISETI IM; BOSCH U, 1992, APPL ENVIRON MICROB, V58, P3233, DOI 10.1128/AEM.58.10.3233-3239.1992; BROOKS F, 2004, 41 AM SAM COMM COLL; Rosado AWC, 2016, PLANT DIS, V100, P561, DOI 10.1094/PDIS-03-15-0242-RE; Cavalcante RD, 2014, EUR J PLANT PATHOL, V140, P251, DOI 10.1007/s10658-014-0459-9; Chaudhary R. G., 2002, Indian Journal of Pulses Research, V15, P193; Chen YY, 2013, PLANT PATHOL, V62, P900, DOI 10.1111/j.1365-3059.2012.02692.x; DELGADO G., 2011, MYCOTAXON, V115, P534; DHINGRA OD, 1972, PHYTOPATHOLOGY, V62, P1108; Dickman MB, 2000, FUNGAL PATHOLOGY, P127; Dixon LJ, 2009, PHYTOPATHOLOGY, V99, P1015, DOI 10.1094/PHYTO-99-9-1015; Domsch K. H., 1980, COMPENDIUM SOIL FUNG, V2; Domsch KH, 1980, COMPENDIUM SOIL FUNG; dos Santos TT, 2016, J APPL MICROBIOL, V120, P388, DOI 10.1111/jam.12985; Dugan FM, 2016, J PHYTOPATHOL, V164, P65, DOI 10.1111/jph.12384; ECHAVEZBADEL R, 1991, J AGR U PUERTO RICO, V75, P419; Farr DF., FUNGAL DATABASES; Goswami RS, 2008, CAN J PLANT PATHOL, V30, P155, DOI 10.1080/07060660809507506; Graham PH, 1997, FIELD CROP RES, V53, P131, DOI 10.1016/S0378-4290(97)00112-3; Guo KF, 2016, PLANT DIS, V100, P529, DOI 10.1094/PDIS-06-15-0694-PDN; Henrique FH, 2015, BRAGANTIA, V74, P84, DOI 10.1590/1678-4499.0265; INTA (Instituto Nicaraguense de Tecnologia Agropecuaria), 2002, GUIA TECN CULT GRAN; ISTA, 1999, SEED SCI TECHNOL, V31, P1; Jimenez OR, 2012, SEED SCI TECHNOL, V40, P73, DOI 10.15258/sst.2012.40.1.08; Jimenez OR, 2013, PLANT BREEDING, V132, P205, DOI 10.1111/pbr.12041; KONING G, 1995, PLANT DIS, V79, P754, DOI 10.1094/PD-79-0754D; Kwon Jin-Hyeuk, 2005, The Plant Pathology Journal, V21, P164; Lehtonen MJ, 2008, PLANT PATHOL, V57, P141, DOI 10.1111/j.1365-3059.2007.01694.x; Lima Joilson Silva, 2013, Summa phytopathol., V39, P81, DOI 10.1590/S0100-54052013000200001; Lisboa WS, 2016, AUSTRALAS PLANT DIS, V11, DOI 10.1007/s13314-016-0203-8; Machado AR, 2014, TROP PLANT PATHOL, V39, P464, DOI 10.1590/S1982-56762014000600008; Mancini V, 2016, PLANT PATHOL, V65, P691, DOI 10.1111/ppa.12515; Marques MW, 2013, FUNGAL DIVERS, V61, P181, DOI 10.1007/s13225-013-0231-z; Martinez-Garnica M, 2014, REV FAC AGRON LUZ, V31, P539; Munimbazi C, 1996, J FOOD PROTECT, V59, P869, DOI 10.4315/0362-028X-59.8.869; Naseri B, 2008, INT J PEST MANAGE, V61, P60; Navas M, 2015, REV FACULTAD AGRONOM, V21, P121; Okoth S., 2010, J YEAST FUNGAL RES, V1, P35; Prester L, 2011, ARH HIG RADA TOKSIKO, V62, P371, DOI 10.2478/10004-1254-62-2011-2126; Probst C, 2010, J APPL MICROBIOL, V108, P600, DOI 10.1111/j.1365-2672.2009.04458.x; Punithalingam E., 1976, BOTRYDIPLODIA THEOBR; Punithalingam E., 1980, BIBLIOTHECA MYCOLOGI; Ramdial H, 2016, PLANT DIS, V100, P526, DOI 10.1094/PDIS-05-15-0550-PDN; Reddy E. C. S., 2011, INT J APPL BIOL PHAR, V2, P180; Rodrigues AAC, 2005, MYCOPATHOLOGIA, V159, P79, DOI 10.1007/s11046-004-7138-x; Santalla M, 1999, J AGRON CROP SCI, V183, P263, DOI 10.1046/j.1439-037x.1999.00348.x; Schwartz HF, 2005, COMPENDIUM BEAN DIS; SEIFERT K, 1996, FUSARIUM INTERACTIVE; Sexton ZF, 2016, CROP PROT, V81, P9, DOI 10.1016/j.cropro.2015.11.012; Sharma Mamta, 2015, Archives of Phytopathology and Plant Protection, V48, P797, DOI 10.1080/03235408.2016.1140564; Silvestro LB, 2013, SPAN J AGRIC RES, V11, P72, DOI 10.5424/2013111-3081; Slippers Bernard, 2007, Fungal Biology Reviews, V21, P90, DOI 10.1016/j.fbr.2007.06.002; Smith K.L., 2000, OHIO VEGETABLE PRODU, P166; Su G, 2001, PHYTOPATHOLOGY, V91, P120, DOI 10.1094/PHYTO.2001.91.2.120; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Teramoto A, 2013, TROP PLANT PATHOL, V38, P68, DOI 10.1590/S1982-56762013000100011; Terashima Yoshie, 2002, Mycoscience, V43, P261, DOI 10.1007/s102670200038; Thompson SM, 2015, PERSOONIA, V35, P39, DOI 10.3767/003158515X687506; TSENG TC, 1995, BOT BULL ACAD SINICA, V36, P229; VALKONEN JPT, 1990, PLANT PATHOL, V39, P510, DOI 10.1111/j.1365-3059.1990.tb02527.x; van Diepeningen AD, 2016, MYCOPATHOLOGIA, V181, P161, DOI 10.1007/s11046-016-9993-7; von Arx JA, 1974, GENERA FUNGI SPORULA; WALLER JM, 2002, PLANT PATHOLOGISTS P; WEBSTER J, 2007, INTRO FUNGI; White DG, 1999, COMPENDIUM CORN DIS; White TJ, 1990, AMPLIFICATION DIRECT, V18, P315; Wyllie TD, 1988, COMPENDIUM SOYBEAN D, P30; Yang HC, 2015, PLANT DIS, V99, P143, DOI 10.1094/PDIS-03-14-0228-RE; You MP, 2011, FUNCT PLANT BIOL, V38, P984, DOI 10.1071/FP11137	77	21	22	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2016	11	12							e0168662	10.1371/journal.pone.0168662	http://dx.doi.org/10.1371/journal.pone.0168662			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI9QF	27997595	Green Published, gold, Green Submitted			2022-12-27	WOS:000392842900066
J	Sekar, SKV; Pagliazzi, M; Negredo, E; Martelli, F; Farina, A; Dalla Mora, A; Lindner, C; Farzam, P; Perez-Alvarez, N; Puig, J; Taroni, P; Pifferi, A; Durduran, T				Sekar, Sanathana Konugolu Venkata; Pagliazzi, Marco; Negredo, Eugenia; Martelli, Fabrizio; Farina, Andrea; Dalla Mora, Alberto; Lindner, Claus; Farzam, Parisa; Perez-Alvarez, Nuria; Puig, Jordi; Taroni, Paola; Pifferi, Antonio; Durduran, Turgut			In Vivo, Non-Invasive Characterization of Human Bone by Hybrid Broadband (600-1200 nm) Diffuse Optical and Correlation Spectroscopies	PLOS ONE			English	Article							TIME-RESOLVED REFLECTANCE; PENETRATION DEPTH; TISSUE; DENSITY; LIGHT; OSTEOPOROSIS; TOMOGRAPHY; ABSORPTION; SCATTERING; DIAGNOSIS	Non-invasive in vivo diffuse optical characterization of human bone opens a new possibility of diagnosing bone related pathologies. We present an in vivo characterization performed on seventeen healthy subjects at six different superficial bone locations: radius distal, radius proximal, ulna distal, ulna proximal, trochanter and calcaneus. A tailored diffuse optical protocol for high penetration depth combined with the rather superficial nature of considered tissues ensured the effective probing of the bone tissue. Measurements were performed using a broadband system for Time-Resolved Diffuse Optical Spectroscopy (TRS) to assess mean absorption and reduced scattering spectra in the 600-1200 nm range and Diffuse Correlation Spectroscopy (DCS) to monitor microvascular blood flow. Significant variations among tissue constituents were found between different locations; with radius distal rich of collagen, suggesting it as a prominent location for bone related measurements, and calcaneus bone having highest blood flow among the body locations being considered. By using TRS and DCS together, we are able to probe the perfusion and oxygen consumption of the tissue without any contrast agents. Therefore, we predict that these methods will be able to evaluate the impairment of the oxygen metabolism of the bone at the point-of-care.	[Sekar, Sanathana Konugolu Venkata; Farina, Andrea; Dalla Mora, Alberto; Taroni, Paola; Pifferi, Antonio] Politecn Milan, Dipartimento Fis, Milan, Italy; [Pagliazzi, Marco; Lindner, Claus; Farzam, Parisa; Durduran, Turgut] Barcelona Inst Sci & Technol, ICFO Inst Ciencies Foton, Barcelona, Spain; [Negredo, Eugenia; Perez-Alvarez, Nuria; Puig, Jordi] Germans Trias & Pujol Univ Hosp, Lluita Sida Fdn, Badalona, Spain; [Negredo, Eugenia; Perez-Alvarez, Nuria; Puig, Jordi] Univ Autonoma Barcelona, Barcelona, Spain; [Negredo, Eugenia] Univ Vic, Univ Cent Catalunya, Barcelona, Spain; [Martelli, Fabrizio] Univ Florence, Dipartimento Fis & Astron, Florence, Italy; [Farina, Andrea] CNR, Ist Foton & Nanotecnol, Milan, Italy; [Perez-Alvarez, Nuria] Univ Politecn Cataluna, Stat & Operat Res Dept, Barcelona, Spain; [Durduran, Turgut] ICREA, Barcelona, Spain	Polytechnic University of Milan; Barcelona Institute of Science & Technology; Universitat Politecnica de Catalunya; Institut de Ciencies Fotoniques (ICFO); Autonomous University of Barcelona; Universitat de Vic - Universitat Central de Catalunya (UVic-UCC); University of Florence; Consiglio Nazionale delle Ricerche (CNR); Universitat Politecnica de Catalunya; ICREA	Sekar, SKV (corresponding author), Politecn Milan, Dipartimento Fis, Milan, Italy.	sanathana.konugolu@polimi.it	Sekar, Sanathana Konugolu Venkata/P-5123-2017; Mora, Alberto Dalla/B-1393-2010; Mora, Alberto Dalla/AAA-7684-2020; Perez-Alvarez, Nuria/O-9244-2014; Farina, Andrea/I-1250-2012; Taroni, Paola/C-4709-2012; Pifferi, Antonio/C-4688-2012; Lindner, Claus/G-4601-2015; Durduran, Turgut/N-7768-2015	Sekar, Sanathana Konugolu Venkata/0000-0003-0912-1282; Mora, Alberto Dalla/0000-0002-2783-6217; Mora, Alberto Dalla/0000-0002-2783-6217; Perez-Alvarez, Nuria/0000-0001-6582-1553; Farina, Andrea/0000-0002-3180-6328; Taroni, Paola/0000-0001-7486-0001; Pifferi, Antonio/0000-0002-2261-2089; Lindner, Claus/0000-0002-9878-037X; Negredo, Eugenia/0000-0001-5298-1734; Durduran, Turgut/0000-0001-5838-1027	EC [317526]; Fundacio CELLEX Barcelona; Obra social "la Caixa" Foundation (LlumMedBcn); Severo Ochoa [SEV-2015-0522]; LASERLAB-EUROPE IV; Ministerio de Economia y Competitividad del Gobierno de Espana [MTM2015-64465-C2-1-R]; Departament d'Economia i Coneixement de la Generalitat de Catalunya [2014 SGR 464]; ICREA Funding Source: Custom	EC(European CommissionEuropean Commission Joint Research Centre); Fundacio CELLEX Barcelona(Foundation CELLEXEuropean Commission); Obra social "la Caixa" Foundation (LlumMedBcn); Severo Ochoa; LASERLAB-EUROPE IV; Ministerio de Economia y Competitividad del Gobierno de Espana(Spanish Government); Departament d'Economia i Coneixement de la Generalitat de Catalunya(Generalitat de Catalunya); ICREA(ICREA)	The research leading to these results has partially received funding from the EC's Seventh Framework Programme under the projects OILTEBIA (grant agreement n. 317526), Fundacio CELLEX Barcelona, Obra social "la Caixa" Foundation (LlumMedBcn), "Severo Ochoa" (SEV-2015-0522), LASERLAB-EUROPE IV, Ministerio de Economia y Competitividad del Gobierno de Espana (grant MTM2015-64465-C2-1-R) and Departament d'Economia i Coneixement de la Generalitat de Catalunya (2014 SGR 464). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The research leading to these results has partially received funding from the EC's Seventh Framework Programme under the projects OILTEBIA (grant agreement n. 317526), Fundacio CELLEX Barcelona, Obra social "la Caixa" Foundation (LlumMedBcn), "Severo Ochoa" (SEV-2015-0522), LASERLAB-EUROPE IV, Ministerio de Economia y Competitividad del Gobierno de Espana (grant MTM2015-64465-C2-1-R) and Departament d'Economia i Coneixement de la Generalitat de Catalunya (2014 SGR 464).	Baker WB, 2014, BIOMED OPT EXPRESS, V5, P4053, DOI 10.1364/BOE.5.004053; Bauer DC, 1997, ARCH INTERN MED, V157, P629, DOI 10.1001/archinte.157.6.629; Beck Thomas J, 2007, Curr Osteoporos Rep, V5, P49; Blake GM, 2007, POSTGRAD MED J, V83, P509, DOI 10.1136/pgmj.2007.057505; Bluestone AY, 2001, OPT EXPRESS, V9, P272, DOI 10.1364/OE.9.000272; BOAS DA, 1995, PHYS REV LETT, V75, P1855, DOI 10.1103/PhysRevLett.75.1855; Boas DA, 1997, J OPT SOC AM A, V14, P192, DOI 10.1364/JOSAA.14.000192; Boonen S, 1997, J INTERN MED, V242, P323, DOI 10.1046/j.1365-2796.1997.00242.x; Choe R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099683; Contini D, 1997, APPL OPTICS, V36, P4587, DOI 10.1364/AO.36.004587; Cubeddu R, 2001, APPL SPECTROSC, V55, P1368, DOI 10.1366/0003702011953496; Dalla Mora A, 2015, OPT EXPRESS, V23, P13937, DOI 10.1364/OE.23.013937; Del Bianco S, 2002, PHYS MED BIOL, V47, P4131, DOI 10.1088/0031-9155/47/23/301; Durduran T, 2002, PHYS MED BIOL, V47, P2847, DOI 10.1088/0031-9155/47/16/302; Durduran T, 2010, REP PROG PHYS, V73, DOI 10.1088/0034-4885/73/7/076701; Farina A, 2015, BIOMED OPT EXPRESS, V6, P2609, DOI 10.1364/BOE.6.002609; Farzam P, 2014, PHYSIOL MEAS, V35, P1469, DOI 10.1088/0967-3334/35/7/1469; Feng X, 2011, ANNU REV PATHOL-MECH, V6, P121, DOI 10.1146/annurev-pathol-011110-130203; Grabtchak S., 2012, BIOMED OPT EXP, V3, P2059; Griffith JF, 2005, RADIOLOGY, V236, P945, DOI 10.1148/radiol.2363041425; Han SF, 2015, BIOMED OPT EXPRESS, V6, P2695, DOI 10.1364/BOE.6.002695; Link TM, 1998, J BONE MINER RES, V13, P1175, DOI 10.1359/jbmr.1998.13.7.1175; Margallo-Balbas E, 2010, PHYS MED BIOL, V55, P4917, DOI 10.1088/0031-9155/55/17/003; Martelli F, 2016, SCI REP-UK, V6, DOI 10.1038/srep27057; Matousek P, 2009, ANALYST, V134, P1058, DOI 10.1039/b821100k; Min JY, 2007, J CLIN DENSITOM, V10, P184, DOI 10.1016/j.jocd.2006.12.004; Montejo LD, 2013, J BIOMED OPT, V18, DOI 10.1117/1.JBO.18.7.076001; Morris MD, 2005, J BIOMED OPT, V10, DOI 10.1117/1.1827605; Mourant JR, 1997, APPL OPTICS, V36, P949, DOI 10.1364/AO.36.000949; PATTERSON MS, 1989, APPL OPTICS, V28, P2331, DOI 10.1364/AO.28.002331; Pifferi A, 2004, J BIOMED OPT, V9, P474, DOI 10.1117/1.1691029; Pifferi A, 2001, OPT LETT, V26, P1963, DOI 10.1364/OL.26.001963; Pifferi A, 2007, REV SCI INSTRUM, V78, DOI 10.1063/1.2735567; POGUE BW, 1994, PHYS MED BIOL, V39, P1157, DOI 10.1088/0031-9155/39/7/008; SEIBEL MJ, 1992, TRENDS ENDOCRIN MET, V3, P263, DOI 10.1016/1043-2760(92)90129-O; Sekar SKV, 2016, IEEE J SEL TOP QUANT, V22, DOI 10.1109/JSTQE.2015.2506613; Sekar SKV, 2015, PROC SPIE, V9538, DOI 10.1117/12.2183724; Sekar SKV, 2015, PROC SPIE, V9538, DOI 10.1117/12.2183835; Selb J, 2014, NEUROPHOTONICS, V1, DOI 10.1117/1.NPh.1.1.015005; Seldin DW, 1987, COMP BONE DENSITY ME, P168; Taroni P, 2009, OPT EXPRESS, V17, P15932, DOI 10.1364/OE.17.015932; Torricelli A, 2001, PHYS MED BIOL, V46, P2227, DOI 10.1088/0031-9155/46/8/313; Torricelli A, 2014, NEUROIMAGE, V85, P28, DOI 10.1016/j.neuroimage.2013.05.106; Tromberg BJ, 2008, MED PHYS, V35, P2443, DOI 10.1118/1.2919078	44	24	24	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2016	11	12							e0168426	10.1371/journal.pone.0168426	http://dx.doi.org/10.1371/journal.pone.0168426			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI9QF	27997565	Green Published, Green Submitted, gold			2022-12-27	WOS:000392842900042
J	Croce, D; Lazzarin, A; Rizzardini, G; Gianotti, N; Scolari, F; Foglia, E; Garagiola, E; Ricci, E; Bini, T; Quirino, T; Vigan, P; Re, T; Monforte, AD; Bonfanti, P				Croce, Davide; Lazzarin, Adriano; Rizzardini, Giuliano; Gianotti, Nicola; Scolari, Francesca; Foglia, Emanuela; Garagiola, Elisabetta; Ricci, Elena; Bini, Teresa; Quirino, Tiziana; Vigan, Paolo; Re, Tiziana; Monforte, Antonella D'Arminio; Bonfanti, Paolo			HIV Clinical Pathway: A New Approach to Combine Guidelines and Sustainability of Anti-Retroviral Treatment in Italy	PLOS ONE			English	Article							STRATEGIES; THERAPY; COSTS; CARE	The present article describes the case study of a "real world" HIV practice within the debate concerning the strategic role of Clinical Governance (CG) tools in the management of a National Healthcare System's sustainability. The study aimed at assessing the impact of a Clinical Pathway (CP) implementation, required by the Regional Healthcare Service, in terms of effectiveness (virological and immunological conditions) and efficiency (economic resources absorption), from the budget holder perspective. Data derived from a multi-centre cohort of patients treated in 6 Hospitals that provided care to approximately 42% of the total HIV+ patients, in Lombardy Region, Italy. Two phases were compared: Pre-CP (2009-2010) vs. Post-CP implementation (2011-2012). All HIV infected adults, observed in the participating hospitals during the study periods, were enrolled and stratified into the 3 categories defined by the Regional CP: first-line, switch for toxicity/other, and switch for failure. The study population was composed of 1,284 patients (Pre-CP phase) and 1,135 patients (Post-CP phase). The results showed that the same level of virological and immunological effectiveness was guaranteed to HIV+ patients: 81.2% of Pre-CP phase population and 83.2% of Post-CP phase population had undetectable HIV-RNA (defined as <50 copies/mL) at 12-month follow up. CD4(+) cell counts increased by 28 +/- 4 cells/mm(3) in Pre-CP Phase and 39 +/- 5 cells/mm(3) in Post-CP Phase. From an economic point of view, the CP implementation led to a substantial advantage: the mean total costs related to the management of the HIV disease (ART, hospital admission and laboratory tests) decreased (-8.60%) in the Post-CP phase (p-value < 0.0001). Results confirmed that the CP provided appropriateness and quality of care, with a cost reduction for the budget holder.	[Croce, Davide; Scolari, Francesca; Foglia, Emanuela; Garagiola, Elisabetta] LIUC Univ Cattaneo, Ctr Res Hlth Econ Social & Hlth Care Management, Varese, Italy; [Croce, Davide] Univ Witwatersrand, Fac Hlth Sci, Sch Publ Hlth, Johannesburg, South Africa; [Lazzarin, Adriano; Gianotti, Nicola] Ist Sci San Raffaele, Clin Infect Dis, Milan, Italy; [Rizzardini, Giuliano; Ricci, Elena] Fatebebefratelli Sacco Hosp, Dept Infect Dis, Milan, Italy; [Rizzardini, Giuliano] Univ Witwatersrand, Fac Hlth Sci, Sch Clin Med, Johannesburg, South Africa; [Bini, Teresa; Monforte, Antonella D'Arminio] Santi Paolo & Carlo Hosp, Infect Dis Unit, Milan, Italy; [Quirino, Tiziana] Valle Olona Hosp, Dept Infect Dis, Busto Arsizio, Italy; [Vigan, Paolo; Re, Tiziana] Ovest Milanese Hosp, Dept Infect Dis, Legnano, Italy; [Bonfanti, Paolo] Lecco Hosp, Dept Infect Dis, Lecce, Italy	Universita Carlo Cattaneo - Liuc; University of Witwatersrand; Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; University of Milan; Luigi Sacco Hospital; University of Witwatersrand; Presidio Ospedaliero di Lecco	Garagiola, E (corresponding author), LIUC Univ Cattaneo, Ctr Res Hlth Econ Social & Hlth Care Management, Varese, Italy.	egaragiola@liuc.it	Bonfanti, Paolo/AAK-9800-2020; LAZZARIN, Adriano/K-3607-2018	Bonfanti, Paolo/0000-0001-7289-8823; Gianotti, Nicola/0000-0002-7182-5080; LAZZARIN, Adriano/0000-0003-2551-7754; Ricci, Elena/0000-0001-5279-0444; CROCE, Davide/0000-0002-9472-3431	ViiV Healthcare	ViiV Healthcare	An unconditional grant was received by ViiV Healthcare (https://www.viivhealthcare.com/), to cover the costs for the reprocessing of data. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angeletti C, 2014, HIV MED, V15, P165, DOI 10.1111/hiv.12097; Annemas L, 2007, ISPOR CONNECTIONS, V13, P5; Camoni L, 2013, NOTIZIARIO ISS, V26, P3; Campbell H, 1998, BMJ-BRIT MED J, V316, P133; De Bleser Leentje, 2006, J Nurs Manag, V14, P553, DOI 10.1111/j.1365-2934.2006.00702.x; Gazzard B, 2012, CLINICOECONOMIC OUTC, V4, P193, DOI 10.2147/CEOR.S12496; Hogg R, 2008, LANCET, V372, P293, DOI 10.1016/S0140-6736(08)61113-7; Kinsman L, 2010, BMC MED, V8, DOI 10.1186/1741-7015-8-31; Llibre JM, 2013, CLINICOECONOMIC OUTC, V5, P215, DOI 10.2147/CEOR.S43662; Lombardy Region Clinical Pathway D. d. g, 2012, AGG DOC AV PER PERC; Monforte AD, 2011, ANTIVIR THER, V16, P1103, DOI 10.3851/IMP1883; Rizzardini G, 2011, JAIDS J ACQUIR IMMUN, V57; Scally G, 1998, BRIT MED J, V317, P61, DOI 10.1136/bmj.317.7150.61; Stoll M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023946; Vanhaecht Kris, 2006, J Nurs Manag, V14, P529, DOI 10.1111/j.1365-2934.2006.00705.x; Volberding PA, 2010, LANCET, V376, P49, DOI 10.1016/S0140-6736(10)60676-9	16	2	3	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2016	11	12							e0168399	10.1371/journal.pone.0168399	http://dx.doi.org/10.1371/journal.pone.0168399			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EG7JB	28030621	Green Published, Green Submitted, gold			2022-12-27	WOS:000391222000047
J	Parsons, JA; Yu, CHY; Baker, NA; Mamdani, MM; Bhattacharyya, O; Zwarenstein, M; Shah, BR				Parsons, Janet A.; Yu, Catherine H. Y.; Baker, Natalie A.; Mamdani, Muhammad M.; Bhattacharyya, Onil; Zwarenstein, Merrick; Shah, Baiju R.			Practice Doesn't Always Make Perfect: A Qualitative Study Explaining Why a Trial of an Educational Toolkit Did Not Improve Quality of Care	PLOS ONE			English	Article							CLINICAL-PRACTICE GUIDELINES; CANADA; MANAGEMENT; PHYSICIANS; MORTALITY; HEALTH; TRENDS	Background Diabetes is a chronic disease commonly managed by family physicians, with the most prevalent complication being cardiovascular disease (CVD). Clinical practice guidelines have been developed to support clinicians in the care of diabetic patients. We conducted a pragmatic cluster randomized controlled trial (RCT) of a printed educational toolkit aimed at improving CVD management in diabetes in primary care, and found no effect, and indeed, the possibility of some harm. We conducted a qualitative evaluation to study the strategy for guideline implementation employed in this trial, and to understand its effects. This paper focuses solely on the qualitative findings, as the RCT's quantitative results have already been reported elsewhere. Methods and Findings All family practices in the province of Ontario had been randomized to receive the educational toolkit by mail, in either the summer of 2009 (intervention arm) or the spring of 2010 (control arm). A subset of 80 family physicians (representing approximately 10% of the practices randomized and approached, with records on 1,592 randomly selected patients with diabetes at high risk for CVD) then took part in a chart audit and reflective feedback exercise related to their own practice in comparison to the guideline recommendations. They were asked to complete two forms (one pre- and one post-audit) in order to understand their awareness of the guidelines pre-trial, their expectations regarding their individual performance pre-audit, and their reflections on their audit results. In addition, individual interviews with thirteen other family physicians were conducted. Textual data from interview transcripts and written commentary from the pre-and post-audit forms underwent qualitative descriptive analysis to identify common themes and patterns. Analysis revealed four main themes: impressions of the toolkit, awareness was not the issue, 'it's not me it's my patients', and chart audit as a more effective intervention than the toolkit. Participants saw neither the toolkit content nor its dissemination strategy to be effective, indicating they perceived themselves to be aware of the guidelines pre-trial. However, their accounts also indicated that they may be struggling to prioritize CVD management in the midst of competing demands for their attention. Upon receiving their chart audit results, many participants expressed surprise that they had not performed better. They reported that the audit results would be an important motivator for behaviour change. Conclusions The qualitative findings outlined in this paper offer important insights into why the intervention was not effective. They also demonstrate that physicians have unperceived needs relative to CVD management and that the chart audit served to identify shortcomings in their practice of which they had been hitherto unaware. The findings also indicate that new methods of intervention development and implementation should be explored. This is important given the high prevalence of diabetes worldwide; appropriate CVD management is critical to addressing the morbidity and mortality associated with the disease.	[Parsons, Janet A.; Baker, Natalie A.] St Michaels Hosp, Li Ka Shing Knowledge Inst, Appl Hlth Res Ctr, Toronto, ON, Canada; [Parsons, Janet A.] Univ Toronto, Dept Phys Therapy, Toronto, ON, Canada; [Yu, Catherine H. Y.] St Michaels Hosp, Dept Med, Div Endocrinol & Metab, Toronto, ON, Canada; [Yu, Catherine H. Y.] St Michaels Hosp, Li Ka Shing Knowledge Inst, Toronto, ON, Canada; [Yu, Catherine H. Y.; Shah, Baiju R.] Univ Toronto, Dept Med, Toronto, ON, Canada; [Baker, Natalie A.] Univ Toronto, Dalla Lana Sch Publ Hlth, Toronto, ON, Canada; [Mamdani, Muhammad M.] St Michaels Hosp, Li Ka Shing Knowledge Inst, Li Ka Shing Ctr Healthcare Analyt Res & Training, Toronto, ON, Canada; [Mamdani, Muhammad M.] Univ Toronto, Leslie Dan Fac Pharm, Toronto, ON, Canada; [Mamdani, Muhammad M.; Shah, Baiju R.] Univ Toronto, Inst Hlth Policy Management & Evaluat, Toronto, ON, Canada; [Bhattacharyya, Onil] Womens Coll Hosp, Res Inst, Toronto, ON, Canada; [Bhattacharyya, Onil] Univ Toronto, Dept Family & Community Med, Toronto, ON, Canada; [Zwarenstein, Merrick] Western Univ, Dept Family Med, Ctr Studies Family Med, London, ON, Canada; [Zwarenstein, Merrick; Shah, Baiju R.] Inst Clin Evaluat Sci, Toronto, ON, Canada; [Shah, Baiju R.] Sunnybrook Hlth Sci Ctr, Toronto, ON, Canada	University of Toronto; Li Ka Shing Knowledge Institute; University Toronto Affiliates; Saint Michaels Hospital Toronto; University of Toronto; University of Toronto; University Toronto Affiliates; Saint Michaels Hospital Toronto; University of Toronto; Li Ka Shing Knowledge Institute; University Toronto Affiliates; Saint Michaels Hospital Toronto; University of Toronto; University of Toronto; University of Toronto; Li Ka Shing Knowledge Institute; University Toronto Affiliates; Saint Michaels Hospital Toronto; University of Toronto; University of Toronto; University of Toronto; University Toronto Affiliates; Womens College Hospital; University of Toronto; Western University (University of Western Ontario); University of Toronto; University of Toronto; Sunnybrook Research Institute; University Toronto Affiliates; Sunnybrook Health Science Center	Parsons, JA (corresponding author), St Michaels Hosp, Li Ka Shing Knowledge Inst, Appl Hlth Res Ctr, Toronto, ON, Canada.; Parsons, JA (corresponding author), Univ Toronto, Dept Phys Therapy, Toronto, ON, Canada.	parsonsj@smh.ca	Zwarenstein, Merrick F/P-5210-2014	Zwarenstein, Merrick F/0000-0003-0162-7027	Canadian Institutes for Health Research (CIHR); Heart and Stroke Foundation of Canada; CIHR; Canadian Diabetes Association; Ontario Ministry of Health and Long-Term Care	Canadian Institutes for Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Heart and Stroke Foundation of Canada(Heart & Stroke Foundation of Canada); CIHR(Canadian Institutes of Health Research (CIHR)); Canadian Diabetes Association; Ontario Ministry of Health and Long-Term Care(Ministry of Health and Long-Term Care, Ontario)	The study was funded by an operating grant from the Canadian Institutes for Health Research (CIHR) and the Heart and Stroke Foundation of Canada. BRS receives salary support from CIHR, and previously received support from the Canadian Diabetes Association. The Institute of Clinical Evaluative Sciences (ICES) is a non-profit research institute funded by the Ontario Ministry of Health and Long-Term Care. The funders had no role in the study design, data collection and analysis, decision to publish or preparation of the manuscript.	[Anonymous], IMPLEMENTATION SCI; Bebb C, 2007, BRIT J GEN PRACT, V57, P136; Boyd CM, 2005, JAMA-J AM MED ASSOC, V294, P716, DOI 10.1001/jama.294.6.716; Braga MFB, 2010, CAN J CARDIOL, V26, P297, DOI 10.1016/S0828-282X(10)70393-7; Brown AF, 2005, DIABETES CARE, V28, P2864, DOI 10.2337/diacare.28.12.2864; Cabana MD, 1999, JAMA-J AM MED ASSOC, V282, P1458, DOI 10.1001/jama.282.15.1458; Canadian Diabetes Association Expert Panel Committee, 2008, CAN J DIABETES, V32, pS168; Canadian Diabetes Association Expert Panel Committee, 2013, CAN J DIABETES, V37, pS168, DOI DOI 10.1016/J.JCJD.2013.01.009; Creswell J.W., 2018, QUAL INQ, V4; Davis D, 2003, BMJ-BRIT MED J, V327, P33, DOI 10.1136/bmj.327.7405.33; Dawson KG, 2002, DIABETES CARE, V25, P1303, DOI 10.2337/diacare.25.8.1303; Giguere A, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004398.pub3; Green J, 2014, QUALITATIVE METHODS; Gregg EW, 2007, ANN INTERN MED, V147, P149, DOI 10.7326/0003-4819-147-3-200708070-00167; Grol R, 2003, LANCET, V362, P1225, DOI 10.1016/S0140-6736(03)14546-1; Gross PA, 2001, MED CARE, V39, pII85; Gupta A, 2015, CAN FAM PHYSICIAN, V61, P811; Harris SB, 2005, DIABETES RES CLIN PR, V70, P90, DOI 10.1016/j.diabres.2005.03.024; International Diabetes Federation Clinical Guidelines Taskforce, 2008, INT DIAB FED CLIN GU; Ivers NM, 2013, IMPLEMENT SCI, V8, P1; Ivers N, 2014, CAN FAM PHYSICIAN, V60, P258; Johnston S, 2010, BMC MED RES METHODOL, V10, DOI 10.1186/1471-2288-10-109; Kastner M, 2015, J CLIN EPIDEMIOL, V68, P498, DOI 10.1016/j.jclinepi.2014.12.013; Kuper A, 2008, BMJ-BRIT MED J, V337, pa288, DOI DOI 10.1136/BMJ.A288; Kuzel AJ, 1999, DOING QUALITATIVE RE, P33; Kvale S, 1996, INTERVIEWS INTRO QUA; Lipscombe LL, 2007, LANCET, V369, P750, DOI 10.1016/S0140-6736(07)60361-4; Patton M. Q., 2002, QUALITATIVE RES EVAL, V3rd; POPE C, 1995, BRIT MED J, V311, P42, DOI 10.1136/bmj.311.6996.42; Saaddine JB, 2006, ANN INTERN MED, V144, P465, DOI 10.7326/0003-4819-144-7-200604040-00005; Sandelowski M, 2000, RES NURS HEALTH, V23, P334, DOI 10.1002/1098-240X(200008)23:4<334::AID-NUR9>3.0.CO;2-G; Sandelowski M, 2010, RES NURS HEALTH, V33, P77, DOI 10.1002/nur.20362; Shah BR, 2007, J GEN INTERN MED, V22, P275, DOI 10.1007/s11606-006-0027-x; Shah BR, 2014, PLOS MED, V11, DOI 10.1371/journal.pmed.1001588; Shah BR, 2010, TRIALS, V11, DOI 10.1186/1745-6215-11-44; Sridharan S, 2011, EVAL PROGRAM PLANN, V34, P135, DOI 10.1016/j.evalprogplan.2010.09.003; Tricco AC, 2012, LANCET, V379, P2252, DOI 10.1016/S0140-6736(12)60480-2	37	5	5	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2016	11	12							e0167878	10.1371/journal.pone.0167878	http://dx.doi.org/10.1371/journal.pone.0167878			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EG7JB	28030547	Green Published, Green Submitted, gold			2022-12-27	WOS:000391222000024
J	Rass, S; Konig, S; Schauer, S				Rass, Stefan; Koenig, Sandra; Schauer, Stefan			Decisions with Uncertain Consequences-A Total Ordering on Loss-Distributions	PLOS ONE			English	Article								Decisions are often based on imprecise, uncertain or vague information. Likewise, the consequences of an action are often equally unpredictable, thus putting the decision maker into a twofold jeopardy. Assuming that the effects of an action can be modeled by a random variable, then the decision problem boils down to comparing different effects (random variables) by comparing their distribution functions. Although the full space of probability distributions cannot be ordered, a properly restricted subset of distributions can be totally ordered in a practically meaningful way. We call these loss-distributions, since they provide a substitute for the concept of loss-functions in decision theory. This article introduces the theory behind the necessary restrictions and the hereby constructible total ordering on random loss variables, which enables decisions under uncertainty of consequences. Using data obtained from simulations, we demonstrate the practical applicability of our approach.	[Rass, Stefan] Univ Klagenfurt, Inst Appl Informat, Klagenfurt, Austria; [Koenig, Sandra; Schauer, Stefan] Austrian Inst Technol, Safety & Secur Dept, Klagenfurt, Austria	University of Klagenfurt	Rass, S (corresponding author), Univ Klagenfurt, Inst Appl Informat, Klagenfurt, Austria.	stefan.rass@aau.at	König, Sandra/AAM-3315-2021	König, Sandra/0000-0003-2881-4519; Rass, Stefan/0000-0003-2821-2489	European Commission [608090]; HyRiM (Hybrid Risk Management for Utility Networks) under the 7th Framework Programme [FP7-SEC-2013-1]	European Commission(European CommissionEuropean Commission Joint Research Centre); HyRiM (Hybrid Risk Management for Utility Networks) under the 7th Framework Programme	This work was supported by the European Commission's Project No. 608090, HyRiM (Hybrid Risk Management for Utility Networks) under the 7th Framework Programme (FP7-SEC-2013-1). The project is online found at https://hyrim.net and http://cordis.europa.eu/project/rcn/185511_en.html.	Bauerle N, 2006, INSUR MATH ECON, V38, P132, DOI 10.1016/j.insmatheco.2005.08.003; Beck A., 2016, ENTWICKLUNG METRIK A; Bundesamt fur Bevolkerungsschutz Bern, 2013, METH RIS KAT NOTL SC; Bundestag D, 2010, VERHANDLUNGEN DTSCH, p17/4178; Buntine W. L., 1995, Uncertainty in Artificial Intelligence. Proceedings of the Eleventh Conference (1995), P46; Busby JS, 2016, EUR J OPER RES, V251, P1029, DOI 10.1016/j.ejor.2015.12.034; Caralli R., 2007, CMUSEI2007TR012; Chiu WH, 2010, GENEVA RISK INS REV, V35, P108, DOI 10.1057/grir.2009.9; Eichner T, 2011, MATH SOC SCI, V61, P109, DOI 10.1016/j.mathsocsci.2010.11.004; Embrechts P., 2003, HDB HEAVY TAILED DIS; Gibbons Robert, 1992, PRIMER GAME THEORY; Goodpasture J., 2004, QUANTITATIVE METHODS; Halpern J. Y., 2003, REASONING UNCERTAINT; Hogg R.V, 1984, WILEY SERIES PROBABI; International Standards Organisation (ISO), 2011, 27005 ISOIEC; International Standards Organisation (ISO), 2009, 31000 ISOIEC; JENSEN FV, 2002, BAYESIAN NETWORKS DE; Karnouskos S, 2011, IEEE IND ELEC, P4490; Konig S., 2016, ARXIV160403558; Koski T., 2009, WILEY SERIES PROBABI; Liu B, 2009, LECT NOTES ARTIF INT, V5476, P302, DOI 10.1007/978-3-642-01307-2_29; McNeil A. J., 2005, QUANTITATIVE RISK MA; Mell P. M., 2007, COMPLETE GUIDE COMMO; Munch I, 2012, DACH SECURITY 2012, P326; Newman MEJ, 2002, PHYS REV E, V66, DOI 10.1103/PhysRevE.66.016128; Nolan, 2016, STABLE DISTRIBUTIONS; PEARL J., 1988, PROBABILISTIC REASON, DOI 10.1016/B978-0-08-051489-5.50008-4; R Development Core Team, 2016, LANG ENV STAT COMP; Rass S., 2015, ARXIV E PRINTS; Rass S., 2015, ARXIV151108591; Rass S., 2015, LNCS, V9406; ROBERT CP, 2001, BAYESIAN CHOICE; Robinson A., 1966, STUDIES LOGIC FDN MA; Shaked M, 2007, SPRINGER SER STAT, P3; Shortliffe E., 1990, READINGS UNCERTAIN R, P259; Silverman BW, 1998, DENSITY ESTIMATION S; Stoyan D, 2002, COMP METHODS STOCHAS; Swedish Civil Contingencies Agency (MSB), 2012, SWED NAT RISK ASS 20; Szekli R., 1995, LECT NOTES STAT, V97, DOI [10.1007/978-1-4612-2528-7, DOI 10.1007/978-1-4612-2528-7]; The Network of Analysts for National Security (ANV), 2011, NAT RISK ASS 2011; Wenner F, 2002, THESIS	42	6	6	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2016	11	12							e0168583	10.1371/journal.pone.0168583	http://dx.doi.org/10.1371/journal.pone.0168583			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EG7JB	28030572	Green Submitted, Green Published, gold			2022-12-27	WOS:000391222000058
J	Tan, J; Martin, SE				Tan, Jenille; Martin, Scott E.			Validation of Synthetic CRISPR Reagents as a Tool for Arrayed Functional Genomic Screening	PLOS ONE			English	Article							GENETIC SCREENS; CANCER-CELLS; RNA; IDENTIFICATION; SUPPRESSION; VIRUS	To date, lentiviral-based CRISPR-Cas9 screens have largely been conducted in pooled format. However, numerous assays are not amenable to pooled approaches, and lentiviral screening in arrayed format presents many challenges. We sought to examine synthetic CRISPR reagents in the context of arrayed screening. Experiments were performed using aberrant DNA replication as an assay. Using synthetic CRISPR RNAs targeting the known control gene GMNN in HCT-116 cells stably expressing Cas9, we observed statistically significant phenotype among the majority of transfected cells within 72 hours. Additional studies revealed near complete loss of GMNN protein and editing of GMNN DNA. We next conducted a screen of synthetic CRISPR RNAs directed against 640 ubiquitin-related genes. Screening identified known and novel DNA replication regulators that were also supported by siRNA gene knockdown. Notably, CRISPR screening identified more statistically significant hits than corresponding siRNA screens run in parallel. These results highlight the possibility of using synthetic CRISPR reagents as an arrayed screening tool.	[Tan, Jenille; Martin, Scott E.] Genentech Inc, Dept Discovery Oncol, San Francisco, CA 94080 USA	Roche Holding; Genentech	Martin, SE (corresponding author), Genentech Inc, Dept Discovery Oncol, San Francisco, CA 94080 USA.	martin.scott@gene.com			Genentech, Inc.	Genentech, Inc.(Roche HoldingGenentech)	The authors received no specific funding for this work. Genentech, Inc. provided support in the form of salaries for authors JT and SEM, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Aguirre AJ, 2016, CANCER DISCOV, V6, P914, DOI 10.1158/2159-8290.CD-16-0154; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bhinder B, 2013, ASSAY DRUG DEV TECHN, V11, P173, DOI 10.1089/adt.2012.475; Birmingham A, 2006, NAT METHODS, V3, P199, DOI 10.1038/NMETH854; Chapard C, 2014, J CELL SCI, V127, P5149, DOI 10.1242/jcs.152579; DeJesus R, 2016, ELIFE, P5, DOI [10.1172/JCI83265, DOI 10.1172/JCI83265]; Evers B, 2016, NAT BIOTECHNOL, V34, P631, DOI 10.1038/nbt.3536; Hart T, 2015, CELL, V163, DOI 10.1016/j.cell.2015.11.015; Hartenian E, 2015, FEBS J, V282, P1383, DOI 10.1111/febs.13248; Hsu JY, 2002, NAT CELL BIOL, V4, P358, DOI 10.1038/ncb785; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Hultquist JF, 2016, CELL REP, V17, P1438, DOI 10.1016/j.celrep.2016.09.080; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; Konig R, 2007, NAT METHODS, V4, P847, DOI 10.1038/NMETH1089; Koike-Yusa H, 2014, NAT BIOTECHNOL, V32, P267, DOI 10.1038/nbt.2800; Ma HM, 2015, CELL REP, V12, P673, DOI 10.1016/j.celrep.2015.06.049; Marceau CD, 2016, NATURE, V535, P159, DOI 10.1038/nature18631; Marine S, 2012, J BIOMOL SCREEN, V17, P370, DOI 10.1177/1087057111427348; McCleland ML, 2016, J CLIN INVEST, V126, P639, DOI 10.1172/JCI83265; Savidis G, 2016, CELL REP, V16, P232, DOI 10.1016/j.celrep.2016.06.028; Schmidt T, 2015, SCI REP-UK, V5, DOI 10.1038/srep14987; Shalem O, 2014, SCIENCE, V343, P84, DOI 10.1126/science.1247005; Sigoillot FD, 2012, NAT METHODS, V9, P363, DOI [10.1038/NMETH.1898, 10.1038/nmeth.1898]; Vassilev A, 2016, ONCOTARGET; Wang H, 2016, J BIOL CHEM, V291, P15256, DOI 10.1074/jbc.M116.722967; Wang T, 2015, SCIENCE, V350, P1096, DOI 10.1126/science.aac7041; Wang T, 2014, SCIENCE, V343, P80, DOI 10.1126/science.1246981; Wu TD, 2010, BIOINFORMATICS, V26, P873, DOI 10.1093/bioinformatics/btq057; Wu YZ, 2016, CELL DISCOV, V2, DOI 10.1038/celldisc.2016.14; Yuan YF, 2016, SCI REP-UK, V6, DOI 10.1038/srep29735; Zhang R, 2016, NATURE, V535, P164, DOI 10.1038/nature18625; Zhong R, 2014, NUCLEIC ACIDS RES, V42, P8214, DOI 10.1093/nar/gku306; Zhu WG, 2009, CANCER RES, V69, P4870, DOI 10.1158/0008-5472.CAN-08-4559	34	26	27	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2016	11	12							e0168968	10.1371/journal.pone.0168968	http://dx.doi.org/10.1371/journal.pone.0168968			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EG7JB	28030641	gold, Green Published			2022-12-27	WOS:000391222000093
J	Kutz, A; Hausfater, P; Amin, D; Amin, A; Canavaggio, P; Sauvin, G; Bernard, M; Conca, A; Haubitz, S; Struja, T; Huber, A; Mueller, B; Schuetz, P				Kutz, Alexander; Hausfater, Pierre; Amin, Devendra; Amin, Adina; Canavaggio, Pauline; Sauvin, Gabrielle; Bernard, Maguy; Conca, Antoinette; Haubitz, Sebastian; Struja, Tristan; Huber, Andreas; Mueller, Beat; Schuetz, Philipp		TRIAGE Study Grp	The TRIAGE-ProADM Score for an Early Risk Stratification of Medical Patients in the Emergency Department - Development Based on a Multi-National, Prospective, Observational Study	PLOS ONE			English	Article							COMMUNITY-ACQUIRED PNEUMONIA; MIDREGIONAL PROADRENOMEDULLIN; SEVERITY INDEX; HEART-FAILURE; ADRENOMEDULLIN; BIOMARKERS; MORTALITY; POPULATION; PREDICTION; PROGNOSIS	Introduction The inflammatory biomarker pro-adrenomedullin (ProADM) provides additional prognostic information for the risk stratification of general medical emergency department (ED) patients. The aim of this analysis was to develop a triage algorithm for improved prognostication and later use in an interventional trial. Methods We used data from the multi-national, prospective, observational TRIAGE trial including consecutive medical ED patients from Switzerland, France and the United States. We investigated triage effects when adding ProADM at two established cut-offs to a five-level ED triage score with respect to adverse clinical outcome. Results Mortality in the 6586 ED patients showed a step-wise, 25-fold increase from 0.6% to 4.5% and 15.4%, respectively, at the two ProADM cut-offs (<= 0.75nmol/L, >0.75-1.5nmol/L, >1.5nmol/L, p ANOVA <0.0001). Risk stratification by combining ProADM within cut-off groups and the triage score resulted in the identification of 1662 patients (25.2% of the population) at a very low risk of mortality (0.3%, n = 5) and 425 patients (6.5% of the population) at very high risk of mortality (19.3%, n = 82). Risk estimation by using ProADM and the triage score from a logistic regression model allowed for a more accurate risk estimation in the whole population with a classification of 3255 patients (49.4% of the population) in the low risk group (0.3% mortality, n = 9) and 1673 (25.4% of the population) in the high-risk group (15.1% mortality, n = 252). Conclusions Within this large international multicenter study, a combined triage score based on ProADM and established triage scores allowed a more accurate mortality risk discrimination. The TRIAGE-ProADM score improved identification of both patients at the highest risk of mortality who may benefit from early therapeutic interventions (rule in), and low risk patients where deferred treatment without negatively affecting outcome may be possible (rule out).	[Kutz, Alexander; Conca, Antoinette; Haubitz, Sebastian; Struja, Tristan; Mueller, Beat; Schuetz, Philipp] Kantonsspital Aarau, Univ Dept Med, Div Gen & Emergency Med, Aarau, Switzerland; [Hausfater, Pierre; Canavaggio, Pauline; Sauvin, Gabrielle] Grp Hosp Pitie Salpetriere, AP HP, Emergency Dept, Paris, France; [Hausfater, Pierre] UPMC, Sorbonne Univ, UMRS INSERM 1166, IHUC ICAN, Paris, France; [Amin, Devendra; Amin, Adina] Morton Plant Hosp, Clearwater, FL USA; [Bernard, Maguy] Hop La Pitie Salpetriere, Dept Biochem, Paris, France; [Bernard, Maguy] Univ Paris 05, Paris, France; [Huber, Andreas] Kantonsspital Aarau, Dept Lab Med, Aarau, Switzerland	Kantonsspital Aarau AG (KSA); Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; UDICE-French Research Universities; Universite Paris Cite; Kantonsspital Aarau AG (KSA)	Kutz, A (corresponding author), Kantonsspital Aarau, Univ Dept Med, Div Gen & Emergency Med, Aarau, Switzerland.	kutz.alexander@gmail.com	Mueller, Beat/G-2662-2012; schuetz, philipp/C-8475-2013	schuetz, philipp/0000-0001-6400-4949; von Felten, Stefanie/0000-0002-5264-6394; De Geest, Sabina/0000-0001-6596-7237	Swiss National Science Foundation (SNSF Professorship) [PP00P3_150531 /1]; Schweizerische Akademie der Medizinischen Wissenschaften (SAMW)	Swiss National Science Foundation (SNSF Professorship)(Swiss National Science Foundation (SNSF)); Schweizerische Akademie der Medizinischen Wissenschaften (SAMW)	Thermo Fisher provided an unrestricted research grant for this study. PS is supported by the Swiss National Science Foundation (SNSF Professorship, PP00P3_150531 /1). This study was also supported by the Schweizerische Akademie der Medizinischen Wissenschaften (SAMW). No sponsor had any influence on study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams HP, 2008, STROKE, V39, P87, DOI 10.1161/STROKEAHA.106.476648; Albrich WC, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-112; Bello S, 2012, EUR RESPIR J, V39, P1144, DOI 10.1183/09031936.00080411; Cantor WJ, 2009, NEW ENGL J MED, V360, P2705, DOI 10.1056/NEJMoa0808276; Cavallazzi R, 2014, RESP MED, V108, P1569, DOI 10.1016/j.rmed.2014.09.018; Christ M, 2010, DTSCH ARZTEBL INT, V107, P892, DOI 10.3238/arztebl.2010.0892; Courtais C, 2013, AM J EMERG MED, V31, P215, DOI 10.1016/j.ajem.2012.07.017; Eggers KM, 2013, INT J CARDIOL, V168, P3537, DOI 10.1016/j.ijcard.2013.05.005; Espana PP, 2015, J INFECTION, V70, P457, DOI 10.1016/j.jinf.2014.12.003; Fine MJ, 1997, NEW ENGL J MED, V336, P243, DOI 10.1056/NEJM199701233360402; Funke-Kaiser A, 2014, ANN MED, V46, P155, DOI 10.3109/07853890.2013.874662; Gordo-Remartinez S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125212; Grolimund E, 2015, COPD, V12, P295, DOI 10.3109/15412555.2014.949002; Grossmann FF, 2011, ANN EMERG MED, V57, P257, DOI 10.1016/j.annemergmed.2010.07.021; Guttmann A, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.d2983; Henriquez-Camacho C, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/547818; Hsia RY, 2016, JAMA INTERNAL MED; Ishimitsu T, 2006, PHARMACOL THERAPEUT, V111, P909, DOI 10.1016/j.pharmthera.2006.02.004; Jougasaki M, 2000, LIFE SCI, V66, P855, DOI 10.1016/S0024-3205(99)00358-6; Kumar A, 2006, CRIT CARE MED, V34, P1589, DOI 10.1097/01.CCM.0000217961.75225.E9; Kutz A, 2015, CLIN CHEM LAB MED CC; Lim WS, 2003, THORAX, V58, P377, DOI 10.1136/thorax.58.5.377; Linscheid P, 2005, ENDOCRINOLOGY, V146, P2699, DOI 10.1210/en.2004-1424; Maisel A, 2010, J AM COLL CARDIOL, V55, P2062, DOI 10.1016/j.jacc.2010.02.025; Morgenthaler NG, 2005, CLIN CHEM, V51, P1823, DOI 10.1373/clinchem.2005.051110; Parenti N, 2014, INT J NURS STUD, V51, P1062, DOI 10.1016/j.ijnurstu.2014.01.013; Pousset F, 2000, EUR HEART J, V21, P1009, DOI 10.1053/euhj.1999.1904; Puskarich MA, 2011, RESUSCITATION, V82, P1289, DOI 10.1016/j.resuscitation.2011.06.015; Schuetz P, 2015, CRIT CARE, V19, DOI 10.1186/s13054-015-1098-z; Schuetz P, 2015, CLIN CHEM LAB MED, V53, P521, DOI 10.1515/cclm-2014-0748; Schuetz P, 2015, SWISS MED WKLY, V145, DOI 10.4414/smw.2015.14079; Schuetz P, 2013, BMC EMERG MED, V13, DOI 10.1186/1471-227X-13-12; Schuetz P, 2010, CRIT CARE, V14, DOI 10.1186/cc9055; Shah KS, 2015, ACAD EMERG MED, V22, P554, DOI 10.1111/acem.12649; Steiner D, 2015, J EMERGENCY MED; Suberviola B, 2013, INTENS CARE MED, V39, P1945, DOI 10.1007/s00134-013-3056-z; Sun BC, 2013, ANN EMERG MED, V61, P605, DOI 10.1016/j.annemergmed.2012.10.026; Yuyun MF, 2015, AM J CARDIOL, V115, P986, DOI 10.1016/j.amjcard.2015.01.027	38	14	14	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2016	11	12							e0168076	10.1371/journal.pone.0168076	http://dx.doi.org/10.1371/journal.pone.0168076			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI9QH	28005916	Green Submitted, Green Published, gold			2022-12-27	WOS:000392843200027
J	Li, GQ; Sun, CJ; Wu, GQ; Shi, FY; Liu, AQ; Yang, N				Li, Guangqi; Sun, Congjiao; Wu, Guiqin; Shi, Fengying; Liu, Aiqiao; Yang, Ning			iTRAQ-Based Quantitative Proteomics Identifies Potential Regulatory Proteins Involved in Chicken Eggshell Brownness	PLoS One			English	Article							SHELL GLAND; BENZODIAZEPINE-RECEPTOR; HEME-BIOSYNTHESIS; 18 KDA; SACCHAROMYCES-CEREVISIAE; GENE-EXPRESSION; JAPANESE-QUAIL; LARGE-SCALE; TSPO; PIGMENTS	Brown eggs are popular in many countries and consumers regard eggshell brownness as an important indicator of egg quality. However, the potential regulatory proteins and detailed molecular mechanisms regulating eggshell brownness have yet to be clearly defined. In the present study, we performed quantitative proteomics analysis with iTRAQ technology in the shell gland epithelium of hens laying dark and light brown eggs to investigate the candidate proteins and molecular mechanisms underlying variation in chicken eggshell brownness. The results indicated 147 differentially expressed proteins between these two groups, among which 65 and 82 proteins were significantly up-regulated in the light and dark groups, respectively. Functional analysis indicated that in the light group, the down-regulated iron-sulfur cluster assembly protein (Iba57) would decrease the synthesis of protoporphyrin IX; furthermore, the up-regulated protein solute carrier family 25 (mitochondrial carrier; adenine nucleotide translocator), member 5 (SLC25A5) and down-regulated translocator protein (TSPO) would lead to increased amounts of protoporphyrin IX transported into the mitochondria matrix to form heme with iron, which is supplied by ovotransferrin protein (TF). In other words, chickens from the light group produce less protoporphyrin IX, which is mainly used for heme synthesis. Therefore, the exported protoporphyrin IX available for eggshell deposition and brownness is reduced in the light group. The current study provides valuable information to elucidate variation of chicken eggshell brownness, and demonstrates the feasibility and sensitivity of iTRAQ-based quantitative proteomics analysis in providing useful insights into the molecular mechanisms underlying brown eggshell pigmentation.	[Li, Guangqi; Sun, Congjiao; Yang, Ning] China Agr Univ, Coll Anim Sci & Technol, Natl Engn Lab Anim Breeding, Beijing, Peoples R China; [Li, Guangqi; Sun, Congjiao; Yang, Ning] China Agr Univ, Coll Anim Sci & Technol, MOA Key Lab Anim Genet & Breeding, Beijing, Peoples R China; [Wu, Guiqin; Shi, Fengying; Liu, Aiqiao] Beijing Engn Res Ctr Layer, Beijing, Peoples R China	China Agricultural University; China Agricultural University	Yang, N (corresponding author), China Agr Univ, Coll Anim Sci & Technol, Natl Engn Lab Anim Breeding, Beijing, Peoples R China.; Yang, N (corresponding author), China Agr Univ, Coll Anim Sci & Technol, MOA Key Lab Anim Genet & Breeding, Beijing, Peoples R China.	nyang@cau.edu.cn		Yang, Ning/0000-0001-5772-3320	National High Technology Development Plan of China [2013AA102501]; China Agricultural Technology Research System for Layer [CARS-41]; Programs for Changjiang Scholars and Innovative Research in University [IRT1191]	National High Technology Development Plan of China; China Agricultural Technology Research System for Layer; Programs for Changjiang Scholars and Innovative Research in University(Program for Changjiang Scholars & Innovative Research Team in University (PCSIRT))	This work was supported by the grants from National High Technology Development Plan of China (2013AA102501), China Agricultural Technology Research System for Layer (CARS-41), and Programs for Changjiang Scholars and Innovative Research in University (IRT1191).	Adav SS, 2014, J PROTEOME RES, V13, P4635, DOI 10.1021/pr500754j; AISEN P, 1980, ANNU REV BIOCHEM, V49, P357, DOI 10.1146/annurev.bi.49.070180.002041; Ajioka RS, 2006, BBA-MOL CELL RES, V1763, P723, DOI 10.1016/j.bbamcr.2006.05.005; [Anonymous], 1997, COLOURLIFE INTRO C; Azuma M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003070; Balsemao-Pires E, 2011, BMC PLANT BIOL, V11, DOI 10.1186/1471-2229-11-108; Bhosale SV, 2013, EUR J ORG CHEM, V2013, P3939, DOI 10.1002/ejoc.201300240; Bolar NA, 2013, HUM MOL GENET, V22, P2590, DOI 10.1093/hmg/ddt107; BRAESTRUP C, 1977, NATURE, V269, P702, DOI 10.1038/269702a0; BREEN PC, 1969, J MORPHOL, V128, P35, DOI 10.1002/jmor.1051280103; Chen TT, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0148487; Cho J, 2015, CELL DEATH DIFFER, V22, P1437, DOI 10.1038/cdd.2014.230; Fan J, 2012, CURR MOL MED, V12, P369; Gelling C, 2008, MOL CELL BIOL, V28, P1851, DOI 10.1128/MCB.01963-07; Giansanti F, 2012, BBA-GEN SUBJECTS, V1820, P218, DOI 10.1016/j.bbagen.2011.08.004; Glibert P, 2015, J PROTEOME RES, V14, P839, DOI 10.1021/pr500889v; Gorchein A, 2012, BIOMED CHROMATOGR, V26, P355, DOI 10.1002/bmc.1665; Gorchein A, 2009, BIOMED CHROMATOGR, V23, P602, DOI 10.1002/bmc.1158; Guo YZ, 2015, SCIENCE, V347, P551, DOI 10.1126/science.aaa1534; Guo ZG, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0133270; Ishizuka M, 2011, INT IMMUNOPHARMACOL, V11, P358, DOI 10.1016/j.intimp.2010.11.029; Johnston NP, 2011, POULTRY SCI, V90, P1074, DOI 10.3382/ps.2010-00914; JORDAN PM, 1994, CURR OPIN STRUC BIOL, V4, P902, DOI 10.1016/0959-440X(94)90273-9; Kambiranda D, 2014, J PROTEOME RES, V13, P555, DOI 10.1021/pr400731p; KENNEDY GY, 1976, COMP BIOCHEM PHYS B, V55, P117, DOI 10.1016/0305-0491(76)90183-8; LANG MR, 1987, WORLD POULTRY SCI J, V43, P238, DOI 10.1079/WPS19870016; Latosinska A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0137048; Li GQ, 2013, POULTRY SCI, V92, P3120, DOI 10.3382/ps.2013-03484; Lossos A, 2015, NEUROLOGY, V84, P659, DOI 10.1212/WNL.0000000000001270; Mann K, 2006, PROTEOMICS, V6, P3801, DOI 10.1002/pmic.200600120; MCENERY MW, 1992, P NATL ACAD SCI USA, V89, P3170, DOI 10.1073/pnas.89.8.3170; Morgan J, 2004, BRIT J DERMATOL, V151, P846, DOI 10.1111/j.1365-2133.2004.06198.x; Muhlenhoff U, 2007, EUKARYOT CELL, V6, P495, DOI 10.1128/EC.00191-06; Nilsson R, 2009, CELL METAB, V10, P119, DOI 10.1016/j.cmet.2009.06.012; Palmieri F, 2004, PFLUG ARCH EUR J PHY, V447, P689, DOI 10.1007/s00424-003-1099-7; PONKA P, 1985, J BIOL CHEM, V260, P4717; PORRA RJ, 1964, BIOCHEM J, V90, P69, DOI 10.1042/bj0900069; Punnett RC, 1920, J GENET, V10, P277, DOI 10.1007/BF02984299; Ross PL, 2004, MOL CELL PROTEOMICS, V3, P1154, DOI 10.1074/mcp.M400129-MCP200; SCHAEFFER E, 1987, GENE, V56, P109, DOI 10.1016/0378-1119(87)90163-6; Sheftel AD, 2012, MOL BIOL CELL, V23, P1157, DOI 10.1091/mbc.E11-09-0772; SNYDER SH, 1987, FASEB J, V1, P282, DOI 10.1096/fasebj.1.4.2820823; SOH T, 1993, J FAC AGR KYUSHU U, V38, P73; SOH T, 1989, POULTRY SCI, V68, P1156, DOI 10.3382/ps.0681156; Sparks NHC, 2011, AVIAN BIOL RES, V4, P162, DOI 10.3184/175815511X13228269481875; Sun CJ, 2013, PROTEOMICS, V13, P3523, DOI 10.1002/pmic.201300286; TAKETANI S, 1994, J BIOL CHEM, V269, P7527; Tamura T., 1966, Journal of the Faculty of Fisheries and Animal Husbandry Hiroshima University, V6, P357; Tamura T., 1965, Journal of the Faculty of Fisheries and Animal Husbandry Hiroshima University, V6, P37; Vanhee C, 2011, PLANT CELL, V23, P785, DOI 10.1105/tpc.110.081570; Veenman L, 2008, J BIOENERG BIOMEMBR, V40, P199, DOI 10.1007/s10863-008-9142-1; Veenman L, 2007, CURR PHARM DESIGN, V13, P2385; Wang XT, 2007, POULTRY SCI, V86, P2236, DOI 10.1093/ps/86.10.2236; Wang ZK, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0153007; WEI R, 1992, POULTRY SCI, V71, P406, DOI 10.3382/ps.0710406; WILLIAMS J, 1968, BIOCHEM J, V108, P57, DOI 10.1042/bj1080057; With T. K., 1973, BIOCHEM J, V137, P597; Yarian CS, 2006, MECH AGEING DEV, V127, P79, DOI 10.1016/j.mad.2005.09.028; Ye H, 2010, ADV HEMATOL, V2010; Zeno S, 2012, CURR MOL MED, V12, P494; Zhang LC, 2005, POULTRY SCI, V84, P1209, DOI 10.1093/ps/84.8.1209; Zheng AJ, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-1167	62	7	9	3	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2016	11	12							e0168750	10.1371/journal.pone.0168750	http://dx.doi.org/10.1371/journal.pone.0168750			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI9QH	28006025	Green Submitted, Green Published, gold			2022-12-27	WOS:000392843200089
J	Pelechrinis, K; Papalexakis, E				Pelechrinis, Konstantinos; Papalexakis, Evangelos			The Anatomy of American Football: Evidence from 7 Years of NFL Game Data	PLoS One			English	Article								How much does a fumble affect the probability of winning an American football game? How balanced should your offense be in order to increase the probability of winning by 10%? These are questions for which the coaching staff of National Football League teams have a clear qualitative answer. Turnovers are costly; turn the ball over several times and you will certainly lose. Nevertheless, what does "several" mean? How "certain" is certainly? In this study, we collected play-by-play data from the past 7 NFL seasons, i.e., 2009-2015, and we build a descriptive model for the probability of winning a game. Despite the fact that our model incorporates simple box score statistics, such as total offensive yards, number of turnovers etc., its overall cross-validation accuracy is 84%. Furthermore, we combine this descriptive model with a statistical bootstrap module to build FPM (short for Football Prediction Matchup) for predicting future match-ups. The contribution of FPM is pertinent to its simplicity and transparency, which however does not sacrifice the system's performance. In particular, our evaluations indicate that our prediction engine performs on par with the current state-of-the-art systems (e.g., ESPN's FPI and Microsoft's Cortana). The latter are typically proprietary but based on their components described publicly they are significantly more complicated than FPM. Moreover, their proprietary nature does not allow for a head-to-head comparison in terms of the core elements of the systems but it should be evident that the features incorporated in FPM are able to capture a large percentage of the observed variance in NFL games.	[Pelechrinis, Konstantinos] Univ Pittsburgh, Sch Informat Sci, Pittsburgh, PA 15260 USA; [Papalexakis, Evangelos] Univ Calif Riverside, Dept Comp Sci & Engn, Riverside, CA 92521 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University of California System; University of California Riverside	Pelechrinis, K (corresponding author), Univ Pittsburgh, Sch Informat Sci, Pittsburgh, PA 15260 USA.	kpele@pitt.edu	Pelechrinis, Konstantinos/ACX-4835-2022	Pelechrinis, Konstantinos/0000-0002-6443-3935; Papalexakis, Evangelos/0000-0002-3411-8483				Agresti A, 2007, WILEY SERIES PROBABI, DOI [10.1002/0470114754, DOI 10.1002/0470114754]; Alamar BC, 2008, J QUANT ANAL SPORTS, V4, DOI 10.2202/1559-0410.1113; [Anonymous], INTRO BOOTSTRAP, DOI DOI 10.1007/978-1-4899-4541-9; [Anonymous], 2015, GAM THEOR AM FOOTB D; Austin PC, 2011, MULTIVAR BEHAV RES, V46, P399, DOI 10.1080/00273171.2011.568786; Bing M, 2016, LOOKING AHEAD BING; BRADLEY RA, 1952, BIOMETRIKA, V39, P324, DOI 10.1093/biomet/39.3-4.324; Clark T, 2013, 7 ANN MIT SLOAN SPOR; Cohea C., 2011, SPORTSCIENCE, V15, P19; Correia V, 2011, HUM MOVEMENT SCI, V30, P984, DOI 10.1016/j.humov.2010.07.008; ESPN, 2016, GUID NFL FPI; GILOVICH T, 1985, COGNITIVE PSYCHOL, V17, P295, DOI 10.1016/0010-0285(85)90010-6; Glickman ME, 1998, J AM STAT ASSOC, V93, P25, DOI 10.2307/2669599; Hochstedler J., 2016, MIT SLOAN SPORTS AN; KAHNEMAN D, 1973, PSYCHOL REV, V80, P237, DOI 10.1037/h0034747; Lamb C.W., 2012, ESSENTIALS MARKETING; Nerd FF, 2015, NFL PICKS ACCURACY L; Pelechrinis K., 2016, ACM SIGKDD WORKSH LA; Pfitzner C, 2014, SPORT J; Stair A, 2008, EC B, V26, P1; Tower N, 2016, CORTANA PREDICTIONS; Warner J., 2010, PREDICTING MARGIN VI	23	2	2	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2016	11	12							e0168716	10.1371/journal.pone.0168716	http://dx.doi.org/10.1371/journal.pone.0168716			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EI9QH	28005971	Green Published, Green Accepted, gold, Green Submitted			2022-12-27	WOS:000392843200086
J	Kaguelidou, F; Alberti, C; Biran, V; Bourdon, O; Farnoux, C; Zohar, S; Jacqz-Aigrain, E				Kaguelidou, Florentia; Alberti, Corinne; Biran, Valerie; Bourdon, Olivier; Farnoux, Caroline; Zohar, Sarah; Jacqz-Aigrain, Evelyne			Dose-Finding Study of Omeprazole on Gastric pH in Neonates with Gastro-Esophageal Acid Reflux Using a Bayesian Sequential Approach	PLoS One			English	Article							PROTON-PUMP INHIBITORS; CONTINUAL REASSESSMENT METHOD; BIRTH-WEIGHT INFANTS; CLINICAL-TRIALS; PRETERM INFANTS; CHILDREN; PHARMACOKINETICS; THERAPY; DISEASE; RISK	Objective Proton pump inhibitors are frequently administered on clinical symptoms in neonates but benefit remains controversial. Clinical trials validating omeprazole dosage in neonates are limited. The objective of this trial was to determine the minimum effective dose (MED) of omeprazole to treat pathological acid reflux in neonates using reflux index as surrogate marker. Design Double blind dose-finding trial with continual reassessment method of individual dose administration using a Bayesian approach, aiming to select drug dose as close as possible to the predefined target level of efficacy (with a credibility interval of 95%). Setting Neonatal Intensive Care unit of the Robert Debre University Hospital in Paris, France. Patients Neonates with a postmenstrual age >= 35 weeks and a pathologic 24-hour intra-esophageal pH monitoring defined by a reflux index >= 5% over 24 hours were considered for participation. Recruitment was stratified to 3 groups according to gestational age at birth. Intervention Five preselected doses of oral omeprazole from 1 to 3 mg/kg/day. Main outcome measures Primary outcome, measured at 35 weeks postmenstrual age or more, was a reflux index <5% during the 24-h pH monitoring registered 72 +/- 24 hours after omeprazole initiation. Results Fifty-four neonates with a reflux index ranging from 5.06 to 27.7% were included. Median age was 37.5 days and median postmenstrual age was 36 weeks. In neonates born at less than 32 weeks of GA (n = 30), the MED was 2.5mg/kg/day with an estimated mean posterior probability of success of 97.7% (95% credibility interval: 90.3-99.7%). The MED was 1 mg/ kg/day for neonates born at more than 32 GA (n = 24). Conclusions Omeprazole is extensively prescribed on clinical symptoms but efficacy is not demonstrated while safety concerns do exist. When treatment is required, the daily dose needs to be validated in preterm and term neonates. Optimal doses of omeprazole to increase gastric pH and decrease reflux index below 5% over 24 hours, determined using an adaptive Bayesian design differ among neonates. Both gestational and postnatal ages account for these differences but their differential impact on omeprazole doses remains to be determined.	[Kaguelidou, Florentia; Jacqz-Aigrain, Evelyne] Hop Robert Debre, AP HP, Dept Pediat Pharmacol & Pharmacogenet, Paris, France; [Kaguelidou, Florentia; Alberti, Corinne; Jacqz-Aigrain, Evelyne] Hop Robert Debre, INSERM, CIC1426, Paris, France; [Kaguelidou, Florentia; Jacqz-Aigrain, Evelyne] Univ Paris 7 Diderot, Sorbonne Paris Cite, ED 563, EA7323, Paris, France; [Alberti, Corinne] Hop Robert Debre, AP HP, Dept Clin Epidemiol, Paris, France; [Alberti, Corinne; Biran, Valerie] Univ Paris 7 Diderot, Sorbonne Paris Cite, France UMR S 1123, Paris, France; [Alberti, Corinne] ECEVE, Paris, France; [Biran, Valerie; Farnoux, Caroline] Hop Robert Debre, AP HP, Dept Neonatol, Paris, France; [Bourdon, Olivier] Hop Robert Debre, AP HP, Dept Pharm, Paris, France; [Bourdon, Olivier] Univ Paris 5 Descartes, Paris, France; [Bourdon, Olivier] Univ Paris 13, Sorbonne Paris Cite, Lab Educ & Prat Sante, EA 3412, Paris, France; [Zohar, Sarah] Univ Paris 6 Pierre & Marie Curie, Paris, France; [Zohar, Sarah] INSERM, Paris, France; [Zohar, Sarah] Ctr Rech Cordeliers, U1138, Paris, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Robert-Debre - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Robert-Debre - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Robert-Debre - APHP; UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Robert-Debre - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Robert-Debre - APHP; UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; Universite Paris 13; UDICE-French Research Universities; Sorbonne Universite; Institut National de la Sante et de la Recherche Medicale (Inserm); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Universite Paris Cite	Jacqz-Aigrain, E (corresponding author), Hop Robert Debre, AP HP, Dept Pediat Pharmacol & Pharmacogenet, Paris, France.; Jacqz-Aigrain, E (corresponding author), Hop Robert Debre, INSERM, CIC1426, Paris, France.; Jacqz-Aigrain, E (corresponding author), Univ Paris 7 Diderot, Sorbonne Paris Cite, ED 563, EA7323, Paris, France.	evelyne.jacqz-aigrain@aphp.fr	Zohar, Sarah/A-5026-2016; Biran, Valerie/GQY-8192-2022; Bourdon, Olivier/AHA-7107-2022; Zohar, Sarah/ACE-9228-2022; Jacqz-Aigrain, Evelyne/AAW-7089-2021	Zohar, Sarah/0000-0002-8429-2340; Jacqz-Aigrain, Evelyne/0000-0002-4285-7067	Hospital Clinical Research Program (Ministry of Health) [AOM05123]	Hospital Clinical Research Program (Ministry of Health)	The study was funded by a grant from the Hospital Clinical Research Program (Ministry of Health, AOM05123) given to EJA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersson T, 2000, AM J GASTROENTEROL, V95, P3101; Barron JJ, 2007, J PEDIATR GASTR NUTR, V45, P421, DOI 10.1097/MPG.0b013e31812e0149; Bishop J, 2007, J PEDIATR GASTR NUTR, V45, P50, DOI 10.1097/MPG.0b013e318049cbcc; Boyle JT, 2003, J PEDIATR GASTR NUTR, V37, pS12, DOI 10.1097/00005176-200311001-00004; Canani RB, 2006, PEDIATRICS, V117, pE817, DOI 10.1542/peds.2005-1655; Canani RB, 2010, CURR OPIN GASTROEN, V26, P31, DOI 10.1097/MOG.0b013e328333d781; Desfrere L, 2005, J CLIN PHARM THER, V30, P121, DOI 10.1111/j.1365-2710.2005.00630.x; Fabre E, 1998, BRIT J CLIN PHARMACO, V46, P395, DOI 10.1046/j.1365-2125.1998.00788.x; Famularo G, 2013, EXPERT OPIN DRUG SAF, V12, P709, DOI 10.1517/14740338.2013.809062; George I, 2011, PEDIATR NEPHROL, V26, P1843, DOI 10.1007/s00467-011-1883-0; Guillet R, 2006, PEDIATRICS, V117, pE137, DOI 10.1542/peds.2005-1543; Hassall E, 2000, J PEDIATR-US, V137, P800, DOI 10.1067/mpd.2000.109607; HYMAN PE, 1985, J PEDIATR-US, V106, P467, DOI 10.1016/S0022-3476(85)80682-X; Kearns GL, 2003, NEW ENGL J MED, V349, P1157, DOI 10.1056/NEJMra035092; KELLY EJ, 1993, EARLY HUM DEV, V35, P215, DOI 10.1016/0378-3782(93)90108-7; Litalien C, 2005, CLIN PHARMACOKINET, V44, P441, DOI 10.2165/00003088-200544050-00001; Malcolm WF, 2008, PEDIATRICS, V121, P22, DOI 10.1542/peds.2007-0381; Mitchell DJ, 2001, ARCH DIS CHILD, V84, P273, DOI 10.1136/adc.84.3.273; Omari TI, 2002, GUT, V51, P475, DOI 10.1136/gut.51.4.475; Orenstein SR, 2007, J PEDIATR GASTR NUTR, V45, P395, DOI 10.1097/MPG.0b013e31812e011d; Pressler RM, 2015, LANCET NEUROL, V14, P469, DOI 10.1016/S1474-4422(14)70303-5; Rhodin MM, 2009, PEDIATR NEPHROL, V24, P67, DOI 10.1007/s00467-008-0997-5; Sachs G, 2006, ALIMENT PHARM THERAP, V23, P2, DOI 10.1111/j.1365-2036.2006.02943.x; Saiman L, 2001, PEDIATR INFECT DIS J, V20, P1119, DOI 10.1097/00006454-200112000-00005; Shakhnovich V, 2012, CLIN PHARMACOL THER, V92, P388, DOI 10.1038/clpt.2012.86; Spiegelhalter DJ, 1999, BRIT MED J, V319, P508, DOI 10.1136/bmj.319.7208.508; Treluyer JM, 2005, J CLIN PHARM THER, V30, P479, DOI 10.1111/j.1365-2710.2005.00678.x; van der Pol RJ, 2011, PEDIATRICS, V127, P925, DOI 10.1542/peds.2010-2719; Vandenplas Y, 2009, J PEDIATR GASTR NUTR, V49, P498, DOI 10.1097/MPG.0b013e3181b7f563; Ward RM, 2013, PEDIATR DRUGS, V15, P119, DOI 10.1007/s40272-013-0012-x; Zohar S, 2003, COMPUT METH PROG BIO, V72, P117, DOI 10.1016/S0169-2607(02)00120-7; Zohar S, 2008, CONTEMP CLIN TRIALS, V29, P608, DOI 10.1016/j.cct.2007.11.005; Zohar Sarah, 2003, J Biopharm Stat, V13, P87, DOI 10.1081/BIP-120017728; Zohar S, 2011, STAT MED, V30, P2109, DOI 10.1002/sim.4121	34	5	5	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2016	11	12							e0166207	10.1371/journal.pone.0166207	http://dx.doi.org/10.1371/journal.pone.0166207			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI9TW	28002471	Green Published, Green Submitted, gold			2022-12-27	WOS:000392853100004
J	Starr, RM; Gleason, MG; Marks, CI; Kline, D; Rienecke, S; Denney, C; Tagini, A; Field, JC				Starr, Richard M.; Gleason, Mary G.; Marks, Corina I.; Kline, Donna; Rienecke, Steve; Denney, Christian; Tagini, Anne; Field, John C.			Targeting Abundant Fish Stocks while Avoiding Overfished Species: Video and Fishing Surveys to Inform Management after Long-Term Fishery Closures	PLOS ONE			English	Article							ROCKFISH SEBASTES SPP.; HABITAT; PRODUCTIVITY; ASSESSMENTS; EXTINCTION; BEHAVIOR; DENSITY; INDEXES; THREATS; TRAWLS	Historically, it has been difficult to balance conservation goals and yield objectives when managing multispecies fisheries that include stocks with various vulnerabilities to fishing. As managers try to maximize yield in mixed-stock fisheries, exploitation rates can lead to less productive stocks becoming overfished. In the late 1990s, population declines of several U.S. West Coast groundfish species caused the U.S. Pacific Fishery Management Council to create coast-wide fishery closures, known as Rockfish Conservation Areas, to rebuild overfished species. The fishery closures and other management measures successfully reduced fishing mortality of these species, but constrained fishing opportunities on abundant stocks. Restrictive regulations also caused the unintended consequence of reducing fishery -dependent data available to assess population status of fished species. As stocks rebuild, managers are faced with the challenge of increasing fishing opportunities while minimizing fishing mortality on rebuilding species. We designed a camera system to evaluate fishes in coastal habitats and used experimental gear and fishing techniques paired with video surveys to determine if abundant species could be caught in rocky habitats with minimal catches of co-occurring rebuilding species. We fished a total of 58 days and completed 741 sets with vertical hook-and-line fishing gear. We also conducted 299 video surveys in the same locations where fishing occurred. Comparison of fishing and stereo-video surveys indicated that fishermen could fish with modified hook-and-line gear to catch abundant species while limiting bycatch of rebuilding species. As populations of overfished species continue to recover along the U.S. West Coast, it is important to improve data collection, and video and fishing surveys may be key to assessing species that occur in rocky habitats.	[Starr, Richard M.] Calif Sea Grant Program, Moss Landing, CA 95039 USA; [Starr, Richard M.; Marks, Corina I.; Kline, Donna; Denney, Christian; Tagini, Anne] Moss Landing Marine Labs, Pob 450, Moss Landing, CA 95039 USA; [Gleason, Mary G.; Rienecke, Steve] Nature Conservancy, Monterey, CA USA; [Field, John C.] Natl Marine Fisheries Serv, Fisheries Ecol Div, Southwest Fishery Sci Ctr, NOAA, Santa Cruz, CA USA	Moss Landing Marine Laboratories; Nature Conservancy; National Oceanic Atmospheric Admin (NOAA) - USA	Starr, RM (corresponding author), Calif Sea Grant Program, Moss Landing, CA 95039 USA.; Starr, RM (corresponding author), Moss Landing Marine Labs, Pob 450, Moss Landing, CA 95039 USA.	starr@mlml.calstate.edu			Nature Conservancy; Resources Legacy Fund; Gordon and Betty Moore Foundation; Environmental Defense Fund; California Sea Grant Program; NMFS National Cooperative Research Program; NOAA Saltonstall-Kennedy Grant [13-SWR-008]	Nature Conservancy; Resources Legacy Fund; Gordon and Betty Moore Foundation(Gordon and Betty Moore Foundation); Environmental Defense Fund; California Sea Grant Program; NMFS National Cooperative Research Program; NOAA Saltonstall-Kennedy Grant	Funding for this research was provided by The Nature Conservancy and private donors, Resources Legacy Fund, the Gordon and Betty Moore Foundation, Environmental Defense Fund, California Sea Grant Program, the NMFS National Cooperative Research Program, and a NOAA Saltonstall-Kennedy Grant #13-SWR-008 to the San Jose State University Research Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agresti A., 2013, CATEGORICAL DATA ANA, V3rd ed.; Amend M, 2001, NEARSHORE ROCKY REEF; Ault JS, 2013, FISH RES, V144, P28, DOI 10.1016/j.fishres.2012.10.007; Berkeley SA, 2004, FISHERIES, V29, P23, DOI 10.1577/1548-8446(2004)29[23:FSVPOA]2.0.CO;2; Bohnsack J.A., 1986, NOAA TECH REP NMFS, V41, P21; Burgess MG, 2013, P NATL ACAD SCI USA, V110, P15943, DOI 10.1073/pnas.1314472110; Cailliet GM, 1999, OCEANOL ACTA, V22, P579, DOI 10.1016/S0399-1784(00)88949-5; Cappo M, 2004, J EXP MAR BIOL ECOL, V302, P123, DOI 10.1016/j.jembe.2003.10.006; Cappo M, 2003, AQUATIC PROTECTED AR, P455; Clark WG, 2002, N AM J FISH MANAGE, V22, P251, DOI 10.1577/1548-8675(2002)022<0251:FRTYL>2.0.CO;2; Cope JM, 2011, N AM J FISH MANAGE, V31, P589, DOI 10.1080/02755947.2011.591264; Cope JM, 2013, DATA MODERATE STOCK; Dick EJ, 2013, STATUS PRODUCTIVITY; Dougherty DT, 2013, CAN J FISH AQUAT SCI, V70, P49, DOI 10.1139/cjfas-2012-0042; Easton RR, 2015, MAR COAST FISH, V7, P87, DOI 10.1080/19425120.2015.1007184; Field JC, 2006, FISH FISH, V7, P284, DOI 10.1111/j.1467-2979.2006.00226.x; Field JC, 2006, MAR POLICY, V30, P552, DOI 10.1016/j.marpol.2005.07.004; FRANCIS R C, 1986, North American Journal of Fisheries Management, V6, P453, DOI 10.1577/1548-8659(1986)6<453:TFBPIW>2.0.CO;2; Hamel OS, 2009, STATUS FUTURE PROSPE; Hannah RW, 2008, OREGON DEP FISH WILD, V2008-03; He X, 2015, STATUS BOCACCIO SEBA; Hilborn R, 2004, B MAR SCI, V74, P493; Holland DS, 2012, ECOL ECON, V78, P132, DOI 10.1016/j.ecolecon.2012.04.010; Holland DS, 2010, NAT RESOUR MODEL, V23, P494, DOI 10.1111/j.1939-7445.2010.00071.x; Johnson KA, 2001, CAL COOP OCEAN FISH, V42, P153; Jones DT, 2012, FISH B-NOAA, V110, P332; Keller AA, 2014, MAR ECOL PROG SER, V501, P169, DOI 10.3354/meps10674; Keller AA, 2012, FISH B-NOAA, V110, P205; Laidig TE, 2013, FISH B-NOAA, V111, P54, DOI 10.7755/FB.111.1.5; Lauth RR, 2004, FISH RES, V70, P39, DOI 10.1016/j.fishres.2004.06.009; Leising AW, 2015, CAL COOP OCEAN FISH, V56, P31; Liberman AM, 2005, AM J EVAL, V26, P253, DOI 10.1177/1098214005275825; Love M. S., 2002, ROCKFISHES NE PACIFI; MacCall AD, 2002, N AM J FISH MANAGE, V22, P272, DOI 10.1577/1548-8675(2002)022<0272:UOKBPM>2.0.CO;2; MacCall AD., 1990, DYNAMIC GEOGRAPHY MA; Marks CI, 2015, CAL COOP OCEAN FISH, P56; Mason J, 2012, MAR POLICY, V36, P1054, DOI 10.1016/j.marpol.2012.03.002; de Mitcheson YS, 2013, FISH FISH, V14, P119, DOI 10.1111/j.1467-2979.2011.00455.x; MURAWSKI SA, 1991, FISHERIES, V16, P5, DOI 10.1577/1548-8446(1991)016<0005:CWMOMF>2.0.CO;2; Ono K, 2015, CAN J FISH AQUAT SCI, V72, P1177, DOI 10.1139/cjfas-2014-0146; Ono K, 2015, ICES J MAR SCI, V72, P31, DOI 10.1093/icesjms/fsu007; Patrick WS, 2010, FISH B-NOAA, V108, P305; Pearson DE, 2000, SC0001 NAT MAR FISH; Ralston S, 2002, N AM J FISH MANAGE, V22, P249, DOI 10.1577/1548-8675(2002)022<0249:WCGHP>2.0.CO;2; Ralston S, 2013, FISH OCEANOGR, V22, P288, DOI 10.1111/fog.12022; Rooper CN, 2015, FISH RES, V172, P157, DOI 10.1016/j.fishres.2015.07.012; Smith SG, 2011, FISH RES, V109, P25, DOI 10.1016/j.fishres.2011.01.012; Stoner AW, 2008, CAN J FISH AQUAT SCI, V65, P1230, DOI 10.1139/F08-032; Taylor IG, 2011, STATUS US YELLOWEYE; Thorson J, 2015, STATUS CANARY ROCKFI; Thorson JT, 2012, ICES J MAR SCI, V69, P635, DOI 10.1093/icesjms/fss003; Tissot BN, 2008, MARINE HABITAT MAPPI; Yoklavich MM, 2007, CAN J FISH AQUAT SCI, V64, P1795, DOI 10.1139/F07-145; Yoklavich MM, 2008, MARINE HABITAT MAPPI	54	10	10	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2016	11	12							e0168645	10.1371/journal.pone.0168645	http://dx.doi.org/10.1371/journal.pone.0168645			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI9TW	28002499	Green Published, gold, Green Submitted			2022-12-27	WOS:000392853100060
J	Cohen, O; Oberhardt, M; Yizhak, K; Ruppin, E				Cohen, Osher; Oberhardt, Matthew; Yizhak, Keren; Ruppin, Eytan			Essential Genes Embody Increased Mutational Robustness to Compensate for the Lack of Backup Genetic Redundancy	PLOS ONE			English	Article							ESCHERICHIA-COLI; CODON USAGE; TRANSLATION EFFICIENCY; NONESSENTIAL GENES; ACETYLATION; EVOLUTION; CONSEQUENCES; MODELS; LEVEL; CELLS	Genetic robustness is a hallmark of cells, occurring through many mechanisms and at many levels. Essential genes lack the common robustness mechanism of genetic redundancy (i.e., existing alongside other genes with the same function), and thus appear at first glance to leave cells highly vulnerable to genetic or environmental perturbations. Here we explore a hypothesis that cells might protect against essential gene loss through mechanisms that occur at various cellular levels aside from the level of the gene. Using Escherichia coli and Saccharomyces cerevisiae as models, we find that essential genes are enriched over nonessential genes for properties we call "coding efficiency"and "coding robustness", denoting respectively a gene's efficiency of translation and robustness to non-synonymous mutations. The coding efficiency levels of essential genes are highly positively correlated with their evolutionary conservation levels, suggesting that this feature plays a key role in protecting conserved, evolutionarily important genes. We then extend our hypothesis into the realm of metabolic networks, showing that essential metabolic reactions are encoded by more "robust" genes than non-essential reactions, and that essential metabolites are produced by more reactions than non-essential metabolites. Taken together, these results testify that robustness at the gene-loss level and at the mutation level (and more generally, at two cellular levels that are usually treated separately) are not decoupled, but rather, that cellular vulnerability exposed due to complete gene loss is compensated by increased mutational robustness. Why some genes are backed up primarily against loss and others against mutations still remains an open question.	[Cohen, Osher; Yizhak, Keren; Ruppin, Eytan] Tel Aviv Univ, Sch Comp Sci, Tel Aviv, Israel; [Cohen, Osher; Yizhak, Keren; Ruppin, Eytan] Tel Aviv Univ, Sackler Sch Med, Tel Aviv, Israel; [Oberhardt, Matthew; Ruppin, Eytan] Univ Maryland, Ctr Bioinformat & Computat Biol, College Pk, MD 20742 USA	Tel Aviv University; Tel Aviv University; Sackler Faculty of Medicine; University System of Maryland; University of Maryland College Park	Ruppin, E (corresponding author), Tel Aviv Univ, Sch Comp Sci, Tel Aviv, Israel.; Ruppin, E (corresponding author), Tel Aviv Univ, Sackler Sch Med, Tel Aviv, Israel.; Ruppin, E (corresponding author), Univ Maryland, Ctr Bioinformat & Computat Biol, College Pk, MD 20742 USA.	eyruppin@gmail.com	Ruppin, Eytan/R-9698-2017	Ruppin, Eytan/0000-0002-7862-3940	EU; I-CORE Program of the Planning and Budgeting Committee; Israel Science Foundation [41/11]; CONTIBUGS EU bacterial research grants	EU(European Commission); I-CORE Program of the Planning and Budgeting Committee; Israel Science Foundation(Israel Science Foundation); CONTIBUGS EU bacterial research grants	ER gratefully acknowledges support from the EU FP7 INFECT project, the I-CORE Program of the Planning and Budgeting Committee, the Israel Science Foundation (grant No 41/11), and CONTIBUGS EU bacterial research grants. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2002, FUNCTIONAL PROFILING; Aung Hnin W, 2013, Ind Biotechnol (New Rochelle N Y), V9, P215; Baba T, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100050; Borenstein E, 2006, P NATL ACAD SCI USA, V103, P6593, DOI 10.1073/pnas.0510600103; Dayhoff M., 1978, ATLAS PROTEIN SEQUEN; de Visser JAGM, 2003, EVOLUTION, V57, P1959, DOI 10.1554/02-750R; dos Reis M, 2004, NUCLEIC ACIDS RES, V32, P5036, DOI 10.1093/nar/gkh834; Drummond DA, 2008, CELL, V134, P341, DOI 10.1016/j.cell.2008.05.042; Durinck S, 2005, BIOINFORMATICS, V21, P3439, DOI 10.1093/bioinformatics/bti525; Freilich S, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000690; Geijer C, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-554; Gerdes SY, 2003, J BACTERIOL, V185, P5673, DOI 10.1128/JB.185.19.5673-5684.2003; Gong XD, 2008, MOL GENET GENOMICS, V279, P87, DOI 10.1007/s00438-007-0298-x; Hashimoto M, 2005, MOL MICROBIOL, V55, P137, DOI 10.1111/j.1365-2958.2004.04386.x; Hu LI, 2010, MOL MICROBIOL, V77, P15, DOI 10.1111/j.1365-2958.2010.07204.x; Hu PZ, 2009, PLOS BIOL, V7, P929, DOI 10.1371/journal.pbio.1000096; Ish-Am O, 2013, THESIS; Jordan IK, 2002, GENOME RES, V12, P962, DOI 10.1101/gr.87702; Joyce AR, 2006, J BACTERIOL, V188, P8259, DOI 10.1128/JB.00740-06; Kanaya S, 1999, GENE, V238, P143, DOI 10.1016/S0378-1119(99)00225-5; Kim PJ, 2007, P NATL ACAD SCI USA, V104, P13638, DOI 10.1073/pnas.0703262104; Kitano H, 2004, NAT REV GENET, V5, P826, DOI 10.1038/nrg1471; Lewis NE, 2009, J BACTERIOL, V191, P3437, DOI 10.1128/JB.00034-09; Li R, 2010, MOL MICROBIOL, V76, P1162, DOI 10.1111/j.1365-2958.2010.07125.x; Liang WX, 2011, MOL CELL, V44, P160, DOI 10.1016/j.molcel.2011.06.037; Ogata H, 1999, NUCLEIC ACIDS RES, V27, P29, DOI 10.1093/nar/27.1.29; Orth JD, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.65; Plotkin JB, 2011, NAT REV GENET, V12, P32, DOI 10.1038/nrg2899; Price ND, 2004, NAT REV MICROBIOL, V2, P886, DOI 10.1038/nrmicro1023; ROBINSON M, 1984, NUCLEIC ACIDS RES, V12, P6663, DOI 10.1093/nar/12.17.6663; Sablok G, 2013, GENOMICS, V101, P290, DOI 10.1016/j.ygeno.2013.02.008; SORENSEN MA, 1989, J MOL BIOL, V207, P365, DOI 10.1016/0022-2836(89)90260-X; Suthers PF, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.56; Tuller T, 2010, P NATL ACAD SCI USA, V107, P3645, DOI 10.1073/pnas.0909910107; VARENNE S, 1984, J MOL BIOL, V180, P549, DOI 10.1016/0022-2836(84)90027-5; Waldman YY, 2010, NUCLEIC ACIDS RES, V38, P2964, DOI 10.1093/nar/gkq009; Wall DP, 2005, P NATL ACAD SCI USA, V102, P5483, DOI 10.1073/pnas.0501761102; Wang QJ, 2010, SCIENCE, V327, P1004, DOI 10.1126/science.1179687; Wang Z, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000329; Wilke CO, 2003, MUTAT RES-FUND MOL M, V522, P3, DOI 10.1016/S0027-5107(02)00307-X; Zhang K, 2013, J PROTEOME RES, V12, P844, DOI 10.1021/pr300912q; Zhou T, 2009, MOL BIOL EVOL, V26, P1571, DOI 10.1093/molbev/msp070	42	4	4	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2016	11	12							e0168444	10.1371/journal.pone.0168444	http://dx.doi.org/10.1371/journal.pone.0168444			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI9QF	27997585	Green Published, Green Submitted, gold			2022-12-27	WOS:000392842900047
J	Horvei, LD; Braekkan, SK; Hansen, JB				Horvei, Lars Daae; Braekkan, Sigrid K.; Hansen, John-Bjarne			Weight Change and Risk of Venous Thromboembolism: The Tromso Study	PLOS ONE			English	Article							TISSUE FACTOR EXPRESSION; CORONARY-HEART-DISEASE; C-REACTIVE PROTEIN; BODY-WEIGHT; PULMONARY-EMBOLISM; METABOLIC SYNDROME; COMPETING RISK; THROMBOSIS; OBESITY; POPULATION	Background Obesity is a major risk factor for venous thromboembolism (VTE), but it is unknown to what extent weight change over time affects VTE risk. Aims To investigate the association between weight change and risk of incident VTE in a population-based cohort with repeated measurements. Methods Participant data were collected from the Tromso 3 (1986-87), 4 (1994-95), 5 (2000-01) and 6 (2007-08) surveys. Subjects who attended two subsequent or more surveys were included (n = 17802), and weight change between the surveys was calculated. Person-time at risk was accrued from the second of two subsequent vists until the next survey, the date of an incident VTE, migration, death or study end (December 31st 2012), whichever came first. Cox regression models were used to calculate risk of VTE according to change in body weight. Results There were 302 incident VTE events during a median of 6.0 years of follow-up. Subjects who gained most weight (7.5-40.0 kg weight gain) had a 1.9-fold higher risk of VTE compared to those with no or a moderate (0-7.4 kg) weight gain (HR 1.92; 95% CI 1.38-2.68). The VTE risk by >= 7.5 kgs over no or moderate (0-7.4 kg) weight gain was highest (HR 3.75; 95% 1.83-7.68) in subjects with baseline body mass index (BMI) >= 30 kg/m(2). There was a joint effect of weight gain and baseline BMI on VTE risk. Those with BMI >= 30 who gained >7.5 kgs had a 6.6-fold increased risk (HR 6.64; 95% CI 3.61-12.22) compared to subjects with BMI <25 and no or moderate (0-7.4 kg) weight gain. Conclusions Our findings imply that further weight gain is a considerable risk factor for VTE, particularly in obese individuals.	[Horvei, Lars Daae; Braekkan, Sigrid K.; Hansen, John-Bjarne] UiT Arctic Univ Norway, Dept Clin Med, KG Jebsen Thrombosis Res & Expertise Ctr, Tromso, Norway; [Horvei, Lars Daae; Braekkan, Sigrid K.; Hansen, John-Bjarne] Univ Hosp North Norway, Div Internal Med, Tromso, Norway	UiT The Arctic University of Tromso; UiT The Arctic University of Tromso; University Hospital of North Norway	Horvei, LD (corresponding author), UiT Arctic Univ Norway, Dept Clin Med, KG Jebsen Thrombosis Res & Expertise Ctr, Tromso, Norway.; Horvei, LD (corresponding author), Univ Hosp North Norway, Div Internal Med, Tromso, Norway.	lars.d.horvei@uit.no		Braekkan, Sigrid/0000-0002-9678-9696	K.G. Jebsen Foundation; Northern Norway Regional Health Authority; Stiftelsen Kristian Gerhard Jebsen	K.G. Jebsen Foundation; Northern Norway Regional Health Authority; Stiftelsen Kristian Gerhard Jebsen	K.G. Jebsen TREC is supported by an independent grant from the K.G. Jebsen Foundation. Lars D. Horvei received a grant from the Northern Norway Regional Health Authority.; The study has used data from the Cancer Registry of Norway. The interpretation and reporting of these data are the sole responsibility of the authors, and no endorsement by the Cancer Registry of Norway is intended nor should be inferred. K.G.Jebsen-Thrombosis Research and Expertise Center (TREC) has received an independent grant from Stiftelsen Kristian Gerhard Jebsen.	Aronson D, 2004, INT J OBESITY, V28, P674, DOI 10.1038/sj.ijo.0802609; Bertina RM, 2009, THROMB RES, V123, pS41, DOI 10.1016/S0049-3848(09)70142-2; Borch KH, 2010, ARTERIOSCL THROM VAS, V30, P121, DOI 10.1161/ATVBAHA.109.188920; Braekkan SK, 2013, SEMIN THROMB HEMOST, V39, P533, DOI 10.1055/s-0033-1343355; Braekkan SK, 2012, ARTERIOSCL THROM VAS, V32, P487, DOI 10.1161/ATVBAHA.111.237545; Chen YJ, 2008, THROMB HAEMOSTASIS, V100, P291, DOI 10.1160/TH08-02-0124; COLDITZ GA, 1995, ANN INTERN MED, V122, P481, DOI 10.7326/0003-4819-122-7-199504010-00001; De Pergola G, 2002, J ENDOCRINOL INVEST, V25, P899, DOI 10.1007/BF03344054; Diaz VA, 2005, J COMMUN HEALTH, V30, P153, DOI 10.1007/s10900-004-1955-1; Enga KF, 2012, J THROMB HAEMOST, V10, P2068, DOI 10.1111/j.1538-7836.2012.04880.x; Faber DR, 2009, OBES REV, V10, P554, DOI 10.1111/j.1467-789X.2009.00593.x; Fine JP, 1999, J AM STAT ASSOC, V94, P496, DOI 10.2307/2670170; Folsom AR, 1996, INT J OBESITY, V20, P704; French SA, 1995, AM J EPIDEMIOL, V142, P1306, DOI 10.1093/oxfordjournals.aje.a117598; Furie B, 2008, NEW ENGL J MED, V359, P938, DOI 10.1056/NEJMra0801082; Hansson PO, 1999, ARCH INTERN MED, V159, P1886, DOI 10.1001/archinte.159.16.1886; Harrington M, 2009, NUTR RES REV, V22, P93, DOI 10.1017/S0954422409990035; Holst AG, 2010, CIRCULATION, V121, P1896, DOI 10.1161/CIRCULATIONAHA.109.921460; Horvei LD, 2014, EUR J EPIDEMIOL, V29, P821, DOI 10.1007/s10654-014-9950-z; Horvei LD, 2016, J THROMB HAEMOST; Huang ZP, 1998, ANN INTERN MED, V128, P81, DOI 10.7326/0003-4819-128-2-199801150-00001; Jacobsen BK, 2012, INT J EPIDEMIOL, V41, P961, DOI 10.1093/ije/dyr049; Joseph L, 2002, BLOOD COAGUL FIBRIN, V13, P105, DOI 10.1097/00001721-200203000-00005; Kimura Y, 2015, EUR J CLIN NUTR, V69, P462, DOI 10.1038/ejcn.2014.257; Larsen IK, 2009, EUR J CANCER, V45, P1218, DOI 10.1016/j.ejca.2008.10.037; LISSNER L, 1991, NEW ENGL J MED, V324, P1839, DOI 10.1056/NEJM199106273242602; Lorenzet R, 2012, THROMB RES, V129, P285, DOI 10.1016/j.thromres.2011.10.021; Mehta T, 2014, OBES REV, V15, P870, DOI 10.1111/obr.12222; Meltzer ME, 2010, BLOOD, V116, P113, DOI 10.1182/blood-2010-02-267740; Napoleone E, 2007, J THROMB HAEMOST, V5, P1462, DOI 10.1111/j.1538-7836.2007.02578.x; Rosendaal FR, 1999, LANCET, V353, P1167, DOI 10.1016/S0140-6736(98)10266-0; Rosengren A, 1999, EUR HEART J, V20, P269, DOI 10.1053/euhj.1998.1235; Severinsen MT, 2009, CIRCULATION, V120, P1850, DOI 10.1161/CIRCULATIONAHA.109.863241; Simonsen MK, 2008, NUTR REV, V66, P375, DOI 10.1111/j.1753-4887.2008.00047.x; Sorensen HT, 1998, NEW ENGL J MED, V338, P1169, DOI 10.1056/NEJM199804233381701; Steffen LM, 2009, J THROMB HAEMOST, V7, P746, DOI 10.1111/j.1538-7836.2009.03295.x; Timp JF, 2013, BLOOD, V122, P1712, DOI 10.1182/blood-2013-04-460121; Tsai AW, 2002, AM J MED, V113, P636, DOI 10.1016/S0002-9343(02)01345-1; Visser M, 1999, JAMA-J AM MED ASSOC, V282, P2131, DOI 10.1001/jama.282.22.2131; Wattanakit K, 2012, THROMB HAEMOSTASIS, V108, P508, DOI 10.1160/TH11-10-0726; Willenberg T, 2010, J VASC SURG, V52, P664, DOI 10.1016/j.jvs.2010.04.023; WILLETT WC, 1995, JAMA-J AM MED ASSOC, V273, P461, DOI 10.1001/jama.273.6.461	42	19	20	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2016	11	12							e0168878	10.1371/journal.pone.0168878	http://dx.doi.org/10.1371/journal.pone.0168878			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI9QF	27997594	Green Published, Green Submitted, gold			2022-12-27	WOS:000392842900081
J	Kao, LT; Kang, JH; Lin, HC; Huang, CC; Lee, HC; Chung, SD				Kao, Li-Ting; Kang, Jiunn-Horng; Lin, Herng-Ching; Huang, Chung-Chien; Lee, Hsin-Chien; Chung, Shiu-Dong			Rheumatoid Arthritis Was Negatively Associated with Alzheimer's Disease: A Population-Based Case-Control Study	PLOS ONE			English	Article							COGNITIVE IMPAIRMENT; GM-CSF; ANTIINFLAMMATORY DRUGS; INFLAMMATORY DISEASES; THERAPEUTIC TARGETS; PROTECTIVE FACTORS; RISK; DEMENTIA; MECHANISMS; METAANALYSIS	Some of the prior literature investigated the potential association between rheumatoid arthritis (RA) and Alzheimer's disease (AD) because these two diseases may share similar inflammatory mechanisms. Nevertheless, to date, findings of the previous literature are still controversial, and some methodological limitations were observed in those studies. The aim of this case-control study was to investigate the relationship between prior RA and AD using a large population-based dataset. This study used the Taiwan Longitudinal Health Insurance Database 2005. We included 2271 patients with AD who had received prescriptions for acetylcholinesterase inhibitors (AChEls) as cases and 6813 patients without AD as controls in this study. In addition, we performed a conditional logistic regression to examine the odds ratio (OR) and 95% confidence interval (CI) for prior RA between cases and controls. The study found that 330 (3.63%) of the total sampled patients had an RA diagnosis before the index date. Additionally, prior RA was found in 60 (2.64%) cases and in 270 (3.96%) controls. The conditional logistic regression analysis showed that the crude OR of prior RA for cases was 0.66 (95% confidence interval (CI): 0.49-0.87) compared to controls. After adjusting for patients' geographic location, urbanization level, and comorbidities, the adjusted OR of prior RA for patients with AD was 0.73 (95% CI: 0.55-0.98) compared to those without AD. We concluded that there was an inverse association between prior RA and AD even after adjusting for potential confounders.	[Kao, Li-Ting] Natl Def Med Ctr, Grad Inst Life Sci, Taipei, Taiwan; [Kao, Li-Ting; Lin, Herng-Ching; Lee, Hsin-Chien; Chung, Shiu-Dong] Taipei Med Univ, Coll Med, Res Ctr Sleep Med, Taipei, Taiwan; [Kang, Jiunn-Horng] Taipei Med Univ Hosp, Dept Phys Med & Rehabil, Taipei, Taiwan; [Lin, Herng-Ching; Huang, Chung-Chien] Taipei Med Univ, Dept Hlth Care Adm, Taipei, Taiwan; [Lee, Hsin-Chien] Taipei Med Univ, Shuang Ho Hosp, Dept Psychiat, Taipei, Taiwan; [Lee, Hsin-Chien] Taipei Med Univ, Coll Med, Sch Med, Dept Psychiat, Taipei, Taiwan; [Chung, Shiu-Dong] Far Eastern Mem Hosp, Dept Surg, Taipei, Taiwan; [Chung, Shiu-Dong] Yuan Ze Univ, Coll Informat, Grad Program Biomed Informat, Chungli, Taiwan	National Defense Medical Center; Taipei Medical University; Taipei Medical University; Taipei Medical University Hospital; Taipei Medical University; Taipei Medical University; Shuang Ho Hospital; Taipei Medical University; Far Eastern Memorial Hospital; Yuan Ze University	Chung, SD (corresponding author), Taipei Med Univ, Coll Med, Res Ctr Sleep Med, Taipei, Taiwan.; Chung, SD (corresponding author), Far Eastern Mem Hosp, Dept Surg, Taipei, Taiwan.; Chung, SD (corresponding author), Yuan Ze Univ, Coll Informat, Grad Program Biomed Informat, Chungli, Taiwan.	chungshiudong@gmail.com	Huang, CC/AAX-5872-2021; Kao, Li-Ting/W-9287-2018	Huang, CC/0000-0003-0818-7175; Kao, Li-Ting/0000-0003-0692-7408; lee, hsin-chien/0000-0002-7557-8259				Akiyama H, 2000, NEUROBIOL AGING, V21, P383, DOI 10.1016/S0197-4580(00)00124-X; Alamanos Y, 2005, AUTOIMMUN REV, V4, P130, DOI 10.1016/j.autrev.2004.09.002; Bettcher BM, 2014, CLIN PHARMACOL THER, V96, P464, DOI 10.1038/clpt.2014.147; Boyd TD, 2010, J ALZHEIMERS DIS, V21, P507, DOI 10.3233/JAD-2010-091471; Cornish AL, 2009, NAT REV RHEUMATOL, V5, P554, DOI 10.1038/nrrheum.2009.178; Cova I, 2016, DEMENT GERIATR COGN, V41, P172, DOI 10.1159/000444216; Dantzer R, 2006, NEUROL CLIN, V24, P441, DOI 10.1016/j.ncl.2006.03.003; Dregan A, 2015, J ALZHEIMERS DIS, V46, P1039, DOI 10.3233/JAD-150171; Dubois B, 2007, LANCET NEUROL, V6, P734, DOI 10.1016/S1474-4422(07)70178-3; Durazzo TC, 2014, ALZHEIMERS DEMENT, V10, pS122, DOI 10.1016/j.jalz.2014.04.009; Hansson GK, 2005, NEW ENGL J MED, V352, P1685, DOI 10.1056/NEJMra043430; Harnden K, 2016, BMJ-BRIT MED J, V352, DOI 10.1136/bmj.i387; Heneka MT, 2015, LANCET NEUROL, V14, P388, DOI 10.1016/S1474-4422(15)70016-5; JENKINSON ML, 1989, BRIT J RHEUMATOL, V28, P86; Kobayashi S, 2008, FEBS J, V275, P4456, DOI 10.1111/j.1742-4658.2008.06581.x; Lim SL, 2015, MICROBES INFECT, V17, P549, DOI 10.1016/j.micinf.2015.04.004; Lu K, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/861812; Martin BK, 2008, ARCH NEUROL-CHICAGO, V65, P896, DOI 10.1001/archneur.2008.65.7.nct70006; McGeer PL, 2006, ALZHEIMER'S DISEASE: A CENTURY OF SCIENTIFIC AND CLINICAL RESEARCH, P271; McGeer PL, 1996, NEUROLOGY, V47, P425, DOI 10.1212/WNL.47.2.425; MCGEER PL, 1990, LANCET, V335, P1037, DOI 10.1016/0140-6736(90)91101-F; McInnes IB, 2011, NEW ENGL J MED, V365, P2205, DOI 10.1056/NEJMra1004965; MYLLYKANGASLUOSUJARVI R, 1994, BRIT J RHEUMATOL, V33, P501; Nourhashemi F, 2000, AM J CLIN NUTR, V71, p643S; Ridwan S, 2012, J NEURAL TRANSM, V119, P1389, DOI 10.1007/s00702-012-0794-y; Scheltens P., 2016, LANCET; Scher JU, 2016, ARTHRITIS RHEUMATOL, V68, P35, DOI 10.1002/art.39259; Siebert S, 2015, PHARMACOL REV, V67, P280, DOI 10.1124/pr.114.009639; Silman AJ, 2002, ARTHRITIS RES THER, V4, pS265, DOI 10.1186/ar578; Smolen JS, 2016, LANCET; Szekely Christine A, 2007, Subcell Biochem, V42, P229; Ungprasert P, 2016, NEUROL INDIA, V64, P56, DOI 10.4103/0028-3886.173623; van Nieuwenhuijze A, 2013, MOL IMMUNOL, V56, P675, DOI 10.1016/j.molimm.2013.05.002; Wallin K, 2012, J ALZHEIMERS DIS, V31, P669, DOI 10.3233/JAD-2012-111736; Wang J, 2015, J ALZHEIMERS DIS, V44, P385, DOI 10.3233/JAD-141506; Whitton PS, 2007, BRIT J PHARMACOL, V150, P963, DOI 10.1038/sj.bjp.0707167; Yaffe K, 2004, JAMA-J AM MED ASSOC, V292, P2237, DOI 10.1001/jama.292.18.2237	37	17	17	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2016	11	12							e0168106	10.1371/journal.pone.0168106	http://dx.doi.org/10.1371/journal.pone.0168106			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI9QF	27997574	gold, Green Published, Green Submitted			2022-12-27	WOS:000392842900023
J	Xing, F; Matsumiya, T; Shiba, Y; Hayakari, R; Yoshida, H; Imaizumi, T				Xing, Fei; Matsumiya, Tomoh; Shiba, Yuko; Hayakari, Ryo; Yoshida, Hidemi; Imaizumi, Tadaatsu			Non-Canonical Role of IKK alpha in the Regulation of STAT1 Phosphorylation in Antiviral Signaling	PLoS One			English	Article							NF-KAPPA-B; INDUCIBLE GENE-I; DOUBLE-STRANDED-RNA; HEPATITIS-C VIRUS; ADAPTER PROTEIN; INNATE IMMUNITY; KINASE-ALPHA; BETA SUBUNIT; ACTIVATION; EXPRESSION	Non-self RNA is recognized by retinoic acid-inducible gene-I (RIG-1)-like receptors (RLRs), inducing type I interferons (IFNs). Type I IFN promotes the expression of IFN-stimulated genes (ISGs), which requires the activation of signal transducer and activator of transcription -1 (STAT1). We previously reported that dsRNA induced STAT1 phosphorylation via a type I IFN-independent pathway in addition to the well-known type I IFN-dependent pathway. IKB kinase a (IKK alpha) is involved in antiviral signaling induced by dsRNA; however, its role is incompletely understood. Here, we explored the function of IKKa in RLR-mediated STAT1 phosphorylation. Silencing of IKKa markedly decreased the level of IFN-beta and STAT1 phosphorylation inHeH response to dsRNA. However, the inhibition of IKKa did not alter the RLR signaling-mediated dimerization of interferon responsive factor 3 (IRF3) or the nuclear translocation of nuclear factor-KB (NFKB). These results suggest a non-canonical role of IKKa in RLR signaling. Furthermore, phosphorylation of STAT1 was suppressed by IKKa knockdown in cells treated with a specific neutralizing antibody for the type I IFN receptor (IFNAR) and in IFNAR-deficient cells. Collectively, the dual regulation of STAT1 by IKKa in antiviral signaling suggests a role for IKKa in the fine-tuning of antiviral signaling in response to non-self RNA.	[Xing, Fei; Matsumiya, Tomoh; Shiba, Yuko; Hayakari, Ryo; Yoshida, Hidemi; Imaizumi, Tadaatsu] Hirosaki Univ, Grad Sch Med, Dept Vasc Biol, Inst Brain Sci, Hirosaki, Aomori, Japan	Hirosaki University	Matsumiya, T (corresponding author), Hirosaki Univ, Grad Sch Med, Dept Vasc Biol, Inst Brain Sci, Hirosaki, Aomori, Japan.	tomo1027@hirosaki-u.ac.jp	Matsumiya, Tomoh/ABA-5861-2021					Akira S, 2006, CELL, V124, P783, DOI 10.1016/j.cell.2006.02.015; Amaya M, 2014, PATHOG DIS, V72, P32, DOI 10.1111/2049-632X.12210; Bonizzi G, 2004, TRENDS IMMUNOL, V25, P280, DOI 10.1016/j.it.2004.03.008; Brierley MM, 2005, J INTERF CYTOK RES, V25, P733, DOI 10.1089/jir.2005.25.733; CHENKIANG S, 1993, CURR OPIN IMMUNOL, V5, P124, DOI 10.1016/0952-7915(93)90091-6; de Weerd NA, 2007, J BIOL CHEM, V282, P20053, DOI 10.1074/jbc.R700006200; Delhase M, 1999, SCIENCE, V284, P309, DOI 10.1126/science.284.5412.309; Dempoya J, 2012, J VIROL, V86, P12760, DOI 10.1128/JVI.01881-12; Dong W, 2012, NUCLEIC ACIDS RES, V40, P2940, DOI 10.1093/nar/gkr1216; Fink Karin, 2013, JAKSTAT, V2, pe27521, DOI 10.4161/jkst.27521; Gregory D, 2004, J VIROL, V78, P13582, DOI 10.1128/JVI.78.24.13582-13590.2004; Hess J, 2004, J CELL SCI, V117, P5965, DOI 10.1242/jcs.01589; Hoshino K, 2006, NATURE, V440, P949, DOI 10.1038/nature04641; Huang WC, 2013, J BIOMED SCI, V20, DOI 10.1186/1423-0127-20-3; Imaizumi T, 2010, NEPHROL DIAL TRANSPL, V25, P3534, DOI 10.1093/ndt/gfq270; Israel A, 2000, TRENDS CELL BIOL, V10, P129, DOI 10.1016/S0962-8924(00)01729-3; Kawai T, 2005, NAT IMMUNOL, V6, P981, DOI 10.1038/ni1243; Kerr IM, 2003, FEBS LETT, V546, P1, DOI 10.1016/S0014-5793(03)00411-3; Kubota K, 2006, ORAL MICROBIOL IMMUN, V21, P399, DOI 10.1111/j.1399-302X.2006.00326.x; Li QS, 2013, NAT MED, V19, P722, DOI 10.1038/nm.3190; Li ZW, 1999, J EXP MED, V189, P1839, DOI 10.1084/jem.189.11.1839; Ling L, 1998, P NATL ACAD SCI USA, V95, P3792, DOI 10.1073/pnas.95.7.3792; Liu F, 2012, IMMUNOL REV, V246, P239, DOI 10.1111/j.1600-065X.2012.01107.x; Mancino A, 2013, EMBO J, V32, P816, DOI 10.1038/emboj.2013.28; Matsumiya T, 2010, CRIT REV IMMUNOL, V30, P489, DOI 10.1615/CritRevImmunol.v30.i6.10; Mattioli I, 2004, J IMMUNOL, V172, P6336, DOI 10.4049/jimmunol.172.10.6336; Meylan E, 2005, NATURE, V437, P1167, DOI 10.1038/nature04193; MULLER M, 1993, NATURE, V366, P129, DOI 10.1038/366129a0; Nichols DB, 2006, J VIROL, V80, P578, DOI 10.1128/JVI.80.2.578-586.2006; Rudolph D, 2000, GENE DEV, V14, P854; Sadler AJ, 2008, NAT REV IMMUNOL, V8, P559, DOI 10.1038/nri2314; Sakurai H, 1999, J BIOL CHEM, V274, P30353, DOI 10.1074/jbc.274.43.30353; Schoggins JW, 2011, CURR OPIN VIROL, V1, P519, DOI 10.1016/j.coviro.2011.10.008; Schoggins JW, 2011, NATURE, V472, P481, DOI 10.1038/nature09907; Seth RB, 2005, CELL, V122, P669, DOI 10.1016/j.cell.2005.08.012; Teijaro JR, 2016, CURR OPIN VIROL, V16, P31, DOI 10.1016/j.coviro.2016.01.001; Thanos D, 1995, CELL, V83, P1091, DOI 10.1016/0092-8674(95)90136-1; Waelchli R, 2006, BIOORG MED CHEM LETT, V16, P108, DOI 10.1016/j.bmcl.2005.09.035; Xing F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045136; Xu LG, 2005, MOL CELL, V19, P727, DOI 10.1016/j.molcel.2005.08.014; Yoneyama M, 2010, REV MED VIROL, V20, P4, DOI 10.1002/rmv.633; Yu FF, 2010, MOL IMMUNOL, V47, P2330, DOI 10.1016/j.molimm.2010.05.282; Zhang YB, 2012, DEV COMP IMMUNOL, V38, P193, DOI 10.1016/j.dci.2012.06.003; Zhao TJ, 2007, NAT IMMUNOL, V8, P592, DOI 10.1038/ni1465; Zhong HH, 2002, MOL CELL, V9, P625, DOI 10.1016/S1097-2765(02)00477-X	45	0	0	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 19	2016	11	12							e0168696	10.1371/journal.pone.0168696	http://dx.doi.org/10.1371/journal.pone.0168696			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI9QC	27992555	Green Published, Green Submitted, gold			2022-12-27	WOS:000392842600089
J	Thankam, FG; Boosani, CS; Dilisio, MF; Dietz, NE; Agrawal, DK				Thankam, Finosh G.; Boosani, Chandra S.; Dilisio, Matthew F.; Dietz, Nicholas E.; Agrawal, Devendra K.			MicroRNAs Associated with Shoulder Tendon Matrisome Disorganization in Glenohumeral Arthritis	PLOS ONE			English	Article							ROTATOR CUFF; AORTIC-ANEURYSM; EXPRESSION; CELLS; NETWORKANALYST; MIR-29; TISSUE; GENES	The extracellular matrix (ECM) provides core support which is essential for the cell and tissue architectural development. The role of ECM in many pathological conditions has been well established and ECM-related abnormalities leading to serious consequences have been identified. Though much has been explored in regards to the role of ECM in soft tissue associated pathologies, very little is known about its role in inflammatory disorders in tendon. In this study, we performed microRNA (miRNA) expression analysis in the long head of the human shoulder biceps tendon to identify key genes whose expression was altered during inflammation in patients with glenohumeral arthritis. We identified differential regulation of matrix metalloproteinases (MMPs) that could be critical in collagen type replacement during tendinopathy. The miRNA profiling showed consistent results between the groups and revealed significant changes in the expression of seven different miRNAs in the inflamed tendons. Interestingly, all of these seven miRNAs were previously reported to have either a direct or indirect role in regulating the ECM organization in other pathological disorders. In addition, these miRNAs were also found to alter the expression levels of MMPs, which are the key matrix degrading enzymes associated with ECM-related abnormalities and pathologies. To our knowledge, this is the first report which identifies specific miRNAs associated with inflammation and the matrix reorganization in the tendons. Furthermore, the findings also support the potential role of these miRNAs in altering the collagen type ratio in the tendons during inflammation which is accompanied with differential expression of MMPs.	[Thankam, Finosh G.; Boosani, Chandra S.; Agrawal, Devendra K.] Creighton Univ, Sch Med, Dept Clin & Translat Sci, Omaha, NE 68102 USA; [Dilisio, Matthew F.] Creighton Univ, Sch Med, Dept Orthoped Surg, Omaha, NE USA; [Dietz, Nicholas E.] Creighton Univ, Sch Med, Dept Pathol, Omaha, NE USA	Creighton University; Creighton University; Creighton University	Agrawal, DK (corresponding author), Creighton Univ, Sch Med, Dept Clin & Translat Sci, Omaha, NE 68102 USA.	dkagr@creighton.edu	Agrawal, Devendra/GLR-3925-2022	Agrawal, Devendra/0000-0001-5445-0013; Boosani, Chandra/0000-0001-6904-8203	National Heart, Lung and Blood Institute, National Institutes of Health, USA [R01 HL112597, R01HL116042, R01 HL120659]; President's Haddix grant	National Heart, Lung and Blood Institute, National Institutes of Health, USA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); President's Haddix grant	This work was supported by research grants R01 HL112597, R01HL116042, and R01 HL120659 to DK Agrawal from the National Heart, Lung and Blood Institute, National Institutes of Health, USA and President's Haddix grant to MF Dilisio. The content of this review article is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Agrawal T, 2013, CLIN EXP ALLERGY; Aro AA, 2015, ANAT REC, V298, P428, DOI 10.1002/ar.23057; Benson RT, 2010, J BONE JOINT SURG BR, V92B, P448, DOI 10.1302/0301-620X.92B3.23074; Bhatt K, 2011, AM J PHYSIOL-RENAL, V300, pF602, DOI 10.1152/ajprenal.00727.2010; Blaine TA, 2005, J SHOULDER ELB SURG, V14, p84S, DOI 10.1016/j.jse.2004.09.022; Bronze-da-Rocha E, 2014, BIOMED RES INT, V2014, P1; Chaturvedi T P, 2009, Indian J Dent Res, V20, P107; Cushing L, 2011, AM J RESP CELL MOL, V45, P287, DOI 10.1165/rcmb.2010-0323OC; DE Giorgi Silvana, 2014, Joints, V2, P26; Fassan M, 2009, BREAST CANCER RES, V11, DOI 10.1186/bcr2348; Franceschi F, 2008, BRIT J SPORT MED, V42, P742, DOI 10.1136/bjsm.2007.040931; Gardner K, 2008, DISABIL REHABIL, V30, P1523, DOI 10.1080/09638280701785395; Goodier HCJ, 2016, ARTHRITIS RES THER, V18, DOI 10.1186/s13075-016-0947-8; Gupta GK, 2012, EXP MOL PATHOL, V93, P82, DOI 10.1016/j.yexmp.2012.04.006; He XJ, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-218; Jiang YG, 2013, BMC MED GENOMICS, V6, DOI 10.1186/1755-8794-6-36; Jing D, 2015, INT J ORAL SCI, V7, P131, DOI 10.1038/ijos.2015.22; Kriegel AJ, 2010, NUCLEIC ACIDS RES, V38, P8338, DOI 10.1093/nar/gkq718; Lee YS, 2009, EXP MOL MED, V41, P259, DOI 10.3858/emm.2009.41.4.029; Li LQ, 2013, CANCER BIOL THER, V14, P796, DOI 10.4161/cbt.25936; Lin TW, 2004, J BIOMECH, V37, P865, DOI 10.1016/j.jbiomech.2003.11.005; Liu G, 2010, J EXP MED, V207, P1589, DOI 10.1084/jem.20100035; Liu LZ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019139; Lopez-Camarillo C, 2012, INT J MOL SCI, V13, P1347, DOI 10.3390/ijms13021347; Lopez-Ramirez MA, 2016, FASEB J, V30, P2662, DOI 10.1096/fj.201600435RR; Ma L, 2016, SCI REP-UK, V6, DOI 10.1038/srep31535; Millar NL, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7774; Minna E, 2014, ONCOTARGET, V5, P2513, DOI 10.18632/oncotarget.1830; Noren Hooten N, 2013, AGING-US, V5, P725, DOI 10.18632/aging.100603; Pandey V, 2015, ASIA-PAC J SPORT MED, V2, P1, DOI 10.1016/j.asmart.2014.11.003; Pasternak B, 2007, ACTA ORTHOP, V78, P680, DOI 10.1080/17453670710014392; Pearce WH, 2006, ANN NY ACAD SCI, V1085, P117, DOI 10.1196/annals.1383.025; Pei H, 2015, EUR J VASC ENDOVASC, V49, P52, DOI 10.1016/j.ejvs.2014.10.018; Potenza N, 2011, NUCLEIC ACIDS RES, V39, P5157, DOI 10.1093/nar/gkr067; Rao VH, 2014, PHYSIOL REP, V2, DOI 10.1002/phy2.224; Rozalski M, 2016, POSTEP DERM ALERGOL, V33, P157, DOI 10.5114/ada.2016.60606; Rutnam ZJ, 2013, MATRIX BIOL, V32, P74, DOI 10.1016/j.matbio.2012.11.003; Sanchez-Jimenez C, 2013, BMC MOL BIOL, V14, DOI 10.1186/1471-2199-14-4; Shen J, 2014, BONE RES, V2, DOI 10.1038/boneres.2014.2; Suh EJ, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-12-r121; Tang QM, 2014, SCI REP-UK, V4, DOI 10.1038/srep05515; Thankam FG, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0165492; Tomankova T, 2012, SCAND J IMMUNOL, V75, P129, DOI 10.1111/j.1365-3083.2011.02650.x; Tomiosso TC, 2009, CELL TISSUE RES, V337, P235, DOI 10.1007/s00441-009-0819-5; van Rooij E, 2008, P NATL ACAD SCI USA, V105, P13027, DOI 10.1073/pnas.0805038105; Voloshin I, 2005, ARTHROSCOPY, V21, P1076, DOI 10.1016/j.arthro.2005.05.017; Wei QQ, 2013, IUBMB LIFE, V65, P602, DOI 10.1002/iub.1174; Wentz-Hunter K K, 2011, Mol Biol Int, V2011, P839872, DOI 10.4061/2011/839872; Xia JG, 2015, NAT PROTOC, V10, P823, DOI 10.1038/nprot.2015.052; Xia JG, 2014, NUCLEIC ACIDS RES, V42, pW167, DOI 10.1093/nar/gku443; Xu M, 2015, MOL THER, V23, P89, DOI 10.1038/mt.2014.197; Xue ML, 2015, ADV WOUND CARE, V4, P119, DOI 10.1089/wound.2013.0485	52	21	21	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2016	11	12							e0168077	10.1371/journal.pone.0168077	http://dx.doi.org/10.1371/journal.pone.0168077			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI8LN	27992561	gold, Green Published, Green Submitted			2022-12-27	WOS:000392758000024
J	Baez-Saldana, R; Delgado-Sanchez, G; Garcia-Garcia, L; Cruz-Hervert, LP; Montesinos-Castillo, M; Ferreyra-Reyes, L; Bobadilla-Del-Valle, M; Canizales-Quintero, S; Ferreira-Guerrero, E; Tellez-Vazquez, N; Montero-Campos, R; Yanes-Lane, M; Mongua-Rodriguez, N; Martinez-Gamboa, RA; Sifuentes-Osornio, J; Ponce-de-Leon, A				Baez-Saldana, Renata; Delgado-Sanchez, Guadalupe; Garcia-Garcia, Lourdes; Pablo Cruz-Hervert, Luis; Montesinos-Castillo, Marlene; Ferreyra-Reyes, Leticia; Bobadilla-del-Valle, Miriam; Canizales-Quintero, Sergio; Ferreira-Guerrero, Elizabeth; Tellez-Vazquez, Norma; Montero-Campos, Rogelio; Yanes-Lane, Mercedes; Mongua-Rodriguez, Norma; Martinez-Gamboa, Rosa Areli; Sifuentes-Osornio, Jose; Ponce-de-Leon, Alfredo			Isoniazid Mono-Resistant Tuberculosis: Impact on Treatment Outcome and Survival of Pulmonary Tuberculosis Patients in Southern Mexico 1995-2010	PLOS ONE			English	Article							SHORT-COURSE CHEMOTHERAPY; ACQUIRED DRUG-RESISTANCE; MYCOBACTERIUM-TUBERCULOSIS; NATIONAL-SURVEY; CONSEQUENCES	Background Isoniazid mono-resistance (IMR) is the most common form of mono-resistance; its world prevalence is estimated to range between 0.0 to 9.5% globally. There is no consensus on how these patients should be treated. Objective To describe the impact of IMR tuberculosis (TB) on treatment outcome and survival among pulmonary TB patients treated under programmatic conditions in Orizaba, Veracruz, Mexico. Materials and Methods We conducted a prospective cohort study of pulmonary TB patients in Southern Mexico. From 1995 to 2010 patients with acid-fast bacilli or culture proven Mycobacterium tuberculosis in sputum samples underwent epidemiological, clinical and microbiological evaluation. We included patients who harbored isoniazid mono-resistant (IMR) strains and patients with strains susceptible to isoniazid, rifampicin, ethambutol and streptomycin. All patients were treated following Mexican TB Program guidelines. We performed annual follow-up to ascertain treatment outcome, recurrence, relapse and mortality. Results Between 1995 and 2010 1,243 patients with pulmonary TB were recruited; 902/1,243 (72.57%) had drug susceptibility testing; 716 (79.38%) harbored pan-susceptible and 88 (9.75%) IMR strains. Having any contact with a person with TB (adjusted odds ratio (aOR)) 1.85, 95% Confidence interval (CI) 1.15-2.96) and homelessness (adjusted odds ratio (aOR) 2.76, 95% CI 1.08-6.99) were associated with IMR. IMR patients had a higher probability of failure (adjusted hazard ratio (HR) 12.35, 95% CI 3.38-45.15) and death due to TB among HIV negative patients (aHR 3.30. 95% CI 1.00-10.84). All the models were adjusted for socio-demographic and clinical variables. Conclusions The results from our study provide evidence that the standardized treatment schedule with first line drugs in new and previously treated cases with pulmonary TB and IMR produces a high frequency of treatment failure and death due to tuberculosis. We recommend re-evaluating the optimal schedule for patients harboring IMR. It is necessary to strengthen scientific research for the evaluation of alternative treatment schedules in similar settings.	[Baez-Saldana, Renata; Delgado-Sanchez, Guadalupe; Garcia-Garcia, Lourdes; Pablo Cruz-Hervert, Luis; Montesinos-Castillo, Marlene; Ferreyra-Reyes, Leticia; Canizales-Quintero, Sergio; Ferreira-Guerrero, Elizabeth; Tellez-Vazquez, Norma; Montero-Campos, Rogelio; Yanes-Lane, Mercedes; Mongua-Rodriguez, Norma] Inst Nacl Salud Publ, Ctr Invest Enfermedades Infecciosas, Cuernavaca, Morelos, Mexico; [Baez-Saldana, Renata] Univ Nacl Autonoma Mexico, Fac Med, Ciudad De Mexico, Mexico; [Bobadilla-del-Valle, Miriam; Martinez-Gamboa, Rosa Areli; Ponce-de-Leon, Alfredo] Inst Nacl Ciencias Med & Nutr Salvador Zubiran, Microbiol Lab, Ciudad De Mexico, Mexico; [Yanes-Lane, Mercedes] Univ Autonoma San Luis Potosi, Fac Med, San Luis Potosi, San Luis Potos, Mexico; [Sifuentes-Osornio, Jose] Inst Nacl Ciencias Med & Nutr Salvador Zubiran, Direcc Med, Ciudad De Mexico, Mexico	Instituto Nacional de Salud Publica; Universidad Nacional Autonoma de Mexico; Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran - Mexico; Universidad Autonoma de San Luis Potosi; Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran - Mexico	Garcia-Garcia, L (corresponding author), Inst Nacl Salud Publ, Ctr Invest Enfermedades Infecciosas, Cuernavaca, Morelos, Mexico.	garcigarml@gmail.com	García, Maria de Lourdes/I-2724-2019; Cruz-Hervert, Luis Pablo/AEI-4595-2022; Bobadilla-del-Valle, Miriam/AAD-6418-2020	García, Maria de Lourdes/0000-0001-5262-1157; Cruz-Hervert, Luis Pablo/0000-0002-6094-958X; BOBADILLA-DEL VALLE, MIRIAM/0000-0003-1184-827X; Ponce-de-Leon, Alfredo/0000-0003-2640-2916; Sifuentes-Osornio, Jose/0000-0001-9584-1360	Mexican Secretariat of Health; National Institute of Health of the United States [A135969, K01TW000001]; Wellcome Trust [176W009]; Howard Hughes Medical Institute [55000632]; Mexican Council of Science and Technology [SALUD 2003-C01-132, SEP-2004-C01-47499/A1, FOSSIS 2005-03 (15203), FOSSIS 2005-2 14475, SALUD-2008-C01-87332, SALUD-2010-01-140178, FOSSEC-2014-1-233506, CB-2014-24175]	Mexican Secretariat of Health; National Institute of Health of the United States(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Wellcome Trust(Wellcome TrustEuropean Commission); Howard Hughes Medical Institute(Howard Hughes Medical Institute); Mexican Council of Science and Technology(Consejo Nacional de Ciencia y Tecnologia (CONACyT))	This work was supported by the Mexican Secretariat of Health, by the National Institute of Health of the United States [A135969 and K01TW000001]; by the Wellcome Trust [176W009]; by the Howard Hughes Medical Institute [55000632] and by the Mexican Council of Science and Technology [SALUD 2003-C01-132, SEP-2004-C01-47499/A1, FOSSIS 2005-03 (15203), FOSSIS 2005-2 14475, SALUD-2008-C01-87332, SALUD-2010-01-140178, FOSSEC-2014-1-233506, CB-2014-24175]. The funding agencies did not participate in the study design; in the collection, analysis, and interpretation of data; in the writing of the report; and in the decision to submit the article for publication. The authors do not have any associations that might pose a conflict of interest.	Abebe Gemeda, 2012, BMC Res Notes, V5, P225, DOI 10.1186/1756-0500-5-225; [Anonymous], 1991, Am Rev Respir Dis, V143, P700; [Anonymous], 2001, PREV TRAT CONTR DIAB; [Anonymous], 2005, PREV CONTR TUB AT PR; [Anonymous], 2000, PREV CONTR TUB AT PR; Arias F, 2015, REV CHIL INFECTOL, V32, P382, DOI 10.4067/S0716-10182015000500002; Bang D, 2010, J INFECTION, V60, P452, DOI 10.1016/j.jinf.2010.03.017; Barlow REL, 2001, J CLIN MICROBIOL, V39, P2453, DOI 10.1128/JCM.39.7.2453-2457.2001; Bemer P, 2002, J CLIN MICROBIOL, V40, P150, DOI 10.1128/JCM.40.1.150-154.2002; Bojorquez-Chapela I, 2013, INT J TUBERC LUNG D, V17, P514, DOI 10.5588/ijtld.12.0167; Cattamanchi A, 2009, CLIN INFECT DIS, V48, P179, DOI 10.1086/595689; Chien JY, 2015, CLIN MICROBIOL INFEC, V21, P59, DOI 10.1016/j.cmi.2014.08.008; Cox HS, 2007, CLIN INFECT DIS, V44, P1421, DOI 10.1086/517536; DeRiemer K, 2005, LANCET, V365, P1239, DOI 10.1016/S0140-6736(05)74812-1; DGE INDRE RLSP, 2015, LIN VIG EP TUB LAB; Espinal MA, 2000, JAMA-J AM MED ASSOC, V283, P2537, DOI 10.1001/jama.283.19.2537; Jimenez-Corona ME, 2013, THORAX, V68, P214, DOI 10.1136/thoraxjnl-2012-201756; Fasih N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050551; Fox L, 2011, EUR J CLIN MICROBIOL, V30, P863, DOI 10.1007/s10096-011-1167-4; Garcia-Garcia MD, 2000, ARCH INTERN MED, V160, P630, DOI 10.1001/archinte.160.5.630; Garcia-Garcia MD, 2000, INT J TUBERC LUNG D, V4, P12; Garcia-Garcia MD, 2002, EMERG INFECT DIS, V8, P1327; Instituto Nacional de Estadistica Geografia e Informatica (INEGI), CENS POBL VIV 2010 G; Jimenez-Corona ME, 2006, THORAX, V61, P348, DOI 10.1136/thx.2005.049452; Maguire H, 2011, EURO SURVEILL, V16; Mathema B, 2006, CLIN MICROBIOL REV, V19, P658, DOI 10.1128/CMR.00061-05; Menzies D, 2009, PLOS MED, V6, DOI [10.1371/journal.pmed.1000150, 10.1371/journal.pmed.1000146]; MITCHISON DA, 1986, AM REV RESPIR DIS, V133, P423; Cruz-Hervert LP, 2012, AGE AGEING, V41, P488, DOI 10.1093/ageing/afs028; PablosMendez A, 1997, AM J MED, V102, P164, DOI 10.1016/S0002-9343(96)00402-0; Peyffer GE, 2011, MANUAL CLIN MICROBIO, V1, P472, DOI DOI 10.1128/9781555816728.CH28; Pinto Lancelot, 2011, Infect Drug Resist, V4, P129, DOI 10.2147/IDR.S10332; Quy HTW, 2003, INT J TUBERC LUNG D, V7, P631; Ramarokoto H, 2010, INT J TUBERC LUNG D, V14, P745; Raviglione M, 2001, INT J TUBERC LUNG D, V5, P213; Secretara de Salud, 2009, ENC NAC AD 2008; Seung KJ, 2004, CLIN INFECT DIS, V39, P1321, DOI 10.1086/425005; UNAIDS and Stop AIDS Alliance, 2015, COMM DEL, P23; Varahram Mohammad, 2013, Open Microbiol J, V8, P1, DOI 10.2174/1874285801408010001; Villa-Rosas C, 2015, SALUD PUBLICA MEXICO, V57, P177; Villegas L, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0152933; Wang TY, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086316; WHO, 2016, GLOB TUB REP; World Health Organization, 2007, GUID PROV IN HIV TES; World Health Organization, 2016, FRAM IND TARG LAB ST; WorldHealthOrganization, 2013, AUT REAL TIM NUCL AM; Wright A, 2008, ANTITUBERCULOSIS DRU	47	15	16	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2016	11	12							e0168955	10.1371/journal.pone.0168955	http://dx.doi.org/10.1371/journal.pone.0168955			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EG7JB	28030600	Green Submitted, Green Published, gold			2022-12-27	WOS:000391222000090
J	Becker, JE; Brown, CA				Becker, Jamie E.; Brown, Christopher A.			Reliable Refuge: Two Sky Island Scorpion Species Select Larger, Thermally Stable Retreat Sites	PLOS ONE			English	Article							CENTRUROIDES-SCULPTURATUS; THERMOREGULATORY BEHAVIOR; BODY TEMPERATURES; FOOD-DEPRIVATION; WATER-LOSS; PREGNANCY; LIZARD; REPRODUCTION; ECTOTHERMS; BIOLOGY	Sky island scorpions shelter under rocks and other surface debris, but, as with other scorpions, it is unclear whether these species select retreat sites randomly. Furthermore, little is known about the thermal preferences of scorpions, and no research has been done to identify whether reproductive condition might influence retreat site selection. The objectives were to (1) identify physical or thermal characteristics for retreat sites occupied by two sky island scorpions (Vaejovis cashi Graham 2007 and V. electrum Hughes 2011) and those not occupied; (2) determine whether retreat site selection differs between the two study species; and (3) identify whether thermal selection differs between species and between gravid and non-gravid females of the same species. Within each scorpion's habitat, maximum dimensions of rocks along a transect line were measured and compared to occupied rocks to determine whether retreat site selection occurred randomly. Temperature loggers were placed under a subset of occupied and unoccupied rocks for 48 hours to compare the thermal characteristics of these rocks. Thermal gradient trials were conducted before parturition and after dispersal of young in order to identify whether gravidity influences thermal preference. Vaejovis cashi and V. electrum both selected larger retreat sites that had more stable thermal profiles. Neither species appeared to have thermal preferences influenced by reproductive condition. However, while thermal selection did not differ among non-gravid individuals, gravid V. electrum selected warmer temperatures than its gravid congener. Sky island scorpions appear to select large retreat sites to maintain thermal stability, although biotic factors (e.g., competition) could also be involved in this choice. Future studies should focus on identifying the various biotic or abiotic factors that could influence retreat site selection in scorpions, as well as determining whether reproductive condition affects thermal selection in other arachnids.	[Becker, Jamie E.] Bowling Green State Univ, Dept Biol, Bowling Green, OH 43403 USA; [Brown, Christopher A.] Tennessee Technol Univ, Dept Biol, Cookeville, TN 38505 USA	University System of Ohio; Bowling Green State University; Tennessee Technological University	Becker, JE (corresponding author), Bowling Green State Univ, Dept Biol, Bowling Green, OH 43403 USA.	jambeck@bgsu.edu			Southwestern Research Station (SWRS)	Southwestern Research Station (SWRS)	The Southwestern Research Station (SWRS) awarded JEB some funds to defray the cost of room and board during her 10-day stay; data collection would not be possible without this aid; http://www.amnh.org/our-research/southwestern-research-station/. The authors received no other funding for this work.	ALEXANDER AJ, 1958, J EXP BIOL, V35, P349; Angilletta MJ, 2004, INTEGR COMP BIOL, V44, P498, DOI 10.1093/icb/44.6.498; Brown RP, 2005, J THERM BIOL, V30, P79, DOI 10.1016/j.jtherbio.2004.07.005; Brownell P, 2001, SCORPION BIOLOGY AND RESEARCH, P159; Carlson BE, 2009, J ARACHNOL, V37, P321, DOI 10.1636/Hi09-06.1; Croak BM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037982; DAUT EF, 1993, J HERPETOL, V27, P6, DOI 10.2307/1564898; Debano LF, 1995, BIODIVERSITY MANAGEM, P669; Dillon ME, 2009, J THERM BIOL, V34, P109, DOI 10.1016/j.jtherbio.2008.11.007; Downes S, 1998, ANIM BEHAV, V55, P1387, DOI 10.1006/anbe.1997.0705; DREISIG H, 1980, OECOLOGIA, V44, P376, DOI 10.1007/BF00545242; Dunham AE, 2013, PHYSIOL ZOOL, V62, P335; Elias R, 1999, INT J INSECT MORPHOL, V28, P337, DOI 10.1016/S0020-7322(99)00035-5; Goldsrough CL, 2004, ECOLOGY, V85, P1635, DOI 10.1890/02-0770; Graham MR, 2007, EUSCORPIUS, P51; HADLEY N F, 1974, Journal of Arachnology, V2, P11; Hadley N. F, 1994, WATER RELATIONS TERR; HADLEY NF, 1982, J EXP BIOL, V101, P343; HADLEY NF, 1970, ECOLOGY, V51, P434, DOI 10.2307/1935378; Hitchcock MA, 2006, J HERPETOL, V40, P185, DOI 10.1670/233-04A.1; Hoshino K, 2006, J VENOM ANIM TOXINS, P59; HUEY RB, 1989, ECOLOGY, V70, P931, DOI 10.2307/1941360; Hughes GB, 2011, J ARACHNOL, V39, P420, DOI 10.1636/Ha11-07.1; HUTCHISON VH, 1979, AM ZOOL, V19, P367; Isaac LA, 2004, J ZOOL, V264, P403, DOI 10.1017/s095283690400593x; Kaib M, 1996, FIRE HIST GALLERY PI, p49p; Li DQ, 1996, J THERM BIOL, V21, P245, DOI 10.1016/0306-4565(96)00009-5; Lighton JRB, 2001, J EXP BIOL, V204, P607; MARSH AC, 1987, J THERM BIOL, V12, P295, DOI 10.1016/0306-4565(87)90031-3; Mathies T, 1997, FUNCT ECOL, V11, P498, DOI 10.1046/j.1365-2435.1997.00119.x; McCormick S., 1990, Biology of scorpion, P145; McReynolds CN, 2008, J ARACHNOL, V36, P557, DOI 10.1636/T07-07.1; NWS Tucson, 2013, ARCH; Polis GA, 1990, BIOL SCORPIONS, P123; Prestwich KN, 2006, J ARACHNOL, V34, P351, DOI 10.1636/S05-75.1; Rock J, 2000, PHYSIOL BIOCHEM ZOOL, V73, P344, DOI 10.1086/316741; Scharf I, 2006, J INSECT BEHAV, V19, P197, DOI 10.1007/s10905-006-9017-4; SHINE R, 1980, Oecologia (Berlin), V46, P92, DOI 10.1007/BF00346972; Skutelsky O, 1996, ANIM BEHAV, V52, P49, DOI 10.1006/anbe.1996.0151; Slip DJ, 1988, COMP BIOCH PHYSL A, P645; Steffenson MM, 2009, THESIS; Stutt AD, 1998, ANIM BEHAV, V55, P1341, DOI 10.1006/anbe.1998.0728; TU MC, 1994, J THERM BIOL, V19, P255, DOI 10.1016/0306-4565(94)90048-5; Wang T, 2006, ANNU REV PHYSIOL, V68, P223, DOI 10.1146/annurev.physiol.68.040104.105739; Warburg M.R., 1990, BIOL SCORPIONS, P112; WARBURG MR, 1981, COMP BIOCHEM PHYS A, V68, P277, DOI 10.1016/0300-9629(81)90354-6; Webb JK, 1998, PHYSIOL ZOOL, V71, P680, DOI 10.1086/515979; Webb JK, 1998, BIOL CONSERV, V86, P233, DOI 10.1016/S0006-3207(97)00180-8; Webb JK, 1996, THESIS; Webber MM, 2015, J EVOLUTION BIOL, V28, P368, DOI 10.1111/jeb.12569; Webber M.M., 2012, EUSCORPIUS, V140, P1, DOI [10.18590/euscorpius.2012, DOI 10.18590/EUSCORPIUS.2012]; Webber MM, 2015, J ARID ENVIRON, V121, P40, DOI 10.1016/j.jaridenv.2015.04.014; Webber MM, 2013, BMC EVOL BIOL, V13, DOI 10.1186/1471-2148-13-197; WHITMORE DH, 1985, PHYSIOL ZOOL, V58, P526, DOI 10.1086/physzool.58.5.30158580; Zari TA, 1998, J ARID ENVIRON, V38, P371, DOI 10.1006/jare.1997.0338	55	1	1	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2016	11	12							e0168105	10.1371/journal.pone.0168105	http://dx.doi.org/10.1371/journal.pone.0168105			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EG7JB	28030603	Green Published, gold, Green Submitted			2022-12-27	WOS:000391222000035
J	Hall, S; Ali, N; Chater, N; Oaksford, M				Hall, Simon; Ali, Nilufa; Chater, Nick; Oaksford, Mike			Discounting and Augmentation in Causal Conditional Reasoning: Causal Models or Shallow Encoding?	PLOS ONE			English	Article							PROBABILITY; INFERENCES	Recent research comparing mental models theory and causal Bayes nets for their ability to account for discounting and augmentation inferences in causal conditional reasoning had some limitations. One of the experiments used an ordinal scale and multiple items and analysed the data by subjects and items. This procedure can create a variety of problems that can be resolved by using an appropriate cumulative link function mixed models approach in which items are treated as random effects. Experiment 1 replicated this earlier experiment and analysed the results using appropriate data analytic techniques. Although successfully replicating earlier research, the pattern of results could be explained by a much simpler "shallow encoding" hypothesis. Experiment 2 introduced a manipulation to critically test this hypothesis. The results favoured the causal Bayes nets predictions and not shallow encoding and were not consistent with mental models theory. Experiment 1 provided qualified support for the causal Bayes net approach using appropriate statistics because it also replicated the failure to observe one of the predicted main effects. Experiment 2 discounted one plausible explanation for this failure. While within the limited goals that were set for these experiments they were successful, more research is required to account for the pattern of findings using this paradigm.	[Hall, Simon; Oaksford, Mike] Univ London, Birkbeck Coll, Dept Psychol Sci, London, England; [Ali, Nilufa] Southampton Solent Univ, Dept Psychol, Southampton, Hants, England; [Chater, Nick] Univ Warwick, Behav Sci Grp, Warwick Business Sch, Coventry, W Midlands, England	University of London; Birkbeck University London; Solent University; University of Warwick	Oaksford, M (corresponding author), Univ London, Birkbeck Coll, Dept Psychol Sci, London, England.	mike.oaksford@bbk.ac.uk	Ali, Nilufa/ABI-6505-2020; Chater, Nick/GRX-6742-2022; Oaksford, Mike/AAY-5481-2021	Oaksford, Mike/0000-0003-3383-3642				Ali N., 2010, COGNITION CONDITIONA, P117, DOI [10.1093/acprof:oso/9780199233298.003.0007, DOI 10.1093/ACPROF:OSO/9780199233298.003.0007]; Baayen RH, 2008, J MEM LANG, V59, P390, DOI 10.1016/j.jml.2007.12.005; Baratgin J, 2015, TRENDS COGN SCI, V19, P547, DOI 10.1016/j.tics.2015.06.013; Byrne RMJ, 1999, J MEM LANG, V40, P347, DOI 10.1006/jmla.1998.2622; Cartwright N, 2001, MONIST, V84, P242, DOI 10.5840/monist20018429; Cartwright N., 1999, DAPPLED WORLD STUDY; Chater N, 2011, BEHAV BRAIN SCI, V34, P194, DOI 10.1017/S0140525X11000239; Chater N, 2006, INFORMATION SAMPLING AND ADAPTIVE COGNITION, P210; Cheng PW, 1997, PSYCHOL REV, V104, P367, DOI 10.1037/0033-295X.104.2.367; Christensen R. H. B., 2015, TUTORIAL FITTING CUM; Christensen R. H. B., 2015, ORD REGR MOD ORD DAT; CLARK HH, 1973, J VERB LEARN VERB BE, V12, P335, DOI 10.1016/S0022-5371(73)80014-3; Cummins DD, 2014, J EXP PSYCHOL LEARN, V40, P1638, DOI 10.1037/xlm0000024; Fernbach PM, 2013, J EXP PSYCHOL LEARN, V39, P1327, DOI 10.1037/a0031851; Hattori M., COGNITION IN PRESS; Johnson-Laird, 1983, MENTAL MODELS; Johnson-Laird PN, 2015, TRENDS COGN SCI, V19, P201, DOI 10.1016/j.tics.2015.02.006; Johnson-Laird PN, 2013, J COGN PSYCHOL, V25, P131, DOI 10.1080/20445911.2012.759935; Johnson-Laird P. N., 1991, DEDUCTION; Johnson-Laird PN, 1999, PSYCHOL REV, V106, P62, DOI 10.1037/0033-295X.106.1.62; Johnson-Laird PN, 2002, PSYCHOL REV, V109, P646, DOI 10.1037//0033-295X.109.4.646; KASS RE, 1995, J AM STAT ASSOC, V90, P773, DOI 10.1080/01621459.1995.10476572; Knauff M., 2013, SPACE REASON SPATIAL; Kruschke JK, 2013, J EXP PSYCHOL GEN, V142, P573, DOI 10.1037/a0029146; Lenth RV, 2016, USING LSMEANS; MORRIS MW, 1995, PSYCHOL REV, V102, P331, DOI 10.1037/0033-295X.102.2.331; Oaksford M, 2000, J EXP PSYCHOL LEARN, V26, P883, DOI 10.1037/0278-7393.26.4.883; Oaksford M., OXFORD HDB IN PRESS; Oaksford M., 2013, 8 AR JONCKH MEM LECT; Oaksford M., 2007, BAYESIAN RATIONALITY; Oaksford M, 2016, TRENDS COGN SCI, V20, P336, DOI 10.1016/j.tics.2016.03.002; Over D. E., INT HDB THI IN PRESS; Over DE, 2007, COGNITIVE PSYCHOL, V54, P62, DOI 10.1016/j.cogpsych.2006.05.002; Over DE, 2009, THINK REASONING, V15, P431, DOI 10.1080/13546780903266188; Park J, 2014, MEM COGNITION, V42, P806, DOI 10.3758/s13421-013-0389-3; Park J, 2013, COGNITIVE PSYCHOL, V67, P186, DOI 10.1016/j.cogpsych.2013.09.002; PEARL J., 1988, PROBABILISTIC REASON, DOI 10.1016/B978-0-08-051489-5.50008-4; Perham N, 2005, COGNITIVE SCI, V29, P681, DOI 10.1207/s15516709cog0000_35; Rehder B, 2015, J EXP PSYCHOL LEARN, V41, P670, DOI 10.1037/xlm0000048; Rehder B, 2014, COGNITIVE PSYCHOL, V72, P54, DOI 10.1016/j.cogpsych.2014.02.002; Rottman BM, 2016, COGNITIVE PSYCHOL, V87, P88, DOI 10.1016/j.cogpsych.2016.05.002; Rottman BM, 2014, PSYCHOL BULL, V140, P109, DOI 10.1037/a0031903; Rouder JN, 2012, J MATH PSYCHOL, V56, P356, DOI 10.1016/j.jmp.2012.08.001; Sloman S., 2005, CAUSAL MODELS PEOPLE; Sloman SA, 2005, COGNITIVE SCI, V29, P5, DOI 10.1207/s15516709cog2901_2; Sloman S, 2009, COGNITIVE SCI, V33, P21, DOI 10.1111/j.1551-6709.2008.01002.x; Staudenmayer H., 1975, REASONING REPRESENTA, P55; WALDMANN MR, 1992, J EXP PSYCHOL GEN, V121, P222, DOI 10.1037/0096-3445.121.2.222	50	7	7	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2016	11	12							e0167741	10.1371/journal.pone.0167741	http://dx.doi.org/10.1371/journal.pone.0167741			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EG7JB	28030583	Green Accepted, Green Published, gold, Green Submitted			2022-12-27	WOS:000391222000019
J	Cebrat, K; Sobczynski, M				Cebrat, Krzysztof; Sobczynski, Maciej			Scaling Laws in City Growth: Setting Limitations with Self-Organizing Maps	PLoS One			English	Article							CITIES; NETWORKS; SIZE	Do scaling relations always provide the means to anticipate the relationships between the size of cities, costs of maintenance, and the socio-economic benefits resulting from their growth? Scaling laws are considered a universal principle that describes the development of complex systems such as cities. It seems that regardless of their location or history, the growth of cities is associated with the super-linear or sublinear scaling of features such as the amount of space required, infrastructure, or human activities. However, the results of our research, based on grouping by Self-Organizing Maps, reveal some limitations in the application of scaling laws: the trends of urban growth behave in a different manner when we consider both a large and diverse collection of cities and a subset of cities alike. This finding complements the existing body of knowledge on the growth of cities and allows for a more accurate prediction of their future.	[Cebrat, Krzysztof] Wroclaw Univ Technol, Fac Architecture, Wroclaw, Poland; [Sobczynski, Maciej] Univ Wroclaw, Fac Biotechnol, Wroclaw, Poland	Wroclaw University of Science & Technology; University of Wroclaw	Cebrat, K (corresponding author), Wroclaw Univ Technol, Fac Architecture, Wroclaw, Poland.	krzysztof.cebrat@pwr.edu.pl		Sobczynski, Maciej/0000-0003-2428-0927; Cebrat, Krzysztof/0000-0002-1733-8492				Barabasi AL, 1999, SCIENCE, V286, P509, DOI 10.1126/science.286.5439.509; Batty M, 2008, EUR PHYS J B, V63, P303, DOI 10.1140/epjb/e2008-00251-5; Batty M, 2013, SCIENCE, V340, P1418, DOI 10.1126/science.1239870; Bernardes AT, ARXIVCONDMAT0111147V; Bettencourt L, 2010, NATURE, V467, P912, DOI 10.1038/467912a; Bettencourt LMA, 2007, P NATL ACAD SCI USA, V104, P7301, DOI 10.1073/pnas.0610172104; Bettencourt LMA, 2013, SCIENCE, V340, P1438, DOI 10.1126/science.1235823; Fuller RA, 2009, BIOL LETTERS, V5, P352, DOI 10.1098/rsbl.2009.0010; Gomez-Lievano A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040393; Kennedy C, 2011, ENVIRON POLLUT, V159, P1965, DOI 10.1016/j.envpol.2010.10.022; Kohonen T., 2001, SELF ORGANIZING MAPS, P347; Kuhnert C, 2006, PHYSICA A, V363, P96, DOI 10.1016/j.physa.2006.01.058; Larson W, 2015, J URBAN ECON, V90, P35, DOI 10.1016/j.jue.2015.08.001; Ma XL, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119044; Mansury Y, 2015, COMPUT ENVIRON URBAN, V54, P428, DOI 10.1016/j.compenvurbsys.2015.08.004; Marshall JD, 2007, URBAN STUD, V44, P1889, DOI 10.1080/00420980701471943; Sarzynski A, 2012, URBAN STUD, V49, P3121, DOI 10.1177/0042098011432557; Shlapfer M, 2014, INTERFACE J ROYAL SO, V11; Strano E, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0159465; van Raan AFJ, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0146775; Zhang Y, 2009, ECOL MODEL, V220, P1431, DOI 10.1016/j.ecolmodel.2009.02.001	21	6	6	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2016	11	12							e0168753	10.1371/journal.pone.0168753	http://dx.doi.org/10.1371/journal.pone.0168753			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI9QH	28005994	Green Published, gold			2022-12-27	WOS:000392843200090
J	de Castro-Miro, M; Tonda, R; Escudero-Ferruz, P; Andres, R; Mayor-Lorenzo, A; Castro, J; Ciccioli, M; Hidalgo, DA; Rodriguez-Ezcurra, JJ; Farrando, J; Perez-Santonja, JJ; Cormand, B; Marfany, G; Gonzalez-Duarte, R				de Castro-Miro, Marta; Tonda, Raul; Escudero-Ferruz, Paula; Andres, Rosa; Mayor-Lorenzo, Andres; Castro, Joaquin; Ciccioli, Marcela; Hidalgo, Daniel A.; Jose Rodriguez-Ezcurra, Juan; Farrando, Jorge; Perez-Santonja, Juan J.; Cormand, Bru; Marfany, Gemma; Gonzalez-Duarte, Roser			Novel Candidate Genes and a Wide Spectrum of Structural and Point Mutations Responsible for Inherited Retinal Dystrophies Revealed by Exome Sequencing	PLOS ONE			English	Article							RECESSIVE RETINITIS-PIGMENTOSA; LEBER CONGENITAL AMAUROSIS; USHER-SYNDROME; MOLECULAR DIAGNOSIS; DISEASE; OFD1; PENETRANCE; PHENOTYPE; GENOTYPE; FAMILIES	Background NGS-based genetic diagnosis has completely revolutionized the human genetics field. In this study, we have aimed to identify new genes and mutations by Whole Exome Sequencing (WES) responsible for inherited retinal dystrophies (IRD). Methods A cohort of 33 pedigrees affected with a variety of retinal disorders was analysed by WES. Initial prioritization analysis included around 300 IRD-associated genes. In non-diagnosed families a search for pathogenic mutations in novel genes was undertaken. Results Genetic diagnosis was attained in 18 families. Moreover, a plausible candidate is proposed for 10 more cases. Two thirds of the mutations were novel, including 4 chromosomal rearrangements, which expand the IRD allelic heterogeneity and highlight the contribution of private mutations. Our results prompted clinical re-evaluation of some patients resulting in assignment to a syndromic instead of non-syndromic IRD. Notably, WES unveiled four new candidates for non-syndromic IRD: SEMA6B, CEP78, CEP250, SCLT1, the two latter previously associated to syndromic disorders. We provide functional data supporting that missense mutations in CEP250 alter cilia formation. Conclusion The diagnostic efficiency of WES, and strictly following the ACMG/AMP criteria is 55% in reported causative genes or functionally supported new candidates, plus 30% families in which likely pathogenic or VGUS/VUS variants were identified in plausible candidates. Our results highlight the clinical utility of WES for molecular diagnosis of IRD, provide a wider spectrum of mutations and concomitant genetic variants, and challenge our view on syndromic vs non-syndromic, and causative vs modifier genes.	[de Castro-Miro, Marta; Escudero-Ferruz, Paula; Andres, Rosa; Cormand, Bru; Marfany, Gemma; Gonzalez-Duarte, Roser] Univ Barcelona, Fac Biol, Dept Genet Microbiol & Estadist, Barcelona, Spain; [de Castro-Miro, Marta; Andres, Rosa; Cormand, Bru; Marfany, Gemma; Gonzalez-Duarte, Roser] Inst Salud Carlos III, CIBERER, Barcelona, Spain; [de Castro-Miro, Marta; Cormand, Bru; Marfany, Gemma; Gonzalez-Duarte, Roser] Univ Barcelona, Inst Biomed IBUB, Barcelona, Spain; [Tonda, Raul] BIST, CRG, CNAG CRG, Barcelona, Spain; [Tonda, Raul] UPF, Barcelona, Spain; [Mayor-Lorenzo, Andres] Asociac EsRetina Asturias, Oviedo, Asturias, Spain; [Castro, Joaquin] Hosp Univ Cent Asturias, Unidad Retina, Serv Oftalmol, Oviedo, Spain; [Ciccioli, Marcela] Stargardt APNES Retina, Buenos Aires, DF, Argentina; [Hidalgo, Daniel A.] Hosp Interzonal Gen Agudos Eva Peron, Buenos Aires, DF, Argentina; [Jose Rodriguez-Ezcurra, Juan] Barraquer Ctr Oftalmol Barcelona, Barcelona, Spain; [Farrando, Jorge] Inst Oftalmol Quiron Barcelona, Barcelona, Spain; [Perez-Santonja, Juan J.] Univ Alicante, Gen Hosp, Alicante Inst Hlth & Biomed Res, Dept Ophthalmol,ISABIAL FISABIO Fdn, Alicante, Spain	University of Barcelona; CIBER - Centro de Investigacion Biomedica en Red; CIBERER; Instituto de Salud Carlos III; University of Barcelona; Barcelona Institute of Science & Technology; Pompeu Fabra University; Centre de Regulacio Genomica (CRG); Pompeu Fabra University; Central University Hospital Asturias; General University Hospital of Alicante; Universidad Miguel Hernandez de Elche; Universitat d'Alacant; Instituto de Investigacion Sanitaria y Biomedica de Alicante (ISABIAL)	Gonzalez-Duarte, R (corresponding author), Univ Barcelona, Fac Biol, Dept Genet Microbiol & Estadist, Barcelona, Spain.; Gonzalez-Duarte, R (corresponding author), Inst Salud Carlos III, CIBERER, Barcelona, Spain.; Gonzalez-Duarte, R (corresponding author), Univ Barcelona, Inst Biomed IBUB, Barcelona, Spain.	rgonzalez@ub.edu	Cormand, Bru/H-5338-2015; /L-5926-2018; Tonda, Raul/I-1606-2015; Marfany, Gemma/I-5668-2015	Cormand, Bru/0000-0001-5318-4382; /0000-0001-8685-3378; Tonda, Raul/0000-0001-7893-2404; Marfany, Gemma/0000-0001-7941-983X; Perez-Santonja, Juan J./0000-0003-1892-2372	Ministerio de Economia y Competitividad [SAF2013-49069-C2-1-R, PT13/0001/0044]; Generalitat de Catalunya [2014SGR-0932]; La Marato TV3 [201417-30-31-32]	Ministerio de Economia y Competitividad(Spanish Government); Generalitat de Catalunya(Generalitat de Catalunya); La Marato TV3	This study was supported by grants SAF2013-49069-C2-1-R (Ministerio de Economia y Competitividad), 2014SGR-0932 (Generalitat de Catalunya), and La Marato TV3 (Project Marato 201417-30-31-32) to G.M. and R. G-D and PT13/0001/0044 (Ministerio de Economia y Competitividad) to R.T. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdulwahab F, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0693-2; Abu Safieh L, 2010, J MED GENET, V47, P236, DOI 10.1136/jmg.2009.070755; Abu-Safieh L, 2013, GENOME RES, V23, P236, DOI 10.1101/gr.144105.112; Adly N, 2014, HUM MUTAT, V35, P36, DOI 10.1002/humu.22477; Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; Aller E, 2006, J MED GENET, V43, DOI 10.1136/jmg.2006.041764; Andermatt I, 2014, DEVELOPMENT, V141, P3709, DOI 10.1242/dev.112185; Beryozkin A, 2015, SCI REP-UK, V5, DOI 10.1038/srep13187; Bisschoff IJ, 2013, HUM MUTAT, V34, P237, DOI 10.1002/humu.22224; Bonnet C, 2011, ORPHANET J RARE DIS, V6, DOI 10.1186/1750-1172-6-21; Bravo-Gil N, 2016, SCI REP-UK, V6, DOI 10.1038/srep23910; Chen R, 2016, NAT BIOTECHNOL, V34, P531, DOI 10.1038/nbt.3514; Cideciyan AV, 2009, HUM MOL GENET, V18, P931, DOI 10.1093/hmg/ddn421; Cooper DN, 2013, HUM GENET, V132, P1077, DOI 10.1007/s00439-013-1331-2; Coppieters F, 2014, GENET MED, V16, P671, DOI 10.1038/gim.2014.24; Corton M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065574; Corton M, 2013, ORPHANET J RARE DIS, V8, DOI 10.1186/1750-1172-8-20; de Castro-Miro M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088410; den Hollander AI, 2006, AM J HUM GENET, V79, P556, DOI 10.1086/507318; Dreyer B, 2008, HUM MUTAT, V29, P451, DOI 10.1002/humu.9524; Ellingford JM, 2016, OPHTHALMOLOGY; Ellingford JM, 2016, J MED GENET; Eudy JD, 1998, SCIENCE, V280, P1753, DOI 10.1126/science.280.5370.1753; Fry AM, 1998, J CELL BIOL, V141, P1563, DOI 10.1083/jcb.141.7.1563; Ge ZQ, 2015, SCI REP-UK, V5, DOI 10.1038/srep18287; Glockle N, 2013, EUR J HUM GENET, P1; Hanein S, 2004, HUM MUTAT, V23, P306, DOI 10.1002/humu.20010; Jansen GA, 2004, HUM MUTAT, V23, P209, DOI 10.1002/humu.10315; Jose PFS, 2015, INVEST OPHTH VIS SCI, V56, P2173, DOI 10.1167/iovs.14-16178; Karwath M, 2015, RUNS HOMOZYGOSITY RE; Khateb S, 2014, J MED GENET, V51, P460, DOI 10.1136/jmedgenet-2014-102287; Kircher M, 2014, NAT GENET, V46, P310, DOI 10.1038/ng.2892; Lee K, 2015, AM J OPHTHALMOL, V160, P354, DOI 10.1016/j.ajo.2015.04.026; Manes G, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095768; Marfany G, 2015, WORLD J MED GENET, V5, P14; Matsuoka RL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063207; Ng PC, 2001, GENOME RES, V11, P863, DOI 10.1101/gr.176601; Nishiguchi KM, 2005, HUM MUTAT, V25, P248, DOI 10.1002/humu.20142; Nishiguchi KM, 2013, P NATL ACAD SCI; Nishiguchi KM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041902; Perez-Carro R, 2016, SCI REP-UK, V6, DOI 10.1038/srep19531; Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033; Rachel Rivka A, 2012, Cilia, V1, P22, DOI 10.1186/2046-2530-1-22; Ratnapriya R, 2013, GENOME MED, V5, DOI 10.1186/gm488; Rivolta C, 2000, AM J HUM GENET, V66, P1975, DOI 10.1086/302926; Robinson JT, 2011, NAT BIOTECHNOL, V29, P24, DOI 10.1038/nbt.1754; Rose AM, 2016, CLIN GENET, V90, P118, DOI 10.1111/cge.12758; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/nmeth.2019, 10.1038/NMETH.2019]; Schwarz JM, 2014, NAT METHODS, V11, P361, DOI 10.1038/nmeth.2890; Stenson PD, 2014, HUM GENET, V133, P1, DOI 10.1007/s00439-013-1358-4; Sundin OH, 2000, NAT GENET, V25, P289, DOI 10.1038/77162; Thauvin-Robinet C, 2013, CLIN GENET, V84, P86, DOI 10.1111/cge.12013; Tiwari A, 2016, SCI REP-UK, V6, DOI 10.1038/srep28755; Wang J, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0155860; Wang Z, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0150555; Webb TR, 2012, HUM MOL GENET, V21, P3647, DOI 10.1093/hmg/dds194; Zernant J, 2014, HUM MOL GENET, V23, P6797, DOI 10.1093/hmg/ddu396	57	30	30	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2016	11	12							e0168966	10.1371/journal.pone.0168966	http://dx.doi.org/10.1371/journal.pone.0168966			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI9QH	28005958	gold, Green Published, Green Submitted			2022-12-27	WOS:000392843200117
J	Nattero, J; Pita, S; Calleros, L; Crocco, L; Panzera, Y; Rodriguez, CS; Panzera, F				Nattero, Julieta; Pita, Sebastian; Calleros, Lucia; Crocco, Liliana; Panzera, Yanina; Rodriguez, Claudia S.; Panzera, Francisco			Morphological and Genetic Differentiation within the Southernmost Vector of Chagas Disease: Triatoma patagonica (Hemiptera - Reduviidae)	PLOS ONE			English	Article							DEL PONTE; EXPERIMENTAL CROSSES; INFESTANS; POPULATION; FLOW; EVOLUTIONARY; PHYLOGENY; SELECTION; HYBRIDS; REVEAL	The epidemiological importance of Chagas disease vectors largely depends on their spreading ability and adaptation to domestic habitats. Triatoma patagonica is a secondary vector of Chagas disease endemic of Argentina, and it has been found colonizing domiciles and most commonly peridomiciliary structures in several Argentine provinces and morphological variation along its distribution range have been described. To asses if population differentiation represents geographic variants or true biological species, multiple genetic and phenotypic approaches and laboratory cross-breeding were performed in T. patagonica peridomestic populations. Analyses of chromatic variation of forewings, their size and the content of C-heterochromatin on chromosomes revealed that populations are structured following a North-South latitudinal variation. Cytochrome c oxidase I mitochondrial gene (COI) nucleotide analysis showed a mean genetic distance of 5.2% between the most distant populations. The cross-breeding experiments suggest a partial reproductive isolation between some populations with 40% of couples not laying eggs and low hatching efficiency. Our findings reveal phenotypic and genetic variations that suggest an incipient differentiation processes among T. patagonica populations with a pronounced phenotypic and genetic divergence between the most distant populations. The population differentiation here reported is probably related to differential environmental conditions and it could reflect the occurrence of an incipient speciation process in T. patagonica.	[Nattero, Julieta; Crocco, Liliana; Rodriguez, Claudia S.] Univ Nacl Cordoba, CONICET, IIByT,Catedra Intro Biol, Fac Ciencias Exactas Fis & Nat, Avda Velez Sarsfield,Piso 2, Cordoba, Argentina; [Nattero, Julieta] UBA, FCEyN, EGE, CONICET,Inst Ecol Genet & Evoluc Buenos Aires,Lab, Intendente Guiraldes 2160,Ciudad Univ,Pabellon 2, Buenos Aires, DF, Argentina; [Pita, Sebastian; Calleros, Lucia; Panzera, Yanina; Panzera, Francisco] Univ Republica, Fac Ciencias, Secc Genet Evolut, Montevideo, Uruguay	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); National University of Cordoba; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); University of Buenos Aires; Universidad de la Republica, Uruguay	Nattero, J (corresponding author), Univ Nacl Cordoba, CONICET, IIByT,Catedra Intro Biol, Fac Ciencias Exactas Fis & Nat, Avda Velez Sarsfield,Piso 2, Cordoba, Argentina.; Nattero, J (corresponding author), UBA, FCEyN, EGE, CONICET,Inst Ecol Genet & Evoluc Buenos Aires,Lab, Intendente Guiraldes 2160,Ciudad Univ,Pabellon 2, Buenos Aires, DF, Argentina.; Panzera, F (corresponding author), Univ Republica, Fac Ciencias, Secc Genet Evolut, Montevideo, Uruguay.	julietanattero@ege.fcen.uba.ar; fcopanzera@gmail.com	Panzera, Francisco/M-9884-2015; Pita, Sebastián/Z-6090-2019	Panzera, Francisco/0000-0001-5148-957X; Pita, Sebastián/0000-0002-4102-5808; Crocco, Liliana/0000-0002-1277-8157	Secretaria de Ciencia y Tecnica, Universidad Nacional de Cordoba from Argentina [05/I554]; "Comision Sectorial de Investigacion Cientifica" (CSIC-Udelar-Uruguay); Programa de Desarrollo de las Ciencias Basicas (PEDECIBA Uruguay); Agencia Nacional de Investigacion e Innovacion (ANII, Uruguay); CONICET (Argentina)	Secretaria de Ciencia y Tecnica, Universidad Nacional de Cordoba from Argentina; "Comision Sectorial de Investigacion Cientifica" (CSIC-Udelar-Uruguay); Programa de Desarrollo de las Ciencias Basicas (PEDECIBA Uruguay); Agencia Nacional de Investigacion e Innovacion (ANII, Uruguay); CONICET (Argentina)(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET))	This research has been supported by project grants (no 05/I554) "Secretaria de Ciencia y Tecnica, Universidad Nacional de Cordoba from Argentina" to LCr, (no. 370) from the "Comision Sectorial de Investigacion Cientifica" (CSIC-Udelar-Uruguay), Programa de Desarrollo de las Ciencias Basicas (PEDECIBA Uruguay) to FP and Agencia Nacional de Investigacion e Innovacion (ANII, Uruguay) to FP. JN is member of CONICET Researcher's Career. This work was done during the course of a fellowship for young researchers from CONICET (Argentina) given to JN. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnold ML, 2004, MOL ECOL, V13, P997, DOI 10.1111/j.1365-294X.2004.02145.x; Bookstein F.L., 1991, MORPHOMETRIC TOOLS L; Burkart R, 1999, ECOREGIONES ARGENTIN; Cabrera AL., 1971, BOLET N SOC ARGENTIN, V14, P1; Calleros L, 2010, INFECT GENET EVOL, V10, P221, DOI 10.1016/j.meegid.2009.12.002; Campos-Soto R, 2016, INFECT GENET EVOL, V45, P205, DOI 10.1016/j.meegid.2016.09.001; Chunco AJ, 2007, EVOLUTION, V61, P2504, DOI 10.1111/j.1558-5646.2007.00213.x; Costa J, 2003, MEM I OSWALDO CRUZ, V98, P637, DOI 10.1590/S0074-02762003000500009; Dobzhansky T, 1970, GENETICS EVOLUTIONAR; Dujardin JP, 2009, ACTA TROP, V110, P101, DOI 10.1016/j.actatropica.2008.09.026; Dujardin JP, 1999, MEM I OSWALDO CRUZ, V94, P223, DOI 10.1590/S0074-02761999000700036; Edh K, 2007, MOL ECOL, V16, P4972, DOI 10.1111/j.1365-294X.2007.03585.x; Efron B, 1996, P NATL ACAD SCI USA, V93, P13429, DOI 10.1073/pnas.93.23.13429; Endler J.A., 1977, Monographs in Population Biology, pi; Ferrero Adriana A., 1999, Revista de la Sociedad Entomologica Argentina, V58, P79; Galvao C., 2014, VETORES DOENCA CHAGA, DOI DOI 10.7476/9788598203096; Garcia BA, 2001, J MED ENTOMOL, V38, P675, DOI 10.1603/0022-2585-38.5.675; Giraldez E, 2009, REV MED ROSARIO, V75, P38; GORLA DE, 1989, MED VET ENTOMOL, V3, P179, DOI 10.1111/j.1365-2915.1989.tb00497.x; Gurgel-Goncalves R, 2011, MED VET ENTOMOL, V25, P84, DOI 10.1111/j.1365-2915.2010.00920.x; Hoffmann KH, 1985, ENV PHYSL BIOCH INSE, P33, DOI [DOI 10.1007/978-3-642-70020-0_2, 10.1007/978-3-642-70020-0_2]; Hypsa V, 2002, MOL PHYLOGENET EVOL, V23, P447, DOI 10.1016/S1055-7903(02)00023-4; Justi SA, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-149; LENT H, 1979, Bulletin of the American Museum of Natural History, V163, P123; Mendonca VJ, 2014, INFECT GENET EVOL, V26, P123, DOI 10.1016/j.meegid.2014.05.015; Monteiro FA, 2003, MOL ECOL, V12, P997, DOI 10.1046/j.1365-294X.2003.01802.x; Nattero J, 2002, MEM I OSWALDO CRUZ, V97, P1063, DOI 10.1590/S0074-02762002000700022; Nattero J, 2013, J VECTOR ECOL, V38, P127, DOI 10.1111/j.1948-7134.2013.12018.x; Nosil P, 2012, OX ECOL EV, P1, DOI 10.1093/acprof:osobl/9780199587100.001.0001; Panzera F, 1997, AM J TROP MED HYG, V57, P732, DOI 10.4269/ajtmh.1997.57.732; Panzera F, 2006, TROP MED INT HEALTH, V11, P1092, DOI 10.1111/j.1365-3156.2006.01656.x; Panzera F, 2004, EMERG INFECT DIS, V10, P438, DOI 10.3201/eid1003.020812; Panzera F, 2010, CYTOGENET GENOME RES, V128, P77, DOI 10.1159/000298824; Panzera F, 2015, PARASITE VECTOR, V8, DOI 10.1186/s13071-015-1109-6; Panzera F, 2014, INFECT GENET EVOL, V27, P105, DOI 10.1016/j.meegid.2014.07.006; Perez R, 2005, GENETICA, V125, P261, DOI 10.1007/s10709-005-0369-z; Pita S, 2016, INFECT GENET EVOL, V43, P225, DOI 10.1016/j.meegid.2016.05.028; Rabinovich J, 2006, PHYSIOL ENTOMOL, V31, P361, DOI 10.1111/j.1365-3032.2006.00529.x; Rodriguez CS, 2013, ACTA TROP, V125, P143, DOI 10.1016/j.actatropica.2012.11.006; Rodriguez CS, 2008, REV SOC BRAS MED TRO, V41, P330, DOI 10.1590/S0037-86822008000400002; Rohlf F. J., 2013, TPSDIG DIGITIZE LAND; RYCKMAN RAYMOND E., 1962, UNIV CALIF PUBLICATION ENTOMOL, V27, P93; SANDOVAL CP, 1994, EVOLUTION, V48, P1866, DOI 10.1111/j.1558-5646.1994.tb02220.x; Schachter-Broide J, 2004, J MED ENTOMOL, V41, P643, DOI 10.1603/0022-2585-41.4.643; Schofield CJ, 2006, TRENDS PARASITOL, V22, P583, DOI 10.1016/j.pt.2006.09.011; SLATKIN M, 1985, ANNU REV ECOL SYST, V16, P393, DOI 10.1146/annurev.ecolsys.16.1.393; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Verma RS, 1988, HETEROCHROMATIN MOL	48	10	10	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2016	11	12							e0168853	10.1371/journal.pone.0168853	http://dx.doi.org/10.1371/journal.pone.0168853			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI9QH	28005972	Green Published, Green Submitted, gold			2022-12-27	WOS:000392843200105
J	Schaefer, PM; von Einem, B; Walther, P; Calzia, E; von Arnim, CAF				Schaefer, Patrick M.; von Einem, Bjoern; Walther, Paul; Calzia, Enrico; von Arnim, Christine A. F.			Metabolic Characterization of Intact Cells Reveals Intracellular Amyloid Beta but Not Its Precursor Protein to Reduce Mitochondrial Respiration	PLOS ONE			English	Article							A-BETA; ALZHEIMERS-DISEASE; OXIDATIVE STRESS; ENERGY-METABOLISM; NEURONAL DEGENERATION; MOLECULAR-MECHANISMS; INSULIN-RESISTANCE; SYNAPSE PATHOLOGY; BRAIN; DYSFUNCTION	One hallmark of Alzheimer's disease are senile plaques consisting of amyloid beta (A beta), which derives from the processing of the amyloid precursor protein (APP). Mitochondrial dysfunction has been linked to the pathogenesis of Alzheimer's disease and both A beta and APP have been reported to affect mitochondrial function in isolated systems. However, in intact cells, considering a physiological localization of APP and A beta, it is pending what triggers the mitochondrial defect. Thus, the aim of this study was to dissect the impact of APP versus A beta in inducing mitochondrial alterations with respect to their subcellular localization. We performed an overexpression of APP or beta-site amyloid precursor protein cleaving enzyme 1 (BACE1), increasing APP and A beta levels or A beta alone, respectively. Conducting a comprehensive metabolic characterization we demonstrate that only APP overexpression reduced mitochondrial respiration, despite lower extracellular A beta levels compared to BACE overexpression. Surprisingly, this could be rescued by a gamma secretase inhibitor, oppositionally indicating an A beta-mediated mitochondrial toxicity. Analyzing A beta localization revealed that intracellular levels of A beta and an increased spatial association of APPA beta with mitochondria are associated with reduced mitochondrial respiration. Thus, our data provide marked evidence for a prominent role of intracellular A beta accumulation in Alzheimer's disease associated mitochondrial dysfunction. Thereby it highlights the importance of the localization of APP processing and intracellular transport as a decisive factor for mitochondrial function, linking two prominent hallmarks of neurodegenerative diseases.	[Schaefer, Patrick M.; von Einem, Bjoern; von Arnim, Christine A. F.] Univ Ulm, Inst Neurol, Ulm, Germany; [Walther, Paul] Univ Ulm, Cent Facil Electron Microscopy, Ulm, Germany; [Calzia, Enrico] Univ Ulm Klinikum, Inst Anasthesiol Pathophysiol & Verfahrensentwick, Ulm, Germany	Ulm University; Ulm University; Ulm University	von Arnim, CAF (corresponding author), Univ Ulm, Inst Neurol, Ulm, Germany.	christine.arnim@uni-ulm.de			German Federal Ministry of Economics and Energy (BMWi) within the Promotion of Joint Industrial Research Program (IGF); German Federation of Industrial Research Associations (AiF) [18239 N]	German Federal Ministry of Economics and Energy (BMWi) within the Promotion of Joint Industrial Research Program (IGF); German Federation of Industrial Research Associations (AiF)	This research was funded by the German Federal Ministry of Economics and Energy (BMWi) within the Promotion of Joint Industrial Research Program (IGF) due to a decision of the German Bundestag. It was part of the research project 18239 N by the Association for Research in Precision Mechanics, Optics and Medical Technology (F.O.M.) under the auspices of the German Federation of Industrial Research Associations (AiF).	Aleardi AM, 2005, J BIOENERG BIOMEMBR, V37, P207, DOI 10.1007/s10863-005-6631-3; Anandatheerthavarada HK, 2007, NEUROSCIENTIST, V13, P626, DOI 10.1177/1073858407303536; Anandatheerthavarada HK, 2003, J CELL BIOL, V161, P41, DOI 10.1083/jcb.200207030; Barone E, 2016, ANTIOXID REDOX SIGNA; Belanger M, 2011, CELL METAB, V14, P724, DOI 10.1016/j.cmet.2011.08.016; Benilova I, 2012, NAT NEUROSCI, V15, P349, DOI 10.1038/nn.3028; Bobba A, 2013, MITOCHONDRION, V13, P298, DOI 10.1016/j.mito.2013.03.008; Buser C, 2008, J MICROSC-OXFORD, V230, P268, DOI 10.1111/j.1365-2818.2008.01984.x; Caspersen C, 2005, FASEB J, V19, P2040, DOI 10.1096/fj.05-3735fje; Cha MY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034929; Chang KL, 2015, J ALZHEIMERS DIS, V44, P215, DOI 10.3233/JAD-140429; Cunnane S, 2011, NUTRITION, V27, P3, DOI 10.1016/j.nut.2010.07.021; de la Monte SM, 2012, CURR ALZHEIMER RES, V9, P35; Devi L, 2006, J NEUROSCI, V26, P9057, DOI 10.1523/JNEUROSCI.1469-06.2006; Devi L, 2012, NEUROBIOL DIS, V45, P417, DOI 10.1016/j.nbd.2011.09.001; Dragicevic N, 2010, J ALZHEIMERS DIS, V20, pS535, DOI 10.3233/JAD-2010-100342; Eckert SH, 2012, J ALZHEIMERS DIS, V31, P21, DOI 10.3233/JAD-2012-120310; Feldhaus P, 2011, METAB BRAIN DIS, V26, P229, DOI 10.1007/s11011-011-9253-y; Hernandez-Zimbron LF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042344; Forkink M, 2014, BBA-BIOENERGETICS, V1837, P1247, DOI 10.1016/j.bbabio.2014.04.008; Gouras GK, 2014, NEURODEGENER DIS, V13, P142, DOI 10.1159/000354776; Gouras GK, 2010, ACTA NEUROPATHOL, V119, P523, DOI 10.1007/s00401-010-0679-9; Gray NE, 2015, J ALZHEIMERS DIS, V45, P933, DOI 10.3233/JAD-142217; Horan MP, 2012, J GERONTOL A-BIOL, V67, P1022, DOI 10.1093/gerona/glr263; Kaminsky YG, 2015, FRONT BIOSCI-LANDMRK, V20, P173, DOI 10.2741/4304; Kinoshita A, 2001, J NEUROSCI, V21, P8354, DOI 10.1523/JNEUROSCI.21-21-08354.2001; Krako N, 2013, J ALZHEIMERS DIS, V37, P747, DOI 10.3233/JAD-130728; Kwon B, 2015, BBA-MOL BASIS DIS, V1852, P1810, DOI 10.1016/j.bbadis.2015.05.012; Landor SKJ, 2011, P NATL ACAD SCI USA, V108, P18814, DOI 10.1073/pnas.1104943108; Lee EB, 2005, J CELL BIOL, V168, P291, DOI 10.1083/jcb.200407070; Lee I, 2001, BIOL CHEM, V382, P1629, DOI 10.1515/BC.2001.198; Lin MT, 2006, NAT MED, V12, P1241, DOI 10.1038/nm1106-1241; Luque-Contreras D, 2014, OXID MED CELL LONGEV, V2014, DOI 10.1155/2014/497802; Lustbader JW, 2004, SCIENCE, V304, P448, DOI 10.1126/science.1091230; Mattson MP, 1999, ANN NY ACAD SCI, V893, P154, DOI 10.1111/j.1749-6632.1999.tb07824.x; Mitani Y, 2012, J NEUROSCI, V32, P2037, DOI 10.1523/JNEUROSCI.4264-11.2012; Mosconi L, 2008, ANN NY ACAD SCI, V1147, P180, DOI 10.1196/annals.1427.007; Pagani Lucia, 2011, Int J Alzheimers Dis, V2011, P925050, DOI 10.4061/2011/925050; Parihar MS, 2007, AM J PHYSIOL-CELL PH, V292, pC8, DOI 10.1152/ajpcell.00232.2006; Parks JK, 2001, J NEUROCHEM, V76, P1050, DOI 10.1046/j.1471-4159.2001.00112.x; Pavlov PF, 2011, FASEB J, V25, P78, DOI 10.1096/fj.10-157230; PERRY EK, 1980, NEUROSCI LETT, V18, P105, DOI 10.1016/0304-3940(80)90220-7; Petersen CAH, 2008, P NATL ACAD SCI USA, V105, P13145, DOI 10.1073/pnas.0806192105; Pohland M, 2015, NEUROCHEM RES; RAPOPORT SI, 1991, ADV EXP MED BIOL, V291, P231; Rhein V, 2009, CELL MOL NEUROBIOL, V29, P1063, DOI 10.1007/s10571-009-9398-y; Rhein V, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012359; Robinson A, 2014, AGING CELL, V13, P263, DOI 10.1111/acel.12183; Rottenberg H, 2009, J BIOL CHEM, V284, P19203, DOI 10.1074/jbc.M109.017376; Sanderson TH, 2013, MOL NEUROBIOL, V47, P9, DOI 10.1007/s12035-012-8344-z; Sarkar S, 2015, BRAIN RES, V1616, P101, DOI 10.1016/j.brainres.2015.04.059; Schreiner B, 2015, J ALZHEIMERS DIS, V43, P369, DOI 10.3233/JAD-132543; Sheng BY, 2009, FREE RADICAL BIO MED, V46, P1362, DOI 10.1016/j.freeradbiomed.2009.02.018; Sultana R, 2009, J BIOENERG BIOMEMBR, V41, P441, DOI 10.1007/s10863-009-9241-7; Upadhaya AR, 2013, ACTA NEUROPATHOL COM, V1, DOI 10.1186/2051-5960-1-77; von Einem B, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129047; Walther Paul, 2013, Methods Mol Biol, V931, P525, DOI 10.1007/978-1-62703-056-4_28; Wang XL, 2008, P NATL ACAD SCI USA, V105, P19318, DOI 10.1073/pnas.0804871105; Weissmiller AM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118379; Wilkat M, 2014, HISTOCHEM CELL BIOL, V142, P171, DOI 10.1007/s00418-014-1189-y; Xie H, 2013, J NEUROSCI, V 33, P17042, DOI 10.1523/JNEUROSCI.1836-13.2013; Zhao W, 2015, NEUROPSYCH DIS TREAT, V11, P565, DOI 10.2147/NDT.S74898	62	18	18	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2016	11	12							e0168157	10.1371/journal.pone.0168157	http://dx.doi.org/10.1371/journal.pone.0168157			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI9QH	28005987	Green Submitted, Green Published, gold			2022-12-27	WOS:000392843200032
J	Sung, JH; Lee, J; Park, J; Sim, CS				Sung, Joo Hyun; Lee, Jiho; Park, Jin; Sim, Chang Sun			Relationship of Transportation Noise and Annoyance for Two Metropolitan Cities in Korea: Population Based Study	PLOS ONE			English	Article							INDUCED HEARING-LOSS; ENVIRONMENTAL NOISE; AIRCRAFT NOISE; EXPOSURE; POLLUTION; ADULTS; HEALTH	Transportation noise is known to have negative impact on both public health and life quality. This study evaluated the relationship between transportation noise and annoyance levels, and also the difference of annoyance levels in two metropolitan cities based on epidemiologic surveys. Two thousand adult subjects living in Seoul and Ulsan were enrolled by stratified random sampling on the basis of noise maps from July 2015 to January 2016. Individual annoyance in accordance with transportation noise levels in two metropolitan cities were surveyed using an 11-point visual analog scale questionnaire. The results show that transportation noise level was significantly correlated with annoyance in both cities. Logistic regression analysis revealed that the risk of being 'highly annoyed' increased with noise level (L-dn, day-night average sound level) in both cities. After adjusting for age, residence period, sociodemographic factors (sex, education, marriage, income, alcohol, smoking, and exercise) and noise sensitivity, the risk of being 'highly annoyed' was increased with noise levels in both cities. In comparison to those of areas with noise levels below 55 dBA, the adjusted odds ratios of 'highly annoyed' for areas with 55-65 dBA and over 65 dBA were 2.056 (95% confidence interval [CI] 1.225-3.450), 3.519 (95% CI 1.982-6.246) in Seoul and 1.022 (95% CI 0.585-1.785), 1.704 (95% CI 1.005-2.889) in Ulsan, respectively. Based on the results of a population study, we showed that transportation noise levels were significantly associated with annoyance in adults. However, there were some differences between the two cities. In this study, there were differences in transportation noise between the two cities. Seoul has complex noise (traffic and aircraft), compared to single road traffic noise in Ulsan. Therefore, single and complex transportation noise may have different effects on annoyance levels.	[Sung, Joo Hyun; Lee, Jiho; Park, Jin; Sim, Chang Sun] Univ Ulsan, Coll Med, Ulsan Univ Hosp, Dept Occupat & Environm Med, Ulsan, South Korea	University of Ulsan; Ulsan University Hospital	Sim, CS (corresponding author), Univ Ulsan, Coll Med, Ulsan Univ Hosp, Dept Occupat & Environm Med, Ulsan, South Korea.	zzz0202@naver.com		Sung, Joo Hyun/0000-0001-9043-1127	Korea Ministry of Environment (MOE) as "the Environmental Health Action Program"; Korea Ministry of Environment [2014001350001]	Korea Ministry of Environment (MOE) as "the Environmental Health Action Program"(Ministry of Environment (ME), Republic of Korea); Korea Ministry of Environment(Ministry of Environment (ME), Republic of Korea)	This study was funded by the Korea Ministry of Environment (MOE) as "the Environmental Health Action Program." CSS and JHS received funding from Korea Ministry of Environment (grant number 2014001350001) (URL: http://www.me.go.kr/home/web/main.do). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarsson JJ, 2010, INT J ENV RES PUB HE, V7, P1036, DOI 10.3390/ijerph7031036; [Anonymous], 2003, ASS NOIS ANN MEANS S; Basner M, 2015, NOISE HEALTH, V17, P57, DOI 10.4103/1463-1741.153373; BORSKY PN, 1979, OTOLARYNG CLIN N AM, V12, P521; Buhaug H, 2013, GLOBAL ENVIRON CHANG, V23, P1, DOI 10.1016/j.gloenvcha.2012.10.016; European Commission, 2002, POS PAP DOS RESP REL; Gilles A, 2012, OTOL NEUROTOL, V33, P899, DOI 10.1097/MAO.0b013e31825d640a; Hammer MS, 2014, ENVIRON HEALTH PERSP, V122, P115, DOI 10.1289/ehp.1307272; Hume KI, 2012, NOISE HEALTH, V14, P297, DOI 10.4103/1463-1741.104897; Hurtley C., 2009, NIGHT NOISE GUIDELIN; Jeon JY, 2010, J ACOUST SOC AM, V127, P1357, DOI 10.1121/1.3298437; Kephalopoulos, 2011, BURDEN DIS ENV NOISE; Korean Ministry of Health and Welfare (KMOHW), 2016, NAT HLTH EX GUID; Lekaviciute J, 2013, NOISE HEALTH, V15, P42, DOI 10.4103/1463-1741.107153; Lewis RC, 2013, ENVIRON SCI TECHNOL, V47, P6393, DOI 10.1021/es305161z; LINDVALL T, 1973, ENVIRON RES, V6, P1, DOI 10.1016/0013-9351(73)90014-5; Mahboubi H, 2013, EUR ARCH OTO-RHINO-L, V270, P461, DOI 10.1007/s00405-012-1979-6; Miedema HME, 2001, ENVIRON HEALTH PERSP, V109, P409, DOI 10.2307/3454901; Ministry of Environment (MOE), 2010, ASS COMB NOIS ANN EI; Munzel T, 2014, EUR HEART J, V35, P829, DOI 10.1093/eurheartj/ehu030; Ndrepepa A, 2011, NOISE HEALTH, V13, P251, DOI 10.4103/1463-1741.80163; Pepper CB, 2003, ENVIRON MANAGE, V32, P418, DOI 10.1007/s00267-003-3024-4; SCHULTZ TJ, 1978, J ACOUST SOC AM, V64, P377, DOI 10.1121/1.382013; Sim CS, 2015, YONSEI MED J, V56, P235, DOI 10.3349/ymj.2015.56.1.235; Stansfeld SA, 2003, BRIT MED BULL, V68, P243, DOI 10.1093/bmb/ldg033; Veerappa MPK, 2011, NOISE HEALTH, V13, P16, DOI 10.4103/1463-1741.73996; Wright BA, 2016, NOISE HEALTH, V18, P117, DOI 10.4103/1463-1741.181995; Wu TN, 1995, ARCH ENVIRON HEALTH, V50, P452, DOI 10.1080/00039896.1995.9935982	28	10	10	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2016	11	12							e0169035	10.1371/journal.pone.0169035	http://dx.doi.org/10.1371/journal.pone.0169035			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI9QH	28005976	Green Submitted, Green Published, gold			2022-12-27	WOS:000392843200128
J	Bartsch, AL; Harter, M; Niedrich, J; Brutt, AL; Buchholz, A				Bartsch, Anna-Lena; Haerter, Martin; Niedrich, Jasmin; Bruett, Anna Levke; Buchholz, Angela			A Systematic Literature Review of Self-Reported Smoking Cessation Counseling by Primary Care Physicians	PLOS ONE			English	Review							GENERAL-PRACTITIONERS; CARDIOVASCULAR-DISEASE; FAMILY PHYSICIANS; ATTITUDES; PREVENTION; TOBACCO; ADVICE; BARRIERS; CANCER; INTERVENTION	Tobacco consumption is a risk factor for chronic diseases and worldwide around six million people die from long-term exposure to first- or second-hand smoke annually. One effective approach to tobacco control is smoking cessation counseling by primary care physicians. However, research suggests that smoking cessation counseling is not sufficiently implemented in primary care. In order to understand and address the discrepancy between evidence and practice, an overview of counseling practices is needed. Therefore, the aim of this systematic literature review is to assess the frequency of smoking cessation counseling in primary care. Self-reported counseling behavior by physicians is categorized according to the 5A's strategy (ask, advise, assess, assist, arrange). An electronic database search was performed in Embase, Medline, PsycINFO, CINAHL and the Cochrane Library and overall, 3491 records were identified. After duplicates were removed, the title and abstracts of 2468 articles were screened for eligibility according to inclusion/exclusion criteria. The remaining 97 full-text articles reporting smoking cessation counseling by primary care physicians were assessed for eligibility. Eligible studies were those that measured physicians' self-reported smoking cessation counseling activities via questionnaire. Thirty-five articles were included in the final review (1 intervention and 34 cross-sectional studies). On average, behavior corresponding to the 5A's was reported by 65% of physicians for "Ask", 63% for "Advise", 36% for "Assess", 44% for "Assist", and 22% of physicians for "Arrange", although the measurement and reporting of each of these counseling practices varied across studies. Overall, the results indicate that the first strategies (ask, advise) were more frequently reported than the subsequent strategies (assess, assist, arrange). Moreover, there was considerable variation in the items used to assess counseling behaviour and developing a standardized instrument to assess the counseling strategies implemented in primary care would help to identify and address current gaps in practice.	[Bartsch, Anna-Lena; Haerter, Martin; Niedrich, Jasmin; Bruett, Anna Levke; Buchholz, Angela] Univ Med Ctr Hamburg Eppendorf, Dept Med Psychol, Hamburg, Germany	University of Hamburg; University Medical Center Hamburg-Eppendorf	Bartsch, AL (corresponding author), Univ Med Ctr Hamburg Eppendorf, Dept Med Psychol, Hamburg, Germany.	a.bartsch@uke.de		Harter, Martin/0000-0001-7443-9890	German Federal Ministry of Health [IIA5-2513DSM231]	German Federal Ministry of Health	This literature review was conducted in the context of the study ENTER, which is funded by the German Federal Ministry of Health (http://www.bmg.bund.de/) under registration code IIA5-2513DSM231. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AAFP, 2016, CLIN PREV SERV REC A; Alomari MA, 2013, J SMOK CESS, V8, P85, DOI 10.1017/jsc.2013.5; [Anonymous], 2015, WHO REP GLOB TOB EP; Asan Onur, 2014, Inform Prim Care, V21, P161, DOI 10.14236/jhi.v21i4.72; AWMF, 2015, S3 LEITL SCREEN DIAG; AWMF, 2015, S3 GUID SCREEN DIAGN; Barengo NC, 2005, SOZ PRAVENTIV MED, V50, P355, DOI 10.1007/s00038-005-4097-z; Bock C, 2012, MED CARE RES REV, V69, P495, DOI 10.1177/1077558712441084; Boldemann C, 2006, NICOTINE TOB RES, V8, P785, DOI 10.1080/14622200601004059; CAN-ADAPTT, 2011, CAN SMOK CESS CLIN P; Coleman T, 1996, BRIT J GEN PRACT, V46, P87; Crawford MA, 2005, QUALITY PRIMARY CARE, V13, P163; Curd Philip, 2004, J Ky Med Assoc, V102, P433; Easton A, 2001, WOMEN HEALTH, V32, P77, DOI 10.1300/J013v32n04_05; Fiore M C, 2000, Respir Care, V45, P1200; Ganry O, 2004, B CANCER, V91, P785; Glasgow RE, 2006, HEALTH PROMOT INT, V21, P245, DOI 10.1093/heapro/dal017; Gokirmak M, 2010, INT J PUBLIC HEALTH, V55, P177, DOI 10.1007/s00038-009-0109-8; Goldberg R J, 1993, J Cancer Educ, V8, P133; Gottlieb N H, 2001, J Am Board Fam Pract, V14, P343; Grant AM, 1998, CAN FAM PHYSICIAN, V44, P780; Grobe T. G., 2015, BARMER GEK ARZTREPOR; Helgason AR, 2002, SCAND J PUBLIC HEALT, V30, P141, DOI 10.1080/14034940210133799; Hoch E, 2004, ADDICTION, V99, P1586, DOI 10.1111/j.1360-0443.2004.00887.x; Hu Shaohua, 2003, Tex Med, V99, P57; Hummers-Pradier E, 2008, FAM PRACT, V25, P105, DOI 10.1093/fampra/cmn015; Hung DY, 2014, HEALTH CARE MANAGE R, V39, P154, DOI 10.1097/HMR.0b013e3182914d11; Invernizzi G, 2001, TUMORI, V87, P117, DOI 10.1177/030089160108700301; Josseran L, 2000, J NATL MED ASSOC, V92, P382; Katz A, 2012, CAN FAM PHYSICIAN, V58, pE62; Kim Jin-Sun, 2004, Taehan Kanho Hakhoe Chi, V34, P1443; Kossler W, 2002, WIEN KLIN WOCHENSCHR, V114, P762; Kruger J, 2015, HARM REDUCT J, V12, DOI 10.1186/s12954-015-0044-3; Lawson PJ, 2009, AM J PREV MED, V37, P248, DOI 10.1016/j.amepre.2009.04.027; Lennox AS, 1995, HLTH ED J, V54, P48; Longo Daniel R, 2006, Mo Med, V103, P180; Mas FGS, 2005, BMC PUBLIC HEALTH, V5, DOI 10.1186/1471-2458/5/120; McEwen A, 2005, PUBLIC HEALTH, V119, P262, DOI 10.1016/j.puhe.2004.05.016; McEwen A, 2001, TOB CONTROL, V10, P27, DOI 10.1136/tc.10.1.27; McLeod D, 2000, NEW ZEAL MED J, V113, P480; McRobbie H, 2008, NEW ZEAL MED J, V121, P57; Meshefedjian GA, 2010, CAN J PUBLIC HEALTH, V101, P290, DOI 10.1007/BF03405288; Moher D, 2009, ANN INTERN MED, V151, P264, DOI 10.7326/0003-4819-151-4-200908180-00135; Ng N, 2007, TOB CONTROL, V16, P190, DOI 10.1136/tc.2006.018895; Nobile CGA, 2014, PREV MED, V66, P107, DOI 10.1016/j.ypmed.2014.06.009; O'Cathain A., 2010, SAGE HDB MIXED METHO, V2nd ed., P531, DOI [10.4135/9781506335193, DOI 10.4135/9781506335193, DOI 10.4135/9781506335193.N21]; O'Loughlin J, 2001, PREV MED, V33, P627, DOI 10.1006/pmed.2001.0937; Pace R, 2012, INT J NURS STUD, V49, P47, DOI 10.1016/j.ijnurstu.2011.07.002; Pbert L, 1999, HEALTH PSYCHOL, V18, P183, DOI 10.1037/0278-6133.18.2.183; Pipe A, 2009, PATIENT EDUC COUNS, V74, P118, DOI 10.1016/j.pec.2008.07.042; Pluye P., 2011, MCGILL U, V2, P1; Podsakoff PM, 2003, J APPL PSYCHOL, V88, P879, DOI 10.1037/0021-9010.88.5.879; Schneider S., 2014, SUCHT, V60, P175, DOI 10.1024/0939-5911.a000310; Schneider S, 2014, INT J ENV RES PUB HE, V11, P4218, DOI 10.3390/ijerph110404218; Schnoll RA, 2006, AM J PREV MED, V31, P233, DOI 10.1016/j.amepre.2006.05.001; Secretariat of the WHO Framework Convention on Tobacco Control, 2019, INF NOT CLASS NOV EM; Skoeries BA, 2010, GESUNDHEITSWESEN, V72, P228, DOI 10.1055/s-0029-1215561; Squier C, 2006, EUR J CANCER PREV, V15, P458, DOI 10.1097/00008469-200610000-00012; Stead LF, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000165.pub4; Tanriover O, 2014, EUR J CANCER PREV, V23, P464, DOI 10.1097/CEJ.0000000000000020; Ulbricht S, 2006, PATIENT EDUC COUNS, V63, P232, DOI 10.1016/j.pec.2005.11.005; van Rossem C, 2015, EUR J GEN PRACT, V21, P111, DOI 10.3109/13814788.2014.990881; Varona P, 2005, J URBAN HEALTH, V82, P71, DOI 10.1093/jurban/jti009; Vogt F, 2005, ADDICTION, V100, P1423, DOI 10.1111/j.1360-0443.2005.01221.x; WHO, 2005, GLOB HLTH PROF SURV; Young JM, 2001, FAM PRACT, V18, P14, DOI 10.1093/fampra/18.1.14	66	40	40	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2016	11	12							e0168482	10.1371/journal.pone.0168482	http://dx.doi.org/10.1371/journal.pone.0168482			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EI9TW	28002498	gold, Green Published, Green Submitted			2022-12-27	WOS:000392853100047
J	El-Ghitany, EM; Farghaly, AG; Farag, S; Abd El-Wahab, EW				El-Ghitany, Engy Mohamed; Farghaly, Azza Galal; Farag, Shehata; Abd El-Wahab, Ekram Wassim			Validation of EGCRISC for Chronic Hepatitis C Infection Screening and Risk Assessment in the Egyptian Population	PLoS One			English	Article							VIRUS-INFECTION; ASSESSMENT TOOL; PRIMARY-CARE	Chronic HCV infection, a highly endemic disease in Egypt, is usually asymptomatic for decades after infection. Prediction questionnaire tool was proofed to be a valuable, feasible and efficient instrument for the screening of several diseases. We previously developed an Egyptian HCV risk screening tool (EGCRISC). This study aims to validate/modify EGCRISC. A cross-sectional study testing 4579 individuals by EGCRISC as well as ELISA/PCR was performed. The sample was a stratified cluster sampling from urban and rural areas in Upper and Lower Egypt using a proportional allocation technique. The degree of agreement and positive and negative posttest probabilities were calculated. ROC curve was done and the cutoff points were customized for best performance. The total score was further classified into three levels according to the risk load. The mean age of the participants was 41.1 +/- 12.2 in whom HCV prevalence was 8.6%. EGCRISC, particularly after modifying the cutoff points, has a good discriminating ability. The degree of agreement was at least 68.1% and the positive posttest probability ranged from 5% to 37.2% whereas the negative posttest probability was in the range 1% to 17%. We conclude that EGCRISC is a valid tool that can potentially screen for HCV infection risk in Egypt and could diminish the demand for mass serologic screening in those apparently at minimal risk. Extensive use of electronic and self-or interviewer-administered risk-based screening strategy may simplify and promote overall screening and detection of HCV dissimilar communities.	[El-Ghitany, Engy Mohamed; Farghaly, Azza Galal; Abd El-Wahab, Ekram Wassim] Univ Alexandria, Trop Hlth Dept, High Inst Publ Hlth, Alexandria, Egypt; [Farag, Shehata] Univ Alexandria, Dept Biostat, High Inst Publ Hlth, Alexandria, Egypt	Egyptian Knowledge Bank (EKB); Alexandria University; Egyptian Knowledge Bank (EKB); Alexandria University	El-Ghitany, EM (corresponding author), Univ Alexandria, Trop Hlth Dept, High Inst Publ Hlth, Alexandria, Egypt.	ingy.elghitany@gmail.com	El-Wahab, Ekram Abd/V-8831-2017; El-Ghitany, Engy Mohamed/AAH-5599-2019	El-Wahab, Ekram Abd/0000-0003-4220-5859; El-Ghitany, Engy Mohamed/0000-0002-3157-1629	Science and Technology Development Fund (STDF), Egypt [3469]	Science and Technology Development Fund (STDF), Egypt(Science and Technology Development Fund (STDF))	This work was supported financially by the Science and Technology Development Fund (STDF), Egypt; Project No. 3469. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alssema M, 2012, DIABETES CARE, V35, P741, DOI 10.2337/dc11-1417; Arumainayagam J, 2009, INT J STD AIDS, V20, P642, DOI 10.1258/ijsa.2008.008424; Berg AO, 2004, ANN INTERN MED, V140, P462, DOI 10.7326/0003-4819-140-6-200403160-00013; Bialek Stephanie R, 2006, Clin Liver Dis, V10, P697, DOI 10.1016/j.cld.2006.08.003; Boyce Daniel E C, 2009, Hawaii Med J, V68, P113; Dore GJ, 2010, GASTROENTEROLOGY, V138, P123, DOI 10.1053/j.gastro.2009.09.019; Edlin BR, 2005, CLIN INFECT DIS S5, V40; El-Ghitany EM, 2016, J MED VIROL, V88, P1767, DOI 10.1002/jmv.24520; El-Zanaty F, 2015, EGYPT HLTH ISSUE SUR; Gerlach JT, 2003, GASTROENTEROLOGY, V125, P80, DOI 10.1016/S0016-5085(03)00668-1; Gower E, 2014, J HEPATOL, V61, pS45, DOI 10.1016/j.jhep.2014.07.027; Kamal SM, 2006, GASTROENTEROLOGY, V130, P632, DOI 10.1053/j.gastro.2006.01.034; Lapane KL, 1998, AM J GASTROENTEROL, V93, P591, DOI 10.1111/j.1572-0241.1998.170_b.x; Mallette C, 2008, AM J GASTROENTEROL, V103, P131, DOI 10.1111/j.1572-0241.2007.01522.x; McGinn T, 2008, ARCH INTERN MED, V168, P2009, DOI 10.1001/archinte.168.18.2009; Mohamoud YA, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-288; National Committee for the Control of Viral Hepatitis, 2008, EG NAT CONTR STRAT V; Nguyen MT, 2005, ARCH INTERN MED, V165, P2013, DOI 10.1001/archinte.165.17.2013; Oh SM, 2016, YONSEI MED J, V57, P187, DOI 10.3349/ymj.2016.57.1.187; Park S, 2014, NEUROPSYCH DIS TREAT, V10, P1837, DOI 10.2147/NDT.S64151; Shehab TM, 2003, AM J GASTROENTEROL, V98, P639, DOI 10.1111/j.1572-0241.2003.07331.x; Vandersmissen GJM, 2015, INT J OCCUP MED ENV, V28, P587, DOI 10.13075/ijomeh.1896.00407; Vickers AJ, 2008, ANN INTERN MED, V149, P200, DOI 10.7326/0003-4819-149-3-200808050-00010; Wand H, 2012, BMJ OPEN, V2, DOI 10.1136/bmjopen-2011-000387; Zuure F, 2010, EUROSURVEILLANCE, V15, P5; Zuure FR, 2013, LIVER INT, V33, P727, DOI 10.1111/liv.12131	26	4	4	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2016	11	12							e0168649	10.1371/journal.pone.0168649	http://dx.doi.org/10.1371/journal.pone.0168649			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI9TW	28002458	gold, Green Submitted, Green Published			2022-12-27	WOS:000392853100061
J	Hwang, AW; Trzeciakiewicz, H; Friedmann, D; Yuan, CX; Marmorstein, R; Lee, VMY; Cohen, TJ				Hwang, Andrew W.; Trzeciakiewicz, Hanna; Friedmann, Dave; Yuan, Chao-Xing; Marmorstein, Ronen; Lee, Virginia M. Y.; Cohen, Todd J.			Conserved Lysine Acetylation within the Microtubule-Binding Domain Regulates MAP2/Tau Family Members	PLoS One			English	Article							TAU-PROTEIN; ACETYLTRANSFERASE ACTIVITY; HISTONE ACETYLTRANSFERASE; CATALYTIC MECHANISM; ALZHEIMERS-DISEASE; AUTOACETYLATION; SITES; CELLS; AGGREGATION; PHOSPHORYLATION	Lysine acetylation has emerged as a dominant post-translational modification (PTM) regulating tau proteins in Alzheimer's disease (AD) and related tauopathies. Mass spectrometry studies indicate that tau acetylation sites cluster within the microtubule-binding region (MTBR), a region that is highly conserved among tau, MAP2, and MAP4 family members, implying that acetylation could represent a conserved regulatory mechanism for MAPs beyond tau. Here, we combined mass spectrometry, biochemical assays, and cell-based approaches to demonstrate that the tau family members MAP2 and MAP4 are also subject to reversible acetylation. We identify a cluster of lysines in the MAP2 and MAP4 MTBR that undergo CBP-catalyzed acetylation, many of which are conserved in tau. Similar to tau, MAP2 acetylation can occur in a cysteine-dependent auto-regulatory manner in the presence of acetyl-CoA. Furthermore, tubulin reduced MAP2 acetylation, suggesting tubulin binding dictates MAP acetylation status. Taken together, these results uncover a striking conservation of MAP2/Tau family post-translational modifications that could expand our understanding of the dynamic mechanisms regulating microtubules.	[Hwang, Andrew W.; Lee, Virginia M. Y.] Univ Penn, Dept Pathol & Lab Med, Perelman Sch Med, Philadelphia, PA USA; [Trzeciakiewicz, Hanna] Univ N Carolina, Dept Biochem & Biophys, Chapel Hill, NC USA; [Friedmann, Dave; Marmorstein, Ronen] Univ Penn, Dept Biochem & Biophys, Abramson Family Canc Res Inst, Perelman Sch Med, Philadelphia, PA 19104 USA; [Yuan, Chao-Xing] Alexion Pharmaceut Inc, New Haven, CT USA; [Cohen, Todd J.] Univ N Carolina, Dept Neurol, UNC Neurosci Ctr, Chapel Hill, NC 27514 USA	University of Pennsylvania; Pennsylvania Medicine; University of North Carolina; University of North Carolina Chapel Hill; University of Pennsylvania; Pennsylvania Medicine; University of North Carolina; University of North Carolina Chapel Hill	Cohen, TJ (corresponding author), Univ N Carolina, Dept Neurol, UNC Neurosci Ctr, Chapel Hill, NC 27514 USA.	toddcohen@neurology.unc.edu	, Proteomics Core UNC/AAH-3777-2022; , Proteomics Core UNC/AFQ-7201-2022		Alzheimer's Association [NIRG-14-321219]; National Center for Advancing Translational Sciences [UL1TR001111]; National Institute of General Medical Sciences [R01GM060293]; National Institute on Aging [P01AG031862, AG17586]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P30NS045892] Funding Source: NIH RePORTER	Alzheimer's Association(Alzheimer's Association); National Center for Advancing Translational Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by the Alzheimer's Association (NIRG-14-321219), the National Center for Advancing Translational Sciences (UL1TR001111), the National Institute of General Medical Sciences (R01GM060293), and the National Institute on Aging (P01AG031862, AG17586). One of the authors (CXY) has a commercial affiliation with Alexion Pharmaceuticals Inc. The funder provided support in the form of salaries for CXY, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. None of the other funders had any role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific role of this author is articulated in the 'author contributions' section.	Akella JS, 2010, NATURE, V467, P218, DOI 10.1038/nature09324; ANDREADIS A, 1992, BIOCHEMISTRY-US, V31, P10626, DOI 10.1021/bi00158a027; BURGIN KE, 1994, MOL BIOL CELL, V5, P511, DOI 10.1091/mbc.5.5.511; BUTNER KA, 1991, J CELL BIOL, V115, P717, DOI 10.1083/jcb.115.3.717; Choudhary C, 2009, SCIENCE, V325, P834, DOI 10.1126/science.1175371; Cohen TJ, 2013, NAT STRUCT MOL BIOL, V20, P756, DOI 10.1038/nsmb.2555; Cohen TJ, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1255; Cook C, 2014, HUM MOL GENET, V23, P104, DOI 10.1093/hmg/ddt402; Creppe C, 2009, CELL, V136, P551, DOI 10.1016/j.cell.2008.11.043; Dehmelt L, 2005, GENOME BIOL, V6; DUPRET JM, 1992, J BIOL CHEM, V267, P7381; GOEDERT M, 1989, NEURON, V3, P519, DOI 10.1016/0896-6273(89)90210-9; GOODE BL, 1994, J CELL BIOL, V124, P769, DOI 10.1083/jcb.124.5.769; Hubbert C, 2002, NATURE, V417, P455, DOI 10.1038/417455a; Illenberger S, 1996, J BIOL CHEM, V271, P10834, DOI 10.1074/jbc.271.18.10834; Irwin DJ, 2013, AM J PATHOL, V183, P344, DOI 10.1016/j.ajpath.2013.04.025; Irwin DJ, 2012, BRAIN, V135, P807, DOI 10.1093/brain/aws013; Jiang HB, 2006, NEUROBIOL DIS, V23, P543, DOI 10.1016/j.nbd.2006.04.011; Kadavath H, 2015, P NATL ACAD SCI USA, V112, P7501, DOI 10.1073/pnas.1504081112; Kamah A, 2014, BIOCHEMISTRY-US, V53, P3020, DOI 10.1021/bi500006v; Karabulut NP, 2015, J STRUCT BIOL, V191, P39, DOI 10.1016/j.jsb.2015.06.001; Karanam B, 2006, J BIOL CHEM, V281, P40292, DOI 10.1074/jbc.M608813200; Kim SC, 2006, MOL CELL, V23, P607, DOI 10.1016/j.molcel.2006.06.026; Li WK, 2006, BIOCHEMISTRY-US, V45, P15692, DOI 10.1021/bi061422+; Lu L, 2011, CELL RES, V21, P1182, DOI 10.1038/cr.2011.71; Lundby A, 2012, CELL REP, V2, P419, DOI 10.1016/j.celrep.2012.07.006; Min SW, 2010, NEURON, V67, P953, DOI 10.1016/j.neuron.2010.08.044; Mohan R, 2015, IUBMB LIFE, V67, P395, DOI 10.1002/iub.1384; Morris M, 2015, NAT NEUROSCI, V18, P1183, DOI 10.1038/nn.4067; Mukrasch MD, 2005, J BIOL CHEM, V280, P24978, DOI 10.1074/jbc.M501565200; North BJ, 2003, MOL CELL, V11, P437, DOI 10.1016/S1097-2765(03)00038-8; Olia AS, 2015, ACS CHEM BIOL, V10, P2034, DOI 10.1021/acschembio.5b00342; OLSON KR, 1995, J CELL BIOL, V130, P639, DOI 10.1083/jcb.130.3.639; Rizzu P, 1999, AM J HUM GENET, V64, P414, DOI 10.1086/302256; Tracy TE, 2016, NEURON, V90, P245, DOI 10.1016/j.neuron.2016.03.005; TRINCZEK B, 1995, MOL BIOL CELL, V6, P1887, DOI 10.1091/mbc.6.12.1887; Vogelsberg-Ragaglia V, 2000, MOL BIOL CELL, V11, P4093, DOI 10.1091/mbc.11.12.4093; Wang JD, 2010, J BIOL CHEM, V285, P11458, DOI 10.1074/jbc.M109.087585; Yan Y, 2002, NAT STRUCT BIOL, V9, P862, DOI 10.1038/nsb849; Yang C, 2012, J BIOL CHEM, V287, P34917, DOI 10.1074/jbc.M112.359356; Yang C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032886; Yuan H, 2012, EMBO J, V31, P58, DOI 10.1038/emboj.2011.382; Zhu XY, 2016, SCI REP-UK, V6, DOI 10.1038/srep19926	43	11	13	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2016	11	12							e0168913	10.1371/journal.pone.0168913	http://dx.doi.org/10.1371/journal.pone.0168913			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI9TW	28002468	Green Submitted, gold, Green Published			2022-12-27	WOS:000392853100076
J	Kutal, M; Vana, M; Suchomel, J; Chapron, G; Lopez-Bao, JV				Kutal, Miroslav; Vana, Martin; Suchomel, Josef; Chapron, Guillaume; Vicente Lopez-Bao, Jose			Trans-Boundary Edge Effects in the Western Carpathians: The Influence of Hunting on Large Carnivore Occupancy	PLOS ONE			English	Article							WOLVES CANIS-LUPUS; SOURCE-SINK DYNAMICS; POPULATION-DYNAMICS; LYNX OCCURRENCE; WOLF; RANGE; CONSERVATION; DISPERSAL; MOUNTAINS; DENSITY	The conservation and management of wolves Canis lupus in the periphery of their distribution is challenging. Edges of wolf distribution are characterized by very few and intermittent occurrences of individuals, which are modulated by multiple factors affecting the overall population such as human-caused mortality, management targets and food availability. The knowledge of population dynamics in the edges becomes crucial when hunting takes place nearby the edges, which may preclude population expansion. Here, using as example the occurrence of wolves in the Beskydy Mountains (Czech-Slovak border), which are the edge distribution of the wolf and Eurasian lynx Lynx/ynxpopulations in the West Carpathians, we explored how food availability and hunting in the Slovakian core area affected the dynamics of wolves in the edges of this population. During 2003-2012, we monitored large carnivore occurrence by snow-tracking surveys and tested potential differences in the occurrence of these species in Beskydy Mountains and potential mechanisms behind detected patterns. Despite the proximity to the core area, with several wolf reproductions being confirmed at least in recent years, the wolf was a very rare species in Beskydy and was recorded 14 times less often than the lynx. The expected abundance of wolves in the Beskydy Mountains was inversely related to prey availability in the Slovakian core area. Wolf hunting the year before influenced the expected abundance of wolves in Beskydy area. We discuss how different life histories and legal status of both species probably account for most of the observed difference of occurrence at range margins.	[Kutal, Miroslav] Mendel Univ Brno, Fac Forestry & Wood Technol, Dept Forest Ecol, Brno, Czech Republic; [Kutal, Miroslav; Vana, Martin] Friends Earth Czech Republ, Olomouc Branch, Olomouc, Czech Republic; [Suchomel, Josef] Mendel Univ Brno, Fac Agron, Dept Zool Fisheries & Apiculture, Brno, Czech Republic; [Chapron, Guillaume] Swedish Univ Agr Sci SLU, Dept Ecol, Riddarhyttan, Sweden; [Vicente Lopez-Bao, Jose] Univ Oviedo, Res Unit Biodivers UO CSIC PA, Mieres, Spain	Mendel University in Brno; Mendel University in Brno; Swedish University of Agricultural Sciences; Consejo Superior de Investigaciones Cientificas (CSIC); University of Oviedo	Kutal, M (corresponding author), Mendel Univ Brno, Fac Forestry & Wood Technol, Dept Forest Ecol, Brno, Czech Republic.; Kutal, M (corresponding author), Friends Earth Czech Republ, Olomouc Branch, Olomouc, Czech Republic.	miroslav.kutal@hnutiduha.cz	VICENTE, LIERN/B-6112-2008; Suchomel, Josef/B-9609-2014; Kutal, Miroslav/B-9612-2014	VICENTE, LIERN/0000-0001-5883-9640; Suchomel, Josef/0000-0002-6455-135X; Kutal, Miroslav/0000-0003-3857-5419; Lopez-Bao, Jose Vicente/0000-0001-9213-998X	EuroNatur Foundation [CZ-14-470-1]; Swiss - Czech Cooperation Programme [67-BG-030]; Financial Mechanisms of EEA and Norway [333147]; Ministry of the Environment of the Czech Republic [102/7, 244/09/34]; European Outdoor Conservation Association; International Visegrad Fund [21110037]; Mendel University Brno [18/2013]; Spanish Ministry of Economy and Competitiveness [JCI-2012-13066]; Swedish Environmental Protection Agency	EuroNatur Foundation; Swiss - Czech Cooperation Programme; Financial Mechanisms of EEA and Norway; Ministry of the Environment of the Czech Republic; European Outdoor Conservation Association; International Visegrad Fund; Mendel University Brno; Spanish Ministry of Economy and Competitiveness(Spanish Government); Swedish Environmental Protection Agency	This work was supported by the EuroNatur Foundation (CZ-14-470-1: http://euronatur.org/) to MK, the Swiss - Czech Cooperation Programme (67-BG-030: http://www.swiss-contribution.cz/) to MK, the Financial Mechanisms of EEA and Norway (333147: http://eeagrants.cz/) to MK, the Ministry of the Environment of the Czech Republic (102/7 and 244/09/34: http://www.mzp.cz) to MK, the European Outdoor Conservation Association (http://www.outdoorconservation.eu/) to MK, the International Visegrad Fund (21110037: http://visegradfund.org/) to MK, an internal grant (18/2013) of the Mendel University Brno (http://www.mendelu.cz.) to MK, the Spanish Ministry of Economy and Competitiveness: (JCI-2012-13066: www.mineco.gob.es) to JVLB, and the Swedish Environmental Protection Agency (http://www.swedishepa.se/) to GC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams LG, 2008, WILDLIFE MONOGR, P1, DOI 10.2193/2008-012; Aikova M, 2016, PROGRAM STAROSTLIVOS; Andera Milos, 2004, Lynx (Prague), P5; Andersen LW, 2015, MAMMAL RES; Andreasen AM, 2012, MOL ECOL, V21, P5689, DOI 10.1111/j.1365-294X.2012.05740.x; [Anonymous], 2021, LANG ENV STAT COMP; Bartosova D, 1998, VERONICA, V12, P1; Boyd DK, 1999, J WILDLIFE MANAGE, V63, P1094, DOI 10.2307/3802828; Brainerd SM, 2008, J WILDLIFE MANAGE, V72, P89, DOI 10.2193/2006-305; Bridle JR, 2007, TRENDS ECOL EVOL, V22, P140, DOI 10.1016/j.tree.2006.11.002; Burbaite Lina, 2010, Acta Zoologica Lituanica, V20, P179, DOI 10.2478/v10043-010-0038-z; Burnham K. P., 2002, MODEL SELECTION MULT, V2nd; Carroll C, 2007, CONSERV BIOL, V21, P1092, DOI 10.1111/j.1523-1739.2007.00719.x; Cerveny Jaroslav, 2002, Acta Zoologica Lituanica, V12, P428; Chapron G, 2003, CR BIOL, V326, P575, DOI 10.1016/S1631-0691(03)00148-3; Chapron G, 2014, SCIENCE, V346, P1517, DOI 10.1126/science.1257553; Ciucci P, 2009, J WILDLIFE MANAGE, V73, P1300, DOI 10.2193/2008-510; Delibes M, 2001, AM NAT, V158, P277, DOI 10.1086/321319; Epstein Y., 2013, GEO INT ENV L, V25, P589; Epstein Y, 2016, CONSERV LETT, V9, P81, DOI 10.1111/conl.12200; European Commission, 2016, SPEC REP CAN IUP; Find'o S, 2008, PERSPECTIVES OF WOLVES IN CENTRAL EUROPE, P15; Fiske IJ, 2011, J STAT SOFTW, V43, P1; Fritts SH, 1981, WILDLIFE MONOGR, V80, P3; Hell P, 1974, TROFEJOVE SELMY SLOV; Hell P, 2003, VLKY RYSI OBLASTI SL, P5; Hell Pavel, 1996, Acta Scientiarum Naturalium Academiae Scientiarum Bohemicae Brno, V30, P64; Herfindal I, 2005, J ZOOL, V265, P63, DOI 10.1017/S0952836904006053; Hurford A, 2006, THEOR POPUL BIOL, V70, P244, DOI 10.1016/j.tpb.2006.06.009; Iliopoulos Y, 2014, EUR J WILDLIFE RES, V60, P23, DOI 10.1007/s10344-013-0746-3; Jedrzejewski W, 2005, ACTA THERIOL, V50, P417, DOI 10.1007/BF03192636; Jedrzejewski W, 2004, DIVERS DISTRIB, V10, P225, DOI 10.1111/j.1366-9516.2004.00073.x; Kaczensky P, 2009, MONITORING LARGE CAR; Knauer F, 2010, WILDLIFE BIOL, V16, P56, DOI 10.2981/07-040; Kovarik P, 2014, J NAT CONSERV, V22, P479, DOI 10.1016/j.jnc.2014.06.001; KRATOCHVIL J, 1968, Prirodovedne Prace Ustavu Ceskoslovenske Akademie Ved v Brne, V2, P35; Krofel M, 2015, SCIENCE, V350, P518, DOI 10.1126/science.350.6260.518-a; Kunc Ludvik, 1996, Acta Scientiarum Naturalium Academiae Scientiarum Bohemicae Brno, V30, P58; Kutal M, 2015, MONITORING STATUS CA, P52; Kutal M, 2014, VELKE SELMY MORAVE S, P108; Kutal M, 2013, ACTA MUSEI BESKIDENS, V5, P121; Kutal M, 2008, PERSPECTIVES OF WOLVES IN CENTRAL EUROPE, P10; Liberg O, 2012, P ROY SOC B-BIOL SCI, V279, P910, DOI 10.1098/rspb.2011.1275; Linnell JD, 2008, GUIDELINES POPULATIO; Linnell JDC, 2012, HYSTRIX, V23, P80, DOI 10.4404/hystrix-23.1-4676; Llaneza L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093015; Llaneza L, 2012, DIVERS DISTRIB, V18, P459, DOI 10.1111/j.1472-4642.2011.00869.x; Lopez-Bao JV, 2013, CONSERV LETT, V6, P448, DOI 10.1111/conl.12014; Marucco F, 2009, J APPL ECOL, V46, P1003, DOI 10.1111/j.1365-2664.2009.01696.x; Mech L. David, 2003, P1; Melis C, 2006, J BIOGEOGR, V33, P803, DOI 10.1111/j.1365-2699.2006.01434.x; Melis C, 2009, GLOBAL ECOL BIOGEOGR, V18, P724, DOI 10.1111/j.1466-8238.2009.00480.x; MESSIER F, 1985, CAN J ZOOL, V63, P239, DOI 10.1139/z85-037; Molinari-Jobin A., 2006, Acta Biologica Slovenica, V49, P3; Navarro LM, 2012, ECOSYSTEMS, V15, P900, DOI 10.1007/s10021-012-9558-7; Niedzialkowska M, 2006, BIOL CONSERV, V133, P63, DOI 10.1016/j.biocon.2006.05.022; Novaro AJ, 2005, J APPL ECOL, V42, P910, DOI 10.1111/j.1365-2664.2005.01067.x; Nowak S, 2008, FOLIA ZOOL, V57, P392; Nowak S, 2007, J ETHOL, V25, P231, DOI 10.1007/s10164-006-0015-y; Nowak S, 2016, MAMMAL RES, V61, P83, DOI 10.1007/s13364-016-0263-3; PETERSON RO, 1988, J MAMMAL, V69, P89, DOI 10.2307/1381751; Plhal R., 2012, Acta Universitatis Agriculturae et Silviculturae Mendelianae Brunensis, V60, P165; Post E, 2002, NATURE, V420, P168, DOI 10.1038/nature01064; Putman R.J., 2011, UNGULATE MANAGEMENT; RAY C, 1991, BIOL J LINN SOC, V42, P123, DOI 10.1111/j.1095-8312.1991.tb00555.x; Rigg R, 2014, REPORT DG ENV; Robinson HS, 2008, ECOL APPL, V18, P1028, DOI 10.1890/07-0352.1; Royle JA, 2004, BIOMETRICS, V60, P108, DOI 10.1111/j.0006-341X.2004.00142.x; Salvatori V, 2002, WILDLIFE BIOL, V8, P3, DOI 10.2981/wlb.2002.002; Schmidt K, 1998, ACTA THERIOL, V43, P391, DOI 10.4098/AT.arch.98-50; Selier SA Jeanetta, 2016, J INT WILDL LAW POLI, V19, P101, DOI DOI 10.1080/13880292.2016.1167460; Taggart-Hodge TD, 2016, ECOL SOC, V21, DOI 10.5751/ES-08669-210429; Lopez-Bao JV, 2015, BIODIVERS CONSERV, V24, P2105, DOI 10.1007/s10531-015-0914-8; Voskar J, 1976, LYNX PRAHA, V18, P99; Wabakken P, 2001, CAN J ZOOL, V79, P710, DOI 10.1139/cjz-79-4-710; Wabakken P, 2007, J WILDLIFE MANAGE, V71, P1631, DOI 10.2193/2006-222; Webb NF, 2011, CAN J ZOOL, V89, P744, DOI [10.1139/Z11-043, 10.1139/z11-043]; Woodroffe R, 1998, SCIENCE, V280, P2126, DOI 10.1126/science.280.5372.2126	78	9	9	1	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2016	11	12							e0168292	10.1371/journal.pone.0168292	http://dx.doi.org/10.1371/journal.pone.0168292			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI9TW	28002475	Green Published, Green Submitted, gold			2022-12-27	WOS:000392853100038
J	Villar, I; Alves, D; Mato, S				Villar, Iria; Alves, David; Mato, Salustiano			Seafood-Processing Sludge Composting: Changes to Microbial Communities and Physico-Chemical Parameters of Static Treatment versus for Turning during the Maturation Stage	PLoS One			English	Article							SEWAGE-SLUDGE; BACTERIAL COMMUNITIES; ORGANIC WASTES; FOOD WASTE; SOIL; NITROGEN; FATS; BIODEGRADATION; SUCCESSION; STABILITY	In general, in composting facilities the active, or intensive, stage of the process is done separately from the maturation stage, using a specific technology and time. The pre-composted material to be matured can contain enough biodegradable substrates to cause microbial proliferation, which in turn can cause temperatures to increase. Therefore, not controlling the maturation period during waste management at an industrial level can result in undesired outcomes. The main hypothesis of this study is that controlling the maturation stage through turning provides one with an optimized process when compared to the static approach. The waste used was sludge from a seafood-processing plant, mixed with shredded wood (1:2, v/v). The composting system consists of an intensive stage in a 600L static reactor, followed by maturation in triplicate in 200L boxes for 112 days. Two tests were carried out with the same process in reactor and different treatments in boxes: static maturation and turning during maturation when the temperature went above 55 degrees C. PLFAs, organic matter, pH, electrical conductivity, forms of nitrogen and carbon, hydrolytic enzymes and respiratory activity were periodically measured. Turning significantly increased the duration of the thermophilic phase and consequently increased the organic-matter degradation. PCA differentiated significantly the two treatments in function of tracking parameters, especially pH, total carbon, forms of nitrogen and C/N ratio. So, stability and maturity optimum values for compost were achieved in less time with turnings. Whereas turning resulted in microbial group stabilization and a low mono/sat ratio, static treatment produced greater variability in microbial groups and a high mono/sat ratio, the presence of more degradable substrates causes changes in microbial communities and their study during maturation gives an approach of the state of organic-matter degradation. Obtaining quality compost and optimizing the composting process requires using turning as a control mechanism during maturation.	[Villar, Iria; Alves, David; Mato, Salustiano] Univ Vigo, Dept Ecol & Anim Biol, Vigo, Pontevedra, Spain	Universidade de Vigo	Villar, I (corresponding author), Univ Vigo, Dept Ecol & Anim Biol, Vigo, Pontevedra, Spain.	iriavillar@uvigo.es	Mato, Salustiano/AAD-4640-2022; Villar, Iria/F-7693-2019	Villar, Iria/0000-0001-6311-6295	Xunta de Galicia [09MDS024310PR]	Xunta de Galicia(Xunta de GaliciaEuropean Commission)	This work was supported by Xunta de Galicia, 09MDS024310PR. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amir S, 2010, INT BIODETER BIODEGR, V64, P614, DOI 10.1016/j.ibiod.2010.01.012; [Anonymous], 1998, FEMS MICROBIOL ECOL, V27, P9; Alburquerque JA, 2009, BIODEGRADATION, V20, P257, DOI 10.1007/s10532-008-9218-y; APHA A.W., 2012, STAND METH EX WAT WA; Bastida F, 2008, APPL SOIL ECOL, V40, P318, DOI 10.1016/j.apsoil.2008.05.007; Bernal MP, 1998, BIORESOURCE TECHNOL, V63, P91, DOI 10.1016/S0960-8524(97)00084-9; Bossio DA, 1998, MICROBIAL ECOL, V35, P265, DOI 10.1007/s002489900082; Boulter-Bitzer JI, 2006, APPL SOIL ECOL, V34, P65, DOI 10.1016/j.apsoil.2005.12.007; Brito LM, 2008, BIORESOURCE TECHNOL, V99, P8955, DOI 10.1016/j.biortech.2008.05.005; CABRERA ML, 1993, SOIL SCI SOC AM J, V57, P1007, DOI 10.2136/sssaj1993.03615995005700040021x; Cahyani VR, 2003, SOIL SCI PLANT NUTR, V49, P619, DOI 10.1080/00380768.2003.10410052; Choi MH, 1998, LETT APPL MICROBIOL, V26, P175, DOI 10.1046/j.1472-765X.1998.00307.x; Cook KL, 2015, WASTE MANAG; Danon M, 2008, FEMS MICROBIOL ECOL, V65, P133, DOI 10.1111/j.1574-6941.2008.00506.x; Diaz L.F., 2002, HDB SOLID WASTE MANA, V2nd; EIVAZI F, 1977, SOIL BIOL BIOCHEM, V9, P167, DOI 10.1016/0038-0717(77)90070-0; EIVAZI F, 1988, SOIL BIOL BIOCHEM, V20, P601, DOI 10.1016/0038-0717(88)90141-1; Elouaqoudi FZ, 2015, INT BIODETER BIODEGR, V97, P75, DOI 10.1016/j.ibiod.2014.08.016; European Commission, 2001, WORK DOC BIOL TREATM; FERNANDES F, 1988, BIOL WASTE, V26, P33, DOI 10.1016/0269-7483(88)90147-4; Garcia-Morales JL, 2015, RESIDUOS AGROALIMENT; Gea T, 2007, BIOCHEM ENG J, V33, P275, DOI 10.1016/j.bej.2006.11.007; Getahun T, 2012, RESOUR CONSERV RECY, V65, P79, DOI 10.1016/j.resconrec.2012.05.007; Gomez-Brandon M, 2010, BIORESOURCE TECHNOL, V101, P1348, DOI 10.1016/j.biortech.2009.09.047; Green SJ, 2004, FEMS MICROBIOL LETT, V233, P115, DOI 10.1016/j.femsle.2004.01.049; Haug T.R., 1993, PRACTICAL HDB COMPOS; Iannotti D. A., 1993, Compost Science and Utilization, V1, P52; Insam H, 2007, WASTE MANAG SER, V8, P25; Jindo K, 2012, SCI TOTAL ENVIRON, V416, P476, DOI 10.1016/j.scitotenv.2011.12.009; Kassambara A., 2015, TACTOEXTRA VISUALIZA; LADD J N, 1972, Soil Biology and Biochemistry, V4, P19, DOI 10.1016/0038-0717(72)90038-7; Lin CSK, 2013, ENERG ENVIRON SCI, V6, P426, DOI 10.1039/c2ee23440h; MCKINLEY VL, 1985, APPL ENVIRON MICROB, V50, P1395, DOI 10.1128/AEM.50.6.1395-1403.1985; Nikaeen M, 2015, WASTE MANAGE, V39, P104, DOI 10.1016/j.wasman.2015.01.028; Ogunwande GA, 2008, BIORESOURCE TECHNOL, V99, P7495, DOI 10.1016/j.biortech.2008.02.020; Pinheiro J, 2015, NLME LINEAR NONLINEA; R Foundation for Statistical Computing, 2014, R LANG ENV STAT COMP; Ruggieri L, 2008, INT BIODETER BIODEGR, V62, P297, DOI 10.1016/j.ibiod.2008.02.004; Ryckeboer J, 2003, ANN MICROBIOL, V53, P349; Rynk R, 2000, BIOCYCLE, V41, P54; SIMS GK, 1995, COMMUN SOIL SCI PLAN, V26, P303, DOI 10.1080/00103629509369298; Sundberg C, 2004, BIORESOURCE TECHNOL, V95, P145, DOI 10.1016/j.biortech.2004.01.016; Tiquia SM, 1997, BIORESOURCE TECHNOL, V62, P37, DOI 10.1016/S0960-8524(97)00080-1; *TMECC, 2002, TEST METH EX COMP CO; Tuomela M, 2000, BIORESOURCE TECHNOL, V72, P169, DOI 10.1016/S0960-8524(99)00104-2; Vargas-Garcia MC, 2010, WASTE MANAGE, V30, P771, DOI 10.1016/j.wasman.2009.12.019; Villar I, 2016, WASTE MANAGE, V54, P83, DOI 10.1016/j.wasman.2016.05.011; Wong JWC, 2001, BIORESOURCE TECHNOL, V76, P99, DOI 10.1016/S0960-8524(00)00103-6; Zelles L, 1999, BIOL FERT SOILS, V29, P111, DOI 10.1007/s003740050533; Zucconi F., 1985, Composting of agricultural and other wastes, P73; ZUCCONI F, 1981, BIOCYCLE, V22, P54	51	6	7	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2016	11	12							e0168590	10.1371/journal.pone.0168590	http://dx.doi.org/10.1371/journal.pone.0168590			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI9TW	28002444	Green Submitted, gold, Green Published			2022-12-27	WOS:000392853100056
J	Liu, YL; Wang, LL; Feng, Y; He, CF; Liu, DY; Cai, XZ; Jiang, L; Chen, HS; Liu, C; Wu, H; Mei, LY				Liu, Yalan; Wang, Lili; Feng, Yong; He, Chufeng; Liu, Deyuan; Cai, Xinzhang; Jiang, Lu; Chen, Hongsheng; Liu, Chang; Wu, Hong; Mei, Lingyun			A New Genetic Diagnostic for Enlarged Vestibular Aqueduct Based on Next-Generation Sequencing	PLOS ONE			English	Article							PERFORMANCE LIQUID-CHROMATOGRAPHY; SENSORINEURAL HEARING-LOSS; SLC26A4 MUTATION SPECTRUM; PENDRED-SYNDROME; MISSENSE MUTATIONS; MOLECULAR ANALYSIS; PDS MUTATIONS; DEAFNESS; DFNB4; FOXI1	Enlarged vestibular aqueduct (EVA) is one of the most common congenital inner ear malformations and accounts for 1-12% of sensorineural deafness in children and adolescents. Multiple genetic defects contribute to EVA; therefore, early molecular diagnosis is critical for EVA patients to ensure that the most effective treatment strategies are employed. This study explored a new genetic diagnosis method for EVA and applied it to clinic diagnoses of EVA patients. Using next-generation sequencing technology, we set up a multiple polymerase chain reaction enrichment system for target regions of EVA pathogenic genes (SLC26A4, FOXI1, and KCNJ10). Forty-six EVA samples were sequenced by this system. Variants were detected in 87.0% (40/46) of cases, including three novel variants (SLC26A4 c.923_929de1, c.1002-8C>G, and FOXI1 c.519C>A). Biallelic potential pathogenic variants were detected in 27/46 patient samples, leading to a purported diagnostic rate of 59%. All results were verified by Sanger sequencing. Our target region capture system was validated to amplify and measure SLC26A4, FOXI1, and KCNJ10 in one reaction system. The result supplemented the mutation spectrum of EVA. Thus, this strategy is an economic, rapid, accurate, and reliable method with many useful applications in the clinical diagnosis of EVA patients.	[Liu, Yalan; Feng, Yong; He, Chufeng; Cai, Xinzhang; Jiang, Lu; Chen, Hongsheng; Liu, Chang; Wu, Hong; Mei, Lingyun] Cent S Univ, Xiangya Hosp, Dept Otolaryngol, Changsha, Hunan, Peoples R China; [Liu, Yalan; Feng, Yong; He, Chufeng; Cai, Xinzhang; Jiang, Lu; Chen, Hongsheng; Liu, Chang; Wu, Hong; Mei, Lingyun] Cent S Univ, Xiangya Hosp, Prov Key Lab Otolaryngol Crit Dis, Changsha, Hunan, Peoples R China; [Wang, Lili] Zhengzhou Univ, Affiliated Hosp 2, Dept Otolaryngol, Zhengzhou, Henan, Peoples R China; [Feng, Yong] Cent S Univ, State Key Lab Med Genet, Changsha, Hunan, Peoples R China; [Liu, Deyuan] Genesky Diagnost Inc, R&D Dept, Suzhou, Jiangsu, Peoples R China	Central South University; Central South University; Zhengzhou University; Central South University	Mei, LY (corresponding author), Cent S Univ, Xiangya Hosp, Dept Otolaryngol, Changsha, Hunan, Peoples R China.; Mei, LY (corresponding author), Cent S Univ, Xiangya Hosp, Prov Key Lab Otolaryngol Crit Dis, Changsha, Hunan, Peoples R China.	entmly@163.com	wang, lili/HDL-7210-2022; CAI, XINZHANG/GQZ-3111-2022	Chen, Hongsheng/0000-0002-1373-6434; CAI, XINZHANG/0000-0003-3211-7521; Feng, Yong/0000-0003-3824-3780	National Basic Research Program of China (973 Program) [2014CB943003]; National Nature Science Foundation of China [81470705, 81301172]; Special Scientific Research Fund for Public Welfare Industry of the Ministry of Health in China [201302001]; Natural Science Foundation of Hunan Province, China [14JJ7009]; Science and Technology Project of Hunan Province, China [52012F1023]; Genesky Diagnostics Inc	National Basic Research Program of China (973 Program)(National Basic Research Program of China); National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC)); Special Scientific Research Fund for Public Welfare Industry of the Ministry of Health in China; Natural Science Foundation of Hunan Province, China(Natural Science Foundation of Hunan Province); Science and Technology Project of Hunan Province, China; Genesky Diagnostics Inc	This study was partly supported by the National Basic Research Program of China (973 Program) (2014CB943003), the National Nature Science Foundation of China (81470705 and 81301172), the Special Scientific Research Fund for Public Welfare Industry of the Ministry of Health in China (201302001), the Natural Science Foundation of Hunan Province, China (14JJ7009), and the Science and Technology Project of Hunan Province, China (52012F1023). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Genesky Diagnostics Inc provided support in the form of salaries for author Deyuan Liu, but did not have any additional role in the research funding, study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of Deyuan Liu are articulated in the 'author contributions' section.	Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; Albert S, 2006, EUR J HUM GENET, V14, P773, DOI 10.1038/sj.ejhg.5201611; Anwar S, 2009, J HUM GENET, V54, P266, DOI 10.1038/jhg.2009.21; ARCAND P, 1991, J OTOLARYNGOL, V20, P247; Bogazzi F, 2004, J ENDOCRINOL INVEST, V27, P430, DOI 10.1007/BF03345286; Chen Dong-ye, 2007, Zhonghua Yi Xue Za Zhi, V87, P2820; Chen KT, 2014, J TRANSL MED, V12, DOI 10.1186/1479-5876-12-64; Chen KT, 2012, OTOLARYNG HEAD NECK, V146, P972, DOI 10.1177/0194599812439670; Choi BY, 2009, J MED GENET, V46, P856, DOI 10.1136/jmg.2009.067892; Choi BY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068692; Cirello V, 2012, MOL CELL ENDOCRINOL, V351, P342, DOI 10.1016/j.mce.2012.01.013; Coucke PJ, 1999, J MED GENET, V36, P475; Coyle B, 1998, HUM MOL GENET, V7, P1105, DOI 10.1093/hmg/7.7.1105; Dai Pu, 2006, Lin Chuang Er Bi Yan Hou Ke Za Zhi, V20, P147; Dale O, 1996, ACTA ANAESTH SCAND, V40, P771, DOI 10.1111/j.1399-6576.1996.tb04530.x; Everett LA, 2001, HUM MOL GENET, V10, P153, DOI 10.1093/hmg/10.2.153; Hu H, 2007, J HUM GENET, V52, P492, DOI 10.1007/s10038-007-0139-0; Jiang Lu, 2010, Lin Chung Er Bi Yan Hou Tou Jing Wai Ke Za Zhi, V24, P587; Jonard L, 2010, INT J PEDIATR OTORHI, V74, P1049, DOI 10.1016/j.ijporl.2010.06.002; Kim KM, 2014, INT J SYST EVOL MICR, V64, P333, DOI 10.1099/ijs.0.054221-0; Koboldt DC, 2012, GENOME RES, V22, P568, DOI 10.1101/gr.129684.111; Lai CC, 2007, METABOLISM, V56, P1279, DOI 10.1016/j.metabol.2007.05.013; Landa P, 2013, BMC MED GENET, V14, DOI 10.1186/1471-2350-14-85; Li H, 2010, BIOINFORMATICS, V26, P589, DOI 10.1093/bioinformatics/btp698; Li XC, 1998, NAT GENET, V18, P215, DOI 10.1038/ng0398-215; Lim L, 2011, OTOL NEUROTOL, V32, P1464, DOI 10.1097/MAO.0b013e318232e370; Massa G, 2003, EUR J PEDIATR, V162, P674, DOI 10.1007/s00431-003-1281-0; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; Men Meichao, 2011, Zhong Nan Da Xue Xue Bao Yi Xue Ban, V36, P1079, DOI 10.3969/j.issn.1672-7347.2011.11.008; Ng PC, 2003, NUCLEIC ACIDS RES, V31, P3812, DOI 10.1093/nar/gkg509; Park HJ, 2003, J MED GENET, V40, P242, DOI 10.1136/jmg.40.4.242; Prasad S, 2004, AM J MED GENET A, V124A, P1, DOI 10.1002/ajmg.a.20272; Preissler R, 2013, ANIM GENET, V44, P502, DOI 10.1111/age.12047; Saliba I, 2012, INT J PEDIATR OTORHI, V76, P492, DOI 10.1016/j.ijporl.2012.01.004; Schuster SC, 2008, NAT METHODS, V5, P16, DOI [10.1038/nmeth1156, 10.1038/NMETH1156]; Schwarz JM, 2010, NAT METHODS, V7, P575, DOI 10.1038/nmeth0810-575; Tekin D, 2016, HEARING RES, V333, P179, DOI 10.1016/j.heares.2016.01.018; Usami S, 1999, HUM GENET, V104, P188, DOI 10.1007/s004390050933; Van Hauwe P, 1998, HUM MOL GENET, V7, P1099, DOI 10.1093/hmg/7.7.1099; Wang K, 2010, NUCLEIC ACIDS RES, V38, P7248, DOI 10.1093/nar/gkq601; Wang QJ, 2007, CLIN GENET, V72, P245, DOI 10.1111/j.1399-0004.2007.00862.x; Wu CC, 2005, LARYNGOSCOPE, V115, P1060, DOI 10.1097/01.MLG.0000163339.61909.D0; Wu CC, 2010, AUDIOL NEURO-OTOL, V15, P57, DOI 10.1159/000231567; Wu H, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0151909; Xuan JK, 2013, CANCER LETT, V340, P284, DOI 10.1016/j.canlet.2012.11.025; Yan D, 2013, GENET TEST MOL BIOMA, V17, P581, DOI 10.1089/gtmb.2012.0464; Yang T, 2007, AM J HUM GENET, V80, P1055, DOI 10.1086/518314; Yang T, 2009, AM J HUM GENET, V84, P651, DOI 10.1016/j.ajhg.2009.04.014; Yuan Huijun, 2014, Yichuan, V36, P1112, DOI 10.3724/SP.J.1005.2014.1112; Zhao JD, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108134; Zhao Juan, 2009, Zhonghua Yixue Yichuanxue Zazhi, V26, P21, DOI 10.3760/cma.j.issn.1003-9406.2009.01.005	51	17	22	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2016	11	12							e0168508	10.1371/journal.pone.0168508	http://dx.doi.org/10.1371/journal.pone.0168508			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI9QF	27997596	Green Published, Green Submitted, gold			2022-12-27	WOS:000392842900053
J	Sun, Y; Ke, HZ; Han, MY; Chen, N; Fang, WH; Yoo, D				Sun, Yan; Ke, Hanzhong; Han, Mingyuan; Chen, Ning; Fang, Weihuan; Yoo, Dongwan			Nonstructural Protein 11 of Porcine Reproductive and Respiratory Syndrome Virus Suppresses Both MAVS and RIG-I Expression as One of the Mechanisms to Antagonize Type I Interferon Production	PLOS ONE			English	Article							MOUSE HEPATITIS-VIRUS; NS1 PROTEIN; ANTIVIRAL RESPONSES; CRYSTAL-STRUCTURE; SARS-CORONAVIRUS; RNA-BINDING; ENDORIBONUCLEASE; INHIBITION; INDUCTION; VIVO	Type I interferons (IFN-alpha/beta) play a key role in antiviral defense, and porcine reproductive and respiratory syndrome virus (PRRSV) is known to down-regulate the IFN response in virus-infected cells and pigs. In this study, we showed that the overexpression of nsp11 of PRRSV induced a strong suppression of IFN production. Nsp11 suppressed both IRF3 and NF-KB activities when stimulated with a dsRNA analogue and TNF-alpha, respectively. This suppression was RLR dependent, since the transcripts and proteins of MAVS and RIG-I, two critical factors in RLR-mediated pathway, were both found to be reduced in the presence of overexpressed nsp11. Since nsp11 is an endoribonuclease (EndoU), the structure function relationship was examined using a series of nsp11 EndoU mutant plasmids. The mutants that impaired the EndoU activity failed to suppress IFN and led to the normal expression of MAVS. Seven single amino acid substitutions (4 in subdomain A and 3 in subdomain B) plus one insertion (frame-shift in nsp11) were then introduced into PRRSV infectious cDNA clones to generate nsp11 mutant viruses. Unfortunately, all EndoU knock-out nsp11 mutant viruses appeared replication-defective and no progenies were produced. Three mutations in EndoU subdomain A expressed the N and nsp2/3 proteins but their infectivity diminished after 2 passages. Taken together, our data show that PRRSV nsp11 endoribonuclease activity is critical for both viral replication and IFN antagonism. More importantly, the endoribonuclease activity of nsp11 demonstrates the substrate specificity towards MAVS and RIG-I (transcripts and proteins) over p65 and IRF3 in the context of gene transfection and overexpression. This is likely a mechanism of nsp11 suppression of type I IFN production.	[Sun, Yan; Ke, Hanzhong; Han, Mingyuan; Chen, Ning; Yoo, Dongwan] Univ Illinois, Dept Pathobiol, Urbana, IL 61801 USA; [Fang, Weihuan] Zhejiang Univ, Inst Prevent Vet Med, Hangzhou, Zhejiang, Peoples R China; [Sun, Yan] Univ Penn, Dept Pathobiol, Philadelphia, PA 19104 USA; [Han, Mingyuan] Univ Michigan, Dept Pediat, Ann Arbor, MI 48109 USA; [Han, Mingyuan] Univ Michigan, Dept Communicable Dis, Ann Arbor, MI 48109 USA; [Chen, Ning] BI Vet R&D Ctr, Shanghai, Peoples R China	University of Illinois System; University of Illinois Urbana-Champaign; Zhejiang University; University of Pennsylvania; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Yoo, D (corresponding author), Univ Illinois, Dept Pathobiol, Urbana, IL 61801 USA.	dyoo@illinois.edu	Yoo, Dongwan/AAG-8884-2021; Han, Mingyuan/O-5065-2019	Yoo, Dongwan/0000-0002-6730-9729; Han, Mingyuan/0000-0002-2970-6715; Ke, Hanzhong/0000-0001-8148-2897	Agriculture and Food Research Initiative (AFRI) Competitive Grants of US Department of Agriculture NIFA (National Institute of Food and Agriculture) [2008-35204-04634, 2013-67015-21243]	Agriculture and Food Research Initiative (AFRI) Competitive Grants of US Department of Agriculture NIFA (National Institute of Food and Agriculture)	This project was supported by funding to DY by the Agriculture and Food Research Initiative (AFRI) Competitive Grants (no. 2008-35204-04634 and no. 2013-67015-21243) of US Department of Agriculture NIFA (National Institute of Food and Agriculture). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BENFIELD DA, 1992, J VET DIAGN INVEST, V4, P127, DOI 10.1177/104063879200400202; Beura LK, 2010, J VIROL, V84, P1574, DOI 10.1128/JVI.01326-09; Bhardwaj K, 2004, J VIROL, V78, P12218, DOI 10.1128/JVI.78.22.12218-12224.2004; Bowie AG, 2008, NAT REV IMMUNOL, V8, P911, DOI 10.1038/nri2436; Buddaert W, 1998, ADV EXP MED BIOL, V440, P461; Cao JZ, 2012, VIRUS RES, V167, P247, DOI 10.1016/j.virusres.2012.05.006; De Clercq E, 2006, J INFECT DIS, V194, pS19, DOI 10.1086/505351; Fang Y, 2012, VIROL J, V9, DOI 10.1186/1743-422X-9-83; Feng PH, 2001, J VIROL, V75, P10272, DOI 10.1128/JVI.75.21.10272-10280.2001; Firth AE, 2011, J GEN VIROL, V92, P1097, DOI 10.1099/vir.0.029264-0; Frieman M, 2009, J VIROL, V83, P6689, DOI 10.1128/JVI.02220-08; Garcia-Sastre A, 2004, CURR TOP MICROBIOL, V283, P249; Genini S, 2008, J GEN VIROL, V89, P2550, DOI 10.1099/vir.0.2008/003244-0; Gorbalenya AE, 2006, VIRUS RES, V117, P17, DOI 10.1016/j.virusres.2006.01.017; Haller O, 2007, CURR TOP MICROBIOL, V316, P315; Huang C, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002433; Ivanov KA, 2004, P NATL ACAD SCI USA, V101, P12694, DOI 10.1073/pnas.0403127101; Jacobs BL, 1998, METHODS, V15, P225, DOI 10.1006/meth.1998.0626; Johnson CR, 2011, J GEN VIROL, V92, P1107, DOI 10.1099/vir.0.030213-0; Joseph JS, 2007, J VIROL, V81, P6700, DOI 10.1128/JVI.02817-06; Kang H, 2007, J VIROL, V81, P13587, DOI 10.1128/JVI.00547-07; Keffaber K., 1989, AM ASS SWINE PRACT N, V1, P1; KIM HS, 1993, ARCH VIROL, V133, P477, DOI 10.1007/BF01313785; Kim O, 2010, VIROLOGY, V402, P315, DOI 10.1016/j.virol.2010.03.039; Laneve P, 2003, J BIOL CHEM, V278, P13026, DOI 10.1074/jbc.M211937200; Langland JO, 2006, VIRUS RES, V119, P100, DOI 10.1016/j.virusres.2005.10.014; Lee SM, 2004, VET IMMUNOL IMMUNOP, V102, P217, DOI 10.1016/j.vetimm.2004.09.009; Li SD, 2006, VIROLOGY, V349, P13, DOI 10.1016/j.virol.2006.01.005; Magkouras I, 2008, J GEN VIROL, V89, P2501, DOI 10.1099/vir.0.2008/003749-0; Min JY, 2006, P NATL ACAD SCI USA, V103, P7100, DOI 10.1073/pnas.0602184103; Nedialkova DD, 2009, J VIROL, V83, P5671, DOI 10.1128/JVI.00261-09; Panne D, 2007, CELL, V129, P1111, DOI 10.1016/j.cell.2007.05.019; Pichlmair A, 2006, SCIENCE, V314, P997, DOI 10.1126/science.1132998; Posthuma CC, 2006, J VIROL, V80, P1653, DOI 10.1128/JVI.80.4.1653-1661.2006; Randall RE, 2008, J GEN VIROL, V89, P1, DOI 10.1099/vir.0.83391-0; Rascon-Castelo E, 2015, VIRUSES-BASEL, V7, P873, DOI 10.3390/v7030873; Ricagno S, 2006, P NATL ACAD SCI USA, V103, P11892, DOI 10.1073/pnas.0601708103; Sadler AJ, 2008, NAT REV IMMUNOL, V8, P559, DOI 10.1038/nri2314; Saffran HA, 2010, J VIROL, V84, P6041, DOI 10.1128/JVI.01819-09; Samuel CE, 2001, CLIN MICROBIOL REV, V14, P778, DOI 10.1128/CMR.14.4.778-809.2001; Shi XB, 2011, MOL IMMUNOL, V48, P1568, DOI 10.1016/j.molimm.2011.03.004; Shi YJ, 2016, J VIROL, V90, P4579, DOI 10.1128/JVI.03065-15; Siu KL, 2009, J BIOL CHEM, V284, P16202, DOI 10.1074/jbc.M109.008227; Snijder EJ, 2003, J MOL BIOL, V331, P991, DOI 10.1016/S0022-2836(03)00865-9; Solorzano A, 2005, J VIROL, V79, P7535, DOI 10.1128/JVI.79.12.7535-7543.2005; Song C, 2010, VIROLOGY, V407, P268, DOI 10.1016/j.virol.2010.08.025; Sun Y, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/430508; Sun Y, 2012, VIRUSES-BASEL, V4, P424, DOI 10.3390/v4040424; Sun Z, 2012, J VIROL, V86, P3839, DOI 10.1128/JVI.06466-11; Truong HM, 2004, VIROLOGY, V325, P308, DOI 10.1016/j.virol.2004.04.046; van Aken D, 2006, J GEN VIROL, V87, P3473, DOI 10.1099/vir.0.82269-0; Wathelet MG, 2007, J VIROL, V81, P11620, DOI 10.1128/JVI.00702-07; Weber F, 2007, BIOCHIMIE, V89, P836, DOI 10.1016/j.biochi.2007.01.005; Welsch C, 2015, J HEPATOL, V62, P779, DOI 10.1016/j.jhep.2014.11.009; XIAO JH, 1991, CELL, V65, P551, DOI 10.1016/0092-8674(91)90088-G; Xu AT, 2010, BIOTECHNOL LETT, V32, P1905, DOI 10.1007/s10529-010-0370-1; Xu XL, 2006, J VIROL, V80, P7909, DOI 10.1128/JVI.00525-06; Yoo D, 2010, VIRUS RES, V154, P48, DOI 10.1016/j.virusres.2010.07.019; Zhou HX, 2007, J VIROL, V81, P568, DOI 10.1128/JVI.01512-06	59	38	42	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2016	11	12							e0168314	10.1371/journal.pone.0168314	http://dx.doi.org/10.1371/journal.pone.0168314			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI9QF	27997564	Green Published, gold, Green Submitted			2022-12-27	WOS:000392842900032
J	Zhang, ZY; Li, C; Gao, W; Yin, XW; Luo, QF; Liu, N; Basnet, S; Dai, ZL; Ge, HY				Zhang, Zhen-yu; Li, Cong; Gao, Wei; Yin, Xiao-wei; Luo, Qi-feng; Liu, Nan; Basnet, Shiva; Dai, Zhen-ling; Ge, Hai-yan			A Nomogram to Predict Adequate Lymph Node Recovery before Resection of Colorectal Cancer	PLOS ONE			English	Article							COMPLETE MESOCOLIC EXCISION; LONG-TERM SURVIVAL; COLON-CANCER; MICROSATELLITE INSTABILITY; INFLAMMATORY RESPONSES; PROGNOSTIC VALUE; TUMOR NECROSIS; COUNT; SURGERY; LYMPHADENECTOMY	Increased lymph node count (LNC) has been associated with prolonged survival in colorectal cancer (CRC), but the underlying mechanisms are still poorly understood. The study aims to identify new predictors and develop a preoperative nomogram for predicting the probability of adequate LNC (>= 12). 501 eligible patients were retrospectively selected to identify clinical-pathological factors associated with LNC >= 12 through univariate and multivariate logistic regression analyses. The nomogram was built according to multivariate analyses of preoperative factors. Model performance was assessed with concordance index (c-index) and area under the receiver operating characteristic curve (AUC), followed by internal validation and calibration using 1000-resample bootstrapping. Clinical validity of the nomogram and LNC impact on stage migration were also evaluated. Multivariate analyses showed patient age, CA19-9, circulating lymphocytes, neutrophils, platelets, tumor diameter, histology and deposit significantly correlated with LNC (P < 0.05). The effects were marginal for CEA, anemia and CRC location (0.05 < P < 0.1). The multivariate analyses of preoperative factors suggested decreased age, CEA, CA19-9, neutrophils, proximal location, and increased platelets and diameter were significantly associated with increased probability of LNC >= 12 (P < 0.05). The nomogram achieved c-indexes of 0.75 and 0.73 before and after correction for overfitting. The AUC was 0.75 (95% CI, 0.70-0.79) and the clinically valid threshold probabilities were between 10% and 60% for the nomogram to predict LNC < 12. Additionally, increased probability of adequate LNC before surgery was associated with increased LNC and negative lymph nodes rather than increased positive lymph nodes, lymph node ratio, pN stages or AJCC stages. Collectively, the results indicate the LNC is multifactorial and irrelevant to stage migration. The significant correlations with preoperative circulating markers may provide new explanations for LNC-related survival advantage which is reflected by the implication of regional and systemic antitumor immune responses.	[Zhang, Zhen-yu; Gao, Wei; Luo, Qi-feng; Liu, Nan; Basnet, Shiva; Dai, Zhen-ling; Ge, Hai-yan] Tongji Univ, Sch Med, Shanghai East Hosp, Dept Gastrointestinal Surg, Shanghai, Peoples R China; [Li, Cong] Tongji Univ, Sch Med, Shanghai East Hosp, Dept Spine Surg, Shanghai, Peoples R China; [Yin, Xiao-wei] Fudan Univ, Zhongshan Hosp, Dept Gen Surg, Qingpu Branch, Shanghai, Peoples R China	Tongji University; Tongji University; Fudan University	Ge, HY (corresponding author), Tongji Univ, Sch Med, Shanghai East Hosp, Dept Gastrointestinal Surg, Shanghai, Peoples R China.	gesurgery@163.com	Gao, Wei/GXH-0380-2022	Basnet, Shiva/0000-0002-6989-911X	Shanghai Science Committee Foundation [34119b0600, 16411970800]; Shanghai Municipal Health Bureau [20134194]; Jiaxing Science Committee Foundation of Zhejiang province [2015AY23071]; Technology Plan Project of Medicine and Health in Zhejiang Province [2016KYB295]	Shanghai Science Committee Foundation; Shanghai Municipal Health Bureau; Jiaxing Science Committee Foundation of Zhejiang province; Technology Plan Project of Medicine and Health in Zhejiang Province	This study was supported by grants from the Shanghai Science Committee Foundation (HYG, no. 34119b0600, no. 16411970800, official website: http://www.stcsm.gov.cn/), Shanghai Municipal Health Bureau (HYG, no. 20134194, official website: http://www.wsjsw.gov.cn/wsj/), Jiaxing Science Committee Foundation of Zhejiang province (HYG, no. 2015AY23071, official website: http.//www.jxkij.gov.cn/) and the Technology Plan Project of Medicine and Health in Zhejiang Province (HYG, no. 2016KYB295, official website: http://www.zjkit.gov.cn/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Belt EJT, 2012, ANN SURG ONCOL, V19, P1222, DOI 10.1245/s10434-011-2091-7; Bertelsen CA, 2015, LANCET ONCOL, V16, P161, DOI 10.1016/S1470-2045(14)71168-4; Budde CN, 2014, J AM COLL SURGEONS, V218, P1004, DOI 10.1016/j.jamcollsurg.2014.01.039; Bui L, 2006, J SURG ONCOL, V93, P439, DOI 10.1002/jso.20499; Chapman B, 2013, DIS COLON RECTUM, V56, P1028, DOI 10.1097/DCR.0b013e31829c41ba; Chen LL, 2014, DIS COLON RECTUM, V57, P432, DOI 10.1097/DCR.0000000000000052; Compton CC, 2000, ARCH PATHOL LAB MED, V124, P979; Compton CC, 2004, CA-CANCER J CLIN, V54, P295, DOI 10.3322/canjclin.54.6.295; De Smedt L, 2015, BRIT J CANCER, V113, P500, DOI 10.1038/bjc.2015.213; Denlinger CS, 2016, J NATL COMPR CANC NE, V14, P715, DOI 10.6004/jnccn.2016.0073; Drescher KM, 2009, FAM CANCER, V8, P231, DOI 10.1007/s10689-009-9233-0; Guthrie GJK, 2013, BRIT J CANCER, V109, P131, DOI 10.1038/bjc.2013.291; Guthrie GJK, 2013, CANCER TREAT REV, V39, P89, DOI 10.1016/j.ctrv.2012.07.003; Hari DM, 2013, J AM COLL SURGEONS, V217, P181, DOI 10.1016/j.jamcollsurg.2013.04.018; Ishizuka M, 2013, BRIT J CANCER, V109, P401, DOI 10.1038/bjc.2013.350; Jakub JW, 2009, ARCH SURG-CHICAGO, V144, P1115, DOI 10.1001/archsurg.2009.210; Johnson PM, 2006, J CLIN ONCOL, V24, P3570, DOI 10.1200/JCO.2006.06.8866; Killeen S, 2014, COLORECTAL DIS, V16, P577, DOI 10.1111/codi.12616; Li Destri G, 2014, WORLD J GASTROENTERO, V20, P1951, DOI 10.3748/wjg.v20.i8.1951; Liang JT, 2015, SURG ENDOSC, V29, P2394, DOI 10.1007/s00464-014-3940-9; Ling Khoon Lin, 2007, Cancer Immun, V7, P7; Lykke J, 2013, COLORECTAL DIS, V15, P559, DOI 10.1111/codi.12059; Mathis KL, 2013, ANN SURG, V257, P102, DOI 10.1097/SLA.0b013e318260a8e6; Moore J, 2010, SURGERY, V147, P358, DOI 10.1016/j.surg.2009.10.003; Murphy B, 2014, IRISH J MED SCI, V183, pS23; Nagtegaal ID, 2015, HISTOPATHOLOGY, V66, P102, DOI 10.1111/his.12563; Nash GM, 2011, ANN SURG, V253, P318, DOI 10.1097/SLA.0b013e318204e637; Ogino S, 2009, CLIN CANCER RES, V15, P6412, DOI 10.1158/1078-0432.CCR-09-1438; Popat S, 2005, J CLIN ONCOL, V23, P609, DOI 10.1200/JCO.2005.01.086; Quirke P, 2011, VIRCHOWS ARCH, V458, P1, DOI 10.1007/s00428-010-0977-6; Roxburgh CSD, 2010, COLORECTAL DIS, V12, P987, DOI 10.1111/j.1463-1318.2009.01961.x; Roxburgh CSD, 2009, ANN SURG, V249, P788, DOI 10.1097/SLA.0b013e3181a3e738; Saha S, 2015, AM J SURG, V209, P570, DOI 10.1016/j.amjsurg.2014.12.008; Sasaki K, 2012, WORLD J SURG, V36, P192, DOI 10.1007/s00268-011-1329-7; Schmoll HJ, 2012, ANN ONCOL, V23, P2479, DOI 10.1093/annonc/mds236; Sjo OH, 2012, DIS COLON RECTUM, V55, P307, DOI 10.1097/DCR.0b013e3182423f62; The Helsinki Declaration of the World Medical Association (WMA), 2014, POL MERKUR LEKARSKI, V36, P298; Troxler M, 2007, BRIT J SURG, V94, P674, DOI 10.1002/bjs.5852; Wang DL, 2015, TUMOR BIOL, V36, P5407, DOI 10.1007/s13277-015-3206-8; Willaert W, 2014, CANCER TREAT REV, V40, P405, DOI 10.1016/j.ctrv.2013.09.013; Wong JH, 2011, J AM COLL SURGEONS, V213, P226, DOI 10.1016/j.jamcollsurg.2011.05.003; Xu BL, 2015, ONCOTARGET, V6, P20592, DOI 10.18632/oncotarget.4112	42	2	3	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2016	11	12							e0168156	10.1371/journal.pone.0168156	http://dx.doi.org/10.1371/journal.pone.0168156			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI8LN	27992611	Green Submitted, gold, Green Published			2022-12-27	WOS:000392758000028
J	Mesarwi, OA; Shin, MK; Bevans-Fonti, S; Schlesinger, C; Shaw, J; Polotsky, VY				Mesarwi, Omar A.; Shin, Mi-Kyung; Bevans-Fonti, Shannon; Schlesinger, Christina; Shaw, Janet; Polotsky, Vsevolod Y.			Hepatocyte Hypoxia Inducible Factor-1 Mediates the Development of Liver Fibrosis in a Mouse Model of Nonalcoholic Fatty Liver Disease	PLOS ONE			English	Article							OBSTRUCTIVE SLEEP-APNEA; CHRONIC INTERMITTENT HYPOXIA; HEPATIC STELLATE CELLS; LYSYL OXIDASE; OBESE-PATIENTS; MICE; STEATOHEPATITIS; METABOLISM; ACTIVATION; EXPRESSION	Background Obstructive sleep apnea (OSA) is associated with the progression of non-alcoholic fatty liver disease (NAFLD) to steatohepatitis and fibrosis. This progression correlates with the severity of OSA-associated hypoxia. In mice with diet induced obesity, hepatic steatosis leads to liver tissue hypoxia, which worsens with exposure to intermittent hypoxia. Emerging data has implicated hepatocyte cell signaling as an important factor in hepatic fibrogenesis. We hypothesized that hepatocyte specific knockout of the oxygen sensing a subunit of hypoxia inducible factor-1 (HIF-1), a master regulator of the global response to hypoxia, may be protective against the development of liver fibrosis. Methods Wild-type mice and mice with hepatocyte-specific HI F-1 a knockout (Hifla(-/-)hep) were fed a high trans-fat diet for six months, as a model of NAFLD. Hepatic fibrosis was evaluated by Sirius red stain and hydroxyproline assay. Liver enzymes, fasting insulin, and hepatic triglyceride content were also assessed. Hepatocytes were isolated from Hifla(-/-)hep mice and wild-type controls and were exposed to sustained hypoxia (1% 02) or normoxia (16% 02) for 24 hours. The culture media was used to reconstitute type I collagen and the resulting matrices were examined for collagen cross-linking. Results Wild-type mice on a high trans-fat diet had 80% more hepatic collagen than Hifla(-/-)hep mice (2.21 pg collagen/mg liver tissue, versus 1.23 pg collagen/mg liver tissue, p = 0.03), which was confirmed by Sirius red staining. Body weight, liver weight, mean hepatic triglyceride content, and fasting insulin were similar between groups. Culture media from wild-type mouse hepatocytes exposed to hypoxia allowed for avid collagen cross-linking, but very little cross-linking was seen when hepatocytes were exposed to normoxia, or when hepatocytes from Hifla(-/-)hep mice were used in hypoxia or normoxia. Conclusions Hepatocyte HIF-1 mediates an increase in liver fibrosis in a mouse model of NAFLD, perhaps due to liver tissue hypoxia in hepatic steatosis. HIF-1 is necessary for collagen cross linking in an in vitro model of fibrosis.	[Mesarwi, Omar A.] Univ Calif San Diego, Sch Med, Dept Med, San Diego, CA 92103 USA; [Shin, Mi-Kyung; Bevans-Fonti, Shannon; Schlesinger, Christina; Polotsky, Vsevolod Y.] Johns Hopkins Univ, Sch Med, Dept Med, Baltimore, MD 21205 USA; [Shaw, Janet] Joint Pathol Ctr, Bethesda, MD USA	University of California System; University of California San Diego; Johns Hopkins University	Mesarwi, OA (corresponding author), Univ Calif San Diego, Sch Med, Dept Med, San Diego, CA 92103 USA.	omesarwi@ucsd.edu			National Institutes of Health [R01HL080105, T32HL007534, T32HL110952]; ResMed Foundation [90048207]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL133100, R01HL080105] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P50ES018176] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ResMed Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported by: 1. National Institutes of Health (http://www.nhlbi.nih.gov/): R01HL080105 (VP), T32HL007534 (OM, institutional grant), T32HL110952 (OM, institutional grant). 2. ResMed Foundation (http://www.resmedfoundation.org/): 90048207 (VP).	Angulo P, 2015, GASTROENTEROLOGY, V149, P389, DOI 10.1053/j.gastro.2015.04.043; Aron-Wisnewsky J, 2012, J HEPATOL, V56, P225, DOI 10.1016/j.jhep.2011.04.022; Brenner David A, 2009, Trans Am Clin Climatol Assoc, V120, P361; Browning JD, 2004, HEPATOLOGY, V40, P1387, DOI 10.1002/hep.20466; Carabelli J, 2011, J CELL MOL MED, V15, P1329, DOI 10.1111/j.1582-4934.2010.01128.x; Carpino G, 2005, DIGEST LIVER DIS, V37, P349, DOI 10.1016/j.dld.2004.11.009; Clapper JR, 2013, AM J PHYSIOL-GASTR L, V305, pG483, DOI 10.1152/ajpgi.00079.2013; Copple BL, 2012, J PHARMACOL EXP THER, V341, P307, DOI 10.1124/jpet.111.189340; Copple BL, 2011, LIVER INT, V31, P230, DOI 10.1111/j.1478-3231.2010.02347.x; Copple BL, 2009, LIVER INT, V29, P1010, DOI 10.1111/j.1478-3231.2009.02015.x; da Rosa DP, 2012, MEDIAT INFLAMM, V2012, DOI 10.1155/2012/879419; Dempsey JA, 2010, PHYSIOL REV, V90, P47, DOI 10.1152/physrev.00043.2008; Elpek GO, 2014, WORLD J GASTROENTERO, V20, P7260, DOI 10.3748/wjg.v20.i23.7260; Erler JT, 2006, NATURE, V440, P1222, DOI 10.1038/nature04695; Higgins DF, 2007, J CLIN INVEST, V117, P3810, DOI 10.1172/JCI30487; Jaakkola P, 2001, SCIENCE, V292, P468, DOI 10.1126/science.1059796; Jouet P, 2007, OBES SURG, V17, P478, DOI 10.1007/s11695-007-9085-3; Kagan HM, 2003, J CELL BIOCHEM, V88, P660, DOI 10.1002/jcb.10413; Kallivitz ER, 2007, J CLIN GASTROENTEROL, V41, P918, DOI 10.1097/01.mcg.0000225692.62121.55; Li WC, 2010, METHODS MOL BIOL, V633, P185, DOI 10.1007/978-1-59745-019-5_13; Mantena SK, 2009, BIOCHEM J, V417, P183, DOI 10.1042/BJ20080868; McCullough Arthur J, 2004, Clin Liver Dis, V8, P521, DOI 10.1016/j.cld.2004.04.004; Mesarwi OA, 2015, SLEEP, V38, P1583, DOI 10.5665/sleep.5052; Moon JO, 2009, AM J PHYSIOL-GASTR L, V296, pG582, DOI 10.1152/ajpgi.90368.2008; MURAWAKI Y, 1991, HEPATOLOGY, V14, P1167, DOI 10.1002/hep.1840140635; NEUMAN RE, 1950, J BIOL CHEM, V184, P299; Nobili V, 2014, AM J RESP CRIT CARE, V189, P66, DOI 10.1164/rccm.201307-1339OC; Ochiai D, 2011, BIOCHEM BIOPH RES CO, V415, P445, DOI 10.1016/j.bbrc.2011.10.089; Polotsky VY, 2009, AM J RESP CRIT CARE, V179, P228, DOI 10.1164/rccm.200804-608OC; Postic C, 1999, J BIOL CHEM, V274, P305, DOI 10.1074/jbc.274.1.305; Qu AJ, 2011, HEPATOLOGY, V54, P472, DOI 10.1002/hep.24400; Rankin EB, 2009, MOL CELL BIOL, V29, P4527, DOI 10.1128/MCB.00200-09; Reinke C, 2011, J APPL PHYSIOL, V111, P881, DOI 10.1152/japplphysiol.00492.2011; Savransky V, 2007, AM J PHYSIOL-GASTR L, V293, pG871, DOI 10.1152/ajpgi.00145.2007; Savransky V, 2007, HEPATOLOGY, V45, P1007, DOI 10.1002/hep.21593; Semenza GL, 2006, EXP PHYSIOL, V91, P803, DOI 10.1113/expphysiol.2006.033498; SIEGEL RC, 1978, P NATL ACAD SCI USA, V75, P2945, DOI 10.1073/pnas.75.6.2945; Suzuki T, 2014, WORLD J GASTROENTERO, V20, P15087, DOI 10.3748/wjg.v20.i41.15087; Tanne F, 2005, HEPATOLOGY, V41, P1290, DOI 10.1002/hep.20725; Trevaskis JL, 2012, AM J PHYSIOL-GASTR L, V302, pG762, DOI 10.1152/ajpgi.00476.2011; Wei L, 2012, CANCER BIOTHER RADIO, V27, P672, DOI 10.1089/cbr.2012.1241; Wilson GK, 2014, J HEPATOL, V61, P1397, DOI 10.1016/j.jhep.2014.08.025; Wong CCL, 2012, J MOL MED, V90, P803, DOI 10.1007/s00109-011-0855-y; Wong CCL, 2011, P NATL ACAD SCI USA, V108, P16369, DOI 10.1073/pnas.1113483108; YOUNG T, 1993, NEW ENGL J MED, V328, P1230, DOI 10.1056/NEJM199304293281704	45	60	64	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2016	11	12							e0168572	10.1371/journal.pone.0168572	http://dx.doi.org/10.1371/journal.pone.0168572			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EG7JB	28030556	gold, Green Published, Green Submitted			2022-12-27	WOS:000391222000057
J	Cao, GD; Xu, XY; Zhang, JW; Chen, B; Xiong, MM				Cao, Guo-dong; Xu, Xing-yu; Zhang, Jia-wei; Chen, Bo; Xiong, Mao-ming			Phosphorylated Mammalian Target of Rapamycin p-mTOR Is a Favorable Prognostic Factor than mTOR in Gastric Cancer	PLOS ONE			English	Article							SIGNALING PATHWAY; TUMOR PROGRESSION; EXPRESSION; ACTIVATION; CARCINOMA; OVEREXPRESSION; ADENOCARCINOMA; METASTASIS; INHIBITION; CELLS	Aims The mammalian target of rapamycin (mTOR) and phosphorylated mTOR (p-mTOR) occurring downstream in the PI3K/Akt/mTOR pathway, are regarded as potential prognostic markers for gastric cancer (GC). However, the prognostic value of mTOR/p-mTOR expression remains controversial. In this study, we determined the expression of mTOR, p-mTOR, p70S6k, and p-p70S6K in GC, and investigated the correlation between their overexpression, clinicopathological parameters, and overall survival (OS). Methods The expression of mTOR, p-mTOR, p70S6k, and p-p70S6K was examined in 120 GC patients by immunohistochemistry (IHC). The association of protein expression with clinicopathological features and OS was explored. The p-mTOR expression was detected in normal, adjacent, and GC tissues using Western blot. Eligible studies retrieved from PubMed, Ovid, Web of Science and Cochrane databases, were reviewed in this meta-analysis. Results IHC showed that the rates of expression of the signal transduction molecules mTOR, pmTOR, p70S6k and p-p70S6K in GC were 60.8%, 54.2%, 53.3% and 53.3%, respectively. Overexpression of mTOR and p70S6K showed no significant association with clinical variables. Expression of p-mTOR was significantly associated with differentiation (P < 0.01), depth of invasion (P < 0.01), lymph node metastasis (P = 0.04) and TNM stage (P = 0.02). Expression of p-p70S6K was associated with differentiation (P = 0.006), depth of invasion (P < 0.001), and TNM stage (P = 0.02). In survival analysis, differentiation, depth of invasion, lymph node metastasis and TNM stage were not related to OS (all P > 0.05). Furthermore, p-mTOR and p-p70S6K expression, but not mTOR and p70S6K, were tightly associated with OS of GC patients (P = 0.006 and P < 0.001, respectively). In Western blot, p-mTOR was significantly higher in GC tissues than in normal and adjacent tissues. In the present meta-analysis, mTOR overexpression showed no relationship with any clinicopathological variables. However, p-mTOR was correlated with depth of invasion, and TNM stage (all P < 0.05), and its overexpression was associated with a shorter survival time (P < 0.001). Conclusion The results suggest that p-mTOR is a more valuable prognostic factor than mTOR in GC.	[Cao, Guo-dong; Xu, Xing-yu] Anhui Med Univ, Hefei, Anhui, Peoples R China; [Zhang, Jia-wei; Chen, Bo; Xiong, Mao-ming] Anhui Med Univ, Affiliated Hosp 1, Dept Gen Surg, Hefei, Anhui, Peoples R China	Anhui Medical University; Anhui Medical University	Chen, B; Xiong, MM (corresponding author), Anhui Med Univ, Affiliated Hosp 1, Dept Gen Surg, Hefei, Anhui, Peoples R China.	chenbo831116@163.com; ayfyxmm@163.com	Cao, Guodong/AAJ-1089-2020		National Natural Science Foundation of China [81602425]; Natural Science Foundation of Anhui Province [1508085QH152, 1608085MH163]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Anhui Province(Natural Science Foundation of Anhui Province)	This work was supported by grants from the National Natural Science Foundation of China (NO: 81602425) and the Natural Science Foundation of Anhui Province (NO: 1508085QH152, 1608085MH163). The funders had no role in study design, data collection and analysis, manuscript preparation, or submission for publication.	Ahn HS, 2010, CANCER-AM CANCER SOC, V116, P5592, DOI 10.1002/cncr.25550; An JY, 2010, INT J CANCER, V126, P2904, DOI 10.1002/ijc.24872; Bian YH, 2015, BIOCHEM BIOPH RES CO, V464, P534, DOI 10.1016/j.bbrc.2015.07.001; Byeon SJ, 2014, J SURG ONCOL, V109, P812, DOI 10.1002/jso.23585; Choo AY, 2008, P NATL ACAD SCI USA, V105, P17414, DOI 10.1073/pnas.0809136105; Faivre S, 2006, NAT REV DRUG DISCOV, V5, P671, DOI 10.1038/nrd2062; Gulhati P, 2009, CLIN CANCER RES, V15, P7207, DOI 10.1158/1078-0432.CCR-09-1249; Hara K, 1998, J BIOL CHEM, V273, P14484, DOI 10.1074/jbc.273.23.14484; Hassan B, 2013, SURG ONCOL CLIN N AM, V22, P641, DOI 10.1016/j.soc.2013.06.008; Hsieh AC, 2012, NATURE, V485, P55, DOI 10.1038/nature10912; Inokuchi M, 2011, EXP THER MED, V2, P251, DOI 10.3892/etm.2011.187; Ji J, 2010, GYNECOL ONCOL, V117, P103, DOI 10.1016/j.ygyno.2009.12.020; Kamangar F, 2006, J CLIN ONCOL, V24, P2137, DOI 10.1200/JCO.2005.05.2308; Li L, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116771; Li M, 2012, ONCOL LETT, V4, P1213, DOI 10.3892/ol.2012.930; Murayama T, 2009, BRIT J CANCER, V100, P782, DOI 10.1038/sj.bjc.6604915; Niu HY, 2011, J EXP CLIN CANC RES, V30, DOI 10.1186/1756-9966-30-28; Osaki M, 2004, J CANCER RES CLIN, V130, P8, DOI 10.1007/s00432-003-0505-z; Oulhen N, 2010, MOL REPROD DEV, V77, P83, DOI 10.1002/mrd.21110; Philp AJ, 2001, CANCER RES, V61, P7426; Riquelme I, 2016, PATHOL ONCOL RES; Sasako M, 2008, NEW ENGL J MED, V359, P453, DOI 10.1056/NEJMoa0707035; Shaw RJ, 2006, NATURE, V441, P424, DOI 10.1038/nature04869; Stang A, 2010, EUR J EPIDEMIOL, V25, P603, DOI 10.1007/s10654-010-9491-z; Torre LA, 2015, CA-CANCER J CLIN, V65, P87, DOI 10.3322/caac.21262; Vivanco I, 2002, NAT REV CANCER, V2, P489, DOI 10.1038/nrc839; Wang D, 2011, ASIAN PAC J CANCER P, V12, P2581; Xiao L, 2009, J EXP CLIN CANC RES, V28, DOI 10.1186/1756-9966-28-152; Xu DZ, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-536; Yang HY, 2013, MOL MED REP, V7, P537, DOI 10.3892/mmr.2012.1208; Yoon DH, 2012, BRIT J CANCER, V106, P1039, DOI 10.1038/bjc.2012.47; Yu GZ, 2009, CLIN CANCER RES, V15, P1821, DOI 10.1158/1078-0432.CCR-08-2138; Zhou XY, 2004, CLIN CANCER RES, V10, P6779, DOI 10.1158/1078-0432.CCR-04-0112; Zou Wen-Bin, 2015, Zhejiang Da Xue Xue Bao Yi Xue Ban, V44, P9	34	13	15	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2016	11	12							e0168085	10.1371/journal.pone.0168085	http://dx.doi.org/10.1371/journal.pone.0168085			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI9QH	28005970	Green Submitted, gold, Green Published			2022-12-27	WOS:000392843200028
J	Hrycyk, J; Kaemmerer, H; Nagdyman, N; Hamann, M; Schneider, KTM; Kuschel, B				Hrycyk, Joris; Kaemmerer, Harald; Nagdyman, Nicole; Hamann, Moritz; Schneider, K. T. M.; Kuschel, Bettina			Mode of Delivery and Pregnancy Outcome in Women with Congenital Heart Disease	PLoS One			English	Article							INDUCTION	Background Advances in cardiac surgery and congenital cardiology have led to an increasing number of women with congenital heart disease (CHD) reaching childbearing age. In general, cardiologists recommend vaginal delivery for women with CHD to avoid complications from Caesarean section as many women with CHD tolerate vaginal delivery well. Methods and Results This is a single-center study comparing mode of delivery, pregnancy outcome, indications for Caesarean section and induction of labor between women with and without CHD. A historical cohort study was conducted including 116 patients with CHD. An individual threefold matching with 348 women without CHD was carried out. Caesarean section was performed in 46.6% of pregnancies with CHD (33.6% without CHD, P = 0.012). Primary Caesarean section increases with severity of CHD (P = 0.036), 33.3% of women with CHD had primary planned Caesarean section due to cardiac reasons. Induction of labor was performed in 45.7% of attempted vaginal deliveries in women with CHD (27.9% without CHD, P = 0.001). Lower mean birth weight (P = 0.004) and Small for Gestational Age (SGA) (P < 0.001) were more common in women with CHD. One CHD patient suffered from postpartum hemorrhage. Conclusions Concerns about maternal deterioration resulting in higher rates of induction of labor seem unjustified in most cases. Along with a possible reduction of Caesarean section on maternal request, a reduction of planned vaginal delivery may be expedient in reducing the rate of Caesarean section in women with CHD.	[Hrycyk, Joris; Hamann, Moritz; Schneider, K. T. M.; Kuschel, Bettina] Tech Univ Munich, Klinikum Rechts Isar, Womens Clin Frauenklin, Munich, Germany; [Kaemmerer, Harald; Nagdyman, Nicole] Tech Univ Munich, German Heart Ctr Munich Deutsch Herzzentrum Muenc, Dept Paediat Cardiol & Congenital Heart Dis, Munich, Germany	Technical University of Munich; German Heart Centre Munich; Technical University of Munich	Kuschel, B (corresponding author), Tech Univ Munich, Klinikum Rechts Isar, Womens Clin Frauenklin, Munich, Germany.	bettinakuschel@hotmail.com						Bamfo JEAK, 2006, BJOG-INT J OBSTET GY, V113, P784, DOI 10.1111/j.1471-0528.2006.00945.x; Cornette J, 2013, INT J CARDIOL, V168, P825, DOI 10.1016/j.ijcard.2012.10.005; Heffner LJ, 2003, OBSTET GYNECOL, V102, P287, DOI 10.1016/S0029-7844(03)00531-3; Karamermer Yusuf, 2007, Expert Rev Cardiovasc Ther, V5, P859, DOI 10.1586/14779072.5.5.859; Opotowsky AR, 2012, HEART, V98, P145, DOI 10.1136/heartjnl-2011-300828; Ouzounian JG, 2012, CARDIOL CLIN, V30, P317, DOI 10.1016/j.ccl.2012.05.004; Perloff J. K., 2008, CONGENITAL HEART DIS; Robertson JE, 2012, J OBSTET GYNAECOL CA, V34, P812, DOI 10.1016/S1701-2163(16)35378-6; Ruys TPE, 2014, HEART, P1; Siu SC, 2001, CIRCULATION, V104, P515, DOI 10.1161/hc3001.093437; Stangl V, 2008, EUR J HEART FAIL, V10, P855, DOI 10.1016/j.ejheart.2008.07.017; Thompson JL, 2015, OBSTET GYNECOL, V126, P346, DOI 10.1097/AOG.0000000000000973; Warnes CA, 2001, J AM COLL CARDIOL, V37, P1170, DOI 10.1016/S0735-1097(01)01272-4; Wood S, 2014, BJOG-INT J OBSTET GY, V121, P674, DOI 10.1111/1471-0528.12328	14	12	12	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2016	11	12							e0167820	10.1371/journal.pone.0167820	http://dx.doi.org/10.1371/journal.pone.0167820			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI9QH	28006009	Green Submitted, Green Published, gold			2022-12-27	WOS:000392843200022
J	Kaczmarczyk, D; Wolnicki, J				Kaczmarczyk, Dariusz; Wolnicki, Jacek			Genetic Diversity of the Critically Endangered Lake Minnow Eupallasella percnurus in Poland and Its Implications for Conservation	PLoS One			English	Article							CROSS-SPECIES AMPLIFICATION; MICROSATELLITE LOCI; POPULATION-STRUCTURE; VARIABILITY; CYPRINIDAE; BOTTLENECK; DIFFERENTIATION; DISTANCES; TELEOSTEI; SOFTWARE	The lake minnow (Eupallasella percnurus) is critically endangered. In this paper we characterize the genetic properties of this fish over its range of occurrence in Poland and propose the use of this knowledge in its active protection. Twelve populations of lake minnow from across its range in Poland were investigated. 13 microsatellite loci were investigated to evaluate genetic variation and distance among populations. The magnitude of the genetic bottleneck or founder effects was investigated. In the studied populations, the allelic diversity and heterozygosity showed that genetic variation in this species is low. At most loci, only 2-3 alleles per population were detected. The average number of alleles detected across all loci was 35, and ranged from 24 to 53. The average observed heterozygosity (Ho) across all investigated loci was 0.38 (range 0.21-0.59); the average expected heterozygosity (He) was 0.36 (range 0.18-0.55). The populations remained in Hardy-Weinberg equilibrium. The average Garza-Williamson M index value for all populations was low (0.47), suggesting a reduction in genetic variation due to a founder effect or a genetic bottleneck. Genetic distance among populations was high or very high (FST range: 0.20-0.64; delta mu(2) range: 1.32-16.98); this was likely a consequence of low gene flow among isolated populations, a founder effect or other genetic bottleneck, and strong genetic drift. The large genetic differences among the investigated lake minnow populations are likely to also exist among other populations of this species, and knowledge of these differences should inform active protection programs based on translocation of wild or cultivated fish of this species. The method presented here can potentially be applied to any population of lake minnows or closely related species.	[Kaczmarczyk, Dariusz] Univ Warmia & Mazury, Dept Environm Biotechnol, Sloneczna 45G, Olsztyn, Poland; [Wolnicki, Jacek] Inland Fisheries Inst, Pond Fishery Dept, Glowna 48, Zabieniec, Piaseczno, Poland	University of Warmia & Mazury	Kaczmarczyk, D (corresponding author), Univ Warmia & Mazury, Dept Environm Biotechnol, Sloneczna 45G, Olsztyn, Poland.	d.kaczmarczyk@uwm.edu.pl		Wolnicki, Jacek/0000-0003-4396-390X	Ministry of Science and Higher Education in Poland [N N304 324839]; National Science Centre in Poland [2014/15/B/NZ9/05240]	Ministry of Science and Higher Education in Poland(Ministry of Science and Higher Education, Poland); National Science Centre in Poland(National Science Centre, Poland)	Those studies were financed by the Ministry of Science and Higher Education in Poland within project No. N N304 324839 for 2010-2013 and by the National Science Centre in Poland within project No. 2014/15/B/NZ9/05240 for 2015-2018.	Aksoy S, 2013, MOL ECOL RESOUR, V13, P341, DOI 10.1111/1755-0998.12061; Balloux F, 2002, MOL ECOL, V11, P155, DOI 10.1046/j.0962-1083.2001.01436.x; Bellinger MR, 2003, CONSERV BIOL, V17, P717, DOI 10.1046/j.1523-1739.2003.01581.x; Bjornstad G, 2003, ANIM GENET, V34, P55, DOI 10.1046/j.1365-2052.2003.00922.x; Bogutskaya NG, 2005, ICHTHYOL EXPLOR FRES, V16, P93; Burridge CP, 2003, CONSERV GENET, V4, P219, DOI 10.1023/A:1023390606975; CARVALHO GR, 1993, J FISH BIOL, V43, P53, DOI 10.1111/j.1095-8649.1993.tb01179.x; Dieringer D, 2003, MOL ECOL NOTES, V3, P167, DOI 10.1046/j.1471-8286.2003.00351.x; Dimsoski P, 2000, MOL ECOL, V9, P2187, DOI 10.1046/j.1365-294X.2000.105318.x; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; Freyhof J., 2007, HDB EUROPEAN FRESHWA; Garza JC, 2001, MOL ECOL, V10, P305, DOI 10.1046/j.1365-294x.2001.01190.x; GOLDSTEIN DB, 1995, GENETICS, V139, P463; Grisolia AB, 2007, GENET MOL RES, V6, P382; GUO SW, 1992, BIOMETRICS, V48, P361, DOI 10.2307/2532296; Heath DD, 2001, HEREDITY, V86, P618, DOI 10.1046/j.1365-2540.2001.00867.x; Holmen J, 2005, J FISH BIOL, V66, P851, DOI 10.1111/j.0022-1112.2005.00637.x; Hughes JM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121858; Kaczmarczyk D, 2015, CONSERV GENET RESOUR, V7, P49, DOI 10.1007/s12686-014-0356-8; Kaczmarczyk Dariusz, 2011, Archives of Polish Fisheries, V19, P145; King TL, 2001, CONSERV GENET, V2, P103, DOI 10.1023/A:1011895429669; Kusznierz J, 2006, FISHERIES MANAG ECOL, V13, P131, DOI 10.1111/j.1365-2400.2006.00482.x; Kusznierz Jan, 2011, Archives of Polish Fisheries, V19, P161; LEVINS R, 1969, Bulletin of the Entomological Society of America, V15, P237; LEVINS RICHARD, 1968; Luenser K, 2005, EUR J WILDLIFE RES, V51, P84, DOI 10.1007/s10344-005-0081-4; Michalakis Y, 1996, GENETICS, V142, P1061; Nei M., 1987, MOL EVOLUTIONARY GEN; OConnell M, 1997, REV FISH BIOL FISHER, V7, P331, DOI 10.1023/A:1018443912945; Paetkau D, 1997, GENETICS, V147, P1943; Piotrowski W., 1994, CHRONMY PRZYR OJCZ, V5, P91; Pritchard JK, 2000, GENETICS, V155, P945; Rowe G, 1998, MOL ECOL, V7, P751, DOI 10.1046/j.1365-294x.1998.00387.x; Ruzzante DE, 1998, CAN J FISH AQUAT SCI, V55, P1, DOI 10.1139/cjfas-55-1-1; Salgueiro P, 2003, BIOL CONSERV, V109, P47, DOI 10.1016/S0006-3207(02)00132-5; Sikorska Justyna, 2011, Archives of Polish Fisheries, V19, P195; Tzika AC, 2008, MOL ECOL, V17, P4943, DOI 10.1111/j.1365-294X.2008.03967.x; Waser PM, 1998, TRENDS ECOL EVOL, V13, P43, DOI 10.1016/S0169-5347(97)01255-X; Whitehouse AM, 2001, MOL ECOL, V10, P2139, DOI 10.1046/j.0962-1083.2001.01356.x; Wisely SM, 2002, J HERED, V93, P231, DOI 10.1093/jhered/93.4.231; Wolnicki J, 2009, KOMUN RYB, V2, P10; Wolnicki Jacek, 2010, Teka Komisji Ochrony i Ksztaltowania Srodowiska Przyrodniczego, V7, P473; Wolnicki Jacek, 2011, Archives of Polish Fisheries, V19, P209, DOI 10.2478/v10086-011-0026-3; Wolnicki Jacek, 2009, Chronmy Przyrode Ojczysta, V65, P329; WRIGHT S, 1951, ANN EUGENIC, V15, P323; Wright S., 1978, EVOLUTION GENETICS P; Zhao N, 2005, J APPL ICHTHYOL, V21, P7, DOI 10.1111/j.1439-0426.2004.00630.x	47	8	11	0	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2016	11	12							e0168191	10.1371/journal.pone.0168191	http://dx.doi.org/10.1371/journal.pone.0168191			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI9QH	28005951	gold, Green Published, Green Submitted			2022-12-27	WOS:000392843200035
J	Komina, A; Palkina, N; Aksenenko, M; Tsyrenzhapova, S; Ruksha, T				Komina, Anna; Palkina, Nadezhda; Aksenenko, Mariya; Tsyrenzhapova, Seseg; Ruksha, Tatiana			Antiproliferative and Pro-Apoptotic Effects of MiR-4286 Inhibition in Melanoma Cells	PLOS ONE			English	Article							MICRORNA EXPRESSION; PATHWAY; GROWTH; CANCER; PROLIFERATION; PROGRESSION; METASTASIS; IMPACT	Introduction MicroRNAs are essential regulators of gene expression at the post-transcriptional level. Their expression is altered in cancer tissues, and evaluation of these alterations is considered a promising tool used to diagnose and identify prognostic markers. Materials and methods The microRNA expression profiles of formalin-fixed, paraffin-embedded melanoma and melanocytic nevi samples were estimated with a microarray and subsequently validated by real-time PCR. Melanoma cells were transfected with miR-4286 inhibitor to evaluate the influence of this microRNA on the viability, proliferation, apoptosis, migration, and invasion of melanoma cells. Results The microarray revealed that the expression of 1,171 microRNAs was altered in melanoma samples compared to melanocytic nevi. Real-time PCR validation experiments found the microRNA expression levels to correspond to the melanoma/melanocytic nevi microarray results. The pathway analysis identified 52 modulated pathways in melanoma. Moreover, the application of miR-4286 inhibitor to BRO melanoma cells resulted in a 2.6-fold increase in the apoptosis rate and a 1.7-fold decrease in the cell proliferation/viability but did not affect the invasiveness and migration of these cells. Furthermore, the use of miR-4286 inhibitor altered the mRNA expression of several miR-4286 gene targets: folylpolyglutamate synthase, RNA polymerase I-specific transcription initiation factor, apelin, G-protein-coupled receptor 55, and high-mobility group A1 protein, which have been implicated in cell proliferation/apoptosis regulation. Lastly, the transiently transfected SK-MEL-1 cells with miR-4286 inhibitor decreased proliferation rate and modulated folylpolyglutamate synthase rates of these cells. Conclusion Our results demonstrate that miR-4286 mediates proliferation and apoptosis in melanoma cells, these findings may represent a novel mechanism underlying these processes.	[Komina, Anna; Palkina, Nadezhda; Aksenenko, Mariya; Tsyrenzhapova, Seseg; Ruksha, Tatiana] Krasnoyarsk State Med Univ, Dept Pathophysiol, Krasnoyarsk, Russia	Krasnoyarsk State Medical University	Ruksha, T (corresponding author), Krasnoyarsk State Med Univ, Dept Pathophysiol, Krasnoyarsk, Russia.	tatyana_ruksha@mail.ru	Palkina, Nadezhda/P-1585-2015; Tyumentseva, Anna V/O-9770-2015; Ruksha, Tatiana/A-4801-2014	Tyumentseva, Anna V/0000-0002-2269-0298; Ruksha, Tatiana/0000-0001-8142-4283; Palkina, Nadezhda Vladimirovna/0000-0002-6801-3452	Russian Science Foundation [14-15-00074]	Russian Science Foundation(Russian Science Foundation (RSF))	The study was supported by the grant of the Russian Science Foundation (Ruksha T.G., project No 14-15-00074), www.rscf.ru.; The study was supported by a grant from the Russian Science Foundation (project No 14-15-00074).	Acunzo M, 2015, J INFECT DIS, V212, pS74, DOI 10.1093/infdis/jiv197; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Boyle GM, 2011, PIGM CELL MELANOMA R, V24, P525, DOI 10.1111/j.1755-148X.2011.00849.x; Brazma A, 2009, THESCIENTIFICWORLDJO, V9, P420, DOI 10.1100/tsw.2009.57; Brennecke J, 2005, PLOS BIOL, V3, P404, DOI 10.1371/journal.pbio.0030085; Cherradi N, 2016, FRONT ENDOCRINOL, V6, DOI 10.3389/fendo.2015.00195; Cui RR, 2010, AMINO ACIDS, V39, P1193, DOI 10.1007/s00726-010-0555-x; de Kok JB, 2005, LAB INVEST, V85, P154, DOI 10.1038/labinvest.3700208; Drahos J, 2015, CANC EPIDEMIOL BIOMA; Eberle J, 2002, J INVEST DERMATOL, V119, P549, DOI 10.1046/j.1523-1747.2002.01848.x; Enright AJ, 2004, GENOME BIOL, V5; Fedorenko IV, 2015, J INVEST DERMATOL, V135, P3115, DOI 10.1038/jid.2015.329; Frampton AE, 2013, EXPERT REV MOL DIAGN, V13, P31, DOI [10.1586/ERM.12.136, 10.1586/erm.12.136]; Han XX, 2016, BIOMED PHARMACOTHER, V82, P312, DOI 10.1016/j.biopha.2016.05.004; Hu FY, 2016, BIOCHEM BIOPH RES CO, V474, P35, DOI 10.1016/j.bbrc.2016.04.055; Jayawardana K, 2016, J INVEST DERMATOL, V136, P245, DOI 10.1038/JID.2015.355; John B, 2004, PLOS BIOL, V2, P1862, DOI 10.1371/journal.pbio.0020363; Kajdaniuk D, 2013, ENDOKRYNOL POL, V64, P384, DOI 10.5603/EP.2013.0022; Kaushik G, 2014, AM J SURG, V208, P995, DOI 10.1016/j.amjsurg.2014.09.014; Kawai Y, 2013, AM J PHYSIOL-CELL PH, V305, pC1139, DOI 10.1152/ajpcell.00199.2013; Kozubek J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072699; Levati L, 2009, INT J ONCOL, V35, P393, DOI 10.3892/ijo_00000352; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Liu H, 2012, PROTEIN CELL, V3, P291, DOI 10.1007/s13238-012-2919-3; LOCKSHIN A, 1985, CANCER RES, V45, P345; Lu J, 2012, GENOME RES, V22, P1243, DOI 10.1101/gr.132514.111; Margue C, 2015, ONCOTARGET, V6, P12110, DOI 10.18632/oncotarget.3661; Mazar J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013779; Mueller DW, 2009, J INVEST DERMATOL, V129, P1740, DOI 10.1038/jid.2008.452; Park H, 2014, GYNECOL ONCOL, V135, P565, DOI 10.1016/j.ygyno.2014.09.010; Pentheroudakis G, 2013, CLIN EXP METASTAS, V30, P431, DOI 10.1007/s10585-012-9548-3; Perrot CY, 2013, ANN DERMATOL, V25, P135, DOI 10.5021/ad.2013.25.2.135; Piskounova E, 2015, NATURE, V527, P186, DOI 10.1038/nature15726; Rajewsky N, 2004, DEV BIOL, V267, P529, DOI 10.1016/j.ydbio.2003.12.003; Ryu B, 2013, J INVEST DERMATOL, V133, P1137, DOI 10.1038/jid.2012.505; Sand M, 2013, CELL TISSUE RES, V351, P85, DOI 10.1007/s00441-012-1514-5; Sandru A, 2014, J Med Life, V7, P572; Schlegel NC, 2015, EXP DERMATOL, V24, P22, DOI 10.1111/exd.12580; Schmuhl E, 2014, BIOCHEM PHARMACOL, V87, P489, DOI 10.1016/j.bcp.2013.11.016; Shuang L, 2016, CLIN EXP OBSTET GYN, V43, P409, DOI 10.12891/ceog2133.2016; Villaruz LC, 2015, CLIN EPIGENETICS, V7, DOI 10.1186/s13148-015-0092-2; Susluer SY, 2015, J NEUROL SCI-TURK, V32, P64; Zecchin KG, 2011, LAB INVEST, V91, P232, DOI 10.1038/labinvest.2010.157; Zhang J.D., 2013, CITESEER, V48, P346, DOI DOI 10.18129/B9.BIOC.DDC; Zhou JD, 2015, CANCER BIOL THER, V16, P846, DOI 10.1080/15384047.2015.1030545	45	28	34	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2016	11	12							e0168229	10.1371/journal.pone.0168229	http://dx.doi.org/10.1371/journal.pone.0168229			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI9QH	28005927	Green Published, Green Submitted, gold			2022-12-27	WOS:000392843200039
J	Schoonvaere, K; De Smet, L; Smagghe, G; Vierstraete, A; Braeckman, BP; de Graaf, DC				Schoonvaere, Karel; De Smet, Lina; Smagghe, Guy; Vierstraete, Andy; Braeckman, Bart P.; de Graaf, Dirk C.			Unbiased RNA Shotgun Metagenomics in Social and Solitary Wild Bees Detects Associations with Eukaryote Parasites and New Viruses	PLOS ONE			English	Article							KROMBEINI ACARI CHAETODACTYLIDAE; SEQUENCE ALIGNMENT; BOMBUS-TERRESTRIS; MOLECULAR CHARACTERIZATION; HYMENOPTERA; PATHOGEN; MICROSPORIDIA; POLLINATORS; PERFORMANCE; PASCUORUM	The diversity of eukaryote organisms and viruses associated with wild bees remains poorly characterized in contrast to the well-documented pathosphere of the western honey bee, Apis mellifera. Using a deliberate RNA shotgun metagenomic sequencing strategy in combination with a dedicated bioinformatics workflow, we identified the (micro-)organisms and viruses associated with two bumble bee hosts, Bombus terrestris and Bombus pascuorum, and two solitary bee hosts, Osmia corn uta and Andrena vaga. Ion Torrent semiconductor sequencing generated approximately 3.8 million high quality reads. The most significant eukaryote associations were two protozoan, Apicystis bombiand Crithidia bombi, and one nematode parasite Sphaerularia bombi in bumble bees. The trypanosome protozoan C. bombi was also found in the solitary bee 0. corn uta. Next to the identification of three honey bee viruses Black queen cell virus, Sacbrood virus and Varroa destructor virus-1 and four plant viruses, we describe two novel RNA viruses Scaldis River bee virus (SRBV) and Ganda bee virus (GABV) based on their partial genomic sequences. The novel viruses belong to the class of negative-sense RNA viruses, SRBV is related to the order Mononegavirales whereas GABV is related to the family Bunyaviridae. The potential biological role of both viruses in bees is discussed in the context of recent advances in the field of arthropod viruses. Further, fragmentary sequence evidence for other undescribed viruses is presented, among which a nudivirus in 0. corn uta and an unclassified virus related to Chronic bee paralysis virus in B. terrestris. Our findings extend the current knowledge of wild bee parasites in general and addsto the growing evidence of unexplored arthropod viruses in valuable insects.	[Schoonvaere, Karel; De Smet, Lina; de Graaf, Dirk C.] Univ Ghent, Fac Sci, Dept Biochem & Microbiol, Lab Mol Entomol & Bee Pathol, Ghent, Belgium; [Smagghe, Guy; Vierstraete, Andy] Univ Ghent, Fac Biosci Engn, Dept Crop Protect, Lab Agrozool, Ghent, Belgium; [Braeckman, Bart P.] Univ Ghent, Dept Biol, Lab Ageing Physiol & Mol Evolut, Ghent, Belgium	Ghent University; Ghent University; Ghent University	Schoonvaere, K (corresponding author), Univ Ghent, Fac Sci, Dept Biochem & Microbiol, Lab Mol Entomol & Bee Pathol, Ghent, Belgium.	karel.schoonvaere@ugent.be	Smagghe, Guy/AAE-8914-2019; de Graaf, Dirk C./HGD-4017-2022	Smagghe, Guy/0000-0001-8334-3313; 	Belgian Science Policy (BELSPO) [BR/132/A1/BELBEES]	Belgian Science Policy (BELSPO)(Belgian Federal Science Policy Office)	Belgian Science Policy (BELSPO; BR/132/A1/BELBEES; Multi-disciplinary assessment of BELgian wild BEE decline to adapt mitigation management policy). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ballinger MJ, 2014, J VIROL, V88, P8783, DOI 10.1128/JVI.00531-14; Biesmeijer JC, 2006, SCIENCE, V313, P351, DOI 10.1126/science.1127863; Buchfink B, 2015, NAT METHODS, V12, P59, DOI 10.1038/nmeth.3176; Chang JM, 2014, MOL BIOL EVOL, V31, P1625, DOI 10.1093/molbev/msu117; Darriba D, 2011, BIOINFORMATICS, V27, P1164, DOI 10.1093/bioinformatics/btr088; de Miranda JR, 2013, J APICULT RES, V52, DOI 10.3896/IBRA.1.52.4.22; DURRER S, 1994, P ROY SOC B-BIOL SCI, V258, P299, DOI 10.1098/rspb.1994.0176; Fan Q.-H., 2007, FAUNA N Z, P291; Folmer O., 1994, Molecular Marine Biology and Biotechnology, V3, P294; Fries I, 1999, EUR J PROTISTOL, V35, P183, DOI 10.1016/S0932-4739(99)80036-4; Genersch E, 2006, J INVERTEBR PATHOL, V91, P61, DOI 10.1016/j.jip.2005.10.002; Goulson D, 2008, ANNU REV ENTOMOL, V53, P191, DOI 10.1146/annurev.ento.53.103106.093454; Goulson D, 2015, SCIENCE, V347, DOI 10.1126/science.1255957; Gouy M, 2010, MOL BIOL EVOL, V27, P221, DOI 10.1093/molbev/msp259; Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010; Hadziavdic K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087624; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Huson DH, 2007, GENOME RES, V17, P377, DOI 10.1101/gr.5969107; Kanzaki N, 2007, ZOOL SCI, V24, P1134, DOI 10.2108/zsj.24.1134; Katoh K, 2013, MOL BIOL EVOL, V30, P772, DOI 10.1093/molbev/mst010; Klatt BK, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2013.2440; Klein AM, 2007, P ROY SOC B-BIOL SCI, V274, P303, DOI 10.1098/rspb.2006.3721; KOONIN EV, 1993, CRIT REV BIOCHEM MOL, V28, P375, DOI 10.3109/10409239309078440; Ladurner E, 2004, J APICULT RES, V43, P118, DOI 10.1080/00218839.2004.11101121; Li C, 2015, ELIFE, V4, DOI [10.7554/eLife.06587, 10.1155/2015/757269]; LIPA JJ, 1992, APIDOLOGIE, V23, P533, DOI 10.1051/apido:19920605; Maebe K, 2013, APIDOLOGIE, V44, P188, DOI 10.1007/s13592-012-0170-9; McKinney MI, 2013, EXP APPL ACAROL, V60, P153, DOI 10.1007/s10493-012-9629-7; McMahon DP, 2015, J ANIM ECOL, V84, P615, DOI 10.1111/1365-2656.12345; Meeus I, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125152; Mu JF, 2014, J GEN VIROL, V95, P2531, DOI 10.1099/vir.0.068262-0; Nouri S, 2016, J VIROL, V90, P2434, DOI 10.1128/JVI.02793-15; Olivier V, 2008, VIRUS RES, V132, P59, DOI 10.1016/j.virusres.2007.10.014; Ollerton J, 2011, OIKOS, V120, P321, DOI 10.1111/j.1600-0706.2010.18644.x; Otti O, 2007, J INVERTEBR PATHOL, V96, P118, DOI 10.1016/j.jip.2007.03.016; Parmentier L, 2016, APIDOLOGIE, V47, P237, DOI 10.1007/s13592-015-0393-7; Parmentier L, 2016, J INVERTEBR PATHOL, V134, P6, DOI 10.1016/j.jip.2015.12.003; Peng WJ, 2011, APIDOLOGIE, V42, P650, DOI 10.1007/s13592-011-0061-5; Plischuk S, 2015, J INVERTEBR PATHOL, V126, P31, DOI 10.1016/j.jip.2015.01.006; POINAR GO, 1972, NEMATOLOGICA, V18, P239, DOI 10.1163/187529272X00476; POINAR GO, 1972, J NEMATOL, V4, P270; Potts SG, 2010, TRENDS ECOL EVOL, V25, P345, DOI 10.1016/j.tree.2010.01.007; POUVREAU A, 1974, Apidologie, V5, P39, DOI 10.1051/apido:19740103; Ratnasingham S, 2007, MOL ECOL NOTES, V7, P355, DOI 10.1111/j.1471-8286.2007.01678.x; Ravoet J, 2014, J INVERTEBR PATHOL, V122, P55, DOI 10.1016/j.jip.2014.08.007; Reaumur RAF, 1742, MEMOIRES SERVIR HIST, V6; Reddy B, 2015, GENET RES INT, V2015, DOI 10.1155/2015/638679; Roossinck MJ, 2011, NAT REV MICROBIOL, V9, P99, DOI 10.1038/nrmicro2491; Schwarz RS, 2016, CURRENT OPI IN PRESS; Shi M, 2016, J VIROL, V90, P659, DOI 10.1128/JVI.02036-15; Singh R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014357; Strand MR, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002757; Tange O, 2011, USENIX MAG, V36, P42, DOI [10.5281/zenodo.16303, DOI 10.5281/ZENODO.16303]; Vasilakis N, 2013, J VIROL, V87, P2475, DOI 10.1128/JVI.00776-12; Wang YJ, 2011, VIRUS GENES, V42, P444, DOI 10.1007/s11262-011-0589-5; White JB, 2009, J ECON ENTOMOL, V102, P2090, DOI 10.1603/029.102.0611; Yin XW, 2013, CELL MOL LIFE SCI, V70, P3029, DOI 10.1007/s00018-013-1308-2; Yourth CP, 2006, P ROY SOC B-BIOL SCI, V273, P655, DOI 10.1098/rspb.2005.3371	58	28	29	1	69	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2016	11	12							e0168456	10.1371/journal.pone.0168456	http://dx.doi.org/10.1371/journal.pone.0168456			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI9QH	28006002	Green Published, Green Submitted, gold			2022-12-27	WOS:000392843200052
J	Torrents, C; Ric, A; Hristovski, R; Torres-Ronda, L; Vicente, E; Sampaio, J				Torrents, Carlota; Ric, Angel; Hristovski, Robert; Torres-Ronda, Lorena; Vicente, Emili; Sampaio, Jaime			Emergence of Exploratory, Technical and Tactical Behavior in Small-Sided Soccer Games when Manipulating the Number of Teammates and Opponents	PLOS ONE			English	Article							HEART-RATE; PHYSIOLOGICAL-RESPONSES; TIME-MOTION; CONSTRAINTS; CREATIVITY; FOOTBALL; MOVEMENT; PLAYERS; STATISTICS; NOVELTY	The effects that different constraints have on the exploratory behavior, measured by the variety and quantity of different responses within a game situation, is of the utmost importance for successful performance in team sports. The aim of this study was to determine how the number of teammates and opponents affects the exploratory behavior of both professional and amateur players in small-sided soccer games. Twenty-two professional (age 25.6 +/- 4.9 years) and 22 amateur (age 23.1 +/- 0.7 years) male soccer players played three small-sided game formats (4 vs. 3, 4 vs. 5, and 4 vs. 7). These trials were video-recorded and a systematic observation instrument was used to notate the actions, which were subsequently analyzed by means of a principal component analysis and the dynamic overlap order parameter (measure to identify the rate and breadth of exploratory behavior on different time scales). Results revealed that a higher the number of opponents required for more frequent ball controls. Moreover, with a higher number of teammates, there were more defensive actions focused on protecting the goal, with more players balancing. In relation to attack, an increase in the number of opponents produced a decrease in passing, driving and controlling actions, while an increase in the number of teammates led to more time being spent in attacking situations. A numerical advantage led to less exploratory behavior, an effect that was especially clear when playing within a team of seven players against four opponents. All teams showed strong effects of the number of teammates on the exploratory behavior when comparing 5 vs 7 or 3 vs 7 teammates. These results seem to be independent of the players' level.	[Torrents, Carlota; Ric, Angel; Vicente, Emili] Univ Lleida, INEFC, Natl Inst Phys Educ Catalonia, Lleida, Spain; [Hristovski, Robert] Sts Cyril & Methodius Univ, Skopje, Macedonia; [Torres-Ronda, Lorena] Texas A&M Univ, Dept Hlth & Kinesiol, Exercise & Sport Nutr Lab, College Stn, TX USA; [Sampaio, Jaime] CIDESD, Res Ctr Sports Sci Hlth Sci & Human Dev, CreativeLab, Vila Real, Portugal; [Sampaio, Jaime] Univ Tras Os Montes & Alto Douro, Sport Sci Dept, Vila Real, Portugal	Universitat de Lleida; Saints Cyril & Methodius University of Skopje; Texas A&M University System; Texas A&M University College Station; University of Tras-os-Montes & Alto Douro	Torrents, C (corresponding author), Univ Lleida, INEFC, Natl Inst Phys Educ Catalonia, Lleida, Spain.	ctorrents@inefc.es	Ric, Angel/F-8977-2016; Sampaio, Jaime/B-7392-2008; Hristovski, Robert/L-4116-2015; Ric, Angel/AAR-6566-2020; Torrents, Carlota/AAX-6166-2020; Torrents, Carlota/D-5704-2017	Ric, Angel/0000-0003-4944-4529; Sampaio, Jaime/0000-0003-2335-9991; Hristovski, Robert/0000-0001-6805-2833; Ric, Angel/0000-0003-4944-4529; Torrents, Carlota/0000-0003-4912-2802; Torrents, Carlota/0000-0003-4912-2802; Mateu Serra, Merce/0000-0001-7809-5597	National Institute of Physical Education of Catalonia (INEFC), Generalitat de Catalunya; Generalitat de Catalunya government project Grup de recerca en Sistemes Complexos i Esport [2014 SGR 975]; Project Symbiotic technology for societal efficiency gains: Deus ex Machina (DEM) [NORTE-01-0145-FEDER-000026]; Fundo Europeu de Desenvolvimento Regional (FEDER) by NORTE	National Institute of Physical Education of Catalonia (INEFC), Generalitat de Catalunya; Generalitat de Catalunya government project Grup de recerca en Sistemes Complexos i Esport; Project Symbiotic technology for societal efficiency gains: Deus ex Machina (DEM); Fundo Europeu de Desenvolvimento Regional (FEDER) by NORTE	This study was supported by the National Institute of Physical Education of Catalonia (INEFC), Generalitat de Catalunya.; We would like to thank the players who volunteered to participate in this study. We gratefully acknowledge the support of the Generalitat de Catalunya government project Grup de recerca en Sistemes Complexos i Esport (2014 SGR 975) and Project Symbiotic technology for societal efficiency gains: Deus ex Machina (DEM), NORTE-01-0145-FEDER-000026, co-financed by Fundo Europeu de Desenvolvimento Regional (FEDER) by NORTE 2020.	Abrantes CI, 2012, J STRENGTH COND RES, V26, P976, DOI 10.1519/JSC.0b013e31822dd398; Aguiar MVD, 2013, J STRENGTH COND RES, V27, P1287, DOI 10.1519/JSC.0b013e318267a35c; Amabile T.M., 1989, GROWING CREATIVE NUR; Araujo D, 2007, ECOL PSYCHOL, V19, P69, DOI 10.1080/10407410709336951; Boden M.A., 1996, DIMENSIONS CREATIVIT, P75; Bruineberg J, 2014, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.00599; Casamichana D, 2010, J SPORT SCI, V28, P1615, DOI 10.1080/02640414.2010.521168; Castaner M, 2009, APUNT EDUC FIS DEPOR, P14; Castellano J, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0127505; Chemero A, 2003, ECOL PSYCHOL, V15, P181, DOI 10.1207/S15326969ECO1502_5; Costa I.T., 2011, MOTRICIDADE, V7, P69, DOI [DOI 10.6063/MOTRICIDADE.7(1).121, 10.6063/motricidade.121, DOI 10.6063/MOTRICIDADE.121]; Davids K, 2013, EXERC SPORT SCI REV, V41, P154, DOI 10.1097/JES.0b013e318292f3ec; Dellal A, 2011, J STRENGTH COND RES, V25, P2371, DOI 10.1519/JSC.0b013e3181fb4296; Drazin R, 1999, ACAD MANAGE REV, V24, P286, DOI 10.2307/259083; Duarte R., 2009, OPEN SPORTS SCI J, V2, P37, DOI [10.2174/1875399X00902010037, DOI 10.2174/1875399X00902010037]; Gibson J.J., 1986, ECOLOGICAL APPROACH; Goncalves B, 2016, J SPORT SCI, V34, P1346, DOI 10.1080/02640414.2016.1143111; Guilford J.P., 1967, NATURE HUMAN INTELLI; Halouani J, 2014, J SPORT SCI, V32, P1485, DOI 10.1080/02640414.2014.899707; Hearn G, 2014, CREATIVE WORK BEYOND THE CREATIVE INDUSTRIES: INNOVATION, EMPLOYMENT AND EDUCATION, P175; Hill-Haas SV, 2011, SPORTS MED, V41, P199, DOI 10.2165/11539740-000000000-00000; Hristovski R., 2012, OPEN SPORTS SCI J S, V5, P26, DOI [10.2174/1875399X01205010026, DOI 10.2174/1875399X01205010026]; Hristovski R., 2009, PERSPECTIVES COGNITI, P43; Hristovski R., 2013, COMPLEX SYSTEMS SPOR, P261; Hristovski R, 2011, NONLIN DYNAM PSYCHOL, V15, P175; Joliffe I. T., 2002, PRINCIPAL COMPONENT, V2nd; Jones S., 2007, KINESIOLOGY, V39, P150; Kasof J, 1995, CREATIVITY RES J, V8, P397; Katis A, 2009, J SPORT SCI MED, V8, P374; Keith F, 2011, IEEE INT C INT ROBOT, P3887, DOI 10.1109/IROS.2011.6048309; Kelso J. A., 2009, ENCY COMPLEXITY SYST, P1537, DOI [10.1007/978-0-387-30440-3_101, DOI 10.1007/978-0-387-30440-3_101]; Kelso JAS, 1995, COMPLEX ADAPTIVE SYS; Los Arcos A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0137224; Memmert D., 2015, TEACHING TACTICAL CR; Memmert D., 2011, ENCY CREATIVITY, V2, P373, DOI [10.1016/B978-0-12-375038-9.00207-7, DOI 10.1016/B978-0-12-375038-9.00207-7]; Memmert D, 2007, J SPORT SCI, V25, P1423, DOI 10.1080/02640410601129755; Memmert M, 2014, RES PHYS ED SPORT HL, V3, P13, DOI DOI 10.4324/9781315146270-11; Mendes RS, 2007, EUR PHYS J B, V57, P357, DOI [10.1140/epjb/e2007-00177-4, 10.1140/epjb/o2007-00177-4]; Mitchell S, 2007, ECOLOGICAL APPROACH, P161; Mumford MD, 1997, J CREATIVE BEHAV, V31, P1; Newell K.M., 1986, MOTOR DEV CHILDREN A, VVolume 34, P341, DOI DOI 10.1007/978-94-009-4460-2_19; Owen A, 2004, INSIGHT, V7, P50; Owen AL, 2014, INT J SPORTS MED, V35, P286, DOI 10.1055/s-0033-1351333; Owen AL, 2011, J STRENGTH COND RES, V25, P2104, DOI 10.1519/JSC.0b013e3181f0a8a3; Ric A, 2015, RES PHYS ED SPORT HL, V4, P35; Ric A, 2016, J SPORT SCI, V34, P1723, DOI 10.1080/02640414.2015.1136068; Riley MA, 2011, FRONT PSYCHOL, V2, DOI 10.3389/fpsyg.2011.00038; RUNCO MA, 1993, PERS INDIV DIFFER, V15, P537, DOI 10.1016/0191-8869(93)90337-3; Runco MA, 2004, ANNU REV PSYCHOL, V55, P657, DOI 10.1146/annurev.psych.55.090902.141502; Sampaio JE, 2014, J SCI MED SPORT, V17, P229, DOI 10.1016/j.jsams.2013.04.005; Schoner G, 1995, ECOL PSYCHOL, V7, P291, DOI 10.1207/s15326969eco0704_5; Sibani P, 2003, EUROPHYS LETT, V64, P8, DOI 10.1209/epl/i2003-00109-0; Silva P, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107112; Sternberg RJ, 1996, AM PSYCHOL, V51, P677, DOI 10.1037/0003-066X.51.7.677; Stokes PD, 2009, PSYCHOL AESTHET CREA, V3, P174, DOI 10.1037/a0014970; Stokes PD, 2008, J CREATIVE BEHAV, V42, P223, DOI 10.1002/j.2162-6057.2008.tb01297.x; Stokes PD, 2001, AM PSYCHOL, V56, P355, DOI 10.1037//0003-066X.56.4.355; Torrents C, 2016, INTERPERSONAL COORDINATION AND PERFORMANCE IN SOCIAL SYSTEMS, P85; Martin CT, 2015, PSYCHOL AESTHET CREA, V9, P65, DOI 10.1037/a0038706; Turvey M. T., 1992, ECOL PSYCHOL, V4, P173, DOI [10.1207/s15326969eco0403_3, DOI 10.1207/S15326969EC00403_]; Westerhuis JA, 1998, J CHEMOMETR, V12, P301, DOI 10.1002/(SICI)1099-128X(199809/10)12:5<301::AID-CEM515>3.0.CO;2-S; Withagen R, 2012, NEW IDEAS PSYCHOL, V30, P250, DOI 10.1016/j.newideapsych.2011.12.003; Yamamoto Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029638	63	42	42	3	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2016	11	12							e0168866	10.1371/journal.pone.0168866	http://dx.doi.org/10.1371/journal.pone.0168866			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EI9QH	28005978	Green Published, Green Submitted, gold			2022-12-27	WOS:000392843200107
J	Vega, ML; Willemoes, M; Thomson, RL; Tolvanen, J; Rutila, J; Samas, P; Strandberg, R; Grim, T; Fossoy, F; Stokke, BG; Thorup, K				Vega, Marta Lomas; Willemoes, Mikkel; Thomson, Robert L.; Tolvanen, Jere; Rutila, Jarkko; Samas, Peter; Strandberg, Roine; Grim, Tomas; Fossoy, Frode; Stokke, Bard Gunnar; Thorup, Kasper			First-Time Migration in Juvenile Common Cuckoos Documented by Satellite Tracking	PLoS One			English	Article							BUZZARDS PERNIS-APIVORUS; CUCULUS-CANORUS; BREEDING SUCCESS; ORIENTATION; POPULATION; BIRDS; TECHNOLOGY; PARASITISM; MIGRANTS; WARBLERS	Being an obligate parasite, juvenile common cuckoos Cuculus canorus are thought to reach their African wintering grounds from Palearctic breeding grounds without guidance from experienced conspecifics but this has not been documented. We used satellite tracking to study naive migrating common cuckoos. Juvenile cuckoos left breeding sites in Finland moving slowly and less consistently directed than adult cuckoos. Migration of the juveniles (N = 5) was initiated later than adults (N = 20), was directed toward the southwest-significantly different from the initial southeast direction of adults-and included strikingly long Baltic Sea crossings (N = 3). After initial migration of juvenile cuckoos toward Poland, the migration direction changed and proceeded due south, directly toward the winter grounds, as revealed by a single tag transmitting until arrival in Northwest Angola where northern adult cuckoos regularly winter. Compared to adults, the juvenile travelled straighter and faster, potentially correcting for wind drift along the route. That both migration route and timing differed from adults indicates that juvenile cuckoos are able to reach proper wintering grounds independently, guided only by their innate migration programme.	[Vega, Marta Lomas; Willemoes, Mikkel; Thorup, Kasper] Univ Copenhagen, Nat Hist Museum Denmark, Ctr Macroecol Evolut & Climate, Copenhagen, Denmark; [Thomson, Robert L.] Univ Turku, Dept Biol, Turku, Finland; [Thomson, Robert L.] Univ Cape Town, FitzPatrick Inst African Ornithol, Cape Town, South Africa; [Tolvanen, Jere] Univ Oulu, Dept Ecol, Oulu, Finland; [Rutila, Jarkko] Univ Eastern Finland, Dept Environm & Biol Sci, Joensuu, Finland; [Samas, Peter; Grim, Tomas] Palacky Univ, Dept Zool, Olomouc, Czech Republic; [Samas, Peter; Grim, Tomas] Palacky Univ, Ornithol Lab, Olomouc, Czech Republic; [Strandberg, Roine] Lund Univ, Dept Biol, Lund, Sweden; [Fossoy, Frode; Stokke, Bard Gunnar] Norwegian Univ Sci & Technol, Dept Biol, Trondheim, Norway; [Fossoy, Frode; Stokke, Bard Gunnar] Norwegian Inst Nat Res NINA, Trondheim, Norway	University of Copenhagen; University of Turku; University of Cape Town; University of Oulu; University of Eastern Finland; Palacky University Olomouc; Palacky University Olomouc; Lund University; Norwegian University of Science & Technology (NTNU); Norwegian Institute Nature Research	Vega, ML (corresponding author), Univ Copenhagen, Nat Hist Museum Denmark, Ctr Macroecol Evolut & Climate, Copenhagen, Denmark.	marta.l.vega@snm.ku.dk	Thomson, Robert L/B-9637-2012; Thorup, Kasper/A-4835-2013; Samas, Peter/E-3152-2016; Fossoy, Frode/O-3073-2017; Willemoes, Mikkel/J-9391-2012; Lomas Vega, Marta/C-6710-2015; Grim, Tomas/A-2852-2008	Thomson, Robert L/0000-0002-6958-1259; Thorup, Kasper/0000-0002-0320-0601; Fossoy, Frode/0000-0002-7535-9574; Willemoes, Mikkel/0000-0001-9363-6304; Lomas Vega, Marta/0000-0002-9397-8803; Grim, Tomas/0000-0002-5775-6269; Tolvanen, Jere/0000-0002-0250-3176	Danish Council for Independent Research [1323-00048B]; Danish National Research Foundation [DNRF96]; Czech Science Foundation [P506/12/2404]; Human Frontier Science Program [RGY69/07, RGY83/12]; Academy of Finland [138049]; Research Council of Norway [218144]	Danish Council for Independent Research(Det Frie Forskningsrad (DFF)); Danish National Research Foundation(Danmarks Grundforskningsfond); Czech Science Foundation(Grant Agency of the Czech Republic); Human Frontier Science Program(Human Frontier Science Program); Academy of Finland(Academy of Finland); Research Council of Norway(Research Council of Norway)	KT, MLV, and MW were supported by The Danish Council for Independent Research through support to the MATCH project (1323-00048B) and Danish National Research Foundation through support to the Center for Macroecology, Evolution and Climate (DNRF96). PS and TG were supported by the Czech Science Foundation (grant no. P506/12/2404) and TG by Human Frontier Science Program (awards RGY69/07 and RGY83/12). RUT was supported by Academy of Finland (#138049). The Research Council of Norway funded BGS and FF (218144). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agostini N, 2004, J AVIAN BIOL, V35, P469, DOI 10.1111/j.0908-8857.2004.03450.x; Akesson S, 2005, CURR BIOL, V15, P1591, DOI 10.1016/j.cub.2005.07.027; ALERSTAM T, 2015, VAR FAGELVARLD, P38; Bridge ES, 2011, BIOSCIENCE, V61, P689, DOI 10.1525/bio.2011.61.9.7; Brown JM, 2015, BIOL LETTERS, V11, DOI 10.1098/rsbl.2015.0593; Davies N.B., 2000, CUCKOOS COWBIRDS OTH; Fossoy F, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10272; Gill RE, 2009, P ROY SOC B-BIOL SCI, V276, P447, DOI 10.1098/rspb.2008.1142; Grim T, 2009, BEHAV ECOL, V20, P1138, DOI 10.1093/beheco/arp108; Guilford T, 2011, J EXP BIOL, V214, P3705, DOI 10.1242/jeb.051292; Hake M, 2003, OIKOS, V103, P385, DOI 10.1034/j.1600-0706.2003.12145.x; Hake M, 2001, J AVIAN BIOL, V32, P47, DOI 10.1034/j.1600-048X.2001.320107.x; Hewson CM, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12296; Kemp MU, 2012, METHODS ECOL EVOL, V3, P65, DOI 10.1111/j.2041-210X.2011.00138.x; Kleven O, 2004, J AVIAN BIOL, V35, P394, DOI 10.1111/j.0908-8857.2004.03359.x; Kovach WL, 2009, ORIANA CIRCULAR STAT; Larkin R.P., 1982, P28; Mellone U, 2013, J AVIAN BIOL, V44, P417, DOI 10.1111/j.1600-048X.2013.00139.x; MEWALDT LR, 1964, SCIENCE, V146, P941, DOI 10.1126/science.146.3646.941; MORTON ML, 1991, ORNIS SCAND, V22, P98, DOI 10.2307/3676540; Mukhin A, 2005, P ROY SOC B-BIOL SCI, V272, P1535, DOI 10.1098/rspb.2005.3120; Oppel S, 2015, IBIS, V157, P545, DOI 10.1111/ibi.12258; Payne R, 2016, HDB BIRDS WORLD ALIV; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; SEEL DC, 1977, IBIS, V119, P309, DOI 10.1111/j.1474-919X.1977.tb08250.x; Sklepowicz B, 2009, ACTA ORNITHOL, V44, P177, DOI 10.3161/000164509X482759; SUTHERLAND WJ, 1988, NATURE, V334, P471, DOI 10.1038/334471a0; Thomson RL, 2016, J AVIAN BIOL, V47, P363, DOI 10.1111/jav.00915; Thorup K, 2003, P ROY SOC B-BIOL SCI, V270, pS8, DOI 10.1098/rsbl.2003.0014; Thorup K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017903; Thorup K, 2010, INTEGR COMP BIOL, V50, P315, DOI 10.1093/icb/icq065; Valkama J., 2014, SUOMEN RENGASTUSATLA, VII; Willemoes M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0083515; Wyllie I., 1981, CUCKOO; ZUUR B, 1984, Vogelwarte, V32, P206	35	25	25	2	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2016	11	12							e0168940	10.1371/journal.pone.0168940	http://dx.doi.org/10.1371/journal.pone.0168940			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI9QH	28005960	gold, Green Published			2022-12-27	WOS:000392843200112
J	Weiss, J; Devoto, SH				Weiss, Julian; Devoto, Stephen H.			Osmotic and Heat Stress Effects on Segmentation	PLoS One			English	Article							CONGENITAL SCOLIOSIS; C. ELEGANS; SHOCK; ZEBRAFISH; SOMITOGENESIS; ETIOLOGY; DEFECTS; EMBRYO; TBX6	During vertebrate embryonic development, early skin, muscle, and bone progenitor populations organize into segments known as somites. Defects in this conserved process of segmentation lead to skeletal and muscular deformities, such as congenital scoliosis, a curvature of the spine caused by vertebral defects. Environmental stresses such as hypoxia or heat shock produce segmentation defects, and significantly increase the penetrance and severity of vertebral defects in genetically susceptible individuals. Here we show that a brief exposure to a high osmolarity solution causes reproducible segmentation defects in developing zebrafish ( Danio rerio) embryos. Both osmotic shock and heat shock produce border defects in a dose-dependent manner, with an increase in both frequency and severity of defects. We also show that osmotic treatment has a delayed effect on somite development, similar to that observed in heat shocked embryos. Our results establish osmotic shock as an alternate experimental model for stress, affecting segmentation in a manner comparable to other known environmental stressors. The similar effects of these two distinct environmental stressors support a model in which a variety of cellular stresses act through a related response pathway that leads to disturbances in the segmentation process.	[Weiss, Julian; Devoto, Stephen H.] Wesleyan Univ, Dept Biol, Middletown, CT 06459 USA	Wesleyan University	Devoto, SH (corresponding author), Wesleyan Univ, Dept Biol, Middletown, CT 06459 USA.	sdevoto@wesleyan.edu	Devoto, Stephen/H-3088-2019	Devoto, Stephen/0000-0001-9513-3962; Weiss, Julian/0000-0003-4050-6690	National Institute of Arthritis and Musculoskeletal and Skin Diseases [1R15AR066284-01]; National Institute of Arthritis and Musculoskeletal and Skin Diseases of the National Institutes of Health [1R15AR066284-01]	National Institute of Arthritis and Musculoskeletal and Skin Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); National Institute of Arthritis and Musculoskeletal and Skin Diseases of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	Funding for this study was provided by the National Institute of Arthritis and Musculoskeletal and Skin Diseases 1R15AR066284-01 to Dr. Stephen Henri Devoto. Research reported in this publication was supported by the National Institute of Arthritis and Musculoskeletal and Skin Diseases of the National Institutes of Health under Award Number 1R15AR066284-01. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akiyama R, 2014, DEVELOPMENT, V141, P1104, DOI 10.1242/dev.098905; Alexander PG, 2010, BIRTH DEFECTS RES C, V90, P118, DOI 10.1002/bdrc.20179; Bando Y, 2012, ANAT SCI INT, V87, P14, DOI 10.1007/s12565-011-0127-5; Burkewitz K, 2011, AM J PHYSIOL-CELL PH, V301, pC566, DOI 10.1152/ajpcell.00030.2011; Eckalbar WL, 2012, WIRES DEV BIOL, V1, P401, DOI 10.1002/wdev.34; ELSDALE T, 1976, J EMBRYOL EXP MORPH, V35, P625; Enserink JM, 2015, CELL DIV, V10, DOI 10.1186/s13008-015-0010-1; Giampietro PF, 2009, ANN NY ACAD SCI, V1151, P38, DOI 10.1111/j.1749-6632.2008.03452.x; Hubaud A, 2014, CELL BIOL, V15, P709, DOI [10.1038/nrm3891, DOI 10.1038/NRM3891]; Maroto M, 2012, DEVELOPMENT, V139, P2453, DOI 10.1242/dev.069310; Pourquie O, 2001, DEV CELL, V1, P619, DOI 10.1016/S1534-5807(01)00082-X; PRIMMETT DRN, 1988, DEVELOPMENT, V104, P331; Rodriguez M, 2013, TRENDS GENET, V29, P367, DOI 10.1016/j.tig.2013.01.010; Roy MN, 1999, MECH DEVELOP, V85, P27, DOI 10.1016/S0925-4773(99)00039-8; Schmidt K, 2010, J EXP ZOOL PART B, V314B, P166, DOI 10.1002/jez.b.21320; Sparrow DB, 2012, CELL, V149, P295, DOI 10.1016/j.cell.2012.02.054; Sparrow DB, 2011, MAMM GENOME, V22, P362, DOI 10.1007/s00335-011-9335-5; Wallace EWJ, 2015, CELL, V162, P1286, DOI 10.1016/j.cell.2015.08.041; Walter P, 2011, SCIENCE, V334, P1081, DOI 10.1126/science.1209038; Wargelius A, 2005, DEV GENES EVOL, V215, P350, DOI 10.1007/s00427-005-0482-0; Westerfield M., 1995, ZEBRAFISH BOOK GUIDE; Windner SE, 2015, DEVELOPMENT, V142, P1159, DOI 10.1242/dev.113431; Wu N, 2015, NEW ENGL J MED, V372, P341, DOI 10.1056/NEJMoa1406829	23	2	2	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2016	11	12							e0168335	10.1371/journal.pone.0168335	http://dx.doi.org/10.1371/journal.pone.0168335			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI9QH	28006008	Green Published, gold, Green Submitted			2022-12-27	WOS:000392843200044
J	Maenner, MJ; Yeargin-Allsopp, M; Braun, KV; Christensen, DL; Schieve, LA				Maenner, Matthew J.; Yeargin-Allsopp, Marshalyn; Braun, Kim Van Naarden; Christensen, Deborah L.; Schieve, Laura A.			Development of a Machine Learning Algorithm for the Surveillance of Autism Spectrum Disorder	PLOS ONE			English	Article							CHILDREN; DIAGNOSIS; COMORBIDITY; PREVALENCE; AGE	The Autism and Developmental Disabilities Monitoring (ADDM) Network conducts population-based surveillance of autism spectrum disorder (ASD) among 8-year old children in multiple US sites. To classify ASD, trained clinicians review developmental evaluations collected from multiple health and education sources to determine whether the child meets the ASD surveillance case criteria. The number of evaluations collected has dramatically increased since the year 2000, challenging the resources and timeliness of the surveillance system. We developed and evaluated a machine learning approach to classify case status in ADDM using words and phrases contained in children's developmental evaluations. We trained a random forest classifier using data from the 2008 Georgia ADDM site which included 1,162 children with 5,396 evaluations (601 children met ADDM ASD criteria using standard ADDM methods). The classifier used the words and phrases from the evaluations to predict ASD case status. We evaluated its performance on the 2010 Georgia ADDM surveillance data (1,450 children with 9,811 evaluations; 754 children met ADDM ASD criteria). We also estimated ASD prevalence using predictions from the classification algorithm. Overall, the machine learning approach predicted ASD case statuses that were 86.5% concordant with the clinician-determined case statuses (84.0% sensitivity, 89.4% predictive value positive). The area under the resulting receiver-operating characteristic curve was 0.932. Algorithm-derived ASD "prevalence" was 1.46% compared to the published (clinician-determined) estimate of 1.55%. Using only the text contained in developmental evaluations, a machine learning algorithm was able to discriminate between children that do and do not meet ASD surveillance criteria at one surveillance site.	[Maenner, Matthew J.; Yeargin-Allsopp, Marshalyn; Braun, Kim Van Naarden; Christensen, Deborah L.; Schieve, Laura A.] Ctr Dis Control & Prevent, Natl Ctr Birth Defects & Dev Disabil, Atlanta, GA 30333 USA; [Maenner, Matthew J.] Ctr Dis Control & Prevent, Epidem Intelligence Serv, Atlanta, GA 30333 USA	Centers for Disease Control & Prevention - USA; Centers for Disease Control & Prevention - USA	Maenner, MJ (corresponding author), Ctr Dis Control & Prevent, Natl Ctr Birth Defects & Dev Disabil, Atlanta, GA 30333 USA.; Maenner, MJ (corresponding author), Ctr Dis Control & Prevent, Epidem Intelligence Serv, Atlanta, GA 30333 USA.	xde8@cdc.gov						American psychiatric association, 2013, DIAGNOSTIC STAT MANU, DOI 10.1176/appi.books.9780890425596; Bakian AV, 2015, J AUTISM DEV DISORD, V45, P873, DOI 10.1007/s10803-014-2187-6; Breiman L, 2001, MACH LEARN, V45, P5, DOI 10.1023/A:1010933404324; Burke JP, 2014, AUTISM, V18, P321, DOI 10.1177/1362361312467709; *CDCP, 2009, MMWR-MORBID MORTAL W, V58, P1; Centers for Disease Control and Prevention (CDC), 2007, MMWR SURVEILL SUMM, V56, P2; Croen LA, 2006, PEDIATRICS, V118, pE1203, DOI 10.1542/peds.2006-0127; Dodds L, 2009, CHRONIC DIS CAN, V29, P102; Doshi-Velez F, 2014, PEDIATRICS, V133, pE54, DOI 10.1542/peds.2013-0819; Fombonne E, 2004, BMC PUBLIC HEALTH, V4, DOI 10.1186/1471-2458-4-5; Hahn Robert, 2007, MMWR Recomm Rep, V56, P1; Henley SJ, 2014, MMWR-MORBID MORTAL W, V63, P1; Hertz-Picciotto I, 2009, EPIDEMIOLOGY, V20, P84, DOI 10.1097/EDE.0b013e3181902d15; Jain A, 2015, JAMA-J AM MED ASSOC, V313, P1534, DOI 10.1001/jama.2015.3077; Lauritsen MB, 2010, J AUTISM DEV DISORD, V40, P139, DOI 10.1007/s10803-009-0818-0; MacFarlane JR, 2009, J CHILD FAM STUD, V18, P662, DOI 10.1007/s10826-009-9268-8; Maenner MJ, 2010, PEDIATRICS, V126, pE1018, DOI 10.1542/peds.2010-1023; Mandell DS, 2010, J AUTISM DEV DISORD, V40, P1241, DOI 10.1007/s10803-010-0982-2; Mandell DS, 2002, J AM ACAD CHILD PSY, V41, P1447, DOI 10.1097/00004583-200212000-00016; Mengwen Liu, 2013, 2013 IEEE International Conference on Bioinformatics and Biomedicine (BIBM), P566, DOI 10.1109/BIBM.2013.6732559; Moshfegh Alanna J., 2012, Morbidity and Mortality Weekly Report, V61, P92; Newschaffer CJ, 2007, ANNU REV PUBL HEALTH, V28, P235, DOI 10.1146/annurev.publhealth.28.021406.144007; Polyak A, 2015, AM J MED GENET B, V168, P600, DOI 10.1002/ajmg.b.32338; Rice CE, 2007, PAEDIATR PERINAT EP, V21, P179, DOI 10.1111/j.1365-3016.2007.00801.x; Rice CE, 2014, IMFAR 2014 ATL GA; Savel Thomas G, 2012, MMWR Suppl, V61, P20	26	36	36	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2016	11	12							e0168224	10.1371/journal.pone.0168224	http://dx.doi.org/10.1371/journal.pone.0168224			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EI9TW	28002438	Green Published, Green Submitted, gold			2022-12-27	WOS:000392853100035
J	Martin, T; Ronnberg-Wastljung, AC; Stenlid, J; Samils, B				Martin, Tom; Ronnberg-Wastljung, Ann-Christin; Stenlid, Jan; Samils, Berit			Identification of a Differentially Expressed TIR-NBS-LRR Gene in a Major QTL Associated to Leaf Rust Resistance in Salix	PLoS One			English	Article							MELAMPSORA-LARICI-POPULINA; STRUCTURAL BASIS; WILLOW; SPECIFICITY; TRICHOCARPA; SELECTION; IMMUNITY; POPLAR; GENOME; FLAX	An earlier identified major quantitative trait locus for resistance towards the willow leaf rust fungus Melampsora larici-epitea in a Salix viminalis x (S. viminalis x S. schwerinii) population was used to identify potential resistance genes to the rust pathogen. Screening a genomic bacterial artificial chromosome library with markers from the peak position of the QTL region revealed one gene with TIR-NBS-LRR (Toll Interleukin1 Receptor-Nucleotide Binding Site-Leucine-Rich Repeat) domain structure indicative of a resistance gene. The resistance gene analog was denoted RGA1 and further analysis revealed a number of non-synonymous single nucleotide polymorphisms in the LRR domain between the resistant and susceptible Salix genotypes. Gene expression levels under controlled conditions showed a significantly lower constitutive expression of RGA1 in the susceptible genotype. In addition, the susceptible genotype showed a significantly reduced expression level of the RGA1 gene at 24 hours post inoculation with M. larici-epitea. This indicates that the pathogen may actively suppress RGA1 gene expression allowing a compatible plant-pathogen interaction and causing infection.	[Martin, Tom; Ronnberg-Wastljung, Ann-Christin] Swedish Univ Agr Sci, Dept Plant Biol, Uppsala, Sweden; [Stenlid, Jan; Samils, Berit] Swedish Univ Agr Sci, Dept Forest Mycol & Plant Pathol, Uppsala, Sweden	Swedish University of Agricultural Sciences; Swedish University of Agricultural Sciences	Samils, B (corresponding author), Swedish Univ Agr Sci, Dept Forest Mycol & Plant Pathol, Uppsala, Sweden.	berit.samils@slu.se	Stenlid, Jan/K-5909-2019		governmental Swedish Energy Agency; NLfaculty at the Swedish University of Agricultural Sciences	governmental Swedish Energy Agency; NLfaculty at the Swedish University of Agricultural Sciences	This research was supported by the governmental Swedish Energy Agency (JS) (http://www.energimyndigheten.se/en/) and The NLfaculty at the Swedish University of Agricultural Sciences (JS) (http //www.slu.se/en/faculties/nj/). The two funders above had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The SNP Technology Platform, Uppsala, Sweden (JS) (http://molmed.medsci.uu.se/SNP+SEQ+Technology+Platform/Genotyping/) performed the high-throughput sequencing.	Baxter RHG, 2010, P NATL ACAD SCI USA, V107, P16817, DOI 10.1073/pnas.1010575107; Berlin S, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-129; Bertholdsson NO, 2001, ASP APPL BIOL, V65, P205; Cao YL, 2007, GENETICS, V177, P523, DOI 10.1534/genetics.107.075176; Chen ZJ, 2014, GENET MOL RES, V13, P2082, DOI 10.4238/2014.March.24.12; De Leonardis AM, 2013, INT J MOL SCI, V14, P7302, DOI [10.3390/ijms14047302, DOI 10.3390/IJMS14047302]; Ellis JG, 2007, MOL PLANT PATHOL, V8, P103, DOI 10.1111/J.1364-3703.2006.00375.X; Garnica DP, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004329; Helft L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021614; Jones JDG, 2006, NATURE, V444, P323, DOI 10.1038/nature05286; Kohler A, 2008, PLANT MOL BIOL, V66, P619, DOI 10.1007/s11103-008-9293-9; Laurans E, 1999, PHYTOPATHOLOGY, V89, P233, DOI 10.1094/PHYTO.1999.89.3.233; McCracken AR, 1998, EUR J FOREST PATHOL, V28, P241; McDonald BA, 2002, ANNU REV PHYTOPATHOL, V40, P349, DOI 10.1146/annurev.phyto.40.120501.101443; Michelmore RW, 1998, GENOME RES, V8, P1113, DOI 10.1101/gr.8.11.1113; Padmanabhan M, 2009, CELL MICROBIOL, V11, P191, DOI 10.1111/j.1462-5822.2008.01260.x; Pei MH, 2000, EUR J PLANT PATHOL, V106, P771, DOI 10.1023/A:1026593119871; Puckett EE, 2012, ENVIRON EXP BOT, V75, P248, DOI 10.1016/j.envexpbot.2011.07.008; Rinaldi C, 2007, PLANT PHYSIOL, V144, P347, DOI 10.1104/pp.106.094987; Salmon J, 2014, PLANT BIOTECHNOL J, V12, P480, DOI 10.1111/pbi.12154; Samils B, 2001, EUR J PLANT PATHOL, V107, P399, DOI 10.1023/A:1011270315251; Samils B, 2011, TREE GENET GENOMES, V7, P1219, DOI 10.1007/s11295-011-0408-0; Sekine KT, 2008, MOL PLANT MICROBE IN, V21, P1398, DOI 10.1094/MPMI-21-11-1398; Takken FLW, 2012, CURR OPIN PLANT BIOL, V15, P375, DOI 10.1016/j.pbi.2012.05.001; Tsarouhas V, 2002, THEOR APPL GENET, V105, P277, DOI 10.1007/s00122-002-0918-0; Tuskan GA, 2006, SCIENCE, V313, P1596, DOI 10.1126/science.1128691; Volk TA, 2004, FRONT ECOL ENVIRON, V2, P411, DOI 10.1890/1540-9295(2004)002[0411:GFASAO]2.0.CO;2; Wang CIA, 2007, PLANT CELL, V19, P2898, DOI 10.1105/tpc.107.053611; Wirthmueller L, 2013, NAT REV MICROBIOL, V11, P761, DOI 10.1038/nrmicro3118; Xu M, 2011, ANAL BIOCHEM, V408, P337, DOI 10.1016/j.ab.2010.08.044	30	10	11	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2016	11	12							e0168776	10.1371/journal.pone.0168776	http://dx.doi.org/10.1371/journal.pone.0168776			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI9TW	28002449	Green Published, gold, Green Submitted			2022-12-27	WOS:000392853100067
J	Quinlan, J; Pearson, LN; Clukay, CJ; Mitchell, MM; Boston, Q; Gravlee, CC; Mulligan, CJ				Quinlan, Jacklyn; Pearson, Laurel N.; Clukay, Christopher J.; Mitchell, Miaisha M.; Boston, Qasimah; Gravlee, Clarence C.; Mulligan, Connie J.			Genetic Loci and Novel Discrimination Measures Associated with Blood Pressure Variation in African Americans Living in Tallahassee	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; HYPOXIA-INDUCIBLE FACTOR-1-ALPHA; MAJOR DEPRESSIVE DISORDER; BODY-MASS INDEX; MISSING HERITABILITY; PERCEIVED DISCRIMINATION; HYPERTROPHIC CARDIOMYOPATHY; CARDIOVASCULAR-DISEASE; RACIAL-DISCRIMINATION; POPULATION-STRUCTURE	Sequencing of the human genome and decades of genetic association and linkage studies have dramatically improved our understanding of the etiology of many diseases. However, the multiple causes of complex diseases are still not well understood, in part because genetic and sociocultural risk factors are not typically investigated concurrently. Hypertension is a leading risk factor for cardiovascular disease and afflicts more African Americans than any other racially defined group in the US. Few genetic loci for hypertension have been replicated across populations, which may reflect population-specific differences in genetic variants and/or inattention to relevant sociocultural factors. Discrimination is a salient sociocultural risk factor for poor health and has been associated with hypertension. Here we use a biocultural approach to study blood pressure (BP) variation in African Americans living in Tallahassee, Florida by genotyping over 30,000 single nucleotide polymorphisms (SNPs) and capturing experiences of discrimination using novel measures of unfair treatment of self and others (n = 157). We perform a joint admixture and genetic association analysis for BP that prioritizes regions of the genome with African ancestry. We only report significant SNPs that were confirmed through our simulation analyses, which were performed to determine the false positive rate. We identify eight significant SNPs in five genes that were previously associated with cardiovascular diseases. When we include measures of unfair treatment and test for interactions between SNPs and unfair treatment, we identify a new class of genes involved in multiple phenotypes including psychosocial distress and mood disorders. Our results suggest that inclusion of culturally relevant stress measures, like unfair treatment in African Americans, may reveal new genes and biological pathways relevant to the etiology of hypertension, and may also improve our understanding of the complexity of gene-environment interactions that underlie complex diseases.	[Quinlan, Jacklyn; Clukay, Christopher J.; Gravlee, Clarence C.; Mulligan, Connie J.] Univ Florida, Dept Anthropol, Gainesville, FL 32611 USA; [Quinlan, Jacklyn; Mulligan, Connie J.] Univ Florida, Genet Inst, Gainesville, FL 32611 USA; [Pearson, Laurel N.] Penn State Univ, Dept Anthropol, University Pk, PA 16802 USA; [Mitchell, Miaisha M.; Boston, Qasimah; Gravlee, Clarence C.] HEAT, Tallahassee, FL USA; [Mitchell, Miaisha M.] Greater Frenchtown Revitalizat Council, Tallahassee, FL USA; [Boston, Qasimah] Florida Dept Children & Families, Subst Abuse & Mental Hlth Program, Tallahassee, FL USA	State University System of Florida; University of Florida; State University System of Florida; University of Florida; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park	Quinlan, J (corresponding author), Univ Florida, Dept Anthropol, Gainesville, FL 32611 USA.; Quinlan, J (corresponding author), Univ Florida, Genet Inst, Gainesville, FL 32611 USA.	jacki.quinlan@gmail.com	Gravlee, Clarence C/A-2249-2009	Gravlee, Clarence C/0000-0002-0913-2320; Clukay, Christopher/0000-0002-4310-6484	National Science Foundation [BCS 0820687, BCS 0724032]	National Science Foundation(National Science Foundation (NSF))	This study was supported by National Science Foundation (http://www.nsf.gov/) grants BCS 0820687 (CJM) and BCS 0724032 (CCG).	Adeyemo A, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000564; Ansari KI, 2011, BIOCHEMISTRY-US, V50, P3517, DOI 10.1021/bi102037t; Ball MK, 2014, AM J RESP CRIT CARE, V189, P314, DOI 10.1164/rccm.201302-0302OC; Beitelshees AL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015180; Biino G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059612; Borrell LN, 2006, SOC SCI MED, V63, P1415, DOI 10.1016/j.socscimed.2006.04.008; Boulter AC, 2015, HUMAN BIOL IN PRESS; Brewster LM, 2004, ANN INTERN MED, V141, P614, DOI 10.7326/0003-4819-141-8-200410190-00009; Brody GH, 2011, DEV PSYCHOPATHOL, V23, P617, DOI 10.1017/S0954579411000046; Busca R, 2005, J CELL BIOL, V170, P49, DOI 10.1083/jcb.200501067; Chen X, 2015, AM J HUM GENET, V97, P708, DOI 10.1016/j.ajhg.2015.10.004; Choi M, 2011, SCIENCE, V331, P768, DOI 10.1126/science.1198785; Congiu C, 2015, PSYCHIAT RES, V225, P489, DOI 10.1016/j.psychres.2014.11.061; Conomos MP, 2015, GENET EPIDEMIOL, V39, P276, DOI 10.1002/gepi.21896; Cui JS, 2002, HYPERTENSION, V40, P7, DOI 10.1161/01.HYP.0000022693.11752.E9; DARLU P, 1990, ANN HUM BIOL, V17, P387, DOI 10.1080/03014469000001162; Deo RC, 2007, PLOS GENET, V3, P2200, DOI 10.1371/journal.pgen.0030196; Eichler EE, 2010, NAT REV GENET, V11, P446, DOI 10.1038/nrg2809; Engert V, 2014, PSYCHONEUROENDOCRINO, V45, P192, DOI 10.1016/j.psyneuen.2014.04.005; Fernandez AP, 2008, P NATL ACAD SCI USA, V105, P12581, DOI 10.1073/pnas.0803174105; Fox ER, 2011, HUM MOL GENET, V20, P2273, DOI 10.1093/hmg/ddr092; Geronimus AT, 2006, AM J PUBLIC HEALTH, V96, P826, DOI 10.2105/AJPH.2004.060749; Goosby BJ, 2015, AM J HUM BIOL, V27, P546, DOI 10.1002/ajhb.22683; Gravlee CC, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006821; Gravlee CC, 2009, AM J PHYS ANTHROPOL, V139, P47, DOI 10.1002/ajpa.20983; GRIENDLING KK, 1993, CIRCULATION, V87, P1816, DOI 10.1161/01.CIR.87.6.1816; HAVLIK RJ, 1979, AM J EPIDEMIOL, V110, P304, DOI 10.1093/oxfordjournals.aje.a112815; Hicken MT, 2014, AM J PUBLIC HEALTH, V104, P117, DOI 10.2105/AJPH.2013.301395; Honda T, 2007, CIRC J, V71, P1263, DOI 10.1253/circj.71.1263; Hosseini M, 2015, EXCLI J, V14, P465, DOI 10.17179/excli2014-635; Huang J, 2010, AM J PSYCHIAT, V167; Kaess BM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014529; Karlsen S, 2002, AM J PUBLIC HEALTH, V92, P624, DOI 10.2105/AJPH.92.4.624; Klimentidis YC, 2012, J HUM HYPERTENS, V26, P98, DOI 10.1038/jhh.2010.130; Law MR, 1997, AM J HYPERTENS, V10, pS42, DOI 10.1016/S0895-7061(97)00073-3; Lettre G, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001300; Levy D, 2000, HYPERTENSION, V36, P477, DOI 10.1161/01.HYP.36.4.477; Levy D, 2009, NAT GENET, V41, P677, DOI 10.1038/ng.384; Liberzon I, 2014, JAMA PSYCHIAT, V71, P1174, DOI 10.1001/jamapsychiatry.2014.999; Liou YJ, 2009, PHARMACOGENET GENOM, V19, P735, DOI 10.1097/FPC.0b013e32832cbe61; Longo D, 2003, BLOOD PRESS MONIT, V8, P91, DOI 10.1097/00126097-200304000-00006; Manichaikul A, 2010, BIOINFORMATICS, V26, P2867, DOI 10.1093/bioinformatics/btq559; Manolio TA, 2009, NATURE, V461, P747, DOI 10.1038/nature08494; Mensah GA, 2007, HEALTH AFFAIR, V26, P38, DOI 10.1377/hlthaff.26.1.38; Non AL, 2012, AM J PUBLIC HEALTH, V102, P1559, DOI 10.2105/AJPH.2011.300448; Ordonez-Razo RM, 2012, GENET TEST MOL BIOMA, V16, P855, DOI 10.1089/gtmb.2011.0343; Pasaniuc B, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001371; Pascoe EA, 2009, PSYCHOL BULL, V135, P531, DOI 10.1037/a0016059; Perlis RH, 2010, AM J PSYCHIAT, V167, P1499, DOI 10.1176/appi.ajp.2010.10040541; Polsinelli G, 2013, J NEURAL TRANSM, V120, P253, DOI 10.1007/s00702-012-0851-6; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Reiner AP, 2005, AM J HUM GENET, V76, P463, DOI 10.1086/428654; Rose JE, 2010, MOL MED, V16, P247, DOI 10.2119/molmed.2009.00159; Ryan AM, 2006, J HEALTH CARE POOR U, V17, P116, DOI 10.1353/hpu.2006.0092; Sankararaman S, 2008, AM J HUM GENET, V82, P290, DOI 10.1016/j.ajhg.2007.09.022; Satcher D, 2005, HEALTH AFFAIR, V24, P459, DOI 10.1377/hlthaff.24.2.459; Schulz AJ, 2006, AM J PUBLIC HEALTH, V96, P1265, DOI 10.2105/AJPH.2005.064543; Shen GQ, 2012, ANN HUM GENET, V76, P193, DOI 10.1111/j.1469-1809.2012.00705.x; Shriner D, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002325; Simon GE, 2001, WESTERN J MED, V175, P292, DOI 10.1136/ewjm.175.5.292; Tang H, 2006, HUM GENET, V119, P624, DOI 10.1007/s00439-006-0175-4; Taylor JY, 2012, ETHNIC DIS, V22, P155; Taylor JY, 2010, BIOL RES NURS, V12, P149, DOI 10.1177/1099800410371225; Tobin MD, 2005, STAT MED, V24, P2911, DOI 10.1002/sim.2165; Trerotola M, 2015, HUM GENOMICS, V9, DOI 10.1186/s40246-015-0041-3; Uher R, 2008, MOL PSYCHIATR, V13, P131, DOI 10.1038/sj.mp.4002067; Visscher PM, 2008, NAT REV GENET, V9, P255, DOI 10.1038/nrg2322; WARD RH, 1983, AM J PHYS ANTHROPOL, V62, P91, DOI 10.1002/ajpa.1330620113; Williams D R, 1997, J Health Psychol, V2, P335, DOI 10.1177/135910539700200305; Williams DR, 2005, HEALTH AFFAIR, V24, P325, DOI 10.1377/hlthaff.24.2.325; WILLIAMS DR, 1995, ANNU REV SOCIOL, V21, P349, DOI 10.1146/annurev.so.21.080195.002025; Yan LJL, 2003, JAMA-J AM MED ASSOC, V290, P2138, DOI 10.1001/jama.290.16.2138; Yu B, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004212; Zhu XF, 2005, NAT GENET, V37, P177, DOI 10.1038/ng1510; Zhu XF, 2011, HUM MOL GENET, V20, P2285, DOI 10.1093/hmg/ddr113; Ziegelstein RC, 2015, J PSYCHOSOM RES, V78, P301, DOI 10.1016/j.jpsychores.2015.02.003	76	21	21	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2016	11	12							e0167700	10.1371/journal.pone.0167700	http://dx.doi.org/10.1371/journal.pone.0167700			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EI9TW	28002425	gold, Green Published, Green Submitted			2022-12-27	WOS:000392853100016
J	Sana, ME; Quilliam, LA; Spitaleri, A; Pezzoli, L; Marchetti, D; Lodrini, C; Candiago, E; Lincesso, AR; Ferrazzi, P; Iascone, M				Sana, Maria Elena; Quilliam, Lawrence A.; Spitaleri, Andrea; Pezzoli, Laura; Marchetti, Daniela; Lodrini, Chiara; Candiago, Elisabetta; Lincesso, Anna Rita; Ferrazzi, Paolo; Iascone, Maria			A Novel HRAS Mutation Independently Contributes to Left Ventricular Hypertrophy in a Family with a Known MYH7 Mutation	PLOS ONE			English	Article							COSTELLO-SYNDROME; GERMLINE KRAS; RAS PROTEIN; MECHANISMS; DATABASE; GTP	Several genetic conditions can lead to left ventricular hypertrophy (LVH). Among them, hypertrophic cardiomyopathy (HCM), caused by mutations in sarcomere genes, is the most common inherited cardiac disease. Instead, RASopathies, a rare class of disorders characterized by neuro-cardio-facial-cutaneous abnormalities and sometimes presenting with LVH, are caused by mutations in the RAS-MAPK pathway. We report on a 62-years-old male who presented isolated severe obstructive LVH but did not carry the sarcomere mutation previously identified in his affected relatives. By exome sequencing, we detected a novel mutation in HRAS gene (NM_005343.2:p.Arg68Trp), present also in the proband's daughter, who showed mild LVH and severe intellectual disability. The cardiac phenotype was indistinguishable between family members carrying either mutation. In silico studies suggested that the mutated HRAS protein is constitutionally activated. Consistently, functional characterization in vitro confirmed elevated HRAS-GTP accumulation and downstream RAS-MAPK pathway activation that are known to drive cell proliferation in LVH. Our study emphasizes the role of RAS signaling in cardiac hypertrophy and highlights the complexity in differential diagnosis of RASopathies. In fact, the mild features of RASopathy and the recurrence of sarcomeric HCM in this family delayed the correct diagnosis until comprehensive genetic testing was performed.	[Sana, Maria Elena; Pezzoli, Laura; Marchetti, Daniela; Lodrini, Chiara; Lincesso, Anna Rita; Iascone, Maria] Azienda Socio Sanit Terr Papa Giovanni XXIII, USSD Lab Genet Med, Bergamo, Italy; [Sana, Maria Elena] Azienda Socio Sanit Terr Papa Giovanni XXIII, FROM Res Fdn, Bergamo, Italy; [Quilliam, Lawrence A.] Indiana Univ, Dept Biochem & Mol Biol, Indianapolis, IN 46204 USA; [Spitaleri, Andrea] Ist Italiano Tecnol, CONCEPT Lab, Genoa, Italy; [Candiago, Elisabetta] Azienda Socio Sanit Terr Papa Giovanni XXIII, USC Anat Patol, Bergamo, Italy; [Ferrazzi, Paolo] Policlin Monza, Ctr Cardiomiopatia Ipertrof & Cardiopatie Valvola, Monza, Italy	ASST Papa Giovanni XXIII; ASST Papa Giovanni XXIII; Indiana University System; Indiana University-Purdue University Indianapolis; Istituto Italiano di Tecnologia - IIT; ASST Papa Giovanni XXIII	Iascone, M (corresponding author), Azienda Socio Sanit Terr Papa Giovanni XXIII, USSD Lab Genet Med, Bergamo, Italy.	miascone@asst-pg23.it	Quilliam, Lawrence/Q-4987-2019; pezzoli, Laura/AAA-4479-2019; Iascone, Maria/AAA-4599-2019; Spitaleri, Andrea/S-9368-2019	pezzoli, Laura/0000-0002-8111-563X; Iascone, Maria/0000-0002-4707-212X; Spitaleri, Andrea/0000-0003-3012-3557	Fondazione per la Ricerca Ospedale Maggiore (FROM); IU Biomedical Research Grant	Fondazione per la Ricerca Ospedale Maggiore (FROM); IU Biomedical Research Grant	Support was provided by Fondazione per la Ricerca Ospedale Maggiore (FROM) to MES (fellowship for data collection and bioinformatic data management of sequencing data, statistical analysis) and IU Biomedical Research Grant to LAQ (for functional validation studies).	Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; Buhrman G, 2011, J BIOL CHEM, V286, P3323, DOI 10.1074/jbc.M110.193854; Castro AF, 2005, METHODS, V37, P190, DOI 10.1016/j.ymeth.2005.05.015; Colicelli John, 2004, Sci STKE, V2004, pRE13, DOI 10.1126/stke.2502004re13; DER CJ, 1986, CELL, V44, P167, DOI 10.1016/0092-8674(86)90495-2; Gersh BJ, 2011, J AM COLL CARDIOL, V58, pE212, DOI 10.1016/j.jacc.2011.06.011; GRANTHAM R, 1974, SCIENCE, V185, P862, DOI 10.1126/science.185.4154.862; Gremer L, 2011, HUM MUTAT, V32, P33, DOI 10.1002/humu.21377; Gripp KW, 2008, AM J MED GENET A, V146A, P683, DOI 10.1002/ajmg.a.32227; Gripp KW, 2015, AM J MED GENET A, V167, P2085, DOI 10.1002/ajmg.a.37128; Gripp KW, 2012, GENET MED, V14, P285, DOI [10.1038/GIM.0b013e31822dd91f, 10.1038/gim.0b013e31822dd91f]; Harvey PA, 2011, J CELL BIOL, V194, P355, DOI 10.1083/jcb.201101100; Iacovoni A, 2012, EUR HEART J, V33, P2080, DOI 10.1093/eurheartj/ehs064; Iascone M R, 2007, Hum Genet, V120, P916; Iascone M, 2012, CIRCULATION, V126, P2764, DOI 10.1161/CIRCULATIONAHA.112.119883; Kollman PA, 2000, ACCOUNTS CHEM RES, V33, P889, DOI 10.1021/ar000033j; Kumar P, 2009, NAT PROTOC, V4, P1073, DOI 10.1038/nprot.2009.86; Lorell BH, 2000, CIRCULATION, V102, P470; Margarit SM, 2003, CELL, V112, P685, DOI 10.1016/S0092-8674(03)00149-1; Maron BJ, 2012, J AM COLL CARDIOL, V60, P705, DOI 10.1016/j.jacc.2012.02.068; Martinez-Quintana E, 2013, REV ESP CARDIOL, V66, P756, DOI 10.1016/j.rec.2013.05.005; Matsumoto K, 2011, J BIOL CHEM, V286, P15403, DOI 10.1074/jbc.M110.204933; Meagher KL, 2003, J COMPUT CHEM, V24, P1016, DOI 10.1002/jcc.10262; Miller Mark Steven, 2012, Frontiers in Genetics, V2, P100, DOI 10.3389/fgene.2011.00100; Niihori T, 2006, NAT GENET, V38, P294, DOI 10.1038/ng1749; Pronk S, 2013, BIOINFORMATICS, V29, P845, DOI 10.1093/bioinformatics/btt055; Quilliam LA, 1999, J BIOL CHEM, V274, P23850, DOI 10.1074/jbc.274.34.23850; QUILLIAM LA, 1995, P NATL ACAD SCI USA, V92, P1272, DOI 10.1073/pnas.92.5.1272; Rauen KA, 2013, ANNU REV GENOM HUM G, V14, P355, DOI 10.1146/annurev-genom-091212-153523; Sana ME, 2011, BIOINFORMATICS, V27, P9, DOI 10.1093/bioinformatics/btq603; Schubbert S, 2006, NAT GENET, V38, P331, DOI 10.1038/ng1748; Schwarz JM, 2010, NAT METHODS, V7, P575, DOI 10.1038/nmeth0810-575; Sherry ST, 2001, NUCLEIC ACIDS RES, V29, P308, DOI 10.1093/nar/29.1.308; Siepel A, 2005, GENOME RES, V15, P1034, DOI 10.1101/gr.3715005; Sousa da Silva Alan W, 2012, BMC Res Notes, V5, P367, DOI 10.1186/1756-0500-5-367; Stenson Peter D, 2009, Hum Genomics, V4, P69; TONG L, 1991, J MOL BIOL, V217, P503, DOI 10.1016/0022-2836(91)90753-S; van der Burgt I, 2007, J MED GENET, V44, P459, DOI 10.1136/jmg.2007.049270; Wang JM, 2004, J COMPUT CHEM, V25, P1157, DOI 10.1002/jcc.20035; Watkins H, 2011, NEW ENGL J MED, V364, P1643, DOI 10.1056/NEJMra0902923	40	8	8	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2016	11	12							e0168501	10.1371/journal.pone.0168501	http://dx.doi.org/10.1371/journal.pone.0168501			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI9TW	28002430	Green Submitted, Green Published, gold			2022-12-27	WOS:000392853100048
J	Jaffe, R; Prous, X; Zampaulo, R; Giannini, TC; Imperatriz-Fonseca, VL; Maurity, C; Oliveira, G; Brandi, IV; Siqueira, JO				Jaffe, Rodolfo; Prous, Xavier; Zampaulo, Robson; Giannini, Tereza C.; Imperatriz-Fonseca, Vera L.; Maurity, Clovis; Oliveira, Guilherme; Brandi, Iuri V.; Siqueira, Jose O.			Reconciling Mining with the Conservation of Cave Biodiversity: A Quantitative Baseline to Help Establish Conservation Priorities	PLOS ONE			English	Article							INVERTEBRATE COMMUNITIES; SEED DISPERSAL; BATS; RANGE; BIRDS; EVOLUTION; ENDEMISM; SERVICE	Caves pose significant challenges for mining projects, since they harbor many endemic and threatened species, and must therefore be protected. Recent discussions between academia, environmental protection agencies, and industry partners, have highlighted problems with the current Brazilian legislation for the protection of caves. While the licensing process is long, complex and cumbersome, the criteria used to assign caves into conservation relevance categories are often subjective, with relevance being mainly determined by the presence of obligate cave dwellers (troglobites) and their presumed rarity. However, the rarity of these troglobitic species is questionable, as most remain unidentified to the species level and their habitats and distribution ranges are poorly known. Using data from 844 iron caves retrieved from different speleology reports for the Carajas region (South-Eastern Amazon, Brazil), one of the world's largest deposits of high-grade iron ore, we assess the influence of different cave characteristics on four biodiversity proxies (species richness, presence of troglobites, presence of rare troglobites, and presence of resident bat populations). We then examine how the current relevance classification scheme ranks caves with different biodiversity indicators. Large caves were found to be important reservoirs of biodiversity, so they should be prioritized in conservation programs. Our results also reveal spatial autocorrelation in all the biodiversity proxies assessed, indicating that iron caves should be treated as components of a cave network immersed in the karst landscape. Finally, we show that by prioritizing the conservation of rare troglobites, the current relevance classification scheme is undermining overall cave biodiversity and leaving ecologically important caves unprotected. We argue that conservation efforts should target subterranean habitats as a whole and propose an alternative relevance ranking scheme, which could help simplify the assessment process and channel more resources to the effective protection of overall cave biodiversity.	[Jaffe, Rodolfo; Giannini, Tereza C.; Imperatriz-Fonseca, Vera L.; Maurity, Clovis; Oliveira, Guilherme; Siqueira, Jose O.] Vale Inst Technol Sustainable Dev, Belem, Para, Brazil; [Prous, Xavier; Zampaulo, Robson; Brandi, Iuri V.] Vale, Environm Licensing & Speleol, Nova Lima, MG, Brazil	Instituto Tecnologico Vale Desenvolvimento Sustentavel	Jaffe, R (corresponding author), Vale Inst Technol Sustainable Dev, Belem, Para, Brazil.	rodolfo.jaffe@itv.org	Prous, Xavier/T-8183-2019; Jaffé, Rodolfo/K-3230-2013; Imperatriz-Fonseca, Vera Lucia/AAU-7633-2021; Giannini, Tereza Cristina/AAA-2958-2019; Giannini, Tereza C/F-2676-2012; Imperatriz-Fonseca, Vera Lucia/H-5582-2012	Jaffé, Rodolfo/0000-0002-2101-5282; Imperatriz-Fonseca, Vera Lucia/0000-0002-1079-2158; Giannini, Tereza Cristina/0000-0001-9830-1204; Imperatriz-Fonseca, Vera Lucia/0000-0002-1079-2158; Prous, Xavier/0000-0001-9260-1441	Vale Institute of Technology	Vale Institute of Technology	The study was funded by the Vale Institute of Technology, a non-profit research institution.	Andelman SJ, 2000, P NATL ACAD SCI USA, V97, P5954, DOI 10.1073/pnas.100126797; Asaad I, BIOL CONSERV; Auler A. S., 2015, HYPOGENE CAVE MORPHO, V18, P15; Auler AS, 2014, ENVIRON EARTH SCI, V1, P487, DOI DOI 10.1007/978-3-642-17435-3_; Bivand R, 2015, COMP IMPLEMENTATIONS; Brunet AK, 2001, J MAMMAL, V82, P1114, DOI 10.1644/1545-1542(2001)082<1114:TSARIB>2.0.CO;2; Campbell JW, 2011, J NAT HIST, V45, P2645, DOI 10.1080/00222933.2011.597884; Cardiff S.G., 2007, MADAGASCAR CONSERV D, V2, P28; Christman MC, 2005, J BIOGEOGR, V32, P1441, DOI 10.1111/j.1365-2699.2005.01263.x; Cleveland CJ, 2006, FRONT ECOL ENVIRON, V4, P238, DOI 10.1890/1540-9295(2006)004[0238:EVOTPC]2.0.CO;2; Csuti B, 1997, BIOL CONSERV, V80, P83, DOI 10.1016/S0006-3207(96)00068-7; Culver D. C., 2009, BIOL CAVES OTHER SUB, P40; Culver David C., 2004, Subterranean Biology, V2, P27; CULVER DC, 1970, EVOLUTION, V24, P463, DOI 10.1111/j.1558-5646.1970.tb01776.x; Ferreira RL, 1999, TROP ZOOL, V12, P231, DOI 10.1080/03946975.1999.10539391; Ferreira RL, 2015, GEOSSISTEMAS FERRUGI, P195; Ferreira RL, 2005, CARSTE, V3, P106; Ferreira Rodrigo Lopes, 1998, Diversity & Distributions, V4, P235; Fleming TH, 2003, BAT ECOLOGY, P156; Fleming TH, 2009, ANN BOT-LONDON, V104, P1017, DOI 10.1093/aob/mcp197; Fortin MJ, 2005, SPATIAL ANALYSIS: A GUIDE FOR ECOLOGISTS; Gardner TA, 2013, CONSERV BIOL, V27, P1254, DOI 10.1111/cobi.12118; Harvey MS, 2011, INVERTEBR SYST, V25, P1, DOI 10.1071/IS11011; Harvey MS, 2002, INVERTEBR SYST, V16, P555, DOI 10.1071/IS02009; Hougner C, 2006, ECOL ECON, V59, P364, DOI 10.1016/j.ecolecon.2005.11.007; Iskali G, 2015, J CAVE KARST STUD, V77, P28, DOI 10.4311/2013LSC0128; Jacomassa FAF, 2010, ACTA OECOL, V36, P493, DOI 10.1016/j.actao.2010.07.001; Juan C, 2010, MOL ECOL, V19, P3865, DOI 10.1111/j.1365-294X.2010.04759.x; Karp DS, 2014, ECOLOGY, V95, P1065, DOI 10.1890/13-1012.1; Kriebel D, 2001, ENVIRON HEALTH PERSP, V109, P871, DOI 10.2307/3454986; Ledford J, 2012, ZOOKEYS, P1, DOI 10.3897/zookeys.167.1833; Lomolino M.V., 2010, BIOGEOGRAPHY, Vfourth; Lunghi E, 2014, ACTA OECOL, V55, P29, DOI 10.1016/j.actao.2013.11.003; Maas B, 2013, ECOL LETT, V16, P1480, DOI 10.1111/ele.12194; MacArthur R.H., 1967, THEORY ISLAND BIOGEO; Maine JJ, 2015, P NATL ACAD SCI USA, V112, P12438, DOI 10.1073/pnas.1505413112; Pape RB, 2014, J CAVE KARST STUD, V76, P1, DOI 10.4311/2012LSC0266; Phalan B, 2011, SCIENCE, V333, P1289, DOI 10.1126/science.1208742; Pinheiro J, 2020, R PACKAGE VERSION 31; Pipan T, 2013, ENCY BIODIVERSITY, P44, DOI DOI 10.1016/B0-12-226865-2/00262-5; Pipan T, 2007, HYDROGEOL J, V15, P817, DOI 10.1007/s10040-006-0114-4; POULSON TL, 1969, SCIENCE, V165, P971; Poveromo JJ, 1999, MAKING SHAPING TREAT, P547; Prous X, 2011, AN 31 C BRAS ESP PON, P515; R-Core T, 2015, R LANG ENV STAT COMP; Sarmento R, 2014, ZOOLOGIA-CURITIBA, V31, P245, DOI 10.1590/S1984-46702014000300006; Scheipl F., 2020, LINEAR MIXED EFFECTS, DOI 10.18637/jss.v067.i01; Silva MS, 2011, BIODIVERS CONSERV, V20, P1713, DOI 10.1007/s10531-011-0057-5; Silveira M, 2011, ACTA OECOL, V37, P31, DOI 10.1016/j.actao.2010.11.003; Simoes Matheus Henrique, 2015, Subterranean Biology, V16, P103, DOI 10.3897/subtbiol.16.5470; Soares G, 2016, 23 INT C SUBT BIOL F, P96; Sochi K, 2016, J APPL ECOL, V53, P317, DOI 10.1111/1365-2664.12583; Souza-Silva M, 2012, ACTA CARSOLOGICA, V1, P41; Stone FD., 2012, ENCYCL CAVES, V2, P658, DOI [10.1016/B978-0-12-383832-2.00097-9, DOI 10.1016/B978-0-12-383832-2.00097-9, 10.1016/b978-0-12-383832-2.00097-9]; Taylor SJ, 2005, AM MIDL NAT, V154, P97, DOI 10.1674/0003-0031(2005)154[0097:FRAHUO]2.0.CO;2; Trajano E, 2010, ESPELEO TEMA, V21, P105; White W. B., 2012, ENCY CAVES; Winter Y, 2001, COGNITIVE ECOLOGY OF POLLINATION: ANIMAL BEHAVIOUR AND FLORAL EVOLUTION, P148, DOI 10.1017/CBO9780511542268.009; Wunderle JM, 1997, FOREST ECOL MANAG, V99, P223, DOI 10.1016/S0378-1127(97)00208-9; Wynne JJ, 2013, W N AM NAT, V74, P1	60	35	35	1	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2016	11	12							e0168348	10.1371/journal.pone.0168348	http://dx.doi.org/10.1371/journal.pone.0168348			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI9QF	27997576	gold, Green Submitted, Green Published			2022-12-27	WOS:000392842900036
J	Laperine, O; Cloitre, A; Caillon, J; Huck, O; Bugueno, IM; Pilet, P; Sourice, S; Le Tilly, E; Palmer, G; Davideau, JL; Geoffroy, V; Guicheux, J; Beck-Cormier, S; Lesclous, P				Laperine, Olivier; Cloitre, Alexandra; Caillon, Jocelyne; Huck, Olivier; Bugueno, Isaac Maximiliano; Pilet, Paul; Sourice, Sophie; Le Tilly, Elodie; Palmer, Gaby; Davideau, Jean-Luc; Geoffroy, Valerie; Guicheux, Jerome; Beck-Cormier, Sarah; Lesclous, Philippe			Interleukin-33 and RANK-L Interplay in the Alveolar Bone Loss Associated to Periodontitis	PLOS ONE			English	Article							PORPHYROMONAS-GINGIVALIS INFECTION; EPITHELIAL-CELLS; IN-VIVO; DISEASE; IL-33; EXPRESSION; CYTOKINE; RECEPTOR; PREVALENCE; SEVERITY	Introduction Chronic Periodontitis (CP) is an inflammatory disease of bacterial origin that results in alveolar bone destruction. Porphyromonas gingivalis (Pg), one of the main periopathogens, initiates an inflammatory cascade by host immune cells thereby increasing recruitment and activity of osteoclasts, the bone resorbing cells, through enhanced production of the crucial osteoclastogenic factor, RANK-L. Antibodies directed against some cytokines (IL-1 beta, IL-6 and TNF-alpha) failed to exhibit convincing therapeutic effect in CP. It has been suggested that IL-33, could be of interest in CP. Objective the present study aims to analyze whether and how IL-33 and RANK-L and/or their interplay are involved in the bone destruction associated to CP. Material and Methods mRNAs and protein expressions of IL-33 and RANK-L were analyzed in healthy and CP human gingival samples by immunohistochemistry (IHC) and RT-qPCR. Murine experimental periodontitis (EP) was induced using Pg infected ligature and Pg free ligature around the first maxillary molar. Alveolar bone loss was recorded by mu CT. Mouse gingival explants were stimulated for 24 hours with IL-33 and RANK-L mRNA expression investigated by RT-qPCR. Human oral epithelial cells were infected by Pg for 6, 12; 24 hours and IL-33 and RANK-L mRNA expressions were analyzed by RT-qPCR. Results IL-33 is overexpressed in gingival epithelial cells in human affected by CP as in the murine EP. In human as in murine gingival cells, RANK-L was independently induced by Pg and IL33. We also showed that the Pg-dependent RANK-L expression in gingival epithelial cells occured earlier than that of IL-33. Conclusion Our results evidence that IL-33 overexpression in gingival epithelial cells is associated with CP and may trigger RANK-L expression in addition to a direct effect of Pg. Finally, IL-33 may act as an extracellular alarmin (danger signal) showing proinflammatory properties in CP perpetuating bone resorption induced by Pg infection.	[Laperine, Olivier; Cloitre, Alexandra; Pilet, Paul; Sourice, Sophie; Le Tilly, Elodie; Guicheux, Jerome; Beck-Cormier, Sarah; Lesclous, Philippe] INSERM, U791, LIOAD, Nantes, France; [Laperine, Olivier; Cloitre, Alexandra; Pilet, Paul; Sourice, Sophie; Le Tilly, Elodie; Guicheux, Jerome; Beck-Cormier, Sarah; Lesclous, Philippe] Univ Nantes, UMR S 791, LIOAD, Nantes, France; [Laperine, Olivier; Cloitre, Alexandra; Pilet, Paul; Sourice, Sophie; Le Tilly, Elodie; Guicheux, Jerome; Beck-Cormier, Sarah; Lesclous, Philippe] UFR Odontol, Nantes, France; [Cloitre, Alexandra; Pilet, Paul; Guicheux, Jerome; Lesclous, Philippe] ONIRIS, UMR S 791, LIOAD, Nantes, France; [Caillon, Jocelyne] EA 3826 Therapeut Clin & Expt Infect, Nantes, France; [Huck, Olivier; Bugueno, Isaac Maximiliano; Davideau, Jean-Luc] INSERM, U1109, Osteoarticular & Dent Regenerat Nanomed, FMTS, Strasbourg, France; [Huck, Olivier; Davideau, Jean-Luc] Univ Strasbourg, Fac Chirurg Dent, Dept Parodontol, Strasbourg, France; [Palmer, Gaby] Univ Hosp Geneva, Div Rheumatol, Dept Internal Med Specialties, Geneva, Switzerland; [Palmer, Gaby] Univ Geneva, Sch Med, Dept Pathol Immunol, Geneva, Switzerland; [Geoffroy, Valerie] Hop Lariboisiere, INSERM, U1132, BIOSCAR, Paris, France; [Geoffroy, Valerie] Univ Paris Diderot, Sorbonne Paris Cite, Paris, France	Ecole Nationale Veterinaire, Agroalimentaire et de l'Alimentation Nantes-Atlantique; Institut National de la Sante et de la Recherche Medicale (Inserm); Ecole Nationale Veterinaire, Agroalimentaire et de l'Alimentation Nantes-Atlantique; Nantes Universite; Ecole Nationale Veterinaire, Agroalimentaire et de l'Alimentation Nantes-Atlantique; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; University of Geneva; University of Geneva; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Lariboisiere-Fernand-Widal - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite	Guicheux, J; Lesclous, P (corresponding author), INSERM, U791, LIOAD, Nantes, France.; Guicheux, J; Lesclous, P (corresponding author), Univ Nantes, UMR S 791, LIOAD, Nantes, France.; Guicheux, J; Lesclous, P (corresponding author), UFR Odontol, Nantes, France.; Guicheux, J; Lesclous, P (corresponding author), ONIRIS, UMR S 791, LIOAD, Nantes, France.	jerome.guicheux@inserm.fr; philippe.lesclous@univ-nantes.fr	CAILLON, Jocelyne/AAF-8179-2020; Cloitre, Alexandra/AAC-4048-2019; Lesclous, Philippe/P-6255-2014; huck, olivier/AFH-8285-2022; Beck-Cormier, Sarah/P-3091-2014; guicheux, Jerome/F-7767-2013; Geoffroy, Valerie/P-1521-2014; palmer, gaby/AAA-7117-2021	Cloitre, Alexandra/0000-0001-9178-5154; Beck-Cormier, Sarah/0000-0001-5258-1933; guicheux, Jerome/0000-0003-2754-3024; Geoffroy, Valerie/0000-0003-3920-7482; palmer, gaby/0000-0001-7567-1798; lesclous, Philippe/0000-0002-9840-4542; Bugueno, Isaac Maximiliano/0000-0002-6994-6262; huck, olivier/0000-0002-7988-2290	Region des pays de la Loire [2012-05775-05776]	Region des pays de la Loire(Region Pays de la Loire)	Support was provided by Region des pays de la Loire (grant 2012-05775-05776) [http://www.paysdelaloire.fr/]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors were supported by the SFBTM (Societe Francaise de Biologie des Tissus Mineralises) for technical support, UTE-IRS-UN for animal facilities and "Region des pays de la Loire" (grant 2012-05775-05776).	Balato A, 2014, ARCH DERMATOL RES, V306, P299, DOI 10.1007/s00403-014-1447-9; Byers DE, 2013, J CLIN INVEST, V123, P3967, DOI 10.1172/JCI65570; Carriere V, 2007, P NATL ACAD SCI USA, V104, P282, DOI 10.1073/pnas.0606854104; da Luz FAC, 2014, MEDIAT INFLAMM, V2014, DOI 10.1155/2014/342410; Eke PI, 2012, J DENT RES, V91, P914, DOI 10.1177/0022034512457373; Eke PI, 2015, J PERIODONTOL, V86, P611, DOI 10.1902/jop.2015.140520; Fujihara R, 2014, J PERIODONTAL RES, V49, P508, DOI 10.1111/jre.12131; Graves Dana T, 2011, J Oral Microbiol, V3, DOI 10.3402/jom.v3i0.5304; Hajishengallis G, 2015, NAT REV IMMUNOL, V15, P30, DOI 10.1038/nri3785; Hajishengallis G, 2011, CELL HOST MICROBE, V10, P497, DOI 10.1016/j.chom.2011.10.006; Han XZ, 2013, INFECT IMMUN, V81, P1502, DOI 10.1128/IAI.00043-13; Hienz SA, 2015, J IMMUNOL RES, V2015, DOI 10.1155/2015/615486; Holtfreter B, 2015, J CLIN PERIODONTOL, V42, P407, DOI 10.1111/jcpe.12392; Kawai T, 2006, AM J PATHOL, V169, P987, DOI 10.2353/ajpath.2006.060180; Kiyomiya H, 2015, BIOCHEM BIOPH RES CO, V460, P320, DOI 10.1016/j.bbrc.2015.03.033; Komai-Koma M, 2011, J IMMUNOL, V186, P2584, DOI 10.4049/jimmunol.1002103; Koseoglu S, 2015, J PERIODONTAL RES, V50, P525, DOI 10.1111/jre.12235; Kursunlu SF, 2015, ARCH ORAL BIOL, V60, P77, DOI 10.1016/j.archoralbio.2014.08.021; Laperine O, 2016, BONEKEY REP, V5, DOI 10.1038/bonekey.2016.21; Liew FY, 2010, NAT REV IMMUNOL, V10, P103, DOI 10.1038/nri2692; Lin J, 2014, INFECT IMMUN, V82, P4127, DOI 10.1128/IAI.02084-14; Liu D, 2003, INT J MOL MED, V11, P17; Malcolm J, 2015, J DENT RES, V94, P968, DOI 10.1177/0022034515577815; Martin P, 2013, ARTHRITIS RES THER, V15, DOI 10.1186/ar4143; Moulin D, 2007, CYTOKINE, V40, P216, DOI 10.1016/j.cyto.2007.09.013; Moussion C, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003331; Palmer G, 2011, NAT REV RHEUMATOL, V7, P321, DOI 10.1038/nrrheum.2011.53; Palmer G, 2009, ARTHRITIS RHEUM-US, V60, P738, DOI 10.1002/art.24305; Papathanasiou E, 2014, J PERIODONTAL RES, V49, P55, DOI 10.1111/jre.12078; Pihlstrom BL, 2005, LANCET, V366, P1809, DOI 10.1016/S0140-6736(05)67728-8; Preshaw PM, 2011, J CLIN PERIODONTOL, V38, P60, DOI 10.1111/j.1600-051X.2010.01671.x; Saadi-Thiers K, 2013, J PERIODONTOL, V84, P396, DOI 10.1902/jop.2012.110540; Saglam M, 2016, INCREASED LEVELS INT; Saidi S, 2011, CYTOKINE, V53, P347, DOI 10.1016/j.cyto.2010.11.021; Schmitz J, 2005, IMMUNITY, V23, P479, DOI 10.1016/j.immuni.2005.09.015; Sundnes O, 2015, J INVEST DERMATOL, V135, P1771, DOI 10.1038/jid.2015.85; Tada H, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0152794; Usui M, 2016, J PERIODONTAL RES, V51, P462, DOI 10.1111/jre.12323; Zhao JJ, 2012, INFLAMMATION, V35, P1330, DOI 10.1007/s10753-012-9446-5	39	29	30	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 19	2016	11	12							e0168080	10.1371/journal.pone.0168080	http://dx.doi.org/10.1371/journal.pone.0168080			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI9QC	27992569	Green Published, gold, Green Submitted			2022-12-27	WOS:000392842600034
J	Jakobsen, MD; Braaten, T; Obstfelder, A; Abelsen, B				Jakobsen, Monika Dybdahl; Braaten, Tonje; Obstfelder, Aud; Abelsen, Birgit			Self-Reported Food Hypersensitivity: Prevalence, Characteristics, and Comorbidities in the Norwegian Women and Cancer Study	PLOS ONE			English	Article							ALLERGY; INTOLERANCE; CHILDREN; COMPLEXITY; SYMPTOMS; PROFILE; BURDEN; COHORT; MODEL	Background This study aims to investigate the prevalence of self-reported food hypersensitivity, (SFH), the characteristics of women with SFH, and whether SFH is associated with multiple health complaints among the participants of the Norwegian Women and Cancer study (NOWAC). Methods We conducted a cross-sectional study among 64,316 women aged 41-76 years. The women were randomly selected from the Norwegian Central Person Register. Information on SFH and all covariates except age and place of residence was collected by questionnaires in 2002-2005. Results The prevalence of SFH in our study sample was 6.8% (95% confidence interval: 6.7-7.0). Logistic regression analysis showed a negative association between SFH and age (odds ratio [OR] 0.97). The odds of SFH increased among women living in or near urban centers, women with more than 9 years of education, women who did not have full-time work, women who had experienced poor economic conditions in childhood, those living without a partner, and those who did not consume alcohol or smoke (OR varied from 1.10 to 1.70). Women with a low body mass index had higher odds of SFH (OR 1.37) than those with a moderate body mass index. SFH was positively associated with poor self-perceived health (OR 2.56). The odds of SFH increased with the number of concurrent health complaints, with an OR for 5-6 comorbidities of 4.93. Conclusion We found an association between SFH, poor health, and different socio demographic and lifestyle characteristics. Women with SFH had increased odds of reporting multiple health complaints.	[Jakobsen, Monika Dybdahl; Braaten, Tonje] UiT Arctic Univ Norway, Dept Community Med, Tromso, Norway; [Obstfelder, Aud] Norwegian Univ Sci & Technol NTNU, Ctr Care Res, Gjovik, Norway; [Obstfelder, Aud] UiT Arctic Univ Norway, Dept Hlth & Care Sci, Tromso, Norway; [Abelsen, Birgit] UiT Arctic Univ Norway, Dept Community Med, Norwegian Ctr Rural Med, Tromso, Norway	UiT The Arctic University of Tromso; Norwegian University of Science & Technology (NTNU); UiT The Arctic University of Tromso; UiT The Arctic University of Tromso	Jakobsen, MD (corresponding author), UiT Arctic Univ Norway, Dept Community Med, Tromso, Norway.	monika.d.jakobsen@uit.no			Department of Community Medicine, UiT, The Arctic University of Norway [4025]	Department of Community Medicine, UiT, The Arctic University of Norway	MJ was supported by the Department of Community Medicine, UiT, The Arctic University of Norway, grant agreement 4025. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akinbami LJ, 2016, J ASTHMA, V53, P356, DOI 10.3109/02770903.2015.1126848; Baanders AN, 2002, EUR J PUBLIC HEALTH, V12, P124, DOI 10.1093/eurpub/12.2.124; Berstad A, 2012, SCAND J GASTROENTERO, V47, P914, DOI 10.3109/00365521.2012.690045; Blekesaune M, 2003, SAMFUNNSSPEILET, V17, P6; Cardona V, 2012, ALLERGY, V67, P1316, DOI [10.1111/j.1398-9995.2012.02877.x, 10.1111/j.1398-9995.2012.02877.x.]; Carroccio A, 2014, BMC MED, V12, DOI 10.1186/s12916-014-0230-2; Ch'ng CL, 2007, CLIN MED RES, V5, P184, DOI 10.3121/cmr.2007.738; Dominguez-Ortega G, 2014, J PEDIATR GASTR NUTR, V59, P210, DOI 10.1097/MPG.0000000000000391; Dong J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0144872; Dyregrov S, 2014, MATINTOLERANSE HAR B; Eiliv L, 2003, CANCER CAUSE CONTROL, V14, P1001, DOI 10.1023/B:CACO.0000007982.18311.2e; Grembowski D, 2014, MED CARE, V52, pS7, DOI 10.1097/MLR.0000000000000045; JANSEN JJN, 1994, J ALLERGY CLIN IMMUN, V93, P446; Johansson SGO, 2001, ALLERGY, V56, P813, DOI 10.1034/j.1398-9995.2001.t01-1-00001.x; Kanny G, 2001, J ALLERGY CLIN IMMUN, V108, P133, DOI 10.1067/mai.2001.116427; Kerr A, 2009, BIOSOCIETIES, V4, P3, DOI 10.1017/S1745855209006401; KNIBB RC, 2000, PSYCHOL HEALTH MED, V5, P419; Lind R, 2005, DIGEST DIS SCI, V50, P1245, DOI 10.1007/s10620-005-2767-6; Lind R, 2008, GASTROENTEROL NURS, V31, P401, DOI 10.1097/SGA.0b013e31818e4a4d; Linneberg A, 2008, CLIN EXP ALLERGY, V38, P145, DOI 10.1111/j.1365-2222.2007.02837.x; Lund E, 2008, INT J EPIDEMIOL, V37, P36, DOI 10.1093/ije/dym137; May CR, 2014, BMC HEALTH SERV RES, V14, DOI 10.1186/1472-6963-14-281; McBride D, 2012, PEDIAT ALLERG IMM-UK, V23, P230, DOI 10.1111/j.1399-3038.2011.01254.x; Molloy J, 2013, INT J ENV RES PUB HE, V10, P7235, DOI 10.3390/ijerph10127235; Nettleton S, 2009, HEALTH-LONDON, V13, P647, DOI 10.1177/1363459308341433; Nwaru BI, 2014, ALLERGY, V69, P62, DOI 10.1111/all.12305; PARKER SL, 1990, J ALLERGY CLIN IMMUN, V86, P503, DOI 10.1016/S0091-6749(05)80206-4; Power C, 2013, ANNU REV PUBL HEALTH, V34, P7, DOI 10.1146/annurev-publhealth-031912-114423; Rona RJ, 2007, J ALLERGY CLIN IMMUN, V120, P638, DOI 10.1016/j.jaci.2007.05.026; Roy A, 2016, DIG DIS SCI; Shippee ND, 2012, J CLIN EPIDEMIOL, V65, P1041, DOI 10.1016/j.jclinepi.2012.05.005; Soost S, 2009, CLIN EXP ALLERGY, V39, P1036, DOI 10.1111/j.1365-2222.2008.03184.x; Sova C, 2013, NUTR CLIN PRACT, V28, P669, DOI 10.1177/0884533613505870; Stein AC, 2015, J CLIN GASTROENTEROL; Sterne JA, 2009, BMJ, V338; Tavakkoli A, 2014, DIGEST DIS SCI, V59, P1255, DOI 10.1007/s10620-013-2981-6; Verrill L, 2015, ALLERGY ASTHMA PROC, V36, P458, DOI 10.2500/aap.2015.36.3895; Voordouw J, 2012, SOC INDIC RES, V107, P465, DOI 10.1007/s11205-011-9858-x; Wong RK, 2013, CLIN GASTROENTEROL H, V11, P151, DOI 10.1016/j.cgh.2012.07.019; Woods RK, 2001, EUR J CLIN NUTR, V55, P298, DOI 10.1038/sj.ejcn.1601159; Zingone F, 2015, UNITED EUR GASTROENT, V3, P136, DOI 10.1177/2050640614560786; Zuidmeer L, 2008, J ALLERGY CLIN IMMUN, V121, P1210, DOI 10.1016/j.jaci.2008.02.019	42	4	4	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2016	11	12							e0168653	10.1371/journal.pone.0168653	http://dx.doi.org/10.1371/journal.pone.0168653			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EI8LN	27992542	gold, Green Published, Green Submitted			2022-12-27	WOS:000392758000074
J	Lin, J; Chen, DR; Wang, YF; Lai, HW				Lin, Joseph; Chen, Dar-Ren; Wang, Yu-Fen; Lai, Hung-Wen			Oncoplastic Surgery for Upper/Upper Inner Quadrant Breast Cancer	PLOS ONE			English	Article							PARTIAL MASTECTOMY; CONSERVING SURGERY; RADICAL-MASTECTOMY; BODY-IMAGE	Tumors located in the upper/upper inner quadrant of the breast warrant more attention. A small lesion relative to the size of breast in this location may be resolved by performing a level I oncoplastic technique. However, a wide excision may significantly reduce the overall quality of the breast shape by distorting the visible breast line. From June 2012 to April 2015, 36 patients with breast cancer located in the upper/upper inner quadrant underwent breast-conservation surgery with matrix rotation mammoplasty. According to the size and location of the tumor relative to the nipple-areola complex, 11 patients underwent matrix rotation with periareolar de-epithelialization (donut group) and the other 25 underwent matrix rotation only (non-donut group). The cosmetic results were self-assessed by questionnaires. The average weights of the excised breast lumps in the donut and non-donut groups were 104.1 and 84.5 g, respectively. During the 3-year follow-up period, local recurrence was observed in one case and was managed with nipple-sparing mastectomy followed by breast reconstruction with prosthetic implants. In total, 31 patients (88.6%) ranked their postoperative result as either acceptable or satisfactory. The treated breasts were also self-evaluated by 27 patients (77.1%) to be nearly identical to or just slightly different from the untreated side. Matrix rotation is an easy breast-preserving technique for treating breast cancer located in the upper/upper inner quadrant of the breast that requires a relatively wide excision. With this technique, a larger breast tumor could be removed without compromising the breast appearance.	[Lin, Joseph; Chen, Dar-Ren; Lai, Hung-Wen] Changhua Christian Hosp, Dept Surg, Comprehens Breast Canc Ctr, Changhua, Taiwan; [Chen, Dar-Ren] Changhua Christian Hosp, Canc Res Ctr, Changhua, Taiwan; [Chen, Dar-Ren; Wang, Yu-Fen] Chung Shan Med Univ, Sch Med, Taichung, Taiwan; [Lai, Hung-Wen] Changhua Christian Hosp, Endoscop & Oncoplast Breast Surg Ctr, Changhua, Taiwan; [Lai, Hung-Wen] Natl Yang Ming Univ, Sch Med, Taipei, Taiwan	Changhua Christian Hospital; Changhua Christian Hospital; Chung Shan Medical University; Changhua Christian Hospital; National Yang Ming Chiao Tung University	Chen, DR (corresponding author), Changhua Christian Hosp, Dept Surg, Comprehens Breast Canc Ctr, Changhua, Taiwan.; Chen, DR (corresponding author), Changhua Christian Hosp, Canc Res Ctr, Changhua, Taiwan.; Chen, DR (corresponding author), Chung Shan Med Univ, Sch Med, Taichung, Taiwan.	darren_chen@cch.org.tw		Lin, Joseph/0000-0003-0623-816X				Al-Ghazal SK, 1999, BREAST, V8, P162, DOI 10.1054/brst.1999.0017; Anderson BO, 2005, LANCET ONCOL, V6, P145, DOI 10.1016/S1470-2045(05)01765-1; Asgeirsson KS, 2005, EJSO-EUR J SURG ONC, V31, P817, DOI 10.1016/j.ejso.2005.05.010; Brierley J D, 1991, Clin Oncol (R Coll Radiol), V3, P3; Chan Sharon W W, 2010, World J Surg, V34, P1447, DOI 10.1007/s00268-009-0278-x; Chen DR, 2014, EUR REV MED PHARMACO, V18, P1748; Clough KB, 2003, ANN SURG, V237, P26, DOI 10.1097/00000658-200301000-00005; Clough KB, 1999, PLAST RECONSTR SURG, V104, P409, DOI 10.1097/00006534-199908000-00014; Clough KB, 2010, ANN SURG ONCOL, V17, P1375, DOI 10.1245/s10434-009-0792-y; Fitoussi AD, 2010, PLAST RECONSTR SURG, V125, P454, DOI 10.1097/PRS.0b013e3181c82d3e; Gabka C J, 1997, Langenbecks Arch Chir Suppl Kongressbd, V114, P1224; Grisotti A., 2006, SURG BREAST PRINCIPL, V2nd, P147; Holmes DR, 2011, INT J BREAST CANCER, V2011, DOI 10.4061/2011/303879; HOPWOOD P, 1993, EUR J CANCER, V29A, P276, DOI 10.1016/0959-8049(93)90193-J; Kaur N, 2005, ANN SURG ONCOL, V12, P539, DOI 10.1245/ASO.2005.12.046; PATTERSON MP, 1985, INT J RADIAT ONCOL, V11, P1849, DOI 10.1016/0360-3016(85)90044-6; ROBBINS TH, 1977, PLAST RECONSTR SURG, V59, P64, DOI 10.1097/00006534-197701000-00011; SCHOVER LR, 1995, CANCER-AM CANCER SOC, V75, P54, DOI 10.1002/1097-0142(19950101)75:1<54::AID-CNCR2820750111>3.0.CO;2-I; Silverstein MJ, 2014, J SURG ONCOL, V110, P82, DOI 10.1002/jso.23641; Silverstein MJ, 2005, J AM COLL SURGEONS, V201, P586, DOI 10.1016/j.jamcollsurg.2005.05.032; VERONESI U, 1977, CANCER, V39, P2822, DOI 10.1002/1097-0142(197706)39:6<2822::AID-CNCR2820390670>3.0.CO;2-#; VERONESI U, 1981, NEW ENGL J MED, V305, P6, DOI 10.1056/NEJM198107023050102; Veronesi U, 2002, NEW ENGL J MED, V347, P1227, DOI 10.1056/NEJMoa020989; von Smitten K, 2008, J SURG ONCOL, V98, P585, DOI 10.1002/jso.21038; *WHO, 1969, M INV EV METH DIAGN	25	12	12	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2016	11	12							e0168434	10.1371/journal.pone.0168434	http://dx.doi.org/10.1371/journal.pone.0168434			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EG7JB	28030581	Green Published, Green Submitted, gold			2022-12-27	WOS:000391222000048
J	Okada, Y; Shirai, K; Miyajima, M; Reinach, PS; Yamanaka, O; Sumioka, T; Kokado, M; Tomoyose, K; Saika, S				Okada, Yuka; Shirai, Kumi; Miyajima, Masayasu; Reinach, Peter S.; Yamanaka, Osamu; Sumioka, Takayoshi; Kokado, Masahide; Tomoyose, Katsuo; Saika, Shizuya			Loss of TRPV4 Function Suppresses Inflammatory Fibrosis Induced by Alkali-Burning Mouse Corneas	PLOS ONE			English	Article							MICE LACKING TRPV4; MYOFIBROBLAST DIFFERENTIATION; LUNG INJURY; TGF-BETA; CHANNELS; INHIBITION; ACTIVATION; SENSATION; CELLS	In humans suffering from pulmonary disease and a mouse model, transient receptor potential vanilloid 4 (TRPV4) channel activation contributes to fibrosis. As a corneal alkali burn induces the same response, we determined if such an effect is also attributable to TRPV4 activation in mice. Accordingly, we determined if the alkali burn wound healing responses in wild-type (WT) mice are different than those in their TRPV4-null (KO) counterpart. Stromal opacification due to fibrosis in KO (n = 128) mice was markedly reduced after 20 days relative to that in WT (n = 157) mice. Immunohistochemistry revealed that increases in polymorphonuclear leukocytes and macrophage infiltration declined in KO mice. Semi-quantitative real time RTPCR of ocular KO fibroblast cultures identified increases in proinflammatory and monocyte chemoattractant protein-1 chemoattractant gene expression after injury. Biomarker gene expression of fibrosis, collagen1a1 and alpha-smooth muscle actin were attenuated along with macrophage release of interleukin-6 whereas transforming growth factor beta, release was unchanged. Tail vein reciprocal bone marrow transplantation between WT and KO chimera mouse models mice showed that reduced scarring and inflammation in KO mice are due to loss of TRPV4 expression on both corneal resident immune cells, fibroblasts and infiltrating polymorphonuclear leukocytes and macrophages. Intraperitoneal TRPV4 receptor antagonist injection of HC-067047 (10 mg/kg, daily) into WT mice reproduced the KO-phenotype. Taken together, alkali-induced TRPV4 activation contributes to inducing fibrosis and inflammation since corneal transparency recovery was markedly improved in KO mice.	[Okada, Yuka; Shirai, Kumi; Yamanaka, Osamu; Sumioka, Takayoshi; Kokado, Masahide; Tomoyose, Katsuo; Saika, Shizuya] Wakayama Med Univ, Ophthalmol, Wakayama, Japan; [Miyajima, Masayasu] Wakayama Med Univ, Lab Anim Ctr, Wakayama, Japan; [Reinach, Peter S.] Wenzhou Med Univ, Sch Ophthalmol & Optometry, Wenzhou, Peoples R China	Wakayama Medical University; Wakayama Medical University; Wenzhou Medical University	Okada, Y (corresponding author), Wakayama Med Univ, Ophthalmol, Wakayama, Japan.	yokada@wakayama-med.ac.jp	Reinach, Peter/AAI-3582-2021		Ministry of Education, Science, Sports and Culture of Japan [C15K10878, C15K10877, C25462759, B24791869, C15K10876, C25462730, C254627729]; Grants-in-Aid for Scientific Research [25462729] Funding Source: KAKEN	Ministry of Education, Science, Sports and Culture of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was supported by the Grants from the Ministry of Education, Science, Sports and Culture of Japan (C15K10878 to YO, C15K10877 to KS, C25462759 to OY, B24791869 to TS, C15K10876 to MK, C25462730 to KT, and C254627729 to SS). The funders had no role in the study design, data collection/analysis, decision to publish, or preparation of the manuscript.	Arima Y, 2012, CELL, V148, P447, DOI 10.1016/j.cell.2012.01.022; Arniges M, 2004, J BIOL CHEM, V279, P54062, DOI 10.1074/jbc.M409708200; Balakrishna S, 2014, AM J PHYSIOL-LUNG C, V307, pL158, DOI 10.1152/ajplung.00065.2014; Banner KH, 2011, PHARMACOL THERAPEUT, V130, P371, DOI 10.1016/j.pharmthera.2011.03.005; De Petrocellis L, 2012, ACTA PHYSIOL, V204, P255, DOI 10.1111/j.1748-1716.2011.02338.x; Everaerts W, 2010, P NATL ACAD SCI USA, V107, P19084, DOI 10.1073/pnas.1005333107; Groot-Kormelink PJ, 2012, BMC IMMUNOL, V13, DOI 10.1186/1471-2172-13-57; Hamanaka K, 2010, AM J PHYSIOL-LUNG C, V299, pL353, DOI 10.1152/ajplung.00315.2009; Janssen LJ, 2015, AM J RESP CELL MOL, V53, P135, DOI 10.1165/rcmb.2014-0269TR; Jester JV, 2002, EXP EYE RES, V75, P645, DOI 10.1006/exer.2002.2066; Liedtke W, 2003, P NATL ACAD SCI USA, V100, P13698, DOI 10.1073/pnas.1735416100; Liedtke W, 2004, AM J PHYSIOL-LUNG C, V287, pL269, DOI 10.1152/ajplung.00153.2004; Lim RR, 2016, SCI REP-UK, V6, DOI 10.1038/srep20841; Ma FF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035144; MANTOVANI A, 1992, FASEB J, V6, P2591, DOI 10.1096/fasebj.6.8.1592209; McLoughlin RM, 2003, J CLIN INVEST, V112, P598, DOI 10.1172/JCI200317129; Mergler S, 2011, J CELL PHYSIOL, V226, P1828, DOI 10.1002/jcp.22514; Mizuno A, 2003, AM J PHYSIOL-CELL PH, V285, pC96, DOI 10.1152/ajpcell.00559.2002; Okada Y, 2014, LAB INVEST, V94, P1030, DOI 10.1038/labinvest.2014.85; Okada Y, 2011, AM J PATHOL, V178, P2654, DOI 10.1016/j.ajpath.2011.02.043; Owsianik G, 2006, ANNU REV PHYSIOL, V68, P685, DOI 10.1146/annurev.physiol.68.040204.101406; Pan Z, 2008, CELL CALCIUM, V44, P374, DOI 10.1016/j.ceca.2008.01.008; Pedersen SF, 2005, CELL CALCIUM, V38, P233, DOI 10.1016/j.ceca.2005.06.028; Rahaman SO, 2014, J CLIN INVEST, V124, P5225, DOI 10.1172/JCI75331; Ramsey IS, 2006, ANNU REV PHYSIOL, V68, P619, DOI 10.1146/annurev.physiol.68.040204.100431; Saika S, 2005, AM J PATHOL, V166, P1393, DOI 10.1016/S0002-9440(10)62357-7; Saika S, 2006, AM J PATHOL, V168, P1848, DOI 10.2353/ajpath.2006.050980; Scheller J, 2011, BBA-MOL CELL RES, V1813, P878, DOI 10.1016/j.bbamcr.2011.01.034; Serini G, 1998, J CELL BIOL, V142, P873, DOI 10.1083/jcb.142.3.873; Suzuki M, 2003, J BIOL CHEM, V278, P22664, DOI 10.1074/jbc.M302561200; Tomasek JJ, 2002, NAT REV MOL CELL BIO, V3, P349, DOI 10.1038/nrm809; Yang YQ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077300	32	28	28	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2016	11	12							e0167200	10.1371/journal.pone.0167200	http://dx.doi.org/10.1371/journal.pone.0167200			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EG7JB	28030558	Green Submitted, Green Published, gold			2022-12-27	WOS:000391222000006
J	Petersen, JK; Jensen, P; Sorensen, MD; Kristensen, BW				Petersen, Jeanette Krogh; Jensen, Per; Sorensen, Mia Dahl; Kristensen, Bjarne Winther			Expression and Prognostic Value of Oct-4 in Astrocytic Brain Tumors	PLOS ONE			English	Article							ISOCITRATE DEHYDROGENASE 1; CANCER STEM-CELLS; INITIATING CELLS; BLADDER-CANCER; GRADE GLIOMAS; IDENTIFICATION; PROGRESSION; PROTEINS; NANOG; CD133	Background Glioblastomas are the most frequent type of malignant primary brain tumor with a median overall survival less than 15 months. Therapy resistance of glioblastomas has been attributed to the presence of tumor initiating stem-like cells (TSCs). TSC-related markers have therefore been suggested to have promising potentials as prognostic markers in gliomas. Methodology/Principal Findings The aim of the present study was to investigate the expression and prognostic impact of the TSC-related marker Oct-4 in astrocytic brain tumors of increasing grade. In total 114 grade II, III and IV astrocytic brain tumors were immunohistochemically stained for Oct-4, and the fraction and intensity of Oct-4 positive cells were determined by morphometric analysis of full tumor sections. Oct-4 was expressed in all tumors, and the Oct-4 positive cell fraction increased with tumor grade (p = 0.045). There was no association between survival and Oct-4 positive cell fraction, neither when combining all tumor grades nor in analysis of individual grades. Oct-4 intensity was not associated with grade, but taking IDH1 status into account we found a tendency for high Oct-4 intensity to be associated with poor prognosis in anaplastic astrocytomas. Double immunofluorescence stainings showed co-localization in the perivascular niches of Oct-4 and two other TSC markers CD133 and nestin in glioblastomas. In some areas Oct-4 was expressed independently of CD133 and nestin. Conclusions In conclusion, high Oct-4 fraction was associated with tumor malignancy, but seemed to be without independent prognostic influence in glioblastomas. Identification of a potential prognostic value in anaplastic astrocytomas requires additional studies using larger patient cohorts.	[Petersen, Jeanette Krogh; Jensen, Per; Sorensen, Mia Dahl; Kristensen, Bjarne Winther] Odense Univ Hosp, Dept Pathol, Odense C, Denmark; [Jensen, Per; Sorensen, Mia Dahl; Kristensen, Bjarne Winther] Univ Southern Denmark, Dept Clin Res, Odense C, Denmark	University of Southern Denmark; Odense University Hospital; University of Southern Denmark	Petersen, JK (corresponding author), Odense Univ Hosp, Dept Pathol, Odense C, Denmark.	Jeanette.Krogh.Petersen@rsyd.dk	Kristensen, Bjarne Winther/AAX-5491-2020; Kristensen, Bjarne Winther/A-6690-2012	Kristensen, Bjarne Winther/0000-0002-6352-0826; Kristensen, Bjarne Winther/0000-0002-6352-0826; Sorensen, Mia Dahl/0000-0002-0105-2940; Krogh Petersen, Jeanette/0000-0002-5093-5985	Danish Cancer Research Foundation; Odense University Hospital Free Research Fund	Danish Cancer Research Foundation; Odense University Hospital Free Research Fund	This work was supported by the Danish Cancer Research Foundation and Odense University Hospital Free Research Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aaberg-Jessen C, 2009, J NEURO-ONCOL, V95, P117, DOI 10.1007/s11060-009-9910-8; Al-Hajj M, 2003, P NATL ACAD SCI USA, V100, P3983, DOI 10.1073/pnas.0530291100; Atlasi Y, 2007, INT J CANCER, V120, P1598, DOI 10.1002/ijc.22508; Babaie Y, 2007, STEM CELLS, V25, P500, DOI 10.1634/stemcells.2006-0426; Bao SD, 2006, NATURE, V444, P756, DOI 10.1038/nature05236; Ceccarelli M, 2016, CELL, V164, P550, DOI 10.1016/j.cell.2015.12.028; Chen YC, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002637; Chiou SH, 2008, CLIN CANCER RES, V14, P4085, DOI 10.1158/1078-0432.CCR-07-4404; Christensen K, 2008, J NEURO-ONCOL, V90, P157, DOI 10.1007/s11060-008-9648-8; Christensen K, 2011, J NEURO-ONCOL, V104, P129, DOI 10.1007/s11060-010-0488-y; Christensen Karina, 2008, Ugeskr Laeger, V170, P2968; Dahlrot Rikke H, 2014, CNS Oncol, V3, P287, DOI 10.2217/cns.14.30; Dahlrot RH, 2014, INT J CLIN EXP PATHO, V7, P3739; Dahlrot RH, 2013, J NEURO-ONCOL, V114, P309, DOI 10.1007/s11060-013-1186-3; Dahlrot RH, 2013, INT J CLIN EXP PATHO, V6, P31; Du ZH, 2009, GLIA, V57, P724, DOI 10.1002/glia.20800; Elsir T, 2014, INT J CANCER, V134, P1123, DOI 10.1002/ijc.28441; Hermansen SK, 2015, J HISTOCHEMISTRY CYT; Jensen SS, 2013, INT J CLIN EXP PATHO, V6, P1294; Jozwicki W, 2014, INT J MOL SCI, V15, P16069, DOI 10.3390/ijms150916069; Li CW, 2007, CANCER RES, V67, P1030, DOI 10.1158/0008-5472.CAN-06-2030; Maitland NJ, 2008, J CLIN ONCOL, V26, P2862, DOI 10.1200/JCO.2007.15.1472; MALHOTRA V, 1986, ACTA NEUROCHIR, V81, P132, DOI 10.1007/BF01401235; O'Brien CA, 2007, NATURE, V445, P106, DOI 10.1038/nature05372; Phillips K, 2000, J MOL BIOL, V302, P1023, DOI 10.1006/jmbi.2000.4107; Sawant S, 2015, CLIN ORAL INVESTIGAT; Singh SK, 2004, NATURE, V432, P396, DOI 10.1038/nature03128; Stupp R, 2005, NEW ENGL J MED, V352, P987, DOI 10.1056/NEJMoa043330; Zhang S, 2008, CANCER RES, V68, P4311, DOI 10.1158/0008-5472.CAN-08-0364; 2008, NATURE, V455, P1061, DOI DOI 10.1038/NATURE07385	30	13	13	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2016	11	12							e0169129	10.1371/journal.pone.0169129	http://dx.doi.org/10.1371/journal.pone.0169129			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EG7JB	28030635	Green Published, Green Submitted, gold			2022-12-27	WOS:000391222000106
J	Pereira, TSS; Cade, NV; Mill, JG; Sichieri, R; Molina, MDB				Silva Pereira, Taisa Sabrina; Cade, Nagela Valadao; Mill, Jose Geraldo; Sichieri, Rosely; Bisi Molina, Maria del Carmen			Use of the Method of Triads in the Validation of Sodium and Potassium Intake in the Brazilian Longitudinal Study of Adult Health (ELSA-Brasil)	PLOS ONE			English	Article							VEGETABLE INTAKE; BIOMARKERS	Introduction Biomarkers are a good choice to be used in the validation of food frequency questionnaire due to the independence of their random errors. Objective To assess the validity of the potassium and sodium intake estimated using the Food Frequency Questionnaire ELSA-Brasil. Subjects/Methods A subsample of participants in the ELSA-Brasil cohort was included in this study in 2009. Sodium and potassium intake were estimated using three methods: Semi-quantitative food frequency questionnaire, 12-hour nocturnal urinary excretion and three 24-hour food records. Correlation coefficients were calculated between the methods, and the validity coefficient was calculated using the method of triads. The 95% confidence intervals for the validity coefficient were estimated using bootstrap sampling. Exact and adjacent agreement and disagreement of the estimated sodium and potassium intake quintiles were compared among three methods. Results The sample consisted of 246 participants, aged 53-8 years, 52% of women. Validity coefficient for sodium were considered weak (pfood frequency questionnaire actual intake = 0.37 and pbiomarker actual intake = 0.21) and moderate (pfood records actual intake 0.56). The validity coefficient were higher for potassium (pfood frequency questionnaire actual intake = 0.60; pbiomarker actual intake = 0.42; pfood records actual intake = 0.79). Conclusions: The Food Frequency Questionnaire ELSA-Brasil showed good validity in estimating potassium intake in epidemiological studies. For sodium validity was weak, likely due to the non-quantification of the added salt to prepared food.	[Silva Pereira, Taisa Sabrina; Cade, Nagela Valadao; Mill, Jose Geraldo; Bisi Molina, Maria del Carmen] Univ Fed Espirito Santo, Post Grad Programme Publ Hlth, Espirito Santo, Brazil; [Sichieri, Rosely] Univ Estado Rio De Janeiro, Inst Social Med, Rio De Janeiro, Brazil	Universidade Federal do Espirito Santo; Universidade do Estado do Rio de Janeiro	Molina, MDB (corresponding author), Univ Fed Espirito Santo, Post Grad Programme Publ Hlth, Espirito Santo, Brazil.	mdmolina@uol.com.br	Pereira, Taísa Sabrina Silva/AAB-3715-2021	Pereira, Taísa Sabrina Silva/0000-0002-5922-7424	Brazilian Ministry of Health (Science and Technology Department); Brazilian Ministry of Science and Technology; CNPq - National Research Council) [01 06 0010.00, 01 06 0212.00, 01 06 0300.00, 01 06 0278.00, 01 06 0115.00, 01 06 0071.00]	Brazilian Ministry of Health (Science and Technology Department); Brazilian Ministry of Science and Technology; CNPq - National Research Council)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	The ELSA-Brasil baseline study including this validation sub study was supported by the Brazilian Ministry of Health (Science and Technology Department) and the Brazilian Ministry of Science and Technology and CNPq - National Research Council) (grants # 01 06 0010.00 RS, 01 06 0212.00 BA, 01 06 0300.00 ES, 01 06 0278.00 MG, 01 06 0115.00 SP, 01 06 0071.00 RJ).	Andersen LF, 2005, BRIT J NUTR, V93, P519, DOI 10.1079/BJN20041381; Andrade Roseli G., 2003, Cad. Saúde Pública, V19, P1485, DOI 10.1590/S0102-311X2003000500027; [Anonymous], 2010, DIET INT DAT WER COL; Aquino EML, 2012, AM J EPIDEMIOL, V175, P315, DOI 10.1093/aje/kwr294; Arnuna P, 2008, P NUTR SOC, V67, P82, DOI 10.1017/S0029665108006058; Molina MDB, 2013, REV NUTR, V26, P167, DOI 10.1590/S1415-52732013000200005; Cantwell MM, 2005, PUBLIC HEALTH NUTR, V8, P97, DOI 10.1079/PHN2005668; Carlsen MH, 2011, BRIT J NUTR, V105, P1530, DOI 10.1017/S0007114510005246; Day NE, 2001, INT J EPIDEMIOL, V30, P309, DOI 10.1093/ije/30.2.309; Fowke JH, 2002, PUBLIC HEALTH NUTR, V5, P791, DOI 10.1079/PHN2002345; Freedman LS, 2015, AM J EPIDEMIOL, V181, P473, DOI 10.1093/aje/kwu325; Kaaks R, 2002, PUBLIC HEALTH NUTR, V5, P969, DOI 10.1079/PHN2002380; Kaaks R, 2006, ANN EPIDEMIOL, V16, P377, DOI 10.1016/j.annepidem.2005.06.057; Kabagambe EK, 2001, AM J EPIDEMIOL, V154, P1126, DOI 10.1093/aje/154.12.1126; Ljungman Susanne, 1995, P1987; Lopes Aline Cristine Souza, 2003, Rev. bras. epidemiol., V6, P209, DOI 10.1590/S1415-790X2003000300004; McNaughton SA, 2005, EUR J CLIN NUTR, V59, P211, DOI 10.1038/sj.ejcn.1602060; Mirmiran P, 2010, PUBLIC HEALTH NUTR, V13, P654, DOI 10.1017/S1368980009991698; Molina M.D.C.B., 2013, CAD SAUDE PUBLICA, V29, P379, DOI 10.1590/S0102-311X2013000600024; Nucleo de Estudos e Pesquisas em Alimentac Universidade Estadual de Campinas, 2006, TAB BRAS COMP AL V 2, V2; Nusser SM, 1996, J AM STAT ASSOC, V91, P1440, DOI 10.2307/2291570; Ocke MC, 1997, AM J CLIN NUTR, V65, P1240; Potischman N, 2003, J NUTR, V133, p873S, DOI 10.1093/jn/133.3.873S; WILLET W, 1998, NUTR EPIDEMIOLOGY, P174; Willett WC, 1997, AM J CLIN NUTR, V65, P1220, DOI 10.1093/ajcn/65.4.1220S; Willett WC, 1998, NUTR EPIDEMIOLOGY, P101	26	11	12	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2016	11	12							e0169085	10.1371/journal.pone.0169085	http://dx.doi.org/10.1371/journal.pone.0169085			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EG7JB	28030625	Green Published, gold, Green Submitted			2022-12-27	WOS:000391222000103
J	Wang, S; Zhao, H; Huang, CH; Li, ZR; Li, W; Zhang, XB; Liu, ZG				Wang, Shen; Zhao, Hui; Huang, Caihong; Li, Zhengri; Li, Wei; Zhang, Xiaobo; Liu, Zuguo			Impact of Chronic Smoking on Meibomian Gland Dysfunction	PLOS ONE			English	Article							SURFACE DISEASE INDEX; DRY EYE; OCULAR SURFACE; CIGARETTE-SMOKING; INTERNATIONAL WORKSHOP; CHINESE POPULATION; RISK-FACTORS; PREVALENCE; PATHOPHYSIOLOGY; SUBCOMMITTEE	Purpose The aim of this study was to explore the relationship between chronic cigarette smoking and meibomian gland dysfunction (MGD). Methods This study enrolled 322 smokers with MGD and 2067 non-smokers with MGD. All enrolled subjects were tested in the following sequence: Ocular Surface Disease Index (OSDI), tear film breakup time (TBUT), corneal fluorescein staining (CFS), Schirmer I test (SIT) and finally slit-lamp microscope examination of lid margin abnormalities, meibomian gland expression as well as meibum. Results Compared with the MGD patients without smoking, the MGD patients with smoking had significantly increased scores of lid margin abnormality and meibum (P<0.01 for each comparison). No significant difference was noted in OSDI, TBUT, CFS, SIT or the score of Meibomian gland expressibility between the smokers and non-smokers (P>0.05 for each comparison). In the smokers, the smoking index was significantly correlated with the scores of lid margin abnormality (Both sexes, R = 0.19, P<0.01; Male, R = 0.18, P<0.01) and meibum (Both sexes, R = 0.29, P<0.01; Male, R = 0.20, P<0.01), whereas it was not significantly correlated with OSDI, TBUT, CFS, SIT or score of Meibomian gland expressibility (P>0.05 for each comparison). Conclusion The findings of this study suggest chronic smoking might be associated with MGD.	[Wang, Shen; Zhao, Hui; Huang, Caihong; Li, Zhengri; Li, Wei; Zhang, Xiaobo; Liu, Zuguo] Xiamen Univ, Coll Med, Inst Eye, Xiamen, Fujian, Peoples R China; [Zhang, Xiaobo; Liu, Zuguo] Xiamen Univ, Chengyi Bldg 401,Xiang An Campus, Xiamen, Fujian, Peoples R China	Xiamen University; Xiamen University	Zhang, XB; Liu, ZG (corresponding author), Xiamen Univ, Coll Med, Inst Eye, Xiamen, Fujian, Peoples R China.; Zhang, XB; Liu, ZG (corresponding author), Xiamen Univ, Chengyi Bldg 401,Xiang An Campus, Xiamen, Fujian, Peoples R China.	xiaoboz@xmu.edu.cn; zuguoliu@xmu.edu.cn	Li, Wei/P-8985-2015	Li, Wei/0000-0001-7458-2590	Key Clinic Medicine Research Program; Ministry of Health, China [201302015]; National Natural Science Foundation of China [81270978, 81330022, U1205025, 31401180, 81500693]	Key Clinic Medicine Research Program; Ministry of Health, China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	Support was provided by grants from the Key Clinic Medicine Research Program, the Ministry of Health, China (No.201302015 to ZL) and National Natural Science Foundation of China (No. 81270978 to ZL, 81330022 to ZL, U1205025 to ZL, 31401180 to ZL and 81500693 to XZ). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afonso AA, 1999, OPHTHALMOLOGY, V106, P803, DOI 10.1016/S0161-6420(99)90170-7; Altinors DD, 2006, AM J OPHTHALMOL, V141, P1016, DOI 10.1016/j.ajo.2005.12.047; Arita R, 2015, OCUL SURF, V13, P321, DOI 10.1016/j.jtos.2015.04.005; Arita R, 2013, BRIT J OPHTHALMOL, V97, P725, DOI 10.1136/bjophthalmol-2012-302668; Arnson Y, 2010, J AUTOIMMUN, V34, pJ258, DOI 10.1016/j.jaut.2009.12.003; BARTECCHI CE, 1994, NEW ENGL J MED, V330, P907, DOI 10.1056/NEJM199403313301307; BARTECCHI CE, 1995, SCI AM, V272, P44, DOI 10.1038/scientificamerican0595-44; Bilkhu PS, 2014, BRIT J OPHTHALMOL, V98, P1707, DOI 10.1136/bjophthalmol-2014-305220; HUGHES DA, 1985, CLIN EXP IMMUNOL, V61, P459; Jie Y, 2008, EYE, V22, P790, DOI 10.1038/sj.eye.6702857; Knop E, 2011, INVEST OPHTH VIS SCI, V52, P1938, DOI 10.1167/iovs.10-6997c; Lee H, 2012, AM J OPHTHALMOL, V154, P949, DOI 10.1016/j.ajo.2012.06.009; Lee KS, 1998, ANN EPIDEMIOL, V8, P31, DOI 10.1016/S1047-2797(97)00113-0; Lekhanont K, 2006, CORNEA, V25, P1162, DOI 10.1097/01.ico.0000244875.92879.1a; Lin PY, 2003, OPHTHALMOLOGY, V110, P1096, DOI 10.1016/S0161-6420(03)00262-8; Loewenstein A, 2000, Harefuah, V139, P280; Miller KL, 2010, ARCH OPHTHALMOL-CHIC, V128, P94, DOI 10.1001/archophthalmol.2009.356; Pflugfelder SC, 2014, EXPERT REV CLIN IMMU, V10, P1137, DOI 10.1586/1744666X.2014.944163; Rummenie VT, 2008, CYTOKINE, V43, P200, DOI 10.1016/j.cyto.2008.05.011; Sayin N, 2014, CUTAN OCUL TOXICOL, V33, P201, DOI 10.3109/15569527.2013.832688; Schaumberg DA, 2011, INVEST OPHTH VIS SCI, V52, P1994, DOI 10.1167/iovs.10-6997e; Schiffman RM, 2000, ARCH OPHTHALMOL-CHIC, V118, P615, DOI 10.1001/archopht.118.5.615; SHIMAZAKI J, 1995, ARCH OPHTHALMOL-CHIC, V113, P1266, DOI 10.1001/archopht.1995.01100100054027; Solberg Y, 1998, SURV OPHTHALMOL, V42, P535, DOI 10.1016/S0039-6257(98)00002-2; Stern ME, 2004, EXP EYE RES, V78, P409, DOI 10.1016/j.exer.2003.09.003; Stern ME, 2013, INT REV IMMUNOL, V32, P19, DOI 10.3109/08830185.2012.748052; THOMAS W, 1973, NATURE, V243, P240, DOI 10.1038/243240a0; Viso E, 2012, INVEST OPHTH VIS SCI, V53, P2601, DOI 10.1167/iovs.11-9228; Zhang XB, 2011, OPHTHALMOLOGY, V118, P902, DOI 10.1016/j.ophtha.2010.08.033	29	16	17	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2016	11	12							e0168763	10.1371/journal.pone.0168763	http://dx.doi.org/10.1371/journal.pone.0168763			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EG7JB	28030610	gold, Green Submitted, Green Published			2022-12-27	WOS:000391222000074
J	Kollndorfer, K; Ohrenberger, I; Schopf, V				Kollndorfer, Kathrin; Ohrenberger, Iris; Schoepf, Veronika			Contraceptive Use Affects Overall Olfactory Performance: Investigation of Estradiol Dosage and Duration of Intake	PLOS ONE			English	Article							MENSTRUAL-CYCLE PHASE; HORMONE REPLACEMENT THERAPY; ODOR IDENTIFICATION; COGNITIVE FUNCTION; NASAL-MUCOSA; WOMEN; DISCRIMINATION; PREFERENCES; SENSITIVITY; IMPAIRMENT	The influence of female sex steroids on cognitive performance and sensory perception has been investigated for decades. However, previous research that studied olfaction revealed inconsistent results. The main aim of this study was to investigate the effects of different ethinyl estradiol (EE) concentrations of oral contraceptives and duration of intake on olfactory function. Forty-two healthy women, with regular intake of either high or low EE dosage over at least one year and up to 15 years participated in this study. Results revealed a significant concordance between a priori categorization in the two groups with high and low EE dosage and data-driven hierarchical clustering (p = 0.008). Furthermore, significantly higher olfactory performance was observed in women using low-dose products compared to women using high-dosed products (p = 0.019). These findings indicate different effects of pill use with regard to EE concentration. We therefore strongly recommend the acquisition of information about EE dosage of oral contraceptives to reduce potential confounding factors when investigating sensory systems.	[Kollndorfer, Kathrin; Ohrenberger, Iris] Med Univ Vienna, Dept Biomed Imaging & Image Guided Therapy, Vienna, Austria; [Schoepf, Veronika] Graz Univ, Inst Psychol, Graz, Austria; [Schoepf, Veronika] BioTechMed, Graz, Austria	Medical University of Vienna; University of Graz	Schopf, V (corresponding author), Graz Univ, Inst Psychol, Graz, Austria.; Schopf, V (corresponding author), BioTechMed, Graz, Austria.	veronika.schoepf@uni-graz.at		Schopf, Veronika/0000-0003-1937-4216; Kollndorfer, Kathrin/0000-0002-5983-5307				Beltz AM, 2015, HORM BEHAV, V74, P209, DOI 10.1016/j.yhbeh.2015.06.012; Bonenberger M, 2013, NEUROREPORT, V24, P951, DOI 10.1097/WNR.0000000000000024; Brinton RD, 2015, NAT REV ENDOCRINOL, V11, P393, DOI 10.1038/nrendo.2015.82; Caruso S, 2004, HUM REPROD, V19, P2959, DOI 10.1093/humrep/deh465; Caruso S, 2001, HUM REPROD, V16, P2288, DOI 10.1093/humrep/16.11.2288; Cherian S, 2014, NEUROSCIENCE, V269, P43, DOI 10.1016/j.neuroscience.2014.03.011; Daniels K, 2014, NATL HLTH STAT REPOR; Daniels Kimberly, 2015, Natl Health Stat Report, P1; DEEMS DA, 1991, ARCH OTOLARYNGOL, V117, P519; Derntl B, 2013, CHEM SENSES, V38, P67, DOI 10.1093/chemse/bjs084; Doty RL, 2015, NEUROBIOL AGING, V36, P2053, DOI 10.1016/j.neurobiolaging.2015.02.028; Doty RL, 2009, PHYSIOL BEHAV, V97, P213, DOI 10.1016/j.physbeh.2009.02.032; EVANS WJ, 1995, ELECTROEN CLIN NEURO, V95, P293, DOI 10.1016/0013-4694(95)00055-4; Farage MA, 2008, ARCH GYNECOL OBSTET, V278, P299, DOI 10.1007/s00404-008-0708-2; Frasnelli J, 2005, EUR ARCH OTO-RHINO-L, V262, P231, DOI 10.1007/s00405-004-0796-y; Gogos A, 2014, NEUROCHEM RES, V39, P2288, DOI 10.1007/s11064-014-1444-6; Grillo C, 2001, ANN OTO RHINOL LARYN, V110, P785; Haskell SG, 1997, J CLIN EPIDEMIOL, V50, P1249, DOI 10.1016/S0895-4356(97)00169-8; Hughes LF, 2002, CLIMACTERIC, V5, P140, DOI 10.1080/713605233; Hummel T, 2007, EUR ARCH OTO-RHINO-L, V264, P237, DOI 10.1007/s00405-006-0173-0; Hummel T, 1997, CHEM SENSES, V22, P39, DOI 10.1093/chemse/22.1.39; Jones J., 2012, CURRENT CONTRACEPTIV; Kobal G., 1996, Rhinology (Utrecht), V34, P222; Kobal G, 2000, EUR ARCH OTO-RHINO-L, V257, P205, DOI 10.1007/s004050050223; Krajnik J, 2014, FRONT NEUROSCI-SWITZ, V8, DOI 10.3389/fnins.2014.00195; Landis BN, 2004, LARYNGOSCOPE, V114, P1764, DOI 10.1097/00005537-200410000-00017; Larsson M, 2004, CHEM SENSES, V29, P547, DOI 10.1093/chemse/bjh059; Little AC, 2013, PSYCHONEUROENDOCRINO, V38, P1777, DOI 10.1016/j.psyneuen.2013.02.014; Mareckova K, 2014, SOC COGN AFFECT NEUR, V9, P191, DOI 10.1093/scan/nss128; Maruska KP, 2010, BEHAV BRAIN RES, V213, P208, DOI 10.1016/j.bbr.2010.04.058; Merkonidis C, 2014, EUR ARCH OTORHINOLAR; Millas I, 2011, CONTRACEPTION, V83, P571, DOI 10.1016/j.contraception.2010.09.008; Miwa T, 2001, ARCH OTOLARYNGOL, V127, P497, DOI 10.1001/archotol.127.5.497; Mordecai KL, 2008, HORM BEHAV, V54, P286, DOI 10.1016/j.yhbeh.2008.03.006; Murphy C, 2002, JAMA-J AM MED ASSOC, V288, P2307, DOI 10.1001/jama.288.18.2307; Nathan BP, 2012, EXP NEUROL, V237, P1, DOI 10.1016/j.expneurol.2012.06.001; Navarrete-Palacios E, 2003, BIOL PSYCHOL, V63, P269, DOI 10.1016/S0301-0511(03)00076-0; Navarrete-Palacios E, 2003, ARCH OTOLARYNGOL, V129, P460, DOI 10.1001/archotol.129.4.460; Ohla K, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00607; Pause BM, 1996, BIOL PSYCHOL, V44, P31, DOI 10.1016/S0301-0511(96)05207-6; PELIKAN Z, 1978, ANN ALLERGY, V40, P211; Petersen N, 2015, SOC COGN AFFECT NEUR, V10, P1266, DOI 10.1093/scan/nsv010; Petersen N, 2014, NEUROIMAGE, V90, P24, DOI 10.1016/j.neuroimage.2013.12.016; Philpott CM, 2008, RHINOLOGY, V46, P221; Philpott CM, 2008, J OTOLARYNGOL-HEAD N, V37, P540, DOI 10.2310/7070.2008.0102; PHOENIX CH, 1959, ENDOCRINOLOGY, V65, P369, DOI 10.1210/endo-65-3-369; Pierman S, 2008, EUR J NEUROSCI, V27, P423, DOI 10.1111/j.1460-9568.2007.06016.x; Pletzer B, 2014, BRAIN RES, V1543, P128, DOI 10.1016/j.brainres.2013.11.007; Renfro KJ, 2013, HORM BEHAV, V63, P491, DOI 10.1016/j.yhbeh.2013.01.001; Roberts SC, 2008, P ROY SOC B-BIOL SCI, V275, P2715, DOI 10.1098/rspb.2008.0825; SANGHERA MK, 1991, ENDOCRINOLOGY, V129, P2834, DOI 10.1210/endo-129-6-2834; Seki N, 2009, ACTA OTO-LARYNGOL, V124, P958; Stubner UP, 1999, ALLERGY, V54, P865, DOI 10.1034/j.1398-9995.1999.00961.x; Temmel AFP, 2002, ARCH OTOLARYNGOL, V128, P635, DOI 10.1001/archotol.128.6.635; Watanabe K, 2002, JPN J PHYSIOL, V52, P353, DOI 10.2170/jjphysiol.52.353; Wolstenholme CR, 2006, AM J RHINOL, V20, P238, DOI 10.1177/194589240602000225	56	15	16	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2016	11	12							e0167520	10.1371/journal.pone.0167520	http://dx.doi.org/10.1371/journal.pone.0167520			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI9TW	28002464	Green Published, Green Submitted, gold			2022-12-27	WOS:000392853100011
J	Busschaert, C; Scherrens, AL; De Bourdeaudhuij, I; Cardon, G; Van Cauwenberg, J; De Cocker, K				Busschaert, Cedric; Scherrens, Anne-Lore; De Bourdeaudhuij, Ilse; Cardon, Greet; Van Cauwenberg, Jelle; De Cocker, Katrien			Socio-Ecological Variables Associated with Context-Specific Sitting Time in Belgian Older Adults: A One-Year Follow-Up Study	PLOS ONE			English	Article							SEDENTARY BEHAVIOR; PHYSICAL-ACTIVITY; DETERMINANTS; RELIABILITY; VALIDITY; FEASIBILITY; ADOLESCENTS; MOTIVATION; BARRIERS; PEOPLE	Introduction Knowledge about variables associated with context-specific sitting time in older adults is limited. Therefore, this study explored cross-sectional and longitudinal associations of sociodemographic, social-cognitive, physical-environmental and health-related variables with sitting during TV viewing, computer use and motorized transport in older adults. Methods A sample of Belgian older adults completed structured interviews on context-specific sitting time and associated variables using a longitudinal study design. Objective measurements of grip strength and physical performance were also completed. Complete baseline data were available of 258 participants (73.98 6.16 years) of which 229 participants remained in the study at one year follow-up (retention rate: 91.60%). Cross-sectional correlates (baseline data) and longitudinal predictors (change-scores in relation with change in sitting time) were explored through multiple linear regression analyses. Results Per context-specific sitting time, most of the cross-sectional correlates differed from the longitudinal predictors. Increases over time in enjoyment of watching TV (+one unit), encouragement of partner to watch less TV (+one unit) and TV time of partner (+30.0 min/day) were associated with respectively 9.1 min/day (p<0.001), 16.0 min/day (p<0.001) and 12.0 min/day (p<0.001) more sitting during TV viewing at follow-up. Increases over time in enjoyment of using a computer (+one unit), the number of smartphones and tablets (+1) and computer use of the partner (+30.0 min/day) were associated with respectively 5.5 min/day (p < .01), 10.4 min/day (p < .05) and 3.0 min/day (p < .05) more sitting during computer use at follow-up. An increase over time in self-efficacy regarding taking a bicycle or walking was associated with 2.9 min/day (p < .05) less sitting during motorized transport at follow-up. Conclusions The results stressed the importance of looking at separate contexts of sitting. Further, the results highlighted the importance of longitudinal research in order to reveal which changes in particular variables predicted changes in context-specific sitting time. Variables at the social-cognitive level were most frequently related to context-specific sitting.	[Busschaert, Cedric; De Bourdeaudhuij, Ilse; Cardon, Greet; De Cocker, Katrien] Univ Ghent, Dept Movement & Sport Sci, Ghent, Belgium; [Busschaert, Cedric; Van Cauwenberg, Jelle; De Cocker, Katrien] Res Fdn Flanders FWO, Brussels, Belgium; [Scherrens, Anne-Lore; Van Cauwenberg, Jelle] Univ Ghent, Dept Publ Hlth, Ghent, Belgium; [Scherrens, Anne-Lore] Vrije Univ Brussel, Dept Primary Care, Brussels, Belgium; [Van Cauwenberg, Jelle] Vrije Univ Brussel, Dept Human Biometry & Biomech, Brussels, Belgium	Ghent University; Ghent University; Vrije Universiteit Brussel; Vrije Universiteit Brussel	De Bourdeaudhuij, I (corresponding author), Univ Ghent, Dept Movement & Sport Sci, Ghent, Belgium.	Ilse.Debourdeaudhuij@UGent.be	De Cocker, Katrien/AEV-4609-2022; De+Bourdeaudhuij, Ilse/AAC-5528-2019; De Cocker, Katrien/AAA-5783-2020	De+Bourdeaudhuij, Ilse/0000-0001-9969-7597; De Cocker, Katrien/0000-0001-7510-4419; Cardon, Greet/0000-0003-4983-6557	Fund for Scientific Research Flanders [B/12530/01]	Fund for Scientific Research Flanders(FWO)	Funded by Fund for Scientific Research Flanders (fund no. B/12530/01): CB IDB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AJZEN I, 1991, ORGAN BEHAV HUM DEC, V50, P179, DOI 10.1016/0749-5978(91)90020-T; Allison DP, 2012, HANDLING MISSING DAT; [Anonymous], 2005, GUIDELINES DATA PROC; Balboa-Castillo T, 2011, HEALTH QUAL LIFE OUT, V9, DOI 10.1186/1477-7525-9-47; Bann D, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116058; Bin Cheung Y, 2002, STAT MED, V21, P1461, DOI 10.1002/sim.1088; Brug J, 2015, INT J BEHAV NUTR PHY, V12, DOI 10.1186/s12966-015-0293-2; Busschaert C, 2015, J ADOLESCENT HLTH OF; Busschaert C, 2015, INT J BEHAV NUTR PHY, V12, DOI 10.1186/s12966-015-0277-2; Chastin SFM, 2014, BONE, V64, P254, DOI 10.1016/j.bone.2014.04.009; Chastin SFM, 2015, INT J BEHAV NUTR PHY, V12, DOI 10.1186/s12966-015-0292-3; Chastin SFM, 2014, INT J ENV RES PUB HE, V11, P773, DOI 10.3390/ijerph110100773; Chastin SFM, 2013, PLOS ONE, V8; De Bourdeaudhuij I, 2005, OBES RES, V13, P1097, DOI 10.1038/oby.2005.128; De Bourdeaudhuij I, 2002, PREV MED, V34, P279, DOI 10.1006/pmed.2001.0979; Deforche B, 2010, PREV MED, V50, pS24, DOI 10.1016/j.ypmed.2009.08.017; Dogra S, 2014, INT J PUBLIC HLTH; Gardiner PA, 2011, AM J PREV MED, V41, P174, DOI 10.1016/j.amepre.2011.03.020; Gardner B, 2014, INT J BEHAV NUTR PHY, V11; Gianoudis J, 2015, OSTEOPOROSIS INT, V26, P571, DOI 10.1007/s00198-014-2895-y; Griffith DM, 2013, AM J MENS HEALTH, V7, P169, DOI 10.1177/1557988312465887; GURALNIK JM, 1995, NEW ENGL J MED, V332, P556, DOI 10.1056/NEJM199503023320902; Hamer M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066222; Harvey JA, 2015, J AGING PHYS ACTIV, V23, P471, DOI 10.1123/japa.2014-0164; Haywood KL, 2005, QUAL LIFE RES, V14, P1651, DOI 10.1007/s11136-005-1743-0; Healy GN, 2008, DIABETES CARE, V31, P661, DOI 10.2337/dc07-2046; Healy GN, 2015, EUROPEAN HEART J; Keevil VL, 2015, MED SCI SPORT EXER, V47, P735, DOI 10.1249/MSS.0000000000000453; Kikuchi H, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-213; Kolbe-Alexander TL, 2006, J AGING PHYS ACTIV, V14, P98, DOI 10.1123/japa.14.1.98; de Rezende LFM, 2014, BMC PUBLIC HEALTH, V14, DOI [10.1186/1471-2458-14-485, 10.1186/1471-2458-14-333]; Meneguci J, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-1426-x; Owen N, 2014, BRIT J SPORT MED, V48, P174, DOI 10.1136/bjsports-2013-093107; Owen N, 2011, AM J PREV MED, V41, P189, DOI 10.1016/j.amepre.2011.05.013; Rosenberg DE, 2015, J GERONTOLOGY A; Rovniak LS, 2014, J SCI MED SPORT, V17, P376, DOI 10.1016/j.jsams.2013.07.014; Salmon J, 2003, HEALTH PSYCHOL, V22, P178, DOI 10.1037/0278-6133.22.2.178; Sedentary Behaviour Research Network, 2012, APPL PHYSIOL NUTR ME, V37, P540, DOI [10.1139/h2012-024, DOI 10.1139/H2012-024]; Stamatakis E, 2012, PREV MED, V54, P82, DOI 10.1016/j.ypmed.2011.10.009; Thogersen-Ntoumani C, 2009, SCAND J MED SCI SPOR, V19, P286, DOI 10.1111/j.1600-0838.2007.00751.x; Tomioka K, 2011, J EPIDEMIOL, V21, P459, DOI 10.2188/jea.JE20110003; Tran DV, 2013, HEALTH PROMOT J AUST, V24, P126, DOI 10.1071/HE13012; Uijtdewilligen L, 2014, SCAND J MED SCI SPOR; Van Cauwenberg J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0133175; Van Cauwenberg J, 2014, J AGING PHYS ACTIV, V22, P508, DOI [10.1123/japa.2013-0015, 10.1123/JAPA.2013-0015]; van der Berg JD, 2014, MED SCI SPORT EXER, V46, P1359, DOI 10.1249/MSS.0000000000000246; Van Dyck D, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-668; Van Holle V, 2014, INT J BEHAV NUTR PHY, V11, DOI 10.1186/s12966-014-0110-3; Walters SJ, 2001, AGE AGEING, V30, P337, DOI 10.1093/ageing/30.4.337; Ware J.E., 1994, SF 36 PHYS MENTAL HL; Zhai L, 2015, BRIT J SPORT MED, V49, P705, DOI 10.1136/bjsports-2014-093613	51	7	7	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2016	11	12							e0167881	10.1371/journal.pone.0167881	http://dx.doi.org/10.1371/journal.pone.0167881			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EI9QF	27997603	gold, Green Accepted, Green Published, Green Submitted			2022-12-27	WOS:000392842900016
J	Davoudi, M; Kotarsky, H; Hansson, E; Kallijarvi, J; Fellman, V				Davoudi, Mina; Kotarsky, Heike; Hansson, Eva; Kallijarvi, Jukka; Fellman, Vineta			COX7A2L/SCAFI and Pre-Complex III Modify Respiratory Chain Supercomplex Formation in Different Mouse Strains with a Bcs1/Mutation	PLOS ONE			English	Article							PROTEIN; MITOCHONDRIA; RCF1	The COX7A2L (Supercomplex Assembly Factor I, SCAFI) protein has been proposed to be a mitochondrial supercomplex assembly factor required for respirasome (supercomplex containing complexes I, III, and IV) formation. In the C57BU6 mouse strain a homozygous in-frame 6-base-pair deletion in the COX7a2I/SCAF1 gene resulting in unstable protein and suggesting loss of function was previously identified. The loss of SCAFI was shown to impede respirasome formation, a major concern for the use of C57BL mouse strains in mitochondrial research. In contradiction, another recent study suggested that supercomplex formation is independent of SCAFI isoforms. We investigated whether SCAFI isoform status affected the disease severity and supercomplex formation in the liver of Bcs1a232A>G knock-in mice with incomplete complex III assembly. In homozygotes (Bcs1/(G/G)) of mixed (C57BL/6:129/Sv) genetic background, the lifespan was similar in mice with wild-type SCAFI allele and in those homozygous (SCAF/(short/short)) for the deleted SCAF1 variant (34 3 days; n = 6 vs. 32 +/- 2 days; n = 7, respectively). SCAFI heterozygosity (SCAF/(long/short)) resulted in decreased SCAFI protein but respirasome assembly was unaffected. Congenic (C57BL/6) mice were of the genotype SCAF(short/short) and had no detectable SCAFI protein. In their liver mitochondria, respirasome composition was altered as compared to mixed background mice. Complex IV was mainly present as monomers and dimers, and only low amounts were found in combination with complex I and complex III or with precomplex III. The main supercomplex in the liver mitochondria of C57BU6 mice comprised only complexes I and III. In conclusion, in liver mitochondria of C57BL/6 mice, supercomplexes had markedly reduced amount of, but were not completely depleted of, complex IV, supporting a role for COX7A2L/SCAFI in supercomplex assembly. However, the disease progression of the Bcs1/mutant mice was unrelated to SCAFI isoforms and supercomplex composition, suggesting that other genetic factors contribute to the different survival in the different genetic backgrounds.	[Davoudi, Mina; Kotarsky, Heike; Hansson, Eva; Fellman, Vineta] Lund Univ, Pediat, Dept Clin Sci, Lund, Sweden; [Kallijarvi, Jukka; Fellman, Vineta] Folkhalsan Res Ctr, Helsinki, Finland; [Fellman, Vineta] Univ Helsinki, Childrens Hosp, Helsinki, Finland	Lund University; Folkhalsan Research Center; University of Helsinki	Fellman, V (corresponding author), Lund Univ, Pediat, Dept Clin Sci, Lund, Sweden.; Fellman, V (corresponding author), Folkhalsan Res Ctr, Helsinki, Finland.; Fellman, V (corresponding author), Univ Helsinki, Childrens Hosp, Helsinki, Finland.	Vineta.Fellman@med.lu.se	Kallijarvi, Jukka/AAV-5091-2021	Kallijarvi, Jukka/0000-0003-3773-7025; Fellman, Vineta/0000-0002-1355-5633; Davoudi, Mina/0000-0002-4952-1099	Lund University; Swedish Research Council [521-2011-3877]; Skane Council Foundation for Research and Development; Academy of Finland [259296]; Folkhalsan Research Center	Lund University; Swedish Research Council(Swedish Research CouncilEuropean Commission); Skane Council Foundation for Research and Development; Academy of Finland(Academy of Finland); Folkhalsan Research Center	This study was supported by grants to VF from Lund University, the Swedish Research Council (grant no. 521-2011-3877), the Skane Council Foundation for Research and Development, and Academy of Finland (Grant 259296), and Folkhalsan Research Center. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acin-Perez R, 2008, MOL CELL, V32, P529, DOI 10.1016/j.molcel.2008.10.021; Boyce R, 2016, SCIENCE, V352, P812, DOI 10.1126/science.aad5252; Chen YC, 2012, CELL METAB, V15, P348, DOI 10.1016/j.cmet.2012.02.006; Davoudi M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086767; Diaz F, 2012, MOL CELL BIOL, V32, P415, DOI 10.1128/MCB.06051-11; Ikeda K, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3147; Kotarsky H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041156; Lapuente-Brun E, 2013, SCIENCE, V340, P1567, DOI 10.1126/science.1230381; Leveen P, 2011, HEPATOLOGY, V53, P437, DOI 10.1002/hep.24031; Maranzana E, 2013, ANTIOXID REDOX SIGN, V19, P1469, DOI 10.1089/ars.2012.4845; McKenzie M, 2006, J MOL BIOL, V361, P462, DOI 10.1016/j.jmb.2006.06.057; Mileykovskaya E, 2014, CHEM PHYS LIPIDS, V179, P42, DOI 10.1016/j.chemphyslip.2013.10.012; Mourier A, 2014, CELL METAB, V20, P1069, DOI 10.1016/j.cmet.2014.11.005; Schagger H, 2000, EMBO J, V19, P1777, DOI 10.1093/emboj/19.8.1777; Strogolova V, 2012, MOL CELL BIOL, V32, P1363, DOI 10.1128/MCB.06369-11; Visapaa I, 2002, AM J HUM GENET, V71, P863, DOI 10.1086/342773; Vukotic M, 2012, CELL METAB, V15, P336, DOI 10.1016/j.cmet.2012.01.016	17	13	13	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2016	11	12							e0168774	10.1371/journal.pone.0168774	http://dx.doi.org/10.1371/journal.pone.0168774			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI9QF	27997587	Green Published, gold			2022-12-27	WOS:000392842900075
J	Nagubadi, S; Mehta, R; Abdoh, M; Nagori, M; Littleton, S; Gueret, R; Tulaimat, A				Nagubadi, Swamy; Mehta, Rohit; Abdoh, Mamoun; Nagori, Mohammedumer; Littleton, Stephen; Gueret, Renaud; Tulaimat, Aiman			The Accuracy of Portable Monitoring in Diagnosing Significant Sleep Disordered Breathing in Hospitalized Patients	PLoS One			English	Article							HOME RESPIRATORY POLYGRAPHY; APNEA SYNDROME; HEART-FAILURE; MYOCARDIAL-INFARCTION; BERLIN QUESTIONNAIRE; HYPOPNEA SYNDROME; RISK; PREVALENCE; HYPOVENTILATION; READMISSION	Background Polysomnograms are not always feasible when sleep disordered breathing (SDB) is suspected in hospitalized patients. Portable monitoring is a practical alternative; however, it has not been recommended in patients with comorbidities. Objective We evaluated the accuracy of portable monitoring in hospitalized patients suspected of having SDB. Design Prospective observational study. Setting Large, public, urban, teaching hospital in the United States. Participants Hospitalized patients suspected of having SDB. Methods Patients underwent portable monitoring combined with actigraphy during the hospitalization and then polysomnography after discharge. We determined the accuracy of portable monitoring in predicting moderate to severe SDB and the agreement between the apnea hypopnea index measured by portable monitor (AHI(PM)) and by polysomnogram (AHI(PSG)). Results Seventy-one symptomatic patients completed both tests. The median time between the two tests was 97 days (IQR 25-75: 24-109). Forty-five percent were hospitalized for cardiovascular disease. Mean age was 52 +/- 10 years, 41% were women, and the majority had symptoms of SDB. Based on AHI(PSG), SDB was moderate in 9 patients and severe in 39. The area under the receiver operator characteristics curve for AHI(PM) was 0.8, and increased to 0.86 in patients without central sleep apnea; it was 0.88 in the 31 patients with hypercapnia. For predicting moderate to severe SDB, an AHI(PM) of 14 had a sensitivity of 90%, and an AHI(PM) of 36 had a specificity of 87%. The mean +/- SD difference between AHI(PM) and AHI(PSG) was 2 +/- 29 event/hr. Conclusion In hospitalized, symptomatic patients, portable monitoring is reasonably accurate in detecting moderate to severe SDB.	[Nagubadi, Swamy; Mehta, Rohit; Abdoh, Mamoun; Nagori, Mohammedumer; Littleton, Stephen; Gueret, Renaud; Tulaimat, Aiman] Cook Cty Hlth & Hosp Syst, Div Pulm Crit Care & Sleep Med, Chicago, IL USA; [Mehta, Rohit] Bluewater Hlth, Sarnia, ON, Canada; [Abdoh, Mamoun] Borgess Med Ctr, Kalamazoo, MI USA; [Nagori, Mohammedumer] Metrohlth Med Ctr, Cleveland, OH USA	John H Stroger Junior Hospital Cook County; MetroHealth System	Nagubadi, S (corresponding author), Cook Cty Hlth & Hosp Syst, Div Pulm Crit Care & Sleep Med, Chicago, IL USA.	snagubadi@cookcountyhhs.org	Gueret, Renaud/AAF-8350-2020	Mehta, Rohit/0000-0001-6399-9374; Littleton, Stephen/0000-0001-8111-7005; Nagubadi, Swamy/0000-0003-1501-052X				BaHammam A, 2006, MED SCI MONITOR, V12, pCR168; Bassetti CL, 2006, STROKE, V37, P967, DOI 10.1161/01.STR.0000208215.49243.c3; Bittencourt LRA, 2001, J SLEEP RES, V10, P245, DOI 10.1046/j.1365-2869.2001.00255.x; Calvin AD, 2011, CHEST, V140, P1517, DOI 10.1378/chest.10-2472; Chan W, 2010, STROKE, V41, P2973, DOI 10.1161/STROKEAHA.110.596759; Chung F, 2008, ANESTHESIOLOGY, V108, P822, DOI 10.1097/ALN.0b013e31816d91b5; Collop NA, 2007, J CLIN SLEEP MED, V3, P737; Elbaz M, 2002, SLEEP, V25, P527; FLEMONS WW, 1994, AM J RESP CRIT CARE, V150, P1279, DOI 10.1164/ajrccm.150.5.7952553; Foster GD, 2009, DIABETES CARE, V32, P1017, DOI 10.2337/dc08-1776; Gantner D, 2010, RESPIROLOGY, V15, P952, DOI 10.1111/j.1440-1843.2010.01797.x; Guerrero A, 2014, SLEEP, V37, P1363, DOI 10.5665/sleep.3932; Iranzo A, 2002, NEUROLOGY, V58, P911, DOI 10.1212/WNL.58.6.911; JOHNS MW, 1991, SLEEP, V14, P540, DOI 10.1093/sleep/14.6.540; Kapur V, 1999, SLEEP, V22, P749, DOI 10.1093/sleep/22.6.749; Kauta SR, 2014, J CLIN SLEEP MED, V10, P1051, DOI 10.5664/jcsm.4096; Khayat R, 2015, EUR HEART J; Khayat R, 2012, J CARD FAIL, V18, P534, DOI 10.1016/j.cardfail.2012.05.003; Khayat RN, 2009, CHEST, V136, P991, DOI 10.1378/chest.09-0597; Kuna ST, 2011, AM J RESP CRIT CARE, V183, P1238, DOI 10.1164/rccm.201011-1770OC; Kuniyoshi FHS, 2011, CHEST, V140, P1192, DOI 10.1378/chest.10-2625; Lecomte P, 2013, DIABETES METAB, V39, P139, DOI 10.1016/j.diabet.2012.10.004; Masa JF, 2015, AM J RESP CRIT CARE; Masa JF, 2011, AM J RESP CRIT CARE, V184, P964, DOI 10.1164/rccm.201103-0428OC; Masa JF, 2011, THORAX, V66, P567, DOI 10.1136/thx.2010.152272; Mehra R, 2006, SLEEP MED, V7, P521, DOI 10.1016/j.sleep.2006.03.012; Missildine K, 2008, J GERONTOL NURS, V34, P15, DOI 10.3928/00989134-20080601-06; Moore C, 2007, ARCH INTERN MED, V167, P1305, DOI 10.1001/archinte.167.12.1305; Nowbar S, 2004, AM J MED, V116, P1, DOI 10.1016/j.amjmed.2003.08.022; Peker Y, 1997, SLEEP, V20, P645, DOI 10.1093/sleep/20.8.645; Peker Y, 2016, AM J RESP CRIT CARE; Pelletier-Fleury N, 2004, EUR RESPIR J, V23, P53, DOI 10.1183/09031936.03.00066903; Priou P, 2010, CHEST, V138, P84, DOI 10.1378/chest.09-2472; Punjabi NM, 2012, AM J RESP CRITICAL C; Ravesloot MJL, 2012, EUR ARCH OTO-RHINO-L, V269, P1865, DOI 10.1007/s00405-012-1948-0; Schiza SE, 2012, J CLIN SLEEP MED, V8, P21, DOI 10.5664/jcsm.1652; Sharma S, 2015, JACC-HEART FAIL, V3, P725, DOI 10.1016/j.jchf.2015.04.015; Shear TC, 2014, J CLIN SLEEP MED, V10, P1061, DOI 10.5664/jcsm.4098; de Oliveira ACT, 2009, CHEST, V135, P330, DOI 10.1378/chest.08-1859; Tsukamoto K, 2006, CIRC J, V70, P1553, DOI 10.1253/circj.70.1553; Wang X, 2013, INT J CARDIOL, V169, P207, DOI 10.1016/j.ijcard.2013.08.088; Wittmann V, 2004, SLEEP MED REV, V8, P269, DOI 10.1016/j.smrv.2004.01.002; YOUDEN W. J., 1950, CANCER, V3, P32, DOI 10.1002/1097-0142(1950)3:1<32::AID-CNCR2820030106>3.0.CO;2-3	43	4	6	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 19	2016	11	12							e0168073	10.1371/journal.pone.0168073	http://dx.doi.org/10.1371/journal.pone.0168073			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI9QC	27992566	Green Published, Green Submitted, gold			2022-12-27	WOS:000392842600032
J	Thor, P; Bailey, A; Halsband, C; Guscelli, E; Gorokhova, E; Fransson, A				Thor, Peter; Bailey, Allison; Halsband, Claudia; Guscelli, Ella; Gorokhova, Elena; Fransson, Agneta			Seawater pH Predicted for the Year 2100 Affects the Metabolic Response to Feeding in Copepodites of the Arctic Copepod Calanus glacialis	PLOS ONE			English	Article							OCEAN ACIDIFICATION; EGG-PRODUCTION; DYNAMIC ACTION; ACARTIA-TONSA; CARBONIC-ACID; LONG-TERM; FINMARCHICUS; TEMPERATURE; POPULATION; STRESS	Widespread ocean acidification (OA) is transforming the chemistry of the global ocean, and the Arctic is recognised as a region where the earliest and strongest impacts of OA are expected. In the present study, metabolic effects of OA and its interaction with food availability was investigated in Calanus glacialis from the Kongsfjord, West Spitsbergen. We measured metabolic rates and RNA/DNA ratios (an indicator of biosynthesis) concurrently in fed and unfed individuals of copepodite stages CII-CIII and CV subjected to two different pH levels representative of present day and the "business as usual" IPCC scenario (RCP8.5) prediction for the year 2100. The copepods responded more strongly to changes in food level than to decreasing pH, both with respect to metabolic rate and RNA/DNA ratio. However, significant interactions between effects of pH and food level showed that effects of pH and food level act in synergy in copepodites of C. glacialis. While metabolic rates in copepodites stage CII-CIII increased by 78% as a response to food under present day conditions (high pH), the increase was 195% in CII-CIlls kept at low pH-a 2.5 times greater increase. This interaction was absent for RNA/DNA, so the increase in metabolic rates were clearly not a reaction to changing biosynthesis at low pH per se but rather a reaction to increased metabolic costs per unit of biosynthesis. Interestingly, we did not observe this difference in costs of growth in stage CV. A 2.5 times increase in metabolic costs of growth will leave the copepodites with much less energy for growth. This may infer significant changes to the C. glacialis population during future OA.	[Thor, Peter; Bailey, Allison; Fransson, Agneta] Norwegian Polar Res Inst, Fram Ctr, Tromso, Norway; [Halsband, Claudia] Akvaplan Niva, Fram Ctr, Tromso, Norway; [Guscelli, Ella] Univ Florence, Florence, Italy; [Gorokhova, Elena] Stockholm Univ, Dept Environm Sci & Analyt Chem, Stockholm, Sweden	Norwegian Polar Institute; Akvaplan-niva; University of Florence; Stockholm University	Thor, P (corresponding author), Norwegian Polar Res Inst, Fram Ctr, Tromso, Norway.	peter.thor@npolar.no	Thor, Peter/ABF-1114-2021; Gorokhova, Elena/E-7105-2018; Thor, Peter/A-7522-2009; Halsband, Claudia/B-7770-2008	Thor, Peter/0000-0002-2603-2284; Gorokhova, Elena/0000-0002-4192-6956; Thor, Peter/0000-0002-2603-2284; Halsband, Claudia/0000-0002-8570-9056	FRAM High North Research Centre for Climate and the Environment; Norwegian Research Council [225279]	FRAM High North Research Centre for Climate and the Environment; Norwegian Research Council(Research Council of NorwayEuropean Commission)	The study was financially supported by grants from the FRAM High North Research Centre for Climate and the Environment through the Ocean Acidification and Ecosystem Effects in Northern Waters Flagship and a grant from the Norwegian Research Council (grant # 225279), both to PT and CH.	AMAP, 2013, AMAP ASS 2013 ARCT O; Anderson MJ, 2001, AUSTRAL ECOL, V26, P32, DOI 10.1046/j.1442-9993.2001.01070.x; Arnkvaern G, 2005, POLAR BIOL, V28, P528, DOI 10.1007/s00300-005-0715-8; Bailey A, 2016, ICES J MAR SCI; Caldarone EM, 2006, LIMNOL OCEANOGR-METH, V4, P153, DOI 10.4319/lom.2006.4.153; Calliari D, 2006, MAR ECOL PROG SER, V312, P177, DOI 10.3354/meps312177; CALOW P, 1990, FUNCT ECOL, V4, P283, DOI 10.2307/2389587; Clark RA, 2003, ICES J MAR SCI, V60, P187, DOI 10.1016/S1054-3139(02)00253-9; Collins M, 2014, PHYS SCI BASIS CONTR; Dahlhoff EP, 2004, ANNU REV PHYSIOL, V66, P183, DOI 10.1146/annurev.physiol.66.032102.114509; Dam HG, 2003, J EXP MAR BIOL ECOL, V292, P119, DOI 10.1016/S0022-0981(03)00162-X; Dickson A.G., 2007, GUIDE BEST PRACTICES, V3; DICKSON AG, 1990, J CHEM THERMODYN, V22, P113, DOI 10.1016/0021-9614(90)90074-Z; DICKSON AG, 1987, DEEP-SEA RES, V34, P1733, DOI 10.1016/0198-0149(87)90021-5; Dupont S, 2010, ESTUAR COAST SHELF S, V89, P182, DOI 10.1016/j.ecss.2010.06.013; Fabry VJ, 2009, OCEANOGRAPHY, V22, P160, DOI 10.5670/oceanog.2009.105; Finke DL, 2004, NATURE, V429, P407, DOI 10.1038/nature02554; Fransson A, 2016, POLAR BIOL, V39, P1841, DOI 10.1007/s00300-016-1955-5; Fransson A, 2001, CONT SHELF RES, V21, P225, DOI 10.1016/S0278-4343(00)00088-1; Freese D, 2015, LIMNOL OCEANOGR, V60, P2121, DOI 10.1002/lno.10158; Gorokhova E, 2002, J PLANKTON RES, V24, P511, DOI 10.1093/plankt/24.5.511; Gorokhova E, 2009, HARMFUL ALGAE, V8, P264, DOI 10.1016/j.hal.2008.06.006; HANSEN B, 1990, J PLANKTON RES, V12, P1173, DOI 10.1093/plankt/12.6.1173; Hernroth B, 2012, FISH SHELLFISH IMMUN, V33, P1095, DOI 10.1016/j.fsi.2012.08.011; Hildebrandt N, 2016, ICES J MAR SCI, V73, P927, DOI 10.1093/icesjms/fsv226; Hildebrandt N, 2014, MAR POLLUT BULL, V80, P59, DOI 10.1016/j.marpolbul.2014.01.050; Hop H, 2013, MAR BIOL RES, V9, P878, DOI 10.1080/17451000.2013.775458; Isari S, 2015, J PLANKTON RES; JOBLING M, 1983, J FISH BIOL, V23, P549, DOI 10.1111/j.1095-8649.1983.tb02934.x; Karnovsky NJ, 2003, MAR ECOL PROG SER, V253, P289, DOI 10.3354/meps253289; KIORBOE T, 1985, MAR ECOL PROG SER, V26, P85, DOI 10.3354/meps026085; Lewis CN, 2013, P NATL ACAD SCI USA, V110, pE4960, DOI 10.1073/pnas.1315162110; Li W, 2012, MAR POLLUT BULL, V64, P699, DOI 10.1016/j.marpolbul.2012.01.033; Lowry L., 1993, BOWHEAD WHALES; Mackas DL, 1998, CAN J FISH AQUAT SCI, V55, P1878, DOI 10.1139/cjfas-55-8-1878; Madsen SD, 2001, MAR BIOL, V139, P75; MEHRBACH C, 1973, LIMNOL OCEANOGR, V18, P897, DOI 10.4319/lo.1973.18.6.0897; Mumm N, 1998, POLAR BIOL, V20, P189, DOI 10.1007/s003000050295; Nielsen TG, 2014, MAR BIOL, V161, P1299, DOI 10.1007/s00227-014-2419-5; Omori M., 1984, METHODS MARINE ZOOPL; Pan T-CF, 2015, P NATL ACAD SCI US; Pedersen SA, 2014, ENVIRON SCI TECHNOL, V48, P12275, DOI 10.1021/es501581j; Petes LE, 2007, J EXP MAR BIOL ECOL, V351, P83, DOI 10.1016/j.jembe.2007.06.025; Portner HO, 2010, J EXP BIOL, V213, P881, DOI 10.1242/jeb.037523; Runge JA, 2016, ICES J MAR SCI, V73, P937, DOI 10.1093/icesjms/fsv258; Scott CL, 2000, POLAR BIOL, V23, P510, DOI 10.1007/s003000000114; Sokolova IM, 2012, MAR ENVIRON RES, V79, P1, DOI 10.1016/j.marenvres.2012.04.003; Steinacher M, 2009, BIOGEOSCIENCES, V6, P515, DOI 10.5194/bg-6-515-2009; STRATHMANN RR, 1967, LIMNOL OCEANOGR, V12, P411, DOI 10.4319/lo.1967.12.3.0411; Stumpp M, 2012, P NATL ACAD SCI USA, V109, P18192, DOI 10.1073/pnas.1209174109; Svetlichny LS, 2005, J PLANKTON RES, V27, P671, DOI 10.1093/plankt/fbi041; Thor P, 2002, J EXP MAR BIOL ECOL, V272, P159, DOI 10.1016/S0022-0981(02)00131-4; Thor P, 2002, J PLANKTON RES, V24, P293, DOI 10.1093/plankt/24.4.293; Thor P, 2000, J EXP MAR BIOL ECOL, V245, P171, DOI 10.1016/S0022-0981(99)00159-8; Thor P, 2015, GLOB CHANGE BIOL; Thor P, 2015, MAR BIOL, V162, P799, DOI 10.1007/s00227-015-2625-9; VIDAL J, 1980, MAR BIOL, V56, P195, DOI 10.1007/BF00645343; Wallace D, 2006, MS EXCEL PROGRAM DEV; Wendt I, 2015, CRUSTACEANA, V88, P675, DOI 10.1163/15685403-00003436; Weydmann A, 2016, POLAR BIOL, V39, P2311, DOI 10.1007/s00300-016-1898-x; Weydmann A, 2012, J EXP MAR BIOL ECOL, V428, P39, DOI 10.1016/j.jembe.2012.06.002; Zervoudaki S, 2014, MEDITERR MAR SCI, V15, P74, DOI 10.12681/mms.553; Zhang DJ, 2012, WATER SCI TECHNOL, V65, P30, DOI 10.2166/wst.2011.821	63	9	9	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 19	2016	11	12							e0168735	10.1371/journal.pone.0168735	http://dx.doi.org/10.1371/journal.pone.0168735			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI9QC	27992579	gold, Green Published, Green Submitted			2022-12-27	WOS:000392842600096
J	Herrera, C; Voisin, MB; Escalante, T; Rucavado, A; Nourshargh, S; Gutierrez, JM				Herrera, Cristina; Voisin, Mathieu-Benoit; Escalante, Teresa; Rucavado, Alexandra; Nourshargh, Sussan; Gutierrez, Jose Maria			Effects of PI and PIII Snake Venom Haemorrhagic Metalloproteinases on the Microvasculature: A Confocal Microscopy Study on the Mouse Cremaster Muscle	PLOS ONE			English	Article							VON-WILLEBRAND-FACTOR; CYSTEINE-RICH DOMAIN; LOCAL TISSUE-DAMAGE; BOTHROPS-ASPER TERCIOPELO; PERMEABILITY IN-VIVO; IV COLLAGEN; MATRIX METALLOPROTEINASES; LEUKOCYTE RECRUITMENT; VASCULAR-PERMEABILITY; ENDOTHELIAL-CELLS	The precise mechanisms by which Snake Venom Metalloproteinases (SVMPs) disrupt the microvasculature and cause haemorrhage have not been completely elucidated, and novel in vivo models are needed. In the present study, we compared the effects induced by BaP1, a PI SVMP isolated from Bothrops asper venom, and CsH1, a PIII SVMP from Crotalus simus venom, on cremaster muscle microvasculature by topical application of the toxins on isolated tissue (i.e., ex vivo model), and by intra-scrotal administration of the toxins (i.e., in vivo model). The whole tissue was fixed and immunostained to visualize the three components of blood vessels by confocal microscopy. In the ex vivo model, BaP1 was able to degrade type IV collagen and laminin from the BM of microvessels. Moreover, both SVMPs degraded type IV collagen from the BM in capillaries to a higher extent than in PCV and arterioles. CsH1 had a stronger effect on type IV collagen than BaP1. In the in vivo model, the effect of BaP1 on type IV collagen was widespread to the BM of arterioles and PCV. On the other hand, BaP1 was able to disrupt the endothelial barrier in PCV and to increase vascular permeability. Moreover, this toxin increased the size of gaps between pericytes in PCV and created new gaps between smooth muscle cells in arterioles in ex vivo conditions. These effects were not observed in the case of CsH1. In conclusion, our findings demonstrate that both SVMPs degrade type IV collagen from the BM in capillaries in vivo. Moreover, while the action of CsH1 is more directed to the BM of microvessels, the effects of BaP1 are widespread to other microvascular components. This study provides new insights in the mechanism of haemorrhage and other pathological effects induced by these toxins.	[Herrera, Cristina] Univ Costa Rica, Fac Farm, San Jose, Costa Rica; [Herrera, Cristina; Escalante, Teresa; Rucavado, Alexandra; Gutierrez, Jose Maria] Univ Costa Rica, Fac Microbiol, Inst Clodomiro Picado, San Jose, Costa Rica; [Voisin, Mathieu-Benoit; Nourshargh, Sussan] Queen Mary Univ London, Barts & London Sch Med & Dent, William Harvey Res Inst, London, England	Universidad Costa Rica; Universidad Costa Rica; University of London; Queen Mary University London	Gutierrez, JM (corresponding author), Univ Costa Rica, Fac Microbiol, Inst Clodomiro Picado, San Jose, Costa Rica.	jose.gutierrez@ucr.ac.cr	Gutiérrez, José/GSJ-1846-2022; Rucavado, Alexandra/AGY-1867-2022	, Mathieu-Benoit/0000-0003-3001-0894; Escalante, Teresa/0000-0003-4140-1620; Nourshargh, Sussan/0000-0001-5677-1806; Gutierrez, Jose Maria/0000-0001-8385-3081	Vicerrectoria de Investigacion, Universidad de Costa Rica [741-B5-285]; Arthritis Research UK [19913]; Wellcome Trust [098291/Z/12/Z]; Versus Arthritis [19913] Funding Source: researchfish	Vicerrectoria de Investigacion, Universidad de Costa Rica; Arthritis Research UK(Versus Arthritis); Wellcome Trust(Wellcome TrustEuropean Commission); Versus Arthritis(Versus Arthritis)	This work was supported by Vicerrectoria de Investigacion, Universidad de Costa Rica (www.vinv.ucr.ac.cr)(project 741-B5-285 to JMG), Arthritis Research UK (http://www.arthritisresearchuk.org/) (project 19913 to MV), and the Wellcome Trust (https://wellcome.ac.uk/) (project 098291/Z/12/Z to SN). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Armulik A, 2005, CIRC RES, V97, P512, DOI 10.1161/01.RES.0000182903.16652.d7; Ashina K, 2015, BIOCHEM BIOPH RES CO, V464, P590, DOI 10.1016/j.bbrc.2015.07.014; Ashina K, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132367; Baldo C, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000727; BARAMOVA EN, 1990, MATRIX, V10, P91, DOI 10.1016/S0934-8832(11)80175-7; BARAMOVA EN, 1989, ARCH BIOCHEM BIOPHYS, V275, P63, DOI 10.1016/0003-9861(89)90350-0; Bergers G, 2005, NEURO-ONCOLOGY, V7, P452, DOI 10.1215/S1152851705000232; Bernardes CP, 2013, J PROTEOMICS, V80, P250, DOI 10.1016/j.jprot.2013.01.021; Bodnar RJ, 2016, WOUND REPAIR REGEN, V24, P204, DOI 10.1111/wrr.12415; Calvete JJ, 2011, EXPERT REV PROTEOMIC, V8, P739, DOI [10.1586/EPR.11.61, 10.1586/epr.11.61]; Corada M, 1999, P NATL ACAD SCI USA, V96, P9815, DOI 10.1073/pnas.96.17.9815; Dejana E, 2008, J CELL SCI, V121, P2115, DOI 10.1242/jcs.017897; Diaz C, 2005, J CELL BIOCHEM, V94, P520, DOI 10.1002/jcb.20322; Escalante T, 2006, ARCH BIOCHEM BIOPHYS, V455, P144, DOI 10.1016/j.abb.2006.09.018; Escalante T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028017; Escalante T, 2011, J PROTEOMICS, V74, P1781, DOI 10.1016/j.jprot.2011.03.026; Escalante T, 2009, J PROTEOME RES, V8, P5120, DOI 10.1021/pr900489m; Farsky SHP, 2000, MEDIAT INFLAMM, V9, P213, DOI 10.1080/09629350020025728; Fernandes CM, 2006, TOXICON, V47, P549, DOI 10.1016/j.toxicon.2006.01.009; Finsterbusch M, 2014, J EXP MED, V211, P1306, DOI 10.1084/jem.20132413; Fox JW, 2005, TOXICON, V45, P969, DOI 10.1016/j.toxicon.2005.02.012; Goncalves LRC, 2000, MEDIAT INFLAMM, V9, P101, DOI 10.1080/096293500411569; Gutierrez J. M, 2011, EMERGENCIAS MED ANIM, P461; Gutierrez J.M., 2010, HDB VENOMS TOXINS RE, P491; GUTIERREZ JM, 1995, TOXICON, V33, P19, DOI 10.1016/0041-0101(94)00138-X; Gutierrez JM, 2005, TOXICON, V45, P997, DOI 10.1016/j.toxicon.2005.02.029; Gutierrez JM, 2000, BIOCHIMIE, V82, P841, DOI 10.1016/S0300-9084(00)01163-9; Gutierrez JM, 2016, TOXINS, V8, DOI 10.3390/toxins8040093; Herrera C, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004599; Herrera C, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003731; Hirschi KK, 1996, CARDIOVASC RES, V32, P687, DOI 10.1016/S0008-6363(96)00063-6; Kucukguven A, 2013, CURR DRUG TARGETS, V14, P287; KUHN K, 1995, MATRIX BIOL, V14, P439, DOI 10.1016/0945-053X(95)90001-2; KUHN K, 1981, FEBS LETT, V125, P123, DOI 10.1016/0014-5793(81)81012-5; LEE J, 1995, ANN BIOMED ENG, V23, P226, DOI 10.1007/BF02584425; LOMONTE B, 1994, TOXICON, V32, P41, DOI 10.1016/0041-0101(94)90020-5; LOMONTE B, 1994, TOXICON, V32, P505, DOI 10.1016/0041-0101(94)90302-6; Mora J, 2008, PLOS NEGLECT TROP D, V2, DOI 10.1371/journal.pntd.0000318; MOREIRA L, 1994, TOXICON, V32, P977, DOI 10.1016/0041-0101(94)90376-X; Moura-da-Silva AM, 2008, BIOCHIMIE, V90, P484, DOI 10.1016/j.biochi.2007.11.009; MULVANY MJ, 1990, PHYSIOL REV, V70, P921, DOI 10.1152/physrev.1990.70.4.921; OHSAKA A, 1975, MICROVASC RES, V10, P208, DOI 10.1016/0026-2862(75)90007-2; OHSAKA A, 1973, BIOCHIM BIOPHYS ACTA, V323, P415, DOI 10.1016/0005-2736(73)90187-9; Orsenigo F, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2199; OWNBY CL, 1978, AM J PATHOL, V93, P201; Pinto AFM, 2007, ARCH BIOCHEM BIOPHYS, V457, P41, DOI 10.1016/j.abb.2006.10.010; Poschl E, 2004, DEVELOPMENT, V131, P1619, DOI 10.1242/dev.01037; Proebstl D, 2012, J EXP MED, V209, P1219, DOI 10.1084/jem.20111622; Radu M, 2013, JOVE-J VIS EXP, DOI 10.3791/50062; Raffetto JD, 2008, J VASC SURG, V48, P447, DOI 10.1016/j.jvs.2008.03.004; Rucavado A, 2002, MEDIAT INFLAMM, V11, P121, DOI 10.1080/09629350220131980; Rucavado A, 1998, INT J EXP PATHOL, V79, P245; Rucavado A, 1995, EXP MOL PATHOL, V63, P186, DOI 10.1006/exmp.1995.1042; Serrano SMT, 2005, BIOCHEM J, V391, P69, DOI 10.1042/BJ20050483; Serrano SMT, 2007, FEBS J, V274, P3611, DOI 10.1111/j.1742-4658.2007.05895.x; Serrano SMT, 2006, J BIOL CHEM, V281, P39746, DOI 10.1074/jbc.M604855200; SHEPRO D, 1993, FASEB J, V7, P1031, DOI 10.1096/fasebj.7.11.8370472; TIMPL R, 1981, EUR J BIOCHEM, V120, P203, DOI 10.1111/j.1432-1033.1981.tb05690.x; Wang S, 2012, NANOSCALE RES LETT, V7, DOI 10.1186/1556-276X-7-219; Watanabe L, 2003, PROTEIN SCI, V12, P2273, DOI 10.1110/ps.03102403; Yurchenco PD, 2004, MATRIX BIOL, V22, P521, DOI 10.1016/j.matbio.2003.10.006; YURCHENCO PD, 2011, BIOL, V3, P3, DOI DOI 10.1101/CSHPERSPECT.A004911; Zhou D, 2005, J ORTHOP RES, V23, P949, DOI 10.1016/j.orthres.2005.01.022	63	9	9	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2016	11	12							e0168643	10.1371/journal.pone.0168643	http://dx.doi.org/10.1371/journal.pone.0168643			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI8LN	27992592	Green Published, gold, Green Submitted			2022-12-27	WOS:000392758000071
J	Kofuji, P; Mure, LS; Massman, LJ; Purrier, N; Panda, S; Engeland, WC				Kofuji, Paulo; Mure, Ludovic S.; Massman, Logan J.; Purrier, Nicole; Panda, Satchidananda; Engeland, William C.			Intrinsically Photosensitive Retinal Ganglion Cells (ipRGCs) Are Necessary for Light Entrainment of Peripheral Clocks	PLOS ONE			English	Article							CIRCADIAN TIMING SYSTEM; SUPRACHIASMATIC NUCLEUS; RETINOHYPOTHALAMIC TRACT; MAMMALIAN RETINA; MELANOPSIN; MOUSE; RESPONSES; OSCILLATORS; RHYTHMS; MICE	Light is a powerful entrainer of circadian clocks in almost all eukaryotic organisms promoting synchronization of internal circadian rhythms with external environmental light-dark (LD) cycles. In mammals, the circadian system is organized in a hierarchical manner, in which a central pacemaker in the suprachiasmatic nucleus (SCN) synchronizes oscillators in peripheral tissues. Recent evidence demonstrates that photoentrainment of the SCN proceeds via signaling from a subpopulation of retinal ganglion cells (RGCs) which are melanopsin-expressing and intrinsically photosensitive (ipRGCs). However, it is still unclear whether photoentrainment of peripheral clocks is mediated exclusively by the ipRGC system or if signaling from RGCs that do not express melanopsin also plays a role. Here we have used genetic "silencing" of ipRGC neurotransmission in mice to investigate whether this photoreceptive system is obligatory for the photoentrainment of peripheral circadian clocks. Genetic silencing of ipRGC neurotransmission in mice was achieved by expression of tetanus toxin light chain in melanopsin-expressing cells (Opn4:: TeNT mouse line). Rhythms of the clock gene Period 2 in various peripheral tissues were measured by crossbreeding Opn4:: TeNT mice with PER2 luciferase knock-in mice (mPER2(Luc)). We found that in Opn4:: TeNT mice the pupillary light reflex, light modulation of activity, and circadian photoentrainment of locomotor activity were severely impaired. Furthermore, ex vivo cultures from Opn4:: TeNT, mPER2(Luc) mice of the adrenal gland, cornea, lung, liver, pituitary and spleen exhibited robust circadian rhythms of PER2:: LUC bioluminescence. However, their peak bioluminescence rhythms were not aligned to the projected LD cycles indicating their lack of photic entrainment in vivo. Finally, we found that the circadian rhythm in adrenal corticosterone in Opn4:: TeNT mice, as monitored by in vivo subcutaneous microdialysis, was desynchronized from environmental LD cycles. Our findings reveal a non-redundant role of ipRGCs for photic entrainment of peripheral tissues, highlighting the importance of this photoreceptive system for the organismal adaptation to daily environmental LD cycles.	[Kofuji, Paulo; Massman, Logan J.; Purrier, Nicole; Engeland, William C.] Univ Minnesota, Dept Neurosci, Minneapolis, MN 55455 USA; [Mure, Ludovic S.; Panda, Satchidananda] Salk Inst Biol Studies, Regulatory Biol Lab, 10010 N Torrey Pines Rd, La Jolla, CA 92037 USA	University of Minnesota System; University of Minnesota Twin Cities; Salk Institute	Kofuji, P (corresponding author), Univ Minnesota, Dept Neurosci, Minneapolis, MN 55455 USA.	kofuj001@umn.edu	Kofuji, Paulo/AAR-7835-2021; Mure, Ludovic/AAR-9132-2021	Kofuji, Paulo/0000-0002-4840-9986; Mure, Ludovic/0000-0002-2485-1032; Massman, Logan/0000-0002-5579-4798	NIH [R03NS094419]	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	Support was provided by NIH grant R03NS094419.	Albrecht U, 2012, NEURON, V74, P246, DOI 10.1016/j.neuron.2012.04.006; Baba K, 2015, INVEST OPHTH VIS SCI, V56, P4753, DOI 10.1167/iovs.15-17124; Balsalobre A, 2000, SCIENCE, V289, P2344, DOI 10.1126/science.289.5488.2344; Buhr ED, 2015, P NATL ACAD SCI USA, V112, P13093, DOI 10.1073/pnas.1516259112; Buhr ED, 2014, P NATL ACAD SCI USA, V111, P8625, DOI 10.1073/pnas.1323350111; COLWELL CS, 1992, J COMP NEUROL, V324, P135, DOI 10.1002/cne.903240202; Davidson AJ, 2009, EUR J NEUROSCI, V29, P171, DOI 10.1111/j.1460-9568.2008.06534.x; Dibner C, 2010, ANNU REV PHYSIOL, V72, P517, DOI 10.1146/annurev-physiol-021909-135821; Ecker JL, 2010, NEURON, V67, P49, DOI 10.1016/j.neuron.2010.05.023; Evans JA, 2015, BMC BIOL, V13, DOI 10.1186/s12915-015-0157-x; Figueiro MG, 2010, INT J ENDOCRINOL, V2010, DOI 10.1155/2010/829351; Golombek DA, 2010, PHYSIOL REV, V90, P1063, DOI 10.1152/physrev.00009.2009; Gooley JJ, 2001, NAT NEUROSCI, V4, P1165, DOI 10.1038/nn768; Guler AD, 2008, NATURE, V453, P102, DOI 10.1038/nature06829; Hannibal J, 2004, NEUROREPORT, V15, P2317, DOI 10.1097/00001756-200410250-00003; Hannibal J, 2004, INVEST OPHTH VIS SCI, V45, P4202, DOI 10.1167/iovs.04-0313; Hannibal J, 2006, INT REV CYTOL, V251, P1, DOI 10.1016/S0074-7696(06)51001-0; Hardin PE, 2013, CURR OPIN NEUROBIOL, V23, P724, DOI 10.1016/j.conb.2013.02.018; Hatori M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002451; Hattar S, 2006, J COMP NEUROL, V497, P326, DOI 10.1002/cne.20970; Husse J, 2015, BIOESSAYS, V37, P1119, DOI 10.1002/bies.201500026; Husse J, 2014, FASEB J, V28, P4950, DOI 10.1096/fj.14-256594; Izumo M, 2014, ELIFE, V3, DOI 10.7554/eLife.04617; Kasahara T, 2010, P NATL ACAD SCI USA, V107, P6412, DOI 10.1073/pnas.0914399107; Kerschensteiner D, 2009, NATURE, V460, P1016, DOI 10.1038/nature08236; KORNHAUSER JM, 1990, NEURON, V5, P127, DOI 10.1016/0896-6273(90)90303-W; Lee IT, 2015, NEURON, V85, P1086, DOI 10.1016/j.neuron.2015.02.006; Menaker M, 2013, CURR OPIN NEUROBIOL, V23, P741, DOI 10.1016/j.conb.2013.03.003; Mohawk JA, 2012, ANNU REV NEUROSCI, V35, P445, DOI 10.1146/annurev-neuro-060909-153128; MOORE RY, 1995, J COMP NEUROL, V352, P351, DOI 10.1002/cne.903520304; Mrosovsky N, 2003, CHRONOBIOL INT, V20, P989, DOI 10.1081/CBI-120026043; Mrosovsky N, 1999, CHRONOBIOL INT, V16, P415, DOI 10.3109/07420529908998717; Nakashiba T, 2008, SCIENCE, V319, P1260, DOI 10.1126/science.1151120; Partch CL, 2013, TRENDS CELL BIOL; Peirson S, 2006, NEURON, V49, P331, DOI 10.1016/j.neuron.2006.01.006; Pezuk P, 2012, ENDOCRINOLOGY, V153, P4775, DOI 10.1210/en.2012-1486; PICKARD GE, 1981, J COMP NEUROL, V196, P155, DOI 10.1002/cne.901960111; Pilorz V, 2016, PLOS BIOL, V14, DOI 10.1371/journal.pbio.1002482; Purrier N, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111449; Qian XX, 2012, ENDOCRINOLOGY, V153, P4346, DOI 10.1210/en.2012-1484; Rahman SA, 2011, AM J PHYSIOL-ENDOC M, V300, pE518, DOI 10.1152/ajpendo.00597.2010; RALPH MR, 1990, SCIENCE, V247, P975, DOI 10.1126/science.2305266; Reddy AB, 2007, HEPATOLOGY, V45, P1478, DOI 10.1002/hep.21571; Reifler ANN, 2015, CURR BIOL, V25, P2763, DOI 10.1016/j.cub.2015.09.018; SCHIAVO G, 1992, NATURE, V359, P832, DOI 10.1038/359832a0; Schmidt TM, 2008, J NEUROPHYSIOL, V100, P371, DOI 10.1152/jn.00062.2008; Schmidt TM, 2011, TRENDS NEUROSCI, V34, P572, DOI 10.1016/j.tins.2011.07.001; Schmidt TM, 2009, J NEUROSCI, V29, P476, DOI 10.1523/JNEUROSCI.4117-08.2009; Sekaran S, 2005, CURR BIOL, V15, P1099, DOI 10.1016/j.cub.2005.05.053; Son GH, 2008, P NATL ACAD SCI USA, V105, P20970, DOI 10.1073/pnas.0806962106; STEPHAN FK, 1972, P NATL ACAD SCI USA, V69, P1583, DOI 10.1073/pnas.69.6.1583; Tu DC, 2005, NEURON, V48, P987, DOI 10.1016/j.neuron.2005.09.031; Welsh DK, 2010, ANNU REV PHYSIOL, V72, P551, DOI 10.1146/annurev-physiol-021909-135919; Windle RJ, 1998, ENDOCRINOLOGY, V139, P4044, DOI 10.1210/en.139.10.4044; Yoder JM, 2014, AM J PHYSIOL-REG I, V306, pR387, DOI 10.1152/ajpregu.00519.2013; Yoo SH, 2004, P NATL ACAD SCI USA, V101, P5339, DOI 10.1073/pnas.0308709101; Zhang YP, 2008, CISP 2008: FIRST INTERNATIONAL CONGRESS ON IMAGE AND SIGNAL PROCESSING, VOL 1, PROCEEDINGS, P60, DOI 10.1109/CISP.2008.483	57	30	30	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2016	11	12							e0168651	10.1371/journal.pone.0168651	http://dx.doi.org/10.1371/journal.pone.0168651			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI8LN	27992553	Green Published, gold, Green Submitted			2022-12-27	WOS:000392758000072
J	Hansen, GM; Belstrom, D; Nilsson, M; Helqvist, S; Nielsen, CH; Holmstrup, P; Tolker-Nielsen, T; Givskov, M; Hansen, PR				Hansen, Gorm Mork; Belstrom, Daniel; Nilsson, Martin; Helqvist, Steffen; Nielsen, Claus Henrik; Holmstrup, Palle; Tolker-Nielsen, Tim; Givskov, Michael; Hansen, Peter Riis			Pseudomonas aeruginosa Microcolonies in Coronary Thrombi from Patients with ST-Segment Elevation Myocardial Infarction	PLOS ONE			English	Article							POLYMORPHONUCLEAR LEUKOCYTES; ATHEROSCLEROTIC PLAQUES; IN-VIVO; INFECTION; BIOFILM; BACTERIA; DISEASE; PERIODONTITIS; INFLAMMATION; COHORT	Chronic infection is associated with an increased risk of atherothrombotic disease and direct bacterial infection of arteries has been suggested to contribute to the development of unstable atherosclerotic plaques. In this study, we examined coronary thrombi obtained in vivo from patients with ST-segment elevation myocardial infarction (STEMI) for the presence of bacterial DNA and bacteria. Aspirated coronary thrombi from 22 patients with STEMI were collected during primary percutaneous coronary intervention and arterial blood control samples were drawn from radial or femoral artery sheaths. Analyses were performed using 16S polymerase chain reaction and with next-generation sequencing to determine bacterial taxonomic classification. In selected thrombi with the highest relative abundance of Pseudomonas aeruginosa DNA, peptide nucleic acid fluorescence in situ hybridization (PNA-FISH) with universal and species specific probes was performed to visualize bacteria within thrombi. From the taxonomic analysis we identified a total of 55 different bacterial species. DNA from Pseudomonas aeruginosa represented the only species that was significantly associated with either thrombi or blood and was >30 times more abundant in thrombi than in arterial blood (p<0.0001). Whole and intact bacteria present as biofilm microcolonies were detected in selected thrombi using universal and P. aeruginosa-specific PNA-FISH probes. P. aeruginosa and vascular biofilm infection in culprit lesions may play a role in STEMI, but causal relationships remain to be determined.	[Hansen, Gorm Mork; Hansen, Peter Riis] Herlev & Gentofte Univ Hosp, Dept Cardiol, Copenhagen, Denmark; [Hansen, Gorm Mork; Nilsson, Martin; Tolker-Nielsen, Tim; Givskov, Michael] Univ Copenhagen, Fac Hlth & Med Sci, Dept Immunol & Microbiol, Costerton Biofilm Ctr, Copenhagen, Denmark; [Belstrom, Daniel; Holmstrup, Palle] Univ Copenhagen, Fac Hlth & Med Sci, Sect Periodontol, Dept Odontol, Copenhagen, Denmark; [Helqvist, Steffen] Rigshosp, Dept Cardiol, Univ Hosp, Copenhagen, Denmark; [Nielsen, Claus Henrik] Rigshosp, Inst Inflammat Res, Dept Infect Dis & Rheumatol, Univ Hosp, Copenhagen, Denmark; [Givskov, Michael] Nanyang Technol Univ, SCELSE, Singapore, Singapore	University of Copenhagen; University of Copenhagen; Rigshospitalet; University of Copenhagen; Rigshospitalet; University of Copenhagen; Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University	Hansen, GM (corresponding author), Herlev & Gentofte Univ Hosp, Dept Cardiol, Copenhagen, Denmark.; Hansen, GM (corresponding author), Univ Copenhagen, Fac Hlth & Med Sci, Dept Immunol & Microbiol, Costerton Biofilm Ctr, Copenhagen, Denmark.	gorm.moerk.hansen@regionh.dk	Nilsson, Martin/AHH-2943-2022; Hansen, Peter Riis/AAR-7659-2020	Tolker-Nielsen, Tim/0000-0002-9751-474X; Nielsen, Claus Henrik/0000-0001-7543-9016; Givskov, Michael/0000-0001-5004-8609; Mork Hansen, Gorm/0000-0002-6000-8835; Hansen, Peter Riis/0000-0002-9056-535X	University of Copenhagen, Faculty of Health and Medical Sciences [624-0013/12-3000]; Danish Heart Foundation [14-R97-A5031-22857]; LEO Foundation	University of Copenhagen, Faculty of Health and Medical Sciences; Danish Heart Foundation; LEO Foundation(LEO Pharma)	This work was supported by grants from University of Copenhagen, Faculty of Health and Medical Sciences (http://www.ku.dk/english; 624-0013/12-3000; Receiver MG); The Danish Heart Foundation (http://www.hjerteforeningen.dk/; 14-R97-A5031-22857; Receiver GMH). PRH was supported by an unrestricted grant from the LEO Foundation (http://leo-foundation.org/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aarabi G, 2015, ATHEROSCLEROSIS, V241, P555, DOI 10.1016/j.atherosclerosis.2015.04.819; Abbood HM, 2016, J PERIODONTOL, V13, P1; Alhede M, 2009, MICROBIOL-SGM, V155, P3500, DOI 10.1099/mic.0.031443-0; Anderson JL, 2004, TEX HEART I J, V31, P33; Belstrom D, 2014, J CLIN PERIODONTOL, V41, P104, DOI 10.1111/jcpe.12190; Bjarnsholt T, 2013, TRENDS MICROBIOL, V21, P466, DOI 10.1016/j.tim.2013.06.002; Calandrini CA, 2014, ORAL DIS, V20, pe128, DOI 10.1111/odi.12205; Campbell LA, 2015, ARCH MED RES, V46, P339, DOI 10.1016/j.arcmed.2015.05.006; Chiang WC, 2013, ANTIMICROB AGENTS CH, V57, P2352, DOI 10.1128/AAC.00001-13; Cole JR, 2014, NUCLEIC ACIDS RES, V42, pD633, DOI 10.1093/nar/gkt1244; Coumbe AG, 2014, AM J MED, V127, P12, DOI 10.1016/j.amjmed.2013.08.013; DeSantis TZ, 2006, APPL ENVIRON MICROB, V72, P5069, DOI 10.1128/AEM.03006-05; Dewhirst FE, 2010, J BACTERIOL, V192, P5002, DOI 10.1128/JB.00542-10; Erlinge D, 2015, EUR HEART J-CARD IMG, V16, P316, DOI 10.1093/ehjci/jeu180; Fadrosh DW, 2014, MICROBIOME, V2, DOI 10.1186/2049-2618-2-6; Fazli M, 2014, METHODS MOL BIOL, V1211, P261, DOI 10.1007/978-1-4939-1459-3_21; Hansen GM, 2016, AM J CARDIOL, V118, P489, DOI 10.1016/j.amjcard.2016.05.036; Hansson GK, 2005, NEW ENGL J MED, V352, P1685, DOI 10.1056/NEJMra043430; Hirsch EB, 2010, EXPERT REV PHARM OUT, V10, P441, DOI [10.1586/erp.10.49, 10.1586/ERP.10.49]; Huber P, 2016, ENV MICROBI IN PRESS; Kozarov EV, 2005, ARTERIOSCL THROM VAS, V25, pE17, DOI 10.1161/01.ATV.0000155018.67835.1a; Lanter BB, 2014, MBIO, V5, DOI 10.1128/mBio.01206-14; Libby P, 2009, J AM COLL CARDIOL, V54, P2129, DOI 10.1016/j.jacc.2009.09.009; Lyczak JB, 2000, MICROBES INFECT, V2, P1051, DOI 10.1016/S1286-4579(00)01259-4; Mitra S, 2015, MICROBIOME, V3, DOI 10.1186/s40168-015-0100-y; Nurmohamed MT, 2015, NAT REV RHEUMATOL, V11, P693, DOI 10.1038/nrrheum.2015.112; Ohki T, 2012, AM HEART J, V163, P164, DOI 10.1016/j.ahj.2011.10.012; Peleg AY, 2010, NEW ENGL J MED, V362, P1804, DOI 10.1056/NEJMra0904124; Pessi T, 2013, CIRCULATION, V127, P1219, DOI 10.1161/CIRCULATIONAHA.112.001254; Qadri SM, 2016, J CELL MOL MED, V20, P710, DOI 10.1111/jcmm.12778; Reyes L, 2013, J PERIODONTOL, V84, pS30, DOI [10.1902/jop.2013.1340012, 10.1111/jcpe.12079]; Rosenfeld ME, 2011, THROMB HAEMOSTASIS, V106, P858, DOI 10.1160/TH11-06-0392; Rybtke M, 2015, J MOL BIOL, V427, P3628, DOI 10.1016/j.jmb.2015.08.016; Silva WSE, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109761; Sessa R, 2014, WORLD J CLIN CASES, V2, P240, DOI 10.12998/wjcc.v2.i7.240; Snow DE, 2016, J WOUND CARE, V25, pS16, DOI 10.12968/jowc.2016.25.Sup2.S16; Souto R, 2014, BRAZ J MICROBIOL, V45, P495, DOI 10.1590/S1517-83822014000200017; Turkay C, 2004, CLIN MICROBIOL INFEC, V10, P705, DOI 10.1111/j.1469-0691.2004.00920.x; van Gennip M, 2012, INFECT IMMUN, V80, P2601, DOI 10.1128/IAI.06215-11; Van Gennip M, 2009, APMIS, V117, P537, DOI 10.1111/j.1600-0463.2009.02466.x; Velsko IM, 2011, PLOS ONE, V9; Wang LX, 2016, INT J CARDIOL, V223, P121, DOI 10.1016/j.ijcard.2016.07.260	42	7	7	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2016	11	12							e0168771	10.1371/journal.pone.0168771	http://dx.doi.org/10.1371/journal.pone.0168771			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EG7JB	28030624	Green Published, Green Submitted, gold			2022-12-27	WOS:000391222000076
J	Shi, CS; Kehrl, JH				Shi, Chong-Shan; Kehrl, John H.			Cytochrome c Negatively Regulates NLRP3 Inflammasomes	PLOS ONE			English	Article							ACTIVATION; APOPTOSIS; MITOCHONDRIA; CARDIOLIPIN; PLATFORM; NEK7; COMPONENT; PROTEIN	The release of cytochrome c from the inner mitochondrial membrane, where it is anchored by caridolipin, triggers the formation of the Apaf-1 apoptosome. Cardiolipin also interacts with NLRP3 recruiting NLRP3 to mitochondria and facilitating inflammasome assembly. In this study we investigated whether cytosolic cytochrome c impacts NLRP3 inflammasome activation in macrophages. We report that cytochrome c binds to the LRR domain of NLRP3 and that cytochrome c reduces the interactions between NLRP3 and cardiolipin and between NLRP3 and NEK7, a recently recognized component of the NLRP3 inflammasome needed for NLRP3 oligomerization. Protein transduction of cytochrome c impairs NLRP3 inflammasome activation, while partially silencing cytochrome c expression enhances it. The addition of cytochrome c to an in vitro inflammasome assay severely limited caspase-1 activation. We propose that there is a crosstalk between the NLRP3 inflammasome and apoptosome pathways mediated by cytochrome c, whose release during apoptosis acts to limit NLRP3 inflammasome activation.	[Shi, Chong-Shan; Kehrl, John H.] NIAID, Cell Mol Immunol Sect B, Immunoregulat Lab, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Shi, CS (corresponding author), NIAID, Cell Mol Immunol Sect B, Immunoregulat Lab, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA.	cshi@niaid.nih.gov	Kehrl, John/AAE-6292-2019		NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI000739] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Bryan NB, 2009, J IMMUNOL, V182, P3173, DOI 10.4049/jimmunol.0802367; Fink SL, 2005, INFECT IMMUN, V73, P1907, DOI 10.1128/IAI.73.4.1907-1916.2005; Germain M, 2002, J BIOL CHEM, V277, P18053, DOI 10.1074/jbc.M201235200; Gonzalvez F, 2007, APOPTOSIS, V12, P877, DOI 10.1007/s10495-007-0718-8; Gonzalvez F, 2008, J CELL BIOL, V183, P681, DOI 10.1083/jcb.200803129; Hara H, 2013, NAT IMMUNOL, V14, P1247, DOI 10.1038/ni.2749; He Y, 2016, NATURE, V530, P354, DOI 10.1038/nature16959; Hornung V, 2008, NAT IMMUNOL, V9, P847, DOI 10.1038/ni.1631; Ichinohe T, 2013, P NATL ACAD SCI USA, V110, P17963, DOI 10.1073/pnas.1312571110; Iyer SS, 2013, IMMUNITY, V39, P311, DOI 10.1016/j.immuni.2013.08.001; Labbe K, 2011, IMMUNITY, V35, P897, DOI 10.1016/j.immuni.2011.10.016; Lamkanfi M, 2014, CELL, V157, P1013, DOI 10.1016/j.cell.2014.04.007; Lamkanfi M, 2012, ANNU REV CELL DEV BI, V28, P137, DOI 10.1146/annurev-cellbio-101011-155745; Martinon F, 2002, MOL CELL, V10, P417, DOI 10.1016/S1097-2765(02)00599-3; Nakahira K, 2011, NAT IMMUNOL, V12, P222, DOI 10.1038/ni.1980; Py BF, 2013, MOL CELL, V49, P331, DOI 10.1016/j.molcel.2012.11.009; Riedl SJ, 2007, NAT REV MOL CELL BIO, V8, P405, DOI 10.1038/nrm2153; Schmid-Burgk JL, 2016, J BIOL CHEM, V291, P103, DOI 10.1074/jbc.C115.700492; Shi HX, 2016, NAT IMMUNOL, V17, P250, DOI 10.1038/ni.3333; Shimada K, 2012, IMMUNITY, V36, P401, DOI 10.1016/j.immuni.2012.01.009; Sutterwala FS, 2014, ANN NY ACAD SCI, P2014; Vince JE, 2012, IMMUNITY, V36, P215, DOI 10.1016/j.immuni.2012.01.012; Wang XD, 2001, GENE DEV, V15, P2922; Zhou RB, 2011, NATURE, V469, P221, DOI 10.1038/nature09663	24	14	15	2	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2016	11	12							e0167636	10.1371/journal.pone.0167636	http://dx.doi.org/10.1371/journal.pone.0167636			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EG7JB	28030552	gold, Green Published, Green Submitted			2022-12-27	WOS:000391222000013
J	Ding, M; Wang, Y; Chi, JC; Wang, T; Tang, XY; Cui, D; Qian, QJ; Zhai, B				Ding, Min; Wang, Ying; Chi, Jiachang; Wang, Tao; Tang, Xiaoyin; Cui, Dan; Qian, Qijun; Zhai, Bo			Is Adjuvant Cellular Immunotherapy Essential after TACE-Predominant Minimally-Invasive Treatment for Hepatocellular Carcinoma? A Systematic Meta-Analysis of Studies Including 1774 Patients	PLOS ONE			English	Article							INDUCED KILLER-CELLS; RADIOFREQUENCY ABLATION; TRANSARTERIAL CHEMOEMBOLIZATION; MICROWAVE ABLATION; COMBINATION; THERAPY	Purpose Cellular immunotherapy has appeared to be a promising modality for the treatment of malignant tumor. The objective of this study was to evaluate the efficacy of cellular immunotherapy combined with minimally invasive therapy. Methods We searched PubMed, Web of Science and The Cochrane Library through March 2016 for relevant studies. Short-term efficacy (the disease control rate, the control rate of quality life and the AFP descent rate) and long-term efficacy (overall survival (OS) and progression-free survival (PFS) rate) were compared as the major outcome measures. The meta-analysis was performed using Review Manager 5.3. Results A total of 1174 references in 3 databases were found of which 19 individual studies with 1774 HCC patients enrolled in this meta-analysis. Meta-analysis results showed that cellular immunotherapy combined with minimally-invasive treatment significantly improved the measures of short-term response (the disease control rate (OR = 5.91, P = 0.007), the control rate of quality lift (OR = 3.38, P = 0.003) and the AFP descent rate (OR = 4.48, P = 0.02)). Also higher 6-month PFS (OR = 2.78, P = 0.05), >= 12-month PFS (OR = 3.56, P<0.00001) rate and 6-month OS (OR = 2.81, P = 0.0009), 12-month OS (OR = 3.05, P<0.00001) and 24-month OS (OR = 3.52, P<0.0001) rate were observed in patients undergoing cellular immunotherapy. Conclusions This meta-analysis suggested that cellular immunotherapy is a feasible adjuvant treatment that could be beneficial for the improvement of the clinical outcomes for hepatocellular carcinoma (HCC) patients after minimally invasive treatment, including short-term response and long-term survival.	[Ding, Min; Chi, Jiachang; Wang, Tao; Tang, Xiaoyin; Cui, Dan; Zhai, Bo] Shanghai Jiao Tong Univ, Sch Med, Renji Hosp, Dept Intervent Oncol, Shanghai, Peoples R China; [Wang, Ying; Qian, Qijun] Second Mil Med Univ, Chinese PLA, Eastern Hepatobiliary Surg Hosp, Lab Gene & Viral Therapy, Shanghai, Peoples R China	Shanghai Jiao Tong University; Naval Medical University	Zhai, B (corresponding author), Shanghai Jiao Tong Univ, Sch Med, Renji Hosp, Dept Intervent Oncol, Shanghai, Peoples R China.	zhaiboshi@sina.com	Wang, Ying/AAY-4117-2021	Wang, Ying/0000-0002-1819-294X; Zhai, Bo/0000-0003-4337-7126	National Natural Science Fund [81472845]	National Natural Science Fund(National Natural Science Foundation of China (NSFC))	This study was funded by The National Natural Science Fund (No. 81472845).	Aerts M, 2016, WORLD J GASTROENTERO, V22, P253, DOI 10.3748/wjg.v22.i1.253; [Anonymous], 2014, RANDOMIZED CONTROLLE; [Anonymous], 2012, CHINESE J PRIMARY ME, V19, P97; Bruix J, 2011, HEPATOLOGY, V53, P1020, DOI 10.1002/hep.24199; Cheng XZ P D, 2014, J PRACTICAL MED, V9, P1401; Deng WJ, 2013, LING NAN XIAN DAI LI, V13, P29; European Assoc Study Liver, 2012, EUR J CANCER, V48, P599, DOI 10.1016/j.ejca.2011.12.021; Greten TF, 2008, REV RECENT CLIN TRIA, V3, P31, DOI 10.2174/157488708783330549; Guo Weiwei, 2014, Nan Fang Yi Ke Da Xue Xue Bao, V34, P674; Hao Ming-Zhi, 2010, Chin J Cancer, V29, P172; [郝明志 HAO Mingzhi], 2006, [中国肿瘤生物治疗杂志, Chinese Journal of Cancer Biotherapy], V13, P303; He XBWJ, 2012, SI CHUANXI XUE, V33, P1696; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Hong YP, 2015, WORLD J HEPATOL, V7, P980, DOI 10.4254/wjh.v7.i7.980; Huang ZM, 2013, J IMMUNOTHER, V36, P287, DOI 10.1097/CJI.0b013e3182948452; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Lencioni R, 2010, HEPATOLOGY, V52, P762, DOI 10.1002/hep.23725; Li XF, 2014, CLIN RES HEPATOL GAS, V38, P583, DOI 10.1016/j.clinre.2014.04.010; Llovet JM, 2003, LANCET, V362, P1907, DOI 10.1016/S0140-6736(03)14964-1; Pan Chang-Chuan, 2010, Chin J Cancer, V29, P596; Poggi G, 2015, WORLD J HEPATOL, V7, P2578, DOI 10.4254/wjh.v7.i25.2578; Poulou LS, 2015, WORLD J HEPATOL, V7, P1054, DOI 10.4254/wjh.v7.i8.1054; Shi Y G C, 2007, J INTERVENT RADIOL, V16, P235; Siegel RL, 2015, CA-CANCER J CLIN, V65, P5, DOI 10.3322/caac.21254; Su YY, 2016, CLIN LAB, V62, P599, DOI 10.7754/Clin.Lab.2015.150804; Thomas MB, 2010, J CLIN ONCOL, V28, P3994, DOI 10.1200/JCO.2010.28.7805; [佟立权 Tong Liquan], 2013, [中国普通外科杂志, Chinese Journal of General Surgery], V22, P876; Tsurusaki M, 2015, LIVER CANCER, V4, P165, DOI 10.1159/000367739; Vauleon E, 2010, CLIN DEV IMMUNOL, DOI 10.1155/2010/689171; Waghray A, 2015, WORLD J HEPATOL, V7, P1020, DOI 10.4254/wjh.v7.i8.1020; Wang Jian-peng, 2012, Zhonghua Yi Xue Za Zhi, V92, P3062; Weng DS, 2008, J IMMUNOTHER, V31, P63, DOI 10.1097/CJI.0b013e31815a121b; Whiting PF, 2011, ANN INTERN MED, V155, P529, DOI 10.7326/0003-4819-155-8-201110180-00009; Xie F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042879; Xu YM X D, 2013, CHIN J CANC PREV TRE, V24, P1928; Yang K, 2016, WORLD J GASTROENTERO, V22, P4835, DOI 10.3748/wjg.v22.i20.4835; Zhang NZ X Y, 2006, DONG NAN GUO FANG YI, V8, P84; Zhang Q, 2014, ORG LETT, V16, P2014, DOI 10.1021/ol500583d; Zhao M, 2012, EUR J RADIOL, V81, P2717, DOI 10.1016/j.ejrad.2011.10.023; Zhao Ming, 2006, Zhonghua Yi Xue Za Zhi, V86, P1823; 黄丽惜, 2007, [广东医学, Guangdong Medical Journal], V28, P1466	41	12	12	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2016	11	12							e0168798	10.1371/journal.pone.0168798	http://dx.doi.org/10.1371/journal.pone.0168798			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI9QH	28006010	Green Published, Green Submitted, gold			2022-12-27	WOS:000392843200095
J	Neugarten, RA; Honzak, M; Carret, P; Koenig, K; Andriamaro, L; Cano, CA; Grantham, HS; Hole, D; Juhn, D; McKinnon, M; Rasolohery, A; Steininger, M; Wright, TM; Turner, WR				Neugarten, Rachel A.; Honzak, Miroslav; Carret, Pierre; Koenig, Kellee; Andriamaro, Luciano; Cano, Carlos Andres; Grantham, Hedley S.; Hole, David; Juhn, Daniel; McKinnon, Madeleine; Rasolohery, Andriambolantsoa; Steininger, Marc; Wright, Timothy Max; Turner, Will R.			Rapid Assessment of Ecosystem Service Co-Benefits of Biodiversity Priority Areas in Madagascar	PLOS ONE			English	Article							DRY FORESTS; CONSERVATION; DEFORESTATION; MANAGEMENT; DIVERSITY; SUPPORT; SCIENCE; POLICY	The importance of ecosystems for supporting human well-being is increasingly recognized by both the conservation and development sectors. Our ability to conserve ecosystems that people rely on is often limited by a lack of spatially explicit data on the location and distribution of ecosystem services (ES), the benefits provided by nature to people. Thus there is a need to map ES to guide conservation investments, to ensure these co-benefits are maintained. To target conservation investments most effectively, ES assessments must be rigorous enough to support conservation planning, rapid enough to respond to decision-making timelines, and often must rely on existing data. We developed a framework for rapid spatial assessment of ES that relies on expert and stakeholder consultation, available data, and spatial analyses in order to rapidly identify sites providing multiple benefits. We applied the framework in Madagascar, a country with globally significant biodiversity and a high level of human dependence on ecosystems. Our objective was to identify the ES co-benefits of biodiversity priority areas in order to guide the investment strategy of a global conservation fund. We assessed key provisioning (fisheries, hunting and non-timber forest products, and water for domestic use, agriculture, and hydropower), regulating (climate mitigation, flood risk reduction and coastal protection), and cultural (nature tourism) ES. We also conducted multi-criteria analyses to identify sites providing multiple benefits. While our approach has limitations, including the reliance on proximity-based indicators for several ES, the results were useful for targeting conservation investments by the Critical Ecosystem Partnership Fund (CEPF). Because our approach relies on available data, standardized methods for linking ES provision to ES use, and expert validation, it has the potential to quickly guide conservation planning and investment decisions in other data-poor regions.	[Neugarten, Rachel A.; Honzak, Miroslav; Koenig, Kellee; Cano, Carlos Andres; Hole, David; Juhn, Daniel; McKinnon, Madeleine; Wright, Timothy Max; Turner, Will R.] Conservat Int, Arlington, VA 22202 USA; [Carret, Pierre] Crit Ecosyst Partnership Fund, Arlington, VA USA; [Andriamaro, Luciano; Rasolohery, Andriambolantsoa] Conservat Int, Antananarivo, Madagascar; [Grantham, Hedley S.] Wildlife Conservat Soc, Byron Bay, Australia; [McKinnon, Madeleine] Vulcan Inc, Seattle, WA USA; [Steininger, Marc] Univ Maryland, Dept Geog Sci, College Pk, MD 20742 USA	Conservation International; University System of Maryland; University of Maryland College Park	Neugarten, RA (corresponding author), Conservat Int, Arlington, VA 22202 USA.	rneugarten@conservation.org	BITOUN, RACHEL Elisabeth/AAC-9538-2021; Hole, David/Q-1692-2019; Neugarten, Rachel A/AAH-9166-2021	BITOUN, RACHEL Elisabeth/0000-0002-3614-9910; Neugarten, Rachel A/0000-0003-0647-0516; Koenig, Kellee/0000-0002-2505-860X	Gordon and Betty Moore Foundation [3519]; Critical Ecosystem Partnership Fund	Gordon and Betty Moore Foundation(Gordon and Betty Moore Foundation); Critical Ecosystem Partnership Fund	This study was supported by funding from the Gordon and Betty Moore Foundation (https://www.moore.org/, Grant Number 3519) and the Critical Ecosystem Partnership Fund (http://www.cepf.net/Pages/default.aspx). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allnutt TF, 2013, TROP CONSERV SCI, V6, P1, DOI 10.1177/194008291300600101; [Anonymous], 2005, EC HUM WELL BEING SY; [Anonymous], [No title captured]; Astuti Rita., 2006, PEOPLE SEA IDENTITY; Bagstad K.J., 2011, ARIES REPORT SERIES; Bagstad KJ, 2013, ECOSYST SERV, V4, P117, DOI 10.1016/j.ecoser.2012.07.012; Bakoariniaina LN, 2006, J AFR EARTH SCI, V44, P241, DOI 10.1016/j.jafrearsci.2005.10.013; Barbier EB, 2008, SCIENCE, V319, P321, DOI 10.1126/science.1150349; Benstead JP, 2003, ECOL APPL, V13, P1473, DOI 10.1890/02-5125; Bottero M, 2013, LAND USE POLICY, V30, P730, DOI 10.1016/j.landusepol.2012.05.015; Boumans R, 2015, ECOSYST SERV, V12, P30, DOI 10.1016/j.ecoser.2015.01.004; Bright E.A., 2012, LANDSCAN 2011; Brown KA, 2004, P NATL ACAD SCI USA, V101, P6045, DOI 10.1073/pnas.0401456101; Burke L., 2011, REEFS RISK REVISITED; Burkhard B, 2013, ECOSYST SERV, V4, P1, DOI 10.1016/j.ecoser.2013.04.005; Cinner JE, 2009, MAR POLICY, V33, P489, DOI 10.1016/j.marpol.2008.11.001; Costanza R, 2014, GLOBAL ENVIRON CHANG, V26, P152, DOI 10.1016/j.gloenvcha.2014.04.002; Crossman ND, 2013, ECOSYST SERV, V4, P4, DOI 10.1016/j.ecoser.2013.02.001; de Groot RS, 2010, ECOL COMPLEX, V7, P260, DOI 10.1016/j.ecocom.2009.10.006; Desbureaux S, 2015, ECOL ECON, V118, P10, DOI 10.1016/j.ecolecon.2015.07.002; Eastman J.R., 2012, IDRISI SELVA TUTORIA; ESRI, 2013, ARCGIS DESKT; Fisher B, 2011, PROG PHYS GEOG, V35, P595, DOI 10.1177/0309133311422968; Foiben-Taosaritanin'i Madagascar, 1998, BD500 BAS DONN VECT; Giri C, 2011, GLOBAL ECOL BIOGEOGR, V20, P154, DOI 10.1111/j.1466-8238.2010.00584.x; Golden CD, 2009, ORYX, V43, P386, DOI 10.1017/S0030605309000131; Goodman SM, 2005, ORYX, V39, P73, DOI 10.1017/S0030605305000128; Grinand C, 2013, REMOTE SENS ENVIRON, V139, P68, DOI 10.1016/j.rse.2013.07.008; Habel JC, 2011, BIODIVERSITY HOTSPOT; Haines-Young Potschin, 2013, EEAIEA09003; Hanson C., 2012, CORPORATE ECOSYSTEM; Harper GJ, 2007, ENVIRON CONSERV, V34, P325, DOI 10.1017/S0376892907004262; Harvey CA, 2014, PHILOS T R SOC B, V369, DOI 10.1098/rstb.2013.0089; Jones JPG, 2008, CONSERV BIOL, V22, P976, DOI 10.1111/j.1523-1739.2008.00970.x; Kew Royal Botanic Gardens Conservation International Missouri Botanic Garden, 2007, MAD VEG ATL; Kramer RA, 1997, J ENVIRON MANAGE, V49, P277, DOI 10.1006/jema.1995.0085; Kremen C, 2008, SCIENCE, V320, P222, DOI 10.1126/science.1155193; Kumar Pushpam, 2010, EC ECOSYSTEMS BIODIV, DOI DOI 10.1017/S1355770X11000088; Langhammer P.F., 2007, IDENTIFICATION GAP A; Le Manach F, 2012, MAR POLICY, V36, P218, DOI 10.1016/j.marpol.2011.05.007; Lehner B., 2006, HYDROSHEDS; Luck Gary W, 2012, F1000Res, V1, P17, DOI 10.12688/f1000research.1-17.v1; Maes J, 2012, ECOSYST SERV, V1, P31, DOI 10.1016/j.ecoser.2012.06.004; Moser C, 2008, SUIVI RECENSEMENT CO; Mulligan M., 2015, TRADING AGR NATURES, DOI [10.1201/b18652, DOI 10.1201/B18652]; Mulligan M, 2013, HYDROL RES, V44, P748, DOI 10.2166/nh.2012.217; Office National pour l'Environnement Directorate-General Forests Foiben-Taosaritanin'i Madagascar Madagascar National Parks Conservation International, 2013, EV COUV FOR NAT MAD; Peh KSH, 2013, ECOSYST SERV, V5, pE51, DOI 10.1016/j.ecoser.2013.06.003; Peypoch N, 2012, TOURISM MANAGE, V33, P1230, DOI 10.1016/j.tourman.2011.11.003; Pickard BR, 2015, ECOSYST SERV, V14, P45, DOI 10.1016/j.ecoser.2015.04.005; Portela R., 2012, ASSESSING VALUING EC; Razafindralambo R, 2004, POVERTY HOUSEHOLD WA; Rogers HM, 2010, LANDSCAPE URBAN PLAN, V96, P48, DOI 10.1016/j.landurbplan.2010.02.002; Saatchi SS, 2011, P NATL ACAD SCI USA, V108, P9899, DOI 10.1073/pnas.1019576108; Seppelt R, 2011, J APPL ECOL, V48, P630, DOI 10.1111/j.1365-2664.2010.01952.x; Swartz W, 2012, ENVIRON RESOUR ECON, P1; Tallis H, 2009, ANN NY ACAD SCI, V1162, P265, DOI 10.1111/j.1749-6632.2009.04152.x; Turner RK, 2008, ENVIRON RESOUR ECON, V39, P25, DOI 10.1007/s10640-007-9176-6; Turner WR, 2007, BIOSCIENCE, V57, P868, DOI 10.1641/B571009; United Nations Environment Program, 2013, PREVIEW GLOB RISK DA; United Nations General Assembly, 2015, A69L85 UN GEN ASS; Vieilledent G, 2012, ECOL APPL, V22, P572, DOI 10.1890/11-0039.1; Waeber PO, 2015, INT FOREST REV, V17, P127, DOI 10.1505/146554815815834822; Wendland KJ, 2010, ECOL ECON, V69, P2093, DOI 10.1016/j.ecolecon.2009.01.002; World Bank, 2010, POV HEADC RAT 1 25 D; Wright PC, 1999, YEARB PHYS ANTHROPOL, V42, P31	66	16	16	1	55	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2016	11	12							e0168575	10.1371/journal.pone.0168575	http://dx.doi.org/10.1371/journal.pone.0168575			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EI9QH	28006005	gold, Green Published			2022-12-27	WOS:000392843200066
J	Schaigorodsky, AL; Perotti, JI; Billoni, OV				Schaigorodsky, Ana L.; Perotti, Juan I.; Billoni, Orlando V.			A Study of Memory Effects in a Chess Database	PLOS ONE			English	Article							LONG-RANGE CORRELATIONS; DISTRIBUTIONS; BURSTS; DYNAMICS; SCIENCE; MODEL	A series of recent works studying a database of chronologically sorted chess games-containing 1.4 million games played by humans between 1998 and 2007-have shown that the popularity distribution of chess game-lines follows a Zipf's law, and that time series inferred from the sequences of those game-lines exhibit long-range memory effects. The presence of Zipf's law together with long-range memory effects was observed in several systems, however, the simultaneous emergence of these two phenomena were always studied separately up to now. In this work, by making use of a variant of the Yule-Simon preferential growth model, introduced by Cattuto et al., we provide an explanation for the simultaneous emergence of Zipf's law and long-range correlations memory effects in a chess database. We find that Cattuto's Model (CM) is able to reproduce both, Zipf's law and the long-range correlations, including size-dependent scaling of the Hurst exponent for the corresponding time series. CM allows an explanation for the simultaneous emergence of these two phenomena via a preferential growth dynamics, including a memory kernel, in the popularity distribution of chess game-lines. This mechanism results in an aging process in the chess game-line choice as the database grows. Moreover, we find burstiness in the activity of subsets of the most active players, although the aggregated activity of the pool of players displays inter-event times without burstiness. We show that CM is not able to produce time series with bursty behavior providing evidence that burstiness is not required for the explanation of the long-range correlation effects in the chess database. Our results provide further evidence favoring the hypothesis that long-range correlations effects are a consequence of the aging of game-lines and not burstiness, and shed light on the mechanism that operates in the simultaneous emergence of Zipf's law and long-range correlations in a community of chess players.	[Schaigorodsky, Ana L.; Billoni, Orlando V.] Univ Nacl Cordoba, Fac Matemat Astron Fis & Computac, Ciudad Univ, Cordoba, Argentina; [Schaigorodsky, Ana L.; Billoni, Orlando V.] Consejo Nacl Invest Cient & Tecn, IFEG, Ciudad Univ, Cordoba, Argentina; [Perotti, Juan I.] IMT Sch Adv Studies Lucca, Piazza San Francesco 19, I-55100 Lucca, Italy	National University of Cordoba; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); IMT School for Advanced Studies Lucca	Schaigorodsky, AL (corresponding author), Univ Nacl Cordoba, Fac Matemat Astron Fis & Computac, Ciudad Univ, Cordoba, Argentina.; Schaigorodsky, AL (corresponding author), Consejo Nacl Invest Cient & Tecn, IFEG, Ciudad Univ, Cordoba, Argentina.	schaigorodsky@famaf.unc.edu.ar	Billoni, Orlando Vito/I-6332-2019	Billoni, Orlando Vito/0000-0001-9452-4400; Perotti, Juan Ignacio/0000-0001-7424-9552	National Council of Scientific and Technical Research of Argentina CONICET [PIP 112 201101 00213]; National University of Cordoba Argentina [05/6370 2014-2015]; IMT School for Advanced Studies Lucca Project MULTIPLEX [317532]; FET Project SIMPOL [610704]; FET project DOLFINS [640772]; CONICET [PIP 112 201101 00213]; SeCyT-Universidad Nacional de Cordoba (Argentina); FET IP Project MULTIPLEX [317532]	National Council of Scientific and Technical Research of Argentina CONICET(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)); National University of Cordoba Argentina; IMT School for Advanced Studies Lucca Project MULTIPLEX; FET Project SIMPOL; FET project DOLFINS; CONICET(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)); SeCyT-Universidad Nacional de Cordoba (Argentina)(Secretaria de Ciencia y Tecnologia (SECYT)); FET IP Project MULTIPLEX	This work was supported by National Council of Scientific and Technical Research of Argentina (http://www.conicet.gov.ar/) Grant number: PIP 112 201101 00213 CONICET, National University of Cordoba Argentina (http://www.unc.edu.ar/investigacion/financiamiento/subsidios-e-incentivos/parainvestigacion) Grant Number: 05/6370 2014-2015, and IMT School for Advanced Studies Lucca Project MULTIPLEX nr. 317532. FET Project SIMPOL nr. 610704, FET project DOLFINS nr. 640772 (https://www.imtlucca.it/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was partially supported by grants from CONICET (PIP 112 201101 00213), SeCyT-Universidad Nacional de Cordoba (Argentina) J.I.P acknowledges support from: FET IP Project MULTIPLEX nr. 317532. FET Project SIMPOL nr. 610704, FET project DOLFINS nr. 640772.	Altmann EG, 2009, PLOS ONE, V4, pA31, DOI 10.1371/journal.pone.0007678; Amit M, 1994, FRACTALS, V2, P7, DOI 10.1142/S0218348X94000028; Bak P, 2002, PHYS REV LETT, V88, DOI 10.1103/PhysRevLett.88.178501; Barabasi AL, 2005, NATURE, V435, P207, DOI 10.1038/nature03459; Barabasi AL, 1999, SCIENCE, V286, P509, DOI 10.1126/science.286.5439.509; Barunik J, 2010, PHYSICA A, V389, P3844, DOI 10.1016/j.physa.2010.05.025; Ben-Naim E, 2007, EPL-EUROPHYS LETT, V77, DOI 10.1209/0295-5075/77/30005; Bittner E, 2009, EUR PHYS J B, V67, P459, DOI 10.1140/epjb/e2008-00396-1; Blasius B, 2009, PHYS REV LETT, V103, DOI 10.1103/PhysRevLett.103.218701; Bryce RM, 2012, SCI REP-UK, V2, P1, DOI 10.1038/srep00315; Bunde A, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.048701; Castellano C, 2009, REV MOD PHYS, V81, P591, DOI 10.1103/RevModPhys.81.591; Cattuto C, 2006, EUROPHYS LETT, V76, P208, DOI 10.1209/epl/i2006-10263-9; Chassy P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026692; Corral A, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.108501; Guerra YD, 2012, PHYSICA A, V391, P2997, DOI 10.1016/j.physa.2012.01.014; Goh KI, 2008, EPL-EUROPHYS LETT, V81, DOI 10.1209/0295-5075/81/48002; Heuer A, 2009, EUR PHYS J B, V67, P445, DOI 10.1140/epjb/e2009-00024-8; Jo HH, 2015, PHYS REV E, V92, DOI 10.1103/PhysRevE.92.022814; Keat J, 2001, NEURON, V30, P803, DOI 10.1016/S0896-6273(01)00322-1; Lazer D, 2009, SCIENCE, V323, P721, DOI 10.1126/science.1167742; Montemurro MA, 2002, FRACTALS, V10, P451, DOI 10.1142/S0218348X02001257; PENG CK, 1992, NATURE, V356, P168, DOI 10.1038/356168a0; Perotti JI, 2013, EPL-EUROPHYS LETT, V104, DOI 10.1209/0295-5075/104/48005; Petersen AM, 2008, EPL-EUROPHYS LETT, V83, DOI 10.1209/0295-5075/83/50010; Prost F., 2012, EPIC SERIES, V10, P268; Ribeiro HV, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054165; Ribeiro HV, 2012, PHYS REV E, V86, DOI 10.1103/PhysRevE.86.022102; Schaigorodsky AL, 2016, CHESS DATABASES; Schaigorodsky AL, 2014, PHYSICA A, V394, P304, DOI 10.1016/j.physa.2013.09.035; Sigman M, 2010, FRONT NEUROSCI-SWITZ, V4, DOI 10.3389/fnins.2010.00060; Simkin MV, 2011, PHYS REP, V502, P1, DOI 10.1016/j.physrep.2010.12.004; SIMON HA, 1955, BIOMETRIKA, V42, P425; Sire C, 2009, EUR PHYS J B, V67, P473, DOI 10.1140/epjb/e2008-00405-5; Watts DJ, 2007, NATURE, V445, P489, DOI 10.1038/445489a; Wheatland MS, 1998, ASTROPHYS J, V509, P448, DOI 10.1086/306492; Xu LG, 2015, EPL-EUROPHYS LETT, V110, DOI 10.1209/0295-5075/110/58004; Yule GU, 1925, PHILOS T R SOC LON B, V213, P21, DOI 10.1098/rstb.1925.0002	38	6	6	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2016	11	12							e0168213	10.1371/journal.pone.0168213	http://dx.doi.org/10.1371/journal.pone.0168213			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI9QH	28005922	gold, Green Published, Green Submitted			2022-12-27	WOS:000392843200037
J	Tadesse, E; Teshome, M; Amsalu, A; Shimelis, T				Tadesse, Endale; Teshome, Million; Amsalu, Anteneh; Shimelis, Techalew			Genital Chlamydia trachomatis Infection among Women of Reproductive Age Attending the Gynecology Clinic of Hawassa University Referral Hospital, Southern Ethiopia	PLOS ONE			English	Article							PELVIC-INFLAMMATORY-DISEASE; RISK; INFERTILITY; PREVALENCE; GONORRHEA	Background Urogenital infection with Chlamydia trachomatis(CT) is one of the most common bacterial sexually transmitted infections (STIs) world-wide, especially in developing nations where routine laboratory diagnosis is unavailable. Little is known about the epidemiology of this infection in Ethiopia where other STIs are prevalent. This study was conducted to determine the prevalence and associated factors of CT infection among women of reproductive age. Methods A cross-sectional study was conducted among 322 consecutive women aged between 15-49 years at Hawassa University Referral Hospital from November 2014 to April 2015. Data on socio-demography and potential risk factors for genital infection were collected using structured questionnaires. Moreover, endocervical swabs were collected from all participants, screened for CT antigen using rapid immunochromatography assay, and cultured following the standard bacteriological method to isolate Neisseria gonorrhoeae. Result In this study, the overall prevalence of CT antigen and N. gonorrhoeae infection was 61 (18.9%) and 1(0.31%), respectively. Women aged 15-24 years had the highest prevalence of CT infection (24.2%),followed by those aged 25-34 years (16.8%) and those aged 35-49 years (9.6%). CTinfection was associated with women who had unprotected sex within the last six months (aOR = 3.459; 95% CI = 1.459-8.222) and were sexually active for 6-10 years (aOR = 3.076; 95% CI = 1.152-8.209). None of the clinical symptoms and diagnoses was significantly associated with CT antigen positivity. Conclusions The high prevalence of genital CT infection in this study highlights the need for further large-scale studies on the general population. Thus, screening of women regardless of their symptoms should be in place.	[Tadesse, Endale; Amsalu, Anteneh; Shimelis, Techalew] Hawassa Univ, Dept Med Lab Sci, Coll Med & Hlth Sci, Hawassa, Ethiopia; [Teshome, Million] Hawassa Univ, Coll Med & Hlth Sci, Gynecol & Obstet Unit, Hawassa, Ethiopia; [Amsalu, Anteneh] Univ Gondar, Dept Med Microbiol, Gondar, Ethiopia	Hawassa University; Hawassa University; University of Gondar	Tadesse, E (corresponding author), Hawassa Univ, Dept Med Lab Sci, Coll Med & Hlth Sci, Hawassa, Ethiopia.	endaletd@yahoo.com	Shimelis, Techalew/AFL-2401-2022; Asfaw, Endale Taddesse/T-6423-2019	Amsalu, Anteneh/0000-0001-7919-4546; Asfaw, Endale Taddesse/0000-0003-0744-896X	Hawassa University, Research Development office; Hawassa University	Hawassa University, Research Development office; Hawassa University	Support was provided by Hawassa University, Research Development office.; We express our gratitude to the study participants who took part in the study. We thank nurses, physicians and laboratory staffs of Hawassa University Referral Hospital for kind assistance during data collection, clinical examination and laboratory diagnosis. Finally, our special acknowledgment goes to Hawassa University for financial support.	Alam N, 2007, SEX TRANSM DIS, V34, P99, DOI 10.1097/01.olq.0000225325.23340.a3; Aslanimehr M, 2015, BIOTECH HLTH SCI, V2; Bender N, 2011, SEX TRANSM INFECT, V87, P601, DOI 10.1136/sextrans-2011-050205; CDC, 2014, DIV SEX TRANSM DIS T; Cheesbrough M, 2006, DISTRICT LAB PRACTIC, V2nd; Chen KT, 2007, BMC PUBLIC HEALTH, V7, DOI 10.1186/1471-2458-7-120; DUNCAN ME, 1992, GENITOURIN MED, V68, P221; Einwalter LA, 2005, PERSPECT SEX REPRO H, V37, P135, DOI 10.1363/3713505; El Qouqa IA, 2009, INT J INFECT DIS, V13, P334, DOI 10.1016/j.ijid.2008.07.013; Elias J, 2011, MANUAL CLIN MICROBIO, V10th, P559; Silva LCF, 2012, BRAZ J INFECT DIS, V16, P335, DOI 10.1016/j.bjid.2012.06.023; FMOH, 2015, NAT GUID MAN SEX TRA; Francis SC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101221; Gewirtzman A, 2011, SEXUALLY TRANSMITTED; Haggerty CL, 2010, J INFECT DIS, V201, pS134, DOI 10.1086/652395; Hailemariam M, 2013, ETHIOP J HEALTH SCI, V23, P10; Kerubo E, 2016, SEX TRANSM INFECT, P1; Mania-Pramanik Jayanti, 2012, J Reprod Infertil, V13, P204; Marks M, 2015, BMJ OPEN, V5, DOI 10.1136/bmjopen-2014-007276; Mawak J. D., 2011, Shiraz E Medical Journal, V12, P100; Musa M, 2016, J HLTH MED NURSING, V26, P20; Nguyen My Huong, 2009, BMC Womens Health, V9, P1, DOI 10.1186/1472-6874-9-1; Nwankwo EO, 2014, AFR HEALTH SCI, V14, P672, DOI 10.4314/ahs.v14i3.24; Okoror L E, 2007, Afr Health Sci, V7, P18; Oloyede OAO, 2009, INT J HLTH RES, V2, P157; Price MJ, 2013, AM J EPIDEMIOL, V178, P484, DOI 10.1093/aje/kws583; Romoren M, 2007, BMC INFECT DIS, V7, DOI 10.1186/1471-2334-7-27; Tibebu M, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-415; Wallace LA, 2008, SEX TRANSM INFECT, V84, P171, DOI 10.1136/sti.2007.026047; World Health Organization, 2012, WHO BAS REP GLOB SEX; Yirenya-Tawiah Dzidzo, 2014, BMC Res Notes, V7, P349, DOI 10.1186/1756-0500-7-349	31	12	12	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2016	11	12							e0168580	10.1371/journal.pone.0168580	http://dx.doi.org/10.1371/journal.pone.0168580			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI9QH	28006003	gold, Green Submitted, Green Published			2022-12-27	WOS:000392843200068
J	Hew, KF; Tan, CY				Hew, Khe Foon; Tan, Cheng Yong			Predictors of Information Technology Integration in Secondary Schools: Evidence from a Large Scale Study of More than 30,000 Students	PLOS ONE			English	Article							K-12 CLASSROOMS; COMPUTER USE; TEACHER; MATHEMATICS; EDUCATION; BELIEFS; METAANALYSIS; ACHIEVEMENT; MANAGEMENT; LAPTOPS	The present study examined the predictors of information technology (IT) integration in secondary school mathematics lessons. The predictors pertained to IT resource availability in schools, school contextual/institutional variables, accountability pressure faced by schools, subject culture in mathematics, and mathematics teachers' pedagogical beliefs and practices. Data from 32,256 secondary school students from 2,519 schools in 16 developed economies who participated in the Program for International Student Assessment (PISA) 2012 were analyzed using hierarchical linear modeling (HLM). Results showed that after controlling for student-level (gender, prior academic achievement and socioeconomic status) and school-level (class size, number of mathematics teachers) variables, students in schools with more computers per student, with more IT resources, with higher levels of IT curricular expectations, with an explicit policy on the use of IT in mathematics, whose teachers believed in student-centered teaching-learning, and whose teachers provided more problem-solving activities in class reported higher levels of IT integration. On the other hand, students who studied in schools with more positive teacher-related school learning climate, and with more academically demanding parents reported lower levels of IT integration. Student-related school learning climate, principal leadership behaviors, schools' public posting of achievement data, tracking of school's achievement data by administrative authorities, and pedagogical and curricular differentiation in mathematics lessons were not related to levels of IT integration. Put together, the predictors explained a total of 15.90% of the school-level variance in levels of IT integration. In particular, school IT resource availability, and mathematics teachers' pedagogical beliefs and practices stood out as the most important determinants of IT integration in mathematics lessons.	[Hew, Khe Foon; Tan, Cheng Yong] Univ Hong Kong, Fac Educ, Hong Kong, Hong Kong, Peoples R China	University of Hong Kong	Hew, KF (corresponding author), Univ Hong Kong, Fac Educ, Hong Kong, Hong Kong, Peoples R China.	kfhew@hku.hk	Hew, Khe/ABB-1737-2020	Hew, Khe/0000-0003-4149-533X				[Anonymous], CAMBRIDGE J ED, DOI DOI 10.1080/0305764042000289956; Baker DP, 2002, COMP EDUC REV, V46, P291, DOI 10.1086/341159; Ball SJ, 2003, J EDUC POLICY, V18, P215, DOI 10.1080/0268093022000043065; Bebell D., 2004, Journal of Research on Technology in Education, V37, P45; Bitter G., 2008, USING TECHNOLOGY CLA; Borenstein M, 2009, INTRO META ANAL; Cheung ACK, 2013, EDUC RES REV-NETH, V9, P88, DOI 10.1016/j.edurev.2013.01.001; CLARK RE, 1983, REV EDUC RES, V53, P445, DOI 10.2307/1170217; Cuban L, 2001, AM EDUC RES J, V38, P813, DOI 10.3102/00028312038004813; Dawson C., 2003, Journal of Research on Technology in Education, V36, P29; Dochy F., 1994, INT ENCY ED, P4698; Ertmer P. A., 1999, Journal of Research on Computing in Education, V32, P54; Ertmer PA, 2005, ETR&D-EDUC TECH RES, V53, P25, DOI 10.1007/BF02504683; Fabry DL, 1997, J EDUC COMPUT RES, V17, P385, DOI 10.2190/C770-AWA1-CMQR-YTYV; Galanouli D, 2004, COMPUT EDUC, V43, P63, DOI 10.1016/j.compedu.2003.12.005; Gordon MF, 2009, AM J EDUC, V116, P1, DOI 10.1086/605098; Green LC, 2002, TEACHER INSTRUCTIONA; Grimes D, 2008, J EDUC COMPUT RES, V38, P305, DOI 10.2190/EC.38.3.d; Hallinger P, 2011, EDUC ADMIN QUART, V47, P271, DOI 10.1177/0013161X10383412; Harris RG, 2001, INT J MANAG REV, V3, P21, DOI 10.1111/1468-2370.00052; HATTIE JAC, 2009, VISIBLE LEARNING SYN; Hendriks MA, 2013, SCH LEADERSH MANAG, V33, P373, DOI 10.1080/13632434.2013.813458; Hennessy S, 2005, J CURRICULUM STUD, V37, P155, DOI 10.1080/0022027032000276961; Hermans R, 2008, COMPUT EDUC, V51, P1499, DOI 10.1016/j.compedu.2008.02.001; Hew KF, 2007, ETR&D-EDUC TECH RES, V55, P223, DOI 10.1007/s11423-006-9022-5; Hughes J., 2005, J TECHNOLOGY TEACHER, V13, P277; Inan FA, 2010, COMPUT EDUC, V55, P937, DOI 10.1016/j.compedu.2010.04.004; Inan FA, 2010, ETR&D-EDUC TECH RES, V58, P137, DOI 10.1007/s11423-009-9132-y; Johnson DW, 1992, CONTEMP EDUC, V63, P173; Ladd HF, 2003, EDUC EVAL POLICY AN, V25, P97, DOI 10.3102/01623737025001095; Lawson T., 1999, Journal of Information Technology for Teacher Education, V8, P41, DOI 10.1080/14759399900200054; Lee M, 2012, J EDUC ADMIN, V50, P586, DOI 10.1108/09578231211249835; Leuven E, 2007, REV ECON STAT, V89, P721, DOI 10.1162/rest.89.4.721; Li Q, 2010, EDUC PSYCHOL REV, V22, P215, DOI 10.1007/s10648-010-9125-8; Liu SH, 2011, COMPUT EDUC, V56, P1012, DOI 10.1016/j.compedu.2010.12.001; Lowther DL, 2008, EDUC MEDIA INT, V45, P195, DOI 10.1080/09523980802284317; Lowther DL, 2003, ETR&D-EDUC TECH RES, V51, P23, DOI 10.1007/BF02504551; Machin S, 2007, ECON J, V117, P1145, DOI 10.1111/j.1468-0297.2007.02070.x; Mathews J.G., 2000, INT J INSTRUCTIONAL, V27, P385; Meirink JA, 2009, TEACH TEACH EDUC, V25, P89, DOI 10.1016/j.tate.2008.07.003; Morrison G. R., 2010, INTEGRATING COMPUTER; Mouza C., 2002, Journal of Research on Technology in Education, V35, P272; O'Dwyer L., 2004, ELEMENTARY TEACHERS; OECD, 2015, STUD COMP LEARN MAK; Papanastasiou E. C., 2003, J SCI EDUC TECHNOL, V12, P325, DOI DOI 10.1023/A:1025093225753; Raudenbush S., 2002, HIERARCHICAL LINER M; Reynolds D, 2014, SCH EFF SCH IMPROV, V25, P197, DOI 10.1080/09243453.2014.885450; Richter T, 2006, DISCOURSE PROCESS, V41, P221, DOI 10.1207/s15326950dp4103_1; Ritzhaupt AD, 2012, J EDUC COMPUT RES, V46, P229, DOI 10.2190/EC.46.3.b; Rosenfeld P, 1996, COMPUT HUM BEHAV, V12, P263, DOI 10.1016/0747-5632(96)00006-4; Sandholtz JH, 2004, TEACH COLL REC, V106, P487, DOI 10.1111/j.1467-9620.2004.00348.x; Sang GY, 2010, COMPUT EDUC, V54, P103, DOI 10.1016/j.compedu.2009.07.010; Schiller J., 2002, Technology, Pedagogy and Education, V11, P289, DOI 10.1080/14759390200200138; Schleicher A., 2009, PROSPECTS, V39, P251, DOI DOI 10.1007/S11125-009-9126-X; Schuh KL, 2004, TEACH TEACH EDUC, V20, P833, DOI 10.1016/j.tate.2004.09.008; Tamim RM, 2011, REV EDUC RES, V81, P4, DOI 10.3102/0034654310393361; Tondeur J, 2008, J COMPUT ASSIST LEAR, V24, P494, DOI 10.1111/j.1365-2729.2008.00285.x; van Braak J, 2004, EUR J PSYCHOL EDUC, V19, P407, DOI 10.1007/BF03173218; Wachira P, 2011, J SCI EDUC TECHNOL, V20, P17, DOI 10.1007/s10956-010-9230-y; Werblow J., 2009, HIGH SCH J, V92, P14, DOI DOI 10.1353/HSJ.0.0022; Yildirim S., 2007, INT J INSTRUCTIONAL, V34, P171; Yong Z, 2003, AM EDUC RES J, V40, P807	62	10	10	2	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2016	11	12							e0168547	10.1371/journal.pone.0168547	http://dx.doi.org/10.1371/journal.pone.0168547			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EI9QF	27997593	Green Published, gold, Green Submitted			2022-12-27	WOS:000392842900058
J	Lim, YJ; Rosita, J; Chieng, JY; Hazizi, AS				Lim, Ying Jye; Rosita, Jamaluddin; Chieng, Jin Yu; Hazizi, Abu Saad			The Prevalence and Symptoms Characteristic of Functional Constipation Using Rome III Diagnostic Criteria among Tertiary Education Students	PLOS ONE			English	Article								Background and Aims Functional constipation is very common with heterogeneous symptoms that have substantial impact on patient quality of life as well as medical resources which are rarely reported as life-threatening. The aim of this study is to examine the prevalence and symptoms characteristic of functional constipation (FC) by using Rome III diagnostic criteria among tertiary education students with an intention to introduce treatment in the future. Methods Demographic, socio-economics characteristics and symptoms of FC using the Rome III criteria were sought using a questionnaire administered to Malaysian students in a tertiary education setting. Other data obtained were the general health status, lifestyle factors and anthropometric measurements. Using a simple random sampling method, a total of 1662 students were recruited in the study with a response rate of 95.0%. Sampled data are presented as frequency and percentage and stratified accordingly into categories for Chi-square analysis. Results The prevalence of functional constipation among the students was 16.2%, with a significantly higher prevalence among women (17.4%) than men (12.5%). Hard or lumpy stool, incomplete evacuation, anorectal obstruction and straining were reported as the commonest symptoms experienced. Type 3 was the most frequent stool consistency experienced among the constipated individuals (35.2%). Only 4.4% of individuals reported having less than three defecations per week. Using univariable analysis, FC was significantly associated with sex (odds ratio: 1.48, 95% CI: 1.06-2.06) and age group (odds ratio: 1.34, 95% CI: 1.01-1.79) with Pvalue < 0.05 significance level. In multivariate logistic regression analysis, only sex was found significantly associated with FC (adjusted odds ratio: 1.53, 95% CI: 1.08-2.17, P < 0.05). Conclusions Based on the prevalence rate, constipation is a common problem among tertiary education students (16.2%), with significantly more prevalence among the female respondents. Early detection of symptoms and further intervention studies focusing on treatment recommendation in improving the symptoms are essential.	[Lim, Ying Jye; Rosita, Jamaluddin; Hazizi, Abu Saad] Univ Putra Malaysia, Fac Med & Hlth Sci, Dept Nutr & Dietet, Upm Serdang, Selangor Darul, Malaysia; [Chieng, Jin Yu] Univ Putra Malaysia, Fac Med & Hlth Sci, Dept Med, Upm Serdang, Selangor Darul, Malaysia	Universiti Putra Malaysia; Universiti Putra Malaysia	Lim, YJ (corresponding author), Univ Putra Malaysia, Fac Med & Hlth Sci, Dept Nutr & Dietet, Upm Serdang, Selangor Darul, Malaysia.	rositaj@upm.edu.my	AS, Hazizi/AAV-5090-2021	AS, Hazizi/0000-0002-0614-6700				Abdollahi A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122222; Amenta Michele, 2006, Acta Biomed, V77, P157; Arora G, 2012, PLOS ONE, V710; Barba C, 2004, LANCET, V363, P157, DOI 10.1016/S0140-6736(03)15268-3; Beery RMM, 2014, CONSTIPATION PRACTIC, P1; Belsey J, 2010, ALIMENT PHARM THER, V31, P938, DOI 10.1111/j.1365-2036.2010.04273.x; Bharucha AE, 2013, GASTROENTEROLOGY, V1441, P218; BOUCHOUCHA M, 1991, DIS COLON RECTUM, V34, P111, DOI 10.1007/BF02049982; Bytzer P, 2001, GUT, V49, P66, DOI 10.1136/gut.49.1.66; Chen L, 2013, PLOS ONE, V83; Cheng C, 2003, ALIMENT PHARM THERAP, V18, P319, DOI 10.1046/j.1365-2036.2003.01663.x; Chiarelli P, 2000, INT UROGYNECOL J PEL, V11, P71, DOI 10.1007/s001920050073; Choung RS, 2011, ALIMENT PHARM THER, V33, P251, DOI 10.1111/j.1365-2036.2010.04513.x; Chu H, 2016, PLOS ONE, V113; Collete VL, 2010, CAD SAUDE PUBLICA, V26, P1391, DOI 10.1590/S0102-311X2010000700018; Curtin F, 1998, EUR J PUBLIC HEALTH, V8, P170, DOI 10.1093/eurpub/8.2.170; Daniel WW, 1999, BIOSTATISTICS FDN AN, V7th; Dong Y-Y, 2013, PLOS ONE, V81; Dukas L, 2003, AM J GASTROENTEROL, V98, P1790, DOI 10.1111/j.1572-0241.2003.07591.x; EVERHART JE, 1989, DIGEST DIS SCI, V34, P1153, DOI 10.1007/BF01537261; Gallagher P, 2009, BEST PRACT RES CL GA, V23, P875, DOI 10.1016/j.bpg.2009.09.001; Gan WY, 2011, APPETITE, V56, P778, DOI 10.1016/j.appet.2011.03.005; Gwee KA, 2013, J NEUROGASTROENTEROL, V19, P149, DOI 10.5056/jnm.2013.19.2.149; Higgins PDR, 2004, AM J GASTROENTEROL, V99, P750, DOI 10.1111/j.1572-0241.2004.04114.x; Iovino P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072608; Jung Hye-Kyung, 2003, Korean J Intern Med, V18, P181; Kaboli SA, 2010, GASTROENTEROLOGY HEP, P32; Kan Z, 2004, ZHONGHUA XIAOHUA ZAZ, V24, P612, DOI [10.3760/j.issn:0254-1432.2004.10.011, DOI 10.3760/J.ISSN:0254-1432.2004.10.011]; Kumar HK, 2012, S CURR MAN MAL DIS A; Lacy BE, 2016, GASTROENTEROLOGY, V150, P1393, DOI 10.1053/j.gastro.2016.02.031; Lee YY, 2012, WORLD J GASTROENTERO, V18, P6475, DOI 10.3748/wjg.v18.i44.6475; Lembo A, 2003, NEW ENGL J MED, V349, P1360, DOI 10.1056/NEJMra020995; Lewis SJ, 1997, SCAND J GASTROENTERO, V32, P920, DOI 10.3109/00365529709011203; Longstreth GF, 2006, GASTROENTEROLOGY, V130, P1480, DOI 10.1053/j.gastro.2005.11.061; Lu CL, 2006, ALIMENT PHARM THER, V24, P429, DOI 10.1111/j.1365-2036.2006.02949.x; Malaysia MoH, 2011, HLTH FACTS 2010; Malaysia MoH, 2012, HLTH FACTS 2012; Malaysia MoH, 2011, ANN REP MIN HLTH 201; Malaysia MoH, 2014, HLTH FACTS 2014; Malaysia MoH, 2011, HLTH FACTS 2011; Malaysia MoH, 2013, HLTH FACTS 2013; Mazlyn MM, 2013, J GASTROEN HEPATOL, V28, P1141, DOI 10.1111/jgh.12168; Nakaji S, 2002, EUR J NUTR, V41, P244, DOI 10.1007/s00394-002-0380-4; Peppas G, 2008, BMC GASTROENTEROL, V8, DOI 10.1186/1471-230X-8-5; Schmidt FMQ, 2015, REV ESC ENFERM USP, V49, P440, DOI 10.1590/S0080-623420150000300012; Rajendra S, 2004, ALIMENT PHARM THERAP, V19, P707, DOI 10.1111/j.1365-2036.2004.01891.x; Rome Foundation, 2016, WHATS NEW ROM 4; Salmoirago-Blotcher E, 2011, AM J MED, V124, P714, DOI 10.1016/j.amjmed.2011.03.026; SANDLER RS, 1987, DIGEST DIS SCI, V32, P841, DOI 10.1007/BF01296706; Sekaran U, 2006, RES METHODS BUSINESS, V6th; Shi W, 2015, PLOS ONE, V107; SONNENBERG A, 1989, DIS COLON RECTUM, V32, P1, DOI 10.1007/BF02554713; Sood R, 2016, NATURE REV GASTROENT, V139, P501; Suares NC, 2011, AM J GASTROENTEROL, V106, P1582, DOI 10.1038/ajg.2011.164; Tan YM, 2003, J GASTROEN HEPATOL, V18, P1412, DOI 10.1046/j.1440-1746.2003.03212.x; Wald A, 2008, ALIMENT PHARM THER, V28, P917, DOI 10.1111/j.1365-2036.2008.03806.x; Wei XQ, 2001, CHIN J GASTROENTEROL, V10, P150; WEXNER SD, 1995, CONSTIPATION ETIOLOG; WGO, 2010, 1285 WGO; Wong ML, 1999, AM J GASTROENTEROL, V94, P1283, DOI 10.1111/j.1572-0241.1999.01078.x; World Health Organization, 2011, MAL COUNTR PROF 2011; Xin H, 2012, J GASTROENTEROL, V2, P29; Zahedi M.J., 2014, GOVARESH, V19, P95	63	11	11	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2016	11	12							e0167243	10.1371/journal.pone.0167243	http://dx.doi.org/10.1371/journal.pone.0167243			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI9QF	27997551	Green Published, Green Accepted, gold, Green Submitted			2022-12-27	WOS:000392842900005
J	Powell, CD; Paullin, TR; Aoisa, C; Menzie, CJ; Ubaldini, A; Westerheide, SD				Powell, Chase D.; Paullin, Trillitye R.; Aoisa, Candice; Menzie, Christopher J.; Ubaldini, Ashley; Westerheide, Sandy D.			The Heat Shock Transcription Factor HSF1 Induces Ovarian Cancer Epithelial-Mesenchymal Transition in a 3D Spheroid Growth Model	PLOS ONE			English	Article							MULTICELLULAR TUMOR SPHEROIDS; HEPATOCELLULAR-CARCINOMA; IN-VITRO; METASTASIS; MIGRATION; INVASION; PROTEIN; GENERATION; GENOMICS; CELLS	Ovarian cancer is the most lethal gynecological cancer, with over 200,000 women diagnosed each year and over half of those cases leading to death. The proteotoxic stress responsive transcription factor HSF1 is frequently overexpressed in a variety of cancers and is vital to cellular proliferation and invasion in some cancers. Upon analysis of various patient data sets, we find that HSF1 is frequently overexpressed in ovarian tumor samples. In order to determine the role of HSF1 in ovarian cancer, inducible HSF1 knockdown cell lines were created. Knockdown of HSF1 in SKOV3 and HEY ovarian cancer cell lines attenuates the epithelial-to-mesenchymal transition (EMT) in cells treated with TG93, as determined by western blot and quantitative RT-PCR analysis of multiple EMT markers. To further explore the role of HSF1 in ovarian cancer EMT, we cultured multicellular spheroids in a non-adherent environment to simulate early avascular tumors. In the spheroid model, cells more readily undergo EMT; however, EMT inhibition by HSF1 becomes more pronounced in the spheroid model. These findings suggest that HSF1 is important in the ovarian cancer TGF beta response and in EMT.	[Powell, Chase D.; Paullin, Trillitye R.; Aoisa, Candice; Menzie, Christopher J.; Ubaldini, Ashley; Westerheide, Sandy D.] Univ S Florida, Coll Arts & Sci, Dept Cell Biol Microbiol & Mol Biol, Tampa, FL 33620 USA	State University System of Florida; University of South Florida	Westerheide, SD (corresponding author), Univ S Florida, Coll Arts & Sci, Dept Cell Biol Microbiol & Mol Biol, Tampa, FL 33620 USA.	swesterheide@usf.edu		Westerheide, Sandy/0000-0003-4683-9648	University of South Florida	University of South Florida	This work was supported by a start-up grant to SDW from the University of South Florida. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Cannistra SA, 2002, J CLIN ONCOL, V20, P1158, DOI 10.1200/JCO.2002.20.5.1158; Cannistra SA, 2004, NEW ENGL J MED, V351, P2519, DOI 10.1056/NEJMra041842; Carpenter RL, 2014, ONCOGENE; Cerami E, 2012, CANCER DISCOV, V2, P401, DOI 10.1158/2159-8290.CD-12-0095; Chen YF, 2013, CANCER SCI, V104, P1683, DOI 10.1111/cas.12277; Dai C, 2007, CELL, V130, P1005, DOI 10.1016/j.cell.2007.07.020; Fang F, 2012, CANCER-AM CANCER SOC, V118, P1782, DOI 10.1002/cncr.26482; Gao JJ, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2004088; Geback T, 2009, BIOTECHNIQUES, V46, P265, DOI 10.2144/000113083; Guettouche Toumy, 2005, BMC Biochemistry, V6, DOI 10.1186/1471-2091-6-4; Hartl FU, 1996, NATURE, V381, P571, DOI 10.1038/381571a0; Hay ED, 1995, ACTA ANAT, V154, P8; Holmberg CI, 2002, TRENDS BIOCHEM SCI, V27, P619, DOI 10.1016/S0968-0004(02)02207-7; Jemal A, 2002, CA-CANCER J CLIN, V52, P23, DOI 10.3322/canjclin.52.1.23; Kelland L, 2007, NAT REV CANCER, V7, P573, DOI 10.1038/nrc2167; Kelm JM, 2003, BIOTECHNOL BIOENG, V83, P173, DOI 10.1002/bit.10655; Korch C, 2012, GYNECOL ONCOL, V127, P241, DOI 10.1016/j.ygyno.2012.06.017; KROEGER PE, 1994, MOL CELL BIOL, V14, P7592, DOI 10.1128/MCB.14.11.7592; Li Y, 2015, ONCOTARGET, V6, P2421, DOI 10.18632/oncotarget.2965; Mendillo ML, 2012, CELL, V150, P549, DOI 10.1016/j.cell.2012.06.031; Moreno-Bueno G, 2009, NAT PROTOC, V4, P1591, DOI 10.1038/nprot.2009.152; Nakamura Y, 2014, CANCER LETT, V354, P329, DOI 10.1016/j.canlet.2014.08.029; O'Callaghan-Sunol C, 2006, CELL CYCLE, V5, P1431, DOI 10.4161/cc.5.13.2915; Olson A, 2006, NUCLEIC ACIDS RES, V34, pD153, DOI 10.1093/nar/gkj051; Schilling D, 2015, CANCER LETT, V360, P294, DOI 10.1016/j.canlet.2015.02.033; Shield K, 2009, GYNECOL ONCOL, V113, P143, DOI 10.1016/j.ygyno.2008.11.032; Thiery JP, 2002, NAT REV CANCER, V2, P442, DOI 10.1038/nrc822; Timmins Nicholas E., 2007, V140, P141; Toma-Jonik A, 2015, CELL SIGNAL, V27, P394, DOI 10.1016/j.cellsig.2014.11.029; Torres MP, 2009, MINERVA MED, V100, P385; Westerheide SD, 2005, J BIOL CHEM, V280, P33097, DOI 10.1074/jbc.R500010200; Xi CX, 2012, J BIOL CHEM, V287, P35646, DOI 10.1074/jbc.M112.377481; Xu J, 2009, CELL RES, V19, P156, DOI 10.1038/cr.2009.5	33	27	27	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2016	11	12							e0168389	10.1371/journal.pone.0168389	http://dx.doi.org/10.1371/journal.pone.0168389			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI9QF	27997575	Green Published, gold, Green Submitted			2022-12-27	WOS:000392842900040
J	Shah, TI; Bell, S; Wilson, K				Shah, Tayyab Ikram; Bell, Scott; Wilson, Kathi			Spatial Accessibility to Health Care Services: Identifying under-Serviced Neighbourhoods in Canadian Urban Areas	PLOS ONE			English	Article							INTEGRATED APPROACH; DEPRIVATION INDEX; POSITIONAL ERROR; ACCESS; ENVIRONMENT; PHYSICIAN; LOCATION; ONTARIO; POLICY; TOOL	Background Urban environments can influence many aspects of health and well-being and access to health care is one of them. Access to primary health care (PHC) in urban settings is a pressing research and policy issue in Canada. Most research on access to healthcare is focused on national and provincial levels in Canada; there is a need to advance current understanding to local scales such as neighbourhoods. Methods This study examines spatial accessibility to family physicians using the Three-Step Floating Catchment Area (3SFCA) method to identify neighbourhoods with poor geographical access to PHC services and their spatial patterning across 14 Canadian urban settings. An index of spatial access to PHC services, representing an accessibility score (physicians per -1000 population), was calculated for neighborhoods using a 3km road network distance. Information about primary health care providers (this definition does not include mobile services such as health buses or nurse practitioners or less distributed services such as emergency rooms) used in this research was gathered from publicly available and routinely updated sources (i.e. provincial colleges of physicians and surgeons). An integrated geocoding approach was used to establish PHC locations. Results The results found that the three methods, Simple Ratio, Neighbourhood Simple Ratio, and 3SFCA that produce City level access scores are positively correlated with each other. Comparative analyses were performed both within and across urban settings to examine disparities in distributions of PHC services. It is found that neighbourhoods with poor accessibility scores in the main urban settings across Canada have further disadvantages in relation to population high health care needs. Conclusions The results of this study show substantial variations in geographical accessibility to PHC services both within and among urban areas. This research enhances our understanding of spatial accessibility to health care services at the neighbourhood level. In particular, the results show that the low access neighbourhoods tend to be clustered in the neighbourhoods at the urban periphery and immediately surrounding the downtown area.	[Shah, Tayyab Ikram] Univ Saskatchewan, Coll Med, Sch Phys Therapy, Saskatoon, SK, Canada; [Bell, Scott] Univ Saskatchewan, Dept Geog & Planning, Saskatoon, SK, Canada; [Wilson, Kathi] Univ Toronto Mississauga, Dept Geog, Mississauga, ON, Canada	University of Saskatchewan; University of Saskatchewan; University of Toronto; University Toronto Mississauga	Shah, TI (corresponding author), Univ Saskatchewan, Coll Med, Sch Phys Therapy, Saskatoon, SK, Canada.	tayyab.shah@usask.ca	Shah, Tayyab/ABA-9591-2021	Bell, Scott/0000-0003-4713-4084	University of Saskatchewan	University of Saskatchewan	This work was supported by the University of Saskatchewan.	Aday L A, 1974, Health Serv Res, V9, P208; Allan DP, 2014, INT J HEALTH GEOGR, V13, DOI 10.1186/1476-072X-13-32; Andersen R.M., 2001, CHANGING US HLTH CAR, P3; Anselin L, 2006, GEOGR ANAL, V38, P5, DOI 10.1111/j.0016-7363.2005.00671.x; ANSELIN L, 1995, GEOGR ANAL, V27, P93, DOI 10.1111/j.1538-4632.1995.tb00338.x; Anselin L., 2010, HDB APPL SPATIAL ANA, P73, DOI [DOI 10.1007/978-3-642-03647-7_5, 10.1007/978-3-642-03647-7_5]; Aspen L, 2012, HEALTHGIS 2012; Bell N, 2012, CAN J PUBLIC HEALTH, V103, pS28, DOI 10.1007/BF03403826; Bell S, 2014, MAPPING SPATIAL PATT; Bell S, 2013, ANN ASSOC AM GEOGR, V103, P85, DOI 10.1080/00045608.2012.685050; Bell S, 2012, SPAT SPATIO-TEMPORAL, V3, P17, DOI 10.1016/j.sste.2012.02.003; BIRCH S, 1993, INT J HEALTH SERV, V23, P629, DOI 10.2190/K18V-T33F-1VC4-14RM; Bissonnette L, 2012, HEALTH PLACE, V18, P841, DOI 10.1016/j.healthplace.2012.03.007; Brazil Ministry of Health Secretariat of Health Care Department of Primary Care, 2006, PRIMARY CARE NOTEBOO; BROADWAY M, 1992, CAN GEOGR-GEOGR CAN, V36, P189, DOI 10.1111/j.1541-0064.1992.tb01131.x; Burrows R, 2001, ENVIRON PLANN A, V33, P1345; Canada, 2001, GEOGR UN DISS AR OTT; Canadian Institute for Health Information, 2015, 9781771094009 CIHI; Canadian Institutes of Health Research, 2014, SPOR NETW PRIM INT H; Canadian Institutes of Health Research, 2011, CAN STRAT PAT OR RES; Chan BTB, 2003, MED CARE, V41, P500; Charney I, 2005, CAN GEOGR-GEOGR CAN, V49, P301, DOI 10.1111/j.0008-3658.2005.00097.x; City of Saskatoon, 2014, NEIGHB PLANN SECT YE; Community Development Halton, 2011, 2011 NAT HOUS SURV N, V18; Cromley EK, 2012, GIS PUBLIC HLTH; Crooks V. A., 2009, PRIMARY HLTH CARE PE, P1; Cummins S, 2005, J EPIDEMIOL COMMUN H, V59, P207, DOI 10.1136/jech.2003.016147; Delamater PL, 2013, HEALTH PLACE, V24, P30, DOI 10.1016/j.healthplace.2013.07.012; Dewan AM, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0001998; DiezRoux AV, 1997, AM J EPIDEMIOL, V146, P48, DOI 10.1093/oxfordjournals.aje.a009191; DMTI Spatial, 2011, NEIGHB NBH COMM CMN; Ellaway A, 2001, URBAN STUD, V38, P2299, DOI 10.1080/00420980120087171; Fahui W., 2006, QUANTITATIVE METHODS; Federal / Provincial / Territorial Advisory Committee on Population Health and Health Security HDTF, 2005, RED HLTH DISP ROL HL; Flowerdew R, 2008, SOC SCI MED, V66, P1241, DOI 10.1016/j.socscimed.2007.11.042; Fotso JC, 2009, MATERN CHILD HLTH J, V13, P130, DOI 10.1007/s10995-008-0326-4; Fransen K, 2015, HEALTH PLACE, V32, P65, DOI 10.1016/j.healthplace.2015.01.002; Galea S, 2005, ANNU REV PUBL HEALTH, V26, P341, DOI 10.1146/annurev.publhealth.26.021304.144708; Giacomini MK, 1999, WHICH HUNT ASSEMBLIN, P715; Goldberg D W, 2007, URISA J, V19, P33, DOI DOI 10.1079/9781780640891.0051; Goodman DC, 2003, HEALTH SERV RES, V38, P287, DOI 10.1111/1475-6773.00116; Gozu A, 2009, AM J MANAG CARE, V15, P195; Griffith DA, 2007, T GIS, V11, P655, DOI [10.1111/j.1467-9671.2007.01067.x28, DOI 10.1111/J.1467-9671.2007.01067.X]; Guagliardo Mark F, 2004, Int J Health Geogr, V3, P3; Hanlon NT, 1998, ENVIRON PLANN C, V16, P559, DOI 10.1068/c160559; Hou Feng, 2004, CANADIAN SOCIAL TREN, V72, P8; Hull A, 2000, GEOJOURNAL, V51, P301, DOI DOI 10.1023/A:1012258625054; Hurley SE, 2003, EPIDEMIOLOGY, V14, P386, DOI 10.1097/01.EDE.0000073161.66729.89; Ionescu-Ittu R, 2007, CAN MED ASSOC J, V177, P1362, DOI 10.1503/cmaj.061615; Jacquez GM, 2012, SPAT SPATIO-TEMPORAL, V3, P7, DOI 10.1016/j.sste.2012.02.002; James AM, 1999, SOC SCI MED, V49, P1021, DOI 10.1016/S0277-9536(99)00180-X; Jamtsho S, 2015, ISPRS INT J GEO-INF, V4, P1584, DOI 10.3390/ijgi4031584; Joseph A., 1984, ACCESSIBILITY UTILIZ; Kazanjian A, 1996, HEALTH PLACE, V2, P27, DOI 10.1016/1353-8292(95)00039-9; KHAN AA, 1992, SOCIO ECON PLAN SCI, V26, P275, DOI 10.1016/0038-0121(92)90004-O; Knight JC, 2009, POPUL HEALTH MANAG, V12, P81, DOI 10.1089/pop.2008.0020; Langford M, 2016, HEALTH PLACE, V38, P70, DOI 10.1016/j.healthplace.2015.11.007; Law M, 2005, HEALTH PLACE, V11, P367, DOI 10.1016/j.healthplace.2004.05.004; Lofters AK, 2010, MED CARE, V48, P611, DOI 10.1097/MLR.0b013e3181d6886f; Luo J, 2016, CARTOGRAPHICA, V51, P12, DOI 10.3138/cart.51.1.3230; Luo W, 2004, HEALTH PLACE, V10, P1, DOI 10.1016/S1353-8292(02)00067-9; Luo W, 2003, ENVIRON PLANN B, V30, P865, DOI 10.1068/b29120; Luo W, 2012, HEALTH PLACE, V18, P789, DOI 10.1016/j.healthplace.2012.04.002; Luo W, 2009, HEALTH PLACE, V15, P1100, DOI 10.1016/j.healthplace.2009.06.002; MACINTYRE S, 1993, J SOC POLICY, V22, P213, DOI 10.1017/S0047279400019310; Malmstrom M, 1999, AM J PUBLIC HEALTH, V89, P1181, DOI 10.2105/AJPH.89.8.1181; Masoodi M, 2015, INT J HEALTH POLICY, V4, P439, DOI 10.15171/ijhpm.2015.23; Matheson FI, 2012, CAN J PUBLIC HEALTH, V103, pS12, DOI 10.1007/BF03403823; McGrail MR, 2012, INT J HEALTH GEOGR, V11, DOI 10.1186/1476-072X-11-50; McGrail MR, 2009, APPL GEOGR, V29, P533, DOI 10.1016/j.apgeog.2008.12.003; Mendelsohn M., 2002, CANADIANSTHOUGHTS TH; Mian O, 2012, CAN FAM PHYSICIAN, V58, pE658; Mitchell R, 2000, HEALTH PLACE, V6, P67, DOI 10.1016/S1353-8292(00)00004-6; Morland K, 2002, AM J PREV MED, V22, P23, DOI 10.1016/S0749-3797(01)00403-2; Murphy K., 2004, ACCESS HLTH CARE SER; Ngui Andre Ngamini, 2011, BMC Health Serv Res, V11, P166, DOI 10.1186/1472-6963-11-166; OCampo P, 1997, AM J PUBLIC HEALTH, V87, P1113, DOI 10.2105/AJPH.87.7.1113; Paez A, 2010, INT J HEALTH GEOGR, V9, DOI 10.1186/1476-072X-9-52; Pampalon R, 2012, CAN J PUBLIC HEALTH, V103, pS17, DOI 10.1007/BF03403824; PENCHANSKY R, 1981, MED CARE, V19, P127, DOI 10.1097/00005650-198102000-00001; Post S, 2013, EVALUATING DATA QUAL; Provincial Health Services Authority, 2011, RED HLTH IN HLTH SYS; Radke J., 2000, GEOGRAPHIC INFORM SC, V6, P105, DOI [10.1080/10824000009480538, DOI 10.1080/10824000009480538]; Rakel RE., 2011, TXB FAMILY MED; Raphael D, 2001, HEALTH PLACE, V7, P179, DOI 10.1016/S1353-8292(01)00008-9; Roos NP, 1997, MILBANK Q, V75, P89, DOI 10.1111/1468-0009.00045; ROSENBERG MW, 1984, CAN GEOGR-GEOGR CAN, V28, P156, DOI 10.1111/j.1541-0064.1984.tb00782.x; Ross NA, 2004, SOC SCI MED, V59, P1485, DOI 10.1016/j.socscimed.2004.01.016; Sanmartin C, 2000, CAN MED ASSOC J, V162, P1305; Schoen C, 2004, HEALTH AFFAIR, V23, pW4487, DOI 10.1377/hlthaff.W4.487; Schuurman N, 2010, CAN GEOGR-GEOGR CAN, V54, P29, DOI 10.1111/j.1541-0064.2009.00301.x; Shah TI, 2014, CAN GEOGR-GEOGR CAN, V58, P400, DOI 10.1111/cag.12091; Statistics Canada, 2011, GEOSUITE 2011 CENS D; Statistics Canada, 2016, UNM HLTH CAR NEEDS; Statistics Canada, 2013, CMA CA DET DEF OTT; Statistics Canada, 2007, CENS POP 2006 TABL 9; Statistics Canada,, 2014, ACC REG MED DOCT CAN; Terry MM, 2013, UNIVERSAL J PUBLIC, V1, P40; Vo A, 2015, 21 AM C INF SYST AUG; Walton-Roberts M, 2014, CAN GEOGR-GEOGR CAN, V58, P34, DOI 10.1111/cag.12065; Wang F., 2012, ANN ASS AM GEOGRAPHE; Wang FH, 2005, HEALTH PLACE, V11, P131, DOI 10.1016/j.healthplace.2004.02.003; Wilson K, 2004, J EPIDEMIOL COMMUN H, V58, P192, DOI 10.1136/jech.2003.014308; Wilson K, 2002, CAN GEOGR-GEOGR CAN, V46, P223, DOI 10.1111/j.1541-0064.2002.tb00742.x; Yen IH, 1999, AM J EPIDEMIOL, V149, P898; Yip AM, 2002, CAN J PUBLIC HEALTH, V93, P303, DOI 10.1007/BF03405022; Zandbergen PA, 2007, BMC PUBLIC HEALTH, V7, DOI 10.1186/1471-2458-7-37	107	42	43	2	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2016	11	12							e0168208	10.1371/journal.pone.0168208	http://dx.doi.org/10.1371/journal.pone.0168208			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EI9QF	27997577	Green Published, Green Submitted, gold			2022-12-27	WOS:000392842900027
J	Chi, C; Shen, YQ; Yin, LH; Ke, XW; Han, D; Zuo, YH				Chi, Chao; Shen, Yongqiang; Yin, Lihua; Ke, Xiwang; Han, Dong; Zuo, Yuhu			Selection and Validation of Reference Genes for Gene Expression Analysis in Vigna angularis Using Quantitative Real-Time RT-PCR	PLOS ONE			English	Article							HOUSEKEEPING GENES; INTERNAL CONTROL; PROTEIN GENES; NORMALIZATION; IDENTIFICATION; ARABIDOPSIS	Adzuki bean (Vigna angularis) is one of the most important legume crops in Asian countries like China, Japan and Korea due to its nutritious protein and starch contents. In spite of its economic importance, gene expression analysis system for gene function verification of adzuki bean is still absent. Therefore, reference genes for gene expression analysis based on the quantitative real time PCR (qRT-PCR) were screened in current study. A total of nine general housekeeping genes, including ACT, Fbox, ZMPP, GAPDH, EF, PP2A, UBC, UBN and PTB were evaluated for their expression stability by qRT-PCR in four adzuki bean cultivars, three different tissues, four abiotic stress and one biotic stress. The best group of candidates as reference genes were as follows: PTB and ACT for different cultivars; EF and UBN for different tissues; ACT and ZMPP for biotic stress and water-logging stress; Fbox and UBC for salinity-alkalinity stress; Fbox and PTB for drought stress. Our results will provide a more accurate and reliable normalization of qRT-PCR data in adzuki bean.	[Chi, Chao; Shen, Yongqiang; Yin, Lihua; Ke, Xiwang; Han, Dong; Zuo, Yuhu] Heilongjiang Bayi Agr Univ, Daqing, Heilongjiang, Peoples R China	Heilongjiang Bayi Agricultural University	Ke, XW; Zuo, YH (corresponding author), Heilongjiang Bayi Agr Univ, Daqing, Heilongjiang, Peoples R China.	kexiwang@byau.edu.cn; zuoyuhu@byau.edu.cn	Ke, Xiwang/AAW-6439-2020		Ministry of Science and Technology of the People's Republic of China [2014BAD07B05-06/H08]; National Natural Science Foundation of China [31501629]; China Postdoctoral Science Foundation [2014M561378]	Ministry of Science and Technology of the People's Republic of China(Ministry of Science and Technology, China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); China Postdoctoral Science Foundation(China Postdoctoral Science Foundation)	2014BAD07B05-06/H08 (http://www.most.gov.cn/, Ministry of Science and Technology of the People's Republic of China, ZYH received the funding. The funder role in study design and decision to publish. 31501629, http://isisn.nsfc.gov.cn/egrantweb/, National Natural Science Foundation of China, KXW received the funding. The funder role in data collection. 2014M561378, http://jj.chinapostdoctor.org.cn/V1/Program2/Default.aspx, China Postdoctoral Science Foundation, YLH received the funding. The funder role in data analysis.	Andersen CL, 2004, CANCER RES, V64, P5245, DOI 10.1158/0008-5472.CAN-04-0496; Bustin SA, 2005, J MOL ENDOCRINOL, V34, P597, DOI 10.1677/jme.1.01755; Bustin SA, 2002, J MOL ENDOCRINOL, V29, DOI 10.1677/jme.0.0290023; Czechowski T, 2005, PLANT PHYSIOL, V139, P5, DOI 10.1104/pp.105.063743; de Vega-Bartol JJ, 2013, PLANT CELL REP, V32, P715, DOI 10.1007/s00299-013-1407-4; Exposito-Rodriguez M, 2008, BMC PLANT BIOL, V8, DOI 10.1186/1471-2229-8-131; Gachon C, 2004, J EXP BOT, V55, P1445, DOI 10.1093/jxb/erh181; Gutierrez L, 2008, PLANT CELL, V20, P1734, DOI 10.1105/tpc.108.059774; Hong SY, 2008, BMC PLANT BIOL, V8, DOI 10.1186/1471-2229-8-112; Hu RB, 2009, BMC MOL BIOL, V10, DOI 10.1186/1471-2199-10-93; Iskandar HM, 2004, PLANT MOL BIOL REP, V22, P325, DOI 10.1007/BF02772676; Jain M, 2006, BIOCHEM BIOPH RES CO, V345, P646, DOI 10.1016/j.bbrc.2006.04.140; Kang YJ, 2015, SCI REP-UK, V5, DOI 10.1038/srep08069; Libault M, 2008, PLANT GENOME-US, V1, P44, DOI 10.3835/plantgenome2008.02.0091; Ma R, 2016, FRONTIERS PLANT SCI, V7; Nakamura T, 2003, PLANT CELL PHYSIOL, V44, P16, DOI 10.1093/pcp/pcg002; Paolacci AR, 2009, BMC MOL BIOL, V10, DOI 10.1186/1471-2199-10-11; Pfaffl MW, 2004, BIOTECHNOL LETT, V26, P509, DOI 10.1023/B:BILE.0000019559.84305.47; Reddy DS, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0148451; Reid KE, 2006, BMC PLANT BIOL, V6, DOI 10.1186/1471-2229-6-27; Remans T, 2008, PLANTA, V227, P1343, DOI 10.1007/s00425-008-0706-4; Ruan WJ, 2007, CLIN CHIM ACTA, V385, P1, DOI 10.1016/j.cca.2007.07.003; Saint-Marcoux D, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118678; Thellin O, 1999, J BIOTECHNOL, V75, P291, DOI 10.1016/S0168-1656(99)00163-7; Thorrez L, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001854; Tong ZG, 2009, BMC MOL BIOL, V10, DOI 10.1186/1471-2199-10-71; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Vasquez-Robinet C, 2010, PLANT PHYSIOL BIOCH, V48, P256, DOI 10.1016/j.plaphy.2009.12.005; Walker NJ, 2002, SCIENCE, V296, P557, DOI 10.1126/science.296.5567.557; Wei YC, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0147224; Xie FL, 2012, PLANT MOL BIOL, V80, P75, DOI 10.1007/s11103-012-9885-2; Yamaguchi M, 1997, PLANT SCI TXB; Yin ZY, 2013, WORLD J MICROB BIOT, V29, P1563, DOI 10.1007/s11274-013-1320-6; Zheng Sujiao, 2015, Weishengwu Xuebao, V55, P425; Zhu J, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-172	35	18	29	2	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2016	11	12							e0168479	10.1371/journal.pone.0168479	http://dx.doi.org/10.1371/journal.pone.0168479			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI8LN	27992593	Green Published, gold, Green Submitted			2022-12-27	WOS:000392758000053
J	Stojak, J; McDevitt, AD; Herman, JS; Krystufek, B; Uhlikova, J; Purger, JJ; Lavrenchenko, LA; Searle, JB; Wojcik, JM				Stojak, Joanna; McDevitt, Allan D.; Herman, Jeremy S.; Krystufek, Boris; Uhlikova, Jitka; Purger, Jeno J.; Lavrenchenko, Leonid A.; Searle, Jeremy B.; Wojcik, Jan M.			Between the Balkans and the Baltic: Phylogeography of a Common Vole Mitochondrial DNA Lineage Limited to Central Europe	PLOS ONE			English	Article							MICROTUS-ARVALIS; POSTGLACIAL COLONIZATION; GLACIAL REFUGIA; POPULATION-STRUCTURE; CLETHRIONOMYS-GLAREOLUS; STATISTICAL TESTS; SMALL MAMMALS; MARKERS; EVOLUTIONARY; SOFTWARE	The common vole (Microtus arvalis) has been a model species of small mammal for studying end-glacial colonization history. In the present study we expanded the sampling from central and eastern Europe, analyzing contemporary genetic structure to identify the role of a potential 'northern glacial refugium', i.e. a refugium at a higher latitude than the traditional Mediterranean refugia. Altogether we analyzed 786 cytochrome b (cytb) sequences (representing mitochondrial DNA; mtDNA) from the whole of Europe, adding 177 new sequences from central and eastern Europe, and we conducted analyses on eight microsatellite loci for 499 individuals (representing nuclear DNA) from central and eastern Europe, adding data on 311 new specimens. Our new data fill gaps in the vicinity of the Carpathian Mountains, the potential northern refugium, such that there is now dense sampling from the Balkans to the Baltic Sea. Here we present evidence that the Eastern mtDNA lineage of the common vole was present in the vicinity of this Carpathian refugium during the Last Glacial Maximum and the Younger Dryas. The Eastern lineage expanded from this refugium to the Baltic and shows low cytb nucleotide diversity in those most northerly parts of the distribution. Analyses of microsatellites revealed a similar pattern but also showed little differentiation between all of the populations sampled in central and eastern Europe.	[Stojak, Joanna; Wojcik, Jan M.] Polish Acad Sci, Mammal Res Inst, Bialowieza, Poland; [Stojak, Joanna; Searle, Jeremy B.] Cornell Univ, Dept Ecol & Evolutionary Biol, Ithaca, NY 14850 USA; [McDevitt, Allan D.] Univ Salford, Sch Environm & Life Sci, Ecosyst & Environm Res Ctr, Salford M5 4WT, Lancs, England; [Herman, Jeremy S.] Natl Museums Scotland, Dept Nat Sci, Edinburgh, Midlothian, Scotland; [Krystufek, Boris] Slovenian Museum Nat Hist, Vertebrate Dept, Ljubljana, Slovenia; [Uhlikova, Jitka] Nat Conservat Agcy Czech Republ, Prague, Czech Republic; [Purger, Jeno J.] Univ Pecs, Inst Biol, Dept Ecol, Pecs, Hungary; [Lavrenchenko, Leonid A.] Russian Acad Sci, AN Severtsov Inst Ecol & Evolut, Dept Mammalian Microevolut, Moscow, Russia	Polish Academy of Sciences; Mammal Research Institute of the Polish Academy of Sciences; Cornell University; University of Salford; University of Pecs; Russian Academy of Sciences; Saratov Scientific Center of the Russian Academy of Sciences; Severtsov Institute of Ecology & Evolution	Stojak, J (corresponding author), Polish Acad Sci, Mammal Res Inst, Bialowieza, Poland.; Stojak, J (corresponding author), Cornell Univ, Dept Ecol & Evolutionary Biol, Ithaca, NY 14850 USA.	jstojak@ibs.bialowieza.pl	Lavrenchenko, Leonid/N-7129-2017; Stojak, Joanna/AAK-2886-2021; Wójcik, Jan/I-4568-2014	Lavrenchenko, Leonid/0000-0001-9961-8748; Wójcik, Jan/0000-0002-4921-6780; Stojak, Joanna/0000-0003-2423-5026; Purger, Jeno/0000-0002-3302-6544	National Science Centre in Poland [UMO-2013/09/N/NZ8/ 03205, N N304 058340, DEC-2015/16/T/NZ8/00015]; European Commission [PIRSES-GA-2009-247652]; Russian Foundation for Basic Research [15-04-03801-a]	National Science Centre in Poland(National Science Centre, Poland); European Commission(European CommissionEuropean Commission Joint Research Centre); Russian Foundation for Basic Research(Russian Foundation for Basic Research (RFBR))	The study was financed by the National Science Centre in Poland (UMO-2013/09/N/NZ8/ 03205 to JS and N N304 058340 to JMW). This study forms part of the PhD thesis of JS, where she was awarded a PhD scholarship from the National Science Centre in Poland (DEC-2015/16/T/NZ8/00015). The research was supported by the European Commission's project No. PIRSES-GA-2009-247652 (BIOGEAST) and the Russian Foundation for Basic Research (project no. 15-04-03801-a). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Avise J. C., 2000, PHYLOGEOGRAPHY HIST; Baele G, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-85; Bandelt HJ, 1999, MOL BIOL EVOL, V16, P37, DOI 10.1093/oxfordjournals.molbev.a026036; Beysard M, 2014, MOL ECOL, V23, P673, DOI 10.1111/mec.12613; Bilton DT, 1998, P ROY SOC B-BIOL SCI, V265, P1219, DOI 10.1098/rspb.1998.0423; Braaker S, 2009, MOL ECOL, V18, P2518, DOI 10.1111/j.1365-294X.2009.04189.x; Brace S, 2012, P NATL ACAD SCI USA, V109, P20532, DOI 10.1073/pnas.1213322109; Bulatova NS, 2010, RUSS J GENET+, V46, P586, DOI 10.1134/S1022795410050121; Buzan EV, 2010, BIOL J LINN SOC, V100, P788, DOI 10.1111/j.1095-8312.2010.01451.x; Canestrelli D, 2014, SCI REP-UK, V4, DOI 10.1038/srep05042; Carlson A.E., 2013, ENCY Q SCI, V3, P126, DOI DOI 10.1016/B978-0-444-53643-3.00029-7; Clark PU, 2009, SCIENCE, V325, P710, DOI 10.1126/science.1172873; de Bruyn M, 2011, TRENDS ECOL EVOL, V26, P405, DOI 10.1016/j.tree.2011.03.021; Deffontaine V, 2005, MOL ECOL, V14, P1727, DOI 10.1111/j.1365-294X.2005.02506.x; DEGLIESPOSTI M, 1993, BIOCHIM BIOPHYS ACTA, V1143, P243, DOI 10.1016/0005-2728(93)90197-N; Drummond AJ, 2005, MOL BIOL EVOL, V22, P1185, DOI [10.1093/molbev/msi103, 10.1093/molbev/mss075]; Drummond AJ, 2006, PLOS BIOL, V4, P699, DOI 10.1371/journal.pbio.0040088; Drummond AJ, 2012, MOL BIOL EVOL, V29, P1969, DOI 10.1093/molbev/mss075; Earl DA, 2012, CONSERV GENET RESOUR, V4, P359, DOI 10.1007/s12686-011-9548-7; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; Frantz AC, 2014, HEREDITY, V113, P443, DOI 10.1038/hdy.2014.45; Fu YX, 1997, GENETICS, V147, P915; Gaziev AI, 2010, MOL BIOL+, V44, P358, DOI 10.1134/S0026893310030027; Goudet J, 2011, FSTAT PROGRAM ESTIMA; Hall T.A., 1999, NUCL ACIDS S SER, V41, P95; Haynes S, 2003, MOL ECOL, V12, P951, DOI 10.1046/j.1365-294X.2003.01795.x; Heckel G, 2005, EVOLUTION, V59, P2231; Herman JS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103949; Hewitt GM, 1999, BIOL J LINN SOC, V68, P87, DOI 10.1111/j.1095-8312.1999.tb01160.x; IRWIN DM, 1991, J MOL EVOL, V32, P128, DOI 10.1007/BF02515385; Jakobsson M, 2007, BIOINFORMATICS, V23, P1801, DOI 10.1093/bioinformatics/btm233; Jensen JL, 2005, BMC GENET, V6, DOI 10.1186/1471-2156-6-13; Jombart T, 2010, BMC GENET, V11, DOI [DOI 10.1186/1471-2156-11-94, 10.1186/1471-2156-11-94]; Jombart T, 2015, TUTORIAL SPATIAL ANA; KASS RE, 1995, J AM STAT ASSOC, V90, P773, DOI 10.1080/01621459.1995.10476572; Kotlik P, 2006, P NATL ACAD SCI USA, V103, P14860, DOI 10.1073/pnas.0603237103; Lagerholm VK, 2014, MOL ECOL, V23, P2060, DOI 10.1111/mec.12698; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Lokrantz H, 2006, TR0636; MANTEL N, 1967, CANCER RES, V27, P209; Markova A.K., 1984, P209; Markova AK, 2011, QUATERN INT, V231, P22, DOI 10.1016/j.quaint.2010.07.016; Martinkova N, 2013, MOL ECOL, V22, P5205, DOI 10.1111/mec.12462; McDevitt AD, 2011, HEREDITY, V107, P548, DOI 10.1038/hdy.2011.41; Mcdevitt AD, 2012, BIOL J LINN SOC, V106, P57, DOI 10.1111/j.1095-8312.2012.01840.x; Meyer MN, 1997, ZOOL ZH, V76, P487; Mix AC, 2001, QUATERNARY SCI REV, V20, P627, DOI 10.1016/S0277-3791(00)00145-1; Mraz P, 2016, BIOL J LINN SOC, V119, P528, DOI 10.1111/bij.12918; Pauperio J, 2012, MOL ECOL, V21, P6015, DOI 10.1111/mec.12024; Pazonyi P, 2004, PALAEOGEOGR PALAEOCL, V212, P295, DOI 10.1016/j.palaeo.2004.06.008; Petit RJ, 2003, SCIENCE, V300, P1563, DOI 10.1126/science.1083264; Pritchard JK, 2000, GENETICS, V155, P945; Rambaut A, 2007, TRACER 1 4; Rasmussen SO, 2006, J GEOPHYS RES-ATMOS, V111, DOI 10.1029/2005JD006079; RICE WR, 1989, EVOLUTION, V43, P223, DOI 10.1111/j.1558-5646.1989.tb04220.x; ROGERS AR, 1995, EVOLUTION, V49, P608, DOI 10.1111/j.1558-5646.1995.tb02297.x; ROGERS AR, 1992, MOL BIOL EVOL, V9, P552; Rosenberg NA, 2004, MOL ECOL NOTES, V4, P137, DOI 10.1046/j.1471-8286.2003.00566.x; RStudio, 2012, RSTUDIO INT DEV ENV; Schenekar T, 2011, HEREDITY, V107, P511, DOI 10.1038/hdy.2011.48; Schneider S, 1999, GENETICS, V152, P1079; Sommer RS, 2006, MAMMAL REV, V36, P251, DOI 10.1111/j.1365-2907.2006.00093.x; Starkel L, 2001, GEOGR SPAT ORG MONOG, V2; Starkel L., 1991, HOLOCENE, V1, P234, DOI [DOI 10.1177/095968369100100305, 10.1177/095968369100100305]; Stewart JR, 2010, P ROY SOC B-BIOL SCI, V277, P661, DOI 10.1098/rspb.2009.1272; Stewart JR, 2001, TRENDS ECOL EVOL, V16, P608, DOI 10.1016/S0169-5347(01)02338-2; Stojak J, 2016, MAMMAL RES, V61, P141, DOI 10.1007/s13364-015-0260-y; Stojak J, 2015, BIOL J LINN SOC, V115, P927, DOI 10.1111/bij.12535; Taberlet P, 1998, MOL ECOL, V7, P453, DOI 10.1046/j.1365-294x.1998.00289.x; Tajima F, 1989, GENETICS, V123, P453; Tougard C, 2013, BIOL J LINN SOC, V108, P434, DOI 10.1111/j.1095-8312.2012.02034.x; Tzedakis PC, 2013, TRENDS ECOL EVOL, V28, P696, DOI 10.1016/j.tree.2013.09.001; Vaha JP, 2006, MOL ECOL, V15, P63, DOI 10.1111/j.1365-294X.2005.02773.x; Valdiosera CE, 2007, MOL ECOL, V16, P5140, DOI 10.1111/j.1365-294X.2007.03590.x; Van Oosterhout C, 2004, MOL ECOL NOTES, V4, P535, DOI 10.1111/j.1471-8286.2004.00684.x; WEBB T, 1992, ANNU REV ECOL SYST, V23, P141, DOI 10.1146/annurev.es.23.110192.001041; WEIR BS, 1984, EVOLUTION, V38, P1358, DOI 10.1111/j.1558-5646.1984.tb05657.x; Wielstra B, 2015, BIOL J LINN SOC, V114, P574, DOI 10.1111/bij.12446; Wojcik JM, 2010, J ZOOL, V281, P249, DOI 10.1111/j.1469-7998.2010.00699.x; WOJCIK JM, 1993, ACTA THERIOL, V38, P315, DOI 10.4098/AT.arch.93-27; WYSOTA W, 2002, GEOCHRONOMETRIA, V21, P137; Wysota W, 2009, QUATERN INT, V207, P26, DOI 10.1016/j.quaint.2008.12.015; Yu ZC, 2001, GEOGR PHYS QUATERN, V55, P171, DOI 10.7202/008301ar; Zagorodnyuk I, 2008, MICROTUS LEVIS IUCN; Zhang DX, 1996, TRENDS ECOL EVOL, V11, P247, DOI 10.1016/0169-5347(96)10031-8	86	21	22	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2016	11	12							e0168621	10.1371/journal.pone.0168621	http://dx.doi.org/10.1371/journal.pone.0168621			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI8LN	27992546	Green Submitted, Green Published, gold			2022-12-27	WOS:000392758000068
J	Kale, A; Rimesso, G; Baker, NE				Kale, Abhijit; Rimesso, Gerard; Baker, Nicholas E.			Local Cell Death Changes the Orientation of Cell Division in the Developing Drosophila Wing Imaginal Disc Without Using Fat or Dachsous as Orienting Signals	PLOS ONE			English	Article							TUMOR-SUPPRESSOR PATHWAY; HIPPO PATHWAY; PLANAR POLARITY; GENETIC MOSAICS; REGULATE GROWTH; TISSUE-GROWTH; ORGAN SIZE; COMPETITION; EYE; PROLIFERATION	Drosophila imaginal disc cells exhibit preferred cell division orientations according to location within the disc. These orientations are altered if cell death occurs within the epithelium, such as is caused by cell competition or by genotypes affecting cell survival. Both normal cell division orientations, and their orientations after cell death, depend on the Fat-Dachsous pathway of planar cell polarity (PCP). The hypothesis that cell death initiates a planar polarity signal was investigated. When clones homozygous for the pineapple eye ( pie) mutation were made to initiate cell death, neither Dachsous nor Fat was required in pie cells for the re-orientation of nearby cells, indicating a distinct signal for this PCP pathway. Dpp and Wg were also not needed for pie clones to re-orient cell division. Cell shapes were evaluated in wild type and mosaic wing discs to assess mechanical consequences of cell loss. Although proximal wing disc cells and cells close to the dorso-ventral boundary were elongated in their preferred cell division axes in wild type discs, cell shapes in much of the wing pouch were symmetrical on average and did not predict their preferred division axis. Cells in pie mutant clones were slightly larger than their normal counterparts, consistent with mechanical stretching following cell loss, but no bias in cell shape was detected in the surrounding cells. These findings indicate that an unidentified signal influences PCP-dependent cell division orientation in imaginal discs.	[Kale, Abhijit; Rimesso, Gerard; Baker, Nicholas E.] Albert Einstein Coll Med, Dept Genet, 1300 Morris Pk Ave, Nyc, NY 10467 USA; [Baker, Nicholas E.] Albert Einstein Coll Med, Dept Ophthalmol & Visual Sci, 1300 Morris Pk Ave, Nyc, NY 10467 USA; [Baker, Nicholas E.] Albert Einstein Coll Med, Dept Dev & Mol Biol, 1300 Morris Pk Ave, Nyc, NY 10467 USA; [Kale, Abhijit] Buck Inst Res Aging, 8001 Redwood Blvd, Novato, CA USA	Yeshiva University; Yeshiva University; Yeshiva University; Buck Institute for Research on Aging	Baker, NE (corresponding author), Albert Einstein Coll Med, Dept Genet, 1300 Morris Pk Ave, Nyc, NY 10467 USA.; Baker, NE (corresponding author), Albert Einstein Coll Med, Dept Ophthalmol & Visual Sci, 1300 Morris Pk Ave, Nyc, NY 10467 USA.; Baker, NE (corresponding author), Albert Einstein Coll Med, Dept Dev & Mol Biol, 1300 Morris Pk Ave, Nyc, NY 10467 USA.	Nicholas.baker@einstein.yu.edu	Kale, Abhijit/I-3787-2019	Rimesso, Gerard/0000-0003-0191-3402; Kale, Abhijit/0000-0002-1105-6953	NIH [GM104213]; Research to Prevent Blindness through the Department of Opthalmology and Visual Sciences; NCI cancer center support grant [P30CA013330]; NATIONAL CANCER INSTITUTE [P30CA013330] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM104213] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Research to Prevent Blindness through the Department of Opthalmology and Visual Sciences; NCI cancer center support grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	NEB received funding from NIH grant number GM104213 https://www.nigms.nih.gov/Pages/default.aspx. NEB received funding from Research to Prevent Blindness through the Department of Opthalmology and Visual Sciences https://www.rpbusa.org/rpb/?. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors thank A. Jenny and A. Kumar for comments on the manuscript, H. McNeil, G. Morata for Drosophila strains, and the Developmental Studies Hybridoma Bank for antibodies. Confocal Imaging was performed at the Analytical Imaging Facility, Albert Einstein College of Medicine, supported by NCI cancer center support grant (P30CA013330). This paper includes data from a thesis partially fulfilling of the requirements for the Degree of Doctor of Philosophy in the Graduate Division of Medical Sciences, Albert Einstein College of Medicine, Yeshiva University.	Adler PN, 1998, DEVELOPMENT, V125, P959; Aegerter-Wilmsen T, 2010, DEVELOPMENT, V137, P499, DOI 10.1242/dev.041731; Ambegaonkar AA, 2015, ELIFE, V4, DOI 10.7554/eLife.09946; Baena-Lopez LA, 2005, CURR BIOL, V15, P1640, DOI 10.1016/j.cub.2005.07.062; BAKER NE, 1988, DEV BIOL, V125, P96, DOI 10.1016/0012-1606(88)90062-0; Baker NE, 2014, METHODS, V68, P252, DOI 10.1016/j.ymeth.2014.04.007; Bennett FC, 2006, CURR BIOL, V16, P2101, DOI 10.1016/j.cub.2006.09.045; Blair SS, 2014, CURR BIOL, V24, pR835, DOI 10.1016/j.cub.2014.08.008; Bosch JA, 2014, ELIFE, V3, DOI 10.7554/eLife.03383; Bosveld F, 2016, NATURE, V530, P495, DOI 10.1038/nature16970; Bosveld F, 2016, DEVELOPMENT, V143, P623, DOI 10.1242/dev.127993; Cadart C, 2014, DEV CELL, V29, P159, DOI 10.1016/j.devcel.2014.04.009; Campinho P, 2013, NAT CELL BIOL, V15, P1405, DOI 10.1038/ncb2869; Carvajal-Gonzalez Jose Maria, 2014, F1000Prime Rep, V6, P98, DOI 10.12703/P6-98; Cho E, 2006, NAT GENET, V38, P1142, DOI 10.1038/ng1887; CLEGG NJ, 1993, GENETICS, V134, P221; de la Cova C, 2004, CELL, V117, P107, DOI 10.1016/S0092-8674(04)00214-4; Devenport D, 2014, J CELL BIOL, V207, P171, DOI 10.1083/jcb.201408039; Fanto M, 2003, DEVELOPMENT, V130, P763, DOI 10.1242/dev.00304; Gaspar P, 2014, CURR OPIN CELL BIOL, V31, P74, DOI 10.1016/j.ceb.2014.09.003; Gillies TE, 2011, CURR BIOL, V21, pR599, DOI 10.1016/j.cub.2011.06.055; Gong Y, 2004, NATURE, V430, P689, DOI 10.1038/nature02796; Harvey KF, 2013, NAT REV CANCER, V13, P246, DOI 10.1038/nrc3458; Hertwig O, 1884, JENAISCHE Z FUER NAT, V18, P21, DOI DOI 10.1101/GAD.610511; Huh JR, 2004, CURR BIOL, V14, P1262, DOI 10.1016/j.cub.2004.06.015; Ishikawa HO, 2008, SCIENCE, V321, P401, DOI 10.1126/science.1158159; Jaiswal M, 2006, DEVELOPMENT, V133, P925, DOI 10.1242/dev.02243; Kale A, 2015, CELL DEATH DIFFER, V22, P1300, DOI 10.1038/cdd.2014.218; LeGoff L, 2013, DEVELOPMENT, V140, P4051, DOI 10.1242/dev.090878; Levayer R, 2015, NATURE, V524, P476, DOI 10.1038/nature14684; Li W, 2009, CURR BIOL, V19, P1821, DOI 10.1016/j.cub.2009.09.023; Ma D, 2003, NATURE, V421, P543, DOI 10.1038/nature01366; Mao YL, 2013, EMBO J, V32, P2790, DOI 10.1038/emboj.2013.197; Mao YL, 2011, GENE DEV, V25, P131, DOI 10.1101/gad.610511; Mao YP, 2006, DEVELOPMENT, V133, P2539, DOI 10.1242/dev.02427; Martin FA, 2004, DEVELOPMENT, V131, P4921, DOI 10.1242/dev.01385; Martin FA, 2009, DEVELOPMENT, V136, P3747, DOI 10.1242/dev.038406; Matakatsu H, 2004, DEVELOPMENT, V131, P3785, DOI 10.1242/dev.01254; Matakatsu H, 2012, DEVELOPMENT, V139, P1498, DOI 10.1242/dev.070367; MORATA G, 1975, DEV BIOL, V42, P211, DOI 10.1016/0012-1606(75)90330-9; Moreno E, 2004, CELL, V117, P117, DOI 10.1016/S0092-8674(04)00262-4; Moreno E, 2002, NATURE, V416, P755, DOI 10.1038/416755a; Panousopoulou E, 2014, SEMIN CELL DEV BIOL, V34, P124, DOI 10.1016/j.semcdb.2014.06.013; POSAKONY LG, 1990, MECH DEVELOP, V33, P69, DOI 10.1016/0925-4773(90)90136-A; Ragkousi K, 2014, J CELL BIOL, V207, P181, DOI 10.1083/jcb.201408044; Rauskolb C, 2014, CELL, V158, P143, DOI 10.1016/j.cell.2014.05.035; Rogulja D, 2008, DEV CELL, V15, P309, DOI 10.1016/j.devcel.2008.06.003; Ryoo HD, 2004, DEV CELL, V7, P491, DOI 10.1016/j.devcel.2004.08.019; Segalen M, 2009, SEMIN CELL DEV BIOL, V20, P972, DOI 10.1016/j.semcdb.2009.03.018; Shi W, 2003, GENETICS, V165, P1869; Silva E, 2006, CURR BIOL, V16, P2081, DOI 10.1016/j.cub.2006.09.004; Simon MA, 2004, DEVELOPMENT, V131, P6175, DOI 10.1242/dev.01550; SIMPSON P, 1979, DEV BIOL, V69, P182, DOI 10.1016/0012-1606(79)90284-7; SIMPSON P, 1981, DEV BIOL, V85, P299, DOI 10.1016/0012-1606(81)90261-X; Staley BK, 2012, DEV DYNAM, V241, P3, DOI 10.1002/dvdy.22723; Strutt H, 2004, DEVELOPMENT, V131, P881, DOI 10.1242/dev.00996; Tyler DM, 2007, GENETICS, V175, P643, DOI 10.1534/genetics.106.061929; Tyler DM, 2007, DEV BIOL, V305, P187, DOI 10.1016/j.ydbio.2007.02.004; VINCENT JP, 1994, DEV BIOL, V164, P328, DOI 10.1006/dbio.1994.1203; Willecke M, 2006, CURR BIOL, V16, P2090, DOI 10.1016/j.cub.2006.09.005; Woods DF, 1996, J CELL BIOL, V134, P1469, DOI 10.1083/jcb.134.6.1469; Wu J, 2013, NAT CELL BIOL, V15, P1045, DOI 10.1038/ncb2806; Wyatt TPJ, 2015, P NATL ACAD SCI USA, V112, P5726, DOI 10.1073/pnas.1420585112; Xing YL, 2012, G3-GENES GENOM GENET, V2, P343, DOI 10.1534/g3.111.001651; XU T, 1993, DEVELOPMENT, V117, P1223; Yang CH, 2002, CELL, V108, P675, DOI 10.1016/S0092-8674(02)00658-X; Yu FX, 2013, GENE DEV, V27, P355, DOI 10.1101/gad.210773.112; Zecca M, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000386	68	2	2	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2016	11	12							e0167637	10.1371/journal.pone.0167637	http://dx.doi.org/10.1371/journal.pone.0167637			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EG7JB	28030539	gold, Green Published, Green Submitted			2022-12-27	WOS:000391222000014
J	Kho, ME; Molloy, AJ; Clarke, FJ; Ajami, D; McCaughan, M; Obrovac, K; Murphy, C; Camposilvan, L; Herridge, MS; Koo, KKY; Rudkowski, J; Seely, AJE; Zanni, JM; Mourtzakis, M; Piraino, T; Cook, DJ				Kho, Michelle E.; Molloy, Alexander J.; Clarke, France J.; Ajami, Daana; McCaughan, Magda; Obrovac, Kristy; Murphy, Christina; Camposilvan, Laura; Herridge, Margaret S.; Koo, Karen K. Y.; Rudkowski, Jill; Seely, Andrew J. E.; Zanni, Jennifer M.; Mourtzakis, Marina; Piraino, Thomas; Cook, Deborah J.		Canadian Critical Care Trials Grp	TryCYCLE: A Prospective Study of the Safety and Feasibility of Early In-Bed Cycling in Mechanically Ventilated Patients	PLOS ONE			English	Article							INTENSIVE-CARE-UNIT; CRITICALLY-ILL PATIENTS; NEUROMUSCULAR ELECTRICAL-STIMULATION; PHYSICAL FUNCTION; INTEROBSERVER AGREEMENT; FUNCTIONAL DISABILITY; HANDGRIP STRENGTH; ACQUIRED WEAKNESS; ICU SURVIVORS; MUSCLE MASS	Introduction The objective of this study was to assess the safety and feasibility of in-bed cycling started within the first 4 days of mechanical ventilation (MV) to inform a future randomized clinical trial. Methods We conducted a 33-patient prospective cohort study in a 21-bed adult academic medical-surgical intensive care unit (ICU) in Hamilton, ON, Canada. We included adult patients (>= 18 years) receiving MV who walked independently pre-ICU. Our intervention was 30 minutes of in-bed supine cycling 6 days/week in the ICU. Our primary outcome was Safety (termination), measured as events prompting cycling termination; secondary Safety (disconnection or dislodgement) outcomes included catheter/tube dislodgements. Feasibility was measured as consent rate and fidelity to intervention. For our primary outcome, we calculated the binary proportion and 95% confidence interval (CI). Results From 10/2013-8/2014, we obtained consent from 34 of 37 patients approached (91.9%), 33 of whom received in-bed cycling. Of those who cycled, 16(48.4%) were female, the mean (SD) age was 65.8(12.2) years, and APACHE II score was 24.3(6.7); 29(87.9%) had medical admitting diagnoses. Cycling termination was infrequent (2.0%, 95% CI: 0.8%-4.9%) and no device dislodgements occurred. Cycling began a median [IQR] of 3 [2, 4] days after ICU admission; patients received 5 [3, 8] cycling sessions with a median duration of 30.7 [21.6, 30.8] minutes per session. During 205 total cycling sessions, patients were receiving invasive MV (150 [73.1%]), vasopressors (6 [2.9%]), sedative or analgesic infusions (77 [37.6%]) and dialysis (4 [2.0%]). Conclusions Early cycling within the first 4 days of MV among hemodynamically stable patients is safe and feasible. Research to evaluate the effect of early cycling on patient function is warranted.	[Kho, Michelle E.] McMaster Univ, Sch Rehabil Sci, Hamilton, ON, Canada; [Kho, Michelle E.; Molloy, Alexander J.; Ajami, Daana; McCaughan, Magda; Obrovac, Kristy; Murphy, Christina; Camposilvan, Laura] St Josephs Healthcare, Dept Physiotherapy, Hamilton, ON, Canada; [Kho, Michelle E.; Zanni, Jennifer M.; Cook, Deborah J.] Johns Hopkins Univ, Dept Phys Med & Rehabil, Baltimore, MD 21218 USA; [Clarke, France J.] McMaster Univ, Dept Clin Epidemiol & Biostat, Hamilton, ON, Canada; [Herridge, Margaret S.] Univ Toronto, Dept Med, Univ Hlth Network, Toronto Gen Res Inst, Toronto, ON, Canada; [Koo, Karen K. Y.] Swedish Early Mobil Program Crit Care, Swedish Med Grp, First Hill Campus, Seattle, WA USA; [Koo, Karen K. Y.] Western Univ, Dept Med, London, ON, Canada; [Rudkowski, Jill] McMaster Univ, Dept Med, Hamilton, ON, Canada; [Seely, Andrew J. E.] Univ Ottawa, Ottawa Hosp, Res Inst, Ottawa, ON, Canada; [Mourtzakis, Marina] Univ Waterloo, Dept Kinesiol, Waterloo, ON, Canada; [Piraino, Thomas] St Josephs Healthcare, Resp Therapy Serv, Hamilton, ON, Canada	McMaster University; Johns Hopkins University; McMaster University; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Toronto General Hospital; Swedish Medical Center; Western University (University of Western Ontario); McMaster University; University of Ottawa; Ottawa Hospital Research Institute; University of Waterloo	Kho, ME (corresponding author), McMaster Univ, Sch Rehabil Sci, Hamilton, ON, Canada.; Kho, ME (corresponding author), St Josephs Healthcare, Dept Physiotherapy, Hamilton, ON, Canada.; Kho, ME (corresponding author), Johns Hopkins Univ, Dept Phys Med & Rehabil, Baltimore, MD 21218 USA.	khome@mcmaster.ca	, Michelle/W-7414-2019; Piraino, Thomas/AAB-8938-2019	Piraino, Thomas/0000-0002-4887-8686; Kho, Michelle/0000-0003-3170-031X; Herridge, Margaret/0000-0002-2903-1631	Canadian Institutes of Health Research; Institute of Musculoskeletal Health and Arthritis Operating grant [131584]; Canada Research Chairs MEK DJC; Canadian Institutes of Health Research; Institute of Musculoskeletal Health and Arthritis Operating grant [131584]; Canada Research Chairs MEK DJC	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Institute of Musculoskeletal Health and Arthritis Operating grant; Canada Research Chairs MEK DJC; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Institute of Musculoskeletal Health and Arthritis Operating grant; Canada Research Chairs MEK DJC	This work was supported by: Canadian Institutes of Health Research (www.cihr-irsc.gc.ca.), Institute of Musculoskeletal Health and Arthritis Operating grant Priority Announcement: IMHA New investigators - Bridge Funding (131584) MEK DJC MSH KK MM JR AS; Canada Research Chairs MEK DJC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adler Joseph, 2012, Cardiopulm Phys Ther J, V23, P5; Ali NA, 2008, AM J RESP CRIT CARE, V178, P261, DOI 10.1164/rccm.200712-1829OC; [Anonymous], 2002, CRIT CARE MED, V166, P111, DOI [10.1164/rccm.166/1/111, DOI 10.1164/RCCM.166/1/111]; Barr J, 2013, CRIT CARE MED, V41, P263, DOI 10.1097/CCM.0b013e3182783b72; Brummel NE, 2014, INTENS CARE MED, V40, P370, DOI 10.1007/s00134-013-3136-0; Burtin C, 2009, CRIT CARE MED, V37, P2499, DOI 10.1097/CCM.0b013e3181a38937; Calvo-Ayala E, 2013, CHEST, V144, P1469, DOI 10.1378/chest.13-0779; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Damluji A, 2013, J CRIT CARE, V28, DOI 10.1016/j.jcrc.2013.01.006; Dantas Camila Moura, 2012, Rev. bras. ter. intensiva, V24, P173, DOI 10.1590/S0103-507X2012000200013; Daugherty EL, 2009, CRIT CARE MED, V37, P1210, DOI [10.1097/CCM.0b013e3181b6fa29, 10.1097/CCM.0b013e31819d67b5]; De Jonghe B, 2002, JAMA-J AM MED ASSOC, V288, P2859, DOI 10.1001/jama.288.22.2859; Denehy L, 2013, PHYS THER, V93, P1636, DOI 10.2522/ptj.20120310; Denehy L, 2013, CRIT CARE, V17, DOI 10.1186/cc12835; Des Jarlais DC, 2004, AM J PUBLIC HEALTH, V94, P361, DOI 10.2105/AJPH.94.3.361; Ely EW, 2003, JAMA-J AM MED ASSOC, V289, P2983, DOI 10.1001/jama.289.22.2983; Esteban A, 2013, AM J RESP CRIT CARE, V188, P220, DOI 10.1164/rccm.201212-2169OC; Fan E, 2010, INTENS CARE MED, V36, P1038, DOI 10.1007/s00134-010-1796-6; Gerovasili V, 2009, CRIT CARE, V13, DOI 10.1186/cc8123; Groll DL, 2005, J CLIN EPIDEMIOL, V58, P595, DOI 10.1016/j.jclinepi.2004.10.018; Hermans G, 2012, MUSCLE NERVE, V45, P18, DOI 10.1002/mus.22219; Herridge MS, 2011, NEW ENGL J MED, V364, P1293, DOI 10.1056/NEJMoa1011802; Hickmann CE, 2014, INTENS CARE MED, V40, P548, DOI 10.1007/s00134-014-3218-7; Hoffmann TC, 2014, BMJ-BRIT MED J, V348, DOI [10.1136/bmj.g1687, 10.1055/s-0041-111066]; Iwashyna TJ, 2010, JAMA-J AM MED ASSOC, V304, P1787, DOI 10.1001/jama.2010.1553; KATZ S, 1963, JAMA-J AM MED ASSOC, V185, P914, DOI 10.1001/jama.1963.03060120024016; Kaukonen KM, 2014, JAMA-J AM MED ASSOC, V311, P1308, DOI 10.1001/jama.2014.2637; Kayambu G, 2015, INTENS CARE MED, V41, P865, DOI 10.1007/s00134-015-3763-8; Kho ME, 2015, J CRIT CARE, V30, pe1, DOI DOI 10.1016/J.JCRC.2015.07.025; Kho ME, 2015, J CRIT CARE, V30, P32, DOI 10.1016/j.jcrc.2014.09.014; Kho ME, 2012, PHYS THER, V92, P1564, DOI 10.2522/ptj.20110437; KNAUS WA, 1985, CRIT CARE MED, V13, P818, DOI 10.1097/00003246-198510000-00009; Korupolu R, 2009, CONT CRIT CARE, V6, P1; LEBLANC AD, 1992, J APPL PHYSIOL, V73, P2172, DOI 10.1152/jappl.1992.73.5.2172; MARSHALL JC, 1995, CRIT CARE MED, V23, P1638, DOI 10.1097/00003246-199510000-00007; Needham DM, 2005, CRIT CARE MED, V33, P574, DOI [10.1097/01.CCM.0000155992.21174.31, 10.1097/01.ccm.0000155992.21174.31]; Parry SM, 2014, J CRIT CARE, V29, DOI 10.1016/j.jcrc.2014.03.017; Pires-Neto RC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074182; Puthucheary ZA, 2013, JAMA-J AM MED ASSOC, V310, P1591, DOI 10.1001/jama.2013.278481; Schweickert WD, 2009, LANCET, V373, P1874, DOI 10.1016/S0140-6736(09)60658-9; Segers J, 2014, J CRIT CARE; Skinner EH, 2009, CRIT CARE RESUSC, V11, P110; Sricharoenchai T, 2014, J CRIT CARE, V29, P395, DOI 10.1016/j.jcrc.2013.12.012; TEAM Study Investigators, 2015, CRIT CARE, V19, DOI 10.1186/s13054-015-0765-4; Thabane L, 2010, BMC MED RES METHODOL, V10, DOI 10.1186/1471-2288-10-1; Vanpee G, 2011, CRIT CARE MED, V39, P1929, DOI 10.1097/CCM.0b013e31821f050b; Vivodtzev I, 2014, CRIT CARE, V18, DOI 10.1186/cc13888; Zanni JM, 2010, J CRIT CARE, V25, P254, DOI 10.1016/j.jcrc.2009.10.010	48	31	35	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2016	11	12							e0167561	10.1371/journal.pone.0167561	http://dx.doi.org/10.1371/journal.pone.0167561			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EG7JB	28030555	gold, Green Published			2022-12-27	WOS:000391222000010
J	Pan, HP; Preisser, EL; Su, Q; Jiao, XG; Xie, W; Wang, SL; Wu, QJ; Zhang, YJ				Pan, Huipeng; Preisser, Evan L.; Su, Qi; Jiao, Xiaoguo; Xie, Wen; Wang, Shaoli; Wu, Qingjun; Zhang, Youjun			Natal Host Plants Can Alter Herbivore Competition	PLOS ONE			English	Article							BEMISIA-TABACI HEMIPTERA; 2 INVASIVE WHITEFLIES; FEEDING-BEHAVIOR; Q-BIOTYPES; ALEYRODIDAE; RESISTANCE; PYRIPROXYFEN; SUITABILITY; PERFORMANCE; RELEVANCE	Interspecific competition between herbivores is widely recognized as an important determinant of community structure. Although researchers have identified a number of factors capable of altering competitive interactions, few studies have addressed the influence of neighboring plant species. If adaptation to/epigenetic effects of an herbivore's natal host plant alter its performance on other host plants, then interspecific herbivore interactions may play out differently in heterogeneous and homogenous plant communities. We tested wether the natal host plant of a whitefly population affected interactions between the Middle-east Asia Minor 1 (MEAM1) and Mediterranean (MED) cryptic species of the whitefly Bemisia tabaci by rearing the offspring of a cabbage-derived MEAM1 population and a poinsettia-derived MED population together on three different host plants: cotton, poinsettia, and cabbage. We found that MED dominated on poinsettia and that MEAM1 dominated on cabbage, results consistent with previous research. MED also dominated when reared with MEAM1 on cotton, however, a result at odds with multiple otherwise-similar studies that reared both species on the same natal plant. Our work provides evidence that natal plants affect competitive interactions on another plant species, and highlights the potential importance of neighboring plant species on herbivore community composition in agricultral systems.	[Pan, Huipeng] South China Agr Univ, Dept Entomol, Guangzhou, Guangdong, Peoples R China; [Pan, Huipeng] Engn Technol Res Ctr Agr Pest Biocontrol Guangdon, Key Lab Biopesticide Innovat & Applicat, Guangzhou, Guangdong, Peoples R China; [Pan, Huipeng; Su, Qi; Jiao, Xiaoguo; Xie, Wen; Wang, Shaoli; Wu, Qingjun; Zhang, Youjun] Chinese Acad Agr Sci, Inst Vegetables & Flowers, Dept Plant Protect, Beijing, Peoples R China; [Preisser, Evan L.] Univ Rhode Isl, Dept Biol Sci, Kingston, RI 02881 USA	South China Agricultural University; Chinese Academy of Agricultural Sciences; Institute of Vegetables & Flowers, CAAS; University of Rhode Island	Zhang, YJ (corresponding author), Chinese Acad Agr Sci, Inst Vegetables & Flowers, Dept Plant Protect, Beijing, Peoples R China.	zhangyoujun@caas.cn	Zhang, Youjun/AAY-7948-2020	Zhang, Youjun/0000-0003-3508-6695	State Key Program of National Natural Science Foundation of China [31420103919]; 973 Program [2013CB127602]; National Department Public Benefit Research Foundation [201303019]; South China Agricultural University; Beijing Key Laboratory for Pest Control and Sustainable Cultivation of Vegetables	State Key Program of National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); 973 Program(National Basic Research Program of China); National Department Public Benefit Research Foundation; South China Agricultural University; Beijing Key Laboratory for Pest Control and Sustainable Cultivation of Vegetables	This work was supported by the State Key Program of National Natural Science Foundation of China (31420103919), the 973 Program (2013CB127602), the National Department Public Benefit Research Foundation (201303019), a start-up fund from the South China Agricultural University, and the Beijing Key Laboratory for Pest Control and Sustainable Cultivation of Vegetables. These agencies had no role in study design, data collection/analysis, manuscript preparation, or the decision to publish. The authors declare no competing financial interests.; Comments by D. Crowder, J. Lau, M. Schadler, and an anonymous reviewer greatly improved this manuscript. This work was supported by the State Key Program of National Natural Science Foundation of China (31420103919), the 973 Program (2013CB127602), the National Department Public Benefit Research Foundation (201303019), a start-up fund from the South China Agricultural University, and the Beijing Key Laboratory for Pest Control and Sustainable Cultivation of Vegetables. These agencies had no role in study design, data collection/analysis, manuscript preparation, or the decision to publish. The authors declare no competing financial interests.	Barbosa P, 2009, ANNU REV ECOL EVOL S, V40, P1, DOI 10.1146/annurev.ecolsys.110308.120242; Bernardo J, 1996, AM ZOOL, V36, P83; Bezemer TM, 2005, TRENDS ECOL EVOL, V20, P617, DOI 10.1016/j.tree.2005.08.006; Brown J. K., 1994, FAO (Food and Agriculture Organization of the United Nations) Plant Protection Bulletin, V42, P3; BUTTER NS, 1992, TROP AGR, V69, P119; Cahenzli F, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2012.2856; CALATAYUD PA, 1994, ENTOMOL EXP APPL, V72, P219, DOI 10.1007/BF02383809; Chu D, 2012, J ECON ENTOMOL, V105, P930, DOI 10.1603/EC10373; Chu D, 2010, ENVIRON ENTOMOL, V39, P1028, DOI 10.1603/EN09161; Crowder DW, 2010, J ANIM ECOL, V79, P563, DOI 10.1111/j.1365-2656.2010.01666.x; Crowder DW, 2010, ANIM BEHAV, V79, P579, DOI 10.1016/j.anbehav.2009.11.025; Dalton R, 2006, NATURE, V443, P898, DOI 10.1038/443898a; De Barro PJ, 2011, ANNU REV ENTOMOL, V56, P1, DOI 10.1146/annurev-ento-112408-085504; DENNO RF, 1995, ANNU REV ENTOMOL, V40, P297, DOI 10.1146/annurev.en.40.010195.001501; Dunn GA, 2011, ENDOCRINOLOGY, V152, P2228, DOI 10.1210/en.2010-1461; Guo JY, 2013, J ECON ENTOMOL, V106, P1379, DOI 10.1603/EC12401; Herman JJ, 2012, INTEGR COMP BIOL, V52, P77, DOI 10.1093/icb/ics041; Horowitz AR, 2005, ARCH INSECT BIOCHEM, V58, P216, DOI 10.1002/arch.20044; Iida H, 2009, APPL ENTOMOL ZOOL, V44, P267, DOI 10.1303/aez.2009.267; Inbar M, 2001, OIKOS, V94, P228, DOI 10.1034/j.1600-0706.2001.940203.x; Jiao XG, 2013, ENTOMOL EXP APPL, V147, P1, DOI 10.1111/eea.12040; Jiao XG, 2012, J PEST SCI, V85, P423, DOI 10.1007/s10340-012-0441-2; Karban R, 2010, NEW PHYTOL, V186, P565, DOI 10.1111/j.1469-8137.2010.03263.x; Liu BM, 2013, ENVIRON ENTOMOL, V42, P980, DOI 10.1603/EN13071; Liu BM, 2013, J VIROL, V87, P4929, DOI 10.1128/JVI.03571-12; Liu BM, 2012, INT J BIOL SCI, V8, P697, DOI 10.7150/ijbs.4108; Liu J, 2009, ANN APPL BIOL, V155, P439, DOI 10.1111/j.1744-7348.2009.00366.x; MASTERS GJ, 1993, OIKOS, V66, P148, DOI 10.2307/3545209; Medina-Ortega KJ, 2011, ENTOMOLOGY, P149; MIAO SL, 1991, ECOLOGY, V72, P1634, DOI 10.2307/1940963; Pan HP, 2015, ECOL APPL, V25, P1585, DOI 10.1890/14-0752.1; Pan HP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034817; Park J, 2012, J ASIA-PAC ENTOMOL, V15, P186, DOI 10.1016/j.aspen.2011.10.005; Price P.W., 2011, INSECT ECOLOGY BEHAV; Qiu BL, 2011, J PEST SCI, V84, P419, DOI 10.1007/s10340-011-0367-0; ROSSITER MC, 1991, OECOLOGIA, V87, P288, DOI 10.1007/BF00325268; Sun DB, 2011, B ENTOMOL RES, V101, P211, DOI 10.1017/S0007485310000416; Sun DB, 2014, B ENTOMOL RES, V104, P334, DOI 10.1017/S0007485314000108; Sun DB, 2013, B ENTOMOL RES, V103, P344, DOI 10.1017/S0007485312000788; Verhoeven KJF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038605; Via S, 2002, AM NAT, V159, pS76, DOI 10.1086/338374; White JA, 2009, HEREDITY, V102, P483, DOI 10.1038/hdy.2009.5; Wilson M, 2007, PEST MANAG SCI, V63, P761, DOI 10.1002/ps.1403; Wu Shu-Wen, 2010, Chinese Bulletin of Entomology, V47, P1118; Youngson NA, 2008, ANNU REV GENOM HUM G, V9, P233, DOI 10.1146/annurev.genom.9.081307.164445	45	6	8	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2016	11	12							e0169142	10.1371/journal.pone.0169142	http://dx.doi.org/10.1371/journal.pone.0169142			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EG7JB	28030636	Green Published, gold, Green Submitted			2022-12-27	WOS:000391222000107
J	De Beer, CJ; Venter, GJ; Vreysen, MJB				De Beer, Chantel J.; Venter, Gert J.; Vreysen, Marc J. B.			Improving the Diet for the Rearing of Glossina brevipalpis Newstead and Glossina austeni Newstead: Blood Source and Collection - Processing - Feeding Procedures	PLOS ONE			English	Article							TSETSE-FLIES GLOSSINA; GORGING RESPONSE; DIPTERA; ATP; MOSQUITOS; PALPALIS; AFRICA	One of the challenges to maintain tsetse fly (Diptera: Glossinidae) colonies is the sustainable supply of high quality blood meals. The effect of using anticoagulants during collection of the blood, the addition of phagostimulants to the blood meals as well as using mixtures of bovine and porcine blood in different proportions for feeding on colony productivity was assessed. Defibrinated bovine blood was found to be suitable to maintain both the Glossina brevipalpis Newstead and Glossina austeni Newstead colonies. Blood collected with the anticoagulants sodium citrate, citric sodium combination, citrate phosphate dextrose adenine and citric acid did not affect colony performance of both species. Defibrinated bovine and porcine blood in a 1:1 ratio or the feeding of either bovine or porcine blood on alternating days improved pupae production of G. austeni and can be used to enhance colony growth. Bovine blood is appropriate to maintain G. brevipalpis colonies, however, feeding either bovine or porcine blood on alternating days did improve productivity. Adding the phagostimulants inosine tri-phosphate, cytosine mono-phosphate and guanosine mono-phosphate to the blood at a concentration of 10(-4) M improved pupae production of the G. brevipalpis colony. The addition of adenosine tri-phosphate and inosine tri-phosphate improved the performance of the G. austeni colony. Decisions on the most suitable rearing diet and feeding protocols will not only depend on the biological requirements of the species but also on the continuous supply of a suitable blood source that can be collected and processed in a cost-effective way.	[De Beer, Chantel J.; Venter, Gert J.] ARC OVI, Parasites Vectors & Vectorborne Dis, Pretoria, South Africa; [De Beer, Chantel J.] Univ Free State, Fac Nat & Agr Sci, Dept Zool & Entomol, Bloemfontein, South Africa; [Venter, Gert J.] Univ Pretoria, Fac Vet Sci, Dept Vet Trop Dis, ZA-0002 Pretoria, South Africa; [Vreysen, Marc J. B.] Insect Pest Control Lab, Joint FAO IAEA Div Nucl Tech Food & Agr, Bloemfontein, South Africa	University of the Free State; University of Pretoria	De Beer, CJ (corresponding author), ARC OVI, Parasites Vectors & Vectorborne Dis, Pretoria, South Africa.; De Beer, CJ (corresponding author), Univ Free State, Fac Nat & Agr Sci, Dept Zool & Entomol, Bloemfontein, South Africa.	debeerc@arc.agric.za		de Beer, Chantel/0000-0002-6244-4905	Agricultural Research Council-Onderstepoort Veterinary Institute [000773]; Joint Food and Agriculture Organization / International Atomic Energy Agency Division of Nuclear Techniques in Food and Agriculture Department of Technical Cooperation of the International Atomic Energy Agency [12618/R0/RBF, RAF 5069]	Agricultural Research Council-Onderstepoort Veterinary Institute; Joint Food and Agriculture Organization / International Atomic Energy Agency Division of Nuclear Techniques in Food and Agriculture Department of Technical Cooperation of the International Atomic Energy Agency	This work was supported by the National Assets (000773) at the Agricultural Research Council-Onderstepoort Veterinary Institute and the Joint Food and Agriculture Organization / International Atomic Energy Agency Division of Nuclear Techniques in Food and Agriculture under the coordinated research project (CRP) 12618/R0/RBF Department of Technical Cooperation of the International Atomic Energy Agency under project RAF 5069. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2003, GRAPHPAD INST VERS 3; Bagnall RJ, 1993, P 24 M SARCCUS STAND, P41; BAUER B, 1976, B ENTOMOL RES, V65, P563, DOI 10.1017/S0007485300006246; Bourtzis K, 2016, ACTA TROP, V157, P115, DOI 10.1016/j.actatropica.2016.01.009; Clausen PH, 1998, MED VET ENTOMOL, V12, P169, DOI 10.1046/j.1365-2915.1998.00097.x; de Beer CJ, 2016, ONDERSTEPOORT J VET, V83, DOI 10.4102/ojvr.v83i1.1172; De Beer CJ, 2012, IAEA TECDOC, P5; DEVI S G, 1985, Proceedings of the Indian National Science Academy Part B Biological Sciences, V51, P566; Du Toit R., 1954, Onderstepoort Journal of Veterinary Research, V26, P317; Feldmann U., 1994, TECHNIQUES INSECT RE, VSecond, P13; Feldmann U, 1994, TECHNIQUES INSECT RE, P449; Food and Agriculture Organization of the United Nations/International Atomic Energy Agency, 2006, FAO IAEA STAND OP PR; GALUN R, 1985, PHYSIOL ENTOMOL, V10, P145, DOI 10.1111/j.1365-3032.1985.tb00029.x; GALUN R, 1988, EXPERIENTIA, V44, P800, DOI 10.1007/BF01959172; GALUN R, 1987, INSECT SCI APPL, V8, P623, DOI 10.1017/S1742758400022700; GALUN R, 1988, PHYSIOL ENTOMOL, V13, P419, DOI 10.1111/j.1365-3032.1988.tb01125.x; GALUN R, 1993, J MED ENTOMOL, V30, P513, DOI 10.1093/jmedent/30.3.513; GALUN R, 1970, T ROY SOC TROP MED H, V64, P171, DOI 10.1016/0035-9203(70)90225-7; GEE JD, 1977, J INSECT PHYSIOL, V23, P137, DOI 10.1016/0022-1910(77)90119-6; Gooding R. H., 1997, The molecular biology of insect disease vectors: a methods manual., P41; KABAYO JP, 1986, J INSECT PHYSIOL, V32, P543, DOI 10.1016/0022-1910(86)90069-7; KABAYO JP, 1988, EXPERIENTIA, V44, P802, DOI 10.1007/BF01959174; Kappmeier Green K., 2002, THESIS; Klassen W, 2005, STERILE INSECT TECHNIQUE: PRINCIPLES AND PRACTICE IN AREA-WIDE INTEGRATED PEST MANAGEMENT, P3, DOI 10.1007/1-4020-4051-2_1; LANGLEY PA, 1972, B ENTOMOL RES, V62, P215, DOI 10.1017/S0007485300047672; Mamabolo MV, 2009, PARASITOLOGY, V136, P425, DOI 10.1017/S0031182009005587; MELLANBY HELEN, 1937, PARASITOLOGY, V29, P131, DOI 10.1017/S0031182000026263; MEWS AR, 1976, B ENTOMOL RES, V65, P631, DOI 10.1017/S0007485300006325; MOLOO SK, 1988, MED VET ENTOMOL, V2, P201, DOI 10.1111/j.1365-2915.1988.tb00074.x; MOLOO SK, 1993, INSECT SCI APPL, V14, P511, DOI 10.1017/S1742758400014211; Motloang M, 2012, ONDERSTEPOORT J VET, V79, DOI 10.4102/ojvr.v79i1.353; Motloang MY, 2014, ONDERSTEPOORT J VET, V81; Parker AG, 2005, STERILE INSECT TECHNIQUE: PRINCIPLES AND PRACTICE IN AREA-WIDE INTEGRATED PEST MANAGEMENT, P209, DOI 10.1007/1-4020-4051-2_8; Robinson AS, 2005, STERILE INSECT TECHNIQUE: PRINCIPLES AND PRACTICE IN AREA-WIDE INTEGRATED PEST MANAGEMENT, P95, DOI 10.1007/1-4020-4051-2_4; Romero A, 2014, J EXP BIOL, V217, P552, DOI 10.1242/jeb.096727; Snedecor GW, 1980, STAT METHODS, V7th; Tarimo C.S., 1988, P271; Vreysen M.J.B., 2007, AREA WIDE CONTROL IN, P308; VSN International, 2012, GENSTAT WINDOWS; WARD R A, 1970, Bulletin of the Entomological Society of America, V16, P111; WETZEL H, 1978, TROPENMED PARASITOL, V29, P239	41	7	7	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2016	11	12							e0168799	10.1371/journal.pone.0168799	http://dx.doi.org/10.1371/journal.pone.0168799			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI9QH	28006007	Green Submitted, Green Published, gold			2022-12-27	WOS:000392843200096
J	Lamprianou, S; Gysemans, C; Saab, JB; Pontes, H; Mathieu, C; Meda, P				Lamprianou, Smaragda; Gysemans, Conny; Saab, Joanna Bou; Pontes, Helena; Mathieu, Chantal; Meda, Paolo			Glibenclamide Prevents Diabetes in NOD Mice	PLoS One			English	Article							PANCREATIC BETA-CELLS; PERIPHERAL-TISSUES; BB RAT; MOUSE; APOPTOSIS; CHANNELS; RECEPTOR; SULFONYLUREAS; EXPRESSION; MANAGEMENT	Previous work has revealed that Cx36, the sole connexin expressed in the insulin-producing beta cells, enhances the secretion of insulin, and promotes the resistance of beta cells against pro-inflammatory cytokines. In parallel, the anti-diabetic sulphonylurea glibenclamide was shown to promote the assembly and function of Cx36 channels. Here, we assessed whether glibenclamide could protect the insulin-producing cells against conditions mimicking those expected at the onset of type 1 diabetes. We found that the drug 1) protected in vitro the mouse MIN6 cells from the apoptosis and loss of Cx36, which are induced by Th1 cytokines; 2) prevented the development of hyperglycemia as well as the loss of beta cells and Cx36, which rapidly develop with aging in untreated NOD mice; 3) modified the proportion of effector CD4(+) and CD8(+) T cells in pancreatic draining lymph nodes. The data imply that an early glibenclamide treatment may help protecting beta cells against the autoimmune attack, which triggers the development of type 1 diabetes.	[Lamprianou, Smaragda; Saab, Joanna Bou; Pontes, Helena; Meda, Paolo] Univ Geneva, Dept Cell Physiol & Metab, Geneva, Switzerland; [Gysemans, Conny; Mathieu, Chantal] Katholieke Univ Leuven KULEUVEN, Lab Clin & Expt Endocrinol, Leuven, Belgium	University of Geneva; KU Leuven	Lamprianou, S (corresponding author), Univ Geneva, Dept Cell Physiol & Metab, Geneva, Switzerland.	Smaragda.Lamprianou@unige.ch	mathieu, chantal/ABD-5505-2021	mathieu, chantal/0000-0002-4055-5233; gysemans, conny/0000-0003-3559-6089	Swiss National Science Foundation [310000-141162]; Juvenile Diabetes Research Foundation [40-2011-11]; European Union [IMIDIA C2008-T7]; KUL [GOA 2014/010]	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Juvenile Diabetes Research Foundation(Juvenile Diabetes Research Foundation); European Union(European Commission); KUL	The Geneva team was supported by grants from the Swiss National Science Foundation (310000-141162), the Juvenile Diabetes Research Foundation (40-2011-11), and the European Union (IMIDIA C2008-T7). The Leuven team is supported by a grant from the KUL (GOA 2014/010). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allagnat F, 2013, CELL DEATH DIFFER, V20, P1742, DOI 10.1038/cdd.2013.134; Ansar MM, 2006, NITRIC OXIDE-BIOL CH, V14, P39, DOI 10.1016/j.niox.2005.09.002; Ashcroft FM, 2013, NAT REV ENDOCRINOL, V9, P660, DOI 10.1038/nrendo.2013.166; Bavamian S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041535; Berggren EK, 2013, CLIN OBSTET GYNECOL, V56, P827, DOI 10.1097/GRF.0b013e3182a8e0a5; Bromley SK, 2005, NAT IMMUNOL, V6, P895, DOI 10.1038/ni1240; Chahal A, 2011, COMP SAFETY EFFICACY; Charpantier E, 2007, DIABETOLOGIA, V50, P2332, DOI 10.1007/s00125-007-0807-9; Cigliola V, 2013, DIABETES RES CLIN PR, V99, P250, DOI 10.1016/j.diabres.2012.10.016; David R, 2009, BLOOD, V113, P3696, DOI 10.1182/blood-2008-09-176511; Debes GF, 2005, NAT IMMUNOL, V6, P889, DOI 10.1038/ni1238; Eizirik DL, 2009, NAT REV ENDOCRINOL, V5, P219, DOI 10.1038/nrendo.2009.21; Grishman EK, 2012, PEDIATR RES, V71, P626, DOI 10.1038/pr.2012.24; HOSSZUFALUSI N, 1994, J AUTOIMMUN, V7, P753, DOI 10.1006/jaut.1994.1059; Jayasimhan A, 2014, CLIN SCI, V126, P1, DOI 10.1042/CS20120627; Jorns A, 2014, DIABETOLOGIA, V57, P512, DOI 10.1007/s00125-013-3125-4; Klee P, 2011, J CLIN INVEST, V121, P4870, DOI 10.1172/JCI40509; Koh GCKW, 2011, CLIN INFECT DIS, V52, P717, DOI 10.1093/cid/ciq192; Kwon MJ, 2013, KOREAN J INTERN MED, V28, P339, DOI 10.3904/kjim.2013.28.3.339; Larsson HE, 2014, PEDIATR DIABETES, V15, P118, DOI 10.1111/pedi.12066; MEDA P, 1979, J CELL BIOL, V82, P441, DOI 10.1083/jcb.82.2.441; MEDA P, 1980, SCIENCE, V209, P1026, DOI 10.1126/science.6773144; Radenkovic M, 2016, CLIN EXP IMMUNOL, V186, P46, DOI 10.1111/cei.12834; Regnell SE, 2013, DIABETIC MED, V30, P155, DOI 10.1111/dme.12099; Rendell M, 2004, DRUGS, V64, P1339, DOI 10.2165/00003495-200464120-00006; Sawada F, 2008, METABOLISM, V57, P1038, DOI 10.1016/j.metabol.2008.01.038; Serre-Beinier V, 2009, HUM MOL GENET, V18, P428, DOI 10.1093/hmg/ddn370; TOCHINO Y, 1988, CRIT REV IMMUNOL, V8, P49; WILLIAMS AJK, 1993, DIABETOLOGIA, V36, P487, DOI 10.1007/BF02743262; Yu JY, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7074	30	15	15	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2016	11	12							e0168839	10.1371/journal.pone.0168839	http://dx.doi.org/10.1371/journal.pone.0168839			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI9QH	28006000	Green Submitted, gold, Green Published			2022-12-27	WOS:000392843200101
J	Sun, Y; Huang, Y; Hu, GJ; Zhang, XH; Ruan, ZQ; Zhao, XM; Guo, CY; Tang, ZJ; Li, XF; You, XX; Lin, HR; Zhang, Y; Shi, Q				Sun, Ying; Huang, Yu; Hu, Guojun; Zhang, Xinhui; Ruan, Zhiqiang; Zhao, Xiaomeng; Guo, Chuanyu; Tang, Zhujing; Li, Xiaofeng; You, Xinxin; Lin, Haoran; Zhang, Yong; Shi, Qiong			Comparative Transcriptomic Study of Muscle Provides New Insights into the Growth Superiority of a Novel Grouper Hybrid	PLOS ONE			English	Article							SKELETAL-MUSCLE; TROPONIN-C; SIGNAL-TRANSDUCTION; MUSCULAR-DYSTROPHY; CANCER METABOLISM; FIBER GROWTH; GLYCOLYSIS; PROTEIN; GLUCONEOGENESIS; HYBRIDIZATION	Grouper (Epinephelus spp.) is a group of fish species with great economic importance in Asian countries. A novel hybrid grouper, generated by us and called the Hulong grouper (Hyb), has better growth performance than its parents, E. fuscoguttatus (Efu, female) and E. lanceolatus (Ela, male). We previously reported that the GH/IGF (growth hormone/insulin-like growth factor) system in the brain and liver contributed to the superior growth of the Hyb. In this study, using transcriptome sequencing (RNA-seq) and quantitative real-time PCR (qRT-PCR), we analyzed RNA expression levels of comprehensive genes in the muscle of the hybrid and its parents. Our data showed that genes involved in glycolysis and calcium signaling in addition to troponins are up-regulated in the Hyb. The results suggested that the activity of the upstream GH/IGF system in the brain and liver, along with the up-regulated glycolytic genes as well as ryanodine receptors (RyRs) and troponins related to the calcium signaling pathway in muscle, led to enhanced growth in the hybrid grouper. Muscle contraction inducing growth could be the major contributor to the growth superiority in our novel hybrid grouper, which may be a common mechanism for hybrid superiority in fishes.	[Sun, Ying; Tang, Zhujing; Lin, Haoran; Zhang, Yong] Sun Yat Sen Univ, Inst Aquat Econ Anim, State Key Lab Biocontrol, Sch Life Sci, Guangzhou, Guangdong, Peoples R China; [Sun, Ying; Tang, Zhujing; Lin, Haoran; Zhang, Yong] Sun Yat Sen Univ, Guangdong Prov Key Lab Aquat Econ Anim, Sch Life Sci, Guangzhou, Guangdong, Peoples R China; [Sun, Ying; Huang, Yu; Hu, Guojun; Zhang, Xinhui; Ruan, Zhiqiang; Zhao, Xiaomeng; Guo, Chuanyu; Li, Xiaofeng; You, Xinxin; Shi, Qiong] BGI, Shenzhen Key Lab Marine Genom, Guangdong Prov Key Lab Mol Breeding Marine Econ A, Shenzhen, Peoples R China; [Shi, Qiong] Shenzhen Univ, Sch Life Sci & Oceanog, Ctr Marine Res, Shenzhen, Peoples R China	Sun Yat Sen University; Sun Yat Sen University; Beijing Genomics Institute (BGI); Shenzhen University	Lin, HR; Zhang, Y (corresponding author), Sun Yat Sen Univ, Inst Aquat Econ Anim, State Key Lab Biocontrol, Sch Life Sci, Guangzhou, Guangdong, Peoples R China.; Lin, HR; Zhang, Y (corresponding author), Sun Yat Sen Univ, Guangdong Prov Key Lab Aquat Econ Anim, Sch Life Sci, Guangzhou, Guangdong, Peoples R China.; Shi, Q (corresponding author), BGI, Shenzhen Key Lab Marine Genom, Guangdong Prov Key Lab Mol Breeding Marine Econ A, Shenzhen, Peoples R China.; Shi, Q (corresponding author), Shenzhen Univ, Sch Life Sci & Oceanog, Ctr Marine Res, Shenzhen, Peoples R China.	lsslhr@mail.sysu.edu.cn; lsszy@mail.sysu.edu.cn; shiqiong@genomics.cn	You, Xinxin/AAL-2095-2020; Huang, Lily/GNH-2128-2022; li, xiao/GSN-6181-2022; li, xiaofeng/GXF-9442-2022; Guo, Chuanyu/AAB-8369-2020; lin, haoran/GXH-3030-2022	Huang, Yu/0000-0002-3875-7581	BGI-Shenzhen; Natural Science Foundation of China [31370047]; Special Project on the Integration of Industry, Education and Research of Guangdong Province [2013B090800017]; Shenzhen Special Program for Future Industrial Development [JSGG20141020113728803]; Shenzhen Dapeng Special Program for Industrial Development [KY20160102]; Special Fund for State Oceanic Administration Scientific Research in the Public Interest [201305018]	BGI-Shenzhen; Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Special Project on the Integration of Industry, Education and Research of Guangdong Province; Shenzhen Special Program for Future Industrial Development; Shenzhen Dapeng Special Program for Industrial Development; Special Fund for State Oceanic Administration Scientific Research in the Public Interest	BGI-Shenzhen provided support in the form of salaries for authors YS, YH, GH, X. Zhang, ZR, X. Zhao, CG, XL, XY and QS but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section. Our work was financially supported by Natural Science Foundation of China (No.31370047), Special Project on the Integration of Industry, Education and Research of Guangdong Province (No. 2013B090800017), Shenzhen Special Program for Future Industrial Development (No. JSGG20141020113728803), Shenzhen Dapeng Special Program for Industrial Development (No. KY20160102), and Special Fund for State Oceanic Administration Scientific Research in the Public Interest (No. 201305018).	Abdi H., 2007, ENCY MEAS STAT, P103; BAANANTE IV, 1991, COMP BIOCHEM PHYS B, V100, P11, DOI 10.1016/0305-0491(91)90077-Q; Baar K, 1999, AM J PHYSIOL-CELL PH, V276, pC120, DOI 10.1152/ajpcell.1999.276.1.C120; Berchtold MW, 2000, PHYSIOL REV, V80, P1215, DOI 10.1152/physrev.2000.80.3.1215; Boyle EI, 2004, BIOINFORMATICS, V20, P3710, DOI 10.1093/bioinformatics/bth456; Brennan C, 2005, J CELL SCI, V118, P5181, DOI 10.1242/jcs.02625; Carracedo A, 2013, NAT REV CANCER, V13, P227, DOI 10.1038/nrc3483; [陈超 Chen Chao], 2014, [渔业科学进展, Progress in Fishery Sciences], V35, P135; Chen SA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015633; Clapham DE, 2007, CELL, V131, P1047, DOI 10.1016/j.cell.2007.11.028; Cohen GN, 2016, MICROBIAL BIOCH, P107; Coley W, 2012, ARTHRITIS RHEUM-US, V64, P3750, DOI 10.1002/art.34625; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; CORONADO R, 1994, AM J PHYSIOL, V266, pC1485, DOI 10.1152/ajpcell.1994.266.6.C1485; DIAMANT YZ, 1978, DIABETOLOGIA, V15, P481, DOI 10.1007/BF02342874; FARAH CS, 1995, FASEB J, V9, P755, DOI 10.1096/fasebj.9.9.7601340; Ferrante MI, 2011, J CELL SCI, V124, P565, DOI 10.1242/jcs.071274; Filatov VL, 1999, BIOCHEMISTRY-MOSCOW+, V64, P969; Flight RM, 2009, BRIEF BIOINFORM, V10, P289, DOI 10.1093/bib/bbn054; FOTHERGILLGILMORE LA, 1993, PROG BIOPHYS MOL BIO, V59, P105, DOI 10.1016/0079-6107(93)90001-Z; Fuentes EN, 2013, GEN COMP ENDOCR, V192, P136, DOI 10.1016/j.ygcen.2013.06.009; Garcia M, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000615; Glamuzina B, 1999, AQUAC RES, V30, P625, DOI 10.1046/j.1365-2109.1999.00365.x; Glamuzina B, 2001, AQUACULTURE, V198, P55, DOI 10.1016/S0044-8486(00)00511-1; Godfrey R, 2016, NAT REV NEUROL, V12, P393, DOI 10.1038/nrneurol.2016.75; Gomes AV, 2002, IUBMB LIFE, V54, P323, DOI 10.1080/15216540216037; Gordon AM, 2000, PHYSIOL REV, V80, P853, DOI 10.1152/physrev.2000.80.2.853; Grabarek Z, 2011, BBA-MOL CELL RES, V1813, P913, DOI 10.1016/j.bbamcr.2011.01.017; GREINER EF, 1994, J BIOL CHEM, V269, P31484; Guo CY, 2015, J FISH DIS, V38, P175, DOI 10.1111/jfd.12221; HERZBERG O, 1985, NATURE, V313, P653, DOI 10.1038/313653a0; Herzberg O, 1985, CIBA F SYMP, V122, P120; Hopperton KE, 2014, EXP CELL RES, V320, P302, DOI 10.1016/j.yexcr.2013.10.016; Izumiya Y, 2008, CELL METAB, V7, P159, DOI 10.1016/j.cmet.2007.11.003; James C. M., 1999, ICLARM Q, V22, P19; Jurynec MJ, 2008, P NATL ACAD SCI USA, V105, P12485, DOI 10.1073/pnas.0806015105; Kalavacharla V, 2011, BMC PLANT BIOL, V11, DOI 10.1186/1471-2229-11-135; Kiriyakit A, 2011, AQUACULTURE, V320, P106, DOI 10.1016/j.aquaculture.2011.05.012; LEE SH, 1979, J BIOL CHEM, V254, P420; Lehman W, 2009, J MOL BIOL, V388, P673, DOI 10.1016/j.jmb.2009.03.060; Li AY, 2011, J MOL BIOL, V413, P699, DOI 10.1016/j.jmb.2011.08.049; [刘付永忠 LIUFU Yongzhong], 2007, [中山大学学报. 自然科学版, Acta Scientiarum Naturalium Universitatis Sunyatseni], V46, P72; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lodi R, 1999, BRAIN, V122, P121, DOI 10.1093/brain/122.1.121; Luo RB, 2012, GIGASCIENCE, V1, DOI 10.1186/2047-217X-1-18; Noguchi R, 2013, MOL SYST BIOL, V9, DOI 10.1038/msb.2013.19; Panchal AR, 2001, AM J PHYSIOL-HEART C, V281, pH1613, DOI 10.1152/ajpheart.2001.281.4.H1613; Parker KC, 2009, MUSCLE NERVE, V39, P739, DOI 10.1002/mus.21230; Pierre S, 2008, AQUAT CONSERV, V18, P297, DOI 10.1002/aqc.840; Polyakov AA, 1997, BIOCHEM J, V321, P873, DOI 10.1042/bj3210873; PROBST I, 1985, EUR J BIOCHEM, V153, P347, DOI 10.1111/j.1432-1033.1985.tb09309.x; Protasi F, 1998, J CELL BIOL, V140, P831, DOI 10.1083/jcb.140.4.831; Rehfeldt C, 2000, LIVEST PROD SCI, V66, P177, DOI 10.1016/S0301-6226(00)00225-6; Risson V, 2009, J CELL BIOL, V187, P859, DOI 10.1083/jcb.200903131; ROWE RWD, 1969, J ANAT, V104, P519; Sehnert AJ, 2002, NAT GENET, V31, P106, DOI 10.1038/ng875; Senoo S., 2006, AQUANET MAGAZINE, V12, P58; SERVIDEI S, 1986, NEUROLOGY, V36, P1465, DOI 10.1212/WNL.36.11.1465; Sharma N, 2005, J PHYSIOL-LONDON, V562, P593, DOI 10.1113/jphysiol.2004.075713; Sharma U, 2003, MAGN RESON IMAGING, V21, P145, DOI 10.1016/S0730-725X(02)00646-X; Short KR, 2008, J CLIN ENDOCR METAB, V93, P597, DOI 10.1210/jc.2007-1814; Sogah VM, 2010, DEV DYNAM, V239, P3115, DOI 10.1002/dvdy.22445; Sotiropoulos A, 2006, P NATL ACAD SCI USA, V103, P7315, DOI 10.1073/pnas.0510033103; STICKLAND NC, 1983, J ANAT, V137, P323; Tidball JG, 2005, J APPL PHYSIOL, V98, P1900, DOI 10.1152/japplphysiol.01178.2004; TIMSON BF, 1990, J ANAT, V173, P33; Tixier V, 2013, P NATL ACAD SCI USA, V110, P18982, DOI 10.1073/pnas.1301262110; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; TSENG WY, 1983, AQUACULTURE, V34, P177, DOI 10.1016/0044-8486(83)90302-2; Wang Yan, 2014, Journal of Fisheries of China, V38, P778; WEATHERLEY AH, 1988, J FISH BIOL, V33, P851, DOI 10.1111/j.1095-8649.1988.tb05532.x; WEATHERLEY AH, 1985, EXPERIENTIA, V41, P353, DOI 10.1007/BF02004500; Xue R, 2016, EURASIP J WIREL COMM, P1, DOI 10.1186/s13638-016-0562-z; Yamaguchi F, 2012, J BIOL CHEM, V287, P13787, DOI 10.1074/jbc.M111.329771; [于欢欢 Yu Huanhuan], 2015, [中国水产科学, Journal of Fishery Sciences of China], V22, P968; Zhou H., 2011, THESIS, P1	76	28	29	2	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2016	11	12							e0168802	10.1371/journal.pone.0168802	http://dx.doi.org/10.1371/journal.pone.0168802			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI9QH	28005961	Green Submitted, gold, Green Published			2022-12-27	WOS:000392843200097
J	Yabuta, S; Urata, M; Kun, RYW; Masaki, M; Shidoji, Y				Yabuta, Suemi; Urata, Masanori; Kun, Roseline Yap Wai; Masaki, Motofumi; Shidoji, Yoshihiro			Common SNP rs6564851 in the BCO1 Gene Affects the Circulating Levels of beta-Carotene and the Daily Intake of Carotenoids in Healthy Japanese Women	PLoS One			English	Article							VITAMIN-A PRODUCTION; PLASMA CAROTENOIDS; ALPHA-TOCOPHEROL; SERUM; ASSOCIATIONS; BIOMARKERS; RETINOL; CANCER; POLYMORPHISMS; METABOLISM	The circulating levels of beta-carotene are modulated not only by sex, but also by autosomal gene variations and fruit intake. The aim of this study was to investigate the interactions between beta-carotene metabolism-related gene single nucleotide polymorphisms (SNPs; genetic factors) and nutrient intake (environmental factors) relating to their effects on circulating beta-carotene. The serum concentrations of beta-carotene and the habitual food intake of 92 healthy Japanese adults were examined. All subjects were genotyped for three common SNPs: rs6564851 in the beta-carotene 15,15'-oxygenase 1 (BCO1) gene, rs2278986 in the scavenger receptor class B member 1 (SCARB1) gene and rs362090 in the intestine-specific homeobox (ISX) gene. Univariate analysis revealed that the circulating beta-carotene levels were significantly higher in rs6564851 GG homozygotes (p = 0.003). Additionally, the daily intake of beta-cryptoxanthin was positively associated with the circulating beta-carotene levels in female GG homozygotes of rs6564851 (p = 0.023), and the daily intake of alpha- and beta-carotenes, and beta-cryptoxanthin was significantly lower in female rs6564851 T allele carries than in female GG homozygotes (p = 0.009, 0.008, 0.009, respectively). The present study apparently indicates that higher circulating beta-carotene levels in female rs6564851 GG homozygotes depend on carotenoid intake.	[Yabuta, Suemi; Urata, Masanori; Shidoji, Yoshihiro] Nagasaki Univ, Grad Sch Human Hlth Sci, Mol & Cellular Biol, Nagasaki, Japan; [Kun, Roseline Yap Wai; Masaki, Motofumi] Nagasaki Univ, Grad Sch Human Hlth Sci, Nutr Epidemiol, Nagasaki, Japan	Nagasaki University; Nagasaki University	Shidoji, Y (corresponding author), Nagasaki Univ, Grad Sch Human Hlth Sci, Mol & Cellular Biol, Nagasaki, Japan.	shidoji@sun.ac.jp			University of Nagasaki [B-3]	University of Nagasaki	YS received a research grant B-3 from the University of Nagasaki (sun.ac.jp). The funder had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Delaimy WK, 2005, EUR J CLIN NUTR, V59, P1397, DOI 10.1038/sj.ejcn.1602253; Al-Delaimy WK, 2005, EUR J CLIN NUTR, V59, P1387, DOI 10.1038/sj.ejcn.1602252; Amengual J, 2013, J BIOL CHEM, V288, P34081, DOI 10.1074/jbc.M113.501049; Brady WE, 1996, J NUTR, V126, P129, DOI 10.1093/jn/126.1.129; Burri BJ, 2015, J SCI FOOD AGR, V95, P1786, DOI 10.1002/jsfa.6942; CAMPBELL DR, 1994, CANCER EPIDEM BIOMAR, V3, P493; CUTLER RG, 1984, P NATL ACAD SCI-BIOL, V81, P7627, DOI 10.1073/pnas.81.23.7627; de Araujo IE, 2008, NEURON, V57, P930, DOI 10.1016/j.neuron.2008.01.032; dela Sena C, 2013, J BIOL CHEM, V288, P37094, DOI 10.1074/jbc.M113.507160; Feigl B, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089069; Ferrucci L, 2009, AM J HUM GENET, V84, P123, DOI 10.1016/j.ajhg.2008.12.019; Ford ES, 2003, EUR J CLIN NUTR, V57, P1157, DOI 10.1038/sj.ejcn.1601667; Gruber M, 2004, J NUTR, V134, P2387, DOI 10.1093/jn/134.9.2387; Higuchi K, 2015, NUTRITION, V31, P975, DOI 10.1016/j.nut.2015.02.015; Jansen MCJF, 2004, EUR J CLIN NUTR, V58, P1386, DOI 10.1038/sj.ejcn.1601981; Kolodziejczyk JK, 2012, WOMEN HEALTH, V52, P731, DOI 10.1080/03630242.2012.728189; Kritchevsky SB, 2000, AM J EPIDEMIOL, V152, P1065, DOI 10.1093/aje/152.11.1065; Leung WC, 2009, FASEB J, V23, P1041, DOI 10.1096/fj.08-121962; Lietz G, 2012, J NUTR, V142, p161S, DOI 10.3945/jn.111.140756; Lobo GP, 2013, J BIOL CHEM, V288, P9017, DOI 10.1074/jbc.M112.444240; Lobo GP, 2010, FASEB J, V24, P1656, DOI 10.1096/fj.09-150995; PARKER RS, 1989, J NUTR, V119, P101, DOI 10.1093/jn/119.1.101; Ryden M, 2012, J INTERN MED, V272, P371, DOI [10.1111/j.1365-2796.2012.2534.x, 10.1111/j.1365-2796.2012.2534x.x]; Sclafani A, 2012, AM J PHYSIOL-REG I, V302, pR1119, DOI 10.1152/ajpregu.00038.2012; Siegel EM, 2004, CANCER EPIDEM BIOMAR, V13, P1693; Takahashi K., 2001, Japanese Journal of Nutrition, V59, P221; TANGNEY CC, 1987, AM J CLIN NUTR, V45, P764, DOI 10.1093/ajcn/45.4.764; Wang L, 2008, AM J CLIN NUTR, V88, P747, DOI 10.1093/ajcn/88.3.747; West M, 2009, J CLIN ENDOCR METAB, V94, P1451, DOI 10.1210/jc.2008-1223; Widjaja-Adhi MAK, 2015, HUM MOL GENET, V24, P3206, DOI 10.1093/hmg/ddv072; Xiang J, 2008, ASIAN PAC J CANCER P, V9, P413; Yabuta S, 2016, J NUTR HEALTH AGING, V20, P267, DOI 10.1007/s12603-015-0577-x	32	21	22	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2016	11	12							e0168857	10.1371/journal.pone.0168857	http://dx.doi.org/10.1371/journal.pone.0168857			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI9QH	28005968	gold, Green Submitted, Green Published			2022-12-27	WOS:000392843200106
J	Hetland, G; Eide, DM; Tangen, JM; Haugen, MH; Mirlashari, MR; Paulsen, JE				Hetland, Geir; Eide, Dag M.; Tangen, Jon M.; Haugen, Mads H.; Mirlashari, Mohammad R.; Paulsen, Jan E.			The Agaricus blazei-Based Mushroom Extract, Andosan (TM), Protects against Intestinal Tumorigenesis in the A/J Min/ plus Mouse	PLOS ONE			English	Article							TUMOR-ASSOCIATED MACROPHAGES; BLOOD EX-VIVO; MEDICINAL MUSHROOM; COLORECTAL-CANCER; LEGUMAIN EXPRESSION; ANTITUMOR-ACTIVITY; GRIFOLA-FRONDOSA; FRUITING BODIES; GENE-EXPRESSION; BREAST-CANCER	Background The novel A/J Min/+ mouse, which is a model for human Familial Adenomatous Polyposis (FAP), develops spontaneously multiple adenocarcinomas in the colon as well as in the small intestine. Agaricus blazei Murill (AbM) is an edible Basidiomycetes mushroom that has been used in traditional medicine against cancer and other diseases. The mushroom contains immunomodulating 8-glucans and is shown to have antitumor effects in murine cancer models. Andosan (TM) is a water extract based on AbM (82%), but it also contains the medicinal Basidiomycetes mushrooms Hericeum erinaceus and Grifola frondosa. Methods and findings Tap water with 10% Andosan (TM) was provided as the only drinking water for 15 or 22 weeks to AM Min/+ mice and A/J wild-type mice (one single-nucleotide polymorphism (SNP) difference), which then were exsanguinated and their intestines preserved in formaldehyde and the serum frozen. The intestines were examined blindly by microscopy and also stained for the tumor-associated protease, legumain. Serum cytokines (pro- and anti-inflammatory, Th1-, Th2 -and Th17 type) were measured by Luminex multiplex analysis. Andosan (TM) treated AM Min/+ mice had a significantly lower number of adenocarcinomas in the intestines, as well as a 60% significantly reduced intestinal tumor load (number of tumors x size) compared to control. There was also reduced legumain expression in intestines from Andosan (TM) treated animals. Moreover, Andosan (TM) had a significant cytotoxic effect correlating with apoptosis on the human cancer colon cell line, Caco-2, in vitro. When examining serum from both AM Min/+ and wild type mice, there was a significant increase in anti-tumor Th1 type and pro-inflammatory cytokines in the Andosan (TM) treated mice. Conclusions The results from this mouse model for colorectal cancer shows significant protection of orally administered Andosan (TM) against development of intestinal cancer. This is supported by the finding of less legumain in intestines of Andosan (TM) treated mice and increased systemic Th1 cytokine response. The mechanism is probably both immuno-modulatory and growth inhibition of tumor cells by induction of apoptosis.	[Hetland, Geir; Mirlashari, Mohammad R.] Oslo Univ Hosp, Dept Immunol, Oslo, Norway; [Hetland, Geir; Tangen, Jon M.] Univ Oslo, Inst Clin Med, Oslo, Norway; [Eide, Dag M.] Norwegian Inst Publ Hlth, Dept Chem & Radiat, Oslo, Norway; [Tangen, Jon M.] Oslo Univ Hosp, Dept Acute Med, Oslo, Norway; [Tangen, Jon M.] Oslo Univ Hosp, Natl CBRNE Med & Advisory Ctr Norway, Oslo, Norway; [Haugen, Mads H.] Norwegian Radium Hosp, Oslo Univ Hosp, Dept Tumor Biol, Inst Canc Res, Oslo, Norway; [Paulsen, Jan E.] Norwegian Univ Life Sci, Dept Food Safety & Infect Biol, Oslo, Norway	University of Oslo; University of Oslo; Norwegian Institute of Public Health (NIPH); University of Oslo; University of Oslo; University of Oslo; Norwegian University of Life Sciences	Hetland, G (corresponding author), Oslo Univ Hosp, Dept Immunol, Oslo, Norway.; Hetland, G (corresponding author), Univ Oslo, Inst Clin Med, Oslo, Norway.	geir.hetland@medisin.uio.no			Norwegian company Immunopharma	Norwegian company Immunopharma	The authors received no specific funding for this work, except for Andosan (TM) that was provided free of charge for the study from the Norwegian company Immunopharma.	Bernardshaw S, 2006, SHOCK, V25, P420, DOI 10.1097/01.shk.0000209526.58614.92; Bernardshaw S, 2007, APMIS, V115, P719, DOI 10.1111/j.1600-0463.2007.apm_619.x; Berven L, 2015, J MED FOOD, V18, P429, DOI 10.1089/jmf.2014.0018; Chan CB, 2009, P NATL ACAD SCI USA, V106, P468, DOI 10.1073/pnas.0809824105; De Jesus M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091002; Ellertsen Linda K, 2009, Clin Mol Allergy, V7, P6, DOI 10.1186/1476-7961-7-6; Ellertsen LK, 2006, INT IMMUNOPHARMACOL, V6, P133, DOI 10.1016/j.intimp.2005.07.007; Fearnhead NS, 2001, HUM MOL GENET, V10, P721, DOI 10.1093/hmg/10.7.721; Fodde R, 2002, EUR J CANCER, V38, P867, DOI 10.1016/S0959-8049(02)00040-0; Fodde R, 2001, TRENDS MOL MED, V7, P369, DOI 10.1016/S1471-4914(01)02050-0; Forland DT, 2011, SCAND J IMMUNOL, V73, P66, DOI 10.1111/j.1365-3083.2010.02477.x; Forland DT, 2010, CYTOKINE, V49, P245, DOI 10.1016/j.cyto.2009.09.002; Gao L, 2007, BRAZ J MED BIOL RES, V40, P1545, DOI 10.1590/S0100-879X2007001100015; Gatner BN, 2003, J EXP MED, V197, P1107, DOI [10.1084/jem.20021787, DOI 10.1084/JEM.20021787]; Gawenda J, 2007, BREAST CANCER RES TR, V102, P1, DOI 10.1007/s10549-006-9311-z; Grinde B, 2006, INT IMMUNOPHARMACOL, V6, P1311, DOI 10.1016/j.intimp.2006.04.005; Half E, 2009, ORPHANET J RARE DIS, V4, DOI 10.1186/1750-1172-4-22; Haugen MH, 2015, EUR J CANCER, V51, P9, DOI 10.1016/j.ejca.2014.10.020; Hetland G, 2008, SCAND J IMMUNOL, V68, P363, DOI 10.1111/j.1365-3083.2008.02156.x; Hetland G, 2011, ADV PHARMACOL SCI, V2011, DOI 10.1155/2011/157015; Holson RR, 2008, NEUROTOXICOL TERATOL, V30, P326, DOI 10.1016/j.ntt.2007.06.001; Hopkins MH, 2012, BIOMARK INSIGHTS, V7, P143, DOI 10.4137/BMI.S10092; IKUZAWA M, 1988, INT J IMMUNOPHARMACO, V10, P415; ITOH H, 1994, JPN J PHARMACOL, V66, P265, DOI 10.1254/jjp.66.265; Johnson E, 2009, SCAND J IMMUNOL, V69, P242, DOI 10.1111/j.1365-3083.2008.02218.x; KAWAGISHI H, 1989, CARBOHYD RES, V186, P267, DOI 10.1016/0008-6215(89)84040-6; Kerrigan RW, 2005, MYCOLOGIA, V97, P12, DOI 10.3852/mycologia.97.1.12; Kim SP, 2013, J AGR FOOD CHEM, V61, P4898, DOI 10.1021/jf400916c; Lin YY, 2013, CANCER SCI, V104, P1217, DOI 10.1111/cas.12202; Liu C, 2003, CANCER RES, V63, P2957; Liu Y, 2012, MOL PHARMACEUT, V9, P168, DOI 10.1021/mp200434n; Luo YP, 2006, J CLIN INVEST, V116, P2132, DOI 10.1172/JCI27648; Masuda Y, 2013, INT J CANCER, V133, P108, DOI 10.1002/ijc.27999; Metzler-Zebeli BU, 2011, FEMS MICROBIOL ECOL, V75, P402, DOI 10.1111/j.1574-6941.2010.01017.x; Miller G, 2011, FASEB J, V25, P1606, DOI 10.1096/fj.10-172312; Morita Y, 2007, FEBS LETT, V581, P1417, DOI 10.1016/j.febslet.2007.02.064; Murthy RV, 2005, CLIN CANCER RES, V11, P2293, DOI 10.1158/1078-0432.CCR-04-1642; Paulsen JE, 1997, CARCINOGENESIS, V18, P1905, DOI 10.1093/carcin/18.10.1905; Paulsen JE, 2000, TOXICOL LETT, V112, P403, DOI 10.1016/S0378-4274(99)00262-3; Pinheiro F, 2003, FOOD CHEM TOXICOL, V41, P1543, DOI 10.1016/S0278-6915(03)00171-6; Sodring M, 2016, INT J CANCER, V138, P1936, DOI 10.1002/ijc.29928; Sorimachi K, 2001, CELL STRUCT FUNCT, V26, P103, DOI 10.1247/csf.26.103; SU LK, 1992, SCIENCE, V256, P668, DOI 10.1126/science.1350108; SUZUKI I, 1984, J PHARMACOBIO-DYNAM, V7, P492; Takaku T, 2001, J NUTR, V131, P1409, DOI 10.1093/jn/131.5.1409; Takimoto H, 2008, IMMUNOPHARM IMMUNOT, V30, P747, DOI [10.1080/08923970802279092, 10.1080/08923970802279092 ]; Tangen J. M., 2014, APPL SCI REPORTS, V1, P1, DOI DOI 10.7243/2054-9903-1-1; Tangen JM, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/718539; Therkelsen SP, 2016, PLOS ONE; van Es JH, 2001, EXP CELL RES, V264, P126, DOI 10.1006/excr.2000.5142; Vetvicka V, 1996, J CLIN INVEST, V98, P50, DOI 10.1172/JCI118777; Yoo JY, 2016, NUTRIENTS, V8, DOI 10.3390/nu8030173; Ziliotto L, 2009, NUTR CANCER, V61, P245, DOI 10.1080/01635580802395717	53	7	8	2	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2016	11	12							e0167754	10.1371/journal.pone.0167754	http://dx.doi.org/10.1371/journal.pone.0167754			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI9TW	28002446	Green Published, Green Accepted, gold			2022-12-27	WOS:000392853100021
J	Jiao, CC; Cui, LH; Ma, AG; Li, N; Si, HZ				Jiao, Congcong; Cui, Lianhua; Ma, Aiguo; Li, Na; Si, Hongzong			Elevated Serum Levels of Retinol-Binding Protein 4 Are Associated with Breast Cancer Risk: A Case-Control Study	PLOS ONE			English	Article							INSULIN-RESISTANCE; METABOLIC SYNDROME; PLASMA ADIPONECTIN; PREDICTIVE-VALUE; PROSTATE-CANCER; FATTY LIVER; WEIGHT-LOSS; OBESITY; ADIPOKINES; RETINOL-BINDING-PROTEIN-4	Background Retinol binding protein 4 (RBP4) is a recently identified adipokine that is elevated in patients with obesity or type 2 diabetes. A growing body of research has shown that RBP4 is associated with several types of cancer. However, no studies have investigated the relationship between serum RBP4 levels and breast cancer risk. We performed a case-control study to evaluate the association between serum RBP4 levels and the risk of breast cancer. Methods From August 2012 to December 2013, four-hundred subjects including 200 patients diagnosed with primary breast cancer and 200 matched healthy women were consecutively enrolled from Affiliated Hospital of Qingdao University Medical College. Blood samples were collected from healthy controls and breast cancer patients before commencement of treatment. Enzyme-linked immunosorbent assay was used to evaluate the serum RBP4 levels in separated serum samples. Meanwhile, the characteristics of breast cancer cases and controls were collected from medical records and pathological data. Results The serum levels of RBP4 were significantly higher in patients with breast cancer than that in the healthy control group (33.77 9.92 vs. 28.77 6.47pg/ml, P < 0.05). Compared to the subjects in the lowest quartile of serum RBP4 level, the adjusted ORs (95% Cls) is 2.16 (1.01-4.61) and 2.07 (1.07-4.00) for women in the second and highest RBP4 tertile, respectively. For breast cancer patients, patients with PR or ER negative displayed significantly higher serum RBP4 levels than those with PR or ER positive. Conclusion Our results for the first time suggested serum RBP4 levels could be associated with the risk of breast cancer. However, further prospective studies are essential to confirm these observed results.	[Jiao, Congcong; Cui, Lianhua; Ma, Aiguo; Li, Na; Si, Hongzong] Qingdao Univ, Coll Med, Dept Publ Hlth, Qingdao, Shandong, Peoples R China	Qingdao University	Cui, LH (corresponding author), Qingdao Univ, Coll Med, Dept Publ Hlth, Qingdao, Shandong, Peoples R China.	lianhuacui520@hanmail.net			Chinese Nutrition Society Research Fund - DSM Specialized Research Fund	Chinese Nutrition Society Research Fund - DSM Specialized Research Fund	This work was supported by 2014 the Chinese Nutrition Society Research Fund - DSM Specialized Research Fund.	Abola MV, 2015, ENDOCR-RELAT CANCER, V22, pL1, DOI 10.1530/ERC-14-0429; Abulaizi Mayinuer, 2011, Int J Proteomics, V2011, P628787, DOI 10.1155/2011/628787; Aliustaoglu M, 2010, MED ONCOL, V27, P388, DOI 10.1007/s12032-009-9222-z; Alsheikh-Ali AA, 2008, J AM COLL CARDIOL, V52, P1141, DOI 10.1016/j.jacc.2008.06.037; Amadou A, 2013, OBES REV, V14, P665, DOI 10.1111/obr.12028; Assiri AMA, 2016, OBES RES CLIN PRACT, V10, P442, DOI 10.1016/j.orcp.2015.08.017; Berry DC, 2014, CANCER RES, V74, P6341, DOI 10.1158/0008-5472.CAN-14-1052; Bluher M, 2014, MOL METAB, V3, P230, DOI 10.1016/j.molmet.2014.01.005; Boyle P, 2013, EUR J NUTR, V52, P1533, DOI 10.1007/s00394-012-0460-z; Chambon P, 1996, FASEB J, V10, P940, DOI 10.1096/fasebj.10.9.8801176; Chang XX, 2015, LIPIDS HEALTH DIS, V14, DOI 10.1186/s12944-015-0033-2; Chen Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109012; Cheng YS, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/179040; Cho YM, 2006, DIABETES CARE, V29, P2457, DOI 10.2337/dc06-0360; COLANTUONI V, 1983, NUCLEIC ACIDS RES, V11, P7769, DOI 10.1093/nar/11.22.7769; Coughlin Steven S, 2015, Cancer Clin Oncol, V4, P24; Cui XH, 2007, CANCER EPIDEM BIOMAR, V16, P1443, DOI 10.1158/1055-9965.EPI-07-0059; Dobbins M, 2013, ISRN Prev Med, V2013, P680536, DOI 10.5402/2013/680536; Duffy MJ, 2005, CLIN CHEM, V51, P494, DOI 10.1373/clinchem.2004.046227; Emens LA, 2005, CANCER RES, V65, P8059, DOI 10.1158/0008-5472.CAN-05-1797; Fan L, 2009, BREAST CANCER RES TR, V117, P409, DOI 10.1007/s10549-008-0303-z; Ferlay J, 2015, INT J CANCER, V136, pE359, DOI 10.1002/ijc.29210; Haider DG, 2007, J CLIN ENDOCR METAB, V92, P1168, DOI 10.1210/jc.2006-1839; Ishikawa M, 2005, CLIN CANCER RES, V11, P466; Janke J, 2006, DIABETES, V55, P2805, DOI 10.2337/db06-0616; Jung UJ, 2014, INT J MOL SCI, V15, P6184, DOI 10.3390/ijms15046184; Kabat GC, 2009, INT J CANCER, V125, P2704, DOI 10.1002/ijc.24609; Kawaguchi R, 2007, SCIENCE, V315, P820, DOI 10.1126/science.1136244; Khan S, 2013, CYTOKINE GROWTH F R, V24, P503, DOI 10.1016/j.cytogfr.2013.10.001; Kotnik P, 2011, EUR J ENDOCRINOL, V165, P703, DOI 10.1530/EJE-11-0431; Kucharska-Newton AM, 2008, ANN EPIDEMIOL, V18, P671, DOI 10.1016/j.annepidem.2008.06.006; Larsson SC, 2007, INT J CANCER, V121, P856, DOI 10.1002/ijc.22717; Lehr S, 2012, PROTEOM CLIN APPL, V6, P91, DOI 10.1002/prca.201100052; Liu Y, 2014, DIABETOL METAB SYNDR, V6, DOI 10.1186/1758-5996-6-25; Lorincz AM, 2006, ENDOCR-RELAT CANCER, V13, P279, DOI 10.1677/erc.1.00729; Maehle BO, 2001, BREAST CANCER RES TR, V68, P159, DOI 10.1023/A:1011977118921; Millikan RC, 2008, BREAST CANCER RES TR, V109, P123, DOI 10.1007/s10549-007-9632-6; Hermsdorff HHM, 2009, NUTRITION, V25, P392, DOI 10.1016/j.nut.2008.09.015; Mistry T, 2007, EUR UROL, V52, P46, DOI 10.1016/j.eururo.2007.03.054; Miyoshi Y, 2003, CLIN CANCER RES, V9, P5699; Muti P, 2002, CANCER EPIDEM BIOMAR, V11, P1361; Nath SD, 2005, JAMA-J AM MED ASSOC, V293, P2210, DOI 10.1001/jama.293.18.2210-b; Patz EF, 2007, J CLIN ONCOL, V25, P5578, DOI 10.1200/JCO.2007.13.5392; Qi QB, 2007, J CLIN ENDOCR METAB, V92, P4827, DOI 10.1210/jc.2007-1219; Ray G, 2001, CLIN BIOCHEM, V34, P71, DOI 10.1016/S0009-9120(00)00200-9; Saki F, 2013, IRAN J PEDIATR, V23, P396; Saki F, 2012, HEPAT MON, V12, DOI 10.5812/hepatmon.7103; Saxena NK, 2010, GASTROENTEROLOGY, V139, P1762, DOI 10.1053/j.gastro.2010.07.001; Sims AH, 2007, NAT CLIN PRACT ONCOL, V4, P516, DOI 10.1038/ncponc0908; Stefan N, 2007, DIABETES CARE, V30, P1173, DOI 10.2337/dc06-2342; Sun Q, 2013, CIRCULATION, V127, P1938, DOI 10.1161/CIRCULATIONAHA.113.002073; Tschoner A, 2008, OBESITY, V16, P2439, DOI 10.1038/oby.2008.391; Tworoger SS, 2007, J CLIN ENDOCR METAB, V92, P1510, DOI 10.1210/jc.2006-1975; Uehara H, 2013, INT J ONCOL, V43, P365, DOI 10.3892/ijo.2013.1954; Viale G, 2007, J CLIN ONCOL, V25, P3846, DOI 10.1200/JCO.2007.11.9453; Vona-Davis L, 2007, ENDOCR-RELAT CANCER, V14, P189, DOI 10.1677/ERC-06-0068; Wang DD, 2011, J CANCER RES CLIN, V137, P651, DOI 10.1007/s00432-010-0927-3; Wang Yong-chuan, 2012, Cancer Biology Medicine, V9, P128, DOI 10.3969/j.issn.2095-3941.2012.02.009; Won JC, 2012, J DIABETES INVEST, V3, P457, DOI 10.1111/j.2040-1124.2012.00213.x; Yang Q, 2005, NATURE, V436, P356, DOI 10.1038/nature03711; Yang XR, 2011, JNCI-J NATL CANCER I, V103, P250, DOI 10.1093/jnci/djq526; ZOVICH DC, 1992, J BIOL CHEM, V267, P13884	62	17	18	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2016	11	12							e0167498	10.1371/journal.pone.0167498	http://dx.doi.org/10.1371/journal.pone.0167498			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI9TW	28002423	Green Published, gold, Green Submitted			2022-12-27	WOS:000392853100010
J	Kirby, RL; Mitchell, D; Sabharwal, S; McCranie, M; Nelson, AL				Kirby, R. Lee; Mitchell, Doug; Sabharwal, Sunil; McCranie, Mark; Nelson, Audrey L.			Manual Wheelchair Skills Training for Community-Dwelling Veterans with Spinal Cord Injury: A Randomized Controlled Trial	PLOS ONE			English	Article							SELF-EFFICACY; CLINICAL-TRIAL; USERS; MOBILITY; PARTICIPATION; PROGRAM; PEOPLE; CONSEQUENCES; INDIVIDUALS; ASSOCIATION	Objectives To test the hypotheses that community-dwelling veterans with spinal cord injury (SCI) who receive the Wheelchair Skills Training Program (WSTP) in their own environments significantly improve their manual wheelchair-skills capacity, retain those improvements at one year and improve participation in comparison with an Educational Control (EC) group. Methods We carried out a randomized controlled trial, studying 106 veterans with SCI from three Veterans Affairs rehabilitation centers. Each participant received either five one-on-one WSTP or EC sessions 30-45 minutes in duration. The main outcome measures were the total and subtotal percentage capacity scores from the Wheelchair Skills Test 4.1 (WST) and Craig Handicap Assessment and Reporting Technique (CHART) scores. Results Participants in the WSTP group improved their total and Advanced-level WST scores by 7.1% and 30.1% relative to baseline (p < 0.001) and retained their scores at one year followup. The success rates for individual skills were consistent with the total and subtotal WST scores. The CHART Mobility sub-score improved by 3.2% over baseline (p = 0.021). Conclusions Individualized wheelchair skills training in the home environment substantially improves the advanced and total wheelchair skills capacity of experienced community-dwelling veterans with SCI but has only a small impact on participation.	[Kirby, R. Lee] Dalhousie Univ, Div Phys Med & Rehabil, Dept Med, Halifax, NS, Canada; [Mitchell, Doug] Charlie Norwood Vet Adm Med Ctr, Augusta, GA USA; [Sabharwal, Sunil] Vet Adm Boston Hlth Care Syst, Boston, MA USA; [Sabharwal, Sunil] Harvard Med Sch, Boston, MA USA; [McCranie, Mark; Nelson, Audrey L.] Univ S Florida, Hlth Serv Res & Dev Ctr Innovat Disabil & Rehabil, James A Haley Vet Hosp, Coll Publ Hlth, Tampa, FL USA	Dalhousie University; US Department of Veterans Affairs; Veterans Health Administration (VHA); Harvard University; Harvard Medical School; State University System of Florida; University of South Florida; US Department of Veterans Affairs; Veterans Health Administration (VHA); James A. Haley Veterans Hospital	Kirby, RL (corresponding author), Dalhousie Univ, Div Phys Med & Rehabil, Dept Med, Halifax, NS, Canada.	kirby@dal.ca			Office of Health Services Research and Development, Department of Veterans Affairs [IIR 06-274-1]	Office of Health Services Research and Development, Department of Veterans Affairs	This material is based upon work supported by the Office of Health Services Research and Development, Department of Veterans Affairs (Grant # IIR 06-274-1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akbar M, 2010, J BONE JOINT SURG AM, V92A, P23, DOI 10.2106/JBJS.H.01373; Armstrong W, 2007, DISABIL REHABIL, V29, P935, DOI 10.1080/09638280701240615; Ben Mortenson W, 2012, J AM GERIATR SOC, V60, P1310, DOI 10.1111/j.1532-5415.2012.04038.x; Ben Mortenson W, 2011, ARCH PHYS MED REHAB, V92, P1587, DOI 10.1016/j.apmr.2011.03.032; Best KL, 2005, ARCH PHYS MED REHAB, V86, P2316, DOI 10.1016/j.apmr.2005.07.300; Best KL, 2016, ARCH PHYS MED REHAB, V97, P37, DOI 10.1016/j.apmr.2015.08.425; Best KL, 2015, DISABIL REHABIL-ASSI, V10, P393, DOI [10.3109/17483107.2014.907368, 10.3109/17483107.2014.907367]; Borg J, 2012, BMC HEALTH SERV RES, V12, DOI 10.1186/1472-6963-12-330; Bullard S, 2001, PERCEPT MOTOR SKILL, V93, P131, DOI 10.2466/PMS.93.5.131-138; Charbonneau R, 2013, ARCH PHYS MED REHAB, V94, P1707, DOI 10.1016/j.apmr.2013.03.001; Cherubini M, 2012, EUR J PHYS REHAB MED, V48, P217; Collinger JL, 2010, PM&R, V2, P920, DOI 10.1016/j.pmrj.2010.06.007; Coolen AL, 2004, ARCH PHYS MED REHAB, V85, P1160, DOI 10.1016/j.apmr.2003.10.019; Department of Veterans Affairs, 2011, VHA HDB, V1176; Donnelly C, 2004, SPINAL CORD, V42, P302, DOI 10.1038/sj.sc.3101589; Fliess-Douer O, 2012, ARCH PHYS MED REHAB, V93, P629, DOI 10.1016/j.apmr.2011.11.017; Fliess-Douer O, 2010, CLIN REHABIL, V24, P867, DOI 10.1177/0269215510367981; Freidman LM, 1998, FUNDAMENTALS CLIN TR; Giesbrecht EM, 2015, ARCH PHYS MED REHAB, V96, P1158, DOI 10.1016/j.apmr.2014.10.002; Greer N, 2012, ANN INTERN MED, V156, P141, DOI 10.7326/0003-4819-156-2-201201170-00010; Groah SL, 2014, PM&R, V6, P412, DOI 10.1016/j.pmrj.2013.11.004; Hoenig H, 2005, J AM GERIATR SOC, V53, P1712, DOI 10.1111/j.1532-5415.2005.53502.x; Hosseini SM, 2012, ARCH PHYS MED REHAB, V93, P2237, DOI 10.1016/j.apmr.2012.05.021; Hubbard SL, 2007, J REHABIL RES DEV, V44, P581, DOI 10.1682/JRRD.2006.10.0136; Hubbard SL, 2006, J REHABIL RES DEV, V43, P831, DOI 10.1682/JRRD.2005.11.0174; Hurwitz E, 2016, P EUR SEAT S JUN 13; Karmarkar AM, 2009, J REHABIL RES DEV, V46, P567, DOI 10.1682/JRRD.2008.08.0102; Kilkens OJE, 2005, J REHABIL RES DEV, V42, P65, DOI 10.1682/JRRD.2004.08.0093; Kilkens OJE, 2003, CLIN REHABIL, V17, P418, DOI 10.1191/0269215503cr633oa; Kirby R, WHEELCHAIR SKILLS PR; Kirby RL, 2016, ARCH PHYS MED REHAB, V97, P1761, DOI 10.1016/j.apmr.2016.05.015; Kirby RL, 2015, ARCH PHYS MED REHAB, V96, P2017, DOI 10.1016/j.apmr.2015.07.009; Kirby RL, WHEELCHAIR SKILLS TE; Kirby RL, WHEELCHAIR SKILLS TR; Kirby RL, 2011, AM J PHYS MED REHAB, V90, P197, DOI 10.1097/PHM.0b013e318206398a; Koontz AM, 2016, J REHABIL RES DEV, V53, P279, DOI 10.1682/JRRD.2015.02.0023; Krause J, 2009, J SPINAL CORD MED, V32, P237, DOI 10.1080/10790268.2009.11760778; Lemay V, 2012, SPINAL CORD, V50, P37, DOI 10.1038/sc.2011.98; MacPhee AH, 2004, ARCH PHYS MED REHAB, V85, P41, DOI 10.1016/S0003-9993(03)00364-2; Morgan KA, 2015, DISABIL REHABIL-ASSI, V3, P1; Morgan KA, 2015, J SPINAL CORD MED, P1; Mountain AD, 2014, AM J PHYS MED REHAB, V93, P1031, DOI 10.1097/PHM.0000000000000229; National Spinal Cord Injury Statistical Center, 2015, 2015 ANN STAT REP SP; Nelson AL, 2010, ARCH PHYS MED REHAB, V91, P1166, DOI 10.1016/j.apmr.2010.05.008; Noreau L, 2000, DISABIL REHABIL, V22, P170; Ozturk A, 2011, CLIN REHABIL, V25, P416, DOI 10.1177/0269215510386979; Perneger TV, 1998, BRIT MED J, V316, P1236, DOI 10.1136/bmj.316.7139.1236; Phang SH, 2012, DISABIL REHABIL, V34, P625, DOI 10.3109/09638288.2011.613516; Rousseau-Harrison K, 2009, DISABIL REHABIL-ASSI, V4, P344, DOI 10.1080/17483100903038550; Routhier F, 2012, ARCH PHYS MED REHAB, V93, P940, DOI 10.1016/j.apmr.2012.01.017; Sakakibara BM, 2015, ARCH PHYS MED REHAB, V96, P1360, DOI 10.1016/j.apmr.2015.03.002; Salminen AL, 2009, J REHABIL MED, V41, P697, DOI 10.2340/16501977-0427; Schulz KF, 2010, ANN INTERN MED, V152, P726, DOI 10.7326/0003-4819-152-11-201006010-00232; Smith EM, 2016, DISABIL REHABIL-ASSI, V11, P361, DOI 10.3109/17483107.2014.989420; Tangsagulwatthana S, 2010, THAI J PHYS THER, V32, P173; Taylor DH, 2004, J AM GERIATR SOC, V52, P72, DOI 10.1111/j.1532-5415.2004.52013.x; Taylor-Schroeder S, 2011, J SPINAL CORD MED, V34, P149, DOI 10.1179/107902611X12971826988057; Toro ML, 2016, BMC HEALTH SERV RES, V16, DOI 10.1186/s12913-016-1268-y; van Zeltzen JM, 2009, AM J PHYS MED REHABI, V88, P47, DOI DOI 10.1097/PHM.0B013E31818E6140; Whiteneck G, 1999, ARCH PHYS MED REHAB, V81, P164; WHITENECK GG, 1992, ARCH PHYS MED REHAB, V73, P519; World Health Organization, 2008, GUID PROV WHEELCH LE; World Health Organization, INT CLASS FUNCT DIS; Worobey L, 2012, AM J PHYS MED REHAB, V91, P463, DOI 10.1097/PHM.0b013e31825ab5ec; Worobey LA, 2016, ARCH PHYS MED REHAB, V97, P1777, DOI 10.1016/j.apmr.2016.04.006; Xiang H, 2006, INJURY PREV, V12, P8, DOI 10.1136/ip.2005.010033; Zanca JM, 2013, ARCH PHYS MED REHAB, V94, pS145, DOI 10.1016/j.apmr.2012.11.049	67	23	23	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2016	11	12							e0168330	10.1371/journal.pone.0168330	http://dx.doi.org/10.1371/journal.pone.0168330			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EI9TW	28002472	Green Published, Green Submitted, gold			2022-12-27	WOS:000392853100039
J	Tsuchiya, M; Giuliani, A; Hashimoto, M; Erenpreisa, J; Yoshikawa, K				Tsuchiya, Masa; Giuliani, Alessandro; Hashimoto, Midori; Erenpreisa, Jekaterina; Yoshikawa, Kenichi			Self-Organizing Global Gene Expression Regulated through Criticality: Mechanism of the Cell-Fate Change	PLOS ONE			English	Article							EMBRYONIC STEM-CELLS; EMERGENT COMPUTATION; ALLOSTERIC DRUGS; HL-60 CELLS; C-MYC; DIFFERENTIATION; DYNAMICS; CHROMATIN; NETWORK; GENOME	Background A fundamental issue in bioscience is to understand the mechanism that underlies the dynamic control of genome-wide expression through the complex temporal-spatial self organization of the genome to regulate the change in cell fate. We address this issue by elucidating a physically motivated mechanism of self-organization. Principal Findings Building upon transcriptome experimental data for seven distinct cell fates, including early embryonic development, we demonstrate that self-organized criticality (SOC) plays an essential role in the dynamic control of global gene expression regulation at both the population and single-cell levels. The novel findings are as follows: i) Mechanism of cell-fate changes: A sandpile-type critical transition self-organizes overall expression into a few transcription response domains (critical states). A cell-fate change occurs by means of a dissipative pulse-like global perturbation in self-organization through the erasure of initial state critical behaviors (criticality). Most notably, the reprogramming of early embryo cells destroys the zygote SOC control to initiate self-organization in the new embryonal genome, which passes through a stochastic overall expression pattern. ii) Mechanism of perturbation of SOC controls: Global perturbations in self-organization involve the temporal regulation of critical states. Quantitative evaluation of this perturbation in terminal cell fates reveals that dynamic interactions between critical states determine the critical-state coherent regulation. The occurrence of a temporal change in criticality perturbs this between-states interaction, which directly affects the entire genomic system. Surprisingly, a sub-critical state, corresponding to an ensemble of genes that shows only marginal changes in expression and consequently are considered to be devoid of any interest, plays an essential role in generating a global perturbation in self-organization directed toward the cell-fate change. Conclusion and Significance 'Whole-genome' regulation of gene expression through self-regulatory SOC control complements gene-by-gene fine tuning and represents a still largely unexplored non-equilibrium statistical mechanism that is responsible for the massive reprogramming of genome expression.	[Tsuchiya, Masa] Keio Univ, Sch Media & Governance, Syst Biol Program, Fujisawa, Kanagawa, Japan; [Giuliani, Alessandro] Ist Super Sanita, Environm & Hlth Dept, Rome, Italy; [Hashimoto, Midori] Univ Tokyo, Grad Sch Frontier Sci, Kashiwa, Chiba, Japan; [Erenpreisa, Jekaterina] Latvian Biomed Res & Study Ctr, Riga, Latvia; [Yoshikawa, Kenichi] Doshisha Univ, Fac Life & Med Sci, Kyotanabe, Japan	Keio University; Istituto Superiore di Sanita (ISS); University of Tokyo; Latvian Biomedical Research & Study Centre; Doshisha University	Tsuchiya, M (corresponding author), Keio Univ, Sch Media & Governance, Syst Biol Program, Fujisawa, Kanagawa, Japan.	tsuchiya.masa@gmail.com	Giuliani, Alessandro/K-7589-2016; Giuliani, Alessandro/AAF-1740-2020; Yoshikawa, Kenichi/N-1867-2019	Giuliani, Alessandro/0000-0002-4640-804X; Giuliani, Alessandro/0000-0002-4640-804X; Yoshikawa, Kenichi/0000-0002-2751-7136	Japan Society for the Promotion of Science [15H02121, 25103012]; Latvian Council of Science (LZP grant), Latvia [341/2012]	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Latvian Council of Science (LZP grant), Latvia	This study was supported in part by Japan Society for the Promotion of Science (Grants-in-Aid, KAKENHI: Nos.15H02121 and 25103012) and by Latvian Council of Science (LZP grant 341/2012), Latvia.	BAK P, 1987, PHYS REV LETT, V59, P381, DOI 10.1103/PhysRevLett.59.381; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; Bonabeau E, 1997, ACTA BIOTHEOR, V45, P29, DOI 10.1023/A:1000259222500; Brandman O, 2005, SCIENCE, V310, P496, DOI 10.1126/science.1113834; Buganim Y, 2013, NAT REV GENET, V14, P427, DOI 10.1038/nrg3473; Choy JS, 2010, J AM CHEM SOC, V132, P1782, DOI 10.1021/ja910264z; Cinquin O, 2005, J THEOR BIOL, V233, P391, DOI 10.1016/j.jtbi.2004.10.027; Ciofani M, 2012, CELL, V151, P289, DOI 10.1016/j.cell.2012.09.016; Clar S, 1996, J PHYS-CONDENS MAT, V8, P6803, DOI 10.1088/0953-8984/8/37/004; de Oliveira PM, 2001, THEOR BIOSCI, V120, P1, DOI 10.1078/1431-7613-00023; DeDecker BS, 2000, CHEM BIOL, V7, pR103, DOI 10.1016/S1074-5521(00)00115-0; Deng QL, 2014, SCIENCE, V343, P193, DOI 10.1126/science.1245316; Dolmetsch RE, 1997, NATURE, V386, P855, DOI 10.1038/386855a0; Dror RO, 2013, NATURE, V503, P295, DOI 10.1038/nature12595; Efroni S, 2008, CELL STEM CELL, V2, P437, DOI 10.1016/j.stem.2008.03.021; Estrada J, 2016, CELL, V166, P234, DOI 10.1016/j.cell.2016.06.012; Frank SR, 2001, GENE DEV, V15, P2069, DOI 10.1101/gad.906601; Gibcus JH, 2013, MOL CELL, V49, P773, DOI 10.1016/j.molcel.2013.02.011; Gilbert S.F, 2013, DEV BIOL, VTenth; Guo HS, 2014, NATURE, V511, P606, DOI 10.1038/nature13544; Halley JD, 2012, STEM CELL RES, V8, P324, DOI 10.1016/j.scr.2011.11.001; Halley JD, 2004, INSECT SOC, V51, P226, DOI 10.1007/s00040-003-0725-x; Halley JD, 2008, BIOSYSTEMS, V92, P148, DOI 10.1016/j.biosystems.2008.01.005; Halley JD, 2009, STEM CELL RES, V2, P165, DOI 10.1016/j.scr.2009.03.001; Huang S, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.128701; Huang S, 2007, DEV BIOL, V305, P695, DOI 10.1016/j.ydbio.2007.02.036; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Jensen H.J., 1998, SELF ORG CRITICALITY; Jost D, 2014, NUCLEIC ACIDS RES, V42, P9553, DOI 10.1093/nar/gku698; Kinouchi O, 1999, PHYS REV E, V59, P4964, DOI 10.1103/PhysRevE.59.4964; Kornyshev AA, 2010, PHYS CHEM CHEM PHYS, V12, P12352, DOI 10.1039/c004107f; LANGTON CG, 1990, PHYSICA D, V42, P12, DOI 10.1016/0167-2789(90)90064-V; Launay S, 1999, BLOOD, V93, P4395, DOI 10.1182/blood.V93.12.4395.412k06_4395_4405; Le Treut G, 2016, BIOPHYS J, V110, P51, DOI 10.1016/j.bpj.2015.10.027; Li FT, 2004, P NATL ACAD SCI USA, V101, P4781, DOI 10.1073/pnas.0305937101; Li GH, 2011, CURR OPIN GENET DEV, V21, P175, DOI 10.1016/j.gde.2011.01.022; Lieberman-Aiden E, 2009, SCIENCE, V326, P289, DOI 10.1126/science.1181369; Lin CY, 2012, CELL, V151, P56, DOI 10.1016/j.cell.2012.08.026; Lukovic M, 2014, PHYSICA A, V416, P430, DOI 10.1016/j.physa.2014.08.066; Ma'ayan A, 2005, SCIENCE, V309, P1078, DOI 10.1126/science.1108876; MacArthur BD, 2013, CELL, V154, P484, DOI 10.1016/j.cell.2013.07.024; Maherali N, 2007, CELL STEM CELL, V1, P55, DOI 10.1016/j.stem.2007.05.014; Markovic D, 2014, PHYS REP, V536, P41, DOI 10.1016/j.physrep.2013.11.002; McClintick JN, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-49; Nagahara H, 2010, CHEM PHYS LETT, V494, P88, DOI 10.1016/j.cplett.2010.05.083; Nagano T, 2013, NATURE, V502, P59, DOI 10.1038/nature12593; Nagashima T, 2007, J BIOL CHEM, V282, P4045, DOI 10.1074/jbc.M608653200; Nakakuki T, 2010, CELL, V141, P884, DOI 10.1016/j.cell.2010.03.054; Niakan KK, 2012, DEVELOPMENT, V139, P829, DOI 10.1242/dev.060426; Nykter M, 2008, P NATL ACAD SCI USA, V105, P1897, DOI 10.1073/pnas.0711525105; Papp B, 2012, BIOMOLECULES, V2, P165, DOI 10.3390/biom2010165; Peaston AE, 2007, BIOCHEM SOC T, V35, P618, DOI 10.1042/BST0350618; Plenz D., 2014, CRITICALITY NEURAL S; Raser JM, 2005, SCIENCE, V309, P2010, DOI 10.1126/science.1105891; Sabo A, 2014, NATURE, V511, P488, DOI 10.1038/nature13537; Saeki Y, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-545; SCHAEFER A, 1994, J BIOL CHEM, V269, P8786; Schiessel H, 2003, J PHYS-CONDENS MAT, V15, pR699, DOI 10.1088/0953-8984/15/19/203; Sexton T, 2009, SEMIN CELL DEV BIOL, V20, P849, DOI 10.1016/j.semcdb.2009.06.004; Sole R., 2011, PHASE TRANSITIONS; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Takenaka Y, 2008, PHYS REV E, V77, DOI 10.1103/PhysRevE.77.031905; TARELLA C, 1982, CANCER RES, V42, P445; TELFORD NA, 1990, MOL REPROD DEV, V26, P90, DOI 10.1002/mrd.1080260113; Transtrum MK, 2015, J CHEM PHYS, V143, DOI 10.1063/1.4923066; Tremethick DJ, 2007, CELL, V128, P651, DOI 10.1016/j.cell.2007.02.008; TSIFTSOGLOU AS, 1985, CANCER RES, V45, P2334; Tsuchiya M., 2015, PLOS ONE, V11, DOI 10. 1371/journal. pone. 0128565 26067993; Tsuchiya M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097411; Tsuchiya M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012116; Tsuchiya M, 2009, PHYSICA A, V388, P1738, DOI 10.1016/j.physa.2008.12.030; Tsuchiya M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004905; Tsuchyia M, 2007, FEBS J, V274, P2878, DOI 10.1111/j.1742-4658.2007.05822.x; Turalska M, 2009, PHYS REV E, V80, DOI 10.1103/PhysRevE.80.021110; Turcotte DL, 2001, NONLINEAR PROC GEOPH, V8, P193, DOI 10.5194/npg-8-193-2001; Wennekamp S, 2013, NAT REV MOL CELL BIO, V14, P452, DOI 10.1038/nrm3602; Whitaker M, 2006, PHYSIOL REV, V86, P25, DOI 10.1152/physrev.00023.2005; Yamanaka S, 2009, NATURE, V460, P49, DOI 10.1038/nature08180; Yan LY, 2013, NAT STRUCT MOL BIOL, V20, P1131, DOI 10.1038/nsmb.2660; Yang CX, 2013, REPRODUCTION, V145, P149, DOI 10.1530/REP-11-0421; YEN A, 1987, CANCER RES, V47, P129; Yoshikawa K, 2002, J BIOL PHYS, V28, P701, DOI 10.1023/A:1021251125101; Young RA, 2011, CELL, V144, P940, DOI 10.1016/j.cell.2011.01.032	83	26	28	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2016	11	12							e0167912	10.1371/journal.pone.0167912	http://dx.doi.org/10.1371/journal.pone.0167912			47	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI9QF	27997556	Green Published, gold, Green Submitted			2022-12-27	WOS:000392842900018
J	Yuan, B; Liang, S; Kwon, JW; Jin, YX; Park, SH; Wang, HY; Sun, TY; Zhang, JB; Kim, NH				Yuan, Bao; Liang, Shuang; Kwon, Jeong-Woo; Jin, Yong-Xun; Park, Shun-Ha; Wang, Hai-Yang; Sun, Tian-Yi; Zhang, Jia-Bao; Kim, Nam-Hyung			The Role of Glucose Metabolism on Porcine Oocyte Cytoplasmic Maturation and Its Possible Mechanisms	PLOS ONE			English	Article							IN-VITRO MATURATION; PENTOSE-PHOSPHATE PATHWAY; MOUSE OOCYTES; FOLLICULAR-FLUID; CUMULUS CELLS; DEVELOPMENTAL COMPETENCE; MEIOTIC MATURATION; EMBRYO DEVELOPMENT; ENERGY-METABOLISM; LIPID-METABOLISM	In the present study, we investigated the potential role of glucose and pyruvate in the cytoplasmic maturation of porcine oocytes by investigating the effect of glucose and/or pyruvate supplementation, in the presence or absence of 10% porcine follicular fluid (PFF), on meiotic maturation and subsequent embryo development. In the absence of 10% PFF, without exogenous addition of glucose and pyruvate, the medium seemed unable to support maturation. In the presence of 10% PFF, the addition of 5.6 mM glucose and/or 2 mM pyruvate during in vitro maturation of cumulus enclosed oocytes increased MII oocyte and blastocyst rates. In contrast, oocytes denuded of cumulus cells were not able to take full advantage of the glucose in the medium, as only pyruvate was able to increase the MII rate and the subsequent early embryo developmental ability. Treatment of cumulus enclosed oocytes undergoing maturation with 200 pM dehydroepiandrosterone (DHEA), a pentose phosphate pathway inhibitor, or 2 pM iodoacetate (IA), a glycolysis inhibitor, significantly reduced GHS, intra-oocyte ATP, maternal gene expression, and MPF activity levels. DHEA was also able to increase ROS and reduce the levels of NADPH. Moreover, blastocysts of the DHEA-or IA-treated groups presented higher apoptosis rates and markedly lower cell proliferation cell rates than those of the non-treated group. In conclusion, our results suggest that oocytes maturing in the presence of 10% PFF can make full use of energy sources through glucose metabolism only when they are accompanied by cumulus cells, and that pentose phosphate pathway (PPP) and glycolysis promote porcine oocyte cytoplasmic maturation by supplying energy, regulating maternal gene expression, and controlling MPF activity.	[Yuan, Bao; Jin, Yong-Xun; Zhang, Jia-Bao; Kim, Nam-Hyung] Jilin Univ, Coll Anim Sci, Dept Lab Anim, Changchun, Jilin, Peoples R China; [Yuan, Bao; Liang, Shuang; Kwon, Jeong-Woo; Jin, Yong-Xun; Park, Shun-Ha; Wang, Hai-Yang; Sun, Tian-Yi; Kim, Nam-Hyung] Chungbuk Natl Univ, Dept Anim Sci, Mol Embryol Lab, Cheongju, Chungbuk, South Korea	Jilin University; Chungbuk National University	Zhang, JB; Kim, NH (corresponding author), Jilin Univ, Coll Anim Sci, Dept Lab Anim, Changchun, Jilin, Peoples R China.; Kim, NH (corresponding author), Chungbuk Natl Univ, Dept Anim Sci, Mol Embryol Lab, Cheongju, Chungbuk, South Korea.	zjb515@126.com; nhkim@chungbuk.ac.kr		WANG, HAIYANG/0000-0002-6362-6022	BioGreen 21 Program [PJ011126]; National Natural Science Foundation of China [31572400, 31501954]	BioGreen 21 Program(Rural Development Administration (RDA), Republic of Korea); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by the BioGreen 21 Program (No. PJ011126) and the National Natural Science Foundation of China (31572400, 31501954). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agung B, 2013, J REPROD DEVELOP, V59, P103, DOI 10.1262/jrd.2011-050; Alvarez GM, 2013, REPROD DOMEST ANIM, V48, P545, DOI 10.1111/rda.12123; Arias-Alvarez M, 2016, IN VIVO IN VITRO MAT; Ashraf S, 2014, J ASSIST REPROD GEN, V31, P1349, DOI 10.1007/s10815-014-0275-3; Boruszewska D, 2015, REPROD BIOL ENDOCRIN, V13, DOI 10.1186/s12958-015-0044-x; Cetica P, 2002, REPRODUCTION, V124, P675, DOI 10.1530/reprod/124.5.675; Comizzoli P, 2003, BIOL REPROD, V68, P1934, DOI 10.1095/biolreprod.102.011452; da Costa NN, 2016, THERIOGENOLOGY, V85, P323, DOI 10.1016/j.theriogenology.2015.08.010; Dai XX, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0142564; Downs SM, 1999, BIOL REPROD, V60, P1446, DOI 10.1095/biolreprod60.6.1446; Downs SM, 1996, MOL REPROD DEV, V44, P121, DOI 10.1002/(SICI)1098-2795(199605)44:1&lt;121::AID-MRD14&gt;3.0.CO;2-7; Downs SM, 2003, MOL REPROD DEV, V66, P90, DOI 10.1002/mrd.10326; Frolova AI, 2011, MOL ENDOCRINOL, V25, P1444, DOI 10.1210/me.2011-0026; Funahashi H, 2008, THERIOGENOLOGY, V70, P1041, DOI 10.1016/j.theriogenology.2008.06.025; Herrick JR, 2006, REPRODUCTION, V131, P289, DOI 10.1530/rep.1.00835; Huang Y, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122370; Jimenez PT, 2013, ENDOCRINOLOGY, V154, P4835, DOI 10.1210/en.2012-2140; Kim Yunna, 2012, Clin Exp Reprod Med, V39, P58, DOI 10.5653/cerm.2012.39.2.58; Krisher RL, 2007, ANIM REPROD SCI, V98, P72, DOI 10.1016/j.anireprosci.2006.10.006; Krisher RL, 1999, MOL REPROD DEV, V53, P19, DOI 10.1002/(SICI)1098-2795(199905)53:1&lt;19::AID-MRD3&gt;3.0.CO;2-U; Lee SK, 2014, J REPROD DEVELOP, V60, P128, DOI 10.1262/jrd.2013-098; Lee YJ, 2006, AM J PHYSIOL-RENAL, V291, pF98, DOI 10.1152/ajprenal.00486.2005; Lin LT, 2016, GYNECOL ENDOCRINOL, P1; Lin ZL, 2014, REPROD DOMEST ANIM, V49, P219, DOI 10.1111/rda.12254; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Mao J, 2012, THERIOGENOLOGY, V78, P887, DOI 10.1016/j.theriogenology.2012.04.002; Alvarez GM, 2016, THERIOGENOLOGY, V86, P2096, DOI 10.1016/j.theriogenology.2015.11.008; MEINECKE B, 1978, Anatomia Histologia Embryologia, V7, P58, DOI 10.1111/j.1439-0264.1978.tb00494.x; Nandi S, 2008, THERIOGENOLOGY, V69, P186, DOI 10.1016/j.theriogenology.2007.08.036; OBrien JK, 1996, REPROD FERT DEVELOP, V8, P1029, DOI 10.1071/RD9961029; Ptak G, 2012, HUM REPROD, V27, P1034, DOI 10.1093/humrep/der454; RAMSOONDAR J, 1995, CAN J VET RES, V59, P8; RIEGER D, 1994, J REPROD FERTIL, V100, P257; Sanchez-Lazo L, 2014, MOL ENDOCRINOL, V28, P1502, DOI 10.1210/me.2014-1049; Schmidt Maike M, 2009, Front Neuroenergetics, V1, P1, DOI 10.3389/neuro.14.001.2009; Somfai T, 2011, REPROD FERT DEVELOP, V23, P912, DOI 10.1071/RD10339; Sturmey RG, 2003, REPRODUCTION, V126, P197, DOI 10.1530/rep.0.1260197; Truman AW, 2012, CELL, V151, P1308, DOI 10.1016/j.cell.2012.10.051; Wang HF, 2006, REPROD BIOL ENDOCRIN, V4, DOI 10.1186/1477-7827-4-4; Wang Q, 2012, AM J PHYSIOL-ENDOC M, V302, pE1511, DOI 10.1152/ajpendo.00016.2012; Xie HL, 2016, SCI REP-UK, V6, DOI 10.1038/srep20764; Yang MY, 2002, ANIM REPROD SCI, V70, P159, DOI 10.1016/S0378-4320(01)00186-5; Yuan B, 2016, PEERJ, V4, DOI 10.7717/peerj.2454; Zhang DX, 2010, MOL REPROD DEV, V77, P38, DOI 10.1002/mrd.21095	44	18	23	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2016	11	12							e0168329	10.1371/journal.pone.0168329	http://dx.doi.org/10.1371/journal.pone.0168329			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI9QF	27997591	Green Submitted, Green Published, gold			2022-12-27	WOS:000392842900035
J	Zhang, BW; Xu, JL; Zhang, H; Zhang, Q; Lu, J; Wang, JH				Zhang, Bi-Wei; Xu, Jin-Long; Zhang, Hua; Zhang, Qiang; Lu, Jie; Wang, Jun-Hui			Structure Elucidation of a Polysaccharide from Umbilicaria esculenta and Its Immunostimulatory Activity	PLOS ONE			English	Article							ANTIOXIDANT ACTIVITIES; ANTITHROMBOTIC ACTIVITY; ANTITUMOR-ACTIVITY; PURIFICATION; METHYLATION; CHINENSIS; FRACTIONS; LICHENS; GLUCAN; STEMS	Umbilicaria esculenta has been used as a tonic food in China for several centuries owing to its pleasant flavor and health benefits. In this study, a water soluble polysaccharide, which we designated as UP2, with an average molecular weight of 3.33 x 10(5) Da, was isolated from U. esculenta cultivated in the Huangshan Mountain, by consecutive hot water extraction and anion-exchange chromatography. Gas chromatography analysis indicated that UP2 contained three kinds of monosaccharides, including mannose, glucose, and galactose at a molar ratio of 1.7:1.0:1.2. Linkage analysis of UP2 revealed the presence of (1 -> 6)-linked glucosyl, (1 -> 3,6)-linked glucosyl, t-linked galactosyl, (1 -> 6)-linked galactosyl and (1 -> 6)-linked mannosyl at a molar ratio of 0.7:4.6:4.1:2.2:9.1. Structural analysis determined that UP2 possessed a backbone consisting of (1 -> 6)-linked /3-D-glucopyranosyl and (1 -> 6)-linked a-D-mannopyranosyl residues, which substituted at the 0-3 position of (1 -> 6)-linked beta-D-glucopyranosyl residues by branches of (1 -> 6)-linked alpha-D-galactopyranosyl and 1-linked beta-D-galactopyranosyl residues. Immunostimulatory activity analysis showed that UP2 could stimulate the proliferation of RAW264.7 cells in a dose-dependent manner, and all the samples (20-500 mu g/mL) were found to enhance nitric oxide production. The highest phagocytic activity of UP2 was observed at 200 mu g/mL. Thus, UP2 may be a potential source of biological and pharmacological agents.	[Zhang, Bi-Wei; Xu, Jin-Long; Zhang, Hua; Wang, Jun-Hui] Hefei Univ Technol, Sch Biotechnol & Food Engn, Hefei, Peoples R China; [Zhang, Qiang; Lu, Jie] Anhui Qiangwang Flavouring Food Co LTD, Dongcheng Dev Zone, Jieshou City, Anhui, Peoples R China	Hefei University of Technology	Wang, JH (corresponding author), Hefei Univ Technol, Sch Biotechnol & Food Engn, Hefei, Peoples R China.	junhuiwang@hfut.edu.cn			National Natural Science Foundation of China [31370371]; Natural Science Foundation of Anhui Province [1408085MC45]; Fundamental Research Funds for the Central Universities [2015HGCH0008]; China Postdoctoral Science Foundation; Anhui Qiangwang Flavouring Food Co., LTD	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Anhui Province(Natural Science Foundation of Anhui Province); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); China Postdoctoral Science Foundation(China Postdoctoral Science Foundation); Anhui Qiangwang Flavouring Food Co., LTD	This research was financially supported by the National Natural Science Foundation of China (No. 31370371), the Natural Science Foundation of Anhui Province (No. 1408085MC45), the Fundamental Research Funds for the Central Universities (No. 2015HGCH0008) and China Postdoctoral Science Foundation. Anhui Qiangwang Flavouring Food Co., LTD provided support in the form of salaries for authors [QZ and JL], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This research was financially supported by the National Natural Science Foundation of China (No. 31370371), the Natural Science Foundation of Anhui Province (No. 1408085MC45), the Fundamental Research Funds for the Central Universities (No. 2015HGCH0008) and China Postdoctoral Science Foundation.	Bates ST, 2011, APPL ENVIRON MICROB, V77, P1309, DOI 10.1128/AEM.02257-10; Beeley JG., 1986, KLIN WOCHENSCHR, V64, P397; Bi HT, 2009, CARBOHYD RES, V344, P1254, DOI 10.1016/j.carres.2009.04.009; BLUMENKR.N, 1973, ANAL BIOCHEM, V54, P484, DOI 10.1016/0003-2697(73)90377-1; Chen S, 2014, MEDIAT INFLAMM, V2014, DOI 10.1155/2014/738631; Chen ZG, 2014, CARBOHYD POLYM, V106, P217, DOI 10.1016/j.carbpol.2014.02.004; Chien RC, 2015, CARBOHYD POLYM, V128, P90, DOI 10.1016/j.carbpol.2015.03.088; Dai H, 2012, GLYCOBIOLOGY, V22, P1673, DOI 10.1093/glycob/cws099; Du YQ, 2015, INT J BIOL MACROMOL, V72, P1272, DOI 10.1016/j.ijbiomac.2014.09.057; Han XQ, 2012, INT J BIOL MACROMOL, V51, P597, DOI 10.1016/j.ijbiomac.2012.06.029; Hartley JW, 2008, RETROVIROLOGY, V5, DOI 10.1186/1742-4690-5-1; HIRABAYASHI K, 1989, CHEM PHARM BULL, V37, P2410, DOI 10.1248/cpb.37.2410; IKEKAWA T, 1969, CANCER RES, V29, P734; Jiang CX, 2015, CARBOHYD POLYM, V115, P200, DOI 10.1016/j.carbpol.2014.08.095; Jing YS, 2014, J AGR FOOD CHEM, V62, P902, DOI 10.1021/jf404752c; Kim MS, 2006, J ETHNOPHARMACOL, V105, P342, DOI 10.1016/j.jep.2005.11.011; Kosanic M, 2014, LWT-FOOD SCI TECHNOL, V59, P518, DOI 10.1016/j.lwt.2014.04.047; Leung MYK, 2004, GLYCOBIOLOGY, V14, P501, DOI 10.1093/glycob/cwh050; Liao NB, 2014, J AGR FOOD CHEM, V62, P2344, DOI 10.1021/jf403896c; Liu Y, 2014, INT J BIOL MACROMOL, V64, P63, DOI 10.1016/j.ijbiomac.2013.11.029; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Lu CL, 2015, CARBOHYD POLYM, V122, P428, DOI 10.1016/j.carbpol.2014.11.035; NEEDS PW, 1993, CARBOHYD RES, V245, P1, DOI 10.1016/0008-6215(93)80055-J; NISHIKAWA Y, 1970, CHEM PHARM BULL, V18, P1431; Olafsdottir ES, 2003, PHYTOMEDICINE, V10, P318, DOI 10.1078/094471103322004811; Omarsdottir S, 2006, CARBOHYD RES, V341, P2449, DOI 10.1016/j.carres.2006.06.026; Omarsdottir S, 2006, INT IMMUNOPHARMACOL, V6, P1642, DOI 10.1016/j.intimp.2006.06.006; Stocker-Worgotter E, 2013, STUD NAT PROD CHEM, V39, P337, DOI 10.1016/B978-0-444-62615-8.00010-2; Sun HX, 2015, CARBOHYD POLYM, V121, P388, DOI 10.1016/j.carbpol.2014.12.023; Wang JH, 2015, CURR TOP NUTRACEUT R, V13, P205; Wang JH, 2015, CARBOHYD POLYM, V131, P240, DOI 10.1016/j.carbpol.2015.05.052; Wang JH, 2015, BIOTECHNOL BIOTEC EQ, V29, P714, DOI 10.1080/13102818.2015.1022222; Wang JH, 2010, FOOD CHEM, V122, P572, DOI 10.1016/j.foodchem.2010.03.012; Wang JH, 2010, CARBOHYD POLYM, V79, P114, DOI 10.1016/j.carbpol.2009.07.032; Wang JunHui, 2015, Journal of Chemical and Pharmaceutical Research, V7, P678; Wang MC, 2013, FOOD CHEM, V138, P41, DOI 10.1016/j.foodchem.2012.09.098; Wang YF, 2014, CARBOHYD POLYM, V105, P231, DOI 10.1016/j.carbpol.2014.01.082; Xie G, 2008, PHYTOCHEMISTRY, V69, P1359, DOI 10.1016/j.phytochem.2008.01.009; Xie JH, 2013, FOOD CHEM, V136, P1453, DOI 10.1016/j.foodchem.2012.09.078; Xu X, 2014, PLOS ONE, V10; Xu X, 2014, J AGR FOOD CHEM, V62, P3168, DOI 10.1021/jf405633n; Yin JY, 2012, CARBOHYD POLYM, V87, P2416, DOI 10.1016/j.carbpol.2011.11.009; Zha XQ, 2015, INT J BIOL MACROMOL, V78, P429, DOI 10.1016/j.ijbiomac.2015.04.047	43	12	12	1	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2016	11	12							e0168472	10.1371/journal.pone.0168472	http://dx.doi.org/10.1371/journal.pone.0168472			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI9QF	27997616	gold, Green Published, Green Submitted			2022-12-27	WOS:000392842900050
J	Bader, LA; Elewa, H				Bader, Loulia Akram; Elewa, Hazem			The Impact of Genetic and Non-Genetic Factors on Warfarin Dose Prediction in MENA Region: A Systematic Review	PLOS ONE			English	Review							REDUCTASE COMPLEX SUBUNIT-1; GREATER-THAN-A; PATIENT CHARACTERISTICS; EGYPTIAN PATIENTS; DOSING ALGORITHM; VKORC1 POLYMORPHISMS; TURKISH POPULATION; CYTOCHROME P4502C9; AFRICAN-AMERICANS; CYP2C9 GENOTYPES	Background Warfarin is the most commonly used oral anticoagulant for the treatment and prevention of thromboembolic disorders. Pharmacogenomics studies have shown that variants in CYP2C9 and VKORC1 genes are strongly and consistently associated with warfarin dose variability. Although different populations from the Middle East and North Africa (MENA) region may share the same ancestry, it is still unclear how they compare in the genetic and non-genetic factors affecting their warfarin dosing. Objective To explore the prevalence of CYP2C9 and VKORC1 variants in MENA, and the effect of these variants along with other non-genetic factors in predicting warfarin dose. Methods In this systematic review, we included observational cross sectional and cohort studies that enrolled patients on stable warfarin dose and had the genetics and non-genetics factors associated with mean warfarin dose as the primary outcome. We searched PubMed, Medline, Scopus, PharmGKB, PHGKB, Google scholar and reference lists of relevant reviews. Results We identified 17 studies in eight different populations: Iranian, Israeli, Egyptian, Lebanese, Omani, Kuwaiti, Sudanese and Turkish. Most common genetic variant in all populations was the VKORC1 (-1639G>A), with a minor allele frequency ranging from 30% in Egyptians and up to 52% and 56% in Lebanese and Iranian, respectively. Variants in the CYP2C9 were less common, with the highest MAF for CYP2C9*2among Iranians (27%). Variants in the VKORC1 and CYP2C9 were the most significant predictors of warfarin dose in all populations. Along with other genetic and non-genetic factors, they explained up to 63% of the dose variability in Omani and Israeli patients. Conclusion Variants of VKORC1 and CYP2C9 are the strongest predictors of warfarin dose variability among the different populations from MENA. Although many of those populations share the same ancestry and are similar in their warfarin dose predictors, a population specific dosing algorithm is needed for the prospective estimation of warfarin dose.	[Bader, Loulia Akram; Elewa, Hazem] Qatar Univ, Coll Pharm, Doha, Qatar	Qatar University	Elewa, H (corresponding author), Qatar Univ, Coll Pharm, Doha, Qatar.	hazem.elewa@qu.edu.qa	elewa, hazem/AAH-8159-2021	elewa, hazem/0000-0003-1594-1199	College of Pharmacy, Qatar University [QUST-CPH-SPR-15/16-8]	College of Pharmacy, Qatar University	This research was funded by the student grant provided by College of Pharmacy, Qatar University (QUST-CPH-SPR-15/16-8, http://www.qu.edu.qa/offices/research/academic/internal-fund.php), to HE. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abu-Amero KK, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-32; Alrashid MH, 2016, MOL DIAGN THER, V20, P183, DOI 10.1007/s40291-016-0190-7; Anderson JL, 2007, CIRCULATION, V116, P2563, DOI 10.1161/CIRCULATIONAHA.107.737312; Aquilante CL, 2006, CLIN PHARMACOL THER, V79, P291, DOI 10.1016/j.clpt.2005.11.011; Bazan NS, 2014, IRISH J MED SCI, V183, P161, DOI 10.1007/s11845-013-0978-y; Behar DM, 2008, AM J HUM GENET, V82, P1130, DOI 10.1016/j.ajhg.2008.04.002; Cadenas AM, 2008, EUR J HUM GENET, V16, P374, DOI 10.1038/sj.ejhg.5201934; Cal Santiago, 2006, BMC Biochemistry, V7, DOI 10.1186/1471-2091-7-9; Caldwell MD, 2008, BLOOD, V111, P4106, DOI 10.1182/blood-2007-11-122010; Caldwell MD, 2007, CLIN MED RES, V5, P8, DOI 10.3121/cmr.2007.724; Carlquist JF, 2006, J THROMB THROMBOLYS, V22, P191, DOI 10.1007/s11239-006-9030-7; Carlquist JF, 2010, J THROMB THROMBOLYS, V30, P358, DOI 10.1007/s11239-010-0467-3; Caulfield T, 2009, GENOME MED, V1, DOI 10.1186/gm8; Cavallari LH, 2010, CLIN PHARMACOL THER, V87, P459, DOI 10.1038/clpt.2009.223; Ekladious SMM, 2013, MOL DIAGN THER, V17, P381, DOI 10.1007/s40291-013-0046-3; Esmerian MO, 2011, J CLIN PHARMACOL, V51, P1418, DOI 10.1177/0091270010382910; Gage BF, 2004, THROMB HAEMOSTASIS, V91, P87, DOI 10.1160/TH03-06-0379; Ghozlan MF, 2015, BLOOD COAGUL FIBRIN, V26, P499, DOI 10.1097/MBC.0000000000000272; Health NIo, 2014, QUAL ASS TOOL OBS CO; Huang Sheng-wen, 2011, Zhonghua Yixue Yichuanxue Zazhi, V28, P661, DOI 10.3760/cma.j.issn.1003-9406.2011.06.014; Issac MSM, 2014, MOL DIAGN THER, V18, P73, DOI 10.1007/s40291-013-0055-2; Johnson JA, 2008, PHARMACOTHERAPY, V28, P1081, DOI 10.1592/phco.28.9.1081; Johnson JA, 2015, TRENDS CARDIOVAS MED, V25, P33, DOI 10.1016/j.tcm.2014.09.001; Santos PCJL, 2013, EUR J CLIN PHARMACOL, V69, P789, DOI 10.1007/s00228-012-1404-5; Kamali F, 2004, CLIN PHARMACOL THER, V75, P204, DOI 10.1016/j.clpt.2003.10.001; Kimmel SE, 2013, NEW ENGL J MED, V369, P2283, DOI 10.1056/NEJMoa1310669; Kirley K, 2012, CIRC-CARDIOVASC QUAL, V5, P615, DOI 10.1161/CIRCOUTCOMES.112.967299; Klein TE, 2009, NEW ENGL J MED, V360, P753, DOI 10.1056/NEJMoa0809329; LANDEFELD CS, 1993, AM J MED, V95, P315, DOI 10.1016/0002-9343(93)90285-W; Liu Y, 2012, CLIN PHARMACOL THER, V91, P660, DOI 10.1038/clpt.2011.269; Loebstein R, 2005, CLIN PHARMACOL THER, V77, P365, DOI 10.1016/j.clpt.2005.01.010; Luis JR, 2004, AM J HUM GENET, V74, P532, DOI 10.1086/382286; McDonald MG, 2009, MOL PHARMACOL, V75, P1337, DOI 10.1124/mol.109.054833; Misquith R, 2012, OPEN J GENETICS; Namazi S, 2010, CLIN THER, V32, P1050, DOI 10.1016/j.clinthera.2010.06.010; Offermanns S, 2008, ENCY MOL PHARM, P948; Ozer M, 2013, BASIC CLIN PHARMACOL, V112, P209, DOI 10.1111/bcpt.12024; Ozer N, 2010, HEART VESSELS, V25, P155, DOI 10.1007/s00380-009-1177-7; Ozgon GO, 2008, EUR J CLIN PHARMACOL, V64, P889, DOI 10.1007/s00228-008-0507-5; Pathare A, 2012, J HUM GENET, V57, P665, DOI 10.1038/jhg.2012.94; Pirmohamed M, 2013, NEW ENGL J MED, V369, P2294, DOI 10.1056/NEJMoa1311386; Shahin MHA, 2013, THROMB HAEMOSTASIS, V109, P1045, DOI 10.1160/TH12-10-0789; Shahin MHA, 2011, PHARMACOGENET GENOM, V21, P130, DOI 10.1097/FPC.0b013e3283436b86; Shrif NEMA, 2011, EUR J CLIN PHARMACOL, V67, P1119, DOI 10.1007/s00228-011-1060-1; Takeuchi F, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000433; Thomas DD, 2015, HEMOSTASIS THROMBOSI, P1; Vecsler M, 2006, THROMB HAEMOSTASIS, V95, P205, DOI 10.1160/TH05-06-0446; Voora D, 2010, CLIN PHARMACOL THER, V87, P445, DOI 10.1038/clpt.2009.291; Wadelius M, 2005, PHARMACOGENOMICS J, V5, P262, DOI 10.1038/sj.tpj.6500313; Wadelius M, 2007, HUM GENET, V121, P23, DOI 10.1007/s00439-006-0260-8; Wu AHB, 2008, PHARMACOGENOMICS, V9, P169, DOI 10.2217/14622416.9.2.169; Wysowski DK, 2007, ARCH INTERN MED, V167, P1414, DOI 10.1001/archinte.167.13.1414; Yildirim E, 2014, HIPPOKRATIA, V18, P319; Yildirim R, 2015, TURK J BIOCHEM, V40, P271, DOI 10.1515/tjb-2015-0012; Yildirim R, 2012, TURK J MED SCI, V42, P981, DOI 10.3906/sag-1112-46; Yuan HY, 2005, HUM MOL GENET, V14, P1745, DOI 10.1093/hmg/ddi180; Zalloua PA, 2008, AM J HUM GENET, V83, P633, DOI 10.1016/j.ajhg.2008.10.012; Zalloua PA, 2008, AM J HUM GENET, V82, P873, DOI 10.1016/j.ajhg.2008.01.020; Zhu Y, 2007, CLIN CHEM, V53, P1199, DOI 10.1373/clinchem.2006.078139	59	21	21	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 19	2016	11	12							e0168732	10.1371/journal.pone.0168732	http://dx.doi.org/10.1371/journal.pone.0168732			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI9QC	27992547	gold, Green Published, Green Submitted			2022-12-27	WOS:000392842600094
J	Lafosse, A; Dufeys, C; Beauloye, C; Horman, S; Dufrane, D				Lafosse, Aurore; Dufeys, Cecile; Beauloye, Christophe; Horman, Sandrine; Dufrane, Denis			Impact of Hyperglycemia and Low Oxygen Tension on Adipose-Derived Stem Cells Compared with Dermal Fibroblasts and Keratinocytes: Importance for Wound Healing in Type 2 Diabetes	PLoS One			English	Article							STROMAL CELLS; MOLECULAR-BASIS; GROWTH-FACTOR; TISSUE; DIFFERENTIATION; DYSFUNCTION; SECRETION; HYPOXIA; DISEASE; ULCERS	Aim Adipose-derived stem cells (ASC) are currently proposed for wound healing in those with type 2 diabetes mellitus (T2DM). Therefore, this study investigated the impact of diabetes on adipose tissue in relation to ASC isolation, proliferation, and growth factor release and the impact of hyperglycemia and low oxygen tension (found in diabetic wounds) on dermal fibroblasts, keratinocytes, and ASC in vitro. Methods Different sequences of hypoxia and hyperglycemia were applied in vitro to ASC from nondiabetic (n = 8) or T2DM patients (n = 4) to study cell survival, proliferation, and growth factor release. Comparisons of dermal fibroblasts (n = 8) and keratinocytes (primary lineage) were made. Results No significant difference of isolation and proliferation capacities was found in ASC from nondiabetic and diabetic humans. Hypoxia and hyperglycemia did not impact cell viability and proliferation. Keratinocyte Growth Factor release was significantly lower in diabetic ASC than in nondiabetic ASC group in each condition, while Vascular Endothelial Growth Factor release was not affected by the diabetic origin. Nondiabetic ASC exposition to hypoxia (0.1% oxygen) combined with hyperglycemia (25mM glucose), resulted in a significant increase in VEGF secretion (+64%, p<0.05) with no deleterious impact on KGF release in comparison to physiological conditions (5% oxygen and 5 mM glucose). Stromal cell-Derived Factor-1 alpha (-93%, p<0.001) and KGF (-20%, p<0.05) secretion by DF decreased in these conditions. Conclusions A better profile of growth factor secretion (regarding wound healing) was found in vitro for ASC in hyperglycemia coupled with hypoxia in comparison to dermal fibroblasts and keratinocytes. Interestingly, ASC from T2DM donors demonstrated cellular growth rates and survival (in hypoxia and hyperglycemic conditions) similar to those of healthy ASC (from normoglycemic donors); however, KGF secretion was significantly depleted in ASC obtained from T2DM patients. This study demonstrated the impact of diabetes on ASC for regenerative medicine and wound healing.	[Lafosse, Aurore] Catholic Univ Louvain, Brussels, Belgium; [Dufeys, Cecile; Beauloye, Christophe; Horman, Sandrine] Catholic Univ Louvain, Pole Rech Cardiovasc CARD, Inst Rech Expt & Clin, Brussels, Belgium; [Dufrane, Denis] Novadip Biosci, Mont St Guibert, Belgium	Universite Catholique Louvain; Universite Catholique Louvain	Dufrane, D (corresponding author), Novadip Biosci, Mont St Guibert, Belgium.	denis.dufrane@novadip.com		Dufeys, Cecile/0000-0002-2042-7218	Fond pour la Recherche Scientifique (FRS-FNRS); Feedeeration Wallonie-Bruxelles (Action de Recherche Concerteee)	Fond pour la Recherche Scientifique (FRS-FNRS)(Fonds de la Recherche Scientifique - FNRS); Feedeeration Wallonie-Bruxelles (Action de Recherche Concerteee)	This work was supported by public grants from the Fond pour la Recherche Scientifique (FRS-FNRS) and from the Feedeeration Wallonie-Bruxelles (Action de Recherche Concerteee). The Fond pour la Recherche Scientifique provided salaries for Aurore Lafosse. The Action de Recherche Concerteee provided support to acquire the research materials. The authors have no financial interest to declare in relation to the content of this article. Novadip Biosciences did not fund the study in terms of study design, data collection and analysis, decision to publish, or preparation of the manuscript. Denis Dufrane is co-founder of Novadip Biosciences which provides a salary for the position of Chief Scientific Officer; however, Novadip Biosciences did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. There are no commercially relevant declarations (relating to employment, consultancy, patents, products in development, or marketed products, etc.) in relation this study.	Amos PJ, 2010, TISSUE ENG PT A, V16, P1595, DOI [10.1089/ten.tea.2009.0616, 10.1089/ten.TEA.2009.0616]; Boulton AJM, 2005, LANCET, V366, P1719, DOI 10.1016/S0140-6736(05)67698-2; Brem H, 2007, J CLIN INVEST, V117, P1219, DOI 10.1172/JCI32169; Cianfarani F, 2013, WOUND REPAIR REGEN, V21, P545, DOI 10.1111/wrr.12051; Coleman SR, 2001, CLIN PLAST SURG, V28, P111; de Meester C, 2014, CARDIOVASC RES, V101, P20, DOI 10.1093/cvr/cvt227; Desmet CM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0144914; Di Rocco G, 2011, STEM CELLS INT, V2011, DOI 10.4061/2011/304562; Dufrane D, 2016, STEM CELLS TRANSL ME; El-Ftesi S, 2009, PLAST RECONSTR SURG, V123, P475, DOI 10.1097/PRS.0b013e3181954d08; Gallagher KA, 2007, J CLIN INVEST, V117, P1249, DOI 10.1172/JCI29710; Harding K, 2013, INT WOUND J, V10, P132, DOI 10.1111/iwj.12053; Hoshino D, 2013, CELL REP, V5, P1159, DOI 10.1016/j.celrep.2013.10.050; Hu Guoku, 2012, Frontiers in Genetics, V3, P56, DOI 10.3389/fgene.2012.00056; Hu L, 2016, SCI REP-UK, V6, DOI 10.1038/srep32993; Johnson KE, 2014, ADV WOUND CARE, V3, P647, DOI 10.1089/wound.2013.0517; Kapur SK, 2013, BIOCHIMIE, V95, P2222, DOI 10.1016/j.biochi.2013.06.001; Kim EK, 2011, PLAST RECONSTR SURG, V128, P387, DOI 10.1097/PRS.0b013e31821e6de2; Kowal J, 2014, CURR OPIN CELL BIOL, V29, P116, DOI 10.1016/j.ceb.2014.05.004; Lafosse A, 2015, PLAST RECONSTR SURG, V136, P279, DOI 10.1097/PRS.0000000000001437; Lerman OZ, 2003, AM J PATHOL, V162, P303, DOI 10.1016/S0002-9440(10)63821-7; Lev-Tov H, 2013, TRIALS, V14, DOI 10.1186/1745-6215-14-8; Li X, 2016, EBIOMEDICINE, V8, P72, DOI 10.1016/j.ebiom.2016.04.030; Ma C, 2015, WOUNDS, V27, P83; Marti Guy P., 2008, V423, P383, DOI 10.1007/978-1-59745-194-9_30; Minamino T, 2009, NAT MED, V15, P1082, DOI 10.1038/nm.2014; Nambu M, 2009, ANN PLAS SURG, V62, P317, DOI 10.1097/SAP.0b013e31817f01b6; Nie CL, 2011, CELL TRANSPLANT, V20, P205, DOI 10.3727/096368910X520065; Patel Rekha S, 2016, Stem Cell Investig, V3, P2, DOI 10.3978/j.issn.2306-9759.2016.01.02; Policha A, 2014, J SURG RES, V192, P656, DOI 10.1016/j.jss.2014.06.041; Qu CQ, 2007, IN VITRO CELL DEV-AN, V43, P95, DOI 10.1007/s11626-006-9008-y; Rennert RC, 2014, STEM CELL RES THER, V5, DOI 10.1186/scrt468; Schubert T, 2013, BIOMATERIALS, V34, P4428, DOI 10.1016/j.biomaterials.2013.02.053; Seeger MA, 2015, ADV WOUND CARE, V4, P213, DOI 10.1089/wound.2014.0540; Shimizu I, 2014, CELL METAB, V20, P967, DOI 10.1016/j.cmet.2014.10.008; Thangarajah H, 2010, CELL CYCLE, V9, P75, DOI 10.4161/cc.9.1.10371; Thangarajah H, 2009, P NATL ACAD SCI USA, V106, P13505, DOI 10.1073/pnas.0906670106; Veriter S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0139566; Veriter S, 2011, BIOMATERIALS, V32, P5945, DOI 10.1016/j.biomaterials.2011.02.061; Wu YJ, 2007, STEM CELLS, V25, P2648, DOI 10.1634/stemcells.2007-0226; Xu X, 2013, CELLS TISSUES ORGANS, V197, P103, DOI 10.1159/000342921; Yan JL, 2012, J AM HEART ASSOC, V1, DOI 10.1161/JAHA.112.002238; Zelen CM, 2015, INT WOUND J, V12, P724, DOI 10.1111/iwj.12395; Zuk PA, 2002, MOL BIOL CELL, V13, P4279, DOI 10.1091/mbc.E02-02-0105	44	18	21	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 19	2016	11	12							e0168058	10.1371/journal.pone.0168058	http://dx.doi.org/10.1371/journal.pone.0168058			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI9QC	27992567	gold, Green Published, Green Submitted			2022-12-27	WOS:000392842600031
J	Wei, WE; Mao, NQ; Ning, SF; Li, JL; Liu, HZ; Xie, T; Zhong, JH; Feng, Y; Wei, CH; Zhang, LT				Wei, Wen-E; Mao, Nai-Quan; Ning, Shu-Fang; Li, Ji-Lin; Liu, Hai-Zhou; Xie, Tong; Zhong, Jian-Hong; Feng, Yan; Wei, Chang-Hong; Zhang, Li-Tu			An Analysis of EGFR Mutations among 1506 Cases of Non-Small Cell Lung Cancer Patients in Guangxi, China	PLOS ONE			English	Article							GROWTH-FACTOR-RECEPTOR; PHASE-II TRIAL; THYROID TRANSCRIPTION FACTOR-1; GENE AMPLIFICATION; KRAS MUTATIONS; NSCLC PATIENTS; GEFITINIB; ADENOCARCINOMA; EXPRESSION; INHIBITOR	An association between epidermal growth factor receptor (EGFR) and clinical characteristics of non-small cell lung cancer (NSCLC) was reported ten years ago. In addition, a different type of relationship was seen in different ethic races. However, the relationship between these factors is not well understood in the Guangxi province. Up to now, there are only very limited data on the association of TTF1/EGFR protein positivity and EGFR mutation status in NSCLC. This study aims to investigate the role of EGFR gene mutation status on the clinical characteristics and the relationship with TTF-1/EGFR protein positivity of patients with NSCLC in Guangxi, China. 1506 samples from different patients with NSCLC were detected by amplification refractory mutation system for 29 hotspot mutations. Analysis of the relationship between clinical characteristics and EGFR mutation status was performed by using the crosstabs Chi-square and SPSS 21.0 software. Of 1506 samples, 537 (35.7%) revealed tyrosine kinase inhibitor (TKI) sensitive EGFR mutations with 27 (1.8%) cases harboring TKI resistant EGFR mutations or union co-existing EGFR-TKIs sensitive mutations. EGFR-TKIs sensitive mutations were not significantly associated with age and TNM-M stage (P = 0.863; P = 0.572, respectively). However, they were significantly associated with p-stage, TNM-T stage and TNM-N stage (P = 0.011, P < 0.001, P = 0.036, respectively). Immunohistochemical studies revealed that TTF-1 and EGFR protein expression level were all associated with EGFR mutation status (P < 0.001, P = 0.002, respectively). Of the 537 EGFR-TKIs sensitive mutation cases, the rates of exon 19-del, 18 G719X point, exon 21 L858R and L861Q points were 54.6, 0.9, 42.3 and 0.9%, respectively. EGFR TKI-sensitive mutations commonly occur in female, non-smoking and adenocarcinoma patients. The p-stage, TNM-T stage, TNM-N stage, EGFR and TTF-1 protein expression levels have close relationships with EGFR mutation status.	[Wei, Wen-E; Ning, Shu-Fang; Li, Ji-Lin; Liu, Hai-Zhou; Zhong, Jian-Hong; Feng, Yan; Zhang, Li-Tu] Guangxi Med Univ, Affiliated Tumor Hosp, Dept Res, Nanning, Peoples R China; [Mao, Nai-Quan; Xie, Tong] Guangxi Med Univ, Affiliated Tumor Hosp, Dept Thorac Surg, Nanning, Peoples R China; [Wei, Chang-Hong] Guangxi Med Univ, Affiliated Tumor Hosp, Dept Pathol, Nanning, Peoples R China	Guangxi Medical University; Guangxi Medical University; Guangxi Medical University	Zhang, LT (corresponding author), Guangxi Med Univ, Affiliated Tumor Hosp, Dept Res, Nanning, Peoples R China.	zhanglitu@gmail.com	ZHANG, LITU/AAI-1671-2019; Liu, Haizhou/GLT-3483-2022	ZHANG, LITU/0000-0002-3305-3294; Liu, Haizhou/0000-0001-5111-5295	Guangxi Scientific Research and Technical Development Program [1298003-2-8]	Guangxi Scientific Research and Technical Development Program	This study was supported by the Guangxi Scientific Research and Technical Development Program (1298003-2-8).	Anagnostou VK, 2009, J CLIN ONCOL, V27, P271, DOI 10.1200/JCO.2008.17.0043; Asahina H, 2006, BRIT J CANCER, V95, P998, DOI 10.1038/sj.bjc.6603393; Barlesi F, 2005, BRIT J CANCER, V93, P450, DOI 10.1038/sj.bjc.6602717; Barletta JA, 2009, J CELL MOL MED, V13, P1977, DOI 10.1111/j.1582-4934.2008.00594.x; Boccardo F, 2008, ONCOLOGY-BASEL, V74, P223, DOI 10.1159/000151391; Chen Z, 2014, NAT REV CANCER, V14, P535, DOI 10.1038/nrc3775; Chiu CH, 2014, CANCER CHEMOTH PHARM, V74, P661, DOI 10.1007/s00280-014-2536-3; Detterbeck FC, 2009, CHEST, V136, P260, DOI 10.1378/chest.08-0978; Dogan S, 2012, CLIN CANCER RES, V18, P6169, DOI 10.1158/1078-0432.CCR-11-3265; Gahr S, 2013, BRIT J CANCER, V109, P1821, DOI 10.1038/bjc.2013.511; Gao B, 2010, J THORAC ONCOL, V5, P1130, DOI 10.1097/JTO.0b013e3181e05016; Hegi ME, 2011, MOL CANCER THER, V10, P1102, DOI 10.1158/1535-7163.MCT-11-0048; Helland A, 2011, J THORAC ONCOL, V6, P947, DOI 10.1097/JTO.0b013e31820db209; Kosaka T, 2004, CANCER RES, V64, P8919, DOI 10.1158/0008-5472.CAN-04-2818; Kuiper JL, 2015, CLIN LUNG CANCER, V16, P60, DOI 10.1016/j.cllc.2014.07.008; Lai YY, 2013, INT J MOL SCI, V14, P24549, DOI 10.3390/ijms141224549; Lee JK, 2014, JAMA-J AM MED ASSOC, V311, P1430, DOI 10.1001/jama.2014.3314; Lynch TJ, 2004, NEW ENGL J MED, V350, P2129, DOI 10.1056/NEJMoa040938; Micke P, 2016, J THORAC ONCOL, V11, P862, DOI 10.1016/j.jtho.2016.01.020; Mitsudomi Tetsuya, 2006, Int J Clin Oncol, V11, P190, DOI 10.1007/s10147-006-0583-4; Mu D, 2013, J BIOL CHEM, V288, P24992, DOI 10.1074/jbc.R113.491647; Paez JG, 2004, SCIENCE, V304, P1497, DOI 10.1126/science.1099314; Perner S, 2009, J PATHOL, V217, P65, DOI 10.1002/path.2443; Ramalingam SS, 2012, J CLIN ONCOL, V30, P3337, DOI 10.1200/JCO.2011.40.9433; Shek D, 2011, INT J CLIN ONCOL, V16, P494, DOI 10.1007/s10147-011-0212-8; Sonobe M, 2005, BRIT J CANCER, V93, P355, DOI 10.1038/sj.bjc.6602707; Sun PL, 2012, J THORAC ONCOL, V7, P323, DOI 10.1097/JTO.0b013e3182381515; Sunaga N, 2007, LUNG CANCER, V56, P383, DOI 10.1016/j.lungcan.2007.01.025; Sutani A, 2006, BRIT J CANCER, V95, P1483, DOI 10.1038/sj.bjc.6603466; Tamura K, 2008, BRIT J CANCER, V98, P907, DOI 10.1038/sj.bjc.6604249; Tanaka T, 2010, INT J CANCER, V126, P651, DOI 10.1002/ijc.24746; Tokumo M, 2005, CLIN CANCER RES, V11, P1167; Torre LA, 2015, CA-CANCER J CLIN, V65, P87, DOI 10.3322/caac.21262; Wan SZ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095479; Xu XY, 2014, PATHOL RES PRACT, V210, P680, DOI 10.1016/j.prp.2014.06.021	35	14	15	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 19	2016	11	12							e0168795	10.1371/journal.pone.0168795	http://dx.doi.org/10.1371/journal.pone.0168795			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI9QC	27992557	Green Published, gold, Green Submitted			2022-12-27	WOS:000392842600098
J	Fall, B; Scott, CR; Mauer, M; Shankland, S; Pippin, J; Jefferson, JA; Wallace, E; Warnock, D; Najafian, B				Fall, Brent; Scott, C. Ronald; Mauer, Michael; Shankland, Stuart; Pippin, Jeffrey; Jefferson, Jonathan A.; Wallace, Eric; Warnock, David; Najafian, Behzad			Urinary Podocyte Loss Is Increased in Patients with Fabry Disease and Correlates with Clinical Severity of Fabry Nephropathy	PLOS ONE			English	Article							ENZYME REPLACEMENT THERAPY; AGALSIDASE-BETA; IGA NEPHROPATHY; KIDNEY-DISEASES; RENAL-DISEASE; GLOMERULOSCLEROSIS; EXCRETION; CELL; PODOCALYXIN; PROGRESSION	Chronic kidney disease is a major complication of Fabry disease. Podocytes accumulate globotriaosylceramide inclusions more than other kidney cell types in Fabry patients. Podocyte injury occurs early in age, and is progressive. Since injured podocytes detach into the urine (podocyturia), we hypothesized that podocyturia would increase in Fabry patients and correlate with clinical severity of Fabry nephropathy. Urine specimens from 39 Fabry patients and 24 healthy subjects were evaluated for podocyturia. Most of the Fabry patients and many healthy subjects had podocyturia. The number of podocytes per gram of urine creatinine (UPodo/g Cr) was 3.6 fold greater in Fabry patients (3,741 +/- 2796; p = 0.001) than healthy subjects (1,040 +/- 972). Fabry patients with normoalbuminuria and normoproteinuria had over 2-fold greater UPodo/g Cr than healthy subjects (p = 0.048). UPodo/gCr was inversely related to eGFR in male patients (r = -0.69, p = 0.003). UPodo/gCr was directly related to urine protein creatinine ratio (r = 0.33; p = 0.04) in all Fabry patients. These studies confirm increased podocyturia in Fabry disease, even when proteinuria and albuminuria are absent. Podocyturia correlates with clinical severity of Fabry nephropathy, and potentially may be of prognostic value.	[Fall, Brent; Najafian, Behzad] Univ Washington, Dept Pathol, Seattle, WA 98195 USA; [Scott, C. Ronald] Univ Washington, Dept Pediat, Seattle, WA 98195 USA; [Mauer, Michael] Univ Minnesota, Dept Pediat, Minneapolis, MN 55455 USA; [Mauer, Michael] Univ Minnesota, Dept Med, Box 736 UMHC, Minneapolis, MN 55455 USA; [Shankland, Stuart; Pippin, Jeffrey; Jefferson, Jonathan A.] Univ Washington, Dept Med, Seattle, WA USA; [Wallace, Eric; Warnock, David] Univ Alabama Birmingham, Dept Med, Birmingham, AL 35294 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of Washington; University of Washington Seattle; University of Alabama System; University of Alabama Birmingham	Najafian, B (corresponding author), Univ Washington, Dept Pathol, Seattle, WA 98195 USA.	najafian@uw.edu	Mauer, Michael/ABD-5415-2020; Jefferson, Jonathan/AAA-9679-2019	Najafian, Behzad/0000-0002-0904-6721				Asao R, 2012, CLIN J AM SOC NEPHRO, V7, P1385, DOI 10.2215/CJN.08110811; Bariety J, 2006, J AM SOC NEPHROL, V17, P2770, DOI 10.1681/ASN.2006040325; Biegstraaten M, 2015, ORPHANET J RARE DIS, V10, DOI 10.1186/s13023-015-0253-6; Germain DP, 2007, J AM SOC NEPHROL, V18, P1547, DOI 10.1681/ASN.2006080816; Germain DP, 2015, J MED GENET, V52, P353, DOI 10.1136/jmedgenet-2014-102797; Hanamura K, 2014, CLIN EXP NEPHROL, V18, P95, DOI 10.1007/s10157-013-0814-8; Hara M, 1998, AM J NEPHROL, V18, P35, DOI 10.1159/000013302; Hara M, 2001, NEPHRON, V89, P342, DOI 10.1159/000046097; Hara M, 2007, CLIN J AM SOC NEPHRO, V2, P231, DOI 10.2215/CJN.01470506; Hodgin JB, 2015, J AM SOC NEPHROL, V26, P3162, DOI 10.1681/ASN.2014080752; Ito S, 2016, PEDIATR NEPHROL, V31, P1369, DOI 10.1007/s00467-016-3387-4; KERJASCHKI D, 1984, J CELL BIOL, V98, P1591, DOI 10.1083/jcb.98.4.1591; Kirk A, 2010, NEPHROL DIAL TRANSPL, V25, P2107, DOI 10.1093/ndt/gfq006; Kriz W, 1996, NEPHROL DIAL TRANSPL, V11, P1738, DOI 10.1093/oxfordjournals.ndt.a027660; Kriz W, 2002, MICROSC RES TECHNIQ, V57, P189, DOI 10.1002/jemt.10072; Levey AS, 2009, ANN INTERN MED, V150, P604, DOI 10.7326/0003-4819-150-9-200905050-00006; Lidove O, 2010, GENET MED, V12, P668, DOI 10.1097/GIM.0b013e3181f13b75; Liebau MC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063506; Mauer M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112188; Melk A, 2003, KIDNEY INT, V63, P2134, DOI 10.1046/j.1523-1755.2003.00032.x; Najafian B, 2011, KIDNEY INT, V79, P663, DOI 10.1038/ki.2010.484; Pereira Ester Miranda, 2016, J Bras Nefrol, V38, P49, DOI 10.5935/0101-2800.20160008; Ramsuran D, 2012, PREGNANCY HYPERTENS, V2, P43, DOI 10.1016/j.preghy.2011.09.004; Rigoldi M, 2014, CLIN GENET, V86, P258, DOI 10.1111/cge.12261; Salako SE, 2006, MED LAW, V25, P341; Schiffer M, 2001, J CLIN INVEST, V108, P807, DOI 10.1172/JCI12367; Selvarajah M, 2011, NEPHROL DIAL TRANSPL, V26, P3195, DOI 10.1093/ndt/gfr084; Shankland SJ, 2014, SEMIN NEPHROL, V34, P418, DOI 10.1016/j.semnephrol.2014.06.008; Shen PC, 2014, CLIN LAB, V60, P1709, DOI 10.7754/Clin.Lab.2014.131225; Skrunes R., 2016, NEPHROL DIAL TRANSPL; Sun D, 2012, RENAL FAILURE, V34, P403, DOI 10.3109/0886022X.2011.649627; Thurberg BL, 2002, KIDNEY INT, V62, P1933, DOI 10.1046/j.1523-1755.2002.00675.x; Tondel C, 2015, NEPHRON, V129, P16, DOI 10.1159/000369309; Tondel C, 2013, J AM SOC NEPHROL, V24, P137, DOI 10.1681/ASN.2012030316; Toyoda M, 2007, DIABETES, V56, P2155, DOI 10.2337/db07-0019; Trimarchi H, 2015, Case Rep Nephrol, V2015, P257628, DOI 10.1155/2015/257628; Trimarchi H, 2016, J NEPHROL; Tsutsumi O, 1985, Asia Oceania J Obstet Gynaecol, V11, P39; Vogelmann SU, 2003, AM J PHYSIOL-RENAL, V285, pF40, DOI 10.1152/ajprenal.00404.2002; Warnock DG, 2014, J AM SOC NEPHROL, V25, P653, DOI 10.1681/ASN.2013121322; Warnock DG, 2012, NEPHROL DIAL TRANSPL, V27, P1042, DOI 10.1093/ndt/gfr420; White WM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092693	42	35	35	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2016	11	12							e0168346	10.1371/journal.pone.0168346	http://dx.doi.org/10.1371/journal.pone.0168346			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI8LN	27992580	Green Published, Green Submitted, gold			2022-12-27	WOS:000392758000037
J	Oral, E; Simonsen, N; Brennan, C; Berken, J; Su, LJ; Mohler, JL; Bensen, JT; Fontham, ETH				Oral, Evrim; Simonsen, Neal; Brennan, Christine; Berken, Jennifer; Su, L. Joseph; Mohler, James L.; Bensen, Jeannette T.; Fontham, Elizabeth T. H.			Unit Nonresponse in a Population-Based Study of Prostate Cancer	PLOS ONE			English	Article							MAILED QUESTIONNAIRE; POSTAL QUESTIONNAIRE; PARTICIPATION RATES; AFRICAN-AMERICANS; CLINICAL-TRIALS; LIFE-STYLE; BIAS; EXPOSURE; HEALTH; NONPARTICIPATION	Low unit response rates can increase bias and compromise study validity. Response rates have continued to fall over the past decade despite all efforts to increase participation. Many factors have been linked to reduced response, yet relatively few studies have employed multivariate approaches to identify characteristics that differentiate respondents from nonrespondents since it is hard to collect information on the latter. We aimed to assess factors contributing to enrollment of prostate cancer (PCa) patients. We combined data from the North Carolina-Louisiana (LA) PCa Project's LA cohort, with additional sources such as US census tract and LA tumor registry data. We included specific analyses focusing on blacks, a group often identified as hard to enroll in health-related research. The ability to study the effect of Hurricane Katrina, which occurred amidst enrollment, as a potential determinant of nonresponse makes our study unique. Older age (>= 70) for blacks (OR 0.65) and study phase with respect to Hurricane Katrina for both races (OR 0.59 for blacks, OR 0.48 for whites) were significant predictors of participation with lower odds. Neighborhood poverty for whites (OR 1.53) also was a significant predictor of participation, but with higher odds. Among blacks, residence in Orleans parish was associated with lower odds of participation (OR 0.33) before Katrina. The opposite occurred in whites, with lower odds (OR 0.43) after Katrina. Our results overall underscore the importance of tailoring enrollment approaches to specific target population characteristics to confront the challenges posed by nonresponse. Our results also show that recruitment-related factors may change when outside forces bring major alterations to a population's environment and demographics.	[Oral, Evrim] LSUHSC Sch Publ Hlth, Biostat Program, New Orleans, LA 70112 USA; [Brennan, Christine] LSUHSC Sch Publ Hlth, Hlth Policy Syst Management Program, New Orleans, LA USA; [Berken, Jennifer] McNeese State Univ, Dept Math Sci, Lake Charles, LA 70605 USA; [Su, L. Joseph] Univ Arkansas Med Sci, Dept Epidemiol, Little Rock, AR 72205 USA; [Mohler, James L.] Roswell Pk Canc Inst, Dept Urol, Buffalo, NY 14263 USA; [Mohler, James L.; Bensen, Jeannette T.] Univ North Carolina Chapel Hill, Lineberger Comprehens Canc Ctr, Chapel Hill, NC USA; [Fontham, Elizabeth T. H.] LSUHSC Sch Publ Hlth, Program Epidemiol, New Orleans, LA USA	Louisiana State University System; Louisiana State University Health Sciences Center New Orleans; Louisiana State University System; Louisiana State University Health Sciences Center New Orleans; University of Louisiana System; McNeese State University; University of Arkansas System; University of Arkansas Medical Sciences; Roswell Park Cancer Institute; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; Louisiana State University System; Louisiana State University Health Sciences Center New Orleans	Oral, E (corresponding author), LSUHSC Sch Publ Hlth, Biostat Program, New Orleans, LA 70112 USA.	eoral@lsuhsc.edu	Oral, Evrim/C-9268-2016	Oral, Evrim/0000-0003-2976-0778	Department of Defense [DAMD 17-03-2-0052]; NIH [NCI R15 CA151031]	Department of Defense(United States Department of Defense); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	The North Carolina-Louisiana Prostate Cancer Project (PCaP) is carried out as a collaborative study supported by the Department of Defense contract DAMD 17-03-2-0052 and NIH grant NCI R15 CA151031. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aanerud M, 2013, J TELEMED TELECARE, P1; Abel GA, 2016, CANCER EPIDEMIOL, V41, P34, DOI 10.1016/j.canep.2015.12.010; BAKKE P, 1990, J EPIDEMIOL COMMUN H, V44, P316, DOI 10.1136/jech.44.4.316; Bakke PS, 2010, RESP MED, V104, P323, DOI 10.1016/j.rmed.2009.11.018; BENNETT CM, 1964, J EDUC RES, V58, P178, DOI 10.1080/00220671.1964.10883202; Bethlehem J., 2011, HDB NONRESPONSE HOUS; Bethlehem J.G., 1985, J OFF STAT, V1, P287; Biemer P., 2003, INTRO SURVEY QUALITY; BOSTROM G, 1993, SCAND J SOC MED, V21, P77, DOI 10.1177/140349489302100204; Brennan C, 2012, AM MED J, V3, P104; Brick JM, 2013, ANN AM ACAD POLIT SS, V645, P36, DOI 10.1177/0002716212456834; Buelens BJ, 2010, SURVEY PRACTICE, V3; Burg JAR, 1997, TOXICOL IND HEALTH, V13, P1; Calderwood L, 2010, WORKING PAPER; Camara RJA, 2011, J EPIDEMIOL, V21, P44, DOI 10.2188/jea.JE20100087; COPE RG, 1968, J EXP EDUC, V36, P32, DOI 10.1080/00220973.1968.11011054; Corbie-Smith G, 1999, J GEN INTERN MED, V14, P537, DOI 10.1046/j.1525-1497.1999.07048.x; Couper MP, 1997, PUBLIC OPIN QUART, V61, P317, DOI 10.1086/297797; Cunradi CB, 2005, SUBST USE MISUSE, V40, P171, DOI 10.1081/JA-200048447; Curtin R, 2005, PUBLIC OPIN QUART, V69, P87, DOI 10.1093/poq/nfi002; De Leeuw E.D, 2005, J OFF STAT, V21, P233, DOI DOI 10.1111/J.1524-4733.2007.00231.X; De Leeuw E, 2007, PUBLIC OPIN QUART, V71, P413, DOI 10.1093/poq/nfm014; DeSantis CE, 2014, CA-CANCER J CLIN, V64, P252, DOI 10.3322/caac.21235; Drivsholm T, 2006, SCAND J PUBLIC HEALT, V34, P623, DOI 10.1080/14034940600607616; Durant RW, 2011, J NATL MED ASSOC, V103, P123, DOI 10.1016/S0027-9684(15)30261-3; Eagan TML, 2002, J CLIN EPIDEMIOL, V55, P775, DOI 10.1016/S0895-4356(02)00431-6; Elliott JR, 2009, ORGAN ENVIRON, V22, P410, DOI 10.1177/1086026609347184; Falk W.W., 2006, DU BOIS REV, V3, P115, DOI DOI 10.1017/S1742058X06060036; Fejer R, 2006, EUR J EPIDEMIOL, V21, P171, DOI 10.1007/s10654-006-0006-x; Ford JG, 2008, CANCER, V112, P228, DOI 10.1002/cncr.23157; Fricker S. S., 2007, THESIS; Fussell E, 2007, J AM HIST, V94, P846, DOI 10.2307/25095147; Fussell E, 2010, POPUL ENVIRON, V31, P20, DOI 10.1007/s11111-009-0092-2; Galea S, 2007, ANN EPIDEMIOL, V17, P643, DOI 10.1016/j.annepidem.2007.03.013; GERSHEN JA, 1983, PSYCHOL REP, V52, P555, DOI 10.2466/pr0.1983.52.2.555; Gomella LG, 2009, UROLOGY, V73, P28, DOI 10.1016/j.urology.2009.03.003; Groves R.M., 1998, NONRESPONSE HOUSEHOL; Hall AE, 2013, J CLIN EPIDEMIOL, V66, P85, DOI 10.1016/j.jclinepi.2012.07.016; Hartge P, 2006, EPIDEMIOLOGY, V17, P252, DOI 10.1097/01.ede.0000209441.24307.92; Heraty S, 2012, 13 ANN RES C, P36; Hill A, 1997, J PUBLIC HEALTH MED, V19, P203, DOI 10.1093/oxfordjournals.pubmed.a024610; Hille ETM, 2005, PEDIATRICS, V116, pE662, DOI 10.1542/peds.2005-0682; Hussain A, 2009, J TRAUMA STRESS, V22, P324, DOI 10.1002/jts.20431; Jackson R, 1996, J CLIN EPIDEMIOL, V49, P1441, DOI 10.1016/0895-4356(95)00047-X; Jacomb PA, 2002, BMC PUBLIC HEALTH, V2, DOI 10.1186/1471-2458-2-4; Johnson T., 2003, 58 ANN M AM ASS PUBL; KESSLER RC, 1995, EPIDEMIOL REV, V17, P192, DOI 10.1093/oxfordjournals.epirev.a036176; Lahaut VMHCJ, 2002, ALCOHOL ALCOHOLISM, V37, P256, DOI 10.1093/alcalc/37.3.256; Link M, 2003, IMPROVING RESPONSE R, P141; Logan JR, 2006, IMPACT KATRINA RACE; Lynn P., 2002, SURVEY NONRESPONSE; Martin E. A., 2007, GUIDELINES DESIGNING; May L, 2014, INFECT CONT HOSP EP, V35, P1114, DOI 10.1086/677637; Mazloum M, 2012, PAEDIATR PERINAT EP, V26, P276, DOI 10.1111/j.1365-3016.2011.01253.x; Moorman PG, 1999, ANN EPIDEMIOL, V9, P188, DOI 10.1016/S1047-2797(98)00057-X; Morton LM, 2006, AM J EPIDEMIOL, V163, P197, DOI 10.1093/aje/kwj036; ONEIL MJ, 1979, PUBLIC OPIN QUART, V43, P218, DOI 10.1086/268513; Partin MR, 2003, J CLIN EPIDEMIOL, V56, P867, DOI 10.1016/S0895-4356(03)00061-1; Reijneveld SA, 1999, INT J EPIDEMIOL, V28, P1134, DOI 10.1093/ije/28.6.1134; Richiardi L, 2002, J CLIN EPIDEMIOL, V55, P1033, DOI 10.1016/S0895-4356(02)00455-9; Ronmark E, 1999, EUR J EPIDEMIOL, V15, P293, DOI 10.1023/A:1007582518922; Safir A, 2008, P AM STAT ASS, P4436; Scharff DP, 2010, J HEALTH CARE POOR U, V21, P879, DOI 10.1353/hpu.0.0323; Schroeder JC, 2006, PROSTATE, V66, P1162, DOI 10.1002/pros.20449; Shahar E, 1996, ANN EPIDEMIOL, V6, P498, DOI 10.1016/S1047-2797(96)00104-4; SINGER E, 2002, USE INCENTIVES REDUC, P163; Sinibaldi J, 2009, INTERVIEWER CHARACTE, P5955; Slattery Martha L., 1995, Annals of Epidemiology, V5, P245, DOI 10.1016/1047-2797(94)00113-8; Smith G, 1999, J GEN INTERNAL MED, V14, P537, DOI [10.1046/j.1525-14971999.07048.x, DOI 10.1046/J.1525-14971999.07048.XPMID:10491242]; SOGAARD AJ, 2004, INT J EQUITY HEALTH, V3, DOI DOI 10.1186/1475-9276-3-3; Stang A, 2003, EUR J EPIDEMIOL, V18, P929, DOI 10.1023/A:1025877501423; Symonds RP, 2012, BRIT J CANCER, V107, P1017, DOI 10.1038/bjc.2012.240; The American Association for Public Opinion Research, 2016, STAND DEF FIN DISP C, V9; TIBBLIN G, 1965, ACTA MED SCAND, V178, P453; Tolonen H, 2006, EUR J EPIDEMIOL, V21, P409, DOI 10.1007/s10654-006-9019-8; Vink JM, 2004, EUR J EPIDEMIOL, V19, P623, DOI 10.1023/B:EJEP.0000036814.56108.66; WILHELMSEN L, 1976, J CHRON DIS, V29, P331, DOI 10.1016/0021-9681(76)90093-X	77	3	3	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2016	11	12							e0168364	10.1371/journal.pone.0168364	http://dx.doi.org/10.1371/journal.pone.0168364			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EI8LN	27992587	Green Published, gold, Green Submitted			2022-12-27	WOS:000392758000040
J	Galtan, L; Laderach, P; Graefe, S; Rao, I; van der Hoek, R				Galtan, Lucia; Laderach, Peter; Graefe, Sophie; Rao, Idupulapati; van der Hoek, Rein			Climate-Smart Livestock Systems: An Assessment of Carbon Stocks and GHG Emissions in Nicaragua	PLOS ONE			English	Article							NITRIFICATION INHIBITION BNI; GREENHOUSE-GAS EMISSIONS; PASTURES; FORAGE; SEQUESTRATION; PRODUCTIVITY; EFFICIENCIES; MANAGEMENT; DYNAMICS; NITROGEN	Livestock systems in the tropics can contribute to mitigate climate change by reducing greenhouse gas (GHG) emissions and increasing carbon accumulation. We quantified C stocks and GHG emissions of 30 dual-purpose cattle farms in Nicaragua using farm inventories and lifecycle analysis. Trees in silvo-pastoral systems were the main C stock above-ground (16-24 Mg ha(-1)), compared with adjacent secondary forests (43 Mg C ha(-1)). We estimated that methane from enteric fermentation contributed 1.6 kg CO2-eq., and nitrous oxide from excreta 0.4 kg CO2-eq. per kg of milk produced. Seven farms that we classified as climate-smart agriculture (CSA) out of 16 farms had highest milk yields (6.2 kg cow(-1) day(-1)) and lowest emissions (1.7 kg CO2-eq. per kg milk produced). Livestock on these farms had higher-quality diets, especially during the dry season, and manure was managed better. Increasing the numbers of CSA farms and improving CSA technology will require better enabling policy and incentives such as payments for ecosystem services.	[Galtan, Lucia; Laderach, Peter; van der Hoek, Rein] Int Ctr Trop Agr CIAT, Managua, Nicaragua; [Graefe, Sophie] Georg August Univ Gottingen, Trop Silviculture & Forest Ecol, Gottingen, Germany; [Rao, Idupulapati] Int Ctr Trop Agr CIAT, Cali, Colombia	Alliance; International Center for Tropical Agriculture - CIAT; University of Gottingen; Alliance; International Center for Tropical Agriculture - CIAT	Galtan, L (corresponding author), Int Ctr Trop Agr CIAT, Managua, Nicaragua.	lucia.gaitan.sanchez@gmail.com	Rao, Idupulapati M./H-4838-2019	Rao, Idupulapati M./0000-0002-8381-9358; Laderach, Peter/0000-0001-8708-6318	CGIAR Fund Council; Australia (ACIAR); Irish Aid; European Union; International Fund for Agricultural Development (IFAD), Netherlands, New Zealand, Switzerland, UK; USAID; Bundesministerium fur wirtschaftliche Zusammenarbeit and Entwicklung (BMZ); International Center for Tropical Agriculture [11.7860.7-001.00]; CGIAR Fund	CGIAR Fund Council(CGIAR); Australia (ACIAR); Irish Aid(CGIAR); European Union(European Commission); International Fund for Agricultural Development (IFAD), Netherlands, New Zealand, Switzerland, UK; USAID(United States Agency for International Development (USAID)); Bundesministerium fur wirtschaftliche Zusammenarbeit and Entwicklung (BMZ); International Center for Tropical Agriculture; CGIAR Fund(CGIAR)	We acknowledge the CGIAR Fund Council, Australia (ACIAR), Irish Aid, European Union, International Fund for Agricultural Development (IFAD), Netherlands, New Zealand, Switzerland, UK, USAID and Thailand for funding to the CGIAR Research Program on Climate Change, Agriculture and Food Security (CCAFS) and the Bundesministerium fur wirtschaftliche Zusammenarbeit and Entwicklung (BMZ) http://www.bmz.de/de/index.html <http://www.bmz.de/de/index.html>. Contact #: 81170344, Project Processing #: 11.7860.7-001.00, CIAT (International Center for Tropical Agriculture) Dr. Peter Laderach, Dr. Rein van der Hoek.; This work was implemented by the International Center for Tropical Agriculture (CIAT) under the CGIAR Research Program on Climate Change, Agriculture and Food Security (CCAFS). We thank BMZ for financing this study as part of a project on carbon insetting, and all other donors who supported this work through their contributions to the CGIAR Fund. We thank staff of CATIE, especially Claudia Sepulveda and Diego Tobar, for their advice and contribution to this work, through the project "Competitividad de la came y leche a traves de la intensificacion sostenible y el acceso a mercados especializados en Nicaragua" supported by Solidaridad Network. We also thank Myles Fisher for his comments and suggestions in preparing the manuscript.	Amezquita M. C., 2010, Integrated Crop Management, V11, P153; [Anonymous], DUAL PURPOSE MILK BE; [Anonymous], [No title captured]; Bowman MS, 2012, LAND USE POLICY, V29, P558, DOI 10.1016/j.landusepol.2011.09.009; Cederberg C, 2011, ENVIRON SCI TECHNOL, V45, P1773, DOI 10.1021/es103240z; Centro Internacional de Agricultura Tropical (CIAT), 2014, LIVESTOCKPLUS FAST T; Chacón-León Mario, 2013, Agron. Mesoam, V24, P17; Chandramoni, 2000, ANIM FEED SCI TECH, V83, P287, DOI 10.1016/S0377-8401(99)00132-7; Chave J, 2005, OECOLOGIA, V145, P87, DOI 10.1007/s00442-005-0100-x; Chuncho G, 2010, THESIS; de Leis CM, 2015, INT J LIFE CYCLE ASS, V20, P46, DOI 10.1007/s11367-014-0813-3; Delgado C, 2001, OUTLOOK AGR, V30, P27, DOI 10.5367/000000001101293427; Douxchamps S, 2014, AGROECOL SUST FOOD, V38, P25, DOI 10.1080/21683565.2013.828667; Ecoinvent, 2010, EC 2 0 DAT; FAO (Food and Agriculture Organization), 2010, CLIM SMART AGR POL P; *FAOSTAT, 2006, STAT DAT; Ferreira CM, 2001, THESIS; Fisher MJ, 2007, TROP GRASSLANDS, V41, P65; FISHER MJ, 1994, NATURE, V371, P236, DOI 10.1038/371236a0; Foley JA, 2011, NATURE, V478, P337, DOI 10.1038/nature10452; Food and Agriculture Organization, 2009, STAT FOOD AGR LIV BA, DOI 10.1017/S2078633610001128; Food and Agriculture Organizations (FAO), 2013, CLIM SMART LIV CLIM; Forest Trends and Katoomba Group, 2008, PAYM EC SERV GETT ST; Franco L, 2006, MANEJO UTILIZACION F; GAMMA (Programa de Ganader A o a y manejo del medio ambiente), 2010, PROGR FOM PROD AGR S; Gerber P, 2010, GREENHOUSE GAS EMISS; Gerber P.J., 2013, TACKLING CLIMATE CHA, P139; Gerber P, 2011, LIVEST SCI, V139, P100, DOI 10.1016/j.livsci.2011.03.012; Guerra L, 2010, HOJA CALCULO GEI; Havlik P, 2013, AM J AGR ECON, V95, P442, DOI 10.1093/ajae/aas085; Henderson C, 2014, CARBON INSETTING COF; Herrero M, 2013, ANIMAL, V7, P3, DOI 10.1017/S1751731112001954; Herrero M, 2013, P NATL ACAD SCI USA, V110, P20888, DOI 10.1073/pnas.1308149110; Herrero M, 2009, CURR OPIN ENV SUST, V1, P111, DOI 10.1016/j.cosust.2009.10.003; Holdridge LR, 1987, ECOLOGIA BASADA ZONA; Holmann F, 1993, MILK BEEF PRODUCTION; Hristov AN, 2015, P NATL ACAD SCI USA, V112, P10663, DOI 10.1073/pnas.1504124112; Ibrahim M., 2007, Agroforesteria en las Americas, P27; Intergovernmental Panel on Climate Change (IPCC), 2006, GUID NAT GREEN HOUS, V11; Intergovernmental Panel on Climate Change (IPCC), 2006, GUID NAT GREEN HOUS, V10; Intergovernmental Panel on Climate Change (IPCC), 2006, GUID NAT GREEN HOUS, V4; IPCC, 2019, REF 2006 IPCC GUID N; ISO, 2006, 14044 ISO; Jank L, 2014, CROP PASTURE SCI, V65, P1132, DOI 10.1071/CP13319; Jarvis A., 2008, CGIAR CSI SRTM 90 M, DOI DOI 10.1111/ecog.00774; Malin D, 2013, DESIGNING TRIPLE WIN; McGroddy ME, 2015, BIOTROPICA, V47, P407, DOI 10.1111/btp.12225; Metz ORDB, 2007, CLIMATE CHANGE 2007; Moreta DE, 2014, TROP GRASSL-FORRAJES, V2, P88, DOI 10.17138/TGFT(2)88-91; Murgueitio E, 2011, TROPICAL GRASSLANDS, V1, P137; Nair PKR, 2010, ADV AGRON, V108, P237, DOI 10.1016/S0065-2113(10)08005-3; National Research Council (NRC), 1978, SUBC DAIR CATTL NUTR; Perez E, 2013, NICARAGUA DUAL PURPO; Peters M., 2013, TROP GRASSLANDS, V1, P137, DOI 10.17138/TGFT(1)156-167; Peters M., 2011, ESPECIES FORRAJERAS; Peters M, 2013, ECOEFFICIENCY VISION; Pierrehumbert RT, 2015, ENVIRON RES LETT, V10, DOI 10.1088/1748-9326/10/8/085002; Rao I, 2015, TROP GRASSL-FORRAJES, V3, P59, DOI 10.17138/TGFT(3)59-82; Rao I., 2015, INC WORKSH CIAT CAL; Rao I., 2014, RURAL21, V21, P12; Rivera J. E., 2014, LIVESTOCK RES RURAL, V26; Rufino MC, 2007, LIVEST SCI, V112, P273, DOI 10.1016/j.livsci.2007.09.011; Rugnitz M. T., 2009, GUIA DETERMINACION C; Ruviaro CF, 2015, J CLEAN PROD, V96, P435, DOI 10.1016/j.jclepro.2014.01.037; Schultze-Kraft R., 1997, GIESSENER BEITRAGE E, V24, P1; Silver WL, 2004, ECOL APPL, V14, P1115, DOI 10.1890/03-5123; Smith P, 2008, PHILOS T R SOC B, V363, P789, DOI 10.1098/rstb.2007.2184; Steinfeld H, 2013, GREENHOUSE GAS EMISS; Steinfeld H., 2006, LIVESTOCKS LONG SHAD, DOI [10.1890/1540-9295(2007)5[4:D]2.0.CO;2, DOI 10.1890/1540-9295(2007)5[4:D]2.0.CO;2]; Subbarao GV, 2007, PLANT SOIL, V294, P5, DOI 10.1007/s11104-006-9159-3; Subbarao GV, 2013, TROP GRASSL-FORRAJES, V1, P168, DOI 10.17138/TGFT(1)168-174; Szott L, SERIE TECNICA CATIE; Thomas RJ, 1993, PTECHNICAL PAPERS IN, VII, P277; Thornton PK, 2010, P NATL ACAD SCI USA, V107, P19667, DOI 10.1073/pnas.0912890107; Tobar D, 2012, GUIA METODOLOGIA MON; Tothill J., 1992, BOTANAL COMPREHENSIV; van Rikxoort H, 2014, AGRON SUSTAIN DEV, V34, P887, DOI 10.1007/s13593-014-0223-8; Wachendorf C, 2008, J PLANT NUTR SOIL SC, V171, P171, DOI 10.1002/jpln.200625217; Waghorn GC, 2004, NEW ZEAL VET J, V52, P320, DOI 10.1080/00480169.2004.36448; Weiler V, 2014, CURR OPIN ENV SUST, V8, P29, DOI 10.1016/j.cosust.2014.07.009; Wirsenius Stefan, 2003, Journal of Industrial Ecology, V7, P47, DOI 10.1162/108819803766729195; Woodward S. L., 2004, Proceedings of the New Zealand Society of Animal Production, V64, P160; Zanne A.E., 2009, DRYAD IDENTIFIER HTT, P235	83	21	21	2	48	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2016	11	12							e0167949	10.1371/journal.pone.0167949	http://dx.doi.org/10.1371/journal.pone.0167949			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EG7JB	28030599	Green Submitted, Green Published, gold			2022-12-27	WOS:000391222000027
J	Haeusler, M; Haas, C; Losch, S; Moghaddam, N; Villa, IM; Walsh, S; Kayser, M; Seiler, R; Ruehli, F; Janosa, M; Papageorgopoulou, C				Haeusler, Martin; Haas, Cordula; Losch, Sandra; Moghaddam, Negahnaz; Villa, Igor M.; Walsh, Susan; Kayser, Manfred; Seiler, Roger; Ruehli, Frank; Janosa, Manuel; Papageorgopoulou, Christina			Multidisciplinary Identification of the Controversial Freedom Fighter Jorg Jenatsch, Assassinated 1639 in Chur, Switzerland	PLOS ONE			English	Article							STRONTIUM ISOTOPE RATIOS; KING RICHARD III; SKELETAL REMAINS; BONE-COLLAGEN; ANCIENT DNA; EYE COLOR; MOBILITY; AGE; MEDIEVAL; EUROPE	Jorg Jenatsch, a leading freedom fighter during the Thirty Year's War in Graubu E nden, Switzerland, was assassinated on carnival 1639. Jenatsch's controversial biography and the unclear circumstances of his death inspired the formation of various legends, novels and films. In 1959, a skeleton discovered in the cathedral of Chur with remains of wealthy baroque clothing was tentatively attributed to Jenatsch. Here, we reassess the skeleton based on a new exhumation. Our multidisciplinary analysis and the head injuries are consistent with reports of the eyewitnesses of the crime, demonstrating that Jenatsch was killed from behind with a semi-sharp implement, supposedly an axe, as well as by a blow with a broad-surfaced object. Moreover, our facial reconstruction closely matches an oil portrait of Jenatsch, and the HIrisPlex system applied to DNA-extracts from the femoral bone reveals brown eye and dark brown hair colour, which coincides well with the portrait, too. Finally, isotope analysis of the femoral bone and a molar support Jenatsch's high social status, luxury diet and a high mobility in the last decade of his life. This multidisciplinary approach thus reinforces personal identification and provides additional insight into the life of this important historic person beyond written resources.	[Haeusler, Martin; Seiler, Roger; Ruehli, Frank] Univ Zurich, Inst Evolutionary Med, Zurich, Switzerland; [Haeusler, Martin] Univ Zurich, Inst Anat, Zurich, Switzerland; [Haas, Cordula] Univ Zurich, Zurich Inst Forens Med, Zurich, Switzerland; [Losch, Sandra; Moghaddam, Negahnaz] Univ Bern, Inst Forens Med, Dept Phys Anthropol, Bern, Switzerland; [Villa, Igor M.] Univ Bern, Inst Geol Sci, Bern, Switzerland; [Villa, Igor M.] Univ Milano Bicocca, Ctr Univ Dataz & Archeometria, Milan, Italy; [Walsh, Susan] Indiana Univ Purdue Univ, Dept Biol, Indianapolis, IN 46205 USA; [Kayser, Manfred] Erasmus MC Univ Med Ctr Rotterdam, Dept Genet Identificat, Rotterdam, Netherlands; [Janosa, Manuel] Archaol Dienst Graubunden, Chur, Switzerland; [Papageorgopoulou, Christina] Demokritus Univ Thrace, Dept Hist & Ethnol, Lab Anthropol, Komotini, Greece	University of Zurich; University of Zurich; University of Zurich; University of Bern; University of Bern; University of Milano-Bicocca; Indiana University System; Indiana University-Purdue University Indianapolis; Erasmus University Rotterdam; Erasmus MC	Haeusler, M (corresponding author), Univ Zurich, Inst Evolutionary Med, Zurich, Switzerland.; Haeusler, M (corresponding author), Univ Zurich, Inst Anat, Zurich, Switzerland.	martin.haeusler@iem.uzh.ch	Lösch, Sandra/AAA-9806-2021; Haas, Cordula/GWM-7074-2022; Lösch, Sandra/H-3230-2013	Lösch, Sandra/0000-0003-3442-9764; Haas, Cordula/0000-0001-8122-1427; Lösch, Sandra/0000-0003-3442-9764; Walsh, Susan/0000-0002-7064-1589; Haeusler, Martin/0000-0002-9100-4183; papageorgopoulou, Christina/0000-0002-4145-950X; Moghaddam, Negahnaz/0000-0002-0615-0451; Villa, Igor M/0000-0002-8070-8142	MN Foundation, Switzerland; Swiss National Science Foundation (SNF grant) [CR1313_149583]	MN Foundation, Switzerland; Swiss National Science Foundation (SNF grant)	Financial support for MH, FR and RS was provided by the MN Foundation, Switzerland. NM and the stable isotope analysis were financially supported by the Swiss National Science Foundation (SNF grant CR1313_149583). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aberg G, 1998, SCI TOTAL ENVIRON, V224, P109, DOI 10.1016/S0048-9697(98)00347-7; Acsadi G., 1970, HIST HUMAN LIFE SPAN; Adamson M., 2004, FOOD MEDIEVAL TIMES; Alterauge A., 2015, J GLACIAL ARCHAEOLOG, V2, P35; Amacher U, 2006, FISCH FISCHER ZWEI J, P95; Ambrose S.H., 1993, INVESTIGATIONS ANCIE, P59; AMBROSE SH, 1990, J ARCHAEOL SCI, V17, P431, DOI 10.1016/0305-4403(90)90007-R; Appleby J, 2015, LANCET, V385, P253, DOI 10.1016/S0140-6736(14)60804-7; AUSTINSMITH D, 1994, J FORENSIC SCI, V39, P446; Bentley RA, 2006, J ARCHAEOL METHOD TH, V13, P135, DOI 10.1007/s10816-006-9009-x; Berger M, 1960, BUNDNER MONATSBLATT, V1960, P153; Bocherens H, 2003, INT J OSTEOARCHAEOL, V13, P46, DOI 10.1002/oa.662; BROTHWELL D, 1963, SCI ARCHAEOL, P427; Buckley R, 2013, ANTIQUITY, V87, P519, DOI 10.1017/S0003598X00049103; Cooper A, 2000, SCIENCE, V289, P1139; Cooper C, 2011, DENKMALPFLEGE ARCHAO, P136; Damas S, 2011, ACM COMPUT SURV, V43, DOI 10.1145/1978802.1978806; DENIRO MJ, 1978, GEOCHIM COSMOCHIM AC, V42, P495, DOI 10.1016/0016-7037(78)90199-0; DENIRO MJ, 1985, NATURE, V317, P806, DOI 10.1038/317806a0; Fischer E., 1928, ANTHROPOL ANZ, V5, P238; Gilbert MTP, 2005, TRENDS ECOL EVOL, V20, P541, DOI 10.1016/j.tree.2005.07.005; Grupe G, 1997, APPL GEOCHEM, V12, P517, DOI 10.1016/S0883-2927(97)00030-9; Haas C, 2013, FORENSIC SCI INT-GEN, V7, P610, DOI 10.1016/j.fsigen.2013.08.006; Haffter E, 1895, G JENATSCH URKUNDENB; Haffter E, 1894, G JENATSCH EIN BEITR; Head RC, 2008, J AXE SOCIAL BOUNDAR; Hedges REM, 2007, AM J PHYS ANTHROPOL, V133, P808, DOI 10.1002/ajpa.20598; Helmer R, 1984, ZUGLEICH BEITRAG KON; Herrmann B, 1990, PRAHISTORISCHE ANTHR, VIX; Hoefs J., 2009, STABLE ISOTOPE GEOCH, V6th; Hoppe KA, 2003, INT J OSTEOARCHAEOL, V13, P20, DOI 10.1002/oa.663; Hug E, 1911, DOCUMENTS CONC UNPUB; Iacumin P, 2014, AM J PHYS ANTHROPOL, V154, P561, DOI 10.1002/ajpa.22553; Janosa M, 2014, UNTER ORGL BEGRABEN; Janosa M, 2010, BUNDER MONATSBLATT, V2010, P431; Jayaprakash PT, 2001, FORENSIC SCI INT, V117, P121, DOI 10.1016/S0379-0738(00)00455-2; Jecklin F, 1924, KOM Z SCHWEIZERISCHE, V4, P396; King TE, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6631; Koepke N, 2005, EUR REV ECON HIST, V9, P61, DOI 10.1017/S1361491604001388; Kuster H, 1992, THESIS, P289; Lamb AL, 2014, J ARCHAEOL SCI, V50, P559, DOI 10.1016/j.jas.2014.06.021; LEAN MEJ, 1995, BRIT MED J, V311, P158, DOI 10.1136/bmj.311.6998.158; Losch S, 2006, AM J PHYS ANTHROPOL, V131, P181, DOI 10.1002/ajpa.20395; Losch S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110489; LONGIN R, 1971, NATURE, V230, P241, DOI 10.1038/230241a0; Lopez B, 2012, HOMO, V63, P21, DOI 10.1016/j.jchb.2011.12.001; LOVEJOY CO, 1985, AM J PHYS ANTHROPOL, V68, P47, DOI 10.1002/ajpa.1330680105; Martin R., 1957, LEHRBUCH ANTHR, V3rd; Meyer CF, 1876, J JENATSCH EINE BUND; Meyer W, 1985, HIRSEBREI HELLEBARDE; Moghaddam N, 2016, ARCHAEOL ANTHROP SCI, V8, P149, DOI 10.1007/s12520-014-0221-4; Montgomery J, 2005, AM J PHYS ANTHROPOL, V126, P123, DOI 10.1002/ajpa.20111; Morin PA, 2007, MOL ECOL NOTES, V7, P937, DOI 10.1111/j.1471-8286.2007.01804.x; Muldner G, 2007, AM J PHYS ANTHROPOL, V133, P682, DOI 10.1002/ajpa.20561; Papageorgopoulou C, 2008, THESIS; Papageorgopoulou C, 2011, AM J HUM BIOL, V23, P381, DOI 10.1002/ajhb.21155; Pfister A, 1991, J JENATSCH SEIN LEBE; Prag J., 1997, MAKING FACES USING F; Price TD, 2002, ARCHAEOMETRY, V44, P117, DOI 10.1111/1475-4754.00047; Prokop O, 1976, FORENSISCHE MED; Reitsema LJ, 2012, AM J PHYS ANTHROPOL, V148, P589, DOI 10.1002/ajpa.22085; Richards MP, 2001, EARTH PLANET SC LETT, V191, P185, DOI 10.1016/S0012-821X(01)00427-7; Rosing FW, 2007, HOMO, V58, P75, DOI 10.1016/j.jchb.2005.07.002; Ruff CB, 2012, AM J PHYS ANTHROPOL, V148, P601, DOI 10.1002/ajpa.22087; Schmid D, 1987, JENATSCH DVD; Steele J, 2000, LATERALITY, V5, P193, DOI 10.1080/135765000406067; Taberlet P, 1996, NUCLEIC ACIDS RES, V24, P3189, DOI 10.1093/nar/24.16.3189; Tutken T, 2008, ANTHROPOL ANZ, V66, P19, DOI 10.1127/aa/66/2008/19; Vika E, 2009, J ARCHAEOL SCI, V36, P2024, DOI 10.1016/j.jas.2009.05.022; Villa IM, 2009, ARCHAEOL ANTHROP SCI, V1, P149, DOI 10.1007/s12520-009-0012-5; Villa IM, 2006, J VOLCANOL GEOTH RES, V152, P20, DOI 10.1016/j.jvolgeores.2005.09.011; Walsh S, 2013, FORENSIC SCI INT-GEN, V7, P98, DOI 10.1016/j.fsigen.2012.07.005; Walsh S, 2012, FORENSIC SCI INT-GEN, V6, P330, DOI 10.1016/j.fsigen.2011.07.009; Walsh S, 2011, FORENSIC SCI INT-GEN, V5, P170, DOI 10.1016/j.fsigen.2010.02.004; Wilkinson C., 2004, FORENSIC FACIAL RECO	75	13	13	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2016	11	12							e0168014	10.1371/journal.pone.0168014	http://dx.doi.org/10.1371/journal.pone.0168014			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EG7JB	28030571	gold, Green Published, Green Submitted, Green Accepted			2022-12-27	WOS:000391222000029
J	Tekleab, AM; Tadesse, BT; Giref, AZ; Shimelis, D; Gebre, M				Tekleab, Atnafu Mekonnen; Tadesse, Birkneh Tilahun; Giref, Ababi Zergaw; Shimelis, Damte; Gebre, Meseret			Anthropometric Improvement among HIV Infected Pre-School Children Following Initiation of First Line Anti-Retroviral Therapy: Implications for Follow Up	PLOS ONE			English	Article							NUTRITIONAL-STATUS; TREATMENT FAILURE; CD4 COUNT; MORTALITY; PREDICTORS; WEIGHT; IMPACT; UNDERNUTRITION; COTRIMOXAZOLE; MALNUTRITION	Background Antiretroviral therapy (ART) is a lifesaving intervention for HIV infected children. There is a scarcity of data on immunological recovery and its relation with growth indicators among HIV infected young children. The current study aims to assess the pattern of anthropometric Z-score improvement following initiation of first-line ART among under-five children and the relationship between anthropometric Z-score improvement and immunologic recovery. Methods We included under-five children who were on first-line ART at five major hospitals in Addis Ababa, Ethiopia. We measured anthropometry and collected clinical and laboratory data at follow up, and we retrieved clinical and anthropometric data at ART initiation from records. Z-scores for each of the anthropometric indices were calculated based on WHO growth standards using ENA for SMART 2011 software. Linear regression was used to assess the relationship between time on ART and anthropometric Z-score improvement; and the relationship between anthropometric Z-score improvement and immunologic recovery. Multiple linear regression was used to assess the independent predictors of anthropometric Z-score change. Results The median age of the participants was 4.1 (Interquartile range (IQR): 3.3 - 4.9) years. More than half (52.48%) were female. The median duration of follow up was 1.69 (IQR: 1.08 - 2.63) years. There was a significant improvement in all anthropometric indices at any follow up after initiation of first-line ART (underweight; 39.5% vs16.5%, stunting; 71.3% vs 62.9% and wasting; 16.3% vs 1.0%; p-value<0.0001). There was an inverse relationship between improvement in weight for age Z-score (WAZ) and duration of ART (R-2 = 0.04; F (1, 158); p = 0.013). Height for age Z-score (HAZ) both at the time of ART initiation and follow up has a positive linear relationship with CD4 percentage at follow up (Coef. = 1.92; R-2 = 0.05; p-value = 0.002). Duration on ART (Std. Err. = 0.206, t = -1.99, p-value = 0.049) and level of maternal education (Std. Err. = 0.290, t = 2.64, p-value = 0.009) were the only independent predictors of the change in WAZ and change in HAZ at any follow up visit respectively. Conclusion There was a significant improvement in all anthropometric indices at any follow-up after initiation of first-line ART among under-five children. HAZ was linearly related with immunologic recovery following ART initiation. The findings indicate that anthropometric indices	[Tekleab, Atnafu Mekonnen] St Pauls Hosp Millennium Med Coll, Addis Ababa, Ethiopia; [Tadesse, Birkneh Tilahun] Hawassa Univ, Dept Pediat, Hawassa, Ethiopia; [Giref, Ababi Zergaw; Shimelis, Damte] Univ Addis Ababa, Sch Med, Addis Ababa, Ethiopia; [Gebre, Meseret] ALERT Med Ctr, Addis Ababa, Ethiopia	Hawassa University; Addis Ababa University	Tadesse, BT (corresponding author), Hawassa Univ, Dept Pediat, Hawassa, Ethiopia.	birknehtilahun@gmail.com		Tadesse, Birkneh Tilahun/0000-0003-4005-8605; Tekleab, Atnafu/0000-0001-8263-6915				Agarwal D, 2008, INDIAN PEDIATR, V45, P140; Anyabolu HC, 2014, PAN AFR MED J, V18, DOI 10.11604/pamj.2014.18.77.3746; Azzoni L, 2011, J INT AIDS SOC, V14, DOI 10.1186/1758-2652-14-37; Bacha T, 2012, BMC INFECT DIS, V12, DOI 10.1186/1471-2334-12-197; Bunupuradah T, 2016, PEDIATR INFECT DIS J, V35, P201, DOI 10.1097/INF.0000000000000961; Castetbon K, 2001, AIDS, V15, P869, DOI 10.1097/00002030-200105040-00007; Chokephaibulkit K, 2014, PEDIATR INFECT DIS J, V33, P291, DOI 10.1097/INF.0b013e3182a18223; Fontana M, 1999, AM J CLIN NUTR, V69, P1282; Gibb DM, 2008, AIDS, V22, P97, DOI 10.1097/01.aids.0000302262.51286.a5; Grinspoon S, 2003, CLIN INFECT DIS, V36, pS69, DOI 10.1086/367561; Guillen S, 2007, PEDIATR INFECT DIS J, V26, P334, DOI 10.1097/01.inf.0000257427.19764.ff; Hughes SM, 2009, PEDIATRICS, V123, pE347, DOI 10.1542/peds.2008-1316; Kariminia A, 2014, JAIDS-J ACQ IMM DEF, V67, P71, DOI 10.1097/QAI.0000000000000227; Katona P, 2008, CLIN INFECT DIS, V46, P1582, DOI 10.1086/587658; Koethe JR, 2010, AM J CLIN NUTR, V91, p1138S, DOI 10.3945/ajcn.2010.28608D; Kosmiski L, 2011, AM J CLIN NUTR, V94, p1677S, DOI 10.3945/ajcn.111.012625; Lewis J, 2012, J INFECT DIS, V205, P548, DOI 10.1093/infdis/jir787; Mukherjee A, 2014, BMC INFECT DIS, V14, DOI 10.1186/s12879-014-0701-2; Musoke PM, 2011, AM J CLIN NUTR, V94, p1716S, DOI 10.3945/ajcn.111.018374; Nerad J, 2003, CLIN INFECT DIS, V36, pS52, DOI 10.1086/367559; Nsanzimana S, 2015, LANCET HIV, V2, pE376, DOI 10.1016/S2352-3018(15)00112-5; Obimbo EM, 2004, PEDIATR INFECT DIS J, V23, P536, DOI 10.1097/01.inf.0000129692.42964.30; Padmapriyadarsini C, 2009, INT J PEDIAT, V2009, DOI 10.1155/2009/837627; Paton NI, 2006, HIV MED, V7, P323, DOI 10.1111/j.1468-1293.2006.00383.x; Rose AM, 2014, ARCH DIS CHILD, V99, P546, DOI 10.1136/archdischild-2012-303348; Saloojee H, 2007, SCAND J PUBLIC HEALT, V35, P96, DOI 10.1080/14034950701356435; Sharma TS, 2008, AM J CLIN NUTR, V88, P384, DOI 10.1093/ajcn/88.2.384; Sunguya BF, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-869; Taye Bineyam, 2010, Ethiop Med J, V48, P1; Villamor E, 2005, INT J EPIDEMIOL, V34, P61, DOI 10.1093/ije/dyh378; Walker AS, 2007, CLIN INFECT DIS, V44, P1361, DOI 10.1086/515396; WHO, 2014, ANT THER HIV INF INF	32	6	6	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2016	11	12							e0167565	10.1371/journal.pone.0167565	http://dx.doi.org/10.1371/journal.pone.0167565			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EG7JB	28030557	Green Published, gold, Green Submitted			2022-12-27	WOS:000391222000011
J	Boer, EF; Jette, CA; Stewart, RA				Boer, Elena F.; Jette, Cicely A.; Stewart, Rodney A.			Neural Crest Migration and Survival Are Susceptible to Morpholino-Induced Artifacts	PLoS One			English	Article							ZEBRAFISH FOXD3; GENE; EXPRESSION; EMBRYO; MUTANT; SPECIFICATION; DERIVATIVES; TECHNOLOGY; KNOCKDOWNS; TFAP2A	The neural crest (NC) is a stem cell-like embryonic population that is essential for generating and patterning the vertebrate body, including the craniofacial skeleton and peripheral nervous system. Defects in NC development underlie many birth defects and contribute to formation of some of the most malignant cancers in humans, such as melanoma and neuroblastoma. For these reasons, significant research efforts have been expended to identify genes that control NC development, as it is expected to lead to a deeper understanding of the genetic mechanisms controlling vertebrate development and identify new treatments for NC-derived diseases and cancers. However, a number of inconsistencies regarding gene function during NC development have emerged from comparative analyses of gene function between mammalian and non-mammalian systems (chick, frog, zebrafish). This poses a significant barrier to identification of single genes and/or redundant pathways to target in NC diseases. Here, we determine whether technical differences, namely morpholino-based approaches used in non mammalian systems, could contribute to these discrepancies, by examining the extent to which NC phenotypes in fascin la (fscnla) morphant embryos are similar to or different from fscnla null mutants in zebrafish. Analysis of fscnla morphants showed that they mimicked early NC phenotypes observed in fscnla null mutants; however, these embryos also displayed NC migration and derivative phenotypes not observed in null mutants, including accumulation of p53-independent cell death. These data demonstrate that morpholinos can cause seemingly specific NC migration and derivative phenotypes, and thus have likely contributed to the inconsistencies surrounding NC gene function between species. We suggest that comparison of genetic mutants between different species is the most rigorous method for identifying conserved genetic mechanisms controlling NC development and is critical to identify new treatments for NC diseases.	[Boer, Elena F.; Jette, Cicely A.; Stewart, Rodney A.] Univ Utah, Dept Oncol Sci, Huntsman Canc Inst, Salt Lake City, UT 84112 USA	Huntsman Cancer Institute; Utah System of Higher Education; University of Utah	Stewart, RA (corresponding author), Univ Utah, Dept Oncol Sci, Huntsman Canc Inst, Salt Lake City, UT 84112 USA.	rodney.stewart@hci.utah.edu	Stewart, Rodney/ABA-6757-2020	Stewart, Rodney/0000-0003-1220-1830; Boer, Elena/0000-0002-7015-4852	March of Dimes Foundation [5-FY12-29]; Huntsman Cancer Foundation; American Cancer Society [124250-RSG-13-025-01-CSM]; NIH Developmental Biology Training Grant [5T32 HD07491]; NCRR Shared Equipment Grant [1S10RR024761-01]	March of Dimes Foundation(March of Dimes); Huntsman Cancer Foundation; American Cancer Society(American Cancer Society); NIH Developmental Biology Training Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NCRR Shared Equipment Grant	RAS is supported by grants from the March of Dimes Foundation 5-FY12-29 (http://www.marchofdimes.com), Huntsman Cancer Foundation (http://healthcare.utah.edu/huntsmancancerinstrtute/giving/huntsrnan-cancer-foundation/) and the American Cancer Society 124250-RSG-13-025-01-CSM (www.cancer.org). EFB was supported by an NIH Developmental Biology Training Grant (5T32 HD07491). Microscopy equipment was obtained using a NCRR Shared Equipment Grant #1S10RR024761-01. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arduini BL, 2009, DEVELOPMENT, V136, P1987, DOI 10.1242/dev.033209; Auer TO, 2014, METHODS, V69, P142, DOI 10.1016/j.ymeth.2014.03.027; Barriga EH, 2015, DEVELOPMENT, V142, P1555, DOI 10.1242/dev.121590; Bill BR, 2009, ZEBRAFISH, V6, P69, DOI 10.1089/zeb.2008.0555; Blader P, 2003, MECH DEVELOP, V120, P211, DOI 10.1016/S0925-4773(02)00413-6; Boer EF, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1004946; Duong TD, 2004, DEV DYNAM, V229, P42, DOI 10.1002/dvdy.10465; Dutton K, 2001, GENESIS, V30, P188, DOI 10.1002/gene.1062; Eisen JS, 2008, DEVELOPMENT, V135, P1735, DOI 10.1242/dev.001115; Ekker SC, 2001, GENESIS, V30, P89, DOI 10.1002/gene.1038; Etchevers HC, 2006, ADV EXP MED BIOL, V589, P213; Fafeur V, 1997, CELL GROWTH DIFFER, V8, P655; Gao ZG, 2010, DEVELOPMENT, V137, P1543, DOI 10.1242/dev.047696; Hashimoto Y, 2011, J PATHOL, V224, P289, DOI 10.1002/path.2894; Hoffman TL, 2007, J EXP ZOOL PART B, V308B, P679, DOI 10.1002/jez.b.21189; Huang P, 2012, J GENET GENOMICS, V39, P421, DOI 10.1016/j.jgg.2012.07.004; Inoue K, 2006, J BIOL CHEM, V281, P33814, DOI 10.1074/jbc.M607290200; Jeffers JR, 2003, CANCER CELL, V4, P321, DOI 10.1016/S1535-6108(03)00244-7; Jette CA, 2008, CELL DEATH DIFFER, V15, P1063, DOI 10.1038/cdd.2008.42; Kimmel CB, 1998, DEV BIOL, V203, P245, DOI 10.1006/dbio.1998.9016; Kirby BB, 2006, NAT NEUROSCI, V9, P1506, DOI 10.1038/nn1803; Knight RD, 2003, DEVELOPMENT, V130, P5755, DOI 10.1242/dev.00575; Kok FO, 2015, DEV CELL, V32, P97, DOI 10.1016/j.devcel.2014.11.018; Law SHW, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100268; Lawson ND, 2011, DEV CELL, V21, P48, DOI 10.1016/j.devcel.2011.06.007; Le Douarin N. M, 2009, NEURAL CREST; Lister JA, 2006, DEV BIOL, V290, P92, DOI 10.1016/j.ydbio.2005.11.014; Maguire LH, 2015, DEV DYNAM, V244, P311, DOI 10.1002/dvdy.24226; Mikami S, 2015, BIOL OPEN, V4, P1576, DOI 10.1242/bio.014225; Montero-Balaguer M, 2006, DEV DYNAM, V235, P3199, DOI 10.1002/dvdy.20959; Murray SA, 2006, P NATL ACAD SCI USA, V103, P10300, DOI 10.1073/pnas.0602234103; Nasevicius A, 2000, NAT GENET, V26, P216, DOI 10.1038/79951; Nechiporuk A, 2007, DEVELOPMENT, V134, P611, DOI 10.1242/dev.02749; Novodvorsky P, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0141611; Piotrowski T, 2000, DEV BIOL, V225, P339, DOI 10.1006/dbio.2000.9842; Robu ME, 2007, PLOS GENET, V3, P787, DOI 10.1371/journal.pgen.0030078; Rossi A, 2015, NATURE, V524, P230, DOI 10.1038/nature14580; Sauka-Spengler T, 2008, NAT REV MOL CELL BIO, V9, P557, DOI 10.1038/nrm2428; Schulte-Merker S, 2014, DEVELOPMENT, V141, P3103, DOI 10.1242/dev.112003; Shmukler BE, 2015, HAEMATOLOGICA, V100, pE483, DOI 10.3324/haematol.2015.132449; Simoes-Costa M, 2015, DEVELOPMENT, V142, P242, DOI 10.1242/dev.105445; Sorrells S, 2013, JOVE-J VIS EXP, DOI 10.3791/51060; Sorrells S, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002922; Stewart RA, 2006, DEV BIOL, V292, P174, DOI 10.1016/j.ydbio.2005.12.035; Taibi A, 2013, DEV DYNAM, V242, P614, DOI 10.1002/dvdy.23958; THISSE C, 1993, DEVELOPMENT, V119, P1203; Tucker B, 2007, ZEBRAFISH, V4, P113, DOI 10.1089/zeb.2007.0508; Wang WD, 2011, DEV BIOL, V360, P173, DOI 10.1016/j.ydbio.2011.09.019; Westerfield M, 1993, ZEBRAFISH BOOK	49	7	7	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2016	11	12							e0167278	10.1371/journal.pone.0167278	http://dx.doi.org/10.1371/journal.pone.0167278			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI9QH	28005909	Green Published, gold, Green Submitted			2022-12-27	WOS:000392843200012
J	Carr, DB; Barco, PP; Babulal, GM; Stout, SH; Johnson, AM; Xiong, CJ; Morris, JC; Roe, CM				Carr, David B.; Barco, Peggy P.; Babulal, Ganesh M.; Stout, Sarah H.; Johnson, Anne M.; Xiong, Chengjie; Morris, John C.; Roe, Catherine M.			Association of Functional Impairments and Co-Morbid Conditions with Driving Performance among Cognitively Normal Older Adults	PLoS One			English	Article							VEHICLE CRASHES; ALZHEIMER-TYPE; ROAD TEST; DRIVERS; DEMENTIA; DISEASE; RISK	Objectives To examine the relationship between key functional impairments, co-morbid conditions and driving performance in a sample of cognitively normal older adults. Design Prospective observational study Setting The Knight Alzheimer's Disease Research Center, Washington University at St. Louis Participants Individuals with normal cognition, 64.9 to 88.2 years old (N = 129), with a valid driver's license, who were currently driving at least once per week, and who had participated in longitudinal studies at the Knight Alzheimer's Disease Research Center Measurements Static visual acuity, contrast sensitivity, physical frailty measures, motor skills, total medical conditions, and the modified Washington University Road Test. Results When controlling for age, race, gender, APOE, and education the total number of medical conditions was unassociated with both road test scores (pass vs. marginal + fail) and the total driver error count. There were marginal associations of our measure of physical frailty (p = 0.06) and contrast sensitivity score (p = 0.06) with total driving error count. Conclusion Future research that focuses on older adults and driving should consider adopting measures of physical frailty and contrast sensitivity, especially in samples that may have a propensity for disease impacting visual and/or physical function (e.g. osteoarthritis, Parkinson's, eye disorders, advanced age >80 years, etc.).	[Carr, David B.] Washington Univ, Rehabil Inst St Louis TRISL, Div Neurorehabil, Div Geriatr & Nutr Sci, Parc Provence, St Louis, MO 63130 USA; [Barco, Peggy P.] Washington Univ, Program Occupat Therapy, St Louis, MO USA; [Babulal, Ganesh M.; Stout, Sarah H.; Morris, John C.; Roe, Catherine M.] Washington Univ, Dept Neurol, St Louis, MO USA; [Stout, Sarah H.; Morris, John C.] Washington Univ, Knight Alzheimers Dis Res Ctr, St Louis, MO USA; [Johnson, Anne M.] Washington Univ, Ctr Clin Studies, St Louis, MO USA; [Xiong, Chengjie] Washington Univ, Div Biostat, St Louis, MO USA; [Morris, John C.] Washington Univ, Ctr Aging, Memory & Aging Project, St Louis, MO USA	Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL)	Carr, DB (corresponding author), Washington Univ, Rehabil Inst St Louis TRISL, Div Neurorehabil, Div Geriatr & Nutr Sci, Parc Provence, St Louis, MO 63130 USA.	DCarr@wustl.edu		Roe, Catherine/0000-0002-1405-0485; Stout, Sarah/0000-0002-8125-4912; Carr, David/0000-0003-2641-3850	National Institute of Health, National Institute on Aging [R01 AG043434]; Alzheimer's Disease Research Center [P50-AG05681]; Healthy Aging & Senile Dementia [P01-AG03991]; Antecedent Biomarkers for AD: The Adult Children Study [P01-AG26276]; NATIONAL INSTITUTE ON AGING [P01AG026276, P01AG003991, P50AG005681] Funding Source: NIH RePORTER	National Institute of Health, National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Alzheimer's Disease Research Center; Healthy Aging & Senile Dementia; Antecedent Biomarkers for AD: The Adult Children Study; NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	CMR: National Institute of Health, National Institute on Aging (R01 AG043434); https://projectreporter.nih.gov/project_info_description.cfrn?aid=8725570&icde=0. JCM: Alzheimer's Disease Research Center (P50-AG05681); http://knightadrc.wustl.edu/About_Us/PrimaryGrants.htm. JCM: Healthy Aging & Senile Dementia (P01-AG03991; 1984 - present); http://knightadrc.wustl.edu/About_Us/PrimaryGrants.htm. JCM: Antecedent Biomarkers for AD: The Adult Children Study (P01-AG26276; 2005 - present) http://knightadrc.wustl.edu/About_Us/PrimaryGrants.htm. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bailey IL, 1976, OPTOMETRY VISION SCI, V53, P740; Balcer LJ, 2003, NEUROLOGY, V61, P1367, DOI 10.1212/01.WNL.0000094315.19931.90; Ball KK, 2006, J AM GERIATR SOC, V54, P77, DOI 10.1111/j.1532-5415.2005.00568.x; Barco PP, 2015, J AM GERIATR SOC, V63, P1373, DOI 10.1111/jgs.13508; Barco PP, 2014, AM J OCCUP THER, V68, P221, DOI 10.5014/ajot.2014.008938; Brunnauer A, 2006, J CLIN PSYCHIAT, V67, P1776, DOI 10.4088/JCP.v67n1116; Center for Disease Control and Prevention, 2015, OLD AD DRIV; Charlton J., 2010, INFLUENCE CHRONIC IL, V2nd; Dobbs BM, 2005, DTNH2294G05297; Duchek JM, 2003, J AM GERIATR SOC, V51, P1342, DOI 10.1046/j.1532-5415.2003.51481.x; Goetz CG, 2008, MOVEMENT DISORD, V23, P2129, DOI 10.1002/mds.22340; Hetland A, 2014, ANN PHARMACOTHER, V48, P494, DOI 10.1177/1060028014520882; Hunt LA, 1997, ARCH NEUROL-CHICAGO, V54, P707, DOI 10.1001/archneur.1997.00550180029008; Insurance Institute for Highway Safety, 2014, OLD PEOPL; Isler RB, 1997, ACCIDENT ANAL PREV, V29, P793, DOI 10.1016/S0001-4575(97)00048-1; Margolis KL, 2002, J GERONTOL A-BIOL, V57, pM186, DOI 10.1093/gerona/57.3.M186; Marottoli RA, 1998, J AM GERIATR SOC, V46, P562, DOI 10.1111/j.1532-5415.1998.tb01071.x; MAROTTOLI RA, 1994, ANN INTERN MED, V121, P842, DOI 10.7326/0003-4819-121-11-199412010-00003; MORRIS JC, 1993, NEUROLOGY, V43, P2412, DOI 10.1212/WNL.43.11.2412-a; Ott BR, 2008, NEUROLOGY, V70, P1171, DOI 10.1212/01.wnl.0000294469.27156.30; Owsley C, 2010, VISION RES, V50, P2348, DOI 10.1016/j.visres.2010.05.021; Papa M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094564; Pelli D., 1988, CLIN VISION SCI; Ragland DR, 2004, GERONTOLOGIST, V44, P237, DOI 10.1093/geront/44.2.237; Roe CM, 2016, ALZHEIMER DIS ASS DI; Sims RV, 2000, J GERONTOL A-BIOL, V55, pM22; Sperling RA, 2011, ALZHEIMERS DEMENT, V7, P280, DOI 10.1016/j.jalz.2011.03.003; Staplin L, 2003, J SAFETY RES, V34, P389, DOI 10.1016/j.jsr.2003.09.002; Szlyk JP, 2005, J GLAUCOMA, V14, P145, DOI 10.1097/01.ijg.0000151686.89162.28; Wilkins CH, 2013, J AM GERIATR SOC, V61, P1055, DOI 10.1111/jgs.12255	30	6	6	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2016	11	12							e0167751	10.1371/journal.pone.0167751	http://dx.doi.org/10.1371/journal.pone.0167751			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EI9QH	28005921	Green Submitted, Green Published, gold			2022-12-27	WOS:000392843200019
J	Neumann, PJ; Thorat, T; Zhong, Y; Anderson, J; Farquhar, M; Salem, M; Sandberg, E; Saret, CJ; Wilkinson, C; Cohen, JT				Neumann, Peter J.; Thorat, Teja; Zhong, Yue; Anderson, Jordan; Farquhar, Megan; Salem, Mark; Sandberg, Eileen; Saret, Cayla J.; Wilkinson, Colby; Cohen, Joshua T.			A Systematic Review of Cost-Effectiveness Studies Reporting Cost-per-DALY Averted	PLOS ONE			English	Review							GLOBAL BURDEN; DISEASE	Introduction Calculating the cost per disability-adjusted life years (DALYs) averted associated with interventions is an increasing popular means of assessing the cost-effectiveness of strategies to improve population health. However, there has been no systematic attempt to characterize the literature and its evolution. Methods We conducted a systematic review of cost-effectiveness studies reporting cost-per-DALY averted from 2000 through 2015. We developed the Global Health Cost-Effectiveness Analysis (GHCEA) Registry, a repository of English-language cost-per-DALY averted studies indexed in PubMed. To identify candidate studies, we searched PubMed for articles with titles or abstracts containing the phrases "disability-adjusted" or "DALY". Two reviewers with training in health economics independently reviewed each article selected in our abstract review, gathering information using a standardized data collection form. We summarized descriptive characteristics on study methodology: e.g., intervention type, country of study, study funder, study perspective, along with methodological and reporting practices over two time periods: 2000-2009 and 2010-2015. We analyzed the types of costs included in analyses, the study quality on a scale from 1 (low) to 7 (high), and examined the correlation between diseases researched and the burden of disease in different world regions. Results We identified 479 cost-per-DALY averted studies published from 2000 through 2015. Studies from Sub-Saharan Africa comprised the largest portion of published studies. The disease areas most commonly studied were communicable, maternal, neonatal, and nutritional disorders (67%), followed by non-communicable diseases (28%). A high proportion of studies evaluated primary prevention strategies (59%). Pharmaceutical interventions were commonly assessed (32%) followed by immunizations (28%). Adherence to good practices for conducting and reporting cost-effectiveness analysis varied considerably. Studies mainly included formal healthcare sector costs. A large number of the studies in Sub-Saharan Africa addressed high-burden conditions such as HIV/AIDS, tuberculosis, neglected tropical diseases and malaria, and diarrhea, lower respiratory infections, meningitis, and other common infectious diseases. Conclusion The Global Health Cost-Effectiveness Analysis Registry reveals a growing and diverse field of cost-per-DALY averted studies. However, study methods and reporting practices have varied substantially.	[Neumann, Peter J.; Thorat, Teja; Zhong, Yue; Anderson, Jordan; Farquhar, Megan; Salem, Mark; Sandberg, Eileen; Saret, Cayla J.; Wilkinson, Colby; Cohen, Joshua T.] Tufts Med Ctr, Inst Clin Res & Hlth Policy Studies, Ctr Evaluat Value & Risk Hlth, Boston, MA 02111 USA	Tufts Medical Center	Neumann, PJ (corresponding author), Tufts Med Ctr, Inst Clin Res & Hlth Policy Studies, Ctr Evaluat Value & Risk Hlth, Boston, MA 02111 USA.	pneumann@tuftsmedicalcenter.org		Anderson, Jordan/0000-0002-8749-9419	Bill & Melinda Gates Foundation	Bill & Melinda Gates Foundation(Bill & Melinda Gates Foundation)	The study was funded by Bill & Melinda Gates Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Devleesschauwer B, 2014, INT J PUBLIC HEALTH, V59, P571, DOI 10.1007/s00038-014-0553-y; Murray, 2002, SUMMARY MEASURES POP, P205; Murray CJL, 2012, LANCET, V380, P2197, DOI 10.1016/S0140-6736(12)61689-4; Murray CJL, 2012, LANCET, V380, P2063, DOI 10.1016/S0140-6736(12)61899-6; Naghavi M, 2015, LANCET, V385, P117, DOI 10.1016/S0140-6736(14)61682-2; Neumann PJ, 2015, VALUE HEALTH, V18, P271, DOI 10.1016/j.jval.2014.12.002; Neumann PJ, 2016, COST EFFECTIVENESS H; Salomon JA, 2015, LANCET GLOB HEALTH, V3, pE712, DOI 10.1016/S2214-109X(15)00069-8; Sanders GD, 2016, JAMA-J AM MED ASSOC, V316, P1093, DOI 10.1001/jama.2016.12195; Thorat T, 2012, J BENEFIT-COST ANAL, V3, DOI 10.1515/2152-2812.1114; WHO, 2016, DIS WEIGHTS DISC AG; WHO, 2016, METR DIS ADJ LIF YEA; *WORLD BANK, 1993, WORLD DEV REP 1993 I	13	39	40	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2016	11	12							e0168512	10.1371/journal.pone.0168512	http://dx.doi.org/10.1371/journal.pone.0168512			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI9QH	28005986	gold, Green Published, Green Submitted			2022-12-27	WOS:000392843200063
J	Strona, G; Mauri, A; Veech, JA; Seufert, G; Ayanz, JSM; Fattorini, S				Strona, Giovanni; Mauri, Achille; Veech, Joseph A.; Seufert, Guenther; Ayanz, Jesus San-Miguel; Fattorini, Simone			Far from Naturalness: How Much Does Spatial Ecological Structure of European Tree Assemblages Depart from Potential Natural Vegetation?	PLOS ONE			English	Article							NULL MODEL; FOREST; NESTEDNESS; DIVERSITY; COOCCURRENCE; COMPETITION; MODULARITY; NETWORKS; PATTERNS; WORLDS	Contemporaneous plant communities may retain a mark of past disturbances in their ecological patterns. However, unraveling the history of disturbance on natural systems at a large scale is often unfeasible, due to the complexity of the factors involved and lack of historical data. Here we aim at demonstrating how comparing observed spatial structure of tree assemblages with that expected in a hypothetical, undisturbed scenario can shed light on how natural European forests are. Borrowing an analytical approach developed in the field of network analysis, we assessed how much the observed ecological patterns of nestedness (i.e. positive co-occurrence), segregation (i.e. negative co-occurrence), and modularity in tree assemblages deviate from randomness, and from those projected by Potential Natural Vegetation (PNV) geobotanical expert assessments. We found clear evidence that European forests are far from a natural condition, showing only moderate signals (especially at higher latitudes) of the ecological spatial structure typical of undisturbed vegetation (i.e. nestedness). Our results highlight how taking into account spatial structure along with diversity can be a fundamental tool to address this problem and assess the degree of naturalness in species assemblages.	[Strona, Giovanni; Mauri, Achille; Seufert, Guenther; Ayanz, Jesus San-Miguel] European Commiss, Joint Res Ctr, Directorate D Sustainable Resources Bioecon Unit, Ispra, VA, Italy; [Veech, Joseph A.] Texas State Univ, Dept Biol, San Marcos, TX USA; [Fattorini, Simone] Univ Laquila, Dept Life Hlth & Environm Sci, Laquila, Italy; [Fattorini, Simone] Azorean Biodivers Grp, CE3C Ctr Ecol Evolut & Environm Changes, Azores, Portugal; [Fattorini, Simone] Univ Acores, Dept Ciencias Agr, Azores, Portugal	European Commission Joint Research Centre; EC JRC ISPRA Site; Texas State University System; Texas State University San Marcos; University of L'Aquila; Universidade dos Acores	Strona, G (corresponding author), European Commiss, Joint Res Ctr, Directorate D Sustainable Resources Bioecon Unit, Ispra, VA, Italy.	goblinshrimp@gmail.com	Fattorini, Simone/E-7075-2012	Fattorini, Simone/0000-0002-4517-2135; Strona, Giovanni/0000-0003-2294-4013				ATTIWILL PM, 1994, FOREST ECOL MANAG, V63, P247, DOI 10.1016/0378-1127(94)90114-7; Azovsky AI, 2009, ECOL COMPLEX, V6, P308, DOI 10.1016/j.ecocom.2008.12.001; Bascompte J, 2003, P NATL ACAD SCI USA, V100, P9383, DOI 10.1073/pnas.1633576100; Bobiec A, 2002, FOREST ECOL MANAG, V165, P125, DOI 10.1016/S0378-1127(01)00655-7; Bohn U, 2003, MAP NATURAL VEGETATI; Bohn Udo, 2006, Biology and Environment, V106B, P199, DOI 10.3318/BIOE.2006.106.3.199; Bradshaw CJA, 2007, GLOBAL CHANGE BIOL, V13, P2379, DOI 10.1111/j.1365-2486.2007.01446.x; Brooks ML, 2004, BIOSCIENCE, V54, P677, DOI 10.1641/0006-3568(2004)054[0677:EOIAPO]2.0.CO;2; Brown J. H., 1995, MACROECOLOGY; Butaye J, 2001, ECOGRAPHY, V24, P369, DOI 10.1034/j.1600-0587.2001.d01-193.x; Chase JM, 2003, OECOLOGIA, V136, P489, DOI 10.1007/s00442-003-1311-7; Chiarucci A, 2010, J VEG SCI, V21, P1172, DOI 10.1111/j.1654-1103.2010.01218.x; Clements F.E., 1916, PLANT SUCCESSION ANA; Diamond J.M., 1975, P342; DIAMOND JM, 1982, OECOLOGIA, V52, P64, DOI 10.1007/BF00349013; Dickie IA, 2005, ECOL LETT, V8, P1191, DOI 10.1111/j.1461-0248.2005.00822.x; Diez JM, 2007, ECOLOGY, V88, P3144, DOI 10.1890/07-0047.1; Durrant T, 2011, 24777 EUR EN, P36; Ellenberg H., 1963, VEGETATION MITTELEUR; Fukami T, 2005, ECOL LETT, V8, P1283, DOI 10.1111/j.1461-0248.2005.00829.x; GAILLARD MJ, 2007, ENCY QUATERNARY SCI, P2570, DOI DOI 10.1016/B0-44-452747-8/00214-3; Gaston K.J., 2000, PATTERN PROCESS MACR, DOI [10.1002/9780470999592, DOI 10.1002/9780470999592]; Gotelli NJ, 2002, ECOLOGY, V83, P2091, DOI 10.2307/3072040; Haas SE, 2011, ECOL LETT, V14, P1108, DOI 10.1111/j.1461-0248.2011.01679.x; Hansen MC, 2000, INT J REMOTE SENS, V21, P1331, DOI 10.1080/014311600210209; Hausdorf B, 2007, OIKOS, V116, P818, DOI 10.1111/j.2007.0030-1299.15661.x; Honnay O, 1999, OIKOS, V84, P119, DOI 10.2307/3546872; Hubbell Stephen P., 2001, V32, pi; HUTCHINSON GE, 1959, AM NAT, V93, P145, DOI 10.1086/282070; Jimenez JJ, 2014, BMC ECOL, V14, DOI 10.1186/s12898-014-0026-4; Kaplan JO, 2009, QUATERNARY SCI REV, V28, P3016, DOI 10.1016/j.quascirev.2009.09.028; Karadimou E, 2015, J VEG SCI, V26, P501, DOI 10.1111/jvs.12255; Kier G, 2005, J BIOGEOGR, V32, P1107, DOI 10.1111/j.1365-2699.2005.01272.x; Leibold MA, 1998, EVOL ECOL, V12, P95, DOI 10.1023/A:1006511124428; Liu JG, 2007, AMBIO, V36, P639, DOI 10.1579/0044-7447(2007)36[639:CHANS]2.0.CO;2; Lloyd C. D., 2010, LOCAL MODELS SPATIAL; Loidi J, 2012, J VEG SCI, V23, P596, DOI 10.1111/j.1654-1103.2012.01387.x; Lomolino M.V., 2010, BIOGEOGRAPHY, Vfourth; Mauri A, 2017, SCI DATA, V4, DOI 10.1038/sdata.2016.123; McGill BJ, 2003, NATURE, V422, P881, DOI 10.1038/nature01583; Montoya JM, 2006, NATURE, V442, P259, DOI 10.1038/nature04927; Olesen JM, 2007, P NATL ACAD SCI USA, V104, P19891, DOI 10.1073/pnas.0706375104; Olson DM, 2001, BIOSCIENCE, V51, P933, DOI 10.1641/0006-3568(2001)051[0933:TEOTWA]2.0.CO;2; Perrings C, 2005, TRENDS ECOL EVOL, V20, P212, DOI 10.1016/j.tree.2005.02.011; Potapov P, 2008, ECOL SOC, V13, DOI 10.5751/es-02670-130251; Proulx SR, 2005, TRENDS ECOL EVOL, V20, P345, DOI 10.1016/j.tree.2005.04.004; Punchi-Manage R, 2014, ECOLOGY, V95, P376, DOI 10.1890/12-2102.1; Ricotta C, 2002, APPL VEG SCI, V5, P271, DOI 10.1111/j.1654-109X.2002.tb00557.x; Simova I, 2015, ECOGRAPHY, V38, P649, DOI 10.1111/ecog.00867; Skelsey P, 2005, PHYTOPATHOLOGY, V95, P328, DOI 10.1094/PHYTO-95-0328; Somodi I, 2012, J VEG SCI, V23, P590, DOI 10.1111/j.1654-1103.2011.01378.x; Staniczenko PPA, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2422; STEADMAN DW, 1993, P NATL ACAD SCI USA, V90, P818, DOI 10.1073/pnas.90.3.818; Stokstad E, 2009, SCIENCE, V326, P33, DOI 10.1126/science.326_33; Strona G, 2015, METHODS ECOL EVOL, V6, P907, DOI 10.1111/2041-210X.12395; Strona G, 2015, OIKOS, V124, P685, DOI 10.1111/oik.01850; Thebault E, 2013, J BIOGEOGR, V40, P759, DOI 10.1111/jbi.12015; TILMAN D, 1994, ECOLOGY, V75, P2, DOI 10.2307/1939377; Ulrich W, 2012, ECOGRAPHY, V35, P865, DOI 10.1111/j.1600-0587.2012.07671.x; Verhoef HermanA., 2010, COMMUNITY ECOLOGY PR, DOI [10.1093/acprof:oso/9780199228973.001.0001, DOI 10.1093/ACPROF:OSO/9780199228973.001.0001]; Westhoff V., 1973, HDB VEGETATION SCI, P617; Zerbe S, 1998, APPL VEG SCI, V1, P165, DOI 10.2307/1478945	62	8	8	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2016	11	12							e0165178	10.1371/journal.pone.0165178	http://dx.doi.org/10.1371/journal.pone.0165178			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI9QH	28005931	Green Submitted, Green Published, gold			2022-12-27	WOS:000392843200003
J	Ward, RE; Beauchamp, MK; Latham, NK; Leveille, SG; Percac-Lima, S; Kurlinski, L; Ni, PS; Goldstein, R; Jette, AM; Bean, JF				Ward, Rachel E.; Beauchamp, Marla K.; Latham, Nancy K.; Leveille, Suzanne G.; Percac-Lima, Sanja; Kurlinski, Laura; Ni, Pengsheng; Goldstein, Richard; Jette, Alan M.; Bean, Jonathan F.			A Novel Approach to Identifying Trajectories of Mobility Change in Older Adults	PLoS One			English	Article							LOWER-EXTREMITY FUNCTION; PHYSICAL PERFORMANCE BATTERY; CONFIDENCE ABC SCALE; MINI-MENTAL-STATE; SUBSEQUENT DISABILITY; LATE-LIFE; HEALTH; BALANCE; INDEPENDENCE; POPULATION	Objectives To validate trajectories of late-life mobility change using a novel approach designed to overcome the constraints of modest sample size and few follow-up time points. Methods Using clinical reasoning and distribution-based methodology, we identified trajectories of mobility change (Late Life Function and Disability Instrument) across 2 years in 391 participants age >= 65 years from a prospective cohort study designed to identify modifiable impairments predictive of mobility in late-life. We validated our approach using model fit indices and comparing baseline mobility-related factors between trajectories. Results Model fit indices confirmed that the optimal number of trajectories were between 4 and 6. Mobility-related factors varied across trajectories with the most unfavorable values in poor mobility trajectories and the most favorable in high mobility trajectories. These factors included leg strength, trunk extension endurance, knee flexion range of motion, limb velocity, physical performance measures, and the number and prevalence of medical conditions including osteoarthritis and back pain. Conclusions Our findings support the validity of this approach and may facilitate the investigation of a broader scope of research questions within aging populations of varied sizes and traits.	[Ward, Rachel E.; Bean, Jonathan F.] Boston VA Healthcare Syst, New England GRECC, Boston, MA 02130 USA; [Ward, Rachel E.; Leveille, Suzanne G.; Percac-Lima, Sanja; Kurlinski, Laura; Goldstein, Richard; Bean, Jonathan F.] Harvard Med Sch, Cambridge, MA USA; [Ward, Rachel E.; Kurlinski, Laura; Goldstein, Richard; Bean, Jonathan F.] Spaulding Rehabil Hosp, Cambridge, MA 02138 USA; [Beauchamp, Marla K.] McMaster Univ, Sch Rehabil Sci, Hamilton, ON, Canada; [Latham, Nancy K.; Ni, Pengsheng; Jette, Alan M.] Boston Univ, Sch Publ Hlth, Hlth & Disabil Res Inst, Boston, MA USA; [Leveille, Suzanne G.] Univ Massachusetts, Coll Nursing & Hlth Sci, Boston, MA 02125 USA; [Percac-Lima, Sanja] Massachusetts Gen Hosp, Boston, MA 02114 USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); Harvard University; VA Boston Healthcare System; Harvard University; Spaulding Rehabilitation Hospital; McMaster University; Boston University; University of Massachusetts System; University of Massachusetts Boston; Harvard University; Massachusetts General Hospital	Ward, RE (corresponding author), Boston VA Healthcare Syst, New England GRECC, Boston, MA 02130 USA.; Ward, RE (corresponding author), Harvard Med Sch, Cambridge, MA USA.; Ward, RE (corresponding author), Spaulding Rehabil Hosp, Cambridge, MA 02138 USA.	reward@partners.org	Bean, Jonathan F/F-5798-2017; Beauchamp, Marla/ABC-7901-2021; Leveille, Suzanne G/ACS-6588-2022	Bean, Jonathan F/0000-0001-8385-8210; Beauchamp, Marla/0000-0003-2843-388X; Leveille, Suzanne G/0000-0003-0427-1580	National Institute on Aging [R01 AG032052-03]; Eunice Kennedy Shriver National Institute of Child Health and Human Development [1K24HD070966-01]; National Center for Research Resources [1 UL1 RR025758-01]; National Institute on Disability, Independent Living, and Rehabilitation Research [H133P120001]; Canadian Institutes of Health Research; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [K24HD070966] Funding Source: NIH RePORTER	National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Eunice Kennedy Shriver National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); National Institute on Disability, Independent Living, and Rehabilitation Research(United States Department of Health & Human Services); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This work was supported by the National Institute on Aging (R01 AG032052-03, https://www.nia.nih.gov/); the Eunice Kennedy Shriver National Institute of Child Health and Human Development (1K24HD070966-01 to JFB, https://www.nichd.nih.gov/Pages/index.aspx); and the National Center for Research Resources in a grant to the Harvard Clinical and Translational Science Center (1 UL1 RR025758-01, http://sdminutes.cit.nih.gov/about/almanac/organization/NCRR.htm). REW is supported by the National Institute on Disability, Independent Living, and Rehabilitation Research (H133P120001, http://www.acl.gov/programs/NIDILRR/). MKB is supported by a fellowship from the Canadian Institutes of Health Research (http://cihr-irsc.gc.ca/e/193.html). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andruff H, 2009, TUTOR QUANT METHODS, V5, P11, DOI 10.20982/tqmp.05.1.p011; Bean JF, 2013, ARCH PHYS MED REHAB, V94, P2381, DOI 10.1016/j.apmr.2013.07.026; Bean JF, 2008, ARCH PHYS MED REHAB, V89, P2278, DOI 10.1016/j.apmr.2008.04.029; Beauchamp MK, 2014, BMC GERIATR, V14, DOI 10.1186/1471-2318-14-12; Beauchamp MK, 2014, J GERONTOLOGY A; Callahan D, 2007, AGING CLIN EXP RES, V19, P194, DOI 10.1007/bf03324689; Carpenter JR, 2007, STAT METHODS MED RES, V16, P259, DOI 10.1177/0962280206075303; CRUM RM, 1993, JAMA-J AM MED ASSOC, V269, P2386, DOI 10.1001/jama.269.18.2386; Curran PJ, 2010, J COGN DEV, V11, P121, DOI 10.1080/15248371003699969; Dodge HH, 2006, J GERONTOL A-BIOL, V61, P1330, DOI 10.1093/gerona/61.12.1330; Eggleston EP, 2004, J QUANT CRIMINOL, V20, P1, DOI 10.1023/B:JOQC.0000016696.02763.ce; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Fried LP, 2000, J GERONTOL A-BIOL, V55, pM43; Gill TM, 2006, J AM GERIATR SOC, V54, P248, DOI 10.1111/j.1532-5415.2005.00586.x; Guralnik JM, 2000, J GERONTOL A-BIOL, V55, pM221, DOI 10.1093/gerona/55.4.M221; GURALNIK JM, 1995, NEW ENGL J MED, V332, P556, DOI 10.1056/NEJM199503023320902; GURALNIK JM, 1994, J GERONTOL, V49, pM85, DOI 10.1093/geronj/49.2.M85; Haley SM, 2002, J GERONTOL A-BIOL, V57, pM217, DOI 10.1093/gerona/57.4.M217; Han L, 2013, ANN EPIDEMIOL, V23, P87, DOI 10.1016/j.annepidem.2012.11.010; Hardy SE, 2005, AM J EPIDEMIOL, V161, P575, DOI 10.1093/aje/kwi083; Hardy SE, 2004, JAMA-J AM MED ASSOC, V291, P1596, DOI 10.1001/jama.291.13.1596; Holt NE, 2013, ARCH PHYS MED REHAB, V94, P347, DOI 10.1016/j.apmr.2012.08.217; Jones BL, 2001, SOCIOL METHOD RES, V29, P374, DOI 10.1177/0049124101029003005; Lee LW, 2007, NEW FRONTIERS GERI S, P301; Liang J, 2010, J GERONTOL B-PSYCHOL, V65, P470, DOI [10.1093/geronb/gbq114, 10.1093/geronb/gbp114]; Liao YL, 2001, J AM GERIATR SOC, V49, P443, DOI 10.1046/j.1532-5415.2001.49089.x; Mavandadi S, 2007, J GERONTOL B-PSYCHOL, V62, pS361, DOI 10.1093/geronb/62.6.S361; Morley JE, 2003, J GERONTOL A-BIOL, V58, P712; Muthen BO, 1997, PSYCHOL METHODS, V2, P371, DOI 10.1037/1082-989X.2.4.371; Myers AM, 1998, J GERONTOL A-BIOL, V53, pM287, DOI 10.1093/gerona/53A.4.M287; Nagi SZ, 1991, DISABILITY AM NATL A, P309, DOI DOI 10.17226/1579; Olaleye D, 2001, DIABETES RES CLIN PR, V54, P115, DOI 10.1016/S0168-8227(01)00278-9; POWELL LE, 1995, J GERONTOL A-BIOL, V50, pM28, DOI 10.1093/gerona/50A.1.M28; Raghavendra P, 2007, AUGMENT ALTERN COMM, V23, P349, DOI 10.1080/07434610701650928; Sangha O, 2003, ARTHRIT RHEUM-ARTHR, V49, P156, DOI 10.1002/art.10993; Studenski S, 2003, J AM GERIATR SOC, V51, P314, DOI 10.1046/j.1532-5415.2003.51104.x; Suri P, 2009, PM&R, V1, P916, DOI 10.1016/j.pmrj.2009.09.009; WATKINS MA, 1991, PHYS THER, V71, P90, DOI 10.1093/ptj/71.2.90; Weiss CO, 2007, ARCH PHYS MED REHAB, V88, P1217, DOI 10.1016/j.apmr.2007.07.007; WHO, 2001, WHO INT CLASS FUNCT; Wolf DA, 2015, J GERONTOL B-PSYCHOL, V70, P745, DOI 10.1093/geronb/gbu182	41	6	6	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2016	11	12							e0169003	10.1371/journal.pone.0169003	http://dx.doi.org/10.1371/journal.pone.0169003			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EI9QH	28006024	gold, Green Published, Green Submitted			2022-12-27	WOS:000392843200121
J	Kim, J; Kim, Y; Pai, H				Kim, Jieun; Kim, Yeonjae; Pai, Hyunjoo			Clinical Characteristics and Treatment Outcomes of Clostridium difficile Infections by PCR Ribotype 017 and 018 Strains	PLOS ONE			English	Article							TOXIN-B; INCREASED SPORULATION; RISK-FACTORS; EPIDEMIOLOGY; EMERGENCE; RESISTANT; JAPAN	The objective of this study was to identify the clinical characteristics of Clostridium difficile infections (CDIs) caused by toxin A-negative/toxin B-positive (A-B+) PCR ribotype 017 (R017) and A+B+ ribotype 018 (R018) strains, prevalent in Asian countries. From February 2010 through January 2013, all CDI patients in our hospital were enrolled; their medical records were retrospectively reviewed, and the isolates were characterized by toxigenic culture and PCR ribotyping. Based on the ribotypes, a total of 510 cases were categorized as R017 (139, 27.3%), R018 (157, 30.8%) and other ribotypes groups (214, 42.0%), and clinical variables were compared between R017 and other ribotypes, R018 and other ribotypes and R018 and R017 groups. The patients with R017 infections had a higher mean Charlson's comorbidity index (OR 1.1, 1-1.21, p = 0.05), lower serum albumin (OR 0.47, 0.31-0.73, p = 0.001) and lower CRP levels (OR 0.96, 0.92-0.99, p = 0.022) than those with other ribotypes. R018 infections caused more azotemia (OR 4.06, 1.28-12.91, p = 0.018) and more frequent severe CDI (OR 1.87, 1.12-3.13, p = 0.016) than the other ribotypes infections. R017 and R018 infections were more often associated with toxin positive stools (OR 2.94, 1.65-4.09, p<0.001; OR 4.55, 2.82-7.33, p<0.001). In terms of treatment outcomes, R017 infections caused a marginally higher 30-day mortality than other ribotypes infection. In a final multiple logistic regression model, 30-day mortality was associated with leukocytosis (OR 2.45, 1.0-6.01, p = 0.05) and hypoalbuminemia (OR 4.57, 1.83-11.39, p = 0.001), but only marginally with R017 infection (OR 2.14, 0.88-5.22, p = 0.094). In conclusion, infections by C. difficile R018 strains tend to cause more severe disease, while there was a trend for higher mortality with R017 infections.	[Kim, Jieun; Pai, Hyunjoo] Hanyang Univ, Dept Internal Med, Coll Med, Seoul, South Korea; [Kim, Yeonjae] Natl Med Ctr, Ctr Infect Dis, Seoul, South Korea	Hanyang University; Korea Centers for Disease Control & Prevention (KCDC); Korea National Institute of Health (KNIH); Korea CDC Center for Infectious Disease; National Medical Center - Korea	Pai, H (corresponding author), Hanyang Univ, Dept Internal Med, Coll Med, Seoul, South Korea.	paihj@hanyang.ac.kr		Kim, Jieun/0000-0002-6214-3889				Awad MM, 2014, GUT MICROBES, V5, P579, DOI 10.4161/19490976.2014.969632; Baldan R, 2015, J CLIN MICROBIOL, V53, P2575, DOI 10.1128/JCM.00533-15; Bauer MP, 2011, LANCET, V377, P63, DOI 10.1016/S0140-6736(10)61266-4; CHARLSON M, 1994, J CLIN EPIDEMIOL, V47, P1245, DOI 10.1016/0895-4356(94)90129-5; Cheng VCC, 2011, EUR J CLIN MICROBIOL, V30, P1371, DOI 10.1007/s10096-011-1231-0; Cohen SH, 2010, INFECT CONT HOSP EP, V31, P431, DOI 10.1086/651706; Collins DA, 2013, ANTIMICROB RESIST IN, V2, DOI 10.1186/2047-2994-2-21; Dingle KE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019993; Erb S, 2015, CLIN MICROBIOL INFEC, V21, DOI 10.1016/j.cmi.2015.07.016; Freeman J, 2015, CLIN MICROBIOL INFEC, V21, DOI [10.1128/AAC.00220-12, DOI 10.1128/AAC.00220-12]; Gerding DN, 2013, CLIN INFECT DIS, V56, P1601, DOI 10.1093/cid/cit133; Goorhuis A, 2011, CLIN INFECT DIS, V53, P860, DOI 10.1093/cid/cir549; Hawkey PM, 2013, J CLIN MICROBIOL, V51, P3308, DOI 10.1128/JCM.00587-13; Huelsenbeck J, 2007, INFECT IMMUN, V75, P801, DOI 10.1128/IAI.01705-06; Johnson S, 2003, J CLIN MICROBIOL, V41, P1543, DOI 10.1128/JCM.41.4.1543-1547.2003; Kato H, 2001, J CLIN MICROBIOL, V39, P1391, DOI 10.1128/JCM.39.4.1391-1395.2001; Khanna S, 2012, AM J GASTROENTEROL, V107, P89, DOI 10.1038/ajg.2011.398; Kim J, 2014, CLIN MICROBIOL INFEC, V20, P1198, DOI 10.1111/1469-0691.12704; Kim J, 2013, CLIN MICROBIOL INFEC, V19, P521, DOI 10.1111/j.1469-0691.2012.03910.x; Kim J, 2012, BMC INFECT DIS, V12, DOI 10.1186/1471-2334-12-109; Kim J, 2012, INT J ANTIMICROB AG, V40, P24, DOI 10.1016/j.ijantimicag.2012.03.015; Kim J, 2011, J KOREAN MED SCI, V26, P1258, DOI 10.3346/jkms.2011.26.10.1258; Komatsu M, 2003, EUR J CLIN MICROBIOL, V22, P525, DOI 10.1007/s10096-003-0992-5; Merrigan M, 2010, J BACTERIOL, V192, P4904, DOI 10.1128/JB.00445-10; See I, 2014, CLIN INFECT DIS, V58, P1394, DOI 10.1093/cid/ciu125; Senoh M, 2015, J MED MICROBIOL, V64, P1226, DOI 10.1099/jmm.0.000149; Spigaglia P, 2010, J CLIN MICROBIOL, V48, P2892, DOI 10.1128/JCM.02482-09; Tenover FC, 2012, ANTIMICROB AGENTS CH, V56, P2929, DOI 10.1128/AAC.00220-12; Vedantam G, 2012, GUT MICROBES, V3, P121, DOI 10.4161/gmic.19399; Walk ST, 2012, CLIN INFECT DIS, V55, P1661, DOI 10.1093/cid/cis786; Walker AS, 2013, CLIN INFECT DIS, V56, P1589, DOI 10.1093/cid/cit127	31	24	24	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2016	11	12							e0168849	10.1371/journal.pone.0168849	http://dx.doi.org/10.1371/journal.pone.0168849			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI9TW	28002482	gold, Green Submitted, Green Published			2022-12-27	WOS:000392853100071
J	Nyborg, AC; Ward, C; Zacco, A; Chacko, B; Grinberg, L; Geoghegan, JC; Bean, R; Wendeler, M; Bartnik, F; O'Connor, E; Gruia, F; Iyer, V; Feng, H; Roy, V; Berge, M; Miner, JN; Wilson, DM; Zhou, DM; Nicholson, S; Wilker, C; Wu, CY; Wilson, S; Jermutus, L; Wu, H; Owen, DA; Osbourn, J; Coats, S; Baca, M				Nyborg, Andrew C.; Ward, Chris; Zacco, Anna; Chacko, Benoy; Grinberg, Luba; Geoghegan, James C.; Bean, Ryan; Wendeler, Michaela; Bartnik, Frank; O'Connor, Ellen; Gruia, Flaviu; Iyer, Vidyashankara; Feng, Hui; Roy, Varnika; Berge, Mark; Miner, Jeffrey N.; Wilson, David M.; Zhou, Dongmei; Nicholson, Simone; Wilker, Clynn; Wu, Chi Y.; Wilson, Susan; Jermutus, Lutz; Wu, Herren; Owen, David A.; Osbourn, Jane; Coats, Steven; Baca, Manuel			A Therapeutic Uricase with Reduced Immunogenicity Risk and Improved Development Properties	PLOS ONE			English	Article							URATE OXIDASE; POLYETHYLENE-GLYCOL; CHRONIC GOUT; ACID; RASBURICASE; PEGLOTICASE; EFFICACY; EVOLUTION; PHARMACOKINETICS; CHROMATOGRAPHY	Humans and higher primates are unique in that they lack uricase, the enzyme capable of oxidizing uric acid. As a consequence of this enzyme deficiency, humans have high serum uric acid levels. In some people, uric acid levels rise above the solubility limit resulting in crystallization in joints, acute inflammation in response to those crystals causes severe pain; a condition known as gout. Treatment for severe gout includes injection of non-human uricase to reduce serum uric acid levels. Krystexxa is a hyper-PEGylated pig-baboon chimeric uricase indicated for chronic refractory gout that induces an immunogenic response in 91% of treated patients, including infusion reactions (26%) and anaphylaxis (6.5%). These properties limit its use and effectiveness. An innovative approach has been used to develop a therapeutic uricase with improved properties such as: soluble expression, neutral pH solubility, high E. coli expression level, thermal stability, and excellent activity. More than 200 diverse uricase sequences were aligned to guide protein engineering and reduce putative sequence liabilities. A single uricase lead candidate was identified, which showed low potential for immunogenicity in >200 human donor samples selected to represent diverse HLA haplotypes. Cysteines were engineered into the lead sequence for site specific PEGylation and studies demonstrated >95% PEGylation efficiency. PEGylated uricase retains enzymatic activity in vitro at neutral pH, in human serum and in vivo (rats and canines) and has an extended half-life. In canines, an 85% reduction in serum uric acid levels was observed with a single subcutaneous injection. This PEGylated, non-immunogenic uricase has the potential to provide meaningful benefits to patients with gout.	[Nyborg, Andrew C.; Ward, Chris; Zacco, Anna; Chacko, Benoy; Grinberg, Luba; Geoghegan, James C.; Bean, Ryan; Wendeler, Michaela; Bartnik, Frank; O'Connor, Ellen; Gruia, Flaviu; Iyer, Vidyashankara; Feng, Hui; Roy, Varnika; Berge, Mark; Nicholson, Simone; Wilson, Susan; Wu, Herren; Coats, Steven; Baca, Manuel] MedImmune LLC, Gaithersburg, MD 20878 USA; [Miner, Jeffrey N.; Wilson, David M.; Zhou, Dongmei; Wilker, Clynn] Ardea Biosci, San Diego, CA USA; [Wu, Chi Y.] MedImmune LLC, Mountain View, CA USA; [Jermutus, Lutz; Owen, David A.; Osbourn, Jane] MedImmune LTD, Cambridge, England	AstraZeneca; Medimmune; AstraZeneca; AstraZeneca; Medimmune; AstraZeneca; Medimmune	Nyborg, AC (corresponding author), MedImmune LLC, Gaithersburg, MD 20878 USA.	nyborga@medimmune.com	Jermutus, Lutz/AAU-2047-2020	Wendeler, Michaela/0000-0001-7503-5257	MedImmune LLC	MedImmune LLC(AstraZenecaMedimmune)	The funder provided support in the form of salaries for authors (MedImmune LLC - ACN CW AZ, BC, LG, JG, RB, MW, FB, EO, FG, VI, HF, VR, MB, SN, CYVV, SW, LJ, HW, SC, and MB; MedImmune LTD - DAO and JO; Ardea - JNM, DMW, DZ, and CW), but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Alvarez-Lario B, 2010, RHEUMATOLOGY, V49, P2010, DOI 10.1093/rheumatology/keq204; Bach MH, 2014, CURR OPIN RHEUMATOL, V26, P169, DOI 10.1097/BOR.0000000000000035; Baraf HSB, 2014, JCR-J CLIN RHEUMATOL, V20, P427, DOI 10.1097/RHU.0000000000000200; BARBAS CF, 1993, P NATL ACAD SCI USA, V90, P10003, DOI 10.1073/pnas.90.21.10003; Bayol A, 2002, BIOTECHNOL APPL BIOC, V36, P21, DOI 10.1042/BA20010083; BAYOL A, 1995, BIOPHYS CHEM, V54, P229, DOI 10.1016/0301-4622(94)00150-I; Bobulescu A, 2012, ADV CHRONIC KIDNEY D, V19, P358, DOI 10.1053/j.ackd.2012.07.009; Bomalaski JS, 2002, J RHEUMATOL, V29, P1942; Cheah CY, 2013, ACTA HAEMATOL-BASEL, V130, P254, DOI 10.1159/000351048; Coiffier B, 2003, J CLIN ONCOL, V21, P4402, DOI 10.1200/JCO.2003.04.115; Cox D, 2010, NAT REV DRUG DISCOV, V9, P804, DOI 10.1038/nrd3266; Fishburn CS, 2008, J PHARM SCI-US, V97, P4167, DOI 10.1002/jps.21278; Fraisse L, 2002, ANAL BIOCHEM, V309, P173, DOI 10.1016/S0003-2697(02)00293-2; Ganson NJ, 2006, ARTHRITIS RES THER, V8, DOI 10.1186/ar1861; Garay RP, 2012, EXPERT OPIN DRUG DEL, V9, P1319, DOI 10.1517/17425247.2012.720969; GILL SC, 1989, ANAL BIOCHEM, V182, P319, DOI 10.1016/0003-2697(89)90602-7; Glantzounis GK, 2005, CURR PHARM DESIGN, V11, P4145, DOI 10.2174/138161205774913255; GOLDFARB E, 1966, ARTHRITIS RHEUM, V9, P414, DOI 10.1002/art.1780090306; Hershfield MS, 2010, P NATL ACAD SCI USA, V107, P14351, DOI 10.1073/pnas.1001072107; Hershfield MS, 2006, USA patent, Patent No. [US 7056713 B1, 7056713]; Jawa V, 2013, CLIN IMMUNOL, V149, P534, DOI 10.1016/j.clim.2013.09.006; Johnson RJ, 2005, SEMIN NEPHROL, V25, P3, DOI 10.1016/j.semnephrol.2004.09.002; Juan ECM, 2008, ACTA CRYSTALLOGR D, V64, P815, DOI 10.1107/S0907444908013590; Kahn K, 1998, BIOCHEMISTRY-US, V37, P11651, DOI 10.1021/bi980446g; Kratzer JT, 2014, P NATL ACAD SCI USA, V111, P3763, DOI 10.1073/pnas.1320393111; Lanaspa MA, 2012, J BIOL CHEM, V287, P40732, DOI 10.1074/jbc.M112.399899; Latha S M, 2015, Indian J Nephrol, V25, P91, DOI 10.4103/0971-4065.139092; Lipsky PE, 2014, ARTHRITIS RES THER, V16, DOI 10.1186/ar4497; MAHLER HR, 1955, J BIOL CHEM, V216, P625; MULLER M, 1969, EUR J BIOCHEM, V9, P424, DOI 10.1111/j.1432-1033.1969.tb00626.x; OROWAN E, 1955, NATURE, V175, P683, DOI 10.1038/175683a0; Parmar MS, 2009, NEW ENGL J MED, V360, P539; Ramazzina I, 2006, NAT CHEM BIOL, V2, P144, DOI 10.1038/nchembio768; Richette P, 2010, LANCET, V375, P318, DOI 10.1016/S0140-6736(09)60883-7; Ruoslahti E, 1996, ANNU REV CELL DEV BI, V12, P697, DOI 10.1146/annurev.cellbio.12.1.697; SAKUMA R, 1987, CLIN CHEM, V33, P1427; Schellekens H, 2013, PHARM RES-DORDR, V30, P1729, DOI 10.1007/s11095-013-1067-7; Shire SJ, 2010, CURRENT TRENDS MONOC, Vxiv; SOFAER JA, 1981, J MED GENET, V18, P410, DOI 10.1136/jmg.18.6.410; Stove V, 2007, CLIN CHEM, V53, P369, DOI 10.1373/clinchem.2006.081414; Sundy JS, 2007, ARTHRITIS RHEUM-US, V56, P1021, DOI 10.1002/art.22403; Sundy JS, 2011, JAMA-J AM MED ASSOC, V306, P711, DOI [10.1001/jama.2011.1169, 10.1001/jama.2011.116]; Ueng Sis, 2005, Proc (Bayl Univ Med Cent), V18, P275; VARELAECHAVARRIA A, 1988, FASEB J, V2, P3092, DOI 10.1096/fasebj.2.15.3192041; Watanabe S, 2002, HYPERTENSION, V40, P355, DOI 10.1161/01.HYP.0000028589.66335.AA; WAYNER EA, 1991, J CELL BIOL, V113, P919, DOI 10.1083/jcb.113.4.919; Wertheimer Albert, 2013, Curr Ther Res Clin Exp, V75, P1, DOI 10.1016/j.curtheres.2013.04.003; Yeldandi AV, 1995, GENE EXPRESSION, V5, P123; Zhang C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039659; Zhang C, 2012, INT J PHARMACEUT, V430, P307, DOI 10.1016/j.ijpharm.2012.03.057	50	25	26	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2016	11	12							e0167935	10.1371/journal.pone.0167935	http://dx.doi.org/10.1371/journal.pone.0167935			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI9TW	28002433	Green Submitted, Green Published, gold			2022-12-27	WOS:000392853100027
J	Jin, M; Wang, J; Chu, MX; Piao, J; Piao, JA; Zhao, FQ				Jin, Mei; Wang, Jing; Chu, Ming-Xing; Piao, Jun; Piao, Jing-Ai; Zhao, Feng-Qin			The Study on Biological Function of Keratin 26, a Novel Member of Liaoning Cashmere Goat Keratin Gene Family	PLOS ONE			English	Article							BONE MORPHOGENETIC PROTEINS; HAIR FOLLICLE GROWTH; IN-VITRO; IGF-I; SKIN; MELATONIN; INDUCTION; CYCLE; DIFFERENTIATION; REGULATOR	In our research, we explored the relationship between Keratin26 and the regulation of fine hair, BMP signaling pathway, MT, FGF5, and IGF-I. The result of hybridization in situ revealed that Keratin 26 was specially expressed in cortex of skin hair follicles; the result of immunohistochemistry indicated that Keratin 26 was expressed in internal root sheath, external root sheath. Then, Real-time quantitative PCR results showed that relative expressive quantity of Keratin 26 was 1.08 or 3.3 x greater in secondary follicle than primary follicle during anagen or catagen; the difference during anagen was not remarkable (p>0.05), however, that of catagen was extremely significant (p<0.01). Relative expressive quantity of Keratin 26 increased during telogen; the difference was extremely significant (p<0.01). Moreover, after Noggin expression interference using RNAi technology, we found that relative expressive quantity of Keratin 26 extremely remarkably declined (p<0.01); after K26 overexpression, we found that relative expressive quantity of Noggin extremely remarkably increased (p<0.01). We detected expressive quantity change of Keratin 26 and Keratin 26 using Real-time quantitative PCR and immunofluorescence technologies after fibroblasts were treated with MT, FGF5 or IGF-I; the results indicated that MT and FGF5 played a positive role in Keratin 26 and Keratin 26 expression, IGF-I played a negative role in Keratin26 expression, positive role in Keratin 26 expression. The results above showed that Keratin 26 could inhibit cashmere growth, and was related to entering to catagen and telogen of hair follicles; Keratin 26 and BMP signaling pathway were two antagonistic pathways each other which could inhibit growth and development of cashmere; MT, FGF5 and IGF-I could affect expression of Keratin 26 and Keratin 26, and Keratin 26 was one of the important pathways that MT induced cashmere production in advance, FGF5 regulated cashmere growth and IGF-I promoted cashmere growth and development.	[Jin, Mei; Wang, Jing; Piao, Jun; Piao, Jing-Ai; Zhao, Feng-Qin] Liaoning Normal Univ, Dept Life Sci, Dalian, Liaoning, Peoples R China; [Chu, Ming-Xing] Chinese Acad Agr Sci, Inst Anim Sci, Beijing, Peoples R China	Liaoning Normal University; Chinese Academy of Agricultural Sciences; Institute of Animal Science, CAAS	Zhao, FQ (corresponding author), Liaoning Normal Univ, Dept Life Sci, Dalian, Liaoning, Peoples R China.	eco-env@163.com			National Natural Science Foundation of China [31172188]; Distinguished Professor Subsidy Scheme in Liaoning Province; Scientific Research Projects in Liaoning Province Department of Education [L2014425]; Agricultural Science and Technology Innovation Program of China [ASTIP-IAS13]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Distinguished Professor Subsidy Scheme in Liaoning Province; Scientific Research Projects in Liaoning Province Department of Education; Agricultural Science and Technology Innovation Program of China	This work was supported by: 1. National Natural Science Foundation of China (No. 31172188); http//www.nsfc.gov.cn/; MJ; 2. Distinguished Professor Subsidy Scheme in Liaoning Province; http://old.lnen.cn/; 3. Scientific Research Projects in Liaoning Province Department of Education (No. L2014425); http//www.Inein.gov.en/kj/web/; JP; and 4. Agricultural Science and Technology Innovation Program of China (No. ASTIP-IAS13); http//www.zgnykj.org/, MJ. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALLAIN D, 1980, REPROD NUTR DEV, V20, P197, DOI 10.1051/rnd:19800114; BHORA FY, 1995, J SURG RES, V59, P236, DOI 10.1006/jsre.1995.1160; Bordeleau F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038780; Botchkarev VA, 2004, DIFFERENTIATION, V72, P512, DOI 10.1111/j.1432-0436.2004.07209005.x; Botchkarev VA, 2003, J INVEST DERMATOL, V120, P36, DOI 10.1046/j.1523-1747.2003.12002.x; Botchkarev VA, 1999, NAT CELL BIOL, V1, P158, DOI 10.1038/11078; Botchkarev VA, 2001, FASEB J, V15, P2205, DOI 10.1096/fj.01-0207com; Caricasole A, 2000, INT J DEV BIOL, V44, P443; Drogemuller C, 2007, ANIM GENET, V38, P218, DOI 10.1111/j.1365-2052.2007.01590.x; Duncan A, 2012, REPROD BIOL ENDOCRIN, V10, DOI 10.1186/1477-7827-10-90; Eriksson JE, 2009, J CLIN INVEST, V119, P1763, DOI 10.1172/JCI38339; Fang Y, 2010, ASIAN J ANIM VET ADV, V5, P34; Fischer TW, 2006, FASEB J, V20, P1564, DOI 10.1096/fj.05-5227fje; Fischer TW, 2008, J PINEAL RES, V44, P1, DOI 10.1111/j.1600-079X.2007.00512.x; Fischer TW, 2004, BRIT J DERMATOL, V150, P341, DOI 10.1111/j.1365-2133.2004.05685.x; Fuchs E, 2008, GENE DEV, V22, P976, DOI 10.1101/gad.1645908; Gao ZY, 2012, INT J OPHTHALMOL-CHI, V5, P661, DOI 10.3980/j.issn.2222-3959.2012.06.02; Gregg K., 1986, BIOL INTEGUMENT, P666; HARRIS PM, 1993, J ENDOCRINOL, V139, P463, DOI 10.1677/joe.0.1390463; HEBERT JM, 1994, CELL, V78, P1017, DOI 10.1016/0092-8674(94)90276-3; Housley DJE, 2006, ANIM GENET, V37, P309, DOI 10.1111/j.1365-2052.2006.01448.x; IBRAHEEM M, 1994, J ANAT, V185, P135; Jin M, 2010, SMALL RUMINANT RES, V93, P24, DOI 10.1016/j.smallrumres.2010.04.026; Jing NH, 2009, CHIN J CELL BIOL, V31, P2; Kan LX, 2011, J BIOMED SCI, V18, DOI 10.1186/1423-0127-18-92; Kaufman CK, 2003, GENE DEV, V17, P2108, DOI 10.1101/gad.1115203; Langbein L, 2003, J INVEST DERMATOL, V120, P512, DOI 10.1046/j.1523-1747.2003.12087.x; Liffers ST, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-137; Mayer JA, 2008, AM J PATHOL, V173, P1339, DOI 10.2353/ajpath.2008.070920; Meng YG, 2009, BMC CELL BIOL, V10, DOI 10.1186/1471-2121-10-96; Mou C, 2006, P NATL ACAD SCI USA, V103, P9075, DOI 10.1073/pnas.0600825103; Nanashima N, 2008, J BIOL CHEM, V283, P16868, DOI 10.1074/jbc.M802539200; NIXON AJ, 1993, J EXP ZOOL, V267, P47, DOI 10.1002/jez.1402670108; Park GT, 2002, NUCLEIC ACIDS RES, V30, P515, DOI 10.1093/nar/30.2.515; Philpott M P, 1995, J Invest Dermatol, V104, p44S; PHILPOTT MP, 1994, J INVEST DERMATOL, V102, P857, DOI 10.1111/1523-1747.ep12382494; Plowman JE, 2000, ELECTROPHORESIS, V21, P1899, DOI 10.1002/(SICI)1522-2683(20000501)21:9<1899::AID-ELPS1899>3.0.CO;2-R; Rogers MA, 2002, J BIOL CHEM, V277, P48993, DOI 10.1074/jbc.M206422200; Rogers MA, 2007, J INVEST DERMATOL, V127, P1197, DOI 10.1038/sj.jid.5700702; Sharov AA, 2006, P NATL ACAD SCI USA, V103, P18166, DOI 10.1073/pnas.0608899103; Slominski A, 2003, J CELL PHYSIOL, V196, P144, DOI 10.1002/jcp.10287; Stewart CEH, 1996, PHYSIOL REV, V76, P1005, DOI 10.1152/physrev.1996.76.4.1005; Suzuki S, 2000, J INVEST DERMATOL, V114, P456, DOI 10.1046/j.1523-1747.2000.00912.x; Tong XM, 2006, GENE DEV, V20, P1353, DOI 10.1101/gad.1387406; Tsumaki N, 2005, CYTOKINE GROWTH F R, V16, P279, DOI 10.1016/j.cytogfr.2005.04.001; Uchiumi A, 2012, EXP THER MED, V3, P443, DOI 10.3892/etm.2011.413; URIST MARSHALL R., 1967, CLIN ORTHOP RELATED RESIN COMPLICATIONS OF ORTHOPAEDIC SURGERY, V53, P243; Weger N, 2005, J INVEST DERMATOL, V125, P873, DOI 10.1111/j.0022-202X.2005.23946.x; XIAO Y, 1995, J REPROD FERTIL, V105, P9, DOI 10.1530/jrf.0.1050009; Yan JC, 2013, INT J CARDIOL, V169, pE87, DOI 10.1016/j.ijcard.2013.10.039; Yu ZD, 2009, DIFFERENTIATION, V77, P307, DOI 10.1016/j.diff.2008.10.009; Zimmerman LB, 1996, CELL, V86, P599, DOI 10.1016/S0092-8674(00)80133-6	52	10	10	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2016	11	12							e0168015	10.1371/journal.pone.0168015	http://dx.doi.org/10.1371/journal.pone.0168015			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI9QF	27997570	gold, Green Submitted, Green Published			2022-12-27	WOS:000392842900021
J	Kram, DE; Krasnow, SM; Levasseur, PR; Zhu, XX; Stork, LC; Marks, DL				Kram, David E.; Krasnow, Stephanie M.; Levasseur, Peter R.; Zhu, Xinxia; Stork, Linda C.; Marks, Daniel L.			Dexamethasone Chemotherapy Does Not Disrupt Orexin Signaling	PLOS ONE			English	Article							ACUTE LYMPHOBLASTIC-LEUKEMIA; OF-THE-LITERATURE; PEDIATRIC-PATIENTS; DIURNAL-VARIATION; GENE-EXPRESSION; REM-SLEEP; RAT-BRAIN; FATIGUE; NARCOLEPSY; HYPOCRETIN	Background Steroid-induced sleep disturbance is a common and highly distressing morbidity for children receiving steroid chemotherapy for the treatment of pediatric acute lymphoblastic leukemia (ALL). Sleep disturbance can negatively impact overall quality of life, neurodevelopment, memory consolidation, and wound healing. Hypothalamic orexin neurons are influential wake-promoting neurons, and disturbances in orexin signaling leads to abnormal sleep behavior. A new class of drug, the orexin receptor antagonists, could be an intriguing option for sleep disorders caused by increased orexinergic output. Our aim was to examine the impact of ALL treatment doses of corticosteroids on the orexin system in rodents and in children undergoing treatment for childhood ALL. Methods We administered repeated injections of dexamethasone to rodents and measured responsive orexin neural activity compared to controls. In children with newly diagnosed standard risk B-cell ALL receiving dexamethasone therapy per Children's Oncology Group (COG) induction therapy from 2014-2016, we collected pre- and during-steroids matched CSF samples and measured the impact of steroids on CSF orexin concentration. Results In both rodents, all markers orexin signaling, including orexin neural output and orexin receptor expression, were preserved in the setting of dexamethasone. Additionally, we did not detect a difference in pre-and during-dexamethasone CSF orexin concentrations in children receiving dexamethasone. Conclusions Our results demonstrate that rodent and human orexin physiology is largely preserved in the setting of high dose dexamethasone. The data obtained in our experimental model fail to demonstrate a causative role for disruption of the orexin pathway in steroid-induced sleep disturbance.	[Kram, David E.; Stork, Linda C.] Oregon Hlth & Sci Univ, Doernbecher Childrens Hosp, Div Pediat Hematol Oncol, Portland, OR 97201 USA; [Krasnow, Stephanie M.; Levasseur, Peter R.; Zhu, Xinxia; Marks, Daniel L.] Oregon Hlth & Sci Univ, Pape Family Pediat Res Inst, Portland, OR 97201 USA	Oregon Health & Science University; Oregon Health & Science University	Marks, DL (corresponding author), Oregon Hlth & Sci Univ, Pape Family Pediat Res Inst, Portland, OR 97201 USA.	marksd@ohsu.edu	Marks, Daniel/C-3712-2009	Kram, David/0000-0002-1928-001X	National Institutes of Health, National Cancer Institute [CM 84324]; NATIONAL CANCER INSTITUTE [R01CA184324] Funding Source: NIH RePORTER	National Institutes of Health, National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by National Institutes of Health, National Cancer Institute, CM 84324. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abercrombie HC, 2004, PSYCHONEUROENDOCRINO, V29, P1082, DOI 10.1016/j.psyneuen.2003.11.003; Ancoli-Israel S, 2003, SLEEP, V26, P342, DOI 10.1093/sleep/26.3.342; BORN J, 1986, NEUROPSYCHOBIOLOGY, V15, P165, DOI 10.1159/000118261; Brisbare-Roch C, 2007, NAT MED, V13, P150, DOI 10.1038/nm1544; Chemelli RM, 1999, CELL, V98, P437, DOI 10.1016/S0092-8674(00)81973-X; Davis JF, 2009, NEUROSCIENCE, V162, P23, DOI 10.1016/j.neuroscience.2009.04.039; de Lecea L, 2012, PROG BRAIN RES, V198, P15, DOI 10.1016/B978-0-444-59489-1.00003-3; Desarnaud F, 2004, SLEEP, V27, P851, DOI 10.1093/sleep/27.5.851; Fronczek R, 2009, SLEEP MED REV, V13, P9, DOI 10.1016/j.smrv.2008.05.002; Gaynon PS, 2010, LEUKEMIA, V24, P285, DOI 10.1038/leu.2009.262; Grady SP, 2006, SLEEP, V29, P295, DOI 10.1093/sleep/29.3.295; Grossberg AJ, 2011, J NEUROSCI, V31, P11376, DOI 10.1523/JNEUROSCI.2311-11.2011; Hara J, 2001, NEURON, V30, P345, DOI 10.1016/S0896-6273(01)00293-8; Harris GC, 2006, TRENDS NEUROSCI, V29, P571, DOI 10.1016/j.tins.2006.08.002; Hinds PS, 2007, CANCER-AM CANCER SOC, V110, P2321, DOI 10.1002/cncr.23039; Hunger SP, 2013, PEDIATR BLOOD CANCER, V60, P957, DOI 10.1002/pbc.24420; Lin L, 1999, CELL, V98, P365, DOI 10.1016/S0092-8674(00)81965-0; Makela KA, 2010, ACTA PHYSIOL, V198, P237, DOI 10.1111/j.1748-1716.2009.02068.x; Malik SW, 2005, PRIMARY CARE, V32, P475, DOI 10.1016/j.pop.2005.02.011; Marcus JN, 2001, J COMP NEUROL, V435, P6, DOI 10.1002/cne.1190; Michelson D, 2014, LANCET NEUROL, V13, P461, DOI 10.1016/S1474-4422(14)70053-5; Moser NJ, 1996, PHARMACOL TOXICOL, V79, P100, DOI 10.1111/j.1600-0773.1996.tb00249.x; Nakamura T, 2000, BRAIN RES, V873, P181, DOI 10.1016/S0006-8993(00)02555-5; Perez-Leighton CE, 2012, AM J PHYSIOL-ENDOC M, V303, pE865, DOI 10.1152/ajpendo.00119.2012; Porkka-Heiskanen T, 2004, NEUROBIOL AGING, V25, P231, DOI 10.1016/S0197-4580(03)00043-5; Reagan-Shaw S, 2008, FASEB J, V22, P659, DOI 10.1096/fj.07-9574LSF; Ripley B, 2001, NEUROLOGY, V57, P2253, DOI 10.1212/WNL.57.12.2253; Sakurai T, 2007, NAT REV NEUROSCI, V8, P171, DOI 10.1038/nrn2092; Saligan LN, 2015, SUPPORT CARE CANCER, V23, P2461, DOI 10.1007/s00520-015-2763-0; Salomon RM, 2003, BIOL PSYCHIAT, V54, P96, DOI 10.1016/S0006-3223(02)01740-7; Scammell TE, 2007, NAT MED, V13, P126, DOI 10.1038/nm0207-126; Spinazzi R, 2006, PHARMACOL REV, V58, P46, DOI 10.1124/pr.58.1.4; Stricker-Krongrad A, 2002, BIOCHEM BIOPH RES CO, V296, P129, DOI 10.1016/S0006-291X(02)00848-3; Stuart FA, 2005, ARCH DIS CHILD, V90, P500, DOI 10.1136/adc.2003.041541; Thompson MD, 2000, ANESTHESIOLOGY, V93, P1279, DOI 10.1097/00000542-200011000-00022; Vallance Kelly, 2011, Oncol Nurs Forum, V38, pE365, DOI 10.1188/11.ONF.E365-E372; Vallance K, 2010, EUR J CANCER, V46, P1848, DOI 10.1016/j.ejca.2010.03.026; Vgontzas AN, 2004, J CLIN ENDOCR METAB, V89, P2119, DOI 10.1210/jc.2003-031562; Vgontzas AN, 1999, J CLIN ENDOCR METAB, V84, P2603, DOI 10.1210/jc.84.8.2603; Walter LM, 2015, SLEEP MED REV, V24, P71, DOI 10.1016/j.smrv.2015.01.001; Wass CT, 1996, ANESTHESIOLOGY, V84, P644, DOI 10.1097/00000542-199603000-00020; Weymann KB, 2014, BRAIN BEHAV IMMUN, V37, P84, DOI 10.1016/j.bbi.2013.11.003; Willie JT, 2011, J MOL NEUROSCI, V43, P155, DOI 10.1007/s12031-010-9437-7; Willie JT, 2003, NEURON, V38, P715, DOI 10.1016/S0896-6273(03)00330-1; Zeitzer JM, 2003, J NEUROSCI, V23, P3555; Zisapel N, 2007, CELL MOL LIFE SCI, V64, P1174, DOI 10.1007/s00018-007-6529-9; Zupanec S, 2010, J PEDIATR ONCOL NURS, V27, P217, DOI 10.1177/1043454209358890	47	2	2	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2016	11	12							e0168731	10.1371/journal.pone.0168731	http://dx.doi.org/10.1371/journal.pone.0168731			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI9QF	27997622	gold, Green Published, Green Submitted			2022-12-27	WOS:000392842900071
J	Liarzi, O; Bucki, P; Miyara, SB; Ezra, D				Liarzi, Orna; Bucki, Patricia; Miyara, Sigal Braun; Ezra, David			Bioactive Volatiles from an Endophytic Daldinia cf. concentrica Isolate Affect the Viability of the Plant Parasitic Nematode Meloidogyne javanica	PLOS ONE			English	Article							ROOT-KNOT NEMATODE; COMPOUNDS IN-VITRO; BIOLOGICAL-CONTROL; MUSCODOR-ALBUS; PSEUDOMONAS-FLUORESCENS; NEMATOCIDAL ACTIVITY; POSTHARVEST DECAY; ORGANIC-COMPOUNDS; BIOCONTROL; TOMATO	Plant-parasitic nematodes form one of the largest sources of biotic stress imposed on plants, and are very difficult to control; among them are the obligate parasites, the sedentary root-knot nematodes (RKNs) Meloidogyne spp. which are extremely polyphagous and exploit a very wide range of hosts. Endophytic fungi are organisms that spend most of their life cycle within plant tissue without causing visible damage to the host plant. Many endophytes secrete specialized metabolites and/or emit volatile organic compounds (VOCs) that exhibit biological activity. Recently, we demonstrated that the endophytic fungus Daldinia cf. concentrica secrets biologically active VOCs. Here we examined the ability of the fungus and its VOCs to control the RKN M. javanica both in vitro and greenhouse experiments. The D. cf. concentrica VOCs showed bionematicidal activity against the second-stage juveniles (J2s) of M. javanica. We found that exposure of J2s to fungal volatiles caused 67% reduction in viability, and that application of a synthetic volatile mixture (SVM), comprising 3-methyl-1-butanol, (+/-)-2-methyl-1-butanol, 4-heptanone, and isoamyl acetate, in volumetric ratio of 1:1:2:1 further reduced J2s viability by 99%. We demonstrated that, although each of the four VOCs significantly reduced the viability of J2s relative to the control, only 4-heptanone elicited the same effect as the whole mixture, with nematicidal activity of 90% reduction in viability of the J2s. Study of the effect of the SVM on egg hatching demonstrated that it decreased eggs hatching by 87%. Finally, application of the SVM to soil inoculated with M. javanica eggs or J2s prior to planting susceptible tomato plants resulted in a significantly reduced galling index and fewer eggs produced on each root system, with no effect on root weight. Thus, D. cf. concentrica and/or SVM based on fungal VOCs may be considered as a novel alternative approach to controlling the RKN M. javanica.	[Liarzi, Orna; Ezra, David] ARO, Dept Plant Pathol & Weed Res, Rishon Leziyyon, Israel; [Bucki, Patricia; Miyara, Sigal Braun] ARO, Dept Entomol, Rishon Leziyyon, Israel; [Bucki, Patricia; Miyara, Sigal Braun] ARO, Nematol Unit, Rishon Leziyyon, Israel; [Bucki, Patricia; Miyara, Sigal Braun] ARO, Chem Unit, Rishon Leziyyon, Israel		Ezra, D (corresponding author), ARO, Dept Plant Pathol & Weed Res, Rishon Leziyyon, Israel.	dezra@volcani.agri.gov.il			Israel's Ministry of Agriculture and Rural Development (MOARD) [132-1252-06]; Israel's Ministry of Economy [47106]; "Kamin" project of the Israeli Ministry of Economy	Israel's Ministry of Agriculture and Rural Development (MOARD); Israel's Ministry of Economy; "Kamin" project of the Israeli Ministry of Economy	This work was financed by the Chief Scientist of Israel's Ministry of Agriculture and Rural Development (MOARD) (https://agriscience.coil), under grant number 132-1252-06, and the Chief Scientist of Israel's Ministry of Economy (http://www.matimop.org.il/ocs.html), under grant number 47106 ("Kamin project). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The grants were given to D.E.; This work was partially financed by the "Kamin" project of the Israeli Ministry of Economy and the Chief Scientist of the Israeli Ministry of Agriculture and Rural Development (MOARD); grant number 132-1252-06. This paper is Contribution No. 557/16 from the Agricultural Research Organization, the Volcani Center, P.O. Box 15159, Rishon LeZion 7528809 Israel.	Abad P, 2003, MOL PLANT PATHOL, V4, P217, DOI [10.1046/j.1364-3703.2003.00170.x, 10.1046/J.1364-3703.2003.00170.X]; Agbenin Nnennaya O., 2011, Plant Protection Science, V47, P62; Anastasiadis I, 2010, COMMUNICATIONS AGR A, V76, P333; ANKE H, 1995, CAN J BOT, V73, pS932, DOI 10.1139/b95-341; Azevedo Joao Lucio, 2000, EJB Electronic Journal of Biotechnology, V3, P1, DOI 10.2225/vol3-issue1-fulltext-4; Bacon C. W., 2000, MICROBIAL ENDOPHYTES, DOI 10.1201/9781482277302; Barker TR., 1985, ADV TREATISE MELOIDO, P19; Barnes EC, 2016, CHEM-EUR J, V22, P4551, DOI 10.1002/chem.201504005; Bashyal B, 1999, MYCOTAXON, V72, P33; Bayram O, 2012, FEMS MICROBIOL REV, V36, P1, DOI 10.1111/j.1574-6976.2011.00285.x; Bird DM, 2004, CURR OPIN PLANT BIOL, V7, P372, DOI 10.1016/j.pbi.2004.05.005; Castillo UF, 2002, MICROBIOL-SGM, V148, P2675, DOI 10.1099/00221287-148-9-2675; Dubreuil G, 2007, NEW PHYTOL, V176, P426, DOI 10.1111/j.1469-8137.2007.02181.x; Ezra D, 2004, MICROBIOL-SGM, V150, P785, DOI 10.1099/mic.0.26645-0; Fialho Mauricio Batista, 2012, Summa phytopathol., V38, P152, DOI 10.1590/S0100-54052012000200008; Freire ES, 2012, J NEMATOL, V44, P321; Gheysen G, 2002, ANNU REV PHYTOPATHOL, V40, P191, DOI 10.1146/annurev.phyto.40.121201.093719; Grimme E, 2007, PLANT DIS, V91, P220, DOI 10.1094/PDIS-91-2-0220; Hamid M, 2003, LETT APPL MICROBIOL, V36, P239, DOI 10.1046/j.1472-765X.2003.01299.x; HUSSEY RS, 1973, PLANT DIS REP, V57, P1025; Iberkleid I, 2014, PHYTOPATHOLOGY, V104, P484, DOI 10.1094/PHYTO-07-13-0181-R; JANSSON HB, 1985, J NEMATOL, V17, P327; JONES MGK, 1981, ANN APPL BIOL, V97, P353, DOI 10.1111/j.1744-7348.1981.tb05122.x; Koenning SR, 1999, J NEMATOL, V31, P587; Lamovsek Janja, 2013, Acta Agriculturae Slovenica, V101, P263, DOI 10.2478/acas-2013-0022; Li Bin, 2005, J Zhejiang Univ Sci B, V6, P496, DOI 10.1631/jzus.2005.B0496; Liarzi O., 2013, ADV ENDOPHYTIC RES, P335, DOI [10.1007/978-81-322-1575-2_18, DOI 10.1007/978-81-322-1575-2_18]; Liarzi O, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0168242; Mari M, 2012, POSTHARVEST BIOL TEC, V73, P56, DOI 10.1016/j.postharvbio.2012.05.014; Mari M, 2012, BIOL CONTROL, V60, P132, DOI 10.1016/j.biocontrol.2011.10.013; McAfee BJ, 1999, NAT TOXINS, V7, P283, DOI 10.1002/1522-7189(199911/12)7:6<283::AID-NT70>3.0.CO;2-N; Miller CM, 1998, J APPL MICROBIOL, V84, P937; Moosavi MR, 2012, PROG BIOL CONTROL, V12, P67, DOI 10.1007/978-94-007-1933-0_4; Moosavi MR, 2010, J INVERTEBR PATHOL, V104, P125, DOI 10.1016/j.jip.2010.03.002; Morath Shannon U., 2012, Fungal Biology Reviews, V26, P73, DOI 10.1016/j.fbr.2012.07.001; Ntalli NG, 2012, J AGR FOOD CHEM, V60, P9929, DOI 10.1021/jf303107j; O'Halloran DM, 2003, PARASITOLOGY, V127, P375, DOI 10.1017/S0031182003003688; Olivares-Bernabeu Concepcion Ma., 2002, Revista Iberoamericana de Micologia, V19, P104; Pazoutova S, 2013, FUNGAL DIVERS, V60, P107, DOI 10.1007/s13225-013-0238-5; Rahul S, 2014, NAT PROD RES, V28, P1399, DOI 10.1080/14786419.2014.904310; Riga E, 2008, BIOL CONTROL, V45, P380, DOI 10.1016/j.biocontrol.2008.01.002; Sharon E, 2001, PHYTOPATHOLOGY, V91, P687, DOI 10.1094/PHYTO.2001.91.7.687; Siddiqui IA, 2004, LETT APPL MICROBIOL, V39, P74, DOI 10.1111/j.1472-765X.2004.01540.x; Siddiqui IA, 2004, LETT APPL MICROBIOL, V38, P169, DOI 10.1111/j.1472-765X.2003.01481.x; Siddiqui IA, 2004, LETT APPL MICROBIOL, V38, P185, DOI 10.1111/j.1472-765X.2003.01472.x; Siddiqui IA, 2002, LETT APPL MICROBIOL, V35, P212, DOI 10.1046/j.1472-765X.2002.01162.x; Siddiqui ZA, 1996, BIORESOURCE TECHNOL, V58, P229, DOI 10.1016/S0960-8524(96)00122-8; Singh LP, 2011, PLANT SIGNAL BEHAV, V6, P175, DOI 10.4161/psb.6.2.14146; Stadler M, 2014, STUD MYCOL, P1, DOI 10.3114/sim0016; Stinson M, 2003, PLANT SCI, V165, P913, DOI 10.1016/S0168-9452(03)00299-1; Stone J, 2011, BIODIVERSITY FUNGI I; Strobel GA, 2001, MICROBIOL-SGM, V147, P2943, DOI 10.1099/00221287-147-11-2943; Strobel G, 2006, J IND MICROBIOL BIOT, V33, P514, DOI 10.1007/s10295-006-0090-7; Strobel G, 2011, FEMS MICROBIOL LETT, V320, P87, DOI 10.1111/j.1574-6968.2011.02297.x; Suwannarach N, 2013, CROP PROT, V45, P63, DOI 10.1016/j.cropro.2012.11.015; Terrill WF, 1996, J CHEM ECOL, V22, P1463, DOI 10.1007/BF02027725; Worapong J, 2001, MYCOTAXON, V79, P67; Xia YF, 2011, FEMS MICROBIOL LETT, V322, P99, DOI 10.1111/j.1574-6968.2011.02336.x; Zasada IA, 2010, ANNU REV PHYTOPATHOL, V48, P311, DOI 10.1146/annurev-phyto-073009-114425	59	31	33	3	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2016	11	12							e0168437	10.1371/journal.pone.0168437	http://dx.doi.org/10.1371/journal.pone.0168437			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI9QF	27997626	Green Published, gold, Green Submitted			2022-12-27	WOS:000392842900046
J	Olanrewaju, O; Kelly, S; Cowan, A; Brayne, C; Lafortune, L				Olanrewaju, Olawale; Kelly, Sarah; Cowan, Andy; Brayne, Carol; Lafortune, Louise			Physical Activity in Community Dwelling Older People: A Systematic Review of Reviews of Interventions and Context	PLOS ONE			English	Review							COGNITIVE FUNCTION; ACTIVITY PROMOTION; ADULTS; EXERCISE; HEALTH; BEHAVIOR; LIFE; PARTICIPATION; IMPAIRMENT; BARRIERS	Background The promotion and maintenance of higher physical activity (PA) levels in the older population is an imperative for cognitive and healthy ageing but it is unclear what approaches are best suited to achieve this for the increasing number of older people living in the community. Effective policies should be informed by robust, multi-disciplinary and multi-dimensional evidence, which not only seeks what works, but in 'what context? In addition to evidence on the efficacy and effectiveness of PA for maintaining cognitive health, social contexts such as `how do we actually get older people to partake in PA?' and 'how do we sustain that activity long-term?' also need highlighting. This review is part of a comprehensive evidence synthesis of preventive interventions in older age, with a focus on healthy behaviours to identify evidence gaps and inform policy relating to ageing well and cognitive health. An overview of systematic reviews of PA was conducted to explore three topics: (1) PA efficacy or effectiveness for primary prevention of cognitive decline in 55+; (2) Interventions efficacious or effective for increasing PA uptake and maintenance in 55+; (3) barriers and facilitators to PA in 55+. Methods Multiple databases were searched for studies in English from OECD countries between 2000 and 2016. Quality of included reviews in questions (1) and (2) were assessed using AMSTAR. Review protocols were registered on PROSPERO (CRD42014015554, 42014015584, CRD42014015557) and reviews follow PRISMA guideline. Findings Overall, 40 systematic reviews were included. Question 1 (n = 14). 8,360 participants. Evidence suggests that PA confer mild positive effects on cognition in older adults with and without previous cognitive impairment. However, there is insufficient evidence of a dose response relationship. Evidence on the effects of PA on delay of dementia onset is inconclusive. Question 2 (n = 17). 79,650 participants. Evidence supports the effectiveness of a variety of interventions, including group delivered, centre-based and cognitive approaches on short-term uptake of PA behaviour. Question 3 (n = 9). 22,413 participants. Barriers include health status, previous PA habits and experiences, and cultural sensitivity, while facilitators include enjoyable activities and convenient scheduling. Conclusion PA can offer small benefits to brain health, but evidence on how much activity is required to produce this effect is lacking. Evidence on the effectiveness of PA for preventing dementia and cognitive decline is lacking. Behavioural (walking, exercise) and cognitive (counselling and motivational interviews) interventions are effective for short-term uptake of physical activity in older people. In order to maintain long-term participation in PA, individualised interventions modelled using behavioural theories may be required. Public health messages should be aimed at promoting acceptable levels of PA above normal daily activities in older people. Policy and strategies aimed at increasing PA in older people should be encouraged while considering barriers and facilitators to behaviour change.	[Olanrewaju, Olawale; Kelly, Sarah; Cowan, Andy; Brayne, Carol; Lafortune, Louise] Cambridge Inst Publ Hlth, Forvie Site,Robinson Way, Cambridge CB2 0SR, England	University of Cambridge	Olanrewaju, O (corresponding author), Cambridge Inst Publ Hlth, Forvie Site,Robinson Way, Cambridge CB2 0SR, England.	oo260@medschl.cam.ac.uk	Brayne, Carol/AAA-4285-2020; Lafortune, Louise/AAJ-9257-2020	Brayne, Carol/0000-0001-5307-663X; Lafortune, Louise/0000-0002-9018-1217; Cowan, Andy/0000-0002-8981-5673; Kelly, Sarah/0000-0002-1114-2456; Olanrewaju, Olawale/0000-0002-0703-1358	National Institute for Health Research (NIHR) School for Public Health Research Ageing Well Programme [RG67185]; NIHR Collaborations for Leadership in Applied Health Research and Care (CLAHRC) East of England; National Institute for Health Research [NF-SI-0611-10084] Funding Source: researchfish	National Institute for Health Research (NIHR) School for Public Health Research Ageing Well Programme(National Institute for Health Research (NIHR)); NIHR Collaborations for Leadership in Applied Health Research and Care (CLAHRC) East of England; National Institute for Health Research(National Institute for Health Research (NIHR))	This review was funded by the National Institute for Health Research (NIHR) School for Public Health Research Ageing Well Programme (RG67185) and the NIHR Collaborations for Leadership in Applied Health Research and Care (CLAHRC) East of England.	Aday L A, 1974, Health Serv Res, V9, P208; ANDERSEN R, 1978, MED CARE, V16, P533, DOI 10.1097/00005650-197807000-00001; Angevaren M, 2008, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD005381.pub3, 10.1002/14651858.CD005381.pub2]; [Anonymous], 2013, WHAT DOES 2011 CENS; Asikainen TM, 2004, SPORTS MED, V34, P753, DOI 10.2165/00007256-200434110-00004; Balsamo S, 2013, INT J GEN MED, V6, P387, DOI 10.2147/IJGM.S35315; Barnett I, 2012, INT J BEHAV NUTR PHY, V9, DOI 10.1186/1479-5868-9-97; Bernd R, 2009, CAN HLTH SYSTEMS RES, P1997; Boehm J, 2013, AUST J RURAL HEALTH, V21, P141, DOI 10.1111/ajr.12032; Booth FW, 2012, COMPR PHYSIOL, V2, P1143, DOI 10.1002/cphy.c110025; Bunn F, 2008, AGEING SOC, V28, P449, DOI 10.1017/S0144686X07006861; Cai Y, 2015, QUALITY PRIMARY CARE, V23, P9; Carvalho A, 2014, CLIN INTERV AGING, V9, P661, DOI 10.2147/CIA.S55520; Centers for Disease Control and Prevention, 2009, GLOSS TERMS EX; Chang YK, 2012, J AGING PHYS ACTIV, V20, P497, DOI 10.1123/japa.20.4.497; Chase J-AD, 2014, GERONTOLOGIST; Chase JAD, 2013, RES THEOR NURS PRACT, V27, P53, DOI 10.1891/1541-6577.27.1.53; Child S, 2012, IMPLEMENT SCI, V7, DOI 10.1186/1748-5908-7-91; Clegg AP, 2011, AGE AGEING, V40, pII30; Colcombe S, 2003, PSYCHOL SCI, V14, P125, DOI 10.1111/1467-9280.t01-1-01430; Conn V. S., 2002, Activities, Adaptation & Aging, V27, P39, DOI 10.1300/J016v27n02_04; Conn VS, 2003, J AM GERIATR SOC, V51, P1159, DOI 10.1046/j.1532-5415.2003.51365.x; Conn VS, 2002, ANN BEHAV MED, V24, P190, DOI 10.1207/S15324796ABM2403_04; Corder K, 2009, AM J EPIDEMIOL, V170, P1078, DOI 10.1093/aje/kwp273; Cunningham GO, 2004, AM J HEALTH PROMOT, V18, P435, DOI 10.4278/0890-1171-18.6.435; Cyarto E V, 2004, J Sci Med Sport, V7, P30, DOI 10.1016/S1440-2440(04)80275-5; Coelho FGD, 2013, ARCH GERONTOL GERIAT, V56, P10, DOI 10.1016/j.archger.2012.06.003; de Vries NM, 2012, AGEING RES REV, V11, P136, DOI 10.1016/j.arr.2011.11.002; Devereux-Fitzgerald A, 2016, SOC SCI MED, V158, P14, DOI 10.1016/j.socscimed.2016.04.006; Di Iulio F, 2010, INT PSYCHOGERIATR, V22, P629, DOI 10.1017/S1041610210000281; Dunsky Ayelet, 2012, Curr Aging Sci, V5, P66; Fairhall N, 2011, AGE AGEING, V40, P666, DOI 10.1093/ageing/afr077; Foot J, 2010, GLASS HALF FULL ASSE, P1; Franco MR, 2015, BRIT J SPORT MED, V49, P1268, DOI 10.1136/bjsports-2014-094015; French DP, 2014, ANN BEHAV MED, V48, P225, DOI 10.1007/s12160-014-9593-z; Gates N, 2013, AM J GERIAT PSYCHIAT, V21, P1086, DOI 10.1016/j.jagp.2013.02.018; Geraedts H, 2013, PATIENT EDUC COUNS, V91, P14, DOI 10.1016/j.pec.2012.10.018; Hobbs N, 2013, BMC MED, V11, DOI 10.1186/1741-7015-11-75; Horne M, 2012, PREV MED, V55, P276, DOI 10.1016/j.ypmed.2012.07.016; Kasneci D, 2007, EUROPEAN PAPERS NEW, P32; Kelly ME, 2014, AGEING RES REV, V16, P12, DOI 10.1016/j.arr.2014.05.002; Kelly S, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0145074; Koutsogeorgou E, 2013, HLTH ED J; Lafortune L, 2014, PROSPERO; Lafortune L, 2014, PROSPERO; Lafortune L, 2014, PROSPERO; Moher D., 2015, STATEMENT SYSTEMATIC, V4, DOI [10.1186/2046-4053-4-1, DOI 10.1186/2046-4053-4-12-S2.0-84920780781, DOI 10.14306/RENHYD.20.2.223]; Muller AM, 2014, INT J BEHAV NUTR PHY, V11, DOI 10.1186/1479-5868-11-35; Neidrick TJ, 2012, J AM ACAD NURSE PRAC, V24, P405, DOI 10.1111/j.1745-7599.2012.00703.x; Nelson ME, 2007, MED SCI SPORT EXER, V39, P1435, DOI [10.1249/mss.0b013e3180616aa2, 10.1161/CIRCULATIONAHA.107.185650]; Nigg CR, 2012, TRANSL BEHAV MED, V2, P163, DOI 10.1007/s13142-012-0130-y; Norton S, 2014, LANCET NEUROL, V13, P788, DOI 10.1016/S1474-4422(14)70136-X; O'Brien N, 2015, HEALTH PSYCHOL REV, V9, P417, DOI 10.1080/17437199.2015.1012177; Ohman H, 2014, DEMENT GERIATR COGN, V38, P347, DOI 10.1159/000365388; Paterson DH, 2010, INT J BEHAV NUTR PHY, V7, DOI 10.1186/1479-5868-7-38; Reis RS, 2016, LANCET, V388, P1337, DOI 10.1016/S0140-6736(16)30728-0; Scherder E, 2014, AM J GERIAT PSYCHIAT, V22, P782, DOI 10.1016/j.jagp.2012.12.026; Soares-Miranda L, 2016, CIRCULATION, V133, P147, DOI 10.1161/CIRCULATIONAHA.115.018323; Stevens Z, 2014, PRIM HEALTH CARE RES, V15, P190, DOI 10.1017/S1463423613000017; Tseng CN, 2011, J NURS RES, V19, P119, DOI 10.1097/JNR.0b013e3182198837; van der Bij AK, 2002, AM J PREV MED, V22, P120, DOI 10.1016/S0749-3797(01)00413-5; van Uffelen JGZ, 2008, CLIN J SPORT MED, V18, P486, DOI 10.1097/JSM.0b013e3181845f0b; Whitty CJM, 2015, BMC MED, V13, DOI 10.1186/s12916-015-0544-8; World Health Organization, 2013, GLOB ACT PLAN PREV C	64	87	87	3	57	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2016	11	12							e0168614	10.1371/journal.pone.0168614	http://dx.doi.org/10.1371/journal.pone.0168614			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EI9QF	27997604	Green Submitted, Green Published, gold			2022-12-27	WOS:000392842900062
J	Bosak, T; Schubotz, F; de Santiago-Torio, A; Kuehl, JV; Carlson, HK; Watson, N; Daye, M; Summons, RE; Arkin, AP; Deutschbauer, AM				Bosak, Tanja; Schubotz, Florence; de Santiago-Torio, Ana; Kuehl, Jennifer V.; Carlson, Hans K.; Watson, Nicki; Daye, Mirna; Summons, Roger E.; Arkin, Adam P.; Deutschbauer, Adam M.			System-Wide Adaptations of Desulfovibrio alaskensis G20 to Phosphate-Limited Conditions	PLOS ONE			English	Article							GLOBAL TRANSCRIPTIONAL ANALYSIS; SULFUR ISOTOPE FRACTIONATION; VULGARIS HILDENBOROUGH; ESCHERICHIA-COLI; BLACK-SEA; SINORHIZOBIUM-MELILOTI; STARVATION RESPONSE; REGULATORY NETWORK; SULFATE REDUCTION; MICROBIAL ECOLOGY	The prevalence of lipids devoid of phosphorus suggests that the availability of phosphorus limits microbial growth and activity in many anoxic, stratified environments. To better understand the response of anaerobic bacteria to phosphate limitation and starvation, this study combines microscopic and lipid analyses with the measurements of fitness of pooled bar-coded transposon mutants of the model sulfate reducing bacterium Desulfovibrio alaskensis G20. Phosphate-limited G20 has lower growth rates and replaces more than 90% of its membrane phospholipids by a mixture of monoglycosyl diacylglycerol (MGDG), glycuronic acid diacylglycerol (GADG) and ornithine lipids, lacks polyphosphate granules, and synthesizes other cellular inclusions. Analyses of pooled and individual mutants reveal the importance of the high-affinity phosphate transport system (the Pst system), PhoR, and glycolipid and ornithine lipid synthases during phosphate limitation. The phosphate-dependent synthesis of MGDG in G20 and the widespread occurrence of the MGDG/GADG synthase among sulfate reducing partial derivative-Proteobacteria implicate these microbes in the production of abundant MGDG in anaerobic environments where the concentrations of phosphate are lower than 10 mu M. Numerous predicted changes in the composition of the cell envelope and systems involved in transport, maintenance of cytoplasmic redox potential, central metabolism and regulatory pathways also suggest an impact of phosphate limitation on the susceptibility of sulfate reducing bacteria to other anthropogenic or environmental stresses.	[Bosak, Tanja; de Santiago-Torio, Ana; Daye, Mirna; Summons, Roger E.] MIT, Dept Earth & Planetary Sci, 77 Massachusetts Ave, Cambridge, MA 02139 USA; [Schubotz, Florence] Univ Bremen, Bremen, Germany; [Schubotz, Florence] MARUM, Bremen, Germany; [Kuehl, Jennifer V.; Carlson, Hans K.; Arkin, Adam P.; Deutschbauer, Adam M.] Lawrence Berkeley Natl Lab, Environm Genom & Syst Biol Div, Berkeley, CA USA; [Watson, Nicki] Whitehead Inst, WM Keck Microscopy Facil, Cambridge, MA 02142 USA; [Arkin, Adam P.] Univ Calif Berkeley, Dept Bioengn, Berkeley, CA 94720 USA	Massachusetts Institute of Technology (MIT); University of Bremen; University of Bremen; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; Massachusetts Institute of Technology (MIT); Whitehead Institute; University of California System; University of California Berkeley	Bosak, T (corresponding author), MIT, Dept Earth & Planetary Sci, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	tbosak@mit.edu	Arkin, Adam P/A-6751-2008; Summons, Roger Everett/AAL-3789-2020; Arkin, Adam/M-9941-2019	Arkin, Adam P/0000-0002-4999-2931; Arkin, Adam/0000-0002-4999-2931; Bosak, Tanja/0000-0001-5179-5323	Simons Foundation Collaboration on the Origins of Life [327126]; Early Career Investigator in Marine Microbiology and Evolution [344707]; Office of Science, Office of Biological and Environmental Research, of the U.S. Department of Energy [DE-AC02-05CH11231]	Simons Foundation Collaboration on the Origins of Life; Early Career Investigator in Marine Microbiology and Evolution; Office of Science, Office of Biological and Environmental Research, of the U.S. Department of Energy(United States Department of Energy (DOE))	TB received grants from the Simons Foundation Collaboration on the Origins of Life #327126 and Early Career Investigator in Marine Microbiology and Evolution #344707; https:https://www.simonsfoundation.org/life-sciences/simons-collaboration-on-the-origins-of-life/simons-investigators/, https://www.simonsfoundation.org/funding/funding-opportunities/life-sciences/simons-early-career-investigator-in-marine-microbial-ecology-and-evolution-awards/. RES received a grant from the Simons Foundation Collaboration on the Origins of Life. This work conducted by ENIGMA was supported by the Office of Science, Office of Biological and Environmental Research, of the U.S. Department of Energy under contract no. DE-AC02-05CH11231 (to AMD and APA).	Alonso-Casajus N, 2006, J BACTERIOL, V188, P5266, DOI 10.1128/JB.01566-05; Vences-Guzman MA, 2015, ENVIRON MICROBIOL, V17, P1487, DOI 10.1111/1462-2920.12562; Aschar-Sobbi R, 2008, J FLUORESC, V18, P859, DOI 10.1007/s10895-008-0315-4; Bar-Yosef Y, 2010, CURR BIOL, V20, P1557, DOI 10.1016/j.cub.2010.07.032; Benitez-Nelson CR, 2000, EARTH-SCI REV, V51, P109, DOI 10.1016/S0012-8252(00)00018-0; BENNING C, 1995, ARCH BIOCHEM BIOPHYS, V317, P103, DOI 10.1006/abbi.1995.1141; BRANDIS A, 1981, J GEN MICROBIOL, V126, P249; Braun S, 2016, GEOCHIMICA COSMOCHIM; Canfield DE, 2010, SCIENCE, V330, P1375, DOI 10.1126/science.1196889; Carini P, 2015, P NATL ACAD SCI USA, V112, P7767, DOI 10.1073/pnas.1505034112; Carlson HK, 2015, ENVIRON SCI TECHNOL, V49, P3727, DOI 10.1021/es505843z; Chakraborty S, 2011, J BIOL CHEM, V286, P39417, DOI 10.1074/jbc.M111.295188; Chhabra SR, 2006, J BACTERIOL, V188, P1817, DOI 10.1128/JB.188.5.1817-1828.2006; CLINE JD, 1969, ENVIRON SCI TECHNOL, V3, P838, DOI 10.1021/es60032a004; Daines DA, 2000, FEMS MICROBIOL LETT, V189, P281, DOI 10.1111/j.1574-6968.2000.tb09244.x; Dehal PS, 2010, NUCLEIC ACIDS RES, V38, pD396, DOI 10.1093/nar/gkp919; Dowhan W, 2009, J LIPID RES, V50, pS305, DOI 10.1194/jlr.R800041-JLR200; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; ELLWOOD DC, 1969, BIOCHEM J, V111, P1; Flohr A, 2014, BIOGEOSCIENCES, V11, P885, DOI 10.5194/bg-11-885-2014; Geiger O, 1999, MOL MICROBIOL, V32, P63, DOI 10.1046/j.1365-2958.1999.01325.x; Godwin CM, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00159; He Q, 2006, APPL ENVIRON MICROB, V72, P4370, DOI 10.1128/AEM.02609-05; Hendrickson EL, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-185; Hoi LT, 2006, PROTEOMICS, V6, P3582, DOI 10.1002/pmic.200500842; INGALL E, 1994, GEOCHIM COSMOCHIM AC, V58, P2571, DOI 10.1016/0016-7037(94)90033-7; Jendrossek D, 2007, APPL ENVIRON MICROB, V73, P586, DOI 10.1128/AEM.01839-06; Krol E, 2004, MOL GENET GENOMICS, V272, P1, DOI 10.1007/s00438-004-1030-8; Kuehl JV, 2014, MBIO, V5, DOI 10.1128/mBio.01041-14; Laganowsky A, 2014, NATURE, V510, P172, DOI 10.1038/nature13419; Lamarche MG, 2008, FEMS MICROBIOL REV, V32, P461, DOI 10.1111/j.1574-6976.2008.00101.x; Lee MHP, 2010, APPL MICROBIOL BIOT, V87, P1109, DOI 10.1007/s00253-010-2596-1; Li YF, 2007, ANTIMICROB AGENTS CH, V51, P2092, DOI 10.1128/AAC.00052-07; LIBEREK K, 1991, P NATL ACAD SCI USA, V88, P2874, DOI 10.1073/pnas.88.7.2874; Lin XJ, 2006, APPL ENVIRON MICROB, V72, P2679, DOI 10.1128/AEM.72.4.2679-2690.2006; Madrid VM, 2001, APPL ENVIRON MICROB, V67, P1663, DOI 10.1128/AEM.67.4.1663-1674.2001; MAKULA RA, 1974, J BACTERIOL, V120, P1279, DOI 10.1128/JB.120.3.1279-1283.1974; Malinverni JC, 2009, P NATL ACAD SCI USA, V106, P8009, DOI 10.1073/pnas.0903229106; Meyer B, 2014, ENVIRON MICROBIOL, V16, P3463, DOI 10.1111/1462-2920.12405; Mileykovskaya E, 2009, J BIOL CHEM, V284, P2990, DOI 10.1074/jbc.M805189200; Millero F. J., 2006, CHEM OCEANOGRAPHY; Minnikin D, 1974, REPLACEMENT ACIDIC P; MINNIKIN DE, 1974, FEBS LETT, V43, P257, DOI 10.1016/0014-5793(74)80655-1; Mukhopadhyay A, 2007, J BACTERIOL, V189, P5996, DOI 10.1128/JB.00368-07; Mukhopadhyay A, 2006, J BACTERIOL, V188, P4068, DOI 10.1128/JB.01921-05; Muyzer G, 2008, NAT REV MICROBIOL, V6, P441, DOI 10.1038/nrmicro1892; N'Guessan AL, 2010, ISME J, V4, P253, DOI 10.1038/ismej.2009.115; Oh J, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq419; Oh J, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001140; Ovecka M, 2012, PLANT SIGNAL BEHAV, V7, P1146, DOI 10.4161/psb.21370; Paytan A, 2007, CHEM REV, V107, P563, DOI 10.1021/cr0503613; Pierce SE, 2007, NAT PROTOC, V2, P2958, DOI 10.1038/nprot.2007.427; Price MN, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00577; Rabus R, 2006, PROKARYOTES: A HANDBOOK ON THE BIOLOGY OF BACTERIA, VOL 2, THIRD EDITION, P659, DOI 10.1007/0-387-30742-7_22; Rattanapoltee P, 2013, WORLD ACAD SCI ENG T, V7, P889; Romano S, 2015, APPL ENVIRON MICROB, V81, P3518, DOI 10.1128/AEM.04167-14; Rossel PE, 2011, GEOCHIM COSMOCHIM AC, V75, P164, DOI 10.1016/j.gca.2010.09.031; Saeed A, 2003, TIGR MEV MULTIEXPERI; Santos-Beneit F, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00402; Schubotz F, NONPHOSPHORUS UNPUB; Schubotz F, 2009, ENVIRON MICROBIOL, V11, P2720, DOI 10.1111/j.1462-2920.2009.01999.x; Sebastian M, 2012, ENVIRON MICROBIOL, V14, P2334, DOI 10.1111/j.1462-2920.2012.02772.x; Seidel M, 2013, ORG GEOCHEM, V59, P133, DOI 10.1016/j.orggeochem.2013.04.004; Semeniuk A, 2014, J BIOL CHEM, V289, P10104, DOI 10.1074/jbc.M113.519298; Sim MS, 2012, APPL ENVIRON MICROB, V78, P8368, DOI 10.1128/AEM.01842-12; Sim MS, 2011, GEOCHIM COSMOCHIM AC, V75, P4244, DOI 10.1016/j.gca.2011.05.021; Sim MS, 2011, SCIENCE, V333, P74, DOI 10.1126/science.1205103; SMITH MW, 1992, FEMS MICROBIOL LETT, V100, P183, DOI 10.1016/0378-1097(92)90207-5; Stewart FJ, 2011, BIOCHEM SOC T, V39, P1859, DOI 10.1042/BST20110708; Stolyar S, 2007, J BACTERIOL, V189, P8944, DOI 10.1128/JB.00284-07; Sturt HF, 2004, RAPID COMMUN MASS SP, V18, P617, DOI 10.1002/rcm.1378; Thingstad TF, 2005, ECOL LETT, V8, P675, DOI 10.1111/j.1461-0248.2005.00768.x; Van Mooy BAS, 2009, NATURE, V458, P69, DOI 10.1038/nature07659; Wakeham SG, 2007, ORG GEOCHEM, V38, P2070, DOI 10.1016/j.orggeochem.2007.08.003; WEIMER PJ, 1988, APPL ENVIRON MICROB, V54, P386, DOI 10.1128/AEM.54.2.386-396.1988; Wetmore KM, 2015, MBIO, V6, DOI 10.1128/mBio.00306-15; Wormer L, 2013, ORG GEOCHEM, V59, P10, DOI 10.1016/j.orggeochem.2013.03.004; Woo HM, 2010, APPL ENVIRON MICROB, V76, P6910, DOI 10.1128/AEM.01375-10; Wu JF, 2000, SCIENCE, V289, P759, DOI 10.1126/science.289.5480.759; Yao M, 2015, ENV MICROBIOLOGY; Yuan ZC, 2006, NUCLEIC ACIDS RES, V34, P2686, DOI 10.1093/nar/gkl365; Yuasa J., 2002, MICROBES ENVIRON, V17, P75; Zane GM, 2010, APPL ENVIRON MICROB, V76, P5500, DOI 10.1128/AEM.00691-10; Zhang WW, 2006, ANTON LEEUW INT J G, V90, P41, DOI 10.1007/s10482-006-9059-9	85	11	11	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2016	11	12							e0168719	10.1371/journal.pone.0168719	http://dx.doi.org/10.1371/journal.pone.0168719			29	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EG7JB	28030630	Green Published, Green Submitted, gold			2022-12-27	WOS:000391222000067
J	Chen, YH; Chen, CL; Lu, DW; Liang, CM; Tai, MC; Chen, JT				Chen, Yi-Hao; Chen, Ching-Long; Lu, Da-Wen; Liang, Chang-Min; Tai, Ming-Cheng; Chen, Jiann-Torng			Silibinin Inhibits Platelet-Derived Growth Factor-Driven Cell Proliferation via Downregulation of N-Glycosylation in Human Tenon's Fibroblasts in a Proteasome-Dependent Manner	PLOS ONE			English	Article							MITOMYCIN-C; FILTRATION SURGERY; SIGNALING PATHWAY; CARCINOMA-CELLS; BLEB LEAKAGE; LONG-TERM; TRABECULECTOMY; GLAUCOMA; CANCER; CYCLE	The objective of this study was to evaluate the effects of silibinin on cell proliferation in platelet-derived growth factor (PDGF)-treated human Tenon's fibroblasts (HTFs). The effect of silibinin on cell proliferation in PDGF-treated HTFs was determined by examining the expression of proliferating cell nuclear antigen (PCNA) and performing WST-1 assays. Cell cycle progression was evaluated using flow cytometry. The related cyclins and cyclin-dependent kinases (CDKs) were also analyzed using western blot. A modified rat trabeculectomy model was established to evaluate the effect of silibinin on cell proliferation in vivo. Western blot analysis was carried out to determine the effect of silibinin on the expression of PDGF receptor and on the downstream signaling pathways regulated by PDGF receptor. PDGF elevated the expression of PCNA in HTFs, and this elevation was inhibited by silibinin. The inhibitory effect of silibinin on cell proliferation was also confirmed via WST-1 assay. PDGF-stimulated cell cycle in HTFs was delayed by silibinin, and the related cyclin D1 and CDK4 were also suppressed by silibinin. In the rat model of trabeculectomy, silibinin reduced the expression of PCNA at the site of blebs in vivo. The effects of silibinin on PDGF-stimulated HTFs were mediated via the downregulation of PDGF receptor-regulated signaling pathways, such as ERKs and STATs, which may be partially caused by the downregulation of N-glycosylation of PDGF receptor beta (PDGFR beta). The effect of silibinin on modulation of N-glycosylation of PDGFR beta was mediated in a proteasome-dependent manner. Silibinin inhibited cell proliferation and delayed cell cycle progression in PDGF-treated HTFs in vitro. PDGF also modulated the process of N-glycosylation of the PDGFR beta in a proteasome-dependent manner. Our findings suggest that silibinin has potential therapeutic applications in glaucoma filtering surgery.	[Chen, Yi-Hao; Chen, Ching-Long; Lu, Da-Wen; Liang, Chang-Min; Tai, Ming-Cheng; Chen, Jiann-Torng] Natl Def Med Ctr, Grad Inst Med Sci, Taipei, Taiwan; [Chen, Yi-Hao; Chen, Ching-Long; Lu, Da-Wen; Liang, Chang-Min; Tai, Ming-Cheng; Chen, Jiann-Torng] Triserv Gen Hosp, Dept Ophthalmol, Natl Def Med Ctr, Taipei, Taiwan	National Defense Medical Center; National Defense Medical Center; Tri-Service General Hospital	Chen, JT (corresponding author), Natl Def Med Ctr, Grad Inst Med Sci, Taipei, Taiwan.; Chen, JT (corresponding author), Triserv Gen Hosp, Dept Ophthalmol, Natl Def Med Ctr, Taipei, Taiwan.	jt66chen@gmail.com			Tri-Service General Hospital, Taiwan [TSGH-C105-099, TSGH-C105-098]; National Science Council, Taiwan [NSC 102-2314-B-016-046-MY3]; Ministry of Science and Technology, Taiwan [MOST 104-2314-B-016-035]	Tri-Service General Hospital, Taiwan; National Science Council, Taiwan(Ministry of Science and Technology, Taiwan); Ministry of Science and Technology, Taiwan(Ministry of Science and Technology, Taiwan)	Yi-Hao Chen was supported by Tri-Service General Hospital, Taiwan-TSGH-C105-099, Da-Wen Lu by Tri-Service General Hospital, Taiwan-TSGH-C105-098, Jiann-Torng Chen by National Science Council, Taiwan-NSC 102-2314-B-016-046-MY3, and Yi-Hao Chen by the Ministry of Science and Technology, Taiwan-MOST 104-2314-B-016-035.	Alvarez RH, 2006, MAYO CLIN PROC, V81, P1241, DOI 10.4065/81.9.1241; Broadway DC, 2001, J GLAUCOMA, V10, P237, DOI 10.1097/00061198-200106000-00017; CHEN CW, 1990, J OCUL PHARMACOL, V6, P175, DOI 10.1089/jop.1990.6.175; Chen Y, 2014, J ASIAN NAT PROD RES, V19, P1, DOI DOI 10.1155/2014/701395; Chen YH, 2013, ACTA OPHTHALMOL, V91, pE506, DOI 10.1111/aos.12160; Cheung CWY, 2010, ANTI-CANCER AGENT ME, V10, P186; CLAESSONWELSH L, 1987, P NATL ACAD SCI USA, V84, P8796, DOI 10.1073/pnas.84.24.8796; COSTA VP, 1993, OPHTHALMIC SURG LAS, V24, P152; Gill RS, 2010, CELL SIGNAL, V22, P285, DOI 10.1016/j.cellsig.2009.09.031; Guo N, 2013, ASIA-PAC J CLIN ONCO, V9, P6, DOI 10.1111/j.1743-7563.2012.01535.x; HART CE, 1987, J BIOL CHEM, V262, P10780; Heldin CH, 2013, CELL COMMUN SIGNAL, V11, DOI 10.1186/1478-811X-11-97; HELDIN CH, 1992, EMBO J, V11, P4251, DOI 10.1002/j.1460-2075.1992.tb05523.x; Heldin CH, 1999, PHYSIOL REV, V79, P1283, DOI 10.1152/physrev.1999.79.4.1283; HEUER DK, 1984, OPHTHALMOLOGY, V91, P384; Hussain SAR, 2007, J MED FOOD, V10, P543, DOI 10.1089/jmf.2006.089; Jang BC, 2007, J BIOL CHEM, V282, P27622, DOI 10.1074/jbc.M610778200; KHAW PT, 1992, INVEST OPHTH VIS SCI, V33, P2043; Li L, 2010, EXPERT OPIN INV DRUG, V19, P243, DOI 10.1517/13543780903533631; Liang L, 2012, ONCOL REP, V28, P999, DOI 10.3892/or.2012.1874; Malumbres M, 2009, NAT REV CANCER, V9, P153, DOI 10.1038/nrc2602; Masoumpour Masoumeh B, 2016, Open Ophthalmol J, V10, P68, DOI 10.2174/1874364101610010068; MAUMENEE A E, 1960, Trans Am Ophthalmol Soc, V58, P319; Mietz H, 1998, GRAEF ARCH CLIN EXP, V236, P467, DOI 10.1007/s004170050107; Moldovan GL, 2007, CELL, V129, P665, DOI 10.1016/j.cell.2007.05.003; Momeny M, 2016, TUMOR BIOL, V37, P3913, DOI 10.1007/s13277-015-4220-6; MORI S, 1995, J BIOL CHEM, V270, P29447, DOI 10.1074/jbc.270.49.29447; NIGG EA, 1995, BIOESSAYS, V17, P471, DOI 10.1002/bies.950170603; Nissen NN, 1998, AM J PATHOL, V152, P1445; PIERCE GF, 1991, J CELL BIOCHEM, V45, P319, DOI 10.1002/jcb.240450403; Quigley HA, 2006, BRIT J OPHTHALMOL, V90, P262, DOI 10.1136/bjo.2005.081224; Quigley HA, 2011, LANCET, V377, P1367, DOI 10.1016/S0140-6736(10)61423-7; Ramasamy K, 2008, CANCER LETT, V269, P352, DOI 10.1016/j.canlet.2008.03.053; Razeghinejad MR, 2012, SURV OPHTHALMOL, V57, P1, DOI 10.1016/j.survophthal.2011.07.005; Sagara H, 2008, EYE, V22, P507, DOI 10.1038/sj.eye.6702674; Shukla SK, 2015, ONCOTARGET, V6, P41146, DOI 10.18632/oncotarget.5843; Singh RR, 2009, CLIN CANCER RES, V15, P613, DOI 10.1158/1078-0432.CCR-08-1846; Son YG, 2007, CANCER RES, V67, P8274, DOI 10.1158/0008-5472.CAN-07-0407; Song JM, 2015, CARCINOGENESIS, V36, P666, DOI 10.1093/carcin/bgv054; Susanna R, 1996, CAN J OPHTHALMOL, V31, P296; Teillet F, 2008, MED RES REV, V28, P715, DOI 10.1002/med.20122; THYLEFORS B, 1995, B WORLD HEALTH ORGAN, V73, P115; Trappoliere M, 2009, J HEPATOL, V50, P1102, DOI 10.1016/j.jhep.2009.02.023; Tyagi A, 2004, CARCINOGENESIS, V25, P1711, DOI 10.1093/carcin/bgh180; Van de Velde S, 2015, PROG BRAIN RES, V221, P319, DOI 10.1016/bs.pbr.2015.05.002; Vargas-Mendoza N, 2014, WORLD J HEPATOL, V6, P144, DOI 10.4254/wjh.v6.i3.144; Volti GL, 2011, CARDIOVASC DIABETOL, V10, DOI 10.1186/1475-2840-10-62; Yi N, 2012, ANAT REC, V295, P1462, DOI 10.1002/ar.22539; Zhan TZ, 2011, J CELL BIOCHEM, V112, P849, DOI 10.1002/jcb.22984; Zhu XS, 2016, EURASIP J ADV SIG PR, P1, DOI 10.1186/s13634-016-0373-8; Zi ZL, 1999, P NATL ACAD SCI USA, V96, P7490, DOI 10.1073/pnas.96.13.7490	51	8	8	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2016	11	12							e0168765	10.1371/journal.pone.0168765	http://dx.doi.org/10.1371/journal.pone.0168765			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EG7JB	28030611	Green Submitted, Green Published, gold			2022-12-27	WOS:000391222000075
J	Ghiassian, S; Greiner, R; Jin, P; Brown, MRG				Ghiassian, Sina; Greiner, Russell; Jin, Ping; Brown, Matthew R. G.			Using Functional or Structural Magnetic Resonance Images and Personal Characteristic Data to Identify ADHD and Autism	PLOS ONE			English	Article							CLASSIFICATION; DISORDER; MACHINE	A clinical tool that can diagnose psychiatric illness using functional or structural magnetic resonance (MR) brain images has the potential to greatly assist physicians and improve treatment efficacy. Working toward the goal of automated diagnosis, we propose an approach for automated classification of ADHD and autism based on histogram of oriented gradients (HOG) features extracted from MR brain images, as well as personal characteristic data features. We describe a learning algorithm that can produce effective classifiers for ADHD and autism when run on two large public datasets. The algorithm is able to distinguish ADHD from control with hold-out accuracy of 69.6% (over baseline 55.0%) using personal characteristics and structural brain scan features when trained on the ADHD-200 dataset (769 participants in training set, 171 in test set). It is able to distinguish autism from control with hold-out accuracy of 65.0% (over baseline 51.6%) using functional images with personal characteristic data when trained on the Autism Brain Imaging Data Exchange (ABIDE) dataset (889 participants in training set, 222 in test set). These results outperform all previously presented methods on both datasets. To our knowledge, this is the first demonstration of a single automated learning process that can produce classifiers for distinguishing patients vs. controls from brain imaging data with above-chance accuracy on large datasets for two different psychiatric illnesses (ADHD and autism). Working toward clinical applications requires robustness against real-world conditions, including the substantial variability that often exists among data collected at different institutions. It is therefore important that our algorithm was successful with the large ADHD-200 and ABIDE datasets, which include data from hundreds of participants collected at multiple institutions. While the resulting classifiers are not yet clinically relevant, this work shows that there is a signal in the (f)MRI data that a learning algorithm is able to find. We anticipate this will lead to yet more accurate classifiers, over these and other psychiatric disorders, working toward the goal of a clinical tool for high accuracy differential diagnosis.	[Ghiassian, Sina; Greiner, Russell; Jin, Ping; Brown, Matthew R. G.] Univ Alberta, Dept Comp Sci, Edmonton, AB, Canada; [Brown, Matthew R. G.] Univ Alberta, Dept Psychiat, Edmonton, AB, Canada; [Ghiassian, Sina; Greiner, Russell; Jin, Ping; Brown, Matthew R. G.] Alberta Machine Learning Inst, Edmonton, AB, Canada	University of Alberta; University of Alberta	Brown, MRG (corresponding author), Univ Alberta, Dept Comp Sci, Edmonton, AB, Canada.; Brown, MRG (corresponding author), Univ Alberta, Dept Psychiat, Edmonton, AB, Canada.; Brown, MRG (corresponding author), Alberta Machine Learning Inst, Edmonton, AB, Canada.	mbrown2@ualberta.ca	Greiner, Russell/AAQ-4502-2020	Greiner, Russell/0000-0001-8327-934X	Alberta Machine Intelligence Institute (AMII); Canadian Institutes of Health Research [CSE125741]; Natural Sciences and Engineering Research Council of Canada (NSERC) [203245]	Alberta Machine Intelligence Institute (AMII); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC))	This work was supported by Alberta Machine Intelligence Institute (AMII), formerly the Alberta Innovates Centre for Machine Learning (AICML), Project Title: Patient Specific fMRI-based Psychiatric Diagnosis and Treatment, Recipient: RG, Website: www.aicmi.ca; Canadian Institutes of Health Research, Recipient: RG, Grant Number: CSE125741, Website: www.cihr-irsc.gc.ca; and Natural Sciences and Engineering Research Council of Canada (NSERC), Recipient: RG, Grant Number: 203245, Website: www.nserc-crsng.gc.ca.	ABIDE, 2011, AUT BRAIN IM DAT EXC; Acuna C, 2012, FRONT SYST NEUROSCI, V6, DOI 10.3389/fnsys.2012.00062; ADHD-200 Consortium, 2011, THE ADHD 200 SAMPL; ADHD-200 Consortium, 2011, ADHD 200 GLOB COMP R; [Anonymous], 2005, COMP VIS PATT REC 20; Bennett MR, 2015, INT J DEV NEUROSCI, V46, P132, DOI 10.1016/j.ijdevneu.2015.02.007; Brown MRG, 2012, FRONT SYST NEUROSCI, V6, DOI 10.3389/fnsys.2012.00069; Cao M, 2014, MOL NEUROBIOL, V50, P1111, DOI 10.1007/s12035-014-8685-x; Chang CW, 2012, FRONT SYST NEUROSCI, V6, DOI 10.3389/fnsys.2012.00066; Chen CP, 2015, NEUROIMAGE-CLIN, V8, P238, DOI 10.1016/j.nicl.2015.04.002; Cody H, 2002, INT J DEV NEUROSCI, V20, P421, DOI 10.1016/S0736-5748(02)00053-9; Collins DL, 1999, LECT NOTES COMPUTER, P210; Demirci O, 2008, BRAIN IMAGING BEHAV, V2, P207, DOI 10.1007/s11682-008-9028-1; Dey S, 2014, FRONT NEURAL CIRCUIT, V8, DOI 10.3389/fncir.2014.00064; Di Martino A., 2013, MOL PSYCHIAT; Ding Chris, 2005, Journal of Bioinformatics and Computational Biology, V3, P185, DOI 10.1142/S0219720005001004; EDELMAN RR, 1993, NEW ENGL J MED, V328, P708, DOI 10.1056/NEJM199303113281008; Fonov V., 2009, NEUROIMAGE, V47, pS102, DOI [DOI 10.1016/S1053-8119(09)70884-5, 10.1016/s1053-8119(09)70884-5]; Fonov V, 2011, NEUROIMAGE, V54, P313, DOI 10.1016/j.neuroimage.2010.07.033; Friston KJ, 1994, HUMAN BRAIN MAPPING, V2, P189, DOI DOI 10.1002/HBM.460020402; Hastie T., 2009, ELEMENTS STAT LEARNI, P520, DOI DOI 10.1007/978-0-387-84858-7; Haufe S, 2014, NEUROIMAGE, V87, P96, DOI 10.1016/j.neuroimage.2013.10.067; Huettel SA., 2008, FUNCTIONAL MAGNETIC, V2nd, P542; Iwabuchi Sarina J, 2013, Front Psychiatry, V4, P95, DOI 10.3389/fpsyt.2013.00095; Johnson WE, 2007, BIOSTATISTICS, V8, P118, DOI 10.1093/biostatistics/kxj037; Katuwal GJ, 2015, IEEE ENG MED BIO, P4270, DOI 10.1109/EMBC.2015.7319338; Leek JT, 2015, SCIENCE, V347, P1314, DOI 10.1126/science.aaa6146; Leek JT, 2010, NAT REV GENET, V11, P733, DOI 10.1038/nrg2825; Minshew NJ, 2010, CURR OPIN NEUROL, V23, P124, DOI 10.1097/WCO.0b013e32833782d4; Nielsen JA, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00599; Nouretdinov I, 2011, NEUROIMAGE, V56, P809, DOI 10.1016/j.neuroimage.2010.05.023; Orru G, 2012, NEUROSCI BIOBEHAV R, V36, P1140, DOI 10.1016/j.neubiorev.2012.01.004; Peng HC, 2005, IEEE T PATTERN ANAL, V27, P1226, DOI 10.1109/TPAMI.2005.159; Shapiro L., 2001, COMPUTER VISION, V2001; Sidhu GS, 2012, FRONT SYST NEUROSCI, V6, DOI 10.3389/fnsys.2012.00074; [Social Scienced and Humanities Research Council of Canada Natural Sciences and Engineering Research Council of Canada Canadian Institutes of Health Research], 2014, TRIC POL STAT ETH CO; SPM, 2009, STAT PARAMETRIC MAPP; Vedaldi A., 2008, VLFEAT OPEN PORTABLE; Wang L, 2015, SCI ADV, V1, DOI 10.1126/sciadv.1500463; Wolfers T, 2015, NEUROSCI BIOBEHAV R, V57, P328, DOI 10.1016/j.neubiorev.2015.08.001; World Health Organization, 2010, GLOBAL BURDEN DIS; World Health Organization, 2001, GLOBAL BURDEN DIS; Zheng Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078476	43	56	56	2	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2016	11	12							e0166934	10.1371/journal.pone.0166934	http://dx.doi.org/10.1371/journal.pone.0166934			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EG7JB	28030565	Green Published, gold, Green Submitted			2022-12-27	WOS:000391222000005
J	Gubensek, J; Orsag, A; Ponikvar, R; Buturovic-Ponikvar, J				Gubensek, Jakob; Orsag, Alesa; Ponikvar, Rafael; Buturovic-Ponikvar, Jadranka			Calcium Mass Balance during Citrate Hemodialysis: A Randomized Controlled Trial Comparing Normal and Low Ionized Calcium Target Ranges	PLOS ONE			English	Article							DIALYSATE CALCIUM; PARATHYROID-HORMONE; MINERAL METABOLISM; ANTICOAGULATION; MORTALITY; DEGRANULATION; DISORDERS; DISEASE	Background Regional citrate anticoagulation (RCA) during hemodialysis interferes with calcium homeostasis. Optimal ionized calcium (iCa) target range during RCA and consequent calcium balance are unknown. Methods In a randomized controlled trial (ACTRN12613001029785) 30 chronic hemodialysis patients were assigned to normal (1.1-1.2 mmol/) or low (0.95-1.05 mmol/I) iCa target range during a single hemodialysis with RCA. The primary outcome was calcium mass balance during the procedure, using a partial spent dialysate collection method; magnesium mass balance was also measured. Intact parathormone (iPTH), total calcium (tCa) and magnesium were measured before and after procedures. Results Mean iCa during procedures was significantly different in the two groups (1.12 +/- 0.06 in normal and 1.06 +/- 0.07 mmol/1 in low iCa group, p <0.001), resulting in different tCa (2.18 +/- 0.22 vs. 1.95 +/- 0.17, p = 0.003) after the procedure. Mean delivered calcium during the procedure was 58.3 +/- 4.8 mmol in the normal and 51.5 +/- 8.2 mmol in the low iCa group (p = 0.010), which resulted in a significantly higher mean positive calcium mass balance of 14.6 +/- 8.3 mmol (584 +/- 333 mg) per procedure in normal as compared to 7.2 +/- 8.5 mmol (290 +/- 341 mg) in low iCa group (p = 0.024). Linear mixed effects model showed a significant interaction effect of time and iCa target range group on iPTH, i.e. a significant increase in iPTH in the low as compared to normal iCa target group (p = 0.008). Magnesium mass balance was mildly negative and comparable in both groups. Conclusions Low iCa target range resulted in a significantly less positive calcium mass balance, but in a significant increase in iPTH. To achieve a more neutral calcium balance, we recommend allowing a mild hypocalcemia during hemodialysis with RCA, especially when it is used for prolonged periods.	[Gubensek, Jakob; Orsag, Alesa; Ponikvar, Rafael; Buturovic-Ponikvar, Jadranka] Univ Med Ctr Ljubljana, Dept Nephrol, Ljubljana, Slovenia; [Gubensek, Jakob; Ponikvar, Rafael; Buturovic-Ponikvar, Jadranka] Univ Ljubljana, Fac Med, Ljubljana, Slovenia	University Medical Centre Ljubljana; University of Ljubljana	Gubensek, J (corresponding author), Univ Med Ctr Ljubljana, Dept Nephrol, Ljubljana, Slovenia.; Gubensek, J (corresponding author), Univ Ljubljana, Fac Med, Ljubljana, Slovenia.	jakob.gubensek@kclj.si	Gubensek, Jakob/A-5077-2010	Gubensek, Jakob/0000-0002-5394-3729; Buturovic-Ponikvar, Jadranka/0000-0001-7473-3731	University Medical Centre Ljubljana [20140029]	University Medical Centre Ljubljana	The study was funded by Research & Development Grant No. 20140029 from the University Medical Centre Ljubljana (Improvements of regional citrate anticoagulation during hemodialysis). The funder had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. There was no additional external funding received for this study.	Alhosaini M, 2015, AM J KIDNEY DIS, V66, P523, DOI 10.1053/j.ajkd.2015.01.029; Apsner R, 2005, AM J KIDNEY DIS, V45, P557, DOI 10.1053/j.ajkd.2004.12.002; Apsner R, 2004, ANESTH ANALG, V99, P1199, DOI 10.1213/01.ANE.0000132780.87036.F5; Argiles A, 1997, KIDNEY INT, V52, P530, DOI 10.1038/ki.1997.364; Bai M, 2015, INTENS CARE MED, V41, P2098, DOI 10.1007/s00134-015-4099-0; Basile C, 2011, INT J NEPHROL, V2011, DOI 10.4061/2011/540592; Basile C, 2012, AM J KIDNEY DIS, V59, P92, DOI 10.1053/j.ajkd.2011.08.033; Bolan CD, 2001, TRANSFUSION, V41, P1165, DOI 10.1046/j.1537-2995.2001.41091165.x; Bos JC, 1997, NEPHROL DIAL TRANSPL, V12, P1387, DOI 10.1093/ndt/12.7.1387; Bosticardo G, 2012, NEPHROL DIAL TRANSPL, V27, P2489, DOI 10.1093/ndt/gfr733; Buturovic J, 2008, ARTIF ORGANS, V32, P77, DOI 10.1111/j.1525-1594.2007.00459.x; Buturovic-Ponikvar J, 2005, THER APHER DIAL, V9, P237, DOI 10.1111/j.1774-9987.2005.00262.x; Buturovic-Ponikvar J, 2016, THER APHER DIAL, V20, P234, DOI 10.1111/1744-9987.12429; Drueke TB, 2009, NEPHROL DIAL TRANSPL, V24, P2990, DOI 10.1093/ndt/gfp365; Eckardt KU, 2012, KIDNEY INT SUPPL, V2, P7, DOI 10.1038/kisup.2012.8; GAWOSKI JM, 1989, CLIN CHEM, V35, P2140; Gotch FA, 2009, NEPHROL DIAL TRANSPL, V24, P2994, DOI 10.1093/ndt/gfp360; Gritters M, 2006, NEPHROL DIAL TRANSPL, V21, P153, DOI 10.1093/ndt/gfi069; Gubensek J, 2011, THER APHER DIAL, V15, P278, DOI 10.1111/j.1744-9987.2011.00951.x; Haris A, 2006, KIDNEY INT, V70, P931, DOI 10.1038/sj.ki.5001666; Hofbauer R, 1999, KIDNEY INT, V56, P1578, DOI 10.1046/j.1523-1755.1999.00671.x; Kidney Disease: Improving Global Outcomes (KDIGO) CKD-MBD Work Group, 2009, Kidney Int Suppl, pS1, DOI 10.1038/ki.2009.188; Kozik-Jaromin J, 2009, NEPHROL DIAL TRANSPL, V24, P2244, DOI 10.1093/ndt/gfp017; Langote A, 2015, AM J KIDNEY DIS, V66, P348, DOI 10.1053/j.ajkd.2015.02.336; Meier-Kriesche HU, 2001, CRIT CARE MED, V29, P748, DOI 10.1097/00003246-200104000-00010; Messa P, 2014, SEMIN DIALYSIS, V27, P4, DOI 10.1111/sdi.12150; Moe SM, 2010, SEMIN DIALYSIS, V23, P492, DOI 10.1111/j.1525-139X.2010.00771.x; Noordzij M, 2011, NEPHROL DIAL TRANSPL, V26, P1662, DOI 10.1093/ndt/gfq582; OMOKAWA S, 1990, INT J ARTIF ORGANS, V13, P768, DOI 10.1177/039139889001301110; Pirklbauer M, 2011, NEPHROL DIAL TRANSPL, V26, P2438, DOI 10.1093/ndt/gfr207; Rodriguez-Garcia M, 2009, NEPHROL DIAL TRANSPL, V24, P239, DOI 10.1093/ndt/gfn466; Sakaguchi Y, 2014, KIDNEY INT, V85, P174, DOI 10.1038/ki.2013.327; Sigrist M, 2006, J RENAL NUTR, V16, P41, DOI 10.1053/j.jrn.2005.10.006; Singer Richard F, 2016, Can J Kidney Health Dis, V3, P22, DOI 10.1186/s40697-016-0113-x; Strobl K, 2013, BLOOD PURIFICAT, V36, P136, DOI 10.1159/000355012; Szamosfalvi B, 2010, BLOOD PURIFICAT, V29, P204, DOI 10.1159/000245648; Unver B, 2002, ACTA MED AUST, V29, P146, DOI 10.1046/j.1563-2571.2002.02019.x	37	9	9	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2016	11	12							e0168593	10.1371/journal.pone.0168593	http://dx.doi.org/10.1371/journal.pone.0168593			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EG7JB	28030601	Green Submitted, gold, Green Published			2022-12-27	WOS:000391222000060
J	Jesus, S; Huertas, I; Bernal-Bernal, I; Bonilla-Toribio, M; Caceres-Redondo, MT; Vargas-Gonzalez, L; Gomez-Llamas, M; Carrillo, F; Calderon, E; Carballo, M; Gomez-Garre, P; Mir, P				Jesus, Silvia; Huertas, Ismael; Bernal-Bernal, Inmaculada; Bonilla-Toribio, Marta; Teresa Caceres-Redondo, Maria; Vargas-Gonzalez, Laura; Gomez-Llamas, Myriam; Carrillo, Fatima; Calderon, Enrique; Carballo, Manuel; Gomez-Garre, Pilar; Mir, Pablo			GBA Variants Influence Motor and Non-Motor Features of Parkinson's Disease	PLOS ONE			English	Article							GLUCOCEREBROSIDASE MUTATIONS; DEMENTIA; COMPLICATIONS; CONFER; RISK; GENE	The presence of mutations in glucocerebrosidase (GBA) gene is a known factor increasing the risk of developing Parkinson's disease (PD). Mutations carriers have earlier disease onset and are more likely to develop neuropsychiatric symptoms than other sporadic PD cases. These symptoms have primarily been observed in Parkinson's patients carrying the most common pathogenic mutations L444P and N370S. However, recent findings suggest that other variants across the gene may have a different impact on the phenotype as well as on the disease progression. We aimed to explore the influence of variants across GBA gene on the clinical features and treatment related complications in PD. In this study, we screened the GBA gene in a cohort of 532 well-characterised PD patients and 542 controls from southern Spain. The potential pathogeniticy of the identified variants was assessed using in-silico analysis and subsequently classified as benign or deleterious. As a result, we observed a higher frequency of GBA variants in PD patients (12.2% vs. 7.9% in controls, p = 0.021), earlier mean age at disease onset in GBA variant carriers (50.6 vs. 56.6 years; p = 0.013), as well as more prevalent motor and non-motor symptoms in patients carrying deleterious variants. In addition, we found that dopaminergic motor complications are influenced by both benign and deleterious variants. Our results highlight the fact that the impact on the phenotype highly depends on the potential pathogenicity of the carried variants. Therefore, the course of motor and non-motor symptoms as well as treatment-related motor complications could be influenced by GBA variants.	[Jesus, Silvia; Huertas, Ismael; Bernal-Bernal, Inmaculada; Bonilla-Toribio, Marta; Teresa Caceres-Redondo, Maria; Vargas-Gonzalez, Laura; Gomez-Llamas, Myriam; Carrillo, Fatima; Carballo, Manuel; Gomez-Garre, Pilar; Mir, Pablo] Univ Seville, Unidad Trastornos Movimiento, Hosp Univ Virgen del Rocio,CSIC, Serv Neurol & Neurofisiol Clin,Inst Biomed Sevill, Seville, Spain; [Calderon, Enrique] Univ Seville, Serv Med Interne, Inst Biomed Sevilla, Hosp Univ Virgen del Rocio,CSIC, Seville, Spain; [Calderon, Enrique] Ctr Invest Biomed Red Epidemiol & Salud Publ CIBE, Madrid, Spain; [Gomez-Garre, Pilar; Mir, Pablo] Ctr Invest Biomed Red Enfermedades Neurodegenerat, Madrid, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); University of Sevilla; CSIC-JA-USE - Instituto de Biomedicina de Sevilla (IBIS); Virgen del Rocio University Hospital; Consejo Superior de Investigaciones Cientificas (CSIC); University of Sevilla; CSIC-JA-USE - Instituto de Biomedicina de Sevilla (IBIS); Virgen del Rocio University Hospital; CIBER - Centro de Investigacion Biomedica en Red; CIBERESP; CIBERNED	Gomez-Garre, P; Mir, P (corresponding author), Univ Seville, Unidad Trastornos Movimiento, Hosp Univ Virgen del Rocio,CSIC, Serv Neurol & Neurofisiol Clin,Inst Biomed Sevill, Seville, Spain.; Gomez-Garre, P; Mir, P (corresponding author), Ctr Invest Biomed Red Enfermedades Neurodegenerat, Madrid, Spain.	mgomez-ibis@us.es; pmir@us.es	Mir, Pablo/C-8662-2013; IBIS, EPIDEMIOLOGIA/O-8791-2015; Termine, Cristinano/AAB-8366-2022; Calderon, Enrique j/A-1997-2013; Gómez-Garre, Pilar/AAG-8048-2020	Mir, Pablo/0000-0003-1656-302X; Calderon, Enrique j/0000-0002-3166-5086; Gómez-Garre, Pilar/0000-0002-0437-6182; Huertas, Ismael/0000-0002-4317-0662; JESUS MAESTRE, SILVIA/0000-0002-1874-4628; BERNAL, INMACULADA/0000-0002-4207-1208; Vargas-Gonzalez, Laura/0000-0003-1173-3704	Ministerio de Economia y Competitividad de Espana [SAF2007-60700]; Instituto de Salud Carlos III [PI10/01674, PI13/01461, PI14/01823]; Consejeria de Economia, Innovacion, Ciencia y Empleo de la Junta de Andalucia [CVI-02526, CTS-7685]; Consejeria deIgualdad, Salud y Politicas Sociales de la Junta de Andalucia [PI-0377/2007, PI-0741/2010, PI-0437-2012, PI-0471-2013]; Sociedad Andaluza de Neurologia; Jacques and Gloria Gossweiler Foundation; Fundacion Alicia Koplowitz; Fundacion Mutua Madrilena; Instituto de Salud Carlos III	Ministerio de Economia y Competitividad de Espana(Spanish Government); Instituto de Salud Carlos III(Instituto de Salud Carlos IIIEuropean Commission); Consejeria de Economia, Innovacion, Ciencia y Empleo de la Junta de Andalucia(Junta de Andalucia); Consejeria deIgualdad, Salud y Politicas Sociales de la Junta de Andalucia(Junta de Andalucia); Sociedad Andaluza de Neurologia; Jacques and Gloria Gossweiler Foundation; Fundacion Alicia Koplowitz; Fundacion Mutua Madrilena(Instituto de Salud Carlos III); Instituto de Salud Carlos III(Instituto de Salud Carlos IIIEuropean Commission)	This work was supported by grants from the Ministerio de Economia y Competitividad de Espana [SAF2007-60700]; the Instituto de Salud Carlos III [PI10/01674, PI13/01461, PI14/01823]; the Consejeria de Economia, Innovacion, Ciencia y Empleo de la Junta de Andalucia [CVI-02526, CTS-7685]; the Consejeria deIgualdad, Salud y Politicas Sociales de la Junta de Andalucia [PI-0377/2007, PI-0741/2010, PI-0437-2012, PI-0471-2013]; the Sociedad Andaluza de Neurologia; the Jacques and Gloria Gossweiler Foundation; the Fundacion Alicia Koplowitz and the Fundacion Mutua Madrilena. Pilar Gomez-Garre was supported by the "Miguel Servet" programme and Ismael Huertas-Fernandez by "PFIS" programme, both from the Instituto de Salud Carlos III. Silvia Jesus hold an attendant contract through the Servicio Andaluz de Salud.	Adams SM, 2008, AM J HUM GENET, V83, P725, DOI 10.1016/j.ajhg.2008.11.007; Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; Alcalay RN, 2015, GLUCOCEREBROSIDASE A; Alves G, 2006, MOVEMENT DISORD, V21, P1123, DOI 10.1002/mds.20897; Bastide MF, 2015, PROG NEUROBIOL, V132, P96, DOI 10.1016/j.pneurobio.2015.07.002; Bras J, 2009, NEUROBIOL AGING, V30, P1515, DOI 10.1016/j.neurobiolaging.2007.11.016; Brockmann K, 2011, NEUROLOGY, V77, P276, DOI 10.1212/WNL.0b013e318225ab77; Brockmann K, 2014, J INHERIT METAB DIS, V37, P643, DOI 10.1007/s10545-014-9714-7; Clark LN, 2007, NEUROLOGY, V69, P1270, DOI 10.1212/01.wnl.0000276989.17578.02; Desmet FO, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp215; Dubois B, 2007, MOVEMENT DISORD, V22, P2314, DOI 10.1002/mds.21844; Emre M, 2007, MOVEMENT DISORD, V22, P1689, DOI 10.1002/mds.21507; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Gamez-Valero A, 2016, GBA MUTATIONS ARE AS; Gan-Or Z, 2015, NEUROLOGY, V84, P880, DOI 10.1212/WNL.0000000000001315; GIBB WRG, 1988, J NEUROL NEUROSUR PS, V51, P745, DOI 10.1136/jnnp.51.6.745; Goker-Alpan O, 2008, ARCH NEUROL-CHICAGO, V65, P1353, DOI 10.1001/archneur.65.10.1353; GRANTHAM R, 1974, SCIENCE, V185, P862, DOI 10.1126/science.185.4154.862; Horowitz M, 2011, MOL GENET METAB, V104, P35, DOI 10.1016/j.ymgme.2011.07.002; Hosmer DW, 2008, APPL SURVIVAL ANAL R, V2nd; Kalinderi K, 2009, NEUROSCI LETT, V452, P87, DOI 10.1016/j.neulet.2009.01.029; Kulisevsky J, 2004, NEUROLOGY, V63, pS28, DOI 10.1212/WNL.63.8_suppl_3.S28; Lesage S, 2011, HUM MOL GENET, V20, P202, DOI 10.1093/hmg/ddq454; Lewis SJG, 2005, J NEUROL NEUROSUR PS, V76, P343, DOI 10.1136/jnnp.2003.033530; Li B, 2009, BIOINFORMATICS, V25, P2744, DOI 10.1093/bioinformatics/btp528; Mata IF, 2016, MOVEMENT DISORD, V31, P95, DOI 10.1002/mds.26359; Mitsui J, 2009, ARCH NEUROL-CHICAGO, V66, P571, DOI 10.1001/archneurol.2009.72; Neikrug AB, 2012, SLEEP MED REV, V16, P415, DOI 10.1016/j.smrv.2011.08.004; Neumann J, 2009, BRAIN, V132, P1783, DOI 10.1093/brain/awp044; Oeda T, 2015, NEUROBIOL AGING, V36, P3306, DOI 10.1016/j.neurobiolaging.2015.08.027; Pagonabarraga J, 2010, MOVEMENT DISORD, V25, P440, DOI 10.1002/mds.22877; Pollard KS, 2010, GENOME RES, V20, P110, DOI 10.1101/gr.097857.109; Puschmann A, 2013, PARKINSONISM RELAT D, V19, P407, DOI 10.1016/j.parkreldis.2013.01.020; Reese MG, 1997, J COMPUT BIOL, V4, P311, DOI 10.1089/cmb.1997.4.311; Schwarz JM, 2014, NAT METHODS, V11, P361, DOI 10.1038/nmeth.2890; Seto-Salvia N, 2012, MOVEMENT DISORD, V27, P393, DOI 10.1002/mds.24045; Sidransky E, 2009, NEW ENGL J MED, V361, P1651, DOI 10.1056/NEJMoa0901281; Siebert M, 2014, BRAIN, V137, P1304, DOI 10.1093/brain/awu002; van Rooden SM, 2011, MOVEMENT DISORD, V26, P51, DOI 10.1002/mds.23346; Winder-Rhodes SE, 2013, BRAIN, V136, P392, DOI 10.1093/brain/aws318	40	52	53	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2016	11	12							e0167749	10.1371/journal.pone.0167749	http://dx.doi.org/10.1371/journal.pone.0167749			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EG7JB	28030538	gold, Green Submitted, Green Published			2022-12-27	WOS:000391222000020
J	Sartakhti, JS; Manshaei, MH; Bateni, S; Archetti, M				Sartakhti, Javad Salimi; Manshaei, Mohammad Hossein; Bateni, Soroosh; Archetti, Marco			Evolutionary Dynamics of Tumor-Stroma Interactions in Multiple Myeloma	PLOS ONE			English	Article							GROWTH-FACTOR PRODUCTION; BONE-DISEASE; GAME-THEORY; CELL-LINES; HETEROGENEITY; COOPERATION; BORTEZOMIB; RESISTANCE; SUBCLONES; HALLMARKS	Cancer cells and stromal cells cooperate by exchanging diffusible factors that sustain tumor growth, a form of frequency-dependent selection that can be studied in the framework of evolutionary game theory. In the case of multiple myeloma, three types of cells (malignant plasma cells, osteoblasts and osteoclasts) exchange growth factors with different effects, and tumor-stroma interactions have been analysed using a model of cooperation with pair-wise interactions. Here we show that a model in which growth factors have autocrine and paracrine effects on multiple cells, a more realistic assumption for tumor-stroma interactions, leads to different results, with implications for disease progression and treatment. In particular, the model reveals that reducing the number of malignant plasma cells below a critical threshold can lead to their extinction and thus to restore a healthy balance between osteoclast and osteoblast, a result in line with current therapies against multiple myeloma.	[Sartakhti, Javad Salimi; Manshaei, Mohammad Hossein; Bateni, Soroosh] Isfahan Univ Technol, Dept Elect & Comp Engn, Esfahan, Iran; [Archetti, Marco] Univ East Anglia, Sch Biol Sci, Norwich, Norfolk, England	Isfahan University of Technology; University of East Anglia	Manshaei, MH (corresponding author), Isfahan Univ Technol, Dept Elect & Comp Engn, Esfahan, Iran.; Archetti, M (corresponding author), Univ East Anglia, Sch Biol Sci, Norwich, Norfolk, England.	manshaei@cc.iut.ac.ir; m.archetti@uea.ac.uk	Bateni, Soroush/Y-9300-2019	Bateni, Soroush/0000-0002-5448-3664				Adams J, 2004, CANCER INVEST, V22, P304, DOI 10.1081/CNV-120030218; Archetti M, 2015, CELL PROLIFERAT, V48, P259, DOI 10.1111/cpr.12169; Archetti M, 2013, BRIT J CANCER, V109, P1056, DOI 10.1038/bjc.2013.336; Archetti M, 2013, EVOL APPL, V6, P1146, DOI 10.1111/eva.12092; Archetti M, 2012, J THEOR BIOL, V299, P9, DOI 10.1016/j.jtbi.2011.06.018; Axelrod R, 2006, P NATL ACAD SCI USA, V103, P13474, DOI 10.1073/pnas.0606053103; Bataille R, 1997, NEW ENGL J MED, V336, P1657, DOI 10.1056/NEJM199706053362307; Cleary AS, 2014, NATURE, V508, P113, DOI 10.1038/nature13187; Curran MP, 2009, DRUGS, V69, P859, DOI 10.2165/00003495-200969070-00006; Dinarello CA, 2009, MAYO CLIN PROC, V84, P105, DOI 10.4065/84.2.105; Dingli D, 2009, BRIT J CANCER, V101, P1130, DOI 10.1038/sj.bjc.6605288; Ehrlich LA, 2005, BLOOD, V106, P1407, DOI 10.1182/blood-2005-03-1080; Epstein Joshua, 2003, Hematol J, V4, P310, DOI 10.1038/sj.thj.6200313; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Hashimoto T, 2004, BRIT J HAEMATOL, V125, P38, DOI 10.1111/j.1365-2141.2004.04864.x; Hauert C., 2003, Complexity, V8, P31, DOI 10.1002/cplx.10092; Hofbauer J, 1998, EVOLUTIONARY GAMES P; Jourdan M, 2005, EUR CYTOKINE NETW, V16, P57; KAREY KP, 1988, CANCER RES, V48, P4083; Kyle RA, 2004, NEW ENGL J MED, V351, P1860, DOI 10.1056/NEJMra041875; Lee JW, 2004, BLOOD, V103, P2308, DOI 10.1182/blood-2003-06-1992; Lust JA, 2009, MAYO CLIN PROC, V84, P114, DOI 10.4065/84.2.114; Moreau P, 2011, LANCET ONCOL, V12, P431, DOI 10.1016/S1470-2045(11)70081-X; Oranger A, 2013, CLIN DEV IMMUNOL, DOI 10.1155/2013/289458; Perc M, 2013, J R SOC INTERFACE, V10, DOI 10.1098/rsif.2012.0997; Pietras K, 2010, EXP CELL RES, V316, P1324, DOI 10.1016/j.yexcr.2010.02.045; Roodman GD, 2009, LEUKEMIA, V23, P435, DOI 10.1038/leu.2008.336; Roodman GD, 2002, J BONE MINER RES, V17, P1921, DOI 10.1359/jbmr.2002.17.11.1921; Terpos E, 2003, BRIT J HAEMATOL, V123, P758, DOI 10.1046/j.1365-2141.2003.04712.x; Terpos E, 2007, BLOOD, V110, P1098, DOI 10.1182/blood-2007-03-067710; Yaccoby S, 2010, BRIT J HAEMATOL, V149, P311, DOI 10.1111/j.1365-2141.2010.08141.x	31	6	7	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2016	11	12							e0168856	10.1371/journal.pone.0168856	http://dx.doi.org/10.1371/journal.pone.0168856			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EG7JB	28030607	Green Published, gold, Green Accepted, Green Submitted			2022-12-27	WOS:000391222000080
J	Kim, GA; Park, SH; Ko, J; Lee, SH; Bae, HW; Seong, GJ; Kim, CY				Kim, Gyu Ah; Park, Se Hee; Ko, Jaesang; Lee, Si Hyung; Bae, Hyoung Won; Seong, Gong Je; Kim, Chan Yun			Albuminuria Is Associated with Open-Angle Glaucoma in Nondiabetic Korean Subjects: A Cross-Sectional Study	PLOS ONE			English	Article							NORMAL-TENSION GLAUCOMA; OCULAR PERFUSION-PRESSURE; ENDOTHELIAL DYSFUNCTION; CARDIOVASCULAR-DISEASE; BLOOD-PRESSURE; EXCRETION; RISK; VARIABILITY; PROTEINURIA; PREVALENCE	Objective Systemic vascular dysfunction has been suggested to contribute to glaucomatous damage. Albuminuria is a surrogate marker of endothelial injury, including vessels. However, their relationship is not well understood. This study aimed to investigate the association between albuminuria and the prevalence of open-angle glaucoma (OAG) in nondiabetic subjects. Methods We conducted a cross-sectional study of 4186 nondiabetic participants aged 19 years or older from the 2011-2012 Korea National Health and Nutrition Examination Survey. OAG was defined based on the criteria of the International Society for Geographic and Epidemiologic Ophthalmology. Urinary albumin excretion was assessed by the urinary albumin-tocreatinine ratio (UACR). A multivariate logistic regression analysis was performed to evaluate the relationship between albuminuria and OAG. Results Among the subjects, 124 had OAG. The weighted prevalences of microalbuminuria (UACR of 30-299 mg/g creatinine [Cr]) and macroalbuminuria (UACR >= 300 mg/g Cr) were 3.2 +/- 0.3% and 0.4 +/- 0.1%, respectively. The percentages of OAG increased in accordance with increasing UACR tertiles. Compared with subjects in the lower UACR tertile, those in the upper tertile showed an increased prevalence of OAG (odds ratio, 1.963; 95% confidence interval 1.072-3.595, P = 0.029) after adjusting for demographic factors, laboratory parameters, kidney function, and intraocular pressure. Furthermore, even after excluding 155 subjects with microalbuminuria and 19 subjects with macroalbuminuria, a positive association persisted between the upper UACR tertile (low-grade albuminuria) and an increased prevalence of OAG (odds ratio, 2.170; 95% confidence interval, 1.174-4.010, P = 0.014). Conclusion Albuminuria, even low-grade, was significantly associated with OAG in nondiabetic subjects. This result implies the role of vascular endothelial dysfunction in the pathogenic mechanism of OAG and suggests that careful monitoring of OAG is required in nondiabetic subjects with albuminuria.	[Kim, Gyu Ah; Ko, Jaesang; Bae, Hyoung Won; Seong, Gong Je; Kim, Chan Yun] Yonsei Univ, Coll Med, Severance Hosp, Inst Vis Res,Dept Ophthalmol, Seoul, South Korea; [Park, Se Hee] Yonsei Univ, Coll Med, Dept Internal Med, Div Endocrinol & Metab, Seoul, South Korea; [Lee, Si Hyung] Eulji Univ, Dept Ophthalmol, Daejeon, South Korea	Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System; Eulji University	Kim, CY (corresponding author), Yonsei Univ, Coll Med, Severance Hosp, Inst Vis Res,Dept Ophthalmol, Seoul, South Korea.	kcyeye@yuhs.ac	Ko, JaeSang/AAS-6259-2021	Seong, Gong Je/0000-0002-5456-4296; Bae, Hyoung Won/0000-0002-8421-5636; Kim, Chan Yun/0000-0002-8373-9999; Ko, JaeSang/0000-0002-3011-7213	World Class 300 Project of the SMBA, Republic of Korea [10031270]	World Class 300 Project of the SMBA, Republic of Korea	This work was supported by the World Class 300 Project (10031270) of the SMBA, Republic of Korea. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnlov J, 2005, CIRCULATION, V112, P969, DOI 10.1161/CIRCULATIONAHA.105.538132; Bourne RRA, 2014, BRIT J OPHTHALMOL, V98, P629, DOI 10.1136/bjophthalmol-2013-304033; Buckley C, 2002, BRIT J OPHTHALMOL, V86, P227, DOI 10.1136/bjo.86.2.227; Chen HB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036718; Choi J, 2006, INVEST OPHTH VIS SCI, V47, P831, DOI 10.1167/iovs.05-1053; Choi JA, 2015, OPHTHALMOLOGY, V122, P976, DOI 10.1016/j.ophtha.2015.01.001; Choi JA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096335; Clausen P, 2001, CIRCULATION, V103, P1869; Danziger J, 2008, MAYO CLIN PROC, V83, P806, DOI 10.4065/83.7.806; DECKERT T, 1989, DIABETOLOGIA, V32, P219, DOI 10.1007/BF00285287; Eknoyan G, 2002, AM J KIDNEY DIS, V39, pS14, DOI 10.1053/ajkd.2002.30939; Fadini GP, 2010, ACTA OPHTHALMOL, V88, P135, DOI 10.1111/j.1755-3768.2009.01573.x; Flammer J, 2002, PROG RETIN EYE RES, V21, P359, DOI 10.1016/S1350-9462(02)00008-3; Foster PJ, 2002, BRIT J OPHTHALMOL, V86, P238, DOI 10.1136/bjo.86.2.238; Gerstein HC, 2001, JAMA-J AM MED ASSOC, V286, P421, DOI 10.1001/jama.286.4.421; Hillege HL, 2002, CIRCULATION, V106, P1777, DOI 10.1161/01.CIR.0000031732.78052.81; Hong JW, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118866; KAISER HJ, 1993, OPHTHALMOLOGICA, V207, P6, DOI 10.1159/000310398; Keane WF, 1999, AM J KIDNEY DIS, V33, P1004, DOI 10.1016/S0272-6386(99)70442-7; Kim CS, 2011, OPHTHALMOLOGY, V118, P1024, DOI 10.1016/j.ophtha.2010.10.016; Kingman S, 2004, B WORLD HEALTH ORGAN, V82, P887; Konno S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0123893; Lee J, 2015, AM J OPHTHALMOL, V160, P522, DOI 10.1016/j.ajo.2015.05.034; Levey AS, 2009, ANN INTERN MED, V150, P604, DOI 10.7326/0003-4819-150-9-200905050-00006; MOGENSEN CE, 1984, NEW ENGL J MED, V310, P356, DOI 10.1056/NEJM198402093100605; Mroczkowska S, 2013, JAMA OPHTHALMOL, V131, P36, DOI 10.1001/2013.jamaophthalmol.1; Na KS, 2010, J GLAUCOMA, V19, P377, DOI 10.1097/IJG.0b013e3181c4ae58; Sahebkar A, 2015, ATHEROSCLEROSIS, V241, P433, DOI 10.1016/j.atherosclerosis.2015.05.022; STEHOUWER CDA, 1992, LANCET, V340, P319, DOI 10.1016/0140-6736(92)91401-S; STROMAN GA, 1995, ARCH OPHTHALMOL-CHIC, V113, P168, DOI 10.1001/archopht.1995.01100020050027; Su WW, 2008, OPHTHALMOLOGY, V115, P1173, DOI 10.1016/j.ophtha.2007.10.026; Suzuki J, 2004, JPN J OPHTHALMOL, V48, P340, DOI 10.1007/s10384-004-0072-0; Traverso CE, 2005, BRIT J OPHTHALMOL, V89, P1245, DOI 10.1136/bjo.2005.067355; Won JC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083273	34	5	5	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2016	11	12							e0168682	10.1371/journal.pone.0168682	http://dx.doi.org/10.1371/journal.pone.0168682			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI9QH	28006020	Green Submitted, gold, Green Published			2022-12-27	WOS:000392843200080
J	Malecki, W; Pawlowski, B; Sorokowski, P				Malecki, Wojciech; Pawlowski, Boguslaw; Sorokowski, Piotr			Literary Fiction Influences Attitudes Toward Animal Welfare	PLoS One			English	Article							READING NARRATIVE FICTION; EXPERIENCE; EMPATHY	Literary fiction has been credited with considerable power to improve attitudes toward out-groups. It was even argued that it has been an important factor behind the global decline of violence against various minorities in the last centuries. Could it also help to reduce the human-inflicted suffering of animals? To test this, we studied the attitude toward animal welfare of n = 921 (experimental group) people of both sexes who read a short fragment of an unpublished novel with a motif of the physical abuse of an animal. The control group (n = 912) read a fragment of a similar length but not related to animals. After reading the text all subjects filled out an on-line questionnaire with seven items (camouflaged among many others items) measuring attitudes toward animal welfare. The questionnaire included also demographical questions, such as whether the subject keeps pets. We found that in comparison with the control group, the experimental group was significantly more concerned about animal welfare. This result indicates that literary fiction can influence attitudes toward other species. It is also worth noting that our study is characterized by a high level of ecological validity, i.e. a relatively high extent to which its results can be generalized (or extended) to real-world settings. Due to its specific design, which involved the cooperation of a best-selling author and his publisher, the study approximated the typical conditions in which people read fiction in a remarkably accurate way. Finally, our research has potential practical implications for promoting animal welfare.	[Malecki, Wojciech] Univ Wroclaw, Inst Polish Philol, Fac Philol, Dept Literary Theory, Wroclaw, Poland; [Pawlowski, Boguslaw] Univ Wroclaw, Fac Biol Sci, Dept Human Biol, Wroclaw, Poland; [Sorokowski, Piotr] Univ Wroclaw, Fac Hist Pedag Sci, Inst Psychol, Dept Expt Social Psychol, Wroclaw, Poland	University of Wroclaw; University of Wroclaw; University of Wroclaw	Malecki, W (corresponding author), Univ Wroclaw, Inst Polish Philol, Fac Philol, Dept Literary Theory, Wroclaw, Poland.	wojciech.malecki@uwr.edu.pl	Malecki, Wojciech W.P./AAL-7332-2020; Pawlowski, Boguslaw/C-1088-2013	Malecki, Wojciech W.P./0000-0003-4768-713X; Pawlowski, Boguslaw/0000-0002-7418-475X; Sorokowski, Piotr/0000-0001-9225-9965	National Science Foundation (Narodowe Centrum Nauki) [2012/07/B/HS2/02278]	National Science Foundation (Narodowe Centrum Nauki)	This work received financial support from the National Science Foundation (Narodowe Centrum Nauki) - https://www.ncn.gov.pl/. Grant number 2012/07/B/HS2/02278. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Appel M, 2007, MEDIA PSYCHOL, V10, P113; Bal PM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055341; Batson C.Daniel., 2015, WHATS WRONG MORALITY; Batson CD, 1997, J PERS SOC PSYCHOL, V72, P105, DOI 10.1037/0022-3514.72.1.105; Berns GS, 2013, BRAIN CONNECT, V3, P590, DOI 10.1089/brain.2013.0166; Buell Lawrence, 2001, WRITING ENDANGERED W; Dawkins MS, 2008, ETHOLOGY, V114, P937, DOI 10.1111/j.1439-0310.2008.01557.x; Elist J, 2012, LOS ANGELES TIMES; Faktorovich Anna, 2014, FORMULAS POPULAR FIC; Gregory N.G., 2008, PHYSL BEHAV ANIMAL S; Grimm D, 2015, SCIENCE, V347, P366, DOI 10.1126/science.347.6220.366; Haidt J, 2001, PSYCHOL REV, V108, P814, DOI 10.1037//0033-295X.108.4.814; Hakemulder F., 2000, MORAL LAB EXPT EXAMI; HERZOG H, 1993, SCIENCE, V262, P1906, DOI 10.1126/science.262.5141.1906; Herzog Jr H. A., 1991, ANTHROZO, V4, p184?191, DOI [10.2752/089279391787057170, DOI 10.2752/089279391787057170]; Hunt L., 2007, INVENTING HUMAN RIGH; Johansen JP, 2001, P NATL ACAD SCI USA, V98, P8077, DOI 10.1073/pnas.141218998; Johnson Claudia Durst, 2002, SOCIAL IMPACT NOVEL; Johnson DR, 2014, BASIC APPL SOC PSYCH, V36, P83, DOI 10.1080/01973533.2013.856791; Johnson DR, 2013, SOC COGNITION, V31, P578, DOI 10.1521/soco.2013.31.5.578; Kaufman GF, 2012, J PERS SOC PSYCHOL, V103, P1, DOI 10.1037/a0027525; Keen Suzanna., 2007, EMPATHY NOVEL; Kidd DC, 2013, SCIENCE, V342, P377, DOI 10.1126/science.1239918; Mar RA, 2008, PERSPECT PSYCHOL SCI, V3, P173, DOI 10.1111/j.1745-6924.2008.00073.x; Marsh EJ, 2003, J MEM LANG, V49, P519, DOI 10.1016/S0749-596X(03)00092-5; McGinn C, 1997, ETHICS EVIL FICTION; Munro L, 2012, SOCIOL COMPASS, V6, P166, DOI 10.1111/j.1751-9020.2011.00440.x; Nussbaum Martha C., 1990, LOVES KNOWLEDGE ESSA; Pinker S., 2011, BETTER ANGELS OUR NA; Prinz J., 2011, EMPATHY PHILOS PSYCH, P211; Regan T, 2010, OTHER NATIONS ANIMAL; Rorty R., 1998, TRUTH PROGR; SHELTON ML, 1981, J APPL SOC PSYCHOL, V11, P366, DOI 10.1111/j.1559-1816.1981.tb00829.x; SINGER P, 1991, NATURE, V353, P613, DOI 10.1038/353613a0; Slovic P, 2007, JUDGM DECIS MAK, V2, P79; Tompkins Jane, 1986, SENSATIONAL DESIGNS; Vezzali L, 2015, J APPL SOC PSYCHOL, V45, P105, DOI 10.1111/jasp.12279; Webster J., 2008, ANIMAL WELFARE LIMPI	38	12	12	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2016	11	12							e0168695	10.1371/journal.pone.0168695	http://dx.doi.org/10.1371/journal.pone.0168695			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EI9QH	28006033	Green Published, Green Submitted, gold			2022-12-27	WOS:000392843200084
J	Mellema, M; Stoller, M; Queau, Y; Ho, SP; Chi, T; Larsen, JA; Passlack, N; Fascetti, AJ; Mohr, C; Westropp, JL				Mellema, M.; Stoller, M.; Queau, Y.; Ho, S. P.; Chi, T.; Larsen, J. A.; Passlack, N.; Fascetti, A. J.; Mohr, C.; Westropp, J. L.			Nanoparticle Tracking Analysis for the Enumeration and Characterization of Mineralo-Organic Nanoparticles in Feline Urine	PLOS ONE			English	Article							CALCIUM-OXALATE UROLITHIASIS; MULTICOLOR FLOW-CYTOMETRY; STONE FORMATION; ELECTRON-MICROSCOPY; KIDNEY-STONES; RENAL STONE; NANOBACTERIA; CATS; EXOSOMES; RECURRENCE	Urinary stone disease, particularly calcium oxalate, is common in both humans and cats. Calcifying nanoparticles (CNP) are spherical nanocrystallite material, and are composed of proteins (fetuin, albumin) and inorganic minerals. CNP are suggested to play a role in a wide array of pathologic mineralization syndromes including urolithiasis. We documented the development of a clinically relevant protocol to assess urinary CNP in 9 healthy cats consuming the same diet in a controlled environment using Nanoparticle Tracking Analysis (NTA). NIA is a novel method that allows for characterization of the CNP in an efficient, accurate method that can differentiate these particles from other urinary submicron particulates. The predominant nanoscale particles in feline urine are characteristic of CNP in terms of their size, their ability to spontaneously form under suitable conditions, and the presence of an outer layer that is rich in calcium and capable of binding to hydroxyapatite binders such as alendronate and osteopontin. The expansion of this particle population can be suppressed by the addition of citrate to urine samples. Further, compounds targeting exosomal surfaces do not label these particulates. As CNP have been associated with a number of significant urologic maladies, the method described herein may prove to be a useful adjunct in evaluating lithogenesis risk in mammals.	[Mellema, M.] Univ Calif Davis, Sch Vet Med, Dept Vet Surg & Radiol Sci, Davis, CA 95616 USA; [Stoller, M.; Chi, T.] Univ Calif San Francisco, Sch Med, Dept Urol, San Francisco, CA 94143 USA; [Queau, Y.] Royal Canin Res & Dev Ctr, Aimargues, France; [Ho, S. P.] Univ Calif San Francisco, Sch Dent, Dept Prevent & Restorat Dent Sci, San Francisco, CA 94143 USA; [Fascetti, A. J.] Univ Calif Davis, Sch Vet Med, Dept Mol Biosci, Davis, CA 95616 USA; [Passlack, N.] Free Univ Berlin, Inst Anim Nutr, Dept Vet Med, Berlin, Germany; [Mohr, C.] Univ Calif Davis, Sch Vet Med, Dept Pathol Microbiol & Immunol, Davis, CA 95616 USA; [Westropp, J. L.] Univ Calif Davis, Sch Vet Med, Dept Vet Med & Epidemiol, Davis, CA 95616 USA	University of California System; University of California Davis; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California Davis; Free University of Berlin; University of California System; University of California Davis; University of California System; University of California Davis	Westropp, JL (corresponding author), Univ Calif Davis, Sch Vet Med, Dept Vet Med & Epidemiol, Davis, CA 95616 USA.	jlwestropp@ucdavis.edu	Ho, Sunita P/B-1084-2008		Royal Canin Research and Development [V435RCG]; Royal Canin	Royal Canin Research and Development; Royal Canin	This study was supported by a grant from Royal Canin Research and Development. Grant number V435RCG. One of the co-authors (YQ), helped participate in study design and writing and editing the manuscript Dr. Yann Queau, an employee of Royal Canin, was a coauthor of this study. Royal Canin provided no salary support for any of the authors. Royal Canin provided a grant/contract for us (MM, JLW, JAL) to purchase the NTA equipment used to analyze the urine samples we obtained from the cats in this study. Dr. Queau did not participate in study design, but did help review and edit the manuscript.	Ahmad I, 2013, PAK J MED SCI, V29, P1363; Albasan H, 2009, JAVMA-J AM VET MED A, V235, P1450, DOI 10.2460/javma.235.12.1450; Cannon AB, 2007, JAVMA-J AM VET MED A, V231, P570, DOI 10.2460/javma.231.4.570; Chi T, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124150; Ciftcioglu N, 1999, KIDNEY INT, V56, P1893, DOI 10.1046/j.1523-1755.1999.00755.x; Ciftcioglu N, 2008, INT J NANOMED, V3, P105; Dijcker JC, 2012, VET REC, V171, P646, DOI 10.1136/vr.101130; Dragovic RA, 2015, METHODS, V87, P64, DOI 10.1016/j.ymeth.2015.03.028; Dragovic RA, 2013, BIOL REPROD, V89, DOI 10.1095/biolreprod.113.113266; Drancourt M, 2003, J CLIN MICROBIOL, V41, P368, DOI 10.1128/JCM.41.1.368-372.2003; Duan CY, 2013, INT J NANOMED, V8, P909, DOI 10.2147/IJN.S39642; Hernandez-Santana A, 2011, BIOANALYSIS, V3, P1085, DOI 10.4155/BIO.11.35; Hesse A, 2003, EUR UROL, V44, P709, DOI 10.1016/S0302-2838(03)00415-9; Hezel A, 2007, VET THER, V8, P247; Kajander EO, 2003, UROL RES, V31, P47, DOI 10.1007/s002440-003-0304-7; Kajander EO, 1998, P NATL ACAD SCI USA, V95, P8274, DOI 10.1073/pnas.95.14.8274; Kumon H, 2011, INT J UROL, V18, P458, DOI 10.1111/j.1442-2042.2011.02763.x; Kutikhin AG, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00214; Lekcharoensuk C, 2001, J AM VET MED ASSOC, V219, P1228, DOI 10.2460/javma.2001.219.1228; Lieske JC, 2014, CLIN J AM SOC NEPHRO, V9, P2141, DOI 10.2215/CJN.05660614; Mehdiani Arash, 2015, J Vis Exp, P50974, DOI 10.3791/50974; Miller J, 2013, J UROLOGY, V190, P1648, DOI 10.1016/j.juro.2013.03.010; National Research Council (US) Steering Group for the Workshop on Size Limits of Very Small Microorganisms, 1999, SIZ LIM VER SMALL MI; Oosthuyzen W, 2013, J PHYSIOL-LONDON, V591, P5833, DOI 10.1113/jphysiol.2013.264069; Pasch A, 2012, J AM SOC NEPHROL, V23, P1744, DOI 10.1681/ASN.2012030240; Plumb D, 2011, VET DRUG HDB; Shiekh FA, 2006, UROL RES, V34, P53, DOI 10.1007/s00240-005-0034-0; Sokolova V, 2011, COLLOID SURFACE B, V87, P146, DOI 10.1016/j.colsurfb.2011.05.013; Soygur T, 2002, J ENDOUROL, V16, P149, DOI 10.1089/089277902753716098; Stamatelou KK, 2003, KIDNEY INT, V63, P1817, DOI 10.1046/j.1523-1755.2003.00917.x; SUTHERLAND JW, 1985, MINER ELECTROL METAB, V11, P267; Trinchieri A, 2013, MINERVA MED, V104, P41; Trinchieri A, 1996, Arch Ital Urol Androl, V68, P203; van der Pol E, 2014, J THROMB HAEMOST, V12, P1182, DOI 10.1111/jth.12602; van der Pol E, 2014, NANO LETT, V14, P6195, DOI 10.1021/nl503371p; WONG TY, 2015, NATURE SCI REPORTS, V5, P15272, DOI DOI 10.1038/SREP15272; Wu CY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075501; Xu HS, 2013, EXPERT OPIN PHARMACO, V14, P435, DOI 10.1517/14656566.2013.775250	38	1	2	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2016	11	12							e0166045	10.1371/journal.pone.0166045	http://dx.doi.org/10.1371/journal.pone.0166045			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI9QH	28005930	Green Published, gold, Green Submitted			2022-12-27	WOS:000392843200004
J	Ruiz-Martinez, J; Ferraguti, M; Figuerola, J; Martinez-de la Puente, J; Williams, RAJ; Herrera-Duenas, A; Aguirre, JI; Soriguer, R; Escudero, C; Moens, MAJ; Perez-Tris, J; Benitez, L				Ruiz-Martinez, Jorge; Ferraguti, Martina; Figuerola, Jordi; Martinez-de la Puente, Josue; John Williams, Richard Alexander; Herrera-Duenas, Amparo; Ignacio Aguirre, Jose; Soriguer, Ramon; Escudero, Clara; Jean Moens, Michael Andre; Perez-Tris, Javier; Benitez, Laura			Prevalence and Genetic Diversity of Avipoxvirus in House Sparrows in Spain	PLOS ONE			English	Article							POX-LIKE LESIONS; AVIAN POX; POXVIRUS; BIRDS; MALARIA; IDENTIFICATION; VIRUS; SEX; PCR	Avipoxvirus (APV) is a fairly common virus affecting birds that causes morbidity and mortality in wild and captive birds. We studied the prevalence of pox-like lesions and genetic diversity of APV in house sparrows (Passer domesticus) in natural, agricultural and urban areas in southern Spain in 2013 and 2014 and in central Spain for 8 months (2012-2013). Overall, 3.2% of 2,341 house sparrows visually examined in southern Spain had cutaneous lesions consistent with avian pox. A similar prevalence (3%) was found in 338 birds from central Spain. Prevalence was higher in hatch-year birds than in adults. We did not detect any clear spatial or temporal patterns of APV distribution. Molecular analyses of poxvirus-like lesions revealed that 63% of the samples were positive. Molecular and phylogenetic analyses of 29 DNA sequences from the fpv167 gene, detected two strains belonging to the canarypox clade (subclades B1 and B2) previously found in Spain. One of them appears predominant in Iberia and North Africa and shares 70% similarity to fowlpox and canarypox virus. This APV strain has been identified in a limited number of species in the Iberian Peninsula, Morocco and Hungary. The second one has a global distribution and has been found in numerous wild bird species around the world. To our knowledge, this represents the largest study of avian poxvirus disease in the broadly distributed house sparrow and strongly supports the findings that Avipox prevalence in this species in South and central Spain is moderate and the genetic diversity low.	[Ruiz-Martinez, Jorge; Escudero, Clara; Benitez, Laura] Univ Complutense Madrid, Fac Biol, Dept Microbiol 3, Madrid, Spain; [Ferraguti, Martina; Figuerola, Jordi; Martinez-de la Puente, Josue; Soriguer, Ramon] CSIC, Estn Biol Donana, Seville, Spain; [Figuerola, Jordi; Martinez-de la Puente, Josue; Soriguer, Ramon] CIBERESP, Madrid, Spain; [John Williams, Richard Alexander; Herrera-Duenas, Amparo; Ignacio Aguirre, Jose; Jean Moens, Michael Andre; Perez-Tris, Javier] Univ Complutense Madrid, Dept Zool & Antropol Fis, Fac Biol, Madrid, Spain; [John Williams, Richard Alexander] Linnaeus Univ, Ctr Ecol & Evolut Microbial Model Syst, Kalmar, Sweden	Complutense University of Madrid; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Estacion Biologica de Donana (EBD); CIBER - Centro de Investigacion Biomedica en Red; CIBERESP; Complutense University of Madrid; Linnaeus University	Benitez, L (corresponding author), Univ Complutense Madrid, Fac Biol, Dept Microbiol 3, Madrid, Spain.	lbenitez@ucm.es	Herrera-Dueñas, Amparo/I-3697-2014; Figuerola, Jordi/B-7917-2008; Williams, Richard/HGB-7918-2022; Aguirre, Jose I/L-1305-2013; Pérez-Tris, Javier/D-4087-2012; Williams, Richard AJ/J-9185-2014; la Puente, Josué Martínez-de/E-8597-2011; Ferraguti, Martina/C-6109-2015; Casimiro-Soriguer, Ramon/J-1494-2014	Herrera-Dueñas, Amparo/0000-0002-0185-7124; Figuerola, Jordi/0000-0002-4664-9011; Aguirre, Jose I/0000-0002-0210-890X; Pérez-Tris, Javier/0000-0001-5535-3100; Williams, Richard AJ/0000-0002-3263-2657; la Puente, Josué Martínez-de/0000-0001-8055-4115; Ferraguti, Martina/0000-0001-7481-4355; Escudero Duch, Clara/0000-0002-5617-0995; Casimiro-Soriguer, Ramon/0000-0002-9165-7766	Spanish Ministry of Science and Innovation [CGL2010-15734/BOS]; Spanish Ministry of Economy and Competitiveness [CGL2013-41642-P/BOS, Juan de la Cierva- JCI-2012-11868, FPI BES-2011-047609]; Innovation and Development Agency of Andalusia (Spain) [P11-RNM-7038]; RAJW [CEI-PICATA2012]; CEI Campus of International Excellence; Spanish Ministry of Education, Culture and Sports [FPU12/0568]; Craaford Foundation [20160971]	Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Spanish Ministry of Economy and Competitiveness(Spanish Government); Innovation and Development Agency of Andalusia (Spain); RAJW; CEI Campus of International Excellence; Spanish Ministry of Education, Culture and Sports(Spanish Government); Craaford Foundation	This study was funded by the Spanish Ministry of Science and Innovation (Project CGL2010-15734/BOS), the Spanish Ministry of Economy and Competitiveness (Project CGL2013-41642-P/BOS) and the Innovation and Development Agency of Andalusia (Spain) (P11-RNM-7038). Grants were awarded to JMP (Juan de la Cierva- JCI-2012-11868) and MAJM (FPI BES-2011-047609), Spanish Ministry of Economy and Competitiveness; RAJW (CEI-PICATA2012), CEI Campus of International Excellence; MM (FPU12/0568), Spanish Ministry of Education, Culture and Sports. RAJW was supported by the Craaford Foundation (grant 20160971) during the writing of this publication. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdallah FM, 2013, VIRUS GENES, V46, P63, DOI 10.1007/s11262-012-0821-y; Aruch S, 2007, J WILDLIFE DIS, V43, P567, DOI 10.7589/0090-3558-43.4.567; Atkinson CT, 2005, CONDOR, V107, P537, DOI 10.1650/0010-5422(2005)107[0537:POPLAM]2.0.CO;2; Bouckaert R, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003537; Daszak P, 2000, SCIENCE, V287, P443, DOI 10.1126/science.287.5452.443; Ferraguti M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066237; Gholami-Ahangaran M, 2014, TROP ANIM HEALTH PRO, V46, P349, DOI 10.1007/s11250-013-0495-z; GIDDENS WE, 1971, VET PATHOL, V8, P260, DOI 10.1177/030098587100800308; Giraudeau M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086747; Griffiths R, 1996, P ROY SOC B-BIOL SCI, V263, P1251, DOI 10.1098/rspb.1996.0184; Griffiths R, 1998, MOL ECOL, V7, P1071, DOI 10.1046/j.1365-294x.1998.00389.x; Gutierrez-Lopez R, 2015, J VECTOR ECOL, V40, P11, DOI 10.1111/jvec.12127; Gyuranecz M, 2013, J VIROL, V87, P4938, DOI 10.1128/JVI.03183-12; Ha HJ, 2011, VET MICROBIOL, V150, P80, DOI 10.1016/j.vetmic.2011.01.011; Henriques AM, 2016, J ZOO WILDLIFE MED, V47, P161, DOI 10.1638/2011-0101.1; Illera JC, 2008, PARASITOL RES, V103, P1435, DOI 10.1007/s00436-008-1153-7; Jarmin S, 2006, J GEN VIROL, V87, P2191, DOI 10.1099/vir.0.81738-0; King A. M., 2012, VIRUS TAXONOMY CLASS; KOCHER TD, 1989, P NATL ACAD SCI USA, V86, P6196, DOI 10.1073/pnas.86.16.6196; Kulich P, 2008, AVIAN PATHOL, V37, P101, DOI 10.1080/03079450701805332; Lachish S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038316; Lanfear R, 2014, BMC EVOL BIOL, V14, DOI 10.1186/1471-2148-14-82; Lawson B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040176; Le Loc'h G, 2014, VET RES, V45, DOI 10.1186/s13567-014-0098-3; Lee LH, 1997, J VIROL METHODS, V63, P113, DOI 10.1016/S0166-0934(96)02119-2; Luschow D, 2004, AVIAN DIS, V48, P453, DOI 10.1637/7111; MCCLURE HE, 1989, J FIELD ORNITHOL, V60, P421; Parker PG, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015989; Pawar RM, 2011, EUR J WILDLIFE RES, V57, P785, DOI 10.1007/s10344-010-0488-4; Perez-Tris J, 2011, AVIAN DIS, V55, P545, DOI 10.1637/9685-021411-Reg.1; Pinilla J., 2001, MANUAL ANILLAMIENTO; Roiz D, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0128112; Smits JE, 2005, VET PATHOL, V42, P59, DOI 10.1354/vp.42-1-59; Svensson L.A., 2006, IDENTIFICATION GUIDE; Thiel T, 2005, J WILDLIFE DIS, V41, P342, DOI 10.7589/0090-3558-41.2.342; Van Riper C, 2002, AUK, V119, P929, DOI 10.1642/0004-8038(2002)119[0929:EAEOAP]2.0.CO;2; van Riper C, 2007, INFECT DIS WILD BIRD, P136; VARGAS H, 1987, J FIELD ORNITHOL, V58, P101; Weli SC, 2004, ARCH VIROL, V149, P2035, DOI 10.1007/s00705-004-0357-0; Young LC, 2008, J FIELD ORNITHOL, V79, P93, DOI 10.1111/j.1557-9263.2008.00149.x; Zylberberg M, 2012, BIOL CONSERV, V153, P72, DOI 10.1016/j.biocon.2012.04.022	41	12	13	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2016	11	12							e0168690	10.1371/journal.pone.0168690	http://dx.doi.org/10.1371/journal.pone.0168690			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI9QH	28005936	Green Submitted, Green Published, gold, Green Accepted			2022-12-27	WOS:000392843200082
J	Perez-Parra, S; Chueca, N; Alvarez, M; Pasquau, J; Omar, M; Collado, A; Vinuesa, D; Lozano, AB; Yebra, G; Garcia, F				Perez-Parra, Santiago; Chueca, Natalia; Alvarez, Marta; Pasquau, Juan; Omar, Mohamed; Collado, Antonio; Vinuesa, David; Lozano, Ana B.; Yebra, Gonzalo; Garcia, Federico			Phylodynamic and Phylogeographic Profiles of Subtype B HIV-1 Epidemics in South Spain	PLOS ONE			English	Article							MOLECULAR EPIDEMIOLOGY; DRUG-RESISTANCE; TRANSMISSION DYNAMICS; POPULATION-DYNAMICS; ANTIRETROVIRAL THERAPY; INFECTED INDIVIDUALS; NORTHWEST SPAIN; BASQUE COUNTRY; PREVALENCE; EVOLUTION	Background Since 1982, HIV-1 epidemics have evolved to different scenarios in terms of transmission routes, subtype distribution and characteristics of transmission clusters. We investigated the evolutionary history of HIV-1 subtype B in south Spain. Patients & Methods We studied all newly diagnosed HIV-1 subtype B patients in East Andalusia during the 2005-2012 period. For the analysis, we used the reverse transcriptase and protease sequences from baseline resistance, and the Trugene (R) HIV Genotyping kit (Siemens, Barcelona, Spain). Subtyping was done with REGA v3.0. The maximum likelihood trees constructed with RAxML were used to study HIV-1 clustering. Phylogeographic and phylodynamic profiles were studied by Bayesian inference methods with BEAST v1.7.5 and SPREAD v1.0.6. Results Of the 493 patients infected with HIV-1 subtype B, 234 grouped into 55 clusters, most of which were small (44 clusters <= 5 patients, 31 with 2 patients, 13 with 3). The rest (133/234) were grouped into 11 clusters with >= 5 patients, and most (82%, 109/133) were men who have sex with men (MSM) grouped into 8 clusters. The association with clusters was more frequent in Spanish (p = 0.02) men (p< 0.001), MSM (p<0.001) younger than 35 years (p = 0.001) and with a CD4+ T-cell count above 350 cells/ul (p<0.001). We estimated the date of HIV-1 subtype B regional epidemic diversification around 1970 (95% CI: 1965-1987), with an evolutionary rate of 2.4 (95%Cl: 1.7-3.1) x 10(-3) substitutions/site/year. Most clusters originated in the 1990s in MSMs. We observed exponential subtype B HIV-1 growth in 1980-1990 and 2005-2008. The most significant migration routes for subtype B went from inland cities to seaside locations. Conclusions We provide the first data on the phylodynamic and phylogeographic profiles of HIV-1 subtype B in south Spain. Our findings of transmission clustering among MSMs should alert healthcare managers to enhance preventive measures in this risk group in order to prevent future outbreaks.	[Perez-Parra, Santiago; Chueca, Natalia; Alvarez, Marta; Garcia, Federico] Hosp Univ San Cecilio, Serv Microbiol Clin, Complejo Hosp, Granada, Spain; [Perez-Parra, Santiago; Chueca, Natalia; Alvarez, Marta; Garcia, Federico] Inst Invest IBS, Granada, Spain; [Pasquau, Juan] Hosp Virgen de las Nieves, Serv Infecciosas, Granada, Spain; [Omar, Mohamed] Hosp Ciudad Jaen, Serv Infecciosas, Jaen, Spain; [Collado, Antonio] Hosp Torrecardenas, Serv Med Interna, Almeria, Spain; [Vinuesa, David] Hosp Univ San Cecilio, Serv Infecciosas, Granada, Spain; [Lozano, Ana B.] Hosp Poniente, Serv Infecciosas, Almeria, Spain; [Yebra, Gonzalo] Univ Edinburgh, Inst Evolutionary Biol, Edinburgh, Midlothian, Scotland	Hospital Universitario San Cecilio; Instituto de Investigacion Biosanitaria IBS Granada; Hospital Universitario Virgen de las Nieves; Hospital Torrecardenas; Hospital Universitario San Cecilio; University of Edinburgh	Garcia, F (corresponding author), Hosp Univ San Cecilio, Serv Microbiol Clin, Complejo Hosp, Granada, Spain.; Garcia, F (corresponding author), Inst Invest IBS, Granada, Spain.	fegarcia@ugr.es	Garcia, Federico/AAA-3175-2020; Chueca, Natalia/T-9734-2019	Garcia, Federico/0000-0001-7611-781X; Chueca, Natalia/0000-0002-3420-3290; Yebra, Gonzalo/0000-0002-3472-3667; Pasquau, Juan/0000-0001-9409-9205	National Plan of I+D+i [RD12/0017/006]; Health institute Carlos III(ISCIII) [RI12/01053]; Ministry of Health of Andalusia [AC-0082-2013]	National Plan of I+D+i; Health institute Carlos III(ISCIII); Ministry of Health of Andalusia	The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Funded by National Plan of I+D+i (RD12/0017/006), Health institute Carlos III(ISCIII), RI12/01053 (General Ministry of Evaluation and European Fund of Regional Development-FEDER), granted to FGG. Ministry of Health of Andalusia (AC-0082-2013), granted to FGG.	Abecasis AB, 2013, RETROVIROLOGY, V10, DOI 10.1186/1742-4690-10-7; Abecasis AB, 2009, J VIROL, V83, P12917, DOI 10.1128/JVI.01022-09; Ambrosioni J, 2012, AIDS, V26, P2079, DOI 10.1097/QAD.0b013e32835805b6; Bannister WP, 2006, ANTIVIR THER, V11, P707; Baral S, 2007, PLOS MED, V4, P1901, DOI 10.1371/journal.pmed.0040339; Bezemer D, 2004, AIDS, V18, P1571, DOI 10.1097/01.aids.0000131357.52457.33; Brown AJL, 2011, J INFECT DIS, V204, P1463, DOI 10.1093/infdis/jir550; Burns S, 2007, AIDS, V21, P1035, DOI 10.1097/QAD.0b013e3280b07761; Castro-Nallar E, 2012, MOL PHYLOGENET EVOL, V62, P777, DOI 10.1016/j.ympev.2011.11.019; Chalmet K, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-262; Ciccozzi M, 2012, AIDS RES HUM RETROV, V28, P1280, DOI 10.1089/aid.2011.0138; COFFIN JM, 1995, SCIENCE, V267, P483, DOI 10.1126/science.7824947; Da vila PF, 2012, CONDUCTAS RIESGO PRU; Dalai SC, 2009, AIDS, V23, P2523, DOI 10.1097/QAD.0b013e3283320ef3; de Silva TI, 2013, AIDS, V27, P125, DOI 10.1097/QAD.0b013e32835ab12c; Delatorre EO, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041904; Dennis AM, 1999, J ACQ IMMUN DEF SYND, V2014, P181; Drummond AJ, 2003, TRENDS ECOL EVOL, V18, P481, DOI 10.1016/S0169-5347(03)00216-7; Drummond AJ, 2005, MOL BIOL EVOL, V22, P1185, DOI [10.1093/molbev/msi103, 10.1093/molbev/mss075]; Drummond AJ, 2002, GENETICS, V161, P1307; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Drummond AJ, 2006, PLOS BIOL, V4, P699, DOI 10.1371/journal.pbio.0040088; Esbjornsson J, 2016, VIRUS EVOL, V2, DOI 10.1093/ve/vew010; Faria NR, 2012, INFECT GENET EVOL, V12, P453, DOI 10.1016/j.meegid.2011.04.028; Fox J, 2010, AIDS, V24, P2397, DOI 10.1097/QAD.0b013e32833cbb5b; Frost SDW, 2010, PHILOS T R SOC B, V365, P1879, DOI 10.1098/rstb.2010.0060; Garcia F, 2011, ANTIVIR RES, V91, P150, DOI 10.1016/j.antiviral.2011.05.010; Grabowski MK, 2014, CURR OPIN HIV AIDS, V9, P126, DOI 10.1097/COH.0000000000000040; Gray RR, 2009, AIDS, V23, pF9, DOI 10.1097/QAD.0b013e32832faf61; HILLIS DM, 1993, SYST BIOL, V42, P182, DOI 10.2307/2992540; Hue S, 2005, P NATL ACAD SCI USA, V102, P4425, DOI 10.1073/pnas.0407534102; Jetzt AE, 2000, J VIROL, V74, P1234, DOI 10.1128/JVI.74.3.1234-1240.2000; Kim GJ, 2012, AIDS RES HUM RETROV, V28, P880, DOI [10.1089/aid.2011.0267, 10.1089/AID.2011.0267]; Kouyos RD, 2010, J INFECT DIS, V201, P1488, DOI 10.1086/651951; Lai A, 2010, HIV MED, V11, P593, DOI 10.1111/j.1468-1293.2010.00832.x; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lohse N, 2006, ANTIVIR THER, V11, P591; Lunar MM, 2015, BMC INFECT DIS, V15, DOI 10.1186/s12879-015-0802-6; Maartens G, 2014, LANCET, V384, P258, DOI 10.1016/S0140-6736(14)60164-1; Mbisa JL, 2012, AIDS RES HUM RETROV, V28, P961, DOI [10.1089/aid.2011.0390, 10.1089/AID.2011.0390]; Mehta SR, 2011, INFECT GENET EVOL, V11, P975, DOI 10.1016/j.meegid.2011.03.009; Miller M.A., 2010, P GAT COMP ENV WORKS; Montagnier L, 2002, SCIENCE, V298, P1727, DOI 10.1126/science.1079027; National AIDS Case Registry, 2010, EP SURV AIDS SPAIN; Ng KT, 2013, PLOS ONE, V8; Palma AC, 2007, INFECT GENET EVOL, V7, P391, DOI 10.1016/j.meegid.2007.01.009; Patino-Galindo JA, 2016, INFECT GENET EVOL, V40, P91, DOI 10.1016/j.meegid.2016.02.028; Perez-Parra S, 2015, ENFERM INFEC MICR CL, V33, P603, DOI 10.1016/j.eimc.2014.11.016; Pernas B, 2015, J MED VIROL, V87, P1319, DOI 10.1002/jmv.24185; Pernas B, 2014, AIDS, V28, P1837, DOI 10.1097/QAD.0000000000000326; Recordon-Pinson P, 2009, ANTIVIR THER, V14, P551; Roy CN, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129896; Siljic M, 2014, ARCH BIOL SCI, V66, P507, DOI 10.2298/ABS1402507S; Cuevas MT, 2009, JAIDS-J ACQ IMM DEF, V51, P99, DOI 10.1097/QAI.0b013e318199063e; Thomson MM, 2012, JAIDS-J ACQ IMM DEF, V59, pE49, DOI 10.1097/QAI.0b013e3182400fc4; Vega Y, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125699; Vercauteren J, 2009, J INFECT DIS, V200, P1503, DOI 10.1086/644505; Volz EM, 2009, GENETICS, V183, P1421, DOI 10.1534/genetics.109.106021; Vrancken B, 2015, AIDS, V29, P1549, DOI 10.1097/QAD.0000000000000731; Walker Polly R., 2005, Infection Genetics and Evolution, V5, P199, DOI 10.1016/j.meegid.2004.06.011; Wertheim JO, 2012, MOL BIOL EVOL, V29, P451, DOI 10.1093/molbev/msr266; Yebra G, 2013, INFECT GENET EVOL, V14, P232, DOI 10.1016/j.meegid.2012.12.006; Yerly S, 2007, AIDS, V21, P2223, DOI 10.1097/QAD.0b013e3282f0b685; Zehender G, 2010, JAIDS-J ACQ IMM DEF, V55, P156, DOI 10.1097/QAI.0b013e3181eb3002	64	5	5	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2016	11	12							e0168099	10.1371/journal.pone.0168099	http://dx.doi.org/10.1371/journal.pone.0168099			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI9TW	28002469	Green Published, gold, Green Submitted			2022-12-27	WOS:000392853100032
J	Rupsys, P				Rupsys, Petras			New Insights into Tree Height Distribution Based on Mixed Effects Univariate Diffusion Processes	PLOS ONE			English	Article							STOCHASTIC DIFFERENTIAL-EQUATIONS; BIVARIATE DISTRIBUTION; LAPLACE APPROXIMATION; MODELS; DIAMETERS; FOREST; REGRESSION; COPULAS; GROWTH; VOLUME	The aim of this paper is twofold: to introduce the mathematics of stochastic differential equations (SDEs) for forest dynamics modeling and to describe how such a model can be applied to aid our understanding of tree height distribution corresponding to a given diameter using the large dataset provided by the Lithuanian National Forest Inventory (LNFI). Tree height diameter dynamics was examined with Ornstein-Uhlenbeck family mixed effects SDEs. Dynamics of a tree height, volume and their coefficients of variation, quantile regression curves of the tree height, and height-diameter ratio were demonstrated using newly developed tree height distributions for a given diameter. The parameters were estimated by considering a discrete sample of the diameter and height and by using an approximated maximum likelihood procedure. All models were evaluated using a validation dataset. The dataset provided by the LNFI (2006-2010) of Scots pine trees is used in this study to estimate parameters and validate our modeling technique. The verification indicated that the newly developed models are able to accurately capture the behavior of tree height distribution corresponding to a given diameter. All of the results were implemented in a MAPLE symbolic algebra system.	[Rupsys, Petras] Aleksandras Stulginskis Univ, Ctr Math Phys & Informat Technol, Kaunas, Lithuania; [Rupsys, Petras] Aleksandras Stulginskis Univ, Inst Forest Management & Wood Sci, Kaunas, Lithuania	Vytautas Magnus University; Vytautas Magnus University	Rupsys, P (corresponding author), Aleksandras Stulginskis Univ, Ctr Math Phys & Informat Technol, Kaunas, Lithuania.; Rupsys, P (corresponding author), Aleksandras Stulginskis Univ, Inst Forest Management & Wood Sci, Kaunas, Lithuania.	petras.rupsys@asu.lt	Rupšys, Petras/I-5255-2019; Rupšys, Petras/AAB-9429-2019	Rupšys, Petras/0000-0002-1738-2039				Adamec Z., 2015, Journal of Forest Science (Prague), V61, P439, DOI 10.17221/68/2015-JFS; AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; Almquist J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124050; [Anonymous], 1928, Z PFLANZENERN DUNGUN, DOI DOI 10.1002/JPLN.19280120502; CAPOCELLI RM, 1974, KYBERNETIK, V15, P147, DOI 10.1007/BF00274586; Chen CM, 1978, MINNESOTA FORESTRY R, P267; CLEVELAND WS, 1979, J AM STAT ASSOC, V74, P829, DOI 10.2307/2286407; Corradi V, 2006, HBK ECON, V24, P197, DOI 10.1016/S1574-0706(05)01005-0; Duan AG, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062605; GARCIA O, 1983, BIOMETRICS, V39, P1059, DOI 10.2307/2531339; Gompertz B., 1825, PHILOS T ROYAL SOC L, V115, P515, DOI [DOI 10.1098/RSTL.1825.0026, 10.1098/rstl.1825.0026]; Gutierrez-Jaimez R, 2014, STOCH ENV RES RISK A, V28, P1125, DOI 10.1007/s00477-013-0802-2; Ito K., 1942, JPN J MATH, V18, P261, DOI [DOI 10.4099/JJM1924.18.0_261, 10.4099/jjm1924.18.0_261]; Joe H, 2008, COMPUT STAT DATA AN, V52, P5066, DOI 10.1016/j.csda.2008.05.002; Kempes CP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020551; Kullback S., 1997, INFORM THEORY STAT; Li FS, 2002, FOREST SCI, V48, P47; Monagan M.B., 2007, MAPLE ADV PROGRAMMIN; Monness E, 2015, CAN J FOREST RES, V45, P307, DOI 10.1139/cjfr-2014-0333; Petrauskas E, 2013, RURAL DEVELOPMENT, V6, P407; Petrauskas E, 2013, BALT FOR, V19, P143; Rennolls K, 2009, FOR BIOM MODEL INFOR, V1, P1; Roitman I, 2015, ECOL MODEL, V297, P118, DOI 10.1016/j.ecolmodel.2014.11.009; Roman-Roman P, 2010, J THEOR BIOL, V263, P59, DOI 10.1016/j.jtbi.2009.12.009; Rupsys P, 2015, AIP CONF PROC, V1684, DOI 10.1063/1.4934322; Rupsys P, 2015, INT J BIOMATH, V8, DOI 10.1142/S1793524515500606; Rupsys P, 2015, MATH PROBL ENG, V2015, DOI 10.1155/2015/375270; Rupsys P, 2015, J FOREST RES-JPN, V20, P9, DOI 10.1007/s10310-014-0454-1; Schmidt M, 1999, FORSTWISS CENTRALBL, V118, P355, DOI 10.1007/BF02768999; SCHREUDER HT, 1977, BIOMETRICS, V33, P471, DOI 10.2307/2529361; Schumacher FX, 1933, J AGRIC RES, V47, P0719; SHUN ZM, 1995, J ROY STAT SOC B MET, V57, P749; Smith LB, 2015, ANN APPL STAT, V9, P1226, DOI 10.1214/15-AOAS841; Suzuki T., 1971, MITT FORSTL BUNDESVE, V91, P69; Uhlenbeck GE, 1930, PHYS REV, V36, P0823, DOI 10.1103/PhysRev.36.823; Vidal C., 2010, NATL FOREST INVENTOR; Wang ML, 2008, FOREST SCI, V54, P284; Wong E, 1985, STOCHASTIC PROCESSES; Xu H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104012; Zucchini W, 2001, SILVA FENN, V35, P169, DOI 10.14214/sf.594	41	12	12	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2016	11	12							e0168507	10.1371/journal.pone.0168507	http://dx.doi.org/10.1371/journal.pone.0168507			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI9TW	28002500	Green Submitted, Green Published, gold			2022-12-27	WOS:000392853100049
J	Shin, JM; Kang, JH; Lee, SA; Park, IH; Lee, HM				Shin, Jae-Min; Kang, Ju-Hyung; Lee, Seoung-Ae; Park, Il-Ho; Lee, Heung-Man			Baicalin Down-Regulates IL-1 beta-Stimulated Extracellular Matrix Production in Nasal Fibroblasts	PLoS One			English	Article							ACUTE LUNG INJURY; NF-KAPPA-B; CHRONIC RHINOSINUSITIS; PULMONARY-FIBROSIS; COLLAGEN-SYNTHESIS; EPITHELIAL-CELLS; EXPRESSION; INTERLEUKIN-1-BETA; INFLAMMATION; PHOSPHORYLATION	Purpose Baicalin, a Chinese herbal medicine, has anti-fibrotic and anti-inflammatory effects. The aims of present study were to investigate the effects of baicalin on the myofibroblast differentiation, extracellular matrix production, migration, and collagen contraction of interleukin (IL)-1 beta-stimulated nasal fibroblasts and to determine the molecular mechanism of baicalin in nasal fibroblasts. Methods Nasal fibroblasts were isolated from the inferior turbinate of patients. Baicalin was used to treat IL-1 beta-stimulated nasal fibroblasts. To evaluate cytotoxicity, a 3-(4,5-dimethylthiazol-2y1)-2,5diphenyl-tetrazolium bromide assay was used. The expression levels of a-smooth muscle actin (SMA), fibronectin, phospho-mitogen-activated protein kinase (p-MAPK), p-Akt, p-p50, p-p65, and p-IKB alpha were measured by western blotting, reverse transcription-polymerase chain reaction (RT-PCR),or immunofluorescence staining. Fibroblast migration was analyzed with scratch assays and transwell migration assays. Total collagen was evaluated with the Sircol collagen assay. Contractile activity was measured with a collagen gel contraction assay. Results Baicalin (0-50 mu M) had no significant cytotoxic effects in nasal fibroblasts. The expression of a SMA and fibronectin were significantly down-regulated in baicalin-treated nasal fibroblasts. Migration, collagen production, and contraction of IL-1 beta-stimulated nasal fibroblasts were significantly inhibited by baicalin treatment. Baicalin also significantly down-regulated p-MAPK, p-Akt, p-p50, p-p65, and p-IKB alpha in IL-1 beta-stimulated nasal fibroblasts. Conclusions We showed that baicalin down-regulated myofibroblast differentiation, extracellular matrix production, migration, and collagen contraction via the MAPK and Akt/NF-kappa B pathways in IL-1 beta-stimulated nasal fibroblasts.	[Shin, Jae-Min; Park, Il-Ho; Lee, Heung-Man] Korea Univ, Coll Med, Dept Otorhinolaryngol Head & Neck Surg, Seoul, South Korea; [Kang, Ju-Hyung; Lee, Heung-Man] Korea Univ, Coll Med, Div Brain Korea Program Biomed Sci 21, Seoul, South Korea; [Lee, Seoung-Ae; Lee, Heung-Man] Korea Univ, Coll Med, Inst Korea Univ Med Devices Support Ctr, Seoul, South Korea	Korea University; Korea University Medicine (KU Medicine); Korea University; Korea University Medicine (KU Medicine); Korea University; Korea University Medicine (KU Medicine)	Lee, HM (corresponding author), Korea Univ, Coll Med, Dept Otorhinolaryngol Head & Neck Surg, Seoul, South Korea.; Lee, HM (corresponding author), Korea Univ, Coll Med, Div Brain Korea Program Biomed Sci 21, Seoul, South Korea.; Lee, HM (corresponding author), Korea Univ, Coll Med, Inst Korea Univ Med Devices Support Ctr, Seoul, South Korea.	lhman@korea.ac.kr		PARK, IL-HO/0000-0002-7011-6071	Korean Health Technology R&D Project, Ministry of Health & Welfare, Republic of Korea [HI15C1512, HI13C1501]	Korean Health Technology R&D Project, Ministry of Health & Welfare, Republic of Korea	This study was supported by a grant from the Korean Health Technology R&D Project, Ministry of Health & Welfare, Republic of Korea (HI15C1512 and HI13C1501). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aumiller V, 2013, AM J RESP CELL MOL, V49, P96, DOI 10.1165/rcmb.2012-0524OC; Bachert C, 2015, J ALLERGY CLIN IMMUN, V136, P1431, DOI 10.1016/j.jaci.2015.10.010; Ball SL, 2016, AM J PATHOL, V186, P225, DOI 10.1016/j.ajpath.2015.09.020; Barkhordar RA, 2002, J ENDODONT, V28, P157, DOI 10.1097/00004770-200203000-00003; Bujak M, 2008, AM J PATHOL, V173, P57, DOI 10.2353/ajpath.2008.070974; Cho JS, 2012, CLIN EXP ALLERGY, V42, P872, DOI 10.1111/j.1365-2222.2011.03931.x; Furukido K, 2005, EUR ARCH OTO-RHINO-L, V262, P50, DOI 10.1007/s00405-003-0713-9; Furuyama A, 2008, MATRIX BIOL, V27, P429, DOI 10.1016/j.matbio.2008.02.005; Grzegorczyk-Karolak I, 2015, ACTA BIOCHIM POL, V62, P253, DOI 10.18388/abp.2014_944; Hong SM, 2013, AM J RHINOL ALLERGY, V27, P278, DOI 10.2500/ajra.2013.27.3909; Hu Q, 2009, NEPHROL DIAL TRANSPL, V24, P3033, DOI 10.1093/ndt/gfp245; Kang JS, 2014, PHYTOTHER RES, V28, P98, DOI 10.1002/ptr.4971; Karin M, 2000, ANNU REV IMMUNOL, V18, P621, DOI 10.1146/annurev.immunol.18.1.621; Kolb M, 2001, J CLIN INVEST, V107, P1529, DOI 10.1172/JCI12568; Liu PP, 2015, INT J MOL MED, V35, P901, DOI 10.3892/ijmm.2015.2110; Lu HK, 2010, J PERIODONTAL RES, V45, P451, DOI 10.1111/j.1600-0765.2009.01255.x; Ren K, 2009, BRAIN RES REV, V60, P57, DOI 10.1016/j.brainresrev.2008.12.020; ROTHWARF DM, 1999, SCI STKE, V5, pRE1; Shin YO, 2015, EVID-BASED COMPL ALT, V2015, DOI 10.1155/2015/456846; Sun J, 2013, PLANTA MED, V79, P199, DOI 10.1055/s-0032-1328197; Viatour P, 2005, TRENDS BIOCHEM SCI, V30, P43, DOI 10.1016/j.tibs.2004.11.009; Wang HZ, 2014, J PHARMACOL EXP THER, V350, P435, DOI 10.1124/jpet.114.215145; White KE, 2008, J IMMUNOL, V180, P637, DOI 10.4049/jimmunol.180.1.637; Xiao Hua, 2008, Shengli Xuebao, V60, P355; Zha WJ, 2016, ALLERGY ASTHMA IMMUN, V8, P161, DOI 10.4168/aair.2016.8.2.161	25	7	7	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2016	11	12							e0168195	10.1371/journal.pone.0168195	http://dx.doi.org/10.1371/journal.pone.0168195			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI9TW	28002421	gold, Green Submitted, Green Published			2022-12-27	WOS:000392853100034
J	Davis, CS				Davis, Christopher Sean			Solar-Aligned Pictographs at the Paleoindian Site of Painel do Pilao along the Lower Amazon River at Monte Alegre, Brazil	PLOS ONE			English	Article								The archaeological sites near Monte Alegre, along Brazil's lower Amazon River, provide new information on the little-known activities and symbolism of South American Paleoindians toward the end of the Ice Age. While paleoindian sites like Monte Verde in Chile, or Guitarrero Cave in Peru, are located near the pacific coast, Monte Alegre lies much further inland, 680 km upriver from the mouth of the Amazon River and the Atlantic Coast. With excavated wood charcoal radiocarbon dated as early as 13,200 calibrated years ago, the hill as a source of sandstone and quartz lithics supplied early pioneers with adequate tools needed for colonizing the interior of the continent. Once there, they painted rock art on the landscape, which bears a record of the sun's horizon positions throughout the year. At just 2 south of the equator, Monte Alegre shows no overt seasonal changes beyond fluctuating rainfall amounts, unlike at higher latitudes where temperature, amount of daylight, foliage, and forms of precipitation markedly change. Near the equator, solar and stellar horizon sightings most visibly track the passage of time and seasonal cycles. However, horizons are often hidden behind high forest canopy throughout much of the Amazon Rainforest; but in the Monte Alegre hill ridges looming above the river, paleoindians could hike above the canopy to peer at the horizon, more effectively synchronizing their activities to ecological cycles. This research suggests that Monte Alegre paleoindians delimited the azimuthal range of the sun in a solar year with notational pictographs aligned to horizon sightings at Painel do Pilao, and leaving a painted grid of tally marks that might have served as a rudimentary early calendar. The broad-reaching implication for early Americans is that through the strategic placement of rock art, these ancient artists fostered predictive archaeorecording from which resources could be optimally extracted, ceremonial activities could be consistently scheduled, and gatherings for social and economic exchange could be more efficiently coordinated.	[Davis, Christopher Sean] Northern Illinois Univ, Dept Anthropol, De Kalb, IL 60115 USA	Northern Illinois University	Davis, CS (corresponding author), Northern Illinois Univ, Dept Anthropol, De Kalb, IL 60115 USA.	christopher.davis@fulbrightmail.org			U.S. Student Fulbright Commission; Fulbright Brasilia	U.S. Student Fulbright Commission; Fulbright Brasilia	U.S. Student Fulbright Commission with Fulbright Brasilia (www.fulbright.org.br) partially supported (cost of living and transportation, research permits) funding for the research of CSD. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. All remaining research was unfunded.	Aguiar R., 2004, REV MULTITEMATICA FA, P91; Aveni A.F., 1990, THE LINES OF NAZCA; Aveni A.F., 1989, EMPIRES TIME CALENDA; Aveni Anthony, 2012, CIRCLING SQUARE CONQ; Aveni Anthony F., 1980, SKYWATCHERS ANCIENT; BELTRAO MDDC, 1990, ANTHROPOLOGIE, V94, P139; Brace G., 2005, BOULDER MONUMENTS SA; Cabral MP, 2009, REV ARQUEOLOGIA, V21; Etchevarne C., 2000, REV USP, P112; Evans Susan Toby, 2013, ANCIENT MEXICO CENTR, V3rd; FABIAN Stephen M, 2001, PATTERNS SKY INTRO E; Fabian Stephen Michael, 1992, SPACE TIME BORORO BR; Guidon N., 2003, ARQUEOLOGIA REGIAO P; Jorge M, 2007, BRASIL RUPESTRE ARTE; Kelley DH, 2011, EXPLORING ANCIENT SKIES: A SURVEY OF ANCIENT AND CULTURAL ASTRONOMY, SECOND EDITION, P1, DOI 10.1007/978-1-4419-7624-6; Krupp EC., 2006, INT ROCK ART C 1994, V3, P353; Lery J., 1992, HIST VOYAGE LAND BRA; Magana E, 1986, MYTH IMAGINARY NEW W; Malatesta P, 1998, UNESCO COURIER, V51, P44; MARTIN Gabriela, 1997, PRE HIST NORDESTE BR; NCEI NCfEI, 2016, MAGN FIELD CALC BOUL; Neves WA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032228; Pavia AF, 2005, AGRUPACION ASTRONOMI, P53; Pereira E., 2002, ARTE RUPESTRE AMAZON; PEREIRA E. S., 2012, ARTE RUPESTRE MONTE; Prous A, 1999, QUATERN INT, V53-4, P21, DOI 10.1016/S1040-6182(98)00005-6; PROUS A., 1992, ARQUEOLOGIA BRASILEI; Reichel-Dolmatoff G., 1982, ARCHAEOASTRONOMY NEW, P165; Roosevelt AC, 1996, SCIENCE, V272, P373, DOI 10.1126/science.272.5260.373; ROOSEVELT AC, 2002, MEMOIRS CALIFORNIA A, V27, P159; Roosevelt AC., 1999, ARCHEOLOGICAL PAPERS, V9, P2, DOI DOI 10.1525/AP3A.1999.9.1.13; Roth WE, 1915, INQUIRY ANIMISM FOLK, P103; Sofaer A, 1983, MAXWELL MUSEUM ANTHR; Southey R., 1810, HIST BRAZIL PART 1; TEDLOCK B, 1999, ARCHAEOASTRONOMY, V14, P39; Titiev M., 1944, STUDY HOPI INDIANS 3, pxi; Truel LR, 1997, ARQUEOLOGIA COSTA CE; Urton Gary, 1981, CROSSROADS EARTH SKY; WALLACE AR, 1889, NARRATIVE TRAVELS AM; Whiffen Thomas, 1915, N W AMAZONS NOTES SO; Wilbert J., 1986, CEDLA LATIN AM STUDI, P427; Zuidema RT., 1981, ARCHAEOASTRONOMY AM, P29	42	3	3	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2016	11	12							e0167692	10.1371/journal.pone.0167692	http://dx.doi.org/10.1371/journal.pone.0167692			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI9QF	27997553	Green Published, gold			2022-12-27	WOS:000392842900013
J	Dixit, VV; Chand, S; Nair, DJ				Dixit, Vinayak V.; Chand, Sai; Nair, Divya J.			Autonomous Vehicles: Disengagements, Accidents and Reaction Times	PLOS ONE			English	Article								Autonomous vehicles are being viewed with scepticism in their ability to improve safety and the driving experience. A critical issue with automated driving at this stage of its development is that it is not yet reliable and safe. When automated driving fails, or is limited, the autonomous mode disengages and the drivers are expected to resume manual driving. For this transition to occur safely, it is imperative that drivers react in an appropriate and timely manner. Recent data released from the California trials provide compelling insights into the current factors influencing disengagements of autonomous mode. Here we show that the number of accidents observed has a significantly high correlation with the autonomous miles travelled. The reaction times to take control of the vehicle in the event of a disengagement was found to have a stable distribution across different companies at 0.83 seconds on average. However, there were differences observed in reaction times based on the type of disengagements, type of roadway and autonomous miles travelled. Lack of trust caused by the exposure to automated disengagements was found to increase the likelihood to take control of the vehicle manually. Further, with increased vehicle miles travelled the reaction times were found to increase, which suggests an increased level of trust with more vehicle miles travelled. We believe that this research would provide insurers, planners, traffic management officials and engineers fundamental insights into trust and reaction times that would help them design and engineer their systems.	[Dixit, Vinayak V.; Chand, Sai; Nair, Divya J.] UNSW Australia, Sch Civil & Environm Engn, Res Ctr Integrated Transport Innovat, Sydney, NSW, Australia	University of New South Wales Sydney	Dixit, VV (corresponding author), UNSW Australia, Sch Civil & Environm Engn, Res Ctr Integrated Transport Innovat, Sydney, NSW, Australia.	v.dixit@unsw.edu.au	Chand, Sai/X-3138-2019	Chand, Sai/0000-0001-8084-1413; Dixit, Vinayak/0000-0001-7643-409X; Nair, Divya J/0000-0002-9873-9166				Anderson J. M., 2014, AUTONOMOUS VEHICLE T; Fagnant DJ, 2015, TRANSPORT RES A-POL, V77, P167, DOI 10.1016/j.tra.2015.04.003; Fambro D.B., 1997, DETERMINATION STOPPI; Helldin T., 2013, P 5 INT C AUTOMOTIVE, P210; Koppa RJ, 2005, REVISED MONOGRAPH TR; Litman T., 2021, AUTONOMOUS VEHICLE I; Martens MH, 2013, IEEE INT C INTELL TR, P2262, DOI 10.1109/ITSC.2013.6728564; Merat N, 2014, TRANSPORT RES F-TRAF, V27, P274, DOI 10.1016/j.trf.2014.09.005; Payre W, 2014, TRANSPORT RES F-TRAF, V27, P252, DOI 10.1016/j.trf.2014.04.009; Rodel C., 2014, P 6 INT C AUT US INT, P11; Shladover SE, 2012, TRANSPORT RES REC, P63, DOI 10.3141/2324-08; Silverman B.W., 1986, DENSITY ESTIMATION S	12	143	146	15	66	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2016	11	12							e0168054	10.1371/journal.pone.0168054	http://dx.doi.org/10.1371/journal.pone.0168054			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI9QF	27997566	Green Published, gold, Green Submitted			2022-12-27	WOS:000392842900022
J	Hoffman, GE; Koban, M				Hoffman, Gloria E.; Koban, Michael			Hypothalamic L-Histidine Decarboxylase Is Up-Regulated During Chronic REM Sleep Deprivation of Rats	PLOS ONE			English	Article							BROWN ADIPOSE-TISSUE; CORTICOTROPIN-RELEASING HORMONE; NEURONAL HISTAMINE INTERACT; SYMPATHETIC-NERVE ACTIVITY; IN-SITU HYBRIDIZATION; ADRENAL AXIS ACTIVITY; TUBEROMAMMILLARY NUCLEUS; FEEDING-BEHAVIOR; GENE-EXPRESSION; BRAIN HISTAMINE	A competition of neurobehavioral drives of sleep and wakefulness occurs during sleep deprivation. When enforced chronically, subjects must remain awake. This study examines histaminergic neurons of the tuberomammillary nucleus of the posterior hypothalamus in response to enforced wakefulness in rats. We tested the hypothesis that the rate-limiting enzyme for histamine biosynthesis, L-histidine decarboxylase (HDC), would be up-regulated during chronic rapid eye movement sleep deprivation (REM-SD) because histamine plays a major role in maintaining wakefulness. Archived brain tissues of male Sprague Dawley rats from a previous study were used. Rats had been subjected to REM-SD by the flowerpot paradigm for 5, 10, or 15 days. For immunocytochemistry, rats were transcardially perfused with acrolein-paraformaldehyde for immunodetection of L-HDC; separate controls used carbodiimide-paraformaldehyde for immunodetection of histamine. Immunolocalization of histamine within the tuberomammillary nucleus was validated using carbodiimide. Because HDC antiserum has cross-reactivity with other decarboxylases at high antibody concentrations, titrations localized L-HDC to only tuberomammillary nucleus at a dilution of >1:300,000. REM-SD increased immunoreactive HDC by day5 and it remained elevated in both dorsal and ventral aspects of the tuberomammillary complex. Our results suggest that up-regulation of L-HDC within the tuberomammillary complex during chronic REM-SD may be responsible for maintaining wakefulness.	[Hoffman, Gloria E.; Koban, Michael] Morgan State Univ, Dept Biol, Baltimore, MD 21239 USA	Morgan State University	Koban, M (corresponding author), Morgan State Univ, Dept Biol, Baltimore, MD 21239 USA.	michael.koban@morgan.edu	Koban, Michael/A-7130-2009; Hoffman, Gloria E/AAU-3760-2021		National Institutes of Health, National Institute of Neurological Disorders and Stroke [5R01NS043788-04]; National Institutes of Health, National Institute of Eunice Kennedy Shriver National Institute of Child Health & Human Development [5U01HD066435-05]; Clinical Nutrition Research Unit of Maryland [P30DK072488, NIH/P30-DK072488-05S1]; National Institute of Health, National Center for Research Resources [5G12RR017581-05]; National Institutes of Health, National Institute of General Medical Sciences [5S06GM051971-05]; TEDCO (Technology Development Corporation of Maryland)/U.S. Army [Q81XWH-07-2-0055]	National Institutes of Health, National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); National Institutes of Health, National Institute of Eunice Kennedy Shriver National Institute of Child Health & Human Development; Clinical Nutrition Research Unit of Maryland; National Institute of Health, National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); National Institutes of Health, National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); TEDCO (Technology Development Corporation of Maryland)/U.S. Army	This work was supported by the National Institutes of Health, National Institute of Neurological Disorders and Stroke, 5R01NS043788-04 (http://www.ninds.nih.gov), GEH; National Institutes of Health, National Institute of Eunice Kennedy Shriver National Institute of Child Health & Human Development, 5U01HD066435-05 (https://www.nichd.nih.gov), GEH Pilot and Feasibility grant from Clinical Nutrition Research Unit of Maryland, P30DK072488, (http:grantome.com/grant/NIH/P30-DK072488-05S1), GEH National Institute of Health, National Center for Research Resources, 5G12RR017581-05 (httn.//www.nih.gov/about/almanac/organization/NCRR.htm), MK National Institutes of Health, National Institute of General Medical Sciences, 5S06GM051971-05 (http://www.nigms.nih.gov/Pages/default.aspx), MK TEDCO (Technology Development Corporation of Maryland, http://tedco.md/)/U.S. Army contract Q81XWH-07-2-0055, MK. TEDCO had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AIRAKSINEN MS, 1989, J COMP NEUROL, V286, P289, DOI 10.1002/cne.902860302; AIRAKSINEN MS, 1992, J COMP NEUROL, V323, P103, DOI 10.1002/cne.903230109; AIRAKSINEN MS, 1988, J COMP NEUROL, V273, P163, DOI 10.1002/cne.902730204; Allada R, 2008, CURR BIOL, V18, pR670, DOI 10.1016/j.cub.2008.06.033; ANDOYAMAMOTO M, 1986, BIOCHEM BIOPH RES CO, V141, P306, DOI 10.1016/S0006-291X(86)80369-2; Banerji A, 2007, ALLERGY ASTHMA PROC, V28, P418, DOI 10.2500/aap.2007.28.3015; Barf RP, 2012, PHYSIOL BEHAV, V107, P322, DOI 10.1016/j.physbeh.2012.09.005; Barf RP, 2012, AM J PHYSIOL-REG I, V302, pR112, DOI 10.1152/ajpregu.00326.2011; Basheer R, 1998, MOL BRAIN RES, V57, P235, DOI 10.1016/S0169-328X(98)00088-6; BAYLISS D A, 1990, Molecular and Cellular Neuroscience, V1, P3, DOI 10.1016/1044-7431(90)90036-4; BENINGTON JH, 1995, PROG NEUROBIOL, V45, P347, DOI 10.1016/0301-0082(94)00057-O; BERGMANN BM, 1989, SLEEP, V12, P31, DOI 10.1093/sleep/12.1.31; Blanco-Centurion C, 2007, J NEUROSCI, V27, P14041, DOI 10.1523/JNEUROSCI.3217-07.2007; Cannon B, 2004, PHYSIOL REV, V84, P277, DOI 10.1152/physrev.00015.2003; Caron AM, 2010, SLEEP, V33, P1226, DOI 10.1093/sleep/33.9.1226; CASTREN E, 1990, NEUROSCI LETT, V120, P113, DOI 10.1016/0304-3940(90)90181-8; Chisholm NC, 2012, ENDOCRINOLOGY, V153, P4874, DOI 10.1210/en.2012-1412; COHEN HB, 1965, SCIENCE, V150, P1318, DOI 10.1126/science.150.3701.1318; EVERSON CA, 1995, BEHAV BRAIN RES, V69, P43, DOI 10.1016/0166-4328(95)00009-I; Everson CA, 2004, AM J PHYSIOL-ENDOC M, V286, pE1060, DOI 10.1152/ajpendo.00553.2003; EVERSON CA, 1989, SLEEP, V12, P13, DOI 10.1093/sleep/12.1.13; Martins PJF, 2010, AM J PHYSIOL-ENDOC M, V298, pE726, DOI 10.1152/ajpendo.00660.2009; Gessa GL, 1995, EUR NEUROPSYCHOPHARM, V5, P89, DOI 10.1016/0924-977X(95)00023-I; Gotoh K, 2013, J NEUROCHEM, V125, P588, DOI 10.1111/jnc.12213; Gotoh K, 2013, J NEUROCHEM, V124, P90, DOI 10.1111/jnc.12066; Haas HL, 2008, PHYSIOL REV, V88, P1183, DOI 10.1152/physrev.00043.2007; Hipolide DC, 2006, J NEUROENDOCRINOL, V18, P231, DOI 10.1111/j.1365-2826.2006.01412.x; Hoffman GE, 2004, PEPTIDES, V25, P425, DOI 10.1016/j.peptides.2004.02.004; HOFFMAN GE, 1992, NEUROPROTOCOLS, V1, P52; Hoffman GE, 2008, CURR PROTOC NEUROSCI, DOI DOI 10.1002/0471142301; INAGAKI N, 1990, EXP BRAIN RES, V80, P374; KENDALL PA, 1971, EXPERIENTIA, V27, P1104, DOI 10.1007/BF02138909; KING JC, 1983, J HISTOCHEM CYTOCHEM, V31, P62, DOI 10.1177/31.1.6187805; KITAHAMA K, 1988, J COMP NEUROL, V270, P337, DOI 10.1002/cne.902700304; Koban M, 2006, ENDOCRINOLOGY, V147, P421, DOI 10.1210/en.2005-0695; Koban M, 2005, AM J PHYSIOL-ENDOC M, V289, pE68, DOI 10.1152/ajpendo.00543.2004; Koban M, 2008, SLEEP, V31, P927; KUSHIDA CA, 1989, SLEEP, V12, P22, DOI 10.1093/sleep/12.1.22; Galvao MDL, 2009, PSYCHONEUROENDOCRINO, V34, P1176, DOI 10.1016/j.psyneuen.2009.03.003; LIN JS, 1988, NEUROPHARMACOLOGY, V27, P111, DOI 10.1016/0028-3908(88)90159-1; LIN JS, 1989, BRAIN RES, V479, P225, DOI 10.1016/0006-8993(89)91623-5; Longordo F, 2009, EUR J NEUROSCI, V29, P1810, DOI 10.1111/j.1460-9568.2009.06719.x; Machado RB, 2004, BRAIN RES, V1004, P45, DOI 10.1016/j.brainres.2004.01.019; MADL JE, 1986, J HISTOCHEM CYTOCHEM, V34, P317, DOI 10.1177/34.3.2419390; Martins PJF, 2008, PHYSIOL BEHAV, V93, P229, DOI 10.1016/j.physbeh.2007.08.026; Martins PJF, 2011, NUTR METAB, V8, DOI 10.1186/1743-7075-8-86; Masaki T, 2004, DIABETES, V53, P2250, DOI 10.2337/diabetes.53.9.2250; MAZURKIEWICZKWILECKI IM, 1982, PHARMACOL BIOCHEM BE, V16, P591, DOI 10.1016/0091-3057(82)90421-X; MAZURKIEWICZKWILECKI IM, 1986, PHARMACOL BIOCHEM BE, V24, P513, DOI 10.1016/0091-3057(86)90550-2; MAZURKIEWICZKWILECKI IM, 1980, PHARMACOL BIOCHEM BE, V12, P35, DOI 10.1016/0091-3057(80)90412-8; Meerlo P, 2002, J NEUROENDOCRINOL, V14, P397, DOI 10.1046/j.0007-1331.2002.00790.x; Miklos IH, 2003, EUR J NEUROSCI, V18, P3069, DOI 10.1111/j.1460-9568.2003.03033.x; MIZUGUCHI H, 1990, BIOCHEM BIOPH RES CO, V173, P1299, DOI 10.1016/S0006-291X(05)80928-3; MONTI JM, 1986, J NEURAL TRANSM, V66, P1, DOI 10.1007/BF01262953; Morimoto T, 1999, PHYSIOL BEHAV, V67, P679, DOI 10.1016/S0031-9384(99)00123-7; PANULA P, 1984, P NATL ACAD SCI-BIOL, V81, P2572, DOI 10.1073/pnas.81.8.2572; PANULA P, 1988, J HISTOCHEM CYTOCHEM, V36, P259, DOI 10.1177/36.3.3343510; PANULA P, 1989, NEUROSCIENCE, V28, P585, DOI 10.1016/0306-4522(89)90007-9; PORKKAHEISKANEN T, 1995, AM J PHYSIOL-REG I, V268, pR1456, DOI 10.1152/ajpregu.1995.268.6.R1456; PORKKAHEISKANEN T, 1994, LIFE SCI, V54, P1719, DOI 10.1016/0024-3205(94)00612-1; Ramesh V, 2004, BEHAV BRAIN RES, V152, P271, DOI 10.1016/j.bbr.2003.10.031; RECHTSCHAFFEN A, 1983, SCIENCE, V221, P182, DOI 10.1126/science.6857280; Rechtschaffen A, 2002, SLEEP, V25, P18, DOI 10.1093/sleep/25.1.18; Sakata T, 2003, EXP BIOL MED, V228, P1106, DOI 10.1177/153537020322801002; Sakata T, 1997, NUTRITION, V13, P403, DOI 10.1016/S0899-9007(97)91277-6; Saper Clifford B, 2013, Continuum (Minneap Minn), V19, P19, DOI 10.1212/01.CON.0000427215.07715.73; Sarvari A, 2012, BRAIN RES, V1488, P72, DOI 10.1016/j.brainres.2012.10.010; Scharf MT, 2008, PROG NEUROBIOL, V86, P264, DOI 10.1016/j.pneurobio.2008.08.003; SCHWARTZ JC, 1991, PHYSIOL REV, V71, P1, DOI 10.1152/physrev.1991.71.1.1; Siegel JM, 2008, TRENDS NEUROSCI, V31, P208, DOI 10.1016/j.tins.2008.02.001; Soya A, 2008, NEUROSCI LETT, V430, P224, DOI 10.1016/j.neulet.2007.11.002; Strecker RE, 2002, NEUROSCIENCE, V113, P663, DOI 10.1016/S0306-4522(02)00158-6; Suchecki D, 2003, J NEUROENDOCRINOL, V15, P815, DOI 10.1046/j.1365-2826.2003.01067.x; Suchecki D, 1998, J SLEEP RES, V7, P276, DOI 10.1046/j.1365-2869.1998.00122.x; Szymusiak R, 2007, SLEEP MED, V8, P291, DOI 10.1016/j.sleep.2007.03.013; TAGUCHI Y, 1985, BRAIN RES, V340, P235, DOI 10.1016/0006-8993(85)90919-9; TAYLOR KM, 1971, SCIENCE, V172, P1037, DOI 10.1126/science.172.3987.1037; Thakkar MM, 2011, SLEEP MED REV, V15, P65, DOI 10.1016/j.smrv.2010.06.004; Ugrumov MV, 2009, J CHEM NEUROANAT, V38, P241, DOI 10.1016/j.jchemneu.2009.08.004; WAHLESTEDT C, 1985, AGENTS ACTIONS, V16, P231, DOI 10.1007/BF01983147; WATANABE T, 1983, NEUROSCI LETT, V39, P249, DOI 10.1016/0304-3940(83)90308-7; WATSON RE, 1986, PEPTIDES, V7, P155, DOI 10.1016/0196-9781(86)90076-8; Whyment AD, 2006, J NEUROPHYSIOL, V95, P2492, DOI 10.1152/jn.01135.2004; Yasuda T, 2004, NEUROSCIENCE, V125, P535, DOI 10.1016/j.neuroscience.2003.11.039; Yasuda T, 2004, NEUROSCI LETT, V362, P71, DOI 10.1016/j.neulet.2003.10.052; Zant JC, 2012, J NEUROSCI, V32, P13244, DOI 10.1523/JNEUROSCI.5933-11.2012	86	2	2	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2016	11	12							e0152252	10.1371/journal.pone.0152252	http://dx.doi.org/10.1371/journal.pone.0152252			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI9QF	27997552	Green Published, gold, Green Submitted			2022-12-27	WOS:000392842900001
J	Del Bene, VA; Foxe, JJ; Ross, LA; Krakowski, MI; Czobor, P; De Sanctis, P				Del Bene, Victor A.; Foxe, John J.; Ross, Lars A.; Krakowski, Menahem I.; Czobor, Pal; De Sanctis, Pierfilippo			Neuroanatomical Abnormalities in Violent Individuals with and without a Diagnosis of Schizophrenia	PLOS ONE			English	Article							ANTISOCIAL PERSONALITY-DISORDER; COGNITIVE NEUROSCIENCE PERSPECTIVE; BARRATT IMPULSIVENESS SCALE; SUPERIOR TEMPORAL SULCUS; AGGRESSION QUESTIONNAIRE; AUTOMATED SEGMENTATION; ALZHEIMERS-DISEASE; AMYGDALA VOLUMES; SERIOUS VIOLENCE; CHILDHOOD ABUSE	Several structural brain abnormalities have been associated with aggression in patients with schizophrenia. However, little is known about shared and distinct abnormalities underlying aggression in these subjects and non-psychotic violent individuals. We applied a region-of interest volumetric analysis of the amygdala, hippocampus, and thalamus bilaterally, as well as whole brain and ventricular volumes to investigate violent (n = 37) and non-violent chronic patients (n = 26) with schizophrenia, non-psychotic violent (n = 24) as well as healthy control subjects (n = 24). Shared and distinct volumetric abnormalities were probed by analysis of variance with the factors violence (non-violent versus violent) and diagnosis (non-psychotic versus psychotic), adjusted for substance abuse, age, academic achievement and negative psychotic symptoms. Patients showed elevated vCSF volume, smaller left hippocampus and smaller left thalamus volumes. This was particularly the case for non-violent individuals diagnosed with schizophrenia. Furthermore, patients had reduction in right thalamus size. With regard to left amygdala, we found an interaction between violence and diagnosis. More specifically, we report a double dissociation with smaller amygdala size linked to violence in non-psychotic individuals, while for psychotic patients smaller size was linked to non-violence. Importantly, the double dissociation appeared to be mostly driven by substance abuse. Overall, we found widespread morphometric abnormalities in subcortical regions in schizophrenia. No evidence for shared volumetric abnormalities in individuals with a history of violence was found. Finally, left amygdala abnormalities in non-psychotic violent individuals were largely accounted for by substance abuse. This might be an indication that the association between amygdala reduction and violence is mediated by substance abuse. Our results indicate the importance of structural abnormalities in aggressive individuals.	[Del Bene, Victor A.; Foxe, John J.; Ross, Lars A.; De Sanctis, Pierfilippo] Albert Einstein Coll Med, Dept Pediat, Sheryl & Daniel R Tishman Cognit Neurophysiol Lab, CERC, Van Etten, NY USA; [Del Bene, Victor A.; Foxe, John J.; Ross, Lars A.; De Sanctis, Pierfilippo] Albert Einstein Coll Med, Dept Neurosci, Sheryl & Daniel R Tishman Cognit Neurophysiol Lab, CERC, Van Etten, NY USA; [Del Bene, Victor A.] Albert Einstein Coll Med, Ferkauf Grad Sch Psychol, Bronx, NY 10467 USA; [Foxe, John J.; Krakowski, Menahem I.; De Sanctis, Pierfilippo] Nathan S Kline Inst Psychiat Res, Orangeburg, NY 10962 USA; [Foxe, John J.] Univ Rochester, Med Ctr, Dept Neurobiol & Anat, Ernest J Del Monte Inst Neuromed, Rochester, NY 14642 USA; [Krakowski, Menahem I.] NYU, Dept Psychiat, Langone Med Ctr, 550 1St Ave, New York, NY 10016 USA; [Czobor, Pal] Semmelweis Univ, Dept Psychiat, UlloiWay 26, Budapest, Hungary; [Czobor, Pal] Semmelweis Univ, Dept Psychotherapy, UlloiWay 26, Budapest, Hungary; [De Sanctis, Pierfilippo] Feinstein Inst Med Res, Ctr Psychiat Neurosci, Manhasset, NY 11030 USA; [De Sanctis, Pierfilippo] Zucker Hillside Hosp, Hofstra Northwell Sch Med, Dept Psychiat, Glen Oaks, NY 11004 USA	Yeshiva University; Albert Einstein College of Medicine; Nathan Kline Institute for Psychiatric Research; University of Rochester; New York University; NYU Langone Medical Center; Semmelweis University; Semmelweis University; Northwell Health; Northwell Health	Foxe, JJ; De Sanctis, P (corresponding author), Albert Einstein Coll Med, Dept Pediat, Sheryl & Daniel R Tishman Cognit Neurophysiol Lab, CERC, Van Etten, NY USA.; Foxe, JJ; De Sanctis, P (corresponding author), Albert Einstein Coll Med, Dept Neurosci, Sheryl & Daniel R Tishman Cognit Neurophysiol Lab, CERC, Van Etten, NY USA.; Foxe, JJ; De Sanctis, P (corresponding author), Nathan S Kline Inst Psychiat Res, Orangeburg, NY 10962 USA.; Foxe, JJ (corresponding author), Univ Rochester, Med Ctr, Dept Neurobiol & Anat, Ernest J Del Monte Inst Neuromed, Rochester, NY 14642 USA.; De Sanctis, P (corresponding author), Feinstein Inst Med Res, Ctr Psychiat Neurosci, Manhasset, NY 11030 USA.; De Sanctis, P (corresponding author), Zucker Hillside Hosp, Hofstra Northwell Sch Med, Dept Psychiat, Glen Oaks, NY 11004 USA.	John_Foxe@urmc.rochester.edu; pierfilippo.sanctis@einstein.yu.edu	Del Bene, Victor/AAD-8017-2021		U.S. National Institute of Mental Health [R01, MH74767];  [MH85322]	U.S. National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); 	Primary support for this work was provided by an R01 grant from the U.S. National Institute of Mental Health (MH74767). Additional support was derived from MH85322.	AGGLETON JP, 1980, BRAIN RES, V190, P347, DOI 10.1016/0006-8993(80)90279-6; Association AP DSM-IV APA on, 2000, DIAGN STAT MAN MENT; Barkataki I, 2006, BEHAV BRAIN RES, V169, P239, DOI 10.1016/j.bbr.2006.01.009; BAYLIS GC, 1985, BRAIN RES, V342, P91, DOI 10.1016/0006-8993(85)91356-3; Bilder RM, 2002, BIOL PSYCHIAT, V52, P701, DOI 10.1016/S0006-3223(02)01416-6; Blair RJR, 2005, DEV PSYCHOPATHOL, V17, P865, DOI 10.1017/S0954579405050418; Bobes Leon MA, 2013, PSYCHOPHYSIOLOGY; Bora E, 2011, SCHIZOPHR RES, V127, P46, DOI 10.1016/j.schres.2010.12.020; Buckholtz JW, 2008, TRENDS NEUROSCI, V31, P120, DOI 10.1016/j.tins.2007.12.006; Bufkin JL, 2005, TRAUMA VIOLENCE ABUS, V6, P176, DOI 10.1177/1524838005275089; BUSS AH, 1992, J PERS SOC PSYCHOL, V63, P452, DOI 10.1037/0022-3514.63.3.452; Chen YB, 2012, HUM GENET, V131, P1081, DOI 10.1007/s00439-011-1131-5; Coccaro EF, 1997, PSYCHIAT RES, V73, P147, DOI 10.1016/S0165-1781(97)00119-4; Coccaro EF, 1996, ANN NY ACAD SCI, V794, P82, DOI 10.1111/j.1749-6632.1996.tb32511.x; Coccaro EF, 2015, CNS SPECTRUMS, V20, P295, DOI 10.1017/S1092852915000310; Davatzikos C, 2005, ARCH GEN PSYCHIAT, V62, P1218, DOI 10.1001/archpsyc.62.11.1218; Davidson RJ, 2000, SCIENCE, V289, P591, DOI 10.1126/science.289.5479.591; de Jong LW, 2008, BRAIN, V131, P3277, DOI 10.1093/brain/awn278; De Luca V, 2006, BRAIN RES, V1097, P26, DOI 10.1016/j.brainres.2006.04.053; Denson TF, 2012, CURR DIR PSYCHOL SCI, V21, P20, DOI 10.1177/0963721411429451; Derogatis L. R., 1977, SCL 90 MANUAL SCORIN; DeWall CN, 2011, SOC PERSONAL PSYCHOL, V5, P458; Ermer E, 2012, J ABNORM PSYCHOL, V121, P649, DOI 10.1037/a0026371; Fairchild G, 2011, AM J PSYCHIAT, V168, P624, DOI 10.1176/appi.ajp.2010.10081184; Fazel S, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000120; First MB., 1997, USERS GUIDE STRUCTUR; Foxe J., 2012, SOCIAL COGNITIVE AFF; Frazzetto G, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000486; Harris JA, 1997, BEHAV RES THER, V35, P1047, DOI 10.1016/S0005-7967(97)00064-8; Heatherton TF, 2011, ANNU REV PSYCHOL, V62, P363, DOI 10.1146/annurev.psych.121208.131616; Hoptman MJ, 2014, AM J PSYCHIAT, V171, P939, DOI 10.1176/appi.ajp.2014.13111553; Hoptman MJ, 2010, SCHIZOPHRENIA BULL, V36, P1020, DOI 10.1093/schbul/sbp012; Hygen BW, 2015, DEV PSYCHOL, V51, P1098, DOI 10.1037/dev0000020; Iidaka T, 2014, JPN PSYCHOL RES, V56, P33, DOI 10.1111/jpr.12018; Jenkinson M, 2002, NEUROIMAGE, V17, P825, DOI 10.1006/nimg.2002.1132; Jenkinson M, 2001, MED IMAGE ANAL, V5, P143, DOI 10.1016/S1361-8415(01)00036-6; Jonsson EG, 2003, SCHIZOPHR RES, V61, P31, DOI 10.1016/S0920-9964(02)00224-4; Kane JA, 2003, J CLIN PSYCHIAT, V64, P5; KAY SR, 1987, SCHIZOPHRENIA BULL, V13, P261, DOI 10.1093/schbul/13.2.261; Kiehl KA, 2006, PSYCHIAT RES, V142, P107, DOI 10.1016/j.psychres.2005.09.013; Kim JJ, 2003, SCHIZOPHR RES, V60, P173, DOI 10.1016/S0920-9964(02)00299-2; Kotler M, 1999, AM J MED GENET, V88, P628, DOI 10.1002/(SICI)1096-8628(19991215)88:6<628::AID-AJMG10>3.0.CO;2-E; Krakowski M., 2003, J NEUROPSYCHIATRY CL; Krakowski MI, 2016, SCHIZOPHRENIA BULL, V42, P963, DOI 10.1093/schbul/sbw005; Krakowski MI, 2014, SCHIZOPHRENIA BULL, V40, P886, DOI 10.1093/schbul/sbt117; Kumari V, 2013, EUR PSYCHIAT, V28, P225, DOI 10.1016/j.eurpsy.2012.03.002; Kumari V, 2009, PSYCHIAT RES-NEUROIM, V173, P39, DOI 10.1016/j.pscychresns.2008.09.003; Kumari V, 2009, SCHIZOPHR RES, V110, P47, DOI 10.1016/j.schres.2009.01.009; Li T, 1996, PSYCHIAT GENET, V6, P131, DOI 10.1097/00041444-199623000-00005; Matthies S, 2012, WORLD J BIOL PSYCHIA, V13, P75, DOI 10.3109/15622975.2010.541282; Morey RA, 2010, HUM BRAIN MAPP, V31, P1751, DOI 10.1002/hbm.20973; Morey RA, 2009, NEUROIMAGE, V45, P855, DOI 10.1016/j.neuroimage.2008.12.033; Mullen PE, 2000, LANCET, V355, P614, DOI 10.1016/S0140-6736(99)05082-5; Nederlof AF, 2013, AGGRESS VIOLENT BEH, V18, P183, DOI 10.1016/j.avb.2012.11.018; Niu L, 2004, PSYCHIAT RES-NEUROIM, V132, P41, DOI 10.1016/j.pscychresns.2004.06.002; Pardini DA, 2014, BIOL PSYCHIAT, V75, P73, DOI 10.1016/j.biopsych.2013.04.003; Patenaude B, 2011, NEUROIMAGE, V56, P907, DOI 10.1016/j.neuroimage.2011.02.046; Patton JH, 1995, J CLIN PSYCHOL, V51, P768, DOI 10.1002/1097-4679(199511)51:6<768::AID-JCLP2270510607>3.0.CO;2-1; PERALTA V, 1994, PSYCHIAT RES, V53, P31, DOI 10.1016/0165-1781(94)90093-0; Raine A, 2006, AGGRESSIVE BEHAV, V32, P159, DOI 10.1002/ab.20115; Rajarethinam RP, 2000, SCHIZOPHR RES, V41, P303, DOI 10.1016/S0920-9964(99)00083-3; Roalf DR, 2016, SCHIZOPHRENIA B; Roberton T, 2012, AGGRESS VIOLENT BEH, V17, P72, DOI 10.1016/j.avb.2011.09.006; Rogers JC, 2016, JAMA PSYCHIAT, V73, P64, DOI 10.1001/jamapsychiatry.2015.2423; Salekin RT, 1996, CLIN PSYCHOL-SCI PR, V3, P203, DOI 10.1111/j.1468-2850.1996.tb00071.x; Sexton CE, 2010, PSYCHIAT RES-NEUROIM, V184, P57, DOI 10.1016/j.pscychresns.2010.07.005; Shepherd AM, 2012, NEUROSCI BIOBEHAV R, V36, P1342, DOI 10.1016/j.neubiorev.2011.12.015; Shifman S, 2004, AM J MED GENET B, V128B, P61, DOI 10.1002/ajmg.b.30032; Shifman S, 2002, AM J HUM GENET, V71, P1296, DOI 10.1086/344514; Siever LJ, 2008, AM J PSYCHIAT, V165, P429, DOI 10.1176/appi.ajp.2008.07111774; Smith SM, 2002, NEUROIMAGE, V17, P479, DOI 10.1006/nimg.2002.1040; Smith SM, 2001, J COMPUT ASSIST TOMO, V25, P466, DOI 10.1097/00004728-200105000-00022; Smith SM, 2004, NEUROIMAGE, V23, pS208, DOI 10.1016/j.neuroimage.2004.07.051; Smith SM, 2007, NEUROIMAGE, V36, P1200, DOI 10.1016/j.neuroimage.2007.04.035; Stanford MS, 2009, PERS INDIV DIFFER, V47, P385, DOI 10.1016/j.paid.2009.04.008; Steen RG, 2006, BRIT J PSYCHIAT, V188, P510, DOI 10.1192/bjp.188.6.510; Swanson JW, 2006, ARCH GEN PSYCHIAT, V63, P490, DOI 10.1001/archpsyc.63.5.490; Tanskanen P, 2009, PSYCHIAT RES-NEUROIM, V174, P116, DOI 10.1016/j.pscychresns.2009.04.009; van Elst LT, 2000, BRAIN, V123, P234, DOI 10.1093/brain/123.2.234; van Erp TGM, 2016, MOL PSYCHIATR, V21, P547, DOI 10.1038/mp.2015.63; Velakoulis D, 2006, ARCH GEN PSYCHIAT, V63, P139, DOI 10.1001/archpsyc.63.2.139; Veroude K, 2015, AM J MED GENETICS B; Widom CS, 2006, BIOL PSYCHIAT, V60, P684, DOI 10.1016/j.biopsych.2006.03.039; Wilkinson G., 2006, REHABIL COUNS BULL, V52, P57, DOI [DOI 10.1177/0034355208320076, 10.1177/0034355208320076]; WONG MTH, 1994, ACTA PSYCHIAT SCAND, V90, P97, DOI 10.1111/j.1600-0447.1994.tb01562.x; Yang YL, 2010, PSYCHIAT RES-NEUROIM, V182, P9, DOI 10.1016/j.pscychresns.2009.10.013; Yang YL, 2009, ARCH GEN PSYCHIAT, V66, P986, DOI 10.1001/archgenpsychiatry.2009.110; Zammit S, 2004, AM J MED GENET B, V128B, P19, DOI 10.1002/ajmg.b.30021	88	17	17	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2016	11	12							e0168100	10.1371/journal.pone.0168100	http://dx.doi.org/10.1371/journal.pone.0168100			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EG7JB	28030584	gold, Green Submitted, Green Published			2022-12-27	WOS:000391222000034
J	Grellety, E; Golden, MH				Grellety, Emmanuel; Golden, Michael H.			The Effect of Random Error on Diagnostic Accuracy Illustrated with the Anthropometric Diagnosis of Malnutrition	PLOS ONE			English	Article							AGE MISSTATEMENT; YOUNG-CHILDREN; RELIABILITY; NUTRITION; QUALITY	Background It is often thought that random measurement error has a minor effect upon the results of an epidemiological survey. Theoretically, errors of measurement should always increase the spread of a distribution. Defining an illness by having a measurement outside an established healthy range will lead to an inflated prevalence of that condition if there are measurement errors. Methods and results A Monte Carlo simulation was conducted of anthropometric assessment of children with malnutrition. Random errors of increasing magnitude were imposed upon the populations and showed that there was an increase in the standard deviation with each of the errors that became exponentially greater with the magnitude of the error. The potential magnitude of the resulting error of reported prevalence of malnutrition were compared with published international data and found to be of sufficient magnitude to make a number of surveys and the numerous reports and analyses that used these data unreliable. Conclusions The effect of random error in public health surveys and the data upon which diagnostic cutoff points are derived to define "health" has been underestimated. Even quite modest random errors can more than double the reported prevalence of conditions such as malnutrition. Increasing sample size does not address this problem, and may even result in less accurate estimates. More attention needs to be paid to the selection, calibration and maintenance of instruments, measurer selection, training & supervision, routine estimation of the likely magnitude of errors using standardization tests, use of statistical likelihood of error to exclude data from analysis and full reporting of these procedures in order to judge the reliability of survey reports.	[Grellety, Emmanuel] Univ Libre Bruxelles, Sch Publ Hlth, Res Ctr Hlth Policy & Syst Int Hlth, Brussels, Belgium; [Golden, Michael H.] Univ Aberdeen, Dept Med & Therapeut, Aberdeen, Scotland	Universite Libre de Bruxelles; University of Aberdeen	Grellety, E (corresponding author), Univ Libre Bruxelles, Sch Publ Hlth, Res Ctr Hlth Policy & Syst Int Hlth, Brussels, Belgium.	Emmanuel.Grellety.Bosviel@ulb.ac.be	Golden, Michael/AAB-8989-2020	Golden, Michael/0000-0002-4039-7538; Grellety Bosviel, Emmanuel/0000-0001-9736-414X	Nutriset	Nutriset	Nutriset provided a PhD maintenance studentship to Universite Libre de Bruxelles in support of EG. No funds were provided to support any aspect of research or publication. Nutriset had no role in any aspect of this research including data collection, design, analysis, interpretation or writing of the article and does not require prior notification of publication.	[Anonymous], 1995, PHYS STAT US INT ANT; BAIRAGI R, 1987, AM J PUBLIC HEALTH, V77, P280, DOI 10.2105/AJPH.77.3.280; BAIRAGI R, 1982, DEMOGRAPHY, V19, P447, DOI 10.2307/2061012; BAIRAGI R, 1986, AM J EPIDEMIOL, V123, P185, DOI 10.1093/oxfordjournals.aje.a114213; BAIRAGI R, 1982, AM J PHYS ANTHROPOL, V58, P331, DOI 10.1002/ajpa.1330580311; BAIRAGI R, 1991, Genus, V47, P193; Bakwin H, 1931, J CLIN INVEST, V10, P369, DOI 10.1172/JCI100357; Bayley N, 1935, BIOMETRIKA, V27, P26, DOI 10.1093/biomet/27.1-2.26; BYERLEE D, 1981, POP STUD-J DEMOG, V35, P455, DOI 10.1080/00324728.1981.11878517; CALDWELL JC, 1966, DEMOGRAPHY, V3, P477, DOI 10.2307/2060173; Crowe S, 2014, PEERJ, V2, DOI 10.7717/peerj.380; Onis M, 2006, ACTA PAEDIATR, V95, P7, DOI 10.1080/08035320500495407; de Onis Mercedes, 2004, Food Nutr Bull, V25, pS27; Dunlop JC, 1923, J R STAT SOC, V86, P547, DOI 10.2307/2341695; Edmonston B, 1981, Rural Demogr, V8, P63; ELLOZY M, 1976, AM J CLIN NUTR, V29, P585, DOI 10.1093/ajcn/29.5.585; Erhardt J, ENA FOR SMART 2016; Fabic MS, 2012, B WORLD HEALTH ORGAN, V90, P604, DOI 10.2471/BLT.11.095513; Golden MH, 2015, SMART PLAUSIBILITY C; Golden MH, 2002, POPULATION NUTR STAT; Golden MH, 2006, SMART METHODOLOGY ME; Grellety E, 2016, BMC NUTR, V2; Harris EF, 2009, ARCH ORAL BIOL, V54, pS107, DOI 10.1016/j.archoralbio.2008.04.010; HESSEL PA, 1986, INT J EPIDEMIOL, V15, P122, DOI 10.1093/ije/15.1.122; HIMES JH, 1989, AM J PHYS ANTHROPOL, V79, P77, DOI 10.1002/ajpa.1330790108; Hood GM, 2016, POPTOOLS VERSION 3 2; Kostermans K, 1993, 101 WORLD BANK; Kouchi M, 1999, J Hum Ergol (Tokyo), V28, P15; Kouchi M, 1996, J Hum Ergol (Tokyo), V25, P155; Lipman TH, 2004, ARCH DIS CHILD, V89, P342, DOI 10.1136/adc.2003.030072; Matsumoto M, 2016, MERSENNE TWISTER ALG; Mei ZG, 2007, B WORLD HEALTH ORGAN, V85, P441, DOI 10.2471/BLT.06.034421; Mueller WH, 1988, ANTHROPOMETRIC STAND, P83; MURPHY EA, 1964, J CHRON DIS, V17, P301, DOI 10.1016/0021-9681(64)90073-6; Myatt M, 2004, RESPONSE SURVEY SD V; Onyango AW, 2006, ACTA PAEDIATR, V95, P38, DOI 10.1080/08035320500494464; OSHAUG A, 1994, J NUTR, V124, P636, DOI 10.1093/jn/124.5.636; Prudhon C, 2007, EMERG THEMES EPIDEMI, V4, DOI 10.1186/1742-7622-4-10; Pullum TW, 2008, ASSESSMENT QUALITY D; SENG YP, 1959, POP STUD-J DEMOG, V13, P164, DOI 10.2307/2172409; Siklar Z, 2005, PEDIATR INT, V47, P645, DOI 10.1111/j.1442-200x.2005.02144.x; Spiegel PB, 2007, EMERG THEMES EPIDEMI, V4, DOI 10.1186/1742-7622-4-12; Spiegel PB, 2004, JAMA-J AM MED ASSOC, V292, P613, DOI 10.1001/jama.292.5.613; Stoddard GD, 1933, REV EDUC RES, V3, P130; SWEEHOCK S, 1967, DEMOGRAPHY, V4, P859, DOI 10.2307/2060325; Ulijaszek SJ, 1999, BRIT J NUTR, V82, P165, DOI 10.1017/S0007114599001348; Ulijaszek SJ, 1997, COLLEGIUM ANTROPOL, V21, P429; WHO, 2016, WHO GLOB DAT CHILD G; WHO, 2006, WHO CHILD GROWTH STA; World Health Organization, 2000, MAN NUTR MAJ EM; World Health Organization, 2016, WHO CHILD GROWTH STA	51	25	25	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2016	11	12							e0168585	10.1371/journal.pone.0168585	http://dx.doi.org/10.1371/journal.pone.0168585			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EG7JB	28030627	Green Submitted, Green Published, gold			2022-12-27	WOS:000391222000059
J	Hooli, S; Colbourn, T; Lufesi, N; Costello, A; Nambiar, B; Thammasitboon, S; Makwenda, C; Mwansambo, C; McCollum, ED; King, C				Hooli, Shubhada; Colbourn, Tim; Lufesi, Norman; Costello, Anthony; Nambiar, Bejoy; Thammasitboon, Satid; Makwenda, Charles; Mwansambo, Charles; McCollum, Eric D.; King, Carina			Predicting Hospitalised Paediatric Pneumonia Mortality Risk: An External Validation of RISC and mRISC, and Local Tool Development (RISC-Malawi) from Malawi	PLOS ONE			English	Article							CHILDREN; QUALITY; CRITERIA; DISEASES; CARE	Background Pneumonia is the leading infectious cause of under-5 mortality in sub-Saharan Africa. Clinical prediction tools may aide case classification, triage, and allocation of hospital resources. We performed an external validation of two published prediction tools and compared this to a locally developed tool to identify children admitted with pneumonia at increased risk for in hospital mortality in Malawi. Methods We retrospectively analyzed the performance of the Respiratory Index of Severity in Children (RISC) and modified RISC (mRISC) scores in a child pneumonia dataset prospectively collected during routine care at seven hospitals in Malawi between 2011-2014. RISC has both an HIV-infected and HIV-uninfected tool. A local score (RISC-Malawi) was developed using multivariable logistic regression with missing data multiply imputed using chained equations. Score performances were assessed using c-statistics, sensitivity, specificity, positive predictive value, negative predictive value, and likelihood statistics. Results 16,475 in-patient pneumonia episodes were recorded (case-fatality rate (CFR): 3.2%), 9,533 with complete data (CFR: 2.0%). The c-statistic for the RISC (HIV-uninfected) score, used to assess its ability to differentiate between children who survived to discharge and those that died, was 0.72. The RISC-Malawi score, using mid-upper arm circumference as an indicator of malnutrition severity, had a c-statistic of 0.79. We were unable to perform a comprehensive external validation of RISC (HIV-infected) and mRISC as both scores include parameters that were not routinely documented variables in our dataset. Conclusion In our population of Malawian children with WHO-defined pneumonia, the RISC (HIV-uninfected) score identified those at high risk for in-hospital mortality. However the refinement of parameters and resultant creation of RISC-Malawi improved performance. Next steps include prospectively studying both scores to determine if incorporation into routine care delivery can have a meaningful impact on in-hospital CFRs of children with WHO-defined pneumonia.	[Hooli, Shubhada; Thammasitboon, Satid] Baylor Coll Med, Dept Pediat, Sect Crit Care Med, Houston, TX 77030 USA; [Hooli, Shubhada; Thammasitboon, Satid] Texas Childrens Hosp, Houston, TX 77030 USA; [Hooli, Shubhada] Baylor Coll Med, Dept Pediat, Sect Emergency Med, Houston, TX 77030 USA; [Colbourn, Tim; Costello, Anthony; Nambiar, Bejoy; McCollum, Eric D.; King, Carina] UCL, Inst Global Hlth, London, England; [Lufesi, Norman; Mwansambo, Charles] Minist Hlth, Lilongwe, Malawi; [Makwenda, Charles] Parent & Child Hlth Initiat, Lilongwe, Malawi; [McCollum, Eric D.] Johns Hopkins Sch Med, Div Pulmonol, Dept Pediat, Baltimore, MD USA	Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; University of London; University College London; Johns Hopkins University; Johns Hopkins Medicine	Hooli, S (corresponding author), Baylor Coll Med, Dept Pediat, Sect Crit Care Med, Houston, TX 77030 USA.; Hooli, S (corresponding author), Texas Childrens Hosp, Houston, TX 77030 USA.; Hooli, S (corresponding author), Baylor Coll Med, Dept Pediat, Sect Emergency Med, Houston, TX 77030 USA.; King, C (corresponding author), UCL, Inst Global Hlth, London, England.	Shubhada.hooli@gmail.com; c.king@ucl.ac.uk	Colbourn, Tim/AAE-6645-2019; McCollum, Eric D./AAE-7120-2020	Colbourn, Tim/0000-0002-6917-6552; Nambiar, Bejoy/0000-0002-1742-522X; Thammasitboon, Satid/0000-0001-6896-092X	Bill and Melinda Gates Foundation [23591]; FOGARTY INTERNATIONAL CENTER [K01TW009988] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL072748] Funding Source: NIH RePORTER	Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	Funding was provided by the Bill and Melinda Gates Foundation [#23591] www.gatesfoundation.org. Funding was received by AC, TC, EDM, BN, and C Makwenda. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2011, IMPACT INNOVATIVE AP; [Anonymous], 2000, APPL LOGISTIC REGRES; Bassat Q, 2011, AM J TROP MED HYG, V85, P626, DOI 10.4269/ajtmh.2011.11-0223; Bjornstad E, 2014, PAEDIATR INT CHILD H, V34, P29, DOI 10.1179/2046905513Y.0000000070; Chisti MJ, 2009, TROP MED INT HEALTH, V14, P1173, DOI 10.1111/j.1365-3156.2009.02364.x; Djelantik IGG, 2003, J TROP PEDIATRICS, V49, P327, DOI 10.1093/tropej/49.6.327; Emukule GO, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092968; Enarson PM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0133365; Enarson PM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102955; Enarson PM, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000137; Fleming S, 2011, LANCET, V377, P1011, DOI 10.1016/S0140-6736(10)62226-X; Kanyuka M, 2016, LANCET GLOB HEALTH, V4, pE201, DOI 10.1016/S2214-109X(15)00294-6; Kelly MS, 2015, J PEDIAT INF DIS SOC, V4, pE117, DOI 10.1093/jpids/piu092; Lazzerini M, 2016, LANCET GLOB HEALTH, V4, pE57, DOI 10.1016/S2214-109X(15)00215-6; Liu L, 2015, LANCET, V385, P430, DOI 10.1016/S0140-6736(14)61698-6; Lufesi NN, 2007, BMC HEALTH SERV RES, V7, DOI 10.1186/1472-6963-7-86; Lupisan SP, 2007, TROP MED INT HEALTH, V12, P962, DOI 10.1111/j.1365-3156.2007.01872.x; McCollum ED, 2013, T ROY SOC TROP MED H, V107, P285, DOI 10.1093/trstmh/trt017; Meyers T, 2012, JAIDS-J ACQ IMM DEF, V60, P503, DOI 10.1097/QAI.0b013e318256b4f8; Olson D, 2013, TROP MED INT HEALTH, V18, P879, DOI 10.1111/tmi.12114; Preidis GA, 2011, J PEDIATR-US, V159, P484, DOI 10.1016/j.jpeds.2011.02.033; Ramachandran P, 2012, INDIAN PEDIATR, V49, P889, DOI 10.1007/s13312-012-0221-3; Reed C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0027793; Sehgal V, 1997, Indian Pediatr, V34, P213; Sinunu MA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100741; Sullivan LM, 2004, STAT MED, V23, P1631, DOI 10.1002/sim.1742; Tiewsoh K, 2009, BMC PEDIATR, V9, DOI 10.1186/1471-2431-9-15; White IR, 2011, STAT MED, V30, P377, DOI 10.1002/sim.4067; Wiens MO, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066698; World Bank, GDP PER CAP CURR US	30	40	42	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2016	11	12							e0168126	10.1371/journal.pone.0168126	http://dx.doi.org/10.1371/journal.pone.0168126			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EG7JB	28030608	Green Submitted, Green Published, gold			2022-12-27	WOS:000391222000037
J	Ribeiro, ALP; Hotta, LK				Ribeiro, Andre L. P.; Hotta, Luiz K.			Estimation of the Heteroskedastic Canonical Contagion Model with Instrumental Variables	PLOS ONE			English	Article							SPECIFICATION	Knowledge of contagion among economies is a relevant issue in economics. The canonical model of contagion is an alternative in this case. Given the existence of endogenous variables in the model, instrumental variables can be used to decrease the bias of the OLS estimator. In the presence of heteroskedastic disturbances this paper proposes the use of conditional volatilities as instruments. Simulation is used to show that the homoscedastic and heteroskedastic estimators which use them as instruments have small bias. These estimators are preferable in comparison with the OLS estimator and their asymptotic distribution can be used to construct confidence intervals.	[Ribeiro, Andre L. P.] Banco Itau Unibanco, Sao Paulo, SP, Brazil; [Hotta, Luiz K.] Univ Estadual Campinas, Dept Stat, Campinas, SP, Brazil	Universidade Estadual de Campinas	Hotta, LK (corresponding author), Univ Estadual Campinas, Dept Stat, Campinas, SP, Brazil.	hotta@ime.unicamp.br	Hotta, Luiz K./D-4985-2012	Hotta, Luiz K./0000-0002-1005-602X	Sao Paulo Research Foundation (FAPESP) [2013/00506-1, 2013/22930-0]; CNPq; Capes	Sao Paulo Research Foundation (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Capes(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	This work was supported by Sao Paulo Research Foundation (FAPESP) 2013/00506-1 and 2013/22930-0, CNPq, Capes.	Abbara OMF, 2009, THESIS; Anderson TW, 2010, J ECONOMETRICS, V157, P191, DOI 10.1016/j.jeconom.2009.12.001; Baum C.F., 2012, UK STAT US GROUP M; BOUND J, 1995, J AM STAT ASSOC, V90, P443, DOI 10.2307/2291055; CRAGG JG, 1993, ECONOMET THEOR, V9, P222, DOI 10.1017/S0266466600007519; Davidson R., 2004, ECONOMETRIC THEORY M; Hahn J, 2002, ECONOMETRICA, V70, P163, DOI 10.1111/1468-0262.00272; Hausman J, 2005, ECON LETT, V89, P333, DOI 10.1016/j.econlet.2005.06.007; Lewbel A, 2012, J BUS ECON STAT, V30, P67, DOI 10.1080/07350015.2012.643126; Metiu N, 2012, ECON LETT, V117, P35, DOI 10.1016/j.econlet.2012.04.074; Milunovich G, 2013, J TIME SER ECONOM, V5, P117, DOI 10.1515/jtse-2013-0010; NELSON CR, 1990, J BUS, V63, pS125, DOI 10.1086/296497; Pesaran MH, 2007, J ECON DYN CONTROL, V31, P1245, DOI 10.1016/j.jedc.2006.03.008; Pick A., 2007, 1392007 NED BANK; Ribeiro ALP, 2013, INT REV FINANC ANAL, V29, P62, DOI 10.1016/j.irfa.2013.03.014; Rigobon R, 2003, REV ECON STAT, V85, P777, DOI 10.1162/003465303772815727; Shin DW, 2016, COMMUN STAT-SIMUL C, V45, P378, DOI 10.1080/03610918.2013.864764; Staiger D, 1997, ECONOMETRICA, V65, P557, DOI 10.2307/2171753; Stock, 2005, IDENTIFICATION INFER; Wooldridge J., 2002, ECONOMETRIC ANAL CRO	20	0	0	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2016	11	12							e0168967	10.1371/journal.pone.0168967	http://dx.doi.org/10.1371/journal.pone.0168967			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EG7JB	28030628	Green Published, Green Submitted, gold			2022-12-27	WOS:000391222000092
J	Satani, N; Lin, YH; Hammoudi, N; Raghavan, S; Georgiou, DK; Muller, FL				Satani, Nikunj; Lin, Yu-Hsi; Hammoudi, Naima; Raghavan, Sudhir; Georgiou, Dimitra K.; Muller, Florian L.			ENOblock Does Not Inhibit the Activity of the Glycolytic Enzyme Enolase	PLOS ONE			English	Article							COMPLEX; CANCER	Inhibition of glycolysis is of great potential for the treatment of cancer. However, inhibitors of glycolytic enzymes with favorable pharmacological profiles have not been forthcoming. Due to the nature of their active sites, most high-affinity transition-state analogue inhibitors of glycolysis enzymes are highly polar with poor cell permeability. A recent publication reported a novel, non-active site inhibitor of the glycolytic enzyme Enolase, termed ENOblock (N-[2-[2-2-aminoethoxy)ethoxy]ethyl]4-4-cyclohexylmethyl)amino]6-4-fluorophenyl) methyl]amino]1,3,5-triazin-2-yl]amino]benzeneacetamide). This would present a major advance, as this is heterocyclic and fully cell permeable molecule. Here, we present evidence that ENOblock does not inhibit Enolase enzymatic activity in vitro as measured by three different assays, including a novel P-31 NMR based method which avoids complications associated with optical interferences in the UV range. Indeed, we note that due to strong UV absorbance, ENOblock interferes with the direct spectrophotometric detection of the product of Enolase, phosphoenolpyruvate. Unlike established Enolase inhibitors, ENOblock does not show selective toxicity to ENO1-deleted glioma cells in culture. While our data do not dispute the biological effects previously attributed to ENOblock, they indicate that such effects must be caused by mechanisms other than direct inhibition of Enolase enzymatic activity.	[Satani, Nikunj] UTHealth, Dept Neurol, McGovern Med Sch, Houston, TX USA; [Satani, Nikunj; Lin, Yu-Hsi; Hammoudi, Naima; Raghavan, Sudhir; Georgiou, Dimitra K.; Muller, Florian L.] Univ Texas MD Anderson Canc Ctr, Dept Canc Syst Imaging, Houston, TX 77030 USA	University of Texas System; University of Texas Health Science Center Houston; University of Texas System; UTMD Anderson Cancer Center	Muller, FL (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Canc Syst Imaging, Houston, TX 77030 USA.	fmuller@mdanderson.org	Satani, Nikunj/U-1119-2017; Raghavan, Sudhir/C-8871-2011	Satani, Nikunj/0000-0003-3908-3731; Muller, Florian/0000-0001-7568-2948; Raghavan, Sudhir/0000-0001-5449-362X	CPRIT Grant [RP140612]; NIH CDP SPORE Grant [P50CA12700107];  [RSG1514501CDD]; NATIONAL CANCER INSTITUTE [P30CA016672, P50CA127001] Funding Source: NIH RePORTER	CPRIT Grant; NIH CDP SPORE Grant; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by: 1) CPRIT Grant: RP140612 (Ronald DePinho); 2) NIH CDP SPORE Grant: P50CA12700107 (F.L.M.); 3) Research Scholar Grant: RSG1514501CDD (F.L.M.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alahuhta M, 2010, PROTEINS, V78, P1878, DOI 10.1002/prot.22701; ANDERSON VE, 1984, BIOCHEMISTRY-US, V23, P2779, DOI 10.1021/bi00307a038; Dax C, 2006, J MED CHEM, V49, P1499, DOI 10.1021/jm050237b; Duncan CG, 2010, ONCOTARGET, V1, P265, DOI 10.18632/oncotarget.137; Erion DM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097139; Gomes Dias SM, 2007, FEBS J, V274, P5077, DOI [10.1111/j.1742-4658.2007.06027.x, DOI 10.1111/J.1742-4658.2007.06027.X]; Hanaya T, 2011, HETEROCYCLES, V82, P1675, DOI 10.3987/COM-10-S(E)80; Jung DW, 2013, ACS CHEM BIOL, V8, P1271, DOI 10.1021/cb300687k; Leonard PG, 2016, NAT CHEM BIOL; Locasale JW, 2010, CELL CYCLE, V9, P4253, DOI 10.4161/cc.9.21.13925; Muller F, 2012, VITRO ENZYMATIC ACTI; Muller F, 2016, US patent, Patent No. [WO2016145113 A1, 2016145113]; Muller FL, 2012, NATURE, V488, P337, DOI 10.1038/nature11331; Pancholi V, 1998, J BIOL CHEM, V273, P14503, DOI 10.1074/jbc.273.23.14503; POYNER RR, 1992, BIOCHEMISTRY-US, V31, P7166, DOI 10.1021/bi00146a020; Pradere U, 2014, CHEM REV, V114, P9154, DOI 10.1021/cr5002035; THOMPSON J, 1984, J BACTERIOL, V158, P791, DOI 10.1128/JB.158.3.791-800.1984; Watanabe H., 1986, SCI REPORTS MEIJI SE, V25, P12	18	17	17	3	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2016	11	12							e0168739	10.1371/journal.pone.0168739	http://dx.doi.org/10.1371/journal.pone.0168739			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EG7JB	28030597	Green Submitted, gold, Green Published			2022-12-27	WOS:000391222000071
J	Badin, PM; Sopariwala, DH; Lorca, S; Narkar, VA				Badin, Pierre-Marie; Sopariwala, Danesh H.; Lorca, Sabina; Narkar, Vihang A.			Muscle Arnt/Hif1 beta Is Dispensable in Myofiber Type Determination, Vascularization and Insulin Sensitivity	PLoS One			English	Article							RECEPTOR NUCLEAR TRANSLOCATOR; ARYL-HYDROCARBON RECEPTOR; HIGH-FAT DIET; SKELETAL-MUSCLE; OXIDATIVE CAPACITY; GENE-EXPRESSION; CELL VIABILITY; LIMB ISCHEMIA; IN-VIVO; ANGIOGENESIS	Aryl Hydrocarbon Receptor Nuclear Translocator/hypoxia-inducible factor 1 beta (ARNT/HIF1 beta), a member of bHLH-PAS family of transcriptional factors, plays a critical role in metabolic homeostasis, insulin resistance and glucose intolerance. The contributions of ARNT in pancreas, liver and adipose tissue to energy balance through gene regulation have been described. Surprisingly, the impact of ARNT signaling in the skeletal muscles, one of the major organs involved in glucose disposal, has not been investigated, especially in type II diabetes. Here we report that ARNT is expressed in the skeletal muscles, particularly in the energy-efficient oxidative slow-twitch myofibers, which are characterized by increased oxidative capacity, mitochondrial content, vascular supply and insulin sensitivity. However, muscle-specific deletion of ARNT did not change myofiber type distribution, oxidative capacity, mitochondrial content, capillarity, or the expression of genes associated with these features. Consequently, the lack of ARNT in the skeletal muscle did not affect weight gain, lean/fat mass, insulin sensitivity and glucose tolerance in lean mice, nor did it impact insulin resistance and glucose intolerance in high fat diet-induced obesity. Therefore, skeletal muscle ARNT is dispensable for controlling muscle fiber type and metabolic regulation, as well as diet-induced weight control, insulin sensitivity and glucose tolerance.	[Badin, Pierre-Marie; Sopariwala, Danesh H.; Lorca, Sabina; Narkar, Vihang A.] UTHealth, McGovern Med Sch, Brown Fdn Inst Mol Med, Metab & Degenerat Dis, Houston, TX 77058 USA; [Narkar, Vihang A.] UTHealth, McGovern Med Sch, Integrat Biol & Pharmacol, Houston, TX 77058 USA; [Narkar, Vihang A.] UTHealth, McGovern Med Sch, Grad Sch Biomed Sci, Houston, TX 77058 USA	University of Texas System; University of Texas Health Science Center Houston; University of Texas System; University of Texas Health Science Center Houston; University of Texas System; University of Texas Health Science Center Houston	Narkar, VA (corresponding author), UTHealth, McGovern Med Sch, Brown Fdn Inst Mol Med, Metab & Degenerat Dis, Houston, TX 77058 USA.; Narkar, VA (corresponding author), UTHealth, McGovern Med Sch, Integrat Biol & Pharmacol, Houston, TX 77058 USA.; Narkar, VA (corresponding author), UTHealth, McGovern Med Sch, Grad Sch Biomed Sci, Houston, TX 77058 USA.	vihang.a.narkar@uth.tmc.edu			UTHealth; Welch Foundation endowment in Chemistry & Related Science [L-AU-0002]; American Diabetes Association (ADA) [1-13-BS-127]; National Institute of Health/National Heart Lung and Blood Institute [1 R01 HL129191-01]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL129191] Funding Source: NIH RePORTER	UTHealth; Welch Foundation endowment in Chemistry & Related Science; American Diabetes Association (ADA)(American Diabetes Association); National Institute of Health/National Heart Lung and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by UTHealth intramural funds and The Welch Foundation endowment in Chemistry & Related Science (#L-AU-0002), as well as grants from American Diabetes Association (ADA#1-13-BS-127) and National Institute of Health/National Heart Lung and Blood Institute (1 R01 HL129191-01) to V.A.N. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albers PH, 2015, DIABETES, V64, P485, DOI 10.2337/db14-0590; Ayala JE, 2010, DIS MODEL MECH, V3, P525, DOI 10.1242/dmm.006239; Badin PM, 2016, SCI REP-UK, V6, DOI 10.1038/srep26442; Badin PM, 2013, ENDOCRINOLOGY, V154, P1444, DOI 10.1210/en.2012-2029; Bajpeyi S, 2012, APPL PHYSIOL NUTR ME, V37, P822, DOI [10.1139/h2012-051, 10.1139/H2012-051]; Cheng K, 2010, J CLIN INVEST, V120, P2171, DOI 10.1172/JCI35846; DeFronzo RA, 2009, DIABETES CARE, V32, pS157, DOI 10.2337/dc09-S302; Goodpaster BH, 2014, DIABETES, V63, P2611, DOI 10.2337/db14-0277; Gunton JE, 2005, CELL, V122, P337, DOI 10.1016/j.cell.2005.05.027; Han Y, 2012, ANGIOGENESIS, V15, P409, DOI 10.1007/s10456-012-9269-x; Iossa S, 2002, INT J OBESITY, V26, P65, DOI 10.1038/sj.ijo.0801844; Jiang CT, 2011, DIABETES, V60, P2484, DOI 10.2337/db11-0174; Krock BL, 2015, BLOOD, V125, P3263, DOI 10.1182/blood-2014-10-607267; LaGory EL, 2015, CELL REP, V12, P116, DOI 10.1016/j.celrep.2015.06.006; Lalwani A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098435; Lau SM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077419; Lee KY, 2011, CELL METAB, V14, P491, DOI 10.1016/j.cmet.2011.08.006; Li MY, 2011, MICROVASC RES, V81, P26, DOI 10.1016/j.mvr.2010.09.008; Lindholm ME, 2016, EXP PHYSIOL, V101, P28, DOI 10.1113/EP085318; MacKrell JG, 2012, J GERONTOL A-BIOL, V67, P1286, DOI 10.1093/gerona/gls194; Majmundar AJ, 2015, DEVELOPMENT, V142, P2405, DOI 10.1242/dev.123026; Maltepe E, 1997, NATURE, V386, P403, DOI 10.1038/386403a0; Mandl M, 2014, MOL MED, V20, P215, DOI 10.2119/molmed.2014.00032; Mason SD, 2004, PLOS BIOL, V2, P1540, DOI 10.1371/journal.pbio.0020288; Matsakas A, 2013, FASEB J, V27, P4004, DOI 10.1096/fj.13-228296; Matsakas A, 2012, CIRC RES, V110, P1087, DOI 10.1161/CIRCRESAHA.112.266478; Milkiewicz M, 2004, J PHYSIOL-LONDON, V560, P21, DOI 10.1113/jphysiol.2004.069757; Niemi H, 2014, EUR J CLIN INVEST, V44, P989, DOI 10.1111/eci.12333; Ouma GO, 2014, J VASC SURG, V59, P786, DOI 10.1016/j.jvs.2013.04.043; Pajusola K, 2005, FASEB J, V19, P1365, DOI 10.1096/fj.05-3720fje; RANDO TA, 1994, J CELL BIOL, V125, P1275, DOI 10.1083/jcb.125.6.1275; Rasbach KA, 2010, P NATL ACAD SCI USA, V107, P21866, DOI 10.1073/pnas.1016089107; Saito Yasuko, 1993, Hokkaido Journal of Medical Science, V68, P190; Sarkar K, 2009, P NATL ACAD SCI USA, V106, P18769, DOI 10.1073/pnas.0910561106; Silvennoinen M, 2013, ANGIOGENESIS, V16, P297, DOI 10.1007/s10456-012-9315-8; STURCHLER C, 1992, NUCLEIC ACIDS RES, V20, P1215, DOI 10.1093/nar/20.6.1215; Thomas MM, 2014, PHYSL REP; Tomita S, 2000, MOL ENDOCRINOL, V14, P1674, DOI 10.1210/me.14.10.1674; Turner N, 2007, DIABETES, V56, P2085, DOI 10.2337/db07-0093; Vila IK, 2014, CELL REP, V7, P1116, DOI 10.1016/j.celrep.2014.03.062; Wang XL, 2009, CELL METAB, V9, P428, DOI 10.1016/j.cmet.2009.04.001; Wu RX, 2014, J CLIN INVEST, V124, P4795, DOI 10.1172/JCI76737; Yadav V, 2014, CELL REP, V8, P783, DOI 10.1016/j.celrep.2014.06.040	43	4	4	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2016	11	12							e0168457	10.1371/journal.pone.0168457	http://dx.doi.org/10.1371/journal.pone.0168457			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI9QH	28005939	Green Published, Green Submitted, gold			2022-12-27	WOS:000392843200053
J	Harada, T; Taniguchi, F; Onishi, K; Kurozawa, Y; Hayashi, K; Harada, T				Harada, Takashi; Taniguchi, Fuminori; Onishi, Kazunari; Kurozawa, Youichi; Hayashi, Kunihiko; Harada, Tasuku		Japan Environm Children's Study Gr	Obstetrical Complications in Women with Endometriosis: A Cohort Study in Japan	PLOS ONE			English	Article							ASSISTED REPRODUCTIVE TECHNOLOGY; ADVERSE PREGNANCY OUTCOMES; PERITONEAL-FLUID; SINGLETON PREGNANCIES; INFERTILE PATIENTS; EMBRYO-TRANSFER; EXPRESSION; RISK; PROSTAGLANDINS; MECHANISMS	Background Endometriosis, which occurs in approximately 10% of women of reproductive age, is defined as the presence of endometrial tissue outside the uterus. Women with endometriosis are more likely to have difficulty conceiving and tend to receive infertility treatment, including assisted reproductive technology (ART) therapy. There has not yet been a prospective cohort study examining the effects of endometriosis on pregnancy outcome in pregnant Japanese women. Methodology This was a prospective cohort study of the incidence of obstetrical complications in women with endometriosis using data of the Japan Environment & Children's Study (JECS). Included in this study were 9,186 pregnant women in the JECS with or without a history of endometriosis who gave birth or stillbirth or whose pregnancy was terminated with abortion between February and December 2011. Main Outcome Measures The effects of endometriosis on pregnancy outcome. Results Of the 9,186 pregnant women in the JECS, 4,119 (44.8%) had obstetrical complications; 330 participants reported a diagnosis of endometriosis before pregnancy, and these women were at higher risk for complications of pregnancy than those without a history of endometriosis (odds ratio (OR) = 1.50; 95% confidence interval (Cl) 1.20 to 1.87). Logistic regression analyses showed that the adjusted OR for obstetrical complications of pregnant women who conceived naturally and had a history of endometriosis was 1.45 (Cl 1.11 to 1.90). Among pregnant women with endometriosis, the ORs of preterm premature rupture of the membranes (PROM) and placenta previa were significantly higher compared with women never diagnosed with endometriosis who conceived naturally or conceived after infertility treatment, except for ART therapy (OR 2.14, CI 1.03-4.45 and OR 3.37, CI 1.32-8.65). Conclusions This study showed that endometriosis significantly increased the incidence of preterm PROM and placenta previa after adjusting for confounding of the data by ART therapy.	[Harada, Takashi; Taniguchi, Fuminori; Harada, Tasuku] Tottori Univ, Fac Med, Dept Obstet & Gynecol, Yonago, Tottori, Japan; [Onishi, Kazunari; Kurozawa, Youichi] Tottori Univ, Fac Med, Dept Publ Hlth, Yonago, Tottori, Japan; [Hayashi, Kunihiko] Gunma Univ, Grad Sch Hlth Sci, Dept Lab Sci & Environm Hlth Sci, Maebashi, Gunma, Japan	Tottori University; Tottori University; Gunma University	Harada, T (corresponding author), Tottori Univ, Fac Med, Dept Obstet & Gynecol, Yonago, Tottori, Japan.	tasuku@med.tottori-u.ac.jp	一成, 大西/D-7193-2019	一成, 大西/0000-0001-5791-4418; Hayashi, Kunihiko/0000-0003-4648-3936; Saito, Hirohisa/0000-0002-6630-8337	Ministry of the Environment, the Government of Japan	Ministry of the Environment, the Government of Japan	The Japan Environment and Children's Study was funded by the Ministry of the Environment, the Government of Japan.	Aris A, 2014, GYNECOL ENDOCRINOL, V30, P34, DOI 10.3109/09513590.2013.848425; BADAWY SZA, 1982, FERTIL STERIL, V38, P166; Benaglia L, 2012, HUM REPROD, V27, P1663, DOI 10.1093/humrep/des054; Brosens I, 2012, FERTIL STERIL, V98, DOI 10.1016/j.fertnstert.2012.02.024; Bulun SE, 2009, NEW ENGL J MED, V360, P268, DOI 10.1056/NEJMra0804690; Fanchin R, 1998, HUM REPROD, V13, P1968, DOI 10.1093/humrep/13.7.1968; Fernando S, 2009, FERTIL STERIL, V91, P325, DOI 10.1016/j.fertnstert.2008.01.096; FRASER IS, 1992, BAILLIERE CLIN OB GY, V6, P829, DOI 10.1016/S0950-3552(05)80191-9; Harada T, 1997, AM J OBSTET GYNECOL, V176, P593, DOI 10.1016/S0002-9378(97)70553-2; Hayashi M, 2012, FERTIL STERIL, V98, P922, DOI 10.1016/j.fertnstert.2012.05.049; Horcajadas JA, 2005, MOL HUM REPROD, V11, P195, DOI 10.1093/molehr/gah150; Iwabe T, 1998, FERTIL STERIL, V69, P924, DOI 10.1016/S0015-0282(98)00049-1; Izawa M, 2008, FERTIL STERIL, V89, P1390, DOI 10.1016/j.fertnstert.2007.03.078; Kanatani KT, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2014-004863; Kawamoto T, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-25; Khine Yin Mon, 2016, Reproductive Medicine and Biology, V15, P217, DOI 10.1007/s12522-016-0237-9; Kortelahti M, 2003, GYNECOL OBSTET INVES, V56, P207, DOI 10.1159/000074815; Maggiore ULR, 2015, HUM REPROD, V30, P299, DOI 10.1093/humrep/deu308; Maggiore ULR, 2016, HUM REPROD UPDATE, V22, P70, DOI 10.1093/humupd/dmv045; Mansour R, 2005, HUM REPROD, V20, P170, DOI 10.1093/humrep/deh573; Mekaru K, 2014, EUR J OBSTET GYN R B, V172, P36, DOI 10.1016/j.ejogrb.2013.10.024; Minakami H, 2011, J OBSTET GYNAECOL RE, V37, P1174, DOI 10.1111/j.1447-0756.2011.01653.x; Osteen KG, 1996, SEMIN REPROD ENDOCR, V14, P247, DOI 10.1055/s-2007-1016334; Pizzo A, 2002, GYNECOL OBSTET INVES, V54, P82, DOI 10.1159/000067717; Qin JB, 2016, FERTIL STERIL, V105, P73, DOI 10.1016/j.fertnstert.2015.09.007; Rosenberg T, 2011, ARCH GYNECOL OBSTET, V284, P47, DOI 10.1007/s00404-010-1598-7; Sales KJ, 2003, REPRODUCTION, V126, P559, DOI 10.1530/rep.0.1260559; Smith R, 2007, NEW ENGL J MED, V356, P271, DOI 10.1056/NEJMra061360; Stephansson O, 2009, HUM REPROD, V24, P2341, DOI 10.1093/humrep/dep186; Van Holsbeke C, 2010, ULTRASOUND OBST GYN, V35, P730, DOI 10.1002/uog.7668; Wu Y, 2006, ENDOCRINOLOGY, V147, P232, DOI 10.1210/en.2005-0426	31	46	48	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2016	11	12							e0168476	10.1371/journal.pone.0168476	http://dx.doi.org/10.1371/journal.pone.0168476			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI9QH	28005934	Green Submitted, Green Published, gold			2022-12-27	WOS:000392843200059
J	Yang, L; Yan, J; Jin, XQ; Jin, Y; Yu, W; Xu, SH; Wu, HB				Yang, Li; Yan, Jing; Jin, Xiaoqing; Jin, Yu; Yu, Wei; Xu, Shanhu; Wu, Haibin			Screening for Dementia in Older Adults: Comparison of Mini-Mental State Examination, Mini-Cog, Clock Drawing Test and AD8	PLoS One			English	Article							MILD COGNITIVE IMPAIRMENT	This study was conducted to estimate screening performance of dementia screening tools including Mini-Mental State Examination (MMSE), Mini-Cog, Clock Drawing Test (CDT) and Ascertain Dementia 8 questionnaire (AD8) for older adults. 2015 participants aged 65 years or more in eastern China were enrolled. 4 screening tests were administered and scored by specifically trained psychiatrists. We used data from two-by-two tables to calculate the sensitivity, specificity, and positive and negative predictive values (PPV/NPV). Our study showed that dementia was highly prevalent among elderly in Zhejiang province. The Mini-Cog, with excellent screening characteristics and spending less time, could be considered to be used as a screening tool among communities to help to diagnose dementia early.	[Yang, Li; Yan, Jing; Yu, Wei] Zhejiang Hosp, Zhejiang Prov Ctr Cardiovasc Dis Control & Preven, Hangzhou, Zhejiang, Peoples R China; [Jin, Xiaoqing; Jin, Yu; Xu, Shanhu] Zhejiang Hosp, Hangzhou, Zhejiang, Peoples R China; [Wu, Haibin] Zhejiang Prov Ctr Dis Control & Prevent, Hangzhou, Zhejiang, Peoples R China	Zhejiang Provincial Center for Disease Control & Prevention	Yang, L (corresponding author), Zhejiang Hosp, Zhejiang Prov Ctr Cardiovasc Dis Control & Preven, Hangzhou, Zhejiang, Peoples R China.	phoebe84331@163.com			Common weal technology and application research of Science and Technology Agency in Zhejiang province [2014 C33242]; General project of Medical Science and Technology in Zhejiang province [2015KYA006, 2015 KYA006]; "Common weal technology and application research of Science and Technology Agency in Zhejiang province [2014 C33242]	Common weal technology and application research of Science and Technology Agency in Zhejiang province; General project of Medical Science and Technology in Zhejiang province; "Common weal technology and application research of Science and Technology Agency in Zhejiang province	This work was supported by the Common weal technology and application research of Science and Technology Agency in Zhejiang province 2014 C33242 Mrs. Li Yang; General project of Medical Science and Technology in Zhejiang province 2015KYA006 Yu Jin" should be taken place by "Common weal technology and application research of Science and Technology Agency in Zhejiang province 2014 C33242 Yu Jin; General project of Medical Science and Technology in Zhejiang province 2015 KYA006 Li Yang. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akl A, 2015, IEEE T BIO-MED ENG, V62, P1383, DOI 10.1109/TBME.2015.2389149; Birks J., 2006, COCHRANE DATABASE SY; Black SA, 2008, J CLINEPIDEMIOL, V52, P1095; Boise L, 1999, GERONTOLOGIST, V39, P457, DOI 10.1093/geront/39.4.457; Borson S, 2000, INT J GERIATR PSYCH, V15, P1021, DOI 10.1002/1099-1166(200011)15:11<1021::AID-GPS234>3.0.CO;2-6; Burns A, 2004, ASSESSMENT SCALES OL; Chin R, 2013, AM J ALZHEIMERS DIS, V28, P284, DOI 10.1177/1533317513481090; Ding D, 2014, NEUROEPIDEMIOLOGY, V43, P114, DOI 10.1159/000366163; Galvin JE, 2006, NEUROLOGY, V67, P1942, DOI 10.1212/01.wnl.0000247042.15547.eb; Henry Brodaty, 2006, AM J GERIAT PSYCHIAT, V14, P391, DOI [10.1097/01.JGP.0000216181.20416.b2, DOI 10.1097/01.JGP.0000216181.20416.B2]; Kelvin K. F, 2005, JAMA INTERN MED, V175, P1450; Kuiper JS, 2015, AGEING RES REV, V22, P39, DOI 10.1016/j.arr.2015.04.006; Lorentz WJ, 2002, CAN J PSYCHIAT, V47, P723, DOI 10.1177/070674370204700803; Manning Kevin J., 2014, ARCH CLIN NEUROPSYCH, V29, P1, DOI [10.1093/arclin/act088, DOI 10.1093/ARCLIN/ACT088]; McShane R., 2006, COCHRANE DATABASE SY; Milian M, 2013, INT PSYCHOGERIATR, V25, P96, DOI 10.1017/S104161021200141X; Prorok JC, 2013, CAN MED ASSOC J, V185, pE669, DOI 10.1503/cmaj.121795; Raina SK, 2014, N AM J MED SCI, V6, P172, DOI 10.4103/1947-2714.131243; Razavi M, 2014, ALZ DIS ASSOC DIS, V28, P156, DOI 10.1097/WAD.0000000000000008; Rolinskil Fox C, 2012, COCHRANE DATABASE SY; Seitz Dallas P, 2013, MINICOG DIAGNOSIS AL; Wilkinson D, 2004, J INT MED RES, V32, P149, DOI 10.1177/147323000403200207; Yang L, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0146181; Yang L, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-903; Yang Li, 2016, AGE AGEING, P1; Zangiacomi Martinez Edson, 2008, CANC INFORM, V6, P33	26	27	29	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2016	11	12							e0168949	10.1371/journal.pone.0168949	http://dx.doi.org/10.1371/journal.pone.0168949			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EI9QH	28006822	Green Published, Green Submitted, gold			2022-12-27	WOS:000392843200114
J	Dhurmeea, Z; Zudaire, I; Chassot, E; Cedras, M; Nikolic, N; Bourjea, J; West, W; Appadoo, C; Bodin, N				Dhurmeea, Zahirah; Zudaire, Iker; Chassot, Emmanuel; Cedras, Maria; Nikolic, Natacha; Bourjea, Jerome; West, Wendy; Appadoo, Chandani; Bodin, Nathalie			Reproductive Biology of Albacore Tuna (Thunnus alalunga) in the Western Indian Ocean	PLOS ONE			English	Article							SWORDFISH XIPHIAS-GLADIUS; COD GADUS-MORHUA; SPAWNING FREQUENCY; BATCH FECUNDITY; YELLOWFIN TUNA; BLUEFIN TUNA; KATSUWONUS-PELAMIS; SEXUAL-MATURITY; SKIPJACK TUNA; L.	The reproductive biology of albacore tuna, Thunnus alalunga, in the western Indian Ocean was examined through analysis of the sex ratio, spawning season, length-at-maturity (L-50), spawning frequency and fecundity. From 2013 to 2015, a total of 923 female and 867 male albacore were sampled. A bias in sex ratio was found in favor of females with fork length (L-F) < 100 cm. Using histological analyses and gonadosomatic index, spawning was found to occur between 10 degrees S and 30 degrees S, mainly to the east of Madagascar from October to January. Large females contributed more to reproduction through their longer spawning period compared to small individuals. The L-50 (mean standard error) of female albacore was estimated at 85.3 +/- 0.7 cm LF. Albacore spawn on average every 2.2 days within the spawning region and spawning months, from November to January. Batch fecundity ranged between 0.26 and 2.09 million oocytes and the relative batch fecundity (mean standard deviation) was estimated at 53.4 +/- 23.2 oocytes g(-1) of somatic-gutted weight. The study provides new information on the reproductive development and classification of albacore in the western Indian Ocean. The reproductive parameters will reduce uncertainty in current stock assessment models which will eventually assist the fishery to be sustainable for future generations.	[Dhurmeea, Zahirah] Univ Mauritius, Fac Sci, Dept Biosci, Reduit, Mauritius; [Dhurmeea, Zahirah; Zudaire, Iker; Chassot, Emmanuel; Bodin, Nathalie] IRD Res Unit MARine Biodivers Exploitat & Conserv, Victoria, Mahe, Seychelles; [Zudaire, Iker] Basque Fdn Sci, Ikerbasque, Bilbao, Spain; [Chassot, Emmanuel; Cedras, Maria; Bodin, Nathalie] SFA, Victoria, Mahe, Seychelles; [Nikolic, Natacha] IFREMER, DOI Reunion, F-97822 Le Port, Reunion, France; [Bourjea, Jerome] IFREMER, Res Unit MARine Biodivers Exploitat & Con, F-34203 Sete, France; [West, Wendy] DAFF, Cape Town, South Africa; [Appadoo, Chandani] Univ Mauritius, Dept Marine & Ocean Sci, Fisheries & Mariculture, Fac Ocean Studies, Reduit, Mauritius	University of Mauritius; Ifremer; Basque Foundation for Science; Ifremer; Ifremer; University of Mauritius	Dhurmeea, Z (corresponding author), Univ Mauritius, Fac Sci, Dept Biosci, Reduit, Mauritius.; Dhurmeea, Z (corresponding author), IRD Res Unit MARine Biodivers Exploitat & Conserv, Victoria, Mahe, Seychelles.	dzahirah@hotmail.com	Bodin, Nathalie/D-2184-2009; Dhurmeea, Zahirah/AAL-4006-2021	Bourjea, Jerome/0000-0001-7149-3648; Natacha, Nikolic/0000-0002-6055-0923; Zudaire, Iker/0000-0002-4249-4622; CHASSOT, Emmanuel/0000-0002-6779-4955; Bodin, Nathalie/0000-0001-8464-0213	"Allocations de Recherche pour une These au Sud" (ARTS) programme of the French Institute of Research for Development (IRD); Western Indian Ocean Marine Science Association (WIOMSA); European Data Collection Framework (EU DCF project) [199/2008, 665/2008]; Fisheries European Funds (EU FEP) [759/DMSOI/2013]; Seychelles Fishing Authority (SFA); University of Mauritius	"Allocations de Recherche pour une These au Sud" (ARTS) programme of the French Institute of Research for Development (IRD); Western Indian Ocean Marine Science Association (WIOMSA); European Data Collection Framework (EU DCF project); Fisheries European Funds (EU FEP); Seychelles Fishing Authority (SFA); University of Mauritius	This work was part of the PhD of the first author ZD co-funded by the "Allocations de Recherche pour une These au Sud" (ARTS) programme of the French Institute of Research for Development (IRD), and the Western Indian Ocean Marine Science Association (WIOMSA). Sampling was conducted under the framework of the European Data Collection Framework (EU DCF project (Reg. 199/2008 and 665/2008) and the Fisheries European Funds (EU FEP 2007-2013 project GERMON No 759/DMSOI/2013). Laboratory analysis was co-funded by Seychelles Fishing Authority (SFA) and University of Mauritius. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], [No title captured]; Aranda G, 2013, J SEA RES, V76, P154, DOI 10.1016/j.seares.2012.08.005; Arocha F., 1994, International Commission for the Conservation of Atlantic Tunas Collective Volume of Scientific Papers, V42, P309; Arocha F., 1996, International Commission for the Conservation of Atlantic Tunas Collective Volume of Scientific Papers, V45, P350; Auguie B, 2017, GRIDEXTRA MISCELLANE; Bard FX, 1981, THESIS; Bivanand R, 2016, PACKAGE RGDAL; Brown-Peterson NJ, 2011, MAR COAST FISH, V3, P52, DOI 10.1080/19425120.2011.555724; Chen IC, 2005, FISH OCEANOGR, V14, P71, DOI 10.1111/j.1365-2419.2004.00322.x; Chen KS, 2010, J FISH BIOL, V77, P119, DOI 10.1111/j.1095-8649.2010.02662.x; Claramunt G, 2007, FISH RES, V85, P248, DOI 10.1016/j.fishres.2007.01.009; Coelho R, 2014, REUNION ISLAND PELAG; Collette BB., 1983, FAO FISH SYNOP, V125; Conand F, 1982, BIOL OCEANOGR, V1, P31; Dhurmeea Z, 2012, IOTC2012WPTMT0412; Dhurmeea Z, 2016, IOTC2016WPTMT0628; Farley J, 2008, WCPFCSC42008BIIP1; Farley JH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0083017; Farley JH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060577; Farley JH, 1998, FISH B-NOAA, V96, P223; FITZHUGH GR, 1995, FISH B-NOAA, V93, P568; FLETCHER DA, 1995, J FISH BIOL, V46, P657, DOI 10.1111/j.1095-8649.1995.tb01102.x; Grande M, 2014, FISH RES, V156, P14, DOI 10.1016/j.fishres.2014.04.011; Guraya Sardul S., 1994, Proceedings of the Indian National Science Academy Part B Biological Sciences, V60, P15; Harley S., 2003, INTERAMERICAN TROPIC; Helfman GS, 2009, DIVERSITY FISHES BIO; Hoyle S, 2008, 4 SCI COMM M W CENTR; Hoyle SD, 2014, IOTC2014WPTMT0524; Hsu CC, 2005, ALB WORK GROUP M 28; Hunter J.R., 1985, NOAA Technical Report NMFS, V36, P63; HUNTER JR, 1992, FISH B-NOAA, V90, P101; HUNTER JR, 1986, FISH B-NOAA, V84, P895; Hunter JR, 1989, CALCOFI REP, V30, P1; IOTC, 2014, 5 SESS IOTC WORK PAR; IOTC, 2013, 16 SESS IOTC SCI COM; IOTC, 2015, IOTC2015SC18R; IOTC, 2012, IOTC2012SC15; ISSF, 2015, 201503A ISSF; Itano DG, 2000, JIMAR CONTRIBUTION; Juan-Jorda MJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070405; KarlouRiga C, 1997, J APPL ICHTHYOL, V13, P97, DOI 10.1111/j.1439-0426.1997.tb00108.x; Kennedy J, 2008, J FISH BIOL, V72, P78, DOI 10.1111/j.1095-8649.2007.01651.x; Kerwath S.E., 2012, INT COMM CONS ATL CO, V68, P604; KJESBU OS, 1991, CAN J FISH AQUAT SCI, V48, P2333, DOI 10.1139/f91-274; Knaggs EH, 1973, 3 CAL DEP FISH GAM, V3; Lambert Yvan, 2003, Journal of Northwest Atlantic Fishery Science, V33, P115, DOI 10.2960/J.v33.a7; Lambert Yvan, 2009, Journal of Northwest Atlantic Fishery Science, V41, P93; Le Gall J.-Y., 1974, FAO Fish Synopsis, VNo. 109, P1; Lowerre-Barbieri SK, 2011, MAR COAST FISH, V3, P71, DOI 10.1080/19425120.2011.556932; MacCall AD, 1980, NOAA TECH REP; Marshall C. Tara, 2009, P395, DOI 10.1002/9781444312133.ch11; Maunder Mark N., 2003, Inter-American Tropical Tuna Commission Bulletin, V22, P435; Morgan MJ, 2009, CAN J FISH AQUAT SCI, V66, P404, DOI 10.1139/F09-009; Morgan M. Joanne, 2009, Journal of Northwest Atlantic Fishery Science, V41, P37; Murua H., 2003, Journal of Northwest Atlantic Fishery Science, V33, P33, DOI 10.2960/J.v33.a3; Murua H., 2003, Journal of Northwest Atlantic Fishery Science, V33, P23, DOI 10.2960/J.v33.a2; Murua H, 2006, J FISH BIOL, V69, P1288, DOI 10.1111/j.1095-8649.2006.01169.x; Murua H, 2010, FISH RES, V104, P100, DOI 10.1016/j.fishres.2009.06.007; Newcombe HC, 2011, THESIS; NIKAIDO H, 1991, B NATL RES I FAR SEA, V28, P47; Nootmorn P, 2005, IOTC2005EPTT14; Okochi Y, 2016, FISH RES, V174, P30, DOI 10.1016/j.fishres.2015.08.020; Ortiz de Zarate V., 2004, International Commission for the Conservation of Atlantic Tunas Collective Volume of Scientific Papers, V56, P1450; Otsu T., 1959, Fishery Bulletin United States, V59, P287; Otsu T., 1962, Fishery Bulletin United States, V62, P151; Poisson F, 2009, AQUAT LIVING RESOUR, V22, P45, DOI 10.1051/alr/2009007; Poisson F, 2009, AQUAT LIVING RESOUR, V22, P59, DOI 10.1051/alr/2009012; Ramon D, 1996, FISH B-NOAA, V94, P725; Saber S., 2011, International Commission for the Conservation of Atlantic Tunas Collective Volume of Scientific Papers, V66, P1919; Saber S, 2016, FISH RES, V176, P76, DOI 10.1016/j.fishres.2015.12.013; Saber S, 2015, J MAR BIOL ASSOC UK, V95, P1705, DOI 10.1017/S002531541500020X; Saborido-Rey F, 1998, ICES J MAR SCI, V55, P515, DOI 10.1006/jmsc.1997.0344; Schaefer KM, 1996, FISH B-NOAA, V94, P98; Schaefer KM, 1998, B INTERAMERICAN TROP, V21, P201; Schaefer Kurt M., 2001, Fish Physiology, V19, P225; Schaefer MB, 1956, INTERAM TROP TUNA CO, V1, P283; Schott FA, 2001, PROG OCEANOGR, V51, P1, DOI 10.1016/S0079-6611(01)00083-0; Shiohama T, 1985, TWS8522 IPTP, P91; Solemdal P, 1997, J SEA RES, V37, P213, DOI 10.1016/S1385-1101(97)00029-4; Suda A, 1974, B FAR SEAS FISH RES, V10, P27; Sun CL, 2006, WCPFCSC22006BIWP1; Tsuruta Y., 1992, Bulletin of National Research Institute of Fisheries Engineering, P129; UEYANAGI S, 1969, Bulletin Far Seas Fisheries Research Laboratory (Shimizu), V2, P177; Williams AJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039318; Wootton R.J., 1984, P1; Wu Chi-Lun, 1993, Journal of the Fisheries Society of Taiwan, V20, P135; Wyrtki K., 1973, ECOL STUD, V3, P18, DOI [10.1007/978-3-642-65468-8_3, DOI 10.1007/978-3-642-65468-8_3]; Xu J, 2005, STATA J, V5, P537, DOI 10.1177/1536867X0500500405; Zudaire I, 2013, FISH RES, V138, P80, DOI 10.1016/j.fishres.2012.07.022; Zudaire I, 2013, FISH B-NOAA, V111, P252, DOI 10.7755/FB.111.3.4	90	15	17	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2016	11	12							e0168605	10.1371/journal.pone.0168605	http://dx.doi.org/10.1371/journal.pone.0168605			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI9TW	28002431	Green Published, gold, Green Submitted			2022-12-27	WOS:000392853100057
J	Forcino, RC; Bustamante, N; Thompson, R; Percac-Lima, S; Elwyn, G; Perez-Arechaederra, D; Barr, PJ				Forcino, Rachel C.; Bustamante, Nitzy; Thompson, Rachel; Percac-Lima, Sanja; Elwyn, Glyn; Perez-Arechaederra, Diana; Barr, Paul J.			Developing and Pilot Testing a Spanish Translation of CollaboRATE for Use in the United States	PLoS One			English	Article							SHARED DECISION-MAKING; CROSS-CULTURAL ADAPTATION; HEALTH-CARE; LANGUAGE BARRIERS; COMMUNICATION; SATISFACTION; DISPARITIES; ETHNICITY; PHYSICIAN; SPEAKING	Background/Aim Given the need for access to patient-facing materials in multiple languages, this study aimed to develop and pilot test an accurate and understandable translation of CollaboRATE, a three-item patient-reported measure of shared decision-making, for Spanish-speaking patients in the United States (US). Method We followed the Translate, Review, Adjudicate, Pre-test, Document (TRAPD) survey translation protocol. Cognitive interviews were conducted with Spanish-speaking adults within an urban Massachusetts internal medicine clinic. For the pilot test, all patients with weekday appointments between May 1 and May 29, 2015 were invited to complete CollaboRATE in either English or Spanish upon exit. We calculated the proportion of respondents giving the best score possible on CollaboRATE and compared scores across key patient subgroups. Results Four rounds of cognitive interviews with 26 people were completed between January and April 2015. Extensive, iterative refinements to survey items between interview rounds led to final items that were generally understood by participants with diverse educational backgrounds. Pilot data collection achieved an overall response rate of 73 percent, with 606 (49%) patients completing Spanish CollaboRATE questionnaires and 624 (51%) patients completing English CollaboRATE questionnaires. The proportion of respondents giving the best score possible on CollaboRATE was the same (86%) for both the English and Spanish versions of the instrument. Discussion Our translation method, guided by emerging best practices in survey and health measurement translation, encompassed multiple levels of review. By conducting four rounds of cognitive interviews with iterative item refinement between each round, we arrived at a Spanish language version of CollaboRATE that was understandable to a majority of cognitive interview participants and was completed by more than 600 pilot questionnaire respondents.	[Forcino, Rachel C.; Thompson, Rachel; Elwyn, Glyn; Barr, Paul J.] Dartmouth Inst Hlth Policy & Clin Practice, Lebanon, NH 03766 USA; [Bustamante, Nitzy; Percac-Lima, Sanja] Harvard Med Sch, Boston, MA USA; [Percac-Lima, Sanja] Massachusetts Gen Hosp, Chelsea HealthCare Ctr, Chelsea, MA USA; [Perez-Arechaederra, Diana] Biomed Res Inst Salamanca IBSAL, Primary Care Res Unit, Alamedilla Hlth Ctr, Salamanca, Spain; [Perez-Arechaederra, Diana] Ctr Univ San Rafael Nebrija, Madrid, Spain	Dartmouth College; Harvard University; Harvard Medical School; Harvard University; Massachusetts General Hospital; Universidad Antonio de Nebrija	Barr, PJ (corresponding author), Dartmouth Inst Hlth Policy & Clin Practice, Lebanon, NH 03766 USA.	paul.j.barr@dartmouth.edu	Elwyn, Glyn/B-4798-2009	Elwyn, Glyn/0000-0002-0917-6286; Thompson, Rachel/0000-0002-1009-0746; Perez-Arechaederra, DIANA/0000-0001-7696-6520	Gordon and Betty Moore Foundation [3929]; Regional Health Management of the Castilla and Leon, Spain [BIO/SA02/15]	Gordon and Betty Moore Foundation(Gordon and Betty Moore Foundation); Regional Health Management of the Castilla and Leon, Spain	The Gordon and Betty Moore Foundation (httos://www.moore.org/) funded this study (#3929). This work was also supported by a grant from the Regional Health Management of the Castilla and Leon, Spain (BIO/SA02/15).	Baker DW, 1996, JAMA-J AM MED ASSOC, V275, P783, DOI 10.1001/jama.275.10.783; Bann CM, 2005, HEALTH CARE FINANC R, V26, P51; Barr PJ, 2014, J MED INTERNET RES, V16, DOI 10.2196/jmir.3085; Barr PJ, 2015, HLTH EXPECT; Barton JL, 2014, J RHEUMATOL, V41, P1290, DOI 10.3899/jrheum.131350; Beaton DE, 2000, SPINE, V25, P3186, DOI 10.1097/00007632-200012150-00014; BERKANOVIC E, 1980, AM J PUBLIC HEALTH, V70, P1273, DOI 10.2105/AJPH.70.12.1273; BRISLIN RW, 1970, J CROSS CULT PSYCHOL, V1, P185, DOI 10.1177/135910457000100301; Durand MA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094670; Elwyn G, 2013, PATIENT EDUC COUNS, V93, P102, DOI 10.1016/j.pec.2013.05.009; Epstein J, 2015, J CLIN EPIDEMIOL, V68, P360, DOI 10.1016/j.jclinepi.2013.07.013; Fiscella K, 2002, MED CARE, V40, P52, DOI 10.1097/00005650-200201000-00007; Flores G, 2006, NEW ENGL J MED, V355, P229, DOI 10.1056/NEJMp058316; Harkness JA, 2011, CROSS CULTURAL SURVE; Harpole LH, 1996, J GEN INTERN MED, V11, P431, DOI 10.1007/BF02600192; Harrison GG, 2003, J NUTR, V133, P1192, DOI 10.1093/jn/133.4.1192; Hayes RP, 1998, MED CARE, V36, P230, DOI 10.1097/00005650-199802000-00011; Legare F, 2013, HEALTH AFFAIR, V32, P276, DOI 10.1377/hlthaff.2012.1078; Levin K., 2009, SURV RES METHODS-GER, V3, P13, DOI [10.18148/srm/2009.v3i1.88, DOI 10.18148/SRM/2009.V3I1.88]; Makoul G, 2007, PATIENT EDUC COUNS, V67, P333, DOI 10.1016/j.pec.2007.05.005; Morales LS, 1999, J GEN INTERN MED, V14, P409, DOI 10.1046/j.1525-1497.1999.06198.x; Morales LS, 2001, HEALTH SERV RES, V36, P595; Mosen DM, 2004, AMBUL PEDIATR, V4, P500, DOI 10.1367/A04-019R1.1; Ponce NA, 2004, PUBLIC HEALTH REP, V119, P388, DOI 10.1016/j.phr.2004.05.002; Saha S, 2007, J GEN INTERN MED, V22, P371, DOI 10.1007/s11606-007-0372-4; United States Census Bureau, 2013, LANGUAGE USE US 2011	27	13	13	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2016	11	12							e0168538	10.1371/journal.pone.0168538	http://dx.doi.org/10.1371/journal.pone.0168538			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EI9TW	28002422	Green Published, gold, Green Submitted			2022-12-27	WOS:000392853100050
J	Kamigaki, T; Chaw, L; Tan, AG; Tamaki, R; Alday, PP; Javier, JB; Olveda, RM; Oshitani, H; Tallo, VL				Kamigaki, Taro; Chaw, Liling; Tan, Alvin G.; Tamaki, Raita; Alday, Portia P.; Javier, Jenaline B.; Olveda, Remigio M.; Oshitani, Hitoshi; Tallo, Veronica L.			Seasonality of Influenza and Respiratory Syncytial Viruses and the Effect of Climate Factors in Subtropical-Tropical Asia Using Influenza-Like Illness Surveillance Data, 2010-2012	PLOS ONE			English	Article							ABSOLUTE-HUMIDITY; METEOROLOGICAL FACTORS; HONG-KONG; INFECTIONS; DISEASE; EPIDEMIOLOGY; TRANSMISSION; ASSOCIATION; TEMPERATURE; PATTERNS	Introduction The seasonality of influenza and respiratory syncytial virus (RSV) is well known, and many analyses have been conducted in temperate countries; however, this is still not well understood in tropical countries. Previous studies suggest that climate factors are involved in the seasonality of these viruses. However, the extent of the effect of each climate variable is yet to be defined. Materials and Methods We investigated the pattern of seasonality and the effect of climate variables on influenza and RSV at three sites of different latitudes: the Eastern Visayas region and Baguio City in the Philippines, and Okinawa Prefecture in Japan. Wavelet analysis and the dynamic linear regression model were applied. Climate variables used in the analysis included mean temperature, relative and specific humidity, precipitation, and number of rainy days. The Akaike Information Criterion estimated in each model was used to test the improvement of fit in comparison with the baseline model. Result At all three study sites, annual seasonal peaks were observed in influenza A and RSV; peaks were unclear for influenza B. Ranges of climate variables at the two Philippine sites were narrower and mean variables were significantly different among the three sites. Whereas all climate variables except the number of rainy days improved model fit to the local trend model, their contributions were modest. Mean temperature and specific humidity were positively associated with influenza and RSV at the Philippine sites and negatively associated with influenza A in Okinawa. Precipitation also improved model fit for influenza and RSV at both Philippine sites, except for the influenza A model in the Eastern Visayas. Conclusions Annual seasonal peaks were observed for influenza A and RSV but were less clear for influenza B at all three study sites. Including additional data from subsequent more years would help to ascertain these findings. Annual amplitude and variation in climate variables are more important than their absolute values for determining their effect on the seasonality of influenza and RSV.	[Kamigaki, Taro; Chaw, Liling; Tamaki, Raita; Oshitani, Hitoshi] Tohoku Univ, Dept Virol, Grad Sch Med, Sendai, Miyagi, Japan; [Tan, Alvin G.; Alday, Portia P.; Javier, Jenaline B.; Tallo, Veronica L.] Dept Hlth, Res Inst Trop Med, Dept Epidemiol & Biostat, Manila, Philippines; [Olveda, Remigio M.] Dept Hlth, Res Inst Trop Med, Manila, Philippines; [Chaw, Liling] Univ Brunei Darussalam, PAPRSB Inst Hlth Sci, Negara, Brunei	Tohoku University; Philippine Department Health; Research Institute for Tropical Medicine - Philippines; Philippine Department Health; Research Institute for Tropical Medicine - Philippines; University Brunei Darussalam	Kamigaki, T (corresponding author), Tohoku Univ, Dept Virol, Grad Sch Med, Sendai, Miyagi, Japan.	kamigakit@med.tohoku.ac.jp	Chaw, Liling/R-1591-2019; Oshitani, Hitoshi/AAE-4349-2019	Chaw, Liling/0000-0003-3301-7565; 	US-CDC [U50/CCU2444, 5U5IIP000335]; Japan Initiative for Global Research Network on Infectious Diseases; JSPS KAKENHI [JP15H05281]	US-CDC(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); Japan Initiative for Global Research Network on Infectious Diseases(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	Funded by US-CDC Cooperative AgreementU50/CCU2444, 5U5IIP000335, Remigio M. Olveda, Ministry of Education, Culture, Sports, Science and Technology, Japan Grant-in-Aid from the Japan Initiative for Global Research Network on Infectious Diseases, Hitoshi Oshitani, Japan Science and Technology Agency/Japan International Cooperation Agency the Science and Technology Research Partnership for Sustainable Development, Hitoshi Oshitani, JSPS KAKENHI JP15H05281, Taro Kamigak.	Agrawal AS, 2009, J MED MICROBIOL, V58, P1616, DOI 10.1099/jmm.0.011304-0; Alonso WJ, 2007, AM J EPIDEMIOL, V165, P1434, DOI 10.1093/aje/kwm012; Alonso WJ, 2015, SCI REP-UK, V5, DOI 10.1038/srep17214; Alonso WJ, 2012, PEDIATR INFECT DIS J, V31, pE9, DOI 10.1097/INF.0b013e31823883be; Baumgartner EA, 2012, J INFECT DIS, V206, P838, DOI 10.1093/infdis/jis467; Belshe RB, 2008, VACCINE, V26, pD10, DOI 10.1016/j.vaccine.2008.06.083; Bloom-Feshbach K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054445; Chan PKS, 2009, J MED VIROL, V81, P1797, DOI 10.1002/jmv.21551; Chan PKS, 1999, EPIDEMIOL INFECT, V123, P257, DOI 10.1017/S0950268899002824; Chan PWK, 2002, PEDIATR PULM, V34, P47, DOI 10.1002/ppul.10095; Chen ZR, 2014, ARCH VIROL, V159, P631, DOI 10.1007/s00705-013-1863-8; Chew FT, 1998, EPIDEMIOL INFECT, V121, P121, DOI 10.1017/S0950268898008905; Chittaganpitch M, 2012, INFLUENZA OTHER RESP, V6, P276, DOI 10.1111/j.1750-2659.2011.00302.x; Gustin KM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125874; Haynes AK, 2013, J INFECT DIS, V208, pS246, DOI 10.1093/infdis/jit515; Heaton MJ, 2012, STAT MED, V31, P2123, DOI 10.1002/sim.5350; Higa F, 2009, JPN J INFECT DIS, V62, P399; Iha Y, 2012, JPN J INFECT DIS, V65, P295, DOI 10.7883/yoken.65.295; Imai C, 2014, GLOBAL HEALTH ACTION, V7, DOI 10.3402/gha.v7.24413; KFAS J H., 2016, KALMAN FILTER SMOOTH; Khor CS, 2012, BMC PEDIATR, V12, DOI 10.1186/1471-2431-12-32; Killingley B, 2013, INFLUENZA OTHER RESP, V7, P42, DOI 10.1111/irv.12080; Kottek M, 2006, METEOROL Z, V15, P259, DOI 10.1127/0941-2948/2006/0130; Koul PA, 2014, EMERG INFECT DIS, V20, P1723, DOI 10.3201/eid2010.140431; Lofgren E, 2007, J VIROL, V81, P5429, DOI 10.1128/JVI.01680-06; Lowen AC, 2008, J VIROL, V82, P5650, DOI 10.1128/JVI.00325-08; Lowen AC, 2007, PLOS PATHOG, V3, P1470, DOI 10.1371/journal.ppat.0030151; Lowen AC, 2014, J VIROL, V88, P7692, DOI 10.1128/JVI.03544-13; McDevitt J, 2010, APPL ENVIRON MICROB, V76, P3943, DOI 10.1128/AEM.02674-09; Meerhoff TJ, 2009, PEDIATR INFECT DIS J, V28, P860, DOI 10.1097/INF.0b013e3181a3e949; Nguyen YT, 2013, VACCINE, V31, P4368, DOI 10.1016/j.vaccine.2013.07.018; Noti JD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057485; Omer SB, 2008, EPIDEMIOL INFECT, V136, P1319, DOI 10.1017/S0950268807000015; Otomaru H, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0123755; Paynter S, 2015, EPIDEMIOL INFECT, V143, P1110, DOI 10.1017/S0950268814002702; Paynter S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090094; Thai PQ, 2015, EPIDEMICS-NETH, V13, P65, DOI 10.1016/j.epidem.2015.06.002; Portland State Aerospace Society, 2004, QUICK DER REL ALT AI; R Development Core Team, 2016, R LANG ENV STAT COMP; Saat Z, 2010, SE ASIAN J TROP MED, V41, P1368; Shaman J, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000316; Shaman J, 2009, P NATL ACAD SCI USA, V106, P3243, DOI 10.1073/pnas.0806852106; Soebiyanto RP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100659; Spicknall IH, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000969; Tallo VL, 2014, INFLUENZA OTHER RESP, V8, P159, DOI 10.1111/irv.12223; Tamerius J, 2011, ENVIRON HEALTH PERSP, V119, P439, DOI 10.1289/ehp.1002383; Tamerius JD, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003194; Tang JLW, 2014, REV MED VIROL, V24, P15, DOI 10.1002/rmv.1771; Tarik C, BIWAVELET CONDUCT UN; Ud-Dean SMM, 2010, J THEOR BIOL, V264, P822, DOI 10.1016/j.jtbi.2010.03.013; Wallace J., 2006, ATMOSPHERIC SCI INTR, V2nd; Welliver Robert, 2009, Paediatr Respir Rev, V10 Suppl 1, P6, DOI 10.1016/S1526-0542(09)70004-1; World Health Organization (WHO), WHO REC SURV STAND; Yang W, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046789; Yu HJ, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001552; Yusuf S, 2007, EPIDEMIOL INFECT, V135, P1077, DOI 10.1017/S095026880600776X	56	24	24	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2016	11	12							e0167712	10.1371/journal.pone.0167712	http://dx.doi.org/10.1371/journal.pone.0167712			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI9TW	28002419	Green Published, Green Submitted, gold			2022-12-27	WOS:000392853100018
J	Trier, NH; Holm, BE; Slot, O; Locht, H; Lindegaard, H; Svendsen, A; Houen, G				Trier, Nicole Hartwig; Holm, Bettina Eide; Slot, Ole; Locht, Henning; Lindegaard, Hanne; Svendsen, Anders; Houen, Gunnar			Physical Characteristics of a Citrullinated Pro-Filaggrin Epitope Recognized by Anti-Citrullinated Protein Antibodies in Rheumatoid Arthritis Sera	PLoS One			English	Article							PROTEIN/PEPTIDE ANTIBODIES; ANTIKERATIN ANTIBODIES; PEPTIDE ANTIBODIES; DISEASE COURSE; CCP ANTIBODY; AUTOANTIBODIES; ASSOCIATION; HLA-DRB1; CLASSIFICATION; IDENTIFICATION	Rheumatoid arthritis (RA) is an autoimmune disease of complex etiology. A characteristic feature of a subset of RA is the presence of anti-citrullinated protein antibodies (ACPA), which correlate with a progressive disease course. In this study, we employed streptavidin capture enzyme-linked immunosorbent assay to analyze ACPA reactivity. Using the profilaggrin peptide HQCHQEST-Cit-GRSRGRCGRSGS, as template, we analyzed the reactivity of RA sera and healthy donor sera to various peptides in order to determine the physical characteristics of the citrullinated pro-filaggrin epitope and to examine whether biotin labelling influence antibody recognition. The full-length cyclic pro-filaggrin peptide and a linear form with a N-terminal biotin, was recognized to the same level, whereas, a notable difference in ACPA reactivity to the linear peptides with a C-terminal biotin was found, probably due to steric hindrance. Screening of linear and cyclic truncated peptides, revealed that small cyclic peptides containing 10-12 amino acids are favored over the linear. Moreover, the charged amino acids C-terminal to citrulline were found to be essential for antibody reactivity, most important was the charged amino acid in position 4 C-terminal to citrulline. Collectively, peptide structure, length, the presence of charged amino acids and biotin labelling markedly influence antibody reactivity. In relation to the clinical diagnostics of ACPA, these findings may reflect the differences in diagnostic assays used for detection of ACPA, which relates to differences in sensitivity and specificity dependent on the assay applied.	[Trier, Nicole Hartwig; Holm, Bettina Eide; Houen, Gunnar] Statens Serum Inst, Dept Autoimmunol & Biomarkers, Copenhagen S, Denmark; [Slot, Ole] Glostrup Cty Hosp, Dept Rheumatol, Glostrup, Denmark; [Locht, Henning] Frederiksberg Univ Hosp, Dept Rheumatol, Frederiksberg, Denmark; [Lindegaard, Hanne] Odense Univ Hosp, Dept Rheumatol, Sondre Blvd, Odense C, Denmark; [Svendsen, Anders] Univ Southern Denmark, Dept Epidemiol Biostat & Biodemog, Inst Publ Hlth, Campusvej, Odense M, Denmark	Statens Serum Institut; University of Copenhagen; University of Southern Denmark; Odense University Hospital; University of Southern Denmark	Trier, NH (corresponding author), Statens Serum Inst, Dept Autoimmunol & Biomarkers, Copenhagen S, Denmark.	nhp@ssi.dk	Lindegaard, Hanne Merete/AAV-5437-2020; Trier, Nicole/AAA-5164-2020; Nekrasov, Alexei/S-1322-2016	Lindegaard, Hanne Merete/0000-0002-5675-3859; Trier, Nicole/0000-0003-1548-2009; Nekrasov, Alexei/0000-0001-6814-3735; Svendsen, Anders/0000-0002-3481-9001				Aho K, 2000, J RHEUMATOL, V27, P2743; Aletaha D, 2010, ARTHRITIS RHEUM-US, V62, P2569, DOI 10.1002/art.27584; ARNETT FC, 1988, ARTHRITIS RHEUM, V31, P315, DOI 10.1002/art.1780310302; Bartold PM, 2010, J CLIN PERIODONTOL, V37, P405, DOI 10.1111/j.1600-051X.2010.01552.x; Beers JJ, 2012, ARTHRITIS RES THER, V14, pR35, DOI [10.1186/ar3744, DOI 10.1186/AR3744]; Burkhardt H, 2005, EUR J IMMUNOL, V35, P1643, DOI 10.1002/eji.200526000; Chibnik LB, 2009, J RHEUMATOL, V36, P706, DOI 10.3899/jrheum.080895; DOROW DS, 1985, MOL IMMUNOL, V22, P1255, DOI 10.1016/0161-5890(85)90044-6; DYSON HJ, 1995, FASEB J, V9, P37, DOI 10.1096/fasebj.9.1.7821757; Engel A, 1966, Vital Health Stat 11, P1; Fernandes-Cerqueira C, 2015, ARTHRITIS RES THER, V17, DOI 10.1186/s13075-015-0666-6; Babos F, 2013, BIOCONJUGATE CHEM, V24, P817, DOI 10.1021/bc400073z; Girbal-Neuhauser E, 1999, J IMMUNOL, V162, P585; Kallberg H, 2007, AM J HUM GENET, V80, P867, DOI 10.1086/516736; Kastbom A, 2004, ANN RHEUM DIS, V63, P1085, DOI 10.1136/ard.2003.016808; Kinloch A, 2005, ARTHRITIS RES THER, V7, pR1421, DOI 10.1186/ar1845; Klareskog L, 2006, ARTHRITIS RHEUM-US, V54, P38, DOI 10.1002/art.21575; Klareskog L, 2008, ANNU REV IMMUNOL, V26, P651, DOI 10.1146/annurev.immunol.26.021607.090244; Kobylyansky AG, 2011, B EXP BIOL MED+, V151, P615; LI SC, 1995, BIOPOLYMERS, V35, P667, DOI 10.1002/bip.360350612; Mahalakshmi R, 2006, D AMINO ACIDS NEW FR, P415; Nair DT, 2002, J IMMUNOL, V168, P2371, DOI 10.4049/jimmunol.168.5.2371; Nell VPK, 2005, ANN RHEUM DIS, V64, P1731, DOI 10.1136/ard.2005.035691; Nielen MMJ, 2004, ARTHRITIS RHEUM-US, V50, P380, DOI 10.1002/art.20018; Pedersen JK, 2009, RHEUMATOL INT, V29, P411, DOI 10.1007/s00296-008-0713-6; Pedersen M, 2007, ARTHRITIS RHEUM-US, V56, P1446, DOI 10.1002/art.22597; Rantapaa-Dahlqvist S, 2003, ARTHRITIS RHEUM, V48, P2741, DOI 10.1002/art.11223; Ronnelid J, 2005, ANN RHEUM DIS, V64, P1744, DOI 10.1136/ard.2004.033571; Sangha O, 2000, RHEUMATOLOGY, V39, P3, DOI 10.1093/rheumatology/39.suppl_2.3; Schellekens GA, 1998, J CLIN INVEST, V101, P273, DOI 10.1172/JCI1316; Schellekens GA, 2000, ARTHRITIS RHEUM-US, V43, P155, DOI 10.1002/1529-0131(200001)43:1<155::AID-ANR20>3.0.CO;2-3; SEBBAG M, 1995, J CLIN INVEST, V95, P2672, DOI 10.1172/JCI117969; SHMERLING RH, 1991, AM J MED, V91, P528, DOI 10.1016/0002-9343(91)90190-9; SIMON M, 1993, J CLIN INVEST, V92, P1387, DOI 10.1172/JCI116713; Snir O, 2009, ANN RHEUM DIS, V68, P736, DOI 10.1136/ard.2008.091355; Soutullo A, 2007, J MOL RECOGNIT, V20, P227, DOI 10.1002/jmr.825; Takizawa Y, 2006, ANN RHEUM DIS, V65, P1013, DOI 10.1136/ard.2005.044743; Tarcsa E, 1996, J BIOL CHEM, V271, P30709, DOI 10.1074/jbc.271.48.30709; Trier NH, 2012, PROTEIN SCI, V21, P1929, DOI 10.1002/pro.2178; van der Helm-van Mil AHM, 2007, ARTHRITIS RHEUM, V56, P425, DOI 10.1002/art.22373; van der Woude D, 2010, ANN RHEUM DIS, V69, P1554, DOI 10.1136/ard.2009.124537; van Venrooij WJ, 2008, ANN NY ACAD SCI, V1143, P268, DOI 10.1196/annals.1443.013; Visser H, 1996, ANN RHEUM DIS, V55, P157, DOI 10.1136/ard.55.3.157; Vossenaar ER, 2004, ARTHRITIS RES THER, V6, pR142, DOI 10.1186/ar1149; Waaler E, 2007, APMIS, V115, P422; Wesoly J, 2005, ARTHRITIS RHEUM-US, V52, P2948, DOI 10.1002/art.21294; WILLIAMSON MP, 1986, INT J PEPT PROT RES, V27, P562	49	19	19	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2016	11	12							e0168542	10.1371/journal.pone.0168542	http://dx.doi.org/10.1371/journal.pone.0168542			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI9TW	28002483	gold, Green Published, Green Submitted			2022-12-27	WOS:000392853100052
J	Adamatzky, A				Adamatzky, Andrew			On Emulation of Flueric Devices in Excitable Chemical Medium	PLOS ONE			English	Article							BELOUSOV-ZHABOTINSKY REACTION; EXPERIMENTAL IMPLEMENTATION; BINARY COLLISIONS; WAVE-PROPAGATION; MODEL; DYNAMICS; GATES; FRAGMENTS; SYSTEMS; MEMORY	Flueric devices are fluidic devices without moving parts. Fluidic devices use fluid as a medium for information transfer and computation. A Belousov-Zhabotinsky (BZ) medium is a thin-layer spatially extended excitable chemical medium which exhibits travelling excitation wave-fronts. The excitation wave-fronts transfer information. Flueric devices compute via jets interaction. BZ devices compute via excitation wave-fronts interaction. In numerical model of BZ medium we show that functions of key flueric devices are implemented in the excitable chemical system: signal generator, AND, XOR, NOT and NOR Boolean gates, delay elements, diodes and sensors. Flueric devices have been widely used in industry since late 1960s and are still employed in automotive and aircraft technologies. Implementation of analog of the flueric devices in the excitable chemical systems opens doors to further applications of excitation wave-based unconventional computing in soft robotics, embedded organic electronics and living technologies.	[Adamatzky, Andrew] Univ West England, Bristol, Avon, England	University of West England	Adamatzky, A (corresponding author), Univ West England, Bristol, Avon, England.	andrew.adamatzky@uwe.ac.uk						Adamatzky A, 2004, CHAOS SOLITON FRACT, V21, P1259, DOI 10.1016/j.chaos.2003.12.068; Adamatzky A, 2004, MAT SCI ENG C-BIO S, V24, P541, DOI 10.1016/j.msec.2004.02.002; Adamatzky A, 2002, NATURWISSENSCHAFTEN, V89, P474, DOI 10.1007/s00114-002-0363-6; Adamatzky A., ARXIV10052301; Adamatzky A, 2007, CHAOS SOLITON FRACT, V34, P307, DOI 10.1016/j.chaos.2006.03.095; Adamatzky A, 2015, PHYS REV E, V92, DOI 10.1103/PhysRevE.92.032811; Adamatzky A, 2014, MATER TODAY, V17, P86, DOI 10.1016/j.mattod.2014.01.018; Adamatzky A, 2011, INT J BIFURCAT CHAOS, V21, P1977, DOI 10.1142/S0218127411029574; Adamatzky A, 2011, ISR J CHEM, V51, P56, DOI 10.1002/ijch.201000046; Adamatzky A, 2009, PHYS LETT A, V374, P264, DOI 10.1016/j.physleta.2009.10.072; Agladze K, 1996, J PHYS CHEM-US, V100, P13895, DOI 10.1021/jp9608990; Amemiya T, 1998, J PHYS CHEM A, V102, P4537, DOI 10.1021/jp980189p; [Anonymous], 1982, WINNING WAYS YOUR MA; [Anonymous], BIOFLZIKA; [Anonymous], 1959, COMPIL ABSTR RADIAT; Arai M, 2016, J PHYS CHEM B, V120, P4654, DOI 10.1021/acs.jpcb.6b02850; ATRUBIN AJ, 1965, IEEE TRANS ELECTRON, VEC14, P394, DOI 10.1109/PGEC.1965.264145; Avery HowardW., 1967, US Patent, Patent No. [3,350,008, 3350008]; Azhand A, 2014, EPL-EUROPHYS LETT, V108, DOI 10.1209/0295-5075/108/10004; Banks ER., 1971, INFORM PROCESSING TR; Beato V, 2003, PROC SPIE, V5114, P353, DOI 10.1117/12.490183; BEEKEN BB, 1970, I&CS-CONTROL TECH EN, V43, P75; Beeken BB, 1970, HIGH SENSITIVITY FLU; Belsterling C.A., 1971, FLUIDIC SYSTEMS DESI; Bowles RE., 1965, US Patent, Patent No. [3,191,623, 3191623]; Briant N., 1964, US Patent, Patent No. [3,136,326, 3136326]; Chapline J.S., 1965, US Patent, Patent No. [3,201,041, 3201041]; Coanda H., 1938, PROPELLING DEVICE; Conway A, 1971, GUIDE TO FLUIDICS; Costello BD, 2005, CHAOS SOLITON FRACT, V25, P535, DOI 10.1016/j.chaos.2004.11.056; Costello B, 2011, CHEM PHYS, V381, P88, DOI 10.1016/j.chemphys.2011.01.014; Costello BD, 2009, PHYS REV E, V79, DOI 10.1103/PhysRevE.79.026114; DOCKERY JD, 1988, PHYSICA D, V30, P177, DOI 10.1016/0167-2789(88)90105-4; Dummer GWA, 2013, PERGAMON ELECT DATA; Escuela G, 2014, NAT COMPUT, V13, P247, DOI 10.1007/s11047-013-9384-7; Fang Y, 2016, SCI ADV, V2, DOI 10.1126/sciadv.1601114; FIELD RJ, 1974, J CHEM PHYS, V60, P1877, DOI 10.1063/1.1681288; FISCHER PC, 1965, J ACM, V12, P388, DOI 10.1145/321281.321290; Foster RH, 1963, US Patent, Patent No. [3,071,157, 3071157]; FREDKIN E, 1982, INT J THEOR PHYS, V21, P219, DOI 10.1007/BF01857727; Gehring J.A.J., 1965, US Patent, Patent No. [3,190,554, 3190554]; Gentili PL, 2012, INT J UNCONV COMPUT, V8, P177; Gorecka J, 2003, PHYS REV E, V67, DOI 10.1103/PhysRevE.67.067203; Gorecki J, 2003, J PHYS CHEM A, V107, P1664, DOI 10.1021/jp021041f; Gorecki J, 2015, PHILOS T R SOC A, V373, DOI 10.1098/rsta.2014.0219; Gorecki J, 2014, PHYS REV E, V89, DOI 10.1103/PhysRevE.89.042910; Gorecki J, 2006, INT J UNCONVENTIONAL, V2; Gorecki J., 2009, NAT COMPUT, V8, P473, DOI DOI 10.1007/s11047-009-9119-y; Gruenert G, 2014, INT J NEURAL SYST; Gruenert G, 2015, INT J NEURAL SYST, V25, DOI 10.1142/S0129065714500324; Gunji YP, 2011, COMPLEX SYST, V20, P93, DOI 10.25088/ComplexSystems.20.2.93; Guo S, 2015, INT J UNCONVENTIONAL; Hastings HM, 2016, J PHYS CHEM A, V120, P8006, DOI 10.1021/acs.jpca.6b06285; Henson A, 2015, PHILOS T R SOC A, V373, DOI 10.1098/rsta.2014.0221; Hsu TJ, 1994, CHEM ENG SCI, V49, P5291, DOI 10.1016/0009-2509(94)00278-9; Ichino T, 2008, J PHYS CHEM C, V112, P3032, DOI 10.1021/jp7097922; Igarashi Y, 2006, LECT NOTES COMPUT SC, V4135, P130; Igarashi Y, 2011, INT J UNCONV COMPUT, V7, P141; JAHNKE W, 1989, J PHYS CHEM-US, V93, P740, DOI 10.1021/j100339a047; Jakubowski M. H., 1996, Complex Systems, V10, P1; Kaminaga A, 2006, ANGEW CHEM INT EDIT, V45, P3087, DOI 10.1002/anie.200600400; Kirshner J. M., 1975, DESIGN THEORY FLUIDI; Kitahata H, 2004, J PHYS CHEM B, V108, P18956, DOI 10.1021/jp048003b; Kitahata H, 2011, PHYS REV E, V84, DOI 10.1103/PhysRevE.84.015101; KRUG HJ, 1990, J PHYS CHEM-US, V94, P4862, DOI 10.1021/j100375a021; Kuhnert L., 1986, NEW OPTICAL PHOTOCHE; Kuhnert Lothar, 1989, IMAGE PROCESSING USI; Liu SB, 2015, SOFT MATTER, V11, P449, DOI 10.1039/c4sm02252a; Margolus Norman, 2002, COLLISION BASED COMP, P107, DOI DOI 10.1007/978-1-4471-0129-1_5; Martinez GJ, 2010, GAME OF LIFE CELLULAR AUTOMATA, P547, DOI 10.1007/978-1-84996-217-9_27; McNamara HM, 2016, PHYS REV X, V6, DOI 10.1103/PhysRevX.6.031001; Mikhailov AS, 2006, PHYS REP, V425, P79, DOI 10.1016/j.physrep.2005.11.003; Morgan AJ, 2016, ARXIV160201084; Motoike IN, 2001, PHYS REV E, V63, DOI 10.1103/PhysRevE.63.036220; Moylan MJ., 1968, FLUID LOGIC SIMPLE T; Nakata S, 2006, J PHYS CHEM A, V110, P3633, DOI 10.1021/jp056881j; Paul F.W., 1969, IFAC S FLUIDICS, V1, P1; Peter B., 1965, AND GATE; Pullela SR, 2009, PHYS CHEM CHEM PHYS, V11, P4236, DOI 10.1039/b820464k; Rambidi NG, 2001, PHYS REV E, V63, DOI 10.1103/PhysRevE.63.026607; Sendina-Nadal I, 2001, PHYS REV LETT, V86, P1646, DOI 10.1103/PhysRevLett.86.1646; Sevcikova H, 1996, J PHYS CHEM-US, V100, P19153, DOI 10.1021/jp961789w; Sielewiesiuk J, 2001, J PHYS CHEM A, V105, P8189, DOI 10.1021/jp011072v; Squier R. K., 1994, Complex Systems, V8, P311; Steinbock O, 1996, J PHYS CHEM-US, V100, P18970, DOI 10.1021/jp961209v; STEINBOCK O, 1995, SCIENCE, V267, P868, DOI 10.1126/science.267.5199.868; Stevens WM, 2012, PHYS REV E, V85, DOI 10.1103/PhysRevE.85.066129; Stovold James, 2012, Information Processing in Cells and Tissues. Proceedings of the 9th International Conference, IPCAT 2012, P143, DOI 10.1007/978-3-642-28792-3_19; Stovold J., 2016, INT J PARALLEL EMERG, P1; Stovold J, 2017, EMERGENCE COMPLEX CO, V23, P141, DOI 10.1007/978-3-319-33921-4_6; Sun MZ, 2013, J CHEM PHYS, V138, DOI 10.1063/1.4794995; Sun MZ, 2015, INT J UNCONVENTIONAL; Taboada JJ, 1994, CHAOS, V4, P519, DOI 10.1063/1.166030; Takigawa-Imamura H, 2011, NEURAL NETWORKS, V24, P1143, DOI 10.1016/j.neunet.2011.05.003; Tesla N, 1920, US Patent, Patent No. [1,329,559, 1329559]; TOMITA K, 1979, PHYS LETT A, V71, P489, DOI 10.1016/0375-9601(79)90644-3; TOTH A, 1994, J PHYS CHEM-US, V98, P522, DOI 10.1021/j100053a029; Toth R, 2009, CHAOS SOLITON FRACT, V41, P1605, DOI 10.1016/j.chaos.2008.07.001; Toth Rita, 2010, THEORETICAL TECHNOLO, P162; Tsuda S, 2004, BIOSYSTEMS, V73, P45, DOI 10.1016/j.biosystems.2003.08.001; Vanag VK, 2000, J PHYS CHEM A, V104, P11566, DOI 10.1021/jp002390h; Vazquez-Otero A, 2014, INT J UNCONV COMPUT, V10, P295; WAKSMAN A, 1966, INFORM CONTROL, V9, P66, DOI 10.1016/S0019-9958(66)90110-0; Wang AL, 2016, EUR PHYS J-SPEC TOP, V225, P211, DOI 10.1140/epjst/e2016-02622-y; Wang XQ, 2015, J POLYM SCI A; WINFREE AT, 1989, J PHYS CHEM-US, V93, P2823, DOI 10.1021/j100344a025; Yokoi H, 2004, INT J BIFURCAT CHAOS, V14, P3347, DOI 10.1142/S0218127404011363; Yoshii M, 2016, LANGMUIR, V32, P3901, DOI 10.1021/acs.langmuir.6b00337; Yoshikawa K, 2009, INT J UNCONV COMPUT, V5, P3; Zhang GM, 2012, J CHEM PHYS, V136, DOI 10.1063/1.3702846	111	5	5	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2016	11	12							e0168267	10.1371/journal.pone.0168267	http://dx.doi.org/10.1371/journal.pone.0168267			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI9QF	27997561	Green Published, Green Submitted, gold			2022-12-27	WOS:000392842900029
J	Khajah, MA; Ananthalakshmi, KV; Edafiogho, I				Khajah, Maitham A.; Ananthalakshmi, Kethireddy V.; Edafiogho, Ivan			Anti-Inflammatory Properties of the Enaminone E121 in the Dextran Sulfate Sodium (DSS) Colitis Model	PLOS ONE			English	Article							NF-KAPPA-B; INFLAMMATORY-BOWEL-DISEASE; NITRIC-OXIDE-SYNTHASE; INTESTINAL EPITHELIAL-CELLS; ANTICONVULSANT ACTIVITY; ULCERATIVE-COLITIS; CROHNS-DISEASE; SIGNALING PATHWAY; PATHOGENESIS; EXPRESSION	Background Enaminones are synthetic compounds with an established role in the prevention of various forms of seizures. Recent evidence suggests potent anti-tussive, bronchodilation and antiinflammatory properties. Pre-treatment with particularly E121 compound resulted in a decrease in leukocyte recruitment in the ovalbumin induced-model of asthma, immune cell proliferation and cytokine release in vitro. We hypothesize that E121 might serve as a therapeutic potential in intestinal inflammation through modulating immune cell functions. Methods Colitis was induced by daily dextran sulfate sodium (DSS) administration for 5 days, and its severity was determined by gross and histological assessments. The plasma level of various cytokines was measured using flow cytometry-based assay. The colonic expression/phosphorylation level of various molecules was determined by immunofluorescence and western blotting. The effects of E121 treatment on in vitro neutrophil chemotaxis (under-agarose assay), superoxide release (luminol oxidation assay) and apoptosis (annexin V/7AAD) were also determined. Results DSS-induced colitis in mice was significantly reduced by daily E121 treatment (30-100 mg/kg) at gross and histological levels. This effect was due to modulated plasma levels of interleukin (IL-2) and colonic expression levels of various signaling molecules and proteins involved in apoptosis. In vitro neutrophil survival, chemotaxis, and superoxide release were also reduced by E121 treatment. Conclusion Our results indicate important anti-inflammatory actions of E121 in the pathogenesis of IBD.	[Khajah, Maitham A.; Ananthalakshmi, Kethireddy V.] Kuwait Univ, Fac Pharm, Safat, Kuwait; [Edafiogho, Ivan] Univ St Joseph, Sch Pharm, Dept Pharmaceut Sci, Hartford, CT USA	Kuwait University	Khajah, MA (corresponding author), Kuwait Univ, Fac Pharm, Safat, Kuwait.	maitham@hsc.edu.kw	Khajah, Maitham/AAZ-8841-2020		Kuwait University Research Sector grant [PT03/15];  [SRUL02/13]	Kuwait University Research Sector grant; 	This work was supported by Kuwait University Research Sector grant PT03/15. Parts of this work were supported by grant SRUL02/13 to the Research Unit for Genomics, Proteomics and Cellomics Studies (OMICS), Kuwait University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmad R, 2014, MUCOSAL IMMUNOL, V7, P1340, DOI 10.1038/mi.2014.21; Ananthalakshmi KVV, 2006, NEUROSCIENCE, V141, P345, DOI 10.1016/j.neuroscience.2006.03.021; Ananthalakshmi KVV, 2007, EPILEPSY RES, V76, P85, DOI 10.1016/j.eplepsyres.2007.07.001; Anderson SL, 2016, EQUINE VET J, V2016, P12576; Anselmi L, 2015, NEUROGASTROENT MOTIL, V27, P509, DOI 10.1111/nmo.12521; Arumugam S, 2015, CYTOKINE, V74, P305, DOI 10.1016/j.cyto.2015.03.017; Bai JA, 2015, WORLD J GASTROENTERO, V21, P6180, DOI 10.3748/wjg.v21.i20.6180; Baumgart DC, 2007, LANCET, V369, P1627, DOI 10.1016/S0140-6736(07)60750-8; BEAL MF, 1995, ANN NEUROL, V38, P357, DOI 10.1002/ana.410380304; Beck PL, 2007, GASTROENTEROLOGY, V132, P1778, DOI 10.1053/j.gastro.2007.01.032; Becker C, 2001, J IMMUNOL, V167, P2608, DOI 10.4049/jimmunol.167.5.2608; Becker C, 2006, J IMMUNOL, V177, P2760, DOI 10.4049/jimmunol.177.5.2760; Berg DJ, 1996, J CLIN INVEST, V98, P1010, DOI 10.1172/JCI118861; Bocker U, 1998, GASTROENTEROLOGY, V115, P1426, DOI 10.1016/S0016-5085(98)70021-6; BOUGHTONSMITH NK, 1993, LANCET, V342, P338, DOI 10.1016/0140-6736(93)91476-3; Chassaing B, 2014, CURR PROTOC IMMUNOL, V2014; Chen TT, 2015, AM J PATHOL, V185, P2441, DOI 10.1016/j.ajpath.2015.05.020; Cory S, 2002, NAT REV CANCER, V2, P647, DOI 10.1038/nrc883; Crespo I, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050407; DANNHARDT G, 1993, ARZNEIMITTEL-FORSCH, V43-1, P441; Dominguez JN, 1997, J MED CHEM, V40, P2726, DOI 10.1021/jm970266p; Du CY, 2000, CELL, V102, P33, DOI 10.1016/S0092-8674(00)00008-8; Duerr RH, 2006, SCIENCE, V314, P1461, DOI 10.1126/science.1135245; Edafiogho IO, 2002, BIOORGAN MED CHEM, V10, P593, DOI 10.1016/S0968-0896(01)00314-5; EDAFIOGHO IO, 1992, J MED CHEM, V35, P2798, DOI 10.1021/jm00093a012; Edafiogho IO, 2007, J PHARM SCI-US, V96, P2509, DOI 10.1002/jps.20967; Edafiogho IO, 2014, EUR J MED CHEM, V76, P20, DOI 10.1016/j.ejmech.2014.02.002; Eddington ND, 2002, EUR J MED CHEM, V37, P635, DOI 10.1016/S0223-5234(02)01377-6; Eddington ND, 2000, CURR MED CHEM, V7, P417, DOI 10.2174/0929867003375092; Edelblum KL, 2008, GASTROENTEROLOGY, V135, P539, DOI 10.1053/j.gastro.2008.04.025; El-Hashim AZ, 2011, LIFE SCI, V89, P378, DOI 10.1016/j.lfs.2011.07.007; Fan H, 2014, J ETHNOPHARMACOL, V154, P88, DOI 10.1016/j.jep.2014.03.021; Ferrari R, 1996, J CARDIOVASC PHARM, V28, pS1; Foster JE, 1999, BIOORGAN MED CHEM, V7, P2415, DOI 10.1016/S0968-0896(99)00185-6; Fujino S, 2003, GUT, V52, P65, DOI 10.1136/gut.52.1.65; Fuss IJ, 1996, J IMMUNOL, V157, P1261; Gayle JM, 2000, J AM VET MED ASSOC, V217, P498, DOI 10.2460/javma.2000.217.498; Gelbmann CM, 2003, GUT, V52, P1448, DOI 10.1136/gut.52.10.1448; Ghobrial IM, 2005, CA-CANCER J CLIN, V55, P178, DOI 10.3322/canjclin.55.3.178; Halpert G, 2014, J BIOL CHEM, V289, P17215, DOI 10.1074/jbc.M113.536664; Heit B, 2002, J CELL BIOL, V159, P91, DOI 10.1083/jcb.200202114; Heit B, 2008, NAT IMMUNOL, V9, P743, DOI 10.1038/ni.1623; Hill MM, 2004, EMBO J, V23, P2134, DOI 10.1038/sj.emboj.7600210; Hirota SA, 2011, INFLAMM BOWEL DIS, V17, P1359, DOI 10.1002/ibd.21478; Holtmann MH, 2004, CURR MOL MED, V4, P439, DOI 10.2174/1566524043360636; Hommes D, 2002, GASTROENTEROLOGY, V122, P7, DOI 10.1053/gast.2002.30770; Huang XL, 2011, INFLAMM RES, V60, P727, DOI 10.1007/s00011-011-0325-6; Iimura M, 2000, GUT, V47, P228, DOI 10.1136/gut.47.2.228; Impellizzeri D, 2015, CLIN NUTR, V34, P1146, DOI 10.1016/j.clnu.2014.11.012; Jin X., 2015, INFLAMMATION, P3; Leon AJ, 2006, MED CLIN-BARCELONA, V127, P145, DOI 10.1157/13090382; Khajah M, 2013, J IMMUNOL, V190, P2208, DOI 10.4049/jimmunol.1200322; Khajah M, 2011, J LEUKOCYTE BIOL, V89, P945, DOI 10.1189/jlb.0809546; Khajah MA, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0150861; Kombian SB, 2005, BRIT J PHARMACOL, V145, P945, DOI 10.1038/sj.bjp.0706250; KORSMEYER SJ, 1995, BBA-MOL BASIS DIS, V1271, P63, DOI 10.1016/0925-4439(95)00011-R; KRISHNA M, 1995, MODERN PATHOL, V8, P654; Laroui H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032084; LI P, 1991, CELL, V64, P479, DOI 10.1016/0092-8674(91)90228-Q; Lieber JG, 2004, BLOOD, V103, P852, DOI 10.1182/blood-2003-04-1030; Liu X, 2016, BIOCHEM PHARMACOL, V2952, P30075; Locksley RM, 2001, CELL, V104, P487, DOI 10.1016/S0092-8674(01)00237-9; Los M, 2001, TRENDS IMMUNOL, V22, P31, DOI 10.1016/S1471-4906(00)01814-7; LOTEM J, 1995, CELL GROWTH DIFFER, V6, P647; LUNDBERG JON, 1994, LANCET, V344, P1673, DOI 10.1016/S0140-6736(94)90460-X; Marquez-Flores YK, 2016, J NUTR BIOCHEM, V30, P143, DOI 10.1016/j.jnutbio.2015.12.002; Martinon F, 2004, CELL, V117, P561, DOI 10.1016/j.cell.2004.05.004; MIDDLETON SJ, 1993, LANCET, V341, P465, DOI 10.1016/0140-6736(93)90211-X; MIYASHITA T, 1994, CANCER RES, V54, P3131; Monteleone G, 1997, GASTROENTEROLOGY, V112, P1169, DOI 10.1016/S0016-5085(97)70128-8; Natsui M, 1997, J GASTROEN HEPATOL, V12, P801, DOI 10.1111/j.1440-1746.1997.tb00375.x; Neurath MF, 1996, NAT MED, V2, P998, DOI 10.1038/nm0996-998; Pallone F, 2001, CURR OPIN GASTROEN, V17, P307, DOI 10.1097/00001574-200107000-00002; Papadakis KA, 2000, ANNU REV MED, V51, P289, DOI 10.1146/annurev.med.51.1.289; Park S, 2014, EUR J PHARMACOL, V735, P184, DOI 10.1016/j.ejphar.2014.04.024; Pasparakis M, 2009, NAT REV IMMUNOL, V9, P778, DOI 10.1038/nri2655; Peng XD, 2010, J PHARMACOL EXP THER, V332, P46, DOI 10.1124/jpet.109.153494; Perse M, 2012, J BIOMED BIOTECHNOL, V2012, P14; Piao JH, 2012, IMMUNOL CELL BIOL, V90, P881, DOI 10.1038/icb.2012.22; Piao JH, 2011, J BIOL CHEM, V286, P17879, DOI 10.1074/jbc.M111.221853; Plevy SE, 1997, J IMMUNOL, V159, P6276; Ponder Alexis, 2013, Clin Epidemiol, V5, P237, DOI 10.2147/CLEP.S33961; Poritz LS, 2007, J SURG RES, V140, P12, DOI 10.1016/j.jss.2006.07.050; Qian J, 2016, MOL IMMUNOL, V75, P48, DOI 10.1016/j.molimm.2016.05.011; Qiao YQ, 2013, J DIGEST DIS, V14, P244, DOI 10.1111/1751-2980.12044; Qualls JE, 2006, J LEUKOCYTE BIOL, V80, P802, DOI 10.1189/jlb.1205734; Regeling A, 2016, BBA-MOL BASIS DIS, V1862, P788, DOI 10.1016/j.bbadis.2016.01.020; Reifen R, 2015, NUTRITION, V31, P1402, DOI 10.1016/j.nut.2015.05.011; Rogler G, 1998, GASTROENTEROLOGY, V115, P357, DOI 10.1016/S0016-5085(98)70202-1; SARTOR RB, 1995, GASTROENTEROL CLIN N, V24, P475; Sartor RB, 2006, NAT CLIN PRACT GASTR, V3, P390, DOI 10.1038/ncpgasthep0528; Sartor RB, 1997, AM J GASTROENTEROL, V92, pS5; Sax JK, 2002, NAT CELL BIOL, V4, P842, DOI 10.1038/ncb866; SCOTT KR, 1995, J MED CHEM, V38, P4033, DOI 10.1021/jm00020a019; SCOTT KR, 1993, J MED CHEM, V36, P1947, DOI 10.1021/jm00066a003; Sklyarov AY, 2011, J PHYSIOL PHARMACOL, V62, P65; Sun J, 2015, INT J CLIN EXP MED, V8, P358; TAN S, 1993, FREE RADICAL BIO MED, V15, P407, DOI 10.1016/0891-5849(93)90040-2; Tang QY, 2015, DIGEST DIS SCI, V60, P393, DOI 10.1007/s10620-014-3189-0; Thoreson R, 2007, SURG CLIN N AM, V87, P575, DOI 10.1016/j.suc.2007.03.001; Tirosh O, 2007, NUTRITION, V23, P878, DOI 10.1016/j.nut.2007.08.019; Vallabhapurapu S, 2009, ANNU REV IMMUNOL, V27, P693, DOI 10.1146/annurev.immunol.021908.132641; Wajant H, 2002, SCIENCE, V296, P1635, DOI 10.1126/science.1071553; Wang LX, 2003, J IMMUNOL, V171, P3194, DOI 10.4049/jimmunol.171.6.3194; Wirtz S, 2007, NAT PROTOC, V2, P541, DOI 10.1038/nprot.2007.41; Xu AT, 2015, INFLAMM BOWEL DIS, V21, P241, DOI 10.1097/MIB.0000000000000267; YAMADA T, 1991, KLIN WOCHENSCHR, V69, P988, DOI 10.1007/BF01645144; Yamaguchi O, 2004, J CLIN INVEST, V114, P937, DOI 10.1172/JCI200420317; Yasukawa K, 2012, FREE RADICAL RES, V46, P1427, DOI 10.3109/10715762.2012.732698	109	7	7	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2016	11	12							e0168567	10.1371/journal.pone.0168567	http://dx.doi.org/10.1371/journal.pone.0168567			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI9QF	27997590	Green Published, gold, Green Submitted			2022-12-27	WOS:000392842900059
J	Prosperini, L; de Rossi, N; Scarpazza, C; Moiola, L; Cosottini, M; Gerevini, S; Capra, R				Prosperini, Luca; de Rossi, Nicola; Scarpazza, Cristina; Moiola, Lucia; Cosottini, Mirco; Gerevini, Simonetta; Capra, Ruggero		Italian PML Study Grp	Natalizumab-Related Progressive Multifocal Leukoencephalopathy in Multiple Sclerosis: Findings from an Italian Independent Registry	PLOS ONE			English	Article							RECONSTITUTION INFLAMMATORY SYNDROME; TREATED MS PATIENTS; PML-IRIS; JC; PATIENT; MRI; RECOMMENDATIONS; DISABILITY; PATTERN; RISK	Background The monoclonal antibody natalizumab (NTZ) is a highly effective treatment for patients with multiple sclerosis (MS). However, this drug is associated with increased risk of developing Progressive Multifocal Leukoencephalopathy (PML), an opportunistic infection of central nervous system (CNS) caused by the John Cunningham polyomavirus (JCV). Objective To describe the 12-month clinical course of 39 patients with MS (28 women, 11 men) who developed NTZ-related PML after a mean exposure of 39 infusions. Methods An Italian independent collaborative repository initiative collected and analyzed socio-demographic, clinical, magnetic resonance imaging (MRI) data and number of JCV-DNA copies detected on cerebrospinal fluid (CSF) samples of patients diagnosed as affected by NTZ-related PML. The evolution of disability, measured by the Expanded Disability Status Scale, was assessed at NTZ start, at PML diagnosis and after 2, 6 and 12 months from PML diagnosis. The effect of clinical and paraclinical characteristics at PML diagnosis on the final outcome was also investigated. Results Ten patients (25.6%) were diagnosed before 24 NTZ infusions. In six cases (15.4%) the PML suspect was made on the basis of highly suggestive MRI findings in absence of any detectable change of clinical conditions (asymptomatic PML). In patients with symptomatic PML, the diagnosis was quicker for those who presented with cognitive symptoms (n = 12) rather than for those with other neurological pictures (n = 21) (p = 0.003). Three patients (7.7%) died during the 12-month observation period, resulting in a survival rate of 92.3%. Asymptomatic PML, more localized brain involvement and gadolinium-enhancement detected at MRI, as well as lower viral load were associated with a better disability outcome (p-values<0.01). Conclusion Our findings support that early PML diagnosis, limited CNS involvement and initial signs of immune restoration are associated with a better outcome and higher survival rate, and confirm the utility of MRI as a surveillance tool for NTZ-treated patients.	[Prosperini, Luca] Sapienza Univ, Dept Neurol & Psychiat, Viale Univ, Rome, Italy; [de Rossi, Nicola; Scarpazza, Cristina; Capra, Ruggero] Spedali Civili Brescia, Multiple Sclerosis Ctr, Via Ciotti, Brescia, Italy; [Moiola, Lucia] Ist Sci San Raffaele, Dept Neurol, Milan, Italy; [Cosottini, Mirco] Univ Pisa, Dept Translat Res & New Surg & Med Technol, Via Paradisa, Pisa, Italy; [Gerevini, Simonetta] Univ Vita Salute San Raffaele, Dept Neuroradiol, San Raffaele Sci Inst, Via Olgettina, Milan, Italy	Sapienza University Rome; Hospital Spedali Civili Brescia; Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; University of Pisa; Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele	Prosperini, L (corresponding author), Sapienza Univ, Dept Neurol & Psychiat, Viale Univ, Rome, Italy.	luca.prosperini@uniroma1.it	Gerevini, Simonetta/ABC-4068-2020; Scarpazza, Cristina/AAA-2306-2022; Moiola, Lucia/AAN-5568-2020; Gerevini, Simonetta/AAL-9594-2020; Prosperini, Luca/K-5712-2016; Cosottini, Mirco/K-7991-2016	Gerevini, Simonetta/0000-0002-2374-194X; Scarpazza, Cristina/0000-0002-4126-426X; Gerevini, Simonetta/0000-0002-2374-194X; Cosottini, Mirco/0000-0001-9400-6574; moiola, lucia/0000-0001-6313-4952; Prosperini, Luca/0000-0003-3237-6267				Baldwin KJ, 2013, CURR OPIN NEUROL, V26, P318, DOI 10.1097/WCO.0b013e328360279f; Berger JR, 2013, NEUROLOGY, V80, P1430, DOI 10.1212/WNL.0b013e31828c2fa1; Blinkenberg M, 2013, MULT SCLER J, V19, P1226, DOI 10.1177/1352458513481010; Boster AL, 2013, JAMA NEUROL, V70, P398, DOI 10.1001/jamaneurol.2013.1960; Cinque P, 2003, J NEUROVIROL, V9, P88, DOI 10.1080/13550280390195298; Cinque P, 2009, LANCET INFECT DIS, V9, P625, DOI 10.1016/S1473-3099(09)70226-9; Clifford DB, 2015, CURR OPIN NEUROL, V28, P295, DOI 10.1097/WCO.0000000000000200; Clifford DB, 2010, LANCET NEUROL, V9, P438, DOI 10.1016/S1474-4422(10)70028-4; Dong-Si T, 2014, ANN CLIN TRANSL NEUR, V1, P755, DOI 10.1002/acn3.114; Du Pasquier RA, 2003, J NEUROVIROL, V9, P25, DOI 10.1080/13550280390195315; Gheuens S, 2012, NEUROLOGY, V78, P1390, DOI [10.1212/WNL.0b013e318253d61e, 10.1212/01.wnl.0000423208.11698.16]; Ghezzi A, 2011, NEUROL SCI, V32, P351, DOI 10.1007/s10072-010-0469-0; Gorelik L, 2010, ANN NEUROL, V68, P295, DOI 10.1002/ana.22128; Hobart J, 2000, BRAIN, V123, P1027, DOI 10.1093/brain/123.5.1027; Hoepner R, 2016, MULT SCLER; Hunt David, 2012, Pract Neurol, V12, P25, DOI 10.1136/practneurol-2011-000092; Ikazabo RNN, 2016, CLIN THER, V38, P670, DOI 10.1016/j.clinthera.2016.01.010; Kappos L, 2011, LANCET NEUROL, V10, P745, DOI 10.1016/S1474-4422(11)70149-1; KURTZKE JF, 1983, NEUROLOGY, V33, P1444, DOI 10.1212/WNL.33.11.1444; McGuigan C, 2016, J NEUROL NEUROSUR PS, V87, P117, DOI 10.1136/jnnp-2015-311100; Minneboo A, 2004, ARCH NEUROL-CHICAGO, V61, P217, DOI 10.1001/archneur.61.2.217; Miskin DP, 2016, ANN CLIN TRANSL NEUR, V3, P386, DOI 10.1002/acn3.301; Ontaneda D, 2016, NEUROLOGY, V86, P484; Pavlovic D, 2015, THER ADV NEUROL DISO, V8, P255, DOI 10.1177/1756285615602832; Phan-Ba R, 2012, NEUROLOGY, V79, P1067, DOI 10.1212/WNL.0b013e31826846b4; Plavina T, 2014, ANN NEUROL, V76, P802, DOI 10.1002/ana.24286; Richert N, 2012, MULT SCLER J, V18, P27; Tan CS, 2010, LANCET NEUROL, V9, P425, DOI 10.1016/S1474-4422(10)70040-5; Tan IL, 2011, NEUROLOGY, V77, P1061, DOI 10.1212/WNL.0b013e31822e55e7; Traboulsee A, 2016, AM J NEURORADIOL, V37, P394, DOI 10.3174/ajnr.A4539; Tuan DS, 2015, J NEUROVIROL, V21, P637, DOI [10.1007/s13365-015-0316-4, 10.1007/s13365-015]; Vermersch P, 2011, NEUROLOGY, V76, P1697, DOI 10.1212/WNL.0b013e31821a446b; Warnke C, 2013, NEUROLOGY, V81, P1400, DOI 10.1212/WNL.0b013e3182a84101; Wattjes MP, 2016, J NEUROL NEUROSUR PS, V87, P879, DOI 10.1136/jnnp-2015-311411; Wattjes MP, 2015, NAT REV NEUROL, V11, P597, DOI 10.1038/nrneurol.2015.157; Wattjes MP, 2015, J NEUROL NEUROSUR PS, V86, P793, DOI 10.1136/jnnp-2014-308630; Wattjes MP, 2013, J NEUROL NEUROSUR PS, V84, P1176, DOI 10.1136/jnnp-2013-304986; Wollebo HS, 2015, ANN NEUROL, V77, P560, DOI 10.1002/ana.24371; YEDNOCK TA, 1992, NATURE, V356, P63, DOI 10.1038/356063a0; Yousry TA, 2012, ANN NEUROL, V72, P779, DOI 10.1002/ana.23676; Ytterberg C, 2008, J NEUROL, V255, P967, DOI 10.1007/s00415-008-0767-0	41	37	37	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2016	11	12							e0168376	10.1371/journal.pone.0168376	http://dx.doi.org/10.1371/journal.pone.0168376			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI9QF	27997580	Green Published, Green Submitted, gold			2022-12-27	WOS:000392842900039
J	Failmezger, J; Nitschel, R; Sanchez-Kopper, A; Kraml, M; Siemann-Herzberg, M				Failmezger, Jurek; Nitschel, Robert; Sanchez-Kopper, Andres; Kraml, Michael; Siemann-Herzberg, Martin			Site-Specific Cleavage of Ribosomal RNA in Escherichia coli-Based Cell-Free Protein Synthesis Systems	PLoS One			English	Article							FREE EXPRESSION SYSTEM; AMINO-ACID; GEL-ELECTROPHORESIS; DEGRADATION; TRANSLATION; BACTERIA; REGENERATION; STARVATION; RESOLUTION; PHOSPHATE	Cell-free protein synthesis, which mimics the biological protein production system, allows rapid expression of proteins without the need to maintain a viable cell. Nevertheless, cell free protein expression relies on active in vivo translation machinery including ribosomes and translation factors. Here, we examined the integrity of the protein synthesis machinery, namely the functionality of ribosomes, during (i) the cell-free extract preparation and (ii) the performance of in vitro protein synthesis by analyzing crucial components involved in translation. Monitoring the 16S rRNA, 23S rRNA, elongation factors and ribosomal protein Si, we show that processing of a cell-free extract results in no substantial alteration of the translation machinery. Moreover, we reveal that the 16S rRNA is specifically cleaved at helix 44 during in vitro translation reactions, resulting in the removal of the anti-Shine-Dalgarno sequence. These defective ribosomes accumulate in the cell-free system. We demonstrate that the specific cleavage of the 16S rRNA is triggered by the decreased concentrations of Mg2+. In addition, we provide evidence that helix 44 of the 30S ribosomal subunit serves as a point-of-entry for ribosome degradation in Escherichia coli. Our results suggest that Mg2+ homeostasis is fundamental to preserving functional ribosomes in cell-free protein synthesis systems, which is of major importance for cell-free protein synthesis at preparative scale, in order to create highly efficient technical in vitro systems.	[Failmezger, Jurek; Nitschel, Robert; Kraml, Michael; Siemann-Herzberg, Martin] Univ Stuttgart, Inst Biochem Engn, Stuttgart, Germany; [Sanchez-Kopper, Andres] Costa Rica Inst Technol, Ceqiatec, Cartago, Costa Rica	University of Stuttgart; Instituto Tecnologico de Costa Rica	Siemann-Herzberg, M (corresponding author), Univ Stuttgart, Inst Biochem Engn, Stuttgart, Germany.	siemann@ibvt.uni-stuttgart.de		SANCHEZ-KOPPER, ANDRES/0000-0002-8469-4366	Bundesministerium fur Bildung and Forschung	Bundesministerium fur Bildung and Forschung(Federal Ministry of Education & Research (BMBF))	This work was supported by the Bundesministerium fur Bildung and Forschung. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Basturea GN, 2011, RNA, V17, P338, DOI 10.1261/rna.2448911; BENHAMID.F, 1966, BIOCHIM BIOPHYS ACTA, V119, P183, DOI 10.1016/0005-2787(66)90049-9; Calhoun KA, 2007, IN VITRO TRANSCRIPTI, P3; Calhoun KA, 2006, J BIOTECHNOL, V123, P193, DOI 10.1016/j.jbiotec.2005.11.011; Caschera F, 2015, METAB ENG, V27, P29, DOI 10.1016/j.ymben.2014.10.007; Caschera F, 2014, BIOCHIMIE, V99, P162, DOI 10.1016/j.biochi.2013.11.025; Catherine C, 2013, BIOTECHNOL ADV, V31, P797, DOI 10.1016/j.biotechadv.2013.04.009; Chi EY, 2003, PHARM RES-DORDR, V20, P1325, DOI 10.1023/A:1025771421906; DAVIS BD, 1986, J BACTERIOL, V166, P439, DOI 10.1128/jb.166.2.439-445.1986; Deutscher MP, 2003, J BIOL CHEM, V278, P45041, DOI 10.1074/jbc.R300031200; DONG HJ, 1995, J BACTERIOL, V177, P1497, DOI 10.1128/jb.177.6.1497-1504.1995; Draper DE, 2005, ANNU REV BIOPH BIOM, V34, P221, DOI 10.1146/annurev.biophys.34.040204.144511; Freischmidt A, 2010, J BIOTECHNOL, V150, P44, DOI 10.1016/j.jbiotec.2010.07.017; Gabashvili IS, 2000, CELL, V100, P537, DOI 10.1016/S0092-8674(00)80690-X; GORISCH H, 1976, BIOCHEMISTRY-US, V15, P5743; Hardiman T, 2008, ANAL BIOCHEM, V374, P79, DOI 10.1016/j.ab.2007.09.032; Hazan R, 2004, J BACTERIOL, V186, P3663, DOI 10.1128/JB.186.11.3663-3669.2004; Hong SH, 2014, ACS SYNTH BIOL, V3, P398, DOI 10.1021/sb400140t; Katzen F, 2005, TRENDS BIOTECHNOL, V23, P150, DOI 10.1016/j.tibtech.2005.01.003; Kiga D, 2002, P NATL ACAD SCI USA, V99, P9715, DOI 10.1073/pnas.142220099; Kim DM, 1999, BIOTECHNOL BIOENG, V66, P180, DOI 10.1002/(SICI)1097-0290(1999)66:3<180::AID-BIT6>3.0.CO;2-S; Kim DM, 2001, BIOTECHNOL BIOENG, V74, P309, DOI 10.1002/bit.1121; Kim HC, 2009, J BIOSCI BIOENG, V108, P1, DOI 10.1016/j.jbiosc.2009.02.007; Kim RG, 2000, J BIOTECHNOL, V84, P27, DOI 10.1016/S0168-1656(00)00326-6; Kim TW, 2007, BIOTECHNOL BIOENG, V97, P1510, DOI 10.1002/bit.21337; Kim TW, 2006, J BIOTECHNOL, V124, P373, DOI 10.1016/j.jbiotec.2005.12.030; Liu DV, 2005, BIOTECHNOL PROGR, V21, P460, DOI 10.1021/bp049789y; MARUYAMA H, 1970, BIOCHIM BIOPHYS ACTA, V199, P159, DOI 10.1016/0005-2787(70)90704-5; Masek T, 2005, ANAL BIOCHEM, V336, P46, DOI 10.1016/j.ab.2004.09.010; MCCARTHY BJ, 1962, BIOCHIM BIOPHYS ACTA, V55, P880; Neidhardt, 1996, ESCHERICHIA COLI SAL; Paier A, 2015, SCI REPORTS, P5; Petrov AI, 2013, RNA, V19, P1327, DOI 10.1261/rna.039438.113; Piir K, 2011, EMBO REP, V12, P458, DOI 10.1038/embor.2011.47; PRATT JM, 1984, TRANSCRIPTION TRANSL, P179; Ramesh A, 2010, RNA BIOL, V7, P77, DOI 10.4161/rna.7.1.10490; Reddy K, 1987, CURRENT PROTOCOLS MO; Rimbon J, 2015, ENG LIFE SCI, V15, P499, DOI 10.1002/elsc.201400103; Schindler PT, 1999, ELECTROPHORESIS, V20, P806, DOI 10.1002/(SICI)1522-2683(19990101)20:4/5<806::AID-ELPS806>3.3.CO;2-9; Shenvi CL, 2005, RNA, V11, P1898, DOI 10.1261/rna.2192805; SHINE J, 1974, Proceedings of the National Academy of Sciences of the United States of America, V71, P1342, DOI 10.1073/pnas.71.4.1342; Smith MT, 2014, FEBS LETT, V588, P2755, DOI 10.1016/j.febslet.2014.05.062; Swartz J, 2006, J IND MICROBIOL BIOT, V33, P476, DOI 10.1007/s10295-006-0127-y; Tabuchi M, 2002, PROTEOMICS, V2, P430, DOI 10.1002/1615-9861(200204)2:4<430::AID-PROT430>3.0.CO;2-5; Underwood KA, 2005, BIOTECHNOL BIOENG, V91, P425, DOI 10.1002/bit.20529; Vesper O, 2011, CELL, V147, P147, DOI 10.1016/j.cell.2011.07.047; Vizcaino JA, 2016, NUCLEIC ACIDS RES, V44, pD447, DOI 10.1093/nar/gkv1145; Wang YR, 2009, BMC BIOTECHNOL, V9, DOI 10.1186/1472-6750-9-58; ZUBAY G, 1973, ANNU REV GENET, V7, P267, DOI 10.1146/annurev.ge.07.120173.001411; Zundel MA, 2009, RNA, V15, P977, DOI 10.1261/rna.1381309	50	13	14	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 19	2016	11	12							e0168764	10.1371/journal.pone.0168764	http://dx.doi.org/10.1371/journal.pone.0168764			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI9QC	27992588	Green Published, Green Submitted, gold			2022-12-27	WOS:000392842600097
J	Halme, HL; Parkkonen, L				Halme, Hanna-Leena; Parkkonen, Lauri			Comparing Features for Classification of MEG Responses to Motor Imagery	PLOS ONE			English	Article							BRAIN-COMPUTER INTERFACE; EEG; BCI; MOVEMENT; SOFTWARE; NEUROFEEDBACK; EXECUTION; PATTERNS; FILTERS; SIGNAL	Background Motor imagery (MI) with real-time neurofeedback could be a viable approach, e.g., in rehabilitation of cerebral stroke. Magnetoencephalography (MEG) noninvasively measures electric brain activity at high temporal resolution and is well-suited for recording oscillatory brain signals. MI is known to modulate 10-and 20-Hz oscillations in the somatomotor system. In order to provide accurate feedback to the subject, the most relevant MI-related features should be extracted from MEG data. In this study, we evaluated several MEG signal features for discriminating between left-and right-hand MI and between MI and rest. Methods MEG was measured from nine healthy participants imagining either left-or right-hand finger tapping according to visual cues. Data preprocessing, feature extraction and classification were performed offline. The evaluated MI-related features were power spectral density (PSD), Morlet wavelets, short-time Fourier transform (STFT), common spatial patterns (CSP), filter-bank common spatial patterns (FBCSP), spatio-spectral decomposition (SSD), and combined SSD+ CSP, CSP+ PSD, CSP+ Morlet, and CSP+ STFT. We also compared four classifiers applied to single trials using 5-fold cross-validation for evaluating the classification accuracy and its possible dependence on the classification algorithm. In addition, we estimated the inter-session left-vs-right accuracy for each subject. Results The SSD+ CSP combination yielded the best accuracy in both left-vs-right (mean 73.7%) and MI-vs-rest (mean 81.3%) classification. CSP+ Morlet yielded the best mean accuracy in inter-session left-vs-right classification (mean 69.1%). There were large inter-subject differences in classification accuracy, and the level of the 20-Hz suppression correlated significantly with the subjective MI-vs-rest accuracy. Selection of the classification algorithm had only a minor effect on the results. Conclusions We obtained good accuracy in sensor-level decoding of MI from single-trial MEG data. Feature extraction methods utilizing both the spatial and spectral profile of MI-related signals provided the best classification results, suggesting good performance of these methods in an online MEG neurofeedback system.	[Halme, Hanna-Leena; Parkkonen, Lauri] Aalto Univ, Sch Sci, Dept Neurosci & Biomed Engn NBE, Espoo, Finland; [Halme, Hanna-Leena] Helsinki Univ Hosp, HUS Med Imaging Ctr, Radiol Unit, Helsinki, Finland; [Parkkonen, Lauri] Aalto Univ, Sch Sci, MEG Core, Aalto Neuroimaging, Espoo, Finland	Aalto University; Hyvinkaan Sairaala; University of Helsinki; Helsinki University Central Hospital; Aalto University	Halme, HL (corresponding author), Aalto Univ, Sch Sci, Dept Neurosci & Biomed Engn NBE, Espoo, Finland.; Halme, HL (corresponding author), Helsinki Univ Hosp, HUS Med Imaging Ctr, Radiol Unit, Helsinki, Finland.	hanna-leena.halme@aalto.fi	Coish, Elizabeth/AAU-1245-2020; Parkkonen, Lauri/G-6755-2012	Parkkonen, Lauri/0000-0002-0130-0801; Halme, Hanna-Leena/0000-0003-2315-5745	Emil Aaltonen Foundation; Academy of Finland [295075]	Emil Aaltonen Foundation; Academy of Finland(Academy of Finland)	The study was supported by Emil Aaltonen Foundation (http://emilaaltonen.fi) and Academy of Finland grant #295075 "NeuroFeed" (http://www.aka.fi/).	Ahn M, 2015, J NEUROSCI METH, V243, P103, DOI 10.1016/j.jneumeth.2015.01.033; Ahn M, 2010, IFMBE PROC, V28, P366; Ang Kai Keng, 2014, Front Neuroeng, V7, P30, DOI 10.3389/fneng.2014.00030; Ang KK, 2010, IEEE ENG MED BIO, P5549, DOI 10.1109/IEMBS.2010.5626782; Ang KK, 2008, IEEE IJCNN, P2390, DOI 10.1109/IJCNN.2008.4634130; Battapady H, 2009, IEEE ENG MED BIO, P524, DOI 10.1109/IEMBS.2009.5333632; Birbaumer N, 2007, J PHYSIOL-LONDON, V579, P621, DOI 10.1113/jphysiol.2006.125633; Blankertz B, 2004, IEEE T BIO-MED ENG, V51, P1044, DOI 10.1109/TBME.2004.826692; Blankertz B, 2008, IEEE SIGNAL PROC MAG, V25, P41, DOI 10.1109/MSP.2008.4408441; Blankertz B, 2006, IEEE T NEUR SYS REH, V14, P153, DOI 10.1109/TNSRE.2006.875642; Blankertz B, 2010, NEUROIMAGE, V51, P1303, DOI 10.1016/j.neuroimage.2010.03.022; Boe S, 2014, NEUROIMAGE, V101, P159, DOI 10.1016/j.neuroimage.2014.06.066; Buch E, 2008, STROKE, V39, P910, DOI 10.1161/STROKEAHA.107.505313; Cochin S, 1999, EUR J NEUROSCI, V11, P1839, DOI 10.1046/j.1460-9568.1999.00598.x; COHEN D, 1991, Brain Topography, V4, P95, DOI 10.1007/BF01132766; Daly JJ, 2008, LANCET NEUROL, V7, P1032, DOI 10.1016/S1474-4422(08)70223-0; Doud AJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026322; Edelman BJ, 2016, IEEE T BIO-MED ENG, V63, P4, DOI 10.1109/TBME.2015.2467312; Florin E, 2014, NEUROIMAGE, V88, P54, DOI 10.1016/j.neuroimage.2013.10.028; Foldes ST, 2011, IEEE ENG MED BIO, P5778, DOI 10.1109/IEMBS.2011.6091430; Foldes ST, 2015, J NEUROENG REHABIL, V12, DOI 10.1186/s12984-015-0076-7; Gomez-Rodriguez M, 2011, J NEURAL ENG, V8, DOI 10.1088/1741-2560/8/3/036005; Gramfort A, 2013, FRONT NEUROSCI-SWITZ, V7, DOI 10.3389/fnins.2013.00267; Guger C, 2003, IEEE T NEUR SYS REH, V11, P145, DOI 10.1109/TNSRE.2003.814481; Guger C, 2000, IEEE T REHABIL ENG, V8, P447, DOI 10.1109/86.895947; Haufe S, 2014, NEUROIMAGE, V101, P583, DOI 10.1016/j.neuroimage.2014.06.073; He B, 2015, P IEEE, V103, P907, DOI [10.1109/JPROC.2015.2407272, 10.1109/jproc.2015.2407272]; Herman P, 2008, IEEE T NEUR SYS REH, V16, P317, DOI 10.1109/TNSRE.2008.926694; Kaiser V, 2011, FRONT NEUROSCI-SWITZ, V5, DOI [10.3389/fnins.2011.00086, 10.3389/fninf.2011.00030]; Kang S, 2010, P SPIE; Kauhanen L., 2004, BIOMED TECH, V49, P2; KOLES Z J, 1990, Brain Topography, V2, P275, DOI 10.1007/BF01129656; Kus R, 2012, IEEE T NEUR SYS REH, V20, P823, DOI 10.1109/TNSRE.2012.2214789; LaFleur K, 2013, J NEURAL ENG, V10, DOI 10.1088/1741-2560/10/4/046003; Lemm S, 2005, IEEE T BIO-MED ENG, V52, P1541, DOI 10.1109/TBME.2005.851521; Lin PT, 2013, HIGH PERFORMANCE MEG; Lotte F, 2011, IEEE T BIO-MED ENG, V58, P355, DOI 10.1109/TBME.2010.2082539; Manganotti P, 2008, NEUROREHAB NEURAL RE, V22, P396, DOI 10.1177/1545968307313505; McFarland D. J., 2010, J NEURAL ENG, V7, P1; McFarland DJ, 2000, BRAIN TOPOGR, V12, P177, DOI 10.1023/A:1023437823106; Mellinger J, 2007, NEUROIMAGE, V36, P581, DOI 10.1016/j.neuroimage.2007.03.019; Miller KJ, 2010, P NATL ACAD SCI USA, V107, P4430, DOI 10.1073/pnas.0913697107; Murase N, 2004, ANN NEUROL, V55, P400, DOI 10.1002/ana.10848; Neuper C, 2005, COGNITIVE BRAIN RES, V25, P668, DOI 10.1016/j.cogbrainres.2005.08.014; Nikulin VV, 2011, NEUROIMAGE, V55, P1528, DOI 10.1016/j.neuroimage.2011.01.057; Oostenveld R, 2011, COMPUT INTEL NEUROSC, V2011, DOI 10.1155/2011/156869; Pedregosa F, 2011, J MACH LEARN RES, V12, P2825; Peirce JW, 2007, J NEUROSCI METH, V162, P8, DOI 10.1016/j.jneumeth.2006.11.017; Pfurtscheller G, 2006, NEUROIMAGE, V31, P153, DOI 10.1016/j.neuroimage.2005.12.003; Pfurtscheller G, 2001, P IEEE, V89, P1123, DOI 10.1109/5.939829; Pfurtscheller G, 1999, CLIN NEUROPHYSIOL, V110, P1842, DOI 10.1016/S1388-2457(99)00141-8; Pfurtscheller G, 1997, NEUROSCI LETT, V239, P65, DOI 10.1016/S0304-3940(97)00889-6; Piitulainen H, 2015, NEUROIMAGE, V112, P310, DOI 10.1016/j.neuroimage.2015.03.006; Qin L, 2005, J NEURAL ENG, V2, P65, DOI 10.1088/1741-2560/2/4/001; Ramos-Murguialday A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047048; SALMELIN R, 1994, NEUROSCIENCE, V60, P537, DOI 10.1016/0306-4522(94)90263-1; Schnitzler A, 1997, NEUROIMAGE, V6, P201, DOI 10.1006/nimg.1997.0286; Spuler M, 2014, COMM COM INF SC, V438, P363; Sudre G, 2011, COMPUT INTEL NEUROSC, V2011, DOI 10.1155/2011/327953; Tangwiriyasakul C, 2014, J NEURAL ENG, V11, DOI 10.1088/1741-2560/11/3/036001; Taulu S, 2004, BRAIN TOPOGR, V16, P269, DOI 10.1023/b:brat.0000032864.93890.f9; Townsend G, 2004, IEEE T NEUR SYS REH, V12, P258, DOI 10.1109/TNSRE.2004.827220; Vidaurre C, 2013, CLIN NEUROPHYSIOL, V124, P1824, DOI 10.1016/j.clinph.2013.03.009; Wang T, 2004, CLIN NEUROPHYSIOL, V115, P2744, DOI 10.1016/j.clinph.2004.06.022; Wang YJ, 2005, P ANN INT IEEE EMBS, P5392; Wolpaw JR, 2004, P NATL ACAD SCI USA, V101, P17849, DOI 10.1073/pnas.0403504101; Yuan H, 2008, IEEE T NEUR SYS REH, V16, P425, DOI 10.1109/TNSRE.2008.2003384	67	19	19	2	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2016	11	12							e0168766	10.1371/journal.pone.0168766	http://dx.doi.org/10.1371/journal.pone.0168766			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI8LN	27992574	Green Published, gold			2022-12-27	WOS:000392758000077
J	Pocock, NS; Kiss, L; Oram, S; Zimmerman, C				Pocock, Nicola S.; Kiss, Ligia; Oram, Sian; Zimmerman, Cathy			Labour Trafficking among Men and Boys in the Greater Mekong Subregion: Exploitation, Violence, Occupational Health Risks and Injuries	PLOS ONE			English	Article							WORK-RELATED INJURIES; MIGRANT WORKERS; DISORDERS; FISHERMEN; SEAFARERS; THAILAND; PATTERNS; INDUSTRY; COST	Background Men comprise nearly two-thirds of trafficked and forced labourers in common low-skilled labour sectors including fishing, agriculture and factory work. Yet, most evidence on human trafficking has focused on women and girls trafficked for sex work, with scant research on trafficked men and boys. Methods We analyse survey data from the largest systematic consecutive sample of trafficked people collected to date to describe the prevalence of violence, occupational health risks and injuries and associated factors. Participants were labour-trafficked men and boys using post-trafficking support services in Thailand, Cambodia and Vietnam. Findings Data are presented on 446 males aged 10-58. Men and boys were mainly trafficked for fishing (61.7%), manufacturing (19.1%) and begging (5.2%). Fishermen worked extensive hours (mean 18.8 hours/day, SD 5.9) and factory workers worked on average 11.9 hours/day (SD 2.9). 35.5% of male survivors had been injured while trafficked; 29.4% received no personal protective equipment (e.g. gloves). The most commonly reported injuries among all males were deep cuts (61.8%) and skin injuries (36.7%), injuries for which fewer than one-quarter reported receiving medical care. Six fishermen lost body parts, none of whom received medical care. Most males (80.5%) had no or very few rest breaks. One-third (37.8%) experienced severe violence. Work-related injuries were associated with severe violence (AOR 3.44, CI: 1.63-7.26), being in the fishing sector, (AOR 4.12, CI: 2.39-7.09) and threats (AOR 2.77, CI: 1.62-4.75). Experiencing any violence was associated with threats (AOR 26.86, CI: 14.0-51.23), being in the fishing sector (AOR 18.53, CI: 8.74-39.28) and fluency in language of destination country (AOR 0.39, CI: 0.20-0.75). Conclusion This study highlights the abuse and extreme occupational hazards suffered by trafficked men and boys. Occupational health and safety interventions are urgently needed to protect male migrant labourers working in high-risk sectors, particularly fishing.	[Pocock, Nicola S.; Kiss, Ligia; Zimmerman, Cathy] London Sch Hyg & Trop Med, Gender Violence & Hlth Ctr, Dept Global Hlth & Dev, London, England; [Oram, Sian] Kings Coll London, Inst Psychiat, Sect Womens Mental Hlth, London, England	University of London; London School of Hygiene & Tropical Medicine; University of London; King's College London	Pocock, NS (corresponding author), London Sch Hyg & Trop Med, Gender Violence & Hlth Ctr, Dept Global Hlth & Dev, London, England.	nicola.pocock@lshtm.ac.uk	Oram, Sian/G-3342-2013	Oram, Sian/0000-0001-8704-0379; Kiss, Ligia/0000-0002-3334-7110	Anesvad Foundation; International Organization for Migration International Development Fund; Economic and Social Science Research Council, UK	Anesvad Foundation; International Organization for Migration International Development Fund; Economic and Social Science Research Council, UK	This study was funded by Anesvad Foundation and the International Organization for Migration International Development Fund, with additional support from the Economic and Social Science Research Council, UK. The funders had no role in the design and conduct of the study; collection, management, analysis, and interpretation of the data; preparation, review, or approval of the manuscript; and decision to submit the manuscript for publication.	Ahonen EQ, 2007, SCAND J WORK ENV HEA, V33, P96, DOI 10.5271/sjweh.1112; Allen P, 2008, INT MARIT HEALTH, V59, P81; Altman DG, 2006, BRIT MED J, V332, P1080, DOI 10.1136/bmj.332.7549.1080; [Anonymous], 2011, WORKING PAPER; [Anonymous], 2006, ARCH EMERG MED; Barron L, 2015, MYANMAR TIMES   1223; Brennan M., 2009, OUT SIGHT OUT MIND H; Buller AM, 2015, LABOUR EXPLOITATION; Carotenuto A, 2012, INT MARIT HEALTH, V63, P188; Cha S, 2014, AM J IND MED, V57, P1043, DOI 10.1002/ajim.22349; Day K., 2015, REINTEGRATION CAMBOD; DRISCOLL TR, 1994, OCCUP ENVIRON MED, V51, P612, DOI 10.1136/oem.51.9.612; Environmental Justice Foundation (EJF), 2015, PIR SLAV OV THAIL FU; FAO, 2005, RISKS FISH FISH AQ T; FIDH SUARAM, 2008, 4892 FIDH SUARAM; Finnwatch, 2014, 3 FINNW; Finnwatch, 2013, CHEAP HAS HIGH PRIC; Finnwatch, 2014, 7 FINNW; Finnwatch SACOM SOMO, 2011, SACOM SOMO GAM CONS; Fitzgerald S, 2013, INJURY PREV, V19, P348, DOI 10.1136/injuryprev-2012-040578; Flood M., 2014, OXFORD TXB VIOLENCE, P201; Flynn MA, 2015, AM J IND MED, V58, P1127, DOI 10.1002/ajim.22531; Fujita K, 2010, 257 JETRO I DEV EC; Gallagher A, 2010, HUM RIGHTS QUART, V32, P73, DOI 10.1353/hrq.0.0136; Garcia-Moreno C, 2005, WHO MULTICOUNTRY STU; Hodal K., 2014, GUARDIAN; Hossain M, 2010, AM J PUBLIC HEALTH, V100, P2442, DOI 10.2105/AJPH.2009.173229; HRW, 2010, TIG CROC AB MIGR WOR; ILO, 2003, COD PRACT WORKPL VIO; ILO (International Labour Office), 2012, GLOB EST FORC LAB RE; ILO (International Labour Organization), 2013, EMPL PRACT WORK COND; International Labor Rights Forum and the Migrant Workers Rights Network (ILRF, 2016, BUILD RIGHTS CULT WO; Isarabhakdi P., 2004, ASIAN PAC MIGR J, V13, P107, DOI DOI 10.1177/011719680401300106; Jin KZ, 2010, INJURY PREV, V16, P42, DOI 10.1136/ip.2008.019737; Kara S., 2011, HARVARD INT REV, V33, P66; Kiss L, 2015, JAMA PEDIATR, V169, DOI 10.1001/jamapediatrics.2015.2278; Kiss L, 2015, LANCET GLOB HEALTH, V3, pE154, DOI 10.1016/S2214-109X(15)70016-1; Kongtip P, 2015, NEW SOLUT, V25, P189, DOI 10.1177/1048291115586036; Lee K., 2011, RES OCCUPATIONAL SAF; LSCW CLEC LICADHO Chab Dai IOM ILO, 2012, CAMB FISH AFR; Marks E, 2015, ANTITRAFFICK REV, V5; Matheson C, 2001, OCCUP MED-OXFORD, V51, P305, DOI 10.1093/occmed/51.5.305; Mayhew C, 2007, INT J LAW PSYCHIAT, V30, P327, DOI 10.1016/j.ijlp.2007.06.006; McDermott S, 1990, J Community Health, V15, P297, DOI 10.1007/BF01325137; McDowell R., 2015, AP EXPLORE SEAFOOD S; Ministry of Social Affairs Veterans and Youth Rehabilitation (MOSVY)., 2015, GUID FORMS PROC PREL; Mischke C, 2013, COCHRANE DATABASE SY, V8; Naing Saw Yan, 2014, IRRAWADDY; Naing T, 2012, BMC INT HEALTH HUM R, V12, DOI 10.1186/1472-698X-12-22; NORRISH AE, 1990, BRIT J IND MED, V47, P726; Office of Anti-Trafficking in Persons Committee Ministry of Social Development and Human Security, 2008, PREL CHECK LIST ID T; Oram S, 2016, AM J PUBLIC HEALTH, V106, P1073, DOI 10.2105/AJPH.2016.303095; Ottisova L, 2016, EPIDEMIOL PSYCHIAT S, V12, P1; Pearson E, 2006, MEKONG CHALLENGE UND, VOne; Robertson P., 2011, TRAFFICKING FISHERME; Santos A, 2014, PUBLIC HEALTH, V128, P759, DOI 10.1016/j.puhe.2014.04.003; Schenker M, 2008, OCCUP ENVIRON MED, V65, P717, DOI 10.1136/oem.2008.040907; Schenker MB, 2010, AM J IND MED, V53, P329, DOI 10.1002/ajim.20834; StataCorp, 2015, STAT STAT SOFTW REL; Sun GW, 1996, J CLIN EPIDEMIOL, V49, P907, DOI 10.1016/0895-4356(96)00025-X; Turner-Moss E, 2014, J IMMIGR MINOR HEALT, V16, P473, DOI 10.1007/s10903-013-9832-6; UNIAP, 2009, CB03 UNIAP; UNOCHA, 2012, HUM TRAFF GLOB SUPPL; Urbina I., 2015, NY TIMES; Verite International, 2014, FORC LAB PROD EL GOO; Walter N, 2004, SOC SCI MED, V59, P1159, DOI 10.1016/j.socscimed.2003.12.013; Walter N, 2002, J GEN INTERN MED, V17, P221, DOI 10.1046/j.1525-1497.2002.10501.x; Wei L, 2013, ECONOMICS; WHITE G, 1989, CAN FAM PHYSICIAN, V35, P2331; WHO, 2002, WHO WORLD REP VIOL H; Wongcha-um P, 2016, CHANNEL NEWS AS 0118; Yang Long-yu, 2013, Zhonghua Yu Fang Yi Xue Za Zhi, V47, P1132; Yea S., 2012, TROUBLED WATERS TRAF; Yu WZ, 2012, ACCIDENT ANAL PREV, V48, P457, DOI 10.1016/j.aap.2012.03.001; Zheng L, 2014, INJURY, V45, P599, DOI 10.1016/j.injury.2013.07.004; Zheng L, 2010, AM J IND MED, V53, P588, DOI 10.1002/ajim.20833; Zimmerman, 2003, WHO ETHICAL SAFETY R; Zimmerman C., 2006, STOLEN SMILES SUMMAR; Zimmerman C, 2014, HUMAN TRAFFICKING FO; Zimmerman C, 2014, HLTH HUMAN TRAFFICKI; Zweynert A, 2015, SLAVERY TRAFFICKED F	81	27	27	2	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2016	11	12							e0168500	10.1371/journal.pone.0168500	http://dx.doi.org/10.1371/journal.pone.0168500			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EI8LN	27992583	Green Accepted, Green Submitted, Green Published, gold			2022-12-27	WOS:000392758000055
J	Chen, L; Bromberger, PD; Nieuwenhuiys, G; Hatti-Kaul, R				Chen, Lu; Bromberger, Paul David; Nieuwenhuiys, Gavin; Hatti-Kaul, Rajni			Redox Balance in Lactobacillus reuteri DSM20016: Roles of Iron-Dependent Alcohol Dehydrogenases in Glucose/ Glycerol Metabolism	PLOS ONE			English	Article							PYRUVATE-FORMATE-LYASE; MOLECULAR CHARACTERIZATION; DIOL DEHYDRATASE; 3-HYDROXYPROPIONALDEHYDE; PATHWAY; PROTEIN; ACID; BIOTRANSFORMATION; 1,3-PROPANEDIOL; 1,2-PROPANEDIOL	Lactobacillus reuteri, a heterofermentative bacterium, metabolizes glycerol via a Pdu (propanediol-utilization) pathway involving dehydration to 3-hydroxypropionaldehyde (3-HPA) followed by reduction to 1,3-propandiol (1,3-PDO) with concomitant generation of an oxidized cofactor, NAD(+) that is utilized to maintain cofactor balance required for glucose metabolism and even for oxidation of 3-HPA by a Pdu oxidative branch to 3-hydroxypropionic acid (3-HP). The Pdu pathway is operative inside Pdu microcompartment that encapsulates different enzymes and cofactors involved in metabolizing glycerol or 1,2-propanediol, and protects the cells from the toxic effect of the aldehyde intermediate. Since L. reuteri excretes high amounts of 3-HPA outside the microcompartment, the organism is likely to have alternative alcohol dehydrogenase(s) in the cytoplasm for transformation of the aldehyde. In this study, diversity of alcohol dehydrogenases in Lactobacillus species was investigated with a focus on L. reuteri. Nine ADH enzymes were found in L. reuteriDSM20016, out of which 3 (PduQ, ADH6 and ADH7) belong to the group of iron-dependent enzymes that are known to transform aldehydes/ketones to alcohols. L. reuteri mutants were generated in which the three ADHs were deleted individually. The lagging growth phenotype of these deletion mutants revealed that limited NAD(+)/NADH recycling could be restricting their growth in the absence of ADHs. Notably, it was demonstrated that PduQ is more active in generating NAD(+) during glycerol metabolism within the microcompartment by resting cells, while ADH7 functions to balance NAD(+)/NADH by converting 3-HPA to 1,3-PDO outside the microcompartment in the growing cells. Moreover, evaluation of ADH6 deletion mutant showed strong decrease in ethanol level, supporting the role of this bifuctional alcohol/aldehyde dehydrogenase in ethanol production. To the best of our knowledge, this is the first report revealing both internal and external recycling for cofactor homeostasis during 3-HPA conversion in L. reuteri.	[Chen, Lu; Bromberger, Paul David; Nieuwenhuiys, Gavin; Hatti-Kaul, Rajni] Lund Univ, Ctr Chem & Chem Engn, Biotechnol, Lund, Sweden; [Bromberger, Paul David] Univ Appl Sci Wiener Neustadt, Biotechnol Proc, Campus Tulln,Konrad Lorenz Str 10, Tulln, Austria	Lund University	Chen, L (corresponding author), Lund Univ, Ctr Chem & Chem Engn, Biotechnol, Lund, Sweden.	lu.chen@biotek.lu.se		CHEN, LU/0000-0001-8867-5851	Erasmus Mundus Action 2 programme; Erasmus+ programme	Erasmus Mundus Action 2 programme; Erasmus+ programme	Erasmus Mundus Action 2 programme and Erasmus+ programme are acknowledged for financial support to Lu Chen and Paul Bromberger, respectively.	Abdel-Rahman MA, 2013, BIOTECHNOL ADV, V31, P877, DOI 10.1016/j.biotechadv.2013.04.002; [Anonymous], THESIS; Antranikian G., 2013, OA ALCOHOL, V1, P3, DOI DOI 10.13172/2053-0285-1-1-489; Arskold E, 2008, J BACTERIOL, V190, P206, DOI 10.1128/JB.01227-07; Asanuma N, 2004, APPL ENVIRON MICROB, V70, P5244, DOI 10.1128/AEM.70.9.5244-5251.2004; Atteia A, 2003, PLANT MOL BIOL, V53, P175, DOI 10.1023/B:PLAN.0000009274.19340.36; Biasini M, 2014, NUCLEIC ACIDS RES, V42, pW252, DOI 10.1093/nar/gku340; Brooijmans RJW, 2009, APPL ENVIRON MICROB, V75, P3580, DOI 10.1128/AEM.00147-09; Burge G, 2015, J MICROBIOL, V53, P702, DOI 10.1007/s12275-015-5056-x; Cai F, 2015, ACS SYNTH BIOL, V4, P444, DOI 10.1021/sb500226j; Cheng SQ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047144; Chowdhury C, 2015, P NATL ACAD SCI USA, V112, P2990, DOI 10.1073/pnas.1423672112; CIRCLE SJ, 1945, IND ENG CHEM, V17, P259, DOI 10.1021/i560140a021; da Silva GP, 2009, BIOTECHNOL ADV, V27, P30, DOI 10.1016/j.biotechadv.2008.07.006; Dishisha T., 2013, THESIS; Dishisha T, 2014, MICROB CELL FACT, V13, DOI 10.1186/1475-2859-13-76; Doleyres Y, 2005, APPL MICROBIOL BIOT, V68, P467, DOI 10.1007/s00253-005-1895-4; Edenberg HJ, 2007, ALCOHOL RES HEALTH, V30, P5; Espinosa A, 2009, J ANTIMICROB CHEMOTH, V63, P675, DOI 10.1093/jac/dkp015; Evans GA, 1990, CELL, V61, P17, DOI DOI 10.1016/0092-8674(90)90210-6; HARDING JW, 1975, BIOCH J, V146; Heravi R. M., 2012, Biotechnology, V11, P50, DOI 10.3923/biotech.2012.50.54; KESSLER D, 1991, FEBS LETT, V281, P59, DOI 10.1016/0014-5793(91)80358-A; Kok J, 2014, MICROB CELL FACT, V13, DOI 10.1186/1475-2859-13-S1-I1; Lambert JM, 2007, APPL ENVIRON MICROB, V73, P1126, DOI 10.1128/AEM.01473-06; Man H, 2014, TOP CATAL, V57, P356, DOI 10.1007/s11244-013-0191-2; Patnaik R, 2002, NAT BIOTECHNOL, V20, P707, DOI 10.1038/nbt0702-707; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Pflugl S, 2014, BIORESOURCE TECHNOL, V152, P499, DOI 10.1016/j.biortech.2013.11.041; Price-Carter M, 2001, J BACTERIOL, V183, P2463, DOI 10.1128/JB.183.8.2463-2475.2001; Radianingtyas H, 2003, FEMS MICROBIOL REV, V27, P593, DOI 10.1016/S0168-6445(03)00068-8; REID MF, 1994, CRIT REV MICROBIOL, V20, P13, DOI 10.3109/10408419409113545; Sabet-Azad R, 2013, ENZYME MICROB TECH, V53, P235, DOI 10.1016/j.enzmictec.2013.05.007; Santos FB dos, 2008, VITAMIN B12 SYNTHESI; Sardari RRR, 2013, J BIOTECHNOL, V168, P534, DOI 10.1016/j.jbiotec.2013.09.009; Sardari RRR, 2013, BIOTECHNOL BIOENG, V110, P1243, DOI 10.1002/bit.24787; Sauvageot N, 2002, FEMS MICROBIOL LETT, V209, P69, DOI 10.1111/j.1574-6968.2002.tb11111.x; She Q, 2001, P NATL ACAD SCI USA, V98, P7835, DOI 10.1073/pnas.141222098; Spinler JK, 2008, ANAEROBE, V14, P166, DOI 10.1016/j.anaerobe.2008.02.001; Sriramulu DD, 2008, J BACTERIOL, V190, P4559, DOI 10.1128/JB.01535-07; TALARICO TL, 1990, APPL ENVIRON MICROB, V56, P943, DOI 10.1128/AEM.56.4.943-948.1990; Trott O, 2010, J COMPUT CHEM, V31, P455, DOI 10.1002/jcc.21334; van der Oost J, 2001, EUR J BIOCHEM, V268, P3062, DOI 10.1046/j.1432-1327.2001.02201.x; ZENG AP, 1993, ENZYME MICROB TECH, V15, P770, DOI 10.1016/0141-0229(93)90008-P	44	10	10	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2016	11	12							e0168107	10.1371/journal.pone.0168107	http://dx.doi.org/10.1371/journal.pone.0168107			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EG7JB	28030590	Green Published, Green Submitted, gold			2022-12-27	WOS:000391222000036
J	Kovacs, G; Avian, A; Foris, V; Tscherner, M; Kqiku, X; Douschan, P; Bachmaier, G; Olschewski, A; Matucci-Cerinic, M; Olschewski, H				Kovacs, Gabor; Avian, Alexander; Foris, Vasile; Tscherner, Maria; Kqiku, Xhylsime; Douschan, Philipp; Bachmaier, Gerhard; Olschewski, Andrea; Matucci-Cerinic, Marco; Olschewski, Horst			Use of ECG and Other Simple Non-Invasive Tools to Assess Pulmonary Hypertension	PLOS ONE			English	Article							BRAIN NATRIURETIC PEPTIDE; ARTERIAL-HYPERTENSION; FOLLOW-UP; PROGNOSTIC-FACTORS; MORTALITY; DIAGNOSIS; GUIDELINES; PRESSURE; SURVIVAL	Background There is a broad consensus that pulmonary hypertension (PH) is to be diagnosed by right heart catheterization (RHC) and that the most important non-invasive tool is echocardiography. However, the role of simple non-invasive tools in the work-up of PH is not clearly defined. We hypothesized that the use of simple non-invasive techniques may help to guide important decisions in the diagnostics of pulmonary hypertension. Objectives We aimed to develop an algorithm with the use of simple, non-invasive tools in order to identify patients with very high or very low likelihood of PH. Methods We retrospectively analyzed all consecutive patients undergoing RHC between 2005 and 2010 in our center and performed logistic regression of simple non-invasive parameters regarding detection and exclusion of PH and derived a two-step algorithm. In a prospective study we evaluated this algorithm between 2011 and 2013. Results The retrospective cohort consisted of n = 394 patients of which 49% presented with PH. Right axis deviation in the ECG was present in 90/394 patients and had a positive predictive value (PPV) of 93% for PH. The combination of non-right axis deviation, N-terminal pro brain natriuretic peptide (NT-proBNP)<333pg/ml, arterial oxygen saturation (SO2)>= 95.5% and WHO functional class I-II was present in 69/394 patients and excluded PH with a negative predictive value (NPV) of 96%. The prospective study confirmed these results in a cohort of n = 168 patients (PPV: 92%, NPV: 97%). Taken together, simple non-invasive tools allowed a prediction regarding the presence or absence of PH in 42% of patients with suspected PH. Conclusion ECG, NT-proBNP, SO2 and WHO functional class may predict the presence or absence of PH in almost half of the patients with suspected PH, suggesting an important role for these variables in the work-up of patients at risk for PH.	[Kovacs, Gabor; Foris, Vasile; Tscherner, Maria; Kqiku, Xhylsime; Douschan, Philipp; Olschewski, Horst] Med Univ Graz, Div Pulmonol, Dept Internal Med, Graz, Austria; [Kovacs, Gabor; Avian, Alexander; Foris, Vasile; Tscherner, Maria; Douschan, Philipp; Olschewski, Andrea; Olschewski, Horst] Ludwig Boltzmann Inst Lung Vasc Res, Graz, Austria; [Avian, Alexander; Bachmaier, Gerhard] Med Univ Graz, Inst Med Informat Stat & Documentat, Graz, Austria; [Olschewski, Andrea] Med Univ Graz, Inst Physiol, Graz, Austria; [Matucci-Cerinic, Marco] Univ Florence, Dept Biomed, Div Rheumatol, AOUC, Florence, Italy; [Matucci-Cerinic, Marco] Univ Florence, Dept Expt & Clin Med, Florence, Italy	Medical University of Graz; Ludwig Boltzmann Institute; Medical University of Graz; Medical University of Graz; University of Florence; Azienda Ospedaliero Universitaria Careggi; University of Florence	Kovacs, G (corresponding author), Med Univ Graz, Div Pulmonol, Dept Internal Med, Graz, Austria.; Kovacs, G (corresponding author), Ludwig Boltzmann Inst Lung Vasc Res, Graz, Austria.	gabor.kovacs@klinikum-graz.at	Olschewski, Horst/L-3547-2019; CERINIC, marco MATUCCI/AAO-2769-2020	Olschewski, Horst/0000-0002-2834-7466; Bachmaier, Gerhard/0000-0002-8291-7255; Avian, Alexander/0000-0003-1084-5763; Olschewski, Andrea/0000-0002-8189-3634				ABRAMSON SV, 1992, ANN INTERN MED, V116, P888, DOI 10.7326/0003-4819-116-11-888; Al-Naamani K, 2008, INT J CARDIOL, V127, P214, DOI 10.1016/j.ijcard.2007.06.005; [Anonymous], 2002, CRIT CARE MED, V166, P111, DOI [10.1164/rccm.166/1/111, DOI 10.1164/RCCM.166/1/111]; Benza RL, 2012, CHEST, V141, P354, DOI 10.1378/chest.11-0676; Bonderman D, 2011, EUR RESPIR J, V37, P1096, DOI 10.1183/09031936.00089610; Coghlan JG, 2014, ANN RHEUM DIS, V73, P1340, DOI 10.1136/annrheumdis-2013-203301; Fisher MR, 2009, AM J RESP CRIT CARE, V179, P615, DOI 10.1164/rccm.200811-1691OC; Foris V, 2013, CHEST, V144, P274, DOI 10.1378/chest.12-1246; Fritz JS, 2013, CHEST, V143, P315, DOI 10.1378/chest.12-0270; Galie N, 2008, LANCET, V371, P2093, DOI 10.1016/S0140-6736(08)60919-8; Galie N, 2004, EUR HEART J, V25, P2243, DOI 10.1016/j.ehj.2004.09.014; Galie N, 2016, EUR HEART J, V37, P67, DOI 10.1093/eurheartj/ehv317; Galie N, 2009, EUR HEART J, V30, P2493, DOI 10.1093/eurheartj/ehp297; Henkens IR, 2008, CHEST, V134, P1250, DOI 10.1378/chest.08-0461; Hoeper MM, 2007, EUR RESPIR J, V29, P944, DOI 10.1183/09031936.00134506; Kane GC, 2011, CHEST, V139, P1285, DOI 10.1378/chest.10-1293; Kovacs G, 2016, PULMONARY CIRCULATIO, P186; Lam CSP, 2009, CIRCULATION, V119, P2663, DOI 10.1161/CIRCULATIONAHA.108.838698; Leuchte HH, 2007, CHEST, V131, P402, DOI 10.1378/chest.06-1758; Leuchte HH, 2005, CHEST, V128, P2368, DOI 10.1378/chest.128.4.2368; Leuchte HH, 2004, J AM COLL CARDIOL, V43, P764, DOI 10.1016/j.jacc.2003.09.051; Miyamoto S, 2000, AM J RESP CRIT CARE, V161, P487, DOI 10.1164/ajrccm.161.2.9906015; Nickel N, 2012, EUR RESPIR J, V39, P589, DOI 10.1183/09031936.00092311; Olsson KM, 2015, RESP RES, V16, DOI 10.1186/s12931-015-0194-6; OSWALDMAMMOSSER M, 1995, CHEST, V107, P1193, DOI 10.1378/chest.107.5.1193; RICH S, 1987, ANN INTERN MED, V107, P216, DOI 10.7326/0003-4819-107-2-216; Sitbon O, 2002, J AM COLL CARDIOL, V40, P780, DOI 10.1016/S0735-1097(02)02012-0; Thakkar V, 2013, ARTHRITIS RES THER, V15, DOI 10.1186/ar4383; Tonelli AR, 2014, ANN NONINVAS ELECTRO, V19, P258, DOI 10.1111/anec.12125	29	13	14	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2016	11	12							e0168706	10.1371/journal.pone.0168706	http://dx.doi.org/10.1371/journal.pone.0168706			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EG7JB	28030578	Green Published, Green Submitted, gold			2022-12-27	WOS:000391222000064
J	Pokrzywinski, KL; Biel, TG; Kryndushkin, D; Rao, VA				Pokrzywinski, Kaytee L.; Biel, Thomas G.; Kryndushkin, Dmitry; Rao, V. Ashutosh			Therapeutic Targeting of the Mitochondria Initiates Excessive Superoxide Production and Mitochondrial Depolarization Causing Decreased mtDNA Integrity	PLOS ONE			English	Article							DNA COPY NUMBER; OXIDATIVE STRESS; DAMAGE; TWINKLE; PROTEIN; TRANSCRIPTION; MAINTENANCE; METABOLISM; AUTOPHAGY; DELETIONS	Mitochondrial dysregulation is closely associated with excessive reactive oxygen species (ROS) production. Altered redox homeostasis has been implicated in the onset of several diseases including cancer. Mitochondrial DNA (mtDNA) and proteins are particularly sensitive to ROS as they are in close proximity to the respiratory chain (RC). Mitoquinone (MitoQ), a mitochondria-targeted redox agent, selectively damages breast cancer cells possibly through damage induced via enhanced ROS production. However, the effects of MitoQ and other triphenylphosphonium (TPP+) conjugated agents on cancer mitochondrial homeostasis remain unknown. The primary objective of this study was to determine the impact of mitochondria-targeted agent [(MTAs) conjugated to TPP+: mitoTEMPOL, mitoquinone and mitochromanol-acetate] on mitochondrial physiology and mtDNA integrity in breast (MDA-MB-231) and lung (H23) cancer cells. The integrity of the mtDNA was assessed by quantifying the degree of mtDNA fragmentation and copy number, as well as by measuring mitochondrial proteins essential to mtDNA stability and maintenance (TFAM, SSBP1, TWINKLE, POLG and POLRMT). Mitochondrial status was evaluated by measuring superoxide production, mitochondrial membrane depolarization, oxygen consumption, extracellular acidification and mRNA or protein levels of the RC complexes along with TCA cycle activity. In this study, we demonstrated that all investigated MTAs impair mitochondrial health and decrease mtDNA integrity in MDA-MB-231 and H23 cells. However, differences in the degree of mitochondrial damage and mtDNA degradation suggest unique properties among each MTA that may be cell line, dose and time dependent. Collectively, our study indicates the potential for TPP+ conjugated molecules to impair breast and lung cancer cells by targeting mitochondrial homeostasis.	[Pokrzywinski, Kaytee L.; Biel, Thomas G.; Kryndushkin, Dmitry; Rao, V. Ashutosh] US FDA, Lab Appl Biochem, Div Biotechnol Res & Review 3, Off Biotechnol Prod,Ctr Drug Evaluat & Res, Silver Spring, MD USA	US Food & Drug Administration (FDA)	Rao, VA (corresponding author), US FDA, Lab Appl Biochem, Div Biotechnol Res & Review 3, Off Biotechnol Prod,Ctr Drug Evaluat & Res, Silver Spring, MD USA.	ashutosh.rao@fda.hhs.gov	Rao, V Ashutosh/A-3569-2013	Rao, V Ashutosh/0000-0001-6817-8049				Beckham TH, 2013, J PHARMACOL EXP THER, V344, P167, DOI 10.1124/jpet.112.199216; Biel TG, 2016, CELL DEATH DIFFER, V23, P279, DOI 10.1038/cdd.2015.96; Chen XJ, 2005, SCIENCE, V307, P714, DOI 10.1126/science.1106391; Cheng G, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-285; Cheng G, 2012, CANCER RES, V72, P2634, DOI 10.1158/0008-5472.CAN-11-3928; Dickey JS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070575; El-Hattab A, 2013, NEUROTHERAPEUTICS, V10, P186, DOI 10.1007/s13311-013-0177-6; Enright H, 1996, CARCINOGENESIS, V17, P1175, DOI 10.1093/carcin/17.5.1175; ENRIGHT HU, 1992, NUCLEIC ACIDS RES, V20, P3341, DOI 10.1093/nar/20.13.3341; Fukasawa Y, 2015, MOL CELL PROTEOMICS, V14, P1113, DOI 10.1074/mcp.M114.043083; Furda A, 2014, METHODS MOL BIOL, V1105, P419, DOI 10.1007/978-1-62703-739-6_31; Fuste JM, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004832; Gane EJ, 2010, LIVER INT, V30, P1019, DOI 10.1111/j.1478-3231.2010.02250.x; Gatenby RA, 2004, NAT REV CANCER, V4, P891, DOI 10.1038/nrc1478; Gonzalez Y, 2014, ONCOTARGET, V5, P1526, DOI 10.18632/oncotarget.1715; Gui YX, 2015, PARKINSONISM RELAT D, V21, P282, DOI 10.1016/j.parkreldis.2014.12.030; Hamanaka RB, 2010, TRENDS BIOCHEM SCI, V35, P505, DOI 10.1016/j.tibs.2010.04.002; HARMAN D, 1956, J GERONTOL, V11, P298, DOI 10.1093/geronj/11.3.298; Holmstrom KM, 2014, NAT REV MOL CELL BIO, V15, P411, DOI 10.1038/nrm3801; Hunter SE, 2010, METHODS, V51, P444, DOI 10.1016/j.ymeth.2010.01.033; Ikeda M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119687; Jin H, 2014, BBA-MOL BASIS DIS, V1842, P1282, DOI 10.1016/j.bbadis.2013.09.007; Khiati S, 2014, MOL PHARMACOL, V86, P193, DOI 10.1124/mol.114.092833; Kuhl I, 2014, NATURE, V514, pE7, DOI 10.1038/nature13690; Lewis W, 2007, LAB INVEST, V87, P326, DOI 10.1038/labinvest.3700523; Linkowska K, 2015, ANN HUMAN GENETICS; Milenkovic D, 2013, HUM MOL GENET, V22, P1983, DOI 10.1093/hmg/ddt051; Minczuk M, 2011, NUCLEIC ACIDS RES, V39, P4284, DOI 10.1093/nar/gkq1224; MIQUEL J, 1992, MUTAT RES, V275, P209, DOI 10.1016/0921-8734(92)90024-J; Murphy MP, 2007, ANNU REV PHARMACOL, V47, P629, DOI 10.1146/annurev.pharmtox.47.120505.105110; Murphy MP, 2009, BIOCHEM J, V417, P1, DOI 10.1042/BJ20081386; Naponelli V, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/121826; Nicholls TJ, 2014, EXP GERONTOL, V56, P175, DOI 10.1016/j.exger.2014.03.027; Ott M, 2007, APOPTOSIS, V12, P913, DOI 10.1007/s10495-007-0756-2; Oyewole AO, 2015, FASEB J, V29, P4766, DOI 10.1096/fj.15-275404; Paramasivam A, 2016, MITOCHONDRION, V26, P81, DOI 10.1016/j.mito.2015.12.006; Pezzini I, 2016, EXPERT OPIN DRUG DEL, P1; Rao VA, 2010, J BIOL CHEM, V285, P34447, DOI 10.1074/jbc.M110.133579; Rooney JP, 2015, METHODS MOL BIOL, V1241, P23, DOI 10.1007/978-1-4939-1875-1_3; Ruhanen H, 2010, BBA-MOL CELL RES, V1803, P931, DOI 10.1016/j.bbamcr.2010.04.008; Shadel GS, 2005, TRENDS BIOCHEM SCI, V30, P294, DOI 10.1016/j.tibs.2005.04.007; Shokolenko I, 2009, NUCLEIC ACIDS RES, V37, P2539, DOI 10.1093/nar/gkp100; Shokolenko IN, 2015, BBA-MOL BASIS DIS, V1852, P1805, DOI 10.1016/j.bbadis.2015.05.016; Smith RAJ, 2010, ANN NY ACAD SCI, V1201, P96, DOI 10.1111/j.1749-6632.2010.05627.x; Snow BJ, 2010, MOVEMENT DISORD, V25, P1670, DOI 10.1002/mds.23148; Spelbrink JN, 2001, NAT GENET, V28, P223, DOI 10.1038/90058; Spinazzi M, 2012, NAT PROTOC, V7, P1235, DOI 10.1038/nprot.2012.058; Turrens JF, 2003, J PHYSIOL-LONDON, V552, P335, DOI 10.1113/jphysiol.2003.049478; Tyynismaa H, 2004, HUM MOL GENET, V13, P3219, DOI 10.1093/hmg/ddh342; Wanrooij S, 2010, BBA-BIOENERGETICS, V1797, P1378, DOI 10.1016/j.bbabio.2010.04.015; Warburg O, 1927, J GEN PHYSIOL, V8, P519, DOI 10.1085/jgp.8.6.519; Warburg O, 1928, SCIENCE, V68, P437, DOI 10.1126/science.68.1767.437; Wojtala A, 2014, METHOD ENZYMOL, V542, P243, DOI 10.1016/B978-0-12-416618-9.00013-3; Wong LJC, 2008, HUM MUTAT, V29, pE150, DOI 10.1002/humu.20824; Yang Y., 2016, J CELLULAR PHYSL	55	41	42	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2016	11	12							e0168283	10.1371/journal.pone.0168283	http://dx.doi.org/10.1371/journal.pone.0168283			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EG7JB	28030582	gold, Green Published, Green Submitted			2022-12-27	WOS:000391222000042
J	Granholm, A; Moller, MH; Krag, M; Perner, A; Hjortrup, PB				Granholm, Anders; Moller, Morten Hylander; Krag, Mette; Perner, Anders; Hjortrup, Peter Buhl			Predictive Performance of the Simplified Acute Physiology Score (SAPS) II and the Initial Sequential Organ Failure Assessment (SOFA) Score in Acutely Ill Intensive Care Patients: Post-Hoc Analyses of the SUP-ICU Inception Cohort Study	PLOS ONE			English	Article							LENGTH-OF-STAY; APACHE-II; PROGNOSTIC PERFORMANCE; EXTERNAL VALIDATION; HOSPITAL MORTALITY; ADMISSION SCORE; CRITICALLY-ILL; CASE-MIX; UNIT; MULTICENTER	Purpose Severity scores including the Simplified Acute Physiology Score (SAPS) II and the Sequential Organ Failure Assessment (SOFA) score are used in intensive care units (ICUs) to assess disease severity, predict mortality and in research. We aimed to assess the predictive performance of SAPS II and the initial SOFA score for in-hospital and 90-day mortality in a contemporary international cohort. Methods This was a post-hoc study of the Stress Ulcer Prophylaxis in the Intensive Care Unit (SUP-ICU) inception cohort study, which included acutely ill adults from ICUs across 11 countries (n = 1034). We compared the discrimination of SAPS II and initial SOFA scores, compared the discrimination of SAPS II in our cohort with the original cohort, assessed the calibration of SAPS II customised to our cohort, and compared the discrimination for 90-day mortality vs. in-hospital mortality for both scores. Discrimination was evaluated using areas under the receiver operating characteristics curves (AUROC). Calibration was evaluated using Hosmer-Lemeshow's goodness-of-fit (C) over cap -statistic. Results AUROC for in-hospital mortality was 0.80 (95% confidence interval (CI) 0.77-0.83) for SAPS II and 0.73 (95% CI 0.69-0.76) for initial SOFA score (P<0.001 for the comparison). Calibration of the customised SAPS II for predicting in-hospital mortality was adequate (P = 0.60). Discrimination of SAPS II was reduced compared with the original SAPS II validation sample (AUROC 0.80 vs. 0.86; P = 0.001). AUROC for 90-day mortality was 0.79 (95% CI 0.76-0.82; P = 0.74 for comparison with in-hospital mortality) for SAPS II and 0.71 (95% CI 0.68-0.75; P = 0.66 for comparison with in-hospital mortality) for the initial SOFA score. Conclusions The predictive performance of SAPS II was similar for in-hospital and 90-day mortality and superior to that of the initial SOFA score, but SAPS II's performance has decreased over time. Use of a contemporary severity score with improved predictive performance may be of value.	[Granholm, Anders; Moller, Morten Hylander; Krag, Mette; Perner, Anders; Hjortrup, Peter Buhl] Rigshosp, Copenhagen Univ Hosp, Dept Intens Care, Copenhagen, Denmark	Rigshospitalet; University of Copenhagen	Granholm, A (corresponding author), Rigshosp, Copenhagen Univ Hosp, Dept Intens Care, Copenhagen, Denmark.	andersgran@gmail.com	Møller, Morten Hylander/AAQ-6891-2020; Granholm, Anders/AAW-7623-2020	Møller, Morten Hylander/0000-0002-6378-9673; Granholm, Anders/0000-0001-5799-7655; Perner, Anders/0000-0002-4668-0123; Krag, Mette/0000-0002-5246-8727	Aase and Ejnar Danielsen's Foundation; Ehrenreich's Foundation; Scandinavian Society of Anaesthesia and Intensive Care Medicine (SSAI); Danish Society of Anaesthesiology and Intensive Care Medicine (DASAIM); Danish Medical Association	Aase and Ejnar Danielsen's Foundation; Ehrenreich's Foundation; Scandinavian Society of Anaesthesia and Intensive Care Medicine (SSAI); Danish Society of Anaesthesiology and Intensive Care Medicine (DASAIM); Danish Medical Association	The authors received no specific funding for this work. The SUP-ICU cohort study was supported by Aase and Ejnar Danielsen's Foundation, Ehrenreich's Foundation, the Scandinavian Society of Anaesthesia and Intensive Care Medicine (SSAI), the Danish Society of Anaesthesiology and Intensive Care Medicine (DASAIM) and the Danish Medical Association. The founders had any role in the conduct of the SUP-ICU cohort study or the present study, nor in the analyses or reporting of the data.	Alberti C, 2014, INTENS CARE MED, V40, P667, DOI 10.1007/s00134-014-3248-1; Apolone G, 1996, INTENS CARE MED, V22, P1368, DOI 10.1007/s001340050266; Beck DH, 2003, INTENS CARE MED, V29, P249, DOI 10.1007/s00134-002-1607-9; Beck DH, 2002, ANAESTHESIA, V57, P785; Brinkman S, 2013, INTENS CARE MED, V39, P1925, DOI 10.1007/s00134-013-3042-5; Capuzzo M, 2009, ACTA ANAESTH SCAND, V53, P589, DOI 10.1111/j.1399-6576.2009.01929.x; DELONG ER, 1988, BIOMETRICS, V44, P837, DOI 10.2307/2531595; Desa K, 2012, CROAT MED J, V53, P442, DOI 10.3325/cmj.2012.53.442; Glance LG, 2002, CRIT CARE MED, V30, P1976, DOI 10.1097/00003246-200209000-00005; Gonen M, 2007, ANAL RECEIVER OPERAT; Haaland OA, 2014, ACTA ANAESTH SCAND, V58, P701, DOI 10.1111/aas.12327; Harrison DA, 2006, CRIT CARE MED, V34, P1378, DOI 10.1097/01.CCM.0000216702.94014.75; Holst LB, 2014, NEW ENGL J MED, V371, P1381, DOI 10.1056/NEJMoa1406617; Hutchings A, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b4353; Jammer I, 2015, EUR J ANAESTH, V32, P88, DOI 10.1097/EJA.0000000000000118; Janssens U, 2000, INTENS CARE MED, V26, P1037, DOI 10.1007/s001340051316; Krag M, 2015, INTENS CARE MED, V41, P833, DOI 10.1007/s00134-015-3725-1; Le Gall JR, 2005, CRIT CARE, V9, pR645, DOI 10.1186/cc3821; Ledoux D, 2008, INTENS CARE MED, V34, P1873, DOI 10.1007/s00134-008-1187-4; LEGALL JR, 1993, JAMA-J AM MED ASSOC, V270, P2957, DOI 10.1001/jama.270.24.2957; Macdonald G, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001930.pub3; Marshall A, 2009, BMC MED RES METHODOL, V9, DOI 10.1186/1471-2288-9-57; Metnitz PGH, 1999, INTENS CARE MED, V25, P192, DOI 10.1007/s001340050815; Metnitz PGH, 2000, INTENS CARE MED, V26, P1466, DOI 10.1007/s001340000638; Metnitz PGH, 2005, INTENS CARE MED, V31, P1336, DOI 10.1007/s00134-005-2762-6; Minne L, 2012, INTENS CARE MED, V38, P40, DOI 10.1007/s00134-011-2390-2; Minne L, 2008, CRIT CARE, V12, DOI 10.1186/cc7160; Moran JL, 2008, CRIT CARE MED, V36, P46, DOI 10.1097/01.CCM.0000295313.08084.58; Moreno R, 1997, INTENS CARE MED, V23, P177, DOI 10.1007/s001340050313; Moreno RP, 2005, INTENS CARE MED, V31, P1345, DOI 10.1007/s00134-005-2763-5; Nfor TK, 2006, ANAESTHESIA, V61, P731, DOI 10.1111/j.1365-2044.2006.04707.x; Perner A, 2012, NEW ENGL J MED, V367, P124, DOI 10.1056/NEJMoa1204242; Poole D, 2012, INTENS CARE MED, V38, P1280, DOI 10.1007/s00134-012-2578-0; Rapsang AG, 2014, INDIAN J CRIT CARE M, V18, P220, DOI 10.4103/0972-5229.130573; Rydenfelt K, 2015, ACTA ANAESTH SCAND, V59, P846, DOI 10.1111/aas.12554; Sakr Y, 2008, BRIT J ANAESTH, V101, P798, DOI 10.1093/bja/aen291; Sicignano A, 1996, INTENS CARE MED, V22, P1048, DOI 10.1007/BF01699226; Strand K, 2008, ACTA ANAESTH SCAND, V52, P467, DOI 10.1111/j.1399-6576.2008.01586.x; Strand K, 2009, ACTA ANAESTH SCAND, V53, P595, DOI 10.1111/j.1399-6576.2009.01948.x; Suistomaa M, 2002, INTENS CARE MED, V28, P479, DOI 10.1007/s00134-002-1214-9; Vesin A, 2013, INTENS CARE MED, V39, P1396, DOI 10.1007/s00134-013-2949-1; Vincent JL, 2010, CRIT CARE, V14, DOI 10.1186/cc8204; Vincent JL, 2010, CRIT CARE MED, V38, P283, DOI 10.1097/CCM.0b013e3181b785a2; Vincent JL, 1998, CRIT CARE MED, V26, P1793, DOI 10.1097/00003246-199811000-00016; Vincent JL, 1996, INTENS CARE MED, V22, P707, DOI 10.1007/BF01709751; von Elm E, 2008, J CLIN EPIDEMIOL, V61, P344, DOI 10.2471/BLT.07.045120; Williams TA, 2010, ANAESTH INTENS CARE, V38, P703, DOI 10.1177/0310057X1003800414; Zimmerman JE, 2013, CRIT CARE, V17, DOI 10.1186/cc12695	48	25	29	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2016	11	12							e0168948	10.1371/journal.pone.0168948	http://dx.doi.org/10.1371/journal.pone.0168948			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI9QH	28006826	Green Submitted, Green Published, gold			2022-12-27	WOS:000392843200113
J	Rheault, L; Beelen, K; Cochrane, C; Hirst, G				Rheault, Ludovic; Beelen, Kaspar; Cochrane, Christopher; Hirst, Graeme			Measuring Emotion in Parliamentary Debates with Automated Textual Analysis	PLOS ONE			English	Article							PROSPECT-THEORY; DECISION; HAPPINESS; CHOICES; INCOME; TIME	An impressive breadth of interdisciplinary research suggests that emotions have an influence on human behavior. Nonetheless, we still know very little about the emotional states of those actors whose daily decisions have a lasting impact on our societies: politicians in parliament. We address this question by making use of methods of natural language processing and a digitized corpus of text data spanning a century of parliamentary debates in the United Kingdom. We use this approach to examine changes in aggregate levels of emotional polarity in the British parliament, and to test a hypothesis about the emotional response of politicians to economic recessions. Our findings suggest that, contrary to popular belief, the mood of politicians has become more positive during the past decades, and that variations in emotional polarity can be predicted by the state of the national economy.	[Rheault, Ludovic; Cochrane, Christopher] Univ Toronto, Dept Polit Sci, Toronto, ON, Canada; [Beelen, Kaspar] Univ Amsterdam, Inst Informat, Amsterdam, Netherlands; [Hirst, Graeme] Univ Toronto, Dept Comp Sci, Toronto, ON, Canada	University of Toronto; University of Amsterdam; University of Toronto	Rheault, L (corresponding author), Univ Toronto, Dept Polit Sci, Toronto, ON, Canada.	ludovic.rheault@utoronto.ca	Hirst, Graeme/A-1825-2008	Cochrane, Christopher/0000-0002-0110-5395; Rheault, Ludovic/0000-0002-9599-0427	Digging into Data Challenge [3147]; National Sciences and Engineering Research Council of Canada (NSERC); Social Sciences and Humanities Research Council of Canada (SSHRC); Canada Foundation for Innovation; Social Sciences and Humanities Research Council of Canada; Natural Sciences and Engineering Research Council of Canada	Digging into Data Challenge; National Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); Social Sciences and Humanities Research Council of Canada (SSHRC)(Social Sciences and Humanities Research Council of Canada (SSHRC)CGIAR); Canada Foundation for Innovation(Canada Foundation for InnovationCGIAR); Social Sciences and Humanities Research Council of Canada(Social Sciences and Humanities Research Council of Canada (SSHRC)); Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR)	This work was supported by 2013 Digging into Data Challenge, Jisc ID 3147, https://did3.liscinvolve.org/wp/projects/dilipad/, with the participation of the National Sciences and Engineering Research Council of Canada (NSERC), Social Sciences and Humanities Research Council of Canada (SSHRC) and Canada Foundation for Innovation. Authors who received funding: CC GH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors acknowledge the financial support of the Social Sciences and Humanities Research Council of Canada and the Natural Sciences and Engineering Research Council of Canada.	Acerbi A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059030; Agerri R, 2010, P 7 INT C LANG RES E; [Anonymous], 2011, SCIENCE, DOI [DOI 10.21055/0370-1069-2020-1-51-60, DOI 10.1016/j.jocs.2010.12.007]; Aue A., 2005, RECENT ADV NATURAL L; Barabasi AL, 2005, NATURE, V435, P207, DOI 10.1038/nature03459; Bechara A, 2000, CEREB CORTEX, V10, P295, DOI 10.1093/cercor/10.3.295; Bentley RA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0083147; Bollen J., 2011, ICWSM, P450; Camerer C, 2005, J ECON LIT, V43, P9, DOI 10.1257/0022051053737843; Coviello L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090315; Cowie R, 2003, SPEECH COMMUN, V40, P5, DOI 10.1016/S0167-6393(02)00071-7; Dalton R., 2004, DEMOCRATIC CHALLENGE, DOI 10.1093/ACPROF:oso/9780199268436.001.0001; Dawes CT, 2012, P NATL ACAD SCI USA, V109, P6479, DOI 10.1073/pnas.1118653109; De Choudhury M, 2013, PROC 7 INT AAAI C WE, V7; Deaton A, 2008, J ECON PERSPECT, V22, P53, DOI 10.1257/jep.22.2.53; DeWall CN, 2011, PSYCHOL AESTHET CREA, V5, P200, DOI 10.1037/a0023195; Di Tella R, 2001, AM ECON REV, V91, P335, DOI 10.1257/aer.91.1.335; Dodds PS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026752; Easterlin RA, 2010, P NATL ACAD SCI USA, V107, P22463, DOI 10.1073/pnas.1015962107; Eggers AC, 2014, AM J POLIT SCI, V58, P873, DOI 10.1111/ajps.12090; Elsner Micha, 2015, LINGUISTIC ISSUES LA, V12, P1; Esuli A., 2006, LREC, P417, DOI DOI 10.1155/2015/715730; Frey BS, 2002, J ECON LIT, V40, P402, DOI 10.1257/002205102320161320; Frey BS, 2001, HAPPINESS EC EC I AF; Granger C. W. J., 1980, Journal of Time Series Analysis, V1, P15, DOI 10.1111/j.1467-9892.1980.tb00297.x; Hirst Graeme, 2014, TEXT POLITICAL POSIT, P61; Hsu M, 2005, SCIENCE, V310, P1680, DOI 10.1126/science.1115327; Hu M., 2004, P 10 ACM SIGKDD INT; Inglehart R, 2008, PERSPECT PSYCHOL SCI, V3, P264, DOI 10.1111/j.1745-6924.2008.00078.x; Ishizuka M, 2012, INT J COGN INFORM NA, V6, P81, DOI 10.4018/jcini.2012100104; Jaywant A, 2012, SPEECH COMMUN, V54, P1, DOI 10.1016/j.specom.2011.05.011; KAHNEMAN D, 1984, AM PSYCHOL, V39, P341, DOI 10.1037/0003-066X.39.4.341; KAHNEMAN D, 1979, ECONOMETRICA, V47, P263, DOI 10.2307/1914185; Lansdall-Welfare T., 2012, P 21 INT C WORLD WID, P1221, DOI [10.1145/2187980.2188264, DOI 10.1145/2187980.2188264]; Le Q.V., 2014, P 31 INT C MACH LEAR; Loewenstein G, 2000, AM ECON REV, V90, P426, DOI 10.1257/aer.90.2.426; LOOMES G, 1982, ECON J, V92, P805, DOI 10.2307/2232669; Maas A. L., 2011, P 49 ANN M ASS COMP, P142; McDermott R., 2004, PERSPECT POLIT, V2, P691, DOI DOI 10.1017/S1537592704040459; Mercer J, 2005, ANNU REV POLIT SCI, V8, P1, DOI 10.1146/annurev.polisci.8.082103.104911; Michel JB, 2011, SCIENCE, V331, P176, DOI 10.1126/science.1199644; Mohammad S., 2012, PROC C N AM CHAPTER, P587; Mohammad SM, 2015, INFORM PROCESS MANAG, V51, P480, DOI 10.1016/j.ipm.2014.09.003; Mohammad SM, 2013, COMPUT INTELL-US, V29, P436, DOI 10.1111/j.1467-8640.2012.00460.x; Mohammad SM, 2012, DECIS SUPPORT SYST, V53, P730, DOI 10.1016/j.dss.2012.05.030; Neuman W. Russell, 2007, AFFECT EFFECT DYNAMI; Pennington J, 2014, P 2014 C EMP METH NA, DOI DOI 10.3115/V1/D14-1162; Picard R. W., 1997, AFFECTIVE COMPUTING; Pinker S., 2011, BETTER ANGELS OUR NA; Qiu Guang, 2009, P INT JOINT C ART IN; Schuller B., 2014, COMPUTATIONAL PARALI, V1st; Settanni M, 2015, FRONT PSYCHOL, V6, DOI 10.3389/fpsyg.2015.00898; SIMON HA, 1967, PSYCHOL REV, V74, P29, DOI 10.1037/h0024127; Stone P.J., 1966, GEN INQUIRER COMPUTE; Strapparava C., 2004, P INT C LANG RES EV; Takahashi H, 2013, NEUROSCI RES, V75, P269, DOI 10.1016/j.neures.2013.01.011; Tausczik YR, 2010, J LANG SOC PSYCHOL, V29, P24, DOI 10.1177/0261927X09351676; Nguyen T, 2014, IEEE T AFFECT COMPUT, V5, P217, DOI 10.1109/TAFFC.2014.2315623; Turney PD, 2003, ACM T INFORM SYST, V21, P315, DOI 10.1145/944012.944013; Vliegenthart R, 2011, POLITICAL COMMUNICATION IN POSTMODERN DEMOCRACY: CHALLENGING THE PRIMACY OF POLITICS, P92; Wiebe J, 2005, LANG RESOUR EVAL, V39, P165, DOI 10.1007/s10579-005-7880-9	62	35	35	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2016	11	12							e0168843	10.1371/journal.pone.0168843	http://dx.doi.org/10.1371/journal.pone.0168843			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EI9QH	28006016	Green Published, Green Submitted, gold			2022-12-27	WOS:000392843200102
J	Wendt, T; Holme, I; Dockter, C; Preuss, A; Thomas, W; Druka, A; Waugh, R; Hansson, M; Braumann, I				Wendt, Toni; Holme, Inger; Dockter, Christoph; Preuss, Aileen; Thomas, William; Druka, Arnis; Waugh, Robbie; Hansson, Mats; Braumann, Ilka			HvDep1 Is a Positive Regulator of Culm Elongation and Grain Size in Barley and Impacts Yield in an Environment-Dependent Manner	PLOS ONE			English	Article							PROTEIN GAMMA-SUBUNIT; ARABIDOPSIS-THALIANA; NATURAL VARIATION; ORGAN SIZE; MUTATION; GENES; DEP1; AGG3; SEED; GS3	Heterotrimeric G proteins are intracellular membrane-attached signal transducers involved in various cellular processes in both plants and animals. They consist of three subunits denoted as alpha, beta and gamma. The gamma-subunits of the so-called AGG3 type, which comprise a transmembrane domain, are exclusively found in plants. In model species, these proteins have been shown to participate in the control of plant height, branching and seed size and could therefore impact the harvestable yield of various crop plants. Whether AGG3-type gamma-subunits influence yield in temperate cereals like barley and wheat remains unknown. Using a transgenic complementation approach, we show here that the Scottish malting barley cultivar (cv.) Golden Promise carries a loss-of-function mutation in HvDep1, an AGG3-type subunit encoding gene that positively regulates culm elongation and seed size in barley. Somewhat intriguingly, agronomic field data collected over a 12-year period reveals that the HvDep1 loss-of-function mutation in cv. Golden Promise has the potential to confer either a significant increase or decrease in harvestable yield depending on the environment. Our results confirm the role of AGG3-type subunit-encoding genes in shaping plant architecture, but interestingly also indicate that the impact HvDep1 has on yield in barley is both genotypically and environmentally sensitive. This may explain why widespread exploitation of variation in AGG3-type subunit-encoding genes has not occurred in temperate cereals while in rice the DEP1 locus is widely exploited to improve harvestable yield.	[Wendt, Toni; Dockter, Christoph; Preuss, Aileen; Braumann, Ilka] Carlsberg Res Lab, Copenhagen, Denmark; [Holme, Inger] Aarhus Univ, Fac Sci & Technol, Dept Mol Biol & Genet, Slagelse, Denmark; [Thomas, William; Druka, Arnis; Waugh, Robbie] James Hutton Inst, Dundee, Scotland; [Waugh, Robbie] Univ Dundee, Div Plant Sci, Dundee DD1 4HN, Scotland; [Hansson, Mats] Lund Univ, Dept Biol, Lund, Sweden	Aarhus University; James Hutton Institute; University of Dundee; Lund University	Braumann, I (corresponding author), Carlsberg Res Lab, Copenhagen, Denmark.	ilka.braumann@carlsberg.com		Hansson, Mats/0000-0002-0168-9968; Holme, Inger/0000-0001-5008-0086	Deutscher Akademischer Austauschdienst (DAAD) [DK-BI-478]; Gront Udviklings- og Demonstrationsprogram (GUDP) [34009-12-0552]; Carlsberg Foundation [2008_01_0291]; Biotechnology and Biological Sciences Research Council [BB/K008188/1] Funding Source: researchfish; BBSRC [BB/K008188/1] Funding Source: UKRI	Deutscher Akademischer Austauschdienst (DAAD)(Deutscher Akademischer Austausch Dienst (DAAD)); Gront Udviklings- og Demonstrationsprogram (GUDP); Carlsberg Foundation(Carlsberg Foundation); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by Deutscher Akademischer Austauschdienst (DAAD, www.daad.de): DK-BI-478 (AP/IB); Gront Udviklings- og Demonstrationsprogram (GUDP, http://www.cartsbergfondet.dk/da): 34009-12-0552 (MH); and Carlsberg Foundation (http://www.cartsbergfondet.dk/da): 2008_01_0291 (MH). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahloowalia BS, 2004, EUPHYTICA, V135, P187, DOI 10.1023/B:EUPH.0000014914.85465.4f; Badr A, 2000, MOL BIOL EVOL, V17, P499, DOI 10.1093/oxfordjournals.molbev.a026330; Baik BK, 2008, J CEREAL SCI, V48, P233, DOI 10.1016/j.jcs.2008.02.002; Belanger S, 2014, EUPHYTICA; Botella JR, 2012, TRENDS PLANT SCI, V17, P563, DOI 10.1016/j.tplants.2012.06.002; Bregitzer P, 2002, BARLEY GENET NEWSL, V32, P86; Chakravorty D, 2011, PLANT J, V67, P840, DOI 10.1111/j.1365-313X.2011.04638.x; Chloupek O, 2006, THEOR APPL GENET, V112, P779, DOI 10.1007/s00122-005-0147-4; Close TJ, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-582; Dockter C, 2014, PLANT PHYSIOL, V166, P1912, DOI 10.1104/pp.114.250738; Druka A, 2011, PLANT PHYSIOL, V155, P617, DOI 10.1104/pp.110.166249; Ellis RP, 2002, J EXP BOT, V53, P1163, DOI 10.1093/jexbot/53.371.1163; Forster BP, 2001, EUPHYTICA, V120, P317, DOI 10.1023/A:1017592618298; Harwood WA., 2011, J EXP BOT; Hiei Y, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00628; Holme IB, 2012, PLANT BIOTECHNOL J, V10, P237, DOI 10.1111/j.1467-7652.2011.00660.x; Huang XZ, 2009, NAT GENET, V41, P494, DOI 10.1038/ng.352; Kesavan M, 2013, PHYSIOL PLANTARUM, V147, P113, DOI 10.1111/j.1399-3054.2012.01664.x; KUCERA J, 1975, HEREDITAS, V80, P263; Kumlehn J, 2014, BIOTECH AGR FOREST, V69, P393, DOI 10.1007/978-3-662-44406-1_21; Li J, 2005, HEREDITY, V95, P221, DOI 10.1038/sj.hdy.6800717; Li SJ, 2012, PLANT SIGNAL BEHAV, V7, P1357, DOI 10.4161/psb.21620; Li SJ, 2012, NEW PHYTOL, V194, P690, DOI 10.1111/j.1469-8137.2012.04083.x; Liu H, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-104; Lundqvist U, 2011, BARLEY GENET NEWSL, V41, P131; Mao HL, 2010, P NATL ACAD SCI USA, V107, P19579, DOI 10.1073/pnas.1014419107; Marthe C, 2015, METHODS MOL BIOL, V1223, P71, DOI 10.1007/978-1-4939-1695-5_6; Mascher M, 2013, PLANT J, V76, P718, DOI 10.1111/tpj.12319; Mason MG, 2001, BBA-GENE STRUCT EXPR, V1520, P147, DOI 10.1016/S0167-4781(01)00262-7; Mason MG, 2000, P NATL ACAD SCI USA, V97, P14784, DOI 10.1073/pnas.97.26.14784; Mayer KFX, 2012, NATURE, V491, P711, DOI 10.1038/nature11543; Meyer RC, 2000, GENETIC APPROACHES I; Munoz-Amatriain M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094688; Taguchi-Shiobara F, 2011, BREEDING SCI, V61, P17, DOI 10.1270/jsbbs.61.17; Temple BRS, 2007, ANNU REV PLANT BIOL, V58, P249, DOI 10.1146/annurev.arplant.58.032806.103827; Tester M, 2010, SCIENCE, V327, P818, DOI 10.1126/science.1183700; THOMAS WTB, 1984, HEREDITY, V53, P177, DOI 10.1038/hdy.1984.73; Thomas WTB, 1998, MOL BREEDING, V4, P381, DOI 10.1023/A:1009646115967; Trusov Yuri, 2012, BMC Res Notes, V5, P608, DOI 10.1186/1756-0500-5-608; Urano D, 2013, OPEN BIOL, V3, DOI 10.1098/rsob.120186; Van Ooijen JW, 2006, SOFTWARE CALCULATION; Wolfenstetter S, 2014, PLANT J; Yi XH, 2011, J GENET GENOMICS, V38, P217, DOI 10.1016/j.jgg.2011.03.011; Zhou Y, 2009, GENETICS, V183, P315, DOI 10.1534/genetics.109.102681	44	43	46	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2016	11	12							e0168924	10.1371/journal.pone.0168924	http://dx.doi.org/10.1371/journal.pone.0168924			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI9QH	28005988	gold, Green Published, Green Submitted			2022-12-27	WOS:000392843200110
J	Marano, F; Rinella, L; Argenziano, M; Cavalli, R; Sassi, F; D'Amelio, P; Battaglia, A; Gontero, P; Bosco, O; Peluso, R; Fortunati, N; Frairia, R; Catalano, MG				Marano, Francesca; Rinella, Letizia; Argenziano, Monica; Cavalli, Roberta; Sassi, Francesca; D'Amelio, Patrizia; Battaglia, Antonino; Gontero, Paolo; Bosco, Ornella; Peluso, Rossella; Fortunati, Nicoletta; Frairia, Roberto; Catalano, Maria Graziella			Targeting Taxanes to Castration-Resistant Prostate Cancer Cells by Nanobubbles and Extracorporeal Shock Waves	PLoS One			English	Article							ANAPLASTIC THYROID-CANCER; DRUG-DELIVERY; PACLITAXEL; THERAPY; NANOPARTICLES; DOXORUBICIN; DOCETAXEL; EFFICACY; RELEASE; ENHANCE	To target taxanes to castration-resistant prostate cancer cells, glycol-chitosan nanobubbles loaded with paclitaxel and docetaxel were constructed. The loaded nanobubbles were then combined with Extracorporeal Shock Waves, acoustic waves widely used in urology and orthopedics, with no side effects. Nanobubbles, with an average diameter of 353.3 +/- 15.5 nm, entered two different castration-resistant prostate cancer cells (PC3 and DU145) as demonstrated by flow cytometry and immunofluorescence. The shock waves applied increased the amount of intracellular nanobubbles. Loading nanobubbles with paclitaxel and docetaxel and combining them with shock waves generated the highest cytotoxic effects, resulting in a paclitaxel GI(50) reduction of about 55% and in a docetaxel GI(50) reduction of about 45% respectively. Combined treatment also affected cell migration. Paclitaxel-loaded nanobubbles and shock waves reduced cell migration by more than 85% with respect to paclitaxel alone; whereas docetaxel-loaded nanobubbles and shock waves reduced cell migration by more than 82% with respect to docetaxel alone. The present data suggest that nanobubbles can act as a stable taxane reservoir in castration-resistant prostate cancer cells and shock waves can further increase drug release from nanobubbles leading to higher cytotoxic and anti-migration effect.	[Marano, Francesca; Rinella, Letizia; Sassi, Francesca; D'Amelio, Patrizia; Bosco, Ornella; Peluso, Rossella; Frairia, Roberto; Catalano, Maria Graziella] Univ Turin, Dept Med Sci, Turin, Italy; [Argenziano, Monica; Cavalli, Roberta] Univ Turin, Dept Drug Sci & Technol, Turin, Italy; [Battaglia, Antonino; Gontero, Paolo] Univ Turin, Dept Surg Sci, Turin, Italy; [Fortunati, Nicoletta] AO Citta Salute & Sci Torino, Oncol Endocrinol, Turin, Italy	University of Turin; University of Turin; University of Turin; A.O.U. Citta della Salute e della Scienza di Torino	Frairia, R (corresponding author), Univ Turin, Dept Med Sci, Turin, Italy.	roberto.frairia@unito.it	Bosco, Ornella/AAB-2105-2019	Frairia, Roberto/0000-0001-9453-772X; Battaglia, Antonino/0000-0003-1961-8217; D'AMELIO, PATRIZIA/0000-0002-4467-8337	Fondazione CRT, University of Turin [2015.1688]	Fondazione CRT, University of Turin	This work was supported by Fondazione CRT 2015.1688 to MGC; "Research Fund ex-60%", University of Turin, to RF and RC.	Boissenot T, 2016, J CONTROL RELEASE, V241, P144, DOI 10.1016/j.jconrel.2016.09.026; Canaparo R, 2008, TECHNOL CANCER RES T, V7, P117, DOI 10.1177/153303460800700204; Catalano MG, 2007, THYROID, V17, P91, DOI 10.1089/thy.2006.0142; Cavalli R, 2016, THER DELIV, V7, P117, DOI 10.4155/tde.15.92; Cavalli R, 2012, INT J NANOMED, V7, P3309, DOI 10.2147/IJN.S30912; Cerqueira BBS, 2015, EUR J PHARM BIOPHARM, V97, P140, DOI 10.1016/j.ejpb.2015.10.007; Darshan MS, 2011, CANCER RES, V71, P6019, DOI 10.1158/0008-5472.CAN-11-1417; Fan XZ, 2016, INT J NANOMED, V11, P3585, DOI 10.2147/IJN.S111808; Ferlay J, 2013, GLOBOCAN 2012 V1 0 C; Frairia R, 2003, BREAST CANCER RES TR, V81, P11, DOI 10.1023/A:1025477421467; Ganju A, 2014, DRUG RESIST UPDATE, V17, P13, DOI 10.1016/j.drup.2014.04.001; Gao Z, 2008, ULTRASONICS, V48, P260, DOI 10.1016/j.ultras.2007.11.002; Gu F, 2009, METHODS MOL BIOL, V544, P589, DOI 10.1007/978-1-59745-483-4_37; JOCHAM D, 1986, UROL INT, V41, P357, DOI 10.1159/000281236; Kim SC, 2005, J PHARMACEUT BIOMED, V39, P170, DOI 10.1016/j.jpba.2005.02.023; Kodama T, 2002, BBA-MOL CELL RES, V1542, P186, DOI 10.1016/S0167-4889(01)00177-X; Loblaw DA, 2013, CLIN ONCOL-UK, V25, P406, DOI 10.1016/j.clon.2013.03.002; Maeda H, 2010, BIOCONJUGATE CHEM, V21, P797, DOI 10.1021/bc100070g; Marano F, 2016, THYROID, V26, P705, DOI 10.1089/thy.2015.0342; Martin SK, 2014, AM J CLIN EXP UROL, V2, P15; Musumeci T, 2006, INT J PHARMACEUT, V325, P172, DOI 10.1016/j.ijpharm.2006.06.023; Ogden JA, 2001, CLIN ORTHOP RELAT R, P22; Ohl SW, 2015, INTERFACE FOCUS, V5, DOI 10.1098/rsfs.2015.0019; Palmero A, 2006, ONCOL REP, V15, P267; Sanna V, 2011, NANOSCALE RES LETT, V6, DOI 10.1186/1556-276X-6-260; Scher HI, 2008, J CLIN ONCOL, V26, P1148, DOI 10.1200/JCO.2007.12.4487; Schutz FA, 2014, CRIT REV ONCOL HEMAT, V91, P248, DOI 10.1016/j.critrevonc.2014.02.003; Shapira A, 2011, DRUG RESIST UPDATE, V14, P150, DOI 10.1016/j.drup.2011.01.003; Shiota M, 2016, INT J UROL, V23, P360, DOI 10.1111/iju.13091; Wadosky KM, 2016, ONCOTARGET; Wasungu L, 2014, BIOELECTROCHEMISTRY, V100, P36, DOI 10.1016/j.bioelechem.2014.06.011; Zhong JP, 2016, J CONTROL RELEASE, V226, P77, DOI 10.1016/j.jconrel.2016.02.010	32	9	9	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2016	11	12							e0168553	10.1371/journal.pone.0168553	http://dx.doi.org/10.1371/journal.pone.0168553			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI9TW	28002459	Green Published, gold, Green Submitted			2022-12-27	WOS:000392853100054
J	Peeters, F; Atamanchuk, D; Tengberg, A; Encinas-Fernandez, J; Hofmann, H				Peeters, Frank; Atamanchuk, Dariia; Tengberg, Anders; Encinas-Fernandez, Jorge; Hofmann, Hilmar			Lake Metabolism: Comparison of Lake Metabolic Rates Estimated from a Diel CO2- and the Common Diel O(2-)Technique	PLoS One			English	Article							LIFETIME-BASED OPTODE; ECOSYSTEM METABOLISM; CARBON-DIOXIDE; WATER; SYSTEM; OXYGEN	Lake metabolism is a key factor for the understanding of turnover of energy and of organic and inorganic matter in lake ecosystems. Long-term time series on metabolic rates are commonly estimated from diel changes in dissolved oxygen. Here we present long-term data on metabolic rates based on diel changes in total dissolved inorganic carbon (DIC) utilizing an open-water diel CO2-technique. Metabolic rates estimated with this technique and the traditional diel O-2-technique agree well in alkaline Lake Illmensee (pHof-8.5), although the diel changes in molar CO2 concentrations are much smaller than those of the molar O-2 concentrations. The open-water diel CO2- and diel O-2-techniques provide independent measures of lake metabolic rates that differ in their sensitivity to transport processes. Hence, the combination of both techniques can help to constrain uncertainties arising from assumptions on vertical fluxes due to gas exchange and turbulent diffusion. This is particularly important for estimates of lake respiration rates because these are much more sensitive to assumptions on gradients in vertical fluxes of O-2 or DIC than estimates of lake gross primary production. Our data suggest that it can be advantageous to estimate respiration rates assuming negligible gradients in vertical fluxes rather than including gas exchange with the atmosphere but neglecting vertical mixing in the water column. During two months in summer the average lake net production was close to zero suggesting at most slightly autotrophic conditions. However, the lake emitted O-2 and CO2 during the entire time period suggesting that O-2 and CO2 emissions from lakes can be decoupled from the metabolism in the near surface layer.	[Peeters, Frank; Encinas-Fernandez, Jorge; Hofmann, Hilmar] Univ Konstanz, Dept Biol, Environm Phys, Constance, Germany; [Atamanchuk, Dariia; Tengberg, Anders] Univ Gothenburg, Dept Marine Sci, Gothenburg, Sweden; [Atamanchuk, Dariia] Dalhousie Univ, Dept Oceanog, Halifax, NS, Canada; [Tengberg, Anders] Aanderaa Data Instruments AS, Bergen, Norway	University of Konstanz; University of Gothenburg; Dalhousie University	Peeters, F (corresponding author), Univ Konstanz, Dept Biol, Environm Phys, Constance, Germany.	frank.peeters@uni-konstanz.de	Hofmann, Hilmar/G-8445-2011	Atamanchuk, Dariia/0000-0002-9117-502X	Ministry of Science, Research and the Arts of the federal state Baden-Wurttemberg, Germany; University of Konstanz [AFF 38/03]; German Research Foundation [YSF-DFG 419-14]	Ministry of Science, Research and the Arts of the federal state Baden-Wurttemberg, Germany; University of Konstanz; German Research Foundation(German Research Foundation (DFG))	JEF received funding from the Ministry of Science, Research and the Arts of the federal state Baden-Wurttemberg, Germany (grant: Water Research Network project: Challenges of Reservoir Management - Meeting Environmental and Social Requirements). University of Konstanz (grant: AFF 38/03) and the German Research Foundation (grant: YSF-DFG 419-14) financially supported the field work and construction of field instruments.The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2009, J GEOPHYS RES, V114; Atamanchuk D, 2015, J MARINE SYST, V148, P272, DOI 10.1016/j.jmarsys.2015.03.002; Atamanchuk D, 2014, LIMNOL OCEANOGR-METH, V12, P63, DOI 10.4319/lom.2014.12.63; Balzer F, 2015, DATA ENV 2015; Bellido JL, 2013, BIOGEOCHEMISTRY, V113, P613, DOI 10.1007/s10533-012-9792-2; Cole JJ, 2007, ECOSYSTEMS, V10, P171, DOI 10.1007/s10021-006-9013-8; Cole JJ, 1998, LIMNOL OCEANOGR, V43, P647, DOI 10.4319/lo.1998.43.4.0647; Cole JJ, 2000, LIMNOL OCEANOGR, V45, P1718, DOI 10.4319/lo.2000.45.8.1718; Coloso JJ, 2011, ECOSYSTEMS, V14, P935, DOI 10.1007/s10021-011-9455-5; Ducharme-Riel V, 2015, ECOSYSTEMS, V18, P547, DOI 10.1007/s10021-015-9846-0; Hanson PC, 2003, LIMNOL OCEANOGR, V48, P1112, DOI 10.4319/lo.2003.48.3.1112; Hoellein TJ, 2013, LIMNOL OCEANOGR, V58, P2089, DOI 10.4319/lo.2013.58.6.2089; Hofmann H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080913; HONDZO M, 1993, J HYDRAUL ENG, V119, P1251, DOI 10.1061/(ASCE)0733-9429(1993)119:11(1251); Livingstone DM, 1996, CAN J FISH AQUAT SCI, V53, P924, DOI 10.1139/cjfas-53-4-924; MILLERO FJ, 1995, GEOCHIM COSMOCHIM AC, V59, P661, DOI 10.1016/0016-7037(94)00354-O; North RP, 2012, INFLUENCE CLIMATE CH; Obrador B, 2014, LIMNOL OCEANOGR, V59, P1228, DOI 10.4319/lo.2014.59.4.1228; ODUM HT, 1956, LIMNOL OCEANOGR, V1, P102, DOI 10.4319/lo.1956.1.2.0102; ODUM HT, 1957, ECOL MONOGR, V27, P55, DOI 10.2307/1948571; OVIATT CA, 1986, MAR ECOL PROG SER, V28, P57, DOI 10.3354/meps028057; Redfield A. C, 1963, SEA, P26, DOI DOI 10.1016/J.ORGGEOCHEM.2014.06.002; Reidel D, 1986, ROLE AIR SEA EXCHANG, P113; Robinson C, 2005, RESPIRATION IN AQUATIC ECOSYSTEMS, P147, DOI 10.1093/acprof:oso/9780198527084.003.0009; SCHINDLE.DW, 1973, J FISH RES BOARD CAN, V30, P1501, DOI 10.1139/f73-240; Staehr PA, 2012, LIMNOL OCEANOGR, V57, P1317, DOI 10.4319/lo.2012.57.5.1317; Staehr PA, 2012, AQUAT SCI, V74, P15, DOI 10.1007/s00027-011-0199-2; Staehr PA, 2010, LIMNOL OCEANOGR-METH, V8, P628, DOI 10.4319/lom.2010.8.0628; Stumm W., 2012, AQUATIC CHEM CHEM EQ; Tengberg A, 2006, LIMNOL OCEANOGR-METH, V4, P7, DOI 10.4319/lom.2006.4.7; Tranvik LJ, 2009, LIMNOL OCEANOGR, V54, P2298, DOI 10.4319/lo.2009.54.6_part_2.2298; Verspagen JMH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104325; Weiss R.F., 1974, MAR CHEM, V2, P203, DOI DOI 10.1016/0304-4203(74)90015-2; WEISS RF, 1970, DEEP-SEA RES, V17, P721, DOI 10.1016/0011-7471(70)90037-9; WILLIAMS PJL, 1991, J PLANKTON RES, V13, pS153; Wolf-Gladrow DA, 2007, MAR CHEM, V106, P287, DOI 10.1016/j.marchem.2007.01.006; WU J, 1980, J PHYS OCEANOGR, V10, P727, DOI 10.1175/1520-0485(1980)010<0727:WSCOSS>2.0.CO;2	37	23	25	3	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2016	11	12							e0168393	10.1371/journal.pone.0168393	http://dx.doi.org/10.1371/journal.pone.0168393			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI9TW	28002477	Green Published, Green Submitted, gold			2022-12-27	WOS:000392853100043
J	Wang, X; Liu, WJ; O'Donnell, M; Lutgendorf, S; Bradley, C; Schrepf, A; Liu, LW; Kreder, K; Luo, Y				Wang, Xu; Liu, Wujiang; O'Donnell, Michael; Lutgendorf, Susan; Bradley, Catherine; Schrepf, Andrew; Liu, Liwei; Kreder, Karl; Luo, Yi			Evidence for the Role of Mast Cells in Cystitis-Associated Lower Urinary Tract Dysfunction: A Multidisciplinary Approach to the Study of Chronic Pelvic Pain Research Network Animal Model Study	PLOS ONE			English	Article							EXPERIMENTAL AUTOIMMUNE CYSTITIS; INTERSTITIAL CYSTITIS; BLADDER INFLAMMATION; MICE; ACTIVATION; MEDIATE	Bladder inflammation frequently causes cystitis pain and lower urinary tract dysfunction (LUTD) such as urinary frequency and urgency. Although mast cells have been identified to play a critical role in bladder inflammation and pain, the role of mast cells in cystitis-associated LUTD has not been demonstrated. Interstitial cystitis/bladder pain syndrome (IC/BPS) is a chronic and debilitating inflammatory condition of the urinary bladder characterized by the hallmark symptoms of pelvic pain and LUTD. In this study we investigated the role of mast cells in LUTD using a transgenic autoimmune cystitis model (URO-OVA) that reproduces many clinical correlates of IC/BPS. URO-OVA mice express the membrane form of the model antigen ovalbumin (OVA) as a self-antigen on the urothelium and develop bladder inflammation upon introduction of OVA-specific T cells. To investigate the role of mast cells, we crossed URO-OVA mice with mast cell-deficient Kit(W-sh) mice to generate URO-OVA/Kit(W-sh) mice that retained urothelial OVA expression but lacked endogenous mast cells. We compared URO-OVA mice with URO-OVA/Kit(W-sh) mice with and without mast cell reconstitution in response to cystitis induction. URO-OVA mice developed profound bladder inflammation with increased mast cell counts and LUTD, including increased total number of voids, decreased mean volume voided per micturition, and decreased maximum volume voided per micturition, after cystitis induction. In contrast, similarly cystitis-induced URO-OVA/Kit(W-sh) mice developed reduced bladder inflammation with no mast cells and LUTD detected. However, after mast cell reconstitution URO-OVA/Kit(W-sh) mice restored the ability to develop bladder inflammation and LUTD following cystitis induction. We further treated URO-OVA mice with cromolyn, a mast cell membrane stabilizer, and found that cromolyn treatment reversed bladder inflammation and LUTD in the animal model. Our results provide direct evidence for the role of mast cells in cystitis-associated LUTD, supporting the use of mast cell inhibitors for treatment of certain forms of IC/BPS.	[Wang, Xu; Liu, Wujiang; O'Donnell, Michael; Lutgendorf, Susan; Bradley, Catherine; Liu, Liwei; Kreder, Karl; Luo, Yi] Univ Iowa, Dept Urol, Iowa City, IA 52242 USA; [Wang, Xu; Liu, Liwei] Tianjin Med Univ, Hosp 2, Tianjin Inst Urol, Tianjin, Peoples R China; [Lutgendorf, Susan; Schrepf, Andrew] Univ Iowa, Dept Psychol, Iowa City, IA 52242 USA; [Lutgendorf, Susan; Bradley, Catherine; Kreder, Karl] Univ Iowa, Dept Obstet & Gynecol, Iowa City, IA 52242 USA	University of Iowa; Tianjin Medical University; University of Iowa; University of Iowa	Luo, Y (corresponding author), Univ Iowa, Dept Urol, Iowa City, IA 52242 USA.	yi-luo@uiowa.edu	Liu, Wujiang/ABG-9073-2021	O'Donnell, Michael/0000-0001-7202-6427; Bradley, Catherine/0000-0002-7402-5476; liu, wujiang/0000-0003-3510-7468; Kreder, Karl/0000-0002-8981-5286; Luo, Yi/0000-0002-4013-6805	National Institutes of Health [U01DK082344, R01DK100891]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK100891, U01DK082316, U01DK082344] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by the National Institutes of Health, U01DK082344, (https://projectreposter.nih.gov/project_info_details.cfrn? aib=9120958&icde=31468144&ddparam=&ddvalue=&ddsub=&cr=1&csb=default&cs=ASC Karl Kreder) and the National Institutes of Health, R01DK100891, (https://projectreporter.nih.gov/project_info_details.cfm?aid=8626530&icde=31468170&ddparam=&ddvalue=&ddsub=&cr=10&csb=default&cs=ASC) to YL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altuntas CZ, 2012, EUR UROL, V61, P193, DOI 10.1016/j.eururo.2011.06.028; Bicer F, 2015, AM J PHYSIOL-RENAL, V308, pF103, DOI 10.1152/ajprenal.00202.2014; Bjorling DE, 1999, J UROLOGY, V162, P231, DOI 10.1097/00005392-199907000-00073; Bouchelouche K, 2003, CURR OPIN UROL, V13, P309, DOI 10.1097/00042307-200307000-00007; BULLOCK AD, 1992, J UROLOGY, V148, P1951, DOI 10.1016/S0022-5347(17)37091-X; Chen MC, 2006, J UROLOGY, V175, P754, DOI 10.1016/S0022-5347(05)00171-0; Clarke SRM, 2000, IMMUNOL CELL BIOL, V78, P110, DOI 10.1046/j.1440-1711.2000.00889.x; Erickson DR, 1997, J UROLOGY, V158, P790, DOI 10.1016/S0022-5347(01)64317-9; Hanno PM, 2015, J UROLOGY, V193, P1545, DOI 10.1016/j.juro.2015.01.086; Kim R, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/937061; Lai H, 2015, UROLOGY, V85, P1454, DOI 10.1016/j.urology.2015.03.007; LIEBERT M, 1993, J UROLOGY, V149, P470, DOI 10.1016/S0022-5347(17)36121-9; Lin YH, 2008, BJU INT, V102, P1724, DOI 10.1111/j.1464-410X.2008.07891.x; Liu HT, 2009, BJU INT, V104, P1476, DOI 10.1111/j.1464-410X.2009.08675.x; Liu W, 2011, MUCOSAL IMMUNOL, V4, P428, DOI 10.1038/mi.2010.90; Liu WJ, 2008, J AUTOIMMUN, V30, P257, DOI 10.1016/j.jaut.2007.10.005; Liu WJ, 2007, J IMMUNOL, V178, P539, DOI 10.4049/jimmunol.178.1.539; LuberNarod J, 1996, UROL RES, V24, P367, DOI 10.1007/BF00389795; MACDERMOTT JP, 1991, J UROLOGY, V145, P274, DOI 10.1016/S0022-5347(17)38313-1; Mitra S, 1999, UROL RES, V27, P351, DOI 10.1007/s002400050162; Park Chang-Shin, 2011, Int Neurourol J, V15, P61, DOI 10.5213/inj.2011.15.2.61; Peeker R, 2003, SCAND J UROL NEPHROL, V37, P60, DOI 10.1080/00365590310008721; Phull H, 2007, BJU INT, V100, P664, DOI 10.1111/j.1464-410X.2007.07035.x; Rudick CN, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002096; Saban R, 2002, AM J PHYSIOL-RENAL, V283, pF616, DOI 10.1152/ajprenal.00096.2002; Sant GR, 2007, UROLOGY, V69, P34, DOI 10.1016/j.urology.2006.08.1109; SHAPIRO GG, 1985, PHARMACOTHERAPY, V5, P156; Taneja R, 2007, SCAND J UROL NEPHROL, V41, P511, DOI 10.1080/00365590701435918; Theoharides TC, 2005, INT J IMMUNOPATH PH, V18, P183, DOI 10.1177/039463200501800119; Theoharides TC, 1997, UROLOGY, V49, P108, DOI 10.1016/S0090-4295(97)00182-9; van de Merwe JP, 2007, NAT CLIN PRACT UROL, V4, P484, DOI 10.1038/ncpuro0874; van de Merwe Joop P, 2003, Int J Urol, V10 Suppl, pS35, DOI 10.1046/j.1442-2042.10.s1.10.x; Wolters PJ, 2005, CLIN EXP ALLERGY, V35, P82, DOI 10.1111/j.1365-2222.2005.02136.x; Worobec AS, 2000, HEMATOL ONCOL CLIN N, V14, P659, DOI 10.1016/S0889-8588(05)70301-4; Xu SM, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0163829	35	23	26	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2016	11	12							e0168772	10.1371/journal.pone.0168772	http://dx.doi.org/10.1371/journal.pone.0168772			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI9TW	28002455	Green Published, Green Submitted, gold			2022-12-27	WOS:000392853100066
J	Brennan, CE; Blanchard, H; Fennel, K				Brennan, Catherine E.; Blanchard, Hannah; Fennel, Katja			Putting Temperature and Oxygen Thresholds of Marine Animals in Context of Environmental Change: A Regional Perspective for the Scotian Shelf and Gulf of St. Lawrence	PLOS ONE			English	Article							FOOD CONVERSION EFFICIENCY; COD GADUS-MORHUA; CLIMATE-CHANGE; OCEAN ACIDIFICATION; HYPOXIA TOLERANCE; ATLANTIC-OCEAN; CTENOPHORE MNEMIOPSIS; SWIMMING PERFORMANCE; FISH RECRUITMENT; NORTH-AMERICAN	We conducted a literature review of reported temperature, salinity, pH, depth and oxygen preferences and thresholds of important marine species found in the Gulf of St. Lawrence and Scotian Shelf region. We classified 54 identified fishes and macroinvertebrates as important either because they support a commercial fishery, have threatened or at risk status, or meet one of the following criteria: bycatch, baitfish, invasive, vagrant, important for ecosystem energy transfer, or predators or prey of the above species. The compiled data allow an assessment of species-level impacts including physiological stress and mortality given predictions of future ocean physical and biogeochemical conditions. If an observed, multi-decadal oxygen trend on the central Scotian Shelf continues, a number of species will lose favorable oxygen conditions, experience oxygen-stress, or disappear due to insufficient oxygen in the coming half-century. Projected regional trends and natural variability are both large, and natural variability will act to alternately amplify and dampen anthropogenic changes. When estimates of variability are included with the trend, species encounter unfavourable oxygen conditions decades sooner. Finally, temperature and oxygen thresholds of adult Atlantic wolffish (Anarhichas lupus) and adult Atlantic cod (Gadus morhua) are assessed in the context of a potential future scenario derived from high-resolution ocean models for the central Scotian Shelf.	[Brennan, Catherine E.; Blanchard, Hannah; Fennel, Katja] Dalhousie Univ, Dept Oceanog, Halifax, NS, Canada; [Brennan, Catherine E.] Bedford Inst Oceanog, Dartmouth, NS, Canada	Dalhousie University; Bedford Institute of Oceanography	Brennan, CE (corresponding author), Dalhousie Univ, Dept Oceanog, Halifax, NS, Canada.; Brennan, CE (corresponding author), Bedford Inst Oceanog, Dartmouth, NS, Canada.	cebrennan.climate@gmail.com	Fennel, Katja/A-7470-2009	Fennel, Katja/0000-0003-3170-2331; Brennan, Catherine/0000-0003-2593-7222	Marine Environmental Observation Prediction and Response Network; Marine Environmental Observation Prediction and Response Network (MEOPAR)	Marine Environmental Observation Prediction and Response Network; Marine Environmental Observation Prediction and Response Network (MEOPAR)	The authors were funded by the Marine Environmental Observation Prediction and Response Network (http://meopar.ca/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We are thankful to the two anonymous reviewers whose comments significantly improved the quality of our manuscript. We thank Mathieu Dever and the OTN Glider Group for assisting with OTN benthic pod data. We are especially grateful to Laura Bianucci, Jae Choi, and Anya Waite for providing helpful comments during preparation of the manuscript. We acknowledge funding by the Marine Environmental Observation Prediction and Response Network (MEOPAR).	Anderson G., 1985, US FISH WILDL SERV B, V82; [Anonymous], 2013, SPEC RISK PUBL REG; [Anonymous], 1977, AQUAT TOXICOL; Arnberg M, 2013, MAR BIOL, V160, P2037, DOI 10.1007/s00227-012-2072-9; Bechmann RK, 2011, J TOXICOL ENV HEAL A, V74, P424, DOI 10.1080/15287394.2011.550460; Belkin IM, 2009, PROG OCEANOGR, V81, P207, DOI 10.1016/j.pocean.2009.04.011; Berge JA, 2006, CHEMOSPHERE, V62, P681, DOI 10.1016/j.chemosphere.2005.04.111; Bianucci L, 2016, ICES J MAR SCI, V73, P263, DOI 10.1093/icesjms/fsv220; Bigelow H.B., 1953, FISHES GULF MAINE, V53; Bopp L, 2013, BIOGEOSCIENCES, V10, P6225, DOI 10.5194/bg-10-6225-2013; Breitburg D, 2002, ESTUARIES, V25, P767, DOI 10.1007/BF02804904; Breitburg DL, 2009, ANNU REV MAR SCI, V1, P329, DOI 10.1146/annurev.marine.010908.163754; Brennan CE, 2016, ATMOS OCEAN, V54, P230, DOI 10.1080/07055900.2016.1147416; Brewer PG, 2009, SCIENCE, V324, P347, DOI 10.1126/science.1170756; Chabot D, 2013, CLIMATE CHANGE IMPAC, Vp, P83; Cheung WWL, 2013, NAT CLIM CHANGE, V3, P254, DOI 10.1038/NCLIMATE1691; Cheung WWL, 2012, AQUAT CONSERV, V22, P368, DOI 10.1002/aqc.2248; Chevin LM, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000357; Childress JJ, 1998, J EXP BIOL, V201, P1223; Choi JS, 2004, CAN J FISH AQUAT SCI, V61, P505, DOI 10.1139/F04-079; Claireaux G, 1999, J SEA RES, V42, P157, DOI 10.1016/S1385-1101(99)00019-2; Collins M, 2014, CLIMATE CHANGE 2013: THE PHYSICAL SCIENCE BASIS, P1029; Corkum CP, 2009, J EXP ZOOL PART A, V311A, P231, DOI 10.1002/jez.520; CRANFORD PJ, 1988, CAN J ZOOL, V66, P459, DOI 10.1139/z88-065; Curran K, 2012, STATE SCOTIAN SHELF; DAVIS JC, 1975, J FISH RES BOARD CAN, V32, P2295, DOI 10.1139/f75-268; Deutsch C, 2015, SCIENCE, V348, P1132, DOI 10.1126/science.aaa1605; DFO, 2016, COMM FISH LAND; DFO, 2009, 2009002 DFO CAN SCI; Doney SC, 2012, ANNU REV MAR SCI, V4, P11, DOI 10.1146/annurev-marine-041911-111611; Drinkwater KF, 2005, ICES J MAR SCI, V62, P1327, DOI 10.1016/j.icesjms.2005.05.015; Dufour R, 2007, CAN TECH REP FISH AQ, p2744E; Ekau W, 2010, BIOGEOSCIENCES, V7, P1669, DOI 10.5194/bg-7-1669-2010; Enfield DB, 2001, GEOPHYS RES LETT, V28, P2077, DOI 10.1029/2000GL012745; Fay C, 1983, EL824 TR US FISH WIL; Foss A, 2003, AQUACULTURE, V220, P607, DOI 10.1016/S0044-8486(02)00613-0; Foss A, 2006, AQUACULTURE, V256, P255, DOI 10.1016/j.aquaculture.2006.02.032; Fowler AE, 2013, AQUAT INVASIONS, V8, P89, DOI 10.3391/ai.2013.8.1.10; Frommel AY, 2013, MAR BIOL, V160, P1825, DOI 10.1007/s00227-011-1876-3; Fry F.E.J., 1971, P1; Fry F.E.J., 1957, PHYSL FISHES, P1; Galbraith PS, 2012, DEEP-SEA RES PT II, V77-80, P10, DOI 10.1016/j.dsr2.2012.04.001; Gilbert D, 2005, LIMNOL OCEANOGR, V50, P1654, DOI 10.4319/lo.2005.50.5.1654; Gilbert D, 2010, BIOGEOSCIENCES, V7, P2283, DOI 10.5194/bg-7-2283-2010; Haigh R, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117533; Hamer HH, 2011, J PLANKTON RES, V33, P137, DOI 10.1093/plankt/fbq100; Handeland SO, 2008, AQUACULTURE, V283, P36, DOI 10.1016/j.aquaculture.2008.06.042; Hendrickson L., 2006, STATUS FISHERY RESOU, P13; Hendrickson L., 2008, ASS 19 NE GROUNDFISH; HOUGHTON RW, 1978, J FISH RES BOARD CAN, V35, P414, DOI 10.1139/f78-073; Hutchings JA, 2012, ENVIRON REV, V20, P220, DOI 10.1139/a2012-011; Kawecki TJ, 2004, ECOL LETT, V7, P1225, DOI 10.1111/j.1461-0248.2004.00684.x; KAZAKOV RV, 1981, AQUACULTURE, V25, P289, DOI 10.1016/0044-8486(81)90192-7; Keeling RF, 2010, ANNU REV MAR SCI, V2, P199, DOI 10.1146/annurev.marine.010908.163855; Keeling RF, 2002, P NATL ACAD SCI USA, V99, P7848, DOI 10.1073/pnas.122154899; Keppel Elise A., 2012, Journal of Northwest Atlantic Fishery Science, V44, P61, DOI 10.2960/J.v44.m683; Klassen G., 2007, CAN MANUSCR REP FISH, pvii; Kordas RL, 2011, J EXP MAR BIOL ECOL, V400, P218, DOI 10.1016/j.jembe.2011.02.029; Levin PS, 2009, PLOS BIOL, V7, P23, DOI 10.1371/journal.pbio.1000014; LOUGH RG, 2004, NMFSNE190 NOAA; LYNCH M, 1993, BIOTIC INTERACTIONS AND GLOBAL CHANGE, P234; Melzner F, 2009, AQUAT TOXICOL, V92, P30, DOI 10.1016/j.aquatox.2008.12.011; Mistri M, 2004, J EXP MAR BIOL ECOL, V312, P385, DOI 10.1016/j.jembe.2004.07.012; Moran D, 2011, AQUAT TOXICOL, V102, P24, DOI 10.1016/j.aquatox.2010.12.014; Moser ML, 1996, MAR ECOL PROG SER, V144, P57, DOI 10.3354/meps144057; Mucci A, 2011, ATMOS OCEAN, V49, P206, DOI 10.1080/07055900.2011.599265; Najjar RG, 2000, GLOBAL BIOGEOCHEM CY, V14, P573, DOI 10.1029/1999GB900086; Neill W. H., 1991, AQUACULTURE WATER QU, V3, P30; NEILL WH, 1994, NETH J SEA RES, V32, P135, DOI 10.1016/0077-7579(94)90037-X; Nye J., 2010, CLIMATE CHANGE ITS E; Nye JA, 2009, MAR ECOL PROG SER, V393, P111, DOI 10.3354/meps08220; O'Boyle R., 2012, FISH STOCK STATUS CO; O'Dea NR, 2002, CAN FIELD NAT, V116, P423; PEDERSEN T, 1989, AQUACULTURE, V81, P161, DOI 10.1016/0044-8486(89)90242-1; PETRIE B, 1993, J GEOPHYS RES-OCEANS, V98, P20079, DOI 10.1029/93JC02191; Petrie B, 2000, CAN J FISH AQUAT SCI, V57, P2536, DOI 10.1139/cjfas-57-12-2536; Petrie B, 2007, ATMOS OCEAN, V45, P141, DOI 10.3137/ao.450302; PIHL L, 1991, MAR BIOL, V108, P349, DOI 10.1007/BF01313644; Pinsky ML, 2013, SCIENCE, V341, P1239, DOI 10.1126/science.1239352; Pinsky ML, 2012, CLIMATIC CHANGE, V115, P883, DOI 10.1007/s10584-012-0599-x; Plante S, 1998, J FISH BIOL, V53, P1342, DOI 10.1006/jfbi.1998.0798; Portner HO, 2010, J EXP BIOL, V213, P881, DOI 10.1242/jeb.037523; Portner HO, 2008, MAR ECOL PROG SER, V373, P203, DOI 10.3354/meps07768; Pohle G., 1990, CANADIAN TECHNICAL R, V1771, P1; Poloczanska ES, 2013, NAT CLIM CHANGE, V3, P919, DOI [10.1038/nclimate1958, 10.1038/NCLIMATE1958]; POSEY MH, 1991, ECOLOGY, V72, P2155, DOI 10.2307/1941567; Purcell JE, 2001, HYDROBIOLOGIA, V451, P145, DOI 10.1023/A:1011826618539; Rhein M., 2013, CLIMATE CHANGE 2013; Ries JB, 2009, GEOLOGY, V37, P1131, DOI 10.1130/G30210A.1; Rijnsdorp AD, 2009, ICES J MAR SCI, V66, P1570, DOI 10.1093/icesjms/fsp056; Roessig JM, 2004, REV FISH BIOL FISHER, V14, P251, DOI 10.1007/s11160-004-6749-0; Rogers NJ, 2016, CONSERV PHYSIOL, V4, DOI 10.1093/conphys/cow012; Roman J, 2006, P ROY SOC B-BIOL SCI, V273, P2453, DOI 10.1098/rspb.2006.3597; Saba VS, 2016, J GEOPHYS RES-OCEANS, V121, P118, DOI 10.1002/2015JC011346; Sanford E, 2011, ANNU REV MAR SCI, V3, P509, DOI 10.1146/annurev-marine-120709-142756; SCOTT J S, 1982, Journal of Northwest Atlantic Fishery Science, V3, P29; Scott W.B., 1988, CAN B FISH AQUAT SCI, V219, P1; Seibel BA, 2011, J EXP BIOL, V214, P326, DOI 10.1242/jeb.049171; Shackell NL, 2012, ICES J MAR SCI, V69, P151, DOI 10.1093/icesjms/fsr195; Shimps EL, 2005, J EXP MAR BIOL ECOL, V325, P146, DOI 10.1016/j.jembe.2005.04.026; Somero GN, 2010, J EXP BIOL, V213, P912, DOI 10.1242/jeb.037473; STEFFENSEN JF, 1994, POLAR BIOL, V14, P49; Steimle FW, 1999, ESSENTIAL FISH HABIT; Stendardo I, 2012, J GEOPHYS RES-OCEANS, V117, DOI 10.1029/2012JC007909; Stevens ED, 1998, CAN J FISH AQUAT SCI, V55, P2028, DOI 10.1139/cjfas-55-9-2028; Stevenson D, 2005, ESSENTIAL FISH HABIT; STICKLE WB, 1989, BIOL BULL, V177, P303, DOI 10.2307/1541945; Stillman JH, 2015, J EXP BIOL, V218, P1946, DOI 10.1242/jeb.115584; Stockwell CA, 2003, TRENDS ECOL EVOL, V18, P94, DOI 10.1016/S0169-5347(02)00044-7; Sunday JM, 2014, TRENDS ECOL EVOL, V29, P117, DOI 10.1016/j.tree.2013.11.001; Sutton RT, 2005, SCIENCE, V309, P115, DOI 10.1126/science.1109496; Tremblay M. J., 1997, Journal of Northwest Atlantic Fishery Science, V21, P7; Vaquer-Sunyer R, 2008, P NATL ACAD SCI USA, V105, P15452, DOI 10.1073/pnas.0803833105; WEARE BC, 1977, Q J ROY METEOR SOC, V103, P467, DOI 10.1002/qj.49710343707; WITTING DA, 1995, MAR ECOL PROG SER, V123, P23, DOI 10.3354/meps123023; Youcef WA, 2013, FISH OCEANOGR, V22, P41, DOI 10.1111/fog.12004	116	22	23	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2016	11	12							e0167411	10.1371/journal.pone.0167411	http://dx.doi.org/10.1371/journal.pone.0167411			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI9QF	27997536	Green Published, Green Submitted, gold			2022-12-27	WOS:000392842900007
J	Chavez, JD; Eng, JK; Schweppe, DK; Cilia, M; Rivera, K; Zhong, XF; Wu, X; Allen, T; Khurgel, M; Kumar, A; Lampropoulos, A; Larsson, M; Maity, S; Morozov, Y; Pathmasiri, W; Perez-Neut, M; Pineyro-Ruiz, C; Polina, E; Post, S; Rider, M; Tokmina-Roszyk, D; Tyson, K; Sant'Ana, DVP; Bruce, JE				Chavez, Juan D.; Eng, Jimmy K.; Schweppe, Devin K.; Cilia, Michelle; Rivera, Keith; Zhong, Xuefei; Wu, Xia; Allen, Terrence; Khurgel, Moshe; Kumar, Akhilesh; Lampropoulos, Athanasios; Larsson, Marten; Maity, Shuvadeep; Morozov, Yaroslav; Pathmasiri, Wimal; Perez-Neut, Mathew; Pineyro-Ruiz, Coriness; Polina, Elizabeth; Post, Stephanie; Rider, Mark; Tokmina-Roszyk, Dorota; Tyson, Katherine; Sant'Ana, Debora Vieira Parrine; Bruce, James E.			A General Method for Targeted Quantitative Cross-Linking Mass Spectrometry	PLOS ONE			English	Article							PROTEIN INTERACTIONS; HSP90; SOFTWARE; DATABASE; CELLS	Chemical cross-linking mass spectrometry (XL-MS) provides protein structural information by identifying covalently linked proximal amino acid residues on protein surfaces. The information gained by this technique is complementary to other structural biology methods such as x-ray crystallography, NMR and cryo-electron microscopy[1]. The extension of traditional quantitative proteomics methods with chemical cross-linking can provide information on the structural dynamics of protein structures and protein complexes. The identification and quantitation of cross-linked peptides remains challenging for the general community, requiring specialized expertise ultimately limiting more widespread adoption of the technique. We describe a general method for targeted quantitative mass spectrometric analysis of cross linked peptide pairs. We report the adaptation of the widely used, open source software package Skyline, for the analysis of quantitative XL-MS data as a means for data analysis and sharing of methods. We demonstrate the utility and robustness of the method with a cross-laboratory study and present data that is supported by and validates previously published data on quantified cross-linked peptide pairs. This advance provides an easy to use resource so that any lab with access to a LC-MS system capable of performing targeted quantitative analysis can quickly and accurately measure dynamic changes in protein structure and protein interactions.	[Chavez, Juan D.; Eng, Jimmy K.; Schweppe, Devin K.; Zhong, Xuefei; Wu, Xia; Bruce, James E.] Univ Washington, Sch Med, Dept Genome Sci, Seattle, WA 98105 USA; [Cilia, Michelle] Boyce Thompson Inst Plant Res, Ithaca, NY USA; [Cilia, Michelle] ARS, USDA, Ithaca, NY USA; [Cilia, Michelle] Cornell Univ, Dept Plant Pathol & Plant Microbe Biol, Ithaca, NY USA; [Rivera, Keith] Cold Spring Harbor Lab, POB 100, Cold Spring Harbor, NY 11724 USA; [Allen, Terrence; Khurgel, Moshe; Kumar, Akhilesh; Lampropoulos, Athanasios; Larsson, Marten; Maity, Shuvadeep; Morozov, Yaroslav; Pathmasiri, Wimal; Perez-Neut, Mathew; Pineyro-Ruiz, Coriness; Polina, Elizabeth; Post, Stephanie; Rider, Mark; Tokmina-Roszyk, Dorota; Tyson, Katherine; Sant'Ana, Debora Vieira Parrine] Cold Spring Harbor Lab, Prote Course 2016, POB 100, Cold Spring Harbor, NY 11724 USA	University of Washington; University of Washington Seattle; Cornell University; Boyce Thompson Institute for Plant Research; United States Department of Agriculture (USDA); Cornell University; Cold Spring Harbor Laboratory; Cold Spring Harbor Laboratory	Bruce, JE (corresponding author), Univ Washington, Sch Med, Dept Genome Sci, Seattle, WA 98105 USA.	jimbruce@uw.edu	Maity, Shuvadeep/I-7846-2019; Eng, Jimmy K/I-4202-2012	Maity, Shuvadeep/0000-0002-6031-4744; Eng, Jimmy K/0000-0001-6352-6737; Pathmasiri, Wimal/0000-0002-5199-5744; Chavez, Juan/0000-0001-8849-0304; Rivera, Keith/0000-0003-2979-9576; Whipple, Stephanie/0000-0003-2354-736X; Larsson, Marten/0000-0002-7855-9539; Schweppe, Devin/0000-0002-3241-6276	National Institutes of Health [5R01RR023334, 1R01GM097112, 5R01GM086688, 7S10RR025107, 5U19AI107775, 4T15HD072999, 1R01HL110879]; UW Proteome Resource [UWPR95794]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [T15HD072999] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [KL2TR001115, UL1TR001117] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [R01RR023334, S10RR025107] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL110879] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI107775] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM113237, R01GM086688, R01GM097112, R25GM109439] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [T32AG041688] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); UW Proteome Resource; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by the National Institutes of Health through grant numbers: 5R01RR023334, 1R01GM097112, 5R01GM086688, 7S10RR025107, 5U19AI107775, 4T15HD072999 and 1R01HL110879 and supported in part by the UW Proteome Resource UWPR95794.; We thank all of the members of the Bruce Laboratory and the UWPR for their advice and helpful discussions. We also thank the organizers of the CSHL 2016 proteomics workshop. This work was supported by the National Institutes of Health through grant numbers: 5R01RR023334, 1R01GM097112, 5R01GM086688, 7S 10RR025107, 5U19AI107775, 4T15HD072999 1R01HL110879, and R01GM113237 and supported in part by the UW Proteome Resource UWPR95794.	Bourmaud A, 2016, PROTEOMICS, V16, P2146, DOI 10.1002/pmic.201500543; Chavez JD, 2016, CELL CHEM BIOL, V23, P716, DOI 10.1016/j.chembiol.2016.05.012; Chavez JD, 2013, MOL CELL PROTEOMICS, V12, P1451, DOI 10.1074/mcp.M112.024497; Chen Z.A., 2016, MOL CELL PROTEOMICS; Eng JK, 2013, PROTEOMICS, V13, P22, DOI 10.1002/pmic.201200439; Holding AN, 2015, METHODS, V89, P54, DOI 10.1016/j.ymeth.2015.06.010; Kaake RM, 2014, MOL CELL PROTEOMICS, V13, P3533, DOI 10.1074/mcp.M114.042630; Kusebauch U, 2016, CELL, V166, P766, DOI 10.1016/j.cell.2016.06.041; Leitner A, 2016, TRENDS BIOCHEM SCI, V41, P20, DOI 10.1016/j.tibs.2015.10.008; Liu F, 2015, NAT METHODS, V12, P1179, DOI 10.1038/nmeth.3603; MacLean B, 2010, BIOINFORMATICS, V26, P966, DOI 10.1093/bioinformatics/btq054; Ong SE, 2006, NAT PROTOC, V1, P2650, DOI 10.1038/nprot.2006.427; Picotti P, 2012, NAT METHODS, V9, P555, DOI [10.1038/NMETH.2015, 10.1038/nmeth.2015]; Schmidt C, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2985; Schulte TW, 1998, CANCER CHEMOTH PHARM, V42, P273, DOI 10.1007/s002800050817; Schweppe DK, 2016, BIOINFORMATICS, V32, P2716, DOI 10.1093/bioinformatics/btw232; Schweppe DK, 2015, CHEM BIOL, V22, P1521, DOI 10.1016/j.chembiol.2015.09.015; Sharma V, 2014, J PROTEOME RES, V13, P4205, DOI 10.1021/pr5006636; Tan D, 2016, ELIFE, V5, DOI 10.7554/eLife.12509; Trepel J, 2010, NAT REV CANCER, V10, P537, DOI 10.1038/nrc2887; Walzthoeni T, 2015, NAT METHODS, V12, P1185, DOI 10.1038/nmeth.3631; Weisbrod CR, 2013, J PROTEOME RES, V12, P1569, DOI 10.1021/pr3011638; Wu X, 2015, MOL CELL PROTEOMICS, V14, P2126, DOI 10.1074/mcp.M115.050161; YERGEY JA, 1983, INT J MASS SPECTROM, V52, P337, DOI 10.1016/0020-7381(83)85053-0; Yu C, 2016, ANAL CHEM; Zheng CX, 2013, J PROTEOME RES, V12, P1989, DOI 10.1021/pr301162j	27	33	33	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2016	11	12							e0167547	10.1371/journal.pone.0167547	http://dx.doi.org/10.1371/journal.pone.0167547			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI9QF	27997545	Green Accepted, Green Published, Green Submitted, gold			2022-12-27	WOS:000392842900010
J	Khanam, R; Creanga, AA; Koffi, AK; Mitra, DK; Mahmud, A; Begum, N; Moin, SMI; Ram, M; Quaiyum, MA; Ahmed, S; Saha, SK; Baqui, AH				Khanam, Rasheda; Creanga, Andreea A.; Koffi, Alain K.; Mitra, Dipak K.; Mahmud, Arif; Begum, Nazma; Moin, Syed Mamun Ibne; Ram, Malathi; Quaiyum, Md Abdul; Ahmed, Saifuddin; Saha, Samir K.; Baqui, Abdullah H.		Projahnmo Study Grp Bangladesh	Patterns and Determinants of Care-Seeking for Antepartum and Intrapartum Complications in Rural Bangladesh: Results from a Cohort Study	PLOS ONE			English	Article							HEALTH-CARE; MATERNAL HEALTH; SYLHET DISTRICT; DECISION-MAKING; WOMENS AUTONOMY; ACCESS; MORTALITY; PREGNANCY; SERVICES; DELIVERY	Background The burden of maternal complications during antepartum and intrapartum periods is high and care seeking from a trained provider is low, particularly in low middle income countries of sub-Saharan Africa and South Asia. Identification of barriers to access to trained care and development of strategies to address them will contribute to improvements in maternal health. Using data from a community-based cohort of pregnant women, this study identified the prevalence of antepartum and intrapartum complications and determinants of care seeking for these complications in rural Bangladesh. Methods The study was conducted in 24,274 pregnant women between June 2011 and December 2013 in rural Sylhet district of Bangladesh. Women were interviewed during pregnancy to collect data on demographic and socioeconomic characteristics; prior miscarriages, stillbirths, live births, and neonatal deaths; as well as data on their ability to make decision to go to health center alone. They were interviewed within the first 7 days of child birth to collect data on self-reported antepartum and intrapartum complications and care seeking for those complications. Bivariate analysis was conducted to explore association between predisposing (socio-demographic), enabling (economic), perceived need, and service related factors with care seeking for self-reported antepartum and intrapartum complications. Multivariable multinomial logistic regression was performed to examine the association of selected factors with care-seeking for self-reported antepartum and intrapartum complications adjusting for co-variates. Results Self-reported antepartum and intrapartum complications among women were 14.8% and 20.9% respectively. Among women with any antepartum complication, 58.9% sought care and of these 46.5% received care from a trained provider. Of the women with intrapartum complications, 61.4% sought care and of them 46.5% did so from a trained provider. Care seeking for both antepartum and intrapartum complications from a trained provider was significantly higher for women with higher household wealth status, higher literacy level of both women and their husbands, and for those living close to a health facility (<10 km). Women's decision making ability to go to health centre alone was associated with untrained care only for antepartum complications, but was associated with both trained and untrained care for intrapartum complications. Conclusions Nearly 40.0% of the women who experienced either an antepartum or intrapartum complications did not seek care from any provider and 11.5%-14.9% received care from untrained providers, primarily because of economic and geographic barriers to access. Development and evaluation of context specific, cost-effective, and sustainable strategies that will address these barriers to access to care for the maternal complications will enhance care seeking from trained health care providers and improve maternal health.	[Khanam, Rasheda; Creanga, Andreea A.; Koffi, Alain K.; Mahmud, Arif; Begum, Nazma; Moin, Syed Mamun Ibne; Ram, Malathi; Baqui, Abdullah H.] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Int Hlth, Int Ctr Maternal & Newborn Hlth, Baltimore, MD 21205 USA; [Khanam, Rasheda; Quaiyum, Md Abdul] Int Ctr Diarrhoeal Dis Res, Dhaka, Bangladesh; [Mitra, Dipak K.] Independent Univ, Dhaka, Bangladesh; [Ahmed, Saifuddin] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Populat Family & Reprod Hlth, Baltimore, MD USA; [Saha, Samir K.] Dhaka Shishu Hosp, Dept Microbiol, Dhaka, Bangladesh	Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; International Centre for Diarrhoeal Disease Research (ICDDR); Independent University Bangladesh (IUB); Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health	Khanam, R (corresponding author), Johns Hopkins Bloomberg Sch Publ Hlth, Dept Int Hlth, Int Ctr Maternal & Newborn Hlth, Baltimore, MD 21205 USA.; Khanam, R (corresponding author), Int Ctr Diarrhoeal Dis Res, Dhaka, Bangladesh.	rkhanam1@jhu.edu	Khanam, Rasheda/P-8050-2018; Mitra, Dipak/W-9569-2018	Khanam, Rasheda/0000-0002-9365-8594; Koffi, Alain/0000-0003-3499-0949; Mitra, Dipak/0000-0001-8680-4146	Bill & Melinda Gates Foundation [OPPGH5307]	Bill & Melinda Gates Foundation(Bill & Melinda Gates Foundation)	This study was funded by Bill & Melinda Gates Foundation (grant no. OPPGH5307), http://www.gatestoundation.org/, AHB and SKS received the funding.; The study was funded by Bill & Melinda Gates Foundation (Grant No. OPPGH5307). The authors thank the members of the Projahnmo study team in Bangladesh and the study participants in Sylhet district who gave their time generously. Projahnmo is a research partnership of Johns Hopkins University (JHU) with the Bangladesh Ministry of Health and Family Welfare (MOHFW) and other Bangladeshi institutions including ICDDR,B, Shimantik, Sylhet Osmani Medical College (SOMC), Banghabandhu Shaik Mujib Medical University (BSMMU), and Child Health Research Foundation (CHRF). The other members of the Projahnmo Study Group include: Dr. A. E. Md. Muhiuddin Osmani; Dr. Habibur Rahman, Dr. Mohammad Sharif, Dr. A K M Saiedur Rahman, Dr. Gour Moni Sinha, Md. Kutub Uddin, Dr. Lutfunnahar Jesmin, Dr. Md. Abul Kalam Azad, Dr. Md. Abdullah Al Mehedi, Dr. Md. Moazzem Ali Khan Chowdhury, Dr. Md. Mashuqur Rahman of MOHFW; Prof. Manajjir Ali of SOMC; Prof. Mohammod Shahidullah of BSMMU; Prof. Mathuram Santosham, Dr. Salahuddin Ahmed, Dr. Arunangshu Dutta Roy, Sayed Mamun Moin of JHU; Prof. Nawshad Ahmed, Maksuda Islam, Iftekhar Rafiquilah, Shahidul Islam, Md. Hasanuzzaman of CHRF; and Dr. Ahmed Al Kabir of Shimantik. Abdullah H. Baqui (abaqui@jhu.edu) is the led author of this group.	Afulani PA, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0154110; Ahmed S, 2011, SOC SCI MED, V72, P1704, DOI 10.1016/j.socscimed.2011.03.031; Alkema L, 2016, LANCET, V387, P462, DOI 10.1016/S0140-6736(15)00838-7; Allanson ER, 2015, BMC PREGNANCY CHILDB, V15, DOI 10.1186/s12884-015-0472-9; ANDERSEN RM, 1995, J HEALTH SOC BEHAV, V36, P1, DOI 10.2307/2137284; Baqui AH, 2008, LANCET, V371, P1936, DOI 10.1016/S0140-6736(08)60835-1; Dietz P, 2014, MATERN CHILD HLTH J, V18, P2489, DOI 10.1007/s10995-014-1487-y; El Arifeen S, 2012, LANCET, V379, P1022, DOI 10.1016/S0140-6736(11)61848-5; Fotso JC, 2009, MATERN CHILD HLTH J, V13, P130, DOI 10.1007/s10995-008-0326-4; Fournier P, 2009, B WORLD HEALTH ORGAN, V87, P30, DOI 10.2471/BLT.07.047076; Glassman A, 2013, J HEALTH POPUL NUTR, V31, P48; Hardee K, 2012, GLOB PUBLIC HEALTH, V7, P603, DOI 10.1080/17441692.2012.668919; Hogan MC, 2010, LANCET, V375, P1609, DOI 10.1016/S0140-6736(10)60518-1; Islam N, 2014, REPROD HEALTH, V11, DOI 10.1186/1742-4755-11-86; Jacobs B, 2012, HEALTH POLICY PLANN, V27, P288, DOI 10.1093/heapol/czr038; Koenig MA, 2007, INT FAM PLAN PERSPEC, V33, P75, DOI 10.1363/3307507; Lagarde M, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD008137; Lakew S, 2015, REPROD HEALTH, V12, DOI 10.1186/s12978-015-0102-z; Malqvist M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066453; Mitra DK, 2016, PEDIATR INFECT DIS J, V35, pS55, DOI 10.1097/INF.0000000000001108; Mpembeni Rose Nm, 2007, BMC Pregnancy Childbirth, V7, P29, DOI 10.1186/1471-2393-7-29; Murray SF, 2014, BMC PREGNANCY CHILDB, V14, DOI 10.1186/1471-2393-14-30; National Institute of Population Research and Training (NIPORT), 2012, MEASURE EV ICDDR B B; Nonyane BAS, 2016, J GLOB HEALTH, V6, DOI 10.7189/jogh.06.010605; Osamor PE, 2016, INT J WOMENS HEALTH, V8, P191, DOI 10.2147/IJWH.S105483; Peters DH, 2008, ANN NY ACAD SCI, V1136, P161, DOI 10.1196/annals.1425.011; Qureshi RN, 2016, REPROD HEALTH, V13, DOI 10.1186/s12978-016-0140-1; Ronsmans C, 1997, STUD FAMILY PLANN, V28, P203, DOI 10.2307/2137888; Rutstein SO, 2004, DHS COMP REPORTS, V6; Say L, 2014, LANCET GLOB HEALTH, V2, pE323, DOI 10.1016/S2214-109X(14)70227-X; Senarath U, 2009, ASIA-PAC J PUBLIC HE, V21, P137, DOI 10.1177/1010539509331590; Sikder SS, 2015, BMC HEALTH SERV RES, V15, DOI 10.1186/s12913-015-0832-1; Vogel JP, 2014, BJOG-INT J OBSTET GY, V121, P76, DOI 10.1111/1471-0528.12633; WHO UNICEF UNFPA Bank W & UNDP, 2014, TRENDS MAT MORT 1990; WHO (World Health Organization), 2015, TRENDS MATERNAL MORT; Worku AG, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060171; World Health Organization (WHO), 2009, INT MAN PREGN CHILDB	37	8	8	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2016	11	12							e0167814	10.1371/journal.pone.0167814	http://dx.doi.org/10.1371/journal.pone.0167814			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EI9QF	27997537	Green Published, gold, Green Submitted			2022-12-27	WOS:000392842900014
J	Zhang, FM; Xu, CF; Ning, LG; Hu, FL; Shan, GD; Chen, HT; Yang, M; Chen, WG; Yu, JK; Xu, GQ				Zhang, Fenming; Xu, Chengfu; Ning, Longgui; Hu, Fengling; Shan, Guodong; Chen, Hongtan; Yang, Ming; Chen, Wenguo; Yu, Jiekai; Xu, Guoqiang			Exploration of Serum Proteomic Profiling and Diagnostic Model That Differentiate Crohn's Disease and Intestinal Tuberculosis	PLOS ONE			English	Article							DESORPTION IONIZATION-TIME; MALDI-TOF MS; ABDOMINAL TUBERCULOSIS; PEPTIDES; IDENTIFICATION; ANGIOGENESIS; BIOPSY; LEPTIN	Aim To explore the diagnostic models of Crohn's disease (CD), Intestinal tuberculosis (ITB) and the differential diagnostic model between CD and ITB by analyzing serum proteome profiles. Methods Serum proteome profiles from 30 CD patients, 21 ITB patients and 30 healthy controls (HCs) were analyzed by using weak cationic magnetic beads combined with MALDI-TOF-MS technique to detect the differentially expressed proteins of serum samples. Three groups were made and compared accordingly: group of CD patients and HCs, group of ITB patients and HCs, group of CD patients and ITB patients. Wilcoxon rank sum test was used to screen the ten most differentiated protein peaks (P < 0.05). Genetic algorithm combining with support vector machine (SVM) was utilized to establish the optimal diagnostic models for CD, ITB and the optimal differential diagnostic model between CD and ITB. The predictive effects of these models were evaluated by Leave one out (LOO) cross validation method. Results There were 236 protein peaks differently expressed between group of CD patients and HCs, 305 protein peaks differently expressed between group of ITB patients and HCs, 332 protein peaks differently expressed between group of CD patients and ITB patients. Ten most differentially expressed peaks were screened out between three groups respectively (P < 0.05) to establish diagnostic models and differential diagnostic model. A diagnostic model comprising of four protein peaks (M/Z 4964, 3029, 2833, 2900) can well distinguish CD patients and HCs, with a specificity and sensitivity of 96.7% and 96.7% respectively. A diagnostic model comprising four protein peaks (M/Z 3030, 2105, 2545, 4210) can well distinguish ITB patients and HCs, with a specificity and sensitivity of 93.3% and 95.2% respectively. A differential diagnostic model comprising three potential biomarkers protein peaks (M/Z 4267, 4223, 1541) can well distinguish CD patients and ITB patients, with a specificity and sensitivity of 76.2% and 80.0% respectively. Among the eleven protein peaks from the diagnostic models and differential diagnostic model, two have been successfully purified and identified, Those two peaks were M/Z 2900 from the diagnostic model between CD and HCs and M/Z 1541 from the differential diagnostic model between CD and ITB. M/Z 2900 was identified as appetite peptide, M/Z 1541 was identified as Lysyl oxidase-like 2 (LOXL-2). Conclusion The differently expressed protein peaks analyzed by serum proteome with weak cationic magnetic beads combined MALDI-TOF-MS technique can effectively distinguish CD patients and HCs, ITB patients and HCs, CD patients and ITB patients. The diagnostic model between CD patients and HCs consisting of four protein peaks (M/Z 4964, 3029, 2833, 2900), the diagnostic model between ITB patients and HCs comprising four protein peaks (M/Z 3030, 2105, 2545, 4210) and the differential diagnostic model between CD patients and ITB patients comprising three protein peaks (M/Z 4267, 4223, 1541) had high specificity and sensitivity and can contribute to diagnoses of CD, ITB and the differential diagnosis between CD and ITB. Two proteins from the diagnostic model of CD and the differential diagnostic model between CD and ITB were identified. Further experiments are required using a larger cohort of samples.	[Zhang, Fenming; Xu, Chengfu; Ning, Longgui; Hu, Fengling; Shan, Guodong; Chen, Hongtan; Yang, Ming; Chen, Wenguo; Xu, Guoqiang] Zhejiang Univ, Sch Med, Affiliated Hosp 1, Dept Gastroenterol, Hangzhou, Zhejiang, Peoples R China; [Yu, Jiekai] Zhejiang Univ, Sch Med, Affiliated Hosp 2, Dept Tumor Res Inst, Hangzhou, Zhejiang, Peoples R China	Zhejiang University; Zhejiang University	Xu, GQ (corresponding author), Zhejiang Univ, Sch Med, Affiliated Hosp 1, Dept Gastroenterol, Hangzhou, Zhejiang, Peoples R China.	xuguoqi@mail.hz.zj.cn	Xu, Cheng/GXH-4815-2022	Xu, Cheng/0000-0003-1000-733X	Major Science and Technology Project of Medical and Health of Zhejiang Province of China [WKJ-ZJ-1516]	Major Science and Technology Project of Medical and Health of Zhejiang Province of China	This work was supported by the Major Science and Technology Project of Medical and Health of Zhejiang Province of China (WKJ-ZJ-1516) to GQ Xu. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albert J, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0149909; Almadi MA, 2009, AM J GASTROENTEROL, V104, P1003, DOI 10.1038/ajg.2008.162; Alvares JF, 2005, ENDOSCOPY, V37, P351, DOI 10.1055/s-2005-861116; Amarapurkar D N, 2004, J Assoc Physicians India, V52, P863; Bignon M, 2011, BLOOD, V118, P3979, DOI 10.1182/blood-2010-10-313296; Chatzicostas Constantinos, 2002, BMC Gastroenterol, V2, P10, DOI 10.1186/1471-230X-2-10; Conconi MT, 2004, PEPTIDES, V25, P2179, DOI 10.1016/j.peptides.2004.08.011; Cravatt BF, 2007, NATURE, V450, P991, DOI 10.1038/nature06525; Dixit VD, 2004, J CLIN INVEST, V114, P57, DOI 10.1172/JCI200421134; Epstein D, 2007, ALIMENT PHARM THER, V25, P1373, DOI 10.1111/j.1365-2036.2007.03332.x; Felley-Bosco E, 2004, PATHOL RES PRACT, V200, P129, DOI 10.1016/j.prp.2004.02.002; Fung ET, 2000, CURR OPIN MOL THER, V2, P643; Gan HT, 2002, AM J GASTROENTEROL, V97, P1446, DOI 10.1111/j.1572-0241.2002.05686.x; Giebel R, 2010, ADV APPL MICROBIOL, V71, P149, DOI 10.1016/S0065-2164(10)71006-6; GILINSKY NH, 1983, S AFR MED J, V64, P849; Hanash SM, 2008, NATURE, V452, P571, DOI 10.1038/nature06916; HOSSSCHEWIETZEK S, 1995, CHIRURG, V66, P731; Kirsch R, 2006, J CLIN PATHOL, V59, P840, DOI 10.1136/jcp.2005.032383; Lee Yun Jung, 2004, Korean J Gastroenterol, V44, P153; Leighton JA, 2006, GASTROINTEST ENDOSC, V63, P558, DOI 10.1016/j.gie.2006.02.005; Liu XW, 2010, WORLD CHIN J DIGESTO, V18, P621; LOGAN VSC, 1969, P ROY SOC MED, V62, P1227, DOI 10.1177/003591576906201214; Lu K, 2012, J PROTEOME RES, V11, P4916, DOI 10.1021/pr300429x; Makharia GK, 2010, AM J GASTROENTEROL, V105, P642, DOI 10.1038/ajg.2009.585; Mao R, 2006, ENDOSCOPY, V38, P592, DOI [10.1055/s-2006-924996, DOI 10.1055/S-2006-924996]; Mazzocchi G, 2004, PEPTIDES, V25, P1269, DOI 10.1016/j.peptides.2004.05.011; Nishi Y, 2005, WORLD J GASTROENTERO, V11, P7314, DOI 10.3748/wjg.v11.i46.7314; Okano T, 2016, INT J ONCOL, V48, P945, DOI 10.3892/ijo.2016.3330; Peng DH, 2016, ONCOGENE; Petroianni A, 2002, PANMINERVA MED, V44, P155; Sailer J, 2005, AM J ROENTGENOL, V185, P1575, DOI 10.2214/AJR.04.1534; Schulthess B, 2013, J CLIN MICROBIOL, V51, P1834, DOI 10.1128/JCM.02654-12; Song JC, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0150005; Sparbier K, 2009, PROTEOMICS, V9, P1442, DOI 10.1002/pmic.200800616; Taleahmad S, 2015, SCI REP-UK, V5, DOI 10.1038/srep17985; Van Assche G, 2010, J CROHNS COLITIS, V4, P7, DOI 10.1016/j.crohns.2009.12.003; Venkatesh PGK, 2011, SAUDI J GASTROENTERO, V17, P95, DOI 10.4103/1319-3767.77236; Villanueva J, 2004, ANAL CHEM, V76, P1560, DOI 10.1021/ac0352171; Wasinger VC, 2016, MOL CELL PROTEOMICS, V15, P256, DOI 10.1074/mcp.M115.055095; Weidenfeld K, 2016, ONCOTARGET; Whiteaker JR, 2007, ANAL BIOCHEM, V362, P44, DOI 10.1016/j.ab.2006.12.023; Wong MYM, 2010, ELECTROPHORESIS, V31, P1721, DOI 10.1002/elps.200900571; Wong WM, 2007, J GASTROEN HEPATOL, V22, P137, DOI 10.1111/j.1440-1746.2006.03311.x; Wu LH, 2016, MOL MED REP, V14, P1923, DOI 10.3892/mmr.2016.5474; Xiao Z, 2005, MOL CELL ENDOCRINOL, V230, P95, DOI 10.1016/j.mce.2004.10.010	45	20	20	2	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2016	11	12							e0167109	10.1371/journal.pone.0167109	http://dx.doi.org/10.1371/journal.pone.0167109			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI9QF	27997555	gold, Green Published, Green Submitted			2022-12-27	WOS:000392842900004
J	Chopin, J; Laga, H; Miklavcic, SJ				Chopin, Joshua; Laga, Hamid; Miklavcic, Stanley J.			A Hybrid Approach for Improving Image Segmentation: Application to Phenotyping of Wheat Leaves	PLOS ONE			English	Article							CORNER DETECTION; COLOR	In this article we propose a novel tool that takes an initial segmented image and returns a more accurate segmentation that accurately captures sharp features such as leaf tips, twists and axils. Our algorithm utilizes basic a-priori information about the shape of plant leaves and local image orientations to fit active contour models to important plant features that have been missed during the initial segmentation. We compare the performance of our approach with three state-of-the-art segmentation techniques, using three error metrics. The results show that leaf tips are detected with roughly one half of the original error, segmentation accuracy is almost always improved and more than half of the leaf breakages are corrected.	[Chopin, Joshua; Miklavcic, Stanley J.] Univ South Australia, Phen & Bioinformat Res Ctr, Mawson Lakes, SA, Australia; [Laga, Hamid] Murdoch Univ, Sch Engn & Informat Technol, Perth, WA, Australia	University of South Australia; Murdoch University	Miklavcic, SJ (corresponding author), Univ South Australia, Phen & Bioinformat Res Ctr, Mawson Lakes, SA, Australia.	stan.miklavcic@unisa.edu.au		Miklavcic, Stanley/0000-0002-2361-246X; Chopin, Joshua/0000-0002-5012-5827	Grains Research and Development Corporation [GRS10512]	Grains Research and Development Corporation(Grains R&D Corp)	JC received a scholarship from the Grains Research and Development Corporation #GRS10512.	Cai J, 2012, IET IMAGE PROCESS, V6, P687, DOI 10.1049/iet-ipr.2011.0281; Cai JH, 2015, J EXP BOT, V66, P6551, DOI 10.1093/jxb/erv359; Chopin J, 2016, COMPUT J, V59, P603, DOI 10.1093/comjnl/bxv086; DICE LR, 1945, ECOLOGY, V26, P297, DOI 10.2307/1932409; Fahlgren N, 2015, MOL PLANT, V8, P1520, DOI 10.1016/j.molp.2015.06.005; Fritsche-Neto R, PHENOMICS NEXT GENER; Harris C., 1988, P ALV VIS C MANCH UK, V15, P147, DOI [10.5244/C.2.23, DOI 10.5244/C.2.23]; Hartigan J. A., 1979, Applied Statistics, V28, P100, DOI 10.2307/2346830; Hartmann A, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-148; Kacira M, 2002, T ASAE, V45, P1147, DOI 10.13031/2013.9923; KASS M, 1987, INT J COMPUT VISION, V1, P321, DOI 10.1007/BF00133570; Klukas C, 2014, PLANT PHYSIOL, V165, P506, DOI 10.1104/pp.113.233932; Kumar P, P INT C CONTR AUT RO, P211; Kumar P, 2014, PLANT SOIL, V380, P193, DOI 10.1007/s11104-014-2071-3; Kurata K, ACTA HORTIC, V440, P389; Laga H, P DICTA DIG IM COMP, P1; Laga H, 2013, 20TH INTERNATIONAL CONGRESS ON MODELLING AND SIMULATION (MODSIM2013), P524; Laga H, 2014, J THEOR BIOL, V363, P41, DOI 10.1016/j.jtbi.2014.07.036; Lin K., 2013, COMMUN COMPUT INF SC, V363, P192, DOI DOI 10.1007/978-3-642-37149-3_23; Manh AG, 2001, J AGR ENG RES, V80, P139, DOI 10.1006/jaer.2001.0725; Midtiby H, INT C AGR ENG; Mokhtarian F, 1998, IEEE T PATTERN ANAL, V20, P1376, DOI 10.1109/34.735812; Mylona EA, 2012, IEEE IMAGE PROC, P2565, DOI 10.1109/ICIP.2012.6467422; OTSU N, 1979, IEEE T SYST MAN CYB, V9, P62, DOI 10.1109/TSMC.1979.4310076; Permuter H, 2006, PATTERN RECOGN, V39, P695, DOI 10.1016/j.patcog.2005.10.028; Pound MP, 2014, PLANT PHYSIOL, V166, P1688, DOI 10.1104/pp.114.248971; Rousseau D., 2015, PHENOMICS CROP PLANT, P61; Ruzon MA, 2001, IEEE T PATTERN ANAL, V23, P1281, DOI 10.1109/34.969118; Seginer I, PLANT WILT DETECTION, V35, P1563; Sorensen T., 1948, BIOL SKAR, V5, P1; Tessmer OL, 2013, BMC SYST BIOL, V7, DOI 10.1186/1752-0509-7-S6-S17; Vantaram SR, 2012, J ELECTRON IMAGING, V21, DOI 10.1117/1.JEI.21.4.040901; Witkin A.P., 1983, P 8 INT JOINT C ART, P1019, DOI DOI 10.1007/978-3-8348-9190-729; Yin X, 2014, IEEE WINT CONF APPL, P437	34	11	11	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 19	2016	11	12							e0168496	10.1371/journal.pone.0168496	http://dx.doi.org/10.1371/journal.pone.0168496			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI9QC	27992594	Green Published, gold, Green Accepted, Green Submitted			2022-12-27	WOS:000392842600069
J	Chen, YX; Zhang, J; Morgan, IG; He, MG				Chen, Yanxian; Zhang, Jian; Morgan, Ian G.; He, Mingguang			Identifying Children at Risk of High Myopia Using Population Centile Curves of Refraction	PLOS ONE			English	Article							OUTDOOR ACTIVITY; ORTHOKERATOLOGY; PREVALENCE; SINGAPORE; SCHOOLCHILDREN; METAANALYSIS; PROGRESSION; ETHNICITY; ATROPINE; SYDNEY	Purpose To construct reference centile curves of refraction based on population-based data as an age-specific severity scale to evaluate their efficacy as a tool for identifying children at risk of developing high myopia in a longitudinal study. Methods Data of 4218 children aged 5-15 years from the Guangzhou Refractive Error Study in Children (RESC) study, and 354 first-born twins from the Guangzhou Twin Eye Study (GTES) with annual visit were included in the analysis. Reference centile curves for refraction were constructed using a quantile regression model based on the cycloplegic refraction data from the RESC. The risk of developing high myopia (spherical equivalent <=-6 diopters [D]) was evaluated as a diagnostic test using the twin follow-up data. Results The centile curves suggested that the 3 rd, 5 th, and 10 th percentile decreased from -0.25 D, 0.00 D and 0.25 D in 5 year-olds to -6.00 D, -5.65D and -4.63 D in 15 year-olds in the population- based data from RESC. In the GTES cohort, the 5 th centile showed the most effective diagnostic value with a sensitivity of 92.9%, a specificity of 97.9% and a positive predictive value (PPV) of 65.0% in predicting high myopia onset (<=-6.00D) before the age of 15 years. The PPV was highest (87.5%) in 3 rd centile but with only 50.0% sensitivity. The Mathew's correlation coefficient of 5 th centile in predicting myopia of -6.0D/-5.0D/-4.0D by age of 15 was 0.77/0.51/0.30 respectively. Conclusions Reference centile curves provide an age-specific estimation on a severity scale of refractive error in school-aged children. Children located under lower percentiles at young age were more likely to have high myopia at 15 years or probably in adulthood.	[Chen, Yanxian; Zhang, Jian; He, Mingguang] Sun Yat Sen Univ, Zhongshan Ophthalm Ctr, State Key Lab Ophthalmol, Guangzhou, Guangdong, Peoples R China; [Morgan, Ian G.] Australian Natl Univ, Res Sch Biol, Canberra, ACT, Australia; [He, Mingguang] Univ Melbourne, Royal Victorian Eye & Ear Hosp, Ctr Eye Res Australia, East Melbourne, Vic, Australia	Sun Yat Sen University; Australian National University; Centre for Eye Research Australia; Royal Victorian Eye & Ear Hospital; University of Melbourne	He, MG (corresponding author), Sun Yat Sen Univ, Zhongshan Ophthalm Ctr, State Key Lab Ophthalmol, Guangzhou, Guangdong, Peoples R China.; He, MG (corresponding author), Univ Melbourne, Royal Victorian Eye & Ear Hosp, Ctr Eye Res Australia, East Melbourne, Vic, Australia.	mingguang_he@yahoo.com	Morgan, Ian G/D-1190-2009; He, Mingguang/AAY-5239-2020	Morgan, Ian G/0000-0002-4548-3574; He, Mingguang/0000-0002-6912-2810	Fundamental Research Funds of the State Key Laboratory in Ophthalmology, Science and Technology Planning Project of Guangdong Province [2013B20400003]; National Natural Science Foundation of China [81300795]; University of Melbourne Research at Melbourne Accelerator Program Professorship	Fundamental Research Funds of the State Key Laboratory in Ophthalmology, Science and Technology Planning Project of Guangdong Province; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); University of Melbourne Research at Melbourne Accelerator Program Professorship	This work was supported by the Fundamental Research Funds of the State Key Laboratory in Ophthalmology, Science and Technology Planning Project of Guangdong Province 2013B20400003, National Natural Science Foundation of China 81300795. Dr He receives support from the University of Melbourne Research at Melbourne Accelerator Program Professorship. The Centre for Eye Research Australia receives operational infrastructural support from the Victorian government. The sponsor or funding organizations had no role in the design or conduct of this research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baird PN, 2010, PROG RETIN EYE RES, V29, P520, DOI 10.1016/j.preteyeres.2010.05.004; Bowditch H P, 1917, GROWTH CHILDREN STUD, VII; Chan TCY, 2014, AM J OPHTHALMOL, V158, P1130, DOI 10.1016/j.ajo.2014.08.026; Cole TJ, 2000, BMJ-BRIT MED J, V320, P1240, DOI 10.1136/bmj.320.7244.1240; deOnis M, 1996, AM J CLIN NUTR, V64, P650, DOI 10.1093/ajcn/64.4.650; Dirani M, 2009, BRIT J OPHTHALMOL, V93, P997, DOI 10.1136/bjo.2008.150979; Fledelius HC, 2010, ACTA OPHTHALMOL, V88, P472, DOI 10.1111/j.1755-3768.2008.01472.x; French AN, 2013, OPHTHAL PHYSL OPT, V33, P318, DOI 10.1111/opo.12045; He MG, 2004, INVEST OPHTH VIS SCI, V45, P793, DOI 10.1167/iovs.03-1051; He MG, 2006, TWIN RES HUM GENET, V9, P753, DOI 10.1375/183242706779462561; Li SM, 2016, CURR EYE RES, V41, P600, DOI 10.3109/02713683.2015.1050743; Li SM, 2014, OPTOMETRY VISION SCI, V91, P342, DOI 10.1097/OPX.0000000000000178; Lim HT, 2012, JPN J OPHTHALMOL, V56, P76, DOI 10.1007/s10384-011-0090-7; Lin LLK, 2004, ANN ACAD MED SINGAP, V33, P27; Mills NL, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.e1533; Neelam K, 2012, PROG RETIN EYE RES, V31, P495, DOI 10.1016/j.preteyeres.2012.04.001; Negrel AD, 2000, AM J OPHTHALMOL, V129, P421, DOI 10.1016/S0002-9394(99)00455-9; Nijman RG, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.e4224; Rose KA, 2008, ARCH OPHTHALMOL-CHIC, V126, P527, DOI 10.1001/archopht.126.4.527; Rose KA, 2008, OPHTHALMOLOGY, V115, P1279, DOI 10.1016/j.ophtha.2007.12.019; Sankaridurg P, 2011, INVEST OPHTH VIS SCI, V52, P9362, DOI 10.1167/iovs.11-7260; Santodomingo-Rubido J, 2012, INVEST OPHTH VIS SCI, V53, P5060, DOI 10.1167/iovs.11-8005; Saw SM, 2008, OPHTHALMOLOGY, V115, P1713, DOI 10.1016/j.ophtha.2008.03.016; Saw SM, 2005, OPHTHAL PHYSL OPT, V25, P381, DOI 10.1111/j.1475-1313.2005.00298.x; Shih YF, 1999, J OCUL PHARMACOL TH, V15, P85, DOI 10.1089/jop.1999.15.85; StataCorp, 2011, STAT STAT SOFTW REL; Stehouwer CD, 2000, ANAL TWINS HYPERTENS, V36, P1008, DOI DOI 10.1161/01.HYP.36.6.1008; Sung RYT, 2007, INT J OBESITY, V31, P550, DOI 10.1038/sj.ijo.0803452; Tokoro T, 1988, Acta Ophthalmol Suppl, V185, P107; Wu JB, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0082763, 10.1371/journal.pone.0081986, 10.1371/journal.pone.0081982]; Zhang MZ, 2011, INVEST OPHTH VIS SCI, V52, P5836, DOI 10.1167/iovs.10-5592	31	20	21	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2016	11	12							e0167642	10.1371/journal.pone.0167642	http://dx.doi.org/10.1371/journal.pone.0167642			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EG7JB	28030593	gold, Green Submitted, Green Published			2022-12-27	WOS:000391222000015
J	De Castro, O; Innangi, M; Di Maio, A; Menale, B; Bacchetta, G; Pires, M; Noble, V; Gestri, G; Conti, F; Peruzzi, L				De Castro, Olga; Innangi, Michele; Di Maio, Antonietta; Menale, Bruno; Bacchetta, Gianluigi; Pires, Mathias; Noble, Virgile; Gestri, Giovanni; Conti, Fabio; Peruzzi, Lorenzo			Disentangling Phylogenetic Relationships in a Hotspot of Diversity: The Butterworts (Pinguicula L., Lentibulariaceae) Endemic to Italy	PLOS ONE			English	Article							DNA-SEQUENCES; PLASTID DNA; EVOLUTION; PLANTS; INHERITANCE; MORPHOLOGY; INVENTORY; INFERENCE; SUPPORT; MRBAYES	The genus Pinguicula (Lentibulariaceae) consists of about 100 carnivorous species, also known as butterworts. Eleven taxa are endemic to Italy, which represents a biodiversity hotspot for butterworts in Europe. The aim of our study was to provide a phylogenetic framework for the Italian endemics, in order to: a) investigate the relationships between species in this group; b) evaluate their actual taxonomic value. To achieve this, we analysed all the taxa endemic to Italy, along with several other species, by means of ITS nrDNA analysis. Our results clarify the relationships between Italian endemics and other Pinguicula taxa identifying a basal polytomy defined by five clades. All of the Italian endemics (with the exception of P. lavalvae) fall within a single large clade, which includes P. vulgaris and allied species. Among them, P. poldinii represents the most isolated lineage. Other taxa show strong molecular similarities and form a single subclade, although their taxonomic ranks can be retained. Pinguicula lattanziae sp. nov., seemingly endemic to Liguria (NW Italy), is also described.	[De Castro, Olga; Di Maio, Antonietta; Menale, Bruno] Univ Naples Federico II, Dipartimento Biol, Naples, Italy; [Innangi, Michele] Seconda Univ Napoli, Dipartimento Sci & Tecnol Ambientali Biol & Farma, Caserta, Italy; [Bacchetta, Gianluigi] Univ Cagliari, Ctr Conservaz Biodiversita, Dipartimento Sci Vitae & Ambiente, Cagliari, Italy; [Pires, Mathias; Noble, Virgile] Conservatoire Bot Natl Mediterraneen, Hyeres, France; [Gestri, Giovanni] Abitazione, Prato, Italy; [Conti, Fabio] Univ Camerino, Scuola Biosci & Med Vet, Ctr Ric Florist Appennino, Parco Nazl Gran Sasso & Monti della Laga, Laquila, Italy; [Peruzzi, Lorenzo] Univ Pisa, Dipartimento Biol, Pisa, Italy	University of Naples Federico II; Universita della Campania Vanvitelli; University of Cagliari; University of Camerino; University of Pisa	De Castro, O (corresponding author), Univ Naples Federico II, Dipartimento Biol, Naples, Italy.	olga.decastro@unina.it	Conti, Fabio/K-4846-2015; Peruzzi, Lorenzo/A-4127-2012; Innangi, Michele/M-2205-2015; Bacchetta, Gianluigi/AAD-5329-2020	Conti, Fabio/0000-0001-7391-6691; Peruzzi, Lorenzo/0000-0001-9008-273X; Innangi, Michele/0000-0003-2362-6025; DE CASTRO, Olga/0000-0002-4861-3960				AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; [Anonymous], 1966, BIBLIOTHECA BOT; Ansaldi M, 2009, WULFENIA, V16, P1; Bacchetta G, 2014, PHYTOTAXA, V186, P279, DOI 10.11646/phytotaxa.186.5.5; Beatty GE, 2014, J BIOGEOGR, V41, P2185, DOI 10.1111/jbi.12371; BIRKY CW, 1995, P NATL ACAD SCI USA, V92, P11331, DOI 10.1073/pnas.92.25.11331; Blanca G, 1999, FOLIA GEOBOT, V34, P337, DOI 10.1007/BF02912819; Blanca G., 2001, FLORA IBERICA, V14, P81; Caparelli KF, 2008, FLORA MEDIT, V18, P594; Casper SJ, 2009, PLANT SYST EVOL, V277, P21, DOI 10.1007/s00606-008-0097-9; Casper SJ, 2006, HAUSSKNECHTIA, V11, P3; Casper SJ., 2001, WULFENIA, V8, P27; Cieslak T, 2005, AM J BOT, V92, P1723, DOI 10.3732/ajb.92.10.1723; Conti F, 2006, ANN BOT FENN, V43, P321; CORRIVEAU JL, 1988, AM J BOT, V75, P1443, DOI 10.2307/2444695; Darriba D, 2012, NAT METHODS, V9, P772, DOI 10.1038/nmeth.2109; De Castro O, 2013, ANN BOT-LONDON, V112, P589, DOI 10.1093/aob/mct134; Degtjareva GV, 2006, PLANT BIOLOGY, V8, P778, DOI 10.1055/s-2006-924560; Degtjareva Galina, 2004, Botanische Jahrbuecher fuer Systematik Pflanzengeschichte und Pflanzengeographie, V125, P431, DOI 10.1127/0006-8152/2004/0125-0431; Di Maio A, 2013, APPL PLANT SCI, V1, DOI 10.3732/apps.1200158; DOULAT E, 1947, CR HEBD ACAD SCI, V225, P354; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; Fleischmann A., 2015, CARNIV PL NEWSLETT, V44, P48; Fleischmann A, 2010, MOL PHYLOGENET EVOL, V56, P768, DOI 10.1016/j.ympev.2010.03.009; Gargiulo R, 2015, TAXON, V64, P754, DOI 10.12705/644.7; Goloboff PA, 1999, CLADISTICS, V15, P415, DOI 10.1111/j.1096-0031.1999.tb00278.x; Greiner S, 2015, BIOESSAYS, V37, P80, DOI 10.1002/bies.201400110; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Gutierrez Jr R, 2003, MOL PHYLOGENY UNPUB; Hall TA., 1999, NUCL ACIDS S SERIES, V41, P95; Hansen AK, 2007, AM J BOT, V94, P42, DOI 10.3732/ajb.94.1.42; Heslop-Harrison Y, 2004, J ECOL, V92, P1071, DOI 10.1111/j.0022-0477.2004.00942.x; Hodac L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103003; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; HUELSENBECK JP, 2001, BIOMETRICS, V17, P754, DOI [DOI 10.1093/BIOINFORMATICS/17.8.754, DOI 10.1093/BI0INF0RMATICS/17.8.754]; Innangi M, 2015, PLANT BIOSYST, V149, P990, DOI 10.1080/11263504.2014.920426; Innangi M, 2007, DELPINOA, V49, P77; J. IAPT/IOPB chromosome data 21, 2016, TAXON, V65, P673; Jobson RW, 2003, SYST BOT, V28, P157; Kondo Katsuhiko, 2006, APG Acta Phytotaxonomica et Geobotanica, V57, P155; Legendre L, 2000, ACTA BOT GALLICA, V147, P77, DOI 10.1080/12538078.2000.10515837; Mikeladse T., 1996, CRYSTALLINA HIRTIFLO; Mogensen HL, 1996, AM J BOT, V83, P383, DOI 10.2307/2446172; Muller KF, 2006, PLANT BIOLOGY, V8, P748, DOI 10.1055/s-2006-924706; Muller K, 2005, PLANT SYST EVOL, V250, P39, DOI 10.1007/s00606-004-0224-1; Muller K, 2004, PLANT BIOLOGY, V6, P477, DOI 10.1055/s-2004-817909; Nixon KC, 1999, CLADISTICS, V15, P407, DOI 10.1111/j.1096-0031.1999.tb00277.x; Peruzzi L, 2013, PLANT BIOSYST, V147, P692, DOI 10.1080/11263504.2012.756073; Peruzzi L, 2006, CARNIV PL NEWSLETT, V35, P89; Peruzzi L., 2004, CARNIVOROUS PLANT NE, V33, P68; Peruzzi L, 2015, PHYTOTAXA, V196, P1; Peruzzi L, 2014, PHYTOTAXA, V168, P1; Pinguicula Steiger J., 1998, 2 C INT CARN PLANT S, P12; Pysek P, 2012, PRESLIA, V84, P155; Sbragia P, 2014, PL BIOSYST; Schmidt AR, 1998, THESIS; Shimai H., 2007, CHROMOSOME BOT, V2, P67, DOI 10.3199/iscb.2.67; Shimai H, 2007, CHROMOSOME BOT, V2, P151, DOI DOI 10.3199/ISCB.2.151; Shuka L, 2007, WULFENIA, V14, P15; Siljak-Yakovlev S, 2012, PLANT BIOSYST, V146, P694, DOI 10.1080/11263504.2012.716796; TAMMARO F, 1987, Informatore Botanico Italiano, V19, P429; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Thompson JD., 2005, PLANT EVOLUTION MEDI, DOI DOI 10.1093/ACPROF:OSO/9780198515340.001.0001; Vargas P, 2009, J BIOGEOGR, V36, P1297, DOI 10.1111/j.1365-2699.2008.02059.x; Veleba A, 2014, NEW PHYTOL, V203, P22, DOI 10.1111/nph.12790; Vijayan K, 2009, AM J BOT, V96, P1348, DOI 10.3732/ajb.0800205; Yildirim H, 2012, PHYTOTAXA, V64, P46	67	13	13	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2016	11	12							e0167610	10.1371/journal.pone.0167610	http://dx.doi.org/10.1371/journal.pone.0167610			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EG7JB	28030566	Green Published, gold, Green Submitted			2022-12-27	WOS:000391222000012
J	Fan, WF; Wang, B; He, SS; Zhang, TF; Yin, CX; Chen, YP; Zheng, SQ; Zhang, JX; Li, L				Fan, Wufang; Wang, Bei; He, Shanshan; Zhang, Tengfei; Yin, Chenxing; Chen, Yunping; Zheng, Shuqi; Zhang, Jixia; Li, Lin			A Novel Missense Mutation 224G> T ( R75M) in SRY Coding Region Interferes with Nuclear Import and Results in 46, XY Complete Gonadal Dysgenesis	PLOS ONE			English	Article							SEX-DETERMINING REGION; DNA-BINDING ACTIVITY; HMG-BOX; GENE; PROTEIN; SOX9	SRY-mutation-caused sex reversal is a rare disease and mostly associated with a de novo mutation since the patients with defective SRY is infertile. There are many reports about SRY-mutation associated 46, XY ovarian disorder of sex development (DSD), but few described their molecular mechanism. Here we report a de novo mutation 224G>T (R75M) in SRY associated with a phenotypic female, 46, XY karyotype and dysgerminoma. The wild and mutated SRY were cloned into recombinant plasmid and expressed in cells in vitro, the result showed the mutated SRY is greatly accumulated in cytoplasm while the wild type SRY is mostly localized in nucleus. To make sure no other genes were involved, we performed the trio-based whole exome sequencing using the DNA samples from the proband and the parents, and no mutations were identified especially in DHH, NR0B1, NR5A1, SOX9 and MAP3K1, indicating the de novo mutation in SRY is the single defect responsible for the female sex reversal. We also used bioinformatics simulation analysis to predict impact of the mutation on SRY function, and find the R75 in wild type SRY can form a hydrogen bond with serine at 91 (S91) that make the SRY protein well fit into the minor groove of target DNA, while the M75 in the mutated SRY can't. Finally, we reviewed SRY mutations based on the available references and analyzed the mutation distribution patterns according to density and continuity, which may be useful for further study of the SRY structure, function, and its relatedness with DSD.	[Fan, Wufang; Wang, Bei; He, Shanshan; Zhang, Tengfei; Yin, Chenxing; Chen, Yunping] Hebei Univ, Sch Life Sci, Baoding, Hebei, Peoples R China; [Zheng, Shuqi; Zhang, Jixia; Li, Lin] Linyi Peoples Hosp, Inst Med Genet, Qingdao, Shandong, Peoples R China	Hebei University	Fan, WF (corresponding author), Hebei Univ, Sch Life Sci, Baoding, Hebei, Peoples R China.; Li, L (corresponding author), Linyi Peoples Hosp, Inst Med Genet, Qingdao, Shandong, Peoples R China.	wfan6888@yahoo.com; lilinxy1996@163.com			Hebei Province from Fund of the Hundred Talents Program [2013 E2012100011]; Fund of Natural Research Joint Special [ZR2012CL10]	Hebei Province from Fund of the Hundred Talents Program; Fund of Natural Research Joint Special	This work was supported by Hebei Province from Fund of the Hundred Talents Program (2013 E2012100011) for Dr. Wufang Fan and by Shandong Province from Fund of Natural Research Joint Special (ZR2012CL10) for Dr. Lin Li.; This work was supported by Hebei Province from Fund of the Hundred Talents Program (2013 E2012100011) for Dr. Wufang Fan and by Shandong Province from Fund of Natural Research Joint Special (ZR2012CL10) for Dr. Lin Li. All the authors have read and approved for the submission, and there is no conflict of interests among the authors in any forms. We sincerely thank Dr. Zhenqiu Li who helped to do the bioinformatics simulation analysis.	Battiloro E, 1997, HUM GENET, V100, P585, DOI 10.1007/s004390050557; Bhandari RK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043380; DINGWALL C, 1988, J CELL BIOL, V107, P841, DOI 10.1083/jcb.107.3.841; FERRARI S, 1992, EMBO J, V11, P4497, DOI 10.1002/j.1460-2075.1992.tb05551.x; Gimelli G, 2007, EUR J HUM GENET, V15, P76, DOI 10.1038/sj.ejhg.5201719; Hall T.A., 1999, NUCL ACIDS S SER, V41, P95; Harley VR, 2003, ENDOCR REV, V24, P466, DOI 10.1210/er.2002-0025; Harley VR, 2003, P NATL ACAD SCI USA, V100, P7045, DOI 10.1073/pnas.1137864100; HARLEY VR, 1992, SCIENCE, V255, P453, DOI 10.1126/science.1734522; Hayden EC, 2016, NATURE, V538, P154; Heinzerling L, 2012, J COMPUT CHEM, V33, P2554, DOI 10.1002/jcc.23094; Kamachi Y, 2000, TRENDS GENET, V16, P182, DOI 10.1016/S0168-9525(99)01955-1; Kaur G, 2011, FASEB J, V25, P665, DOI 10.1096/fj.10-173351; Kaur G, 2010, BIOCHEM J, V430, P39, DOI 10.1042/BJ20091758; KING CY, 1993, P NATL ACAD SCI USA, V90, P11990, DOI 10.1073/pnas.90.24.11990; King TFJ, 2014, CURR OPIN ENDOCRINOL, V21, P504, DOI 10.1097/MED.0000000000000113; Knower KC, 2003, CYTOGENET GENOME RES, V101, P185, DOI 10.1159/000074336; KOOPMAN P, 1991, NATURE, V351, P117, DOI 10.1038/351117a0; Lim ET, 2013, NEURON, V77, P235, DOI 10.1016/j.neuron.2012.12.029; MacArthur DG, 2012, SCIENCE, V335, P823, DOI 10.1126/science.1215040; Mitchell CL, 2002, MOL GENET METAB, V77, P217, DOI 10.1016/S1096-7192(02)00165-8; Sanchez-Moreno I, 2009, MOL CELL ENDOCRINOL, V299, P212, DOI 10.1016/j.mce.2008.10.012; Scherer G, 1998, CYTOGENET CELL GENET, V80, P188, DOI 10.1159/000014978; Shaffer LG, 2013, ISCN INT SYSTEM HUMA, V2013; SINCLAIR AH, 1990, NATURE, V346, P240, DOI 10.1038/346240a0; Smith JM, 2004, TRENDS GENET, V20, P4, DOI 10.1016/j.tig.2003.11.007; Stenson PD, 2014, HUM GENET, V133, P1, DOI 10.1007/s00439-013-1358-4; TAJIMA T, 1994, HUM MOL GENET, V3, P1187, DOI 10.1093/hmg/3.7.1187; Thomas JO, 2001, BIOCHEM SOC T, V29, P395, DOI 10.1042/BST0290395; Uehara S, 2002, J HUM GENET, V47, P279, DOI 10.1007/s100380200040; Wegner M, 1999, NUCLEIC ACIDS RES, V27, P1409, DOI 10.1093/nar/27.6.1409	31	8	9	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2016	11	12							e0168484	10.1371/journal.pone.0168484	http://dx.doi.org/10.1371/journal.pone.0168484			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EG7JB	28030592	Green Published, Green Submitted, gold			2022-12-27	WOS:000391222000049
J	Wolfe, MK; Wells, E; Mitro, B; Desmarais, AM; Scheinman, P; Lantagne, D				Wolfe, Marlene K.; Wells, Emma; Mitro, Brittany; Desmarais, Anne Marie; Scheinman, Pamela; Lantagne, Daniele			Seeking Clearer Recommendations for Hand Hygiene in Communities Facing Ebola: A Randomized Trial Investigating the Impact of Six Handwashing Methods on Skin Irritation and Dermatitis	PLOS ONE			English	Article							HEALTH-CARE WORKERS; SODIUM-HYPOCHLORITE; CONTACT-DERMATITIS; BARRIER FUNCTION; ATOPIC-DERMATITIS; ECZEMA; DISINFECTION; SENSITIVITY; POPULATION; PHYSIOLOGY	To prevent disease transmission, 0.05% chlorine solution is commonly recommended for handwashing in Ebola Treatment Units. In the 2014 West Africa outbreak this recommendation was widely extended to community settings, although many organizations recommend soap and hand sanitizer over chlorine. To evaluate skin irritation caused by frequent handwashing that may increase transmission risk in Ebola-affected communities, we conducted a randomized trial with 91 subjects who washed their hands 10 times a day for 28 days. Subjects used soap and water, sanitizer, or one of four chlorine solutions used by Ebola responders (calcium hypochlorite (HTH), sodium dichloroisocyanurate (NaDCC), and generated or pH-stabilized sodium hypochlorite (NaOCl)). Outcomes were self-reported hand feel, irritation as measured by the Hand Eczema Score Index (HECSI) (range 0-360), signs of transmission risk (e.g., cracking), and dermatitis diagnosis. All groups experienced statistically significant increases in HECSI score. Subjects using sanitizer had the smallest increases, followed by higher pH chlorine solutions (HTH and stabilized NaOCl), and soap and water. The greatest increases were among neutral pH chlorine solutions (NaDCC and generated NaOCl). Signs of irritation related to higher transmission risk were observed most frequently in subjects using soap and least frequently by those using sanitizer or HTH. Despite these irritation increases, all methods represented minor changes in HECSI score. Average HECSI score was only 9.10 at endline (range 1-33) and 4% (4/91) of subjects were diagnosed with dermatitis, one each in four groups. Each handwashing method has benefits and drawbacks: soap is widely available and inexpensive, but requires water and does not inactivate the virus; sanitizer is easy-to use and effective but expensive and unacceptable to many communities, and chlorine is easy-to-use but difficult to produce properly and distribute. Overall, we recommend Ebola responders and communities use whichever handwashing method(s) are most acceptable, available, and sustainable for community handwashing.	[Wolfe, Marlene K.; Wells, Emma; Mitro, Brittany; Desmarais, Anne Marie; Lantagne, Daniele] Tuft Univ, Dept Civil & Environm Engn, Medford, MA 02155 USA; [Scheinman, Pamela] Brigham & Womens Hosp, Dept Dermatol, 75 Francis St, Boston, MA 02115 USA	Harvard University; Brigham & Women's Hospital	Wolfe, MK (corresponding author), Tuft Univ, Dept Civil & Environm Engn, Medford, MA 02155 USA.	marlene.wolfe@tufts.edu			United States Agency for International Development, Office of Foreign Disaster Assistance [AID-OFDA-A-15-00026]; National Science Foundation [0966093]	United States Agency for International Development, Office of Foreign Disaster Assistance(United States Agency for International Development (USAID)); National Science Foundation(National Science Foundation (NSF))	This study was funded by a grant from the United States Agency for International Development, Office of Foreign Disaster Assistance (AID-OFDA-A-15-00026). MW was supported by the National Science Foundation (grant 0966093). The funders had no role in data collection and analysis, decision to publish, or preparation of the manuscript. The funders did have a small role in study design - in that the initial design we proposed was 15 participants per study arm, and the funders came back to us in the proposal stage and suggested increasing the funding to support 18 participants per study arm, which was done. The funders had no input into study design after the grant was awarded. The funders were provided a final version of the manuscript before submission, and had only minor grammatical comments.	Allegranzi B, 2009, AM J INFECT CONTROL, V37, P28, DOI 10.1016/j.ajic.2008.01.014; Angelova-Fischer I, 2014, ACTA DERM-VENEREOL, V94, P640, DOI 10.2340/00015555-1815; [Anonymous], HAND HYG W AFR GEN N; [Anonymous], 2014, IF USING CHLORINE HA; [Anonymous], 1988, DERMATOS BER UMWELT, V37, P96; [Anonymous], EB EB VIR DIS SIGNS; Antonov D, 2015, AM J CLIN DERMATOL; Baize S, 2002, CLIN EXP IMMUNOL, V128, P163, DOI 10.1046/j.1365-2249.2002.01800.x; Callahan A, 2013, DERMATITIS, V24, P170, DOI 10.1097/DER.0b013e318290c57f; Curtis VA, 2009, HEALTH EDUC RES, V24, P655, DOI 10.1093/her/cyp002; Darlenski R, 2012, CLIN DERMATOL, V30, P269, DOI 10.1016/j.clindermatol.2011.08.013; Emmanuel J, 2015, REPORT WHO ASSESSMEN; English JSC, 2004, OCCUP ENVIRON MED, V61, P722, DOI 10.1136/oem.2003.010710; ESCOFFIER C, 1989, J INVEST DERMATOL, V93, P353, DOI 10.1111/1523-1747.ep12280259; Eun HC, 1984, CONTACT DERMATITIS, P11; Feldmann H., FILOVIRIDAE MARBURG; Florentin A, 2011, INT J HYG ENVIR HEAL, V214, P461, DOI 10.1016/j.ijheh.2011.07.012; Gatherer D, 2014, J GEN VIROL, V95, P1619, DOI 10.1099/vir.0.067199-0; Geisbert TW, 2008, VACCINE, V26, P6894, DOI 10.1016/j.vaccine.2008.09.082; Gire SK, 2014, SCIENCE, V345, P1369, DOI 10.1126/science.1259657; HABETS JMW, 1986, CONTACT DERMATITIS, V15, P140, DOI 10.1111/j.1600-0536.1986.tb01314.x; HANSEN KS, 1983, CONTACT DERMATITIS, V9, P343, DOI 10.1111/j.1600-0536.1983.tb04426.x; Held E, 2005, BRIT J DERMATOL, V152, P302, DOI 10.1111/J.1365-2133.2004.06305.X; HOSTYNEK JJ, 1990, CONTACT DERMATITIS, V23, P316, DOI 10.1111/j.1600-0536.1990.tb05165.x; HOSTYNEK JJ, 1989, CONTACT DERMATITIS, V20, P32, DOI 10.1111/j.1600-0536.1989.tb03092.x; Houben E, 2006, CONTACT DERMATITIS, V54, P261, DOI 10.1111/j.0105-1873.2006.00817.x; Ibler KS, 2012, CONTACT DERMATITIS, V66, P247, DOI 10.1111/j.1600-0536.2011.02027.x; JM Boyce, 2002, GUIDELINE HAND HYGIE, V51; Jungbauer FHW, 2004, CONTACT DERMATITIS, V51, P135, DOI 10.1111/j.0105-1873.2004.00422.x; Kortepeter MG, 2011, J INFECT DIS, V204, pS810, DOI 10.1093/infdis/jir299; Luther N, 2012, SKIN PHARMACOL PHYS, V25, P182, DOI 10.1159/000337933; OSMUNDSEN PE, 1978, CONTACT DERMATITIS, V4, P177, DOI 10.1111/j.1600-0536.1978.tb03779.x; PATTYN S, 1977, LANCET, V1, P573; Pedersen LK, 2005, BRIT J DERMATOL, V153, P1142, DOI 10.1111/j.1365-2133.2005.06875.x; REED JT, 1995, ARCH DERMATOL, V131, P1134, DOI 10.1001/archderm.131.10.1134; Robinson MK, 1999, CONTACT DERMATITIS, V41, P65; Salphale PS, 2003, CONTACT DERMATITIS, V48, P162, DOI 10.1034/j.1600-0536.2003.00001.x; Schmid-Wendtner MH, 2006, SKIN PHARMACOL PHYS, V19, P296, DOI 10.1159/000094670; SHUSTER S, 1975, BRIT J DERMATOL, V93, P639, DOI 10.1111/j.1365-2133.1975.tb05113.x; Staff MC, 2015, DIS COND DERM 2015; Sterk E., 2008, MED SANS FILOVIRUS H; Thyssen JP, 2010, CONTACT DERMATITIS, V62, P75, DOI 10.1111/j.1600-0536.2009.01669.x; Visser MJ, 2014, CONTACT DERMATITIS, V70, P139, DOI 10.1111/cod.12139; Wahlberg JE, 2001, TXB CONTACT DERMAT, P435; Wesley NO, 2003, AM J CLIN DERMATOL, V4, P843, DOI 10.2165/00128071-200304120-00004; WHO CDC, 1998, INF CONTR VIR HAEM F; World Health Organisation, 2016, EB SIT REP 30 MARCH; World Health Organization, 2009, WHO GUID HAND HYG HL; World Health Organization, 2014, REP EB VIR DIS EVD K; World Health Organization, 2009, WHO GUID HAND HYG HL, V30; WORLD HEALTHY ORGANIZATION, 2009, WHO REC HANDR FORM; Zaki SR, 1999, CURR TOP MICROBIOL, V235, P97	52	11	11	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2016	11	12							e0167378	10.1371/journal.pone.0167378	http://dx.doi.org/10.1371/journal.pone.0167378			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EG7JB	28030544	gold, Green Published, Green Submitted			2022-12-27	WOS:000391222000007
J	Brunel, H; Massanet, R; Martinez-Perez, A; Ziyatdinov, A; Martin-Fernandez, L; Souto, JC; Perera, A; Soria, JM				Brunel, Helena; Massanet, Raimon; Martinez-Perez, Angel; Ziyatdinov, Andrey; Martin-Fernandez, Laura; Carlos Souto, Juan; Perera, Alexandre; Manuel Soria, Jose			The Central Role of KNG1 Gene as a Genetic Determinant of Coagulation Pathway-Related Traits: Exploring Metaphenotypes	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; LINKAGE ANALYSIS; PLASMA-LEVELS; LOCI; SUSCEPTIBILITY; PHENOTYPES; REGRESSION; SCAN; RISK	Traditional genetic studies of single traits may be unable to detect the pleiotropic effects involved in complex diseases. To detect the correlation that exists between several phenotypes involved in the same biological process, we introduce an original methodology to analyze sets of correlated phenotypes involved in the coagulation cascade in genome-wide association studies. The methodology consists of a two-stage process. First, we define new phenotypic meta-variables (linear combinations of the original phenotypes), named meta phenotypes, by applying Independent Component Analysis for the multivariate analysis of correlated phenotypes (i.e. the levels of coagulation pathway related proteins). The resulting metaphenotypes integrate the information regarding the underlying biological process (i.e. thrombus/clot formation). Secondly, we take advantage of a family based Genome Wide Association Study to identify genetic elements influencing these metaphenotypes and consequently thrombosis risk. Our study utilized data from the GAIT Project (Genetic Analysis of Idiopathic Thrombophilia). We obtained 15 metaphenotypes, which showed significant heritabilities, ranging from 0.2 to 0.7. These results indicate the importance of genetic factors in the variability of these traits. We found 4 metaphenotypes that showed significant associations with SNPs. The most relevant were those mapped in a region near the HRG, FETUB and KNG1 genes. Our results are provocative since they show that the KNG1 locus plays a central role as a genetic determinant of the entire coagulation pathway and thrombus/clot formation. Integrating data from multiple correlated measurements through meta phenotypes is a promising approach to elucidate the hidden genetic mechanisms underlying complex diseases.	[Brunel, Helena; Martinez-Perez, Angel; Ziyatdinov, Andrey; Martin-Fernandez, Laura; Manuel Soria, Jose] Sant Pau Inst Biomed Res IIB Sant Pau, Unit Genom Complex Dis, Barcelona, Spain; [Massanet, Raimon] Univ Politecn Cataluna, Dept Engn Sistemes Automat & Informat Ind, B2SLab, Barcelona, Spain; [Carlos Souto, Juan; Perera, Alexandre] St Pau Inst Biomed Res IIB St Pau, Thrombosis & Haemostasis Unit, Barcelona, Spain	Universitat Politecnica de Catalunya	Soria, JM (corresponding author), Sant Pau Inst Biomed Res IIB Sant Pau, Unit Genom Complex Dis, Barcelona, Spain.	jsoria@santpau.cat	Perera Lluna, Alexandre/CAG-2156-2022; Lluna, Alexandre Perera/R-8546-2018; Martinez-Perez, Angel/AAC-4339-2019; Soria Fernández, José Manuel/AAD-6761-2019	Perera Lluna, Alexandre/0000-0001-6427-851X; Lluna, Alexandre Perera/0000-0001-6427-851X; Martinez-Perez, Angel/0000-0002-5934-1454; Soria Fernández, José Manuel/0000-0002-6226-4293; Martin-Fernandez, Laura/0000-0002-8909-508X	Institut de Salud Carlos III Fondo de Investigacion Sanitaria [PI 11/0184, PI 14/00582]; Red Investigacion Cardiovascular [RD12/0042/0032]; Generalitat de Catalunya [2009 SGR 1147, 2014 SGR 1063]; Ayudas Predoctorales de Formacion en Investigacion en Salud (PFIS) [FI12/00322]; Spanish National Grants from Ministry of Economy and Competitiveness [TEC2014-60337-R]	Institut de Salud Carlos III Fondo de Investigacion Sanitaria; Red Investigacion Cardiovascular; Generalitat de Catalunya(Generalitat de Catalunya); Ayudas Predoctorales de Formacion en Investigacion en Salud (PFIS); Spanish National Grants from Ministry of Economy and Competitiveness	This study was supported by funds from the Institut de Salud Carlos III Fondo de Investigacion Sanitaria PI 11/0184 and PI 14/00582, Red Investigacion Cardiovascular RD12/0042/0032 and AGAUR 2009 SGR 1147 from Generalitat de Catalunya. Laura Martin-Fernandez was supported by Ayudas Predoctorales de Formacion en Investigacion en Salud (PFIS) FI12/00322. This work has been partially supported by the Supported by the Spanish National Grants from Ministry of Economy and Competitiveness with grant TEC2014-60337-R, and the Generalitat de Catalunya, under the grant 2014 SGR 1063. CIBER-BBN is an initiative of the ISCIII.014 SGR 1063. CIBER-BBN is an initiative of the ISCIII. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almasy L, 1998, AM J HUM GENET, V62, P1198, DOI 10.1086/301844; Aschard H, 2014, AM J HUM GENET, V94, P662, DOI 10.1016/j.ajhg.2014.03.016; Athanasiadis G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029168; Aulchenko YS, 2007, GENETICS, V177, P577, DOI 10.1534/genetics.107.075614; Aulchenko YS, 2007, BIOINFORMATICS, V23, P1294, DOI 10.1093/bioinformatics/btm108; Houlihan LM, 2010, AM J HUM GENET, V86, P626, DOI 10.1016/j.ajhg.2010.02.016; Hyvarinen A, 2000, NEURAL NETWORKS, V13, P411, DOI 10.1016/S0893-6080(00)00026-5; Josse J, 2012, COMPUT STAT DATA AN, V56, P1869, DOI 10.1016/j.csda.2011.11.012; Khachidze M, 2006, J THROMB HAEMOST, V4, P1537, DOI 10.1111/j.1538-7836.2006.02024.x; Klei L, 2010, GENETIC EPIDEMIOLOGY, V34, P444; Knott SA, 2000, GENETICS, V156, P899; Lee C, 2009, FRONT BIOSCI-LANDMRK, V14, P2911, DOI 10.2741/3422; Lefkowitz J.B., 2008, ALGORITHMIC APPROACH, P3; Soria JM, 2009, HUM BIOL, V81, P853, DOI 10.3378/027.081.0627; Mathias RA, 2010, BMC MED GENOMICS, V3, DOI 10.1186/1755-8794-3-22; Mei H, 2010, BMC GENET, V11, DOI 10.1186/1471-2156-11-100; Morange PE, 2011, BLOOD, V117, P3692, DOI 10.1182/blood-2010-11-319053; Park KJ, 2012, BLOOD COAGUL FIBRIN, V23, P35, DOI 10.1097/MBC.0b013e32834a6136; Sabater-Lleal M, 2012, ARTERIOSCL THROM VAS, V32, P2008, DOI 10.1161/ATVBAHA.112.248492; Soria JM, 2005, ARTERIOSCL THROM VAS, V25, P1287, DOI 10.1161/01.ATV.0000161927.38739.6f; Soria JM, 2002, AM J HUM GENET, V70, P567, DOI 10.1086/339259; Souto JC, 2000, AM J HUM GENET, V67, P1452, DOI 10.1086/316903; Souto JC, 2003, THROMB HAEMOSTASIS, V89, P468; Souto JC, 2001, THROMB HAEMOSTASIS, V85, P88; Stacklies W, 2007, BIOINFORMATICS, V23, P1164, DOI 10.1093/bioinformatics/btm069; Stephens M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065245; Tang WH, 2012, AM J HUM GENET, V91, P152, DOI 10.1016/j.ajhg.2012.05.009; Viel KR, 2007, BLOOD, V109, P3713, DOI 10.1182/blood-2006-06-026104; Weller JI, 1996, THEOR APPL GENET, V92, P998, DOI 10.1007/BF00224040; Xu X, 2003, BIOSTATISTICS, V4, P223, DOI 10.1093/biostatistics/4.2.223; Yang QO, 2010, GENET EPIDEMIOL, V34, P444, DOI 10.1002/gepi.20497; Ziyatdinov A, 2016, BIOINFORMATICS	32	7	7	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2016	11	12							e0167187	10.1371/journal.pone.0167187	http://dx.doi.org/10.1371/journal.pone.0167187			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI9QH	28005926	Green Submitted, Green Published, gold			2022-12-27	WOS:000392843200010
J	Calvente, A; Santos, JL; Rufas, JS				Calvente, Adela; Luis Santos, Juan; Rufas, Julio S.			Do Exogenous DNA Double-Strand Breaks Change Incomplete Synapsis and Chiasma Localization in the Grasshopper Stethophyma grossum?	PLoS One			English	Article							MEIOTIC RECOMBINATION HOTSPOTS; SISTER-CHROMATID COHESION; SYNAPTONEMAL COMPLEXES; MOUSE SPERMATOCYTES; CROSSOVER HOTSPOTS; AXIAL ELEMENTS; CROSSING-OVER; MEIOSIS; CHROMOSOMES; PROTEINS	Meiotic recombination occurs as a programmed event that initiates by the formation of DNA double-strand breaks (DSBs) that give rise to the formation of crossovers that are observed as chiasmata. Chiasmata are essential for the accurate chromosome segregation and the generation of new combinations of parental alleles. Some treatments that provoke exogenous DSBs also lead to alterations in the recombination pattern of some species in which full homologous synapsis is achieved at pachytene. We have carried out a similar approach in males of the grasshopper Stethophyma grossum, whose homologues show incomplete synapsis and proximal chiasma localization. After irradiating males with. rays we have studied the distribution of both the histone variant gamma-H2AX and the recombinase RAD51. These proteins are cytological markers of DSBs at early prophase I. We have inferred synaptonemal complex (SC) formation via identification of SMC3 and RAD 21 cohesin subunits. Whereas thick and thin SMC3 filaments would correspond to synapsed and unsynapsed regions, the presence of RAD21 is only restricted to synapsed regions. Results show that irradiated spermatocytes maintain restricted synapsis between homologues. However, the frequency and distribution of chiasmata in metaphase I bivalents is slightly changed and quadrivalents were also observed. These results could be related to the singular nuclear polarization displayed by the spermatocytes of this species.	[Calvente, Adela; Rufas, Julio S.] Univ Autonoma Madrid, Dept Biol, Edificio Biol, Madrid, Spain; [Luis Santos, Juan] Univ Complutense Madrid, Fac Biol, Dept Genet, Madrid, Spain	Autonomous University of Madrid; Complutense University of Madrid	Rufas, JS (corresponding author), Univ Autonoma Madrid, Dept Biol, Edificio Biol, Madrid, Spain.	Julio.S.Rufas@uam.es	Santos, Juan/R-1410-2017; Rufas, Julio S/L-5174-2014	Santos, Juan/0000-0003-4475-9628; Rufas, Julio S/0000-0002-7516-809X	Ministerio de Ciencia e Innovacion [BFU2015-71786-REDT]; Ministerio de Economia y Competitividad (Spain);  [AGL2012-38852];  [CGL2014-53106-P]	Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government); Ministerio de Economia y Competitividad (Spain)(Spanish Government); ; 	This work was supported by grants BFU2015-71786-REDT from Ministerio de Ciencia e Innovacion, and grants AGL2012-38852 and CGL2014-53106-P and from Ministerio de Economia y Competitividad (Spain).	Ahmed EA, 2010, MUTAT RES-FUND MOL M, V688, P12, DOI 10.1016/j.mrfmmm.2010.02.004; ALBINI SM, 1984, EXP CELL RES, V155, P588, DOI 10.1016/0014-4827(84)90219-2; BISHOP DK, 1994, CELL, V79, P1081, DOI 10.1016/0092-8674(94)90038-8; Cai X, 2011, MUTAGENESIS, V26, P721, DOI 10.1093/mutage/ger038; Calvente A, 2005, J CELL SCI, V118, P2957, DOI 10.1242/jcs.02391; Darlington CD, 1931, SCIENCE, V73, P561, DOI 10.1126/science.73.1899.561-a; delCerro AL, 1997, CHROMOSOME RES, V5, P69, DOI 10.1023/A:1018449604187; Eijpe M, 2000, J CELL SCI, V113, P673; Falk M, 2008, BBA-MOL CELL RES, V1783, P2398, DOI 10.1016/j.bbamcr.2008.07.010; FLETCHER HL, 1978, CHROMOSOMA, V65, P247, DOI 10.1007/BF00327621; Hanneman WH, 1997, P NATL ACAD SCI USA, V94, P8681, DOI 10.1073/pnas.94.16.8681; JONES GH, 1973, CHROMOSOMA, V42, P145, DOI 10.1007/BF00320937; Keeney S, 2006, BIOCHEM SOC T, V34, P523, DOI 10.1042/BST0340523; Klein F, 1999, CELL, V98, P91, DOI 10.1016/S0092-8674(00)80609-1; Lake CM, 2016, SEMIN CELL DEV BIOL, V54, P117, DOI 10.1016/j.semcdb.2016.01.008; Lichten M, 1995, ANNU REV GENET, V29, P423, DOI 10.1146/annurev.ge.29.120195.002231; Mercier R, 2001, GENE DEV, V15, P1859, DOI 10.1101/gad.203201; Mezard C, 2006, BIOCHEM SOC T, V34, P531, DOI 10.1042/BST0340531; Moens PB, 1997, CHROMOSOMA, V106, P207, DOI 10.1007/s004120050241; Moens PB, 2002, J CELL SCI, V115, P1611; Murr R, 2006, NAT CELL BIOL, V8, P91, DOI 10.1038/ncb1343; Neumann R, 2006, HUM MOL GENET, V15, P1401, DOI 10.1093/hmg/ddl063; Nussenzweig A, 2006, NATURE, V439, P406, DOI 10.1038/439406a; Page J, 1998, CHROMOSOME RES, V6, P639, DOI 10.1023/A:1009209628300; Page J, 2003, J CELL SCI, V116, P551, DOI 10.1242/jcs.00252; Paigen K, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000119; Paull TT, 2000, CURR BIOL, V10, P886, DOI 10.1016/S0960-9822(00)00610-2; Pelttari J, 2001, MOL CELL BIOL, V21, P5667, DOI 10.1128/MCB.21.16.5667-5677.2001; PERRY PE, 1974, CHROMOSOMA, V47, P227, DOI 10.1007/BF00328858; Plug AW, 1998, J CELL SCI, V111, P413; Price BD, 2013, CELL, V152, P1344, DOI 10.1016/j.cell.2013.02.011; Sanchez-Moran E, 2007, GENE DEV, V21, P2220, DOI 10.1101/gad.439007; Schoenmakers S, 2008, DEV BIOL, V317, P270, DOI 10.1016/j.ydbio.2008.02.027; Serrentino ME, 2012, EXP CELL RES, V318, P1347, DOI 10.1016/j.yexcr.2012.03.025; SHAW DD, 1971, CHROMOSOMA, V34, P19, DOI 10.1007/BF00285514; Storlazzi A, 2003, GENE DEV, V17, P2675, DOI 10.1101/gad.275203; Tarsounas M, 1999, J CELL BIOL, V147, P207, DOI 10.1083/jcb.147.2.207; Valdeolmillos AM, 2007, PLOS GENET, V3, P204, DOI 10.1371/journal.pgen.0030028; Viera A, 2004, EMBO REP, V5, P385, DOI 10.1038/sj.embor.7400112; Viera A, 2003, CHROMOSOME RES, V11, P797, DOI 10.1023/B:CHRO.0000005781.71466.da; Viera A, 2010, CYTOGENET GENOME RES, V128, P139, DOI 10.1159/000290637; Viera A, 2009, CHROMOSOMA; Viera Alberto, 2010, Journal of Orthoptera Research, V19, P267, DOI 10.1665/034.019.0213; Viera A, 2009, CHROMOSOMA, V118, P377, DOI 10.1007/s00412-009-0204-x; WALLACE BMN, 1978, HEREDITY, V40, P385, DOI 10.1038/hdy.1978.45; WHITE M. J. D., 1936, ZEITSCHR ZELLFORSCH U MIKROSK ANAT, V24, P128, DOI 10.1007/BF00401218; Yokoo R, 2012, CELL, V149, P75, DOI 10.1016/j.cell.2012.01.052; Zickler D, 1999, ANNU REV GENET, V33, P603, DOI 10.1146/annurev.genet.33.1.603	48	11	11	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2016	11	12							e0168499	10.1371/journal.pone.0168499	http://dx.doi.org/10.1371/journal.pone.0168499			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI9QH	28005992	Green Published, Green Submitted, gold			2022-12-27	WOS:000392843200062
J	Forti, IRN; Young, RJ				Forti, Isabela Rodrigues Nogueira; Young, Robert John			Human Commercial Models' Eye Colour Shows Negative Frequency-Dependent Selection	PLoS One			English	Article							BEHAVIORAL-INHIBITION; IRIS PIGMENTATION; BLUE	In this study we investigated the eye colour of human commercial models registered in the UK (400 female and 400 male) and Brazil (400 female and 400 male) to test the hypothesis that model eye colour frequency was the result of negative frequency-dependent selection. The eye colours of the models were classified as: blue, brown or intermediate. Chi-square analyses of data for countries separated by sex showed that in the United Kingdom brown eyes and intermediate colours were significantly more frequent than expected in comparison to the general United Kingdom population (P<0.001). In Brazil, the most frequent eye colour brown was significantly less frequent than expected in comparison to the general Brazilian population. These results support the hypothesis that model eye colour is the result of negative frequency-dependent selection. This could be the result of people using eye colour as a marker of genetic diversity and finding rarer eye colours more attractive because of the potential advantage more genetically diverse offspring that could result from such a choice. Eye colour may be important because in comparison to many other physical traits (e.g., hair colour) it is hard to modify, hide or disguise, and it is highly polymorphic.	[Forti, Isabela Rodrigues Nogueira; Young, Robert John] Univ Salford Manchester, Sch Environm & Life Sci, Peel Bldg, Salford, Lancs, England		Young, RJ (corresponding author), Univ Salford Manchester, Sch Environm & Life Sci, Peel Bldg, Salford, Lancs, England.	r.j.young@salford.ac.uk	Young, Robert/B-7356-2013	Young, Robert/0000-0002-8407-2348	Science without Borders, a Brazilian Government Federal Programme	Science without Borders, a Brazilian Government Federal Programme	Isabela Forti was supported by a PhD scholarship from Science without Borders, a Brazilian Government Federal Programme to Support young scientists.	Bennett ES, 2005, CLINCIAL CONTACT LEN; Chaudhri SK, 2009, ASIAN J PHARM, V3, P164, DOI 10.4103/0973-8398.56292; Chelnokova OV, 2011, J VIS, V11, ps1; Coplan RJ, 1998, DEV PSYCHOBIOL, V32, P37, DOI 10.1002/(SICI)1098-2302(199801)32:1<37::AID-DEV4>3.0.CO;2-U; Davenport GC, 1907, SCIENCE, V26, P589, DOI 10.1126/science.26.670.589-b; Eiberg H, 2008, HUM GENET, V123, P177, DOI 10.1007/s00439-007-0460-x; Entwistle J., 2002, J CONSUM CULT, V2, P317, DOI [DOI 10.1177/146954050200200302, 10.1177/146954050200200302]; Frost P., 2014, ADV ANTHR, V4, P78, DOI [10.4236/aa.2014.42011, DOI 10.4236/AA.2014.42011]; Janif ZJ, 2014, BIOL LETTERS, V10, DOI 10.1098/rsbl.2013.0958; Kagan J., 2004, LONG SHADOW TEMPERAM; Kleisner K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053285; Laeng B, 2007, BEHAV ECOL SOCIOBIOL, V61, P371, DOI 10.1007/s00265-006-0266-1; Lazaridis I, 2014, NATURE, V513, P409, DOI 10.1038/nature13673; Little AC, 2003, EVOL HUM BEHAV, V24, P43, DOI 10.1016/S1090-5138(02)00119-8; LYNN M, 1984, PERS SOC PSYCHOL B, V10, P349, DOI 10.1177/0146167284103002; ROSENBERG A, 1987, DEV PSYCHOBIOL, V20, P377, DOI 10.1002/dev.420200403; ROSENBERG AA, 1989, DEV PSYCHOBIOL, V22, P753, DOI 10.1002/dev.420220802; Ruiz-Linares A, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004572; SUTTON PRN, 1959, NATURE, V184, P122, DOI 10.1038/184122a0; THELEN TH, 1983, SOC BIOL, V30, P162; Walsh S, 2012, FORENSIC SCI INT-GEN, V6, P330, DOI 10.1016/j.fsigen.2011.07.009; Watts I, 2010, J HUM EVOL, V59, P392, DOI 10.1016/j.jhevol.2010.07.006; White D, 2011, J HUM GENET, V56, P5, DOI 10.1038/jhg.2010.126; Worthy M., 1999, EYE COLOR KEY HUMAN	24	4	4	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2016	11	12							e0168458	10.1371/journal.pone.0168458	http://dx.doi.org/10.1371/journal.pone.0168458			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EI9QH	28005995	Green Published, Green Submitted, gold			2022-12-27	WOS:000392843200054
J	Lee, K; Yoo, J; Choi, M; Zo, H; Ciganek, AP				Lee, Kibaek; Yoo, Jaeheung; Choi, Munkee; Zo, Hangjung; Ciganek, Andrew P.			Does External Knowledge Sourcing Enhance Market Performance? Evidence from the Korean Manufacturing Industry	PLOS ONE			English	Article							RESEARCH-AND-DEVELOPMENT; INNOVATIVE PERFORMANCE; TECHNOLOGICAL-INNOVATION; PRODUCT; FIRM; CAPABILITIES; COMMERCIALIZATION; EXPLOITATION; ORIENTATION; COOPERATION	Firms continuously search for external knowledge that can contribute to product innovation, which may ultimately increase market performance. The relationship between external knowledge sourcing and market performance is not well-documented. The extant literature primarily examines the causal relationship between external knowledge sources and product innovation performance or to identify factors which moderates the relationship between external knowledge sourcing and product innovation. Non-technological innovations, such as organization and marketing innovations, intervene in the process of external knowledge sourcing to product innovation to market performance but has not been extensively examined. This study addresses two research questions: does external knowledge sourcing lead to market performance and how does external knowledge sourcing interact with a firm's different innovation activities to enhance market performance. This study proposes a comprehensive model to capture the causal mechanism from external knowledge sourcing to market performance. The research model was tested using survey data from manufacturing firms in South Korea and the results demonstrate a strong statistical relationship in the path of external knowledge sourcing (EKS) to product innovation performance (PIP) to market performance (MP). Organizational innovation is an antecedent to EKS while marketing innovation is a consequence of EKS, which significantly influences PIP and MP. The results imply that any potential EKS effort should also consider organizational innovations which may ultimately enhance market performance. Theoretical and practical implications are discussed as well as concluding remarks.	[Lee, Kibaek; Choi, Munkee; Zo, Hangjung] Korea Adv Inst Sci & Technol, Coll Business, Sch Business & Technol Management, Daejeon, South Korea; [Lee, Kibaek] Korea Res Inst Chem Technol, Daejeon, South Korea; [Yoo, Jaeheung] Software Policy & Res Inst, Seongnam, South Korea; [Ciganek, Andrew P.] Univ Wisconsin, Coll Business & Econ, Whitewater, WI 53190 USA	Korea Advanced Institute of Science & Technology (KAIST); Korea Research Institute of Chemical Technology (KRICT); University of Wisconsin System	Zo, H (corresponding author), Korea Adv Inst Sci & Technol, Coll Business, Sch Business & Technol Management, Daejeon, South Korea.	joezo@kaist.edu	Zo, Hangjung/C-1786-2011	Zo, Hangjung/0000-0002-2892-1659				[Anonymous], 2005, MEAS SCI TECHN ACT O; Bagozzi R.P., 1988, J ACAD MARKET SCI, V16, P74, DOI [10.1007/BF02723327, DOI 10.1007/BF02723327]; Baum JAC, 2000, STRATEGIC MANAGE J, V21, P267, DOI 10.1002/(SICI)1097-0266(200003)21:3<267::AID-SMJ89>3.0.CO;2-8; Bayona-Saez C, 2001, RES POLICY, V30, P1289, DOI 10.1016/S0048-7333(00)00151-7; Becker W, 2004, RES POLICY, V33, P209, DOI 10.1016/j.respol.2003.07.003; Belderbos R, 2004, RES POLICY, V33, P1477, DOI 10.1016/j.respol.2004.07.003; Boer H, 2003, INT J TECHNOL MANAGE, V26, P805, DOI 10.1504/IJTM.2003.003391; Brabham D.C., 2008, CONVERGENCE-US, V14, P75, DOI DOI 10.1177/1354856507084420; Broring S, 2010, INT J TECHNOL MANAGE, V49, P272, DOI 10.1504/IJTM.2010.029421; Chandy RK, 2000, J MARKETING, V64, P1, DOI 10.1509/jmkg.64.3.1.18033; Chesbrough H., 2003, OPEN INNOVATION NEW; Chesbrough H, 2013, OPEN BUSINESS MODELS; Chesbrough H.W., 2006, MANAG INNOV CHANGE, V127, P34; Christensen C. M., 2001, INNOVATORS DILEMMA N; CORDERO R, 1990, RES POLICY, V19, P185, DOI 10.1016/0048-7333(90)90048-B; Cummings T., 1977, MANAGEMENT WORK SOCI; DAMANPOUR F, 1984, ADMIN SCI QUART, V29, P392, DOI 10.2307/2393031; Damanpour F, 2001, J MANAGE STUD, V38, P45, DOI 10.1111/1467-6486.00227; DAMANPOUR F, 1989, J MANAGE STUD, V26, P587, DOI 10.1111/j.1467-6486.1989.tb00746.x; DESHPANDE R, 1993, J MARKETING, V57, P23, DOI 10.2307/1252055; Dhewanto W, 2014, R D MANAGEMENT; DOSI G, 1988, J ECON LIT, V26, P1120; Eng TY, 2011, TECHNOL ANAL STRATEG, V23, P1001, DOI 10.1080/09537325.2011.616700; Faems D, 2005, J PROD INNOVAT MANAG, V22, P238, DOI 10.1111/j.0737-6782.2005.00120.x; Fornell C., 1982, 2 GENERATION MULTIVA, V2; Gatignon H, 1997, J MARKETING RES, V34, P77, DOI 10.2307/3152066; Gold AH, 2001, J MANAGE INFORM SYST, V18, P185, DOI 10.1080/07421222.2001.11045669; Hagedoorn J, 2003, RES POLICY, V32, P1365, DOI 10.1016/S0048-7333(02)00137-3; Hair J.F., 2010, MULTIVARIATE DATA AN, V7th; HERSTATT C, 1992, J PROD INNOVAT MANAG, V9, P213, DOI 10.1016/0737-6782(92)90031-7; Hwang J, 2010, TELECOMMUN POLICY, V34, P562, DOI 10.1016/j.telpol.2010.04.004; Inoue H, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121973; Jones G.R., 2010, ORG THEORY DESIGN CH; Kang KH, 2014, J PROD INNOVAT MANAG, V31, P176, DOI 10.1111/jpim.12087; Kang KH, 2009, INT J INNOV MANAG, V13, P1, DOI 10.1142/S1363919609002194; Kessler EH, 1996, ACAD MANAGE REV, V21, P1143, DOI 10.2307/259167; Lichtenthaler U, 2010, TECHNOVATION, V30, P429, DOI 10.1016/j.technovation.2010.04.001; Lichtenthaler U, 2009, R&D MANAGE, V39, P317, DOI 10.1111/j.1467-9310.2009.00561.x; Link AN, 2010, RES POLICY, V39, P589, DOI 10.1016/j.respol.2010.02.006; Lockett A, 2005, RES POLICY, V34, P1043, DOI 10.1016/j.respol.2005.05.006; MacPherson AD, 1997, GROWTH CHANGE, V28, P289; MICHEL A, 1984, FINANC MANAGE, V13, P18, DOI 10.2307/3665297; Moon S, 2011, ASIAN J TECHNOL INNO, V19, P185, DOI 10.1080/19761597.2011.630502; Moore G.A., 1991, CROSSING CHASM MARKE; MORIARTY RT, 1989, SLOAN MANAGE REV, V30, P7; Mu JF, 2011, R&D MANAGE, V41, P337, DOI 10.1111/j.1467-9310.2011.00650.x; Prajogo DI, 2006, R&D MANAGE, V36, P499, DOI 10.1111/j.1467-9310.2006.00450.x; Raisch S, 2009, ORGAN SCI, V20, P685, DOI 10.1287/orsc.1090.0428; Ram S., 1989, J CONSUM MARK, V6, P5, DOI [DOI 10.1108/EUM0000000002542, 10.1108/ EUM0000000002542]; Ram S., 1987, NA ADV CONSUMER RES, V14; RANSLEY DL, 1994, RES TECHNOL MANAGE, V37, P19, DOI 10.1080/08956308.1994.11670965; Rogers EM, 1983, DIFIUSION INNOVATION, V18, P271; Saenz-Royo C, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126076; Segarra-Cipres M, 2014, KNOWL MAN RES PRACT, V12, P203, DOI 10.1057/kmrp.2012.55; Siegel DS, 2003, RES POLICY, V32, P27, DOI 10.1016/S0048-7333(01)00196-2; Slater SF, 2006, J PROD INNOVAT MANAG, V23, P26, DOI 10.1111/j.1540-5885.2005.00178.x; Sohn SY, 2003, TECHNOL FORECAST SOC, V70, P885, DOI 10.1016/S0040-1625(03)00004-0; Teece DJ, 1997, STRATEGIC MANAGE J, V18, P509, DOI 10.1002/(SICI)1097-0266(199708)18:7<509::AID-SMJ882>3.0.CO;2-Z; Tether BS, 2008, RES POLICY, V37, P720, DOI 10.1016/j.respol.2008.01.005; Tether BS, 2002, RES POLICY, V31, P947, DOI 10.1016/S0048-7333(01)00172-X; Toole JL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029528; Trist EL, 1951, HUM RELAT, V4, P3, DOI 10.1177/001872675100400101; Tsai KH, 2009, RES POLICY, V38, P765, DOI 10.1016/j.respol.2008.12.012; Ulrich K., 2011, EBOOK PRODUCT DESIGN; URBAN GL, 1988, MANAGE SCI, V34, P569, DOI 10.1287/mnsc.34.5.569; van de Vrande V, 2009, TECHNOVATION, V29, P423, DOI 10.1016/j.technovation.2008.10.001; Van den Bosch FAJ, 1999, ORGAN SCI, V10, P551, DOI 10.1287/orsc.10.5.551; van Wijk R, 2012, TECHNOL ANAL STRATEG, V24, P929, DOI 10.1080/09537325.2012.718666; Vega-Jurado J, 2009, IND CORP CHANGE, V18, P637, DOI 10.1093/icc/dtp023; von Hippel E, 2002, MANAGE SCI, V48, P821, DOI 10.1287/mnsc.48.7.821.2817; VONHIPPEL E, 1986, MANAGE SCI, V32, P791, DOI 10.1287/mnsc.32.7.791; Yam RCM, 2004, RES POLICY, V33, P1123, DOI 10.1016/j.respol.2004.05.004; Yoo J, 2013, COMMUNICATIONS STRAT, V89, P73; Zook C, 2007, HARVARD BUS REV, V85, P66	74	4	4	2	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2016	11	12							e0168676	10.1371/journal.pone.0168676	http://dx.doi.org/10.1371/journal.pone.0168676			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EI9QH	28006022	Green Submitted, gold, Green Published			2022-12-27	WOS:000392843200078
J	Liebl, ME; Elmer, N; Schroeder, I; Schwedtke, C; Baack, A; Reisshauer, A				Liebl, Max E.; Elmer, Nancy; Schroeder, Isabelle; Schwedtke, Christine; Baack, Angelika; Reisshauer, Anett			Introduction of the Charite A Mobility Index (CHARMI) - A Novel Clinical Mobility Assessment for Acute Care Rehabilitation	PLOS ONE			English	Article							CONTENT VALIDITY; SKELETAL-MUSCLE; BED REST; ELDERLY-PATIENTS; BRAIN-INJURY; OLDER-ADULTS; ACUTE STROKE; UNIT; DISABILITY; WEAKNESS	Introduction Mobility is an essential part of a person's functioning and independence. It encompasses locomotive functions, but also the more basic functions of positioning and transferring. Despite the availability of several mobility-related assessment instruments to date, there is a need for assessment instruments with the specific capability to display the full range of mobilisation. Our aim was to develop and validate a scoring instrument with hierarchical composition where every score value stands for a defined mobility level. Participants and Methods A previously developed and validated pilot instrument was applied to assess patients (n = 113) admitted to an acute rehabilitation programme. Mobility was assessed during admission, subsequently at weekly intervals and at discharge to acquire a detailed status of mobility at multiple time points and individual mobilisation profiles over time. The scoring instrument was then remodelled based on clinical criteria to establish an easy-to-use scoring system with hierarchical composition. Psychometric properties were calculated using an independent sample of 87 consecutive patients. Results Content validity could be affirmed. The psychometric tests demonstrated excellent convergent validity with the three mobility items of the Barthel Index (r = 0.93), despite an adequately lower correlation with the whole Barthel Index (r = 0.63). Adequate floor and ceiling effects (20%) and a large responsiveness to change (vertical bar d vertical bar = 1.7, p < 0.001) between admission and discharge values were demonstrated. Inter-rater reliability was excellent (kappa = 0.88). Conclusions The Charite A Mobility Index (CHARMI) is a promising, easy-to-use hierarchical scoring instrument assessing the full individual spectrum from immobility to unlimited mobility, including positioning, transfer and locomotion items. It allows for monitoring of mobilisation.	[Liebl, Max E.; Elmer, Nancy; Schroeder, Isabelle; Schwedtke, Christine; Baack, Angelika; Reisshauer, Anett] Charite, Dept Phys Med & Rehabil, Berlin, Germany; [Baack, Angelika; Reisshauer, Anett] Charite, Charite Physiotherapy & Prevent Ctr, Berlin, Germany	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Liebl, ME (corresponding author), Charite, Dept Phys Med & Rehabil, Berlin, Germany.	max.liebl@charite.de		Liebl, Max Emanuel/0000-0002-6608-4281				Adams SA, 1997, CLIN REHABIL, V11, P42, DOI 10.1177/026921559701100107; Andresen EM, 2000, ARCH PHYS MED REHAB, V81, pS15, DOI 10.1053/apmr.2000.20619; [Anonymous], 2019, J HUM NUTR DIET, DOI [DOI 10.1186/1477-7525-6-63, DOI 10.1111/jhn.12659]; Ayre C, 2014, MEAS EVAL COUNS DEV, V47, P79, DOI 10.1177/0748175613513808; Berg HE, 1997, J APPL PHYSIOL, V82, P182, DOI 10.1152/jappl.1997.82.1.182; BERG K, 1995, SCAND J REHABIL MED, V27, P27; BERG KO, 1992, CAN J PUBLIC HEALTH, V83, pS7; Beyer J, 2015, PHYS MED REHAB KUROR, V25, P260, DOI 10.1055/s-0035-1564089; Blottner D, 2006, EUR J APPL PHYSIOL, V97, P261, DOI 10.1007/s00421-006-0160-6; Cameron S, 2015, J CRIT CARE, V30, P664, DOI 10.1016/j.jcrc.2015.03.032; Collen F M, 1991, Int Disabil Stud, V13, P50; Collen F M, 1990, Int Disabil Stud, V12, P6; de Morton NA, 2008, ARCH PHYS MED REHAB, V89, P641, DOI 10.1016/j.apmr.2007.10.021; de Morton Natalie A, 2013, J Appl Meas, V14, P159; Fitzpatrick R, 1998, Health Technol Assess, V2, pi; Gosselink R, 2008, INTENS CARE MED, V34, P1188, DOI 10.1007/s00134-008-1026-7; GRANGER CV, 1995, INT J TECHNOL ASSESS, V11, P262, DOI 10.1017/S0266462300006875; GUYATT GH, 1992, J CLIN EPIDEMIOL, V45, P1341, DOI 10.1016/0895-4356(92)90194-R; Hardy SE, 2007, J AM GERIATR SOC, V55, P1727, DOI 10.1111/j.1532-5415.2007.01413.x; HOLDEN MK, 1986, PHYS THER, V66, P1530, DOI 10.1093/ptj/66.10.1530; Keith R A, 1987, Adv Clin Rehabil, V1, P6; Kelly-Hayes M, 1998, STROKE, V29, P1274, DOI 10.1161/01.STR.29.6.1274; Kortebein P, 2007, JAMA-J AM MED ASSOC, V297, P1772, DOI 10.1001/jama.297.16.1772-b; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; LAWSHE CH, 1975, PERS PSYCHOL, V28, P563, DOI 10.1111/j.1744-6570.1975.tb01393.x; Liebl M, 2011, 7 EFSMA EUR C SPORTS; Liebl ME, 2016, CHARITE ARBEITSBEREI; Lincoln N, 1979, Physiotherapy, V65, P48; MAHONEY F I, 1965, Md State Med J, V14, P61; Martin BJ., 1996, CLIN REHABIL, V10, P44, DOI [10.1177/026921559601000109, DOI 10.1177/026921559601000109]; Needham DM, 2008, JAMA-J AM MED ASSOC, V300, P1685, DOI 10.1001/jama.300.14.1685; Nosova EV, 2014, J SURG RES, V190, P672, DOI 10.1016/j.jss.2014.02.001; PODSIADLO D, 1991, J AM GERIATR SOC, V39, P142, DOI 10.1111/j.1532-5415.1991.tb01616.x; Schweickert WD, 2007, CHEST, V131, P1541, DOI 10.1378/chest.06-2065; Schweickert WD, 2009, LANCET, V373, P1874, DOI 10.1016/S0140-6736(09)60658-9; Smith R., 1994, PHYSIOTHERAPY, V80, P5, DOI [10.1016/S0031-9406(10)60612-8, DOI 10.1016/S0031-9406(10)60612-8]; Sosnowski K, 2015, AUST CRIT CARE, V28, P216, DOI 10.1016/j.aucc.2015.05.002; Sourdet S, 2015, J AM MED DIR ASSOC, V16, P674, DOI 10.1016/j.jamda.2015.03.011; TINETTI ME, 1986, J AM GERIATR SOC, V34, P119, DOI 10.1111/j.1532-5415.1986.tb05480.x; Trudel G, 2000, ARCH PHYS MED REHAB, V81, P6, DOI 10.1053/apmr.2000.0810006; Williams GP, 2009, BRAIN INJURY, V23, P307, DOI 10.1080/02699050902774170; Williams GP, 2005, BRAIN INJURY, V19, P833, DOI 10.1080/02699050500058711; World Health Organisation (WHO), 2001, INT CLASS FUNCT DIS; Yosef-Brauner O, 2015, CLIN RESPIR J, V9, P1, DOI 10.1111/crj.12091	44	9	9	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2016	11	12							e0169010	10.1371/journal.pone.0169010	http://dx.doi.org/10.1371/journal.pone.0169010			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EI9QH	28006023	Green Submitted, gold, Green Published			2022-12-27	WOS:000392843200123
J	Povoa, TF; Oliveira, ERA; Basilio-de-Oliveira, CA; Nuovo, GJ; Chagas, VLA; Salomao, NG; Mota, EM; Paes, MV				Povoa, Tiago F.; Oliveira, Edson R. A.; Basilio-de-Oliveira, Carlos. A.; Nuovo, Gerard J.; Chagas, Vera L. A.; Salomao, Natalia G.; Mota, Ester M.; Paes, Marciano V.			Peripheral Organs of Dengue Fatal Cases Present Strong Pro-Inflammatory Response with Participation of IFN-Gamma-, TNF-Alpha- and RANTES-Producing Cells	PLOS ONE			English	Article							ORIGINAL ANTIGENIC SIN; NATURAL-KILLER-CELLS; HEMORRHAGIC-FEVER; VIRUS-INFECTION; NK CELLS; ENDOTHELIAL-CELLS; INDUCED APOPTOSIS; VIRAL-INFECTIONS; SHOCK SYNDROME; YELLOW-FEVER	Dengue disease is an acute viral illness caused by dengue virus (DENV) that can progress to hemorrhagic stages leading to about 20000 deaths every year worldwide. Despite many clinical investigations regarding dengue, the immunopathogenic process by which infected patients evolve to the severe forms is not fully understood. Apart from differences in virulence and the antibody cross reactivity that can potentially augment virus replication, imbalanced cellular immunity is also seen as a major concern in the establishment of severe dengue. In this context, the investigation of cellular immunity and its products in dengue fatal cases may provide valuable data to help revealing dengue immunopathogenesis. Here, based in four dengue fatal cases infected by the serotype 3 in Brazil, different peripheral organs (livers, lungs and kidneys) were studied to evaluate the presence of cell infiltrates and the patterns of local cytokine response. The overall scenario of the studied cases revealed a considerable systemic involvement of infection with mononuclear cells targeted to all of the evaluated organs, as measured by immunohistochemistry (IHC). Quantification of cytokine-expressing cells in peripheral tissues was also performed to characterize the ongoing inflammatory process by the severe stage of the disease. Increased levels of IFN-gamma-and TNF-alpha-expressing cells in liver, lung and kidney samples of post-mortem subjects evidenced a strong pro-inflammatory induction in these tissues. The presence of increased RANTES-producing cell numbers in all analyzed organs suggested a possible link between the clinical status and altered vascular permeability. Co-staining of DENV RNA and IFN-gamma or TNF-alpha using in situ hibridization and IHC confirmed the virus-specific trigger of the proinflammatory response. Taken together, this work provided additional evidences that corroborated with the traditional theories regarding the "cytokine storm" and the occurrence of uneven cellular immunity in response to DENV as major reasons for progress to severe disease.	[Povoa, Tiago F.] Fundacao Oswaldo Cruz, Inst Oswaldo Cruz, Lab Biotechnol & Physiol Viral Infect, Rio De Janeiro, Brazil; [Oliveira, Edson R. A.] Univ Fed Rio de Janeiro, Lab Mol Modeling, Rio De Janeiro, Brazil; [Basilio-de-Oliveira, Carlos. A.] Univ Rio de Janeiro, Gaffree Guinle Hosp, Pathol Anat, Rio De Janeiro, Brazil; [Nuovo, Gerard J.] Ohio State Univ, Ctr Comprehens Canc, Columbus, OH 43210 USA; [Nuovo, Gerard J.] Phylogeny Inc, Powell, OH USA; [Chagas, Vera L. A.] Clementino Fraga Filho Univ Hosp, Pathol Anat, Rio De Janeiro, Brazil; [Salomao, Natalia G.; Paes, Marciano V.] Fundacao Oswaldo Cruz, Inst Oswaldo Cruz, Interdisciplinary Lab Med Res, Rio De Janeiro, Brazil; [Mota, Ester M.] Fundacao Oswaldo Cruz, Inst Oswaldo Cruz, Pathol Lab, Rio De Janeiro, Brazil	Fundacao Oswaldo Cruz; Universidade Federal do Rio de Janeiro; Universidade do Grande Rio; Universidade Federal do Rio de Janeiro; James Cancer Hospital & Solove Research Institute; University System of Ohio; Ohio State University; Fundacao Oswaldo Cruz; Fundacao Oswaldo Cruz	Paes, MV (corresponding author), Fundacao Oswaldo Cruz, Inst Oswaldo Cruz, Interdisciplinary Lab Med Res, Rio De Janeiro, Brazil.	marciano@ioc.fiocruz.br		Paes, Marciano/0000-0002-2266-2801; Oliveira, Edson RA/0000-0002-8606-7454	Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ) [E-26/110.511/2014]	Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ)(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ))	This work was funded by the Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ, Grant: E-26/110.511/2014) www.faperj.br to MVP. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atrasheuskaya A, 2003, FEMS IMMUNOL MED MIC, V35, P33, DOI 10.1111/j.1574-695X.2003.tb00646.x; Beltran D, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00192; Bhargava R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079037; Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060; Carabali M, 2015, BMC INFECT DIS, V15, DOI 10.1186/s12879-015-1058-x; Chan KWK, 2015, ANTIVIR RES, V123, P5, DOI 10.1016/j.antiviral.2015.08.013; Chaturvedi UC, 2000, FEMS IMMUNOL MED MIC, V28, P183, DOI 10.1111/j.1574-695X.2000.tb01474.x; Chen JC, 2008, VIROL J, V5, DOI 10.1186/1743-422X-5-165; Croft M, 2013, NAT REV DRUG DISCOV, V12, P147, DOI 10.1038/nrd3930; Cui L, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004607; Dalrymple NA, 2012, J VIROL, V86, P6408, DOI 10.1128/JVI.00213-12; Iani FCD, 2016, AM J TROP MED HYG, V95, P193, DOI 10.4269/ajtmh.15-0537; de-Oliveira-Pinto LM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038527; Ding WX, 2004, J CELL MOL MED, V8, P445, DOI 10.1111/j.1582-4934.2004.tb00469.x; Ebert LA, 2005, MOL IMMUNOL, V42, P799, DOI 10.1016/j.molimm.2004.06.040; Glass WG, 2003, CURR OPIN ALLERGY CL, V3, P467, DOI 10.1097/01.all.0000104448.09202.91; Grandvaux N, 2002, J VIROL, V76, P5532, DOI 10.1128/JVI.76.11.5532-5539.2002; Green S, 1999, J INFECT DIS, V179, P755, DOI 10.1086/314680; Green S, 2006, CURR OPIN INFECT DIS, V19, P429, DOI 10.1097/01.qco.0000244047.31135.fa; GRONECK P, 1994, PEDIATRICS, V93, P712; Guzman MG, 2010, NAT REV MICROBIOL, pS7, DOI 10.1038/nrmicro2460; Halstead S. B., 2015, F1000RES, V4; Halstead SB, 2014, MICROBIOL SPECTR, V2, DOI 10.1128/microbiolspec.AID-0022-2014; Halstead SB, 2015, MICROBIOL MOL BIOL R, V79, P281, DOI 10.1128/MMBR.00009-15; HOBER D, 1993, AM J TROP MED HYG, V48, P324, DOI 10.4269/ajtmh.1993.48.324; Huerre MR, 2001, VIRCHOWS ARCH, V438, P107; John DV, 2015, J BIOMED SCI, V22, DOI 10.1186/s12929-015-0191-6; Kwong KY, 1998, J CLIN IMMUNOL, V18, P71, DOI 10.1023/A:1023244005765; La Braga E, 2001, MEM I OSWALDO CRUZ, V96, P229, DOI 10.1590/S0074-02762001000200015; Lim DSL, 2014, J IMMUNOL, V193, P5065, DOI 10.4049/jimmunol.1302240; Mathew A, 1998, J VIROL, V72, P3999, DOI 10.1128/JVI.72.5.3999-4004.1998; Mongkolsapaya J, 2003, NAT MED, V9, P921, DOI 10.1038/nm887; Huy NT, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002412; Nielsen DG, 2009, VIROL J, V6, DOI 10.1186/1743-422X-6-211; Paes MV, 2009, LAB INVEST, V89, P1140, DOI 10.1038/labinvest.2009.83; Pagliari C, 2016, J CLIN VIROL, V75, P16, DOI 10.1016/j.jcv.2015.12.005; Pang T, 2007, IMMUNOL CELL BIOL, V85, P43, DOI 10.1038/sj.icb.7100008; Pawitan Jeanne A, 2011, Acta Med Indones, V43, P129; Petitdemange C, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004499; Petitdemangew C, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00209; Povoa TF, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0083386; Quaresma JAS, 2006, VIROLOGY, V345, P22, DOI 10.1016/j.virol.2005.09.058; Quaresma JAS, 2013, REV MED VIROL, V23, P305, DOI 10.1002/rmv.1752; Rimkunas VM, 2009, J LIPID RES, V50, P327, DOI 10.1194/jlr.M800415-JLR200; Rodrigues RS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096313; Rothman AL, 1999, VIROLOGY, V257, P1, DOI 10.1006/viro.1999.9656; Rothman AL, 2011, NAT REV IMMUNOL, V11, P532, DOI 10.1038/nri3014; Rothman AL, 2010, CURR TOP MICROBIOL, V338, P83, DOI 10.1007/978-3-642-02215-9_7; Rowan PJ, 2007, J VIRAL HEPATITIS, V14, P883, DOI 10.1111/j.1365-2893.2007.00884.x; Samanta J, 2015, WORLD J CLIN CASES, V3, P125, DOI 10.12998/wjcc.v3.i2.125; Seneviratne SL, 2006, T ROY SOC TROP MED H, V100, P608, DOI 10.1016/j.trstmh.2005.10.007; Shresta S, 2006, J VIROL, V80, P10208, DOI 10.1128/JVI.00062-06; Spender LC, 1998, J GEN VIROL, V79, P1751, DOI 10.1099/0022-1317-79-7-1751; Sundstrom JB, 2001, J VIROL, V75, P6070, DOI 10.1128/JVI.75.13.6070-6085.2001; Tauseef A, 2016, JCPSP-J COLL PHYSICI, V26, P187, DOI 03.2016/JCPSP.187190; Tillu H, 2016, EUR J CLIN MICROBIOL, V35, P453, DOI 10.1007/s10096-015-2561-0; Townsley E, 2016, CLIN EXP IMMUNOL, V183, P419, DOI 10.1111/cei.12722; Vachvanichsanong P, 2016, ARCH VIROL, V161, P771, DOI 10.1007/s00705-015-2727-1; van Wilgenburg B, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11653; WHO, 2009, DENG GUID DIAGN TREA; World Health Organization (WHO), 2012, WHO GLOB STRAT DENG	61	18	19	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2016	11	12							e0168973	10.1371/journal.pone.0168973	http://dx.doi.org/10.1371/journal.pone.0168973			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI9QH	28006034	Green Published, gold, Green Submitted			2022-12-27	WOS:000392843200119
J	Tugume, AK; Mukasa, SB; Valkonen, JPT				Tugume, Arthur K.; Mukasa, Settumba B.; Valkonen, Jari P. T.			Mixed Infections of Four Viruses, the Incidence and Phylogenetic Relationships of Sweet Potato Chlorotic Fleck Virus (Betaflexiviridae) Isolates in Wild Species and Sweetpotatoes in Uganda and Evidence of Distinct Isolates in East Africa	PLOS ONE			English	Article							FEATHERY-MOTTLE-VIRUS; MULTIPLE SEQUENCE ALIGNMENT; RNA SILENCING SUPPRESSION; BROWN-STREAK-VIRUS; STUNT-VIRUS; COAT PROTEIN; MOSAIC-VIRUS; MILD-MOTTLE; SYNERGISTIC INTERACTIONS; SELECTION PRESSURE	Viruses infecting wild flora may have a significant negative impact on nearby crops, and vice-versa. Only limited information is available on wild species able to host economically important viruses that infect sweetpotatoes (Ipomoea batatas). In this study, Sweet potato chlorotic fleck virus (SPCFV; Carla virus, Betaflexiviridae) and Sweet potato chlorotic stunt virus (SPCSV; Crinivirus, Closteroviridae) were surveyed in wild plants of family ConvoIvulaceae (genera Astripomoea, Ipomoea, Hewittia and Lepistemon) in Uganda. Plants belonging to 26 wild species, including annuals, biannuals and perennials from four agroecological zones, were observed for virus-like symptoms in 2004 and 2007 and sampled for virus testing. SPCFV was detected in 84 (2.9%) of 2864 plants tested from 17 species. SPCSV was detected in 66 (5.4%) of the 1224 plants from 12 species sampled in 2007. Some SPCSV-infected plants were also infected with Sweet potato feathery mottle virus (SPFMV; Potyvirus, Potyviridae; 1.3%), Sweet potato mild mottle virus (SPMMV; Ipomovirus, Potyviridae; 0.5%) or both (0.4%), but none of these three viruses were detected in SPCFV-infected plants. Co-infection of SPFMV with SPMMV was detected in 1.2% of plants sampled. Virus-like symptoms were observed in 367 wild plants (12.8%), of which 42 plants (11.4%) were negative for the viruses tested. Almost all (92.4%) the 419 sweetpotato plants sampled from fields close to the tested wild plants displayed virus-like symptoms, and 87.1% were infected with one or more of the four viruses. Phylogenetic and evolutionary analyses of the 3'-proximal genomic region of SPCFV, including the silencing suppressor (NaBP)- and coat protein (CP)-coding regions implicated strong purifying selection on the CP and NaBP, and that the SPCFV strains from East Africa are distinguishable from those from other continents. However, the strains from wild species and sweetpotato were indistinguishable, suggesting reciprocal movement of SPCFV between wild and cultivated Convolvulaceae plants in the field.	[Tugume, Arthur K.; Valkonen, Jari P. T.] Univ Helsinki, Fac Agr & Forestry, Dept Agr Sci, Helsinki, Finland; [Tugume, Arthur K.] Makerere Univ, Sch Biosci, Dept Plant Sci Microbiol & Biotechnol, Coll Nat Sci, Kampala, Uganda; [Mukasa, Settumba B.] Makerere Univ, Sch Agr Sci, Dept Agr Prod, Coll Agr & Environm Sci, Kampala, Uganda	University of Helsinki; Makerere University; Makerere University	Tugume, AK (corresponding author), Univ Helsinki, Fac Agr & Forestry, Dept Agr Sci, Helsinki, Finland.; Tugume, AK (corresponding author), Makerere Univ, Sch Biosci, Dept Plant Sci Microbiol & Biotechnol, Coll Nat Sci, Kampala, Uganda.	aktugume@cns.mak.ac.ug		Tugume, Arthur/0000-0003-3689-6745; Valkonen, Jari/0000-0002-3704-9911	Academy of Finland [1276136]	Academy of Finland(Academy of Finland)	This work was funded by the Academy of Finland (1276136 to JPTV) and is gratefully acknowledged. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abubakar Z, 2003, J GEN VIROL, V84, P733, DOI 10.1099/vir.0.18759-0; Adikini S, 2015, CAN J PLANT PATHOL, V37, P136, DOI 10.1080/07060661.2015.1004111; Alabi OJ, 2011, ONLINE APSNET FEATUR; Alabi OJ, 2008, ARCH VIROL, V153, P1743, DOI 10.1007/s00705-008-0169-8; Alexander HM, 2014, EUR J PLANT PATHOL, V138, P529, DOI 10.1007/s10658-013-0317-1; Alicai T, 1999, PLANT PATHOL, V48, P718, DOI 10.1046/j.1365-3059.1999.00402.x; Anderson PK, 2004, TRENDS ECOL EVOL, V19, P535, DOI 10.1016/j.tree.2004.07.021; Aritua V, 2009, PLANT DIS, V93, P87, DOI 10.1094/PDIS-93-1-0087; Aritua V, 2007, ARCH VIROL, V152, P813, DOI 10.1007/s00705-006-0891-z; Ateka EM, 2004, ANN APPL BIOL, V144, P371, DOI 10.1111/j.1744-7348.2004.tb00353.x; BENNETZEN JL, 1982, J BIOL CHEM, V257, P3026; Bi YQ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042758; Bigirimana S., 2011, New Disease Reports, V24, P26; Borer ET, 2007, P NATL ACAD SCI USA, V104, P5473, DOI 10.1073/pnas.0608573104; Borer ET, 2010, ECOL LETT, V13, P810, DOI 10.1111/j.1461-0248.2010.01475.x; Borer ET, 2009, P NATL ACAD SCI USA, V106, P503, DOI 10.1073/pnas.0808778106; Bruen TC, 2006, GENETICS, V172, P2665, DOI 10.1534/genetics.105.048975; Brunt A. A., 1996, VIRUSES PLANTS DESCR; Canto T, 2009, GLOBAL CHANGE BIOL, V15, P1884, DOI 10.1111/j.1365-2486.2008.01820.x; Chare ER, 2004, J GEN VIROL, V85, P3149, DOI 10.1099/vir.0.80134-0; Clark CA, 2012, PLANT DIS, V96, P168, DOI 10.1094/PDIS-07-11-0550; Cooper I, 2006, ADV VIRUS RES, V67, P1, DOI 10.1016/S0065-3527(06)67001-2; Cronin JP, 2014, AM NAT, V184, P172, DOI 10.1086/676854; Cronin JP, 2010, ECOL LETT, V13, P1221, DOI 10.1111/j.1461-0248.2010.01513.x; Cuellar WJ, 2008, J GEN VIROL, V89, P573, DOI 10.1099/vir.0.83471-0; Cuellar WJ, 2015, MOL PLANT PATHOL, V16, P459, DOI 10.1111/mpp.12200; Cuellar WJ, 2011, VIRUS RES, V157, P111, DOI 10.1016/j.virusres.2011.01.010; De Bruyn A, 2012, BMC EVOL BIOL, V12, DOI 10.1186/1471-2148-12-228; De Souza J, 2013, ARCH VIROL, V158, P1393, DOI 10.1007/s00705-013-1614-x; Deng XG, 2014, PLANT DIS, V98, P163, DOI 10.1094/PDIS-05-13-0578-PDN; Deng XG, 2015, MOL PLANT PATHOL, V16, P365, DOI 10.1111/mpp.12186; Fargette D, 2006, ANNU REV PHYTOPATHOL, V44, P235, DOI 10.1146/annurev.phyto.44.120705.104644; Fargette D, 2004, J VIROL, V78, P3252, DOI 10.1128/JVI.78.7.3252-3261.2004; Fraile A, 2016, CURR OPIN VIROL, V17, P50, DOI 10.1016/j.coviro.2016.01.008; Friess N, 1996, NEW PHYTOL, V132, P103, DOI 10.1111/j.1469-8137.1996.tb04514.x; Funayama S, 2001, AM J BOT, V88, P616, DOI 10.2307/2657060; Garcia-Andres S, 2006, VIROLOGY, V350, P433, DOI 10.1016/j.virol.2006.02.028; GIBB KS, 1993, INT J PEST MANAGE, V39, P223, DOI 10.1080/09670879309371795; Gibson RW, 1998, PLANT PATHOL, V47, P95, DOI 10.1046/j.1365-3059.1998.00196.x; Gibson RW, 2009, REV SWEETPOTATO SEED; GOLDMAN N, 1994, MOL BIOL EVOL, V11, P725; Gu YH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098884; Ha C, 2008, ARCH VIROL, V153, P45, DOI 10.1007/s00705-007-1067-1; HAMMOND J, 1981, PLANT PATHOL, V30, P237, DOI 10.1111/j.1365-3059.1981.tb01263.x; HilleRisLambers J, 2010, J ECOL, V98, P1147, DOI 10.1111/j.1365-2745.2010.01706.x; HOLLINGS M, 1976, ANN APPL BIOL, V82, P511, DOI 10.1111/j.1744-7348.1976.tb00588.x; Horrocks M, 2006, J ARCHAEOL SCI, V33, P200, DOI 10.1016/j.jas.2005.07.014; Huson DH, 2006, MOL BIOL EVOL, V23, P254, DOI 10.1093/molbev/msj030; Ivanov KI, 2012, CURR OPIN VIROL, V2, P712, DOI 10.1016/j.coviro.2012.10.001; Jones RAC, 2007, AUSTRALAS PLANT PATH, V36, P591, DOI 10.1071/AP07069; Jones RAC, 2014, ANN APPL BIOL, V164, P320, DOI 10.1111/aab.12123; Jones RAC, 2015, MOL PLANT PATHOL, V16, P541, DOI 10.1111/mpp.12268; Jones RAC, 2009, VIRUS RES, V141, P113, DOI 10.1016/j.virusres.2008.07.028; Karyeija RF, 2000, VIROLOGY, V269, P26, DOI 10.1006/viro.1999.0169; Karyeija RF, 1998, ANN APPL BIOL, V133, P39, DOI 10.1111/j.1744-7348.1998.tb05800.x; Kashif M, 2012, PLANT DIS, V96, P1430, DOI 10.1094/PDIS-03-12-0268-RE; Kreuze JF, 2009, VIROLOGY, V388, P1, DOI 10.1016/j.virol.2009.03.024; Kreuze JF, 2000, ARCH VIROL, V145, P567, DOI 10.1007/s007050050047; Kwak HR, 2014, PLANT PATHOLOGY J, V30, P416, DOI 10.5423/PPJ.OA.04.2014.0029; Kwon SJ, 2016, PLANT PATHOLOGY J, V32, P65, DOI 10.5423/PPJ.NT.07.2015.0138; Legg JP, 2011, VIRUS RES, V159, P161, DOI 10.1016/j.virusres.2011.04.018; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Lovisolo O, 2003, ADV VIRUS RES, V62, P325, DOI 10.1016/S0065-3527(03)62006-3; Low J., 2009, P359, DOI 10.1007/978-1-4020-9475-0_16; Lukhovitskaya NI, 2013, PLANT SIGNAL BEHAV, V8, DOI 10.4161/psb.25263; Maina S, 2016, GENOME ANNOUNCEMENTS, V4, DOI 10.1128/genomeA.00414-16; Malmstrom CM, 2016, CURR OPIN VIROL, V19, P30, DOI 10.1016/j.coviro.2016.06.008; Malmstrom CM, 2005, OECOLOGIA, V145, P153, DOI 10.1007/s00442-005-0099-z; Malmstrom CM, 2005, NEW PHYTOL, V168, P217, DOI 10.1111/j.1469-8137.2005.01479.x; Martin DP, 2015, VIRUS EVOL, V1, DOI 10.1093/ve/vev003; Maskell LC, 1999, ANN APPL BIOL, V135, P401, DOI 10.1111/j.1744-7348.1999.tb00867.x; Mbanzibwa DR, 2014, ANN APPL BIOL, V165, P329, DOI 10.1111/aab.12136; Mbanzibwa DR, 2011, J VIROL METHODS, V171, P394, DOI 10.1016/j.jviromet.2010.09.024; Mbanzibwa DR, 2011, J GEN VIROL, V92, P974, DOI 10.1099/vir.0.026922-0; Mbanzibwa DR, 2009, ARCH VIROL, V154, P353, DOI 10.1007/s00705-008-0301-9; Hily JM, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004492; MIYATA T, 1979, J MOL EVOL, V12, P219, DOI 10.1007/BF01732340; Moore SM, 2011, B MATH BIOL, V73, P2707, DOI 10.1007/s11538-011-9654-4; Moore SM, 2012, ECOLOGY, V93, P1095, DOI 10.1890/11-0086.1; Moreno-Perez MG, 2014, J VIROL, V88, P3359, DOI 10.1128/JVI.02980-13; Mukasa SB, 2006, PLANT PATHOL, V55, P458, DOI 10.1111/j.1365-3059.2006.01350.x; Mukasa SB, 2003, PLANT DIS, V87, P329, DOI 10.1094/PDIS.2003.87.4.329; Mukasa SB, 2003, VIRUS GENES, V27, P49, DOI 10.1023/A:1025172402230; Mukasa SB, 2003, ARCH VIROL, V148, P487, DOI 10.1007/s00705-002-0930-3; Mukhopadhyay SK, 2011, FOOD SECUR, V3, P283, DOI 10.1007/s12571-011-0134-3; Mulimbi W., 2012, New Disease Reports, V26, P11, DOI 10.5197/j.2044-0588.2012.026.011; Muthukumar V, 2009, VIRUS RES, V141, P169, DOI 10.1016/j.virusres.2008.06.016; Nagano AJ, 2015, METHODS MOL BIOL, V1236, P89, DOI 10.1007/978-1-4939-1743-3_8; Namanda S, 2011, J SUSTAIN AGR, V35, P870, DOI 10.1080/10440046.2011.590572; Ndunguru J, 2005, VIROL J, V2, DOI 10.1186/1743-422X-2-21; Ndunguru J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0139321; Ndunguru J, 2009, AFR J AGR RES, V4, P334; Ngailo S, 2016, ACTA AGR SCAND B-S P, V66, P52, DOI 10.1080/09064710.2015.1063684; Nguyen HD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055336; Njeru RW, 2008, ANN APPL BIOL, V153, P215, DOI 10.1111/j.1744-7348.2008.00252.x; Njeru RW, 2004, ANN APPL BIOL, V145, P71, DOI 10.1111/j.1744-7348.2004.tb00360.x; OBRIEN PJ, 1972, AM ANTHROPOL, V74, P342, DOI 10.1525/aa.1972.74.3.02a00070; Ochola D, 2015, VIRUS RES, V195, P64, DOI 10.1016/j.virusres.2014.09.004; Ooi K, 1997, J PLANT RES, V110, P247, DOI 10.1007/BF02509313; Opiyo SA, 2010, J PLANT PATHOL, V92, P797; Power AG, 2011, VIRUS RES, V159, P95, DOI 10.1016/j.virusres.2011.05.016; Power Alison G., 2008, P15, DOI 10.1007/978-3-540-75763-4_2; Prendeville HR, 2014, NEW PHYTOL, V202, P1346, DOI 10.1111/nph.12730; Prendeville HR, 2012, AM J BOT, V99, P1033, DOI 10.3732/ajb.1100509; Qin YH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106323; Rannali M, 2009, PLANT DIS, V93, P933, DOI 10.1094/PDIS-93-9-0933; Raybould AF, 1999, NEW PHYTOL, V141, P265, DOI 10.1046/j.1469-8137.1999.00339.x; Remold SK, 2002, J ECOL, V90, P967, DOI 10.1046/j.1365-2745.2002.00731.x; Reynolds TW, 2015, FOOD SECUR, V7, P795, DOI 10.1007/s12571-015-0478-1; Roossinck MJ, 2015, PHYTOPATHOLOGY, V105, P716, DOI 10.1094/PHYTO-12-14-0356-RVW; Roossinck MJ, 2015, CURR OPIN VIROL, V10, P56, DOI 10.1016/j.coviro.2015.01.005; Roossinck MJ, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003304; Roossinck MJ, 2012, ANNU REV GENET, V46, P359, DOI 10.1146/annurev-genet-110711-155600; Roossinck MJ, 2010, PHILOS T R SOC B, V365, P1899, DOI 10.1098/rstb.2010.0057; Roossinck MJ, 2010, MOL ECOL, V19, P81, DOI 10.1111/j.1365-294X.2009.04470.x; Roullier C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062707; Rybicki EP, 1999, ADV VIRUS RES, V53, P127, DOI 10.1016/S0065-3527(08)60346-2; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; SCHAEFERS GA, 1976, PHYTOPATHOLOGY, V66, P642, DOI 10.1094/Phyto-66-642; Seabloom EW, 2015, ECOL LETT, V18, P401, DOI 10.1111/ele.12418; Seabloom EW, 2010, ECOLOGY, V91, P721, DOI 10.1890/08-2170.1; Seabloom EW, 2009, J ECOL, V97, P1264, DOI 10.1111/j.1365-2745.2009.01550.x; Seabloom EW, 2009, AM NAT, V173, pE79, DOI 10.1086/596529; Senshu H, 2011, J VIROL, V85, P10269, DOI 10.1128/JVI.05273-11; Senshu H, 2009, J GEN VIROL, V90, P1014, DOI 10.1099/vir.0.008243-0; Sossah FL, 2015, J PLANT PATHOL, V97, P109; Srisuwan S, 2006, PLANT SCI, V171, P424, DOI 10.1016/j.plantsci.2006.05.007; Stobbe AH, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00150; Strange RN, 2005, ANNU REV PHYTOPATHOL, V43, P83, DOI 10.1146/annurev.phyto.43.113004.133839; Sumner JG, 2012, J THEOR BIOL, V298, P16, DOI 10.1016/j.jtbi.2011.12.017; Sumner JG, 2012, SYST BIOL, V61, P1069, DOI 10.1093/sysbio/sys042; Swanson WJ, 2003, MOL BIOL EVOL, V20, P18, DOI 10.1093/oxfordjournals.molbev.a004233; Tairo F, 2005, MOL PLANT PATHOL, V6, P199, DOI 10.1111/j.1364-3703.2005.00267.x; TAMURA K, 1992, MOL BIOL EVOL, V9, P678; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Tavare S., 1986, LECT MATH LIFE SCI, V17, P57; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Thresh JM, 2006, ADV VIRUS RES, V67, P245, DOI 10.1016/S0065-3527(06)67007-3; Thurston MI, 2001, ANN APPL BIOL, V139, P277, DOI 10.1111/j.1744-7348.2001.tb00140.x; Tomitaka Y, 2006, MOL ECOL, V15, P4437, DOI 10.1111/j.1365-294X.2006.03094.x; Traore O, 2005, MOL ECOL, V14, P2097, DOI 10.1111/j.1365-294X.2005.02578.x; Traore O, 2009, VIRUS RES, V141, P258, DOI 10.1016/j.virusres.2009.01.011; Tsuneyoshi T, 1998, ARCH VIROL, V143, P1093, DOI 10.1007/s007050050358; Tugume AK, 2008, PHYTOPATHOLOGY, V98, P640, DOI 10.1094/PHYTO-98-6-0640; Tugume AK, 2016, VECTOR MEDIATED TRAN, P447; Tugume AK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081479; Tugume AK, 2010, MOL ECOL, V19, P3139, DOI 10.1111/j.1365-294X.2010.04682.x; Tugume AK, 2010, J GEN VIROL, V91, P1092, DOI 10.1099/vir.0.016089-0; Untiveros M, 2008, ARCH VIROL, V153, P473, DOI 10.1007/s00705-007-0019-0; Untiveros M, 2007, PLANT DIS, V91, P669, DOI 10.1094/PDIS-91-6-0669; Untiveros M, 2010, ARCH VIROL, V155, P2059, DOI 10.1007/s00705-010-0805-y; Valkonen JPT, 2002, MOL PLANT MICROBE IN, V15, P683, DOI 10.1094/MPMI.2002.15.7.683; Valverde RA., 2007, PLANT VIRUSES, V1, P116; Verdcourt B., 1963, FLORA TROPICAL E AFR; Vincent SJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091224; Visser M, 2016, VIROLOGY, V495, P122, DOI 10.1016/j.virol.2016.05.008; Weber PH, 2015, VIRUS RES, V196, P140, DOI 10.1016/j.virusres.2014.11.014; WERLE E, 1994, NUCLEIC ACIDS RES, V22, P4354, DOI 10.1093/nar/22.20.4354; Wong WSW, 2004, GENETICS, V168, P1041, DOI 10.1534/genetics.104.031153; Wren JD, 2006, PLOS BIOL, V4, P314, DOI 10.1371/journal.pbio.0040080; WRIGHT F, 1990, GENE, V87, P23, DOI 10.1016/0378-1119(90)90491-9; YAHARA T, 1993, OECOLOGIA, V96, P310, DOI 10.1007/BF00317499; Yang ZH, 2000, GENETICS, V155, P431; Yang ZH, 2005, MOL BIOL EVOL, V22, P1107, DOI 10.1093/molbev/msi097; Yang ZH, 2007, MOL BIOL EVOL, V24, P1586, DOI 10.1093/molbev/msm088; YEN D. E., 1963, ECON BOT, V17, P31, DOI 10.1007/BF02985351; Zhang DP, 2004, GENET RESOUR CROP EV, V51, P115, DOI 10.1023/B:GRES.0000020853.04508.a0	168	19	19	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2016	11	12							e0167769	10.1371/journal.pone.0167769	http://dx.doi.org/10.1371/journal.pone.0167769			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI9QH	28005969	Green Submitted, Green Published, gold			2022-12-27	WOS:000392843200020
J	Campbell, TM; Castro, MAA; Ponder, BAJ; Meyer, KB				Campbell, Thomas M.; Castro, Mauro A. A.; Ponder, Bruce A. J.; Meyer, Kerstin B.			Identification of Post-Transcriptional Modulators of Breast Cancer Transcription Factor Activity Using MINDy	PLOS ONE			English	Article							GENE-EXPRESSION; TUMOR-METASTASIS; PROSTATE-CANCER; RECEPTOR; PDEF; RISK; SUPPRESSOR; REGULATORS	We have recently identified transcription factors (TFs) that are key drivers of breast cancer risk. To better understand the pathways or sub-networks in which these TFs mediate their function we sought to identify upstream modulators of their activity. We applied the MINDy (Modulator Inference by Network Dynamics) algorithm to four TFs (ESR1, FOXA1, GATA3 and SPDEF) that are key drivers of estrogen receptor-positive (ER+) breast cancer risk, as well as cancer progression. Our computational analysis identified over 500 potential modulators. We assayed 189 of these and identified 55 genes with functional characteristics that were consistent with a role as TF modulators. In the future, the identified modulators may be tested as potential therapeutic targets, able to alter the activity of TFs that are critical in the development of breast cancer.	[Campbell, Thomas M.; Ponder, Bruce A. J.; Meyer, Kerstin B.] Univ Cambridge, Canc Res UK Cambridge Inst, Li Ka Shing Ctr, Robinson Way, Cambridge, England; [Castro, Mauro A. A.] Fed Univ Parana UFPR, Bioinformat & Syst Biol Lab, Polytech Ctr, Rua Alcides Vieira Arcoverde, Curitiba, Parana, Brazil	Cancer Research UK; CRUK Cambridge Institute; University of Cambridge; Universidade Federal do Parana	Meyer, KB (corresponding author), Univ Cambridge, Canc Res UK Cambridge Inst, Li Ka Shing Ctr, Robinson Way, Cambridge, England.	Kerstin.Meyer@cruk.cam.ac.uk	Castro, Mauro A. A./A-5467-2008	Castro, Mauro A. A./0000-0003-4942-8131	Cancer Research UK [C20/A17031]; Breast Cancer Research Foundation [BCRF-16-127]; Cancer Research UK Gibb Fellowship Award [C20/A16967]	Cancer Research UK(Cancer Research UK); Breast Cancer Research Foundation; Cancer Research UK Gibb Fellowship Award	This work was supported by Cancer Research UK C20/A17031 (http://www.cancerresearchuk.org/); Breast Cancer Research Foundation BCRF-16-127 (https://www.bcrfcure.org/) and the Cancer Research UK Gibb Fellowship Award C20/A16967 (http://www.cancerresearchuk.org/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Banerji S, 2012, NATURE, V486, P405, DOI 10.1038/nature11154; Bansal M, 2012, METHODS MOL BIOL, V786, P131, DOI 10.1007/978-1-61779-292-2_8; Campbell TM, 2016, CARCINOGENESIS, V37, P741, DOI 10.1093/carcin/bgw065; Carroll JS, 2006, NAT GENET, V38, P1289, DOI 10.1038/ng1901; Castro MAA, 2016, NAT GENET, V48, P12, DOI 10.1038/ng.3458; Ciriello G, 2015, CELL, V163, P506, DOI 10.1016/j.cell.2015.09.033; Eirew P, 2015, NATURE, V518, P422, DOI 10.1038/nature13952; Feldman RJ, 2003, CANCER RES, V63, P4626; Fletcher MNC, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3464; Forbes SA, 2015, NUCLEIC ACIDS RES, V43, pD805, DOI 10.1093/nar/gku1075; Hurtado A, 2011, NAT GENET, V43, P27, DOI 10.1038/ng.730; Jozwik KM, 2012, NAT REV CANCER, V12, P381, DOI 10.1038/nrc3263; Koboldt DC, 2012, NATURE, V490, P61, DOI 10.1038/nature11412; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Oettgen P, 2000, J BIOL CHEM, V275, P1216, DOI 10.1074/jbc.275.2.1216; Shah SP, 2012, NATURE, V486, P395, DOI 10.1038/nature10933; Sood AK, 2007, HUM PATHOL, V38, P1628, DOI 10.1016/j.humpath.2007.03.010; Sood AK, 2012, PROSTATE, V72, P592, DOI 10.1002/pros.21461; Steffan JJ, 2012, J BIOL CHEM, V287, P29968, DOI 10.1074/jbc.M112.379396; Steffan JJ, 2011, CANCER LETT, V310, P109, DOI 10.1016/j.canlet.2011.06.011; Stephens PJ, 2012, NATURE, V486, P400, DOI 10.1038/nature11017; Takaku M, 2015, GENE EXPRESSION, V16, P163, DOI 10.3727/105221615X14399878166113; Turcotte S, 2007, NEOPLASIA, V9, P788, DOI 10.1593/neo.07460; Verdine GL, 2007, CLIN CANCER RES, V13, P7264, DOI 10.1158/1078-0432.CCR-07-2184; Wang K, 2009, NAT BIOTECHNOL, V27, P829, DOI 10.1038/nbt.1563; Welboren WJ, 2007, MOL ONCOL, V1, P138, DOI 10.1016/j.molonc.2007.04.001	26	4	4	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2016	11	12							e0168770	10.1371/journal.pone.0168770	http://dx.doi.org/10.1371/journal.pone.0168770			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI9QF	27997592	Green Submitted, Green Published, gold			2022-12-27	WOS:000392842900074
J	Chitrala, KN; Nagarkatti, P; Nagarkatti, M				Chitrala, Kumaraswamy Naidu; Nagarkatti, Prakash; Nagarkatti, Mitzi			Prediction of Possible Biomarkers and Novel Pathways Conferring Risk to Post-Traumatic Stress Disorder	PLOS ONE			English	Article							DIFFERENTIALLY EXPRESSED GENES; QUALITY-CONTROL; PTSD; TWIN; DEPRESSION; GENETICS; TRAUMA; COMBAT; BIOINFORMATICS; BIOCONDUCTOR	Post-traumatic stress disorder is one of the common mental ailments that is triggered by exposure to traumatic events. Till date, the molecular factors conferring risk to the development of PTSD is not well understood. In this study, we have conducted a meta-analysis followed by hierarchical clustering and functional enrichment, to uncover the potential molecular networks and critical genes which play an important role in PTSD. Two datasets of expression profiles from Peripheral Blood Mononuclear Cells from 62 control samples and 63 PTSD samples were included in our study. In PTSD samples of GSE860 dataset, we identified 26 genes informative when compared with Post-deploy PTSD condition and 58 genes informative when compared with Pre-deploy and Post-deploy PTSD of GSE63878 dataset. We conducted the meta-analysis using Fisher, roP, Stouffer, AW, SR, PR and RP methods in MetaDE package. Results from the rOP method of MetaDE package showed that among these genes, the following showed significant changes including, OR2B6, SOX21, MOBP, 1L15, PTPRK, PPBPP2 and SEC14L5. Gene ontology analysis revealed enrichment of these significant PTSD-related genes for cell proliferation, DNA damage and repair (p-value < 0.05). Furthermore, interaction network analysis was performed on these 7 significant genes. This analysis revealed highly connected functional interaction networks with two candidate genes, IL15 and SEC14L5 highly enriched in networks. Overall, from these results, we concluded that these genes can be recommended as some of the potential targets for PTSD.	[Chitrala, Kumaraswamy Naidu; Nagarkatti, Prakash; Nagarkatti, Mitzi] Univ South Carolina, Sch Med, Dept Pathol Microbiol & Immunol, Columbia, SC 29208 USA	University of South Carolina System; University of South Carolina Columbia	Nagarkatti, M (corresponding author), Univ South Carolina, Sch Med, Dept Pathol Microbiol & Immunol, Columbia, SC 29208 USA.	Mitzi.Nagarkatti@uscmed.sc.edu	Chitrala, Kumara Swamy Naidu/U-1617-2019	Nagarkatti, Prakash/0000-0003-2663-0759; Chitrala, Kumaraswamy naidu/0000-0003-0663-9529	NIH [P01AT003961, R01AT006888, R01ES019313, R01MH094755, R01AI129788, P20GM103641]; National Center for Complementary & Integrative Health [P01AT003961] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI129788] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM103641] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH094755] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Center for Complementary & Integrative Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	The present study was supported by NIH grants P01AT003961, R01AT006888, R01ES019313, R01MH094755, R01AI129788, and P20GM103641.	Alim TN, 2006, J NATL MED ASSOC, V98, P1630; Almli LM, 2014, INT J NEUROPSYCHOPH, V17, P355, DOI 10.1017/S1461145713001090; Amador-Arjona A, 2015, P NATL ACAD SCI USA, V112, pE1936, DOI 10.1073/pnas.1421480112; American Psychiatric Association, 1994, DIAGN STAT MAN MENT; Amstadter AB, 2009, PSYCHIAT ANN, V39, P358, DOI 10.3928/00485713-20090526-01; Andrews JA, 2012, J NEUROCHEM, V120, P26, DOI 10.1111/j.1471-4159.2011.07545.x; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Ashley-Koch AE, 2015, J AFFECT DISORDERS, V184, P225, DOI 10.1016/j.jad.2015.03.049; Atwoli L, 2015, CURR OPIN PSYCHIATR, V28, P307, DOI 10.1097/YCO.0000000000000167; Barrett T, 2011, NUCLEIC ACIDS RES, V39, pD1005, DOI 10.1093/nar/gkq1184; Becker KG, 2000, BIOINFORMATICS, V16, P745, DOI 10.1093/bioinformatics/16.8.745; Boyd Oa, 1925, STAT METHODS RES WOR; Breen MS, 2015, MOL PSYCHIAT; Breitling R, 2004, FEBS LETT, V573, P83, DOI 10.1016/j.febslet.2004.07.055; Bremner JD, 2007, PROG BRAIN RES, V167, P171, DOI 10.1016/S0079-6123(07)67012-5; Breslau N, 2002, CAN J PSYCHIAT, V47, P923, DOI 10.1177/070674370204701003; Broekman BFP, 2007, NEUROSCI BIOBEHAV R, V31, P348, DOI 10.1016/j.neubiorev.2006.10.001; Cabrera OA, 2007, AM J PREV MED, V33, P77, DOI 10.1016/j.amepre.2007.03.019; Caglayan D, 2013, INT J CANCER, V133, P1345, DOI 10.1002/ijc.28147; Chu CM, 2014, DIS MARKERS, V2014, DOI 10.1155/2014/634123; Cornelis MC, 2010, CURR PSYCHIAT REP, V12, P313, DOI 10.1007/s11920-010-0126-6; Croft D, 2011, NUCLEIC ACIDS RES, V39, pD691, DOI 10.1093/nar/gkq1018; Dreyfuss JM, 2009, MOL CANCER, V8, DOI 10.1186/1476-4598-8-71; Fare TL, 2003, ANAL CHEM, V75, P4672, DOI 10.1021/ac034241b; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Geracioti TD, 2008, PSYCHONEUROENDOCRINO, V33, P416, DOI 10.1016/j.psyneuen.2007.12.012; Gillespie CF, 2009, DEPRESS ANXIETY, V26, P984, DOI 10.1002/da.20605; Giot L, 2003, SCIENCE, V302, P1727, DOI 10.1126/science.1090289; Gola H, 2013, BMC PSYCHIATRY, V13, DOI 10.1186/1471-244X-13-40; Hariri AR, 2002, SCIENCE, V297, P400, DOI 10.1126/science.1071829; Hong FX, 2006, BIOINFORMATICS, V22, P2825, DOI 10.1093/bioinformatics/btl476; Huang DW, 2007, NUCLEIC ACIDS RES, V35, pW169, DOI 10.1093/nar/gkm415; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Jiao XL, 2012, BIOINFORMATICS, V28, P1805, DOI 10.1093/bioinformatics/bts251; Kanehisa M, 2002, NOVART FDN SYMP, V247, P91; Kapfhammer HP, 2014, DIALOGUES CLIN NEURO, V16, P227; Kauffmann A, 2010, GENOMICS, V95, P138, DOI 10.1016/j.ygeno.2010.01.003; Keane TM, 2006, ANNU REV CLIN PSYCHO, V2, P161, DOI 10.1146/annurev.clinpsy.2.022305.095305; King DW, 1996, J CONSULT CLIN PSYCH, V64, P520, DOI 10.1037/0022-006X.64.3.520; Koenen KC, 2009, BMC PSYCHIATRY, V9, DOI 10.1186/1471-244X-9-29; Koenen KC, 2005, ARCH GEN PSYCHIAT, V62, P1258, DOI 10.1001/archpsyc.62.11.1258; Koenen KC, 2003, TWIN RES, V6, P218, DOI 10.1375/136905203765693870; Komori T, 2004, J EXP CLIN CANC RES, V23, P521; Koren D, 2005, AM J PSYCHIAT, V162, P276, DOI 10.1176/appi.ajp.162.2.276; Kristiansson M, 2004, J AM ACAD PSYCHIATRY, V32, P399; Krzywinski M, 2009, GENOME RES, V19, P1639, DOI 10.1101/gr.092759.109; Li J, 2011, ANN APPL STAT, V5, P994, DOI 10.1214/10-AOAS393; Logue MW, 2015, PSYCHONEUROENDOCRINO, V57, P1, DOI 10.1016/j.psyneuen.2015.03.016; Marinova Z, 2015, EUR J PSYCHOTRAUMATO, V6, DOI 10.3402/ejpt.v6.25913; Mehta D, 2013, P NATL ACAD SCI USA, V110, P8302, DOI 10.1073/pnas.1217750110; Nakamura M, 2003, CANCER RES, V63, P737; Nemeroff CB, 2004, J CLIN PSYCHIAT, V65, P18; Olff M, 2007, PSYCHOL BULL, V133, P183, DOI 10.1037/0033-2909.133.2.183; Parkitny L, 2015, BMC IMMUNOL, V16, DOI 10.1186/s12865-015-0122-z; Passos IC, 2015, LANCET PSYCHIAT, V2, P1002, DOI 10.1016/S2215-0366(15)00309-0; Raabe Florian Joachim, 2013, Front Psychiatry, V4, P80, DOI 10.3389/fpsyt.2013.00080; Rajkowska G, 2015, J PSYCHIATR RES, V65, P53, DOI 10.1016/j.jpsychires.2015.04.010; Rauch SL, 2006, BIOL PSYCHIAT, V60, P376, DOI 10.1016/j.biopsych.2006.06.004; Raychaudhuri S, 2000, Pac Symp Biocomput, P455; Ressler KJ, 2011, NATURE, V470, P492, DOI 10.1038/nature09856; Risch N, 2009, JAMA-J AM MED ASSOC, V301, P2462, DOI 10.1001/jama.2009.878; Saito K, 2007, BBA-MOL CELL BIOL L, V1771, P719, DOI 10.1016/j.bbalip.2007.02.010; Segman RH, 2005, MOL PSYCHIATR, V10, P514, DOI 10.1038/sj.mp.4001654; Skelton K, 2012, NEUROPHARMACOLOGY, V62, P628, DOI 10.1016/j.neuropharm.2011.02.013; Song C, 2014, ANN APPL STAT, V8, P777, DOI 10.1214/13-AOAS683; Steenkamp MM, 2015, J AFFECT DISORDERS, V176, P87, DOI 10.1016/j.jad.2015.01.043; Stein MB, 2002, BIOL PSYCHIAT, V52, P1079, DOI 10.1016/S0006-3223(02)01414-2; Stevens D, 2013, DEPRESS ANXIETY, V30, P940, DOI 10.1002/da.22160; STOUFFER S A, 1949, Sci Am, V180, P11; Strawn JR, 2008, DEPRESS ANXIETY, V25, P260, DOI 10.1002/da.20292; Sturn A, 2002, BIOINFORMATICS, V18, P207, DOI 10.1093/bioinformatics/18.1.207; Szklarczyk D, 2011, NUCLEIC ACIDS RES, V39, pD561, DOI 10.1093/nar/gkq973; TRUE WR, 1993, ARCH GEN PSYCHIAT, V50, P257, DOI 10.1001/archpsyc.1993.01820160019002; Tseng GC, 2012, NUCLEIC ACIDS RES, V40, P3785, DOI 10.1093/nar/gkr1265; Voisey J, 2014, J ANXIETY DISORD, V28, P873, DOI 10.1016/j.janxdis.2014.09.014; Waldron L, 2014, JNCI-J NATL CANCER I, V106, DOI 10.1093/jnci/dju049; Wang XB, 2012, BIOINFORMATICS, V28, P2534, DOI 10.1093/bioinformatics/bts485; Wilk JE, 2015, AGGRESS BEHAV; Xian H, 2000, DRUG ALCOHOL DEPEN, V61, P95, DOI 10.1016/S0376-8716(00)00127-7; Yehuda R, 1999, CAN J PSYCHIAT, V44, P34, DOI 10.1177/070674379904400104; Yehuda R, 2006, ANN NY ACAD SCI, V1071, P137, DOI 10.1196/annals.1364.012; Yehuda R, 2013, PSYCHONEUROENDOCRINO, V38, P1912, DOI 10.1016/j.psyneuen.2013.06.009; Young JM, 2002, HUM MOL GENET, V11, P1153, DOI 10.1093/hmg/11.10.1153	83	8	8	3	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2016	11	12							e0168404	10.1371/journal.pone.0168404	http://dx.doi.org/10.1371/journal.pone.0168404			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EI9QF	27997584	Green Published, gold, Green Submitted			2022-12-27	WOS:000392842900041
J	Nathan, HL; Cottam, K; Hezelgrave, NL; Seed, PT; Briley, A; Bewley, S; Chappell, LC; Shennan, AH				Nathan, Hannah L.; Cottam, Kate; Hezelgrave, Natasha L.; Seed, Paul T.; Briley, Annette; Bewley, Susan; Chappell, Lucy C.; Shennan, Andrew H.			Determination of Normal Ranges of Shock Index and Other Haemodynamic Variables in the Immediate Postpartum Period: A Cohort Study	PLOS ONE			English	Article							RUPTURED ECTOPIC PREGNANCY; VITAL SIGNS; MATERNAL HEMODYNAMICS; MASSIVE TRANSFUSION; HEMORRHAGE; MORTALITY; UTILITY; TRAUMA; EMERGENCY; DELIVERY	Objective To determine the normal ranges of vital signs, including blood pressure (BP), mean arterial pressure (MAP), heart rate (HR) and shock index (SI) (HR/systolic BP), in the immediate postpartum period to inform the development of robust obstetric early warning scores. Study Design We conducted a secondary analysis of a prospective observational cohort study evaluating vital signs collected within one hour following delivery in women with estimated blood loss (EBL) <500ml (316 women) delivering at a UK tertiary centre over a one-year period. Simple and multiple linear regression were used to explore associations of demographic and obstetric factors with SI. Results Median (90% reference range) was 120 (100-145) for systolic BP, 75 (58-90) for diastolic BP, 90 (73-108) for MAP, 81 (61-102) for HR, and 0.66 (0.52-0.89) for SI. Third stage Syntometrine administration was associated with a 0.03 decrease in SI (p = 0.035) and epidural use with a 0.05 increase (p = 0.003). No other demographic or obstetric factors were associated with a change in shock index in this cohort. Conclusion This is the first study to determine normal ranges of maternal BP, MAP, HR and SI within one hour of birth, a time of considerable haemodynamic adjustment, with minimal effect of demographic and obstetric factors demonstrated. The lower 90% reference point for systolic BP and upper 90% reference point for HR correspond to triggers used to recognise shock in obstetric practice, as do the upper 90% reference points for systolic and diastolic BP for obstetric hypertensive triggers. The SI upper limit of 0.89 in well postpartum women supports current literature suggesting a threshold of 0.9 as indicating increased risk of adverse outcomes.	[Nathan, Hannah L.; Cottam, Kate; Hezelgrave, Natasha L.; Seed, Paul T.; Briley, Annette; Bewley, Susan; Chappell, Lucy C.; Shennan, Andrew H.] Kings Coll London, Womens Hlth Acad Ctr, London, England	University of London; King's College London	Shennan, AH (corresponding author), Kings Coll London, Womens Hlth Acad Ctr, London, England.	andrew.shennan@kcl.ac.uk	Briley, Annette/N-1704-2019; Seed, Paul T/C-4435-2008; Briley, Annette/AAZ-5305-2020	Seed, Paul T/0000-0001-7904-7933; Briley, Annette/0000-0002-4266-920X; Shennan, Andrew/0000-0001-5273-3132	Bill and Melinda Gates Foundation [OPP1086183]; National Institute for Health Research (NIHR) Biomedical Research Centre based at Guy's and St Thomas' NHS Foundation Trust; King's College London; CLAHRC South London (NIHR); Tommy's Charity [1060508]; NIHR Research Professorship [RP-2014-05-019]; MOAWLAR; MRC [MR/N006240/1] Funding Source: UKRI; Medical Research Council [MR/N006240/1] Funding Source: researchfish; National Institute for Health Research [DRF-2013-06-171, ACF-2009-17-019, ACF-2015-17-014, RP-2014-05-019] Funding Source: researchfish	Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); National Institute for Health Research (NIHR) Biomedical Research Centre based at Guy's and St Thomas' NHS Foundation Trust; King's College London; CLAHRC South London (NIHR); Tommy's Charity; NIHR Research Professorship; MOAWLAR; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR))	Funded by Bill and Melinda Gates Foundation (OPP1086183), MOAWLAR, HLN, AHS, The National Institute for Health Research (NIHR) Biomedical Research Centre based at Guy's and St Thomas' NHS Foundation Trust and King's College London, LCC, AB, PTS, CLAHRC South London (NIHR), PTS, Tommy's Charity (registered charity no 1060508), PTS, AB. LCC is funded by a NIHR Research Professorship, (RP-2014-05-019). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbas AE, 2005, INT J CARDIOL, V98, P179, DOI 10.1016/j.ijcard.2003.10.028; ALLGOWER M, 1967, DEUT MED WOCHENSCHR, V92, P1947, DOI 10.1055/s-0028-1106070; ALTMAN DG, 1994, BRIT J OBSTET GYNAEC, V101, P29, DOI 10.1111/j.1471-0528.1994.tb13006.x; [Anonymous], 2007, INTR CAR CAR HLTH WO; Asaari H, 2012, MED J MALAYSIA, V67, P407; Baron BJ, 2004, J TRAUMA, V57, P69, DOI 10.1097/01.TA.0000090754.94232.2C; Birkhahn RH, 2003, AM J OBSTET GYNECOL, V189, P1293, DOI 10.1067/S0002-9378(03)00663-X; Birkhahn RH, 2002, ACAD EMERG MED, V9, P115, DOI 10.1197/aemj.9.2.115; Briley A, 2014, BJOG-INT J OBSTET GY, V121, P876, DOI 10.1111/1471-0528.12588; Campbell OMR, 2006, LANCET, V368, P1284, DOI 10.1016/S0140-6736(06)69381-1; Cancio LC, 2008, J TRAUMA, V64, pS51, DOI 10.1097/TA.0b013e3181608c21; Cannon CM, 2009, J TRAUMA, V67, P1426, DOI 10.1097/TA.0b013e3181bbf728; Chen LY, 2007, P ANN INT IEEE EMBS, P3748, DOI 10.1109/IEMBS.2007.4353147; Dyer RA, 2010, INT J OBSTET ANESTH, V19, P313, DOI 10.1016/j.ijoa.2010.04.011; Dyer RA, 2011, CURR OPIN ANESTHESIO, V24, P255, DOI 10.1097/ACO.0b013e328345331c; EASTERLING TR, 1990, OBSTET GYNECOL, V76, P1061; Grindheim G, 2012, J HYPERTENS, V30, P342, DOI 10.1097/HJH.0b013e32834f0b1c; Hagiwara A, 2010, J TRAUMA, V69, P1161, DOI 10.1097/TA.0b013e3181d27c94; Hick JL, 2001, AM J EMERG MED, V19, P488, DOI 10.1053/ajem.2001.27133; Holte K, 2004, ANESTHESIOLOGY, V100, P281, DOI 10.1097/00000542-200402000-00016; Jaramillo S, 2011, INT J GYNECOL OBSTET, V112, P68, DOI 10.1016/j.ijgo.2010.08.005; Knight M, 2014, SAVING LIVES IMPROVI, P2014; Le Bas A, 2014, INT J GYNECOL OBSTET, V124, P253, DOI 10.1016/j.ijgo.2013.08.020; Liu YC, 2012, WORLD J EMERG MED, V3, P114, DOI [10.5847/wjem.j.issn.1920-8642.2012.02.006, 10.5847/wjem.j.1920-8642.2012.02.006]; Mhyre JM, 2014, JOGNN-J OBST GYN NEO, V43, P771, DOI 10.1111/1552-6909.12504; Nathan HL, 2015, BJOG-INT J OBSTET GY, V122, P268, DOI 10.1111/1471-0528.13206; Pacagnella RC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057594; Paladino L, 2011, EUR J EMERG MED, V18, P94, DOI 10.1097/MEJ.0b013e32833f212b; RADY MY, 1992, RESUSCITATION, V23, P227, DOI 10.1016/0300-9572(92)90006-X; RADY MY, 1994, ANN EMERG MED, V24, P685, DOI 10.1016/S0196-0644(94)70279-9; RADY MY, 1992, AM J EMERG MED, V10, P538, DOI 10.1016/0735-6757(92)90178-Z; ROBSON SC, 1989, OBSTET GYNECOL, V74, P234; ROBSON SC, 1987, BRIT MED J, V294, P1065, DOI 10.1136/bmj.294.6579.1065; Say L, 2014, LANCET GLOB HEALTH, V2, pE323, DOI 10.1016/S2214-109X(14)70227-X; Schoon M, 2012, PROPOSED COLOUR BAND; Schorn MN, 2010, J MIDWIFERY WOM HEAL, V55, P20, DOI 10.1016/j.jmwh.2009.02.014; Singh S, 2012, ANAESTHESIA, V67, P12, DOI 10.1111/j.1365-2044.2011.06896.x; Vandromme MJ, 2011, J TRAUMA, V70, P384, DOI 10.1097/TA.0b013e3182095a0a; Walvekar V, 2012, COMPREHENSIVE TXB PO, P539; World Health Organization Department of Maternal N, 2013, WHO REC POSTN CAR MO	40	23	23	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2016	11	12							e0168535	10.1371/journal.pone.0168535	http://dx.doi.org/10.1371/journal.pone.0168535			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI9QF	27997586	Green Published, Green Submitted, gold			2022-12-27	WOS:000392842900056
J	Dissanayake, AA; Wagner, CM; Nair, MG				Dissanayake, Amila A.; Wagner, C. Michael; Nair, Muraleedharan G.			Chemical Characterization of Lipophilic Constituents in the Skin of Migratory Adult Sea Lamprey from the Great Lakes Region	PLOS ONE			English	Article							FATTY-ACID-COMPOSITION; PETROMYZON-MARINUS; ESTERS; BIODEGRADATION; PHOSPHOLIPIDS; INACTIVATION; DEGRADATION; MECHANISMS; MUSCLE; GROWTH	The sea lamprey (Petromzons marinus) is an invasive ectoparasite of large-bodied fishes that adversely affects the fishing industry and ecology of the Laurentian Great Lakes. Lipid content in the whole sea lamprey and muscles, liver and kidney of metamorphosing larval stages has been reported. Similarly, the fatty acid profile of the rope tissues of sexually-mature male sea lampreys has also been reported. The average body weight of a sub-adult migratory sea lamprey is 250 g, which includes 14.4% skin (36 g). Our preliminary extraction data of an adult sea lamprey skin revealed that it contained approximately 8.5% of lipophilic compounds. Lamprey skin is home to a naturally aversive compound (an alarm cue) that is being developed into a repellent for use in pest management. As part of an ongoing investigation to identify the chemical structure of the sea lamprey alarm cue, we extracted the skin with water and methanol, respectively. The methanolic extract (1.55%) contained exclusively lipophilic compounds and did not include the alarm cue. We chemically characterized all compounds present in the methanolic extract as cholesterol esters (CE), tri- and di-glycerides (TG and DG), cholesterol, free fatty acids (FFA) and minor amounts of plasticizers. The free fatty acids fraction was composed of saturated (41.8%), monounsaturated (40.7%) and polyunsaturated (17.4%) fatty acids, respectively. The plasticizers characterized were phthalate and benzoate and found to be 0.95 mg and 2.54 mg, respectively, per adult sea lamprey skin. This is the first report of the chemical characterization of all the lipophilic constituents in the skin of sub-adult migratory sea lamprey. The CEs isolated and characterized from sea lamprey skin are also for the first time.	[Dissanayake, Amila A.; Nair, Muraleedharan G.] Michigan State Univ, Dept Hort, E Lansing, MI 48824 USA; [Wagner, C. Michael] Michigan State Univ, Dept Fisheries & Wildlife, E Lansing, MI 48824 USA; [Nair, Muraleedharan G.] King Saud Univ, Chair Date Palm Res, Coll Food & Agr Sci, Riyadh, Saudi Arabia	Michigan State University; Michigan State University; King Saud University	Nair, MG (corresponding author), Michigan State Univ, Dept Hort, E Lansing, MI 48824 USA.; Nair, MG (corresponding author), King Saud Univ, Chair Date Palm Res, Coll Food & Agr Sci, Riyadh, Saudi Arabia.	nairm@msu.edu	Nair, Muraleedharan G./AAF-9984-2019	Nair, Muraleedharan G./0000-0001-9604-0055; Dissanayake, Amila/0000-0001-6274-6017	Great Lake Fisheries Commission (GLFC) [2016-NAI-54051]; NIH [1-S10-RR04750]; NSF [CHE-88-00770, CHE-92-13241]; Biotechnology Research Technology Program [DRR-00480]; National Center for Research Resources, National Institutes of Health	Great Lake Fisheries Commission (GLFC); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSF(National Science Foundation (NSF)); Biotechnology Research Technology Program; National Center for Research Resources, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This research is a contribution from Michigan State University AgBioResearch and funded by the Great Lake Fisheries Commission (GLFC) under the contract 2016-NAI-54051. The NMR data were obtained on instrumentation that was purchased, in part, with the funds from NIH grant no. 1-S10-RR04750, NSF grant no. CHE-88-00770, and NSF grant no. CHE-92-13241. MS data were obtained at the Michigan State University Mass Spectrometry Facility, which is supported, in part, by a grant (DRR-00480) from the Biotechnology Research Technology Program, National Center for Research Resources, National Institutes of Health.; This research is a contribution from Michigan State University AgBioResearch and funded by the Great Lake Fisheries Commission (GLFC) under the contract 2016-NAI-54051. The NMR data were obtained on instrumentation that was purchased, in part, with the funds from NIH grant no. 1-S10-RR04750, NSF grant no. CHE-88-00770, and NSF grant no. CHE-92-13241. MS data were obtained at the Michigan State University Mass Spectrometry Facility, which is supported, in part, by a grant (DRR-00480) from the Biotechnology Research Technology Program, National Center for Research Resources, National Institutes of Health. Authors acknowledge Dr. Chuan-Rui Zhang for his assistance in the sequential extraction of lyophilized whole sea lampreys.	Almeida PR, 2002, LARVAL HABITAT SEA L, P121; Alvarez JA, 2006, J LIQ CHROMATOGR, V10, P1291; Applegate VC, 1950, NATURAL HIST SEA LAM; Araujo MJ, 2013, J APPL ICHTHYOL, V29, P808, DOI 10.1111/jai.12192; Bals JD, 2012, BEHAVIOUR, V149, P901, DOI 10.1163/1568539X-00003009; Bell JG, 2006, AQUAC RES, V37, P606, DOI 10.1111/j.1365-2109.2006.01470.x; Bergsson G, 1998, ANTIMICROB AGENTS CH, V42, P2290, DOI 10.1128/AAC.42.9.2290; Bergsson G, 2001, APMIS, V109, P670, DOI 10.1034/j.1600-0463.2001.d01-131.x; BIRD DJ, 1983, COMP BIOCHEM PHYS B, V75, P31, DOI 10.1016/0305-0491(83)90036-6; BORGMANN U, 1991, J GREAT LAKES RES, V17, P368, DOI 10.1016/S0380-1330(91)71373-7; Botelho G, 2004, POLYM DEGRAD STABIL, V85, P991, DOI 10.1016/j.polymdegradstab.2003.04.006; Bulla M. K., 2011, Food and Nutrition Sciences, V2, P440, DOI 10.4236/fns.2011.25062; Chivers DP, 2007, P ROY SOC B-BIOL SCI, V274, P2611, DOI 10.1098/rspb.2007.0709; Christie GC, 2003, J GREAT LAKES RES, V29, P1, DOI 10.1016/S0380-1330(03)70474-2; Chung-Davidson YW, 2013, J EXP BIOL, V216, P2702, DOI 10.1242/jeb.085746; Cline TJ, 2014, ECOSPHERE, V5, DOI 10.1890/ES14-00059.1; Desbois AP, 2010, APPL MICROBIOL BIOT, V85, P1629, DOI 10.1007/s00253-009-2355-3; Elliot SL, 2002, P ROY SOC B-BIOL SCI, V269, P1599, DOI 10.1098/rspb.2002.2067; FELLOWS FCI, 1982, LIPIDS, V17, P741, DOI 10.1007/BF02534661; GALBRAITH H, 1971, J APPL BACTERIOL, V34, P803, DOI 10.1111/j.1365-2672.1971.tb01019.x; Gartshore J, 2003, ENVIRON TOXICOL CHEM, V22, P1244, DOI 10.1897/1551-5028(2003)022&lt;1244:BOPBRR&gt;2.0.CO;2; GIBBONS JA, 1989, ENVIRON TOXICOL CHEM, V8, P283, DOI 10.1897/1552-8618(1989)8[283:MDOSSO]2.0.CO;2; Hardisty M.W, 1971, P127; Hardisty MW, 1979, BIOL CYCLOSTOMES, P272; HENDERSON RJ, 1987, PROG LIPID RES, V26, P281, DOI 10.1016/0163-7827(87)90002-6; Jensen IJ, 2012, NUTR BULL, V37, P25, DOI 10.1111/j.1467-3010.2011.01941.x; JIE MSFLK, 1995, CHEM PHYS LIPIDS, V77, P155; Kao YH, 2002, COMP BIOCHEM PHYS B, V131, P153, DOI 10.1016/S1096-4959(01)00491-2; Kao YH, 1997, FISH PHYSIOL BIOCHEM, V16, P281, DOI 10.1023/A:1007799028951; Kaya Y., 2008, Journal of FisheriesSciences.com, V2, P693; KEITH LH, 1979, ENVIRON SCI TECHNOL, V13, P416, DOI 10.1021/es60152a601; KROON PA, 1981, J BIOL CHEM, V256, P5340; Kumar S, 1998, NATURE, V392, P917, DOI 10.1038/31927; Lanca MJ, 2013, SCI MAR, V77, P281, DOI 10.3989/scimar.03779.27B; LARSEN LO, 1980, CAN J FISH AQUAT SCI, V37, P1762, DOI 10.1139/f80-221; LEBLANC PJ, 1995, CAN J ZOOL, V73, P916, DOI 10.1139/z95-107; Liao CY, 2013, ENVIRON SCI TECHNOL, V47, P3918, DOI 10.1021/es400724s; Malcolmson RJ, 1996, CHEM PHYS LIPIDS, V84, P93, DOI 10.1016/S0009-3084(96)02626-6; Manzon RG, 2015, FISH FISH SER, V37, P139, DOI 10.1007/978-94-017-9306-3_4; Marichamy G., 2009, CURR RES J BIOL SCI, V1, P109; McCauley DW, 2015, BIOSCIENCE, V65, P1046, DOI 10.1093/biosci/biv139; McDaniel JC, 2008, WOUND REPAIR REGEN, V16, P337, DOI 10.1111/j.1524-475X.2008.00388.x; MCGRATTAN CJ, 1976, J PHYCOL, V12, P129, DOI 10.1111/j.1529-8817.1976.tb02839.x; Nieva-Echevarria B, 2014, FOOD RES INT, V66, P379, DOI 10.1016/j.foodres.2014.09.031; NIKITINA N, 2009, COLD SPRING HARB PRO, V4, P4, DOI DOI 10.1101/PDB.PROT5124); Pinela S, 2009, SCI MAR, V73, P785, DOI 10.3989/scimar.2009.73n4785; Pour AK, 2013, BIOCHEM ENG J, V70, P35, DOI 10.1016/j.bej.2012.09.014; Pour AK, 2009, CHEMOSPHERE, V77, P258, DOI 10.1016/j.chemosphere.2009.06.048; Quintella BR, 2009, J APPL ICHTHYOL, V25, P46, DOI 10.1111/j.1439-0426.2008.01200.x; Quintella BR, 2003, ECOL FRESHW FISH, V12, P286, DOI 10.1046/j.1600-0633.2002.00030.x; SACCHI R, 1994, CHEM PHYS LIPIDS, V69, P65, DOI 10.1016/0009-3084(94)90028-0; Shu DG, 1999, NATURE, V402, P42, DOI 10.1038/46965; Soni MG, 2005, FOOD CHEM TOXICOL, V43, P985, DOI 10.1016/j.fct.2005.01.020; Sorensen PW, 2005, NAT CHEM BIOL, V1, P324, DOI 10.1038/nchembio739; Soubias O, 2004, CHEM-EUR J, V10, P6005, DOI 10.1002/chem.200400246; THORMAR H, 1987, ANTIMICROB AGENTS CH, V31, P27, DOI 10.1128/AAC.31.1.27; Xue J, 2016, ACCUMULATIO IN PRESS; YOUSON JH, 1979, CAN J ZOOL, V57, P237, DOI 10.1139/z79-022; Zhang CR, 2015, J FUNCT FOODS, V18, P266, DOI 10.1016/j.jff.2015.07.012; Zhang CR, 2013, J AGR FOOD CHEM, V61, P5834, DOI 10.1021/jf401371v	60	9	9	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 19	2016	11	12							e0168609	10.1371/journal.pone.0168609	http://dx.doi.org/10.1371/journal.pone.0168609			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI9QC	27992570	Green Published, Green Submitted, gold			2022-12-27	WOS:000392842600080
J	Novo-Veleiro, I; Cieza-Borrella, C; Pastor, I; Chamorro, AJ; Laso, FJ; Gonzalez-Sarmiento, R; Marcos, M				Novo-Veleiro, Ignacio; Cieza-Borrella, Clara; Pastor, Isabel; Chamorro, Antonio-Javier; Laso, Francisco-Javier; Gonzalez-Sarmiento, Rogelio; Marcos, Miguel			A Single Nucleotide Polymorphism in the RASGRF2 Gene Is Associated with Alcoholic Liver Cirrhosis in Men	PLOS ONE			English	Article							RAS; ERK; INFLAMMATION; METAANALYSIS; PATHWAYS; ETHANOL; SAMPLE	Background Genetic polymorphisms in the RAS gene family are associated with different diseases, which may include alcohol-related disorders. Previous studies showed an association of the allelic variant rs26907 in RASGRF2 gene with higher alcohol intake. Additionally, the rs61764370 polymorphism in the KRAS gene is located in a binding site for the let-7 micro RNA family, which is potentially involved in alcohol-induced inflammation. Therefore, this study was designed to explore the association between these two polymorphisms and susceptibility to alcoholism or alcoholic liver disease (ALD). Methods We enrolled 301 male alcoholic patients and 156 healthy male volunteers in this study. Polymorphisms were genotyped by using TaqMan (R) PCR assays for allelic discrimination. Allelic and genotypic frequencies were compared between the two groups. Logistic regression analysis was performed to analyze the inheritance model. Results The A allele of the RASGRF2 polymorphism (rs26907) was significantly more prevalent among alcoholic patients with cirrhosis (23.2%) compared to alcoholic patients without ALD (14.2%). This difference remained significant in the group of patients with alcohol dependence (28.8% vs. 14.3%) but not in those with alcohol abuse (15.1% vs. 14.4%). Multivariable logistic regression analysis showed that the A allele of this polymorphism (AA or GA genotype) was associated with alcoholic cirrhosis both in the total group of alcoholics (odds ratio [OR]: 2.33, 95% confidence interval [CI]: 1.32-4.11; P = 0.002) and in the group of patients with alcohol dependence (OR: 3.1, 95% CI: 1.50-6.20; P = 0.001). Allelic distributions of the KRAS polymorphism (rs61764370) did not differ between the groups. Conclusions To our knowledge, this genetic association study represents the first to show an association of the RASGRF2 G>A (rs26907) polymorphism with ALD in men, particularly in the subgroup of patients with AD. The findings suggest the potential relevance of the RAS gene family in alcoholism and ALD.	[Novo-Veleiro, Ignacio] Univ Hosp Santiago de Compostela, Dept Internal Med, La Coruna, Spain; [Cieza-Borrella, Clara; Pastor, Isabel; Gonzalez-Sarmiento, Rogelio; Marcos, Miguel] Univ Salamanca, Mol Med Unit, Dept, Salamanca, Spain; [Cieza-Borrella, Clara; Pastor, Isabel; Chamorro, Antonio-Javier; Laso, Francisco-Javier; Gonzalez-Sarmiento, Rogelio; Marcos, Miguel] Inst Biomed Res Salamanca IBSAL, Salamanca, Spain; [Pastor, Isabel; Chamorro, Antonio-Javier; Laso, Francisco-Javier; Marcos, Miguel] Univ Hosp Salamanca, Alcoholism Unit, Dept Internal Med, Salamanca, Spain	Complexo Hospitalario Universitario de Santiago de Compostela; University of Salamanca; University of Salamanca	Marcos, M (corresponding author), Univ Salamanca, Mol Med Unit, Dept, Salamanca, Spain.; Marcos, M (corresponding author), Inst Biomed Res Salamanca IBSAL, Salamanca, Spain.; Marcos, M (corresponding author), Univ Hosp Salamanca, Alcoholism Unit, Dept Internal Med, Salamanca, Spain.	mmarcos@usal.es	Marcos, Miguel/B-3550-2008; Chamorro, Antonio-J/A-6257-2013; Gonzalez-Sarmiento, Rogelio/V-5526-2019; Novo-Veleiro, Ignacio/S-4606-2019	Marcos, Miguel/0000-0003-1269-4487; Chamorro, Antonio-J/0000-0002-2345-2873; Gonzalez-Sarmiento, Rogelio/0000-0002-2726-6795; Novo-Veleiro, Ignacio/0000-0003-0948-2440; Cieza-Borrella, Clara/0000-0003-2739-1040	Spanish Ministry of Science and Innovation [PI10/01692, PI10/00219]; Institute de Salud Carlos III (ISCIII); European Union FEDER funds ("Una manera de hacer Europa"); Junta de Castilla y Leon, Spain [GRS 531/A/10]; ISCIII [I3SNS-INT12/049]	Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Institute de Salud Carlos III (ISCIII); European Union FEDER funds ("Una manera de hacer Europa"); Junta de Castilla y Leon, Spain(Junta de Castilla y Leon); ISCIII(Instituto de Salud Carlos III)	This work has been supported by projects PI10/01692 and PI10/00219 from the Spanish Ministry of Science and Innovation, Institute de Salud Carlos III (ISCIII) and the European Union FEDER funds ("Una manera de hacer Europa") and by projects GRS 531/A/10 from Junta de Castilla y Leon, Spain and I3SNS-INT12/049 from ISCIII. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American Psychiatric Association, 2000, DIAGN STAT MAN MENT; Bala S, 2011, J BIOL CHEM, V286, P1436, DOI 10.1074/jbc.M110.145870; BARBACID M, 1987, ANNU REV BIOCHEM, V56, P779, DOI 10.1146/annurev.bi.56.070187.004023; Caiola E, 2012, AM J CANCER RES, V2, P298; Coste I, 2010, J CLIN INVEST, V120, P3663, DOI 10.1172/JCI42771; Dupont WD, 1998, CONTROL CLIN TRIALS, V19, P589, DOI 10.1016/S0197-2456(98)00037-3; Easton AC, 2014, PSYCHOPHARMACOLOGY, V231, P4199, DOI 10.1007/s00213-014-3562-x; Faccidomo S, 2009, PSYCHOPHARMACOLOGY, V204, P135, DOI 10.1007/s00213-008-1444-9; Gao W, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112698; Girault JA, 2007, CURR OPIN PHARMACOL, V7, P77, DOI 10.1016/j.coph.2006.08.012; Gonzalez-Quintela A, 2008, ALCOHOL, V42, P513, DOI 10.1016/j.alcohol.2008.04.008; Gori M, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/741465; Johnson C, 930 REGULATION HEPAT; Karachaliou N, 2013, CLIN LUNG CANCER, V14, P205, DOI 10.1016/j.cllc.2012.09.007; Koehnke MD, 2008, BIOCHEM PHARMACOL, V75, P160, DOI 10.1016/j.bcp.2007.06.021; Kyriakis JM, 2012, PHYSIOL REV, V92, P689, DOI 10.1152/physrev.00028.2011; Lewohl JM, 2011, ALCOHOL CLIN EXP RES, V35, P1928, DOI 10.1111/j.1530-0277.2011.01544.x; Maiya R, 2007, GENES BRAIN BEHAV, V6, P97, DOI 10.1111/j.1601-183X.2006.00236.x; Mandrekar P, 2009, J HEPATOL, V50, P1258, DOI 10.1016/j.jhep.2009.03.007; Marcos M, 2011, ALIMENT PHARM THER, V34, P1159, DOI 10.1111/j.1365-2036.2011.04862.x; Marcos M, 2008, ALCOHOL ALCOHOLISM, V43, P523, DOI 10.1093/alcalc/agn026; Marcos M, 2008, EUR J GASTROEN HEPAT, V20, P855, DOI 10.1097/MEG.0b013e3282fd0db1; Marcos M, 2009, AM J EPIDEMIOL, V170, P948, DOI 10.1093/aje/kwp236; Novo-Veleiro I, 2013, ALCOHOL ALCOHOLISM, V48, P564, DOI 10.1093/alcalc/agt044; Pilarski R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037891; Posada D, 2004, SYST BIOL, V53, P793, DOI 10.1080/10635150490522304; Prescott CA, 1999, AM J PSYCHIAT, V156, P34, DOI 10.1176/ajp.156.1.34; Reed T, 1996, ALCOHOL CLIN EXP RES, V20, P1528, DOI 10.1111/j.1530-0277.1996.tb01695.x; Repunte-Canonigo V, 2010, BRAIN RES, V1339, P1, DOI 10.1016/j.brainres.2010.03.063; Roussotte FF, 2013, FRONT AGING NEUROSCI, V5, DOI 10.3389/fnagi.2013.00093; Schumann G, 2011, P NATL ACAD SCI USA, V108, P7119, DOI 10.1073/pnas.1017288108; Schwechter B, 2013, P NATL ACAD SCI USA, V110, P14462, DOI 10.1073/pnas.1304340110; Sebio A, 2013, PHARMACOGENET GENOM, V23, P142, DOI 10.1097/FPC.0b013e32835d9b0b; Shi L, 2002, J BIOL CHEM, V277, P14777, DOI 10.1074/jbc.M108967200; Stacey D, 2012, P NATL ACAD SCI USA, V109, P21128, DOI 10.1073/pnas.1211844110; Tapia-Abellan A, 2012, BMC IMMUNOL, V13, DOI 10.1186/1471-2172-13-42; Tian XJ, 2004, EMBO J, V23, P1567, DOI 10.1038/sj.emboj.7600151; Toth R, 2011, DIS MARKERS, V31, P267, DOI [10.1155/2011/350528, 10.3233/DMA-2011-0828]; Vinci S, 2010, SYNAPSE, V64, P916, DOI 10.1002/syn.20811; Wang Q, 2013, BIOCHEM J, V449, P771, DOI 10.1042/BJ20121170; Zuo LJ, 2015, ALCOHOL CLIN EXP RES, V39, P1388, DOI 10.1111/acer.12786	41	1	1	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 19	2016	11	12							e0168685	10.1371/journal.pone.0168685	http://dx.doi.org/10.1371/journal.pone.0168685			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI9QC	27992614	Green Published, Green Accepted, Green Submitted, gold			2022-12-27	WOS:000392842600088
J	Kaneko, M; Hashikami, K; Yamamoto, S; Matsumoto, H; Nishimoto, T				Kaneko, Manami; Hashikami, Kentarou; Yamamoto, Satoshi; Matsumoto, Hirokazu; Nishimoto, Tomoyuki			Phospholamban Ablation Using CRISPR/Cas9 System Improves Mortality in a Murine Heart Failure Model	PLOS ONE			English	Article							GENE-TRANSFER; CARDIAC-HYPERTROPHY; MOUSE MODEL; SURVIVAL; RESYNCHRONIZATION; CARDIOMYOPATHY; CARDIOMYOCYTES; CONTRACTILITY; MYOCARDIUM; MECHANISMS	Sarcoplasmic reticulum Ca2+-ATPase 2a (SERCA2a) and its inhibitory protein called phospholamban (PLN) are pivotal for Ca2+ handling in cardiomyocyte and are known that their expression level and activity were changed in the heart failure patients. To examine whether PLN inhibition can improve survival rate as well as cardiac function in heart failure, we performed PLN ablation in calsequestrin overexpressing (CSQ-Tg) mice, a severe heart failure model, using clustered regularly interspaced short palindromic repeat (CRISPR)/CRISPR-associated (Cas) system. According this method, generation rate of PLN wild type mice (PLN copy >0.95) and PLN homozygous knockout (KO) mice (PLN copy <0.05) were 39.1% and 10.5%, respectively. While CSQ overexpression causes severe heart failure symptoms and premature death, a significant ameliorating effect on survival rate was observed in PLN homozygous KO/CSQ-Tg mice compared to PLN wild type/CSQ-Tg mice (median survival days are 55 and 50 days, respectively). Measurement of cardiac function with cardiac catheterization at the age of 5 weeks revealed that PLN ablation improved cardiac function in CSQ-Tg mice without affecting heart rate and blood pressure. Furthermore, increases in atrial and lung weight, an index of congestion, were significantly inhibited by PLN ablation. These results suggest that PLN deletion would be a promising approach to improve both mortality and cardiac function in the heart failure.	[Kaneko, Manami; Nishimoto, Tomoyuki] Takeda Pharmaceut Co Ltd, Cardiovasc & Metab Drug Discovery Unit, Div Pharmaceut Res, Fujisawa, Kanagawa, Japan; [Hashikami, Kentarou; Yamamoto, Satoshi; Matsumoto, Hirokazu] Takeda Pharmaceut Co Ltd, Integrated Technol Res Labs, Div Pharmaceut Res, Fujisawa, Kanagawa, Japan	Takeda Pharmaceutical Company Ltd; Takeda Pharmaceutical Company Ltd	Kaneko, M (corresponding author), Takeda Pharmaceut Co Ltd, Cardiovasc & Metab Drug Discovery Unit, Div Pharmaceut Res, Fujisawa, Kanagawa, Japan.	manami.kaneko@takeda.com			Takeda Pharmaceutical Company Limited	Takeda Pharmaceutical Company Limited(Takeda Pharmaceutical Company Ltd)	This study was financially supported by Takeda Pharmaceutical Company Limited. The authors as employees of Takeda played their roles in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham WT, 2005, J AM COLL CARDIOL, V46, P57, DOI 10.1016/j.jacc.2005.03.051; Bernardo BC, 2010, PHARMACOL THERAPEUT, V128, P191, DOI 10.1016/j.pharmthera.2010.04.005; Bristow MR, 2004, NEW ENGL J MED, V350, P2140, DOI 10.1056/NEJMoa032423; Byrne MJ, 2008, GENE THER, V15, P1550, DOI 10.1038/gt.2008.120; Chang NN, 2013, CELL RES, V23, P465, DOI 10.1038/cr.2013.45; Cho GW, 2016, BBA-MOL BASIS DIS, V1862, P763, DOI 10.1016/j.bbadis.2016.01.011; Cleland JGF, 2005, NEW ENGL J MED, V352, P1539, DOI 10.1056/NEJMoa050496; del Monte F, 1999, CIRCULATION, V100, P2308, DOI 10.1161/01.CIR.100.23.2308; del Monte F, 2002, CIRCULATION, V105, P904, DOI 10.1161/hc0802.105564; del Monte F, 2001, CIRCULATION, V104, P1424, DOI 10.1161/hc3601.095574; Doudna JA, 2014, SCIENCE, V346, P1077, DOI 10.1126/science.1258096; Engelhardt S, 2004, CIRCULATION, V109, P1154, DOI 10.1161/01.CIR.0000117254.68497.39; Gheorghiade M, 2009, J AM COLL CARDIOL, V53, P557, DOI 10.1016/j.jacc.2008.10.041; Go AS, 2014, CIRCULATION, V129, pE28, DOI 10.1161/01.cir.0000441139.02102.80; Gorski PA, 2015, CELL METAB, V21, P183, DOI 10.1016/j.cmet.2015.01.005; GWATHMEY JK, 1985, CIRC RES, V57, P836, DOI 10.1161/01.RES.57.6.836; GWATHMEY JK, 1987, CIRC RES, V61, P70, DOI 10.1161/01.RES.61.1.70; Hai T, 2014, CELL RES, V24, P372, DOI 10.1038/cr.2014.11; Harding VB, 2001, P NATL ACAD SCI USA, V98, P5809, DOI 10.1073/pnas.091102398; Jones LR, 1998, J CLIN INVEST, V101, P1385, DOI 10.1172/JCI1362; Kaye DM, 2007, J AM COLL CARDIOL, V50, P253, DOI 10.1016/j.jacc.2007.03.047; Kranias EG, 2012, CIRC RES, V110, P1646, DOI 10.1161/CIRCRESAHA.111.259754; LECHAT P, 1994, CIRCULATION, V90, P1765, DOI 10.1161/01.CIR.90.4.1765; Li DL, 2013, NAT BIOTECHNOL, V31, P681, DOI 10.1038/nbt.2661; LUO WS, 1994, CIRC RES, V75, P401, DOI 10.1161/01.RES.75.3.401; Lyon AR, 2011, CIRC-ARRHYTHMIA ELEC, V4, P362, DOI 10.1161/CIRCEP.110.961615; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; Marks AR, 2013, J CLIN INVEST, V123, P46, DOI 10.1172/JCI62834; McMullen JR, 2003, P NATL ACAD SCI USA, V100, P12355, DOI 10.1073/pnas.1934654100; Minamisawa S, 1999, CELL, V99, P313, DOI 10.1016/S0092-8674(00)81662-1; Moore JD, 2015, DRUG DISCOV TODAY, V20, P450, DOI 10.1016/j.drudis.2014.12.016; O'Connor CM, 1999, AM HEART J, V138, P78, DOI 10.1016/S0002-8703(99)70250-4; Pfeffer MA, 2003, LANCET, V362, P759, DOI 10.1016/S0140-6736(03)14282-1; Pogwizd SM, 2002, J CARDIOVASC ELECTR, V13, P88, DOI 10.1046/j.1540-8167.2002.00088.x; Sakata S, 2006, MOL THER, V13, P987, DOI 10.1016/j.ymthe.2006.01.002; Sato Y, 2001, J BIOL CHEM, V276, P9392, DOI 10.1074/jbc.M006889200; Shen B, 2013, CELL RES, V23, P720, DOI 10.1038/cr.2013.46; Suzuki M, 2002, CIRCULATION, V105, P1824, DOI 10.1161/01.CIR.0000014926.32463.89; SWEDBERG K, 1987, NEW ENGL J MED, V316, P1429; Szymanska G, 2000, PFLUG ARCH EUR J PHY, V439, P339, DOI 10.1007/s004240050948; Tham YK, 2015, ARCH TOXICOL, V89, P1401, DOI 10.1007/s00204-015-1477-x; Wheeler FC, 2005, MAMM GENOME, V16, P414, DOI 10.1007/s00335-005-2468-7; Yen ST, 2014, DEV BIOL, V393, P3, DOI 10.1016/j.ydbio.2014.06.017; Zhao ZZ, 2012, AM J PHYSIOL-HEART C, V302, pH1636, DOI 10.1152/ajpheart.00742.2011; Zhong H, 2015, SCI REP-UK, V5, DOI 10.1038/srep08366	45	16	17	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2016	11	12							e0168486	10.1371/journal.pone.0168486	http://dx.doi.org/10.1371/journal.pone.0168486			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI8LN	27992596	Green Published, gold, Green Submitted			2022-12-27	WOS:000392758000054
J	Chen, XY; Li, N; Bi, S; Wang, XG; Wang, BN				Chen, Xianyang; Li, Ning; Bi, Shuai; Wang, Xiaoguang; Wang, Beinan			Co-Activation of Th17 and Antibody Responses Provides Efficient Protection against Mucosal Infection by Group A Streptococcus	PLOS ONE			English	Article							LYMPHOID-TISSUE; PYOGENES; NEUTROPHILS; VACCINE; CELLS; COLONIZATION; INFILTRATION; ACTIVATION; CLEARANCE; PROTEINS	Conserved protein antigens among serotypes of group A Streptococcus pyogenes (GAS) have been focused for vaccine development because of the diversity of GAS serotypes and risks of autoimmunity post-GAS infection. Precise delineation of protective immune response to each of GAS antigens is critical for vaccine efficacy and safety. We recently reported that immunization with SrtA of GAS provides Th17-dependent clearance of heterologous serotypes of GAS in NALT. SCPA is a surface virulence molecule of GAS and known to induce antibody-mediated protection against GAS. We hypothesized that co-immunization with SrtA and SCPA would provide more efficient protection by eliciting combined Th17 and antibody responses. The present study showed that mice that were intranasally coimmunized with SrtA/SCPA cleared GAS more efficiently than the mice that were immunized with either SrtA or SCPA individually, and as efficient as the mice that experienced repeated GAS infections. The co-immunization induced Th17 and robust SCPA antibody responses, accompanied by a rapid influx of neutrophils and high myeloperoxidase activity in NALT, suggesting that simultaneous induction of mucosal Th17 and neutralizing antibody responses offers more effective GAS elimination through rapid infiltration and activation of neutrophils. Moreover, Th17 response was strongly induced in mice that experienced repeated GAS-infection and maintained at a high level even after the bacteria were cleared; whereas, it was moderately induced and promptly returned to baseline following bacterial elimination in SrtA/SCPA co-immunized mice. Additional results showed that the survival rate of systemic challenge was significantly higher in infection experienced than in co-immunized mice, indicating that more immune elements are required for protection against systemic than mucosal GAS infection.	[Chen, Xianyang; Li, Ning; Bi, Shuai; Wang, Xiaoguang; Wang, Beinan] Chinese Acad Sci, Inst Microbiol, Key Lab Pathogen Microbiol & Immunol, Beijing, Peoples R China	Chinese Academy of Sciences; Institute of Microbiology, CAS	Wang, BN (corresponding author), Chinese Acad Sci, Inst Microbiol, Key Lab Pathogen Microbiol & Immunol, Beijing, Peoples R China.	wangbn@im.ac.cn		Wang, Beinan/0000-0002-9260-7197	National Natural Science Foundation of China [31370928]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Natural Science Foundation of China Grant 31370928 to BW (http://www.nsfc.gov.cn). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bohnsack JF, 1997, J INFECT DIS, V175, P847, DOI 10.1086/513981; Carapetis JR, 2005, LANCET INFECT DIS, V5, P685, DOI 10.1016/S1473-3099(05)70267-X; Christensen D, 2016, MUCOSAL IMMUNOL; Dale JB, 2008, ADV EXP MED BIOL, V609, P53, DOI 10.1007/978-0-387-73960-1_5; Dale JB, 2013, VACCINE, V31, pB216, DOI 10.1016/j.vaccine.2012.09.045; Dileepan T, 2016, J CLIN INVEST, V126, P303, DOI 10.1172/JCI80792; Fan X, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107638; HEINECKE JW, 1993, J CLIN INVEST, V91, P2866, DOI 10.1172/JCI116531; Jeyaseelan S, 2004, INFECT IMMUN, V72, P7247, DOI 10.1128/IAI.72.12.7247-7256.2004; Ji YD, 1996, INFECT IMMUN, V64, P503, DOI 10.1128/IAI.64.2.503-510.1996; Ji YD, 1997, INFECT IMMUN, V65, P2080, DOI 10.1128/IAI.65.6.2080-2087.1997; Ji YD, 1998, INFECT IMMUN, V66, P5399, DOI 10.1128/IAI.66.11.5399-5405.1998; Kumar P, 2013, CURR OPIN IMMUNOL, V25, P373, DOI 10.1016/j.coi.2013.03.011; Kunisawa J, 2008, TRENDS IMMUNOL, V29, P505, DOI 10.1016/j.it.2008.07.008; Kwinn LA, 2007, FUTURE MICROBIOL, V2, P75, DOI 10.2217/17460913.2.1.75; Laan M, 2003, EUR RESPIR J, V21, P387, DOI 10.1183/09031936.03.00303503; Lau D, 2005, P NATL ACAD SCI USA, V102, P431, DOI 10.1073/pnas.0405193102; Li YM, 2002, J IMMUNOL, V168, P816, DOI 10.4049/jimmunol.168.2.816; OCONNOR SP, 1987, J INFECT DIS, V156, P495, DOI 10.1093/infdis/156.3.495; Park HS, 2005, INFECT IMMUN, V73, P7878, DOI 10.1128/IAI.73.12.7878-7886.2005; Park HS, 2003, J IMMUNOL, V171, P2532, DOI 10.4049/jimmunol.171.5.2532; Perry M, 1998, IMMUNOL TODAY, V19, P414, DOI 10.1016/S0167-5699(98)01307-3; Raz A, 2008, P NATL ACAD SCI USA, V105, P18549, DOI 10.1073/pnas.0808301105; Reglinski M, 2016, J INFECTION, V72, P450, DOI 10.1016/j.jinf.2016.02.002; Roberts Samantha, 2006, Curr Protoc Microbiol, VChapter 9, DOI 10.1002/9780471729259.mc09d05s02; Ruiz-Romeu E, 2016, J ALLERGY CLIN IMMUN, V138, P491, DOI 10.1016/j.jaci.2016.02.008; Shet A, 2004, INDIAN J MED RES, V119, P95; Terao Y, 2006, J BIOL CHEM, V281, P14215, DOI 10.1074/jbc.M513408200; Wang BN, 2010, P NATL ACAD SCI USA, V107, P5937, DOI 10.1073/pnas.0904831107; Wang W, 2014, INFECT IMMUN, V82, P2368, DOI 10.1128/IAI.00006-14; Wilson R, 2015, MUCOSAL IMMUNOL, V8, P627, DOI 10.1038/mi.2014.95; Witowski J, 2000, J IMMUNOL, V165, P5814, DOI 10.4049/jimmunol.165.10.5814	32	6	7	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2016	11	12							e0168861	10.1371/journal.pone.0168861	http://dx.doi.org/10.1371/journal.pone.0168861			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EG7JB	28030629	Green Submitted, gold, Green Published			2022-12-27	WOS:000391222000082
J	Jiang, JP; Gao, YH; Hou, YL; Li, WH; Zhang, SL; Zhang, Q; Sun, DX				Jiang, Jianping; Gao, Yahui; Hou, Yali; Li, Wenhui; Zhang, Shengli; Zhang, Qin; Sun, Dongxiao			Whole-Genome Resequencing of Holstein Bulls for Indel Discovery and Identification of Genes Associated with Milk Composition Traits in Dairy Cattle	PLOS ONE			English	Article							WIDE ASSOCIATION; TUMOR-SUPPRESSOR; BREAST-CANCER; CENP-E; VARIANTS; PATTERNS; NUCLEOTIDE; DELETION; OBESITY; IMPACT	The use of whole-genome resequencing to obtain more information on genetic variation could produce a range of benefits for the dairy cattle industry, especially with regard to increasing milk production and improving milk composition. In this study, we sequenced the genomes of eight Holstein bulls from four half-or full-sib families, with high and low estimated breeding values (EBVs) of milk protein percentage and fat percentage at an average effective depth of 10x, using Illumina sequencing. Over 0.9 million nonredundant short insertions and deletions (indels) [1-49 base pairs (bp)] were obtained. Among them, 3,625 indels that were polymorphic between the high and low groups of bulls were revealed and subjected to further analysis. The vast majority (76.67%) of these indels were novel. Followup validation assays confirmed that most (70%) of the randomly selected indels represented true variations. The indels that were polymorphic between the two groups were annotated based on the cattle genome sequence assembly (UMD3.1.69); as a result, nearly 1,137 of them were found to be located within 767 annotated genes, only 5 (0.138%) of which were located in exons. Then, by integrated analysis of the 767 genes with known quantitative trait loci (QTL); significant single-nucleotide polymorphisms (SNPs) previously identified by genome-wide association studies (GWASs) to be associated with bovine milk protein and fat traits; and the well-known pathways involved in protein, fat synthesis, and metabolism, we identified a total of 11 promising candidate genes potentially affecting milk composition traits. These were FCGR2B, CENPE, RETSAT, ACSBG2, NFKB2, TBC1D1, NLK, MAP3K1, SLC30A2, ANGPT1 and UGDH. Our findings provide a basis for further study and reveal key genes for milk composition traits in dairy cattle.	[Jiang, Jianping; Gao, Yahui; Li, Wenhui; Zhang, Shengli; Zhang, Qin; Sun, Dongxiao] China Agr Univ, Dept Anim Genet & Breeding, Coll Anim Sci & Technol, Natl Engn Lab Anim Breeding,Minist Agr,Key Lab An, Beijing, Peoples R China; [Hou, Yali] Chinese Acad Sci, Beijing Inst Genom, Lab Dis Genom & Individualized Med, Beijing, Peoples R China	China Agricultural University; Ministry of Agriculture & Rural Affairs; Chinese Academy of Sciences; Beijing Institute of Genomics, CAS	Sun, DX (corresponding author), China Agr Univ, Dept Anim Genet & Breeding, Coll Anim Sci & Technol, Natl Engn Lab Anim Breeding,Minist Agr,Key Lab An, Beijing, Peoples R China.	sundx@cau.edu.cn			National Science and Technology Programs of China [2013AA102504, 2011BAD28602, 2014ZX08009-053B]; Beijing Natural Science Foundation [6152013]; Beijing Dairy Industry Innovation Team [BAIC06-2016]; earmarked fund for Modern Agro-industry Technology Research System [CARS-37]; Program for Changjiang Scholar and Innovation Research Team in University [IRT1191]	National Science and Technology Programs of China; Beijing Natural Science Foundation(Beijing Natural Science Foundation); Beijing Dairy Industry Innovation Team; earmarked fund for Modern Agro-industry Technology Research System; Program for Changjiang Scholar and Innovation Research Team in University	This work was financially supported by the National Science and Technology Programs of China (2013AA102504, 2011BAD28602, 2014ZX08009-053B), Beijing Natural Science Foundation (6152013), the Beijing Dairy Industry Innovation Team (BAIC06-2016), the earmarked fund for Modern Agro-industry Technology Research System (CARS-37) and the Program for Changjiang Scholar and Innovation Research Team in University (IRT1191). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alam S, 2015, J MAMMARY GLAND BIOL, V20, P159, DOI 10.1007/s10911-015-9338-z; Bionaz M, 2011, BIOINFORM BIOL INSIG, V5, P83, DOI 10.4137/BBI.S7003; Blott S, 2003, GENETICS, V163, P253; Boussaha M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135931; Chen L, 2016, P NATL ACAD SCI USA, V113, P7219, DOI 10.1073/pnas.1600581113; Chen SA, 2008, BIOCHEM J, V409, P449, DOI 10.1042/BJ20071114; Choi JW, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101127; Choi JW, 2013, MOL CELLS, V36, P203, DOI 10.1007/s10059-013-2347-0; Clemente-Ruiz M, 2014, CELL CYCLE, V13, P1450, DOI 10.4161/cc.28417; Cole JB, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-408; COLLINS FS, 1987, SCIENCE, V235, P1046, DOI 10.1126/science.2950591; Cuevas BD, 2006, ONCOGENE, V25, P4998, DOI 10.1038/sj.onc.1209507; D'Andre HC, 2013, J ANIM SCI BIOTECHNO, V4, DOI 10.1186/2049-1891-4-43; Dempsey C, 2012, J NUTR, V142, P655, DOI 10.3945/jn.111.150623; Doan R, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-78; Fan WL, 2013, GENOME BIOL EVOL, V5, P1376, DOI 10.1093/gbe/evt097; Fan Z, 2014, MOL BIOL EVOL; Flisikowski K, 2009, GENOME BIOL, V10, P1; Frazer KA, 2007, NATURE, V448, P1050, DOI 10.1038/nature06067; GEORGES M, 1995, GENETICS, V139, P907; Glubb DM, 2015, AM J HUM GENET, V96, P5, DOI 10.1016/j.ajhg.2014.11.009; Grisart B, 2004, P NATL ACAD SCI USA, V101, P2398, DOI 10.1073/pnas.0308518100; Grobet L, 1997, NAT GENET, V17, P71, DOI 10.1038/ng0997-71; Guo JZ, 2012, BMC GENET, V13, DOI 10.1186/1471-2156-13-82; Hinds DA, 2005, SCIENCE, V307, P1072, DOI 10.1126/science.1105436; Hu J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077940; Jiang L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013661; Kim S, 2007, NAT GENET, V39, P1151, DOI 10.1038/ng2115; Koboldt DC, 2013, CELL, V155, P27, DOI 10.1016/j.cell.2013.09.006; Kung PP, 2014, MOL CANCER THER, V13, P2104, DOI 10.1158/1535-7163.MCT-14-0083-T; Lai JS, 2010, NAT GENET, V42, P1027, DOI 10.1038/ng.684; Lam HM, 2010, NAT GENET, V42, P1053, DOI 10.1038/ng.715; Lee S, 2015, J BIOL CHEM, V290, P13064, DOI 10.1074/jbc.M115.637439; Lee SST, 2004, J LIPID RES, V45, P2025, DOI 10.1194/jlr.M400078-JLR200; Li C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096186; Li H, 2009, BIOINFORMATICS, V25, P2078, DOI 10.1093/bioinformatics/btp352; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Lopez V, 2009, BIOCHEM J, V422, P43, DOI 10.1042/BJ20081189; Mai MD, 2010, J ANIM SCI, V88, P3522, DOI 10.2527/jas.2009-2713; Meredith BK, 2012, BMC GENET, V13, DOI 10.1186/1471-2156-13-21; Metzker ML, 2010, NAT REV GENET, V11, P31, DOI 10.1038/nrg2626; Mills RE, 2006, GENOME RES, V16, P1182, DOI 10.1101/gr.4565806; Minozzi G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080219; Moise AR, 2010, FASEB J, V24, P1261, DOI 10.1096/fj.09-147207; Montgomery SB, 2013, GENOME RES, V23, P749, DOI 10.1101/gr.148718.112; Ng PC, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000160; Patel RK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030619; Pei YF, 2014, HUM MOL GENET, V23, P820, DOI 10.1093/hmg/ddt464; Pelak K, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001111; Prosser CG, 1996, J DAIRY SCI, V79, P1184, DOI 10.3168/jds.S0022-0302(96)76472-X; SATO TN, 1995, NATURE, V376, P70, DOI 10.1038/376070a0; Schopen GCB, 2011, J DAIRY SCI, V94, P3148, DOI 10.3168/jds.2010-4030; Seo YA, 2010, PHYSIOL GENOMICS, V42A, P219, DOI 10.1152/physiolgenomics.00137.2010; Stone S, 2006, HUM MOL GENET, V15, P2709, DOI 10.1093/hmg/ddl204; Stothard P, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-559; Sun CJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0137145; Sun X-F, 2007, NFKB NFKBI POLYMORPH; Supakankul P, 2016, MEAT SCI, V118, P61, DOI 10.1016/j.meatsci.2016.03.025; Wang K, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq603; WARREN ST, 1987, SCIENCE, V237, P420, DOI 10.1126/science.3603029; Weaver BAA, 2007, CANCER CELL, V11, P25, DOI 10.1016/j.ccr.2006.12.003; Weischenfeldt J, 2013, NAT REV GENET, V14, P125, DOI 10.1038/nrg3373; Xie C, 2011, NUCLEIC ACIDS RES, V39, pW316, DOI 10.1093/nar/gkr483; Xu Q, 2012, BMC GENOMICS, V13, P1; Yan YY, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104652; Zheng LY, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-11-r114	67	17	19	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2016	11	12							e0168946	10.1371/journal.pone.0168946	http://dx.doi.org/10.1371/journal.pone.0168946			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EG7JB	28030618	Green Published, gold, Green Submitted			2022-12-27	WOS:000391222000088
J	Michaud, K; de Tayrac, M; D'Astous, M; Duval, C; Paquet, C; Samassekou, O; Gould, PV; Saikali, S				Michaud, Karine; de Tayrac, Marie; D'Astous, Myreille; Duval, Celine; Paquet, Claudie; Samassekou, Oumar; Gould, Peter Vincent; Saikali, Stephan			Contribution of 1p, 19q, 9p and 10q Automated Analysis by FISH to the Diagnosis and Prognosis of Oligodendroglial Tumors According to WHO 2016 Guidelines	PLOS ONE			English	Article							IN-SITU HYBRIDIZATION; COMPARATIVE GENOMIC HYBRIDIZATION; ANAPLASTIC OLIGODENDROGLIOMAS; 1P/19Q CODELETION; ASTROCYTIC TUMORS; IDH2 MUTATIONS; FREQUENT ATRX; GLIOMAS; CLASSIFICATION; CHROMOSOMES	Objective To study the feasibility and the diagnostic and prognostic interest of automated analysis of 1p, 19q, 9p and 10q status by FISH technique in oligodendroglial tumors. Methods We analyzed a retrospective series of 33 consecutive gliomas with oligodendroglial histology (originally diagnosed as 24 oligodendrogliomas and 9 oligoastrocytomas). For all cases, automated FISH analysis of 1p, 19q, 9p and 10q status were performed and compared to clinical and histological data, ATRX, IDH1R132H and alpha-internexin status (studied by immunohistochemistry) and overall survival (OS). Manual analysis of 9p and 10q status were also performed and compared to automated analysis to verify the concordance of the two methods. Results The 33 gliomas were reclassified into 13 low-grade oligodendrogliomas (OII), 10 anaplastic oligodendrogliomas (OIII), 3 diffuse astrocytomas (AII), 3 anaplastic astrocytomas (AIII) and 4 glioblastomas (GBM) according to the WHO 2016 histological criteria. The 1p and/or 19q imbalanced status were restricted to astrocytomas with no correlation to their grade or their OS. Chromosome 9p deletion was restricted to OIII (70%) and GBM (100%) and was correlated with a shorter OS in the total cohort (p = 0.0007), the oligodendroglioma cohort (p = 0.03) and the astrocytoma cohort (p = 0.001). Concordance between 9p manual and automated analysis was satisfactory (81%, kappa = 0.69). Chromosome 10q deletion was restricted to GBMs (50%) and was correlated with a poor OS in both the total cohort (p = 0.003) and the astrocytoma (AS) cohort (p = 0.04). Concordance between manual and automated analysis was satisfactory (79%, kappa = 0.62). Conclusion Automated analysis of 1p, 19q, 9p and 10q status by FISH is a reliable technique which allows for refined classification of oligodendroglial tumors. 1p and/or 19q imbalanced status is evidence of astrocytic differentiation. 9p deletion is found in high grade oligodendrogliomas and astrocytomas with a poor OS. 10q is related to GBM status and a poor OS.	[Michaud, Karine; D'Astous, Myreille] Ctr Hosp Univ Quebec, Dept Neurosurg, Quebec City, PQ, Canada; [de Tayrac, Marie] Ctr Hosp Univ Rennes, Dept Genom & Mol Genet, Rennes, France; [Duval, Celine; Paquet, Claudie; Samassekou, Oumar; Gould, Peter Vincent; Saikali, Stephan] Ctr Hosp Univ Quebec, Dept Pathol, Quebec City, PQ, Canada	Laval University; CHU Rennes; Universite de Rennes; Laval University	Saikali, S (corresponding author), Ctr Hosp Univ Quebec, Dept Pathol, Quebec City, PQ, Canada.	stephan.saikali.cha@ssss.gouv.qc.ca	de Tayrac, Marie/AAG-7800-2020; Michaud, Karine/AAM-3026-2020		Fondation du CHU de Quebec [2139]	Fondation du CHU de Quebec	The first author KM received a funding from "The Fondation du CHU de Quebec": grant#2139. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alentorn A, 2015, NEUROLOGY, V85, P1325, DOI 10.1212/WNL.0000000000002014; Ambros PF, 2001, MED PEDIATR ONCOL, V37, P492, DOI 10.1002/mpo.1242; Belaud-Rotureau MA, 2006, ACTA NEUROPATHOL, V111, P255, DOI 10.1007/s00401-005-0001-4; Bigner SH, 1999, AM J PATHOL, V155, P375, DOI 10.1016/S0002-9440(10)65134-6; Brat DJ, 2004, NEURO-ONCOLOGY, V6, P96, DOI 10.1215/S1152851703000231; Cairncross G, 2013, J CLIN ONCOL, V31, P337, DOI 10.1200/JCO.2012.43.2674; Cairncross G, 2008, CANCER J, V14, P352, DOI 10.1097/PPO.0b013e31818d8178; Crespo I, 2011, J MOL DIAGN, V13, P634, DOI 10.1016/j.jmoldx.2011.06.003; Duijf PHG, 2013, INT J CANCER, V132, P2316, DOI 10.1002/ijc.27924; Duval C, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132125; Fallon KB, 2004, J NEUROPATH EXP NEUR, V63, P314, DOI 10.1093/jnen/63.4.314; Figarella-Branger D, 2014, NEURO-ONCOLOGY, V16, P1244, DOI 10.1093/neuonc/nou047; Fuller CE, 2002, BRAIN PATHOL, V12, P67; Giannini C, 2001, J NEUROPATH EXP NEUR, V60, P248, DOI 10.1093/jnen/60.3.248; Giannini C, 2008, BRAIN PATHOL, V18, P360, DOI 10.1111/j.1750-3639.2008.00129.x; Godraind C, 2003, NEUROPATH APPL NEURO, V29, P462, DOI 10.1046/j.1365-2990.2003.00484.x; Hartmann C, 2009, ACTA NEUROPATHOL, V118, P469, DOI 10.1007/s00401-009-0561-9; Hayashi S, 2015, ONCOTARGET, V6, P15871, DOI 10.18632/oncotarget.3869; Horbinski C, 2012, J NEUROPATH EXP NEUR, V71, P73, DOI 10.1097/NEN.0b013e318240fa65; Houillier C, 2010, NEURO-ONCOLOGY, V12, P2, DOI 10.1093/neuonc/nop002; Jiao YC, 2012, ONCOTARGET, V3, P709, DOI 10.18632/oncotarget.588; Kitange G, 2005, GENE CHROMOSOME CANC, V42, P68, DOI 10.1002/gcc.20108; Koschny R, 2006, PATHOL RES PRACT, V202, P23, DOI 10.1016/j.prp.2005.10.010; Kros JM, 2007, J NEUROPATH EXP NEUR, V66, P545, DOI 10.1097/01.jnen.0000263869.84188.72; Liu XY, 2012, ACTA NEUROPATHOL, V124, P615, DOI 10.1007/s00401-012-1031-3; Louis DN, 2016, ACTA NEUROPATHOL, V5, P429; MARTIN F, 1952, AM J PATHOL, V28, P1107; Mokhtari K, 2011, CANCER-AM CANCER SOC, V117, P3014, DOI 10.1002/cncr.25827; Ohgaki H, 2005, J NEUROPATH EXP NEUR, V64, P479, DOI 10.1093/jnen/64.6.479; Ohgaki H, 2007, AM J PATHOL, V170, P1445, DOI 10.2353/ajpath.2007.070011; Qaddoumi I, 2016, ACTA NEUROPATHOL, V131, P833, DOI 10.1007/s00401-016-1539-z; Ramirez C, 2010, NEURO-ONCOLOGY, V12, P490, DOI 10.1093/neuonc/nop071; Reifenberger G, 2003, J NEUROPATH EXP NEUR, V62, P111, DOI 10.1093/jnen/62.2.111; Reyes-Botero G, 2014, NEURO-ONCOLOGY, V16, P662, DOI 10.1093/neuonc/not235; Sahm F, 2014, ACTA NEUROPATHOL, V128, P551, DOI 10.1007/s00401-014-1326-7; Sasaki H, 2007, AJP, V159, P359; Senetta R, 2013, J NEUROPATH EXP NEUR, V72, P432, DOI 10.1097/NEN.0b013e3182901f41; SHIMIZU KT, 1993, RADIOLOGY, V186, P569, DOI 10.1148/radiology.186.2.8421767; Snuderl M, 2009, CLIN CANCER RES, V15, P6430, DOI 10.1158/1078-0432.CCR-09-0867; The WHO, 2020, CLASSIFICATION TUMOU; Wesseling P, 2015, ACTA NEUROPATHOL, V129, P809, DOI 10.1007/s00401-015-1424-1; Wick W, 2009, J CLIN ONCOL, V27, P5874, DOI 10.1200/JCO.2009.23.6497; Wiens AL, 2012, J NEUROPATH EXP NEUR, V71, P618, DOI 10.1097/NEN.0b013e31825b5f7a; Wiestler B, 2013, ACTA NEUROPATHOL, V126, P443, DOI 10.1007/s00401-013-1156-z; Yan H, 2009, NEW ENGL J MED, V360, P765, DOI 10.1056/NEJMoa0808710; Zhao JX, 2014, NEURO-ONCOLOGY, V16, P103, DOI 10.1093/neuonc/not145; Zlatescu MC, 2001, CANCER RES, V61, P6713; Zulfiqar M, 2012, AM J NEURORADIOL, V33, P858, DOI 10.3174/ajnr.A2862	48	4	4	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2016	11	12							e0168728	10.1371/journal.pone.0168728	http://dx.doi.org/10.1371/journal.pone.0168728			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EG7JB	28030632	Green Published, gold, Green Submitted			2022-12-27	WOS:000391222000068
J	Saville, AC; Martin, MD; Ristaino, JB				Saville, Amanda C.; Martin, Michael D.; Ristaino, Jean B.			Historic Late Blight Outbreaks Caused by a Widespread Dominant Lineage of Phytophthora infestans (Mont.) de Bary	PLOS ONE			English	Article							IRISH POTATO FAMINE; EASTERN UNITED-STATES; DNA-SEQUENCE; POPULATION-STRUCTURE; PCR AMPLIFICATION; PATHOGEN; INFERENCE; POLYMORPHISMS; MIGRATION; PROGRAM	Phytophthora infestans (Mont.) de Bary, the causal agent of potato late blight, was responsible for the Irish potato famine of the 1840s. Initial disease outbreaks occurred in the US in 1843, two years prior to European outbreaks. We examined the evolutionary relationships and source of the 19th-century outbreaks using herbarium specimens of P. infestans from historic (1846 - 1970) and more recent isolates (1992 - 2014) of the pathogen. The same unique SSR multilocus genotype, named here as FAM-1, caused widespread outbreaks in both US and Europe. The FAM-1 lineage shared allelic diversity and grouped with the oldest specimens collected in Colombia and Central America. The FAM-1 lineage of P. infestans formed a genetic group that was distinct from more recent aggressive lineages found in the US. The US-1 lineage formed a second, mid-20th century group. Recent modern US lineages and the oldest Mexican lineages formed a genetic group with recent Mexican lineages, suggesting a Mexican origin of recent US lineages. A survey of mitochondrial haplotypes in a larger set of global herbarium specimens documented the more frequent occurrence of the HERB-1 (type Ia) mitochondrial haplotype in archival collections from 1866-75 and 1906-1915 and the rise of the Ib mitochondrial lineage (US-1) between 1946-1955. The FAM-1 SSR lineage survived for almost 100 years in the US, was geographically widespread, and was displaced first in the mid-20th century by the US-1 lineage and then by distinct new aggressive lineages that migrated from Mexico.	[Saville, Amanda C.; Ristaino, Jean B.] North Carolina State Univ, Dept Entomol & Plant Pathol, Raleigh, NC 27695 USA; [Martin, Michael D.] Norwegian Univ Sci & Technol NTNU, NTNU Univ Museum, Dept Nat Hist, Trondheim, Norway; [Martin, Michael D.] Univ Copenhagen, Nat Hist Museum Denmark, Ctr GeoGenet, Copenhagen, Denmark	University of North Carolina; North Carolina State University; Norwegian University of Science & Technology (NTNU); University of Copenhagen	Ristaino, JB (corresponding author), North Carolina State Univ, Dept Entomol & Plant Pathol, Raleigh, NC 27695 USA.	jbr@ncsu.edu	Ristaino, Jean Beagle/N-3616-2018	Ristaino, Jean Beagle/0000-0002-9458-0514; Martin, Michael/0000-0002-2010-5139	National Institute of Food and Agriculture, U.S. Department of Agriculture [2011-68004-30154]; North Carolina Agricultural Research Service	National Institute of Food and Agriculture, U.S. Department of Agriculture(United States Department of Agriculture (USDA)); North Carolina Agricultural Research Service	This work was partially supported by the National Institute of Food and Agriculture, U.S. Department of Agriculture (https://nifa.usda.gov/), under award number 2011-68004-30154 to JBR and by the North Carolina Agricultural Research Service to JBR. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abad ZG, 1997, PLANT DIS, V81, P682, DOI 10.1094/PDIS.1997.81.6.682; Anderson PK, 2004, TRENDS ECOL EVOL, V19, P535, DOI 10.1016/j.tree.2004.07.021; Andrivon D, 1996, PLANT PATHOL, V45, P1027, DOI 10.1046/j.1365-3059.1996.d01-196.x; [Anonymous], J ROYAL AGR SOC; Avila-Adame C, 2006, CURR GENET, V49, P39, DOI 10.1007/s00294-005-0016-3; Aylor DL, 2006, BIOINFORMATICS, V22, P1399, DOI 10.1093/bioinformatics/btl136; Berkeley M.J., 1846, J HORTICULT SOC LOND, V1, P9; Birch PRJ, 2013, ELIFE, V2, DOI 10.7554/eLife.00954; BOURKE PMA, 1964, NATURE, V203, P805, DOI 10.1038/203805a0; Bowden LC, 2008, SNAP CLADE MATRIX VE; Brurberg MB, 2011, FUNGAL BIOL-UK, V115, P335, DOI 10.1016/j.funbio.2011.01.003; Cardenas M, 2011, BMC GENET, P12; Chen Y, 1996, GENE, V181, P89, DOI 10.1016/S0378-1119(96)00469-6; Cooke DEL, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002940; Cornuet JM, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-401; Danies G, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0116354; DRENTH A, 1993, PHYTOPATHOLOGY, V83, P1087, DOI 10.1094/Phyto-83-1087; Earl DA, 2012, CONSERV GENET RESOUR, V4, P359, DOI 10.1007/s12686-011-9548-7; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; Flier WG, 2003, PHYTOPATHOLOGY, V93, P382, DOI 10.1094/PHYTO.2003.93.4.382; Forbes GA, 2013, CABI PLANT PROT SER, P48, DOI 10.1079/9781780640938.0048; Fry WE, 2015, PHYTOPATHOLOGY, V105, P966, DOI 10.1094/PHYTO-01-15-0005-FI; Fry WE, 2013, PLANT DIS, V97, P296, DOI 10.1094/PDIS-08-12-0791-FE; Fu YX, 1997, GENETICS, V147, P915; Gavino PD, PLANT DIS, V200, P731; Gilroy EM, 2011, NEW PHYTOL, V191, P763, DOI 10.1111/j.1469-8137.2011.03736.x; Gomez-Alpizar L, 2008, MYCOLOGIA, V100, P590, DOI 10.3852/07-074R1; Gomez-Alpizar L, 2007, P NATL ACAD SCI USA, V104, P3306, DOI 10.1073/pnas.0611479104; Goodwin SB, 1998, PHYTOPATHOLOGY, V88, P939, DOI 10.1094/PHYTO.1998.88.9.939; GOODWIN SB, 1994, P NATL ACAD SCI USA, V91, P11591, DOI 10.1073/pnas.91.24.11591; Goss EM, 2011, PLOS ONE, P6; Goss EM, 2014, P NATL ACAD SCI USA, V111, P8791, DOI 10.1073/pnas.1401884111; Griffith GW, 1998, APPL ENVIRON MICROB, V64, P4007; GRIFFITHS RC, 1994, STAT SCI, V9, P307, DOI 10.1214/ss/1177010378; Gronberg L, 2012, PHYTOPATHOLOGY, V102, P429, DOI 10.1094/PHYTO-07-11-0192; Grunwald NJ, 2005, ANNU REV PHYTOPATHOL, V43, P171, DOI 10.1146/annurev.phyto.43.040204.135906; Gunter R., GARDENERS CHRONICLES, V39, P657; Hall T.A., 1999, NUCL ACIDS S SER, V41, P95; Hey J, 2004, GENETICS, V167, P747, DOI 10.1534/genetics.103.024182; Hu CH, 2012, PLANT DIS, V96, P1323, DOI 10.1094/PDIS-03-11-0156-RE; Hudson RR, 2000, GENETICS, V155, P2011; HUDSON RR, 1992, MOL BIOL EVOL, V9, P138; HUDSON RR, 1992, GENETICS, V132, P583; Jakobsson M, 2007, BIOINFORMATICS, V23, P1801, DOI 10.1093/bioinformatics/btm233; Jombart T, 2008, BIOINFORMATICS, V24, P1403, DOI 10.1093/bioinformatics/btn129; Kamvar ZN, 2014, PEERJ, V2, DOI 10.7717/peerj.281; Lassiter ES, 2015, CURR GENET, V61, P567, DOI 10.1007/s00294-015-0480-3; Li Y, 2013, J MICROBIOL METH, V92, P316, DOI 10.1016/j.mimet.2012.11.021; Lyngso RB, 2005, LECT NOTES COMPUT SC, V3692, P239; Martin MD, 2016, MOL BIOL EVOL, V33, P478, DOI 10.1093/molbev/msv241; Martin MD, 2014, MOL BIOL EVOL, V31, P1414, DOI 10.1093/molbev/msu086; Martin MD, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3172; May KJ, 2004, MYCOL RES, V108, P471, DOI [10.1017/S0953756204009876, 10.1017/s0953756204009876]; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; Monacell JT, 2014, BIOINFORMATICS, V30, P1488, DOI 10.1093/bioinformatics/btu055; National Research Council of the National Academies, 2002, COUNT AGR BIOT; Niederhauser J.S., 1991, PHYTOPHTHORA, P25; Oliva RF, 2010, PLANT PATHOL, V59, P613, DOI 10.1111/j.1365-3059.2010.02287.x; Pritchard JK, 2000, GENETICS, V155, P945; REDDICK D., 1939, CHRON BOT, V5, P410; Ristaino JB, 2009, ACTA HORTIC, V834, P27, DOI 10.17660/ActaHortic.2009.834.2; Ristaino JB, 2001, NATURE, V411, P695, DOI 10.1038/35079606; Rosenberg NA, 2004, MOL ECOL NOTES, V4, P137, DOI 10.1046/j.1471-8286.2003.00566.x; Saville A, 2015, PLANT DIS, V99, P659, DOI 10.1094/PDIS-05-14-0452-RE; Stukenbrock EH, 2008, ANNU REV PHYTOPATHOL, V46, P75, DOI 10.1146/annurev.phyto.010708.154114; TAJIMA F, 1989, GENETICS, V123, P585; TAJIMA F, 1983, GENETICS, V105, P437; Teschemacher J. E., 1845, GARDENERS CHRONICLE, P125; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; TOOLEY PW, 1989, PHYTOPATHOLOGY, V79, P478, DOI 10.1094/Phyto-79-478; WANG H, 1993, NUCLEIC ACIDS RES, V21, P4153, DOI 10.1093/nar/21.17.4153; WATTERSON GA, 1975, THEOR POPUL BIOL, V7, P256, DOI 10.1016/0040-5809(75)90020-9; Yoshida K, 2014, PLOS PATHOG, P10; Yoshida K, 2013, ELIFE, V2, DOI 10.7554/eLife.00731; Yuen JE, 2013, PLANT PATHOL, V62, P485, DOI 10.1111/j.1365-3059.2012.02685.x	75	29	30	1	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2016	11	12							e0168381	10.1371/journal.pone.0168381	http://dx.doi.org/10.1371/journal.pone.0168381			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EG7JB	28030580	Green Published, gold, Green Submitted			2022-12-27	WOS:000391222000045
J	Szmydynger-Chodobska, J; Shan, RZ; Thomasian, N; Chodobski, A				Szmydynger-Chodobska, Joanna; Shan, Rongzi; Thomasian, Nicole; Chodobski, Adam			The Involvement of Pial Microvessels in Leukocyte Invasion after Mild Traumatic Brain Injury	PLOS ONE			English	Article							NEUTROPHIL INFILTRATION; MONOCLONAL-ANTIBODY; ENDOTHELIAL-CELLS; HEAD-INJURY; P-SELECTIN; EXPRESSION; BARRIER; MODEL; INFLAMMATION; RECRUITMENT	The pathophysiological mechanisms underlying mild traumatic brain injury (mTBI) are not well understood, but likely involve neuroinflammation. Here the controlled cortical impact model of mTBI in rats was used to test this hypothesis. Mild TBI caused a rapid (within 6 h post-mTBI) upregulation of synthesis of TNF-alpha and IL-1 beta in the cerebral cortex and hippocampus, followed by an increase in production of neutrophil (CXCL1 - 3) and monocyte (CCL2) chemoattractants. While astrocytes were not a significant source of CXC chemokines, they highly expressed CCL2. An increase in production of CXC chemokines coincided with the influx of neutrophils into the injured brain. At 6 h post-mTBI, we observed a robust influx of CCL2-expressing neutrophils across pial microvessels into the subarachnoid space (SAS) near the injury site. Mild TBI was not accompanied by any significant influx of neutrophils into the brain parenchyma until 24 h after injury. This was associated with an early induction of expression of intercellular adhesion molecule 1 on the endothelium of the ipsilateral pial, but not intraparenchymal, microvessels. At 6 h post-mTBI, we also observed a robust influx of neutrophils into the ipsilateral cistern of velum interpositum (CVI), a slit-shaped cerebrospinal fluid space located above the 3rd ventricle with highly vascularized pia mater. From SAS and CVI, neutrophils appeared to move along the perivascular spaces to enter the brain parenchyma. The monocyte influx was not observed until 24 h post-mTBI, and these inflammatory cells predominantly entered the ipsilateral SAS and CVI, with a limited invasion of brain parenchyma. These observations indicate that the endothelium of pial microvessels responds to injury differently than that of intraparenchymal microvessels, which may be associated with the lack of astrocytic ensheathment of cerebrovascular endothelium in pial microvessels. These findings also suggest that neuroinflammation represents the potential therapeutic target in mTBI.	[Szmydynger-Chodobska, Joanna; Shan, Rongzi; Thomasian, Nicole; Chodobski, Adam] Brown Univ, Alpert Med Sch, Dept Emergency Med, Neurotrauma & Brain Barriers Res Lab, Providence, RI 02912 USA	Brown University	Szmydynger-Chodobska, J (corresponding author), Brown Univ, Alpert Med Sch, Dept Emergency Med, Neurotrauma & Brain Barriers Res Lab, Providence, RI 02912 USA.	Joanna_Szmydynger-Chodobska@brown.edu		Thomasian, Nicole/0000-0001-9563-4580	NIH [NS94440, NS99605]; Department of Emergency Medicine at the Alpert Medical School of Brown University; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS094440, R21NS099605] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Emergency Medicine at the Alpert Medical School of Brown University; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by grants NS94440 and NS99605 from NIH (to AC), and by funds from Diane N. Weiss and from the Department of Emergency Medicine at the Alpert Medical School of Brown University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allt G, 1997, BRAIN RES REV, V24, P67, DOI 10.1016/S0165-0173(97)00011-8; Alvarez JI, 2006, J NEUROIMMUNOL, V173, P45, DOI 10.1016/j.jneuroim.2005.11.020; ANDERSSON PB, 1992, J EXP MED, V176, P255, DOI 10.1084/jem.176.1.255; Bao F, 2012, J NEUROTRAUM, V29, P2375, DOI 10.1089/neu.2012.2408; Bartholomaus I, 2009, NATURE, V462, P94, DOI 10.1038/nature08478; Bonneh-Barkay D, 2010, J NEUROTRAUM, V27, P1215, DOI 10.1089/neu.2010.1310; Cassidy JD, 2004, J REHABIL MED, V36, P28, DOI 10.1080/16501960410023732; Cera MR, 2009, J CELL SCI, V122, P268, DOI 10.1242/jcs.037127; DeWitt DS, 2013, J NEUROTRAUM, V30, P688, DOI 10.1089/neu.2012.2349; Didier N, 2003, J NEUROCHEM, V86, P246, DOI 10.1046/j.1471-4159.2003.01829.x; Faul M, 2010, TRAUMATIC BRAIN INJU, DOI DOI 10.15620/CDC.5571; GOTSCH U, 1994, CELL ADHES COMMUN, V2, P7, DOI 10.3109/15419069409014198; Hadass O, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076904; Hou RH, 2012, J NEUROL NEUROSUR PS, V83, P217, DOI 10.1136/jnnp-2011-300767; Kawada M, 2012, ONCOGENE, V31, P3111, DOI 10.1038/onc.2011.498; Kenne E, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-17; Lee CG, 2011, ANNU REV PHYSIOL, V73, P479, DOI 10.1146/annurev-physiol-012110-142250; McCrea M, 2013, J INT NEUROPSYCH SOC, V19, P22, DOI 10.1017/S1355617712000872; MCEVER RP, 1989, J CLIN INVEST, V84, P92, DOI 10.1172/JCI114175; Mishra PK, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002099; Perez-Polo JR, 2013, J NEUROTRAUM, V30, P727, DOI 10.1089/neu.2012.2650; Rabinowitz AR, 2015, J NEUROTRAUM, V32, P1488, DOI 10.1089/neu.2014.3555; Redell JB, 2013, J NEUROTRAUM, V30, P752, DOI 10.1089/neu.2012.2437; Rot A, 2009, METHOD ENZYMOL, V461, P191, DOI 10.1016/S0076-6879(09)05409-3; Royo NC, 1999, NEUROREPORT, V10, P1363, DOI 10.1097/00001756-199904260-00038; Scapini P, 2000, IMMUNOL REV, V177, P195, DOI 10.1034/j.1600-065X.2000.17706.x; Semple BD, 2010, NEUROBIOL DIS, V40, P394, DOI 10.1016/j.nbd.2010.06.015; Semple BD, 2010, J CEREBR BLOOD F MET, V30, P769, DOI 10.1038/jcbfm.2009.262; Shan RZ, 2016, J NEUROTRAUM, V33, P49, DOI 10.1089/neu.2014.3811; Szmydynger-Chodobska J, 2010, J NEUROTRAUM, V27, P1449, DOI 10.1089/neu.2010.1331; Szmydynger-Chodobska J, 2009, J CEREBR BLOOD F MET, V29, P1503, DOI 10.1038/jcbfm.2009.71; Tagliaferri F, 2006, ACTA NEUROCHIR, V148, P255, DOI 10.1007/s00701-005-0651-y; Tran ND, 1999, STROKE, V30, P1671, DOI 10.1161/01.STR.30.8.1671; Utagawa A, 2008, BRAIN RES, V1207, P155, DOI 10.1016/j.brainres.2008.02.057; Vestweber D, 2015, NAT REV IMMUNOL, V15, P692, DOI 10.1038/nri3908; Villapol S, 2015, AM J PATHOL, V185, P2641, DOI 10.1016/j.ajpath.2015.06.016; Walker-Caulfield ME, 2015, J NEUROIMMUNOL, V278, P112, DOI 10.1016/j.jneuroim.2014.12.009; Walter UM, 1997, HYBRIDOMA, V16, P249, DOI 10.1089/hyb.1997.16.249; Wang XY, 2000, J NEUROSCI, V20, P7037, DOI 10.1523/JNEUROSCI.20-18-07037.2000; Yeates KO, 2009, PEDIATRICS, V123, P735, DOI 10.1542/peds.2008-1056; ZHANG ET, 1990, J ANAT, V170, P111	41	14	15	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2016	11	12							e0167677	10.1371/journal.pone.0167677	http://dx.doi.org/10.1371/journal.pone.0167677			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EG7JB	28030563	gold, Green Published, Green Submitted			2022-12-27	WOS:000391222000017
J	Chiha, J; Mitchell, P; Gopinath, B; Burlutsky, G; Plant, A; Kovoor, P; Thiagalingam, A				Chiha, Joseph; Mitchell, Paul; Gopinath, Bamini; Burlutsky, George; Plant, Adam; Kovoor, Pramesh; Thiagalingam, Aravinda			Prediction of Coronary Artery Disease Extent and Severity Using Pulse Wave Velocity	PLOS ONE			English	Article							EXPERT CONSENSUS DOCUMENT; ANGIOGRAPHIC ANALYSIS; MYOCARDIAL-INFARCTION; SYNDROME-X; STIFFNESS; WOMEN; HEART; ANGINA; MEN; ATHEROSCLEROSIS	Background Pulse-wave velocity (PWV) measures aortic stiffness. It is an independent predictor of cardiovascular events and mortality, yet there is paucity in the literature on its association with the severity and extent of coronary artery disease (CAD). Methods To examine the utility of PWV in predicting CAD burden in men and women the PWV was determined in 344 patients (Men = 266, Women = 78) presenting for invasive coronary angiography for the assessment of suspected CAD. Pearson correlations and multivariate analysis were used to evaluate the relationship between these coronary scores, PWV and traditional cardiovascular risk factors. Results Compared to men, women with chest pain had lower mean Extent scores (19.2 vs. 35.6; p = 0.0001) and Gensini scores (23.6 vs. 41.9; p = 0.0001). PWV was similar between men and women (12.35 +/- 3.74 vs. 12.43 +/- 4.58; p = 0.88) and correlated with Extent score (r = 0.21, p = 0.0001) but not Gensini or vessel score (r = 0.03, p = 0.64 and r = 0.06, p = 0.26, respectively). PWV was associated with Extent score in men (B = 2.25 +/- 0.78, p = 0.004 for men and B = 1.50 +/- 0.88, p = 0.09 for women). It was not a predictor of Gensini score (B = -0.10, P = 0.90). Conclusion PWV correlates with the extent of CAD, as measured by the 'Extent' score in men more than women. However, it does not correlate with the severity of obstructive CAD in either gender.	[Chiha, Joseph; Kovoor, Pramesh; Thiagalingam, Aravinda] Univ Sydney, Westmead Millennium Inst, Ctr Heart Res, Sydney, NSW, Australia; [Mitchell, Paul; Gopinath, Bamini; Burlutsky, George; Plant, Adam] Univ Sydney, Westmead Millennium Inst, Dept Ophthalmol, Ctr Vis Res, Sydney, NSW, Australia	University of Sydney; Westmead Institute for Medical Research; University of Sydney; Westmead Institute for Medical Research	Chiha, J (corresponding author), Univ Sydney, Westmead Millennium Inst, Ctr Heart Res, Sydney, NSW, Australia.	chiha.j@gmail.com	Gopinath, Bamini/K-4286-2019; Stefanadis, Christodoulos/ABH-2232-2020; Mitchell, Paul/P-1498-2014	Gopinath, Bamini/0000-0003-3573-359X; Stefanadis, Christodoulos/0000-0001-5974-6454; 	Australian National Health and Medical Research Council [571012]; Westmead Millennium Institute, University of Sydney	Australian National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); Westmead Millennium Institute, University of Sydney(University of Sydney)	Funding was provided by the Australian National Health and Medical Research Council (Grant No. 571012); and the Westmead Millennium Institute, University of Sydney. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abhayaratna WP, 2006, AM J CARDIOL, V98, P1387, DOI 10.1016/j.amjcard.2006.06.035; Ben-Shlomo Y, 2014, J AM COLL CARDIOL, V63, P636, DOI 10.1016/j.jacc.2013.09.063; Bigi R, 2003, HEART, V89, P1009, DOI 10.1136/heart.89.9.1009; Bugiardini R, 2005, JAMA-J AM MED ASSOC, V293, P477, DOI 10.1001/jama.293.4.477; Coutinho T, 2011, JACC-CARDIOVASC IMAG, V4, P754, DOI 10.1016/j.jcmg.2011.04.011; DUCIMETIERE P, 1993, EUR HEART J, V14, P727, DOI 10.1093/eurheartj/14.6.727; Enbergs A, 2000, EUR HEART J, V21, P45, DOI 10.1053/euhj.1999.1763; Gehrie ER, 2009, AM HEART J, V158, P688, DOI 10.1016/j.ahj.2009.08.004; GENSINI GG, 1983, AM J CARDIOL, V51, P606, DOI 10.1016/S0002-9149(83)80105-2; HACKETT D, 1988, EUR HEART J, V9, P1317, DOI 10.1093/oxfordjournals.eurheartj.a062449; HERMILLER JB, 1992, CATHETER CARDIO DIAG, V25, P110, DOI 10.1002/ccd.1810250207; Hope SA, 2007, J HYPERTENS, V25, P2105, DOI 10.1097/HJH.0b013e3282a9be41; Jespersen L, 2012, EUR HEART J, V33, P734, DOI 10.1093/eurheartj/ehr331; Jones E, 2012, TRENDS CARDIOVAS MED, V22, P161, DOI 10.1016/j.tcm.2012.07.014; Jousilahti P, 1999, CIRCULATION, V99, P1165, DOI 10.1161/01.cir.99.9.1165; KEMP HG, 1986, J AM COLL CARDIOL, V7, P479, DOI 10.1016/S0735-1097(86)80456-9; Kreis AJ, 2009, MICROCIRCULATION, V16, P177, DOI 10.1080/10739680802458980; Kullo IJ, 2006, HYPERTENSION, V47, P174, DOI 10.1161/01.HYP.0000199605.35173.14; Lamendola P, 2010, INT J CARDIOL, V140, P197, DOI 10.1016/j.ijcard.2008.11.026; Laurent S, 2006, EUR HEART J, V27, P2588, DOI 10.1093/eurheartj/ehl254; Mancia G, 2007, EUR HEART J, V28, P1462, DOI [10.1093/eurheartj/eht151, 10.1093/eurheartj/ehm236]; Mattace-Raso FUS, 2010, EUR HEART J, V31, P2338, DOI 10.1093/eurheartj/ehq165; McLeod AL, 2004, J HYPERTENS, V22, P363, DOI 10.1097/00004872-200402000-00021; Merz CNB, 2011, CIRCULATION, V124, P1477, DOI 10.1161/CIRCULATIONAHA.110.974212; Neeland IJ, 2012, AM HEART J, V164, P547, DOI 10.1016/j.ahj.2012.07.007; Norgaz T, 2005, INT HEART J, V46, P639, DOI 10.1536/ihj.46.639; ORourke MF, 1996, J HYPERTENS, V14, pS147; Patel Manesh R, 2010, N Engl J Med, V362, P886, DOI 10.1056/NEJMoa0907272; Pepine CJ, 2010, J AM COLL CARDIOL, V55, P2825, DOI 10.1016/j.jacc.2010.01.054; QIAO JH, 1991, J AM COLL CARDIOL, V17, P1138, DOI 10.1016/0735-1097(91)90844-Y; RUMBERGER JA, 1994, AM J CARDIOL, V73, P1169, DOI 10.1016/0002-9149(94)90176-7; Sharaf BL, 2001, AM J CARDIOL, V87, P937, DOI 10.1016/S0002-9149(01)01424-2; SULLIVAN DR, 1990, AM HEART J, V119, P1262, DOI 10.1016/S0002-8703(05)80173-5; Van Bortel LM, 2012, J HYPERTENS, V30, P445, DOI 10.1097/HJH.0b013e32834fa8b0; Vlachopoulos C, 2010, J AM COLL CARDIOL, V55, P1318, DOI 10.1016/j.jacc.2009.10.061; Weber T, 2003, CURR PHARM DESIGN, V9, P1049, DOI 10.2174/1381612033455080; Weintraub WS, 2011, J AM COLL CARDIOL, V58, P202, DOI 10.1016/j.jacc.2011.05.001	37	10	11	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2016	11	12							e0168598	10.1371/journal.pone.0168598	http://dx.doi.org/10.1371/journal.pone.0168598			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI9QH	28005967	Green Submitted, Green Published, gold			2022-12-27	WOS:000392843200070
J	Kaliszewski, K; Strutynska-Karpinska, M; Zubkiewicz-Kucharska, A; Wojtczak, B; Domoslawski, P; Balcerzak, W; Lukienczuk, T; Forkasiewicz, Z				Kaliszewski, Krzysztof; Strutynska-Karpinska, Marta; Zubkiewicz-Kucharska, Agnieszka; Wojtczak, Beata; Domoslawski, Pawel; Balcerzak, Waldemar; Lukienczuk, Tadeusz; Forkasiewicz, Zdzislaw			Should the Prevalence of Incidental Thyroid Cancer Determine the Extent of Surgery in Multinodular Goiter?	PLOS ONE			English	Article							COMPLETION THYROIDECTOMY; SUBTOTAL THYROIDECTOMY; SURGICAL-MANAGEMENT; PROGNOSTIC-FACTORS; NONTOXIC GOITER; NODULAR GOITER; CARCINOMA; DISEASE; COMPLICATIONS; MALIGNANCY	Background The most appropriate surgical procedure for multinodular goiter (MNG) remains under debate. Incidental thyroid carcinoma (ITC) is often identified on histopathological examination after thyroidectomy performed for presumed benign MNG. Aim of the study The aim of the study was to determine the value of radical surgery for MNG patients considering the prevalence of ITC diagnosed postoperatively. Materials and Methods We conducted retrospective analysis of the medical records of 2,306 patients surgically treated for MNG between 2008 and 2013 at one center. None of the patients presented with any suspicion of malignancy, history of familial thyroid cancer, multiple endocrine neoplasia syndrome or previous head or neck radiation exposure. Results Among the 2,306 MNG patients, ITC was detected in 49 (2.12%) (44 women and 5 men, with average ages of 52.2 (21-79) and 55.6 (52-62), respectively). Papillary thyroid carcinoma was significantly more frequently observed than other types of ITC (p<0.00001). Among the MNG patients, 866 (37.5%) underwent total/near total surgery, 464 (20.1%) received subtotal thyroidectomy, and 701 (30.3%) received the Dunhill operation. The remaining 275 (11.9%) patients underwent a less radical procedure and were classified as "others." Among the 49 (100%) patients with ITC, 28 (57.1%) underwent radical surgery. Another 21 (42.9%) patients required completion surgery due to an insufficient primary surgical procedure. A total of 21 (2.42%) patients in the total/near total surgery group were diagnosed with ITC, as well as 16 (2.48%) in the subtotal thyroidectomy group and 12 (1.71%) in the Dunhill operation group; 21 (100%), 4 (25%) and 3 (25%) of these patients, respectively, underwent radical surgery; thus, 0 (0%), 12 (75%) and 9 (75%) required completion surgery. The prevalence rates of ITC were comparable between the radical and subtotal surgery groups (2.42% and 3.44%, respectively, p = 0.4046), and the prevalence was higher in the radical surgery group than in the Dunhill operation group (2.42% and 1.71%, respectively, p = 0.0873). A significant difference was observed between the group of patients who underwent total/near total surgery, among whom all of the patients with ITC (100%) received primary radical surgery, and the groups of patients who received the subtotal and Dunhill operations, among whom only 25% of the patients with ITC in each group received primary radical surgery (p<0.0001). Conclusions More radical procedures for MNG result in a lower risk of reoperation for ITC. The prevalence of ITC on postoperative histopathological examination should determine the extent of surgery in MNG patients. In the future, total/near total thyroidectomy should be considered for MNG patients due to the increased prevalence of ITC to avoid the necessity for reoperation.	[Kaliszewski, Krzysztof; Strutynska-Karpinska, Marta; Wojtczak, Beata; Domoslawski, Pawel; Balcerzak, Waldemar; Lukienczuk, Tadeusz; Forkasiewicz, Zdzislaw] Wroclaw Med Univ, Dept & Clin Gen Gastroenterol & Endocrine Surg 1, Wroclaw, Poland; [Zubkiewicz-Kucharska, Agnieszka] Wroclaw Med Univ, Dept Endocrinol & Diabetol Children & Adolescents, Wroclaw, Poland	Wroclaw Medical University; Wroclaw Medical University	Kaliszewski, K (corresponding author), Wroclaw Med Univ, Dept & Clin Gen Gastroenterol & Endocrine Surg 1, Wroclaw, Poland.	krzysztofkali@wp.pl	Zubkiewicz-Kucharska, Agnieszka/AAY-5957-2020	Zubkiewicz-Kucharska, Agnieszka/0000-0002-6641-6776; Domoslawski, Pawel/0000-0003-1903-0843; Kaliszewski, Krzysztof/0000-0002-3291-5294; Wojtczak, Beata/0000-0002-9953-0460				Bae JS, 2009, WORLD J SURG ONCOL, V7, DOI 10.1186/1477-7819-7-63; Bahl M, 2014, WORLD J SURG, V38, P1312, DOI 10.1007/s00268-013-2407-9; Baloch Z, 2013, J CLIN PATHOL, V66, P733, DOI 10.1136/jclinpath-2013-201626; Barczynski M, 2010, WORLD J SURG, V34, P1203, DOI 10.1007/s00268-010-0491-7; Baudin E, 1998, CANCER, V83, P553, DOI 10.1002/(SICI)1097-0142(19980801)83:3<553::AID-CNCR25>3.0.CO;2-U; Bergamaschi R, 1998, AM J SURG, V176, P71, DOI 10.1016/S0002-9610(98)00099-3; Bombil I, 2014, S AFR J SURG, V52, DOI 10.7196/SAJS.1970; Bononi M, 2000, INT SURG, V85, P190; Bradly DP, 2009, SURGERY, V146, P1099, DOI 10.1016/j.surg.2009.09.025; Brindle R, 2014, EJSO-EUR J SURG ONC, V40, P1528, DOI 10.1016/j.ejso.2014.05.005; CALABRO S, 1988, HEAD NECK-J SCI SPEC, V10, P235, DOI 10.1002/j.1930-2398.1988.tb00005.x; Cerci C, 2007, J POSTGRAD MED, V53, P157, DOI 10.4103/0022-3859.33855; Chao TC, 1997, WORLD J SURG, V21, P644, DOI 10.1007/s002689900287; Chun AR, 2015, ENDOCRINOL METAB, V30, P71, DOI 10.3803/EnM.2015.30.1.71; Ciftci F, 2015, INT J CLIN EXP MED, V8, P4596; Costamagna D, 2013, G CHIR, V34, P21; Delbridge L, 1999, ARCH SURG-CHICAGO, V134, P1389, DOI 10.1001/archsurg.134.12.1389; Ergin AB, 2014, AM J OTOLARYNG, V35, P784, DOI 10.1016/j.amjoto.2014.04.013; Gal Istvan, 2013, Magy Seb, V66, P245, DOI 10.1556/MaSeb.66.2013.5.3; GEERDSEN JP, 1986, ACTA MED SCAND, V220, P341; GEERDSEN JP, 1984, CLIN ENDOCRINOL, V21, P529, DOI 10.1111/j.1365-2265.1984.tb01391.x; Gilbert MR, 2012, OTOLARYNG HEAD NECK, V147, P647, DOI 10.1177/0194599812451559; Giles Y, 2004, ARCH SURG-CHICAGO, V139, P179, DOI 10.1001/archsurg.139.2.179; Gough IR, 2000, WORLD J SURG, V24, P962, DOI 10.1007/s002680010158; GOULD EA, 1965, ARCH SURG-CHICAGO, V90, P81; Haugen BR, 2016, THYROID, V26, P1, DOI 10.1089/thy.2015.0020; HAY ID, 1993, SURGERY, V114, P1050; Hoang JK, 2015, RADIOL CLIN N AM, V53, P145, DOI 10.1016/j.rcl.2014.09.002; Huang LY, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127354; John Anulekha Mary, 2014, Indian J Endocrinol Metab, V18, P410, DOI 10.4103/2230-8210.131211; Kang HW, 2004, THYROID, V14, P29, DOI 10.1089/105072504322783812; Karakoyun R, 2013, INT J CLIN EXP MED, V6, P922; KRAIMPS JL, 1993, SURG GYNECOL OBSTET, V176, P319; Lasithiotakis K, 2012, WORLD J SURG, V36, P1286, DOI 10.1007/s00268-012-1554-8; Liu Q, 1998, SURGERY, V123, P2, DOI 10.1067/msy.1998.83301; Lombardi C P, 2007, Minerva Chir, V62, P395; Luo J, 2012, J SURG RES, V174, P207, DOI 10.1016/j.jss.2011.11.1035; Menegaux F, 1999, SURGERY, V126, P479, DOI 10.1016/S0039-6060(99)70088-7; Miccoli P, 2006, ANZ J SURG, V76, P123, DOI 10.1111/j.1445-2197.2006.03667.x; Mishra A, 2001, WORLD J SURG, V25, P307, DOI 10.1007/s002680020100; Nayan S, 2014, OTOLARYNG HEAD NECK, V151, P190, DOI 10.1177/0194599814530861; Nikiforova MN, 2003, J CLIN ENDOCR METAB, V88, P5399, DOI 10.1210/jc.2003-030838; Ozbas S, 2005, ENDOCR J, V52, P199, DOI 10.1507/endocrj.52.199; Pacini F, 2001, THYROID, V11, P877, DOI 10.1089/105072501316973145; Pappalardo G, 1998, EUR J SURG, V164, P501; Pattou F, 1998, WORLD J SURG, V22, P718, DOI 10.1007/s002689900459; Pedrazzini L, 2013, MINERVA ENDOCRINOL, V38, P269; Pezzullo L, 1997, EUR J SURG ONCOL, V23, P215, DOI 10.1016/S0748-7983(97)92340-4; Preece J, 2014, SURGERY, V156, P1153, DOI 10.1016/j.surg.2014.04.025; REEVE TS, 1987, ANN SURG, V206, P782, DOI 10.1097/00000658-198712000-00016; Rios A, 2005, ARCH SURG-CHICAGO, V140, P49, DOI 10.1001/archsurg.140.1.49; ROJDMARK J, 1995, EUR J SURG, V161, P725; Sachmechi I, 2000, Endocr Pract, V6, P5; Sakorafas GH, 2007, J POSTGRAD MED, V53, P23, DOI 10.4103/0022-3859.30323; Sakorafas GH, 2005, CANCER TREAT REV, V31, P423, DOI 10.1016/j.ctrv.2005.04.009; Scheffler P, 2014, THYROID, V24, P852, DOI 10.1089/thy.2013.0191; Senchenkov A, 2004, SURG CLIN N AM, V84, P973, DOI 10.1016/j.suc.2004.04.007; SHAH JP, 1992, AM J SURG, V164, P658, DOI 10.1016/S0002-9610(05)80729-9; SIMONOWITZ D, 1976, ARCH SURG-CHICAGO, V111, P477; Slijepcevic N, 2015, BMC CANCER, V15, DOI 10.1186/s12885-015-1352-4; Smith JJ, 2013, J AM COLL SURGEONS, V216, P571, DOI 10.1016/j.jamcollsurg.2012.12.022; Tollin SR, 2000, THYROID, V10, P235, DOI 10.1089/thy.2000.10.235; Untch BR, 2014, ANN SURG ONCOL, V21, P1374, DOI 10.1245/s10434-013-3428-1; Wilhelm S, 2014, SURG CLIN N AM, V94, P485, DOI 10.1016/j.suc.2014.02.004; Wilson DB, 1998, AM SURGEON, V64, P674; Yaylali O, 2014, INDIAN J CANCER, V51, P236, DOI 10.4103/0019-509X.146737; Yoshida A, 2014, WORLD J SURG, V38, P2311, DOI 10.1007/s00268-014-2536-9; Zaraca F, 2000, Chir Ital, V52, P41	68	17	18	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2016	11	12							e0168654	10.1371/journal.pone.0168654	http://dx.doi.org/10.1371/journal.pone.0168654			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI9QH	28005977	Green Published, gold, Green Submitted			2022-12-27	WOS:000392843200075
J	Yuan, HF; Wang, W; Hu, B; Pan, CK; Chen, ML; Ke, LL; Yang, LR; Chen, JM				Yuan, Huifang; Wang, Wei; Hu, Bin; Pan, Changkun; Chen, Mingliang; Ke, Linlin; Yang, Lirong; Chen, Jianming			Cloning and Functional Analysis of Pax6 from the Hydrothermal Vent Tubeworm Ridgeia piscesae	PLoS One			English	Article							MEXICAN BLIND CAVEFISH; EYE-SPECIFIC ENHANCER; TWIN-OF-EYELESS; FINE-STRUCTURE; SINE-OCULIS; PLATYNEREIS-DUMERILII; LINEAGE SPECIFICATION; ECTOPIC EYES; ADULT EYES; CELL-DEATH	The paired box 6 (Pax6) gene encodes a transcription factor essential for eye development in a wide range of animal lineages. Here we describe the cloning and characterization of Pax6 gene from the blind hydrothermal vent tubeworm Ridgeia piscesae (RpPax6). The deduced RpPax6 protein shares extensive sequence identity with Pax6 proteins from other species and contains both the paired domain and a complete homeodomain. Phylogenetic analysis indicates that it clusters with the corresponding sequence from the closely related species Platynereis dumerilii (P. dumerilii) of Annelida. Luciferase reporter assay indicate that RpPax6 protein suppresses the transcription of sine oculis (so) in D. melanogaster, interfering with the C-terminal of RpPax6. Taking advantage of Drosophila model, we show that RpPax6 expression is not able to rescue small eye phenotype of ey(2) mutant, only to cause a more severe headless phenotype. In addition, RpPax6 expression induced apoptosis and inhibition of apoptosis can partially rescue RpPax6-induced headless phenotype. We provide evidence RpPax6 plays at least two roles: it blocks the expression of later-acting transcription factors in the eye development cascade, and it promotes cell apoptosis. Our results indicate alternation of the Pax6 function may be one of the possible causes that lead the eye absence in vestimentiferan tubeworms.	[Yuan, Huifang; Wang, Wei; Hu, Bin; Pan, Changkun; Chen, Mingliang; Ke, Linlin; Yang, Lirong; Chen, Jianming] State Ocean Adm, Inst Oceanog 3, Key Lab Marine Biogenet Resources, Xiamen, Fujian Province, Peoples R China; [Pan, Changkun] Ningbo Univ, Sch Marine Sci, Ningbo, Zhejiang, Peoples R China	State Oceanic Administration; Ningbo University	Wang, W; Chen, JM (corresponding author), State Ocean Adm, Inst Oceanog 3, Key Lab Marine Biogenet Resources, Xiamen, Fujian Province, Peoples R China.	wangw.sz@tio.org.cn; chenjm@xmu.edu.cn			Scientific Research Foundation of Third Institute of Oceanography (SOA) [2015001]; China Ocean Mineral Resources R & D Association (COMRA) [DY125-22-QY-05, DY-125-15-T-08]; Natural Science Foundation of China [31271567, 31272684]; Fujian Marine Hi-tech Industry Program [2014-05]; Aquatic Sanxin Engineering Project of Jiangsu Province [D2015-11-5]	Scientific Research Foundation of Third Institute of Oceanography (SOA); China Ocean Mineral Resources R & D Association (COMRA); Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fujian Marine Hi-tech Industry Program; Aquatic Sanxin Engineering Project of Jiangsu Province	This work was supported by the Scientific Research Foundation of Third Institute of Oceanography (SOA, grant: 2015001), the China Ocean Mineral Resources R & D Association (COMRA, grants: DY125-22-QY-05 and DY-125-15-T-08), the Natural Science Foundation of China (grants: 31271567 and 31272684), the Fujian Marine Hi-tech Industry Program (grant: 2014-05), and the Aquatic Sanxin Engineering Project of Jiangsu Province (grant: D2015-11-5). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABRAMS JM, 1993, DEVELOPMENT, V117, P29; Arendt D, 2002, DEVELOPMENT, V129, P1143; Bartolomaeus Thomas, 1993, Microfauna Marina, V8, P99; Behrens M, 1997, MOL BIOL EVOL, V14, P299, DOI 10.1093/oxfordjournals.molbev.a025765; Blake JA, 2014, DEVELOPMENT, V141, P737, DOI 10.1242/dev.091785; Bouchard M, 2002, GENE DEV, V16, P2958, DOI 10.1101/gad.240102; BRANDENBURGER JL, 1973, Z ZELLFORSCH MIK ANA, V142, P89, DOI 10.1007/BF00306706; Buckingham M, 2007, ANNU REV CELL DEV BI, V23, P645, DOI 10.1146/annurev.cellbio.23.090506.123438; Callaerts P, 1997, ANNU REV NEUROSCI, V20, P483, DOI 10.1146/annurev.neuro.20.1.483; CARRIERE C, 1995, CELL GROWTH DIFFER, V6, P1531; Caullery M, 1914, CR HEBD ACAD SCI, V158, P2014; Chen R, 1997, CELL, V91, P893, DOI 10.1016/S0092-8674(00)80481-X; Chow RL, 1999, DEVELOPMENT, V126, P4213; Czerny T, 1999, MOL CELL, V3, P297, DOI 10.1016/S1097-2765(00)80457-8; Dahl E, 1997, BIOESSAYS, V19, P755, DOI 10.1002/bies.950190905; EAKIN RM, 1965, Z ZELLFORSCH MIK ANA, V68, P278, DOI 10.1007/BF00342434; Friedrich M, 2006, ARTHROPOD STRUCT DEV, V35, P357, DOI 10.1016/j.asd.2006.08.010; Gage J. D., 1991, DEEP SEA BIOL NATURA; Gehring WJ, 2005, J HERED, V96, P171, DOI 10.1093/jhered/esi027; Gehring WJ, 1999, TRENDS GENET, V15, P371, DOI 10.1016/S0168-9525(99)01776-X; Glardon S, 1997, DEVELOPMENT, V124, P817; HALDER G, 1995, SCIENCE, V267, P1788, DOI 10.1126/science.7892602; Halder G, 1998, DEVELOPMENT, V125, P2181; Hauck B, 1999, P NATL ACAD SCI USA, V96, P564, DOI 10.1073/pnas.96.2.564; Heanue TA, 1999, GENE DEV, V13, P3231, DOI 10.1101/gad.13.24.3231; HERMANS CO, 1969, Z ZELLFORSCH MIK ANA, V100, P325, DOI 10.1007/BF00571490; HERMANS CO, 1974, Z MORPHOL TIERE, V79, P245; Herring PJ, 2002, BIOL DEEP OCEAN; HILL RE, 1991, NATURE, V354, P522, DOI 10.1038/354522a0; Ikeda K, 2002, MOL CELL BIOL, V22, P6759, DOI 10.1128/MCB.22.19.6759-6766.2002; Jacobsson L, 2009, MOL GENET GENOMICS, V282, P217, DOI 10.1007/s00438-009-0458-2; Jeffery WR, 2005, J HERED, V96, P185, DOI 10.1093/jhered/esi028; Jeffery WR, 2003, INTEGR COMP BIOL, V43, P531, DOI 10.1093/icb/43.4.531; Jeffery WR, 1998, AM ZOOL, V38, P685; Jones ML., 1985, P BIOL SOC WASH, V6, P117; Jordanova A, 2006, NAT GENET, V38, P197, DOI 10.1038/ng1727; Karim FD, 1998, DEVELOPMENT, V125, P1; KOJIMA S, 1993, J MOL EVOL, V37, P66; Kronhamn J, 2002, DEVELOPMENT, V129, P1015; Kumar S, 2004, BRIEF BIOINFORM, V5, P150, DOI 10.1093/bib/5.2.150; Lacalli TC, 1996, PHILOS T ROY SOC B, V351, P243, DOI 10.1098/rstb.1996.0022; Land MF, 2002, ANIMAL EYES; Leys SP, 2001, BIOL BULL-US, V201, P323, DOI 10.2307/1543611; Lionakis MS, 2005, J INFECT DIS, V191, P1188, DOI 10.1086/428587; Little CTS, 1997, NATURE, V385, P146, DOI 10.1038/385146a0; Loosli F, 1996, P NATL ACAD SCI USA, V93, P2658, DOI 10.1073/pnas.93.7.2658; Lynch VJ, 2011, J EXP ZOOL PART B, V316B, P93, DOI 10.1002/jez.b.21373; McMullin ER, 2003, SYMBIOSIS, V34, P1; Morante J, 2011, DEVELOPMENT, V138, P687, DOI 10.1242/dev.056069; Niimi T, 1999, DEVELOPMENT, V126, P2253; Nordstrom K, 2003, P ROY SOC B-BIOL SCI, V270, P2349, DOI 10.1098/rspb.2003.2504; Nyholm SV, 2008, BIOL BULL-US, V214, P255, DOI 10.2307/25470667; Ohto H, 1999, MOL CELL BIOL, V19, P6815; Onuma Y, 2002, P NATL ACAD SCI USA, V99, P2020, DOI 10.1073/pnas.022626999; Pauli T, 2005, DEVELOPMENT, V132, P2771, DOI 10.1242/dev.01841; Pignoni F, 1997, CELL, V91, P881, DOI 10.1016/S0092-8674(00)80480-8; Punzo C, 2004, DEVELOPMENT, V131, P3943, DOI 10.1242/dev.01278; Punzo C, 2001, GENE DEV, V15, P1716, DOI 10.1101/gad.196401; Purschke G, 2006, ARTHROPOD STRUCT DEV, V35, P211, DOI 10.1016/j.asd.2006.07.005; Purschke G, 2015, ACTA ZOOL-STOCKHOLM, V96, P67, DOI 10.1111/azo.12052; Raupach MJ, 2009, P ROY SOC B-BIOL SCI, V276, P799, DOI 10.1098/rspb.2008.1063; Relaix F, 2005, NATURE, V435, P948, DOI 10.1038/nature03594; Relaix F, 2015, SEMIN CELL DEV BIOL, V44, P62, DOI 10.1016/j.semcdb.2015.10.036; REX MA, 1981, ANNU REV ECOL SYST, V12, P331, DOI 10.1146/annurev.es.12.110181.001555; RHODE B, 1993, J MORPHOL, V217, P327, DOI 10.1002/jmor.1052170307; RHODE B, 1992, J MORPHOL, V212, P71, DOI 10.1002/jmor.1052120108; Riesenberg AN, 2009, GENESIS, V47, P175, DOI 10.1002/dvg.20479; Ruan LW, 2008, EXTREMOPHILES, V12, P735, DOI 10.1007/s00792-008-0172-8; Schulze A, 2003, ZOOL SCR, V32, P321, DOI 10.1046/j.1463-6409.2003.00119.x; Suschenko D, 2009, ZOOMORPHOLOGY, V128, P75, DOI 10.1007/s00435-008-0075-3; Tomarev SI, 1997, P NATL ACAD SCI USA, V94, P2421, DOI 10.1073/pnas.94.6.2421; Tunnicliffe V, 1998, ADV MAR BIOL, V34, P353, DOI 10.1016/S0065-2881(08)60213-8; TUNNICLIFFE V, 1991, OCEANOGR MAR BIOL, V29, P319; Urcuyo IA, 2003, DEEP-SEA RES PT I, V50, P763, DOI 10.1016/S0967-0637(03)00061-X; van Heyningen V, 2002, HUM MOL GENET, V11, P1161, DOI 10.1093/hmg/11.10.1161; von Dohren J, 2007, ZOOLOGY, V110, P430, DOI 10.1016/j.zool.2007.07.006; WALTHER C, 1991, DEVELOPMENT, V113, P1435; Warrant E, 2004, J COMP PHYSIOL A, V190, P765, DOI 10.1007/s00359-004-0546-z; Weasner BM, 2009, DEV BIOL, V334, P492, DOI 10.1016/j.ydbio.2009.04.027; Xu PX, 1997, DEVELOPMENT, V124, P219; YAMAMOTO T, 1965, J CELL BIOL, V25, P345, DOI 10.1083/jcb.25.2.345; Yamamoto Y, 2002, METHODS, V28, P420, DOI 10.1016/S1046-2023(02)00261-X; Zeidler D, 2004, P NATL ACAD SCI USA, V101, P15811, DOI 10.1073/pnas.0404536101; Zhang TY, 2006, DEVELOPMENT, V133, P4881, DOI 10.1242/dev.02669; Zimmerman JE, 2000, GENETICS, V154, P237	85	0	0	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2016	11	12							e0168579	10.1371/journal.pone.0168579	http://dx.doi.org/10.1371/journal.pone.0168579			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI9QH	28005979	gold, Green Submitted, Green Published			2022-12-27	WOS:000392843200067
J	Baseia, IG; Silva, BDB; Ishikawa, NK; Soares, JVC; Franca, IF; Ushijima, S; Maekawa, N; Martin, MP				Baseia, Iuri G.; Silva, Bianca D. B.; Ishikawa, Noemia K.; Soares, Joao V. C.; Franca, Isadora F.; Ushijima, Shuji; Maekawa, Nitaro; Martin, Maria P.			Discovery or Extinction of New Scleroderma Species in Amazonia?	PLOS ONE			English	Article							ECTOMYCORRHIZAL FUNGI; GASTEROID FUNGI; DIVERSITY; RECORDS; FOREST; PLANT; DEFORESTATION; CONSERVATION; BIODIVERSITY; EVOLUTION	The Amazon Forest is a hotspot of biodiversity harboring an unknown number of undescribed taxa. Inventory studies are urgent, mainly in the areas most endangered by human activities such as extensive dam construction, where species could be in risk of extinction before being described and named. In 2015, intensive studies performed in a few locations in the Brazilian Amazon rainforest revealed three new species of the genus Scleroderma: S. anomalosporum, S. camassuense and S. duckei. The two first species were located in one of the many areas flooded by construction of hydroelectric dams throughout the Amazon; and the third in the Reserva Florestal Adolpho Ducke, a protected reverse by the INPA. The species were identified through morphology and molecular analyses of barcoding sequences (Internal Transcribed Spacer nrDNA). Scleroderma anomalosporum is characterized mainly by the smooth spores under LM in mature basidiomata (under SEM with small, unevenly distributed granules, a characteristic not observed in other species of the genus), the large size of the basidiomata, up to 120 mm diameter, and the stelliform dehiscence; S. camassuense mainly by the irregular to stellate dehiscence, the subreticulated spores and the bright sulfur-yellow colour, and Scleroderma duckei mainly by the verrucose exoperidium, stelliform dehiscence, and verrucose spores. Description, illustration and affinities with other species of the genus are provided.	[Baseia, Iuri G.] Univ Fed Rio Grande do Norte, Dept Bot & Zool, Natal, RN, Brazil; [Baseia, Iuri G.; Silva, Bianca D. B.] Univ Fed Bahia, Inst Biol, Dept Bot, Salvador, BA, Brazil; [Ishikawa, Noemia K.] Inst Nacl de Pesquisas da Amazonia, Coordenacao Biodiversidade, Manaus, Amazonas, Brazil; [Soares, Joao V. C.] Inst Nacl de Pesquisas da Amazonia, Div Suporte Estacoes & Reservas, Manaus, Amazonas, Brazil; [Franca, Isadora F.] Univ Fed Para, Fac Ciencias Biol, Campus Univ Altamira, Altamira, Para, Brazil; [Ushijima, Shuji; Maekawa, Nitaro] Tottori Univ, Fac Agr, Fungus Mushroom Resource & Res Ctr, Tottori, Japan; [Martin, Maria P.] CSIC, RJB, Dept Micol, Madrid, Spain	Universidade Federal do Rio Grande do Norte; Universidade Federal da Bahia; Institute Nacional de Pesquisas da Amazonia; Institute Nacional de Pesquisas da Amazonia; Universidade Federal do Para; Tottori University; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Real Jardin Botanico de Madrid	Martin, MP (corresponding author), CSIC, RJB, Dept Micol, Madrid, Spain.	maripaz@rjb.csic.es	Martín, María/HDL-9512-2022; Martín, María/H-8069-2012	Martín, María/0000-0002-1235-4418; Silva, Bianca/0000-0002-8920-0652	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq-Brazil) [PVE/407474/2013-7, PPBio/457476/2012-5]; Fundacao de Amparo a Pesquisas do Estado do Amazonas (FAPEAM-Brazil); Centro de Estudos Integrados da Biodiversidade Amazonica	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq-Brazil)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Fundacao de Amparo a Pesquisas do Estado do Amazonas (FAPEAM-Brazil); Centro de Estudos Integrados da Biodiversidade Amazonica	We are grateful to the Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq-Brazil, process PVE/407474/2013-7 and PPBio/457476/2012-5), and Fundacao de Amparo a Pesquisas do Estado do Amazonas (FAPEAM-Brazil) for the financial support; as well as to Centro de Estudos Integrados da Biodiversidade Amazonica.	Alfredo DS, 2012, MYCOSPHERE, V3, P294, DOI 10.5943/mycosphere/3/3/4; Alfredo DS, 2012, MYCOSPHERE, V3, P66, DOI 10.5943/mycosphere/3/1/8; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; da Silva BDB, 2013, NOVA HEDWIGIA, V96, P445, DOI 10.1127/0029-5035/2013/0089; Baseis I. G., 2000, Acta Botanica Brasilica, V14, P181; Benchimol M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129818; Binder M, 2002, MYCOLOGIA, V94, P85, DOI 10.2307/3761848; Blackwell M, 2011, AM J BOT, V98, P426, DOI 10.3732/ajb.1000298; BONONI V L R, 1981, Rickia, V9, P37; Brook BW, 2006, BIOTROPICA, V38, P302, DOI 10.1111/j.1744-7429.2006.00141.x; Cabral TS, 2015, MYCOTAXON, V130, P315, DOI 10.5248/130.315; Cabral TS, 2014, PHYTOTAXA, V183, P239, DOI 10.11646/phytotaxa.183.4.3; Calonge F.D., 1998, FL MYCOL IBER, V3, P1; Cameron SA, 2011, P NATL ACAD SCI USA, V108, P662, DOI 10.1073/pnas.1014743108; Casadevall A, 2005, FUNGAL GENET BIOL, V42, P98, DOI 10.1016/j.fgb.2004.11.008; Cisneros E, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0136402; Clement CR, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004564; Cochrane G, 2011, NUCLEIC ACIDS RES, V39, pD15, DOI 10.1093/nar/gkq1150; Cortez V.G., 2011, J YEAST FUNGAL RES, V2, P44; Cracraft J, 1985, ORNITHOLOGICAL MONOG, V36, P49, DOI DOI 10.2307/40168278; Crous PW, 2016, PERSOONIA, V36, P316, DOI 10.3767/003158516X692185; Drechsler-Santos ER, 2008, MYCOTAXON, V104, P9; Fearnside PM, 2008, ECOL SOC, V13; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; Finer M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035126; Fisher MC, 2012, NATURE, V484, P186, DOI 10.1038/nature10947; Frick WF, 2010, SCIENCE, V329, P679, DOI 10.1126/science.1188594; GARDES M, 1993, MOL ECOL, V2, P113, DOI 10.1111/j.1365-294X.1993.tb00005.x; Gargas A, 2009, MYCOTAXON, V108, P147, DOI 10.5248/108.147; Giachini AJ, 2000, MYCOLOGIA, V92, P1166, DOI 10.2307/3761484; Gibbons JW, 2000, BIOSCIENCE, V50, P653, DOI 10.1641/0006-3568(2000)050[0653:TGDORD]2.0.CO;2; Grgurinovic C.A., 1997, LARGER FUNGI S AUSTR; Gurgel FE, 2008, MYCOTAXON, V105, P399; Guzman G, 2004, MYCOLOGIA, V96, P1370, DOI 10.2307/3762153; GUZMAN G, 1970, Darwiniana (San Isidro), V16, P233; Guzman G, 2000, MYCOLOGIA, V92, P174, DOI 10.2307/3761461; Guzman G, 2013, REV MEX BIODIVERS, V84, pS173, DOI 10.7550/rmb.31979; Haffer J, 2008, BRAZ J BIOL, V68, P917, DOI 10.1590/S1519-69842008000500003; Hanson MA, 2012, SCIENCE, V335, P851, DOI [10.1126/science.1244693, 10.1126/science.1215904]; Hawksworth DL, 1997, PHYTOPATHOLOGY, V87, P888, DOI 10.1094/PHYTO.1997.87.9.888; Hawksworth DL, 2001, MYCOL RES, V105, P1422, DOI 10.1017/S0953756201004725; Hayes TB, 2010, J EXP BIOL, V213, P921, DOI 10.1242/jeb.040865; Hennings P., 1904, HEDWIGIA, V43, P154; Hopkins MJG, 2007, J BIOGEOGR, V34, P1400, DOI 10.1111/j.1365-2699.2007.01737.x; Huelsenbeck JP, 2000, GENETICS, V154, P1879; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Hyde KD, 2001, MYCOL RES, V105, P1514, DOI 10.1017/S0953756201004889; Kahn JR, 2014, ENERGIES, V7, P6063, DOI 10.3390/en7096063; Kirk P., 2008, Ainsworth and Bisby�s Dictionary of the Fungi, DOI 10.1079/9780851998268.0000; KORNERUP A., 1967, Methuen handbook of colour.; Kumla J, 2013, MYCOTAXON, V123, P1, DOI 10.5248/123.1; Ladle R., 2013, FRONT BIOGEOGR, V5, P103; Larget B, 1999, MOL BIOL EVOL, V16, P750, DOI 10.1093/oxfordjournals.molbev.a026160; Lees AC, 2016, BIODIVERS CONSERV, V25, P451, DOI 10.1007/s10531-016-1072-3; Leite AG, 2011, MYCOTAXON, V118, P383, DOI 10.5248/118.383; Lorch JM, 2011, NATURE, V480, P376, DOI 10.1038/nature10590; Luizao FJ, 2002, FLORESTA TROPICAL UM; Lutzoni F, 2004, AM J BOT, V91, P1446, DOI 10.3732/ajb.91.10.1446; Maia Leonor C., 2015, Rodriguésia, V66, P1033, DOI 10.1590/2175-7860201566407; Martin MP, 2000, LICHENOLOGIST, V32, P189, DOI 10.1006/lich.1999.0254; Meijer AAR de, 2006, B MUSEU BOT ANICO MU, V68, P1; Miller M. A., 2010, CIPRES PORTALS; Milliken W., 2011, KEW B, V65, P1; Mittermeier RA, 1998, CONSERV BIOL, V12, P516, DOI 10.1046/j.1523-1739.1998.012003516.x; Nilsson RH, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000059; Page RDM, 1996, COMPUT APPL BIOSCI, V12, P357; Phosri C, 2009, AN JARDIN BOT MADRID, V66, P83, DOI 10.3989/ajbm.2199; Pringle CM, 2000, BIOSCIENCE, V50, P807, DOI 10.1641/0006-3568(2000)050[0807:REOHAO]2.0.CO;2; RICK J., 1961, BRASILIA IHERINGIA, V9, P451; RODRIGUEZ F, 1990, J THEOR BIOL, V142, P485, DOI 10.1016/S0022-5193(05)80104-3; Roy M, 2016, BIOTROPICA, V48, P90, DOI 10.1111/btp.12297; Rusevska K, 2014, TURK J BOT, V38, P375, DOI 10.3906/bot-1301-36; Rylands A.B., 2002, WILDERNESS EARTHS LA, P56; Sobestiansky G, 2005, BRAZ ARCH BIOL TECHN, V48, P437, DOI 10.1590/S1516-89132005000300015; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Swofford D.L, 1998, PAUP 4 0 PHYLOGENETI; Tabarelli M, 2005, CONSERV BIOL, V19, P695, DOI 10.1111/j.1523-1739.2005.00694.x; TERBORGH J, 1990, ECOL MONOGR, V60, P213, DOI 10.2307/1943045; THIOLLAY JM, 1994, J TROP ECOL, V10, P449, DOI 10.1017/S0266467400008154; Tibbett M, 2002, ANN BOT-LONDON, V89, P783, DOI 10.1093/aob/mcf129; Trierveiler-Pereira L, 2009, MYCOTAXON, V110, P73, DOI 10.5248/110.73; Veresoglou SD, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9862; Viegas A. P., 1945, BRAGANTIA, V5, P583; Vieira ICG, 2008, BRAZ J BIOL, V68, P949, DOI 10.1590/S1519-69842008000500004; Watling R, 2004, MEM NEW YORK BOTAN G, V89, P93; White TJ, 1990, AMPLIFICATION DIRECT, V18, P315; Wilson AW, 2012, NEW PHYTOL, V194, P1079, DOI 10.1111/j.1469-8137.2012.04109.x	87	10	13	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2016	11	12							e0167879	10.1371/journal.pone.0167879	http://dx.doi.org/10.1371/journal.pone.0167879			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI9TW	28002414	Green Published, Green Submitted, gold			2022-12-27	WOS:000392853100024
J	Savage, AF; Kolev, NG; Franklin, JB; Vigneron, A; Aksoy, S; Tschudi, C				Savage, Amy F.; Kolev, Nikolay G.; Franklin, Joseph B.; Vigneron, Aurelien; Aksoy, Serap; Tschudi, Christian			Transcriptome Profiling of Trypanosoma brucei Development in the Tsetse Fly Vector Glossina morsitans	PLOS ONE			English	Article							VARIANT SURFACE GLYCOPROTEIN; ADENYLATE CYCLASES; GENE-EXPRESSION; LIFE-CYCLE; AFRICAN TRYPANOSOMES; ANTIGEN REPERTOIRE; STAGE; DIFFERENTIATION; PROTEINS; RHODESIENSE	African trypanosomes, the causative agents of sleeping sickness in humans and nagana in animals, have a complex digenetic life cycle between a mammalian host and an insect vector, the blood-feeding tsetse fly. Although the importance of the insect vector to transmit the disease was first realized over a century ago, many aspects of trypanosome development in tsetse have not progressed beyond a morphological analysis, mainly due to considerable challenges to obtain sufficient material for molecular studies. Here, we used high-throughput RNA-Sequencing (RNA-Seq) to profile Trypanosoma brucei transcript levels in three distinct tissues of the tsetse fly, namely the midgut, proventriculus and salivary glands. Consistent with current knowledge and providing a proof of principle, transcripts coding for procyclin isoforms and several components of the cytochrome oxidase complex were highly up-regulated in the midgut transcriptome, whereas transcripts encoding metacyclic VSGs (mVSGs) and the surface coat protein brucei alanine rich protein or BARP were extremely up-regulated in the salivary gland transcriptome. Gene ontology analysis also supported the upregulation of biological processes such as DNA metabolism and DNA replication in the proventriculus transcriptome and major changes in signal transduction and cyclic nucleotide metabolism in the salivary gland transcriptome. Our data highlight a small repertoire of expressed mVSGs and potential signaling pathways involving receptor-type adenylate cyclases and members of a surface carboxylate transporter family, called PADs (Proteins Associated with Differentiation), to cope with the changing environment, as well as RNA-binding proteins as a possible global regulators of gene expression.	[Savage, Amy F.; Kolev, Nikolay G.; Vigneron, Aurelien; Aksoy, Serap; Tschudi, Christian] Yale Univ, Sch Publ Hlth, Dept Epidemiol Microbial Dis, New Haven, CT USA; [Franklin, Joseph B.] Yale Univ, Sch Med, Dept Cell Biol, New Haven, CT 06510 USA; [Savage, Amy F.] Bard Coll, Dept Biol, Annandale On Hudson, NY USA; [Franklin, Joseph B.] US FDA, 10903 New Hampshire Ave, Silver Spring, MD USA	Yale University; Yale University; US Food & Drug Administration (FDA)	Aksoy, S; Tschudi, C (corresponding author), Yale Univ, Sch Publ Hlth, Dept Epidemiol Microbial Dis, New Haven, CT USA.	serap.aksoy@yale.edu; christian.tschudi@yale.edu	Aksoy, Serap/K-2244-2019; Vigneron, Aurélien/G-7268-2011	Aksoy, Serap/0000-0001-9941-143X; Vigneron, Aurélien/0000-0003-4986-6465	National Institutes of Health [AI051584, AI076879, AI028798, AI110325]; Ambrose-Monell Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI076879, R01AI051584, R01AI028798, R01AI110325] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ambrose-Monell Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by National Institutes of Health (http://www.nih.gov) grants AI051584 and AI076879 to S.A. and AI028798 and AI110325 to C.T., and by the Ambrose-Monell Foundation (http://www.monellfoundation.org/) to S.A. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acosta-Serrano A, 2001, P NATL ACAD SCI USA, V98, P1513, DOI 10.1073/pnas.041611698; ALARCON CM, 1994, MOL CELL BIOL, V14, P5579, DOI 10.1128/MCB.14.8.5579; Alexandre S, 1996, MOL BIOCHEM PARASIT, V77, P173, DOI 10.1016/0166-6851(96)02591-1; ALEXANDRE S, 1990, MOL BIOCHEM PARASIT, V43, P279, DOI 10.1016/0166-6851(90)90152-C; Alsford S, 2012, NATURE, V482, P232, DOI 10.1038/nature10771; Archer SK, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000565; Barry JD, 1998, MOL BIOCHEM PARASIT, V91, P93, DOI 10.1016/S0166-6851(97)00193-X; BARRY JD, 1983, NATURE, V306, P699, DOI 10.1038/306699a0; Blankenberg D, 2010, BIOINFORMATICS, V26, P1783, DOI 10.1093/bioinformatics/btq281; BRINGAUD F, 1992, MOL BIOCHEM PARASIT, V52, P111, DOI 10.1016/0166-6851(92)90040-Q; CAPALDI RA, 1990, ANNU REV BIOCHEM, V59, P569, DOI 10.1146/annurev.bi.59.070190.003033; Dean S, 2009, NATURE, V459, P213, DOI 10.1038/nature07997; Dyer NA, 2013, TRENDS PARASITOL, V29, P188, DOI 10.1016/j.pt.2013.02.003; Giardine B, 2005, GENOME RES, V15, P1451, DOI 10.1101/gr.4086505; Ginger ML, 2002, EUKARYOT CELL, V1, P1000, DOI 10.1128/EC.1.6.1000-1009.2002; Goecks J, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-8-r86; GRAHAM SV, 1995, MOL CELL BIOL, V15, P5945; Graham SV, 1999, MOL BIOCHEM PARASIT, V103, P141, DOI 10.1016/S0166-6851(99)00128-0; Gunzl A, 2010, EUKARYOT CELL, V9, P1159, DOI 10.1128/EC.00113-10; Hendriks EF, 2001, EMBO J, V20, P6700, DOI 10.1093/emboj/20.23.6700; Horn D, 2014, MOL BIOCHEM PARASIT, V195, P123, DOI 10.1016/j.molbiopara.2014.05.001; Imhoft S, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004493; Jackson AP, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002121; Kolev NG, 2014, CELL MICROBIOL, V16, P482, DOI 10.1111/cmi.12268; Kolev NG, 2012, SCIENCE, V338, P1352, DOI 10.1126/science.1229641; Kolev NG, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001090; LENARDO MJ, 1984, P NATL ACAD SCI-BIOL, V81, P6642, DOI 10.1073/pnas.81.21.6642; LEWIS EA, 1947, ANN TROP MED PARASIT, V41, P6, DOI 10.1080/00034983.1947.11685305; Ling AS, 2011, J BIOL CHEM, V286, P20152, DOI 10.1074/jbc.M110.139261; MacGregor P, 2012, NAT REV MICROBIOL, V10, P431, DOI 10.1038/nrmicro2779; Mani J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022463; Oberholzer M, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M111.010538; Ooi Cher-Pheng, 2013, Front Cell Infect Microbiol, V3, P71, DOI 10.3389/fcimb.2013.00071; PAINDAVOINE P, 1992, MOL CELL BIOL, V12, P1218, DOI 10.1128/MCB.12.3.1218; PAYS E, 1989, CELL, V57, P835, DOI 10.1016/0092-8674(89)90798-8; PRIEST JW, 1994, J BIOENERG BIOMEMBR, V26, P179, DOI 10.1007/BF00763067; Prohaska K, 2009, EUKARYOT CELL, V8, P77, DOI 10.1128/EC.00234-08; Rico E, 2013, FRONT CELL INFECT MI, V3, DOI 10.3389/fcimb.2013.00078; Saada EA, 2014, EUKARYOT CELL, V13, P1064, DOI 10.1128/EC.00019-14; Salmon D, 2012, SCIENCE, V337, P463, DOI 10.1126/science.1222753; Salmon D, 2012, MOL MICROBIOL, V84, P225, DOI 10.1111/j.1365-2958.2012.08013.x; Savage AF, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001708; Sharma R, 2008, PROTIST, V159, P137, DOI 10.1016/j.protis.2007.07.004; Sharma R, 2009, TRENDS PARASITOL, V25, P517, DOI 10.1016/j.pt.2009.08.001; Simarro PP, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001007; Subota I, 2014, MOL CELL PROTEOMICS, V13, P1769, DOI 10.1074/mcp.M113.033357; Supek F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021800; Szoor B, 2010, GENE DEV, V24, P1306, DOI 10.1101/gad.570310; Szoor B, 2006, J CELL BIOL, V175, P293, DOI 10.1083/jcb.200605090; Telleria EL, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002649; TETLEY L, 1987, J CELL SCI, V87, P363; TURNER CMR, 1988, PARASITOLOGY, V97, P269, DOI 10.1017/S0031182000058479; Urwyler S, 2007, MOL MICROBIOL, V63, P218, DOI 10.1111/j.1365-2958.2006.05492.x; Van den Abbeele J, 1999, PARASITOLOGY, V118, P469, DOI 10.1017/S0031182099004217; van Hellemond JJ, 2005, ADV MICROB PHYSIOL, V50, P199, DOI 10.1016/S0065-2911(05)50005-5; Vassella E, 2000, GENE DEV, V14, P615; VICKERMAN K, 1985, BRIT MED BULL, V41, P105, DOI 10.1093/oxfordjournals.bmb.a072036; Weirather JL, 2012, MOL BIOCHEM PARASIT, V181, P141, DOI 10.1016/j.molbiopara.2011.10.011; ZIEGELBAUER K, 1992, J BIOL CHEM, V267, P10791	59	36	37	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2016	11	12							e0168877	10.1371/journal.pone.0168877	http://dx.doi.org/10.1371/journal.pone.0168877			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI9TW	28002435	Green Published, gold, Green Submitted			2022-12-27	WOS:000392853100074
J	Waddell, LA; Greig, J; Mascarenhas, M; Harding, S; Lindsay, R; Ogden, N				Waddell, Lisa A.; Greig, Judy; Mascarenhas, Mariola; Harding, Shannon; Lindsay, Robbin; Ogden, Nicholas			The Accuracy of Diagnostic Tests for Lyme Disease in Humans, A Systematic Review and Meta-Analysis of North American Research	PLOS ONE			English	Review							LINKED-IMMUNOSORBENT-ASSAY; VECTOR IXODES-SCAPULARIS; BURGDORFERI-SENSU-LATO; BORRELIA-BURGDORFERI; BLOOD CULTURES; UNITED-STATES; LABORATORY DIAGNOSIS; RECOMBINANT ANTIGENS; PEPTIDE ANTIGENS; IGM ANTIBODIES	There has been an increasing incidence of Lyme disease (LD) in Canada and the United States corresponding to the expanding range of the Ixodes tick vector and Lyme disease agent (Borrelia burgdorferi sensu stricto). There are many diagnostic tests for LD available in North America, all of which have some performance issues, and physicians are concerned about the appropriate use and interpretation of these tests. The objective of this systematic review is to summarize the North American evidence on the accuracy of diagnostic tests and test regimes at various stages of LD. Included in the review are 48 studies on diagnostic tests used in North America published since 1995. Thirteen studies examined a twotier serological test protocol vs. clinical diagnosis, 24 studies examined single assays vs. clinical diagnosis, 9 studies examined single immunoblot vs. clinical diagnosis, 7 studies compared culture or PCR direct detection methods vs. clinical diagnosis, 22 studies compared two or more tests with each other and 8 studies compared a two-tiered serological test protocol to another test. Recent studies examining the sensitivity and specificity of various test protocols noted that the Immunetics (R) C6 B. burgdorferi ELISA (TM) and the two tier approach have superior specificity compared to proposed replacements, and the CDC recommended western blot algorithm has equivalent or superior specificity over other proposed test algorithms. There is a dramatic increase in test sensitivity with progression of B. burgdorferi infection from early to late LD. Direct detection methods, culture and PCR of tissue or blood samples were not as sensitive or timely compared to serological testing. It was also noted that there are a large number of both commercial (n = 42) and in-house developed tests used by private laboratories which have not been evaluated in the primary literature.	[Waddell, Lisa A.; Greig, Judy; Mascarenhas, Mariola; Harding, Shannon] Publ Hlth Agcy Canada, Natl Microbiol Lab, Guelph, ON, Canada; [Lindsay, Robbin] Publ Hlth Agcy Canada, Natl Microbiol Lab, Winnipeg, MB, Canada; [Ogden, Nicholas] Publ Hlth Agcy Canada, Natl Microbiol Lab, St Hyacinthe, PQ, Canada	Public Health Agency of Canada; Public Health Agency of Canada; Public Health Agency of Canada	Waddell, LA (corresponding author), Publ Hlth Agcy Canada, Natl Microbiol Lab, Guelph, ON, Canada.	lisa.waddell@phac-aspc.gc.ca	DeHaas, Keith/I-4957-2017	Lindsay, Robbin/0000-0001-7236-2930; waddell, lisa/0000-0003-4887-5124				Bacon RM, 2003, J INFECT DIS, V187, P1187, DOI 10.1086/374395; Berkman ND, 2015, J CLIN EPIDEMIOL, V68, P1312, DOI 10.1016/j.jclinepi.2014.11.023; Binnicker MJ, 2008, J CLIN MICROBIOL, V46, P2216, DOI 10.1128/JCM.00200-08; Branda JA, 2013, CLIN INFECT DIS, V57, P333, DOI 10.1093/cid/cit235; Branda JA, 2011, CLIN INFECT DIS, V53, P541, DOI 10.1093/cid/cir464; Branda JA, 2010, CLIN INFECT DIS, V50, P20, DOI 10.1086/648674; Brissette CA, 2010, CLIN VACCINE IMMUNOL, V17, P274, DOI 10.1128/CVI.00437-09; Brownstein John S., 2005, EcoHealth, V2, P38, DOI 10.1007/s10393-004-0139-x; Burbelo PD, 2010, CLIN VACCINE IMMUNOL, V17, P904, DOI 10.1128/CVI.00476-09; Centers for Disease Control and Prevention, 2015, POSTTR LYM DIS SYNDR; Centers for Disease Control and Prevention, 2015, SIGNS SYMPT UNTR LYM; Centers for Disease Control and Prevention (CDC), 1995, MMWR Morb Mortal Wkly Rep, V44, P590; Centers for Disease Control and Prevention (CDC), 2015, LYM DIS 2 STEP LAB T; Cerar T, 2008, J CLIN MICROBIOL, V46, P3375, DOI 10.1128/JCM.00410-08; Dessau RB, 2015, J MED MICROBIOL, V64, P224, DOI 10.1099/jmm.0.000009; Dumler JS, 2001, MOL DIAGN, V6, P1; Eisen RJ, 2012, J MED ENTOMOL, V49, P11, DOI 10.1603/ME11138; Eshoo MW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036825; Fallon BA, 2014, CLIN INFECT DIS, V59, P1705, DOI 10.1093/cid/ciu703; Fawcett PT, 1998, CLIN DIAGN LAB IMMUN, V5, P503, DOI 10.1128/CDLI.5.4.503-506.1998; Feder HM, 2007, NEW ENGL J MED, V357, P1422, DOI 10.1056/NEJMra072023; Gomes-Solecki MJC, 2007, CLIN VACCINE IMMUNOL, V14, P875, DOI 10.1128/CVI.00122-07; Gomes-Solecki MJC, 2002, J CLIN MICROBIOL, V40, P193, DOI 10.1128/JCM.40.1.193-197.2002; Gomes-Solecki MJC, 2001, ARCH INTERN MED, V161, P2015, DOI 10.1001/archinte.161.16.2015; Greig J, SCOPING REV RES LYME; Hamer SA, 2010, ECOHEALTH, V7, P47, DOI 10.1007/s10393-010-0287-0; Harbord RM, 2009, STATA J, V9, P211, DOI 10.1177/1536867X0900900203; Health Canada Medical Devices Branch, 2015, MDALL YOUR REF TOOL; Henningsson AJ, 2014, EUR J CLIN MICROBIOL, V33, P797, DOI 10.1007/s10096-013-2014-6; Hinckley AF, 2014, CLIN INFECT DIS, V59, P676, DOI 10.1093/cid/ciu397; Jobe DA, 2008, CLIN VACCINE IMMUNOL, V15, P981, DOI 10.1128/CVI.00079-08; Johnson BJB, 2014, J CLIN MICROBIOL, V52, P721, DOI 10.1128/JCM.01674-13; Koffi JK, 2012, J MED ENTOMOL, V49, P400, DOI 10.1603/ME11210; Kuschak T, 2007, CAN J INFECT DIS MED, V18, P145; Lahey LJ, 2015, J CLIN MICROBIOL, V53, P3834, DOI 10.1128/JCM.02111-15; Ledue TB, 2008, CLIN VACCINE IMMUNOL, V15, P1796, DOI 10.1128/CVI.00195-08; Leeflang MMG, 2016, BMC INFECT DIS, V16, DOI 10.1186/s12879-016-1468-4; Liang FT, 1999, J CLIN MICROBIOL, V37, P3990, DOI 10.1128/JCM.37.12.3990-3996.1999; Lindsay LR, 2014, CCDR, V40; Liveris D, 2002, J CLIN MICROBIOL, V40, P1249, DOI 10.1128/JCM.40.4.1249-1253.2002; Liveris D, 2012, DIAGN MICR INFEC DIS, V73, P243, DOI 10.1016/j.diagmicrobio.2012.03.026; Liveris D, 2011, J CLIN MICROBIOL, V49, P2166, DOI 10.1128/JCM.00350-11; Magnarelli LA, 1996, J CLIN MICROBIOL, V34, P237, DOI 10.1128/JCM.34.2.237-240.1996; Maraspin V, 2011, INFECTION, V39, P35, DOI 10.1007/s15010-010-0062-8; Marques AR, 2015, INFECT DIS CLIN N AM, V29, P295, DOI 10.1016/j.idc.2015.02.005; Marques AR, 2000, J CLIN MICROBIOL, V38, P4239, DOI 10.1128/JCM.38.11.4239-4241.2000; Mogilyansky E, 2004, CLIN DIAGN LAB IMMUN, V11, P924, DOI 10.1128/CDLI.11.5.924-929.2004; Molins CR, 2014, J CLIN MICROBIOL, V52, P3755, DOI 10.1128/JCM.01409-14; Nelder MP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105358; Nelson C, 2014, MMWR-MORBID MORTAL W, V63, P333; Nelson CA, 2015, EMERG INFECT DIS, V21, P1625, DOI 10.3201/eid2109.150417; Nocton JJ, 1996, J INFECT DIS, V174, P623, DOI 10.1093/infdis/174.3.623; Nowakowski J, 2009, CLIN INFECT DIS, V49, P1733, DOI 10.1086/648076; Ogden NH, 2006, INT J PARASITOL, V36, P63, DOI 10.1016/j.ijpara.2005.08.016; Ogden NH, 2009, CAN MED ASSOC J, V180, P1221, DOI 10.1503/cmaj.080148; Onyett H, 2014, PAED CHILD HEALT-CAN, V19, P379, DOI 10.1093/pch/19.7.379; Pavia CS, 2000, J MICROBIOL METH, V40, P163, DOI 10.1016/S0167-7012(00)00119-6; Phillips SE, 1998, INFECTION, V26, P364, DOI 10.1007/BF02770837; Porwancher RB, 2011, CLIN VACCINE IMMUNOL, V18, P851, DOI 10.1128/CVI.00409-10; Pritt BS, 2016, LANCET INFECT DIS; Qiu B, 2000, BIOPOLYMERS, V55, P319, DOI 10.1002/1097-0282(2000)55:4<319::AID-BIP1005>3.0.CO;2-W; Reitsma JB, 2005, J CLIN EPIDEMIOL, V58, P982, DOI 10.1016/j.jclinepi.2005.02.022; Rutter CM, 2001, STAT MED, V20, P2865, DOI 10.1002/sim.942; Sapi E, 2013, INT J MED SCI, V10, P362, DOI 10.7150/ijms.5698; Schoen RT, 2013, CLIN INFECT DIS, V57, P341, DOI 10.1093/cid/cit238; SCRIMENTI RJ, 1970, ARCH DERMATOL, V102, P104, DOI 10.1001/archderm.102.1.104; Sillanpaa H, 2007, INT J MED MICROBIOL, V297, P45, DOI 10.1016/j.ijmm.2006.09.001; Stanek G, 2011, CLIN MICROBIOL INFEC, V17, P69, DOI 10.1111/j.1469-0691.2010.03175.x; Stanek G, 2014, MED MICROBIOL IMMUN, V203, P125, DOI 10.1007/s00430-013-0322-1; Stanek G, 2012, LANCET, V379, P461, DOI 10.1016/S0140-6736(11)60103-7; STEERE AC, 1977, ARTHRITIS RHEUM, V20, P7, DOI 10.1002/art.1780200102; Stone BL, 2015, APPL ENVIRON MICROB, V81, P48, DOI 10.1128/AEM.02422-14; Takwoingi Y, 2015, STAT METHODS MED RES; Tilton RC, 2001, J CLIN MICROBIOL, V39, P2747, DOI 10.1128/JCM.39.7.2747.2001; Tilton RC, 1997, CLIN INFECT DIS, V25, pS31, DOI 10.1086/516173; Trevejo RT, 1999, J INFECT DIS, V179, P931, DOI 10.1086/314663; US Food and Drug Administration, 2015, DEV FDA; Viswanathan M, 2008, ANONYMOUS METHODS GU; Vyas J, 2014, LYME DIS; Wang GQ, 2004, INFECT IMMUN, V72, P6702, DOI 10.1128/IAI.72.11.6702-6706.2004; Whiting P, 2008, J HEALTH SERV RES PO, V13, P57, DOI 10.1258/jhsrp.2008.008025; Whiting PF, 2013, J CLIN EPIDEMIOL, V66, P1093, DOI 10.1016/j.jclinepi.2013.05.014; Whiting PF, 2011, ANN INTERN MED, V155, P529, DOI 10.7326/0003-4819-155-8-201110180-00009; Wormser GP, 2014, MED MICROBIOL IMMUN, V203, P65, DOI 10.1007/s00430-013-0315-0; Wormser GP, 2013, DIAGN MICR INFEC DIS, V75, P9, DOI 10.1016/j.diagmicrobio.2012.09.003; Wormser GP, 2000, J CLIN MICROBIOL, V38, P1648, DOI 10.1128/JCM.38.4.1648-1650.2000; Wormser GP, 1998, J CLIN MICROBIOL, V36, P296, DOI 10.1128/JCM.36.1.296-298.1998; Yu ZG, 1996, J IMMUNOL METHODS, V198, P25, DOI 10.1016/0022-1759(96)00140-8; Zwinderman AH, 2008, STAT MED, V27, P687, DOI 10.1002/sim.2992	89	70	72	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2016	11	12							e0168613	10.1371/journal.pone.0168613	http://dx.doi.org/10.1371/journal.pone.0168613			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI9TW	28002488	Green Published, gold, Green Submitted			2022-12-27	WOS:000392853100058
J	Wang, Y; Li, Z; Hu, G; Hao, SY; Deng, XH; Huang, M; Ren, M; Jiang, XY; Kanegaye, JT; Ha, KS; Lee, J; Li, XF; Jiang, XJ; Yu, YX; Tremoulet, AH; Burns, JC; Whitin, JC; Shin, AY; Sylvester, KG; McElhinney, DB; Cohen, HJ; Ling, XFB				Wang, Yue; Li, Zhen; Hu, Guang; Hao, Shiying; Deng, Xiaohong; Huang, Min; Ren, Miao; Jiang, Xiyuan; Kanegaye, John T.; Ha, Kee-Soo; Lee, JungHwa; Li, Xiaofeng; Jiang, Xuejun; Yu, Yunxian; Tremoulet, Adriana H.; Burns, Jane C.; Whitin, John C.; Shin, Andrew Y.; Sylvester, Karl G.; McElhinney, Doff B.; Cohen, Harvey J.; Ling, Xuefeng B.		Pediat Emergency Med Kawasaki Dis	Unique Molecular Patterns Uncovered in Kawasaki Disease Patients with Elevated Serum Gamma Glutamyl Transferase Levels: Implications for Intravenous Immunoglobulin Responsiveness	PLOS ONE			English	Article							COLONY-STIMULATING FACTOR; AUTOIMMUNE NEUTROPENIA; UNITED-STATES; THERAPY; PREDICTION; RESISTANCE; GLOBULIN; CHILDREN; AUTOANTIBODIES; ASSOCIATION	Background Resistance to intravenous immunoglobulin (IVIG) occurs in 10-20% of patients with Kawasaki disease (KD). The risk of resistance is about two-fold higher in patients with elevated gamma glutamyl transferase (GGT) levels. We sought to understand the biological mechanisms underlying IVIG resistance in patients with elevated GGT levels. Method We explored the association between elevated GGT levels and IVIG-resistance with a cohort of 686 KD patients (Cohort I). Gene expression data from 130 children with acute KD (Cohort II) were analyzed using the R square statistic and false discovery analysis to identify genes that were differentially represented in patients with elevated GGT levels with regard to IVIG responsiveness. Two additional KD cohorts (Cohort III and IV) were used to test the hypothesis that sialylation and GGT may be involved in IVIG resistance through neutrophil apoptosis. Results Thirty-six genes were identified that significantly explained the variations of both GGT levels and IVIG responsiveness in KD patients. After Bonferroni correction, significant associations with IVIG resistance persisted for 12 out of 36 genes among patients with elevated GGT levels and none among patients with normal GGT levels. With the discovery of ST6GALNAC3, a sialyltransferase, as the most differentially expressed gene, we hypothesized that sialylation and GGT are involved in IVIG resistance through neutrophil apoptosis. We then confirmed that in Cohort III and IV there was significantly less reduction in neutrophil count in IVIG non-responders. Conclusions Gene expression analyses combining molecular and clinical datasets support the hypotheses that: (1) neutrophil apoptosis induced by IVIG may be a mechanism of action of IVIG in KD; (2) changes in sialylation and GGT level in KD patients may contribute synergistically to IVIG resistance through blocking IVIG-induced neutrophil apoptosis. These findings have implications for understanding the mechanism of action in IVIG resistance, and possibly for development of novel therapeutics.	[Wang, Yue; Yu, Yunxian; Ling, Xuefeng B.] Zhejiang Univ, Sch Publ Hlth, Sch Med, Hangzhou, Zhejiang, Peoples R China; [Wang, Yue; Li, Zhen; Hu, Guang; Hao, Shiying; Deng, Xiaohong; Ren, Miao; Jiang, Xiyuan; Whitin, John C.; Shin, Andrew Y.; Sylvester, Karl G.; McElhinney, Doff B.; Cohen, Harvey J.; Ling, Xuefeng B.] Stanford Univ, Stanford, CA 94305 USA; [Li, Zhen] Southeast Univ, Sch Elect Engn, Nanjing, Jiangsu, Peoples R China; [Huang, Min] Shanghai Jiao Tong Univ, Shanghai Childrens Hosp, Shanghai, Peoples R China; [Kanegaye, John T.; Tremoulet, Adriana H.; Burns, Jane C.] Univ Calif San Diego, La Jolla, CA 92093 USA; [Kanegaye, John T.; Tremoulet, Adriana H.; Burns, Jane C.] Rady Childrens Hosp San Diego, San Diego, CA USA; [Ha, Kee-Soo; Lee, JungHwa] Korea Univ, Med Ctr, Guro Hosp, Dept Pediat, Seoul, South Korea; [Li, Xiaofeng] Beijing Childrens Hosp, Dept Heart Ctr, Beijing, Peoples R China; [Jiang, Xuejun] Mem Sloan Kettering Canc Ctr, 1275 York Ave, New York, NY 10021 USA	Zhejiang University; Stanford University; Southeast University - China; Shanghai Jiao Tong University; University of California System; University of California San Diego; Rady Childrens Hospital San Diego; Korea University; Korea University Medicine (KU Medicine); Capital Medical University; Memorial Sloan Kettering Cancer Center	Ling, XFB (corresponding author), Zhejiang Univ, Sch Publ Hlth, Sch Med, Hangzhou, Zhejiang, Peoples R China.; Ling, XFB (corresponding author), Stanford Univ, Stanford, CA 94305 USA.	bxling@stanford.edu	li, xiao/GSN-6181-2022; li, xiaofeng/GXF-9442-2022	McElhinney, Doff/0000-0001-7242-0934; Hao, Shiying/0000-0002-7527-2460; Sylvester, Karl G./0000-0002-8559-0155; Jiang, Xiyuan/0000-0003-3508-2221; Ling, Bruce/0000-0002-5386-3884; Ha, Kee Soo/0000-0001-6753-5411	American Heart Association; Stanford University Spark Program; David Gordon Louis Daniel Foundation; Mario Batali Foundation; National Institutes of Health, National Heart, Lung, Blood Institute [HL69413]; Hartwell Foundation; Harold Amos Medical Faculty Development Program/Robert Wood Johnson Foundation; NATIONAL CANCER INSTITUTE [P30CA008748] Funding Source: NIH RePORTER	American Heart Association(American Heart Association); Stanford University Spark Program(Stanford University); David Gordon Louis Daniel Foundation; Mario Batali Foundation; National Institutes of Health, National Heart, Lung, Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Hartwell Foundation; Harold Amos Medical Faculty Development Program/Robert Wood Johnson Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported in part by grants from the American Heart Association to HJC and XBL, Stanford University Spark Program Grant to HJC and XBL, the David Gordon Louis Daniel Foundation to JCB, the Mario Batali Foundation to JCB, the National Institutes of Health, National Heart, Lung, Blood Institute HL69413 to JCB, The Hartwell Foundation to AHT, and The Harold Amos Medical Faculty Development Program/Robert Wood Johnson Foundation to AHT.	Abe J, 2008, J ALLERGY CLIN IMMUN, V122, P1008, DOI 10.1016/j.jaci.2008.09.011; [Anonymous], 1984, REP SUBC STAND DIAGN; Biezeveld MH, 2005, CLIN EXP IMMUNOL, V141, P183, DOI 10.1111/j.1365-2249.2005.02829.x; Bonferroni CE, 1936, SUPERIORE SCI EC COM, V8, P3; Burns JC, 2004, LANCET, V364, P533, DOI 10.1016/S0140-6736(04)16814-1; Burns JC, 1998, PEDIATR INFECT DIS J, V17, P1144, DOI 10.1097/00006454-199812000-00009; DURONGPISITKUL K, 1995, PEDIATRICS, V96, P1057; Fu PP, 2013, PEDIATR INFECT DIS J, V32, pE319, DOI 10.1097/INF.0b013e31828e887f; Fukunishi M, 2000, J PEDIATR-US, V137, P172, DOI 10.1067/mpd.2000.104815; Fury W, 2010, HUM IMMUNOL, V71, P865, DOI 10.1016/j.humimm.2010.06.008; Galeotti C, 2015, TRENDS MOL MED, V21, P145, DOI 10.1016/j.molmed.2015.01.005; Ha KS, 2015, AM J CARDIOL, V116, P301, DOI 10.1016/j.amjcard.2015.04.021; Hoang LT, 2014, GENOME MED, V6, DOI 10.1186/s13073-014-0102-6; Hwang JY, 2011, ARCH DIS CHILD, V96, P1088, DOI 10.1136/adc.2010.184101; Igarashi H, 1999, BRIT J HAEMATOL, V105, P613, DOI 10.1046/j.1365-2141.1999.01381.x; Jandus C, 2011, BIOCHEM PHARMACOL, V82, P323, DOI 10.1016/j.bcp.2011.05.018; Kanai T, 2011, CIRCULATION, V124, P2822, DOI 10.1161/CIRCULATIONAHA.111.028423; Kato H, 1996, CIRCULATION, V94, P1379, DOI 10.1161/01.CIR.94.6.1379; Kobayashi T, 2006, CIRCULATION, V113, P2606, DOI 10.1161/CIRCULATIONAHA.105.592865; Lee SM, 2014, KOREAN CIRC J, V44, P415, DOI 10.4070/kcj.2014.44.6.415; Lin MC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063399; Ling XB, 2009, BIOINFORMATICS, V25, P1461, DOI 10.1093/bioinformatics/btp176; Liu L, 2015, INFLAMMATION RES OFF; Long JS, 1997, REGRESSION MODELS CA, P104; Marschner IC, 2011, R J, V3, P12; MATSUBARA T, 1990, CLIN IMMUNOL IMMUNOP, V56, P29, DOI 10.1016/0090-1229(90)90166-N; McFadden D., 1973, FRONTIERS ECONOMETRI, P105, DOI [10.1108/eb028592, DOI 10.1108/EB028592]; Miller RGJ, 1991, SIMULTANEOUS STAT IN; Newburger JW, 2004, CIRCULATION, V110, P2747, DOI 10.1161/01.CIR.0000145143.19711.78; NEWBURGER JW, 1991, NEW ENGL J MED, V324, P1633, DOI 10.1056/NEJM199106063242305; NEWBURGER JW, 1986, NEW ENGL J MED, V315, P341, DOI 10.1056/NEJM198608073150601; Ogata S, 2013, INT J CARDIOL, V168, P3825, DOI 10.1016/j.ijcard.2013.06.027; Okada S, 2015, PEDIATR INT, V57, P1012, DOI 10.1111/ped.12701; R-Core-Team, 2015, LANG ENV STAT COMP; Schaub A, 2011, ALLERGY, V66, P1030, DOI 10.1111/j.1398-9995.2011.02579.x; Ting EC, 1998, PEDIATR INFECT DIS J, V17, P431, DOI 10.1097/00006454-199805000-00020; Tremoulet AH, 2008, J PEDIATR-US, V153, P117, DOI 10.1016/j.jpeds.2007.12.021; Tremoulet AH, 2014, LANCET, V383, P1731, DOI 10.1016/S0140-6736(13)62298-9; Tremoulet AH, 2011, PEDIATR INFECT DIS J, V30, P1022, DOI 10.1097/INF.0b013e31822d4f56; Tsai MH, 2006, J PEDIATR-US, V148, P38, DOI 10.1016/j.jpeds.2005.08.024; Tsuchida A, 2005, J BIOCHEM, V138, P237, DOI 10.1093/jb/mvi124; Tsujimoto H, 2002, CLIN IMMUNOL, V103, P161, DOI 10.1006/clim.2002.5209; Uehara R, 2012, J EPIDEMIOL, V22, P79, DOI 10.2188/jea.JE20110131; Ueno K, 2011, PEDIATR INT, V53, P388, DOI 10.1111/j.1442-200X.2011.03376.x; von Gunten S, 2008, AUTOIMMUN REV, V7, P453, DOI 10.1016/j.autrev.2008.03.015; von Gunten S, 2006, BLOOD, V108, P4255, DOI 10.1182/blood-2006-05-021568; Wickham H, 2009, USE R, P1, DOI 10.1007/978-0-387-98141-3_1; Yamaji T, 2002, J BIOL CHEM, V277, P6324, DOI 10.1074/jbc.M110146200; Yoshimura K, 2009, EUR J PEDIATR, V168, P1037, DOI 10.1007/s00431-008-0872-1; Zhang JQ, 2000, J BIOL CHEM, V275, P22121, DOI 10.1074/jbc.M002788200	50	11	11	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2016	11	12							e0167434	10.1371/journal.pone.0167434	http://dx.doi.org/10.1371/journal.pone.0167434			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI9TW	28002448	Green Published, gold, Green Submitted			2022-12-27	WOS:000392853100008
J	Olsen, KN; Dean, RT; Leung, Y				Olsen, Kirk N.; Dean, Roger T.; Leung, Yvonne			What Constitutes a Phrase in Sound-Based Music? A Mixed-Methods Investigation of Perception and Acoustics	PLOS ONE			English	Article							TIME-SERIES ANALYSIS; SPEECH-PERCEPTION; MOTOR THEORY; TIMBRE; PITCH; SEGMENTATION; REPRESENTATION; DESCRIPTORS; DIMENSIONS; DYNAMICS	Phrasing facilitates the organization of auditory information and is central to speech and music. Not surprisingly, aspects of changing intensity, rhythm, and pitch are key determinants of musical phrases and their boundaries in instrumental note-based music. Different kinds of speech (such as tone-vs. stress-languages) share these features in different proportions and form an instructive comparison. However, little is known about whether or how musical phrasing is perceived in sound-based music, where the basic musical unit from which a piece is created is commonly non-instrumental continuous sounds, rather than instrumental discontinuous notes. This issue forms the target of the present paper. Twenty participants (17 untrained in music) were presented with six stimuli derived from sound based music, note-based music, and environmental sound. Their task was to indicate each occurrence of a perceived phrase and qualitatively describe key characteristics of the stimulus associated with each phrase response. It was hypothesized that sound-based music does elicit phrase perception, and that this is primarily associated with temporal changes in intensity and timbre, rather than rhythm and pitch. Results supported this hypothesis. Qualitative analysis of participant descriptions showed that for sound-based music, the majority of perceived phrases were associated with intensity or timbral change. For the note-based piano piece, rhythm was the main theme associated with perceived musical phrasing. We modeled the occurrence in time of perceived musical phrases with recurrent event 'hazard' analyses using time-series data representing acoustic predictors associated with intensity, spectral flatness, and rhythmic density. Acoustic intensity and timbre (represented here by spectral flatness) were strong predictors of perceived musical phrasing in sound-based music, and rhythm was only predictive for the piano piece. A further analysis including five additional spectral measures linked to timbre strengthened the models. Overall, results show that even when little of the pitch and rhythm information important for phrasing in note based music is available, phrasing is still perceived, primarily in response to changes of intensity and timbre. Implications for electroacoustic music composition and music recommender systems are discussed.	[Olsen, Kirk N.; Dean, Roger T.; Leung, Yvonne] Univ Western Sydney, MARCS Inst Brain Behav & Dev, Sydney, NSW, Australia; [Olsen, Kirk N.] Macquarie Univ, Dept Psychol, Sydney, NSW, Australia	Western Sydney University; Macquarie University	Dean, RT (corresponding author), Univ Western Sydney, MARCS Inst Brain Behav & Dev, Sydney, NSW, Australia.	roger.dean@westernsydney.edu.au	Leung, Yvonne/M-5086-2017	Leung, Yvonne/0000-0001-9110-7054; Olsen, Kirk/0000-0002-8238-8816; Dean, Roger Thornton/0000-0002-8859-8902	Australian Research Council (ARC) [LP150100487]	Australian Research Council (ARC)(Australian Research Council)	This research was funded by an Australian Research Council (ARC) Linkage Project Grant (LP150100487) awarded to RD. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Supported by an Australian Research Council Linkage Project grant (LP150100487) held by the second author. We thank William Dunsmuir and Stephen McAdams for advice on experimental design and analysis, and the MARCS Institute Music Cognition and Action research group for helpful comments on an earlier draft.	Abel AK, 2015, NEUR NETW IJCNN 2015; [Anonymous], 2003, HYPERIMPROVISATION C; Bailes F., 2014, PSYCHOMUSICOLOGY MUS, V24, P103; Bailes F, 2007, J NEW MUSIC RES, V36, P83, DOI 10.1080/09298210701755123; Bailes F, 2013, SCI REP-UK, V3, DOI 10.1038/srep02690; Bailes F, 2012, MUSIC PERCEPT, V29, P359, DOI 10.1525/MP.2012.29.4.359; Bailes F, 2007, EMPIR MUSICOL REV, V2, P74, DOI 10.18061/1811/28854; Bailes F, 2009, PERCEPTION, V38, P1386, DOI 10.1068/p6063; Balkwill LL, 2004, JPN PSYCHOL RES, V46, P337, DOI 10.1111/j.1468-5584.2004.00265.x; Balkwill LL, 1999, MUSIC PERCEPT, V17, P43, DOI 10.2307/40285811; Bao YC, 2013, J APPL STAT, V40, P123, DOI 10.1080/02664763.2012.735225; BREGMAN AS, 1973, PERCEPT PSYCHOPHYS, V13, P308, DOI 10.3758/BF03214144; Bregman AS, 1999, AUDITORY SCENE ANAL, pxiii; Caclin A, 2005, J ACOUST SOC AM, V118, P471, DOI 10.1121/1.1929229; CLARKE EF, 1990, MUSIC PERCEPT, V7, P213; Cox D. R., 1984, ANAL SURVIVAL DATA; Cunillera T, 2016, NEUROPSYCHOLOGIA; CUTLER A, 1990, ACL MIT NAT, P105; Cutler Anne, 2012, NATIVE LISTENING LAN; de Cheveigne A, 2005, SPR HDB AUD, V24, P169; Dean RT, 2016, MUSIC PERCEPT, V34, P104, DOI 10.1525/MP.2016.34.1.104; Dean RT, 2015, PSYCHOL MUSIC, V43, P3, DOI 10.1177/0305735613489917; Dean RT, 2011, EMPIR MUSICOL REV, V6, P131, DOI 10.18061/1811/51217; Dean RT, 2010, EMPIR MUSICOL REV, V5, P152, DOI 10.18061/1811/48550; Dean RT, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018591; Dean Roger T., 2009, OXFORD HDB COMPUTER; Dean RT, 2013, P INT S XEN EL MUS, P2; Dean RT, 2012, P INT S XEN MUS EL, P1; DEUTSCH D, 1981, PSYCHOL REV, V88, P503, DOI 10.1037/0033-295X.88.6.503; Frost RLA, 2016, COGNITION, V147, P70, DOI 10.1016/j.cognition.2015.11.010; Galantucci B, 2006, PSYCHON B REV, V13, P361, DOI 10.3758/BF03193857; GAVER WW, 1993, ECOL PSYCHOL, V5, P1, DOI 10.1207/s15326969eco0501_1; GAVER WW, 1993, ECOL PSYCHOL, V5, P285, DOI 10.1207/s15326969eco0504_2; Gingras B, 2016, J EXP PSYCHOL HUMAN, V42, P594, DOI 10.1037/xhp0000141; Godoy R. I., 2006, ORGAN SOUND, V11, P149, DOI [DOI 10.1017/S1355771806001439, 10.1017/S1355771806001439]; Godoy RI, 2003, LEONARDO, V36, P317, DOI 10.1162/002409403322258781; Godoy RI, 2010, ACTA ACUST UNITED AC, V96, P690, DOI 10.3813/AAA.918323; Grossberg S, 2000, PSYCHOL REV, V107, P735, DOI 10.1037//0033-295X.107.4.735; Hawthorne K, 2016, INFANCY; Hutchison JL, 2015, PSYCHOMUSICOLOGY MUS, V25, P103, DOI DOI 10.1037/PMU0000085; IVERSON P, 1995, J EXP PSYCHOL HUMAN, V21, P751, DOI 10.1037/0096-1523.21.4.751; JAHNKE JC, 1963, J VERB LEARN VERB BE, V2, P284, DOI 10.1016/S0022-5371(63)80095-X; JESTEADT W, 1982, J ACOUST SOC AM, V71, P950, DOI 10.1121/1.387576; Johnson EK, 2016, ANNU REV LINGUIST, V2, P391, DOI 10.1146/annurev-linguistics-011415-040616; JUSCZYK PW, 1992, COGNITIVE PSYCHOL, V24, P252, DOI 10.1016/0010-0285(92)90009-Q; Klien V, 2012, J NEW MUSIC RES, V41, P153, DOI 10.1080/09298215.2011.618226; Knosche TR, 2005, HUM BRAIN MAPP, V24, P259, DOI 10.1002/hbm.20088; KRUMHANSL CL, 1990, PSYCHOL SCI, V1, P70, DOI 10.1111/j.1467-9280.1990.tb00070.x; Kuhl PK, 2004, NAT REV NEUROSCI, V5, P831, DOI 10.1038/nrn1533; Landy L., 2009, OXFORD HDB COMPUTER, P518; Landy L., 2009, OXFORD HDB COMPUTER; Mannel C, 2016, BRAIN RES, V1632, P27, DOI 10.1016/j.brainres.2015.12.009; Massaro DW, 2008, PSYCHON B REV, V15, P453, DOI 10.3758/PBR.15.2.453; McAdams S, 1999, COMPUT MUSIC J, V23, P85, DOI 10.1162/014892699559797; MCADAMS S, 1995, PSYCHOL RES-PSYCH FO, V58, P177, DOI 10.1007/BF00419633; McNealy K, 2006, J NEUROSCI, V26, P7629, DOI 10.1523/JNEUROSCI.5501-05.2006; Mendoza Garay JI, 2014, THESIS; Minard A, 2008, P CHI WORKSH SON INT; Misdariis N, 2010, EURASIP J AUDIO SPEE, DOI 10.1155/2010/362013; Neuhoff J., 2004, ECOLOGICAL PSYCHOACO; Olsen K.N., 2014, PSYCHOMUSICOLOGY, V24, P147, DOI [10.1037/pmu0000044, DOI 10.1037/PMU0000044]; Olsen K.N., 2015, PSYCHOMUSICOLOGY, V25, P124, DOI [10.1037/pmu0000087, DOI 10.1037/PMU0000087]; Olsen KN, 2014, ACOUST AUST, V42, P159; Olsen KN, 2013, J PSYCHOPHYSIOL, V27, P16, DOI 10.1027/0269-8803/a000082; Olsen KN, 2012, PERCEPTION, V41, P594, DOI 10.1068/p7128; PALMER C, 1987, PERCEPT PSYCHOPHYS, V41, P505, DOI 10.3758/BF03210485; PALMER C, 1987, J EXP PSYCHOL HUMAN, V13, P116, DOI 10.1037/0096-1523.13.1.116; Palmer SD, 2016, Q J EXP PSYCHOL, V69, P2390, DOI 10.1080/17470218.2015.1112825; Patel A. D., 2007, MUSIC LANGUAGE BRAIN; Peeters G, 2011, J ACOUST SOC AM, V130, P2902, DOI 10.1121/1.3642604; Pena M, 2002, SCIENCE, V298, P604, DOI 10.1126/science.1072901; Piantadosi ST, 2011, P NATL ACAD SCI USA, V108, P3526, DOI 10.1073/pnas.1012551108; Saffran JR, 1996, SCIENCE, V274, P1926, DOI 10.1126/science.274.5294.1926; Sandell G, 1998, J ACOUST SOC AM, V103, P2966; Seidl A, 2007, J MEM LANG, V57, P24, DOI 10.1016/j.jml.2006.10.004; Seidl A, 2006, DEVELOPMENTAL SCI, V9, P565, DOI 10.1111/j.1467-7687.2006.00534.x; Siedenburg K, 2016, J NEW MUSIC RES, V45, P27, DOI 10.1080/09298215.2015.1132737; STOFFER TH, 1985, MUSIC PERCEPT, V3, P191; STREETER LA, 1978, J ACOUST SOC AM, V64, P1582, DOI 10.1121/1.382142; ten Bosch L, 2005, SPEECH COMMUN, V47, P80, DOI 10.1016/j.specom.2005.05.009; Zhao TC, 2015, J ACOUST SOC AM, V137, P1452, DOI 10.1121/1.4913457	81	6	6	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2016	11	12							e0167643	10.1371/journal.pone.0167643	http://dx.doi.org/10.1371/journal.pone.0167643			29	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI); Arts &amp; Humanities Citation Index (A&amp;HCI)	Science & Technology - Other Topics	EI9QF	27997625	Green Published, gold, Green Submitted			2022-12-27	WOS:000392842900012
J	Song, YX; Xu, LY; Chen, Y; Zhang, LP; Gao, HJ; Zhu, B; Niu, H; Zhang, WG; Xia, JW; Gao, X; Li, JY				Song, Yuxin; Xu, Lingyang; Chen, Yan; Zhang, Lupei; Gao, Huijiang; Zhu, Bo; Niu, Hong; Zhang, Wengang; Xia, Jiangwei; Gao, Xue; Li, Junya			Genome-Wide Association Study Reveals the PLAG1 Gene for Knuckle, Biceps and Shank Weight in Simmental Beef Cattle	PLOS ONE			English	Article							SEQUENCE VARIANTS; CARCASS TRAITS; BODY-WEIGHT; GROWTH; PREDICTION	Carcass traits of beef cattle have been genetically improved to increase yield of high quality meat. Genome-wide association study (GWAS) is a powerful method to identify genetic variants associated with carcass traits. For the 770K genotyped SNPs from 1141 Chinese Simmental cattle, we used the compressed mixed linear model (CMLM) to perform a genomewide association study for knuckle, biceps and shank of beef carcass traits. Seventeen significantly associated SNPs were found, which are located on BTA6, BTA14 and BTA15. Interestingly, one pleiotropic quantitative trait nucleotide (QTN), named BovineHD1400007259 (p < 10(-8)) within the well-known gene region PLAG1-CHCHD7 on BTA14, was found to govern variation of the knuckle, biceps and shank traits. The QTN accounted for 8.6% of phenotypic variance for biceps. In addition, 16 more SNPs distributed on BTA14 were detected as being associated with the carcass traits.	[Song, Yuxin; Xu, Lingyang; Chen, Yan; Zhang, Lupei; Gao, Huijiang; Zhu, Bo; Niu, Hong; Zhang, Wengang; Xia, Jiangwei; Gao, Xue; Li, Junya] Chinese Acad Agr Sci, Inst Anim Sci, Lab Mol Biol & Bovine Breeding, Beijing, Peoples R China	Chinese Academy of Agricultural Sciences; Institute of Animal Science, CAAS	Gao, X; Li, JY (corresponding author), Chinese Acad Agr Sci, Inst Anim Sci, Lab Mol Biol & Bovine Breeding, Beijing, Peoples R China.	gaoxue76@126.com; jl1@iascaas.net.cn	Xu, Lingyang/W-8664-2019	Gao, Xue/0000-0002-9083-6658	Cattle Breeding Innovative Research Team [cxgc-ias-03]; 12th "Five-Year" National Science and Technology Support Project [2011BAD28B04]; Basic Research Fund Program; Chinese Academy of Agricultural Sciences Fundamental Research Budget Increment Projects [2013ZL031, 2014ZL006]; Chinese Academy of Agricultural Sciences Foundation [2014ywf-yb-4]; Beijing Natural Science Foundation [6154032]; National Natural Science Foundations of China [31472079, 31372294, 31402039]; National High Technology Research and Development Program of China (863 Program) [2013AA102505-4]	Cattle Breeding Innovative Research Team; 12th "Five-Year" National Science and Technology Support Project; Basic Research Fund Program; Chinese Academy of Agricultural Sciences Fundamental Research Budget Increment Projects; Chinese Academy of Agricultural Sciences Foundation(Chinese Academy of Sciences); Beijing Natural Science Foundation(Beijing Natural Science Foundation); National Natural Science Foundations of China(National Natural Science Foundation of China (NSFC)); National High Technology Research and Development Program of China (863 Program)(National High Technology Research and Development Program of China)	This study was supported by Cattle Breeding Innovative Research Team (cxgc-ias-03), the 12th "Five-Year" National Science and Technology Support Project (2011BAD28B04) Basic Research Fund Program, the National High Technology Research and Development Program of China (863 Program 2013AA102505-4), Chinese Academy of Agricultural Sciences Fundamental Research Budget Increment Projects (2013ZL031 and 2014ZL006), Chinese Academy of Agricultural Sciences Foundation (2014ywf-yb-4), Beijing Natural Science Foundation (6154032), and the National Natural Science Foundations of China (31472079, 31372294, and 31402039).	Barendse W, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029601; Bolormaa S, 2013, J ANIM SCI, V91, P3088, DOI 10.2527/jas.2012-5827; Bolormaa S, 2011, J ANIM SCI, V89, P2297, DOI 10.2527/jas.2010-3138; Bolormaa S, 2011, J ANIM SCI, V89, P1684, DOI 10.2527/jas.2010-3079; Browning SR, 2007, AM J HUM GENET, V81, P1084, DOI 10.1086/521987; Cesar ASM, 2014, BMC GENET, V15, DOI 10.1186/1471-2156-15-39; Cordell HJ, 2009, NAT REV GENET, V10, P392, DOI 10.1038/nrg2579; Crispim AC, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0139906; Dang CG, 2014, ASIAN AUSTRAL J ANIM, V27, P1328, DOI 10.5713/ajas.2013.13690; Fan HZ, 2015, SCI REP-UK, V5, DOI 10.1038/srep18389; Gautier M, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-550; Goddard ME, 2009, NAT REV GENET, V10, P381, DOI 10.1038/nrg2575; Gudbjartsson DF, 2008, NAT GENET, V40, P609, DOI 10.1038/ng.122; Hayes BJ, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001139; Hensen K, 2004, DEV GROWTH DIFFER, V46, P459, DOI 10.1111/j.1440-169x.2004.00762.x; Hibbard MK, 2000, CANCER RES, V60, P4869; Hoshiba H, 2013, ANIM SCI J, V84, P529, DOI 10.1111/asj.12033; Jiang L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013661; Karim L, 2011, NAT GENET, V43, P405, DOI 10.1038/ng.814; Kim Y, 2011, ANIM GENET, V42, P361, DOI 10.1111/j.1365-2052.2010.02156.x; Lee SH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074677; Lee Seung Hwan, 2013, PLOS ONE; Lindholm-Perry AK, 2011, BMC GENET, V12, DOI 10.1186/1471-2156-12-103; Lipka AE, 2012, BIOINFORMATICS, V28, P2397, DOI 10.1093/bioinformatics/bts444; Littlejohn M, 2012, ANIM GENET, V43, P591, DOI 10.1111/j.1365-2052.2011.02293.x; Martins C, 2005, MODERN PATHOL, V18, P1048, DOI 10.1038/modpathol.3800386; Matukumalli LK, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005350; Nishimura S, 2012, BMC GENET, V13, DOI 10.1186/1471-2156-13-40; Pant SD, 2010, GENOMICS, V95, P176, DOI 10.1016/j.ygeno.2010.01.001; Pryce JE, 2011, GENETICS, V187, P981, DOI 10.1534/genetics.110.123943; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Sasaki S, 2015, BMC GENET, V16, DOI 10.1186/s12863-015-0282-0; Snelling WM, 2010, J ANIM SCI, V88, P837, DOI 10.2527/jas.2009-2257; WANG H, 2014, BMC BIOINFORMATICS, V15, DOI DOI 10.1186/S12863-014-0125-4; Weng ZQ, 2016, LIVEST SCI, V183, P4, DOI 10.1016/j.livsci.2015.11.011; Wu XP, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-897; Wu Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109330; Xu LY, 2015, MOL BIOL EVOL, V32, P711, DOI 10.1093/molbev/msu333; Zhou X, 2012, NAT GENET, V44, P821, DOI 10.1038/ng.2310	39	13	14	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2016	11	12							e0168316	10.1371/journal.pone.0168316	http://dx.doi.org/10.1371/journal.pone.0168316			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI9QF	27997562	Green Published, Green Submitted, gold			2022-12-27	WOS:000392842900033
J	Comber, H; Cancela, MD; Haase, T; Johnson, H; Sharp, L; Pratschke, J				Comber, Harry; Cancela, Marianna De Camargo; Haase, Trutz; Johnson, Howard; Sharp, Linda; Pratschke, Jonathan			Affluence and Private Health Insurance Influence Treatment and Survival in Non-Hodgkin's Lymphoma	PLOS ONE			English	Article							CANCER SURVIVAL; ELDERLY-PATIENTS; COMMON CANCERS; SOCIOECONOMIC INEQUALITIES; MARITAL-STATUS; BREAST-CANCER; RARER CANCERS; AGE; DISPARITIES; DIAGNOSIS	Background The aim of this study was to investigate inequalities in survival for non-Hodgkin's lymphoma (NHL), distinguishing between direct and indirect effects of patient, social and process-of care factors. Methods All cases of NHL diagnosed in Ireland in 2004-2008 were included. Variables describing patient, cancer, stage and process of care were included in a discrete-time model of survival using Structural Equation Modelling software. Results Emergency admissions were more common in patients with co-morbid conditions or with more aggressive cancers, and less frequent for patients from more affluent areas. Aggressive morphology, female sex, emergency admission, increasing age, comorbidity, treatment in a high caseload hospital and late stage were associated with increased hazard of mortality. Private patients had a reduced hazard of mortality, mediated by systemic therapy, admission to high caseload hospitals and fewer emergency admissions. Discussion The higher rate of emergency presentation, and consequent poorer survival, of uninsured patients, suggests they face barriers to early presentation. Social, educational and cultural factors may also discourage disadvantaged patients from consulting with early symptoms of NHL. Non-insured patients, who present later and have more emergency admissions would benefit from better access to diagnostic services. Older patients remain disadvantaged by sub-optimal treatment, treatment in non-specialist centres and emergency admission.	[Comber, Harry] Natl Canc Registry, Cork, Ireland; [Cancela, Marianna De Camargo] Brazilian Natl Canc Inst, Div Epidemiol, Rio De Janeiro, Brazil; [Johnson, Howard] Hlth Serv Execut, Hlth & Wellbeing Directorate, Hlth Intelligence Unit, Dublin, Ireland; [Sharp, Linda] Newcastle Univ, Inst Hlth & Soc, Newcastle Upon Tyne, Tyne & Wear, England; [Pratschke, Jonathan] Univ Salerno, Dept Econ & Stat, Salerno, Italy	National Cancer Institute (Inca); Newcastle University - UK; University of Salerno	Comber, H (corresponding author), Natl Canc Registry, Cork, Ireland.	hcomber1@gmail.com	De Camargo Cancela, Marianna/D-4053-2015; de Camargo Cancela, Marianna/F-7309-2017	De Camargo Cancela, Marianna/0000-0002-8169-8054; 	Department of Health; Irish Cancer Society [H1COM12]	Department of Health; Irish Cancer Society	The National Cancer Registry is funded by the Department of Health. Additional funding for this study was provided by Irish Cancer Society grant H1COM12. There was no additional external source of funding for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abel GA, 2015, BRIT J CANCER, V112, pS129, DOI 10.1038/bjc.2015.52; Aizer AA, 2013, J CLIN ONCOL, V31, P3869, DOI 10.1200/JCO.2013.49.6489; Al-Hamadani M, 2015, AM J HEMATOL, V90, P790, DOI 10.1002/ajh.24086; Alberto Q, 2013, CRIT REV ONCOL HEMAT, V85, P266, DOI 10.1016/j.critrevonc.2012.08.007; Bonnet C, 2007, J CLIN ONCOL, V25, P787, DOI 10.1200/JCO.2006.07.0722; Braga IC, 2015, J CANC ED; Bray C, 2008, LEUKEMIA LYMPHOMA, V49, P917, DOI 10.1080/10428190801933377; Brown LM, 2015, INT J CANC; Burns RM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106456; Cancela MDC, 2015, CANCER EPIDEMIOL, V39, P778, DOI 10.1016/j.canep.2015.08.006; Chang CM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044325; Charlson M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112479; Coiffier B, 2002, NEW ENGL J MED, V346, P235, DOI 10.1056/NEJMoa011795; Cox B, 2014, J CANCER EPIDEMIOL, V2014, DOI 10.1155/2014/315378; Crozier JA, 2015, CL LYMPH MYELOM LEUK, V15, P578, DOI 10.1016/j.clml.2015.06.005; De Angelis R, 2015, EUR J CANCER, V51, P2254, DOI 10.1016/j.ejca.2015.08.003; De Angelis R, 2014, LANCET ONCOL, V15, P23, DOI 10.1016/S1470-2045(13)70546-1; deRijke JM, 1996, ANN ONCOL, V7, P677; Economic and Social Research Institute Department of Health Health Service Executive, 2013, ACT AC PUBL HOSP IR; Ewing J C, 2003, Hematology, V8, P211, DOI 10.1080/1024533031000135685; Firat S, 2006, AM J CLIN ONCOL-CANC, V29, P252, DOI 10.1097/01.coc.0000217824.20290.ab; Forbes LJL, 2011, BRIT J CANCER, V105, P1474, DOI 10.1038/bjc.2011.406; Frederiksen BL, 2012, BRIT J CANCER, V106, P988, DOI 10.1038/bjc.2012.3; Frederiksen BL, 2011, EUR J CANCER, V47, P910, DOI 10.1016/j.ejca.2010.11.014; Haase T, 2012, POBAL HP DEPRIVATION; Hastert TA, 2016, SOC SCI MED, V148, P52, DOI 10.1016/j.socscimed.2015.11.023; Health Service Executive, 2014, HLTH SERV PERF ASS R; Inverso G, 2015, CANCER-AM CANCER SOC, V121, P1273, DOI 10.1002/cncr.29171; Irish Health, 2011, ALL HAIL MIGHT WAIT; Issa DE, 2015, HAEMATOLOGICA, V100, P528, DOI 10.3324/haematol.2014.107300; Jansen L, 2015, INT J CANCER, V136, P2649, DOI 10.1002/ijc.29316; Kato Ikuko, 2012, J Registry Manag, V39, P158; Kent EE, 2015, CANCER CAUSE CONTROL, V26, P1153, DOI 10.1007/s10552-015-0609-1; Kogevinas M, 1997, IARC Sci Publ, P177; Luddy G, 2007, Ir Med J, V100, P71; Lyratzopoulos G, 2015, BRIT J CANCER, V112, pS35, DOI 10.1038/bjc.2015.40; Lyratzopoulos G, 2015, CANCER EPIDEM BIOMAR, V24, P720, DOI 10.1158/1055-9965.EPI-14-0969; Macleod U, 2009, BRIT J CANCER, V101, pS92, DOI 10.1038/sj.bjc.6605398; Marlow LAV, 2014, PSYCHO-ONCOLOGY, V23, P749, DOI 10.1002/pon.3464; Muthen L, 2007, MUTH N MUTH N; O'Brien K, 2014, IRISH J MED SCI, V183, P219, DOI 10.1007/s11845-013-0993-z; Olszewski AJ, 2015, ONCOLOGIST, V20, P1223, DOI 10.1634/theoncologist.2015-0228; Ozturk C, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0141244; Pratschke J, 2016, BMC MED RES METHODOL, V16, DOI 10.1186/s12874-016-0130-6; Pulte D, 2008, ARCH INTERN MED, V168, P469, DOI 10.1001/archinternmed.2007.125; Quaglia A, 2005, CRIT REV ONCOL HEMAT, V54, P117, DOI 10.1016/j.critrevonc.2004.12.001; Roswall N, 2008, EUR J CANCER, V44, P2058, DOI 10.1016/j.ejca.2008.06.011; Sant M, 2014, LANCET ONCOL, V15, P931, DOI 10.1016/S1470-2045(14)70282-7; Scottish Cancer Intelligence Unit, 2000, TRENDS CANC SURV SCO; Sharp L, 2014, J URBAN HEALTH, V91, P510, DOI 10.1007/s11524-013-9846-3; Shephard EA, 2015, BRIT J GEN PRACT, V65, pE289, DOI 10.3399/bjgp15X684805; Shiels MS, 2013, CANCER EPIDEM BIOMAR, V22, P1069, DOI 10.1158/1055-9965.EPI-13-0040; Smith A, 2015, CANC EPIDEMIOL; Tang SY, 2015, SOCIOL HEALTH ILL, V37, P698, DOI 10.1111/1467-9566.12236; The Health Insurance Authority, 2014, ANN REP ACC 2013; Thompson AS, 2016, J MULTILING MULTICUL, V37, P115, DOI 10.1080/01434632.2015.1031136; Vasudev NS, 2004, BRIT J GEN PRACT, V54, P595; Vedsted P, 2011, BRIT J GEN PRACT, V61, DOI 10.3399/bjgp11X588484; Vulto AJCM, 2006, CANCER-AM CANCER SOC, V106, P2734, DOI 10.1002/cncr.21934; Wang M, 2008, CANCER-AM CANCER SOC, V113, P3231, DOI 10.1002/cncr.23914; Woods LM, 2006, ANN ONCOL, V17, P5, DOI 10.1093/annonc/mdj007; Zhang Amy Y, 2003, Oncol Nurs Forum, V30, P1022; Zhou R, 2015, J GASTROENTEROL HEPA	63	5	5	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 19	2016	11	12							e0168684	10.1371/journal.pone.0168684	http://dx.doi.org/10.1371/journal.pone.0168684			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EI9QC	27992551	Green Published, Green Submitted, gold			2022-12-27	WOS:000392842600087
J	Ge, L; Zhao, YL; Zhou, K; Mu, XM; Yu, HB; Wang, YF; Wang, N; Fan, H; Guo, LQ; Huo, XX				Ge, Liang; Zhao, Youlin; Zhou, Kui; Mu, Xiangming; Yu, Haibo; Wang, Yongfeng; Wang, Ning; Fan, Hong; Guo, Liqiang; Huo, XiXiang			Spatio-Temporal Pattern and Influencing Factors of Hemorrhagic Fever with Renal Syndrome (HFRS) in Hubei Province (China) between 2005 and 2014	PLOS ONE			English	Article								Hemorrhagic Fever with Renal Syndrome (HFRS) is considered as a globally distributed infectious disease, which results in many deaths annually in Hubei Province, China. The outbreak of HFRS is usually characterized with spatio-temporal heterogeneity and is seasonally distributed. Further, it might also be impacted by the influencing factors such as socio-economic and geographical environment. To better understand and predict the outbreak of HFRS in the Hubei Province, the spatio-temporal pattern and influencing factors were investigated in this study. Moran's I Index value was adopted in spatial global autocorrelation analysis to identify the overall spatio-temporal pattern of HFRS outbreak. Kulldorff scan statistical analysis was performed to further identify the changing trends of the clustering patterns of HFRS outbreak. Spearman's rank correlation analysis was used to explore the possible influencing factors on HFRS epidemics such as climate and geographic. The results demonstrated that HFRS outbreak in Hubei Province decreased from 2005 to 2012 in general while increasing slightly from 2012 to 2014. The spatial and temporal scan statistical analysis indicated that HFRS epidemic was temporally clustered in summer and autumn from 2005 to 2014 except 2008 and 2011. The seasonal epidemic pattern of HFRS in Hubei Province was characterized by a bimodal pattern (March to May and September to November) while peaks often occurring in the spring time. SEOV-type HFRS was presumed to influence more on the total number of HFRS incidence than HTNV-type HFRS do. The average humidity and human population density were the main influencing factors during these years. HFRS outbreaks were more in plains than in other areas of Hubei Province. We did not find that whether the terrain of the wetland (water system) plays a significant role in the outbreak of HFRS incidence. With a better understanding of rodent infection rate, socioeconomic status and ecological environment characteristics, this study may help to reduce the outbreak of HFRS disease.	[Ge, Liang; Fan, Hong] Wuhan Univ, State Key Lab Informat Engn Surveying Mapping & R, Wuhan, Hubei Province, Peoples R China; [Ge, Liang; Zhou, Kui; Yu, Haibo; Wang, Yongfeng; Guo, Liqiang] Tianjin Inst Surveying & Mapping, Tianjin, Peoples R China; [Zhao, Youlin] Hohai Univ, Sch Business, Nanjing, Jiangsu, Peoples R China; [Mu, Xiangming] Univ Wisconsin, Sch Informat Studies, 2025 E Newpot Ave NWQB, Milwaukee, WI 53201 USA; [Wang, Ning] China Earthquake Adm, Crust Deformat Monitoring & Applicat Ctr 1, Tianjin, Peoples R China; [Huo, XiXiang] Hubei Prov Ctr Dis Control & Prevent, Wuhan, Peoples R China	Wuhan University; Hohai University; University of Wisconsin System; University of Wisconsin Milwaukee; China Earthquake Administration	Ge, L (corresponding author), Wuhan Univ, State Key Lab Informat Engn Surveying Mapping & R, Wuhan, Hubei Province, Peoples R China.; Ge, L (corresponding author), Tianjin Inst Surveying & Mapping, Tianjin, Peoples R China.	geliang0021@126.com; xixianghuo@163.com	Wang, Yuan/HHC-1520-2022; Wang, Yin/HCI-9352-2022; wang, yan/GSE-6489-2022; Wang, Yanbo/HFZ-8018-2022	Ge, Liang/0000-0002-3365-353X	National Natural Science Foundation of China [71503068]; Fundamental Research Funds in Key Research Areas for the Central Universities [2015B09614]; Fundamental Research Funds for the Central Universities [2014B15114]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fundamental Research Funds in Key Research Areas for the Central Universities; Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	Funded by National Natural Science Foundation of China, No. 71503068,http://www.nsfc.gov.cn and Fundamental Research Funds in Key Research Areas for the Central Universities, No. 2015B09614; Fundamental Research Funds for the Central Universities, No. 2014B15114 http://www.moe.edu.cn/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by the National Natural Science Foundation of China, No. 71503068; Fundamental Research Funds in Key Research Areas for the Central Universities, No. 2015B09614; Fundamental Research Funds for the Central Universities, No. 2014B15114.	Alvarez J, 2016, PREV VET MED, V123, P155, DOI 10.1016/j.prevetmed.2015.11.003; [Anonymous], LANDSCAPE ELEMENTS H; Azage M, 2015, PLOS ONE, V12; Bi P, 1998, AM J EPIDEMIOL, V148, P276, DOI 10.1093/oxfordjournals.aje.a009636; Bi P, 2002, INT J EPIDEMIOL, V31, P189, DOI 10.1093/ije/31.1.189; Chen J, 2008, INT J HEALTH GEOGR, V7, DOI 10.1186/1476-072X-7-57; Cui F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067490; Du H, 2014, BMC INFECT DIS, V14, DOI 10.1186/1471-2334-14-191; Fang LQ, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000789; Fang LQ, 2009, EMERG INFECT DIS, V15, P2043, DOI 10.3201/eid1512.081078; Fang LQ, 2006, BMC INFECT DIS, V6, DOI 10.1186/1471-2334-6-77; Ge EJ, 2016, INFECT DIS POVERTY, V5, DOI 10.1186/s40249-016-0104-2; Guan P, 2009, BMC INFECT DIS, V9, DOI 10.1186/1471-2334-9-109; Hardestam J, 2007, APPL ENVIRON MICROB, V73, P2547, DOI 10.1128/AEM.02869-06; Kelly-Hope L, 2008, ADV GLOB CHANGE RES, V30, P31, DOI 10.1007/978-1-4020-6877-5_3; Lefebvre A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0139920; Li Q, 2005, ACTA VIROL, V49, P51; Li S, 2014, INT J ENV RES PUB HE; Li X, 2012, ORG MED CHEM LETT, V2, P2, DOI DOI 10.1371/J0URNAL.P0NE.0044916; Lin HL, 2007, BMC PUBLIC HEALTH, V7, DOI 10.1186/1471-2458-7-207; Liu J, 2012, VIRUS RES, V163, P439, DOI 10.1016/j.virusres.2011.11.006; Liu Q, 2011, BMC INFECT DIS; MORAN PAP, 1950, BIOMETRIKA, V37, P17, DOI 10.1093/biomet/37.1-2.17; Myers J. L., 2003, RES DESIGN STAT ANAL; Odoi Agricola, 2004, Int J Health Geogr, V3, P11, DOI 10.1186/1476-072X-3-11; Piechotowski I, 2008, PARASITOL RES, V103, pS131, DOI 10.1007/s00436-008-1055-8; Puth MT, 2015, ANIM BEHAV, V102, P77, DOI 10.1016/j.anbehav.2015.01.010; Schmaljohn C, 1997, EMERG INFECT DIS, V3, P95, DOI 10.3201/eid0302.970202; Sugumaran R, 2009, INT J HEALTH GEOGR, V8, DOI 10.1186/1476-072X-8-43; Tiwari Neeraj, 2006, Int J Health Geogr, V5, P33, DOI 10.1186/1476-072X-5-33; Wikipedia, 2011, WIK VAND, V3, P35; WU JQGZ W, 2009, EPIDEMIOL INFECT; Wu W, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-229; Xiao H, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-305; XU ZY, 1985, J INFECT DIS, V152, P137, DOI 10.1093/infdis/152.1.137; Zeier M, 2005, VIRUS GENES, V30, P157, DOI 10.1007/s11262-004-5625-2; [张世煌 Zhang Shihuang], 2006, [玉米科学, Maize Science], V14, P1; Zhang WY, 2010, ENVIRON HEALTH PERSP, V118, P915, DOI 10.1289/ehp.0901504; Zhang WY, 2009, AM J TROP MED HYG, V80, P678, DOI 10.4269/ajtmh.2009.80.678; Zhang WY, 2015, PLOS ONE, V7; Zhang YH, 2014, PLOS ONE, V3; Zheng L, 2015, EPIDEMIOL INFECT, V143, P2451, DOI 10.1017/S0950268814003598; Zou Y, 2008, J MED VIROL, V80, P680, DOI 10.1002/jmv.21119; Zuo SQ, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0000945	44	9	15	1	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2016	11	12							e0167836	10.1371/journal.pone.0167836	http://dx.doi.org/10.1371/journal.pone.0167836			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EG7JB	28030550	Green Submitted, Green Published, gold			2022-12-27	WOS:000391222000023
J	Liu, HZ; Li, Y; Chen, L; Zhang, Q; Pan, N; Nichols, DH; Zhang, WPJ; Fritzsch, B; He, DZZ				Liu, Huizhan; Li, Yi; Chen, Lei; Zhang, Qian; Pan, Ning; Nichols, David H.; Zhang, Weiping J.; Fritzsch, Bernd; He, David Z. Z.			Organ of Corti and Stria Vascularis: Is there an Interdependence for Survival?	PLOS ONE			English	Article							OUTER HAIR-CELLS; WAARDENBURG SYNDROME; INTERMEDIATE CELLS; FINE-STRUCTURE; COCHLEAR; INNER; POTASSIUM; FUROSEMIDE; MUTATIONS; K+	Cochlear hair cells and the stria vascularis are critical for normal hearing. Hair cells transduce mechanical stimuli into electrical signals, whereas the stria is responsible for generating the endocochlear potential (EP), which is the driving force for hair cell mechanotransduction. We questioned whether hair cells and the stria interdepend for survival by using two mouse models. Atoh1 conditional knockout mice, which lose all hair cells within four weeks after birth, were used to determine whether the absence of hair cells would affect function and survival of stria. We showed that stria morphology and EP remained normal for long time despite a complete loss of all hair cells. We then used a mouse model that has an abnormal stria morphology and function due to mutation of the Mitf gene to determine whether hair cells are able to survive and transduce sound signals without a normal electrochemical environment in the endolymph. A strial defect, reflected by missing intermediate cells in the stria and by reduction of EP, led to systematic outer hair cell death from the base to the apex after postnatal day 18. However, an 18-mV EP was sufficient for outer hair cell survival. Surprisingly, inner hair cell survival was less vulnerable to reduction of the EP. Our studies show that normal function of the stria is essential for adult outer hair cell survival, while the survival and normal function of the stria vascularis do not depend on functional hair cells.	[Liu, Huizhan; Li, Yi; Chen, Lei; Zhang, Qian; Nichols, David H.; He, David Z. Z.] Creighton Univ, Sch Med, Dept Biomed Sci, Omaha, NE 68178 USA; [Li, Yi] Beijing Capital Med Univ, Beijing Tongren Hosp, Dept Otorhinolaryngol, Beijing, Peoples R China; [Chen, Lei] Chongqing Acad Anim Sci, Chongqing, Peoples R China; [Pan, Ning; Fritzsch, Bernd] Univ Iowa, Dept Biol, Iowa City, IA 52242 USA; [Zhang, Weiping J.] Second Mil Med Univ, Dept Pathophysiol, Shanghai, Peoples R China	Creighton University; Capital Medical University; University of Iowa; Naval Medical University	He, DZZ (corresponding author), Creighton Univ, Sch Med, Dept Biomed Sci, Omaha, NE 68178 USA.	hed@creighton.edu		Li (li yi), Yi/0000-0002-9986-6546; He (he zhi zhou), Zhi-Zhou/0000-0001-8383-9634; Fritzsch, Bernd/0000-0002-4882-8398	NIH from the NIDCD [R01 DC004696]; National Natural Science Foundation of China [81600798]; NIH from the National Center for Research Resources [G20RR024001, C06RR17417]; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC004696] Funding Source: NIH RePORTER	NIH from the NIDCD; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); NIH from the National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	The work has been supported by NIH grant R01 DC004696 to DZH from the NIDCD and by a grant from National Natural Science Foundation of China (#81600798) to YL. The animal and imaging facility has also been supported by NIH grants G20RR024001 and C06RR17417 from the National Center for Research Resources. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Center for Research Resources or the NIH.	Ashmore J. F., 1989, COCHLEAR MECH, P107; ASHMORE JF, 1986, NATURE, V322, P368, DOI 10.1038/322368a0; Bermingham NA, 1999, SCIENCE, V284, P1837, DOI 10.1126/science.284.5421.1837; BROWNELL WE, 1985, SCIENCE, V227, P194, DOI 10.1126/science.3966153; Cai TT, 2015, J NEUROSCI, V35, P5870, DOI 10.1523/JNEUROSCI.5083-14.2015; Cai TT, 2013, J NEUROSCI, V33, P10110, DOI 10.1523/JNEUROSCI.5606-12.2013; Chen L, 2016, BMC BIOL, V14, DOI 10.1186/s12915-016-0273-2; Chiba T, 2000, J MEMBRANE BIOL, V174, P167, DOI 10.1007/s002320001041; Cohen-Salmon M, 2002, CURR BIOL, V12, P1106, DOI 10.1016/S0960-9822(02)00904-1; Cohen-Salmon M, 2007, P NATL ACAD SCI USA, V104, P6229, DOI 10.1073/pnas.0605108104; DALLOS P, 1990, J ACOUST SOC AM, V87, P1636, DOI 10.1121/1.399411; Dallos P., 1996, COCHLEA, P1, DOI [10.1007/978-1-4612-0757-3, DOI 10.1007/978-1-4612-0757-3_1]; DAVIS H, 1965, COLD SPRING HARB SYM, V30, P181, DOI 10.1101/SQB.1965.030.01.020; DEOL MS, 1970, PROC R SOC SER B-BIO, V175, P201, DOI 10.1098/rspb.1970.0019; DURRANT JD, 1972, J ACOUST SOC AM, V52, P1725, DOI 10.1121/1.1913307; EVANS EF, 1982, J PHYSIOL-LONDON, V331, P409, DOI 10.1113/jphysiol.1982.sp014379; Farris HE, 2006, J NEUROSCI, V26, P12526, DOI 10.1523/JNEUROSCI.3569-06.2006; Gow A, 2004, J NEUROSCI, V24, P7051, DOI 10.1523/JNEUROSCI.1640-04.2004; He DZZ, 1999, J NEUROPHYSIOL, V81, P1162, DOI 10.1152/jn.1999.81.3.1162; He DZZ, 2004, NATURE, V429, P766, DOI 10.1038/nature02591; HODGKINSON CA, 1993, CELL, V74, P395, DOI 10.1016/0092-8674(93)90429-T; HOUSLEY GD, 1992, J PHYSIOL-LONDON, V448, P73, DOI 10.1113/jphysiol.1992.sp019030; Jia SP, 2005, NAT NEUROSCI, V8, P1028, DOI 10.1038/nn1509; Johnson SL, 2017, J NEUROSCI, V37, P258, DOI [10.1523/JNEUROSCI.2251-16.2016, 10.1523/JNEUROSCI.2251-16.2017]; Johnson SL, 2011, NEURON, V70, P1143, DOI 10.1016/j.neuron.2011.04.024; Johnstone BM, 1964, ACTA OTO-LARYNGOL, V60, P113; Kharkovets T, 2006, EMBO J, V25, P642, DOI 10.1038/sj.emboj.7600951; Kikuchi Toshihiko, 2000, Medical Electron Microscopy, V33, P51, DOI 10.1007/s007950070001; Kim HJ, 2013, J NEUROSCI, V33, P14601, DOI 10.1523/JNEUROSCI.2147-13.2013; KONISHI T, 1978, ACTA OTO-LARYNGOL, V86, P22, DOI 10.3109/00016487809124717; KONISHI T, 1979, ACTA OTO-LARYNGOL, V87, P506, DOI 10.3109/00016487909126459; Li Y, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0151291; Liu HZ, 2014, J NEUROSCI, V34, P11085, DOI 10.1523/JNEUROSCI.1690-14.2014; Marcus DC, 1999, HEARING RES, V134, P48, DOI 10.1016/S0378-5955(99)00074-X; Marcus DC, 2002, AM J PHYSIOL-CELL PH, V282, pC403, DOI 10.1152/ajpcell.00312.2001; MARCUS DC, 1984, AM J PHYSIOL, V247, pC240, DOI 10.1152/ajpcell.1984.247.3.C240; Muller M, 2005, HEARING RES, V202, P63, DOI 10.1016/j.heares.2004.08.011; Ni C, 2013, PIGM CELL MELANOMA R, V26, P78, DOI 10.1111/pcmr.12030; Ohlemiller KK, 2006, HEARING RES, V220, P10, DOI 10.1016/j.heares.2006.06.012; Pan N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030358; Pan N, 2011, HEARING RES, V275, P66, DOI 10.1016/j.heares.2010.12.002; Pingault V, 2010, HUM MUTAT, V31, P391, DOI 10.1002/humu.21211; RUGGERO MA, 1991, J NEUROSCI, V11, P1057; RUSSELL IJ, 1983, NATURE, V301, P334, DOI 10.1038/301334a0; RYBAK LP, 1982, HEARING RES, V7, P223, DOI 10.1016/0378-5955(82)90015-6; SALT AN, 1987, LARYNGOSCOPE, V97, P984; SALT AN, 1993, ANN OTO RHINOL LARYN, V102, P64, DOI 10.1177/000348949310200112; SANTOS-SACCHI J, 1989, J NEUROSCI, V9, P2954; Santos-Sacchi J, 2001, HEARING RES, V159, P69, DOI 10.1016/S0378-5955(01)00321-5; Scheffer DI, 2015, J NEUROSCI, V35, P6366, DOI 10.1523/JNEUROSCI.5126-14.2015; SEWELL WF, 1984, HEARING RES, V14, P305, DOI 10.1016/0378-5955(84)90057-1; Spicer SS, 1996, HEARING RES, V100, P80, DOI 10.1016/0378-5955(96)00106-2; Spicer SS, 1998, HEARING RES, V118, P1, DOI 10.1016/S0378-5955(98)00006-9; STEEL KP, 1989, DEVELOPMENT, V107, P453; STEINGRIMSSON E, 1994, NAT GENET, V8, P256, DOI 10.1038/ng1194-256; Takeuchi S, 2000, BIOPHYS J, V79, P2572, DOI 10.1016/S0006-3495(00)76497-6; TASAKI I, 1959, J NEUROPHYSIOL, V22, P149, DOI 10.1152/jn.1959.22.2.149; TASSABEHJI M, 1994, NAT GENET, V8, P251, DOI 10.1038/ng1194-251; WAARDENBURG PJ, 1951, AM J HUM GENET, V3, P195; Wangemann P, 2002, HEARING RES, V165, P1, DOI 10.1016/S0378-5955(02)00279-4; Wangemann P, 2006, J PHYSIOL-LONDON, V576, P11, DOI 10.1113/jphysiol.2006.112888; WOOLF NK, 1986, AM J PHYSIOL, V250, pR493, DOI 10.1152/ajpregu.1986.250.3.R493; Yang Sienhung, 2012, Evid Based Complement Alternat Med, V2012, P521780, DOI 10.1155/2012/521780; Zdebik AA, 2009, PHYSIOLOGY, V24, P307, DOI 10.1152/physiol.00018.2009; Zhang Q, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112857; Zhang Q, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062786; Zheng J, 2000, NATURE, V405, P149, DOI 10.1038/35012009; ZIDANIC M, 1990, BIOPHYS J, V57, P1253, DOI 10.1016/S0006-3495(90)82644-8	68	31	33	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2016	11	12							e0168953	10.1371/journal.pone.0168953	http://dx.doi.org/10.1371/journal.pone.0168953			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EG7JB	28030585	Green Published, gold, Green Submitted			2022-12-27	WOS:000391222000089
J	Cortjens, B; Lutter, R; Boon, L; Bem, RA; van Woensel, JBM				Cortjens, Bart; Lutter, Rene; Boon, Louis; Bem, Reinout A.; van Woensel, Job B. M.			Pneumovirus-Induced Lung Disease in Mice Is Independent of Neutrophil-Driven Inflammation	PLoS One			English	Article							RESPIRATORY SYNCYTIAL VIRUS; INFLUENZA INFECTION; VIRAL BRONCHIOLITIS; DISTRESS-SYNDROME; PNEUMONIA VIRUS; INFANTS; RESPONSES; SEVERITY; INJURY; MOUSE	The human pneumovirus respiratory syncytial virus (RSV) is the most common pathogen causing lower respiratory tract disease in young children worldwide. A hallmark of severe human RSV infection is the strong neutrophil recruitment to the airways and lungs. Massive neutrophil activation has been proven detrimental in numerous diseases, yet in RSV the contribution of neutrophils to disease severity, and thereby, the relevance of targeting them, is largely unknown. To determine the relevance of potential neutrophil targeting therapies, we implemented antibody-mediated neutrophil depletion in a mouse pneumonia virus of mice (PVM) model. PVM is a host specific murine pneumovirus closely related to human RSV, which reproduces many of the features of RSV infection, such as high viral replication and neutrophil recruitment. Clinical disease and markers of lung inflammation and injury were studied in PVM-infected mice treated with either depleting or isotype control antibodies. To confirm our results we performed all experiments in two mice strains: C57Bl6 and BALBc mice. Neutrophil depletion in blood and lungs was efficient throughout the disease. Remarkably, in both mouse strains we found no difference in clinical disease severity between neutrophil-depleted and control arms. In line with this observation, we found no differences between groups in histopathological lung injury and lung viral loads. In conclusion, our study shows that in mice neutrophil recruitment to the lungs does not affect disease outcome or viral clearance during severe PVM infection. As such, this model does not support the notion that neutrophils play a key role in mouse pneumovirus disease.	[Cortjens, Bart; Bem, Reinout A.; van Woensel, Job B. M.] Emma Childrens Hosp AMC, Pediat Intens Care Unit, Amsterdam, Netherlands; [Lutter, Rene] Acad Med Ctr, Expt Immunol & Resp Med, Amsterdam, Netherlands; [Boon, Louis] Epirus Biopharmaceut Netherlands, Utrecht, Netherlands	Emma Children's Hospital; University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam	Cortjens, B (corresponding author), Emma Childrens Hosp AMC, Pediat Intens Care Unit, Amsterdam, Netherlands.	b.cortjens@amc.nl	Boon, Laurence/HCI-3629-2022; A., Reinout/AAN-1411-2021	Cortjens, Bart/0000-0002-0289-4250; Bem, Reinout Alexander/0000-0002-9454-5321; Boon, Louis/0000-0002-0937-9171	Epirus Biopharmaceuticals Netherlands	Epirus Biopharmaceuticals Netherlands	Epirus Biopharmaceuticals Netherlands provided support in the form of salaries for author LB, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Anh DBT, 2006, AM J PHYSIOL-LUNG C, V291, pL426, DOI 10.1152/ajplung.00483.2005; Awasthi YC, 2008, FREE RADICAL BIO MED, V45, P111, DOI 10.1016/j.freeradbiomed.2008.04.007; Bem RA, 2011, AM J PHYSIOL-LUNG C, V301, pL148, DOI 10.1152/ajplung.00065.2011; Bem RA, 2010, J IMMUNOL, V184, P931, DOI 10.4049/jimmunol.0903029; Bem RA, 2009, AM J PHYSIOL-LUNG C, V296, pL46, DOI 10.1152/ajplung.00467.2007; Bonville CA, 2007, VIROLOGY, V368, P182, DOI 10.1016/j.virol.2007.06.020; Bonville CA, 2006, VIROLOGY, V349, P87, DOI 10.1016/j.virol.2006.02.017; Brandes M, 2013, CELL, V154, P197, DOI 10.1016/j.cell.2013.06.013; Cortjens B, 2016, J PATHOL, V238, P401, DOI 10.1002/path.4660; Daley JM, 2008, J LEUKOCYTE BIOL, V83, P64, DOI 10.1189/jlb.0407247; DeVincenzo JP, 2010, AM J RESP CRIT CARE, V182, P1305, DOI 10.1164/rccm.201002-0221OC; DeVincenzo JP, 2005, J INFECT DIS, V191, P1861, DOI 10.1086/430008; Domachowske JB, 2000, CELL IMMUNOL, V206, P1, DOI 10.1006/cimm.2000.1730; EVERARD ML, 1994, ARCH DIS CHILD, V71, P428, DOI 10.1136/adc.71.5.428; Frey S, 2008, J VIROL, V82, P11619, DOI 10.1128/JVI.00375-08; Geerdink RJ, 2015, J ALLERGY CLIN IMMUN, V136, P838, DOI 10.1016/j.jaci.2015.06.034; Halfhide CP, 2011, J INFECT DIS, V204, P451, DOI 10.1093/infdis/jir280; Jain S, 2015, NEW ENGL J MED, V372, P835, DOI 10.1056/NEJMoa1405870; Jenne CN, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004546; Marguet C, 2008, PEDIAT ALLERG IMM-UK, V19, P157, DOI 10.1111/j.1399-3038.2007.00600.x; Meissner HC, 2016, NEW ENGL J MED, V374, P62, DOI 10.1056/NEJMra1413456; Mestas J, 2004, J IMMUNOL, V172, P2731, DOI 10.4049/jimmunol.172.5.2731; Mizgerd JP, 2008, NEW ENGL J MED, V358, P716, DOI 10.1056/NEJMra074111; Nair H, 2010, LANCET, V375, P1545, DOI 10.1016/S0140-6736(10)60206-1; Narasaraju T, 2011, AM J PATHOL, V179, P199, DOI 10.1016/j.ajpath.2011.03.013; Nauseef WM, 2014, NAT IMMUNOL, V15, P602, DOI 10.1038/ni.2921; Pickles RJ, 2015, J PATHOL, V235, P266, DOI 10.1002/path.4462; Rygiel TP, 2009, J IMMUNOL, V183, P1990, DOI 10.4049/jimmunol.0900252; Schene KM, 2014, PEDIATR PULM, V49, P1138, DOI 10.1002/ppul.22974; Smyth RL, 2002, PEDIATR PULM, V33, P339, DOI 10.1002/ppul.10080; Stokes KL, 2013, J VIROL, V87, P10070, DOI 10.1128/JVI.01347-13; Tate MD, 2012, IMMUNOL CELL BIOL, V90, P197, DOI 10.1038/icb.2011.26; Tate MD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017618; Tate MD, 2009, J IMMUNOL, V183, P7441, DOI 10.4049/jimmunol.0902497; Wang S Z, 2000, Respirology, V5, P1, DOI 10.1046/j.1440-1843.2000.00219.x; Ware LB, 2000, NEW ENGL J MED, V342, P1334, DOI 10.1056/NEJM200005043421806; Welliver TP, 2007, J INFECT DIS, V195, P1126, DOI 10.1086/512615; Wojtasiak M, 2010, J GEN VIROL, V91, P2158, DOI 10.1099/vir.0.021915-0	38	12	12	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2016	11	12							e0168779	10.1371/journal.pone.0168779	http://dx.doi.org/10.1371/journal.pone.0168779			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI9QH	28005954	Green Published, gold, Green Submitted			2022-12-27	WOS:000392843200092
J	Gallen, CL; Baniqued, PL; Chapman, SB; Aslan, S; Keebler, M; Didehbani, N; D'Esposito, M				Gallen, Courtney L.; Baniqued, Pauline L.; Chapman, Sandra B.; Aslan, Sina; Keebler, Molly; Didehbani, Nyaz; D'Esposito, Mark			Modular Brain Network Organization Predicts Response to Cognitive Training in Older Adults	PLOS ONE			English	Article							FUNCTIONAL CONNECTIVITY; WHITE-MATTER; HEAD MOTION; PLASTICITY; DYNAMICS; IMPACT; SKILL	Cognitive training interventions are a promising approach to mitigate cognitive deficits common in aging and, ultimately, to improve functioning in older adults. Baseline neural factors, such as properties of brain networks, may predict training outcomes and can be used to improve the effectiveness of interventions. Here, we investigated the relationship between baseline brain network modularity, a measure of the segregation of brain sub-networks, and training-related gains in cognition in older adults. We found that older adults with more segregated brain sub-networks (i.e., more modular networks) at baseline exhibited greater training improvements in the ability to synthesize complex information. Further, the relationship between modularity and training-related gains was more pronounced in sub-networks mediating "associative" functions compared with those involved in sensory-motor processing. These results suggest that assessments of brain networks can be used as a biomarker to guide the implementation of cognitive interventions and improve outcomes across individuals. More broadly, these findings also suggest that properties of brain networks may capture individual differences in learning and neuroplasticity.	[Gallen, Courtney L.; Baniqued, Pauline L.; D'Esposito, Mark] Univ Calif Berkeley, Helen Wills Neurosci Inst, Berkeley, CA 94720 USA; [Chapman, Sandra B.; Aslan, Sina; Keebler, Molly; Didehbani, Nyaz] Univ Texas Dallas, Ctr BrainHlth, Dallas, TX USA; [D'Esposito, Mark] Univ Calif Berkeley, Dept Psychol, 3210 Tolman Hall, Berkeley, CA 94720 USA	University of California System; University of California Berkeley; University of Texas System; University of Texas Dallas; University of California System; University of California Berkeley	Gallen, CL (corresponding author), Univ Calif Berkeley, Helen Wills Neurosci Inst, Berkeley, CA 94720 USA.	clg5026@berkeley.edu		Didehbani, Nyaz/0000-0001-6121-5759	National Institutes of Health [NS79698, RC1-AG035954]; Department of Defense Air Force Office of Scientific Research (National Defense Science and Engineering Graduate Fellowship) [32 CFR 168a]; Lyda Hill Foundation; T. Boone Pickens Foundation; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS079698] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [RC1AG035954] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Defense Air Force Office of Scientific Research (National Defense Science and Engineering Graduate Fellowship); Lyda Hill Foundation; T. Boone Pickens Foundation; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by the National Institutes of Health (grant number NS79698 to MD and RC1-AG035954 to SBC), the Department of Defense Air Force Office of Scientific Research (National Defense Science and Engineering Graduate Fellowship 32 CFR 168a to CLG), and by grants from the Lyda Hill Foundation and the T. Boone Pickens Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], [No title captured]; [Anonymous], [No title captured]; [Anonymous], [No title captured]; [Anonymous], 2006, ENCY STAT SCI; [Anonymous], [No title captured]; Arnemann KL, 2015, NEUROLOGY, V84, P1568, DOI 10.1212/WNL.0000000000001476; Ballesteros S, 2015, NEUROSCI BIOBEHAV R, V55, P453, DOI 10.1016/j.neubiorev.2015.06.008; Basak C, 2011, BRAIN COGNITION, V76, P407, DOI 10.1016/j.bandc.2011.03.017; Bassett DS, 2015, NAT NEUROSCI, V18, P744, DOI 10.1038/nn.3993; Behzadi Y, 2007, NEUROIMAGE, V37, P90, DOI 10.1016/j.neuroimage.2007.04.042; Betzel RF, 2014, NEUROIMAGE, V102, P345, DOI 10.1016/j.neuroimage.2014.07.067; Bherer L, 2015, ANN NY ACAD SCI, V1337, P1, DOI 10.1111/nyas.12682; Brehmer Y, 2014, PSYCHOL RES-PSYCH FO, V78, P790, DOI 10.1007/s00426-014-0587-z; Cao WF, 2016, FRONT AGING NEUROSCI, V8, DOI 10.3389/fnagi.2016.00070; Chan MY, 2014, P NATL ACAD SCI USA, V111, pE4997, DOI 10.1073/pnas.1415122111; Chen ZJ, 2011, NEUROIMAGE, V56, P235, DOI 10.1016/j.neuroimage.2011.01.010; Cohen J., 2003, APPL MULTIPLE REGRES; Ellefsen KO, 2015, PLOS COMPUT BIOL, V11, DOI 10.1371/journal.pcbi.1004128; Engvig A, 2012, HUM BRAIN MAPP, V33, P2390, DOI 10.1002/hbm.21370; Erickson KI, 2010, CEREB CORTEX, V20, P2522, DOI 10.1093/cercor/bhp293; Fortunato S, 2016, PHYS REP, V659, P1, DOI 10.1016/j.physrep.2016.09.002; Friston KJ, 1996, MAGNET RESON MED, V35, P346, DOI 10.1002/mrm.1910350312; Gallen CL, 2016, NEUROBIOL AGING, V44, P42, DOI 10.1016/j.neurobiolaging.2016.04.003; Geerligs L, 2015, CEREB CORTEX, V25, P1987, DOI 10.1093/cercor/bhu012; Grady C, 2012, NAT REV NEUROSCI, V13, P491, DOI 10.1038/nrn3256; Kashtan N, 2005, P NATL ACAD SCI USA, V102, P13773, DOI 10.1073/pnas.0503610102; Kelly ME, 2014, AGEING RES REV, V15, P28, DOI 10.1016/j.arr.2014.02.004; Liang X, 2016, CEREB CORTEX, V26, P1501, DOI 10.1093/cercor/bhu316; Lovden M, 2010, NEUROPSYCHOLOGIA, V48, P3878, DOI 10.1016/j.neuropsychologia.2010.08.026; Lustig C, 2009, NEUROPSYCHOL REV, V19, P504, DOI 10.1007/s11065-009-9119-9; Mathewson KE, 2012, PSYCHOPHYSIOLOGY, V49, P1558, DOI 10.1111/j.1469-8986.2012.01474.x; Mattar MG, 2015, PLOS COMPUT BIOL, V11, DOI 10.1371/journal.pcbi.1004533; Medaglia JD, 2015, J COGNITIVE NEUROSCI, V27, P1471, DOI 10.1162/jocn_a_00810; Meunier D., 2009, FRONT NEUROINFORM, V30, DOI [10.3389/neuro.11.037.2009, 10.3389/neuro.11.037.2009.eCollection2009]; Newman MEJ, 2006, P NATL ACAD SCI USA, V103, P8577, DOI 10.1073/pnas.0601602103; Newman MEJ, 2004, PHYS REV E, V69, DOI 10.1103/PhysRevE.69.066133; Onoda K, 2013, NEUROSCI LETT, V556, P104, DOI 10.1016/j.neulet.2013.10.023; Power JD, 2012, NEUROIMAGE, V59, P2142, DOI 10.1016/j.neuroimage.2011.10.018; Power JD, 2011, NEURON, V72, P665, DOI 10.1016/j.neuron.2011.09.006; Sadaghiani S, 2015, P NATL ACAD SCI USA, V112, P8463, DOI 10.1073/pnas.1420687112; Satterthwaite TD, 2012, NEUROIMAGE, V60, P623, DOI 10.1016/j.neuroimage.2011.12.063; Schultz DH, 2016, J NEUROSCI, V36, P8551, DOI 10.1523/JNEUROSCI.0358-16.2016; Seeley WW, 2007, J NEUROSCI, V27, P2349, DOI 10.1523/JNEUROSCI.5587-06.2007; Sporns O, 2016, ANNU REV PSYCHOL, V67, P613, DOI 10.1146/annurev-psych-122414-033634; Sridharan D, 2008, P NATL ACAD SCI USA, V105, P12569, DOI 10.1073/pnas.0800005105; Stanley ML, 2014, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.00954; Stevens AA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030468; Van Dijk KRA, 2012, NEUROIMAGE, V59, P431, DOI 10.1016/j.neuroimage.2011.07.044; Vas AK, 2011, J HEAD TRAUMA REHAB, V26, P224, DOI 10.1097/HTR.0b013e318218dd3d; Vatansever D, 2015, J NEUROSCI, V35, P15254, DOI 10.1523/JNEUROSCI.2135-15.2015; Vo LTK, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016093; Wechsler D, 1997, WAIS 3 WECHSLER ADUL; Wen X, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132518	53	56	57	2	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2016	11	12							e0169015	10.1371/journal.pone.0169015	http://dx.doi.org/10.1371/journal.pone.0169015			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI9QH	28006029	gold, Green Published, Green Submitted			2022-12-27	WOS:000392843200125
J	Gill, MM; Hoffman, HJ; Bobrow, EA; Mugwaneza, P; Ndatimana, D; Ndayisaba, GF; Baribwira, C; Guay, L; Asiimwe, A				Gill, Michelle M.; Hoffman, Heather J.; Bobrow, Emily A.; Mugwaneza, Placidie; Ndatimana, Dieudonne; Ndayisaba, Gilles F.; Baribwira, Cyprien; Guay, Laura; Asiimwe, Anita			Detectable Viral Load in Late Pregnancy among Women in the Rwanda Option B plus PMTCT Program: Enrollment Results from the Kabeho Study	PLoS One			English	Article							ACTIVE ANTIRETROVIRAL THERAPY; CHILD HIV TRANSMISSION; DRUG-RESISTANCE; SOUTH-AFRICA; POSTPARTUM; FAILURE; TIME; INITIATION; DELIVERY; DECLINE	There are limited viral load (VL) data available from programs implementing "Option B+," lifelong antiretroviral treatment (ART) to all HIV-positive pregnant and postpartum women, in resource-limited settings. Extent of viral suppression from a prevention of mother-to-child transmission of HIV program in Rwanda was assessed among women enrolled in the Kigali Antiretroviral and Breastfeeding Assessment for the Elimination of HIV (Kabeho) Study. ARV drug resistance testing was conducted on women with VL>2000 copies/ml. In April 2013-January 2014, 608 pregnant or early postpartum HIV-positive women were enrolled in 14 facilities. Factors associated with detectable enrollment VL>20 copies/ml) were examined using generalized estimating equations. The most common antiretroviral regimen (56.7%, 344/607) was tenofovir/lamivudine/efavirenz. Median ART duration was 13.5 months (IQR 3.0-48.8); 76.1% of women were on ART at first antenatal visit. Half of women (315/603) had undetectable RNA-PCR VL and 84.6% (510) had <1,000 copies/ml. Detectable VL increased among those on ART > 36 months compared to those on ART 4-36 months (72/191, 37.7% versus 56/187, 29.9%), though the difference was not significant. The odds of having detectable enrollment VL decreased significantly as duration on ART at enrollment increased (AOR = 0.99, 95% CI: 0.9857, 0.9998, p = 0.043). There was a higher likelihood of detectable VL for women with lower gravidity (AOR = 0.90, 95% CI: 0.84, 0.97, p = 0.0039), no education (AOR = 2.25, (95% CI: 1.37, 3.70, p = 0.0004), nondisclosure to partner (AOR = 1.97, 95% CI: 1.21, 3.21, p = 0.0063) and side effects (AOR = 2.63, 95% CI: 1.72, 4.03, p<0.0001). ARV drug resistance mutations were detected in all of the eleven women on ART > 36 months with genotyping available. Most women were receiving ART at first antenatal visit, with relatively high viral suppression rates. Shorter ART duration was associated with higher VL, with a concerning increasing trend for higher viremia and drug resistance among women on ART for >3 years.	[Gill, Michelle M.; Bobrow, Emily A.; Guay, Laura] Elizabeth Glaser Pediat AIDS Fdn, Washington, DC 20036 USA; [Hoffman, Heather J.; Guay, Laura] George Washington Univ, Milken Inst Sch Publ Hlth, Dept Epidemiol & Biostat, Washington, DC USA; [Mugwaneza, Placidie] Rwanda Minist Hlth, Kigali, Rwanda; [Ndatimana, Dieudonne; Ndayisaba, Gilles F.] Elizabeth Glaser Pediat AIDS Fdn, Kigali, Rwanda; [Baribwira, Cyprien] Univ Maryland, Baltimore, MD 21201 USA; [Asiimwe, Anita] Rwanda Univ Teaching Hosp, Kigali, Rwanda	George Washington University; University System of Maryland; University of Maryland Baltimore	Gill, MM (corresponding author), Elizabeth Glaser Pediat AIDS Fdn, Washington, DC 20036 USA.	mgill@pedaids.org	Hoffman, Heather/AAF-6429-2020		United States President's Emergency Plan for AIDS Relief through the United States Agency for International Development; American people [AID-OAA-A-12-00024]	United States President's Emergency Plan for AIDS Relief through the United States Agency for International Development(United States Agency for International Development (USAID)United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); American people	This study is funded by the United States President's Emergency Plan for AIDS Relief (www.pepfar.gov) through the United States Agency for International Development (www.usaid.gov) and the generous support of the American people through Cooperative Agreement No. AID-OAA-A-12-00024. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aziz N, 2013, BJOG-INT J OBSTET GY, V120, P1534, DOI 10.1111/1471-0528.12226; Chibwesha CJ, 2011, JAIDS-J ACQ IMM DEF, V58, P224, DOI 10.1097/QAI.0b013e318229147e; Denoeud-Ndam L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059446; Haas AD, 2016, CLIN INFECT DIS; Hoffman RM, 2010, JAIDS-J ACQ IMM DEF, V54, P35, DOI 10.1097/QAI.0b013e3181cf9979; Hoffmann CJ, 2016, JAIDS-J ACQ IMM DEF, V71, P31, DOI 10.1097/QAI.0000000000000811; IDF (International Diabetes Federation), 2021, CONSOLIDATED GUIDELI, V10th ed.; Jasseron C, 2013, AIDS BEHAV, V17, P488, DOI 10.1007/s10461-011-0084-y; Jobanputra K, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116144; Katz IT, 2010, JAIDS-J ACQ IMM DEF, V54, P27, DOI 10.1097/QAI.0b013e3181caea89; Labhardt ND, 2014, J INT AIDS SOC, V17, P115, DOI 10.7448/IAS.17.4.19666; Mancinelli S, 2016, AIDS RES HUM RETROV, V32, P737, DOI [10.1089/aid.2015.0366, 10.1089/AID.2015.0366]; Mandelbrot L, 2015, C RETR OPP INF SEATT; Musiime S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027832; Myer L, 2016, HIV MED; Myer L, 2015, C RETR OPP INF SEATT; Myer L, 2015, J INT AIDS SOC, V18, DOI 10.7448/IAS.18.1.20045; Ngarina M, 2015, BMC INFECT DIS, V15, DOI 10.1186/s12879-015-0914-z; Nielsen-Saines K, 2012, NEW ENGL J MED, V366, P2368, DOI 10.1056/NEJMoa1108275; Patel D, 2007, CLIN INFECT DIS, V44, P1647, DOI 10.1086/518284; Read PJ, 2012, AIDS, V26, P1095, DOI 10.1097/QAD.0b013e3283536a6c; Rwanda Biomedical Center, 2013, NAT GUID PREV MAN HI; Stadeli KM, 2013, ANTIVIR THER, V18, P115, DOI 10.3851/IMP2437; Stanford HIV drug resistance database, 2015, MAJ HIV 1 DRUG RES M; Townsend CL, 2014, AIDS, V28, P1049, DOI 10.1097/QAD.0000000000000212; Warszawski J, 2008, AIDS, V22, P289, DOI 10.1097/QAD.0b013e3282f3d63c; World Health Organization, 2015, GUID START ANT THER	27	20	20	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2016	11	12							e0168671	10.1371/journal.pone.0168671	http://dx.doi.org/10.1371/journal.pone.0168671			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI9QH	28006001	Green Submitted, Green Published, gold			2022-12-27	WOS:000392843200076
J	Morin-Moncet, O; Therrien-Blanchet, JM; Ferland, MC; Theoret, H; West, GL				Morin-Moncet, Olivier; Therrien-Blanchet, Jean-Marc; Ferland, Marie C.; Theoret, Hugo; West, Greg L.			Action Video Game Playing Is Reflected In Enhanced Visuomotor Performance and Increased Corticospinal Excitability	PLoS One			English	Article							TRANSCRANIAL MAGNETIC STIMULATION; HUMAN MOTOR CORTEX; WHITE-MATTER; INTERHEMISPHERIC INHIBITION; FINGER MOVEMENTS; THRESHOLD; PLASTICITY; PLAYERS; SKILL; BRAIN	Action video game playing is associated with improved visuomotor performance; however, the underlying neural mechanisms associated with this increased performance are not well understood. Using the Serial Reaction Time Task in conjunction with Transcranial Magnetic Stimulation, we investigated if improved visuomotor performance displayed in action video game players (actionVGPs) was associated with increased corticospinal plasticity in primary motor cortex (M1) compared to non-video game players (nonVGPs). Further, we assessed if actionVGPs and nonVGPs displayed differences in procedural motor learning as measured by the SRTT. We found that at the behavioral level, both the actionVGPs and nonVGPs showed evidence of procedural learning with no significant difference between groups. However, the actionVGPs displayed higher visuomotor performance as evidenced by faster reaction times in the SRTT. This observed enhancement in visuomotor performance amongst actionVGPs was associated with increased corticospinal plasticity in M1, as measured by corticospinal excitability changes pre- and post-SRTT and corticospinal excitability at rest before motor practice. Our results show that aVGPs, who are known to have better performance on visual and motor tasks, also display increased corticospinal excitability after completing a novel visuomotor task.	[Morin-Moncet, Olivier; Therrien-Blanchet, Jean-Marc; Ferland, Marie C.; Theoret, Hugo; West, Greg L.] Univ Montreal, Dept Psychol, Montreal, PQ, Canada; [Theoret, Hugo] Hop St Justine, Res Ctr, Montreal, PQ, Canada	Universite de Montreal; Universite de Montreal	West, GL (corresponding author), Univ Montreal, Dept Psychol, Montreal, PQ, Canada.	gregory.west@umontreal.ca		Theoret, Hugo/0000-0002-7458-8797; Therrien-Blanchet, Jean-Marc/0000-0003-1867-1606	Natural Sciences and Engineering Research Council of Canada; Canada Graduate Scholarship; Natural Sciences and Engineering Research Council of Canada [436140-2013]; Fonds de Recherche du Quebec - Nature et Technologies [181515]	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Canada Graduate Scholarship; Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Fonds de Recherche du Quebec - Nature et Technologies	Natural Sciences and Engineering Research Council of Canada (http://dx.doi.org/10.13039/501100000038) Canada Graduate Scholarship to Olivier Morin-Moncet; Natural Sciences and Engineering Research Council of Canada (http://dx.doi.org/10.13939/501100000038) 436140-2013 to Prof. Greg West; Fonds de Recherche du Quebec - Nature et Technologies (http://dx.doi.org/10.13039/501100003151) 181515 to Prof. Greg West.	Bastani A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047582; Bavelier D, 2012, VISION RES, V61, P132, DOI 10.1016/j.visres.2011.08.007; Bavelier D, 2012, ANNU REV NEUROSCI, V35, P391, DOI 10.1146/annurev-neuro-060909-152832; Bischoff-Grethe A, 2004, J COGNITIVE NEUROSCI, V16, P127, DOI 10.1162/089892904322755610; Blacker KJ, 2013, ATTEN PERCEPT PSYCHO, V75, P1128, DOI 10.3758/s13414-013-0487-0; Borecki L, 2013, ADV EXP MED BIOL, V755, P343, DOI 10.1007/978-94-007-4546-9_43; Castel AD, 2005, ACTA PSYCHOL, V119, P217, DOI 10.1016/j.actpsy.2005.02.004; Chang WH, 2016, CLIN NEUROPHYSIOL, V127, P2892, DOI 10.1016/j.clinph.2016.04.001; Chen R, 2004, EXP BRAIN RES, V154, P1, DOI 10.1007/s00221-003-1684-1; Cicinelli P, 1997, MUSCLE NERVE, V20, P535, DOI 10.1002/(SICI)1097-4598(199705)20:5<535::AID-MUS1>3.0.CO;2-A; Classen J, 1998, J NEUROPHYSIOL, V79, P1117, DOI 10.1152/jn.1998.79.2.1117; Daselaar SM, 2003, NEUROBIOL AGING, V24, P1013, DOI 10.1016/S0197-4580(03)00030-7; Di Lazzaro V, 1999, EXP BRAIN RES, V124, P520, DOI 10.1007/s002210050648; Di Lazzaro V, 2004, CLIN NEUROPHYSIOL, V115, P255, DOI 10.1016/j.clinph.2003.10.009; Doeltgen SH, 2009, J NEUROSCI METH, V178, P134, DOI 10.1016/j.jneumeth.2008.12.005; Doyon J, 2003, NEUROPSYCHOLOGIA, V41, P252, DOI 10.1016/S0028-3932(02)00158-6; Doyon J, 2009, BEHAV BRAIN RES, V199, P61, DOI 10.1016/j.bbr.2008.11.012; Duncan N., 2012, DEMISE GUYS WHY BOYS; Dye MWG, 2009, NEUROPSYCHOLOGIA, V47, P1780, DOI 10.1016/j.neuropsychologia.2009.02.002; Feng J, 2007, PSYCHOL SCI, V18, P850, DOI 10.1111/j.1467-9280.2007.01990.x; FERBERT A, 1992, J PHYSIOL-LONDON, V453, P525, DOI 10.1113/jphysiol.1992.sp019243; Fields RD, 2015, NAT REV NEUROSCI, V16, P756, DOI 10.1038/nrn4023; Ghacibeh GA, 2007, CLIN NEUROPHYSIOL, V118, P325, DOI 10.1016/j.clinph.2006.10.003; Gozli DG, 2014, HUM MOVEMENT SCI, V38, P152, DOI 10.1016/j.humov.2014.09.004; Grafton ST, 1998, J NEUROSCI, V18, P9420; Green CS, 2007, PSYCHOL SCI, V18, P88, DOI 10.1111/j.1467-9280.2007.01853.x; Green CS, 2006, COGNITION, V101, P217, DOI 10.1016/j.cognition.2005.10.004; Green CS, 2012, COMPUT HUM BEHAV, V28, P984, DOI 10.1016/j.chb.2011.12.020; Green CS, 2003, NATURE, V423, P534, DOI 10.1038/nature01647; Hallett M, 1996, Electroencephalogr Clin Neurophysiol Suppl, V46, P43; Hardwick RM, 2013, NEUROIMAGE, V67, P283, DOI 10.1016/j.neuroimage.2012.11.020; Herbsman T, 2009, HUM BRAIN MAPP, V30, P2044, DOI 10.1002/hbm.20649; Holper L, 2009, NEUROIMAGE, V46, P1105, DOI 10.1016/j.neuroimage.2009.03.027; Honda M, 1998, BRAIN, V121, P2159, DOI 10.1093/brain/121.11.2159; Japikse KC, 2003, EXP BRAIN RES, V148, P38, DOI 10.1007/s00221-002-1264-9; Kloppel S, 2008, NEUROIMAGE, V40, P1782, DOI 10.1016/j.neuroimage.2008.01.019; Kobayashi M, 2004, NEUROLOGY, V62, P91, DOI 10.1212/WNL.62.1.91; Kobayashi M, 2003, NEUROIMAGE, V20, P2259, DOI 10.1016/S1053-8119(03)00220-9; Kobayashi M, 2009, EUR J NEUROSCI, V29, P833, DOI 10.1111/j.1460-9568.2009.06628.x; Koeneke S, 2006, EXP BRAIN RES, V174, P199, DOI 10.1007/s00221-006-0440-8; Kozel FA, 2000, J NEUROPSYCH CLIN N, V12, P376, DOI 10.1176/appi.neuropsych.12.3.376; Li RJ, 2009, NAT NEUROSCI, V12, P549, DOI 10.1038/nn.2296; McConnell KA, 2001, BIOL PSYCHIAT, V49, P454, DOI 10.1016/S0006-3223(00)01039-8; MEYER BU, 1995, BRAIN, V118, P429, DOI 10.1093/brain/118.2.429; Mills KR, 1997, MUSCLE NERVE, V20, P570, DOI 10.1002/(SICI)1097-4598(199705)20:5<570::AID-MUS5>3.3.CO;2-F; Mishra J, 2011, J NEUROSCI, V31, P992, DOI 10.1523/JNEUROSCI.4834-10.2011; Morin-Moncet O, 2014, J NEUROPHYSIOL, V111, P2094, DOI 10.1152/jn.00388.2013; Muellbacher W, 2002, ARCH NEUROL-CHICAGO, V59, P1278, DOI 10.1001/archneur.59.8.1278; Muellbacher W, 2000, CLIN NEUROPHYSIOL, V111, P344, DOI 10.1016/S1388-2457(99)00243-6; Muellbacher W, 2001, EXP BRAIN RES, V136, P431, DOI 10.1007/s002210000614; Muller-Dahlhaus JFM, 2008, EXP BRAIN RES, V187, P467, DOI 10.1007/s00221-008-1319-7; Murakami T, 2012, J PHYSIOL-LONDON, V590, P5765, DOI 10.1113/jphysiol.2012.238519; PARLOW SE, 1989, BRAIN COGNITION, V11, P98, DOI 10.1016/0278-2626(89)90008-0; Pascual-Leone A, 1999, NEUROPSYCHOLOGIA, V37, P207; PASCUALLEONE A, 1994, SCIENCE, V263, P1287, DOI 10.1126/science.8122113; PASCUALLEONE A, 1995, J NEUROPHYSIOL, V74, P1037, DOI 10.1152/jn.1995.74.3.1037; Perez MA, 2007, J NEUROSCI, V27, P1045, DOI 10.1523/JNEUROSCI.4128-06.2007; Powers KL, 2013, PSYCHON B REV, V20, P1055, DOI 10.3758/s13423-013-0418-z; Rand MK, 1998, EXP BRAIN RES, V118, P293, DOI 10.1007/s002210050284; Reis J, 2008, J PHYSIOL-LONDON, V586, P325, DOI 10.1113/jphysiol.2007.144824; Rioult-Pedotti MS, 2000, SCIENCE, V290, P533, DOI 10.1126/science.290.5491.533; Rossi S, 2011, CLIN NEUROPHYSIOL, V122, P1686, DOI 10.1016/j.clinph.2010.12.037; ROSSINI PM, 1994, ELECTROEN CLIN NEURO, V91, P79, DOI 10.1016/0013-4694(94)90029-9; Sampaio-Baptista C, 2013, J NEUROSCI, V33, P19499, DOI 10.1523/JNEUROSCI.3048-13.2013; Sanes JN, 2000, ANNU REV NEUROSCI, V23, P393, DOI 10.1146/annurev.neuro.23.1.393; Stokes MG, 2005, J NEUROPHYSIOL, V94, P4520, DOI 10.1152/jn.00067.2005; Tinazzi M, 1998, NEUROSCI LETT, V244, P121, DOI 10.1016/S0304-3940(98)00150-5; Waldvogel D, 2000, NATURE, V406, P995, DOI 10.1038/35023171; WASSERMANN EM, 1992, ELECTROEN CLIN NEURO, V85, P1, DOI 10.1016/0168-5597(92)90094-R; West GL, 2015, P ROY SOC B-BIOL SCI, V282, DOI 10.1098/rspb.2014.2952; West GL, 2013, ACTA PSYCHOL, V142, P38, DOI 10.1016/j.actpsy.2011.08.005; West GL, 2008, J VISION, V8, DOI 10.1167/8.16.13; Willingham DB, 2000, MEM COGNITION, V28, P366, DOI 10.3758/BF03198552; Zhang Y, 2015, FRONT HUM NEUROSCI, V9, DOI 10.3389/fnhum.2015.00098; Ziemann U, 1996, ANN NEUROL, V40, P367, DOI 10.1002/ana.410400306; Ziemann U, 2001, BRAIN, V124, P1171, DOI 10.1093/brain/124.6.1171	76	11	12	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2016	11	12							e0169013	10.1371/journal.pone.0169013	http://dx.doi.org/10.1371/journal.pone.0169013			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EI9QH	28005989	Green Submitted, gold, Green Published			2022-12-27	WOS:000392843200124
J	Popovic, B; Agrinier, N; Voilliot, D; Elfarra, M; Villemot, JP; Maureira, P				Popovic, Batric; Agrinier, Nelly; Voilliot, Damien; Elfarra, Mazen; Villemot, Jean Pierre; Maureira, Pablo			Ventricular Dysfunction in Patients with Acute Coronary Syndrome Undergoing Coronary Surgical Revascularization: Prognostic Impact on Long-Term Outcomes	PLOS ONE			English	Article							HEART-FAILURE; MYOCARDIAL-INFARCTION; RENAL DYSFUNCTION; RISK; SURGERY; MANAGEMENT; STRATEGY; SURVIVAL; REGISTRY; SOCIETY	Background Patients with non-ST elevation acute coronary syndrome complicated by left ventricular dysfunction (LVEF) are a poor prognosis group. The aim of our study was to assess the short and long term LEVF prognostic value in a cohort of NSTE-ACS patients undergoing surgical revascularization. Methods We performed elective and isolated CABG on a cohort of 206 consecutive patients with LVEF <= 0.40 complicating acute coronary syndrome. The case cohort was compared with a cohort of controls (LVEF>0.40) randomly selected (2: 1) among patients who underwent the procedure during this period. Results The Kaplan-Meier 5-year estimated survival rates for patients in the low and normal LVEF groups were 70.8% (95% confidence interval CI:64.2-77.4) and 81.7% (95% CI: 77.8-85.6), respectively. A low LVEF was associated with both a higher all-cause (HR [95% CI] = 1.84[1.18-2.86]) and a higher cardiovascular mortality (HR = 2.07 [1.27-3.38]) during the first 12 months of follow-up. After adjustment for potential confounders, a low LVEF remained associated with a higher cardiovascular mortality only (1.87[1.03-3.38]) during the first 12 months of follow-up. After 12 months of follow-up, a low LVEF was no more associated with all-cause, nor cardiovascular mortality. Conclusion Patients with low LVEF might require more intensive care than patients with normal LVEF during the year after the surgical procedure, but once the first postoperative year over, the initial low LVEF was no more associated with long term mortality.	[Popovic, Batric; Voilliot, Damien] CHU Nancy, Dept Cardiol, Nancy, France; [Agrinier, Nelly] CHU Nancy, Epidemiol & Evaluat Clin, Nancy, France; [Elfarra, Mazen; Villemot, Jean Pierre; Maureira, Pablo] CHU Nancy, Serv Chirurg Malad Cardiovasc & Transplantat, Nancy, France	CHU de Nancy; CHU de Nancy; CHU de Nancy	Popovic, B (corresponding author), CHU Nancy, Dept Cardiol, Nancy, France.	b.popovic@chu-nancy.fr		AGRINIER, Nelly/0000-0002-3906-7670				Ad N, 2016, ANN THORAC SURG, V102, P573, DOI 10.1016/j.athoracsur.2016.01.105; Appoo J, 2004, CIRCULATION, V110, pII13, DOI 10.1161/01.CIR.0000128345.69540.ed; Ben-Gal Y, 2010, JACC-CARDIOVASC INTE, V3, P1059, DOI 10.1016/j.jcin.2010.06.017; Bonow RO, 2011, NEW ENGL J MED, V364, P1617, DOI 10.1056/NEJMoa1100358; Cannon CP, 2001, NEW ENGL J MED, V344, P1879, DOI 10.1056/NEJM200106213442501; Eagle KA, 2004, JAMA-J AM MED ASSOC, V291, P2727, DOI 10.1001/jama.291.22.2727; Fattouch K, 2010, ANN THORAC SURG, V90, P1187, DOI 10.1016/j.athoracsur.2010.03.103; Fox KAA, 2002, LANCET, V360, P743, DOI 10.1016/S0140-6736(02)09894-X; Gheorghiade M, 2006, CIRCULATION, V114, P1202, DOI 10.1161/CIRCULATIONAHA.106.623199; Grossi EA, 2006, CIRCULATION, V114, pI573, DOI 10.1161/CIRCULATIONAHA.105.001230; Hamm CW, 2011, EUR HEART J, V32, P2999, DOI 10.1093/eurheartj/ehr236; Holzmann MJ, 2013, AM J CARDIOL, V112, P1342, DOI 10.1016/j.amjcard.2013.05.077; Holzmann MJ, 2013, AM HEART J, V166, P142, DOI 10.1016/j.ahj.2013.03.005; Lagerqvist B, 2006, LANCET, V368, P998, DOI 10.1016/S0140-6736(06)69416-6; Lang RM, 2006, EUR J ECHOCARDIOGR, V7, P79, DOI 10.1016/j.euje.2005.12.014; Nashef SAM, 1999, EUR J CARDIO-THORAC, V16, P9, DOI 10.1016/S1010-7940(99)00134-7; Ranasinghe I, 2012, EUR J HEART FAIL, V14, P464, DOI 10.1093/eurjhf/hfs041; Spencer FA, 2002, CIRCULATION, V105, P2605, DOI 10.1161/01.CIR.0000017861.00991.2F; Steg PG, 2004, CIRCULATION, V109, P494, DOI 10.1161/01.CIR.0000109691.16944.DA; Steg PG, 2008, CIRCULATION, V118, P1163, DOI 10.1161/CIRCULATIONAHA.108.789685; Task Force on Myocardial Revascularization of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS), 2010, Eur Heart J, V31, P2501, DOI 10.1093/eurheartj/ehq277; Velazquez EJ, 2011, NEW ENGL J MED, V364, P1607, DOI 10.1056/NEJMoa1100356	22	5	5	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2016	11	12							e0168634	10.1371/journal.pone.0168634	http://dx.doi.org/10.1371/journal.pone.0168634			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI9QH	28005944	gold, Green Published, Green Submitted			2022-12-27	WOS:000392843200072
J	Kamat, P; Vandenberghe, S; Christen, S; Bongoni, AK; Meier, B; Rieben, R; Khattab, AA				Kamat, Pranitha; Vandenberghe, Stijn; Christen, Stephan; Bongoni, Anjan K.; Meier, Bernhard; Rieben, Robert; Khattab, Ahmed A.			Dexrazoxane Shows No Protective Effect in the Acute Phase of Reperfusion during Myocardial Infarction in Pigs	PLoS One			English	Article							CHRONIC DOXORUBICIN CARDIOTOXICITY; CARDIOPROTECTIVE DRUG DEXRAZOXANE; ISCHEMIA-REPERFUSION; FREE-RADICALS; ISCHAEMIA/REPERFUSION INJURY; ANTHRACYCLINE CHEMOTHERAPY; HYDROLYSIS-ACTIVATION; ENDOTHELIAL FUNCTION; RAT-HEART; IN-VIVO	Calcium and iron overload participate in the mechanisms of ischemia/reperfusion (I/R) injury during myocardial infarction (MI). Calcium overload induces cardiomyocyte death by hyper contraction, while iron catalyses generation of reactive oxygen species (ROS). We therefore hypothesized that dexrazoxane, an intracellular metal chelator, would attenuate I/R injury. MI was induced in pigs by occlusion of the left anterior descending artery for 1 hour followed by 2 hours reperfusion. Thirty minutes before reperfusion either 5 mg/mI dexrazoxane (n = 5) or saline (n = 5) was infused intravenously. Myocardial necrosis as percentage of the area at ischemic risk was found to be similar in both groups (77.2 +/- 18% for dexrazoxane and 76.4 +/- 14% for saline group) as determined by triphenyl tetrazolium chloride staining of the ischemic myocardium. Also, serum levels of troponin-I were similar in both groups. A conductance catheter was used to measure left ventricular pressure and volume at all times. Markers for tissue damage due to ROS (HNE), endothelial cell activation (CD31) and inflammation (IgG, C3b/c, C5b9, MCP-1) were assessed on tissue and/or in serum. No significant differences were observed between the groups for the parameters analyzed. To conclude, in this clinically relevant model of early reperfusion after acute myocardial ischemia, dexrazoxane lacked attenuating effects on I/R injury as shown by the measured parameters.	[Kamat, Pranitha; Bongoni, Anjan K.; Rieben, Robert] Univ Bern, Dept Clin Res, Bern, Switzerland; [Vandenberghe, Stijn] Univ Bern, ARTORG Ctr, Bern, Switzerland; [Christen, Stephan] Univ Bern, Dept Infect Dis, Bern, Switzerland; [Meier, Bernhard; Khattab, Ahmed A.] Univ Hosp Bern, Dept Cardiol, Bern, Switzerland; [Vandenberghe, Stijn] Cardioctr Ticino, Ticino, Switzerland; [Christen, Stephan] Univ Zurich, Dept Mol Mech Dis, Zurich, Switzerland; [Bongoni, Anjan K.] St Vincents Hosp, Immunol Res Ctr, Melbourne, Vic, Australia	University of Bern; University of Bern; University of Bern; University of Bern; University Hospital of Bern; University of Zurich; St Vincent's Hospital Melbourne	Rieben, R (corresponding author), Univ Bern, Dept Clin Res, Bern, Switzerland.	robert.rieben@dkf.unibe.ch	Christen, Stephan/B-8602-2009; Vandenberghe, Stijn/T-9364-2019; Rieben, Robert/D-7044-2017	Vandenberghe, Stijn/0000-0003-1464-0597; Kamat, Pranitha/0000-0002-9177-3513; Rieben, Robert/0000-0003-4179-8891	Swiss National Science Foundation [3200B0-116618, 32003B_135272]	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	This study was supported by the Swiss National Science Foundation, grants no. 3200B0-116618 and 32003B_135272. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BAGCHI M, 1989, FREE RADICAL RES COM, V7, P375, DOI 10.3109/10715768909087964; Banz Y, 2005, EUR HEART J, V26, P2334, DOI 10.1093/eurheartj/ehi421; Banz Y, 2007, CARDIOVASC RES, V76, P482, DOI 10.1016/j.cardiores.2007.07.016; Banz Y, 2012, CARDIOLOGY, V121, P59, DOI 10.1159/000336485; Berenshtein E, 1997, J MOL CELL CARDIOL, V29, P3025, DOI 10.1006/jmcc.1997.0535; BOLLI R, 1990, CIRCULATION, V82, P723, DOI 10.1161/01.CIR.82.3.723; BOLLI R, 1989, P NATL ACAD SCI USA, V86, P4695, DOI 10.1073/pnas.86.12.4695; Chen XL, 2004, AM J PHYSIOL-HEART C, V286, pH1001, DOI 10.1152/ajpheart.00716.2003; COUDRAY C, 1995, INT J BIOCHEM CELL B, V27, P61, DOI 10.1016/1357-2725(94)00055-7; Cvetkokic RS, 2005, DRUGS, V65, P1005, DOI 10.2165/00003495-200565070-00008; Duilio C, 2001, AM J PHYSIOL-HEART C, V280, pH2649, DOI 10.1152/ajpheart.2001.280.6.H2649; Fox KAA, 2007, JAMA-J AM MED ASSOC, V297, P1892, DOI 10.1001/jama.297.17.1892; Frangogiannis NG, 2015, COMPR PHYSIOL, V5, P1841, DOI 10.1002/cphy.c150006; Hasinoff BB, 1998, CURR MED CHEM, V5, P1; Hasinoff BB, 1998, SEMIN ONCOL, V25, P3; HASINOFF BB, 1994, J PHARM SCI, V83, P64, DOI 10.1002/jps.2600830115; Hasinoff BB, 2003, MOL PHARMACOL, V64, P670, DOI 10.1124/mol.64.3.670; HASINOFF BB, 1990, DRUG METAB DISPOS, V18, P344; Hasinoff Brian B, 2002, Cardiovasc Toxicol, V2, P111, DOI 10.1385/CT:2:2:111; HERMAN EH, 1981, CANCER RES, V41, P3436; HERMAN EH, 1983, LAB INVEST, V49, P69; HESS ML, 1984, J MOL CELL CARDIOL, V16, P969, DOI 10.1016/S0022-2828(84)80011-5; Kane RC, 2008, ONCOLOGIST, V13, P445, DOI 10.1634/theoncologist.2007-0247; Karck M, 2001, J THORAC CARDIOV SUR, V121, P1169, DOI 10.1067/mtc.2001.113325; KLONER RA, 1989, CIRCULATION, V80, P1115, DOI 10.1161/01.CIR.80.5.1115; Krumholz HM, 2009, JAMA-J AM MED ASSOC, V302, P767, DOI 10.1001/jama.2009.1178; Kumar AG, 1997, CIRCULATION, V95, P693, DOI 10.1161/01.CIR.95.3.693; Lakshminarayanan V, 2001, AM J PATHOL, V159, P1301, DOI 10.1016/S0002-9440(10)62517-5; Lakshminarayanan V, 1997, J BIOL CHEM, V272, P32910, DOI 10.1074/jbc.272.52.32910; Liochev SI, 1999, MET IONS BIOL SYST, V36, P1; Lloyd-Jones D, 2010, CIRCULATION, V121, pE46, DOI 10.1161/CIRCULATIONAHA.109.192667; LOETSCHER P, 1994, FASEB J, V8, P1055, DOI 10.1096/fasebj.8.13.7926371; McCormick J, 2006, FASEB J, V20, P2115, DOI 10.1096/fj.06-6188fje; MINEZAKI KK, 1994, J PHYSIOL-LONDON, V476, P459, DOI 10.1113/jphysiol.1994.sp020147; MITSOS SE, 1986, CIRCULATION, V73, P1077, DOI 10.1161/01.CIR.73.5.1077; Mochizuki S, 1998, JPN HEART J, V39, P707; Neckar J, 2012, CAN J PHYSIOL PHARM, V90, P1303, DOI [10.1139/Y2012-096, 10.1139/y2012-096]; POWELL SR, 1992, J SURG RES, V53, P417, DOI 10.1016/0022-4804(92)90070-G; Ramu E, 2006, CARDIOVASC DRUG THER, V20, P343, DOI 10.1007/s10557-006-0497-4; Schroeder PE, 2005, DRUG METAB DISPOS, V33, P1367, DOI 10.1124/dmd.105.005546; SEINO Y, 1995, CYTOKINE, V7, P301, DOI 10.1006/cyto.1995.0037; Sinning JM, 2011, EUR HEART J; Sukmawan R, 2007, J PHARMACOL SCI, V104, P341, DOI 10.1254/jphs.FP0070186; Szocs K, 2004, GEN PHYSIOL BIOPHYS, V23, P265; Tompkins AJ, 2006, BBA-MOL BASIS DIS, V1762, P223, DOI 10.1016/j.bbadis.2005.10.001; van Diepen S, J THROMB THROMBOLYSI; Werner N, 2006, ARTERIOSCL THROM VAS, V26, P112, DOI 10.1161/01.ATV.0000191634.13057.15	47	4	4	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2016	11	12							e0168541	10.1371/journal.pone.0168541	http://dx.doi.org/10.1371/journal.pone.0168541			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI9TW	28002439	Green Submitted, Green Published, gold			2022-12-27	WOS:000392853100051
J	Ladds, MA; Thompson, AP; Slip, DJ; Hocking, DP; Harcourt, RG				Ladds, Monique A.; Thompson, Adam P.; Slip, David J.; Hocking, David P.; Harcourt, Robert G.			Seeing It All: Evaluating Supervised Machine Learning Methods for the Classification of Diverse Otariid Behaviours	PLOS ONE			English	Article							ACCELERATION DATA; ENERGY-EXPENDITURE; BODY ACCELERATION; PHYSICAL-ACTIVITY; FUR SEALS; ACCELEROMETRY; ANIMALS; RECOGNITION; PLAY	Constructing activity budgets for marine animals when they are at sea and cannot be directly observed is challenging, but recent advances in bio-logging technology offer solutions to this problem. Accelerometers can potentially identify a wide range of behaviours for animals based on unique patterns of acceleration. However, when analysing data derived from accelerometers, there are many statistical techniques available which when applied to different data sets produce different classification accuracies. We investigated a selection of supervised machine learning methods for interpreting behavioural data from captive otariids (fur seals and sea lions). We conducted controlled experiments with 12 seals, where their behaviours were filmed while they were wearing 3-axis accelerometers. From video we identified 26 behaviours that could be grouped into one of four categories (foraging, resting, travelling and grooming) representing key behaviour states for wild seals. We used data from 10 seals to train four predictive classification models: stochastic gradient boosting (GBM), random forests, support vector machine using four different kernels and a baseline model: penalised logistic regression. We then took the best parameters from each model and cross-validated the results on the two seals unseen so far. We also investigated the influence of feature statistics (describing some characteristic of the seal), testing the models both with and without these. Cross-validation accuracies were lower than training accuracy, but the SVM with a polynomial kernel was still able to classify seal behaviour with high accuracy (>70%). Adding feature statistics improved accuracies across all models tested. Most categories of behaviour-resting, grooming and feeding were all predicted with reasonable accuracy (52-81%) by the SVM while travelling was poorly categorised (31-41%). These results show that model selection is important when classifying behaviour and that by using animal characteristics we can strengthen the overall accuracy.	[Ladds, Monique A.; Slip, David J.; Harcourt, Robert G.] Macquarie Univ, Dept Biol Sci, Marine Predator Res Grp, N Ryde, NSW, Australia; [Thompson, Adam P.] ABC, Digital Network, Sydney, NSW, Australia; [Slip, David J.] Taronga Conservat Soc Australia, Bradleys Head Rd, Mosman, NSW, Australia; [Hocking, David P.] Monash Univ, Sch Biol Sci, Melbourne, Vic, Australia; [Hocking, David P.] Museum Victoria, Geosci, Melbourne, Vic, Australia	Macquarie University; Monash University; Museum Victoria	Ladds, MA (corresponding author), Macquarie Univ, Dept Biol Sci, Marine Predator Res Grp, N Ryde, NSW, Australia.	monique.ladds@hdr.mq.edu.au	; Hocking, David/A-2666-2017	Slip, David/0000-0002-9010-7236; Harcourt, Robert/0000-0003-4666-2934; Hocking, David/0000-0001-6848-1208	Australian Research Council Linkage Grant [LP110200603]; Taronga Conservation Society Australia; Macquarie University Research Excellence Scholarship	Australian Research Council Linkage Grant(Australian Research Council); Taronga Conservation Society Australia; Macquarie University Research Excellence Scholarship	This project is funded by Australian Research Council Linkage Grant [Grant number LP110200603 http://www.arc.gov.au/grants] to RH and DS, with support from Taronga Conservation Society Australia. ML is a recipient of a Macquarie University Research Excellence Scholarship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrews RD, 1998, MAR ECOL PROG SER, V175, P289, DOI 10.3354/meps175289; [Anonymous], 2016, R PACK VERS 6 0 29; [Anonymous], 2015, E1071 MISC FUNCTIONS; Austin D, 2006, ECOLOGY, V87, P3095, DOI 10.1890/0012-9658(2006)87[3095:LMDAHT]2.0.CO;2; Battaile BC, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118761; BEENTJES MP, 1990, ZOOL J LINN SOC-LOND, V98, P307, DOI 10.1111/j.1096-3642.1990.tb01204.x; Beniczky S, 2013, EPILEPSIA, V54, pe58, DOI 10.1111/epi.12120; Bom RA, 2014, MOV ECOL, V2, DOI 10.1186/2051-3933-2-6; Boyd IL, 1999, BEHAV ECOL, V10, P198, DOI 10.1093/beheco/10.2.198; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Brown DD, 2013, ANIM BIOTELEM, V1, P20, DOI DOI 10.1186/2050-3385-1-20; Campbell HA, 2013, J EXP BIOL, V216, P4501, DOI 10.1242/jeb.089805; Carroll G, 2014, J EXP BIOL, V217, P4295, DOI 10.1242/jeb.113076; Cooke SJ, 2004, TRENDS ECOL EVOL, V19, P334, DOI 10.1016/j.tree.2004.04.003; CORTES C, 1995, MACH LEARN, V20, P273, DOI 10.1023/A:1022627411411; Dewancker I, 2014, P REH ENG ASS TECHN; Friedman J, 2010, J STAT SOFTW, V33, P1, DOI 10.18637/jss.v033.i01; Friedman JH, 2002, COMPUT STAT DATA AN, V38, P367, DOI 10.1016/S0167-9473(01)00065-2; gbm, 2015, GPM GEN BOOSTED REGR; Gerencser L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077814; GOLDSTEIN DL, 1988, AM ZOOL, V28, P829; Graf PM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0136751; Halsey LG, 2009, PHYSIOL BIOCHEM ZOOL, V82, P396, DOI 10.1086/589815; Halsey LG, 2009, COMP BIOCHEM PHYS A, V152, P197, DOI 10.1016/j.cbpa.2008.09.021; Halsey LG, 2011, COMP BIOCHEM PHYS A, V158, P305, DOI 10.1016/j.cbpa.2010.09.002; Hammond TT, 2016, J EXP BIOL, V219, P1618, DOI 10.1242/jeb.136135; HARCOURT R, 1991, ANIM BEHAV, V42, P509, DOI 10.1016/S0003-3472(05)80055-7; HARCOURT R, 1991, ETHOLOGY, V88, P191; Hocking D, 2016, PREY CAPTURE PROCESS; Hocking DP, 2016, MAR MAMMAL SCI, V32, P568, DOI 10.1111/mms.12285; Hussey NE, 2015, SCIENCE, V348, DOI 10.1126/science.1255642; Insley Stephen J., 2003, Aquatic Mammals, V29, P181, DOI 10.1578/016754203101024149; Iwata T, 2013, AQUAT MAMM, V39, P378, DOI 10.1578/AM.39.4.2013.378; MARLOW B J, 1975, Mammalia, V39, P159, DOI 10.1515/mamm.1975.39.2.159; Martin P., 1993, MEASURING BEHAV INTR; Martiskainen P, 2009, APPL ANIM BEHAV SCI, V119, P32, DOI 10.1016/j.applanim.2009.03.005; McClune D.W., 2014, ANIM BIOTELEM, V2, P1, DOI [10.1186/2050-3385-2-5, DOI 10.1186/2050-3385-2-5]; Naito Y, 2010, POLAR SCI, V4, P309, DOI 10.1016/j.polar.2010.05.009; Nathan R, 2012, J EXP BIOL, V215, P986, DOI 10.1242/jeb.058602; Nishizawa H, 2013, J ETHOL, V31, P315, DOI 10.1007/s10164-013-0381-1; Pierce SE, 2011, J ANAT, V219, P502, DOI 10.1111/j.1469-7580.2011.01406.x; Pober DM, 2006, MED SCI SPORT EXER, V38, P1626, DOI 10.1249/01.mss.0000227542.43669.45; Qasem L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031187; R Core Team, 2021, R LANGUAGE ENV STAT; Ravi N., 2005, P 17 C INN APPL ART, P1541, DOI DOI 10.1007/978-3-642-02481-8_120; Sakamoto KQ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005379; Sathya R., 2013, International Journal of Advanced Research in Artificial Intelligence, V2, P34; Shepard Emily L. C., 2010, Endangered Species Research, V10, P47, DOI 10.3354/esr00084; Shepard ELC, 2009, AQUAT BIOL, V4, P235, DOI 10.3354/ab00104; Skinner JP, 2014, J EXP MAR BIOL ECOL, V461, P107, DOI 10.1016/j.jembe.2014.08.002; STIRLING I, 1970, J MAMMAL, V51, P766, DOI 10.2307/1378300; Tapia EM, 2004, P EXT ABSTR UB 2004; Vazquez Diosdado J.A., 2015, ANIM BIOTELEM, V3, P15, DOI [10.1186/s40317-015-0045-8, DOI 10.1186/S40317-015-0045-8]; Viviant M, 2010, POLAR BIOL, V33, P713, DOI 10.1007/s00300-009-0750-y; Watanabe S, 2005, APPL ANIM BEHAV SCI, V94, P117, DOI 10.1016/j.applanim.2005.01.010; Westerterp KR, 2009, EUR J APPL PHYSIOL, V105, P823, DOI 10.1007/s00421-009-1000-2; Whitney Nicholas M., 2010, Endangered Species Research, V10, P71, DOI 10.3354/esr00247; Wilson Rory P., 2008, Endangered Species Research, V4, P123, DOI 10.3354/esr00064; Wilson RP, 2006, J ANIM ECOL, V75, P1081, DOI 10.1111/j.1365-2656.2006.01127.x; Yang JY, 2008, PATTERN RECOGN LETT, V29, P2213, DOI 10.1016/j.patrec.2008.08.002; Ydesen KS, 2014, J EXP BIOL, V217, P2239, DOI 10.1242/jeb.100016; Zughrat A, 2014, P 19 WORLD C INT FED	62	20	20	2	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2016	11	12							e0166898	10.1371/journal.pone.0166898	http://dx.doi.org/10.1371/journal.pone.0166898			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI9TW	28002450	Green Published, gold, Green Submitted			2022-12-27	WOS:000392853100005
J	Goel, S; Angeli, F; Singla, N; Ruwaard, D				Goel, Sonu; Angeli, Federica; Singla, Neetu; Ruwaard, Dirk			Development and Validation of the Motivations for Selection of Medical Study (MSMS) Questionnaire in India	PLOS ONE			English	Article							CAREER PLANS; STUDENTS; CHOICE; ASPIRATIONS; AMOTIVATION; MIGRATION; SPECIALTY; EDUCATION; SCHOOL	Background and Objective Understanding medical students' motivation to select medical studies is particularly salient to inform practice and policymaking in countries-such as India-where shortage of medical personnel poses crucial and chronical challenges to healthcare systems. This study aims to develop and validate a questionnaire to assess the motivation of medical students to select medical studies. Methods A Motivation for Selection of Medical Study (MSMS) questionnaire was developed using extensive literature review followed by Delphi technique. The scale consisted of 12 items, 5 measuring intrinsic dimensions of motivations and 7 measuring extrinsic dimensions. Exploratory factor analysis (EFA), confirmatory factor analysis (CFA), validity, reliability and data quality checks were conducted on a sample of 636 medical students from six medical colleges of three North Indian states. Results The MSMS questionnaire consisted of 3 factors (subscales) and 8 items. The three principal factors that emerged after EFA were the scientific factor (e.g. research opportunities and the ability to use new cutting edge technologies), the societal factor (e.g. job security) and the humanitarian factor (e.g. desire to help others). The CFA conducted showed goodness of -fit indices supporting the 3-factor model. Conclusion The three extracted factors cut across the traditional dichotomy between intrinsic and extrinsic motivation and uncover a novel three-faceted motivation construct based on scientific factors, societal expectations and humanitarian needs. This validated instrument can be used to evaluate the motivational factors of medical students to choose medical study in India and similar settings and constitutes a powerful tool for policymakers to design measures able to increase selection of medical curricula.	[Goel, Sonu; Singla, Neetu] Post Grad Inst Med Educ & Res, Sch Publ Hlth, Chandigarh, India; [Angeli, Federica; Ruwaard, Dirk] Maastricht Univ, Fac Hlth Med & Life Sci, Dept Hlth Serv Res, Maastricht, Netherlands	Post Graduate Institute of Medical Education & Research (PGIMER), Chandigarh; Maastricht University	Goel, S (corresponding author), Post Grad Inst Med Educ & Res, Sch Publ Hlth, Chandigarh, India.	sonugoel007@yahoo.co.in	Goel, Sonu/F-7956-2010	Goel, Sonu/0000-0001-5231-7083; Ruwaard, Dirk/0000-0003-4887-8413; Angeli, Federica/0000-0003-4010-3103	Indian Council of Medical Research (ICMR) Adhoc Research Grant	Indian Council of Medical Research (ICMR) Adhoc Research Grant	This paper was supported by the Indian Council of Medical Research (ICMR) Adhoc Research Grant and PhD work of SG. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aasland Olaf Gjerlow, 2008, Tidsskr Nor Laegeforen, V128, P1833; Aggarwal S, 2014, J PIONEER MED SCI, V4, P155; Agyei-Baffour P, 2011, BMC MED EDUC, V11, DOI 10.1186/1472-6920-11-56; Al-Fouzan R, 2012, MED EDUC ONLINE, V17, DOI 10.3402/meo.v17i0.19587; Amin Z, 2009, MED TEACH, V31, pE560, DOI 10.3109/01421590903193554; [Anonymous], 2011, HIGH LEVEL EXPERT GR; Astor A, 2005, SOC SCI MED, V61, P2492, DOI 10.1016/j.socscimed.2005.05.003; Avgerinos ED, 2006, HEALTH POLICY, V79, P101, DOI 10.1016/j.healthpol.2005.12.007; Baboolal NS, 2007, MED EDUC, V41, P50, DOI 10.1111/j.1365-2929.2006.02646.x; Baharvand M, 2011, J DENT EDUC, V75, P1489; Bodger O, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027161; Crossley ML, 2002, BRIT DENT J, V193, P471, DOI 10.1038/sj.bdj.4801599; de Vries E, 2010, SAMJ S AFR MED J, V100, P227, DOI 10.7196/SAMJ.3856; Diderichsen S, 2011, INT J MED EDUC, V2, P140, DOI 10.5116/ijme.4ec5.92b8; Dikici MF, 2008, CROAT MED J, V49, P415, DOI 10.3325/cmj.2008.3.415; Diwan V, 2013, BMC MED EDUC, V13, DOI 10.1186/1472-6920-13-127; Draper C, 2007, MED TEACH, V29, pE100, DOI 10.1080/01421590701481359; Drinkwater J, 2008, MED EDUC, V42, P420, DOI 10.1111/j.1365-2923.2008.03031.x; Fayers PM, 2007, QUALITY LIFE ASSESSM; Ferrinho P, 2011, HUM RESOUR HEALTH, V9, DOI 10.1186/1478-4491-9-9; Gadit Amin A Muhammad, 2008, J Pak Med Assoc, V58, P342; Greenhalgh T, 2004, BRIT MED J, V328, P1541, DOI 10.1136/bmj.328.7455.1541; Hair J., 1995, MULTIVAR DATA ANAL, P373; HARTH SC, 1990, MED EDUC, V24, P488, DOI 10.1111/j.1365-2923.1990.tb02664.x; Hazarika Indrajit, 2013, WHO South East Asia J Public Health, V2, P106, DOI 10.4103/2224-3151.122944; Heiligers PJM, 2012, BMC MED EDUC, V12, DOI 10.1186/1472-6920-12-82; Heritage B, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092879; Jenkins R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009049; KAISER HF, 1974, PSYCHOMETRIKA, V39, P31, DOI 10.1007/BF02291575; KAISER HF, 1960, EDUC PSYCHOL MEAS, V20, P141, DOI 10.1177/001316446002000116; Kuriakose S., 2015, J EVID BASED MED HEA, V2, P206, DOI [10.18410/jebmh/2015/28, DOI 10.18410/JEBMH/2015/28]; Kusurkar RA, 2011, MED TEACH, V33, pE242, DOI 10.3109/0142159X.2011.558539; Kusurkar R, 2011, ADV HEALTH SCI EDUC, V16, P183, DOI 10.1007/s10459-010-9253-4; Leach CW, 2008, J PERS SOC PSYCHOL, V95, P144, DOI 10.1037/0022-3514.95.1.144; LYNN MR, 1986, NURS RES, V35, P382; MacCallum RC, 1999, PSYCHOL METHODS, V4, P84, DOI 10.1037/1082-989x.4.1.84; Mandeville KL, 2012, HUM RESOUR HEALTH, V10, DOI 10.1186/1478-4491-10-29; McManus I C, 2006, BMC Med Educ, V6, P11, DOI 10.1186/1472-6920-6-11; Millan Luiz Roberto, 2005, Clinics, V60, P143, DOI 10.1590/S1807-59322005000200011; Nath A., 2007, INDIAN J COMMUNITY M, V32, P217, DOI [10.4103/0970-0218.36835, DOI 10.4103/0970-0218.36835]; Nieuwhof MGH, 2004, MED ED ONLINE, V9, P16; Perara KM, 1981, INDIAN J MED ED, V20, P68; Puljak L, 2007, MED TEACH, V29, pE227, DOI 10.1080/01421590701551714; Rao M, 2011, LANCET, V377, P587, DOI 10.1016/S0140-6736(10)61888-0; Razali SM, 1996, MED EDUC, V30, P418, DOI 10.1111/j.1365-2923.1996.tb00861.x; Schaufeli WB, 2002, J CROSS CULT PSYCHOL, V33, P464, DOI 10.1177/0022022102033005003; Schumacker R.E., 2010, BEGINNERS GUIDE STRU, V3rd ed.; Shah S., WHY STUDENTS WANT JO; Shahab F, 2011, J PAK MED ASSOC, V61, P832; Sharma S., 1996, APPL MULTIVARIATE TE; Syed NA, 2008, MED EDUC, V42, P61, DOI 10.1111/j.1365-2923.2007.02904.x; Talati JJ, 2006, ACAD MED, V81, pS55, DOI 10.1097/01.ACM.0000243543.99794.07; Terwee CB, 2007, J CLIN EPIDEMIOL, V60, P34, DOI 10.1016/j.jclinepi.2006.03.012; Vahid Dastjerdi Marzieh, 2012, Acta Med Iran, V50, P417; VALLERAND RJ, 1992, EDUC PSYCHOL MEAS, V52, P1003, DOI 10.1177/0013164492052004025; VALLERAND RJ, 1989, CAN J BEHAV SCI, V21, P323, DOI 10.1037/h0079855; VALLERAND RJ, 1993, EDUC PSYCHOL MEAS, V53, P159, DOI 10.1177/0013164493053001018; Vujicic Marko, 2004, Hum Resour Health, V2, P3, DOI 10.1186/1478-4491-2-3	58	7	7	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2016	11	12							e0164581	10.1371/journal.pone.0164581	http://dx.doi.org/10.1371/journal.pone.0164581			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EI9QF	27997928	Green Published, Green Submitted, gold, Green Accepted			2022-12-27	WOS:000392842900002
J	Steiniger, BS; Stachniss, V; Wilhelmi, V; Seiler, A; Lampp, K; Neff, A; Guthe, M; Lobachev, O				Steiniger, Birte S.; Stachniss, Vitus; Wilhelmi, Verena; Seiler, Anja; Lampp, Katrin; Neff, Andreas; Guthe, Michael; Lobachev, Oleg			Three-Dimensional Arrangement of Human Bone Marrow Microvessels Revealed by Immunohistology in Undecalcified Sections	PLOS ONE			English	Article							HEMATOPOIETIC STEM; CELLS; NICHES; ANGIOGENESIS; DENSITY; MEMORY	The arrangement of microvessels in human bone marrow is so far unknown. We combined monoclonal antibodies against CD34 and against CD141 to visualise all microvessel endothelia in 21 serial sections of about 1 cm(2) size derived from a human iliac crest. The specimen was not decalcified and embedded in Technovit (R) 9100. In different regions of interest, the microvasculature was reconstructed in three dimensions using automatic methods. The three-dimensional models were subject to a rigid semiautomatic and manual quality control. In iliac crest bone marrow, the adipose tissue harbours irregularly distributed haematopoietic areas. These are fed by networks of large sinuses, which are loosely connected to networks of small capillaries prevailing in areas of pure adipose tissue. Our findings are compatible with the hypothesis that capillaries and sinuses in human iliac crest bone marrow are partially arranged in parallel.	[Steiniger, Birte S.; Wilhelmi, Verena; Seiler, Anja; Lampp, Katrin] Univ Marburg, Inst Anat & Cell Biol, Dept Immunobiol, Marburg, Germany; [Stachniss, Vitus] Univ Marburg, Histol Lab, Dent Clin, Marburg, Germany; [Neff, Andreas] Marburg Univ Hosp, Dept Oral & Maxillofacial Surg, Marburg, Germany; [Guthe, Michael; Lobachev, Oleg] Univ Bayreuth, Inst Comp Sci, Visual Comp, Bayreuth, Germany	Philipps University Marburg; Philipps University Marburg; University of Bayreuth	Steiniger, BS (corresponding author), Univ Marburg, Inst Anat & Cell Biol, Dept Immunobiol, Marburg, Germany.; Lobachev, O (corresponding author), Univ Bayreuth, Inst Comp Sci, Visual Comp, Bayreuth, Germany.	steinigb@staff.uni-marburg.de; oleg.lobachev@uni-bayreuth.de	Lobachev, Oleg/F-2843-2012	Lobachev, Oleg/0000-0002-7193-6258; Steiniger, Birte/0000-0002-3602-7331	Dental Clinics, Universitat Marburg, Marburg, Germany; German Research Foundation (DFG); University of Marburg; University of Bayreuth	Dental Clinics, Universitat Marburg, Marburg, Germany; German Research Foundation (DFG)(German Research Foundation (DFG)); University of Marburg; University of Bayreuth	Our thanks are due to Prof. Dr. R. Frankenberger, former managing director of the Dental Clinics, Universitat Marburg, Marburg, Germany, for financial support concerning hardware for video editing. Open access publication of this work was funded by the German Research Foundation (DFG), the University of Marburg and the University of Bayreuth.; Our thanks are due to Prof. Dr. R. Frankenberger, former managing director of the Dental Clinics, Universitat Marburg, Marburg, Germany, for financial support concerning hardware for video editing. S. Fischer, former representative of Leica Microsystems, gave decisive advice and technical support with respect to microtomy of hard tissues. U. Schneider, former representative of Heraeus Kulzer, gave technical information for handling of Technovit sections after cutting. Dr. A. Schauss, Dr. S. Iden, and Dr. N. Kladt, CECAD Imaging Facility, Institute of Genetics, Universitat Koln, Cologne, Germany, helped with image acquisition and kindly provided access to the Leica SCN 400 slide scanning microscope. W. Bockler and S. Bubel, Precision Engineering Research Centre, Universitat Marburg, Marburg, Germany, skilfully manufactured the pressure embedding device and further laboratory equipment. Open access publication of this work was funded by the German Research Foundation (DFG), the University of Marburg and the University of Bayreuth.	Acar M, 2015, NATURE, V526, P126, DOI 10.1038/nature15250; Alt H, 2000, HANDBOOK OF COMPUTATIONAL GEOMETRY, P121, DOI 10.1016/B978-044482537-7/50004-8; Boveri E, 2008, BRIT J HAEMATOL, V140, P162, DOI 10.1111/j.1365-2141.2007.06885.x; Bradski G., 2008, LEARNING OPENCV COMP; Cariappa A, 2005, IMMUNITY, V23, P397, DOI 10.1016/j.immuni.2005.09.004; Cassoni P, 2008, J Cell Mol Med, V12, P564, DOI 10.1111/j.1582-4934.2007.00206.x; Cignoni P, 2008, COMPUTING, P129, DOI DOI 10.2312/LOCALCHAPTEREVENTS/ITALCHAP/ITALIANCHAPCONF2008/129-136; Farneback G, 2003, LECT NOTES COMPUT SC, V2749, P363, DOI 10.1007/3-540-45103-x_50; Fedorov A, 2012, MAGN RESON IMAGING, V30, P1323, DOI 10.1016/j.mri.2012.05.001; Gijtenbeek J. M. M., 2005, Angiogenesis, V8, P297; Gilhuis H. Jacobus, 2006, Angiogenesis, V9, P201, DOI 10.1007/s10456-006-9054-9; Gur-Cohen S, 2015, NAT MED, V21, P1307, DOI 10.1038/nm.3960; Hooper AT, 2009, CELL STEM CELL, V4, P263, DOI 10.1016/j.stem.2009.01.006; Iones A, 2003, IEEE COMPUT GRAPH, V23, P54, DOI 10.1109/MCG.2003.1198263; Itkin T, 2016, NATURE, V532, P323, DOI 10.1038/nature17624; Ju T, 2004, ACM T GRAPHIC, V23, P888, DOI 10.1145/1015706.1015815; Kiel MJ, 2008, NAT REV IMMUNOL, V8, P290, DOI 10.1038/nri2279; Kopp HG, 2009, ANN NY ACAD SCI, V1176, P47, DOI 10.1111/j.1749-6632.2009.04964.x; Kunisaki Y, 2013, NATURE, V502, P637, DOI 10.1038/nature12612; Kusumbe AP, 2016, NATURE, V532, P380, DOI 10.1038/nature17638; Kusumbe AP, 2014, NATURE, V507, P323, DOI 10.1038/nature13145; Kvasnicka HM, 2004, HISTOL HISTOPATHOL, V19, P1245, DOI 10.14670/HH-19.1245; Li XM, 2009, CIRCULATION, V120, P1910, DOI 10.1161/CIRCULATIONAHA.109.871574; Lo Celso C, 2009, NATURE, V457, P92, DOI 10.1038/nature07434; Lobachev O, 2016, MED IMAGE A IN PRESS; Lorensen W.E., 1987, ACM SIGGRAPH COMPUTE, V21, P163, DOI [DOI 10.1145/37402.37422, 10.1145/37401.37422]; Meixlsperger S, 2013, BLOOD, V121, P5034, DOI 10.1182/blood-2012-12-473413; Mercier FE, 2012, NAT REV IMMUNOL, V12, P49, DOI 10.1038/nri3132; Negaard HFS, 2009, LEUKEMIA, V23, P162, DOI 10.1038/leu.2008.255; Nombela-Arrieta C, 2013, NAT CELL BIOL, V15, P533, DOI 10.1038/ncb2730; Panteli K, 2005, ACTA HAEMATOL-BASEL, V114, P99, DOI 10.1159/000086583; Schmidt R, 2013, IEEE COMPUT GRAPH, V33, P26, DOI 10.1109/MCG.2013.90; Shapira L, 2008, VISUAL COMPUT, V24, P249, DOI 10.1007/s00371-007-0197-5; Sipkins DA, 2005, NATURE, V435, P969, DOI 10.1038/nature03703; Steiniger BS, 2013, CELLS TISSUES ORGANS, V198, P57, DOI 10.1159/000351608; Takaku T, 2010, BLOOD, V116, pE41, DOI 10.1182/blood-2010-02-268466; Taubin G., 1995, Computer Graphics Proceedings. SIGGRAPH 95, P351, DOI 10.1145/218380.218473; Tokoyoda K, 2010, NAT REV IMMUNOL, V10, P193, DOI 10.1038/nri2727; Tokoyoda K, 2009, IMMUNITY, V30, P721, DOI 10.1016/j.immuni.2009.03.015; Ulrich C., 2014, P 4 EUROGRAPHICS WOR, P69, DOI DOI 10.2312/VCBM.20141185; Willbold E, 2010, ACTA BIOMATER, V6, P4447, DOI 10.1016/j.actbio.2010.06.022; Yang R, 2003, Eur Cell Mater, V6, P57; Zehentmeier S, 2014, EUR J IMMUNOL, V44, P2306, DOI 10.1002/eji.201344313	43	5	5	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 20	2016	11	12							e0168173	10.1371/journal.pone.0168173	http://dx.doi.org/10.1371/journal.pone.0168173			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI9QF	27997569	gold, Green Published, Green Submitted			2022-12-27	WOS:000392842900024
